id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
145717901|NCT00603304|525483064|FG000|Overall Study|Lost to Follow-up|5|||
145717902|NCT00603304|525483065|FG001|Overall Study|Lost to Follow-up|7|||
145717903|NCT00603304|525483064|FG000|Overall Study|Withdrawal by Subject|8|||
145717904|NCT00603304|525483065|FG001|Overall Study|Withdrawal by Subject|5|||
145717905|NCT00603304|525483064|FG000|Overall Study|Protocol Violation|1|||
145717906|NCT00603304|525483065|FG001|Overall Study|Protocol Violation|0|||
145717907|NCT00603304|525483064|FG000|Overall Study|Adverse Event|4|||
145717908|NCT00603304|525483065|FG001|Overall Study|Adverse Event|2|||
145717909|NCT00603304|525483064|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
145717910|NCT00603304|525483065|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
145717911|NCT00603304|525483064|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
145717912|NCT00603304|525483065|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
145717913|NCT00603304|525483064|FG000|Overall Study|Exclusionary Medication|2|||
145717914|NCT00603304|525483065|FG001|Overall Study|Exclusionary Medication|3|||
145717915|NCT00603304|525483064|FG000|Overall Study|Non-Compliant|0|||
145717916|NCT00603304|525483065|FG001|Overall Study|Non-Compliant|1|||
145717917|NCT00603304|525483064|FG000|Overall Study|Moved Away|0|||
145717918|NCT00603304|525483065|FG001|Overall Study|Moved Away|2|||
145717919|NCT00603304|525483064|FG000|Overall Study|Other|2|||
145717920|NCT00603304|525483065|FG001|Overall Study|Other|0|||
145717921|NCT00603304|525483064|FG000|Overall Study|Patient Decision|2|||
145717922|NCT00603304|525483065|FG001|Overall Study|Patient Decision|0|||
145717923|NCT01076192|525483066|FG000|Overall Study|Other|197|||
145717924|NCT01034176|525483067|FG000|Overall Study|Physician Decision|2|||
145717925|NCT01034176|525483068|FG001|Overall Study|Physician Decision|0|||
145717926|NCT01034176|525483067|FG000|Overall Study|Withdrawal by Subject|0|||
145717927|NCT01034176|525483068|FG001|Overall Study|Withdrawal by Subject|1|||
145717928|NCT01034176|525483067|FG000|Overall Study|Lost to Follow-up|0|||
145717929|NCT01034176|525483068|FG001|Overall Study|Lost to Follow-up|1|||
145717930|NCT05087979|525483071|FG000|Overall Study|Converted to general anesthesia|1|||
145717931|NCT05087979|525483072|FG001|Overall Study|Converted to general anesthesia|0|||
145717932|NCT00616902|525483073|FG000|Overall Study|Termination of study|6|||
145717933|NCT00616902|525483074|FG001|Overall Study|Termination of study|6|||
145717934|NCT02680002|525483076|FG000|Overall Study|Lost to Follow-up|5|||
145717935|NCT02680002|525483077|FG001|Overall Study|Lost to Follow-up|1|||
145378792|NCT01709864|524239335|FG000|Overall Study|Physician Decision|0|||
145378793|NCT01709864|524239336|FG001|Overall Study|Physician Decision|1|||
145378794|NCT01709864|524239335|FG000|Overall Study|subject/guardian decision|5|||
145378795|NCT01709864|524239336|FG001|Overall Study|subject/guardian decision|6|||
145378796|NCT01709864|524239335|FG000|Overall Study|Lost to Follow-up|1|||
145717936|NCT02680002|525483078|FG002|Overall Study|Lost to Follow-up|4|||
145717937|NCT02680002|525483079|FG003|Overall Study|Lost to Follow-up|2|||
145717938|NCT02680002|525483080|FG004|Overall Study|Lost to Follow-up|0|||
145717939|NCT02680002|525483081|FG005|Overall Study|Lost to Follow-up|2|||
145717940|NCT02680002|525483076|FG000|Overall Study|Physician Decision|5|||
145717941|NCT02680002|525483077|FG001|Overall Study|Physician Decision|1|||
145717942|NCT02680002|525483078|FG002|Overall Study|Physician Decision|1|||
145717943|NCT02680002|525483079|FG003|Overall Study|Physician Decision|1|||
145717944|NCT02680002|525483080|FG004|Overall Study|Physician Decision|1|||
145717945|NCT02680002|525483081|FG005|Overall Study|Physician Decision|1|||
145717946|NCT02680002|525483076|FG000|Overall Study|Protocol Violation|1|||
145717947|NCT02680002|525483077|FG001|Overall Study|Protocol Violation|0|||
145717948|NCT02680002|525483078|FG002|Overall Study|Protocol Violation|1|||
145717949|NCT02680002|525483079|FG003|Overall Study|Protocol Violation|0|||
145717950|NCT02680002|525483080|FG004|Overall Study|Protocol Violation|1|||
145717951|NCT02680002|525483081|FG005|Overall Study|Protocol Violation|2|||
145717952|NCT02680002|525483076|FG000|Overall Study|Withdrawal by Subject|0|||
145717953|NCT02680002|525483077|FG001|Overall Study|Withdrawal by Subject|0|||
145717954|NCT02680002|525483078|FG002|Overall Study|Withdrawal by Subject|1|||
145717955|NCT02680002|525483079|FG003|Overall Study|Withdrawal by Subject|0|||
145717956|NCT02680002|525483080|FG004|Overall Study|Withdrawal by Subject|2|||
145717957|NCT02680002|525483081|FG005|Overall Study|Withdrawal by Subject|2|||
145717958|NCT02680002|525483076|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
145717959|NCT02680002|525483077|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
145717960|NCT02680002|525483078|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
145717961|NCT02680002|525483079|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
145717962|NCT02680002|525483080|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
145717963|NCT02680002|525483081|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
145717964|NCT02680002|525483076|FG000|Overall Study|Other|0|||
145717965|NCT02680002|525483077|FG001|Overall Study|Other|1|||
145717966|NCT02680002|525483078|FG002|Overall Study|Other|0|||
145717967|NCT02680002|525483079|FG003|Overall Study|Other|0|||
145717968|NCT02680002|525483080|FG004|Overall Study|Other|1|||
145717969|NCT02680002|525483081|FG005|Overall Study|Other|0|||
145265485|NCT01422876|523821393|FG000|Week 24|Lost to Follow-up|1|||
145717970|NCT02680002|525483076|FG000|Overall Study|Adverse Event|0|||
145717971|NCT02680002|525483077|FG001|Overall Study|Adverse Event|0|||
145717972|NCT02680002|525483078|FG002|Overall Study|Adverse Event|0|||
145717973|NCT02680002|525483079|FG003|Overall Study|Adverse Event|0|||
145717974|NCT02680002|525483080|FG004|Overall Study|Adverse Event|1|||
145717975|NCT02680002|525483081|FG005|Overall Study|Adverse Event|2|||
145717976|NCT00705679|525483082|FG000|Overall Study|Adverse Event|1|||
145717977|NCT00705679|525483083|FG001|Overall Study|Adverse Event|1|||
145717978|NCT00705679|525483084|FG002|Overall Study|Adverse Event|0|||
145717979|NCT00705679|525483085|FG003|Overall Study|Adverse Event|0|||
145717980|NCT00705679|525483086|FG004|Overall Study|Adverse Event|0|||
145717981|NCT00705679|525483082|FG000|Overall Study|Death|0|||
145717982|NCT00705679|525483083|FG001|Overall Study|Death|0|||
145717983|NCT00705679|525483084|FG002|Overall Study|Death|3|||
145717984|NCT00705679|525483085|FG003|Overall Study|Death|2|||
145717985|NCT00705679|525483086|FG004|Overall Study|Death|1|||
145717986|NCT00705679|525483082|FG000|Overall Study|Lost to Follow-up|32|||
145717987|NCT00705679|525483083|FG001|Overall Study|Lost to Follow-up|60|||
145717988|NCT00705679|525483084|FG002|Overall Study|Lost to Follow-up|44|||
145717989|NCT00705679|525483085|FG003|Overall Study|Lost to Follow-up|30|||
145717990|NCT00705679|525483086|FG004|Overall Study|Lost to Follow-up|35|||
145717991|NCT00705679|525483082|FG000|Overall Study|Physician Decision|0|||
145717992|NCT00705679|525483083|FG001|Overall Study|Physician Decision|1|||
145717993|NCT00705679|525483084|FG002|Overall Study|Physician Decision|0|||
145717994|NCT00705679|525483085|FG003|Overall Study|Physician Decision|1|||
145717995|NCT00705679|525483086|FG004|Overall Study|Physician Decision|0|||
145717996|NCT00705679|525483082|FG000|Overall Study|Withdrawal by Subject|32|||
145717997|NCT00705679|525483083|FG001|Overall Study|Withdrawal by Subject|77|||
145717998|NCT00705679|525483084|FG002|Overall Study|Withdrawal by Subject|68|||
145717999|NCT00705679|525483085|FG003|Overall Study|Withdrawal by Subject|47|||
145718000|NCT00705679|525483086|FG004|Overall Study|Withdrawal by Subject|33|||
145718001|NCT00759915|525483087|FG000|Overall Study|Withdrawal by Subject|1|||
145718002|NCT00759915|525483088|FG001|Overall Study|Withdrawal by Subject|0|||
145718003|NCT00759915|525483087|FG000|Overall Study|Adverse Event|0|||
145718004|NCT00759915|525483088|FG001|Overall Study|Adverse Event|1|||
145718005|NCT03527173|525483089|FG000|Overall Study|Lost to Follow-up|4|||
145718006|NCT03527173|525483090|FG001|Overall Study|Lost to Follow-up|2|||
145718007|NCT03527173|525483089|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
145718008|NCT03527173|525483090|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
145718009|NCT03527173|525483089|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145718010|NCT03527173|525483090|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
145718011|NCT03527173|525483089|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145718012|NCT03527173|525483090|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145718013|NCT03730480|525483093|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
145718014|NCT01248780|525483094|FG000|Overall Study|Lack of Efficacy|2|||
145718015|NCT01248780|525483095|FG001|Overall Study|Lack of Efficacy|0|||
145718016|NCT01248780|525483094|FG000|Overall Study|Lost to Follow-up|0|||
145718017|NCT01248780|525483095|FG001|Overall Study|Lost to Follow-up|1|||
145718018|NCT01248780|525483094|FG000|Overall Study|Death|0|||
145718019|NCT01248780|525483095|FG001|Overall Study|Death|1|||
145718020|NCT01248780|525483094|FG000|Overall Study|Adverse Event|2|||
145718021|NCT01248780|525483095|FG001|Overall Study|Adverse Event|7|||
145718022|NCT01248780|525483094|FG000|Overall Study|Protocol Violation|1|||
145718023|NCT01248780|525483095|FG001|Overall Study|Protocol Violation|1|||
145718024|NCT01248780|525483094|FG000|Overall Study|Withdrawal by Subject|4|||
145718025|NCT01248780|525483095|FG001|Overall Study|Withdrawal by Subject|4|||
145718026|NCT01248780|525483094|FG000|Overall Study|Not treated|0|||
145718027|NCT01248780|525483095|FG001|Overall Study|Not treated|1|||
145718028|NCT01664598|525483096|FG000|Overall Study|Sponsor Decision|1|||
145718029|NCT01664598|525483096|FG000|Overall Study|Withdrawal of Informed Consent|4|||
145718030|NCT01664598|525483096|FG000|Overall Study|Adverse Event|1|||
145718031|NCT03245151|525483097|FG000|Overall Study|Withdrawal by Subject|2|||
145718032|NCT03245151|525483098|FG001|Overall Study|Withdrawal by Subject|0|||
145718033|NCT03245151|525483099|FG002|Overall Study|Withdrawal by Subject|0|||
145718034|NCT03245151|525483100|FG003|Overall Study|Withdrawal by Subject|2|||
145718035|NCT03245151|525483101|FG004|Overall Study|Withdrawal by Subject|1|||
145718036|NCT03245151|525483097|FG000|Overall Study|Death|3|||
145718037|NCT03245151|525483098|FG001|Overall Study|Death|14|||
145718038|NCT03245151|525483099|FG002|Overall Study|Death|9|||
145718039|NCT03245151|525483100|FG003|Overall Study|Death|16|||
145718040|NCT03245151|525483101|FG004|Overall Study|Death|7|||
145718041|NCT03245151|525483097|FG000|Overall Study|Sponsor's decision|0|||
145718042|NCT03245151|525483098|FG001|Overall Study|Sponsor's decision|1|||
145718043|NCT03245151|525483099|FG002|Overall Study|Sponsor's decision|0|||
145718044|NCT03245151|525483100|FG003|Overall Study|Sponsor's decision|0|||
145718045|NCT03245151|525483101|FG004|Overall Study|Sponsor's decision|0|||
145718046|NCT00768079|525483110|FG000|Overall Study|Lost to Follow-up|2|||
145718047|NCT00768079|525483111|FG001|Overall Study|Lost to Follow-up|0|||
145718048|NCT00768079|525483112|FG002|Overall Study|Lost to Follow-up|4|||
145718049|NCT00768079|525483110|FG000|Overall Study|Participant incarcerated|0|||
145718050|NCT00768079|525483111|FG001|Overall Study|Participant incarcerated|1|||
145718051|NCT00768079|525483112|FG002|Overall Study|Participant incarcerated|0|||
145718052|NCT03212989|525483114|FG000|Overall Study|Physician Decision|8|||
145718053|NCT02057523|525483116|FG000|Overall Study|Withdrawal by Subject|1|||
145718054|NCT02057523|525483116|FG000|Overall Study|Lack of Efficacy|1|||
145718055|NCT03047395|525483117|FG000|Overall Study|Adverse Event|142|||
145718056|NCT03047395|525483117|FG000|Overall Study|Withdrawal by Subject|155|||
145718057|NCT03047395|525483117|FG000|Overall Study|Lost to Follow-up|144|||
145718058|NCT03047395|525483117|FG000|Overall Study|COVID-19 Infection|2|||
145718059|NCT03047395|525483117|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
145718060|NCT03047395|525483117|FG000|Overall Study|Other, Not Specified|117|||
145265486|NCT01422876|523821394|FG001|Week 24|Lost to Follow-up|1|||
145265487|NCT01422876|523821395|FG002|Week 24|Lost to Follow-up|2|||
145265488|NCT01422876|523821396|FG003|Week 24|Lost to Follow-up|4|||
145265489|NCT01422876|523821397|FG004|Week 24|Lost to Follow-up|2|||
145265490|NCT01422876|523821398|FG005|Week 24|Lost to Follow-up|0|||
145265491|NCT01422876|523821399|FG006|Week 24|Lost to Follow-up|1|||
145265492|NCT01422876|523821400|FG007|Week 24|Lost to Follow-up|3|||
145265493|NCT01422876|523821401|FG008|Week 24|Lost to Follow-up|3|||
145265494|NCT01422876|523821402|FG009|Week 24|Lost to Follow-up|4|||
145265495|NCT01422876|523821393|FG000|Week 24|Consent withdrawn|5|||
145265496|NCT01422876|523821394|FG001|Week 24|Consent withdrawn|1|||
145265497|NCT01422876|523821395|FG002|Week 24|Consent withdrawn|3|||
145265498|NCT01422876|523821396|FG003|Week 24|Consent withdrawn|4|||
145265499|NCT01422876|523821397|FG004|Week 24|Consent withdrawn|5|||
145265500|NCT01422876|523821398|FG005|Week 24|Consent withdrawn|6|||
145265501|NCT01422876|523821399|FG006|Week 24|Consent withdrawn|5|||
145265502|NCT01422876|523821400|FG007|Week 24|Consent withdrawn|4|||
145265503|NCT01422876|523821401|FG008|Week 24|Consent withdrawn|3|||
145265504|NCT01422876|523821402|FG009|Week 24|Consent withdrawn|6|||
145265505|NCT01422876|523821393|FG000|Week 24|Death|0|||
145265506|NCT01422876|523821394|FG001|Week 24|Death|1|||
145265507|NCT01422876|523821395|FG002|Week 24|Death|0|||
145265508|NCT01422876|523821396|FG003|Week 24|Death|0|||
145265509|NCT01422876|523821397|FG004|Week 24|Death|0|||
145265510|NCT01422876|523821398|FG005|Week 24|Death|0|||
145265511|NCT01422876|523821399|FG006|Week 24|Death|0|||
145265512|NCT01422876|523821400|FG007|Week 24|Death|0|||
145265513|NCT01422876|523821401|FG008|Week 24|Death|0|||
145265514|NCT01422876|523821402|FG009|Week 24|Death|0|||
145265515|NCT01422876|523821393|FG000|Week 52|Lost to Follow-up|3|||
145265516|NCT01422876|523821394|FG001|Week 52|Lost to Follow-up|5|||
145265517|NCT01422876|523821395|FG002|Week 52|Lost to Follow-up|7|||
145265518|NCT01422876|523821396|FG003|Week 52|Lost to Follow-up|5|||
145265519|NCT01422876|523821397|FG004|Week 52|Lost to Follow-up|8|||
145265520|NCT01422876|523821398|FG005|Week 52|Lost to Follow-up|5|||
145265521|NCT01422876|523821399|FG006|Week 52|Lost to Follow-up|5|||
145265522|NCT01422876|523821400|FG007|Week 52|Lost to Follow-up|8|||
145265523|NCT01422876|523821401|FG008|Week 52|Lost to Follow-up|7|||
145265524|NCT01422876|523821402|FG009|Week 52|Lost to Follow-up|8|||
145265525|NCT01422876|523821393|FG000|Week 52|Consent withdrawn|9|||
145265526|NCT01422876|523821394|FG001|Week 52|Consent withdrawn|4|||
145265527|NCT01422876|523821395|FG002|Week 52|Consent withdrawn|6|||
145265528|NCT01422876|523821396|FG003|Week 52|Consent withdrawn|12|||
145265529|NCT01422876|523821397|FG004|Week 52|Consent withdrawn|7|||
145265530|NCT01422876|523821398|FG005|Week 52|Consent withdrawn|12|||
145265531|NCT01422876|523821399|FG006|Week 52|Consent withdrawn|10|||
145265532|NCT01422876|523821400|FG007|Week 52|Consent withdrawn|12|||
145265533|NCT01422876|523821401|FG008|Week 52|Consent withdrawn|13|||
145265534|NCT01422876|523821402|FG009|Week 52|Consent withdrawn|9|||
145265535|NCT01422876|523821393|FG000|Week 52|Death|0|||
145265536|NCT01422876|523821394|FG001|Week 52|Death|1|||
145265537|NCT01422876|523821395|FG002|Week 52|Death|0|||
145265538|NCT01422876|523821396|FG003|Week 52|Death|1|||
145265539|NCT01422876|523821397|FG004|Week 52|Death|0|||
145265540|NCT01422876|523821398|FG005|Week 52|Death|0|||
145265541|NCT01422876|523821399|FG006|Week 52|Death|1|||
145265542|NCT01422876|523821400|FG007|Week 52|Death|3|||
145265543|NCT01422876|523821401|FG008|Week 52|Death|1|||
145265544|NCT01422876|523821402|FG009|Week 52|Death|0|||
145265545|NCT00536991|523821403|FG000|Overall Study|Withdrawal by Subject|10|||
145265546|NCT00536991|523821403|FG000|Overall Study|Physician Decision|1|||
145265547|NCT00536991|523821403|FG000|Overall Study|patient ineligible|2|||
145718061|NCT01871805|525483124|FG000|Phase I|Death|7|||
145718062|NCT01871805|525483125|FG001|Phase I|Death|4|||
145265548|NCT00054639|523821404|FG000|Overall Study|Lack of Efficacy|1|||
145265549|NCT00054639|523821404|FG000|Overall Study|Physician Decision|1|||
145265550|NCT01600755|523821405|FG000|Overall Study|Withdrawal by Subject|6|||
145265551|NCT01548573|523821410|FG000|Overall Study|Death|3|||
145265552|NCT01548573|523821410|FG000|Overall Study|Withdrawal by Subject|2|||
145265553|NCT01366846|523821411|FG000|Overall Study|Withdrawal by Subject|2|||
145265554|NCT01366846|523821412|FG001|Overall Study|Withdrawal by Subject|0|||
145265555|NCT01366846|523821413|FG002|Overall Study|Withdrawal by Subject|0|||
145265556|NCT01366846|523821414|FG003|Overall Study|Withdrawal by Subject|0|||
145265557|NCT01366846|523821411|FG000|Overall Study|Communication Difficulties|1|||
145265558|NCT01366846|523821412|FG001|Overall Study|Communication Difficulties|4|||
145265559|NCT01366846|523821413|FG002|Overall Study|Communication Difficulties|0|||
145265560|NCT01366846|523821414|FG003|Overall Study|Communication Difficulties|1|||
145265561|NCT01366846|523821411|FG000|Overall Study|Scheduling Conflicts|0|||
145718063|NCT01871805|525483126|FG002|Phase I|Death|6|||
145265562|NCT01366846|523821412|FG001|Overall Study|Scheduling Conflicts|0|||
145265563|NCT01366846|523821413|FG002|Overall Study|Scheduling Conflicts|1|||
145265564|NCT01366846|523821414|FG003|Overall Study|Scheduling Conflicts|0|||
145265565|NCT00290511|523821420|FG000|Overall Study|Adverse Event|1|||
145265566|NCT00290511|523821420|FG000|Overall Study|Death|1|||
145265567|NCT00290511|523821420|FG000|Overall Study|Physician Decision|1|||
145265568|NCT00290511|523821420|FG000|Overall Study|Withdrawal by Subject|1|||
145265569|NCT00447265|523821421|FG000|Overall Study|Physician Decision|1|||
145265570|NCT00447265|523821422|FG001|Overall Study|Physician Decision|0|||
145265571|NCT02204449|523821425|FG000|Overall Study|Lost to Follow-up|7|||
145265572|NCT02204449|523821426|FG001|Overall Study|Lost to Follow-up|9|||
145265573|NCT02204449|523821425|FG000|Overall Study|Death|0|||
145265574|NCT02204449|523821426|FG001|Overall Study|Death|1|||
145265575|NCT02204449|523821425|FG000|Overall Study|Withdrawal by Subject|0|||
145265576|NCT02204449|523821426|FG001|Overall Study|Withdrawal by Subject|1|||
145265577|NCT01976663|523821430|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
145265578|NCT01976663|523821430|FG000|Overall Study|Personal Reasons|6|||
145265579|NCT01976663|523821430|FG000|Overall Study|Withdrawal by Subject|4|||
145265580|NCT01976663|523821430|FG000|Overall Study|Screen Failure|3|||
145265581|NCT01976663|523821430|FG000|Overall Study|Adverse Event|2|||
145265582|NCT01976663|523821430|FG000|Overall Study|Lost to Follow-up|3|||
145265583|NCT05299359|523821431|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
145265584|NCT05299359|523821432|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
145265585|NCT05299359|523821431|FG000|Main Part: Day 1 up to Day 366|Other|2|||
145265586|NCT05299359|523821432|FG001|Main Part: Day 1 up to Day 366|Other|0|||
145265587|NCT05299359|523821431|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
145265588|NCT05299359|523821432|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
145265589|NCT05299359|523821431|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
145265590|NCT05299359|523821432|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
145265591|NCT05299359|523821431|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
145265592|NCT05299359|523821432|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
145265593|NCT05299359|523821431|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
145265594|NCT05299359|523821432|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
145265595|NCT05299359|523821431|FG000|Extension Part: Day 1 to Day 366|Other|0|||
145265596|NCT05299359|523821432|FG001|Extension Part: Day 1 to Day 366|Other|1|||
145265597|NCT04780776|523821437|FG000|Titration Week 1-5|Lost to Follow-up|2|||
145265598|NCT04780776|523821438|FG001|Titration Week 1-5|Lost to Follow-up|8|||
145265599|NCT04780776|523821437|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
145265600|NCT04780776|523821438|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
145265601|NCT04780776|523821437|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
145265602|NCT04780776|523821438|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
145265603|NCT03113760|523821439|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
145265604|NCT03113760|523821440|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
145718064|NCT01871805|525483127|FG003|Phase I|Death|2|||
145718065|NCT01871805|525483128|FG004|Phase I|Death|9|||
145718066|NCT01871805|525483129|FG005|Phase I|Death|0|||
145718067|NCT01871805|525483124|FG000|Phase I|Alive in Survival Follow-up|0|||
145718068|NCT01871805|525483125|FG001|Phase I|Alive in Survival Follow-up|2|||
145718069|NCT01871805|525483126|FG002|Phase I|Alive in Survival Follow-up|4|||
145718070|NCT01871805|525483127|FG003|Phase I|Alive in Survival Follow-up|5|||
145718071|NCT01871805|525483128|FG004|Phase I|Alive in Survival Follow-up|4|||
145718072|NCT01871805|525483129|FG005|Phase I|Alive in Survival Follow-up|0|||
145718073|NCT01871805|525483124|FG000|Phase I|Lost to Follow-up|0|||
145718074|NCT01871805|525483125|FG001|Phase I|Lost to Follow-up|1|||
145718075|NCT01871805|525483126|FG002|Phase I|Lost to Follow-up|3|||
145718076|NCT01871805|525483127|FG003|Phase I|Lost to Follow-up|0|||
145718077|NCT01871805|525483128|FG004|Phase I|Lost to Follow-up|0|||
145718078|NCT01871805|525483129|FG005|Phase I|Lost to Follow-up|0|||
145718079|NCT01871805|525483124|FG000|Phase II|Death|0|||
145718080|NCT01871805|525483125|FG001|Phase II|Death|0|||
145718081|NCT01871805|525483126|FG002|Phase II|Death|0|||
145718082|NCT01871805|525483127|FG003|Phase II|Death|0|||
145718083|NCT01871805|525483128|FG004|Phase II|Death|0|||
145718084|NCT01871805|525483129|FG005|Phase II|Death|45|||
145718085|NCT01871805|525483124|FG000|Phase II|Alive in Survival Follow-up|0|||
145718086|NCT01871805|525483125|FG001|Phase II|Alive in Survival Follow-up|0|||
145718087|NCT01871805|525483126|FG002|Phase II|Alive in Survival Follow-up|0|||
145718088|NCT01871805|525483127|FG003|Phase II|Alive in Survival Follow-up|0|||
145265605|NCT03113760|523821441|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
145265606|NCT03113760|523821442|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
145265607|NCT03113760|523821439|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
145718089|NCT01871805|525483128|FG004|Phase II|Alive in Survival Follow-up|0|||
145718090|NCT01871805|525483129|FG005|Phase II|Alive in Survival Follow-up|29|||
145718091|NCT01871805|525483124|FG000|Phase II|Lost to Follow-up|0|||
145718092|NCT01871805|525483125|FG001|Phase II|Lost to Follow-up|0|||
145718093|NCT01871805|525483126|FG002|Phase II|Lost to Follow-up|0|||
145718094|NCT01871805|525483127|FG003|Phase II|Lost to Follow-up|0|||
145265608|NCT03113760|523821440|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
145265609|NCT03113760|523821441|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
145265610|NCT03113760|523821442|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
145265611|NCT03113760|523821439|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
145265612|NCT03113760|523821440|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
145265613|NCT03113760|523821441|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
145265614|NCT03113760|523821442|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
145265615|NCT02506101|523821445|FG000|Overall Study|Transportation issues|1|||
145265616|NCT02506101|523821446|FG001|Overall Study|Transportation issues|0|||
145265617|NCT02506101|523821445|FG000|Overall Study|No enrollment and staff unavailability|1|||
145265618|NCT02506101|523821446|FG001|Overall Study|No enrollment and staff unavailability|0|||
145265619|NCT01151085|523821447|FG000|Overall Study|Lost to Follow-up|31|||
145265620|NCT01151085|523821447|FG000|Overall Study|Protocol Violation|25|||
145265621|NCT01308476|523821448|FG000|Overall Study|Lost to Follow-up|2|||
145265622|NCT01308476|523821449|FG001|Overall Study|Lost to Follow-up|2|||
145265623|NCT01308476|523821448|FG000|Overall Study|Other|1|||
145265624|NCT01308476|523821449|FG001|Overall Study|Other|0|||
145265625|NCT02696382|523821450|FG000|Overall Study|Death|7|||
145265626|NCT02696382|523821451|FG001|Overall Study|Death|2|||
145265627|NCT02696382|523821450|FG000|Overall Study|Withdrawal by Subject|5|||
145265628|NCT02696382|523821451|FG001|Overall Study|Withdrawal by Subject|12|||
145265629|NCT02696382|523821450|FG000|Overall Study|Lost to Follow-up|4|||
145265630|NCT02696382|523821451|FG001|Overall Study|Lost to Follow-up|7|||
145265631|NCT00423137|523821455|FG000|Overall Study|Lost to Follow-up|0|||
145265632|NCT00423137|523821456|FG001|Overall Study|Lost to Follow-up|0|||
145265633|NCT00423137|523821457|FG002|Overall Study|Lost to Follow-up|1|||
145265634|NCT00423137|523821458|FG003|Overall Study|Lost to Follow-up|0|||
145265635|NCT00423137|523821455|FG000|Overall Study|Protocol Violation|0|||
145265636|NCT00423137|523821456|FG001|Overall Study|Protocol Violation|0|||
145265637|NCT00423137|523821457|FG002|Overall Study|Protocol Violation|0|||
145265638|NCT00423137|523821458|FG003|Overall Study|Protocol Violation|1|||
145265639|NCT00423137|523821455|FG000|Overall Study|Adverse Event Study disease worse|1|||
145265640|NCT00423137|523821456|FG001|Overall Study|Adverse Event Study disease worse|0|||
145265641|NCT00423137|523821457|FG002|Overall Study|Adverse Event Study disease worse|3|||
145265642|NCT00423137|523821458|FG003|Overall Study|Adverse Event Study disease worse|1|||
145265643|NCT00423137|523821455|FG000|Overall Study|Adverse Event Other|0|||
145265644|NCT00423137|523821456|FG001|Overall Study|Adverse Event Other|0|||
145265645|NCT00423137|523821457|FG002|Overall Study|Adverse Event Other|2|||
145265646|NCT00423137|523821458|FG003|Overall Study|Adverse Event Other|0|||
145265647|NCT03246152|523821459|FG000|Overall Study|Lost to Follow-up|2|||
145265648|NCT03246152|523821459|FG000|Overall Study|Protocol Violation|1|||
145265649|NCT01243762|523821461|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
145265650|NCT01243762|523821462|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
145265651|NCT01243762|523821463|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
145265652|NCT01243762|523821464|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
145265653|NCT01243762|523821465|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
145265654|NCT01243762|523821466|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
145265655|NCT01243762|523821467|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
145265656|NCT01243762|523821461|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
145265657|NCT01243762|523821462|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
145265658|NCT01243762|523821463|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
145265659|NCT01243762|523821464|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
145265660|NCT01243762|523821465|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
145265661|NCT01243762|523821466|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
145265662|NCT01243762|523821467|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
145265663|NCT01243762|523821461|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
145378797|NCT01709864|524239336|FG001|Overall Study|Lost to Follow-up|0|||
145718095|NCT01871805|525483128|FG004|Phase II|Lost to Follow-up|0|||
145718096|NCT01871805|525483129|FG005|Phase II|Lost to Follow-up|13|||
145718097|NCT00564889|525483130|FG000|Overall Study|Death|7|||
145718098|NCT00564889|525483130|FG000|Overall Study|Adverse Event|12|||
145718099|NCT00564889|525483130|FG000|Overall Study|Alternative treatment|3|||
145718100|NCT00564889|525483130|FG000|Overall Study|Disease progression|3|||
145718101|NCT00564889|525483130|FG000|Overall Study|Other, not specified|4|||
145718102|NCT00635427|525483131|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
145718103|NCT00635427|525483132|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
145718104|NCT00635427|525483133|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
145718105|NCT00635427|525483134|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
145718106|NCT00635427|525483135|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
145718107|NCT00635427|525483131|FG000|Overall Study|Death|0|||
145718108|NCT00635427|525483132|FG001|Overall Study|Death|0|||
145718109|NCT00635427|525483133|FG002|Overall Study|Death|0|||
145718110|NCT00635427|525483134|FG003|Overall Study|Death|1|||
145718111|NCT00635427|525483135|FG004|Overall Study|Death|0|||
145718112|NCT00635427|525483131|FG000|Overall Study|Termination Of Study By Sponsor|12|||
145718113|NCT00635427|525483132|FG001|Overall Study|Termination Of Study By Sponsor|6|||
145265664|NCT01243762|523821462|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
145265665|NCT01243762|523821463|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
145265666|NCT01243762|523821464|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
145265667|NCT01243762|523821465|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
145265668|NCT01243762|523821466|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
145265669|NCT01243762|523821467|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
145265670|NCT01243762|523821461|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145265671|NCT01243762|523821462|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
145265672|NCT01243762|523821463|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145265673|NCT01243762|523821464|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145718114|NCT00635427|525483133|FG002|Overall Study|Termination Of Study By Sponsor|10|||
145718115|NCT00635427|525483134|FG003|Overall Study|Termination Of Study By Sponsor|6|||
145718116|NCT00635427|525483135|FG004|Overall Study|Termination Of Study By Sponsor|6|||
145718117|NCT00635427|525483131|FG000|Overall Study|Withdrawal Of Consent|0|||
145718118|NCT00635427|525483132|FG001|Overall Study|Withdrawal Of Consent|0|||
145718119|NCT00635427|525483133|FG002|Overall Study|Withdrawal Of Consent|0|||
145718120|NCT00635427|525483134|FG003|Overall Study|Withdrawal Of Consent|2|||
145718121|NCT00635427|525483135|FG004|Overall Study|Withdrawal Of Consent|2|||
145718122|NCT00468104|525483139|FG000|First Intervention|Protocol Violation|2|||
145718123|NCT00468104|525483140|FG001|First Intervention|Protocol Violation|1|||
145718124|NCT00468104|525483139|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
145718125|NCT00468104|525483140|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
145718126|NCT00468104|525483139|FG000|First Intervention|died within 3 weeks|1|||
145718127|NCT00468104|525483140|FG001|First Intervention|died within 3 weeks|0|||
145718128|NCT00468104|525483139|FG000|First Intervention|malposition/blocked chest tube tube|2|||
145718129|NCT00468104|525483140|FG001|First Intervention|malposition/blocked chest tube tube|0|||
145718130|NCT00468104|525483139|FG000|First Intervention|large lung mass with minimal effusion|1|||
145265674|NCT01243762|523821465|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145265675|NCT01243762|523821466|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145265676|NCT01243762|523821467|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
145265677|NCT01243762|523821461|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
145265678|NCT01243762|523821462|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
145265679|NCT01243762|523821463|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
145265680|NCT01243762|523821464|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
145265681|NCT01243762|523821465|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
145265682|NCT01243762|523821466|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
145265683|NCT01243762|523821467|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
145265684|NCT01243762|523821461|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
145265685|NCT01243762|523821462|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
145265686|NCT01243762|523821463|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
145265687|NCT01243762|523821464|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
145718131|NCT00468104|525483140|FG001|First Intervention|large lung mass with minimal effusion|0|||
145265688|NCT01243762|523821465|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
145265689|NCT01243762|523821466|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
145265690|NCT01243762|523821467|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
145265691|NCT01243762|523821461|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
145265692|NCT01243762|523821462|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
145265693|NCT01243762|523821463|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
145265694|NCT01243762|523821464|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
145265695|NCT01243762|523821465|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
145265696|NCT01243762|523821466|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
145265697|NCT01243762|523821467|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
145265698|NCT01243762|523821461|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
145265699|NCT01243762|523821462|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
145265700|NCT01243762|523821463|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
145265701|NCT01243762|523821464|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
145265702|NCT01243762|523821465|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
145265703|NCT01243762|523821466|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
145265704|NCT01243762|523821467|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
145265705|NCT00003526|523821468|FG000|Overall Study|Not evaluable|6|||
145265706|NCT02059265|523821469|FG000|Overall Study|Ineligible|4|||
145265707|NCT04196023|523821470|FG000|Overall Study|Withdrawal by Subject|0|||
145265708|NCT04196023|523821471|FG001|Overall Study|Withdrawal by Subject|1|||
145265709|NCT04196023|523821470|FG000|Overall Study|Adverse Event|3|||
145378798|NCT01709864|524239335|FG000|Overall Study|non-compliance with study treatment|1|||
145718132|NCT00468104|525483139|FG000|First Intervention|associated prolonged pneumothorax|1|||
145265710|NCT04196023|523821471|FG001|Overall Study|Adverse Event|1|||
145265711|NCT04196023|523821470|FG000|Overall Study|Lost to Follow-up|0|||
145265712|NCT04196023|523821471|FG001|Overall Study|Lost to Follow-up|1|||
145265713|NCT03358407|523821476|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265714|NCT03358407|523821477|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265715|NCT03358407|523821478|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
145265716|NCT03358407|523821479|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265717|NCT03358407|523821480|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265718|NCT03358407|523821481|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265719|NCT03358407|523821482|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265720|NCT03358407|523821483|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265721|NCT03358407|523821484|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265722|NCT03358407|523821485|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
145265723|NCT03358407|523821476|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265724|NCT03358407|523821477|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265725|NCT03358407|523821478|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265726|NCT03358407|523821479|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265727|NCT03358407|523821480|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
145265728|NCT03358407|523821481|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265729|NCT03358407|523821482|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265730|NCT03358407|523821483|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265731|NCT03358407|523821484|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265732|NCT03358407|523821485|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265733|NCT03358407|523821476|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265734|NCT03358407|523821477|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265735|NCT03358407|523821478|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265736|NCT03358407|523821479|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265737|NCT03358407|523821480|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265738|NCT03358407|523821481|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
145265739|NCT03358407|523821482|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265740|NCT03358407|523821483|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
145265741|NCT03358407|523821484|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265742|NCT03358407|523821485|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
145265743|NCT03358407|523821476|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265744|NCT03358407|523821477|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265745|NCT03358407|523821478|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265746|NCT03358407|523821479|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265747|NCT03358407|523821480|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265748|NCT03358407|523821481|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
145265749|NCT03358407|523821482|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265750|NCT03358407|523821483|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
145265751|NCT03358407|523821484|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265752|NCT03358407|523821485|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
145265753|NCT03358407|523821476|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265754|NCT03358407|523821477|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265755|NCT03358407|523821478|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265756|NCT03358407|523821479|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265757|NCT03358407|523821480|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265758|NCT03358407|523821481|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
145265759|NCT03358407|523821482|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
145265760|NCT03358407|523821483|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265761|NCT03358407|523821484|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265762|NCT03358407|523821485|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
145265763|NCT03358407|523821476|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265764|NCT03358407|523821477|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265765|NCT03358407|523821478|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265766|NCT03358407|523821479|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265767|NCT03358407|523821480|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265768|NCT03358407|523821481|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
145265769|NCT03358407|523821482|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
145265770|NCT03358407|523821483|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
145265771|NCT03358407|523821484|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265772|NCT03358407|523821485|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
145265773|NCT00483574|523821486|FG000|Overall Study|Adverse Event|6|||
145378799|NCT01709864|524239336|FG001|Overall Study|non-compliance with study treatment|1|||
145265774|NCT00483574|523821487|FG001|Overall Study|Adverse Event|0|||
145265775|NCT00483574|523821486|FG000|Overall Study|Protocol Violation|28|||
145265776|NCT00483574|523821487|FG001|Overall Study|Protocol Violation|9|||
145265777|NCT00483574|523821486|FG000|Overall Study|Lost to Follow-up|16|||
145265778|NCT00483574|523821487|FG001|Overall Study|Lost to Follow-up|4|||
145265779|NCT00483574|523821486|FG000|Overall Study|Withdrawal by Subject|52|||
145265780|NCT00483574|523821487|FG001|Overall Study|Withdrawal by Subject|0|||
145265781|NCT03605758|523821488|FG000|Overall Study|Lost to Follow-up|2|||
145265782|NCT03605758|523821489|FG001|Overall Study|Lost to Follow-up|1|||
145265783|NCT03605758|523821488|FG000|Overall Study|Illness|0|||
145265784|NCT03605758|523821489|FG001|Overall Study|Illness|1|||
145265785|NCT03605758|523821488|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
145265786|NCT03605758|523821489|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
145265787|NCT01748162|523821492|FG000|Overall Study|no additional croup episodes to evaluate|2|||
145265788|NCT01748162|523821493|FG001|Overall Study|no additional croup episodes to evaluate|2|||
145265789|NCT01748162|523821492|FG000|Overall Study|participant consented but did not begin|0|||
145265790|NCT01748162|523821493|FG001|Overall Study|participant consented but did not begin|1|||
145265791|NCT01748162|523821492|FG000|Overall Study|reasons not available|3|||
145265792|NCT01748162|523821493|FG001|Overall Study|reasons not available|2|||
145265793|NCT03841331|523821494|FG000|Overall Study|Withdrawal by Subject|4|||
145265794|NCT03841331|523821495|FG001|Overall Study|Withdrawal by Subject|9|||
145265795|NCT03841331|523821494|FG000|Overall Study|Lost to Follow-up|5|||
145265796|NCT03841331|523821495|FG001|Overall Study|Lost to Follow-up|1|||
145265797|NCT04640168|523821496|FG000|Overall Study|Withdrawal by Subject|8|||
145265798|NCT04640168|523821497|FG001|Overall Study|Withdrawal by Subject|7|||
145265799|NCT04640168|523821496|FG000|Overall Study|Lost to Follow-up|1|||
145265800|NCT04640168|523821497|FG001|Overall Study|Lost to Follow-up|0|||
145265801|NCT04640168|523821496|FG000|Overall Study|Enrolled but not treated|12|||
145265802|NCT04640168|523821497|FG001|Overall Study|Enrolled but not treated|12|||
145265803|NCT00779857|523821498|FG000|Overall Study|Death|1|||
145265804|NCT00779857|523821498|FG000|Overall Study|Withdrawal by Subject|3|||
145265805|NCT00779857|523821498|FG000|Overall Study|Missed Visit|2|||
145265806|NCT00442572|523821506|FG000|Overall Study|Relapse|8|||
145265807|NCT00442572|523821507|FG001|Overall Study|Relapse|1|||
145265808|NCT00442572|523821506|FG000|Overall Study|Lost to Follow-up|0|||
145265809|NCT00442572|523821507|FG001|Overall Study|Lost to Follow-up|1|||
145265810|NCT00442572|523821506|FG000|Overall Study|Withdrawal by Subject|0|||
145265811|NCT00442572|523821507|FG001|Overall Study|Withdrawal by Subject|1|||
145265812|NCT04366258|523821508|FG000|Baseline Assessments|Screen Failure|21|||
145265813|NCT04366258|523821508|FG000|Baseline Assessments|Early Termination|3|||
145265814|NCT03557775|523821509|FG000|Overall Study|Withdrawal by Subject|1|||
145265815|NCT03557775|523821510|FG001|Overall Study|Withdrawal by Subject|2|||
145265816|NCT03557775|523821511|FG002|Overall Study|Withdrawal by Subject|4|||
145265817|NCT03557775|523821509|FG000|Overall Study|Physician Decision|0|||
145265818|NCT03557775|523821510|FG001|Overall Study|Physician Decision|1|||
145265819|NCT03557775|523821511|FG002|Overall Study|Physician Decision|0|||
145265820|NCT00276458|523821518|FG000|Overall Study|Adverse Event|0|||
145265821|NCT00276458|523821519|FG001|Overall Study|Adverse Event|2|||
145265822|NCT00276458|523821518|FG000|Overall Study|Lost to Follow-up|2|||
145265823|NCT00276458|523821519|FG001|Overall Study|Lost to Follow-up|2|||
145265824|NCT00276458|523821518|FG000|Overall Study|Protocol Violation|4|||
145265825|NCT00276458|523821519|FG001|Overall Study|Protocol Violation|3|||
145265826|NCT02940392|523821520|FG000|Overall Study|Lost to Follow-up|3|||
145265827|NCT02940392|523821520|FG000|Overall Study|Retreatment|3|||
145265828|NCT02940392|523821520|FG000|Overall Study|Death|2|||
145265829|NCT03205046|523821522|FG000|Overall Study|Death|10|||
145265830|NCT03205046|523821523|FG001|Overall Study|Death|6|||
145265831|NCT03205046|523821522|FG000|Overall Study|Withdrawal by Subject|1|||
145265832|NCT03205046|523821523|FG001|Overall Study|Withdrawal by Subject|2|||
145265833|NCT03205046|523821522|FG000|Overall Study|Lost to Follow-up|0|||
145265834|NCT03205046|523821523|FG001|Overall Study|Lost to Follow-up|1|||
145265835|NCT03205046|523821522|FG000|Overall Study|Study terminated by sponsor|2|||
145292660|NCT00950807|523922203|FG000|Washout Period 2|Adverse Event|3|||
145292661|NCT00950807|523922204|FG001|Washout Period 2|Adverse Event|0|||
145292662|NCT00950807|523922205|FG002|Washout Period 2|Adverse Event|0|||
145292663|NCT00950807|523922206|FG003|Washout Period 2|Adverse Event|1|||
145292664|NCT00950807|523922207|FG004|Washout Period 2|Adverse Event|0|||
145292665|NCT00950807|523922208|FG005|Washout Period 2|Adverse Event|0|||
145292666|NCT00950807|523922209|FG006|Washout Period 2|Adverse Event|0|||
145292667|NCT00950807|523922210|FG007|Washout Period 2|Adverse Event|0|||
145292668|NCT00950807|523922211|FG008|Washout Period 2|Adverse Event|0|||
145292669|NCT00950807|523922212|FG009|Washout Period 2|Adverse Event|0|||
145292670|NCT00950807|523922203|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145292671|NCT00950807|523922204|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145292672|NCT00950807|523922205|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145292673|NCT00950807|523922206|FG003|Treatment Period 3|Withdrawal by Subject|0|||
145292674|NCT00950807|523922207|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145292675|NCT00950807|523922208|FG005|Treatment Period 3|Withdrawal by Subject|0|||
145265836|NCT03205046|523821523|FG001|Overall Study|Study terminated by sponsor|1|||
145265837|NCT01023815|523821524|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
145265838|NCT01023815|523821525|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
145265839|NCT01023815|523821526|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
145265840|NCT01023815|523821527|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
145265841|NCT01023815|523821524|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
145265842|NCT01023815|523821525|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
145265843|NCT01023815|523821526|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
145265844|NCT01023815|523821527|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
145265845|NCT01023815|523821524|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
145265846|NCT01023815|523821525|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
145265847|NCT01023815|523821526|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
145265848|NCT01023815|523821527|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
145265849|NCT01023815|523821524|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
145265850|NCT01023815|523821525|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
145265851|NCT01023815|523821526|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
145265852|NCT01023815|523821527|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
145265853|NCT01023815|523821524|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
145265854|NCT01023815|523821525|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
145265855|NCT01023815|523821526|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
145265856|NCT01023815|523821527|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
145265857|NCT03253809|523821530|FG000|Overall Study|Unable to obtain study related data|14|||
145265858|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
145265859|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
145265860|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
145265861|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
145265862|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
145265863|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Death|1|||
145265864|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Death|0|||
145265865|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Death|0|||
145265866|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Death|0|||
145265867|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Death|0|||
145265868|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
145265869|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
145265870|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
145265871|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
145265872|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
145265873|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
145265874|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
145265875|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
145265876|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
145265877|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
145265878|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
145265879|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
145265880|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
145265881|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
145265882|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
145265883|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
145265884|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
145265885|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
145265886|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
145265887|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
145265888|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
145265889|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
145265890|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
145265891|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
145265892|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
145265893|NCT00634933|523821534|FG000|Part A: Baseline to Week 24|Other|1|||
145265894|NCT00634933|523821535|FG001|Part A: Baseline to Week 24|Other|8|||
145265895|NCT00634933|523821536|FG002|Part A: Baseline to Week 24|Other|5|||
145265896|NCT00634933|523821537|FG003|Part A: Baseline to Week 24|Other|0|||
145265897|NCT00634933|523821538|FG004|Part A: Baseline to Week 24|Other|0|||
145265898|NCT00634933|523821534|FG000|Between Part A and Part B|Physician Decision|0|||
145265899|NCT00634933|523821535|FG001|Between Part A and Part B|Physician Decision|1|||
145265900|NCT00634933|523821536|FG002|Between Part A and Part B|Physician Decision|0|||
145265901|NCT00634933|523821537|FG003|Between Part A and Part B|Physician Decision|0|||
145265902|NCT00634933|523821538|FG004|Between Part A and Part B|Physician Decision|0|||
145378800|NCT01709864|524239335|FG000|Overall Study|Adverse Event|0|||
145265903|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
145265904|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
145265905|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
145265906|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
145265907|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
145265908|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
145265909|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
145265910|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
145265911|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
145265912|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
145265913|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
145265914|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
145265915|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
145265916|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
145265917|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
145265918|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
145265919|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
145265920|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
145265921|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
145265922|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
145265923|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
145265924|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
145265925|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
145265926|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
145265927|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
145265928|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
145265929|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
145265930|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
145265931|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
145265932|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
145265933|NCT00634933|523821534|FG000|Part B: Week 24 to Week 52|Other|0|||
145265934|NCT00634933|523821535|FG001|Part B: Week 24 to Week 52|Other|0|||
145265935|NCT00634933|523821536|FG002|Part B: Week 24 to Week 52|Other|5|||
145265936|NCT00634933|523821537|FG003|Part B: Week 24 to Week 52|Other|0|||
145265937|NCT00634933|523821538|FG004|Part B: Week 24 to Week 52|Other|1|||
145265938|NCT02058849|523821539|FG000|Overall Study|Hospitalization|1|||
145265939|NCT02058849|523821540|FG001|Overall Study|Hospitalization|1|||
145265940|NCT02058849|523821539|FG000|Overall Study|Death|1|||
145265941|NCT02058849|523821540|FG001|Overall Study|Death|0|||
145265942|NCT02058849|523821539|FG000|Overall Study|Lost to Follow-up|1|||
145265943|NCT02058849|523821540|FG001|Overall Study|Lost to Follow-up|0|||
145265944|NCT02058849|523821539|FG000|Overall Study|Withdrawal by Subject|4|||
145265945|NCT02058849|523821540|FG001|Overall Study|Withdrawal by Subject|0|||
145265946|NCT01250418|523821542|FG000|Overall Study|monitor data failure|1|||
145265947|NCT01250418|523821543|FG001|Overall Study|monitor data failure|1|||
145265948|NCT01761565|523821544|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
145265949|NCT05966129|523821547|FG000|Overall Study|Death|1|||
145265950|NCT05966129|523821548|FG001|Overall Study|Death|2|||
145265951|NCT05966129|523821547|FG000|Overall Study|Lost to Follow-up|63|||
145265952|NCT05966129|523821548|FG001|Overall Study|Lost to Follow-up|66|||
145265953|NCT05966129|523821547|FG000|Overall Study|Protocol Violation|1|||
145265954|NCT05966129|523821548|FG001|Overall Study|Protocol Violation|0|||
145265955|NCT05966129|523821547|FG000|Overall Study|Withdrawal by Subject|26|||
145265956|NCT05966129|523821548|FG001|Overall Study|Withdrawal by Subject|25|||
145265957|NCT05966129|523821547|FG000|Overall Study|Surgery not completed|63|||
145265958|NCT05966129|523821548|FG001|Overall Study|Surgery not completed|69|||
145265959|NCT05966129|523821547|FG000|Overall Study|Surgery logistics issue|2|||
145265960|NCT05966129|523821548|FG001|Overall Study|Surgery logistics issue|1|||
145265961|NCT02500732|523821557|FG000|Overall Study|Physician Decision|0|||
145265962|NCT02500732|523821558|FG001|Overall Study|Physician Decision|1|||
145265963|NCT04409262|523821559|FG000|Overall Study|Adverse Event|0|||
145265964|NCT04409262|523821560|FG001|Overall Study|Adverse Event|2|||
145265965|NCT04409262|523821559|FG000|Overall Study|Death|55|||
145265966|NCT04409262|523821560|FG001|Overall Study|Death|97|||
145265967|NCT04409262|523821559|FG000|Overall Study|Lost to Follow-up|12|||
145265968|NCT04409262|523821560|FG001|Overall Study|Lost to Follow-up|23|||
145265969|NCT04409262|523821559|FG000|Overall Study|Lack of Staff|0|||
145265970|NCT04409262|523821560|FG001|Overall Study|Lack of Staff|1|||
145378801|NCT01709864|524239336|FG001|Overall Study|Adverse Event|2|||
145378802|NCT01709864|524239335|FG000|Overall Study|Death|0|||
145265971|NCT04409262|523821559|FG000|Overall Study|Protocol Violation|3|||
145265972|NCT04409262|523821560|FG001|Overall Study|Protocol Violation|1|||
145265973|NCT04409262|523821559|FG000|Overall Study|Withdrawal by Subject|5|||
145265974|NCT04409262|523821560|FG001|Overall Study|Withdrawal by Subject|10|||
145265975|NCT03205605|523821561|FG000|Overall Study|Withdrawal by Subject|1|||
145265976|NCT02396849|523821562|FG000|Overall Study|Lost to Follow-up|1|||
145265977|NCT02396849|523821563|FG001|Overall Study|Lost to Follow-up|1|||
145378803|NCT01709864|524239336|FG001|Overall Study|Death|1|||
145265978|NCT02396849|523821562|FG000|Overall Study|Did not tolerate intervention|1|||
145265979|NCT02396849|523821563|FG001|Overall Study|Did not tolerate intervention|1|||
145265980|NCT03328325|523821566|FG000|Overall Study|Lost to Follow-up|4|||
145265981|NCT03328325|523821566|FG000|Overall Study|Physician Decision|1|||
145265982|NCT03328325|523821566|FG000|Overall Study|Withdrawal by Subject|3|||
145265983|NCT03328325|523821566|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
145265984|NCT01869959|523821569|FG000|Randomization Period|Physician Decision|0|||
145265985|NCT01869959|523821570|FG001|Randomization Period|Physician Decision|0|||
145265986|NCT01869959|523821571|FG002|Randomization Period|Physician Decision|0|||
145265987|NCT01869959|523821572|FG003|Randomization Period|Physician Decision|0|||
145265988|NCT01869959|523821573|FG004|Randomization Period|Physician Decision|1|||
145265989|NCT01869959|523821569|FG000|Treatment Period|Adverse Event|1|||
145265990|NCT01869959|523821570|FG001|Treatment Period|Adverse Event|0|||
145265991|NCT01869959|523821571|FG002|Treatment Period|Adverse Event|3|||
145265992|NCT01869959|523821572|FG003|Treatment Period|Adverse Event|1|||
145265993|NCT01869959|523821573|FG004|Treatment Period|Adverse Event|0|||
145265994|NCT01869959|523821569|FG000|Treatment Period|Sponsor decision|0|||
145265995|NCT01869959|523821570|FG001|Treatment Period|Sponsor decision|1|||
145265996|NCT01869959|523821571|FG002|Treatment Period|Sponsor decision|0|||
145265997|NCT01869959|523821572|FG003|Treatment Period|Sponsor decision|1|||
145265998|NCT01869959|523821573|FG004|Treatment Period|Sponsor decision|0|||
145265999|NCT01869959|523821569|FG000|Treatment Period|Withdrawal by Subject|0|||
145266000|NCT01869959|523821570|FG001|Treatment Period|Withdrawal by Subject|1|||
145266001|NCT01869959|523821571|FG002|Treatment Period|Withdrawal by Subject|0|||
145266002|NCT01869959|523821572|FG003|Treatment Period|Withdrawal by Subject|0|||
145266003|NCT01869959|523821573|FG004|Treatment Period|Withdrawal by Subject|0|||
145266004|NCT01965600|523821574|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
145266005|NCT01965600|523821575|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
145266006|NCT01965600|523821576|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
145266007|NCT01965600|523821577|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
145266008|NCT01965600|523821574|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
145266009|NCT01965600|523821575|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
145266010|NCT01965600|523821576|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
145266011|NCT01965600|523821577|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
145266012|NCT01965600|523821574|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
145266013|NCT01965600|523821575|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
145266014|NCT01965600|523821576|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
145266015|NCT01965600|523821577|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
145266016|NCT01965600|523821574|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
145266017|NCT01965600|523821575|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
145266018|NCT01965600|523821576|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
145266019|NCT01965600|523821577|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
145266020|NCT01965600|523821574|FG000|Second Intervention|Study terminated by Sponsor|0|||
145266021|NCT01965600|523821575|FG001|Second Intervention|Study terminated by Sponsor|0|||
145266022|NCT01965600|523821576|FG002|Second Intervention|Study terminated by Sponsor|2|||
145266023|NCT01965600|523821577|FG003|Second Intervention|Study terminated by Sponsor|2|||
145292676|NCT00950807|523922209|FG006|Treatment Period 3|Withdrawal by Subject|0|||
145292677|NCT00950807|523922210|FG007|Treatment Period 3|Withdrawal by Subject|0|||
145292678|NCT00950807|523922211|FG008|Treatment Period 3|Withdrawal by Subject|0|||
145292679|NCT00950807|523922212|FG009|Treatment Period 3|Withdrawal by Subject|1|||
145292680|NCT00950807|523922203|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
145292681|NCT00950807|523922204|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292682|NCT00950807|523922205|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292683|NCT00950807|523922206|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292684|NCT00950807|523922207|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292685|NCT00950807|523922208|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292686|NCT00950807|523922209|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292687|NCT00950807|523922210|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
145292688|NCT00950807|523922211|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292689|NCT00950807|523922212|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145292690|NCT00950807|523922203|FG000|Treatment Period 3|Adverse Event|0|||
145292691|NCT00950807|523922204|FG001|Treatment Period 3|Adverse Event|0|||
145292692|NCT00950807|523922205|FG002|Treatment Period 3|Adverse Event|0|||
145292693|NCT00950807|523922206|FG003|Treatment Period 3|Adverse Event|0|||
145292694|NCT00950807|523922207|FG004|Treatment Period 3|Adverse Event|0|||
145292695|NCT00950807|523922208|FG005|Treatment Period 3|Adverse Event|0|||
145292696|NCT00950807|523922209|FG006|Treatment Period 3|Adverse Event|1|||
145292697|NCT00950807|523922210|FG007|Treatment Period 3|Adverse Event|0|||
145292698|NCT00950807|523922211|FG008|Treatment Period 3|Adverse Event|0|||
145292699|NCT00950807|523922212|FG009|Treatment Period 3|Adverse Event|0|||
145292700|NCT00337077|523922213|FG000|Overall Study|Progressive disease|25|||
145266024|NCT00509223|523823186|FG000|Overall Study|Lost to Follow-up|1|||
145266025|NCT00509223|523823187|FG001|Overall Study|Lost to Follow-up|1|||
145266026|NCT00509223|523823186|FG000|Overall Study|Adverse Event|1|||
145266027|NCT00509223|523823187|FG001|Overall Study|Adverse Event|1|||
145266028|NCT00509223|523823186|FG000|Overall Study|Withdrawal by Subject|25|||
145266029|NCT00509223|523823187|FG001|Overall Study|Withdrawal by Subject|6|||
145266030|NCT00509223|523823186|FG000|Overall Study|Including: subject change of address|5|||
145266031|NCT00509223|523823187|FG001|Overall Study|Including: subject change of address|2|||
145266032|NCT00509223|523823186|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
145266033|NCT00509223|523823187|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
145266034|NCT01473602|523823195|FG000|Overall Study|Adverse Event|1|||
145266035|NCT01473602|523823196|FG001|Overall Study|Adverse Event|2|||
145266036|NCT01473602|523823195|FG000|Overall Study|Death|0|||
145266037|NCT01473602|523823196|FG001|Overall Study|Death|1|||
145266038|NCT01473602|523823195|FG000|Overall Study|Lost to Follow-up|1|||
145266039|NCT01473602|523823196|FG001|Overall Study|Lost to Follow-up|1|||
145266040|NCT01473602|523823195|FG000|Overall Study|Withdrawal by Subject|5|||
145266041|NCT01473602|523823196|FG001|Overall Study|Withdrawal by Subject|4|||
145266042|NCT01473602|523823195|FG000|Overall Study|Physician Decision|1|||
145266043|NCT01473602|523823196|FG001|Overall Study|Physician Decision|0|||
145266044|NCT00449761|523823197|FG000|Overall Study|Disease progression|12|||
145266045|NCT00449761|523823197|FG000|Overall Study|Death|5|||
145266046|NCT00449761|523823197|FG000|Overall Study|New cancer therapy|1|||
145266047|NCT00560573|523823198|FG000|Overall Study|Death|4|||
145266048|NCT00560573|523823199|FG001|Overall Study|Death|1|||
145266049|NCT00560573|523823200|FG002|Overall Study|Death|4|||
145266050|NCT00560573|523823201|FG003|Overall Study|Death|5|||
145266051|NCT00560573|523823202|FG004|Overall Study|Death|1|||
145266052|NCT00560573|523823203|FG005|Overall Study|Death|10|||
145266053|NCT00560573|523823198|FG000|Overall Study|Lost to Follow-up|0|||
145266054|NCT00560573|523823199|FG001|Overall Study|Lost to Follow-up|0|||
145266055|NCT00560573|523823200|FG002|Overall Study|Lost to Follow-up|0|||
145266056|NCT00560573|523823201|FG003|Overall Study|Lost to Follow-up|1|||
145266057|NCT00560573|523823202|FG004|Overall Study|Lost to Follow-up|1|||
145266058|NCT00560573|523823203|FG005|Overall Study|Lost to Follow-up|0|||
145266059|NCT00560573|523823198|FG000|Overall Study|Withdrawal by Subject|0|||
145266060|NCT00560573|523823199|FG001|Overall Study|Withdrawal by Subject|0|||
145266061|NCT00560573|523823200|FG002|Overall Study|Withdrawal by Subject|0|||
145266062|NCT00560573|523823201|FG003|Overall Study|Withdrawal by Subject|1|||
145266063|NCT00560573|523823202|FG004|Overall Study|Withdrawal by Subject|1|||
145266064|NCT00560573|523823203|FG005|Overall Study|Withdrawal by Subject|0|||
145266065|NCT00560573|523823198|FG000|Overall Study|Other|2|||
145266066|NCT00560573|523823199|FG001|Overall Study|Other|2|||
145266067|NCT00560573|523823200|FG002|Overall Study|Other|2|||
145266068|NCT00560573|523823201|FG003|Overall Study|Other|3|||
145266069|NCT00560573|523823202|FG004|Overall Study|Other|3|||
145266070|NCT00560573|523823203|FG005|Overall Study|Other|3|||
145266071|NCT00560573|523823198|FG000|Overall Study|Enrolled, not treated|0|||
145266072|NCT00560573|523823199|FG001|Overall Study|Enrolled, not treated|0|||
145266073|NCT00560573|523823200|FG002|Overall Study|Enrolled, not treated|0|||
145266074|NCT00560573|523823201|FG003|Overall Study|Enrolled, not treated|0|||
145266075|NCT00560573|523823202|FG004|Overall Study|Enrolled, not treated|1|||
145266076|NCT00560573|523823203|FG005|Overall Study|Enrolled, not treated|0|||
145266077|NCT00726882|523823204|FG000|Overall Study|Withdrawal by Subject|5|||
145266078|NCT00726882|523823204|FG000|Overall Study|Lost to Follow-up|7|||
145266079|NCT00726882|523823204|FG000|Overall Study|Other|10|||
145266080|NCT01339273|523823205|FG000|Overall Study|Lost to Follow-up|8|||
145266081|NCT01339273|523823206|FG001|Overall Study|Lost to Follow-up|8|||
145266082|NCT00594568|523823207|FG000|Initial Treatment|Adverse Event|51|||
145266083|NCT00594568|523823208|FG001|Initial Treatment|Adverse Event|121|||
145266084|NCT00594568|523823209|FG002|Initial Treatment|Adverse Event|144|||
145266085|NCT00594568|523823207|FG000|Initial Treatment|Death|6|||
145266086|NCT00594568|523823208|FG001|Initial Treatment|Death|11|||
145266087|NCT00594568|523823209|FG002|Initial Treatment|Death|15|||
145266088|NCT00594568|523823207|FG000|Initial Treatment|Lost to Follow-up|4|||
145266089|NCT00594568|523823208|FG001|Initial Treatment|Lost to Follow-up|1|||
145266090|NCT00594568|523823209|FG002|Initial Treatment|Lost to Follow-up|4|||
145266091|NCT00594568|523823207|FG000|Initial Treatment|Physician Decision|3|||
145378804|NCT01066793|524239343|FG000|Overall Study|Death|4|||
145266092|NCT00594568|523823208|FG001|Initial Treatment|Physician Decision|2|||
145266093|NCT00594568|523823209|FG002|Initial Treatment|Physician Decision|4|||
145266094|NCT00594568|523823207|FG000|Initial Treatment|Protocol Violation|2|||
145266095|NCT00594568|523823208|FG001|Initial Treatment|Protocol Violation|2|||
145266096|NCT00594568|523823209|FG002|Initial Treatment|Protocol Violation|5|||
145266097|NCT00594568|523823207|FG000|Initial Treatment|Withdrawal by Subject|25|||
145266098|NCT00594568|523823208|FG001|Initial Treatment|Withdrawal by Subject|31|||
145266099|NCT00594568|523823209|FG002|Initial Treatment|Withdrawal by Subject|46|||
145266100|NCT00594568|523823207|FG000|Initial Treatment|Sponsor decision|193|||
145266101|NCT00594568|523823208|FG001|Initial Treatment|Sponsor decision|142|||
145378805|NCT01066793|524239344|FG001|Overall Study|Death|1|||
145266102|NCT00594568|523823209|FG002|Initial Treatment|Sponsor decision|147|||
145266103|NCT00594568|523823207|FG000|Initial Treatment|Caregiver decision|21|||
145266104|NCT00594568|523823208|FG001|Initial Treatment|Caregiver decision|36|||
145266105|NCT00594568|523823209|FG002|Initial Treatment|Caregiver decision|36|||
145266106|NCT00594568|523823207|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
145266107|NCT00594568|523823208|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
145266108|NCT00594568|523823209|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
145266109|NCT00594568|523823207|FG000|Initial Treatment|Entry criteria exclusion|0|||
145266110|NCT00594568|523823208|FG001|Initial Treatment|Entry criteria exclusion|1|||
145266111|NCT00594568|523823209|FG002|Initial Treatment|Entry criteria exclusion|1|||
145266112|NCT00594568|523823207|FG000|Delayed Start|Death|0|||
145266113|NCT00594568|523823208|FG001|Delayed Start|Death|0|||
145266114|NCT00594568|523823209|FG002|Delayed Start|Death|1|||
145266115|NCT00594568|523823207|FG000|Delayed Start|Adverse Event|12|||
145266116|NCT00594568|523823208|FG001|Delayed Start|Adverse Event|2|||
145266117|NCT00594568|523823209|FG002|Delayed Start|Adverse Event|2|||
145266118|NCT00594568|523823207|FG000|Delayed Start|Withdrawal by Subject|4|||
145266119|NCT00594568|523823208|FG001|Delayed Start|Withdrawal by Subject|3|||
145266120|NCT00594568|523823209|FG002|Delayed Start|Withdrawal by Subject|0|||
145266121|NCT00594568|523823207|FG000|Delayed Start|Physician Decision|0|||
145266122|NCT00594568|523823208|FG001|Delayed Start|Physician Decision|0|||
145266123|NCT00594568|523823209|FG002|Delayed Start|Physician Decision|1|||
145266124|NCT00594568|523823207|FG000|Delayed Start|Lost to Follow-up|0|||
145266125|NCT00594568|523823208|FG001|Delayed Start|Lost to Follow-up|0|||
145266126|NCT00594568|523823209|FG002|Delayed Start|Lost to Follow-up|1|||
145266127|NCT00594568|523823207|FG000|Delayed Start|Caregiver Decision|5|||
145266128|NCT00594568|523823208|FG001|Delayed Start|Caregiver Decision|6|||
145266129|NCT00594568|523823209|FG002|Delayed Start|Caregiver Decision|2|||
145266130|NCT00594568|523823207|FG000|Delayed Start|Sponsor Decision|77|||
145266131|NCT00594568|523823208|FG001|Delayed Start|Sponsor Decision|66|||
145266132|NCT00594568|523823209|FG002|Delayed Start|Sponsor Decision|59|||
145266133|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
145266134|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
145266135|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
145266136|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
145266137|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
145266138|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
145266139|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
145266140|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
145266141|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
145266142|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
145266143|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
145266144|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
145266145|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
145266146|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
145266147|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
145266148|NCT00594568|523823207|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
145266149|NCT00594568|523823208|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
145266150|NCT00594568|523823209|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
145266151|NCT02526017|523823210|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266152|NCT02526017|523823211|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266153|NCT02526017|523823212|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266154|NCT02526017|523823213|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266155|NCT02526017|523823214|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
145266156|NCT02526017|523823215|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266157|NCT02526017|523823216|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266158|NCT02526017|523823217|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266159|NCT02526017|523823218|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
145266160|NCT00518531|523823220|FG000|Treatment Period 1|Adverse Event|5|||
145266161|NCT00518531|523823221|FG001|Treatment Period 1|Adverse Event|0|||
145266162|NCT00518531|523823220|FG000|Treatment Period 1|Lost to Follow-up|5|||
145266163|NCT00518531|523823221|FG001|Treatment Period 1|Lost to Follow-up|3|||
145266164|NCT00518531|523823220|FG000|Treatment Period 1|Physician Decision|1|||
145266165|NCT00518531|523823221|FG001|Treatment Period 1|Physician Decision|0|||
145266166|NCT00518531|523823220|FG000|Treatment Period 1|Protocol Violation|2|||
145266167|NCT00518531|523823221|FG001|Treatment Period 1|Protocol Violation|0|||
145266168|NCT00518531|523823220|FG000|Treatment Period 1|Withdrawal by Subject|4|||
145266169|NCT00518531|523823221|FG001|Treatment Period 1|Withdrawal by Subject|6|||
145266170|NCT00518531|523823220|FG000|Treatment Period 1|Early crossover|1|||
145266171|NCT00518531|523823221|FG001|Treatment Period 1|Early crossover|3|||
145266172|NCT00518531|523823220|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145266173|NCT00518531|523823221|FG001|Treatment Period 2|Withdrawal by Subject|8|||
145266174|NCT00518531|523823220|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
145266175|NCT00518531|523823221|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
145266176|NCT00518531|523823220|FG000|Treatment Period 2|Adverse Event|1|||
145266177|NCT00518531|523823221|FG001|Treatment Period 2|Adverse Event|7|||
145266178|NCT00518531|523823220|FG000|Treatment Period 2|Protocol-specified criteria|0|||
145266179|NCT00518531|523823221|FG001|Treatment Period 2|Protocol-specified criteria|1|||
145266180|NCT00518531|523823220|FG000|Treatment Period 2|Non-compliance|1|||
145266181|NCT00518531|523823221|FG001|Treatment Period 2|Non-compliance|2|||
145266182|NCT04621227|523823224|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
145266183|NCT04621227|523823224|FG000|Period 3 (29 Days)|Adverse Event|1|||
145266184|NCT04621227|523823224|FG000|Period 8 (2 Days)|Adverse Event|1|||
145266185|NCT01728376|523823225|FG000|Overall Study|Adverse Event|1|||
145266186|NCT01728376|523823226|FG001|Overall Study|Adverse Event|1|||
145266187|NCT01728376|523823227|FG002|Overall Study|Adverse Event|1|||
145266188|NCT01728376|523823228|FG003|Overall Study|Adverse Event|1|||
145266189|NCT01728376|523823229|FG004|Overall Study|Adverse Event|1|||
145266190|NCT01728376|523823230|FG005|Overall Study|Adverse Event|0|||
145266191|NCT01728376|523823225|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
145266192|NCT01728376|523823226|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
145266193|NCT01728376|523823227|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
145266194|NCT01728376|523823228|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
145266195|NCT01728376|523823229|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
145266196|NCT01728376|523823230|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
145266197|NCT01728376|523823225|FG000|Overall Study|No relevant bacteria|2|||
145266198|NCT01728376|523823226|FG001|Overall Study|No relevant bacteria|0|||
145266199|NCT01728376|523823227|FG002|Overall Study|No relevant bacteria|0|||
145266200|NCT01728376|523823228|FG003|Overall Study|No relevant bacteria|0|||
145266201|NCT01728376|523823229|FG004|Overall Study|No relevant bacteria|1|||
145266202|NCT01728376|523823230|FG005|Overall Study|No relevant bacteria|1|||
145266203|NCT01728376|523823225|FG000|Overall Study|Did not receive treatment|0|||
145266204|NCT01728376|523823226|FG001|Overall Study|Did not receive treatment|1|||
145266205|NCT01728376|523823227|FG002|Overall Study|Did not receive treatment|0|||
145266206|NCT01728376|523823228|FG003|Overall Study|Did not receive treatment|0|||
145266207|NCT01728376|523823229|FG004|Overall Study|Did not receive treatment|0|||
145266208|NCT01728376|523823230|FG005|Overall Study|Did not receive treatment|0|||
145266209|NCT01728376|523823225|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
145266210|NCT01728376|523823226|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
145266211|NCT01728376|523823227|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
145266212|NCT01728376|523823228|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
145266213|NCT01728376|523823229|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
145266214|NCT01728376|523823230|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
145266215|NCT02856282|523823236|FG000|Overall Study|Withdrawal by Subject|1|||
145266216|NCT00057330|523823237|FG000|Overall Study|Adverse Event|9|||
145266217|NCT00057330|523823238|FG001|Overall Study|Adverse Event|12|||
145266218|NCT00057330|523823237|FG000|Overall Study|Death|1|||
145266219|NCT00057330|523823238|FG001|Overall Study|Death|0|||
145266220|NCT00057330|523823237|FG000|Overall Study|Protocol Violation|1|||
145266221|NCT00057330|523823238|FG001|Overall Study|Protocol Violation|1|||
145266222|NCT00057330|523823237|FG000|Overall Study|Withdrawal by Subject|115|||
145266223|NCT00057330|523823238|FG001|Overall Study|Withdrawal by Subject|84|||
145266224|NCT00057330|523823237|FG000|Overall Study|Lost to Follow-up|745|||
145266225|NCT00057330|523823238|FG001|Overall Study|Lost to Follow-up|617|||
145266226|NCT00057330|523823237|FG000|Overall Study|Physician Decision|1|||
145266227|NCT00057330|523823238|FG001|Overall Study|Physician Decision|0|||
145266228|NCT00057330|523823237|FG000|Overall Study|Other|260|||
145266229|NCT00057330|523823238|FG001|Overall Study|Other|206|||
145266230|NCT04888377|523823244|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
145266231|NCT04888377|523823245|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
145266232|NCT04888377|523823244|FG000|Overall Study|Physician Decision|6|||
145266233|NCT04888377|523823245|FG001|Overall Study|Physician Decision|6|||
145266234|NCT04888377|523823244|FG000|Overall Study|Withdrawal by Subject|7|||
145266235|NCT04888377|523823245|FG001|Overall Study|Withdrawal by Subject|3|||
145378806|NCT01066793|524239345|FG002|Overall Study|Death|1|||
145266236|NCT04753606|523823252|FG000|Overall Study|Adverse Event|1|||
145266237|NCT04753606|523823253|FG001|Overall Study|Adverse Event|0|||
145266238|NCT04753606|523823254|FG002|Overall Study|Adverse Event|0|||
145378807|NCT01066793|524239346|FG003|Overall Study|Death|0|||
145266239|NCT01012609|523823257|FG000|Overall Study|Withdrawal by Subject|1|||
145266240|NCT01012609|523823258|FG001|Overall Study|Withdrawal by Subject|1|||
145266241|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
145266242|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
145266243|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
145266244|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
145378808|NCT01066793|524239347|FG004|Overall Study|Death|0|||
145266245|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
145266246|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
145266247|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
145266248|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
145266249|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
145266250|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
145266251|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
145266252|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
145266253|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
145266254|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
145266255|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
145266256|NCT01694849|523823268|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
145266257|NCT01694849|523823269|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
145266258|NCT01694849|523823270|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
145266259|NCT01694849|523823268|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
145266260|NCT01694849|523823269|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
145266261|NCT01694849|523823270|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
145266262|NCT01694849|523823268|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
145266263|NCT01694849|523823269|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
145266264|NCT01694849|523823270|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
145266265|NCT05147311|523823273|FG000|Overall Study|Did not complete survey|2|||
145266266|NCT05147311|523823274|FG001|Overall Study|Did not complete survey|1|||
145266267|NCT05147311|523823273|FG000|Overall Study|Patient too sick|1|||
145266268|NCT05147311|523823274|FG001|Overall Study|Patient too sick|2|||
145266269|NCT05147311|523823273|FG000|Overall Study|Death|0|||
145266270|NCT05147311|523823274|FG001|Overall Study|Death|1|||
145266271|NCT05147311|523823273|FG000|Overall Study|Declined survey|1|||
145266272|NCT05147311|523823274|FG001|Overall Study|Declined survey|0|||
145266273|NCT02279888|523823276|FG000|Overall Study|Death|326|||
145266274|NCT02279888|523823276|FG000|Overall Study|Withdrawal by Subject|38|||
145266275|NCT02279888|523823276|FG000|Overall Study|Lost to Follow-up|21|||
145266276|NCT02279888|523823276|FG000|Overall Study|Physician Decision|62|||
145266277|NCT02279888|523823276|FG000|Overall Study|Subject Non-compliance|43|||
145266278|NCT02279888|523823276|FG000|Overall Study|Not implanted|14|||
145266279|NCT02279888|523823276|FG000|Overall Study|Visit not performed|26|||
145266280|NCT04505592|523823277|FG000|Overall Study|Death|2|||
145266281|NCT04505592|523823278|FG001|Overall Study|Death|1|||
145266282|NCT02161380|523823289|FG000|Overall Study|Lost to Follow-up|0|||
145266283|NCT02161380|523823290|FG001|Overall Study|Lost to Follow-up|1|||
145266284|NCT02161380|523823291|FG002|Overall Study|Lost to Follow-up|0|||
145266285|NCT02161380|523823292|FG003|Overall Study|Lost to Follow-up|0|||
145266286|NCT00931515|523823295|FG000|Overall Study|Lost to Follow-up|2|||
145266287|NCT00931515|523823296|FG001|Overall Study|Lost to Follow-up|5|||
145266288|NCT00948896|523823297|FG000|Randomization to 24 Months of Age|Death|1|||
145266289|NCT00948896|523823298|FG001|Randomization to 24 Months of Age|Death|0|||
145266290|NCT00948896|523823299|FG002|Randomization to 24 Months of Age|Death|0|||
145266291|NCT00948896|523823300|FG003|Randomization to 24 Months of Age|Death|0|||
145266292|NCT00948896|523823301|FG004|Randomization to 24 Months of Age|Death|2|||
145266293|NCT00948896|523823302|FG005|Randomization to 24 Months of Age|Death|1|||
145266294|NCT00948896|523823303|FG006|Randomization to 24 Months of Age|Death|2|||
145266295|NCT00948896|523823304|FG007|Randomization to 24 Months of Age|Death|1|||
145378809|NCT01066793|524239348|FG005|Overall Study|Death|0|||
145378810|NCT01066793|524239343|FG000|Overall Study|Lack of Efficacy|2|||
145378811|NCT01066793|524239344|FG001|Overall Study|Lack of Efficacy|1|||
145378812|NCT01066793|524239345|FG002|Overall Study|Lack of Efficacy|0|||
145378813|NCT01066793|524239346|FG003|Overall Study|Lack of Efficacy|0|||
145378814|NCT01066793|524239347|FG004|Overall Study|Lack of Efficacy|0|||
145378815|NCT01066793|524239348|FG005|Overall Study|Lack of Efficacy|0|||
145378816|NCT01066793|524239343|FG000|Overall Study|Lost to Follow-up|180|||
145378817|NCT01066793|524239344|FG001|Overall Study|Lost to Follow-up|39|||
145378818|NCT01066793|524239345|FG002|Overall Study|Lost to Follow-up|82|||
145378819|NCT01066793|524239346|FG003|Overall Study|Lost to Follow-up|16|||
145378820|NCT01066793|524239347|FG004|Overall Study|Lost to Follow-up|0|||
145378821|NCT01066793|524239348|FG005|Overall Study|Lost to Follow-up|1|||
145378822|NCT01066793|524239343|FG000|Overall Study|Physician Decision|3|||
145378823|NCT01066793|524239344|FG001|Overall Study|Physician Decision|0|||
145378824|NCT01066793|524239345|FG002|Overall Study|Physician Decision|0|||
145378825|NCT01066793|524239346|FG003|Overall Study|Physician Decision|0|||
145378826|NCT01066793|524239347|FG004|Overall Study|Physician Decision|0|||
145378827|NCT01066793|524239348|FG005|Overall Study|Physician Decision|0|||
145378828|NCT01066793|524239343|FG000|Overall Study|Protocol Violation|3|||
145378829|NCT01066793|524239344|FG001|Overall Study|Protocol Violation|2|||
145378830|NCT01066793|524239345|FG002|Overall Study|Protocol Violation|2|||
145378831|NCT01066793|524239346|FG003|Overall Study|Protocol Violation|0|||
145378832|NCT01066793|524239347|FG004|Overall Study|Protocol Violation|0|||
145378833|NCT01066793|524239348|FG005|Overall Study|Protocol Violation|0|||
145378834|NCT01066793|524239343|FG000|Overall Study|Withdrawal by Subject|7|||
145378835|NCT01066793|524239344|FG001|Overall Study|Withdrawal by Subject|4|||
145378836|NCT01066793|524239345|FG002|Overall Study|Withdrawal by Subject|1|||
145378837|NCT01066793|524239346|FG003|Overall Study|Withdrawal by Subject|0|||
145378838|NCT01066793|524239347|FG004|Overall Study|Withdrawal by Subject|0|||
145378839|NCT01066793|524239348|FG005|Overall Study|Withdrawal by Subject|0|||
145378840|NCT01066793|524239343|FG000|Overall Study|Early Termination|3|||
145378841|NCT01066793|524239344|FG001|Overall Study|Early Termination|0|||
145378842|NCT01066793|524239345|FG002|Overall Study|Early Termination|0|||
145378843|NCT01066793|524239346|FG003|Overall Study|Early Termination|0|||
145378844|NCT01066793|524239347|FG004|Overall Study|Early Termination|0|||
145378845|NCT01066793|524239348|FG005|Overall Study|Early Termination|0|||
145378846|NCT01066793|524239343|FG000|Overall Study|Lab test not done|7|||
145378847|NCT01066793|524239344|FG001|Overall Study|Lab test not done|0|||
145378848|NCT01066793|524239345|FG002|Overall Study|Lab test not done|0|||
145378849|NCT01066793|524239346|FG003|Overall Study|Lab test not done|1|||
145378850|NCT01066793|524239347|FG004|Overall Study|Lab test not done|0|||
145378851|NCT01066793|524239348|FG005|Overall Study|Lab test not done|0|||
145378852|NCT01066793|524239343|FG000|Overall Study|Miscellaneous|4|||
145378853|NCT01066793|524239344|FG001|Overall Study|Miscellaneous|5|||
145378854|NCT01066793|524239345|FG002|Overall Study|Miscellaneous|6|||
145378855|NCT01066793|524239346|FG003|Overall Study|Miscellaneous|0|||
145378856|NCT01066793|524239347|FG004|Overall Study|Miscellaneous|0|||
145378857|NCT01066793|524239348|FG005|Overall Study|Miscellaneous|0|||
145378858|NCT01066793|524239343|FG000|Overall Study|Non-responders|104|||
145378859|NCT01066793|524239344|FG001|Overall Study|Non-responders|5|||
145378860|NCT01066793|524239345|FG002|Overall Study|Non-responders|11|||
145378861|NCT01066793|524239346|FG003|Overall Study|Non-responders|25|||
145378862|NCT01066793|524239347|FG004|Overall Study|Non-responders|0|||
145378863|NCT01066793|524239348|FG005|Overall Study|Non-responders|0|||
145378864|NCT01066793|524239343|FG000|Overall Study|Other|15|||
145378865|NCT01066793|524239344|FG001|Overall Study|Other|5|||
145378866|NCT01066793|524239345|FG002|Overall Study|Other|6|||
145378867|NCT01066793|524239346|FG003|Overall Study|Other|2|||
145378868|NCT01066793|524239347|FG004|Overall Study|Other|0|||
145378869|NCT01066793|524239348|FG005|Overall Study|Other|0|||
145378870|NCT01066793|524239343|FG000|Overall Study|Relapse|20|||
145378871|NCT01066793|524239344|FG001|Overall Study|Relapse|8|||
145378872|NCT01066793|524239345|FG002|Overall Study|Relapse|2|||
145378873|NCT01066793|524239346|FG003|Overall Study|Relapse|3|||
145378874|NCT01066793|524239347|FG004|Overall Study|Relapse|0|||
145378875|NCT01066793|524239348|FG005|Overall Study|Relapse|0|||
145378876|NCT01066793|524239343|FG000|Overall Study|Result Not Available|1|||
145378877|NCT01066793|524239344|FG001|Overall Study|Result Not Available|0|||
145378878|NCT01066793|524239345|FG002|Overall Study|Result Not Available|0|||
145378879|NCT01066793|524239346|FG003|Overall Study|Result Not Available|0|||
145378880|NCT01066793|524239347|FG004|Overall Study|Result Not Available|0|||
145378881|NCT01066793|524239348|FG005|Overall Study|Result Not Available|0|||
145378882|NCT01066793|524239343|FG000|Overall Study|Treatment Interrupted|1|||
145378883|NCT01066793|524239344|FG001|Overall Study|Treatment Interrupted|1|||
145378884|NCT01066793|524239345|FG002|Overall Study|Treatment Interrupted|0|||
145378885|NCT01066793|524239346|FG003|Overall Study|Treatment Interrupted|0|||
145378886|NCT01066793|524239347|FG004|Overall Study|Treatment Interrupted|0|||
145378887|NCT01066793|524239348|FG005|Overall Study|Treatment Interrupted|0|||
145378888|NCT01066793|524239343|FG000|Overall Study|Treatment Never Started|18|||
145378889|NCT01066793|524239344|FG001|Overall Study|Treatment Never Started|5|||
145378890|NCT01066793|524239345|FG002|Overall Study|Treatment Never Started|4|||
145378891|NCT01066793|524239346|FG003|Overall Study|Treatment Never Started|1|||
145378892|NCT01066793|524239347|FG004|Overall Study|Treatment Never Started|0|||
145378893|NCT01066793|524239348|FG005|Overall Study|Treatment Never Started|0|||
145378894|NCT01066793|524239343|FG000|Overall Study|Treatment Stopped|2|||
145378895|NCT01066793|524239344|FG001|Overall Study|Treatment Stopped|1|||
145378896|NCT01066793|524239345|FG002|Overall Study|Treatment Stopped|0|||
145378897|NCT01066793|524239346|FG003|Overall Study|Treatment Stopped|1|||
145378898|NCT01066793|524239347|FG004|Overall Study|Treatment Stopped|0|||
145378899|NCT01066793|524239348|FG005|Overall Study|Treatment Stopped|0|||
145378900|NCT03334422|524239349|FG000|Overall Study|Adverse Event|1|||
145378901|NCT03334422|524239350|FG001|Overall Study|Adverse Event|3|||
145378902|NCT03334422|524239351|FG002|Overall Study|Adverse Event|2|||
145378903|NCT03334422|524239352|FG003|Overall Study|Adverse Event|2|||
145378904|NCT03334422|524239349|FG000|Overall Study|Lack of Efficacy|10|||
145378905|NCT03334422|524239350|FG001|Overall Study|Lack of Efficacy|2|||
145378906|NCT03334422|524239351|FG002|Overall Study|Lack of Efficacy|7|||
145378907|NCT03334422|524239352|FG003|Overall Study|Lack of Efficacy|3|||
145378908|NCT03334422|524239349|FG000|Overall Study|Withdrawal by Subject|8|||
145378909|NCT03334422|524239350|FG001|Overall Study|Withdrawal by Subject|3|||
145378910|NCT03334422|524239351|FG002|Overall Study|Withdrawal by Subject|1|||
145378911|NCT03334422|524239352|FG003|Overall Study|Withdrawal by Subject|0|||
145378912|NCT03334422|524239349|FG000|Overall Study|Lost to Follow-up|0|||
145378913|NCT03334422|524239350|FG001|Overall Study|Lost to Follow-up|0|||
145378914|NCT03334422|524239351|FG002|Overall Study|Lost to Follow-up|0|||
145378915|NCT03334422|524239352|FG003|Overall Study|Lost to Follow-up|1|||
145378916|NCT03334422|524239349|FG000|Overall Study|Inability to obtain laboratory samples|0|||
145378917|NCT03334422|524239350|FG001|Overall Study|Inability to obtain laboratory samples|1|||
145378918|NCT03334422|524239351|FG002|Overall Study|Inability to obtain laboratory samples|0|||
145378919|NCT03334422|524239352|FG003|Overall Study|Inability to obtain laboratory samples|0|||
145378920|NCT03334422|524239349|FG000|Overall Study|Pregnancy|0|||
145378921|NCT03334422|524239350|FG001|Overall Study|Pregnancy|1|||
145378922|NCT03334422|524239351|FG002|Overall Study|Pregnancy|0|||
145378923|NCT03334422|524239352|FG003|Overall Study|Pregnancy|0|||
145266296|NCT00948896|523823297|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
145266297|NCT00948896|523823298|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
145266298|NCT00948896|523823299|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
145266299|NCT00948896|523823300|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
145266300|NCT00948896|523823301|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
145266301|NCT00948896|523823302|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
145266302|NCT00948896|523823303|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
145266303|NCT00948896|523823304|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
145266304|NCT00948896|523823297|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
145266305|NCT00948896|523823298|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
145266306|NCT00948896|523823299|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
145266307|NCT00948896|523823300|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
145266308|NCT00948896|523823301|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
145266309|NCT00948896|523823302|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
145266310|NCT00948896|523823303|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
145266311|NCT00948896|523823304|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
145266312|NCT00948896|523823297|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
145266313|NCT00948896|523823298|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
145266314|NCT00948896|523823299|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
145266315|NCT00948896|523823300|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
145266316|NCT00948896|523823301|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
145266317|NCT00948896|523823302|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
145266318|NCT00948896|523823303|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
145266319|NCT00948896|523823304|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
145266320|NCT00948896|523823297|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
145266321|NCT00948896|523823298|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
145266322|NCT00948896|523823299|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
145266323|NCT00948896|523823300|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
145266324|NCT00948896|523823301|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
145266325|NCT00948896|523823302|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
145266326|NCT00948896|523823303|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
145266327|NCT00948896|523823304|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
145266328|NCT00948896|523823297|FG000|24 Months of Age to 36 Months of Age|Death|0|||
145266329|NCT00948896|523823298|FG001|24 Months of Age to 36 Months of Age|Death|2|||
145378924|NCT01313221|524239353|FG000|Overall Study|Protocol Violation|0|||
145378925|NCT01313221|524239354|FG001|Overall Study|Protocol Violation|1|||
145378926|NCT01313221|524239355|FG002|Overall Study|Protocol Violation|1|||
145378927|NCT01313221|524239353|FG000|Overall Study|Non-compliance|3|||
145378928|NCT01313221|524239354|FG001|Overall Study|Non-compliance|0|||
145378929|NCT01313221|524239355|FG002|Overall Study|Non-compliance|2|||
145378930|NCT01313221|524239353|FG000|Overall Study|Withdrawal by Subject|2|||
145378931|NCT01313221|524239354|FG001|Overall Study|Withdrawal by Subject|3|||
145378932|NCT01313221|524239355|FG002|Overall Study|Withdrawal by Subject|5|||
145378933|NCT01313221|524239353|FG000|Overall Study|Requirement for alternative therapy|0|||
145378934|NCT01313221|524239354|FG001|Overall Study|Requirement for alternative therapy|1|||
145266330|NCT00948896|523823299|FG002|24 Months of Age to 36 Months of Age|Death|2|||
145266331|NCT00948896|523823300|FG003|24 Months of Age to 36 Months of Age|Death|0|||
145266332|NCT00948896|523823301|FG004|24 Months of Age to 36 Months of Age|Death|0|||
145266333|NCT00948896|523823302|FG005|24 Months of Age to 36 Months of Age|Death|1|||
145266334|NCT00948896|523823303|FG006|24 Months of Age to 36 Months of Age|Death|0|||
145266335|NCT00948896|523823304|FG007|24 Months of Age to 36 Months of Age|Death|0|||
145266336|NCT00948896|523823297|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
145266337|NCT00948896|523823298|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
145266338|NCT00948896|523823299|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
145266339|NCT00948896|523823300|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
145378935|NCT01313221|524239355|FG002|Overall Study|Requirement for alternative therapy|1|||
145378936|NCT01313221|524239353|FG000|Overall Study|Lost to Follow-up|6|||
145378937|NCT01313221|524239354|FG001|Overall Study|Lost to Follow-up|3|||
145378938|NCT01313221|524239355|FG002|Overall Study|Lost to Follow-up|1|||
145378939|NCT01313221|524239353|FG000|Overall Study|Other|1|||
145266340|NCT00948896|523823301|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
145266341|NCT00948896|523823302|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
145266342|NCT00948896|523823303|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
145266343|NCT00948896|523823304|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
145266344|NCT00948896|523823297|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
145266345|NCT00948896|523823298|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
145266346|NCT00948896|523823299|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
145266347|NCT00948896|523823300|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
145266348|NCT00948896|523823301|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
145266349|NCT00948896|523823302|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
145266350|NCT00948896|523823303|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
145266351|NCT00948896|523823304|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
145266352|NCT00948896|523823297|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266353|NCT00948896|523823298|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266354|NCT00948896|523823299|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
145266355|NCT00948896|523823300|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266356|NCT00948896|523823301|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266357|NCT00948896|523823302|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
145266358|NCT00948896|523823303|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266359|NCT00948896|523823304|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
145266360|NCT00948896|523823297|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266361|NCT00948896|523823298|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266362|NCT00948896|523823299|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266363|NCT00948896|523823300|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
145266364|NCT00948896|523823301|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266365|NCT00948896|523823302|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266366|NCT00948896|523823303|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266367|NCT00948896|523823304|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
145266368|NCT04678557|523823306|FG000|Overall Study|Withdrawal by Subject|1|||
145266369|NCT04678557|523823307|FG001|Overall Study|Withdrawal by Subject|0|||
145266370|NCT04678557|523823306|FG000|Overall Study|Lack of Efficacy|0|||
145266371|NCT04678557|523823307|FG001|Overall Study|Lack of Efficacy|13|||
145266372|NCT04678557|523823306|FG000|Overall Study|Safety Evaluation|0|||
145266373|NCT04678557|523823307|FG001|Overall Study|Safety Evaluation|1|||
145266374|NCT00157157|523823308|FG000|Overall Study|Withdrawal by Subject|6|||
145266375|NCT00157157|523823308|FG000|Overall Study|Physician Decision|1|||
145266376|NCT00157157|523823308|FG000|Overall Study|Lost to Follow-up|1|||
145266377|NCT00157157|523823308|FG000|Overall Study|Enrolled in another study|1|||
145266378|NCT00157157|523823308|FG000|Overall Study|Met exclusion criteria|1|||
145266379|NCT00157157|523823308|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
145266380|NCT02260804|523823313|FG000|Induction Study Period|Protocol Violation|2|||
145266381|NCT02260804|523823314|FG001|Induction Study Period|Protocol Violation|0|||
145266382|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
145266383|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
145266384|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
145266385|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
145266386|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
145266387|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
145266388|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
145266389|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
145266390|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
145266391|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
145266392|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
145266393|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
145266394|NCT02260804|523823313|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
145266395|NCT02260804|523823314|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
145378940|NCT01313221|524239354|FG001|Overall Study|Other|0|||
145378941|NCT01313221|524239355|FG002|Overall Study|Other|0|||
145378942|NCT01313221|524239353|FG000|Overall Study|Adverse Event|0|||
145378943|NCT01313221|524239354|FG001|Overall Study|Adverse Event|0|||
145378944|NCT01313221|524239355|FG002|Overall Study|Adverse Event|7|||
145378945|NCT01313221|524239353|FG000|Overall Study|Disease progression|0|||
145266396|NCT02260804|523823313|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
145266397|NCT02260804|523823314|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
145266398|NCT02260804|523823313|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
145266399|NCT02260804|523823314|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
145378946|NCT01313221|524239354|FG001|Overall Study|Disease progression|0|||
145378947|NCT01313221|524239355|FG002|Overall Study|Disease progression|2|||
145378948|NCT01313221|524239353|FG000|Overall Study|Physician Decision|0|||
145378949|NCT01313221|524239354|FG001|Overall Study|Physician Decision|0|||
145378950|NCT01313221|524239355|FG002|Overall Study|Physician Decision|2|||
145378951|NCT01313221|524239353|FG000|Overall Study|Pregnancy|0|||
145378952|NCT01313221|524239354|FG001|Overall Study|Pregnancy|0|||
145378953|NCT01313221|524239355|FG002|Overall Study|Pregnancy|2|||
145378954|NCT02864316|524239360|FG000|Overall Study|Progressive Disease|2|||
145378955|NCT02864316|524239361|FG001|Overall Study|Progressive Disease|1|||
145378956|NCT02864316|524239360|FG000|Overall Study|Adverse Event|0|||
145378957|NCT02864316|524239361|FG001|Overall Study|Adverse Event|1|||
145378958|NCT05459558|524239362|FG000|Overall Study|Adverse Event|1|||
145378959|NCT05459558|524239363|FG001|Overall Study|Adverse Event|0|||
145378960|NCT05459558|524239364|FG002|Overall Study|Adverse Event|0|||
145378961|NCT05459558|524239362|FG000|Overall Study|Scheduling issue|0|||
145378962|NCT05459558|524239363|FG001|Overall Study|Scheduling issue|1|||
145378963|NCT05459558|524239364|FG002|Overall Study|Scheduling issue|3|||
145266400|NCT02260804|523823313|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
145266401|NCT02260804|523823314|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
145266402|NCT00437294|523825152|FG000|Overall Study|Adverse Event|5|||
145266403|NCT00437294|523825153|FG001|Overall Study|Adverse Event|4|||
145266404|NCT00437294|523825152|FG000|Overall Study|Death|5|||
145266405|NCT00437294|523825153|FG001|Overall Study|Death|2|||
145266406|NCT00437294|523825152|FG000|Overall Study|Physician Decision|0|||
145266407|NCT00437294|523825153|FG001|Overall Study|Physician Decision|3|||
145266408|NCT00437294|523825152|FG000|Overall Study|Withdrawal by Subject|5|||
145266409|NCT00437294|523825153|FG001|Overall Study|Withdrawal by Subject|0|||
145266410|NCT00437294|523825152|FG000|Overall Study|Progressive Disease|19|||
145266411|NCT00437294|523825153|FG001|Overall Study|Progressive Disease|23|||
145266412|NCT00437294|523825152|FG000|Overall Study|Sponsor Decision|8|||
145266413|NCT00437294|523825153|FG001|Overall Study|Sponsor Decision|9|||
145266414|NCT00437294|523825152|FG000|Overall Study|Protocol Violation|0|||
145266415|NCT00437294|523825153|FG001|Overall Study|Protocol Violation|1|||
145266416|NCT00437294|523825152|FG000|Overall Study|Entry criteria not met|1|||
145266417|NCT00437294|523825153|FG001|Overall Study|Entry criteria not met|1|||
145266418|NCT00812968|523825164|FG000|Overall Study|Relapse after erythroid response|6|||
145266419|NCT00812968|523825164|FG000|Overall Study|Disease progression|1|||
145266420|NCT00812968|523825164|FG000|Overall Study|No further treatment required|1|||
145266421|NCT00812968|523825164|FG000|Overall Study|Study closed due to marketing approval|3|||
145266422|NCT00494234|523825165|FG000|Overall Study|Withdrawal by Subject|1|||
145266423|NCT00494234|523825166|FG001|Overall Study|Withdrawal by Subject|0|||
145266424|NCT00494234|523825165|FG000|Overall Study|Disease progression|11|||
145266425|NCT00494234|523825166|FG001|Overall Study|Disease progression|8|||
145266426|NCT00494234|523825165|FG000|Overall Study|Death|2|||
145266427|NCT00494234|523825166|FG001|Overall Study|Death|1|||
145266428|NCT04359758|523825167|FG000|Overall Study|Protocol Violation|3|||
145266429|NCT04359758|523825168|FG001|Overall Study|Protocol Violation|2|||
145266430|NCT01298362|523825172|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
145266431|NCT01298362|523825173|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
145266432|NCT00505765|523825180|FG000|Overall Study|Withdrawal by Subject|1|||
145266433|NCT00505765|523825181|FG001|Overall Study|Withdrawal by Subject|0|||
145266434|NCT00505765|523825182|FG002|Overall Study|Withdrawal by Subject|0|||
145266435|NCT00505765|523825180|FG000|Overall Study|Adverse Event|1|||
145266436|NCT00505765|523825181|FG001|Overall Study|Adverse Event|2|||
145266437|NCT00505765|523825182|FG002|Overall Study|Adverse Event|0|||
145266438|NCT00505765|523825180|FG000|Overall Study|Noncompliance|0|||
145266439|NCT00505765|523825181|FG001|Overall Study|Noncompliance|1|||
145266440|NCT00505765|523825182|FG002|Overall Study|Noncompliance|3|||
145266441|NCT01207219|523825184|FG000|Overall Study|changed diagnosis during study period|5|||
145266442|NCT01207219|523825185|FG001|Overall Study|changed diagnosis during study period|3|||
145266443|NCT01207219|523825186|FG002|Overall Study|changed diagnosis during study period|1|||
145266444|NCT01207219|523825184|FG000|Overall Study|Lost to Follow-up|6|||
145266445|NCT01207219|523825185|FG001|Overall Study|Lost to Follow-up|8|||
145266446|NCT01207219|523825186|FG002|Overall Study|Lost to Follow-up|6|||
145266447|NCT00620776|523825187|FG000|Overall Study|Did not receive treatment|3|||
145266448|NCT00620776|523825188|FG001|Overall Study|Did not receive treatment|5|||
145266449|NCT00620776|523825187|FG000|Overall Study|Adverse Event|2|||
145266450|NCT00620776|523825188|FG001|Overall Study|Adverse Event|3|||
145266451|NCT00620776|523825187|FG000|Overall Study|Lack of Efficacy|2|||
145266452|NCT00620776|523825188|FG001|Overall Study|Lack of Efficacy|1|||
145266453|NCT00620776|523825187|FG000|Overall Study|Lost to Follow-up|2|||
145266454|NCT00620776|523825188|FG001|Overall Study|Lost to Follow-up|5|||
145266455|NCT00620776|523825187|FG000|Overall Study|Withdrawal by Subject|3|||
145378964|NCT05459558|524239362|FG000|Overall Study|Withdrawal by Subject|0|||
145378965|NCT05459558|524239363|FG001|Overall Study|Withdrawal by Subject|0|||
145378966|NCT05459558|524239364|FG002|Overall Study|Withdrawal by Subject|2|||
145378967|NCT02921750|524239369|FG000|Overall Study|Adverse Event|1|||
145266456|NCT00620776|523825188|FG001|Overall Study|Withdrawal by Subject|2|||
145378968|NCT02921750|524239370|FG001|Overall Study|Adverse Event|2|||
145378969|NCT02921750|524239369|FG000|Overall Study|Withdrawal by Subject|1|||
145266457|NCT00183170|523825191|FG000|First Intervention|Did not complete study|1|||
145266458|NCT00183170|523825192|FG001|First Intervention|Did not complete study|0|||
145266459|NCT00183170|523825191|FG000|First Intervention|Did not meet targeted BrAC|1|||
145266460|NCT00183170|523825192|FG001|First Intervention|Did not meet targeted BrAC|0|||
145266461|NCT00183170|523825191|FG000|Washout 1 Week|Did not complete study|6|||
145266462|NCT00183170|523825192|FG001|Washout 1 Week|Did not complete study|8|||
145266463|NCT00183170|523825191|FG000|Second Intervention|Did not complete study|1|||
145266464|NCT00183170|523825192|FG001|Second Intervention|Did not complete study|0|||
145266465|NCT00183170|523825191|FG000|Second Intervention|Did not meet targeted BrAC|0|||
145266466|NCT00183170|523825192|FG001|Second Intervention|Did not meet targeted BrAC|2|||
145378970|NCT02921750|524239370|FG001|Overall Study|Withdrawal by Subject|1|||
145378971|NCT02921750|524239369|FG000|Overall Study|Lost to Follow-up|3|||
145378972|NCT02921750|524239370|FG001|Overall Study|Lost to Follow-up|3|||
145378973|NCT02921750|524239369|FG000|Overall Study|Wound healed|3|||
145378974|NCT02921750|524239370|FG001|Overall Study|Wound healed|3|||
145378975|NCT02921750|524239369|FG000|Overall Study|Serious Adverse Event|1|||
145378976|NCT02921750|524239370|FG001|Overall Study|Serious Adverse Event|2|||
145378977|NCT03292458|524239371|FG000|Period 1|Adverse Event|2|||
145378978|NCT03292458|524239372|FG001|Period 1|Adverse Event|0|||
145378979|NCT01472939|524239375|FG000|Overall Study|Adverse Event|3|||
145378980|NCT01472939|524239376|FG001|Overall Study|Adverse Event|7|||
145378981|NCT01472939|524239377|FG002|Overall Study|Adverse Event|7|||
145378982|NCT01472939|524239378|FG003|Overall Study|Adverse Event|14|||
145378983|NCT01472939|524239375|FG000|Overall Study|Lack of Efficacy|1|||
145266467|NCT00924820|523825193|FG000|Overall Study|Death|2|||
145266468|NCT00924820|523825193|FG000|Overall Study|Ineligible, Screen Failure|5|||
145266469|NCT00761969|523825194|FG000|Overall Study|Death|112|||
145266470|NCT00761969|523825195|FG001|Overall Study|Death|47|||
145266471|NCT00761969|523825194|FG000|Overall Study|Lost to Follow-up|88|||
145378984|NCT01472939|524239376|FG001|Overall Study|Lack of Efficacy|0|||
145378985|NCT01472939|524239377|FG002|Overall Study|Lack of Efficacy|0|||
145378986|NCT01472939|524239378|FG003|Overall Study|Lack of Efficacy|1|||
145378987|NCT01472939|524239375|FG000|Overall Study|Lost to Follow-up|3|||
145378988|NCT01472939|524239376|FG001|Overall Study|Lost to Follow-up|0|||
145378989|NCT01472939|524239377|FG002|Overall Study|Lost to Follow-up|2|||
145378990|NCT01472939|524239378|FG003|Overall Study|Lost to Follow-up|0|||
145378991|NCT01472939|524239375|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145266472|NCT00761969|523825195|FG001|Overall Study|Lost to Follow-up|93|||
145266473|NCT01725217|523825196|FG000|Overall Study|Withdrawal by Subject|1|||
145266474|NCT01725217|523825197|FG001|Overall Study|Withdrawal by Subject|0|||
145266475|NCT01725217|523825198|FG002|Overall Study|Withdrawal by Subject|0|||
145266476|NCT03992456|523825199|FG000|Overall Study|Withdrawal by Subject|1|||
145266477|NCT03992456|523825200|FG001|Overall Study|Withdrawal by Subject|0|||
145266478|NCT03992456|523825199|FG000|Overall Study|Disease progression|4|||
145266479|NCT03992456|523825200|FG001|Overall Study|Disease progression|5|||
145266480|NCT03992456|523825199|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
145266481|NCT03992456|523825200|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
145266482|NCT01068418|523825203|FG000|Overall Study|Physician Decision|12|||
145266483|NCT00910000|523825204|FG000|Overall Study|Adverse Event|0|||
145266484|NCT00910000|523825205|FG001|Overall Study|Adverse Event|3|||
145266485|NCT00910000|523825206|FG002|Overall Study|Adverse Event|2|||
145266486|NCT00910000|523825207|FG003|Overall Study|Adverse Event|2|||
145266487|NCT00910000|523825208|FG004|Overall Study|Adverse Event|0|||
145266488|NCT00910000|523825209|FG005|Overall Study|Adverse Event|1|||
145266489|NCT00910000|523825204|FG000|Overall Study|Withdrawal by Subject|0|||
145266490|NCT00910000|523825205|FG001|Overall Study|Withdrawal by Subject|0|||
145266491|NCT00910000|523825206|FG002|Overall Study|Withdrawal by Subject|1|||
145266492|NCT00910000|523825207|FG003|Overall Study|Withdrawal by Subject|0|||
145266493|NCT00910000|523825208|FG004|Overall Study|Withdrawal by Subject|1|||
145266494|NCT00910000|523825209|FG005|Overall Study|Withdrawal by Subject|0|||
145266495|NCT04637815|523825210|FG000|Overall Study|Death|1|||
145266496|NCT04637815|523825211|FG001|Overall Study|Death|0|||
145266497|NCT04637815|523825210|FG000|Overall Study|Lost to Follow-up|5|||
145266498|NCT04637815|523825211|FG001|Overall Study|Lost to Follow-up|2|||
145266499|NCT01977625|523825212|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
145266500|NCT01977625|523825213|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145266501|NCT01977625|523825212|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145378992|NCT01472939|524239376|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145378993|NCT01472939|524239377|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
145378994|NCT01472939|524239378|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
145266502|NCT01977625|523825213|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145266503|NCT02594384|523825214|FG000|Overall Study|Disease Progression|3|||
145266504|NCT02594384|523825215|FG001|Overall Study|Disease Progression|7|||
145266505|NCT02594384|523825216|FG002|Overall Study|Disease Progression|0|||
145266506|NCT02594384|523825217|FG003|Overall Study|Disease Progression|2|||
145266507|NCT02594384|523825218|FG004|Overall Study|Disease Progression|2|||
145378995|NCT01472939|524239375|FG000|Overall Study|Prohibited Medication|0|||
145378996|NCT01472939|524239376|FG001|Overall Study|Prohibited Medication|1|||
145378997|NCT01472939|524239377|FG002|Overall Study|Prohibited Medication|0|||
145378998|NCT01472939|524239378|FG003|Overall Study|Prohibited Medication|0|||
145378999|NCT01472939|524239375|FG000|Overall Study|Withdrawal By PI|1|||
145266508|NCT02594384|523825219|FG005|Overall Study|Disease Progression|12|||
145266509|NCT02594384|523825220|FG006|Overall Study|Disease Progression|5|||
145379000|NCT01472939|524239376|FG001|Overall Study|Withdrawal By PI|0|||
145379001|NCT01472939|524239377|FG002|Overall Study|Withdrawal By PI|0|||
145379002|NCT01472939|524239378|FG003|Overall Study|Withdrawal By PI|0|||
145379003|NCT01472939|524239375|FG000|Overall Study|Protocol Violation|3|||
145379004|NCT01472939|524239376|FG001|Overall Study|Protocol Violation|3|||
145379005|NCT01472939|524239377|FG002|Overall Study|Protocol Violation|0|||
145379006|NCT01472939|524239378|FG003|Overall Study|Protocol Violation|1|||
145379007|NCT01472939|524239375|FG000|Overall Study|Withdrawal by Subject|9|||
145379008|NCT01472939|524239376|FG001|Overall Study|Withdrawal by Subject|3|||
145379009|NCT01472939|524239377|FG002|Overall Study|Withdrawal by Subject|1|||
145379010|NCT01472939|524239378|FG003|Overall Study|Withdrawal by Subject|4|||
145379011|NCT00114738|524239379|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
145379012|NCT00114738|524239380|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
145379013|NCT00114738|524239381|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
145379014|NCT00114738|524239379|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
145379015|NCT00114738|524239380|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
145379016|NCT00114738|524239381|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
145379017|NCT00114738|524239379|FG000|Screening for Randomization|Neuropathy|17|||
145379018|NCT00114738|524239380|FG001|Screening for Randomization|Neuropathy|0|||
145379019|NCT00114738|524239381|FG002|Screening for Randomization|Neuropathy|0|||
145379020|NCT00114738|524239379|FG000|Screening for Randomization|Progressive disease|2|||
145379021|NCT00114738|524239380|FG001|Screening for Randomization|Progressive disease|0|||
145379022|NCT00114738|524239381|FG002|Screening for Randomization|Progressive disease|0|||
145379023|NCT00114738|524239379|FG000|Screening for Randomization|CNS Hemorrhage|1|||
145379024|NCT00114738|524239380|FG001|Screening for Randomization|CNS Hemorrhage|0|||
145379025|NCT00114738|524239381|FG002|Screening for Randomization|CNS Hemorrhage|0|||
145379026|NCT00114738|524239379|FG000|Screening for Randomization|Other|1|||
145379027|NCT00114738|524239380|FG001|Screening for Randomization|Other|0|||
145379028|NCT00114738|524239381|FG002|Screening for Randomization|Other|0|||
145379029|NCT01492101|524239382|FG000|Overall Study|Death|323|||
145379030|NCT01492101|524239383|FG001|Overall Study|Death|322|||
145379031|NCT01492101|524239382|FG000|Overall Study|Withdrawal by Subject|14|||
145379032|NCT01492101|524239383|FG001|Overall Study|Withdrawal by Subject|18|||
145379033|NCT01492101|524239382|FG000|Overall Study|Lost to Follow-up|0|||
145379034|NCT01492101|524239383|FG001|Overall Study|Lost to Follow-up|2|||
145379035|NCT02696434|524239384|FG000|Overall Study|Adverse Event|3|||
145379036|NCT02696434|524239385|FG001|Overall Study|Adverse Event|1|||
145379037|NCT02696434|524239384|FG000|Overall Study|Lost to Follow-up|5|||
145379038|NCT02696434|524239385|FG001|Overall Study|Lost to Follow-up|4|||
145379039|NCT02696434|524239384|FG000|Overall Study|Withdrawal by Subject|14|||
145379040|NCT02696434|524239385|FG001|Overall Study|Withdrawal by Subject|12|||
145379041|NCT02696434|524239384|FG000|Overall Study|Physician Decision|0|||
145379042|NCT02696434|524239385|FG001|Overall Study|Physician Decision|1|||
145379043|NCT00316914|524239386|FG000|Overall Study|Withdrawal by Subject|5|||
145379044|NCT00316914|524239387|FG001|Overall Study|Withdrawal by Subject|3|||
145379045|NCT00316914|524239386|FG000|Overall Study|Adverse Event|8|||
145379046|NCT00316914|524239387|FG001|Overall Study|Adverse Event|7|||
145379047|NCT00316914|524239386|FG000|Overall Study|Other Problems|6|||
145379048|NCT00316914|524239387|FG001|Overall Study|Other Problems|11|||
145379049|NCT00316914|524239386|FG000|Overall Study|Missing end of treatment documentation|14|||
145379050|NCT00316914|524239387|FG001|Overall Study|Missing end of treatment documentation|15|||
145379051|NCT01675154|524239388|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145379052|NCT01675154|524239389|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
145379053|NCT01675154|524239390|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145379054|NCT01675154|524239391|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
145379055|NCT00427999|524239392|FG000|Overall Study|Adverse Event|6|||
145379056|NCT00427999|524239392|FG000|Overall Study|Abnormal laboratory values|1|||
145379057|NCT00427999|524239392|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
145379058|NCT00427999|524239392|FG000|Overall Study|Protocol Violation|2|||
145266510|NCT02594384|523825221|FG007|Overall Study|Disease Progression|5|||
145266511|NCT02594384|523825214|FG000|Overall Study|Adverse Event|0|||
145266512|NCT02594384|523825215|FG001|Overall Study|Adverse Event|1|||
145266513|NCT02594384|523825216|FG002|Overall Study|Adverse Event|4|||
145266514|NCT02594384|523825217|FG003|Overall Study|Adverse Event|1|||
145379059|NCT00427999|524239392|FG000|Overall Study|Withdrawal by Subject|9|||
145379060|NCT00427999|524239392|FG000|Overall Study|Death|1|||
145379061|NCT02971800|524239393|FG000|Overall Study|Protocol Violation|1|||
145266515|NCT02594384|523825218|FG004|Overall Study|Adverse Event|0|||
145379062|NCT02971800|524239393|FG000|Overall Study|Withdrawal by Subject|1|||
145379063|NCT02971800|524239393|FG000|Overall Study|Exclusion criteria prior intervention|1|||
145379064|NCT02971800|524239393|FG000|Overall Study|Number evaluable participant already reached|4|||
145379065|NCT00616603|524239394|FG000|Overall Study|Physician Decision|2|||
145379066|NCT00616603|524239395|FG001|Overall Study|Physician Decision|0|||
145379067|NCT00616603|524239396|FG002|Overall Study|Physician Decision|2|||
145379068|NCT00766467|524239399|FG000|Overall Study|Withdrawal by Subject|7|||
145379069|NCT00766467|524239400|FG001|Overall Study|Withdrawal by Subject|2|||
145379070|NCT00766467|524239399|FG000|Overall Study|Adverse Event|1|||
145379071|NCT00766467|524239400|FG001|Overall Study|Adverse Event|1|||
145379072|NCT00766467|524239399|FG000|Overall Study|Protocol Violation|2|||
145379073|NCT00766467|524239400|FG001|Overall Study|Protocol Violation|4|||
145379074|NCT00766467|524239399|FG000|Overall Study|Tumor Progression on Study|0|||
145379075|NCT00766467|524239400|FG001|Overall Study|Tumor Progression on Study|1|||
145379076|NCT00766467|524239399|FG000|Overall Study|Physician Decision|1|||
145379077|NCT00766467|524239400|FG001|Overall Study|Physician Decision|0|||
145379078|NCT01917344|524239401|FG000|Overall Study|Withdrawal by Subject|1|||
145379079|NCT00367484|524239402|FG000|Overall Study|Adverse Event|7|||
145379080|NCT00367484|524239402|FG000|Overall Study|Withdrew informed consent|5|||
145379081|NCT00367484|524239402|FG000|Overall Study|Travel to USA|1|||
145379082|NCT00367484|524239402|FG000|Overall Study|Lost to Follow-up|1|||
145379083|NCT00367484|524239402|FG000|Overall Study|Protocol Violation|1|||
145379084|NCT00367484|524239402|FG000|Overall Study|The choice of the patient|1|||
145379085|NCT00367484|524239402|FG000|Overall Study|Lack of Efficacy|1|||
145379086|NCT01777295|524239403|FG000|Overall Study|Withdrawal by Subject|2|||
145379087|NCT01777295|524239404|FG001|Overall Study|Withdrawal by Subject|2|||
145379088|NCT01777295|524239403|FG000|Overall Study|Pregnancy|0|||
145379089|NCT01777295|524239404|FG001|Overall Study|Pregnancy|1|||
145379090|NCT01777295|524239403|FG000|Overall Study|Personal problem|1|||
145379091|NCT01777295|524239404|FG001|Overall Study|Personal problem|0|||
145379092|NCT01777295|524239403|FG000|Overall Study|Investigator call for AEs check|1|||
145379093|NCT01777295|524239404|FG001|Overall Study|Investigator call for AEs check|0|||
145379094|NCT01546038|524239406|FG000|Overall Study|Death|15|||
145379095|NCT01546038|524239407|FG001|Overall Study|Death|6|||
145379096|NCT01546038|524239408|FG002|Overall Study|Death|4|||
145379097|NCT01546038|524239409|FG003|Overall Study|Death|2|||
145379098|NCT01546038|524239410|FG004|Overall Study|Death|9|||
145379099|NCT01546038|524239411|FG005|Overall Study|Death|3|||
145379100|NCT01546038|524239412|FG006|Overall Study|Death|46|||
145379101|NCT01546038|524239413|FG007|Overall Study|Death|76|||
145379102|NCT01546038|524239414|FG008|Overall Study|Death|39|||
145379103|NCT01546038|524239406|FG000|Overall Study|Lost to Follow-up|0|||
145379104|NCT01546038|524239407|FG001|Overall Study|Lost to Follow-up|0|||
145379105|NCT01546038|524239408|FG002|Overall Study|Lost to Follow-up|0|||
145379106|NCT01546038|524239409|FG003|Overall Study|Lost to Follow-up|0|||
145379107|NCT01546038|524239410|FG004|Overall Study|Lost to Follow-up|1|||
145379108|NCT01546038|524239411|FG005|Overall Study|Lost to Follow-up|0|||
145379109|NCT01546038|524239412|FG006|Overall Study|Lost to Follow-up|2|||
145379110|NCT01546038|524239413|FG007|Overall Study|Lost to Follow-up|1|||
145379111|NCT01546038|524239414|FG008|Overall Study|Lost to Follow-up|0|||
145379112|NCT01546038|524239406|FG000|Overall Study|Withdrawal by Subject|1|||
145379113|NCT01546038|524239407|FG001|Overall Study|Withdrawal by Subject|0|||
145379114|NCT01546038|524239408|FG002|Overall Study|Withdrawal by Subject|0|||
145379115|NCT01546038|524239409|FG003|Overall Study|Withdrawal by Subject|1|||
145379116|NCT01546038|524239410|FG004|Overall Study|Withdrawal by Subject|0|||
145379117|NCT01546038|524239411|FG005|Overall Study|Withdrawal by Subject|1|||
145379118|NCT01546038|524239412|FG006|Overall Study|Withdrawal by Subject|3|||
145379119|NCT01546038|524239413|FG007|Overall Study|Withdrawal by Subject|3|||
145379120|NCT01546038|524239414|FG008|Overall Study|Withdrawal by Subject|1|||
145379121|NCT01546038|524239406|FG000|Overall Study|: Randomized, not treated|0|||
145379122|NCT01546038|524239407|FG001|Overall Study|: Randomized, not treated|0|||
145379123|NCT01546038|524239408|FG002|Overall Study|: Randomized, not treated|0|||
145379124|NCT01546038|524239409|FG003|Overall Study|: Randomized, not treated|0|||
145379125|NCT01546038|524239410|FG004|Overall Study|: Randomized, not treated|0|||
145379126|NCT01546038|524239411|FG005|Overall Study|: Randomized, not treated|0|||
145379127|NCT01546038|524239412|FG006|Overall Study|: Randomized, not treated|2|||
145379128|NCT01546038|524239413|FG007|Overall Study|: Randomized, not treated|4|||
145379129|NCT01546038|524239414|FG008|Overall Study|: Randomized, not treated|3|||
145379130|NCT04245202|524239415|FG000|Overall Study|Lack of Efficacy|10|||
145379131|NCT04245202|524239416|FG001|Overall Study|Lack of Efficacy|1|||
145379132|NCT03515629|524239417|FG000|Overall Study|Death|0|||
145379133|NCT03515629|524239418|FG001|Overall Study|Death|1|||
145379134|NCT03515629|524239419|FG002|Overall Study|Death|1|||
145379135|NCT03515629|524239417|FG000|Overall Study|Progressive disease|0|||
145379136|NCT03515629|524239418|FG001|Overall Study|Progressive disease|1|||
145379137|NCT03515629|524239419|FG002|Overall Study|Progressive disease|0|||
145379138|NCT00312572|524239423|FG000|Overall Study|Adverse Event|10|||
145379139|NCT00312572|524239424|FG001|Overall Study|Adverse Event|16|||
145379140|NCT00312572|524239423|FG000|Overall Study|Lost to Follow-up|1|||
145379141|NCT00312572|524239424|FG001|Overall Study|Lost to Follow-up|1|||
145379142|NCT00312572|524239423|FG000|Overall Study|Administrative|4|||
145379143|NCT00312572|524239424|FG001|Overall Study|Administrative|2|||
145379144|NCT00312572|524239423|FG000|Overall Study|Lack of Efficacy|1|||
145379145|NCT00312572|524239424|FG001|Overall Study|Lack of Efficacy|2|||
145379146|NCT05385224|524239425|FG000|Overall Study|Unable to swallow capsule|2|||
145379147|NCT05385224|524239425|FG000|Overall Study|Withdrawal by Subject|2|||
145379148|NCT05385224|524239425|FG000|Overall Study|Did not meet study criteria|1|||
145379149|NCT01133288|524239432|FG000|Eligibility Assessment|met exclusion criteria|5|||
145379150|NCT01133288|524239432|FG000|Intervention Allocation|study terminated|2|||
145379151|NCT01832818|524239433|FG000|Overall Study|Lost to Follow-up|6|||
145379152|NCT00551161|524239434|FG000|Overall Study|Withdrawal by Subject|1|||
145379153|NCT01672294|524239436|FG000|Overall Study|Withdrawal by Subject|4|||
145379154|NCT01672294|524239437|FG001|Overall Study|Withdrawal by Subject|4|||
145379155|NCT01672294|524239438|FG002|Overall Study|Withdrawal by Subject|4|||
145379156|NCT01672294|524239439|FG003|Overall Study|Withdrawal by Subject|4|||
145379157|NCT01672294|524239436|FG000|Overall Study|Excluded by study|1|||
145379158|NCT01672294|524239437|FG001|Overall Study|Excluded by study|1|||
145379159|NCT01672294|524239438|FG002|Overall Study|Excluded by study|0|||
145379160|NCT01672294|524239439|FG003|Overall Study|Excluded by study|0|||
145379161|NCT01672294|524239436|FG000|Overall Study|Lost to Follow-up|1|||
145379162|NCT01672294|524239437|FG001|Overall Study|Lost to Follow-up|16|||
145379163|NCT01672294|524239438|FG002|Overall Study|Lost to Follow-up|7|||
145379164|NCT01672294|524239439|FG003|Overall Study|Lost to Follow-up|9|||
145379165|NCT03379792|524239440|FG000|Overall Study|Physician Decision|0|||
145379166|NCT03379792|524239441|FG001|Overall Study|Physician Decision|0|||
145379167|NCT03379792|524239442|FG002|Overall Study|Physician Decision|0|||
145379168|NCT03379792|524239443|FG003|Overall Study|Physician Decision|1|||
145379169|NCT03379792|524239444|FG004|Overall Study|Physician Decision|0|||
145379170|NCT03379792|524239445|FG005|Overall Study|Physician Decision|0|||
145379171|NCT03379792|524239440|FG000|Overall Study|Withdrawal by Subject|0|||
145379172|NCT03379792|524239441|FG001|Overall Study|Withdrawal by Subject|0|||
145379173|NCT03379792|524239442|FG002|Overall Study|Withdrawal by Subject|0|||
145379174|NCT03379792|524239443|FG003|Overall Study|Withdrawal by Subject|0|||
145379175|NCT03379792|524239444|FG004|Overall Study|Withdrawal by Subject|1|||
145379176|NCT03379792|524239445|FG005|Overall Study|Withdrawal by Subject|1|||
145379177|NCT01121536|524239447|FG000|Overall Study|Adverse Event|63|||
145379178|NCT01121536|524239447|FG000|Overall Study|Lack of Efficacy|35|||
145379179|NCT01121536|524239447|FG000|Overall Study|Withdrawal by Subject|65|||
145379180|NCT01121536|524239447|FG000|Overall Study|Protocol Violation|20|||
145379181|NCT01121536|524239447|FG000|Overall Study|Noncompliance with study medication|12|||
145379182|NCT01121536|524239447|FG000|Overall Study|Noncompliance with study procedures|9|||
145379183|NCT01121536|524239447|FG000|Overall Study|Lost to Follow-up|39|||
145379184|NCT01121536|524239447|FG000|Overall Study|Other|118|||
145379185|NCT01273155|524239448|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
145379186|NCT01273155|524239449|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
145379187|NCT01273155|524239450|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
145379188|NCT01273155|524239451|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
145379189|NCT01273155|524239452|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
145379190|NCT01273155|524239453|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
145379191|NCT01273155|524239454|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
145379192|NCT01273155|524239448|FG000|Overall Study|Change in liver function/no longer eval.|0|||
145379193|NCT01273155|524239449|FG001|Overall Study|Change in liver function/no longer eval.|1|||
145379194|NCT01273155|524239450|FG002|Overall Study|Change in liver function/no longer eval.|0|||
145379195|NCT01273155|524239451|FG003|Overall Study|Change in liver function/no longer eval.|0|||
145379196|NCT01273155|524239452|FG004|Overall Study|Change in liver function/no longer eval.|1|||
145379197|NCT01273155|524239453|FG005|Overall Study|Change in liver function/no longer eval.|0|||
145379198|NCT01273155|524239454|FG006|Overall Study|Change in liver function/no longer eval.|0|||
145379199|NCT01273155|524239448|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
145379200|NCT01273155|524239449|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
145379201|NCT01273155|524239450|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
145379202|NCT01273155|524239451|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
145379203|NCT01273155|524239452|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
145379204|NCT01273155|524239453|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
145379205|NCT01273155|524239454|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
145379206|NCT01273155|524239448|FG000|Overall Study|Died during Cycle 1|0|||
145379207|NCT01273155|524239449|FG001|Overall Study|Died during Cycle 1|0|||
145379208|NCT01273155|524239450|FG002|Overall Study|Died during Cycle 1|1|||
145379209|NCT01273155|524239451|FG003|Overall Study|Died during Cycle 1|1|||
145379210|NCT01273155|524239452|FG004|Overall Study|Died during Cycle 1|0|||
145379211|NCT01273155|524239453|FG005|Overall Study|Died during Cycle 1|2|||
145379212|NCT01273155|524239454|FG006|Overall Study|Died during Cycle 1|2|||
145379213|NCT01273155|524239448|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
145379214|NCT01273155|524239449|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
145379215|NCT01273155|524239450|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
145379216|NCT01273155|524239451|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
145379217|NCT01273155|524239452|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
145379218|NCT01273155|524239453|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
145379219|NCT01273155|524239454|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
145379220|NCT01256385|524239455|FG000|Overall Study|Physician Decision|1|||
145379221|NCT01256385|524239456|FG001|Overall Study|Physician Decision|1|||
145379222|NCT01256385|524239455|FG000|Overall Study|Withdrawal by Subject|2|||
145379223|NCT01256385|524239456|FG001|Overall Study|Withdrawal by Subject|2|||
145379224|NCT00401960|524239457|FG000|Overall Study|Lost to Follow-up|3|||
145379225|NCT00401960|524239458|FG001|Overall Study|Lost to Follow-up|0|||
145379226|NCT00401960|524239457|FG000|Overall Study|Death|2|||
145379227|NCT00401960|524239458|FG001|Overall Study|Death|0|||
145379228|NCT02649426|524239459|FG000|Overall Study|Follow-up on going|1|||
145379229|NCT02649426|524239460|FG001|Overall Study|Follow-up on going|26|||
145379230|NCT02649426|524239461|FG002|Overall Study|Follow-up on going|28|||
145379231|NCT02649426|524239462|FG003|Overall Study|Follow-up on going|31|||
145379232|NCT01606202|524239463|FG000|Overall Study|Adverse Event|5|||
145379233|NCT01606202|524239464|FG001|Overall Study|Adverse Event|0|||
145379234|NCT01606202|524239463|FG000|Overall Study|Withdrawal by Subject|2|||
145379235|NCT01606202|524239464|FG001|Overall Study|Withdrawal by Subject|1|||
145379236|NCT01606202|524239463|FG000|Overall Study|Personal problems|0|||
145379237|NCT01606202|524239464|FG001|Overall Study|Personal problems|1|||
145379238|NCT01606202|524239463|FG000|Overall Study|Problems with administration|0|||
145379239|NCT01606202|524239464|FG001|Overall Study|Problems with administration|1|||
145379240|NCT03008278|524239465|FG000|Overall Study|Progressive Disease|0|||
145379241|NCT03008278|524239466|FG001|Overall Study|Progressive Disease|0|||
145379242|NCT03008278|524239467|FG002|Overall Study|Progressive Disease|32|||
145379243|NCT03008278|524239465|FG000|Overall Study|Adverse Event|0|||
145379244|NCT03008278|524239466|FG001|Overall Study|Adverse Event|0|||
145379245|NCT03008278|524239467|FG002|Overall Study|Adverse Event|4|||
145379246|NCT03008278|524239465|FG000|Overall Study|Withdrawal by Subject|0|||
145379247|NCT03008278|524239466|FG001|Overall Study|Withdrawal by Subject|0|||
145379248|NCT03008278|524239467|FG002|Overall Study|Withdrawal by Subject|3|||
145379249|NCT03008278|524239465|FG000|Overall Study|Physician Decision|0|||
145379250|NCT03008278|524239466|FG001|Overall Study|Physician Decision|2|||
145379251|NCT03008278|524239467|FG002|Overall Study|Physician Decision|0|||
145379252|NCT01389258|524239468|FG000|Overall Study|Lost to Follow-up|5|||
145379253|NCT01217385|524239469|FG000|Overall Study|Withdrawal by Subject|3|||
145379254|NCT01217385|524239469|FG000|Overall Study|DOSI not performed/not eval|12|||
145379255|NCT01217385|524239469|FG000|Overall Study|Central Path not Available|1|||
145379256|NCT01217385|524239469|FG000|Overall Study|Normal Breast TOI not available|10|||
145379257|NCT02918552|524239470|FG000|Overall Study|Failed Pharmacokinetics|1|||
145379258|NCT02918552|524239471|FG001|Overall Study|Failed Pharmacokinetics|0|||
145379259|NCT02918552|524239470|FG000|Overall Study|Withdrawal by Subject|0|||
145379260|NCT02918552|524239471|FG001|Overall Study|Withdrawal by Subject|1|||
145379261|NCT02918552|524239470|FG000|Overall Study|Lost to Follow-up|0|||
145379262|NCT02918552|524239471|FG001|Overall Study|Lost to Follow-up|1|||
145379263|NCT04395274|524239472|FG000|Overall Study|Lost to Follow-up|20|||
145379264|NCT04395274|524239473|FG001|Overall Study|Lost to Follow-up|11|||
145379265|NCT04395274|524239472|FG000|Overall Study|Withdrawal by Subject|13|||
145379266|NCT04395274|524239473|FG001|Overall Study|Withdrawal by Subject|10|||
145379267|NCT04395274|524239472|FG000|Overall Study|Moved Abroad|0|||
145379268|NCT04395274|524239473|FG001|Overall Study|Moved Abroad|1|||
145379269|NCT03482167|524239474|FG000|Allocated to Intervention|Physician Decision|1|||
145379270|NCT03482167|524239475|FG001|Allocated to Intervention|Physician Decision|2|||
145379271|NCT03482167|524239474|FG000|Received Intervention|Adverse Event|3|||
145379272|NCT03482167|524239475|FG001|Received Intervention|Adverse Event|1|||
145379273|NCT03482167|524239474|FG000|Received Intervention|Physician Decision|1|||
145379274|NCT03482167|524239475|FG001|Received Intervention|Physician Decision|1|||
145379275|NCT03482167|524239474|FG000|Received Intervention|Withdrawal by Subject|1|||
145379276|NCT03482167|524239475|FG001|Received Intervention|Withdrawal by Subject|0|||
145379277|NCT02680834|524239477|FG000|Overall Study|Physician Decision|5|||
145379278|NCT02680834|524239478|FG001|Overall Study|Physician Decision|2|||
145718133|NCT00468104|525483140|FG001|First Intervention|associated prolonged pneumothorax|0|||
145379279|NCT02680834|524239477|FG000|Overall Study|Withdrawal by Subject|6|||
145379280|NCT02680834|524239478|FG001|Overall Study|Withdrawal by Subject|0|||
145379281|NCT02680834|524239477|FG000|Overall Study|Lost to Follow-up|0|||
145379282|NCT02680834|524239478|FG001|Overall Study|Lost to Follow-up|1|||
145379283|NCT01362244|524239479|FG000|Overall Study|Adverse Event|3|||
145379284|NCT01362244|524239480|FG001|Overall Study|Adverse Event|5|||
145379285|NCT01362244|524239479|FG000|Overall Study|Lack of Efficacy|5|||
145379286|NCT01362244|524239480|FG001|Overall Study|Lack of Efficacy|11|||
145379287|NCT01362244|524239479|FG000|Overall Study|Lost to Follow-up|0|||
145379288|NCT01362244|524239480|FG001|Overall Study|Lost to Follow-up|2|||
145379289|NCT01362244|524239479|FG000|Overall Study|Protocol Violation|5|||
145379290|NCT01362244|524239480|FG001|Overall Study|Protocol Violation|1|||
145379291|NCT01362244|524239479|FG000|Overall Study|Withdrawal by Subject|2|||
145379292|NCT01362244|524239480|FG001|Overall Study|Withdrawal by Subject|1|||
145379293|NCT01362244|524239479|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
145379294|NCT01362244|524239480|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
145379295|NCT01362244|524239479|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
145379296|NCT01362244|524239480|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
145379297|NCT02407054|524239483|FG000|Overall Study|Adverse Event|1|||
145379298|NCT02407054|524239484|FG001|Overall Study|Adverse Event|4|||
145379299|NCT02407054|524239485|FG002|Overall Study|Adverse Event|1|||
145379300|NCT02407054|524239483|FG000|Overall Study|Non-compliance with Study|0|||
145379301|NCT02407054|524239484|FG001|Overall Study|Non-compliance with Study|2|||
145379302|NCT02407054|524239485|FG002|Overall Study|Non-compliance with Study|1|||
145379303|NCT02407054|524239483|FG000|Overall Study|Physician Decision|1|||
145379304|NCT02407054|524239484|FG001|Overall Study|Physician Decision|3|||
145379305|NCT02407054|524239485|FG002|Overall Study|Physician Decision|3|||
145379306|NCT02407054|524239483|FG000|Overall Study|Withdrawal by Subject|5|||
145379307|NCT02407054|524239484|FG001|Overall Study|Withdrawal by Subject|9|||
145379308|NCT02407054|524239485|FG002|Overall Study|Withdrawal by Subject|2|||
145379309|NCT00415597|524239486|FG000|Enrollment|Withdrawal by Subject|1|||
145379310|NCT00415597|524239486|FG000|Enrollment|Protocol Violation|1|||
145379311|NCT00415597|524239486|FG000|Treatment|Adverse Event|110|||
145379312|NCT00415597|524239486|FG000|Treatment|Lack of Efficacy|39|||
145379313|NCT00415597|524239486|FG000|Treatment|Protocol Violation|67|||
145379314|NCT00415597|524239486|FG000|Treatment|Physician Decision|3|||
145379315|NCT00415597|524239486|FG000|Treatment|Withdrawal by Subject|51|||
145379316|NCT00415597|524239486|FG000|Treatment|Lost to Follow-up|28|||
145379317|NCT00415597|524239486|FG000|Treatment|Drug Screen|2|||
145379318|NCT00415597|524239486|FG000|Treatment|Administrative|3|||
145379319|NCT00415597|524239486|FG000|Treatment|Sponsor Decision|1|||
145379320|NCT00415597|524239486|FG000|Treatment|Multiple Reasons|1|||
145379321|NCT04102865|524239488|FG000|Overall Study|Adverse Event|4|||
145379322|NCT04102865|524239489|FG001|Overall Study|Adverse Event|0|||
145379323|NCT04102865|524239488|FG000|Overall Study|Lost to Follow-up|1|||
145379324|NCT04102865|524239489|FG001|Overall Study|Lost to Follow-up|0|||
145379325|NCT04102865|524239488|FG000|Overall Study|Withdrawal by Subject|2|||
145379326|NCT04102865|524239489|FG001|Overall Study|Withdrawal by Subject|0|||
145379327|NCT01764997|524239490|FG000|Run-in Period|Adverse Event|15|||
145379328|NCT01764997|524239491|FG001|Run-in Period|Adverse Event|0|||
145379329|NCT01764997|524239492|FG002|Run-in Period|Adverse Event|0|||
145379330|NCT01764997|524239493|FG003|Run-in Period|Adverse Event|0|||
145379331|NCT01764997|524239494|FG004|Run-in Period|Adverse Event|0|||
145379332|NCT01764997|524239490|FG000|Run-in Period|Lack of Efficacy|5|||
145379333|NCT01764997|524239491|FG001|Run-in Period|Lack of Efficacy|0|||
145379334|NCT01764997|524239492|FG002|Run-in Period|Lack of Efficacy|0|||
145379335|NCT01764997|524239493|FG003|Run-in Period|Lack of Efficacy|0|||
145379336|NCT01764997|524239494|FG004|Run-in Period|Lack of Efficacy|0|||
145379337|NCT01764997|524239490|FG000|Run-in Period|Poor compliance to protocol|1|||
145379338|NCT01764997|524239491|FG001|Run-in Period|Poor compliance to protocol|0|||
145379339|NCT01764997|524239492|FG002|Run-in Period|Poor compliance to protocol|0|||
145379340|NCT01764997|524239493|FG003|Run-in Period|Poor compliance to protocol|0|||
145379341|NCT01764997|524239494|FG004|Run-in Period|Poor compliance to protocol|0|||
145379342|NCT01764997|524239490|FG000|Run-in Period|Other than specified above|17|||
145379343|NCT01764997|524239491|FG001|Run-in Period|Other than specified above|0|||
145379344|NCT01764997|524239492|FG002|Run-in Period|Other than specified above|0|||
145379345|NCT01764997|524239493|FG003|Run-in Period|Other than specified above|0|||
145379346|NCT01764997|524239494|FG004|Run-in Period|Other than specified above|0|||
145379347|NCT01764997|524239490|FG000|Study Drug Treatment Period|Adverse Event|0|||
145379348|NCT01764997|524239491|FG001|Study Drug Treatment Period|Adverse Event|1|||
145379349|NCT01764997|524239492|FG002|Study Drug Treatment Period|Adverse Event|0|||
145379350|NCT01764997|524239493|FG003|Study Drug Treatment Period|Adverse Event|0|||
145379351|NCT01764997|524239494|FG004|Study Drug Treatment Period|Adverse Event|24|||
145379352|NCT01764997|524239490|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
145379353|NCT01764997|524239491|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
145379354|NCT01764997|524239492|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
145379355|NCT01764997|524239493|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
145379356|NCT01764997|524239494|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
145379357|NCT01764997|524239490|FG000|Study Drug Treatment Period|Other than specified above|0|||
145379358|NCT01764997|524239491|FG001|Study Drug Treatment Period|Other than specified above|0|||
145605465|NCT02202434|525070730|FG000|Overall Study|Death|70|||
145379359|NCT01764997|524239492|FG002|Study Drug Treatment Period|Other than specified above|0|||
145379360|NCT01764997|524239493|FG003|Study Drug Treatment Period|Other than specified above|0|||
145379361|NCT01764997|524239494|FG004|Study Drug Treatment Period|Other than specified above|10|||
145379362|NCT00787917|524239495|FG000|Blinded Treatment|Adverse Event|1|||
145379363|NCT00787917|524239496|FG001|Blinded Treatment|Adverse Event|0|||
145379364|NCT00787917|524239495|FG000|Blinded Treatment|Lack of Efficacy|1|||
145379365|NCT00787917|524239496|FG001|Blinded Treatment|Lack of Efficacy|0|||
145379366|NCT00787917|524239495|FG000|Blinded Treatment|Administrative problems|3|||
145379367|NCT00787917|524239496|FG001|Blinded Treatment|Administrative problems|2|||
145379368|NCT00787917|524239495|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
145379369|NCT00787917|524239496|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
145379370|NCT00787917|524239495|FG000|Open Label|Administrative problems|3|||
145379371|NCT00787917|524239496|FG001|Open Label|Administrative problems|0|||
145379372|NCT02172040|524239500|FG000|Overall Study|Adverse Event|0|||
145379373|NCT02172040|524239501|FG001|Overall Study|Adverse Event|2|||
145379374|NCT02172040|524239502|FG002|Overall Study|Adverse Event|0|||
145379375|NCT02172040|524239503|FG003|Overall Study|Adverse Event|0|||
145379376|NCT02172040|524239500|FG000|Overall Study|Protocol Violation|0|||
145379377|NCT02172040|524239501|FG001|Overall Study|Protocol Violation|1|||
145379378|NCT02172040|524239502|FG002|Overall Study|Protocol Violation|0|||
145379379|NCT02172040|524239503|FG003|Overall Study|Protocol Violation|0|||
145379380|NCT02172040|524239500|FG000|Overall Study|Withdrawal by Subject|0|||
145379381|NCT02172040|524239501|FG001|Overall Study|Withdrawal by Subject|0|||
145379382|NCT02172040|524239502|FG002|Overall Study|Withdrawal by Subject|1|||
145379383|NCT02172040|524239503|FG003|Overall Study|Withdrawal by Subject|0|||
145379384|NCT02172040|524239500|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
145379385|NCT02172040|524239501|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
145379386|NCT02172040|524239502|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
145379387|NCT02172040|524239503|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
145379388|NCT02172040|524239500|FG000|Overall Study|Family emergency abroad|0|||
145379389|NCT02172040|524239501|FG001|Overall Study|Family emergency abroad|0|||
145379390|NCT02172040|524239502|FG002|Overall Study|Family emergency abroad|0|||
145379391|NCT02172040|524239503|FG003|Overall Study|Family emergency abroad|1|||
145407444|NCT03806296|524347000|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
145407445|NCT03806296|524346998|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
145407446|NCT03806296|524346999|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
145407447|NCT03806296|524347000|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
145407448|NCT00790036|524347001|FG000|Overall Study|Abnormal lab values|3|||
145407449|NCT00790036|524347002|FG001|Overall Study|Abnormal lab values|2|||
145407450|NCT00790036|524347001|FG000|Overall Study|Administrative problems|5|||
145407451|NCT00790036|524347002|FG001|Overall Study|Administrative problems|9|||
145407452|NCT00790036|524347001|FG000|Overall Study|Adverse Event|113|||
145407453|NCT00790036|524347002|FG001|Overall Study|Adverse Event|44|||
145407454|NCT00790036|524347001|FG000|Overall Study|Death|1|||
145407455|NCT00790036|524347002|FG001|Overall Study|Death|0|||
145407456|NCT00790036|524347001|FG000|Overall Study|Disease progression|24|||
145407457|NCT00790036|524347002|FG001|Overall Study|Disease progression|48|||
145407458|NCT00790036|524347001|FG000|Overall Study|Lost to Follow-up|1|||
145407459|NCT00790036|524347002|FG001|Overall Study|Lost to Follow-up|2|||
145407460|NCT00790036|524347001|FG000|Overall Study|Protocol Violation|10|||
145407461|NCT00790036|524347002|FG001|Overall Study|Protocol Violation|2|||
145407462|NCT00790036|524347001|FG000|Overall Study|Withdrawal by Subject|18|||
145407463|NCT00790036|524347002|FG001|Overall Study|Withdrawal by Subject|7|||
145407464|NCT00790036|524347001|FG000|Overall Study|Subject/guardian decision|20|||
145407465|NCT00790036|524347002|FG001|Overall Study|Subject/guardian decision|7|||
145407466|NCT02340949|524347005|FG000|Overall Study|Adverse Event|4|||
145407467|NCT02340949|524347006|FG001|Overall Study|Adverse Event|2|||
145407468|NCT02340949|524347005|FG000|Overall Study|Withdrawal by Subject|2|||
145407469|NCT02340949|524347006|FG001|Overall Study|Withdrawal by Subject|0|||
145407470|NCT02340949|524347005|FG000|Overall Study|Progression disease|6|||
145407471|NCT02340949|524347006|FG001|Overall Study|Progression disease|2|||
145407472|NCT02340949|524347005|FG000|Overall Study|Death|3|||
145407473|NCT02340949|524347006|FG001|Overall Study|Death|0|||
145407474|NCT02340949|524347005|FG000|Overall Study|Physician Decision|1|||
145407475|NCT02340949|524347006|FG001|Overall Study|Physician Decision|0|||
145407476|NCT00296517|524347007|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
145407477|NCT00296517|524347008|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
145407478|NCT00296517|524347007|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
145407479|NCT00296517|524347008|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
145407480|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
145407481|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
145407482|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
145605466|NCT02202434|525070731|FG001|Overall Study|Death|39|||
145407483|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
145407484|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
145407485|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
145407486|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
145407487|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
145407488|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
145407489|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
145407490|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
145407491|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
145605467|NCT02202434|525070732|FG002|Overall Study|Death|13|||
145379392|NCT01911793|524241164|FG000|Overall Study|Physician Decision|1|||
145379393|NCT01911793|524241165|FG001|Overall Study|Physician Decision|5|||
145379394|NCT02697916|524241166|FG000|Overall Study|Death|357|||
145379395|NCT02697916|524241167|FG001|Overall Study|Death|315|||
145379396|NCT02697916|524241166|FG000|Overall Study|Withdrawal by Subject|221|||
145379397|NCT02697916|524241167|FG001|Overall Study|Withdrawal by Subject|393|||
145379398|NCT03774394|524241168|FG000|Overall Study|Withdrawal by Subject|2|||
145379399|NCT03774394|524241169|FG001|Overall Study|Withdrawal by Subject|0|||
145379400|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145379401|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
145379402|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145379403|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
145379404|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145379405|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145379406|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
145379407|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
145379408|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
145379409|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145379410|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145379411|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
145379412|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
145379413|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
145379414|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
145379415|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
145379416|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145379417|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145379418|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
145379419|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
145379420|NCT00994214|524241170|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
145379421|NCT00994214|524241171|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
145379422|NCT00994214|524241172|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
145379423|NCT00994214|524241173|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
145379424|NCT03246061|524241174|FG000|Overall Study|Still in follow-up|15|||
145379425|NCT03246061|524241175|FG001|Overall Study|Still in follow-up|21|||
145379426|NCT04710368|524241176|FG000|Overall Study|Withdrawal by Subject|9|||
145379427|NCT04710368|524241176|FG000|Overall Study|Lost to Follow-up|4|||
145379428|NCT04710368|524241176|FG000|Overall Study|Death|2|||
145379429|NCT04710368|524241176|FG000|Overall Study|Patient preference|11|||
145379430|NCT04710368|524241176|FG000|Overall Study|Treatment discontinuation|1|||
145379431|NCT02667587|524241188|FG000|Pre-Treatment|Not reported|1|||
145379432|NCT02667587|524241189|FG001|Pre-Treatment|Not reported|0|||
145379433|NCT02667587|524241188|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
145379434|NCT02667587|524241189|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
145379435|NCT02667587|524241188|FG000|Pre-Treatment|Participant withdrew consent|0|||
145379436|NCT02667587|524241189|FG001|Pre-Treatment|Participant withdrew consent|1|||
145379437|NCT02667587|524241188|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
145379438|NCT02667587|524241189|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
145379439|NCT02667587|524241188|FG000|End of Treatment|Disease Progression|193|||
145379440|NCT02667587|524241189|FG001|End of Treatment|Disease Progression|226|||
145379441|NCT02667587|524241188|FG000|End of Treatment|Study Drug Toxicity|75|||
145379442|NCT02667587|524241189|FG001|End of Treatment|Study Drug Toxicity|19|||
145379443|NCT02667587|524241188|FG000|End of Treatment|Death|2|||
145379444|NCT02667587|524241189|FG001|End of Treatment|Death|1|||
145379445|NCT02667587|524241188|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
145379446|NCT02667587|524241189|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
145379447|NCT02667587|524241188|FG000|End of Treatment|participant request to discontinue treatment|33|||
145379448|NCT02667587|524241189|FG001|End of Treatment|participant request to discontinue treatment|35|||
145379449|NCT02667587|524241188|FG000|End of Treatment|participant withdrew consent|5|||
145379450|NCT02667587|524241189|FG001|End of Treatment|participant withdrew consent|6|||
145379451|NCT02667587|524241188|FG000|End of Treatment|Lost to Follow-up|1|||
145379452|NCT02667587|524241189|FG001|End of Treatment|Lost to Follow-up|2|||
145379453|NCT02667587|524241188|FG000|End of Treatment|maximum clinical benefit|4|||
145379454|NCT02667587|524241189|FG001|End of Treatment|maximum clinical benefit|4|||
145379455|NCT02667587|524241188|FG000|End of Treatment|poor or non compliant|0|||
145379456|NCT02667587|524241189|FG001|End of Treatment|poor or non compliant|1|||
145379457|NCT02667587|524241188|FG000|End of Treatment|participant no longer meets study criteria|1|||
145379458|NCT02667587|524241189|FG001|End of Treatment|participant no longer meets study criteria|1|||
145379459|NCT02667587|524241188|FG000|End of Treatment|administrative reason by sponsor|1|||
145718134|NCT00468104|525483139|FG000|First Intervention|trapped lung|1|||
145379460|NCT02667587|524241189|FG001|End of Treatment|administrative reason by sponsor|29|||
145379461|NCT02667587|524241188|FG000|End of Treatment|other reasonse|21|||
145379462|NCT02667587|524241189|FG001|End of Treatment|other reasonse|10|||
145379463|NCT05940077|524241190|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
145379464|NCT00388297|524241192|FG000|Overall Study|Lost to Follow-up|16|||
145379465|NCT00388297|524241193|FG001|Overall Study|Lost to Follow-up|12|||
145379466|NCT00388297|524241194|FG002|Overall Study|Lost to Follow-up|11|||
145379467|NCT00388297|524241195|FG003|Overall Study|Lost to Follow-up|8|||
145379468|NCT04105010|524241218|FG000|Overall Study|Death|3|||
145379469|NCT04105010|524241219|FG001|Overall Study|Death|1|||
145379470|NCT04105010|524241220|FG002|Overall Study|Death|1|||
145379471|NCT04105010|524241221|FG003|Overall Study|Death|54|||
145379472|NCT04105010|524241218|FG000|Overall Study|Lost to Follow-up|0|||
145379473|NCT04105010|524241219|FG001|Overall Study|Lost to Follow-up|0|||
145379474|NCT04105010|524241220|FG002|Overall Study|Lost to Follow-up|0|||
145379475|NCT04105010|524241221|FG003|Overall Study|Lost to Follow-up|4|||
145379476|NCT04105010|524241218|FG000|Overall Study|Withdrawal by Subject|8|||
145379477|NCT04105010|524241219|FG001|Overall Study|Withdrawal by Subject|1|||
145379478|NCT04105010|524241220|FG002|Overall Study|Withdrawal by Subject|1|||
145379479|NCT04105010|524241221|FG003|Overall Study|Withdrawal by Subject|4|||
145379480|NCT04105010|524241218|FG000|Overall Study|Other reason|4|||
145379481|NCT04105010|524241219|FG001|Overall Study|Other reason|7|||
145379482|NCT04105010|524241220|FG002|Overall Study|Other reason|0|||
145379483|NCT04105010|524241221|FG003|Overall Study|Other reason|19|||
145379484|NCT05323994|524241224|FG000|Overall Study|Protocol Violation|1|||
145379485|NCT03570554|524241225|FG000|Overall Study|Non-compliance with study drug|0|||
145379486|NCT03570554|524241226|FG001|Overall Study|Non-compliance with study drug|0|||
145379487|NCT03570554|524241227|FG002|Overall Study|Non-compliance with study drug|1|||
145379488|NCT03570554|524241228|FG003|Overall Study|Non-compliance with study drug|0|||
145379489|NCT03570554|524241225|FG000|Overall Study|Adverse Event|0|||
145379490|NCT03570554|524241226|FG001|Overall Study|Adverse Event|0|||
145379491|NCT03570554|524241227|FG002|Overall Study|Adverse Event|0|||
145379492|NCT03570554|524241228|FG003|Overall Study|Adverse Event|1|||
145379493|NCT01420679|524241248|FG000|Overall Study|Disease Progression|3|||
145379494|NCT01420679|524241249|FG001|Overall Study|Disease Progression|2|||
145379495|NCT01420679|524241248|FG000|Overall Study|Adverse Event|4|||
145379496|NCT01420679|524241249|FG001|Overall Study|Adverse Event|0|||
145379497|NCT01420679|524241248|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
145379498|NCT01420679|524241249|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
145379499|NCT01420679|524241248|FG000|Overall Study|Patient Decision|1|||
145379500|NCT01420679|524241249|FG001|Overall Study|Patient Decision|0|||
145379501|NCT01420679|524241248|FG000|Overall Study|Investigator Decision|1|||
145379502|NCT01420679|524241249|FG001|Overall Study|Investigator Decision|2|||
145379503|NCT01420679|524241248|FG000|Overall Study|Sponsor Decision|3|||
145379504|NCT01420679|524241249|FG001|Overall Study|Sponsor Decision|3|||
145379505|NCT01420679|524241248|FG000|Overall Study|Other|1|||
145379506|NCT01420679|524241249|FG001|Overall Study|Other|0|||
145379507|NCT00943670|524241250|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
145379508|NCT00943670|524241250|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
145379509|NCT00943670|524241250|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
145379510|NCT00943670|524241250|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
145379511|NCT00943670|524241250|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
145379512|NCT00943670|524241250|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
145379513|NCT00943670|524241250|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
145379514|NCT00943670|524241250|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
145379515|NCT00943670|524241250|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
145379516|NCT00943670|524241250|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
145379517|NCT04472026|524241251|FG000|Overall Study|Lost to Follow-up|5|||
145379518|NCT03114657|524241252|FG000|Overall Study|Adverse Event|9|||
145379519|NCT03114657|524241253|FG001|Overall Study|Adverse Event|6|||
145379520|NCT03114657|524241252|FG000|Overall Study|Death|4|||
145379521|NCT03114657|524241253|FG001|Overall Study|Death|0|||
145379522|NCT03114657|524241252|FG000|Overall Study|Multiple Reasons|1|||
145379523|NCT03114657|524241253|FG001|Overall Study|Multiple Reasons|2|||
145379524|NCT03114657|524241252|FG000|Overall Study|Physician Decision|2|||
145379525|NCT03114657|524241253|FG001|Overall Study|Physician Decision|2|||
145379526|NCT03114657|524241252|FG000|Overall Study|Study Terminated By Sponsor|355|||
145379527|NCT03114657|524241253|FG001|Overall Study|Study Terminated By Sponsor|374|||
145379528|NCT03114657|524241252|FG000|Overall Study|Symptomatic Deterioration|0|||
145379529|NCT03114657|524241253|FG001|Overall Study|Symptomatic Deterioration|1|||
145379530|NCT03114657|524241252|FG000|Overall Study|Withdrawal by Subject|28|||
145379531|NCT03114657|524241253|FG001|Overall Study|Withdrawal by Subject|22|||
145379532|NCT00115037|524241254|FG000|Phase1|Lost to Follow-up|16|||
145379533|NCT00115037|524241255|FG001|Phase1|Lost to Follow-up|23|||
145379534|NCT00115037|524241256|FG002|Phase1|Lost to Follow-up|0|||
145379535|NCT00115037|524241257|FG003|Phase1|Lost to Follow-up|0|||
145379536|NCT00115037|524241258|FG004|Phase1|Lost to Follow-up|0|||
145379537|NCT00115037|524241259|FG005|Phase1|Lost to Follow-up|0|||
145379538|NCT00115037|524241254|FG000|Phase1|Withdrawal by Subject|9|||
145379539|NCT00115037|524241255|FG001|Phase1|Withdrawal by Subject|4|||
145379540|NCT00115037|524241256|FG002|Phase1|Withdrawal by Subject|0|||
145379541|NCT00115037|524241257|FG003|Phase1|Withdrawal by Subject|0|||
145379542|NCT00115037|524241258|FG004|Phase1|Withdrawal by Subject|0|||
145379543|NCT00115037|524241259|FG005|Phase1|Withdrawal by Subject|0|||
145379544|NCT00115037|524241254|FG000|Phase2|Death|0|||
145379545|NCT00115037|524241255|FG001|Phase2|Death|0|||
145379546|NCT00115037|524241256|FG002|Phase2|Death|1|||
145379547|NCT00115037|524241257|FG003|Phase2|Death|0|||
145379548|NCT00115037|524241258|FG004|Phase2|Death|0|||
145379549|NCT00115037|524241259|FG005|Phase2|Death|1|||
145379550|NCT00115037|524241254|FG000|Phase2|Withdrawal by Subject|0|||
145379551|NCT00115037|524241255|FG001|Phase2|Withdrawal by Subject|0|||
145379552|NCT00115037|524241256|FG002|Phase2|Withdrawal by Subject|2|||
145379553|NCT00115037|524241257|FG003|Phase2|Withdrawal by Subject|1|||
145379554|NCT00115037|524241258|FG004|Phase2|Withdrawal by Subject|2|||
145379555|NCT00115037|524241259|FG005|Phase2|Withdrawal by Subject|1|||
145379556|NCT00115037|524241254|FG000|Phase2|Lost to Follow-up|0|||
145379557|NCT00115037|524241255|FG001|Phase2|Lost to Follow-up|0|||
145379558|NCT00115037|524241256|FG002|Phase2|Lost to Follow-up|12|||
145379559|NCT00115037|524241257|FG003|Phase2|Lost to Follow-up|14|||
145379560|NCT00115037|524241258|FG004|Phase2|Lost to Follow-up|4|||
145379561|NCT00115037|524241259|FG005|Phase2|Lost to Follow-up|10|||
145379562|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
145379563|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
145379564|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
145379565|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
145379566|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
145379567|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
145379568|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
145379569|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
145379570|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
145379571|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
145379572|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
145379573|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
145379574|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2|Death|0|||
145379575|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2|Death|0|||
145379576|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2|Death|1|||
145379577|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2|Death|0|||
145379578|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145379579|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
145379580|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145379581|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
145379582|NCT01179737|524241260|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
145379583|NCT01179737|524241261|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
145379584|NCT01179737|524241262|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
145379585|NCT01179737|524241263|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
145379586|NCT01179737|524241260|FG000|Extension|The study was terminated|3|||
145379587|NCT01179737|524241261|FG001|Extension|The study was terminated|0|||
145379588|NCT01179737|524241262|FG002|Extension|The study was terminated|0|||
145379589|NCT01179737|524241263|FG003|Extension|The study was terminated|0|||
145379590|NCT01398410|524241264|FG000|Overall Study|Adverse Event|12|||
145379591|NCT01398410|524241265|FG001|Overall Study|Adverse Event|16|||
145605468|NCT02202434|525070733|FG003|Overall Study|Death|27|||
145605469|NCT02202434|525070730|FG000|Overall Study|Lost to Follow-up|1|||
145379592|NCT01398410|524241264|FG000|Overall Study|Participants Choice|8|||
145379593|NCT01398410|524241265|FG001|Overall Study|Participants Choice|11|||
145379594|NCT01398410|524241264|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
145379595|NCT01398410|524241265|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
145379596|NCT01398410|524241264|FG000|Overall Study|Other|36|||
145379597|NCT01398410|524241265|FG001|Overall Study|Other|29|||
145718135|NCT00468104|525483140|FG001|First Intervention|trapped lung|0|||
145379598|NCT00424021|524241267|FG000|NCT00046319 Study Period|Adverse Event|1|||
145379599|NCT00424021|524241268|FG001|NCT00046319 Study Period|Adverse Event|0|||
145379600|NCT00424021|524241269|FG002|NCT00046319 Study Period|Adverse Event|1|||
145379601|NCT00424021|524241270|FG003|NCT00046319 Study Period|Adverse Event|1|||
145379602|NCT00424021|524241267|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
145379603|NCT00424021|524241268|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
145379604|NCT00424021|524241269|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
145379605|NCT00424021|524241270|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
145379606|NCT00424021|524241267|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
145379607|NCT00424021|524241268|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
145379608|NCT00424021|524241269|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
145379609|NCT00424021|524241270|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
145379610|NCT00424021|524241267|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
145379611|NCT00424021|524241268|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
145379612|NCT00424021|524241269|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
145379613|NCT00424021|524241270|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
145379614|NCT00424021|524241267|FG000|AMB-220-E Study Period|Adverse Event|1|||
145379615|NCT00424021|524241268|FG001|AMB-220-E Study Period|Adverse Event|1|||
145379616|NCT00424021|524241269|FG002|AMB-220-E Study Period|Adverse Event|3|||
145379617|NCT00424021|524241270|FG003|AMB-220-E Study Period|Adverse Event|7|||
145379618|NCT00424021|524241267|FG000|AMB-220-E Study Period|Death|0|||
145379619|NCT00424021|524241268|FG001|AMB-220-E Study Period|Death|0|||
145379620|NCT00424021|524241269|FG002|AMB-220-E Study Period|Death|1|||
145379621|NCT00424021|524241270|FG003|AMB-220-E Study Period|Death|1|||
145379622|NCT00424021|524241267|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
145379623|NCT00424021|524241268|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
145379624|NCT00424021|524241269|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
145379625|NCT00424021|524241270|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
145379626|NCT00424021|524241267|FG000|AMB-220-E Study Period|Physician Decision|0|||
145379627|NCT00424021|524241268|FG001|AMB-220-E Study Period|Physician Decision|0|||
145379628|NCT00424021|524241269|FG002|AMB-220-E Study Period|Physician Decision|0|||
145379629|NCT00424021|524241270|FG003|AMB-220-E Study Period|Physician Decision|1|||
145379630|NCT03769194|524241271|FG000|Overall Study|Withdrawal by Subject|0|||
145379631|NCT03769194|524241272|FG001|Overall Study|Withdrawal by Subject|7|||
145379632|NCT03769194|524241273|FG002|Overall Study|Withdrawal by Subject|4|||
145379633|NCT03769194|524241274|FG003|Overall Study|Withdrawal by Subject|1|||
145379634|NCT03769194|524241271|FG000|Overall Study|moved from study area|0|||
145379635|NCT03769194|524241272|FG001|Overall Study|moved from study area|2|||
145379636|NCT03769194|524241273|FG002|Overall Study|moved from study area|1|||
145379637|NCT03769194|524241274|FG003|Overall Study|moved from study area|1|||
145379638|NCT03769194|524241271|FG000|Overall Study|Lost to Follow-up|3|||
145379639|NCT03769194|524241272|FG001|Overall Study|Lost to Follow-up|6|||
145379640|NCT03769194|524241273|FG002|Overall Study|Lost to Follow-up|3|||
145379641|NCT03769194|524241274|FG003|Overall Study|Lost to Follow-up|6|||
145379642|NCT03769194|524241271|FG000|Overall Study|other|1|||
145379643|NCT03769194|524241272|FG001|Overall Study|other|3|||
145379644|NCT03769194|524241273|FG002|Overall Study|other|0|||
145379645|NCT03769194|524241274|FG003|Overall Study|other|1|||
145379646|NCT03597022|524241275|FG000|Overall Study|Premature termination of the study|7|||
145379647|NCT03597022|524241276|FG001|Overall Study|Premature termination of the study|7|||
145379648|NCT03597022|524241277|FG002|Overall Study|Premature termination of the study|8|||
145379649|NCT03597022|524241275|FG000|Overall Study|Serious adverse event|1|||
145379650|NCT03597022|524241276|FG001|Overall Study|Serious adverse event|1|||
145379651|NCT03597022|524241277|FG002|Overall Study|Serious adverse event|0|||
145379652|NCT00553358|524241278|FG000|Overall Study|Randomized but did not receive treatment|3|||
145379653|NCT00553358|524241279|FG001|Overall Study|Randomized but did not receive treatment|3|||
145379654|NCT00553358|524241280|FG002|Overall Study|Randomized but did not receive treatment|1|||
145379655|NCT00553358|524241278|FG000|Overall Study|Lost to Follow-up|22|||
145379656|NCT00553358|524241279|FG001|Overall Study|Lost to Follow-up|26|||
145379657|NCT00553358|524241280|FG002|Overall Study|Lost to Follow-up|18|||
145379658|NCT00553358|524241278|FG000|Overall Study|Withdrew completely|23|||
145379659|NCT00553358|524241279|FG001|Overall Study|Withdrew completely|33|||
145379660|NCT00553358|524241280|FG002|Overall Study|Withdrew completely|34|||
145379661|NCT00553358|524241278|FG000|Overall Study|Died during clinical follow-up|25|||
145379662|NCT00553358|524241279|FG001|Overall Study|Died during clinical follow-up|29|||
145379663|NCT00553358|524241280|FG002|Overall Study|Died during clinical follow-up|32|||
145379664|NCT00553358|524241278|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
145379665|NCT00553358|524241279|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
145379666|NCT00553358|524241280|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
145379667|NCT00553358|524241278|FG000|Overall Study|Died after clinical follow-up ended|1|||
145379668|NCT00553358|524241279|FG001|Overall Study|Died after clinical follow-up ended|2|||
145379669|NCT00553358|524241280|FG002|Overall Study|Died after clinical follow-up ended|0|||
145379670|NCT00553358|524241278|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145379671|NCT00553358|524241279|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145379672|NCT00553358|524241280|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
145379673|NCT03209518|524241281|FG000|Overall Study|Case Report Forms Uncollected|1|||
145379674|NCT03209518|524241281|FG000|Overall Study|Protocol Deviation|1|||
145379675|NCT00236899|524241286|FG000|Overall Study|Adverse Event (Study Related)|1|||
145379676|NCT00236899|524241287|FG001|Overall Study|Adverse Event (Study Related)|1|||
145379677|NCT00236899|524241288|FG002|Overall Study|Adverse Event (Study Related)|2|||
145379678|NCT00236899|524241289|FG003|Overall Study|Adverse Event (Study Related)|1|||
145379679|NCT00236899|524241286|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
145379680|NCT00236899|524241287|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
145379681|NCT00236899|524241288|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
145379682|NCT00236899|524241289|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
145379683|NCT00236899|524241286|FG000|Overall Study|Death (Study Disease)|1|||
145379684|NCT00236899|524241287|FG001|Overall Study|Death (Study Disease)|4|||
145379685|NCT00236899|524241288|FG002|Overall Study|Death (Study Disease)|0|||
145379686|NCT00236899|524241289|FG003|Overall Study|Death (Study Disease)|0|||
145379687|NCT00236899|524241286|FG000|Overall Study|Death (Not Study Related)|2|||
145379688|NCT00236899|524241287|FG001|Overall Study|Death (Not Study Related)|0|||
145379689|NCT00236899|524241288|FG002|Overall Study|Death (Not Study Related)|0|||
145379690|NCT00236899|524241289|FG003|Overall Study|Death (Not Study Related)|0|||
145379691|NCT00236899|524241286|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
145379692|NCT00236899|524241287|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
145379693|NCT00236899|524241288|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
145379694|NCT00236899|524241289|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
145379695|NCT00236899|524241286|FG000|Overall Study|Lost to Follow-up|0|||
145379696|NCT00236899|524241287|FG001|Overall Study|Lost to Follow-up|1|||
145379697|NCT00236899|524241288|FG002|Overall Study|Lost to Follow-up|0|||
145379698|NCT00236899|524241289|FG003|Overall Study|Lost to Follow-up|0|||
145379699|NCT00236899|524241286|FG000|Overall Study|Entry Criteria Exclusion|0|||
145379700|NCT00236899|524241287|FG001|Overall Study|Entry Criteria Exclusion|1|||
145379701|NCT00236899|524241288|FG002|Overall Study|Entry Criteria Exclusion|1|||
145379702|NCT00236899|524241289|FG003|Overall Study|Entry Criteria Exclusion|0|||
145379703|NCT00236899|524241286|FG000|Overall Study|Protocol Violation|1|||
145379704|NCT00236899|524241287|FG001|Overall Study|Protocol Violation|0|||
145379705|NCT00236899|524241288|FG002|Overall Study|Protocol Violation|0|||
145379706|NCT00236899|524241289|FG003|Overall Study|Protocol Violation|0|||
145379707|NCT00236899|524241286|FG000|Overall Study|Withdrawal by Subject|6|||
145379708|NCT00236899|524241287|FG001|Overall Study|Withdrawal by Subject|4|||
145379709|NCT00236899|524241288|FG002|Overall Study|Withdrawal by Subject|5|||
145379710|NCT00236899|524241289|FG003|Overall Study|Withdrawal by Subject|2|||
145379711|NCT00236899|524241286|FG000|Overall Study|Physician Decision|7|||
145379712|NCT00236899|524241287|FG001|Overall Study|Physician Decision|8|||
145379713|NCT00236899|524241288|FG002|Overall Study|Physician Decision|7|||
145379714|NCT00236899|524241289|FG003|Overall Study|Physician Decision|6|||
145379715|NCT00236899|524241286|FG000|Overall Study|Satisfactory Response|2|||
145379716|NCT00236899|524241287|FG001|Overall Study|Satisfactory Response|0|||
145379717|NCT00236899|524241288|FG002|Overall Study|Satisfactory Response|0|||
145379718|NCT00236899|524241289|FG003|Overall Study|Satisfactory Response|1|||
145379719|NCT00236899|524241286|FG000|Overall Study|Lack of Efficacy|18|||
145379720|NCT00236899|524241287|FG001|Overall Study|Lack of Efficacy|18|||
145379721|NCT00236899|524241288|FG002|Overall Study|Lack of Efficacy|25|||
145379722|NCT00236899|524241289|FG003|Overall Study|Lack of Efficacy|23|||
145379723|NCT01285492|524241290|FG000|Overall Study|Adverse Event|11|||
145379724|NCT01285492|524241291|FG001|Overall Study|Adverse Event|0|||
145379725|NCT01285492|524241290|FG000|Overall Study|Protocol Violation|3|||
145379726|NCT01285492|524241291|FG001|Overall Study|Protocol Violation|0|||
145379727|NCT01285492|524241290|FG000|Overall Study|Withdrawal by Subject|2|||
145379728|NCT01285492|524241291|FG001|Overall Study|Withdrawal by Subject|1|||
145379729|NCT01285492|524241290|FG000|Overall Study|Death|1|||
145379730|NCT01285492|524241291|FG001|Overall Study|Death|0|||
145379731|NCT00306787|524241292|FG000|Overall Study|Discontinued without taking study drug|208|||
145379732|NCT00306787|524241293|FG001|Overall Study|Discontinued without taking study drug|215|||
145379733|NCT00306787|524241292|FG000|Overall Study|Adverse Event|1|||
145379734|NCT00306787|524241293|FG001|Overall Study|Adverse Event|1|||
145379735|NCT00306787|524241292|FG000|Overall Study|Lack of Efficacy|1|||
145379736|NCT00306787|524241293|FG001|Overall Study|Lack of Efficacy|0|||
145379737|NCT00306787|524241292|FG000|Overall Study|Protocol Violation|8|||
145718136|NCT00468104|525483139|FG000|Second Intervention|Withdrawal by Subject|5|||
145718137|NCT00468104|525483140|FG001|Second Intervention|Withdrawal by Subject|2|||
145718138|NCT00468104|525483139|FG000|Second Intervention|discarded for malposition of chest tube|0|||
145379738|NCT00306787|524241293|FG001|Overall Study|Protocol Violation|10|||
145379739|NCT00306787|524241292|FG000|Overall Study|Withdrawal by Subject|2|||
145379740|NCT00306787|524241293|FG001|Overall Study|Withdrawal by Subject|9|||
145379741|NCT00306787|524241292|FG000|Overall Study|Lost to Follow-up|9|||
145379742|NCT00306787|524241293|FG001|Overall Study|Lost to Follow-up|6|||
145379743|NCT00306787|524241292|FG000|Overall Study|Administrative problems|4|||
145379744|NCT00306787|524241293|FG001|Overall Study|Administrative problems|0|||
145379745|NCT00306787|524241292|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145379746|NCT00306787|524241293|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145379747|NCT02273908|524241294|FG000|Overall Study|Adverse Event|16|||
145379748|NCT02273908|524241295|FG001|Overall Study|Adverse Event|0|||
145379749|NCT02273908|524241294|FG000|Overall Study|Lost to Follow-up|10|||
145379750|NCT02273908|524241295|FG001|Overall Study|Lost to Follow-up|1|||
145379751|NCT02273908|524241294|FG000|Overall Study|Did not meet entrance criteria|3|||
145379752|NCT02273908|524241295|FG001|Overall Study|Did not meet entrance criteria|2|||
145379753|NCT02273908|524241294|FG000|Overall Study|Withdrawal by Subject|4|||
145379754|NCT02273908|524241295|FG001|Overall Study|Withdrawal by Subject|2|||
145379755|NCT04908475|524241296|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
145379756|NCT04908475|524241297|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145379757|NCT04908475|524241298|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145379758|NCT04908475|524241299|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145379759|NCT04908475|524241300|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145379760|NCT04908475|524241301|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145379761|NCT04908475|524241296|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
145379762|NCT04908475|524241297|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145379763|NCT04908475|524241298|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145379764|NCT04908475|524241299|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145379765|NCT04908475|524241300|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145379766|NCT04908475|524241301|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
145379767|NCT04908475|524241296|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
145379768|NCT04908475|524241297|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145379769|NCT04908475|524241298|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145379770|NCT04908475|524241299|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145379771|NCT04908475|524241300|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145379772|NCT04908475|524241301|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
145379773|NCT04908475|524241296|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145379774|NCT04908475|524241297|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
145379775|NCT04908475|524241298|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
145379776|NCT04908475|524241299|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
145379777|NCT04908475|524241300|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145379778|NCT04908475|524241301|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145379779|NCT04908475|524241296|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
145379780|NCT04908475|524241297|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
145379781|NCT04908475|524241298|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
145379782|NCT04908475|524241299|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
145379783|NCT04908475|524241300|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
145379784|NCT04908475|524241301|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
145379785|NCT04908475|524241296|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
145379786|NCT04908475|524241297|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
145379787|NCT04908475|524241298|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
145379788|NCT04908475|524241299|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
145379789|NCT04908475|524241300|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
145379790|NCT04908475|524241301|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
145379791|NCT00404924|524241302|FG000|Overall Study|Adverse Event|75|||
145379792|NCT00404924|524241303|FG001|Overall Study|Adverse Event|16|||
145379793|NCT00404924|524241302|FG000|Overall Study|Condition under investigation worsened|475|||
145379794|NCT00404924|524241303|FG001|Overall Study|Condition under investigation worsened|264|||
145379795|NCT00404924|524241302|FG000|Overall Study|Lost to Follow-up|1|||
145379796|NCT00404924|524241303|FG001|Overall Study|Lost to Follow-up|1|||
145379797|NCT00404924|524241302|FG000|Overall Study|Withdrawal by Subject|26|||
145379798|NCT00404924|524241303|FG001|Overall Study|Withdrawal by Subject|13|||
145379799|NCT00404924|524241302|FG000|Overall Study|Other|25|||
145379800|NCT00404924|524241303|FG001|Overall Study|Other|11|||
145379801|NCT00404924|524241302|FG000|Overall Study|Randomised but not received treatment|1|||
145379802|NCT00404924|524241303|FG001|Overall Study|Randomised but not received treatment|1|||
145379803|NCT01074255|524241310|FG000|Overall Study|Did not receive EMEND|2|||
145379804|NCT00422422|524241311|FG000|Overall Study|Lack of Efficacy|1|||
145379805|NCT00422422|524241311|FG000|Overall Study|Protocol Violation|1|||
145379806|NCT00422422|524241311|FG000|Overall Study|Withdrawal by Subject|2|||
145379807|NCT00422422|524241311|FG000|Overall Study|SAE, non-fatal|1|||
145379808|NCT00422422|524241311|FG000|Overall Study|AE, non-serious non-fatal|5|||
145379809|NCT02943785|524241312|FG000|Overall Study|Adverse Event|112|||
145379810|NCT02943785|524241313|FG001|Overall Study|Adverse Event|97|||
145379811|NCT02943785|524241312|FG000|Overall Study|Withdrawal by Subject|63|||
145379812|NCT02943785|524241313|FG001|Overall Study|Withdrawal by Subject|126|||
145379813|NCT02943785|524241312|FG000|Overall Study|Physician Decision|23|||
145379814|NCT02943785|524241313|FG001|Overall Study|Physician Decision|47|||
145379815|NCT02943785|524241312|FG000|Overall Study|Death|46|||
145379816|NCT02943785|524241313|FG001|Overall Study|Death|46|||
145379817|NCT02943785|524241312|FG000|Overall Study|Lost to Follow-up|1|||
145379818|NCT02943785|524241313|FG001|Overall Study|Lost to Follow-up|0|||
145379819|NCT02943785|524241312|FG000|Overall Study|Other|16|||
145379820|NCT02943785|524241313|FG001|Overall Study|Other|19|||
145379821|NCT02943785|524241312|FG000|Overall Study|Did not receive any study medication|21|||
145379822|NCT02943785|524241313|FG001|Overall Study|Did not receive any study medication|28|||
145379823|NCT00090987|524241317|FG000|Overall Study|Adverse Event|5|||
145379824|NCT00090987|524241317|FG000|Overall Study|Lack of Efficacy|7|||
145379825|NCT00090987|524241317|FG000|Overall Study|Withdrawal by Subject|3|||
145379826|NCT00090987|524241317|FG000|Overall Study|alternative therapy|1|||
145379827|NCT00090987|524241317|FG000|Overall Study|Non-compliance|4|||
145379828|NCT00090987|524241317|FG000|Overall Study|Incarcerated|1|||
145379829|NCT01534208|524241323|FG000|Overall Study|Lost to Follow-up|19|||
145379830|NCT01534208|524241324|FG001|Overall Study|Lost to Follow-up|14|||
145379831|NCT01534208|524241323|FG000|Overall Study|Withdrawal by Subject|6|||
145379832|NCT01534208|524241324|FG001|Overall Study|Withdrawal by Subject|20|||
145379833|NCT01534208|524241323|FG000|Overall Study|Adverse Event|15|||
145379834|NCT01534208|524241324|FG001|Overall Study|Adverse Event|8|||
145379835|NCT01534208|524241323|FG000|Overall Study|Physician Decision|2|||
145379836|NCT01534208|524241324|FG001|Overall Study|Physician Decision|0|||
145379837|NCT01534208|524241323|FG000|Overall Study|Lack of Efficacy|0|||
145379838|NCT01534208|524241324|FG001|Overall Study|Lack of Efficacy|3|||
145379839|NCT01534208|524241323|FG000|Overall Study|Protocol Violation|2|||
145379840|NCT01534208|524241324|FG001|Overall Study|Protocol Violation|2|||
145379841|NCT01534208|524241323|FG000|Overall Study|Sponsor decision|4|||
145379842|NCT01534208|524241324|FG001|Overall Study|Sponsor decision|1|||
145379843|NCT01534208|524241323|FG000|Overall Study|Subject relocation|2|||
145379844|NCT01534208|524241324|FG001|Overall Study|Subject relocation|0|||
145379845|NCT01534208|524241323|FG000|Overall Study|Lab assessment|2|||
145379846|NCT01534208|524241324|FG001|Overall Study|Lab assessment|1|||
145379847|NCT01534208|524241323|FG000|Overall Study|Eligibility error|3|||
145379848|NCT01534208|524241324|FG001|Overall Study|Eligibility error|0|||
145379849|NCT01534208|524241323|FG000|Overall Study|PCP decision|1|||
145379850|NCT01534208|524241324|FG001|Overall Study|PCP decision|0|||
145379851|NCT01534208|524241323|FG000|Overall Study|Needed prohibited meds|1|||
145718139|NCT00468104|525483140|FG001|Second Intervention|discarded for malposition of chest tube|2|||
145718140|NCT02706899|525483141|FG000|Overall Study|Withdrawal by Subject|1|||
145718141|NCT02706899|525483142|FG001|Overall Study|Withdrawal by Subject|0|||
145718142|NCT02706899|525483141|FG000|Overall Study|Death|8|||
145718143|NCT02706899|525483142|FG001|Overall Study|Death|0|||
145718144|NCT02706899|525483141|FG000|Overall Study|Study Termination by Sponsor|4|||
145718145|NCT02706899|525483142|FG001|Overall Study|Study Termination by Sponsor|6|||
145718146|NCT00324675|525483143|FG000|Overall Study|Adverse Event|1|||
145718147|NCT00324675|525483144|FG001|Overall Study|Adverse Event|0|||
145718148|NCT00381615|525483145|FG000|Overall Study|Withdrawal by Subject|1|||
145718149|NCT00381615|525483146|FG001|Overall Study|Withdrawal by Subject|3|||
145718150|NCT00381615|525483147|FG002|Overall Study|Withdrawal by Subject|0|||
145379852|NCT01534208|524241324|FG001|Overall Study|Needed prohibited meds|0|||
145379853|NCT01904903|524241325|FG000|Overall Study|Withdrawal by Subject|1|||
145379854|NCT03578146|524241330|FG000|Overall Study|Did Not Receive Treatment|1|||
145379855|NCT03578146|524241331|FG001|Overall Study|Did Not Receive Treatment|0|||
145379856|NCT03578146|524241332|FG002|Overall Study|Did Not Receive Treatment|0|||
145379857|NCT03578146|524241333|FG003|Overall Study|Did Not Receive Treatment|0|||
145379858|NCT03578146|524241334|FG004|Overall Study|Did Not Receive Treatment|0|||
145379859|NCT03578146|524241335|FG005|Overall Study|Did Not Receive Treatment|2|||
145379860|NCT03578146|524241330|FG000|Overall Study|Lost to Follow-up|0|||
145379861|NCT03578146|524241331|FG001|Overall Study|Lost to Follow-up|1|||
145379862|NCT03578146|524241332|FG002|Overall Study|Lost to Follow-up|1|||
145379863|NCT03578146|524241333|FG003|Overall Study|Lost to Follow-up|0|||
145379864|NCT03578146|524241334|FG004|Overall Study|Lost to Follow-up|0|||
145379865|NCT03578146|524241335|FG005|Overall Study|Lost to Follow-up|1|||
145379866|NCT00634049|524241336|FG000|Overall Study|Never received study drug|1|||
145379867|NCT00634049|524241336|FG000|Overall Study|Died prior to receiving study drug|1|||
145379868|NCT00634049|524241336|FG000|Overall Study|Screening failure|1|||
145379869|NCT01717391|524241337|FG000|Overall Study|Withdrawal by Subject|5|||
145379870|NCT01717391|524241337|FG000|Overall Study|Physician Decision|1|||
145379871|NCT01717391|524241337|FG000|Overall Study|FLT technical failure|3|||
145379872|NCT00314132|524241338|FG000|Overall Study|Lost to Follow-up|3|||
145379873|NCT00314132|524241339|FG001|Overall Study|Lost to Follow-up|13|||
145379874|NCT00314132|524241338|FG000|Overall Study|Withdrawal by Subject|3|||
145379875|NCT00314132|524241339|FG001|Overall Study|Withdrawal by Subject|5|||
145379876|NCT00314132|524241338|FG000|Overall Study|Adverse Event|1|||
145379877|NCT00314132|524241339|FG001|Overall Study|Adverse Event|0|||
145379878|NCT00314132|524241338|FG000|Overall Study|Physician Decision|1|||
145379879|NCT00314132|524241339|FG001|Overall Study|Physician Decision|0|||
145379880|NCT04769739|524241340|FG000|Overall Study|Colorectal cancer obstruction|2|||
145379881|NCT04769739|524241341|FG001|Overall Study|Colorectal cancer obstruction|0|||
145379882|NCT04769739|524241342|FG002|Overall Study|Colorectal cancer obstruction|0|||
145379883|NCT04769739|524241343|FG003|Overall Study|Colorectal cancer obstruction|0|||
145379884|NCT04769739|524241340|FG000|Overall Study|Failed cecal intubation|1|||
145379885|NCT04769739|524241341|FG001|Overall Study|Failed cecal intubation|0|||
145379886|NCT04769739|524241342|FG002|Overall Study|Failed cecal intubation|0|||
145379887|NCT04769739|524241343|FG003|Overall Study|Failed cecal intubation|1|||
145379888|NCT04769739|524241340|FG000|Overall Study|Poor bowel preparation|0|||
145379889|NCT04769739|524241341|FG001|Overall Study|Poor bowel preparation|0|||
145379890|NCT04769739|524241342|FG002|Overall Study|Poor bowel preparation|0|||
145379891|NCT04769739|524241343|FG003|Overall Study|Poor bowel preparation|1|||
145379892|NCT01260584|524241344|FG000|Period 1|Protocol Violation|0|||
145379893|NCT01260584|524241345|FG001|Period 1|Protocol Violation|0|||
145379894|NCT01260584|524241346|FG002|Period 1|Protocol Violation|1|||
145379895|NCT01260584|524241347|FG003|Period 1|Protocol Violation|1|||
145379896|NCT01260584|524241344|FG000|Period 1|Adverse Event|0|||
145379897|NCT01260584|524241345|FG001|Period 1|Adverse Event|0|||
145379898|NCT01260584|524241346|FG002|Period 1|Adverse Event|1|||
145379899|NCT01260584|524241347|FG003|Period 1|Adverse Event|0|||
145379900|NCT01260584|524241344|FG000|Period 2|Protocol Violation|0|||
145379901|NCT01260584|524241345|FG001|Period 2|Protocol Violation|2|||
145379902|NCT01260584|524241346|FG002|Period 2|Protocol Violation|3|||
145379903|NCT01260584|524241347|FG003|Period 2|Protocol Violation|1|||
145379904|NCT01260584|524241344|FG000|Period 2|Adverse Event|1|||
145379905|NCT01260584|524241345|FG001|Period 2|Adverse Event|0|||
145379906|NCT01260584|524241346|FG002|Period 2|Adverse Event|2|||
145379907|NCT01260584|524241347|FG003|Period 2|Adverse Event|0|||
145379908|NCT01260584|524241344|FG000|Period 2|Withdrawal by Subject|0|||
145379909|NCT01260584|524241345|FG001|Period 2|Withdrawal by Subject|1|||
145379910|NCT01260584|524241346|FG002|Period 2|Withdrawal by Subject|0|||
145379911|NCT01260584|524241347|FG003|Period 2|Withdrawal by Subject|0|||
145379912|NCT00824382|524241352|FG000|Overall Study|Adverse Event|4|||
145379913|NCT00824382|524241353|FG001|Overall Study|Adverse Event|1|||
145379914|NCT00824382|524241354|FG002|Overall Study|Adverse Event|1|||
145379915|NCT00824382|524241355|FG003|Overall Study|Adverse Event|4|||
145718151|NCT00381615|525483148|FG003|Overall Study|Withdrawal by Subject|1|||
145718152|NCT00381615|525483145|FG000|Overall Study|Lost to Follow-up|3|||
145718153|NCT00381615|525483146|FG001|Overall Study|Lost to Follow-up|2|||
145718154|NCT00381615|525483147|FG002|Overall Study|Lost to Follow-up|0|||
145718155|NCT00381615|525483148|FG003|Overall Study|Lost to Follow-up|1|||
145718156|NCT00381615|525483145|FG000|Overall Study|Protocol Violation|0|||
145718157|NCT00381615|525483146|FG001|Overall Study|Protocol Violation|0|||
145718158|NCT00381615|525483147|FG002|Overall Study|Protocol Violation|1|||
145718159|NCT00381615|525483148|FG003|Overall Study|Protocol Violation|0|||
145718160|NCT04860297|525483150|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
145718161|NCT04860297|525483151|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
145718162|NCT04860297|525483152|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
145718163|NCT04860297|525483153|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
145718164|NCT04860297|525483154|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
145718165|NCT04860297|525483155|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
145718166|NCT04860297|525483156|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
145718167|NCT04860297|525483157|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
145718168|NCT04860297|525483150|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
145718169|NCT04860297|525483151|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
145718170|NCT04860297|525483152|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
145718171|NCT04860297|525483153|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
145718172|NCT04860297|525483154|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
145718173|NCT04860297|525483155|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
145718174|NCT04860297|525483156|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
145718175|NCT04860297|525483157|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
145718176|NCT04860297|525483150|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
145718177|NCT04860297|525483151|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
145718178|NCT04860297|525483152|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
145718179|NCT04860297|525483153|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
145718180|NCT04860297|525483154|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
145718181|NCT04860297|525483155|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
145718182|NCT04860297|525483156|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
145718183|NCT04860297|525483157|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
145718184|NCT04860297|525483150|FG000|Part B (Booster Dose)|Other Than Specified|0|||
145718185|NCT04860297|525483151|FG001|Part B (Booster Dose)|Other Than Specified|0|||
145718186|NCT04860297|525483152|FG002|Part B (Booster Dose)|Other Than Specified|0|||
145718187|NCT04860297|525483153|FG003|Part B (Booster Dose)|Other Than Specified|0|||
145718188|NCT04860297|525483154|FG004|Part B (Booster Dose)|Other Than Specified|0|||
145718189|NCT04860297|525483155|FG005|Part B (Booster Dose)|Other Than Specified|1|||
145718190|NCT04860297|525483156|FG006|Part B (Booster Dose)|Other Than Specified|1|||
145718191|NCT04860297|525483157|FG007|Part B (Booster Dose)|Other Than Specified|0|||
145718192|NCT04860297|525483150|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718193|NCT04860297|525483151|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718194|NCT04860297|525483152|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718195|NCT04860297|525483153|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718196|NCT04860297|525483154|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718197|NCT04860297|525483155|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
145718198|NCT04860297|525483156|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
145718199|NCT04860297|525483157|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
145718200|NCT04860297|525483150|FG000|Part B (Booster Dose)|Death|0|||
145718201|NCT04860297|525483151|FG001|Part B (Booster Dose)|Death|0|||
145718202|NCT04860297|525483152|FG002|Part B (Booster Dose)|Death|0|||
145718203|NCT04860297|525483153|FG003|Part B (Booster Dose)|Death|0|||
145718204|NCT04860297|525483154|FG004|Part B (Booster Dose)|Death|1|||
145379916|NCT00824382|524241352|FG000|Overall Study|Protocol Violation|1|||
145718205|NCT04860297|525483155|FG005|Part B (Booster Dose)|Death|2|||
145718206|NCT04860297|525483156|FG006|Part B (Booster Dose)|Death|1|||
145718207|NCT04860297|525483157|FG007|Part B (Booster Dose)|Death|0|||
145718208|NCT04860297|525483150|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
145718209|NCT04860297|525483151|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
145718210|NCT04860297|525483152|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
145718211|NCT04860297|525483153|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
145718212|NCT04860297|525483154|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
145718213|NCT04860297|525483155|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
145718214|NCT04860297|525483156|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
145718215|NCT04860297|525483157|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
145718216|NCT04811131|525483160|FG000|Overall Study|Adverse Event|0|||
145718217|NCT04811131|525483161|FG001|Overall Study|Adverse Event|0|||
145718218|NCT04811131|525483162|FG002|Overall Study|Adverse Event|1|||
145718219|NCT04811131|525483163|FG003|Overall Study|Adverse Event|0|||
145718220|NCT04811131|525483160|FG000|Overall Study|Lack of Efficacy|0|||
145718221|NCT04811131|525483161|FG001|Overall Study|Lack of Efficacy|0|||
145718222|NCT04811131|525483162|FG002|Overall Study|Lack of Efficacy|0|||
145718223|NCT04811131|525483163|FG003|Overall Study|Lack of Efficacy|1|||
145718224|NCT04811131|525483160|FG000|Overall Study|Lost to Follow-up|0|||
145718225|NCT04811131|525483161|FG001|Overall Study|Lost to Follow-up|1|||
145718226|NCT04811131|525483162|FG002|Overall Study|Lost to Follow-up|0|||
145718227|NCT04811131|525483163|FG003|Overall Study|Lost to Follow-up|0|||
145718228|NCT04811131|525483160|FG000|Overall Study|Sponsor request|31|||
145718229|NCT04811131|525483161|FG001|Overall Study|Sponsor request|35|||
145718230|NCT04811131|525483162|FG002|Overall Study|Sponsor request|27|||
145718231|NCT04811131|525483163|FG003|Overall Study|Sponsor request|10|||
145718232|NCT04811131|525483160|FG000|Overall Study|Withdrawal by Subject|3|||
145718233|NCT04811131|525483161|FG001|Overall Study|Withdrawal by Subject|1|||
145718234|NCT04811131|525483162|FG002|Overall Study|Withdrawal by Subject|3|||
145718235|NCT04811131|525483163|FG003|Overall Study|Withdrawal by Subject|1|||
145718236|NCT00620282|525483168|FG000|Overall Study|Adverse Event|0|||
145718237|NCT00620282|525483169|FG001|Overall Study|Adverse Event|1|||
145718238|NCT00620282|525483170|FG002|Overall Study|Adverse Event|0|||
145718239|NCT00620282|525483168|FG000|Overall Study|Arterial line unable to be placed|0|||
145718240|NCT00620282|525483169|FG001|Overall Study|Arterial line unable to be placed|0|||
145718241|NCT00620282|525483170|FG002|Overall Study|Arterial line unable to be placed|1|||
145718242|NCT00620282|525483168|FG000|Overall Study|Withdrawal by Subject|0|||
145718243|NCT00620282|525483169|FG001|Overall Study|Withdrawal by Subject|1|||
145379917|NCT00824382|524241353|FG001|Overall Study|Protocol Violation|0|||
145379918|NCT00824382|524241354|FG002|Overall Study|Protocol Violation|0|||
145379919|NCT00824382|524241355|FG003|Overall Study|Protocol Violation|1|||
145379920|NCT00824382|524241352|FG000|Overall Study|Investigator's decision|0|||
145379921|NCT00824382|524241353|FG001|Overall Study|Investigator's decision|1|||
145379922|NCT00824382|524241354|FG002|Overall Study|Investigator's decision|2|||
145379923|NCT00824382|524241355|FG003|Overall Study|Investigator's decision|0|||
145379924|NCT02824562|524243053|FG000|Overall Study|Lost to Follow-up|3|||
145379925|NCT02824562|524243054|FG001|Overall Study|Lost to Follow-up|4|||
145379926|NCT02824562|524243053|FG000|Overall Study|Death|0|||
145379927|NCT02824562|524243054|FG001|Overall Study|Death|1|||
145379928|NCT02168777|524243055|FG000|Overall Study|Withdrawal by Subject|1|||
145379929|NCT02168777|524243056|FG001|Overall Study|Withdrawal by Subject|0|||
145379930|NCT02168777|524243057|FG002|Overall Study|Withdrawal by Subject|2|||
145379931|NCT02168777|524243055|FG000|Overall Study|Adverse Event|1|||
145379932|NCT02168777|524243056|FG001|Overall Study|Adverse Event|0|||
145379933|NCT02168777|524243057|FG002|Overall Study|Adverse Event|1|||
145379934|NCT02168777|524243055|FG000|Overall Study|Disease recurrence|0|||
145379935|NCT02168777|524243056|FG001|Overall Study|Disease recurrence|0|||
145379936|NCT02168777|524243057|FG002|Overall Study|Disease recurrence|1|||
145379937|NCT02168777|524243055|FG000|Overall Study|Radiological disease progression|0|||
145379938|NCT02168777|524243056|FG001|Overall Study|Radiological disease progression|5|||
145379939|NCT02168777|524243057|FG002|Overall Study|Radiological disease progression|5|||
145379940|NCT02168777|524243055|FG000|Overall Study|Clinical disease progression|0|||
145379941|NCT02168777|524243056|FG001|Overall Study|Clinical disease progression|1|||
145379942|NCT02168777|524243057|FG002|Overall Study|Clinical disease progression|2|||
145379943|NCT02168777|524243055|FG000|Overall Study|Other reason|0|||
145379944|NCT02168777|524243056|FG001|Overall Study|Other reason|1|||
145379945|NCT02168777|524243057|FG002|Overall Study|Other reason|0|||
145379946|NCT01663857|524243058|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
145379947|NCT01663857|524243059|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
145379948|NCT01663857|524243060|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
145379949|NCT01663857|524243061|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
145718244|NCT00620282|525483170|FG002|Overall Study|Withdrawal by Subject|0|||
145718245|NCT02703259|525483171|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
145718246|NCT02703259|525483172|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
145718247|NCT02703259|525483171|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
145718248|NCT02703259|525483172|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
145718249|NCT02703259|525483171|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
145718250|NCT02703259|525483172|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
145718251|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|Death|1|||
145718252|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|Death|1|||
145718253|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
145718254|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
145718255|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
145379950|NCT01663857|524243058|FG000|Overall Study|Lost to Follow-up|0|||
145379951|NCT01663857|524243059|FG001|Overall Study|Lost to Follow-up|0|||
145379952|NCT01663857|524243060|FG002|Overall Study|Lost to Follow-up|3|||
145379953|NCT01663857|524243061|FG003|Overall Study|Lost to Follow-up|1|||
145379954|NCT01172808|524243062|FG000|Overall Study|Adverse Event|8|||
145379955|NCT01172808|524243063|FG001|Overall Study|Adverse Event|4|||
145379956|NCT01172808|524243064|FG002|Overall Study|Adverse Event|8|||
145379957|NCT01172808|524243065|FG003|Overall Study|Adverse Event|3|||
145379958|NCT01172808|524243062|FG000|Overall Study|Lack of Efficacy|1|||
145379959|NCT01172808|524243063|FG001|Overall Study|Lack of Efficacy|0|||
145379960|NCT01172808|524243064|FG002|Overall Study|Lack of Efficacy|0|||
145379961|NCT01172808|524243065|FG003|Overall Study|Lack of Efficacy|0|||
145379962|NCT01172808|524243062|FG000|Overall Study|Protocol Violation|2|||
145379963|NCT01172808|524243063|FG001|Overall Study|Protocol Violation|2|||
145379964|NCT01172808|524243064|FG002|Overall Study|Protocol Violation|2|||
145379965|NCT01172808|524243065|FG003|Overall Study|Protocol Violation|0|||
145379966|NCT01172808|524243062|FG000|Overall Study|Lost to Follow-up|0|||
145379967|NCT01172808|524243063|FG001|Overall Study|Lost to Follow-up|1|||
145379968|NCT01172808|524243064|FG002|Overall Study|Lost to Follow-up|1|||
145379969|NCT01172808|524243065|FG003|Overall Study|Lost to Follow-up|3|||
145379970|NCT01172808|524243062|FG000|Overall Study|Withdrawal by Subject|4|||
145379971|NCT01172808|524243063|FG001|Overall Study|Withdrawal by Subject|1|||
145379972|NCT01172808|524243064|FG002|Overall Study|Withdrawal by Subject|3|||
145379973|NCT01172808|524243065|FG003|Overall Study|Withdrawal by Subject|2|||
145379974|NCT01172808|524243062|FG000|Overall Study|Other|6|||
145379975|NCT01172808|524243063|FG001|Overall Study|Other|5|||
145379976|NCT01172808|524243064|FG002|Overall Study|Other|9|||
145379977|NCT01172808|524243065|FG003|Overall Study|Other|7|||
145379978|NCT00290693|524243066|FG000|Overall Study|Withdrawal by Subject|2|||
145379979|NCT05625477|524243067|FG000|Overall Study|Lost to Follow-up|2|||
145379980|NCT05625477|524243068|FG001|Overall Study|Lost to Follow-up|2|||
145379981|NCT05625477|524243069|FG002|Overall Study|Lost to Follow-up|1|||
145379982|NCT05625477|524243070|FG003|Overall Study|Lost to Follow-up|1|||
145379983|NCT05625477|524243071|FG004|Overall Study|Lost to Follow-up|0|||
145379984|NCT05625477|524243067|FG000|Overall Study|Covid quarantine|1|||
145379985|NCT05625477|524243068|FG001|Overall Study|Covid quarantine|0|||
145379986|NCT05625477|524243069|FG002|Overall Study|Covid quarantine|0|||
145379987|NCT05625477|524243070|FG003|Overall Study|Covid quarantine|0|||
145379988|NCT05625477|524243071|FG004|Overall Study|Covid quarantine|0|||
145379989|NCT00717275|524243073|FG000|Overall Study|Premature study termination.|3|||
145379990|NCT01254721|524243074|FG000|Overall Study|Lost to Follow-up|0|||
145379991|NCT01254721|524243075|FG001|Overall Study|Lost to Follow-up|4|||
145379992|NCT01254721|524243074|FG000|Overall Study|Lack of Efficacy|4|||
145379993|NCT01254721|524243075|FG001|Overall Study|Lack of Efficacy|2|||
145379994|NCT01254721|524243074|FG000|Overall Study|Death|0|||
145379995|NCT01254721|524243075|FG001|Overall Study|Death|1|||
145379996|NCT01254721|524243074|FG000|Overall Study|technical problum|1|||
145379997|NCT01254721|524243075|FG001|Overall Study|technical problum|0|||
145379998|NCT01254721|524243074|FG000|Overall Study|Adverse Event|2|||
145379999|NCT01254721|524243075|FG001|Overall Study|Adverse Event|3|||
145380000|NCT01254721|524243074|FG000|Overall Study|Withdrawal by Subject|8|||
145380001|NCT01254721|524243075|FG001|Overall Study|Withdrawal by Subject|11|||
145380002|NCT01254721|524243074|FG000|Overall Study|Wrongly randomization|0|||
145380003|NCT01254721|524243075|FG001|Overall Study|Wrongly randomization|1|||
145380004|NCT01438814|524243076|FG000|Overall Study|Adverse Event|3|||
145380005|NCT01438814|524243077|FG001|Overall Study|Adverse Event|3|||
145380006|NCT01438814|524243076|FG000|Overall Study|Protocol Violation|1|||
145380007|NCT01438814|524243077|FG001|Overall Study|Protocol Violation|2|||
145380008|NCT01438814|524243076|FG000|Overall Study|Lost to Follow-up|4|||
145380009|NCT01438814|524243077|FG001|Overall Study|Lost to Follow-up|3|||
145380010|NCT01438814|524243076|FG000|Overall Study|Withdrawal by Subject|4|||
145380011|NCT01438814|524243077|FG001|Overall Study|Withdrawal by Subject|2|||
145380012|NCT01438814|524243076|FG000|Overall Study|Other|2|||
145380013|NCT01438814|524243077|FG001|Overall Study|Other|4|||
145380014|NCT00369161|524243078|FG000|Overall Study|Adverse Event|15|||
145380015|NCT00369161|524243079|FG001|Overall Study|Adverse Event|13|||
145380016|NCT00369161|524243078|FG000|Overall Study|Abnormal laboratory value|0|||
145380017|NCT00369161|524243079|FG001|Overall Study|Abnormal laboratory value|1|||
145380018|NCT00369161|524243078|FG000|Overall Study|Lack of Efficacy|3|||
145380019|NCT00369161|524243079|FG001|Overall Study|Lack of Efficacy|1|||
145380020|NCT00369161|524243078|FG000|Overall Study|Protocol Violation|0|||
145380021|NCT00369161|524243079|FG001|Overall Study|Protocol Violation|2|||
145380022|NCT00369161|524243078|FG000|Overall Study|Withdrawal by Subject|2|||
145380023|NCT00369161|524243079|FG001|Overall Study|Withdrawal by Subject|3|||
145380024|NCT00369161|524243078|FG000|Overall Study|Death|1|||
145380025|NCT00369161|524243079|FG001|Overall Study|Death|2|||
145380026|NCT00369161|524243078|FG000|Overall Study|Graft loss|4|||
145380027|NCT00369161|524243079|FG001|Overall Study|Graft loss|0|||
145380028|NCT00369161|524243078|FG000|Overall Study|Administrative Problem|2|||
145380029|NCT00369161|524243079|FG001|Overall Study|Administrative Problem|2|||
145380030|NCT01870297|524243080|FG000|Overall Study|Adverse Event|0|||
145380031|NCT01870297|524243081|FG001|Overall Study|Adverse Event|0|||
145380032|NCT01870297|524243082|FG002|Overall Study|Adverse Event|0|||
145380033|NCT01870297|524243083|FG003|Overall Study|Adverse Event|0|||
145380034|NCT01870297|524243084|FG004|Overall Study|Adverse Event|2|||
145380035|NCT01870297|524243085|FG005|Overall Study|Adverse Event|0|||
145380036|NCT01870297|524243086|FG006|Overall Study|Adverse Event|0|||
145380037|NCT01870297|524243080|FG000|Overall Study|Lost to Follow-up|0|||
145380038|NCT01870297|524243081|FG001|Overall Study|Lost to Follow-up|1|||
145380039|NCT01870297|524243082|FG002|Overall Study|Lost to Follow-up|1|||
145380040|NCT01870297|524243083|FG003|Overall Study|Lost to Follow-up|0|||
145380041|NCT01870297|524243084|FG004|Overall Study|Lost to Follow-up|0|||
145380042|NCT01870297|524243085|FG005|Overall Study|Lost to Follow-up|0|||
145380043|NCT01870297|524243086|FG006|Overall Study|Lost to Follow-up|0|||
145380044|NCT01870297|524243080|FG000|Overall Study|Withdrawal by Subject|0|||
145380045|NCT01870297|524243081|FG001|Overall Study|Withdrawal by Subject|0|||
145380046|NCT01870297|524243082|FG002|Overall Study|Withdrawal by Subject|0|||
145380047|NCT01870297|524243083|FG003|Overall Study|Withdrawal by Subject|0|||
145380048|NCT01870297|524243084|FG004|Overall Study|Withdrawal by Subject|1|||
145380049|NCT01870297|524243085|FG005|Overall Study|Withdrawal by Subject|1|||
145380050|NCT01870297|524243086|FG006|Overall Study|Withdrawal by Subject|1|||
145380051|NCT01870297|524243080|FG000|Overall Study|Sponsor Decision|0|||
145380052|NCT01870297|524243081|FG001|Overall Study|Sponsor Decision|6|||
145380053|NCT01870297|524243082|FG002|Overall Study|Sponsor Decision|0|||
145380054|NCT01870297|524243083|FG003|Overall Study|Sponsor Decision|0|||
145380055|NCT01870297|524243084|FG004|Overall Study|Sponsor Decision|0|||
145380056|NCT01870297|524243085|FG005|Overall Study|Sponsor Decision|0|||
145380057|NCT01870297|524243086|FG006|Overall Study|Sponsor Decision|1|||
145380058|NCT01739764|524243087|FG000|Overall Study|Adverse Event|0|||
145380059|NCT01739764|524243088|FG001|Overall Study|Adverse Event|3|||
145380060|NCT01739764|524243089|FG002|Overall Study|Adverse Event|4|||
145380061|NCT01739764|524243087|FG000|Overall Study|Death|4|||
145380062|NCT01739764|524243088|FG001|Overall Study|Death|6|||
145380063|NCT01739764|524243089|FG002|Overall Study|Death|38|||
145380064|NCT01739764|524243087|FG000|Overall Study|Lost to Follow-up|0|||
145380065|NCT01739764|524243088|FG001|Overall Study|Lost to Follow-up|0|||
145380066|NCT01739764|524243089|FG002|Overall Study|Lost to Follow-up|5|||
145380067|NCT01739764|524243087|FG000|Overall Study|Non-Compliance|0|||
145380068|NCT01739764|524243088|FG001|Overall Study|Non-Compliance|0|||
145380069|NCT01739764|524243089|FG002|Overall Study|Non-Compliance|1|||
145380070|NCT01739764|524243087|FG000|Overall Study|Multiple Reasons|3|||
145380071|NCT01739764|524243088|FG001|Overall Study|Multiple Reasons|2|||
145380072|NCT01739764|524243089|FG002|Overall Study|Multiple Reasons|3|||
145380073|NCT01739764|524243087|FG000|Overall Study|Physician Decision|2|||
145380074|NCT01739764|524243088|FG001|Overall Study|Physician Decision|2|||
145380075|NCT01739764|524243089|FG002|Overall Study|Physician Decision|4|||
145380076|NCT01739764|524243087|FG000|Overall Study|Progressive Disease|3|||
145380077|NCT01739764|524243088|FG001|Overall Study|Progressive Disease|5|||
145380078|NCT01739764|524243089|FG002|Overall Study|Progressive Disease|16|||
145380079|NCT01739764|524243087|FG000|Overall Study|Protocol Violation|0|||
145380080|NCT01739764|524243088|FG001|Overall Study|Protocol Violation|0|||
145380081|NCT01739764|524243089|FG002|Overall Study|Protocol Violation|2|||
145380082|NCT01739764|524243087|FG000|Overall Study|Study Terminated by Sponsor|8|||
145380083|NCT01739764|524243088|FG001|Overall Study|Study Terminated by Sponsor|13|||
145380084|NCT01739764|524243089|FG002|Overall Study|Study Terminated by Sponsor|26|||
145380085|NCT01739764|524243087|FG000|Overall Study|Withdrawal by Subject|6|||
145380086|NCT01739764|524243088|FG001|Overall Study|Withdrawal by Subject|5|||
145380087|NCT01739764|524243089|FG002|Overall Study|Withdrawal by Subject|27|||
145380088|NCT00337779|524243090|FG000|Overall Study|Withdrawal by Subject|10|||
145380089|NCT00337779|524243091|FG001|Overall Study|Withdrawal by Subject|12|||
145380090|NCT00337779|524243090|FG000|Overall Study|Sponsor decision|1|||
145380091|NCT00337779|524243091|FG001|Overall Study|Sponsor decision|1|||
145380092|NCT00337779|524243090|FG000|Overall Study|Physician Decision|3|||
145380093|NCT00337779|524243091|FG001|Overall Study|Physician Decision|6|||
145380094|NCT00337779|524243090|FG000|Overall Study|Protocol Violation|1|||
145380095|NCT00337779|524243091|FG001|Overall Study|Protocol Violation|1|||
145380096|NCT00337779|524243090|FG000|Overall Study|Lost to Follow-up|6|||
145380097|NCT00337779|524243091|FG001|Overall Study|Lost to Follow-up|5|||
145380098|NCT00337779|524243090|FG000|Overall Study|Adverse Event|28|||
145380099|NCT00337779|524243091|FG001|Overall Study|Adverse Event|51|||
145380100|NCT00337779|524243090|FG000|Overall Study|Pregnancy|3|||
145380101|NCT00337779|524243091|FG001|Overall Study|Pregnancy|2|||
145380102|NCT00337779|524243090|FG000|Overall Study|Death|0|||
145380103|NCT00337779|524243091|FG001|Overall Study|Death|1|||
145380104|NCT03313310|524243093|FG000|Phase 2|Lost to Follow-up|4|||
145380105|NCT03313310|524243094|FG001|Phase 2|Lost to Follow-up|0|||
145380106|NCT03313310|524243093|FG000|Phase 3|Lost to Follow-up|0|||
145380107|NCT03313310|524243094|FG001|Phase 3|Lost to Follow-up|1|||
145380108|NCT01281956|524243095|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
145380109|NCT01281956|524243096|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
145380110|NCT03170609|524243097|FG000|Overall Study|Death|0|||
145380111|NCT03170609|524243098|FG001|Overall Study|Death|0|||
145380112|NCT03170609|524243099|FG002|Overall Study|Death|1|||
145380113|NCT03170609|524243100|FG003|Overall Study|Death|0|||
145380114|NCT03170609|524243101|FG004|Overall Study|Death|0|||
145380115|NCT03170609|524243102|FG005|Overall Study|Death|0|||
145380116|NCT03170609|524243103|FG006|Overall Study|Death|0|||
145380117|NCT03170609|524243097|FG000|Overall Study|Withdrawal by Subject|1|||
145380118|NCT03170609|524243098|FG001|Overall Study|Withdrawal by Subject|2|||
145380119|NCT03170609|524243099|FG002|Overall Study|Withdrawal by Subject|0|||
145380120|NCT03170609|524243100|FG003|Overall Study|Withdrawal by Subject|0|||
145380121|NCT03170609|524243101|FG004|Overall Study|Withdrawal by Subject|0|||
145380122|NCT03170609|524243102|FG005|Overall Study|Withdrawal by Subject|0|||
145380123|NCT03170609|524243103|FG006|Overall Study|Withdrawal by Subject|1|||
145380124|NCT03170609|524243097|FG000|Overall Study|Lost to Follow-up|1|||
145380125|NCT03170609|524243098|FG001|Overall Study|Lost to Follow-up|0|||
145380126|NCT03170609|524243099|FG002|Overall Study|Lost to Follow-up|5|||
145380127|NCT03170609|524243100|FG003|Overall Study|Lost to Follow-up|2|||
145380128|NCT03170609|524243101|FG004|Overall Study|Lost to Follow-up|1|||
145380129|NCT03170609|524243102|FG005|Overall Study|Lost to Follow-up|1|||
145380130|NCT03170609|524243103|FG006|Overall Study|Lost to Follow-up|0|||
145380131|NCT03170609|524243097|FG000|Overall Study|Other|1|||
145380132|NCT03170609|524243098|FG001|Overall Study|Other|0|||
145380133|NCT03170609|524243099|FG002|Overall Study|Other|0|||
145380134|NCT03170609|524243100|FG003|Overall Study|Other|0|||
145380135|NCT03170609|524243101|FG004|Overall Study|Other|0|||
145380136|NCT03170609|524243102|FG005|Overall Study|Other|1|||
145380137|NCT03170609|524243103|FG006|Overall Study|Other|0|||
145380138|NCT01593254|524243108|FG000|Overall Study|Disease progression|2|||
145380139|NCT01593254|524243109|FG001|Overall Study|Disease progression|7|||
145380140|NCT01593254|524243108|FG000|Overall Study|Study drug toxicity|6|||
145380141|NCT01593254|524243109|FG001|Overall Study|Study drug toxicity|20|||
145380142|NCT01593254|524243108|FG000|Overall Study|Death|3|||
145380143|NCT01593254|524243109|FG001|Overall Study|Death|3|||
145380144|NCT01593254|524243108|FG000|Overall Study|AE unrelated to study drug|0|||
145380145|NCT01593254|524243109|FG001|Overall Study|AE unrelated to study drug|1|||
145380146|NCT01593254|524243108|FG000|Overall Study|participant request to discontinue study treatment|1|||
145380147|NCT01593254|524243109|FG001|Overall Study|participant request to discontinue study treatment|3|||
145380148|NCT01593254|524243108|FG000|Overall Study|participant withdrew consent|0|||
145380149|NCT01593254|524243109|FG001|Overall Study|participant withdrew consent|9|||
145380150|NCT01593254|524243108|FG000|Overall Study|lost to follow up|1|||
145380151|NCT01593254|524243109|FG001|Overall Study|lost to follow up|6|||
145380152|NCT01593254|524243108|FG000|Overall Study|maximum clinical benefit|1|||
145380153|NCT01593254|524243109|FG001|Overall Study|maximum clinical benefit|2|||
145380154|NCT01593254|524243108|FG000|Overall Study|Poor/non compliance|1|||
145380155|NCT01593254|524243109|FG001|Overall Study|Poor/non compliance|1|||
145380156|NCT01593254|524243108|FG000|Overall Study|Pregnancy|0|||
145380157|NCT01593254|524243109|FG001|Overall Study|Pregnancy|3|||
145380158|NCT01593254|524243108|FG000|Overall Study|participant no longer meets study criteria|1|||
145380159|NCT01593254|524243109|FG001|Overall Study|participant no longer meets study criteria|1|||
145380160|NCT01593254|524243108|FG000|Overall Study|Admin reason by sponsor|7|||
145380161|NCT01593254|524243109|FG001|Overall Study|Admin reason by sponsor|3|||
145380162|NCT01593254|524243108|FG000|Overall Study|Imatinib treatment failure|2|||
145380163|NCT01593254|524243109|FG001|Overall Study|Imatinib treatment failure|0|||
145380164|NCT01593254|524243108|FG000|Overall Study|Other Reasons|61|||
145380165|NCT01593254|524243109|FG001|Overall Study|Other Reasons|115|||
145380166|NCT03013985|524243112|FG000|Overall Study|Protocol Violation|2|||
145380167|NCT03013985|524243113|FG001|Overall Study|Protocol Violation|2|||
145380168|NCT03013985|524243112|FG000|Overall Study|Withdrawal by Subject|14|||
145380169|NCT03013985|524243113|FG001|Overall Study|Withdrawal by Subject|17|||
145380170|NCT03411902|524243114|FG000|Overall Study|Lost to Follow-up|3|||
145380171|NCT03411902|524243115|FG001|Overall Study|Lost to Follow-up|0|||
145380172|NCT00791492|524243116|FG000|Overall Study|Withdrawal by Subject|1|||
145380173|NCT00791492|524243117|FG001|Overall Study|Withdrawal by Subject|2|||
145380174|NCT00791492|524243116|FG000|Overall Study|Liver transplantation|5|||
145380175|NCT00791492|524243117|FG001|Overall Study|Liver transplantation|1|||
145380176|NCT00076999|524243120|FG000|Overall Study|Adverse Event|2|||
145380177|NCT00076999|524243121|FG001|Overall Study|Adverse Event|8|||
145380178|NCT00076999|524243122|FG002|Overall Study|Adverse Event|6|||
145380179|NCT00076999|524243123|FG003|Overall Study|Adverse Event|0|||
145380180|NCT00076999|524243124|FG004|Overall Study|Adverse Event|2|||
145380181|NCT00076999|524243120|FG000|Overall Study|Protocol Violation|0|||
145380182|NCT00076999|524243121|FG001|Overall Study|Protocol Violation|3|||
145380183|NCT00076999|524243122|FG002|Overall Study|Protocol Violation|4|||
145380184|NCT00076999|524243123|FG003|Overall Study|Protocol Violation|0|||
145380185|NCT00076999|524243124|FG004|Overall Study|Protocol Violation|9|||
145380186|NCT00076999|524243120|FG000|Overall Study|Lost to Follow-up|2|||
145380187|NCT00076999|524243121|FG001|Overall Study|Lost to Follow-up|1|||
145380188|NCT00076999|524243122|FG002|Overall Study|Lost to Follow-up|0|||
145380189|NCT00076999|524243123|FG003|Overall Study|Lost to Follow-up|0|||
145380190|NCT00076999|524243124|FG004|Overall Study|Lost to Follow-up|0|||
145380191|NCT00076999|524243120|FG000|Overall Study|Withdrawal by Subject|0|||
145380192|NCT00076999|524243121|FG001|Overall Study|Withdrawal by Subject|4|||
145380193|NCT00076999|524243122|FG002|Overall Study|Withdrawal by Subject|3|||
145380194|NCT00076999|524243123|FG003|Overall Study|Withdrawal by Subject|0|||
145380195|NCT00076999|524243124|FG004|Overall Study|Withdrawal by Subject|1|||
145380196|NCT00076999|524243120|FG000|Overall Study|Other reason (not specified)|8|||
145380197|NCT00076999|524243121|FG001|Overall Study|Other reason (not specified)|8|||
145380198|NCT00076999|524243122|FG002|Overall Study|Other reason (not specified)|4|||
145380199|NCT00076999|524243123|FG003|Overall Study|Other reason (not specified)|1|||
145380200|NCT00076999|524243124|FG004|Overall Study|Other reason (not specified)|13|||
145380201|NCT00990665|524243127|FG000|Overall Study|Unsuccessful Implant|8|||
145380202|NCT00990665|524243127|FG000|Overall Study|Death|29|||
145380203|NCT00990665|524243127|FG000|Overall Study|Heart Transplant|1|||
145380204|NCT00990665|524243127|FG000|Overall Study|Withdrawal by Subject|6|||
145380205|NCT00990665|524243127|FG000|Overall Study|Lost to Follow-up|1|||
145380206|NCT00990665|524243127|FG000|Overall Study|System Explant|3|||
145380207|NCT02603562|524243128|FG000|Overall Study|Lost to Follow-up|1|||
145380208|NCT03677934|524243129|FG000|Overall Study|Adverse Event|1|||
145380209|NCT03677934|524243130|FG001|Overall Study|Adverse Event|1|||
145380210|NCT03677934|524243129|FG000|Overall Study|Death|8|||
145380211|NCT03677934|524243130|FG001|Overall Study|Death|4|||
145380212|NCT03677934|524243129|FG000|Overall Study|Lost to Follow-up|3|||
145380213|NCT03677934|524243130|FG001|Overall Study|Lost to Follow-up|0|||
145380214|NCT03677934|524243129|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145380215|NCT03677934|524243130|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145380216|NCT03677934|524243129|FG000|Overall Study|Physician Decision|0|||
145380217|NCT03677934|524243130|FG001|Overall Study|Physician Decision|1|||
145380218|NCT03677934|524243129|FG000|Overall Study|Withdrawal by Subject|1|||
145380219|NCT03677934|524243130|FG001|Overall Study|Withdrawal by Subject|7|||
145380220|NCT00045734|524243131|FG000|Overall Study|Protocol Violation|1|||
145380221|NCT02069093|524243132|FG000|Overall Study|Disease progression|14|||
145380222|NCT02069093|524243132|FG000|Overall Study|New cancer therapy|1|||
145380223|NCT02069093|524243132|FG000|Overall Study|Death|1|||
145380224|NCT02069093|524243132|FG000|Overall Study|Administrative problems|1|||
145380225|NCT02069093|524243132|FG000|Overall Study|Withdrawal by Subject|2|||
145380226|NCT02069093|524243132|FG000|Overall Study|Abnormal laboratory values|1|||
145380227|NCT02069093|524243132|FG000|Overall Study|Adverse Event|10|||
145380228|NCT00335959|524243138|FG000|Overall Study|Adverse Event|2|||
145380229|NCT00335959|524243138|FG000|Overall Study|Ineligible|1|||
145380230|NCT01001598|524243139|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
145380231|NCT01001598|524243139|FG000|Overall Study|Adverse Event|1|||
145380232|NCT02450552|524243142|FG000|Overall Study|Withdrawal by Subject|4|||
145380233|NCT02450552|524243143|FG001|Overall Study|Withdrawal by Subject|0|||
145380234|NCT02450552|524243144|FG002|Overall Study|Withdrawal by Subject|4|||
145380235|NCT02450552|524243142|FG000|Overall Study|Physician Decision|1|||
145380236|NCT02450552|524243143|FG001|Overall Study|Physician Decision|0|||
145380237|NCT02450552|524243144|FG002|Overall Study|Physician Decision|1|||
145380238|NCT04148287|524243152|FG000|Overall Study|Death|2|||
145380239|NCT05079230|524243153|FG000|Overall Study|Study Terminated by Sponsor|101|||
145380240|NCT05079230|524243154|FG001|Overall Study|Study Terminated by Sponsor|102|||
145380241|NCT05079230|524243153|FG000|Overall Study|Death|72|||
145380242|NCT05079230|524243154|FG001|Overall Study|Death|66|||
145380243|NCT05079230|524243153|FG000|Overall Study|Withdrew Consent|16|||
145380244|NCT05079230|524243154|FG001|Overall Study|Withdrew Consent|18|||
145380245|NCT05079230|524243153|FG000|Overall Study|Lost to Follow-up|0|||
145380246|NCT05079230|524243154|FG001|Overall Study|Lost to Follow-up|3|||
145380247|NCT03164265|524243156|FG000|Overall Study|Physician Decision|3|||
145380248|NCT03673345|524243157|FG000|Overall Study|Lost to Follow-up|1|||
145380249|NCT03673345|524243158|FG001|Overall Study|Lost to Follow-up|0|||
145380250|NCT03673345|524243159|FG002|Overall Study|Lost to Follow-up|3|||
145380251|NCT03673345|524243160|FG003|Overall Study|Lost to Follow-up|3|||
145380252|NCT03673345|524243161|FG004|Overall Study|Lost to Follow-up|2|||
145380253|NCT03673345|524243162|FG005|Overall Study|Lost to Follow-up|1|||
145380254|NCT03673345|524243163|FG006|Overall Study|Lost to Follow-up|0|||
145380255|NCT03673345|524243164|FG007|Overall Study|Lost to Follow-up|0|||
145380256|NCT03673345|524243157|FG000|Overall Study|Withdrawal by Subject|1|||
145380257|NCT03673345|524243158|FG001|Overall Study|Withdrawal by Subject|0|||
145380258|NCT03673345|524243159|FG002|Overall Study|Withdrawal by Subject|4|||
145380259|NCT03673345|524243160|FG003|Overall Study|Withdrawal by Subject|2|||
145380260|NCT03673345|524243161|FG004|Overall Study|Withdrawal by Subject|0|||
145380261|NCT03673345|524243162|FG005|Overall Study|Withdrawal by Subject|0|||
145380262|NCT03673345|524243163|FG006|Overall Study|Withdrawal by Subject|0|||
145380263|NCT03673345|524243164|FG007|Overall Study|Withdrawal by Subject|0|||
145380264|NCT03673345|524243157|FG000|Overall Study|Physician Decision|0|||
145380265|NCT03673345|524243158|FG001|Overall Study|Physician Decision|0|||
145380266|NCT03673345|524243159|FG002|Overall Study|Physician Decision|2|||
145380267|NCT03673345|524243160|FG003|Overall Study|Physician Decision|0|||
145380268|NCT03673345|524243161|FG004|Overall Study|Physician Decision|0|||
145380269|NCT03673345|524243162|FG005|Overall Study|Physician Decision|0|||
145380270|NCT03673345|524243163|FG006|Overall Study|Physician Decision|0|||
145380271|NCT03673345|524243164|FG007|Overall Study|Physician Decision|0|||
145380272|NCT00932698|524243165|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
145380273|NCT00932698|524243166|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
145380274|NCT00932698|524243167|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
145380275|NCT00932698|524243168|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
145380276|NCT00932698|524243169|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
145380277|NCT00932698|524243170|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
145380278|NCT00932698|524243171|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
145380279|NCT00932698|524243172|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
145380280|NCT00932698|524243173|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
145380281|NCT00932698|524243174|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
145380282|NCT00932698|524243175|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
145380283|NCT00932698|524243165|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380284|NCT00932698|524243166|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145380285|NCT00932698|524243167|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380286|NCT00932698|524243168|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145380287|NCT00932698|524243169|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380288|NCT00932698|524243170|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145380289|NCT00932698|524243171|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
145380290|NCT00932698|524243172|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380291|NCT00932698|524243173|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380292|NCT00932698|524243174|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380293|NCT00932698|524243175|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
145380294|NCT00932698|524243165|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
145380295|NCT00932698|524243166|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
145380296|NCT00932698|524243167|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
145380297|NCT00932698|524243168|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
145380298|NCT00932698|524243169|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
145380299|NCT00932698|524243170|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
145380300|NCT00932698|524243171|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
145380301|NCT00932698|524243172|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
145380302|NCT00932698|524243173|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
145380303|NCT00932698|524243174|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
145380304|NCT00932698|524243175|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
145380305|NCT00932698|524243165|FG000|Part 1 (Dose Escalation)|Other|0|||
145380306|NCT00932698|524243166|FG001|Part 1 (Dose Escalation)|Other|0|||
145380307|NCT00932698|524243167|FG002|Part 1 (Dose Escalation)|Other|1|||
145380308|NCT00932698|524243168|FG003|Part 1 (Dose Escalation)|Other|0|||
145380309|NCT00932698|524243169|FG004|Part 1 (Dose Escalation)|Other|0|||
145380310|NCT00932698|524243170|FG005|Part 1 (Dose Escalation)|Other|0|||
145380311|NCT00932698|524243171|FG006|Part 1 (Dose Escalation)|Other|1|||
145380312|NCT00932698|524243172|FG007|Part 1 (Dose Escalation)|Other|0|||
145380313|NCT00932698|524243173|FG008|Part 1 (Dose Escalation)|Other|0|||
145380314|NCT00932698|524243174|FG009|Part 1 (Dose Escalation)|Other|0|||
145380315|NCT00932698|524243175|FG010|Part 1 (Dose Escalation)|Other|0|||
145380316|NCT00932698|524243165|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380317|NCT00932698|524243166|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380318|NCT00932698|524243167|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380319|NCT00932698|524243168|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380320|NCT00932698|524243169|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380321|NCT00932698|524243170|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380322|NCT00932698|524243171|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
145380323|NCT00932698|524243172|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
145380324|NCT00932698|524243173|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
145380325|NCT00932698|524243174|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
145380326|NCT00932698|524243175|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
145380327|NCT00932698|524243165|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380328|NCT00932698|524243166|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380329|NCT00932698|524243167|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380330|NCT00932698|524243168|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380331|NCT00932698|524243169|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380332|NCT00932698|524243170|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380333|NCT00932698|524243171|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380334|NCT00932698|524243172|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
145380335|NCT00932698|524243173|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
145380336|NCT00932698|524243174|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
145380337|NCT00932698|524243175|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
145380338|NCT00932698|524243165|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
145380339|NCT00932698|524243166|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
145380340|NCT00932698|524243167|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
145380341|NCT00932698|524243168|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
145380342|NCT00932698|524243169|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
145380343|NCT00932698|524243170|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
145380344|NCT00932698|524243171|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
145380345|NCT00932698|524243172|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
145380346|NCT00932698|524243173|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
145380347|NCT00932698|524243174|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
145380348|NCT00932698|524243175|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
145380349|NCT04608344|524243176|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
145380350|NCT04608344|524243177|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
145380351|NCT04608344|524243176|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
145380352|NCT04608344|524243177|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
145380353|NCT02607306|524243178|FG000|Overall Study|Adverse Event|8|||
145380354|NCT02607306|524243179|FG001|Overall Study|Adverse Event|6|||
145380355|NCT02607306|524243180|FG002|Overall Study|Adverse Event|6|||
145380356|NCT02607306|524243178|FG000|Overall Study|Unclassified|1|||
145380357|NCT02607306|524243179|FG001|Overall Study|Unclassified|4|||
145380358|NCT02607306|524243180|FG002|Overall Study|Unclassified|0|||
145380359|NCT02607306|524243178|FG000|Overall Study|Withdrawal by Subject|8|||
145380360|NCT02607306|524243179|FG001|Overall Study|Withdrawal by Subject|10|||
145380361|NCT02607306|524243180|FG002|Overall Study|Withdrawal by Subject|2|||
145380362|NCT02607306|524243178|FG000|Overall Study|Lack of Efficacy|0|||
145380363|NCT02607306|524243179|FG001|Overall Study|Lack of Efficacy|1|||
145380364|NCT02607306|524243180|FG002|Overall Study|Lack of Efficacy|1|||
145380365|NCT02607306|524243178|FG000|Overall Study|Protocol Violation|4|||
145380366|NCT02607306|524243179|FG001|Overall Study|Protocol Violation|2|||
145380367|NCT02607306|524243180|FG002|Overall Study|Protocol Violation|1|||
145380368|NCT04849416|524244986|FG000|Overall Study|Ongoing Treatment|12|||
145380369|NCT04849416|524244987|FG001|Overall Study|Ongoing Treatment|5|||
145380370|NCT04849416|524244988|FG002|Overall Study|Ongoing Treatment|3|||
145380371|NCT04849416|524244986|FG000|Overall Study|On Post-Treatment Follow-up|8|||
145380372|NCT04849416|524244987|FG001|Overall Study|On Post-Treatment Follow-up|9|||
145380373|NCT04849416|524244988|FG002|Overall Study|On Post-Treatment Follow-up|10|||
145380374|NCT04849416|524244986|FG000|Overall Study|Withdrawal by Subject|0|||
145380375|NCT04849416|524244987|FG001|Overall Study|Withdrawal by Subject|0|||
145380376|NCT04849416|524244988|FG002|Overall Study|Withdrawal by Subject|1|||
145380377|NCT04849416|524244986|FG000|Overall Study|Lost to Follow-up|1|||
145380378|NCT04849416|524244987|FG001|Overall Study|Lost to Follow-up|0|||
145380379|NCT04849416|524244988|FG002|Overall Study|Lost to Follow-up|0|||
145380380|NCT01636947|524244989|FG000|Overall Study|Not Treated|2|||
145380381|NCT01636947|524244990|FG001|Overall Study|Not Treated|2|||
145380382|NCT01636947|524244989|FG000|Overall Study|Lost to Follow-up|4|||
145380383|NCT01636947|524244990|FG001|Overall Study|Lost to Follow-up|0|||
145380384|NCT01636947|524244989|FG000|Overall Study|Protocol Violation|1|||
145380385|NCT01636947|524244990|FG001|Overall Study|Protocol Violation|1|||
145380386|NCT01636947|524244989|FG000|Overall Study|Withdrawal by Subject|3|||
145380387|NCT01636947|524244990|FG001|Overall Study|Withdrawal by Subject|3|||
145380388|NCT01636947|524244989|FG000|Overall Study|Adverse Event|1|||
145380389|NCT01636947|524244990|FG001|Overall Study|Adverse Event|1|||
145380390|NCT01636947|524244989|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
145380391|NCT01636947|524244990|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
145380392|NCT00460265|524244993|FG000|Overall Study|Lost to Follow-up|14|||
145380393|NCT00460265|524244994|FG001|Overall Study|Lost to Follow-up|15|||
145380394|NCT00460265|524244993|FG000|Overall Study|Physician Decision|1|||
145380395|NCT00460265|524244994|FG001|Overall Study|Physician Decision|2|||
145380396|NCT00460265|524244993|FG000|Overall Study|Withdrawal by Subject|10|||
145380397|NCT00460265|524244994|FG001|Overall Study|Withdrawal by Subject|25|||
145380398|NCT00460265|524244993|FG000|Overall Study|Ongoing|60|||
145380399|NCT00460265|524244994|FG001|Overall Study|Ongoing|47|||
145380400|NCT03956615|524244996|FG000|Overall Study|No multiple myeloma confirmed|2|||
145380401|NCT03956615|524244996|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
145380402|NCT03956615|524244996|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
145380403|NCT03956615|524244996|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
145380404|NCT00412217|524244997|FG000|Overall Study|Insufficient Data Available|8|||
145380405|NCT00412217|524244998|FG001|Overall Study|Insufficient Data Available|3|||
145380406|NCT00412217|524244997|FG000|Overall Study|Death|5|||
145380407|NCT00412217|524244998|FG001|Overall Study|Death|4|||
145380408|NCT00412217|524244997|FG000|Overall Study|Disease Progression|2|||
145380409|NCT00412217|524244998|FG001|Overall Study|Disease Progression|3|||
145380410|NCT00412217|524244997|FG000|Overall Study|Investigator Decision|1|||
145380411|NCT00412217|524244998|FG001|Overall Study|Investigator Decision|0|||
145380412|NCT00412217|524244997|FG000|Overall Study|Withdrawal by Subject|2|||
145380413|NCT00412217|524244998|FG001|Overall Study|Withdrawal by Subject|0|||
145380414|NCT00412217|524244997|FG000|Overall Study|Lost to Follow-up|1|||
145380415|NCT00412217|524244998|FG001|Overall Study|Lost to Follow-up|4|||
145380416|NCT00412217|524244997|FG000|Overall Study|Study Terminated by Sponsor|26|||
145380417|NCT00412217|524244998|FG001|Overall Study|Study Terminated by Sponsor|33|||
145380418|NCT00412217|524244997|FG000|Overall Study|Other|1|||
145380419|NCT00412217|524244998|FG001|Overall Study|Other|1|||
145380420|NCT01069419|524244999|FG000|Overall Study|Adverse Event|233|||
145380421|NCT01069419|524244999|FG000|Overall Study|Lack of Efficacy|332|||
145380422|NCT01069419|524244999|FG000|Overall Study|Lost to Follow-up|49|||
145380423|NCT01069419|524244999|FG000|Overall Study|Remission of disease|11|||
145380424|NCT01069419|524244999|FG000|Overall Study|Withdrawal by Subject|34|||
145380425|NCT01069419|524244999|FG000|Overall Study|Other Reason|43|||
145380426|NCT01069419|524244999|FG000|Overall Study|Missing termination information|13|||
145380427|NCT01897571|524245000|FG000|Overall Study|Lost to Follow-up|3|||
145380428|NCT01897571|524245001|FG001|Overall Study|Lost to Follow-up|0|||
145380429|NCT01897571|524245002|FG002|Overall Study|Lost to Follow-up|0|||
145380430|NCT01897571|524245003|FG003|Overall Study|Lost to Follow-up|0|||
145380431|NCT01897571|524245004|FG004|Overall Study|Lost to Follow-up|2|||
145380432|NCT01897571|524245005|FG005|Overall Study|Lost to Follow-up|0|||
145380433|NCT01897571|524245006|FG006|Overall Study|Lost to Follow-up|0|||
145380434|NCT01897571|524245007|FG007|Overall Study|Lost to Follow-up|0|||
145380435|NCT01897571|524245008|FG008|Overall Study|Lost to Follow-up|1|||
145380436|NCT01897571|524245009|FG009|Overall Study|Lost to Follow-up|2|||
145380437|NCT01897571|524245010|FG010|Overall Study|Lost to Follow-up|4|||
145380438|NCT01897571|524245000|FG000|Overall Study|Withdrawal by Subject|0|||
145380439|NCT01897571|524245001|FG001|Overall Study|Withdrawal by Subject|0|||
145380440|NCT01897571|524245002|FG002|Overall Study|Withdrawal by Subject|0|||
145380441|NCT01897571|524245003|FG003|Overall Study|Withdrawal by Subject|0|||
145380442|NCT01897571|524245004|FG004|Overall Study|Withdrawal by Subject|0|||
145380443|NCT01897571|524245005|FG005|Overall Study|Withdrawal by Subject|0|||
145380444|NCT01897571|524245006|FG006|Overall Study|Withdrawal by Subject|0|||
145380445|NCT01897571|524245007|FG007|Overall Study|Withdrawal by Subject|1|||
145380446|NCT01897571|524245008|FG008|Overall Study|Withdrawal by Subject|4|||
145380447|NCT01897571|524245009|FG009|Overall Study|Withdrawal by Subject|3|||
145380448|NCT01897571|524245010|FG010|Overall Study|Withdrawal by Subject|1|||
145380449|NCT01897571|524245000|FG000|Overall Study|Other|1|||
145380450|NCT01897571|524245001|FG001|Overall Study|Other|0|||
145380451|NCT01897571|524245002|FG002|Overall Study|Other|0|||
145380452|NCT01897571|524245003|FG003|Overall Study|Other|3|||
145380453|NCT01897571|524245004|FG004|Overall Study|Other|3|||
145380454|NCT01897571|524245005|FG005|Overall Study|Other|4|||
145380455|NCT01897571|524245006|FG006|Overall Study|Other|7|||
145380456|NCT01897571|524245007|FG007|Overall Study|Other|0|||
145380457|NCT01897571|524245008|FG008|Overall Study|Other|0|||
145380458|NCT01897571|524245009|FG009|Overall Study|Other|0|||
145380459|NCT01897571|524245010|FG010|Overall Study|Other|0|||
145380460|NCT01897571|524245000|FG000|Overall Study|Enrolled in rollover study|0|||
145380461|NCT01897571|524245001|FG001|Overall Study|Enrolled in rollover study|0|||
145380462|NCT01897571|524245002|FG002|Overall Study|Enrolled in rollover study|0|||
145380463|NCT01897571|524245003|FG003|Overall Study|Enrolled in rollover study|0|||
145380464|NCT01897571|524245004|FG004|Overall Study|Enrolled in rollover study|0|||
145380465|NCT01897571|524245005|FG005|Overall Study|Enrolled in rollover study|0|||
145380466|NCT01897571|524245006|FG006|Overall Study|Enrolled in rollover study|0|||
145380467|NCT01897571|524245007|FG007|Overall Study|Enrolled in rollover study|9|||
145380468|NCT01897571|524245008|FG008|Overall Study|Enrolled in rollover study|7|||
145380469|NCT01897571|524245009|FG009|Overall Study|Enrolled in rollover study|9|||
145380470|NCT01897571|524245010|FG010|Overall Study|Enrolled in rollover study|1|||
145380471|NCT01897571|524245000|FG000|Overall Study|Death|2|||
145380472|NCT01897571|524245001|FG001|Overall Study|Death|2|||
145380473|NCT01897571|524245002|FG002|Overall Study|Death|3|||
145380474|NCT01897571|524245003|FG003|Overall Study|Death|6|||
145380475|NCT01897571|524245004|FG004|Overall Study|Death|7|||
145380476|NCT01897571|524245005|FG005|Overall Study|Death|9|||
145380477|NCT01897571|524245006|FG006|Overall Study|Death|5|||
145380478|NCT01897571|524245007|FG007|Overall Study|Death|22|||
145380479|NCT01897571|524245008|FG008|Overall Study|Death|23|||
145380480|NCT01897571|524245009|FG009|Overall Study|Death|129|||
145380481|NCT01897571|524245010|FG010|Overall Study|Death|59|||
145380482|NCT01797094|524245011|FG000|Overall Study|Adverse Event|1|||
145380483|NCT01797094|524245012|FG001|Overall Study|Adverse Event|1|||
145380484|NCT01797094|524245011|FG000|Overall Study|Personal Reasons|4|||
145380485|NCT01797094|524245012|FG001|Overall Study|Personal Reasons|0|||
145380486|NCT01797094|524245011|FG000|Overall Study|Protocol Violation|0|||
145380487|NCT01797094|524245012|FG001|Overall Study|Protocol Violation|1|||
145380488|NCT01797094|524245011|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145380489|NCT01797094|524245012|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145380490|NCT00089635|524245013|FG000|Overall Study|Adverse Event|2|||
145380491|NCT00089635|524245013|FG000|Overall Study|Death|17|||
145380492|NCT00089635|524245013|FG000|Overall Study|Disease Progression|12|||
145380493|NCT00089635|524245013|FG000|Overall Study|Lost to Follow-up|3|||
145380494|NCT00089635|524245013|FG000|Overall Study|Withdrawal by Subject|6|||
145380495|NCT00089635|524245013|FG000|Overall Study|Ineligibility determined|1|||
145380496|NCT00089635|524245013|FG000|Overall Study|Other|2|||
145380497|NCT00821015|524245016|FG000|Overall Study|Lost to Follow-up|12|||
145605470|NCT02202434|525070731|FG001|Overall Study|Lost to Follow-up|1|||
145605471|NCT02202434|525070732|FG002|Overall Study|Lost to Follow-up|1|||
145605472|NCT02202434|525070733|FG003|Overall Study|Lost to Follow-up|0|||
145605473|NCT02202434|525070730|FG000|Overall Study|Physician Decision|2|||
145605474|NCT02202434|525070731|FG001|Overall Study|Physician Decision|3|||
145605475|NCT02202434|525070732|FG002|Overall Study|Physician Decision|0|||
145605476|NCT02202434|525070733|FG003|Overall Study|Physician Decision|0|||
145605477|NCT02202434|525070730|FG000|Overall Study|Withdrawal by Subject|13|||
145605478|NCT02202434|525070731|FG001|Overall Study|Withdrawal by Subject|14|||
145605479|NCT02202434|525070732|FG002|Overall Study|Withdrawal by Subject|1|||
145605480|NCT02202434|525070733|FG003|Overall Study|Withdrawal by Subject|4|||
145605481|NCT02202434|525070730|FG000|Overall Study|Completed Study|1|||
145605482|NCT02202434|525070731|FG001|Overall Study|Completed Study|0|||
145605483|NCT02202434|525070732|FG002|Overall Study|Completed Study|0|||
145605484|NCT02202434|525070733|FG003|Overall Study|Completed Study|0|||
145605485|NCT02202434|525070730|FG000|Overall Study|Visit Missed|21|||
145605486|NCT02202434|525070731|FG001|Overall Study|Visit Missed|12|||
145605487|NCT02202434|525070732|FG002|Overall Study|Visit Missed|0|||
145605488|NCT02202434|525070733|FG003|Overall Study|Visit Missed|5|||
145605489|NCT02202434|525070730|FG000|Overall Study|Other|1|||
145605490|NCT02202434|525070731|FG001|Overall Study|Other|0|||
145605491|NCT02202434|525070732|FG002|Overall Study|Other|0|||
145605492|NCT02202434|525070733|FG003|Overall Study|Other|1|||
145605493|NCT03237858|525070734|FG000|Overall Study|Death|19|||
145605494|NCT03237858|525070734|FG000|Overall Study|Withdrawal by Subject|37|||
145605495|NCT04858802|525070737|FG000|Overall Study|Lost to Follow-up|1|||
145605496|NCT04858802|525070738|FG001|Overall Study|Lost to Follow-up|1|||
145605497|NCT04858802|525070737|FG000|Overall Study|Withdrawal by Subject|1|||
145605498|NCT04858802|525070738|FG001|Overall Study|Withdrawal by Subject|1|||
145605499|NCT03610737|525070741|FG000|Overall Study|Withdrawal by Subject|1|||
145605500|NCT03610737|525070742|FG001|Overall Study|Withdrawal by Subject|5|||
145605501|NCT03610737|525070741|FG000|Overall Study|Death|1|||
145605502|NCT03610737|525070742|FG001|Overall Study|Death|0|||
145605503|NCT03610737|525070741|FG000|Overall Study|Not treated|5|||
145605504|NCT03610737|525070742|FG001|Overall Study|Not treated|2|||
145605505|NCT03610737|525070741|FG000|Overall Study|Missed Visit|1|||
145605506|NCT03610737|525070742|FG001|Overall Study|Missed Visit|2|||
145605507|NCT02013388|525070745|FG000|Overall Study|work emergency|1|||
145605508|NCT02013388|525070746|FG001|Overall Study|work emergency|0|||
145605509|NCT02013388|525070747|FG002|Overall Study|work emergency|0|||
145605510|NCT02013388|525070748|FG003|Overall Study|work emergency|0|||
145605511|NCT02013388|525070749|FG004|Overall Study|work emergency|1|||
145605512|NCT02013388|525070750|FG005|Overall Study|work emergency|0|||
145605513|NCT02013388|525070751|FG006|Overall Study|work emergency|0|||
145605514|NCT02013388|525070752|FG007|Overall Study|work emergency|0|||
145605515|NCT03243422|525070753|FG000|Overall Study|Death|20|||
145605516|NCT03243422|525070754|FG001|Overall Study|Death|21|||
145605517|NCT03243422|525070753|FG000|Overall Study|Lost to Follow-up|9|||
145605518|NCT03243422|525070754|FG001|Overall Study|Lost to Follow-up|21|||
145605519|NCT03243422|525070753|FG000|Overall Study|Withdrawal by Subject|22|||
145605520|NCT03243422|525070754|FG001|Overall Study|Withdrawal by Subject|8|||
145605521|NCT00215540|525070758|FG000|Overall Study|Withdrew from study medication|1|||
145605522|NCT00215540|525070759|FG001|Overall Study|Withdrew from study medication|0|||
145605523|NCT00215540|525070760|FG002|Overall Study|Withdrew from study medication|0|||
145605524|NCT03145766|525070761|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
145605525|NCT03145766|525070762|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
145605526|NCT03145766|525070763|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
145605527|NCT03145766|525070764|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
145605528|NCT03145766|525070765|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
145605529|NCT03145766|525070761|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
145605530|NCT03145766|525070762|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
145605531|NCT03145766|525070763|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
145605532|NCT03145766|525070764|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
145380498|NCT01887678|524245017|FG000|Overall Study|Adverse Event|4|||
145380499|NCT01887678|524245018|FG001|Overall Study|Adverse Event|6|||
145380500|NCT01887678|524245017|FG000|Overall Study|Exceeded rescue medication dosage|4|||
145380501|NCT01887678|524245018|FG001|Overall Study|Exceeded rescue medication dosage|5|||
145380502|NCT01887678|524245017|FG000|Overall Study|Withdrawal of consent|3|||
145380503|NCT01887678|524245018|FG001|Overall Study|Withdrawal of consent|4|||
145380504|NCT01887678|524245017|FG000|Overall Study|Lost to Follow-up|4|||
145380505|NCT01887678|524245018|FG001|Overall Study|Lost to Follow-up|2|||
145380506|NCT01887678|524245017|FG000|Overall Study|Deterioration of clinical condition|0|||
145380507|NCT01887678|524245018|FG001|Overall Study|Deterioration of clinical condition|4|||
145380508|NCT01887678|524245017|FG000|Overall Study|Lack of Efficacy|1|||
145380509|NCT01887678|524245018|FG001|Overall Study|Lack of Efficacy|2|||
145380510|NCT01887678|524245017|FG000|Overall Study|Non-compliance|0|||
145380511|NCT01887678|524245018|FG001|Overall Study|Non-compliance|3|||
145380512|NCT01887678|524245017|FG000|Overall Study|Specified|1|||
145380513|NCT01887678|524245018|FG001|Overall Study|Specified|2|||
145380514|NCT00270231|524245027|FG000|First Intervention|Lost to Follow-up|1|||
145380515|NCT00270231|524245028|FG001|First Intervention|Lost to Follow-up|1|||
145380516|NCT00270231|524245027|FG000|Washout Period|Lost to Follow-up|1|||
145380517|NCT00270231|524245028|FG001|Washout Period|Lost to Follow-up|0|||
145380518|NCT00270231|524245027|FG000|Second Intervention|Lost to Follow-up|0|||
145380519|NCT00270231|524245028|FG001|Second Intervention|Lost to Follow-up|1|||
145380520|NCT01080391|524245037|FG000|Overall Study|Randomized but not treated|7|||
145380521|NCT01080391|524245038|FG001|Overall Study|Randomized but not treated|4|||
145380522|NCT00574795|524245048|FG000|Infant Series|Withdrawal by Subject|2|||
145380523|NCT00574795|524245048|FG000|Infant Series|Protocol Violation|2|||
145380524|NCT00574795|524245048|FG000|Infant Series|Adverse Event|1|||
145380525|NCT00574795|524245048|FG000|After Infant Series|Withdrawal by Subject|1|||
145380526|NCT00574795|524245048|FG000|After Infant Series|Adverse Event|2|||
145380527|NCT00574795|524245048|FG000|Toddler Dose|Withdrawal by Subject|1|||
145380528|NCT00672841|524245049|FG000|Overall Study|Comfort care|1|||
145380529|NCT00672841|524245050|FG001|Overall Study|Comfort care|4|||
145380530|NCT00672841|524245049|FG000|Overall Study|icteric specimens|0|||
145380531|NCT00672841|524245050|FG001|Overall Study|icteric specimens|3|||
145380532|NCT00672841|524245049|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
145380533|NCT00672841|524245050|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
145380534|NCT00672841|524245049|FG000|Overall Study|Adverse Event|0|||
145380535|NCT00672841|524245050|FG001|Overall Study|Adverse Event|3|||
145380536|NCT00672841|524245049|FG000|Overall Study|Pregnancy|0|||
145380537|NCT00672841|524245050|FG001|Overall Study|Pregnancy|1|||
145380538|NCT02638259|524245051|FG000|Treatment Period 1|Adverse Event|1|||
145380539|NCT02638259|524245052|FG001|Treatment Period 1|Adverse Event|5|||
145380540|NCT02638259|524245051|FG000|Treatment Period 1|Death|0|||
145380541|NCT02638259|524245052|FG001|Treatment Period 1|Death|1|||
145380542|NCT02638259|524245051|FG000|Treatment Period 1|Lack of Efficacy|0|||
145380543|NCT02638259|524245052|FG001|Treatment Period 1|Lack of Efficacy|1|||
145380544|NCT02638259|524245051|FG000|Treatment Period 1|Protocol Violation|0|||
145380545|NCT02638259|524245052|FG001|Treatment Period 1|Protocol Violation|3|||
145380546|NCT02638259|524245051|FG000|Treatment Period 1|Withdrawal by Subject|4|||
145380547|NCT02638259|524245052|FG001|Treatment Period 1|Withdrawal by Subject|6|||
145380548|NCT02638259|524245051|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
145380549|NCT02638259|524245052|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
145380550|NCT02638259|524245051|FG000|Treatment Period 2|Adverse Event|5|||
145380551|NCT02638259|524245052|FG001|Treatment Period 2|Adverse Event|4|||
145380552|NCT02638259|524245051|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145380553|NCT02638259|524245052|FG001|Treatment Period 2|Withdrawal by Subject|7|||
145380554|NCT04299048|524245053|FG000|Overall Study|Death|1|||
145380555|NCT04299048|524245053|FG000|Overall Study|Global deterioration of health status|2|||
145380556|NCT04299048|524245053|FG000|Overall Study|Enrolled and not treated|1|||
145380557|NCT00586508|524245071|FG000|Overall Study|Progressive disease|52|||
145380558|NCT00586508|524245072|FG001|Overall Study|Progressive disease|8|||
145380559|NCT00586508|524245071|FG000|Overall Study|Death|0|||
145380560|NCT00586508|524245072|FG001|Overall Study|Death|1|||
145380561|NCT00586508|524245071|FG000|Overall Study|Adverse Event|12|||
145380562|NCT00586508|524245072|FG001|Overall Study|Adverse Event|4|||
145380563|NCT00586508|524245071|FG000|Overall Study|Withdrawal by Subject|4|||
145380564|NCT00586508|524245072|FG001|Overall Study|Withdrawal by Subject|0|||
145380565|NCT02079636|524245073|FG000|Overall Study|Death|2|||
145380566|NCT02079636|524245074|FG001|Overall Study|Death|1|||
145380567|NCT02079636|524245075|FG002|Overall Study|Death|0|||
145380568|NCT02079636|524245076|FG003|Overall Study|Death|5|||
145380569|NCT02079636|524245077|FG004|Overall Study|Death|1|||
145380570|NCT02079636|524245078|FG005|Overall Study|Death|2|||
145380571|NCT02079636|524245079|FG006|Overall Study|Death|1|||
145380572|NCT02079636|524245080|FG007|Overall Study|Death|0|||
145380573|NCT02079636|524245081|FG008|Overall Study|Death|0|||
145380574|NCT02079636|524245082|FG009|Overall Study|Death|0|||
145380575|NCT02079636|524245083|FG010|Overall Study|Death|0|||
145380576|NCT02079636|524245084|FG011|Overall Study|Death|1|||
145380577|NCT02079636|524245085|FG012|Overall Study|Death|1|||
145380578|NCT02079636|524245086|FG013|Overall Study|Death|0|||
145380579|NCT02079636|524245087|FG014|Overall Study|Death|2|||
145380580|NCT02079636|524245073|FG000|Overall Study|Adverse Event|1|||
145380581|NCT02079636|524245074|FG001|Overall Study|Adverse Event|1|||
145380582|NCT02079636|524245075|FG002|Overall Study|Adverse Event|0|||
145380583|NCT02079636|524245076|FG003|Overall Study|Adverse Event|1|||
145380584|NCT02079636|524245077|FG004|Overall Study|Adverse Event|1|||
145380585|NCT02079636|524245078|FG005|Overall Study|Adverse Event|2|||
145380586|NCT02079636|524245079|FG006|Overall Study|Adverse Event|0|||
145380587|NCT02079636|524245080|FG007|Overall Study|Adverse Event|0|||
145380588|NCT02079636|524245081|FG008|Overall Study|Adverse Event|0|||
145380589|NCT02079636|524245082|FG009|Overall Study|Adverse Event|0|||
145380590|NCT02079636|524245083|FG010|Overall Study|Adverse Event|0|||
145380591|NCT02079636|524245084|FG011|Overall Study|Adverse Event|0|||
145380592|NCT02079636|524245085|FG012|Overall Study|Adverse Event|0|||
145380593|NCT02079636|524245086|FG013|Overall Study|Adverse Event|0|||
145380594|NCT02079636|524245087|FG014|Overall Study|Adverse Event|0|||
145380595|NCT02079636|524245073|FG000|Overall Study|Progressive disease|0|||
145380596|NCT02079636|524245074|FG001|Overall Study|Progressive disease|0|||
145380597|NCT02079636|524245075|FG002|Overall Study|Progressive disease|0|||
145380598|NCT02079636|524245076|FG003|Overall Study|Progressive disease|2|||
145380599|NCT02079636|524245077|FG004|Overall Study|Progressive disease|0|||
145380600|NCT02079636|524245078|FG005|Overall Study|Progressive disease|0|||
145380601|NCT02079636|524245079|FG006|Overall Study|Progressive disease|0|||
145380602|NCT02079636|524245080|FG007|Overall Study|Progressive disease|0|||
145380603|NCT02079636|524245081|FG008|Overall Study|Progressive disease|0|||
145380604|NCT02079636|524245082|FG009|Overall Study|Progressive disease|0|||
145380605|NCT02079636|524245083|FG010|Overall Study|Progressive disease|0|||
145380606|NCT02079636|524245084|FG011|Overall Study|Progressive disease|0|||
145380607|NCT02079636|524245085|FG012|Overall Study|Progressive disease|1|||
145380608|NCT02079636|524245086|FG013|Overall Study|Progressive disease|0|||
145380609|NCT02079636|524245087|FG014|Overall Study|Progressive disease|0|||
145380610|NCT02079636|524245073|FG000|Overall Study|Withdrawal by Subject|0|||
145380611|NCT02079636|524245074|FG001|Overall Study|Withdrawal by Subject|0|||
145380612|NCT02079636|524245075|FG002|Overall Study|Withdrawal by Subject|0|||
145380613|NCT02079636|524245076|FG003|Overall Study|Withdrawal by Subject|4|||
145380614|NCT02079636|524245077|FG004|Overall Study|Withdrawal by Subject|0|||
145380615|NCT02079636|524245078|FG005|Overall Study|Withdrawal by Subject|1|||
145380616|NCT02079636|524245079|FG006|Overall Study|Withdrawal by Subject|0|||
145380617|NCT02079636|524245080|FG007|Overall Study|Withdrawal by Subject|0|||
145380618|NCT02079636|524245081|FG008|Overall Study|Withdrawal by Subject|0|||
145380619|NCT02079636|524245082|FG009|Overall Study|Withdrawal by Subject|2|||
145380620|NCT02079636|524245083|FG010|Overall Study|Withdrawal by Subject|1|||
145380621|NCT02079636|524245084|FG011|Overall Study|Withdrawal by Subject|1|||
145380622|NCT02079636|524245085|FG012|Overall Study|Withdrawal by Subject|1|||
145380623|NCT02079636|524245086|FG013|Overall Study|Withdrawal by Subject|0|||
145380624|NCT02079636|524245087|FG014|Overall Study|Withdrawal by Subject|2|||
145380625|NCT02079636|524245073|FG000|Overall Study|Physician Decision|0|||
145380626|NCT02079636|524245074|FG001|Overall Study|Physician Decision|0|||
145380627|NCT02079636|524245075|FG002|Overall Study|Physician Decision|0|||
145380628|NCT02079636|524245076|FG003|Overall Study|Physician Decision|0|||
145380629|NCT02079636|524245077|FG004|Overall Study|Physician Decision|0|||
145380630|NCT02079636|524245078|FG005|Overall Study|Physician Decision|1|||
145380631|NCT02079636|524245079|FG006|Overall Study|Physician Decision|0|||
145380632|NCT02079636|524245080|FG007|Overall Study|Physician Decision|0|||
145380633|NCT02079636|524245081|FG008|Overall Study|Physician Decision|0|||
145380634|NCT02079636|524245082|FG009|Overall Study|Physician Decision|1|||
145380635|NCT02079636|524245083|FG010|Overall Study|Physician Decision|1|||
145380636|NCT02079636|524245084|FG011|Overall Study|Physician Decision|0|||
145380637|NCT02079636|524245085|FG012|Overall Study|Physician Decision|0|||
145380638|NCT02079636|524245086|FG013|Overall Study|Physician Decision|0|||
145380639|NCT02079636|524245087|FG014|Overall Study|Physician Decision|1|||
145380640|NCT02079636|524245073|FG000|Overall Study|Lost to Follow-up|0|||
145380641|NCT02079636|524245074|FG001|Overall Study|Lost to Follow-up|0|||
145380642|NCT02079636|524245075|FG002|Overall Study|Lost to Follow-up|0|||
145380643|NCT02079636|524245076|FG003|Overall Study|Lost to Follow-up|0|||
145380644|NCT02079636|524245077|FG004|Overall Study|Lost to Follow-up|0|||
145380645|NCT02079636|524245078|FG005|Overall Study|Lost to Follow-up|0|||
145380646|NCT02079636|524245079|FG006|Overall Study|Lost to Follow-up|0|||
145380647|NCT02079636|524245080|FG007|Overall Study|Lost to Follow-up|1|||
145380648|NCT02079636|524245081|FG008|Overall Study|Lost to Follow-up|0|||
145380649|NCT02079636|524245082|FG009|Overall Study|Lost to Follow-up|0|||
145380650|NCT02079636|524245083|FG010|Overall Study|Lost to Follow-up|0|||
145380651|NCT02079636|524245084|FG011|Overall Study|Lost to Follow-up|0|||
145380652|NCT02079636|524245085|FG012|Overall Study|Lost to Follow-up|0|||
145616789|NCT01254565|525111334|FG003|Overall Study|Other|1|||
145380653|NCT02079636|524245086|FG013|Overall Study|Lost to Follow-up|0|||
145380654|NCT02079636|524245087|FG014|Overall Study|Lost to Follow-up|0|||
145380655|NCT00561470|524245088|FG000|Overall Study|Adverse Event|74|||
145380656|NCT00561470|524245089|FG001|Overall Study|Adverse Event|163|||
145380657|NCT00561470|524245088|FG000|Overall Study|Disease progression|437|||
145380658|NCT00561470|524245089|FG001|Overall Study|Disease progression|305|||
145380659|NCT00561470|524245088|FG000|Overall Study|poor compliance to protocol|4|||
145380660|NCT00561470|524245089|FG001|Overall Study|poor compliance to protocol|4|||
145380661|NCT00561470|524245088|FG000|Overall Study|Lost to Follow-up|2|||
145380662|NCT00561470|524245089|FG001|Overall Study|Lost to Follow-up|0|||
145380663|NCT00561470|524245088|FG000|Overall Study|Physician Decision|21|||
145380664|NCT00561470|524245089|FG001|Overall Study|Physician Decision|20|||
145380665|NCT00561470|524245088|FG000|Overall Study|Consent Withdrawn|2|||
145380666|NCT00561470|524245089|FG001|Overall Study|Consent Withdrawn|6|||
145380667|NCT00561470|524245088|FG000|Overall Study|Subject request|43|||
145380668|NCT00561470|524245089|FG001|Overall Study|Subject request|77|||
145380669|NCT00561470|524245088|FG000|Overall Study|Metastatic surgery|10|||
145380670|NCT00561470|524245089|FG001|Overall Study|Metastatic surgery|12|||
145380671|NCT00561470|524245088|FG000|Overall Study|Unauthorized procedure|3|||
145380672|NCT00561470|524245089|FG001|Overall Study|Unauthorized procedure|1|||
145380673|NCT00561470|524245088|FG000|Overall Study|Randomized but not treated|5|||
145380674|NCT00561470|524245089|FG001|Overall Study|Randomized but not treated|5|||
145380675|NCT00561470|524245088|FG000|Overall Study|Missed visit window|1|||
145380676|NCT00561470|524245089|FG001|Overall Study|Missed visit window|4|||
145380677|NCT00561470|524245088|FG000|Overall Study|Planning surgery|1|||
145380678|NCT00561470|524245089|FG001|Overall Study|Planning surgery|1|||
145380679|NCT00561470|524245088|FG000|Overall Study|Ongoing Treatment|11|||
145380680|NCT00561470|524245089|FG001|Overall Study|Ongoing Treatment|14|||
145380681|NCT03434249|524245090|FG000|Overall Study|Adverse Event|1|||
145380682|NCT03434249|524245091|FG001|Overall Study|Adverse Event|0|||
145380683|NCT03434249|524245090|FG000|Overall Study|Lost to Follow-up|0|||
145380684|NCT03434249|524245091|FG001|Overall Study|Lost to Follow-up|1|||
145380685|NCT03434249|524245090|FG000|Overall Study|Non-compliance of family|2|||
145380686|NCT03434249|524245091|FG001|Overall Study|Non-compliance of family|1|||
145380687|NCT03434249|524245090|FG000|Overall Study|Difficulties in completing daily diary|2|||
145380688|NCT03434249|524245091|FG001|Overall Study|Difficulties in completing daily diary|1|||
145380689|NCT03325894|524245092|FG000|Overall Study|Adverse Event|2|||
145380690|NCT03325894|524245093|FG001|Overall Study|Adverse Event|3|||
145380691|NCT03325894|524245092|FG000|Overall Study|Protocol Violation|1|||
145380692|NCT03325894|524245093|FG001|Overall Study|Protocol Violation|2|||
145380693|NCT03325894|524245092|FG000|Overall Study|Withdrawal by Subject|10|||
145380694|NCT03325894|524245093|FG001|Overall Study|Withdrawal by Subject|6|||
145380695|NCT03325894|524245092|FG000|Overall Study|Lost to Follow-up|4|||
145380696|NCT03325894|524245093|FG001|Overall Study|Lost to Follow-up|9|||
145380697|NCT03325894|524245092|FG000|Overall Study|Lack of Efficacy|8|||
145380698|NCT03325894|524245093|FG001|Overall Study|Lack of Efficacy|14|||
145380699|NCT03325894|524245092|FG000|Overall Study|Study Terminated by Sponsor|38|||
145380700|NCT03325894|524245093|FG001|Overall Study|Study Terminated by Sponsor|43|||
145380701|NCT03325894|524245092|FG000|Overall Study|Other (Not received Treatment)|1|||
145380702|NCT03325894|524245093|FG001|Overall Study|Other (Not received Treatment)|0|||
145380703|NCT01524783|524245104|FG000|Blinded Period|Adverse Event|64|||
145380704|NCT01524783|524245105|FG001|Blinded Period|Adverse Event|7|||
145380705|NCT01524783|524245106|FG002|Blinded Period|Adverse Event|0|||
145380706|NCT01524783|524245104|FG000|Blinded Period|Disease Progression|89|||
145380707|NCT01524783|524245105|FG001|Blinded Period|Disease Progression|75|||
145380708|NCT01524783|524245106|FG002|Blinded Period|Disease Progression|0|||
145380709|NCT01524783|524245104|FG000|Blinded Period|Withdrawal by Subject|19|||
145380710|NCT01524783|524245105|FG001|Blinded Period|Withdrawal by Subject|6|||
145380711|NCT01524783|524245106|FG002|Blinded Period|Withdrawal by Subject|0|||
145380712|NCT01524783|524245104|FG000|Blinded Period|Protocol deviation|2|||
145380713|NCT01524783|524245105|FG001|Blinded Period|Protocol deviation|1|||
145380714|NCT01524783|524245106|FG002|Blinded Period|Protocol deviation|0|||
145380715|NCT01524783|524245104|FG000|Blinded Period|Death|5|||
145380716|NCT01524783|524245105|FG001|Blinded Period|Death|2|||
145380717|NCT01524783|524245106|FG002|Blinded Period|Death|0|||
145380718|NCT01524783|524245104|FG000|Open-label Period|Disease progression|13|||
145380719|NCT01524783|524245105|FG001|Open-label Period|Disease progression|0|||
145380720|NCT01524783|524245106|FG002|Open-label Period|Disease progression|2|||
145380721|NCT01524783|524245104|FG000|Open-label Period|Administrative problems|5|||
145380722|NCT01524783|524245105|FG001|Open-label Period|Administrative problems|0|||
145380723|NCT01524783|524245106|FG002|Open-label Period|Administrative problems|2|||
145380724|NCT01524783|524245104|FG000|Open-label Period|Adverse Event|5|||
145380725|NCT01524783|524245105|FG001|Open-label Period|Adverse Event|0|||
145380726|NCT01524783|524245106|FG002|Open-label Period|Adverse Event|1|||
145380727|NCT01524783|524245104|FG000|Open-label Period|Withdrawal by Subject|2|||
145380728|NCT01524783|524245105|FG001|Open-label Period|Withdrawal by Subject|0|||
145380729|NCT01524783|524245106|FG002|Open-label Period|Withdrawal by Subject|1|||
145380730|NCT01524783|524245104|FG000|Open-label Period|Protocol deviation|1|||
145380731|NCT01524783|524245105|FG001|Open-label Period|Protocol deviation|0|||
145380732|NCT01524783|524245106|FG002|Open-label Period|Protocol deviation|0|||
145380733|NCT00106639|524245107|FG000|Overall Study|Adverse Event|3|||
145380734|NCT00106639|524245108|FG001|Overall Study|Adverse Event|4|||
145380735|NCT00106639|524245109|FG002|Overall Study|Adverse Event|1|||
145380736|NCT00106639|524245107|FG000|Overall Study|Protocol Violation|0|||
145380737|NCT00106639|524245108|FG001|Overall Study|Protocol Violation|1|||
145380738|NCT00106639|524245109|FG002|Overall Study|Protocol Violation|0|||
145380739|NCT00106639|524245107|FG000|Overall Study|Withdrawal by Subject|0|||
145380740|NCT00106639|524245108|FG001|Overall Study|Withdrawal by Subject|1|||
145380741|NCT00106639|524245109|FG002|Overall Study|Withdrawal by Subject|0|||
145380742|NCT00106639|524245107|FG000|Overall Study|Participant defaulted|0|||
145380743|NCT00106639|524245108|FG001|Overall Study|Participant defaulted|1|||
145380744|NCT00106639|524245109|FG002|Overall Study|Participant defaulted|1|||
145380745|NCT01876979|524245110|FG000|Overall Study|Physician Decision|2|||
145380746|NCT01876979|524245111|FG001|Overall Study|Physician Decision|3|||
145380747|NCT02240069|524245112|FG000|Overall Study|Withdrawal by Subject|5|||
145380748|NCT02240069|524245113|FG001|Overall Study|Withdrawal by Subject|5|||
145380749|NCT02240069|524245114|FG002|Overall Study|Withdrawal by Subject|2|||
145380750|NCT01096589|524245115|FG000|Overall Study|Adverse Event|2|||
145380751|NCT01096589|524245116|FG001|Overall Study|Adverse Event|1|||
145380752|NCT01096589|524245117|FG002|Overall Study|Adverse Event|2|||
145380753|NCT01096589|524245118|FG003|Overall Study|Adverse Event|1|||
145380754|NCT01096589|524245115|FG000|Overall Study|Withdrawal by Subject|2|||
145380755|NCT01096589|524245116|FG001|Overall Study|Withdrawal by Subject|1|||
145380756|NCT01096589|524245117|FG002|Overall Study|Withdrawal by Subject|1|||
145380757|NCT01096589|524245118|FG003|Overall Study|Withdrawal by Subject|1|||
145380758|NCT01096589|524245115|FG000|Overall Study|Compliance with protocol|0|||
145380759|NCT01096589|524245116|FG001|Overall Study|Compliance with protocol|0|||
145380760|NCT01096589|524245117|FG002|Overall Study|Compliance with protocol|1|||
145380761|NCT01096589|524245118|FG003|Overall Study|Compliance with protocol|0|||
145380762|NCT01096589|524245115|FG000|Overall Study|found treatment exhausting|0|||
145380763|NCT01096589|524245116|FG001|Overall Study|found treatment exhausting|0|||
145380764|NCT01096589|524245117|FG002|Overall Study|found treatment exhausting|0|||
145380765|NCT01096589|524245118|FG003|Overall Study|found treatment exhausting|1|||
145380766|NCT00721279|524245122|FG000|Overall Study|Lack of Efficacy|6|||
145380767|NCT00721279|524245123|FG001|Overall Study|Lack of Efficacy|3|||
145380768|NCT00721279|524245122|FG000|Overall Study|Tolerability insufficient|5|||
145380769|NCT00721279|524245123|FG001|Overall Study|Tolerability insufficient|2|||
145380770|NCT00721279|524245122|FG000|Overall Study|Withdrawal by Subject|13|||
145380771|NCT00721279|524245123|FG001|Overall Study|Withdrawal by Subject|3|||
145380772|NCT00721279|524245122|FG000|Overall Study|Other|12|||
145380773|NCT00721279|524245123|FG001|Overall Study|Other|16|||
145380774|NCT05153148|524245124|FG000|Overall Study|Adverse Event|1|||
145380775|NCT05153148|524245125|FG001|Overall Study|Adverse Event|0|||
145380776|NCT05153148|524245126|FG002|Overall Study|Adverse Event|3|||
145380777|NCT05153148|524245127|FG003|Overall Study|Adverse Event|5|||
145380778|NCT05153148|524245124|FG000|Overall Study|Lost to Follow-up|1|||
145380779|NCT05153148|524245125|FG001|Overall Study|Lost to Follow-up|1|||
145380780|NCT05153148|524245126|FG002|Overall Study|Lost to Follow-up|2|||
145380781|NCT05153148|524245127|FG003|Overall Study|Lost to Follow-up|0|||
145380782|NCT05153148|524245124|FG000|Overall Study|Withdrawal by Subject|6|||
145380783|NCT05153148|524245125|FG001|Overall Study|Withdrawal by Subject|8|||
145380784|NCT05153148|524245126|FG002|Overall Study|Withdrawal by Subject|6|||
145380785|NCT05153148|524245127|FG003|Overall Study|Withdrawal by Subject|8|||
145380786|NCT05153148|524245124|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145380787|NCT05153148|524245125|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145380788|NCT05153148|524245126|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
145718256|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
145718257|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
145718258|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
145718259|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
145718260|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
145718261|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
145718262|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
145718263|NCT00371683|525483173|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
145380789|NCT05153148|524245127|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
145380790|NCT05153148|524245124|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145380791|NCT05153148|524245125|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145380792|NCT05153148|524245126|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
145380793|NCT05153148|524245127|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
145380794|NCT05153148|524245124|FG000|Overall Study|Reason not Specified|1|||
145380795|NCT05153148|524245125|FG001|Overall Study|Reason not Specified|1|||
145380796|NCT05153148|524245126|FG002|Overall Study|Reason not Specified|1|||
145380797|NCT05153148|524245127|FG003|Overall Study|Reason not Specified|1|||
145380798|NCT00232596|524245128|FG000|6-Week Titration Phase|Adverse Event|6|||
145380799|NCT00232596|524245129|FG001|6-Week Titration Phase|Adverse Event|19|||
145380800|NCT00232596|524245128|FG000|6-Week Titration Phase|Failed to Return|2|||
145380801|NCT00232596|524245129|FG001|6-Week Titration Phase|Failed to Return|1|||
145380802|NCT00232596|524245128|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
145380803|NCT00232596|524245129|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
145380804|NCT00232596|524245128|FG000|6-Week Titration Phase|Protocol Violation|1|||
145380805|NCT00232596|524245129|FG001|6-Week Titration Phase|Protocol Violation|3|||
145380806|NCT00232596|524245128|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
145380807|NCT00232596|524245129|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
145380808|NCT00232596|524245128|FG000|6-Week Titration Phase|Other|3|||
145380809|NCT00232596|524245129|FG001|6-Week Titration Phase|Other|3|||
145380810|NCT00232596|524245128|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145380811|NCT00232596|524245129|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
145380812|NCT00232596|524245128|FG000|12-Week Maintenance Phase|Adverse Event|7|||
145380813|NCT00232596|524245129|FG001|12-Week Maintenance Phase|Adverse Event|22|||
145380814|NCT00232596|524245128|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
145380815|NCT00232596|524245129|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
145380816|NCT00232596|524245128|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
145380817|NCT00232596|524245129|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
145380818|NCT00232596|524245128|FG000|12-Week Maintenance Phase|Other|1|||
145380819|NCT00232596|524245129|FG001|12-Week Maintenance Phase|Other|3|||
145380820|NCT01712334|524245130|FG000|Treatment Period 1|Randomized in Error|0|||
145380821|NCT01712334|524245131|FG001|Treatment Period 1|Randomized in Error|2|||
145380822|NCT01253174|524245132|FG000|Period 1|Randomized but not treated|0|||
145380823|NCT01253174|524245133|FG001|Period 1|Randomized but not treated|1|||
145380824|NCT01253174|524245134|FG002|Period 1|Randomized but not treated|1|||
145380825|NCT01253174|524245135|FG003|Period 1|Randomized but not treated|0|||
145380826|NCT01253174|524245136|FG004|Period 1|Randomized but not treated|1|||
145380827|NCT01253174|524245137|FG005|Period 1|Randomized but not treated|0|||
145380828|NCT01253174|524245132|FG000|Period 2|Adverse Event|0|||
145380829|NCT01253174|524245133|FG001|Period 2|Adverse Event|0|||
145380830|NCT01253174|524245134|FG002|Period 2|Adverse Event|1|||
145380831|NCT01253174|524245135|FG003|Period 2|Adverse Event|0|||
145380832|NCT01253174|524245136|FG004|Period 2|Adverse Event|0|||
145380833|NCT01253174|524245137|FG005|Period 2|Adverse Event|0|||
145380834|NCT01253174|524245132|FG000|Period 3|Withdrawal by Subject|0|||
145380835|NCT01253174|524245133|FG001|Period 3|Withdrawal by Subject|1|||
145380836|NCT01253174|524245134|FG002|Period 3|Withdrawal by Subject|0|||
145380837|NCT01253174|524245135|FG003|Period 3|Withdrawal by Subject|0|||
145380838|NCT01253174|524245136|FG004|Period 3|Withdrawal by Subject|1|||
145380839|NCT01253174|524245137|FG005|Period 3|Withdrawal by Subject|0|||
145380840|NCT01253174|524245132|FG000|Period 3|Pregnancy|0|||
145380841|NCT01253174|524245133|FG001|Period 3|Pregnancy|0|||
145380842|NCT01253174|524245134|FG002|Period 3|Pregnancy|1|||
145380843|NCT01253174|524245135|FG003|Period 3|Pregnancy|0|||
145380844|NCT01253174|524245136|FG004|Period 3|Pregnancy|0|||
145380845|NCT01253174|524245137|FG005|Period 3|Pregnancy|0|||
145380846|NCT02267135|524245138|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
145380847|NCT02267135|524245139|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
145380848|NCT02267135|524245138|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
145380849|NCT02267135|524245139|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
145380850|NCT02267135|524245138|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
145380851|NCT02267135|524245139|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
145380852|NCT02267135|524245138|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
145380853|NCT02267135|524245139|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
145380854|NCT02267135|524245138|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
145380855|NCT02267135|524245139|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
145380856|NCT00900731|524245140|FG000|Overall Study|Adverse Event|31|||
145380857|NCT00900731|524245141|FG001|Overall Study|Adverse Event|27|||
145380858|NCT00900731|524245140|FG000|Overall Study|Withdrawal by Subject|8|||
145380859|NCT00900731|524245141|FG001|Overall Study|Withdrawal by Subject|7|||
145605533|NCT03145766|525070765|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
145605534|NCT03145766|525070761|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
145605535|NCT03145766|525070762|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
145605536|NCT03145766|525070763|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
145605537|NCT03145766|525070764|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
145605538|NCT03145766|525070765|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
145605539|NCT03145766|525070761|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
145605540|NCT03145766|525070762|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
145605541|NCT03145766|525070763|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
145616790|NCT01254565|525111335|FG004|Overall Study|Other|0|||
145380860|NCT00900731|524245140|FG000|Overall Study|Protocol Deviation|8|||
145380861|NCT00900731|524245141|FG001|Overall Study|Protocol Deviation|11|||
145380862|NCT00900731|524245140|FG000|Overall Study|Administrative Problems|5|||
145380863|NCT00900731|524245141|FG001|Overall Study|Administrative Problems|4|||
145380864|NCT00900731|524245140|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
145380865|NCT00900731|524245141|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145380866|NCT00900731|524245140|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
145380867|NCT00900731|524245141|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
145380868|NCT00900731|524245140|FG000|Overall Study|Lost to Follow-up|2|||
145380869|NCT00900731|524245141|FG001|Overall Study|Lost to Follow-up|3|||
145380870|NCT00900731|524245140|FG000|Overall Study|Lack of Efficacy|1|||
145380871|NCT00900731|524245141|FG001|Overall Study|Lack of Efficacy|3|||
145380872|NCT00900731|524245140|FG000|Overall Study|Death|0|||
145380873|NCT00900731|524245141|FG001|Overall Study|Death|2|||
145380874|NCT03806231|524245142|FG000|Overall Study|Physician Decision|1|||
145380875|NCT03806231|524245143|FG001|Overall Study|Physician Decision|0|||
145380876|NCT03806231|524245142|FG000|Overall Study|Withdrawal by Subject|1|||
145380877|NCT03806231|524245143|FG001|Overall Study|Withdrawal by Subject|0|||
145380878|NCT02919267|524245144|FG000|Overall Study|Protocol Violation|0|||
145380879|NCT02919267|524245145|FG001|Overall Study|Protocol Violation|3|||
145380880|NCT02919267|524245146|FG002|Overall Study|Protocol Violation|3|||
145380881|NCT02919267|524245147|FG003|Overall Study|Protocol Violation|4|||
145380882|NCT03467763|524245148|FG000|Overall Study|Lost to Follow-up|1|||
145380883|NCT03467763|524245148|FG000|Overall Study|Protocol Violation|2|||
145380884|NCT00131365|524245151|FG000|Overall Study|Withdrawal by Subject|1|||
145380885|NCT00131365|524245151|FG000|Overall Study|Alternative treatment|3|||
145380886|NCT05249127|524245152|FG000|Overall Study|Protocol Violation|13|||
145380887|NCT05249127|524245152|FG000|Overall Study|Physician Decision|4|||
145380888|NCT05249127|524245152|FG000|Overall Study|Withdrawal by Subject|2|||
145380889|NCT05249127|524245152|FG000|Overall Study|Participant Non-compliance|1|||
145380890|NCT02908074|524245153|FG000|Overall Study|sponsor/ICON decision|0|||
145380891|NCT02908074|524245154|FG001|Overall Study|sponsor/ICON decision|0|||
145380892|NCT02908074|524245155|FG002|Overall Study|sponsor/ICON decision|1|||
145380893|NCT02908074|524245156|FG003|Overall Study|sponsor/ICON decision|0|||
145380894|NCT02908074|524245157|FG004|Overall Study|sponsor/ICON decision|0|||
145380895|NCT02908074|524245158|FG005|Overall Study|sponsor/ICON decision|0|||
145380896|NCT02908074|524245153|FG000|Overall Study|Protocol Violation|0|||
145380897|NCT02908074|524245154|FG001|Overall Study|Protocol Violation|1|||
145380898|NCT02908074|524245155|FG002|Overall Study|Protocol Violation|0|||
145380899|NCT02908074|524245156|FG003|Overall Study|Protocol Violation|0|||
145380900|NCT02908074|524245157|FG004|Overall Study|Protocol Violation|0|||
145380901|NCT02908074|524245158|FG005|Overall Study|Protocol Violation|0|||
145380902|NCT02908074|524245153|FG000|Overall Study|Adverse Event|5|||
145380903|NCT02908074|524245154|FG001|Overall Study|Adverse Event|2|||
145380904|NCT02908074|524245155|FG002|Overall Study|Adverse Event|0|||
145380905|NCT02908074|524245156|FG003|Overall Study|Adverse Event|0|||
145380906|NCT02908074|524245157|FG004|Overall Study|Adverse Event|1|||
145380907|NCT02908074|524245158|FG005|Overall Study|Adverse Event|0|||
145380908|NCT02908074|524245153|FG000|Overall Study|AESI|1|||
145380909|NCT02908074|524245154|FG001|Overall Study|AESI|0|||
145380910|NCT02908074|524245155|FG002|Overall Study|AESI|1|||
145380911|NCT02908074|524245156|FG003|Overall Study|AESI|0|||
145380912|NCT02908074|524245157|FG004|Overall Study|AESI|1|||
145380913|NCT02908074|524245158|FG005|Overall Study|AESI|0|||
145380914|NCT02908074|524245153|FG000|Overall Study|Discontinuation criteria per protocol|0|||
145380915|NCT02908074|524245154|FG001|Overall Study|Discontinuation criteria per protocol|0|||
145380916|NCT02908074|524245155|FG002|Overall Study|Discontinuation criteria per protocol|1|||
145380917|NCT02908074|524245156|FG003|Overall Study|Discontinuation criteria per protocol|0|||
145380918|NCT02908074|524245157|FG004|Overall Study|Discontinuation criteria per protocol|0|||
145380919|NCT02908074|524245158|FG005|Overall Study|Discontinuation criteria per protocol|1|||
145380920|NCT02908074|524245153|FG000|Overall Study|Withdrawal by Subject|3|||
145380921|NCT02908074|524245154|FG001|Overall Study|Withdrawal by Subject|2|||
145380922|NCT02908074|524245155|FG002|Overall Study|Withdrawal by Subject|2|||
145380923|NCT02908074|524245156|FG003|Overall Study|Withdrawal by Subject|2|||
145380924|NCT02908074|524245157|FG004|Overall Study|Withdrawal by Subject|2|||
145380925|NCT02908074|524245158|FG005|Overall Study|Withdrawal by Subject|2|||
145380926|NCT02908074|524245153|FG000|Overall Study|Lost to Follow-up|0|||
145380927|NCT02908074|524245154|FG001|Overall Study|Lost to Follow-up|1|||
145380928|NCT02908074|524245155|FG002|Overall Study|Lost to Follow-up|1|||
145380929|NCT02908074|524245156|FG003|Overall Study|Lost to Follow-up|1|||
145380930|NCT02908074|524245157|FG004|Overall Study|Lost to Follow-up|0|||
145380931|NCT02908074|524245158|FG005|Overall Study|Lost to Follow-up|1|||
145380932|NCT02073565|524245159|FG000|Cohort A|Withdrawal by Subject|1|||
145380933|NCT02073565|524245160|FG001|Cohort A|Withdrawal by Subject|0|||
145380934|NCT02073565|524245159|FG000|Cohort B|Withdrawal by Subject|1|||
145380935|NCT02073565|524245160|FG001|Cohort B|Withdrawal by Subject|2|||
145380936|NCT02073565|524245159|FG000|Cohort C|Withdrawal by Subject|0|||
145380937|NCT02073565|524245160|FG001|Cohort C|Withdrawal by Subject|2|||
145380938|NCT02073565|524245159|FG000|Cohort C|Lost to Follow-up|0|||
145380939|NCT02073565|524245160|FG001|Cohort C|Lost to Follow-up|2|||
145380940|NCT03646305|524245161|FG000|Overall Study|Lost to Follow-up|4|||
145380941|NCT03646305|524245162|FG001|Overall Study|Lost to Follow-up|2|||
145380942|NCT03646305|524245163|FG002|Overall Study|Lost to Follow-up|2|||
145380943|NCT03646305|524245164|FG003|Overall Study|Lost to Follow-up|1|||
145380944|NCT03646305|524245161|FG000|Overall Study|Withdrawal by Subject|1|||
145380945|NCT03646305|524245162|FG001|Overall Study|Withdrawal by Subject|0|||
145380946|NCT03646305|524245163|FG002|Overall Study|Withdrawal by Subject|0|||
145380947|NCT03646305|524245164|FG003|Overall Study|Withdrawal by Subject|1|||
145380948|NCT01554176|524245165|FG000|Treatment Phase|Protocol Violation|1|||
145380949|NCT01554176|524245166|FG001|Treatment Phase|Protocol Violation|2|||
145380950|NCT01554176|524245167|FG002|Treatment Phase|Protocol Violation|0|||
145380951|NCT01554176|524245168|FG003|Treatment Phase|Protocol Violation|0|||
145380952|NCT01554176|524245169|FG004|Treatment Phase|Protocol Violation|0|||
145380953|NCT01554176|524245165|FG000|Treatment Phase|Physician Decision|1|||
145380954|NCT01554176|524245166|FG001|Treatment Phase|Physician Decision|1|||
145380955|NCT01554176|524245167|FG002|Treatment Phase|Physician Decision|0|||
145380956|NCT01554176|524245168|FG003|Treatment Phase|Physician Decision|0|||
145380957|NCT01554176|524245169|FG004|Treatment Phase|Physician Decision|0|||
145380958|NCT01554176|524245165|FG000|Treatment Phase|Lack of Efficacy|0|||
145380959|NCT01554176|524245166|FG001|Treatment Phase|Lack of Efficacy|1|||
145380960|NCT01554176|524245167|FG002|Treatment Phase|Lack of Efficacy|0|||
145492001|NCT00740220|524656936|FG000|Overall Study|screen failures (non-COPD patients)|9|||
145492002|NCT01908426|524656941|FG000|Overall Study|Adverse Event|98|||
145492003|NCT01908426|524656942|FG001|Overall Study|Adverse Event|11|||
145492004|NCT01908426|524656941|FG000|Overall Study|Clinical Deterioration|72|||
145492005|NCT01908426|524656942|FG001|Overall Study|Clinical Deterioration|38|||
145492006|NCT01908426|524656941|FG000|Overall Study|Lack of Efficacy|3|||
145492007|NCT01908426|524656942|FG001|Overall Study|Lack of Efficacy|0|||
145492008|NCT01908426|524656941|FG000|Overall Study|Lost to Follow-up|0|||
145492009|NCT01908426|524656942|FG001|Overall Study|Lost to Follow-up|1|||
145492010|NCT01908426|524656941|FG000|Overall Study|Physician Decision|3|||
145492011|NCT01908426|524656942|FG001|Overall Study|Physician Decision|3|||
145492012|NCT01908426|524656941|FG000|Overall Study|Withdrawal by Subject|11|||
145492013|NCT01908426|524656942|FG001|Overall Study|Withdrawal by Subject|6|||
145492014|NCT01908426|524656941|FG000|Overall Study|Progressive Disease|206|||
145492015|NCT01908426|524656942|FG001|Overall Study|Progressive Disease|152|||
145492016|NCT01908426|524656941|FG000|Overall Study|Protocol Violation|1|||
145492017|NCT01908426|524656942|FG001|Overall Study|Protocol Violation|0|||
145492018|NCT01908426|524656941|FG000|Overall Study|No Study Treatment Given|3|||
145492019|NCT01908426|524656942|FG001|Overall Study|No Study Treatment Given|0|||
145492020|NCT03346434|524656943|FG000|Overall Study|Randomized in Error|0|||
145492021|NCT03346434|524656944|FG001|Overall Study|Randomized in Error|0|||
145492022|NCT03346434|524656945|FG002|Overall Study|Randomized in Error|0|||
145492023|NCT03346434|524656946|FG003|Overall Study|Randomized in Error|0|||
145492024|NCT03346434|524656947|FG004|Overall Study|Randomized in Error|1|||
145492025|NCT03346434|524656948|FG005|Overall Study|Randomized in Error|0|||
145492026|NCT03346434|524656943|FG000|Overall Study|Withdrawal by Subject|0|||
145492027|NCT03346434|524656944|FG001|Overall Study|Withdrawal by Subject|0|||
145492028|NCT03346434|524656945|FG002|Overall Study|Withdrawal by Subject|1|||
145492029|NCT03346434|524656946|FG003|Overall Study|Withdrawal by Subject|0|||
145492030|NCT03346434|524656947|FG004|Overall Study|Withdrawal by Subject|1|||
145492031|NCT03346434|524656948|FG005|Overall Study|Withdrawal by Subject|0|||
145492032|NCT03346434|524656943|FG000|Overall Study|Lost to Follow-up|0|||
145492033|NCT03346434|524656944|FG001|Overall Study|Lost to Follow-up|0|||
145492034|NCT03346434|524656945|FG002|Overall Study|Lost to Follow-up|0|||
145492035|NCT03346434|524656946|FG003|Overall Study|Lost to Follow-up|0|||
145492036|NCT03346434|524656947|FG004|Overall Study|Lost to Follow-up|1|||
145492037|NCT03346434|524656948|FG005|Overall Study|Lost to Follow-up|1|||
145605542|NCT03145766|525070764|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
145605543|NCT03145766|525070765|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
145605544|NCT03145766|525070761|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
145605545|NCT03145766|525070762|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
145605546|NCT03145766|525070763|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
145605547|NCT03145766|525070764|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
145605548|NCT03145766|525070765|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
145605549|NCT03145766|525070761|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
145605550|NCT03145766|525070762|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
145605551|NCT03145766|525070763|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
145605552|NCT03145766|525070764|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
145605553|NCT03145766|525070765|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
145605554|NCT03145766|525070761|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
145605555|NCT03145766|525070762|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
145605556|NCT03145766|525070763|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
145605557|NCT03145766|525070764|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
145380961|NCT01554176|524245168|FG003|Treatment Phase|Lack of Efficacy|0|||
145492038|NCT03346434|524656943|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
145492039|NCT03346434|524656944|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
145492040|NCT03346434|524656945|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
145605558|NCT03145766|525070765|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
145605559|NCT02801669|525070767|FG000|Overall Study|Death|66|||
145605560|NCT02801669|525070768|FG001|Overall Study|Death|69|||
145605561|NCT02801669|525070767|FG000|Overall Study|Withdrawal by Subject|81|||
145605562|NCT02801669|525070768|FG001|Overall Study|Withdrawal by Subject|77|||
145605563|NCT02801669|525070767|FG000|Overall Study|Other|4|||
145605564|NCT02801669|525070768|FG001|Overall Study|Other|6|||
145605565|NCT04461795|525070770|FG000|Overall Study|Lost to Follow-up|2|||
145605566|NCT04461795|525070770|FG000|Overall Study|Withdrawal by Subject|2|||
145605567|NCT04461795|525070770|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
145605568|NCT00615264|525070771|FG000|Overall Study|Withdrawal by Subject|17|||
145605569|NCT00615264|525070772|FG001|Overall Study|Withdrawal by Subject|19|||
145605570|NCT00615264|525070771|FG000|Overall Study|Lost to Follow-up|6|||
145605571|NCT00615264|525070772|FG001|Overall Study|Lost to Follow-up|13|||
145605572|NCT00615264|525070771|FG000|Overall Study|Adverse Event|8|||
145605573|NCT00615264|525070772|FG001|Overall Study|Adverse Event|5|||
145605574|NCT00615264|525070771|FG000|Overall Study|Death|1|||
145605575|NCT00615264|525070772|FG001|Overall Study|Death|1|||
145605576|NCT00615264|525070771|FG000|Overall Study|Protocol Violation|11|||
145605577|NCT00615264|525070772|FG001|Overall Study|Protocol Violation|7|||
145605578|NCT00615264|525070771|FG000|Overall Study|Not defined|7|||
145605579|NCT00615264|525070772|FG001|Overall Study|Not defined|4|||
145605580|NCT00615264|525070771|FG000|Overall Study|Dermal Hypersensitivity|0|||
145605581|NCT00615264|525070772|FG001|Overall Study|Dermal Hypersensitivity|3|||
145605582|NCT00058422|525070773|FG000|Overall Study|Not treated|2|||
145605583|NCT00185640|525070774|FG000|Overall Study|Not Eligible|4|||
145605584|NCT00185640|525070774|FG000|Overall Study|Withdrawal by Subject|3|||
145605585|NCT00185640|525070774|FG000|Overall Study|Death|138|||
145605586|NCT02396537|525070777|FG000|Overall Study|Protocol Violation|0|||
145605587|NCT02396537|525070778|FG001|Overall Study|Protocol Violation|1|||
145605588|NCT01982435|525070779|FG000|Overall Study|Adverse Event|1|||
145605589|NCT01982435|525070780|FG001|Overall Study|Adverse Event|0|||
145605590|NCT00871403|525070781|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
145605591|NCT00871403|525070782|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
145605592|NCT00871403|525070783|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
145605593|NCT00871403|525070781|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
145605594|NCT00871403|525070782|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
145605595|NCT00871403|525070783|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
145605596|NCT00871403|525070781|FG000|Combination Treatment Phase|Adverse Event|0|||
145605597|NCT00871403|525070782|FG001|Combination Treatment Phase|Adverse Event|17|||
145605598|NCT00871403|525070783|FG002|Combination Treatment Phase|Adverse Event|2|||
145605599|NCT00871403|525070781|FG000|Combination Treatment Phase|Disease Progression|0|||
145605600|NCT00871403|525070782|FG001|Combination Treatment Phase|Disease Progression|8|||
145605601|NCT00871403|525070783|FG002|Combination Treatment Phase|Disease Progression|5|||
145605602|NCT00871403|525070781|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
145605603|NCT00871403|525070782|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
145605604|NCT00871403|525070783|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
145605605|NCT00871403|525070781|FG000|Combination Treatment Phase|Physician Decision|0|||
145605606|NCT00871403|525070782|FG001|Combination Treatment Phase|Physician Decision|1|||
145605607|NCT00871403|525070783|FG002|Combination Treatment Phase|Physician Decision|3|||
145605608|NCT00871403|525070781|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
145605609|NCT00871403|525070782|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
145605610|NCT00871403|525070783|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
145605611|NCT00871403|525070781|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
145605612|NCT00871403|525070782|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
145605613|NCT00871403|525070783|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
145605614|NCT03075904|525070787|FG000|Overall Study|Physician Decision|3|||
145605615|NCT03075904|525070787|FG000|Overall Study|Need for Medication not Permitted|1|||
145605616|NCT00985985|525070790|FG000|Overall Study|Adverse Event|4|||
145605617|NCT00985985|525070791|FG001|Overall Study|Adverse Event|2|||
145605618|NCT00985985|525070792|FG002|Overall Study|Adverse Event|2|||
145605619|NCT00985985|525070793|FG003|Overall Study|Adverse Event|2|||
145605620|NCT00985985|525070790|FG000|Overall Study|Lost to Follow-up|4|||
145605621|NCT00985985|525070791|FG001|Overall Study|Lost to Follow-up|11|||
145605622|NCT00985985|525070792|FG002|Overall Study|Lost to Follow-up|2|||
145605623|NCT00985985|525070793|FG003|Overall Study|Lost to Follow-up|3|||
145605624|NCT00985985|525070790|FG000|Overall Study|Protocol Violation|1|||
145605625|NCT00985985|525070791|FG001|Overall Study|Protocol Violation|2|||
145605626|NCT00985985|525070792|FG002|Overall Study|Protocol Violation|0|||
145605627|NCT00985985|525070793|FG003|Overall Study|Protocol Violation|1|||
145605628|NCT00985985|525070790|FG000|Overall Study|Lack of Efficacy|5|||
145605629|NCT00985985|525070791|FG001|Overall Study|Lack of Efficacy|6|||
145605630|NCT00985985|525070792|FG002|Overall Study|Lack of Efficacy|1|||
145605631|NCT00985985|525070793|FG003|Overall Study|Lack of Efficacy|3|||
145605632|NCT00985985|525070790|FG000|Overall Study|Withdrawal by Subject|4|||
145605633|NCT00985985|525070791|FG001|Overall Study|Withdrawal by Subject|2|||
145605634|NCT00985985|525070792|FG002|Overall Study|Withdrawal by Subject|2|||
145605635|NCT00985985|525070793|FG003|Overall Study|Withdrawal by Subject|2|||
145605636|NCT00985985|525070790|FG000|Overall Study|Other Reason|6|||
145605637|NCT00985985|525070791|FG001|Overall Study|Other Reason|1|||
145605638|NCT00985985|525070792|FG002|Overall Study|Other Reason|4|||
145605639|NCT00985985|525070793|FG003|Overall Study|Other Reason|2|||
145605640|NCT00509236|525070796|FG000|Overall Study|Adverse Event|7|||
145605641|NCT00509236|525070797|FG001|Overall Study|Adverse Event|9|||
145605642|NCT00509236|525070796|FG000|Overall Study|Withdrawal by Subject|5|||
145605643|NCT00509236|525070797|FG001|Overall Study|Withdrawal by Subject|10|||
145605644|NCT00509236|525070796|FG000|Overall Study|Protocol Violation|3|||
145605645|NCT00509236|525070797|FG001|Overall Study|Protocol Violation|0|||
145605646|NCT00509236|525070796|FG000|Overall Study|Excluded Medication|1|||
145605647|NCT00509236|525070797|FG001|Overall Study|Excluded Medication|1|||
145605648|NCT00509236|525070796|FG000|Overall Study|Scheduled Kidney Transplant|1|||
145605649|NCT00509236|525070797|FG001|Overall Study|Scheduled Kidney Transplant|0|||
145605650|NCT00927355|525070798|FG000|Overall Study|Adverse Event|1|||
145605651|NCT00927355|525070799|FG001|Overall Study|Adverse Event|1|||
145605652|NCT01572389|525070800|FG000|Overall Study|Death|1|||
145605653|NCT01572389|525070801|FG001|Overall Study|Death|3|||
145605654|NCT01572389|525070800|FG000|Overall Study|Withdrawal by Subject|14|||
145605655|NCT01572389|525070801|FG001|Overall Study|Withdrawal by Subject|2|||
145605656|NCT01572389|525070800|FG000|Overall Study|Lost to Follow-up|25|||
145605657|NCT01572389|525070801|FG001|Overall Study|Lost to Follow-up|14|||
145605658|NCT01572389|525070800|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
145605659|NCT01572389|525070801|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
145605660|NCT03954743|525070802|FG000|Overall Study|Adverse Event|1|||
145605661|NCT03954743|525070803|FG001|Overall Study|Adverse Event|0|||
145605662|NCT03954743|525070802|FG000|Overall Study|Lost to Follow-up|6|||
145605663|NCT03954743|525070803|FG001|Overall Study|Lost to Follow-up|4|||
145605664|NCT03954743|525070802|FG000|Overall Study|Protocol Violation|1|||
145605665|NCT03954743|525070803|FG001|Overall Study|Protocol Violation|0|||
145605666|NCT03954743|525070802|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
145605667|NCT03954743|525070803|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
145605668|NCT03954743|525070802|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
145605669|NCT03954743|525070803|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145605670|NCT01446796|525070814|FG000|Overall Study|Withdrawal by Subject|1|||
145605671|NCT01446796|525070815|FG001|Overall Study|Withdrawal by Subject|0|||
145605672|NCT03579290|525070823|FG000|Overall Study|Lost to Follow-up|9|||
145605673|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
145605674|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
145605675|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
145605676|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
145605677|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
145605678|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
145605679|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
145605680|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Physician Decision|4|||
145605681|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Physician Decision|1|||
145605682|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Physician Decision|3|||
145605683|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Physician Decision|0|||
145605684|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Physician Decision|0|||
145605685|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Physician Decision|1|||
145605686|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Physician Decision|0|||
145605687|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Other|0|||
145605688|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Other|1|||
145605689|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Other|0|||
145605690|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Other|0|||
145605691|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Other|0|||
145605692|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Other|0|||
145605693|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Other|0|||
145605694|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605695|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605696|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605697|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605698|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605699|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
145605700|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
145605701|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
145605702|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
145605703|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
145605704|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
145605705|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
145605706|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
145605707|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
145605708|NCT05375955|525070824|FG000|Treatment (12 Weeks)|Pregnancy|0|||
145605709|NCT05375955|525070825|FG001|Treatment (12 Weeks)|Pregnancy|0|||
145605710|NCT05375955|525070826|FG002|Treatment (12 Weeks)|Pregnancy|1|||
145605711|NCT05375955|525070827|FG003|Treatment (12 Weeks)|Pregnancy|0|||
145605712|NCT05375955|525070828|FG004|Treatment (12 Weeks)|Pregnancy|0|||
145605713|NCT05375955|525070829|FG005|Treatment (12 Weeks)|Pregnancy|0|||
145605714|NCT05375955|525070830|FG006|Treatment (12 Weeks)|Pregnancy|0|||
145605715|NCT05375955|525070824|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605716|NCT05375955|525070825|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605717|NCT05375955|525070826|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
145605718|NCT05375955|525070827|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605719|NCT05375955|525070828|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605720|NCT05375955|525070829|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605721|NCT05375955|525070830|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
145605722|NCT05375955|525070824|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
145605723|NCT05375955|525070825|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
145605724|NCT05375955|525070826|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
145605725|NCT05375955|525070827|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
145605726|NCT05375955|525070828|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
145605727|NCT05375955|525070829|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
145605728|NCT05375955|525070830|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
145605729|NCT05375955|525070824|FG000|Follow-up (up to 5 Weeks)|Other|0|||
145605730|NCT05375955|525070825|FG001|Follow-up (up to 5 Weeks)|Other|1|||
145605731|NCT05375955|525070826|FG002|Follow-up (up to 5 Weeks)|Other|0|||
145605732|NCT05375955|525070827|FG003|Follow-up (up to 5 Weeks)|Other|0|||
145605733|NCT05375955|525070828|FG004|Follow-up (up to 5 Weeks)|Other|0|||
145605734|NCT05375955|525070829|FG005|Follow-up (up to 5 Weeks)|Other|0|||
145605735|NCT05375955|525070830|FG006|Follow-up (up to 5 Weeks)|Other|0|||
145605736|NCT05375955|525070824|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
145605737|NCT05375955|525070825|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
145605738|NCT05375955|525070826|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
145605739|NCT05375955|525070827|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
145605740|NCT05375955|525070828|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
145605741|NCT05375955|525070829|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
145605742|NCT05375955|525070830|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
145605743|NCT05375955|525070824|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
145605744|NCT05375955|525070825|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
145605745|NCT05375955|525070826|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
145605746|NCT05375955|525070827|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
145605747|NCT05375955|525070828|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
145605748|NCT05375955|525070829|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
145605749|NCT05375955|525070830|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
145605750|NCT05454410|525070831|FG000|Overall Study|Withdrawal by Subject|0|||
145605751|NCT05454410|525070832|FG001|Overall Study|Withdrawal by Subject|0|||
145605752|NCT05454410|525070833|FG002|Overall Study|Withdrawal by Subject|1|||
145605753|NCT05454410|525070834|FG003|Overall Study|Withdrawal by Subject|1|||
145605754|NCT05004688|525070844|FG000|Overall Study|Protocol Violation|7|||
145605755|NCT05004688|525070844|FG000|Overall Study|Physician Decision|2|||
145605756|NCT05004688|525070844|FG000|Overall Study|Withdrawal by Subject|2|||
145605757|NCT00895622|525070845|FG000|Overall Study|Protocol Violation|5|||
145605758|NCT00895622|525070846|FG001|Overall Study|Protocol Violation|4|||
145605759|NCT00895622|525070847|FG002|Overall Study|Protocol Violation|4|||
145605760|NCT03879408|525070848|FG000|Overall Study|Lost to Follow-up|0|||
145605761|NCT03879408|525070849|FG001|Overall Study|Lost to Follow-up|3|||
145605762|NCT03879408|525070850|FG002|Overall Study|Lost to Follow-up|2|||
145605763|NCT03879408|525070851|FG003|Overall Study|Lost to Follow-up|1|||
145605764|NCT03879408|525070852|FG004|Overall Study|Lost to Follow-up|0|||
145605765|NCT03879408|525070848|FG000|Overall Study|Withdrawal by Subject|2|||
145605766|NCT03879408|525070849|FG001|Overall Study|Withdrawal by Subject|1|||
145605767|NCT03879408|525070850|FG002|Overall Study|Withdrawal by Subject|1|||
145605768|NCT03879408|525070851|FG003|Overall Study|Withdrawal by Subject|0|||
145605769|NCT03879408|525070852|FG004|Overall Study|Withdrawal by Subject|1|||
145605770|NCT01320943|525070853|FG000|Overall Study|Lost to Follow-up|1|||
145605771|NCT01320943|525070854|FG001|Overall Study|Lost to Follow-up|0|||
145605772|NCT01320943|525070853|FG000|Overall Study|Physician Decision|0|||
145605773|NCT01320943|525070854|FG001|Overall Study|Physician Decision|1|||
145605774|NCT01320943|525070853|FG000|Overall Study|Randomized but not Treated|0|||
145605775|NCT01320943|525070854|FG001|Overall Study|Randomized but not Treated|1|||
145605776|NCT03489057|525070863|FG000|Overall Study|Lost to Follow-up|16|||
145605777|NCT03489057|525070864|FG001|Overall Study|Lost to Follow-up|16|||
145605778|NCT03489057|525070865|FG002|Overall Study|Lost to Follow-up|14|||
145605779|NCT03489057|525070866|FG003|Overall Study|Lost to Follow-up|14|||
145605780|NCT03489057|525070863|FG000|Overall Study|Withdrawal by Subject|12|||
145605781|NCT03489057|525070864|FG001|Overall Study|Withdrawal by Subject|12|||
145605782|NCT03489057|525070865|FG002|Overall Study|Withdrawal by Subject|8|||
145605783|NCT03489057|525070866|FG003|Overall Study|Withdrawal by Subject|8|||
145605784|NCT03489057|525070863|FG000|Overall Study|Protocol Violation|7|||
145605785|NCT03489057|525070864|FG001|Overall Study|Protocol Violation|7|||
145605786|NCT03489057|525070865|FG002|Overall Study|Protocol Violation|2|||
145605787|NCT03489057|525070866|FG003|Overall Study|Protocol Violation|2|||
145605788|NCT05158296|525070867|FG000|Overall Study|Sponsor Decision|2|||
145605789|NCT05158296|525070868|FG001|Overall Study|Sponsor Decision|3|||
145605790|NCT05158296|525070869|FG002|Overall Study|Sponsor Decision|2|||
145605791|NCT02010632|525070870|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
145605792|NCT02010632|525070871|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
145605793|NCT03324880|525070872|FG000|Overall Study|Adverse Event|0|||
145605794|NCT03324880|525070873|FG001|Overall Study|Adverse Event|2|||
145605795|NCT03324880|525070872|FG000|Overall Study|Withdrawal by Subject|2|||
145605796|NCT03324880|525070873|FG001|Overall Study|Withdrawal by Subject|2|||
145605797|NCT03324880|525070872|FG000|Overall Study|Lost to Follow-up|0|||
145718264|NCT00371683|525483174|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
145718265|NCT00371683|525483173|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
145718266|NCT00371683|525483174|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
145718267|NCT00371683|525483173|FG000|Follow-Up Period - Randomized Patients|Death|0|||
145718268|NCT00371683|525483174|FG001|Follow-Up Period - Randomized Patients|Death|2|||
145718269|NCT00371683|525483173|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
145718270|NCT00371683|525483174|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
145718271|NCT00371683|525483173|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
145718272|NCT00371683|525483174|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
145718273|NCT03181789|525483175|FG000|Overall Study|Withdrawal by Subject|0|||
145718274|NCT03181789|525483176|FG001|Overall Study|Withdrawal by Subject|1|||
145718275|NCT03181789|525483177|FG002|Overall Study|Withdrawal by Subject|1|||
145718276|NCT03181789|525483178|FG003|Overall Study|Withdrawal by Subject|0|||
145718277|NCT03181789|525483175|FG000|Overall Study|Lost to Follow-up|7|||
145718278|NCT03181789|525483176|FG001|Overall Study|Lost to Follow-up|1|||
145718279|NCT03181789|525483177|FG002|Overall Study|Lost to Follow-up|0|||
145718280|NCT03181789|525483178|FG003|Overall Study|Lost to Follow-up|0|||
145718281|NCT03181789|525483175|FG000|Overall Study|Participant unable to adhere to visit|0|||
145718282|NCT03181789|525483176|FG001|Overall Study|Participant unable to adhere to visit|1|||
145718283|NCT03181789|525483177|FG002|Overall Study|Participant unable to adhere to visit|0|||
145718284|NCT03181789|525483178|FG003|Overall Study|Participant unable to adhere to visit|0|||
145718285|NCT01131182|525483179|FG000|Overall Study|Withdrawal by Subject|1|||
145718286|NCT01131182|525483180|FG001|Overall Study|Withdrawal by Subject|1|||
145718287|NCT01131182|525483179|FG000|Overall Study|Lost to Follow-up|14|||
145718288|NCT01131182|525483180|FG001|Overall Study|Lost to Follow-up|15|||
145718289|NCT01131182|525483179|FG000|Overall Study|Other Reason|1|||
145718290|NCT01131182|525483180|FG001|Overall Study|Other Reason|0|||
145718291|NCT00998790|525483183|FG000|Overall Study|Withdrawal by Subject|21|||
145718292|NCT01080716|525483184|FG000|Part 1|Physician Decision|1|||
145718293|NCT01080716|525483185|FG001|Part 1|Physician Decision|0|||
145718294|NCT01080716|525483186|FG002|Part 1|Physician Decision|0|||
145718295|NCT01080716|525483187|FG003|Part 1|Physician Decision|0|||
145718296|NCT01993927|525483188|FG000|Overall Study|Case Report Forms Uncollected|18|||
145718297|NCT01993927|525483188|FG000|Overall Study|Protocol Violation|11|||
145718298|NCT00895154|525483189|FG000|Overall Study|Lost to Follow-up|1|||
145718299|NCT00895154|525483190|FG001|Overall Study|Lost to Follow-up|1|||
145718300|NCT00895154|525483189|FG000|Overall Study|Withdrawal by Subject|0|||
145718301|NCT00895154|525483190|FG001|Overall Study|Withdrawal by Subject|1|||
145718302|NCT00287690|525483191|FG000|Overall Study|Protocol Violation|20|||
145718303|NCT00287690|525483192|FG001|Overall Study|Protocol Violation|26|||
145718304|NCT01146782|525483193|FG000|Screening Cohort|Screen Failure|187|||
145718305|NCT01146782|525483193|FG000|Screening Cohort|Lost to Follow-up|4|||
145718306|NCT01146782|525483193|FG000|Screening Cohort|Physician Decision|1|||
145718307|NCT01146782|525483193|FG000|Screening Cohort|Withdrawal by Subject|29|||
145718308|NCT01146782|525483193|FG000|Safety Cohort|Screen Failure|61|||
145718309|NCT01146782|525483193|FG000|Safety Cohort|Withdrawal by Subject|4|||
145718310|NCT01146782|525483193|FG000|Safety Cohort|Control AHI <5|4|||
145718311|NCT01146782|525483193|FG000|Safety Cohort|TST <4 hrs|14|||
145718312|NCT01146782|525483193|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
145718313|NCT01146782|525483193|FG000|Primary Endpoint Cohort|Physician Decision|1|||
145718314|NCT00470366|525483194|FG000|Overall Study|Adverse Event|3|||
145718315|NCT00470366|525483194|FG000|Overall Study|Poor compliance|1|||
145718316|NCT03562975|525483208|FG000|Overall Study|Death|1|||
145718317|NCT03562975|525483208|FG000|Overall Study|Lost to Follow-up|1|||
145718318|NCT03562975|525483208|FG000|Overall Study|Withdrawal by Subject|1|||
145718319|NCT01758900|525483213|FG000|Overall Study|difficulty for further intubation|7|||
145718320|NCT01758900|525483214|FG001|Overall Study|difficulty for further intubation|8|||
145718321|NCT00935818|525483216|FG000|Overall Study|Withdrawal by Subject|45|||
145718322|NCT00935818|525483217|FG001|Overall Study|Withdrawal by Subject|50|||
145718323|NCT00935818|525483216|FG000|Overall Study|Lost to Follow-up|40|||
145718324|NCT00935818|525483217|FG001|Overall Study|Lost to Follow-up|42|||
145718325|NCT00935818|525483216|FG000|Overall Study|Adverse Event|6|||
145718326|NCT00935818|525483217|FG001|Overall Study|Adverse Event|7|||
145718327|NCT00935818|525483216|FG000|Overall Study|Physician Decision|0|||
145718328|NCT00935818|525483217|FG001|Overall Study|Physician Decision|1|||
145718329|NCT05593445|525483220|FG000|12-Week DBVC Period|Adverse Event|1|||
145718330|NCT05593445|525483221|FG001|12-Week DBVC Period|Adverse Event|0|||
145718331|NCT05593445|525483222|FG002|12-Week DBVC Period|Adverse Event|0|||
145718332|NCT05593445|525483223|FG003|12-Week DBVC Period|Adverse Event|0|||
145718333|NCT05593445|525483220|FG000|12-Week DBVC Period|Physician Decision|0|||
145718334|NCT05593445|525483221|FG001|12-Week DBVC Period|Physician Decision|1|||
145718335|NCT05593445|525483222|FG002|12-Week DBVC Period|Physician Decision|0|||
145718336|NCT05593445|525483223|FG003|12-Week DBVC Period|Physician Decision|0|||
145718337|NCT05593445|525483220|FG000|12-Week DBVC Period|Protocol Violation|0|||
145718338|NCT05593445|525483221|FG001|12-Week DBVC Period|Protocol Violation|1|||
145718339|NCT05593445|525483222|FG002|12-Week DBVC Period|Protocol Violation|0|||
145718340|NCT05593445|525483223|FG003|12-Week DBVC Period|Protocol Violation|0|||
145718341|NCT05593445|525483220|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
145718342|NCT05593445|525483221|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
145718343|NCT05593445|525483222|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
145718344|NCT05593445|525483223|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
145718345|NCT05593445|525483220|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
145718346|NCT05593445|525483221|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
145718347|NCT05593445|525483222|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
145718348|NCT05593445|525483223|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
145718349|NCT05593445|525483220|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
145718350|NCT05593445|525483221|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
145718351|NCT05593445|525483222|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
145718352|NCT05593445|525483223|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
145718353|NCT05593445|525483220|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
145718354|NCT05593445|525483221|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
145718355|NCT05593445|525483222|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
145718356|NCT05593445|525483223|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
145718357|NCT05593445|525483220|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145718358|NCT05593445|525483221|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145718359|NCT05593445|525483222|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
145718360|NCT05593445|525483223|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145718361|NCT00432666|525484766|FG000|Main Period|Adverse Event|1|||
145718362|NCT00432666|525484767|FG001|Main Period|Adverse Event|1|||
145718363|NCT00432666|525484766|FG000|Main Period|Consent Withdrawn|1|||
145718364|NCT00432666|525484767|FG001|Main Period|Consent Withdrawn|0|||
145718365|NCT00432666|525484766|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
145605798|NCT03324880|525070873|FG001|Overall Study|Lost to Follow-up|1|||
145605799|NCT03324880|525070872|FG000|Overall Study|Product Recall|0|||
145605800|NCT03324880|525070873|FG001|Overall Study|Product Recall|1|||
145605801|NCT01412801|525070874|FG000|Overall Study|Death|0|||
145605802|NCT01412801|525070875|FG001|Overall Study|Death|1|||
145605803|NCT01412801|525070876|FG002|Overall Study|Death|0|||
145718366|NCT00432666|525484767|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
145718367|NCT00432666|525484766|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
145718368|NCT00432666|525484767|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
145605804|NCT01412801|525070877|FG003|Overall Study|Death|4|||
145605805|NCT01412801|525070878|FG004|Overall Study|Death|2|||
145605806|NCT01412801|525070879|FG005|Overall Study|Death|2|||
145605807|NCT01412801|525070874|FG000|Overall Study|Lost to Follow-up|1|||
145605808|NCT01412801|525070875|FG001|Overall Study|Lost to Follow-up|2|||
145605809|NCT01412801|525070876|FG002|Overall Study|Lost to Follow-up|4|||
145605810|NCT01412801|525070877|FG003|Overall Study|Lost to Follow-up|0|||
145605811|NCT01412801|525070878|FG004|Overall Study|Lost to Follow-up|1|||
145605812|NCT01412801|525070879|FG005|Overall Study|Lost to Follow-up|1|||
145605813|NCT01412801|525070874|FG000|Overall Study|Withdrawal by Subject|3|||
145605814|NCT01412801|525070875|FG001|Overall Study|Withdrawal by Subject|2|||
145605815|NCT01412801|525070876|FG002|Overall Study|Withdrawal by Subject|1|||
145605816|NCT01412801|525070877|FG003|Overall Study|Withdrawal by Subject|0|||
145605817|NCT01412801|525070878|FG004|Overall Study|Withdrawal by Subject|0|||
145605818|NCT01412801|525070879|FG005|Overall Study|Withdrawal by Subject|0|||
145605819|NCT01412801|525070874|FG000|Overall Study|Relocated to another area|0|||
145605820|NCT01412801|525070875|FG001|Overall Study|Relocated to another area|0|||
145605821|NCT01412801|525070876|FG002|Overall Study|Relocated to another area|2|||
145605822|NCT01412801|525070877|FG003|Overall Study|Relocated to another area|0|||
145605823|NCT01412801|525070878|FG004|Overall Study|Relocated to another area|0|||
145605824|NCT01412801|525070879|FG005|Overall Study|Relocated to another area|0|||
145605825|NCT01547299|525070880|FG000|Overall Study|Withdrawal by Subject|2|||
145605826|NCT01547299|525070881|FG001|Overall Study|Withdrawal by Subject|2|||
145605827|NCT02272725|525070882|FG000|Overall Study|equipment malfunction|2|||
145605828|NCT02272725|525070883|FG001|Overall Study|equipment malfunction|0|||
145605829|NCT04739761|525070884|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
145718369|NCT00432666|525484766|FG000|Open-Label Extension Period|Adverse Event|5|||
145718370|NCT00432666|525484767|FG001|Open-Label Extension Period|Adverse Event|0|||
145718371|NCT00432666|525484766|FG000|Open-Label Extension Period|Consent withdrawn|10|||
145718372|NCT00432666|525484767|FG001|Open-Label Extension Period|Consent withdrawn|0|||
145718373|NCT00432666|525484766|FG000|Open-Label Extension Period|Physician Decision|3|||
145718374|NCT00432666|525484767|FG001|Open-Label Extension Period|Physician Decision|0|||
145718375|NCT00978627|525484768|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
145718376|NCT00978627|525484769|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
145718377|NCT00978627|525484768|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
145718378|NCT00978627|525484769|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
145718379|NCT00978627|525484768|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
145718380|NCT00978627|525484769|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
145718381|NCT00978627|525484768|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
145718382|NCT00978627|525484769|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
145718383|NCT00978627|525484768|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
145718384|NCT00978627|525484769|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
145718385|NCT00978627|525484768|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
145718386|NCT00978627|525484769|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
145718387|NCT00978627|525484768|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
145718388|NCT00978627|525484769|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
145718389|NCT00978627|525484768|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
145718390|NCT00978627|525484769|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
145718391|NCT00978627|525484768|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
145718392|NCT00978627|525484769|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
145718393|NCT00565851|525484770|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
145718394|NCT00565851|525484771|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
145718395|NCT00565851|525484772|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
145718396|NCT00565851|525484773|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
145718397|NCT00565851|525484774|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
145718398|NCT00565851|525484775|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
145718399|NCT00565851|525484776|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
145718400|NCT00565851|525484777|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
145718401|NCT00565851|525484770|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
145718402|NCT00565851|525484771|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
145718403|NCT00565851|525484772|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
145718404|NCT00565851|525484773|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
145718405|NCT00565851|525484774|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
145718406|NCT00565851|525484775|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
145718407|NCT00565851|525484776|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
145718408|NCT00565851|525484777|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
145718409|NCT04058366|525484778|FG000|Overall Study|Adverse Event|14|||
145718410|NCT04058366|525484778|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
145718411|NCT04058366|525484778|FG000|Overall Study|Commercial drug is available for participants|6|||
145718412|NCT04058366|525484778|FG000|Overall Study|Death|1|||
145718413|NCT04058366|525484778|FG000|Overall Study|Other non-compliance|2|||
145718414|NCT04058366|525484778|FG000|Overall Study|Other|6|||
145718415|NCT02594163|525484779|FG000|Treatment Period|Progressive disease|2|||
145718416|NCT02594163|525484780|FG001|Treatment Period|Progressive disease|3|||
145718417|NCT02594163|525484779|FG000|Treatment Period|Adverse Event|1|||
145718418|NCT02594163|525484780|FG001|Treatment Period|Adverse Event|5|||
145718419|NCT02594163|525484779|FG000|Treatment Period|Physician Decision|1|||
145718420|NCT02594163|525484780|FG001|Treatment Period|Physician Decision|3|||
145718421|NCT02594163|525484779|FG000|Treatment Period|Study termination by sponsor|2|||
145718422|NCT02594163|525484780|FG001|Treatment Period|Study termination by sponsor|1|||
145718423|NCT02594163|525484779|FG000|Treatment Period|Other, Non-AE|1|||
145718424|NCT02594163|525484780|FG001|Treatment Period|Other, Non-AE|0|||
145718425|NCT02594163|525484779|FG000|Follow-up Period|Withdrawal by Subject|0|||
145718426|NCT02594163|525484780|FG001|Follow-up Period|Withdrawal by Subject|1|||
145718427|NCT02594163|525484779|FG000|Follow-up Period|Study Termination by Sponsor|6|||
145718428|NCT02594163|525484780|FG001|Follow-up Period|Study Termination by Sponsor|4|||
145718429|NCT02594163|525484779|FG000|Follow-up Period|Lost to Follow-up|1|||
145718430|NCT02594163|525484780|FG001|Follow-up Period|Lost to Follow-up|0|||
145718431|NCT02594163|525484779|FG000|Follow-up Period|Death|2|||
145718432|NCT02594163|525484780|FG001|Follow-up Period|Death|5|||
145718433|NCT02594163|525484779|FG000|Follow-up Period|Adverse Event|0|||
145718434|NCT02594163|525484780|FG001|Follow-up Period|Adverse Event|1|||
145718435|NCT02594163|525484779|FG000|Follow-up Period|Progressive Disease|2|||
145718436|NCT02594163|525484780|FG001|Follow-up Period|Progressive Disease|0|||
145718437|NCT02594163|525484779|FG000|Follow-up Period|Physician Decision|0|||
145718438|NCT02594163|525484780|FG001|Follow-up Period|Physician Decision|1|||
145718439|NCT02233543|525484783|FG000|Period 1|Withdrawal by Subject|1|||
145718440|NCT02233543|525484784|FG001|Period 1|Withdrawal by Subject|0|||
145718441|NCT02233543|525484783|FG000|Period 1|Participants required other treatment.|2|||
145718442|NCT02233543|525484784|FG001|Period 1|Participants required other treatment.|3|||
145718443|NCT02233543|525484783|FG000|Period 2|Adverse Event|1|||
145718444|NCT02233543|525484784|FG001|Period 2|Adverse Event|0|||
145718445|NCT02233543|525484783|FG000|Period 2|Participant required other treatment.|0|||
145718446|NCT02233543|525484784|FG001|Period 2|Participant required other treatment.|1|||
145718447|NCT02233543|525484783|FG000|Period 2|COPD exacerbation|1|||
145718448|NCT02233543|525484784|FG001|Period 2|COPD exacerbation|0|||
145718449|NCT04097301|525484785|FG000|Overall Study|Death|1|||
145718450|NCT04097301|525484785|FG000|Overall Study|Withdrawal by Subject|1|||
145718451|NCT04097301|525484785|FG000|Overall Study|Screening Failure|5|||
145718452|NCT01227577|525484786|FG000|Overall Study|Protocol deviation|3|||
145718453|NCT01227577|525484786|FG000|Overall Study|Death|3|||
145718454|NCT01227577|525484786|FG000|Overall Study|Administrative problems|2|||
145718455|NCT01227577|525484786|FG000|Overall Study|Lost to Follow-up|1|||
145718456|NCT01227577|525484786|FG000|Overall Study|Withdrawal by Subject|4|||
145718457|NCT01227577|525484786|FG000|Overall Study|Lack of Efficacy|5|||
145718458|NCT01227577|525484786|FG000|Overall Study|Adverse Event|17|||
145718459|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
145718460|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
145718461|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
145718462|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
145718463|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
145718464|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
145718465|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
145718466|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
145718467|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
145718468|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
145718469|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
145718470|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
145718471|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
145718472|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
145718473|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
145718474|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
145718475|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
145718476|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
145718477|NCT02480153|525484787|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
145718478|NCT02480153|525484788|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
145718479|NCT02480153|525484789|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
145718480|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
145718481|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
145718482|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
145718483|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
145718484|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
145718485|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
145718486|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
145718487|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
145718488|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
145718489|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
145718490|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
145718491|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
145718492|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
145718493|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
145718494|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
145718495|NCT02480153|525484787|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
145718496|NCT02480153|525484788|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
145718497|NCT02480153|525484789|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
145718498|NCT02480153|525484787|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
145718499|NCT02480153|525484788|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
145718500|NCT02480153|525484789|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
145718501|NCT02480153|525484787|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
145718502|NCT02480153|525484788|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
145718503|NCT02480153|525484789|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
145718504|NCT02480153|525484787|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
145718505|NCT02480153|525484788|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
145718506|NCT02480153|525484789|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
145718507|NCT02480153|525484787|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
145718508|NCT02480153|525484788|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
145718509|NCT02480153|525484789|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
145718510|NCT02480153|525484787|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
145718511|NCT02480153|525484788|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
145718512|NCT02480153|525484789|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
145718513|NCT00107120|525484790|FG000|Overall Study|Adverse Event|4|||
145718514|NCT00107120|525484791|FG001|Overall Study|Adverse Event|1|||
145718515|NCT00107120|525484790|FG000|Overall Study|Lack of Efficacy|5|||
145718516|NCT00107120|525484791|FG001|Overall Study|Lack of Efficacy|5|||
145718517|NCT00107120|525484790|FG000|Overall Study|Protocol Violation|3|||
145718518|NCT00107120|525484791|FG001|Overall Study|Protocol Violation|0|||
145718519|NCT00107120|525484790|FG000|Overall Study|Withdrawal by Subject|8|||
145718520|NCT00107120|525484791|FG001|Overall Study|Withdrawal by Subject|9|||
145718521|NCT00107120|525484790|FG000|Overall Study|Lost to Follow-up|8|||
145718522|NCT00107120|525484791|FG001|Overall Study|Lost to Follow-up|6|||
145718523|NCT00107120|525484790|FG000|Overall Study|Pregnancy|0|||
145718524|NCT00107120|525484791|FG001|Overall Study|Pregnancy|1|||
145718525|NCT00107120|525484790|FG000|Overall Study|moving away from site|1|||
145718526|NCT00107120|525484791|FG001|Overall Study|moving away from site|1|||
145718527|NCT00107120|525484790|FG000|Overall Study|death of parent|0|||
145718528|NCT00107120|525484791|FG001|Overall Study|death of parent|1|||
145718529|NCT03241225|525484792|FG000|Overall Study|Lost to Follow-up|2|||
145718530|NCT03241225|525484793|FG001|Overall Study|Lost to Follow-up|1|||
145718531|NCT03241225|525484792|FG000|Overall Study|Protocol Violation|4|||
145718532|NCT03241225|525484793|FG001|Overall Study|Protocol Violation|1|||
145718533|NCT03241225|525484792|FG000|Overall Study|Withdrawal by Subject|1|||
145718534|NCT03241225|525484793|FG001|Overall Study|Withdrawal by Subject|0|||
145718535|NCT00852540|525484794|FG000|Overall Study|Adverse Event|10|||
145718536|NCT00852540|525484795|FG001|Overall Study|Adverse Event|3|||
145718537|NCT00852540|525484794|FG000|Overall Study|Lack of Efficacy|15|||
145718538|NCT00852540|525484795|FG001|Overall Study|Lack of Efficacy|3|||
145718539|NCT00852540|525484794|FG000|Overall Study|Protocol Violation|1|||
145718540|NCT00852540|525484795|FG001|Overall Study|Protocol Violation|2|||
145718541|NCT00852540|525484794|FG000|Overall Study|Lost to Follow-up|2|||
145718542|NCT00852540|525484795|FG001|Overall Study|Lost to Follow-up|3|||
145718543|NCT00852540|525484794|FG000|Overall Study|Investigator Discretion|2|||
145718544|NCT00852540|525484795|FG001|Overall Study|Investigator Discretion|3|||
145718545|NCT00852540|525484794|FG000|Overall Study|Withdrawal by Subject|3|||
145718546|NCT00852540|525484795|FG001|Overall Study|Withdrawal by Subject|1|||
145718547|NCT00852540|525484794|FG000|Overall Study|Did Not Receive Study Drug|3|||
145718548|NCT00852540|525484795|FG001|Overall Study|Did Not Receive Study Drug|3|||
145718549|NCT01119105|525484796|FG000|Overall Study|Withdrawal by Subject|1|||
145718550|NCT01119105|525484797|FG001|Overall Study|Withdrawal by Subject|1|||
145718551|NCT01119105|525484798|FG002|Overall Study|Withdrawal by Subject|1|||
145718552|NCT01119105|525484796|FG000|Overall Study|Lost to Follow-up|0|||
145718553|NCT01119105|525484797|FG001|Overall Study|Lost to Follow-up|2|||
145718554|NCT01119105|525484798|FG002|Overall Study|Lost to Follow-up|5|||
145718555|NCT01119105|525484796|FG000|Overall Study|Adverse Event|1|||
145718556|NCT01119105|525484797|FG001|Overall Study|Adverse Event|0|||
145718557|NCT01119105|525484798|FG002|Overall Study|Adverse Event|1|||
145718558|NCT01119105|525484796|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
145718559|NCT01119105|525484797|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
145718560|NCT01119105|525484798|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
145718561|NCT01119105|525484796|FG000|Overall Study|Other|1|||
145718562|NCT01119105|525484797|FG001|Overall Study|Other|1|||
145718563|NCT01119105|525484798|FG002|Overall Study|Other|0|||
145718564|NCT01639495|525484799|FG000|Overall Study|Lost to Follow-up|6|||
145718565|NCT01639495|525484799|FG000|Overall Study|Consented but didn't have study catheter|4|||
145718566|NCT01639495|525484799|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
145718567|NCT01639495|525484799|FG000|Overall Study|No radiofrequency energy applied|2|||
145718568|NCT04214600|525484802|FG000|Overall Study|Lost to Follow-up|9|||
145718569|NCT04214600|525484803|FG001|Overall Study|Lost to Follow-up|14|||
145718570|NCT01635920|525484810|FG000|Overall Study|Adverse Event|1|||
145718571|NCT01635920|525484811|FG001|Overall Study|Adverse Event|0|||
145718572|NCT01635920|525484810|FG000|Overall Study|Lost to Follow-up|0|||
145718573|NCT01635920|525484811|FG001|Overall Study|Lost to Follow-up|1|||
145718574|NCT01635920|525484810|FG000|Overall Study|Subject decision|2|||
145380962|NCT01554176|524245169|FG004|Treatment Phase|Lack of Efficacy|0|||
145718575|NCT01635920|525484811|FG001|Overall Study|Subject decision|0|||
145718576|NCT01813929|525484813|FG000|Overall Study|Withdrawal by Subject|0|||
145718577|NCT01813929|525484814|FG001|Overall Study|Withdrawal by Subject|1|||
145718578|NCT00007345|525484815|FG000|Overall Study|Refused further treatment|0|||
145718579|NCT00007345|525484816|FG001|Overall Study|Refused further treatment|7|||
145718580|NCT00007345|525484815|FG000|Overall Study|Switched to alternative treatment|0|||
145718581|NCT00007345|525484816|FG001|Overall Study|Switched to alternative treatment|3|||
145380963|NCT01554176|524245165|FG000|Treatment Phase|Adverse event, non-fatal|1|||
145718582|NCT00007345|525484815|FG000|Overall Study|Intercurrent illness|1|||
145718583|NCT00007345|525484816|FG001|Overall Study|Intercurrent illness|0|||
145718584|NCT00007345|525484815|FG000|Overall Study|Death on study|1|||
145718585|NCT00007345|525484816|FG001|Overall Study|Death on study|1|||
145718586|NCT04433585|525484817|FG000|Overall Study|Withdrawal by Subject|15|||
145718587|NCT04433585|525484818|FG001|Overall Study|Withdrawal by Subject|3|||
145718588|NCT04433585|525484819|FG002|Overall Study|Withdrawal by Subject|15|||
145718589|NCT04433585|525484820|FG003|Overall Study|Withdrawal by Subject|6|||
145718590|NCT04433585|525484817|FG000|Overall Study|Adverse Event|10|||
145718591|NCT04433585|525484818|FG001|Overall Study|Adverse Event|4|||
145718592|NCT04433585|525484819|FG002|Overall Study|Adverse Event|1|||
145718593|NCT04433585|525484820|FG003|Overall Study|Adverse Event|0|||
145718594|NCT04433585|525484817|FG000|Overall Study|Due to the conflict in Ukraine|2|||
145718595|NCT04433585|525484818|FG001|Overall Study|Due to the conflict in Ukraine|1|||
145718596|NCT04433585|525484819|FG002|Overall Study|Due to the conflict in Ukraine|1|||
145718597|NCT04433585|525484820|FG003|Overall Study|Due to the conflict in Ukraine|2|||
145718598|NCT04433585|525484817|FG000|Overall Study|Physician Decision|1|||
145718599|NCT04433585|525484818|FG001|Overall Study|Physician Decision|2|||
145718600|NCT04433585|525484819|FG002|Overall Study|Physician Decision|0|||
145718601|NCT04433585|525484820|FG003|Overall Study|Physician Decision|0|||
145718602|NCT04433585|525484817|FG000|Overall Study|Lost to Follow-up|1|||
145718603|NCT04433585|525484818|FG001|Overall Study|Lost to Follow-up|1|||
145718604|NCT04433585|525484819|FG002|Overall Study|Lost to Follow-up|1|||
145718605|NCT04433585|525484820|FG003|Overall Study|Lost to Follow-up|0|||
145718606|NCT04433585|525484817|FG000|Overall Study|Lack of Efficacy|0|||
145718607|NCT04433585|525484818|FG001|Overall Study|Lack of Efficacy|1|||
145718608|NCT04433585|525484819|FG002|Overall Study|Lack of Efficacy|1|||
145718609|NCT04433585|525484820|FG003|Overall Study|Lack of Efficacy|1|||
145718610|NCT04433585|525484817|FG000|Overall Study|Death|0|||
145718611|NCT04433585|525484818|FG001|Overall Study|Death|1|||
145718612|NCT04433585|525484819|FG002|Overall Study|Death|0|||
145718613|NCT04433585|525484820|FG003|Overall Study|Death|0|||
145718614|NCT00194987|525484821|FG000|Overall Study|Withdrawal by Subject|0|||
145718615|NCT00194987|525484822|FG001|Overall Study|Withdrawal by Subject|3|||
145718616|NCT02342743|525484823|FG000|Baseline Period|Withdrawal by Subject|3|||
145718617|NCT02342743|525484823|FG000|Baseline Period|Lost to Follow-up|2|||
145718618|NCT02342743|525484823|FG000|Baseline Period|Change in prophylactic medication|3|||
145718619|NCT02342743|525484823|FG000|Baseline Period|Screening failure regarding baseline|7|||
145718620|NCT02342743|525484823|FG000|Treatment Period|Withdrawal by Subject|2|||
145718621|NCT02342743|525484823|FG000|Treatment Period|Lost to Follow-up|8|||
145718622|NCT02342743|525484823|FG000|Treatment Period|Change in prophylactic medication|1|||
145718623|NCT00686725|525484824|FG000|Overall Study|Adverse Event|1|||
145718624|NCT00686725|525484825|FG001|Overall Study|Adverse Event|1|||
145718625|NCT00686725|525484824|FG000|Overall Study|Progressive Disease|17|||
145718626|NCT00686725|525484825|FG001|Overall Study|Progressive Disease|23|||
145718627|NCT00686725|525484824|FG000|Overall Study|Lost to Follow-up|7|||
145718628|NCT00686725|525484825|FG001|Overall Study|Lost to Follow-up|5|||
145718629|NCT00686725|525484824|FG000|Overall Study|Death|6|||
145718630|NCT00686725|525484825|FG001|Overall Study|Death|3|||
145718631|NCT00686725|525484824|FG000|Overall Study|Withdrawal by Subject|13|||
145718632|NCT00686725|525484825|FG001|Overall Study|Withdrawal by Subject|4|||
145718633|NCT00686725|525484824|FG000|Overall Study|Protocol Violation|1|||
145718634|NCT00686725|525484825|FG001|Overall Study|Protocol Violation|3|||
145718635|NCT00686725|525484824|FG000|Overall Study|Other|1|||
145718636|NCT00686725|525484825|FG001|Overall Study|Other|3|||
145718637|NCT00092495|525484826|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
145718638|NCT00092495|525484827|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
145718639|NCT00092495|525484828|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145718640|NCT00092495|525484829|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
145718641|NCT00092495|525484830|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145718642|NCT00092495|525484826|FG000|Base Study Vaccination Period|Extended|0|||
145718643|NCT00092495|525484827|FG001|Base Study Vaccination Period|Extended|0|||
145718644|NCT00092495|525484828|FG002|Base Study Vaccination Period|Extended|0|||
145718645|NCT00092495|525484829|FG003|Base Study Vaccination Period|Extended|1|||
145718646|NCT00092495|525484830|FG004|Base Study Vaccination Period|Extended|0|||
145718647|NCT00092495|525484826|FG000|Base Study Vaccination Period|*Clinical AE|1|||
145718648|NCT00092495|525484827|FG001|Base Study Vaccination Period|*Clinical AE|0|||
145718649|NCT00092495|525484828|FG002|Base Study Vaccination Period|*Clinical AE|1|||
145718650|NCT00092495|525484829|FG003|Base Study Vaccination Period|*Clinical AE|2|||
145718651|NCT00092495|525484830|FG004|Base Study Vaccination Period|*Clinical AE|0|||
145718652|NCT00092495|525484826|FG000|Base Study Vaccination Period|*Other reasons|1|||
145718653|NCT00092495|525484827|FG001|Base Study Vaccination Period|*Other reasons|0|||
145718654|NCT00092495|525484828|FG002|Base Study Vaccination Period|*Other reasons|0|||
145718655|NCT00092495|525484829|FG003|Base Study Vaccination Period|*Other reasons|1|||
145380964|NCT01554176|524245166|FG001|Treatment Phase|Adverse event, non-fatal|1|||
145605830|NCT04739761|525070885|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
145718656|NCT00092495|525484830|FG004|Base Study Vaccination Period|*Other reasons|0|||
145718657|NCT00092495|525484826|FG000|Base Study Vaccination Period|*Pregnancy|0|||
145718658|NCT00092495|525484827|FG001|Base Study Vaccination Period|*Pregnancy|2|||
145718659|NCT00092495|525484828|FG002|Base Study Vaccination Period|*Pregnancy|5|||
145718660|NCT00092495|525484829|FG003|Base Study Vaccination Period|*Pregnancy|7|||
145718661|NCT00092495|525484830|FG004|Base Study Vaccination Period|*Pregnancy|0|||
145718662|NCT00092495|525484826|FG000|Base Study Vaccination Period|Adverse Event|1|||
145718663|NCT00092495|525484827|FG001|Base Study Vaccination Period|Adverse Event|0|||
145718664|NCT00092495|525484828|FG002|Base Study Vaccination Period|Adverse Event|0|||
145718665|NCT00092495|525484829|FG003|Base Study Vaccination Period|Adverse Event|3|||
145718666|NCT00092495|525484830|FG004|Base Study Vaccination Period|Adverse Event|0|||
145718667|NCT00092495|525484826|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
145718668|NCT00092495|525484827|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
145718669|NCT00092495|525484828|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
145718670|NCT00092495|525484829|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
145718671|NCT00092495|525484830|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
145718672|NCT00092495|525484826|FG000|Base Study Vaccination Period|Moved|3|||
145718673|NCT00092495|525484827|FG001|Base Study Vaccination Period|Moved|1|||
145718674|NCT00092495|525484828|FG002|Base Study Vaccination Period|Moved|2|||
145718675|NCT00092495|525484829|FG003|Base Study Vaccination Period|Moved|2|||
145718676|NCT00092495|525484830|FG004|Base Study Vaccination Period|Moved|0|||
145718677|NCT00092495|525484826|FG000|Base Study Vaccination Period|Other|1|||
145718678|NCT00092495|525484827|FG001|Base Study Vaccination Period|Other|1|||
145718679|NCT00092495|525484828|FG002|Base Study Vaccination Period|Other|0|||
145718680|NCT00092495|525484829|FG003|Base Study Vaccination Period|Other|2|||
145718681|NCT00092495|525484830|FG004|Base Study Vaccination Period|Other|0|||
145718682|NCT00092495|525484826|FG000|Base Study Vaccination Period|Pregnancy|2|||
145718683|NCT00092495|525484827|FG001|Base Study Vaccination Period|Pregnancy|0|||
145718684|NCT00092495|525484828|FG002|Base Study Vaccination Period|Pregnancy|0|||
145718685|NCT00092495|525484829|FG003|Base Study Vaccination Period|Pregnancy|0|||
145718686|NCT00092495|525484830|FG004|Base Study Vaccination Period|Pregnancy|0|||
145718687|NCT00092495|525484826|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
145718688|NCT00092495|525484827|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
145718689|NCT00092495|525484828|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
145718690|NCT00092495|525484829|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
145718691|NCT00092495|525484830|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
145718692|NCT00092495|525484826|FG000|Base Study Vaccination Period|Protocol Violation|1|||
145718693|NCT00092495|525484827|FG001|Base Study Vaccination Period|Protocol Violation|0|||
145718694|NCT00092495|525484828|FG002|Base Study Vaccination Period|Protocol Violation|0|||
145718695|NCT00092495|525484829|FG003|Base Study Vaccination Period|Protocol Violation|0|||
145718696|NCT00092495|525484830|FG004|Base Study Vaccination Period|Protocol Violation|0|||
145718697|NCT00092495|525484826|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
145718698|NCT00092495|525484827|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
145718699|NCT00092495|525484828|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
145718700|NCT00092495|525484829|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
145718701|NCT00092495|525484830|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
145718702|NCT00092495|525484826|FG000|Base Study Follow-up Period|Extended|0|||
145718703|NCT00092495|525484827|FG001|Base Study Follow-up Period|Extended|0|||
145718704|NCT00092495|525484828|FG002|Base Study Follow-up Period|Extended|1|||
145718705|NCT00092495|525484829|FG003|Base Study Follow-up Period|Extended|2|||
145718706|NCT00092495|525484830|FG004|Base Study Follow-up Period|Extended|0|||
145718707|NCT00092495|525484826|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
145718708|NCT00092495|525484827|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
145718709|NCT00092495|525484828|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
145718710|NCT00092495|525484829|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
145718711|NCT00092495|525484830|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
145718712|NCT00092495|525484826|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
145718713|NCT00092495|525484827|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
145718714|NCT00092495|525484828|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
145718715|NCT00092495|525484829|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
145718716|NCT00092495|525484830|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
145718717|NCT00938470|525484835|FG000|Overall Study|Disease Progression|3|||
145718718|NCT00938470|525484836|FG001|Overall Study|Disease Progression|0|||
145718719|NCT00938470|525484835|FG000|Overall Study|Alternate Treatment|1|||
145718720|NCT00938470|525484836|FG001|Overall Study|Alternate Treatment|0|||
145718721|NCT00938470|525484835|FG000|Overall Study|Death|3|||
145718722|NCT00938470|525484836|FG001|Overall Study|Death|2|||
145718723|NCT00938470|525484835|FG000|Overall Study|Other Reason|0|||
145718724|NCT00938470|525484836|FG001|Overall Study|Other Reason|1|||
145718725|NCT01346475|525484838|FG000|First Intervention|Lost to Follow-up|4|||
145718726|NCT01346475|525484839|FG001|First Intervention|Lost to Follow-up|3|||
145718727|NCT01552603|525484840|FG000|Overall Study|Physician Decision|1|||
145718728|NCT00618618|525484841|FG000|Overall Study|Patient Request|0|||
145718729|NCT00618618|525484842|FG001|Overall Study|Patient Request|0|||
145718730|NCT00618618|525484843|FG002|Overall Study|Patient Request|2|||
145718731|NCT00618618|525484844|FG003|Overall Study|Patient Request|0|||
145718732|NCT00618618|525484841|FG000|Overall Study|Inability to Complete Study Procedures|0|||
145718733|NCT00618618|525484842|FG001|Overall Study|Inability to Complete Study Procedures|1|||
145718734|NCT00618618|525484843|FG002|Overall Study|Inability to Complete Study Procedures|0|||
145718735|NCT00618618|525484844|FG003|Overall Study|Inability to Complete Study Procedures|0|||
145718736|NCT00618618|525484841|FG000|Overall Study|Lost to Follow-up|3|||
145718737|NCT00618618|525484842|FG001|Overall Study|Lost to Follow-up|0|||
145718738|NCT00618618|525484843|FG002|Overall Study|Lost to Follow-up|0|||
145718739|NCT00618618|525484844|FG003|Overall Study|Lost to Follow-up|1|||
145718740|NCT00618618|525484841|FG000|Overall Study|Non-compliance|1|||
145718741|NCT00618618|525484842|FG001|Overall Study|Non-compliance|1|||
145718742|NCT00618618|525484843|FG002|Overall Study|Non-compliance|0|||
145718743|NCT00618618|525484844|FG003|Overall Study|Non-compliance|0|||
145718744|NCT00618618|525484841|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
145718745|NCT00618618|525484842|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
145718746|NCT00618618|525484843|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
145718747|NCT00618618|525484844|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
145718748|NCT00618618|525484841|FG000|Overall Study|Death|0|||
145718749|NCT00618618|525484842|FG001|Overall Study|Death|1|||
145718750|NCT00618618|525484843|FG002|Overall Study|Death|0|||
145718751|NCT00618618|525484844|FG003|Overall Study|Death|0|||
145718752|NCT04797650|525484847|FG000|Overall Study|Reason Not Specified|5|||
145718753|NCT04797650|525484848|FG001|Overall Study|Reason Not Specified|12|||
145718754|NCT04797650|525484849|FG002|Overall Study|Reason Not Specified|5|||
145718755|NCT04797650|525484847|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
145718756|NCT04797650|525484848|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
145718757|NCT04797650|525484849|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
145718758|NCT04797650|525484847|FG000|Overall Study|Lack of Efficacy|1|||
145718759|NCT04797650|525484848|FG001|Overall Study|Lack of Efficacy|0|||
145718760|NCT04797650|525484849|FG002|Overall Study|Lack of Efficacy|1|||
145718761|NCT04797650|525484847|FG000|Overall Study|Non-compliance with Study Drug|0|||
145718762|NCT04797650|525484848|FG001|Overall Study|Non-compliance with Study Drug|0|||
145718763|NCT04797650|525484849|FG002|Overall Study|Non-compliance with Study Drug|2|||
145718764|NCT04797650|525484847|FG000|Overall Study|Lost to Follow-up|4|||
145718765|NCT04797650|525484848|FG001|Overall Study|Lost to Follow-up|6|||
145718766|NCT04797650|525484849|FG002|Overall Study|Lost to Follow-up|1|||
145718767|NCT01183234|525484852|FG000|First Intervention|Adverse Event|1|||
145718768|NCT01183234|525484853|FG001|First Intervention|Adverse Event|0|||
145718769|NCT00473265|525484854|FG000|Overall Study|Unrelated adverse event|5|||
145718770|NCT00473265|525484854|FG000|Overall Study|Off treatment early|15|||
145718771|NCT00309959|525484855|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
145718772|NCT02947087|525484856|FG000|Overall Study|Withdrawal by Subject|3|||
145718773|NCT02947087|525484857|FG001|Overall Study|Withdrawal by Subject|2|||
145718774|NCT01844687|525484858|FG000|Visit 1|Protocol Violation|3|||
145718775|NCT01844687|525484858|FG000|Visit 1|Lost to Follow-up|5|||
145718776|NCT01844687|525484858|FG000|Visit 2|Withdrawal by Subject|1|||
145718777|NCT01844687|525484858|FG000|Visit 2|Protocol Violation|1|||
145718778|NCT01844687|525484858|FG000|Visit 3|Lost to Follow-up|1|||
145718779|NCT01844687|525484858|FG000|Visit 3|Withdrawal by Subject|3|||
145718780|NCT01844687|525484858|FG000|Visit 3|child care problems|1|||
145718781|NCT01844687|525484858|FG000|Visit 4|Pregnancy|1|||
145718782|NCT01844687|525484858|FG000|Visit 4|Lost to Follow-up|1|||
145718783|NCT01844687|525484858|FG000|Visit 4|Withdrawal by Subject|2|||
145718784|NCT01021215|525484864|FG000|Overall Study|Lost to Follow-up|3|||
145718785|NCT01021215|525484865|FG001|Overall Study|Lost to Follow-up|0|||
145718786|NCT01942590|525484866|FG000|Overall Study|Withdrawal by Subject|0|||
145718787|NCT01942590|525484867|FG001|Overall Study|Withdrawal by Subject|1|||
145718788|NCT01942590|525484866|FG000|Overall Study|Adverse Event|1|||
145718789|NCT01942590|525484867|FG001|Overall Study|Adverse Event|0|||
145718790|NCT02631577|525484873|FG000|Overall Study|Death|1|||
145718791|NCT02631577|525484874|FG001|Overall Study|Death|7|||
145718792|NCT02631577|525484873|FG000|Overall Study|Withdrawal by Subject|0|||
145718793|NCT02631577|525484874|FG001|Overall Study|Withdrawal by Subject|3|||
145718794|NCT00979134|525484875|FG000|Overall Study|Disease progression|18|||
145718795|NCT00979134|525484876|FG001|Overall Study|Disease progression|2|||
145718796|NCT00979134|525484877|FG002|Overall Study|Disease progression|5|||
145718797|NCT00979134|525484875|FG000|Overall Study|Adverse Event|0|||
145718798|NCT00979134|525484876|FG001|Overall Study|Adverse Event|0|||
145718799|NCT00979134|525484877|FG002|Overall Study|Adverse Event|2|||
145718800|NCT00979134|525484875|FG000|Overall Study|Withdrawal by Subject|1|||
145718801|NCT00979134|525484876|FG001|Overall Study|Withdrawal by Subject|1|||
145718802|NCT00979134|525484877|FG002|Overall Study|Withdrawal by Subject|2|||
145718803|NCT00979134|525484875|FG000|Overall Study|Lost to Follow-up|2|||
145718804|NCT00979134|525484876|FG001|Overall Study|Lost to Follow-up|2|||
145718805|NCT00979134|525484877|FG002|Overall Study|Lost to Follow-up|0|||
145718806|NCT00979134|525484875|FG000|Overall Study|Death|4|||
145718807|NCT00979134|525484876|FG001|Overall Study|Death|0|||
145718808|NCT00979134|525484877|FG002|Overall Study|Death|26|||
145718809|NCT00979134|525484875|FG000|Overall Study|Other|8|||
145718810|NCT00979134|525484876|FG001|Overall Study|Other|1|||
145718811|NCT00979134|525484877|FG002|Overall Study|Other|5|||
145718812|NCT00604825|525484878|FG000|Overall Study|Adverse Event|2|||
145718813|NCT00604825|525484879|FG001|Overall Study|Adverse Event|6|||
145718814|NCT00604825|525484880|FG002|Overall Study|Adverse Event|7|||
145718815|NCT00604825|525484881|FG003|Overall Study|Adverse Event|4|||
145718816|NCT00604825|525484878|FG000|Overall Study|Lost to Follow-up|0|||
145718817|NCT00604825|525484879|FG001|Overall Study|Lost to Follow-up|3|||
145718818|NCT00604825|525484880|FG002|Overall Study|Lost to Follow-up|1|||
145718819|NCT00604825|525484881|FG003|Overall Study|Lost to Follow-up|0|||
145718820|NCT00604825|525484878|FG000|Overall Study|Protocol Violation|0|||
145718821|NCT00604825|525484879|FG001|Overall Study|Protocol Violation|1|||
145718822|NCT00604825|525484880|FG002|Overall Study|Protocol Violation|0|||
145718823|NCT00604825|525484881|FG003|Overall Study|Protocol Violation|0|||
145718824|NCT00604825|525484878|FG000|Overall Study|Withdrawal by Subject|4|||
145718825|NCT00604825|525484879|FG001|Overall Study|Withdrawal by Subject|3|||
145718826|NCT00604825|525484880|FG002|Overall Study|Withdrawal by Subject|5|||
145718827|NCT00604825|525484881|FG003|Overall Study|Withdrawal by Subject|5|||
145718828|NCT00604825|525484878|FG000|Overall Study|Lack of Efficacy|3|||
145718829|NCT00604825|525484879|FG001|Overall Study|Lack of Efficacy|2|||
145718830|NCT00604825|525484880|FG002|Overall Study|Lack of Efficacy|1|||
145718831|NCT00604825|525484881|FG003|Overall Study|Lack of Efficacy|0|||
145718832|NCT00604825|525484878|FG000|Overall Study|Did not meet eligibility criteria|0|||
145718833|NCT00604825|525484879|FG001|Overall Study|Did not meet eligibility criteria|0|||
145718834|NCT00604825|525484880|FG002|Overall Study|Did not meet eligibility criteria|2|||
145718835|NCT00604825|525484881|FG003|Overall Study|Did not meet eligibility criteria|0|||
145718836|NCT00604825|525484878|FG000|Overall Study|Physician Decision|0|||
145718837|NCT00604825|525484879|FG001|Overall Study|Physician Decision|0|||
145718838|NCT00604825|525484880|FG002|Overall Study|Physician Decision|0|||
145718839|NCT00604825|525484881|FG003|Overall Study|Physician Decision|1|||
145718840|NCT00604825|525484878|FG000|Overall Study|Exclusion criterion met|0|||
145718841|NCT00604825|525484879|FG001|Overall Study|Exclusion criterion met|0|||
145718842|NCT00604825|525484880|FG002|Overall Study|Exclusion criterion met|0|||
145718843|NCT00604825|525484881|FG003|Overall Study|Exclusion criterion met|1|||
145718844|NCT03647488|525486541|FG000|Overall Study|Progressive disease|10|||
145718845|NCT03647488|525486542|FG001|Overall Study|Progressive disease|0|||
145718846|NCT03647488|525486543|FG002|Overall Study|Progressive disease|0|||
145718847|NCT03647488|525486541|FG000|Overall Study|Adverse Event|5|||
145718848|NCT03647488|525486542|FG001|Overall Study|Adverse Event|0|||
145718849|NCT03647488|525486543|FG002|Overall Study|Adverse Event|0|||
145718850|NCT03647488|525486541|FG000|Overall Study|Clinical progression|2|||
145718851|NCT03647488|525486542|FG001|Overall Study|Clinical progression|0|||
145718852|NCT03647488|525486543|FG002|Overall Study|Clinical progression|0|||
145718853|NCT03647488|525486541|FG000|Overall Study|Participant refused to take investigational product|1|||
145718854|NCT03647488|525486542|FG001|Overall Study|Participant refused to take investigational product|0|||
145718855|NCT03647488|525486543|FG002|Overall Study|Participant refused to take investigational product|0|||
145718856|NCT00812331|525486544|FG000|Overall Study|Adverse Event|1|||
145718857|NCT00812331|525486545|FG001|Overall Study|Adverse Event|0|||
145718858|NCT00812331|525486546|FG002|Overall Study|Adverse Event|0|||
145718859|NCT00812331|525486547|FG003|Overall Study|Adverse Event|0|||
145718860|NCT00812331|525486548|FG004|Overall Study|Adverse Event|0|||
145718861|NCT01506453|525486549|FG000|Overall Study|Withdrawal prior to treatment|0|||
145718862|NCT01506453|525486550|FG001|Overall Study|Withdrawal prior to treatment|2|||
145718863|NCT03694275|525486551|FG000|Overall Study|Adverse Event|0|||
145718864|NCT03694275|525486552|FG001|Overall Study|Adverse Event|1|||
145718865|NCT03694275|525486551|FG000|Overall Study|Reason not Specified|0|||
145718866|NCT03694275|525486552|FG001|Overall Study|Reason not Specified|1|||
145718867|NCT02502799|525486553|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
145718868|NCT02502799|525486554|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
145718869|NCT02502799|525486555|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
145718870|NCT02502799|525486556|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
145718871|NCT02502799|525486553|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
145718872|NCT02502799|525486554|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
145718873|NCT02502799|525486555|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
145718874|NCT02502799|525486556|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
145718875|NCT02502799|525486553|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
145718876|NCT02502799|525486554|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
145718877|NCT02502799|525486555|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
145266516|NCT02594384|523825219|FG005|Overall Study|Adverse Event|6|||
145407492|NCT00296517|524347007|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
145718878|NCT02502799|525486556|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
145266517|NCT02594384|523825220|FG006|Overall Study|Adverse Event|1|||
145718879|NCT02502799|525486553|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
145718880|NCT02502799|525486554|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
145718881|NCT02502799|525486555|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
145718882|NCT02502799|525486556|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
145718883|NCT02502799|525486553|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
145718884|NCT02502799|525486554|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
145718885|NCT02502799|525486555|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
145718886|NCT02502799|525486556|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
145718887|NCT00153062|525486562|FG000|Overall Study|Death|360|||
145718888|NCT00153062|525486563|FG001|Overall Study|Death|352|||
145718889|NCT00153062|525486564|FG002|Overall Study|Death|369|||
145718890|NCT00153062|525486565|FG003|Overall Study|Death|365|||
145718891|NCT00153062|525486562|FG000|Overall Study|Withdrawal by Subject|14|||
145718892|NCT00153062|525486563|FG001|Overall Study|Withdrawal by Subject|30|||
145718893|NCT00153062|525486564|FG002|Overall Study|Withdrawal by Subject|27|||
145718894|NCT00153062|525486565|FG003|Overall Study|Withdrawal by Subject|28|||
145718895|NCT00153062|525486562|FG000|Overall Study|Lost to Follow-up|12|||
145718896|NCT00153062|525486563|FG001|Overall Study|Lost to Follow-up|20|||
145718897|NCT00153062|525486564|FG002|Overall Study|Lost to Follow-up|15|||
145718898|NCT00153062|525486565|FG003|Overall Study|Lost to Follow-up|16|||
145718899|NCT00153062|525486562|FG000|Overall Study|Adverse Event|0|||
145718900|NCT00153062|525486563|FG001|Overall Study|Adverse Event|1|||
145718901|NCT00153062|525486564|FG002|Overall Study|Adverse Event|1|||
145718902|NCT00153062|525486565|FG003|Overall Study|Adverse Event|0|||
145718903|NCT00153062|525486562|FG000|Overall Study|Protocol Violation|0|||
145718904|NCT00153062|525486563|FG001|Overall Study|Protocol Violation|2|||
145718905|NCT00153062|525486564|FG002|Overall Study|Protocol Violation|1|||
145718906|NCT00153062|525486565|FG003|Overall Study|Protocol Violation|1|||
145718907|NCT00153062|525486562|FG000|Overall Study|No disposition data available|1|||
145718908|NCT00153062|525486563|FG001|Overall Study|No disposition data available|1|||
145718909|NCT00153062|525486564|FG002|Overall Study|No disposition data available|1|||
145718910|NCT00153062|525486565|FG003|Overall Study|No disposition data available|1|||
145718911|NCT00153062|525486562|FG000|Overall Study|Other|0|||
145718912|NCT00153062|525486563|FG001|Overall Study|Other|0|||
145718913|NCT00153062|525486564|FG002|Overall Study|Other|1|||
145718914|NCT00153062|525486565|FG003|Overall Study|Other|0|||
145718915|NCT01589237|525486587|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
145718916|NCT01589237|525486588|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
145718917|NCT01589237|525486589|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
145718918|NCT01589237|525486590|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
145718919|NCT01589237|525486587|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
145718920|NCT01589237|525486588|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
145718921|NCT01589237|525486589|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
145718922|NCT01589237|525486590|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
145718923|NCT01589237|525486587|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
145718924|NCT01589237|525486588|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
145718925|NCT01589237|525486589|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
145718926|NCT01589237|525486590|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
145718927|NCT01589237|525486587|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
145718928|NCT01589237|525486588|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
145718929|NCT01589237|525486589|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
145718930|NCT01589237|525486590|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
145718931|NCT00117845|525486591|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
145718932|NCT00734097|525486592|FG000|Screening|Protocol Violation|12|||
145718933|NCT00734097|525486592|FG000|Screening|Withdrawal by Subject|5|||
145718934|NCT00734097|525486592|FG000|Screening|Lost to Follow-up|2|||
145718935|NCT00734097|525486592|FG000|Screening|Unconfirmed pregnancy|1|||
145718936|NCT00734097|525486592|FG000|Open Label|Lost to Follow-up|7|||
145718937|NCT00734097|525486592|FG000|Open Label|Withdrawal by Subject|5|||
145718938|NCT00734097|525486592|FG000|Open Label|Protocol Violation|4|||
145718939|NCT00910689|525486593|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
145718940|NCT00910689|525486594|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
145718941|NCT00910689|525486595|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
145718942|NCT00910689|525486596|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
145718943|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
145718944|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
145718945|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
145718946|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
145718947|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
145718948|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
145718949|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
145718950|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
145718951|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
145266518|NCT02594384|523825221|FG007|Overall Study|Adverse Event|1|||
145380965|NCT01554176|524245167|FG002|Treatment Phase|Adverse event, non-fatal|0|||
145380966|NCT01554176|524245168|FG003|Treatment Phase|Adverse event, non-fatal|0|||
145380967|NCT01554176|524245169|FG004|Treatment Phase|Adverse event, non-fatal|0|||
145380968|NCT01554176|524245165|FG000|Treatment Phase|Non-compliance with study drug|1|||
145380969|NCT01554176|524245166|FG001|Treatment Phase|Non-compliance with study drug|0|||
145380970|NCT01554176|524245167|FG002|Treatment Phase|Non-compliance with study drug|0|||
145380971|NCT01554176|524245168|FG003|Treatment Phase|Non-compliance with study drug|0|||
145380972|NCT01554176|524245169|FG004|Treatment Phase|Non-compliance with study drug|0|||
145380973|NCT01554176|524245165|FG000|Treatment Phase|Withdrawal by Subject|1|||
145380974|NCT01554176|524245166|FG001|Treatment Phase|Withdrawal by Subject|0|||
145380975|NCT01554176|524245167|FG002|Treatment Phase|Withdrawal by Subject|0|||
145380976|NCT01554176|524245168|FG003|Treatment Phase|Withdrawal by Subject|0|||
145605831|NCT04739761|525070884|FG000|Overall Study|By complete response from the participant|1|||
145605832|NCT04739761|525070885|FG001|Overall Study|By complete response from the participant|0|||
145605833|NCT04739761|525070884|FG000|Overall Study|Lost to Follow-up|3|||
145605834|NCT04739761|525070885|FG001|Overall Study|Lost to Follow-up|3|||
145605835|NCT04739761|525070884|FG000|Overall Study|Death|13|||
145605836|NCT04739761|525070885|FG001|Overall Study|Death|13|||
145605837|NCT04739761|525070884|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
145605838|NCT04739761|525070885|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
145605839|NCT04739761|525070884|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
145605840|NCT04739761|525070885|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
145605841|NCT04739761|525070884|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
145605842|NCT04739761|525070885|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
145605843|NCT04739761|525070884|FG000|Overall Study|Adverse Event|0|||
145605844|NCT04739761|525070885|FG001|Overall Study|Adverse Event|3|||
145605845|NCT04739761|525070884|FG000|Overall Study|Participant decision|1|||
145605846|NCT04739761|525070885|FG001|Overall Study|Participant decision|0|||
145605847|NCT04739761|525070884|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
145605848|NCT04739761|525070885|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
145605849|NCT04739761|525070884|FG000|Overall Study|Participant immediately started next line of treatment|1|||
145605850|NCT04739761|525070885|FG001|Overall Study|Participant immediately started next line of treatment|0|||
145605851|NCT04739761|525070884|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
145605852|NCT04739761|525070885|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
145605853|NCT04739761|525070884|FG000|Overall Study|Lack of clinical benefit|1|||
145605854|NCT04739761|525070885|FG001|Overall Study|Lack of clinical benefit|0|||
145605855|NCT04739761|525070884|FG000|Overall Study|Disease progression|5|||
145605856|NCT04739761|525070885|FG001|Overall Study|Disease progression|5|||
145605857|NCT04739761|525070884|FG000|Overall Study|Withdrawal by Subject|14|||
145605858|NCT04739761|525070885|FG001|Overall Study|Withdrawal by Subject|13|||
145605859|NCT04739761|525070884|FG000|Overall Study|Protocol Violation|1|||
145605860|NCT04739761|525070885|FG001|Overall Study|Protocol Violation|0|||
145605861|NCT04739761|525070884|FG000|Overall Study|Physician Decision|2|||
145605862|NCT04739761|525070885|FG001|Overall Study|Physician Decision|0|||
145605863|NCT01966003|525073028|FG000|Overall Study|Death|43|||
145605864|NCT01966003|525073029|FG001|Overall Study|Death|36|||
145605865|NCT01966003|525073028|FG000|Overall Study|Protocol Violation|6|||
145605866|NCT01966003|525073029|FG001|Overall Study|Protocol Violation|4|||
145605867|NCT01966003|525073028|FG000|Overall Study|Lost to Follow-up|4|||
145605868|NCT01966003|525073029|FG001|Overall Study|Lost to Follow-up|3|||
145605869|NCT01966003|525073028|FG000|Overall Study|Physician Decision|12|||
145605870|NCT01966003|525073029|FG001|Overall Study|Physician Decision|13|||
145605871|NCT01966003|525073028|FG000|Overall Study|Withdrawal by Subject|29|||
145605872|NCT01966003|525073029|FG001|Overall Study|Withdrawal by Subject|19|||
145605873|NCT01966003|525073028|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
145605874|NCT01966003|525073029|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
145605875|NCT01966003|525073028|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
145605876|NCT01966003|525073029|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
145605877|NCT01966003|525073028|FG000|Overall Study|Other|1|||
145605878|NCT01966003|525073029|FG001|Overall Study|Other|1|||
145605879|NCT00674570|525073030|FG000|Overall Study|Withdrawal by Subject|0|||
145605880|NCT00674570|525073031|FG001|Overall Study|Withdrawal by Subject|2|||
145605881|NCT00674570|525073032|FG002|Overall Study|Withdrawal by Subject|0|||
145605882|NCT00633932|525073034|FG000|Overall Study|Adverse Event|1|||
145605883|NCT00633932|525073035|FG001|Overall Study|Adverse Event|3|||
145605884|NCT00633932|525073036|FG002|Overall Study|Adverse Event|4|||
145605885|NCT00633932|525073034|FG000|Overall Study|Withdrawal by Subject|3|||
145266519|NCT02594384|523825214|FG000|Overall Study|Withdrawal by Subject|0|||
145380977|NCT01554176|524245169|FG004|Treatment Phase|Withdrawal by Subject|0|||
145380978|NCT01554176|524245165|FG000|Treatment Phase|Lost to Follow-up|3|||
145380979|NCT01554176|524245166|FG001|Treatment Phase|Lost to Follow-up|0|||
145380980|NCT01554176|524245167|FG002|Treatment Phase|Lost to Follow-up|0|||
145380981|NCT01554176|524245168|FG003|Treatment Phase|Lost to Follow-up|0|||
145380982|NCT01554176|524245169|FG004|Treatment Phase|Lost to Follow-up|0|||
145380983|NCT01554176|524245165|FG000|Run-out Phase|Protocol Violation|0|||
145380984|NCT01554176|524245166|FG001|Run-out Phase|Protocol Violation|0|||
145380985|NCT01554176|524245167|FG002|Run-out Phase|Protocol Violation|0|||
145380986|NCT01554176|524245168|FG003|Run-out Phase|Protocol Violation|1|||
145380987|NCT01554176|524245169|FG004|Run-out Phase|Protocol Violation|0|||
145380988|NCT02333383|524245172|FG000|Overall Study|Adalimumab discontinuation|21|||
145380989|NCT02333383|524245172|FG000|Overall Study|Lost to Follow-up|15|||
145380990|NCT02333383|524245172|FG000|Overall Study|Withdrawal by Subject|3|||
145380991|NCT02333383|524245172|FG000|Overall Study|Transfer to another hospital|2|||
145380992|NCT00463840|524245173|FG000|Overall Study|Disease progression|7|||
145380993|NCT00463840|524245173|FG000|Overall Study|Withdrawal by Subject|2|||
145380994|NCT00463840|524245173|FG000|Overall Study|Adverse Event|3|||
145380995|NCT01653327|524245174|FG000|Overall Study|Withdrawal by Subject|1|||
145380996|NCT03089853|524246840|FG000|Overall Study|Lost to Follow-up|2|||
145380997|NCT03089853|524246841|FG001|Overall Study|Lost to Follow-up|1|||
145380998|NCT00642954|524246842|FG000|Overall Study|Progressive Disease|3|||
145380999|NCT00642954|524246843|FG001|Overall Study|Progressive Disease|3|||
145381000|NCT00642954|524246844|FG002|Overall Study|Progressive Disease|3|||
145381001|NCT00642954|524246845|FG003|Overall Study|Progressive Disease|3|||
145381002|NCT00642954|524246846|FG004|Overall Study|Progressive Disease|9|||
145381003|NCT00642954|524246842|FG000|Overall Study|Withdrawal by Subject|0|||
145381004|NCT00642954|524246843|FG001|Overall Study|Withdrawal by Subject|0|||
145381005|NCT00642954|524246844|FG002|Overall Study|Withdrawal by Subject|0|||
145381006|NCT00642954|524246845|FG003|Overall Study|Withdrawal by Subject|0|||
145381007|NCT00642954|524246846|FG004|Overall Study|Withdrawal by Subject|1|||
145381008|NCT00642954|524246842|FG000|Overall Study|Adverse Event|1|||
145381009|NCT00642954|524246843|FG001|Overall Study|Adverse Event|1|||
145381010|NCT00642954|524246844|FG002|Overall Study|Adverse Event|0|||
145381011|NCT00642954|524246845|FG003|Overall Study|Adverse Event|0|||
145381012|NCT00642954|524246846|FG004|Overall Study|Adverse Event|6|||
145381013|NCT05243563|524246847|FG000|Overall Study|Withdrawal by Subject|1|||
145381014|NCT05243563|524246848|FG001|Overall Study|Withdrawal by Subject|0|||
145381015|NCT05243563|524246847|FG000|Overall Study|Physician Decision|1|||
145381016|NCT05243563|524246848|FG001|Overall Study|Physician Decision|0|||
145381017|NCT00441363|524246849|FG000|Overall Study|Adverse Event|4|||
145381018|NCT00441363|524246850|FG001|Overall Study|Adverse Event|2|||
145381019|NCT00441363|524246849|FG000|Overall Study|Withdrawal by Subject|3|||
145381020|NCT00441363|524246850|FG001|Overall Study|Withdrawal by Subject|4|||
145381021|NCT00441363|524246849|FG000|Overall Study|Physician Decision|6|||
145381022|NCT00441363|524246850|FG001|Overall Study|Physician Decision|7|||
145381023|NCT00441363|524246849|FG000|Overall Study|Lost to Follow-up|2|||
145381024|NCT00441363|524246850|FG001|Overall Study|Lost to Follow-up|2|||
145381025|NCT00441363|524246849|FG000|Overall Study|Other|2|||
145381026|NCT00441363|524246850|FG001|Overall Study|Other|0|||
145381027|NCT02437188|524246851|FG000|Overall Study|Randomized but did not receive surgery|4|||
145381028|NCT02437188|524246852|FG001|Overall Study|Randomized but did not receive surgery|8|||
145381029|NCT02437188|524246851|FG000|Overall Study|Adverse Event|0|||
145381030|NCT02437188|524246852|FG001|Overall Study|Adverse Event|1|||
145381031|NCT02661061|524246853|FG000|Overall Study|Lack of Efficacy|1|||
145381032|NCT02661061|524246854|FG001|Overall Study|Lack of Efficacy|1|||
145381033|NCT02661061|524246853|FG000|Overall Study|Withdrawal by Subject|1|||
145381034|NCT02661061|524246854|FG001|Overall Study|Withdrawal by Subject|1|||
145381035|NCT03052920|524246855|FG000|Overall Study|Withdrawal by Subject|1|||
145381036|NCT00298363|524246856|FG000|Overall Study|Lost to Follow-up|0|||
145381037|NCT00298363|524246857|FG001|Overall Study|Lost to Follow-up|0|||
145381038|NCT00298363|524246858|FG002|Overall Study|Lost to Follow-up|1|||
145381039|NCT00298363|524246856|FG000|Overall Study|Physician Decision|4|||
145381040|NCT00298363|524246857|FG001|Overall Study|Physician Decision|1|||
145381041|NCT00298363|524246858|FG002|Overall Study|Physician Decision|0|||
145381042|NCT00298363|524246856|FG000|Overall Study|Protocol Violation|1|||
145381043|NCT00298363|524246857|FG001|Overall Study|Protocol Violation|1|||
145381044|NCT00298363|524246858|FG002|Overall Study|Protocol Violation|0|||
145381045|NCT00298363|524246856|FG000|Overall Study|Withdrawal by Subject|5|||
145381046|NCT00298363|524246857|FG001|Overall Study|Withdrawal by Subject|1|||
145381047|NCT00298363|524246858|FG002|Overall Study|Withdrawal by Subject|3|||
145381048|NCT00298363|524246856|FG000|Overall Study|Adverse Event|5|||
145381049|NCT00298363|524246857|FG001|Overall Study|Adverse Event|2|||
145718952|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
145381050|NCT00298363|524246858|FG002|Overall Study|Adverse Event|2|||
145381051|NCT00298363|524246856|FG000|Overall Study|Lack of Efficacy|2|||
145381052|NCT00298363|524246857|FG001|Overall Study|Lack of Efficacy|3|||
145381053|NCT00298363|524246858|FG002|Overall Study|Lack of Efficacy|0|||
145381054|NCT00153816|524246859|FG000|Overall Study|Death|6|||
145381055|NCT00153816|524246860|FG001|Overall Study|Death|5|||
145381056|NCT00153816|524246861|FG002|Overall Study|Death|4|||
145381057|NCT00153816|524246862|FG003|Overall Study|Death|6|||
145381058|NCT00153816|524246863|FG004|Overall Study|Death|0|||
145381059|NCT00153816|524246864|FG005|Overall Study|Death|2|||
145381060|NCT00153816|524246859|FG000|Overall Study|Lost to Follow-up|7|||
145381061|NCT00153816|524246860|FG001|Overall Study|Lost to Follow-up|8|||
145381062|NCT00153816|524246861|FG002|Overall Study|Lost to Follow-up|5|||
145381063|NCT00153816|524246862|FG003|Overall Study|Lost to Follow-up|8|||
145381064|NCT00153816|524246863|FG004|Overall Study|Lost to Follow-up|7|||
145381065|NCT00153816|524246864|FG005|Overall Study|Lost to Follow-up|9|||
145381066|NCT00153816|524246859|FG000|Overall Study|Withdrawal by Subject|9|||
145381067|NCT00153816|524246860|FG001|Overall Study|Withdrawal by Subject|9|||
145381068|NCT00153816|524246861|FG002|Overall Study|Withdrawal by Subject|9|||
145381069|NCT00153816|524246862|FG003|Overall Study|Withdrawal by Subject|4|||
145381070|NCT00153816|524246863|FG004|Overall Study|Withdrawal by Subject|1|||
145381071|NCT00153816|524246864|FG005|Overall Study|Withdrawal by Subject|5|||
145381072|NCT00153816|524246859|FG000|Overall Study|Follow-up exam not done|8|||
145381073|NCT00153816|524246860|FG001|Overall Study|Follow-up exam not done|7|||
145381074|NCT00153816|524246861|FG002|Overall Study|Follow-up exam not done|11|||
145381075|NCT00153816|524246862|FG003|Overall Study|Follow-up exam not done|10|||
145381076|NCT00153816|524246863|FG004|Overall Study|Follow-up exam not done|8|||
145381077|NCT00153816|524246864|FG005|Overall Study|Follow-up exam not done|9|||
145381078|NCT00153816|524246859|FG000|Overall Study|Follow-up exam done, histology missing|2|||
145381079|NCT00153816|524246860|FG001|Overall Study|Follow-up exam done, histology missing|3|||
145381080|NCT00153816|524246861|FG002|Overall Study|Follow-up exam done, histology missing|3|||
145381081|NCT00153816|524246862|FG003|Overall Study|Follow-up exam done, histology missing|3|||
145381082|NCT00153816|524246863|FG004|Overall Study|Follow-up exam done, histology missing|1|||
145381083|NCT00153816|524246864|FG005|Overall Study|Follow-up exam done, histology missing|2|||
145381084|NCT01533688|524246867|FG000|Overall Study|Withdrawal by Subject|5|||
145381085|NCT01533688|524246868|FG001|Overall Study|Withdrawal by Subject|4|||
145381086|NCT01533688|524246869|FG002|Overall Study|Withdrawal by Subject|3|||
145381087|NCT01533688|524246867|FG000|Overall Study|Medically unstable|1|||
145381088|NCT01533688|524246868|FG001|Overall Study|Medically unstable|3|||
145381089|NCT01533688|524246869|FG002|Overall Study|Medically unstable|3|||
145381090|NCT01533688|524246867|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
145381091|NCT01533688|524246868|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
145381092|NCT01533688|524246869|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
145381093|NCT02509078|524246870|FG000|Overall Study|Protocol Violation|1|||
145381094|NCT02509078|524246871|FG001|Overall Study|Protocol Violation|1|||
145381095|NCT03959488|524246874|FG000|Season 1|Other|6|||
145381096|NCT03959488|524246875|FG001|Season 1|Other|7|||
145381097|NCT03959488|524246876|FG002|Season 1|Other|0|||
145381098|NCT03959488|524246877|FG003|Season 1|Other|0|||
145381099|NCT03959488|524246878|FG004|Season 1|Other|0|||
145381100|NCT03959488|524246874|FG000|Season 1|Withdrawal by parent/guardian|43|||
145381101|NCT03959488|524246875|FG001|Season 1|Withdrawal by parent/guardian|28|||
145381102|NCT03959488|524246876|FG002|Season 1|Withdrawal by parent/guardian|0|||
145381103|NCT03959488|524246877|FG003|Season 1|Withdrawal by parent/guardian|0|||
145381104|NCT03959488|524246878|FG004|Season 1|Withdrawal by parent/guardian|0|||
145381105|NCT03959488|524246874|FG000|Season 1|Due to COVID-19 pandemic|2|||
145381106|NCT03959488|524246875|FG001|Season 1|Due to COVID-19 pandemic|3|||
145381107|NCT03959488|524246876|FG002|Season 1|Due to COVID-19 pandemic|0|||
145381108|NCT03959488|524246877|FG003|Season 1|Due to COVID-19 pandemic|0|||
145381109|NCT03959488|524246878|FG004|Season 1|Due to COVID-19 pandemic|0|||
145381110|NCT03959488|524246874|FG000|Season 1|Lost to Follow-up|17|||
145381111|NCT03959488|524246875|FG001|Season 1|Lost to Follow-up|7|||
145381112|NCT03959488|524246876|FG002|Season 1|Lost to Follow-up|0|||
145381113|NCT03959488|524246877|FG003|Season 1|Lost to Follow-up|0|||
145381114|NCT03959488|524246878|FG004|Season 1|Lost to Follow-up|0|||
145381115|NCT03959488|524246874|FG000|Season 1|Death|5|||
145381116|NCT03959488|524246875|FG001|Season 1|Death|1|||
145381117|NCT03959488|524246876|FG002|Season 1|Death|0|||
145381118|NCT03959488|524246877|FG003|Season 1|Death|0|||
145381119|NCT03959488|524246878|FG004|Season 1|Death|0|||
145381120|NCT03959488|524246874|FG000|Season 2|Other|0|||
145381121|NCT03959488|524246875|FG001|Season 2|Other|0|||
145381122|NCT03959488|524246876|FG002|Season 2|Other|2|||
145381123|NCT03959488|524246877|FG003|Season 2|Other|0|||
145381124|NCT03959488|524246878|FG004|Season 2|Other|0|||
145381125|NCT03959488|524246874|FG000|Season 2|Withdrawal by parent/guardian|0|||
145381126|NCT03959488|524246875|FG001|Season 2|Withdrawal by parent/guardian|0|||
145381127|NCT03959488|524246876|FG002|Season 2|Withdrawal by parent/guardian|3|||
145381128|NCT03959488|524246877|FG003|Season 2|Withdrawal by parent/guardian|1|||
145381129|NCT03959488|524246878|FG004|Season 2|Withdrawal by parent/guardian|1|||
145381130|NCT03959488|524246874|FG000|Season 2|Lost to Follow-up|0|||
145381131|NCT03959488|524246875|FG001|Season 2|Lost to Follow-up|0|||
145381132|NCT03959488|524246876|FG002|Season 2|Lost to Follow-up|1|||
145381133|NCT03959488|524246877|FG003|Season 2|Lost to Follow-up|0|||
145381134|NCT03959488|524246878|FG004|Season 2|Lost to Follow-up|1|||
145381135|NCT01760447|524246879|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
145381136|NCT01760447|524246880|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
145381137|NCT01760447|524246881|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
145381138|NCT01760447|524246882|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
145381139|NCT01760447|524246879|FG000|Weeks 0-20|Withdrawal by Subject|2|||
145381140|NCT01760447|524246880|FG001|Weeks 0-20|Withdrawal by Subject|0|||
145381141|NCT01760447|524246881|FG002|Weeks 0-20|Withdrawal by Subject|1|||
145381142|NCT01760447|524246882|FG003|Weeks 0-20|Withdrawal by Subject|0|||
145381143|NCT01760447|524246879|FG000|Weeks 0-20|Lost to Follow-up|1|||
145381144|NCT01760447|524246880|FG001|Weeks 0-20|Lost to Follow-up|0|||
145381145|NCT01760447|524246881|FG002|Weeks 0-20|Lost to Follow-up|1|||
145381146|NCT01760447|524246882|FG003|Weeks 0-20|Lost to Follow-up|1|||
145381147|NCT01760447|524246879|FG000|Weeks 0-20|Randomized but not treated|0|||
145381148|NCT01760447|524246880|FG001|Weeks 0-20|Randomized but not treated|0|||
145381149|NCT01760447|524246881|FG002|Weeks 0-20|Randomized but not treated|2|||
145381150|NCT01760447|524246882|FG003|Weeks 0-20|Randomized but not treated|0|||
145381151|NCT01760447|524246879|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145381152|NCT01760447|524246880|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145381153|NCT01760447|524246881|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
145381154|NCT01760447|524246882|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
145381155|NCT01760447|524246879|FG000|Weeks 20-54|Withdrawal by Subject|2|||
145381156|NCT01760447|524246880|FG001|Weeks 20-54|Withdrawal by Subject|1|||
145381157|NCT01760447|524246881|FG002|Weeks 20-54|Withdrawal by Subject|1|||
145381158|NCT01760447|524246882|FG003|Weeks 20-54|Withdrawal by Subject|2|||
145381159|NCT01760447|524246879|FG000|Weeks 20-54|Lost to Follow-up|0|||
145381160|NCT01760447|524246880|FG001|Weeks 20-54|Lost to Follow-up|0|||
145718953|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
145718954|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
145718955|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
145718956|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
145718957|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
145718958|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
145718959|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
145718960|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
145718961|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
145718962|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
145718963|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
145718964|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
145718965|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
145718966|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
145718967|NCT00910689|525486593|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
145718968|NCT00910689|525486594|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
145718969|NCT00910689|525486595|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
145718970|NCT00910689|525486596|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
145718971|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
145718972|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
145718973|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
145718974|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
145718975|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
145718976|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
145718977|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
145718978|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
145718979|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
145718980|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
145718981|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
145718982|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
145718983|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
145718984|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
145718985|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
145718986|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
145718987|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
145718988|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
145381161|NCT01760447|524246881|FG002|Weeks 20-54|Lost to Follow-up|1|||
145381162|NCT01760447|524246882|FG003|Weeks 20-54|Lost to Follow-up|2|||
145381163|NCT04767529|524246890|FG000|Overall Study|Adverse Event|0|||
145381164|NCT04767529|524246891|FG001|Overall Study|Adverse Event|4|||
145718989|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
145718990|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
145718991|NCT00910689|525486593|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
145381165|NCT04767529|524246892|FG002|Overall Study|Adverse Event|3|||
145381166|NCT04767529|524246890|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
145381167|NCT04767529|524246891|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
145381168|NCT04767529|524246892|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
145381169|NCT04767529|524246890|FG000|Overall Study|Required use of a prohibited medication|0|||
145718992|NCT00910689|525486594|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
145718993|NCT00910689|525486595|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
145718994|NCT00910689|525486596|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
145718995|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
145718996|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
145718997|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
145718998|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
145718999|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
145719000|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
145719001|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
145719002|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
145719003|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
145719004|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
145719005|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
145719006|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
145719007|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
145719008|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
145719009|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
145719010|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
145719011|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
145719012|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
145719013|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
145719014|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
145719015|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
145719016|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
145719017|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
145719018|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
145719019|NCT00910689|525486593|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
145719020|NCT00910689|525486594|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
145719021|NCT00910689|525486595|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
145719022|NCT00910689|525486596|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
145719023|NCT03207009|525486597|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
145719024|NCT00645801|525486598|FG000|Overall Study|unclear if patient took all the medication.|1|||
145719025|NCT00645801|525486599|FG001|Overall Study|unclear if patient took all the medication.|0|||
145719026|NCT00645801|525486598|FG000|Overall Study|Lost to Follow-up|19|||
145719027|NCT00645801|525486599|FG001|Overall Study|Lost to Follow-up|15|||
145719028|NCT00203476|525486600|FG000|Overall Study|Lost to Follow-up|1|||
145719029|NCT00203476|525486601|FG001|Overall Study|Lost to Follow-up|0|||
145719030|NCT00203476|525486602|FG002|Overall Study|Lost to Follow-up|0|||
145719031|NCT00203476|525486600|FG000|Overall Study|Withdrawal by Subject|0|||
145719032|NCT00203476|525486601|FG001|Overall Study|Withdrawal by Subject|1|||
145719033|NCT00203476|525486602|FG002|Overall Study|Withdrawal by Subject|0|||
145719034|NCT00512317|525486604|FG000|Overall Study|Insufficient clinical response|36|||
145719035|NCT00512317|525486604|FG000|Overall Study|Withdrawal by Subject|23|||
145719036|NCT00512317|525486604|FG000|Overall Study|Sponsor closure of study|21|||
145719037|NCT00512317|525486604|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
145719038|NCT00512317|525486604|FG000|Overall Study|Adverse Event|13|||
145719039|NCT00512317|525486604|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
145719040|NCT00512317|525486604|FG000|Overall Study|Lost to Follow-up|2|||
145719041|NCT00512317|525486604|FG000|Overall Study|Other|2|||
145719042|NCT02074553|525486605|FG000|Intervention Period 1|Family Emergency|0|||
145719043|NCT02074553|525486606|FG001|Intervention Period 1|Family Emergency|0|||
145719044|NCT02074553|525486607|FG002|Intervention Period 1|Family Emergency|0|||
145719045|NCT02074553|525486608|FG003|Intervention Period 1|Family Emergency|1|||
145719046|NCT02074553|525486609|FG004|Intervention Period 1|Family Emergency|0|||
145719047|NCT02074553|525486610|FG005|Intervention Period 1|Family Emergency|0|||
145719048|NCT02074553|525486611|FG006|Intervention Period 1|Family Emergency|0|||
145719049|NCT02074553|525486612|FG007|Intervention Period 1|Family Emergency|0|||
145719050|NCT02074553|525486605|FG000|Washout Period 1|Adverse Event|1|||
145719051|NCT02074553|525486606|FG001|Washout Period 1|Adverse Event|0|||
145719052|NCT02074553|525486607|FG002|Washout Period 1|Adverse Event|0|||
145719053|NCT02074553|525486608|FG003|Washout Period 1|Adverse Event|0|||
145719054|NCT02074553|525486609|FG004|Washout Period 1|Adverse Event|0|||
145719055|NCT02074553|525486610|FG005|Washout Period 1|Adverse Event|0|||
145719056|NCT02074553|525486611|FG006|Washout Period 1|Adverse Event|0|||
145719057|NCT02074553|525486612|FG007|Washout Period 1|Adverse Event|0|||
145719058|NCT02074553|525486605|FG000|Washout Period 1|Physician Decision|0|||
145719059|NCT02074553|525486606|FG001|Washout Period 1|Physician Decision|0|||
145719060|NCT02074553|525486607|FG002|Washout Period 1|Physician Decision|0|||
145719061|NCT02074553|525486608|FG003|Washout Period 1|Physician Decision|1|||
145719062|NCT02074553|525486609|FG004|Washout Period 1|Physician Decision|0|||
145719063|NCT02074553|525486610|FG005|Washout Period 1|Physician Decision|0|||
145719064|NCT02074553|525486611|FG006|Washout Period 1|Physician Decision|0|||
145719065|NCT02074553|525486612|FG007|Washout Period 1|Physician Decision|0|||
145719066|NCT02074553|525486605|FG000|Washout Period 1|Other|0|||
145719067|NCT02074553|525486606|FG001|Washout Period 1|Other|0|||
145719068|NCT02074553|525486607|FG002|Washout Period 1|Other|0|||
145719069|NCT02074553|525486608|FG003|Washout Period 1|Other|0|||
145719070|NCT02074553|525486609|FG004|Washout Period 1|Other|0|||
145719071|NCT02074553|525486610|FG005|Washout Period 1|Other|1|||
145719072|NCT02074553|525486611|FG006|Washout Period 1|Other|0|||
145719073|NCT02074553|525486612|FG007|Washout Period 1|Other|0|||
145719074|NCT02074553|525486605|FG000|Washout Period 2|Adverse Event|0|||
145719075|NCT02074553|525486606|FG001|Washout Period 2|Adverse Event|0|||
145719076|NCT02074553|525486607|FG002|Washout Period 2|Adverse Event|0|||
145719077|NCT02074553|525486608|FG003|Washout Period 2|Adverse Event|0|||
145719078|NCT02074553|525486609|FG004|Washout Period 2|Adverse Event|0|||
145719079|NCT02074553|525486610|FG005|Washout Period 2|Adverse Event|0|||
145719080|NCT02074553|525486611|FG006|Washout Period 2|Adverse Event|1|||
145719081|NCT02074553|525486612|FG007|Washout Period 2|Adverse Event|0|||
145719082|NCT02074553|525486605|FG000|Washout Period 2|Physician Decision|0|||
145719083|NCT02074553|525486606|FG001|Washout Period 2|Physician Decision|0|||
145719084|NCT02074553|525486607|FG002|Washout Period 2|Physician Decision|0|||
145719085|NCT02074553|525486608|FG003|Washout Period 2|Physician Decision|0|||
145719086|NCT02074553|525486609|FG004|Washout Period 2|Physician Decision|0|||
145719087|NCT02074553|525486610|FG005|Washout Period 2|Physician Decision|1|||
145719088|NCT02074553|525486611|FG006|Washout Period 2|Physician Decision|0|||
145719089|NCT02074553|525486612|FG007|Washout Period 2|Physician Decision|0|||
145719090|NCT02074553|525486605|FG000|Washout Period 2|Lost to Follow-up|0|||
145719091|NCT02074553|525486606|FG001|Washout Period 2|Lost to Follow-up|0|||
145719092|NCT02074553|525486607|FG002|Washout Period 2|Lost to Follow-up|1|||
145719093|NCT02074553|525486608|FG003|Washout Period 2|Lost to Follow-up|0|||
145719094|NCT02074553|525486609|FG004|Washout Period 2|Lost to Follow-up|0|||
145719095|NCT02074553|525486610|FG005|Washout Period 2|Lost to Follow-up|0|||
145719096|NCT02074553|525486611|FG006|Washout Period 2|Lost to Follow-up|0|||
145719097|NCT02074553|525486612|FG007|Washout Period 2|Lost to Follow-up|0|||
145719098|NCT02074553|525486605|FG000|Washout Period 3|Physician Decision|0|||
145719099|NCT02074553|525486606|FG001|Washout Period 3|Physician Decision|0|||
145719100|NCT02074553|525486607|FG002|Washout Period 3|Physician Decision|0|||
145719101|NCT02074553|525486608|FG003|Washout Period 3|Physician Decision|0|||
145719102|NCT02074553|525486609|FG004|Washout Period 3|Physician Decision|0|||
145719103|NCT02074553|525486610|FG005|Washout Period 3|Physician Decision|0|||
145719104|NCT02074553|525486611|FG006|Washout Period 3|Physician Decision|0|||
145719105|NCT02074553|525486612|FG007|Washout Period 3|Physician Decision|1|||
145719106|NCT04875676|525486613|FG000|Overall Study|Lost to Follow-up|1|||
145719107|NCT04875676|525486614|FG001|Overall Study|Lost to Follow-up|0|||
145719108|NCT04875676|525486615|FG002|Overall Study|Lost to Follow-up|0|||
145719109|NCT01970345|525486618|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
145719110|NCT01970345|525486619|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
145719111|NCT01970345|525486618|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
145719112|NCT01970345|525486619|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
145719113|NCT04289051|525486626|FG000|Overall Study|Lost to Follow-up|0|||
145719114|NCT04289051|525486627|FG001|Overall Study|Lost to Follow-up|0|||
145719115|NCT04289051|525486628|FG002|Overall Study|Lost to Follow-up|2|||
145719116|NCT00657020|525486629|FG000|PERIOD 1|Adverse Event|0|||
145719117|NCT00657020|525486630|FG001|PERIOD 1|Adverse Event|1|||
145719118|NCT02937454|525486637|FG000|Overall Study|Adverse Event|0|||
145719119|NCT02937454|525486638|FG001|Overall Study|Adverse Event|1|||
145719120|NCT02937454|525486637|FG000|Overall Study|Death|98|||
145719121|NCT02937454|525486638|FG001|Overall Study|Death|95|||
145719122|NCT02937454|525486637|FG000|Overall Study|Lost to Follow-up|1|||
145719123|NCT02937454|525486638|FG001|Overall Study|Lost to Follow-up|1|||
145719124|NCT02937454|525486637|FG000|Overall Study|Physician Decision|0|||
145719125|NCT02937454|525486638|FG001|Overall Study|Physician Decision|1|||
145719126|NCT02937454|525486637|FG000|Overall Study|Protocol Violation|6|||
145719127|NCT02937454|525486638|FG001|Overall Study|Protocol Violation|10|||
145719128|NCT02937454|525486637|FG000|Overall Study|Withdrawal by Subject|27|||
145719129|NCT02937454|525486638|FG001|Overall Study|Withdrawal by Subject|15|||
145719130|NCT02937454|525486637|FG000|Overall Study|Other|8|||
145719131|NCT02937454|525486638|FG001|Overall Study|Other|5|||
145719132|NCT01156792|525486639|FG000|Overall Study|Adverse Event|1|||
145719133|NCT01156792|525486639|FG000|Overall Study|Lack of Efficacy|36|||
145719134|NCT01156792|525486639|FG000|Overall Study|Protocol Violation|6|||
145719135|NCT01156792|525486639|FG000|Overall Study|Lost to Follow-up|3|||
145719136|NCT01156792|525486639|FG000|Overall Study|Physician Decision|3|||
145719137|NCT01156792|525486639|FG000|Overall Study|Withdrawal by Subject|9|||
145719138|NCT01156792|525486639|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
145719139|NCT01097707|525486640|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145719140|NCT01097707|525486641|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145719141|NCT01097707|525486642|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145719142|NCT01097707|525486643|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145719143|NCT01097707|525486644|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145719144|NCT01097707|525486640|FG000|Overall Study|Adverse Event|4|||
145719145|NCT01097707|525486641|FG001|Overall Study|Adverse Event|2|||
145719146|NCT01097707|525486642|FG002|Overall Study|Adverse Event|3|||
145719147|NCT01097707|525486643|FG003|Overall Study|Adverse Event|1|||
145719148|NCT01097707|525486644|FG004|Overall Study|Adverse Event|3|||
145719149|NCT01097707|525486640|FG000|Overall Study|Entry Criteria Not Met|2|||
145719150|NCT01097707|525486641|FG001|Overall Study|Entry Criteria Not Met|1|||
145719151|NCT01097707|525486642|FG002|Overall Study|Entry Criteria Not Met|1|||
145719152|NCT01097707|525486643|FG003|Overall Study|Entry Criteria Not Met|0|||
145719153|NCT01097707|525486644|FG004|Overall Study|Entry Criteria Not Met|1|||
145719154|NCT01097707|525486640|FG000|Overall Study|Lack of Efficacy|1|||
145719155|NCT01097707|525486641|FG001|Overall Study|Lack of Efficacy|0|||
145719156|NCT01097707|525486642|FG002|Overall Study|Lack of Efficacy|0|||
145719157|NCT01097707|525486643|FG003|Overall Study|Lack of Efficacy|1|||
145719158|NCT01097707|525486644|FG004|Overall Study|Lack of Efficacy|0|||
145719159|NCT01097707|525486640|FG000|Overall Study|Lost to Follow-up|1|||
145719160|NCT01097707|525486641|FG001|Overall Study|Lost to Follow-up|1|||
145719161|NCT01097707|525486642|FG002|Overall Study|Lost to Follow-up|2|||
145719162|NCT01097707|525486643|FG003|Overall Study|Lost to Follow-up|0|||
145719163|NCT01097707|525486644|FG004|Overall Study|Lost to Follow-up|3|||
145719164|NCT01097707|525486640|FG000|Overall Study|Protocol Violation|2|||
145381170|NCT04767529|524246891|FG001|Overall Study|Required use of a prohibited medication|1|||
145381171|NCT04767529|524246892|FG002|Overall Study|Required use of a prohibited medication|0|||
145381172|NCT04767529|524246890|FG000|Overall Study|Withdrawal by Subject|7|||
145381173|NCT04767529|524246891|FG001|Overall Study|Withdrawal by Subject|5|||
145381174|NCT04767529|524246892|FG002|Overall Study|Withdrawal by Subject|4|||
145381175|NCT04767529|524246890|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
145381176|NCT04767529|524246891|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
145381177|NCT04767529|524246892|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
145381178|NCT04767529|524246890|FG000|Overall Study|Lost to Follow-up|0|||
145381179|NCT04767529|524246891|FG001|Overall Study|Lost to Follow-up|2|||
145381180|NCT04767529|524246892|FG002|Overall Study|Lost to Follow-up|3|||
145381181|NCT02290925|524246898|FG000|First Period of Three Months|Lost to Follow-up|2|||
145381182|NCT02290925|524246899|FG001|First Period of Three Months|Lost to Follow-up|1|||
145381183|NCT02290925|524246898|FG000|First Period of Three Months|Death|1|||
145381184|NCT02290925|524246899|FG001|First Period of Three Months|Death|0|||
145381185|NCT02290925|524246898|FG000|First Period of Three Months|Insulin Started|1|||
145381186|NCT02290925|524246899|FG001|First Period of Three Months|Insulin Started|1|||
145381187|NCT02290925|524246898|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
145381188|NCT02290925|524246899|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
145381189|NCT02290925|524246898|FG000|Second Period of 3 Months|insulin started|0|||
145381190|NCT02290925|524246899|FG001|Second Period of 3 Months|insulin started|1|||
145381191|NCT00981058|524246902|FG000|Overall Study|Progressive Disease|38|||
145381192|NCT00981058|524246903|FG001|Overall Study|Progressive Disease|31|||
145381193|NCT00981058|524246902|FG000|Overall Study|Lost to Follow-up|3|||
145381194|NCT00981058|524246903|FG001|Overall Study|Lost to Follow-up|2|||
145381195|NCT00981058|524246902|FG000|Overall Study|Physician Decision|4|||
145381196|NCT00981058|524246903|FG001|Overall Study|Physician Decision|5|||
145381197|NCT00981058|524246902|FG000|Overall Study|Randomization Error|0|||
145381198|NCT00981058|524246903|FG001|Overall Study|Randomization Error|1|||
145381199|NCT00981058|524246902|FG000|Overall Study|Withdrawal by Subject|24|||
145381200|NCT00981058|524246903|FG001|Overall Study|Withdrawal by Subject|22|||
145381201|NCT05916131|524246904|FG000|Overall Study|Lost to Follow-up|0|||
145381202|NCT05916131|524246905|FG001|Overall Study|Lost to Follow-up|0|||
145381203|NCT05916131|524246906|FG002|Overall Study|Lost to Follow-up|1|||
145381204|NCT05916131|524246907|FG003|Overall Study|Lost to Follow-up|0|||
145381205|NCT02305446|524246914|FG000|Overall Study|Adverse Event|1|||
145719165|NCT01097707|525486641|FG001|Overall Study|Protocol Violation|2|||
145719166|NCT01097707|525486642|FG002|Overall Study|Protocol Violation|3|||
145719167|NCT01097707|525486643|FG003|Overall Study|Protocol Violation|2|||
145719168|NCT01097707|525486644|FG004|Overall Study|Protocol Violation|2|||
145381206|NCT01211483|524246919|FG000|Phase 1b|Death|6|||
145381207|NCT01211483|524246920|FG001|Phase 1b|Death|0|||
145381208|NCT01211483|524246921|FG002|Phase 1b|Death|0|||
145381209|NCT01211483|524246922|FG003|Phase 1b|Death|0|||
145381210|NCT01211483|524246919|FG000|Phase 1b|Withdrawal by Subject|1|||
145381211|NCT01211483|524246920|FG001|Phase 1b|Withdrawal by Subject|0|||
145381212|NCT01211483|524246921|FG002|Phase 1b|Withdrawal by Subject|0|||
145381213|NCT01211483|524246922|FG003|Phase 1b|Withdrawal by Subject|0|||
145381214|NCT01211483|524246919|FG000|Phase 2|Lost to Follow-up|0|||
145381215|NCT01211483|524246920|FG001|Phase 2|Lost to Follow-up|1|||
145381216|NCT01211483|524246921|FG002|Phase 2|Lost to Follow-up|1|||
145719169|NCT01097707|525486640|FG000|Overall Study|Sponsor Decision|31|||
145719170|NCT01097707|525486641|FG001|Overall Study|Sponsor Decision|31|||
145719171|NCT01097707|525486642|FG002|Overall Study|Sponsor Decision|34|||
145719172|NCT01097707|525486643|FG003|Overall Study|Sponsor Decision|35|||
145381217|NCT01211483|524246922|FG003|Phase 2|Lost to Follow-up|2|||
145381218|NCT01211483|524246919|FG000|Phase 2|Death|0|||
145381219|NCT01211483|524246920|FG001|Phase 2|Death|64|||
145381220|NCT01211483|524246921|FG002|Phase 2|Death|53|||
145381221|NCT01211483|524246922|FG003|Phase 2|Death|53|||
145381222|NCT01211483|524246919|FG000|Phase 2|Withdrawal by Subject|0|||
145381223|NCT01211483|524246920|FG001|Phase 2|Withdrawal by Subject|1|||
145381224|NCT01211483|524246921|FG002|Phase 2|Withdrawal by Subject|10|||
145381225|NCT01211483|524246922|FG003|Phase 2|Withdrawal by Subject|5|||
145381226|NCT01211483|524246919|FG000|Phase 2|Study terminated by Sponsor|0|||
145381227|NCT01211483|524246920|FG001|Phase 2|Study terminated by Sponsor|6|||
145381228|NCT01211483|524246921|FG002|Phase 2|Study terminated by Sponsor|8|||
145381229|NCT01211483|524246922|FG003|Phase 2|Study terminated by Sponsor|11|||
145381230|NCT02284568|524246923|FG000|Overall Study|Adverse Event|2|||
145381231|NCT02284568|524246924|FG001|Overall Study|Adverse Event|9|||
145381232|NCT02284568|524246925|FG002|Overall Study|Adverse Event|4|||
145381233|NCT02284568|524246923|FG000|Overall Study|Withdrawal by Subject|22|||
145381234|NCT02284568|524246924|FG001|Overall Study|Withdrawal by Subject|21|||
145381235|NCT02284568|524246925|FG002|Overall Study|Withdrawal by Subject|1|||
145381236|NCT02284568|524246923|FG000|Overall Study|Noncompliance with study drug admin|1|||
145381237|NCT02284568|524246924|FG001|Overall Study|Noncompliance with study drug admin|2|||
145381238|NCT02284568|524246925|FG002|Overall Study|Noncompliance with study drug admin|0|||
145381239|NCT02284568|524246923|FG000|Overall Study|Noncompliance|1|||
145381240|NCT02284568|524246924|FG001|Overall Study|Noncompliance|0|||
145381241|NCT02284568|524246925|FG002|Overall Study|Noncompliance|0|||
145381242|NCT02284568|524246923|FG000|Overall Study|Protocol Violation|0|||
145381243|NCT02284568|524246924|FG001|Overall Study|Protocol Violation|1|||
145381244|NCT02284568|524246925|FG002|Overall Study|Protocol Violation|0|||
145381245|NCT02284568|524246923|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
145381246|NCT02284568|524246924|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
145381247|NCT02284568|524246925|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
145381248|NCT02284568|524246923|FG000|Overall Study|Lost to Follow-up|0|||
145381249|NCT02284568|524246924|FG001|Overall Study|Lost to Follow-up|3|||
145381250|NCT02284568|524246925|FG002|Overall Study|Lost to Follow-up|0|||
145381251|NCT02284568|524246923|FG000|Overall Study|Lack of Efficacy|4|||
145381252|NCT02284568|524246924|FG001|Overall Study|Lack of Efficacy|7|||
145381253|NCT02284568|524246925|FG002|Overall Study|Lack of Efficacy|0|||
145381254|NCT02284568|524246923|FG000|Overall Study|Other|1|||
145381255|NCT02284568|524246924|FG001|Overall Study|Other|2|||
145381256|NCT02284568|524246925|FG002|Overall Study|Other|0|||
145381257|NCT02284568|524246923|FG000|Overall Study|Withdrew before taking study drug|0|||
145381258|NCT02284568|524246924|FG001|Overall Study|Withdrew before taking study drug|1|||
145381259|NCT02284568|524246925|FG002|Overall Study|Withdrew before taking study drug|0|||
145381260|NCT02719353|524246926|FG000|First Intervention|Physician Decision|0|||
145381261|NCT02719353|524246927|FG001|First Intervention|Physician Decision|1|||
145381262|NCT02854605|524246930|FG000|Overall Study|Adverse Event|1|||
145381263|NCT02854605|524246931|FG001|Overall Study|Adverse Event|5|||
145381264|NCT02854605|524246932|FG002|Overall Study|Adverse Event|2|||
145381265|NCT02854605|524246930|FG000|Overall Study|Lost to Follow-up|0|||
145381266|NCT02854605|524246931|FG001|Overall Study|Lost to Follow-up|2|||
145381267|NCT02854605|524246932|FG002|Overall Study|Lost to Follow-up|0|||
145381268|NCT02854605|524246930|FG000|Overall Study|Withdrew Consent|1|||
145381269|NCT02854605|524246931|FG001|Overall Study|Withdrew Consent|0|||
145381270|NCT02854605|524246932|FG002|Overall Study|Withdrew Consent|1|||
145381271|NCT02854605|524246930|FG000|Overall Study|Investigator's Discretion|1|||
145719173|NCT01097707|525486644|FG004|Overall Study|Sponsor Decision|36|||
145719174|NCT01097707|525486640|FG000|Overall Study|Withdrawal by Subject|3|||
145719175|NCT01097707|525486641|FG001|Overall Study|Withdrawal by Subject|6|||
145719176|NCT01097707|525486642|FG002|Overall Study|Withdrawal by Subject|1|||
145381272|NCT02854605|524246931|FG001|Overall Study|Investigator's Discretion|0|||
145381273|NCT02854605|524246932|FG002|Overall Study|Investigator's Discretion|0|||
145381274|NCT02854605|524246930|FG000|Overall Study|Protocol Violation|0|||
145381275|NCT02854605|524246931|FG001|Overall Study|Protocol Violation|0|||
145381276|NCT02854605|524246932|FG002|Overall Study|Protocol Violation|1|||
145381277|NCT00568334|524246933|FG000|Overall Study|Withdrawal by Subject|0|||
145381278|NCT00568334|524246934|FG001|Overall Study|Withdrawal by Subject|1|||
145381279|NCT00568334|524246933|FG000|Overall Study|Lost to Follow-up|1|||
145381280|NCT00568334|524246934|FG001|Overall Study|Lost to Follow-up|0|||
145381281|NCT03217968|524246935|FG000|Overall Study|Withdrawal by Subject|4|||
145381282|NCT03217968|524246935|FG000|Overall Study|Lost to Follow-up|1|||
145381283|NCT03217968|524246935|FG000|Overall Study|Protocol Violation|6|||
145381284|NCT05268016|524246938|FG000|Overall Study|Unacceptable toxicity or AE|2|||
145381285|NCT05268016|524246939|FG001|Overall Study|Unacceptable toxicity or AE|2|||
145381286|NCT05268016|524246940|FG002|Overall Study|Unacceptable toxicity or AE|4|||
145381287|NCT05268016|524246941|FG003|Overall Study|Unacceptable toxicity or AE|3|||
145381288|NCT05268016|524246942|FG004|Overall Study|Unacceptable toxicity or AE|1|||
145381289|NCT05268016|524246938|FG000|Overall Study|Withdrawal by Subject|1|||
145381290|NCT05268016|524246939|FG001|Overall Study|Withdrawal by Subject|3|||
145381291|NCT05268016|524246940|FG002|Overall Study|Withdrawal by Subject|2|||
145381292|NCT05268016|524246941|FG003|Overall Study|Withdrawal by Subject|2|||
145381293|NCT05268016|524246942|FG004|Overall Study|Withdrawal by Subject|1|||
145381294|NCT05268016|524246938|FG000|Overall Study|Lost to Follow-up|4|||
145381295|NCT05268016|524246939|FG001|Overall Study|Lost to Follow-up|7|||
145381296|NCT05268016|524246940|FG002|Overall Study|Lost to Follow-up|1|||
145719177|NCT01097707|525486643|FG003|Overall Study|Withdrawal by Subject|4|||
145719178|NCT01097707|525486644|FG004|Overall Study|Withdrawal by Subject|3|||
145719179|NCT01097707|525486640|FG000|Overall Study|Reason unknown|0|||
145719180|NCT01097707|525486641|FG001|Overall Study|Reason unknown|0|||
145719181|NCT01097707|525486642|FG002|Overall Study|Reason unknown|0|||
145719182|NCT01097707|525486643|FG003|Overall Study|Reason unknown|0|||
145381297|NCT05268016|524246941|FG003|Overall Study|Lost to Follow-up|3|||
145381298|NCT05268016|524246942|FG004|Overall Study|Lost to Follow-up|5|||
145381299|NCT05268016|524246938|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
145381300|NCT05268016|524246939|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
145381301|NCT05268016|524246940|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
145381302|NCT05268016|524246941|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
145381303|NCT05268016|524246942|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
145381304|NCT05268016|524246938|FG000|Overall Study|Lack of Efficacy|0|||
145381305|NCT05268016|524246939|FG001|Overall Study|Lack of Efficacy|0|||
145381306|NCT05268016|524246940|FG002|Overall Study|Lack of Efficacy|0|||
145381307|NCT05268016|524246941|FG003|Overall Study|Lack of Efficacy|0|||
145381308|NCT05268016|524246942|FG004|Overall Study|Lack of Efficacy|4|||
145381309|NCT05268016|524246938|FG000|Overall Study|Physician Decision|0|||
145381310|NCT05268016|524246939|FG001|Overall Study|Physician Decision|0|||
145381311|NCT05268016|524246940|FG002|Overall Study|Physician Decision|0|||
145381312|NCT05268016|524246941|FG003|Overall Study|Physician Decision|1|||
145381313|NCT05268016|524246942|FG004|Overall Study|Physician Decision|0|||
145381314|NCT05268016|524246938|FG000|Overall Study|Other|1|||
145381315|NCT05268016|524246939|FG001|Overall Study|Other|0|||
145381316|NCT05268016|524246940|FG002|Overall Study|Other|1|||
145381317|NCT05268016|524246941|FG003|Overall Study|Other|2|||
145381318|NCT05268016|524246942|FG004|Overall Study|Other|0|||
145381319|NCT02603107|524246943|FG000|Randomized Phase|Withdrew consent|8|||
145381320|NCT02603107|524246944|FG001|Randomized Phase|Withdrew consent|15|||
145381321|NCT02603107|524246943|FG000|Randomized Phase|Lost to Follow-up|1|||
145381322|NCT02603107|524246944|FG001|Randomized Phase|Lost to Follow-up|3|||
145381323|NCT02603107|524246943|FG000|Randomized Phase|Adverse Event|2|||
145381324|NCT02603107|524246944|FG001|Randomized Phase|Adverse Event|0|||
145381325|NCT02603107|524246943|FG000|Randomized Phase|Death|1|||
145381326|NCT02603107|524246944|FG001|Randomized Phase|Death|1|||
145381327|NCT02603107|524246943|FG000|Randomized Phase|Non-compliance with study drug|1|||
145381328|NCT02603107|524246944|FG001|Randomized Phase|Non-compliance with study drug|1|||
145381329|NCT02603107|524246943|FG000|Randomized Phase|Investigator's discretion|0|||
145381330|NCT02603107|524246944|FG001|Randomized Phase|Investigator's discretion|1|||
145381331|NCT02603107|524246943|FG000|Randomized Phase|Lack of Efficacy|1|||
145381332|NCT02603107|524246944|FG001|Randomized Phase|Lack of Efficacy|0|||
145381333|NCT02603107|524246943|FG000|Randomized Phase|Protocol Violation|1|||
145381334|NCT02603107|524246944|FG001|Randomized Phase|Protocol Violation|0|||
145381335|NCT02603107|524246943|FG000|Optional Extension Phase|Lost to Follow-up|3|||
145381336|NCT02603107|524246944|FG001|Optional Extension Phase|Lost to Follow-up|3|||
145381337|NCT02603107|524246943|FG000|Optional Extension Phase|Withdrew consent|3|||
145381338|NCT02603107|524246944|FG001|Optional Extension Phase|Withdrew consent|2|||
145381339|NCT02603107|524246943|FG000|Optional Extension Phase|Investigator's discretion|2|||
145381340|NCT02603107|524246944|FG001|Optional Extension Phase|Investigator's discretion|2|||
145381341|NCT02603107|524246943|FG000|Optional Extension Phase|Pregnancy|0|||
145381342|NCT02603107|524246944|FG001|Optional Extension Phase|Pregnancy|3|||
145381343|NCT02603107|524246943|FG000|Optional Extension Phase|Adverse Event|0|||
145381344|NCT02603107|524246944|FG001|Optional Extension Phase|Adverse Event|2|||
145381345|NCT02603107|524246943|FG000|Optional Extension Phase|Not treated in extension phase|0|||
145719183|NCT01097707|525486644|FG004|Overall Study|Reason unknown|1|||
145719184|NCT01236534|525486647|FG000|Overall Study|Adverse Event|3|||
145719185|NCT01236534|525486648|FG001|Overall Study|Adverse Event|0|||
145719186|NCT03606668|525486649|FG000|Overall Study|Screen Failure|1|||
145719187|NCT03606668|525486649|FG000|Overall Study|Lost to Follow-up|1|||
145719188|NCT01014143|525486656|FG000|Second Intervention|Lost to Follow-up|2|||
145719189|NCT01014143|525486657|FG001|Second Intervention|Lost to Follow-up|0|||
145719190|NCT01014143|525486658|FG002|Second Intervention|Lost to Follow-up|0|||
145719191|NCT01801735|525486663|FG000|Overall Study|Adverse Event|79|||
145719192|NCT01801735|525486663|FG000|Overall Study|Lack of Efficacy|28|||
145719193|NCT01801735|525486663|FG000|Overall Study|Withdrawal by Subject|27|||
145719194|NCT01801735|525486663|FG000|Overall Study|Protocol Violation|25|||
145719195|NCT01801735|525486663|FG000|Overall Study|Lost to Follow-up|15|||
145719196|NCT01801735|525486663|FG000|Overall Study|Non-compliance with Trial Drug|13|||
145719197|NCT01801735|525486663|FG000|Overall Study|Physician Decision|3|||
145381346|NCT02603107|524246944|FG001|Optional Extension Phase|Not treated in extension phase|1|||
145381347|NCT02603107|524246943|FG000|Optional Extension Phase|Protocol Violation|1|||
145381348|NCT02603107|524246944|FG001|Optional Extension Phase|Protocol Violation|0|||
145381349|NCT00187278|524246951|FG000|Overall Study|Protocol Violation|10|||
145381350|NCT00187278|524246952|FG001|Overall Study|Protocol Violation|13|||
145381351|NCT01857102|524246953|FG000|Period 1|No longer meets Eligibility Criteria|0|||
145381352|NCT01857102|524246954|FG001|Period 1|No longer meets Eligibility Criteria|2|||
145381353|NCT01857102|524246953|FG000|Period 1|Lost to Follow-up|0|||
145381354|NCT01857102|524246954|FG001|Period 1|Lost to Follow-up|3|||
145381355|NCT01857102|524246953|FG000|Period 1|Unsatisfactory Lens Fit|1|||
145381356|NCT01857102|524246954|FG001|Period 1|Unsatisfactory Lens Fit|0|||
145381357|NCT01857102|524246953|FG000|Period 1|Unsatisfactory Visual Response|1|||
145381358|NCT01857102|524246954|FG001|Period 1|Unsatisfactory Visual Response|0|||
145381359|NCT01857102|524246953|FG000|Period 1|Physician Decision|1|||
145719198|NCT01801735|525486663|FG000|Overall Study|Death|1|||
145719199|NCT01801735|525486663|FG000|Overall Study|Other, including site closure|19|||
145719200|NCT00938860|525486664|FG000|Overall Study|Adverse Event|2|||
145719201|NCT00938860|525486665|FG001|Overall Study|Adverse Event|1|||
145719202|NCT00938860|525486664|FG000|Overall Study|Abnormal laboratory values|2|||
145719203|NCT00938860|525486665|FG001|Overall Study|Abnormal laboratory values|2|||
145719204|NCT00938860|525486664|FG000|Overall Study|Withdrawal by Subject|11|||
145719205|NCT00938860|525486665|FG001|Overall Study|Withdrawal by Subject|8|||
145719206|NCT00938860|525486664|FG000|Overall Study|Lost to Follow-up|4|||
145719207|NCT00938860|525486665|FG001|Overall Study|Lost to Follow-up|4|||
145719208|NCT00938860|525486664|FG000|Overall Study|Administration problems|2|||
145719209|NCT00938860|525486665|FG001|Overall Study|Administration problems|0|||
145719210|NCT00938860|525486664|FG000|Overall Study|Death|1|||
145719211|NCT00938860|525486665|FG001|Overall Study|Death|1|||
145719212|NCT00938860|525486664|FG000|Overall Study|Protocol Violation|3|||
145719213|NCT00938860|525486665|FG001|Overall Study|Protocol Violation|1|||
145719214|NCT01605019|525486666|FG000|Overall Study|pt did not meet transplant endpoint|3|||
145719215|NCT01605019|525486667|FG001|Overall Study|pt did not meet transplant endpoint|0|||
145719216|NCT00468559|525486668|FG000|Open-label Treatment Phase|Adverse Event|5|||
145719217|NCT00468559|525486669|FG001|Open-label Treatment Phase|Adverse Event|0|||
145719218|NCT00468559|525486670|FG002|Open-label Treatment Phase|Adverse Event|0|||
145719219|NCT00468559|525486668|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
145719220|NCT00468559|525486669|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
145719221|NCT00468559|525486670|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
145719222|NCT00468559|525486668|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
145719223|NCT00468559|525486669|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
145719224|NCT00468559|525486670|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
145719225|NCT00468559|525486668|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
145719226|NCT00468559|525486669|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
145381360|NCT01857102|524246954|FG001|Period 1|Physician Decision|0|||
145381361|NCT01857102|524246953|FG000|Period 2|Lens Discomfort|1|||
145381362|NCT01857102|524246954|FG001|Period 2|Lens Discomfort|0|||
145381363|NCT01857102|524246953|FG000|Period 2|Unsatisfactory Lens Fit|1|||
145381364|NCT01857102|524246954|FG001|Period 2|Unsatisfactory Lens Fit|0|||
145381365|NCT00090584|524246960|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
145381366|NCT00090584|524246961|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
145381367|NCT00090584|524246960|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
145381368|NCT00090584|524246961|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
145381369|NCT02920177|524246963|FG000|Overall Study|Withdrawal by Subject|1|||
145381370|NCT02920177|524246964|FG001|Overall Study|Withdrawal by Subject|1|||
145381371|NCT02920177|524246963|FG000|Overall Study|Physician Decision|1|||
145381372|NCT02920177|524246964|FG001|Overall Study|Physician Decision|0|||
145381373|NCT02920177|524246963|FG000|Overall Study|Lost to Follow-up|0|||
145381374|NCT02920177|524246964|FG001|Overall Study|Lost to Follow-up|1|||
145381375|NCT02054910|524246965|FG000|Overall Study|Lost to Follow-up|4|||
145381376|NCT02054910|524246966|FG001|Overall Study|Lost to Follow-up|1|||
145381377|NCT03053427|524246967|FG000|Overall Study|Adverse Event|4|||
145381378|NCT03053427|524246968|FG001|Overall Study|Adverse Event|4|||
145381379|NCT03053427|524246967|FG000|Overall Study|Lack of Efficacy|1|||
145381380|NCT03053427|524246968|FG001|Overall Study|Lack of Efficacy|3|||
145381381|NCT03053427|524246967|FG000|Overall Study|Lost to Follow-up|2|||
145381382|NCT03053427|524246968|FG001|Overall Study|Lost to Follow-up|2|||
145381383|NCT03053427|524246967|FG000|Overall Study|Worsening of the target disease|0|||
145381384|NCT03053427|524246968|FG001|Overall Study|Worsening of the target disease|1|||
145381385|NCT03053427|524246967|FG000|Overall Study|Protocol Deviation|3|||
145381386|NCT03053427|524246968|FG001|Overall Study|Protocol Deviation|3|||
145381387|NCT03053427|524246967|FG000|Overall Study|Withdrawal by Subject|3|||
145719227|NCT00468559|525486670|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
145381388|NCT03053427|524246968|FG001|Overall Study|Withdrawal by Subject|2|||
145381389|NCT03053427|524246967|FG000|Overall Study|Miscellaneous|0|||
145381390|NCT03053427|524246968|FG001|Overall Study|Miscellaneous|1|||
145381391|NCT01324570|524246976|FG000|Overall Study|Adverse Event|4|||
145719228|NCT00468559|525486668|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
145719229|NCT00468559|525486669|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
145719230|NCT00468559|525486670|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
145719231|NCT00324116|525486671|FG000|Overall Study|Adverse Event|5|||
145719232|NCT00324116|525486671|FG000|Overall Study|Lack of Efficacy|17|||
145719233|NCT00324116|525486671|FG000|Overall Study|Withdrawal by Subject|5|||
145719234|NCT00324116|525486671|FG000|Overall Study|Other|5|||
145719235|NCT01153958|525486672|FG000|Overall Study|Study Terminated|36|||
145719236|NCT01153958|525486673|FG001|Overall Study|Study Terminated|32|||
145719237|NCT02971761|525486675|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
145719238|NCT02624791|525486676|FG000|Overall Study|Withdrawal by Subject|2|||
145719239|NCT02624791|525486677|FG001|Overall Study|Withdrawal by Subject|0|||
145719240|NCT02624791|525486678|FG002|Overall Study|Withdrawal by Subject|0|||
145719241|NCT02624791|525486679|FG003|Overall Study|Withdrawal by Subject|0|||
145719242|NCT02624791|525486680|FG004|Overall Study|Withdrawal by Subject|0|||
145719243|NCT02624791|525486681|FG005|Overall Study|Withdrawal by Subject|0|||
145719244|NCT01034163|525486682|FG000|Overall Study|Treatment completed as per protocol|8|||
145719245|NCT01034163|525486683|FG001|Overall Study|Treatment completed as per protocol|7|||
145719246|NCT01034163|525486682|FG000|Overall Study|Withdrawal by Subject|8|||
145719247|NCT01034163|525486683|FG001|Overall Study|Withdrawal by Subject|2|||
145719248|NCT01034163|525486682|FG000|Overall Study|Protocol deviation|1|||
145719249|NCT01034163|525486683|FG001|Overall Study|Protocol deviation|0|||
145719250|NCT01034163|525486682|FG000|Overall Study|Disease progression|3|||
145719251|NCT01034163|525486683|FG001|Overall Study|Disease progression|4|||
145719252|NCT01034163|525486682|FG000|Overall Study|Adverse Event|6|||
145381392|NCT01324570|524246977|FG001|Overall Study|Adverse Event|7|||
145381393|NCT01324570|524246976|FG000|Overall Study|Withdrawal by Subject|0|||
145381394|NCT01324570|524246977|FG001|Overall Study|Withdrawal by Subject|3|||
145381395|NCT01324570|524246976|FG000|Overall Study|Lack of Efficacy|0|||
145381396|NCT01324570|524246977|FG001|Overall Study|Lack of Efficacy|1|||
145381397|NCT01324570|524246976|FG000|Overall Study|Confirmed or suspected diversion|0|||
145381398|NCT01324570|524246977|FG001|Overall Study|Confirmed or suspected diversion|1|||
145381399|NCT01324570|524246976|FG000|Overall Study|Administrative|0|||
145381400|NCT01324570|524246977|FG001|Overall Study|Administrative|2|||
145381401|NCT00207727|524246982|FG000|Overall Study|Withdrawal by Subject|0|||
145381402|NCT00207727|524246983|FG001|Overall Study|Withdrawal by Subject|0|||
145381403|NCT00207727|524246984|FG002|Overall Study|Withdrawal by Subject|0|||
145381404|NCT00207727|524246985|FG003|Overall Study|Withdrawal by Subject|0|||
145381405|NCT00207727|524246986|FG004|Overall Study|Withdrawal by Subject|1|||
145381406|NCT00207727|524246982|FG000|Overall Study|Lost to Follow-up|0|||
145381407|NCT00207727|524246983|FG001|Overall Study|Lost to Follow-up|1|||
145381408|NCT00207727|524246984|FG002|Overall Study|Lost to Follow-up|0|||
145381409|NCT00207727|524246985|FG003|Overall Study|Lost to Follow-up|0|||
145381410|NCT00207727|524246986|FG004|Overall Study|Lost to Follow-up|0|||
145381411|NCT00207727|524246982|FG000|Overall Study|Other|38|||
145381412|NCT00207727|524246983|FG001|Overall Study|Other|41|||
145381413|NCT00207727|524246984|FG002|Overall Study|Other|41|||
145381414|NCT00207727|524246985|FG003|Overall Study|Other|37|||
145381415|NCT00207727|524246986|FG004|Overall Study|Other|33|||
145381416|NCT00539032|524246990|FG000|Overall Study|Withdrawal by Subject|2|||
145381417|NCT00539032|524246991|FG001|Overall Study|Withdrawal by Subject|1|||
145381418|NCT04683939|524246998|FG000|Overall Study|Study termination by the sponsor|0|||
145381419|NCT04683939|524246999|FG001|Overall Study|Study termination by the sponsor|1|||
145381420|NCT04683939|524247000|FG002|Overall Study|Study termination by the sponsor|2|||
145381421|NCT04683939|524247001|FG003|Overall Study|Study termination by the sponsor|2|||
145381422|NCT04683939|524246998|FG000|Overall Study|Death|1|||
145381423|NCT04683939|524246999|FG001|Overall Study|Death|1|||
145381424|NCT04683939|524247000|FG002|Overall Study|Death|2|||
145381425|NCT04683939|524247001|FG003|Overall Study|Death|1|||
145381426|NCT04683939|524246998|FG000|Overall Study|Withdrawal by Subject|1|||
145381427|NCT04683939|524246999|FG001|Overall Study|Withdrawal by Subject|0|||
145381428|NCT04683939|524247000|FG002|Overall Study|Withdrawal by Subject|0|||
145381429|NCT04683939|524247001|FG003|Overall Study|Withdrawal by Subject|0|||
145381430|NCT04683939|524246998|FG000|Overall Study|Physician Decision|1|||
145381431|NCT04683939|524246999|FG001|Overall Study|Physician Decision|0|||
145381432|NCT04683939|524247000|FG002|Overall Study|Physician Decision|0|||
145381433|NCT04683939|524247001|FG003|Overall Study|Physician Decision|0|||
145381434|NCT04683939|524246998|FG000|Overall Study|Lost to Follow-up|0|||
145719253|NCT01034163|525486683|FG001|Overall Study|Adverse Event|0|||
145381435|NCT04683939|524246999|FG001|Overall Study|Lost to Follow-up|1|||
145381436|NCT04683939|524247000|FG002|Overall Study|Lost to Follow-up|0|||
145381437|NCT04683939|524247001|FG003|Overall Study|Lost to Follow-up|0|||
145381438|NCT02227368|524248491|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
145381439|NCT02227368|524248492|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
145719254|NCT01034163|525486682|FG000|Overall Study|Administrative problems|0|||
145719255|NCT01034163|525486683|FG001|Overall Study|Administrative problems|1|||
145719256|NCT01034163|525486682|FG000|Overall Study|Abnormal laboratory value|1|||
145381440|NCT02227368|524248491|FG000|Overall Study|Lost to Follow-up|1|||
145381441|NCT02227368|524248492|FG001|Overall Study|Lost to Follow-up|0|||
145381442|NCT02227368|524248491|FG000|Overall Study|Adverse Event|1|||
145381443|NCT02227368|524248492|FG001|Overall Study|Adverse Event|0|||
145381444|NCT02510820|524248496|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145381445|NCT02510820|524248497|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145381446|NCT02510820|524248496|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145381447|NCT02510820|524248497|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145381448|NCT03046056|524248498|FG000|Overall Study|Non-responder at Week 10|6|||
145381449|NCT03046056|524248499|FG001|Overall Study|Non-responder at Week 10|6|||
145719257|NCT01034163|525486683|FG001|Overall Study|Abnormal laboratory value|0|||
145719258|NCT01642251|525486684|FG000|Overall Study|Progressive disease|0|||
145719259|NCT01642251|525486685|FG001|Overall Study|Progressive disease|0|||
145719260|NCT01642251|525486686|FG002|Overall Study|Progressive disease|3|||
145719261|NCT01642251|525486687|FG003|Overall Study|Progressive disease|3|||
145719262|NCT01642251|525486684|FG000|Overall Study|Adverse Event|0|||
145719263|NCT01642251|525486685|FG001|Overall Study|Adverse Event|0|||
145719264|NCT01642251|525486686|FG002|Overall Study|Adverse Event|5|||
145719265|NCT01642251|525486687|FG003|Overall Study|Adverse Event|4|||
145719266|NCT01642251|525486684|FG000|Overall Study|Death|0|||
145719267|NCT01642251|525486685|FG001|Overall Study|Death|0|||
145719268|NCT01642251|525486686|FG002|Overall Study|Death|1|||
145719269|NCT01642251|525486687|FG003|Overall Study|Death|3|||
145719270|NCT01642251|525486684|FG000|Overall Study|Withdrawal by Subject|0|||
145719271|NCT01642251|525486685|FG001|Overall Study|Withdrawal by Subject|0|||
145719272|NCT01642251|525486686|FG002|Overall Study|Withdrawal by Subject|1|||
145719273|NCT01642251|525486687|FG003|Overall Study|Withdrawal by Subject|3|||
145719274|NCT01642251|525486684|FG000|Overall Study|Alternative therapy|0|||
145381450|NCT03046056|524248500|FG002|Overall Study|Non-responder at Week 10|4|||
145381451|NCT03046056|524248498|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
145381452|NCT03046056|524248499|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
145381453|NCT03046056|524248500|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
145381454|NCT03046056|524248498|FG000|Overall Study|Adverse Event|1|||
145381455|NCT03046056|524248499|FG001|Overall Study|Adverse Event|5|||
145381456|NCT03046056|524248500|FG002|Overall Study|Adverse Event|0|||
145381457|NCT03046056|524248498|FG000|Overall Study|Non-compliance With Study Drug|0|||
145381458|NCT03046056|524248499|FG001|Overall Study|Non-compliance With Study Drug|0|||
145381459|NCT03046056|524248500|FG002|Overall Study|Non-compliance With Study Drug|2|||
145381460|NCT03046056|524248498|FG000|Overall Study|Protocol Violation|1|||
145381461|NCT03046056|524248499|FG001|Overall Study|Protocol Violation|1|||
145719275|NCT01642251|525486685|FG001|Overall Study|Alternative therapy|0|||
145719276|NCT01642251|525486686|FG002|Overall Study|Alternative therapy|0|||
145719277|NCT01642251|525486687|FG003|Overall Study|Alternative therapy|2|||
145719278|NCT01642251|525486684|FG000|Overall Study|Other complicating disease|0|||
145719279|NCT01642251|525486685|FG001|Overall Study|Other complicating disease|0|||
145719280|NCT01642251|525486686|FG002|Overall Study|Other complicating disease|1|||
145719281|NCT01642251|525486687|FG003|Overall Study|Other complicating disease|0|||
145381462|NCT03046056|524248500|FG002|Overall Study|Protocol Violation|0|||
145381463|NCT03046056|524248498|FG000|Overall Study|Investigator's Discretion|0|||
145381464|NCT03046056|524248499|FG001|Overall Study|Investigator's Discretion|1|||
145381465|NCT03046056|524248500|FG002|Overall Study|Investigator's Discretion|0|||
145381466|NCT03046056|524248498|FG000|Overall Study|Withdrew Consent|1|||
145381467|NCT03046056|524248499|FG001|Overall Study|Withdrew Consent|0|||
145381468|NCT03046056|524248500|FG002|Overall Study|Withdrew Consent|0|||
145381469|NCT02913105|524248501|FG000|Overall Study|Adverse Event|11|||
145381470|NCT02913105|524248502|FG001|Overall Study|Adverse Event|0|||
145381471|NCT02913105|524248503|FG002|Overall Study|Adverse Event|4|||
145381472|NCT02913105|524248501|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145381473|NCT02913105|524248502|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145381474|NCT02913105|524248503|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145381475|NCT02913105|524248501|FG000|Overall Study|Reason Not Specified|3|||
145381476|NCT02913105|524248502|FG001|Overall Study|Reason Not Specified|1|||
145381477|NCT02913105|524248503|FG002|Overall Study|Reason Not Specified|1|||
145381478|NCT02913105|524248501|FG000|Overall Study|Physician Decision|1|||
145381479|NCT02913105|524248502|FG001|Overall Study|Physician Decision|1|||
145381480|NCT02913105|524248503|FG002|Overall Study|Physician Decision|0|||
145381481|NCT02913105|524248501|FG000|Overall Study|Withdrawal by Subject|0|||
145381482|NCT02913105|524248502|FG001|Overall Study|Withdrawal by Subject|3|||
145381483|NCT02913105|524248503|FG002|Overall Study|Withdrawal by Subject|1|||
145381484|NCT01317004|524248504|FG000|Overall Study|Withdrawal by Subject|1|||
145381485|NCT01317004|524248505|FG001|Overall Study|Withdrawal by Subject|4|||
145719282|NCT01642251|525486684|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
145719283|NCT01642251|525486685|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
145719284|NCT01642251|525486686|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
145719285|NCT01642251|525486687|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
145381486|NCT01317004|524248504|FG000|Overall Study|Protocol Violation|0|||
145492041|NCT03346434|524656946|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
145381487|NCT01317004|524248505|FG001|Overall Study|Protocol Violation|2|||
145381488|NCT01317004|524248504|FG000|Overall Study|Adverse Event|3|||
145381489|NCT01317004|524248505|FG001|Overall Study|Adverse Event|3|||
145381490|NCT04114656|524248508|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
145381491|NCT04114656|524248509|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
145381492|NCT04114656|524248508|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
145381493|NCT04114656|524248509|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
145381494|NCT04114656|524248508|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
145381495|NCT04114656|524248509|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
145381496|NCT04114656|524248508|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
145381497|NCT04114656|524248509|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
145381498|NCT04114656|524248508|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
145381499|NCT04114656|524248509|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
145381500|NCT01980628|524248512|FG000|Overall Study|Adverse Event|12|||
145381501|NCT01980628|524248512|FG000|Overall Study|Physician Decision|5|||
145381502|NCT01980628|524248512|FG000|Overall Study|Withdrawal by Subject|4|||
145381503|NCT01980628|524248512|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
145381504|NCT02578940|524248513|FG000|Overall Study|Screening failure|5|||
145381505|NCT02578940|524248513|FG000|Overall Study|Lost to Follow-up|1|||
145381506|NCT01937715|524248522|FG000|Overall Study|Death|0|||
145381507|NCT01937715|524248523|FG001|Overall Study|Death|0|||
145381508|NCT01937715|524248524|FG002|Overall Study|Death|0|||
145381509|NCT01937715|524248525|FG003|Overall Study|Death|1|||
145381510|NCT01937715|524248526|FG004|Overall Study|Death|0|||
145381511|NCT01937715|524248522|FG000|Overall Study|Withdrawal by Subject|0|||
145381512|NCT01937715|524248523|FG001|Overall Study|Withdrawal by Subject|1|||
145381513|NCT01937715|524248524|FG002|Overall Study|Withdrawal by Subject|0|||
145381514|NCT01937715|524248525|FG003|Overall Study|Withdrawal by Subject|0|||
145381515|NCT01937715|524248526|FG004|Overall Study|Withdrawal by Subject|2|||
145381516|NCT01937715|524248522|FG000|Overall Study|Other|0|||
145381517|NCT01937715|524248523|FG001|Overall Study|Other|0|||
145381518|NCT01937715|524248524|FG002|Overall Study|Other|0|||
145381519|NCT01937715|524248525|FG003|Overall Study|Other|3|||
145381520|NCT01937715|524248526|FG004|Overall Study|Other|0|||
145381521|NCT01698268|524248529|FG000|Overall Study|Physician Decision|2|||
145381522|NCT01698268|524248530|FG001|Overall Study|Physician Decision|1|||
145381523|NCT02469168|524248532|FG000|Overall Study|Trial closed|1|||
145381524|NCT02469168|524248533|FG001|Overall Study|Trial closed|0|||
145381525|NCT00135356|524248534|FG000|Overall Study|Adverse Event|6|||
145381526|NCT00135356|524248535|FG001|Overall Study|Adverse Event|2|||
145381527|NCT00135356|524248534|FG000|Overall Study|Lack of Efficacy|2|||
145381528|NCT00135356|524248535|FG001|Overall Study|Lack of Efficacy|0|||
145381529|NCT00135356|524248534|FG000|Overall Study|Lost to Follow-up|3|||
145381530|NCT00135356|524248535|FG001|Overall Study|Lost to Follow-up|1|||
145616791|NCT01254565|525111336|FG005|Overall Study|Other|0|||
145616792|NCT02726399|525111337|FG000|Overall Study|Participant Non-Compliance|1|||
145616793|NCT02726399|525111337|FG000|Overall Study|Adverse Event|2|||
145616794|NCT02726399|525111337|FG000|Overall Study|Progression of disease|4|||
145616795|NCT04747275|525111338|FG000|Overall Study|Study terminated|0|||
145616796|NCT04747275|525111339|FG001|Overall Study|Study terminated|1|||
145616797|NCT00531011|525111342|FG000|Overall Study|Withdrawal by Subject|2|||
145616798|NCT00531011|525111343|FG001|Overall Study|Withdrawal by Subject|4|||
145616799|NCT00531011|525111342|FG000|Overall Study|Death|1|||
145616800|NCT00531011|525111343|FG001|Overall Study|Death|0|||
145616801|NCT00531011|525111342|FG000|Overall Study|Lost to Follow-up|1|||
145616802|NCT00531011|525111343|FG001|Overall Study|Lost to Follow-up|0|||
145616803|NCT00531011|525111342|FG000|Overall Study|Physician Decision|0|||
145616804|NCT00531011|525111343|FG001|Overall Study|Physician Decision|3|||
145616805|NCT03268590|525111344|FG000|Overall Study|Previously unknown exclusion criteria|1|||
145616806|NCT02206152|525111347|FG000|Pre-Randomization|Withdrawal by Subject|2|||
145616807|NCT00794820|525111351|FG000|Overall Study|Adverse Event|11|||
145616808|NCT00794820|525111351|FG000|Overall Study|Secondary Malignancies|2|||
145616809|NCT00794820|525111351|FG000|Overall Study|Resistant Disease|2|||
145616810|NCT00794820|525111351|FG000|Overall Study|Ineligible/Screen Failure|1|||
145616811|NCT04076020|525111353|FG000|Overall Study|Death|4|||
145616812|NCT04076020|525111354|FG001|Overall Study|Death|6|||
145616813|NCT04076020|525111353|FG000|Overall Study|Withdrawal by Subject|12|||
145616814|NCT04076020|525111354|FG001|Overall Study|Withdrawal by Subject|8|||
145616815|NCT02406261|525111356|FG000|Period 1|Lost to Follow-up|2|||
145616816|NCT02406261|525111357|FG001|Period 1|Lost to Follow-up|0|||
145616817|NCT02406261|525111356|FG000|Period 1|Adverse Event|1|||
145616818|NCT02406261|525111357|FG001|Period 1|Adverse Event|0|||
145616819|NCT02406261|525111356|FG000|Period 2|Physician Decision|0|||
145616820|NCT02406261|525111357|FG001|Period 2|Physician Decision|1|||
145381531|NCT00135356|524248534|FG000|Overall Study|Surgery for abdominal fat|1|||
145381532|NCT00135356|524248535|FG001|Overall Study|Surgery for abdominal fat|0|||
145381533|NCT00135356|524248534|FG000|Overall Study|Change in antiviral regimen|0|||
145381534|NCT00135356|524248535|FG001|Overall Study|Change in antiviral regimen|1|||
145492042|NCT03346434|524656947|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
145492043|NCT03346434|524656948|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
145492044|NCT04416204|524656952|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
145492045|NCT04416204|524656953|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
145492046|NCT04416204|524656954|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
145492047|NCT04416204|524656955|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
145492048|NCT00812708|524656956|FG000|Overall Study|Device could not be implanted|2|||
145492049|NCT00812708|524656956|FG000|Overall Study|Lack of medical insurance|1|||
145492050|NCT00812708|524656956|FG000|Overall Study|Switched to another study|1|||
145492051|NCT00812708|524656956|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
145492052|NCT00812708|524656956|FG000|Overall Study|Signed consent but later withdrew|3|||
145492053|NCT02587520|524656960|FG000|Overall Study|Protocol Violation|2|||
145492054|NCT02587520|524656961|FG001|Overall Study|Protocol Violation|0|||
145492055|NCT02587520|524656962|FG002|Overall Study|Protocol Violation|0|||
145492056|NCT02587520|524656963|FG003|Overall Study|Protocol Violation|2|||
145492057|NCT02587520|524656964|FG004|Overall Study|Protocol Violation|0|||
145492058|NCT02587520|524656965|FG005|Overall Study|Protocol Violation|1|||
145492059|NCT02587520|524656966|FG006|Overall Study|Protocol Violation|1|||
145492060|NCT02587520|524656967|FG007|Overall Study|Protocol Violation|1|||
145492061|NCT02587520|524656968|FG008|Overall Study|Protocol Violation|3|||
145492062|NCT02587520|524656969|FG009|Overall Study|Protocol Violation|3|||
145492063|NCT02587520|524656970|FG010|Overall Study|Protocol Violation|1|||
145492064|NCT02587520|524656971|FG011|Overall Study|Protocol Violation|2|||
145492065|NCT02587520|524656972|FG012|Overall Study|Protocol Violation|0|||
145381535|NCT00135356|524248534|FG000|Overall Study|Poor/noncompliance|1|||
145381536|NCT00135356|524248535|FG001|Overall Study|Poor/noncompliance|1|||
145381537|NCT00135356|524248534|FG000|Overall Study|No longer meets study criteria|2|||
145381538|NCT00135356|524248535|FG001|Overall Study|No longer meets study criteria|0|||
145381539|NCT00135356|524248534|FG000|Overall Study|Withdrawal by Subject|2|||
145381540|NCT00135356|524248535|FG001|Overall Study|Withdrawal by Subject|4|||
145381541|NCT02263729|524248536|FG000|Overall Study|Lost to Follow-up|1|||
145381542|NCT02263729|524248537|FG001|Overall Study|Lost to Follow-up|1|||
145492066|NCT02587520|524656973|FG013|Overall Study|Protocol Violation|0|||
145492067|NCT02587520|524656974|FG014|Overall Study|Protocol Violation|0|||
145492068|NCT02587520|524656975|FG015|Overall Study|Protocol Violation|0|||
145492069|NCT02587520|524656976|FG016|Overall Study|Protocol Violation|0|||
145492070|NCT02587520|524656977|FG017|Overall Study|Protocol Violation|0|||
145492071|NCT02587520|524656960|FG000|Overall Study|Adverse Event|0|||
145492072|NCT02587520|524656961|FG001|Overall Study|Adverse Event|0|||
145492073|NCT02587520|524656962|FG002|Overall Study|Adverse Event|0|||
145492074|NCT02587520|524656963|FG003|Overall Study|Adverse Event|0|||
145492075|NCT02587520|524656964|FG004|Overall Study|Adverse Event|0|||
145492076|NCT02587520|524656965|FG005|Overall Study|Adverse Event|0|||
145492077|NCT02587520|524656966|FG006|Overall Study|Adverse Event|0|||
145492078|NCT02587520|524656967|FG007|Overall Study|Adverse Event|0|||
145492079|NCT02587520|524656968|FG008|Overall Study|Adverse Event|0|||
145492080|NCT02587520|524656969|FG009|Overall Study|Adverse Event|0|||
145492081|NCT02587520|524656970|FG010|Overall Study|Adverse Event|0|||
145492082|NCT02587520|524656971|FG011|Overall Study|Adverse Event|1|||
145492083|NCT02587520|524656972|FG012|Overall Study|Adverse Event|0|||
145492084|NCT02587520|524656973|FG013|Overall Study|Adverse Event|0|||
145492085|NCT02587520|524656974|FG014|Overall Study|Adverse Event|0|||
145492086|NCT02587520|524656975|FG015|Overall Study|Adverse Event|0|||
145492087|NCT02587520|524656976|FG016|Overall Study|Adverse Event|0|||
145492088|NCT02587520|524656977|FG017|Overall Study|Adverse Event|0|||
145492089|NCT02587520|524656960|FG000|Overall Study|Withdrawal by Subject|0|||
145492090|NCT02587520|524656961|FG001|Overall Study|Withdrawal by Subject|0|||
145492091|NCT02587520|524656962|FG002|Overall Study|Withdrawal by Subject|1|||
145492092|NCT02587520|524656963|FG003|Overall Study|Withdrawal by Subject|1|||
145492093|NCT02587520|524656964|FG004|Overall Study|Withdrawal by Subject|0|||
145492094|NCT02587520|524656965|FG005|Overall Study|Withdrawal by Subject|1|||
145492095|NCT02587520|524656966|FG006|Overall Study|Withdrawal by Subject|1|||
145492096|NCT02587520|524656967|FG007|Overall Study|Withdrawal by Subject|0|||
145492097|NCT02587520|524656968|FG008|Overall Study|Withdrawal by Subject|0|||
145492098|NCT02587520|524656969|FG009|Overall Study|Withdrawal by Subject|0|||
145492099|NCT02587520|524656970|FG010|Overall Study|Withdrawal by Subject|0|||
145492100|NCT02587520|524656971|FG011|Overall Study|Withdrawal by Subject|0|||
145492101|NCT02587520|524656972|FG012|Overall Study|Withdrawal by Subject|0|||
145492102|NCT02587520|524656973|FG013|Overall Study|Withdrawal by Subject|1|||
145492103|NCT02587520|524656974|FG014|Overall Study|Withdrawal by Subject|0|||
145492104|NCT02587520|524656975|FG015|Overall Study|Withdrawal by Subject|0|||
145492105|NCT02587520|524656976|FG016|Overall Study|Withdrawal by Subject|0|||
145492106|NCT02587520|524656977|FG017|Overall Study|Withdrawal by Subject|0|||
145719286|NCT02414932|525486689|FG000|Overall Study|Withdrawal by Subject|2|||
145719287|NCT02414932|525486690|FG001|Overall Study|Withdrawal by Subject|3|||
145719288|NCT02414932|525486689|FG000|Overall Study|Adverse Event|1|||
145719289|NCT02414932|525486690|FG001|Overall Study|Adverse Event|0|||
145719290|NCT02996474|525486691|FG000|Overall Study|Physician Decision|5|||
145719291|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
145719292|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
145719293|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
145719294|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
145719295|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
145719296|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
145719297|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
145719298|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
145719299|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
145719300|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
145719301|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
145719302|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
145719303|NCT04493502|525486692|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
145719304|NCT04493502|525486693|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
145719305|NCT04493502|525486692|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
145719306|NCT04493502|525486693|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
145719307|NCT04493502|525486692|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
145719308|NCT04493502|525486693|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
145719309|NCT04493502|525486692|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
145719310|NCT04493502|525486693|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
145719311|NCT04493502|525486692|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
145719312|NCT04493502|525486693|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
145719313|NCT04493502|525486692|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
145719314|NCT04493502|525486693|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
145719315|NCT04493502|525486692|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
145719316|NCT04493502|525486693|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
145719317|NCT00540046|525486694|FG000|Overall Study|Lost to Follow-up|33|||
145719318|NCT00540046|525486695|FG001|Overall Study|Lost to Follow-up|23|||
145719319|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
145719320|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
145719321|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
145719322|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
145719323|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
145719324|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
145719325|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
145719326|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
145719327|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
145719328|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
145719329|NCT01237587|525486697|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
145719330|NCT01237587|525486698|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
145719331|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
145719332|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
145719333|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
145719334|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
145719335|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
145719336|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
145719337|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
145719338|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
145719339|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
145719340|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
145719341|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
145719342|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
145719343|NCT01237587|525486697|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
145719344|NCT01237587|525486698|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
145719345|NCT01237587|525486697|FG000|Taper Phase|Adverse Event|0|||
145719346|NCT01237587|525486698|FG001|Taper Phase|Adverse Event|2|||
145719347|NCT01237587|525486697|FG000|Taper Phase|Protocol Violation|2|||
145719348|NCT01237587|525486698|FG001|Taper Phase|Protocol Violation|0|||
145719349|NCT01237587|525486697|FG000|Taper Phase|Lack of Efficacy|2|||
145719350|NCT01237587|525486698|FG001|Taper Phase|Lack of Efficacy|5|||
145719351|NCT01237587|525486697|FG000|Taper Phase|Parent/Guardian Decision|0|||
145719352|NCT01237587|525486698|FG001|Taper Phase|Parent/Guardian Decision|2|||
145719353|NCT01237587|525486697|FG000|Taper Phase|Sponsor Decision|1|||
145719354|NCT01237587|525486698|FG001|Taper Phase|Sponsor Decision|0|||
145719355|NCT01237587|525486697|FG000|Taper Phase|Withdrawal by Subject|0|||
145719356|NCT01237587|525486698|FG001|Taper Phase|Withdrawal by Subject|1|||
145719357|NCT02533531|525486699|FG000|Overall Study|Device did not turn on|1|||
145719358|NCT02047903|525486700|FG000|Overall Study|Adverse Event|14|||
145719359|NCT02047903|525486700|FG000|Overall Study|Serious adverse event|10|||
145719360|NCT02047903|525486700|FG000|Overall Study|Withdrawal by Subject|16|||
145719361|NCT02047903|525486700|FG000|Overall Study|Lost to Follow-up|4|||
145719362|NCT02047903|525486700|FG000|Overall Study|Reason not listed|6|||
145719363|NCT02047903|525486700|FG000|Overall Study|Not Treated|9|||
145719364|NCT01226095|525486703|FG000|Overall Study|Poor compliance|1|||
145719365|NCT01688830|525486704|FG000|Overall Study|Lost to Follow-up|0|||
145719366|NCT01688830|525486705|FG001|Overall Study|Lost to Follow-up|0|||
145719367|NCT01688830|525486706|FG002|Overall Study|Lost to Follow-up|0|||
145719368|NCT01688830|525486707|FG003|Overall Study|Lost to Follow-up|0|||
145719369|NCT01688830|525486708|FG004|Overall Study|Lost to Follow-up|0|||
145719370|NCT01688830|525486709|FG005|Overall Study|Lost to Follow-up|0|||
145719371|NCT01688830|525486710|FG006|Overall Study|Lost to Follow-up|0|||
145719372|NCT01688830|525486711|FG007|Overall Study|Lost to Follow-up|0|||
145719373|NCT01688830|525486712|FG008|Overall Study|Lost to Follow-up|0|||
145719374|NCT01688830|525486713|FG009|Overall Study|Lost to Follow-up|0|||
145719375|NCT01688830|525486714|FG010|Overall Study|Lost to Follow-up|1|||
145719376|NCT01688830|525486715|FG011|Overall Study|Lost to Follow-up|0|||
145719377|NCT01688830|525486716|FG012|Overall Study|Lost to Follow-up|0|||
145719378|NCT01688830|525486717|FG013|Overall Study|Lost to Follow-up|0|||
145719379|NCT01688830|525486718|FG014|Overall Study|Lost to Follow-up|0|||
145719380|NCT01688830|525486719|FG015|Overall Study|Lost to Follow-up|0|||
145719381|NCT01688830|525486720|FG016|Overall Study|Lost to Follow-up|0|||
145719382|NCT01688830|525486721|FG017|Overall Study|Lost to Follow-up|0|||
145719383|NCT01688830|525486722|FG018|Overall Study|Lost to Follow-up|0|||
145719384|NCT01688830|525486723|FG019|Overall Study|Lost to Follow-up|0|||
145719385|NCT01688830|525486724|FG020|Overall Study|Lost to Follow-up|0|||
145719386|NCT01285609|525486725|FG000|Randomized|Progressive Disease|41|||
145719387|NCT01285609|525486726|FG001|Randomized|Progressive Disease|61|||
145719388|NCT01285609|525486725|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
145719389|NCT01285609|525486726|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
145719390|NCT01285609|525486725|FG000|Randomized|Study Drug Toxicity|13|||
145719391|NCT01285609|525486726|FG001|Randomized|Study Drug Toxicity|14|||
145719392|NCT01285609|525486725|FG000|Randomized|Death|5|||
145719393|NCT01285609|525486726|FG001|Randomized|Death|7|||
145719394|NCT01285609|525486725|FG000|Randomized|Withdrawal by Subject|8|||
145719395|NCT01285609|525486726|FG001|Randomized|Withdrawal by Subject|11|||
145719396|NCT01285609|525486725|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
145719397|NCT01285609|525486726|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
145719398|NCT01285609|525486725|FG000|Randomized|Undisclosed Reasons|1|||
145719399|NCT01285609|525486726|FG001|Randomized|Undisclosed Reasons|0|||
145719400|NCT01285609|525486725|FG000|Randomized|Randomized but not Treated|4|||
145719401|NCT01285609|525486726|FG001|Randomized|Randomized but not Treated|4|||
145719402|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
145719403|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
145719404|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
145719405|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
145719406|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
145719407|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
145719408|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
145719409|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
145719410|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Death|11|||
145719411|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Death|3|||
145719412|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
145719413|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
145719414|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Not Reported|0|||
145719415|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Not Reported|2|||
145719416|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
145719417|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
145719418|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
145719419|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
145719420|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
145719421|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
145719422|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
145719423|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
145719424|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
145719425|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
145719426|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
145492107|NCT02587520|524656960|FG000|Overall Study|Lost to Follow-up|0|||
145492108|NCT02587520|524656961|FG001|Overall Study|Lost to Follow-up|2|||
145492109|NCT02587520|524656962|FG002|Overall Study|Lost to Follow-up|0|||
145492110|NCT02587520|524656963|FG003|Overall Study|Lost to Follow-up|2|||
145492111|NCT02587520|524656964|FG004|Overall Study|Lost to Follow-up|0|||
145492112|NCT02587520|524656965|FG005|Overall Study|Lost to Follow-up|1|||
145492113|NCT02587520|524656966|FG006|Overall Study|Lost to Follow-up|1|||
145492114|NCT02587520|524656967|FG007|Overall Study|Lost to Follow-up|1|||
145492115|NCT02587520|524656968|FG008|Overall Study|Lost to Follow-up|0|||
145492116|NCT02587520|524656969|FG009|Overall Study|Lost to Follow-up|2|||
145492117|NCT02587520|524656970|FG010|Overall Study|Lost to Follow-up|2|||
145492118|NCT02587520|524656971|FG011|Overall Study|Lost to Follow-up|1|||
145492119|NCT02587520|524656972|FG012|Overall Study|Lost to Follow-up|0|||
145492120|NCT02587520|524656973|FG013|Overall Study|Lost to Follow-up|0|||
145492121|NCT02587520|524656974|FG014|Overall Study|Lost to Follow-up|0|||
145492122|NCT02587520|524656975|FG015|Overall Study|Lost to Follow-up|0|||
145492123|NCT02587520|524656976|FG016|Overall Study|Lost to Follow-up|0|||
145492124|NCT02587520|524656977|FG017|Overall Study|Lost to Follow-up|0|||
145492125|NCT00435409|524656979|FG000|Overall Study|Protocol Violation|1|||
145492126|NCT00435409|524656980|FG001|Overall Study|Protocol Violation|2|||
145492127|NCT00435409|524656981|FG002|Overall Study|Protocol Violation|0|||
145492128|NCT00435409|524656979|FG000|Overall Study|Lost to Follow-up|1|||
145492129|NCT00435409|524656980|FG001|Overall Study|Lost to Follow-up|2|||
145492130|NCT00435409|524656981|FG002|Overall Study|Lost to Follow-up|0|||
145492131|NCT00435409|524656979|FG000|Overall Study|Death|8|||
145492132|NCT00435409|524656980|FG001|Overall Study|Death|6|||
145492133|NCT00435409|524656981|FG002|Overall Study|Death|6|||
145492134|NCT00435409|524656979|FG000|Overall Study|Objective progression or relapse|158|||
145492135|NCT00435409|524656980|FG001|Overall Study|Objective progression or relapse|93|||
145381543|NCT04591015|524248538|FG000|Overall Study|Death|6|||
145381544|NCT04591015|524248539|FG001|Overall Study|Death|4|||
145381545|NCT04591015|524248538|FG000|Overall Study|Withdrawal by Subject|6|||
145381546|NCT04591015|524248539|FG001|Overall Study|Withdrawal by Subject|3|||
145381547|NCT04591015|524248538|FG000|Overall Study|Lost to Follow-up|16|||
145381548|NCT04591015|524248539|FG001|Overall Study|Lost to Follow-up|11|||
145381549|NCT02686814|524248540|FG000|Overall Study|Physician Decision|14|||
145381550|NCT02686814|524248540|FG000|Overall Study|Withdrawal by Subject|4|||
145381551|NCT02686814|524248540|FG000|Overall Study|Death|1|||
145381552|NCT01716520|524248546|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
145381553|NCT01716520|524248547|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145381554|NCT01716520|524248548|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
145381555|NCT01716520|524248549|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
145381556|NCT01716520|524248550|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
145381557|NCT01716520|524248551|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
145381558|NCT01716520|524248546|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145381559|NCT01716520|524248547|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381560|NCT01716520|524248548|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
145381561|NCT01716520|524248549|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145381562|NCT01716520|524248550|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381563|NCT01716520|524248551|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
145381564|NCT01716520|524248546|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145381565|NCT01716520|524248547|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145381566|NCT01716520|524248548|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145381567|NCT01716520|524248549|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145381568|NCT01716520|524248550|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145381569|NCT01716520|524248551|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145492136|NCT00435409|524656981|FG002|Overall Study|Objective progression or relapse|58|||
145616821|NCT02406261|525111356|FG000|Period 2|Protocol Violation|0|||
145616822|NCT02406261|525111357|FG001|Period 2|Protocol Violation|1|||
145616823|NCT02406261|525111356|FG000|Period 2|Withdrawal by Subject|0|||
145616824|NCT02406261|525111357|FG001|Period 2|Withdrawal by Subject|1|||
145616825|NCT01591460|525111358|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
145616826|NCT01591460|525111358|FG000|Overall Study|Futility Rule (Week 12)|7|||
145616827|NCT01591460|525111358|FG000|Overall Study|Futility Rule (Week 24)|3|||
145616828|NCT01591460|525111358|FG000|Overall Study|Rebound or Breakthrough|3|||
145616829|NCT01591460|525111358|FG000|Overall Study|Treatment Discontinued by Error|1|||
145616830|NCT01591460|525111358|FG000|Overall Study|Lost to Follow-up|1|||
145616831|NCT01591460|525111358|FG000|Overall Study|Noncompliance|1|||
145616832|NCT01591460|525111358|FG000|Overall Study|Participant Refusal|3|||
145616833|NCT01591460|525111358|FG000|Overall Study|Withdrawal by Subject|1|||
145616834|NCT01591460|525111358|FG000|Overall Study|Protocol Violation|1|||
145616835|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
145616836|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
145616837|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
145381570|NCT01716520|524248546|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145381571|NCT01716520|524248547|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
145381572|NCT01716520|524248548|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145381573|NCT01716520|524248549|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145381574|NCT01716520|524248550|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145381575|NCT01716520|524248551|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
145381576|NCT01716520|524248546|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145381577|NCT01716520|524248547|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145381578|NCT01716520|524248548|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145381579|NCT01716520|524248549|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145381580|NCT01716520|524248550|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145381581|NCT01716520|524248551|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
145381582|NCT01716520|524248546|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145492137|NCT00435409|524656979|FG000|Overall Study|Global deterioration of health status|0|||
145492138|NCT00435409|524656980|FG001|Overall Study|Global deterioration of health status|0|||
145492139|NCT00435409|524656981|FG002|Overall Study|Global deterioration of health status|4|||
145492140|NCT00435409|524656979|FG000|Overall Study|Withdrawal by Subject|8|||
145492141|NCT00435409|524656980|FG001|Overall Study|Withdrawal by Subject|7|||
145492142|NCT00435409|524656981|FG002|Overall Study|Withdrawal by Subject|1|||
145492143|NCT00435409|524656979|FG000|Overall Study|Other|45|||
145492144|NCT00435409|524656980|FG001|Overall Study|Other|30|||
145492145|NCT00435409|524656981|FG002|Overall Study|Other|1|||
145492146|NCT00435409|524656979|FG000|Overall Study|Adverse Event|0|||
145492147|NCT00435409|524656980|FG001|Overall Study|Adverse Event|0|||
145492148|NCT00435409|524656981|FG002|Overall Study|Adverse Event|8|||
145492149|NCT00435409|524656979|FG000|Overall Study|Sponsor decision|0|||
145492150|NCT00435409|524656980|FG001|Overall Study|Sponsor decision|3|||
145492151|NCT00435409|524656981|FG002|Overall Study|Sponsor decision|0|||
145492152|NCT03661723|524656986|FG000|Overall Study|Disease Progression|4|||
145492153|NCT03661723|524656987|FG001|Overall Study|Disease Progression|24|||
145492154|NCT03661723|524656988|FG002|Overall Study|Disease Progression|4|||
145492155|NCT03661723|524656989|FG003|Overall Study|Disease Progression|19|||
145492156|NCT03661723|524656986|FG000|Overall Study|Withdrawal by Subject|1|||
145492157|NCT03661723|524656987|FG001|Overall Study|Withdrawal by Subject|0|||
145492158|NCT03661723|524656988|FG002|Overall Study|Withdrawal by Subject|2|||
145492159|NCT03661723|524656989|FG003|Overall Study|Withdrawal by Subject|4|||
145492160|NCT03661723|524656986|FG000|Overall Study|Physician Decision|1|||
145492161|NCT03661723|524656987|FG001|Overall Study|Physician Decision|0|||
145492162|NCT03661723|524656988|FG002|Overall Study|Physician Decision|0|||
145492163|NCT03661723|524656989|FG003|Overall Study|Physician Decision|0|||
145492164|NCT03661723|524656986|FG000|Overall Study|Clinical Deterioration|0|||
145492165|NCT03661723|524656987|FG001|Overall Study|Clinical Deterioration|0|||
145492166|NCT03661723|524656988|FG002|Overall Study|Clinical Deterioration|0|||
145492167|NCT03661723|524656989|FG003|Overall Study|Clinical Deterioration|1|||
145492168|NCT03562195|524656992|FG000|Overall Study|Adverse Event|0|||
145492169|NCT03562195|524656993|FG001|Overall Study|Adverse Event|6|||
145492170|NCT03562195|524656992|FG000|Overall Study|Lack of Efficacy|0|||
145492171|NCT03562195|524656993|FG001|Overall Study|Lack of Efficacy|5|||
145492172|NCT03562195|524656992|FG000|Overall Study|Protocol Violation|0|||
145492173|NCT03562195|524656993|FG001|Overall Study|Protocol Violation|1|||
145492174|NCT03562195|524656992|FG000|Overall Study|Lost to Follow-up|0|||
145492175|NCT03562195|524656993|FG001|Overall Study|Lost to Follow-up|1|||
145492176|NCT03562195|524656992|FG000|Overall Study|Physician Decision|1|||
145492177|NCT03562195|524656993|FG001|Overall Study|Physician Decision|0|||
145492178|NCT03562195|524656992|FG000|Overall Study|Withdrawal by Subject|3|||
145492179|NCT03562195|524656993|FG001|Overall Study|Withdrawal by Subject|0|||
145492180|NCT02529852|524656994|FG000|Overall Study|Withdrawal by Subject|2|||
145492181|NCT00614575|524656996|FG000|Overall Study|Adverse Event|106|||
145492182|NCT00614575|524656996|FG000|Overall Study|Lost to Follow-up|55|||
145492183|NCT00614575|524656996|FG000|Overall Study|Lack of Efficacy|14|||
145492184|NCT00614575|524656996|FG000|Overall Study|Withdrawal by Subject|6|||
145492185|NCT00614575|524656996|FG000|Overall Study|Death|3|||
145492186|NCT00614575|524656996|FG000|Overall Study|Physician Decision|2|||
145492187|NCT00614575|524656996|FG000|Overall Study|No data were collected.|18|||
145492188|NCT00614575|524656996|FG000|Overall Study|Irregularly enrolled patients|23|||
145492189|NCT00614575|524656996|FG000|Overall Study|No treatment|1|||
145492190|NCT03452540|524656997|FG000|Overall Study|Adverse Event|1|||
145381583|NCT01716520|524248547|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145381584|NCT01716520|524248548|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
145381585|NCT01716520|524248549|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145381586|NCT01716520|524248550|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
145492191|NCT03452540|524656997|FG000|Overall Study|Withdrawal by Subject|1|||
145492192|NCT03452540|524656997|FG000|Overall Study|Other SAE and AE|2|||
145492193|NCT01045460|524656998|FG000|Overall Study|Physician Decision|3|||
145492194|NCT01045460|524656999|FG001|Overall Study|Physician Decision|2|||
145719427|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
145492195|NCT01045460|524656998|FG000|Overall Study|Lost to Follow-up|0|||
145492196|NCT01045460|524656999|FG001|Overall Study|Lost to Follow-up|1|||
145492197|NCT01045460|524656998|FG000|Overall Study|Lack of Efficacy|3|||
145492198|NCT01045460|524656999|FG001|Overall Study|Lack of Efficacy|0|||
145492199|NCT00524485|524657003|FG000|Overall Study|Withdrawal by Subject|5|||
145492200|NCT01600885|524657006|FG000|First Period|Adverse Event|1|||
145492201|NCT01600885|524657007|FG001|First Period|Adverse Event|1|||
145492202|NCT01600885|524657006|FG000|First Period|moved out of area|1|||
145492203|NCT01600885|524657007|FG001|First Period|moved out of area|0|||
145492204|NCT04201431|524657008|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
145492205|NCT04201431|524657009|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
145492206|NCT04201431|524657010|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
145492207|NCT00300755|524657015|FG000|Overall Study|Adverse Event|1|||
145492208|NCT00300755|524657016|FG001|Overall Study|Adverse Event|2|||
145492209|NCT00300755|524657017|FG002|Overall Study|Adverse Event|1|||
145492210|NCT00300755|524657015|FG000|Overall Study|Withdrawal by Subject|0|||
145492211|NCT00300755|524657016|FG001|Overall Study|Withdrawal by Subject|2|||
145492212|NCT00300755|524657017|FG002|Overall Study|Withdrawal by Subject|0|||
145492213|NCT00300755|524657015|FG000|Overall Study|Protocol Violation|0|||
145492214|NCT00300755|524657016|FG001|Overall Study|Protocol Violation|0|||
145381587|NCT01716520|524248551|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
145381588|NCT01716520|524248546|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
145381589|NCT01716520|524248547|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
145381590|NCT01716520|524248548|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
145381591|NCT01716520|524248549|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
145381592|NCT01716520|524248550|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
145381593|NCT01716520|524248551|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
145381594|NCT01716520|524248546|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145381595|NCT01716520|524248547|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145381596|NCT01716520|524248548|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145381597|NCT01716520|524248549|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145381598|NCT01716520|524248550|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145381599|NCT01716520|524248551|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145381600|NCT01716520|524248546|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381601|NCT01716520|524248547|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381602|NCT01716520|524248548|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381603|NCT01716520|524248549|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
145381604|NCT01716520|524248550|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381605|NCT01716520|524248551|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
145381606|NCT01716520|524248546|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145381607|NCT01716520|524248547|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145381608|NCT01716520|524248548|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145381609|NCT01716520|524248549|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145381610|NCT01716520|524248550|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
145381611|NCT01716520|524248551|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
145381612|NCT01716520|524248546|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
145381613|NCT01716520|524248547|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145381614|NCT01716520|524248548|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145381615|NCT01716520|524248549|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145381616|NCT01716520|524248550|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145381617|NCT01716520|524248551|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
145381618|NCT01716520|524248546|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145381619|NCT01716520|524248547|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145381620|NCT01716520|524248548|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145381621|NCT01716520|524248549|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145381622|NCT01716520|524248550|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
145381623|NCT01716520|524248551|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
145381624|NCT01716520|524248546|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145381625|NCT01716520|524248547|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
145381626|NCT01716520|524248548|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145381627|NCT01716520|524248549|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145381628|NCT01716520|524248550|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145381629|NCT01716520|524248551|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
145381630|NCT01716520|524248546|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145381631|NCT01716520|524248547|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145381632|NCT01716520|524248548|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145492215|NCT00300755|524657017|FG002|Overall Study|Protocol Violation|1|||
145492216|NCT04571944|524657018|FG000|Overall Study|Death|1|||
145492217|NCT04571944|524657019|FG001|Overall Study|Death|0|||
145492218|NCT04571944|524657018|FG000|Overall Study|Withdrawal by Subject|3|||
145381633|NCT01716520|524248549|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145381634|NCT01716520|524248550|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145381635|NCT01716520|524248551|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
145381636|NCT01716520|524248546|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145381637|NCT01716520|524248547|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145381638|NCT01716520|524248548|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
145381639|NCT01716520|524248549|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145381640|NCT01716520|524248550|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145381641|NCT01716520|524248551|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145381642|NCT00253370|524248552|FG000|Overall Study|Adverse Event|18|||
145381643|NCT00253370|524248552|FG000|Overall Study|Disease progression|13|||
145381644|NCT00253370|524248552|FG000|Overall Study|Death|2|||
145381645|NCT00253370|524248552|FG000|Overall Study|Withdrawal by Subject|6|||
145381646|NCT00253370|524248552|FG000|Overall Study|Non-protocol therapy|1|||
145381647|NCT00253370|524248552|FG000|Overall Study|Physician Decision|1|||
145381648|NCT00253370|524248552|FG000|Overall Study|Protocol Violation|1|||
145381649|NCT00253370|524248552|FG000|Overall Study|Abdominal pain due to disease|1|||
145381650|NCT00004088|524248557|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
145381651|NCT00004088|524248557|FG000|Overall Study|Withdrawal by Subject|1|||
145381652|NCT00004088|524248557|FG000|Overall Study|Protocol Violation|3|||
145381653|NCT00004088|524248557|FG000|Overall Study|Physician Decision|1|||
145381654|NCT01955109|524248571|FG000|Overall Study|Adverse Event|2|||
145381655|NCT01955109|524248572|FG001|Overall Study|Adverse Event|0|||
145381656|NCT01955109|524248571|FG000|Overall Study|Participant unwilling to continue|35|||
145381657|NCT01955109|524248572|FG001|Overall Study|Participant unwilling to continue|7|||
145381658|NCT01955109|524248571|FG000|Overall Study|Physician Decision|2|||
145381659|NCT01955109|524248572|FG001|Overall Study|Physician Decision|0|||
145381660|NCT01955109|524248571|FG000|Overall Study|Lost to Follow-up|3|||
145381661|NCT01955109|524248572|FG001|Overall Study|Lost to Follow-up|1|||
145381662|NCT01955109|524248571|FG000|Overall Study|Non-compliance|3|||
145381663|NCT01955109|524248572|FG001|Overall Study|Non-compliance|1|||
145381664|NCT00904839|524248574|FG000|Overall Study|Adverse Event|0|||
145381665|NCT00904839|524248575|FG001|Overall Study|Adverse Event|5|||
145381666|NCT00904839|524248576|FG002|Overall Study|Adverse Event|4|||
145381667|NCT00904839|524248574|FG000|Overall Study|Protocol Violation|0|||
145381668|NCT00904839|524248575|FG001|Overall Study|Protocol Violation|1|||
145381669|NCT00904839|524248576|FG002|Overall Study|Protocol Violation|1|||
145381670|NCT00904839|524248574|FG000|Overall Study|Lost to Follow-up|0|||
145381671|NCT00904839|524248575|FG001|Overall Study|Lost to Follow-up|1|||
145381672|NCT00904839|524248576|FG002|Overall Study|Lost to Follow-up|2|||
145381673|NCT00904839|524248574|FG000|Overall Study|Withdrawal by Subject|0|||
145492219|NCT04571944|524657019|FG001|Overall Study|Withdrawal by Subject|0|||
145492220|NCT04571944|524657018|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
145492221|NCT04571944|524657019|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
145492222|NCT04079296|524657022|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
145492223|NCT04079296|524657023|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
145492224|NCT04079296|524657024|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
145492225|NCT04079296|524657025|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
145492226|NCT04079296|524657026|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
145492227|NCT04079296|524657022|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
145381674|NCT00904839|524248575|FG001|Overall Study|Withdrawal by Subject|2|||
145381675|NCT00904839|524248576|FG002|Overall Study|Withdrawal by Subject|0|||
145381676|NCT00904839|524248574|FG000|Overall Study|Not treated|1|||
145381677|NCT00904839|524248575|FG001|Overall Study|Not treated|0|||
145381678|NCT00904839|524248576|FG002|Overall Study|Not treated|1|||
145381679|NCT00904839|524248574|FG000|Overall Study|Other than above|0|||
145381680|NCT00904839|524248575|FG001|Overall Study|Other than above|9|||
145381681|NCT00904839|524248576|FG002|Overall Study|Other than above|7|||
145381682|NCT04521114|524248581|FG000|Overall Study|Lost to Follow-up|1|||
145381683|NCT04521114|524248582|FG001|Overall Study|Lost to Follow-up|2|||
145381684|NCT04521114|524248583|FG002|Overall Study|Lost to Follow-up|0|||
145381685|NCT04521114|524248581|FG000|Overall Study|Withdrawal by Subject|1|||
145381686|NCT04521114|524248582|FG001|Overall Study|Withdrawal by Subject|2|||
145381687|NCT04521114|524248583|FG002|Overall Study|Withdrawal by Subject|2|||
145381688|NCT04521114|524248581|FG000|Overall Study|Adverse Event|1|||
145381689|NCT04521114|524248582|FG001|Overall Study|Adverse Event|0|||
145381690|NCT04521114|524248583|FG002|Overall Study|Adverse Event|0|||
145381691|NCT04521114|524248581|FG000|Overall Study|Sponsor Wish|1|||
145381692|NCT04521114|524248582|FG001|Overall Study|Sponsor Wish|0|||
145381693|NCT04521114|524248583|FG002|Overall Study|Sponsor Wish|0|||
145381694|NCT04521114|524248581|FG000|Overall Study|Withdrawal of Consent|2|||
145381695|NCT04521114|524248582|FG001|Overall Study|Withdrawal of Consent|2|||
145381696|NCT04521114|524248583|FG002|Overall Study|Withdrawal of Consent|0|||
145381697|NCT01167634|524248584|FG000|Overall Study|Lost to Follow-up|1|||
145381698|NCT01167634|524248585|FG001|Overall Study|Lost to Follow-up|3|||
145381699|NCT01167634|524248586|FG002|Overall Study|Lost to Follow-up|3|||
145381700|NCT01167634|524248587|FG003|Overall Study|Lost to Follow-up|4|||
145381701|NCT01167634|524248584|FG000|Overall Study|Withdrawal by Subject|1|||
145381702|NCT01167634|524248585|FG001|Overall Study|Withdrawal by Subject|1|||
145381703|NCT01167634|524248586|FG002|Overall Study|Withdrawal by Subject|0|||
145381704|NCT01167634|524248587|FG003|Overall Study|Withdrawal by Subject|0|||
145381705|NCT02614131|524248588|FG000|Overall Study|Withdrawal by Subject|1|||
145381706|NCT02614131|524248589|FG001|Overall Study|Withdrawal by Subject|0|||
145381707|NCT02614131|524248590|FG002|Overall Study|Withdrawal by Subject|0|||
145381708|NCT02614131|524248591|FG003|Overall Study|Withdrawal by Subject|0|||
145381709|NCT02614131|524248592|FG004|Overall Study|Withdrawal by Subject|0|||
145381710|NCT02614131|524248593|FG005|Overall Study|Withdrawal by Subject|0|||
145381711|NCT02614131|524248594|FG006|Overall Study|Withdrawal by Subject|0|||
145381712|NCT02614131|524248588|FG000|Overall Study|Adverse Event|0|||
145381713|NCT02614131|524248589|FG001|Overall Study|Adverse Event|0|||
145381714|NCT02614131|524248590|FG002|Overall Study|Adverse Event|0|||
145381715|NCT02614131|524248591|FG003|Overall Study|Adverse Event|0|||
145381716|NCT02614131|524248592|FG004|Overall Study|Adverse Event|0|||
145381717|NCT02614131|524248593|FG005|Overall Study|Adverse Event|0|||
145381718|NCT02614131|524248594|FG006|Overall Study|Adverse Event|1|||
145381719|NCT00419159|524248595|FG000|Overall Study|Adverse Event|7|||
145381720|NCT00419159|524248596|FG001|Overall Study|Adverse Event|15|||
145381721|NCT00419159|524248595|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145381722|NCT00419159|524248596|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145381723|NCT00419159|524248595|FG000|Overall Study|Subject's no longer requires study drug|0|||
145381724|NCT00419159|524248596|FG001|Overall Study|Subject's no longer requires study drug|1|||
145381725|NCT00419159|524248595|FG000|Overall Study|Protocol Violation|1|||
145381726|NCT00419159|524248596|FG001|Overall Study|Protocol Violation|0|||
145381727|NCT00419159|524248595|FG000|Overall Study|Withdrawal by Subject|10|||
145492228|NCT04079296|524657023|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
145492229|NCT04079296|524657024|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
145492230|NCT04079296|524657025|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
145492231|NCT04079296|524657026|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
145492232|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
145492233|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
145492234|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
145492235|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
145492236|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
145492237|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
145492238|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
145492239|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
145492240|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
145492241|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
145492242|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
145492243|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
145492244|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
145492245|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
145492246|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
145492247|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
145492248|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
145492249|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
145492250|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
145492251|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
145492252|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
145492253|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
145492254|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
145492255|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
145492256|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
145492257|NCT04079296|524657022|FG000|Dose Expansion Phase (168 Days)|Death|0|||
145492258|NCT04079296|524657023|FG001|Dose Expansion Phase (168 Days)|Death|0|||
145492259|NCT04079296|524657024|FG002|Dose Expansion Phase (168 Days)|Death|0|||
145492260|NCT04079296|524657025|FG003|Dose Expansion Phase (168 Days)|Death|1|||
145492261|NCT04079296|524657026|FG004|Dose Expansion Phase (168 Days)|Death|0|||
145492262|NCT03535974|524657027|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
145492263|NCT03535974|524657028|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
145492264|NCT03535974|524657029|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
145492265|NCT03535974|524657027|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
145492266|NCT03535974|524657028|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
145492267|NCT03535974|524657029|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
145492268|NCT04059549|524657030|FG000|Overall Study|Withdrawal by Subject|2|||
145381728|NCT00419159|524248596|FG001|Overall Study|Withdrawal by Subject|3|||
145492269|NCT04059549|524657031|FG001|Overall Study|Withdrawal by Subject|0|||
145492270|NCT01919229|524657033|FG000|Overall Study|Subject/guardian decision|0|||
145492271|NCT01919229|524657034|FG001|Overall Study|Subject/guardian decision|0|||
145492272|NCT01919229|524657035|FG002|Overall Study|Subject/guardian decision|1|||
145492273|NCT01011673|524657036|FG000|Randomized|Secondary headache|2|||
145492274|NCT01011673|524657037|FG001|Randomized|Secondary headache|1|||
145492275|NCT01011673|524657036|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
145492276|NCT01011673|524657037|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
145492277|NCT00549640|524657039|FG000|Overall Study|Withdrawal by Subject|6|||
145492278|NCT00549640|524657040|FG001|Overall Study|Withdrawal by Subject|12|||
145492279|NCT00549640|524657039|FG000|Overall Study|Adverse Event|5|||
145492280|NCT00549640|524657040|FG001|Overall Study|Adverse Event|0|||
145492281|NCT00549640|524657039|FG000|Overall Study|Lost to Follow-up|7|||
145492282|NCT00549640|524657040|FG001|Overall Study|Lost to Follow-up|4|||
145492283|NCT00626275|524657043|FG000|Part A - Treatment Period 1|Adverse Event|1|||
145492284|NCT00626275|524657044|FG001|Part A - Treatment Period 1|Adverse Event|0|||
145492285|NCT00626275|524657045|FG002|Part A - Treatment Period 1|Adverse Event|0|||
145492286|NCT00626275|524657046|FG003|Part A - Treatment Period 1|Adverse Event|0|||
145492287|NCT00626275|524657047|FG004|Part A - Treatment Period 1|Adverse Event|0|||
145492288|NCT00626275|524657048|FG005|Part A - Treatment Period 1|Adverse Event|0|||
145492289|NCT00626275|524657049|FG006|Part A - Treatment Period 1|Adverse Event|0|||
145492290|NCT00626275|524657050|FG007|Part A - Treatment Period 1|Adverse Event|0|||
145492291|NCT00626275|524657043|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492292|NCT00626275|524657044|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492293|NCT00626275|524657045|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
145492294|NCT00626275|524657046|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492295|NCT00626275|524657047|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492296|NCT00626275|524657048|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492297|NCT00626275|524657049|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492298|NCT00626275|524657050|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
145492299|NCT00626275|524657043|FG000|Part B|Lost to Follow-up|0|||
145492300|NCT00626275|524657044|FG001|Part B|Lost to Follow-up|0|||
145492301|NCT00626275|524657045|FG002|Part B|Lost to Follow-up|0|||
145492302|NCT00626275|524657046|FG003|Part B|Lost to Follow-up|0|||
145492303|NCT00626275|524657047|FG004|Part B|Lost to Follow-up|0|||
145492304|NCT00626275|524657048|FG005|Part B|Lost to Follow-up|0|||
145492305|NCT00626275|524657049|FG006|Part B|Lost to Follow-up|1|||
145492306|NCT00626275|524657050|FG007|Part B|Lost to Follow-up|0|||
145492307|NCT00626275|524657043|FG000|Part B|Withdrawal by Subject|0|||
145492308|NCT00626275|524657044|FG001|Part B|Withdrawal by Subject|0|||
145492309|NCT00626275|524657045|FG002|Part B|Withdrawal by Subject|0|||
145492310|NCT00626275|524657046|FG003|Part B|Withdrawal by Subject|0|||
145492311|NCT00626275|524657047|FG004|Part B|Withdrawal by Subject|0|||
145492312|NCT00626275|524657048|FG005|Part B|Withdrawal by Subject|0|||
145492313|NCT00626275|524657049|FG006|Part B|Withdrawal by Subject|0|||
145492314|NCT00626275|524657050|FG007|Part B|Withdrawal by Subject|1|||
145492315|NCT00651924|524657051|FG000|Overall Study|Withdrawal by PI|0|||
145492316|NCT00651924|524657052|FG001|Overall Study|Withdrawal by PI|2|||
145492317|NCT00651924|524657051|FG000|Overall Study|Withdrawal by Subject|0|||
145492318|NCT00651924|524657052|FG001|Overall Study|Withdrawal by Subject|5|||
145492319|NCT00960063|524657053|FG000|Overall Study|Adverse Event|1|||
145492320|NCT00960063|524657054|FG001|Overall Study|Adverse Event|0|||
145492321|NCT00960063|524657055|FG002|Overall Study|Adverse Event|0|||
145492322|NCT00960063|524657053|FG000|Overall Study|Progression of Disease|0|||
145492323|NCT00960063|524657054|FG001|Overall Study|Progression of Disease|0|||
145492324|NCT00960063|524657055|FG002|Overall Study|Progression of Disease|3|||
145492325|NCT03883581|524657058|FG000|Overall Study|Withdrawal by Subject|4|||
145492326|NCT05190120|524657062|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
145492327|NCT05190120|524657063|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
145492328|NCT05190120|524657064|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
145492329|NCT05190120|524657065|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
145492330|NCT05190120|524657062|FG000|Overall Study|Lost to Follow-up|5|||
145492331|NCT05190120|524657063|FG001|Overall Study|Lost to Follow-up|0|||
145492332|NCT05190120|524657064|FG002|Overall Study|Lost to Follow-up|2|||
145492333|NCT05190120|524657065|FG003|Overall Study|Lost to Follow-up|3|||
145492334|NCT03062358|524657067|FG000|Overall Study|Death|269|||
145492335|NCT03062358|524657068|FG001|Overall Study|Death|145|||
145492336|NCT03062358|524657067|FG000|Overall Study|Withdrawal by Subject|2|||
145492337|NCT03062358|524657068|FG001|Overall Study|Withdrawal by Subject|1|||
145492338|NCT03062358|524657067|FG000|Overall Study|Sponsor Decision|29|||
145492339|NCT03062358|524657068|FG001|Overall Study|Sponsor Decision|7|||
145492340|NCT00880698|524657073|FG000|Overall Study|Death|0|||
145492341|NCT00880698|524657074|FG001|Overall Study|Death|0|||
145492342|NCT00880698|524657075|FG002|Overall Study|Death|1|||
145492343|NCT00880698|524657076|FG003|Overall Study|Death|2|||
145492344|NCT00880698|524657073|FG000|Overall Study|Lost to Follow-up|1|||
145492345|NCT00880698|524657074|FG001|Overall Study|Lost to Follow-up|3|||
145492346|NCT00880698|524657075|FG002|Overall Study|Lost to Follow-up|0|||
145492347|NCT00880698|524657076|FG003|Overall Study|Lost to Follow-up|1|||
145492348|NCT04972162|524657077|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
145492349|NCT04972162|524657078|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
145492350|NCT01602224|524659505|FG000|Overall Study|Adverse Event|0|||
145492351|NCT01602224|524659506|FG001|Overall Study|Adverse Event|1|||
145492352|NCT01602224|524659507|FG002|Overall Study|Adverse Event|0|||
145492353|NCT01602224|524659505|FG000|Overall Study|Investigator Decison|1|||
145492354|NCT01602224|524659506|FG001|Overall Study|Investigator Decison|0|||
145492355|NCT01602224|524659507|FG002|Overall Study|Investigator Decison|0|||
145492356|NCT01602224|524659505|FG000|Overall Study|Lost to Follow-up|0|||
145492357|NCT01602224|524659506|FG001|Overall Study|Lost to Follow-up|0|||
145492358|NCT01602224|524659507|FG002|Overall Study|Lost to Follow-up|1|||
145492359|NCT01602224|524659505|FG000|Overall Study|Protocol Violation|0|||
145492360|NCT01602224|524659506|FG001|Overall Study|Protocol Violation|1|||
145492361|NCT01602224|524659507|FG002|Overall Study|Protocol Violation|0|||
145492362|NCT01602224|524659505|FG000|Overall Study|Sponsor Decision|2|||
145492363|NCT01602224|524659506|FG001|Overall Study|Sponsor Decision|3|||
145492364|NCT01602224|524659507|FG002|Overall Study|Sponsor Decision|2|||
145492365|NCT01602224|524659505|FG000|Overall Study|Withdrawal by Subject|5|||
145492366|NCT01602224|524659506|FG001|Overall Study|Withdrawal by Subject|3|||
145492367|NCT01602224|524659507|FG002|Overall Study|Withdrawal by Subject|3|||
145492368|NCT00770653|524659511|FG000|Overall Study|Adverse Event|13|||
145492369|NCT00770653|524659512|FG001|Overall Study|Adverse Event|5|||
145492370|NCT00770653|524659511|FG000|Overall Study|Protocol Violation|8|||
145492371|NCT00770653|524659512|FG001|Overall Study|Protocol Violation|6|||
145492372|NCT00770653|524659511|FG000|Overall Study|Withdrawal by Subject|4|||
145492373|NCT00770653|524659512|FG001|Overall Study|Withdrawal by Subject|7|||
145492374|NCT00770653|524659511|FG000|Overall Study|Lack of Compliance|1|||
145492375|NCT00770653|524659512|FG001|Overall Study|Lack of Compliance|4|||
145492376|NCT00770653|524659511|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
145492377|NCT00770653|524659512|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
145492378|NCT00770653|524659511|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
145492379|NCT00770653|524659512|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
145492380|NCT00770653|524659511|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
145492381|NCT00770653|524659512|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
145492382|NCT00770653|524659511|FG000|Overall Study|Lost to Follow-up|1|||
145492383|NCT00770653|524659512|FG001|Overall Study|Lost to Follow-up|2|||
145492384|NCT00770653|524659511|FG000|Overall Study|Physician Decision|1|||
145492385|NCT00770653|524659512|FG001|Overall Study|Physician Decision|0|||
145492386|NCT04906499|524659514|FG000|Overall Study|Lack of time|1|||
145492387|NCT00179621|524659515|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
145492388|NCT00179621|524659516|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
145492389|NCT00179621|524659517|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
145492390|NCT00179621|524659518|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
145492391|NCT00179621|524659515|FG000|Double-Blind Period|Adverse Event|2|||
145492392|NCT00179621|524659516|FG001|Double-Blind Period|Adverse Event|7|||
145492393|NCT00179621|524659517|FG002|Double-Blind Period|Adverse Event|4|||
145492394|NCT00179621|524659518|FG003|Double-Blind Period|Adverse Event|0|||
145492395|NCT00179621|524659515|FG000|Double-Blind Period|Withdrawal by Subject|2|||
145492396|NCT00179621|524659516|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145492397|NCT00179621|524659517|FG002|Double-Blind Period|Withdrawal by Subject|3|||
145492398|NCT00179621|524659518|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145492399|NCT00179621|524659515|FG000|Double-Blind Period|Death|0|||
145492400|NCT00179621|524659516|FG001|Double-Blind Period|Death|1|||
145492401|NCT00179621|524659517|FG002|Double-Blind Period|Death|2|||
145492402|NCT00179621|524659518|FG003|Double-Blind Period|Death|0|||
145492403|NCT00179621|524659515|FG000|Double-Blind Period|Protocol Violation|1|||
145492404|NCT00179621|524659516|FG001|Double-Blind Period|Protocol Violation|0|||
145492405|NCT00179621|524659517|FG002|Double-Blind Period|Protocol Violation|0|||
145492406|NCT00179621|524659518|FG003|Double-Blind Period|Protocol Violation|0|||
145492407|NCT00179621|524659515|FG000|Double-Blind Period|Other|0|||
145492408|NCT00179621|524659516|FG001|Double-Blind Period|Other|2|||
145492409|NCT00179621|524659517|FG002|Double-Blind Period|Other|2|||
145492410|NCT00179621|524659518|FG003|Double-Blind Period|Other|0|||
145492411|NCT00179621|524659515|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
145492412|NCT00179621|524659516|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
145492413|NCT00179621|524659517|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
145492414|NCT00179621|524659518|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
145492415|NCT00179621|524659515|FG000|Open-Label Period|Adverse Event|0|||
145492416|NCT00179621|524659516|FG001|Open-Label Period|Adverse Event|6|||
145492417|NCT00179621|524659517|FG002|Open-Label Period|Adverse Event|5|||
145492418|NCT00179621|524659518|FG003|Open-Label Period|Adverse Event|6|||
145492419|NCT00179621|524659515|FG000|Open-Label Period|Withdrawal by Subject|0|||
145492420|NCT00179621|524659516|FG001|Open-Label Period|Withdrawal by Subject|2|||
145492421|NCT00179621|524659517|FG002|Open-Label Period|Withdrawal by Subject|2|||
145492422|NCT00179621|524659518|FG003|Open-Label Period|Withdrawal by Subject|2|||
145492423|NCT00179621|524659515|FG000|Open-Label Period|Death|0|||
145492424|NCT00179621|524659516|FG001|Open-Label Period|Death|0|||
145492425|NCT00179621|524659517|FG002|Open-Label Period|Death|1|||
145492426|NCT00179621|524659518|FG003|Open-Label Period|Death|2|||
145492427|NCT00179621|524659515|FG000|Open-Label Period|Other|0|||
145492428|NCT00179621|524659516|FG001|Open-Label Period|Other|1|||
145492429|NCT00179621|524659517|FG002|Open-Label Period|Other|1|||
145492430|NCT00179621|524659518|FG003|Open-Label Period|Other|2|||
145492431|NCT03525444|524659523|FG000|Overall Study|Adverse Event|0|||
145492432|NCT03525444|524659524|FG001|Overall Study|Adverse Event|1|||
145492433|NCT03525444|524659523|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
145492434|NCT03525444|524659524|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
145492435|NCT03525444|524659523|FG000|Overall Study|Other|0|||
145492436|NCT03525444|524659524|FG001|Overall Study|Other|1|||
145492437|NCT00262860|524659525|FG000|Overall Study|Adverse Event|2|||
145492438|NCT02741128|524659526|FG000|Overall Study|Protocol Violation|4|||
145492439|NCT02741128|524659527|FG001|Overall Study|Protocol Violation|1|||
145492440|NCT02741128|524659526|FG000|Overall Study|Withdrawal by Subject|2|||
145492441|NCT02741128|524659527|FG001|Overall Study|Withdrawal by Subject|0|||
145492442|NCT02741128|524659526|FG000|Overall Study|Lost to Follow-up|1|||
145492443|NCT02741128|524659527|FG001|Overall Study|Lost to Follow-up|0|||
145492444|NCT02973100|524659528|FG000|Overall Study|Adverse Event|1|||
145492445|NCT02973100|524659529|FG001|Overall Study|Adverse Event|2|||
145492446|NCT02973100|524659530|FG002|Overall Study|Adverse Event|1|||
145492447|NCT02973100|524659531|FG003|Overall Study|Adverse Event|2|||
145492448|NCT02973100|524659528|FG000|Overall Study|Lost to Follow-up|3|||
145492449|NCT02973100|524659529|FG001|Overall Study|Lost to Follow-up|1|||
145492450|NCT02973100|524659530|FG002|Overall Study|Lost to Follow-up|1|||
145492451|NCT02973100|524659531|FG003|Overall Study|Lost to Follow-up|0|||
145492452|NCT02973100|524659528|FG000|Overall Study|Withdrawal by Subject|3|||
145492453|NCT02973100|524659529|FG001|Overall Study|Withdrawal by Subject|5|||
145492454|NCT02973100|524659530|FG002|Overall Study|Withdrawal by Subject|1|||
145492455|NCT02973100|524659531|FG003|Overall Study|Withdrawal by Subject|4|||
145492456|NCT02973100|524659528|FG000|Overall Study|Notification of change in address|0|||
145492457|NCT02973100|524659529|FG001|Overall Study|Notification of change in address|0|||
145492458|NCT02973100|524659530|FG002|Overall Study|Notification of change in address|0|||
145492459|NCT02973100|524659531|FG003|Overall Study|Notification of change in address|1|||
145492460|NCT02973100|524659528|FG000|Overall Study|Failed to attend Safety followup period|0|||
145492461|NCT02973100|524659529|FG001|Overall Study|Failed to attend Safety followup period|0|||
145492462|NCT02973100|524659530|FG002|Overall Study|Failed to attend Safety followup period|1|||
145492463|NCT02973100|524659531|FG003|Overall Study|Failed to attend Safety followup period|0|||
145492464|NCT01419769|524659532|FG000|Overall Study|Did not receive the AXIOS stent|3|||
145492465|NCT01419769|524659532|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
145492466|NCT00878501|524659533|FG000|Overall Study|Adverse Event|11|||
145492467|NCT00878501|524659534|FG001|Overall Study|Adverse Event|3|||
145492468|NCT00878501|524659535|FG002|Overall Study|Adverse Event|3|||
145492469|NCT00878501|524659533|FG000|Overall Study|Lack of Efficacy|2|||
145492470|NCT00878501|524659534|FG001|Overall Study|Lack of Efficacy|1|||
145492471|NCT00878501|524659535|FG002|Overall Study|Lack of Efficacy|0|||
145492472|NCT00878501|524659533|FG000|Overall Study|Withdrawal by Subject|2|||
145492473|NCT00878501|524659534|FG001|Overall Study|Withdrawal by Subject|1|||
145492474|NCT00878501|524659535|FG002|Overall Study|Withdrawal by Subject|2|||
145492475|NCT00878501|524659533|FG000|Overall Study|Protocol Violation|0|||
145492476|NCT00878501|524659534|FG001|Overall Study|Protocol Violation|0|||
145492477|NCT00878501|524659535|FG002|Overall Study|Protocol Violation|1|||
145492478|NCT00878501|524659533|FG000|Overall Study|Incorrect enrolment|1|||
145492479|NCT00878501|524659534|FG001|Overall Study|Incorrect enrolment|2|||
145492480|NCT00878501|524659535|FG002|Overall Study|Incorrect enrolment|0|||
145492481|NCT00878501|524659533|FG000|Overall Study|Intake of prohibited concom. medication|0|||
145492482|NCT00878501|524659534|FG001|Overall Study|Intake of prohibited concom. medication|0|||
145492483|NCT00878501|524659535|FG002|Overall Study|Intake of prohibited concom. medication|1|||
145492484|NCT00878501|524659533|FG000|Overall Study|Mis-randomisation of patient|1|||
145492485|NCT00878501|524659534|FG001|Overall Study|Mis-randomisation of patient|0|||
145492486|NCT00878501|524659535|FG002|Overall Study|Mis-randomisation of patient|0|||
145492487|NCT00878501|524659533|FG000|Overall Study|Administrative|0|||
145492488|NCT00878501|524659534|FG001|Overall Study|Administrative|0|||
145492489|NCT00878501|524659535|FG002|Overall Study|Administrative|1|||
145492490|NCT01959503|524659536|FG000|Overall Study|Death|2|||
145492491|NCT01959503|524659537|FG001|Overall Study|Death|1|||
145492492|NCT01959503|524659536|FG000|Overall Study|Randomized but not treated|1|||
145492493|NCT01959503|524659537|FG001|Overall Study|Randomized but not treated|1|||
145492494|NCT01419236|524659538|FG000|Overall Study|Adverse Event|1|||
145492495|NCT01419236|524659539|FG001|Overall Study|Adverse Event|0|||
145492496|NCT01419236|524659538|FG000|Overall Study|Lack of Efficacy|0|||
145492497|NCT01419236|524659539|FG001|Overall Study|Lack of Efficacy|1|||
145492498|NCT01419236|524659538|FG000|Overall Study|Lost to Follow-up|1|||
145492499|NCT01419236|524659539|FG001|Overall Study|Lost to Follow-up|0|||
145492500|NCT01419236|524659538|FG000|Overall Study|Physician Decision|1|||
145492501|NCT01419236|524659539|FG001|Overall Study|Physician Decision|0|||
145492502|NCT01419236|524659538|FG000|Overall Study|Withdrawal by Subject|1|||
145492503|NCT01419236|524659539|FG001|Overall Study|Withdrawal by Subject|4|||
145492504|NCT01419236|524659538|FG000|Overall Study|Entry Criteria Not Met|1|||
145492505|NCT01419236|524659539|FG001|Overall Study|Entry Criteria Not Met|0|||
145492506|NCT03224130|524659543|FG000|Overall Study|consent issue|0|||
145492507|NCT03224130|524659544|FG001|Overall Study|consent issue|1|||
145492508|NCT03598036|524659547|FG000|Overall Study|Withdrawal by Subject|1|||
145492509|NCT03598036|524659548|FG001|Overall Study|Withdrawal by Subject|0|||
145492510|NCT04124939|524659549|FG000|Overall Study|Lost to Follow-up|1|||
145492511|NCT04124939|524659550|FG001|Overall Study|Lost to Follow-up|3|||
145492512|NCT04607668|524659553|FG000|Overall Study|Death|49|||
145492513|NCT04607668|524659554|FG001|Overall Study|Death|26|||
145492514|NCT04607668|524659553|FG000|Overall Study|Lost to Follow-up|3|||
145492515|NCT04607668|524659554|FG001|Overall Study|Lost to Follow-up|4|||
145492516|NCT04607668|524659553|FG000|Overall Study|Study terminated by Sponsor|92|||
145492517|NCT04607668|524659554|FG001|Overall Study|Study terminated by Sponsor|114|||
145492518|NCT04607668|524659553|FG000|Overall Study|Withdrawal by Subject|12|||
145492519|NCT04607668|524659554|FG001|Overall Study|Withdrawal by Subject|11|||
145492520|NCT04607668|524659553|FG000|Overall Study|Other, unspecified|8|||
145492521|NCT04607668|524659554|FG001|Overall Study|Other, unspecified|7|||
145492522|NCT02250326|524659555|FG000|Treatment|Death|1|||
145492523|NCT02250326|524659556|FG001|Treatment|Death|13|||
145492524|NCT02250326|524659557|FG002|Treatment|Death|2|||
145492525|NCT02250326|524659555|FG000|Treatment|Adverse Event|8|||
145492526|NCT02250326|524659556|FG001|Treatment|Adverse Event|8|||
145492527|NCT02250326|524659557|FG002|Treatment|Adverse Event|9|||
145492528|NCT02250326|524659555|FG000|Treatment|Progressive Disease|42|||
145492529|NCT02250326|524659556|FG001|Treatment|Progressive Disease|40|||
145492530|NCT02250326|524659557|FG002|Treatment|Progressive Disease|47|||
145492531|NCT02250326|524659555|FG000|Treatment|Symptomatic Deterioration|9|||
145492532|NCT02250326|524659556|FG001|Treatment|Symptomatic Deterioration|4|||
145492533|NCT02250326|524659557|FG002|Treatment|Symptomatic Deterioration|10|||
145492534|NCT02250326|524659555|FG000|Treatment|Withdrawal by Subject|11|||
145492535|NCT02250326|524659556|FG001|Treatment|Withdrawal by Subject|6|||
145492536|NCT02250326|524659557|FG002|Treatment|Withdrawal by Subject|4|||
145492537|NCT02250326|524659555|FG000|Treatment|Other reasons|8|||
145492538|NCT02250326|524659556|FG001|Treatment|Other reasons|7|||
145492539|NCT02250326|524659557|FG002|Treatment|Other reasons|7|||
145492540|NCT02250326|524659555|FG000|Extension Period|Progressive Disease|0|||
145492541|NCT02250326|524659556|FG001|Extension Period|Progressive Disease|2|||
145492542|NCT02250326|524659557|FG002|Extension Period|Progressive Disease|0|||
145492543|NCT02250326|524659555|FG000|Extension Period|Withdrawal by Subject|0|||
145492544|NCT02250326|524659556|FG001|Extension Period|Withdrawal by Subject|1|||
145492545|NCT02250326|524659557|FG002|Extension Period|Withdrawal by Subject|0|||
145492546|NCT02250326|524659555|FG000|Extension Period|Withdrawal by investigator|0|||
145492547|NCT02250326|524659556|FG001|Extension Period|Withdrawal by investigator|1|||
145492548|NCT02250326|524659557|FG002|Extension Period|Withdrawal by investigator|0|||
145492549|NCT04516746|524659560|FG000|Overall Study|Randomized but not Treated|51|||
145492550|NCT04516746|524659561|FG001|Overall Study|Randomized but not Treated|19|||
145492551|NCT04516746|524659560|FG000|Overall Study|Adverse Event|0|||
145492552|NCT04516746|524659561|FG001|Overall Study|Adverse Event|1|||
145492553|NCT04516746|524659560|FG000|Overall Study|Death|62|||
145492554|NCT04516746|524659561|FG001|Overall Study|Death|32|||
145492555|NCT04516746|524659560|FG000|Overall Study|Lost to Follow-up|3431|||
145492556|NCT04516746|524659561|FG001|Overall Study|Lost to Follow-up|1831|||
145492557|NCT04516746|524659560|FG000|Overall Study|Withdrawal by Subject|1946|||
145492558|NCT04516746|524659561|FG001|Overall Study|Withdrawal by Subject|1696|||
145492559|NCT04516746|524659560|FG000|Overall Study|Physician Decision|10|||
145492560|NCT04516746|524659561|FG001|Overall Study|Physician Decision|8|||
145492561|NCT04516746|524659560|FG000|Overall Study|Other|35|||
145492562|NCT04516746|524659561|FG001|Overall Study|Other|16|||
145492563|NCT01751061|524659562|FG000|Overall Study|Death|1|||
145492564|NCT01751061|524659563|FG001|Overall Study|Death|0|||
145492565|NCT01751061|524659562|FG000|Overall Study|patient death|5|||
145492566|NCT01751061|524659563|FG001|Overall Study|patient death|0|||
145492567|NCT01751061|524659562|FG000|Overall Study|Lost to Follow-up|40|||
145492568|NCT01751061|524659563|FG001|Overall Study|Lost to Follow-up|25|||
145492569|NCT01751061|524659562|FG000|Overall Study|patient regained decisional capacity|4|||
145492570|NCT01751061|524659563|FG001|Overall Study|patient regained decisional capacity|8|||
145492571|NCT01751061|524659562|FG000|Overall Study|Withdrawal by Subject|4|||
145492572|NCT01751061|524659563|FG001|Overall Study|Withdrawal by Subject|1|||
145492573|NCT01751061|524659562|FG000|Overall Study|Physician Decision|2|||
145492574|NCT01751061|524659563|FG001|Overall Study|Physician Decision|0|||
145492575|NCT03760029|524659568|FG000|Overall Study|Death|1|||
145492576|NCT03760029|524659569|FG001|Overall Study|Death|0|||
145492577|NCT03760029|524659570|FG002|Overall Study|Death|0|||
145492578|NCT03760029|524659568|FG000|Overall Study|Lost to Follow-up|0|||
145266520|NCT02594384|523825215|FG001|Overall Study|Withdrawal by Subject|0|||
145492579|NCT03760029|524659569|FG001|Overall Study|Lost to Follow-up|2|||
145492580|NCT03760029|524659570|FG002|Overall Study|Lost to Follow-up|1|||
145492581|NCT03760029|524659568|FG000|Overall Study|Withdrawal by Subject|1|||
145492582|NCT03760029|524659569|FG001|Overall Study|Withdrawal by Subject|4|||
145492583|NCT03760029|524659570|FG002|Overall Study|Withdrawal by Subject|1|||
145492584|NCT03760029|524659568|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145492585|NCT03760029|524659569|FG001|Overall Study|Withdrawal by parent/guardian|4|||
145492586|NCT03760029|524659570|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145492587|NCT03760029|524659568|FG000|Overall Study|Other|2|||
145492588|NCT03760029|524659569|FG001|Overall Study|Other|1|||
145492589|NCT03760029|524659570|FG002|Overall Study|Other|0|||
145492590|NCT03532542|524659571|FG000|Overall Study|Death|1|||
145492591|NCT03532542|524659572|FG001|Overall Study|Death|0|||
145492592|NCT03532542|524659571|FG000|Overall Study|Study Terminated by Sponsor|41|||
145492593|NCT03532542|524659572|FG001|Overall Study|Study Terminated by Sponsor|65|||
145492594|NCT03532542|524659571|FG000|Overall Study|Withdrawal by Subject|6|||
145492595|NCT03532542|524659572|FG001|Overall Study|Withdrawal by Subject|5|||
145492596|NCT00436332|524659573|FG000|Overall Study|Adverse Event|9|||
145492597|NCT00436332|524659573|FG000|Overall Study|Withdrawal by Subject|2|||
145492598|NCT00436332|524659573|FG000|Overall Study|Progression|59|||
145492599|NCT00436332|524659573|FG000|Overall Study|Death|2|||
145492600|NCT00436332|524659573|FG000|Overall Study|Not Protocol Specified|6|||
145492601|NCT00436332|524659573|FG000|Overall Study|Ineligible|2|||
145492602|NCT00436332|524659573|FG000|Overall Study|Never Received Treatment|3|||
145492603|NCT04698343|524659574|FG000|Overall Study|Withdrawal by Subject|6|||
145492604|NCT04698343|524659574|FG000|Overall Study|Physician Decision|2|||
145492605|NCT04698343|524659574|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
145492606|NCT04698343|524659574|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
145492607|NCT04698343|524659574|FG000|Overall Study|Personal reasons|3|||
145492608|NCT04698343|524659574|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
145492609|NCT00286442|524659575|FG000|Overall Study|Hyperglycemic Rescue|19|||
145492610|NCT00286442|524659576|FG001|Overall Study|Hyperglycemic Rescue|17|||
145492611|NCT00286442|524659577|FG002|Overall Study|Hyperglycemic Rescue|25|||
145492612|NCT00286442|524659575|FG000|Overall Study|Adverse Event|7|||
145492613|NCT00286442|524659576|FG001|Overall Study|Adverse Event|6|||
145492614|NCT00286442|524659577|FG002|Overall Study|Adverse Event|1|||
145492615|NCT00286442|524659575|FG000|Overall Study|Protocol Violation|2|||
145492616|NCT00286442|524659576|FG001|Overall Study|Protocol Violation|4|||
145492617|NCT00286442|524659577|FG002|Overall Study|Protocol Violation|2|||
145492618|NCT00286442|524659575|FG000|Overall Study|Lost to Follow-up|5|||
145492619|NCT00286442|524659576|FG001|Overall Study|Lost to Follow-up|2|||
145492620|NCT00286442|524659577|FG002|Overall Study|Lost to Follow-up|1|||
145492621|NCT00286442|524659575|FG000|Overall Study|Physician Decision|1|||
145492622|NCT00286442|524659576|FG001|Overall Study|Physician Decision|1|||
145492623|NCT00286442|524659577|FG002|Overall Study|Physician Decision|1|||
145492624|NCT00286442|524659575|FG000|Overall Study|Administrative Error|1|||
145492625|NCT00286442|524659576|FG001|Overall Study|Administrative Error|1|||
145492626|NCT00286442|524659577|FG002|Overall Study|Administrative Error|0|||
145492627|NCT00286442|524659575|FG000|Overall Study|Withdrawal by Subject|2|||
145492628|NCT00286442|524659576|FG001|Overall Study|Withdrawal by Subject|14|||
145492629|NCT00286442|524659577|FG002|Overall Study|Withdrawal by Subject|2|||
145492630|NCT02756338|524659578|FG000|Overall Study|Withdrawn by Investigator|1|||
145492631|NCT02756338|524659578|FG000|Overall Study|Device Replaced with Pacemaker|4|||
145492632|NCT01339689|524659579|FG000|Overall Study|Adverse Event|1|||
145492633|NCT01339689|524659580|FG001|Overall Study|Adverse Event|2|||
145492634|NCT01339689|524659579|FG000|Overall Study|Lost to Follow-up|9|||
145492635|NCT01339689|524659580|FG001|Overall Study|Lost to Follow-up|3|||
145492636|NCT01339689|524659579|FG000|Overall Study|Withdrawal by Subject|3|||
145492637|NCT01339689|524659580|FG001|Overall Study|Withdrawal by Subject|0|||
145492638|NCT01339689|524659579|FG000|Overall Study|Noncompliance|1|||
145492639|NCT01339689|524659580|FG001|Overall Study|Noncompliance|0|||
145492640|NCT01339689|524659579|FG000|Overall Study|Relocated out of area|0|||
145492641|NCT01339689|524659580|FG001|Overall Study|Relocated out of area|1|||
145492642|NCT01339689|524659579|FG000|Overall Study|Other|2|||
145492643|NCT01339689|524659580|FG001|Overall Study|Other|2|||
145492644|NCT01339689|524659579|FG000|Overall Study|multiple reasons|1|||
145492645|NCT01339689|524659580|FG001|Overall Study|multiple reasons|1|||
145492646|NCT00467740|524659581|FG000|Overall Study|Adverse Event|0|||
145492647|NCT00467740|524659582|FG001|Overall Study|Adverse Event|0|||
145492648|NCT00467740|524659583|FG002|Overall Study|Adverse Event|1|||
145492649|NCT00467740|524659584|FG003|Overall Study|Adverse Event|0|||
145492650|NCT00467740|524659585|FG004|Overall Study|Adverse Event|0|||
145492651|NCT00467740|524659581|FG000|Overall Study|Protocol Violation|0|||
145492652|NCT00467740|524659582|FG001|Overall Study|Protocol Violation|0|||
145492653|NCT00467740|524659583|FG002|Overall Study|Protocol Violation|1|||
145492654|NCT00467740|524659584|FG003|Overall Study|Protocol Violation|0|||
145492655|NCT00467740|524659585|FG004|Overall Study|Protocol Violation|0|||
145492656|NCT00467740|524659581|FG000|Overall Study|Lost to Follow-up|0|||
145492657|NCT00467740|524659582|FG001|Overall Study|Lost to Follow-up|1|||
145492658|NCT00467740|524659583|FG002|Overall Study|Lost to Follow-up|0|||
145492659|NCT00467740|524659584|FG003|Overall Study|Lost to Follow-up|0|||
145492660|NCT00467740|524659585|FG004|Overall Study|Lost to Follow-up|0|||
145492661|NCT00467740|524659581|FG000|Overall Study|Withdrawal by Subject|1|||
145492662|NCT00467740|524659582|FG001|Overall Study|Withdrawal by Subject|1|||
145492663|NCT00467740|524659583|FG002|Overall Study|Withdrawal by Subject|0|||
145492664|NCT00467740|524659584|FG003|Overall Study|Withdrawal by Subject|1|||
145492665|NCT00467740|524659585|FG004|Overall Study|Withdrawal by Subject|0|||
145492666|NCT00467740|524659581|FG000|Overall Study|Lack of Efficacy|0|||
145492667|NCT00467740|524659582|FG001|Overall Study|Lack of Efficacy|1|||
145492668|NCT00467740|524659583|FG002|Overall Study|Lack of Efficacy|0|||
145492669|NCT00467740|524659584|FG003|Overall Study|Lack of Efficacy|0|||
145492670|NCT00467740|524659585|FG004|Overall Study|Lack of Efficacy|0|||
145492671|NCT00730158|524659586|FG000|Overall Study|Withdrawal by Subject|1|||
145492672|NCT00730158|524659587|FG001|Overall Study|Withdrawal by Subject|1|||
145492673|NCT04999839|524659588|FG000|Overall Study|Adverse Event|1|||
145492674|NCT04999839|524659589|FG001|Overall Study|Adverse Event|1|||
145492675|NCT04999839|524659590|FG002|Overall Study|Adverse Event|1|||
145492676|NCT04999839|524659591|FG003|Overall Study|Adverse Event|1|||
145492677|NCT04999839|524659592|FG004|Overall Study|Adverse Event|1|||
145492678|NCT04999839|524659588|FG000|Overall Study|Lost to Follow-up|2|||
145492679|NCT04999839|524659589|FG001|Overall Study|Lost to Follow-up|0|||
145492680|NCT04999839|524659590|FG002|Overall Study|Lost to Follow-up|2|||
145492681|NCT04999839|524659591|FG003|Overall Study|Lost to Follow-up|4|||
145492682|NCT04999839|524659592|FG004|Overall Study|Lost to Follow-up|1|||
145492683|NCT04999839|524659588|FG000|Overall Study|Withdrawal by Subject|6|||
145492684|NCT04999839|524659589|FG001|Overall Study|Withdrawal by Subject|5|||
145492685|NCT04999839|524659590|FG002|Overall Study|Withdrawal by Subject|3|||
145492686|NCT04999839|524659591|FG003|Overall Study|Withdrawal by Subject|2|||
145492687|NCT04999839|524659592|FG004|Overall Study|Withdrawal by Subject|2|||
145492688|NCT04999839|524659588|FG000|Overall Study|Lack of Efficacy|0|||
145492689|NCT04999839|524659589|FG001|Overall Study|Lack of Efficacy|1|||
145492690|NCT04999839|524659590|FG002|Overall Study|Lack of Efficacy|0|||
145492691|NCT04999839|524659591|FG003|Overall Study|Lack of Efficacy|0|||
145492692|NCT04999839|524659592|FG004|Overall Study|Lack of Efficacy|0|||
145492693|NCT04999839|524659588|FG000|Overall Study|Physician Decision|0|||
145492694|NCT04999839|524659589|FG001|Overall Study|Physician Decision|0|||
145492695|NCT04999839|524659590|FG002|Overall Study|Physician Decision|0|||
145492696|NCT04999839|524659591|FG003|Overall Study|Physician Decision|0|||
145492697|NCT04999839|524659592|FG004|Overall Study|Physician Decision|1|||
145492698|NCT04999839|524659588|FG000|Overall Study|Sponsor request|0|||
145492699|NCT04999839|524659589|FG001|Overall Study|Sponsor request|1|||
145492700|NCT04999839|524659590|FG002|Overall Study|Sponsor request|0|||
145492701|NCT04999839|524659591|FG003|Overall Study|Sponsor request|0|||
145492702|NCT04999839|524659592|FG004|Overall Study|Sponsor request|0|||
145492703|NCT04999839|524659588|FG000|Overall Study|Other|0|||
145492704|NCT04999839|524659589|FG001|Overall Study|Other|0|||
145492705|NCT04999839|524659590|FG002|Overall Study|Other|1|||
145492706|NCT04999839|524659591|FG003|Overall Study|Other|0|||
145492707|NCT04999839|524659592|FG004|Overall Study|Other|0|||
145492708|NCT03740048|524659593|FG000|Overall Study|Withdrawal by Subject|1|||
145492709|NCT03740048|524659594|FG001|Overall Study|Withdrawal by Subject|1|||
145492710|NCT03740048|524659593|FG000|Overall Study|Death|1|||
145492711|NCT03740048|524659594|FG001|Overall Study|Death|6|||
145492712|NCT03740048|524659593|FG000|Overall Study|Switched to thrice-weekly HD|2|||
145492713|NCT03740048|524659594|FG001|Overall Study|Switched to thrice-weekly HD|0|||
145492714|NCT03740048|524659593|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
145492715|NCT03740048|524659594|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
145492716|NCT03740048|524659593|FG000|Overall Study|Lost to Follow-up|0|||
145492717|NCT03740048|524659594|FG001|Overall Study|Lost to Follow-up|1|||
145492718|NCT03740048|524659593|FG000|Overall Study|Non-compliance with HD|0|||
145492719|NCT03740048|524659594|FG001|Overall Study|Non-compliance with HD|1|||
145492720|NCT01476722|524659596|FG000|Overall Study|Adverse Event|1|||
145492721|NCT03261336|524659597|FG000|Overall Study|Adverse Event|1|||
145492722|NCT00292942|524659599|FG000|Overall Study|Withdrawal by Subject|0|||
145492723|NCT00292942|524659600|FG001|Overall Study|Withdrawal by Subject|0|||
145492724|NCT00292942|524659601|FG002|Overall Study|Withdrawal by Subject|1|||
145492725|NCT00292942|524659602|FG003|Overall Study|Withdrawal by Subject|0|||
145492726|NCT00292942|524659599|FG000|Overall Study|Adverse Event|0|||
145492727|NCT00292942|524659600|FG001|Overall Study|Adverse Event|0|||
145492728|NCT00292942|524659601|FG002|Overall Study|Adverse Event|0|||
145492729|NCT00292942|524659602|FG003|Overall Study|Adverse Event|1|||
145492730|NCT00644358|524659603|FG000|Overall Study|Adverse Event|124|||
145492731|NCT00644358|524659603|FG000|Overall Study|Lost to Follow-up|105|||
145492732|NCT00644358|524659603|FG000|Overall Study|Consent Withdrawal|64|||
145492733|NCT00644358|524659603|FG000|Overall Study|Lack of Effectiveness|39|||
145492734|NCT00644358|524659603|FG000|Overall Study|Protocol Violation|5|||
145492735|NCT00644358|524659603|FG000|Overall Study|Noncompliance|14|||
145492736|NCT00644358|524659603|FG000|Overall Study|Other Unspecified|11|||
145492737|NCT00758771|524659609|FG000|Overall Study|Withdrawal by Subject|1|||
145492738|NCT00758771|524659610|FG001|Overall Study|Withdrawal by Subject|1|||
145492739|NCT00758771|524659609|FG000|Overall Study|Did not meet eligibility criteria|2|||
145492740|NCT00758771|524659610|FG001|Overall Study|Did not meet eligibility criteria|4|||
145492741|NCT00528957|524659611|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
145492742|NCT00528957|524659612|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
145492743|NCT00528957|524659611|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
145492744|NCT00528957|524659612|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
145492745|NCT00528957|524659611|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
145492746|NCT00528957|524659612|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
145492747|NCT00528957|524659611|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
145492748|NCT00528957|524659612|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
145492749|NCT00528957|524659611|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
145492750|NCT00528957|524659612|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
145492751|NCT00528957|524659611|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
145492752|NCT00528957|524659612|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
145492753|NCT00528957|524659611|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
145492754|NCT00528957|524659612|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
145492755|NCT00528957|524659611|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
145492756|NCT00528957|524659612|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
145492757|NCT00528957|524659611|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
145492758|NCT00528957|524659612|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
145492759|NCT00528957|524659611|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
145492760|NCT00528957|524659612|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
145492761|NCT00528957|524659611|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
145492762|NCT00528957|524659612|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
145492763|NCT00528957|524659611|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
145492764|NCT00528957|524659612|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
145492765|NCT00528957|524659611|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
145492766|NCT00528957|524659612|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
145492767|NCT00528957|524659611|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
145492768|NCT00528957|524659612|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
145492769|NCT00528957|524659611|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
145492770|NCT00528957|524659612|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
145492771|NCT00528957|524659611|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
145492772|NCT00528957|524659612|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
145492773|NCT00539981|524659613|FG000|Overall Study|Adverse events (AE)|3|||
145492774|NCT00539981|524659614|FG001|Overall Study|Adverse events (AE)|3|||
145492775|NCT00539981|524659613|FG000|Overall Study|Lost to Follow-up|260|||
145719428|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
145719429|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
145492776|NCT00539981|524659614|FG001|Overall Study|Lost to Follow-up|251|||
145492777|NCT00539981|524659613|FG000|Overall Study|Withdrew consent|22|||
145492778|NCT00539981|524659614|FG001|Overall Study|Withdrew consent|14|||
145492779|NCT00539981|524659613|FG000|Overall Study|Death|1|||
145492780|NCT00539981|524659614|FG001|Overall Study|Death|1|||
145492781|NCT00539981|524659613|FG000|Overall Study|Other reason-unspecified|9|||
145492782|NCT00539981|524659614|FG001|Overall Study|Other reason-unspecified|13|||
145492783|NCT01323582|524659615|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
145492784|NCT01323582|524659616|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
145492785|NCT01323582|524659615|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
145492786|NCT01323582|524659616|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
145492787|NCT01323582|524659615|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
145492788|NCT01323582|524659616|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
145492789|NCT01759420|524659617|FG000|Overall Study|Screen failure|5|||
145492790|NCT01759420|524659617|FG000|Overall Study|Inaccurate EKG machine readings|1|||
145492791|NCT01129622|524659618|FG000|Overall Study|Withdrawal by Subject|2|||
145492792|NCT02051764|524659619|FG000|Overall Study|Study terminated by sponsor|0|||
145492793|NCT02051764|524659620|FG001|Overall Study|Study terminated by sponsor|7|||
145492794|NCT00591006|524659621|FG000|Overall Study|Withdrawal by Subject|0|||
145719430|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
145719431|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
145719432|NCT01285609|525486725|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
145719433|NCT01285609|525486726|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
145719434|NCT01285609|525486725|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
145719435|NCT01285609|525486726|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
145492795|NCT00591006|524659622|FG001|Overall Study|Withdrawal by Subject|0|||
145492796|NCT00591006|524659623|FG002|Overall Study|Withdrawal by Subject|0|||
145492797|NCT00591006|524659624|FG003|Overall Study|Withdrawal by Subject|0|||
145492798|NCT00591006|524659625|FG004|Overall Study|Withdrawal by Subject|0|||
145492799|NCT00591006|524659626|FG005|Overall Study|Withdrawal by Subject|0|||
145492800|NCT00591006|524659627|FG006|Overall Study|Withdrawal by Subject|0|||
145492801|NCT00591006|524659628|FG007|Overall Study|Withdrawal by Subject|0|||
145492802|NCT00591006|524659629|FG008|Overall Study|Withdrawal by Subject|0|||
145492803|NCT00591006|524659630|FG009|Overall Study|Withdrawal by Subject|0|||
145492804|NCT00591006|524659631|FG010|Overall Study|Withdrawal by Subject|0|||
145492805|NCT00591006|524659632|FG011|Overall Study|Withdrawal by Subject|0|||
145492806|NCT00591006|524659633|FG012|Overall Study|Withdrawal by Subject|0|||
145492807|NCT00591006|524659634|FG013|Overall Study|Withdrawal by Subject|0|||
145492808|NCT00591006|524659635|FG014|Overall Study|Withdrawal by Subject|0|||
145492809|NCT00591006|524659636|FG015|Overall Study|Withdrawal by Subject|1|||
145492810|NCT00591006|524659637|FG016|Overall Study|Withdrawal by Subject|0|||
145492811|NCT00591006|524659638|FG017|Overall Study|Withdrawal by Subject|0|||
145492812|NCT00591006|524659639|FG018|Overall Study|Withdrawal by Subject|0|||
145492813|NCT00591006|524659640|FG019|Overall Study|Withdrawal by Subject|0|||
145492814|NCT00591006|524659641|FG020|Overall Study|Withdrawal by Subject|0|||
145492815|NCT00591006|524659642|FG021|Overall Study|Withdrawal by Subject|0|||
145492816|NCT00591006|524659643|FG022|Overall Study|Withdrawal by Subject|0|||
145492817|NCT00591006|524659644|FG023|Overall Study|Withdrawal by Subject|1|||
145492818|NCT00591006|524659621|FG000|Overall Study|Adverse Event|0|||
145492819|NCT00591006|524659622|FG001|Overall Study|Adverse Event|0|||
145492820|NCT00591006|524659623|FG002|Overall Study|Adverse Event|0|||
145492821|NCT00591006|524659624|FG003|Overall Study|Adverse Event|0|||
145492822|NCT00591006|524659625|FG004|Overall Study|Adverse Event|0|||
145492823|NCT00591006|524659626|FG005|Overall Study|Adverse Event|0|||
145492824|NCT00591006|524659627|FG006|Overall Study|Adverse Event|0|||
145492825|NCT00591006|524659628|FG007|Overall Study|Adverse Event|0|||
145492826|NCT00591006|524659629|FG008|Overall Study|Adverse Event|0|||
145492827|NCT00591006|524659630|FG009|Overall Study|Adverse Event|0|||
145492828|NCT00591006|524659631|FG010|Overall Study|Adverse Event|0|||
145492829|NCT00591006|524659632|FG011|Overall Study|Adverse Event|0|||
145492830|NCT00591006|524659633|FG012|Overall Study|Adverse Event|0|||
145492831|NCT00591006|524659634|FG013|Overall Study|Adverse Event|0|||
145492832|NCT00591006|524659635|FG014|Overall Study|Adverse Event|0|||
145492833|NCT00591006|524659636|FG015|Overall Study|Adverse Event|0|||
145492834|NCT00591006|524659637|FG016|Overall Study|Adverse Event|0|||
145492835|NCT00591006|524659638|FG017|Overall Study|Adverse Event|0|||
145492836|NCT00591006|524659639|FG018|Overall Study|Adverse Event|0|||
145492837|NCT00591006|524659640|FG019|Overall Study|Adverse Event|0|||
145492838|NCT00591006|524659641|FG020|Overall Study|Adverse Event|0|||
145492839|NCT00591006|524659642|FG021|Overall Study|Adverse Event|0|||
145492840|NCT00591006|524659643|FG022|Overall Study|Adverse Event|1|||
145492841|NCT00591006|524659644|FG023|Overall Study|Adverse Event|0|||
145719436|NCT04822597|525486727|FG000|Overall Study|Withdrawal by Subject|0|||
145719437|NCT04822597|525486728|FG001|Overall Study|Withdrawal by Subject|1|||
145719438|NCT04822597|525486729|FG002|Overall Study|Withdrawal by Subject|1|||
145719439|NCT04822597|525486730|FG003|Overall Study|Withdrawal by Subject|0|||
145719440|NCT04822597|525486727|FG000|Overall Study|Physician Decision|0|||
145719441|NCT04822597|525486728|FG001|Overall Study|Physician Decision|0|||
145719442|NCT04822597|525486729|FG002|Overall Study|Physician Decision|1|||
145719443|NCT04822597|525486730|FG003|Overall Study|Physician Decision|1|||
145719444|NCT04822597|525486727|FG000|Overall Study|Subject withdrawn after enrollment|0|||
145719445|NCT04822597|525486728|FG001|Overall Study|Subject withdrawn after enrollment|1|||
145719446|NCT04822597|525486729|FG002|Overall Study|Subject withdrawn after enrollment|0|||
145719447|NCT04822597|525486730|FG003|Overall Study|Subject withdrawn after enrollment|1|||
145719448|NCT04822597|525486727|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
145719449|NCT04822597|525486728|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
145719450|NCT04822597|525486729|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
145719451|NCT04822597|525486730|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
145719452|NCT00911768|525486736|FG000|Overall Study|Protocol Violation|5|||
145719453|NCT00911768|525486737|FG001|Overall Study|Protocol Violation|4|||
145719454|NCT00911768|525486736|FG000|Overall Study|Withdrawal by Subject|1|||
145719455|NCT00911768|525486737|FG001|Overall Study|Withdrawal by Subject|0|||
145492842|NCT03473236|524659646|FG000|Overall Study|Withdrawal by Subject|0|||
145492843|NCT03473236|524659647|FG001|Overall Study|Withdrawal by Subject|0|||
145492844|NCT03473236|524659648|FG002|Overall Study|Withdrawal by Subject|0|||
145492845|NCT03473236|524659649|FG003|Overall Study|Withdrawal by Subject|0|||
145492846|NCT03473236|524659650|FG004|Overall Study|Withdrawal by Subject|0|||
145492847|NCT03473236|524659651|FG005|Overall Study|Withdrawal by Subject|1|||
145492848|NCT03473236|524659652|FG006|Overall Study|Withdrawal by Subject|0|||
145492849|NCT03473236|524659653|FG007|Overall Study|Withdrawal by Subject|0|||
145492850|NCT03473236|524659654|FG008|Overall Study|Withdrawal by Subject|1|||
145719456|NCT00515853|525486739|FG000|Overall Study|Lost to Follow-up|9|||
145719457|NCT00515853|525486740|FG001|Overall Study|Lost to Follow-up|13|||
145719458|NCT00515853|525486739|FG000|Overall Study|Withdrawal by Subject|6|||
145719459|NCT00515853|525486740|FG001|Overall Study|Withdrawal by Subject|4|||
145719460|NCT00867308|525486741|FG000|Overall Study|Death|1|||
145719461|NCT00867308|525486742|FG001|Overall Study|Death|0|||
145719462|NCT00867308|525486741|FG000|Overall Study|Adverse Event|1|||
145719463|NCT00867308|525486742|FG001|Overall Study|Adverse Event|4|||
145719464|NCT00867308|525486741|FG000|Overall Study|Lack of Efficacy|6|||
145719465|NCT00867308|525486742|FG001|Overall Study|Lack of Efficacy|12|||
145719466|NCT00867308|525486741|FG000|Overall Study|Withdrawal by Subject|1|||
145719467|NCT00867308|525486742|FG001|Overall Study|Withdrawal by Subject|2|||
145719468|NCT01022268|525488689|FG000|Overall Study|Withdrawal by Subject|1|||
145719469|NCT01022268|525488690|FG001|Overall Study|Withdrawal by Subject|0|||
145719470|NCT01022268|525488689|FG000|Overall Study|Withdrawal by Subject|1|||
145719471|NCT01022268|525488690|FG001|Overall Study|Withdrawal by Subject|0|||
145719472|NCT00932113|525488695|FG000|Overall Study|Lost to Follow-up|1|||
145719473|NCT00932113|525488696|FG001|Overall Study|Lost to Follow-up|0|||
145719474|NCT01403610|525488697|FG000|Overall Study|Withdrawal by Subject|2|||
145719475|NCT01403610|525488698|FG001|Overall Study|Withdrawal by Subject|0|||
145719476|NCT01403610|525488699|FG002|Overall Study|Withdrawal by Subject|0|||
145719477|NCT01403610|525488700|FG003|Overall Study|Withdrawal by Subject|0|||
145719478|NCT01403610|525488697|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
145719479|NCT01403610|525488698|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
145719480|NCT01403610|525488699|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
145719481|NCT01403610|525488700|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
145719482|NCT01190514|525488701|FG000|First Intervention (Period 1)|Adverse Event|1|||
145719483|NCT01190514|525488702|FG001|First Intervention (Period 1)|Adverse Event|0|||
145719484|NCT01190514|525488703|FG002|First Intervention (Period 1)|Adverse Event|0|||
145719485|NCT01190514|525488704|FG003|First Intervention (Period 1)|Adverse Event|0|||
145719486|NCT01190514|525488701|FG000|Third Intervention (Period 3)|Adverse Event|1|||
145719487|NCT01190514|525488702|FG001|Third Intervention (Period 3)|Adverse Event|0|||
145719488|NCT01190514|525488703|FG002|Third Intervention (Period 3)|Adverse Event|0|||
145719489|NCT01190514|525488704|FG003|Third Intervention (Period 3)|Adverse Event|0|||
145719490|NCT01775475|525488710|FG000|Overall Study|Death|3|||
145719491|NCT01775475|525488711|FG001|Overall Study|Death|3|||
145719492|NCT00896051|525488713|FG000|Overall Study|Adverse Event|2|||
145719493|NCT00896051|525488714|FG001|Overall Study|Adverse Event|1|||
145719494|NCT00896051|525488713|FG000|Overall Study|Lost to Follow-up|3|||
145719495|NCT00896051|525488714|FG001|Overall Study|Lost to Follow-up|2|||
145719496|NCT00896051|525488713|FG000|Overall Study|Withdrawal by Subject|3|||
145719497|NCT00896051|525488714|FG001|Overall Study|Withdrawal by Subject|2|||
145719498|NCT00896051|525488713|FG000|Overall Study|Subject noncompliant|1|||
145719499|NCT00896051|525488714|FG001|Overall Study|Subject noncompliant|3|||
145719500|NCT00896051|525488713|FG000|Overall Study|Other|1|||
145719501|NCT00896051|525488714|FG001|Overall Study|Other|1|||
145719502|NCT02935452|525488715|FG000|Overall Study|work and life commintment|3|||
145719503|NCT02935452|525488716|FG001|Overall Study|work and life commintment|1|||
145719504|NCT03103763|525488717|FG000|Overall Study|Death|15|||
145719505|NCT03103763|525488718|FG001|Overall Study|Death|5|||
145719506|NCT03103763|525488719|FG002|Overall Study|Death|5|||
145719507|NCT03103763|525488717|FG000|Overall Study|Withdrawal by Subject|0|||
145719508|NCT03103763|525488718|FG001|Overall Study|Withdrawal by Subject|3|||
145719509|NCT03103763|525488719|FG002|Overall Study|Withdrawal by Subject|2|||
145719510|NCT00618982|525488720|FG000|Overall Study|Adverse Event|23|||
145719511|NCT00618982|525488720|FG000|Overall Study|Withdrawal by Subject|1|||
145719512|NCT00618982|525488720|FG000|Overall Study|Protocol Violation|1|||
145719513|NCT00618982|525488720|FG000|Overall Study|ongoing, still treated with study med.|25|||
145719514|NCT00717067|525488723|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
145719515|NCT00717067|525488724|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
145719516|NCT00717067|525488725|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
145719517|NCT00717067|525488726|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
145719518|NCT00717067|525488727|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
145719519|NCT00822172|525488730|FG000|Overall Study|Adverse Event|10|||
145719520|NCT00822172|525488731|FG001|Overall Study|Adverse Event|12|||
145719521|NCT00822172|525488730|FG000|Overall Study|Death|1|||
145719522|NCT00822172|525488731|FG001|Overall Study|Death|0|||
145719523|NCT00822172|525488730|FG000|Overall Study|Lost to Follow-up|3|||
145719524|NCT00822172|525488731|FG001|Overall Study|Lost to Follow-up|1|||
145719525|NCT00822172|525488730|FG000|Overall Study|Withdrawal by Subject|1|||
145719526|NCT00822172|525488731|FG001|Overall Study|Withdrawal by Subject|4|||
145719527|NCT00822172|525488730|FG000|Overall Study|site closed|0|||
145719528|NCT00822172|525488731|FG001|Overall Study|site closed|1|||
145719529|NCT00822172|525488730|FG000|Overall Study|Other|0|||
145719530|NCT00822172|525488731|FG001|Overall Study|Other|1|||
145719531|NCT00700258|525488732|FG000|Overall Study|Premature discontinuation of documentation|136|||
145719532|NCT00700258|525488732|FG000|Overall Study|Type of study end not documented|1|||
145719533|NCT00700258|525488732|FG000|Overall Study|Lost to Follow-up|81|||
145719534|NCT00700258|525488732|FG000|Overall Study|Premature discontinuation of therapy|1013|||
145719535|NCT00370331|525488733|FG000|Overall Study|Adverse Event|4|||
145719536|NCT00370331|525488734|FG001|Overall Study|Adverse Event|13|||
145719537|NCT00370331|525488733|FG000|Overall Study|Withdrawal by Subject|2|||
145719538|NCT00370331|525488734|FG001|Overall Study|Withdrawal by Subject|4|||
145719539|NCT00370331|525488733|FG000|Overall Study|Lost to Follow-up|0|||
145719540|NCT00370331|525488734|FG001|Overall Study|Lost to Follow-up|3|||
145719541|NCT00370331|525488733|FG000|Overall Study|Lack of Efficacy|0|||
145719542|NCT00370331|525488734|FG001|Overall Study|Lack of Efficacy|1|||
145719543|NCT00370331|525488733|FG000|Overall Study|Non-compliance|0|||
145719544|NCT00370331|525488734|FG001|Overall Study|Non-compliance|1|||
145719545|NCT00370331|525488733|FG000|Overall Study|Protocol Violation|1|||
145719546|NCT00370331|525488734|FG001|Overall Study|Protocol Violation|1|||
145719547|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
145719548|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
145719549|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
145719550|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
145719551|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
145719552|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
145719553|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
145719554|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
145719555|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
145719556|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
145719557|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
145719558|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
145719559|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
145719560|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
145719561|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
145719562|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
145719563|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
145719564|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
145719565|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
145719566|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
145719567|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
145719568|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
145719569|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
145719570|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
145719571|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
145719572|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
145719573|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
145719574|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
145719575|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
145719576|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
145719577|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
145719578|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
145719579|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
145719580|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
145719581|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
145719582|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
145492851|NCT03473236|524659655|FG009|Overall Study|Withdrawal by Subject|0|||
145492852|NCT03155724|524659657|FG000|Overall Study|Death|3|||
145492853|NCT03155724|524659657|FG000|Overall Study|Physician Decision|1|||
145492854|NCT03155724|524659657|FG000|Overall Study|Study closure|7|||
145492855|NCT00525512|524659658|FG000|Double-Blind Phase|Adverse Event|48|||
145492856|NCT00525512|524659659|FG001|Double-Blind Phase|Adverse Event|28|||
145492857|NCT00525512|524659660|FG002|Double-Blind Phase|Adverse Event|0|||
145492858|NCT00525512|524659661|FG003|Double-Blind Phase|Adverse Event|0|||
145719583|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
145719584|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
145719585|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
145492859|NCT00525512|524659658|FG000|Double-Blind Phase|Protocol Violation|3|||
145492860|NCT00525512|524659659|FG001|Double-Blind Phase|Protocol Violation|1|||
145492861|NCT00525512|524659660|FG002|Double-Blind Phase|Protocol Violation|0|||
145492862|NCT00525512|524659661|FG003|Double-Blind Phase|Protocol Violation|0|||
145719586|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
145719587|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
145719588|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
145719589|NCT01160289|525488735|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
145492863|NCT00525512|524659658|FG000|Double-Blind Phase|Lost to Follow-up|3|||
145492864|NCT00525512|524659659|FG001|Double-Blind Phase|Lost to Follow-up|7|||
145492865|NCT00525512|524659660|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145492866|NCT00525512|524659661|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145719590|NCT01160289|525488736|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
145719591|NCT01160289|525488737|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
145719592|NCT01160289|525488738|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
145492867|NCT00525512|524659658|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
145492868|NCT00525512|524659659|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
145492869|NCT00525512|524659660|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145492870|NCT00525512|524659661|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145492871|NCT00525512|524659658|FG000|Double-Blind Phase|Lack of Efficacy|13|||
145492872|NCT00525512|524659659|FG001|Double-Blind Phase|Lack of Efficacy|5|||
145492873|NCT00525512|524659660|FG002|Double-Blind Phase|Lack of Efficacy|0|||
145492874|NCT00525512|524659661|FG003|Double-Blind Phase|Lack of Efficacy|0|||
145492875|NCT00525512|524659658|FG000|Double-Blind Phase|Other reason (not specified)|12|||
145492876|NCT00525512|524659659|FG001|Double-Blind Phase|Other reason (not specified)|13|||
145492877|NCT00525512|524659660|FG002|Double-Blind Phase|Other reason (not specified)|0|||
145492878|NCT00525512|524659661|FG003|Double-Blind Phase|Other reason (not specified)|0|||
145492879|NCT00525512|524659658|FG000|Open-Label Phase|Adverse Event|0|||
145492880|NCT00525512|524659659|FG001|Open-Label Phase|Adverse Event|0|||
145492881|NCT00525512|524659660|FG002|Open-Label Phase|Adverse Event|1|||
145492882|NCT00525512|524659661|FG003|Open-Label Phase|Adverse Event|0|||
145492883|NCT00525512|524659658|FG000|Open-Label Phase|Lost to Follow-up|0|||
145492884|NCT00525512|524659659|FG001|Open-Label Phase|Lost to Follow-up|0|||
145492885|NCT00525512|524659660|FG002|Open-Label Phase|Lost to Follow-up|1|||
145492886|NCT00525512|524659661|FG003|Open-Label Phase|Lost to Follow-up|0|||
145492887|NCT00525512|524659658|FG000|Open-Label Phase|Other reason (not specified)|0|||
145492888|NCT00525512|524659659|FG001|Open-Label Phase|Other reason (not specified)|0|||
145492889|NCT00525512|524659660|FG002|Open-Label Phase|Other reason (not specified)|4|||
145492890|NCT00525512|524659661|FG003|Open-Label Phase|Other reason (not specified)|5|||
145492891|NCT05893862|524659666|FG000|Overall Study|Physician Decision|0|||
145492892|NCT05893862|524659667|FG001|Overall Study|Physician Decision|1|||
145492893|NCT05893862|524659668|FG002|Overall Study|Physician Decision|0|||
145492894|NCT05893862|524659669|FG003|Overall Study|Physician Decision|0|||
145492895|NCT05893862|524659670|FG004|Overall Study|Physician Decision|1|||
145492896|NCT05893862|524659671|FG005|Overall Study|Physician Decision|0|||
145492897|NCT05893862|524659666|FG000|Overall Study|Withdrawal by Subject|1|||
145492898|NCT05893862|524659667|FG001|Overall Study|Withdrawal by Subject|7|||
145492899|NCT05893862|524659668|FG002|Overall Study|Withdrawal by Subject|1|||
145492900|NCT05893862|524659669|FG003|Overall Study|Withdrawal by Subject|3|||
145492901|NCT05893862|524659670|FG004|Overall Study|Withdrawal by Subject|3|||
145492902|NCT05893862|524659671|FG005|Overall Study|Withdrawal by Subject|2|||
145492903|NCT05893862|524659666|FG000|Overall Study|Adverse Event|1|||
145492904|NCT05893862|524659667|FG001|Overall Study|Adverse Event|4|||
145492905|NCT05893862|524659668|FG002|Overall Study|Adverse Event|2|||
145492906|NCT05893862|524659669|FG003|Overall Study|Adverse Event|2|||
145492907|NCT05893862|524659670|FG004|Overall Study|Adverse Event|1|||
145492908|NCT05893862|524659671|FG005|Overall Study|Adverse Event|0|||
145492909|NCT02919761|524659672|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
145492910|NCT02919761|524659673|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
145719593|NCT01160289|525488739|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
145719594|NCT01160289|525488740|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
145719595|NCT01160289|525488735|FG000|Post-Randomization Period|Adverse Event|0|||
145719596|NCT01160289|525488736|FG001|Post-Randomization Period|Adverse Event|4|||
145719597|NCT01160289|525488737|FG002|Post-Randomization Period|Adverse Event|4|||
145719598|NCT01160289|525488738|FG003|Post-Randomization Period|Adverse Event|2|||
145719599|NCT01160289|525488739|FG004|Post-Randomization Period|Adverse Event|0|||
145719600|NCT01160289|525488740|FG005|Post-Randomization Period|Adverse Event|0|||
145719601|NCT01160289|525488735|FG000|Post-Randomization Period|Death|0|||
145719602|NCT01160289|525488736|FG001|Post-Randomization Period|Death|0|||
145719603|NCT01160289|525488737|FG002|Post-Randomization Period|Death|0|||
145719604|NCT01160289|525488738|FG003|Post-Randomization Period|Death|1|||
145719605|NCT01160289|525488739|FG004|Post-Randomization Period|Death|0|||
145719606|NCT01160289|525488740|FG005|Post-Randomization Period|Death|0|||
145719607|NCT01160289|525488735|FG000|Post-Randomization Period|Lack of Efficacy|0|||
145492911|NCT02919761|524659674|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
145492912|NCT02919761|524659672|FG000|Part 1: Open Label|Adverse Event|1|||
145492913|NCT02919761|524659673|FG001|Part 1: Open Label|Adverse Event|0|||
145492914|NCT02919761|524659674|FG002|Part 1: Open Label|Adverse Event|0|||
145492915|NCT02919761|524659672|FG000|Part 1: Open Label|Lost to Follow-up|1|||
145492916|NCT02919761|524659673|FG001|Part 1: Open Label|Lost to Follow-up|0|||
145719608|NCT01160289|525488736|FG001|Post-Randomization Period|Lack of Efficacy|1|||
145719609|NCT01160289|525488737|FG002|Post-Randomization Period|Lack of Efficacy|0|||
145719610|NCT01160289|525488738|FG003|Post-Randomization Period|Lack of Efficacy|3|||
145719611|NCT01160289|525488739|FG004|Post-Randomization Period|Lack of Efficacy|0|||
145719612|NCT01160289|525488740|FG005|Post-Randomization Period|Lack of Efficacy|0|||
145719613|NCT01160289|525488735|FG000|Post-Randomization Period|Lost to Follow-up|0|||
145719614|NCT01160289|525488736|FG001|Post-Randomization Period|Lost to Follow-up|3|||
145719615|NCT01160289|525488737|FG002|Post-Randomization Period|Lost to Follow-up|2|||
145719616|NCT01160289|525488738|FG003|Post-Randomization Period|Lost to Follow-up|5|||
145719617|NCT01160289|525488739|FG004|Post-Randomization Period|Lost to Follow-up|3|||
145719618|NCT01160289|525488740|FG005|Post-Randomization Period|Lost to Follow-up|4|||
145719619|NCT01160289|525488735|FG000|Post-Randomization Period|Physician Decision|0|||
145719620|NCT01160289|525488736|FG001|Post-Randomization Period|Physician Decision|0|||
145719621|NCT01160289|525488737|FG002|Post-Randomization Period|Physician Decision|1|||
145719622|NCT01160289|525488738|FG003|Post-Randomization Period|Physician Decision|0|||
145719623|NCT01160289|525488739|FG004|Post-Randomization Period|Physician Decision|0|||
145719624|NCT01160289|525488740|FG005|Post-Randomization Period|Physician Decision|0|||
145719625|NCT01160289|525488735|FG000|Post-Randomization Period|Protocol Violation|0|||
145719626|NCT01160289|525488736|FG001|Post-Randomization Period|Protocol Violation|4|||
145719627|NCT01160289|525488737|FG002|Post-Randomization Period|Protocol Violation|2|||
145719628|NCT01160289|525488738|FG003|Post-Randomization Period|Protocol Violation|0|||
145719629|NCT01160289|525488739|FG004|Post-Randomization Period|Protocol Violation|1|||
145719630|NCT01160289|525488740|FG005|Post-Randomization Period|Protocol Violation|3|||
145719631|NCT01160289|525488735|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
145719632|NCT01160289|525488736|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
145719633|NCT01160289|525488737|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
145719634|NCT01160289|525488738|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
145719635|NCT01160289|525488739|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
145719636|NCT01160289|525488740|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
145719637|NCT01160289|525488735|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
145719638|NCT01160289|525488736|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
145719639|NCT01160289|525488737|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
145719640|NCT01160289|525488738|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
145719641|NCT01160289|525488739|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
145719642|NCT01160289|525488740|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
145719643|NCT01160289|525488735|FG000|Post-Randomization Period|Sponsor Decision|0|||
145719644|NCT01160289|525488736|FG001|Post-Randomization Period|Sponsor Decision|1|||
145719645|NCT01160289|525488737|FG002|Post-Randomization Period|Sponsor Decision|0|||
145719646|NCT01160289|525488738|FG003|Post-Randomization Period|Sponsor Decision|0|||
145719647|NCT01160289|525488739|FG004|Post-Randomization Period|Sponsor Decision|0|||
145719648|NCT01160289|525488740|FG005|Post-Randomization Period|Sponsor Decision|0|||
145719649|NCT00993668|525488741|FG000|Single-Blind Period|Adverse Event|1|||
145719650|NCT00993668|525488742|FG001|Single-Blind Period|Adverse Event|1|||
145719651|NCT00993668|525488741|FG000|Single-Blind Period|Lack of Efficacy|0|||
145719652|NCT00993668|525488742|FG001|Single-Blind Period|Lack of Efficacy|1|||
145492917|NCT02919761|524659674|FG002|Part 1: Open Label|Lost to Follow-up|0|||
145492918|NCT02919761|524659672|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
145492919|NCT02919761|524659673|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
145492920|NCT02919761|524659674|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
145492921|NCT02919761|524659672|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
145492922|NCT02919761|524659673|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
145492923|NCT02919761|524659674|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
145492924|NCT02919761|524659672|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
145492925|NCT02919761|524659673|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
145492926|NCT02919761|524659674|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
145492927|NCT02919761|524659672|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
145492928|NCT02919761|524659673|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
145492929|NCT02919761|524659674|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
145492930|NCT02919761|524659672|FG000|Part 1: Open Label|Termination by Sponsor|1|||
145492931|NCT02919761|524659673|FG001|Part 1: Open Label|Termination by Sponsor|0|||
145492932|NCT02919761|524659674|FG002|Part 1: Open Label|Termination by Sponsor|0|||
145492933|NCT02919761|524659672|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
145492934|NCT02919761|524659673|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
145492935|NCT02919761|524659674|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
145492936|NCT02919761|524659672|FG000|Part 2: Double-blind|Adverse Event|0|||
145492937|NCT02919761|524659673|FG001|Part 2: Double-blind|Adverse Event|1|||
145492938|NCT02919761|524659674|FG002|Part 2: Double-blind|Adverse Event|0|||
145492939|NCT02919761|524659672|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
145492940|NCT02919761|524659673|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
145492941|NCT02919761|524659674|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
145492942|NCT02919761|524659672|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
145492943|NCT02919761|524659673|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
145719653|NCT00993668|525488741|FG000|Single-Blind Period|Lost to Follow-up|3|||
145719654|NCT00993668|525488742|FG001|Single-Blind Period|Lost to Follow-up|1|||
145492944|NCT02919761|524659674|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
145492945|NCT02919761|524659672|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
145492946|NCT02919761|524659673|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
145492947|NCT02919761|524659674|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
145492948|NCT02919761|524659672|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
145492949|NCT02919761|524659673|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
145492950|NCT02919761|524659674|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
145492951|NCT02919761|524659672|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
145492952|NCT02919761|524659673|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
145492953|NCT02919761|524659674|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
145492954|NCT02919761|524659672|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
145492955|NCT02919761|524659673|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
145492956|NCT02919761|524659674|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
145492957|NCT00633477|524661086|FG000|Overall Study|Death|1|||
145492958|NCT00633477|524661087|FG001|Overall Study|Death|0|||
145492959|NCT00633477|524661086|FG000|Overall Study|Randomized but not treated|1|||
145492960|NCT00633477|524661087|FG001|Overall Study|Randomized but not treated|0|||
145492961|NCT01838694|524661096|FG000|Overall Study|Adverse Event|0|||
145492962|NCT01838694|524661097|FG001|Overall Study|Adverse Event|1|||
145492963|NCT00672555|524661099|FG000|Overall Study|Lost to Follow-up|4|||
145492964|NCT00672555|524661099|FG000|Overall Study|Did not want to answer questionnaire|2|||
145492965|NCT02153086|524661103|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
145492966|NCT02153086|524661103|FG000|Overall Study|Other|2|||
145492967|NCT00446849|524661104|FG000|Acute Phase|Lack of Efficacy|64|||
145492968|NCT00446849|524661104|FG000|Acute Phase|Protocol Violation|10|||
145492969|NCT00446849|524661104|FG000|Acute Phase|Consent withdrawn|4|||
145492970|NCT00446849|524661104|FG000|Acute Phase|Lost to Follow-up|2|||
145492971|NCT00446849|524661104|FG000|Acute Phase|Physician Decision|1|||
145492972|NCT00446849|524661104|FG000|Acute Phase|noncompliance|1|||
145492973|NCT00446849|524661104|FG000|Maintenance Phase|Lack of Efficacy|40|||
145492974|NCT00446849|524661104|FG000|Maintenance Phase|Protocol Violation|7|||
145492975|NCT00446849|524661104|FG000|Maintenance Phase|Adverse Event|6|||
145492976|NCT00446849|524661104|FG000|Maintenance Phase|Consent withdrawn|5|||
145492977|NCT00446849|524661104|FG000|Maintenance Phase|Lost to Follow-up|3|||
145492978|NCT00446849|524661104|FG000|Maintenance Phase|Pregnancy|1|||
145492979|NCT00446849|524661104|FG000|Maintenance Phase|noncompliance|2|||
145492980|NCT00446849|524661104|FG000|Maintenance Phase|prohibited medication use|2|||
145492981|NCT00446849|524661104|FG000|Maintenance Phase|antibiotic use|1|||
145492982|NCT00446849|524661104|FG000|Maintenance Phase|study closure|1|||
145492983|NCT00446849|524661104|FG000|Maintenance Phase|hydrocodone use|1|||
145492984|NCT00446849|524661104|FG000|Maintenance Phase|concomitant medication use|1|||
145492985|NCT01194830|524661105|FG000|Overall Study|Adverse Event|3|||
145492986|NCT01194830|524661106|FG001|Overall Study|Adverse Event|2|||
145492987|NCT01194830|524661105|FG000|Overall Study|Protocol Violation|5|||
145492988|NCT01194830|524661106|FG001|Overall Study|Protocol Violation|4|||
145492989|NCT01194830|524661105|FG000|Overall Study|Lost to Follow-up|9|||
145492990|NCT01194830|524661106|FG001|Overall Study|Lost to Follow-up|7|||
145492991|NCT01194830|524661105|FG000|Overall Study|Withdrawal by Subject|2|||
145492992|NCT01194830|524661106|FG001|Overall Study|Withdrawal by Subject|1|||
145492993|NCT01194830|524661105|FG000|Overall Study|Lack of Efficacy|1|||
145492994|NCT01194830|524661106|FG001|Overall Study|Lack of Efficacy|1|||
145492995|NCT01194830|524661105|FG000|Overall Study|Non-compliance issues|4|||
145492996|NCT01194830|524661106|FG001|Overall Study|Non-compliance issues|4|||
145492997|NCT01194830|524661105|FG000|Overall Study|Other Reason|12|||
145492998|NCT01194830|524661106|FG001|Overall Study|Other Reason|8|||
145492999|NCT03115359|524661107|FG000|Overall Study|Withdrawal by Subject|29|||
145493000|NCT03115359|524661108|FG001|Overall Study|Withdrawal by Subject|39|||
145493001|NCT03115359|524661107|FG000|Overall Study|Scheduling conflict|25|||
145493002|NCT03115359|524661108|FG001|Overall Study|Scheduling conflict|23|||
145493003|NCT03115359|524661107|FG000|Overall Study|Personal reasons including health|12|||
145493004|NCT03115359|524661108|FG001|Overall Study|Personal reasons including health|9|||
145493005|NCT03115359|524661107|FG000|Overall Study|Transportation barriers|3|||
145493006|NCT03115359|524661108|FG001|Overall Study|Transportation barriers|0|||
145493007|NCT03115359|524661107|FG000|Overall Study|No longer interested|5|||
145493008|NCT03115359|524661108|FG001|Overall Study|No longer interested|4|||
145493009|NCT03115359|524661107|FG000|Overall Study|No reason provided|45|||
145493010|NCT03115359|524661108|FG001|Overall Study|No reason provided|47|||
145493011|NCT01317472|524661111|FG000|Overall Study|Withdrawal by Subject|1|||
145493012|NCT01317472|524661112|FG001|Overall Study|Withdrawal by Subject|0|||
145493013|NCT01317472|524661111|FG000|Overall Study|Unrelated hospitalization|1|||
145493014|NCT01317472|524661112|FG001|Overall Study|Unrelated hospitalization|0|||
145493015|NCT01815918|524661113|FG000|Overall Study|Patient samples not analyzable|3|||
145493016|NCT01815918|524661114|FG001|Overall Study|Patient samples not analyzable|4|||
145493017|NCT01815918|524661113|FG000|Overall Study|Lack of Efficacy|15|||
145493018|NCT01815918|524661114|FG001|Overall Study|Lack of Efficacy|15|||
145493019|NCT03284710|524661117|FG000|Overall Study|Withdrawal by Subject|1|||
145493020|NCT03284710|524661118|FG001|Overall Study|Withdrawal by Subject|0|||
145493021|NCT03284710|524661119|FG002|Overall Study|Withdrawal by Subject|1|||
145493022|NCT03284710|524661120|FG003|Overall Study|Withdrawal by Subject|6|||
145493023|NCT03284710|524661117|FG000|Overall Study|Lost to Follow-up|3|||
145493024|NCT03284710|524661118|FG001|Overall Study|Lost to Follow-up|3|||
145493025|NCT03284710|524661119|FG002|Overall Study|Lost to Follow-up|1|||
145493026|NCT03284710|524661120|FG003|Overall Study|Lost to Follow-up|0|||
145493027|NCT03284710|524661117|FG000|Overall Study|Physician Decision|1|||
145493028|NCT03284710|524661118|FG001|Overall Study|Physician Decision|0|||
145493029|NCT03284710|524661119|FG002|Overall Study|Physician Decision|0|||
145493030|NCT03284710|524661120|FG003|Overall Study|Physician Decision|0|||
145493031|NCT03284710|524661117|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
145493032|NCT03284710|524661118|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
145493033|NCT03284710|524661119|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
145493034|NCT03284710|524661120|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
145493035|NCT03284710|524661117|FG000|Overall Study|HIV Infection|0|||
145493036|NCT03284710|524661118|FG001|Overall Study|HIV Infection|2|||
145493037|NCT03284710|524661119|FG002|Overall Study|HIV Infection|2|||
145493038|NCT03284710|524661120|FG003|Overall Study|HIV Infection|1|||
145493039|NCT02412306|524661123|FG000|Overall Study|Lost to Follow-up|0|||
145493040|NCT02412306|524661124|FG001|Overall Study|Lost to Follow-up|1|||
145493041|NCT02412306|524661125|FG002|Overall Study|Lost to Follow-up|0|||
145493042|NCT02412306|524661126|FG003|Overall Study|Lost to Follow-up|0|||
145493043|NCT02412306|524661127|FG004|Overall Study|Lost to Follow-up|0|||
145493044|NCT02412306|524661123|FG000|Overall Study|Withdrawal by Subject|0|||
145493045|NCT02412306|524661124|FG001|Overall Study|Withdrawal by Subject|0|||
145493046|NCT02412306|524661125|FG002|Overall Study|Withdrawal by Subject|1|||
145493047|NCT02412306|524661126|FG003|Overall Study|Withdrawal by Subject|0|||
145493048|NCT02412306|524661127|FG004|Overall Study|Withdrawal by Subject|0|||
145493049|NCT02412306|524661123|FG000|Overall Study|Death|5|||
145493050|NCT02412306|524661124|FG001|Overall Study|Death|7|||
145493051|NCT02412306|524661125|FG002|Overall Study|Death|15|||
145493052|NCT02412306|524661126|FG003|Overall Study|Death|0|||
145493053|NCT02412306|524661127|FG004|Overall Study|Death|2|||
145493054|NCT04750824|524661145|FG000|Overall Study|Toxicity/intolerability|3|||
145493055|NCT04750824|524661146|FG001|Overall Study|Toxicity/intolerability|1|||
145493056|NCT04750824|524661145|FG000|Overall Study|Death|1|||
145493057|NCT04750824|524661146|FG001|Overall Study|Death|3|||
145493058|NCT04750824|524661145|FG000|Overall Study|Scheduled duration of therapy complete|1|||
145493059|NCT04750824|524661146|FG001|Overall Study|Scheduled duration of therapy complete|9|||
145493060|NCT04750824|524661145|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
145493061|NCT04750824|524661146|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
145493062|NCT00807911|524661147|FG000|Overall Study|Withdrawal by Subject|12|||
145493063|NCT00807911|524661148|FG001|Overall Study|Withdrawal by Subject|10|||
145493064|NCT00807911|524661147|FG000|Overall Study|Ineligible|0|||
145493065|NCT00807911|524661148|FG001|Overall Study|Ineligible|4|||
145493066|NCT04349891|524661151|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
145493067|NCT04349891|524661152|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
145493068|NCT04349891|524661151|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
145493069|NCT04349891|524661152|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
145493070|NCT04349891|524661151|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
145493071|NCT04349891|524661152|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
145493072|NCT04349891|524661151|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
145493073|NCT04349891|524661152|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
145493074|NCT00836589|524661157|FG000|Overall Study|Lost to Follow-up|246|||
145493075|NCT00836589|524661157|FG000|Overall Study|Death|429|||
145493076|NCT00836589|524661157|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
145493077|NCT02914639|524661159|FG000|Overall Study|Withdrawal by Subject|0|||
145493078|NCT02914639|524661160|FG001|Overall Study|Withdrawal by Subject|2|||
145493079|NCT01018030|524661162|FG000|Overall Study|Adverse Event|10|||
145493080|NCT01018030|524661163|FG001|Overall Study|Adverse Event|5|||
145493081|NCT01018030|524661164|FG002|Overall Study|Adverse Event|5|||
145493082|NCT01018030|524661162|FG000|Overall Study|Withdrawal by Subject|2|||
145493083|NCT01018030|524661163|FG001|Overall Study|Withdrawal by Subject|2|||
145493084|NCT01018030|524661164|FG002|Overall Study|Withdrawal by Subject|4|||
145493085|NCT01018030|524661162|FG000|Overall Study|Lost to Follow-up|2|||
145493086|NCT01018030|524661163|FG001|Overall Study|Lost to Follow-up|0|||
145493087|NCT01018030|524661164|FG002|Overall Study|Lost to Follow-up|3|||
145493088|NCT01018030|524661162|FG000|Overall Study|Protocol Violation|2|||
145493089|NCT01018030|524661163|FG001|Overall Study|Protocol Violation|1|||
145493090|NCT01018030|524661164|FG002|Overall Study|Protocol Violation|0|||
145493091|NCT01018030|524661162|FG000|Overall Study|Physician Decision|1|||
145493092|NCT01018030|524661163|FG001|Overall Study|Physician Decision|0|||
145493093|NCT01018030|524661164|FG002|Overall Study|Physician Decision|1|||
145493094|NCT01018030|524661162|FG000|Overall Study|Lack of Efficacy|1|||
145493095|NCT01018030|524661163|FG001|Overall Study|Lack of Efficacy|0|||
145493096|NCT01018030|524661164|FG002|Overall Study|Lack of Efficacy|0|||
145493097|NCT01018030|524661162|FG000|Overall Study|Did Not Receive Study Drug|1|||
145493098|NCT01018030|524661163|FG001|Overall Study|Did Not Receive Study Drug|3|||
145493099|NCT01018030|524661164|FG002|Overall Study|Did Not Receive Study Drug|0|||
145493100|NCT00062439|524661165|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
145493101|NCT00062439|524661165|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
145493102|NCT00062439|524661165|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
145493103|NCT00062439|524661165|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
145493104|NCT00062439|524661165|FG000|Post Chemoradiation Assessment|Death|1|||
145493105|NCT00062439|524661165|FG000|Post Chemoradiation Assessment|Disease progression|2|||
145493106|NCT00062439|524661165|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
145493107|NCT00062439|524661165|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
145719655|NCT00993668|525488741|FG000|Open-Label Period|Adverse Event|9|||
145719656|NCT00993668|525488742|FG001|Open-Label Period|Adverse Event|8|||
145719657|NCT00993668|525488741|FG000|Open-Label Period|Lack of Efficacy|4|||
145719658|NCT00993668|525488742|FG001|Open-Label Period|Lack of Efficacy|3|||
145719659|NCT00993668|525488741|FG000|Open-Label Period|Withdrawal by Subject|4|||
145719660|NCT00993668|525488742|FG001|Open-Label Period|Withdrawal by Subject|3|||
145719661|NCT00993668|525488741|FG000|Open-Label Period|Lost to Follow-up|6|||
145719662|NCT00993668|525488742|FG001|Open-Label Period|Lost to Follow-up|1|||
145719663|NCT01029652|525488746|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
145719664|NCT01029652|525488747|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
145719665|NCT01029652|525488746|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
145719666|NCT01029652|525488747|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
145719667|NCT01029652|525488746|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
145719668|NCT01029652|525488747|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
145719669|NCT01029652|525488746|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
145719670|NCT01029652|525488747|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
145719671|NCT01029652|525488746|FG000|Core Study (0-12 Weeks)|Death|0|||
145719672|NCT01029652|525488747|FG001|Core Study (0-12 Weeks)|Death|1|||
145719673|NCT01029652|525488746|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
145719674|NCT01029652|525488747|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
145719675|NCT01029652|525488746|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
145719676|NCT01029652|525488747|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
145719677|NCT01029652|525488746|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
145719678|NCT01029652|525488747|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
145719679|NCT01029652|525488746|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
145719680|NCT01029652|525488747|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
145719681|NCT01029652|525488746|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
145719682|NCT01029652|525488747|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
145719683|NCT01029652|525488746|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
145719684|NCT01029652|525488747|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
145719685|NCT01029652|525488746|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
145719686|NCT01029652|525488747|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
145719687|NCT02313233|525488748|FG000|Overall Study|Withdrawal by Subject|1|||
145719688|NCT02313233|525488749|FG001|Overall Study|Withdrawal by Subject|2|||
145719689|NCT02313233|525488748|FG000|Overall Study|Administrative reason|1|||
145719690|NCT02313233|525488749|FG001|Overall Study|Administrative reason|1|||
145719691|NCT02095951|525488750|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
145719692|NCT02095951|525488751|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
145719693|NCT04638920|525488752|FG000|Overall Study|Withdrawal by Subject|5|||
145719694|NCT05383508|525488753|FG000|Overall Study|Withdrawal by Subject|1|||
145719695|NCT05383508|525488754|FG001|Overall Study|Withdrawal by Subject|0|||
145719696|NCT05383508|525488755|FG002|Overall Study|Withdrawal by Subject|1|||
145719697|NCT05383508|525488756|FG003|Overall Study|Withdrawal by Subject|1|||
145719698|NCT05383508|525488757|FG004|Overall Study|Withdrawal by Subject|2|||
145719699|NCT05383508|525488758|FG005|Overall Study|Withdrawal by Subject|0|||
145719700|NCT03775434|525488760|FG000|Overall Study|Adverse Event|2|||
145719701|NCT03775434|525488760|FG000|Overall Study|Withdrawal by Subject|1|||
145719702|NCT01621568|525488761|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
145719703|NCT01621568|525488762|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
145719704|NCT01621568|525488761|FG000|Week 5-6 No Treatment|Death|1|||
145719705|NCT01621568|525488762|FG001|Week 5-6 No Treatment|Death|0|||
145719706|NCT01859988|525488763|FG000|Overall Study|Withdrawal by Subject|6|||
145719707|NCT01859988|525488764|FG001|Overall Study|Withdrawal by Subject|3|||
145719708|NCT01859988|525488765|FG002|Overall Study|Withdrawal by Subject|4|||
145719709|NCT01859988|525488766|FG003|Overall Study|Withdrawal by Subject|3|||
145719710|NCT01859988|525488767|FG004|Overall Study|Withdrawal by Subject|2|||
145719711|NCT01859988|525488768|FG005|Overall Study|Withdrawal by Subject|2|||
145493108|NCT00062439|524661165|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
145493109|NCT00062439|524661165|FG000|Surgery|Physician Decision|4|||
145493110|NCT00062439|524661165|FG000|Surgery|Death|1|||
145719712|NCT01859988|525488763|FG000|Overall Study|Lack of Efficacy|1|||
145719713|NCT01859988|525488764|FG001|Overall Study|Lack of Efficacy|1|||
145719714|NCT01859988|525488765|FG002|Overall Study|Lack of Efficacy|5|||
145719715|NCT01859988|525488766|FG003|Overall Study|Lack of Efficacy|0|||
145719716|NCT01859988|525488767|FG004|Overall Study|Lack of Efficacy|7|||
145719717|NCT01859988|525488768|FG005|Overall Study|Lack of Efficacy|9|||
145719718|NCT01859988|525488763|FG000|Overall Study|Physician Decision|1|||
145719719|NCT01859988|525488764|FG001|Overall Study|Physician Decision|3|||
145719720|NCT01859988|525488765|FG002|Overall Study|Physician Decision|1|||
145719721|NCT01859988|525488766|FG003|Overall Study|Physician Decision|3|||
145719722|NCT01859988|525488767|FG004|Overall Study|Physician Decision|4|||
145719723|NCT01859988|525488768|FG005|Overall Study|Physician Decision|1|||
145719724|NCT01859988|525488763|FG000|Overall Study|Adverse Event|2|||
145719725|NCT01859988|525488764|FG001|Overall Study|Adverse Event|1|||
145719726|NCT01859988|525488765|FG002|Overall Study|Adverse Event|3|||
145719727|NCT01859988|525488766|FG003|Overall Study|Adverse Event|1|||
145719728|NCT01859988|525488767|FG004|Overall Study|Adverse Event|2|||
145719729|NCT01859988|525488768|FG005|Overall Study|Adverse Event|2|||
145719730|NCT01859988|525488763|FG000|Overall Study|Lost to Follow-up|1|||
145719731|NCT01859988|525488764|FG001|Overall Study|Lost to Follow-up|2|||
145719732|NCT01859988|525488765|FG002|Overall Study|Lost to Follow-up|3|||
145719733|NCT01859988|525488766|FG003|Overall Study|Lost to Follow-up|0|||
145719734|NCT01859988|525488767|FG004|Overall Study|Lost to Follow-up|3|||
145719735|NCT01859988|525488768|FG005|Overall Study|Lost to Follow-up|2|||
145719736|NCT01859988|525488763|FG000|Overall Study|Protocol Violation|0|||
145719737|NCT01859988|525488764|FG001|Overall Study|Protocol Violation|0|||
145719738|NCT01859988|525488765|FG002|Overall Study|Protocol Violation|1|||
145719739|NCT01859988|525488766|FG003|Overall Study|Protocol Violation|0|||
145719740|NCT01859988|525488767|FG004|Overall Study|Protocol Violation|0|||
145719741|NCT01859988|525488768|FG005|Overall Study|Protocol Violation|0|||
145719742|NCT01859988|525488763|FG000|Overall Study|Other than specified above|0|||
145719743|NCT01859988|525488764|FG001|Overall Study|Other than specified above|2|||
145719744|NCT01859988|525488765|FG002|Overall Study|Other than specified above|11|||
145719745|NCT01859988|525488766|FG003|Overall Study|Other than specified above|3|||
145719746|NCT01859988|525488767|FG004|Overall Study|Other than specified above|5|||
145719747|NCT01859988|525488768|FG005|Overall Study|Other than specified above|3|||
145719748|NCT02081417|525488769|FG000|Overall Study|Lost to Follow-up|26|||
145719749|NCT02081417|525488770|FG001|Overall Study|Lost to Follow-up|23|||
145719750|NCT02081417|525488769|FG000|Overall Study|Moved Away|1|||
145719751|NCT02081417|525488770|FG001|Overall Study|Moved Away|2|||
145719752|NCT02081417|525488769|FG000|Overall Study|Incarcerated|2|||
145719753|NCT02081417|525488770|FG001|Overall Study|Incarcerated|2|||
145719754|NCT02081417|525488769|FG000|Overall Study|Death|4|||
145719755|NCT02081417|525488770|FG001|Overall Study|Death|3|||
145719756|NCT02081417|525488769|FG000|Overall Study|Withdrawal by Subject|4|||
145719757|NCT02081417|525488770|FG001|Overall Study|Withdrawal by Subject|0|||
145719758|NCT02081417|525488769|FG000|Overall Study|Admitted to Residential Treatment|2|||
145719759|NCT02081417|525488770|FG001|Overall Study|Admitted to Residential Treatment|0|||
145719760|NCT02081417|525488769|FG000|Overall Study|Did not start treatment|17|||
145719761|NCT02081417|525488770|FG001|Overall Study|Did not start treatment|21|||
145719762|NCT01157676|525488774|FG000|Randomization|Death|1|||
145719763|NCT01157676|525488775|FG001|Randomization|Death|1|||
145719764|NCT01157676|525488774|FG000|Randomization|unresectable|2|||
145719765|NCT01157676|525488775|FG001|Randomization|unresectable|3|||
145719766|NCT01157676|525488774|FG000|Randomization|Withdrawal by Subject|17|||
145719767|NCT01157676|525488775|FG001|Randomization|Withdrawal by Subject|13|||
145719768|NCT01157676|525488774|FG000|Randomization|Physician Decision|1|||
145719769|NCT01157676|525488775|FG001|Randomization|Physician Decision|0|||
145719770|NCT01157676|525488774|FG000|Surgery|underwent open cystectomy|0|||
145719771|NCT01157676|525488775|FG001|Surgery|underwent open cystectomy|4|||
145719772|NCT01157676|525488774|FG000|Surgery|converted to open procedure|0|||
145719773|NCT01157676|525488775|FG001|Surgery|converted to open procedure|5|||
145719774|NCT01157676|525488774|FG000|Surgery|underwent robotic cystectomy|1|||
145719775|NCT01157676|525488775|FG001|Surgery|underwent robotic cystectomy|0|||
145719776|NCT00682890|525488776|FG000|Overall Study|Lost to Follow-up|1|||
145719777|NCT00682890|525488777|FG001|Overall Study|Lost to Follow-up|1|||
145719778|NCT00682890|525488776|FG000|Overall Study|subject moved away|0|||
145719779|NCT00682890|525488777|FG001|Overall Study|subject moved away|1|||
145719780|NCT00682890|525488776|FG000|Overall Study|heavy menstrual bleeding|1|||
145719781|NCT00682890|525488777|FG001|Overall Study|heavy menstrual bleeding|0|||
145719782|NCT01506609|525488781|FG000|Overall Study|Adverse Event Related to Progression|0|||
145493111|NCT00062439|524661165|FG000|Surgery|Adverse Event|2|||
145719783|NCT01506609|525488782|FG001|Overall Study|Adverse Event Related to Progression|0|||
145719784|NCT01506609|525488783|FG002|Overall Study|Adverse Event Related to Progression|0|||
145719785|NCT01506609|525488784|FG003|Overall Study|Adverse Event Related to Progression|3|||
145719786|NCT01506609|525488785|FG004|Overall Study|Adverse Event Related to Progression|7|||
145266521|NCT02594384|523825216|FG002|Overall Study|Withdrawal by Subject|0|||
145719787|NCT01506609|525488786|FG005|Overall Study|Adverse Event Related to Progression|3|||
145719788|NCT01506609|525488781|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
145719789|NCT01506609|525488782|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
145719790|NCT01506609|525488783|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
145719791|NCT01506609|525488784|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
145719792|NCT01506609|525488785|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
145719793|NCT01506609|525488786|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
145719794|NCT01506609|525488781|FG000|Overall Study|Withdrawal by Subject|0|||
145719795|NCT01506609|525488782|FG001|Overall Study|Withdrawal by Subject|0|||
145719796|NCT01506609|525488783|FG002|Overall Study|Withdrawal by Subject|0|||
145719797|NCT01506609|525488784|FG003|Overall Study|Withdrawal by Subject|9|||
145719798|NCT01506609|525488785|FG004|Overall Study|Withdrawal by Subject|7|||
145719799|NCT01506609|525488786|FG005|Overall Study|Withdrawal by Subject|7|||
145719800|NCT01506609|525488781|FG000|Overall Study|Lost to Follow-up|0|||
145719801|NCT01506609|525488782|FG001|Overall Study|Lost to Follow-up|0|||
145719802|NCT01506609|525488783|FG002|Overall Study|Lost to Follow-up|0|||
145719803|NCT01506609|525488784|FG003|Overall Study|Lost to Follow-up|1|||
145719804|NCT01506609|525488785|FG004|Overall Study|Lost to Follow-up|2|||
145719805|NCT01506609|525488786|FG005|Overall Study|Lost to Follow-up|0|||
145719806|NCT01506609|525488781|FG000|Overall Study|Sponsor Discontinued Study|0|||
145719807|NCT01506609|525488782|FG001|Overall Study|Sponsor Discontinued Study|0|||
145719808|NCT01506609|525488783|FG002|Overall Study|Sponsor Discontinued Study|0|||
145719809|NCT01506609|525488784|FG003|Overall Study|Sponsor Discontinued Study|2|||
145719810|NCT01506609|525488785|FG004|Overall Study|Sponsor Discontinued Study|2|||
145719811|NCT01506609|525488786|FG005|Overall Study|Sponsor Discontinued Study|0|||
145719812|NCT01506609|525488781|FG000|Overall Study|Progressive Disease per Protocol|1|||
145719813|NCT01506609|525488782|FG001|Overall Study|Progressive Disease per Protocol|0|||
145719814|NCT01506609|525488783|FG002|Overall Study|Progressive Disease per Protocol|0|||
145719815|NCT01506609|525488784|FG003|Overall Study|Progressive Disease per Protocol|64|||
145719816|NCT01506609|525488785|FG004|Overall Study|Progressive Disease per Protocol|57|||
145719817|NCT01506609|525488786|FG005|Overall Study|Progressive Disease per Protocol|74|||
145719818|NCT01506609|525488781|FG000|Overall Study|Other, Not Specified|0|||
145719819|NCT01506609|525488782|FG001|Overall Study|Other, Not Specified|0|||
145719820|NCT01506609|525488783|FG002|Overall Study|Other, Not Specified|0|||
145719821|NCT01506609|525488784|FG003|Overall Study|Other, Not Specified|10|||
145719822|NCT01506609|525488785|FG004|Overall Study|Other, Not Specified|7|||
145719823|NCT01506609|525488786|FG005|Overall Study|Other, Not Specified|3|||
145719824|NCT01506609|525488781|FG000|Overall Study|Missing / Unknown Reason|1|||
145719825|NCT01506609|525488782|FG001|Overall Study|Missing / Unknown Reason|0|||
145719826|NCT01506609|525488783|FG002|Overall Study|Missing / Unknown Reason|1|||
145719827|NCT01506609|525488784|FG003|Overall Study|Missing / Unknown Reason|4|||
145719828|NCT01506609|525488785|FG004|Overall Study|Missing / Unknown Reason|4|||
145719829|NCT01506609|525488786|FG005|Overall Study|Missing / Unknown Reason|2|||
145719830|NCT00577473|525488791|FG000|Overall Study|Protocol Violation|1|||
145719831|NCT00577473|525488792|FG001|Overall Study|Protocol Violation|4|||
145719832|NCT00577473|525488791|FG000|Overall Study|Adverse Event|8|||
145719833|NCT00577473|525488792|FG001|Overall Study|Adverse Event|5|||
145719834|NCT00577473|525488791|FG000|Overall Study|Withdrawal by Subject|2|||
145719835|NCT00577473|525488792|FG001|Overall Study|Withdrawal by Subject|6|||
145719836|NCT00577473|525488791|FG000|Overall Study|Physician Decision|2|||
145719837|NCT00577473|525488792|FG001|Overall Study|Physician Decision|2|||
145719838|NCT00577473|525488791|FG000|Overall Study|Lack of Efficacy|8|||
145719839|NCT00577473|525488792|FG001|Overall Study|Lack of Efficacy|7|||
145719840|NCT02595073|525488795|FG000|Overall Study|Progressive Disease|0|||
145719841|NCT02595073|525488796|FG001|Overall Study|Progressive Disease|1|||
145719842|NCT02595073|525488795|FG000|Overall Study|Protocol Violation|2|||
145719843|NCT02595073|525488796|FG001|Overall Study|Protocol Violation|0|||
145719844|NCT01990560|525488799|FG000|Overall Study|Withdrawal by Subject|1|||
145719845|NCT02884908|525488805|FG000|Overall Study|Lost to Follow-up|13|||
145719846|NCT02884908|525488806|FG001|Overall Study|Lost to Follow-up|18|||
145719847|NCT01324440|525488807|FG000|Overall Study|Subject moved|0|||
145719848|NCT01324440|525488808|FG001|Overall Study|Subject moved|1|||
145719849|NCT02054741|525488809|FG000|Overall Study|Protocol Violation|13|||
145719850|NCT02054741|525488810|FG001|Overall Study|Protocol Violation|2|||
145719851|NCT02054741|525488809|FG000|Overall Study|Withdrawal by Subject|10|||
145719852|NCT02054741|525488810|FG001|Overall Study|Withdrawal by Subject|5|||
145719853|NCT02054741|525488809|FG000|Overall Study|Death|94|||
145719854|NCT02054741|525488810|FG001|Overall Study|Death|90|||
145719855|NCT02054741|525488809|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
145719856|NCT02054741|525488810|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
145719857|NCT02325557|525488812|FG000|Overall Study|Progressive disease|1|||
145719858|NCT02325557|525488813|FG001|Overall Study|Progressive disease|0|||
145719859|NCT02325557|525488814|FG002|Overall Study|Progressive disease|0|||
145719860|NCT02325557|525488815|FG003|Overall Study|Progressive disease|0|||
145719861|NCT02325557|525488812|FG000|Overall Study|Withdrawal by Subject|4|||
145719862|NCT02325557|525488813|FG001|Overall Study|Withdrawal by Subject|0|||
145719863|NCT02325557|525488814|FG002|Overall Study|Withdrawal by Subject|0|||
145719864|NCT02325557|525488815|FG003|Overall Study|Withdrawal by Subject|15|||
145719865|NCT02325557|525488812|FG000|Overall Study|Death|5|||
145719866|NCT02325557|525488813|FG001|Overall Study|Death|1|||
145719867|NCT02325557|525488814|FG002|Overall Study|Death|1|||
145719868|NCT02325557|525488815|FG003|Overall Study|Death|16|||
145719869|NCT02325557|525488812|FG000|Overall Study|Lost to Follow-up|0|||
145719870|NCT02325557|525488813|FG001|Overall Study|Lost to Follow-up|0|||
145719871|NCT02325557|525488814|FG002|Overall Study|Lost to Follow-up|1|||
145719872|NCT02325557|525488815|FG003|Overall Study|Lost to Follow-up|1|||
145719873|NCT02325557|525488812|FG000|Overall Study|Other|0|||
145719874|NCT02325557|525488813|FG001|Overall Study|Other|0|||
145719875|NCT02325557|525488814|FG002|Overall Study|Other|0|||
145719876|NCT02325557|525488815|FG003|Overall Study|Other|5|||
145719877|NCT00528645|525488816|FG000|Overall Study|Adverse Event|3|||
145719878|NCT01445301|525488817|FG000|Overall Study|Adverse Event|15|||
145719879|NCT01445301|525488818|FG001|Overall Study|Adverse Event|25|||
145719880|NCT01445301|525488819|FG002|Overall Study|Adverse Event|4|||
145719881|NCT01445301|525488817|FG000|Overall Study|Lack of Efficacy|0|||
145719882|NCT01445301|525488818|FG001|Overall Study|Lack of Efficacy|1|||
145719883|NCT01445301|525488819|FG002|Overall Study|Lack of Efficacy|0|||
145719884|NCT01445301|525488817|FG000|Overall Study|Protocol Violation|1|||
145719885|NCT01445301|525488818|FG001|Overall Study|Protocol Violation|0|||
145719886|NCT01445301|525488819|FG002|Overall Study|Protocol Violation|0|||
145719887|NCT01445301|525488817|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
145719888|NCT01445301|525488818|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
145719889|NCT01445301|525488819|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
145719890|NCT01445301|525488817|FG000|Overall Study|Physician Decision|0|||
145719891|NCT01445301|525488818|FG001|Overall Study|Physician Decision|2|||
145719892|NCT01445301|525488819|FG002|Overall Study|Physician Decision|0|||
145719893|NCT01445301|525488817|FG000|Overall Study|Withdrawal by Subject|5|||
145719894|NCT01445301|525488818|FG001|Overall Study|Withdrawal by Subject|6|||
145719895|NCT01445301|525488819|FG002|Overall Study|Withdrawal by Subject|4|||
145719896|NCT00752557|525488820|FG000|Overall Study|Withdrawal by Subject|4|||
145719897|NCT00752557|525488821|FG001|Overall Study|Withdrawal by Subject|3|||
145719898|NCT00752557|525488822|FG002|Overall Study|Withdrawal by Subject|3|||
145719899|NCT00752557|525488820|FG000|Overall Study|Unspecified resaons|0|||
145719900|NCT00752557|525488821|FG001|Overall Study|Unspecified resaons|2|||
145719901|NCT00752557|525488822|FG002|Overall Study|Unspecified resaons|2|||
145719902|NCT00752557|525488820|FG000|Overall Study|Lost to Follow-up|1|||
145719903|NCT00752557|525488821|FG001|Overall Study|Lost to Follow-up|0|||
145719904|NCT00752557|525488822|FG002|Overall Study|Lost to Follow-up|1|||
145719905|NCT00190749|525488823|FG000|Overall Study|Lost to Follow-up|8|||
145719906|NCT00190749|525488824|FG001|Overall Study|Lost to Follow-up|11|||
145719907|NCT00190749|525488823|FG000|Overall Study|Withdrawal by Subject|10|||
145719908|NCT00190749|525488824|FG001|Overall Study|Withdrawal by Subject|6|||
145719909|NCT00190749|525488823|FG000|Overall Study|Protocol Violation|5|||
145719910|NCT00190749|525488824|FG001|Overall Study|Protocol Violation|4|||
145719911|NCT00190749|525488823|FG000|Overall Study|Adverse Event|0|||
145719912|NCT00190749|525488824|FG001|Overall Study|Adverse Event|5|||
145719913|NCT00190749|525488823|FG000|Overall Study|Lack of Efficacy|2|||
145719914|NCT00190749|525488824|FG001|Overall Study|Lack of Efficacy|3|||
145719915|NCT00190749|525488823|FG000|Overall Study|Reason Not Specified|0|||
145719916|NCT00190749|525488824|FG001|Overall Study|Reason Not Specified|2|||
145719917|NCT00190749|525488823|FG000|Overall Study|Sponsor Decision|1|||
145719918|NCT00190749|525488824|FG001|Overall Study|Sponsor Decision|0|||
145719919|NCT01605916|525488827|FG000|Overall Study|Adverse Event|1|||
145719920|NCT01605916|525488828|FG001|Overall Study|Adverse Event|0|||
145719921|NCT01605916|525488829|FG002|Overall Study|Adverse Event|0|||
145719922|NCT01605916|525488830|FG003|Overall Study|Adverse Event|1|||
145719923|NCT01605916|525488831|FG004|Overall Study|Adverse Event|0|||
145719924|NCT01605916|525488827|FG000|Overall Study|Lack of Efficacy|2|||
145719925|NCT01605916|525488828|FG001|Overall Study|Lack of Efficacy|3|||
145719926|NCT01605916|525488829|FG002|Overall Study|Lack of Efficacy|3|||
145719927|NCT01605916|525488830|FG003|Overall Study|Lack of Efficacy|5|||
145719928|NCT01605916|525488831|FG004|Overall Study|Lack of Efficacy|4|||
145719929|NCT01605916|525488827|FG000|Overall Study|Withdrawal by Subject|1|||
145719930|NCT01605916|525488828|FG001|Overall Study|Withdrawal by Subject|1|||
145719931|NCT01605916|525488829|FG002|Overall Study|Withdrawal by Subject|0|||
145719932|NCT01605916|525488830|FG003|Overall Study|Withdrawal by Subject|0|||
145719933|NCT01605916|525488831|FG004|Overall Study|Withdrawal by Subject|2|||
145719934|NCT01465347|525488832|FG000|Overall Study|Withdrawal by Subject|1|||
145719935|NCT01465347|525488833|FG001|Overall Study|Withdrawal by Subject|1|||
145719936|NCT01465347|525488832|FG000|Overall Study|Physician Decision|0|||
145719937|NCT01465347|525488833|FG001|Overall Study|Physician Decision|1|||
145719938|NCT01465347|525488832|FG000|Overall Study|Admitted to hospice|0|||
145719939|NCT01465347|525488833|FG001|Overall Study|Admitted to hospice|1|||
145719940|NCT02891837|525488834|FG000|Overall Study|Lost to Follow-up|2|||
145719941|NCT02891837|525488835|FG001|Overall Study|Lost to Follow-up|0|||
145719942|NCT02891837|525488834|FG000|Overall Study|Withdrawal by Subject|1|||
145719943|NCT02891837|525488835|FG001|Overall Study|Withdrawal by Subject|0|||
145719944|NCT01103362|525488838|FG000|Overall Study|study terminated|596|||
145719945|NCT03538301|525488839|FG000|Overall Study|Adverse Event|1|||
145719946|NCT03538301|525488840|FG001|Overall Study|Adverse Event|4|||
145719947|NCT03538301|525488841|FG002|Overall Study|Adverse Event|4|||
145719948|NCT03538301|525488839|FG000|Overall Study|Death|1|||
145719949|NCT03538301|525488840|FG001|Overall Study|Death|1|||
145719950|NCT03538301|525488841|FG002|Overall Study|Death|0|||
145719951|NCT03538301|525488839|FG000|Overall Study|Physician Decision|0|||
145719952|NCT03538301|525488840|FG001|Overall Study|Physician Decision|1|||
145719953|NCT03538301|525488841|FG002|Overall Study|Physician Decision|0|||
145719954|NCT03538301|525488839|FG000|Overall Study|Protocol Violation|0|||
145719955|NCT03538301|525488840|FG001|Overall Study|Protocol Violation|0|||
145719956|NCT03538301|525488841|FG002|Overall Study|Protocol Violation|1|||
145719957|NCT03538301|525488839|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
145719958|NCT03538301|525488840|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
145719959|NCT03538301|525488841|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
145719960|NCT03616977|525488842|FG000|Period 1|Physician Decision|0|||
145719961|NCT03616977|525488843|FG001|Period 1|Physician Decision|1|||
145719962|NCT03616977|525488842|FG000|Period 3|Adverse Event|1|||
145719963|NCT03616977|525488843|FG001|Period 3|Adverse Event|1|||
145719964|NCT02665338|525488844|FG000|Overall Study|Withdrawal by Subject|0|||
145719965|NCT02665338|525488845|FG001|Overall Study|Withdrawal by Subject|1|||
145719966|NCT04617275|525488847|FG000|Treatment Period|Adverse Event|1|||
145719967|NCT04617275|525488848|FG001|Treatment Period|Adverse Event|6|||
145719968|NCT04617275|525488849|FG002|Treatment Period|Adverse Event|4|||
145719969|NCT04617275|525488850|FG003|Treatment Period|Adverse Event|6|||
145719970|NCT04617275|525488851|FG004|Treatment Period|Adverse Event|7|||
145719971|NCT04617275|525488852|FG005|Treatment Period|Adverse Event|8|||
145719972|NCT04617275|525488853|FG006|Treatment Period|Adverse Event|0|||
145719973|NCT04617275|525488854|FG007|Treatment Period|Adverse Event|12|||
145719974|NCT04617275|525488847|FG000|Treatment Period|Lost to Follow-up|0|||
145719975|NCT04617275|525488848|FG001|Treatment Period|Lost to Follow-up|0|||
145719976|NCT04617275|525488849|FG002|Treatment Period|Lost to Follow-up|2|||
145719977|NCT04617275|525488850|FG003|Treatment Period|Lost to Follow-up|0|||
145719978|NCT04617275|525488851|FG004|Treatment Period|Lost to Follow-up|0|||
145719979|NCT04617275|525488852|FG005|Treatment Period|Lost to Follow-up|3|||
145719980|NCT04617275|525488853|FG006|Treatment Period|Lost to Follow-up|0|||
145719981|NCT04617275|525488854|FG007|Treatment Period|Lost to Follow-up|2|||
145719982|NCT04617275|525488847|FG000|Treatment Period|No longer meets eligibility criteria|0|||
145719983|NCT04617275|525488848|FG001|Treatment Period|No longer meets eligibility criteria|0|||
145719984|NCT04617275|525488849|FG002|Treatment Period|No longer meets eligibility criteria|0|||
145719985|NCT04617275|525488850|FG003|Treatment Period|No longer meets eligibility criteria|1|||
145719986|NCT04617275|525488851|FG004|Treatment Period|No longer meets eligibility criteria|0|||
145719987|NCT04617275|525488852|FG005|Treatment Period|No longer meets eligibility criteria|0|||
145719988|NCT04617275|525488853|FG006|Treatment Period|No longer meets eligibility criteria|0|||
145719989|NCT04617275|525488854|FG007|Treatment Period|No longer meets eligibility criteria|0|||
145719990|NCT04617275|525488847|FG000|Treatment Period|Other|0|||
145719991|NCT04617275|525488848|FG001|Treatment Period|Other|1|||
145719992|NCT04617275|525488849|FG002|Treatment Period|Other|0|||
145719993|NCT04617275|525488850|FG003|Treatment Period|Other|0|||
145719994|NCT04617275|525488851|FG004|Treatment Period|Other|0|||
145719995|NCT04617275|525488852|FG005|Treatment Period|Other|0|||
145719996|NCT04617275|525488853|FG006|Treatment Period|Other|0|||
145719997|NCT04617275|525488854|FG007|Treatment Period|Other|0|||
145719998|NCT04617275|525488847|FG000|Treatment Period|Withdrawal by Subject|2|||
145719999|NCT04617275|525488848|FG001|Treatment Period|Withdrawal by Subject|0|||
145720000|NCT04617275|525488849|FG002|Treatment Period|Withdrawal by Subject|0|||
145720001|NCT04617275|525488850|FG003|Treatment Period|Withdrawal by Subject|2|||
145720002|NCT04617275|525488851|FG004|Treatment Period|Withdrawal by Subject|2|||
145720003|NCT04617275|525488852|FG005|Treatment Period|Withdrawal by Subject|0|||
145720004|NCT04617275|525488853|FG006|Treatment Period|Withdrawal by Subject|1|||
145720005|NCT04617275|525488854|FG007|Treatment Period|Withdrawal by Subject|2|||
145720006|NCT04617275|525488847|FG000|Follow-up Period|Adverse Event|1|||
145720007|NCT04617275|525488848|FG001|Follow-up Period|Adverse Event|1|||
145720008|NCT04617275|525488849|FG002|Follow-up Period|Adverse Event|2|||
145720009|NCT04617275|525488850|FG003|Follow-up Period|Adverse Event|3|||
145720010|NCT04617275|525488851|FG004|Follow-up Period|Adverse Event|4|||
145720011|NCT04617275|525488852|FG005|Follow-up Period|Adverse Event|3|||
145720012|NCT04617275|525488853|FG006|Follow-up Period|Adverse Event|0|||
145720013|NCT04617275|525488854|FG007|Follow-up Period|Adverse Event|3|||
145720014|NCT04617275|525488847|FG000|Follow-up Period|Lost to Follow-up|0|||
145720015|NCT04617275|525488848|FG001|Follow-up Period|Lost to Follow-up|1|||
145720016|NCT04617275|525488849|FG002|Follow-up Period|Lost to Follow-up|2|||
145720017|NCT04617275|525488850|FG003|Follow-up Period|Lost to Follow-up|0|||
145720018|NCT04617275|525488851|FG004|Follow-up Period|Lost to Follow-up|0|||
145720019|NCT04617275|525488852|FG005|Follow-up Period|Lost to Follow-up|4|||
145720020|NCT04617275|525488853|FG006|Follow-up Period|Lost to Follow-up|0|||
145720021|NCT04617275|525488854|FG007|Follow-up Period|Lost to Follow-up|3|||
145720022|NCT04617275|525488847|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
145720023|NCT04617275|525488848|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
145720024|NCT04617275|525488849|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
145720025|NCT04617275|525488850|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
145720026|NCT04617275|525488851|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
145720027|NCT04617275|525488852|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
145720028|NCT04617275|525488853|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
145720029|NCT04617275|525488854|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
145720030|NCT04617275|525488847|FG000|Follow-up Period|Other|0|||
145720031|NCT04617275|525488848|FG001|Follow-up Period|Other|1|||
145720032|NCT04617275|525488849|FG002|Follow-up Period|Other|0|||
145720033|NCT04617275|525488850|FG003|Follow-up Period|Other|0|||
145720034|NCT04617275|525488851|FG004|Follow-up Period|Other|0|||
145720035|NCT04617275|525488852|FG005|Follow-up Period|Other|0|||
145720036|NCT04617275|525488853|FG006|Follow-up Period|Other|0|||
145720037|NCT04617275|525488854|FG007|Follow-up Period|Other|0|||
145720038|NCT04617275|525488847|FG000|Follow-up Period|Withdrawal by Subject|2|||
145720039|NCT04617275|525488848|FG001|Follow-up Period|Withdrawal by Subject|0|||
145720040|NCT04617275|525488849|FG002|Follow-up Period|Withdrawal by Subject|0|||
145720041|NCT04617275|525488850|FG003|Follow-up Period|Withdrawal by Subject|2|||
145720042|NCT04617275|525488851|FG004|Follow-up Period|Withdrawal by Subject|2|||
145720043|NCT04617275|525488852|FG005|Follow-up Period|Withdrawal by Subject|0|||
145720044|NCT04617275|525488853|FG006|Follow-up Period|Withdrawal by Subject|1|||
145720045|NCT04617275|525488854|FG007|Follow-up Period|Withdrawal by Subject|2|||
145720046|NCT04927884|525488855|FG000|Overall Study|Progressive Disease|2|||
145720047|NCT05917470|525488856|FG000|Overall Study|Progressive Disease|1|||
145720048|NCT05917470|525488857|FG001|Overall Study|Progressive Disease|1|||
145720049|NCT05917470|525488858|FG002|Overall Study|Progressive Disease|2|||
145720050|NCT05917470|525488859|FG003|Overall Study|Progressive Disease|3|||
145720051|NCT05917470|525488860|FG004|Overall Study|Progressive Disease|1|||
145720052|NCT05917470|525488861|FG005|Overall Study|Progressive Disease|1|||
145720053|NCT05917470|525488862|FG006|Overall Study|Progressive Disease|0|||
145720054|NCT05917470|525488863|FG007|Overall Study|Progressive Disease|0|||
145720055|NCT05917470|525488856|FG000|Overall Study|Withdrawal by Subject|0|||
145720056|NCT05917470|525488857|FG001|Overall Study|Withdrawal by Subject|0|||
145720057|NCT05917470|525488858|FG002|Overall Study|Withdrawal by Subject|1|||
145720058|NCT05917470|525488859|FG003|Overall Study|Withdrawal by Subject|0|||
145720059|NCT05917470|525488860|FG004|Overall Study|Withdrawal by Subject|0|||
145720060|NCT05917470|525488861|FG005|Overall Study|Withdrawal by Subject|0|||
145720061|NCT05917470|525488862|FG006|Overall Study|Withdrawal by Subject|0|||
145720062|NCT05917470|525488863|FG007|Overall Study|Withdrawal by Subject|0|||
145720063|NCT05917470|525488856|FG000|Overall Study|Sponsor Decision|0|||
145720064|NCT05917470|525488857|FG001|Overall Study|Sponsor Decision|0|||
145720065|NCT05917470|525488858|FG002|Overall Study|Sponsor Decision|1|||
145720066|NCT05917470|525488859|FG003|Overall Study|Sponsor Decision|0|||
145720067|NCT05917470|525488860|FG004|Overall Study|Sponsor Decision|2|||
145720068|NCT05917470|525488861|FG005|Overall Study|Sponsor Decision|1|||
145720069|NCT05917470|525488862|FG006|Overall Study|Sponsor Decision|3|||
145720070|NCT05917470|525488863|FG007|Overall Study|Sponsor Decision|3|||
145720071|NCT05917470|525488856|FG000|Overall Study|Adverse Event|0|||
145720072|NCT05917470|525488857|FG001|Overall Study|Adverse Event|0|||
145720073|NCT05917470|525488858|FG002|Overall Study|Adverse Event|0|||
145720074|NCT05917470|525488859|FG003|Overall Study|Adverse Event|0|||
145720075|NCT05917470|525488860|FG004|Overall Study|Adverse Event|0|||
145720076|NCT05917470|525488861|FG005|Overall Study|Adverse Event|1|||
145720077|NCT05917470|525488862|FG006|Overall Study|Adverse Event|0|||
145720078|NCT05917470|525488863|FG007|Overall Study|Adverse Event|0|||
145720079|NCT02924428|525492188|FG000|Overall Study|Adverse Event|1|||
145720080|NCT02924428|525492189|FG001|Overall Study|Adverse Event|0|||
145720081|NCT02924428|525492188|FG000|Overall Study|Physician Decision|1|||
145720082|NCT02924428|525492189|FG001|Overall Study|Physician Decision|0|||
145720083|NCT02924428|525492188|FG000|Overall Study|Lost to Follow-up|2|||
145720084|NCT02924428|525492189|FG001|Overall Study|Lost to Follow-up|4|||
145720085|NCT02924428|525492188|FG000|Overall Study|Pregnancy|0|||
145720086|NCT02924428|525492189|FG001|Overall Study|Pregnancy|1|||
145720087|NCT01877837|525492190|FG000|Overall Study|Lost to Follow-up|1|||
145720088|NCT01877837|525492190|FG000|Overall Study|Ineligible|4|||
145720089|NCT03064035|525492191|FG000|Overall Study|Did not receive allocated intervention|4|||
145720090|NCT03064035|525492192|FG001|Overall Study|Did not receive allocated intervention|2|||
145720091|NCT03064035|525492191|FG000|Overall Study|Lost to Follow-up|1|||
145720092|NCT03064035|525492192|FG001|Overall Study|Lost to Follow-up|1|||
145720093|NCT01143038|525492193|FG000|Overall Study|Withdrawal by Subject|4|||
145720094|NCT01143038|525492193|FG000|Overall Study|Requirement for alternative therapy|5|||
145720095|NCT01143038|525492193|FG000|Overall Study|Adverse Event|3|||
145720096|NCT01143038|525492193|FG000|Overall Study|Lost to Follow-up|2|||
145720097|NCT01143038|525492193|FG000|Overall Study|Protocol Deviation|1|||
145720098|NCT01143038|525492193|FG000|Overall Study|Death|1|||
145720099|NCT02336178|525492194|FG000|Overall Study|Lost to Follow-up|1|||
145720100|NCT02336178|525492194|FG000|Overall Study|Protocol Violation|1|||
145720101|NCT02336178|525492194|FG000|Overall Study|Withdrawal by Subject|1|||
145720102|NCT02336178|525492194|FG000|Overall Study|Other|1|||
145720103|NCT03310268|525492195|FG000|Overall Study|(Not specified)|1|||
145720104|NCT03310268|525492196|FG001|Overall Study|(Not specified)|5|||
145720105|NCT03310268|525492197|FG002|Overall Study|(Not specified)|0|||
145720106|NCT00706433|525492201|FG000|Overall Study|Lost to Follow-up|3|||
145720107|NCT00706433|525492202|FG001|Overall Study|Lost to Follow-up|1|||
145720108|NCT00706433|525492203|FG002|Overall Study|Lost to Follow-up|6|||
145720109|NCT00706433|525492204|FG003|Overall Study|Lost to Follow-up|0|||
145720110|NCT00706433|525492201|FG000|Overall Study|Withdrawal by Subject|1|||
145720111|NCT00706433|525492202|FG001|Overall Study|Withdrawal by Subject|2|||
145720112|NCT00706433|525492203|FG002|Overall Study|Withdrawal by Subject|3|||
145720113|NCT00706433|525492204|FG003|Overall Study|Withdrawal by Subject|1|||
145720114|NCT00706433|525492201|FG000|Overall Study|Adverse Event|0|||
145720115|NCT00706433|525492202|FG001|Overall Study|Adverse Event|0|||
145720116|NCT00706433|525492203|FG002|Overall Study|Adverse Event|1|||
145720117|NCT00706433|525492204|FG003|Overall Study|Adverse Event|0|||
145720118|NCT00706433|525492201|FG000|Overall Study|Protocol Violation|1|||
145720119|NCT00706433|525492202|FG001|Overall Study|Protocol Violation|0|||
145720120|NCT00706433|525492203|FG002|Overall Study|Protocol Violation|0|||
145720121|NCT00706433|525492204|FG003|Overall Study|Protocol Violation|0|||
145720122|NCT00706433|525492201|FG000|Overall Study|new job|0|||
145720123|NCT00706433|525492202|FG001|Overall Study|new job|0|||
145720124|NCT00706433|525492203|FG002|Overall Study|new job|0|||
145720125|NCT00706433|525492204|FG003|Overall Study|new job|1|||
145720126|NCT01236365|525492206|FG000|Overall Study|Lost to Follow-up|0|||
145720127|NCT01236365|525492207|FG001|Overall Study|Lost to Follow-up|2|||
145720128|NCT01236365|525492206|FG000|Overall Study|Moved Out of State|1|||
145720129|NCT01236365|525492207|FG001|Overall Study|Moved Out of State|0|||
145720130|NCT01236365|525492206|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
145720131|NCT01236365|525492207|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
145720132|NCT00545051|525492208|FG000|Overall Study|Adverse Event|7|||
145720133|NCT00545051|525492209|FG001|Overall Study|Adverse Event|3|||
145720134|NCT00545051|525492208|FG000|Overall Study|Death|1|||
145720135|NCT00545051|525492209|FG001|Overall Study|Death|0|||
145720136|NCT00545051|525492208|FG000|Overall Study|Violation of inclusion/exclusion|0|||
145720137|NCT00545051|525492209|FG001|Overall Study|Violation of inclusion/exclusion|2|||
145720138|NCT00545051|525492208|FG000|Overall Study|Protocol Violation|1|||
145720139|NCT00545051|525492209|FG001|Overall Study|Protocol Violation|0|||
145720140|NCT00545051|525492208|FG000|Overall Study|Withdrawal by Subject|0|||
145720141|NCT00545051|525492209|FG001|Overall Study|Withdrawal by Subject|1|||
145720142|NCT00545051|525492208|FG000|Overall Study|Administrative reasons|0|||
145720143|NCT00545051|525492209|FG001|Overall Study|Administrative reasons|1|||
145720144|NCT03271021|525492211|FG000|Overall Study|Adverse Event|3|||
145720145|NCT03271021|525492212|FG001|Overall Study|Adverse Event|2|||
145720146|NCT03271021|525492211|FG000|Overall Study|Withdrawal by Subject|36|||
145720147|NCT03271021|525492212|FG001|Overall Study|Withdrawal by Subject|53|||
145720148|NCT03271021|525492211|FG000|Overall Study|Lost to Follow-up|34|||
145720149|NCT03271021|525492212|FG001|Overall Study|Lost to Follow-up|39|||
145720150|NCT03271021|525492211|FG000|Overall Study|Protocol Violation|6|||
145720151|NCT03271021|525492212|FG001|Overall Study|Protocol Violation|4|||
145720152|NCT03271021|525492211|FG000|Overall Study|Abnormal Lab Results|1|||
145720153|NCT03271021|525492212|FG001|Overall Study|Abnormal Lab Results|0|||
145720154|NCT03271021|525492211|FG000|Overall Study|Miscellaneous|9|||
145720155|NCT03271021|525492212|FG001|Overall Study|Miscellaneous|8|||
145720156|NCT01474434|525492213|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
145720157|NCT01474434|525492214|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
145720158|NCT01474434|525492215|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
145720159|NCT01474434|525492216|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
145720160|NCT01474434|525492213|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
145720161|NCT01474434|525492214|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
145720162|NCT01474434|525492215|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
145720163|NCT01474434|525492216|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
145720164|NCT01474434|525492213|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
145720165|NCT01474434|525492214|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
145720166|NCT01474434|525492215|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
145720167|NCT01474434|525492216|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
145720168|NCT02207569|525492220|FG000|1-Month|Death|6|||
145720169|NCT02207569|525492220|FG000|1-Month|Withdrawal by Subject|2|||
145720170|NCT02207569|525492220|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
145720171|NCT02207569|525492220|FG000|6-Month|Death|8|||
145720172|NCT02207569|525492220|FG000|6-Month|Withdrawal by Subject|2|||
145720173|NCT02207569|525492220|FG000|12-Month|Death|14|||
145720174|NCT02207569|525492220|FG000|12-Month|Withdrawal by Subject|2|||
145720175|NCT02207569|525492220|FG000|24-Month|Death|23|||
145720176|NCT02207569|525492220|FG000|24-Month|Withdrawal by Subject|3|||
145720177|NCT02207569|525492220|FG000|36-Month|Death|23|||
145720178|NCT02207569|525492220|FG000|36-Month|Withdrawal by Subject|4|||
145720179|NCT02207569|525492220|FG000|48-Month|Death|25|||
145720180|NCT02207569|525492220|FG000|48-Month|Withdrawal by Subject|2|||
145720181|NCT02207569|525492220|FG000|48-Month|Lost to Follow-up|4|||
145720182|NCT02207569|525492220|FG000|60-Month|Death|1|||
145720183|NCT02207569|525492220|FG000|60-Month|Lost to Follow-up|1|||
145720184|NCT02207569|525492220|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
145720185|NCT02207569|525492220|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
145720186|NCT00495586|525492223|FG000|Overall Study|Withdrawal by Subject|4|||
145720187|NCT00495586|525492224|FG001|Overall Study|Withdrawal by Subject|4|||
145720188|NCT03038438|525492225|FG000|Overall Study|Death|3|||
145720189|NCT03038438|525492225|FG000|Overall Study|Lost to Follow-up|8|||
145720190|NCT03038438|525492225|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
145720191|NCT03038438|525492225|FG000|Overall Study|Withdrawal by Subject|5|||
145720192|NCT03038438|525492225|FG000|Overall Study|No 36-Month Follow-Up|18|||
145720193|NCT03215810|525492226|FG000|Overall Study|Still responding to nivolumab|1|||
145720194|NCT03215810|525492226|FG000|Overall Study|Insufficient TIL growth|1|||
145720195|NCT03215810|525492226|FG000|Overall Study|Decline in performance status|1|||
145720196|NCT03215810|525492226|FG000|Overall Study|Withdrawal by Subject|1|||
145720197|NCT02038543|525492227|FG000|Overall Study|Screen Failure|0|||
145720198|NCT02038543|525492228|FG001|Overall Study|Screen Failure|0|||
145720199|NCT02038543|525492229|FG002|Overall Study|Screen Failure|0|||
145720200|NCT02038543|525492230|FG003|Overall Study|Screen Failure|1|||
145720201|NCT02038543|525492227|FG000|Overall Study|Withdrawal by Subject|0|||
145720202|NCT02038543|525492228|FG001|Overall Study|Withdrawal by Subject|0|||
145720203|NCT02038543|525492229|FG002|Overall Study|Withdrawal by Subject|0|||
145720204|NCT02038543|525492230|FG003|Overall Study|Withdrawal by Subject|1|||
145720205|NCT02647866|525492231|FG000|Overall Study|Adverse Event|0|||
145720206|NCT02647866|525492232|FG001|Overall Study|Adverse Event|0|||
145720207|NCT02647866|525492233|FG002|Overall Study|Adverse Event|2|||
145720208|NCT02647866|525492234|FG003|Overall Study|Adverse Event|2|||
145720209|NCT02647866|525492235|FG004|Overall Study|Adverse Event|1|||
145720210|NCT02647866|525492231|FG000|Overall Study|Disease Worsening|3|||
145720211|NCT02647866|525492232|FG001|Overall Study|Disease Worsening|1|||
145720212|NCT02647866|525492233|FG002|Overall Study|Disease Worsening|0|||
145720213|NCT02647866|525492234|FG003|Overall Study|Disease Worsening|0|||
145720214|NCT02647866|525492235|FG004|Overall Study|Disease Worsening|1|||
145720215|NCT02647866|525492231|FG000|Overall Study|Withdrawal by Subject|1|||
145720216|NCT02647866|525492232|FG001|Overall Study|Withdrawal by Subject|1|||
145720217|NCT02647866|525492233|FG002|Overall Study|Withdrawal by Subject|2|||
145720218|NCT02647866|525492234|FG003|Overall Study|Withdrawal by Subject|4|||
145720219|NCT02647866|525492235|FG004|Overall Study|Withdrawal by Subject|4|||
145720220|NCT02647866|525492231|FG000|Overall Study|Physician Decision|0|||
145720221|NCT02647866|525492232|FG001|Overall Study|Physician Decision|1|||
145720222|NCT02647866|525492233|FG002|Overall Study|Physician Decision|1|||
145720223|NCT02647866|525492234|FG003|Overall Study|Physician Decision|0|||
145720224|NCT02647866|525492235|FG004|Overall Study|Physician Decision|2|||
145720225|NCT02647866|525492231|FG000|Overall Study|Death|0|||
145720226|NCT02647866|525492232|FG001|Overall Study|Death|1|||
145720227|NCT02647866|525492233|FG002|Overall Study|Death|0|||
145720228|NCT02647866|525492234|FG003|Overall Study|Death|0|||
145720229|NCT02647866|525492235|FG004|Overall Study|Death|0|||
145720230|NCT02647866|525492231|FG000|Overall Study|Subject moved to different country|1|||
145720231|NCT02647866|525492232|FG001|Overall Study|Subject moved to different country|0|||
145720232|NCT02647866|525492233|FG002|Overall Study|Subject moved to different country|0|||
145720233|NCT02647866|525492234|FG003|Overall Study|Subject moved to different country|0|||
145720234|NCT02647866|525492235|FG004|Overall Study|Subject moved to different country|0|||
145720235|NCT03406260|525492236|FG000|Period 1|Adverse Event|0|||
145720236|NCT03406260|525492237|FG001|Period 1|Adverse Event|0|||
145720237|NCT03406260|525492238|FG002|Period 1|Adverse Event|0|||
145720238|NCT03406260|525492239|FG003|Period 1|Adverse Event|0|||
145720239|NCT03406260|525492240|FG004|Period 1|Adverse Event|1|||
145720240|NCT03406260|525492241|FG005|Period 1|Adverse Event|0|||
145720241|NCT03618823|525492248|FG000|Overall Study|Lost to Follow-up|63|||
145720242|NCT03618823|525492249|FG001|Overall Study|Lost to Follow-up|61|||
145720243|NCT02292927|525492252|FG000|Overall Study|Protocol Violation|13|||
145720244|NCT02292927|525492253|FG001|Overall Study|Protocol Violation|7|||
145720245|NCT01656733|525492257|FG000|Overall Study|No permission to collect birth outcomes|0|||
145720246|NCT01656733|525492258|FG001|Overall Study|No permission to collect birth outcomes|1|||
145720247|NCT01656733|525492257|FG000|Overall Study|Delivery at another hospital|0|||
145720248|NCT01656733|525492258|FG001|Overall Study|Delivery at another hospital|2|||
145720249|NCT01656733|525492257|FG000|Overall Study|Spontaneous abortion|0|||
145720250|NCT01656733|525492258|FG001|Overall Study|Spontaneous abortion|1|||
145720251|NCT00141219|525492259|FG000|Overall Study|Protocol violations|5|||
145720252|NCT00141219|525492260|FG001|Overall Study|Protocol violations|4|||
145720253|NCT00141219|525492259|FG000|Overall Study|Adverse Event|8|||
145720254|NCT00141219|525492260|FG001|Overall Study|Adverse Event|6|||
145720255|NCT00141219|525492259|FG000|Overall Study|Lack of Efficacy|5|||
145720256|NCT00141219|525492260|FG001|Overall Study|Lack of Efficacy|4|||
145720257|NCT00141219|525492259|FG000|Overall Study|Withdrawal by Subject|6|||
145720258|NCT00141219|525492260|FG001|Overall Study|Withdrawal by Subject|2|||
145720259|NCT01488487|525492262|FG000|Overall Study|Adverse Event|6|||
145720260|NCT01488487|525492262|FG000|Overall Study|Death|1|||
145720261|NCT01488487|525492262|FG000|Overall Study|Withdrawal by Subject|2|||
145720262|NCT02084056|525492263|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
145720263|NCT02084056|525492264|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145720264|NCT02084056|525492265|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145720265|NCT02084056|525492266|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145720266|NCT02084056|525492263|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
145720267|NCT02084056|525492264|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145720268|NCT02084056|525492265|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145720269|NCT02084056|525492266|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145720270|NCT01293487|525492268|FG000|Overall Study|Lost to Follow-up|0|||
145720271|NCT01293487|525492269|FG001|Overall Study|Lost to Follow-up|0|||
145720272|NCT01293487|525492270|FG002|Overall Study|Lost to Follow-up|0|||
145720273|NCT01293487|525492271|FG003|Overall Study|Lost to Follow-up|1|||
145720274|NCT01293487|525492272|FG004|Overall Study|Lost to Follow-up|0|||
145720275|NCT01293487|525492273|FG005|Overall Study|Lost to Follow-up|0|||
145720276|NCT01293487|525492274|FG006|Overall Study|Lost to Follow-up|0|||
145720277|NCT01293487|525492275|FG007|Overall Study|Lost to Follow-up|0|||
145720278|NCT01293487|525492268|FG000|Overall Study|Withdrawal by Subject|0|||
145720279|NCT01293487|525492269|FG001|Overall Study|Withdrawal by Subject|0|||
145720280|NCT01293487|525492270|FG002|Overall Study|Withdrawal by Subject|0|||
145720281|NCT01293487|525492271|FG003|Overall Study|Withdrawal by Subject|0|||
145720282|NCT01293487|525492272|FG004|Overall Study|Withdrawal by Subject|0|||
145720283|NCT01293487|525492273|FG005|Overall Study|Withdrawal by Subject|0|||
145720284|NCT01293487|525492274|FG006|Overall Study|Withdrawal by Subject|0|||
145720285|NCT01293487|525492275|FG007|Overall Study|Withdrawal by Subject|2|||
145720286|NCT01737827|525492280|FG000|Overall Study|Adverse Event|3|||
145720287|NCT01737827|525492281|FG001|Overall Study|Adverse Event|6|||
145720288|NCT01737827|525492282|FG002|Overall Study|Adverse Event|0|||
145720289|NCT01737827|525492280|FG000|Overall Study|Lost to Follow-up|0|||
145720290|NCT01737827|525492281|FG001|Overall Study|Lost to Follow-up|1|||
145720291|NCT01737827|525492282|FG002|Overall Study|Lost to Follow-up|0|||
145720292|NCT01737827|525492280|FG000|Overall Study|Physician Decision|0|||
145720293|NCT01737827|525492281|FG001|Overall Study|Physician Decision|2|||
145720294|NCT01737827|525492282|FG002|Overall Study|Physician Decision|0|||
145720295|NCT01737827|525492280|FG000|Overall Study|Progressive Disease|5|||
145720296|NCT01737827|525492281|FG001|Overall Study|Progressive Disease|16|||
145720297|NCT01737827|525492282|FG002|Overall Study|Progressive Disease|2|||
145720298|NCT01737827|525492280|FG000|Overall Study|Study Terminated by Sponsor|0|||
145720299|NCT01737827|525492281|FG001|Overall Study|Study Terminated by Sponsor|1|||
145720300|NCT01737827|525492282|FG002|Overall Study|Study Terminated by Sponsor|0|||
145720301|NCT01737827|525492280|FG000|Overall Study|Subject/Guardian Decision|0|||
145720302|NCT01737827|525492281|FG001|Overall Study|Subject/Guardian Decision|2|||
145720303|NCT01737827|525492282|FG002|Overall Study|Subject/Guardian Decision|0|||
145720304|NCT01451827|525492283|FG000|Overall Study|Adverse Event|2|||
145720305|NCT01451827|525492284|FG001|Overall Study|Adverse Event|0|||
145720306|NCT01451827|525492285|FG002|Overall Study|Adverse Event|1|||
145720307|NCT01451827|525492286|FG003|Overall Study|Adverse Event|1|||
145720308|NCT01451827|525492283|FG000|Overall Study|Protocol deviation|1|||
145720309|NCT01451827|525492284|FG001|Overall Study|Protocol deviation|0|||
145720310|NCT01451827|525492285|FG002|Overall Study|Protocol deviation|0|||
145720311|NCT01451827|525492286|FG003|Overall Study|Protocol deviation|0|||
145720312|NCT01451827|525492283|FG000|Overall Study|Lost to Follow-up|0|||
145720313|NCT01451827|525492284|FG001|Overall Study|Lost to Follow-up|3|||
145720314|NCT01451827|525492285|FG002|Overall Study|Lost to Follow-up|0|||
145720315|NCT01451827|525492286|FG003|Overall Study|Lost to Follow-up|2|||
145720316|NCT01451827|525492283|FG000|Overall Study|Participant met withdrawal criteria|0|||
145720317|NCT01451827|525492284|FG001|Overall Study|Participant met withdrawal criteria|2|||
145720318|NCT01451827|525492285|FG002|Overall Study|Participant met withdrawal criteria|0|||
145720319|NCT01451827|525492286|FG003|Overall Study|Participant met withdrawal criteria|0|||
145720320|NCT01451827|525492283|FG000|Overall Study|Withdrawal by Subject|0|||
145720321|NCT01451827|525492284|FG001|Overall Study|Withdrawal by Subject|0|||
145720322|NCT01451827|525492285|FG002|Overall Study|Withdrawal by Subject|1|||
145720323|NCT01451827|525492286|FG003|Overall Study|Withdrawal by Subject|1|||
145720324|NCT01964924|525492287|FG000|Trametinib Monotherapy|Progression|19|||
145720325|NCT01964924|525492288|FG001|Trametinib Monotherapy|Progression|0|||
145720326|NCT01528345|525492289|FG000|Overall Study|Adverse Event|10|||
145720327|NCT01528345|525492290|FG001|Overall Study|Adverse Event|1|||
145720328|NCT01528345|525492289|FG000|Overall Study|Death|1|||
145720329|NCT01528345|525492290|FG001|Overall Study|Death|1|||
145720330|NCT01528345|525492289|FG000|Overall Study|Non-compliance with study treatment|1|||
145720331|NCT01528345|525492290|FG001|Overall Study|Non-compliance with study treatment|0|||
145720332|NCT01528345|525492289|FG000|Overall Study|Progressive Disease|26|||
145720333|NCT01528345|525492290|FG001|Overall Study|Progressive Disease|40|||
145720334|NCT01528345|525492289|FG000|Overall Study|Study Terminated by Sponsor|4|||
145720335|NCT01528345|525492290|FG001|Overall Study|Study Terminated by Sponsor|8|||
145720336|NCT01528345|525492289|FG000|Overall Study|Subject/Guardian Decision|5|||
145720337|NCT01528345|525492290|FG001|Overall Study|Subject/Guardian Decision|0|||
145720338|NCT02150343|525492295|FG000|Overall Study|Adverse Event|2|||
145720339|NCT02150343|525492296|FG001|Overall Study|Adverse Event|0|||
145720340|NCT02150343|525492297|FG002|Overall Study|Adverse Event|1|||
145720341|NCT02150343|525492298|FG003|Overall Study|Adverse Event|1|||
145720342|NCT02150343|525492295|FG000|Overall Study|Withdrawal by Subject|13|||
145720343|NCT02150343|525492296|FG001|Overall Study|Withdrawal by Subject|10|||
145720344|NCT02150343|525492297|FG002|Overall Study|Withdrawal by Subject|9|||
145720345|NCT02150343|525492298|FG003|Overall Study|Withdrawal by Subject|4|||
145720346|NCT02150343|525492295|FG000|Overall Study|Lost to Follow-up|4|||
145720347|NCT02150343|525492296|FG001|Overall Study|Lost to Follow-up|4|||
145720348|NCT02150343|525492297|FG002|Overall Study|Lost to Follow-up|2|||
145720349|NCT02150343|525492298|FG003|Overall Study|Lost to Follow-up|3|||
145720350|NCT02150343|525492295|FG000|Overall Study|Other|2|||
145720351|NCT02150343|525492296|FG001|Overall Study|Other|6|||
145720352|NCT02150343|525492297|FG002|Overall Study|Other|0|||
145720353|NCT02150343|525492298|FG003|Overall Study|Other|2|||
145720354|NCT02729753|525492299|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
145720355|NCT02729753|525492300|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
145720356|NCT01090427|525492301|FG000|After Controlled Period|Death|0|||
145720357|NCT01090427|525492302|FG001|After Controlled Period|Death|0|||
145720358|NCT01090427|525492303|FG002|After Controlled Period|Death|0|||
145720359|NCT01090427|525492304|FG003|After Controlled Period|Death|0|||
145720360|NCT01090427|525492305|FG004|After Controlled Period|Death|0|||
145720361|NCT01090427|525492306|FG005|After Controlled Period|Death|1|||
145720362|NCT01090427|525492307|FG006|After Controlled Period|Death|0|||
145720363|NCT01090427|525492301|FG000|After Controlled Period|Lack of Efficacy|0|||
145720364|NCT01090427|525492302|FG001|After Controlled Period|Lack of Efficacy|0|||
145720365|NCT01090427|525492303|FG002|After Controlled Period|Lack of Efficacy|0|||
145720366|NCT01090427|525492304|FG003|After Controlled Period|Lack of Efficacy|0|||
145720367|NCT01090427|525492305|FG004|After Controlled Period|Lack of Efficacy|0|||
145720368|NCT01090427|525492306|FG005|After Controlled Period|Lack of Efficacy|3|||
145720369|NCT01090427|525492307|FG006|After Controlled Period|Lack of Efficacy|2|||
145720370|NCT01090427|525492301|FG000|After Controlled Period|Adverse Event|0|||
145720371|NCT01090427|525492302|FG001|After Controlled Period|Adverse Event|0|||
145720372|NCT01090427|525492303|FG002|After Controlled Period|Adverse Event|0|||
145720373|NCT01090427|525492304|FG003|After Controlled Period|Adverse Event|2|||
145720374|NCT01090427|525492305|FG004|After Controlled Period|Adverse Event|0|||
145720375|NCT01090427|525492306|FG005|After Controlled Period|Adverse Event|1|||
145720376|NCT01090427|525492307|FG006|After Controlled Period|Adverse Event|0|||
145720377|NCT01154010|525492308|FG000|Overall Study|Lost to Follow-up|0|||
145720378|NCT01154010|525492309|FG001|Overall Study|Lost to Follow-up|1|||
145720379|NCT00439231|525492310|FG000|Overall Study|Lack of Efficacy|28|||
145720380|NCT02413333|525492314|FG000|Period 1|Adverse Event|1|||
145720381|NCT02413333|525492315|FG001|Period 1|Adverse Event|0|||
145720382|NCT02413333|525492314|FG000|Period 1|Reason Not Specified|0|||
145720383|NCT02413333|525492315|FG001|Period 1|Reason Not Specified|1|||
145720384|NCT02413333|525492314|FG000|Period 2|Protocol Deviation|1|||
145720385|NCT02413333|525492315|FG001|Period 2|Protocol Deviation|0|||
145720386|NCT01048671|525492322|FG000|Overall Study|Protocol Violation|0|||
145720387|NCT01048671|525492323|FG001|Overall Study|Protocol Violation|1|||
145720388|NCT01048671|525492324|FG002|Overall Study|Protocol Violation|1|||
145720389|NCT01014533|525492325|FG000|Overall Study|Protocol Violation|3|||
145720390|NCT01014533|525492326|FG001|Overall Study|Protocol Violation|2|||
145720391|NCT01014533|525492325|FG000|Overall Study|Withdrawal by Subject|2|||
145720392|NCT01014533|525492326|FG001|Overall Study|Withdrawal by Subject|0|||
145720393|NCT01014533|525492325|FG000|Overall Study|unable to come to appointment|0|||
145720394|NCT01014533|525492326|FG001|Overall Study|unable to come to appointment|3|||
145720395|NCT00296400|525492330|FG000|Overall Study|Adverse Event|7|||
145720396|NCT00296400|525492331|FG001|Overall Study|Adverse Event|7|||
145720397|NCT00296400|525492332|FG002|Overall Study|Adverse Event|7|||
145720398|NCT00296400|525492330|FG000|Overall Study|Withdrawal by Subject|5|||
145720399|NCT00296400|525492331|FG001|Overall Study|Withdrawal by Subject|6|||
145720400|NCT00296400|525492332|FG002|Overall Study|Withdrawal by Subject|2|||
145720401|NCT00296400|525492330|FG000|Overall Study|Incorrect enrollment|2|||
145720402|NCT00296400|525492331|FG001|Overall Study|Incorrect enrollment|0|||
145720403|NCT00296400|525492332|FG002|Overall Study|Incorrect enrollment|0|||
145720404|NCT00296400|525492330|FG000|Overall Study|Protocol Violation|1|||
145720405|NCT00296400|525492331|FG001|Overall Study|Protocol Violation|1|||
145720406|NCT00296400|525492332|FG002|Overall Study|Protocol Violation|1|||
145720407|NCT00296400|525492330|FG000|Overall Study|Lost to Follow-up|1|||
145720408|NCT00296400|525492331|FG001|Overall Study|Lost to Follow-up|1|||
145720409|NCT00296400|525492332|FG002|Overall Study|Lost to Follow-up|2|||
145720410|NCT00296400|525492330|FG000|Overall Study|Study specific discontinuation criteria|0|||
145720411|NCT00296400|525492331|FG001|Overall Study|Study specific discontinuation criteria|0|||
145720412|NCT00296400|525492332|FG002|Overall Study|Study specific discontinuation criteria|1|||
145720413|NCT00296400|525492330|FG000|Overall Study|Visit 10 was performed earlier|0|||
145720414|NCT00296400|525492331|FG001|Overall Study|Visit 10 was performed earlier|1|||
145720415|NCT00296400|525492332|FG002|Overall Study|Visit 10 was performed earlier|0|||
145720416|NCT00296400|525492330|FG000|Overall Study|Pregnancy|1|||
145720417|NCT00296400|525492331|FG001|Overall Study|Pregnancy|2|||
145720418|NCT00296400|525492332|FG002|Overall Study|Pregnancy|0|||
145720419|NCT00412061|525492334|FG000|Double Blind Phase|Disease Progression|101|||
145720420|NCT00412061|525492335|FG001|Double Blind Phase|Disease Progression|154|||
145720421|NCT00412061|525492334|FG000|Double Blind Phase|Adverse Event|61|||
145720422|NCT00412061|525492335|FG001|Double Blind Phase|Adverse Event|16|||
145720423|NCT00412061|525492334|FG000|Double Blind Phase|Final Primary Analysis|26|||
145720424|NCT00412061|525492335|FG001|Double Blind Phase|Final Primary Analysis|14|||
145720425|NCT00412061|525492334|FG000|Double Blind Phase|Withdrawal by Subject|18|||
145720426|NCT00412061|525492335|FG001|Double Blind Phase|Withdrawal by Subject|20|||
145720427|NCT00412061|525492334|FG000|Double Blind Phase|Death|6|||
145720428|NCT00412061|525492335|FG001|Double Blind Phase|Death|3|||
145720429|NCT00412061|525492334|FG000|Double Blind Phase|Protocol Violation|3|||
145720430|NCT00412061|525492335|FG001|Double Blind Phase|Protocol Violation|4|||
145720431|NCT00412061|525492334|FG000|Double Blind Phase|New Cander Therapy|1|||
145720432|NCT00412061|525492335|FG001|Double Blind Phase|New Cander Therapy|1|||
145720433|NCT00412061|525492334|FG000|Double Blind Phase|Lost to Follow-up|0|||
145720434|NCT00412061|525492335|FG001|Double Blind Phase|Lost to Follow-up|1|||
145720435|NCT00412061|525492334|FG000|Open Label Phase|Disease Progression|0|||
145720436|NCT00412061|525492335|FG001|Open Label Phase|Disease Progression|86|||
145720437|NCT00412061|525492334|FG000|Open Label Phase|Adverse Event|0|||
145720438|NCT00412061|525492335|FG001|Open Label Phase|Adverse Event|46|||
145720439|NCT00412061|525492334|FG000|Open Label Phase|Withdrawal by Subject|0|||
145720440|NCT00412061|525492335|FG001|Open Label Phase|Withdrawal by Subject|15|||
145720441|NCT00412061|525492334|FG000|Open Label Phase|Administrative Problems|0|||
145720442|NCT00412061|525492335|FG001|Open Label Phase|Administrative Problems|13|||
145720443|NCT00412061|525492334|FG000|Open Label Phase|Death|0|||
145720444|NCT00412061|525492335|FG001|Open Label Phase|Death|7|||
145720445|NCT00412061|525492334|FG000|Open Label Phase|Lost to Follow-up|0|||
145720446|NCT00412061|525492335|FG001|Open Label Phase|Lost to Follow-up|2|||
145720447|NCT00412061|525492334|FG000|Open Label Phase|New Cancer Therapy|0|||
145720448|NCT00412061|525492335|FG001|Open Label Phase|New Cancer Therapy|1|||
145720449|NCT02689518|525492337|FG000|Overall Study|Withdrawal by Subject|3|||
145720450|NCT02433340|525492341|FG000|Overall Study|Adverse Event|0|||
145720451|NCT02433340|525492342|FG001|Overall Study|Adverse Event|0|||
145720452|NCT02433340|525492343|FG002|Overall Study|Adverse Event|1|||
145720453|NCT02433340|525492344|FG003|Overall Study|Adverse Event|0|||
145720454|NCT02433340|525492341|FG000|Overall Study|Withdrawal by Subject|1|||
145720455|NCT02433340|525492342|FG001|Overall Study|Withdrawal by Subject|0|||
145720456|NCT02433340|525492343|FG002|Overall Study|Withdrawal by Subject|1|||
145720457|NCT02433340|525492344|FG003|Overall Study|Withdrawal by Subject|2|||
145720458|NCT02433340|525492341|FG000|Overall Study|Lost to Follow-up|0|||
145720459|NCT02433340|525492342|FG001|Overall Study|Lost to Follow-up|1|||
145720460|NCT02433340|525492343|FG002|Overall Study|Lost to Follow-up|0|||
145720461|NCT02433340|525492344|FG003|Overall Study|Lost to Follow-up|0|||
145720462|NCT02433340|525492341|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
145720463|NCT02433340|525492342|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
145720464|NCT02433340|525492343|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
145720465|NCT02433340|525492344|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
145720466|NCT02433340|525492341|FG000|Overall Study|Other|0|||
145720467|NCT02433340|525492342|FG001|Overall Study|Other|1|||
145720468|NCT02433340|525492343|FG002|Overall Study|Other|0|||
145720469|NCT02433340|525492344|FG003|Overall Study|Other|0|||
145720470|NCT01178385|525492345|FG000|Overall Study|Withdrawal by Subject|2|||
145720471|NCT01178385|525492346|FG001|Overall Study|Withdrawal by Subject|0|||
145720472|NCT02679508|525492350|FG000|Healing Phase|Protocol Violation|1|||
145720473|NCT02679508|525492351|FG001|Healing Phase|Protocol Violation|1|||
145720474|NCT02679508|525492350|FG000|Healing Phase|Lost to Follow-up|1|||
145720475|NCT02679508|525492351|FG001|Healing Phase|Lost to Follow-up|0|||
145720476|NCT02679508|525492350|FG000|Maintenance Phase|Adverse Event|12|||
145720477|NCT02679508|525492351|FG001|Maintenance Phase|Adverse Event|2|||
145720478|NCT02679508|525492350|FG000|Maintenance Phase|Lost to Follow-up|0|||
145720479|NCT02679508|525492351|FG001|Maintenance Phase|Lost to Follow-up|1|||
145720480|NCT02679508|525492350|FG000|Maintenance Phase|Withdrawal by Subject|15|||
145720481|NCT02679508|525492351|FG001|Maintenance Phase|Withdrawal by Subject|8|||
145720482|NCT02679508|525492350|FG000|Maintenance Phase|Other|5|||
145720483|NCT02679508|525492351|FG001|Maintenance Phase|Other|4|||
145720484|NCT03143166|525492352|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
145720485|NCT00589121|525492357|FG000|Overall Study|Protocol Violation|2|||
145720486|NCT00589121|525492358|FG001|Overall Study|Protocol Violation|6|||
145720487|NCT00589121|525492357|FG000|Overall Study|No protocol treatment received|0|||
145720488|NCT00589121|525492358|FG001|Overall Study|No protocol treatment received|1|||
145720489|NCT00847808|525492359|FG000|Overall Study|Adverse Event|7|||
145720490|NCT00847808|525492359|FG000|Overall Study|Protocol Violation|1|||
145720491|NCT00847808|525492359|FG000|Overall Study|Lost to Follow-up|1|||
145720492|NCT00847808|525492359|FG000|Overall Study|Withdrawal by Subject|4|||
145720493|NCT00847808|525492359|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
145720494|NCT00847808|525492359|FG000|Overall Study|Participant Took Excluded Medication|1|||
145720495|NCT05326815|525492360|FG000|Overall Study|Withdrawal by Subject|3|||
145720496|NCT05326815|525492360|FG000|Overall Study|Did not complete required labs|6|||
145720497|NCT05326815|525492360|FG000|Overall Study|Screen fail- abnormal labs|5|||
145720498|NCT00925132|525492361|FG000|Overall Study|Withdrawal by Subject|2|||
145720499|NCT00925132|525492362|FG001|Overall Study|Withdrawal by Subject|0|||
145720500|NCT00925132|525492363|FG002|Overall Study|Withdrawal by Subject|0|||
145720501|NCT00925132|525492364|FG003|Overall Study|Withdrawal by Subject|0|||
145720502|NCT00925132|525492365|FG004|Overall Study|Withdrawal by Subject|1|||
145720503|NCT00925132|525492361|FG000|Overall Study|Removed due to disease progression|0|||
145720504|NCT00925132|525492362|FG001|Overall Study|Removed due to disease progression|0|||
145720505|NCT00925132|525492363|FG002|Overall Study|Removed due to disease progression|0|||
145720506|NCT00925132|525492364|FG003|Overall Study|Removed due to disease progression|0|||
145720507|NCT00925132|525492365|FG004|Overall Study|Removed due to disease progression|4|||
145720508|NCT02545933|525492366|FG000|Overall Study|Adverse Event|3|||
145720509|NCT02545933|525492367|FG001|Overall Study|Adverse Event|0|||
145720510|NCT02545933|525492368|FG002|Overall Study|Adverse Event|0|||
145720511|NCT02545933|525492366|FG000|Overall Study|Withdrawal by Subject|2|||
145720512|NCT02545933|525492367|FG001|Overall Study|Withdrawal by Subject|3|||
145720513|NCT02545933|525492368|FG002|Overall Study|Withdrawal by Subject|3|||
145720514|NCT02545933|525492366|FG000|Overall Study|Protocol Violation|1|||
145720515|NCT02545933|525492367|FG001|Overall Study|Protocol Violation|0|||
145720516|NCT02545933|525492368|FG002|Overall Study|Protocol Violation|1|||
145720517|NCT01370590|525492369|FG000|Period 1|Adverse Event|8|||
145720518|NCT01370590|525492370|FG001|Period 1|Adverse Event|4|||
145720519|NCT01370590|525492369|FG000|Period 1|Lost to Follow-up|2|||
145720520|NCT01370590|525492370|FG001|Period 1|Lost to Follow-up|2|||
145720521|NCT01370590|525492369|FG000|Period 1|Protocol Violation|2|||
145720522|NCT01370590|525492370|FG001|Period 1|Protocol Violation|2|||
145720523|NCT01370590|525492369|FG000|Period 1|Withdrawal by Subject|4|||
145720524|NCT01370590|525492370|FG001|Period 1|Withdrawal by Subject|2|||
145720525|NCT01370590|525492369|FG000|Period 1|Could not access randomization system|0|||
145720526|NCT01370590|525492370|FG001|Period 1|Could not access randomization system|1|||
145720527|NCT01370590|525492369|FG000|Crossover Washout Period|Adverse Event|1|||
145720528|NCT01370590|525492370|FG001|Crossover Washout Period|Adverse Event|4|||
145720529|NCT01370590|525492369|FG000|Crossover Washout Period|Lost to Follow-up|2|||
145720530|NCT01370590|525492370|FG001|Crossover Washout Period|Lost to Follow-up|0|||
145720531|NCT01370590|525492369|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
145720532|NCT01370590|525492370|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
145720533|NCT01370590|525492369|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
145720534|NCT01370590|525492370|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
145720535|NCT01370590|525492369|FG000|Period 2|Adverse Event|0|||
145720536|NCT01370590|525492370|FG001|Period 2|Adverse Event|1|||
145720537|NCT01370590|525492369|FG000|Period 2|Withdrawal by Subject|1|||
145720538|NCT01370590|525492370|FG001|Period 2|Withdrawal by Subject|1|||
145720539|NCT05172050|525492371|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
145720540|NCT05172050|525492372|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
145720541|NCT05172050|525492373|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
145720542|NCT05172050|525492371|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
145720543|NCT05172050|525492372|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
145720544|NCT05172050|525492373|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
145720545|NCT05172050|525492371|FG000|Overall Study|Other|2|||
145720546|NCT05172050|525492372|FG001|Overall Study|Other|2|||
145720547|NCT05172050|525492373|FG002|Overall Study|Other|1|||
145720548|NCT05180500|525492374|FG000|Overall Study|Adverse Event|1|||
145720549|NCT05180500|525492375|FG001|Overall Study|Adverse Event|0|||
145720550|NCT05180500|525492374|FG000|Overall Study|Withdrawal by Subject|2|||
145720551|NCT05180500|525492375|FG001|Overall Study|Withdrawal by Subject|0|||
145720552|NCT03992846|525492376|FG000|Overall Study|Adverse Event|8|||
145720553|NCT03992846|525492377|FG001|Overall Study|Adverse Event|6|||
145493112|NCT00062439|524661165|FG000|Consolidation Chemotherapy|Adverse Event|2|||
145720554|NCT03992846|525492378|FG002|Overall Study|Adverse Event|3|||
145720555|NCT03992846|525492376|FG000|Overall Study|Lost to Follow-up|0|||
145720556|NCT03992846|525492377|FG001|Overall Study|Lost to Follow-up|1|||
145720557|NCT03992846|525492378|FG002|Overall Study|Lost to Follow-up|1|||
145720558|NCT03992846|525492376|FG000|Overall Study|Pregnancy|2|||
145720559|NCT03992846|525492377|FG001|Overall Study|Pregnancy|0|||
145720560|NCT03992846|525492378|FG002|Overall Study|Pregnancy|1|||
145720561|NCT03992846|525492376|FG000|Overall Study|Protocol Violation|1|||
145720562|NCT03992846|525492377|FG001|Overall Study|Protocol Violation|2|||
145720563|NCT03992846|525492378|FG002|Overall Study|Protocol Violation|0|||
145720564|NCT03992846|525492376|FG000|Overall Study|Withdrawal by Subject|8|||
145720565|NCT03992846|525492377|FG001|Overall Study|Withdrawal by Subject|10|||
145720566|NCT03992846|525492378|FG002|Overall Study|Withdrawal by Subject|20|||
145720567|NCT03992846|525492376|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
145720568|NCT03992846|525492377|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
145720569|NCT03992846|525492378|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
145720570|NCT01290029|525494089|FG000|Overall Study|Other|2|||
145720571|NCT00189488|525494090|FG000|Overall Study|Ineligibility determined|1|||
145720572|NCT00189488|525494091|FG001|Overall Study|Ineligibility determined|0|||
145720573|NCT00189488|525494090|FG000|Overall Study|Protocol deviation|2|||
145720574|NCT00189488|525494091|FG001|Overall Study|Protocol deviation|1|||
145720575|NCT00189488|525494090|FG000|Overall Study|Adverse Event|2|||
145720576|NCT00189488|525494091|FG001|Overall Study|Adverse Event|1|||
145720577|NCT00189488|525494090|FG000|Overall Study|Withdrawal by Subject|2|||
145720578|NCT00189488|525494091|FG001|Overall Study|Withdrawal by Subject|6|||
145720579|NCT00189488|525494090|FG000|Overall Study|Disease progression|2|||
145720580|NCT00189488|525494091|FG001|Overall Study|Disease progression|4|||
145720581|NCT00189488|525494090|FG000|Overall Study|Administrative Decision|0|||
145720582|NCT00189488|525494091|FG001|Overall Study|Administrative Decision|2|||
145720583|NCT00189488|525494090|FG000|Overall Study|Death|5|||
145720584|NCT00189488|525494091|FG001|Overall Study|Death|8|||
145720585|NCT00189488|525494090|FG000|Overall Study|Other|1|||
145720586|NCT00189488|525494091|FG001|Overall Study|Other|0|||
145720587|NCT02349425|525494092|FG000|Period 1|Adverse Event|1|||
145720588|NCT02349425|525494093|FG001|Period 1|Adverse Event|1|||
145720589|NCT02349425|525494094|FG002|Period 1|Adverse Event|0|||
145720590|NCT02349425|525494095|FG003|Period 1|Adverse Event|0|||
145720591|NCT02349425|525494092|FG000|Period 2|Adverse Event|0|||
145720592|NCT02349425|525494093|FG001|Period 2|Adverse Event|1|||
145720593|NCT02349425|525494094|FG002|Period 2|Adverse Event|1|||
145720594|NCT02349425|525494095|FG003|Period 2|Adverse Event|0|||
145720595|NCT01773291|525494098|FG000|Overall Study|Protocol Violation|1|||
145720596|NCT01773291|525494099|FG001|Overall Study|Protocol Violation|0|||
145720597|NCT01773291|525494100|FG002|Overall Study|Protocol Violation|0|||
145720598|NCT01773291|525494098|FG000|Overall Study|Withdrawal by Subject|0|||
145720599|NCT01773291|525494099|FG001|Overall Study|Withdrawal by Subject|0|||
145720600|NCT01773291|525494100|FG002|Overall Study|Withdrawal by Subject|1|||
145720601|NCT01491672|525494101|FG000|Overall Study|Lost to Follow-up|0|||
145720602|NCT01491672|525494102|FG001|Overall Study|Lost to Follow-up|4|||
145720603|NCT01491672|525494103|FG002|Overall Study|Lost to Follow-up|1|||
145720604|NCT01491672|525494101|FG000|Overall Study|Withdrawal by Subject|6|||
145720605|NCT01491672|525494102|FG001|Overall Study|Withdrawal by Subject|7|||
145720606|NCT01491672|525494103|FG002|Overall Study|Withdrawal by Subject|0|||
145720607|NCT01491672|525494101|FG000|Overall Study|Adverse Event|8|||
145720608|NCT01491672|525494102|FG001|Overall Study|Adverse Event|10|||
145720609|NCT01491672|525494103|FG002|Overall Study|Adverse Event|4|||
145720610|NCT01491672|525494101|FG000|Overall Study|Disease progression|42|||
145720611|NCT01491672|525494102|FG001|Overall Study|Disease progression|34|||
145720612|NCT01491672|525494103|FG002|Overall Study|Disease progression|6|||
145720613|NCT01491672|525494101|FG000|Overall Study|Protocol deviation|0|||
145720614|NCT01491672|525494102|FG001|Overall Study|Protocol deviation|1|||
145720615|NCT01491672|525494103|FG002|Overall Study|Protocol deviation|0|||
145720616|NCT01491672|525494101|FG000|Overall Study|Death|0|||
145720617|NCT01491672|525494102|FG001|Overall Study|Death|4|||
145720618|NCT01491672|525494103|FG002|Overall Study|Death|0|||
145720619|NCT02090959|525494104|FG000|Overall Study|Withdrawal by Subject|10|||
145720620|NCT02090959|525494104|FG000|Overall Study|Adverse Event|1|||
145720621|NCT02090959|525494104|FG000|Overall Study|Investigator decision|2|||
145720622|NCT02090959|525494104|FG000|Overall Study|Study termination|6|||
145720623|NCT02090959|525494104|FG000|Overall Study|Enrolled but not treated|1|||
145720624|NCT02090959|525494104|FG000|Overall Study|Transfer for compassionate use medicine|4|||
145720625|NCT02090959|525494104|FG000|Overall Study|Move to medical need program|3|||
145720626|NCT02090959|525494104|FG000|Overall Study|Entered in to other study|34|||
145720627|NCT02090959|525494104|FG000|Overall Study|Switched to commercial supply|88|||
145720628|NCT02090959|525494104|FG000|Overall Study|Other than specified|2|||
145720629|NCT02808143|525494105|FG000|Maintenance Phase|Disease recurrence|1|||
145720630|NCT02808143|525494106|FG001|Maintenance Phase|Disease recurrence|3|||
145720631|NCT02808143|525494105|FG000|Maintenance Phase|Disease progression|1|||
145720632|NCT02808143|525494106|FG001|Maintenance Phase|Disease progression|2|||
145720633|NCT02808143|525494105|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
145720634|NCT02808143|525494106|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
145720635|NCT02808143|525494105|FG000|Survival Follow-Up|Disease recurrence|0|||
145720636|NCT02808143|525494106|FG001|Survival Follow-Up|Disease recurrence|2|||
145720637|NCT02808143|525494105|FG000|Survival Follow-Up|Adverse Event|0|||
145720638|NCT02808143|525494106|FG001|Survival Follow-Up|Adverse Event|1|||
145720639|NCT02808143|525494105|FG000|Survival Follow-Up|Death|1|||
145720640|NCT02808143|525494106|FG001|Survival Follow-Up|Death|0|||
145720641|NCT00522873|525494109|FG000|Overall Study|Adverse Event|41|||
145720642|NCT00522873|525494110|FG001|Overall Study|Adverse Event|26|||
145720643|NCT00522873|525494109|FG000|Overall Study|Withdrawal by Subject|20|||
145720644|NCT00522873|525494110|FG001|Overall Study|Withdrawal by Subject|9|||
145720645|NCT00522873|525494109|FG000|Overall Study|Protocol Violation|14|||
145720646|NCT00522873|525494110|FG001|Overall Study|Protocol Violation|4|||
145720647|NCT00522873|525494109|FG000|Overall Study|Lost to Follow-up|11|||
145720648|NCT00522873|525494110|FG001|Overall Study|Lost to Follow-up|3|||
145720649|NCT00522873|525494109|FG000|Overall Study|Personal Reasons|8|||
145720650|NCT00522873|525494110|FG001|Overall Study|Personal Reasons|1|||
145720651|NCT00522873|525494109|FG000|Overall Study|Medication Errors|1|||
145720652|NCT00522873|525494110|FG001|Overall Study|Medication Errors|1|||
145720653|NCT00522873|525494109|FG000|Overall Study|Never Received Medication|1|||
145720654|NCT00522873|525494110|FG001|Overall Study|Never Received Medication|0|||
145720655|NCT01874431|525494112|FG000|Overall Study|Physician Decision|0|||
145720656|NCT01874431|525494113|FG001|Overall Study|Physician Decision|0|||
145720657|NCT01874431|525494114|FG002|Overall Study|Physician Decision|1|||
145720658|NCT01874431|525494115|FG003|Overall Study|Physician Decision|0|||
145720659|NCT01874431|525494116|FG004|Overall Study|Physician Decision|0|||
145720660|NCT01874431|525494117|FG005|Overall Study|Physician Decision|0|||
145720661|NCT01874431|525494118|FG006|Overall Study|Physician Decision|0|||
145720662|NCT01874431|525494119|FG007|Overall Study|Physician Decision|0|||
145720663|NCT01874431|525494112|FG000|Overall Study|Adverse Event|5|||
145720664|NCT01874431|525494113|FG001|Overall Study|Adverse Event|4|||
145720665|NCT01874431|525494114|FG002|Overall Study|Adverse Event|6|||
145720666|NCT01874431|525494115|FG003|Overall Study|Adverse Event|5|||
145720667|NCT01874431|525494116|FG004|Overall Study|Adverse Event|2|||
145720668|NCT01874431|525494117|FG005|Overall Study|Adverse Event|8|||
145720669|NCT01874431|525494118|FG006|Overall Study|Adverse Event|2|||
145720670|NCT01874431|525494119|FG007|Overall Study|Adverse Event|3|||
145720671|NCT01874431|525494112|FG000|Overall Study|Protocol Violation|1|||
145720672|NCT01874431|525494113|FG001|Overall Study|Protocol Violation|1|||
145720673|NCT01874431|525494114|FG002|Overall Study|Protocol Violation|1|||
145720674|NCT01874431|525494115|FG003|Overall Study|Protocol Violation|0|||
145720675|NCT01874431|525494116|FG004|Overall Study|Protocol Violation|3|||
145720676|NCT01874431|525494117|FG005|Overall Study|Protocol Violation|2|||
145720677|NCT01874431|525494118|FG006|Overall Study|Protocol Violation|1|||
145720678|NCT01874431|525494119|FG007|Overall Study|Protocol Violation|1|||
145720679|NCT01874431|525494112|FG000|Overall Study|Non-compliance|0|||
145720680|NCT01874431|525494113|FG001|Overall Study|Non-compliance|0|||
145720681|NCT01874431|525494114|FG002|Overall Study|Non-compliance|0|||
145720682|NCT01874431|525494115|FG003|Overall Study|Non-compliance|0|||
145720683|NCT01874431|525494116|FG004|Overall Study|Non-compliance|1|||
145720684|NCT01874431|525494117|FG005|Overall Study|Non-compliance|0|||
145720685|NCT01874431|525494118|FG006|Overall Study|Non-compliance|1|||
145720686|NCT01874431|525494119|FG007|Overall Study|Non-compliance|0|||
145720687|NCT01874431|525494112|FG000|Overall Study|Logistical difficulties|0|||
145720688|NCT01874431|525494113|FG001|Overall Study|Logistical difficulties|0|||
145720689|NCT01874431|525494114|FG002|Overall Study|Logistical difficulties|0|||
145720690|NCT01874431|525494115|FG003|Overall Study|Logistical difficulties|0|||
145720691|NCT01874431|525494116|FG004|Overall Study|Logistical difficulties|0|||
145720692|NCT01874431|525494117|FG005|Overall Study|Logistical difficulties|0|||
145720693|NCT01874431|525494118|FG006|Overall Study|Logistical difficulties|1|||
145720694|NCT01874431|525494119|FG007|Overall Study|Logistical difficulties|0|||
145720695|NCT01874431|525494112|FG000|Overall Study|Withdrawal by Subject|0|||
145720696|NCT01874431|525494113|FG001|Overall Study|Withdrawal by Subject|0|||
145720697|NCT01874431|525494114|FG002|Overall Study|Withdrawal by Subject|1|||
145720698|NCT01874431|525494115|FG003|Overall Study|Withdrawal by Subject|2|||
145720699|NCT01874431|525494116|FG004|Overall Study|Withdrawal by Subject|1|||
145720700|NCT01874431|525494117|FG005|Overall Study|Withdrawal by Subject|1|||
145720701|NCT01874431|525494118|FG006|Overall Study|Withdrawal by Subject|3|||
145720702|NCT01874431|525494119|FG007|Overall Study|Withdrawal by Subject|0|||
145720703|NCT01874431|525494112|FG000|Overall Study|Sponsor decision|0|||
145720704|NCT01874431|525494113|FG001|Overall Study|Sponsor decision|0|||
145720705|NCT01874431|525494114|FG002|Overall Study|Sponsor decision|0|||
145720706|NCT01874431|525494115|FG003|Overall Study|Sponsor decision|0|||
145720707|NCT01874431|525494116|FG004|Overall Study|Sponsor decision|1|||
145720708|NCT01874431|525494117|FG005|Overall Study|Sponsor decision|0|||
145720709|NCT01874431|525494118|FG006|Overall Study|Sponsor decision|0|||
145720710|NCT01874431|525494119|FG007|Overall Study|Sponsor decision|0|||
145720711|NCT01874431|525494112|FG000|Overall Study|Lost to Follow-up|0|||
145720712|NCT01874431|525494113|FG001|Overall Study|Lost to Follow-up|0|||
145720713|NCT01874431|525494114|FG002|Overall Study|Lost to Follow-up|1|||
145720714|NCT01874431|525494115|FG003|Overall Study|Lost to Follow-up|0|||
145720715|NCT01874431|525494116|FG004|Overall Study|Lost to Follow-up|0|||
145720716|NCT01874431|525494117|FG005|Overall Study|Lost to Follow-up|0|||
145720717|NCT01874431|525494118|FG006|Overall Study|Lost to Follow-up|0|||
145720718|NCT01874431|525494119|FG007|Overall Study|Lost to Follow-up|0|||
145720719|NCT00523640|525494126|FG000|Overall Study|Death|1|||
145720720|NCT02399254|525494127|FG000|Overall Study|Physician Decision|2|||
145720721|NCT02334423|525494128|FG000|Overall Study|Protocol Violation|10|||
145720722|NCT02334423|525494129|FG001|Overall Study|Protocol Violation|3|||
145720723|NCT02930226|525494130|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
145720724|NCT02930226|525494131|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
145720725|NCT02930226|525494132|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
145720726|NCT02930226|525494133|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
145720727|NCT02930226|525494134|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
145720728|NCT02930226|525494135|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
145720729|NCT00652327|525494136|FG000|Overall Study|Adverse Event|0|||
145720730|NCT00652327|525494137|FG001|Overall Study|Adverse Event|2|||
145720731|NCT00652327|525494136|FG000|Overall Study|Lost to Follow-up|0|||
145720732|NCT00652327|525494137|FG001|Overall Study|Lost to Follow-up|3|||
145720733|NCT01076647|525494138|FG000|Overall Study|Adverse Event|4|||
145720734|NCT01076647|525494139|FG001|Overall Study|Adverse Event|1|||
145720735|NCT01076647|525494138|FG000|Overall Study|Lack of Efficacy|0|||
145720736|NCT01076647|525494139|FG001|Overall Study|Lack of Efficacy|1|||
145720737|NCT01076647|525494138|FG000|Overall Study|Protocol Violation|7|||
145720738|NCT01076647|525494139|FG001|Overall Study|Protocol Violation|9|||
145720739|NCT01076647|525494138|FG000|Overall Study|Withdrawal criteria|2|||
145720740|NCT01076647|525494139|FG001|Overall Study|Withdrawal criteria|2|||
145720741|NCT01076647|525494138|FG000|Overall Study|Unclassified|12|||
145720742|NCT01076647|525494139|FG001|Overall Study|Unclassified|12|||
145720743|NCT02224690|525494147|FG000|Overall Study|Adverse Event|8|||
145720744|NCT02224690|525494148|FG001|Overall Study|Adverse Event|1|||
145720745|NCT02224690|525494147|FG000|Overall Study|Met Withdrawal Criteria|4|||
145720746|NCT02224690|525494148|FG001|Overall Study|Met Withdrawal Criteria|0|||
145720747|NCT02224690|525494147|FG000|Overall Study|Use of G-tube|1|||
145720748|NCT02224690|525494148|FG001|Overall Study|Use of G-tube|0|||
145720749|NCT02224690|525494147|FG000|Overall Study|Did not meet eligibility criteria|1|||
145720750|NCT02224690|525494148|FG001|Overall Study|Did not meet eligibility criteria|0|||
145720751|NCT01577745|525494149|FG000|Overall Study|Withdrawal by Subject|0|||
145720752|NCT01577745|525494150|FG001|Overall Study|Withdrawal by Subject|1|||
145720753|NCT01577745|525494151|FG002|Overall Study|Withdrawal by Subject|0|||
145720754|NCT01577745|525494152|FG003|Overall Study|Withdrawal by Subject|3|||
145720755|NCT01577745|525494153|FG004|Overall Study|Withdrawal by Subject|2|||
145720756|NCT01577745|525494154|FG005|Overall Study|Withdrawal by Subject|0|||
145720757|NCT01577745|525494149|FG000|Overall Study|Death|3|||
145720758|NCT01577745|525494150|FG001|Overall Study|Death|2|||
145720759|NCT01577745|525494151|FG002|Overall Study|Death|2|||
145720760|NCT01577745|525494152|FG003|Overall Study|Death|1|||
145720761|NCT01577745|525494153|FG004|Overall Study|Death|1|||
145720762|NCT01577745|525494154|FG005|Overall Study|Death|3|||
145720763|NCT01577745|525494149|FG000|Overall Study|Physician Decision|0|||
145720764|NCT01577745|525494150|FG001|Overall Study|Physician Decision|0|||
145720765|NCT01577745|525494151|FG002|Overall Study|Physician Decision|0|||
145720766|NCT01577745|525494152|FG003|Overall Study|Physician Decision|1|||
145720767|NCT01577745|525494153|FG004|Overall Study|Physician Decision|1|||
145720768|NCT01577745|525494154|FG005|Overall Study|Physician Decision|0|||
145720769|NCT01577745|525494149|FG000|Overall Study|Lost to Follow-up|0|||
145720770|NCT01577745|525494150|FG001|Overall Study|Lost to Follow-up|0|||
145720771|NCT01577745|525494151|FG002|Overall Study|Lost to Follow-up|0|||
145720772|NCT01577745|525494152|FG003|Overall Study|Lost to Follow-up|0|||
145720773|NCT01577745|525494153|FG004|Overall Study|Lost to Follow-up|0|||
145720774|NCT01577745|525494154|FG005|Overall Study|Lost to Follow-up|1|||
145720775|NCT01577745|525494149|FG000|Overall Study|Alternative Therapy|0|||
145720776|NCT01577745|525494150|FG001|Overall Study|Alternative Therapy|0|||
145720777|NCT01577745|525494151|FG002|Overall Study|Alternative Therapy|0|||
145720778|NCT01577745|525494152|FG003|Overall Study|Alternative Therapy|1|||
145720779|NCT01577745|525494153|FG004|Overall Study|Alternative Therapy|1|||
145720780|NCT01577745|525494154|FG005|Overall Study|Alternative Therapy|0|||
145720781|NCT00122460|525494155|FG000|Overall Study|investigational study phase ongoing|7|||
145720782|NCT00122460|525494156|FG001|Overall Study|investigational study phase ongoing|1|||
145720783|NCT00825916|525494157|FG000|Overall Study|Lost to Follow-up|4|||
145720784|NCT00825916|525494158|FG001|Overall Study|Lost to Follow-up|2|||
145720785|NCT00825916|525494159|FG002|Overall Study|Lost to Follow-up|1|||
145720786|NCT02962960|525494160|FG000|Overall Study|Withdrawal by Subject|1|||
145720787|NCT02962960|525494161|FG001|Overall Study|Withdrawal by Subject|1|||
145720788|NCT02962960|525494162|FG002|Overall Study|Withdrawal by Subject|0|||
145720789|NCT02962960|525494160|FG000|Overall Study|Adverse Event|1|||
145720790|NCT02962960|525494161|FG001|Overall Study|Adverse Event|1|||
145720791|NCT02962960|525494162|FG002|Overall Study|Adverse Event|0|||
145720792|NCT02962960|525494160|FG000|Overall Study|Protocol Violation|1|||
145720793|NCT02962960|525494161|FG001|Overall Study|Protocol Violation|0|||
145720794|NCT02962960|525494162|FG002|Overall Study|Protocol Violation|0|||
145720795|NCT02344004|525494170|FG000|Overall Study|Adverse Event|11|||
145720796|NCT02344004|525494171|FG001|Overall Study|Adverse Event|1|||
145720797|NCT02344004|525494170|FG000|Overall Study|Death|9|||
145720798|NCT02344004|525494171|FG001|Overall Study|Death|7|||
145720799|NCT02344004|525494170|FG000|Overall Study|Physician Decision|4|||
145720800|NCT02344004|525494171|FG001|Overall Study|Physician Decision|1|||
145720801|NCT02344004|525494170|FG000|Overall Study|Withdrawal by Subject|22|||
145720802|NCT02344004|525494171|FG001|Overall Study|Withdrawal by Subject|5|||
145720803|NCT02344004|525494170|FG000|Overall Study|Rescue Medication|2|||
145720804|NCT02344004|525494171|FG001|Overall Study|Rescue Medication|0|||
145720805|NCT02344004|525494170|FG000|Overall Study|Other Not Specified|12|||
145720806|NCT02344004|525494171|FG001|Overall Study|Other Not Specified|0|||
145720807|NCT02344004|525494170|FG000|Overall Study|Protocol Violation|1|||
145720808|NCT02344004|525494171|FG001|Overall Study|Protocol Violation|0|||
145720809|NCT01502631|525494172|FG000|Overall Study|Adverse Event|5|||
145720810|NCT01502631|525494173|FG001|Overall Study|Adverse Event|8|||
145720811|NCT01502631|525494172|FG000|Overall Study|Lost to Follow-up|2|||
145720812|NCT01502631|525494173|FG001|Overall Study|Lost to Follow-up|2|||
145720813|NCT01502631|525494172|FG000|Overall Study|Participant withdrew consent|2|||
145720814|NCT01502631|525494173|FG001|Overall Study|Participant withdrew consent|4|||
145720815|NCT01502631|525494172|FG000|Overall Study|Participant non-compliant|1|||
145720816|NCT01502631|525494173|FG001|Overall Study|Participant non-compliant|0|||
145720817|NCT01502631|525494172|FG000|Overall Study|Investigator's decision|0|||
145720818|NCT01502631|525494173|FG001|Overall Study|Investigator's decision|1|||
145720819|NCT01502631|525494172|FG000|Overall Study|Other|10|||
145720820|NCT01502631|525494173|FG001|Overall Study|Other|5|||
145720821|NCT00395460|525494174|FG000|Overall Study|Withdrawal by Subject|1|||
145720822|NCT00395460|525494175|FG001|Overall Study|Withdrawal by Subject|0|||
145720823|NCT04223830|525494176|FG000|Overall Study|Lost to Follow-up|9|||
145720824|NCT04223830|525494176|FG000|Overall Study|Adverse Event|1|||
145720825|NCT00862719|525494177|FG000|Overall Study|Disease Progression|5|||
145720826|NCT00862719|525494178|FG001|Overall Study|Disease Progression|0|||
145720827|NCT00862719|525494179|FG002|Overall Study|Disease Progression|1|||
145720828|NCT00862719|525494180|FG003|Overall Study|Disease Progression|0|||
145720829|NCT00862719|525494177|FG000|Overall Study|Death|5|||
145720830|NCT00862719|525494178|FG001|Overall Study|Death|6|||
145720831|NCT00862719|525494179|FG002|Overall Study|Death|1|||
145720832|NCT00862719|525494180|FG003|Overall Study|Death|1|||
145720833|NCT00862719|525494177|FG000|Overall Study|Engraftment failure|0|||
145720834|NCT00862719|525494178|FG001|Overall Study|Engraftment failure|0|||
145720835|NCT00862719|525494179|FG002|Overall Study|Engraftment failure|1|||
145720836|NCT00862719|525494180|FG003|Overall Study|Engraftment failure|0|||
145720837|NCT00862719|525494177|FG000|Overall Study|Veno-Occlusive Disease|0|||
145720838|NCT00862719|525494178|FG001|Overall Study|Veno-Occlusive Disease|0|||
145720839|NCT00862719|525494179|FG002|Overall Study|Veno-Occlusive Disease|1|||
145720840|NCT00862719|525494180|FG003|Overall Study|Veno-Occlusive Disease|0|||
145720841|NCT01806623|525494181|FG000|Overall Study|Withdrawal by Subject|1|||
145720842|NCT01806623|525494181|FG000|Overall Study|Adverse Event|1|||
145720843|NCT01806623|525494181|FG000|Overall Study|Did not meet the inclusion criteria|56|||
145720844|NCT02424734|525494182|FG000|Overall Study|Treatment stopped to be discharged home|2|||
145720845|NCT02424734|525494183|FG001|Overall Study|Treatment stopped to be discharged home|2|||
145720846|NCT02424734|525494184|FG002|Overall Study|Treatment stopped to be discharged home|0|||
145720847|NCT00709852|525494187|FG000|Period 1|Adverse Event|2|||
145720848|NCT00709852|525494188|FG001|Period 1|Adverse Event|0|||
145720849|NCT00709852|525494187|FG000|Period 1|Withdrawal by Subject|4|||
145720850|NCT00709852|525494188|FG001|Period 1|Withdrawal by Subject|2|||
145720851|NCT00709852|525494187|FG000|Period 1|Protocol Violation|1|||
145720852|NCT00709852|525494188|FG001|Period 1|Protocol Violation|0|||
145720853|NCT00709852|525494187|FG000|Period 1|Defective scanner|0|||
145720854|NCT00709852|525494188|FG001|Period 1|Defective scanner|1|||
145720855|NCT00709852|525494187|FG000|Period 1|Lost to Follow-up|1|||
145720856|NCT00709852|525494188|FG001|Period 1|Lost to Follow-up|0|||
145720857|NCT00709852|525494187|FG000|Period 2|Protocol Violation|4|||
145720858|NCT00709852|525494188|FG001|Period 2|Protocol Violation|1|||
145720859|NCT00709852|525494187|FG000|Period 2|Adverse Event|1|||
145720860|NCT00709852|525494188|FG001|Period 2|Adverse Event|1|||
145720861|NCT00709852|525494187|FG000|Period 2|Lost to Follow-up|1|||
145720862|NCT00709852|525494188|FG001|Period 2|Lost to Follow-up|0|||
145720863|NCT00709852|525494187|FG000|Period 2|No 72-hour follow-up|3|||
145720864|NCT00709852|525494188|FG001|Period 2|No 72-hour follow-up|0|||
145720865|NCT00185965|525494189|FG000|Overall Study|Adverse Event|0|||
145720866|NCT00185965|525494190|FG001|Overall Study|Adverse Event|1|||
145720867|NCT03814187|525494191|FG000|Overall Study|Sponsor's Administrative Decision|0|||
145720868|NCT03814187|525494192|FG001|Overall Study|Sponsor's Administrative Decision|0|||
145720869|NCT03814187|525494193|FG002|Overall Study|Sponsor's Administrative Decision|272|||
145720870|NCT03814187|525494191|FG000|Overall Study|Death|80|||
145720871|NCT03814187|525494192|FG001|Overall Study|Death|81|||
145720872|NCT03814187|525494193|FG002|Overall Study|Death|4|||
145720873|NCT03814187|525494191|FG000|Overall Study|Withdrew Consent|77|||
145720874|NCT03814187|525494192|FG001|Overall Study|Withdrew Consent|78|||
145720875|NCT03814187|525494193|FG002|Overall Study|Withdrew Consent|2|||
145720876|NCT03814187|525494191|FG000|Overall Study|Lost to Follow-up|47|||
145720877|NCT03814187|525494192|FG001|Overall Study|Lost to Follow-up|52|||
145720878|NCT03814187|525494193|FG002|Overall Study|Lost to Follow-up|1|||
145720879|NCT03814187|525494191|FG000|Overall Study|Adverse Event|22|||
145720880|NCT03814187|525494192|FG001|Overall Study|Adverse Event|23|||
145720881|NCT03814187|525494193|FG002|Overall Study|Adverse Event|0|||
145720882|NCT03814187|525494191|FG000|Overall Study|Physician Decision|7|||
145720883|NCT03814187|525494192|FG001|Overall Study|Physician Decision|4|||
145720884|NCT03814187|525494193|FG002|Overall Study|Physician Decision|2|||
145720885|NCT03814187|525494191|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
145720886|NCT03814187|525494192|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
145720887|NCT03814187|525494193|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
145720888|NCT03814187|525494191|FG000|Overall Study|Other reasons|34|||
145720889|NCT03814187|525494192|FG001|Overall Study|Other reasons|40|||
145720890|NCT03814187|525494193|FG002|Overall Study|Other reasons|2|||
145720891|NCT02009761|525494195|FG000|Overall Study|Adverse Event|4|||
145720892|NCT00825825|525494196|FG000|First Medication Period (14 Days)|Adverse Event|1|||
145720893|NCT00825825|525494197|FG001|First Medication Period (14 Days)|Adverse Event|0|||
145720894|NCT00825825|525494198|FG002|First Medication Period (14 Days)|Adverse Event|0|||
145720895|NCT00825825|525494199|FG003|First Medication Period (14 Days)|Adverse Event|0|||
145720896|NCT00825825|525494200|FG004|First Medication Period (14 Days)|Adverse Event|0|||
145720897|NCT00825825|525494201|FG005|First Medication Period (14 Days)|Adverse Event|1|||
145720898|NCT00825825|525494196|FG000|First Medication Period (14 Days)|Physician Decision|2|||
145720899|NCT00825825|525494197|FG001|First Medication Period (14 Days)|Physician Decision|0|||
145720900|NCT00825825|525494198|FG002|First Medication Period (14 Days)|Physician Decision|1|||
145720901|NCT00825825|525494199|FG003|First Medication Period (14 Days)|Physician Decision|0|||
145720902|NCT00825825|525494200|FG004|First Medication Period (14 Days)|Physician Decision|0|||
145720903|NCT00825825|525494201|FG005|First Medication Period (14 Days)|Physician Decision|1|||
145720904|NCT00825825|525494196|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
145720905|NCT00825825|525494197|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
145720906|NCT00825825|525494198|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
145720907|NCT00825825|525494199|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
145720908|NCT00825825|525494200|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
145720909|NCT00825825|525494201|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
145720910|NCT00825825|525494196|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
145720911|NCT00825825|525494197|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
145720912|NCT00825825|525494198|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
145720913|NCT00825825|525494199|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
145720914|NCT00825825|525494200|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
145720915|NCT00825825|525494201|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
145720916|NCT00825825|525494196|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
145720917|NCT00825825|525494197|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
145720918|NCT00825825|525494198|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
145720919|NCT00825825|525494199|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
145720920|NCT00825825|525494200|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
145720921|NCT00825825|525494201|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
145720922|NCT00825825|525494196|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
145720923|NCT00825825|525494197|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
145720924|NCT00825825|525494198|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
145720925|NCT00825825|525494199|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
145720926|NCT00825825|525494200|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
145720927|NCT00825825|525494201|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
145720928|NCT00825825|525494196|FG000|Third Medication Period (14 Days)|poor data quality|0|||
145720929|NCT00825825|525494197|FG001|Third Medication Period (14 Days)|poor data quality|1|||
145720930|NCT00825825|525494198|FG002|Third Medication Period (14 Days)|poor data quality|0|||
145720931|NCT00825825|525494199|FG003|Third Medication Period (14 Days)|poor data quality|0|||
145720932|NCT00825825|525494200|FG004|Third Medication Period (14 Days)|poor data quality|0|||
145720933|NCT00825825|525494201|FG005|Third Medication Period (14 Days)|poor data quality|0|||
145720934|NCT00757783|525494203|FG000|Overall Study|Adverse Event|0|||
145720935|NCT00757783|525494204|FG001|Overall Study|Adverse Event|2|||
145720936|NCT00757783|525494203|FG000|Overall Study|Lost to Follow-up|1|||
145720937|NCT00757783|525494204|FG001|Overall Study|Lost to Follow-up|1|||
145720938|NCT00757783|525494203|FG000|Overall Study|Protocol Violation|1|||
145720939|NCT00757783|525494204|FG001|Overall Study|Protocol Violation|0|||
145720940|NCT00757783|525494203|FG000|Overall Study|Withdrawal by Subject|2|||
145720941|NCT00757783|525494204|FG001|Overall Study|Withdrawal by Subject|1|||
145720942|NCT00757783|525494203|FG000|Overall Study|Other|1|||
145720943|NCT00757783|525494204|FG001|Overall Study|Other|2|||
145720944|NCT03265938|525494205|FG000|Overall Study|Withdrawal by Subject|1|||
145720945|NCT03265938|525494205|FG000|Overall Study|Physician Decision|1|||
145720946|NCT03265938|525494205|FG000|Overall Study|friable mass|6|||
145720947|NCT03965351|525494206|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
145720948|NCT03965351|525494207|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
145720949|NCT03965351|525494206|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
145720950|NCT03965351|525494207|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
145720951|NCT00994682|525494208|FG000|Double Bilnd|Withdrawal by Subject|5|||
145720952|NCT00994682|525494209|FG001|Double Bilnd|Withdrawal by Subject|6|||
145720953|NCT00994682|525494208|FG000|Double Bilnd|Lost to Follow-up|3|||
145720954|NCT00994682|525494209|FG001|Double Bilnd|Lost to Follow-up|3|||
145720955|NCT00994682|525494208|FG000|Double Bilnd|Adverse Event|1|||
145720956|NCT00994682|525494209|FG001|Double Bilnd|Adverse Event|0|||
145720957|NCT00994682|525494208|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
145720958|NCT00994682|525494209|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
145720959|NCT00994682|525494208|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
145720960|NCT00994682|525494209|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
145720961|NCT00994682|525494208|FG000|Pioglitazone Open Label|Physician Decision|6|||
145720962|NCT00994682|525494209|FG001|Pioglitazone Open Label|Physician Decision|1|||
145720963|NCT01323972|525494210|FG000|Overall Study|Withdrawal by Subject|1|||
145720964|NCT01323972|525494211|FG001|Overall Study|Withdrawal by Subject|0|||
145720965|NCT01323972|525494212|FG002|Overall Study|Withdrawal by Subject|1|||
145720966|NCT01323972|525494213|FG003|Overall Study|Withdrawal by Subject|0|||
145720967|NCT01323972|525494210|FG000|Overall Study|Migrated/moved from study area|1|||
145720968|NCT01323972|525494211|FG001|Overall Study|Migrated/moved from study area|2|||
145720969|NCT01323972|525494212|FG002|Overall Study|Migrated/moved from study area|0|||
145720970|NCT01323972|525494213|FG003|Overall Study|Migrated/moved from study area|0|||
145720971|NCT01323972|525494210|FG000|Overall Study|Lost to Follow-up|0|||
145720972|NCT01323972|525494211|FG001|Overall Study|Lost to Follow-up|1|||
145720973|NCT01323972|525494212|FG002|Overall Study|Lost to Follow-up|1|||
145720974|NCT01323972|525494213|FG003|Overall Study|Lost to Follow-up|1|||
145720975|NCT01049217|525494216|FG000|Overall Study|Adverse Event|2|||
145720976|NCT01049217|525494217|FG001|Overall Study|Adverse Event|1|||
145720977|NCT01049217|525494216|FG000|Overall Study|Lack of Efficacy|1|||
145720978|NCT01049217|525494217|FG001|Overall Study|Lack of Efficacy|1|||
145720979|NCT01049217|525494216|FG000|Overall Study|Lost to Follow-up|3|||
145720980|NCT01049217|525494217|FG001|Overall Study|Lost to Follow-up|8|||
145720981|NCT01049217|525494216|FG000|Overall Study|Withdrawal by Subject|4|||
145720982|NCT01049217|525494217|FG001|Overall Study|Withdrawal by Subject|3|||
145720983|NCT01049217|525494216|FG000|Overall Study|Protocol Violation|1|||
145720984|NCT01049217|525494217|FG001|Overall Study|Protocol Violation|3|||
145720985|NCT01049217|525494216|FG000|Overall Study|Pregnancy|1|||
145720986|NCT01049217|525494217|FG001|Overall Study|Pregnancy|0|||
145720987|NCT01049217|525494216|FG000|Overall Study|Study Terminated by Sponsor|43|||
145720988|NCT01049217|525494217|FG001|Overall Study|Study Terminated by Sponsor|43|||
145720989|NCT01049217|525494216|FG000|Overall Study|Other|1|||
145720990|NCT01049217|525494217|FG001|Overall Study|Other|2|||
145720991|NCT01049217|525494216|FG000|Overall Study|Randomized but not Treated|0|||
145720992|NCT01049217|525494217|FG001|Overall Study|Randomized but not Treated|2|||
145720993|NCT01946438|525494218|FG000|Overall Study|Adverse Event|0|||
145720994|NCT01946438|525494219|FG001|Overall Study|Adverse Event|0|||
145720995|NCT01946438|525494220|FG002|Overall Study|Adverse Event|0|||
145720996|NCT01946438|525494221|FG003|Overall Study|Adverse Event|1|||
145720997|NCT01946438|525494218|FG000|Overall Study|Serious Adverse event|1|||
145720998|NCT01946438|525494219|FG001|Overall Study|Serious Adverse event|0|||
145720999|NCT01946438|525494220|FG002|Overall Study|Serious Adverse event|0|||
145721000|NCT01946438|525494221|FG003|Overall Study|Serious Adverse event|0|||
145721001|NCT01946438|525494218|FG000|Overall Study|Protocol Violation|0|||
145721002|NCT01946438|525494219|FG001|Overall Study|Protocol Violation|0|||
145721003|NCT01946438|525494220|FG002|Overall Study|Protocol Violation|1|||
145721004|NCT01946438|525494221|FG003|Overall Study|Protocol Violation|0|||
145721005|NCT01946438|525494218|FG000|Overall Study|Withdrawal by Subject|1|||
145721006|NCT01946438|525494219|FG001|Overall Study|Withdrawal by Subject|0|||
145721007|NCT01946438|525494220|FG002|Overall Study|Withdrawal by Subject|0|||
145721008|NCT01946438|525494221|FG003|Overall Study|Withdrawal by Subject|0|||
145721009|NCT02412371|525494222|FG000|Overall Study|Withdrawal by Subject|0|||
145721010|NCT02412371|525494223|FG001|Overall Study|Withdrawal by Subject|2|||
145721011|NCT02412371|525494224|FG002|Overall Study|Withdrawal by Subject|0|||
145721012|NCT02412371|525494225|FG003|Overall Study|Withdrawal by Subject|1|||
145721013|NCT02412371|525494226|FG004|Overall Study|Withdrawal by Subject|1|||
145721014|NCT02412371|525494227|FG005|Overall Study|Withdrawal by Subject|0|||
145721015|NCT02412371|525494222|FG000|Overall Study|Sponsor Discontinued Study|1|||
145721016|NCT02412371|525494223|FG001|Overall Study|Sponsor Discontinued Study|4|||
145721017|NCT02412371|525494224|FG002|Overall Study|Sponsor Discontinued Study|6|||
145721018|NCT02412371|525494225|FG003|Overall Study|Sponsor Discontinued Study|4|||
145721019|NCT02412371|525494226|FG004|Overall Study|Sponsor Discontinued Study|5|||
145721020|NCT02412371|525494227|FG005|Overall Study|Sponsor Discontinued Study|0|||
145721021|NCT02412371|525494222|FG000|Overall Study|Death|4|||
145721022|NCT02412371|525494223|FG001|Overall Study|Death|2|||
145721023|NCT02412371|525494224|FG002|Overall Study|Death|1|||
145721024|NCT02412371|525494225|FG003|Overall Study|Death|3|||
145721025|NCT02412371|525494226|FG004|Overall Study|Death|5|||
145721026|NCT02412371|525494227|FG005|Overall Study|Death|2|||
145721027|NCT02412371|525494222|FG000|Overall Study|Other|2|||
145721028|NCT02412371|525494223|FG001|Overall Study|Other|1|||
145721029|NCT02412371|525494224|FG002|Overall Study|Other|0|||
145721030|NCT02412371|525494225|FG003|Overall Study|Other|0|||
145721031|NCT02412371|525494226|FG004|Overall Study|Other|1|||
145721032|NCT02412371|525494227|FG005|Overall Study|Other|3|||
145721033|NCT01892540|525494228|FG000|Overall Study|Did not complete PET/MRI|0|||
145721034|NCT01892540|525494229|FG001|Overall Study|Did not complete PET/MRI|0|||
145721035|NCT01892540|525494230|FG002|Overall Study|Did not complete PET/MRI|2|||
145721036|NCT01892540|525494228|FG000|Overall Study|Did not fit in scanner|0|||
145721037|NCT01892540|525494229|FG001|Overall Study|Did not fit in scanner|0|||
145721038|NCT01892540|525494230|FG002|Overall Study|Did not fit in scanner|1|||
145721039|NCT03141905|525494231|FG000|Overall Study|Death|3|||
145721040|NCT03141905|525494232|FG001|Overall Study|Death|2|||
145721041|NCT03141905|525494231|FG000|Overall Study|Withdrawal by Subject|1|||
145721042|NCT03141905|525494232|FG001|Overall Study|Withdrawal by Subject|0|||
145721043|NCT03141905|525494231|FG000|Overall Study|Lost to Follow-up|3|||
145721044|NCT03141905|525494232|FG001|Overall Study|Lost to Follow-up|7|||
145721045|NCT03141905|525494231|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
145721046|NCT03141905|525494232|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
145721047|NCT02317432|525494236|FG000|Overall Study|Death|4|||
145721048|NCT02317432|525494237|FG001|Overall Study|Death|1|||
145721049|NCT02317432|525494236|FG000|Overall Study|Lost to Follow-up|0|||
145721050|NCT02317432|525494237|FG001|Overall Study|Lost to Follow-up|5|||
145721051|NCT02317432|525494236|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
145721052|NCT02317432|525494237|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
145721053|NCT00727311|525494242|FG000|Overall Study|Did not receive drug|316|||
145721054|NCT00727311|525494242|FG000|Overall Study|Missing end of therapy data|205|||
145721055|NCT00727311|525494242|FG000|Overall Study|Adverse Event|58|||
145721056|NCT00727311|525494242|FG000|Overall Study|Lack of Efficacy|242|||
145721057|NCT00727311|525494242|FG000|Overall Study|Lost to Follow-up|73|||
145721058|NCT00727311|525494242|FG000|Overall Study|Withdrawal by Subject|77|||
145721059|NCT00727311|525494242|FG000|Overall Study|Other|97|||
145721060|NCT00727311|525494242|FG000|Overall Study|Multiple reasons|39|||
145721061|NCT02359877|525495828|FG000|Overall Study|Withdrawal by Subject|1|||
145721062|NCT02359877|525495829|FG001|Overall Study|Withdrawal by Subject|0|||
145721063|NCT02359877|525495830|FG002|Overall Study|Withdrawal by Subject|0|||
145721064|NCT02359877|525495831|FG003|Overall Study|Withdrawal by Subject|2|||
145721065|NCT02359877|525495828|FG000|Overall Study|Adverse Event|0|||
145721066|NCT02359877|525495829|FG001|Overall Study|Adverse Event|0|||
145721067|NCT02359877|525495830|FG002|Overall Study|Adverse Event|0|||
145721068|NCT02359877|525495831|FG003|Overall Study|Adverse Event|1|||
145721069|NCT02186223|525495833|FG000|Overall Study|Not eligible for device placement|6|||
145721070|NCT02186223|525495833|FG000|Overall Study|Unable to obtain femoral access|3|||
145721071|NCT02186223|525495833|FG000|Overall Study|Death|3|||
145721072|NCT02186223|525495833|FG000|Overall Study|Device in place less than 48 hours|9|||
145721073|NCT00252733|525495834|FG000|Overall Study|Withdrawal by Subject|73|||
145721074|NCT00252733|525495835|FG001|Overall Study|Withdrawal by Subject|67|||
145721075|NCT00252733|525495834|FG000|Overall Study|Death|7|||
145721076|NCT00252733|525495835|FG001|Overall Study|Death|5|||
145721077|NCT00252733|525495834|FG000|Overall Study|Lost to Follow-up|12|||
145721078|NCT00252733|525495835|FG001|Overall Study|Lost to Follow-up|6|||
145721079|NCT00252733|525495834|FG000|Overall Study|Multiple Reasons|14|||
145721080|NCT00252733|525495835|FG001|Overall Study|Multiple Reasons|14|||
145721081|NCT00876928|525495836|FG000|Overall Study|Lost to Follow-up|2|||
145721082|NCT00876928|525495837|FG001|Overall Study|Lost to Follow-up|5|||
145721083|NCT00876928|525495836|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
145721084|NCT00876928|525495837|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
145721085|NCT01111474|525495838|FG000|Overall Study|Lost to Follow-up|12|||
145721086|NCT04101318|525495841|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
145721087|NCT04101318|525495842|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
145721088|NCT04101318|525495841|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
145721089|NCT04101318|525495842|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
145721090|NCT04101318|525495841|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
145721091|NCT04101318|525495842|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
145721092|NCT00558259|525495843|FG000|Overall Study|Adverse Event|50|||
145721093|NCT00558259|525495844|FG001|Overall Study|Adverse Event|81|||
145721094|NCT00558259|525495843|FG000|Overall Study|Protocol Violation|9|||
145721095|NCT00558259|525495844|FG001|Overall Study|Protocol Violation|5|||
145721096|NCT00558259|525495843|FG000|Overall Study|Withdrawal by Subject|12|||
145721097|NCT00558259|525495844|FG001|Overall Study|Withdrawal by Subject|13|||
145721098|NCT02874924|525495845|FG000|Overall Study|Adverse Event|2|||
145721099|NCT02874924|525495846|FG001|Overall Study|Adverse Event|0|||
145721100|NCT02874924|525495847|FG002|Overall Study|Adverse Event|0|||
145721101|NCT02874924|525495845|FG000|Overall Study|Withdrawal by Subject|1|||
145721102|NCT02874924|525495846|FG001|Overall Study|Withdrawal by Subject|0|||
145721103|NCT02874924|525495847|FG002|Overall Study|Withdrawal by Subject|0|||
145721104|NCT02029846|525495850|FG000|Overall Study|n=1 each arm|1|||
145721105|NCT02029846|525495851|FG001|Overall Study|n=1 each arm|1|||
145721106|NCT02966301|525495852|FG000|Overall Study|Death|2|||
145721107|NCT02966301|525495852|FG000|Overall Study|Withdrawal by Subject|1|||
145721108|NCT03718533|525495859|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
145721109|NCT03718533|525495859|FG000|Overall Study|Protocol deviation|1|||
145721110|NCT03718533|525495859|FG000|Overall Study|Disease progression|1|||
145721111|NCT03718533|525495859|FG000|Overall Study|Relapse|1|||
145721112|NCT03718533|525495859|FG000|Overall Study|Physician Decision|2|||
145721113|NCT03718533|525495859|FG000|Overall Study|Physician Decision and Adverse Event|1|||
145721114|NCT01375114|525495862|FG000|Overall Study|Lost to Follow-up|1|||
145721115|NCT01375114|525495863|FG001|Overall Study|Lost to Follow-up|0|||
145721116|NCT01375114|525495864|FG002|Overall Study|Lost to Follow-up|1|||
145721117|NCT01375114|525495862|FG000|Overall Study|Disease Progression|3|||
145721118|NCT01375114|525495863|FG001|Overall Study|Disease Progression|2|||
145721119|NCT01375114|525495864|FG002|Overall Study|Disease Progression|2|||
145721120|NCT01375114|525495862|FG000|Overall Study|Patient Changed Mind|0|||
145721121|NCT01375114|525495863|FG001|Overall Study|Patient Changed Mind|0|||
145721122|NCT01375114|525495864|FG002|Overall Study|Patient Changed Mind|2|||
145721123|NCT01375114|525495862|FG000|Overall Study|Pruritus|0|||
145721124|NCT01375114|525495863|FG001|Overall Study|Pruritus|0|||
145721125|NCT01375114|525495864|FG002|Overall Study|Pruritus|1|||
145721126|NCT01375114|525495862|FG000|Overall Study|Restlessness|0|||
145721127|NCT01375114|525495863|FG001|Overall Study|Restlessness|0|||
145721128|NCT01375114|525495864|FG002|Overall Study|Restlessness|1|||
145721129|NCT01375114|525495862|FG000|Overall Study|Diarrhea|0|||
145721130|NCT01375114|525495863|FG001|Overall Study|Diarrhea|0|||
145721131|NCT01375114|525495864|FG002|Overall Study|Diarrhea|1|||
145721132|NCT01375114|525495862|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
145721133|NCT01375114|525495863|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
145721134|NCT01375114|525495864|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
145721135|NCT01375114|525495862|FG000|Overall Study|Nausea|0|||
145721136|NCT01375114|525495863|FG001|Overall Study|Nausea|1|||
145721137|NCT01375114|525495864|FG002|Overall Study|Nausea|0|||
145721138|NCT01375114|525495862|FG000|Overall Study|Increased AST/ALT|0|||
145721139|NCT01375114|525495863|FG001|Overall Study|Increased AST/ALT|1|||
145721140|NCT01375114|525495864|FG002|Overall Study|Increased AST/ALT|0|||
145721141|NCT01375114|525495862|FG000|Overall Study|Vaginal Hemorrhage|0|||
145721142|NCT01375114|525495863|FG001|Overall Study|Vaginal Hemorrhage|1|||
145721143|NCT01375114|525495864|FG002|Overall Study|Vaginal Hemorrhage|0|||
145721144|NCT01375114|525495862|FG000|Overall Study|Family problem|0|||
145721145|NCT01375114|525495863|FG001|Overall Study|Family problem|1|||
145721146|NCT01375114|525495864|FG002|Overall Study|Family problem|0|||
145721147|NCT01375114|525495862|FG000|Overall Study|Protocol Violation|2|||
145721148|NCT01375114|525495863|FG001|Overall Study|Protocol Violation|0|||
145721149|NCT01375114|525495864|FG002|Overall Study|Protocol Violation|0|||
145721150|NCT01888900|525495870|FG000|Overall Study|failed treatment|0|||
145721151|NCT01888900|525495871|FG001|Overall Study|failed treatment|2|||
145721152|NCT01248065|525495872|FG000|Overall Study|Lost to Follow-up|3|||
145721153|NCT01248065|525495873|FG001|Overall Study|Lost to Follow-up|5|||
145721154|NCT01248065|525495872|FG000|Overall Study|Withdrawal by Subject|14|||
145721155|NCT01248065|525495873|FG001|Overall Study|Withdrawal by Subject|11|||
145721156|NCT01248065|525495872|FG000|Overall Study|Adverse Event|3|||
145721157|NCT01248065|525495873|FG001|Overall Study|Adverse Event|0|||
145721158|NCT01248065|525495872|FG000|Overall Study|Third treatment failure event|3|||
145721159|NCT01248065|525495873|FG001|Overall Study|Third treatment failure event|1|||
145721160|NCT01248065|525495872|FG000|Overall Study|Other|3|||
145721161|NCT01248065|525495873|FG001|Overall Study|Other|5|||
145721162|NCT02518490|525495880|FG000|Overall Study|Withdrawal by Subject|1|||
145721163|NCT02518490|525495881|FG001|Overall Study|Withdrawal by Subject|1|||
145721164|NCT04256629|525495882|FG000|Overall Study|Adverse Event|0|||
145721165|NCT04256629|525495883|FG001|Overall Study|Adverse Event|0|||
145721166|NCT04256629|525495884|FG002|Overall Study|Adverse Event|0|||
145721167|NCT04256629|525495885|FG003|Overall Study|Adverse Event|0|||
145721168|NCT04256629|525495886|FG004|Overall Study|Adverse Event|0|||
145721169|NCT04256629|525495887|FG005|Overall Study|Adverse Event|1|||
145721170|NCT04256629|525495882|FG000|Overall Study|Protocol Violation|0|||
145721171|NCT04256629|525495883|FG001|Overall Study|Protocol Violation|1|||
145721172|NCT04256629|525495884|FG002|Overall Study|Protocol Violation|0|||
145721173|NCT04256629|525495885|FG003|Overall Study|Protocol Violation|0|||
145721174|NCT04256629|525495886|FG004|Overall Study|Protocol Violation|0|||
145721175|NCT04256629|525495887|FG005|Overall Study|Protocol Violation|0|||
145721176|NCT00346632|525495888|FG000|Overall Study|Progressive Disease|2|||
145721177|NCT00346632|525495889|FG001|Overall Study|Progressive Disease|2|||
145721178|NCT00346632|525495890|FG002|Overall Study|Progressive Disease|4|||
145721179|NCT00346632|525495891|FG003|Overall Study|Progressive Disease|3|||
145721180|NCT00346632|525495892|FG004|Overall Study|Progressive Disease|3|||
145721181|NCT00346632|525495893|FG005|Overall Study|Progressive Disease|1|||
145721182|NCT00346632|525495894|FG006|Overall Study|Progressive Disease|2|||
145721183|NCT00346632|525495895|FG007|Overall Study|Progressive Disease|2|||
145721184|NCT00346632|525495896|FG008|Overall Study|Progressive Disease|2|||
145721185|NCT00346632|525495897|FG009|Overall Study|Progressive Disease|2|||
145721186|NCT00346632|525495888|FG000|Overall Study|Adverse Event|0|||
145721187|NCT00346632|525495889|FG001|Overall Study|Adverse Event|0|||
145721188|NCT00346632|525495890|FG002|Overall Study|Adverse Event|0|||
145721189|NCT00346632|525495891|FG003|Overall Study|Adverse Event|0|||
145721190|NCT00346632|525495892|FG004|Overall Study|Adverse Event|1|||
145721191|NCT00346632|525495893|FG005|Overall Study|Adverse Event|1|||
145721192|NCT00346632|525495894|FG006|Overall Study|Adverse Event|1|||
145721193|NCT00346632|525495895|FG007|Overall Study|Adverse Event|0|||
145721194|NCT00346632|525495896|FG008|Overall Study|Adverse Event|0|||
145721195|NCT00346632|525495897|FG009|Overall Study|Adverse Event|0|||
145721196|NCT00346632|525495888|FG000|Overall Study|Death|0|||
145721197|NCT00346632|525495889|FG001|Overall Study|Death|0|||
145721198|NCT00346632|525495890|FG002|Overall Study|Death|1|||
145721199|NCT00346632|525495891|FG003|Overall Study|Death|0|||
145721200|NCT00346632|525495892|FG004|Overall Study|Death|0|||
145721201|NCT00346632|525495893|FG005|Overall Study|Death|0|||
145721202|NCT00346632|525495894|FG006|Overall Study|Death|0|||
145721203|NCT00346632|525495895|FG007|Overall Study|Death|0|||
145721204|NCT00346632|525495896|FG008|Overall Study|Death|0|||
145721205|NCT00346632|525495897|FG009|Overall Study|Death|0|||
145721206|NCT00346632|525495888|FG000|Overall Study|Protocol Violation|0|||
145721207|NCT00346632|525495889|FG001|Overall Study|Protocol Violation|0|||
145721208|NCT00346632|525495890|FG002|Overall Study|Protocol Violation|0|||
145721209|NCT00346632|525495891|FG003|Overall Study|Protocol Violation|0|||
145721210|NCT00346632|525495892|FG004|Overall Study|Protocol Violation|0|||
145721211|NCT00346632|525495893|FG005|Overall Study|Protocol Violation|0|||
145721212|NCT00346632|525495894|FG006|Overall Study|Protocol Violation|1|||
145721213|NCT00346632|525495895|FG007|Overall Study|Protocol Violation|0|||
145721214|NCT00346632|525495896|FG008|Overall Study|Protocol Violation|0|||
145721215|NCT00346632|525495897|FG009|Overall Study|Protocol Violation|0|||
145721216|NCT00346632|525495888|FG000|Overall Study|Withdrawal by Subject|0|||
145721217|NCT00346632|525495889|FG001|Overall Study|Withdrawal by Subject|0|||
145721218|NCT00346632|525495890|FG002|Overall Study|Withdrawal by Subject|0|||
145721219|NCT00346632|525495891|FG003|Overall Study|Withdrawal by Subject|0|||
145721220|NCT00346632|525495892|FG004|Overall Study|Withdrawal by Subject|0|||
145721221|NCT00346632|525495893|FG005|Overall Study|Withdrawal by Subject|0|||
145721222|NCT00346632|525495894|FG006|Overall Study|Withdrawal by Subject|1|||
145721223|NCT00346632|525495895|FG007|Overall Study|Withdrawal by Subject|0|||
145721224|NCT00346632|525495896|FG008|Overall Study|Withdrawal by Subject|0|||
145721225|NCT00346632|525495897|FG009|Overall Study|Withdrawal by Subject|0|||
145721226|NCT00346632|525495888|FG000|Overall Study|Switched to alternative treatment|0|||
145721227|NCT00346632|525495889|FG001|Overall Study|Switched to alternative treatment|0|||
145721228|NCT00346632|525495890|FG002|Overall Study|Switched to alternative treatment|1|||
145721229|NCT00346632|525495891|FG003|Overall Study|Switched to alternative treatment|0|||
145721230|NCT00346632|525495892|FG004|Overall Study|Switched to alternative treatment|0|||
145721231|NCT00346632|525495893|FG005|Overall Study|Switched to alternative treatment|0|||
145721232|NCT00346632|525495894|FG006|Overall Study|Switched to alternative treatment|0|||
145721233|NCT00346632|525495895|FG007|Overall Study|Switched to alternative treatment|0|||
145721234|NCT00346632|525495896|FG008|Overall Study|Switched to alternative treatment|0|||
145721235|NCT00346632|525495897|FG009|Overall Study|Switched to alternative treatment|0|||
145721236|NCT00346632|525495888|FG000|Overall Study|Not Stated|1|||
145721237|NCT00346632|525495889|FG001|Overall Study|Not Stated|1|||
145721238|NCT00346632|525495890|FG002|Overall Study|Not Stated|0|||
145721239|NCT00346632|525495891|FG003|Overall Study|Not Stated|0|||
145721240|NCT00346632|525495892|FG004|Overall Study|Not Stated|0|||
145721241|NCT00346632|525495893|FG005|Overall Study|Not Stated|0|||
145721242|NCT00346632|525495894|FG006|Overall Study|Not Stated|0|||
145721243|NCT00346632|525495895|FG007|Overall Study|Not Stated|2|||
145721244|NCT00346632|525495896|FG008|Overall Study|Not Stated|2|||
145721245|NCT00346632|525495897|FG009|Overall Study|Not Stated|1|||
145721246|NCT00477334|525495898|FG000|Overall Study|Discontinued prior to taking study drug|106|||
145721247|NCT00477334|525495899|FG001|Overall Study|Discontinued prior to taking study drug|53|||
145721248|NCT00477334|525495898|FG000|Overall Study|Adverse Event|1|||
145721249|NCT00477334|525495899|FG001|Overall Study|Adverse Event|2|||
145721250|NCT00477334|525495898|FG000|Overall Study|Withdrawal by Subject|2|||
145721251|NCT00477334|525495899|FG001|Overall Study|Withdrawal by Subject|1|||
145721252|NCT00477334|525495898|FG000|Overall Study|Lost to Follow-up|15|||
145721253|NCT00477334|525495899|FG001|Overall Study|Lost to Follow-up|4|||
145721254|NCT00477334|525495898|FG000|Overall Study|Administrative Problems|39|||
145721255|NCT00477334|525495899|FG001|Overall Study|Administrative Problems|15|||
145721256|NCT00477334|525495898|FG000|Overall Study|Protocol Violation|7|||
145721257|NCT00477334|525495899|FG001|Overall Study|Protocol Violation|1|||
145721258|NCT00297232|525495900|FG000|Overall Study|Lack of Efficacy|7|||
145721259|NCT00297232|525495900|FG000|Overall Study|Lost to Follow-up|10|||
145721260|NCT00297232|525495900|FG000|Overall Study|Adverse Event|63|||
145721261|NCT00297232|525495900|FG000|Overall Study|Voluntary Withdrawal|120|||
145721262|NCT00297232|525495900|FG000|Overall Study|Subject was Noncompliant|9|||
145721263|NCT00297232|525495900|FG000|Overall Study|Death|9|||
145721264|NCT00297232|525495900|FG000|Overall Study|Anti-natalizumab Positive|8|||
145721265|NCT00297232|525495900|FG000|Overall Study|Switched to Commercial Tysabri|22|||
145721266|NCT00297232|525495900|FG000|Overall Study|Disease Progression|8|||
145721267|NCT00297232|525495900|FG000|Overall Study|Fear of PML|10|||
145721268|NCT00297232|525495900|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
145721269|NCT00297232|525495900|FG000|Overall Study|Miscellaneous|5|||
145721270|NCT00297232|525495900|FG000|Overall Study|Sponsor Decision|34|||
145721271|NCT00297232|525495900|FG000|Overall Study|Subject Relocated|7|||
145721272|NCT00297232|525495900|FG000|Overall Study|Subject Withdrew Consent|37|||
145721273|NCT00297232|525495900|FG000|Overall Study|Persistently Positive Antibodies|11|||
145721274|NCT00297232|525495900|FG000|Overall Study|Investigator Withdrew From Program|19|||
145721275|NCT00297232|525495900|FG000|Overall Study|Did Not Enroll to Week 264|34|||
145721276|NCT00297232|525495900|FG000|Overall Study|Did Not Enroll to Week 480|17|||
145721277|NCT00297232|525495900|FG000|Overall Study|No data available after Week 264|161|||
145721278|NCT00297232|525495900|FG000|Overall Study|Other|1|||
145721279|NCT03625895|525495903|FG000|Overall Study|Protocol Violation|585|||
145721280|NCT01065844|525495906|FG000|Overall Study|Adverse Event|5|||
145721281|NCT00552240|525495907|FG000|Overall Study|Adverse Event|9|||
145721282|NCT00552240|525495908|FG001|Overall Study|Adverse Event|9|||
145721283|NCT00552240|525495907|FG000|Overall Study|Protocol Violation|1|||
145721284|NCT00552240|525495908|FG001|Overall Study|Protocol Violation|1|||
145721285|NCT00552240|525495907|FG000|Overall Study|Lost to Follow-up|5|||
145721286|NCT00552240|525495908|FG001|Overall Study|Lost to Follow-up|6|||
145721287|NCT00552240|525495907|FG000|Overall Study|Withdrawal by Subject|2|||
145721288|NCT00552240|525495908|FG001|Overall Study|Withdrawal by Subject|2|||
145721289|NCT00552240|525495907|FG000|Overall Study|Lack of Efficacy|6|||
145721290|NCT00552240|525495908|FG001|Overall Study|Lack of Efficacy|0|||
145721291|NCT00552240|525495907|FG000|Overall Study|Other|1|||
145721292|NCT00552240|525495908|FG001|Overall Study|Other|0|||
145721293|NCT01415531|525495909|FG000|Overall Study|Adverse Event|7|||
145721294|NCT01415531|525495910|FG001|Overall Study|Adverse Event|10|||
145721295|NCT01415531|525495909|FG000|Overall Study|Lack of Efficacy|3|||
145721296|NCT01415531|525495910|FG001|Overall Study|Lack of Efficacy|2|||
145721297|NCT01415531|525495909|FG000|Overall Study|Protocol Violation|0|||
145721298|NCT01415531|525495910|FG001|Overall Study|Protocol Violation|1|||
145721299|NCT01415531|525495909|FG000|Overall Study|Withdrawal by Subject|5|||
145721300|NCT01415531|525495910|FG001|Overall Study|Withdrawal by Subject|4|||
145721301|NCT01415531|525495909|FG000|Overall Study|Lost to Follow-up|6|||
145721302|NCT01415531|525495910|FG001|Overall Study|Lost to Follow-up|14|||
145721303|NCT01415531|525495909|FG000|Overall Study|Lack of Compliance|1|||
145721304|NCT01415531|525495910|FG001|Overall Study|Lack of Compliance|4|||
145721305|NCT01415531|525495909|FG000|Overall Study|Other Reasons|3|||
145721306|NCT01415531|525495910|FG001|Overall Study|Other Reasons|2|||
145721307|NCT00394082|525495911|FG000|Overall Study|Unacceptable toxicity|15|||
145721308|NCT00394082|525495911|FG000|Overall Study|Adverse Event|4|||
145721309|NCT00394082|525495911|FG000|Overall Study|Physician Decision|4|||
145721310|NCT00394082|525495911|FG000|Overall Study|Withdrawal by Subject|2|||
145721311|NCT00394082|525495911|FG000|Overall Study|Other|1|||
145721312|NCT02319525|525495912|FG000|Overall Study|Withdrawal by Subject|2|||
145721313|NCT02319525|525495913|FG001|Overall Study|Withdrawal by Subject|1|||
145721314|NCT00577577|525495914|FG000|Overall Study|Adverse Event|3|||
145721315|NCT00577577|525495915|FG001|Overall Study|Adverse Event|2|||
145721316|NCT00577577|525495914|FG000|Overall Study|Lost to Follow-up|1|||
145721317|NCT00577577|525495915|FG001|Overall Study|Lost to Follow-up|0|||
145721318|NCT00577577|525495914|FG000|Overall Study|Protocol Violation|0|||
145721319|NCT00577577|525495915|FG001|Overall Study|Protocol Violation|3|||
145721320|NCT00577577|525495914|FG000|Overall Study|Transportation|1|||
145721321|NCT00577577|525495915|FG001|Overall Study|Transportation|0|||
145721322|NCT01200589|525495916|FG000|Overall Study|Withdrawal by Subject|13|||
145721323|NCT01200589|525495917|FG001|Overall Study|Withdrawal by Subject|11|||
145721324|NCT01200589|525495916|FG000|Overall Study|Physician Decision|2|||
145721325|NCT01200589|525495917|FG001|Overall Study|Physician Decision|2|||
145721326|NCT01200589|525495916|FG000|Overall Study|Lost to Follow-up|5|||
145721327|NCT01200589|525495917|FG001|Overall Study|Lost to Follow-up|4|||
145721328|NCT01200589|525495916|FG000|Overall Study|Study terminated|170|||
145721329|NCT01200589|525495917|FG001|Overall Study|Study terminated|172|||
145721330|NCT02549196|525495918|FG000|Overall Study|Protocol Violation|0|||
145721331|NCT02549196|525495919|FG001|Overall Study|Protocol Violation|0|||
145721332|NCT02549196|525495920|FG002|Overall Study|Protocol Violation|0|||
145721333|NCT02549196|525495921|FG003|Overall Study|Protocol Violation|1|||
145721334|NCT02549196|525495918|FG000|Overall Study|Withdrawal by Subject|1|||
145721335|NCT02549196|525495919|FG001|Overall Study|Withdrawal by Subject|0|||
145721336|NCT02549196|525495920|FG002|Overall Study|Withdrawal by Subject|1|||
145721337|NCT02549196|525495921|FG003|Overall Study|Withdrawal by Subject|0|||
145721338|NCT01442779|525495922|FG000|Overall Study|Withdrawal by Subject|3|||
145721339|NCT01442779|525495922|FG000|Overall Study|Death|3|||
145721340|NCT01442779|525495922|FG000|Overall Study|Non-compliance|1|||
145721341|NCT01047293|525495923|FG000|Overall Study|DLT criteria not fulfilled|1|||
145721342|NCT01047293|525495924|FG001|Overall Study|DLT criteria not fulfilled|1|||
145721343|NCT01047293|525495925|FG002|Overall Study|DLT criteria not fulfilled|0|||
145721344|NCT01047293|525495926|FG003|Overall Study|DLT criteria not fulfilled|0|||
145721345|NCT02372136|525495934|FG000|Overall Study|Death|3|||
145721346|NCT02372136|525495935|FG001|Overall Study|Death|1|||
145721347|NCT00985946|525495936|FG000|Overall Study|Lost to Follow-up|6|||
145721348|NCT00985946|525495936|FG000|Overall Study|Withdrawal by Subject|1|||
145721349|NCT02673515|525495940|FG000|Overall Study|Lack of motivation|2|||
145721350|NCT02673515|525495941|FG001|Overall Study|Lack of motivation|1|||
145721351|NCT03683823|525495942|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
145721352|NCT03683823|525495943|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
145721353|NCT03683823|525495942|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
145721354|NCT03683823|525495943|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
145721355|NCT03683823|525495942|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
145721356|NCT03683823|525495943|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
145721357|NCT00928018|525495946|FG000|Overall Study|Withdrawal by Subject|1|||
145721358|NCT00928018|525495947|FG001|Overall Study|Withdrawal by Subject|0|||
145721359|NCT00943111|525495948|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
145721360|NCT00943111|525495949|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
145721361|NCT00943111|525495950|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
145721362|NCT00943111|525495948|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
145721363|NCT00943111|525495949|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
145721364|NCT00943111|525495950|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
145721365|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
145721366|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
145721367|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
145721368|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
145721369|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
145721370|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
145721371|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
145721372|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
145721373|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
145721374|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
145721375|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
145721376|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
145721377|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
145721378|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
145721379|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
145721380|NCT00943111|525495948|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
145721381|NCT00943111|525495949|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
145721382|NCT00943111|525495950|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
145721383|NCT02859324|525495951|FG000|Overall Study|Death|4|||
145721384|NCT02859324|525495952|FG001|Overall Study|Death|6|||
145721385|NCT02859324|525495953|FG002|Overall Study|Death|5|||
145721386|NCT02859324|525495951|FG000|Overall Study|Other reasons|3|||
145721387|NCT02859324|525495952|FG001|Overall Study|Other reasons|3|||
145721388|NCT02859324|525495953|FG002|Overall Study|Other reasons|0|||
145721389|NCT02008877|525495954|FG000|Overall Study|Inevaluable|0|||
145721390|NCT02008877|525495955|FG001|Overall Study|Inevaluable|1|||
145721391|NCT02008877|525495956|FG002|Overall Study|Inevaluable|0|||
145721392|NCT00998335|525495957|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
145721393|NCT00998335|525495958|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
145721394|NCT05000931|525495967|FG000|Overall Study|Lost to Follow-up|1|||
145721395|NCT03149549|525495968|FG000|Study Discontinuation--Treatment Period|Death|0|||
145721396|NCT03149549|525495969|FG001|Study Discontinuation--Treatment Period|Death|0|||
145721397|NCT03149549|525495970|FG002|Study Discontinuation--Treatment Period|Death|0|||
145721398|NCT03149549|525495971|FG003|Study Discontinuation--Treatment Period|Death|1|||
145721399|NCT03149549|525495972|FG004|Study Discontinuation--Treatment Period|Death|2|||
145721400|NCT03149549|525495973|FG005|Study Discontinuation--Treatment Period|Death|1|||
145721401|NCT03149549|525495974|FG006|Study Discontinuation--Treatment Period|Death|1|||
145721402|NCT03149549|525495975|FG007|Study Discontinuation--Treatment Period|Death|2|||
145721403|NCT03149549|525495976|FG008|Study Discontinuation--Treatment Period|Death|4|||
145721404|NCT03149549|525495977|FG009|Study Discontinuation--Treatment Period|Death|1|||
145721405|NCT03149549|525495978|FG010|Study Discontinuation--Treatment Period|Death|0|||
145721406|NCT03149549|525495979|FG011|Study Discontinuation--Treatment Period|Death|0|||
145721407|NCT03149549|525495980|FG012|Study Discontinuation--Treatment Period|Death|1|||
145721408|NCT03149549|525495968|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721409|NCT03149549|525495969|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721410|NCT03149549|525495970|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721411|NCT03149549|525495971|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721412|NCT03149549|525495972|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721413|NCT03149549|525495973|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721414|NCT03149549|525495974|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721415|NCT03149549|525495975|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
145721416|NCT03149549|525495976|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721417|NCT03149549|525495977|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721418|NCT03149549|525495978|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721419|NCT03149549|525495979|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
145721420|NCT03149549|525495980|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
145721421|NCT03149549|525495968|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721422|NCT03149549|525495969|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721423|NCT03149549|525495970|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721424|NCT03149549|525495971|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
145721425|NCT03149549|525495972|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
145721426|NCT03149549|525495973|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
145721427|NCT03149549|525495974|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
145721428|NCT03149549|525495975|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721429|NCT03149549|525495976|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
145721430|NCT03149549|525495977|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721431|NCT03149549|525495978|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721432|NCT03149549|525495979|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721433|NCT03149549|525495980|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
145721434|NCT03149549|525495968|FG000|Study Discontinuation--Treatment Period|Other|0|||
145721435|NCT03149549|525495969|FG001|Study Discontinuation--Treatment Period|Other|0|||
145721436|NCT03149549|525495970|FG002|Study Discontinuation--Treatment Period|Other|0|||
145721437|NCT03149549|525495971|FG003|Study Discontinuation--Treatment Period|Other|0|||
145721438|NCT03149549|525495972|FG004|Study Discontinuation--Treatment Period|Other|0|||
145721439|NCT03149549|525495973|FG005|Study Discontinuation--Treatment Period|Other|0|||
145721440|NCT03149549|525495974|FG006|Study Discontinuation--Treatment Period|Other|0|||
145721441|NCT03149549|525495975|FG007|Study Discontinuation--Treatment Period|Other|1|||
145721442|NCT03149549|525495976|FG008|Study Discontinuation--Treatment Period|Other|0|||
145721443|NCT03149549|525495977|FG009|Study Discontinuation--Treatment Period|Other|1|||
145721444|NCT03149549|525495978|FG010|Study Discontinuation--Treatment Period|Other|0|||
145721445|NCT03149549|525495979|FG011|Study Discontinuation--Treatment Period|Other|0|||
145721446|NCT03149549|525495980|FG012|Study Discontinuation--Treatment Period|Other|0|||
145721447|NCT03149549|525495968|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721448|NCT03149549|525495969|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721449|NCT03149549|525495970|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721450|NCT03149549|525495971|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721451|NCT03149549|525495972|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721452|NCT03149549|525495973|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
145721453|NCT03149549|525495974|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
145721454|NCT03149549|525495975|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721455|NCT03149549|525495976|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
145721456|NCT03149549|525495977|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721457|NCT03149549|525495978|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721458|NCT03149549|525495979|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721459|NCT03149549|525495980|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
145721460|NCT03149549|525495968|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721461|NCT03149549|525495969|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721462|NCT03149549|525495970|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721463|NCT03149549|525495971|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721464|NCT03149549|525495972|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
145721465|NCT03149549|525495973|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721466|NCT03149549|525495974|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721467|NCT03149549|525495975|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
145721468|NCT03149549|525495976|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
145721469|NCT03149549|525495977|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721470|NCT03149549|525495978|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
145721471|NCT03149549|525495979|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
145721472|NCT03149549|525495980|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
145721473|NCT03149549|525495968|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721474|NCT03149549|525495969|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721475|NCT03149549|525495970|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721476|NCT03149549|525495971|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721477|NCT03149549|525495972|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
145721478|NCT03149549|525495973|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721479|NCT03149549|525495974|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721480|NCT03149549|525495975|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
145721481|NCT03149549|525495976|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
145721482|NCT03149549|525495977|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
145721483|NCT03149549|525495978|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
145721484|NCT03149549|525495979|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
145721485|NCT03149549|525495980|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
145721486|NCT03149549|525495968|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
145721487|NCT03149549|525495969|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
145721488|NCT03149549|525495970|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
145721489|NCT03149549|525495971|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
145721490|NCT03149549|525495972|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
145721491|NCT03149549|525495973|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
145721492|NCT03149549|525495974|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
145721493|NCT03149549|525495975|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
145721494|NCT03149549|525495976|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
145721495|NCT03149549|525495977|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
145721496|NCT03149549|525495978|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
145721497|NCT03149549|525495979|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
145721498|NCT03149549|525495980|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
145721499|NCT03149549|525495968|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
145721500|NCT03149549|525495969|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
145721501|NCT03149549|525495970|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
145721502|NCT03149549|525495971|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
145721503|NCT03149549|525495972|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
145721504|NCT03149549|525495973|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
145721505|NCT03149549|525495974|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
145721506|NCT03149549|525495975|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
145721507|NCT03149549|525495976|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
145721508|NCT03149549|525495977|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
145721509|NCT03149549|525495978|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
145721510|NCT03149549|525495979|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
145721511|NCT03149549|525495980|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
145721512|NCT04227704|525495990|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
145721513|NCT04227704|525495991|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
145721514|NCT04227704|525495992|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
145721515|NCT04227704|525495990|FG000|Overall Study|due to C/S being cancelled|1|||
145721516|NCT04227704|525495991|FG001|Overall Study|due to C/S being cancelled|0|||
145721517|NCT04227704|525495992|FG002|Overall Study|due to C/S being cancelled|0|||
145721518|NCT01775124|525495993|FG000|Core Period|Disease Progression|0|||
145721519|NCT01775124|525495994|FG001|Core Period|Disease Progression|1|||
145721520|NCT01775124|525495993|FG000|Core Period|Physician Decision|1|||
145721521|NCT01775124|525495994|FG001|Core Period|Physician Decision|1|||
145721522|NCT01775124|525495993|FG000|Core Period|Death|0|||
145721523|NCT01775124|525495994|FG001|Core Period|Death|1|||
145721524|NCT01775124|525495993|FG000|Core Period|Administrative problems|1|||
145721525|NCT01775124|525495994|FG001|Core Period|Administrative problems|0|||
145721526|NCT01775124|525495993|FG000|Core Period|Withdrawal by Subject|4|||
145721527|NCT01775124|525495994|FG001|Core Period|Withdrawal by Subject|2|||
145721528|NCT01775124|525495993|FG000|Core Period|Adverse Event|5|||
145721529|NCT01775124|525495994|FG001|Core Period|Adverse Event|5|||
145721530|NCT01775124|525495993|FG000|Extension Period|Adverse Event|3|||
145721531|NCT01775124|525495994|FG001|Extension Period|Adverse Event|2|||
145721532|NCT01775124|525495993|FG000|Extension Period|Physician Decision|0|||
145721533|NCT01775124|525495994|FG001|Extension Period|Physician Decision|2|||
145721534|NCT01775124|525495993|FG000|Extension Period|Administrative problems|0|||
145721535|NCT01775124|525495994|FG001|Extension Period|Administrative problems|1|||
145721536|NCT01775124|525495993|FG000|Extension Period|Lost to Follow-up|0|||
145721537|NCT01775124|525495994|FG001|Extension Period|Lost to Follow-up|1|||
145721538|NCT01775124|525495993|FG000|Extension Period|Withdrawal by Subject|9|||
145721539|NCT01775124|525495994|FG001|Extension Period|Withdrawal by Subject|12|||
145721540|NCT00346268|525497726|FG000|Overall Study|Adverse Event|1|||
145721541|NCT00346268|525497727|FG001|Overall Study|Adverse Event|0|||
145721542|NCT00346268|525497726|FG000|Overall Study|Protocol Violation|1|||
145721543|NCT00346268|525497727|FG001|Overall Study|Protocol Violation|0|||
145721544|NCT00346268|525497726|FG000|Overall Study|Participant refused|0|||
145721545|NCT00346268|525497727|FG001|Overall Study|Participant refused|3|||
145721546|NCT02164383|525497728|FG000|Overall Study|Lost to Follow-up|1|||
145721547|NCT02164383|525497729|FG001|Overall Study|Lost to Follow-up|0|||
145721548|NCT00743275|525497730|FG000|Overall Study|Protocol Violation|0|||
145721549|NCT00743275|525497731|FG001|Overall Study|Protocol Violation|1|||
145721550|NCT01672723|525497732|FG000|First Intervention|Adverse Event|3|||
145721551|NCT01672723|525497733|FG001|First Intervention|Adverse Event|0|||
145721552|NCT00484289|525497742|FG000|Long Term Phase|Adverse Event|1|||
145721553|NCT00484289|525497743|FG001|Long Term Phase|Adverse Event|17|||
145721554|NCT00484289|525497744|FG002|Long Term Phase|Adverse Event|5|||
145721555|NCT00484289|525497742|FG000|Long Term Phase|Withdrawal by Subject|0|||
145721556|NCT00484289|525497743|FG001|Long Term Phase|Withdrawal by Subject|7|||
145721557|NCT00484289|525497744|FG002|Long Term Phase|Withdrawal by Subject|6|||
145721558|NCT00484289|525497742|FG000|Long Term Phase|Inadequate response|2|||
145721559|NCT00484289|525497743|FG001|Long Term Phase|Inadequate response|7|||
145721560|NCT00484289|525497744|FG002|Long Term Phase|Inadequate response|4|||
145721561|NCT00484289|525497742|FG000|Long Term Phase|Other Reason|0|||
145721562|NCT00484289|525497743|FG001|Long Term Phase|Other Reason|5|||
145721563|NCT00484289|525497744|FG002|Long Term Phase|Other Reason|1|||
145721564|NCT00484289|525497742|FG000|Post Marketing Phase|Adverse Event|0|||
145721565|NCT00484289|525497743|FG001|Post Marketing Phase|Adverse Event|1|||
145721566|NCT00484289|525497744|FG002|Post Marketing Phase|Adverse Event|0|||
145721567|NCT02831387|525497745|FG000|Overall Study|Withdrawal by Subject|1|||
145721568|NCT02831387|525497746|FG001|Overall Study|Withdrawal by Subject|1|||
145721569|NCT02831387|525497745|FG000|Overall Study|Discontinued due to stock recovery|0|||
145721570|NCT02831387|525497746|FG001|Overall Study|Discontinued due to stock recovery|1|||
145721571|NCT01776541|525497747|FG000|Overall Study|Administrative Reason|6|||
145721572|NCT01776541|525497748|FG001|Overall Study|Administrative Reason|2|||
145721573|NCT01776541|525497747|FG000|Overall Study|Death|4|||
145721574|NCT01776541|525497748|FG001|Overall Study|Death|0|||
145721575|NCT01776541|525497747|FG000|Overall Study|Lost to Follow-up|27|||
145721576|NCT01776541|525497748|FG001|Overall Study|Lost to Follow-up|48|||
145721577|NCT01776541|525497747|FG000|Overall Study|Unclassified|5|||
145721578|NCT01776541|525497748|FG001|Overall Study|Unclassified|4|||
145721579|NCT01776541|525497747|FG000|Overall Study|Protocol Violation|2|||
145721580|NCT01776541|525497748|FG001|Overall Study|Protocol Violation|1|||
145721581|NCT01776541|525497747|FG000|Overall Study|Withdrawal by Subject|12|||
145721582|NCT01776541|525497748|FG001|Overall Study|Withdrawal by Subject|20|||
145721583|NCT01171807|525497749|FG000|Overall Study|Treatment failure|2|||
145721584|NCT01171807|525497750|FG001|Overall Study|Treatment failure|4|||
145721585|NCT01171807|525497749|FG000|Overall Study|Non compliance|1|||
145721586|NCT01171807|525497750|FG001|Overall Study|Non compliance|0|||
145721587|NCT01171807|525497749|FG000|Overall Study|Lost to Follow-up|3|||
145721588|NCT01171807|525497750|FG001|Overall Study|Lost to Follow-up|0|||
145721589|NCT01981473|525497751|FG000|Overall Study|Incorrect diagnosis of RA|0|||
145721590|NCT01981473|525497752|FG001|Overall Study|Incorrect diagnosis of RA|0|||
145721591|NCT01981473|525497753|FG002|Overall Study|Incorrect diagnosis of RA|1|||
145721592|NCT01981473|525497751|FG000|Overall Study|Received treatment for < 6 months|0|||
145721593|NCT01981473|525497752|FG001|Overall Study|Received treatment for < 6 months|0|||
145721594|NCT01981473|525497753|FG002|Overall Study|Received treatment for < 6 months|1|||
145721595|NCT01981473|525497751|FG000|Overall Study|Received treatment for >24 months|2|||
145721596|NCT01981473|525497752|FG001|Overall Study|Received treatment for >24 months|0|||
145721597|NCT01981473|525497753|FG002|Overall Study|Received treatment for >24 months|6|||
145721598|NCT02781844|525497758|FG000|Treatment Period 1|Adverse Event|0|||
145721599|NCT02781844|525497759|FG001|Treatment Period 1|Adverse Event|0|||
145721600|NCT02781844|525497760|FG002|Treatment Period 1|Adverse Event|0|||
145721601|NCT02781844|525497761|FG003|Treatment Period 1|Adverse Event|0|||
145721602|NCT02781844|525497762|FG004|Treatment Period 1|Adverse Event|0|||
145721603|NCT02781844|525497763|FG005|Treatment Period 1|Adverse Event|1|||
145721604|NCT02781844|525497764|FG006|Treatment Period 1|Adverse Event|0|||
145721605|NCT02781844|525497765|FG007|Treatment Period 1|Adverse Event|0|||
145721606|NCT00321373|525497770|FG000|Overall Study|Adverse Event|0|||
145721607|NCT00321373|525497771|FG001|Overall Study|Adverse Event|0|||
145721608|NCT00321373|525497772|FG002|Overall Study|Adverse Event|1|||
145721609|NCT00321373|525497770|FG000|Overall Study|Lost to Follow-up|1|||
145721610|NCT00321373|525497771|FG001|Overall Study|Lost to Follow-up|0|||
145721611|NCT00321373|525497772|FG002|Overall Study|Lost to Follow-up|1|||
145721612|NCT00321373|525497770|FG000|Overall Study|Withdrawal by Subject|1|||
145721613|NCT00321373|525497771|FG001|Overall Study|Withdrawal by Subject|0|||
145721614|NCT00321373|525497772|FG002|Overall Study|Withdrawal by Subject|0|||
145721615|NCT00321373|525497770|FG000|Overall Study|Other|0|||
145721616|NCT00321373|525497771|FG001|Overall Study|Other|0|||
145721617|NCT00321373|525497772|FG002|Overall Study|Other|1|||
145721618|NCT01774487|525497773|FG000|Overall Study|Did not tolerate taste|4|||
145721619|NCT01774487|525497774|FG001|Overall Study|Did not tolerate taste|4|||
145721620|NCT04275089|525497775|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
145721621|NCT02354508|525497779|FG000|Period 1: Core Phase|Adverse Event|1|||
145721622|NCT02354508|525497780|FG001|Period 1: Core Phase|Adverse Event|1|||
145721623|NCT02354508|525497781|FG002|Period 1: Core Phase|Adverse Event|2|||
145721624|NCT02354508|525497779|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
145721625|NCT02354508|525497780|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
145721626|NCT02354508|525497781|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
145721627|NCT02354508|525497779|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
145721628|NCT02354508|525497780|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
145721629|NCT02354508|525497781|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
145721630|NCT02354508|525497779|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
145721631|NCT02354508|525497780|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
145721632|NCT02354508|525497781|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
145721633|NCT02354508|525497779|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
145721634|NCT02354508|525497780|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
145721635|NCT02354508|525497781|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
145721636|NCT02354508|525497779|FG000|Period 2: Extension Phase|Physician Decision|5|||
145721637|NCT02354508|525497780|FG001|Period 2: Extension Phase|Physician Decision|0|||
145721638|NCT02354508|525497781|FG002|Period 2: Extension Phase|Physician Decision|1|||
145721639|NCT02354508|525497779|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
145721640|NCT02354508|525497780|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
145721641|NCT02354508|525497781|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
145721642|NCT02354508|525497779|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
145721643|NCT02354508|525497780|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
145721644|NCT02354508|525497781|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
145721645|NCT02354508|525497779|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
145721646|NCT02354508|525497780|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
145721647|NCT02354508|525497781|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
145721648|NCT02585232|525497784|FG000|Overall Study|Lost to Follow-up|8|||
145721649|NCT02585232|525497785|FG001|Overall Study|Lost to Follow-up|8|||
145721650|NCT02585232|525497784|FG000|Overall Study|Withdrawal by Subject|4|||
145721651|NCT02585232|525497785|FG001|Overall Study|Withdrawal by Subject|8|||
145721652|NCT00461032|525497786|FG000|Overall Study|Adverse Event|5|||
145721653|NCT00461032|525497787|FG001|Overall Study|Adverse Event|6|||
145721654|NCT00461032|525497786|FG000|Overall Study|Lack of Efficacy|5|||
145721655|NCT00461032|525497787|FG001|Overall Study|Lack of Efficacy|1|||
145721656|NCT00461032|525497786|FG000|Overall Study|Lost to Follow-up|7|||
145721657|NCT00461032|525497787|FG001|Overall Study|Lost to Follow-up|12|||
145721658|NCT00461032|525497786|FG000|Overall Study|Protocol Violation|4|||
145721659|NCT00461032|525497787|FG001|Overall Study|Protocol Violation|4|||
145721660|NCT00461032|525497786|FG000|Overall Study|Withdrawal by Subject|7|||
145721661|NCT00461032|525497787|FG001|Overall Study|Withdrawal by Subject|15|||
145721662|NCT00461032|525497786|FG000|Overall Study|Patient Moved or Relocated|2|||
145721663|NCT00461032|525497787|FG001|Overall Study|Patient Moved or Relocated|1|||
145721664|NCT00461032|525497786|FG000|Overall Study|Other|7|||
145721665|NCT00461032|525497787|FG001|Overall Study|Other|5|||
145721666|NCT04447846|525497788|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
145721667|NCT02257567|525497790|FG000|Overall Study|Adverse Event|0|||
145721668|NCT02257567|525497791|FG001|Overall Study|Adverse Event|0|||
145721669|NCT02257567|525497792|FG002|Overall Study|Adverse Event|0|||
145721670|NCT02257567|525497793|FG003|Overall Study|Adverse Event|1|||
145721671|NCT02257567|525497794|FG004|Overall Study|Adverse Event|1|||
145721672|NCT02257567|525497795|FG005|Overall Study|Adverse Event|0|||
145721673|NCT02257567|525497796|FG006|Overall Study|Adverse Event|0|||
145721674|NCT02257567|525497797|FG007|Overall Study|Adverse Event|0|||
145721675|NCT02257567|525497798|FG008|Overall Study|Adverse Event|1|||
145721676|NCT02257567|525497799|FG009|Overall Study|Adverse Event|0|||
145721677|NCT02257567|525497800|FG010|Overall Study|Adverse Event|0|||
145721678|NCT02257567|525497790|FG000|Overall Study|Death|2|||
145721679|NCT02257567|525497791|FG001|Overall Study|Death|2|||
145721680|NCT02257567|525497792|FG002|Overall Study|Death|2|||
145721681|NCT02257567|525497793|FG003|Overall Study|Death|4|||
145721682|NCT02257567|525497794|FG004|Overall Study|Death|15|||
145721683|NCT02257567|525497795|FG005|Overall Study|Death|11|||
145721684|NCT02257567|525497796|FG006|Overall Study|Death|26|||
145721685|NCT02257567|525497797|FG007|Overall Study|Death|30|||
145721686|NCT02257567|525497798|FG008|Overall Study|Death|2|||
145721687|NCT02257567|525497799|FG009|Overall Study|Death|18|||
145721688|NCT02257567|525497800|FG010|Overall Study|Death|65|||
145721689|NCT02257567|525497790|FG000|Overall Study|Lost to Follow-up|0|||
145721690|NCT02257567|525497791|FG001|Overall Study|Lost to Follow-up|0|||
145721691|NCT02257567|525497792|FG002|Overall Study|Lost to Follow-up|0|||
145721692|NCT02257567|525497793|FG003|Overall Study|Lost to Follow-up|0|||
145721693|NCT02257567|525497794|FG004|Overall Study|Lost to Follow-up|2|||
145721694|NCT02257567|525497795|FG005|Overall Study|Lost to Follow-up|2|||
145721695|NCT02257567|525497796|FG006|Overall Study|Lost to Follow-up|0|||
145721696|NCT02257567|525497797|FG007|Overall Study|Lost to Follow-up|0|||
145721697|NCT02257567|525497798|FG008|Overall Study|Lost to Follow-up|0|||
145721698|NCT02257567|525497799|FG009|Overall Study|Lost to Follow-up|1|||
145721699|NCT02257567|525497800|FG010|Overall Study|Lost to Follow-up|1|||
145721700|NCT02257567|525497790|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721701|NCT02257567|525497791|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721702|NCT02257567|525497792|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721703|NCT02257567|525497793|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721704|NCT02257567|525497794|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
145721705|NCT02257567|525497795|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721706|NCT02257567|525497796|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
145721707|NCT02257567|525497797|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721708|NCT02257567|525497798|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721709|NCT02257567|525497799|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721710|NCT02257567|525497800|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
145721711|NCT02257567|525497790|FG000|Overall Study|Physician Decision|0|||
145721712|NCT02257567|525497791|FG001|Overall Study|Physician Decision|0|||
145721713|NCT02257567|525497792|FG002|Overall Study|Physician Decision|0|||
145721714|NCT02257567|525497793|FG003|Overall Study|Physician Decision|0|||
145721715|NCT02257567|525497794|FG004|Overall Study|Physician Decision|0|||
145721716|NCT02257567|525497795|FG005|Overall Study|Physician Decision|0|||
145721717|NCT02257567|525497796|FG006|Overall Study|Physician Decision|0|||
145721718|NCT02257567|525497797|FG007|Overall Study|Physician Decision|2|||
145721719|NCT02257567|525497798|FG008|Overall Study|Physician Decision|0|||
145721720|NCT02257567|525497799|FG009|Overall Study|Physician Decision|1|||
145721721|NCT02257567|525497800|FG010|Overall Study|Physician Decision|0|||
145721722|NCT02257567|525497790|FG000|Overall Study|Withdrawal by Subject|0|||
145721723|NCT02257567|525497791|FG001|Overall Study|Withdrawal by Subject|0|||
145721724|NCT02257567|525497792|FG002|Overall Study|Withdrawal by Subject|2|||
145721725|NCT02257567|525497793|FG003|Overall Study|Withdrawal by Subject|0|||
145721726|NCT02257567|525497794|FG004|Overall Study|Withdrawal by Subject|0|||
145721727|NCT02257567|525497795|FG005|Overall Study|Withdrawal by Subject|6|||
145721728|NCT02257567|525497796|FG006|Overall Study|Withdrawal by Subject|6|||
145721729|NCT02257567|525497797|FG007|Overall Study|Withdrawal by Subject|6|||
145721730|NCT02257567|525497798|FG008|Overall Study|Withdrawal by Subject|1|||
145721731|NCT02257567|525497799|FG009|Overall Study|Withdrawal by Subject|1|||
145721732|NCT02257567|525497800|FG010|Overall Study|Withdrawal by Subject|10|||
145721733|NCT00871780|525497803|FG000|Overall Study|Enrolled But Not Treated|6|||
145721734|NCT00871780|525497803|FG000|Overall Study|Withdrawal by Subject|9|||
145721735|NCT00871780|525497803|FG000|Overall Study|Adverse Event|6|||
145721736|NCT00871780|525497803|FG000|Overall Study|Voluntary Discontinuation|4|||
145721737|NCT00871780|525497803|FG000|Overall Study|Death|1|||
145721738|NCT00871780|525497803|FG000|Overall Study|Physician Decision|1|||
145721739|NCT05767021|525497804|FG000|Overall Study|Adverse Event|2|||
145721740|NCT05767021|525497804|FG000|Overall Study|Protocol Deviation|1|||
145721741|NCT05767021|525497804|FG000|Overall Study|Withdrawal by Subject|1|||
145721742|NCT05767021|525497804|FG000|Overall Study|Physician Decision|1|||
145721743|NCT05767021|525497804|FG000|Overall Study|Lack of Efficacy|11|||
145721744|NCT05767021|525497804|FG000|Overall Study|Assigned Treatment by Mistake|1|||
145721745|NCT06377488|525497805|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
145721746|NCT06377488|525497805|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
145721747|NCT06377488|525497805|FG000|Overall Study|Protocol Violation|1|||
145721748|NCT06377488|525497805|FG000|Overall Study|Lost to Follow-up|1|||
145721749|NCT06377488|525497805|FG000|Overall Study|Incorrect Lens Dispensed|2|||
145721750|NCT02679573|525497806|FG000|Overall Study|Adverse Event|13|||
145721751|NCT02679573|525497807|FG001|Overall Study|Adverse Event|6|||
145721752|NCT02679573|525497806|FG000|Overall Study|Lack of Efficacy|12|||
145721753|NCT02679573|525497807|FG001|Overall Study|Lack of Efficacy|15|||
145721754|NCT02679573|525497806|FG000|Overall Study|Could not complete required study visits|6|||
145721755|NCT02679573|525497807|FG001|Overall Study|Could not complete required study visits|2|||
145721756|NCT02679573|525497806|FG000|Overall Study|Withdrawal by Subject|2|||
145721757|NCT02679573|525497807|FG001|Overall Study|Withdrawal by Subject|9|||
145721758|NCT02679573|525497806|FG000|Overall Study|Death|2|||
145721759|NCT02679573|525497807|FG001|Overall Study|Death|0|||
145721760|NCT02679573|525497806|FG000|Overall Study|Physician Decision|2|||
145721761|NCT02679573|525497807|FG001|Overall Study|Physician Decision|4|||
145721762|NCT02679573|525497806|FG000|Overall Study|Lost to Follow-up|0|||
145721763|NCT02679573|525497807|FG001|Overall Study|Lost to Follow-up|3|||
145721764|NCT03545503|525497808|FG000|Overall Study|Protocol Violation|14|||
145721765|NCT03545503|525497809|FG001|Overall Study|Protocol Violation|16|||
145721766|NCT05753670|525497810|FG000|Overall Study|Withdrawal by Subject|6|||
145721767|NCT05753670|525497811|FG001|Overall Study|Withdrawal by Subject|8|||
145721768|NCT05753670|525497810|FG000|Overall Study|Protocol Violation|3|||
145721769|NCT05753670|525497811|FG001|Overall Study|Protocol Violation|1|||
145721770|NCT02483585|525497812|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
145721771|NCT02483585|525497813|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
145721772|NCT02483585|525497812|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
145721773|NCT02483585|525497813|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
145721774|NCT02483585|525497812|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
145721775|NCT02483585|525497813|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
145721776|NCT02483585|525497812|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
145721777|NCT02483585|525497813|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
145721778|NCT02483585|525497812|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
145721779|NCT02483585|525497813|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
145721780|NCT02483585|525497812|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
145721781|NCT02483585|525497813|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
145721782|NCT02483585|525497812|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
145721783|NCT02483585|525497813|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
145721784|NCT01236339|525497819|FG000|Overall Study|Termination of study by sponsor|11|||
145721785|NCT01236339|525497820|FG001|Overall Study|Termination of study by sponsor|13|||
145721786|NCT01098097|525497821|FG000|Overall Study|Adverse Event|17|||
145721787|NCT01098097|525497821|FG000|Overall Study|Lost to Follow-up|18|||
145721788|NCT01098097|525497821|FG000|Overall Study|Status unknown|16|||
145721789|NCT01098097|525497821|FG000|Overall Study|No reason reported|31|||
145721790|NCT01945060|525497822|FG000|Overall Study|Lost to follow up|1|||
145493113|NCT01924845|524661166|FG000|Overall Study|Adverse Event|3|||
145721791|NCT01945060|525497823|FG001|Overall Study|Lost to follow up|0|||
145721792|NCT01945060|525497822|FG000|Overall Study|Distress related to IV access|0|||
145721793|NCT01945060|525497823|FG001|Overall Study|Distress related to IV access|1|||
145721794|NCT00232544|525497831|FG000|Overall Study|Lost to Follow-up|20|||
145721795|NCT00232544|525497832|FG001|Overall Study|Lost to Follow-up|15|||
145721796|NCT00116753|525497833|FG000|Overall Study|Adverse Event|16|||
145721797|NCT00116753|525497834|FG001|Overall Study|Adverse Event|10|||
145721798|NCT00116753|525497835|FG002|Overall Study|Adverse Event|7|||
145721799|NCT00116753|525497833|FG000|Overall Study|Withdrawal by Subject|11|||
145721800|NCT00116753|525497834|FG001|Overall Study|Withdrawal by Subject|12|||
145721801|NCT00116753|525497835|FG002|Overall Study|Withdrawal by Subject|8|||
145721802|NCT00116753|525497833|FG000|Overall Study|Lost to Follow-up|0|||
145721803|NCT00116753|525497834|FG001|Overall Study|Lost to Follow-up|2|||
145721804|NCT00116753|525497835|FG002|Overall Study|Lost to Follow-up|1|||
145721805|NCT00116753|525497833|FG000|Overall Study|Protocol Violation|0|||
145721806|NCT00116753|525497834|FG001|Overall Study|Protocol Violation|0|||
145721807|NCT00116753|525497835|FG002|Overall Study|Protocol Violation|1|||
145721808|NCT00116753|525497833|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
145721809|NCT00116753|525497834|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
145721810|NCT00116753|525497835|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
145721811|NCT00116753|525497833|FG000|Overall Study|Disease Progression|3|||
145721812|NCT00116753|525497834|FG001|Overall Study|Disease Progression|4|||
145721813|NCT00116753|525497835|FG002|Overall Study|Disease Progression|3|||
145721814|NCT00116753|525497833|FG000|Overall Study|Abnormal Echocardiogram|0|||
145721815|NCT00116753|525497834|FG001|Overall Study|Abnormal Echocardiogram|0|||
145721816|NCT00116753|525497835|FG002|Overall Study|Abnormal Echocardiogram|1|||
145721817|NCT00116753|525497833|FG000|Overall Study|Progressive Parkinson's Disease|1|||
145721818|NCT00116753|525497834|FG001|Overall Study|Progressive Parkinson's Disease|0|||
145721819|NCT00116753|525497835|FG002|Overall Study|Progressive Parkinson's Disease|0|||
145721820|NCT00116753|525497833|FG000|Overall Study|Dosing Error|0|||
145721821|NCT00116753|525497834|FG001|Overall Study|Dosing Error|1|||
145721822|NCT00116753|525497835|FG002|Overall Study|Dosing Error|0|||
145721823|NCT01590082|525497836|FG000|Overall Study|Withdrawal by Subject|1|||
145721824|NCT01590082|525497837|FG001|Overall Study|Withdrawal by Subject|0|||
145721825|NCT01590082|525497836|FG000|Overall Study|Ineligible|1|||
145721826|NCT01590082|525497837|FG001|Overall Study|Ineligible|0|||
145721827|NCT01210664|525497838|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
145721828|NCT01210664|525497839|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
145721829|NCT01210664|525497840|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
145721830|NCT01210664|525497841|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
145721831|NCT01210664|525497838|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721832|NCT01210664|525497839|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721833|NCT01210664|525497840|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
145721834|NCT01210664|525497841|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721835|NCT01210664|525497838|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721836|NCT01210664|525497839|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721837|NCT01210664|525497840|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
145721838|NCT01210664|525497841|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
145721839|NCT01853644|525497842|FG000|Registration and Treatment Start|Did not start treatment|1|||
145721840|NCT01853644|525497842|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
145721841|NCT01853644|525497842|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
145721842|NCT01853644|525497842|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
145721843|NCT01853644|525497842|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
145721844|NCT01853644|525497842|FG000|Continued Treatment After First Response|Adverse Event|2|||
145266522|NCT02594384|523825217|FG003|Overall Study|Withdrawal by Subject|1|||
145266523|NCT02594384|523825218|FG004|Overall Study|Withdrawal by Subject|0|||
145266524|NCT02594384|523825219|FG005|Overall Study|Withdrawal by Subject|0|||
145266525|NCT02594384|523825220|FG006|Overall Study|Withdrawal by Subject|0|||
145266526|NCT02594384|523825221|FG007|Overall Study|Withdrawal by Subject|1|||
145266527|NCT02594384|523825214|FG000|Overall Study|Physician Decision|0|||
145266528|NCT02594384|523825215|FG001|Overall Study|Physician Decision|0|||
145266529|NCT02594384|523825216|FG002|Overall Study|Physician Decision|0|||
145266530|NCT02594384|523825217|FG003|Overall Study|Physician Decision|0|||
145266531|NCT02594384|523825218|FG004|Overall Study|Physician Decision|0|||
145266532|NCT02594384|523825219|FG005|Overall Study|Physician Decision|1|||
145721845|NCT01853644|525497842|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
145721846|NCT02891408|525497843|FG000|Overall Study|Lost to Follow-up|0|||
145721847|NCT02891408|525497844|FG001|Overall Study|Lost to Follow-up|0|||
145721848|NCT02891408|525497845|FG002|Overall Study|Lost to Follow-up|1|||
145721849|NCT02891408|525497846|FG003|Overall Study|Lost to Follow-up|0|||
145721850|NCT02891408|525497847|FG004|Overall Study|Lost to Follow-up|0|||
145721851|NCT02891408|525497848|FG005|Overall Study|Lost to Follow-up|0|||
145721852|NCT02891408|525497849|FG006|Overall Study|Lost to Follow-up|0|||
145721853|NCT01054170|525497850|FG000|Overall Study|Protocol Violation|1|||
145721854|NCT01054170|525497851|FG001|Overall Study|Protocol Violation|0|||
145721855|NCT01054170|525497850|FG000|Overall Study|Withdrawal by Subject|3|||
145721856|NCT01054170|525497851|FG001|Overall Study|Withdrawal by Subject|2|||
145721857|NCT01054170|525497850|FG000|Overall Study|Adverse Event|0|||
145721858|NCT01054170|525497851|FG001|Overall Study|Adverse Event|4|||
145721859|NCT02951767|525497852|FG000|Overall Study|Study Terminated By Sponsor|9|||
145721860|NCT02951767|525497852|FG000|Overall Study|Withdrawal by Subject|11|||
145721861|NCT02951767|525497852|FG000|Overall Study|Death|96|||
145721862|NCT02951767|525497852|FG000|Overall Study|Lost to Follow-up|2|||
145721863|NCT02951767|525497852|FG000|Overall Study|Physician Decision|1|||
145721864|NCT00609765|525497855|FG000|Overall Study|Study ended prior to 12 months|1|||
145721865|NCT00950950|525497856|FG000|Overall Study|Adverse Event|1|||
145721866|NCT00950950|525497857|FG001|Overall Study|Adverse Event|0|||
145721867|NCT00950950|525497856|FG000|Overall Study|Withdrawal by Subject|0|||
145721868|NCT00950950|525497857|FG001|Overall Study|Withdrawal by Subject|1|||
145721869|NCT01920854|525497860|FG000|Overall Study|Withdrawal by Subject|1|||
145721870|NCT01920854|525497861|FG001|Overall Study|Withdrawal by Subject|0|||
145721871|NCT01920854|525497862|FG002|Overall Study|Withdrawal by Subject|0|||
145721872|NCT01920854|525497863|FG003|Overall Study|Withdrawal by Subject|0|||
145721873|NCT01920854|525497864|FG004|Overall Study|Withdrawal by Subject|1|||
145721874|NCT01920854|525497865|FG005|Overall Study|Withdrawal by Subject|0|||
145721875|NCT01920854|525497866|FG006|Overall Study|Withdrawal by Subject|1|||
145721876|NCT00729378|525500366|FG000|Baseline|Did not complete study measurements|72|||
145721877|NCT00729378|525500367|FG001|Baseline|Did not complete study measurements|33|||
145721878|NCT00729378|525500366|FG000|Baseline|Withdrawal by Subject|66|||
145721879|NCT00729378|525500367|FG001|Baseline|Withdrawal by Subject|59|||
145721880|NCT00729378|525500366|FG000|12-months|Lost to Follow-up|100|||
145721881|NCT00729378|525500367|FG001|12-months|Lost to Follow-up|65|||
145721882|NCT00729378|525500366|FG000|24-months|Lost to Follow-up|72|||
145721883|NCT00729378|525500367|FG001|24-months|Lost to Follow-up|51|||
145721884|NCT00729378|525500366|FG000|36-months|Lost to Follow-up|15|||
145721885|NCT00729378|525500367|FG001|36-months|Lost to Follow-up|6|||
145721886|NCT01586910|525500368|FG000|Overall Study|Death|4|||
145721887|NCT01586910|525500369|FG001|Overall Study|Death|4|||
145721888|NCT01586910|525500368|FG000|Overall Study|Withdrawal by Subject|6|||
145721889|NCT01586910|525500369|FG001|Overall Study|Withdrawal by Subject|43|||
145721890|NCT01586910|525500368|FG000|Overall Study|Physician withdrew Subject|5|||
145721891|NCT01586910|525500369|FG001|Overall Study|Physician withdrew Subject|24|||
145721892|NCT00031551|525500370|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
145721893|NCT00031551|525500371|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
145721894|NCT00192647|525500374|FG000|Overall Study|Death|1|||
145721895|NCT00192647|525500375|FG001|Overall Study|Death|1|||
145721896|NCT00192647|525500374|FG000|Overall Study|Adverse Event|35|||
145721897|NCT00192647|525500375|FG001|Overall Study|Adverse Event|29|||
145721898|NCT00192647|525500374|FG000|Overall Study|Laboratory Test Abnormality|4|||
145721899|NCT00192647|525500375|FG001|Overall Study|Laboratory Test Abnormality|2|||
145721900|NCT00192647|525500374|FG000|Overall Study|Insufficient Therapeutic Response|53|||
145721901|NCT00192647|525500375|FG001|Overall Study|Insufficient Therapeutic Response|83|||
145721902|NCT00192647|525500374|FG000|Overall Study|Entry Criteria Violation|6|||
145721903|NCT00192647|525500375|FG001|Overall Study|Entry Criteria Violation|6|||
145721904|NCT00192647|525500374|FG000|Overall Study|Protocol Violation|3|||
145721905|NCT00192647|525500375|FG001|Overall Study|Protocol Violation|1|||
145721906|NCT00192647|525500374|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
145721907|NCT00192647|525500375|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
145721908|NCT00192647|525500374|FG000|Overall Study|Failure to Return|11|||
145721909|NCT00192647|525500375|FG001|Overall Study|Failure to Return|13|||
145721910|NCT00192647|525500374|FG000|Overall Study|Other/Administrative|5|||
145381729|NCT00419159|524248595|FG000|Overall Study|Lost to Follow-up|0|||
145381730|NCT00419159|524248596|FG001|Overall Study|Lost to Follow-up|1|||
145381731|NCT00419159|524248595|FG000|Overall Study|Death|2|||
145381732|NCT00419159|524248596|FG001|Overall Study|Death|2|||
145381733|NCT00419159|524248595|FG000|Overall Study|Disease progression|79|||
145381734|NCT00419159|524248596|FG001|Overall Study|Disease progression|76|||
145381735|NCT02117713|524248597|FG000|Week 48|Adverse Event|4|||
145381736|NCT02117713|524248597|FG000|Week 48|Withdrawal by caregiver|2|||
145381737|NCT02117713|524248597|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
145381738|NCT02117713|524248597|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
145381739|NCT02117713|524248597|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
145381740|NCT02117713|524248597|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
145381741|NCT01094782|524248598|FG000|Overall Study|Withdrawal by Subject|5|||
145381742|NCT01094782|524248599|FG001|Overall Study|Withdrawal by Subject|5|||
145381743|NCT01094782|524248600|FG002|Overall Study|Withdrawal by Subject|1|||
145381744|NCT01094782|524248601|FG003|Overall Study|Withdrawal by Subject|5|||
145381745|NCT01094782|524248602|FG004|Overall Study|Withdrawal by Subject|5|||
145721911|NCT00192647|525500375|FG001|Overall Study|Other/Administrative|3|||
145721912|NCT01828073|525500376|FG000|Overall Study|Lost to Follow-up|1|||
145721913|NCT01828073|525500377|FG001|Overall Study|Lost to Follow-up|2|||
145721914|NCT00690443|525500382|FG000|Overall Study|Adverse Event|1|||
145721915|NCT00690443|525500383|FG001|Overall Study|Adverse Event|2|||
145721916|NCT03057977|525500384|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
145721917|NCT03057977|525500385|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
145721918|NCT03057977|525500384|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
145721919|NCT03057977|525500385|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
145721920|NCT03057977|525500384|FG000|Discontinuation From Treatment|Protocol Violation|6|||
145721921|NCT03057977|525500385|FG001|Discontinuation From Treatment|Protocol Violation|5|||
145721922|NCT03057977|525500384|FG000|Discontinuation From Treatment|Not treated|4|||
145721923|NCT03057977|525500385|FG001|Discontinuation From Treatment|Not treated|0|||
145721924|NCT03057977|525500384|FG000|Discontinuation From Treatment|Adverse Event|343|||
145721925|NCT03057977|525500385|FG001|Discontinuation From Treatment|Adverse Event|337|||
145721926|NCT03057977|525500384|FG000|Discontinuation From Treatment|Reason Unknown|0|||
145721927|NCT03057977|525500385|FG001|Discontinuation From Treatment|Reason Unknown|1|||
145721928|NCT03057977|525500384|FG000|Discontinuation From Treatment|Personal Reasons|1|||
145721929|NCT03057977|525500385|FG001|Discontinuation From Treatment|Personal Reasons|1|||
145721930|NCT03057977|525500384|FG000|Discontinuation From Treatment|Unblinded medication|1|||
145721931|NCT03057977|525500385|FG001|Discontinuation From Treatment|Unblinded medication|0|||
145721932|NCT03057977|525500384|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
145721933|NCT03057977|525500385|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
145721934|NCT03057977|525500384|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
145721935|NCT03057977|525500385|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
145721936|NCT03057977|525500384|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
145721937|NCT03057977|525500385|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
145721938|NCT03057977|525500384|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
145721939|NCT03057977|525500385|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
145721940|NCT03057977|525500384|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
145721941|NCT03057977|525500385|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
145721942|NCT03057977|525500384|FG000|Discontinuation From Treatment|Not attending study visit|3|||
145721943|NCT03057977|525500385|FG001|Discontinuation From Treatment|Not attending study visit|10|||
145721944|NCT03057977|525500384|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
145381746|NCT01094782|524248603|FG005|Overall Study|Withdrawal by Subject|0|||
145381747|NCT01094782|524248598|FG000|Overall Study|Lost to Follow-up|1|||
145381748|NCT01094782|524248599|FG001|Overall Study|Lost to Follow-up|0|||
145381749|NCT01094782|524248600|FG002|Overall Study|Lost to Follow-up|0|||
145381750|NCT01094782|524248601|FG003|Overall Study|Lost to Follow-up|2|||
145381751|NCT01094782|524248602|FG004|Overall Study|Lost to Follow-up|1|||
145381752|NCT01094782|524248603|FG005|Overall Study|Lost to Follow-up|4|||
145381753|NCT01094782|524248598|FG000|Overall Study|Positive Drug Screen|2|||
145381754|NCT01094782|524248599|FG001|Overall Study|Positive Drug Screen|2|||
145381755|NCT01094782|524248600|FG002|Overall Study|Positive Drug Screen|1|||
145381756|NCT01094782|524248601|FG003|Overall Study|Positive Drug Screen|1|||
145381757|NCT01094782|524248602|FG004|Overall Study|Positive Drug Screen|3|||
145381758|NCT01094782|524248603|FG005|Overall Study|Positive Drug Screen|2|||
145381759|NCT01094782|524248598|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
145381760|NCT01094782|524248599|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
145381761|NCT01094782|524248600|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
145381762|NCT01094782|524248601|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
145381763|NCT01094782|524248602|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
145381764|NCT01094782|524248603|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
145381765|NCT01094782|524248598|FG000|Overall Study|Unable to Complete Questionnaires|0|||
145381766|NCT01094782|524248599|FG001|Overall Study|Unable to Complete Questionnaires|1|||
145381767|NCT01094782|524248600|FG002|Overall Study|Unable to Complete Questionnaires|0|||
145381768|NCT01094782|524248601|FG003|Overall Study|Unable to Complete Questionnaires|0|||
145381769|NCT01094782|524248602|FG004|Overall Study|Unable to Complete Questionnaires|0|||
145381770|NCT01094782|524248603|FG005|Overall Study|Unable to Complete Questionnaires|0|||
145381771|NCT01094782|524248598|FG000|Overall Study|Healthy Subject Had Pain|0|||
145381772|NCT01094782|524248599|FG001|Overall Study|Healthy Subject Had Pain|1|||
145381773|NCT01094782|524248600|FG002|Overall Study|Healthy Subject Had Pain|0|||
145381774|NCT01094782|524248601|FG003|Overall Study|Healthy Subject Had Pain|0|||
145381775|NCT01094782|524248602|FG004|Overall Study|Healthy Subject Had Pain|0|||
145381776|NCT01094782|524248603|FG005|Overall Study|Healthy Subject Had Pain|0|||
145381777|NCT01094782|524248598|FG000|Overall Study|Hypertension|0|||
145381778|NCT01094782|524248599|FG001|Overall Study|Hypertension|0|||
145381779|NCT01094782|524248600|FG002|Overall Study|Hypertension|1|||
145381780|NCT01094782|524248601|FG003|Overall Study|Hypertension|0|||
145381781|NCT01094782|524248602|FG004|Overall Study|Hypertension|0|||
145381782|NCT01094782|524248603|FG005|Overall Study|Hypertension|0|||
145381783|NCT01094782|524248598|FG000|Overall Study|Wrong Pain Condition|0|||
145381784|NCT01094782|524248599|FG001|Overall Study|Wrong Pain Condition|0|||
145381785|NCT01094782|524248600|FG002|Overall Study|Wrong Pain Condition|0|||
145381786|NCT01094782|524248601|FG003|Overall Study|Wrong Pain Condition|2|||
145381787|NCT01094782|524248602|FG004|Overall Study|Wrong Pain Condition|1|||
145381788|NCT01094782|524248603|FG005|Overall Study|Wrong Pain Condition|1|||
145381789|NCT01094782|524248598|FG000|Overall Study|Recent Interventional Injection|0|||
145381790|NCT01094782|524248599|FG001|Overall Study|Recent Interventional Injection|0|||
145381791|NCT01094782|524248600|FG002|Overall Study|Recent Interventional Injection|0|||
145381792|NCT01094782|524248601|FG003|Overall Study|Recent Interventional Injection|0|||
145381793|NCT01094782|524248602|FG004|Overall Study|Recent Interventional Injection|0|||
145381794|NCT01094782|524248603|FG005|Overall Study|Recent Interventional Injection|1|||
145381795|NCT01094782|524248598|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145381796|NCT01094782|524248599|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145381797|NCT01094782|524248600|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145381798|NCT01094782|524248601|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145381799|NCT01094782|524248602|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
145381800|NCT01094782|524248603|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
145721945|NCT03057977|525500385|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
145381801|NCT01094782|524248598|FG000|Overall Study|Noncompliance With Study Schedule|0|||
145381802|NCT01094782|524248599|FG001|Overall Study|Noncompliance With Study Schedule|0|||
145381803|NCT01094782|524248600|FG002|Overall Study|Noncompliance With Study Schedule|0|||
145381804|NCT01094782|524248601|FG003|Overall Study|Noncompliance With Study Schedule|1|||
145381805|NCT01094782|524248602|FG004|Overall Study|Noncompliance With Study Schedule|0|||
145381806|NCT01094782|524248603|FG005|Overall Study|Noncompliance With Study Schedule|0|||
145381807|NCT00957905|524248605|FG000|Part B|Not Treated|0|||
145381808|NCT00957905|524248606|FG001|Part B|Not Treated|1|||
145381809|NCT00957905|524248605|FG000|Part B|Physician Decision|0|||
145381810|NCT00957905|524248606|FG001|Part B|Physician Decision|1|||
145381811|NCT00957905|524248605|FG000|Part B|Death|0|||
145381812|NCT00957905|524248606|FG001|Part B|Death|1|||
145381813|NCT00957905|524248605|FG000|Part B|Protocol Violation|0|||
145721946|NCT03057977|525500384|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
145721947|NCT03057977|525500385|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
145721948|NCT03057977|525500384|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
145721949|NCT03057977|525500385|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
145721950|NCT03057977|525500384|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
145721951|NCT03057977|525500385|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
145721952|NCT03057977|525500384|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
145721953|NCT03057977|525500385|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
145721954|NCT00953407|525500386|FG000|Overall Study|Failed inclusion criteria|1|||
145721955|NCT00953407|525500387|FG001|Overall Study|Failed inclusion criteria|1|||
145721956|NCT00953407|525500388|FG002|Overall Study|Failed inclusion criteria|1|||
145721957|NCT00953407|525500389|FG003|Overall Study|Failed inclusion criteria|1|||
145721958|NCT00953407|525500390|FG004|Overall Study|Failed inclusion criteria|1|||
145721959|NCT00953407|525500386|FG000|Overall Study|Lost to Follow-up|0|||
145721960|NCT00953407|525500387|FG001|Overall Study|Lost to Follow-up|0|||
145721961|NCT00953407|525500388|FG002|Overall Study|Lost to Follow-up|0|||
145721962|NCT00953407|525500389|FG003|Overall Study|Lost to Follow-up|1|||
145721963|NCT00953407|525500390|FG004|Overall Study|Lost to Follow-up|0|||
145721964|NCT02502097|525500391|FG000|Period 1|Adverse Event|0|||
145721965|NCT02502097|525500392|FG001|Period 1|Adverse Event|0|||
145721966|NCT02502097|525500393|FG002|Period 1|Adverse Event|1|||
145721967|NCT02502097|525500394|FG003|Period 1|Adverse Event|0|||
145721968|NCT02502097|525500391|FG000|Wash Out Period|Adverse Event|0|||
145721969|NCT02502097|525500392|FG001|Wash Out Period|Adverse Event|1|||
145721970|NCT02502097|525500393|FG002|Wash Out Period|Adverse Event|1|||
145721971|NCT02502097|525500394|FG003|Wash Out Period|Adverse Event|1|||
145721972|NCT02502097|525500391|FG000|Period 2|Adverse Event|0|||
145721973|NCT02502097|525500392|FG001|Period 2|Adverse Event|0|||
145721974|NCT02502097|525500393|FG002|Period 2|Adverse Event|1|||
145721975|NCT02502097|525500394|FG003|Period 2|Adverse Event|0|||
145266533|NCT02594384|523825220|FG006|Overall Study|Physician Decision|2|||
145266534|NCT02594384|523825221|FG007|Overall Study|Physician Decision|0|||
145266535|NCT02594384|523825214|FG000|Overall Study|Progressive Leukocytosis|0|||
145266536|NCT02594384|523825215|FG001|Overall Study|Progressive Leukocytosis|0|||
145266537|NCT02594384|523825216|FG002|Overall Study|Progressive Leukocytosis|1|||
145266538|NCT02594384|523825217|FG003|Overall Study|Progressive Leukocytosis|0|||
145266539|NCT02594384|523825218|FG004|Overall Study|Progressive Leukocytosis|0|||
145266540|NCT02594384|523825219|FG005|Overall Study|Progressive Leukocytosis|0|||
145266541|NCT02594384|523825220|FG006|Overall Study|Progressive Leukocytosis|0|||
145266542|NCT02594384|523825221|FG007|Overall Study|Progressive Leukocytosis|0|||
145266543|NCT02594384|523825214|FG000|Overall Study|Lack of Efficacy|0|||
145266544|NCT02594384|523825215|FG001|Overall Study|Lack of Efficacy|0|||
145266545|NCT02594384|523825216|FG002|Overall Study|Lack of Efficacy|0|||
145266546|NCT02594384|523825217|FG003|Overall Study|Lack of Efficacy|0|||
145266547|NCT02594384|523825218|FG004|Overall Study|Lack of Efficacy|1|||
145266548|NCT02594384|523825219|FG005|Overall Study|Lack of Efficacy|0|||
145266549|NCT02594384|523825220|FG006|Overall Study|Lack of Efficacy|0|||
145266550|NCT02594384|523825221|FG007|Overall Study|Lack of Efficacy|0|||
145266551|NCT02594384|523825214|FG000|Overall Study|Substantial noncompliance|0|||
145266552|NCT02594384|523825215|FG001|Overall Study|Substantial noncompliance|0|||
145266553|NCT02594384|523825216|FG002|Overall Study|Substantial noncompliance|0|||
145266554|NCT02594384|523825217|FG003|Overall Study|Substantial noncompliance|0|||
145266555|NCT02594384|523825218|FG004|Overall Study|Substantial noncompliance|0|||
145266556|NCT02594384|523825219|FG005|Overall Study|Substantial noncompliance|0|||
145266557|NCT02594384|523825220|FG006|Overall Study|Substantial noncompliance|1|||
145266558|NCT02594384|523825221|FG007|Overall Study|Substantial noncompliance|0|||
145266559|NCT03919669|523825225|FG000|Overall Study|Withdrawal by Subject|1|||
145266560|NCT03919669|523825226|FG001|Overall Study|Withdrawal by Subject|0|||
145266561|NCT03919669|523825227|FG002|Overall Study|Withdrawal by Subject|0|||
145266562|NCT02319642|523825228|FG000|Overall Study|Adverse Event|2|||
145266563|NCT02319642|523825229|FG001|Overall Study|Adverse Event|4|||
145266564|NCT02319642|523825228|FG000|Overall Study|Lack of Efficacy|1|||
145266565|NCT02319642|523825229|FG001|Overall Study|Lack of Efficacy|1|||
145266566|NCT02319642|523825228|FG000|Overall Study|Withdrawal by Subject|1|||
145266567|NCT02319642|523825229|FG001|Overall Study|Withdrawal by Subject|1|||
145266568|NCT01265875|523825230|FG000|Overall Study|Uncooperative/unreliable|1|||
145266569|NCT04409509|523825231|FG000|Overall Study|Failure to meet randomization requirement|1|||
145266570|NCT04409509|523825232|FG001|Overall Study|Failure to meet randomization requirement|0|||
145266571|NCT04409509|523825231|FG000|Overall Study|Adverse Event|0|||
145266572|NCT04409509|523825232|FG001|Overall Study|Adverse Event|1|||
145266573|NCT04409509|523825231|FG000|Overall Study|Death|11|||
145266574|NCT04409509|523825232|FG001|Overall Study|Death|10|||
145266575|NCT04409509|523825231|FG000|Overall Study|Non-compliance with study drug|0|||
145266576|NCT04409509|523825232|FG001|Overall Study|Non-compliance with study drug|1|||
145266577|NCT04409509|523825231|FG000|Overall Study|Lost to Follow-up|0|||
145266578|NCT04409509|523825232|FG001|Overall Study|Lost to Follow-up|3|||
145266579|NCT04409509|523825231|FG000|Overall Study|Withdrawal by Subject|0|||
145721976|NCT01350336|525500395|FG000|Overall Study|Lost to Follow-up|31|||
145721977|NCT01350336|525500395|FG000|Overall Study|Withdrawal by Subject|14|||
145721978|NCT01350336|525500395|FG000|Overall Study|Physician Decision|8|||
145721979|NCT01350336|525500395|FG000|Overall Study|Death|4|||
145721980|NCT01016977|525500403|FG000|Overall Study|Lost to Follow-up|1|||
145721981|NCT01016977|525500404|FG001|Overall Study|Lost to Follow-up|0|||
145721982|NCT01016977|525500403|FG000|Overall Study|Withdrawal by Subject|2|||
145721983|NCT01016977|525500404|FG001|Overall Study|Withdrawal by Subject|2|||
145721984|NCT05081388|525500407|FG000|Overall Study|Adverse Event|1|||
145721985|NCT05081388|525500408|FG001|Overall Study|Adverse Event|0|||
145721986|NCT05081388|525500409|FG002|Overall Study|Adverse Event|0|||
145721987|NCT05081388|525500410|FG003|Overall Study|Adverse Event|0|||
145721988|NCT05081388|525500411|FG004|Overall Study|Adverse Event|0|||
145721989|NCT05081388|525500407|FG000|Overall Study|Lost to Follow-up|0|||
145721990|NCT05081388|525500408|FG001|Overall Study|Lost to Follow-up|1|||
145721991|NCT05081388|525500409|FG002|Overall Study|Lost to Follow-up|0|||
145721992|NCT05081388|525500410|FG003|Overall Study|Lost to Follow-up|0|||
145721993|NCT05081388|525500411|FG004|Overall Study|Lost to Follow-up|0|||
145721994|NCT05081388|525500407|FG000|Overall Study|Subject decision|0|||
145721995|NCT05081388|525500408|FG001|Overall Study|Subject decision|0|||
145721996|NCT05081388|525500409|FG002|Overall Study|Subject decision|0|||
145721997|NCT05081388|525500410|FG003|Overall Study|Subject decision|1|||
145721998|NCT05081388|525500411|FG004|Overall Study|Subject decision|0|||
145721999|NCT04279392|525500412|FG000|Overall Study|Physician Decision|1|||
145722000|NCT04279392|525500413|FG001|Overall Study|Physician Decision|0|||
145722001|NCT01901341|525500414|FG000|Overall Study|Adverse Event|4|||
145722002|NCT01901341|525500415|FG001|Overall Study|Adverse Event|2|||
145722003|NCT01901341|525500414|FG000|Overall Study|Lack of Efficacy|0|||
145722004|NCT01901341|525500415|FG001|Overall Study|Lack of Efficacy|2|||
145722005|NCT01901341|525500414|FG000|Overall Study|Lost to Follow-up|0|||
145722006|NCT01901341|525500415|FG001|Overall Study|Lost to Follow-up|1|||
145722007|NCT01901341|525500414|FG000|Overall Study|Protocol Violation|2|||
145722008|NCT01901341|525500415|FG001|Overall Study|Protocol Violation|0|||
145722009|NCT01901341|525500414|FG000|Overall Study|Study Terminated by Sponsor|13|||
145722010|NCT01901341|525500415|FG001|Overall Study|Study Terminated by Sponsor|15|||
145722011|NCT01901341|525500414|FG000|Overall Study|Withdrawal by Subject|1|||
145722012|NCT01901341|525500415|FG001|Overall Study|Withdrawal by Subject|1|||
145722013|NCT00156819|525500416|FG000|Overall Study|Lost to Follow-up|1|||
145722014|NCT00156819|525500417|FG001|Overall Study|Lost to Follow-up|1|||
145722015|NCT00156819|525500418|FG002|Overall Study|Lost to Follow-up|3|||
145722016|NCT01689337|525500419|FG000|Overall Study|Study Discontinuation|1|||
145722017|NCT00738582|525500420|FG000|Combination Therapy|Completed Combination Therapy|1|||
145722018|NCT00738582|525500421|FG001|Combination Therapy|Completed Combination Therapy|0|||
145722019|NCT00738582|525500420|FG000|Combination Therapy|Physician Decision|1|||
145722020|NCT00738582|525500421|FG001|Combination Therapy|Physician Decision|0|||
145722021|NCT00738582|525500420|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
145722022|NCT00738582|525500421|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
145722023|NCT00738582|525500420|FG000|Combination Therapy|Other|5|||
145722024|NCT00738582|525500421|FG001|Combination Therapy|Other|0|||
145722025|NCT00738582|525500420|FG000|Combination Therapy|Adverse Event|16|||
145722026|NCT00738582|525500421|FG001|Combination Therapy|Adverse Event|0|||
145722027|NCT00738582|525500420|FG000|Combination Therapy|Progressive Disease|9|||
145722028|NCT00738582|525500421|FG001|Combination Therapy|Progressive Disease|0|||
145722029|NCT00738582|525500420|FG000|Maintenance Therapy|Other|0|||
145722030|NCT00738582|525500421|FG001|Maintenance Therapy|Other|2|||
145722031|NCT00738582|525500420|FG000|Maintenance Therapy|Adverse Event|0|||
145722032|NCT00738582|525500421|FG001|Maintenance Therapy|Adverse Event|6|||
145722033|NCT00738582|525500420|FG000|Maintenance Therapy|Progressive Disease|0|||
145722034|NCT00738582|525500421|FG001|Maintenance Therapy|Progressive Disease|47|||
145722035|NCT00738582|525500420|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
145722036|NCT00738582|525500421|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
145722037|NCT00642772|525500422|FG000|Overall Study|Lost to Follow-up|3|||
145722038|NCT00642772|525500422|FG000|Overall Study|Withdrawal by Subject|7|||
145722039|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
145722040|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
145722041|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
145722042|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
145722043|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
145722044|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
145722045|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
145722046|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
145722047|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
145722048|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
145722049|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
145722050|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
145722051|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
145722052|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
145722053|NCT00757588|525500423|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
145722054|NCT00757588|525500424|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
145722055|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
145722056|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
145722057|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
145722058|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
145722059|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
145722060|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
145722061|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
145722062|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
145722063|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
145722064|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
145722065|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
145722066|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
145722067|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
145722068|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
145722069|NCT00757588|525500423|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
145722070|NCT00757588|525500424|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
145722071|NCT00799513|525500432|FG000|Overall Study|Physician Decision|1|||
145722072|NCT00799513|525500432|FG000|Overall Study|Adverse Event|1|||
145722073|NCT05398237|525500433|FG000|Overall Study|Withdrawal by Subject|1|||
145722074|NCT01312857|525500435|FG000|Overall Study|Adverse Event|1|||
145722075|NCT01312857|525500436|FG001|Overall Study|Adverse Event|1|||
145722076|NCT01312857|525500435|FG000|Overall Study|Lost to Follow-up|2|||
145722077|NCT01312857|525500436|FG001|Overall Study|Lost to Follow-up|0|||
145722078|NCT01312857|525500435|FG000|Overall Study|Physician Decision|3|||
145722079|NCT01312857|525500436|FG001|Overall Study|Physician Decision|0|||
145722080|NCT01312857|525500435|FG000|Overall Study|Withdrawal by Subject|2|||
145722081|NCT01312857|525500436|FG001|Overall Study|Withdrawal by Subject|0|||
145722082|NCT00906945|525500437|FG000|Overall Study|Found to be not eligible|0|||
145722083|NCT00906945|525500438|FG001|Overall Study|Found to be not eligible|0|||
145722084|NCT00906945|525500439|FG002|Overall Study|Found to be not eligible|0|||
145722085|NCT00906945|525500440|FG003|Overall Study|Found to be not eligible|1|||
145722086|NCT00906945|525500441|FG004|Overall Study|Found to be not eligible|1|||
145722087|NCT00906945|525500442|FG005|Overall Study|Found to be not eligible|1|||
145722088|NCT00906945|525500437|FG000|Overall Study|Physician Decision|0|||
145722089|NCT00906945|525500438|FG001|Overall Study|Physician Decision|0|||
145722090|NCT00906945|525500439|FG002|Overall Study|Physician Decision|0|||
145722091|NCT00906945|525500440|FG003|Overall Study|Physician Decision|0|||
145722092|NCT00906945|525500441|FG004|Overall Study|Physician Decision|0|||
145722093|NCT00906945|525500442|FG005|Overall Study|Physician Decision|1|||
145722094|NCT02751320|525500444|FG000|Overall Study|Adverse Event|2|||
145722095|NCT02751320|525500444|FG000|Overall Study|Withdrawal by Subject|1|||
145722096|NCT05249829|525500445|FG000|Overall Study|Participant Relocation|0|||
145722097|NCT05249829|525500446|FG001|Overall Study|Participant Relocation|1|||
145722098|NCT05249829|525500447|FG002|Overall Study|Participant Relocation|2|||
145722099|NCT05249829|525500448|FG003|Overall Study|Participant Relocation|2|||
145722100|NCT05249829|525500445|FG000|Overall Study|Withdrawal by Subject|9|||
145722101|NCT05249829|525500446|FG001|Overall Study|Withdrawal by Subject|17|||
145722102|NCT05249829|525500447|FG002|Overall Study|Withdrawal by Subject|40|||
145722103|NCT05249829|525500448|FG003|Overall Study|Withdrawal by Subject|35|||
145722104|NCT05249829|525500445|FG000|Overall Study|Physician Decision|1|||
145722105|NCT05249829|525500446|FG001|Overall Study|Physician Decision|0|||
145722106|NCT05249829|525500447|FG002|Overall Study|Physician Decision|0|||
145722107|NCT05249829|525500448|FG003|Overall Study|Physician Decision|0|||
145722108|NCT05249829|525500445|FG000|Overall Study|Lost to Follow-up|16|||
145722109|NCT05249829|525500446|FG001|Overall Study|Lost to Follow-up|16|||
145722110|NCT05249829|525500447|FG002|Overall Study|Lost to Follow-up|57|||
145722111|NCT05249829|525500448|FG003|Overall Study|Lost to Follow-up|60|||
145722112|NCT05249829|525500445|FG000|Overall Study|Adverse Event|2|||
145722113|NCT05249829|525500446|FG001|Overall Study|Adverse Event|2|||
145722114|NCT05249829|525500447|FG002|Overall Study|Adverse Event|2|||
145722115|NCT05249829|525500448|FG003|Overall Study|Adverse Event|2|||
145722116|NCT05249829|525500445|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
145722117|NCT05249829|525500446|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
145722118|NCT05249829|525500447|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
145722119|NCT05249829|525500448|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
145722120|NCT05249829|525500445|FG000|Overall Study|Protocol Violation|2|||
145722121|NCT05249829|525500446|FG001|Overall Study|Protocol Violation|0|||
145722122|NCT05249829|525500447|FG002|Overall Study|Protocol Violation|5|||
145722123|NCT05249829|525500448|FG003|Overall Study|Protocol Violation|3|||
145722124|NCT05249829|525500445|FG000|Overall Study|Death|0|||
145722125|NCT05249829|525500446|FG001|Overall Study|Death|1|||
145722126|NCT05249829|525500447|FG002|Overall Study|Death|2|||
145722127|NCT05249829|525500448|FG003|Overall Study|Death|4|||
145722128|NCT00513604|525500449|FG000|Overall Study|Not treated|2|||
145722129|NCT00513604|525500450|FG001|Overall Study|Not treated|0|||
145722130|NCT00513604|525500451|FG002|Overall Study|Not treated|1|||
145722131|NCT00513604|525500452|FG003|Overall Study|Not treated|0|||
145722132|NCT00513604|525500453|FG004|Overall Study|Not treated|0|||
145722133|NCT00513604|525500449|FG000|Overall Study|Death during treatment|0|||
145722134|NCT00513604|525500450|FG001|Overall Study|Death during treatment|3|||
145722135|NCT00513604|525500451|FG002|Overall Study|Death during treatment|2|||
145722136|NCT00513604|525500452|FG003|Overall Study|Death during treatment|0|||
145722137|NCT00513604|525500453|FG004|Overall Study|Death during treatment|0|||
145722138|NCT00196976|525500454|FG000|Primary Study|Migrated from study area|0|||
145722139|NCT00196976|525500455|FG001|Primary Study|Migrated from study area|0|||
145722140|NCT00196976|525500456|FG002|Primary Study|Migrated from study area|0|||
145722141|NCT00196976|525500457|FG003|Primary Study|Migrated from study area|0|||
145381814|NCT00957905|524248606|FG001|Part B|Protocol Violation|1|||
145381815|NCT02073656|524248607|FG000|Primary Study|Lost to Follow-up|6|||
145381816|NCT02073656|524248607|FG000|Primary Study|Death|1|||
145381817|NCT02073656|524248607|FG000|Primary Study|Withdrew Consent|1|||
145381818|NCT01987232|524248608|FG000|Overall Study|Ongoing in Study|0|||
145381819|NCT01987232|524248609|FG001|Overall Study|Ongoing in Study|0|||
145381820|NCT01987232|524248610|FG002|Overall Study|Ongoing in Study|0|||
145381821|NCT01987232|524248611|FG003|Overall Study|Ongoing in Study|1|||
145381822|NCT01987232|524248612|FG004|Overall Study|Ongoing in Study|0|||
145381823|NCT04907227|524248615|FG000|Overall Study|Death|12|||
145381824|NCT04907227|524248616|FG001|Overall Study|Death|8|||
145381825|NCT04907227|524248615|FG000|Overall Study|Withdrawal by Subject|2|||
145381826|NCT04907227|524248616|FG001|Overall Study|Withdrawal by Subject|2|||
145381827|NCT04907227|524248615|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
145381828|NCT04907227|524248616|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145381829|NCT04907227|524248615|FG000|Overall Study|Sponsor Decision|25|||
145381830|NCT04907227|524248616|FG001|Overall Study|Sponsor Decision|30|||
145381831|NCT04907227|524248615|FG000|Overall Study|Physician Decision|1|||
145381832|NCT04907227|524248616|FG001|Overall Study|Physician Decision|0|||
145381833|NCT03723070|524248617|FG000|Overall Study|Lost to Follow-up|2|||
145381834|NCT03723070|524248617|FG000|Overall Study|Physician Decision|1|||
145381835|NCT03723070|524248617|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
145381836|NCT02208050|524248618|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
145381837|NCT02208050|524248619|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
145381838|NCT00477607|524248620|FG000|Overall Study|Lost to Follow-up|7|||
145381839|NCT00477607|524248621|FG001|Overall Study|Lost to Follow-up|7|||
145381840|NCT01732471|524248622|FG000|Overall Study|Withdrawal by Subject|1|||
145381841|NCT02892513|524248625|FG000|Overall Study|Withdrawal by Subject|0|||
145381842|NCT02892513|524248626|FG001|Overall Study|Withdrawal by Subject|1|||
145381843|NCT00432276|524248627|FG000|Overall Study|Hyperglycemic Rescue|44|||
145381844|NCT00432276|524248628|FG001|Overall Study|Hyperglycemic Rescue|87|||
145381845|NCT00432276|524248627|FG000|Overall Study|Adverse Event|13|||
145381846|NCT00432276|524248628|FG001|Overall Study|Adverse Event|16|||
145381847|NCT00432276|524248627|FG000|Overall Study|Protocol Violation|25|||
145722142|NCT00196976|525500458|FG004|Primary Study|Migrated from study area|0|||
145722143|NCT00196976|525500459|FG005|Primary Study|Migrated from study area|0|||
145722144|NCT00196976|525500460|FG006|Primary Study|Migrated from study area|0|||
145722145|NCT00196976|525500461|FG007|Primary Study|Migrated from study area|1|||
145722146|NCT00196976|525500462|FG008|Primary Study|Migrated from study area|0|||
145722147|NCT00196976|525500463|FG009|Primary Study|Migrated from study area|0|||
145381848|NCT00432276|524248628|FG001|Overall Study|Protocol Violation|20|||
145381849|NCT00432276|524248627|FG000|Overall Study|Lost to Follow-up|6|||
145493114|NCT01924845|524661166|FG000|Overall Study|Withdrawal by Subject|2|||
145722148|NCT00196976|525500464|FG010|Primary Study|Migrated from study area|0|||
145722149|NCT00196976|525500465|FG011|Primary Study|Migrated from study area|0|||
145722150|NCT00196976|525500466|FG012|Primary Study|Migrated from study area|0|||
145722151|NCT00196976|525500467|FG013|Primary Study|Migrated from study area|0|||
145722152|NCT00196976|525500454|FG000|Primary Study|Protocol Violation|0|||
145722153|NCT00196976|525500455|FG001|Primary Study|Protocol Violation|1|||
145722154|NCT00196976|525500456|FG002|Primary Study|Protocol Violation|1|||
145722155|NCT00196976|525500457|FG003|Primary Study|Protocol Violation|0|||
145722156|NCT00196976|525500458|FG004|Primary Study|Protocol Violation|0|||
145381850|NCT00432276|524248628|FG001|Overall Study|Lost to Follow-up|2|||
145381851|NCT00432276|524248627|FG000|Overall Study|Withdrawal by Subject|25|||
145381852|NCT00432276|524248628|FG001|Overall Study|Withdrawal by Subject|20|||
145381853|NCT00432276|524248627|FG000|Overall Study|Physician Decision|6|||
145381854|NCT00432276|524248628|FG001|Overall Study|Physician Decision|8|||
145381855|NCT00432276|524248627|FG000|Overall Study|Other|2|||
145381856|NCT00432276|524248628|FG001|Overall Study|Other|3|||
145381857|NCT00655681|524248629|FG000|Overall Study|Lost to Follow-up|1|||
145381858|NCT00655681|524248630|FG001|Overall Study|Lost to Follow-up|1|||
145381859|NCT00467961|524248632|FG000|Overall Study|Technical Failures|5|||
145381860|NCT00467961|524248632|FG000|Overall Study|Disease Progression|2|||
145722157|NCT00196976|525500459|FG005|Primary Study|Protocol Violation|0|||
145722158|NCT00196976|525500460|FG006|Primary Study|Protocol Violation|0|||
145722159|NCT00196976|525500461|FG007|Primary Study|Protocol Violation|0|||
145722160|NCT00196976|525500462|FG008|Primary Study|Protocol Violation|0|||
145722161|NCT00196976|525500463|FG009|Primary Study|Protocol Violation|0|||
145722162|NCT00196976|525500464|FG010|Primary Study|Protocol Violation|0|||
145722163|NCT00196976|525500465|FG011|Primary Study|Protocol Violation|0|||
145722164|NCT00196976|525500466|FG012|Primary Study|Protocol Violation|0|||
145722165|NCT00196976|525500467|FG013|Primary Study|Protocol Violation|0|||
145722166|NCT00196976|525500454|FG000|Primary Study|Withdrawal by Subject|1|||
145722167|NCT00196976|525500455|FG001|Primary Study|Withdrawal by Subject|0|||
145722168|NCT00196976|525500456|FG002|Primary Study|Withdrawal by Subject|1|||
145722169|NCT00196976|525500457|FG003|Primary Study|Withdrawal by Subject|1|||
145722170|NCT00196976|525500458|FG004|Primary Study|Withdrawal by Subject|2|||
145722171|NCT00196976|525500459|FG005|Primary Study|Withdrawal by Subject|1|||
145722172|NCT00196976|525500460|FG006|Primary Study|Withdrawal by Subject|0|||
145722173|NCT00196976|525500461|FG007|Primary Study|Withdrawal by Subject|0|||
145722174|NCT00196976|525500462|FG008|Primary Study|Withdrawal by Subject|0|||
145722175|NCT00196976|525500463|FG009|Primary Study|Withdrawal by Subject|1|||
145722176|NCT00196976|525500464|FG010|Primary Study|Withdrawal by Subject|0|||
145722177|NCT00196976|525500465|FG011|Primary Study|Withdrawal by Subject|0|||
145722178|NCT00196976|525500466|FG012|Primary Study|Withdrawal by Subject|0|||
145722179|NCT00196976|525500467|FG013|Primary Study|Withdrawal by Subject|0|||
145722180|NCT00196976|525500454|FG000|Primary Study|Lost to Follow-up|0|||
145722181|NCT00196976|525500455|FG001|Primary Study|Lost to Follow-up|0|||
145722182|NCT00196976|525500456|FG002|Primary Study|Lost to Follow-up|0|||
145722183|NCT00196976|525500457|FG003|Primary Study|Lost to Follow-up|0|||
145722184|NCT00196976|525500458|FG004|Primary Study|Lost to Follow-up|1|||
145722185|NCT00196976|525500459|FG005|Primary Study|Lost to Follow-up|1|||
145722186|NCT00196976|525500460|FG006|Primary Study|Lost to Follow-up|0|||
145722187|NCT00196976|525500461|FG007|Primary Study|Lost to Follow-up|2|||
145722188|NCT00196976|525500462|FG008|Primary Study|Lost to Follow-up|0|||
145722189|NCT00196976|525500463|FG009|Primary Study|Lost to Follow-up|0|||
145722190|NCT00196976|525500464|FG010|Primary Study|Lost to Follow-up|0|||
145722191|NCT00196976|525500465|FG011|Primary Study|Lost to Follow-up|0|||
145722192|NCT00196976|525500466|FG012|Primary Study|Lost to Follow-up|0|||
145722193|NCT00196976|525500467|FG013|Primary Study|Lost to Follow-up|0|||
145722194|NCT00196976|525500454|FG000|Primary Study|Other|0|||
145722195|NCT00196976|525500455|FG001|Primary Study|Other|0|||
145722196|NCT00196976|525500456|FG002|Primary Study|Other|2|||
145722197|NCT00196976|525500457|FG003|Primary Study|Other|0|||
145722198|NCT00196976|525500458|FG004|Primary Study|Other|0|||
145722199|NCT00196976|525500459|FG005|Primary Study|Other|0|||
145722200|NCT00196976|525500460|FG006|Primary Study|Other|0|||
145722201|NCT00196976|525500461|FG007|Primary Study|Other|0|||
145722202|NCT00196976|525500462|FG008|Primary Study|Other|0|||
145722203|NCT00196976|525500463|FG009|Primary Study|Other|0|||
145722204|NCT00196976|525500464|FG010|Primary Study|Other|0|||
145722205|NCT00196976|525500465|FG011|Primary Study|Other|0|||
145722206|NCT00196976|525500466|FG012|Primary Study|Other|0|||
145722207|NCT00196976|525500467|FG013|Primary Study|Other|0|||
145722208|NCT00196976|525500454|FG000|Booster Study|Withdrawal by Subject|0|||
145722209|NCT00196976|525500455|FG001|Booster Study|Withdrawal by Subject|0|||
145722210|NCT00196976|525500456|FG002|Booster Study|Withdrawal by Subject|0|||
145722211|NCT00196976|525500457|FG003|Booster Study|Withdrawal by Subject|0|||
145722212|NCT00196976|525500458|FG004|Booster Study|Withdrawal by Subject|0|||
145722213|NCT00196976|525500459|FG005|Booster Study|Withdrawal by Subject|0|||
145722214|NCT00196976|525500460|FG006|Booster Study|Withdrawal by Subject|0|||
145722215|NCT00196976|525500461|FG007|Booster Study|Withdrawal by Subject|0|||
145722216|NCT00196976|525500462|FG008|Booster Study|Withdrawal by Subject|0|||
145722217|NCT00196976|525500463|FG009|Booster Study|Withdrawal by Subject|0|||
145722218|NCT00196976|525500464|FG010|Booster Study|Withdrawal by Subject|1|||
145722219|NCT00196976|525500465|FG011|Booster Study|Withdrawal by Subject|0|||
145722220|NCT00196976|525500466|FG012|Booster Study|Withdrawal by Subject|0|||
145722221|NCT00196976|525500467|FG013|Booster Study|Withdrawal by Subject|0|||
145722222|NCT00196976|525500454|FG000|Booster Study|Lost to Follow-up|0|||
145722223|NCT00196976|525500455|FG001|Booster Study|Lost to Follow-up|0|||
145722224|NCT00196976|525500456|FG002|Booster Study|Lost to Follow-up|0|||
145722225|NCT00196976|525500457|FG003|Booster Study|Lost to Follow-up|0|||
145722226|NCT00196976|525500458|FG004|Booster Study|Lost to Follow-up|0|||
145722227|NCT00196976|525500459|FG005|Booster Study|Lost to Follow-up|0|||
145722228|NCT00196976|525500460|FG006|Booster Study|Lost to Follow-up|0|||
145722229|NCT00196976|525500461|FG007|Booster Study|Lost to Follow-up|0|||
145722230|NCT00196976|525500462|FG008|Booster Study|Lost to Follow-up|0|||
145722231|NCT00196976|525500463|FG009|Booster Study|Lost to Follow-up|0|||
145722232|NCT00196976|525500464|FG010|Booster Study|Lost to Follow-up|1|||
145722233|NCT00196976|525500465|FG011|Booster Study|Lost to Follow-up|2|||
145722234|NCT00196976|525500466|FG012|Booster Study|Lost to Follow-up|0|||
145722235|NCT00196976|525500467|FG013|Booster Study|Lost to Follow-up|0|||
145722236|NCT01535560|525500468|FG000|Overall Study|Adverse Event|12|||
145722237|NCT01535560|525500469|FG001|Overall Study|Adverse Event|7|||
145722238|NCT01535560|525500468|FG000|Overall Study|Lost to Follow-up|1|||
145722239|NCT01535560|525500469|FG001|Overall Study|Lost to Follow-up|3|||
145722240|NCT01535560|525500468|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
145722241|NCT01535560|525500469|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
145722242|NCT01535560|525500468|FG000|Overall Study|Treatment Failure|21|||
145722243|NCT01535560|525500469|FG001|Overall Study|Treatment Failure|83|||
145722244|NCT01535560|525500468|FG000|Overall Study|Other|0|||
145722245|NCT01535560|525500469|FG001|Overall Study|Other|1|||
145722246|NCT01535560|525500468|FG000|Overall Study|Randomized in Error|0|||
145722247|NCT01535560|525500469|FG001|Overall Study|Randomized in Error|1|||
145722248|NCT02842827|525500472|FG000|Overall Study|Adverse Event|0|||
145722249|NCT02842827|525500473|FG001|Overall Study|Adverse Event|1|||
145722250|NCT02842827|525500474|FG002|Overall Study|Adverse Event|0|||
145722251|NCT02842827|525500475|FG003|Overall Study|Adverse Event|1|||
145722252|NCT02842827|525500476|FG004|Overall Study|Adverse Event|0|||
145722253|NCT02842827|525500477|FG005|Overall Study|Adverse Event|1|||
145722254|NCT02842827|525500478|FG006|Overall Study|Adverse Event|0|||
145722255|NCT02842827|525500479|FG007|Overall Study|Adverse Event|0|||
145722256|NCT02842827|525500472|FG000|Overall Study|Death|1|||
145722257|NCT02842827|525500473|FG001|Overall Study|Death|0|||
145722258|NCT02842827|525500474|FG002|Overall Study|Death|2|||
145722259|NCT02842827|525500475|FG003|Overall Study|Death|3|||
145722260|NCT02842827|525500476|FG004|Overall Study|Death|2|||
145722261|NCT02842827|525500477|FG005|Overall Study|Death|1|||
145266580|NCT04409509|523825232|FG001|Overall Study|Withdrawal by Subject|3|||
145266581|NCT04409509|523825231|FG000|Overall Study|Randomized by mistake|0|||
145266582|NCT04409509|523825232|FG001|Overall Study|Randomized by mistake|1|||
145266583|NCT04409509|523825231|FG000|Overall Study|Other|1|||
145266584|NCT04409509|523825232|FG001|Overall Study|Other|1|||
145266585|NCT00483119|523825233|FG000|Overall Study|Adverse Event|0|||
145266586|NCT00483119|523825234|FG001|Overall Study|Adverse Event|1|||
145266587|NCT00483119|523825233|FG000|Overall Study|Physician Decision|1|||
145266588|NCT00483119|523825234|FG001|Overall Study|Physician Decision|0|||
145266589|NCT04668066|523825237|FG000|Part 1: Treatment Phase|Adverse Event|0|||
145266590|NCT04668066|523825238|FG001|Part 1: Treatment Phase|Adverse Event|0|||
145266591|NCT04668066|523825239|FG002|Part 1: Treatment Phase|Adverse Event|0|||
145266592|NCT04668066|523825240|FG003|Part 1: Treatment Phase|Adverse Event|0|||
145266593|NCT04668066|523825241|FG004|Part 1: Treatment Phase|Adverse Event|0|||
145266594|NCT04668066|523825242|FG005|Part 1: Treatment Phase|Adverse Event|0|||
145266595|NCT04668066|523825243|FG006|Part 1: Treatment Phase|Adverse Event|0|||
145266596|NCT04668066|523825244|FG007|Part 1: Treatment Phase|Adverse Event|0|||
145266597|NCT04668066|523825245|FG008|Part 1: Treatment Phase|Adverse Event|0|||
145266598|NCT04668066|523825246|FG009|Part 1: Treatment Phase|Adverse Event|0|||
145266599|NCT04668066|523825247|FG010|Part 1: Treatment Phase|Adverse Event|0|||
145266600|NCT04668066|523825248|FG011|Part 1: Treatment Phase|Adverse Event|1|||
145266601|NCT04668066|523825249|FG012|Part 1: Treatment Phase|Adverse Event|1|||
145266602|NCT04668066|523825250|FG013|Part 1: Treatment Phase|Adverse Event|0|||
145266603|NCT04668066|523825251|FG014|Part 1: Treatment Phase|Adverse Event|0|||
145266604|NCT04668066|523825252|FG015|Part 1: Treatment Phase|Adverse Event|0|||
145266605|NCT04668066|523825253|FG016|Part 1: Treatment Phase|Adverse Event|0|||
145266606|NCT04668066|523825254|FG017|Part 1: Treatment Phase|Adverse Event|0|||
145266607|NCT04668066|523825255|FG018|Part 1: Treatment Phase|Adverse Event|0|||
145266608|NCT04668066|523825237|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266609|NCT04668066|523825238|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266610|NCT04668066|523825239|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
145266611|NCT04668066|523825240|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266612|NCT04668066|523825241|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266613|NCT04668066|523825242|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266614|NCT04668066|523825243|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266615|NCT04668066|523825244|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266616|NCT04668066|523825245|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266617|NCT04668066|523825246|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266618|NCT04668066|523825247|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266619|NCT04668066|523825248|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266620|NCT04668066|523825249|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266621|NCT04668066|523825250|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266622|NCT04668066|523825251|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266623|NCT04668066|523825252|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266624|NCT04668066|523825253|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266625|NCT04668066|523825254|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266626|NCT04668066|523825255|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
145266627|NCT04668066|523825237|FG000|Part 1: Treatment Phase|Other|0|||
145266628|NCT04668066|523825238|FG001|Part 1: Treatment Phase|Other|0|||
145266629|NCT04668066|523825239|FG002|Part 1: Treatment Phase|Other|0|||
145722262|NCT02842827|525500478|FG006|Overall Study|Death|0|||
145722263|NCT02842827|525500479|FG007|Overall Study|Death|4|||
145722264|NCT02842827|525500472|FG000|Overall Study|Physician Decision|1|||
145722265|NCT02842827|525500473|FG001|Overall Study|Physician Decision|3|||
145722266|NCT02842827|525500474|FG002|Overall Study|Physician Decision|0|||
145722267|NCT02842827|525500475|FG003|Overall Study|Physician Decision|0|||
145722268|NCT02842827|525500476|FG004|Overall Study|Physician Decision|1|||
145722269|NCT02842827|525500477|FG005|Overall Study|Physician Decision|4|||
145722270|NCT02842827|525500478|FG006|Overall Study|Physician Decision|2|||
145722271|NCT02842827|525500479|FG007|Overall Study|Physician Decision|1|||
145722272|NCT02842827|525500472|FG000|Overall Study|Protocol Defined Disease Progression|0|||
145722273|NCT02842827|525500473|FG001|Overall Study|Protocol Defined Disease Progression|0|||
145722274|NCT02842827|525500474|FG002|Overall Study|Protocol Defined Disease Progression|0|||
145722275|NCT02842827|525500475|FG003|Overall Study|Protocol Defined Disease Progression|0|||
145722276|NCT02842827|525500476|FG004|Overall Study|Protocol Defined Disease Progression|0|||
145722277|NCT02842827|525500477|FG005|Overall Study|Protocol Defined Disease Progression|1|||
145722278|NCT02842827|525500478|FG006|Overall Study|Protocol Defined Disease Progression|0|||
145381861|NCT02429310|524248634|FG000|Overall Study|Lost to Follow-up|1|||
145381862|NCT02429310|524248635|FG001|Overall Study|Lost to Follow-up|2|||
145381863|NCT02429310|524248634|FG000|Overall Study|Protocol Violation|1|||
145381864|NCT02429310|524248635|FG001|Overall Study|Protocol Violation|1|||
145381865|NCT03417024|524248636|FG000|Overall Study|Study Termination prior to follow-up|11|||
145381866|NCT03417024|524248636|FG000|Overall Study|Physician Decision|2|||
145381867|NCT00386425|524248637|FG000|Overall Study|Physician Decision|3|||
145381868|NCT00386425|524248638|FG001|Overall Study|Physician Decision|0|||
145722279|NCT02842827|525500479|FG007|Overall Study|Protocol Defined Disease Progression|0|||
145722280|NCT02842827|525500472|FG000|Overall Study|Participant Withdrawal of Consent|1|||
145722281|NCT02842827|525500473|FG001|Overall Study|Participant Withdrawal of Consent|2|||
145722282|NCT02842827|525500474|FG002|Overall Study|Participant Withdrawal of Consent|2|||
145722283|NCT02842827|525500475|FG003|Overall Study|Participant Withdrawal of Consent|2|||
145722284|NCT02842827|525500476|FG004|Overall Study|Participant Withdrawal of Consent|2|||
145722285|NCT02842827|525500477|FG005|Overall Study|Participant Withdrawal of Consent|1|||
145722286|NCT02842827|525500478|FG006|Overall Study|Participant Withdrawal of Consent|2|||
145722287|NCT02842827|525500479|FG007|Overall Study|Participant Withdrawal of Consent|1|||
145722288|NCT02649946|525500485|FG000|Overall Study|Withdrawal by Subject|1|||
145722289|NCT02649946|525500486|FG001|Overall Study|Withdrawal by Subject|1|||
145722290|NCT02649946|525500485|FG000|Overall Study|Death|7|||
145722291|NCT02649946|525500486|FG001|Overall Study|Death|9|||
145722292|NCT02649946|525500485|FG000|Overall Study|Physician Decision|1|||
145722293|NCT02649946|525500486|FG001|Overall Study|Physician Decision|0|||
145722294|NCT02649946|525500485|FG000|Overall Study|Lost to Follow-up|2|||
145722295|NCT02649946|525500486|FG001|Overall Study|Lost to Follow-up|1|||
145722296|NCT02649946|525500485|FG000|Overall Study|Erroneously enrolled|1|||
145722297|NCT02649946|525500486|FG001|Overall Study|Erroneously enrolled|0|||
145722298|NCT02649946|525500485|FG000|Overall Study|Missed 6-month follow-up visit|0|||
145722299|NCT02649946|525500486|FG001|Overall Study|Missed 6-month follow-up visit|4|||
145722300|NCT02054520|525500487|FG000|Overall Study|Adverse Event|1|||
145722301|NCT02054520|525500488|FG001|Overall Study|Adverse Event|4|||
145722302|NCT02054520|525500489|FG002|Overall Study|Adverse Event|2|||
145722303|NCT02054520|525500490|FG003|Overall Study|Adverse Event|1|||
145722304|NCT02054520|525500491|FG004|Overall Study|Adverse Event|1|||
145722305|NCT02054520|525500492|FG005|Overall Study|Adverse Event|0|||
145722306|NCT02054520|525500487|FG000|Overall Study|Lack of Efficacy|7|||
145722307|NCT02054520|525500488|FG001|Overall Study|Lack of Efficacy|0|||
145722308|NCT02054520|525500489|FG002|Overall Study|Lack of Efficacy|2|||
145722309|NCT02054520|525500490|FG003|Overall Study|Lack of Efficacy|1|||
145722310|NCT02054520|525500491|FG004|Overall Study|Lack of Efficacy|3|||
145722311|NCT02054520|525500492|FG005|Overall Study|Lack of Efficacy|2|||
145722312|NCT02054520|525500487|FG000|Overall Study|Withdrawal by Subject|1|||
145722313|NCT02054520|525500488|FG001|Overall Study|Withdrawal by Subject|0|||
145722314|NCT02054520|525500489|FG002|Overall Study|Withdrawal by Subject|0|||
145722315|NCT02054520|525500490|FG003|Overall Study|Withdrawal by Subject|2|||
145722316|NCT02054520|525500491|FG004|Overall Study|Withdrawal by Subject|1|||
145722317|NCT02054520|525500492|FG005|Overall Study|Withdrawal by Subject|0|||
145722318|NCT02054520|525500487|FG000|Overall Study|Physician Decision|0|||
145722319|NCT02054520|525500488|FG001|Overall Study|Physician Decision|1|||
145722320|NCT02054520|525500489|FG002|Overall Study|Physician Decision|0|||
145722321|NCT02054520|525500490|FG003|Overall Study|Physician Decision|1|||
145722322|NCT02054520|525500491|FG004|Overall Study|Physician Decision|0|||
145722323|NCT02054520|525500492|FG005|Overall Study|Physician Decision|1|||
145722324|NCT02054520|525500487|FG000|Overall Study|Study terminated by Sponsor|0|||
145722325|NCT02054520|525500488|FG001|Overall Study|Study terminated by Sponsor|0|||
145722326|NCT02054520|525500489|FG002|Overall Study|Study terminated by Sponsor|2|||
145722327|NCT02054520|525500490|FG003|Overall Study|Study terminated by Sponsor|1|||
145722328|NCT02054520|525500491|FG004|Overall Study|Study terminated by Sponsor|0|||
145722329|NCT02054520|525500492|FG005|Overall Study|Study terminated by Sponsor|0|||
145722330|NCT01272804|525500493|FG000|Overall Study|Adverse Event|1|||
145722331|NCT01272804|525500494|FG001|Overall Study|Adverse Event|0|||
145722332|NCT01272804|525500495|FG002|Overall Study|Adverse Event|0|||
145722333|NCT01272804|525500496|FG003|Overall Study|Adverse Event|0|||
145722334|NCT01272804|525500497|FG004|Overall Study|Adverse Event|2|||
145722335|NCT01272804|525500498|FG005|Overall Study|Adverse Event|1|||
145722336|NCT03801915|525500499|FG000|Overall Study|Screen failure|0|||
145722337|NCT03801915|525500500|FG001|Overall Study|Screen failure|0|||
145722338|NCT03801915|525500501|FG002|Overall Study|Screen failure|1|||
145722339|NCT03801915|525500499|FG000|Overall Study|Ineligible|1|||
145722340|NCT03801915|525500500|FG001|Overall Study|Ineligible|0|||
145722341|NCT03801915|525500501|FG002|Overall Study|Ineligible|0|||
145722342|NCT03801915|525500499|FG000|Overall Study|Physician Decision|2|||
145722343|NCT03801915|525500500|FG001|Overall Study|Physician Decision|1|||
145722344|NCT03801915|525500501|FG002|Overall Study|Physician Decision|0|||
145722345|NCT01211288|525500502|FG000|Overall Study|Lost to Follow-up|1|||
145722346|NCT01211288|525500503|FG001|Overall Study|Lost to Follow-up|1|||
145722347|NCT01588496|525500504|FG000|Overall Study|Withdrawal by Subject|0|||
145722348|NCT01588496|525500505|FG001|Overall Study|Withdrawal by Subject|1|||
145722349|NCT01588496|525500506|FG002|Overall Study|Withdrawal by Subject|0|||
145722350|NCT01551212|525500507|FG000|Overall Study|Graft loss/Retransplantation|0|||
145722351|NCT01551212|525500508|FG001|Overall Study|Graft loss/Retransplantation|1|||
145722352|NCT01551212|525500507|FG000|Overall Study|Administrative problems|1|||
145722353|NCT01551212|525500508|FG001|Overall Study|Administrative problems|2|||
145722354|NCT01551212|525500507|FG000|Overall Study|Lost to Follow-up|0|||
145722355|NCT01551212|525500508|FG001|Overall Study|Lost to Follow-up|1|||
145722356|NCT01551212|525500507|FG000|Overall Study|Protocol Violation|0|||
145722357|NCT01551212|525500508|FG001|Overall Study|Protocol Violation|1|||
145722358|NCT01551212|525500507|FG000|Overall Study|Withdrawal by Subject|0|||
145722359|NCT01551212|525500508|FG001|Overall Study|Withdrawal by Subject|7|||
145722360|NCT01551212|525500507|FG000|Overall Study|Death|2|||
145722361|NCT01551212|525500508|FG001|Overall Study|Death|4|||
145722362|NCT01551212|525500507|FG000|Overall Study|Never Received Study Treatment|2|||
145722363|NCT01551212|525500508|FG001|Overall Study|Never Received Study Treatment|4|||
145722364|NCT05924945|525500509|FG000|Overall Study|Withdrawal by Subject|3|||
145722365|NCT05924945|525500510|FG001|Overall Study|Withdrawal by Subject|4|||
145722366|NCT02471833|525500511|FG000|Overall Study|Lost to Follow-up|1|||
145722367|NCT02471833|525500512|FG001|Overall Study|Lost to Follow-up|0|||
145722368|NCT02471833|525500513|FG002|Overall Study|Lost to Follow-up|0|||
145722369|NCT02471833|525500511|FG000|Overall Study|Withdrawal by Subject|2|||
145722370|NCT02471833|525500512|FG001|Overall Study|Withdrawal by Subject|1|||
145722371|NCT02471833|525500513|FG002|Overall Study|Withdrawal by Subject|5|||
145722372|NCT04217590|525500514|FG000|Overall Study|Other|1|||
145722373|NCT04217590|525500515|FG001|Overall Study|Other|1|||
145722374|NCT04217590|525500514|FG000|Overall Study|Withdrawal by Subject|3|||
145381869|NCT00386425|524248639|FG002|Overall Study|Physician Decision|0|||
145381870|NCT00386425|524248637|FG000|Overall Study|Withdrawal by Subject|0|||
145381871|NCT00386425|524248638|FG001|Overall Study|Withdrawal by Subject|1|||
145381872|NCT00386425|524248639|FG002|Overall Study|Withdrawal by Subject|0|||
145381873|NCT04852276|524248640|FG000|Overall Study|Death|2|||
145381874|NCT04852276|524248641|FG001|Overall Study|Death|0|||
145381875|NCT04852276|524248640|FG000|Overall Study|Lost to Follow-up|15|||
145381876|NCT04852276|524248641|FG001|Overall Study|Lost to Follow-up|9|||
145381877|NCT04852276|524248640|FG000|Overall Study|Withdrawal by Subject|26|||
145381878|NCT04852276|524248641|FG001|Overall Study|Withdrawal by Subject|6|||
145381879|NCT00715520|524250435|FG000|Overall Study|Screen failure|8|||
145381880|NCT00715520|524250436|FG001|Overall Study|Screen failure|1|||
145381881|NCT00715520|524250437|FG002|Overall Study|Screen failure|1|||
145381882|NCT00715520|524250435|FG000|Overall Study|Withdrawal by Subject|2|||
145381883|NCT00715520|524250436|FG001|Overall Study|Withdrawal by Subject|0|||
145381884|NCT00715520|524250437|FG002|Overall Study|Withdrawal by Subject|1|||
145381885|NCT04122625|524250438|FG000|Part A (up to 2.92 Years)|Death|2|||
145381886|NCT04122625|524250439|FG001|Part A (up to 2.92 Years)|Death|4|||
145381887|NCT04122625|524250440|FG002|Part A (up to 2.92 Years)|Death|0|||
145381888|NCT04122625|524250441|FG003|Part A (up to 2.92 Years)|Death|0|||
145381889|NCT04122625|524250442|FG004|Part A (up to 2.92 Years)|Death|0|||
145722375|NCT04217590|525500515|FG001|Overall Study|Withdrawal by Subject|1|||
145722376|NCT04217590|525500514|FG000|Overall Study|Death|0|||
145266630|NCT04668066|523825240|FG003|Part 1: Treatment Phase|Other|0|||
145381890|NCT04122625|524250443|FG005|Part A (up to 2.92 Years)|Death|0|||
145381891|NCT04122625|524250438|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145381892|NCT04122625|524250439|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145381893|NCT04122625|524250440|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
145381894|NCT04122625|524250441|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
145722377|NCT04217590|525500515|FG001|Overall Study|Death|1|||
145722378|NCT02232243|525500518|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
145722379|NCT02232243|525500519|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
145722380|NCT02232243|525500520|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
145722381|NCT05026710|525500521|FG000|Overall Study|No longer met eligibility criteria|3|||
145722382|NCT05026710|525500522|FG001|Overall Study|No longer met eligibility criteria|1|||
145722383|NCT00490724|525500523|FG000|Period I|Physician Decision|0|||
145722384|NCT00490724|525500524|FG001|Period I|Physician Decision|0|||
145381895|NCT04122625|524250442|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
145381896|NCT04122625|524250443|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
145381897|NCT04122625|524250438|FG000|Part B (up to 2.33 Years)|Death|0|||
145381898|NCT04122625|524250439|FG001|Part B (up to 2.33 Years)|Death|0|||
145381899|NCT04122625|524250440|FG002|Part B (up to 2.33 Years)|Death|5|||
145381900|NCT04122625|524250441|FG003|Part B (up to 2.33 Years)|Death|7|||
145381901|NCT04122625|524250442|FG004|Part B (up to 2.33 Years)|Death|6|||
145381902|NCT04122625|524250443|FG005|Part B (up to 2.33 Years)|Death|7|||
145381903|NCT02697591|524250444|FG000|Overall Study|Lost to Follow-up|0|||
145381904|NCT02697591|524250445|FG001|Overall Study|Lost to Follow-up|0|||
145381905|NCT02697591|524250446|FG002|Overall Study|Lost to Follow-up|0|||
145381906|NCT02697591|524250447|FG003|Overall Study|Lost to Follow-up|0|||
145381907|NCT02697591|524250448|FG004|Overall Study|Lost to Follow-up|0|||
145381908|NCT02697591|524250449|FG005|Overall Study|Lost to Follow-up|1|||
145381909|NCT02697591|524250450|FG006|Overall Study|Lost to Follow-up|1|||
145381910|NCT02697591|524250451|FG007|Overall Study|Lost to Follow-up|0|||
145381911|NCT02697591|524250452|FG008|Overall Study|Lost to Follow-up|0|||
145381912|NCT02697591|524250453|FG009|Overall Study|Lost to Follow-up|1|||
145381913|NCT02697591|524250444|FG000|Overall Study|Withdrawal by Subject|1|||
145381914|NCT02697591|524250445|FG001|Overall Study|Withdrawal by Subject|1|||
145381915|NCT02697591|524250446|FG002|Overall Study|Withdrawal by Subject|2|||
145381916|NCT02697591|524250447|FG003|Overall Study|Withdrawal by Subject|1|||
145381917|NCT02697591|524250448|FG004|Overall Study|Withdrawal by Subject|7|||
145381918|NCT02697591|524250449|FG005|Overall Study|Withdrawal by Subject|6|||
145381919|NCT02697591|524250450|FG006|Overall Study|Withdrawal by Subject|9|||
145381920|NCT02697591|524250451|FG007|Overall Study|Withdrawal by Subject|1|||
145381921|NCT02697591|524250452|FG008|Overall Study|Withdrawal by Subject|6|||
145381922|NCT02697591|524250453|FG009|Overall Study|Withdrawal by Subject|10|||
145381923|NCT02697591|524250444|FG000|Overall Study|Physician Decision|1|||
145381924|NCT02697591|524250445|FG001|Overall Study|Physician Decision|0|||
145381925|NCT02697591|524250446|FG002|Overall Study|Physician Decision|0|||
145381926|NCT02697591|524250447|FG003|Overall Study|Physician Decision|0|||
145381927|NCT02697591|524250448|FG004|Overall Study|Physician Decision|1|||
145381928|NCT02697591|524250449|FG005|Overall Study|Physician Decision|2|||
145381929|NCT02697591|524250450|FG006|Overall Study|Physician Decision|0|||
145381930|NCT02697591|524250451|FG007|Overall Study|Physician Decision|0|||
145381931|NCT02697591|524250452|FG008|Overall Study|Physician Decision|1|||
145381932|NCT02697591|524250453|FG009|Overall Study|Physician Decision|1|||
145381933|NCT02697591|524250444|FG000|Overall Study|Death|2|||
145381934|NCT02697591|524250445|FG001|Overall Study|Death|3|||
145381935|NCT02697591|524250446|FG002|Overall Study|Death|1|||
145381936|NCT02697591|524250447|FG003|Overall Study|Death|1|||
145381937|NCT02697591|524250448|FG004|Overall Study|Death|4|||
145381938|NCT02697591|524250449|FG005|Overall Study|Death|5|||
145381939|NCT02697591|524250450|FG006|Overall Study|Death|3|||
145381940|NCT02697591|524250451|FG007|Overall Study|Death|1|||
145381941|NCT02697591|524250452|FG008|Overall Study|Death|1|||
145381942|NCT02697591|524250453|FG009|Overall Study|Death|5|||
145381943|NCT02697591|524250444|FG000|Overall Study|Reason not Specified|0|||
145381944|NCT02697591|524250445|FG001|Overall Study|Reason not Specified|0|||
145381945|NCT02697591|524250446|FG002|Overall Study|Reason not Specified|0|||
145381946|NCT02697591|524250447|FG003|Overall Study|Reason not Specified|1|||
145381947|NCT02697591|524250448|FG004|Overall Study|Reason not Specified|1|||
145381948|NCT02697591|524250449|FG005|Overall Study|Reason not Specified|2|||
145381949|NCT02697591|524250450|FG006|Overall Study|Reason not Specified|3|||
145381950|NCT02697591|524250451|FG007|Overall Study|Reason not Specified|1|||
145381951|NCT02697591|524250452|FG008|Overall Study|Reason not Specified|1|||
145381952|NCT02697591|524250453|FG009|Overall Study|Reason not Specified|3|||
145381953|NCT01937884|524250454|FG000|Overall Study|Withdrawal by Subject|1|||
145381954|NCT01937884|524250455|FG001|Overall Study|Withdrawal by Subject|0|||
145381955|NCT02147067|524250465|FG000|Overall Study|Withdrawal by Subject|2|||
145381956|NCT02147067|524250466|FG001|Overall Study|Withdrawal by Subject|2|||
145381957|NCT01017601|524250468|FG000|Overall Study|Disease Progression|12|||
145381958|NCT01017601|524250469|FG001|Overall Study|Disease Progression|12|||
145381959|NCT01017601|524250468|FG000|Overall Study|Withdrawal by Subject|0|||
145381960|NCT01017601|524250469|FG001|Overall Study|Withdrawal by Subject|1|||
145381961|NCT02735096|524250470|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
145381962|NCT03742258|524250471|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
145381963|NCT03742258|524250472|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
145381964|NCT03742258|524250473|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
145381965|NCT03742258|524250471|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
145381966|NCT03742258|524250472|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
145381967|NCT03742258|524250473|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
145381968|NCT03742258|524250471|FG000|Survival Follow-Up|Still in Follow-up|0|||
145381969|NCT03742258|524250472|FG001|Survival Follow-Up|Still in Follow-up|0|||
145381970|NCT03742258|524250473|FG002|Survival Follow-Up|Still in Follow-up|2|||
145381971|NCT02083653|524250474|FG000|Overall Study|Randomized but not Treated|0|||
145722385|NCT00490724|525500525|FG002|Period I|Physician Decision|1|||
145381972|NCT02083653|524250475|FG001|Overall Study|Randomized but not Treated|2|||
145381973|NCT02083653|524250476|FG002|Overall Study|Randomized but not Treated|7|||
145381974|NCT02083653|524250474|FG000|Overall Study|Adverse Event|12|||
145381975|NCT02083653|524250475|FG001|Overall Study|Adverse Event|5|||
145722386|NCT00490724|525500523|FG000|Period II|Treatment Discontinuation|3|||
145722387|NCT00490724|525500524|FG001|Period II|Treatment Discontinuation|1|||
145722388|NCT00490724|525500525|FG002|Period II|Treatment Discontinuation|3|||
145381976|NCT02083653|524250476|FG002|Overall Study|Adverse Event|4|||
145381977|NCT02083653|524250474|FG000|Overall Study|Lost to Follow-up|1|||
145381978|NCT02083653|524250475|FG001|Overall Study|Lost to Follow-up|0|||
145381979|NCT02083653|524250476|FG002|Overall Study|Lost to Follow-up|0|||
145381980|NCT02083653|524250474|FG000|Overall Study|Death|2|||
145381981|NCT02083653|524250475|FG001|Overall Study|Death|2|||
145381982|NCT02083653|524250476|FG002|Overall Study|Death|2|||
145381983|NCT02083653|524250474|FG000|Overall Study|Progressive Disease|65|||
145381984|NCT02083653|524250475|FG001|Overall Study|Progressive Disease|73|||
145381985|NCT02083653|524250476|FG002|Overall Study|Progressive Disease|63|||
145381986|NCT02083653|524250474|FG000|Overall Study|Withdrawal by Subject|2|||
145381987|NCT02083653|524250475|FG001|Overall Study|Withdrawal by Subject|1|||
145381988|NCT02083653|524250476|FG002|Overall Study|Withdrawal by Subject|2|||
145381989|NCT02083653|524250474|FG000|Overall Study|Other Events|0|||
145381990|NCT02083653|524250475|FG001|Overall Study|Other Events|2|||
145381991|NCT02083653|524250476|FG002|Overall Study|Other Events|2|||
145381992|NCT02083653|524250474|FG000|Overall Study|Reason Missing|0|||
145381993|NCT02083653|524250475|FG001|Overall Study|Reason Missing|0|||
145381994|NCT02083653|524250476|FG002|Overall Study|Reason Missing|4|||
145381995|NCT01380691|524250482|FG000|Washout (7 Days)|Protocol Violation|0|||
145381996|NCT01380691|524250483|FG001|Washout (7 Days)|Protocol Violation|0|||
145381997|NCT01380691|524250484|FG002|Washout (7 Days)|Protocol Violation|0|||
145381998|NCT01380691|524250485|FG003|Washout (7 Days)|Protocol Violation|1|||
145381999|NCT01380691|524250482|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
145382000|NCT01380691|524250483|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
145382001|NCT01380691|524250484|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
145382002|NCT01380691|524250485|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
145382003|NCT02536781|524250487|FG000|Overall Study|Lost to Follow-up|2|||
145382004|NCT02536781|524250488|FG001|Overall Study|Lost to Follow-up|0|||
145382005|NCT03423147|524250489|FG000|Overall Study|Lost to Follow-up|5|||
145382006|NCT03423147|524250490|FG001|Overall Study|Lost to Follow-up|8|||
145382007|NCT03423147|524250489|FG000|Overall Study|Withdrawal by Subject|1|||
145382008|NCT03423147|524250490|FG001|Overall Study|Withdrawal by Subject|0|||
145382009|NCT03423147|524250489|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
145382010|NCT03423147|524250490|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
145382011|NCT03423147|524250489|FG000|Overall Study|Age < 18|1|||
145382012|NCT03423147|524250490|FG001|Overall Study|Age < 18|0|||
145382013|NCT03423147|524250489|FG000|Overall Study|No Trial of Labor|0|||
145722389|NCT03218397|525500526|FG000|Overall Study|Prior positive blood culture|8|||
145722390|NCT03218397|525500527|FG001|Overall Study|Prior positive blood culture|13|||
145722391|NCT03218397|525500526|FG000|Overall Study|Comfort care|8|||
145722392|NCT03218397|525500527|FG001|Overall Study|Comfort care|5|||
145722393|NCT03218397|525500526|FG000|Overall Study|Comfort care and positive blood culture|1|||
145722394|NCT03218397|525500527|FG001|Overall Study|Comfort care and positive blood culture|0|||
145722395|NCT03218397|525500526|FG000|Overall Study|Comfort care and mixed culture|0|||
145722396|NCT03218397|525500527|FG001|Overall Study|Comfort care and mixed culture|1|||
145722397|NCT03218397|525500526|FG000|Overall Study|Mixed culture|2|||
145722398|NCT03218397|525500527|FG001|Overall Study|Mixed culture|2|||
145722399|NCT03218397|525500526|FG000|Overall Study|Inaccessible hospital records|2|||
145722400|NCT03218397|525500527|FG001|Overall Study|Inaccessible hospital records|5|||
145722401|NCT03218397|525500526|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
145722402|NCT03218397|525500527|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
145722403|NCT03218397|525500526|FG000|Overall Study|Randomized during laboratory off hours|2|||
145722404|NCT03218397|525500527|FG001|Overall Study|Randomized during laboratory off hours|1|||
145722405|NCT01796548|525500528|FG000|Overall Study|Lost to Follow-up|1|||
145722406|NCT01796548|525500528|FG000|Overall Study|Other|2|||
145722407|NCT00126503|525500529|FG000|Overall Study|disease progression|23|||
145382014|NCT03423147|524250490|FG001|Overall Study|No Trial of Labor|1|||
145382015|NCT00508157|524250491|FG000|Overall Study|Adverse Event|0|||
145382016|NCT00508157|524250492|FG001|Overall Study|Adverse Event|1|||
145722408|NCT00126503|525500530|FG001|Overall Study|disease progression|14|||
145722409|NCT00126503|525500529|FG000|Overall Study|Withdrawal by Subject|0|||
145382017|NCT00508157|524250491|FG000|Overall Study|Subject Withdrew Consent|1|||
145382018|NCT00508157|524250492|FG001|Overall Study|Subject Withdrew Consent|0|||
145382019|NCT00508157|524250491|FG000|Overall Study|Lost to Follow-up|1|||
145382020|NCT00508157|524250492|FG001|Overall Study|Lost to Follow-up|0|||
145722410|NCT00126503|525500530|FG001|Overall Study|Withdrawal by Subject|1|||
145382021|NCT00508157|524250491|FG000|Overall Study|Subject no longer met study criteria|0|||
145722411|NCT00126503|525500529|FG000|Overall Study|alternative therapy|1|||
145722412|NCT00126503|525500530|FG001|Overall Study|alternative therapy|1|||
145722413|NCT00126503|525500529|FG000|Overall Study|other complicating disease|4|||
145722414|NCT00126503|525500530|FG001|Overall Study|other complicating disease|1|||
145722415|NCT00126503|525500529|FG000|Overall Study|Death|3|||
145722416|NCT00126503|525500530|FG001|Overall Study|Death|0|||
145722417|NCT00126503|525500529|FG000|Overall Study|Adverse Event|13|||
145722418|NCT00126503|525500530|FG001|Overall Study|Adverse Event|3|||
145722419|NCT00126503|525500529|FG000|Overall Study|non-compliant|1|||
145722420|NCT00126503|525500530|FG001|Overall Study|non-compliant|0|||
145722421|NCT00126503|525500529|FG000|Overall Study|Physician Decision|2|||
145722422|NCT00126503|525500530|FG001|Overall Study|Physician Decision|1|||
145722423|NCT02457559|525500531|FG000|Overall Study|Progressive Disease|1|||
145722424|NCT02457559|525500532|FG001|Overall Study|Progressive Disease|2|||
145722425|NCT02457559|525500533|FG002|Overall Study|Progressive Disease|3|||
145722426|NCT02457559|525500534|FG003|Overall Study|Progressive Disease|0|||
145722427|NCT02457559|525500535|FG004|Overall Study|Progressive Disease|0|||
145722428|NCT02457559|525500536|FG005|Overall Study|Progressive Disease|2|||
145722429|NCT02457559|525500537|FG006|Overall Study|Progressive Disease|1|||
145722430|NCT02457559|525500538|FG007|Overall Study|Progressive Disease|0|||
145722431|NCT02457559|525500539|FG008|Overall Study|Progressive Disease|1|||
145722432|NCT02457559|525500540|FG009|Overall Study|Progressive Disease|1|||
145722433|NCT02457559|525500541|FG010|Overall Study|Progressive Disease|1|||
145722434|NCT02457559|525500531|FG000|Overall Study|Investigator's Discretion|0|||
145722435|NCT02457559|525500532|FG001|Overall Study|Investigator's Discretion|0|||
145722436|NCT02457559|525500533|FG002|Overall Study|Investigator's Discretion|2|||
145722437|NCT02457559|525500534|FG003|Overall Study|Investigator's Discretion|0|||
145722438|NCT02457559|525500535|FG004|Overall Study|Investigator's Discretion|1|||
145382022|NCT00508157|524250492|FG001|Overall Study|Subject no longer met study criteria|1|||
145382023|NCT00508157|524250491|FG000|Overall Study|Other known cause|0|||
145382024|NCT00508157|524250492|FG001|Overall Study|Other known cause|1|||
145382025|NCT01952080|524250493|FG000|Overall Study|Withdrawal by Subject|0|||
145382026|NCT01952080|524250494|FG001|Overall Study|Withdrawal by Subject|0|||
145382027|NCT01952080|524250495|FG002|Overall Study|Withdrawal by Subject|0|||
145382028|NCT01952080|524250496|FG003|Overall Study|Withdrawal by Subject|1|||
145382029|NCT01952080|524250493|FG000|Overall Study|Protocol Non-compliance|0|||
145382030|NCT01952080|524250494|FG001|Overall Study|Protocol Non-compliance|1|||
145382031|NCT01952080|524250495|FG002|Overall Study|Protocol Non-compliance|0|||
145382032|NCT01952080|524250496|FG003|Overall Study|Protocol Non-compliance|0|||
145382033|NCT02028169|524250497|FG000|Overall Study|Lost to Follow-up|21|||
145382034|NCT02028169|524250497|FG000|Overall Study|Lack of Efficacy|2|||
145382035|NCT02028169|524250497|FG000|Overall Study|Withdrawal by Subject|2|||
145382036|NCT02028169|524250497|FG000|Overall Study|Adverse Event|1|||
145382037|NCT02028169|524250497|FG000|Overall Study|Cessation of Drug|1|||
145382038|NCT02028169|524250497|FG000|Overall Study|Concomitant Medication Usage|1|||
145382039|NCT02258334|524250498|FG000|Overall Study|Adverse Event|1|||
145382040|NCT02258334|524250499|FG001|Overall Study|Adverse Event|0|||
145382041|NCT02258334|524250500|FG002|Overall Study|Adverse Event|0|||
145382042|NCT02258334|524250501|FG003|Overall Study|Adverse Event|0|||
145382043|NCT01969084|524250502|FG000|Overall Study|Adverse Event|0|||
145382044|NCT01969084|524250503|FG001|Overall Study|Adverse Event|1|||
145382045|NCT03564795|524250506|FG000|Overall Study|Withdrawal by Subject|3|||
145382046|NCT03564795|524250506|FG000|Overall Study|Lost to Follow-up|6|||
145382047|NCT03564795|524250506|FG000|Overall Study|Physician Decision|2|||
145382048|NCT00862459|524250507|FG000|Overall Study|Lost to Follow-up|1|||
145382049|NCT00862459|524250508|FG001|Overall Study|Lost to Follow-up|2|||
145382050|NCT00862459|524250509|FG002|Overall Study|Lost to Follow-up|2|||
145382051|NCT00862459|524250507|FG000|Overall Study|Protocol Violation|1|||
145382052|NCT00862459|524250508|FG001|Overall Study|Protocol Violation|0|||
145382053|NCT00862459|524250509|FG002|Overall Study|Protocol Violation|0|||
145382054|NCT00862459|524250507|FG000|Overall Study|Withdrawal by Subject|1|||
145382055|NCT00862459|524250508|FG001|Overall Study|Withdrawal by Subject|1|||
145382056|NCT00862459|524250509|FG002|Overall Study|Withdrawal by Subject|3|||
145382057|NCT00862459|524250507|FG000|Overall Study|Adverse Event|0|||
145382058|NCT00862459|524250508|FG001|Overall Study|Adverse Event|1|||
145382059|NCT00862459|524250509|FG002|Overall Study|Adverse Event|0|||
145722439|NCT02457559|525500536|FG005|Overall Study|Investigator's Discretion|0|||
145722440|NCT02457559|525500537|FG006|Overall Study|Investigator's Discretion|1|||
145722441|NCT02457559|525500538|FG007|Overall Study|Investigator's Discretion|0|||
145722442|NCT02457559|525500539|FG008|Overall Study|Investigator's Discretion|1|||
145722443|NCT02457559|525500540|FG009|Overall Study|Investigator's Discretion|0|||
145722444|NCT02457559|525500541|FG010|Overall Study|Investigator's Discretion|1|||
145722445|NCT02457559|525500531|FG000|Overall Study|Adverse Event|0|||
145382060|NCT00862459|524250507|FG000|Overall Study|Personal reasons|1|||
145382061|NCT00862459|524250508|FG001|Overall Study|Personal reasons|0|||
145382062|NCT00862459|524250509|FG002|Overall Study|Personal reasons|0|||
145722446|NCT02457559|525500532|FG001|Overall Study|Adverse Event|1|||
145722447|NCT02457559|525500533|FG002|Overall Study|Adverse Event|2|||
145722448|NCT02457559|525500534|FG003|Overall Study|Adverse Event|0|||
145382063|NCT00862459|524250507|FG000|Overall Study|Operation|1|||
145722449|NCT02457559|525500535|FG004|Overall Study|Adverse Event|0|||
145722450|NCT02457559|525500536|FG005|Overall Study|Adverse Event|0|||
145722451|NCT02457559|525500537|FG006|Overall Study|Adverse Event|0|||
145722452|NCT02457559|525500538|FG007|Overall Study|Adverse Event|0|||
145722453|NCT02457559|525500539|FG008|Overall Study|Adverse Event|0|||
145722454|NCT02457559|525500540|FG009|Overall Study|Adverse Event|0|||
145722455|NCT02457559|525500541|FG010|Overall Study|Adverse Event|0|||
145722456|NCT02457559|525500531|FG000|Overall Study|Reason not Specified|1|||
145722457|NCT02457559|525500532|FG001|Overall Study|Reason not Specified|0|||
145722458|NCT02457559|525500533|FG002|Overall Study|Reason not Specified|0|||
145722459|NCT02457559|525500534|FG003|Overall Study|Reason not Specified|0|||
145722460|NCT02457559|525500535|FG004|Overall Study|Reason not Specified|0|||
145722461|NCT02457559|525500536|FG005|Overall Study|Reason not Specified|0|||
145722462|NCT02457559|525500537|FG006|Overall Study|Reason not Specified|0|||
145722463|NCT02457559|525500538|FG007|Overall Study|Reason not Specified|0|||
145722464|NCT02457559|525500539|FG008|Overall Study|Reason not Specified|0|||
145722465|NCT02457559|525500540|FG009|Overall Study|Reason not Specified|2|||
145722466|NCT02457559|525500541|FG010|Overall Study|Reason not Specified|0|||
145722467|NCT02457559|525500531|FG000|Overall Study|Death|0|||
145722468|NCT02457559|525500532|FG001|Overall Study|Death|0|||
145722469|NCT02457559|525500533|FG002|Overall Study|Death|0|||
145722470|NCT02457559|525500534|FG003|Overall Study|Death|0|||
145722471|NCT02457559|525500535|FG004|Overall Study|Death|0|||
145722472|NCT02457559|525500536|FG005|Overall Study|Death|0|||
145722473|NCT02457559|525500537|FG006|Overall Study|Death|0|||
145722474|NCT02457559|525500538|FG007|Overall Study|Death|0|||
145722475|NCT02457559|525500539|FG008|Overall Study|Death|1|||
145722476|NCT02457559|525500540|FG009|Overall Study|Death|1|||
145722477|NCT02457559|525500541|FG010|Overall Study|Death|0|||
145722478|NCT02374671|525500544|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
145722479|NCT02374671|525500545|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
145722480|NCT02374671|525500546|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
145722481|NCT02374671|525500544|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
145722482|NCT02374671|525500545|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
145722483|NCT02374671|525500546|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
145722484|NCT02374671|525500544|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
145722485|NCT02374671|525500545|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
145722486|NCT02374671|525500546|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
145722487|NCT02374671|525500544|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
145722488|NCT02374671|525500545|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
145722489|NCT02374671|525500546|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
145722490|NCT02374671|525500544|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
145722491|NCT02374671|525500545|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
145722492|NCT02374671|525500546|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
145722493|NCT02495792|525500549|FG000|Overall Study|Lost to Follow-up|5|||
145722494|NCT02495792|525500550|FG001|Overall Study|Lost to Follow-up|9|||
145722495|NCT02495792|525500549|FG000|Overall Study|Protocol Violation|32|||
145722496|NCT02495792|525500550|FG001|Overall Study|Protocol Violation|31|||
145722497|NCT02523599|525500551|FG000|Overall Study|Adverse Event|1|||
145722498|NCT02523599|525500552|FG001|Overall Study|Adverse Event|0|||
145722499|NCT02523599|525500551|FG000|Overall Study|Physician Decision|1|||
145722500|NCT02523599|525500552|FG001|Overall Study|Physician Decision|0|||
145722501|NCT02523599|525500551|FG000|Overall Study|Lost to Follow-up|4|||
145722502|NCT02523599|525500552|FG001|Overall Study|Lost to Follow-up|1|||
145722503|NCT02523599|525500551|FG000|Overall Study|Did not return for Day 30 visit|2|||
145722504|NCT02523599|525500552|FG001|Overall Study|Did not return for Day 30 visit|0|||
145722505|NCT06729606|525500557|FG000|Overall Study|Adverse Event|0|||
145722506|NCT06729606|525500558|FG001|Overall Study|Adverse Event|2|||
145722507|NCT06729606|525500557|FG000|Overall Study|Death|1|||
145722508|NCT06729606|525500558|FG001|Overall Study|Death|0|||
145722509|NCT06729606|525500557|FG000|Overall Study|Physician Decision|0|||
145722510|NCT06729606|525500558|FG001|Overall Study|Physician Decision|1|||
145722511|NCT06729606|525500557|FG000|Overall Study|Withdrawal by Subject|2|||
145722512|NCT06729606|525500558|FG001|Overall Study|Withdrawal by Subject|4|||
145722513|NCT03570892|525500559|FG000|Overall Study|Death|51|||
145722514|NCT03570892|525500560|FG001|Overall Study|Death|45|||
145722515|NCT03570892|525500559|FG000|Overall Study|Subject decision|5|||
145722516|NCT03570892|525500560|FG001|Overall Study|Subject decision|3|||
145722517|NCT03570892|525500559|FG000|Overall Study|Protocol Violation|1|||
145722518|NCT03570892|525500560|FG001|Overall Study|Protocol Violation|4|||
145722519|NCT03570892|525500559|FG000|Overall Study|Physician Decision|0|||
145722520|NCT03570892|525500560|FG001|Overall Study|Physician Decision|2|||
145722521|NCT01328717|525502445|FG000|Overall Study|Adverse Event|1|||
145722522|NCT01201317|525502446|FG000|Overall Study|Withdrawal by Subject|5|||
145722523|NCT01201317|525502447|FG001|Overall Study|Withdrawal by Subject|0|||
145722524|NCT01201317|525502448|FG002|Overall Study|Withdrawal by Subject|3|||
145722525|NCT01201317|525502446|FG000|Overall Study|Adverse Event|2|||
145722526|NCT01201317|525502447|FG001|Overall Study|Adverse Event|2|||
145722527|NCT01201317|525502448|FG002|Overall Study|Adverse Event|2|||
145722528|NCT01201317|525502446|FG000|Overall Study|Screen failure|1|||
145722529|NCT01201317|525502447|FG001|Overall Study|Screen failure|1|||
145722530|NCT01201317|525502448|FG002|Overall Study|Screen failure|0|||
145722531|NCT01201317|525502446|FG000|Overall Study|Protocol Violation|0|||
145722532|NCT01201317|525502447|FG001|Overall Study|Protocol Violation|1|||
145722533|NCT01201317|525502448|FG002|Overall Study|Protocol Violation|1|||
145722534|NCT01201317|525502446|FG000|Overall Study|Death|0|||
145722535|NCT01201317|525502447|FG001|Overall Study|Death|1|||
145722536|NCT01201317|525502448|FG002|Overall Study|Death|0|||
145722537|NCT01201317|525502446|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145722538|NCT01201317|525502447|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145722539|NCT01201317|525502448|FG002|Overall Study|Study-specific withdrawal criteria|1|||
145722540|NCT01201317|525502446|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
145722541|NCT01201317|525502447|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
145722542|NCT01201317|525502448|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
145722543|NCT01201317|525502446|FG000|Overall Study|Decrease in renal function|0|||
145722544|NCT01201317|525502447|FG001|Overall Study|Decrease in renal function|1|||
145722545|NCT01201317|525502448|FG002|Overall Study|Decrease in renal function|0|||
145722546|NCT01201317|525502446|FG000|Overall Study|Lack of Efficacy|1|||
145722547|NCT01201317|525502447|FG001|Overall Study|Lack of Efficacy|0|||
145722548|NCT01201317|525502448|FG002|Overall Study|Lack of Efficacy|0|||
145722549|NCT01201317|525502446|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
145722550|NCT01201317|525502447|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
145722551|NCT01201317|525502448|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
145722552|NCT02079610|525502449|FG000|Overall Study|Withdrawal by Subject|1|||
145722553|NCT02079610|525502450|FG001|Overall Study|Withdrawal by Subject|1|||
145722554|NCT04964388|525502451|FG000|Overall Study|Lost to Follow-up|3|||
145722555|NCT04964388|525502452|FG001|Overall Study|Lost to Follow-up|2|||
145722556|NCT01052103|525502453|FG000|Overall Study|Adverse Event|10|||
145722557|NCT01052103|525502454|FG001|Overall Study|Adverse Event|6|||
145722558|NCT01052103|525502453|FG000|Overall Study|Entry Criteria Not Met|3|||
145722559|NCT01052103|525502454|FG001|Overall Study|Entry Criteria Not Met|1|||
145722560|NCT01052103|525502453|FG000|Overall Study|Lost to Follow-up|3|||
145722561|NCT01052103|525502454|FG001|Overall Study|Lost to Follow-up|5|||
145722562|NCT01052103|525502453|FG000|Overall Study|Protocol Violation|10|||
145722563|NCT01052103|525502454|FG001|Overall Study|Protocol Violation|4|||
145722564|NCT01052103|525502453|FG000|Overall Study|Scheduling conflict|2|||
145722565|NCT01052103|525502454|FG001|Overall Study|Scheduling conflict|1|||
145722566|NCT01052103|525502453|FG000|Overall Study|Sponsor Decision|2|||
145722567|NCT01052103|525502454|FG001|Overall Study|Sponsor Decision|0|||
145722568|NCT01052103|525502453|FG000|Overall Study|Withdrawal by Subject|3|||
145722569|NCT01052103|525502454|FG001|Overall Study|Withdrawal by Subject|6|||
145722570|NCT01052103|525502453|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145722571|NCT01052103|525502454|FG001|Overall Study|Perceived Lack of Efficacy|0|||
145722572|NCT04874415|525502457|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722573|NCT04874415|525502458|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722574|NCT04874415|525502459|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722575|NCT04874415|525502460|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722576|NCT04874415|525502461|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722577|NCT04874415|525502462|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722578|NCT04874415|525502463|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
145722579|NCT04874415|525502464|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722580|NCT04874415|525502465|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
145722581|NCT04874415|525502466|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
145722582|NCT04874415|525502467|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722583|NCT04874415|525502468|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
145722584|NCT04874415|525502469|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
145722585|NCT04874415|525502470|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
145722586|NCT04874415|525502471|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
145722587|NCT04874415|525502472|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
145722588|NCT04874415|525502457|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722589|NCT04874415|525502458|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722590|NCT04874415|525502459|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722591|NCT04874415|525502460|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722592|NCT04874415|525502461|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722593|NCT04874415|525502462|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722594|NCT04874415|525502463|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722595|NCT04874415|525502464|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722596|NCT04874415|525502465|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722597|NCT04874415|525502466|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
145722598|NCT04874415|525502467|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722599|NCT04874415|525502468|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722600|NCT04874415|525502469|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722601|NCT04874415|525502470|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722602|NCT04874415|525502471|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
145722603|NCT04874415|525502472|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
145722604|NCT04874415|525502457|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722605|NCT04874415|525502458|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722606|NCT04874415|525502459|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722607|NCT04874415|525502460|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722608|NCT04874415|525502461|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
145722609|NCT04874415|525502462|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722610|NCT04874415|525502463|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722611|NCT04874415|525502464|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722612|NCT04874415|525502465|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722613|NCT04874415|525502466|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722614|NCT04874415|525502467|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722615|NCT04874415|525502468|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722616|NCT04874415|525502469|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722617|NCT04874415|525502470|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722618|NCT04874415|525502471|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722619|NCT04874415|525502472|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
145722620|NCT05062759|525502473|FG000|Overall Study|Death|0|||
145722621|NCT05062759|525502474|FG001|Overall Study|Death|1|||
145722622|NCT05062759|525502473|FG000|Overall Study|Lost to Follow-up|1|||
145722623|NCT05062759|525502474|FG001|Overall Study|Lost to Follow-up|0|||
145722624|NCT00903006|525502475|FG000|Overall Study|Withdrawal by Subject|2|||
145722625|NCT00903006|525502476|FG001|Overall Study|Withdrawal by Subject|0|||
145722626|NCT00903006|525502477|FG002|Overall Study|Withdrawal by Subject|0|||
145722627|NCT00903006|525502478|FG003|Overall Study|Withdrawal by Subject|0|||
145722628|NCT00903006|525502475|FG000|Overall Study|Progressive Disease|0|||
145722629|NCT00903006|525502476|FG001|Overall Study|Progressive Disease|3|||
145722630|NCT00903006|525502477|FG002|Overall Study|Progressive Disease|1|||
145722631|NCT00903006|525502478|FG003|Overall Study|Progressive Disease|0|||
145722632|NCT03405792|525502479|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
145722633|NCT03405792|525502480|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
145722634|NCT03405792|525502479|FG000|Overall Study|o Did not receive pembrolizumab|1|||
145382064|NCT00862459|524250508|FG001|Overall Study|Operation|1|||
145382065|NCT00862459|524250509|FG002|Overall Study|Operation|0|||
145722635|NCT03405792|525502480|FG001|Overall Study|o Did not receive pembrolizumab|0|||
145722636|NCT01383499|525502481|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
145722637|NCT01383499|525502482|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145722638|NCT01383499|525502483|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145722639|NCT01383499|525502484|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145722640|NCT02572882|525502485|FG000|Overall Study|Withdrawal by Subject|1|||
145722641|NCT02572882|525502485|FG000|Overall Study|Participant received kidney transplant|1|||
145722642|NCT01079663|525502489|FG000|Overall Study|Adverse Event|0|||
145722643|NCT01079663|525502490|FG001|Overall Study|Adverse Event|2|||
145722644|NCT01079663|525502489|FG000|Overall Study|Protocol Violation|0|||
145722645|NCT01079663|525502490|FG001|Overall Study|Protocol Violation|2|||
145722646|NCT03587974|525502491|FG000|Overall Study|caregiver demented, care recipient died|3|||
145722647|NCT03587974|525502492|FG001|Overall Study|caregiver demented, care recipient died|3|||
145722648|NCT03587974|525502491|FG000|Overall Study|Withdrawal by Subject|2|||
145722649|NCT03587974|525502492|FG001|Overall Study|Withdrawal by Subject|1|||
145722650|NCT00372229|525502495|FG000|Study Phase|Graft loss|0|||
145722651|NCT00372229|525502496|FG001|Study Phase|Graft loss|3|||
145722652|NCT00372229|525502495|FG000|Study Phase|Protocol Violation|3|||
145722653|NCT00372229|525502496|FG001|Study Phase|Protocol Violation|4|||
145722654|NCT00372229|525502495|FG000|Study Phase|Consent withdrawn|16|||
145722655|NCT00372229|525502496|FG001|Study Phase|Consent withdrawn|14|||
145722656|NCT00372229|525502495|FG000|Study Phase|Refused treatment/did not cooperate|3|||
145722657|NCT00372229|525502496|FG001|Study Phase|Refused treatment/did not cooperate|1|||
145722658|NCT00372229|525502495|FG000|Study Phase|Death|3|||
145722659|NCT00372229|525502496|FG001|Study Phase|Death|2|||
145722660|NCT00372229|525502495|FG000|Study Phase|Reason not specified|3|||
145722661|NCT00372229|525502496|FG001|Study Phase|Reason not specified|2|||
145722662|NCT00372229|525502495|FG000|Study Phase|Lost to Follow-up|3|||
145722663|NCT00372229|525502496|FG001|Study Phase|Lost to Follow-up|3|||
145382066|NCT00862459|524250507|FG000|Overall Study|Intravenous (IV) site problems|1|||
145382067|NCT00862459|524250508|FG001|Overall Study|Intravenous (IV) site problems|0|||
145382068|NCT00862459|524250509|FG002|Overall Study|Intravenous (IV) site problems|1|||
145382069|NCT00862459|524250507|FG000|Overall Study|Unable to hold still for imaging|0|||
145382070|NCT00862459|524250508|FG001|Overall Study|Unable to hold still for imaging|1|||
145382071|NCT00862459|524250509|FG002|Overall Study|Unable to hold still for imaging|0|||
145382072|NCT00862459|524250507|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
145382073|NCT00862459|524250508|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
145382074|NCT00862459|524250509|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
145382075|NCT00862459|524250507|FG000|Overall Study|Administrative problems|0|||
145382076|NCT00862459|524250508|FG001|Overall Study|Administrative problems|1|||
145382077|NCT00862459|524250509|FG002|Overall Study|Administrative problems|0|||
145382078|NCT00564395|524250514|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
145382079|NCT00564395|524250515|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
145382080|NCT00564395|524250514|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
145382081|NCT00564395|524250515|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
145382082|NCT00474786|524250522|FG000|Overall Study|Not Meeting Study Criteria|0|||
145382083|NCT00474786|524250523|FG001|Overall Study|Not Meeting Study Criteria|1|||
145382084|NCT00474786|524250522|FG000|Overall Study|Investigator Request|2|||
145382085|NCT00474786|524250523|FG001|Overall Study|Investigator Request|1|||
145382086|NCT00474786|524250522|FG000|Overall Study|Death|189|||
145382087|NCT00474786|524250523|FG001|Overall Study|Death|170|||
145382088|NCT00474786|524250522|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
145382089|NCT00474786|524250523|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
145382090|NCT00474786|524250522|FG000|Overall Study|Lost to Follow-up|4|||
145382091|NCT00474786|524250523|FG001|Overall Study|Lost to Follow-up|7|||
145382092|NCT00474786|524250522|FG000|Overall Study|Protocol Violation|2|||
145382093|NCT00474786|524250523|FG001|Overall Study|Protocol Violation|0|||
145382094|NCT00474786|524250522|FG000|Overall Study|Withdrawal by Subject|15|||
145382095|NCT00474786|524250523|FG001|Overall Study|Withdrawal by Subject|15|||
145382096|NCT00474786|524250522|FG000|Overall Study|Other|5|||
145382097|NCT00474786|524250523|FG001|Overall Study|Other|0|||
145382098|NCT04776018|524250524|FG000|Overall Study|Death|0|||
145382099|NCT04776018|524250525|FG001|Overall Study|Death|1|||
145382100|NCT04776018|524250526|FG002|Overall Study|Death|4|||
145382101|NCT04776018|524250527|FG003|Overall Study|Death|1|||
145382102|NCT04776018|524250528|FG004|Overall Study|Death|4|||
145382103|NCT04776018|524250529|FG005|Overall Study|Death|0|||
145382104|NCT04776018|524250530|FG006|Overall Study|Death|0|||
145382105|NCT04776018|524250524|FG000|Overall Study|Study terminated by sponsor|2|||
145382106|NCT04776018|524250525|FG001|Overall Study|Study terminated by sponsor|1|||
145382107|NCT04776018|524250526|FG002|Overall Study|Study terminated by sponsor|4|||
145382108|NCT04776018|524250527|FG003|Overall Study|Study terminated by sponsor|0|||
145382109|NCT04776018|524250528|FG004|Overall Study|Study terminated by sponsor|3|||
145382110|NCT04776018|524250529|FG005|Overall Study|Study terminated by sponsor|0|||
145382111|NCT04776018|524250530|FG006|Overall Study|Study terminated by sponsor|0|||
145382112|NCT04776018|524250524|FG000|Overall Study|Withdrawal by Subject|1|||
145722664|NCT00372229|525502495|FG000|Follow-Up Phase|Graft loss|8|||
145722665|NCT00372229|525502496|FG001|Follow-Up Phase|Graft loss|7|||
145722666|NCT00372229|525502495|FG000|Follow-Up Phase|Consent withdrawn|13|||
145722667|NCT00372229|525502496|FG001|Follow-Up Phase|Consent withdrawn|19|||
145722668|NCT00372229|525502495|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
145722669|NCT00372229|525502496|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
145722670|NCT00372229|525502495|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
145722671|NCT00372229|525502496|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
145722672|NCT00372229|525502495|FG000|Follow-Up Phase|Death|9|||
145722673|NCT00372229|525502496|FG001|Follow-Up Phase|Death|12|||
145722674|NCT00372229|525502495|FG000|Follow-Up Phase|Administrative|1|||
145722675|NCT00372229|525502496|FG001|Follow-Up Phase|Administrative|0|||
145722676|NCT00372229|525502495|FG000|Follow-Up Phase|Reason not specified|2|||
145722677|NCT00372229|525502496|FG001|Follow-Up Phase|Reason not specified|3|||
145722678|NCT00372229|525502495|FG000|Follow-Up Phase|Lost to Follow-up|12|||
145722679|NCT00372229|525502496|FG001|Follow-Up Phase|Lost to Follow-up|10|||
145722680|NCT03536143|525502497|FG000|Overall Study|Early termination, Sponsor decision|1|||
145722681|NCT01878214|525502498|FG000|Overall Study|Withdrawal by Subject|18|||
145722682|NCT01878214|525502499|FG001|Overall Study|Withdrawal by Subject|7|||
145722683|NCT01878214|525502498|FG000|Overall Study|Death|0|||
145722684|NCT01878214|525502499|FG001|Overall Study|Death|1|||
145722685|NCT01878214|525502498|FG000|Overall Study|Lost to Follow-up|35|||
145722686|NCT01878214|525502499|FG001|Overall Study|Lost to Follow-up|36|||
145722687|NCT01174160|525502500|FG000|Overall Study|Adverse Event|1|||
145722688|NCT01174160|525502501|FG001|Overall Study|Adverse Event|0|||
145722689|NCT01174160|525502500|FG000|Overall Study|Lost to Follow-up|1|||
145722690|NCT01174160|525502501|FG001|Overall Study|Lost to Follow-up|0|||
145722691|NCT01174160|525502500|FG000|Overall Study|Physician Decision|1|||
145722692|NCT01174160|525502501|FG001|Overall Study|Physician Decision|0|||
145722693|NCT01174160|525502500|FG000|Overall Study|Protocol Violation|4|||
145722694|NCT01174160|525502501|FG001|Overall Study|Protocol Violation|6|||
145722695|NCT01174160|525502500|FG000|Overall Study|Withdrawal by Subject|1|||
145722696|NCT01174160|525502501|FG001|Overall Study|Withdrawal by Subject|0|||
145722697|NCT01590017|525502502|FG000|Overall Study|Adverse Event|1|||
145722698|NCT01590017|525502502|FG000|Overall Study|Withdrawal by Subject|1|||
145722699|NCT01590017|525502502|FG000|Overall Study|Lack of Efficacy|1|||
145722700|NCT01590017|525502502|FG000|Overall Study|Physician Decision|1|||
145722701|NCT02527343|525502503|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
145722702|NCT02527343|525502504|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
145722703|NCT02527343|525502505|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
145722704|NCT02527343|525502506|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
145722705|NCT02527343|525502507|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
145722706|NCT02527343|525502508|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
145722707|NCT02527343|525502503|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
145722708|NCT02527343|525502504|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
145722709|NCT02527343|525502505|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
145722710|NCT02527343|525502506|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
145722711|NCT02527343|525502507|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
145722712|NCT02527343|525502508|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
145722713|NCT02527343|525502503|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145722714|NCT02527343|525502504|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
145722715|NCT02527343|525502505|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145722716|NCT02527343|525502506|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145722717|NCT02527343|525502507|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145722718|NCT02527343|525502508|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145722719|NCT02527343|525502503|FG000|RT Period: Weeks 1 to 52|Other|4|||
145722720|NCT02527343|525502504|FG001|RT Period: Weeks 1 to 52|Other|3|||
145722721|NCT02527343|525502505|FG002|RT Period: Weeks 1 to 52|Other|0|||
145722722|NCT02527343|525502506|FG003|RT Period: Weeks 1 to 52|Other|0|||
145722723|NCT02527343|525502507|FG004|RT Period: Weeks 1 to 52|Other|0|||
145722724|NCT02527343|525502508|FG005|RT Period: Weeks 1 to 52|Other|0|||
145722725|NCT02527343|525502503|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
145722726|NCT02527343|525502504|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
145722727|NCT02527343|525502505|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
145722728|NCT02527343|525502506|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
145722729|NCT02527343|525502507|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
145722730|NCT02527343|525502508|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
145722731|NCT02527343|525502503|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145722732|NCT02527343|525502504|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145722733|NCT02527343|525502505|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145722734|NCT02527343|525502506|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
145722735|NCT02527343|525502507|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145722736|NCT02527343|525502508|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
145722737|NCT02527343|525502503|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
145722738|NCT02527343|525502504|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
145722739|NCT02527343|525502505|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
145722740|NCT02527343|525502506|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
145382113|NCT04776018|524250525|FG001|Overall Study|Withdrawal by Subject|0|||
145382114|NCT04776018|524250526|FG002|Overall Study|Withdrawal by Subject|0|||
145382115|NCT04776018|524250527|FG003|Overall Study|Withdrawal by Subject|2|||
145382116|NCT04776018|524250528|FG004|Overall Study|Withdrawal by Subject|1|||
145722741|NCT02527343|525502507|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
145722742|NCT02527343|525502508|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
145722743|NCT02527343|525502503|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
145382117|NCT04776018|524250529|FG005|Overall Study|Withdrawal by Subject|0|||
145382118|NCT04776018|524250530|FG006|Overall Study|Withdrawal by Subject|0|||
145382119|NCT04776018|524250524|FG000|Overall Study|Other|0|||
145382120|NCT04776018|524250525|FG001|Overall Study|Other|1|||
145382121|NCT04776018|524250526|FG002|Overall Study|Other|1|||
145382122|NCT04776018|524250527|FG003|Overall Study|Other|0|||
145382123|NCT04776018|524250528|FG004|Overall Study|Other|0|||
145382124|NCT04776018|524250529|FG005|Overall Study|Other|0|||
145382125|NCT04776018|524250530|FG006|Overall Study|Other|0|||
145382126|NCT04776018|524250524|FG000|Overall Study|Lost to Follow-up|0|||
145382127|NCT04776018|524250525|FG001|Overall Study|Lost to Follow-up|0|||
145382128|NCT04776018|524250526|FG002|Overall Study|Lost to Follow-up|1|||
145382129|NCT04776018|524250527|FG003|Overall Study|Lost to Follow-up|0|||
145382130|NCT04776018|524250528|FG004|Overall Study|Lost to Follow-up|0|||
145382131|NCT04776018|524250529|FG005|Overall Study|Lost to Follow-up|0|||
145382132|NCT04776018|524250530|FG006|Overall Study|Lost to Follow-up|0|||
145382133|NCT00394433|524250531|FG000|Overall Study|Adverse Event|2|||
145382134|NCT00394433|524250531|FG000|Overall Study|Alternative Therapy|1|||
145382135|NCT00594386|524250534|FG000|Overall Study|Major protocol violation|2|||
145382136|NCT00594386|524250534|FG000|Overall Study|Lack of Efficacy|12|||
145382137|NCT00594386|524250534|FG000|Overall Study|Adverse Event|68|||
145382138|NCT00594386|524250534|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
145382139|NCT00594386|524250534|FG000|Overall Study|Subject withdrew consent|35|||
145382140|NCT00594386|524250534|FG000|Overall Study|Study ended per sponsor|115|||
145382141|NCT00594386|524250534|FG000|Overall Study|Lost to Follow-up|6|||
145382142|NCT00594386|524250534|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
145382143|NCT00594386|524250534|FG000|Overall Study|Other: Subject moved to Seattle|1|||
145382144|NCT00594386|524250534|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
145382145|NCT00594386|524250534|FG000|Overall Study|Other: Study terminated per investigator|2|||
145382146|NCT00594386|524250534|FG000|Overall Study|Other: Sponsor closure of study|1|||
145382147|NCT00594386|524250534|FG000|Overall Study|Other: Site terminated participation|1|||
145382148|NCT00594386|524250534|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
145382149|NCT00594386|524250534|FG000|Overall Study|Other: Loss of drivers license|1|||
145382150|NCT03168919|524250535|FG000|Overall Study|Withdrawal by Subject|2|||
145382151|NCT01085136|524250536|FG000|Part A|Other Adverse event|223|||
145382152|NCT01085136|524250537|FG001|Part A|Other Adverse event|0|||
145382153|NCT01085136|524250538|FG002|Part A|Other Adverse event|0|||
145382154|NCT01085136|524250536|FG000|Part A|Protocol Violation|3|||
145382155|NCT01085136|524250537|FG001|Part A|Protocol Violation|0|||
145382156|NCT01085136|524250538|FG002|Part A|Protocol Violation|0|||
145382157|NCT01085136|524250536|FG000|Part A|Lost to Follow-up|3|||
145382158|NCT01085136|524250537|FG001|Part A|Lost to Follow-up|0|||
145382159|NCT01085136|524250538|FG002|Part A|Lost to Follow-up|0|||
145382160|NCT01085136|524250536|FG000|Part A|Refusal to continue trial medication|64|||
145382161|NCT01085136|524250537|FG001|Part A|Refusal to continue trial medication|0|||
145382162|NCT01085136|524250538|FG002|Part A|Refusal to continue trial medication|0|||
145382163|NCT01085136|524250536|FG000|Part A|Other reason not defined above|30|||
145382164|NCT01085136|524250537|FG001|Part A|Other reason not defined above|0|||
145382165|NCT01085136|524250538|FG002|Part A|Other reason not defined above|0|||
145722744|NCT02527343|525502504|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
145722745|NCT02527343|525502505|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
145722746|NCT02527343|525502506|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
145722747|NCT02527343|525502507|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
145722748|NCT02527343|525502508|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
145722749|NCT02527343|525502503|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
145722750|NCT02527343|525502504|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
145722751|NCT02527343|525502505|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
145722752|NCT02527343|525502506|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
145722753|NCT02527343|525502507|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
145722754|NCT02527343|525502508|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
145722755|NCT02527343|525502503|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
145722756|NCT02527343|525502504|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
145382166|NCT01085136|524250536|FG000|Part B|Other AE|0|||
145382167|NCT01085136|524250537|FG001|Part B|Other AE|29|||
145382168|NCT01085136|524250538|FG002|Part B|Other AE|8|||
145382169|NCT01085136|524250536|FG000|Part B|Refusal to continue trial medication|0|||
145722757|NCT02527343|525502505|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
145722758|NCT02527343|525502506|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
145722759|NCT02527343|525502507|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
145722760|NCT02527343|525502508|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
145722761|NCT02527343|525502503|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
145722762|NCT02527343|525502504|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
145722763|NCT02527343|525502505|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
145722764|NCT02527343|525502506|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
145722765|NCT02527343|525502507|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
145722766|NCT02527343|525502508|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
145722767|NCT02527343|525502503|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
145722768|NCT02527343|525502504|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
145722769|NCT02527343|525502505|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
145722770|NCT02527343|525502506|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
145722771|NCT02527343|525502507|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
145722772|NCT02527343|525502508|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
145722773|NCT02527343|525502503|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
145722774|NCT02527343|525502504|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
145722775|NCT02527343|525502505|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
145722776|NCT02527343|525502506|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
145722777|NCT02527343|525502507|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
145722778|NCT02527343|525502508|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
145722779|NCT05559099|525502513|FG000|Overall Study|Death|5|||
145722780|NCT05559099|525502514|FG001|Overall Study|Death|4|||
145722781|NCT05559099|525502513|FG000|Overall Study|Lost to Follow-up|0|||
145722782|NCT05559099|525502514|FG001|Overall Study|Lost to Follow-up|2|||
145722783|NCT05559099|525502513|FG000|Overall Study|Adverse Event|1|||
145722784|NCT05559099|525502514|FG001|Overall Study|Adverse Event|1|||
145722785|NCT04018092|525502515|FG000|Overall Study|Withdrawal by Subject|1|||
145722786|NCT04018092|525502516|FG001|Overall Study|Withdrawal by Subject|1|||
145722787|NCT04018092|525502515|FG000|Overall Study|Withdrawal by Subject|1|||
145722788|NCT04018092|525502516|FG001|Overall Study|Withdrawal by Subject|1|||
145722789|NCT04745026|525502519|FG000|Overall Study|Physician Decision|1|||
145722790|NCT04745026|525502520|FG001|Overall Study|Physician Decision|0|||
145722791|NCT04745026|525502519|FG000|Overall Study|Adverse Event|2|||
145722792|NCT04745026|525502520|FG001|Overall Study|Adverse Event|2|||
145722793|NCT04745026|525502519|FG000|Overall Study|Protocol Violation|1|||
145722794|NCT04745026|525502520|FG001|Overall Study|Protocol Violation|3|||
145722795|NCT04745026|525502519|FG000|Overall Study|Lost to Follow-up|4|||
145722796|NCT04745026|525502520|FG001|Overall Study|Lost to Follow-up|3|||
145722797|NCT04745026|525502519|FG000|Overall Study|Withdrawal by Subject|5|||
145722798|NCT04745026|525502520|FG001|Overall Study|Withdrawal by Subject|5|||
145722799|NCT05478499|525502521|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
145722800|NCT05478499|525502522|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
145722801|NCT05478499|525502521|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
145722802|NCT05478499|525502522|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
145722803|NCT05478499|525502521|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
145722804|NCT05478499|525502522|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
145722805|NCT05478499|525502521|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
145722806|NCT05478499|525502522|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
145722807|NCT05478499|525502521|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
145722808|NCT05478499|525502522|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
145722809|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
145722810|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
145722811|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
145722812|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
145722813|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
145722814|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
145722815|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
145722816|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
145722817|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
145722818|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
145722819|NCT05478499|525502521|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
145722820|NCT05478499|525502522|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
145722821|NCT04426851|525502523|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
145722822|NCT04426851|525502524|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
145722823|NCT04426851|525502523|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
145722824|NCT04426851|525502524|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
145722825|NCT03256851|525502525|FG000|Overall Study|Withdrawal by Subject|1|||
145722826|NCT03256851|525502526|FG001|Overall Study|Withdrawal by Subject|0|||
145722827|NCT00903630|525502533|FG000|Phase 2|Adverse Event|0|||
145722828|NCT00903630|525502534|FG001|Phase 2|Adverse Event|0|||
145722829|NCT00903630|525502535|FG002|Phase 2|Adverse Event|1|||
145722830|NCT01831856|525502538|FG000|Overall Study|Adverse Event|5|||
145722831|NCT01831856|525502539|FG001|Overall Study|Adverse Event|8|||
145722832|NCT01831856|525502538|FG000|Overall Study|Lack of Efficacy|13|||
145722833|NCT01831856|525502539|FG001|Overall Study|Lack of Efficacy|11|||
145722834|NCT01831856|525502538|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
145722835|NCT01831856|525502539|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
145722836|NCT05208866|525502540|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
145722837|NCT02581631|525502552|FG000|Overall Study|Disease progression|29|||
145722838|NCT02581631|525502553|FG001|Overall Study|Disease progression|19|||
145722839|NCT02581631|525502554|FG002|Overall Study|Disease progression|13|||
145722840|NCT02581631|525502555|FG003|Overall Study|Disease progression|5|||
145722841|NCT02581631|525502556|FG004|Overall Study|Disease progression|8|||
145722842|NCT02581631|525502552|FG000|Overall Study|Study drug toxicity|4|||
145722843|NCT02581631|525502553|FG001|Overall Study|Study drug toxicity|6|||
145722844|NCT02581631|525502554|FG002|Overall Study|Study drug toxicity|7|||
145722845|NCT02581631|525502555|FG003|Overall Study|Study drug toxicity|0|||
145722846|NCT02581631|525502556|FG004|Overall Study|Study drug toxicity|3|||
145722847|NCT02581631|525502552|FG000|Overall Study|AE unrelated to study drug|3|||
145722848|NCT02581631|525502553|FG001|Overall Study|AE unrelated to study drug|1|||
145722849|NCT02581631|525502554|FG002|Overall Study|AE unrelated to study drug|1|||
145722850|NCT02581631|525502555|FG003|Overall Study|AE unrelated to study drug|0|||
145722851|NCT02581631|525502556|FG004|Overall Study|AE unrelated to study drug|2|||
145722852|NCT02581631|525502552|FG000|Overall Study|Request to discontinue|1|||
145722853|NCT02581631|525502553|FG001|Overall Study|Request to discontinue|0|||
145722854|NCT02581631|525502554|FG002|Overall Study|Request to discontinue|3|||
145722855|NCT02581631|525502555|FG003|Overall Study|Request to discontinue|0|||
145722856|NCT02581631|525502556|FG004|Overall Study|Request to discontinue|1|||
145722857|NCT02581631|525502552|FG000|Overall Study|participant withdrew consent|3|||
145722858|NCT02581631|525502553|FG001|Overall Study|participant withdrew consent|0|||
145722859|NCT02581631|525502554|FG002|Overall Study|participant withdrew consent|1|||
145722860|NCT02581631|525502555|FG003|Overall Study|participant withdrew consent|0|||
145722861|NCT02581631|525502556|FG004|Overall Study|participant withdrew consent|0|||
145722862|NCT02581631|525502552|FG000|Overall Study|Maximum clinical benefit|1|||
145722863|NCT02581631|525502553|FG001|Overall Study|Maximum clinical benefit|7|||
145722864|NCT02581631|525502554|FG002|Overall Study|Maximum clinical benefit|1|||
145722865|NCT02581631|525502555|FG003|Overall Study|Maximum clinical benefit|3|||
145722866|NCT02581631|525502556|FG004|Overall Study|Maximum clinical benefit|13|||
145722867|NCT02581631|525502552|FG000|Overall Study|Other Reasons|1|||
145722868|NCT02581631|525502553|FG001|Overall Study|Other Reasons|0|||
145722869|NCT02581631|525502554|FG002|Overall Study|Other Reasons|2|||
145722870|NCT02581631|525502555|FG003|Overall Study|Other Reasons|2|||
145722871|NCT02581631|525502556|FG004|Overall Study|Other Reasons|3|||
145722872|NCT02581631|525502552|FG000|Overall Study|Poor/Non-Compliance|0|||
145722873|NCT02581631|525502553|FG001|Overall Study|Poor/Non-Compliance|0|||
145722874|NCT02581631|525502554|FG002|Overall Study|Poor/Non-Compliance|1|||
145722875|NCT02581631|525502555|FG003|Overall Study|Poor/Non-Compliance|0|||
145722876|NCT02581631|525502556|FG004|Overall Study|Poor/Non-Compliance|0|||
145722877|NCT00986973|525502557|FG000|Overall Study|Withdrawn by study team|1|||
145722878|NCT00598273|525502558|FG000|Overall Study|Adverse Event|4|||
145722879|NCT00598273|525502559|FG001|Overall Study|Adverse Event|5|||
145722880|NCT00598273|525502560|FG002|Overall Study|Adverse Event|2|||
145722881|NCT00598273|525502558|FG000|Overall Study|Death|6|||
145722882|NCT00598273|525502559|FG001|Overall Study|Death|12|||
145722883|NCT00598273|525502560|FG002|Overall Study|Death|8|||
145722884|NCT00598273|525502558|FG000|Overall Study|Lost to Follow-up|8|||
145722885|NCT00598273|525502559|FG001|Overall Study|Lost to Follow-up|3|||
145722886|NCT00598273|525502560|FG002|Overall Study|Lost to Follow-up|5|||
145722887|NCT00598273|525502558|FG000|Overall Study|Physician Decision|0|||
145722888|NCT00598273|525502559|FG001|Overall Study|Physician Decision|0|||
145722889|NCT00598273|525502560|FG002|Overall Study|Physician Decision|1|||
145722890|NCT00598273|525502558|FG000|Overall Study|Withdrawal by Subject|12|||
145722891|NCT00598273|525502559|FG001|Overall Study|Withdrawal by Subject|10|||
145722892|NCT00598273|525502560|FG002|Overall Study|Withdrawal by Subject|10|||
145722893|NCT00598273|525502558|FG000|Overall Study|Noncompliance|3|||
145722894|NCT00598273|525502559|FG001|Overall Study|Noncompliance|2|||
145722895|NCT00598273|525502560|FG002|Overall Study|Noncompliance|3|||
145722896|NCT00598273|525502558|FG000|Overall Study|Relocation|0|||
145722897|NCT00598273|525502559|FG001|Overall Study|Relocation|2|||
145722898|NCT00598273|525502560|FG002|Overall Study|Relocation|4|||
145722899|NCT00598273|525502558|FG000|Overall Study|Renal transplant|1|||
145722900|NCT00598273|525502559|FG001|Overall Study|Renal transplant|0|||
145722901|NCT00598273|525502560|FG002|Overall Study|Renal transplant|1|||
145722902|NCT00598273|525502558|FG000|Overall Study|Site elected to close|1|||
145722903|NCT00598273|525502559|FG001|Overall Study|Site elected to close|0|||
145722904|NCT00598273|525502560|FG002|Overall Study|Site elected to close|0|||
145722905|NCT00598273|525502558|FG000|Overall Study|Started dialysis|6|||
145722906|NCT00598273|525502559|FG001|Overall Study|Started dialysis|4|||
145722907|NCT00598273|525502560|FG002|Overall Study|Started dialysis|5|||
145722908|NCT03426605|525502561|FG000|Overall Study|AML relapse or progression|2|||
145722909|NCT03426605|525502562|FG001|Overall Study|AML relapse or progression|1|||
145722910|NCT03426605|525502563|FG002|Overall Study|AML relapse or progression|2|||
145722911|NCT03426605|525502564|FG003|Overall Study|AML relapse or progression|2|||
145382170|NCT01085136|524250537|FG001|Part B|Refusal to continue trial medication|12|||
145382171|NCT01085136|524250538|FG002|Part B|Refusal to continue trial medication|7|||
145382172|NCT01085136|524250536|FG000|Part B|Not treated|0|||
145382173|NCT01085136|524250537|FG001|Part B|Not treated|4|||
145382174|NCT01085136|524250538|FG002|Part B|Not treated|8|||
145382175|NCT01085136|524250536|FG000|Part B|Other reason not defined above|0|||
145382176|NCT01085136|524250537|FG001|Part B|Other reason not defined above|6|||
145382177|NCT01085136|524250538|FG002|Part B|Other reason not defined above|3|||
145382178|NCT02195427|524250539|FG000|Overall Study|Did not consent to study extension|13|||
145722912|NCT03426605|525502561|FG000|Overall Study|Treatment failure|3|||
145382179|NCT02195427|524250540|FG001|Overall Study|Did not consent to study extension|9|||
145382180|NCT02195427|524250539|FG000|Overall Study|Withdrawal by Subject|4|||
145382181|NCT02195427|524250540|FG001|Overall Study|Withdrawal by Subject|2|||
145382182|NCT02195427|524250539|FG000|Overall Study|Lost to Follow-up|0|||
145382183|NCT02195427|524250540|FG001|Overall Study|Lost to Follow-up|1|||
145382184|NCT02195427|524250539|FG000|Overall Study|Protocol Violation|7|||
145382185|NCT02195427|524250540|FG001|Overall Study|Protocol Violation|14|||
145382186|NCT02195427|524250539|FG000|Overall Study|Conditional re-treatment at W52|2|||
145382187|NCT02195427|524250540|FG001|Overall Study|Conditional re-treatment at W52|1|||
145382188|NCT01210144|524250544|FG000|Overall Study|Lack of ovarian response|1|||
145382189|NCT01210144|524250545|FG001|Overall Study|Lack of ovarian response|0|||
145382190|NCT01210144|524250544|FG000|Overall Study|No fertilization|1|||
145382191|NCT01210144|524250545|FG001|Overall Study|No fertilization|0|||
145382192|NCT01210144|524250544|FG000|Overall Study|No transfer|1|||
145382193|NCT01210144|524250545|FG001|Overall Study|No transfer|0|||
145722913|NCT03426605|525502562|FG001|Overall Study|Treatment failure|2|||
145722914|NCT03426605|525502563|FG002|Overall Study|Treatment failure|0|||
145722915|NCT03426605|525502564|FG003|Overall Study|Treatment failure|0|||
145722916|NCT03426605|525502561|FG000|Overall Study|Adverse Event|1|||
145722917|NCT03426605|525502562|FG001|Overall Study|Adverse Event|0|||
145722918|NCT03426605|525502563|FG002|Overall Study|Adverse Event|1|||
145722919|NCT03426605|525502564|FG003|Overall Study|Adverse Event|1|||
145722920|NCT03426605|525502561|FG000|Overall Study|Withdrawal by Subject|0|||
145722921|NCT03426605|525502562|FG001|Overall Study|Withdrawal by Subject|0|||
145722922|NCT03426605|525502563|FG002|Overall Study|Withdrawal by Subject|1|||
145722923|NCT03426605|525502564|FG003|Overall Study|Withdrawal by Subject|1|||
145722924|NCT01815138|525502567|FG000|Overall Study|Withdrawal by Subject|0|||
145722925|NCT01815138|525502568|FG001|Overall Study|Withdrawal by Subject|1|||
145382194|NCT02678000|524250546|FG000|PART 2|Adverse Event|0|||
145382195|NCT02678000|524250547|FG001|PART 2|Adverse Event|0|||
145382196|NCT02678000|524250548|FG002|PART 2|Adverse Event|2|||
145382197|NCT02678000|524250549|FG003|PART 2|Adverse Event|1|||
145382198|NCT02678000|524250550|FG004|PART 2|Adverse Event|0|||
145382199|NCT02678000|524250546|FG000|PART 2|Withdrawal by Subject|0|||
145382200|NCT02678000|524250547|FG001|PART 2|Withdrawal by Subject|0|||
145382201|NCT02678000|524250548|FG002|PART 2|Withdrawal by Subject|1|||
145382202|NCT02678000|524250549|FG003|PART 2|Withdrawal by Subject|0|||
145382203|NCT02678000|524250550|FG004|PART 2|Withdrawal by Subject|0|||
145382204|NCT02360475|524250551|FG000|Overall Study|Lost to Follow-up|4|||
145382205|NCT02360475|524250552|FG001|Overall Study|Lost to Follow-up|12|||
145722926|NCT01815138|525502567|FG000|Overall Study|Physician Decision|8|||
145722927|NCT01815138|525502568|FG001|Overall Study|Physician Decision|5|||
145722928|NCT02308020|525502571|FG000|Overall Study|Lost to Follow-up|1|||
145722929|NCT02308020|525502572|FG001|Overall Study|Lost to Follow-up|7|||
145722930|NCT02308020|525502573|FG002|Overall Study|Lost to Follow-up|0|||
145722931|NCT02308020|525502574|FG003|Overall Study|Lost to Follow-up|0|||
145722932|NCT02308020|525502575|FG004|Overall Study|Lost to Follow-up|1|||
145722933|NCT02308020|525502576|FG005|Overall Study|Lost to Follow-up|2|||
145722934|NCT02308020|525502571|FG000|Overall Study|Sponsor Decision|0|||
145722935|NCT02308020|525502572|FG001|Overall Study|Sponsor Decision|8|||
145722936|NCT02308020|525502573|FG002|Overall Study|Sponsor Decision|0|||
145722937|NCT02308020|525502574|FG003|Overall Study|Sponsor Decision|2|||
145722938|NCT02308020|525502575|FG004|Overall Study|Sponsor Decision|2|||
145722939|NCT02308020|525502576|FG005|Overall Study|Sponsor Decision|1|||
145722940|NCT02308020|525502571|FG000|Overall Study|Withdrawal by Subject|3|||
145722941|NCT02308020|525502572|FG001|Overall Study|Withdrawal by Subject|5|||
145722942|NCT02308020|525502573|FG002|Overall Study|Withdrawal by Subject|3|||
145722943|NCT02308020|525502574|FG003|Overall Study|Withdrawal by Subject|2|||
145722944|NCT02308020|525502575|FG004|Overall Study|Withdrawal by Subject|1|||
145722945|NCT02308020|525502576|FG005|Overall Study|Withdrawal by Subject|2|||
145722946|NCT01270971|525502577|FG000|Overall Study|Withdrawal by Subject|24|||
145722947|NCT01270971|525502578|FG001|Overall Study|Withdrawal by Subject|11|||
145722948|NCT01270971|525502577|FG000|Overall Study|Lost to Follow-up|18|||
145722949|NCT01270971|525502578|FG001|Overall Study|Lost to Follow-up|5|||
145722950|NCT01270971|525502577|FG000|Overall Study|Adverse Event|1|||
145722951|NCT01270971|525502578|FG001|Overall Study|Adverse Event|2|||
145722952|NCT01270971|525502577|FG000|Overall Study|Non compliance|2|||
145722953|NCT01270971|525502578|FG001|Overall Study|Non compliance|2|||
145722954|NCT01270971|525502577|FG000|Overall Study|Non-specific|7|||
145722955|NCT01270971|525502578|FG001|Overall Study|Non-specific|3|||
145722956|NCT02003573|525502582|FG000|Overall Study|Progressive disease|2|||
145722957|NCT02003573|525502583|FG001|Overall Study|Progressive disease|0|||
145722958|NCT02003573|525502584|FG002|Overall Study|Progressive disease|1|||
145722959|NCT02003573|525502582|FG000|Overall Study|Other Adverse event|0|||
145722960|NCT02003573|525502583|FG001|Overall Study|Other Adverse event|1|||
145722961|NCT02003573|525502584|FG002|Overall Study|Other Adverse event|1|||
145722962|NCT02003573|525502582|FG000|Overall Study|Refuse to take trial medication|0|||
145722963|NCT02003573|525502583|FG001|Overall Study|Refuse to take trial medication|1|||
145722964|NCT02003573|525502584|FG002|Overall Study|Refuse to take trial medication|1|||
145722965|NCT02003573|525502582|FG000|Overall Study|Other than specified|1|||
145722966|NCT02003573|525502583|FG001|Overall Study|Other than specified|2|||
145722967|NCT02003573|525502584|FG002|Overall Study|Other than specified|3|||
145722968|NCT00704405|525502587|FG000|Overall Study (NC Population)|Adverse Event|1|||
145722969|NCT00704405|525502588|FG001|Overall Study (NC Population)|Adverse Event|0|||
145722970|NCT00704405|525502589|FG002|Overall Study (NC Population)|Adverse Event|0|||
145722971|NCT00704405|525502590|FG003|Overall Study (NC Population)|Adverse Event|0|||
145722972|NCT00704405|525502591|FG004|Overall Study (NC Population)|Adverse Event|0|||
145722973|NCT00704405|525502587|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
145722974|NCT00704405|525502588|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
145722975|NCT00704405|525502589|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
145722976|NCT00704405|525502590|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
145722977|NCT00704405|525502591|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
145722978|NCT00704405|525502587|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
145722979|NCT00704405|525502588|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
145722980|NCT00704405|525502589|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
145722981|NCT00704405|525502590|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
145722982|NCT00704405|525502591|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
145722983|NCT00704405|525502587|FG000|Overall Study (NC Population)|Other|0|||
145722984|NCT00704405|525502588|FG001|Overall Study (NC Population)|Other|0|||
145722985|NCT00704405|525502589|FG002|Overall Study (NC Population)|Other|0|||
145722986|NCT00704405|525502590|FG003|Overall Study (NC Population)|Other|0|||
145722987|NCT00704405|525502591|FG004|Overall Study (NC Population)|Other|1|||
145722988|NCT00704405|525502587|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
145722989|NCT00704405|525502588|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
145722990|NCT00704405|525502589|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
145722991|NCT00704405|525502590|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
145722992|NCT00704405|525502591|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
145722993|NCT00704405|525502587|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
145722994|NCT00704405|525502588|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
145722995|NCT00704405|525502589|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
145722996|NCT00704405|525502590|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
145722997|NCT00704405|525502591|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
145722998|NCT01395888|525502592|FG000|2-week Run-in Period|Adverse Event|2|||
145722999|NCT01395888|525502593|FG001|2-week Run-in Period|Adverse Event|0|||
145723000|NCT01395888|525502594|FG002|2-week Run-in Period|Adverse Event|0|||
145723001|NCT01395888|525502592|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
145723002|NCT01395888|525502593|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
145723003|NCT01395888|525502594|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
145723004|NCT01395888|525502592|FG000|2-week Run-in Period|Lost to Follow-up|1|||
145723005|NCT01395888|525502593|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145723006|NCT01395888|525502594|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145723007|NCT01395888|525502592|FG000|2-week Run-in Period|Protocol Violation|2|||
145723008|NCT01395888|525502593|FG001|2-week Run-in Period|Protocol Violation|0|||
145723009|NCT01395888|525502594|FG002|2-week Run-in Period|Protocol Violation|0|||
145723010|NCT01395888|525502592|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
145723011|NCT01395888|525502593|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145723012|NCT01395888|525502594|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145723013|NCT01395888|525502592|FG000|Treatment Period (TP)|Adverse Event|0|||
145723014|NCT01395888|525502593|FG001|Treatment Period (TP)|Adverse Event|7|||
145723015|NCT01395888|525502594|FG002|Treatment Period (TP)|Adverse Event|6|||
145493115|NCT01924845|524661166|FG000|Overall Study|Protocol Violation|1|||
145723016|NCT01395888|525502592|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
145723017|NCT01395888|525502593|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
145723018|NCT01395888|525502594|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
145723019|NCT01395888|525502592|FG000|Treatment Period (TP)|Protocol Violation|0|||
145723020|NCT01395888|525502593|FG001|Treatment Period (TP)|Protocol Violation|1|||
145723021|NCT01395888|525502594|FG002|Treatment Period (TP)|Protocol Violation|5|||
145723022|NCT01395888|525502592|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
145723023|NCT01395888|525502593|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
145723024|NCT01395888|525502594|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
145723025|NCT01395888|525502592|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
145382206|NCT02360475|524250553|FG002|Overall Study|Lost to Follow-up|6|||
145382207|NCT02360475|524250554|FG003|Overall Study|Lost to Follow-up|4|||
145382208|NCT02360475|524250551|FG000|Overall Study|Withdrawal by Subject|0|||
145382209|NCT02360475|524250552|FG001|Overall Study|Withdrawal by Subject|1|||
145382210|NCT02360475|524250553|FG002|Overall Study|Withdrawal by Subject|2|||
145382211|NCT02360475|524250554|FG003|Overall Study|Withdrawal by Subject|0|||
145382212|NCT02360475|524250551|FG000|Overall Study|Migrated/moved from study area|0|||
145382213|NCT02360475|524250552|FG001|Overall Study|Migrated/moved from study area|0|||
145382214|NCT02360475|524250553|FG002|Overall Study|Migrated/moved from study area|0|||
145382215|NCT02360475|524250554|FG003|Overall Study|Migrated/moved from study area|1|||
145382216|NCT03759366|524250556|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
145382217|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
145382218|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
145382219|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
145382220|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
145382221|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
145382222|NCT03759366|524250556|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
145382223|NCT04226495|524250557|FG000|Overall Study|Withdrawal by Subject|3|||
145382224|NCT04226495|524250558|FG001|Overall Study|Withdrawal by Subject|3|||
145382225|NCT04226495|524250557|FG000|Overall Study|PI discretion|3|||
145382226|NCT04226495|524250558|FG001|Overall Study|PI discretion|4|||
145382227|NCT00435019|524250559|FG000|Overall Study|Adverse Event|1|||
145382228|NCT00435019|524250560|FG001|Overall Study|Adverse Event|0|||
145382229|NCT00435019|524250559|FG000|Overall Study|Lack of Efficacy|1|||
145382230|NCT00435019|524250560|FG001|Overall Study|Lack of Efficacy|2|||
145382231|NCT00435019|524250559|FG000|Overall Study|Protocol Violation|3|||
145382232|NCT00435019|524250560|FG001|Overall Study|Protocol Violation|1|||
145382233|NCT00435019|524250559|FG000|Overall Study|Personal reasons for withdrawal|8|||
145382234|NCT00435019|524250560|FG001|Overall Study|Personal reasons for withdrawal|7|||
145382235|NCT00505661|524250565|FG000|Overall Study|Not Eligible|4|||
145382236|NCT04459598|524250568|FG000|Overall Study|Adverse Event|1|||
145382237|NCT04459598|524250569|FG001|Overall Study|Adverse Event|1|||
145382238|NCT01764659|524250570|FG000|Overall Study|Death|1|||
145382239|NCT01764659|524250570|FG000|Overall Study|Physician Decision|1|||
145382240|NCT01210352|524250571|FG000|Overall Study|Adverse Event|0|||
145382241|NCT01210352|524250572|FG001|Overall Study|Adverse Event|0|||
145382242|NCT01210352|524250573|FG002|Overall Study|Adverse Event|0|||
145382243|NCT01210352|524250574|FG003|Overall Study|Adverse Event|0|||
145382244|NCT01210352|524250575|FG004|Overall Study|Adverse Event|0|||
145382245|NCT01210352|524250576|FG005|Overall Study|Adverse Event|0|||
145382246|NCT01210352|524250577|FG006|Overall Study|Adverse Event|0|||
145382247|NCT01210352|524250578|FG007|Overall Study|Adverse Event|2|||
145382248|NCT01210352|524250579|FG008|Overall Study|Adverse Event|1|||
145382249|NCT01210352|524250571|FG000|Overall Study|Lack of Efficacy|0|||
145382250|NCT01210352|524250572|FG001|Overall Study|Lack of Efficacy|0|||
145382251|NCT01210352|524250573|FG002|Overall Study|Lack of Efficacy|0|||
145382252|NCT01210352|524250574|FG003|Overall Study|Lack of Efficacy|0|||
145382253|NCT01210352|524250575|FG004|Overall Study|Lack of Efficacy|0|||
145382254|NCT01210352|524250576|FG005|Overall Study|Lack of Efficacy|0|||
145382255|NCT01210352|524250577|FG006|Overall Study|Lack of Efficacy|1|||
145382256|NCT01210352|524250578|FG007|Overall Study|Lack of Efficacy|0|||
145382257|NCT01210352|524250579|FG008|Overall Study|Lack of Efficacy|0|||
145382258|NCT01210352|524250571|FG000|Overall Study|Physician Decision|0|||
145723026|NCT01395888|525502593|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
145723027|NCT01395888|525502594|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
145382259|NCT01210352|524250572|FG001|Overall Study|Physician Decision|0|||
145382260|NCT01210352|524250573|FG002|Overall Study|Physician Decision|0|||
145382261|NCT01210352|524250574|FG003|Overall Study|Physician Decision|0|||
145382262|NCT01210352|524250575|FG004|Overall Study|Physician Decision|0|||
145382263|NCT01210352|524250576|FG005|Overall Study|Physician Decision|0|||
145382264|NCT01210352|524250577|FG006|Overall Study|Physician Decision|0|||
145382265|NCT01210352|524250578|FG007|Overall Study|Physician Decision|1|||
145382266|NCT01210352|524250579|FG008|Overall Study|Physician Decision|2|||
145723028|NCT00903682|525502595|FG000|Overall Study|Adverse Event|6|||
145723029|NCT00903682|525502596|FG001|Overall Study|Adverse Event|13|||
145723030|NCT00903682|525502595|FG000|Overall Study|Lost to Follow-up|1|||
145723031|NCT00903682|525502596|FG001|Overall Study|Lost to Follow-up|0|||
145723032|NCT00903682|525502595|FG000|Overall Study|Withdrawal by Subject|5|||
145723033|NCT00903682|525502596|FG001|Overall Study|Withdrawal by Subject|0|||
145723034|NCT00903682|525502595|FG000|Overall Study|Pregnancy|0|||
145723035|NCT00903682|525502596|FG001|Overall Study|Pregnancy|1|||
145723036|NCT00903682|525502595|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
145382267|NCT01210352|524250571|FG000|Overall Study|Withdrawal by Subject|0|||
145382268|NCT01210352|524250572|FG001|Overall Study|Withdrawal by Subject|0|||
145382269|NCT01210352|524250573|FG002|Overall Study|Withdrawal by Subject|1|||
145382270|NCT01210352|524250574|FG003|Overall Study|Withdrawal by Subject|0|||
145723037|NCT00903682|525502596|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
145723038|NCT00903682|525502595|FG000|Overall Study|Subject Non-Compliant|1|||
145723039|NCT00903682|525502596|FG001|Overall Study|Subject Non-Compliant|0|||
145723040|NCT00903682|525502595|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
145723041|NCT00903682|525502596|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
145723042|NCT00903682|525502595|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
145723043|NCT00903682|525502596|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
145723044|NCT03169101|525502597|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
145723045|NCT03169101|525502598|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
145723046|NCT03169101|525502599|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
145723047|NCT03169101|525502600|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
145723048|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
145723049|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
145723050|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
145723051|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
145723052|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
145723053|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
145723054|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
145723055|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
145723056|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
145723057|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
145723058|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
145723059|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
145723060|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
145723061|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
145723062|NCT00600886|525502601|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
145723063|NCT00600886|525502602|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
145723064|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
145723065|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
145723066|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
145723067|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
145723068|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
145723069|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
145723070|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
145723071|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
145723072|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
145723073|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
145723074|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
145723075|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
145723076|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Death|1|||
145723077|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Death|1|||
145723078|NCT00600886|525502601|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
145723079|NCT00600886|525502602|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
145723080|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
145723081|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
145723082|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
145723083|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
145723084|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
145723085|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
145723086|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
145723087|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
145723088|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
145723089|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
145723090|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
145723091|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
145723092|NCT00600886|525502601|FG000|Extension - After Crossover (CAS)|Death|1|||
145723093|NCT00600886|525502602|FG001|Extension - After Crossover (CAS)|Death|0|||
145723094|NCT02053792|525502603|FG000|Overall Study|Physician Decision|0|||
145723095|NCT02053792|525502604|FG001|Overall Study|Physician Decision|1|||
145723096|NCT02053792|525502603|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
145723097|NCT02053792|525502604|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
145723098|NCT02053792|525502603|FG000|Overall Study|Lack of Efficacy|1|||
145723099|NCT02053792|525502604|FG001|Overall Study|Lack of Efficacy|0|||
145723100|NCT02053792|525502603|FG000|Overall Study|Adverse Event|1|||
145723101|NCT02053792|525502604|FG001|Overall Study|Adverse Event|0|||
145723102|NCT02053792|525502603|FG000|Overall Study|Withdrawal by Subject|2|||
145382271|NCT01210352|524250575|FG004|Overall Study|Withdrawal by Subject|0|||
145382272|NCT01210352|524250576|FG005|Overall Study|Withdrawal by Subject|0|||
145382273|NCT01210352|524250577|FG006|Overall Study|Withdrawal by Subject|1|||
145382274|NCT01210352|524250578|FG007|Overall Study|Withdrawal by Subject|0|||
145723103|NCT02053792|525502604|FG001|Overall Study|Withdrawal by Subject|2|||
145723104|NCT02053792|525502603|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
145723105|NCT02053792|525502604|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
145723106|NCT02053792|525502603|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
145723107|NCT02053792|525502604|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
145723108|NCT00790751|525502608|FG000|Overall Study|Protocol non-compliance|16|||
145723109|NCT00790751|525502609|FG001|Overall Study|Protocol non-compliance|16|||
145723110|NCT00790751|525502610|FG002|Overall Study|Protocol non-compliance|10|||
145723111|NCT00790751|525502611|FG003|Overall Study|Protocol non-compliance|11|||
145723112|NCT00790751|525502608|FG000|Overall Study|Lost to Follow-up|4|||
145723113|NCT00790751|525502609|FG001|Overall Study|Lost to Follow-up|9|||
145723114|NCT00790751|525502610|FG002|Overall Study|Lost to Follow-up|4|||
145723115|NCT00790751|525502611|FG003|Overall Study|Lost to Follow-up|5|||
145723116|NCT00790751|525502608|FG000|Overall Study|Adverse Event|5|||
145723117|NCT00790751|525502609|FG001|Overall Study|Adverse Event|3|||
145723118|NCT00790751|525502610|FG002|Overall Study|Adverse Event|5|||
145723119|NCT00790751|525502611|FG003|Overall Study|Adverse Event|4|||
145723120|NCT00790751|525502608|FG000|Overall Study|Requirement for restricted medication|0|||
145723121|NCT00790751|525502609|FG001|Overall Study|Requirement for restricted medication|2|||
145723122|NCT00790751|525502610|FG002|Overall Study|Requirement for restricted medication|0|||
145382275|NCT01210352|524250579|FG008|Overall Study|Withdrawal by Subject|1|||
145382276|NCT01210352|524250571|FG000|Overall Study|Patient Discharged Early|0|||
145382277|NCT01210352|524250572|FG001|Overall Study|Patient Discharged Early|0|||
145382278|NCT01210352|524250573|FG002|Overall Study|Patient Discharged Early|1|||
145382279|NCT01210352|524250574|FG003|Overall Study|Patient Discharged Early|0|||
145382280|NCT01210352|524250575|FG004|Overall Study|Patient Discharged Early|0|||
145382281|NCT01210352|524250576|FG005|Overall Study|Patient Discharged Early|0|||
145382282|NCT01210352|524250577|FG006|Overall Study|Patient Discharged Early|0|||
145382283|NCT01210352|524250578|FG007|Overall Study|Patient Discharged Early|0|||
145382284|NCT01210352|524250579|FG008|Overall Study|Patient Discharged Early|0|||
145382285|NCT02669082|524250580|FG000|Overall Study|Adverse Event|1|||
145382286|NCT04918355|524250581|FG000|Overall Study|no qualifying health encounter|497|||
145382287|NCT04918355|524250582|FG001|Overall Study|no qualifying health encounter|192|||
145382288|NCT04918355|524250583|FG002|Overall Study|no qualifying health encounter|438|||
145382289|NCT04918355|524250584|FG003|Overall Study|no qualifying health encounter|424|||
145382290|NCT01890759|524252381|FG000|Overall Study|Protocol Violation|0|||
145382291|NCT01890759|524252382|FG001|Overall Study|Protocol Violation|2|||
145382292|NCT01890759|524252381|FG000|Overall Study|Lost to Follow-up|0|||
145382293|NCT01890759|524252382|FG001|Overall Study|Lost to Follow-up|2|||
145382294|NCT01890759|524252381|FG000|Overall Study|Withdrawal by Subject|2|||
145382295|NCT01890759|524252382|FG001|Overall Study|Withdrawal by Subject|8|||
145382296|NCT00703326|524252383|FG000|Overall Study|Lost to Follow-up|47|||
145382297|NCT00703326|524252384|FG001|Overall Study|Lost to Follow-up|18|||
145382298|NCT00703326|524252383|FG000|Overall Study|Withdrawal by Subject|54|||
145382299|NCT00703326|524252384|FG001|Overall Study|Withdrawal by Subject|20|||
145382300|NCT00703326|524252383|FG000|Overall Study|Adverse Event|1|||
145382301|NCT00703326|524252384|FG001|Overall Study|Adverse Event|0|||
145382302|NCT01393106|524252386|FG000|Overall Study|Adverse Event|3|||
145382303|NCT01393106|524252386|FG000|Overall Study|Withdrawal by Subject|1|||
145382304|NCT01393106|524252386|FG000|Overall Study|Lack of Efficacy|1|||
145382305|NCT03041467|524252387|FG000|Overall Study|Death|46|||
145382306|NCT03041467|524252388|FG001|Overall Study|Death|39|||
145382307|NCT03041467|524252387|FG000|Overall Study|Withdrawal by Subject|36|||
145382308|NCT03041467|524252388|FG001|Overall Study|Withdrawal by Subject|37|||
145382309|NCT03041467|524252387|FG000|Overall Study|Lost to Follow-up|6|||
145382310|NCT03041467|524252388|FG001|Overall Study|Lost to Follow-up|8|||
145382311|NCT03041467|524252387|FG000|Overall Study|Declined consent for study extension|21|||
145382312|NCT03041467|524252388|FG001|Overall Study|Declined consent for study extension|33|||
145723123|NCT00790751|525502611|FG003|Overall Study|Requirement for restricted medication|0|||
145723124|NCT00790751|525502608|FG000|Overall Study|Death|0|||
145723125|NCT00790751|525502609|FG001|Overall Study|Death|0|||
145723126|NCT00790751|525502610|FG002|Overall Study|Death|1|||
145382313|NCT03041467|524252387|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
145382314|NCT03041467|524252388|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
145382315|NCT02732015|524252389|FG000|Overall Study|Lost to Follow-up|0|||
145382316|NCT02732015|524252390|FG001|Overall Study|Lost to Follow-up|1|||
145382317|NCT05437640|524252393|FG000|Washout (1 Week)|Adverse Event|1|||
145382318|NCT05437640|524252394|FG001|Washout (1 Week)|Adverse Event|0|||
145382319|NCT02474355|524252395|FG000|Overall Study|Other|43|||
145723127|NCT00790751|525502611|FG003|Overall Study|Death|0|||
145723128|NCT00790751|525502608|FG000|Overall Study|Physician Decision|0|||
145723129|NCT00790751|525502609|FG001|Overall Study|Physician Decision|0|||
145723130|NCT00790751|525502610|FG002|Overall Study|Physician Decision|0|||
145723131|NCT00790751|525502611|FG003|Overall Study|Physician Decision|1|||
145723132|NCT05590884|525502612|FG000|Overall Study|Withdrawal by Subject|1|||
145723133|NCT05590884|525502613|FG001|Overall Study|Withdrawal by Subject|0|||
145723134|NCT05590884|525502614|FG002|Overall Study|Withdrawal by Subject|0|||
145723135|NCT04428151|525502615|FG000|Overall Study|Death|100|||
145723136|NCT04428151|525502616|FG001|Overall Study|Death|86|||
145723137|NCT04428151|525502617|FG002|Overall Study|Death|57|||
145723138|NCT04428151|525502615|FG000|Overall Study|Lost to Follow-up|1|||
145723139|NCT04428151|525502616|FG001|Overall Study|Lost to Follow-up|1|||
145723140|NCT04428151|525502617|FG002|Overall Study|Lost to Follow-up|0|||
145723141|NCT04428151|525502615|FG000|Overall Study|Withdrawal by Subject|2|||
145723142|NCT04428151|525502616|FG001|Overall Study|Withdrawal by Subject|2|||
145723143|NCT04428151|525502617|FG002|Overall Study|Withdrawal by Subject|3|||
145723144|NCT04428151|525502615|FG000|Overall Study|Participant Ongoing in Study|41|||
145723145|NCT04428151|525502616|FG001|Overall Study|Participant Ongoing in Study|53|||
145723146|NCT04428151|525502617|FG002|Overall Study|Participant Ongoing in Study|28|||
145723147|NCT05227703|525502620|FG000|Overall Study|Adverse Event|2|||
145723148|NCT05227703|525502621|FG001|Overall Study|Adverse Event|6|||
145723149|NCT05227703|525502622|FG002|Overall Study|Adverse Event|4|||
145723150|NCT05227703|525502620|FG000|Overall Study|Lack of Efficacy|4|||
145723151|NCT05227703|525502621|FG001|Overall Study|Lack of Efficacy|0|||
145723152|NCT05227703|525502622|FG002|Overall Study|Lack of Efficacy|1|||
145723153|NCT05227703|525502620|FG000|Overall Study|Physician Decision|2|||
145723154|NCT05227703|525502621|FG001|Overall Study|Physician Decision|2|||
145723155|NCT05227703|525502622|FG002|Overall Study|Physician Decision|1|||
145723156|NCT05227703|525502620|FG000|Overall Study|Protocol Violation|2|||
145723157|NCT05227703|525502621|FG001|Overall Study|Protocol Violation|1|||
145723158|NCT05227703|525502622|FG002|Overall Study|Protocol Violation|0|||
145723159|NCT05227703|525502620|FG000|Overall Study|Withdrawal by Subject|17|||
145723160|NCT05227703|525502621|FG001|Overall Study|Withdrawal by Subject|26|||
145493116|NCT04529083|524661167|FG000|Overall Study|Withdrawal by Subject|3|||
145493117|NCT04196686|524661168|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
145493118|NCT04196686|524661169|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
145723161|NCT05227703|525502622|FG002|Overall Study|Withdrawal by Subject|32|||
145723162|NCT05227703|525502620|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
145723163|NCT05227703|525502621|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
145723164|NCT05227703|525502622|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
145723165|NCT05227703|525502620|FG000|Overall Study|Other|1|||
145723166|NCT05227703|525502621|FG001|Overall Study|Other|1|||
145723167|NCT05227703|525502622|FG002|Overall Study|Other|0|||
145723168|NCT04134845|525502624|FG000|Overall Study|withdrawl by PI|12|||
145723169|NCT04134845|525502625|FG001|Overall Study|withdrawl by PI|5|||
145723170|NCT03110224|525502626|FG000|Overall Study|Death|3|||
145723171|NCT03110224|525502626|FG000|Overall Study|Lost to Follow-up|132|||
145723172|NCT03110224|525502626|FG000|Overall Study|Physician Decision|2|||
145723173|NCT03110224|525502626|FG000|Overall Study|Site Closed by Physician|35|||
145723174|NCT03110224|525502626|FG000|Overall Study|Site Closed by Sponsor|202|||
145723175|NCT03110224|525502626|FG000|Overall Study|Withdrawal by Subject|9|||
145723176|NCT05328167|525502627|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
145723177|NCT05328167|525502627|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
145723178|NCT00112047|525502628|FG000|Randomized Phase|Lost to Follow-up|26|||
145723179|NCT00112047|525502629|FG001|Randomized Phase|Lost to Follow-up|33|||
145723180|NCT00112047|525502628|FG000|Randomized Phase|Adverse Event|10|||
145723181|NCT00112047|525502629|FG001|Randomized Phase|Adverse Event|10|||
145723182|NCT00112047|525502628|FG000|Randomized Phase|Withrawal of consent|10|||
145723183|NCT00112047|525502629|FG001|Randomized Phase|Withrawal of consent|18|||
145723184|NCT00112047|525502628|FG000|Randomized Phase|Sub-optimal virological response|3|||
145723185|NCT00112047|525502629|FG001|Randomized Phase|Sub-optimal virological response|13|||
145723186|NCT00112047|525502628|FG000|Randomized Phase|Noncompliance|8|||
145723187|NCT00112047|525502629|FG001|Randomized Phase|Noncompliance|4|||
145723188|NCT00112047|525502628|FG000|Randomized Phase|Protocol Violation|2|||
145723189|NCT00112047|525502629|FG001|Randomized Phase|Protocol Violation|0|||
145723190|NCT00112047|525502628|FG000|Randomized Phase|Pregnancy|3|||
145723191|NCT00112047|525502629|FG001|Randomized Phase|Pregnancy|1|||
145723192|NCT00112047|525502628|FG000|Randomized Phase|Death|1|||
145723193|NCT00112047|525502629|FG001|Randomized Phase|Death|3|||
145723194|NCT00112047|525502628|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
145723195|NCT00112047|525502629|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
145723196|NCT00112047|525502628|FG000|Randomized Phase|Inability to swallow pills|0|||
145723197|NCT00112047|525502629|FG001|Randomized Phase|Inability to swallow pills|1|||
145493119|NCT00265564|524661170|FG000|Overall Study|Lost to Follow-up|5|||
145723198|NCT00112047|525502628|FG000|Randomized Phase|Incarceration|3|||
145723199|NCT00112047|525502629|FG001|Randomized Phase|Incarceration|2|||
145723200|NCT00112047|525502628|FG000|Randomized Phase|Moved out of State|0|||
145723201|NCT00112047|525502629|FG001|Randomized Phase|Moved out of State|1|||
145723202|NCT00112047|525502628|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
145723203|NCT00112047|525502629|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
145382320|NCT02474355|524252395|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
145382321|NCT02474355|524252395|FG000|Overall Study|Lost to Follow-up|98|||
145382322|NCT02474355|524252395|FG000|Overall Study|Withdrawal by Subject|124|||
145382323|NCT02474355|524252395|FG000|Overall Study|Death|1361|||
145382324|NCT04228965|524252398|FG000|Overall Study|Lost to Follow-up|26|||
145382325|NCT04228965|524252399|FG001|Overall Study|Lost to Follow-up|11|||
145382326|NCT04228965|524252398|FG000|Overall Study|Withdrawal by Subject|18|||
145382327|NCT04228965|524252399|FG001|Overall Study|Withdrawal by Subject|5|||
145382328|NCT00734656|524252402|FG000|Lab Session 1|Withdrawal by Subject|2|||
145382329|NCT00734656|524252403|FG001|Lab Session 1|Withdrawal by Subject|0|||
145382330|NCT00734656|524252404|FG002|Lab Session 1|Withdrawal by Subject|0|||
145382331|NCT00734656|524252405|FG003|Lab Session 1|Withdrawal by Subject|0|||
145382332|NCT00734656|524252402|FG000|Washout 1|Withdrawal by Subject|1|||
145382333|NCT00734656|524252403|FG001|Washout 1|Withdrawal by Subject|5|||
145382334|NCT00734656|524252404|FG002|Washout 1|Withdrawal by Subject|2|||
145382335|NCT00734656|524252405|FG003|Washout 1|Withdrawal by Subject|3|||
145382336|NCT00734656|524252402|FG000|Lab Session 2|Withdrawal by Subject|1|||
145382337|NCT00734656|524252403|FG001|Lab Session 2|Withdrawal by Subject|0|||
145382338|NCT00734656|524252404|FG002|Lab Session 2|Withdrawal by Subject|0|||
145382339|NCT00734656|524252405|FG003|Lab Session 2|Withdrawal by Subject|1|||
145382340|NCT00734656|524252402|FG000|Washout 2|Withdrawal by Subject|1|||
145382341|NCT00734656|524252403|FG001|Washout 2|Withdrawal by Subject|1|||
145382342|NCT00734656|524252404|FG002|Washout 2|Withdrawal by Subject|1|||
145382343|NCT00734656|524252405|FG003|Washout 2|Withdrawal by Subject|0|||
145382344|NCT00734656|524252402|FG000|Washout 3|Withdrawal by Subject|1|||
145382345|NCT00734656|524252403|FG001|Washout 3|Withdrawal by Subject|0|||
145382346|NCT00734656|524252404|FG002|Washout 3|Withdrawal by Subject|0|||
145382347|NCT00734656|524252405|FG003|Washout 3|Withdrawal by Subject|1|||
145382348|NCT00734656|524252402|FG000|Lab Session 4|Withdrawal by Subject|0|||
145382349|NCT00734656|524252403|FG001|Lab Session 4|Withdrawal by Subject|0|||
145382350|NCT00734656|524252404|FG002|Lab Session 4|Withdrawal by Subject|0|||
145382351|NCT00734656|524252405|FG003|Lab Session 4|Withdrawal by Subject|1|||
145382352|NCT03214679|524252407|FG000|Overall Study|Lost to Follow-up|12|||
145382353|NCT03214679|524252408|FG001|Overall Study|Lost to Follow-up|14|||
145382354|NCT03214679|524252407|FG000|Overall Study|not eligible|2|||
145382355|NCT03214679|524252408|FG001|Overall Study|not eligible|0|||
145382356|NCT03915626|524252409|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
145382357|NCT03015194|524252412|FG000|Overall Study|Death|10|||
145382358|NCT03015194|524252412|FG000|Overall Study|Withdrawal by Subject|2|||
145382359|NCT01754766|524252419|FG000|Overall Study|Personal reasons|1|||
145382360|NCT01754766|524252420|FG001|Overall Study|Personal reasons|1|||
145382361|NCT01754766|524252421|FG002|Overall Study|Personal reasons|0|||
145382362|NCT00433017|524252422|FG000|Overall Study|Adverse Event|5|||
145382363|NCT00433017|524252423|FG001|Overall Study|Adverse Event|3|||
145382364|NCT00433017|524252422|FG000|Overall Study|Withdrawal by Subject|4|||
145382365|NCT00433017|524252423|FG001|Overall Study|Withdrawal by Subject|5|||
145382366|NCT00433017|524252422|FG000|Overall Study|Lost to Follow-up|3|||
145382367|NCT00433017|524252423|FG001|Overall Study|Lost to Follow-up|4|||
145723204|NCT00112047|525502628|FG000|Randomized Phase|High Hepatitis B DNA|0|||
145723205|NCT00112047|525502629|FG001|Randomized Phase|High Hepatitis B DNA|1|||
145723206|NCT00112047|525502628|FG000|Atripla Phase|Adverse Event|2|||
145723207|NCT00112047|525502629|FG001|Atripla Phase|Adverse Event|1|||
145723208|NCT00112047|525502628|FG000|Atripla Phase|Lost to Follow-up|5|||
145723209|NCT00112047|525502629|FG001|Atripla Phase|Lost to Follow-up|7|||
145723210|NCT00112047|525502628|FG000|Atripla Phase|Pregnancy|0|||
145723211|NCT00112047|525502629|FG001|Atripla Phase|Pregnancy|1|||
145723212|NCT00112047|525502628|FG000|Atripla Phase|Death|0|||
145723213|NCT00112047|525502629|FG001|Atripla Phase|Death|2|||
145723214|NCT00112047|525502628|FG000|Atripla Phase|Withdrew consent|7|||
145723215|NCT00112047|525502629|FG001|Atripla Phase|Withdrew consent|7|||
145723216|NCT00112047|525502628|FG000|Atripla Phase|Sub-optimal virological response|0|||
145723217|NCT00112047|525502629|FG001|Atripla Phase|Sub-optimal virological response|1|||
145723218|NCT00112047|525502628|FG000|Atripla Phase|Non-compliance|1|||
145723219|NCT00112047|525502629|FG001|Atripla Phase|Non-compliance|0|||
145723220|NCT00112047|525502628|FG000|Atripla Phase|Other|3|||
145723221|NCT00112047|525502629|FG001|Atripla Phase|Other|1|||
145723222|NCT01307579|525502630|FG000|Overall Study|Death|3|||
145723223|NCT01307579|525502631|FG001|Overall Study|Death|6|||
145723224|NCT01307579|525502630|FG000|Overall Study|Physician Decision|26|||
145723225|NCT01307579|525502631|FG001|Overall Study|Physician Decision|29|||
145723226|NCT01307579|525502630|FG000|Overall Study|Withdrawal by Subject|7|||
145723227|NCT01307579|525502631|FG001|Overall Study|Withdrawal by Subject|3|||
145723228|NCT01307579|525502630|FG000|Overall Study|Institutional diagnosis of IFD|21|||
145723229|NCT01307579|525502631|FG001|Overall Study|Institutional diagnosis of IFD|36|||
145382368|NCT00433017|524252422|FG000|Overall Study|Administrative problems|80|||
145382369|NCT00433017|524252423|FG001|Overall Study|Administrative problems|86|||
145723230|NCT01307579|525502630|FG000|Overall Study|Begin conditioning for HSCT|42|||
145723231|NCT01307579|525502631|FG001|Overall Study|Begin conditioning for HSCT|44|||
145723232|NCT01307579|525502630|FG000|Overall Study|Refractory or relapsed AML|38|||
145723233|NCT01307579|525502631|FG001|Overall Study|Refractory or relapsed AML|23|||
145723234|NCT01307579|525502630|FG000|Overall Study|Ineligible|3|||
145723235|NCT01307579|525502631|FG001|Overall Study|Ineligible|4|||
145723236|NCT03727438|525502632|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
145723237|NCT03727438|525502633|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
145723238|NCT03727438|525502632|FG000|Intervention Period|Excluded (health)|1|||
145723239|NCT03727438|525502633|FG001|Intervention Period|Excluded (health)|0|||
145723240|NCT03727438|525502632|FG000|Intervention Period|Withdrawal by Subject|3|||
145723241|NCT03727438|525502633|FG001|Intervention Period|Withdrawal by Subject|1|||
145723242|NCT03727438|525502632|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
145723243|NCT03727438|525502633|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
145723244|NCT03727438|525502632|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
145723245|NCT03727438|525502633|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
145723246|NCT03727438|525502632|FG000|8 Week Assessment|Withdrawal by Subject|6|||
145723247|NCT03727438|525502633|FG001|8 Week Assessment|Withdrawal by Subject|1|||
145723248|NCT03727438|525502632|FG000|6 mo Assessment|did not complete assessment|10|||
145723249|NCT03727438|525502633|FG001|6 mo Assessment|did not complete assessment|11|||
145723250|NCT01177722|525504785|FG000|Overall Study|Serious Adverse Event|0|||
145723251|NCT01177722|525504786|FG001|Overall Study|Serious Adverse Event|0|||
145723252|NCT01177722|525504787|FG002|Overall Study|Serious Adverse Event|1|||
145723253|NCT01177722|525504788|FG003|Overall Study|Serious Adverse Event|0|||
145723254|NCT01177722|525504785|FG000|Overall Study|Protocol Violation|0|||
145723255|NCT01177722|525504786|FG001|Overall Study|Protocol Violation|0|||
145723256|NCT01177722|525504787|FG002|Overall Study|Protocol Violation|1|||
145723257|NCT01177722|525504788|FG003|Overall Study|Protocol Violation|0|||
145723258|NCT01177722|525504785|FG000|Overall Study|Lost to Follow-up|3|||
145723259|NCT01177722|525504786|FG001|Overall Study|Lost to Follow-up|4|||
145723260|NCT01177722|525504787|FG002|Overall Study|Lost to Follow-up|3|||
145723261|NCT01177722|525504788|FG003|Overall Study|Lost to Follow-up|1|||
145723262|NCT01177722|525504785|FG000|Overall Study|Withdrawal by Subject|10|||
145723263|NCT01177722|525504786|FG001|Overall Study|Withdrawal by Subject|6|||
145723264|NCT01177722|525504787|FG002|Overall Study|Withdrawal by Subject|4|||
145723265|NCT01177722|525504788|FG003|Overall Study|Withdrawal by Subject|6|||
145723266|NCT02563522|525504792|FG000|Overall Study|Adverse Event|2|||
145723267|NCT02563522|525504793|FG001|Overall Study|Adverse Event|3|||
145723268|NCT02563522|525504792|FG000|Overall Study|Lost to Follow-up|1|||
145723269|NCT02563522|525504793|FG001|Overall Study|Lost to Follow-up|0|||
145723270|NCT02563522|525504792|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
145723271|NCT02563522|525504793|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
145723272|NCT00918580|525504794|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
145723273|NCT00918580|525504794|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
145723274|NCT00918580|525504794|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
145723275|NCT00918580|525504794|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
145723276|NCT00918580|525504794|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
145723277|NCT00918580|525504794|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
145723278|NCT00918580|525504794|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
145723279|NCT03486457|525504795|FG000|Up to Month 3|Adverse Event|2|||
145723280|NCT03486457|525504796|FG001|Up to Month 3|Adverse Event|5|||
145723281|NCT03486457|525504795|FG000|Up to Month 3|Lack of Efficacy|1|||
145723282|NCT03486457|525504796|FG001|Up to Month 3|Lack of Efficacy|0|||
145723283|NCT03486457|525504795|FG000|Up to Month 3|Withdrawal by Subject|1|||
145382370|NCT00433017|524252422|FG000|Overall Study|Protocol Violation|1|||
145382371|NCT00433017|524252423|FG001|Overall Study|Protocol Violation|0|||
145382372|NCT00433017|524252422|FG000|Overall Study|Death|2|||
145382373|NCT00433017|524252423|FG001|Overall Study|Death|2|||
145382374|NCT00433017|524252422|FG000|Overall Study|Subject no longer requires study drug|1|||
145382375|NCT00433017|524252423|FG001|Overall Study|Subject no longer requires study drug|1|||
145382376|NCT05025332|524252424|FG000|Screening|Screen failure|12|||
145382377|NCT05025332|524252424|FG000|Treatment & Follow Up|Protocol Violation|1|||
145382378|NCT05025332|524252424|FG000|Treatment & Follow Up|Adverse Event|4|||
145382379|NCT01306214|524252425|FG000|Overall Study|Death|0|||
145382380|NCT01306214|524252426|FG001|Overall Study|Death|0|||
145382381|NCT01306214|524252427|FG002|Overall Study|Death|1|||
145382382|NCT01306214|524252425|FG000|Overall Study|Lost to Follow-up|3|||
145382383|NCT01306214|524252426|FG001|Overall Study|Lost to Follow-up|5|||
145382384|NCT01306214|524252427|FG002|Overall Study|Lost to Follow-up|4|||
145382385|NCT01306214|524252425|FG000|Overall Study|Withdrawal by Subject|24|||
145382386|NCT01306214|524252426|FG001|Overall Study|Withdrawal by Subject|22|||
145382387|NCT01306214|524252427|FG002|Overall Study|Withdrawal by Subject|16|||
145382388|NCT01306214|524252425|FG000|Overall Study|Not treated|1|||
145382389|NCT01306214|524252426|FG001|Overall Study|Not treated|1|||
145382390|NCT01306214|524252427|FG002|Overall Study|Not treated|1|||
145382391|NCT01026818|524252428|FG000|Screening Period|Entry Criteria Not Met|105|||
145382392|NCT01026818|524252429|FG001|Screening Period|Entry Criteria Not Met|0|||
145382393|NCT01026818|524252430|FG002|Screening Period|Entry Criteria Not Met|0|||
145382394|NCT01026818|524252431|FG003|Screening Period|Entry Criteria Not Met|0|||
145382395|NCT01026818|524252428|FG000|Screening Period|Withdrawal by Subject|49|||
145382396|NCT01026818|524252429|FG001|Screening Period|Withdrawal by Subject|0|||
145382397|NCT01026818|524252430|FG002|Screening Period|Withdrawal by Subject|0|||
145382398|NCT01026818|524252431|FG003|Screening Period|Withdrawal by Subject|0|||
145382399|NCT01026818|524252428|FG000|Screening Period|Protocol Deviation|3|||
145382400|NCT01026818|524252429|FG001|Screening Period|Protocol Deviation|0|||
145382401|NCT01026818|524252430|FG002|Screening Period|Protocol Deviation|0|||
145382402|NCT01026818|524252431|FG003|Screening Period|Protocol Deviation|0|||
145382403|NCT01026818|524252428|FG000|Screening Period|Adverse Event|2|||
145382404|NCT01026818|524252429|FG001|Screening Period|Adverse Event|0|||
145382405|NCT01026818|524252430|FG002|Screening Period|Adverse Event|0|||
145382406|NCT01026818|524252431|FG003|Screening Period|Adverse Event|0|||
145493120|NCT00265564|524661171|FG001|Overall Study|Lost to Follow-up|7|||
145723284|NCT03486457|525504796|FG001|Up to Month 3|Withdrawal by Subject|0|||
145723285|NCT03486457|525504795|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
145723286|NCT03486457|525504796|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
145723287|NCT03486457|525504795|FG000|Up to Month 3|Other|1|||
145723288|NCT03486457|525504796|FG001|Up to Month 3|Other|0|||
145723289|NCT03486457|525504795|FG000|Month 3 to Month 6|Adverse Event|2|||
145723290|NCT03486457|525504796|FG001|Month 3 to Month 6|Adverse Event|0|||
145723291|NCT03486457|525504795|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
145723292|NCT03486457|525504796|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
145723293|NCT03486457|525504795|FG000|Month 3 to Month 6|Pregnancy|0|||
145723294|NCT03486457|525504796|FG001|Month 3 to Month 6|Pregnancy|1|||
145723295|NCT03486457|525504795|FG000|Month 3 to Month 6|Other|1|||
145723296|NCT03486457|525504796|FG001|Month 3 to Month 6|Other|0|||
145723297|NCT00946101|525504797|FG000|Overall Study|Lost to Follow-up|2|||
145723298|NCT00946101|525504798|FG001|Overall Study|Lost to Follow-up|1|||
145723299|NCT00946101|525504797|FG000|Overall Study|Withdrawal of consent|2|||
145723300|NCT00946101|525504798|FG001|Overall Study|Withdrawal of consent|0|||
145723301|NCT00946101|525504797|FG000|Overall Study|Physician Decision|0|||
145723302|NCT00946101|525504798|FG001|Overall Study|Physician Decision|1|||
145723303|NCT01347762|525504799|FG000|Overall Study|Lost to Follow-up|0|||
145723304|NCT01347762|525504800|FG001|Overall Study|Lost to Follow-up|1|||
145723305|NCT01347762|525504801|FG002|Overall Study|Lost to Follow-up|6|||
145723306|NCT01347762|525504802|FG003|Overall Study|Lost to Follow-up|5|||
145723307|NCT01347762|525504799|FG000|Overall Study|Withdrawal by Subject|4|||
145723308|NCT01347762|525504800|FG001|Overall Study|Withdrawal by Subject|1|||
145723309|NCT01347762|525504801|FG002|Overall Study|Withdrawal by Subject|3|||
145723310|NCT01347762|525504802|FG003|Overall Study|Withdrawal by Subject|3|||
145723311|NCT00093808|525504803|FG000|Overall Study|Cancel participation before receiving tx|1|||
145723312|NCT00093808|525504803|FG000|Overall Study|Protocol Violation|1|||
145723313|NCT00701220|525504804|FG000|Overall Study|Withdrawal by Subject|0|||
145723314|NCT00701220|525504805|FG001|Overall Study|Withdrawal by Subject|2|||
145723315|NCT00701220|525504804|FG000|Overall Study|Protocol Violation|2|||
145723316|NCT00701220|525504805|FG001|Overall Study|Protocol Violation|0|||
145723317|NCT03235284|525504806|FG000|Overall Study|Adverse Event|1|||
145723318|NCT03235284|525504807|FG001|Overall Study|Adverse Event|2|||
145723319|NCT03235284|525504808|FG002|Overall Study|Adverse Event|1|||
145723320|NCT00310037|525504809|FG000|Overall Study|Adverse Event|7|||
145723321|NCT00310037|525504810|FG001|Overall Study|Adverse Event|14|||
145723322|NCT00310037|525504809|FG000|Overall Study|Withdrawal by Subject|4|||
145723323|NCT00310037|525504810|FG001|Overall Study|Withdrawal by Subject|3|||
145723324|NCT00310037|525504809|FG000|Overall Study|Progression|6|||
145723325|NCT00310037|525504810|FG001|Overall Study|Progression|0|||
145723326|NCT00310037|525504809|FG000|Overall Study|Non-protocol treatment|1|||
145723327|NCT00310037|525504810|FG001|Overall Study|Non-protocol treatment|0|||
145723328|NCT01382706|525504821|FG000|Overall Study|Adverse Event|1|||
145723329|NCT01382706|525504821|FG000|Overall Study|Withdrawal by Subject|1|||
145723330|NCT04055090|525504822|FG000|Overall Study|screen failure|1|||
145723331|NCT04055090|525504823|FG001|Overall Study|screen failure|0|||
145723332|NCT04055090|525504822|FG000|Overall Study|Withdrawal by Subject|1|||
145723333|NCT04055090|525504823|FG001|Overall Study|Withdrawal by Subject|0|||
145723334|NCT02476279|525504826|FG000|Overall Study|Lost to Follow-up|1|||
145723335|NCT02476279|525504827|FG001|Overall Study|Lost to Follow-up|1|||
145723336|NCT02208999|525504828|FG000|Overall Study|Lost to Follow-up|1|||
145723337|NCT00319839|525504829|FG000|Overall Study|Adverse Event|5|||
145382407|NCT01026818|524252428|FG000|Screening Period|Physician Decision|1|||
145382408|NCT01026818|524252429|FG001|Screening Period|Physician Decision|0|||
145493121|NCT00265564|524661170|FG000|Overall Study|met exclusion criteria|5|||
145723338|NCT00319839|525504829|FG000|Overall Study|Withdrawal by Subject|1|||
145723339|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
145723340|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
145723341|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
145723342|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
145723343|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
145723344|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
145723345|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
145723346|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723347|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723348|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723349|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723350|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
145723351|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723352|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
145723353|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723354|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723355|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723356|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723357|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
145723358|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723359|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
145723360|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723361|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723362|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723363|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
145723364|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
145723365|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723366|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723367|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
145723368|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
145723369|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
145723370|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
145723371|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
145723372|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
145723373|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
145723374|NCT04494256|525504830|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723375|NCT04494256|525504831|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723376|NCT04494256|525504832|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723377|NCT04494256|525504833|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723378|NCT04494256|525504834|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
145723379|NCT04494256|525504835|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723380|NCT04494256|525504836|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
145723381|NCT04494256|525504830|FG000|Part 2: Open Label Period|Death|0|||
145723382|NCT04494256|525504831|FG001|Part 2: Open Label Period|Death|0|||
145723383|NCT04494256|525504832|FG002|Part 2: Open Label Period|Death|0|||
145723384|NCT04494256|525504833|FG003|Part 2: Open Label Period|Death|0|||
145723385|NCT04494256|525504834|FG004|Part 2: Open Label Period|Death|0|||
145723386|NCT04494256|525504835|FG005|Part 2: Open Label Period|Death|4|||
145723387|NCT04494256|525504836|FG006|Part 2: Open Label Period|Death|2|||
145723388|NCT04494256|525504830|FG000|Part 2: Open Label Period|Adverse Event|0|||
145723389|NCT04494256|525504831|FG001|Part 2: Open Label Period|Adverse Event|0|||
145723390|NCT04494256|525504832|FG002|Part 2: Open Label Period|Adverse Event|0|||
145723391|NCT04494256|525504833|FG003|Part 2: Open Label Period|Adverse Event|0|||
145723392|NCT04494256|525504834|FG004|Part 2: Open Label Period|Adverse Event|0|||
145723393|NCT04494256|525504835|FG005|Part 2: Open Label Period|Adverse Event|0|||
145723394|NCT04494256|525504836|FG006|Part 2: Open Label Period|Adverse Event|2|||
145723395|NCT04494256|525504830|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
145723396|NCT04494256|525504831|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
145723397|NCT04494256|525504832|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
145723398|NCT04494256|525504833|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
145723399|NCT04494256|525504834|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
145723400|NCT04494256|525504835|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
145723401|NCT04494256|525504836|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
145723402|NCT04494256|525504830|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145723403|NCT04494256|525504831|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145723404|NCT04494256|525504832|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145723405|NCT04494256|525504833|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145493122|NCT00265564|524661171|FG001|Overall Study|met exclusion criteria|2|||
145493123|NCT01277744|524661178|FG000|Overall Study|Physician Decision|2|||
145493124|NCT00475670|524661184|FG000|Overall Study|Death|0|||
145493125|NCT00475670|524661185|FG001|Overall Study|Death|1|||
145493126|NCT00475670|524661184|FG000|Overall Study|Lack of Efficacy|3|||
145493127|NCT00475670|524661185|FG001|Overall Study|Lack of Efficacy|34|||
145493128|NCT00475670|524661184|FG000|Overall Study|Refused treatment|0|||
145493129|NCT00475670|524661185|FG001|Overall Study|Refused treatment|2|||
145493130|NCT00475670|524661184|FG000|Overall Study|Failure to Return|0|||
145493131|NCT00475670|524661185|FG001|Overall Study|Failure to Return|1|||
145493132|NCT00475670|524661184|FG000|Overall Study|Other|0|||
145493133|NCT00475670|524661185|FG001|Overall Study|Other|3|||
145493134|NCT04949191|524661186|FG000|Overall Study|Non-compliance with Study Drug|1|||
145493135|NCT04949191|524661187|FG001|Overall Study|Non-compliance with Study Drug|0|||
145493136|NCT04949191|524661188|FG002|Overall Study|Non-compliance with Study Drug|0|||
145493137|NCT04949191|524661189|FG003|Overall Study|Non-compliance with Study Drug|0|||
145493138|NCT04949191|524661186|FG000|Overall Study|Progressive Disease|0|||
145493139|NCT04949191|524661187|FG001|Overall Study|Progressive Disease|1|||
145493140|NCT04949191|524661188|FG002|Overall Study|Progressive Disease|0|||
145493141|NCT04949191|524661189|FG003|Overall Study|Progressive Disease|0|||
145493142|NCT04949191|524661186|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
145493143|NCT04949191|524661187|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
145493144|NCT04949191|524661188|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
145493145|NCT04949191|524661189|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
145493146|NCT04949191|524661186|FG000|Overall Study|Sponsor Terminated Study|0|||
145493147|NCT04949191|524661187|FG001|Overall Study|Sponsor Terminated Study|0|||
145493148|NCT04949191|524661188|FG002|Overall Study|Sponsor Terminated Study|1|||
145493149|NCT04949191|524661189|FG003|Overall Study|Sponsor Terminated Study|1|||
145493150|NCT01168349|524661190|FG000|Overall Study|Death|157|||
145493151|NCT01168349|524661190|FG000|Overall Study|Lost to Follow-up|34|||
145493152|NCT01168349|524661190|FG000|Overall Study|Withdrawal by Subject|9|||
145493153|NCT01168349|524661190|FG000|Overall Study|Kidney transplantation|3|||
145493154|NCT01168349|524661190|FG000|Overall Study|Other|22|||
145493155|NCT01168349|524661190|FG000|Overall Study|Protocol Violation|76|||
145493156|NCT02678351|524661191|FG000|Overall Study|Withdrawal by Subject|1|||
145493157|NCT01632020|524661192|FG000|Overall Study|Withdrawal by Subject|1|||
145493158|NCT01632020|524661193|FG001|Overall Study|Withdrawal by Subject|0|||
145723406|NCT04494256|525504834|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145723407|NCT04494256|525504835|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
145723408|NCT04494256|525504836|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
145723409|NCT04494256|525504830|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
145723410|NCT04494256|525504831|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
145723411|NCT04494256|525504832|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
145723412|NCT04494256|525504833|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
145723413|NCT04494256|525504834|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
145723414|NCT04494256|525504835|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
145723415|NCT04494256|525504836|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
145723416|NCT04494256|525504830|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723417|NCT04494256|525504831|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723418|NCT04494256|525504832|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723419|NCT04494256|525504833|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723420|NCT04494256|525504834|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
145723421|NCT04494256|525504835|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
145723422|NCT04494256|525504836|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
145723423|NCT04494256|525504830|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
145723424|NCT04494256|525504831|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
145493159|NCT01632020|524661192|FG000|Overall Study|Adverse Event|1|||
145493160|NCT01632020|524661193|FG001|Overall Study|Adverse Event|0|||
145493161|NCT05083351|524661199|FG000|Overall Study|Adverse Event|3|||
145493162|NCT05083351|524661199|FG000|Overall Study|Did not meet data inclusion criteria|8|||
145493163|NCT05083351|524661199|FG000|Overall Study|Did not meet eligibility criteria|19|||
145493164|NCT05083351|524661199|FG000|Overall Study|Study Staff Decision|19|||
145493165|NCT03416868|524661203|FG000|Overall Study|Withdrawal by Subject|2|||
145493166|NCT03416868|524661203|FG000|Overall Study|Lost to Follow-up|1|||
145382409|NCT01026818|524252430|FG002|Screening Period|Physician Decision|0|||
145382410|NCT01026818|524252431|FG003|Screening Period|Physician Decision|0|||
145382411|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
145382412|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
145382413|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
145382414|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
145382415|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
145382416|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
145382417|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
145382418|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
145382419|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
145382420|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
145382421|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
145382422|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
145382423|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
145382424|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
145382425|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
145382426|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
145382427|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
145382428|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
145382429|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
145382430|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
145382431|NCT01026818|524252428|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
145382432|NCT01026818|524252429|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
145382433|NCT01026818|524252430|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
145382434|NCT01026818|524252431|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
145382435|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
145382436|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
145382437|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
145382438|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
145382439|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
145382440|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
145382441|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
145382442|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
145382443|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145382444|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
145382445|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145382446|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
145382447|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
145382448|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
145382449|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
145382450|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
145382451|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
145382452|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
145382453|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
145382454|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
145382455|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145382456|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
145382457|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145382458|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
145382459|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
145382460|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
145382461|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
145382462|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
145382463|NCT01026818|524252428|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145382464|NCT01026818|524252429|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145382465|NCT01026818|524252430|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
145382466|NCT01026818|524252431|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
145382467|NCT01026818|524252428|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145382468|NCT01026818|524252429|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
145382469|NCT01026818|524252430|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145382470|NCT01026818|524252431|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
145382471|NCT01026818|524252428|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145382472|NCT01026818|524252429|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
145407493|NCT00296517|524347008|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
145723425|NCT04494256|525504832|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
145723426|NCT04494256|525504833|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
145723427|NCT04494256|525504834|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
145723428|NCT04494256|525504835|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
145723429|NCT04494256|525504836|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
145723430|NCT02128542|525504837|FG000|Overall Study|Lost to Follow-up|3|||
145723431|NCT02128542|525504838|FG001|Overall Study|Lost to Follow-up|0|||
145723432|NCT02128542|525504837|FG000|Overall Study|Withdrew Consent|1|||
145723433|NCT02128542|525504838|FG001|Overall Study|Withdrew Consent|0|||
145723434|NCT01778023|525504839|FG000|Overall Study|Withdrawal by Subject|0|||
145723435|NCT01778023|525504840|FG001|Overall Study|Withdrawal by Subject|3|||
145723436|NCT01411215|525504841|FG000|Overall Study|Adverse Event|1|||
145723437|NCT01411215|525504842|FG001|Overall Study|Adverse Event|2|||
145723438|NCT01411215|525504841|FG000|Overall Study|Lack of Efficacy|2|||
145723439|NCT01411215|525504842|FG001|Overall Study|Lack of Efficacy|4|||
145723440|NCT01411215|525504841|FG000|Overall Study|Lost to Follow-up|12|||
145723441|NCT01411215|525504842|FG001|Overall Study|Lost to Follow-up|18|||
145723442|NCT01411215|525504841|FG000|Overall Study|Did not meet entrance criteria|0|||
145723443|NCT01411215|525504842|FG001|Overall Study|Did not meet entrance criteria|1|||
145723444|NCT01411215|525504841|FG000|Overall Study|Study terminated by sponsor|2|||
145723445|NCT01411215|525504842|FG001|Overall Study|Study terminated by sponsor|15|||
145382473|NCT01026818|524252430|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145382474|NCT01026818|524252431|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
145382475|NCT01026818|524252428|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
145382476|NCT01026818|524252429|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
145382477|NCT01026818|524252430|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
145382478|NCT01026818|524252431|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
145382479|NCT01026818|524252428|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
145382480|NCT01026818|524252429|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
145382481|NCT01026818|524252430|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
145382482|NCT01026818|524252431|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
145382483|NCT01026818|524252428|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
145382484|NCT01026818|524252429|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
145382485|NCT01026818|524252430|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
145382486|NCT01026818|524252431|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
145382487|NCT02634801|524252432|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
145382488|NCT02634801|524252433|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
145382489|NCT02634801|524252434|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
145382490|NCT02634801|524252432|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
145382491|NCT02634801|524252433|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
145382492|NCT02634801|524252434|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
145382493|NCT02634801|524252432|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
145382494|NCT02634801|524252433|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
145382495|NCT02634801|524252434|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
145382496|NCT02634801|524252432|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
145382497|NCT02634801|524252433|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
145382498|NCT02634801|524252434|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
145382499|NCT02634801|524252432|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
145382500|NCT02634801|524252433|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
145382501|NCT02634801|524252434|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
145382502|NCT02634801|524252432|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
145382503|NCT02634801|524252433|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
145382504|NCT02634801|524252434|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
145382505|NCT02634801|524252432|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
145382506|NCT02634801|524252433|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
145382507|NCT02634801|524252434|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
145382508|NCT02634801|524252432|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145382509|NCT02634801|524252433|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145382510|NCT02634801|524252434|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
145382511|NCT02634801|524252432|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
145382512|NCT02634801|524252433|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
145382513|NCT02634801|524252434|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
145382514|NCT02634801|524252432|FG000|Follow-up Period|Lost to Follow-up|3|||
145382515|NCT02634801|524252433|FG001|Follow-up Period|Lost to Follow-up|1|||
145382516|NCT02634801|524252434|FG002|Follow-up Period|Lost to Follow-up|2|||
145382517|NCT02634801|524252432|FG000|Follow-up Period|Physician Decision|0|||
145382518|NCT02634801|524252433|FG001|Follow-up Period|Physician Decision|0|||
145382519|NCT02634801|524252434|FG002|Follow-up Period|Physician Decision|1|||
145382520|NCT02634801|524252432|FG000|Follow-up Period|Withdrawal by Subject|1|||
145382521|NCT02634801|524252433|FG001|Follow-up Period|Withdrawal by Subject|2|||
145382522|NCT02634801|524252434|FG002|Follow-up Period|Withdrawal by Subject|5|||
145382523|NCT02634801|524252432|FG000|Follow-up Period|Adverse Event|1|||
145382524|NCT02634801|524252433|FG001|Follow-up Period|Adverse Event|5|||
145382525|NCT02634801|524252434|FG002|Follow-up Period|Adverse Event|0|||
145382526|NCT03594955|524252437|FG000|Overall Study|Adverse Event|1|||
145382527|NCT03594955|524252437|FG000|Overall Study|Progressive disease|5|||
145382528|NCT03594955|524252437|FG000|Overall Study|Sponsor's decision|1|||
145382529|NCT02065518|524252439|FG000|Overall Study|Lost to Follow-up|3|||
145382530|NCT02065518|524252440|FG001|Overall Study|Lost to Follow-up|4|||
145382531|NCT02065518|524252441|FG002|Overall Study|Lost to Follow-up|0|||
145382532|NCT02065518|524252442|FG003|Overall Study|Lost to Follow-up|3|||
145382533|NCT02065518|524252439|FG000|Overall Study|Withdrawal by Subject|3|||
145382534|NCT02065518|524252440|FG001|Overall Study|Withdrawal by Subject|4|||
145382535|NCT02065518|524252441|FG002|Overall Study|Withdrawal by Subject|9|||
145382536|NCT02065518|524252442|FG003|Overall Study|Withdrawal by Subject|2|||
145382537|NCT00564278|524252444|FG000|Overall Study|Lost to Follow-up|35|||
145382538|NCT00564278|524252445|FG001|Overall Study|Lost to Follow-up|33|||
145382539|NCT00564278|524252444|FG000|Overall Study|Physician Decision|1|||
145382540|NCT00564278|524252445|FG001|Overall Study|Physician Decision|2|||
145382541|NCT00564278|524252444|FG000|Overall Study|Withdrawal by Subject|11|||
145382542|NCT00564278|524252445|FG001|Overall Study|Withdrawal by Subject|7|||
145382543|NCT00560703|524252446|FG000|Overall Study|Adverse Event|0|||
145382544|NCT00560703|524252447|FG001|Overall Study|Adverse Event|2|||
145723446|NCT01411215|525504841|FG000|Overall Study|Protocol Violation|3|||
145723447|NCT01411215|525504842|FG001|Overall Study|Protocol Violation|5|||
145723448|NCT01411215|525504841|FG000|Overall Study|Withdrawal by Subject|34|||
145723449|NCT01411215|525504842|FG001|Overall Study|Withdrawal by Subject|21|||
145723450|NCT01411215|525504841|FG000|Overall Study|Other|12|||
145723451|NCT01411215|525504842|FG001|Overall Study|Other|17|||
145382545|NCT00560703|524252446|FG000|Overall Study|Protocol Violation|0|||
145382546|NCT00560703|524252447|FG001|Overall Study|Protocol Violation|2|||
145382547|NCT00560703|524252446|FG000|Overall Study|Withdrawal by Subject|0|||
145382548|NCT00560703|524252447|FG001|Overall Study|Withdrawal by Subject|1|||
145382549|NCT00560703|524252446|FG000|Overall Study|non-compliance|0|||
145382550|NCT00560703|524252447|FG001|Overall Study|non-compliance|1|||
145382551|NCT06439095|524252448|FG000|Overall Study|Lost to Follow-up|2|||
145382552|NCT03341936|524252449|FG000|Overall Study|Ineligible|1|||
145382553|NCT03341936|524252449|FG000|Overall Study|Disease Progression|2|||
145382554|NCT03341936|524252449|FG000|Overall Study|Withdrew Consent|4|||
145382555|NCT03341936|524252449|FG000|Overall Study|Non-Compliance|1|||
145382556|NCT03341936|524252449|FG000|Overall Study|Physician Decision|1|||
145382557|NCT03341936|524252449|FG000|Overall Study|Withdrawal by Subject|1|||
145382558|NCT03341936|524252449|FG000|Overall Study|Other|1|||
145382559|NCT02368886|524252450|FG000|Overall Study|Cancel|1|||
145382560|NCT02368886|524252451|FG001|Overall Study|Cancel|1|||
145382561|NCT02368886|524252452|FG002|Overall Study|Cancel|1|||
145382562|NCT02368886|524252453|FG003|Overall Study|Cancel|3|||
145382563|NCT02368886|524252450|FG000|Overall Study|Ineligible|0|||
145382564|NCT02368886|524252451|FG001|Overall Study|Ineligible|0|||
145382565|NCT02368886|524252452|FG002|Overall Study|Ineligible|0|||
145382566|NCT02368886|524252453|FG003|Overall Study|Ineligible|1|||
145382567|NCT02131636|524252458|FG000|Overall Study|Personal Reasons|4|||
145382568|NCT02131636|524252459|FG001|Overall Study|Personal Reasons|4|||
145382569|NCT02131636|524252458|FG000|Overall Study|Lost to Follow-up|4|||
145382570|NCT02131636|524252459|FG001|Overall Study|Lost to Follow-up|0|||
145493167|NCT03353675|524661216|FG000|Overall Study|Adverse Event|4|||
145493168|NCT03309020|524661217|FG000|Overall Study|Death|1|||
145493169|NCT03309020|524661218|FG001|Overall Study|Death|0|||
145493170|NCT03309020|524661217|FG000|Overall Study|Did not undergo surgery|2|||
145493171|NCT03309020|524661218|FG001|Overall Study|Did not undergo surgery|1|||
145493172|NCT00402168|524661219|FG000|Randomized|Lost to Follow-up|1|||
145493173|NCT00402168|524661220|FG001|Randomized|Lost to Follow-up|0|||
145723452|NCT01411215|525504841|FG000|Overall Study|Screen failure|0|||
145723453|NCT01411215|525504842|FG001|Overall Study|Screen failure|1|||
145723454|NCT00848926|525504843|FG000|Treatment Period|Progressive disease|45|||
145723455|NCT00848926|525504843|FG000|Treatment Period|Adverse Event|20|||
145723456|NCT00848926|525504843|FG000|Treatment Period|Physician Decision|12|||
145723457|NCT00848926|525504843|FG000|Treatment Period|Withdrawal by Subject|7|||
145723458|NCT00848926|525504843|FG000|Follow-up Period|Lost to Follow-up|7|||
145723459|NCT00848926|525504843|FG000|Follow-up Period|Withdrawal by Subject|3|||
145723460|NCT00848926|525504843|FG000|Follow-up Period|Other|2|||
145723461|NCT02203695|525504844|FG000|Overall Study|Patient withdrew consent|1|||
145723462|NCT02203695|525504845|FG001|Overall Study|Patient withdrew consent|1|||
145723463|NCT02203695|525504844|FG000|Overall Study|Started non-study treatment|1|||
145723464|NCT02203695|525504845|FG001|Overall Study|Started non-study treatment|0|||
145723465|NCT04025580|525504846|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
145723466|NCT04025580|525504847|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
145723467|NCT04025580|525504848|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
145723468|NCT01249274|525504852|FG000|Overall Study|Lost to Follow-up|3|||
145723469|NCT01249274|525504853|FG001|Overall Study|Lost to Follow-up|4|||
145723470|NCT01249274|525504852|FG000|Overall Study|Received inpatient substance treatment|1|||
145723471|NCT01249274|525504853|FG001|Overall Study|Received inpatient substance treatment|2|||
145723472|NCT01000636|525504854|FG000|Overall Study|Withdrawal by Subject|1|||
145723473|NCT01000636|525504854|FG000|Overall Study|Adverse Event|1|||
145723474|NCT00138671|525504855|FG000|Overall Study|Death|0|||
145723475|NCT00138671|525504856|FG001|Overall Study|Death|3|||
145723476|NCT00138671|525504855|FG000|Overall Study|Adverse Event|6|||
145723477|NCT00138671|525504856|FG001|Overall Study|Adverse Event|3|||
145723478|NCT00138671|525504855|FG000|Overall Study|Lost to Follow-up|1|||
145723479|NCT00138671|525504856|FG001|Overall Study|Lost to Follow-up|2|||
145723480|NCT00138671|525504855|FG000|Overall Study|Withdrawal by Subject|3|||
145723481|NCT00138671|525504856|FG001|Overall Study|Withdrawal by Subject|5|||
145382571|NCT02131636|524252458|FG000|Overall Study|Adverse Event|4|||
145723482|NCT00138671|525504855|FG000|Overall Study|Other|3|||
145723483|NCT00138671|525504856|FG001|Overall Study|Other|3|||
145723484|NCT03451162|525504857|FG000|Overall Study|Lost to Follow-up|1|||
145382572|NCT02131636|524252459|FG001|Overall Study|Adverse Event|1|||
145382573|NCT03484403|524252460|FG000|Overall Study|Withdrawal by Subject|6|||
145382574|NCT03484403|524252461|FG001|Overall Study|Withdrawal by Subject|4|||
145382575|NCT02173379|524252462|FG000|Overall Study|Lost to Follow-up|89|||
145382576|NCT02173379|524252463|FG001|Overall Study|Lost to Follow-up|81|||
145382577|NCT02173379|524252462|FG000|Overall Study|Withdrawal by Subject|24|||
145493174|NCT00402168|524661219|FG000|Randomized|Withdrawal by Subject|0|||
145723485|NCT03451162|525504858|FG001|Overall Study|Lost to Follow-up|0|||
145723486|NCT03451162|525504859|FG002|Overall Study|Lost to Follow-up|0|||
145723487|NCT03451162|525504860|FG003|Overall Study|Lost to Follow-up|0|||
145723488|NCT03451162|525504861|FG004|Overall Study|Lost to Follow-up|0|||
145723489|NCT03451162|525504857|FG000|Overall Study|Physician Decision|0|||
145723490|NCT03451162|525504858|FG001|Overall Study|Physician Decision|1|||
145723491|NCT03451162|525504859|FG002|Overall Study|Physician Decision|0|||
145723492|NCT03451162|525504860|FG003|Overall Study|Physician Decision|0|||
145723493|NCT03451162|525504861|FG004|Overall Study|Physician Decision|0|||
145723494|NCT03451162|525504857|FG000|Overall Study|Withdrawal by Subject|1|||
145723495|NCT03451162|525504858|FG001|Overall Study|Withdrawal by Subject|1|||
145723496|NCT03451162|525504859|FG002|Overall Study|Withdrawal by Subject|0|||
145723497|NCT03451162|525504860|FG003|Overall Study|Withdrawal by Subject|0|||
145723498|NCT03451162|525504861|FG004|Overall Study|Withdrawal by Subject|0|||
145382578|NCT02173379|524252463|FG001|Overall Study|Withdrawal by Subject|29|||
145382579|NCT02173379|524252462|FG000|Overall Study|Physician Decision|8|||
145382580|NCT02173379|524252463|FG001|Overall Study|Physician Decision|8|||
145382581|NCT02173379|524252462|FG000|Overall Study|Death|75|||
145382582|NCT02173379|524252463|FG001|Overall Study|Death|72|||
145382583|NCT02173379|524252462|FG000|Overall Study|Other Reason|1|||
145382584|NCT02173379|524252463|FG001|Overall Study|Other Reason|0|||
145382585|NCT04278924|524252464|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
145382586|NCT04278924|524252465|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
145382587|NCT04278924|524252466|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145382588|NCT04278924|524252467|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
145382589|NCT04278924|524252468|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145382590|NCT04278924|524252469|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145382591|NCT04278924|524252470|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
145382592|NCT04278924|524252464|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382593|NCT04278924|524252465|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
145382594|NCT04278924|524252466|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382595|NCT04278924|524252467|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382596|NCT04278924|524252468|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382597|NCT04278924|524252469|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382598|NCT04278924|524252470|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
145382599|NCT06226649|524252471|FG000|Overall Study|Withdrawal by Subject|4|||
145382600|NCT06226649|524252472|FG001|Overall Study|Withdrawal by Subject|1|||
145382601|NCT05600036|524252473|FG000|Overall Study|Adverse Event|0|||
145382602|NCT05600036|524252474|FG001|Overall Study|Adverse Event|2|||
145382603|NCT05600036|524252475|FG002|Overall Study|Adverse Event|1|||
145382604|NCT05600036|524252476|FG003|Overall Study|Adverse Event|0|||
145382605|NCT05600036|524252477|FG004|Overall Study|Adverse Event|1|||
145382606|NCT05600036|524252478|FG005|Overall Study|Adverse Event|0|||
145382607|NCT05600036|524252473|FG000|Overall Study|Lost to Follow-up|0|||
145382608|NCT05600036|524252474|FG001|Overall Study|Lost to Follow-up|2|||
145382609|NCT05600036|524252475|FG002|Overall Study|Lost to Follow-up|1|||
145382610|NCT05600036|524252476|FG003|Overall Study|Lost to Follow-up|1|||
145382611|NCT05600036|524252477|FG004|Overall Study|Lost to Follow-up|0|||
145382612|NCT05600036|524252478|FG005|Overall Study|Lost to Follow-up|0|||
145382613|NCT05600036|524252473|FG000|Overall Study|Protocol Violation|0|||
145382614|NCT05600036|524252474|FG001|Overall Study|Protocol Violation|0|||
145382615|NCT05600036|524252475|FG002|Overall Study|Protocol Violation|2|||
145382616|NCT05600036|524252476|FG003|Overall Study|Protocol Violation|0|||
145382617|NCT05600036|524252477|FG004|Overall Study|Protocol Violation|0|||
145382618|NCT05600036|524252478|FG005|Overall Study|Protocol Violation|0|||
145382619|NCT05600036|524252473|FG000|Overall Study|Withdrawal by Subject|0|||
145382620|NCT05600036|524252474|FG001|Overall Study|Withdrawal by Subject|1|||
145382621|NCT05600036|524252475|FG002|Overall Study|Withdrawal by Subject|2|||
145382622|NCT05600036|524252476|FG003|Overall Study|Withdrawal by Subject|0|||
145382623|NCT05600036|524252477|FG004|Overall Study|Withdrawal by Subject|3|||
145382624|NCT05600036|524252478|FG005|Overall Study|Withdrawal by Subject|5|||
145382625|NCT05600036|524252473|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145382626|NCT05600036|524252474|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145382627|NCT05600036|524252475|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145382628|NCT05600036|524252476|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
145382629|NCT05600036|524252477|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145382630|NCT05600036|524252478|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
145382631|NCT05600036|524252473|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145382632|NCT05600036|524252474|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
145382633|NCT05600036|524252475|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145382634|NCT05600036|524252476|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145382635|NCT05600036|524252477|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145382636|NCT05600036|524252478|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
145723499|NCT04634825|525504862|FG000|Overall Study|Death|10|||
145723500|NCT04634825|525504863|FG001|Overall Study|Death|3|||
145723501|NCT04634825|525504862|FG000|Overall Study|Lost to Follow-up|1|||
145723502|NCT04634825|525504863|FG001|Overall Study|Lost to Follow-up|0|||
145723503|NCT04634825|525504862|FG000|Overall Study|Study terminated by sponsor|35|||
145723504|NCT04634825|525504863|FG001|Overall Study|Study terminated by sponsor|11|||
145723505|NCT04634825|525504862|FG000|Overall Study|Withdrawal by Subject|2|||
145723506|NCT04634825|525504863|FG001|Overall Study|Withdrawal by Subject|0|||
145493175|NCT00402168|524661220|FG001|Randomized|Withdrawal by Subject|1|||
145493176|NCT00402168|524661219|FG000|Treatment (up to 12 Months)|Death|0|||
145493177|NCT00402168|524661220|FG001|Treatment (up to 12 Months)|Death|1|||
145493178|NCT00402168|524661219|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
145723507|NCT01100034|525504866|FG000|Overall Study|Lost to Follow-up|11|||
145723508|NCT01100034|525504866|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
145723509|NCT01100034|525504866|FG000|Overall Study|Withdrawal by Subject|4|||
145723510|NCT01100034|525504866|FG000|Overall Study|Sponsor decision|21|||
145723511|NCT01100034|525504866|FG000|Overall Study|Participated in another clinical trial|1|||
145723512|NCT01100034|525504866|FG000|Overall Study|Participants moved to another hospital|4|||
145723513|NCT01100034|525504866|FG000|Overall Study|Site closed due to non-responsiveness|1|||
145723514|NCT00402597|525504867|FG000|Overall Study|Death|15|||
145723515|NCT00402597|525504868|FG001|Overall Study|Death|7|||
145723516|NCT00402597|525504869|FG002|Overall Study|Death|6|||
145723517|NCT00402597|525504870|FG003|Overall Study|Death|4|||
145723518|NCT00402597|525504871|FG004|Overall Study|Death|6|||
145723519|NCT00402597|525504867|FG000|Overall Study|Adverse Event|81|||
145723520|NCT00402597|525504868|FG001|Overall Study|Adverse Event|18|||
145723521|NCT00402597|525504869|FG002|Overall Study|Adverse Event|106|||
145723522|NCT00402597|525504870|FG003|Overall Study|Adverse Event|39|||
145723523|NCT00402597|525504871|FG004|Overall Study|Adverse Event|71|||
145723524|NCT00402597|525504867|FG000|Overall Study|Lost to Follow-up|8|||
145723525|NCT00402597|525504868|FG001|Overall Study|Lost to Follow-up|1|||
145723526|NCT00402597|525504869|FG002|Overall Study|Lost to Follow-up|8|||
145723527|NCT00402597|525504870|FG003|Overall Study|Lost to Follow-up|2|||
145493179|NCT00402168|524661220|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
145493180|NCT00402168|524661219|FG000|Treatment (up to 12 Months)|non-specified|0|||
145723528|NCT00402597|525504871|FG004|Overall Study|Lost to Follow-up|3|||
145723529|NCT00402597|525504867|FG000|Overall Study|Withdrawal by Subject|57|||
145723530|NCT00402597|525504868|FG001|Overall Study|Withdrawal by Subject|16|||
145723531|NCT00402597|525504869|FG002|Overall Study|Withdrawal by Subject|65|||
145723532|NCT00402597|525504870|FG003|Overall Study|Withdrawal by Subject|15|||
145723533|NCT00402597|525504871|FG004|Overall Study|Withdrawal by Subject|24|||
145723534|NCT00402597|525504867|FG000|Overall Study|reason not specified|30|||
145723535|NCT00402597|525504868|FG001|Overall Study|reason not specified|4|||
145723536|NCT00402597|525504869|FG002|Overall Study|reason not specified|27|||
145723537|NCT00402597|525504870|FG003|Overall Study|reason not specified|14|||
145723538|NCT00402597|525504871|FG004|Overall Study|reason not specified|20|||
145493181|NCT00402168|524661220|FG001|Treatment (up to 12 Months)|non-specified|1|||
145382637|NCT05600036|524252473|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145382638|NCT05600036|524252474|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145382639|NCT05600036|524252475|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145382640|NCT05600036|524252476|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
145382641|NCT05600036|524252477|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145382642|NCT05600036|524252478|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
145382643|NCT00631163|524252479|FG000|Number of Participants in Year 1|Adverse Event|12|||
145382644|NCT00631163|524252479|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
145382645|NCT00631163|524252479|FG000|Number of Participants in Year 1|Death|6|||
145382646|NCT00631163|524252479|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
145382647|NCT00631163|524252479|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
145382648|NCT00631163|524252479|FG000|Number of Participants in Year 1|Administrative problems|6|||
145382649|NCT00631163|524252479|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
145382650|NCT00631163|524252479|FG000|Number of Participants in Year 2|Adverse Event|1|||
145382651|NCT00631163|524252479|FG000|Number of Participants in Year 2|Protocol Violation|1|||
145382652|NCT00631163|524252479|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
145382653|NCT02636699|524252480|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
145382654|NCT02636699|524252481|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
145382655|NCT02636699|524252482|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
145382656|NCT02636699|524252480|FG000|Screening Period|Withdrawal by Subject|0|||
145382657|NCT02636699|524252481|FG001|Screening Period|Withdrawal by Subject|0|||
145382658|NCT02636699|524252482|FG002|Screening Period|Withdrawal by Subject|23|||
145382659|NCT02636699|524252480|FG000|Screening Period|Adverse Event|0|||
145382660|NCT02636699|524252481|FG001|Screening Period|Adverse Event|0|||
145382661|NCT02636699|524252482|FG002|Screening Period|Adverse Event|1|||
145382662|NCT02636699|524252480|FG000|Screening Period|Other not specified|0|||
145382663|NCT02636699|524252481|FG001|Screening Period|Other not specified|0|||
145382664|NCT02636699|524252482|FG002|Screening Period|Other not specified|3|||
145382665|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
145382666|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
145382667|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
145382668|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
145382669|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
145382670|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
145382671|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
145382672|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
145382673|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
145382674|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
145382675|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
145382676|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
145382677|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
145382678|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
145382679|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
145382680|NCT02636699|524252480|FG000|Treatment and Follow-up Periods|Other|3|||
145382681|NCT02636699|524252481|FG001|Treatment and Follow-up Periods|Other|1|||
145382682|NCT02636699|524252482|FG002|Treatment and Follow-up Periods|Other|0|||
145382683|NCT00438256|524252485|FG000|Overall Study|Ineligible for Resection|2|||
145382684|NCT00438256|524252486|FG001|Overall Study|Ineligible for Resection|1|||
145382685|NCT00438256|524252487|FG002|Overall Study|Ineligible for Resection|1|||
145382686|NCT00438256|524252488|FG003|Overall Study|Ineligible for Resection|7|||
145382687|NCT00438256|524252485|FG000|Overall Study|Excluded final Diagnosis|0|||
145382688|NCT00438256|524252486|FG001|Overall Study|Excluded final Diagnosis|0|||
145382689|NCT00438256|524252487|FG002|Overall Study|Excluded final Diagnosis|0|||
145382690|NCT00438256|524252488|FG003|Overall Study|Excluded final Diagnosis|2|||
145382691|NCT01490697|524252492|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
145382692|NCT01490697|524252493|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
145493182|NCT00402168|524661219|FG000|Long Term (LT)|Adverse Event|1|||
145493183|NCT00402168|524661220|FG001|Long Term (LT)|Adverse Event|5|||
145493184|NCT00402168|524661219|FG000|Long Term (LT)|Withdrawal by Subject|4|||
145493185|NCT00402168|524661220|FG001|Long Term (LT)|Withdrawal by Subject|7|||
145493186|NCT00402168|524661219|FG000|Long Term (LT)|Pregnancy|0|||
145266631|NCT04668066|523825241|FG004|Part 1: Treatment Phase|Other|0|||
145382693|NCT00379808|524252494|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
145382694|NCT00379808|524252495|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
145382695|NCT01048099|524252503|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
145382696|NCT01048099|524252503|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
145382697|NCT01731470|524252505|FG000|Overall Study|Withdrawal by Subject|1|||
145382698|NCT01731470|524252505|FG000|Overall Study|Did not meet study criteria|1|||
145382699|NCT01625689|524252508|FG000|Overall Study|Migration|2|||
145382700|NCT01625689|524252509|FG001|Overall Study|Migration|1|||
145382701|NCT01333956|524252518|FG000|Overall Study|Lost to Follow-up|1|||
145382702|NCT01333956|524252519|FG001|Overall Study|Lost to Follow-up|2|||
145382703|NCT01333956|524252520|FG002|Overall Study|Lost to Follow-up|0|||
145382704|NCT01333956|524252521|FG003|Overall Study|Lost to Follow-up|1|||
145382705|NCT01333956|524252518|FG000|Overall Study|Unable to complete study procedure|1|||
145382706|NCT01333956|524252519|FG001|Overall Study|Unable to complete study procedure|0|||
145382707|NCT01333956|524252520|FG002|Overall Study|Unable to complete study procedure|0|||
145382708|NCT01333956|524252521|FG003|Overall Study|Unable to complete study procedure|1|||
145382709|NCT01333956|524252518|FG000|Overall Study|Withdrawal by Subject|0|||
145382710|NCT01333956|524252519|FG001|Overall Study|Withdrawal by Subject|2|||
145382711|NCT01333956|524252520|FG002|Overall Study|Withdrawal by Subject|1|||
145382712|NCT01333956|524252521|FG003|Overall Study|Withdrawal by Subject|0|||
145382713|NCT02134353|524252522|FG000|Overall Study|Adverse Event|10|||
145382714|NCT02134353|524252523|FG001|Overall Study|Adverse Event|6|||
145382715|NCT02134353|524252522|FG000|Overall Study|Lost to Follow-up|1|||
145382716|NCT02134353|524252523|FG001|Overall Study|Lost to Follow-up|1|||
145382717|NCT02134353|524252522|FG000|Overall Study|Lack of Efficacy|2|||
145382718|NCT02134353|524252523|FG001|Overall Study|Lack of Efficacy|1|||
145382719|NCT02134353|524252522|FG000|Overall Study|Withdrawal by Subject|12|||
145382720|NCT02134353|524252523|FG001|Overall Study|Withdrawal by Subject|13|||
145382721|NCT02134353|524252522|FG000|Overall Study|Death|0|||
145382722|NCT02134353|524252523|FG001|Overall Study|Death|1|||
145382723|NCT02134353|524252522|FG000|Overall Study|Pregnancy|0|||
145382724|NCT02134353|524252523|FG001|Overall Study|Pregnancy|1|||
145382725|NCT02134353|524252522|FG000|Overall Study|Relocation|1|||
145382726|NCT02134353|524252523|FG001|Overall Study|Relocation|0|||
145382727|NCT02134353|524252522|FG000|Overall Study|Other - Patient's Choice|0|||
145382728|NCT02134353|524252523|FG001|Overall Study|Other - Patient's Choice|1|||
145382729|NCT03426436|524252524|FG000|Overall Study|Incorrect lead placement|12|||
145382730|NCT03426436|524252524|FG000|Overall Study|Withdrawal by Subject|2|||
145382731|NCT03426436|524252524|FG000|Overall Study|Consent issue|1|||
145382732|NCT03426436|524252524|FG000|Overall Study|ECGs not saved|4|||
145382733|NCT03611582|524252525|FG000|Overall Study|Adverse Event|26|||
145382734|NCT03611582|524252526|FG001|Overall Study|Adverse Event|6|||
145382735|NCT03611582|524252525|FG000|Overall Study|Protocol Violation|0|||
145382736|NCT03611582|524252526|FG001|Overall Study|Protocol Violation|1|||
145382737|NCT03611582|524252525|FG000|Overall Study|Pregnancy|1|||
145382738|NCT03611582|524252526|FG001|Overall Study|Pregnancy|2|||
145382739|NCT03611582|524252525|FG000|Overall Study|Lack of Efficacy|0|||
145382740|NCT03611582|524252526|FG001|Overall Study|Lack of Efficacy|1|||
145382741|NCT03611582|524252525|FG000|Overall Study|At the discretion of the investigator|1|||
145382742|NCT03611582|524252526|FG001|Overall Study|At the discretion of the investigator|0|||
145382743|NCT03611582|524252525|FG000|Overall Study|Safety concern as judged by the investigator|1|||
145382744|NCT03611582|524252526|FG001|Overall Study|Safety concern as judged by the investigator|2|||
145382745|NCT03611582|524252525|FG000|Overall Study|Withdrawal by Subject|4|||
145382746|NCT03611582|524252526|FG001|Overall Study|Withdrawal by Subject|3|||
145382747|NCT03611582|524252525|FG000|Overall Study|Lost to Follow-up|18|||
145382748|NCT03611582|524252526|FG001|Overall Study|Lost to Follow-up|7|||
145382749|NCT03611582|524252525|FG000|Overall Study|other|17|||
145382750|NCT03611582|524252526|FG001|Overall Study|other|16|||
145382751|NCT01783821|524252527|FG000|Overall Study|Screen Failure|1|||
145382752|NCT01783821|524252528|FG001|Overall Study|Screen Failure|1|||
145382753|NCT01907217|524252529|FG000|Overall Study|Withdrawal by Subject|0|||
145382754|NCT01907217|524252530|FG001|Overall Study|Withdrawal by Subject|2|||
145382755|NCT00866333|524252537|FG000|Overall Study|Withdrawal of consent|0|||
145382756|NCT00866333|524252538|FG001|Overall Study|Withdrawal of consent|1|||
145382757|NCT00866333|524252539|FG002|Overall Study|Withdrawal of consent|2|||
145382758|NCT00866333|524252537|FG000|Overall Study|Reason not Specified|3|||
145382759|NCT00866333|524252538|FG001|Overall Study|Reason not Specified|1|||
145382760|NCT00866333|524252539|FG002|Overall Study|Reason not Specified|1|||
145382761|NCT00866333|524252537|FG000|Overall Study|Study Terminated by Sponsor|2|||
145382762|NCT00866333|524252538|FG001|Overall Study|Study Terminated by Sponsor|5|||
145382763|NCT00866333|524252539|FG002|Overall Study|Study Terminated by Sponsor|9|||
145382764|NCT00422292|524252540|FG000|Overall Study|Serious adverse events|1|||
145382765|NCT00422292|524252541|FG001|Overall Study|Serious adverse events|4|||
145382766|NCT00422292|524252542|FG002|Overall Study|Serious adverse events|0|||
145382767|NCT00422292|524252543|FG003|Overall Study|Serious adverse events|0|||
145382768|NCT00422292|524252540|FG000|Overall Study|Adverse Event|1|||
145382769|NCT00422292|524252541|FG001|Overall Study|Adverse Event|0|||
145382770|NCT00422292|524252542|FG002|Overall Study|Adverse Event|1|||
145382771|NCT00422292|524252543|FG003|Overall Study|Adverse Event|0|||
145382772|NCT00422292|524252540|FG000|Overall Study|Protocol Violation|4|||
145382773|NCT00422292|524252541|FG001|Overall Study|Protocol Violation|25|||
145382774|NCT00422292|524252542|FG002|Overall Study|Protocol Violation|8|||
145382775|NCT00422292|524252543|FG003|Overall Study|Protocol Violation|5|||
145382776|NCT00422292|524252540|FG000|Overall Study|Lost to Follow-up|6|||
145382777|NCT00422292|524252541|FG001|Overall Study|Lost to Follow-up|12|||
145382778|NCT00422292|524252542|FG002|Overall Study|Lost to Follow-up|6|||
145382779|NCT00422292|524252543|FG003|Overall Study|Lost to Follow-up|6|||
145382780|NCT00422292|524252540|FG000|Overall Study|Withdrawal by Subject|6|||
145382781|NCT00422292|524252541|FG001|Overall Study|Withdrawal by Subject|25|||
145382782|NCT00422292|524252542|FG002|Overall Study|Withdrawal by Subject|7|||
145382783|NCT00422292|524252543|FG003|Overall Study|Withdrawal by Subject|13|||
145382784|NCT02440854|524252544|FG000|Overall Study|Relocation of patient|1|||
145382785|NCT02440854|524252544|FG000|Overall Study|Death|6|||
145382786|NCT02440854|524252544|FG000|Overall Study|Lost to Follow-up|10|||
145382787|NCT02440854|524252544|FG000|Overall Study|Afatinib discontinuation|46|||
145382788|NCT02440854|524252544|FG000|Overall Study|stopped study at earlier timepoint|14|||
145382789|NCT02440854|524252544|FG000|Overall Study|Study medication not received|1|||
145382790|NCT02440854|524252544|FG000|Overall Study|Violation of inclusion criteria|2|||
145382791|NCT03338569|524252545|FG000|Overall Study|Physician Decision|8|||
145382792|NCT03338569|524252546|FG001|Overall Study|Physician Decision|3|||
145382793|NCT03338569|524252545|FG000|Overall Study|Withdrawal by Subject|0|||
145382794|NCT03338569|524252546|FG001|Overall Study|Withdrawal by Subject|1|||
145382795|NCT03338569|524252545|FG000|Overall Study|Lost to Follow-up|0|||
145382796|NCT03338569|524252546|FG001|Overall Study|Lost to Follow-up|1|||
145382797|NCT01854879|524252547|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
145382798|NCT01854879|524252547|FG000|Overall Study|screen fail|3|||
145382799|NCT01854879|524252547|FG000|Overall Study|incomplete data set|1|||
145382800|NCT04494425|524254414|FG000|Overall Study|Death|160|||
145382801|NCT04494425|524254415|FG001|Overall Study|Death|166|||
145382802|NCT04494425|524254414|FG000|Overall Study|Withdrawal by Subject|10|||
145382803|NCT04494425|524254415|FG001|Overall Study|Withdrawal by Subject|40|||
145382804|NCT04494425|524254414|FG000|Overall Study|Other|1|||
145382805|NCT04494425|524254415|FG001|Overall Study|Other|1|||
145382806|NCT04494425|524254414|FG000|Overall Study|Ongoing at the time of PCD|265|||
145382807|NCT04494425|524254415|FG001|Overall Study|Ongoing at the time of PCD|223|||
145382808|NCT01270321|524254416|FG000|Overall Study|Death|3|||
145382809|NCT01270321|524254417|FG001|Overall Study|Death|1|||
145382810|NCT01270321|524254418|FG002|Overall Study|Death|4|||
145382811|NCT01270321|524254416|FG000|Overall Study|Adverse Event|7|||
145382812|NCT01270321|524254417|FG001|Overall Study|Adverse Event|9|||
145382813|NCT01270321|524254418|FG002|Overall Study|Adverse Event|5|||
145382814|NCT04003623|524254422|FG000|Overall Study|Withdrawal by Subject|1|||
145382815|NCT04003623|524254423|FG001|Overall Study|Withdrawal by Subject|0|||
145382816|NCT01744483|524254429|FG000|Overall Study|Death|9|||
145382817|NCT01744483|524254430|FG001|Overall Study|Death|4|||
145382818|NCT01744483|524254431|FG002|Overall Study|Death|11|||
145382819|NCT01744483|524254429|FG000|Overall Study|Lost to Follow-up|8|||
145382820|NCT01744483|524254430|FG001|Overall Study|Lost to Follow-up|9|||
145382821|NCT01744483|524254431|FG002|Overall Study|Lost to Follow-up|11|||
145382822|NCT01744483|524254429|FG000|Overall Study|Protocol Violation|1|||
145382823|NCT01744483|524254430|FG001|Overall Study|Protocol Violation|2|||
145382824|NCT01744483|524254431|FG002|Overall Study|Protocol Violation|1|||
145382825|NCT01744483|524254429|FG000|Overall Study|Withdrawal by Subject|4|||
145382826|NCT01744483|524254430|FG001|Overall Study|Withdrawal by Subject|6|||
145382827|NCT01744483|524254431|FG002|Overall Study|Withdrawal by Subject|2|||
145382828|NCT01744483|524254429|FG000|Overall Study|No ICU Admit|5|||
145382829|NCT01744483|524254430|FG001|Overall Study|No ICU Admit|1|||
145382830|NCT01744483|524254431|FG002|Overall Study|No ICU Admit|2|||
145382831|NCT01744483|524254429|FG000|Overall Study|Routed to OSH|2|||
145382832|NCT01744483|524254430|FG001|Overall Study|Routed to OSH|0|||
145382833|NCT01744483|524254431|FG002|Overall Study|Routed to OSH|1|||
145382834|NCT01190189|524254432|FG000|Overall Study|Lost to Follow-up|4|||
145382835|NCT01190189|524254432|FG000|Overall Study|Withdrawal by Subject|1|||
145382836|NCT01190189|524254432|FG000|Overall Study|Migrated/moved from study area|1|||
145382837|NCT04575584|524254433|FG000|Overall Study|Death|6|||
145382838|NCT04575584|524254434|FG001|Overall Study|Death|4|||
145382839|NCT04575584|524254435|FG002|Overall Study|Death|6|||
145382840|NCT04575584|524254436|FG003|Overall Study|Death|2|||
145382841|NCT04575584|524254437|FG004|Overall Study|Death|0|||
145382842|NCT04575584|524254438|FG005|Overall Study|Death|0|||
145382843|NCT04575584|524254433|FG000|Overall Study|Lost to Follow-up|1|||
145382844|NCT04575584|524254434|FG001|Overall Study|Lost to Follow-up|1|||
145382845|NCT04575584|524254435|FG002|Overall Study|Lost to Follow-up|1|||
145382846|NCT04575584|524254436|FG003|Overall Study|Lost to Follow-up|1|||
145382847|NCT04575584|524254437|FG004|Overall Study|Lost to Follow-up|0|||
145382848|NCT04575584|524254438|FG005|Overall Study|Lost to Follow-up|0|||
145493187|NCT00402168|524661220|FG001|Long Term (LT)|Pregnancy|1|||
145493188|NCT00402168|524661219|FG000|Long Term (LT)|Lost to Follow-up|1|||
145723539|NCT01136772|525504872|FG000|Overall Study|Adverse Event|15|||
145723540|NCT01136772|525504873|FG001|Overall Study|Adverse Event|14|||
145723541|NCT01136772|525504872|FG000|Overall Study|Lack of Efficacy|42|||
145723542|NCT01136772|525504873|FG001|Overall Study|Lack of Efficacy|39|||
145723543|NCT01136772|525504872|FG000|Overall Study|Administrative|14|||
145723544|NCT01136772|525504873|FG001|Overall Study|Administrative|12|||
145723545|NCT01136772|525504872|FG000|Overall Study|Withdrawal by Subject|33|||
145493189|NCT00402168|524661220|FG001|Long Term (LT)|Lost to Follow-up|0|||
145493190|NCT00402168|524661219|FG000|Long Term (LT)|Death|4|||
145723546|NCT01136772|525504873|FG001|Overall Study|Withdrawal by Subject|36|||
145723547|NCT01136772|525504872|FG000|Overall Study|Did not receive injection|10|||
145493191|NCT00402168|524661220|FG001|Long Term (LT)|Death|0|||
145493192|NCT00402168|524661219|FG000|Long Term (LT)|Lack of Efficacy|0|||
145493193|NCT00402168|524661220|FG001|Long Term (LT)|Lack of Efficacy|2|||
145493194|NCT00402168|524661219|FG000|Long Term (LT)|non-specified|1|||
145493195|NCT00402168|524661220|FG001|Long Term (LT)|non-specified|2|||
145493196|NCT00402168|524661219|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
145493197|NCT00402168|524661220|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
145493198|NCT00402168|524661219|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
145493199|NCT00402168|524661220|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
145493200|NCT00601835|524661224|FG000|Overall Study|Withdrawal by Subject|9|||
145493201|NCT00601835|524661225|FG001|Overall Study|Withdrawal by Subject|6|||
145493202|NCT00601835|524661224|FG000|Overall Study|Physician Decision|1|||
145493203|NCT00601835|524661225|FG001|Overall Study|Physician Decision|0|||
145493204|NCT00601835|524661224|FG000|Overall Study|Lost to Follow-up|37|||
145493205|NCT00601835|524661225|FG001|Overall Study|Lost to Follow-up|5|||
145493206|NCT00601835|524661224|FG000|Overall Study|Adverse Event|1|||
145493207|NCT00601835|524661225|FG001|Overall Study|Adverse Event|1|||
145493208|NCT00601835|524661224|FG000|Overall Study|Relocate|12|||
145493209|NCT00601835|524661225|FG001|Overall Study|Relocate|2|||
145493210|NCT02370420|524661226|FG000|Overall Study|Physician Decision|3|||
145493211|NCT02370420|524661227|FG001|Overall Study|Physician Decision|3|||
145493212|NCT02370420|524661226|FG000|Overall Study|Lost to Follow-up|11|||
145493213|NCT02370420|524661227|FG001|Overall Study|Lost to Follow-up|9|||
145493214|NCT00880620|524661228|FG000|Overall Study|Adverse Event|4|||
145493215|NCT00880620|524661229|FG001|Overall Study|Adverse Event|5|||
145493216|NCT00880620|524661230|FG002|Overall Study|Adverse Event|15|||
145493217|NCT00880620|524661231|FG003|Overall Study|Adverse Event|15|||
145493218|NCT00880620|524661228|FG000|Overall Study|Death|0|||
145493219|NCT00880620|524661229|FG001|Overall Study|Death|0|||
145493220|NCT00880620|524661230|FG002|Overall Study|Death|1|||
145493221|NCT00880620|524661231|FG003|Overall Study|Death|0|||
145493222|NCT00880620|524661228|FG000|Overall Study|Lack of Efficacy|12|||
145493223|NCT00880620|524661229|FG001|Overall Study|Lack of Efficacy|4|||
145493224|NCT00880620|524661230|FG002|Overall Study|Lack of Efficacy|0|||
145493225|NCT00880620|524661231|FG003|Overall Study|Lack of Efficacy|1|||
145493226|NCT00880620|524661228|FG000|Overall Study|Lost to Follow-up|0|||
145493227|NCT00880620|524661229|FG001|Overall Study|Lost to Follow-up|1|||
145493228|NCT00880620|524661230|FG002|Overall Study|Lost to Follow-up|1|||
145493229|NCT00880620|524661231|FG003|Overall Study|Lost to Follow-up|0|||
145493230|NCT00880620|524661228|FG000|Overall Study|Protocol Violation|0|||
145493231|NCT00880620|524661229|FG001|Overall Study|Protocol Violation|1|||
145493232|NCT00880620|524661230|FG002|Overall Study|Protocol Violation|0|||
145493233|NCT00880620|524661231|FG003|Overall Study|Protocol Violation|2|||
145493234|NCT00880620|524661228|FG000|Overall Study|Withdrawal by Subject|4|||
145493235|NCT00880620|524661229|FG001|Overall Study|Withdrawal by Subject|3|||
145493236|NCT00880620|524661230|FG002|Overall Study|Withdrawal by Subject|1|||
145493237|NCT00880620|524661231|FG003|Overall Study|Withdrawal by Subject|3|||
145493238|NCT00880620|524661228|FG000|Overall Study|Noncompliance|0|||
145493239|NCT00880620|524661229|FG001|Overall Study|Noncompliance|0|||
145493240|NCT00880620|524661230|FG002|Overall Study|Noncompliance|1|||
145493241|NCT00880620|524661231|FG003|Overall Study|Noncompliance|1|||
145493242|NCT00880620|524661228|FG000|Overall Study|Other|1|||
145493243|NCT00880620|524661229|FG001|Overall Study|Other|1|||
145493244|NCT00880620|524661230|FG002|Overall Study|Other|2|||
145493245|NCT00880620|524661231|FG003|Overall Study|Other|2|||
145493246|NCT01400698|524661232|FG000|Overall Study|Lost to Follow-up|2|||
145493247|NCT01400698|524661233|FG001|Overall Study|Lost to Follow-up|5|||
145493248|NCT01400698|524661234|FG002|Overall Study|Lost to Follow-up|2|||
145493249|NCT01400698|524661235|FG003|Overall Study|Lost to Follow-up|1|||
145493250|NCT01400698|524661236|FG004|Overall Study|Lost to Follow-up|4|||
145493251|NCT01400698|524661237|FG005|Overall Study|Lost to Follow-up|3|||
145493252|NCT01400698|524661232|FG000|Overall Study|Withdrawal by Subject|8|||
145493253|NCT01400698|524661233|FG001|Overall Study|Withdrawal by Subject|2|||
145493254|NCT01400698|524661234|FG002|Overall Study|Withdrawal by Subject|0|||
145493255|NCT01400698|524661235|FG003|Overall Study|Withdrawal by Subject|4|||
145493256|NCT01400698|524661236|FG004|Overall Study|Withdrawal by Subject|1|||
145493257|NCT01400698|524661237|FG005|Overall Study|Withdrawal by Subject|3|||
145493258|NCT01400698|524661232|FG000|Overall Study|Protocol Violation|0|||
145493259|NCT01400698|524661233|FG001|Overall Study|Protocol Violation|1|||
145493260|NCT01400698|524661234|FG002|Overall Study|Protocol Violation|0|||
145493261|NCT01400698|524661235|FG003|Overall Study|Protocol Violation|0|||
145493262|NCT01400698|524661236|FG004|Overall Study|Protocol Violation|1|||
145493263|NCT01400698|524661237|FG005|Overall Study|Protocol Violation|0|||
145493264|NCT01400698|524661232|FG000|Overall Study|Non-compliance|0|||
145493265|NCT01400698|524661233|FG001|Overall Study|Non-compliance|1|||
145493266|NCT01400698|524661234|FG002|Overall Study|Non-compliance|0|||
145493267|NCT01400698|524661235|FG003|Overall Study|Non-compliance|1|||
145493268|NCT01400698|524661236|FG004|Overall Study|Non-compliance|0|||
145493269|NCT01400698|524661237|FG005|Overall Study|Non-compliance|0|||
145493270|NCT01400698|524661232|FG000|Overall Study|Adverse Event|1|||
145493271|NCT01400698|524661233|FG001|Overall Study|Adverse Event|0|||
145382849|NCT04575584|524254433|FG000|Overall Study|Physician Decision|0|||
145382850|NCT04575584|524254434|FG001|Overall Study|Physician Decision|1|||
145382851|NCT04575584|524254435|FG002|Overall Study|Physician Decision|1|||
145382852|NCT04575584|524254436|FG003|Overall Study|Physician Decision|1|||
145382853|NCT04575584|524254437|FG004|Overall Study|Physician Decision|0|||
145382854|NCT04575584|524254438|FG005|Overall Study|Physician Decision|0|||
145382855|NCT04575584|524254433|FG000|Overall Study|Withdrawal by Subject|7|||
145382856|NCT04575584|524254434|FG001|Overall Study|Withdrawal by Subject|9|||
145382857|NCT04575584|524254435|FG002|Overall Study|Withdrawal by Subject|5|||
145382858|NCT04575584|524254436|FG003|Overall Study|Withdrawal by Subject|3|||
145382859|NCT04575584|524254437|FG004|Overall Study|Withdrawal by Subject|0|||
145382860|NCT04575584|524254438|FG005|Overall Study|Withdrawal by Subject|0|||
145382861|NCT04575584|524254433|FG000|Overall Study|Not recorded|0|||
145382862|NCT04575584|524254434|FG001|Overall Study|Not recorded|0|||
145382863|NCT04575584|524254435|FG002|Overall Study|Not recorded|0|||
145382864|NCT04575584|524254436|FG003|Overall Study|Not recorded|1|||
145382865|NCT04575584|524254437|FG004|Overall Study|Not recorded|0|||
145382866|NCT04575584|524254438|FG005|Overall Study|Not recorded|0|||
145382867|NCT02335346|524254439|FG000|Overall Study|Adverse Event|11|||
145382868|NCT02335346|524254439|FG000|Overall Study|Withdrawal by Subject|1|||
145382869|NCT01548768|524254440|FG000|Overall Study|Withdrawal by Subject|0|||
145382870|NCT01548768|524254441|FG001|Overall Study|Withdrawal by Subject|2|||
145382871|NCT01548768|524254442|FG002|Overall Study|Withdrawal by Subject|1|||
145382872|NCT01548768|524254443|FG003|Overall Study|Withdrawal by Subject|0|||
145382873|NCT01548768|524254440|FG000|Overall Study|Physician Decision|1|||
145382874|NCT01548768|524254441|FG001|Overall Study|Physician Decision|0|||
145382875|NCT01548768|524254442|FG002|Overall Study|Physician Decision|0|||
145382876|NCT01548768|524254443|FG003|Overall Study|Physician Decision|0|||
145382877|NCT01548768|524254440|FG000|Overall Study|Adverse Event|0|||
145382878|NCT01548768|524254441|FG001|Overall Study|Adverse Event|0|||
145382879|NCT01548768|524254442|FG002|Overall Study|Adverse Event|0|||
145382880|NCT01548768|524254443|FG003|Overall Study|Adverse Event|1|||
145382881|NCT01548768|524254440|FG000|Overall Study|Non-Compliance|0|||
145382882|NCT01548768|524254441|FG001|Overall Study|Non-Compliance|0|||
145382883|NCT01548768|524254442|FG002|Overall Study|Non-Compliance|0|||
145382884|NCT01548768|524254443|FG003|Overall Study|Non-Compliance|3|||
145382885|NCT02907619|524254444|FG000|Overall Study|Study terminated by sponsor|18|||
145382886|NCT02907619|524254445|FG001|Overall Study|Study terminated by sponsor|18|||
145382887|NCT02907619|524254446|FG002|Overall Study|Study terminated by sponsor|19|||
145382888|NCT02907619|524254444|FG000|Overall Study|Death|0|||
145382889|NCT02907619|524254445|FG001|Overall Study|Death|0|||
145382890|NCT02907619|524254446|FG002|Overall Study|Death|1|||
145382891|NCT02907619|524254444|FG000|Overall Study|Withdrawal by Subject|1|||
145382892|NCT02907619|524254445|FG001|Overall Study|Withdrawal by Subject|1|||
145382893|NCT02907619|524254446|FG002|Overall Study|Withdrawal by Subject|0|||
145382894|NCT02907619|524254444|FG000|Overall Study|Other|0|||
145382895|NCT02907619|524254445|FG001|Overall Study|Other|1|||
145382896|NCT02907619|524254446|FG002|Overall Study|Other|0|||
145382897|NCT01375374|524254447|FG000|Overall Study|Adverse Event|1|||
145382898|NCT01908582|524254448|FG000|Period 2|Physician Decision|1|||
145382899|NCT01908582|524254448|FG000|Period 2|Withdrawal by Subject|1|||
145382900|NCT04847232|524254449|FG000|Overall Study|Death|123|||
145382901|NCT04847232|524254450|FG001|Overall Study|Death|115|||
145382902|NCT04847232|524254449|FG000|Overall Study|Lost to Follow-up|3|||
145382903|NCT04847232|524254450|FG001|Overall Study|Lost to Follow-up|10|||
145382904|NCT04847232|524254449|FG000|Overall Study|Withdrawal by Subject|73|||
145382905|NCT04847232|524254450|FG001|Overall Study|Withdrawal by Subject|101|||
145382906|NCT04847232|524254449|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
145382907|NCT04847232|524254450|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
145382908|NCT02476916|524254455|FG000|Core Period|Adverse Event|2|||
145493272|NCT01400698|524661234|FG002|Overall Study|Adverse Event|0|||
145493273|NCT01400698|524661235|FG003|Overall Study|Adverse Event|0|||
145382909|NCT02476916|524254456|FG001|Core Period|Adverse Event|2|||
145382910|NCT02476916|524254455|FG000|Core Period|Investigator decision|1|||
145382911|NCT02476916|524254456|FG001|Core Period|Investigator decision|1|||
145382912|NCT02476916|524254455|FG000|Core Period|Withdrawal by Subject|3|||
145382913|NCT02476916|524254456|FG001|Core Period|Withdrawal by Subject|0|||
145382914|NCT02476916|524254455|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
145382915|NCT02476916|524254456|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
145493274|NCT01400698|524661236|FG004|Overall Study|Adverse Event|0|||
145493275|NCT01400698|524661237|FG005|Overall Study|Adverse Event|0|||
145382916|NCT02476916|524254455|FG000|Extension Period|On Treatment|12|||
145382917|NCT02476916|524254456|FG001|Extension Period|On Treatment|17|||
145382918|NCT04401202|524254457|FG000|Overall Study|Lost to Follow-up|2|||
145382919|NCT04401202|524254458|FG001|Overall Study|Lost to Follow-up|2|||
145382920|NCT04401202|524254457|FG000|Overall Study|Adverse Event|0|||
145493276|NCT01400698|524661232|FG000|Overall Study|Other|4|||
145382921|NCT04401202|524254458|FG001|Overall Study|Adverse Event|1|||
145382922|NCT04401202|524254457|FG000|Overall Study|Hospitalized|4|||
145382923|NCT04401202|524254458|FG001|Overall Study|Hospitalized|1|||
145382924|NCT01006590|524254459|FG000|Overall Study|Adverse Event|2|||
145382925|NCT01006590|524254460|FG001|Overall Study|Adverse Event|3|||
145382926|NCT01006590|524254459|FG000|Overall Study|Death|1|||
145382927|NCT01006590|524254460|FG001|Overall Study|Death|1|||
145382928|NCT01006590|524254459|FG000|Overall Study|Lost to Follow-up|1|||
145382929|NCT01006590|524254460|FG001|Overall Study|Lost to Follow-up|1|||
145382930|NCT01006590|524254459|FG000|Overall Study|Protocol Violation|1|||
145382931|NCT01006590|524254460|FG001|Overall Study|Protocol Violation|0|||
145382932|NCT01006590|524254459|FG000|Overall Study|Withdrawal by Subject|4|||
145382933|NCT01006590|524254460|FG001|Overall Study|Withdrawal by Subject|2|||
145382934|NCT01006590|524254459|FG000|Overall Study|Study specific discontinuation criteria|16|||
145382935|NCT01006590|524254460|FG001|Overall Study|Study specific discontinuation criteria|23|||
145382936|NCT01006590|524254459|FG000|Overall Study|Other|3|||
145382937|NCT01006590|524254460|FG001|Overall Study|Other|2|||
145382938|NCT03332095|524254461|FG000|Overall Study|Lost to Follow-up|1|||
145382939|NCT03332095|524254462|FG001|Overall Study|Lost to Follow-up|0|||
145382940|NCT03332095|524254461|FG000|Overall Study|Pregnancy|0|||
145382941|NCT03332095|524254462|FG001|Overall Study|Pregnancy|1|||
145382942|NCT02570750|524254468|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
145382943|NCT02570750|524254469|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
145382944|NCT02570750|524254468|FG000|Overall Study|Protocol deviation|4|||
145382945|NCT02570750|524254469|FG001|Overall Study|Protocol deviation|2|||
145382946|NCT02570750|524254468|FG000|Overall Study|Withdrawal by Subject|5|||
145382947|NCT02570750|524254469|FG001|Overall Study|Withdrawal by Subject|0|||
145382948|NCT02570750|524254468|FG000|Overall Study|Lost to Follow-up|2|||
145382949|NCT02570750|524254469|FG001|Overall Study|Lost to Follow-up|2|||
145382950|NCT02570750|524254468|FG000|Overall Study|Adverse Event|2|||
145382951|NCT02570750|524254469|FG001|Overall Study|Adverse Event|1|||
145382952|NCT01410240|524254470|FG000|Overall Study|Physician Decision|0|||
145382953|NCT01410240|524254471|FG001|Overall Study|Physician Decision|0|||
145382954|NCT01410240|524254472|FG002|Overall Study|Physician Decision|1|||
145382955|NCT01410240|524254470|FG000|Overall Study|Missed week 6 assessments|1|||
145382956|NCT01410240|524254471|FG001|Overall Study|Missed week 6 assessments|1|||
145382957|NCT01410240|524254472|FG002|Overall Study|Missed week 6 assessments|1|||
145382958|NCT04348500|524254473|FG000|Overall Study|Death|2|||
145382959|NCT04348500|524254474|FG001|Overall Study|Death|2|||
145382960|NCT04348500|524254473|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
145382961|NCT04348500|524254474|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
145382962|NCT02776670|524254475|FG000|Overall Study|Adverse Event|0|||
145382963|NCT02776670|524254476|FG001|Overall Study|Adverse Event|2|||
145382964|NCT02776670|524254475|FG000|Overall Study|Protocol Violation|0|||
145382965|NCT02776670|524254476|FG001|Overall Study|Protocol Violation|2|||
145382966|NCT02776670|524254475|FG000|Overall Study|Withdrawal by Subject|0|||
145382967|NCT02776670|524254476|FG001|Overall Study|Withdrawal by Subject|1|||
145382968|NCT02776670|524254475|FG000|Overall Study|Other - Reason not given|0|||
145382969|NCT02776670|524254476|FG001|Overall Study|Other - Reason not given|1|||
145382970|NCT03699540|524254477|FG000|Overall Study|Lost to Follow-up|1|||
145382971|NCT00624832|524254480|FG000|Overall Study|Adverse Event|0|||
145382972|NCT00624832|524254481|FG001|Overall Study|Adverse Event|1|||
145382973|NCT00624832|524254482|FG002|Overall Study|Adverse Event|0|||
145382974|NCT00624832|524254483|FG003|Overall Study|Adverse Event|1|||
145382975|NCT00624832|524254480|FG000|Overall Study|Abnormal Laboratory Value|2|||
145382976|NCT00624832|524254481|FG001|Overall Study|Abnormal Laboratory Value|0|||
145382977|NCT00624832|524254482|FG002|Overall Study|Abnormal Laboratory Value|0|||
145382978|NCT00624832|524254483|FG003|Overall Study|Abnormal Laboratory Value|0|||
145382979|NCT01939223|524254484|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
145382980|NCT01939223|524254485|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
145382981|NCT01939223|524254484|FG000|Overall Study|Disease recurrence (radiological)|1|||
145382982|NCT01939223|524254485|FG001|Overall Study|Disease recurrence (radiological)|3|||
145382983|NCT01939223|524254484|FG000|Overall Study|Study stopped by Sponsor|5|||
145382984|NCT01939223|524254485|FG001|Overall Study|Study stopped by Sponsor|7|||
145382985|NCT01939223|524254484|FG000|Overall Study|Withdrawal by Subject|6|||
145723548|NCT01136772|525504873|FG001|Overall Study|Did not receive injection|7|||
145723549|NCT01136772|525504872|FG000|Overall Study|Did not follow up after first injection|2|||
145723550|NCT01136772|525504873|FG001|Overall Study|Did not follow up after first injection|2|||
145723551|NCT01498653|525504875|FG000|Overall Study|Adverse Event|2|||
145723552|NCT01498653|525504876|FG001|Overall Study|Adverse Event|2|||
145723553|NCT01498653|525504875|FG000|Overall Study|Lack of Efficacy|12|||
145723554|NCT01498653|525504876|FG001|Overall Study|Lack of Efficacy|26|||
145723555|NCT01498653|525504875|FG000|Overall Study|Protocol Violation|0|||
145723556|NCT01498653|525504876|FG001|Overall Study|Protocol Violation|4|||
145382986|NCT01939223|524254485|FG001|Overall Study|Withdrawal by Subject|0|||
145382987|NCT00957424|524254492|FG000|Overall Study|Lost to Follow-up|19|||
145382988|NCT00957424|524254492|FG000|Overall Study|Protocol Violation|3|||
145382989|NCT00957424|524254492|FG000|Overall Study|Withdrawal by Subject|1|||
145723557|NCT01498653|525504875|FG000|Overall Study|Lost to Follow-up|1|||
145723558|NCT01498653|525504876|FG001|Overall Study|Lost to Follow-up|0|||
145493277|NCT01400698|524661233|FG001|Overall Study|Other|2|||
145493278|NCT01400698|524661234|FG002|Overall Study|Other|0|||
145723559|NCT01498653|525504875|FG000|Overall Study|Physician Decision|2|||
145723560|NCT01498653|525504876|FG001|Overall Study|Physician Decision|0|||
145723561|NCT01498653|525504875|FG000|Overall Study|Withdrawal by Subject|2|||
145723562|NCT01498653|525504876|FG001|Overall Study|Withdrawal by Subject|3|||
145723563|NCT00836095|525504877|FG000|Overall Study|Physician Decision|0|||
145723564|NCT00836095|525504878|FG001|Overall Study|Physician Decision|3|||
145723565|NCT01602562|525504879|FG000|Overall Study|Adverse Event|3|||
145723566|NCT01602562|525504880|FG001|Overall Study|Adverse Event|1|||
145723567|NCT01602562|525504879|FG000|Overall Study|Physician Decision|1|||
145723568|NCT01602562|525504880|FG001|Overall Study|Physician Decision|1|||
145723569|NCT01602562|525504879|FG000|Overall Study|Withdrawal by Subject|1|||
145723570|NCT01602562|525504880|FG001|Overall Study|Withdrawal by Subject|1|||
145723571|NCT04964414|525504881|FG000|Overall Study|Lost to Follow-up|10|||
145723572|NCT04964414|525504882|FG001|Overall Study|Lost to Follow-up|8|||
145723573|NCT04964414|525504881|FG000|Overall Study|Withdrawal by Subject|1|||
145723574|NCT04964414|525504882|FG001|Overall Study|Withdrawal by Subject|1|||
145723575|NCT00819390|525504883|FG000|Overall Study|Lost to Follow-up|1|||
145723576|NCT00819390|525504884|FG001|Overall Study|Lost to Follow-up|1|||
145723577|NCT00819390|525504885|FG002|Overall Study|Lost to Follow-up|0|||
145723578|NCT00819390|525504886|FG003|Overall Study|Lost to Follow-up|0|||
145723579|NCT00819390|525504883|FG000|Overall Study|Withdrawal by Subject|2|||
145723580|NCT00819390|525504884|FG001|Overall Study|Withdrawal by Subject|0|||
145493279|NCT01400698|524661235|FG003|Overall Study|Other|2|||
145493280|NCT01400698|524661236|FG004|Overall Study|Other|1|||
145493281|NCT01400698|524661237|FG005|Overall Study|Other|0|||
145382990|NCT02700698|524254493|FG000|Overall Study|Withdrawal by Subject|1|||
145382991|NCT02700698|524254494|FG001|Overall Study|Withdrawal by Subject|0|||
145382992|NCT00703118|524254495|FG000|Overall Study|Adverse Event|1|||
145382993|NCT00703118|524254496|FG001|Overall Study|Adverse Event|2|||
145382994|NCT00703118|524254497|FG002|Overall Study|Adverse Event|2|||
145382995|NCT00703118|524254495|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
145382996|NCT00703118|524254496|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
145382997|NCT00703118|524254497|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
145382998|NCT00703118|524254495|FG000|Overall Study|Lost to Follow-up|6|||
145382999|NCT00703118|524254496|FG001|Overall Study|Lost to Follow-up|4|||
145383000|NCT00703118|524254497|FG002|Overall Study|Lost to Follow-up|4|||
145383001|NCT00703118|524254495|FG000|Overall Study|Withdrawal by Subject|8|||
145383002|NCT00703118|524254496|FG001|Overall Study|Withdrawal by Subject|7|||
145383003|NCT00703118|524254497|FG002|Overall Study|Withdrawal by Subject|13|||
145383004|NCT00703118|524254495|FG000|Overall Study|Other|0|||
145383005|NCT00703118|524254496|FG001|Overall Study|Other|0|||
145383006|NCT00703118|524254497|FG002|Overall Study|Other|1|||
145383007|NCT04165135|524254498|FG000|Overall Study|Protocol Violation|10|||
145383008|NCT04165135|524254498|FG000|Overall Study|Participants withdrawal of consent|5|||
145383009|NCT00530790|524254499|FG000|Overall Study|Adverse Event|2|||
145383010|NCT00530790|524254499|FG000|Overall Study|Withdrawal by Subject|2|||
145383011|NCT00530790|524254499|FG000|Overall Study|Physician Decision|1|||
145383012|NCT05053035|524254504|FG000|Overall Study|Withdrawal by Subject|1|||
145383013|NCT05053035|524254505|FG001|Overall Study|Withdrawal by Subject|0|||
145383014|NCT02005627|524254509|FG000|Overall Study|Lost to Follow-up|1|||
145383015|NCT02005627|524254510|FG001|Overall Study|Lost to Follow-up|2|||
145383016|NCT02005627|524254509|FG000|Overall Study|Withdrawal by Subject|1|||
145383017|NCT02005627|524254510|FG001|Overall Study|Withdrawal by Subject|2|||
145383018|NCT03003000|524254518|FG000|Overall Study|Adverse Event|1|||
145383019|NCT03003000|524254519|FG001|Overall Study|Adverse Event|2|||
145383020|NCT03003000|524254520|FG002|Overall Study|Adverse Event|3|||
145383021|NCT03003000|524254518|FG000|Overall Study|Lack of Efficacy|1|||
145383022|NCT03003000|524254519|FG001|Overall Study|Lack of Efficacy|0|||
145383023|NCT03003000|524254520|FG002|Overall Study|Lack of Efficacy|0|||
145383024|NCT03003000|524254518|FG000|Overall Study|Non-compliant with protocol|0|||
145383025|NCT03003000|524254519|FG001|Overall Study|Non-compliant with protocol|1|||
145383026|NCT03003000|524254520|FG002|Overall Study|Non-compliant with protocol|1|||
145383027|NCT03003000|524254518|FG000|Overall Study|Refused to continue medication|2|||
145383028|NCT03003000|524254519|FG001|Overall Study|Refused to continue medication|0|||
145383029|NCT03003000|524254520|FG002|Overall Study|Refused to continue medication|0|||
145383030|NCT03003000|524254518|FG000|Overall Study|Other than listed|1|||
145383031|NCT03003000|524254519|FG001|Overall Study|Other than listed|1|||
145383032|NCT03003000|524254520|FG002|Overall Study|Other than listed|1|||
145383033|NCT04933617|524254521|FG000|Dose Escalation|Early closure of study|0|||
145383034|NCT04933617|524254522|FG001|Dose Escalation|Early closure of study|3|||
145383035|NCT04933617|524254523|FG002|Dose Escalation|Early closure of study|0|||
145383036|NCT04933617|524254524|FG003|Dose Escalation|Early closure of study|0|||
145383037|NCT04933617|524254525|FG004|Dose Escalation|Early closure of study|0|||
145383038|NCT02191046|524254535|FG000|Overall Study|low compliance|5|||
145383039|NCT02191046|524254536|FG001|Overall Study|low compliance|1|||
145383040|NCT01964716|524254537|FG000|Overall Study|Withdrawal by Subject|2|||
145383041|NCT01964716|524254538|FG001|Overall Study|Withdrawal by Subject|3|||
145383042|NCT01964716|524254537|FG000|Overall Study|Lost to Follow-up|1|||
145383043|NCT01964716|524254538|FG001|Overall Study|Lost to Follow-up|2|||
145383044|NCT01964716|524254537|FG000|Overall Study|No longer met eligibility criteria|1|||
145383045|NCT01964716|524254538|FG001|Overall Study|No longer met eligibility criteria|1|||
145383046|NCT01964716|524254537|FG000|Overall Study|Death|1|||
145383047|NCT01964716|524254538|FG001|Overall Study|Death|0|||
145383048|NCT03913104|524254543|FG000|Overall Study|Lost to Follow-up|20|||
145383049|NCT03913104|524254543|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
145383050|NCT03913104|524254543|FG000|Overall Study|Withdrawal by Subject|2|||
145383051|NCT01119846|524254544|FG000|Overall Study|Adverse Event|1|||
145383052|NCT01119846|524254545|FG001|Overall Study|Adverse Event|0|||
145493282|NCT05546476|524663339|FG000|Period 1: Part A|Adverse Event|2|||
145493283|NCT05546476|524663340|FG001|Period 1: Part A|Adverse Event|0|||
145493284|NCT05546476|524663341|FG002|Period 1: Part A|Adverse Event|0|||
145383053|NCT01119846|524254546|FG002|Overall Study|Adverse Event|6|||
145383054|NCT01119846|524254544|FG000|Overall Study|Physician Decision|1|||
145383055|NCT01119846|524254545|FG001|Overall Study|Physician Decision|0|||
145383056|NCT01119846|524254546|FG002|Overall Study|Physician Decision|0|||
145383057|NCT01119846|524254544|FG000|Overall Study|Protocol Violation|0|||
145383058|NCT01119846|524254545|FG001|Overall Study|Protocol Violation|0|||
145493285|NCT05546476|524663342|FG003|Period 1: Part A|Adverse Event|1|||
145383059|NCT01119846|524254546|FG002|Overall Study|Protocol Violation|1|||
145383060|NCT01119846|524254544|FG000|Overall Study|Withdrawal by Subject|0|||
145383061|NCT01119846|524254545|FG001|Overall Study|Withdrawal by Subject|0|||
145383062|NCT01119846|524254546|FG002|Overall Study|Withdrawal by Subject|4|||
145493286|NCT05546476|524663339|FG000|Period 1: Part A|Death|4|||
145493287|NCT05546476|524663340|FG001|Period 1: Part A|Death|4|||
145493288|NCT05546476|524663341|FG002|Period 1: Part A|Death|5|||
145383063|NCT02906033|524254548|FG000|Baseline|Protocol Violation|37|||
145383064|NCT02906033|524254549|FG001|Baseline|Protocol Violation|33|||
145383065|NCT02906033|524254548|FG000|Follow-up|Lost to Follow-up|46|||
145383066|NCT02906033|524254549|FG001|Follow-up|Lost to Follow-up|62|||
145383067|NCT00358956|524254550|FG000|Overall Study|Adverse Event|3|||
145383068|NCT00358956|524254550|FG000|Overall Study|condition under investigation worsened|4|||
145383069|NCT00358956|524254550|FG000|Overall Study|Withdrawal by Subject|1|||
145383070|NCT02243046|524254552|FG000|Overall Study|Lost to Follow-up|1|||
145383071|NCT02243046|524254553|FG001|Overall Study|Lost to Follow-up|1|||
145383072|NCT02243046|524254554|FG002|Overall Study|Lost to Follow-up|4|||
145383073|NCT04607980|524254555|FG000|Overall Study|Adverse Event|3|||
145383074|NCT04607980|524254556|FG001|Overall Study|Adverse Event|4|||
145383075|NCT04607980|524254555|FG000|Overall Study|Death|0|||
145383076|NCT04607980|524254556|FG001|Overall Study|Death|1|||
145383077|NCT04607980|524254555|FG000|Overall Study|Withdrawal by Subject|2|||
145383078|NCT04607980|524254556|FG001|Overall Study|Withdrawal by Subject|5|||
145383079|NCT04607980|524254555|FG000|Overall Study|Lost to Follow-up|4|||
145383080|NCT04607980|524254556|FG001|Overall Study|Lost to Follow-up|8|||
145383081|NCT04607980|524254555|FG000|Overall Study|Protocol Violation|0|||
145383082|NCT04607980|524254556|FG001|Overall Study|Protocol Violation|3|||
145383083|NCT04607980|524254555|FG000|Overall Study|Other|3|||
145383084|NCT04607980|524254556|FG001|Overall Study|Other|0|||
145383085|NCT02012959|524254557|FG000|Treatment Phase A|Adverse Event|2|||
145383086|NCT02012959|524254558|FG001|Treatment Phase A|Adverse Event|0|||
145383087|NCT02012959|524254559|FG002|Treatment Phase A|Adverse Event|0|||
145383088|NCT02012959|524254560|FG003|Treatment Phase A|Adverse Event|0|||
145383089|NCT02012959|524254561|FG004|Treatment Phase A|Adverse Event|0|||
145383090|NCT01859949|524256396|FG000|Overall Study|Family Matters|0|||
145383091|NCT01859949|524256397|FG001|Overall Study|Family Matters|1|||
145383092|NCT01859949|524256396|FG000|Overall Study|Physician Decision|2|||
145383093|NCT01859949|524256397|FG001|Overall Study|Physician Decision|4|||
145383094|NCT01859949|524256396|FG000|Overall Study|Withdrawal by Subject|11|||
145383095|NCT01859949|524256397|FG001|Overall Study|Withdrawal by Subject|10|||
145383096|NCT01859949|524256396|FG000|Overall Study|Protocol Violation|1|||
145383097|NCT01859949|524256397|FG001|Overall Study|Protocol Violation|1|||
145383098|NCT01859949|524256396|FG000|Overall Study|Adverse Event|0|||
145383099|NCT01859949|524256397|FG001|Overall Study|Adverse Event|1|||
145383100|NCT01709409|524256402|FG000|Overall Study|Protocol Violation|1|||
145383101|NCT01709409|524256403|FG001|Overall Study|Protocol Violation|0|||
145383102|NCT02412878|524256404|FG000|Overall Study|Withdrawal by Subject|19|||
145383103|NCT02412878|524256405|FG001|Overall Study|Withdrawal by Subject|10|||
145383104|NCT02412878|524256404|FG000|Overall Study|Lost to Follow-up|2|||
145383105|NCT02412878|524256405|FG001|Overall Study|Lost to Follow-up|3|||
145383106|NCT02190721|524256406|FG000|Overall Study|Patient was out of the city|0|||
145383107|NCT02190721|524256407|FG001|Overall Study|Patient was out of the city|1|||
145383108|NCT02190721|524256408|FG002|Overall Study|Patient was out of the city|0|||
145383109|NCT04571385|524256409|FG000|Overall Study|Participant non-compliance|1|||
145383110|NCT04571385|524256410|FG001|Overall Study|Participant non-compliance|0|||
145383111|NCT04571385|524256411|FG002|Overall Study|Participant non-compliance|0|||
145383112|NCT04571385|524256409|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
145383113|NCT04571385|524256410|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
145383114|NCT04571385|524256411|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
145383115|NCT04571385|524256409|FG000|Overall Study|Screen failure|0|||
145383116|NCT04571385|524256410|FG001|Overall Study|Screen failure|0|||
145383117|NCT04571385|524256411|FG002|Overall Study|Screen failure|1|||
145383118|NCT01928199|524256413|FG000|Overall Study|Lost to Follow-up|2|||
145383119|NCT01928199|524256414|FG001|Overall Study|Lost to Follow-up|1|||
145383120|NCT01928199|524256413|FG000|Overall Study|Withdrawal by Subject|3|||
145383121|NCT01928199|524256414|FG001|Overall Study|Withdrawal by Subject|5|||
145383122|NCT03300050|524256441|FG000|Overall Study|Lost to Follow-up|2|||
145383123|NCT03300050|524256442|FG001|Overall Study|Lost to Follow-up|1|||
145383124|NCT03300050|524256443|FG002|Overall Study|Lost to Follow-up|0|||
145383125|NCT03300050|524256444|FG003|Overall Study|Lost to Follow-up|0|||
145383126|NCT03300050|524256445|FG004|Overall Study|Lost to Follow-up|1|||
145383127|NCT03300050|524256441|FG000|Overall Study|Withdrawal by Subject|1|||
145383128|NCT03300050|524256442|FG001|Overall Study|Withdrawal by Subject|1|||
145383129|NCT03300050|524256443|FG002|Overall Study|Withdrawal by Subject|1|||
145383130|NCT03300050|524256444|FG003|Overall Study|Withdrawal by Subject|0|||
145383131|NCT03300050|524256445|FG004|Overall Study|Withdrawal by Subject|0|||
145383132|NCT03300050|524256441|FG000|Overall Study|Death|0|||
145383133|NCT03300050|524256442|FG001|Overall Study|Death|0|||
145383134|NCT03300050|524256443|FG002|Overall Study|Death|1|||
145383135|NCT03300050|524256444|FG003|Overall Study|Death|0|||
145383136|NCT03300050|524256445|FG004|Overall Study|Death|0|||
145383137|NCT03300050|524256441|FG000|Overall Study|Not Eligible at Randomization|0|||
145383138|NCT03300050|524256442|FG001|Overall Study|Not Eligible at Randomization|0|||
145383139|NCT03300050|524256443|FG002|Overall Study|Not Eligible at Randomization|1|||
145383140|NCT03300050|524256444|FG003|Overall Study|Not Eligible at Randomization|1|||
145383141|NCT03300050|524256445|FG004|Overall Study|Not Eligible at Randomization|0|||
145383142|NCT03326518|524256446|FG000|Overall Study|Protocol Violation|1|||
145383143|NCT03326518|524256447|FG001|Overall Study|Protocol Violation|0|||
145383144|NCT03326518|524256448|FG002|Overall Study|Protocol Violation|0|||
145383145|NCT03326518|524256446|FG000|Overall Study|Withdrawal by Subject|1|||
145383146|NCT03326518|524256447|FG001|Overall Study|Withdrawal by Subject|0|||
145383147|NCT03326518|524256448|FG002|Overall Study|Withdrawal by Subject|0|||
145383148|NCT03326518|524256446|FG000|Overall Study|Lost to Follow-up|1|||
145383149|NCT03326518|524256447|FG001|Overall Study|Lost to Follow-up|0|||
145383150|NCT03326518|524256448|FG002|Overall Study|Lost to Follow-up|1|||
145383151|NCT06010732|524256450|FG000|Crossover Period 1|Protocol Violation|0|||
145383152|NCT06010732|524256451|FG001|Crossover Period 1|Protocol Violation|0|||
145383153|NCT06010732|524256452|FG002|Crossover Period 1|Protocol Violation|1|||
145383154|NCT06010732|524256453|FG003|Crossover Period 1|Protocol Violation|0|||
145383155|NCT06010732|524256454|FG004|Crossover Period 1|Protocol Violation|1|||
145383156|NCT06010732|524256455|FG005|Crossover Period 1|Protocol Violation|0|||
145383157|NCT06010732|524256450|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145383158|NCT06010732|524256451|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
145383159|NCT06010732|524256452|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145383160|NCT06010732|524256453|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145383161|NCT06010732|524256454|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145383162|NCT06010732|524256455|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
145383163|NCT06010732|524256450|FG000|Crossover Period 2|Adverse Event|0|||
145383164|NCT06010732|524256451|FG001|Crossover Period 2|Adverse Event|1|||
145383165|NCT06010732|524256452|FG002|Crossover Period 2|Adverse Event|0|||
145493289|NCT05546476|524663342|FG003|Period 1: Part A|Death|6|||
145493290|NCT05546476|524663339|FG000|Period 1: Part A|Lack of Efficacy|0|||
145723581|NCT00819390|525504885|FG002|Overall Study|Withdrawal by Subject|0|||
145383166|NCT06010732|524256453|FG003|Crossover Period 2|Adverse Event|0|||
145383167|NCT06010732|524256454|FG004|Crossover Period 2|Adverse Event|0|||
145383168|NCT06010732|524256455|FG005|Crossover Period 2|Adverse Event|0|||
145383169|NCT06010732|524256450|FG000|Crossover Period 2|broken denture|0|||
145383170|NCT06010732|524256451|FG001|Crossover Period 2|broken denture|0|||
145383171|NCT06010732|524256452|FG002|Crossover Period 2|broken denture|1|||
145383172|NCT06010732|524256453|FG003|Crossover Period 2|broken denture|0|||
145383173|NCT06010732|524256454|FG004|Crossover Period 2|broken denture|0|||
145383174|NCT06010732|524256455|FG005|Crossover Period 2|broken denture|0|||
145383175|NCT02714036|524256457|FG000|Overall Study|Adverse Event|9|||
145383176|NCT02714036|524256458|FG001|Overall Study|Adverse Event|2|||
145383177|NCT02714036|524256457|FG000|Overall Study|Withdrawal by Subject|3|||
145383178|NCT02714036|524256458|FG001|Overall Study|Withdrawal by Subject|2|||
145383179|NCT04942210|524256460|FG000|Overall Study|Adverse Event|0|||
145383180|NCT04942210|524256461|FG001|Overall Study|Adverse Event|1|||
145383181|NCT04942210|524256460|FG000|Overall Study|Protocol Deviation|4|||
145383182|NCT04942210|524256461|FG001|Overall Study|Protocol Deviation|1|||
145383183|NCT04942210|524256460|FG000|Overall Study|Withdrawal by Subject|5|||
145383184|NCT04942210|524256461|FG001|Overall Study|Withdrawal by Subject|2|||
145383185|NCT04942210|524256460|FG000|Overall Study|Lost to Follow-up|16|||
145383186|NCT04942210|524256461|FG001|Overall Study|Lost to Follow-up|7|||
145383187|NCT04942210|524256460|FG000|Overall Study|Ongoing at the time of DBL date|60|||
145383188|NCT04942210|524256461|FG001|Overall Study|Ongoing at the time of DBL date|25|||
145383189|NCT04942210|524256460|FG000|Overall Study|Randomized but did not receive vaccination|3|||
145383190|NCT04942210|524256461|FG001|Overall Study|Randomized but did not receive vaccination|0|||
145383191|NCT05697627|524256462|FG000|Overall Study|Adverse Event|1|||
145383192|NCT02722746|524256463|FG000|Overall Study|Withdrawal by Subject|0|||
145383193|NCT02722746|524256464|FG001|Overall Study|Withdrawal by Subject|1|||
145383194|NCT02722746|524256465|FG002|Overall Study|Withdrawal by Subject|0|||
145383195|NCT02722746|524256463|FG000|Overall Study|Protocol Violation|8|||
145383196|NCT02722746|524256464|FG001|Overall Study|Protocol Violation|4|||
145383197|NCT02722746|524256465|FG002|Overall Study|Protocol Violation|6|||
145383198|NCT01618916|524256468|FG000|Overall Study|Adverse Event|1|||
145383199|NCT01618916|524256469|FG001|Overall Study|Adverse Event|0|||
145383200|NCT01618916|524256470|FG002|Overall Study|Adverse Event|0|||
145383201|NCT01618916|524256471|FG003|Overall Study|Adverse Event|0|||
145383202|NCT01618916|524256472|FG004|Overall Study|Adverse Event|0|||
145383203|NCT01618916|524256473|FG005|Overall Study|Adverse Event|0|||
145383204|NCT01618916|524256468|FG000|Overall Study|Withdrawal by Subject|0|||
145383205|NCT01618916|524256469|FG001|Overall Study|Withdrawal by Subject|1|||
145383206|NCT01618916|524256470|FG002|Overall Study|Withdrawal by Subject|1|||
145493291|NCT05546476|524663340|FG001|Period 1: Part A|Lack of Efficacy|0|||
145493292|NCT05546476|524663341|FG002|Period 1: Part A|Lack of Efficacy|0|||
145383207|NCT01618916|524256471|FG003|Overall Study|Withdrawal by Subject|0|||
145383208|NCT01618916|524256472|FG004|Overall Study|Withdrawal by Subject|1|||
145383209|NCT01618916|524256473|FG005|Overall Study|Withdrawal by Subject|0|||
145383210|NCT01618916|524256468|FG000|Overall Study|Lost to Follow-up|1|||
145383211|NCT01618916|524256469|FG001|Overall Study|Lost to Follow-up|0|||
145383212|NCT01618916|524256470|FG002|Overall Study|Lost to Follow-up|0|||
145383213|NCT01618916|524256471|FG003|Overall Study|Lost to Follow-up|2|||
145383214|NCT01618916|524256472|FG004|Overall Study|Lost to Follow-up|0|||
145493293|NCT05546476|524663342|FG003|Period 1: Part A|Lack of Efficacy|1|||
145493294|NCT05546476|524663339|FG000|Period 1: Part A|Lost to Follow-up|0|||
145493295|NCT05546476|524663340|FG001|Period 1: Part A|Lost to Follow-up|0|||
145493296|NCT05546476|524663341|FG002|Period 1: Part A|Lost to Follow-up|0|||
145493297|NCT05546476|524663342|FG003|Period 1: Part A|Lost to Follow-up|1|||
145493298|NCT05546476|524663339|FG000|Period 1: Part A|Physician Decision|1|||
145493299|NCT05546476|524663340|FG001|Period 1: Part A|Physician Decision|0|||
145493300|NCT05546476|524663341|FG002|Period 1: Part A|Physician Decision|0|||
145493301|NCT05546476|524663342|FG003|Period 1: Part A|Physician Decision|0|||
145493302|NCT05546476|524663339|FG000|Period 1: Part A|Progressive disease|3|||
145493303|NCT05546476|524663340|FG001|Period 1: Part A|Progressive disease|5|||
145493304|NCT05546476|524663341|FG002|Period 1: Part A|Progressive disease|0|||
145383215|NCT01618916|524256473|FG005|Overall Study|Lost to Follow-up|0|||
145383216|NCT01853696|524256474|FG000|Overall Study|Withdrawal by Subject|1|||
145383217|NCT01853696|524256475|FG001|Overall Study|Withdrawal by Subject|1|||
145383218|NCT01853696|524256474|FG000|Overall Study|Lost to Follow-up|5|||
145383219|NCT01853696|524256475|FG001|Overall Study|Lost to Follow-up|4|||
145383220|NCT03004924|524256476|FG000|Overall Study|Adverse Event|6|||
145383221|NCT03004924|524256477|FG001|Overall Study|Adverse Event|5|||
145383222|NCT03004924|524256478|FG002|Overall Study|Adverse Event|10|||
145383223|NCT03004924|524256476|FG000|Overall Study|Protocol Violation|4|||
145383224|NCT03004924|524256477|FG001|Overall Study|Protocol Violation|0|||
145383225|NCT03004924|524256478|FG002|Overall Study|Protocol Violation|1|||
145383226|NCT03004924|524256476|FG000|Overall Study|Withdrawal by Subject|5|||
145383227|NCT03004924|524256477|FG001|Overall Study|Withdrawal by Subject|3|||
145383228|NCT03004924|524256478|FG002|Overall Study|Withdrawal by Subject|5|||
145383229|NCT03004924|524256476|FG000|Overall Study|Lost to Follow-up|6|||
145383230|NCT03004924|524256477|FG001|Overall Study|Lost to Follow-up|1|||
145383231|NCT03004924|524256478|FG002|Overall Study|Lost to Follow-up|4|||
145383232|NCT03004924|524256476|FG000|Overall Study|Lack of Efficacy|2|||
145383233|NCT03004924|524256477|FG001|Overall Study|Lack of Efficacy|4|||
145383234|NCT03004924|524256478|FG002|Overall Study|Lack of Efficacy|2|||
145383235|NCT03004924|524256476|FG000|Overall Study|Physician Decision|1|||
145383236|NCT03004924|524256477|FG001|Overall Study|Physician Decision|0|||
145383237|NCT03004924|524256478|FG002|Overall Study|Physician Decision|1|||
145383238|NCT03004924|524256476|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145383239|NCT03004924|524256477|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145383240|NCT03004924|524256478|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145383241|NCT03004924|524256476|FG000|Overall Study|Screen Failure|1|||
145383242|NCT03004924|524256477|FG001|Overall Study|Screen Failure|0|||
145383243|NCT03004924|524256478|FG002|Overall Study|Screen Failure|0|||
145383244|NCT03004924|524256476|FG000|Overall Study|Pregnancy|0|||
145383245|NCT03004924|524256477|FG001|Overall Study|Pregnancy|1|||
145383246|NCT03004924|524256478|FG002|Overall Study|Pregnancy|0|||
145383247|NCT03004924|524256476|FG000|Overall Study|Terminated by Sponsor|0|||
145383248|NCT03004924|524256477|FG001|Overall Study|Terminated by Sponsor|0|||
145383249|NCT03004924|524256478|FG002|Overall Study|Terminated by Sponsor|1|||
145383250|NCT03004924|524256476|FG000|Overall Study|Missed Study Visit|0|||
145383251|NCT03004924|524256477|FG001|Overall Study|Missed Study Visit|0|||
145383252|NCT03004924|524256478|FG002|Overall Study|Missed Study Visit|2|||
145383253|NCT03004924|524256476|FG000|Overall Study|HSV1 Positive|1|||
145383254|NCT03004924|524256477|FG001|Overall Study|HSV1 Positive|0|||
145383255|NCT03004924|524256478|FG002|Overall Study|HSV1 Positive|0|||
145383256|NCT00048997|524256494|FG000|Overall Study|Protocol Violation|7|||
145383257|NCT00048997|524256495|FG001|Overall Study|Protocol Violation|2|||
145383258|NCT00048997|524256494|FG000|Overall Study|Withdrawal by Subject|6|||
145383259|NCT00048997|524256495|FG001|Overall Study|Withdrawal by Subject|1|||
145383260|NCT00048165|524256496|FG000|Completed 6 Months Study|Administration/Other|8|||
145383261|NCT00048165|524256497|FG001|Completed 6 Months Study|Administration/Other|8|||
145383262|NCT00048165|524256496|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
145383263|NCT00048165|524256497|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
145383264|NCT00048165|524256496|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
145383265|NCT00048165|524256497|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
145383266|NCT00048165|524256496|FG000|Completed 6 Months Study|Death|12|||
145383267|NCT00048165|524256497|FG001|Completed 6 Months Study|Death|6|||
145383268|NCT00048165|524256496|FG000|Completed 6 Months Study|Insufficient therapy|1|||
145383269|NCT00048165|524256497|FG001|Completed 6 Months Study|Insufficient therapy|4|||
145383270|NCT00048165|524256496|FG000|Completed 6 Months Study|Other violation|4|||
145383271|NCT00048165|524256497|FG001|Completed 6 Months Study|Other violation|6|||
145383272|NCT00048165|524256496|FG000|Completed 6 Months Study|Refused treatment|5|||
145383273|NCT00048165|524256497|FG001|Completed 6 Months Study|Refused treatment|5|||
145383274|NCT00048165|524256496|FG000|Completed 6 Months Study|Violation criteria|0|||
145493305|NCT05546476|524663342|FG003|Period 1: Part A|Progressive disease|1|||
145383275|NCT00048165|524256497|FG001|Completed 6 Months Study|Violation criteria|2|||
145383276|NCT00048165|524256496|FG000|Completed 6 Months Study|Did not receive study drug|6|||
145383277|NCT00048165|524256497|FG001|Completed 6 Months Study|Did not receive study drug|6|||
145383278|NCT00048165|524256496|FG000|Completed 12 Months Study|Administration/Other|0|||
145383279|NCT00048165|524256497|FG001|Completed 12 Months Study|Administration/Other|2|||
145383280|NCT00048165|524256496|FG000|Completed 12 Months Study|Death|2|||
145383281|NCT00048165|524256497|FG001|Completed 12 Months Study|Death|1|||
145383282|NCT00048165|524256496|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
145383283|NCT00048165|524256497|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
145383284|NCT01370616|524256498|FG000|Overall Study|Adverse Event|11|||
145383285|NCT01370616|524256499|FG001|Overall Study|Adverse Event|16|||
145383286|NCT01370616|524256498|FG000|Overall Study|Death|1|||
145383287|NCT01370616|524256499|FG001|Overall Study|Death|0|||
145383288|NCT01370616|524256498|FG000|Overall Study|Lack of Efficacy|6|||
145383289|NCT01370616|524256499|FG001|Overall Study|Lack of Efficacy|2|||
145383290|NCT01370616|524256498|FG000|Overall Study|Lost to Follow-up|0|||
145383291|NCT01370616|524256499|FG001|Overall Study|Lost to Follow-up|3|||
145383292|NCT01370616|524256498|FG000|Overall Study|Physician Decision|6|||
145383293|NCT01370616|524256499|FG001|Overall Study|Physician Decision|6|||
145383294|NCT01370616|524256498|FG000|Overall Study|Progressive Disease|0|||
145383295|NCT01370616|524256499|FG001|Overall Study|Progressive Disease|1|||
145493306|NCT05546476|524663339|FG000|Period 1: Part A|Withdrawal by Subject|1|||
145493307|NCT05546476|524663340|FG001|Period 1: Part A|Withdrawal by Subject|1|||
145493308|NCT05546476|524663341|FG002|Period 1: Part A|Withdrawal by Subject|1|||
145493309|NCT05546476|524663342|FG003|Period 1: Part A|Withdrawal by Subject|2|||
145493310|NCT05546476|524663339|FG000|Period 1: Part A|Global deterioration of health status|2|||
145493311|NCT05546476|524663340|FG001|Period 1: Part A|Global deterioration of health status|2|||
145493312|NCT05546476|524663341|FG002|Period 1: Part A|Global deterioration of health status|1|||
145493313|NCT05546476|524663342|FG003|Period 1: Part A|Global deterioration of health status|4|||
145493314|NCT05546476|524663339|FG000|Period 1: Part A|Other: Unspecified|0|||
145493315|NCT05546476|524663340|FG001|Period 1: Part A|Other: Unspecified|2|||
145493316|NCT05546476|524663341|FG002|Period 1: Part A|Other: Unspecified|0|||
145493317|NCT05546476|524663342|FG003|Period 1: Part A|Other: Unspecified|0|||
145493318|NCT05546476|524663339|FG000|Period 2: Part B|Ongoing|26|||
145493319|NCT05546476|524663340|FG001|Period 2: Part B|Ongoing|27|||
145493320|NCT05546476|524663341|FG002|Period 2: Part B|Ongoing|35|||
145493321|NCT05546476|524663342|FG003|Period 2: Part B|Ongoing|29|||
145493322|NCT02814916|524663343|FG000|Overall Study|Withdrawal of consent|0|||
145493323|NCT02814916|524663344|FG001|Overall Study|Withdrawal of consent|2|||
145493324|NCT02814916|524663345|FG002|Overall Study|Withdrawal of consent|0|||
145493325|NCT02814916|524663343|FG000|Overall Study|Lost to Follow-up|0|||
145493326|NCT02814916|524663344|FG001|Overall Study|Lost to Follow-up|1|||
145493327|NCT02814916|524663345|FG002|Overall Study|Lost to Follow-up|0|||
145493328|NCT02814916|524663343|FG000|Overall Study|Other, not specified|0|||
145493329|NCT02814916|524663344|FG001|Overall Study|Other, not specified|1|||
145493330|NCT02814916|524663345|FG002|Overall Study|Other, not specified|0|||
145493331|NCT04890652|524663348|FG000|Overall Study|Withdrawal by Subject|2|||
145493332|NCT05543265|524663349|FG000|Overall Study|Lost to Follow-up|3|||
145493333|NCT05543265|524663350|FG001|Overall Study|Lost to Follow-up|3|||
145493334|NCT05543265|524663349|FG000|Overall Study|Withdrawal by Subject|0|||
145493335|NCT05543265|524663350|FG001|Overall Study|Withdrawal by Subject|1|||
145493336|NCT05316597|524663351|FG000|First Session|Withdrawal by Subject|0|||
145493337|NCT05316597|524663352|FG001|First Session|Withdrawal by Subject|1|||
145493338|NCT05316597|524663351|FG000|Washout Period|Lost to Follow-up|1|||
145493339|NCT05316597|524663352|FG001|Washout Period|Lost to Follow-up|2|||
145493340|NCT05316597|524663351|FG000|Washout Period|Physician Decision|1|||
145493341|NCT05316597|524663352|FG001|Washout Period|Physician Decision|1|||
145493342|NCT05316597|524663351|FG000|Washout Period|Excluded before second session|1|||
145493343|NCT05316597|524663352|FG001|Washout Period|Excluded before second session|1|||
145493344|NCT05316597|524663351|FG000|Washout Period|Withdrawal by Subject|0|||
145493345|NCT05316597|524663352|FG001|Washout Period|Withdrawal by Subject|4|||
145493346|NCT01706458|524663358|FG000|Overall Study|Physician Decision|3|||
145493347|NCT01706458|524663359|FG001|Overall Study|Physician Decision|4|||
145493348|NCT03547518|524663360|FG000|Overall Study|Lost to Follow-up|2|||
145493349|NCT03547518|524663361|FG001|Overall Study|Lost to Follow-up|0|||
145493350|NCT02953652|524663368|FG000|Overall Study|Adverse Event|18|||
145493351|NCT02953652|524663368|FG000|Overall Study|Withdrawal by Subject|6|||
145383296|NCT01370616|524256498|FG000|Overall Study|Recovery|1|||
145383297|NCT01370616|524256499|FG001|Overall Study|Recovery|0|||
145383298|NCT01370616|524256498|FG000|Overall Study|Technical Problems|3|||
145383299|NCT01370616|524256499|FG001|Overall Study|Technical Problems|5|||
145493352|NCT02953652|524663368|FG000|Overall Study|Protocol Violation|1|||
145493353|NCT02953652|524663368|FG000|Overall Study|Disease Progression|27|||
145493354|NCT03192176|524663370|FG000|Overall Study|Adverse Event|1|||
145493355|NCT03192176|524663371|FG001|Overall Study|Adverse Event|0|||
145493356|NCT03192176|524663372|FG002|Overall Study|Adverse Event|4|||
145493357|NCT03192176|524663373|FG003|Overall Study|Adverse Event|5|||
145383300|NCT01370616|524256498|FG000|Overall Study|Withdrawal by Subject|34|||
145383301|NCT01370616|524256499|FG001|Overall Study|Withdrawal by Subject|34|||
145383302|NCT01084538|524256500|FG000|Overall Study|Drug not available|30|||
145383303|NCT01084538|524256500|FG000|Overall Study|Adverse Event|9|||
145383304|NCT01084538|524256500|FG000|Overall Study|Kidney transplant|6|||
145383305|NCT01084538|524256500|FG000|Overall Study|Serious Adverse Event|3|||
145383306|NCT01084538|524256500|FG000|Overall Study|Lack of effectiveness|2|||
145383307|NCT01084538|524256500|FG000|Overall Study|Patient noncompliance|2|||
145383308|NCT01084538|524256500|FG000|Overall Study|Hyperphosphatemia|2|||
145383309|NCT01084538|524256500|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
145383310|NCT01084538|524256500|FG000|Overall Study|Change of residence|2|||
145383311|NCT01084538|524256500|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
145383312|NCT01084538|524256500|FG000|Overall Study|Reason unknown|8|||
145383313|NCT01429441|524256501|FG000|Overall Study|Adverse Event|5|||
145383314|NCT01429441|524256502|FG001|Overall Study|Adverse Event|1|||
145383315|NCT01429441|524256501|FG000|Overall Study|Death|0|||
145383316|NCT01429441|524256502|FG001|Overall Study|Death|2|||
145383317|NCT01429441|524256501|FG000|Overall Study|Lost to Follow-up|5|||
145383318|NCT01429441|524256502|FG001|Overall Study|Lost to Follow-up|2|||
145383319|NCT01429441|524256501|FG000|Overall Study|Physician Decision|1|||
145383320|NCT01429441|524256502|FG001|Overall Study|Physician Decision|0|||
145383321|NCT01429441|524256501|FG000|Overall Study|Withdrawal by Subject|27|||
145383322|NCT01429441|524256502|FG001|Overall Study|Withdrawal by Subject|18|||
145383323|NCT00803205|524256507|FG000|Overall Study|Adverse Event|7|||
145383324|NCT00803205|524256508|FG001|Overall Study|Adverse Event|2|||
145383325|NCT00803205|524256507|FG000|Overall Study|Lost to Follow-up|1|||
145383326|NCT00803205|524256508|FG001|Overall Study|Lost to Follow-up|0|||
145383327|NCT00803205|524256507|FG000|Overall Study|Withdrawal by Subject|9|||
145383328|NCT00803205|524256508|FG001|Overall Study|Withdrawal by Subject|9|||
145383329|NCT00803205|524256507|FG000|Overall Study|Physician Decision|1|||
145383330|NCT00803205|524256508|FG001|Overall Study|Physician Decision|0|||
145383331|NCT00803205|524256507|FG000|Overall Study|Protocol Violation|1|||
145383332|NCT00803205|524256508|FG001|Overall Study|Protocol Violation|1|||
145383333|NCT00803205|524256507|FG000|Overall Study|Medical Monitor Decision|1|||
145383334|NCT00803205|524256508|FG001|Overall Study|Medical Monitor Decision|0|||
145383335|NCT00803205|524256507|FG000|Overall Study|Acquired a Lung Infection|0|||
145383336|NCT00803205|524256508|FG001|Overall Study|Acquired a Lung Infection|1|||
145383337|NCT00803205|524256507|FG000|Overall Study|Sponsor Decision|0|||
145383338|NCT00803205|524256508|FG001|Overall Study|Sponsor Decision|1|||
145383339|NCT00380718|524256511|FG000|Overall Study|Adverse Event|1|||
145383340|NCT00380718|524256511|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
145383341|NCT01706575|524256512|FG000|Overall Study|Participant Withdrew Consent|4|||
145383342|NCT01706575|524256512|FG000|Overall Study|Lost to Follow-up|2|||
145383343|NCT01706575|524256512|FG000|Overall Study|Started but not Treated|6|||
145383344|NCT02912455|524256513|FG000|Overall Study|Withdrawal by Subject|0|||
145383345|NCT02912455|524256514|FG001|Overall Study|Withdrawal by Subject|1|||
145383346|NCT02912455|524256513|FG000|Overall Study|Lack of Efficacy|0|||
145383347|NCT02912455|524256514|FG001|Overall Study|Lack of Efficacy|1|||
145383348|NCT02912455|524256513|FG000|Overall Study|Lost to Follow-up|2|||
145383349|NCT02912455|524256514|FG001|Overall Study|Lost to Follow-up|1|||
145383350|NCT03084315|524256517|FG000|Overall Study|Lost to Follow-up|8|||
145383351|NCT03084315|524256518|FG001|Overall Study|Lost to Follow-up|7|||
145383352|NCT03084315|524256517|FG000|Overall Study|Withdrawal by Subject|2|||
145383353|NCT03084315|524256518|FG001|Overall Study|Withdrawal by Subject|2|||
145383354|NCT01810783|524256524|FG000|Overall Study|Adverse Event|32|||
145383355|NCT01810783|524256524|FG000|Overall Study|Withdrawal by Subject|22|||
145383356|NCT01810783|524256524|FG000|Overall Study|Lack of Efficacy|12|||
145383357|NCT01810783|524256524|FG000|Overall Study|Lost to Follow-up|10|||
145383358|NCT01810783|524256524|FG000|Overall Study|Protocol Violation|5|||
145383359|NCT01810783|524256524|FG000|Overall Study|Non-compliance with IMP|4|||
145383360|NCT01810783|524256524|FG000|Overall Study|Adminstrative or other reason(s)|23|||
145383361|NCT01810783|524256524|FG000|Overall Study|Enrolled, not treated|1|||
145383362|NCT00094536|524256529|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
145383363|NCT00094536|524256529|FG000|Treatment and Follow-up|Adverse Event|4|||
145383364|NCT00094536|524256529|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
145383365|NCT00094536|524256529|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
145383366|NCT00094536|524256529|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
145383367|NCT00094536|524256529|FG000|Treatment and Follow-up|Subject non-compliance|9|||
145383368|NCT00094536|524256529|FG000|Treatment and Follow-up|Unable to attend visits|1|||
145383369|NCT02655419|524256530|FG000|Overall Study|Enrolled but not treated|1|||
145383370|NCT02655419|524256531|FG001|Overall Study|Enrolled but not treated|5|||
145383371|NCT02655419|524256530|FG000|Overall Study|Withdrawal by Subject|4|||
145383372|NCT02655419|524256531|FG001|Overall Study|Withdrawal by Subject|1|||
145383373|NCT02655419|524256530|FG000|Overall Study|Other|0|||
145383374|NCT02655419|524256531|FG001|Overall Study|Other|1|||
145383375|NCT01900431|524256532|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
145383376|NCT01900431|524256533|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
145383377|NCT01900431|524256534|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
145383378|NCT01900431|524256532|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
145383379|NCT01900431|524256533|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
145383380|NCT01900431|524256534|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
145383381|NCT01900431|524256532|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
145383382|NCT01900431|524256533|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
145383383|NCT01900431|524256534|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
145383384|NCT01900431|524256532|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
145383385|NCT01900431|524256533|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
145383386|NCT01900431|524256534|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
145383387|NCT01900431|524256532|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
145383388|NCT01900431|524256533|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
145383389|NCT01900431|524256534|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
145383390|NCT01900431|524256532|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
145383391|NCT01900431|524256533|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
145383392|NCT01900431|524256534|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
145383393|NCT01900431|524256532|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
145383394|NCT01900431|524256533|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
145383395|NCT01900431|524256534|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
145383396|NCT01900431|524256532|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
145383397|NCT01900431|524256533|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
145383398|NCT01900431|524256534|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
145493358|NCT03192176|524663374|FG004|Overall Study|Adverse Event|3|||
145493359|NCT03192176|524663375|FG005|Overall Study|Adverse Event|2|||
145383399|NCT01900431|524256532|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
145383400|NCT01900431|524256533|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
145383401|NCT01900431|524256534|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
145383402|NCT04503668|524256535|FG000|Overall Study|Incomplete data|4|||
145383403|NCT04503668|524256536|FG001|Overall Study|Incomplete data|3|||
145383404|NCT04503668|524256535|FG000|Overall Study|Withdrawal by Subject|1|||
145493360|NCT03192176|524663376|FG006|Overall Study|Adverse Event|3|||
145493361|NCT03192176|524663377|FG007|Overall Study|Adverse Event|3|||
145493362|NCT03192176|524663370|FG000|Overall Study|Lost to Follow-up|0|||
145493363|NCT03192176|524663371|FG001|Overall Study|Lost to Follow-up|0|||
145493364|NCT03192176|524663372|FG002|Overall Study|Lost to Follow-up|1|||
145493365|NCT03192176|524663373|FG003|Overall Study|Lost to Follow-up|2|||
145493366|NCT03192176|524663374|FG004|Overall Study|Lost to Follow-up|3|||
145493367|NCT03192176|524663375|FG005|Overall Study|Lost to Follow-up|1|||
145493368|NCT03192176|524663376|FG006|Overall Study|Lost to Follow-up|1|||
145493369|NCT03192176|524663377|FG007|Overall Study|Lost to Follow-up|1|||
145493370|NCT03192176|524663370|FG000|Overall Study|Physician Decision|1|||
145493371|NCT03192176|524663371|FG001|Overall Study|Physician Decision|0|||
145383405|NCT04503668|524256536|FG001|Overall Study|Withdrawal by Subject|1|||
145383406|NCT04503668|524256535|FG000|Overall Study|Adverse Event|2|||
145383407|NCT04503668|524256536|FG001|Overall Study|Adverse Event|0|||
145383408|NCT03403621|524256537|FG000|Overall Study|Withdrawal by Subject|2|||
145383409|NCT03403621|524256538|FG001|Overall Study|Withdrawal by Subject|2|||
145383410|NCT00395642|524256539|FG000|Overall Study|Death|4|||
145383411|NCT00395642|524256539|FG000|Overall Study|Lost to Follow-up|1|||
145383412|NCT00395642|524256539|FG000|Overall Study|Physician Decision|7|||
145383413|NCT00395642|524256539|FG000|Overall Study|Withdrawal by Subject|1|||
145383414|NCT00659776|524256541|FG000|Overall Study|Withdrawal by Subject|12|||
145383415|NCT00659776|524256542|FG001|Overall Study|Withdrawal by Subject|2|||
145383416|NCT00659776|524256543|FG002|Overall Study|Withdrawal by Subject|0|||
145383417|NCT01687283|524257657|FG000|Overall Study|Adverse Event|11|||
145383418|NCT01687283|524257658|FG001|Overall Study|Adverse Event|4|||
145383419|NCT01687283|524257657|FG000|Overall Study|Lack of Efficacy|3|||
145383420|NCT01687283|524257658|FG001|Overall Study|Lack of Efficacy|1|||
145383421|NCT01687283|524257657|FG000|Overall Study|Protocol Violation|1|||
145383422|NCT01687283|524257658|FG001|Overall Study|Protocol Violation|3|||
145383423|NCT01687283|524257657|FG000|Overall Study|protocol defined stopping criteria|8|||
145383424|NCT01687283|524257658|FG001|Overall Study|protocol defined stopping criteria|10|||
145383425|NCT01687283|524257657|FG000|Overall Study|Lost to Follow-up|1|||
145383426|NCT01687283|524257658|FG001|Overall Study|Lost to Follow-up|1|||
145383427|NCT01687283|524257657|FG000|Overall Study|Investigator discretion|2|||
145383428|NCT01687283|524257658|FG001|Overall Study|Investigator discretion|0|||
145383429|NCT01687283|524257657|FG000|Overall Study|Withdrawal by Subject|9|||
145383430|NCT01687283|524257658|FG001|Overall Study|Withdrawal by Subject|8|||
145383431|NCT01344759|524257662|FG000|Overall Study|Patients failed to reach sedation level|0|||
145383432|NCT01344759|524257663|FG001|Overall Study|Patients failed to reach sedation level|2|||
145383433|NCT01153009|524257664|FG000|Overall Study|Adverse Event|4|||
145383434|NCT01153009|524257665|FG001|Overall Study|Adverse Event|14|||
145383435|NCT01153009|524257666|FG002|Overall Study|Adverse Event|14|||
145383436|NCT01153009|524257667|FG003|Overall Study|Adverse Event|10|||
145383437|NCT01153009|524257664|FG000|Overall Study|Lack of Efficacy|9|||
145383438|NCT01153009|524257665|FG001|Overall Study|Lack of Efficacy|0|||
145383439|NCT01153009|524257666|FG002|Overall Study|Lack of Efficacy|2|||
145383440|NCT01153009|524257667|FG003|Overall Study|Lack of Efficacy|1|||
145383441|NCT01153009|524257664|FG000|Overall Study|Noncompliance with Study Medication|1|||
145383442|NCT01153009|524257665|FG001|Overall Study|Noncompliance with Study Medication|3|||
145383443|NCT01153009|524257666|FG002|Overall Study|Noncompliance with Study Medication|4|||
145383444|NCT01153009|524257667|FG003|Overall Study|Noncompliance with Study Medication|1|||
145383445|NCT01153009|524257664|FG000|Overall Study|Protocol Deviations|4|||
145383446|NCT01153009|524257665|FG001|Overall Study|Protocol Deviations|3|||
145383447|NCT01153009|524257666|FG002|Overall Study|Protocol Deviations|3|||
145383448|NCT01153009|524257667|FG003|Overall Study|Protocol Deviations|2|||
145383449|NCT01153009|524257664|FG000|Overall Study|Withdrawal of Consent|5|||
145383450|NCT01153009|524257665|FG001|Overall Study|Withdrawal of Consent|5|||
145383451|NCT01153009|524257666|FG002|Overall Study|Withdrawal of Consent|4|||
145383452|NCT01153009|524257667|FG003|Overall Study|Withdrawal of Consent|6|||
145383453|NCT01153009|524257664|FG000|Overall Study|Lost to Follow-up|8|||
145383454|NCT01153009|524257665|FG001|Overall Study|Lost to Follow-up|8|||
145383455|NCT01153009|524257666|FG002|Overall Study|Lost to Follow-up|11|||
145383456|NCT01153009|524257667|FG003|Overall Study|Lost to Follow-up|15|||
145383457|NCT01153009|524257664|FG000|Overall Study|Other|1|||
145383458|NCT01153009|524257665|FG001|Overall Study|Other|1|||
145383459|NCT01153009|524257666|FG002|Overall Study|Other|3|||
145383460|NCT01153009|524257667|FG003|Overall Study|Other|2|||
145383461|NCT00410072|524257668|FG000|Day 1 to Week 48|Adverse Event|1|||
145383462|NCT00410072|524257669|FG001|Day 1 to Week 48|Adverse Event|2|||
145383463|NCT00410072|524257668|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
145383464|NCT00410072|524257669|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
145383465|NCT00410072|524257668|FG000|Day 1 to Week 48|Other|0|||
145383466|NCT00410072|524257669|FG001|Day 1 to Week 48|Other|1|||
145383467|NCT00410072|524257668|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
145383468|NCT00410072|524257669|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
145383469|NCT00410072|524257668|FG000|Day 1 to Week 48|Pregnancy|0|||
145383470|NCT00410072|524257669|FG001|Day 1 to Week 48|Pregnancy|2|||
145383471|NCT00410072|524257668|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
145383472|NCT00410072|524257669|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
145383473|NCT00410072|524257668|FG000|After Week 48 to Week 96|Adverse Event|1|||
145383474|NCT00410072|524257669|FG001|After Week 48 to Week 96|Adverse Event|2|||
145383475|NCT00410072|524257668|FG000|After Week 48 to Week 96|Death|0|||
145383476|NCT00410072|524257669|FG001|After Week 48 to Week 96|Death|1|||
145383477|NCT00410072|524257668|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
145383478|NCT00410072|524257669|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
145383479|NCT00410072|524257668|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
145383480|NCT00410072|524257669|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
145383481|NCT00410072|524257668|FG000|After Week 48 to Week 96|Other|2|||
145383482|NCT00410072|524257669|FG001|After Week 48 to Week 96|Other|0|||
145383483|NCT00410072|524257668|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
145383484|NCT00410072|524257669|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
145383485|NCT00410072|524257668|FG000|After Week 48 to Week 96|Pregnancy|0|||
145383486|NCT00410072|524257669|FG001|After Week 48 to Week 96|Pregnancy|2|||
145383487|NCT00410072|524257668|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
145383488|NCT00410072|524257669|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
145383489|NCT01212159|524257673|FG000|Overall Study|Withdrawal by Subject|12|||
145383490|NCT01212159|524257674|FG001|Overall Study|Withdrawal by Subject|12|||
145383491|NCT04676152|524257675|FG000|Overall Study|screen fail|9|||
145383492|NCT01038752|524257679|FG000|Overall Study|Tumor Progression|2|||
145383493|NCT01038752|524257680|FG001|Overall Study|Tumor Progression|2|||
145383494|NCT01038752|524257679|FG000|Overall Study|Lost to Follow-up|3|||
145383495|NCT01038752|524257680|FG001|Overall Study|Lost to Follow-up|3|||
145383496|NCT01404949|524257700|FG000|Overall Study|Not Treated|1|||
145383497|NCT00002525|524257701|FG000|Overall Study|Adverse Event|36|||
145383498|NCT00002525|524257702|FG001|Overall Study|Adverse Event|0|||
145383499|NCT00002525|524257701|FG000|Overall Study|Death|5|||
145383500|NCT00002525|524257702|FG001|Overall Study|Death|0|||
145383501|NCT00002525|524257701|FG000|Overall Study|Withdrawal by Subject|11|||
145383502|NCT00002525|524257702|FG001|Overall Study|Withdrawal by Subject|0|||
145383503|NCT00002525|524257701|FG000|Overall Study|Start non-protocol therapy|1|||
145383504|NCT00002525|524257702|FG001|Overall Study|Start non-protocol therapy|0|||
145383505|NCT00002525|524257701|FG000|Overall Study|Other complicating disease|1|||
145383506|NCT00002525|524257702|FG001|Overall Study|Other complicating disease|0|||
145383507|NCT00002525|524257701|FG000|Overall Study|Duke's A, B1, D disease|92|||
145383508|NCT00002525|524257702|FG001|Overall Study|Duke's A, B1, D disease|0|||
145383509|NCT00002525|524257701|FG000|Overall Study|Error|6|||
145383510|NCT00002525|524257702|FG001|Overall Study|Error|0|||
145383511|NCT00002525|524257701|FG000|Overall Study|Other|26|||
145383512|NCT00002525|524257702|FG001|Overall Study|Other|0|||
145383513|NCT00002525|524257701|FG000|Overall Study|Never start protocol therapy|8|||
145383514|NCT00002525|524257702|FG001|Overall Study|Never start protocol therapy|0|||
145383515|NCT00435188|524257705|FG000|Overall Study|Death|1|||
145383516|NCT00435188|524257706|FG001|Overall Study|Death|6|||
145383517|NCT00435188|524257705|FG000|Overall Study|Withdrawal by Subject|16|||
145383518|NCT00435188|524257706|FG001|Overall Study|Withdrawal by Subject|11|||
145383519|NCT00435188|524257705|FG000|Overall Study|Lost to Follow-up|5|||
145383520|NCT00435188|524257706|FG001|Overall Study|Lost to Follow-up|6|||
145383521|NCT00575510|524257709|FG000|Overall Study|Lost to Follow-up|4|||
145383522|NCT00575510|524257710|FG001|Overall Study|Lost to Follow-up|6|||
145383523|NCT00575510|524257711|FG002|Overall Study|Lost to Follow-up|9|||
145383524|NCT00575510|524257709|FG000|Overall Study|Withdrawal by Subject|1|||
145383525|NCT00575510|524257710|FG001|Overall Study|Withdrawal by Subject|0|||
145383526|NCT00575510|524257711|FG002|Overall Study|Withdrawal by Subject|0|||
145383527|NCT00575510|524257709|FG000|Overall Study|Clinic Called Patient|7|||
145383528|NCT00575510|524257710|FG001|Overall Study|Clinic Called Patient|7|||
145383529|NCT00575510|524257711|FG002|Overall Study|Clinic Called Patient|7|||
145383530|NCT00575510|524257709|FG000|Overall Study|Pregnancy|0|||
145383531|NCT00575510|524257710|FG001|Overall Study|Pregnancy|0|||
145383532|NCT00575510|524257711|FG002|Overall Study|Pregnancy|1|||
145383533|NCT02651688|524257717|FG000|Overall Study|Non-compliance|0|||
145383534|NCT02651688|524257718|FG001|Overall Study|Non-compliance|0|||
145383535|NCT02651688|524257719|FG002|Overall Study|Non-compliance|1|||
145383536|NCT02651688|524257717|FG000|Overall Study|Principal Investigator (PI) decision|0|||
145383537|NCT02651688|524257718|FG001|Overall Study|Principal Investigator (PI) decision|2|||
145383538|NCT02651688|524257719|FG002|Overall Study|Principal Investigator (PI) decision|0|||
145383539|NCT02651688|524257717|FG000|Overall Study|Lost to Follow-up|1|||
145383540|NCT02651688|524257718|FG001|Overall Study|Lost to Follow-up|3|||
145383541|NCT02651688|524257719|FG002|Overall Study|Lost to Follow-up|0|||
145383542|NCT02651688|524257717|FG000|Overall Study|Withdrawal by Subject|1|||
145383543|NCT02651688|524257718|FG001|Overall Study|Withdrawal by Subject|0|||
145383544|NCT02651688|524257719|FG002|Overall Study|Withdrawal by Subject|2|||
145383545|NCT04527978|524257720|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
145383546|NCT04527978|524257721|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
145383547|NCT00055497|524257722|FG000|Overall Study|Adverse Event|1|||
145383548|NCT00055497|524257723|FG001|Overall Study|Adverse Event|1|||
145383549|NCT00055497|524257724|FG002|Overall Study|Adverse Event|1|||
145383550|NCT00055497|524257725|FG003|Overall Study|Adverse Event|28|||
145383551|NCT00055497|524257722|FG000|Overall Study|Withdrawal by Subject|3|||
145383552|NCT00055497|524257723|FG001|Overall Study|Withdrawal by Subject|1|||
145383553|NCT00055497|524257724|FG002|Overall Study|Withdrawal by Subject|1|||
145383554|NCT00055497|524257725|FG003|Overall Study|Withdrawal by Subject|15|||
145383555|NCT00055497|524257722|FG000|Overall Study|Lost to Follow-up|0|||
145383556|NCT00055497|524257723|FG001|Overall Study|Lost to Follow-up|1|||
145383557|NCT00055497|524257724|FG002|Overall Study|Lost to Follow-up|0|||
145493372|NCT03192176|524663372|FG002|Overall Study|Physician Decision|0|||
145493373|NCT03192176|524663373|FG003|Overall Study|Physician Decision|0|||
145493374|NCT03192176|524663374|FG004|Overall Study|Physician Decision|0|||
145493375|NCT03192176|524663375|FG005|Overall Study|Physician Decision|2|||
145493376|NCT03192176|524663376|FG006|Overall Study|Physician Decision|1|||
145493377|NCT03192176|524663377|FG007|Overall Study|Physician Decision|0|||
145493378|NCT03192176|524663370|FG000|Overall Study|Protocol Deviation|1|||
145493379|NCT03192176|524663371|FG001|Overall Study|Protocol Deviation|1|||
145493380|NCT03192176|524663372|FG002|Overall Study|Protocol Deviation|0|||
145493381|NCT03192176|524663373|FG003|Overall Study|Protocol Deviation|0|||
145493382|NCT03192176|524663374|FG004|Overall Study|Protocol Deviation|2|||
145493383|NCT03192176|524663375|FG005|Overall Study|Protocol Deviation|0|||
145493384|NCT03192176|524663376|FG006|Overall Study|Protocol Deviation|0|||
145493385|NCT03192176|524663377|FG007|Overall Study|Protocol Deviation|0|||
145493386|NCT03192176|524663370|FG000|Overall Study|Withdrawal by Subject|3|||
145493387|NCT03192176|524663371|FG001|Overall Study|Withdrawal by Subject|4|||
145493388|NCT03192176|524663372|FG002|Overall Study|Withdrawal by Subject|0|||
145493389|NCT03192176|524663373|FG003|Overall Study|Withdrawal by Subject|4|||
145493390|NCT03192176|524663374|FG004|Overall Study|Withdrawal by Subject|3|||
145493391|NCT03192176|524663375|FG005|Overall Study|Withdrawal by Subject|4|||
145493392|NCT03192176|524663376|FG006|Overall Study|Withdrawal by Subject|4|||
145493393|NCT03192176|524663377|FG007|Overall Study|Withdrawal by Subject|2|||
145493394|NCT03192176|524663370|FG000|Overall Study|Miscellaneous|1|||
145493395|NCT03192176|524663371|FG001|Overall Study|Miscellaneous|0|||
145493396|NCT03192176|524663372|FG002|Overall Study|Miscellaneous|1|||
145493397|NCT03192176|524663373|FG003|Overall Study|Miscellaneous|1|||
145493398|NCT03192176|524663374|FG004|Overall Study|Miscellaneous|1|||
145493399|NCT03192176|524663375|FG005|Overall Study|Miscellaneous|2|||
145493400|NCT03192176|524663376|FG006|Overall Study|Miscellaneous|0|||
145493401|NCT03192176|524663377|FG007|Overall Study|Miscellaneous|1|||
145493402|NCT02384551|524663380|FG000|Overall Study|Lost to Follow-up|13|||
145493403|NCT02384551|524663381|FG001|Overall Study|Lost to Follow-up|14|||
145493404|NCT02384551|524663382|FG002|Overall Study|Lost to Follow-up|14|||
145493405|NCT02384551|524663383|FG003|Overall Study|Lost to Follow-up|14|||
145493406|NCT02927301|524663386|FG000|Overall Study|Death|39|||
145493407|NCT02927301|524663386|FG000|Overall Study|Lost to Follow-up|8|||
145493408|NCT02927301|524663386|FG000|Overall Study|Physician Decision|2|||
145493409|NCT02927301|524663386|FG000|Overall Study|Withdrawal by Subject|12|||
145493410|NCT02927301|524663386|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
145493411|NCT04247347|524663389|FG000|Overall Study|Withdrawal by Subject|2|||
145493412|NCT04247347|524663390|FG001|Overall Study|Withdrawal by Subject|3|||
145493413|NCT04247347|524663391|FG002|Overall Study|Withdrawal by Subject|3|||
145493414|NCT04247347|524663389|FG000|Overall Study|Lost to Follow-up|1|||
145493415|NCT04247347|524663390|FG001|Overall Study|Lost to Follow-up|1|||
145493416|NCT04247347|524663391|FG002|Overall Study|Lost to Follow-up|1|||
145493417|NCT03035032|524663392|FG000|Overall Study|Adverse Event|2|||
145493418|NCT03035032|524663392|FG000|Overall Study|Death|9|||
145493419|NCT03035032|524663392|FG000|Overall Study|Lost to Follow-up|1|||
145493420|NCT03035032|524663392|FG000|Overall Study|Progressive Disease|22|||
145493421|NCT03035032|524663392|FG000|Overall Study|Protocol Violation|2|||
145383558|NCT00055497|524257725|FG003|Overall Study|Lost to Follow-up|5|||
145383559|NCT00055497|524257722|FG000|Overall Study|Protocol Violation|0|||
145383560|NCT00055497|524257723|FG001|Overall Study|Protocol Violation|0|||
145383561|NCT00055497|524257724|FG002|Overall Study|Protocol Violation|0|||
145383562|NCT00055497|524257725|FG003|Overall Study|Protocol Violation|3|||
145493422|NCT03035032|524663392|FG000|Overall Study|Withdrawal by Subject|2|||
145493423|NCT03035032|524663392|FG000|Overall Study|Physician Decision|5|||
145493424|NCT00189540|524663399|FG000|Overall Study|Withdrawal by Subject|3|||
145493425|NCT00189540|524663400|FG001|Overall Study|Withdrawal by Subject|0|||
145493426|NCT00189540|524663399|FG000|Overall Study|Death|4|||
145493427|NCT00189540|524663400|FG001|Overall Study|Death|1|||
145493428|NCT01089504|524663401|FG000|Overall Study|Lost to Follow-up|1|||
145493429|NCT01089504|524663402|FG001|Overall Study|Lost to Follow-up|1|||
145493430|NCT01089504|524663401|FG000|Overall Study|Withdrawal by Subject|2|||
145383563|NCT00055497|524257722|FG000|Overall Study|Lack of Efficacy|1|||
145383564|NCT00055497|524257723|FG001|Overall Study|Lack of Efficacy|0|||
145493431|NCT01089504|524663402|FG001|Overall Study|Withdrawal by Subject|0|||
145493432|NCT00001832|524663403|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
145493433|NCT00001832|524663404|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
145493434|NCT00001832|524663405|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
145493435|NCT00001832|524663406|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
145493436|NCT00001832|524663407|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
145493437|NCT00001832|524663408|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
145493438|NCT00001832|524663409|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
145493439|NCT00001832|524663410|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
145493440|NCT00001832|524663411|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
145493441|NCT00001832|524663412|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
145493442|NCT00001832|524663413|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
145493443|NCT00001832|524663414|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
145493444|NCT00001832|524663415|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
145493445|NCT00001832|524663416|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
145493446|NCT00001832|524663417|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
145493447|NCT00001832|524663403|FG000|Treatment Period|Death during treatment|0|||
145493448|NCT00001832|524663404|FG001|Treatment Period|Death during treatment|0|||
145493449|NCT00001832|524663405|FG002|Treatment Period|Death during treatment|0|||
145493450|NCT00001832|524663406|FG003|Treatment Period|Death during treatment|0|||
145493451|NCT00001832|524663407|FG004|Treatment Period|Death during treatment|0|||
145493452|NCT00001832|524663408|FG005|Treatment Period|Death during treatment|1|||
145493453|NCT00001832|524663409|FG006|Treatment Period|Death during treatment|0|||
145493454|NCT00001832|524663410|FG007|Treatment Period|Death during treatment|0|||
145493455|NCT00001832|524663411|FG008|Treatment Period|Death during treatment|0|||
145493456|NCT00001832|524663412|FG009|Treatment Period|Death during treatment|0|||
145493457|NCT00001832|524663413|FG010|Treatment Period|Death during treatment|0|||
145493458|NCT00001832|524663414|FG011|Treatment Period|Death during treatment|0|||
145493459|NCT00001832|524663415|FG012|Treatment Period|Death during treatment|0|||
145493460|NCT00001832|524663416|FG013|Treatment Period|Death during treatment|0|||
145493461|NCT00001832|524663417|FG014|Treatment Period|Death during treatment|0|||
145493462|NCT00001832|524663403|FG000|Treatment Period|Not treated|0|||
145493463|NCT00001832|524663404|FG001|Treatment Period|Not treated|0|||
145493464|NCT00001832|524663405|FG002|Treatment Period|Not treated|0|||
145493465|NCT00001832|524663406|FG003|Treatment Period|Not treated|0|||
145493466|NCT00001832|524663407|FG004|Treatment Period|Not treated|0|||
145493467|NCT00001832|524663408|FG005|Treatment Period|Not treated|0|||
145493468|NCT00001832|524663409|FG006|Treatment Period|Not treated|0|||
145493469|NCT00001832|524663410|FG007|Treatment Period|Not treated|1|||
145493470|NCT00001832|524663411|FG008|Treatment Period|Not treated|0|||
145493471|NCT00001832|524663412|FG009|Treatment Period|Not treated|0|||
145493472|NCT00001832|524663413|FG010|Treatment Period|Not treated|0|||
145493473|NCT00001832|524663414|FG011|Treatment Period|Not treated|0|||
145493474|NCT00001832|524663415|FG012|Treatment Period|Not treated|0|||
145493475|NCT00001832|524663416|FG013|Treatment Period|Not treated|0|||
145493476|NCT00001832|524663417|FG014|Treatment Period|Not treated|0|||
145493477|NCT01903356|524663418|FG000|Overall Study|Lost to Follow-up|7|||
145493478|NCT01903356|524663418|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
145493479|NCT01903356|524663418|FG000|Overall Study|Violated the dosage and administration|3|||
145493480|NCT05106959|524663423|FG000|Overall Study|Lost to Follow-up|1|||
145493481|NCT01553084|524663431|FG000|Overall Study|Withdrawal by Subject|15|||
145493482|NCT01553084|524663432|FG001|Overall Study|Withdrawal by Subject|13|||
145493483|NCT01553084|524663433|FG002|Overall Study|Withdrawal by Subject|35|||
145493484|NCT03988400|524663434|FG000|Overall Study|Adverse Event|1|||
145493485|NCT03988400|524663435|FG001|Overall Study|Adverse Event|0|||
145493486|NCT03988400|524663434|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
145493487|NCT03988400|524663435|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
145493488|NCT03988400|524663434|FG000|Overall Study|Lost to Follow-up|0|||
145493489|NCT03988400|524663435|FG001|Overall Study|Lost to Follow-up|1|||
145493490|NCT02542865|524663437|FG000|Overall Study|Identified as screen failure|1|||
145493491|NCT02542865|524663438|FG001|Overall Study|Identified as screen failure|0|||
145493492|NCT02542865|524663437|FG000|Overall Study|Withdrawal by Subject|16|||
145493493|NCT02542865|524663438|FG001|Overall Study|Withdrawal by Subject|0|||
145493494|NCT03582215|524663439|FG000|Overall Study|Adverse Event|1|||
145493495|NCT03582215|524663440|FG001|Overall Study|Adverse Event|0|||
145493496|NCT03582215|524663441|FG002|Overall Study|Adverse Event|0|||
145493497|NCT03582215|524663442|FG003|Overall Study|Adverse Event|0|||
145493498|NCT03582215|524663443|FG004|Overall Study|Adverse Event|0|||
145493499|NCT03582215|524663444|FG005|Overall Study|Adverse Event|0|||
145493500|NCT03582215|524663445|FG006|Overall Study|Adverse Event|2|||
145493501|NCT03582215|524663446|FG007|Overall Study|Adverse Event|2|||
145493502|NCT00659061|524663447|FG000|Overall Study|Migration due to political unrest|21|||
145493503|NCT00659061|524663448|FG001|Overall Study|Migration due to political unrest|15|||
145493504|NCT03186209|524663451|FG000|Overall Study|Withdrawal by Subject|11|||
145493505|NCT03186209|524663452|FG001|Overall Study|Withdrawal by Subject|22|||
145493506|NCT03186209|524663451|FG000|Overall Study|Pregnancy|1|||
145493507|NCT03186209|524663452|FG001|Overall Study|Pregnancy|0|||
145493508|NCT03186209|524663451|FG000|Overall Study|Adverse Event|4|||
145493509|NCT03186209|524663452|FG001|Overall Study|Adverse Event|0|||
145493510|NCT03186209|524663451|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
145493511|NCT03186209|524663452|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
145493512|NCT03186209|524663451|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
145493513|NCT03186209|524663452|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
145493514|NCT03186209|524663451|FG000|Overall Study|Fail to meet randomization criteria|0|||
145493515|NCT03186209|524663452|FG001|Overall Study|Fail to meet randomization criteria|1|||
145493516|NCT03186209|524663451|FG000|Overall Study|Lost to Follow-up|0|||
145493517|NCT03186209|524663452|FG001|Overall Study|Lost to Follow-up|1|||
145493518|NCT02240485|524663453|FG000|3 Months Post-admission|Lost to Follow-up|1|||
145493519|NCT02240485|524663454|FG001|3 Months Post-admission|Lost to Follow-up|5|||
145493520|NCT02240485|524663453|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
145493521|NCT02240485|524663454|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
145493522|NCT02240485|524663453|FG000|9 Months Post-admission|Lost to Follow-up|3|||
145493523|NCT02240485|524663454|FG001|9 Months Post-admission|Lost to Follow-up|1|||
145493524|NCT02240485|524663453|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
145493525|NCT02240485|524663454|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
145493526|NCT02240485|524663453|FG000|18 Months Post-admission|Lost to Follow-up|1|||
145493527|NCT02240485|524663454|FG001|18 Months Post-admission|Lost to Follow-up|1|||
145493528|NCT02240485|524663453|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
145493529|NCT02240485|524663454|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
145493530|NCT00953667|524663455|FG000|Overall Study|Lost to Follow-up|11|||
145493531|NCT00953667|524663455|FG000|Overall Study|Physician Decision|35|||
145493532|NCT00953667|524663455|FG000|Overall Study|Withdrawal by Subject|63|||
145493533|NCT00953667|524663455|FG000|Overall Study|Adverse Event|10|||
145493534|NCT00953667|524663455|FG000|Overall Study|poor venous access,unable to draw blood|4|||
145493535|NCT04038359|524663456|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
145493536|NCT04038359|524663457|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
145493537|NCT04038359|524663456|FG000|Overall Study|Death|8|||
145493538|NCT04038359|524663457|FG001|Overall Study|Death|7|||
145493539|NCT04038359|524663456|FG000|Overall Study|Lost to Follow-up|3|||
145493540|NCT04038359|524663457|FG001|Overall Study|Lost to Follow-up|0|||
145493541|NCT04038359|524663456|FG000|Overall Study|Participant Moved|1|||
145493542|NCT04038359|524663457|FG001|Overall Study|Participant Moved|0|||
145493543|NCT04038359|524663456|FG000|Overall Study|Withdrawal by Subject|4|||
145493544|NCT04038359|524663457|FG001|Overall Study|Withdrawal by Subject|3|||
145493545|NCT04038359|524663456|FG000|Overall Study|Physician Decision|3|||
145493546|NCT04038359|524663457|FG001|Overall Study|Physician Decision|2|||
145493547|NCT04038359|524663456|FG000|Overall Study|Adverse Event|0|||
145493548|NCT04038359|524663457|FG001|Overall Study|Adverse Event|2|||
145493549|NCT04038359|524663456|FG000|Overall Study|Progressive Disease|0|||
145493550|NCT04038359|524663457|FG001|Overall Study|Progressive Disease|1|||
145493551|NCT05468814|524663458|FG000|Overall Study|Lost to Follow-up|5|||
145493552|NCT05468814|524663459|FG001|Overall Study|Lost to Follow-up|6|||
145493553|NCT04716426|524663463|FG000|Overall Study|Vaccination|1|||
145493554|NCT04716426|524663464|FG001|Overall Study|Vaccination|1|||
145493555|NCT04716426|524663463|FG000|Overall Study|Contamination|1|||
145493556|NCT04716426|524663464|FG001|Overall Study|Contamination|0|||
145493557|NCT01046565|524663467|FG000|Overall Study|Adverse Event|2|||
145493558|NCT01046565|524663467|FG000|Overall Study|Withdrawal by Subject|7|||
145493559|NCT01650558|524663468|FG000|Overall Study|Migration out of study area|61|||
145493560|NCT01650558|524663469|FG001|Overall Study|Migration out of study area|71|||
145493561|NCT01650558|524663470|FG002|Overall Study|Migration out of study area|56|||
145493562|NCT01650558|524663468|FG000|Overall Study|Lost to Follow-up|10|||
145493563|NCT01650558|524663469|FG001|Overall Study|Lost to Follow-up|13|||
145493564|NCT01650558|524663470|FG002|Overall Study|Lost to Follow-up|6|||
145493565|NCT01650558|524663468|FG000|Overall Study|Death|10|||
145493566|NCT01650558|524663469|FG001|Overall Study|Death|6|||
145493567|NCT01650558|524663470|FG002|Overall Study|Death|8|||
145493568|NCT01650558|524663468|FG000|Overall Study|Withdrawal by Subject|1|||
145493569|NCT01650558|524663469|FG001|Overall Study|Withdrawal by Subject|1|||
145493570|NCT01650558|524663470|FG002|Overall Study|Withdrawal by Subject|3|||
145493571|NCT01650558|524663468|FG000|Overall Study|Non-compliant participant|1|||
145493572|NCT01650558|524663469|FG001|Overall Study|Non-compliant participant|0|||
145493573|NCT01650558|524663470|FG002|Overall Study|Non-compliant participant|2|||
145493574|NCT01650558|524663468|FG000|Overall Study|Physician Decision|0|||
145493575|NCT01650558|524663469|FG001|Overall Study|Physician Decision|1|||
145493576|NCT01650558|524663470|FG002|Overall Study|Physician Decision|0|||
145493577|NCT01069484|524663471|FG000|Overall Study|Death-in-near-family|1|||
145493578|NCT01069484|524663472|FG001|Overall Study|Death-in-near-family|0|||
145493579|NCT01069484|524663471|FG000|Overall Study|No specific reason|8|||
145493580|NCT01069484|524663472|FG001|Overall Study|No specific reason|2|||
145383565|NCT00055497|524257724|FG002|Overall Study|Lack of Efficacy|0|||
145383566|NCT00055497|524257725|FG003|Overall Study|Lack of Efficacy|27|||
145383567|NCT00055497|524257722|FG000|Overall Study|Administrative Reasons|0|||
145383568|NCT00055497|524257723|FG001|Overall Study|Administrative Reasons|0|||
145383569|NCT00055497|524257724|FG002|Overall Study|Administrative Reasons|0|||
145383570|NCT00055497|524257725|FG003|Overall Study|Administrative Reasons|1|||
145383571|NCT00055497|524257722|FG000|Overall Study|Other|0|||
145383572|NCT00055497|524257723|FG001|Overall Study|Other|0|||
145383573|NCT00055497|524257724|FG002|Overall Study|Other|0|||
145383574|NCT00055497|524257725|FG003|Overall Study|Other|11|||
145383575|NCT02112877|524257727|FG000|Overall Study|Withdrawal by Subject|1|||
145383576|NCT02112877|524257728|FG001|Overall Study|Withdrawal by Subject|7|||
145383577|NCT02112877|524257727|FG000|Overall Study|Visit Missed|1|||
145383578|NCT02112877|524257728|FG001|Overall Study|Visit Missed|6|||
145383579|NCT01693185|524257729|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
145383580|NCT01693185|524257730|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
145383581|NCT01606748|524257747|FG000|Overall Study|Adverse Event|1|||
145383582|NCT01606748|524257748|FG001|Overall Study|Adverse Event|0|||
145383583|NCT01606748|524257747|FG000|Overall Study|Progressive Disease|1|||
145383584|NCT01606748|524257748|FG001|Overall Study|Progressive Disease|0|||
145383585|NCT01606748|524257747|FG000|Overall Study|Withdrawal by Subject|1|||
145383586|NCT01606748|524257748|FG001|Overall Study|Withdrawal by Subject|0|||
145383587|NCT00621517|524257752|FG000|Overall Study|Lost to Follow-up|3|||
145383588|NCT00621517|524257753|FG001|Overall Study|Lost to Follow-up|3|||
145383589|NCT00621517|524257752|FG000|Overall Study|Withdrawal by Subject|3|||
145383590|NCT00621517|524257753|FG001|Overall Study|Withdrawal by Subject|4|||
145383591|NCT00621517|524257752|FG000|Overall Study|Adverse Event|1|||
145383592|NCT00621517|524257753|FG001|Overall Study|Adverse Event|0|||
145383593|NCT01863732|524257755|FG000|Overall Study|Adverse Event|2|||
145383594|NCT01863732|524257756|FG001|Overall Study|Adverse Event|0|||
145383595|NCT01863732|524257757|FG002|Overall Study|Adverse Event|3|||
145383596|NCT01863732|524257758|FG003|Overall Study|Adverse Event|3|||
145383597|NCT01863732|524257755|FG000|Overall Study|Lack of Efficacy|1|||
145383598|NCT01863732|524257756|FG001|Overall Study|Lack of Efficacy|0|||
145383599|NCT01863732|524257757|FG002|Overall Study|Lack of Efficacy|2|||
145383600|NCT01863732|524257758|FG003|Overall Study|Lack of Efficacy|1|||
145383601|NCT01863732|524257755|FG000|Overall Study|Lost to Follow-up|2|||
145383602|NCT01863732|524257756|FG001|Overall Study|Lost to Follow-up|2|||
145383603|NCT01863732|524257757|FG002|Overall Study|Lost to Follow-up|1|||
145383604|NCT01863732|524257758|FG003|Overall Study|Lost to Follow-up|1|||
145383605|NCT01863732|524257755|FG000|Overall Study|Physician Decision|1|||
145383606|NCT01863732|524257756|FG001|Overall Study|Physician Decision|0|||
145383607|NCT01863732|524257757|FG002|Overall Study|Physician Decision|1|||
145383608|NCT01863732|524257758|FG003|Overall Study|Physician Decision|0|||
145383609|NCT01863732|524257755|FG000|Overall Study|Pregnancy|0|||
145383610|NCT01863732|524257756|FG001|Overall Study|Pregnancy|0|||
145383611|NCT01863732|524257757|FG002|Overall Study|Pregnancy|0|||
145383612|NCT01863732|524257758|FG003|Overall Study|Pregnancy|1|||
145383613|NCT01863732|524257755|FG000|Overall Study|Technical problems|0|||
145383614|NCT01863732|524257756|FG001|Overall Study|Technical problems|1|||
145383615|NCT01863732|524257757|FG002|Overall Study|Technical problems|1|||
145383616|NCT01863732|524257758|FG003|Overall Study|Technical problems|0|||
145383617|NCT01863732|524257755|FG000|Overall Study|Subject/guardian decision|6|||
145383618|NCT01863732|524257756|FG001|Overall Study|Subject/guardian decision|9|||
145383619|NCT01863732|524257757|FG002|Overall Study|Subject/guardian decision|3|||
145383620|NCT01863732|524257758|FG003|Overall Study|Subject/guardian decision|1|||
145383621|NCT01863732|524257755|FG000|Overall Study|Death|1|||
145383622|NCT01863732|524257756|FG001|Overall Study|Death|0|||
145383623|NCT01863732|524257757|FG002|Overall Study|Death|0|||
145383624|NCT01863732|524257758|FG003|Overall Study|Death|1|||
145383625|NCT01428115|524257759|FG000|Overall Study|Lack of Efficacy|3|||
145383626|NCT01428115|524257759|FG000|Overall Study|Lost to Follow-up|10|||
145383627|NCT01428115|524257759|FG000|Overall Study|Pregnancy|1|||
145383628|NCT01428115|524257759|FG000|Overall Study|Protocol Violation|3|||
145383629|NCT01428115|524257759|FG000|Overall Study|Withdrawal by Subject|4|||
145383630|NCT02620384|524257760|FG000|Overall Study|Adverse Event|2|||
145383631|NCT02620384|524257761|FG001|Overall Study|Adverse Event|1|||
145383632|NCT02620384|524257760|FG000|Overall Study|Discharged prior to 2nd dose|2|||
145383633|NCT02620384|524257761|FG001|Overall Study|Discharged prior to 2nd dose|5|||
145383634|NCT02620384|524257760|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
145383635|NCT02620384|524257761|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
145383636|NCT02071082|524257762|FG000|Overall Study|Enrolled and Never Treated|1|||
145383637|NCT02071082|524257763|FG001|Overall Study|Enrolled and Never Treated|1|||
145383638|NCT02071082|524257762|FG000|Overall Study|Adverse Event|0|||
145383639|NCT02071082|524257763|FG001|Overall Study|Adverse Event|1|||
145383640|NCT02071082|524257762|FG000|Overall Study|Withdrew Consent|0|||
145383641|NCT02071082|524257763|FG001|Overall Study|Withdrew Consent|4|||
145383642|NCT02071082|524257762|FG000|Overall Study|Lost to Follow-up|1|||
145383643|NCT02071082|524257763|FG001|Overall Study|Lost to Follow-up|1|||
145493581|NCT01069484|524663471|FG000|Overall Study|Illness mother or child|3|||
145493582|NCT01069484|524663472|FG001|Overall Study|Illness mother or child|1|||
145493583|NCT02978417|524663475|FG000|Overall Study|Lost to Follow-up|2|||
145493584|NCT02978417|524663476|FG001|Overall Study|Lost to Follow-up|2|||
145493585|NCT00960375|524663487|FG000|Overall Study|Lost to Follow-up|20|||
145493586|NCT00960375|524663488|FG001|Overall Study|Lost to Follow-up|22|||
145493587|NCT00083889|524663489|FG000|Overall Study|Adverse Event|76|||
145493588|NCT00083889|524663490|FG001|Overall Study|Adverse Event|86|||
145493589|NCT00083889|524663489|FG000|Overall Study|Protocol Violation|2|||
145493590|NCT00083889|524663490|FG001|Overall Study|Protocol Violation|2|||
145493591|NCT00083889|524663489|FG000|Overall Study|Withdrawal by Subject|22|||
145493592|NCT00083889|524663490|FG001|Overall Study|Withdrawal by Subject|24|||
145493593|NCT00083889|524663489|FG000|Overall Study|Lack of Efficacy|240|||
145493594|NCT00083889|524663490|FG001|Overall Study|Lack of Efficacy|219|||
145493595|NCT00083889|524663489|FG000|Overall Study|Decision of sponsor|32|||
145493596|NCT00083889|524663490|FG001|Overall Study|Decision of sponsor|4|||
145493597|NCT00083889|524663489|FG000|Overall Study|Randomized: did not take study drug|0|||
145493598|NCT00083889|524663490|FG001|Overall Study|Randomized: did not take study drug|15|||
145493599|NCT00083889|524663489|FG000|Overall Study|Completed on marketed sunitinub|3|||
145493600|NCT00083889|524663490|FG001|Overall Study|Completed on marketed sunitinub|0|||
145493601|NCT00083889|524663489|FG000|Overall Study|Crossover to SU011248|0|||
145493602|NCT00083889|524663490|FG001|Overall Study|Crossover to SU011248|25|||
145493603|NCT03624881|524663491|FG000|Overall Study|Screen Failure|14|||
145493604|NCT03624881|524663492|FG001|Overall Study|Screen Failure|0|||
145493605|NCT03624881|524663491|FG000|Overall Study|No Catheter Inserted|6|||
145493606|NCT03624881|524663492|FG001|Overall Study|No Catheter Inserted|1|||
145493607|NCT03624881|524663491|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
145493608|NCT03624881|524663492|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
145493609|NCT03624881|524663491|FG000|Overall Study|Death|2|||
145493610|NCT03624881|524663492|FG001|Overall Study|Death|0|||
145493611|NCT03624881|524663491|FG000|Overall Study|Lost to Follow-up|10|||
145493612|NCT03624881|524663492|FG001|Overall Study|Lost to Follow-up|4|||
145493613|NCT03624881|524663491|FG000|Overall Study|Withdrawal by Subject|12|||
145493614|NCT03624881|524663492|FG001|Overall Study|Withdrawal by Subject|1|||
145493615|NCT03019406|524663497|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
145493616|NCT03019406|524663498|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
145493617|NCT03019406|524663499|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
145493618|NCT03019406|524663500|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
145493619|NCT04199351|524665418|FG000|Overall Study|Decision by sponsor|0|||
145493620|NCT04199351|524665419|FG001|Overall Study|Decision by sponsor|0|||
145493621|NCT04199351|524665420|FG002|Overall Study|Decision by sponsor|0|||
145493622|NCT04199351|524665421|FG003|Overall Study|Decision by sponsor|2|||
145493623|NCT04199351|524665422|FG004|Overall Study|Decision by sponsor|0|||
145493624|NCT04199351|524665423|FG005|Overall Study|Decision by sponsor|0|||
145493625|NCT04199351|524665424|FG006|Overall Study|Decision by sponsor|0|||
145493626|NCT04199351|524665425|FG007|Overall Study|Decision by sponsor|0|||
145493627|NCT04199351|524665426|FG008|Overall Study|Decision by sponsor|0|||
145493628|NCT04199351|524665427|FG009|Overall Study|Decision by sponsor|6|||
145493629|NCT04199351|524665418|FG000|Overall Study|Lost to Follow-up|0|||
145493630|NCT04199351|524665419|FG001|Overall Study|Lost to Follow-up|0|||
145493631|NCT04199351|524665420|FG002|Overall Study|Lost to Follow-up|1|||
145493632|NCT04199351|524665421|FG003|Overall Study|Lost to Follow-up|0|||
145493633|NCT04199351|524665422|FG004|Overall Study|Lost to Follow-up|0|||
145493634|NCT04199351|524665423|FG005|Overall Study|Lost to Follow-up|1|||
145493635|NCT04199351|524665424|FG006|Overall Study|Lost to Follow-up|0|||
145493636|NCT04199351|524665425|FG007|Overall Study|Lost to Follow-up|0|||
145493637|NCT04199351|524665426|FG008|Overall Study|Lost to Follow-up|0|||
145493638|NCT04199351|524665427|FG009|Overall Study|Lost to Follow-up|0|||
145493639|NCT04199351|524665418|FG000|Overall Study|Withdrawal by Subject|0|||
145493640|NCT04199351|524665419|FG001|Overall Study|Withdrawal by Subject|1|||
145493641|NCT04199351|524665420|FG002|Overall Study|Withdrawal by Subject|0|||
145493642|NCT04199351|524665421|FG003|Overall Study|Withdrawal by Subject|0|||
145493643|NCT04199351|524665422|FG004|Overall Study|Withdrawal by Subject|1|||
145493644|NCT04199351|524665423|FG005|Overall Study|Withdrawal by Subject|4|||
145493645|NCT04199351|524665424|FG006|Overall Study|Withdrawal by Subject|2|||
145493646|NCT04199351|524665425|FG007|Overall Study|Withdrawal by Subject|0|||
145493647|NCT04199351|524665426|FG008|Overall Study|Withdrawal by Subject|3|||
145493648|NCT04199351|524665427|FG009|Overall Study|Withdrawal by Subject|0|||
145493649|NCT03623243|524665428|FG000|Overall Study|Adverse Event|15|||
145493650|NCT03623243|524665428|FG000|Overall Study|Guardian Decision|1|||
145493651|NCT03623243|524665428|FG000|Overall Study|New Therapy for Study Indication|1|||
145493652|NCT03623243|524665428|FG000|Overall Study|Protocol Deviation|3|||
145493653|NCT03623243|524665428|FG000|Overall Study|Physician Decision|4|||
145493654|NCT03623243|524665428|FG000|Overall Study|Patient Decision|15|||
145493655|NCT03007966|524665429|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
145493656|NCT03007966|524665430|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
145493657|NCT00474487|524665434|FG000|Overall Study|Withdrawal by Subject|6|||
145493658|NCT00474487|524665435|FG001|Overall Study|Withdrawal by Subject|0|||
145493659|NCT00474487|524665436|FG002|Overall Study|Withdrawal by Subject|0|||
145493660|NCT00474487|524665437|FG003|Overall Study|Withdrawal by Subject|0|||
145493661|NCT00474487|524665434|FG000|Overall Study|Lost to Follow-up|20|||
145493662|NCT00474487|524665435|FG001|Overall Study|Lost to Follow-up|1|||
145493663|NCT00474487|524665436|FG002|Overall Study|Lost to Follow-up|7|||
145493664|NCT00474487|524665437|FG003|Overall Study|Lost to Follow-up|0|||
145493665|NCT00474487|524665434|FG000|Overall Study|Inappropriate enrollment|4|||
145493666|NCT00474487|524665435|FG001|Overall Study|Inappropriate enrollment|0|||
145493667|NCT00474487|524665436|FG002|Overall Study|Inappropriate enrollment|7|||
145493668|NCT00474487|524665437|FG003|Overall Study|Inappropriate enrollment|0|||
145493669|NCT00474487|524665434|FG000|Overall Study|Death|0|||
145493670|NCT00474487|524665435|FG001|Overall Study|Death|1|||
145493671|NCT00474487|524665436|FG002|Overall Study|Death|0|||
145493672|NCT00474487|524665437|FG003|Overall Study|Death|0|||
145493673|NCT01428258|524665438|FG000|Intervention 1|Withdrawal by Subject|2|||
145493674|NCT01428258|524665439|FG001|Intervention 1|Withdrawal by Subject|0|||
145493675|NCT00419393|524665440|FG000|Overall Study|Adverse Event|5|||
145493676|NCT00419393|524665440|FG000|Overall Study|Protocol Violation|5|||
145493677|NCT00419393|524665440|FG000|Overall Study|Withdrawal by Subject|7|||
145493678|NCT00419393|524665440|FG000|Overall Study|Other: Sponsor request|3|||
145493679|NCT00419393|524665440|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
145493680|NCT00419393|524665440|FG000|Overall Study|Other: Site closure|1|||
145493681|NCT00419393|524665440|FG000|Overall Study|Other: Other health problems|1|||
145493682|NCT00419393|524665440|FG000|Overall Study|Other: Investigator decision|1|||
145493683|NCT00979901|524665441|FG000|Overall Study|Adverse Event|1|||
145493684|NCT00979901|524665442|FG001|Overall Study|Adverse Event|3|||
145493685|NCT00979901|524665443|FG002|Overall Study|Adverse Event|9|||
145493686|NCT00979901|524665444|FG003|Overall Study|Adverse Event|2|||
145493687|NCT00979901|524665441|FG000|Overall Study|Lack of Efficacy|8|||
145493688|NCT00979901|524665442|FG001|Overall Study|Lack of Efficacy|4|||
145493689|NCT00979901|524665443|FG002|Overall Study|Lack of Efficacy|9|||
145493690|NCT00979901|524665444|FG003|Overall Study|Lack of Efficacy|0|||
145493691|NCT00979901|524665441|FG000|Overall Study|Lost to Follow-up|1|||
145493692|NCT00979901|524665442|FG001|Overall Study|Lost to Follow-up|1|||
145493693|NCT00979901|524665443|FG002|Overall Study|Lost to Follow-up|2|||
145493694|NCT00979901|524665444|FG003|Overall Study|Lost to Follow-up|0|||
145493695|NCT00979901|524665441|FG000|Overall Study|Protocol Violation|2|||
145493696|NCT00979901|524665442|FG001|Overall Study|Protocol Violation|2|||
145493697|NCT00979901|524665443|FG002|Overall Study|Protocol Violation|7|||
145493698|NCT00979901|524665444|FG003|Overall Study|Protocol Violation|1|||
145493699|NCT00979901|524665441|FG000|Overall Study|Withdrawal by Subject|2|||
145493700|NCT00979901|524665442|FG001|Overall Study|Withdrawal by Subject|1|||
145493701|NCT00979901|524665443|FG002|Overall Study|Withdrawal by Subject|1|||
145493702|NCT00979901|524665444|FG003|Overall Study|Withdrawal by Subject|1|||
145493703|NCT00979901|524665441|FG000|Overall Study|Noncompliance|1|||
145493704|NCT00979901|524665442|FG001|Overall Study|Noncompliance|0|||
145493705|NCT00979901|524665443|FG002|Overall Study|Noncompliance|0|||
145493706|NCT00979901|524665444|FG003|Overall Study|Noncompliance|0|||
145493707|NCT00979901|524665441|FG000|Overall Study|out-of-state|1|||
145493708|NCT00979901|524665442|FG001|Overall Study|out-of-state|0|||
145493709|NCT00979901|524665443|FG002|Overall Study|out-of-state|0|||
145493710|NCT00979901|524665444|FG003|Overall Study|out-of-state|0|||
145493711|NCT00979901|524665441|FG000|Overall Study|vacation|1|||
145493712|NCT00979901|524665442|FG001|Overall Study|vacation|0|||
145493713|NCT00979901|524665443|FG002|Overall Study|vacation|0|||
145493714|NCT00979901|524665444|FG003|Overall Study|vacation|0|||
145493715|NCT00979901|524665441|FG000|Overall Study|elevated lab values pre-randomization|1|||
145493716|NCT00979901|524665442|FG001|Overall Study|elevated lab values pre-randomization|0|||
145493717|NCT00979901|524665443|FG002|Overall Study|elevated lab values pre-randomization|0|||
145493718|NCT00979901|524665444|FG003|Overall Study|elevated lab values pre-randomization|0|||
145493719|NCT00979901|524665441|FG000|Overall Study|Discontinued in Error|0|||
145493720|NCT00979901|524665442|FG001|Overall Study|Discontinued in Error|1|||
145493721|NCT00979901|524665443|FG002|Overall Study|Discontinued in Error|0|||
145493722|NCT00979901|524665444|FG003|Overall Study|Discontinued in Error|0|||
145493723|NCT00979901|524665441|FG000|Overall Study|Left Country|0|||
145493724|NCT00979901|524665442|FG001|Overall Study|Left Country|0|||
145493725|NCT00979901|524665443|FG002|Overall Study|Left Country|1|||
145493726|NCT00979901|524665444|FG003|Overall Study|Left Country|0|||
145493727|NCT00979901|524665441|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
145493728|NCT00979901|524665442|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
145493729|NCT00979901|524665443|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
145493730|NCT00979901|524665444|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
145493731|NCT04742556|524665450|FG000|Overall Study|Withdrawal by Subject|0|||
145493732|NCT04742556|524665451|FG001|Overall Study|Withdrawal by Subject|1|||
145493733|NCT04742556|524665452|FG002|Overall Study|Withdrawal by Subject|0|||
145493734|NCT04742556|524665450|FG000|Overall Study|Adverse Event|0|||
145493735|NCT04742556|524665451|FG001|Overall Study|Adverse Event|0|||
145493736|NCT04742556|524665452|FG002|Overall Study|Adverse Event|2|||
145493737|NCT04742556|524665450|FG000|Overall Study|Clinical disease progression|0|||
145493738|NCT04742556|524665451|FG001|Overall Study|Clinical disease progression|1|||
145493739|NCT04742556|524665452|FG002|Overall Study|Clinical disease progression|2|||
145493740|NCT04742556|524665450|FG000|Overall Study|Objective disease progression|3|||
145493741|NCT04742556|524665451|FG001|Overall Study|Objective disease progression|2|||
145493742|NCT04742556|524665452|FG002|Overall Study|Objective disease progression|4|||
145493743|NCT02399215|524665461|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
145493744|NCT02399215|524665461|FG000|Overall Study|Withdrawal by Subject|1|||
145493745|NCT00772538|524665462|FG000|Overall Study|Adverse Event|6|||
145493746|NCT00772538|524665463|FG001|Overall Study|Adverse Event|6|||
145493747|NCT00772538|524665462|FG000|Overall Study|Protocol Violation|3|||
145493748|NCT00772538|524665463|FG001|Overall Study|Protocol Violation|3|||
145493749|NCT00772538|524665462|FG000|Overall Study|Lost to Follow-up|1|||
145493750|NCT00772538|524665463|FG001|Overall Study|Lost to Follow-up|1|||
145493751|NCT00772538|524665462|FG000|Overall Study|Withdrawal by Subject|3|||
145493752|NCT00772538|524665463|FG001|Overall Study|Withdrawal by Subject|8|||
145493753|NCT00772538|524665462|FG000|Overall Study|Lack of Efficacy|0|||
145493754|NCT00772538|524665463|FG001|Overall Study|Lack of Efficacy|1|||
145493755|NCT00772538|524665462|FG000|Overall Study|Other|7|||
145493756|NCT00772538|524665463|FG001|Overall Study|Other|7|||
145493757|NCT00713609|524665464|FG000|Overall Study|Adverse Event|2|||
145493758|NCT00713609|524665465|FG001|Overall Study|Adverse Event|0|||
145493759|NCT00713609|524665466|FG002|Overall Study|Adverse Event|2|||
145493760|NCT00713609|524665467|FG003|Overall Study|Adverse Event|2|||
145493761|NCT00713609|524665468|FG004|Overall Study|Adverse Event|3|||
145493762|NCT00713609|524665469|FG005|Overall Study|Adverse Event|1|||
145493763|NCT00713609|524665464|FG000|Overall Study|Lost to Follow-up|5|||
145493764|NCT00713609|524665465|FG001|Overall Study|Lost to Follow-up|7|||
145493765|NCT00713609|524665466|FG002|Overall Study|Lost to Follow-up|5|||
145493766|NCT00713609|524665467|FG003|Overall Study|Lost to Follow-up|5|||
145493767|NCT00713609|524665468|FG004|Overall Study|Lost to Follow-up|7|||
145493768|NCT00713609|524665469|FG005|Overall Study|Lost to Follow-up|0|||
145493769|NCT00713609|524665464|FG000|Overall Study|Lack of Efficacy|1|||
145493770|NCT00713609|524665465|FG001|Overall Study|Lack of Efficacy|3|||
145493771|NCT00713609|524665466|FG002|Overall Study|Lack of Efficacy|0|||
145493772|NCT00713609|524665467|FG003|Overall Study|Lack of Efficacy|0|||
145493773|NCT00713609|524665468|FG004|Overall Study|Lack of Efficacy|1|||
145493774|NCT00713609|524665469|FG005|Overall Study|Lack of Efficacy|0|||
145493775|NCT00713609|524665464|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
145493776|NCT00713609|524665465|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
145493777|NCT00713609|524665466|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
145493778|NCT00713609|524665467|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
145493779|NCT00713609|524665468|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
145493780|NCT00713609|524665469|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
145493781|NCT00713609|524665464|FG000|Overall Study|Withdrawal by Subject|6|||
145493782|NCT00713609|524665465|FG001|Overall Study|Withdrawal by Subject|1|||
145493783|NCT00713609|524665466|FG002|Overall Study|Withdrawal by Subject|5|||
145493784|NCT00713609|524665467|FG003|Overall Study|Withdrawal by Subject|1|||
145493785|NCT00713609|524665468|FG004|Overall Study|Withdrawal by Subject|5|||
145493786|NCT00713609|524665469|FG005|Overall Study|Withdrawal by Subject|7|||
145493787|NCT00713609|524665464|FG000|Overall Study|Protocol Violation|6|||
145493788|NCT00713609|524665465|FG001|Overall Study|Protocol Violation|3|||
145493789|NCT00713609|524665466|FG002|Overall Study|Protocol Violation|1|||
145493790|NCT00713609|524665467|FG003|Overall Study|Protocol Violation|1|||
145493791|NCT00713609|524665468|FG004|Overall Study|Protocol Violation|2|||
145493792|NCT00713609|524665469|FG005|Overall Study|Protocol Violation|0|||
145493793|NCT03305666|524665470|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
145493794|NCT03305666|524665471|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
145493795|NCT04913610|524665473|FG000|Randomized Participants|Did Not Receive Treatment|0|||
145493796|NCT04913610|524665474|FG001|Randomized Participants|Did Not Receive Treatment|0|||
145493797|NCT04913610|524665475|FG002|Randomized Participants|Did Not Receive Treatment|1|||
145493798|NCT04913610|524665476|FG003|Randomized Participants|Did Not Receive Treatment|1|||
145493799|NCT04913610|524665477|FG004|Randomized Participants|Did Not Receive Treatment|0|||
145493800|NCT04913610|524665473|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
145493801|NCT04913610|524665474|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
145493802|NCT04913610|524665475|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
145493803|NCT04913610|524665476|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
145493804|NCT04913610|524665477|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
145493805|NCT01791244|524665484|FG000|Overall Study|Adverse Event|5|||
145493806|NCT01791244|524665485|FG001|Overall Study|Adverse Event|7|||
145493807|NCT01791244|524665484|FG000|Overall Study|Insufficient clinical response|10|||
145493808|NCT01791244|524665485|FG001|Overall Study|Insufficient clinical response|10|||
145493809|NCT01791244|524665484|FG000|Overall Study|Laboratory Abnormality|0|||
145723582|NCT00819390|525504886|FG003|Overall Study|Withdrawal by Subject|0|||
145723583|NCT00819390|525504883|FG000|Overall Study|Adverse Event|0|||
145383644|NCT00630747|524257766|FG000|Overall Study|Death|1|||
145383645|NCT00630747|524257766|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
145383646|NCT00630747|524257766|FG000|Overall Study|Returned to country of origin|1|||
145383647|NCT03782974|524257769|FG000|Overall Study|Withdrawal by Subject|7|||
145383648|NCT03782974|524257770|FG001|Overall Study|Withdrawal by Subject|7|||
145383649|NCT03782974|524257769|FG000|Overall Study|Pregnancy|1|||
145383650|NCT03782974|524257770|FG001|Overall Study|Pregnancy|0|||
145383651|NCT00628927|524257780|FG000|Overall Study|Problems performing blood draw|6|||
145383652|NCT00628927|524257781|FG001|Overall Study|Problems performing blood draw|0|||
145383653|NCT00628927|524257780|FG000|Overall Study|Lost to Follow-up|1|||
145383654|NCT00628927|524257781|FG001|Overall Study|Lost to Follow-up|0|||
145383655|NCT00628927|524257780|FG000|Overall Study|Equipment failure|1|||
145383656|NCT00628927|524257781|FG001|Overall Study|Equipment failure|0|||
145383657|NCT01298141|524257782|FG000|Overall Study|Adverse Event|3|||
145383658|NCT01298141|524257782|FG000|Overall Study|Refusal of Required Study Procedures|1|||
145383659|NCT01298141|524257782|FG000|Overall Study|Withdrawal by Subject|6|||
145383660|NCT01298141|524257782|FG000|Overall Study|Termination of Study by the Investigator|5|||
145383661|NCT01298141|524257782|FG000|Overall Study|Other|5|||
145383662|NCT01298141|524257782|FG000|Overall Study|Lost to Follow-up|1|||
145383663|NCT01298141|524257782|FG000|Overall Study|Death|6|||
145383664|NCT01298141|524257782|FG000|Overall Study|Not treated|4|||
145383665|NCT00448812|524257784|FG000|Year 2|Missed visit but remained in study|4|||
145383666|NCT00448812|524257785|FG001|Year 2|Missed visit but remained in study|1|||
145383667|NCT00448812|524257784|FG000|Year 3|Withdrawal by Subject|1|||
145383668|NCT00448812|524257785|FG001|Year 3|Withdrawal by Subject|3|||
145383669|NCT00448812|524257784|FG000|Year 3|Lost to Follow-up|1|||
145383670|NCT00448812|524257785|FG001|Year 3|Lost to Follow-up|0|||
145383671|NCT00448812|524257784|FG000|Year 3|Missed visit but remained in study|2|||
145383672|NCT00448812|524257785|FG001|Year 3|Missed visit but remained in study|0|||
145383673|NCT00448812|524257784|FG000|Year 5|Missed visit but remained in study|1|||
145383674|NCT00448812|524257785|FG001|Year 5|Missed visit but remained in study|0|||
145383675|NCT01421147|524260115|FG000|Treatment Period|Adverse Event|2|||
145383676|NCT01421147|524260116|FG001|Treatment Period|Adverse Event|3|||
145383677|NCT01421147|524260115|FG000|Treatment Period|Lost to Follow-up|2|||
145383678|NCT01421147|524260116|FG001|Treatment Period|Lost to Follow-up|1|||
145383679|NCT01421147|524260115|FG000|Treatment Period|Physician Decision|2|||
145383680|NCT01421147|524260116|FG001|Treatment Period|Physician Decision|2|||
145383681|NCT01421147|524260115|FG000|Treatment Period|Withdrawal by Subject|10|||
145383682|NCT01421147|524260116|FG001|Treatment Period|Withdrawal by Subject|5|||
145383683|NCT01421147|524260115|FG000|Extension Period|Adverse Event|0|||
145383684|NCT01421147|524260116|FG001|Extension Period|Adverse Event|2|||
145383685|NCT01421147|524260115|FG000|Extension Period|Death|0|||
145383686|NCT01421147|524260116|FG001|Extension Period|Death|1|||
145383687|NCT01421147|524260115|FG000|Extension Period|Lost to Follow-up|2|||
145383688|NCT01421147|524260116|FG001|Extension Period|Lost to Follow-up|5|||
145383689|NCT01421147|524260115|FG000|Extension Period|Physician Decision|1|||
145383690|NCT01421147|524260116|FG001|Extension Period|Physician Decision|0|||
145383691|NCT01421147|524260115|FG000|Extension Period|Withdrawal by Subject|5|||
145383692|NCT01421147|524260116|FG001|Extension Period|Withdrawal by Subject|3|||
145383693|NCT03307837|524260117|FG000|Overall Study|Withdrawal by Subject|0|||
145383694|NCT03307837|524260118|FG001|Overall Study|Withdrawal by Subject|0|||
145383695|NCT03307837|524260119|FG002|Overall Study|Withdrawal by Subject|1|||
145383696|NCT03307837|524260120|FG003|Overall Study|Withdrawal by Subject|0|||
145383697|NCT03307837|524260121|FG004|Overall Study|Withdrawal by Subject|0|||
145383698|NCT03307837|524260122|FG005|Overall Study|Withdrawal by Subject|1|||
145383699|NCT03307837|524260117|FG000|Overall Study|Lost to Follow-up|1|||
145383700|NCT03307837|524260118|FG001|Overall Study|Lost to Follow-up|1|||
145383701|NCT03307837|524260119|FG002|Overall Study|Lost to Follow-up|0|||
145383702|NCT03307837|524260120|FG003|Overall Study|Lost to Follow-up|0|||
145383703|NCT03307837|524260121|FG004|Overall Study|Lost to Follow-up|0|||
145383704|NCT03307837|524260122|FG005|Overall Study|Lost to Follow-up|1|||
145383705|NCT00904917|524260124|FG000|Overall Study|Lost to Follow-up|2|||
145383706|NCT00904917|524260125|FG001|Overall Study|Lost to Follow-up|2|||
145383707|NCT00904917|524260126|FG002|Overall Study|Lost to Follow-up|2|||
145383708|NCT00904917|524260127|FG003|Overall Study|Lost to Follow-up|2|||
145383709|NCT00762034|524260128|FG000|Induction Period|Protocol Violation|1|||
145383710|NCT00762034|524260129|FG001|Induction Period|Protocol Violation|2|||
145383711|NCT00762034|524260128|FG000|Induction Period|Entry Criterion Not Met|12|||
145383712|NCT00762034|524260129|FG001|Induction Period|Entry Criterion Not Met|11|||
145383713|NCT00762034|524260128|FG000|Induction Period|Adverse Event|27|||
145383714|NCT00762034|524260129|FG001|Induction Period|Adverse Event|38|||
145383715|NCT00762034|524260128|FG000|Induction Period|Lost to Follow-up|1|||
145383716|NCT00762034|524260129|FG001|Induction Period|Lost to Follow-up|1|||
145383717|NCT00762034|524260128|FG000|Induction Period|Progressive Disease|73|||
145493810|NCT01791244|524665485|FG001|Overall Study|Laboratory Abnormality|1|||
145493811|NCT05121766|524665490|FG000|Overall Study|Covid reinfection|3|||
145493812|NCT05121766|524665491|FG001|Overall Study|Covid reinfection|0|||
145493813|NCT05121766|524665490|FG000|Overall Study|Withdrawal by Subject|3|||
145493814|NCT05121766|524665491|FG001|Overall Study|Withdrawal by Subject|1|||
145493815|NCT05121766|524665490|FG000|Overall Study|Adverse Event|2|||
145493816|NCT05121766|524665491|FG001|Overall Study|Adverse Event|4|||
145493817|NCT05121766|524665490|FG000|Overall Study|Lost to Follow-up|0|||
145493818|NCT05121766|524665491|FG001|Overall Study|Lost to Follow-up|1|||
145493819|NCT03259230|524665493|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
145493820|NCT03259230|524665494|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
145493821|NCT01033240|524665495|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
145493822|NCT01033240|524665496|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
145493823|NCT01033240|524665497|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
145493824|NCT01033240|524665495|FG000|Overall Study|Death|2|||
145493825|NCT01033240|524665496|FG001|Overall Study|Death|0|||
145493826|NCT01033240|524665497|FG002|Overall Study|Death|0|||
145493827|NCT01033240|524665495|FG000|Overall Study|Withdrew Consent|2|||
145493828|NCT01033240|524665496|FG001|Overall Study|Withdrew Consent|9|||
145493829|NCT01033240|524665497|FG002|Overall Study|Withdrew Consent|2|||
145493830|NCT01033240|524665495|FG000|Overall Study|Disease Progression|35|||
145493831|NCT01033240|524665496|FG001|Overall Study|Disease Progression|32|||
145493832|NCT01033240|524665497|FG002|Overall Study|Disease Progression|41|||
145493833|NCT01033240|524665495|FG000|Overall Study|Investigator Discretion|0|||
145493834|NCT01033240|524665496|FG001|Overall Study|Investigator Discretion|0|||
145493835|NCT01033240|524665497|FG002|Overall Study|Investigator Discretion|2|||
145493836|NCT01033240|524665495|FG000|Overall Study|Other|0|||
145493837|NCT01033240|524665496|FG001|Overall Study|Other|1|||
145493838|NCT01033240|524665497|FG002|Overall Study|Other|2|||
145493839|NCT02913482|524665498|FG000|Overall Study|Death|0|||
145493840|NCT02913482|524665499|FG001|Overall Study|Death|2|||
145493841|NCT02913482|524665500|FG002|Overall Study|Death|2|||
145493842|NCT02913482|524665498|FG000|Overall Study|Progressive Disease|1|||
145493843|NCT02913482|524665499|FG001|Overall Study|Progressive Disease|1|||
145493844|NCT02913482|524665500|FG002|Overall Study|Progressive Disease|1|||
145493845|NCT02913482|524665498|FG000|Overall Study|Reason not specified|0|||
145493846|NCT02913482|524665499|FG001|Overall Study|Reason not specified|0|||
145493847|NCT02913482|524665500|FG002|Overall Study|Reason not specified|1|||
145493848|NCT02913482|524665498|FG000|Overall Study|Withdrawal by Subject|0|||
145493849|NCT02913482|524665499|FG001|Overall Study|Withdrawal by Subject|1|||
145493850|NCT02913482|524665500|FG002|Overall Study|Withdrawal by Subject|1|||
145493851|NCT02960217|524665501|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
145493852|NCT02960217|524665502|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
145493853|NCT02960217|524665501|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
145493854|NCT02960217|524665502|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
145493855|NCT02960217|524665501|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
145493856|NCT02960217|524665502|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
145493857|NCT02960217|524665501|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
145493858|NCT02960217|524665502|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
145493859|NCT02960217|524665501|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
145493860|NCT02960217|524665502|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
145493861|NCT02960217|524665501|FG000|Open-Label Extension Phase|Adverse Event|1|||
145493862|NCT02960217|524665502|FG001|Open-Label Extension Phase|Adverse Event|0|||
145493863|NCT02960217|524665501|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
145493864|NCT02960217|524665502|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
145493865|NCT02960217|524665501|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
145493866|NCT02960217|524665502|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
145493867|NCT02960217|524665501|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
145493868|NCT02960217|524665502|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
145493869|NCT00918385|524665503|FG000|Monotherapy|Adverse Event|1|||
145493870|NCT00918385|524665504|FG001|Monotherapy|Adverse Event|6|||
145493871|NCT00918385|524665503|FG000|Monotherapy|Complicating illness|1|||
145493872|NCT00918385|524665504|FG001|Monotherapy|Complicating illness|0|||
145493873|NCT00918385|524665503|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
145493874|NCT00918385|524665504|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
145493875|NCT00918385|524665503|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
145493876|NCT00918385|524665504|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
145493877|NCT00918385|524665503|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
145493878|NCT00918385|524665504|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
145493879|NCT00918385|524665503|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
145493880|NCT00918385|524665504|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
145493881|NCT00168844|524665508|FG000|Overall Study|Adverse Event|31|||
145493882|NCT00168844|524665509|FG001|Overall Study|Adverse Event|32|||
145493883|NCT00168844|524665510|FG002|Overall Study|Adverse Event|48|||
145493884|NCT00168844|524665508|FG000|Overall Study|Lost to Follow-up|4|||
145493885|NCT00168844|524665509|FG001|Overall Study|Lost to Follow-up|5|||
145493886|NCT00168844|524665510|FG002|Overall Study|Lost to Follow-up|11|||
145493887|NCT00168844|524665508|FG000|Overall Study|Withdrawal by Subject|12|||
145493888|NCT00168844|524665509|FG001|Overall Study|Withdrawal by Subject|9|||
145493889|NCT00168844|524665510|FG002|Overall Study|Withdrawal by Subject|19|||
145493890|NCT00168844|524665508|FG000|Overall Study|Protocol Violation|2|||
145493891|NCT00168844|524665509|FG001|Overall Study|Protocol Violation|2|||
145493892|NCT00168844|524665510|FG002|Overall Study|Protocol Violation|4|||
145493893|NCT00168844|524665508|FG000|Overall Study|Other|6|||
145493894|NCT00168844|524665509|FG001|Overall Study|Other|7|||
145493895|NCT00168844|524665510|FG002|Overall Study|Other|9|||
145493896|NCT03557970|524665515|FG000|Overall Study|Study closure|1|||
145493897|NCT03557970|524665516|FG001|Overall Study|Study closure|0|||
145493898|NCT03557970|524665515|FG000|Overall Study|Physician Decision|0|||
145493899|NCT03557970|524665516|FG001|Overall Study|Physician Decision|1|||
145493900|NCT03557970|524665515|FG000|Overall Study|Death|0|||
145493901|NCT03557970|524665516|FG001|Overall Study|Death|1|||
145493902|NCT00112736|524665517|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
145493903|NCT00112736|524665518|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
145493904|NCT02138890|524665519|FG000|Overall Study|Adverse Event|1|||
145493905|NCT02138890|524665520|FG001|Overall Study|Adverse Event|0|||
145493906|NCT05435339|524665521|FG000|Overall Study|Death|1|||
145493907|NCT05435339|524665522|FG001|Overall Study|Death|0|||
145493908|NCT05435339|524665523|FG002|Overall Study|Death|3|||
145493909|NCT05435339|524665524|FG003|Overall Study|Death|1|||
145493910|NCT05435339|524665525|FG004|Overall Study|Death|3|||
145493911|NCT05435339|524665526|FG005|Overall Study|Death|2|||
145493912|NCT05435339|524665527|FG006|Overall Study|Death|4|||
145493913|NCT05435339|524665528|FG007|Overall Study|Death|6|||
145493914|NCT05435339|524665521|FG000|Overall Study|Sponsor Decision|0|||
145493915|NCT05435339|524665522|FG001|Overall Study|Sponsor Decision|1|||
145493916|NCT05435339|524665523|FG002|Overall Study|Sponsor Decision|0|||
145493917|NCT05435339|524665524|FG003|Overall Study|Sponsor Decision|0|||
145493918|NCT05435339|524665525|FG004|Overall Study|Sponsor Decision|2|||
145493919|NCT05435339|524665526|FG005|Overall Study|Sponsor Decision|1|||
145493920|NCT05435339|524665527|FG006|Overall Study|Sponsor Decision|2|||
145493921|NCT05435339|524665528|FG007|Overall Study|Sponsor Decision|2|||
145493922|NCT05435339|524665521|FG000|Overall Study|Withdrawal by Subject|0|||
145493923|NCT05435339|524665522|FG001|Overall Study|Withdrawal by Subject|0|||
145493924|NCT05435339|524665523|FG002|Overall Study|Withdrawal by Subject|0|||
145493925|NCT05435339|524665524|FG003|Overall Study|Withdrawal by Subject|0|||
145493926|NCT05435339|524665525|FG004|Overall Study|Withdrawal by Subject|1|||
145493927|NCT05435339|524665526|FG005|Overall Study|Withdrawal by Subject|0|||
145493928|NCT05435339|524665527|FG006|Overall Study|Withdrawal by Subject|1|||
145493929|NCT05435339|524665528|FG007|Overall Study|Withdrawal by Subject|1|||
145493930|NCT03668873|524665529|FG000|Overall Study|Lost to Follow-up|6|||
145493931|NCT03668873|524665530|FG001|Overall Study|Lost to Follow-up|3|||
145493932|NCT00849940|524665540|FG000|Overall Study|Physician Decision|4|||
145493933|NCT04258423|524665541|FG000|Overall Study|Study Closure|2|||
145493934|NCT04258423|524665542|FG001|Overall Study|Study Closure|2|||
145493935|NCT01601535|524665545|FG000|Phase 1|Adverse Event|1|||
145493936|NCT01601535|524665546|FG001|Phase 1|Adverse Event|0|||
145493937|NCT01601535|524665547|FG002|Phase 1|Adverse Event|2|||
145493938|NCT01601535|524665548|FG003|Phase 1|Adverse Event|1|||
145493939|NCT01601535|524665549|FG004|Phase 1|Adverse Event|0|||
145493940|NCT01601535|524665550|FG005|Phase 1|Adverse Event|0|||
145493941|NCT01601535|524665545|FG000|Phase 1|Withdrawal by Subject|2|||
145493942|NCT01601535|524665546|FG001|Phase 1|Withdrawal by Subject|1|||
145493943|NCT01601535|524665547|FG002|Phase 1|Withdrawal by Subject|1|||
145493944|NCT01601535|524665548|FG003|Phase 1|Withdrawal by Subject|2|||
145493945|NCT01601535|524665549|FG004|Phase 1|Withdrawal by Subject|0|||
145493946|NCT01601535|524665550|FG005|Phase 1|Withdrawal by Subject|0|||
145493947|NCT01601535|524665545|FG000|Phase 1|Progressive Disease|2|||
145493948|NCT01601535|524665546|FG001|Phase 1|Progressive Disease|3|||
145493949|NCT01601535|524665547|FG002|Phase 1|Progressive Disease|2|||
145493950|NCT01601535|524665548|FG003|Phase 1|Progressive Disease|1|||
145493951|NCT01601535|524665549|FG004|Phase 1|Progressive Disease|0|||
145493952|NCT01601535|524665550|FG005|Phase 1|Progressive Disease|0|||
145493953|NCT01601535|524665545|FG000|Phase 1|Started Another Treatment|1|||
145493954|NCT01601535|524665546|FG001|Phase 1|Started Another Treatment|2|||
145493955|NCT01601535|524665547|FG002|Phase 1|Started Another Treatment|0|||
145493956|NCT01601535|524665548|FG003|Phase 1|Started Another Treatment|0|||
145493957|NCT01601535|524665549|FG004|Phase 1|Started Another Treatment|0|||
145493958|NCT01601535|524665550|FG005|Phase 1|Started Another Treatment|0|||
145493959|NCT01601535|524665545|FG000|Phase 2|Adverse Event|0|||
145493960|NCT01601535|524665546|FG001|Phase 2|Adverse Event|0|||
145493961|NCT01601535|524665547|FG002|Phase 2|Adverse Event|0|||
145493962|NCT01601535|524665548|FG003|Phase 2|Adverse Event|0|||
145493963|NCT01601535|524665549|FG004|Phase 2|Adverse Event|5|||
145493964|NCT01601535|524665550|FG005|Phase 2|Adverse Event|1|||
145493965|NCT01601535|524665545|FG000|Phase 2|Withdrawal by Subject|0|||
145493966|NCT01601535|524665546|FG001|Phase 2|Withdrawal by Subject|0|||
145493967|NCT01601535|524665547|FG002|Phase 2|Withdrawal by Subject|0|||
145493968|NCT01601535|524665548|FG003|Phase 2|Withdrawal by Subject|0|||
145493969|NCT01601535|524665549|FG004|Phase 2|Withdrawal by Subject|8|||
145493970|NCT01601535|524665550|FG005|Phase 2|Withdrawal by Subject|2|||
145493971|NCT01601535|524665545|FG000|Phase 2|Progressive Disease|0|||
145493972|NCT01601535|524665546|FG001|Phase 2|Progressive Disease|0|||
145493973|NCT01601535|524665547|FG002|Phase 2|Progressive Disease|0|||
145493974|NCT01601535|524665548|FG003|Phase 2|Progressive Disease|0|||
145493975|NCT01601535|524665549|FG004|Phase 2|Progressive Disease|5|||
145493976|NCT01601535|524665550|FG005|Phase 2|Progressive Disease|7|||
145493977|NCT01601535|524665545|FG000|Phase 2|Started Another Treatment|0|||
145493978|NCT01601535|524665546|FG001|Phase 2|Started Another Treatment|0|||
145493979|NCT01601535|524665547|FG002|Phase 2|Started Another Treatment|0|||
145493980|NCT01601535|524665548|FG003|Phase 2|Started Another Treatment|0|||
145493981|NCT01601535|524665549|FG004|Phase 2|Started Another Treatment|1|||
145493982|NCT01601535|524665550|FG005|Phase 2|Started Another Treatment|2|||
145493983|NCT02025179|524665551|FG000|Overall Study|Lost to Follow-up|0|||
145493984|NCT02025179|524665552|FG001|Overall Study|Lost to Follow-up|0|||
145493985|NCT02025179|524665553|FG002|Overall Study|Lost to Follow-up|1|||
145493986|NCT02362724|524665554|FG000|Overall Study|Withdrawal by Subject|3|||
145493987|NCT02362724|524665555|FG001|Overall Study|Withdrawal by Subject|1|||
145493988|NCT02362724|524665554|FG000|Overall Study|Adverse Event|3|||
145493989|NCT02362724|524665555|FG001|Overall Study|Adverse Event|0|||
145493990|NCT04764162|524665558|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
145493991|NCT04764162|524665559|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
145493992|NCT05556265|524665560|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
145493993|NCT05556265|524665561|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
145493994|NCT05556265|524665562|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
145493995|NCT05556265|524665563|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
145493996|NCT05556265|524665564|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
145493997|NCT05556265|524665560|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
145493998|NCT05556265|524665561|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
145493999|NCT05556265|524665562|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
145494000|NCT05556265|524665563|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
145494001|NCT05556265|524665564|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
145494002|NCT05556265|524665560|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
145494003|NCT05556265|524665561|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
145494004|NCT05556265|524665562|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
145494005|NCT05556265|524665563|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
145494006|NCT05556265|524665564|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
145494007|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
145494008|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
145494009|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
145494010|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
145494011|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
145494012|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
145494013|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
145494014|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
145494015|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
145494016|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
145494017|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
145494018|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
145494019|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
145494020|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
145494021|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
145494022|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
145494023|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
145494024|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
145494025|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
145494026|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
145494027|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
145494028|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
145494029|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
145494030|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
145494031|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
145494032|NCT05556265|524665560|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
145494033|NCT05556265|524665561|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
145494034|NCT05556265|524665562|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
145494035|NCT05556265|524665563|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
145494036|NCT05556265|524665564|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
145494037|NCT03077542|524665565|FG000|Overall Study|Death|4|||
145494038|NCT03077542|524665566|FG001|Overall Study|Death|0|||
145494039|NCT03077542|524665565|FG000|Overall Study|Physician Decision|6|||
145494040|NCT03077542|524665566|FG001|Overall Study|Physician Decision|1|||
145494041|NCT03077542|524665565|FG000|Overall Study|Withdrawal by Subject|0|||
145494042|NCT03077542|524665566|FG001|Overall Study|Withdrawal by Subject|1|||
145494043|NCT03980730|524665567|FG000|Overall Study|Study Terminated by Sponsor|0|||
145494044|NCT03980730|524665568|FG001|Overall Study|Study Terminated by Sponsor|3|||
145494045|NCT03980730|524665567|FG000|Overall Study|Adverse Event|2|||
145494046|NCT03980730|524665568|FG001|Overall Study|Adverse Event|0|||
145494047|NCT03980730|524665567|FG000|Overall Study|Sponsor Request|0|||
145494048|NCT03980730|524665568|FG001|Overall Study|Sponsor Request|1|||
145494049|NCT01300728|524665569|FG000|Overall Study|Withdrawal by Subject|1|||
145494050|NCT01300728|524665570|FG001|Overall Study|Withdrawal by Subject|1|||
145494051|NCT01300728|524665569|FG000|Overall Study|Physician Decision|1|||
145494052|NCT01300728|524665570|FG001|Overall Study|Physician Decision|0|||
145494053|NCT00301808|524665576|FG000|Overall Study|Adverse Event|5|||
145494054|NCT00301808|524665576|FG000|Overall Study|Death|3|||
145494055|NCT00301808|524665576|FG000|Overall Study|Lack of Efficacy|4|||
145494056|NCT03724942|524665581|FG000|Overall Study|Adverse Event|20|||
145494057|NCT03724942|524665582|FG001|Overall Study|Adverse Event|14|||
145494058|NCT03724942|524665581|FG000|Overall Study|Lack of Efficacy|0|||
145494059|NCT03724942|524665582|FG001|Overall Study|Lack of Efficacy|1|||
145494060|NCT03724942|524665581|FG000|Overall Study|Physician Decision|5|||
145494061|NCT03724942|524665582|FG001|Overall Study|Physician Decision|2|||
145494062|NCT03724942|524665581|FG000|Overall Study|Protocol Violation|1|||
145494063|NCT03724942|524665582|FG001|Overall Study|Protocol Violation|0|||
145494064|NCT03724942|524665581|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
145494065|NCT03724942|524665582|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
145494066|NCT03724942|524665581|FG000|Overall Study|Withdrawal by Legal Representative|3|||
145494067|NCT03724942|524665582|FG001|Overall Study|Withdrawal by Legal Representative|0|||
145494068|NCT02429830|524665583|FG000|Overall Study|Lost to Follow-up|1|||
145494069|NCT02429830|524665583|FG000|Overall Study|Device Explant|2|||
145494070|NCT01352117|524667715|FG000|Overall Study|Death|15|||
145494071|NCT01352117|524667716|FG001|Overall Study|Death|16|||
145494072|NCT01352117|524667715|FG000|Overall Study|Withdrawal by Subject|1|||
145494073|NCT01352117|524667716|FG001|Overall Study|Withdrawal by Subject|0|||
145494074|NCT01352117|524667715|FG000|Overall Study|Lost to Follow-up|2|||
145494075|NCT01352117|524667716|FG001|Overall Study|Lost to Follow-up|7|||
145494076|NCT01352117|524667715|FG000|Overall Study|Non-adherent to study requirements|1|||
145494077|NCT01352117|524667716|FG001|Overall Study|Non-adherent to study requirements|1|||
145494078|NCT01352117|524667715|FG000|Overall Study|Did not initiate study treatment|1|||
145494079|NCT01352117|524667716|FG001|Overall Study|Did not initiate study treatment|0|||
145494080|NCT01352117|524667715|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
145494081|NCT01352117|524667716|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
145494082|NCT01766050|524667717|FG000|Overall Study|Adverse Event|1|||
145494083|NCT01766050|524667717|FG000|Overall Study|Lost to Follow-up|1|||
145494084|NCT01766050|524667717|FG000|Overall Study|Withdrawal by Subject|2|||
145494085|NCT02081677|524667719|FG000|Overall Study|Adverse Event|0|||
145494086|NCT02081677|524667720|FG001|Overall Study|Adverse Event|0|||
145494087|NCT02081677|524667721|FG002|Overall Study|Adverse Event|1|||
145494088|NCT02081677|524667722|FG003|Overall Study|Adverse Event|0|||
145494089|NCT02081677|524667719|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145494090|NCT02081677|524667720|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145494091|NCT02081677|524667721|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
145494092|NCT02081677|524667722|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145494093|NCT02081677|524667719|FG000|Overall Study|Not comfortable with lens care system|1|||
145494094|NCT02081677|524667720|FG001|Overall Study|Not comfortable with lens care system|0|||
145494095|NCT02081677|524667721|FG002|Overall Study|Not comfortable with lens care system|0|||
145494096|NCT02081677|524667722|FG003|Overall Study|Not comfortable with lens care system|0|||
145494097|NCT02081677|524667719|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
145494098|NCT02081677|524667720|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
145494099|NCT02081677|524667721|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
145494100|NCT02081677|524667722|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
145605886|NCT00633932|525073035|FG001|Overall Study|Withdrawal by Subject|9|||
145605887|NCT00633932|525073036|FG002|Overall Study|Withdrawal by Subject|1|||
145494101|NCT01097668|524667723|FG000|Overall Study|Withdrawal by Subject|1|||
145494102|NCT01097668|524667724|FG001|Overall Study|Withdrawal by Subject|2|||
145494103|NCT01097668|524667723|FG000|Overall Study|Lost to Follow-up|1|||
145494104|NCT01097668|524667724|FG001|Overall Study|Lost to Follow-up|0|||
145494105|NCT01910298|524667725|FG000|Overall Study|Adverse Event|1|||
145494106|NCT01910298|524667726|FG001|Overall Study|Adverse Event|0|||
145494107|NCT01910298|524667725|FG000|Overall Study|Withdrawal by Subject|2|||
145494108|NCT01910298|524667726|FG001|Overall Study|Withdrawal by Subject|7|||
145494109|NCT01910298|524667725|FG000|Overall Study|Protocol Deviation|0|||
145494110|NCT01910298|524667726|FG001|Overall Study|Protocol Deviation|5|||
145494111|NCT01910298|524667725|FG000|Overall Study|Lost to Follow-up|1|||
145494112|NCT01910298|524667726|FG001|Overall Study|Lost to Follow-up|1|||
145494113|NCT01910298|524667725|FG000|Overall Study|Study Terminated by Sponsor|1|||
145494114|NCT01910298|524667726|FG001|Overall Study|Study Terminated by Sponsor|17|||
145494115|NCT01910298|524667725|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145494116|NCT01910298|524667726|FG001|Overall Study|Other Miscellaneous Reasons|2|||
145494117|NCT03037385|524667729|FG000|Overall Study|Adverse Event|0|||
145494118|NCT03037385|524667730|FG001|Overall Study|Adverse Event|0|||
145494119|NCT03037385|524667731|FG002|Overall Study|Adverse Event|1|||
145494120|NCT03037385|524667732|FG003|Overall Study|Adverse Event|0|||
145494121|NCT03037385|524667733|FG004|Overall Study|Adverse Event|0|||
145494122|NCT03037385|524667734|FG005|Overall Study|Adverse Event|0|||
145494123|NCT03037385|524667735|FG006|Overall Study|Adverse Event|0|||
145494124|NCT03037385|524667736|FG007|Overall Study|Adverse Event|0|||
145494125|NCT03037385|524667737|FG008|Overall Study|Adverse Event|0|||
145494126|NCT03037385|524667738|FG009|Overall Study|Adverse Event|6|||
145494127|NCT03037385|524667729|FG000|Overall Study|Death|1|||
145494128|NCT03037385|524667730|FG001|Overall Study|Death|4|||
145494129|NCT03037385|524667731|FG002|Overall Study|Death|2|||
145494130|NCT03037385|524667732|FG003|Overall Study|Death|2|||
145494131|NCT03037385|524667733|FG004|Overall Study|Death|5|||
145494132|NCT03037385|524667734|FG005|Overall Study|Death|2|||
145494133|NCT03037385|524667735|FG006|Overall Study|Death|1|||
145494134|NCT03037385|524667736|FG007|Overall Study|Death|4|||
145494135|NCT03037385|524667737|FG008|Overall Study|Death|3|||
145494136|NCT03037385|524667738|FG009|Overall Study|Death|240|||
145494137|NCT03037385|524667729|FG000|Overall Study|Initiation of Another Therapy|1|||
145494138|NCT03037385|524667730|FG001|Overall Study|Initiation of Another Therapy|0|||
145494139|NCT03037385|524667731|FG002|Overall Study|Initiation of Another Therapy|0|||
145494140|NCT03037385|524667732|FG003|Overall Study|Initiation of Another Therapy|0|||
145494141|NCT03037385|524667733|FG004|Overall Study|Initiation of Another Therapy|0|||
145494142|NCT03037385|524667734|FG005|Overall Study|Initiation of Another Therapy|0|||
145494143|NCT03037385|524667735|FG006|Overall Study|Initiation of Another Therapy|0|||
145494144|NCT03037385|524667736|FG007|Overall Study|Initiation of Another Therapy|1|||
145494145|NCT03037385|524667737|FG008|Overall Study|Initiation of Another Therapy|0|||
145494146|NCT03037385|524667738|FG009|Overall Study|Initiation of Another Therapy|2|||
145494147|NCT03037385|524667729|FG000|Overall Study|Lost to Follow-up|0|||
145494148|NCT03037385|524667730|FG001|Overall Study|Lost to Follow-up|0|||
145494149|NCT03037385|524667731|FG002|Overall Study|Lost to Follow-up|0|||
145494150|NCT03037385|524667732|FG003|Overall Study|Lost to Follow-up|0|||
145494151|NCT03037385|524667733|FG004|Overall Study|Lost to Follow-up|0|||
145494152|NCT03037385|524667734|FG005|Overall Study|Lost to Follow-up|1|||
145494153|NCT03037385|524667735|FG006|Overall Study|Lost to Follow-up|0|||
145494154|NCT03037385|524667736|FG007|Overall Study|Lost to Follow-up|0|||
145494155|NCT03037385|524667737|FG008|Overall Study|Lost to Follow-up|0|||
145494156|NCT03037385|524667738|FG009|Overall Study|Lost to Follow-up|16|||
145494157|NCT03037385|524667729|FG000|Overall Study|Physician Decision|0|||
145494158|NCT03037385|524667730|FG001|Overall Study|Physician Decision|0|||
145494159|NCT03037385|524667731|FG002|Overall Study|Physician Decision|0|||
145494160|NCT03037385|524667732|FG003|Overall Study|Physician Decision|0|||
145494161|NCT03037385|524667733|FG004|Overall Study|Physician Decision|0|||
145494162|NCT03037385|524667734|FG005|Overall Study|Physician Decision|0|||
145494163|NCT03037385|524667735|FG006|Overall Study|Physician Decision|0|||
145494164|NCT03037385|524667736|FG007|Overall Study|Physician Decision|0|||
145494165|NCT03037385|524667737|FG008|Overall Study|Physician Decision|0|||
145494166|NCT03037385|524667738|FG009|Overall Study|Physician Decision|1|||
145494167|NCT03037385|524667729|FG000|Overall Study|Progressive Disease|0|||
145494168|NCT03037385|524667730|FG001|Overall Study|Progressive Disease|1|||
145494169|NCT03037385|524667731|FG002|Overall Study|Progressive Disease|1|||
145494170|NCT03037385|524667732|FG003|Overall Study|Progressive Disease|5|||
145494171|NCT03037385|524667733|FG004|Overall Study|Progressive Disease|2|||
145494172|NCT03037385|524667734|FG005|Overall Study|Progressive Disease|0|||
145494173|NCT03037385|524667735|FG006|Overall Study|Progressive Disease|1|||
145494174|NCT03037385|524667736|FG007|Overall Study|Progressive Disease|0|||
145494175|NCT03037385|524667737|FG008|Overall Study|Progressive Disease|0|||
145494176|NCT03037385|524667738|FG009|Overall Study|Progressive Disease|30|||
145494177|NCT03037385|524667729|FG000|Overall Study|Withdrawal by Subject|0|||
145494178|NCT03037385|524667730|FG001|Overall Study|Withdrawal by Subject|0|||
145494179|NCT03037385|524667731|FG002|Overall Study|Withdrawal by Subject|1|||
145494180|NCT03037385|524667732|FG003|Overall Study|Withdrawal by Subject|2|||
145494181|NCT03037385|524667733|FG004|Overall Study|Withdrawal by Subject|1|||
145494182|NCT03037385|524667734|FG005|Overall Study|Withdrawal by Subject|3|||
145494183|NCT03037385|524667735|FG006|Overall Study|Withdrawal by Subject|0|||
145494184|NCT03037385|524667736|FG007|Overall Study|Withdrawal by Subject|0|||
145494185|NCT03037385|524667737|FG008|Overall Study|Withdrawal by Subject|0|||
145494186|NCT03037385|524667738|FG009|Overall Study|Withdrawal by Subject|52|||
145494187|NCT03037385|524667729|FG000|Overall Study|Reason Not Specified|0|||
145494188|NCT03037385|524667730|FG001|Overall Study|Reason Not Specified|1|||
145494189|NCT03037385|524667731|FG002|Overall Study|Reason Not Specified|0|||
145494190|NCT03037385|524667732|FG003|Overall Study|Reason Not Specified|4|||
145494191|NCT03037385|524667733|FG004|Overall Study|Reason Not Specified|3|||
145494192|NCT03037385|524667734|FG005|Overall Study|Reason Not Specified|6|||
145494193|NCT03037385|524667735|FG006|Overall Study|Reason Not Specified|2|||
145494194|NCT03037385|524667736|FG007|Overall Study|Reason Not Specified|0|||
145494195|NCT03037385|524667737|FG008|Overall Study|Reason Not Specified|1|||
145494196|NCT03037385|524667738|FG009|Overall Study|Reason Not Specified|181|||
145494197|NCT04515771|524667739|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
145494198|NCT04515771|524667740|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
145494199|NCT04515771|524667739|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
145494200|NCT04515771|524667740|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
145494201|NCT04515771|524667739|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
145494202|NCT04515771|524667740|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
145494203|NCT01021020|524667741|FG000|Period I|Protocol Violation|1|||
145494204|NCT01021020|524667741|FG000|Period I|Withdrawal by Subject|1|||
145494205|NCT01021020|524667741|FG000|14 Day Washout Period A|Physician Decision|1|||
145494206|NCT00948246|524667744|FG000|Overall Study|Lost to Follow-up|11|||
145494207|NCT00948246|524667744|FG000|Overall Study|Adverse Event|11|||
145494208|NCT00948246|524667744|FG000|Overall Study|Death|1|||
145494209|NCT00948246|524667744|FG000|Overall Study|Withdrawal by Subject|1|||
145494210|NCT00148317|524667745|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
145494211|NCT00148317|524667745|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
145494212|NCT00148317|524667745|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
145494213|NCT03924622|524667747|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
145494214|NCT03924622|524667748|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
145494215|NCT03924622|524667749|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
145494216|NCT03924622|524667750|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
145494217|NCT03924622|524667751|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
145494218|NCT03924622|524667752|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
145494219|NCT00286468|524667753|FG000|Overall Study|Hyperglycemic Rescue|28|||
145494220|NCT00286468|524667754|FG001|Overall Study|Hyperglycemic Rescue|30|||
145494221|NCT00286468|524667755|FG002|Overall Study|Hyperglycemic Rescue|31|||
145494222|NCT00286468|524667753|FG000|Overall Study|Adverse Event|2|||
145494223|NCT00286468|524667754|FG001|Overall Study|Adverse Event|6|||
145494224|NCT00286468|524667755|FG002|Overall Study|Adverse Event|4|||
145494225|NCT00286468|524667753|FG000|Overall Study|Protocol Violation|0|||
145494226|NCT00286468|524667754|FG001|Overall Study|Protocol Violation|3|||
145494227|NCT00286468|524667755|FG002|Overall Study|Protocol Violation|1|||
145494228|NCT00286468|524667753|FG000|Overall Study|Lost to Follow-up|1|||
145494229|NCT00286468|524667754|FG001|Overall Study|Lost to Follow-up|1|||
145494230|NCT00286468|524667755|FG002|Overall Study|Lost to Follow-up|2|||
145494231|NCT00286468|524667753|FG000|Overall Study|Withdrawal by Subject|3|||
145494232|NCT00286468|524667754|FG001|Overall Study|Withdrawal by Subject|8|||
145494233|NCT00286468|524667755|FG002|Overall Study|Withdrawal by Subject|11|||
145494234|NCT00286468|524667753|FG000|Overall Study|Physician Decision|3|||
145494235|NCT00286468|524667754|FG001|Overall Study|Physician Decision|2|||
145494236|NCT00286468|524667755|FG002|Overall Study|Physician Decision|1|||
145494237|NCT02923726|524667756|FG000|Overall Study|Death|196|||
145494238|NCT02923726|524667757|FG001|Overall Study|Death|175|||
145494239|NCT02923726|524667756|FG000|Overall Study|Withdrawal by Subject|337|||
145494240|NCT02923726|524667757|FG001|Overall Study|Withdrawal by Subject|307|||
145494241|NCT03617172|524667761|FG000|Overall Study|Lost to Follow-up|1|||
145494242|NCT03617172|524667762|FG001|Overall Study|Lost to Follow-up|0|||
145494243|NCT02546609|524667766|FG000|Overall Study|Withdrawal by Subject|0|||
145494244|NCT02546609|524667767|FG001|Overall Study|Withdrawal by Subject|1|||
145494245|NCT02546609|524667768|FG002|Overall Study|Withdrawal by Subject|2|||
145494246|NCT02546609|524667766|FG000|Overall Study|Adverse Event|0|||
145494247|NCT02546609|524667767|FG001|Overall Study|Adverse Event|6|||
145494248|NCT02546609|524667768|FG002|Overall Study|Adverse Event|1|||
145494249|NCT02546609|524667766|FG000|Overall Study|Protocol Violation|0|||
145494250|NCT02546609|524667767|FG001|Overall Study|Protocol Violation|1|||
145494251|NCT02546609|524667768|FG002|Overall Study|Protocol Violation|1|||
145494252|NCT02546609|524667766|FG000|Overall Study|Lost to Follow-up|2|||
145494253|NCT02546609|524667767|FG001|Overall Study|Lost to Follow-up|3|||
145494254|NCT02546609|524667768|FG002|Overall Study|Lost to Follow-up|1|||
145494255|NCT02546609|524667766|FG000|Overall Study|travel or work schedule restriction|0|||
145494256|NCT02546609|524667767|FG001|Overall Study|travel or work schedule restriction|0|||
145494257|NCT02546609|524667768|FG002|Overall Study|travel or work schedule restriction|2|||
145494258|NCT03780452|524667773|FG000|Overall Study|Screening failure|2|||
145494259|NCT00914849|524667776|FG000|Overall Study|Withdrawal by Subject|1|||
145494260|NCT00914849|524667777|FG001|Overall Study|Withdrawal by Subject|0|||
145494261|NCT00914849|524667776|FG000|Overall Study|Not eligible|0|||
145494262|NCT00914849|524667777|FG001|Overall Study|Not eligible|1|||
145494263|NCT01001221|524667778|FG000|Overall Study|Adverse Event|1|||
145494264|NCT01001221|524667779|FG001|Overall Study|Adverse Event|2|||
145494265|NCT01001221|524667780|FG002|Overall Study|Adverse Event|0|||
145494266|NCT01001221|524667781|FG003|Overall Study|Adverse Event|2|||
145494267|NCT01001221|524667782|FG004|Overall Study|Adverse Event|0|||
145494268|NCT01001221|524667778|FG000|Overall Study|Disease progression|3|||
145494269|NCT01001221|524667779|FG001|Overall Study|Disease progression|2|||
145494270|NCT01001221|524667780|FG002|Overall Study|Disease progression|2|||
145494271|NCT01001221|524667781|FG003|Overall Study|Disease progression|4|||
145494272|NCT01001221|524667782|FG004|Overall Study|Disease progression|0|||
145494273|NCT01001221|524667778|FG000|Overall Study|Other|1|||
145494274|NCT01001221|524667779|FG001|Overall Study|Other|1|||
145494275|NCT01001221|524667780|FG002|Overall Study|Other|0|||
145494276|NCT01001221|524667781|FG003|Overall Study|Other|0|||
145494277|NCT01001221|524667782|FG004|Overall Study|Other|0|||
145494278|NCT01001221|524667778|FG000|Overall Study|Not treated; protocol exclusion|0|||
145494279|NCT01001221|524667779|FG001|Overall Study|Not treated; protocol exclusion|0|||
145494280|NCT01001221|524667780|FG002|Overall Study|Not treated; protocol exclusion|1|||
145494281|NCT01001221|524667781|FG003|Overall Study|Not treated; protocol exclusion|0|||
145494282|NCT01001221|524667782|FG004|Overall Study|Not treated; protocol exclusion|0|||
145494283|NCT02388269|524667783|FG000|Overall Study|Adverse Event|2|||
145494284|NCT02388269|524667784|FG001|Overall Study|Adverse Event|0|||
145494285|NCT02388269|524667785|FG002|Overall Study|Adverse Event|0|||
145494286|NCT02388269|524667783|FG000|Overall Study|Withdrawal by Subject|1|||
145494287|NCT02388269|524667784|FG001|Overall Study|Withdrawal by Subject|2|||
145494288|NCT02388269|524667785|FG002|Overall Study|Withdrawal by Subject|0|||
145494289|NCT02388269|524667783|FG000|Overall Study|less than 50% stimulations|1|||
145494290|NCT02388269|524667784|FG001|Overall Study|less than 50% stimulations|0|||
145494291|NCT02388269|524667785|FG002|Overall Study|less than 50% stimulations|0|||
145494292|NCT02388269|524667783|FG000|Overall Study|no diary data|3|||
145494293|NCT02388269|524667784|FG001|Overall Study|no diary data|0|||
145494294|NCT02388269|524667785|FG002|Overall Study|no diary data|0|||
145494295|NCT02388269|524667783|FG000|Overall Study|Protocol Violation|2|||
145494296|NCT02388269|524667784|FG001|Overall Study|Protocol Violation|0|||
145494297|NCT02388269|524667785|FG002|Overall Study|Protocol Violation|0|||
145494298|NCT02388269|524667783|FG000|Overall Study|Screen Failure|0|||
145494299|NCT02388269|524667784|FG001|Overall Study|Screen Failure|0|||
145494300|NCT02388269|524667785|FG002|Overall Study|Screen Failure|10|||
145494301|NCT03448406|524667786|FG000|Overall Study|Noncompliance of scheduled visits|1|||
145494302|NCT03448406|524667787|FG001|Overall Study|Noncompliance of scheduled visits|2|||
145494303|NCT03448406|524667786|FG000|Overall Study|Withdrawal by Subject|1|||
145494304|NCT03448406|524667787|FG001|Overall Study|Withdrawal by Subject|2|||
145494305|NCT03448406|524667786|FG000|Overall Study|Protocol Violation|1|||
145494306|NCT03448406|524667787|FG001|Overall Study|Protocol Violation|0|||
145494307|NCT03448406|524667786|FG000|Overall Study|Adverse Event|8|||
145494308|NCT03448406|524667787|FG001|Overall Study|Adverse Event|9|||
145494309|NCT01292486|524667788|FG000|Overall Study|Protocol Violation|2|||
145494310|NCT01292486|524667788|FG000|Overall Study|Did not meet screening criteria|2|||
145494311|NCT01292486|524667788|FG000|Overall Study|Adverse Event|1|||
145494312|NCT01292486|524667788|FG000|Overall Study|Physician Decision|1|||
145494313|NCT00087152|524667789|FG000|Overall Study|Ineligible|6|||
145494314|NCT04602390|524667790|FG000|Overall Study|Withdrawal by Subject|0|||
145494315|NCT04602390|524667791|FG001|Overall Study|Withdrawal by Subject|0|||
145494316|NCT04602390|524667792|FG002|Overall Study|Withdrawal by Subject|0|||
145494317|NCT04602390|524667793|FG003|Overall Study|Withdrawal by Subject|0|||
145494318|NCT04602390|524667794|FG004|Overall Study|Withdrawal by Subject|1|||
145494319|NCT04602390|524667795|FG005|Overall Study|Withdrawal by Subject|0|||
145494320|NCT04602390|524667790|FG000|Overall Study|Adverse Event|0|||
145494321|NCT04602390|524667791|FG001|Overall Study|Adverse Event|0|||
145494322|NCT04602390|524667792|FG002|Overall Study|Adverse Event|0|||
145494323|NCT04602390|524667793|FG003|Overall Study|Adverse Event|0|||
145494324|NCT04602390|524667794|FG004|Overall Study|Adverse Event|0|||
145494325|NCT04602390|524667795|FG005|Overall Study|Adverse Event|1|||
145494326|NCT03882021|524667796|FG000|Enrollment|Procedure aborted/cancelled|2|||
145494327|NCT03882021|524667796|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
145494328|NCT03882021|524667796|FG000|Enrollment to 3-Month|Death|1|||
145494329|NCT03882021|524667796|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
145494330|NCT03882021|524667796|FG000|Enrollment to 3-Month|Missed Visit|4|||
145494331|NCT03882021|524667796|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
145494332|NCT03882021|524667796|FG000|6-Month to 12-Month Visit|Death|1|||
145494333|NCT03882021|524667796|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
145494334|NCT01546857|524667797|FG000|Overall Study|Withdrawal by Subject|2|||
145723584|NCT00819390|525504884|FG001|Overall Study|Adverse Event|0|||
145723585|NCT00819390|525504885|FG002|Overall Study|Adverse Event|1|||
145723586|NCT00819390|525504886|FG003|Overall Study|Adverse Event|0|||
145723587|NCT01191268|525504887|FG000|Overall Study|Withdrawal by Subject|19|||
145723588|NCT01191268|525504888|FG001|Overall Study|Withdrawal by Subject|25|||
145723589|NCT01191268|525504889|FG002|Overall Study|Withdrawal by Subject|21|||
145723590|NCT01191268|525504887|FG000|Overall Study|Adverse Event|21|||
145723591|NCT01191268|525504888|FG001|Overall Study|Adverse Event|13|||
145723592|NCT01191268|525504889|FG002|Overall Study|Adverse Event|8|||
145723593|NCT01191268|525504887|FG000|Overall Study|Physician Decision|6|||
145723594|NCT01191268|525504888|FG001|Overall Study|Physician Decision|8|||
145723595|NCT01191268|525504889|FG002|Overall Study|Physician Decision|9|||
145723596|NCT01191268|525504887|FG000|Overall Study|Lost to Follow-up|8|||
145723597|NCT01191268|525504888|FG001|Overall Study|Lost to Follow-up|5|||
145723598|NCT01191268|525504889|FG002|Overall Study|Lost to Follow-up|9|||
145723599|NCT01191268|525504887|FG000|Overall Study|Entry Criteria Not Met|3|||
145723600|NCT01191268|525504888|FG001|Overall Study|Entry Criteria Not Met|1|||
145723601|NCT01191268|525504889|FG002|Overall Study|Entry Criteria Not Met|1|||
145723602|NCT01191268|525504887|FG000|Overall Study|Death|0|||
145723603|NCT01191268|525504888|FG001|Overall Study|Death|1|||
145723604|NCT01191268|525504889|FG002|Overall Study|Death|3|||
145723605|NCT01191268|525504887|FG000|Overall Study|Protocol Violation|1|||
145723606|NCT01191268|525504888|FG001|Overall Study|Protocol Violation|0|||
145723607|NCT01191268|525504889|FG002|Overall Study|Protocol Violation|1|||
145723608|NCT01191268|525504887|FG000|Overall Study|Sponsor Decision|0|||
145723609|NCT01191268|525504888|FG001|Overall Study|Sponsor Decision|2|||
145723610|NCT01191268|525504889|FG002|Overall Study|Sponsor Decision|0|||
145723611|NCT00336895|525504890|FG000|Overall Study|diarrhea|1|||
145723612|NCT00336895|525504890|FG000|Overall Study|nausea and upset stomach|1|||
145723613|NCT00336895|525504890|FG000|Overall Study|Physician Decision|1|||
145723614|NCT00336895|525504890|FG000|Overall Study|screen failed|1|||
145723615|NCT03333837|525504895|FG000|Overall Study|Adverse Event|2|||
145723616|NCT03333837|525504896|FG001|Overall Study|Adverse Event|1|||
145723617|NCT03333837|525504897|FG002|Overall Study|Adverse Event|1|||
145723618|NCT03333837|525504898|FG003|Overall Study|Adverse Event|1|||
145723619|NCT03333837|525504899|FG004|Overall Study|Adverse Event|0|||
145723620|NCT03333837|525504895|FG000|Overall Study|Caregiver withdrew|0|||
145723621|NCT03333837|525504896|FG001|Overall Study|Caregiver withdrew|2|||
145723622|NCT03333837|525504897|FG002|Overall Study|Caregiver withdrew|1|||
145723623|NCT03333837|525504898|FG003|Overall Study|Caregiver withdrew|0|||
145723624|NCT03333837|525504899|FG004|Overall Study|Caregiver withdrew|0|||
145723625|NCT03333837|525504895|FG000|Overall Study|Withdrawal by Subject|0|||
145723626|NCT03333837|525504896|FG001|Overall Study|Withdrawal by Subject|0|||
145723627|NCT03333837|525504897|FG002|Overall Study|Withdrawal by Subject|1|||
145723628|NCT03333837|525504898|FG003|Overall Study|Withdrawal by Subject|1|||
145723629|NCT03333837|525504899|FG004|Overall Study|Withdrawal by Subject|3|||
145723630|NCT03333837|525504895|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
145723631|NCT03333837|525504896|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
145723632|NCT03333837|525504897|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
145723633|NCT03333837|525504898|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
145723634|NCT03333837|525504899|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
145723635|NCT00705523|525504900|FG000|Overall Study|Lost to Follow-up|2|||
145723636|NCT00705523|525504901|FG001|Overall Study|Lost to Follow-up|3|||
145723637|NCT01013285|525504903|FG000|Overall Study|Death|48|||
145723638|NCT01013285|525504904|FG001|Overall Study|Death|89|||
145723639|NCT02112708|525504918|FG000|Baseline|Physician Decision|16|||
145723640|NCT02112708|525504919|FG001|Baseline|Physician Decision|11|||
145723641|NCT02112708|525504918|FG000|Baseline|Lost to Follow-up|12|||
145723642|NCT02112708|525504919|FG001|Baseline|Lost to Follow-up|0|||
145723643|NCT02112708|525504918|FG000|4 Month|Death|0|||
145494335|NCT01546857|524667798|FG001|Overall Study|Withdrawal by Subject|3|||
145723644|NCT02112708|525504919|FG001|4 Month|Death|1|||
145723645|NCT02112708|525504918|FG000|4 Month|Withdrawal by Subject|12|||
145723646|NCT02112708|525504919|FG001|4 Month|Withdrawal by Subject|0|||
145723647|NCT03866473|525504922|FG000|Phase 1|Death|1|||
145723648|NCT03866473|525504923|FG001|Phase 1|Death|0|||
145494336|NCT01176032|524667799|FG000|Overall Study|Adverse Event|1|||
145494337|NCT01176032|524667800|FG001|Overall Study|Adverse Event|0|||
145494338|NCT01176032|524667799|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145494339|NCT01176032|524667800|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145494340|NCT01176032|524667799|FG000|Overall Study|Protocol Violation|1|||
145494341|NCT01176032|524667800|FG001|Overall Study|Protocol Violation|0|||
145494342|NCT01176032|524667799|FG000|Overall Study|Informed consent withdrawn|3|||
145494343|NCT01176032|524667800|FG001|Overall Study|Informed consent withdrawn|0|||
145494344|NCT01176032|524667799|FG000|Overall Study|Other|1|||
145494345|NCT01176032|524667800|FG001|Overall Study|Other|0|||
145494346|NCT01469221|524667801|FG000|Double Blind Phase|Protocol Violation|1|||
145494347|NCT01469221|524667802|FG001|Double Blind Phase|Protocol Violation|0|||
145494348|NCT01469221|524667803|FG002|Double Blind Phase|Protocol Violation|0|||
145494349|NCT01469221|524667801|FG000|Double Blind Phase|Physician Decision|1|||
145494350|NCT01469221|524667802|FG001|Double Blind Phase|Physician Decision|1|||
145494351|NCT01469221|524667803|FG002|Double Blind Phase|Physician Decision|0|||
145494352|NCT01469221|524667801|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
145494353|NCT01469221|524667802|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
145494354|NCT01469221|524667803|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
145494355|NCT01149096|524667805|FG000|Overall Study|Lost to Follow-up|0|||
145494356|NCT01149096|524667806|FG001|Overall Study|Lost to Follow-up|1|||
145494357|NCT02358473|524667807|FG000|Overall Study|Disease Progession|6|||
145494358|NCT02358473|524667807|FG000|Overall Study|Adverse Event|3|||
145494359|NCT02358473|524667807|FG000|Overall Study|Withdrawal by Subject|2|||
145494360|NCT02358473|524667807|FG000|Overall Study|Physician Decision|2|||
145494361|NCT01263769|524667808|FG000|Overall Study|Non-Compliant with treatment|1|||
145494362|NCT04819945|524667821|FG000|Overall Study|Lost to Follow-up|1|||
145494363|NCT00703014|524667822|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
145494364|NCT00703014|524667823|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
145494365|NCT00703014|524667824|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
145494366|NCT00703014|524667825|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
145494367|NCT00703014|524667822|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
145494368|NCT00703014|524667823|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
145494369|NCT00703014|524667824|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
145494370|NCT00703014|524667825|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
145494371|NCT02004236|524667826|FG000|Overall Study|Lack of Efficacy|0|||
145494372|NCT02004236|524667827|FG001|Overall Study|Lack of Efficacy|0|||
145494373|NCT02004236|524667828|FG002|Overall Study|Lack of Efficacy|16|||
145494374|NCT00625131|524667833|FG000|Overall Study|Lost to Follow-up|3|||
145494375|NCT00625131|524667834|FG001|Overall Study|Lost to Follow-up|2|||
145494376|NCT00625131|524667835|FG002|Overall Study|Lost to Follow-up|0|||
145494377|NCT00625131|524667833|FG000|Overall Study|Withdrawal by Subject|1|||
145494378|NCT00625131|524667834|FG001|Overall Study|Withdrawal by Subject|0|||
145494379|NCT00625131|524667835|FG002|Overall Study|Withdrawal by Subject|5|||
145494380|NCT00918281|524667838|FG000|Overall Study|Physician Decision|29|||
145494381|NCT01446159|524667839|FG000|Overall Study|Withdrawal by Subject|1|||
145494382|NCT01446159|524667840|FG001|Overall Study|Withdrawal by Subject|0|||
145494383|NCT01446159|524667841|FG002|Overall Study|Withdrawal by Subject|14|||
145494384|NCT01446159|524667842|FG003|Overall Study|Withdrawal by Subject|11|||
145494385|NCT01446159|524667839|FG000|Overall Study|Lost to Follow-up|0|||
145494386|NCT01446159|524667840|FG001|Overall Study|Lost to Follow-up|0|||
145494387|NCT01446159|524667841|FG002|Overall Study|Lost to Follow-up|1|||
145494388|NCT01446159|524667842|FG003|Overall Study|Lost to Follow-up|2|||
145494389|NCT01446159|524667839|FG000|Overall Study|Death|2|||
145494390|NCT01446159|524667840|FG001|Overall Study|Death|3|||
145494391|NCT01446159|524667841|FG002|Overall Study|Death|43|||
145494392|NCT01446159|524667842|FG003|Overall Study|Death|36|||
145494393|NCT01446159|524667839|FG000|Overall Study|Other|0|||
145494394|NCT01446159|524667840|FG001|Overall Study|Other|0|||
145494395|NCT01446159|524667841|FG002|Overall Study|Other|13|||
145494396|NCT01446159|524667842|FG003|Overall Study|Other|13|||
145494397|NCT00537394|524667843|FG000|First Year of Follow-up|Death|7|||
145494398|NCT00537394|524667844|FG001|First Year of Follow-up|Death|0|||
145494399|NCT00537394|524667845|FG002|First Year of Follow-up|Death|0|||
145494400|NCT00537394|524667843|FG000|First Year of Follow-up|Severe debilitation|1|||
145494401|NCT00537394|524667844|FG001|First Year of Follow-up|Severe debilitation|0|||
145494402|NCT00537394|524667845|FG002|First Year of Follow-up|Severe debilitation|1|||
145494403|NCT00537394|524667843|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
145494404|NCT00537394|524667844|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
145494405|NCT00537394|524667845|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
145494406|NCT00537394|524667843|FG000|First Year of Follow-up|Lost to Follow-up|1|||
145494407|NCT00537394|524667844|FG001|First Year of Follow-up|Lost to Follow-up|5|||
145494408|NCT00537394|524667845|FG002|First Year of Follow-up|Lost to Follow-up|1|||
145494409|NCT00537394|524667843|FG000|2nd Year of Follow-up|Death|4|||
145494410|NCT00537394|524667844|FG001|2nd Year of Follow-up|Death|1|||
145494411|NCT00537394|524667845|FG002|2nd Year of Follow-up|Death|2|||
145494412|NCT00537394|524667843|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
145494413|NCT00537394|524667844|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
145494414|NCT00537394|524667845|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
145494415|NCT00537394|524667843|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
145494416|NCT00537394|524667844|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
145494417|NCT00537394|524667845|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
145494418|NCT00537394|524667843|FG000|2nd Year of Follow-up|Clinic site closure|1|||
145494419|NCT00537394|524667844|FG001|2nd Year of Follow-up|Clinic site closure|0|||
145494420|NCT00537394|524667845|FG002|2nd Year of Follow-up|Clinic site closure|0|||
145494421|NCT00762164|524667846|FG000|Overall Study|Lost to Follow-up|1|||
145494422|NCT00762164|524667847|FG001|Overall Study|Lost to Follow-up|1|||
145494423|NCT00762164|524667846|FG000|Overall Study|Discontinued medication|2|||
145494424|NCT00762164|524667847|FG001|Overall Study|Discontinued medication|0|||
145494425|NCT00762164|524667846|FG000|Overall Study|Withdrawal by Subject|0|||
145494426|NCT00762164|524667847|FG001|Overall Study|Withdrawal by Subject|1|||
145494427|NCT00321789|524667851|FG000|Overall Study|Lost to Follow-up|4|||
145494428|NCT00321789|524667852|FG001|Overall Study|Lost to Follow-up|7|||
145494429|NCT00321789|524667851|FG000|Overall Study|Withdrawal by Subject|6|||
145494430|NCT00321789|524667852|FG001|Overall Study|Withdrawal by Subject|6|||
145494431|NCT00321789|524667851|FG000|Overall Study|Protocol Violation|5|||
145494432|NCT00321789|524667852|FG001|Overall Study|Protocol Violation|3|||
145494433|NCT03137992|524667855|FG000|Washout Period 1|Adverse Event|1|||
145494434|NCT03137992|524667856|FG001|Washout Period 1|Adverse Event|1|||
145494435|NCT03137992|524667857|FG002|Washout Period 1|Adverse Event|0|||
145494436|NCT03137992|524667858|FG003|Washout Period 1|Adverse Event|0|||
145494437|NCT03137992|524667859|FG004|Washout Period 1|Adverse Event|0|||
145494438|NCT03137992|524667860|FG005|Washout Period 1|Adverse Event|1|||
145494439|NCT03137992|524667855|FG000|Washout Period 1|Withdrawal by Subject|0|||
145494440|NCT03137992|524667856|FG001|Washout Period 1|Withdrawal by Subject|1|||
145494441|NCT03137992|524667857|FG002|Washout Period 1|Withdrawal by Subject|1|||
145494442|NCT03137992|524667858|FG003|Washout Period 1|Withdrawal by Subject|0|||
145494443|NCT03137992|524667859|FG004|Washout Period 1|Withdrawal by Subject|0|||
145494444|NCT03137992|524667860|FG005|Washout Period 1|Withdrawal by Subject|0|||
145494445|NCT03137992|524667855|FG000|Washout Period 1|Principal Investigator Discretion|0|||
145494446|NCT03137992|524667856|FG001|Washout Period 1|Principal Investigator Discretion|1|||
145494447|NCT03137992|524667857|FG002|Washout Period 1|Principal Investigator Discretion|0|||
145494448|NCT03137992|524667858|FG003|Washout Period 1|Principal Investigator Discretion|0|||
145494449|NCT03137992|524667859|FG004|Washout Period 1|Principal Investigator Discretion|0|||
145494450|NCT03137992|524667860|FG005|Washout Period 1|Principal Investigator Discretion|0|||
145494451|NCT03137992|524667855|FG000|Washout Period 1|COPD Exacerbation|1|||
145494452|NCT03137992|524667856|FG001|Washout Period 1|COPD Exacerbation|1|||
145494453|NCT03137992|524667857|FG002|Washout Period 1|COPD Exacerbation|1|||
145494454|NCT03137992|524667858|FG003|Washout Period 1|COPD Exacerbation|0|||
145494455|NCT03137992|524667859|FG004|Washout Period 1|COPD Exacerbation|1|||
145494456|NCT03137992|524667860|FG005|Washout Period 1|COPD Exacerbation|1|||
145494457|NCT03137992|524667855|FG000|Washout Period 1|Subject Noncompliance|1|||
145494458|NCT03137992|524667856|FG001|Washout Period 1|Subject Noncompliance|0|||
145494459|NCT03137992|524667857|FG002|Washout Period 1|Subject Noncompliance|0|||
145494460|NCT03137992|524667858|FG003|Washout Period 1|Subject Noncompliance|0|||
145494461|NCT03137992|524667859|FG004|Washout Period 1|Subject Noncompliance|1|||
145494462|NCT03137992|524667860|FG005|Washout Period 1|Subject Noncompliance|0|||
145494463|NCT03137992|524667855|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
145494464|NCT03137992|524667856|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
145494465|NCT03137992|524667857|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
145494466|NCT03137992|524667858|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
145494467|NCT03137992|524667859|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
145494468|NCT03137992|524667860|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
145494469|NCT03137992|524667855|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
145494470|NCT03137992|524667856|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
145494471|NCT03137992|524667857|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
145494472|NCT03137992|524667858|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
145494473|NCT03137992|524667859|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
145494474|NCT03137992|524667860|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
145494475|NCT03137992|524667855|FG000|Period 2 (Visit 3)|Adverse Event|0|||
145494476|NCT03137992|524667856|FG001|Period 2 (Visit 3)|Adverse Event|1|||
145494477|NCT03137992|524667857|FG002|Period 2 (Visit 3)|Adverse Event|0|||
145494478|NCT03137992|524667858|FG003|Period 2 (Visit 3)|Adverse Event|0|||
145494479|NCT03137992|524667859|FG004|Period 2 (Visit 3)|Adverse Event|0|||
145494480|NCT03137992|524667860|FG005|Period 2 (Visit 3)|Adverse Event|0|||
145494481|NCT03137992|524667855|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
145494482|NCT03137992|524667856|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
145494483|NCT03137992|524667857|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
145494484|NCT03137992|524667858|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
145494485|NCT03137992|524667859|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
145494486|NCT03137992|524667860|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
145494487|NCT03137992|524667855|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
145494488|NCT03137992|524667856|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
145494489|NCT03137992|524667857|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
145494490|NCT03137992|524667858|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
145494491|NCT03137992|524667859|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
145494492|NCT03137992|524667860|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
145494493|NCT03137992|524667855|FG000|Washout Period 2|COPD Exacerbation|1|||
145494494|NCT03137992|524667856|FG001|Washout Period 2|COPD Exacerbation|1|||
145494495|NCT03137992|524667857|FG002|Washout Period 2|COPD Exacerbation|0|||
145494496|NCT03137992|524667858|FG003|Washout Period 2|COPD Exacerbation|0|||
145494497|NCT03137992|524667859|FG004|Washout Period 2|COPD Exacerbation|1|||
145494498|NCT03137992|524667860|FG005|Washout Period 2|COPD Exacerbation|0|||
145494499|NCT03137992|524667855|FG000|Washout Period 2|Subject Non-compliance|0|||
145494500|NCT03137992|524667856|FG001|Washout Period 2|Subject Non-compliance|1|||
145494501|NCT03137992|524667857|FG002|Washout Period 2|Subject Non-compliance|0|||
145494502|NCT03137992|524667858|FG003|Washout Period 2|Subject Non-compliance|0|||
145494503|NCT03137992|524667859|FG004|Washout Period 2|Subject Non-compliance|0|||
145494504|NCT03137992|524667860|FG005|Washout Period 2|Subject Non-compliance|0|||
145494505|NCT03137992|524667855|FG000|Washout Period 2|Adverse Event|0|||
145494506|NCT03137992|524667856|FG001|Washout Period 2|Adverse Event|0|||
145494507|NCT03137992|524667857|FG002|Washout Period 2|Adverse Event|0|||
145494508|NCT03137992|524667858|FG003|Washout Period 2|Adverse Event|1|||
145494509|NCT03137992|524667859|FG004|Washout Period 2|Adverse Event|1|||
145494510|NCT03137992|524667860|FG005|Washout Period 2|Adverse Event|0|||
145494511|NCT03137992|524667855|FG000|Washout Period 2|Withdrawal by Subject|1|||
145494512|NCT03137992|524667856|FG001|Washout Period 2|Withdrawal by Subject|0|||
145494513|NCT03137992|524667857|FG002|Washout Period 2|Withdrawal by Subject|0|||
145494514|NCT03137992|524667858|FG003|Washout Period 2|Withdrawal by Subject|0|||
145494515|NCT03137992|524667859|FG004|Washout Period 2|Withdrawal by Subject|1|||
145494516|NCT03137992|524667860|FG005|Washout Period 2|Withdrawal by Subject|0|||
145494517|NCT03137992|524667855|FG000|Washout Period 2|Sponsor Decision|0|||
145494518|NCT03137992|524667856|FG001|Washout Period 2|Sponsor Decision|0|||
145494519|NCT03137992|524667857|FG002|Washout Period 2|Sponsor Decision|0|||
145494520|NCT03137992|524667858|FG003|Washout Period 2|Sponsor Decision|0|||
145494521|NCT03137992|524667859|FG004|Washout Period 2|Sponsor Decision|0|||
145494522|NCT03137992|524667860|FG005|Washout Period 2|Sponsor Decision|1|||
145494523|NCT03137992|524667855|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
145494524|NCT03137992|524667856|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
145494525|NCT03137992|524667857|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
145494526|NCT03137992|524667858|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
145494527|NCT03137992|524667859|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
145494528|NCT03137992|524667860|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
145494529|NCT03137992|524667855|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
145494530|NCT03137992|524667856|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
145494531|NCT03137992|524667857|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
145494532|NCT03137992|524667858|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
145494533|NCT03137992|524667859|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
145723649|NCT03866473|525504922|FG000|Phase 2|Death|0|||
145723650|NCT03866473|525504923|FG001|Phase 2|Death|2|||
145723651|NCT03866473|525504922|FG000|Phase 2|Dropped|1|||
145723652|NCT03866473|525504923|FG001|Phase 2|Dropped|1|||
145723653|NCT03866473|525504922|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
145723654|NCT03866473|525504923|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
145383718|NCT00762034|524260129|FG001|Induction Period|Progressive Disease|55|||
145383719|NCT00762034|524260128|FG000|Induction Period|Physician Decision|21|||
145383720|NCT00762034|524260129|FG001|Induction Period|Physician Decision|20|||
145383721|NCT00762034|524260128|FG000|Induction Period|Withdrawal by Subject|15|||
145383722|NCT00762034|524260129|FG001|Induction Period|Withdrawal by Subject|19|||
145383723|NCT00762034|524260128|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
145383724|NCT00762034|524260129|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
145383725|NCT00762034|524260128|FG000|Induction Period|Deaths Due to Study Disease|9|||
145383726|NCT00762034|524260129|FG001|Induction Period|Deaths Due to Study Disease|9|||
145383727|NCT00762034|524260128|FG000|Maintenance Period|Protocol Violation|1|||
145383728|NCT00762034|524260129|FG001|Maintenance Period|Protocol Violation|3|||
145383729|NCT00762034|524260128|FG000|Maintenance Period|Entry Criterion Not Met|0|||
145383730|NCT00762034|524260129|FG001|Maintenance Period|Entry Criterion Not Met|2|||
145383731|NCT00762034|524260128|FG000|Maintenance Period|Adverse Event|42|||
145383732|NCT00762034|524260129|FG001|Maintenance Period|Adverse Event|26|||
145383733|NCT00762034|524260128|FG000|Maintenance Period|Progressive Disease|186|||
145383734|NCT00762034|524260129|FG001|Maintenance Period|Progressive Disease|224|||
145383735|NCT00762034|524260128|FG000|Maintenance Period|Physician Decision|25|||
145383736|NCT00762034|524260129|FG001|Maintenance Period|Physician Decision|20|||
145383737|NCT00762034|524260128|FG000|Maintenance Period|Withdrawal by Subject|34|||
145383738|NCT00762034|524260129|FG001|Maintenance Period|Withdrawal by Subject|14|||
145383739|NCT00762034|524260128|FG000|Maintenance Period|Death not due to study disease|2|||
145383740|NCT00762034|524260129|FG001|Maintenance Period|Death not due to study disease|5|||
145383741|NCT00762034|524260128|FG000|Maintenance Period|Death due to study disease|3|||
145383742|NCT00762034|524260129|FG001|Maintenance Period|Death due to study disease|3|||
145383743|NCT00762034|524260128|FG000|Maintenance Period|Other|1|||
145383744|NCT00762034|524260129|FG001|Maintenance Period|Other|1|||
145383745|NCT02442206|524260130|FG000|Period 1|Adverse Event|1|||
145383746|NCT02442206|524260131|FG001|Period 1|Adverse Event|1|||
145383747|NCT02442206|524260130|FG000|Period 1|withdrew consent|0|||
145383748|NCT02442206|524260131|FG001|Period 1|withdrew consent|1|||
145383749|NCT02442206|524260130|FG000|Period 1|COPD exacerbation|0|||
145383750|NCT02442206|524260131|FG001|Period 1|COPD exacerbation|1|||
145383751|NCT02442206|524260130|FG000|Period 2|Adverse Event|1|||
145383752|NCT02442206|524260131|FG001|Period 2|Adverse Event|0|||
145383753|NCT01471444|524260132|FG000|Overall Study|Physician Decision|3|||
145383754|NCT01471444|524260133|FG001|Overall Study|Physician Decision|2|||
145383755|NCT01471444|524260132|FG000|Overall Study|Withdrawal by Subject|0|||
145383756|NCT01471444|524260133|FG001|Overall Study|Withdrawal by Subject|1|||
145383757|NCT02107313|524260135|FG000|Overall Study|One participant did not do the FED cohor|0|||
145383758|NCT02107313|524260136|FG001|Overall Study|One participant did not do the FED cohor|1|||
145383759|NCT01031004|524260139|FG000|Overall Study|Protocol Violation|0|||
145383760|NCT01031004|524260140|FG001|Overall Study|Protocol Violation|1|||
145383761|NCT01031004|524260139|FG000|Overall Study|Lost to Follow-up|1|||
145383762|NCT01031004|524260140|FG001|Overall Study|Lost to Follow-up|0|||
145383763|NCT01641471|524260141|FG000|Overall Study|Withdrawal by Subject|19|||
145383764|NCT01641471|524260142|FG001|Overall Study|Withdrawal by Subject|19|||
145383765|NCT01641471|524260141|FG000|Overall Study|Lost to Follow-up|2|||
145383766|NCT01641471|524260142|FG001|Overall Study|Lost to Follow-up|4|||
145383767|NCT01641471|524260141|FG000|Overall Study|Protocol Violation|2|||
145383768|NCT01641471|524260142|FG001|Overall Study|Protocol Violation|4|||
145383769|NCT01214668|524260148|FG000|Overall Study|Adverse Event|0|||
145383770|NCT01214668|524260149|FG001|Overall Study|Adverse Event|1|||
145383771|NCT01214668|524260150|FG002|Overall Study|Adverse Event|0|||
145383772|NCT01214668|524260151|FG003|Overall Study|Adverse Event|2|||
145383773|NCT01214668|524260152|FG004|Overall Study|Adverse Event|1|||
145383774|NCT01214668|524260153|FG005|Overall Study|Adverse Event|1|||
145383775|NCT01214668|524260148|FG000|Overall Study|Death|0|||
145383776|NCT01214668|524260149|FG001|Overall Study|Death|0|||
145383777|NCT01214668|524260150|FG002|Overall Study|Death|1|||
145383778|NCT01214668|524260151|FG003|Overall Study|Death|0|||
145383779|NCT01214668|524260152|FG004|Overall Study|Death|0|||
145383780|NCT01214668|524260153|FG005|Overall Study|Death|0|||
145383781|NCT01214668|524260148|FG000|Overall Study|Progressive Disease|4|||
145383782|NCT01214668|524260149|FG001|Overall Study|Progressive Disease|2|||
145383783|NCT01214668|524260150|FG002|Overall Study|Progressive Disease|5|||
145383784|NCT01214668|524260151|FG003|Overall Study|Progressive Disease|4|||
145383785|NCT01214668|524260152|FG004|Overall Study|Progressive Disease|4|||
145383786|NCT01214668|524260153|FG005|Overall Study|Progressive Disease|5|||
145383787|NCT01214668|524260148|FG000|Overall Study|Withdrawal by Subject|0|||
145383788|NCT01214668|524260149|FG001|Overall Study|Withdrawal by Subject|0|||
145383789|NCT01214668|524260150|FG002|Overall Study|Withdrawal by Subject|0|||
145494534|NCT03137992|524667860|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
145494535|NCT03137992|524667855|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
145494536|NCT03137992|524667856|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
145494537|NCT03137992|524667857|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
145494538|NCT03137992|524667858|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
145494539|NCT03137992|524667859|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
145494540|NCT03137992|524667860|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
145494541|NCT03137992|524667855|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
145494542|NCT03137992|524667856|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
145494543|NCT03137992|524667857|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
145494544|NCT03137992|524667858|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
145494545|NCT03137992|524667859|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
145494546|NCT03137992|524667860|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
145494547|NCT03137992|524667855|FG000|Part 2 (Open-label Extension)|Per study team|1|||
145494548|NCT03137992|524667856|FG001|Part 2 (Open-label Extension)|Per study team|0|||
145494549|NCT03137992|524667857|FG002|Part 2 (Open-label Extension)|Per study team|0|||
145494550|NCT03137992|524667858|FG003|Part 2 (Open-label Extension)|Per study team|0|||
145494551|NCT03137992|524667859|FG004|Part 2 (Open-label Extension)|Per study team|0|||
145494552|NCT03137992|524667860|FG005|Part 2 (Open-label Extension)|Per study team|0|||
145494553|NCT03137992|524667855|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
145494554|NCT03137992|524667856|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
145494555|NCT03137992|524667857|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
145494556|NCT03137992|524667858|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
145494557|NCT03137992|524667859|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
145494558|NCT03137992|524667860|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
145494559|NCT00795704|524667865|FG000|Overall Study|Withdrawal by Subject|3|||
145494560|NCT00795704|524667866|FG001|Overall Study|Withdrawal by Subject|2|||
145494561|NCT00795704|524667865|FG000|Overall Study|Adverse Event|1|||
145494562|NCT00795704|524667866|FG001|Overall Study|Adverse Event|1|||
145494563|NCT01247324|524667867|FG000|Overall Study|Death|6|||
145494564|NCT01247324|524667868|FG001|Overall Study|Death|10|||
145494565|NCT01247324|524667867|FG000|Overall Study|Physician Decision|2|||
145494566|NCT01247324|524667868|FG001|Overall Study|Physician Decision|3|||
145494567|NCT01247324|524667867|FG000|Overall Study|Non-compliance with study drug|3|||
145494568|NCT01247324|524667868|FG001|Overall Study|Non-compliance with study drug|0|||
145494569|NCT01247324|524667867|FG000|Overall Study|Lack of Efficacy|24|||
145494570|NCT01247324|524667868|FG001|Overall Study|Lack of Efficacy|14|||
145494571|NCT01247324|524667867|FG000|Overall Study|Non-compliance|3|||
145494572|NCT01247324|524667868|FG001|Overall Study|Non-compliance|2|||
145723655|NCT04948333|525504931|FG000|Overall Study|Adverse Event|6|||
145723656|NCT04948333|525504932|FG001|Overall Study|Adverse Event|4|||
145723657|NCT04948333|525504933|FG002|Overall Study|Adverse Event|0|||
145723658|NCT04948333|525504934|FG003|Overall Study|Adverse Event|2|||
145723659|NCT04948333|525504931|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
145723660|NCT04948333|525504932|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145494573|NCT01247324|524667867|FG000|Overall Study|Pregnancy|5|||
145494574|NCT01247324|524667868|FG001|Overall Study|Pregnancy|10|||
145494575|NCT01247324|524667867|FG000|Overall Study|Protocol Violation|1|||
145494576|NCT01247324|524667868|FG001|Overall Study|Protocol Violation|1|||
145494577|NCT01247324|524667867|FG000|Overall Study|Reason not specified|42|||
145494578|NCT01247324|524667868|FG001|Overall Study|Reason not specified|32|||
145494579|NCT01247324|524667867|FG000|Overall Study|Consent withdrawn by participant|41|||
145494580|NCT01247324|524667868|FG001|Overall Study|Consent withdrawn by participant|56|||
145494581|NCT01247324|524667867|FG000|Overall Study|Adverse Event|49|||
145494582|NCT01247324|524667868|FG001|Overall Study|Adverse Event|35|||
145494583|NCT01247324|524667867|FG000|Overall Study|Lost to Follow-up|3|||
145494584|NCT01247324|524667868|FG001|Overall Study|Lost to Follow-up|6|||
145494585|NCT01247324|524667867|FG000|Overall Study|Study Terminated by Sponsor|4|||
145494586|NCT01247324|524667868|FG001|Overall Study|Study Terminated by Sponsor|1|||
145494587|NCT01247324|524667867|FG000|Overall Study|Missing|2|||
145494588|NCT01247324|524667868|FG001|Overall Study|Missing|1|||
145494589|NCT01607957|524667869|FG000|Overall Study|Not treated|1|||
145494590|NCT01607957|524667870|FG001|Overall Study|Not treated|1|||
145494591|NCT01607957|524667869|FG000|Overall Study|Death|367|||
145494592|NCT01607957|524667870|FG001|Overall Study|Death|211|||
145494593|NCT01607957|524667869|FG000|Overall Study|Lost to Follow-up|3|||
145723661|NCT04948333|525504933|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145723662|NCT04948333|525504934|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145494594|NCT01607957|524667870|FG001|Overall Study|Lost to Follow-up|3|||
145494595|NCT01607957|524667869|FG000|Overall Study|Participant refusal|1|||
145494596|NCT01607957|524667870|FG001|Overall Study|Participant refusal|0|||
145494597|NCT04972786|524667871|FG000|First Intervention (1 Day)|Adverse Event|1|||
145494598|NCT04972786|524667872|FG001|First Intervention (1 Day)|Adverse Event|0|||
145494599|NCT03905096|524667873|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
145494600|NCT03905096|524667874|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
145494601|NCT02016781|524667876|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
145494602|NCT02016781|524667877|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
145494603|NCT02016781|524667876|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
145494604|NCT02016781|524667877|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
145494605|NCT02016781|524667876|FG000|Final Database Lock|Withdrawal by Subject|2|||
145494606|NCT02016781|524667877|FG001|Final Database Lock|Withdrawal by Subject|1|||
145494607|NCT02016781|524667876|FG000|Final Database Lock|Lost to Follow-up|11|||
145494608|NCT02016781|524667877|FG001|Final Database Lock|Lost to Follow-up|4|||
145494609|NCT02016781|524667876|FG000|Final Database Lock|Missing data|0|||
145494610|NCT02016781|524667877|FG001|Final Database Lock|Missing data|3|||
145494611|NCT02994108|524670103|FG000|Intervention Messages|Withdrawal by Subject|2|||
145494612|NCT02994108|524670104|FG001|Intervention Messages|Withdrawal by Subject|0|||
145494613|NCT02994108|524670103|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
145494614|NCT02994108|524670104|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
145494615|NCT02994108|524670103|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
145494616|NCT02994108|524670104|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
145494617|NCT02994108|524670103|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
145494618|NCT02994108|524670104|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
145494619|NCT00089297|524670105|FG000|Overall Study|Adverse Event|9|||
145494620|NCT00089297|524670105|FG000|Overall Study|Death|1|||
145494621|NCT00089297|524670105|FG000|Overall Study|Withdrawal by Subject|12|||
145494622|NCT00089297|524670105|FG000|Overall Study|Disease progression|2|||
145494623|NCT00089297|524670105|FG000|Overall Study|Ineligible|11|||
145494624|NCT00089297|524670105|FG000|Overall Study|Secondary malignancy|1|||
145494625|NCT00089297|524670105|FG000|Overall Study|IRB approval not ready|1|||
145494626|NCT00089297|524670105|FG000|Overall Study|Non-compliance|1|||
145494627|NCT00385671|524670108|FG000|Overall Study|Adverse Event|14|||
145494628|NCT00385671|524670109|FG001|Overall Study|Adverse Event|27|||
145494629|NCT00385671|524670110|FG002|Overall Study|Adverse Event|18|||
145494630|NCT00385671|524670108|FG000|Overall Study|Lack of Efficacy|5|||
145494631|NCT00385671|524670109|FG001|Overall Study|Lack of Efficacy|9|||
145494632|NCT00385671|524670110|FG002|Overall Study|Lack of Efficacy|5|||
145494633|NCT00385671|524670108|FG000|Overall Study|Lost to Follow-up|6|||
145494634|NCT00385671|524670109|FG001|Overall Study|Lost to Follow-up|6|||
145494635|NCT00385671|524670110|FG002|Overall Study|Lost to Follow-up|5|||
145494636|NCT00385671|524670108|FG000|Overall Study|Physician Decision|2|||
145494637|NCT00385671|524670109|FG001|Overall Study|Physician Decision|1|||
145494638|NCT00385671|524670110|FG002|Overall Study|Physician Decision|2|||
145494639|NCT00385671|524670108|FG000|Overall Study|Protocol Violation|5|||
145494640|NCT00385671|524670109|FG001|Overall Study|Protocol Violation|2|||
145494641|NCT00385671|524670110|FG002|Overall Study|Protocol Violation|1|||
145494642|NCT00385671|524670108|FG000|Overall Study|Sponsor Decision|2|||
145494643|NCT00385671|524670109|FG001|Overall Study|Sponsor Decision|2|||
145494644|NCT00385671|524670110|FG002|Overall Study|Sponsor Decision|1|||
145494645|NCT00385671|524670108|FG000|Overall Study|Withdrawal by Subject|4|||
145494646|NCT00385671|524670109|FG001|Overall Study|Withdrawal by Subject|4|||
145494647|NCT00385671|524670110|FG002|Overall Study|Withdrawal by Subject|4|||
145494648|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
145494649|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
145494650|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
145494651|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Death|9|||
145494652|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Death|0|||
145494653|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Death|0|||
145494654|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
145494655|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
145494656|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
145494657|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
145494658|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
145494659|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
145494660|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Other|135|||
145494661|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Other|0|||
145494662|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Other|0|||
145494663|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
145494664|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
145494665|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
145494666|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
145494667|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
145494668|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
145494669|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
145494670|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
145494671|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
145494672|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Other|3|||
145494673|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Other|0|||
145494674|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Other|0|||
145494675|NCT02118584|524670116|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
145494676|NCT02118584|524670117|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
145494677|NCT02118584|524670118|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
145494678|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
145494679|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
145494680|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
145494681|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
145494682|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
145494683|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
145494684|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
145494685|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
145494686|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
145494687|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
145494688|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
145494689|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
145494690|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
145494691|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
145723663|NCT04948333|525504931|FG000|Overall Study|Progressive Disease|1|||
145723664|NCT04948333|525504932|FG001|Overall Study|Progressive Disease|5|||
145723665|NCT04948333|525504933|FG002|Overall Study|Progressive Disease|0|||
145723666|NCT04948333|525504934|FG003|Overall Study|Progressive Disease|0|||
145723667|NCT04948333|525504931|FG000|Overall Study|Physician Decision|2|||
145723668|NCT04948333|525504932|FG001|Overall Study|Physician Decision|2|||
145723669|NCT04948333|525504933|FG002|Overall Study|Physician Decision|0|||
145723670|NCT04948333|525504934|FG003|Overall Study|Physician Decision|0|||
145723671|NCT04948333|525504931|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
145723672|NCT04948333|525504932|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
145723673|NCT04948333|525504933|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
145723674|NCT04948333|525504934|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
145723675|NCT04948333|525504931|FG000|Overall Study|Withdrawal by Subject|2|||
145723676|NCT04948333|525504932|FG001|Overall Study|Withdrawal by Subject|0|||
145723677|NCT04948333|525504933|FG002|Overall Study|Withdrawal by Subject|0|||
145723678|NCT04948333|525504934|FG003|Overall Study|Withdrawal by Subject|1|||
145723679|NCT04948333|525504931|FG000|Overall Study|Protocol Violation|0|||
145723680|NCT04948333|525504932|FG001|Overall Study|Protocol Violation|1|||
145723681|NCT04948333|525504933|FG002|Overall Study|Protocol Violation|0|||
145723682|NCT04948333|525504934|FG003|Overall Study|Protocol Violation|0|||
145723683|NCT04948333|525504931|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
145723684|NCT04948333|525504932|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
145723685|NCT04948333|525504933|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
145723686|NCT04948333|525504934|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
145723687|NCT04976621|525504936|FG000|Overall Study|Lost to Follow-up|2|||
145723688|NCT04976621|525504937|FG001|Overall Study|Lost to Follow-up|2|||
145723689|NCT04976621|525504936|FG000|Overall Study|Withdrawal by Subject|1|||
145723690|NCT04976621|525504937|FG001|Overall Study|Withdrawal by Subject|1|||
145723691|NCT04443153|525504942|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
145723692|NCT04443153|525504943|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
145723693|NCT04443153|525504942|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
145723694|NCT04443153|525504943|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
145723695|NCT04443153|525504942|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
145723696|NCT04443153|525504943|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
145723697|NCT04443153|525504942|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
145723698|NCT04443153|525504943|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
145723699|NCT05182125|525504944|FG000|Overall Study|Withdrawal by Subject|0|||
145494692|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
145494693|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
145605888|NCT00633932|525073034|FG000|Overall Study|Lost to Follow-up|1|||
145723700|NCT05182125|525504945|FG001|Overall Study|Withdrawal by Subject|0|||
145723701|NCT05182125|525504946|FG002|Overall Study|Withdrawal by Subject|0|||
145723702|NCT05182125|525504947|FG003|Overall Study|Withdrawal by Subject|0|||
145723703|NCT05182125|525504948|FG004|Overall Study|Withdrawal by Subject|2|||
145723704|NCT05182125|525504949|FG005|Overall Study|Withdrawal by Subject|0|||
145723705|NCT05182125|525504944|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
145723706|NCT05182125|525504945|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
145723707|NCT05182125|525504946|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
145723708|NCT05182125|525504947|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
145723709|NCT05182125|525504948|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
145723710|NCT05182125|525504949|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
145723711|NCT05182125|525504944|FG000|Overall Study|Death|0|||
145723712|NCT05182125|525504945|FG001|Overall Study|Death|0|||
145723713|NCT05182125|525504946|FG002|Overall Study|Death|0|||
145723714|NCT05182125|525504947|FG003|Overall Study|Death|0|||
145723715|NCT05182125|525504948|FG004|Overall Study|Death|1|||
145723716|NCT05182125|525504949|FG005|Overall Study|Death|0|||
145723717|NCT03519971|525504950|FG000|Overall Study|Death|142|||
145723718|NCT03519971|525504951|FG001|Overall Study|Death|69|||
145723719|NCT03519971|525504950|FG000|Overall Study|Lost to Follow-up|0|||
145723720|NCT03519971|525504951|FG001|Overall Study|Lost to Follow-up|1|||
145723721|NCT03519971|525504950|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
145723722|NCT03519971|525504951|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
145723723|NCT03519971|525504950|FG000|Overall Study|Withdrawal by Subject|3|||
145723724|NCT03519971|525504951|FG001|Overall Study|Withdrawal by Subject|2|||
145723725|NCT03519971|525504950|FG000|Overall Study|Other|1|||
145723726|NCT03519971|525504951|FG001|Overall Study|Other|0|||
145723727|NCT01078454|525504954|FG000|Overall Study|Adverse Event|1|||
145723728|NCT01078454|525504955|FG001|Overall Study|Adverse Event|1|||
145723729|NCT01078454|525504954|FG000|Overall Study|Death|0|||
145723730|NCT01078454|525504955|FG001|Overall Study|Death|1|||
145723731|NCT03170349|525504962|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
145723732|NCT03170349|525504962|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
145723733|NCT03170349|525504962|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
145723734|NCT03170349|525504962|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
145723735|NCT03170349|525504962|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
145723736|NCT03170349|525504962|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
145723737|NCT03170349|525504962|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
145723738|NCT03170349|525504962|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
145723739|NCT03170349|525504962|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
145723740|NCT03170349|525504962|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
145723741|NCT03170349|525504962|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
145723742|NCT03170349|525504962|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
145723743|NCT03170349|525504962|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
145723744|NCT03170349|525504962|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
145723745|NCT03170349|525504962|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
145723746|NCT03170349|525504962|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
145723747|NCT05195489|525506559|FG000|Overall Study|Lost to Follow-up|1|||
145723748|NCT05195489|525506560|FG001|Overall Study|Lost to Follow-up|0|||
145723749|NCT05195489|525506559|FG000|Overall Study|Protocol Violation|0|||
145723750|NCT05195489|525506560|FG001|Overall Study|Protocol Violation|2|||
145723751|NCT05195489|525506559|FG000|Overall Study|Withdrawal by Subject|1|||
145723752|NCT05195489|525506560|FG001|Overall Study|Withdrawal by Subject|1|||
145723753|NCT05195489|525506559|FG000|Overall Study|Removed|0|||
145723754|NCT05195489|525506560|FG001|Overall Study|Removed|1|||
145723755|NCT01919814|525506562|FG000|Overall Study|Adverse Event|1|||
145723756|NCT01919814|525506563|FG001|Overall Study|Adverse Event|0|||
145723757|NCT01919814|525506562|FG000|Overall Study|Protocol Violation|1|||
145723758|NCT01919814|525506563|FG001|Overall Study|Protocol Violation|0|||
145723759|NCT01919814|525506562|FG000|Overall Study|Withdrawal by Subject|1|||
145723760|NCT01919814|525506563|FG001|Overall Study|Withdrawal by Subject|0|||
145407494|NCT00964782|524347009|FG000|Overall Study|Lost to Follow-up|1|||
145266632|NCT04668066|523825242|FG005|Part 1: Treatment Phase|Other|0|||
145723761|NCT05220254|525506567|FG000|Overall Study|Withdrawal by Subject|4|||
145723762|NCT05220254|525506567|FG000|Overall Study|Removed due to ineligibility|1|||
145723763|NCT05220254|525506567|FG000|Overall Study|Lost to Follow-up|7|||
145723764|NCT04363801|525506570|FG000|Overall Study|Death|18|||
145723765|NCT04363801|525506571|FG001|Overall Study|Death|14|||
145723766|NCT04363801|525506572|FG002|Overall Study|Death|16|||
145723767|NCT04363801|525506573|FG003|Overall Study|Death|48|||
145723768|NCT04363801|525506574|FG004|Overall Study|Death|38|||
145723769|NCT04363801|525506570|FG000|Overall Study|Withdrawal by Subject|1|||
145723770|NCT04363801|525506571|FG001|Overall Study|Withdrawal by Subject|6|||
145723771|NCT04363801|525506572|FG002|Overall Study|Withdrawal by Subject|1|||
145723772|NCT04363801|525506573|FG003|Overall Study|Withdrawal by Subject|4|||
145723773|NCT04363801|525506574|FG004|Overall Study|Withdrawal by Subject|14|||
145723774|NCT04363801|525506570|FG000|Overall Study|Sponsor Decision|6|||
145723775|NCT04363801|525506571|FG001|Overall Study|Sponsor Decision|4|||
145723776|NCT04363801|525506572|FG002|Overall Study|Sponsor Decision|10|||
145723777|NCT04363801|525506573|FG003|Overall Study|Sponsor Decision|33|||
145723778|NCT04363801|525506574|FG004|Overall Study|Sponsor Decision|32|||
145723779|NCT04363801|525506570|FG000|Overall Study|Lost to Follow-up|0|||
145723780|NCT04363801|525506571|FG001|Overall Study|Lost to Follow-up|0|||
145723781|NCT04363801|525506572|FG002|Overall Study|Lost to Follow-up|1|||
145723782|NCT04363801|525506573|FG003|Overall Study|Lost to Follow-up|0|||
145723783|NCT04363801|525506574|FG004|Overall Study|Lost to Follow-up|1|||
145723784|NCT00250679|525506577|FG000|Overall Study|Adverse Event|12|||
145723785|NCT00250679|525506578|FG001|Overall Study|Adverse Event|15|||
145723786|NCT00250679|525506579|FG002|Overall Study|Adverse Event|16|||
145723787|NCT00250679|525506577|FG000|Overall Study|Protocol Violation|2|||
145723788|NCT00250679|525506578|FG001|Overall Study|Protocol Violation|4|||
145723789|NCT00250679|525506579|FG002|Overall Study|Protocol Violation|3|||
145723790|NCT00250679|525506577|FG000|Overall Study|Withdrawal by Subject|15|||
145723791|NCT00250679|525506578|FG001|Overall Study|Withdrawal by Subject|18|||
145723792|NCT00250679|525506579|FG002|Overall Study|Withdrawal by Subject|15|||
145723793|NCT00250679|525506577|FG000|Overall Study|Lost to Follow-up|3|||
145723794|NCT00250679|525506578|FG001|Overall Study|Lost to Follow-up|4|||
145723795|NCT00250679|525506579|FG002|Overall Study|Lost to Follow-up|2|||
145723796|NCT00250679|525506577|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
145723797|NCT00250679|525506578|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
145723798|NCT00250679|525506579|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
145723799|NCT00250679|525506577|FG000|Overall Study|Lack of Efficacy|0|||
145723800|NCT00250679|525506578|FG001|Overall Study|Lack of Efficacy|1|||
145723801|NCT00250679|525506579|FG002|Overall Study|Lack of Efficacy|3|||
145723802|NCT00250679|525506577|FG000|Overall Study|Technical Holter issues|1|||
145723803|NCT00250679|525506578|FG001|Overall Study|Technical Holter issues|0|||
145723804|NCT00250679|525506579|FG002|Overall Study|Technical Holter issues|2|||
145723805|NCT00250679|525506577|FG000|Overall Study|Moved|1|||
145723806|NCT00250679|525506578|FG001|Overall Study|Moved|1|||
145723807|NCT00250679|525506579|FG002|Overall Study|Moved|0|||
145723808|NCT00250679|525506577|FG000|Overall Study|Non-compliance|1|||
145723809|NCT00250679|525506578|FG001|Overall Study|Non-compliance|1|||
145723810|NCT00250679|525506579|FG002|Overall Study|Non-compliance|0|||
145723811|NCT00250679|525506577|FG000|Overall Study|various single events: hip surgery,diary|3|||
145723812|NCT00250679|525506578|FG001|Overall Study|various single events: hip surgery,diary|1|||
145723813|NCT00250679|525506579|FG002|Overall Study|various single events: hip surgery,diary|1|||
145723814|NCT00448279|525506580|FG000|Overall Study|Lost to Follow-up|2|||
145723815|NCT00448279|525506581|FG001|Overall Study|Lost to Follow-up|2|||
145723816|NCT00448279|525506580|FG000|Overall Study|Adverse Event|1|||
145723817|NCT00448279|525506581|FG001|Overall Study|Adverse Event|1|||
145723818|NCT00448279|525506580|FG000|Overall Study|Disease progression|16|||
145723819|NCT00448279|525506581|FG001|Overall Study|Disease progression|18|||
145723820|NCT00448279|525506580|FG000|Overall Study|Withdrawal by Subject|4|||
145723821|NCT00448279|525506581|FG001|Overall Study|Withdrawal by Subject|3|||
145723822|NCT00448279|525506580|FG000|Overall Study|Other|6|||
145723823|NCT00448279|525506581|FG001|Overall Study|Other|4|||
145723824|NCT00448279|525506580|FG000|Overall Study|Protocol Violation|0|||
145723825|NCT00448279|525506581|FG001|Overall Study|Protocol Violation|1|||
145723826|NCT03907410|525506582|FG000|Overall Study|Lost to Follow-up|4|||
145723827|NCT03907410|525506583|FG001|Overall Study|Lost to Follow-up|1|||
145723828|NCT03907410|525506584|FG002|Overall Study|Lost to Follow-up|1|||
145723829|NCT03907410|525506582|FG000|Overall Study|Lost to follow-up and research burden|0|||
145723830|NCT03907410|525506583|FG001|Overall Study|Lost to follow-up and research burden|0|||
145723831|NCT03907410|525506584|FG002|Overall Study|Lost to follow-up and research burden|1|||
145723832|NCT04776148|525506585|FG000|Overall Study|Death|249|||
145723833|NCT04776148|525506586|FG001|Overall Study|Death|260|||
145723834|NCT04776148|525506585|FG000|Overall Study|Lost to Follow-up|0|||
145723835|NCT04776148|525506586|FG001|Overall Study|Lost to Follow-up|1|||
145723836|NCT04776148|525506585|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145723837|NCT04776148|525506586|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145723838|NCT04776148|525506585|FG000|Overall Study|Withdrawal by Subject|3|||
145723839|NCT04776148|525506586|FG001|Overall Study|Withdrawal by Subject|4|||
145723840|NCT04776148|525506585|FG000|Overall Study|Sponsor Decision|30|||
145723841|NCT04776148|525506586|FG001|Overall Study|Sponsor Decision|15|||
145723842|NCT00666679|525506590|FG000|First Intervention|Lost to Follow-up|1|||
145723843|NCT00666679|525506591|FG001|First Intervention|Lost to Follow-up|0|||
145723844|NCT00666679|525506590|FG000|First Intervention|Protocol Violation|1|||
145723845|NCT00666679|525506591|FG001|First Intervention|Protocol Violation|0|||
145723846|NCT00666679|525506590|FG000|First Intervention|Withdrawal by Subject|1|||
145723847|NCT00666679|525506591|FG001|First Intervention|Withdrawal by Subject|0|||
145723848|NCT00666679|525506590|FG000|First Intervention|Randomized did not start treatment|1|||
145723849|NCT00666679|525506591|FG001|First Intervention|Randomized did not start treatment|1|||
145723850|NCT00666679|525506590|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
145723851|NCT00666679|525506591|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
145723852|NCT00666679|525506590|FG000|Washout Period of 1 Week|Protocol Violation|0|||
145723853|NCT00666679|525506591|FG001|Washout Period of 1 Week|Protocol Violation|1|||
145723854|NCT00666679|525506590|FG000|Second Intervention|Adverse Event|1|||
145723855|NCT00666679|525506591|FG001|Second Intervention|Adverse Event|0|||
145723856|NCT00666679|525506590|FG000|Second Intervention|Death|0|||
145723857|NCT00666679|525506591|FG001|Second Intervention|Death|1|||
145723858|NCT04882995|525506594|FG000|Overall Study|Withdrawal by Subject|1|||
145723859|NCT04882995|525506595|FG001|Overall Study|Withdrawal by Subject|2|||
145723860|NCT04882995|525506594|FG000|Overall Study|Protocol Violation|4|||
145723861|NCT04882995|525506595|FG001|Overall Study|Protocol Violation|4|||
145723862|NCT04882995|525506594|FG000|Overall Study|Surgery postponed due to COVID|1|||
145723863|NCT04882995|525506595|FG001|Overall Study|Surgery postponed due to COVID|1|||
145723864|NCT04371198|525506596|FG000|Overall Study|inadequate sample|4|||
145723865|NCT00440999|525506597|FG000|Overall Study|Adverse Event|0|||
145723866|NCT00440999|525506598|FG001|Overall Study|Adverse Event|2|||
145723867|NCT00440999|525506597|FG000|Overall Study|Lack of Efficacy|6|||
145723868|NCT00440999|525506598|FG001|Overall Study|Lack of Efficacy|7|||
145723869|NCT00440999|525506597|FG000|Overall Study|Lost to Follow-up|19|||
145723870|NCT00440999|525506598|FG001|Overall Study|Lost to Follow-up|12|||
145723871|NCT00440999|525506597|FG000|Overall Study|Protocol Violation|1|||
145723872|NCT00440999|525506598|FG001|Overall Study|Protocol Violation|0|||
145723873|NCT00440999|525506597|FG000|Overall Study|Withdrawal by Subject|2|||
145723874|NCT00440999|525506598|FG001|Overall Study|Withdrawal by Subject|5|||
145723875|NCT00440999|525506597|FG000|Overall Study|Subjets missed the visit|1|||
145723876|NCT00440999|525506598|FG001|Overall Study|Subjets missed the visit|0|||
145723877|NCT00440999|525506597|FG000|Overall Study|Mixed infection at entry|1|||
145723878|NCT00440999|525506598|FG001|Overall Study|Mixed infection at entry|0|||
145723879|NCT00440999|525506597|FG000|Overall Study|P. falciparum malaria|5|||
145723880|NCT00440999|525506598|FG001|Overall Study|P. falciparum malaria|14|||
145723881|NCT00440999|525506597|FG000|Overall Study|Subj left hosp without inform staff|0|||
145723882|NCT00440999|525506598|FG001|Overall Study|Subj left hosp without inform staff|1|||
145723883|NCT04572841|525506599|FG000|Overall Study|Adverse Event|1|||
145723884|NCT04572841|525506600|FG001|Overall Study|Adverse Event|1|||
145723885|NCT04572841|525506599|FG000|Overall Study|Withdrawal by Subject|2|||
145723886|NCT04572841|525506600|FG001|Overall Study|Withdrawal by Subject|1|||
145723887|NCT05041101|525506601|FG000|Overall Study|Adverse Event|1|||
145723888|NCT05041101|525506602|FG001|Overall Study|Adverse Event|0|||
145723889|NCT05041101|525506603|FG002|Overall Study|Adverse Event|0|||
145723890|NCT05041101|525506601|FG000|Overall Study|Diease Progression|5|||
145723891|NCT05041101|525506602|FG001|Overall Study|Diease Progression|0|||
145723892|NCT05041101|525506603|FG002|Overall Study|Diease Progression|0|||
145723893|NCT01205152|525506604|FG000|Overall Study|Death|1|||
145723894|NCT00249002|525506605|FG000|Overall Study|Adverse Event|2|||
145723895|NCT00249002|525506605|FG000|Overall Study|Study cancellation|3|||
145723896|NCT00249002|525506605|FG000|Overall Study|Other|2|||
145723897|NCT00069108|525506606|FG000|Overall Study|Withdrawal by Subject|5|||
145723898|NCT00069108|525506607|FG001|Overall Study|Withdrawal by Subject|9|||
145723899|NCT00069108|525506606|FG000|Overall Study|Adverse Event|64|||
145723900|NCT00069108|525506607|FG001|Overall Study|Adverse Event|42|||
145723901|NCT00069108|525506606|FG000|Overall Study|Death|6|||
145723902|NCT00069108|525506607|FG001|Overall Study|Death|6|||
145723903|NCT00069108|525506606|FG000|Overall Study|Administration|15|||
145723904|NCT00069108|525506607|FG001|Overall Study|Administration|4|||
145723905|NCT00069108|525506606|FG000|Overall Study|Insufficient therapy|117|||
145723906|NCT00069108|525506607|FG001|Overall Study|Insufficient therapy|144|||
145723907|NCT00069108|525506606|FG000|Overall Study|Violation criteria|1|||
145723908|NCT00069108|525506607|FG001|Overall Study|Violation criteria|4|||
145723909|NCT00069108|525506606|FG000|Overall Study|Refused treatment|5|||
145723910|NCT00069108|525506607|FG001|Overall Study|Refused treatment|10|||
145723911|NCT02783768|525506608|FG000|Overall Study|Lost to Follow-up|1|||
145723912|NCT02783768|525506609|FG001|Overall Study|Lost to Follow-up|0|||
145723913|NCT01323647|525506610|FG000|Overall Study|Migrated/moved from study area|2|||
145723914|NCT01323647|525506611|FG001|Overall Study|Migrated/moved from study area|0|||
145723915|NCT01323647|525506610|FG000|Overall Study|Withdrawal by Subject|5|||
145723916|NCT01323647|525506611|FG001|Overall Study|Withdrawal by Subject|0|||
145723917|NCT01323647|525506610|FG000|Overall Study|Lost to Follow-up|2|||
145723918|NCT01323647|525506611|FG001|Overall Study|Lost to Follow-up|0|||
145723919|NCT00262951|525506612|FG000|Overall Study|Progressive disease/relapse|3|||
145723920|NCT00262951|525506612|FG000|Overall Study|Adverse Event|7|||
145723921|NCT00262951|525506612|FG000|Overall Study|Death|1|||
145723922|NCT00262951|525506612|FG000|Overall Study|Withdrawal by Subject|1|||
145723923|NCT00262951|525506612|FG000|Overall Study|Alternative treatment|3|||
145723924|NCT00262951|525506612|FG000|Overall Study|Off treatment for other disease|1|||
145723925|NCT01853137|525506613|FG000|Overall Study|Lost to Follow-up|4|||
145723926|NCT01853137|525506614|FG001|Overall Study|Lost to Follow-up|1|||
145723927|NCT03401229|525506615|FG000|Overall Study|Lost to Follow-up|2|||
145723928|NCT03401229|525506616|FG001|Overall Study|Lost to Follow-up|1|||
145723929|NCT03401229|525506615|FG000|Overall Study|Other|1|||
145723930|NCT03401229|525506616|FG001|Overall Study|Other|3|||
145723931|NCT03401229|525506615|FG000|Overall Study|Adverse Event|8|||
145723932|NCT03401229|525506616|FG001|Overall Study|Adverse Event|6|||
145723933|NCT03401229|525506615|FG000|Overall Study|Withdrawal by Subject|29|||
145723934|NCT03401229|525506616|FG001|Overall Study|Withdrawal by Subject|26|||
145723935|NCT03401229|525506615|FG000|Overall Study|COVID-19|0|||
145723936|NCT03401229|525506616|FG001|Overall Study|COVID-19|1|||
145723937|NCT03658668|525506618|FG000|Overall Study|Time Commitment|1|||
145723938|NCT03658668|525506619|FG001|Overall Study|Time Commitment|1|||
145723939|NCT03305731|525506620|FG000|Overall Study|Protocol Violation|1|||
145723940|NCT01952054|525506621|FG000|Overall Study|Physician Decision|1|||
145723941|NCT01127139|525506622|FG000|Overall Study|Adverse Event|40|||
145723942|NCT01127139|525506622|FG000|Overall Study|Incompliance|12|||
145723943|NCT01127139|525506622|FG000|Overall Study|Lack of Efficacy|4|||
145723944|NCT01127139|525506622|FG000|Overall Study|Reason not specified|1|||
145723945|NCT03881553|525506629|FG000|Overall Study|Discharged prior to participation|1|||
145723946|NCT03881553|525506630|FG001|Overall Study|Discharged prior to participation|1|||
145723947|NCT03881553|525506631|FG002|Overall Study|Discharged prior to participation|0|||
145723948|NCT03881553|525506629|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
145723949|NCT03881553|525506630|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
145723950|NCT03881553|525506631|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
145723951|NCT01718353|525506632|FG000|Overall Study|Lost to Follow-up|0|||
145723952|NCT01718353|525506633|FG001|Overall Study|Lost to Follow-up|1|||
145723953|NCT01718353|525506632|FG000|Overall Study|Principal Investigator's Decision|10|||
145723954|NCT01718353|525506633|FG001|Overall Study|Principal Investigator's Decision|4|||
145723955|NCT01718353|525506632|FG000|Overall Study|Randomized but not treated|2|||
145723956|NCT01718353|525506633|FG001|Overall Study|Randomized but not treated|0|||
145723957|NCT00455325|525506634|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
145723958|NCT00455325|525506635|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
145723959|NCT00455325|525506636|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
145723960|NCT00455325|525506637|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
145723961|NCT00455325|525506634|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
145723962|NCT00455325|525506635|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
145723963|NCT00455325|525506636|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
145723964|NCT00455325|525506637|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
145723965|NCT00455325|525506634|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
145723966|NCT00455325|525506635|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
145723967|NCT00455325|525506636|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
145723968|NCT00455325|525506637|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
145723969|NCT00455325|525506634|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
145723970|NCT00455325|525506635|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
145723971|NCT00455325|525506636|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
145723972|NCT00455325|525506637|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
145723973|NCT00455325|525506634|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
145723974|NCT00455325|525506635|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
145723975|NCT00455325|525506636|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
145723976|NCT00455325|525506637|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
145723977|NCT00455325|525506634|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
145723978|NCT00455325|525506635|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
145723979|NCT00455325|525506636|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
145723980|NCT00455325|525506637|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
145723981|NCT00455325|525506634|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
145723982|NCT00455325|525506635|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
145723983|NCT00455325|525506636|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
145723984|NCT00455325|525506637|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
145723985|NCT04620811|525506638|FG000|Overall Study|Withdrawal by Subject|18|||
145723986|NCT04620811|525506639|FG001|Overall Study|Withdrawal by Subject|15|||
145723987|NCT04620811|525506638|FG000|Overall Study|Adverse Event|6|||
145723988|NCT04620811|525506639|FG001|Overall Study|Adverse Event|11|||
145723989|NCT04620811|525506638|FG000|Overall Study|Lost to Follow-up|4|||
145723990|NCT04620811|525506639|FG001|Overall Study|Lost to Follow-up|8|||
145723991|NCT04620811|525506638|FG000|Overall Study|Physician Decision|1|||
145723992|NCT04620811|525506639|FG001|Overall Study|Physician Decision|4|||
145723993|NCT04620811|525506638|FG000|Overall Study|Sponsor Decision|0|||
145723994|NCT04620811|525506639|FG001|Overall Study|Sponsor Decision|1|||
145723995|NCT04620811|525506638|FG000|Overall Study|Elevation of ALT or AST|1|||
145723996|NCT04620811|525506639|FG001|Overall Study|Elevation of ALT or AST|0|||
145723997|NCT04620811|525506638|FG000|Overall Study|Other|3|||
145723998|NCT04620811|525506639|FG001|Overall Study|Other|5|||
145723999|NCT00928746|525506645|FG000|Overall Study|Adverse Event|2|||
145724000|NCT00928746|525506645|FG000|Overall Study|Protocol Violation|1|||
145724001|NCT00928746|525506645|FG000|Overall Study|Withdrawal by Subject|1|||
145724002|NCT00928746|525506645|FG000|Overall Study|Other|2|||
145724003|NCT02004353|525506648|FG000|Overall Study|Voluntary participation|1334|||
145724004|NCT01759368|525506652|FG000|Overall Study|Lost to Follow-up|1|||
145724005|NCT01759368|525506653|FG001|Overall Study|Lost to Follow-up|0|||
145724006|NCT03110185|525506661|FG000|Overall Study|Death|0|||
145724007|NCT03110185|525506662|FG001|Overall Study|Death|1|||
145724008|NCT03110185|525506661|FG000|Overall Study|Withdrawal by Subject|2|||
145724009|NCT03110185|525506662|FG001|Overall Study|Withdrawal by Subject|7|||
145724010|NCT03110185|525506661|FG000|Overall Study|Time Constraints|0|||
145724011|NCT03110185|525506662|FG001|Overall Study|Time Constraints|6|||
145724012|NCT03110185|525506661|FG000|Overall Study|Conflict with care|5|||
145724013|NCT03110185|525506662|FG001|Overall Study|Conflict with care|12|||
145724014|NCT03110185|525506661|FG000|Overall Study|Protocol Violation|1|||
145724015|NCT03110185|525506662|FG001|Overall Study|Protocol Violation|4|||
145724016|NCT03110185|525506661|FG000|Overall Study|MRI Incompatible|2|||
145724017|NCT03110185|525506662|FG001|Overall Study|MRI Incompatible|0|||
145724018|NCT03110185|525506661|FG000|Overall Study|Patient Refusal|0|||
145724019|NCT03110185|525506662|FG001|Overall Study|Patient Refusal|1|||
145724020|NCT02641496|525506663|FG000|Overall Study|Lost to Follow-up|13|||
145724021|NCT02641496|525506664|FG001|Overall Study|Lost to Follow-up|12|||
145724022|NCT02641496|525506663|FG000|Overall Study|Withdrawal by Subject|1|||
145724023|NCT02641496|525506664|FG001|Overall Study|Withdrawal by Subject|0|||
145724024|NCT03075410|525506667|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
145724025|NCT03075410|525506668|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724026|NCT03075410|525506669|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
145724027|NCT03075410|525506670|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724028|NCT03075410|525506671|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724029|NCT03075410|525506672|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724030|NCT03075410|525506673|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724031|NCT03075410|525506674|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724032|NCT03075410|525506675|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
145724033|NCT03075410|525506667|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
145724034|NCT03075410|525506668|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724035|NCT03075410|525506669|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724036|NCT03075410|525506670|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724037|NCT03075410|525506671|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724038|NCT03075410|525506672|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724039|NCT03075410|525506673|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724040|NCT03075410|525506674|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724041|NCT03075410|525506675|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
145724042|NCT01427751|525506676|FG000|Overall Study|Adverse Event|18|||
145724043|NCT01427751|525506677|FG001|Overall Study|Adverse Event|2|||
145724044|NCT01427751|525506676|FG000|Overall Study|No further treatment benefit expected|5|||
145724045|NCT01427751|525506677|FG001|Overall Study|No further treatment benefit expected|1|||
145724046|NCT01427751|525506676|FG000|Overall Study|Lost to Follow-up|3|||
145724047|NCT01427751|525506677|FG001|Overall Study|Lost to Follow-up|1|||
145724048|NCT01427751|525506676|FG000|Overall Study|Withdrawal of consent|2|||
145724049|NCT01427751|525506677|FG001|Overall Study|Withdrawal of consent|2|||
145724050|NCT01427751|525506676|FG000|Overall Study|Protocol Violation|6|||
145724051|NCT01427751|525506677|FG001|Overall Study|Protocol Violation|4|||
145724052|NCT01427751|525506676|FG000|Overall Study|Death|2|||
145724053|NCT01427751|525506677|FG001|Overall Study|Death|0|||
145724054|NCT01427751|525506676|FG000|Overall Study|Other miscellaneous reasons|6|||
145724055|NCT01427751|525506677|FG001|Overall Study|Other miscellaneous reasons|4|||
145724056|NCT01028027|525506678|FG000|Overall Study|Lost to Follow-up|4|||
145724057|NCT01028027|525506679|FG001|Overall Study|Lost to Follow-up|1|||
145724058|NCT01028027|525506678|FG000|Overall Study|Withdrawal by Subject|5|||
145724059|NCT01028027|525506679|FG001|Overall Study|Withdrawal by Subject|3|||
145724060|NCT01028027|525506678|FG000|Overall Study|Adverse Event|4|||
145724061|NCT01028027|525506679|FG001|Overall Study|Adverse Event|7|||
145724062|NCT01028027|525506678|FG000|Overall Study|Protocol Violation|3|||
145724063|NCT01028027|525506679|FG001|Overall Study|Protocol Violation|1|||
145724064|NCT01028027|525506678|FG000|Overall Study|Lack of Efficacy|0|||
145724065|NCT01028027|525506679|FG001|Overall Study|Lack of Efficacy|1|||
145724066|NCT05330312|525506681|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
145724067|NCT05330312|525506682|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
145724068|NCT05330312|525506683|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
145724069|NCT05330312|525506681|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
145724070|NCT05330312|525506682|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
145724071|NCT05330312|525506683|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
145724072|NCT05330312|525506681|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
145724073|NCT05330312|525506682|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
145724074|NCT05330312|525506683|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
145724075|NCT05330312|525506681|FG000|Pivotal Investigation - Part 2|Death|1|||
145724076|NCT05330312|525506682|FG001|Pivotal Investigation - Part 2|Death|4|||
145724077|NCT05330312|525506683|FG002|Pivotal Investigation - Part 2|Death|0|||
145724078|NCT02572843|525506684|FG000|Accrual|Brain metastasis retrospectively detected|1|||
145724079|NCT02572843|525506684|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
145724080|NCT02572843|525506684|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
145724081|NCT02572843|525506684|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
145724082|NCT02572843|525506684|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
145724083|NCT02572843|525506684|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
145724084|NCT02572843|525506684|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
145724085|NCT02572843|525506684|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
145724086|NCT02572843|525506684|FG000|Surgery|lost to follow up|7|||
145724087|NCT02572843|525506684|FG000|Surgery|Death|1|||
145724088|NCT03464097|525506689|FG000|Overall Study|Withdrawal by Subject|15|||
145724089|NCT03464097|525506690|FG001|Overall Study|Withdrawal by Subject|13|||
145724090|NCT03464097|525506691|FG002|Overall Study|Withdrawal by Subject|11|||
145724091|NCT03464097|525506689|FG000|Overall Study|Study terminated by sponsor|47|||
145724092|NCT03464097|525506690|FG001|Overall Study|Study terminated by sponsor|44|||
145724093|NCT03464097|525506691|FG002|Overall Study|Study terminated by sponsor|40|||
145724094|NCT03464097|525506689|FG000|Overall Study|Pregnancy|0|||
145724095|NCT03464097|525506690|FG001|Overall Study|Pregnancy|1|||
145724096|NCT03464097|525506691|FG002|Overall Study|Pregnancy|0|||
145724097|NCT03464097|525506689|FG000|Overall Study|Other reasons|5|||
145724098|NCT03464097|525506690|FG001|Overall Study|Other reasons|12|||
145724099|NCT03464097|525506691|FG002|Overall Study|Other reasons|14|||
145724100|NCT03464097|525506689|FG000|Overall Study|Lost to Follow-up|0|||
145724101|NCT03464097|525506690|FG001|Overall Study|Lost to Follow-up|1|||
145724102|NCT03464097|525506691|FG002|Overall Study|Lost to Follow-up|1|||
145724103|NCT03464097|525506689|FG000|Overall Study|Lack of Efficacy|11|||
145724104|NCT03464097|525506690|FG001|Overall Study|Lack of Efficacy|18|||
145724105|NCT03464097|525506691|FG002|Overall Study|Lack of Efficacy|30|||
145724106|NCT03464097|525506689|FG000|Overall Study|Death|1|||
145724107|NCT03464097|525506690|FG001|Overall Study|Death|0|||
145724108|NCT03464097|525506691|FG002|Overall Study|Death|0|||
145724109|NCT03464097|525506689|FG000|Overall Study|Adverse Event|13|||
145724110|NCT03464097|525506690|FG001|Overall Study|Adverse Event|6|||
145724111|NCT03464097|525506691|FG002|Overall Study|Adverse Event|8|||
145724112|NCT03035201|525506692|FG000|Overall Study|Death|9|||
145724113|NCT03035201|525506693|FG001|Overall Study|Death|12|||
145724114|NCT03035201|525506694|FG002|Overall Study|Death|9|||
145724115|NCT03035201|525506695|FG003|Overall Study|Death|10|||
145724116|NCT03035201|525506692|FG000|Overall Study|Withdrawal by Subject|51|||
145724117|NCT03035201|525506693|FG001|Overall Study|Withdrawal by Subject|49|||
145724118|NCT03035201|525506694|FG002|Overall Study|Withdrawal by Subject|37|||
145724119|NCT03035201|525506695|FG003|Overall Study|Withdrawal by Subject|46|||
145724120|NCT03035201|525506692|FG000|Overall Study|Lost to Follow-up|67|||
145724121|NCT03035201|525506693|FG001|Overall Study|Lost to Follow-up|51|||
145724122|NCT03035201|525506694|FG002|Overall Study|Lost to Follow-up|64|||
145724123|NCT03035201|525506695|FG003|Overall Study|Lost to Follow-up|69|||
145724124|NCT05572021|525506702|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
145724125|NCT05572021|525506703|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
145724126|NCT04576455|525506704|FG000|Overall Study|Ongoing in the Study|48|||
145724127|NCT04576455|525506705|FG001|Overall Study|Ongoing in the Study|58|||
145724128|NCT04576455|525506704|FG000|Overall Study|Death|83|||
145724129|NCT04576455|525506705|FG001|Overall Study|Death|77|||
145724130|NCT04576455|525506704|FG000|Overall Study|Lost to Follow-up|4|||
145724131|NCT04576455|525506705|FG001|Overall Study|Lost to Follow-up|5|||
145724132|NCT04576455|525506704|FG000|Overall Study|Withdrawal by Subject|16|||
145724133|NCT04576455|525506705|FG001|Overall Study|Withdrawal by Subject|12|||
145724134|NCT03432260|525506706|FG000|Overall Study|Lost to Follow-up|1|||
145724135|NCT03432260|525506707|FG001|Overall Study|Lost to Follow-up|1|||
145724136|NCT03432260|525506708|FG002|Overall Study|Lost to Follow-up|0|||
145724137|NCT03432260|525506709|FG003|Overall Study|Lost to Follow-up|0|||
145724138|NCT03432260|525506710|FG004|Overall Study|Lost to Follow-up|1|||
145724139|NCT02186847|525506711|FG000|Overall Study|Protocol Violation|3|||
145724140|NCT02186847|525506712|FG001|Overall Study|Protocol Violation|0|||
145724141|NCT04873232|525506716|FG000|Overall Study|Lost to Follow-up|1|||
145724142|NCT04873232|525506717|FG001|Overall Study|Lost to Follow-up|4|||
145724143|NCT04873232|525506716|FG000|Overall Study|Withdrawal by Subject|1|||
145724144|NCT04873232|525506717|FG001|Overall Study|Withdrawal by Subject|0|||
145724145|NCT03440320|525508397|FG000|Overall Study|Withdrawal by Subject|0|||
145724146|NCT03440320|525508398|FG001|Overall Study|Withdrawal by Subject|1|||
145724147|NCT00409773|525508399|FG000|Overall Study|Adverse Event|3|||
145724148|NCT00409773|525508400|FG001|Overall Study|Adverse Event|4|||
145724149|NCT00409773|525508401|FG002|Overall Study|Adverse Event|4|||
145724150|NCT00409773|525508402|FG003|Overall Study|Adverse Event|2|||
145724151|NCT00409773|525508403|FG004|Overall Study|Adverse Event|6|||
145724152|NCT00409773|525508399|FG000|Overall Study|Lost to Follow-up|6|||
145724153|NCT00409773|525508400|FG001|Overall Study|Lost to Follow-up|1|||
145724154|NCT00409773|525508401|FG002|Overall Study|Lost to Follow-up|2|||
145724155|NCT00409773|525508402|FG003|Overall Study|Lost to Follow-up|3|||
145724156|NCT00409773|525508403|FG004|Overall Study|Lost to Follow-up|1|||
145724157|NCT00409773|525508399|FG000|Overall Study|Physician Decision|0|||
145724158|NCT00409773|525508400|FG001|Overall Study|Physician Decision|0|||
145724159|NCT00409773|525508401|FG002|Overall Study|Physician Decision|0|||
145724160|NCT00409773|525508402|FG003|Overall Study|Physician Decision|2|||
145724161|NCT00409773|525508403|FG004|Overall Study|Physician Decision|0|||
145724162|NCT00409773|525508399|FG000|Overall Study|Protocol Violation|0|||
145724163|NCT00409773|525508400|FG001|Overall Study|Protocol Violation|2|||
145724164|NCT00409773|525508401|FG002|Overall Study|Protocol Violation|3|||
145724165|NCT00409773|525508402|FG003|Overall Study|Protocol Violation|3|||
145724166|NCT00409773|525508403|FG004|Overall Study|Protocol Violation|1|||
145724167|NCT00409773|525508399|FG000|Overall Study|Withdrawal by Subject|0|||
145724168|NCT00409773|525508400|FG001|Overall Study|Withdrawal by Subject|0|||
145724169|NCT00409773|525508401|FG002|Overall Study|Withdrawal by Subject|0|||
145724170|NCT00409773|525508402|FG003|Overall Study|Withdrawal by Subject|2|||
145724171|NCT00409773|525508403|FG004|Overall Study|Withdrawal by Subject|1|||
145724172|NCT00409773|525508399|FG000|Overall Study|Lack of Eligibility|0|||
145724173|NCT00409773|525508400|FG001|Overall Study|Lack of Eligibility|0|||
145724174|NCT00409773|525508401|FG002|Overall Study|Lack of Eligibility|0|||
145724175|NCT00409773|525508402|FG003|Overall Study|Lack of Eligibility|0|||
145724176|NCT00409773|525508403|FG004|Overall Study|Lack of Eligibility|1|||
145724177|NCT01201343|525508404|FG000|Overall Study|Adverse Event|6|||
145724178|NCT01201343|525508404|FG000|Overall Study|Withdrawal by Subject|5|||
145724179|NCT01201343|525508404|FG000|Overall Study|Lost to Follow-up|2|||
145724180|NCT01201343|525508404|FG000|Overall Study|Lack of Efficacy|2|||
145724181|NCT01201343|525508404|FG000|Overall Study|Participant wrongly included in trial|1|||
145724182|NCT01201343|525508404|FG000|Overall Study|Randomized, not treated|3|||
145724183|NCT01440374|525508409|FG000|Part 1: Open-label Phase|Adverse Event|5|||
145724184|NCT01440374|525508410|FG001|Part 1: Open-label Phase|Adverse Event|0|||
145724185|NCT01440374|525508411|FG002|Part 1: Open-label Phase|Adverse Event|0|||
145724186|NCT01440374|525508412|FG003|Part 1: Open-label Phase|Adverse Event|0|||
145724187|NCT01440374|525508409|FG000|Part 1: Open-label Phase|Physician Decision|1|||
145724188|NCT01440374|525508410|FG001|Part 1: Open-label Phase|Physician Decision|0|||
145724189|NCT01440374|525508411|FG002|Part 1: Open-label Phase|Physician Decision|0|||
145724190|NCT01440374|525508412|FG003|Part 1: Open-label Phase|Physician Decision|0|||
145724191|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
145724192|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
145724193|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
145724194|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
145724195|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
145724196|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
145724197|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
145724198|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
145724199|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
145724200|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
145724201|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
145724202|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
145724203|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
145724204|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
145724205|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
145724206|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
145724207|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
145724208|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
145724209|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
145724210|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
145724211|NCT01440374|525508409|FG000|Part 2; Double-blind Phase|Not treated|0|||
145724212|NCT01440374|525508410|FG001|Part 2; Double-blind Phase|Not treated|0|||
145724213|NCT01440374|525508411|FG002|Part 2; Double-blind Phase|Not treated|1|||
145724214|NCT01440374|525508412|FG003|Part 2; Double-blind Phase|Not treated|0|||
145724215|NCT01440374|525508409|FG000|Part 3: Extension|Withdrawal by Subject|0|||
145724216|NCT01440374|525508410|FG001|Part 3: Extension|Withdrawal by Subject|0|||
145724217|NCT01440374|525508411|FG002|Part 3: Extension|Withdrawal by Subject|0|||
145724218|NCT01440374|525508412|FG003|Part 3: Extension|Withdrawal by Subject|5|||
145724219|NCT01440374|525508409|FG000|Part 3: Extension|Adverse Event|0|||
145724220|NCT01440374|525508410|FG001|Part 3: Extension|Adverse Event|0|||
145724221|NCT01440374|525508411|FG002|Part 3: Extension|Adverse Event|0|||
145724222|NCT01440374|525508412|FG003|Part 3: Extension|Adverse Event|13|||
145724223|NCT01440374|525508409|FG000|Part 3: Extension|Physician Decision|0|||
145724224|NCT01440374|525508410|FG001|Part 3: Extension|Physician Decision|0|||
145724225|NCT01440374|525508411|FG002|Part 3: Extension|Physician Decision|0|||
145724226|NCT01440374|525508412|FG003|Part 3: Extension|Physician Decision|14|||
145724227|NCT01036763|525508413|FG000|Overall Study|Adverse Event|25|||
145724228|NCT01036763|525508413|FG000|Overall Study|Lost to Follow-up|28|||
145724229|NCT01036763|525508413|FG000|Overall Study|Other reason (not specified)|40|||
145724230|NCT04812548|525508415|FG000|Overall Study|Adverse Event|2|||
145724231|NCT04812548|525508416|FG001|Overall Study|Adverse Event|7|||
145724232|NCT04812548|525508415|FG000|Overall Study|HSCT Planned|2|||
145724233|NCT04812548|525508416|FG001|Overall Study|HSCT Planned|3|||
145724234|NCT04812548|525508415|FG000|Overall Study|Progressive Disease|0|||
145724235|NCT04812548|525508416|FG001|Overall Study|Progressive Disease|2|||
145724236|NCT04812548|525508415|FG000|Overall Study|Death|0|||
145724237|NCT04812548|525508416|FG001|Overall Study|Death|1|||
145724238|NCT04812548|525508415|FG000|Overall Study|Post Study Access to Treatment|0|||
145724239|NCT04812548|525508416|FG001|Overall Study|Post Study Access to Treatment|1|||
145724240|NCT04812548|525508415|FG000|Overall Study|Withdrawal by Subject|0|||
145724241|NCT04812548|525508416|FG001|Overall Study|Withdrawal by Subject|1|||
145724242|NCT04812548|525508415|FG000|Overall Study|Physician Decision|1|||
145724243|NCT04812548|525508416|FG001|Overall Study|Physician Decision|0|||
145724244|NCT02141984|525508420|FG000|Overall Study|Lack of Efficacy|2|||
145724245|NCT03938545|525508421|FG000|Overall Study|Lost to Follow-up|0|||
145724246|NCT03938545|525508422|FG001|Overall Study|Lost to Follow-up|0|||
145724247|NCT03938545|525508423|FG002|Overall Study|Lost to Follow-up|0|||
145724248|NCT03938545|525508424|FG003|Overall Study|Lost to Follow-up|1|||
145724249|NCT03938545|525508421|FG000|Overall Study|Non-compliance with study drug|0|||
145724250|NCT03938545|525508422|FG001|Overall Study|Non-compliance with study drug|0|||
145724251|NCT03938545|525508423|FG002|Overall Study|Non-compliance with study drug|1|||
145724252|NCT03938545|525508424|FG003|Overall Study|Non-compliance with study drug|0|||
145724253|NCT03938545|525508421|FG000|Overall Study|Pregnancy|1|||
145724254|NCT03938545|525508422|FG001|Overall Study|Pregnancy|0|||
145724255|NCT03938545|525508423|FG002|Overall Study|Pregnancy|0|||
145724256|NCT03938545|525508424|FG003|Overall Study|Pregnancy|0|||
145724257|NCT03938545|525508421|FG000|Overall Study|Study terminated by sponsor|6|||
145724258|NCT03938545|525508422|FG001|Overall Study|Study terminated by sponsor|4|||
145724259|NCT03938545|525508423|FG002|Overall Study|Study terminated by sponsor|2|||
145724260|NCT03938545|525508424|FG003|Overall Study|Study terminated by sponsor|4|||
145724261|NCT03938545|525508421|FG000|Overall Study|Withdrawal by Subject|0|||
145724262|NCT03938545|525508422|FG001|Overall Study|Withdrawal by Subject|1|||
145724263|NCT03938545|525508423|FG002|Overall Study|Withdrawal by Subject|0|||
145724264|NCT03938545|525508424|FG003|Overall Study|Withdrawal by Subject|0|||
145724265|NCT03938545|525508421|FG000|Overall Study|Adverse Event|1|||
145724266|NCT03938545|525508422|FG001|Overall Study|Adverse Event|0|||
145383790|NCT01214668|524260151|FG003|Overall Study|Withdrawal by Subject|0|||
145724267|NCT03938545|525508423|FG002|Overall Study|Adverse Event|0|||
145724268|NCT03938545|525508424|FG003|Overall Study|Adverse Event|0|||
145724269|NCT01060540|525508425|FG000|Overall Study|Withdrawal by Subject|10|||
145724270|NCT01060540|525508426|FG001|Overall Study|Withdrawal by Subject|20|||
145724271|NCT01060540|525508425|FG000|Overall Study|Lost to Follow-up|52|||
145724272|NCT01060540|525508426|FG001|Overall Study|Lost to Follow-up|43|||
145724273|NCT01060540|525508425|FG000|Overall Study|Death|2|||
145724274|NCT01060540|525508426|FG001|Overall Study|Death|1|||
145724275|NCT01060540|525508425|FG000|Overall Study|Physician Decision|0|||
145724276|NCT01060540|525508426|FG001|Overall Study|Physician Decision|1|||
145724277|NCT01222507|525508430|FG000|Overall Study|Physician Decision|1|||
145724278|NCT01222507|525508430|FG000|Overall Study|Withdrawal by Subject|1|||
145724279|NCT00320541|525508432|FG000|Overall Study|Adverse Event|21|||
145724280|NCT00320541|525508433|FG001|Overall Study|Adverse Event|19|||
145724281|NCT00320541|525508432|FG000|Overall Study|Protocol Violation|0|||
145724282|NCT00320541|525508433|FG001|Overall Study|Protocol Violation|1|||
145724283|NCT00320541|525508432|FG000|Overall Study|Withdrawal by Subject|12|||
145724284|NCT00320541|525508433|FG001|Overall Study|Withdrawal by Subject|16|||
145724285|NCT00320541|525508432|FG000|Overall Study|Physician Decision|9|||
145724286|NCT00320541|525508433|FG001|Overall Study|Physician Decision|13|||
145724287|NCT00320541|525508432|FG000|Overall Study|Other|3|||
145724288|NCT00320541|525508433|FG001|Overall Study|Other|4|||
145724289|NCT00320541|525508432|FG000|Overall Study|Sponsor Decision|2|||
145724290|NCT00320541|525508433|FG001|Overall Study|Sponsor Decision|1|||
145724291|NCT00320541|525508432|FG000|Overall Study|Death due to Study Disease|1|||
145724292|NCT00320541|525508433|FG001|Overall Study|Death due to Study Disease|3|||
145724293|NCT00320541|525508432|FG000|Overall Study|Death due to Adverse Event(s)|1|||
145724294|NCT00320541|525508433|FG001|Overall Study|Death due to Adverse Event(s)|0|||
145724295|NCT00320541|525508432|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
145724296|NCT00320541|525508433|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
145724297|NCT02401867|525508434|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
145724298|NCT02401867|525508434|FG000|Analysis|Cervical assay could not be conducted|9|||
145724299|NCT01650246|525508435|FG000|Overall Study|Adverse Event|23|||
145724300|NCT01650246|525508435|FG000|Overall Study|Protocol Violation|5|||
145724301|NCT01650246|525508435|FG000|Overall Study|Sponsor terminated study|53|||
145724302|NCT01650246|525508435|FG000|Overall Study|Lost to Follow-up|5|||
145724303|NCT01650246|525508435|FG000|Overall Study|Withdrawal by Subject|26|||
145724304|NCT01650246|525508435|FG000|Overall Study|Death|1|||
145724305|NCT01650246|525508435|FG000|Overall Study|Lack of Efficacy|30|||
145724306|NCT00081770|525508436|FG000|Overall Study|Adverse Event|130|||
145724307|NCT00081770|525508437|FG001|Overall Study|Adverse Event|98|||
145724308|NCT00081770|525508438|FG002|Overall Study|Adverse Event|136|||
145724309|NCT00081770|525508436|FG000|Overall Study|Lack of Efficacy|262|||
145724310|NCT00081770|525508437|FG001|Overall Study|Lack of Efficacy|357|||
145724311|NCT00081770|525508438|FG002|Overall Study|Lack of Efficacy|211|||
145724312|NCT00081770|525508436|FG000|Overall Study|Lost to Follow-up|45|||
145724313|NCT00081770|525508437|FG001|Overall Study|Lost to Follow-up|34|||
145724314|NCT00081770|525508438|FG002|Overall Study|Lost to Follow-up|45|||
145724315|NCT00081770|525508436|FG000|Overall Study|Protocol Violation|15|||
145724316|NCT00081770|525508437|FG001|Overall Study|Protocol Violation|10|||
145724317|NCT00081770|525508438|FG002|Overall Study|Protocol Violation|10|||
145724318|NCT00081770|525508436|FG000|Overall Study|Withdrawal by Subject|45|||
145724319|NCT00081770|525508437|FG001|Overall Study|Withdrawal by Subject|40|||
145724320|NCT00081770|525508438|FG002|Overall Study|Withdrawal by Subject|42|||
145724321|NCT00081770|525508436|FG000|Overall Study|Did not meet protocol eligibility|2|||
145724322|NCT00081770|525508437|FG001|Overall Study|Did not meet protocol eligibility|0|||
145724323|NCT00081770|525508438|FG002|Overall Study|Did not meet protocol eligibility|3|||
145724324|NCT00081770|525508436|FG000|Overall Study|Administrative|1|||
145724325|NCT00081770|525508437|FG001|Overall Study|Administrative|0|||
145724326|NCT00081770|525508438|FG002|Overall Study|Administrative|1|||
145724327|NCT00081770|525508436|FG000|Overall Study|Other|2|||
145724328|NCT00081770|525508437|FG001|Overall Study|Other|7|||
145724329|NCT00081770|525508438|FG002|Overall Study|Other|8|||
145724330|NCT02795429|525508449|FG000|Overall Study|Adverse Event|1|||
145724331|NCT02795429|525508450|FG001|Overall Study|Adverse Event|2|||
145724332|NCT02795429|525508451|FG002|Overall Study|Adverse Event|1|||
145724333|NCT02795429|525508452|FG003|Overall Study|Adverse Event|2|||
145724334|NCT02795429|525508453|FG004|Overall Study|Adverse Event|1|||
145724335|NCT02795429|525508449|FG000|Overall Study|Death|1|||
145724336|NCT02795429|525508450|FG001|Overall Study|Death|0|||
145724337|NCT02795429|525508451|FG002|Overall Study|Death|1|||
145724338|NCT02795429|525508452|FG003|Overall Study|Death|2|||
145724339|NCT02795429|525508453|FG004|Overall Study|Death|1|||
145724340|NCT02795429|525508449|FG000|Overall Study|Physician Decision|0|||
145724341|NCT02795429|525508450|FG001|Overall Study|Physician Decision|0|||
145724342|NCT02795429|525508451|FG002|Overall Study|Physician Decision|2|||
145724343|NCT02795429|525508452|FG003|Overall Study|Physician Decision|1|||
145724344|NCT02795429|525508453|FG004|Overall Study|Physician Decision|5|||
145724345|NCT02795429|525508449|FG000|Overall Study|Progressive disease|3|||
145724346|NCT02795429|525508450|FG001|Overall Study|Progressive disease|7|||
145724347|NCT02795429|525508451|FG002|Overall Study|Progressive disease|6|||
145724348|NCT02795429|525508452|FG003|Overall Study|Progressive disease|26|||
145724349|NCT02795429|525508453|FG004|Overall Study|Progressive disease|20|||
145724350|NCT02795429|525508449|FG000|Overall Study|Subject/guardian decision|1|||
145724351|NCT02795429|525508450|FG001|Overall Study|Subject/guardian decision|1|||
145724352|NCT02795429|525508451|FG002|Overall Study|Subject/guardian decision|1|||
145724353|NCT02795429|525508452|FG003|Overall Study|Subject/guardian decision|1|||
145724354|NCT02795429|525508453|FG004|Overall Study|Subject/guardian decision|3|||
145724355|NCT04281004|525508456|FG000|Overall Study|Physician Decision|1|||
145724356|NCT04281004|525508457|FG001|Overall Study|Physician Decision|0|||
145724357|NCT01640054|525508458|FG000|Overall Study|Study-specific disc criteria|1|||
145724358|NCT01640054|525508458|FG000|Overall Study|Lack of Efficacy|3|||
145724359|NCT01640054|525508458|FG000|Overall Study|Adverse Event|2|||
145724360|NCT01716117|525508460|FG000|Overall Study|Death|5|||
145724361|NCT01716117|525508461|FG001|Overall Study|Death|2|||
145724362|NCT01716117|525508460|FG000|Overall Study|Withdrawal by Subject|2|||
145724363|NCT01716117|525508461|FG001|Overall Study|Withdrawal by Subject|0|||
145724364|NCT03645057|525508462|FG000|Randomization to Baseline|Lost to Follow-up|1|||
145724365|NCT03645057|525508463|FG001|Randomization to Baseline|Lost to Follow-up|0|||
145724366|NCT03645057|525508464|FG002|Randomization to Baseline|Lost to Follow-up|1|||
145724367|NCT03645057|525508465|FG003|Randomization to Baseline|Lost to Follow-up|0|||
145724368|NCT03645057|525508462|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
145724369|NCT03645057|525508463|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
145724370|NCT03645057|525508464|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
145724371|NCT03645057|525508465|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
145724372|NCT03645057|525508462|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
145724373|NCT03645057|525508463|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
145724374|NCT03645057|525508464|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
145724375|NCT03645057|525508465|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
145724376|NCT03645057|525508462|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
145724377|NCT03645057|525508463|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
145724378|NCT03645057|525508464|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
145724379|NCT03645057|525508465|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
145724380|NCT01206777|525508466|FG000|Overall Study|Death|1|||
145724381|NCT01206777|525508466|FG000|Overall Study|Adverse Event|1|||
145724382|NCT02080221|525508469|FG000|Overall Study|Withdrawal by Subject|1|||
145724383|NCT02080221|525508469|FG000|Overall Study|Clinical Progression of Disease|1|||
145724384|NCT03184870|525508473|FG000|Initial Treatment|Death|6|||
145724385|NCT03184870|525508474|FG001|Initial Treatment|Death|6|||
145724386|NCT03184870|525508475|FG002|Initial Treatment|Death|8|||
145724387|NCT03184870|525508476|FG003|Initial Treatment|Death|8|||
145724388|NCT03184870|525508477|FG004|Initial Treatment|Death|6|||
145724389|NCT03184870|525508478|FG005|Initial Treatment|Death|6|||
145724390|NCT03184870|525508479|FG006|Initial Treatment|Death|6|||
145724391|NCT03184870|525508480|FG007|Initial Treatment|Death|7|||
145724392|NCT03184870|525508481|FG008|Initial Treatment|Death|1|||
145724393|NCT03184870|525508482|FG009|Initial Treatment|Death|2|||
145724394|NCT03184870|525508483|FG010|Initial Treatment|Death|26|||
145724395|NCT03184870|525508484|FG011|Initial Treatment|Death|28|||
145724396|NCT03184870|525508485|FG012|Initial Treatment|Death|10|||
145724397|NCT03184870|525508486|FG013|Initial Treatment|Death|33|||
145724398|NCT03184870|525508487|FG014|Initial Treatment|Death|34|||
145724399|NCT03184870|525508488|FG015|Initial Treatment|Death|26|||
145724400|NCT03184870|525508489|FG016|Initial Treatment|Death|20|||
145724401|NCT03184870|525508490|FG017|Initial Treatment|Death|18|||
145724402|NCT03184870|525508473|FG000|Initial Treatment|Other Reasons|2|||
145724403|NCT03184870|525508474|FG001|Initial Treatment|Other Reasons|2|||
145724404|NCT03184870|525508475|FG002|Initial Treatment|Other Reasons|0|||
145724405|NCT03184870|525508476|FG003|Initial Treatment|Other Reasons|1|||
145724406|NCT03184870|525508477|FG004|Initial Treatment|Other Reasons|0|||
145724407|NCT03184870|525508478|FG005|Initial Treatment|Other Reasons|0|||
145724408|NCT03184870|525508479|FG006|Initial Treatment|Other Reasons|0|||
145724409|NCT03184870|525508480|FG007|Initial Treatment|Other Reasons|2|||
145724410|NCT03184870|525508481|FG008|Initial Treatment|Other Reasons|0|||
145724411|NCT03184870|525508482|FG009|Initial Treatment|Other Reasons|0|||
145724412|NCT03184870|525508483|FG010|Initial Treatment|Other Reasons|4|||
145724413|NCT03184870|525508484|FG011|Initial Treatment|Other Reasons|2|||
145724414|NCT03184870|525508485|FG012|Initial Treatment|Other Reasons|2|||
145724415|NCT03184870|525508486|FG013|Initial Treatment|Other Reasons|0|||
145724416|NCT03184870|525508487|FG014|Initial Treatment|Other Reasons|0|||
145724417|NCT03184870|525508488|FG015|Initial Treatment|Other Reasons|1|||
145724418|NCT03184870|525508489|FG016|Initial Treatment|Other Reasons|0|||
145724419|NCT03184870|525508490|FG017|Initial Treatment|Other Reasons|2|||
145724420|NCT03184870|525508473|FG000|Initial Treatment|Lost to Follow-up|2|||
145724421|NCT03184870|525508474|FG001|Initial Treatment|Lost to Follow-up|0|||
145724422|NCT03184870|525508475|FG002|Initial Treatment|Lost to Follow-up|0|||
145724423|NCT03184870|525508476|FG003|Initial Treatment|Lost to Follow-up|1|||
145724424|NCT03184870|525508477|FG004|Initial Treatment|Lost to Follow-up|1|||
145724425|NCT03184870|525508478|FG005|Initial Treatment|Lost to Follow-up|1|||
145724426|NCT03184870|525508479|FG006|Initial Treatment|Lost to Follow-up|0|||
145724427|NCT03184870|525508480|FG007|Initial Treatment|Lost to Follow-up|2|||
145724428|NCT03184870|525508481|FG008|Initial Treatment|Lost to Follow-up|0|||
145724429|NCT03184870|525508482|FG009|Initial Treatment|Lost to Follow-up|0|||
145724430|NCT03184870|525508483|FG010|Initial Treatment|Lost to Follow-up|2|||
145724431|NCT03184870|525508484|FG011|Initial Treatment|Lost to Follow-up|0|||
145724432|NCT03184870|525508485|FG012|Initial Treatment|Lost to Follow-up|2|||
145724433|NCT03184870|525508486|FG013|Initial Treatment|Lost to Follow-up|2|||
145724434|NCT03184870|525508487|FG014|Initial Treatment|Lost to Follow-up|0|||
145724435|NCT03184870|525508488|FG015|Initial Treatment|Lost to Follow-up|0|||
145724436|NCT03184870|525508489|FG016|Initial Treatment|Lost to Follow-up|2|||
145724437|NCT03184870|525508490|FG017|Initial Treatment|Lost to Follow-up|2|||
145724438|NCT03184870|525508473|FG000|Initial Treatment|Withdrawal by Subject|0|||
145724439|NCT03184870|525508474|FG001|Initial Treatment|Withdrawal by Subject|0|||
145724440|NCT03184870|525508475|FG002|Initial Treatment|Withdrawal by Subject|2|||
145724441|NCT03184870|525508476|FG003|Initial Treatment|Withdrawal by Subject|1|||
145724442|NCT03184870|525508477|FG004|Initial Treatment|Withdrawal by Subject|1|||
145724443|NCT03184870|525508478|FG005|Initial Treatment|Withdrawal by Subject|0|||
145724444|NCT03184870|525508479|FG006|Initial Treatment|Withdrawal by Subject|1|||
145724445|NCT03184870|525508480|FG007|Initial Treatment|Withdrawal by Subject|0|||
145724446|NCT03184870|525508481|FG008|Initial Treatment|Withdrawal by Subject|0|||
145724447|NCT03184870|525508482|FG009|Initial Treatment|Withdrawal by Subject|0|||
145724448|NCT03184870|525508483|FG010|Initial Treatment|Withdrawal by Subject|0|||
145724449|NCT03184870|525508484|FG011|Initial Treatment|Withdrawal by Subject|2|||
145724450|NCT03184870|525508485|FG012|Initial Treatment|Withdrawal by Subject|3|||
145724451|NCT03184870|525508486|FG013|Initial Treatment|Withdrawal by Subject|0|||
145724452|NCT03184870|525508487|FG014|Initial Treatment|Withdrawal by Subject|1|||
145724453|NCT03184870|525508488|FG015|Initial Treatment|Withdrawal by Subject|5|||
145724454|NCT03184870|525508489|FG016|Initial Treatment|Withdrawal by Subject|2|||
145724455|NCT03184870|525508490|FG017|Initial Treatment|Withdrawal by Subject|2|||
145724456|NCT03184870|525508473|FG000|Initial Treatment|Moved to crossover treatment|0|||
145724457|NCT03184870|525508474|FG001|Initial Treatment|Moved to crossover treatment|0|||
145724458|NCT03184870|525508475|FG002|Initial Treatment|Moved to crossover treatment|0|||
145724459|NCT03184870|525508476|FG003|Initial Treatment|Moved to crossover treatment|0|||
145724460|NCT03184870|525508477|FG004|Initial Treatment|Moved to crossover treatment|0|||
145724461|NCT03184870|525508478|FG005|Initial Treatment|Moved to crossover treatment|0|||
145724462|NCT03184870|525508479|FG006|Initial Treatment|Moved to crossover treatment|0|||
145724463|NCT03184870|525508480|FG007|Initial Treatment|Moved to crossover treatment|0|||
145724464|NCT03184870|525508481|FG008|Initial Treatment|Moved to crossover treatment|0|||
145724465|NCT03184870|525508482|FG009|Initial Treatment|Moved to crossover treatment|0|||
145724466|NCT03184870|525508483|FG010|Initial Treatment|Moved to crossover treatment|0|||
145724467|NCT03184870|525508484|FG011|Initial Treatment|Moved to crossover treatment|0|||
145724468|NCT03184870|525508485|FG012|Initial Treatment|Moved to crossover treatment|9|||
145724469|NCT03184870|525508486|FG013|Initial Treatment|Moved to crossover treatment|0|||
145724470|NCT03184870|525508487|FG014|Initial Treatment|Moved to crossover treatment|0|||
145724471|NCT03184870|525508488|FG015|Initial Treatment|Moved to crossover treatment|0|||
145724472|NCT03184870|525508489|FG016|Initial Treatment|Moved to crossover treatment|0|||
145724473|NCT03184870|525508490|FG017|Initial Treatment|Moved to crossover treatment|0|||
145724474|NCT03184870|525508473|FG000|Crossover Treatment|Other reasons|0|||
145724475|NCT03184870|525508474|FG001|Crossover Treatment|Other reasons|0|||
145724476|NCT03184870|525508475|FG002|Crossover Treatment|Other reasons|0|||
145724477|NCT03184870|525508476|FG003|Crossover Treatment|Other reasons|0|||
145724478|NCT03184870|525508477|FG004|Crossover Treatment|Other reasons|0|||
145724479|NCT03184870|525508478|FG005|Crossover Treatment|Other reasons|0|||
145724480|NCT03184870|525508479|FG006|Crossover Treatment|Other reasons|0|||
145724481|NCT03184870|525508480|FG007|Crossover Treatment|Other reasons|0|||
145724482|NCT03184870|525508481|FG008|Crossover Treatment|Other reasons|0|||
145724483|NCT03184870|525508482|FG009|Crossover Treatment|Other reasons|0|||
145724484|NCT03184870|525508483|FG010|Crossover Treatment|Other reasons|0|||
145724485|NCT03184870|525508484|FG011|Crossover Treatment|Other reasons|0|||
145724486|NCT03184870|525508485|FG012|Crossover Treatment|Other reasons|0|||
145724487|NCT03184870|525508486|FG013|Crossover Treatment|Other reasons|0|||
145724488|NCT03184870|525508487|FG014|Crossover Treatment|Other reasons|0|||
145724489|NCT03184870|525508488|FG015|Crossover Treatment|Other reasons|0|||
145724490|NCT03184870|525508489|FG016|Crossover Treatment|Other reasons|0|||
145724491|NCT03184870|525508490|FG017|Crossover Treatment|Other reasons|2|||
145724492|NCT03184870|525508473|FG000|Crossover Treatment|Death|0|||
145724493|NCT03184870|525508474|FG001|Crossover Treatment|Death|0|||
145724494|NCT03184870|525508475|FG002|Crossover Treatment|Death|0|||
145724495|NCT03184870|525508476|FG003|Crossover Treatment|Death|0|||
145724496|NCT03184870|525508477|FG004|Crossover Treatment|Death|0|||
145724497|NCT03184870|525508478|FG005|Crossover Treatment|Death|0|||
145724498|NCT03184870|525508479|FG006|Crossover Treatment|Death|0|||
145724499|NCT03184870|525508480|FG007|Crossover Treatment|Death|0|||
145724500|NCT03184870|525508481|FG008|Crossover Treatment|Death|0|||
145724501|NCT03184870|525508482|FG009|Crossover Treatment|Death|0|||
145724502|NCT03184870|525508483|FG010|Crossover Treatment|Death|0|||
145724503|NCT03184870|525508484|FG011|Crossover Treatment|Death|0|||
145724504|NCT03184870|525508485|FG012|Crossover Treatment|Death|0|||
145724505|NCT03184870|525508486|FG013|Crossover Treatment|Death|0|||
145724506|NCT03184870|525508487|FG014|Crossover Treatment|Death|0|||
145724507|NCT03184870|525508488|FG015|Crossover Treatment|Death|0|||
145724508|NCT03184870|525508489|FG016|Crossover Treatment|Death|0|||
145724509|NCT03184870|525508490|FG017|Crossover Treatment|Death|7|||
145724510|NCT03786783|525508491|FG000|Overall Study|Death|1|||
145724511|NCT03786783|525508491|FG000|Overall Study|Physician Decision|6|||
145724512|NCT03786783|525508491|FG000|Overall Study|Withdrawal by Subject|2|||
145724513|NCT03786783|525508491|FG000|Overall Study|Disease Progression|7|||
145724514|NCT03786783|525508491|FG000|Overall Study|Patient/Parent Refusal|4|||
145724515|NCT04754477|525508492|FG000|Overall Study|Withdrawal by Subject|1|||
145724516|NCT06469242|525508493|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
145724517|NCT06469242|525508494|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
145724518|NCT06469242|525508493|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
145724519|NCT06469242|525508494|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
145724520|NCT00690820|525508495|FG000|Period 1|Withdrawal by Subject|0|||
145724521|NCT00690820|525508496|FG001|Period 1|Withdrawal by Subject|1|||
145724522|NCT05333224|525508497|FG000|Overall Study - Infants|Lost to Follow-up|1|||
145724523|NCT05333224|525508498|FG001|Overall Study - Infants|Lost to Follow-up|1|||
145724524|NCT01768117|525508500|FG000|Overall Study|Lost to Follow-up|1|||
145724525|NCT01768117|525508500|FG000|Overall Study|Withdrawal by Subject|2|||
145724526|NCT01768117|525508500|FG000|Overall Study|Protocol Violation|3|||
145724527|NCT00966277|525508502|FG000|Overall Study|Withdrawal by Subject|3|||
145724528|NCT00966277|525508503|FG001|Overall Study|Withdrawal by Subject|0|||
145724529|NCT00966277|525508502|FG000|Overall Study|Ineligible|1|||
145724530|NCT00966277|525508503|FG001|Overall Study|Ineligible|3|||
145724531|NCT00966277|525508502|FG000|Overall Study|Treatment Plan Changed|0|||
145724532|NCT00966277|525508503|FG001|Overall Study|Treatment Plan Changed|1|||
145724533|NCT01959516|525508507|FG000|Epoch 1|Adverse Event|4|||
145724534|NCT01959516|525508508|FG001|Epoch 1|Adverse Event|1|||
145724535|NCT01959516|525508507|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
145724536|NCT01959516|525508508|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
145724537|NCT01959516|525508507|FG000|Epoch 1|Subject withdrew consent|3|||
145724538|NCT01959516|525508508|FG001|Epoch 1|Subject withdrew consent|2|||
145724539|NCT01959516|525508507|FG000|Epoch 1|Administrative problems|1|||
145724540|NCT01959516|525508508|FG001|Epoch 1|Administrative problems|0|||
145724541|NCT01959516|525508507|FG000|Epoch 1|Use of prohibited treatment|1|||
145724542|NCT01959516|525508508|FG001|Epoch 1|Use of prohibited treatment|0|||
145724543|NCT01959516|525508507|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
145724544|NCT01959516|525508508|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
145724545|NCT01959516|525508507|FG000|Epoch 1|Protocol deviation|0|||
145724546|NCT01959516|525508508|FG001|Epoch 1|Protocol deviation|1|||
145724547|NCT01959516|525508507|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
145724548|NCT01959516|525508508|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
145724549|NCT01959516|525508507|FG000|Epoch 2|Subject withdrew consent|1|||
145724550|NCT01959516|525508508|FG001|Epoch 2|Subject withdrew consent|0|||
145724551|NCT01959516|525508507|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
145724552|NCT01959516|525508508|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
145724553|NCT01477333|525508509|FG000|Overall Study|Adverse Event|1|||
145724554|NCT01477333|525508509|FG000|Overall Study|Withdrawal by Subject|1|||
145724555|NCT01477333|525508509|FG000|Overall Study|Clinical Deterioration|1|||
145724556|NCT01078675|525508510|FG000|Overall Study|Withdrawal by Subject|7|||
145724557|NCT01078675|525508511|FG001|Overall Study|Withdrawal by Subject|3|||
145724558|NCT01078675|525508510|FG000|Overall Study|Protocol Violation|56|||
145724559|NCT01078675|525508511|FG001|Overall Study|Protocol Violation|0|||
145724560|NCT01078675|525508510|FG000|Overall Study|Provided in CRF for specific reasons|2|||
145724561|NCT01078675|525508511|FG001|Overall Study|Provided in CRF for specific reasons|3|||
145724562|NCT01078675|525508510|FG000|Overall Study|Adverse Event|3|||
145724563|NCT01078675|525508511|FG001|Overall Study|Adverse Event|0|||
145724564|NCT02513303|525508516|FG000|Overall Study|Withdrawal by Subject|9|||
145724565|NCT02513303|525508517|FG001|Overall Study|Withdrawal by Subject|7|||
145724566|NCT02513303|525508518|FG002|Overall Study|Withdrawal by Subject|2|||
145724567|NCT02513303|525508516|FG000|Overall Study|Lost to Follow-up|2|||
145724568|NCT02513303|525508517|FG001|Overall Study|Lost to Follow-up|4|||
145724569|NCT02513303|525508518|FG002|Overall Study|Lost to Follow-up|0|||
145724570|NCT02513303|525508516|FG000|Overall Study|Adverse Event|0|||
145724571|NCT02513303|525508517|FG001|Overall Study|Adverse Event|1|||
145724572|NCT02513303|525508518|FG002|Overall Study|Adverse Event|0|||
145724573|NCT02513303|525508516|FG000|Overall Study|Physician Decision|1|||
145724574|NCT02513303|525508517|FG001|Overall Study|Physician Decision|1|||
145724575|NCT02513303|525508518|FG002|Overall Study|Physician Decision|0|||
145724576|NCT02513303|525508516|FG000|Overall Study|Death|8|||
145724577|NCT02513303|525508517|FG001|Overall Study|Death|4|||
145724578|NCT02513303|525508518|FG002|Overall Study|Death|2|||
145724579|NCT01691768|525508519|FG000|Overall Study|Death|0|||
145724580|NCT01691768|525508520|FG001|Overall Study|Death|2|||
145724581|NCT01691768|525508519|FG000|Overall Study|Lost to Follow-up|4|||
145724582|NCT01691768|525508520|FG001|Overall Study|Lost to Follow-up|3|||
145724583|NCT01691768|525508519|FG000|Overall Study|Withdrawal by Subject|10|||
145724584|NCT01691768|525508520|FG001|Overall Study|Withdrawal by Subject|9|||
145724585|NCT01691768|525508519|FG000|Overall Study|Relocated|0|||
145724586|NCT01691768|525508520|FG001|Overall Study|Relocated|1|||
145724587|NCT01691768|525508519|FG000|Overall Study|Investigator decision|1|||
145724588|NCT01691768|525508520|FG001|Overall Study|Investigator decision|1|||
145724589|NCT02294227|525508525|FG000|Overall Study|Death|0|||
145724590|NCT02294227|525508526|FG001|Overall Study|Death|0|||
145724591|NCT02294227|525508527|FG002|Overall Study|Death|1|||
145724592|NCT02294227|525508525|FG000|Overall Study|Subject/Guardian Decision|6|||
145724593|NCT02294227|525508526|FG001|Overall Study|Subject/Guardian Decision|3|||
145724594|NCT02294227|525508527|FG002|Overall Study|Subject/Guardian Decision|7|||
145724595|NCT02294227|525508525|FG000|Overall Study|Physician Decision|1|||
145724596|NCT02294227|525508526|FG001|Overall Study|Physician Decision|2|||
145724597|NCT02294227|525508527|FG002|Overall Study|Physician Decision|1|||
145724598|NCT02294227|525508525|FG000|Overall Study|Lost to Follow-up|1|||
145724599|NCT02294227|525508526|FG001|Overall Study|Lost to Follow-up|0|||
145724600|NCT02294227|525508527|FG002|Overall Study|Lost to Follow-up|0|||
145724601|NCT02294227|525508525|FG000|Overall Study|Lack of Efficacy|11|||
145724602|NCT02294227|525508526|FG001|Overall Study|Lack of Efficacy|12|||
145724603|NCT02294227|525508527|FG002|Overall Study|Lack of Efficacy|8|||
145724604|NCT02294227|525508525|FG000|Overall Study|Adverse Event|6|||
145724605|NCT02294227|525508526|FG001|Overall Study|Adverse Event|8|||
145724606|NCT02294227|525508527|FG002|Overall Study|Adverse Event|2|||
145724607|NCT01768637|525508528|FG000|Overall Study|Lost to Follow-up|2|||
145724608|NCT01768637|525508529|FG001|Overall Study|Lost to Follow-up|7|||
145724609|NCT01768637|525508528|FG000|Overall Study|Difficult blood draw|1|||
145724610|NCT01768637|525508529|FG001|Overall Study|Difficult blood draw|0|||
145724611|NCT02481947|525508530|FG000|Overall Study|Withdrawal by Subject|24|||
145724612|NCT02481947|525508531|FG001|Overall Study|Withdrawal by Subject|10|||
145724613|NCT02481947|525508530|FG000|Overall Study|Lost to Follow-up|11|||
145724614|NCT02481947|525508531|FG001|Overall Study|Lost to Follow-up|5|||
145724615|NCT02481947|525508530|FG000|Overall Study|Adverse Event|6|||
145724616|NCT02481947|525508531|FG001|Overall Study|Adverse Event|11|||
145724617|NCT02481947|525508530|FG000|Overall Study|Physician Decision|4|||
145724618|NCT02481947|525508531|FG001|Overall Study|Physician Decision|5|||
145724619|NCT02481947|525508530|FG000|Overall Study|Protocol Violation|1|||
145724620|NCT02481947|525508531|FG001|Overall Study|Protocol Violation|5|||
145724621|NCT03426267|525508537|FG000|Overall Study|Physician Decision|1|||
145724622|NCT03426267|525508538|FG001|Overall Study|Physician Decision|4|||
145724623|NCT03426267|525508537|FG000|Overall Study|Lost to Follow-up|1|||
145724624|NCT03426267|525508538|FG001|Overall Study|Lost to Follow-up|0|||
145724625|NCT03426267|525508537|FG000|Overall Study|Withdrawal by Subject|4|||
145724626|NCT03426267|525508538|FG001|Overall Study|Withdrawal by Subject|10|||
145724627|NCT03426267|525508537|FG000|Overall Study|Protocol Violation|1|||
145724628|NCT03426267|525508538|FG001|Overall Study|Protocol Violation|3|||
145724629|NCT03426267|525508537|FG000|Overall Study|Adverse Event|9|||
145724630|NCT03426267|525508538|FG001|Overall Study|Adverse Event|27|||
145724631|NCT03426267|525508537|FG000|Overall Study|Prohibited Treatment Intake|2|||
145724632|NCT03426267|525508538|FG001|Overall Study|Prohibited Treatment Intake|3|||
145724633|NCT03426267|525508537|FG000|Overall Study|Lack of Efficacy|0|||
145724634|NCT03426267|525508538|FG001|Overall Study|Lack of Efficacy|25|||
145724635|NCT03426267|525508537|FG000|Overall Study|other|3|||
145724636|NCT03426267|525508538|FG001|Overall Study|other|0|||
145724637|NCT00448123|525508543|FG000|Overall Study|Lost to Follow-up|9|||
145724638|NCT00448123|525508544|FG001|Overall Study|Lost to Follow-up|6|||
145724639|NCT00448123|525508543|FG000|Overall Study|Physician Decision|6|||
145724640|NCT00448123|525508544|FG001|Overall Study|Physician Decision|6|||
145724641|NCT02027623|525508545|FG000|Overall Study|Lost to Follow-up|3|||
145724642|NCT02027623|525508546|FG001|Overall Study|Lost to Follow-up|3|||
145724643|NCT02027623|525508545|FG000|Overall Study|Withdrawal by Subject|6|||
145724644|NCT02027623|525508546|FG001|Overall Study|Withdrawal by Subject|9|||
145724645|NCT01275131|525508550|FG000|Period 1|Withdrawal by Subject|1|||
145724646|NCT01275131|525508551|FG001|Period 1|Withdrawal by Subject|0|||
145724647|NCT01275131|525508552|FG002|Period 1|Withdrawal by Subject|3|||
145724648|NCT01275131|525508553|FG003|Period 1|Withdrawal by Subject|2|||
145724649|NCT01275131|525508550|FG000|Period 1|Physician Decision|1|||
145724650|NCT01275131|525508551|FG001|Period 1|Physician Decision|0|||
145724651|NCT01275131|525508552|FG002|Period 1|Physician Decision|0|||
145724652|NCT01275131|525508553|FG003|Period 1|Physician Decision|0|||
145724653|NCT01275131|525508550|FG000|Period 2 (Crossover)|Adverse Event|0|||
145724654|NCT01275131|525508551|FG001|Period 2 (Crossover)|Adverse Event|1|||
145724655|NCT01275131|525508552|FG002|Period 2 (Crossover)|Adverse Event|0|||
145724656|NCT01275131|525508553|FG003|Period 2 (Crossover)|Adverse Event|0|||
145724657|NCT01275131|525508550|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
145724658|NCT01275131|525508551|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
145724659|NCT01275131|525508552|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
145724660|NCT01275131|525508553|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
145724661|NCT01912456|525510211|FG000|Period 1|Physician Decision|0|||
145724662|NCT01912456|525510212|FG001|Period 1|Physician Decision|0|||
145724663|NCT01912456|525510213|FG002|Period 1|Physician Decision|1|||
145724664|NCT01912456|525510214|FG003|Period 1|Physician Decision|0|||
145724665|NCT01912456|525510211|FG000|Period 1|non-compliance|1|||
145724666|NCT01912456|525510212|FG001|Period 1|non-compliance|0|||
145724667|NCT01912456|525510213|FG002|Period 1|non-compliance|0|||
145724668|NCT01912456|525510214|FG003|Period 1|non-compliance|1|||
145724669|NCT01912456|525510211|FG000|Period 1|Adverse Event|1|||
145724670|NCT01912456|525510212|FG001|Period 1|Adverse Event|0|||
145724671|NCT01912456|525510213|FG002|Period 1|Adverse Event|0|||
145724672|NCT01912456|525510214|FG003|Period 1|Adverse Event|1|||
145724673|NCT01912456|525510211|FG000|Period 1|Withdrawal by Subject|0|||
145724674|NCT01912456|525510212|FG001|Period 1|Withdrawal by Subject|1|||
145724675|NCT01912456|525510213|FG002|Period 1|Withdrawal by Subject|1|||
145724676|NCT01912456|525510214|FG003|Period 1|Withdrawal by Subject|1|||
145724677|NCT01912456|525510211|FG000|Period 2|Lack of Efficacy|0|||
145724678|NCT01912456|525510212|FG001|Period 2|Lack of Efficacy|2|||
145724679|NCT01912456|525510213|FG002|Period 2|Lack of Efficacy|0|||
145724680|NCT01912456|525510214|FG003|Period 2|Lack of Efficacy|0|||
145724681|NCT01912456|525510211|FG000|Period 2|Adverse Event|0|||
145724682|NCT01912456|525510212|FG001|Period 2|Adverse Event|0|||
145724683|NCT01912456|525510213|FG002|Period 2|Adverse Event|0|||
145724684|NCT01912456|525510214|FG003|Period 2|Adverse Event|1|||
145724685|NCT00171704|525510215|FG000|Overall Study|Adverse Event|24|||
145724686|NCT00171704|525510216|FG001|Overall Study|Adverse Event|33|||
145724687|NCT00171704|525510215|FG000|Overall Study|Disease Progression|14|||
145724688|NCT00171704|525510216|FG001|Overall Study|Disease Progression|9|||
145724689|NCT00171704|525510215|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
145724690|NCT00171704|525510216|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
145724691|NCT00171704|525510215|FG000|Overall Study|Administrative Problems|2|||
145724692|NCT00171704|525510216|FG001|Overall Study|Administrative Problems|1|||
145724693|NCT00171704|525510215|FG000|Overall Study|Death|2|||
145724694|NCT00171704|525510216|FG001|Overall Study|Death|2|||
145724695|NCT00171704|525510215|FG000|Overall Study|Withdrawal by Subject|1|||
145724696|NCT00171704|525510216|FG001|Overall Study|Withdrawal by Subject|3|||
145724697|NCT00171704|525510215|FG000|Overall Study|Protocol Violation|0|||
145724698|NCT00171704|525510216|FG001|Overall Study|Protocol Violation|1|||
145724699|NCT02647320|525510219|FG000|Overall Study|Adverse Event|0|||
145724700|NCT02647320|525510220|FG001|Overall Study|Adverse Event|1|||
145724701|NCT02647320|525510221|FG002|Overall Study|Adverse Event|3|||
145724702|NCT02647320|525510222|FG003|Overall Study|Adverse Event|2|||
145724703|NCT02647320|525510223|FG004|Overall Study|Adverse Event|1|||
145724704|NCT02647320|525510219|FG000|Overall Study|Protocol Violation|0|||
145724705|NCT02647320|525510220|FG001|Overall Study|Protocol Violation|0|||
145724706|NCT02647320|525510221|FG002|Overall Study|Protocol Violation|3|||
145724707|NCT02647320|525510222|FG003|Overall Study|Protocol Violation|0|||
145724708|NCT02647320|525510223|FG004|Overall Study|Protocol Violation|0|||
145724709|NCT02647320|525510219|FG000|Overall Study|Withdrawal by Subject|7|||
145724710|NCT02647320|525510220|FG001|Overall Study|Withdrawal by Subject|4|||
145724711|NCT02647320|525510221|FG002|Overall Study|Withdrawal by Subject|2|||
145724712|NCT02647320|525510222|FG003|Overall Study|Withdrawal by Subject|2|||
145724713|NCT02647320|525510223|FG004|Overall Study|Withdrawal by Subject|7|||
145724714|NCT02647320|525510219|FG000|Overall Study|Persistent hyperglycemia|0|||
145724715|NCT02647320|525510220|FG001|Overall Study|Persistent hyperglycemia|1|||
145724716|NCT02647320|525510221|FG002|Overall Study|Persistent hyperglycemia|1|||
145724717|NCT02647320|525510222|FG003|Overall Study|Persistent hyperglycemia|1|||
145724718|NCT02647320|525510223|FG004|Overall Study|Persistent hyperglycemia|1|||
145724719|NCT02647320|525510219|FG000|Overall Study|Study terminated by sponsor|1|||
145724720|NCT02647320|525510220|FG001|Overall Study|Study terminated by sponsor|1|||
145724721|NCT02647320|525510221|FG002|Overall Study|Study terminated by sponsor|1|||
145724722|NCT02647320|525510222|FG003|Overall Study|Study terminated by sponsor|1|||
145724723|NCT02647320|525510223|FG004|Overall Study|Study terminated by sponsor|2|||
145724724|NCT02647320|525510219|FG000|Overall Study|Reason not provided|0|||
145724725|NCT02647320|525510220|FG001|Overall Study|Reason not provided|0|||
145724726|NCT02647320|525510221|FG002|Overall Study|Reason not provided|1|||
145724727|NCT02647320|525510222|FG003|Overall Study|Reason not provided|0|||
145724728|NCT02647320|525510223|FG004|Overall Study|Reason not provided|2|||
145724729|NCT02647320|525510219|FG000|Overall Study|Lost to Follow-up|1|||
145724730|NCT02647320|525510220|FG001|Overall Study|Lost to Follow-up|1|||
145724731|NCT02647320|525510221|FG002|Overall Study|Lost to Follow-up|0|||
145724732|NCT02647320|525510222|FG003|Overall Study|Lost to Follow-up|0|||
145724733|NCT02647320|525510223|FG004|Overall Study|Lost to Follow-up|0|||
145724734|NCT02647320|525510219|FG000|Overall Study|Develop anemia|1|||
145724735|NCT02647320|525510220|FG001|Overall Study|Develop anemia|0|||
145724736|NCT02647320|525510221|FG002|Overall Study|Develop anemia|0|||
145724737|NCT02647320|525510222|FG003|Overall Study|Develop anemia|0|||
145383791|NCT01214668|524260152|FG004|Overall Study|Withdrawal by Subject|1|||
145724738|NCT02647320|525510223|FG004|Overall Study|Develop anemia|0|||
145724739|NCT02647320|525510219|FG000|Overall Study|Lack of Efficacy|0|||
145724740|NCT02647320|525510220|FG001|Overall Study|Lack of Efficacy|0|||
145724741|NCT02647320|525510221|FG002|Overall Study|Lack of Efficacy|0|||
145724742|NCT02647320|525510222|FG003|Overall Study|Lack of Efficacy|1|||
145724743|NCT02647320|525510223|FG004|Overall Study|Lack of Efficacy|0|||
145724744|NCT02647320|525510219|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
145724745|NCT02647320|525510220|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
145724746|NCT02647320|525510221|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
145724747|NCT02647320|525510222|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
145724748|NCT02647320|525510223|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
145724749|NCT00596427|525510224|FG000|Overall Study|Withdrawal by Subject|2|||
145724750|NCT00596427|525510225|FG001|Overall Study|Withdrawal by Subject|2|||
145724751|NCT00596427|525510224|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
145724752|NCT00596427|525510225|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
145724753|NCT00596427|525510224|FG000|Overall Study|Protocol Violation|1|||
145724754|NCT00596427|525510225|FG001|Overall Study|Protocol Violation|0|||
145724755|NCT03435497|525510230|FG000|Overall Study|Lost to Follow-up|1|||
145724756|NCT03435497|525510231|FG001|Overall Study|Lost to Follow-up|0|||
145724757|NCT03435497|525510230|FG000|Overall Study|Death|1|||
145724758|NCT03435497|525510231|FG001|Overall Study|Death|0|||
145724759|NCT03435497|525510230|FG000|Overall Study|Withdrawal by Subject|0|||
145724760|NCT03435497|525510231|FG001|Overall Study|Withdrawal by Subject|4|||
145724761|NCT03435497|525510230|FG000|Overall Study|Wrong survey administered|0|||
145724762|NCT03435497|525510231|FG001|Overall Study|Wrong survey administered|2|||
145724763|NCT00701779|525510232|FG000|Overall Study|Adverse Event|6|||
145724764|NCT00701779|525510232|FG000|Overall Study|Lost to Follow-up|1|||
145724765|NCT00701779|525510232|FG000|Overall Study|Withdrawal by Subject|2|||
145724766|NCT03442985|525510233|FG000|Overall Study|Sponsor Request|55|||
145724767|NCT03442985|525510234|FG001|Overall Study|Sponsor Request|60|||
145724768|NCT03442985|525510235|FG002|Overall Study|Sponsor Request|54|||
145724769|NCT03442985|525510233|FG000|Overall Study|Lost to Follow-up|5|||
145724770|NCT03442985|525510234|FG001|Overall Study|Lost to Follow-up|2|||
145724771|NCT03442985|525510235|FG002|Overall Study|Lost to Follow-up|7|||
145724772|NCT03442985|525510233|FG000|Overall Study|Withdrawal by Subject|2|||
145724773|NCT03442985|525510234|FG001|Overall Study|Withdrawal by Subject|3|||
145724774|NCT03442985|525510235|FG002|Overall Study|Withdrawal by Subject|4|||
145724775|NCT03442985|525510233|FG000|Overall Study|Adverse Event|0|||
145724776|NCT03442985|525510234|FG001|Overall Study|Adverse Event|1|||
145724777|NCT03442985|525510235|FG002|Overall Study|Adverse Event|0|||
145724778|NCT01620255|525510236|FG000|Overall Study|Withdrawal by Subject|4|||
145724779|NCT01620255|525510237|FG001|Overall Study|Withdrawal by Subject|1|||
145724780|NCT01620255|525510238|FG002|Overall Study|Withdrawal by Subject|1|||
145724781|NCT01620255|525510239|FG003|Overall Study|Withdrawal by Subject|2|||
145724782|NCT01620255|525510240|FG004|Overall Study|Withdrawal by Subject|4|||
145724783|NCT01620255|525510236|FG000|Overall Study|Participant underwent fecal transplant|0|||
145724784|NCT01620255|525510237|FG001|Overall Study|Participant underwent fecal transplant|0|||
145724785|NCT01620255|525510238|FG002|Overall Study|Participant underwent fecal transplant|1|||
145724786|NCT01620255|525510239|FG003|Overall Study|Participant underwent fecal transplant|0|||
145724787|NCT01620255|525510240|FG004|Overall Study|Participant underwent fecal transplant|0|||
145724788|NCT01620255|525510236|FG000|Overall Study|Non-compliance|0|||
145724789|NCT01620255|525510237|FG001|Overall Study|Non-compliance|1|||
145724790|NCT01620255|525510238|FG002|Overall Study|Non-compliance|0|||
145724791|NCT01620255|525510239|FG003|Overall Study|Non-compliance|0|||
145724792|NCT01620255|525510240|FG004|Overall Study|Non-compliance|0|||
145724793|NCT01620255|525510236|FG000|Overall Study|Adverse Event|0|||
145724794|NCT01620255|525510237|FG001|Overall Study|Adverse Event|4|||
145724795|NCT01620255|525510238|FG002|Overall Study|Adverse Event|0|||
145724796|NCT01620255|525510239|FG003|Overall Study|Adverse Event|1|||
145724797|NCT01620255|525510240|FG004|Overall Study|Adverse Event|1|||
145724798|NCT01620255|525510236|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
145724799|NCT01620255|525510237|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
145724800|NCT01620255|525510238|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
145724801|NCT01620255|525510239|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
145724802|NCT01620255|525510240|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
145724803|NCT01557283|525510244|FG000|Overall Study|Lost to Follow-up|7|||
145724804|NCT01557283|525510244|FG000|Overall Study|Non-responder|19|||
145724805|NCT01557283|525510244|FG000|Overall Study|Adverse Event|7|||
145724806|NCT01557283|525510244|FG000|Overall Study|Lack of Efficacy|1|||
145724807|NCT01557283|525510244|FG000|Overall Study|Non-compliance|1|||
145724808|NCT01557283|525510244|FG000|Overall Study|Withdrawal by Subject|1|||
145724809|NCT01557283|525510244|FG000|Overall Study|Participant's weight too high for dose|1|||
145724810|NCT01557283|525510244|FG000|Overall Study|Worsening of psoriasis|1|||
145724811|NCT01557283|525510244|FG000|Overall Study|Other|6|||
145724812|NCT01873495|525510247|FG000|Overall Study|Withdrawal by Subject|1|||
145724813|NCT01873495|525510247|FG000|Overall Study|Physician Decision|3|||
145724814|NCT01873495|525510247|FG000|Overall Study|Adverse Event|1|||
145724815|NCT01873495|525510247|FG000|Overall Study|Removed for Transplantation|1|||
145724816|NCT01873495|525510247|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
145724817|NCT00879762|525510248|FG000|Overall Study|Lost to Follow-up|3|||
145724818|NCT00879762|525510249|FG001|Overall Study|Lost to Follow-up|1|||
145724819|NCT04981366|525510250|FG000|Overall Study|Withdrawal by Subject|5|||
145724820|NCT04981366|525510251|FG001|Overall Study|Withdrawal by Subject|4|||
145724821|NCT04981366|525510252|FG002|Overall Study|Withdrawal by Subject|8|||
145724822|NCT04981366|525510250|FG000|Overall Study|Health issues unrelated to the trial|1|||
145724823|NCT04981366|525510251|FG001|Overall Study|Health issues unrelated to the trial|2|||
145724824|NCT04981366|525510252|FG002|Overall Study|Health issues unrelated to the trial|0|||
145724825|NCT00881608|525510253|FG000|Overall Study|Study prematurely terminated|11|||
145724826|NCT03214094|525510254|FG000|Overall Study|Case Report Forms Uncollected|14|||
145724827|NCT03214094|525510254|FG000|Overall Study|Protocol Deviation|46|||
145494694|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
145494695|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
145494696|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
145494697|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
145494698|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
145494699|NCT02118584|524670116|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
145494700|NCT02118584|524670117|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
145494701|NCT02118584|524670118|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
145494702|NCT02766023|524670119|FG000|Overall Study|Lost to Follow-up|23|||
145494703|NCT02766023|524670120|FG001|Overall Study|Lost to Follow-up|11|||
145494704|NCT02766023|524670119|FG000|Overall Study|Pregnancy|1|||
145494705|NCT02766023|524670120|FG001|Overall Study|Pregnancy|0|||
145494706|NCT02766023|524670119|FG000|Overall Study|Adverse Event|1|||
145494707|NCT02766023|524670120|FG001|Overall Study|Adverse Event|0|||
145494708|NCT02766023|524670119|FG000|Overall Study|Withdrawal by Subject|4|||
145494709|NCT02766023|524670120|FG001|Overall Study|Withdrawal by Subject|5|||
145494710|NCT02766023|524670119|FG000|Overall Study|Physician Decision|1|||
145494711|NCT02766023|524670120|FG001|Overall Study|Physician Decision|0|||
145494712|NCT02766023|524670119|FG000|Overall Study|Not Eligible at Enrollment|0|||
145494713|NCT02766023|524670120|FG001|Overall Study|Not Eligible at Enrollment|1|||
145494714|NCT02587221|524670130|FG000|Overall Study|Adverse Event|3|||
145494715|NCT02587221|524670131|FG001|Overall Study|Adverse Event|3|||
145494716|NCT02587221|524670130|FG000|Overall Study|Death|33|||
145494717|NCT02587221|524670131|FG001|Overall Study|Death|34|||
145494718|NCT02587221|524670130|FG000|Overall Study|Withdrawal by Subject|66|||
145494719|NCT02587221|524670131|FG001|Overall Study|Withdrawal by Subject|61|||
145494720|NCT02587221|524670130|FG000|Overall Study|Lost to Follow-up|21|||
145494721|NCT02587221|524670131|FG001|Overall Study|Lost to Follow-up|19|||
145494722|NCT02587221|524670130|FG000|Overall Study|Protocol Violation|6|||
145494723|NCT02587221|524670131|FG001|Overall Study|Protocol Violation|5|||
145494724|NCT02587221|524670130|FG000|Overall Study|Other Reason or Unspecified|2|||
145494725|NCT02587221|524670131|FG001|Overall Study|Other Reason or Unspecified|1|||
145494726|NCT02476617|524670136|FG000|Overall Study|Adverse Event|1|||
145494727|NCT02476617|524670136|FG000|Overall Study|Lost to Follow-up|1|||
145494728|NCT02491684|524670138|FG000|Treatment Phase|Adverse Event|2|||
145494729|NCT02491684|524670139|FG001|Treatment Phase|Adverse Event|2|||
145494730|NCT02491684|524670138|FG000|Treatment Phase|Incorrect randomisation|1|||
145494731|NCT02491684|524670139|FG001|Treatment Phase|Incorrect randomisation|0|||
145494732|NCT02491684|524670138|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
145494733|NCT02491684|524670139|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
145494734|NCT04914364|524670141|FG000|Overall Study|No longer eligible for study|1|||
145494735|NCT04914364|524670141|FG000|Overall Study|Lost to Follow-up|2|||
145494736|NCT01346358|524670146|FG000|Overall Study|Withdrawal by Subject|1|||
145494737|NCT01346358|524670147|FG001|Overall Study|Withdrawal by Subject|0|||
145494738|NCT01346358|524670148|FG002|Overall Study|Withdrawal by Subject|1|||
145494739|NCT01346358|524670149|FG003|Overall Study|Withdrawal by Subject|1|||
145494740|NCT01346358|524670150|FG004|Overall Study|Withdrawal by Subject|0|||
145494741|NCT01346358|524670151|FG005|Overall Study|Withdrawal by Subject|2|||
145494742|NCT01346358|524670152|FG006|Overall Study|Withdrawal by Subject|1|||
145494743|NCT01346358|524670153|FG007|Overall Study|Withdrawal by Subject|1|||
145494744|NCT01346358|524670154|FG008|Overall Study|Withdrawal by Subject|1|||
145494745|NCT01346358|524670146|FG000|Overall Study|Adverse Event|1|||
145494746|NCT01346358|524670147|FG001|Overall Study|Adverse Event|0|||
145494747|NCT01346358|524670148|FG002|Overall Study|Adverse Event|0|||
145494748|NCT01346358|524670149|FG003|Overall Study|Adverse Event|0|||
145494749|NCT01346358|524670150|FG004|Overall Study|Adverse Event|1|||
145494750|NCT01346358|524670151|FG005|Overall Study|Adverse Event|0|||
145494751|NCT01346358|524670152|FG006|Overall Study|Adverse Event|0|||
145494752|NCT01346358|524670153|FG007|Overall Study|Adverse Event|0|||
145494753|NCT01346358|524670154|FG008|Overall Study|Adverse Event|1|||
145494754|NCT01346358|524670146|FG000|Overall Study|Non-Compliance|0|||
145494755|NCT01346358|524670147|FG001|Overall Study|Non-Compliance|0|||
145494756|NCT01346358|524670148|FG002|Overall Study|Non-Compliance|0|||
145494757|NCT01346358|524670149|FG003|Overall Study|Non-Compliance|0|||
145494758|NCT01346358|524670150|FG004|Overall Study|Non-Compliance|0|||
145494759|NCT01346358|524670151|FG005|Overall Study|Non-Compliance|0|||
145494760|NCT01346358|524670152|FG006|Overall Study|Non-Compliance|0|||
145494761|NCT01346358|524670153|FG007|Overall Study|Non-Compliance|2|||
145494762|NCT01346358|524670154|FG008|Overall Study|Non-Compliance|0|||
145494763|NCT01346358|524670146|FG000|Overall Study|Physician Decision|0|||
145494764|NCT01346358|524670147|FG001|Overall Study|Physician Decision|1|||
145494765|NCT01346358|524670148|FG002|Overall Study|Physician Decision|0|||
145494766|NCT01346358|524670149|FG003|Overall Study|Physician Decision|0|||
145494767|NCT01346358|524670150|FG004|Overall Study|Physician Decision|0|||
145494768|NCT01346358|524670151|FG005|Overall Study|Physician Decision|0|||
145494769|NCT01346358|524670152|FG006|Overall Study|Physician Decision|0|||
145494770|NCT01346358|524670153|FG007|Overall Study|Physician Decision|1|||
145724828|NCT01313637|525510257|FG000|Overall Study|Adverse Event|17|||
145724829|NCT01313637|525510258|FG001|Overall Study|Adverse Event|24|||
145724830|NCT01313637|525510259|FG002|Overall Study|Adverse Event|25|||
145724831|NCT01313637|525510260|FG003|Overall Study|Adverse Event|18|||
145724832|NCT01313637|525510257|FG000|Overall Study|Lack of Efficacy|44|||
145724833|NCT01313637|525510258|FG001|Overall Study|Lack of Efficacy|38|||
145724834|NCT01313637|525510259|FG002|Overall Study|Lack of Efficacy|37|||
145724835|NCT01313637|525510260|FG003|Overall Study|Lack of Efficacy|24|||
145724836|NCT01313637|525510257|FG000|Overall Study|Protocol Violation|4|||
145724837|NCT01313637|525510258|FG001|Overall Study|Protocol Violation|3|||
145724838|NCT01313637|525510259|FG002|Overall Study|Protocol Violation|11|||
145724839|NCT01313637|525510260|FG003|Overall Study|Protocol Violation|5|||
145724840|NCT01313637|525510257|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
145724841|NCT01313637|525510258|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
145724842|NCT01313637|525510259|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
145724843|NCT01313637|525510260|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
145724844|NCT01313637|525510257|FG000|Overall Study|Lost to Follow-up|0|||
145724845|NCT01313637|525510258|FG001|Overall Study|Lost to Follow-up|2|||
145724846|NCT01313637|525510259|FG002|Overall Study|Lost to Follow-up|1|||
145724847|NCT01313637|525510260|FG003|Overall Study|Lost to Follow-up|3|||
145724848|NCT01313637|525510257|FG000|Overall Study|Withdrawal by Subject|11|||
145724849|NCT01313637|525510258|FG001|Overall Study|Withdrawal by Subject|13|||
145724850|NCT01313637|525510259|FG002|Overall Study|Withdrawal by Subject|18|||
145724851|NCT01313637|525510260|FG003|Overall Study|Withdrawal by Subject|15|||
145724852|NCT00795951|525510261|FG000|Overall Study|Lost to Follow-up|1|||
145724853|NCT00795951|525510261|FG000|Overall Study|Withdrawal by Subject|1|||
145724854|NCT00655486|525510267|FG000|Overall Study|Adverse Event|10|||
145724855|NCT00655486|525510267|FG000|Overall Study|Lack of Efficacy|8|||
145724856|NCT00655486|525510267|FG000|Overall Study|Withdrawal by Subject|4|||
145724857|NCT00655486|525510267|FG000|Overall Study|Protocol Violation|1|||
145724858|NCT00655486|525510267|FG000|Overall Study|Unsatisfactory compliance|2|||
145724859|NCT00655486|525510267|FG000|Overall Study|Other: Pregnancy|1|||
145724860|NCT00655486|525510267|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
145724861|NCT00655486|525510267|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
145724862|NCT04218084|525510268|FG000|Overall Study|Adverse Event|7|||
145724863|NCT04218084|525510269|FG001|Overall Study|Adverse Event|2|||
145724864|NCT04218084|525510268|FG000|Overall Study|Withdrawal of Consent|4|||
145724865|NCT04218084|525510269|FG001|Overall Study|Withdrawal of Consent|5|||
145724866|NCT04218084|525510268|FG000|Overall Study|Physician Decision|1|||
145724867|NCT04218084|525510269|FG001|Overall Study|Physician Decision|1|||
145724868|NCT04218084|525510268|FG000|Overall Study|Lost to Follow-up|1|||
145724869|NCT04218084|525510269|FG001|Overall Study|Lost to Follow-up|1|||
145724870|NCT04218084|525510268|FG000|Overall Study|Non-compliance with study drug|1|||
145724871|NCT04218084|525510269|FG001|Overall Study|Non-compliance with study drug|1|||
145724872|NCT04218084|525510268|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
145724873|NCT04218084|525510269|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
145724874|NCT04218084|525510268|FG000|Overall Study|Other|0|||
145724875|NCT04218084|525510269|FG001|Overall Study|Other|1|||
145724876|NCT04218084|525510268|FG000|Overall Study|Ongoing at data cut-off date|62|||
145724877|NCT04218084|525510269|FG001|Overall Study|Ongoing at data cut-off date|58|||
145724878|NCT00986674|525510270|FG000|Overall Study|Lack of Efficacy|28|||
145724879|NCT00986674|525510271|FG001|Overall Study|Lack of Efficacy|25|||
145724880|NCT00986674|525510272|FG002|Overall Study|Lack of Efficacy|23|||
145724881|NCT00986674|525510270|FG000|Overall Study|Adverse Event|4|||
145724882|NCT00986674|525510271|FG001|Overall Study|Adverse Event|8|||
145724883|NCT00986674|525510272|FG002|Overall Study|Adverse Event|9|||
145724884|NCT00986674|525510270|FG000|Overall Study|Death|5|||
145724885|NCT00986674|525510271|FG001|Overall Study|Death|0|||
145724886|NCT00986674|525510272|FG002|Overall Study|Death|4|||
145724887|NCT00986674|525510270|FG000|Overall Study|Withdrawal by Subject|6|||
145724888|NCT00986674|525510271|FG001|Overall Study|Withdrawal by Subject|2|||
145724889|NCT00986674|525510272|FG002|Overall Study|Withdrawal by Subject|1|||
145724890|NCT00986674|525510270|FG000|Overall Study|alternative therapy|0|||
145724891|NCT00986674|525510271|FG001|Overall Study|alternative therapy|0|||
145724892|NCT00986674|525510272|FG002|Overall Study|alternative therapy|1|||
145724893|NCT00986674|525510270|FG000|Overall Study|not start protocol therapy|4|||
145724894|NCT00986674|525510271|FG001|Overall Study|not start protocol therapy|3|||
145724895|NCT00986674|525510272|FG002|Overall Study|not start protocol therapy|1|||
145724896|NCT00986674|525510270|FG000|Overall Study|unknown/not specify|0|||
145724897|NCT00986674|525510271|FG001|Overall Study|unknown/not specify|7|||
145724898|NCT00986674|525510272|FG002|Overall Study|unknown/not specify|9|||
145724899|NCT02435966|525510275|FG000|Overall Study|Withdrawal by Subject|0|||
145724900|NCT02435966|525510276|FG001|Overall Study|Withdrawal by Subject|1|||
145724901|NCT02435966|525510277|FG002|Overall Study|Withdrawal by Subject|0|||
145266633|NCT04668066|523825243|FG006|Part 1: Treatment Phase|Other|0|||
145724902|NCT02745392|525510281|FG000|Overall Study|Lost to Follow-up|0|||
145724903|NCT02745392|525510282|FG001|Overall Study|Lost to Follow-up|1|||
145724904|NCT02745392|525510283|FG002|Overall Study|Lost to Follow-up|0|||
145724905|NCT02745392|525510284|FG003|Overall Study|Lost to Follow-up|0|||
145724906|NCT01959334|525510285|FG000|Second Dose|Adverse Event|1|||
145724907|NCT01959334|525510286|FG001|Second Dose|Adverse Event|0|||
145724908|NCT01959334|525510285|FG000|Third Dose|Adverse Event|0|||
145724909|NCT01959334|525510286|FG001|Third Dose|Adverse Event|1|||
145724910|NCT01007448|525510288|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
145724911|NCT01007448|525510289|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
145724912|NCT01007448|525510288|FG000|Overall Study|Staph Skin Infection Flare|1|||
145724913|NCT01007448|525510289|FG001|Overall Study|Staph Skin Infection Flare|0|||
145724914|NCT01007448|525510288|FG000|Overall Study|Participant Leaving the Country|1|||
145724915|NCT01007448|525510289|FG001|Overall Study|Participant Leaving the Country|0|||
145724916|NCT01007448|525510288|FG000|Overall Study|Participant Given Prohibited Medication|1|||
145724917|NCT01007448|525510289|FG001|Overall Study|Participant Given Prohibited Medication|0|||
145724918|NCT01007448|525510288|FG000|Overall Study|Progressive Disease|1|||
145724919|NCT01007448|525510289|FG001|Overall Study|Progressive Disease|2|||
145724920|NCT01007448|525510288|FG000|Overall Study|Lack of Efficacy|2|||
145724921|NCT01007448|525510289|FG001|Overall Study|Lack of Efficacy|0|||
145724922|NCT01007448|525510288|FG000|Overall Study|Withdrawal by Subject|2|||
145724923|NCT01007448|525510289|FG001|Overall Study|Withdrawal by Subject|3|||
145724924|NCT01007448|525510288|FG000|Overall Study|Adverse Event|1|||
145724925|NCT01007448|525510289|FG001|Overall Study|Adverse Event|4|||
145724926|NCT00887432|525510290|FG000|Overall Study|Start Excluded Therapy|3|||
145724927|NCT00887432|525510291|FG001|Overall Study|Start Excluded Therapy|0|||
145724928|NCT00887432|525510290|FG000|Overall Study|Did not complete treatment|6|||
145724929|NCT00887432|525510291|FG001|Overall Study|Did not complete treatment|8|||
145724930|NCT00887432|525510290|FG000|Overall Study|Protocol Violation|2|||
145724931|NCT00887432|525510291|FG001|Overall Study|Protocol Violation|3|||
145724932|NCT00887432|525510290|FG000|Overall Study|Withdrawal by Subject|3|||
145724933|NCT00887432|525510291|FG001|Overall Study|Withdrawal by Subject|2|||
145724934|NCT00887432|525510290|FG000|Overall Study|Lost to Follow-up|1|||
145724935|NCT00887432|525510291|FG001|Overall Study|Lost to Follow-up|0|||
145724936|NCT00887432|525510290|FG000|Overall Study|No reason provided|0|||
145724937|NCT00887432|525510291|FG001|Overall Study|No reason provided|1|||
145724938|NCT00899548|525510292|FG000|Overall Study|Physician Decision|3|||
145724939|NCT01337115|525510293|FG000|Overall Study|Protocol Violation|2|||
145724940|NCT01337115|525510294|FG001|Overall Study|Protocol Violation|0|||
145724941|NCT01636960|525510295|FG000|Induction Phase|Adverse Event|2|||
145724942|NCT01636960|525510295|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
145724943|NCT01636960|525510295|FG000|Maintenance Phase|Adverse Event|3|||
145724944|NCT01636960|525510295|FG000|Maintenance Phase|Progressive disease|1|||
145724945|NCT01209780|525510296|FG000|Overall Study|Adverse Event|0|||
145724946|NCT01209780|525510297|FG001|Overall Study|Adverse Event|1|||
145724947|NCT01209780|525510298|FG002|Overall Study|Adverse Event|0|||
145724948|NCT01209780|525510299|FG003|Overall Study|Adverse Event|0|||
145724949|NCT01209780|525510300|FG004|Overall Study|Adverse Event|0|||
145724950|NCT01209780|525510296|FG000|Overall Study|Withdrawal by Subject|9|||
145724951|NCT01209780|525510297|FG001|Overall Study|Withdrawal by Subject|2|||
145724952|NCT01209780|525510298|FG002|Overall Study|Withdrawal by Subject|1|||
145724953|NCT01209780|525510299|FG003|Overall Study|Withdrawal by Subject|1|||
145724954|NCT01209780|525510300|FG004|Overall Study|Withdrawal by Subject|0|||
145724955|NCT01209780|525510296|FG000|Overall Study|Lost to Follow-up|17|||
145724956|NCT01209780|525510297|FG001|Overall Study|Lost to Follow-up|12|||
145724957|NCT01209780|525510298|FG002|Overall Study|Lost to Follow-up|3|||
145724958|NCT01209780|525510299|FG003|Overall Study|Lost to Follow-up|9|||
145724959|NCT01209780|525510300|FG004|Overall Study|Lost to Follow-up|4|||
145724960|NCT01209780|525510296|FG000|Overall Study|Protocol Violation|0|||
145724961|NCT01209780|525510297|FG001|Overall Study|Protocol Violation|1|||
145724962|NCT01209780|525510298|FG002|Overall Study|Protocol Violation|0|||
145494771|NCT01346358|524670154|FG008|Overall Study|Physician Decision|1|||
145724963|NCT01209780|525510299|FG003|Overall Study|Protocol Violation|0|||
145724964|NCT01209780|525510300|FG004|Overall Study|Protocol Violation|0|||
145724965|NCT01209780|525510296|FG000|Overall Study|Inappropriate enrollment|0|||
145724966|NCT01209780|525510297|FG001|Overall Study|Inappropriate enrollment|2|||
145724967|NCT01209780|525510298|FG002|Overall Study|Inappropriate enrollment|0|||
145724968|NCT01209780|525510299|FG003|Overall Study|Inappropriate enrollment|0|||
145724969|NCT01209780|525510300|FG004|Overall Study|Inappropriate enrollment|1|||
145724970|NCT01580969|525510301|FG000|Overall Study|Physician Decision|3|||
145724971|NCT01580969|525510302|FG001|Overall Study|Physician Decision|0|||
145724972|NCT01580969|525510303|FG002|Overall Study|Physician Decision|0|||
145724973|NCT01745848|525510304|FG000|Overall Study|Adverse Event|6|||
145724974|NCT01886378|525510307|FG000|Overall Study|Adverse Event|1|||
145724975|NCT01886378|525510307|FG000|Overall Study|Withdrawal by Subject|4|||
145724976|NCT02318797|525510308|FG000|Overall Study|Death|3|||
145724977|NCT02318797|525510309|FG001|Overall Study|Death|6|||
145724978|NCT02318797|525510308|FG000|Overall Study|Lost to Follow-up|85|||
145724979|NCT02318797|525510309|FG001|Overall Study|Lost to Follow-up|96|||
145724980|NCT01079741|525510316|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
145724981|NCT01079741|525510317|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
145724982|NCT01079741|525510318|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
145724983|NCT01079741|525510319|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
145724984|NCT01079741|525510320|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
145724985|NCT01079741|525510316|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
145724986|NCT01079741|525510317|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
145724987|NCT01079741|525510318|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
145724988|NCT01079741|525510319|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
145724989|NCT01079741|525510320|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
145724990|NCT02709096|525510321|FG000|Overall Study|non-compliance|1|||
145724991|NCT02709096|525510322|FG001|Overall Study|non-compliance|1|||
145724992|NCT00406653|525510323|FG000|Induction Period|Adverse Event|1|||
145724993|NCT00406653|525510324|FG001|Induction Period|Adverse Event|10|||
145724994|NCT00406653|525510325|FG002|Induction Period|Adverse Event|4|||
145724995|NCT00406653|525510326|FG003|Induction Period|Adverse Event|11|||
145724996|NCT00406653|525510327|FG004|Induction Period|Adverse Event|0|||
145724997|NCT00406653|525510328|FG005|Induction Period|Adverse Event|0|||
145724998|NCT00406653|525510329|FG006|Induction Period|Adverse Event|0|||
145724999|NCT00406653|525510323|FG000|Induction Period|Lack of Efficacy|11|||
145725000|NCT00406653|525510324|FG001|Induction Period|Lack of Efficacy|14|||
145725001|NCT00406653|525510325|FG002|Induction Period|Lack of Efficacy|8|||
145725002|NCT00406653|525510326|FG003|Induction Period|Lack of Efficacy|10|||
145725003|NCT00406653|525510327|FG004|Induction Period|Lack of Efficacy|0|||
145725004|NCT00406653|525510328|FG005|Induction Period|Lack of Efficacy|0|||
145725005|NCT00406653|525510329|FG006|Induction Period|Lack of Efficacy|0|||
145725006|NCT00406653|525510323|FG000|Induction Period|Lost to Follow-up|0|||
145725007|NCT00406653|525510324|FG001|Induction Period|Lost to Follow-up|2|||
145725008|NCT00406653|525510325|FG002|Induction Period|Lost to Follow-up|0|||
145725009|NCT00406653|525510326|FG003|Induction Period|Lost to Follow-up|0|||
145725010|NCT00406653|525510327|FG004|Induction Period|Lost to Follow-up|0|||
145725011|NCT00406653|525510328|FG005|Induction Period|Lost to Follow-up|0|||
145725012|NCT00406653|525510329|FG006|Induction Period|Lost to Follow-up|0|||
145725013|NCT00406653|525510323|FG000|Induction Period|Withdrawal of Consent|2|||
145725014|NCT00406653|525510324|FG001|Induction Period|Withdrawal of Consent|5|||
145725015|NCT00406653|525510325|FG002|Induction Period|Withdrawal of Consent|1|||
145725016|NCT00406653|525510326|FG003|Induction Period|Withdrawal of Consent|2|||
145725017|NCT00406653|525510327|FG004|Induction Period|Withdrawal of Consent|0|||
145725018|NCT00406653|525510328|FG005|Induction Period|Withdrawal of Consent|0|||
145725019|NCT00406653|525510329|FG006|Induction Period|Withdrawal of Consent|0|||
145725020|NCT00406653|525510323|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725021|NCT00406653|525510324|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725022|NCT00406653|525510325|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725023|NCT00406653|525510326|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
145725024|NCT00406653|525510327|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725025|NCT00406653|525510328|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725026|NCT00406653|525510329|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
145725027|NCT00406653|525510323|FG000|Induction Period|Pregnancy|1|||
145725028|NCT00406653|525510324|FG001|Induction Period|Pregnancy|0|||
145725029|NCT00406653|525510325|FG002|Induction Period|Pregnancy|0|||
145725030|NCT00406653|525510326|FG003|Induction Period|Pregnancy|0|||
145725031|NCT00406653|525510327|FG004|Induction Period|Pregnancy|0|||
145725032|NCT00406653|525510328|FG005|Induction Period|Pregnancy|0|||
145725033|NCT00406653|525510329|FG006|Induction Period|Pregnancy|0|||
145725034|NCT00406653|525510323|FG000|Induction Period|Declined participation but followup done|0|||
145725035|NCT00406653|525510324|FG001|Induction Period|Declined participation but followup done|2|||
145725036|NCT00406653|525510325|FG002|Induction Period|Declined participation but followup done|1|||
145725037|NCT00406653|525510326|FG003|Induction Period|Declined participation but followup done|1|||
145725038|NCT00406653|525510327|FG004|Induction Period|Declined participation but followup done|0|||
145725039|NCT00406653|525510328|FG005|Induction Period|Declined participation but followup done|0|||
145725040|NCT00406653|525510329|FG006|Induction Period|Declined participation but followup done|0|||
145725041|NCT00406653|525510323|FG000|Induction Period|Given prohibited drug|0|||
145725042|NCT00406653|525510324|FG001|Induction Period|Given prohibited drug|1|||
145725043|NCT00406653|525510325|FG002|Induction Period|Given prohibited drug|2|||
145725044|NCT00406653|525510326|FG003|Induction Period|Given prohibited drug|0|||
145725045|NCT00406653|525510327|FG004|Induction Period|Given prohibited drug|0|||
145725046|NCT00406653|525510328|FG005|Induction Period|Given prohibited drug|0|||
145725047|NCT00406653|525510329|FG006|Induction Period|Given prohibited drug|0|||
145725048|NCT00406653|525510323|FG000|Induction Period|Incarcerated|0|||
145725049|NCT00406653|525510324|FG001|Induction Period|Incarcerated|0|||
145725050|NCT00406653|525510325|FG002|Induction Period|Incarcerated|1|||
145725051|NCT00406653|525510326|FG003|Induction Period|Incarcerated|0|||
145725052|NCT00406653|525510327|FG004|Induction Period|Incarcerated|0|||
145725053|NCT00406653|525510328|FG005|Induction Period|Incarcerated|0|||
145725054|NCT00406653|525510329|FG006|Induction Period|Incarcerated|0|||
145725055|NCT00406653|525510323|FG000|Induction Period|Patient relocated|0|||
145725056|NCT00406653|525510324|FG001|Induction Period|Patient relocated|0|||
145725057|NCT00406653|525510325|FG002|Induction Period|Patient relocated|1|||
145725058|NCT00406653|525510326|FG003|Induction Period|Patient relocated|0|||
145725059|NCT00406653|525510327|FG004|Induction Period|Patient relocated|0|||
145725060|NCT00406653|525510328|FG005|Induction Period|Patient relocated|0|||
145725061|NCT00406653|525510329|FG006|Induction Period|Patient relocated|0|||
145725062|NCT00406653|525510323|FG000|Maintenance Period|Adverse Event|0|||
145725063|NCT00406653|525510324|FG001|Maintenance Period|Adverse Event|0|||
145725064|NCT00406653|525510325|FG002|Maintenance Period|Adverse Event|0|||
145725065|NCT00406653|525510326|FG003|Maintenance Period|Adverse Event|0|||
145725066|NCT00406653|525510327|FG004|Maintenance Period|Adverse Event|1|||
145725067|NCT00406653|525510328|FG005|Maintenance Period|Adverse Event|1|||
145725068|NCT00406653|525510329|FG006|Maintenance Period|Adverse Event|0|||
145725069|NCT00406653|525510323|FG000|Maintenance Period|Lack of Efficacy|0|||
145725070|NCT00406653|525510324|FG001|Maintenance Period|Lack of Efficacy|0|||
145725071|NCT00406653|525510325|FG002|Maintenance Period|Lack of Efficacy|0|||
145725072|NCT00406653|525510326|FG003|Maintenance Period|Lack of Efficacy|0|||
145725073|NCT00406653|525510327|FG004|Maintenance Period|Lack of Efficacy|20|||
145725074|NCT00406653|525510328|FG005|Maintenance Period|Lack of Efficacy|26|||
145725075|NCT00406653|525510329|FG006|Maintenance Period|Lack of Efficacy|0|||
145725076|NCT00406653|525510323|FG000|Maintenance Period|Lost to Follow-up|0|||
145725077|NCT00406653|525510324|FG001|Maintenance Period|Lost to Follow-up|0|||
145725078|NCT00406653|525510325|FG002|Maintenance Period|Lost to Follow-up|0|||
145725079|NCT00406653|525510326|FG003|Maintenance Period|Lost to Follow-up|0|||
145725080|NCT00406653|525510327|FG004|Maintenance Period|Lost to Follow-up|2|||
145725081|NCT00406653|525510328|FG005|Maintenance Period|Lost to Follow-up|1|||
145725082|NCT00406653|525510329|FG006|Maintenance Period|Lost to Follow-up|0|||
145725083|NCT00406653|525510323|FG000|Maintenance Period|Withdrawal of Consent|0|||
145725084|NCT00406653|525510324|FG001|Maintenance Period|Withdrawal of Consent|0|||
145725085|NCT00406653|525510325|FG002|Maintenance Period|Withdrawal of Consent|0|||
145725086|NCT00406653|525510326|FG003|Maintenance Period|Withdrawal of Consent|0|||
145725087|NCT00406653|525510327|FG004|Maintenance Period|Withdrawal of Consent|2|||
145725088|NCT00406653|525510328|FG005|Maintenance Period|Withdrawal of Consent|0|||
145725089|NCT00406653|525510329|FG006|Maintenance Period|Withdrawal of Consent|0|||
145725090|NCT00406653|525510323|FG000|Maintenance Period|Pregnancy|0|||
145725091|NCT00406653|525510324|FG001|Maintenance Period|Pregnancy|0|||
145725092|NCT00406653|525510325|FG002|Maintenance Period|Pregnancy|0|||
145725093|NCT00406653|525510326|FG003|Maintenance Period|Pregnancy|0|||
145725094|NCT00406653|525510327|FG004|Maintenance Period|Pregnancy|0|||
145725095|NCT00406653|525510328|FG005|Maintenance Period|Pregnancy|1|||
145725096|NCT00406653|525510329|FG006|Maintenance Period|Pregnancy|0|||
145725097|NCT00406653|525510323|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
145725098|NCT00406653|525510324|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
145725099|NCT00406653|525510325|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
145725100|NCT00406653|525510326|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
145725101|NCT00406653|525510327|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
145725102|NCT00406653|525510328|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
145725103|NCT00406653|525510329|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
145725104|NCT00406653|525510323|FG000|Maintenance Period|Error in disease score evaluation|0|||
145725105|NCT00406653|525510324|FG001|Maintenance Period|Error in disease score evaluation|0|||
145725106|NCT00406653|525510325|FG002|Maintenance Period|Error in disease score evaluation|0|||
145725107|NCT00406653|525510326|FG003|Maintenance Period|Error in disease score evaluation|0|||
145725108|NCT00406653|525510327|FG004|Maintenance Period|Error in disease score evaluation|1|||
145725109|NCT00406653|525510328|FG005|Maintenance Period|Error in disease score evaluation|0|||
145725110|NCT00406653|525510329|FG006|Maintenance Period|Error in disease score evaluation|0|||
145725111|NCT00406653|525510323|FG000|Open-Label Period|Death|0|||
145725112|NCT00406653|525510324|FG001|Open-Label Period|Death|0|||
145725113|NCT00406653|525510325|FG002|Open-Label Period|Death|0|||
145725114|NCT00406653|525510326|FG003|Open-Label Period|Death|0|||
145725115|NCT00406653|525510327|FG004|Open-Label Period|Death|0|||
145725116|NCT00406653|525510328|FG005|Open-Label Period|Death|0|||
145725117|NCT00406653|525510329|FG006|Open-Label Period|Death|1|||
145725118|NCT00406653|525510323|FG000|Open-Label Period|Adverse Event|0|||
145725119|NCT00406653|525510324|FG001|Open-Label Period|Adverse Event|0|||
145725120|NCT00406653|525510325|FG002|Open-Label Period|Adverse Event|0|||
145725121|NCT00406653|525510326|FG003|Open-Label Period|Adverse Event|0|||
145725122|NCT00406653|525510327|FG004|Open-Label Period|Adverse Event|0|||
145725123|NCT00406653|525510328|FG005|Open-Label Period|Adverse Event|0|||
145725124|NCT00406653|525510329|FG006|Open-Label Period|Adverse Event|18|||
145725125|NCT00406653|525510323|FG000|Open-Label Period|Lack of Efficacy|0|||
145725126|NCT00406653|525510324|FG001|Open-Label Period|Lack of Efficacy|0|||
145725127|NCT00406653|525510325|FG002|Open-Label Period|Lack of Efficacy|0|||
145725128|NCT00406653|525510326|FG003|Open-Label Period|Lack of Efficacy|0|||
145725129|NCT00406653|525510327|FG004|Open-Label Period|Lack of Efficacy|0|||
145725130|NCT00406653|525510328|FG005|Open-Label Period|Lack of Efficacy|0|||
145725131|NCT00406653|525510329|FG006|Open-Label Period|Lack of Efficacy|160|||
145725132|NCT00406653|525510323|FG000|Open-Label Period|Lost to Follow-up|0|||
145725133|NCT00406653|525510324|FG001|Open-Label Period|Lost to Follow-up|0|||
145725134|NCT00406653|525510325|FG002|Open-Label Period|Lost to Follow-up|0|||
145725135|NCT00406653|525510326|FG003|Open-Label Period|Lost to Follow-up|0|||
145725136|NCT00406653|525510327|FG004|Open-Label Period|Lost to Follow-up|0|||
145725137|NCT00406653|525510328|FG005|Open-Label Period|Lost to Follow-up|0|||
145725138|NCT00406653|525510329|FG006|Open-Label Period|Lost to Follow-up|6|||
145725139|NCT00406653|525510323|FG000|Open-Label Period|Withdrawal of Consent|0|||
145725140|NCT00406653|525510324|FG001|Open-Label Period|Withdrawal of Consent|0|||
145725141|NCT00406653|525510325|FG002|Open-Label Period|Withdrawal of Consent|0|||
145725142|NCT00406653|525510326|FG003|Open-Label Period|Withdrawal of Consent|0|||
145725143|NCT00406653|525510327|FG004|Open-Label Period|Withdrawal of Consent|0|||
145725144|NCT00406653|525510328|FG005|Open-Label Period|Withdrawal of Consent|0|||
145725145|NCT00406653|525510329|FG006|Open-Label Period|Withdrawal of Consent|11|||
145725146|NCT00406653|525510323|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725147|NCT00406653|525510324|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725148|NCT00406653|525510325|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725149|NCT00406653|525510326|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725150|NCT00406653|525510327|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725151|NCT00406653|525510328|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
145725152|NCT00406653|525510329|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
145725153|NCT00406653|525510323|FG000|Open-Label Period|Pregnancy|0|||
145725154|NCT00406653|525510324|FG001|Open-Label Period|Pregnancy|0|||
145725155|NCT00406653|525510325|FG002|Open-Label Period|Pregnancy|0|||
145725156|NCT00406653|525510326|FG003|Open-Label Period|Pregnancy|0|||
145725157|NCT00406653|525510327|FG004|Open-Label Period|Pregnancy|0|||
145725158|NCT00406653|525510328|FG005|Open-Label Period|Pregnancy|0|||
145725159|NCT00406653|525510329|FG006|Open-Label Period|Pregnancy|2|||
145725160|NCT00406653|525510323|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
145725161|NCT00406653|525510324|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
145725162|NCT00406653|525510325|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
145725163|NCT00406653|525510326|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
145725164|NCT00406653|525510327|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
145725165|NCT00406653|525510328|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
145725166|NCT00406653|525510329|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
145494772|NCT05058365|524670157|FG000|Overall Study|Migration|1|||
145494773|NCT05058365|524670158|FG001|Overall Study|Migration|1|||
145494774|NCT00702702|524670161|FG000|Overall Study|Study prematurely terminated|56|||
145494775|NCT00771914|524670164|FG000|Overall Study|Physician Decision|0|||
145494776|NCT00771914|524670165|FG001|Overall Study|Physician Decision|0|||
145494777|NCT00771914|524670166|FG002|Overall Study|Physician Decision|0|||
145494778|NCT00771914|524670167|FG003|Overall Study|Physician Decision|1|||
145494779|NCT00771914|524670164|FG000|Overall Study|Lost to Follow-up|0|||
145494780|NCT00771914|524670165|FG001|Overall Study|Lost to Follow-up|0|||
145494781|NCT00771914|524670166|FG002|Overall Study|Lost to Follow-up|0|||
145494782|NCT00771914|524670167|FG003|Overall Study|Lost to Follow-up|1|||
145494783|NCT01667900|524670168|FG000|Part B|Death|0|||
145494784|NCT01667900|524670169|FG001|Part B|Death|0|||
145494785|NCT01667900|524670170|FG002|Part B|Death|0|||
145494786|NCT01667900|524670171|FG003|Part B|Death|0|||
145494787|NCT01667900|524670172|FG004|Part B|Death|0|||
145494788|NCT01667900|524670173|FG005|Part B|Death|0|||
145494789|NCT01667900|524670174|FG006|Part B|Death|0|||
145494790|NCT01667900|524670175|FG007|Part B|Death|0|||
145494791|NCT01667900|524670176|FG008|Part B|Death|0|||
145494792|NCT01667900|524670177|FG009|Part B|Death|0|||
145494793|NCT01667900|524670178|FG010|Part B|Death|0|||
145494794|NCT01667900|524670179|FG011|Part B|Death|0|||
145494795|NCT01667900|524670180|FG012|Part B|Death|0|||
145725167|NCT00406653|525510323|FG000|Open-Label Period|Declined participation but followup done|0|||
145725168|NCT00406653|525510324|FG001|Open-Label Period|Declined participation but followup done|0|||
145494796|NCT01667900|524670181|FG013|Part B|Death|0|||
145494797|NCT01667900|524670182|FG014|Part B|Death|0|||
145494798|NCT01667900|524670183|FG015|Part B|Death|0|||
145494799|NCT01667900|524670184|FG016|Part B|Death|1|||
145494800|NCT01667900|524670185|FG017|Part B|Death|0|||
145494801|NCT01667900|524670186|FG018|Part B|Death|0|||
145494802|NCT01667900|524670187|FG019|Part B|Death|0|||
145494803|NCT01283139|524670190|FG000|Overall Study|Lost to Follow-up|5|||
145494804|NCT01283139|524670191|FG001|Overall Study|Lost to Follow-up|2|||
145494805|NCT01283139|524670192|FG002|Overall Study|Lost to Follow-up|3|||
145494806|NCT01283139|524670193|FG003|Overall Study|Lost to Follow-up|1|||
145494807|NCT01283139|524670190|FG000|Overall Study|Withdrawal by Subject|8|||
145494808|NCT01283139|524670191|FG001|Overall Study|Withdrawal by Subject|8|||
145494809|NCT01283139|524670192|FG002|Overall Study|Withdrawal by Subject|6|||
145494810|NCT01283139|524670193|FG003|Overall Study|Withdrawal by Subject|8|||
145494811|NCT01283139|524670190|FG000|Overall Study|Death|2|||
145494812|NCT01283139|524670191|FG001|Overall Study|Death|0|||
145494813|NCT01283139|524670192|FG002|Overall Study|Death|2|||
145725169|NCT00406653|525510325|FG002|Open-Label Period|Declined participation but followup done|0|||
145725170|NCT00406653|525510326|FG003|Open-Label Period|Declined participation but followup done|0|||
145725171|NCT00406653|525510327|FG004|Open-Label Period|Declined participation but followup done|0|||
145725172|NCT00406653|525510328|FG005|Open-Label Period|Declined participation but followup done|0|||
145725173|NCT00406653|525510329|FG006|Open-Label Period|Declined participation but followup done|8|||
145725174|NCT00406653|525510323|FG000|Open-Label Period|Discontinued by Sponsor|0|||
145725175|NCT00406653|525510324|FG001|Open-Label Period|Discontinued by Sponsor|0|||
145725176|NCT00406653|525510325|FG002|Open-Label Period|Discontinued by Sponsor|0|||
145725177|NCT00406653|525510326|FG003|Open-Label Period|Discontinued by Sponsor|0|||
145725178|NCT00406653|525510327|FG004|Open-Label Period|Discontinued by Sponsor|0|||
145725179|NCT00406653|525510328|FG005|Open-Label Period|Discontinued by Sponsor|0|||
145725180|NCT00406653|525510329|FG006|Open-Label Period|Discontinued by Sponsor|1|||
145725181|NCT00406653|525510323|FG000|Open-Label Period|Refused followup|0|||
145725182|NCT00406653|525510324|FG001|Open-Label Period|Refused followup|0|||
145725183|NCT00406653|525510325|FG002|Open-Label Period|Refused followup|0|||
145725184|NCT00406653|525510326|FG003|Open-Label Period|Refused followup|0|||
145725185|NCT00406653|525510327|FG004|Open-Label Period|Refused followup|0|||
145725186|NCT00406653|525510328|FG005|Open-Label Period|Refused followup|0|||
145725187|NCT00406653|525510329|FG006|Open-Label Period|Refused followup|1|||
145725188|NCT00953745|525510330|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
145725189|NCT00953745|525510331|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
145725190|NCT00953745|525510330|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
145725191|NCT00953745|525510331|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
145725192|NCT00953745|525510330|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
145725193|NCT00953745|525510331|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
145725194|NCT00953745|525510330|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
145725195|NCT00953745|525510331|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
145725196|NCT00953745|525510330|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
145725197|NCT00953745|525510331|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
145725198|NCT00953745|525510330|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
145725199|NCT00953745|525510331|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
145725200|NCT02427464|525510335|FG000|Overall Study|Adverse Event|6|||
145725201|NCT02427464|525510336|FG001|Overall Study|Adverse Event|1|||
145725202|NCT02427464|525510335|FG000|Overall Study|Lost to Follow-up|16|||
145725203|NCT02427464|525510336|FG001|Overall Study|Lost to Follow-up|5|||
145725204|NCT02427464|525510335|FG000|Overall Study|Physician Decision|2|||
145725205|NCT02427464|525510336|FG001|Overall Study|Physician Decision|0|||
145725206|NCT02427464|525510335|FG000|Overall Study|Withdrawal by Subject|10|||
145725207|NCT02427464|525510336|FG001|Overall Study|Withdrawal by Subject|8|||
145725208|NCT02427464|525510335|FG000|Overall Study|Noncompliance|16|||
145725209|NCT02427464|525510336|FG001|Overall Study|Noncompliance|10|||
145725210|NCT04737187|525510338|FG000|Overall Study|Switched to marketed drug|32|||
145725211|NCT04737187|525510339|FG001|Overall Study|Switched to marketed drug|4|||
145725212|NCT04737187|525510338|FG000|Overall Study|Radiological Progressive Disease|145|||
145725213|NCT04737187|525510339|FG001|Overall Study|Radiological Progressive Disease|146|||
145725214|NCT04737187|525510338|FG000|Overall Study|Clinical Progressive Disease|20|||
145725215|NCT04737187|525510339|FG001|Overall Study|Clinical Progressive Disease|20|||
145725216|NCT04737187|525510338|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
145725217|NCT04737187|525510339|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
145725218|NCT04737187|525510338|FG000|Overall Study|Adverse Event|16|||
145725219|NCT04737187|525510339|FG001|Overall Study|Adverse Event|16|||
145725220|NCT04737187|525510338|FG000|Overall Study|Physician Decision|2|||
145725221|NCT04737187|525510339|FG001|Overall Study|Physician Decision|0|||
145725222|NCT04737187|525510338|FG000|Overall Study|Withdrawal by Subject|5|||
145725223|NCT04737187|525510339|FG001|Overall Study|Withdrawal by Subject|8|||
145725224|NCT03756129|525510340|FG000|Overall Study|Adverse Event|1|||
145725225|NCT03756129|525510341|FG001|Overall Study|Adverse Event|1|||
145725226|NCT03756129|525510342|FG002|Overall Study|Adverse Event|0|||
145725227|NCT03756129|525510343|FG003|Overall Study|Adverse Event|2|||
145725228|NCT03756129|525510344|FG004|Overall Study|Adverse Event|0|||
145725229|NCT03756129|525510345|FG005|Overall Study|Adverse Event|0|||
145725230|NCT03756129|525510340|FG000|Overall Study|Withdrawal by Subject|2|||
145725231|NCT03756129|525510341|FG001|Overall Study|Withdrawal by Subject|1|||
145725232|NCT03756129|525510342|FG002|Overall Study|Withdrawal by Subject|3|||
145725233|NCT03756129|525510343|FG003|Overall Study|Withdrawal by Subject|1|||
145725234|NCT03756129|525510344|FG004|Overall Study|Withdrawal by Subject|1|||
145725235|NCT03756129|525510345|FG005|Overall Study|Withdrawal by Subject|3|||
145725236|NCT03756129|525510340|FG000|Overall Study|Lost to Follow-up|0|||
145383792|NCT01214668|524260153|FG005|Overall Study|Withdrawal by Subject|0|||
145725237|NCT03756129|525510341|FG001|Overall Study|Lost to Follow-up|0|||
145725238|NCT03756129|525510342|FG002|Overall Study|Lost to Follow-up|0|||
145725239|NCT03756129|525510343|FG003|Overall Study|Lost to Follow-up|0|||
145725240|NCT03756129|525510344|FG004|Overall Study|Lost to Follow-up|0|||
145725241|NCT03756129|525510345|FG005|Overall Study|Lost to Follow-up|1|||
145725242|NCT03756129|525510340|FG000|Overall Study|Physician Decision|0|||
145725243|NCT03756129|525510341|FG001|Overall Study|Physician Decision|0|||
145725244|NCT03756129|525510342|FG002|Overall Study|Physician Decision|0|||
145725245|NCT03756129|525510343|FG003|Overall Study|Physician Decision|0|||
145725246|NCT03756129|525510344|FG004|Overall Study|Physician Decision|0|||
145725247|NCT03756129|525510345|FG005|Overall Study|Physician Decision|1|||
145725248|NCT03567434|525510346|FG000|Overall Study|Lost to Follow-up|1|||
145725249|NCT03567434|525510347|FG001|Overall Study|Lost to Follow-up|3|||
145725250|NCT01439360|525510348|FG000|Overall Study|Adverse Event|4|||
145725251|NCT01439360|525510349|FG001|Overall Study|Adverse Event|16|||
145725252|NCT01439360|525510348|FG000|Overall Study|Lost to Follow-up|43|||
145725253|NCT01439360|525510349|FG001|Overall Study|Lost to Follow-up|58|||
145725254|NCT01439360|525510348|FG000|Overall Study|Others|10|||
145725255|NCT01439360|525510349|FG001|Overall Study|Others|5|||
145725256|NCT01439360|525510348|FG000|Overall Study|Protocol Violation|1|||
145725257|NCT01439360|525510349|FG001|Overall Study|Protocol Violation|0|||
145725258|NCT01439360|525510348|FG000|Overall Study|Withdrawal by Subject|140|||
145725259|NCT01439360|525510349|FG001|Overall Study|Withdrawal by Subject|129|||
145725260|NCT00345293|525510350|FG000|Overall Study|Unable to access line for sample|1|||
145725261|NCT00345293|525510351|FG001|Overall Study|Unable to access line for sample|0|||
145725262|NCT00345293|525510350|FG000|Overall Study|Withdrawal by Subject|1|||
145725263|NCT00345293|525510351|FG001|Overall Study|Withdrawal by Subject|0|||
145725264|NCT03319849|525510352|FG000|Overall Study|Adverse Event|1|||
145725265|NCT03319849|525510353|FG001|Overall Study|Adverse Event|0|||
145725266|NCT03319849|525510352|FG000|Overall Study|Physician Decision|0|||
145725267|NCT03319849|525510353|FG001|Overall Study|Physician Decision|1|||
145725268|NCT03319849|525510352|FG000|Overall Study|Withdrawal by Subject|0|||
145725269|NCT03319849|525510353|FG001|Overall Study|Withdrawal by Subject|1|||
145725270|NCT03319849|525510352|FG000|Overall Study|COVID-19|0|||
145725271|NCT03319849|525510353|FG001|Overall Study|COVID-19|1|||
145725272|NCT03319849|525510352|FG000|Overall Study|Other|1|||
145725273|NCT03319849|525510353|FG001|Overall Study|Other|2|||
145725274|NCT03319849|525510352|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
145725275|NCT03319849|525510353|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
145725276|NCT03319849|525510352|FG000|Overall Study|Lost to Follow-up|0|||
145725277|NCT03319849|525510353|FG001|Overall Study|Lost to Follow-up|2|||
145725278|NCT00001962|525512076|FG000|Overall Study|Lack of Efficacy|18|||
145725279|NCT00001962|525512076|FG000|Overall Study|Lack of Accrual|6|||
145725280|NCT00001962|525512076|FG000|Overall Study|Death|1|||
145725281|NCT00001962|525512076|FG000|Overall Study|Lost to Follow-up|2|||
145725282|NCT00001962|525512076|FG000|Overall Study|Adverse Event|1|||
145725283|NCT00816400|525512077|FG000|Overall Study|Death|2|||
145725284|NCT00816400|525512078|FG001|Overall Study|Death|3|||
145725285|NCT00816400|525512079|FG002|Overall Study|Death|3|||
145725286|NCT00816400|525512080|FG003|Overall Study|Death|3|||
145725287|NCT00816400|525512081|FG004|Overall Study|Death|2|||
145725288|NCT00816400|525512082|FG005|Overall Study|Death|3|||
145725289|NCT00816400|525512083|FG006|Overall Study|Death|2|||
145725290|NCT00816400|525512084|FG007|Overall Study|Death|5|||
145725291|NCT00816400|525512085|FG008|Overall Study|Death|6|||
145725292|NCT00816400|525512077|FG000|Overall Study|In hospice care at the end of the study|0|||
145725293|NCT00816400|525512078|FG001|Overall Study|In hospice care at the end of the study|0|||
145725294|NCT00816400|525512079|FG002|Overall Study|In hospice care at the end of the study|2|||
145725295|NCT00816400|525512080|FG003|Overall Study|In hospice care at the end of the study|0|||
145725296|NCT00816400|525512081|FG004|Overall Study|In hospice care at the end of the study|0|||
145725297|NCT00816400|525512082|FG005|Overall Study|In hospice care at the end of the study|0|||
145725298|NCT00816400|525512083|FG006|Overall Study|In hospice care at the end of the study|0|||
145725299|NCT00816400|525512084|FG007|Overall Study|In hospice care at the end of the study|0|||
145725300|NCT00816400|525512085|FG008|Overall Study|In hospice care at the end of the study|0|||
145725301|NCT01786174|525512086|FG000|Overall Study|Discontinued Study Drug|2|||
145725302|NCT01786174|525512087|FG001|Overall Study|Discontinued Study Drug|0|||
145725303|NCT00876694|525512090|FG000|Overall Study|Adverse Event|10|||
145725304|NCT00876694|525512091|FG001|Overall Study|Adverse Event|7|||
145725305|NCT00876694|525512090|FG000|Overall Study|Subject withdrew consent|6|||
145725306|NCT00876694|525512091|FG001|Overall Study|Subject withdrew consent|4|||
145725307|NCT00876694|525512090|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145725308|NCT00876694|525512091|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145725309|NCT00876694|525512090|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145725310|NCT00876694|525512091|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145725311|NCT00876694|525512090|FG000|Overall Study|Administrative problems|1|||
145725312|NCT00876694|525512091|FG001|Overall Study|Administrative problems|1|||
145725313|NCT00876694|525512090|FG000|Overall Study|Death|1|||
145725314|NCT00876694|525512091|FG001|Overall Study|Death|0|||
145725315|NCT01386788|525512096|FG000|Overall Study|Lost to Follow-up|2|||
145725316|NCT00120406|525512099|FG000|Overall Study|Death|9|||
145725317|NCT00120406|525512100|FG001|Overall Study|Death|4|||
145725318|NCT00120406|525512099|FG000|Overall Study|Withdrawal by Subject|5|||
145725319|NCT00120406|525512100|FG001|Overall Study|Withdrawal by Subject|7|||
145725320|NCT00120406|525512099|FG000|Overall Study|Lost to Follow-up|5|||
145725321|NCT00120406|525512100|FG001|Overall Study|Lost to Follow-up|2|||
145725322|NCT00120406|525512099|FG000|Overall Study|received non-study stent|0|||
145725323|NCT00120406|525512100|FG001|Overall Study|received non-study stent|2|||
145725324|NCT00120406|525512099|FG000|Overall Study|patient moved but has not withdrawn|0|||
145725325|NCT00120406|525512100|FG001|Overall Study|patient moved but has not withdrawn|1|||
145725326|NCT01155375|525512101|FG000|Overall Study|Adverse Event|1|||
145725327|NCT01155375|525512102|FG001|Overall Study|Adverse Event|0|||
145725328|NCT00762970|525512103|FG000|Overall Study|Withdrawal by Subject|7|||
145725329|NCT00762970|525512104|FG001|Overall Study|Withdrawal by Subject|4|||
145725330|NCT00762970|525512105|FG002|Overall Study|Withdrawal by Subject|0|||
145725331|NCT00762970|525512103|FG000|Overall Study|Protocol Violation|3|||
145725332|NCT00762970|525512104|FG001|Overall Study|Protocol Violation|1|||
145725333|NCT00762970|525512105|FG002|Overall Study|Protocol Violation|1|||
145725334|NCT00762970|525512103|FG000|Overall Study|Lost to Follow-up|1|||
145725335|NCT00762970|525512104|FG001|Overall Study|Lost to Follow-up|2|||
145725336|NCT00762970|525512105|FG002|Overall Study|Lost to Follow-up|0|||
145725337|NCT00762970|525512103|FG000|Overall Study|Difficulty of handling lens|1|||
145725338|NCT00762970|525512104|FG001|Overall Study|Difficulty of handling lens|2|||
145725339|NCT00762970|525512105|FG002|Overall Study|Difficulty of handling lens|0|||
145725340|NCT00975507|525512106|FG000|Overall Study|Adverse Event|1|||
145725341|NCT00975507|525512107|FG001|Overall Study|Adverse Event|0|||
145725342|NCT00975507|525512106|FG000|Overall Study|Lost to Follow-up|7|||
145725343|NCT00975507|525512107|FG001|Overall Study|Lost to Follow-up|1|||
145725344|NCT00975507|525512106|FG000|Overall Study|Protocol Violation|2|||
145725345|NCT00975507|525512107|FG001|Overall Study|Protocol Violation|0|||
145725346|NCT00975507|525512106|FG000|Overall Study|Withdrawal by Subject|10|||
145725347|NCT00975507|525512107|FG001|Overall Study|Withdrawal by Subject|3|||
145725348|NCT01295034|525512108|FG000|Overall Study|Lost to Follow-up|5|||
145725349|NCT01295034|525512109|FG001|Overall Study|Lost to Follow-up|5|||
145725350|NCT03818204|525512110|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725351|NCT03818204|525512111|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725352|NCT03818204|525512112|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725353|NCT03818204|525512113|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725354|NCT03818204|525512114|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
145725355|NCT03818204|525512115|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725356|NCT03818204|525512116|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725357|NCT03818204|525512117|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725358|NCT03818204|525512118|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725359|NCT03818204|525512119|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725360|NCT03818204|525512120|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725361|NCT03818204|525512121|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725362|NCT03818204|525512122|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725363|NCT03818204|525512123|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
145725364|NCT03818204|525512124|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725365|NCT03818204|525512125|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725366|NCT03818204|525512126|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725367|NCT03818204|525512127|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725368|NCT03818204|525512128|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
145725369|NCT03818204|525512110|FG000|Overall Study|Physician Decision|0|||
145725370|NCT03818204|525512111|FG001|Overall Study|Physician Decision|0|||
145725371|NCT03818204|525512112|FG002|Overall Study|Physician Decision|0|||
145725372|NCT03818204|525512113|FG003|Overall Study|Physician Decision|0|||
145725373|NCT03818204|525512114|FG004|Overall Study|Physician Decision|0|||
145725374|NCT03818204|525512115|FG005|Overall Study|Physician Decision|0|||
145725375|NCT03818204|525512116|FG006|Overall Study|Physician Decision|0|||
145725376|NCT03818204|525512117|FG007|Overall Study|Physician Decision|0|||
145725377|NCT03818204|525512118|FG008|Overall Study|Physician Decision|0|||
145725378|NCT03818204|525512119|FG009|Overall Study|Physician Decision|0|||
145725379|NCT03818204|525512120|FG010|Overall Study|Physician Decision|0|||
145725380|NCT03818204|525512121|FG011|Overall Study|Physician Decision|0|||
145725381|NCT03818204|525512122|FG012|Overall Study|Physician Decision|0|||
145725382|NCT03818204|525512123|FG013|Overall Study|Physician Decision|0|||
145725383|NCT03818204|525512124|FG014|Overall Study|Physician Decision|1|||
145725384|NCT03818204|525512125|FG015|Overall Study|Physician Decision|0|||
145725385|NCT03818204|525512126|FG016|Overall Study|Physician Decision|0|||
145725386|NCT03818204|525512127|FG017|Overall Study|Physician Decision|0|||
145725387|NCT03818204|525512128|FG018|Overall Study|Physician Decision|0|||
145725388|NCT00887250|525512129|FG000|Overall Study|Adverse Event|3|||
145725389|NCT00887250|525512130|FG001|Overall Study|Adverse Event|0|||
145725390|NCT00887250|525512131|FG002|Overall Study|Adverse Event|7|||
145725391|NCT00887250|525512129|FG000|Overall Study|Lack of Efficacy|9|||
145725392|NCT00887250|525512130|FG001|Overall Study|Lack of Efficacy|6|||
145725393|NCT00887250|525512131|FG002|Overall Study|Lack of Efficacy|1|||
145725394|NCT00887250|525512129|FG000|Overall Study|Lost to Follow-up|2|||
145725395|NCT00887250|525512130|FG001|Overall Study|Lost to Follow-up|3|||
145725396|NCT00887250|525512131|FG002|Overall Study|Lost to Follow-up|1|||
145725397|NCT00887250|525512129|FG000|Overall Study|Protocol Violation|2|||
145725398|NCT00887250|525512130|FG001|Overall Study|Protocol Violation|2|||
145725399|NCT00887250|525512131|FG002|Overall Study|Protocol Violation|1|||
145725400|NCT00887250|525512129|FG000|Overall Study|Withdrawal by Subject|2|||
145725401|NCT00887250|525512130|FG001|Overall Study|Withdrawal by Subject|1|||
145725402|NCT00887250|525512131|FG002|Overall Study|Withdrawal by Subject|2|||
145725403|NCT00887250|525512129|FG000|Overall Study|Patient uncooperative|0|||
145725404|NCT00887250|525512130|FG001|Overall Study|Patient uncooperative|0|||
145725405|NCT00887250|525512131|FG002|Overall Study|Patient uncooperative|1|||
145725406|NCT05754333|525512132|FG000|Overall Study|Miscellaneous|3|||
145725407|NCT05754333|525512133|FG001|Overall Study|Miscellaneous|0|||
145725408|NCT05754333|525512134|FG002|Overall Study|Miscellaneous|0|||
145725409|NCT05754333|525512135|FG003|Overall Study|Miscellaneous|0|||
145725410|NCT05754333|525512132|FG000|Overall Study|Lost to Follow-up|2|||
145725411|NCT05754333|525512133|FG001|Overall Study|Lost to Follow-up|1|||
145725412|NCT05754333|525512134|FG002|Overall Study|Lost to Follow-up|0|||
145725413|NCT05754333|525512135|FG003|Overall Study|Lost to Follow-up|1|||
145725414|NCT03864146|525512136|FG000|Overall Study|Lost to Follow-up|14|||
145725415|NCT03864146|525512137|FG001|Overall Study|Lost to Follow-up|23|||
145725416|NCT03864146|525512136|FG000|Overall Study|Withdrawal by Subject|3|||
145725417|NCT03864146|525512137|FG001|Overall Study|Withdrawal by Subject|2|||
145725418|NCT00824161|525512138|FG000|Overall Study|Withdrawal by Subject|1|||
145725419|NCT00824161|525512138|FG000|Overall Study|Screen Failure|1|||
145725420|NCT01112306|525512139|FG000|Overall Study|Death|175|||
145725421|NCT01112306|525512139|FG000|Overall Study|Lost to Follow-up|9|||
145725422|NCT01112306|525512139|FG000|Overall Study|Withdrawal by Subject|31|||
145725423|NCT01112306|525512139|FG000|Overall Study|Other|70|||
145725424|NCT00211185|525512148|FG000|Overall Study|Death|2|||
145725425|NCT00211185|525512148|FG000|Overall Study|Disease progression|7|||
145725426|NCT00211185|525512148|FG000|Overall Study|Withdrawal by Subject|6|||
145725427|NCT00211185|525512148|FG000|Overall Study|Physician Decision|5|||
145725428|NCT00842985|525512149|FG000|Screening|Did not meet entrance requirements|27|||
145725429|NCT00842985|525512149|FG000|First Intervention|Withdrawal by Subject|3|||
145725430|NCT00842985|525512149|FG000|First Intervention|Protocol Violation|3|||
145725431|NCT00842985|525512149|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
145725432|NCT00842985|525512149|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
145725433|NCT01037244|525512150|FG000|Overall Study|Adverse Event|3|||
145725434|NCT01037244|525512151|FG001|Overall Study|Adverse Event|2|||
145725435|NCT01037244|525512152|FG002|Overall Study|Adverse Event|6|||
145725436|NCT01037244|525512153|FG003|Overall Study|Adverse Event|3|||
145725437|NCT01037244|525512150|FG000|Overall Study|Lack of Efficacy|1|||
145725438|NCT01037244|525512151|FG001|Overall Study|Lack of Efficacy|1|||
145725439|NCT01037244|525512152|FG002|Overall Study|Lack of Efficacy|0|||
145725440|NCT01037244|525512153|FG003|Overall Study|Lack of Efficacy|1|||
145725441|NCT01037244|525512150|FG000|Overall Study|Lost to Follow-up|3|||
145725442|NCT01037244|525512151|FG001|Overall Study|Lost to Follow-up|3|||
145725443|NCT01037244|525512152|FG002|Overall Study|Lost to Follow-up|4|||
145725444|NCT01037244|525512153|FG003|Overall Study|Lost to Follow-up|4|||
145725445|NCT01037244|525512150|FG000|Overall Study|Withdrawal by Subject|1|||
145725446|NCT01037244|525512151|FG001|Overall Study|Withdrawal by Subject|5|||
145725447|NCT01037244|525512152|FG002|Overall Study|Withdrawal by Subject|3|||
145725448|NCT01037244|525512153|FG003|Overall Study|Withdrawal by Subject|5|||
145725449|NCT01037244|525512150|FG000|Overall Study|Partner Withdrew Consent|2|||
145725450|NCT01037244|525512151|FG001|Overall Study|Partner Withdrew Consent|1|||
145725451|NCT01037244|525512152|FG002|Overall Study|Partner Withdrew Consent|0|||
145725452|NCT01037244|525512153|FG003|Overall Study|Partner Withdrew Consent|0|||
145725453|NCT01037244|525512150|FG000|Overall Study|Various|3|||
145725454|NCT01037244|525512151|FG001|Overall Study|Various|2|||
145725455|NCT01037244|525512152|FG002|Overall Study|Various|1|||
145725456|NCT01037244|525512153|FG003|Overall Study|Various|1|||
145725457|NCT04507126|525512154|FG000|Overall Study|Withdrawal by Subject|1|||
145725458|NCT04507126|525512154|FG000|Overall Study|Protocol Violation|2|||
145725459|NCT04507126|525512154|FG000|Overall Study|Physician Decision|1|||
145725460|NCT02875977|525512156|FG000|Overall Study|Lost to Follow-up|42|||
145725461|NCT02875977|525512157|FG001|Overall Study|Lost to Follow-up|29|||
145725462|NCT03421431|525512160|FG000|Overall Study|Adverse Event|2|||
145725463|NCT03421431|525512161|FG001|Overall Study|Adverse Event|1|||
145725464|NCT03421431|525512162|FG002|Overall Study|Adverse Event|12|||
145725465|NCT03421431|525512160|FG000|Overall Study|Lost to Follow-up|1|||
145725466|NCT03421431|525512161|FG001|Overall Study|Lost to Follow-up|1|||
145725467|NCT03421431|525512162|FG002|Overall Study|Lost to Follow-up|1|||
145725468|NCT03421431|525512160|FG000|Overall Study|Withdrawal by Subject|3|||
145725469|NCT03421431|525512161|FG001|Overall Study|Withdrawal by Subject|2|||
145725470|NCT03421431|525512162|FG002|Overall Study|Withdrawal by Subject|1|||
145725471|NCT03421431|525512160|FG000|Overall Study|Protocol Violation|0|||
145725472|NCT03421431|525512161|FG001|Overall Study|Protocol Violation|1|||
145725473|NCT03421431|525512162|FG002|Overall Study|Protocol Violation|0|||
145725474|NCT03421431|525512160|FG000|Overall Study|Participant met Stopping Rules|0|||
145725475|NCT03421431|525512161|FG001|Overall Study|Participant met Stopping Rules|1|||
145725476|NCT03421431|525512162|FG002|Overall Study|Participant met Stopping Rules|0|||
145725477|NCT00141726|525512163|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
145725478|NCT02216357|525512164|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
145725479|NCT02216357|525512165|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
145725480|NCT00235326|525512170|FG000|Overall Study|Lost to Follow-up|746|||
145725481|NCT00235326|525512171|FG001|Overall Study|Lost to Follow-up|1400|||
145725482|NCT01178671|525512172|FG000|Overall Study|Adverse Event|4|||
145725483|NCT01178671|525512173|FG001|Overall Study|Adverse Event|6|||
145725484|NCT01178671|525512172|FG000|Overall Study|Protocol Violation|1|||
145725485|NCT01178671|525512173|FG001|Overall Study|Protocol Violation|1|||
145725486|NCT01178671|525512172|FG000|Overall Study|Lack of Efficacy|0|||
145725487|NCT01178671|525512173|FG001|Overall Study|Lack of Efficacy|1|||
145725488|NCT01178671|525512172|FG000|Overall Study|Lost to Follow-up|3|||
145725489|NCT01178671|525512173|FG001|Overall Study|Lost to Follow-up|1|||
145725490|NCT01178671|525512172|FG000|Overall Study|Physician Decision|4|||
145725491|NCT01178671|525512173|FG001|Overall Study|Physician Decision|6|||
145725492|NCT01313689|525512174|FG000|24-Week Randomization 1|Adverse Event|10|||
145725493|NCT01313689|525512175|FG001|24-Week Randomization 1|Adverse Event|5|||
145725494|NCT01313689|525512176|FG002|24-Week Randomization 1|Adverse Event|0|||
145725495|NCT01313689|525512177|FG003|24-Week Randomization 1|Adverse Event|0|||
145725496|NCT01313689|525512178|FG004|24-Week Randomization 1|Adverse Event|0|||
145725497|NCT01313689|525512174|FG000|24-Week Randomization 1|Physician Decision|4|||
145725498|NCT01313689|525512175|FG001|24-Week Randomization 1|Physician Decision|5|||
145725499|NCT01313689|525512176|FG002|24-Week Randomization 1|Physician Decision|0|||
145725500|NCT01313689|525512177|FG003|24-Week Randomization 1|Physician Decision|0|||
145725501|NCT01313689|525512178|FG004|24-Week Randomization 1|Physician Decision|0|||
145725502|NCT01313689|525512174|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
145725503|NCT01313689|525512175|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
145725504|NCT01313689|525512176|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
145725505|NCT01313689|525512177|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
145725506|NCT01313689|525512178|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
145725507|NCT01313689|525512174|FG000|24-Week Randomization 2|Adverse Event|0|||
145725508|NCT01313689|525512175|FG001|24-Week Randomization 2|Adverse Event|0|||
145725509|NCT01313689|525512176|FG002|24-Week Randomization 2|Adverse Event|2|||
145725510|NCT01313689|525512177|FG003|24-Week Randomization 2|Adverse Event|0|||
145725511|NCT01313689|525512178|FG004|24-Week Randomization 2|Adverse Event|8|||
145725512|NCT01313689|525512174|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
145725513|NCT01313689|525512175|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
145725514|NCT01313689|525512176|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
145725515|NCT01313689|525512177|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
145725516|NCT01313689|525512178|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
145725517|NCT01313689|525512174|FG000|24-Week Randomization 2|Physician Decision|0|||
145725518|NCT01313689|525512175|FG001|24-Week Randomization 2|Physician Decision|0|||
145725519|NCT01313689|525512176|FG002|24-Week Randomization 2|Physician Decision|0|||
145725520|NCT01313689|525512177|FG003|24-Week Randomization 2|Physician Decision|0|||
145725521|NCT01313689|525512178|FG004|24-Week Randomization 2|Physician Decision|4|||
145725522|NCT00551460|525512181|FG000|Overall Study|Adverse Event|1|||
145725523|NCT00551460|525512181|FG000|Overall Study|Withdrawal by Subject|1|||
145725524|NCT00551460|525512181|FG000|Overall Study|Physician Decision|1|||
145725525|NCT00551460|525512181|FG000|Overall Study|Death|7|||
145725526|NCT00551460|525512181|FG000|Overall Study|Ineligible|4|||
145725527|NCT00551460|525512181|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
145725528|NCT04781387|525512182|FG000|Overall Study|Withdrawal by Subject|1|||
145725529|NCT04781387|525512183|FG001|Overall Study|Withdrawal by Subject|0|||
145725530|NCT04781387|525512184|FG002|Overall Study|Withdrawal by Subject|1|||
145725531|NCT04781387|525512182|FG000|Overall Study|Lost to Follow-up|1|||
145725532|NCT04781387|525512183|FG001|Overall Study|Lost to Follow-up|0|||
145725533|NCT04781387|525512184|FG002|Overall Study|Lost to Follow-up|0|||
145725534|NCT00679627|525512186|FG000|Overall Study|Death|41|||
145725535|NCT00679627|525512187|FG001|Overall Study|Death|29|||
145725536|NCT00679627|525512186|FG000|Overall Study|Adverse Event|43|||
145725537|NCT00679627|525512187|FG001|Overall Study|Adverse Event|53|||
145725538|NCT00679627|525512186|FG000|Overall Study|Withdrawal by Subject|168|||
145725539|NCT00679627|525512187|FG001|Overall Study|Withdrawal by Subject|172|||
145725540|NCT00679627|525512186|FG000|Overall Study|Lost to Follow-up|22|||
145725541|NCT00679627|525512187|FG001|Overall Study|Lost to Follow-up|26|||
145725542|NCT00679627|525512186|FG000|Overall Study|Early Study Closure|425|||
145725543|NCT00679627|525512187|FG001|Overall Study|Early Study Closure|405|||
145725544|NCT00511472|525512188|FG000|Overall Study|Clinical Adverse Event|1|||
145725545|NCT00511472|525512189|FG001|Overall Study|Clinical Adverse Event|2|||
145725546|NCT00511472|525512188|FG000|Overall Study|Laboratory Adverse Event|0|||
145725547|NCT00511472|525512189|FG001|Overall Study|Laboratory Adverse Event|2|||
145725548|NCT00511472|525512188|FG000|Overall Study|Not reported|2|||
145725549|NCT00511472|525512189|FG001|Overall Study|Not reported|2|||
145725550|NCT00446992|525512190|FG000|Overall Study|Adverse Event|11|||
145725551|NCT00446992|525512190|FG000|Overall Study|Lost to Follow-up|5|||
145725552|NCT00818649|525512191|FG000|Overall Study|Declining performance status|2|||
145725553|NCT00818649|525512191|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
145725554|NCT00818649|525512191|FG000|Overall Study|Adverse Event|1|||
145725555|NCT03513588|525512192|FG000|Overall Study|Lost to Follow-up|0|||
145725556|NCT03513588|525512193|FG001|Overall Study|Lost to Follow-up|1|||
145725557|NCT03513588|525512194|FG002|Overall Study|Lost to Follow-up|1|||
145725558|NCT03513588|525512192|FG000|Overall Study|Study dosing paused by sponsor|1|||
145725559|NCT03513588|525512193|FG001|Overall Study|Study dosing paused by sponsor|1|||
145725560|NCT03513588|525512194|FG002|Overall Study|Study dosing paused by sponsor|0|||
145725561|NCT03513588|525512192|FG000|Overall Study|Death|0|||
145725562|NCT03513588|525512193|FG001|Overall Study|Death|0|||
145725563|NCT03513588|525512194|FG002|Overall Study|Death|1|||
145725564|NCT00505284|525512195|FG000|Overall Study|Adverse Event|3|||
145725565|NCT00505284|525512196|FG001|Overall Study|Adverse Event|7|||
145725566|NCT00505284|525512197|FG002|Overall Study|Adverse Event|9|||
145725567|NCT00505284|525512198|FG003|Overall Study|Adverse Event|14|||
145725568|NCT00505284|525512199|FG004|Overall Study|Adverse Event|22|||
145725569|NCT00505284|525512195|FG000|Overall Study|Protocol Violation|0|||
145725570|NCT00505284|525512196|FG001|Overall Study|Protocol Violation|1|||
145725571|NCT00505284|525512197|FG002|Overall Study|Protocol Violation|1|||
145725572|NCT00505284|525512198|FG003|Overall Study|Protocol Violation|0|||
145725573|NCT00505284|525512199|FG004|Overall Study|Protocol Violation|0|||
145725574|NCT00505284|525512195|FG000|Overall Study|Withdrawal by Subject|2|||
145725575|NCT00505284|525512196|FG001|Overall Study|Withdrawal by Subject|6|||
145725576|NCT00505284|525512197|FG002|Overall Study|Withdrawal by Subject|1|||
145725577|NCT00505284|525512198|FG003|Overall Study|Withdrawal by Subject|0|||
145725578|NCT00505284|525512199|FG004|Overall Study|Withdrawal by Subject|6|||
145725579|NCT00505284|525512195|FG000|Overall Study|Lack of Efficacy|0|||
145725580|NCT00505284|525512196|FG001|Overall Study|Lack of Efficacy|1|||
145725581|NCT00505284|525512197|FG002|Overall Study|Lack of Efficacy|1|||
145725582|NCT00505284|525512198|FG003|Overall Study|Lack of Efficacy|1|||
145725583|NCT00505284|525512199|FG004|Overall Study|Lack of Efficacy|1|||
145725584|NCT00505284|525512195|FG000|Overall Study|Physician Decision|0|||
145725585|NCT00505284|525512196|FG001|Overall Study|Physician Decision|1|||
145725586|NCT00505284|525512197|FG002|Overall Study|Physician Decision|0|||
145725587|NCT00505284|525512198|FG003|Overall Study|Physician Decision|0|||
145725588|NCT00505284|525512199|FG004|Overall Study|Physician Decision|0|||
145725589|NCT00505284|525512195|FG000|Overall Study|Other|5|||
145725590|NCT00505284|525512196|FG001|Overall Study|Other|0|||
145725591|NCT00505284|525512197|FG002|Overall Study|Other|0|||
145725592|NCT00505284|525512198|FG003|Overall Study|Other|4|||
145725593|NCT00505284|525512199|FG004|Overall Study|Other|4|||
145725594|NCT01740323|525512203|FG000|Overall Study|Adverse Event|1|||
145725595|NCT01740323|525512204|FG001|Overall Study|Adverse Event|0|||
145725596|NCT01740323|525512203|FG000|Overall Study|Randomized but did not take study drug|1|||
145725597|NCT01740323|525512204|FG001|Overall Study|Randomized but did not take study drug|0|||
145725598|NCT06338462|525512209|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
145725599|NCT00069238|525512210|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
145725600|NCT00069238|525512211|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
145725601|NCT00069238|525512212|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
145725602|NCT00069238|525512210|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
145725603|NCT00069238|525512211|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
145725604|NCT00069238|525512212|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
145725605|NCT00069238|525512210|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
145725606|NCT00069238|525512211|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
145725607|NCT00069238|525512212|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
145725608|NCT01668667|525512219|FG000|Overall Study|Adverse Event|3|||
145725609|NCT01668667|525512220|FG001|Overall Study|Adverse Event|6|||
145725610|NCT01668667|525512221|FG002|Overall Study|Adverse Event|4|||
145725611|NCT01668667|525512222|FG003|Overall Study|Adverse Event|4|||
145725612|NCT01668667|525512219|FG000|Overall Study|Lack of Efficacy|3|||
145725613|NCT01668667|525512220|FG001|Overall Study|Lack of Efficacy|2|||
145725614|NCT01668667|525512221|FG002|Overall Study|Lack of Efficacy|2|||
145725615|NCT01668667|525512222|FG003|Overall Study|Lack of Efficacy|3|||
145725616|NCT01668667|525512219|FG000|Overall Study|Protocol Violation|6|||
145725617|NCT01668667|525512220|FG001|Overall Study|Protocol Violation|10|||
145725618|NCT01668667|525512221|FG002|Overall Study|Protocol Violation|12|||
145725619|NCT01668667|525512222|FG003|Overall Study|Protocol Violation|5|||
145725620|NCT01668667|525512219|FG000|Overall Study|Lost to Follow-up|9|||
145725621|NCT01668667|525512220|FG001|Overall Study|Lost to Follow-up|4|||
145725622|NCT01668667|525512221|FG002|Overall Study|Lost to Follow-up|7|||
145725623|NCT01668667|525512222|FG003|Overall Study|Lost to Follow-up|6|||
145725624|NCT01668667|525512219|FG000|Overall Study|Physician Decision|3|||
145725625|NCT01668667|525512220|FG001|Overall Study|Physician Decision|0|||
145725626|NCT01668667|525512221|FG002|Overall Study|Physician Decision|1|||
145725627|NCT01668667|525512222|FG003|Overall Study|Physician Decision|0|||
145725628|NCT01668667|525512219|FG000|Overall Study|Withdrawal by Subject|7|||
145725629|NCT01668667|525512220|FG001|Overall Study|Withdrawal by Subject|4|||
145725630|NCT01668667|525512221|FG002|Overall Study|Withdrawal by Subject|5|||
145725631|NCT01668667|525512222|FG003|Overall Study|Withdrawal by Subject|5|||
145725632|NCT00511901|525512224|FG000|Overall Study|Withdrawal by Subject|1|||
145725633|NCT00511901|525512225|FG001|Overall Study|Withdrawal by Subject|3|||
145725634|NCT04640077|525512229|FG000|Period 1|Withdrawal by Subject|4|||
145725635|NCT04640077|525512230|FG001|Period 1|Withdrawal by Subject|5|||
145725636|NCT04640077|525512231|FG002|Period 1|Withdrawal by Subject|0|||
145725637|NCT04640077|525512229|FG000|Period 1|Adverse Event|1|||
145725638|NCT04640077|525512230|FG001|Period 1|Adverse Event|1|||
145725639|NCT04640077|525512231|FG002|Period 1|Adverse Event|0|||
145725640|NCT04640077|525512229|FG000|Period 1|Screen Failure|2|||
145725641|NCT04640077|525512230|FG001|Period 1|Screen Failure|0|||
145725642|NCT04640077|525512231|FG002|Period 1|Screen Failure|0|||
145725643|NCT04640077|525512229|FG000|Period 2|Withdrawal by Subject|0|||
145725644|NCT04640077|525512230|FG001|Period 2|Withdrawal by Subject|0|||
145725645|NCT04640077|525512231|FG002|Period 2|Withdrawal by Subject|18|||
145725646|NCT04640077|525512229|FG000|Period 2|Adverse Event|0|||
145725647|NCT04640077|525512230|FG001|Period 2|Adverse Event|0|||
145725648|NCT04640077|525512231|FG002|Period 2|Adverse Event|6|||
145725649|NCT04640077|525512229|FG000|Period 2|Lost to Follow-up|0|||
145725650|NCT04640077|525512230|FG001|Period 2|Lost to Follow-up|0|||
145725651|NCT04640077|525512231|FG002|Period 2|Lost to Follow-up|2|||
145725652|NCT04640077|525512229|FG000|Period 2|Death|0|||
145725653|NCT04640077|525512230|FG001|Period 2|Death|0|||
145725654|NCT04640077|525512231|FG002|Period 2|Death|2|||
145725655|NCT04640077|525512229|FG000|Period 2|Progressive Disease|0|||
145725656|NCT04640077|525512230|FG001|Period 2|Progressive Disease|0|||
145725657|NCT04640077|525512231|FG002|Period 2|Progressive Disease|1|||
145725658|NCT04640077|525512229|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
145725659|NCT04640077|525512230|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
145725660|NCT04640077|525512231|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
145725661|NCT01257425|525512232|FG000|Overall Study|Lack of Efficacy|3|||
145725662|NCT01257425|525512233|FG001|Overall Study|Lack of Efficacy|3|||
145725663|NCT01257425|525512232|FG000|Overall Study|Adverse Event|1|||
145725664|NCT01257425|525512233|FG001|Overall Study|Adverse Event|1|||
145725665|NCT01257425|525512232|FG000|Overall Study|Protocol Violation|1|||
145725666|NCT01257425|525512233|FG001|Overall Study|Protocol Violation|1|||
145725667|NCT01257425|525512232|FG000|Overall Study|Withdrawal by Subject|0|||
145725668|NCT01257425|525512233|FG001|Overall Study|Withdrawal by Subject|1|||
145725669|NCT01257425|525512232|FG000|Overall Study|Death|1|||
145725670|NCT01257425|525512233|FG001|Overall Study|Death|0|||
145725671|NCT00368992|525512237|FG000|Overall Study|Ineligible|5|||
145725672|NCT00368992|525512237|FG000|Overall Study|Refused treatment|3|||
145725673|NCT00368992|525512237|FG000|Overall Study|Lack of Efficacy|63|||
145725674|NCT00368992|525512237|FG000|Overall Study|Adverse Event|26|||
145725675|NCT00368992|525512237|FG000|Overall Study|Death|4|||
145725676|NCT00368992|525512237|FG000|Overall Study|Other|9|||
145725677|NCT01013597|525512244|FG000|Overall Study|Withdrawal by Subject|1|||
145725678|NCT00427895|525512245|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725679|NCT00427895|525512246|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725680|NCT00427895|525512247|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725681|NCT00427895|525512248|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
145725682|NCT00427895|525512249|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725683|NCT00427895|525512250|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725684|NCT00427895|525512251|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725685|NCT00427895|525512252|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
145725686|NCT00427895|525512245|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725687|NCT00427895|525512246|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725688|NCT00427895|525512247|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725689|NCT00427895|525512248|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725690|NCT00427895|525512249|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725691|NCT00427895|525512250|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725692|NCT00427895|525512251|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
145725693|NCT00427895|525512252|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
145725694|NCT00427895|525512245|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725695|NCT00427895|525512246|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725696|NCT00427895|525512247|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725697|NCT00427895|525512248|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725698|NCT00427895|525512249|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725699|NCT00427895|525512250|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725700|NCT00427895|525512251|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
145725701|NCT00427895|525512252|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
145725702|NCT00427895|525512245|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
145725703|NCT00427895|525512246|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
145725704|NCT00427895|525512247|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
145725705|NCT00427895|525512248|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
145725706|NCT00427895|525512249|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
145725707|NCT00427895|525512250|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
145725708|NCT00427895|525512251|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
145725709|NCT00427895|525512252|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
145725710|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
145725711|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
145725712|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
145725713|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
145725714|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
145725715|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
145725716|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
145725717|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
145725718|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
145725719|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
145725720|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
145725721|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
145725722|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
145725723|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
145725724|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
145725725|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
145725726|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
145725727|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
145725728|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725729|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725730|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725731|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725732|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725733|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
145725734|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
145725735|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
145725736|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
145725737|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
145725738|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
145725739|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
145725740|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
145725741|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
145725742|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725743|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725744|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725745|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
145725746|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725747|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725748|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725749|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
145725750|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
145725751|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
145725752|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
145725753|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
145725754|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
145266634|NCT04668066|523825244|FG007|Part 1: Treatment Phase|Other|0|||
145725755|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
145725756|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
145725757|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
145725758|NCT00427895|525512245|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725759|NCT00427895|525512246|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725760|NCT00427895|525512247|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
145725761|NCT00427895|525512248|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
145725762|NCT00427895|525512249|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725763|NCT00427895|525512250|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725764|NCT00427895|525512251|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725765|NCT00427895|525512252|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
145725766|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
145725767|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
145725768|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
145725769|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
145725770|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
145725771|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
145725772|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
145725773|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
145725774|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
145725775|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
145725776|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145725777|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
145725778|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145725779|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145725780|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145725781|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
145725782|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
145725783|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
145725784|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
145725785|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
145725786|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
145725787|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
145725788|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
145725789|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
145725790|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725791|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
145725792|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725793|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725794|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725795|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725796|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725797|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
145725798|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Death|1|||
145725799|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Death|0|||
145725800|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Death|0|||
145725801|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Death|0|||
145725802|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Death|0|||
145725803|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Death|0|||
145725804|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Death|0|||
145725805|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Death|0|||
145725806|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725807|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725808|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
145725809|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
145725810|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725811|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725812|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725813|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
145725814|NCT00427895|525512245|FG000|Vax 1/Year 1 Follow-up|Other|0|||
145725815|NCT00427895|525512246|FG001|Vax 1/Year 1 Follow-up|Other|0|||
145725816|NCT00427895|525512247|FG002|Vax 1/Year 1 Follow-up|Other|0|||
145725817|NCT00427895|525512248|FG003|Vax 1/Year 1 Follow-up|Other|2|||
145725818|NCT00427895|525512249|FG004|Vax 1/Year 1 Follow-up|Other|0|||
145725819|NCT00427895|525512250|FG005|Vax 1/Year 1 Follow-up|Other|0|||
145725820|NCT00427895|525512251|FG006|Vax 1/Year 1 Follow-up|Other|0|||
145266635|NCT04668066|523825245|FG008|Part 1: Treatment Phase|Other|0|||
145725821|NCT00427895|525512252|FG007|Vax 1/Year 1 Follow-up|Other|0|||
145725822|NCT00427895|525512245|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
145725823|NCT00427895|525512246|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
145725824|NCT00427895|525512247|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
145725825|NCT00427895|525512248|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
145725826|NCT00427895|525512249|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
145725827|NCT00427895|525512250|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
145725828|NCT00427895|525512251|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
145725829|NCT00427895|525512252|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
145725830|NCT03573401|525512253|FG000|Overall Study|Withdrawal by Subject|2|||
145725831|NCT03573401|525512254|FG001|Overall Study|Withdrawal by Subject|0|||
145725832|NCT03573401|525512253|FG000|Overall Study|Subject non-compliance with study schedule|1|||
145725833|NCT03573401|525512254|FG001|Overall Study|Subject non-compliance with study schedule|0|||
145725834|NCT03573401|525512253|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
145725835|NCT03573401|525512254|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
145725836|NCT03573401|525512253|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
145725837|NCT03573401|525512254|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
145725838|NCT01340196|525513817|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
145725839|NCT00604279|525513822|FG000|Overall Study|Lack of Efficacy|22|||
145725840|NCT00604279|525513823|FG001|Overall Study|Lack of Efficacy|9|||
145725841|NCT00604279|525513822|FG000|Overall Study|Lost to Follow-up|9|||
145725842|NCT00604279|525513823|FG001|Overall Study|Lost to Follow-up|14|||
145725843|NCT00604279|525513822|FG000|Overall Study|Pregnancy|2|||
145725844|NCT00604279|525513823|FG001|Overall Study|Pregnancy|0|||
145725845|NCT00604279|525513822|FG000|Overall Study|Protocol Violation|3|||
145725846|NCT00604279|525513823|FG001|Overall Study|Protocol Violation|1|||
145725847|NCT00604279|525513822|FG000|Overall Study|Withdrawal by Subject|16|||
145725848|NCT00604279|525513823|FG001|Overall Study|Withdrawal by Subject|5|||
145725849|NCT00604279|525513822|FG000|Overall Study|Adverse Event|4|||
145725850|NCT00604279|525513823|FG001|Overall Study|Adverse Event|5|||
145725851|NCT00604279|525513822|FG000|Overall Study|Other|8|||
145725852|NCT00604279|525513823|FG001|Overall Study|Other|4|||
145725853|NCT00601419|525513824|FG000|Overall Study|Lost to Follow-up|3|||
145725854|NCT00601419|525513824|FG000|Overall Study|Missed Visits|1|||
145725855|NCT01614197|525513825|FG000|Overall Study|Withdrawal by Subject|0|||
145725856|NCT01614197|525513826|FG001|Overall Study|Withdrawal by Subject|1|||
145725857|NCT01614197|525513827|FG002|Overall Study|Withdrawal by Subject|0|||
145725858|NCT01614197|525513828|FG003|Overall Study|Withdrawal by Subject|0|||
145725859|NCT03628898|525513830|FG000|Overall Study|Device deficiency|1|||
145725860|NCT00971932|525513831|FG000|Overall Study|Withdrawal by Subject|1|||
145725861|NCT00971932|525513831|FG000|Overall Study|Investigator's decision|2|||
145725862|NCT00971932|525513831|FG000|Overall Study|Ongoing|4|||
145725863|NCT01217957|525513832|FG000|Phase 1|Withdrawal by Patient|1|||
145725864|NCT01217957|525513833|FG001|Phase 1|Withdrawal by Patient|0|||
145725865|NCT01217957|525513834|FG002|Phase 1|Withdrawal by Patient|1|||
145725866|NCT01217957|525513835|FG003|Phase 1|Withdrawal by Patient|1|||
145725867|NCT01217957|525513836|FG004|Phase 1|Withdrawal by Patient|0|||
145725868|NCT01217957|525513832|FG000|Phase 2|Withdrawal by Patient|0|||
145725869|NCT01217957|525513833|FG001|Phase 2|Withdrawal by Patient|0|||
145725870|NCT01217957|525513834|FG002|Phase 2|Withdrawal by Patient|0|||
145725871|NCT01217957|525513835|FG003|Phase 2|Withdrawal by Patient|0|||
145725872|NCT01217957|525513836|FG004|Phase 2|Withdrawal by Patient|1|||
145725873|NCT00288509|525513841|FG000|Treatment Cycle 1|Adverse Event|1|||
145725874|NCT00288509|525513841|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
145725875|NCT00288509|525513841|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
145725876|NCT00288509|525513841|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
145725877|NCT00288509|525513841|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
145725878|NCT00288509|525513841|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
145725879|NCT00288509|525513841|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
145725880|NCT00288509|525513841|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
145725881|NCT00288509|525513841|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
145725882|NCT00288509|525513841|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
145725883|NCT00288509|525513841|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
145725884|NCT00288509|525513841|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
145725885|NCT00288509|525513841|FG000|Treatment Cycle 4|Physician Decision|4|||
145725886|NCT00288509|525513841|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
145725887|NCT02382016|525513842|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
145725888|NCT02382016|525513843|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
145725889|NCT02382016|525513842|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
145725890|NCT02382016|525513843|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
145725891|NCT02382016|525513842|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
145725892|NCT02382016|525513843|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
145725893|NCT02382016|525513842|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
145725894|NCT02382016|525513843|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
145725895|NCT02382016|525513842|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
145725896|NCT02382016|525513843|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
145725897|NCT02382016|525513842|FG000|Open-label (OL) Treatment Period|Death|4|||
145725898|NCT02382016|525513843|FG001|Open-label (OL) Treatment Period|Death|0|||
145725899|NCT02382016|525513842|FG000|OL Extension Period|Physician Decision|3|||
145725900|NCT02382016|525513843|FG001|OL Extension Period|Physician Decision|0|||
145725901|NCT02382016|525513842|FG000|OL Extension Period|Death|2|||
145725902|NCT02382016|525513843|FG001|OL Extension Period|Death|0|||
145725903|NCT02382016|525513842|FG000|OL Extension Period|Withdrawal by Subject|1|||
145725904|NCT02382016|525513843|FG001|OL Extension Period|Withdrawal by Subject|0|||
145725905|NCT00084266|525513844|FG000|Overall Study|Death|42|||
145725906|NCT00084266|525513845|FG001|Overall Study|Death|39|||
145725907|NCT00084266|525513844|FG000|Overall Study|Adverse Event|8|||
145725908|NCT00084266|525513845|FG001|Overall Study|Adverse Event|5|||
145725909|NCT00084266|525513844|FG000|Overall Study|Lack of Efficacy|2|||
145725910|NCT00084266|525513845|FG001|Overall Study|Lack of Efficacy|4|||
145725911|NCT00084266|525513844|FG000|Overall Study|Lost to Follow-up|5|||
145725912|NCT00084266|525513845|FG001|Overall Study|Lost to Follow-up|3|||
145725913|NCT00084266|525513844|FG000|Overall Study|Participant not willing to participate|3|||
145725914|NCT00084266|525513845|FG001|Overall Study|Participant not willing to participate|8|||
145725915|NCT00084266|525513844|FG000|Overall Study|Other|360|||
145725916|NCT00084266|525513845|FG001|Overall Study|Other|344|||
145725917|NCT00084266|525513844|FG000|Overall Study|Randomized not treated|21|||
145725918|NCT00084266|525513845|FG001|Overall Study|Randomized not treated|20|||
145725919|NCT00063154|525513850|FG000|Overall Study|Disease progression|27|||
145725920|NCT00063154|525513850|FG000|Overall Study|Adverse Event|2|||
145725921|NCT00063154|525513850|FG000|Overall Study|Physician Decision|10|||
145725922|NCT00063154|525513850|FG000|Overall Study|Death|3|||
145725923|NCT00063154|525513850|FG000|Overall Study|Reason unspecified|1|||
145725924|NCT00063154|525513850|FG000|Overall Study|Did not receive treatment|8|||
145725925|NCT01122862|525513851|FG000|Period 1|Protocol Violation|0|||
145725926|NCT01122862|525513852|FG001|Period 1|Protocol Violation|1|||
145725927|NCT01122862|525513853|FG002|Period 1|Protocol Violation|0|||
145725928|NCT01122862|525513851|FG000|Period 2|Adverse Event|0|||
145725929|NCT01122862|525513852|FG001|Period 2|Adverse Event|0|||
145725930|NCT01122862|525513853|FG002|Period 2|Adverse Event|1|||
145725931|NCT00846391|525513854|FG000|Overall Study|Physician Decision|0|||
145725932|NCT00846391|525513855|FG001|Overall Study|Physician Decision|0|||
145725933|NCT00846391|525513856|FG002|Overall Study|Physician Decision|1|||
145725934|NCT00846391|525513854|FG000|Overall Study|Study Terminated by Sponsor|1|||
145725935|NCT00846391|525513855|FG001|Overall Study|Study Terminated by Sponsor|2|||
145725936|NCT00846391|525513856|FG002|Overall Study|Study Terminated by Sponsor|2|||
145725937|NCT02699983|525513857|FG000|Overall Study|Withdrawal by Subject|1|||
145725938|NCT02699983|525513858|FG001|Overall Study|Withdrawal by Subject|0|||
145725939|NCT02070588|525513864|FG000|Overall Study|Withdrawal by Subject|29|||
145725940|NCT02070588|525513865|FG001|Overall Study|Withdrawal by Subject|1|||
145725941|NCT02070588|525513866|FG002|Overall Study|Withdrawal by Subject|0|||
145725942|NCT02070588|525513864|FG000|Overall Study|Writhdrawal due to early termination|9|||
145725943|NCT02070588|525513865|FG001|Overall Study|Writhdrawal due to early termination|0|||
145725944|NCT02070588|525513866|FG002|Overall Study|Writhdrawal due to early termination|0|||
145725945|NCT02070588|525513864|FG000|Overall Study|Adverse Event|1|||
145725946|NCT02070588|525513865|FG001|Overall Study|Adverse Event|0|||
145725947|NCT02070588|525513866|FG002|Overall Study|Adverse Event|0|||
145725948|NCT01790126|525513872|FG000|Overall Study|PSA Progression|12|||
145725949|NCT01790126|525513873|FG001|Overall Study|PSA Progression|16|||
145725950|NCT01790126|525513874|FG002|Overall Study|PSA Progression|16|||
145725951|NCT01790126|525513872|FG000|Overall Study|Other|5|||
145725952|NCT01790126|525513873|FG001|Overall Study|Other|4|||
145725953|NCT01790126|525513874|FG002|Overall Study|Other|8|||
145725954|NCT01790126|525513872|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
145725955|NCT01790126|525513873|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
145725956|NCT01790126|525513874|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
145725957|NCT01790126|525513872|FG000|Overall Study|Withdrawal by Physician|1|||
145725958|NCT01790126|525513873|FG001|Overall Study|Withdrawal by Physician|1|||
145725959|NCT01790126|525513874|FG002|Overall Study|Withdrawal by Physician|2|||
145725960|NCT01790126|525513872|FG000|Overall Study|Withdrawal by Subject|3|||
145725961|NCT01790126|525513873|FG001|Overall Study|Withdrawal by Subject|1|||
145725962|NCT01790126|525513874|FG002|Overall Study|Withdrawal by Subject|2|||
145725963|NCT01790126|525513872|FG000|Overall Study|Lost to Follow-up|1|||
145725964|NCT01790126|525513873|FG001|Overall Study|Lost to Follow-up|0|||
145725965|NCT01790126|525513874|FG002|Overall Study|Lost to Follow-up|1|||
145725966|NCT01790126|525513872|FG000|Overall Study|Adverse Event|0|||
145725967|NCT01790126|525513873|FG001|Overall Study|Adverse Event|2|||
145725968|NCT01790126|525513874|FG002|Overall Study|Adverse Event|0|||
145725969|NCT01790126|525513872|FG000|Overall Study|Death|2|||
145725970|NCT01790126|525513873|FG001|Overall Study|Death|0|||
145725971|NCT01790126|525513874|FG002|Overall Study|Death|0|||
145266636|NCT04668066|523825246|FG009|Part 1: Treatment Phase|Other|0|||
145725972|NCT01790126|525513872|FG000|Overall Study|Radiographic Progression|3|||
145725973|NCT01790126|525513873|FG001|Overall Study|Radiographic Progression|1|||
145725974|NCT01790126|525513874|FG002|Overall Study|Radiographic Progression|0|||
145725975|NCT00940108|525513878|FG000|Overall Study|Adverse Event|2|||
145494814|NCT01283139|524670193|FG003|Overall Study|Death|2|||
145494815|NCT01283139|524670190|FG000|Overall Study|Lack of Efficacy|1|||
145494816|NCT01283139|524670191|FG001|Overall Study|Lack of Efficacy|2|||
145494817|NCT01283139|524670192|FG002|Overall Study|Lack of Efficacy|2|||
145494818|NCT01283139|524670193|FG003|Overall Study|Lack of Efficacy|1|||
145494819|NCT01283139|524670190|FG000|Overall Study|Early termination due to AE/SAE|1|||
145494820|NCT01283139|524670191|FG001|Overall Study|Early termination due to AE/SAE|1|||
145494821|NCT01283139|524670192|FG002|Overall Study|Early termination due to AE/SAE|0|||
145494822|NCT01283139|524670193|FG003|Overall Study|Early termination due to AE/SAE|0|||
145494823|NCT01283139|524670190|FG000|Overall Study|Participant's refusal to continue|0|||
145494824|NCT01283139|524670191|FG001|Overall Study|Participant's refusal to continue|3|||
145494825|NCT01283139|524670192|FG002|Overall Study|Participant's refusal to continue|1|||
145494826|NCT01283139|524670193|FG003|Overall Study|Participant's refusal to continue|1|||
145494827|NCT01283139|524670190|FG000|Overall Study|Pregnancy|0|||
145494828|NCT01283139|524670191|FG001|Overall Study|Pregnancy|1|||
145494829|NCT01283139|524670192|FG002|Overall Study|Pregnancy|1|||
145494830|NCT01283139|524670193|FG003|Overall Study|Pregnancy|0|||
145494831|NCT01283139|524670190|FG000|Overall Study|Missed follow-up visit|0|||
145494832|NCT01283139|524670191|FG001|Overall Study|Missed follow-up visit|1|||
145494833|NCT01283139|524670192|FG002|Overall Study|Missed follow-up visit|2|||
145494834|NCT01283139|524670193|FG003|Overall Study|Missed follow-up visit|2|||
145494835|NCT01283139|524670190|FG000|Overall Study|Participant randomized in error|0|||
145494836|NCT01283139|524670191|FG001|Overall Study|Participant randomized in error|0|||
145494837|NCT01283139|524670192|FG002|Overall Study|Participant randomized in error|1|||
145494838|NCT01283139|524670193|FG003|Overall Study|Participant randomized in error|0|||
145494839|NCT00004563|524670194|FG000|Overall Study|Withdrawal by Subject|20|||
145494840|NCT00004563|524670195|FG001|Overall Study|Withdrawal by Subject|16|||
145494841|NCT00004563|524670194|FG000|Overall Study|Lack of Efficacy|3|||
145494842|NCT00004563|524670195|FG001|Overall Study|Lack of Efficacy|5|||
145494843|NCT00004563|524670194|FG000|Overall Study|Death|2|||
145494844|NCT00004563|524670195|FG001|Overall Study|Death|3|||
145494845|NCT02954536|524670197|FG000|Overall Study|Adverse Event|2|||
145494846|NCT02954536|524670197|FG000|Overall Study|Death|12|||
145494847|NCT00685165|524670202|FG000|Washout Period of 14 Days|Adverse Event|1|||
145494848|NCT00685165|524670203|FG001|Washout Period of 14 Days|Adverse Event|0|||
145494849|NCT04576988|524670210|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
145494850|NCT04576988|524670211|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
145494851|NCT04576988|524670210|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
145494852|NCT04576988|524670211|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
145494853|NCT04576988|524670210|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
145494854|NCT04576988|524670211|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
145494855|NCT04576988|524670210|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
145494856|NCT04576988|524670211|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
145494857|NCT04576988|524670210|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
145494858|NCT04576988|524670211|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
145494859|NCT04576988|524670210|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
145494860|NCT04576988|524670211|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
145494861|NCT04576988|524670210|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
145494862|NCT04576988|524670211|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
145494863|NCT04576988|524670210|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
145494864|NCT04576988|524670211|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
145494865|NCT04576988|524670210|FG000|Long Term Double Blind (LTDB)|Death|2|||
145494866|NCT04576988|524670211|FG001|Long Term Double Blind (LTDB)|Death|1|||
145494867|NCT04576988|524670210|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
145494868|NCT04576988|524670211|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
145494869|NCT01576341|524670214|FG000|Overall Study|Withdrawal by Subject|24|||
145494870|NCT01576341|524670214|FG000|Overall Study|Adverse Event|10|||
145494871|NCT01576341|524670214|FG000|Overall Study|Death|21|||
145494872|NCT01576341|524670214|FG000|Overall Study|Physician Decision|2|||
145494873|NCT01576341|524670214|FG000|Overall Study|Lost to Follow-up|2|||
145494874|NCT01576341|524670214|FG000|Overall Study|Kidney transplantation|10|||
145494875|NCT01576341|524670214|FG000|Overall Study|Protocol Violation|12|||
145494876|NCT01576341|524670214|FG000|Overall Study|Other|12|||
145494877|NCT01844765|524670215|FG000|Overall Study|Adverse Event|6|||
145494878|NCT01844765|524670216|FG001|Overall Study|Adverse Event|8|||
145494879|NCT01844765|524670215|FG000|Overall Study|Withdrawal by Subject|2|||
145494880|NCT01844765|524670216|FG001|Overall Study|Withdrawal by Subject|3|||
145494881|NCT01844765|524670215|FG000|Overall Study|Disease progression|1|||
145494882|NCT01844765|524670216|FG001|Overall Study|Disease progression|0|||
145494883|NCT01844765|524670215|FG000|Overall Study|Administrative problems|3|||
145494884|NCT01844765|524670216|FG001|Overall Study|Administrative problems|4|||
145494885|NCT01844765|524670215|FG000|Overall Study|Protocol deviation|2|||
145494886|NCT01844765|524670216|FG001|Overall Study|Protocol deviation|0|||
145494887|NCT01844765|524670215|FG000|Overall Study|Untreated|1|||
145494888|NCT01844765|524670216|FG001|Overall Study|Untreated|0|||
145725976|NCT00940108|525513879|FG001|Overall Study|Adverse Event|4|||
145725977|NCT00940108|525513880|FG002|Overall Study|Adverse Event|0|||
145725978|NCT00940108|525513881|FG003|Overall Study|Adverse Event|2|||
145725979|NCT00940108|525513878|FG000|Overall Study|Withdrew Consent|2|||
145725980|NCT00940108|525513879|FG001|Overall Study|Withdrew Consent|1|||
145725981|NCT00940108|525513880|FG002|Overall Study|Withdrew Consent|0|||
145725982|NCT00940108|525513881|FG003|Overall Study|Withdrew Consent|1|||
145725983|NCT00940108|525513878|FG000|Overall Study|Dose 2 contraindicated|1|||
145725984|NCT00940108|525513879|FG001|Overall Study|Dose 2 contraindicated|1|||
145725985|NCT00940108|525513880|FG002|Overall Study|Dose 2 contraindicated|0|||
145725986|NCT00940108|525513881|FG003|Overall Study|Dose 2 contraindicated|1|||
145725987|NCT00940108|525513878|FG000|Overall Study|Declined further vaccination|0|||
145725988|NCT00940108|525513879|FG001|Overall Study|Declined further vaccination|1|||
145725989|NCT00940108|525513880|FG002|Overall Study|Declined further vaccination|3|||
145725990|NCT00940108|525513881|FG003|Overall Study|Declined further vaccination|0|||
145725991|NCT00940108|525513878|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
145725992|NCT00940108|525513879|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
145725993|NCT00940108|525513880|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
145725994|NCT00940108|525513881|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
145725995|NCT00940108|525513878|FG000|Overall Study|Viral illness after Dose 1|0|||
145725996|NCT00940108|525513879|FG001|Overall Study|Viral illness after Dose 1|1|||
145725997|NCT00940108|525513880|FG002|Overall Study|Viral illness after Dose 1|0|||
145725998|NCT00940108|525513881|FG003|Overall Study|Viral illness after Dose 1|0|||
145725999|NCT00940108|525513878|FG000|Overall Study|Diagnosed with H1N1|0|||
145726000|NCT00940108|525513879|FG001|Overall Study|Diagnosed with H1N1|0|||
145726001|NCT00940108|525513880|FG002|Overall Study|Diagnosed with H1N1|0|||
145726002|NCT00940108|525513881|FG003|Overall Study|Diagnosed with H1N1|1|||
145726003|NCT02434939|525513882|FG000|Overall Study|Lack of Efficacy|34|||
145726004|NCT02434939|525513883|FG001|Overall Study|Lack of Efficacy|48|||
145726005|NCT02434939|525513882|FG000|Overall Study|Withdrawal by Subject|3|||
145726006|NCT02434939|525513883|FG001|Overall Study|Withdrawal by Subject|0|||
145726007|NCT02434939|525513882|FG000|Overall Study|Adverse Event|0|||
145726008|NCT02434939|525513883|FG001|Overall Study|Adverse Event|1|||
145726009|NCT00051363|525513897|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
145726010|NCT00051363|525513898|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
145726011|NCT00051363|525513897|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
145726012|NCT00051363|525513898|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
145726013|NCT00051363|525513897|FG000|Overall Study|Death|2|||
145726014|NCT00051363|525513898|FG001|Overall Study|Death|2|||
145726015|NCT00051363|525513897|FG000|Overall Study|Excluded Pre-Randomization|2|||
145726016|NCT00051363|525513898|FG001|Overall Study|Excluded Pre-Randomization|5|||
145726017|NCT02640157|525513900|FG000|Overall Study|Adverse Event|2|||
145726018|NCT02640157|525513901|FG001|Overall Study|Adverse Event|2|||
145726019|NCT02640157|525513902|FG002|Overall Study|Adverse Event|1|||
145726020|NCT02640157|525513900|FG000|Overall Study|Withdrew consent|2|||
145726021|NCT02640157|525513901|FG001|Overall Study|Withdrew consent|0|||
145726022|NCT02640157|525513902|FG002|Overall Study|Withdrew consent|2|||
145726023|NCT02640157|525513900|FG000|Overall Study|Lost to Follow-up|9|||
145726024|NCT02640157|525513901|FG001|Overall Study|Lost to Follow-up|2|||
145726025|NCT02640157|525513902|FG002|Overall Study|Lost to Follow-up|7|||
145726026|NCT02640157|525513900|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
145726027|NCT02640157|525513901|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
145726028|NCT02640157|525513902|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
145726029|NCT01679405|525513903|FG000|Overall Study|Death|2|||
145726030|NCT01679405|525513904|FG001|Overall Study|Death|5|||
145494889|NCT00556075|524670225|FG000|Overall Study|Lost to Follow-up|3|||
145494890|NCT00556075|524670226|FG001|Overall Study|Lost to Follow-up|0|||
145494891|NCT00556075|524670227|FG002|Overall Study|Lost to Follow-up|3|||
145494892|NCT00556075|524670225|FG000|Overall Study|Withdrawal by Subject|3|||
145494893|NCT00556075|524670226|FG001|Overall Study|Withdrawal by Subject|3|||
145494894|NCT00556075|524670227|FG002|Overall Study|Withdrawal by Subject|0|||
145494895|NCT00556075|524670225|FG000|Overall Study|Protocol Violation|1|||
145494896|NCT00556075|524670226|FG001|Overall Study|Protocol Violation|1|||
145494897|NCT00556075|524670227|FG002|Overall Study|Protocol Violation|3|||
145494898|NCT00556075|524670225|FG000|Overall Study|Not eligible|1|||
145494899|NCT00556075|524670226|FG001|Overall Study|Not eligible|1|||
145726031|NCT04677179|525513905|FG000|Induction Treatment Period|Adverse Event|1|||
145494900|NCT00556075|524670227|FG002|Overall Study|Not eligible|2|||
145726032|NCT04677179|525513906|FG001|Induction Treatment Period|Adverse Event|0|||
145494901|NCT00556075|524670225|FG000|Overall Study|Adverse Event|1|||
145726033|NCT04677179|525513907|FG002|Induction Treatment Period|Adverse Event|0|||
145726034|NCT04677179|525513908|FG003|Induction Treatment Period|Adverse Event|0|||
145726035|NCT04677179|525513909|FG004|Induction Treatment Period|Adverse Event|0|||
145726036|NCT04677179|525513910|FG005|Induction Treatment Period|Adverse Event|0|||
145726037|NCT04677179|525513911|FG006|Induction Treatment Period|Adverse Event|0|||
145726038|NCT04677179|525513912|FG007|Induction Treatment Period|Adverse Event|0|||
145726039|NCT04677179|525513913|FG008|Induction Treatment Period|Adverse Event|0|||
145726040|NCT04677179|525513914|FG009|Induction Treatment Period|Adverse Event|0|||
145726041|NCT04677179|525513905|FG000|Induction Treatment Period|Physician Decision|1|||
145726042|NCT04677179|525513906|FG001|Induction Treatment Period|Physician Decision|0|||
145726043|NCT04677179|525513907|FG002|Induction Treatment Period|Physician Decision|1|||
145726044|NCT04677179|525513908|FG003|Induction Treatment Period|Physician Decision|0|||
145726045|NCT04677179|525513909|FG004|Induction Treatment Period|Physician Decision|0|||
145726046|NCT04677179|525513910|FG005|Induction Treatment Period|Physician Decision|0|||
145726047|NCT04677179|525513911|FG006|Induction Treatment Period|Physician Decision|0|||
145726048|NCT04677179|525513912|FG007|Induction Treatment Period|Physician Decision|0|||
145726049|NCT04677179|525513913|FG008|Induction Treatment Period|Physician Decision|0|||
145726050|NCT04677179|525513914|FG009|Induction Treatment Period|Physician Decision|0|||
145726051|NCT04677179|525513905|FG000|Induction Treatment Period|Protocol Violation|0|||
145726052|NCT04677179|525513906|FG001|Induction Treatment Period|Protocol Violation|1|||
145726053|NCT04677179|525513907|FG002|Induction Treatment Period|Protocol Violation|0|||
145726054|NCT04677179|525513908|FG003|Induction Treatment Period|Protocol Violation|0|||
145726055|NCT04677179|525513909|FG004|Induction Treatment Period|Protocol Violation|0|||
145726056|NCT04677179|525513910|FG005|Induction Treatment Period|Protocol Violation|0|||
145726057|NCT04677179|525513911|FG006|Induction Treatment Period|Protocol Violation|0|||
145726058|NCT04677179|525513912|FG007|Induction Treatment Period|Protocol Violation|0|||
145726059|NCT04677179|525513913|FG008|Induction Treatment Period|Protocol Violation|0|||
145726060|NCT04677179|525513914|FG009|Induction Treatment Period|Protocol Violation|0|||
145726061|NCT04677179|525513905|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
145726062|NCT04677179|525513906|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
145726063|NCT04677179|525513907|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
145726064|NCT04677179|525513908|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
145726065|NCT04677179|525513909|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
145726066|NCT04677179|525513910|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
145726067|NCT04677179|525513911|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
145726068|NCT04677179|525513912|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
145726069|NCT04677179|525513913|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
145726070|NCT04677179|525513914|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
145726071|NCT04677179|525513905|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
145726072|NCT04677179|525513906|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
145726073|NCT04677179|525513907|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
145726074|NCT04677179|525513908|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
145726075|NCT04677179|525513909|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
145726076|NCT04677179|525513910|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
145726077|NCT04677179|525513911|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
145726078|NCT04677179|525513912|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
145726079|NCT04677179|525513913|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
145726080|NCT04677179|525513914|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
145726081|NCT04677179|525513905|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
145726082|NCT04677179|525513906|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
145726083|NCT04677179|525513907|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
145726084|NCT04677179|525513908|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
145726085|NCT04677179|525513909|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
145726086|NCT04677179|525513910|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
145726087|NCT04677179|525513911|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
145726088|NCT04677179|525513912|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
145726089|NCT04677179|525513913|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
145726090|NCT04677179|525513914|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
145726091|NCT04677179|525513905|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726092|NCT04677179|525513906|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726093|NCT04677179|525513907|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726094|NCT04677179|525513908|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
145726095|NCT04677179|525513909|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726096|NCT04677179|525513910|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726097|NCT04677179|525513911|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726098|NCT04677179|525513912|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726099|NCT04677179|525513913|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726100|NCT04677179|525513914|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
145726101|NCT04677179|525513905|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726102|NCT04677179|525513906|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726103|NCT04677179|525513907|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726104|NCT04677179|525513908|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
145726105|NCT04677179|525513909|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
145726106|NCT04677179|525513910|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
145726107|NCT04677179|525513911|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726108|NCT04677179|525513912|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726109|NCT04677179|525513913|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726110|NCT04677179|525513914|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
145726111|NCT04677179|525513905|FG000|Extension Treatment Period|Lack of Efficacy|0|||
145726112|NCT04677179|525513906|FG001|Extension Treatment Period|Lack of Efficacy|0|||
145726113|NCT04677179|525513907|FG002|Extension Treatment Period|Lack of Efficacy|0|||
145726114|NCT04677179|525513908|FG003|Extension Treatment Period|Lack of Efficacy|0|||
145726115|NCT04677179|525513909|FG004|Extension Treatment Period|Lack of Efficacy|0|||
145726116|NCT04677179|525513910|FG005|Extension Treatment Period|Lack of Efficacy|0|||
145726117|NCT04677179|525513911|FG006|Extension Treatment Period|Lack of Efficacy|6|||
145726118|NCT04677179|525513912|FG007|Extension Treatment Period|Lack of Efficacy|0|||
145726119|NCT04677179|525513913|FG008|Extension Treatment Period|Lack of Efficacy|0|||
145726120|NCT04677179|525513914|FG009|Extension Treatment Period|Lack of Efficacy|0|||
145726121|NCT04677179|525513905|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
145726122|NCT04677179|525513906|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145383793|NCT02815267|524260154|FG000|Double-Blind Phase|Adverse Event|0|||
145383794|NCT02815267|524260155|FG001|Double-Blind Phase|Adverse Event|3|||
145726123|NCT04677179|525513907|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
145726124|NCT04677179|525513908|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
145726125|NCT04677179|525513909|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
145726126|NCT04677179|525513910|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
145726127|NCT04677179|525513911|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
145726128|NCT04677179|525513912|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
145726129|NCT04677179|525513913|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
145726130|NCT04677179|525513914|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
145726131|NCT04677179|525513905|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
145726132|NCT04677179|525513906|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
145726133|NCT04677179|525513907|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
145726134|NCT04677179|525513908|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
145726135|NCT04677179|525513909|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
145726136|NCT04677179|525513910|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
145726137|NCT04677179|525513911|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
145726138|NCT04677179|525513912|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
145726139|NCT04677179|525513913|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
145726140|NCT04677179|525513914|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
145726141|NCT04677179|525513905|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
145726142|NCT04677179|525513906|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
145726143|NCT04677179|525513907|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
145726144|NCT04677179|525513908|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
145726145|NCT04677179|525513909|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
145726146|NCT04677179|525513910|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
145726147|NCT04677179|525513911|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
145494902|NCT00556075|524670226|FG001|Overall Study|Adverse Event|2|||
145494903|NCT00556075|524670227|FG002|Overall Study|Adverse Event|0|||
145494904|NCT00556075|524670225|FG000|Overall Study|Personal issues|4|||
145494905|NCT00556075|524670226|FG001|Overall Study|Personal issues|1|||
145494906|NCT00556075|524670227|FG002|Overall Study|Personal issues|0|||
145726148|NCT04677179|525513912|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
145726149|NCT04677179|525513913|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
145726150|NCT04677179|525513914|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
145726151|NCT04677179|525513905|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726152|NCT04677179|525513906|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726153|NCT04677179|525513907|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726154|NCT04677179|525513908|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726155|NCT04677179|525513909|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726156|NCT04677179|525513910|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726157|NCT04677179|525513911|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726158|NCT04677179|525513912|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
145726159|NCT04677179|525513913|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
145726160|NCT04677179|525513914|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
145726161|NCT04677179|525513905|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726162|NCT04677179|525513906|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726163|NCT04677179|525513907|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726164|NCT04677179|525513908|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726165|NCT04677179|525513909|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726166|NCT04677179|525513910|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726167|NCT04677179|525513911|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726168|NCT04677179|525513912|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
145726169|NCT04677179|525513913|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726170|NCT04677179|525513914|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145726171|NCT04677179|525513905|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726172|NCT04677179|525513906|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726173|NCT04677179|525513907|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726174|NCT04677179|525513908|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726175|NCT04677179|525513909|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726176|NCT04677179|525513910|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726177|NCT04677179|525513911|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726178|NCT04677179|525513912|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
145726179|NCT04677179|525513913|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
145726180|NCT04677179|525513914|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145726181|NCT04677179|525513905|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726182|NCT04677179|525513906|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726183|NCT04677179|525513907|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726184|NCT04677179|525513908|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726185|NCT04677179|525513909|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726186|NCT04677179|525513910|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726187|NCT04677179|525513911|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
145726188|NCT04677179|525513912|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
145726189|NCT04677179|525513913|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
145726190|NCT04677179|525513914|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
145726191|NCT00585195|525513916|FG000|Overall Study|Adverse Event|0|||
145726192|NCT00585195|525513917|FG001|Overall Study|Adverse Event|0|||
145726193|NCT00585195|525513918|FG002|Overall Study|Adverse Event|0|||
145726194|NCT00585195|525513919|FG003|Overall Study|Adverse Event|0|||
145726195|NCT00585195|525513920|FG004|Overall Study|Adverse Event|2|||
145726196|NCT00585195|525513921|FG005|Overall Study|Adverse Event|1|||
145726197|NCT00585195|525513922|FG006|Overall Study|Adverse Event|0|||
145726198|NCT00585195|525513923|FG007|Overall Study|Adverse Event|1|||
145726199|NCT00585195|525513924|FG008|Overall Study|Adverse Event|0|||
145726200|NCT00585195|525513925|FG009|Overall Study|Adverse Event|0|||
145726201|NCT00585195|525513926|FG010|Overall Study|Adverse Event|3|||
145726202|NCT00585195|525513927|FG011|Overall Study|Adverse Event|0|||
145726203|NCT00585195|525513928|FG012|Overall Study|Adverse Event|8|||
145726204|NCT00585195|525513929|FG013|Overall Study|Adverse Event|6|||
145726205|NCT00585195|525513930|FG014|Overall Study|Adverse Event|4|||
145726206|NCT00585195|525513931|FG015|Overall Study|Adverse Event|1|||
145726207|NCT00585195|525513932|FG016|Overall Study|Adverse Event|14|||
145726208|NCT00585195|525513933|FG017|Overall Study|Adverse Event|9|||
145726209|NCT00585195|525513934|FG018|Overall Study|Adverse Event|2|||
145726210|NCT00585195|525513935|FG019|Overall Study|Adverse Event|3|||
145726211|NCT00585195|525513936|FG020|Overall Study|Adverse Event|1|||
145726212|NCT00585195|525513916|FG000|Overall Study|Progressive Disease|2|||
145383795|NCT02815267|524260154|FG000|Double-Blind Phase|Lost to Follow-up|17|||
145726213|NCT00585195|525513917|FG001|Overall Study|Progressive Disease|2|||
145726214|NCT00585195|525513918|FG002|Overall Study|Progressive Disease|5|||
145726215|NCT00585195|525513919|FG003|Overall Study|Progressive Disease|4|||
145726216|NCT00585195|525513920|FG004|Overall Study|Progressive Disease|6|||
145726217|NCT00585195|525513921|FG005|Overall Study|Progressive Disease|4|||
145726218|NCT00585195|525513922|FG006|Overall Study|Progressive Disease|6|||
145726219|NCT00585195|525513923|FG007|Overall Study|Progressive Disease|3|||
145726220|NCT00585195|525513924|FG008|Overall Study|Progressive Disease|0|||
145726221|NCT00585195|525513925|FG009|Overall Study|Progressive Disease|5|||
145726222|NCT00585195|525513926|FG010|Overall Study|Progressive Disease|2|||
145726223|NCT00585195|525513927|FG011|Overall Study|Progressive Disease|25|||
145726224|NCT00585195|525513928|FG012|Overall Study|Progressive Disease|29|||
145726225|NCT00585195|525513929|FG013|Overall Study|Progressive Disease|26|||
145726226|NCT00585195|525513930|FG014|Overall Study|Progressive Disease|21|||
145726227|NCT00585195|525513931|FG015|Overall Study|Progressive Disease|12|||
145726228|NCT00585195|525513932|FG016|Overall Study|Progressive Disease|94|||
145726229|NCT00585195|525513933|FG017|Overall Study|Progressive Disease|42|||
145726230|NCT00585195|525513934|FG018|Overall Study|Progressive Disease|4|||
145726231|NCT00585195|525513935|FG019|Overall Study|Progressive Disease|9|||
145726232|NCT00585195|525513936|FG020|Overall Study|Progressive Disease|8|||
145726233|NCT00585195|525513916|FG000|Overall Study|Withdrawal by Subject|1|||
145726234|NCT00585195|525513917|FG001|Overall Study|Withdrawal by Subject|1|||
145726235|NCT00585195|525513918|FG002|Overall Study|Withdrawal by Subject|2|||
145726236|NCT00585195|525513919|FG003|Overall Study|Withdrawal by Subject|2|||
145726237|NCT00585195|525513920|FG004|Overall Study|Withdrawal by Subject|0|||
145726238|NCT00585195|525513921|FG005|Overall Study|Withdrawal by Subject|0|||
145726239|NCT00585195|525513922|FG006|Overall Study|Withdrawal by Subject|0|||
145726240|NCT00585195|525513923|FG007|Overall Study|Withdrawal by Subject|1|||
145726241|NCT00585195|525513924|FG008|Overall Study|Withdrawal by Subject|0|||
145726242|NCT00585195|525513925|FG009|Overall Study|Withdrawal by Subject|0|||
145726243|NCT00585195|525513926|FG010|Overall Study|Withdrawal by Subject|3|||
145726244|NCT00585195|525513927|FG011|Overall Study|Withdrawal by Subject|8|||
145726245|NCT00585195|525513928|FG012|Overall Study|Withdrawal by Subject|15|||
145726246|NCT00585195|525513929|FG013|Overall Study|Withdrawal by Subject|0|||
145726247|NCT00585195|525513930|FG014|Overall Study|Withdrawal by Subject|3|||
145726248|NCT00585195|525513931|FG015|Overall Study|Withdrawal by Subject|0|||
145726249|NCT00585195|525513932|FG016|Overall Study|Withdrawal by Subject|7|||
145726250|NCT00585195|525513933|FG017|Overall Study|Withdrawal by Subject|1|||
145726251|NCT00585195|525513934|FG018|Overall Study|Withdrawal by Subject|2|||
145726252|NCT00585195|525513935|FG019|Overall Study|Withdrawal by Subject|2|||
145726253|NCT00585195|525513936|FG020|Overall Study|Withdrawal by Subject|0|||
145726254|NCT00585195|525513916|FG000|Overall Study|Other|0|||
145726255|NCT00585195|525513917|FG001|Overall Study|Other|1|||
145726256|NCT00585195|525513918|FG002|Overall Study|Other|1|||
145726257|NCT00585195|525513919|FG003|Overall Study|Other|1|||
145726258|NCT00585195|525513920|FG004|Overall Study|Other|0|||
145726259|NCT00585195|525513921|FG005|Overall Study|Other|1|||
145726260|NCT00585195|525513922|FG006|Overall Study|Other|0|||
145726261|NCT00585195|525513923|FG007|Overall Study|Other|0|||
145726262|NCT00585195|525513924|FG008|Overall Study|Other|2|||
145726263|NCT00585195|525513925|FG009|Overall Study|Other|1|||
145726264|NCT00585195|525513926|FG010|Overall Study|Other|0|||
145726265|NCT00585195|525513927|FG011|Overall Study|Other|19|||
145726266|NCT00585195|525513928|FG012|Overall Study|Other|24|||
145726267|NCT00585195|525513929|FG013|Overall Study|Other|7|||
145726268|NCT00585195|525513930|FG014|Overall Study|Other|11|||
145726269|NCT00585195|525513931|FG015|Overall Study|Other|3|||
145726270|NCT00585195|525513932|FG016|Overall Study|Other|28|||
145726271|NCT00585195|525513933|FG017|Overall Study|Other|12|||
145726272|NCT00585195|525513934|FG018|Overall Study|Other|10|||
145726273|NCT00585195|525513935|FG019|Overall Study|Other|4|||
145726274|NCT00585195|525513936|FG020|Overall Study|Other|2|||
145726275|NCT00585195|525513916|FG000|Overall Study|Randomized not treated|0|||
145726276|NCT00585195|525513917|FG001|Overall Study|Randomized not treated|0|||
145726277|NCT00585195|525513918|FG002|Overall Study|Randomized not treated|1|||
145726278|NCT00585195|525513919|FG003|Overall Study|Randomized not treated|0|||
145726279|NCT00585195|525513920|FG004|Overall Study|Randomized not treated|1|||
145726280|NCT00585195|525513921|FG005|Overall Study|Randomized not treated|0|||
145726281|NCT00585195|525513922|FG006|Overall Study|Randomized not treated|1|||
145726282|NCT00585195|525513923|FG007|Overall Study|Randomized not treated|0|||
145726283|NCT00585195|525513924|FG008|Overall Study|Randomized not treated|0|||
145726284|NCT00585195|525513925|FG009|Overall Study|Randomized not treated|0|||
145726285|NCT00585195|525513926|FG010|Overall Study|Randomized not treated|2|||
145726286|NCT00585195|525513927|FG011|Overall Study|Randomized not treated|0|||
145726287|NCT00585195|525513928|FG012|Overall Study|Randomized not treated|0|||
145726288|NCT00585195|525513929|FG013|Overall Study|Randomized not treated|0|||
145726289|NCT00585195|525513930|FG014|Overall Study|Randomized not treated|0|||
145726290|NCT00585195|525513931|FG015|Overall Study|Randomized not treated|1|||
145726291|NCT00585195|525513932|FG016|Overall Study|Randomized not treated|0|||
145726292|NCT00585195|525513933|FG017|Overall Study|Randomized not treated|1|||
145494907|NCT00556075|524670225|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
145494908|NCT00556075|524670226|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
145494909|NCT00556075|524670227|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
145494910|NCT01927497|524670228|FG000|Overall Study|Death|0|||
145494911|NCT01927497|524670229|FG001|Overall Study|Death|1|||
145494912|NCT01927497|524670228|FG000|Overall Study|Protocol Violation|2|||
145494913|NCT01927497|524670229|FG001|Overall Study|Protocol Violation|0|||
145494914|NCT00395746|524670230|FG000|Overall Study|Adverse Event|5|||
145494915|NCT00395746|524670231|FG001|Overall Study|Adverse Event|2|||
145494916|NCT00395746|524670232|FG002|Overall Study|Adverse Event|2|||
145494917|NCT00395746|524670230|FG000|Overall Study|Protocol Violation|0|||
145494918|NCT00395746|524670231|FG001|Overall Study|Protocol Violation|1|||
145494919|NCT00395746|524670232|FG002|Overall Study|Protocol Violation|0|||
145494920|NCT00395746|524670230|FG000|Overall Study|Lack of Efficacy|2|||
145494921|NCT00395746|524670231|FG001|Overall Study|Lack of Efficacy|0|||
145494922|NCT00395746|524670232|FG002|Overall Study|Lack of Efficacy|17|||
145494923|NCT00395746|524670230|FG000|Overall Study|Hypoglycaemia|2|||
145494924|NCT00395746|524670231|FG001|Overall Study|Hypoglycaemia|1|||
145494925|NCT00395746|524670232|FG002|Overall Study|Hypoglycaemia|0|||
145494926|NCT00395746|524670230|FG000|Overall Study|Subject decision|0|||
145494927|NCT00395746|524670231|FG001|Overall Study|Subject decision|0|||
145494928|NCT00395746|524670232|FG002|Overall Study|Subject decision|1|||
145494929|NCT00395746|524670230|FG000|Overall Study|Withdrawal of consent|0|||
145494930|NCT00395746|524670231|FG001|Overall Study|Withdrawal of consent|0|||
145494931|NCT00395746|524670232|FG002|Overall Study|Withdrawal of consent|1|||
145494932|NCT00395746|524670230|FG000|Overall Study|Difficultulty in use of device|0|||
145494933|NCT00395746|524670231|FG001|Overall Study|Difficultulty in use of device|0|||
145494934|NCT00395746|524670232|FG002|Overall Study|Difficultulty in use of device|1|||
145494935|NCT00395746|524670230|FG000|Overall Study|Unable to visit site on schedule|1|||
145494936|NCT00395746|524670231|FG001|Overall Study|Unable to visit site on schedule|0|||
145494937|NCT00395746|524670232|FG002|Overall Study|Unable to visit site on schedule|0|||
145494938|NCT04528641|524670233|FG000|Overall Study|Withdrawal by Subject|0|||
145494939|NCT04528641|524670234|FG001|Overall Study|Withdrawal by Subject|0|||
145494940|NCT04528641|524670235|FG002|Overall Study|Withdrawal by Subject|0|||
145494941|NCT04528641|524670236|FG003|Overall Study|Withdrawal by Subject|1|||
145494942|NCT04528641|524670237|FG004|Overall Study|Withdrawal by Subject|0|||
145494943|NCT04528641|524670238|FG005|Overall Study|Withdrawal by Subject|1|||
145494944|NCT03914417|524670239|FG000|Overall Study|Withdrawal by Subject|2|||
145494945|NCT03836625|524670242|FG000|Overall Study|Lost to Follow-up|9|||
145494946|NCT03836625|524670243|FG001|Overall Study|Lost to Follow-up|9|||
145494947|NCT03836625|524670242|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
145494948|NCT03836625|524670243|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
145494949|NCT03836625|524670242|FG000|Overall Study|Death|0|||
145494950|NCT03836625|524670243|FG001|Overall Study|Death|1|||
145494951|NCT03836625|524670242|FG000|Overall Study|Refused follow-up|0|||
145494952|NCT03836625|524670243|FG001|Overall Study|Refused follow-up|1|||
145494953|NCT00517296|524670244|FG000|Overall Study|Withdrawal by Subject|1|||
145494954|NCT00517296|524670245|FG001|Overall Study|Withdrawal by Subject|0|||
145494955|NCT03361137|524670248|FG000|Overall Study|Reason not specified|1|||
145494956|NCT03361137|524670249|FG001|Overall Study|Reason not specified|0|||
145494957|NCT03361137|524670250|FG002|Overall Study|Reason not specified|0|||
145494958|NCT03361137|524670251|FG003|Overall Study|Reason not specified|0|||
145494959|NCT03361137|524670252|FG004|Overall Study|Reason not specified|0|||
145494960|NCT00791934|524670253|FG000|Overall Study|Withdrawal by Subject|2|||
145494961|NCT00791934|524670253|FG000|Overall Study|Did not consent for extended follow-up|13|||
145494962|NCT03413891|524670255|FG000|Overall Study|Lost to Follow-up|2|||
145494963|NCT03413891|524670256|FG001|Overall Study|Lost to Follow-up|1|||
145494964|NCT03413891|524670255|FG000|Overall Study|Protocol Violation|0|||
145494965|NCT03413891|524670256|FG001|Overall Study|Protocol Violation|1|||
145494966|NCT04905134|524670257|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
145494967|NCT04905134|524670257|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
145494968|NCT03009058|524670258|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
145494969|NCT03221556|524670259|FG000|Allocation|post-randomization exclusion|0|||
145494970|NCT03221556|524670260|FG001|Allocation|post-randomization exclusion|1|||
145494971|NCT03221556|524670259|FG000|Follow-Up|Withdrawal by Subject|0|||
145494972|NCT03221556|524670260|FG001|Follow-Up|Withdrawal by Subject|1|||
145494973|NCT02783690|524670261|FG000|Overall Study|Withdrawal by Subject|3|||
145494974|NCT02783690|524670262|FG001|Overall Study|Withdrawal by Subject|3|||
145494975|NCT01486966|524670265|FG000|Overall Study|Adverse Event|0|||
145494976|NCT01486966|524670266|FG001|Overall Study|Adverse Event|1|||
145494977|NCT01486966|524670265|FG000|Overall Study|Withdrawal by Subject|0|||
145494978|NCT01486966|524670266|FG001|Overall Study|Withdrawal by Subject|1|||
145726293|NCT00585195|525513934|FG018|Overall Study|Randomized not treated|3|||
145726294|NCT00585195|525513935|FG019|Overall Study|Randomized not treated|0|||
145726295|NCT00585195|525513936|FG020|Overall Study|Randomized not treated|2|||
145726296|NCT00585195|525513916|FG000|Overall Study|Death|0|||
145726297|NCT00585195|525513917|FG001|Overall Study|Death|0|||
145726298|NCT00585195|525513918|FG002|Overall Study|Death|0|||
145726299|NCT00585195|525513919|FG003|Overall Study|Death|0|||
145726300|NCT00585195|525513920|FG004|Overall Study|Death|0|||
145726301|NCT00585195|525513921|FG005|Overall Study|Death|0|||
145726302|NCT00585195|525513922|FG006|Overall Study|Death|0|||
145726303|NCT00585195|525513923|FG007|Overall Study|Death|0|||
145726304|NCT00585195|525513924|FG008|Overall Study|Death|1|||
145726305|NCT00585195|525513925|FG009|Overall Study|Death|0|||
145726306|NCT00585195|525513926|FG010|Overall Study|Death|1|||
145726307|NCT00585195|525513927|FG011|Overall Study|Death|1|||
145726308|NCT00585195|525513928|FG012|Overall Study|Death|7|||
145726309|NCT00585195|525513929|FG013|Overall Study|Death|2|||
145726310|NCT00585195|525513930|FG014|Overall Study|Death|8|||
145726311|NCT00585195|525513931|FG015|Overall Study|Death|2|||
145726312|NCT00585195|525513932|FG016|Overall Study|Death|11|||
145726313|NCT00585195|525513933|FG017|Overall Study|Death|0|||
145726314|NCT00585195|525513934|FG018|Overall Study|Death|0|||
145726315|NCT00585195|525513935|FG019|Overall Study|Death|0|||
145726316|NCT00585195|525513936|FG020|Overall Study|Death|1|||
145726317|NCT00585195|525513916|FG000|Overall Study|Lost to Follow-up|0|||
145726318|NCT00585195|525513917|FG001|Overall Study|Lost to Follow-up|0|||
145726319|NCT00585195|525513918|FG002|Overall Study|Lost to Follow-up|0|||
145726320|NCT00585195|525513919|FG003|Overall Study|Lost to Follow-up|0|||
145726321|NCT00585195|525513920|FG004|Overall Study|Lost to Follow-up|0|||
145726322|NCT00585195|525513921|FG005|Overall Study|Lost to Follow-up|0|||
145726323|NCT00585195|525513922|FG006|Overall Study|Lost to Follow-up|0|||
145726324|NCT00585195|525513923|FG007|Overall Study|Lost to Follow-up|0|||
145726325|NCT00585195|525513924|FG008|Overall Study|Lost to Follow-up|0|||
145726326|NCT00585195|525513925|FG009|Overall Study|Lost to Follow-up|0|||
145726327|NCT00585195|525513926|FG010|Overall Study|Lost to Follow-up|0|||
145726328|NCT00585195|525513927|FG011|Overall Study|Lost to Follow-up|0|||
145726329|NCT00585195|525513928|FG012|Overall Study|Lost to Follow-up|1|||
145726330|NCT00585195|525513929|FG013|Overall Study|Lost to Follow-up|0|||
145726331|NCT00585195|525513930|FG014|Overall Study|Lost to Follow-up|0|||
145726332|NCT00585195|525513931|FG015|Overall Study|Lost to Follow-up|0|||
145726333|NCT00585195|525513932|FG016|Overall Study|Lost to Follow-up|0|||
145726334|NCT00585195|525513933|FG017|Overall Study|Lost to Follow-up|2|||
145726335|NCT00585195|525513934|FG018|Overall Study|Lost to Follow-up|0|||
145726336|NCT00585195|525513935|FG019|Overall Study|Lost to Follow-up|0|||
145726337|NCT00585195|525513936|FG020|Overall Study|Lost to Follow-up|0|||
145726338|NCT00585195|525513916|FG000|Overall Study|Site Terminated by Sponsor|0|||
145726339|NCT00585195|525513917|FG001|Overall Study|Site Terminated by Sponsor|0|||
145726340|NCT00585195|525513918|FG002|Overall Study|Site Terminated by Sponsor|0|||
145726341|NCT00585195|525513919|FG003|Overall Study|Site Terminated by Sponsor|0|||
145726342|NCT00585195|525513920|FG004|Overall Study|Site Terminated by Sponsor|0|||
145726343|NCT00585195|525513921|FG005|Overall Study|Site Terminated by Sponsor|0|||
145726344|NCT00585195|525513922|FG006|Overall Study|Site Terminated by Sponsor|0|||
145726345|NCT00585195|525513923|FG007|Overall Study|Site Terminated by Sponsor|0|||
145726346|NCT00585195|525513924|FG008|Overall Study|Site Terminated by Sponsor|0|||
145726347|NCT00585195|525513925|FG009|Overall Study|Site Terminated by Sponsor|0|||
145726348|NCT00585195|525513926|FG010|Overall Study|Site Terminated by Sponsor|0|||
145726349|NCT00585195|525513927|FG011|Overall Study|Site Terminated by Sponsor|0|||
145726350|NCT00585195|525513928|FG012|Overall Study|Site Terminated by Sponsor|1|||
145726351|NCT00585195|525513929|FG013|Overall Study|Site Terminated by Sponsor|0|||
145726352|NCT00585195|525513930|FG014|Overall Study|Site Terminated by Sponsor|0|||
145726353|NCT00585195|525513931|FG015|Overall Study|Site Terminated by Sponsor|0|||
145726354|NCT00585195|525513932|FG016|Overall Study|Site Terminated by Sponsor|0|||
145726355|NCT00585195|525513933|FG017|Overall Study|Site Terminated by Sponsor|0|||
145726356|NCT00585195|525513934|FG018|Overall Study|Site Terminated by Sponsor|0|||
145726357|NCT00585195|525513935|FG019|Overall Study|Site Terminated by Sponsor|0|||
145726358|NCT00585195|525513936|FG020|Overall Study|Site Terminated by Sponsor|0|||
145726359|NCT00585195|525513916|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
145726360|NCT00585195|525513917|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
145726361|NCT00585195|525513918|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
145726362|NCT00585195|525513919|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
145726363|NCT00585195|525513920|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
145726364|NCT00585195|525513921|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
145726365|NCT00585195|525513922|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
145726366|NCT00585195|525513923|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
145726367|NCT00585195|525513924|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
145726368|NCT00585195|525513925|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
145726369|NCT00585195|525513926|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
145726370|NCT00585195|525513927|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
145726371|NCT00585195|525513928|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
145726372|NCT00585195|525513929|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
145726373|NCT00585195|525513930|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
145726374|NCT00585195|525513931|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
145726375|NCT00585195|525513932|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
145726376|NCT00585195|525513933|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
145726377|NCT00585195|525513934|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
145726378|NCT00585195|525513935|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
145726379|NCT00585195|525513936|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
145726380|NCT02796560|525513942|FG000|Overall Study|Adverse Event|2|||
145726381|NCT02796560|525513943|FG001|Overall Study|Adverse Event|0|||
145726382|NCT02796560|525513942|FG000|Overall Study|Withdrawal by Subject|2|||
145726383|NCT02796560|525513943|FG001|Overall Study|Withdrawal by Subject|2|||
145726384|NCT02533570|525513944|FG000|Overall Study|Adverse Event|0|||
145726385|NCT02533570|525513945|FG001|Overall Study|Adverse Event|1|||
145726386|NCT02533570|525513946|FG002|Overall Study|Adverse Event|1|||
145726387|NCT00529958|525513947|FG000|2-Year Follow-up|Lost to Follow-up|1|||
145726388|NCT00529958|525513948|FG001|2-Year Follow-up|Lost to Follow-up|2|||
145726389|NCT00529958|525513949|FG002|2-Year Follow-up|Lost to Follow-up|2|||
145726390|NCT00529958|525513947|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
145726391|NCT00529958|525513948|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
145726392|NCT00529958|525513949|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
145726393|NCT00529958|525513947|FG000|5-Year Follow-up|Lost to Follow-up|2|||
145726394|NCT00529958|525513948|FG001|5-Year Follow-up|Lost to Follow-up|3|||
145726395|NCT00529958|525513949|FG002|5-Year Follow-up|Lost to Follow-up|1|||
145726396|NCT00529958|525513947|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
145726397|NCT00529958|525513948|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
145726398|NCT00529958|525513949|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
145726399|NCT03816332|525513950|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
145726400|NCT03816332|525513950|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
145726401|NCT03534284|525513953|FG000|Overall Study|Death|2|||
145726402|NCT03534284|525513954|FG001|Overall Study|Death|3|||
145726403|NCT03534284|525513955|FG002|Overall Study|Death|3|||
145726404|NCT03534284|525513953|FG000|Overall Study|Withdrawal by Subject|5|||
145726405|NCT03534284|525513954|FG001|Overall Study|Withdrawal by Subject|0|||
145383796|NCT02815267|524260155|FG001|Double-Blind Phase|Lost to Follow-up|9|||
145383797|NCT02815267|524260154|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
145383798|NCT02815267|524260155|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
145383799|NCT02815267|524260154|FG000|Double-Blind Phase|Protocol Violation|3|||
145383800|NCT02815267|524260155|FG001|Double-Blind Phase|Protocol Violation|2|||
145383801|NCT02815267|524260154|FG000|Double-Blind Phase|Site withdrawal|1|||
145383802|NCT02815267|524260155|FG001|Double-Blind Phase|Site withdrawal|6|||
145383803|NCT02815267|524260154|FG000|Double-Blind Phase|Received a disallowed medication|1|||
145383804|NCT02815267|524260155|FG001|Double-Blind Phase|Received a disallowed medication|1|||
145383805|NCT02815267|524260154|FG000|Open-Label Phase|Adverse Event|1|||
145383806|NCT02815267|524260155|FG001|Open-Label Phase|Adverse Event|1|||
145383807|NCT02815267|524260154|FG000|Open-Label Phase|Lost to Follow-up|23|||
145383808|NCT02815267|524260155|FG001|Open-Label Phase|Lost to Follow-up|9|||
145383809|NCT02815267|524260154|FG000|Open-Label Phase|Withdrawal by Subject|24|||
145383810|NCT02815267|524260155|FG001|Open-Label Phase|Withdrawal by Subject|13|||
145383811|NCT02815267|524260154|FG000|Open-Label Phase|Protocol Violation|0|||
145383812|NCT02815267|524260155|FG001|Open-Label Phase|Protocol Violation|1|||
145383813|NCT02815267|524260154|FG000|Open-Label Phase|Administrative|21|||
145383814|NCT02815267|524260155|FG001|Open-Label Phase|Administrative|12|||
145383815|NCT02815267|524260154|FG000|Open-Label Phase|Other|2|||
145383816|NCT02815267|524260155|FG001|Open-Label Phase|Other|5|||
145383817|NCT01108237|524260156|FG000|Overall Study|No alignment data|2|||
145383818|NCT01108237|524260157|FG001|Overall Study|No alignment data|15|||
145383819|NCT01108237|524260156|FG000|Overall Study|Did not meet criteria for analysis|7|||
145383820|NCT01108237|524260157|FG001|Overall Study|Did not meet criteria for analysis|0|||
145726406|NCT03534284|525513955|FG002|Overall Study|Withdrawal by Subject|0|||
145726407|NCT03164564|525513956|FG000|Overall Study|Death|3|||
145726408|NCT03164564|525513957|FG001|Overall Study|Death|0|||
145726409|NCT03164564|525513956|FG000|Overall Study|Withdrawal by Subject|20|||
145726410|NCT03164564|525513957|FG001|Overall Study|Withdrawal by Subject|15|||
145726411|NCT03164564|525513956|FG000|Overall Study|Lost to Follow-up|2|||
145726412|NCT03164564|525513957|FG001|Overall Study|Lost to Follow-up|0|||
145726413|NCT03164564|525513956|FG000|Overall Study|Physician Decision|0|||
145726414|NCT03164564|525513957|FG001|Overall Study|Physician Decision|1|||
145726415|NCT03164564|525513956|FG000|Overall Study|Adverse Event|0|||
145726416|NCT03164564|525513957|FG001|Overall Study|Adverse Event|1|||
145726417|NCT03164564|525513956|FG000|Overall Study|Ongoing|1586|||
145726418|NCT03164564|525513957|FG001|Overall Study|Ongoing|1586|||
145726419|NCT02656823|525513958|FG000|Overall Study|Adverse Event|3|||
145726420|NCT02656823|525513958|FG000|Overall Study|Lost to Follow-up|2|||
145726421|NCT01315353|525513959|FG000|Overall Study|Death|2|||
145726422|NCT01315353|525513960|FG001|Overall Study|Death|1|||
145726423|NCT01315353|525513961|FG002|Overall Study|Death|0|||
145726424|NCT01315353|525513959|FG000|Overall Study|Withdrawal by Subject|2|||
145726425|NCT01315353|525513960|FG001|Overall Study|Withdrawal by Subject|6|||
145726426|NCT01315353|525513961|FG002|Overall Study|Withdrawal by Subject|1|||
145726427|NCT01315353|525513959|FG000|Overall Study|Lost to Follow-up|13|||
145726428|NCT01315353|525513960|FG001|Overall Study|Lost to Follow-up|6|||
145726429|NCT01315353|525513961|FG002|Overall Study|Lost to Follow-up|6|||
145726430|NCT01315353|525513959|FG000|Overall Study|Unwilling to adhere to requirements|5|||
145726431|NCT01315353|525513960|FG001|Overall Study|Unwilling to adhere to requirements|5|||
145726432|NCT01315353|525513961|FG002|Overall Study|Unwilling to adhere to requirements|4|||
145726433|NCT01315353|525513959|FG000|Overall Study|Site closing|7|||
145726434|NCT01315353|525513960|FG001|Overall Study|Site closing|4|||
145726435|NCT01315353|525513961|FG002|Overall Study|Site closing|0|||
145726436|NCT01315353|525513959|FG000|Overall Study|Taken off study by site in error|0|||
145726437|NCT01315353|525513960|FG001|Overall Study|Taken off study by site in error|1|||
145726438|NCT01315353|525513961|FG002|Overall Study|Taken off study by site in error|0|||
145726439|NCT01315353|525513959|FG000|Overall Study|Inadvertent randomization/assignment|0|||
145726440|NCT01315353|525513960|FG001|Overall Study|Inadvertent randomization/assignment|0|||
145726441|NCT01315353|525513961|FG002|Overall Study|Inadvertent randomization/assignment|2|||
145726442|NCT01009580|525513962|FG000|Overall Study|Adverse Event|4|||
145407495|NCT00964782|524347010|FG001|Overall Study|Lost to Follow-up|0|||
145726443|NCT01009580|525513963|FG001|Overall Study|Adverse Event|4|||
145726444|NCT01009580|525513962|FG000|Overall Study|Lack of Efficacy|0|||
145726445|NCT01009580|525513963|FG001|Overall Study|Lack of Efficacy|1|||
145726446|NCT01009580|525513962|FG000|Overall Study|Protocol Violation|2|||
145726447|NCT01009580|525513963|FG001|Overall Study|Protocol Violation|3|||
145726448|NCT01009580|525513962|FG000|Overall Study|Withdrawal Criteria|4|||
145726449|NCT01009580|525513963|FG001|Overall Study|Withdrawal Criteria|6|||
145726450|NCT01009580|525513962|FG000|Overall Study|Unclassified|17|||
145726451|NCT01009580|525513963|FG001|Overall Study|Unclassified|21|||
145726452|NCT04469270|525513964|FG000|Overall Study|Adverse Event|2|||
145726453|NCT04469270|525513965|FG001|Overall Study|Adverse Event|0|||
145726454|NCT04469270|525513964|FG000|Overall Study|Lost to Follow-up|4|||
145726455|NCT04469270|525513965|FG001|Overall Study|Lost to Follow-up|3|||
145726456|NCT04469270|525513964|FG000|Overall Study|Withdrawal by Subject|7|||
145726457|NCT04469270|525513965|FG001|Overall Study|Withdrawal by Subject|3|||
145726458|NCT04469270|525513964|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
145726459|NCT04469270|525513965|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
145726460|NCT04469270|525513964|FG000|Overall Study|missing|1|||
145726461|NCT04469270|525513965|FG001|Overall Study|missing|0|||
145726462|NCT02254278|525513968|FG000|Overall Study|Protocol Violation|1|||
145726463|NCT02254278|525513969|FG001|Overall Study|Protocol Violation|1|||
145726464|NCT05437510|525513974|FG000|Overall Study|Adverse Event|2|||
145726465|NCT05437510|525513975|FG001|Overall Study|Adverse Event|1|||
145726466|NCT05437510|525513974|FG000|Overall Study|Protocol Deviation|1|||
145726467|NCT05437510|525513975|FG001|Overall Study|Protocol Deviation|6|||
145726468|NCT05437510|525513974|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
145726469|NCT05437510|525513975|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
145726470|NCT05437510|525513974|FG000|Overall Study|Lost to Follow-up|265|||
145726471|NCT05437510|525513975|FG001|Overall Study|Lost to Follow-up|358|||
145726472|NCT00355056|525515359|FG000|Randomization Period|Early Termination|4|||
145726473|NCT00355056|525515360|FG001|Randomization Period|Early Termination|6|||
145726474|NCT00995020|525515364|FG000|Overall Study|margin analysis not performed|2|||
145726475|NCT00995020|525515365|FG001|Overall Study|margin analysis not performed|5|||
145726476|NCT00995020|525515364|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
145726477|NCT00995020|525515365|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
145726478|NCT00730171|525515370|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
145726479|NCT00730171|525515370|FG000|Overall Study|Adverse Event|193|||
145726480|NCT00730171|525515370|FG000|Overall Study|Protocol Violation|48|||
145726481|NCT00730171|525515370|FG000|Overall Study|Withdrawal by Subject|202|||
145726482|NCT00730171|525515370|FG000|Overall Study|Lost to Follow-up|121|||
145726483|NCT00730171|525515370|FG000|Overall Study|Insufficient Therapeutic Response|141|||
145726484|NCT00730171|525515370|FG000|Overall Study|Other|61|||
145726485|NCT01215422|525515371|FG000|Overall Study|Relocation|1|||
145726486|NCT01215422|525515372|FG001|Overall Study|Relocation|0|||
145726487|NCT01215422|525515373|FG002|Overall Study|Relocation|0|||
145726488|NCT01215422|525515374|FG003|Overall Study|Relocation|0|||
145726489|NCT01215422|525515371|FG000|Overall Study|Failed intubations|0|||
145726490|NCT01215422|525515372|FG001|Overall Study|Failed intubations|0|||
145726491|NCT01215422|525515373|FG002|Overall Study|Failed intubations|3|||
145726492|NCT01215422|525515374|FG003|Overall Study|Failed intubations|8|||
145726493|NCT01215422|525515371|FG000|Overall Study|Did not complete all intubations|7|||
145726494|NCT01215422|525515372|FG001|Overall Study|Did not complete all intubations|0|||
145726495|NCT01215422|525515373|FG002|Overall Study|Did not complete all intubations|0|||
145726496|NCT01215422|525515374|FG003|Overall Study|Did not complete all intubations|0|||
145726497|NCT01729156|525515375|FG000|Overall Study|Withdrawal by Subject|1|||
145726498|NCT01729156|525515376|FG001|Overall Study|Withdrawal by Subject|0|||
145726499|NCT01729156|525515377|FG002|Overall Study|Withdrawal by Subject|0|||
145726500|NCT01256658|525515378|FG000|Period 1|Lost to Follow-up|837|||
145726501|NCT01256658|525515379|FG001|Period 1|Lost to Follow-up|661|||
145726502|NCT01256658|525515378|FG000|Period 1|Withdrawal by Subject|35|||
145726503|NCT01256658|525515379|FG001|Period 1|Withdrawal by Subject|43|||
145726504|NCT01256658|525515378|FG000|Period 1|Death|48|||
145726505|NCT01256658|525515379|FG001|Period 1|Death|44|||
145726506|NCT00719563|525515384|FG000|Overall Study|Adverse Event|16|||
145726507|NCT00719563|525515385|FG001|Overall Study|Adverse Event|13|||
145726508|NCT00719563|525515384|FG000|Overall Study|Medical condition changed|3|||
145726509|NCT00719563|525515385|FG001|Overall Study|Medical condition changed|5|||
145726510|NCT00719563|525515384|FG000|Overall Study|Lack of Efficacy|3|||
145726511|NCT00719563|525515385|FG001|Overall Study|Lack of Efficacy|7|||
145726512|NCT00719563|525515384|FG000|Overall Study|Personal reasons|6|||
145383821|NCT02178358|524260162|FG000|Overall Study|Withdrawal by Subject|0|||
145383822|NCT02178358|524260163|FG001|Overall Study|Withdrawal by Subject|2|||
145383823|NCT02178358|524260164|FG002|Overall Study|Withdrawal by Subject|2|||
145383824|NCT02178358|524260162|FG000|Overall Study|Lost to Follow-up|1|||
145383825|NCT02178358|524260163|FG001|Overall Study|Lost to Follow-up|0|||
145383826|NCT02178358|524260164|FG002|Overall Study|Lost to Follow-up|0|||
145383827|NCT01066663|524260166|FG000|Overall Study|Adverse Event|0|||
145383828|NCT01066663|524260167|FG001|Overall Study|Adverse Event|0|||
145383829|NCT01066663|524260168|FG002|Overall Study|Adverse Event|1|||
145383830|NCT01090050|524260169|FG000|Overall Study|Lost to Follow-up|0|||
145383831|NCT01090050|524260170|FG001|Overall Study|Lost to Follow-up|1|||
145383832|NCT01090050|524260169|FG000|Overall Study|Lack of Efficacy|1|||
145383833|NCT01090050|524260170|FG001|Overall Study|Lack of Efficacy|5|||
145383834|NCT01090050|524260169|FG000|Overall Study|Physician Decision|0|||
145383835|NCT01090050|524260170|FG001|Overall Study|Physician Decision|1|||
145383836|NCT03539484|524260171|FG000|Overall Study|Death|1|||
145383837|NCT03539484|524260172|FG001|Overall Study|Death|0|||
145383838|NCT03539484|524260173|FG002|Overall Study|Death|0|||
145383839|NCT03539484|524260174|FG003|Overall Study|Death|2|||
145383840|NCT03539484|524260175|FG004|Overall Study|Death|8|||
145383841|NCT03539484|524260176|FG005|Overall Study|Death|3|||
145726513|NCT00719563|525515385|FG001|Overall Study|Personal reasons|7|||
145726514|NCT00719563|525515384|FG000|Overall Study|Unknown reasons|4|||
145726515|NCT00719563|525515385|FG001|Overall Study|Unknown reasons|6|||
145726516|NCT00719563|525515384|FG000|Overall Study|Noncompliant|1|||
145726517|NCT00719563|525515385|FG001|Overall Study|Noncompliant|1|||
145726518|NCT00719563|525515384|FG000|Overall Study|Lost to Follow-up|5|||
145726519|NCT00719563|525515385|FG001|Overall Study|Lost to Follow-up|3|||
145726520|NCT02986334|525515386|FG000|Overall Study|Withdrawal by Subject|0|||
145726521|NCT02986334|525515387|FG001|Overall Study|Withdrawal by Subject|1|||
145726522|NCT02986334|525515388|FG002|Overall Study|Withdrawal by Subject|2|||
145726523|NCT02986334|525515386|FG000|Overall Study|Lost to Follow-up|1|||
145726524|NCT02986334|525515387|FG001|Overall Study|Lost to Follow-up|2|||
145726525|NCT02986334|525515388|FG002|Overall Study|Lost to Follow-up|1|||
145726526|NCT02986334|525515386|FG000|Overall Study|Adverse Event|0|||
145726527|NCT02986334|525515387|FG001|Overall Study|Adverse Event|2|||
145726528|NCT02986334|525515388|FG002|Overall Study|Adverse Event|1|||
145726529|NCT02986334|525515386|FG000|Overall Study|non compliance in phone ratings|2|||
145726530|NCT02986334|525515387|FG001|Overall Study|non compliance in phone ratings|1|||
145726531|NCT02986334|525515388|FG002|Overall Study|non compliance in phone ratings|2|||
145726532|NCT02986334|525515386|FG000|Overall Study|undisclosed comorbidities|0|||
145726533|NCT02986334|525515387|FG001|Overall Study|undisclosed comorbidities|1|||
145726534|NCT02986334|525515388|FG002|Overall Study|undisclosed comorbidities|1|||
145726535|NCT01146054|525515389|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
145726536|NCT01146054|525515389|FG000|Overall Study|Rapid tumor progression|2|||
145726537|NCT01146054|525515389|FG000|Overall Study|Other illness precluded treatment|2|||
145726538|NCT01146054|525515389|FG000|Overall Study|Lost to Follow-up|1|||
145726539|NCT05580588|525515390|FG000|Overall Study|Lack of Efficacy|12|||
145726540|NCT00712673|525515393|FG000|Overall Study|Adverse Event|3|||
145726541|NCT00712673|525515394|FG001|Overall Study|Adverse Event|3|||
145726542|NCT00712673|525515395|FG002|Overall Study|Adverse Event|21|||
145726543|NCT00712673|525515396|FG003|Overall Study|Adverse Event|26|||
145726544|NCT00712673|525515393|FG000|Overall Study|Lack of Efficacy|2|||
145726545|NCT00712673|525515394|FG001|Overall Study|Lack of Efficacy|8|||
145726546|NCT00712673|525515395|FG002|Overall Study|Lack of Efficacy|8|||
145726547|NCT00712673|525515396|FG003|Overall Study|Lack of Efficacy|6|||
145726548|NCT00712673|525515393|FG000|Overall Study|Poor Compliance to Protocol|3|||
145726549|NCT00712673|525515394|FG001|Overall Study|Poor Compliance to Protocol|3|||
145726550|NCT00712673|525515395|FG002|Overall Study|Poor Compliance to Protocol|4|||
145726551|NCT00712673|525515396|FG003|Overall Study|Poor Compliance to Protocol|16|||
145726552|NCT00712673|525515393|FG000|Overall Study|Lost to Follow-up|1|||
145726553|NCT00712673|525515394|FG001|Overall Study|Lost to Follow-up|0|||
145726554|NCT00712673|525515395|FG002|Overall Study|Lost to Follow-up|2|||
145726555|NCT00712673|525515396|FG003|Overall Study|Lost to Follow-up|0|||
145726556|NCT00712673|525515393|FG000|Overall Study|Withdrawal by Subject|6|||
145726557|NCT00712673|525515394|FG001|Overall Study|Withdrawal by Subject|7|||
145726558|NCT00712673|525515395|FG002|Overall Study|Withdrawal by Subject|15|||
145726559|NCT00712673|525515396|FG003|Overall Study|Withdrawal by Subject|20|||
145726560|NCT00712673|525515393|FG000|Overall Study|Familial and Personal Reasons|5|||
145726561|NCT00712673|525515394|FG001|Overall Study|Familial and Personal Reasons|0|||
145726562|NCT00712673|525515395|FG002|Overall Study|Familial and Personal Reasons|5|||
145726563|NCT00712673|525515396|FG003|Overall Study|Familial and Personal Reasons|2|||
145726564|NCT00712673|525515393|FG000|Overall Study|Investigator's Decision|1|||
145726565|NCT00712673|525515394|FG001|Overall Study|Investigator's Decision|0|||
145726566|NCT00712673|525515395|FG002|Overall Study|Investigator's Decision|0|||
145726567|NCT00712673|525515396|FG003|Overall Study|Investigator's Decision|0|||
145726568|NCT00712673|525515393|FG000|Overall Study|Protocol Violation|0|||
145726569|NCT00712673|525515394|FG001|Overall Study|Protocol Violation|0|||
145726570|NCT00712673|525515395|FG002|Overall Study|Protocol Violation|2|||
145726571|NCT00712673|525515396|FG003|Overall Study|Protocol Violation|0|||
145726572|NCT03603028|525515397|FG000|Overall Study|Withdrawal by Subject|1|||
145726573|NCT02963610|525515400|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
145726574|NCT02924064|525515402|FG000|Overall Study|Adverse Event|2|||
145726575|NCT02924064|525515403|FG001|Overall Study|Adverse Event|2|||
145726576|NCT02924064|525515402|FG000|Overall Study|Lost to Follow-up|0|||
145726577|NCT02924064|525515403|FG001|Overall Study|Lost to Follow-up|2|||
145726578|NCT02924064|525515402|FG000|Overall Study|Physician Decision|0|||
145726579|NCT02924064|525515403|FG001|Overall Study|Physician Decision|2|||
145726580|NCT02924064|525515402|FG000|Overall Study|Protocol Violation|1|||
145726581|NCT02924064|525515403|FG001|Overall Study|Protocol Violation|3|||
145726582|NCT02924064|525515402|FG000|Overall Study|Withdrawal by Subject|4|||
145726583|NCT02924064|525515403|FG001|Overall Study|Withdrawal by Subject|5|||
145726584|NCT02924064|525515402|FG000|Overall Study|Other|17|||
145726585|NCT02924064|525515403|FG001|Overall Study|Other|29|||
145726586|NCT03575143|525515404|FG000|Overall Study|Lost to Follow-up|0|||
145726587|NCT03575143|525515405|FG001|Overall Study|Lost to Follow-up|0|||
145726588|NCT03575143|525515406|FG002|Overall Study|Lost to Follow-up|4|||
145383842|NCT03539484|524260177|FG006|Overall Study|Death|0|||
145383843|NCT03539484|524260171|FG000|Overall Study|Lost to Follow-up|0|||
145383844|NCT03539484|524260172|FG001|Overall Study|Lost to Follow-up|1|||
145383845|NCT03539484|524260173|FG002|Overall Study|Lost to Follow-up|0|||
145383846|NCT03539484|524260174|FG003|Overall Study|Lost to Follow-up|0|||
145383847|NCT03539484|524260175|FG004|Overall Study|Lost to Follow-up|1|||
145383848|NCT03539484|524260176|FG005|Overall Study|Lost to Follow-up|0|||
145383849|NCT03539484|524260177|FG006|Overall Study|Lost to Follow-up|0|||
145383850|NCT03539484|524260171|FG000|Overall Study|Withdrawal by Subject|0|||
145383851|NCT03539484|524260172|FG001|Overall Study|Withdrawal by Subject|0|||
145383852|NCT03539484|524260173|FG002|Overall Study|Withdrawal by Subject|0|||
145383853|NCT03539484|524260174|FG003|Overall Study|Withdrawal by Subject|0|||
145383854|NCT03539484|524260175|FG004|Overall Study|Withdrawal by Subject|2|||
145383855|NCT03539484|524260176|FG005|Overall Study|Withdrawal by Subject|0|||
145383856|NCT03539484|524260177|FG006|Overall Study|Withdrawal by Subject|1|||
145383857|NCT03539484|524260171|FG000|Overall Study|Study Terminated by Sponsor|0|||
145383858|NCT03539484|524260172|FG001|Overall Study|Study Terminated by Sponsor|0|||
145383859|NCT03539484|524260173|FG002|Overall Study|Study Terminated by Sponsor|1|||
145383860|NCT03539484|524260174|FG003|Overall Study|Study Terminated by Sponsor|1|||
145383861|NCT03539484|524260175|FG004|Overall Study|Study Terminated by Sponsor|2|||
145383862|NCT03539484|524260176|FG005|Overall Study|Study Terminated by Sponsor|2|||
145383863|NCT03539484|524260177|FG006|Overall Study|Study Terminated by Sponsor|1|||
145383864|NCT02232061|524260178|FG000|Overall Study|Administrative problems|1|||
145383865|NCT02232061|524260178|FG000|Overall Study|Withdrawal by Subject|1|||
145383866|NCT00571103|524260179|FG000|Overall Study|Withdrawal by Subject|1|||
145383867|NCT00571103|524260179|FG000|Overall Study|Lost to Follow-up|1|||
145383868|NCT00948922|524260181|FG000|Overall Study|Did not start study treatment|2|||
145383869|NCT00948922|524260182|FG001|Overall Study|Did not start study treatment|5|||
145383870|NCT00948922|524260183|FG002|Overall Study|Did not start study treatment|0|||
145383871|NCT00948922|524260181|FG000|Overall Study|Withdrawal by Subject|0|||
145383872|NCT00948922|524260182|FG001|Overall Study|Withdrawal by Subject|2|||
145383873|NCT00948922|524260183|FG002|Overall Study|Withdrawal by Subject|1|||
145383874|NCT00948922|524260181|FG000|Overall Study|Death|3|||
145383875|NCT00948922|524260182|FG001|Overall Study|Death|0|||
145383876|NCT00948922|524260183|FG002|Overall Study|Death|0|||
145383877|NCT00948922|524260181|FG000|Overall Study|Disease progression|0|||
145383878|NCT00948922|524260182|FG001|Overall Study|Disease progression|1|||
145383879|NCT00948922|524260183|FG002|Overall Study|Disease progression|0|||
145383880|NCT00948922|524260181|FG000|Overall Study|Insurance issues|1|||
145383881|NCT00948922|524260182|FG001|Overall Study|Insurance issues|0|||
145383882|NCT00948922|524260183|FG002|Overall Study|Insurance issues|0|||
145383883|NCT00948922|524260181|FG000|Overall Study|Transplant eligibility issues|2|||
145383884|NCT00948922|524260182|FG001|Overall Study|Transplant eligibility issues|3|||
145383885|NCT00948922|524260183|FG002|Overall Study|Transplant eligibility issues|0|||
145383886|NCT00948922|524260181|FG000|Overall Study|Not evaluable at time of analysis|0|||
145383887|NCT00948922|524260182|FG001|Overall Study|Not evaluable at time of analysis|3|||
145383888|NCT00948922|524260183|FG002|Overall Study|Not evaluable at time of analysis|0|||
145383889|NCT02784288|524260184|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
145383890|NCT02757625|524260185|FG000|Overall Study|Investigator's discretion|0|||
145383891|NCT02757625|524260186|FG001|Overall Study|Investigator's discretion|0|||
145383892|NCT02757625|524260187|FG002|Overall Study|Investigator's discretion|1|||
145383893|NCT02757625|524260188|FG003|Overall Study|Investigator's discretion|0|||
145383894|NCT02757625|524260185|FG000|Overall Study|Adverse Event|0|||
145383895|NCT02757625|524260186|FG001|Overall Study|Adverse Event|0|||
145383896|NCT02757625|524260187|FG002|Overall Study|Adverse Event|1|||
145383897|NCT02757625|524260188|FG003|Overall Study|Adverse Event|0|||
145383898|NCT02131233|524260189|FG000|Overall Study|Not Treated|2|||
145383899|NCT02131233|524260190|FG001|Overall Study|Not Treated|3|||
145383900|NCT02131233|524260189|FG000|Overall Study|Adverse Event|7|||
145383901|NCT02131233|524260190|FG001|Overall Study|Adverse Event|6|||
145383902|NCT02131233|524260189|FG000|Overall Study|Death|0|||
145383903|NCT02131233|524260190|FG001|Overall Study|Death|1|||
145383904|NCT02131233|524260189|FG000|Overall Study|Lack of Efficacy|6|||
145383905|NCT02131233|524260190|FG001|Overall Study|Lack of Efficacy|3|||
145383906|NCT02131233|524260189|FG000|Overall Study|Lost to Follow-up|14|||
145383907|NCT02131233|524260190|FG001|Overall Study|Lost to Follow-up|13|||
145383908|NCT02131233|524260189|FG000|Overall Study|Non-Compliance With Study Drug|8|||
145383909|NCT02131233|524260190|FG001|Overall Study|Non-Compliance With Study Drug|5|||
145383910|NCT02131233|524260189|FG000|Overall Study|Physician Decision|7|||
145383911|NCT02131233|524260190|FG001|Overall Study|Physician Decision|0|||
145383912|NCT02131233|524260189|FG000|Overall Study|Pregnancy|4|||
145383913|NCT02131233|524260190|FG001|Overall Study|Pregnancy|0|||
145383914|NCT02131233|524260189|FG000|Overall Study|Withdrawal by Subject|18|||
145383915|NCT02131233|524260190|FG001|Overall Study|Withdrawal by Subject|11|||
145383916|NCT00645671|524260191|FG000|Overall Study|Protocol Violation|1|||
145383917|NCT00645671|524260192|FG001|Overall Study|Protocol Violation|0|||
145383918|NCT00645671|524260191|FG000|Overall Study|Withdrawal by Subject|0|||
145383919|NCT00645671|524260192|FG001|Overall Study|Withdrawal by Subject|4|||
145383920|NCT00645671|524260191|FG000|Overall Study|Adverse Event|0|||
145383921|NCT00645671|524260192|FG001|Overall Study|Adverse Event|1|||
145383922|NCT00645671|524260191|FG000|Overall Study|Physician Decision|0|||
145383923|NCT00645671|524260192|FG001|Overall Study|Physician Decision|1|||
145383924|NCT02095197|524260193|FG000|Overall Study|Lost to Follow-up|0|||
145383925|NCT02095197|524260194|FG001|Overall Study|Lost to Follow-up|3|||
145383926|NCT00482170|524260199|FG000|Overall Study|Adverse Event|5|||
145383927|NCT00482170|524260200|FG001|Overall Study|Adverse Event|14|||
145383928|NCT00482170|524260199|FG000|Overall Study|Withdrawal by Subject|6|||
145383929|NCT00482170|524260200|FG001|Overall Study|Withdrawal by Subject|1|||
145383930|NCT00482170|524260199|FG000|Overall Study|Protocol Violation|2|||
145383931|NCT00482170|524260200|FG001|Overall Study|Protocol Violation|3|||
145383932|NCT00482170|524260199|FG000|Overall Study|Lost to Follow-up|2|||
145383933|NCT00482170|524260200|FG001|Overall Study|Lost to Follow-up|0|||
145383934|NCT00482170|524260199|FG000|Overall Study|Unspecified reason|0|||
145383935|NCT00482170|524260200|FG001|Overall Study|Unspecified reason|2|||
145383936|NCT04379700|524260201|FG000|Overall Study|Withdrawal by Subject|10|||
145383937|NCT04379700|524260201|FG000|Overall Study|Screen Fail|4|||
145383938|NCT04379700|524260201|FG000|Overall Study|Lost to Follow-up|3|||
145383939|NCT03624569|524260202|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145383940|NCT03624569|524260203|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
145383941|NCT03624569|524260202|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
145383942|NCT03624569|524260203|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
145383943|NCT01134263|524260204|FG000|Overall Study|Serious adverse event|2|||
145383944|NCT01134263|524260205|FG001|Overall Study|Serious adverse event|1|||
145383945|NCT01134263|524260206|FG002|Overall Study|Serious adverse event|1|||
145383946|NCT01134263|524260207|FG003|Overall Study|Serious adverse event|1|||
145383947|NCT01134263|524260208|FG004|Overall Study|Serious adverse event|1|||
145383948|NCT01134263|524260204|FG000|Overall Study|Other adverse event|1|||
145383949|NCT01134263|524260205|FG001|Overall Study|Other adverse event|2|||
145383950|NCT01134263|524260206|FG002|Overall Study|Other adverse event|5|||
145383951|NCT01134263|524260207|FG003|Overall Study|Other adverse event|3|||
145383952|NCT01134263|524260208|FG004|Overall Study|Other adverse event|0|||
145383953|NCT01134263|524260204|FG000|Overall Study|Protocol Violation|8|||
145383954|NCT01134263|524260205|FG001|Overall Study|Protocol Violation|7|||
145383955|NCT01134263|524260206|FG002|Overall Study|Protocol Violation|2|||
145383956|NCT01134263|524260207|FG003|Overall Study|Protocol Violation|4|||
145383957|NCT01134263|524260208|FG004|Overall Study|Protocol Violation|2|||
145383958|NCT01134263|524260204|FG000|Overall Study|Lost to Follow-up|4|||
145383959|NCT01134263|524260205|FG001|Overall Study|Lost to Follow-up|3|||
145383960|NCT01134263|524260206|FG002|Overall Study|Lost to Follow-up|5|||
145383961|NCT01134263|524260207|FG003|Overall Study|Lost to Follow-up|3|||
145383962|NCT01134263|524260208|FG004|Overall Study|Lost to Follow-up|1|||
145383963|NCT01134263|524260204|FG000|Overall Study|Withdrawal by Subject|8|||
145383964|NCT01134263|524260205|FG001|Overall Study|Withdrawal by Subject|6|||
145383965|NCT01134263|524260206|FG002|Overall Study|Withdrawal by Subject|16|||
145383966|NCT01134263|524260207|FG003|Overall Study|Withdrawal by Subject|7|||
145383967|NCT01134263|524260208|FG004|Overall Study|Withdrawal by Subject|5|||
145383968|NCT01134263|524260204|FG000|Overall Study|Enrolled, but not treated|1|||
145383969|NCT01134263|524260205|FG001|Overall Study|Enrolled, but not treated|1|||
145383970|NCT01134263|524260206|FG002|Overall Study|Enrolled, but not treated|0|||
145383971|NCT01134263|524260207|FG003|Overall Study|Enrolled, but not treated|1|||
145383972|NCT01134263|524260208|FG004|Overall Study|Enrolled, but not treated|0|||
145383973|NCT03517449|524260217|FG000|Overall Study|Death|184|||
145383974|NCT03517449|524260218|FG001|Overall Study|Death|236|||
145383975|NCT03517449|524260217|FG000|Overall Study|Lost to Follow-up|0|||
145383976|NCT03517449|524260218|FG001|Overall Study|Lost to Follow-up|2|||
145383977|NCT03517449|524260217|FG000|Overall Study|Withdrawal by Subject|7|||
145383978|NCT03517449|524260218|FG001|Overall Study|Withdrawal by Subject|26|||
145383979|NCT03517449|524260217|FG000|Overall Study|Participants Ongoing|220|||
145383980|NCT03517449|524260218|FG001|Overall Study|Participants Ongoing|152|||
145383981|NCT00269477|524260219|FG000|Overall Study|Protocol Violation|5|||
145383982|NCT00269477|524260220|FG001|Overall Study|Protocol Violation|5|||
145383983|NCT00269477|524260221|FG002|Overall Study|Protocol Violation|1|||
145383984|NCT00269477|524260222|FG003|Overall Study|Protocol Violation|0|||
145383985|NCT00269477|524260219|FG000|Overall Study|Missed post-vaccination blood draw|0|||
145383986|NCT00269477|524260220|FG001|Overall Study|Missed post-vaccination blood draw|1|||
145383987|NCT00269477|524260221|FG002|Overall Study|Missed post-vaccination blood draw|0|||
145383988|NCT00269477|524260222|FG003|Overall Study|Missed post-vaccination blood draw|0|||
145383989|NCT00431067|524260223|FG000|Overall Study|Other Adverse Event|9|||
145383990|NCT00431067|524260223|FG000|Overall Study|Progressive disease|30|||
145383991|NCT00431067|524260223|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
145383992|NCT00938587|524260224|FG000|Overall Study|Adverse Event|2|||
145383993|NCT00938587|524260225|FG001|Overall Study|Adverse Event|0|||
145383994|NCT00938587|524260226|FG002|Overall Study|Adverse Event|0|||
145383995|NCT00938587|524260227|FG003|Overall Study|Adverse Event|2|||
145383996|NCT00938587|524260224|FG000|Overall Study|Did not meet entrance criteria|0|||
145383997|NCT00938587|524260225|FG001|Overall Study|Did not meet entrance criteria|0|||
145383998|NCT00938587|524260226|FG002|Overall Study|Did not meet entrance criteria|1|||
145383999|NCT00938587|524260227|FG003|Overall Study|Did not meet entrance criteria|0|||
145384000|NCT00938587|524260224|FG000|Overall Study|Withdrawal by Subject|1|||
145384001|NCT00938587|524260225|FG001|Overall Study|Withdrawal by Subject|1|||
145384002|NCT00938587|524260226|FG002|Overall Study|Withdrawal by Subject|0|||
145384003|NCT00938587|524260227|FG003|Overall Study|Withdrawal by Subject|0|||
145384004|NCT00548249|524260228|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
145384005|NCT00548249|524260229|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
145384006|NCT00548249|524260230|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
145384007|NCT00548249|524260231|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
145384008|NCT00548249|524260232|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
145384009|NCT00548249|524260228|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
145384010|NCT00548249|524260229|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
145384011|NCT00548249|524260230|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
145384012|NCT00548249|524260231|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
145384013|NCT00548249|524260232|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
145384014|NCT00548249|524260228|FG000|Overall Study|Protocol Violation|1|||
145384015|NCT00548249|524260229|FG001|Overall Study|Protocol Violation|1|||
145384016|NCT00548249|524260230|FG002|Overall Study|Protocol Violation|4|||
145384017|NCT00548249|524260231|FG003|Overall Study|Protocol Violation|0|||
145384018|NCT00548249|524260232|FG004|Overall Study|Protocol Violation|3|||
145384019|NCT00548249|524260228|FG000|Overall Study|Miscellaneous|2|||
145384020|NCT00548249|524260229|FG001|Overall Study|Miscellaneous|3|||
145384021|NCT00548249|524260230|FG002|Overall Study|Miscellaneous|2|||
145384022|NCT00548249|524260231|FG003|Overall Study|Miscellaneous|0|||
145384023|NCT00548249|524260232|FG004|Overall Study|Miscellaneous|2|||
145384024|NCT00548249|524260228|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
145384025|NCT00548249|524260229|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
145384026|NCT00548249|524260230|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
145384027|NCT00548249|524260231|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
145384028|NCT00548249|524260232|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
145384029|NCT00548249|524260228|FG000|Overall Study|Adverse Event|2|||
145384030|NCT00548249|524260229|FG001|Overall Study|Adverse Event|2|||
145384031|NCT00548249|524260230|FG002|Overall Study|Adverse Event|0|||
145384032|NCT00548249|524260231|FG003|Overall Study|Adverse Event|1|||
145384033|NCT00548249|524260232|FG004|Overall Study|Adverse Event|1|||
145384034|NCT00548249|524260228|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
145384035|NCT00548249|524260229|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
145384036|NCT00548249|524260230|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
145384037|NCT00548249|524260231|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
145384038|NCT00548249|524260232|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
145384039|NCT00548249|524260228|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
145384040|NCT00548249|524260229|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
145384041|NCT00548249|524260230|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
145384042|NCT00548249|524260231|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
145384043|NCT00548249|524260232|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
145384044|NCT00548249|524260228|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145384045|NCT00548249|524260229|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145384046|NCT00548249|524260230|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145384047|NCT00548249|524260231|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
145384048|NCT00548249|524260232|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
145384049|NCT00548249|524260228|FG000|Overall Study|Prolonged hospitalization|0|||
145384050|NCT00548249|524260229|FG001|Overall Study|Prolonged hospitalization|0|||
145384051|NCT00548249|524260230|FG002|Overall Study|Prolonged hospitalization|2|||
145384052|NCT00548249|524260231|FG003|Overall Study|Prolonged hospitalization|1|||
145384053|NCT00548249|524260232|FG004|Overall Study|Prolonged hospitalization|0|||
145384054|NCT00548249|524260228|FG000|Overall Study|Withdrawal by Subject|2|||
145384055|NCT00548249|524260229|FG001|Overall Study|Withdrawal by Subject|0|||
145384056|NCT00548249|524260230|FG002|Overall Study|Withdrawal by Subject|0|||
145384057|NCT00548249|524260231|FG003|Overall Study|Withdrawal by Subject|0|||
145726589|NCT03575143|525515404|FG000|Overall Study|Withdrawal by Subject|0|||
145384058|NCT00548249|524260232|FG004|Overall Study|Withdrawal by Subject|0|||
145384059|NCT00548249|524260228|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145384060|NCT00548249|524260229|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
145384061|NCT00548249|524260230|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145384062|NCT00548249|524260231|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
145726590|NCT03575143|525515405|FG001|Overall Study|Withdrawal by Subject|0|||
145384063|NCT00548249|524260232|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
145384064|NCT00548249|524260228|FG000|Overall Study|Sponsor's request|0|||
145726591|NCT03575143|525515406|FG002|Overall Study|Withdrawal by Subject|5|||
145384065|NCT00548249|524260229|FG001|Overall Study|Sponsor's request|0|||
145384066|NCT00548249|524260230|FG002|Overall Study|Sponsor's request|0|||
145384067|NCT00548249|524260231|FG003|Overall Study|Sponsor's request|1|||
145384068|NCT00548249|524260232|FG004|Overall Study|Sponsor's request|0|||
145384069|NCT03760458|524260234|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
145384070|NCT03760458|524260235|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
145384071|NCT03760458|524260236|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145384072|NCT03760458|524260237|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145384073|NCT03760458|524260238|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
145384074|NCT00750919|524260239|FG000|Overall Study|Adverse Event|9|||
145384075|NCT00750919|524260239|FG000|Overall Study|Withdrawal by Subject|1|||
145384076|NCT00750919|524260239|FG000|Overall Study|Lack of Efficacy|8|||
145384077|NCT00750919|524260239|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
145384078|NCT00750919|524260239|FG000|Overall Study|Other|36|||
145384079|NCT01464619|524260240|FG000|Overall Study|Lost to Follow-up|3|||
145384080|NCT01464619|524260241|FG001|Overall Study|Lost to Follow-up|4|||
145384081|NCT00080483|524260244|FG000|Overall Study|Lost to Follow-up|1|||
145384082|NCT00080483|524260245|FG001|Overall Study|Lost to Follow-up|1|||
145384083|NCT00080483|524260244|FG000|Overall Study|Physician Decision|1|||
145384084|NCT00080483|524260245|FG001|Overall Study|Physician Decision|1|||
145384085|NCT02819440|524260246|FG000|Overall Study|Adverse Event|3|||
145384086|NCT02819440|524260247|FG001|Overall Study|Adverse Event|1|||
145384087|NCT02819440|524260246|FG000|Overall Study|Lost to Follow-up|1|||
145384088|NCT02819440|524260247|FG001|Overall Study|Lost to Follow-up|3|||
145384089|NCT02819440|524260246|FG000|Overall Study|Withdrawal by Subject|9|||
145384090|NCT02819440|524260247|FG001|Overall Study|Withdrawal by Subject|8|||
145384091|NCT03304184|524260250|FG000|Overall Study|Withdrawal by Subject|1|||
145384092|NCT03304184|524260251|FG001|Overall Study|Withdrawal by Subject|2|||
145384093|NCT00731731|524260252|FG000|Overall Study|Protocol Violation|0|||
145384094|NCT00731731|524260253|FG001|Overall Study|Protocol Violation|0|||
145384095|NCT00731731|524260254|FG002|Overall Study|Protocol Violation|1|||
145384096|NCT00731731|524260252|FG000|Overall Study|Cancel prior to treatment|0|||
145384097|NCT00731731|524260253|FG001|Overall Study|Cancel prior to treatment|0|||
145384098|NCT00731731|524260254|FG002|Overall Study|Cancel prior to treatment|2|||
145384099|NCT01578499|524260256|FG000|Overall Study|Reason not Specified|0|||
145384100|NCT01578499|524260257|FG001|Overall Study|Reason not Specified|1|||
145384101|NCT01578499|524260256|FG000|Overall Study|Lost to Follow-up|2|||
145384102|NCT01578499|524260257|FG001|Overall Study|Lost to Follow-up|1|||
145384103|NCT01578499|524260256|FG000|Overall Study|Withdrawal by Subject|10|||
145384104|NCT01578499|524260257|FG001|Overall Study|Withdrawal by Subject|16|||
145384105|NCT01578499|524260256|FG000|Overall Study|Death|20|||
145384106|NCT01578499|524260257|FG001|Overall Study|Death|25|||
145384107|NCT01578499|524260256|FG000|Overall Study|Died and End of Study Page not Completed|2|||
145384108|NCT01578499|524260257|FG001|Overall Study|Died and End of Study Page not Completed|0|||
145384109|NCT00394771|524260258|FG000|Overall Study|Did not meet protocol requirements|1|||
145384110|NCT00394771|524260259|FG001|Overall Study|Did not meet protocol requirements|0|||
145384111|NCT00394771|524260260|FG002|Overall Study|Did not meet protocol requirements|2|||
145384112|NCT00394771|524260261|FG003|Overall Study|Did not meet protocol requirements|0|||
145384113|NCT00394771|524260258|FG000|Overall Study|Protocol Violation|2|||
145384114|NCT00394771|524260259|FG001|Overall Study|Protocol Violation|4|||
145384115|NCT00394771|524260260|FG002|Overall Study|Protocol Violation|9|||
145384116|NCT00394771|524260261|FG003|Overall Study|Protocol Violation|7|||
145384117|NCT00394771|524260258|FG000|Overall Study|Withdrawal by Subject|10|||
145384118|NCT00394771|524260259|FG001|Overall Study|Withdrawal by Subject|6|||
145384119|NCT00394771|524260260|FG002|Overall Study|Withdrawal by Subject|8|||
145384120|NCT00394771|524260261|FG003|Overall Study|Withdrawal by Subject|12|||
145726592|NCT03575143|525515404|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
145726593|NCT03575143|525515405|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
145726594|NCT03575143|525515406|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
145726595|NCT01287065|525515407|FG000|Treatment Period 1|Adverse Event|0|||
145726596|NCT01287065|525515408|FG001|Treatment Period 1|Adverse Event|0|||
145726597|NCT01287065|525515409|FG002|Treatment Period 1|Adverse Event|0|||
145726598|NCT01287065|525515410|FG003|Treatment Period 1|Adverse Event|0|||
145384121|NCT00394771|524260258|FG000|Overall Study|Adverse Event|10|||
145384122|NCT00394771|524260259|FG001|Overall Study|Adverse Event|5|||
145384123|NCT00394771|524260260|FG002|Overall Study|Adverse Event|12|||
145384124|NCT00394771|524260261|FG003|Overall Study|Adverse Event|8|||
145384125|NCT00394771|524260258|FG000|Overall Study|Participant pregnant|0|||
145384126|NCT00394771|524260259|FG001|Overall Study|Participant pregnant|1|||
145384127|NCT00394771|524260260|FG002|Overall Study|Participant pregnant|2|||
145384128|NCT00394771|524260261|FG003|Overall Study|Participant pregnant|2|||
145384129|NCT00394771|524260258|FG000|Overall Study|Lost to Follow-up|15|||
145384130|NCT00394771|524260259|FG001|Overall Study|Lost to Follow-up|15|||
145384131|NCT00394771|524260260|FG002|Overall Study|Lost to Follow-up|13|||
145384132|NCT00394771|524260261|FG003|Overall Study|Lost to Follow-up|10|||
145384133|NCT00394771|524260258|FG000|Overall Study|Other|3|||
145384134|NCT00394771|524260259|FG001|Overall Study|Other|3|||
145384135|NCT00394771|524260260|FG002|Overall Study|Other|1|||
145384136|NCT00394771|524260261|FG003|Overall Study|Other|0|||
145384137|NCT02839876|524260262|FG000|Overall Study|Protocol Violation|10|||
145384138|NCT02839876|524260263|FG001|Overall Study|Protocol Violation|11|||
145384139|NCT03816007|524260266|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
145384140|NCT03816007|524260267|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
145384141|NCT03816007|524260266|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
145384142|NCT03816007|524260267|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
145384143|NCT03816007|524260266|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
145384144|NCT03816007|524260267|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
145384145|NCT00494221|524260269|FG000|Overall Study|Death|15|||
145384146|NCT00494221|524260270|FG001|Overall Study|Death|9|||
145384147|NCT00494221|524260271|FG002|Overall Study|Death|14|||
145384148|NCT00494221|524260269|FG000|Overall Study|Withdrawal by Subject|1|||
145384149|NCT00494221|524260270|FG001|Overall Study|Withdrawal by Subject|2|||
145384150|NCT00494221|524260271|FG002|Overall Study|Withdrawal by Subject|0|||
145384151|NCT03755518|524260276|FG000|Overall Study|Lack of Efficacy|10|||
145384152|NCT03755518|524260276|FG000|Overall Study|Adverse Event|7|||
145384153|NCT03755518|524260276|FG000|Overall Study|Study Terminated by Sponsor|5|||
145384154|NCT03755518|524260276|FG000|Overall Study|Death|1|||
145384155|NCT03755518|524260276|FG000|Overall Study|Withdrawal by Subject|3|||
145384156|NCT03755518|524260276|FG000|Overall Study|Progressive Disease|4|||
145384157|NCT03755518|524260276|FG000|Overall Study|Bone Marrow Transplant|4|||
145384158|NCT03755518|524260276|FG000|Overall Study|Physicians Decision|1|||
145384159|NCT03755518|524260276|FG000|Overall Study|Relapse|1|||
145384160|NCT03755518|524260276|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
145384161|NCT03755518|524260276|FG000|Overall Study|Withdrawal by PI|1|||
145384162|NCT03172364|524260277|FG000|Overall Study|Adverse Event|1|||
145384163|NCT03172364|524260278|FG001|Overall Study|Adverse Event|1|||
145384164|NCT03172364|524260277|FG000|Overall Study|Protocol Violation|1|||
145384165|NCT03172364|524260278|FG001|Overall Study|Protocol Violation|0|||
145384166|NCT01714609|524260279|FG000|Overall Study|Protocol Violation|1|||
145384167|NCT01714609|524260280|FG001|Overall Study|Protocol Violation|0|||
145384168|NCT02732327|524260281|FG000|Overall Study|Protocol Violation|0|||
145384169|NCT02732327|524260282|FG001|Overall Study|Protocol Violation|1|||
145384170|NCT02306694|524260283|FG000|Overall Study|Withdrawal by Subject|3|||
145384171|NCT02306694|524260283|FG000|Overall Study|Lost to Follow-up|1|||
145384172|NCT00603382|524260284|FG000|Overall Study|Adverse Event|0|||
145384173|NCT00603382|524260285|FG001|Overall Study|Adverse Event|1|||
145384174|NCT00603382|524260286|FG002|Overall Study|Adverse Event|1|||
145384175|NCT00603382|524260287|FG003|Overall Study|Adverse Event|2|||
145384176|NCT00603382|524260288|FG004|Overall Study|Adverse Event|1|||
145384177|NCT00603382|524260289|FG005|Overall Study|Adverse Event|2|||
145384178|NCT00603382|524260284|FG000|Overall Study|Lack of Efficacy|14|||
145384179|NCT00603382|524260285|FG001|Overall Study|Lack of Efficacy|9|||
145384180|NCT00603382|524260286|FG002|Overall Study|Lack of Efficacy|3|||
145384181|NCT00603382|524260287|FG003|Overall Study|Lack of Efficacy|6|||
145384182|NCT00603382|524260288|FG004|Overall Study|Lack of Efficacy|6|||
145384183|NCT00603382|524260289|FG005|Overall Study|Lack of Efficacy|11|||
145384184|NCT00603382|524260284|FG000|Overall Study|Protocol Violation|1|||
145384185|NCT00603382|524260285|FG001|Overall Study|Protocol Violation|0|||
145384186|NCT00603382|524260286|FG002|Overall Study|Protocol Violation|1|||
145384187|NCT00603382|524260287|FG003|Overall Study|Protocol Violation|2|||
145384188|NCT00603382|524260288|FG004|Overall Study|Protocol Violation|1|||
145384189|NCT00603382|524260289|FG005|Overall Study|Protocol Violation|0|||
145384190|NCT00603382|524260284|FG000|Overall Study|Lost to Follow-up|0|||
145384191|NCT00603382|524260285|FG001|Overall Study|Lost to Follow-up|1|||
145384192|NCT00603382|524260286|FG002|Overall Study|Lost to Follow-up|1|||
145384193|NCT00603382|524260287|FG003|Overall Study|Lost to Follow-up|1|||
145384194|NCT00603382|524260288|FG004|Overall Study|Lost to Follow-up|0|||
145384195|NCT00603382|524260289|FG005|Overall Study|Lost to Follow-up|1|||
145384196|NCT00603382|524260284|FG000|Overall Study|Physician Decision|0|||
145384197|NCT00603382|524260285|FG001|Overall Study|Physician Decision|0|||
145384198|NCT00603382|524260286|FG002|Overall Study|Physician Decision|2|||
145384199|NCT00603382|524260287|FG003|Overall Study|Physician Decision|0|||
145384200|NCT00603382|524260288|FG004|Overall Study|Physician Decision|1|||
145384201|NCT00603382|524260289|FG005|Overall Study|Physician Decision|3|||
145384202|NCT00603382|524260284|FG000|Overall Study|Withdrawal by Subject|3|||
145384203|NCT00603382|524260285|FG001|Overall Study|Withdrawal by Subject|3|||
145384204|NCT00603382|524260286|FG002|Overall Study|Withdrawal by Subject|1|||
145384205|NCT00603382|524260287|FG003|Overall Study|Withdrawal by Subject|1|||
145384206|NCT00603382|524260288|FG004|Overall Study|Withdrawal by Subject|0|||
145384207|NCT00603382|524260289|FG005|Overall Study|Withdrawal by Subject|1|||
145384208|NCT00583102|524260290|FG000|Overall Study|Adverse Event|3|||
145384209|NCT01078298|524260295|FG000|Overall Study|Lost to Follow-up|12|||
145384210|NCT01078298|524260296|FG001|Overall Study|Lost to Follow-up|13|||
145384211|NCT01078298|524260295|FG000|Overall Study|Withdrawal by Subject|31|||
145407496|NCT01143324|524347018|FG000|Overall Study|Lost to Follow-up|11|||
145726599|NCT01287065|525515411|FG004|Treatment Period 1|Adverse Event|1|||
145726600|NCT01287065|525515412|FG005|Treatment Period 1|Adverse Event|0|||
145726601|NCT01287065|525515407|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145726602|NCT01287065|525515408|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145726603|NCT01287065|525515409|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145726604|NCT01287065|525515410|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145726605|NCT01287065|525515411|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145726606|NCT01287065|525515412|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145726607|NCT01259726|525515413|FG000|Overall Study|Death|1|||
145726608|NCT01259726|525515414|FG001|Overall Study|Death|0|||
145726609|NCT01259726|525515415|FG002|Overall Study|Death|0|||
145726610|NCT01259726|525515416|FG003|Overall Study|Death|0|||
145726611|NCT01259726|525515413|FG000|Overall Study|Physician Decision|2|||
145726612|NCT01259726|525515414|FG001|Overall Study|Physician Decision|0|||
145726613|NCT01259726|525515415|FG002|Overall Study|Physician Decision|1|||
145726614|NCT01259726|525515416|FG003|Overall Study|Physician Decision|1|||
145726615|NCT01259726|525515413|FG000|Overall Study|Withdrawal by Subject|1|||
145726616|NCT01259726|525515414|FG001|Overall Study|Withdrawal by Subject|3|||
145726617|NCT01259726|525515415|FG002|Overall Study|Withdrawal by Subject|2|||
145726618|NCT01259726|525515416|FG003|Overall Study|Withdrawal by Subject|1|||
145726619|NCT01259726|525515413|FG000|Overall Study|Lost to Follow-up|1|||
145726620|NCT01259726|525515414|FG001|Overall Study|Lost to Follow-up|1|||
145726621|NCT01259726|525515415|FG002|Overall Study|Lost to Follow-up|1|||
145726622|NCT01259726|525515416|FG003|Overall Study|Lost to Follow-up|3|||
145726623|NCT01009203|525515417|FG000|Overall Study|Withdrawal by Subject|1|||
145726624|NCT01009203|525515417|FG000|Overall Study|Adverse Event|5|||
145726625|NCT01009203|525515417|FG000|Overall Study|Treatment-unrelated death|1|||
145726626|NCT02076178|525515418|FG000|Oral Phase|Adverse Event|0|||
145726627|NCT02076178|525515419|FG001|Oral Phase|Adverse Event|7|||
145726628|NCT02076178|525515418|FG000|Oral Phase|Withdrawal by Subject|0|||
145726629|NCT02076178|525515419|FG001|Oral Phase|Withdrawal by Subject|4|||
145726630|NCT02076178|525515418|FG000|Oral Phase|Physician Decision|0|||
145726631|NCT02076178|525515419|FG001|Oral Phase|Physician Decision|1|||
145726632|NCT02076178|525515418|FG000|Injection Phase|Protocol defined stopping criteria|1|||
145726633|NCT02076178|525515419|FG001|Injection Phase|Protocol defined stopping criteria|0|||
145726634|NCT02076178|525515418|FG000|Injection Phase|Withdrawal by Subject|0|||
145726635|NCT02076178|525515419|FG001|Injection Phase|Withdrawal by Subject|3|||
145726636|NCT02076178|525515418|FG000|Injection Phase|Physician Decision|0|||
145726637|NCT02076178|525515419|FG001|Injection Phase|Physician Decision|3|||
145726638|NCT02076178|525515418|FG000|Injection Phase|Lost to Follow-up|0|||
145726639|NCT02076178|525515419|FG001|Injection Phase|Lost to Follow-up|1|||
145726640|NCT03021954|525515422|FG000|Overall Study|Lost to Follow-up|10|||
145726641|NCT03021954|525515423|FG001|Overall Study|Lost to Follow-up|43|||
145726642|NCT03021954|525515422|FG000|Overall Study|Subjects had avulsion trauma|4|||
145726643|NCT03021954|525515423|FG001|Overall Study|Subjects had avulsion trauma|1|||
145726644|NCT01001832|525515424|FG000|Short-term Period|Adverse Event|2|||
145726645|NCT01001832|525515425|FG001|Short-term Period|Adverse Event|3|||
145726646|NCT01001832|525515424|FG000|Long-term Period|Adverse Event|2|||
145726647|NCT01001832|525515425|FG001|Long-term Period|Adverse Event|1|||
145726648|NCT01001832|525515424|FG000|Long-term Period|Withdrawal by Subject|1|||
145726649|NCT01001832|525515425|FG001|Long-term Period|Withdrawal by Subject|0|||
145726650|NCT01001832|525515424|FG000|Long-term Period|Lack of Efficacy|0|||
145726651|NCT01001832|525515425|FG001|Long-term Period|Lack of Efficacy|2|||
145726652|NCT01001832|525515424|FG000|Long-term Period|Other|1|||
145726653|NCT01001832|525515425|FG001|Long-term Period|Other|2|||
145726654|NCT01001832|525515424|FG000|Follow-up Period|Withdrawal by Subject|1|||
145726655|NCT01001832|525515425|FG001|Follow-up Period|Withdrawal by Subject|0|||
145726656|NCT01001832|525515424|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
145726657|NCT01001832|525515425|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
145726658|NCT01001832|525515424|FG000|Follow-up Period|Other|2|||
145726659|NCT01001832|525515425|FG001|Follow-up Period|Other|1|||
145726660|NCT01012713|525515426|FG000|Overall Study|Lack of Efficacy|3|||
145384212|NCT01078298|524260296|FG001|Overall Study|Withdrawal by Subject|33|||
145726661|NCT01242800|525515427|FG000|Overall Study|Patient refusal|0|||
145384213|NCT01078298|524260295|FG000|Overall Study|Protocol Violation|6|||
145726662|NCT01242800|525515428|FG001|Overall Study|Patient refusal|10|||
145726663|NCT01242800|525515427|FG000|Overall Study|Physician Decision|0|||
145726664|NCT01242800|525515428|FG001|Overall Study|Physician Decision|1|||
145726665|NCT01242800|525515427|FG000|Overall Study|Disease progression|0|||
145726666|NCT01242800|525515428|FG001|Overall Study|Disease progression|3|||
145726667|NCT01242800|525515427|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
145726668|NCT01242800|525515428|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
145726669|NCT01242800|525515427|FG000|Overall Study|Reasons not reported|0|||
145726670|NCT01242800|525515428|FG001|Overall Study|Reasons not reported|4|||
145726671|NCT01596621|525515430|FG000|Overall Study|Death|4|||
145726672|NCT01596621|525515430|FG000|Overall Study|Withdrawal by Subject|9|||
145726673|NCT01596621|525515430|FG000|Overall Study|Disease Progression|49|||
145384214|NCT01078298|524260296|FG001|Overall Study|Protocol Violation|6|||
145726674|NCT01596621|525515430|FG000|Overall Study|Lost to Follow-up|3|||
145726675|NCT01596621|525515430|FG000|Overall Study|Other than specified|13|||
145726676|NCT00710021|525515431|FG000|Overall Study|Lost to Follow-up|1|||
145726677|NCT00710021|525515432|FG001|Overall Study|Lost to Follow-up|0|||
145726678|NCT00710021|525515433|FG002|Overall Study|Lost to Follow-up|0|||
145726679|NCT00710021|525515431|FG000|Overall Study|Subject's Decision|0|||
145726680|NCT00710021|525515432|FG001|Overall Study|Subject's Decision|1|||
145726681|NCT00710021|525515433|FG002|Overall Study|Subject's Decision|0|||
145726682|NCT00710021|525515431|FG000|Overall Study|Subject misrandomized|0|||
145726683|NCT00710021|525515432|FG001|Overall Study|Subject misrandomized|1|||
145726684|NCT00710021|525515433|FG002|Overall Study|Subject misrandomized|1|||
145726685|NCT00710021|525515431|FG000|Overall Study|Physician Decision|0|||
145726686|NCT00710021|525515432|FG001|Overall Study|Physician Decision|1|||
145726687|NCT00710021|525515433|FG002|Overall Study|Physician Decision|0|||
145726688|NCT01536015|525515434|FG000|Overall Study|Adverse Event|1|||
145726689|NCT01536015|525515435|FG001|Overall Study|Adverse Event|4|||
145726690|NCT01536015|525515434|FG000|Overall Study|Lost to Follow-up|0|||
145726691|NCT01536015|525515435|FG001|Overall Study|Lost to Follow-up|1|||
145726692|NCT01536015|525515434|FG000|Overall Study|Inclusion Criterion not met|2|||
145726693|NCT01536015|525515435|FG001|Overall Study|Inclusion Criterion not met|0|||
145726694|NCT01536015|525515434|FG000|Overall Study|Study closure|5|||
145726695|NCT01536015|525515435|FG001|Overall Study|Study closure|5|||
145726696|NCT04508023|525515436|FG000|Overall Study|Withdrawal by Subject|1|||
145726697|NCT04508023|525515437|FG001|Overall Study|Withdrawal by Subject|2|||
145726698|NCT03581825|525515445|FG000|Period 1|Lens Discomfort|1|||
145726699|NCT03581825|525515446|FG001|Period 1|Lens Discomfort|0|||
145726700|NCT03581825|525515445|FG000|Period 2|Unsatisfactory Vision to Test|0|||
145726701|NCT03581825|525515446|FG001|Period 2|Unsatisfactory Vision to Test|1|||
145726702|NCT01204398|525515447|FG000|Overall Study|Adverse Event|1|||
145726703|NCT03261700|525515448|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
145726704|NCT03261700|525515449|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
145726705|NCT01723254|525515451|FG000|Overall Study|Conflict with work schedule|0|||
145726706|NCT01723254|525515452|FG001|Overall Study|Conflict with work schedule|0|||
145726707|NCT01723254|525515453|FG002|Overall Study|Conflict with work schedule|0|||
145726708|NCT01723254|525515454|FG003|Overall Study|Conflict with work schedule|0|||
145726709|NCT01723254|525515455|FG004|Overall Study|Conflict with work schedule|0|||
145726710|NCT01723254|525515456|FG005|Overall Study|Conflict with work schedule|0|||
145726711|NCT01723254|525515457|FG006|Overall Study|Conflict with work schedule|0|||
145726712|NCT01723254|525515458|FG007|Overall Study|Conflict with work schedule|1|||
145726713|NCT01723254|525515451|FG000|Overall Study|Personal issues|0|||
145726714|NCT01723254|525515452|FG001|Overall Study|Personal issues|0|||
145726715|NCT01723254|525515453|FG002|Overall Study|Personal issues|0|||
145726716|NCT01723254|525515454|FG003|Overall Study|Personal issues|0|||
145726717|NCT01723254|525515455|FG004|Overall Study|Personal issues|0|||
145726718|NCT01723254|525515456|FG005|Overall Study|Personal issues|1|||
145726719|NCT01723254|525515457|FG006|Overall Study|Personal issues|0|||
145726720|NCT01723254|525515458|FG007|Overall Study|Personal issues|0|||
145726721|NCT01723254|525515451|FG000|Overall Study|No longer have time to participate|0|||
145726722|NCT01723254|525515452|FG001|Overall Study|No longer have time to participate|0|||
145726723|NCT01723254|525515453|FG002|Overall Study|No longer have time to participate|0|||
145726724|NCT01723254|525515454|FG003|Overall Study|No longer have time to participate|1|||
145726725|NCT01723254|525515455|FG004|Overall Study|No longer have time to participate|0|||
145726726|NCT01723254|525515456|FG005|Overall Study|No longer have time to participate|0|||
145726727|NCT01723254|525515457|FG006|Overall Study|No longer have time to participate|0|||
145726728|NCT01723254|525515458|FG007|Overall Study|No longer have time to participate|0|||
145726729|NCT01723254|525515451|FG000|Overall Study|Move/Left to another country/city|0|||
145726730|NCT01723254|525515452|FG001|Overall Study|Move/Left to another country/city|0|||
145726731|NCT01723254|525515453|FG002|Overall Study|Move/Left to another country/city|2|||
145726732|NCT01723254|525515454|FG003|Overall Study|Move/Left to another country/city|1|||
145726733|NCT01723254|525515455|FG004|Overall Study|Move/Left to another country/city|1|||
145726734|NCT01723254|525515456|FG005|Overall Study|Move/Left to another country/city|0|||
145726735|NCT01723254|525515457|FG006|Overall Study|Move/Left to another country/city|0|||
145726736|NCT01723254|525515458|FG007|Overall Study|Move/Left to another country/city|0|||
145726737|NCT01723254|525515451|FG000|Overall Study|Protocol Violation|0|||
145726738|NCT01723254|525515452|FG001|Overall Study|Protocol Violation|1|||
145726739|NCT01723254|525515453|FG002|Overall Study|Protocol Violation|0|||
145726740|NCT01723254|525515454|FG003|Overall Study|Protocol Violation|0|||
145726741|NCT01723254|525515455|FG004|Overall Study|Protocol Violation|0|||
145726742|NCT01723254|525515456|FG005|Overall Study|Protocol Violation|0|||
145726743|NCT01723254|525515457|FG006|Overall Study|Protocol Violation|0|||
145726744|NCT01723254|525515458|FG007|Overall Study|Protocol Violation|0|||
145726745|NCT01723254|525515451|FG000|Overall Study|Withdrawal by Subject|1|||
145726746|NCT01723254|525515452|FG001|Overall Study|Withdrawal by Subject|2|||
145726747|NCT01723254|525515453|FG002|Overall Study|Withdrawal by Subject|1|||
145726748|NCT01723254|525515454|FG003|Overall Study|Withdrawal by Subject|0|||
145726749|NCT01723254|525515455|FG004|Overall Study|Withdrawal by Subject|1|||
145726750|NCT01723254|525515456|FG005|Overall Study|Withdrawal by Subject|1|||
145726751|NCT01723254|525515457|FG006|Overall Study|Withdrawal by Subject|1|||
145726752|NCT01723254|525515458|FG007|Overall Study|Withdrawal by Subject|2|||
145726753|NCT02668185|525515459|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
145726754|NCT02668185|525515460|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
145726755|NCT02668185|525515459|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
145726756|NCT02668185|525515460|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
145726757|NCT02668185|525515459|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
145726758|NCT02668185|525515460|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
145726759|NCT02668185|525515459|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
145726760|NCT02668185|525515460|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
145726761|NCT00770341|525515461|FG000|Overall Study|Did not meet eligibility criteria|1|||
145726762|NCT00770341|525515462|FG001|Overall Study|Did not meet eligibility criteria|0|||
145726763|NCT00770341|525515463|FG002|Overall Study|Did not meet eligibility criteria|0|||
145726764|NCT00770341|525515461|FG000|Overall Study|Withdrawal by Subject|0|||
145726765|NCT00770341|525515462|FG001|Overall Study|Withdrawal by Subject|1|||
145726766|NCT00770341|525515463|FG002|Overall Study|Withdrawal by Subject|0|||
145726767|NCT00770341|525515461|FG000|Overall Study|Clinical Adverse Event|3|||
145726768|NCT00770341|525515462|FG001|Overall Study|Clinical Adverse Event|1|||
145726769|NCT00770341|525515463|FG002|Overall Study|Clinical Adverse Event|2|||
145726770|NCT00770341|525515461|FG000|Overall Study|Laboratory adverse event|3|||
145726771|NCT00770341|525515462|FG001|Overall Study|Laboratory adverse event|3|||
145726772|NCT00770341|525515463|FG002|Overall Study|Laboratory adverse event|0|||
145726773|NCT00770341|525515461|FG000|Overall Study|Lack of Efficacy|3|||
145726774|NCT00770341|525515462|FG001|Overall Study|Lack of Efficacy|0|||
145726775|NCT00770341|525515463|FG002|Overall Study|Lack of Efficacy|1|||
145726776|NCT00770341|525515461|FG000|Overall Study|Other|1|||
145726777|NCT00770341|525515462|FG001|Overall Study|Other|0|||
145726778|NCT00770341|525515463|FG002|Overall Study|Other|0|||
145726779|NCT00770341|525515461|FG000|Overall Study|Not treated|1|||
145726780|NCT00770341|525515462|FG001|Overall Study|Not treated|0|||
145726781|NCT00770341|525515463|FG002|Overall Study|Not treated|0|||
145726782|NCT03316300|525515465|FG000|Overall Study|Withdrawal by Subject|3|||
145726783|NCT03316300|525515466|FG001|Overall Study|Withdrawal by Subject|2|||
145726784|NCT03316300|525515465|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
145726785|NCT03316300|525515466|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
145726786|NCT03316300|525515465|FG000|Overall Study|Adverse Event|1|||
145726787|NCT03316300|525515466|FG001|Overall Study|Adverse Event|0|||
145726788|NCT03316300|525515465|FG000|Overall Study|COVID-19|0|||
145726789|NCT03316300|525515466|FG001|Overall Study|COVID-19|1|||
145726790|NCT01910181|525515469|FG000|Overall Study|Death|37|||
145726791|NCT01910181|525515469|FG000|Overall Study|Lost to Follow-up|3|||
145726792|NCT01910181|525515469|FG000|Overall Study|Study Terminated by Sponsor|6|||
145726793|NCT01340651|525515473|FG000|Overall Study|Adverse Event|3|||
145726794|NCT01340651|525515473|FG000|Overall Study|Consent Withdrawn|2|||
145726795|NCT01340651|525515473|FG000|Overall Study|Commercial Supply per Sponsor|12|||
145726796|NCT05269355|525515477|FG000|Overall Study|Progressive Disease|104|||
145726797|NCT05269355|525515478|FG001|Overall Study|Progressive Disease|68|||
145726798|NCT05269355|525515477|FG000|Overall Study|Study Terminated by Sponsor|87|||
145726799|NCT05269355|525515478|FG001|Overall Study|Study Terminated by Sponsor|29|||
145726800|NCT05269355|525515477|FG000|Overall Study|Adverse Event|15|||
145726801|NCT05269355|525515478|FG001|Overall Study|Adverse Event|8|||
145726802|NCT05269355|525515477|FG000|Overall Study|Withdrawal by Subject|18|||
145726803|NCT05269355|525515478|FG001|Overall Study|Withdrawal by Subject|5|||
145726804|NCT05269355|525515477|FG000|Overall Study|Physician Decision|6|||
145726805|NCT05269355|525515478|FG001|Overall Study|Physician Decision|4|||
145726806|NCT05269355|525515477|FG000|Overall Study|Death|3|||
145384215|NCT01078298|524260295|FG000|Overall Study|Adverse Event|6|||
145384216|NCT01078298|524260296|FG001|Overall Study|Adverse Event|5|||
145384217|NCT01078298|524260295|FG000|Overall Study|Death|2|||
145384218|NCT01078298|524260296|FG001|Overall Study|Death|0|||
145384219|NCT01078298|524260295|FG000|Overall Study|Did not meet entrance criteria|0|||
145384220|NCT01078298|524260296|FG001|Overall Study|Did not meet entrance criteria|1|||
145384221|NCT01078298|524260295|FG000|Overall Study|Other|24|||
145726807|NCT05269355|525515478|FG001|Overall Study|Death|5|||
145726808|NCT05269355|525515477|FG000|Overall Study|Other Than Specified|5|||
145726809|NCT05269355|525515478|FG001|Overall Study|Other Than Specified|1|||
145726810|NCT05269355|525515477|FG000|Overall Study|Randomized But Not Treated|1|||
145726811|NCT05269355|525515478|FG001|Overall Study|Randomized But Not Treated|0|||
145726812|NCT03705832|525515479|FG000|Overall Study|Physician Decision|0|||
145726813|NCT03705832|525515480|FG001|Overall Study|Physician Decision|1|||
145726814|NCT03705832|525515479|FG000|Overall Study|Withdrawal by Subject|1|||
145726815|NCT03705832|525515480|FG001|Overall Study|Withdrawal by Subject|0|||
145726816|NCT01050790|525515481|FG000|Overall Study|Adverse Event|1|||
145726817|NCT01880528|525515482|FG000|Overall Study|Other|1|||
145726818|NCT01880528|525515483|FG001|Overall Study|Other|1|||
145384222|NCT01078298|524260296|FG001|Overall Study|Other|32|||
145726819|NCT00081497|525515484|FG000|Overall Study|Adverse Event|2|||
145726820|NCT00081497|525515485|FG001|Overall Study|Adverse Event|0|||
145726821|NCT00081497|525515484|FG000|Overall Study|Death|0|||
145726822|NCT00081497|525515485|FG001|Overall Study|Death|1|||
145726823|NCT00081497|525515484|FG000|Overall Study|Withdrawal by Subject|1|||
145726824|NCT00081497|525515485|FG001|Overall Study|Withdrawal by Subject|0|||
145726825|NCT00081497|525515484|FG000|Overall Study|Non-compliance|0|||
145726826|NCT00081497|525515485|FG001|Overall Study|Non-compliance|1|||
145726827|NCT02390245|525515486|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
145726828|NCT02390245|525515487|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
145726829|NCT02390245|525515488|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
145726830|NCT02390245|525515486|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
145726831|NCT02390245|525515487|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
145726832|NCT02390245|525515488|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
145726833|NCT01072877|525517166|FG000|Overall Study|Lost to Follow-up|1|||
145726834|NCT01072877|525517167|FG001|Overall Study|Lost to Follow-up|1|||
145726835|NCT01072877|525517168|FG002|Overall Study|Lost to Follow-up|0|||
145726836|NCT01072877|525517169|FG003|Overall Study|Lost to Follow-up|2|||
145726837|NCT01072877|525517170|FG004|Overall Study|Lost to Follow-up|0|||
145726838|NCT02245672|525517171|FG000|Overall Study|Adverse Event|4|||
145726839|NCT02245672|525517172|FG001|Overall Study|Adverse Event|4|||
145726840|NCT02245672|525517173|FG002|Overall Study|Adverse Event|4|||
145726841|NCT02245672|525517171|FG000|Overall Study|Lost to Follow-up|3|||
145726842|NCT02245672|525517172|FG001|Overall Study|Lost to Follow-up|5|||
145726843|NCT02245672|525517173|FG002|Overall Study|Lost to Follow-up|1|||
145726844|NCT02245672|525517171|FG000|Overall Study|Withdrawal by Subject|6|||
145726845|NCT02245672|525517172|FG001|Overall Study|Withdrawal by Subject|3|||
145726846|NCT02245672|525517173|FG002|Overall Study|Withdrawal by Subject|0|||
145726847|NCT02245672|525517171|FG000|Overall Study|Randomized in error (not treated)|0|||
145726848|NCT02245672|525517172|FG001|Overall Study|Randomized in error (not treated)|1|||
145726849|NCT02245672|525517173|FG002|Overall Study|Randomized in error (not treated)|0|||
145726850|NCT01765192|525517175|FG000|Treatment Period 1|Adverse Event|0|||
145726851|NCT01765192|525517176|FG001|Treatment Period 1|Adverse Event|1|||
145726852|NCT01765192|525517175|FG000|Washout Period|Voluntary Withdrawal|1|||
145726853|NCT01765192|525517176|FG001|Washout Period|Voluntary Withdrawal|1|||
145726854|NCT01765192|525517175|FG000|Washout Period|Reason not specified|1|||
145726855|NCT01765192|525517176|FG001|Washout Period|Reason not specified|0|||
145726856|NCT01765192|525517175|FG000|Treatment Period 2|Reason not specified|0|||
145726857|NCT01765192|525517176|FG001|Treatment Period 2|Reason not specified|2|||
145726858|NCT01765192|525517175|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
145726859|NCT01765192|525517176|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
145726860|NCT00294554|525517177|FG000|Overall Study|Lack of Efficacy|0|||
145726861|NCT00294554|525517178|FG001|Overall Study|Lack of Efficacy|1|||
145726862|NCT00294554|525517177|FG000|Overall Study|Physician Decision|0|||
145726863|NCT00294554|525517178|FG001|Overall Study|Physician Decision|1|||
145726864|NCT00462865|525517179|FG000|Overall Study|Adverse Event|1|||
145726865|NCT04142450|525517180|FG000|Overall Study|Screen Failure|1|||
145726866|NCT04142450|525517180|FG000|Overall Study|Lost to Follow-up|1|||
145726867|NCT06336603|525517181|FG000|Overall Study|Withdrawal by Subject|1|||
145726868|NCT06336603|525517181|FG000|Overall Study|Lost to Follow-up|2|||
145726869|NCT04335812|525517184|FG000|Overall Study|Withdrawal by Subject|1|||
145726870|NCT04335812|525517185|FG001|Overall Study|Withdrawal by Subject|3|||
145726871|NCT04335812|525517184|FG000|Overall Study|Lost to Follow-up|12|||
145726872|NCT04335812|525517185|FG001|Overall Study|Lost to Follow-up|12|||
145726873|NCT04335812|525517184|FG000|Overall Study|Did not engage in the intervention|22|||
145726874|NCT04335812|525517185|FG001|Overall Study|Did not engage in the intervention|18|||
145726875|NCT02901041|525517191|FG000|Overall Study|Withdrawal by PI|4|||
145726876|NCT02901041|525517192|FG001|Overall Study|Withdrawal by PI|8|||
145726877|NCT02901041|525517191|FG000|Overall Study|Withdrawal by Subject|7|||
145726878|NCT02901041|525517192|FG001|Overall Study|Withdrawal by Subject|3|||
145726879|NCT01480674|525517193|FG000|Overall Study|Death|23|||
145726880|NCT01480674|525517193|FG000|Overall Study|Lost to Follow-up|2|||
145726881|NCT01480674|525517193|FG000|Overall Study|visit not done|10|||
145494979|NCT02234843|524670267|FG000|Overall Study|Death|1|||
145726882|NCT03249714|525517197|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
145726883|NCT03249714|525517198|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
145726884|NCT03249714|525517197|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
145726885|NCT03249714|525517198|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
145726886|NCT03249714|525517197|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
145726887|NCT03249714|525517198|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
145726888|NCT03249714|525517197|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
145726889|NCT03249714|525517198|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
145726890|NCT00655863|525517206|FG000|Overall Study|Lost to Follow-up|0|||
145726891|NCT00655863|525517207|FG001|Overall Study|Lost to Follow-up|0|||
145726892|NCT00655863|525517208|FG002|Overall Study|Lost to Follow-up|1|||
145726893|NCT01138007|525517209|FG000|Overall Study|Adverse Event|4|||
145726894|NCT01138007|525517210|FG001|Overall Study|Adverse Event|12|||
145726895|NCT01138007|525517211|FG002|Overall Study|Adverse Event|9|||
145726896|NCT01138007|525517209|FG000|Overall Study|Lack of Efficacy|2|||
145726897|NCT01138007|525517210|FG001|Overall Study|Lack of Efficacy|0|||
145726898|NCT01138007|525517211|FG002|Overall Study|Lack of Efficacy|6|||
145726899|NCT01138007|525517209|FG000|Overall Study|Protocol Violation|2|||
145726900|NCT01138007|525517210|FG001|Overall Study|Protocol Violation|3|||
145726901|NCT01138007|525517211|FG002|Overall Study|Protocol Violation|2|||
145726902|NCT01138007|525517209|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
145726903|NCT01138007|525517210|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
145726904|NCT01138007|525517211|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
145726905|NCT01138007|525517209|FG000|Overall Study|Lost to Follow-up|3|||
145726906|NCT01138007|525517210|FG001|Overall Study|Lost to Follow-up|3|||
145726907|NCT01138007|525517211|FG002|Overall Study|Lost to Follow-up|5|||
145726908|NCT01138007|525517209|FG000|Overall Study|Physician Decision|0|||
145726909|NCT01138007|525517210|FG001|Overall Study|Physician Decision|5|||
145726910|NCT01138007|525517211|FG002|Overall Study|Physician Decision|3|||
145726911|NCT01138007|525517209|FG000|Overall Study|Withdrawal by Subject|5|||
145726912|NCT01138007|525517210|FG001|Overall Study|Withdrawal by Subject|6|||
145726913|NCT01138007|525517211|FG002|Overall Study|Withdrawal by Subject|15|||
145726914|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
145726915|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
145726916|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
145726917|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
145726918|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
145726919|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
145726920|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
145726921|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
145726922|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
145726923|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
145726924|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
145726925|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
145726926|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
145726927|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
145726928|NCT03548987|525517212|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
145726929|NCT03548987|525517213|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
145726930|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
145726931|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
145726932|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
145726933|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
145726934|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
145726935|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
145726936|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
145726937|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
145726938|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
145726939|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
145726940|NCT03548987|525517212|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
145726941|NCT03548987|525517213|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
145726942|NCT04661878|525517214|FG000|Overall Study|Lost to Follow-up|6|||
145726943|NCT04661878|525517215|FG001|Overall Study|Lost to Follow-up|5|||
145726944|NCT00640016|525517218|FG000|Overall Study|Withdrawal by Subject|0|||
145726945|NCT00640016|525517219|FG001|Overall Study|Withdrawal by Subject|1|||
145726946|NCT00640016|525517220|FG002|Overall Study|Withdrawal by Subject|0|||
145726947|NCT00640016|525517221|FG003|Overall Study|Withdrawal by Subject|0|||
145726948|NCT00640016|525517218|FG000|Overall Study|Study termination|2|||
145726949|NCT00640016|525517219|FG001|Overall Study|Study termination|1|||
145726950|NCT00640016|525517220|FG002|Overall Study|Study termination|3|||
145726951|NCT00640016|525517221|FG003|Overall Study|Study termination|2|||
145726952|NCT00640016|525517218|FG000|Overall Study|Adverse Event|0|||
145726953|NCT00640016|525517219|FG001|Overall Study|Adverse Event|0|||
145726954|NCT00640016|525517220|FG002|Overall Study|Adverse Event|0|||
145726955|NCT00640016|525517221|FG003|Overall Study|Adverse Event|1|||
145726956|NCT00887679|525517223|FG000|Overall Study|Withdrawal by Subject|1|||
145726957|NCT00887679|525517223|FG000|Overall Study|Lost to Follow-up|4|||
145726958|NCT00887679|525517223|FG000|Overall Study|Physician Decision|5|||
145726959|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
145726960|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
145726961|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
145726962|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
145726963|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
145726964|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
145726965|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
145384223|NCT00171158|524261677|FG000|Core Study|Death|27|||
145384224|NCT00171158|524261677|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
145384225|NCT00171158|524261677|FG000|Core Study|Protocol Violation|4|||
145384226|NCT00171158|524261677|FG000|Core Study|Administrative problems|1|||
145384227|NCT00171158|524261677|FG000|Core Study|Adverse event, non-fatal|21|||
145384228|NCT00171158|524261677|FG000|Core Study|Consent withdrawn by subject|6|||
145384229|NCT00171158|524261677|FG000|Core Study|No longer required drug (BMT)|14|||
145384230|NCT00171158|524261677|FG000|Core Study|Abnormal Laboratory Values|2|||
145384231|NCT00171158|524261677|FG000|Core Study|Lost to Follow-up|1|||
145384232|NCT00171158|524261677|FG000|E2 Extension|Other|7|||
145726966|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
145726967|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
145726968|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
145726969|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
145726970|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
145726971|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
145726972|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
145726973|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
145726974|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
145726975|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
145726976|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
145726977|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
145726978|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
145726979|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
145726980|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
145726981|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
145726982|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
145726983|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
145726984|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
145726985|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
145726986|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
145726987|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
145726988|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
145726989|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Other|10|||
145726990|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Other|7|||
145726991|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Other|8|||
145726992|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Other|8|||
145726993|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Other|0|||
145726994|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
145726995|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
145726996|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
145726997|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
145726998|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
145726999|NCT00615836|525517224|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
145727000|NCT00615836|525517225|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
145727001|NCT00615836|525517226|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
145727002|NCT00615836|525517227|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
145727003|NCT00615836|525517228|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
145727004|NCT01630434|525517229|FG000|Overall Study|Donor lungs turned down|1|||
145727005|NCT01630434|525517230|FG001|Overall Study|Donor lungs turned down|0|||
145727006|NCT01630434|525517229|FG000|Overall Study|Protocol Violation|9|||
145727007|NCT01630434|525517230|FG001|Overall Study|Protocol Violation|4|||
145727008|NCT01630434|525517229|FG000|Overall Study|Death|20|||
145727009|NCT01630434|525517230|FG001|Overall Study|Death|26|||
145727010|NCT00687973|525517231|FG000|Overall Study|Adverse Event|18|||
145727011|NCT00687973|525517232|FG001|Overall Study|Adverse Event|28|||
145727012|NCT00687973|525517231|FG000|Overall Study|Lack of Efficacy|2|||
145727013|NCT00687973|525517232|FG001|Overall Study|Lack of Efficacy|3|||
145727014|NCT00687973|525517231|FG000|Overall Study|Protocol Violation|1|||
145727015|NCT00687973|525517232|FG001|Overall Study|Protocol Violation|2|||
145727016|NCT00687973|525517231|FG000|Overall Study|Administrative Reasons|0|||
145727017|NCT00687973|525517232|FG001|Overall Study|Administrative Reasons|2|||
145727018|NCT00687973|525517231|FG000|Overall Study|Withdrawal by Subject|3|||
145727019|NCT00687973|525517232|FG001|Overall Study|Withdrawal by Subject|3|||
145727020|NCT02578862|525517234|FG000|Overall Study|Withdrawal by Subject|0|||
145384233|NCT02757352|524261681|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
145494980|NCT02234843|524670268|FG001|Overall Study|Death|0|||
145727021|NCT02578862|525517235|FG001|Overall Study|Withdrawal by Subject|1|||
145494981|NCT02234843|524670269|FG002|Overall Study|Death|0|||
145384234|NCT02757352|524261682|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384235|NCT02757352|524261683|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
145384236|NCT02757352|524261684|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384237|NCT02757352|524261685|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384238|NCT02757352|524261686|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384239|NCT02757352|524261687|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384240|NCT02757352|524261688|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384241|NCT02757352|524261689|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145727022|NCT02578862|525517234|FG000|Overall Study|Unplanned unilateral procedure|0|||
145727023|NCT02578862|525517235|FG001|Overall Study|Unplanned unilateral procedure|1|||
145727024|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
145727025|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
145727026|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Death|0|||
145727027|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Death|2|||
145727028|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
145727029|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
145727030|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
145384242|NCT02757352|524261690|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
145384243|NCT02757352|524261681|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384244|NCT02757352|524261682|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384245|NCT02757352|524261683|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
145727031|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
145727032|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
145727033|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
145727034|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
145727035|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
145727036|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
145727037|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
145727038|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
145727039|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
145727040|NCT00343252|525517239|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
145727041|NCT00343252|525517240|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
145727042|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
145727043|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
145727044|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Death|3|||
145727045|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Death|3|||
145727046|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
145727047|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
145727048|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
145727049|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
145727050|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
145727051|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
145727052|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
145727053|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
145727054|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
145727055|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
145727056|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
145727057|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
145727058|NCT00343252|525517239|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
145727059|NCT00343252|525517240|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
145727060|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
145266637|NCT04668066|523825247|FG010|Part 1: Treatment Phase|Other|0|||
145384246|NCT02757352|524261684|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384247|NCT02757352|524261685|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384248|NCT02757352|524261686|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384249|NCT02757352|524261687|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145384250|NCT02757352|524261688|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145727061|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
145727062|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Death|4|||
145727063|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Death|5|||
145727064|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
145727065|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
145727066|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
145727067|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
145727068|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
145727069|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
145727070|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
145727071|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
145727072|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
145727073|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
145727074|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
145727075|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
145727076|NCT00343252|525517239|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
145727077|NCT00343252|525517240|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
145727078|NCT00731120|525517241|FG000|Overall Study|Adverse Event|7|||
145727079|NCT00731120|525517242|FG001|Overall Study|Adverse Event|6|||
145727080|NCT00731120|525517243|FG002|Overall Study|Adverse Event|8|||
145727081|NCT00731120|525517241|FG000|Overall Study|Lack of Efficacy|4|||
145727082|NCT00731120|525517242|FG001|Overall Study|Lack of Efficacy|5|||
145727083|NCT00731120|525517243|FG002|Overall Study|Lack of Efficacy|4|||
145727084|NCT00731120|525517241|FG000|Overall Study|Noncompliance with Study Drug|3|||
145727085|NCT00731120|525517242|FG001|Overall Study|Noncompliance with Study Drug|3|||
145727086|NCT00731120|525517243|FG002|Overall Study|Noncompliance with Study Drug|1|||
145727087|NCT00731120|525517241|FG000|Overall Study|Protocol Deviations|1|||
145727088|NCT00731120|525517242|FG001|Overall Study|Protocol Deviations|6|||
145727089|NCT00731120|525517243|FG002|Overall Study|Protocol Deviations|1|||
145727090|NCT00731120|525517241|FG000|Overall Study|Withdrawal of Consent|13|||
145727091|NCT00731120|525517242|FG001|Overall Study|Withdrawal of Consent|8|||
145727092|NCT00731120|525517243|FG002|Overall Study|Withdrawal of Consent|4|||
145727093|NCT00731120|525517241|FG000|Overall Study|Lost to Follow-up|10|||
145727094|NCT00731120|525517242|FG001|Overall Study|Lost to Follow-up|15|||
145727095|NCT00731120|525517243|FG002|Overall Study|Lost to Follow-up|17|||
145727096|NCT00731120|525517241|FG000|Overall Study|Other|4|||
145727097|NCT00731120|525517242|FG001|Overall Study|Other|0|||
145727098|NCT00731120|525517243|FG002|Overall Study|Other|1|||
145727099|NCT01142596|525517244|FG000|Overall Study|Withdrawal by Subject|9|||
145727100|NCT01142596|525517245|FG001|Overall Study|Withdrawal by Subject|35|||
145727101|NCT01142596|525517244|FG000|Overall Study|Adverse Event|8|||
145727102|NCT01142596|525517245|FG001|Overall Study|Adverse Event|35|||
145727103|NCT01142596|525517244|FG000|Overall Study|Lack of Efficacy|5|||
145727104|NCT01142596|525517245|FG001|Overall Study|Lack of Efficacy|9|||
145727105|NCT01142596|525517244|FG000|Overall Study|Lost to Follow-up|2|||
145727106|NCT01142596|525517245|FG001|Overall Study|Lost to Follow-up|3|||
145727107|NCT01142596|525517244|FG000|Overall Study|Other reason (not specified)|5|||
145727108|NCT01142596|525517245|FG001|Overall Study|Other reason (not specified)|4|||
145727109|NCT03181451|525517248|FG000|Overall Study|Adverse Event|0|||
145727110|NCT03181451|525517249|FG001|Overall Study|Adverse Event|1|||
145727111|NCT03181451|525517250|FG002|Overall Study|Adverse Event|0|||
145727112|NCT03181451|525517248|FG000|Overall Study|Withdrawal by Subject|0|||
145727113|NCT03181451|525517249|FG001|Overall Study|Withdrawal by Subject|1|||
145727114|NCT03181451|525517250|FG002|Overall Study|Withdrawal by Subject|0|||
145727115|NCT02988622|525517251|FG000|Overall Study|Lost to Follow-up|17|||
145727116|NCT02447172|525517252|FG000|Overall Study|Adverse Event|11|||
145727117|NCT02447172|525517253|FG001|Overall Study|Adverse Event|8|||
145727118|NCT02447172|525517254|FG002|Overall Study|Adverse Event|7|||
145727119|NCT02447172|525517252|FG000|Overall Study|Death|3|||
145727120|NCT02447172|525517253|FG001|Overall Study|Death|1|||
145727121|NCT02447172|525517254|FG002|Overall Study|Death|0|||
145727122|NCT02447172|525517252|FG000|Overall Study|Protocol Violation|2|||
145727123|NCT02447172|525517253|FG001|Overall Study|Protocol Violation|1|||
145727124|NCT02447172|525517254|FG002|Overall Study|Protocol Violation|2|||
145727125|NCT02447172|525517252|FG000|Overall Study|Lost to Follow-up|7|||
145727126|NCT02447172|525517253|FG001|Overall Study|Lost to Follow-up|4|||
145727127|NCT02447172|525517254|FG002|Overall Study|Lost to Follow-up|4|||
145727128|NCT02447172|525517252|FG000|Overall Study|Withdrawal by Subject|5|||
145727129|NCT02447172|525517253|FG001|Overall Study|Withdrawal by Subject|1|||
145727130|NCT02447172|525517254|FG002|Overall Study|Withdrawal by Subject|3|||
145727131|NCT02447172|525517252|FG000|Overall Study|protocol specific treatment unrelated|3|||
145727132|NCT02447172|525517253|FG001|Overall Study|protocol specific treatment unrelated|0|||
145727133|NCT02447172|525517254|FG002|Overall Study|protocol specific treatment unrelated|2|||
145727134|NCT03562247|525517258|FG000|Overall Study|Lost to Follow-up|3|||
145727135|NCT03562247|525517259|FG001|Overall Study|Lost to Follow-up|1|||
145384251|NCT02757352|524261689|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145727136|NCT03562247|525517260|FG002|Overall Study|Lost to Follow-up|1|||
145727137|NCT00983931|525517261|FG000|14 Day Washout Period|Physician Decision|1|||
145727138|NCT01201265|525517262|FG000|Overall Study|Death|14|||
145727139|NCT01201265|525517262|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145727140|NCT01201265|525517262|FG000|Overall Study|Lost to Follow-up|10|||
145727141|NCT01201265|525517262|FG000|Overall Study|Withdrawal by Subject|7|||
145727142|NCT01201265|525517262|FG000|Overall Study|Disease Progression|4|||
145727143|NCT03343301|525517263|FG000|Overall Study|Withdrawal by Subject|1|||
145266638|NCT04668066|523825248|FG011|Part 1: Treatment Phase|Other|1|||
145727144|NCT03343301|525517264|FG001|Overall Study|Withdrawal by Subject|1|||
145727145|NCT03343301|525517263|FG000|Overall Study|Death|0|||
145727146|NCT03343301|525517264|FG001|Overall Study|Death|2|||
145727147|NCT03343301|525517263|FG000|Overall Study|Other|0|||
145727148|NCT03343301|525517264|FG001|Overall Study|Other|6|||
145727149|NCT03343301|525517263|FG000|Overall Study|Missing|2|||
145727150|NCT03343301|525517264|FG001|Overall Study|Missing|0|||
145727151|NCT00723021|525517275|FG000|Intervention Period 4|Adverse Event|0|||
145727152|NCT00723021|525517276|FG001|Intervention Period 4|Adverse Event|0|||
145727153|NCT00723021|525517277|FG002|Intervention Period 4|Adverse Event|0|||
145727154|NCT00723021|525517278|FG003|Intervention Period 4|Adverse Event|0|||
145727155|NCT00723021|525517279|FG004|Intervention Period 4|Adverse Event|1|||
145727156|NCT04002401|525517282|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
145727157|NCT04002401|525517282|FG000|Overall Study|Death|10|||
145727158|NCT04002401|525517282|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
145727159|NCT04002401|525517282|FG000|Overall Study|Enrolled but Never Treated|1|||
145727160|NCT04002401|525517282|FG000|Overall Study|Lost to Follow-up|1|||
145727161|NCT02337751|525517283|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
145727162|NCT02337751|525517284|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
145727163|NCT02337751|525517283|FG000|Overall Study|Voluntary Withdrawal|6|||
145727164|NCT02337751|525517284|FG001|Overall Study|Voluntary Withdrawal|8|||
145727165|NCT02337751|525517283|FG000|Overall Study|Lack of Efficacy|2|||
145727166|NCT02337751|525517284|FG001|Overall Study|Lack of Efficacy|5|||
145727167|NCT02337751|525517283|FG000|Overall Study|Investigator's Judgement|1|||
145727168|NCT02337751|525517284|FG001|Overall Study|Investigator's Judgement|0|||
145727169|NCT02881957|525517289|FG000|Overall Study|Comfort care|0|||
145727170|NCT02881957|525517290|FG001|Overall Study|Comfort care|1|||
145727171|NCT02881957|525517289|FG000|Overall Study|Concurrent trial enrollment|0|||
145727172|NCT02881957|525517290|FG001|Overall Study|Concurrent trial enrollment|1|||
145727173|NCT02881957|525517289|FG000|Overall Study|Discharged within 48 hours|0|||
145727174|NCT02881957|525517290|FG001|Overall Study|Discharged within 48 hours|1|||
145727175|NCT02881957|525517289|FG000|Overall Study|Withdrawal by Subject|2|||
145727176|NCT02881957|525517290|FG001|Overall Study|Withdrawal by Subject|1|||
145727177|NCT02881957|525517289|FG000|Overall Study|Protocol Violation|1|||
145727178|NCT02881957|525517290|FG001|Overall Study|Protocol Violation|0|||
145727179|NCT00959647|525517297|FG000|Overall Study|Adverse Event|2|||
145727180|NCT00959647|525517297|FG000|Overall Study|Progressive disease|6|||
145727181|NCT00959647|525517297|FG000|Overall Study|Study terminated by sponsor|4|||
145727182|NCT00959647|525517297|FG000|Overall Study|Withdrawal by Subject|7|||
145727183|NCT05959629|525517300|FG000|Overall Study|partially necrotic/technical issues|2|||
145727184|NCT05959629|525517301|FG001|Overall Study|partially necrotic/technical issues|2|||
145727185|NCT02768870|525518954|FG000|Overall Study|Death|1|||
145727186|NCT02768870|525518954|FG000|Overall Study|Reoperation|6|||
145727187|NCT02768870|525518954|FG000|Overall Study|Lost to Follow-up|1|||
145727188|NCT02768870|525518954|FG000|Overall Study|Exit|4|||
145727189|NCT01774110|525518955|FG000|Overall Study|Lost to Follow-up|7|||
145727190|NCT02683941|525518956|FG000|Double-blind Phase|Adverse Event|0|||
145727191|NCT02683941|525518957|FG001|Double-blind Phase|Adverse Event|1|||
145727192|NCT02683941|525518956|FG000|Double-blind Phase|Withdrawal by Subject|4|||
145727193|NCT02683941|525518957|FG001|Double-blind Phase|Withdrawal by Subject|2|||
145727194|NCT02683941|525518956|FG000|Double-blind Phase|Lost to Follow-up|1|||
145727195|NCT02683941|525518957|FG001|Double-blind Phase|Lost to Follow-up|0|||
145727196|NCT02683941|525518956|FG000|Double-blind Phase|Disease Progression|5|||
145727197|NCT02683941|525518957|FG001|Double-blind Phase|Disease Progression|2|||
145727198|NCT02683941|525518956|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
145727199|NCT02683941|525518957|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
145727200|NCT02683941|525518956|FG000|Open-label Treatment Phase|Disease Progression|1|||
145727201|NCT02683941|525518957|FG001|Open-label Treatment Phase|Disease Progression|2|||
145727202|NCT02683941|525518956|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
145727203|NCT02683941|525518957|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
145727204|NCT02683941|525518956|FG000|Open-label Treatment Phase|Other|1|||
145727205|NCT02683941|525518957|FG001|Open-label Treatment Phase|Other|0|||
145384252|NCT02757352|524261690|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
145494982|NCT02234843|524670270|FG003|Overall Study|Death|0|||
145727206|NCT02683941|525518956|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
145727207|NCT02683941|525518957|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
145727208|NCT02683941|525518956|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
145727209|NCT02683941|525518957|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
145727210|NCT02683941|525518956|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
145727211|NCT02683941|525518957|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
145727212|NCT02683941|525518956|FG000|Open-label Follow-up Phase|Other|8|||
145727213|NCT02683941|525518957|FG001|Open-label Follow-up Phase|Other|1|||
145727214|NCT00261846|525518958|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
145727215|NCT00261846|525518959|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
145727216|NCT00261846|525518960|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
145727217|NCT00261846|525518961|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727218|NCT00261846|525518962|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727219|NCT00261846|525518963|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727220|NCT00261846|525518964|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727221|NCT00261846|525518965|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727222|NCT00261846|525518966|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727223|NCT00261846|525518967|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727224|NCT00261846|525518968|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727225|NCT00261846|525518969|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
145727226|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727227|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727228|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727229|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
145727230|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727231|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727232|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727233|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727234|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
145727235|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727236|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727237|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
145727238|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727239|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727240|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727241|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
145727242|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
145727243|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
145727244|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
145727245|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
145727246|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727247|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
145727248|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727249|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
145727250|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727251|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727252|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727253|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
145727254|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
145727255|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727256|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
145727257|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727258|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
145727259|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
145727260|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
145727261|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
145727262|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
145727263|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
145727264|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
145727265|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
145727266|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
145727267|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
145727268|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
145727269|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
145727270|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
145727271|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
145727272|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
145727273|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
145727274|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
145727275|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
145727276|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
145727277|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
145727278|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
145727279|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
145727280|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
145384253|NCT02757352|524261681|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
145384254|NCT02757352|524261682|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
145727281|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
145727282|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
145727283|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
145727284|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
145727285|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
145384255|NCT02757352|524261683|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
145727286|NCT00261846|525518958|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
145727287|NCT00261846|525518959|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
145727288|NCT00261846|525518960|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
145727289|NCT00261846|525518961|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
145727290|NCT00261846|525518962|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
145727291|NCT00261846|525518963|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
145727292|NCT00261846|525518964|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
145727293|NCT00261846|525518965|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
145727294|NCT00261846|525518966|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
145727295|NCT00261846|525518967|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
145727296|NCT00261846|525518968|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
145727297|NCT00261846|525518969|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
145727298|NCT00325039|525518973|FG000|Overall Study|Lost to Follow-up|18|||
145727299|NCT00325039|525518974|FG001|Overall Study|Lost to Follow-up|14|||
145727300|NCT01776424|525518976|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
145727301|NCT01776424|525518977|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
145727302|NCT01776424|525518978|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
145727303|NCT01776424|525518976|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
145727304|NCT01776424|525518977|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
145727305|NCT01776424|525518978|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
145727306|NCT01776424|525518976|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
145727307|NCT01776424|525518977|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
145727308|NCT01776424|525518978|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
145727309|NCT01776424|525518976|FG000|LTOLE Part (Open Label)|Refused|5|||
145727310|NCT01776424|525518977|FG001|LTOLE Part (Open Label)|Refused|2|||
145727311|NCT01776424|525518978|FG002|LTOLE Part (Open Label)|Refused|11|||
145727312|NCT01776424|525518976|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
145727313|NCT01776424|525518977|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
145727314|NCT01776424|525518978|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
145727315|NCT02121834|525518981|FG000|Overall Study|Protocol Violation|0|||
145727316|NCT02121834|525518982|FG001|Overall Study|Protocol Violation|1|||
145727317|NCT02121834|525518983|FG002|Overall Study|Protocol Violation|0|||
145727318|NCT02121834|525518984|FG003|Overall Study|Protocol Violation|0|||
145727319|NCT02121834|525518985|FG004|Overall Study|Protocol Violation|0|||
145727320|NCT02121834|525518986|FG005|Overall Study|Protocol Violation|0|||
145727321|NCT02121834|525518987|FG006|Overall Study|Protocol Violation|0|||
145727322|NCT02121834|525518981|FG000|Overall Study|Withdrawal by Subject|0|||
145727323|NCT02121834|525518982|FG001|Overall Study|Withdrawal by Subject|1|||
145727324|NCT02121834|525518983|FG002|Overall Study|Withdrawal by Subject|1|||
145727325|NCT02121834|525518984|FG003|Overall Study|Withdrawal by Subject|0|||
145727326|NCT02121834|525518985|FG004|Overall Study|Withdrawal by Subject|0|||
145727327|NCT02121834|525518986|FG005|Overall Study|Withdrawal by Subject|0|||
145727328|NCT02121834|525518987|FG006|Overall Study|Withdrawal by Subject|0|||
145727329|NCT02121834|525518981|FG000|Overall Study|Lost to Follow-up|0|||
145727330|NCT02121834|525518982|FG001|Overall Study|Lost to Follow-up|0|||
145727331|NCT02121834|525518983|FG002|Overall Study|Lost to Follow-up|1|||
145727332|NCT02121834|525518984|FG003|Overall Study|Lost to Follow-up|0|||
145727333|NCT02121834|525518985|FG004|Overall Study|Lost to Follow-up|0|||
145727334|NCT02121834|525518986|FG005|Overall Study|Lost to Follow-up|0|||
145727335|NCT02121834|525518987|FG006|Overall Study|Lost to Follow-up|0|||
145727336|NCT02075541|525518992|FG000|Overall Study|Serious Adverse Event|1|||
145727337|NCT02075541|525518993|FG001|Overall Study|Serious Adverse Event|4|||
145727338|NCT02075541|525518992|FG000|Overall Study|Protocol Violation|1|||
145727339|NCT02075541|525518993|FG001|Overall Study|Protocol Violation|0|||
145727340|NCT02075541|525518992|FG000|Overall Study|Withdrawal by Subject|1|||
145727341|NCT02075541|525518993|FG001|Overall Study|Withdrawal by Subject|3|||
145727342|NCT02075541|525518992|FG000|Overall Study|Sponsor study termination|0|||
145727343|NCT02075541|525518993|FG001|Overall Study|Sponsor study termination|1|||
145727344|NCT02075541|525518992|FG000|Overall Study|Other- unable to perform study procedure|1|||
145727345|NCT02075541|525518993|FG001|Overall Study|Other- unable to perform study procedure|0|||
145727346|NCT02019927|525518997|FG000|Overall Study|Lost to Follow-up|2|||
145727347|NCT02019927|525518998|FG001|Overall Study|Lost to Follow-up|4|||
145727348|NCT02019927|525518999|FG002|Overall Study|Lost to Follow-up|1|||
145384256|NCT02757352|524261684|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145384257|NCT02757352|524261685|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145727349|NCT02019927|525519000|FG003|Overall Study|Lost to Follow-up|2|||
145727350|NCT02019927|525519001|FG004|Overall Study|Lost to Follow-up|3|||
145727351|NCT02019927|525519002|FG005|Overall Study|Lost to Follow-up|1|||
145384258|NCT02757352|524261686|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145384259|NCT02757352|524261687|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145727352|NCT01054846|525519005|FG000|Overall Study|Lost to Follow-up|76|||
145727353|NCT01054846|525519006|FG001|Overall Study|Lost to Follow-up|17|||
145727354|NCT00394953|525519007|FG000|First Treatment Period|Adverse Event|1|||
145727355|NCT00394953|525519008|FG001|First Treatment Period|Adverse Event|2|||
145727356|NCT00394953|525519007|FG000|First Treatment Period|Death|6|||
145727357|NCT00394953|525519008|FG001|First Treatment Period|Death|7|||
145727358|NCT00394953|525519007|FG000|First Treatment Period|Lack of Efficacy|1|||
145727359|NCT00394953|525519008|FG001|First Treatment Period|Lack of Efficacy|1|||
145727360|NCT00394953|525519007|FG000|First Treatment Period|Withdrawal by Subject|6|||
145727361|NCT00394953|525519008|FG001|First Treatment Period|Withdrawal by Subject|3|||
145727362|NCT00394953|525519007|FG000|First Treatment Period|Lost to Follow-up|0|||
145727363|NCT00394953|525519008|FG001|First Treatment Period|Lost to Follow-up|1|||
145727364|NCT00394953|525519007|FG000|First Treatment Period|Renal transplant|11|||
145727365|NCT00394953|525519008|FG001|First Treatment Period|Renal transplant|7|||
145727366|NCT00394953|525519007|FG000|First Treatment Period|Not defined|4|||
145727367|NCT00394953|525519008|FG001|First Treatment Period|Not defined|1|||
145727368|NCT00394953|525519007|FG000|Second Treatment Period|Adverse Event|2|||
145727369|NCT00394953|525519008|FG001|Second Treatment Period|Adverse Event|5|||
145727370|NCT00394953|525519007|FG000|Second Treatment Period|Death|8|||
145727371|NCT00394953|525519008|FG001|Second Treatment Period|Death|4|||
145727372|NCT00394953|525519007|FG000|Second Treatment Period|Lack of Efficacy|9|||
145727373|NCT00394953|525519008|FG001|Second Treatment Period|Lack of Efficacy|47|||
145727374|NCT00394953|525519007|FG000|Second Treatment Period|Withdrawal by Subject|3|||
145727375|NCT00394953|525519008|FG001|Second Treatment Period|Withdrawal by Subject|3|||
145727376|NCT00394953|525519007|FG000|Second Treatment Period|Lost to Follow-up|0|||
145727377|NCT00394953|525519008|FG001|Second Treatment Period|Lost to Follow-up|1|||
145727378|NCT00394953|525519007|FG000|Second Treatment Period|Renal transplant|4|||
145727379|NCT00394953|525519008|FG001|Second Treatment Period|Renal transplant|6|||
145727380|NCT00394953|525519007|FG000|Second Treatment Period|Not defined|3|||
145727381|NCT00394953|525519008|FG001|Second Treatment Period|Not defined|8|||
145727382|NCT00928447|525519015|FG000|Overall Study|Withdrawal by Subject|1|||
145727383|NCT00928447|525519015|FG000|Overall Study|Investigator's decision|1|||
145727384|NCT01259284|525519018|FG000|Overall Study|Study Termination|2|||
145727385|NCT01259284|525519019|FG001|Overall Study|Study Termination|0|||
145727386|NCT01259284|525519020|FG002|Overall Study|Study Termination|0|||
145727387|NCT02196714|525519028|FG000|Overall Study|Protocol Violation|0|||
145727388|NCT02196714|525519029|FG001|Overall Study|Protocol Violation|0|||
145727389|NCT02196714|525519030|FG002|Overall Study|Protocol Violation|1|||
145727390|NCT02196714|525519031|FG003|Overall Study|Protocol Violation|0|||
145727391|NCT01592864|525519033|FG000|Overall Study|Withdrawal by Subject|0|||
145727392|NCT01592864|525519034|FG001|Overall Study|Withdrawal by Subject|1|||
145727393|NCT01326533|525519038|FG000|Overall Study|Lost to Follow-up|2|||
145727394|NCT01326533|525519039|FG001|Overall Study|Lost to Follow-up|0|||
145727395|NCT01326533|525519038|FG000|Overall Study|Withdrawal by Subject|1|||
145727396|NCT01326533|525519039|FG001|Overall Study|Withdrawal by Subject|0|||
145727397|NCT01326533|525519038|FG000|Overall Study|Adverse Event|1|||
145727398|NCT01326533|525519039|FG001|Overall Study|Adverse Event|0|||
145727399|NCT03353350|525519040|FG000|30-week Core Treatment Period|Protocol Violation|1|||
145727400|NCT03353350|525519041|FG001|30-week Core Treatment Period|Protocol Violation|1|||
145727401|NCT03353350|525519042|FG002|30-week Core Treatment Period|Protocol Violation|1|||
145727402|NCT03353350|525519043|FG003|30-week Core Treatment Period|Protocol Violation|0|||
145727403|NCT03353350|525519040|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
145727404|NCT03353350|525519041|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
145727405|NCT03353350|525519042|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
145727406|NCT03353350|525519043|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
145727407|NCT03353350|525519040|FG000|30-week Core Treatment Period|Adverse Event|0|||
145727408|NCT03353350|525519041|FG001|30-week Core Treatment Period|Adverse Event|4|||
145727409|NCT03353350|525519042|FG002|30-week Core Treatment Period|Adverse Event|2|||
145727410|NCT03353350|525519043|FG003|30-week Core Treatment Period|Adverse Event|3|||
145727411|NCT03353350|525519040|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
145727412|NCT03353350|525519041|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
145727413|NCT03353350|525519042|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
145727414|NCT03353350|525519043|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
145727415|NCT03353350|525519040|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
145727416|NCT03353350|525519041|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
145727417|NCT03353350|525519042|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
145727418|NCT03353350|525519043|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
145727419|NCT03353350|525519040|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
145384260|NCT02757352|524261688|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145727420|NCT03353350|525519041|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
145727421|NCT03353350|525519042|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
145727422|NCT03353350|525519043|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
145727423|NCT03353350|525519040|FG000|26-week Treatment Extension Period|Adverse Event|1|||
145727424|NCT03353350|525519041|FG001|26-week Treatment Extension Period|Adverse Event|0|||
145727425|NCT03353350|525519042|FG002|26-week Treatment Extension Period|Adverse Event|0|||
145727426|NCT03353350|525519043|FG003|26-week Treatment Extension Period|Adverse Event|1|||
145727427|NCT03353350|525519040|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
145727428|NCT03353350|525519041|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
145727429|NCT03353350|525519042|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
145727430|NCT03353350|525519043|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
145727431|NCT03037619|525519044|FG000|Overall Study|Lost to Follow-up|0|||
145727432|NCT03037619|525519045|FG001|Overall Study|Lost to Follow-up|1|||
145727433|NCT01794923|525519048|FG000|Overall Study|Adverse Event|0|||
145727434|NCT01794923|525519049|FG001|Overall Study|Adverse Event|0|||
145727435|NCT01794923|525519050|FG002|Overall Study|Adverse Event|1|||
145727436|NCT01881750|525519055|FG000|Overall Study|Changes in concomitant therapies|2|||
145727437|NCT01881750|525519056|FG001|Overall Study|Changes in concomitant therapies|3|||
145727438|NCT01881750|525519055|FG000|Overall Study|Lost to Follow-up|0|||
145727439|NCT01881750|525519056|FG001|Overall Study|Lost to Follow-up|1|||
145727440|NCT00307125|525519059|FG000|Screening Phase|Adverse Event|1|||
145727441|NCT00307125|525519060|FG001|Screening Phase|Adverse Event|0|||
145727442|NCT00307125|525519061|FG002|Screening Phase|Adverse Event|0|||
145727443|NCT00307125|525519059|FG000|Screening Phase|Protocol Violation|27|||
145727444|NCT00307125|525519060|FG001|Screening Phase|Protocol Violation|0|||
145727445|NCT00307125|525519061|FG002|Screening Phase|Protocol Violation|0|||
145727446|NCT00307125|525519059|FG000|Screening Phase|Lost to Follow-up|87|||
145727447|NCT00307125|525519060|FG001|Screening Phase|Lost to Follow-up|0|||
145727448|NCT00307125|525519061|FG002|Screening Phase|Lost to Follow-up|0|||
145727449|NCT00307125|525519059|FG000|Screening Phase|Death|10|||
145727450|NCT00307125|525519060|FG001|Screening Phase|Death|0|||
145727451|NCT00307125|525519061|FG002|Screening Phase|Death|0|||
145727452|NCT00307125|525519059|FG000|Screening Phase|Withdrawal by Subject|77|||
145727453|NCT00307125|525519060|FG001|Screening Phase|Withdrawal by Subject|0|||
145727454|NCT00307125|525519061|FG002|Screening Phase|Withdrawal by Subject|0|||
145727455|NCT00307125|525519059|FG000|Screening Phase|Physician Decision|26|||
145727456|NCT00307125|525519060|FG001|Screening Phase|Physician Decision|0|||
145727457|NCT00307125|525519061|FG002|Screening Phase|Physician Decision|0|||
145727458|NCT00307125|525519059|FG000|Screening Phase|Sponsor Decision|4|||
145727459|NCT00307125|525519060|FG001|Screening Phase|Sponsor Decision|0|||
145727460|NCT00307125|525519061|FG002|Screening Phase|Sponsor Decision|0|||
145727461|NCT00307125|525519059|FG000|Screening Phase|Study Terminated|17|||
145727462|NCT00307125|525519060|FG001|Screening Phase|Study Terminated|0|||
145727463|NCT00307125|525519061|FG002|Screening Phase|Study Terminated|0|||
145727464|NCT00307125|525519059|FG000|Screening Phase|Graft Loss|3|||
145727465|NCT00307125|525519060|FG001|Screening Phase|Graft Loss|0|||
145727466|NCT00307125|525519061|FG002|Screening Phase|Graft Loss|0|||
145727467|NCT00307125|525519059|FG000|Screening Phase|Graft Failure|8|||
145727468|NCT00307125|525519060|FG001|Screening Phase|Graft Failure|0|||
145727469|NCT00307125|525519061|FG002|Screening Phase|Graft Failure|0|||
145727470|NCT00307125|525519059|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
145727471|NCT00307125|525519060|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
145727472|NCT00307125|525519061|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
145727473|NCT00307125|525519059|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
145727474|NCT00307125|525519060|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
145727475|NCT00307125|525519061|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
145727476|NCT00307125|525519059|FG000|Screening Phase|Moved or transferred facilities|34|||
145727477|NCT00307125|525519060|FG001|Screening Phase|Moved or transferred facilities|0|||
145727478|NCT00307125|525519061|FG002|Screening Phase|Moved or transferred facilities|0|||
145727479|NCT00307125|525519059|FG000|Screening Phase|Received Pancreas Transplant|8|||
145727480|NCT00307125|525519060|FG001|Screening Phase|Received Pancreas Transplant|0|||
145727481|NCT00307125|525519061|FG002|Screening Phase|Received Pancreas Transplant|0|||
145727482|NCT00307125|525519059|FG000|Screening Phase|Ineligible for pilot|4|||
145727483|NCT00307125|525519060|FG001|Screening Phase|Ineligible for pilot|0|||
145727484|NCT00307125|525519061|FG002|Screening Phase|Ineligible for pilot|0|||
145727485|NCT00307125|525519059|FG000|Screening Phase|Try to get pregnant|1|||
145727486|NCT00307125|525519060|FG001|Screening Phase|Try to get pregnant|0|||
145727487|NCT00307125|525519061|FG002|Screening Phase|Try to get pregnant|0|||
145727488|NCT00307125|525519059|FG000|Screening Phase|Developed acute leukemia|1|||
145727489|NCT00307125|525519060|FG001|Screening Phase|Developed acute leukemia|0|||
145727490|NCT00307125|525519061|FG002|Screening Phase|Developed acute leukemia|0|||
145727491|NCT00307125|525519059|FG000|Screening Phase|Metastatic colon cancer|1|||
145727492|NCT00307125|525519060|FG001|Screening Phase|Metastatic colon cancer|0|||
145727493|NCT00307125|525519061|FG002|Screening Phase|Metastatic colon cancer|0|||
145727494|NCT00307125|525519059|FG000|Screening Phase|Malignancy|1|||
145727495|NCT00307125|525519060|FG001|Screening Phase|Malignancy|0|||
145727496|NCT00307125|525519061|FG002|Screening Phase|Malignancy|0|||
145727497|NCT00307125|525519059|FG000|Screening Phase|PAK|1|||
145727498|NCT00307125|525519060|FG001|Screening Phase|PAK|0|||
145494983|NCT02234843|524670271|FG004|Overall Study|Death|0|||
145727499|NCT00307125|525519061|FG002|Screening Phase|PAK|0|||
145727500|NCT00307125|525519059|FG000|Screening Phase|Ineligible|1|||
145727501|NCT00307125|525519060|FG001|Screening Phase|Ineligible|0|||
145727502|NCT00307125|525519061|FG002|Screening Phase|Ineligible|0|||
145727503|NCT00307125|525519059|FG000|Screening Phase|Screen Error|1|||
145727504|NCT00307125|525519060|FG001|Screening Phase|Screen Error|0|||
145727505|NCT00307125|525519061|FG002|Screening Phase|Screen Error|0|||
145727506|NCT00307125|525519059|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
145727507|NCT00307125|525519060|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
145727508|NCT00307125|525519061|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
145727509|NCT00307125|525519059|FG000|Screening Phase|AMR and treated with rituximab|1|||
145727510|NCT00307125|525519060|FG001|Screening Phase|AMR and treated with rituximab|0|||
145727511|NCT00307125|525519061|FG002|Screening Phase|AMR and treated with rituximab|0|||
145727512|NCT00307125|525519059|FG000|Screening Phase|Coronary artery bypass|1|||
145727513|NCT00307125|525519060|FG001|Screening Phase|Coronary artery bypass|0|||
145727514|NCT00307125|525519061|FG002|Screening Phase|Coronary artery bypass|0|||
145727515|NCT00307125|525519059|FG000|Pilot Phase|Lost to Follow-up|0|||
145727516|NCT00307125|525519060|FG001|Pilot Phase|Lost to Follow-up|1|||
145727517|NCT00307125|525519061|FG002|Pilot Phase|Lost to Follow-up|0|||
145727518|NCT00307125|525519059|FG000|Pilot Phase|Withdrawal by Subject|0|||
145727519|NCT00307125|525519060|FG001|Pilot Phase|Withdrawal by Subject|1|||
145727520|NCT00307125|525519061|FG002|Pilot Phase|Withdrawal by Subject|1|||
145727521|NCT00807235|525519064|FG000|Overall Study|Adverse Event|1|||
145727522|NCT00807235|525519065|FG001|Overall Study|Adverse Event|0|||
145727523|NCT00926211|525519066|FG000|Overall Study|Lost to Follow-up|1|||
145727524|NCT02571049|525519067|FG000|Screening|Did not meet entry criteria|2|||
145727525|NCT02571049|525519068|FG001|Screening|Did not meet entry criteria|2|||
145727526|NCT02571049|525519067|FG000|Randomization|No migraine attack|0|||
145727527|NCT02571049|525519068|FG001|Randomization|No migraine attack|1|||
145727528|NCT02571049|525519067|FG000|Randomization|Adverse Event|0|||
145727529|NCT02571049|525519068|FG001|Randomization|Adverse Event|1|||
145727530|NCT00985153|525519069|FG000|Overall Study|Lost to Follow-up|16|||
145727531|NCT00985153|525519070|FG001|Overall Study|Lost to Follow-up|19|||
145727532|NCT00985153|525519071|FG002|Overall Study|Lost to Follow-up|17|||
145727533|NCT00985153|525519072|FG003|Overall Study|Lost to Follow-up|20|||
145727534|NCT00985153|525519069|FG000|Overall Study|Protocol Violation|3|||
145727535|NCT00985153|525519070|FG001|Overall Study|Protocol Violation|2|||
145727536|NCT00985153|525519071|FG002|Overall Study|Protocol Violation|4|||
145727537|NCT00985153|525519072|FG003|Overall Study|Protocol Violation|3|||
145727538|NCT00985153|525519069|FG000|Overall Study|Withdrawal by Subject|6|||
145727539|NCT00985153|525519070|FG001|Overall Study|Withdrawal by Subject|11|||
145727540|NCT00985153|525519071|FG002|Overall Study|Withdrawal by Subject|11|||
145727541|NCT00985153|525519072|FG003|Overall Study|Withdrawal by Subject|10|||
145727542|NCT00985153|525519069|FG000|Overall Study|Missed One or More Bleeds|7|||
145727543|NCT00985153|525519070|FG001|Overall Study|Missed One or More Bleeds|7|||
145727544|NCT00985153|525519071|FG002|Overall Study|Missed One or More Bleeds|8|||
145727545|NCT00985153|525519072|FG003|Overall Study|Missed One or More Bleeds|10|||
145727546|NCT00985153|525519069|FG000|Overall Study|Incomplete Safety Follow-up|3|||
145727547|NCT00985153|525519070|FG001|Overall Study|Incomplete Safety Follow-up|5|||
145727548|NCT00985153|525519071|FG002|Overall Study|Incomplete Safety Follow-up|4|||
145727549|NCT00985153|525519072|FG003|Overall Study|Incomplete Safety Follow-up|4|||
145727550|NCT01055262|525519075|FG000|Overall Study|Adverse Event|5|||
145727551|NCT01055262|525519075|FG000|Overall Study|Protocol Violation|3|||
145727552|NCT01055262|525519075|FG000|Overall Study|Uncooperativeness|1|||
145727553|NCT03370471|525519076|FG000|Overall Study|Withdrawal by Subject|6|||
145727554|NCT03370471|525519077|FG001|Overall Study|Withdrawal by Subject|1|||
145727555|NCT03370471|525519076|FG000|Overall Study|Unable to access veins for blood draw|0|||
145727556|NCT03370471|525519077|FG001|Overall Study|Unable to access veins for blood draw|1|||
145727557|NCT03370471|525519076|FG000|Overall Study|Screen fail|1|||
145727558|NCT03370471|525519077|FG001|Overall Study|Screen fail|0|||
145727559|NCT00561951|525519079|FG000|Overall Study|Adverse Event|11|||
145727560|NCT00561951|525519080|FG001|Overall Study|Adverse Event|14|||
145727561|NCT00561951|525519081|FG002|Overall Study|Adverse Event|14|||
145727562|NCT00561951|525519079|FG000|Overall Study|Lack of Efficacy|5|||
145727563|NCT00561951|525519080|FG001|Overall Study|Lack of Efficacy|3|||
145727564|NCT00561951|525519081|FG002|Overall Study|Lack of Efficacy|2|||
145494984|NCT02234843|524670272|FG005|Overall Study|Death|0|||
145494985|NCT02234843|524670273|FG006|Overall Study|Death|0|||
145727565|NCT00561951|525519079|FG000|Overall Study|Lost to Follow-up|1|||
145727566|NCT00561951|525519080|FG001|Overall Study|Lost to Follow-up|1|||
145727567|NCT00561951|525519081|FG002|Overall Study|Lost to Follow-up|0|||
145727568|NCT00561951|525519079|FG000|Overall Study|Withdrawal by Subject|10|||
145727569|NCT00561951|525519080|FG001|Overall Study|Withdrawal by Subject|9|||
145727570|NCT00561951|525519081|FG002|Overall Study|Withdrawal by Subject|10|||
145727571|NCT00561951|525519079|FG000|Overall Study|Protocol Violation|4|||
145727572|NCT00561951|525519080|FG001|Overall Study|Protocol Violation|3|||
145727573|NCT00561951|525519081|FG002|Overall Study|Protocol Violation|4|||
145727574|NCT00561951|525519079|FG000|Overall Study|Physician Decision|1|||
145727575|NCT00561951|525519080|FG001|Overall Study|Physician Decision|0|||
145727576|NCT00561951|525519081|FG002|Overall Study|Physician Decision|0|||
145494986|NCT02234843|524670274|FG007|Overall Study|Death|0|||
145727577|NCT00561951|525519079|FG000|Overall Study|Pregnancy|0|||
145727578|NCT00561951|525519080|FG001|Overall Study|Pregnancy|1|||
145727579|NCT00561951|525519081|FG002|Overall Study|Pregnancy|0|||
145727580|NCT00561951|525519079|FG000|Overall Study|Meet Withdrawal Criterion|0|||
145727581|NCT00561951|525519080|FG001|Overall Study|Meet Withdrawal Criterion|1|||
145727582|NCT00561951|525519081|FG002|Overall Study|Meet Withdrawal Criterion|1|||
145727583|NCT00561951|525519079|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
145727584|NCT00561951|525519080|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
145727585|NCT00561951|525519081|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
145727586|NCT01765179|525519082|FG000|Overall Study|Adverse Event|3|||
145727587|NCT01765179|525519082|FG000|Overall Study|Lost to Follow-up|5|||
145727588|NCT01765179|525519082|FG000|Overall Study|Non-compliance with study drug|2|||
145727589|NCT01765179|525519082|FG000|Overall Study|Protocol Violation|1|||
145727590|NCT01765179|525519082|FG000|Overall Study|Withdrawal by Subject|8|||
145727591|NCT01765179|525519082|FG000|Overall Study|Hematocrit >54%|3|||
145727592|NCT01765179|525519082|FG000|Overall Study|prohibited med|1|||
145727593|NCT01765179|525519082|FG000|Overall Study|Out of country unable to finish study|1|||
145727594|NCT01765179|525519082|FG000|Overall Study|lack of venous access|1|||
145727595|NCT01765179|525519082|FG000|Overall Study|work conflict|1|||
145727596|NCT01765179|525519082|FG000|Overall Study|Ca elevated 10.6|1|||
145727597|NCT00392327|525519096|FG000|Overall Study|Death|1|||
145727598|NCT00392327|525519097|FG001|Overall Study|Death|0|||
145727599|NCT00392327|525519098|FG002|Overall Study|Death|1|||
145727600|NCT00392327|525519099|FG003|Overall Study|Death|0|||
145727601|NCT00392327|525519100|FG004|Overall Study|Death|0|||
145727602|NCT00392327|525519101|FG005|Overall Study|Death|0|||
145727603|NCT00392327|525519102|FG006|Overall Study|Death|0|||
145384261|NCT02757352|524261689|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145384262|NCT02757352|524261690|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
145384263|NCT02757352|524261681|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384264|NCT02757352|524261682|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
145384265|NCT02757352|524261683|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384266|NCT02757352|524261684|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384267|NCT02757352|524261685|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384268|NCT02757352|524261686|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384269|NCT02757352|524261687|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384270|NCT02757352|524261688|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384271|NCT02757352|524261689|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145384272|NCT02757352|524261690|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
145494987|NCT02234843|524670275|FG008|Overall Study|Death|0|||
145494988|NCT02234843|524670276|FG009|Overall Study|Death|0|||
145494989|NCT02234843|524670267|FG000|Overall Study|Protocol Violation|1|||
145494990|NCT02234843|524670268|FG001|Overall Study|Protocol Violation|0|||
145494991|NCT02234843|524670269|FG002|Overall Study|Protocol Violation|1|||
145494992|NCT02234843|524670270|FG003|Overall Study|Protocol Violation|0|||
145494993|NCT02234843|524670271|FG004|Overall Study|Protocol Violation|0|||
145494994|NCT02234843|524670272|FG005|Overall Study|Protocol Violation|0|||
145494995|NCT02234843|524670273|FG006|Overall Study|Protocol Violation|0|||
145494996|NCT02234843|524670274|FG007|Overall Study|Protocol Violation|0|||
145494997|NCT02234843|524670275|FG008|Overall Study|Protocol Violation|0|||
145494998|NCT02234843|524670276|FG009|Overall Study|Protocol Violation|0|||
145494999|NCT02234843|524670267|FG000|Overall Study|Efficacy outcome reached|2|||
145495000|NCT02234843|524670268|FG001|Overall Study|Efficacy outcome reached|0|||
145495001|NCT02234843|524670269|FG002|Overall Study|Efficacy outcome reached|0|||
145495002|NCT02234843|524670270|FG003|Overall Study|Efficacy outcome reached|0|||
145495003|NCT02234843|524670271|FG004|Overall Study|Efficacy outcome reached|0|||
145495004|NCT02234843|524670272|FG005|Overall Study|Efficacy outcome reached|2|||
145495005|NCT02234843|524670273|FG006|Overall Study|Efficacy outcome reached|0|||
145495006|NCT02234843|524670274|FG007|Overall Study|Efficacy outcome reached|0|||
145495007|NCT02234843|524670275|FG008|Overall Study|Efficacy outcome reached|0|||
145495008|NCT02234843|524670276|FG009|Overall Study|Efficacy outcome reached|0|||
145495009|NCT02234843|524670267|FG000|Overall Study|Patient convenience|2|||
145495010|NCT02234843|524670268|FG001|Overall Study|Patient convenience|0|||
145727604|NCT00392327|525519103|FG007|Overall Study|Death|0|||
145384273|NCT02757352|524261681|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145495011|NCT02234843|524670269|FG002|Overall Study|Patient convenience|0|||
145727605|NCT00392327|525519096|FG000|Overall Study|Lack of Efficacy|8|||
145727606|NCT00392327|525519097|FG001|Overall Study|Lack of Efficacy|8|||
145727607|NCT00392327|525519098|FG002|Overall Study|Lack of Efficacy|9|||
145727608|NCT00392327|525519099|FG003|Overall Study|Lack of Efficacy|6|||
145727609|NCT00392327|525519100|FG004|Overall Study|Lack of Efficacy|3|||
145495012|NCT02234843|524670270|FG003|Overall Study|Patient convenience|0|||
145495013|NCT02234843|524670271|FG004|Overall Study|Patient convenience|0|||
145495014|NCT02234843|524670272|FG005|Overall Study|Patient convenience|1|||
145495015|NCT02234843|524670273|FG006|Overall Study|Patient convenience|0|||
145495016|NCT02234843|524670274|FG007|Overall Study|Patient convenience|0|||
145727610|NCT00392327|525519101|FG005|Overall Study|Lack of Efficacy|3|||
145727611|NCT00392327|525519102|FG006|Overall Study|Lack of Efficacy|3|||
145727612|NCT00392327|525519103|FG007|Overall Study|Lack of Efficacy|3|||
145727613|NCT00392327|525519096|FG000|Overall Study|Physician Decision|3|||
145727614|NCT00392327|525519097|FG001|Overall Study|Physician Decision|5|||
145727615|NCT00392327|525519098|FG002|Overall Study|Physician Decision|2|||
145727616|NCT00392327|525519099|FG003|Overall Study|Physician Decision|2|||
145727617|NCT00392327|525519100|FG004|Overall Study|Physician Decision|0|||
145727618|NCT00392327|525519101|FG005|Overall Study|Physician Decision|1|||
145727619|NCT00392327|525519102|FG006|Overall Study|Physician Decision|5|||
145727620|NCT00392327|525519103|FG007|Overall Study|Physician Decision|3|||
145727621|NCT00392327|525519096|FG000|Overall Study|Protocol Violation|0|||
145727622|NCT00392327|525519097|FG001|Overall Study|Protocol Violation|0|||
145727623|NCT00392327|525519098|FG002|Overall Study|Protocol Violation|1|||
145727624|NCT00392327|525519099|FG003|Overall Study|Protocol Violation|0|||
145727625|NCT00392327|525519100|FG004|Overall Study|Protocol Violation|0|||
145727626|NCT00392327|525519101|FG005|Overall Study|Protocol Violation|0|||
145727627|NCT00392327|525519102|FG006|Overall Study|Protocol Violation|0|||
145727628|NCT00392327|525519103|FG007|Overall Study|Protocol Violation|0|||
145727629|NCT00392327|525519096|FG000|Overall Study|Withdrawal by Subject|3|||
145727630|NCT00392327|525519097|FG001|Overall Study|Withdrawal by Subject|2|||
145727631|NCT00392327|525519098|FG002|Overall Study|Withdrawal by Subject|4|||
145727632|NCT00392327|525519099|FG003|Overall Study|Withdrawal by Subject|6|||
145727633|NCT00392327|525519100|FG004|Overall Study|Withdrawal by Subject|0|||
145727634|NCT00392327|525519101|FG005|Overall Study|Withdrawal by Subject|1|||
145727635|NCT00392327|525519102|FG006|Overall Study|Withdrawal by Subject|1|||
145727636|NCT00392327|525519103|FG007|Overall Study|Withdrawal by Subject|5|||
145727637|NCT00392327|525519096|FG000|Overall Study|Ineligible|0|||
145727638|NCT00392327|525519097|FG001|Overall Study|Ineligible|4|||
145727639|NCT00392327|525519098|FG002|Overall Study|Ineligible|3|||
145727640|NCT00392327|525519099|FG003|Overall Study|Ineligible|2|||
145727641|NCT00392327|525519100|FG004|Overall Study|Ineligible|0|||
145727642|NCT00392327|525519101|FG005|Overall Study|Ineligible|0|||
145727643|NCT00392327|525519102|FG006|Overall Study|Ineligible|0|||
145727644|NCT00392327|525519103|FG007|Overall Study|Ineligible|0|||
145727645|NCT01281969|525519106|FG000|Overall Study|not randomized didn't meet criteria|0|||
145727646|NCT01281969|525519107|FG001|Overall Study|not randomized didn't meet criteria|0|||
145727647|NCT01281969|525519108|FG002|Overall Study|not randomized didn't meet criteria|7|||
145727648|NCT01281969|525519106|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
145727649|NCT01281969|525519107|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
145727650|NCT01281969|525519108|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
145727651|NCT01281969|525519106|FG000|Overall Study|not randomized, child consent not given|0|||
145727652|NCT01281969|525519107|FG001|Overall Study|not randomized, child consent not given|0|||
145727653|NCT01281969|525519108|FG002|Overall Study|not randomized, child consent not given|2|||
145727654|NCT01323634|525519109|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
145727655|NCT01323634|525519110|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
145727656|NCT01323634|525519111|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
145727657|NCT01323634|525519109|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
145727658|NCT01323634|525519110|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
145727659|NCT01323634|525519111|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
145727660|NCT01323634|525519109|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
145727661|NCT01323634|525519110|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145727662|NCT01323634|525519111|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145727663|NCT01323634|525519109|FG000|2-week Run-in Period|Physician Decision|5|||
145727664|NCT01323634|525519110|FG001|2-week Run-in Period|Physician Decision|0|||
145727665|NCT01323634|525519111|FG002|2-week Run-in Period|Physician Decision|0|||
145727666|NCT01323634|525519109|FG000|2-week Run-in Period|Protocol Violation|1|||
145727667|NCT01323634|525519110|FG001|2-week Run-in Period|Protocol Violation|0|||
145727668|NCT01323634|525519111|FG002|2-week Run-in Period|Protocol Violation|0|||
145727669|NCT01323634|525519109|FG000|2-week Run-in Period|Adverse Event|1|||
145384274|NCT02757352|524261682|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145384275|NCT02757352|524261683|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384276|NCT02757352|524261684|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384277|NCT02757352|524261685|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384278|NCT02757352|524261686|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384279|NCT02757352|524261687|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145495017|NCT02234843|524670275|FG008|Overall Study|Patient convenience|0|||
145727670|NCT01323634|525519110|FG001|2-week Run-in Period|Adverse Event|0|||
145727671|NCT01323634|525519111|FG002|2-week Run-in Period|Adverse Event|0|||
145727672|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145727673|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
145727674|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
145727675|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145727676|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145727677|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
145727678|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145727679|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
145727680|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
145727681|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145727682|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
145727683|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
145727684|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
145727685|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
145727686|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
145727687|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145727688|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
145727689|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
145727690|NCT01323634|525519109|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
145727691|NCT01323634|525519110|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
145727692|NCT01323634|525519111|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
145727693|NCT01575028|525519112|FG000|Overall Study|Physician Decision|0|||
145727694|NCT01575028|525519113|FG001|Overall Study|Physician Decision|1|||
145727695|NCT01182194|525519114|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
145727696|NCT01182194|525519115|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
145727697|NCT00147823|525519116|FG000|Overall Study|Lost to Follow-up|6|||
145727698|NCT00147823|525519117|FG001|Overall Study|Lost to Follow-up|12|||
145727699|NCT00147823|525519116|FG000|Overall Study|Physician Decision|1|||
145727700|NCT00147823|525519117|FG001|Overall Study|Physician Decision|0|||
145727701|NCT00147823|525519116|FG000|Overall Study|Withdrawal by Subject|0|||
145727702|NCT00147823|525519117|FG001|Overall Study|Withdrawal by Subject|1|||
145727703|NCT00147823|525519116|FG000|Overall Study|Did not receive vitoss due to infection|6|||
145727704|NCT00147823|525519117|FG001|Overall Study|Did not receive vitoss due to infection|2|||
145727705|NCT01717989|525520404|FG000|Overall Study|Ineligibility determined|6|||
145727706|NCT01717989|525520404|FG000|Overall Study|Protocol deviation|6|||
145727707|NCT01717989|525520404|FG000|Overall Study|Withdrawal by Subject|11|||
145727708|NCT01717989|525520404|FG000|Overall Study|Physician Decision|2|||
145727709|NCT01717989|525520404|FG000|Overall Study|Lost to Follow-up|11|||
145727710|NCT01717989|525520404|FG000|Overall Study|Death|439|||
145727711|NCT01717989|525520404|FG000|Overall Study|Protocol-specified criteria|551|||
145727712|NCT01717989|525520404|FG000|Overall Study|Other|40|||
145727713|NCT03224325|525520405|FG000|Overall Study|Adverse Event|1|||
145727714|NCT03224325|525520406|FG001|Overall Study|Adverse Event|0|||
145727715|NCT03224325|525520407|FG002|Overall Study|Adverse Event|0|||
145727716|NCT03224325|525520408|FG003|Overall Study|Adverse Event|0|||
145727717|NCT03224325|525520409|FG004|Overall Study|Adverse Event|0|||
145727718|NCT03224325|525520410|FG005|Overall Study|Adverse Event|0|||
145727719|NCT03224325|525520411|FG006|Overall Study|Adverse Event|1|||
145727720|NCT03224325|525520405|FG000|Overall Study|Withdrawal by Subject|0|||
145727721|NCT03224325|525520406|FG001|Overall Study|Withdrawal by Subject|0|||
145727722|NCT03224325|525520407|FG002|Overall Study|Withdrawal by Subject|0|||
145727723|NCT03224325|525520408|FG003|Overall Study|Withdrawal by Subject|1|||
145727724|NCT03224325|525520409|FG004|Overall Study|Withdrawal by Subject|0|||
145727725|NCT03224325|525520410|FG005|Overall Study|Withdrawal by Subject|0|||
145727726|NCT03224325|525520411|FG006|Overall Study|Withdrawal by Subject|0|||
145727727|NCT02864381|525520412|FG000|Overall Study|Death|58|||
145727728|NCT02864381|525520413|FG001|Overall Study|Death|61|||
145727729|NCT02864381|525520412|FG000|Overall Study|Withdrew Consent|5|||
145727730|NCT02864381|525520413|FG001|Overall Study|Withdrew Consent|6|||
145727731|NCT02864381|525520412|FG000|Overall Study|Reason Unknown|7|||
145727732|NCT02864381|525520413|FG001|Overall Study|Reason Unknown|3|||
145727733|NCT02864381|525520412|FG000|Overall Study|Lost to Follow-up|1|||
145727734|NCT02864381|525520413|FG001|Overall Study|Lost to Follow-up|1|||
145727735|NCT02864381|525520412|FG000|Overall Study|Investigator's Discretion|1|||
145727736|NCT02864381|525520413|FG001|Overall Study|Investigator's Discretion|0|||
145727737|NCT02864381|525520412|FG000|Overall Study|Protocol Violation|0|||
145727738|NCT02864381|525520413|FG001|Overall Study|Protocol Violation|1|||
145727739|NCT02120625|525520415|FG000|Overall Study|Physician Decision|2|||
145727740|NCT02525861|525520416|FG000|Overall Study|Adverse Event|1|||
145727741|NCT02525861|525520417|FG001|Overall Study|Adverse Event|0|||
145727742|NCT02525861|525520416|FG000|Overall Study|Withdrawal by Subject|0|||
145727743|NCT02525861|525520417|FG001|Overall Study|Withdrawal by Subject|1|||
145727744|NCT02525861|525520416|FG000|Overall Study|Physician Decision|0|||
145727745|NCT02525861|525520417|FG001|Overall Study|Physician Decision|1|||
145727746|NCT03278106|525520421|FG000|Overall Study|No protocol treatment|1|||
145727747|NCT01607554|525520423|FG000|Overall Study|Disease progression|2|||
145727748|NCT03952806|525520424|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
145727749|NCT03952806|525520425|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
145727750|NCT03952806|525520424|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
145727751|NCT03952806|525520425|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
145727752|NCT03952806|525520424|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
145727753|NCT03952806|525520425|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
145384280|NCT02757352|524261688|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384281|NCT02757352|524261689|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384282|NCT02757352|524261690|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384283|NCT02757352|524261681|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145384284|NCT02757352|524261682|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145384285|NCT02757352|524261683|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
145384286|NCT02757352|524261684|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384287|NCT02757352|524261685|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384288|NCT02757352|524261686|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384289|NCT02757352|524261687|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384290|NCT02757352|524261688|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384291|NCT02757352|524261689|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384292|NCT02757352|524261690|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384293|NCT02757352|524261681|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
145384294|NCT02757352|524261682|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
145384295|NCT02757352|524261683|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
145384296|NCT02757352|524261684|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384297|NCT02757352|524261685|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384298|NCT02757352|524261686|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384299|NCT02757352|524261687|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384300|NCT02757352|524261688|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384301|NCT02757352|524261689|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384302|NCT02757352|524261690|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
145384303|NCT02757352|524261681|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384304|NCT02757352|524261682|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384305|NCT02757352|524261683|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384306|NCT02757352|524261684|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
145384307|NCT02757352|524261685|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145727754|NCT03952806|525520424|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
145727755|NCT03952806|525520425|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
145727756|NCT03952806|525520424|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
145727757|NCT03952806|525520425|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
145727758|NCT03952806|525520424|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
145727759|NCT03952806|525520425|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
145727760|NCT03952806|525520424|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
145727761|NCT03952806|525520425|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
145727762|NCT03952806|525520424|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
145727763|NCT03952806|525520425|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
145727764|NCT03952806|525520424|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
145727765|NCT03952806|525520425|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
145727766|NCT03952806|525520424|FG000|OLE Phase (48 Weeks)|Other|16|||
145384308|NCT02757352|524261686|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
145384309|NCT02757352|524261687|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384310|NCT02757352|524261688|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384311|NCT02757352|524261689|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384312|NCT02757352|524261690|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
145384313|NCT02757352|524261681|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145727767|NCT03952806|525520425|FG001|OLE Phase (48 Weeks)|Other|13|||
145727768|NCT01137955|525520426|FG000|Overall Study|Withdrawal by Subject|5|||
145727769|NCT01137955|525520427|FG001|Overall Study|Withdrawal by Subject|4|||
145727770|NCT01211197|525520430|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145727771|NCT01211197|525520431|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145727772|NCT01211197|525520432|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145727773|NCT01211197|525520433|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145727774|NCT01211197|525520434|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145727775|NCT01211197|525520435|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145727776|NCT01211197|525520430|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
145727777|NCT01211197|525520431|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
145727778|NCT01211197|525520432|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
145727779|NCT01211197|525520433|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
145727780|NCT01211197|525520434|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
145727781|NCT01211197|525520435|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
145727782|NCT05116046|525520438|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145727783|NCT05116046|525520439|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145727784|NCT05116046|525520440|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145727785|NCT05116046|525520438|FG000|Overall Study|Study terminated by sponsor|14|||
145727786|NCT05116046|525520439|FG001|Overall Study|Study terminated by sponsor|16|||
145727787|NCT05116046|525520440|FG002|Overall Study|Study terminated by sponsor|1|||
145727788|NCT02168842|525520441|FG000|Overall Study|Withdrawal by Subject|5|||
145727789|NCT02168842|525520442|FG001|Overall Study|Withdrawal by Subject|3|||
145727790|NCT02168842|525520441|FG000|Overall Study|Lost to Follow-up|0|||
145727791|NCT02168842|525520442|FG001|Overall Study|Lost to Follow-up|2|||
145727792|NCT02168842|525520441|FG000|Overall Study|Death|2|||
145727793|NCT02168842|525520442|FG001|Overall Study|Death|1|||
145727794|NCT02168842|525520441|FG000|Overall Study|Physician Decision|1|||
145727795|NCT02168842|525520442|FG001|Overall Study|Physician Decision|2|||
145727796|NCT02147353|525520443|FG000|Overall Study|Lost to Follow-up|2|||
145727797|NCT02147353|525520444|FG001|Overall Study|Lost to Follow-up|0|||
145727798|NCT02147353|525520443|FG000|Overall Study|unable to make visits|4|||
145727799|NCT02147353|525520444|FG001|Overall Study|unable to make visits|0|||
145727800|NCT02147353|525520443|FG000|Overall Study|medication noncompliance|3|||
145727801|NCT02147353|525520444|FG001|Overall Study|medication noncompliance|0|||
145727802|NCT02974088|525520448|FG000|Overall Study|Lost to Follow-up|0|||
145727803|NCT02974088|525520449|FG001|Overall Study|Lost to Follow-up|2|||
145727804|NCT02974088|525520448|FG000|Overall Study|Adverse Event|0|||
145727805|NCT02974088|525520449|FG001|Overall Study|Adverse Event|1|||
145727806|NCT00892723|525520450|FG000|Overall Study|Lost to Follow-up|1|||
145727807|NCT00892723|525520451|FG001|Overall Study|Lost to Follow-up|3|||
145727808|NCT00892723|525520452|FG002|Overall Study|Lost to Follow-up|1|||
145727809|NCT00892723|525520450|FG000|Overall Study|Withdrawal by Subject|1|||
145727810|NCT00892723|525520451|FG001|Overall Study|Withdrawal by Subject|1|||
145727811|NCT00892723|525520452|FG002|Overall Study|Withdrawal by Subject|1|||
145727812|NCT01026454|525520453|FG000|Second Intervention|Pregnancy|1|||
145727813|NCT01026454|525520454|FG001|Second Intervention|Pregnancy|1|||
145727814|NCT01971203|525520455|FG000|Overall Study|Protocol Violation|3|||
145727815|NCT01971203|525520456|FG001|Overall Study|Protocol Violation|2|||
145727816|NCT01971203|525520455|FG000|Overall Study|Withdrawal by Subject|5|||
145727817|NCT01971203|525520456|FG001|Overall Study|Withdrawal by Subject|6|||
145727818|NCT01971203|525520455|FG000|Overall Study|Adverse Event|1|||
145727819|NCT01971203|525520456|FG001|Overall Study|Adverse Event|0|||
145727820|NCT04079803|525520457|FG000|Overall Study|Withdrawal by Subject|0|||
145727821|NCT04079803|525520458|FG001|Overall Study|Withdrawal by Subject|0|||
145727822|NCT04079803|525520459|FG002|Overall Study|Withdrawal by Subject|1|||
145727823|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
145727824|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
145384314|NCT02757352|524261682|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384315|NCT02757352|524261683|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145727825|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
145727826|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
145727827|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
145727828|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
145727829|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
145727830|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
145727831|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
145727832|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
145727833|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
145727834|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
145727835|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
145727836|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
145727837|NCT01294683|525520461|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
145727838|NCT01294683|525520462|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
145727839|NCT01294683|525520461|FG000|Post Crossover (Period III)|Adverse Event|6|||
145727840|NCT01294683|525520462|FG001|Post Crossover (Period III)|Adverse Event|6|||
145727841|NCT01294683|525520461|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
145727842|NCT01294683|525520462|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
145727843|NCT01294683|525520461|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
145727844|NCT01294683|525520462|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
145727845|NCT01294683|525520461|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
145727846|NCT01294683|525520462|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
145727847|NCT02804178|525520465|FG000|Overall Study|Adverse Event|1|||
145727848|NCT01032382|525520466|FG000|Overall Study|Disease dissemination|1|||
145727849|NCT01032382|525520467|FG001|Overall Study|Disease dissemination|1|||
145727850|NCT01032382|525520466|FG000|Overall Study|Treatment failure|3|||
145727851|NCT01032382|525520467|FG001|Overall Study|Treatment failure|1|||
145727852|NCT01032382|525520466|FG000|Overall Study|Index lesion relapse|1|||
145727853|NCT01032382|525520467|FG001|Overall Study|Index lesion relapse|3|||
145727854|NCT00178126|525520468|FG000|Overall Study|Lost to Follow-up|21|||
145727855|NCT00178126|525520469|FG001|Overall Study|Lost to Follow-up|21|||
145727856|NCT00178126|525520468|FG000|Overall Study|did not receive intervention|4|||
145727857|NCT00178126|525520469|FG001|Overall Study|did not receive intervention|6|||
145727858|NCT00421707|525520470|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
145727859|NCT00421707|525520471|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
145727860|NCT00421707|525520470|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
145727861|NCT00421707|525520471|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
145727862|NCT00421707|525520470|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
145727863|NCT00421707|525520471|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
145727864|NCT00421707|525520470|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
145727865|NCT00421707|525520471|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
145727866|NCT00421707|525520470|FG000|Period 2: Washout|Adverse Event|1|||
145727867|NCT00421707|525520471|FG001|Period 2: Washout|Adverse Event|1|||
145727868|NCT00421707|525520470|FG000|Period 2: Washout|Withdrawal by Subject|0|||
145727869|NCT00421707|525520471|FG001|Period 2: Washout|Withdrawal by Subject|1|||
145727870|NCT00421707|525520470|FG000|Period 2: Washout|Lost to Follow-up|0|||
145727871|NCT00421707|525520471|FG001|Period 2: Washout|Lost to Follow-up|1|||
145727872|NCT00421707|525520470|FG000|Period 2: Washout|Other: Pregnancy|0|||
145727873|NCT00421707|525520471|FG001|Period 2: Washout|Other: Pregnancy|1|||
145727874|NCT00421707|525520470|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
145727875|NCT00421707|525520471|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
145727876|NCT00421707|525520470|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
145384316|NCT02757352|524261684|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
145384317|NCT02757352|524261685|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145384318|NCT02757352|524261686|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
145384319|NCT02757352|524261687|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384320|NCT02757352|524261688|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384321|NCT02757352|524261689|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384322|NCT02757352|524261690|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145384323|NCT02757352|524261681|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384324|NCT02757352|524261682|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384325|NCT02757352|524261683|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384326|NCT02757352|524261684|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384327|NCT02757352|524261685|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
145384328|NCT02757352|524261686|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384329|NCT02757352|524261687|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145727877|NCT00421707|525520471|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
145727878|NCT00421707|525520470|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
145727879|NCT00421707|525520471|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
145384330|NCT02757352|524261688|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384331|NCT02757352|524261689|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145384332|NCT02757352|524261690|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
145727880|NCT01585987|525520472|FG000|Randomized|Withdrawal by Subject|0|||
145727881|NCT01585987|525520473|FG001|Randomized|Withdrawal by Subject|4|||
145727882|NCT01585987|525520472|FG000|Randomized|No longer met criteria|0|||
145727883|NCT01585987|525520473|FG001|Randomized|No longer met criteria|2|||
145727884|NCT01585987|525520472|FG000|Treated|Disease Progression|39|||
145727885|NCT01585987|525520473|FG001|Treated|Disease Progression|36|||
145727886|NCT01585987|525520472|FG000|Treated|Study Drug Toxicity|9|||
145727887|NCT01585987|525520473|FG001|Treated|Study Drug Toxicity|5|||
145727888|NCT01585987|525520472|FG000|Treated|Adverse Event|3|||
145727889|NCT01585987|525520473|FG001|Treated|Adverse Event|0|||
145727890|NCT01585987|525520472|FG000|Treated|Withdrawal by Subject|1|||
145727891|NCT01585987|525520473|FG001|Treated|Withdrawal by Subject|2|||
145727892|NCT01585987|525520472|FG000|Treated|Death|1|||
145727893|NCT01585987|525520473|FG001|Treated|Death|0|||
145727894|NCT01585987|525520472|FG000|Treated|Lost to Follow-up|0|||
145727895|NCT01585987|525520473|FG001|Treated|Lost to Follow-up|1|||
145727896|NCT01585987|525520472|FG000|Treated|Maximum Clinical Benefit|0|||
145727897|NCT01585987|525520473|FG001|Treated|Maximum Clinical Benefit|1|||
145727898|NCT01585987|525520472|FG000|Treated|Non-Specified|1|||
145727899|NCT01585987|525520473|FG001|Treated|Non-Specified|2|||
145727900|NCT01585987|525520472|FG000|Treated|Subject Request|0|||
145727901|NCT01585987|525520473|FG001|Treated|Subject Request|1|||
145727902|NCT01585987|525520472|FG000|Treated|Poor/Non-Compliance|0|||
145727903|NCT01585987|525520473|FG001|Treated|Poor/Non-Compliance|1|||
145727904|NCT00413972|525520474|FG000|Overall Study|Adverse Event|2|||
145727905|NCT00413972|525520475|FG001|Overall Study|Adverse Event|1|||
145727906|NCT00413972|525520476|FG002|Overall Study|Adverse Event|0|||
145727907|NCT00413972|525520477|FG003|Overall Study|Adverse Event|0|||
145727908|NCT00413972|525520474|FG000|Overall Study|Lost to Follow-up|1|||
145727909|NCT00413972|525520475|FG001|Overall Study|Lost to Follow-up|2|||
145727910|NCT00413972|525520476|FG002|Overall Study|Lost to Follow-up|1|||
145727911|NCT00413972|525520477|FG003|Overall Study|Lost to Follow-up|0|||
145727912|NCT00413972|525520474|FG000|Overall Study|Withdrawal by Subject|4|||
145727913|NCT00413972|525520475|FG001|Overall Study|Withdrawal by Subject|5|||
145384333|NCT02757352|524261681|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384334|NCT02757352|524261682|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384335|NCT02757352|524261683|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384336|NCT02757352|524261684|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384337|NCT02757352|524261685|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384338|NCT02757352|524261686|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
145384339|NCT02757352|524261687|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384340|NCT02757352|524261688|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384341|NCT02757352|524261689|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384342|NCT02757352|524261690|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
145384343|NCT02757352|524261681|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384344|NCT02757352|524261682|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145727914|NCT00413972|525520476|FG002|Overall Study|Withdrawal by Subject|7|||
145727915|NCT00413972|525520477|FG003|Overall Study|Withdrawal by Subject|2|||
145727916|NCT00413972|525520474|FG000|Overall Study|Protocol Violation|0|||
145727917|NCT00413972|525520475|FG001|Overall Study|Protocol Violation|0|||
145727918|NCT00413972|525520476|FG002|Overall Study|Protocol Violation|2|||
145727919|NCT00413972|525520477|FG003|Overall Study|Protocol Violation|0|||
145727920|NCT00413972|525520474|FG000|Overall Study|Other|0|||
145727921|NCT00413972|525520475|FG001|Overall Study|Other|0|||
145727922|NCT00413972|525520476|FG002|Overall Study|Other|0|||
145384345|NCT02757352|524261683|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384346|NCT02757352|524261684|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
145727923|NCT00413972|525520477|FG003|Overall Study|Other|1|||
145384347|NCT02757352|524261685|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145384348|NCT02757352|524261686|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
145727924|NCT01759407|525520478|FG000|Overall Study|Protocol Violation|0|||
145727925|NCT01759407|525520479|FG001|Overall Study|Protocol Violation|2|||
145727926|NCT02520284|525520480|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
145727927|NCT02520284|525520481|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
145727928|NCT02520284|525520482|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
145727929|NCT02520284|525520480|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
145727930|NCT02520284|525520481|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
145727931|NCT02520284|525520482|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
145727932|NCT02520284|525520480|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
145727933|NCT02520284|525520481|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
145727934|NCT02520284|525520482|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
145727935|NCT02520284|525520480|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
145727936|NCT02520284|525520481|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
145727937|NCT02520284|525520482|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
145727938|NCT02520284|525520480|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
145727939|NCT02520284|525520481|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
145384349|NCT02757352|524261687|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384350|NCT02757352|524261688|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384351|NCT02757352|524261689|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145384352|NCT02757352|524261690|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145727940|NCT02520284|525520482|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
145727941|NCT02520284|525520480|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
145727942|NCT02520284|525520481|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
145727943|NCT02520284|525520482|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
145727944|NCT02520284|525520480|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
145727945|NCT02520284|525520481|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
145384353|NCT02757352|524261681|FG000|Follow-Up Period|Adverse Event|0|||
145384354|NCT02757352|524261682|FG001|Follow-Up Period|Adverse Event|0|||
145384355|NCT02757352|524261683|FG002|Follow-Up Period|Adverse Event|0|||
145384356|NCT02757352|524261684|FG003|Follow-Up Period|Adverse Event|0|||
145384357|NCT02757352|524261685|FG004|Follow-Up Period|Adverse Event|0|||
145384358|NCT02757352|524261686|FG005|Follow-Up Period|Adverse Event|0|||
145384359|NCT02757352|524261687|FG006|Follow-Up Period|Adverse Event|1|||
145727946|NCT02520284|525520482|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
145727947|NCT02520284|525520480|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
145727948|NCT02520284|525520481|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
145727949|NCT02520284|525520482|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
145727950|NCT02520284|525520480|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
145727951|NCT02520284|525520481|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
145384360|NCT02757352|524261688|FG007|Follow-Up Period|Adverse Event|0|||
145384361|NCT02757352|524261689|FG008|Follow-Up Period|Adverse Event|2|||
145384362|NCT02757352|524261690|FG009|Follow-Up Period|Adverse Event|0|||
145384363|NCT02757352|524261681|FG000|Follow-Up Period|Lost to Follow-up|0|||
145384364|NCT02757352|524261682|FG001|Follow-Up Period|Lost to Follow-up|0|||
145384365|NCT02757352|524261683|FG002|Follow-Up Period|Lost to Follow-up|0|||
145384366|NCT02757352|524261684|FG003|Follow-Up Period|Lost to Follow-up|0|||
145384367|NCT02757352|524261685|FG004|Follow-Up Period|Lost to Follow-up|0|||
145727952|NCT02520284|525520482|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
145727953|NCT02520284|525520480|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
145384368|NCT02757352|524261686|FG005|Follow-Up Period|Lost to Follow-up|0|||
145384369|NCT02757352|524261687|FG006|Follow-Up Period|Lost to Follow-up|0|||
145384370|NCT02757352|524261688|FG007|Follow-Up Period|Lost to Follow-up|0|||
145384371|NCT02757352|524261689|FG008|Follow-Up Period|Lost to Follow-up|1|||
145727954|NCT02520284|525520481|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
145727955|NCT02520284|525520482|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
145727956|NCT02520284|525520480|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
145727957|NCT02520284|525520481|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
145727958|NCT02520284|525520482|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
145727959|NCT01898923|525520483|FG000|Overall Study|Lack of Efficacy|5|||
145727960|NCT01898923|525520484|FG001|Overall Study|Lack of Efficacy|6|||
145727961|NCT01898923|525520483|FG000|Overall Study|Adverse Event|3|||
145727962|NCT01898923|525520484|FG001|Overall Study|Adverse Event|1|||
145727963|NCT01898923|525520483|FG000|Overall Study|Lost to Follow-up|0|||
145727964|NCT01898923|525520484|FG001|Overall Study|Lost to Follow-up|1|||
145727965|NCT01898923|525520483|FG000|Overall Study|Withdrawal by Subject|4|||
145727966|NCT01898923|525520484|FG001|Overall Study|Withdrawal by Subject|7|||
145727967|NCT01898923|525520483|FG000|Overall Study|Physician Decision|3|||
145727968|NCT01898923|525520484|FG001|Overall Study|Physician Decision|4|||
145727969|NCT01898923|525520483|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
145727970|NCT01898923|525520484|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
145727971|NCT02739360|525520489|FG000|Overall Study|Adverse Event|1|||
145727972|NCT02739360|525520489|FG000|Overall Study|Study terminated by Sponsor|2|||
145727973|NCT01163916|525520490|FG000|Overall Study|Withdrawal by Subject|2|||
145727974|NCT01163916|525520491|FG001|Overall Study|Withdrawal by Subject|0|||
145727975|NCT01163916|525520492|FG002|Overall Study|Withdrawal by Subject|2|||
145727976|NCT01163916|525520490|FG000|Overall Study|Adverse Event|2|||
145384372|NCT02757352|524261690|FG009|Follow-Up Period|Lost to Follow-up|0|||
145384373|NCT02757352|524261681|FG000|Follow-Up Period|Lack of Efficacy|0|||
145384374|NCT02757352|524261682|FG001|Follow-Up Period|Lack of Efficacy|0|||
145384375|NCT02757352|524261683|FG002|Follow-Up Period|Lack of Efficacy|0|||
145384376|NCT02757352|524261684|FG003|Follow-Up Period|Lack of Efficacy|0|||
145384377|NCT02757352|524261685|FG004|Follow-Up Period|Lack of Efficacy|0|||
145384378|NCT02757352|524261686|FG005|Follow-Up Period|Lack of Efficacy|0|||
145384379|NCT02757352|524261687|FG006|Follow-Up Period|Lack of Efficacy|0|||
145384380|NCT02757352|524261688|FG007|Follow-Up Period|Lack of Efficacy|0|||
145384381|NCT02757352|524261689|FG008|Follow-Up Period|Lack of Efficacy|1|||
145384382|NCT02757352|524261690|FG009|Follow-Up Period|Lack of Efficacy|1|||
145384383|NCT02757352|524261681|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145384384|NCT02757352|524261682|FG001|Follow-Up Period|Withdrawal by Subject|0|||
145384385|NCT02757352|524261683|FG002|Follow-Up Period|Withdrawal by Subject|0|||
145384386|NCT02757352|524261684|FG003|Follow-Up Period|Withdrawal by Subject|0|||
145384387|NCT02757352|524261685|FG004|Follow-Up Period|Withdrawal by Subject|0|||
145384388|NCT02757352|524261686|FG005|Follow-Up Period|Withdrawal by Subject|0|||
145384389|NCT02757352|524261687|FG006|Follow-Up Period|Withdrawal by Subject|0|||
145384390|NCT02757352|524261688|FG007|Follow-Up Period|Withdrawal by Subject|1|||
145384391|NCT02757352|524261689|FG008|Follow-Up Period|Withdrawal by Subject|6|||
145727977|NCT01163916|525520491|FG001|Overall Study|Adverse Event|0|||
145727978|NCT01163916|525520492|FG002|Overall Study|Adverse Event|1|||
145727979|NCT01163916|525520490|FG000|Overall Study|Lack of Efficacy|2|||
145384392|NCT02757352|524261690|FG009|Follow-Up Period|Withdrawal by Subject|2|||
145727980|NCT01163916|525520491|FG001|Overall Study|Lack of Efficacy|0|||
145727981|NCT01163916|525520492|FG002|Overall Study|Lack of Efficacy|1|||
145727982|NCT01163916|525520490|FG000|Overall Study|Other|24|||
145727983|NCT01163916|525520491|FG001|Overall Study|Other|4|||
145727984|NCT01163916|525520492|FG002|Overall Study|Other|16|||
145727985|NCT00026208|525520493|FG000|Overall Study|Complications of auto accident|1|||
145727986|NCT00026208|525520494|FG001|Overall Study|Complications of auto accident|0|||
145384393|NCT03536663|524261691|FG000|Endexo|Protocol Violation|1|||
145384394|NCT00497146|524261693|FG000|Treatment Period|Adverse Event|6|||
145384395|NCT00497146|524261694|FG001|Treatment Period|Adverse Event|2|||
145384396|NCT00497146|524261693|FG000|Treatment Period|Withdrawal by Subject|5|||
145384397|NCT00497146|524261694|FG001|Treatment Period|Withdrawal by Subject|9|||
145384398|NCT00497146|524261693|FG000|Treatment Period|Lost to Follow-up|1|||
145384399|NCT00497146|524261694|FG001|Treatment Period|Lost to Follow-up|3|||
145384400|NCT00497146|524261693|FG000|Treatment Period|Required dialysis|4|||
145727987|NCT00423930|525520496|FG000|Overall Study|Withdrawal by Subject|2|||
145727988|NCT04223856|525520500|FG000|Overall Study|Progressive disease|153|||
145727989|NCT04223856|525520501|FG001|Overall Study|Progressive disease|73|||
145727990|NCT04223856|525520500|FG000|Overall Study|Adverse Event|97|||
145727991|NCT04223856|525520501|FG001|Overall Study|Adverse Event|62|||
145727992|NCT04223856|525520500|FG000|Overall Study|Physician Decision|9|||
145727993|NCT04223856|525520501|FG001|Overall Study|Physician Decision|28|||
145727994|NCT04223856|525520500|FG000|Overall Study|Withdrawal by Subject|22|||
145727995|NCT04223856|525520501|FG001|Overall Study|Withdrawal by Subject|24|||
145727996|NCT04223856|525520500|FG000|Overall Study|Other|7|||
145727997|NCT04223856|525520501|FG001|Overall Study|Other|2|||
145727998|NCT04223856|525520500|FG000|Overall Study|Randomized but not treated|2|||
145727999|NCT04223856|525520501|FG001|Overall Study|Randomized but not treated|11|||
145728000|NCT04223856|525520500|FG000|Overall Study|On-treatment|144|||
145728001|NCT04223856|525520501|FG001|Overall Study|On-treatment|0|||
145728002|NCT03226275|525520502|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
145728003|NCT03226275|525520503|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
145728004|NCT03226275|525520504|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
145728005|NCT03226275|525520505|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
145728006|NCT03226275|525520502|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
145728007|NCT03226275|525520503|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
145728008|NCT03226275|525520504|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
145728009|NCT03226275|525520505|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
145728010|NCT03442114|525520506|FG000|Overall Study|Lost to Follow-up|13|||
145728011|NCT03442114|525520507|FG001|Overall Study|Lost to Follow-up|13|||
145728012|NCT03442114|525520506|FG000|Overall Study|Physician Decision|2|||
145728013|NCT03442114|525520507|FG001|Overall Study|Physician Decision|2|||
145728014|NCT03442114|525520506|FG000|Overall Study|Protocol Violation|0|||
145728015|NCT03442114|525520507|FG001|Overall Study|Protocol Violation|2|||
145728016|NCT03442114|525520506|FG000|Overall Study|Withdrawal by Subject|1|||
145728017|NCT03442114|525520507|FG001|Overall Study|Withdrawal by Subject|3|||
145728018|NCT03442114|525520506|FG000|Overall Study|Guardianship Change|0|||
145728019|NCT03442114|525520507|FG001|Overall Study|Guardianship Change|1|||
145728020|NCT02903368|525520508|FG000|Part 1|Adverse Event|3|||
145728021|NCT02903368|525520509|FG001|Part 1|Adverse Event|0|||
145728022|NCT02903368|525520510|FG002|Part 1|Adverse Event|0|||
145728023|NCT02903368|525520511|FG003|Part 1|Adverse Event|0|||
145728024|NCT02903368|525520508|FG000|Part 1|Withdrawal by Subject|1|||
145728025|NCT02903368|525520509|FG001|Part 1|Withdrawal by Subject|0|||
145728026|NCT02903368|525520510|FG002|Part 1|Withdrawal by Subject|0|||
145728027|NCT02903368|525520511|FG003|Part 1|Withdrawal by Subject|0|||
145728028|NCT02903368|525520508|FG000|Part 2|Adverse Event|0|||
145728029|NCT02903368|525520509|FG001|Part 2|Adverse Event|0|||
145728030|NCT02903368|525520510|FG002|Part 2|Adverse Event|5|||
145728031|NCT02903368|525520511|FG003|Part 2|Adverse Event|0|||
145728032|NCT02903368|525520508|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
145728033|NCT02903368|525520509|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
145728034|NCT02903368|525520510|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
145728035|NCT02903368|525520511|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
145728036|NCT02903368|525520508|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
145728037|NCT02903368|525520509|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
145728038|NCT02903368|525520510|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
145728039|NCT02903368|525520511|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
145728040|NCT02903368|525520508|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
145728041|NCT02903368|525520509|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
145728042|NCT02903368|525520510|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
145728043|NCT02903368|525520511|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
145728044|NCT06515483|525520512|FG000|Overall Study|Subject withdraw due to family issues|1|||
145728045|NCT06515483|525520513|FG001|Overall Study|Subject withdraw due to family issues|0|||
145728046|NCT00720941|525523275|FG000|Overall Study|Protocol Violation|1|||
145728047|NCT00720941|525523276|FG001|Overall Study|Protocol Violation|2|||
145728048|NCT00720941|525523275|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
145728049|NCT00720941|525523276|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
145728050|NCT00720941|525523275|FG000|Overall Study|Lost to Follow-up|20|||
145728051|NCT00720941|525523276|FG001|Overall Study|Lost to Follow-up|15|||
145728052|NCT00720941|525523275|FG000|Overall Study|Physician Decision|14|||
145728053|NCT00720941|525523276|FG001|Overall Study|Physician Decision|12|||
145728054|NCT00720941|525523275|FG000|Overall Study|Withdrawal by Subject|29|||
145384401|NCT00497146|524261694|FG001|Treatment Period|Required dialysis|1|||
145728055|NCT00720941|525523276|FG001|Overall Study|Withdrawal by Subject|36|||
145728056|NCT02544217|525523277|FG000|Overall Study|Withdrawal by Subject|1|||
145728057|NCT02544217|525523278|FG001|Overall Study|Withdrawal by Subject|1|||
145728058|NCT02544217|525523279|FG002|Overall Study|Withdrawal by Subject|0|||
145728059|NCT02544217|525523280|FG003|Overall Study|Withdrawal by Subject|0|||
145728060|NCT02544217|525523281|FG004|Overall Study|Withdrawal by Subject|0|||
145728061|NCT02544217|525523282|FG005|Overall Study|Withdrawal by Subject|0|||
145728062|NCT00937833|525523283|FG000|Overall Study|Protocol Violation|1|||
145728063|NCT00937833|525523284|FG001|Overall Study|Protocol Violation|2|||
145728064|NCT00937833|525523283|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
145728065|NCT00937833|525523284|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
145728066|NCT00937833|525523283|FG000|Overall Study|Lost to Follow-up|10|||
145728067|NCT00937833|525523284|FG001|Overall Study|Lost to Follow-up|8|||
145728068|NCT00937833|525523283|FG000|Overall Study|Withdrawal by Subject|4|||
145728069|NCT00937833|525523284|FG001|Overall Study|Withdrawal by Subject|6|||
145728070|NCT00818389|525523285|FG000|Overall Study|Death|1|||
145728071|NCT00818389|525523286|FG001|Overall Study|Death|3|||
145728072|NCT00818389|525523285|FG000|Overall Study|ALS Disease Progression|1|||
145728073|NCT00818389|525523286|FG001|Overall Study|ALS Disease Progression|0|||
145728074|NCT00818389|525523285|FG000|Overall Study|Withdrawal by Subject|2|||
145728075|NCT00818389|525523286|FG001|Overall Study|Withdrawal by Subject|2|||
145728076|NCT00818389|525523285|FG000|Overall Study|Adverse Event|0|||
145728077|NCT00818389|525523286|FG001|Overall Study|Adverse Event|1|||
145728078|NCT03840486|525523287|FG000|Overall Study|Withdrawal by Subject|0|||
145728079|NCT03840486|525523288|FG001|Overall Study|Withdrawal by Subject|1|||
145728080|NCT03840486|525523289|FG002|Overall Study|Withdrawal by Subject|0|||
145728081|NCT03840486|525523290|FG003|Overall Study|Withdrawal by Subject|0|||
145728082|NCT03840486|525523291|FG004|Overall Study|Withdrawal by Subject|0|||
145728083|NCT03840486|525523292|FG005|Overall Study|Withdrawal by Subject|0|||
145728084|NCT03840486|525523293|FG006|Overall Study|Withdrawal by Subject|0|||
145728085|NCT03840486|525523294|FG007|Overall Study|Withdrawal by Subject|0|||
145728086|NCT03840486|525523295|FG008|Overall Study|Withdrawal by Subject|0|||
145728087|NCT03840486|525523296|FG009|Overall Study|Withdrawal by Subject|0|||
145728088|NCT03840486|525523297|FG010|Overall Study|Withdrawal by Subject|0|||
145728089|NCT03840486|525523298|FG011|Overall Study|Withdrawal by Subject|0|||
145728090|NCT04442737|525523301|FG000|Overall Study|Lost to Follow-up|1|||
145728091|NCT04442737|525523302|FG001|Overall Study|Lost to Follow-up|3|||
145728092|NCT04442737|525523301|FG000|Overall Study|Withdrawal by Subject|3|||
145728093|NCT04442737|525523302|FG001|Overall Study|Withdrawal by Subject|2|||
145728094|NCT04442737|525523301|FG000|Overall Study|Adverse Event|3|||
145728095|NCT04442737|525523302|FG001|Overall Study|Adverse Event|2|||
145728096|NCT04442737|525523301|FG000|Overall Study|Death|0|||
145728097|NCT04442737|525523302|FG001|Overall Study|Death|1|||
145728098|NCT04442737|525523301|FG000|Overall Study|Protocol Violation|0|||
145728099|NCT04442737|525523302|FG001|Overall Study|Protocol Violation|2|||
145728100|NCT04442737|525523301|FG000|Overall Study|Other|1|||
145728101|NCT04442737|525523302|FG001|Overall Study|Other|1|||
145728102|NCT00744523|525523303|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
145728103|NCT00744523|525523304|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
145728104|NCT01139021|525523307|FG000|Overall Study|Adverse Event|0|||
145728105|NCT01139021|525523308|FG001|Overall Study|Adverse Event|0|||
145728106|NCT01139021|525523309|FG002|Overall Study|Adverse Event|0|||
145728107|NCT01139021|525523310|FG003|Overall Study|Adverse Event|0|||
145728108|NCT01139021|525523311|FG004|Overall Study|Adverse Event|1|||
145728109|NCT01139021|525523312|FG005|Overall Study|Adverse Event|0|||
145728110|NCT01139021|525523307|FG000|Overall Study|Lost to Follow-up|0|||
145728111|NCT01139021|525523308|FG001|Overall Study|Lost to Follow-up|0|||
145728112|NCT01139021|525523309|FG002|Overall Study|Lost to Follow-up|0|||
145728113|NCT01139021|525523310|FG003|Overall Study|Lost to Follow-up|0|||
145728114|NCT01139021|525523311|FG004|Overall Study|Lost to Follow-up|2|||
145728115|NCT01139021|525523312|FG005|Overall Study|Lost to Follow-up|0|||
145728116|NCT01139021|525523307|FG000|Overall Study|Protocol Violation|1|||
145728117|NCT01139021|525523308|FG001|Overall Study|Protocol Violation|0|||
145728118|NCT01139021|525523309|FG002|Overall Study|Protocol Violation|0|||
145728119|NCT01139021|525523310|FG003|Overall Study|Protocol Violation|0|||
145728120|NCT01139021|525523311|FG004|Overall Study|Protocol Violation|2|||
145384402|NCT00497146|524261693|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
145728121|NCT01139021|525523312|FG005|Overall Study|Protocol Violation|0|||
145728122|NCT01139021|525523307|FG000|Overall Study|Withdrawal by Subject|0|||
145728123|NCT01139021|525523308|FG001|Overall Study|Withdrawal by Subject|0|||
145728124|NCT01139021|525523309|FG002|Overall Study|Withdrawal by Subject|0|||
145728125|NCT01139021|525523310|FG003|Overall Study|Withdrawal by Subject|1|||
145728126|NCT01139021|525523311|FG004|Overall Study|Withdrawal by Subject|4|||
145728127|NCT01139021|525523312|FG005|Overall Study|Withdrawal by Subject|0|||
145728128|NCT03588728|525523317|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
145728129|NCT03588728|525523318|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
145728130|NCT03588728|525523319|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
145728131|NCT03588728|525523320|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
145728132|NCT03588728|525523317|FG000|Overall Study|Lab shut down due to COVID-19|0|||
145728133|NCT03588728|525523318|FG001|Overall Study|Lab shut down due to COVID-19|0|||
145728134|NCT03588728|525523319|FG002|Overall Study|Lab shut down due to COVID-19|0|||
145728135|NCT03588728|525523320|FG003|Overall Study|Lab shut down due to COVID-19|1|||
145728136|NCT03588728|525523317|FG000|Overall Study|multiple technical issues|1|||
145728137|NCT03588728|525523318|FG001|Overall Study|multiple technical issues|0|||
145728138|NCT03588728|525523319|FG002|Overall Study|multiple technical issues|0|||
145728139|NCT03588728|525523320|FG003|Overall Study|multiple technical issues|0|||
145728140|NCT03588728|525523317|FG000|Overall Study|Hospitalized for COVID|1|||
145728141|NCT03588728|525523318|FG001|Overall Study|Hospitalized for COVID|0|||
145728142|NCT03588728|525523319|FG002|Overall Study|Hospitalized for COVID|0|||
145728143|NCT03588728|525523320|FG003|Overall Study|Hospitalized for COVID|0|||
145728144|NCT03588728|525523317|FG000|Overall Study|Schedule change unable to attend sessions|1|||
145728145|NCT03588728|525523318|FG001|Overall Study|Schedule change unable to attend sessions|0|||
145728146|NCT03588728|525523319|FG002|Overall Study|Schedule change unable to attend sessions|0|||
145728147|NCT03588728|525523320|FG003|Overall Study|Schedule change unable to attend sessions|0|||
145728148|NCT02027701|525523321|FG000|Overall Study|Adverse Event|3|||
145728149|NCT02027701|525523321|FG000|Overall Study|Lack of Efficacy|8|||
145728150|NCT02027701|525523321|FG000|Overall Study|Physician Decision|2|||
145728151|NCT02027701|525523321|FG000|Overall Study|Withdrawal by Subject|3|||
145728152|NCT00756470|525523322|FG000|Overall Study|Withdrawal by Subject|1|||
145728153|NCT00756470|525523322|FG000|Overall Study|Adverse Event|4|||
145728154|NCT00820027|525523323|FG000|Overall Study|Adverse Event|15|||
145728155|NCT00820027|525523324|FG001|Overall Study|Adverse Event|8|||
145728156|NCT00820027|525523325|FG002|Overall Study|Adverse Event|10|||
145728157|NCT00820027|525523326|FG003|Overall Study|Adverse Event|5|||
145728158|NCT00820027|525523323|FG000|Overall Study|Lack of Efficacy|2|||
145728159|NCT00820027|525523324|FG001|Overall Study|Lack of Efficacy|1|||
145728160|NCT00820027|525523325|FG002|Overall Study|Lack of Efficacy|2|||
145728161|NCT00820027|525523326|FG003|Overall Study|Lack of Efficacy|2|||
145728162|NCT00820027|525523323|FG000|Overall Study|Physician Decision|0|||
145728163|NCT00820027|525523324|FG001|Overall Study|Physician Decision|1|||
145728164|NCT00820027|525523325|FG002|Overall Study|Physician Decision|1|||
145728165|NCT00820027|525523326|FG003|Overall Study|Physician Decision|0|||
145728166|NCT00820027|525523323|FG000|Overall Study|Protocol Violation|3|||
145728167|NCT00820027|525523324|FG001|Overall Study|Protocol Violation|0|||
145728168|NCT00820027|525523325|FG002|Overall Study|Protocol Violation|4|||
145728169|NCT00820027|525523326|FG003|Overall Study|Protocol Violation|0|||
145728170|NCT00820027|525523323|FG000|Overall Study|Withdrawal by Subject|6|||
145728171|NCT00820027|525523324|FG001|Overall Study|Withdrawal by Subject|4|||
145728172|NCT00820027|525523325|FG002|Overall Study|Withdrawal by Subject|4|||
145728173|NCT00820027|525523326|FG003|Overall Study|Withdrawal by Subject|6|||
145728174|NCT01978262|525523327|FG000|Overall Study|Withdrawal by Subject|9|||
145728175|NCT01978262|525523327|FG000|Overall Study|Lost to Follow-up|2|||
145728176|NCT02982187|525523328|FG000|Overall Study|Withdrawal by Subject|0|||
145728177|NCT02982187|525523329|FG001|Overall Study|Withdrawal by Subject|0|||
145728178|NCT02982187|525523330|FG002|Overall Study|Withdrawal by Subject|0|||
145728179|NCT02982187|525523331|FG003|Overall Study|Withdrawal by Subject|0|||
145728180|NCT02982187|525523332|FG004|Overall Study|Withdrawal by Subject|0|||
145728181|NCT02982187|525523333|FG005|Overall Study|Withdrawal by Subject|0|||
145728182|NCT02982187|525523334|FG006|Overall Study|Withdrawal by Subject|1|||
145728183|NCT02982187|525523335|FG007|Overall Study|Withdrawal by Subject|0|||
145728184|NCT02604433|525523336|FG000|Overall Study|Withdrawal by Subject|37|||
145728185|NCT02604433|525523337|FG001|Overall Study|Withdrawal by Subject|16|||
145728186|NCT02604433|525523336|FG000|Overall Study|Adverse Event|4|||
145728187|NCT02604433|525523337|FG001|Overall Study|Adverse Event|0|||
145728188|NCT02604433|525523336|FG000|Overall Study|Other reasons|3|||
145728189|NCT02604433|525523337|FG001|Overall Study|Other reasons|5|||
145728190|NCT02604433|525523336|FG000|Overall Study|Death|4|||
145728191|NCT02604433|525523337|FG001|Overall Study|Death|1|||
145728192|NCT02604433|525523336|FG000|Overall Study|Transition to Rollover Protocol|169|||
145728193|NCT02604433|525523337|FG001|Overall Study|Transition to Rollover Protocol|82|||
145728194|NCT02604433|525523336|FG000|Overall Study|Physician Decision|1|||
145728195|NCT02604433|525523337|FG001|Overall Study|Physician Decision|1|||
145728196|NCT02604433|525523336|FG000|Overall Study|Lack of Efficacy|0|||
145728197|NCT02604433|525523337|FG001|Overall Study|Lack of Efficacy|1|||
145728198|NCT03285178|525523338|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
145728199|NCT03285178|525523339|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728200|NCT03285178|525523340|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728201|NCT03285178|525523341|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728202|NCT03285178|525523342|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728203|NCT03285178|525523343|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728204|NCT03285178|525523344|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
145728205|NCT03285178|525523338|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
145728206|NCT03285178|525523339|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145384403|NCT00497146|524261694|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
145384404|NCT00497146|524261693|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
145384405|NCT00497146|524261694|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
145384406|NCT00497146|524261693|FG000|Treatment Period|Other Reason|2|||
145384407|NCT00497146|524261694|FG001|Treatment Period|Other Reason|3|||
145384408|NCT00497146|524261693|FG000|Long-term Follow-up Period|Adverse Event|2|||
145384409|NCT00497146|524261694|FG001|Long-term Follow-up Period|Adverse Event|2|||
145384410|NCT00497146|524261693|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
145384411|NCT00497146|524261694|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
145384412|NCT00497146|524261693|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
145384413|NCT00497146|524261694|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
145384414|NCT00497146|524261693|FG000|Long-term Follow-up Period|Other|0|||
145384415|NCT00497146|524261694|FG001|Long-term Follow-up Period|Other|1|||
145384416|NCT01964989|524261709|FG000|Overall Study|Protocol Violation|3|||
145728207|NCT03285178|525523340|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145728208|NCT03285178|525523341|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145728209|NCT03285178|525523342|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145728210|NCT03285178|525523343|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145728211|NCT03285178|525523344|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
145728212|NCT03285178|525523338|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
145728213|NCT03285178|525523339|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
145728214|NCT03285178|525523340|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
145728215|NCT03285178|525523341|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
145728216|NCT03285178|525523342|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
145728217|NCT03285178|525523343|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
145728218|NCT03285178|525523344|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
145728219|NCT03285178|525523338|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
145728220|NCT03285178|525523339|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728221|NCT03285178|525523340|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728222|NCT03285178|525523341|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728223|NCT03285178|525523342|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728224|NCT03285178|525523343|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728225|NCT03285178|525523344|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
145728226|NCT03285178|525523338|FG000|Single-Blind Run-In Period|Physician Decision|2|||
145728227|NCT03285178|525523339|FG001|Single-Blind Run-In Period|Physician Decision|0|||
145728228|NCT03285178|525523340|FG002|Single-Blind Run-In Period|Physician Decision|0|||
145728229|NCT03285178|525523341|FG003|Single-Blind Run-In Period|Physician Decision|0|||
145728230|NCT03285178|525523342|FG004|Single-Blind Run-In Period|Physician Decision|0|||
145728231|NCT03285178|525523343|FG005|Single-Blind Run-In Period|Physician Decision|0|||
145728232|NCT03285178|525523344|FG006|Single-Blind Run-In Period|Physician Decision|0|||
145728233|NCT03285178|525523338|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
145728234|NCT03285178|525523339|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
145728235|NCT03285178|525523340|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
145728236|NCT03285178|525523341|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
145728237|NCT03285178|525523342|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
145728238|NCT03285178|525523343|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
145384417|NCT01964989|524261710|FG001|Overall Study|Protocol Violation|4|||
145384418|NCT01964989|524261709|FG000|Overall Study|Administrative Reason|103|||
145384419|NCT01964989|524261710|FG001|Overall Study|Administrative Reason|95|||
145384420|NCT01964989|524261709|FG000|Overall Study|Adverse Event|0|||
145384421|NCT01964989|524261710|FG001|Overall Study|Adverse Event|1|||
145384422|NCT01964989|524261709|FG000|Overall Study|Death|1|||
145384423|NCT01964989|524261710|FG001|Overall Study|Death|3|||
145384424|NCT01964989|524261709|FG000|Overall Study|Withdrawal by Subject|156|||
145384425|NCT01964989|524261710|FG001|Overall Study|Withdrawal by Subject|160|||
145384426|NCT01964989|524261709|FG000|Overall Study|Lost to Follow-up|254|||
145384427|NCT01964989|524261710|FG001|Overall Study|Lost to Follow-up|232|||
145384428|NCT01964989|524261709|FG000|Overall Study|Other|267|||
145384429|NCT01964989|524261710|FG001|Overall Study|Other|252|||
145384430|NCT02769312|524261711|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
145384431|NCT02769312|524261712|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
145384432|NCT02769312|524261711|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
145384433|NCT02769312|524261712|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
145384434|NCT02769312|524261711|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
145384435|NCT02769312|524261712|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
145728239|NCT03285178|525523344|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
145728240|NCT03285178|525523338|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145728241|NCT03285178|525523339|FG001|Double-Blind Treatment Period|Adverse Event|0|||
145728242|NCT03285178|525523340|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145728243|NCT03285178|525523341|FG003|Double-Blind Treatment Period|Adverse Event|0|||
145728244|NCT03285178|525523342|FG004|Double-Blind Treatment Period|Adverse Event|0|||
145728245|NCT03285178|525523343|FG005|Double-Blind Treatment Period|Adverse Event|0|||
145728246|NCT03285178|525523344|FG006|Double-Blind Treatment Period|Adverse Event|2|||
145728247|NCT03285178|525523338|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145728248|NCT03285178|525523339|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145728249|NCT03285178|525523340|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
145728250|NCT03285178|525523341|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
145728251|NCT03285178|525523342|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
145728252|NCT03285178|525523343|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
145728253|NCT03285178|525523344|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
145728254|NCT03285178|525523338|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145728255|NCT03285178|525523339|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145728256|NCT03285178|525523340|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145728257|NCT03285178|525523341|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145728258|NCT03285178|525523342|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145728259|NCT03285178|525523343|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145728260|NCT03285178|525523344|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145728261|NCT03285178|525523338|FG000|Double-Blind Treatment Period|COVID-19|0|||
145728262|NCT03285178|525523339|FG001|Double-Blind Treatment Period|COVID-19|0|||
145728263|NCT03285178|525523340|FG002|Double-Blind Treatment Period|COVID-19|1|||
145728264|NCT03285178|525523341|FG003|Double-Blind Treatment Period|COVID-19|0|||
145728265|NCT03285178|525523342|FG004|Double-Blind Treatment Period|COVID-19|0|||
145728266|NCT03285178|525523343|FG005|Double-Blind Treatment Period|COVID-19|0|||
145728267|NCT03285178|525523344|FG006|Double-Blind Treatment Period|COVID-19|0|||
145728268|NCT01388790|525523345|FG000|Overall Study|Ongoing at data cut-off date|8|||
145728269|NCT01128894|525523346|FG000|Overall Study|Adverse Event|31|||
145728270|NCT01128894|525523347|FG001|Overall Study|Adverse Event|41|||
145728271|NCT01128894|525523346|FG000|Overall Study|Protocol Violation|2|||
145728272|NCT01128894|525523347|FG001|Overall Study|Protocol Violation|1|||
145728273|NCT01128894|525523346|FG000|Overall Study|Noncompliance|4|||
145728274|NCT01128894|525523347|FG001|Overall Study|Noncompliance|5|||
145728275|NCT01128894|525523346|FG000|Overall Study|Lost to Follow-up|8|||
145728276|NCT01128894|525523347|FG001|Overall Study|Lost to Follow-up|8|||
145728277|NCT01128894|525523346|FG000|Overall Study|Withdrawal by Subject|10|||
145728278|NCT01128894|525523347|FG001|Overall Study|Withdrawal by Subject|12|||
145728279|NCT01128894|525523346|FG000|Overall Study|Physician Decision|2|||
145728280|NCT01128894|525523347|FG001|Overall Study|Physician Decision|1|||
145728281|NCT01128894|525523346|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
145728282|NCT01128894|525523347|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
145728283|NCT03437278|525523348|FG000|Overall Study|Adverse Event|0|||
145728284|NCT03437278|525523349|FG001|Overall Study|Adverse Event|0|||
145728285|NCT03437278|525523350|FG002|Overall Study|Adverse Event|1|||
145728286|NCT03437278|525523348|FG000|Overall Study|Progressive disease|1|||
145728287|NCT03437278|525523349|FG001|Overall Study|Progressive disease|0|||
145728288|NCT03437278|525523350|FG002|Overall Study|Progressive disease|0|||
145728289|NCT03437278|525523348|FG000|Overall Study|Physician Decision|1|||
145728290|NCT03437278|525523349|FG001|Overall Study|Physician Decision|0|||
145728291|NCT03437278|525523350|FG002|Overall Study|Physician Decision|1|||
145728292|NCT00195507|525523351|FG000|Overall Study|Adverse Event|24|||
145728293|NCT00195507|525523352|FG001|Overall Study|Adverse Event|13|||
145728294|NCT00195507|525523351|FG000|Overall Study|Death|0|||
145728295|NCT00195507|525523352|FG001|Overall Study|Death|1|||
145728296|NCT00195507|525523351|FG000|Overall Study|Failed to Return|4|||
145728297|NCT00195507|525523352|FG001|Overall Study|Failed to Return|3|||
145728298|NCT00195507|525523351|FG000|Overall Study|Physician Decision|1|||
145384436|NCT02769312|524261711|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
145384437|NCT02769312|524261712|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
145384438|NCT02769312|524261711|FG000|Follow-up|Lost to Follow-up|1|||
145384439|NCT02769312|524261712|FG001|Follow-up|Lost to Follow-up|1|||
145728299|NCT00195507|525523352|FG001|Overall Study|Physician Decision|2|||
145728300|NCT00195507|525523351|FG000|Overall Study|Lost to Follow-up|3|||
145728301|NCT00195507|525523352|FG001|Overall Study|Lost to Follow-up|2|||
145728302|NCT00195507|525523351|FG000|Overall Study|Protocol Violation|5|||
145728303|NCT00195507|525523352|FG001|Overall Study|Protocol Violation|4|||
145728304|NCT00195507|525523351|FG000|Overall Study|Lack of Efficacy|40|||
145728305|NCT00195507|525523352|FG001|Overall Study|Lack of Efficacy|67|||
145728306|NCT00195507|525523351|FG000|Overall Study|Withdrawal by Subject|16|||
145728307|NCT00195507|525523352|FG001|Overall Study|Withdrawal by Subject|23|||
145384440|NCT02496039|524261713|FG000|Overall Study|Adverse Event|3|||
145384441|NCT02496039|524261713|FG000|Overall Study|Protocol Violation|1|||
145728308|NCT00195507|525523351|FG000|Overall Study|Protocol Deviation|6|||
145728309|NCT00195507|525523352|FG001|Overall Study|Protocol Deviation|3|||
145728310|NCT01128738|525523353|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
145728311|NCT01128738|525523354|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
145728312|NCT01128738|525523353|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
145728313|NCT01128738|525523354|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
145728314|NCT01128738|525523353|FG000|Second TP|Lost to Follow-up|0|||
145728315|NCT01128738|525523354|FG001|Second TP|Lost to Follow-up|1|||
145728316|NCT01128738|525523353|FG000|Second TP|Withdrawal by Subject|0|||
145728317|NCT01128738|525523354|FG001|Second TP|Withdrawal by Subject|2|||
145728318|NCT00973362|525523355|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
145728319|NCT00973362|525523356|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
145728320|NCT00973362|525523355|FG000|Baseline Evaluation|No colposcopy visit|62|||
145728321|NCT00973362|525523356|FG001|Baseline Evaluation|No colposcopy visit|0|||
145728322|NCT00973362|525523355|FG000|Baseline Evaluation|Inevaluable|686|||
145728323|NCT00973362|525523356|FG001|Baseline Evaluation|Inevaluable|223|||
145728324|NCT00973362|525523355|FG000|3-Year Follow-up|Lost to Follow-up|17|||
145728325|NCT00973362|525523356|FG001|3-Year Follow-up|Lost to Follow-up|0|||
145728326|NCT02202551|525523357|FG000|Overall Study|Adverse Event|8|||
145728327|NCT02202551|525523358|FG001|Overall Study|Adverse Event|19|||
145728328|NCT02202551|525523359|FG002|Overall Study|Adverse Event|5|||
145728329|NCT02202551|525523360|FG003|Overall Study|Adverse Event|9|||
145728330|NCT02202551|525523357|FG000|Overall Study|Death|3|||
145728331|NCT02202551|525523358|FG001|Overall Study|Death|2|||
145728332|NCT02202551|525523359|FG002|Overall Study|Death|1|||
145728333|NCT02202551|525523360|FG003|Overall Study|Death|1|||
145728334|NCT02202551|525523357|FG000|Overall Study|Lost to Follow-up|0|||
145728335|NCT02202551|525523358|FG001|Overall Study|Lost to Follow-up|1|||
145728336|NCT02202551|525523359|FG002|Overall Study|Lost to Follow-up|0|||
145728337|NCT02202551|525523360|FG003|Overall Study|Lost to Follow-up|1|||
145728338|NCT02202551|525523357|FG000|Overall Study|Needed to take excluded medication|0|||
145728339|NCT02202551|525523358|FG001|Overall Study|Needed to take excluded medication|2|||
145728340|NCT02202551|525523359|FG002|Overall Study|Needed to take excluded medication|0|||
145728341|NCT02202551|525523360|FG003|Overall Study|Needed to take excluded medication|1|||
145728342|NCT02202551|525523357|FG000|Overall Study|Subject moved away|0|||
145728343|NCT02202551|525523358|FG001|Overall Study|Subject moved away|1|||
145728344|NCT02202551|525523359|FG002|Overall Study|Subject moved away|0|||
145728345|NCT02202551|525523360|FG003|Overall Study|Subject moved away|0|||
145728346|NCT02202551|525523357|FG000|Overall Study|DBS surgery|3|||
145728347|NCT02202551|525523358|FG001|Overall Study|DBS surgery|0|||
145728348|NCT02202551|525523359|FG002|Overall Study|DBS surgery|0|||
145728349|NCT02202551|525523360|FG003|Overall Study|DBS surgery|0|||
145728350|NCT02202551|525523357|FG000|Overall Study|Dyskinesia upon taper|1|||
145728351|NCT02202551|525523358|FG001|Overall Study|Dyskinesia upon taper|0|||
145728352|NCT02202551|525523359|FG002|Overall Study|Dyskinesia upon taper|0|||
145728353|NCT02202551|525523360|FG003|Overall Study|Dyskinesia upon taper|0|||
145728354|NCT02202551|525523357|FG000|Overall Study|Lack of Efficacy|0|||
145728355|NCT02202551|525523358|FG001|Overall Study|Lack of Efficacy|1|||
145728356|NCT02202551|525523359|FG002|Overall Study|Lack of Efficacy|0|||
145728357|NCT02202551|525523360|FG003|Overall Study|Lack of Efficacy|0|||
145728358|NCT02202551|525523357|FG000|Overall Study|Physician Decision|1|||
145728359|NCT02202551|525523358|FG001|Overall Study|Physician Decision|0|||
145728360|NCT02202551|525523359|FG002|Overall Study|Physician Decision|0|||
145728361|NCT02202551|525523360|FG003|Overall Study|Physician Decision|0|||
145728362|NCT02202551|525523357|FG000|Overall Study|Site closure|3|||
145728363|NCT02202551|525523358|FG001|Overall Study|Site closure|0|||
145728364|NCT02202551|525523359|FG002|Overall Study|Site closure|0|||
145728365|NCT02202551|525523360|FG003|Overall Study|Site closure|1|||
145728366|NCT02202551|525523357|FG000|Overall Study|Unable to complete visits per protocol|1|||
145728367|NCT02202551|525523358|FG001|Overall Study|Unable to complete visits per protocol|0|||
145728368|NCT02202551|525523359|FG002|Overall Study|Unable to complete visits per protocol|0|||
145728369|NCT02202551|525523360|FG003|Overall Study|Unable to complete visits per protocol|0|||
145728370|NCT02202551|525523357|FG000|Overall Study|Worsening Dyskinesia|0|||
145728371|NCT02202551|525523358|FG001|Overall Study|Worsening Dyskinesia|0|||
145728372|NCT02202551|525523359|FG002|Overall Study|Worsening Dyskinesia|0|||
145728373|NCT02202551|525523360|FG003|Overall Study|Worsening Dyskinesia|1|||
145728374|NCT02202551|525523357|FG000|Overall Study|Protocol Violation|0|||
145728375|NCT02202551|525523358|FG001|Overall Study|Protocol Violation|1|||
145728376|NCT02202551|525523359|FG002|Overall Study|Protocol Violation|0|||
145728377|NCT02202551|525523360|FG003|Overall Study|Protocol Violation|0|||
145728378|NCT02202551|525523357|FG000|Overall Study|Sponsor's decision|2|||
145728379|NCT02202551|525523358|FG001|Overall Study|Sponsor's decision|0|||
145728380|NCT02202551|525523359|FG002|Overall Study|Sponsor's decision|0|||
145728381|NCT02202551|525523360|FG003|Overall Study|Sponsor's decision|0|||
145728382|NCT02202551|525523357|FG000|Overall Study|Subject unwilling to proceed|1|||
145728383|NCT02202551|525523358|FG001|Overall Study|Subject unwilling to proceed|5|||
145728384|NCT02202551|525523359|FG002|Overall Study|Subject unwilling to proceed|3|||
145728385|NCT02202551|525523360|FG003|Overall Study|Subject unwilling to proceed|5|||
145728386|NCT02202551|525523357|FG000|Overall Study|Subject consent withdrawn|0|||
145728387|NCT02202551|525523358|FG001|Overall Study|Subject consent withdrawn|3|||
145728388|NCT02202551|525523359|FG002|Overall Study|Subject consent withdrawn|1|||
145384442|NCT05114564|524261715|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
145384443|NCT05114564|524261716|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
145384444|NCT05114564|524261715|FG000|First Intervention|Adverse Event|0|||
145384445|NCT05114564|524261716|FG001|First Intervention|Adverse Event|1|||
145384446|NCT00493311|524261717|FG000|Overall Study|Need for rescue medication|2|||
145384447|NCT00493311|524261718|FG001|Overall Study|Need for rescue medication|2|||
145384448|NCT02779075|524261719|FG000|Overall Study|Withdrawal by Subject|1|||
145384449|NCT02779075|524261720|FG001|Overall Study|Withdrawal by Subject|3|||
145384450|NCT02779075|524261719|FG000|Overall Study|IV lost during 2nd study|1|||
145384451|NCT02779075|524261720|FG001|Overall Study|IV lost during 2nd study|0|||
145384452|NCT00790556|524261721|FG000|Treatment Period 1|Physician Decision|1|||
145384453|NCT00790556|524261722|FG001|Treatment Period 1|Physician Decision|0|||
145728389|NCT02202551|525523360|FG003|Overall Study|Subject consent withdrawn|2|||
145728390|NCT02202551|525523357|FG000|Overall Study|eGFR<50mL/min/m2|2|||
145728391|NCT02202551|525523358|FG001|Overall Study|eGFR<50mL/min/m2|2|||
145728392|NCT02202551|525523359|FG002|Overall Study|eGFR<50mL/min/m2|0|||
145728393|NCT02202551|525523360|FG003|Overall Study|eGFR<50mL/min/m2|1|||
145728394|NCT02349451|525523361|FG000|Overall Study|Withdrawal by Subject|0|||
145728395|NCT02349451|525523362|FG001|Overall Study|Withdrawal by Subject|1|||
145728396|NCT02349451|525523363|FG002|Overall Study|Withdrawal by Subject|2|||
145728397|NCT02349451|525523364|FG003|Overall Study|Withdrawal by Subject|1|||
145728398|NCT00150969|525523365|FG000|24 Month Main Study|Adverse Event|3|||
145728399|NCT00150969|525523366|FG001|24 Month Main Study|Adverse Event|4|||
145728400|NCT00150969|525523365|FG000|24 Month Main Study|Death|1|||
145728401|NCT00150969|525523366|FG001|24 Month Main Study|Death|1|||
145728402|NCT00150969|525523365|FG000|24 Month Main Study|Lack of Efficacy|1|||
145728403|NCT00150969|525523366|FG001|24 Month Main Study|Lack of Efficacy|8|||
145728404|NCT00150969|525523365|FG000|24 Month Main Study|Lost to Follow-up|3|||
145728405|NCT00150969|525523366|FG001|24 Month Main Study|Lost to Follow-up|2|||
145728406|NCT00150969|525523365|FG000|24 Month Main Study|Protocol Violation|4|||
145728407|NCT00150969|525523366|FG001|24 Month Main Study|Protocol Violation|2|||
145728408|NCT00150969|525523365|FG000|24 Month Main Study|Withdrawal by Subject|7|||
145728409|NCT00150969|525523366|FG001|24 Month Main Study|Withdrawal by Subject|4|||
145728410|NCT00150969|525523365|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
145728411|NCT00150969|525523366|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
145728412|NCT00150969|525523365|FG000|24-48 Month Extension|Lack of Efficacy|0|||
145728413|NCT00150969|525523366|FG001|24-48 Month Extension|Lack of Efficacy|1|||
145728414|NCT00150969|525523365|FG000|24-48 Month Extension|Adverse Event|1|||
145728415|NCT00150969|525523366|FG001|24-48 Month Extension|Adverse Event|3|||
145728416|NCT00150969|525523365|FG000|24-48 Month Extension|Other Reason|81|||
145728417|NCT00150969|525523366|FG001|24-48 Month Extension|Other Reason|91|||
145728418|NCT00146757|525523367|FG000|Overall Study|Death|1|||
145728419|NCT00146757|525523368|FG001|Overall Study|Death|0|||
145728420|NCT00146757|525523367|FG000|Overall Study|Adverse Event|1|||
145728421|NCT00146757|525523368|FG001|Overall Study|Adverse Event|0|||
145728422|NCT02893930|525523382|FG000|Overall Study|Adverse Event|3|||
145728423|NCT02893930|525523382|FG000|Overall Study|Death|1|||
145728424|NCT02893930|525523382|FG000|Overall Study|Disease progression|5|||
145728425|NCT02893930|525523382|FG000|Overall Study|Withdrawal by Subject|2|||
145728426|NCT02893930|525523382|FG000|Overall Study|Physician Decision|1|||
145728427|NCT02893930|525523382|FG000|Overall Study|Ineligible|1|||
145728428|NCT02349360|525523383|FG000|Overall Study|Withdrawal by Subject|0|||
145728429|NCT02349360|525523384|FG001|Overall Study|Withdrawal by Subject|1|||
145728430|NCT01176773|525523385|FG000|Overall Study|Screen Failure|2|||
145728431|NCT01176773|525523385|FG000|Overall Study|Withdrew consent|1|||
145384454|NCT00790556|524261721|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145728432|NCT02446886|525523394|FG000|Overall Study|Adverse Event|1|||
145384455|NCT00790556|524261722|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145728433|NCT02446886|525523395|FG001|Overall Study|Adverse Event|3|||
145728434|NCT02446886|525523394|FG000|Overall Study|Withdrawal by Subject|1|||
145728435|NCT02446886|525523395|FG001|Overall Study|Withdrawal by Subject|1|||
145384456|NCT00255840|524261723|FG000|Overall Study|Lost to Follow-up|10|||
145728436|NCT01498289|525523404|FG000|Overall Study|Adverse Event|16|||
145728437|NCT01498289|525523405|FG001|Overall Study|Adverse Event|18|||
145728438|NCT01498289|525523404|FG000|Overall Study|Death|6|||
145728439|NCT01498289|525523405|FG001|Overall Study|Death|8|||
145728440|NCT01498289|525523404|FG000|Overall Study|Withdrawal unrelated to AE|16|||
145728441|NCT01498289|525523405|FG001|Overall Study|Withdrawal unrelated to AE|16|||
145728442|NCT01498289|525523404|FG000|Overall Study|Progression/relapse|53|||
145728443|NCT01498289|525523405|FG001|Overall Study|Progression/relapse|59|||
145728444|NCT01498289|525523404|FG000|Overall Study|Not protocol specified|7|||
145728445|NCT01498289|525523405|FG001|Overall Study|Not protocol specified|2|||
145728446|NCT01498289|525523404|FG000|Overall Study|Reason under review|0|||
145728447|NCT01498289|525523405|FG001|Overall Study|Reason under review|1|||
145728448|NCT01423253|525523406|FG000|Overall Study|Adverse Event|2|||
145728449|NCT01423253|525523406|FG000|Overall Study|Lack of Efficacy|2|||
145728450|NCT01423253|525523406|FG000|Overall Study|Lost to Follow-up|1|||
145728451|NCT01423253|525523406|FG000|Overall Study|Protocol Violation|2|||
145728452|NCT01423253|525523406|FG000|Overall Study|Withdrawal by Subject|2|||
145728453|NCT00412971|525523410|FG000|Overall Study|Lost to Follow-up|17|||
145728454|NCT00412971|525523411|FG001|Overall Study|Lost to Follow-up|9|||
145728455|NCT00412971|525523410|FG000|Overall Study|Protocol Violation|13|||
145728456|NCT00412971|525523411|FG001|Overall Study|Protocol Violation|1|||
145728457|NCT01290601|525523412|FG000|Overall Study|Adverse Event|0|||
145728458|NCT01290601|525523413|FG001|Overall Study|Adverse Event|2|||
145728459|NCT01290601|525523414|FG002|Overall Study|Adverse Event|0|||
145728460|NCT01290601|525523415|FG003|Overall Study|Adverse Event|0|||
145728461|NCT01290601|525523412|FG000|Overall Study|Lack of Efficacy|2|||
145728462|NCT01290601|525523413|FG001|Overall Study|Lack of Efficacy|1|||
145728463|NCT01290601|525523414|FG002|Overall Study|Lack of Efficacy|0|||
145728464|NCT01290601|525523415|FG003|Overall Study|Lack of Efficacy|0|||
145728465|NCT01290601|525523412|FG000|Overall Study|Lost to Follow-up|7|||
145728466|NCT01290601|525523413|FG001|Overall Study|Lost to Follow-up|2|||
145728467|NCT01290601|525523414|FG002|Overall Study|Lost to Follow-up|0|||
145728468|NCT01290601|525523415|FG003|Overall Study|Lost to Follow-up|0|||
145728469|NCT01290601|525523412|FG000|Overall Study|Other|1|||
145728470|NCT01290601|525523413|FG001|Overall Study|Other|0|||
145728471|NCT01290601|525523414|FG002|Overall Study|Other|0|||
145728472|NCT01290601|525523415|FG003|Overall Study|Other|0|||
145728473|NCT01290601|525523412|FG000|Overall Study|Protocol Violation|1|||
145728474|NCT01290601|525523413|FG001|Overall Study|Protocol Violation|0|||
145728475|NCT01290601|525523414|FG002|Overall Study|Protocol Violation|0|||
145728476|NCT01290601|525523415|FG003|Overall Study|Protocol Violation|0|||
145728477|NCT00775450|525523416|FG000|Overall Study|Serious Adverse Event|2|||
145728478|NCT00775450|525523417|FG001|Overall Study|Serious Adverse Event|0|||
145728479|NCT00775450|525523418|FG002|Overall Study|Serious Adverse Event|0|||
145728480|NCT00775450|525523419|FG003|Overall Study|Serious Adverse Event|0|||
145728481|NCT00775450|525523420|FG004|Overall Study|Serious Adverse Event|0|||
145728482|NCT00775450|525523416|FG000|Overall Study|Protocol Violation|0|||
145728483|NCT00775450|525523417|FG001|Overall Study|Protocol Violation|0|||
145728484|NCT00775450|525523418|FG002|Overall Study|Protocol Violation|0|||
145728485|NCT00775450|525523419|FG003|Overall Study|Protocol Violation|0|||
145728486|NCT00775450|525523420|FG004|Overall Study|Protocol Violation|1|||
145728487|NCT00775450|525523416|FG000|Overall Study|Withdrawal by Subject|1|||
145728488|NCT00775450|525523417|FG001|Overall Study|Withdrawal by Subject|0|||
145728489|NCT00775450|525523418|FG002|Overall Study|Withdrawal by Subject|0|||
145728490|NCT00775450|525523419|FG003|Overall Study|Withdrawal by Subject|0|||
145728491|NCT00775450|525523420|FG004|Overall Study|Withdrawal by Subject|1|||
145728492|NCT01749540|525523428|FG000|Overall Study|Protocol Violation|0|||
145728493|NCT01749540|525523429|FG001|Overall Study|Protocol Violation|0|||
145728494|NCT01749540|525523430|FG002|Overall Study|Protocol Violation|0|||
145728495|NCT01749540|525523431|FG003|Overall Study|Protocol Violation|0|||
145728496|NCT01749540|525523432|FG004|Overall Study|Protocol Violation|0|||
145728497|NCT01749540|525523433|FG005|Overall Study|Protocol Violation|1|||
145728498|NCT01749540|525523434|FG006|Overall Study|Protocol Violation|1|||
145728499|NCT01749540|525523428|FG000|Overall Study|Withdrawal by Subject|0|||
145728500|NCT01749540|525523429|FG001|Overall Study|Withdrawal by Subject|0|||
145728501|NCT01749540|525523430|FG002|Overall Study|Withdrawal by Subject|0|||
145728502|NCT01749540|525523431|FG003|Overall Study|Withdrawal by Subject|1|||
145728503|NCT01749540|525523432|FG004|Overall Study|Withdrawal by Subject|0|||
145728504|NCT01749540|525523433|FG005|Overall Study|Withdrawal by Subject|0|||
145728505|NCT01749540|525523434|FG006|Overall Study|Withdrawal by Subject|0|||
145728506|NCT01749540|525523428|FG000|Overall Study|Initiated into extension study A536-06|0|||
145728507|NCT01749540|525523429|FG001|Overall Study|Initiated into extension study A536-06|0|||
145728508|NCT01749540|525523430|FG002|Overall Study|Initiated into extension study A536-06|0|||
145728509|NCT01749540|525523431|FG003|Overall Study|Initiated into extension study A536-06|0|||
145728510|NCT01749540|525523432|FG004|Overall Study|Initiated into extension study A536-06|0|||
145728511|NCT01749540|525523433|FG005|Overall Study|Initiated into extension study A536-06|2|||
145728512|NCT01749540|525523434|FG006|Overall Study|Initiated into extension study A536-06|24|||
145728513|NCT00894686|525523435|FG000|Overall Study|Withdrawal by Subject|50|||
145728514|NCT00894686|525523435|FG000|Overall Study|Physician Decision|1|||
145728515|NCT00894686|525523435|FG000|Overall Study|Other|5|||
145728516|NCT00564018|525523436|FG000|Overall Study|Withdrawal by Subject|2|||
145728517|NCT00564018|525523437|FG001|Overall Study|Withdrawal by Subject|3|||
145728518|NCT00564018|525523438|FG002|Overall Study|Withdrawal by Subject|1|||
145728519|NCT00986440|525523439|FG000|Overall Study|Progressive disease|27|||
145728520|NCT00986440|525523440|FG001|Overall Study|Progressive disease|37|||
145728521|NCT00986440|525523439|FG000|Overall Study|Serious adverse event or adverse event|9|||
145728522|NCT00986440|525523440|FG001|Overall Study|Serious adverse event or adverse event|2|||
145728523|NCT00986440|525523439|FG000|Overall Study|Withdrawal by Subject|1|||
145728524|NCT00986440|525523440|FG001|Overall Study|Withdrawal by Subject|2|||
145728525|NCT00986440|525523439|FG000|Overall Study|Screen failure (not dosed)|4|||
145728526|NCT00986440|525523440|FG001|Overall Study|Screen failure (not dosed)|2|||
145728527|NCT05056987|525523443|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
145728528|NCT05056987|525523444|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
145728529|NCT05056987|525523443|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
145728530|NCT05056987|525523444|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
145728531|NCT02409368|525523445|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
145728532|NCT02409368|525523446|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
145728533|NCT02409368|525523447|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
145728534|NCT02409368|525523448|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
145728535|NCT02409368|525523445|FG000|ECOG Reclassification|Death|1|||
145728536|NCT02409368|525523446|FG001|ECOG Reclassification|Death|5|||
145728537|NCT02409368|525523447|FG002|ECOG Reclassification|Death|0|||
145728538|NCT02409368|525523448|FG003|ECOG Reclassification|Death|0|||
145728539|NCT02409368|525523445|FG000|ECOG Reclassification|Disease Progression|113|||
145728540|NCT02409368|525523446|FG001|ECOG Reclassification|Disease Progression|382|||
145728541|NCT02409368|525523447|FG002|ECOG Reclassification|Disease Progression|70|||
145728542|NCT02409368|525523448|FG003|ECOG Reclassification|Disease Progression|1|||
145728543|NCT02409368|525523445|FG000|ECOG Reclassification|Lost to Follow-up|1|||
145728544|NCT02409368|525523446|FG001|ECOG Reclassification|Lost to Follow-up|5|||
145728545|NCT02409368|525523447|FG002|ECOG Reclassification|Lost to Follow-up|0|||
145728546|NCT02409368|525523448|FG003|ECOG Reclassification|Lost to Follow-up|0|||
145728547|NCT02409368|525523445|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
145728548|NCT02409368|525523446|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
145728549|NCT02409368|525523447|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
145728550|NCT02409368|525523448|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
145728551|NCT02409368|525523445|FG000|ECOG Reclassification|Poor/non-compliance|0|||
145728552|NCT02409368|525523446|FG001|ECOG Reclassification|Poor/non-compliance|3|||
145728553|NCT02409368|525523447|FG002|ECOG Reclassification|Poor/non-compliance|2|||
145728554|NCT02409368|525523448|FG003|ECOG Reclassification|Poor/non-compliance|0|||
145384457|NCT00255840|524261724|FG001|Overall Study|Lost to Follow-up|14|||
145384458|NCT00255840|524261723|FG000|Overall Study|Discontinued intervention|53|||
145384459|NCT00255840|524261724|FG001|Overall Study|Discontinued intervention|56|||
145384460|NCT00339833|524261727|FG000|Overall Study|Withdrawal by Subject|1|||
145384461|NCT00339833|524261728|FG001|Overall Study|Withdrawal by Subject|2|||
145384462|NCT00339833|524261727|FG000|Overall Study|toothache|0|||
145384463|NCT00339833|524261728|FG001|Overall Study|toothache|1|||
145384464|NCT00339833|524261727|FG000|Overall Study|indigestion|0|||
145384465|NCT00339833|524261728|FG001|Overall Study|indigestion|1|||
145384466|NCT00339833|524261727|FG000|Overall Study|Chest pain|0|||
145384467|NCT00339833|524261728|FG001|Overall Study|Chest pain|1|||
145384468|NCT00339833|524261727|FG000|Overall Study|minor infection|0|||
145384469|NCT00339833|524261728|FG001|Overall Study|minor infection|1|||
145384470|NCT00339833|524261727|FG000|Overall Study|Poor venous access|2|||
145384471|NCT00339833|524261728|FG001|Overall Study|Poor venous access|2|||
145384472|NCT00339833|524261727|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
145384473|NCT00339833|524261728|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
145384474|NCT00339833|524261727|FG000|Overall Study|Error in data records|1|||
145384475|NCT00339833|524261728|FG001|Overall Study|Error in data records|0|||
145384476|NCT00217581|524261729|FG000|Overall Study|Withdrawal by Subject|1|||
145384477|NCT02829047|524261730|FG000|Overall Study|Withdrawal by Subject|1|||
145384478|NCT01597492|524261731|FG000|Overall Study|Withdrawal by Subject|1|||
145384479|NCT01597492|524261732|FG001|Overall Study|Withdrawal by Subject|2|||
145384480|NCT01597492|524261731|FG000|Overall Study|Adverse Event|3|||
145384481|NCT01597492|524261732|FG001|Overall Study|Adverse Event|0|||
145384482|NCT01597492|524261731|FG000|Overall Study|Lost to Follow-up|0|||
145384483|NCT01597492|524261732|FG001|Overall Study|Lost to Follow-up|2|||
145384484|NCT01597492|524261731|FG000|Overall Study|Other Reason|2|||
145384485|NCT01597492|524261732|FG001|Overall Study|Other Reason|0|||
145384486|NCT00496587|524261733|FG000|Overall Study|Adverse Event|2|||
145384487|NCT00496587|524261733|FG000|Overall Study|Progressive Disease|24|||
145728555|NCT02409368|525523445|FG000|ECOG Reclassification|Study drug toxicity|17|||
145728556|NCT02409368|525523446|FG001|ECOG Reclassification|Study drug toxicity|42|||
145728557|NCT02409368|525523447|FG002|ECOG Reclassification|Study drug toxicity|7|||
145728558|NCT02409368|525523448|FG003|ECOG Reclassification|Study drug toxicity|0|||
145728559|NCT02409368|525523445|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
145728560|NCT02409368|525523446|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
145728561|NCT02409368|525523447|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
145728562|NCT02409368|525523448|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
145384488|NCT00496587|524261733|FG000|Overall Study|Withdrawal by Subject|2|||
145384489|NCT00496587|524261733|FG000|Overall Study|Death|1|||
145384490|NCT00496587|524261733|FG000|Overall Study|Complications unrelated|2|||
145384491|NCT05259917|524261738|FG000|Overall Study|Protocol Violation|0|||
145384492|NCT05259917|524261739|FG001|Overall Study|Protocol Violation|0|||
145384493|NCT05259917|524261740|FG002|Overall Study|Protocol Violation|1|||
145384494|NCT05259917|524261741|FG003|Overall Study|Protocol Violation|0|||
145384495|NCT05259917|524261742|FG004|Overall Study|Protocol Violation|0|||
145384496|NCT05259917|524261743|FG005|Overall Study|Protocol Violation|0|||
145384497|NCT05259917|524261738|FG000|Overall Study|Lost to Follow-up|0|||
145384498|NCT05259917|524261739|FG001|Overall Study|Lost to Follow-up|0|||
145384499|NCT05259917|524261740|FG002|Overall Study|Lost to Follow-up|1|||
145384500|NCT05259917|524261741|FG003|Overall Study|Lost to Follow-up|0|||
145384501|NCT05259917|524261742|FG004|Overall Study|Lost to Follow-up|0|||
145384502|NCT05259917|524261743|FG005|Overall Study|Lost to Follow-up|1|||
145384503|NCT05259917|524261738|FG000|Overall Study|Physician Decision|0|||
145384504|NCT05259917|524261739|FG001|Overall Study|Physician Decision|1|||
145384505|NCT05259917|524261740|FG002|Overall Study|Physician Decision|0|||
145384506|NCT05259917|524261741|FG003|Overall Study|Physician Decision|0|||
145384507|NCT05259917|524261742|FG004|Overall Study|Physician Decision|0|||
145384508|NCT05259917|524261743|FG005|Overall Study|Physician Decision|0|||
145384509|NCT05259917|524261738|FG000|Overall Study|Withdrawal by Subject|0|||
145384510|NCT05259917|524261739|FG001|Overall Study|Withdrawal by Subject|1|||
145384511|NCT05259917|524261740|FG002|Overall Study|Withdrawal by Subject|0|||
145384512|NCT05259917|524261741|FG003|Overall Study|Withdrawal by Subject|0|||
145384513|NCT05259917|524261742|FG004|Overall Study|Withdrawal by Subject|1|||
145384514|NCT05259917|524261743|FG005|Overall Study|Withdrawal by Subject|1|||
145384515|NCT05259917|524261738|FG000|Overall Study|Trial Termination by Sponsor|7|||
145384516|NCT05259917|524261739|FG001|Overall Study|Trial Termination by Sponsor|2|||
145384517|NCT05259917|524261740|FG002|Overall Study|Trial Termination by Sponsor|3|||
145384518|NCT05259917|524261741|FG003|Overall Study|Trial Termination by Sponsor|5|||
145384519|NCT05259917|524261742|FG004|Overall Study|Trial Termination by Sponsor|11|||
145384520|NCT05259917|524261743|FG005|Overall Study|Trial Termination by Sponsor|4|||
145384521|NCT05259917|524261738|FG000|Overall Study|Other|1|||
145384522|NCT05259917|524261739|FG001|Overall Study|Other|0|||
145384523|NCT05259917|524261740|FG002|Overall Study|Other|2|||
145384524|NCT05259917|524261741|FG003|Overall Study|Other|0|||
145384525|NCT05259917|524261742|FG004|Overall Study|Other|0|||
145384526|NCT05259917|524261743|FG005|Overall Study|Other|0|||
145384527|NCT00592592|524261744|FG000|Overall Study|Patient found ineligible upon chart review|1|||
145728563|NCT02409368|525523445|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
145728564|NCT02409368|525523446|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
145728565|NCT02409368|525523447|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
145728566|NCT02409368|525523448|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
145728567|NCT02409368|525523445|FG000|ECOG Reclassification|Participant withdrew consent|2|||
145728568|NCT02409368|525523446|FG001|ECOG Reclassification|Participant withdrew consent|3|||
145728569|NCT02409368|525523447|FG002|ECOG Reclassification|Participant withdrew consent|4|||
145728570|NCT02409368|525523448|FG003|ECOG Reclassification|Participant withdrew consent|0|||
145728571|NCT02409368|525523445|FG000|ECOG Reclassification|Other Reasons|5|||
145728572|NCT02409368|525523446|FG001|ECOG Reclassification|Other Reasons|26|||
145728573|NCT02409368|525523447|FG002|ECOG Reclassification|Other Reasons|2|||
145728574|NCT02409368|525523448|FG003|ECOG Reclassification|Other Reasons|0|||
145728575|NCT02409368|525523445|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
145728576|NCT02409368|525523446|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
145728577|NCT02409368|525523447|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
145728578|NCT02409368|525523448|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
145728579|NCT01296347|525523449|FG000|Allocation|Withdrawal by Subject|1|||
145728580|NCT01296347|525523450|FG001|Allocation|Withdrawal by Subject|2|||
145728581|NCT01296347|525523449|FG000|Allocation|Lack of Efficacy|1|||
145728582|NCT01296347|525523450|FG001|Allocation|Lack of Efficacy|2|||
145728583|NCT01296347|525523449|FG000|Allocation|not received infusion|1|||
145728584|NCT01296347|525523450|FG001|Allocation|not received infusion|0|||
145728585|NCT01296347|525523449|FG000|6 Week Follow up|Death|0|||
145728586|NCT01296347|525523450|FG001|6 Week Follow up|Death|1|||
145728587|NCT01296347|525523449|FG000|3 Month Follow up|Death|1|||
145728588|NCT01296347|525523450|FG001|3 Month Follow up|Death|0|||
145728589|NCT01296347|525523449|FG000|3 Month Follow up|Lost to Follow-up|0|||
145728590|NCT01296347|525523450|FG001|3 Month Follow up|Lost to Follow-up|1|||
145728591|NCT01296347|525523449|FG000|6 Month Follow up|Death|2|||
145728592|NCT01296347|525523450|FG001|6 Month Follow up|Death|1|||
145728593|NCT01296347|525523449|FG000|6 Month Follow up|Lost to Follow-up|0|||
145728594|NCT01296347|525523450|FG001|6 Month Follow up|Lost to Follow-up|1|||
145728595|NCT01296347|525523449|FG000|12 Month Follow up|Lost to Follow-up|3|||
145728596|NCT01296347|525523450|FG001|12 Month Follow up|Lost to Follow-up|1|||
145384528|NCT01557517|524261745|FG000|Overall Study|Death|1|||
145728597|NCT01296347|525523449|FG000|12 Month Follow up|Death|1|||
145728598|NCT01296347|525523450|FG001|12 Month Follow up|Death|1|||
145384529|NCT01557517|524261746|FG001|Overall Study|Death|0|||
145384530|NCT01557517|524261745|FG000|Overall Study|Refused further treatment|0|||
145384531|NCT01557517|524261746|FG001|Overall Study|Refused further treatment|2|||
145728599|NCT01296347|525523449|FG000|12 Month Follow up|Withdrawal by Subject|0|||
145728600|NCT01296347|525523450|FG001|12 Month Follow up|Withdrawal by Subject|1|||
145728601|NCT02240693|525523451|FG000|Overall Study|Adverse Event|0|||
145728602|NCT02240693|525523452|FG001|Overall Study|Adverse Event|0|||
145728603|NCT02240693|525523453|FG002|Overall Study|Adverse Event|0|||
145728604|NCT02240693|525523454|FG003|Overall Study|Adverse Event|0|||
145728605|NCT02240693|525523455|FG004|Overall Study|Adverse Event|1|||
145728606|NCT02240693|525523451|FG000|Overall Study|Withdrawal by Subject|0|||
145728607|NCT02240693|525523452|FG001|Overall Study|Withdrawal by Subject|0|||
145728608|NCT02240693|525523453|FG002|Overall Study|Withdrawal by Subject|2|||
145728609|NCT02240693|525523454|FG003|Overall Study|Withdrawal by Subject|1|||
145728610|NCT02240693|525523455|FG004|Overall Study|Withdrawal by Subject|0|||
145728611|NCT02240693|525523451|FG000|Overall Study|Other than specified|0|||
145728612|NCT02240693|525523452|FG001|Overall Study|Other than specified|0|||
145728613|NCT02240693|525523453|FG002|Overall Study|Other than specified|2|||
145384532|NCT01557517|524261745|FG000|Overall Study|Adverse Event|0|||
145728614|NCT02240693|525523454|FG003|Overall Study|Other than specified|0|||
145728615|NCT02240693|525523455|FG004|Overall Study|Other than specified|0|||
145728616|NCT01948908|525523456|FG000|Overall Study|Protocol Violation|1|||
145728617|NCT01948908|525523457|FG001|Overall Study|Protocol Violation|0|||
145728618|NCT01948908|525523458|FG002|Overall Study|Protocol Violation|2|||
145728619|NCT02041520|525523460|FG000|Overall Study|Adverse Event|2|||
145728620|NCT02041520|525523461|FG001|Overall Study|Adverse Event|1|||
145728621|NCT02041520|525523460|FG000|Overall Study|Withdrawal by Subject|3|||
145728622|NCT02041520|525523461|FG001|Overall Study|Withdrawal by Subject|4|||
145728623|NCT02041520|525523460|FG000|Overall Study|Protocol Violation|1|||
145728624|NCT02041520|525523461|FG001|Overall Study|Protocol Violation|0|||
145728625|NCT02041520|525523460|FG000|Overall Study|Lost to Follow-up|0|||
145728626|NCT02041520|525523461|FG001|Overall Study|Lost to Follow-up|1|||
145728627|NCT02041520|525523460|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
145728628|NCT02041520|525523461|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
145728629|NCT02678247|525523464|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
145728630|NCT02678247|525523465|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
145728631|NCT02678247|525523464|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
145728632|NCT02678247|525523465|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
145728633|NCT02678247|525523464|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
145728634|NCT02678247|525523465|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
145728635|NCT02678247|525523464|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
145728636|NCT02678247|525523465|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
145728637|NCT02678247|525523464|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
145728638|NCT02678247|525523465|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
145728639|NCT02678247|525523464|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
145728640|NCT02678247|525523465|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
145728641|NCT02225353|525523466|FG000|Overall Study|Lost to Follow-up|0|||
145728642|NCT02225353|525523467|FG001|Overall Study|Lost to Follow-up|1|||
145728643|NCT02225353|525523468|FG002|Overall Study|Lost to Follow-up|3|||
145728644|NCT02225353|525523466|FG000|Overall Study|Protocol Violation|4|||
145728645|NCT02225353|525523467|FG001|Overall Study|Protocol Violation|5|||
145728646|NCT02225353|525523468|FG002|Overall Study|Protocol Violation|12|||
145728647|NCT02910739|525523469|FG000|Overall Study|Adverse Event|1|||
145728648|NCT02910739|525523470|FG001|Overall Study|Adverse Event|0|||
145728649|NCT02910739|525523471|FG002|Overall Study|Adverse Event|0|||
145728650|NCT02910739|525523472|FG003|Overall Study|Adverse Event|0|||
145728651|NCT05677893|525525046|FG000|Overall Study|Withdrawal by Subject|0|||
145728652|NCT05677893|525525047|FG001|Overall Study|Withdrawal by Subject|0|||
145728653|NCT05677893|525525048|FG002|Overall Study|Withdrawal by Subject|0|||
145728654|NCT05677893|525525049|FG003|Overall Study|Withdrawal by Subject|0|||
145728655|NCT05677893|525525050|FG004|Overall Study|Withdrawal by Subject|1|||
145728656|NCT05677893|525525051|FG005|Overall Study|Withdrawal by Subject|1|||
145728657|NCT05677893|525525052|FG006|Overall Study|Withdrawal by Subject|0|||
145728658|NCT05677893|525525046|FG000|Overall Study|Others|1|||
145728659|NCT05677893|525525047|FG001|Overall Study|Others|0|||
145728660|NCT05677893|525525048|FG002|Overall Study|Others|0|||
145728661|NCT05677893|525525049|FG003|Overall Study|Others|0|||
145728662|NCT05677893|525525050|FG004|Overall Study|Others|0|||
145728663|NCT05677893|525525051|FG005|Overall Study|Others|0|||
145728664|NCT05677893|525525052|FG006|Overall Study|Others|0|||
145728665|NCT03217266|525525053|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
145728666|NCT03217266|525525054|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
145728667|NCT03217266|525525055|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
145728668|NCT03217266|525525056|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
145728669|NCT03217266|525525053|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
145728670|NCT03217266|525525054|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
145728671|NCT03217266|525525055|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
145728672|NCT03217266|525525056|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
145728673|NCT03217266|525525053|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
145728674|NCT03217266|525525054|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
145384533|NCT01557517|524261746|FG001|Overall Study|Adverse Event|2|||
145728675|NCT03217266|525525055|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
145728676|NCT03217266|525525056|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
145728677|NCT02101034|525525057|FG000|Overall Study|Enrolled but did not start treatment|0|||
145728678|NCT02101034|525525058|FG001|Overall Study|Enrolled but did not start treatment|0|||
145728679|NCT02101034|525525059|FG002|Overall Study|Enrolled but did not start treatment|1|||
145728680|NCT02101034|525525060|FG003|Overall Study|Enrolled but did not start treatment|0|||
145728681|NCT02101034|525525061|FG004|Overall Study|Enrolled but did not start treatment|0|||
145728682|NCT01390181|525525062|FG000|Overall Study|Lost to Follow-up|1|||
145728683|NCT01390181|525525062|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
145728684|NCT01101477|525525073|FG000|Overall Study|Protocol Violation|5|||
145728685|NCT01101477|525525074|FG001|Overall Study|Protocol Violation|3|||
145728686|NCT01101477|525525075|FG002|Overall Study|Protocol Violation|1|||
145728687|NCT00146328|525525077|FG000|Overall Study|Adverse Event|39|||
145728688|NCT00146328|525525078|FG001|Overall Study|Adverse Event|48|||
145728689|NCT00146328|525525079|FG002|Overall Study|Adverse Event|79|||
145728690|NCT00146328|525525077|FG000|Overall Study|Protocol Violation|11|||
145728691|NCT00146328|525525078|FG001|Overall Study|Protocol Violation|6|||
145728692|NCT00146328|525525079|FG002|Overall Study|Protocol Violation|12|||
145728693|NCT00146328|525525077|FG000|Overall Study|Lost to Follow-up|7|||
145728694|NCT00146328|525525078|FG001|Overall Study|Lost to Follow-up|4|||
145728695|NCT00146328|525525079|FG002|Overall Study|Lost to Follow-up|7|||
145728696|NCT00146328|525525077|FG000|Overall Study|Withdrawal by Subject|16|||
145728697|NCT00146328|525525078|FG001|Overall Study|Withdrawal by Subject|16|||
145728698|NCT00146328|525525079|FG002|Overall Study|Withdrawal by Subject|22|||
145728699|NCT00146328|525525077|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
145728700|NCT00146328|525525078|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
145728701|NCT00146328|525525079|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
145728702|NCT00146328|525525077|FG000|Overall Study|Trial ended/site closed|8|||
145728703|NCT00146328|525525078|FG001|Overall Study|Trial ended/site closed|2|||
145728704|NCT00146328|525525079|FG002|Overall Study|Trial ended/site closed|19|||
145728705|NCT00146328|525525077|FG000|Overall Study|Patient decision to end|0|||
145728706|NCT00146328|525525078|FG001|Overall Study|Patient decision to end|1|||
145728707|NCT00146328|525525079|FG002|Overall Study|Patient decision to end|6|||
145728708|NCT00146328|525525077|FG000|Overall Study|Enroll into other trial|2|||
145728709|NCT00146328|525525078|FG001|Overall Study|Enroll into other trial|4|||
145728710|NCT00146328|525525079|FG002|Overall Study|Enroll into other trial|2|||
145728711|NCT00146328|525525077|FG000|Overall Study|Death|0|||
145728712|NCT00146328|525525078|FG001|Overall Study|Death|1|||
145728713|NCT00146328|525525079|FG002|Overall Study|Death|1|||
145728714|NCT00146328|525525077|FG000|Overall Study|Moved|2|||
145728715|NCT00146328|525525078|FG001|Overall Study|Moved|0|||
145728716|NCT00146328|525525079|FG002|Overall Study|Moved|0|||
145728717|NCT00146328|525525077|FG000|Overall Study|Interaction with other medication|2|||
145728718|NCT00146328|525525078|FG001|Overall Study|Interaction with other medication|0|||
145728719|NCT00146328|525525079|FG002|Overall Study|Interaction with other medication|1|||
145728720|NCT00792805|525525080|FG000|Overall Study|Adverse Event|12|||
145728721|NCT00792805|525525081|FG001|Overall Study|Adverse Event|10|||
145728722|NCT00792805|525525082|FG002|Overall Study|Adverse Event|10|||
145728723|NCT00792805|525525080|FG000|Overall Study|Subject withdrew consent|5|||
145728724|NCT00792805|525525081|FG001|Overall Study|Subject withdrew consent|6|||
145728725|NCT00792805|525525082|FG002|Overall Study|Subject withdrew consent|5|||
145728726|NCT00792805|525525080|FG000|Overall Study|Administrative problems|2|||
145728727|NCT00792805|525525081|FG001|Overall Study|Administrative problems|0|||
145728728|NCT00792805|525525082|FG002|Overall Study|Administrative problems|4|||
145728729|NCT00792805|525525080|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145728730|NCT00792805|525525081|FG001|Overall Study|Abnormal test procedure result(s)|2|||
145728731|NCT00792805|525525082|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145728732|NCT00792805|525525080|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145728733|NCT00792805|525525081|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
145728734|NCT00792805|525525082|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
145728735|NCT00792805|525525080|FG000|Overall Study|Lost to Follow-up|1|||
145728736|NCT00792805|525525081|FG001|Overall Study|Lost to Follow-up|1|||
145728737|NCT00792805|525525082|FG002|Overall Study|Lost to Follow-up|6|||
145728738|NCT00792805|525525080|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145728739|NCT00792805|525525081|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145728740|NCT00792805|525525082|FG002|Overall Study|Abnormal laboratory value(s)|1|||
145728741|NCT00792805|525525080|FG000|Overall Study|Protocol deviation|0|||
145728742|NCT00792805|525525081|FG001|Overall Study|Protocol deviation|1|||
145728743|NCT00792805|525525082|FG002|Overall Study|Protocol deviation|1|||
145728744|NCT02952001|525525086|FG000|Overall Study|Adverse Event|3|||
145728745|NCT02952001|525525087|FG001|Overall Study|Adverse Event|0|||
145728746|NCT02952001|525525086|FG000|Overall Study|Prohibited therapy|10|||
145728747|NCT02952001|525525087|FG001|Overall Study|Prohibited therapy|3|||
145728748|NCT02952001|525525086|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
145728749|NCT02952001|525525087|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
145728750|NCT02276872|525525092|FG000|Overall Study|Adverse Event|1|||
145728751|NCT02276872|525525093|FG001|Overall Study|Adverse Event|0|||
145728752|NCT02276872|525525094|FG002|Overall Study|Adverse Event|0|||
145728753|NCT04356183|525525096|FG000|Overall Study|Lost to Follow-up|1|||
145728754|NCT04356183|525525097|FG001|Overall Study|Lost to Follow-up|0|||
145728755|NCT04356183|525525096|FG000|Overall Study|Withdrawal by Subject|1|||
145384534|NCT01557517|524261745|FG000|Overall Study|Pt declined before treatment started|1|||
145384535|NCT01557517|524261746|FG001|Overall Study|Pt declined before treatment started|0|||
145384536|NCT00162097|524261747|FG000|Overall Study|Participant no longer met study criteria|0|||
145384537|NCT00162097|524261748|FG001|Overall Study|Participant no longer met study criteria|0|||
145384538|NCT00162097|524261749|FG002|Overall Study|Participant no longer met study criteria|0|||
145384539|NCT00162097|524261750|FG003|Overall Study|Participant no longer met study criteria|1|||
145384540|NCT01204918|524261751|FG000|Overall Study|Withdrawal by Subject|4|||
145384541|NCT01204918|524261752|FG001|Overall Study|Withdrawal by Subject|10|||
145384542|NCT01204918|524261753|FG002|Overall Study|Withdrawal by Subject|5|||
145384543|NCT03585712|524261754|FG000|Treatment Period 1|Protocol Violation|1|||
145384544|NCT03585712|524261755|FG001|Treatment Period 1|Protocol Violation|0|||
145384545|NCT03585712|524261756|FG002|Treatment Period 1|Protocol Violation|0|||
145384546|NCT03585712|524261754|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
145384547|NCT03585712|524261755|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
145384548|NCT03585712|524261756|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
145384549|NCT03585712|524261754|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
145384550|NCT03585712|524261755|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
145384551|NCT03585712|524261756|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
145384552|NCT03585712|524261754|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
145384553|NCT03585712|524261755|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
145384554|NCT03585712|524261756|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
145384555|NCT01280682|524261759|FG000|Overall Study|Lost to Follow-up|0|||
145384556|NCT01280682|524261760|FG001|Overall Study|Lost to Follow-up|6|||
145384557|NCT01280682|524261759|FG000|Overall Study|Withdrawal by Subject|0|||
145384558|NCT01280682|524261760|FG001|Overall Study|Withdrawal by Subject|7|||
145384559|NCT00849290|524261761|FG000|Overall Study|Adverse Event|3|||
145384560|NCT00849290|524261761|FG000|Overall Study|Death|14|||
145384561|NCT00849290|524261761|FG000|Overall Study|Withdrawal by Subject|11|||
145384562|NCT00849290|524261761|FG000|Overall Study|Lost to Follow-up|2|||
145384563|NCT00849290|524261761|FG000|Overall Study|Protocol Violation|5|||
145384564|NCT00849290|524261761|FG000|Overall Study|Disease Progression|20|||
145384565|NCT02007278|524261762|FG000|Overall Study|Failure to comply with an eligibility|0|||
145384566|NCT02007278|524261763|FG001|Overall Study|Failure to comply with an eligibility|1|||
145384567|NCT02007278|524261762|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
145384568|NCT02007278|524261763|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
145384569|NCT02007278|524261762|FG000|Overall Study|Incorrect medication administration|1|||
145384570|NCT02007278|524261763|FG001|Overall Study|Incorrect medication administration|0|||
145384571|NCT02007278|524261762|FG000|Overall Study|Mis-randomization|1|||
145384572|NCT02007278|524261763|FG001|Overall Study|Mis-randomization|1|||
145384573|NCT03230838|524261769|FG000|Overall Study|Withdrawal by Subject|3|||
145384574|NCT03230838|524261770|FG001|Overall Study|Withdrawal by Subject|0|||
145384575|NCT03230838|524261769|FG000|Overall Study|Temperature excursion|1|||
145384576|NCT03230838|524261770|FG001|Overall Study|Temperature excursion|0|||
145384577|NCT01915771|524261771|FG000|Day 1|Withdrawal by Subject|1|||
145384578|NCT01915771|524261771|FG000|Day 15|Withdrawal by Subject|1|||
145384579|NCT03420222|524261774|FG000|Overall Study|Withdrawal by Subject|5|||
145384580|NCT03420222|524261775|FG001|Overall Study|Withdrawal by Subject|0|||
145384581|NCT03420222|524261774|FG000|Overall Study|Physician Decision|0|||
145384582|NCT03420222|524261775|FG001|Overall Study|Physician Decision|1|||
145384583|NCT02334384|524261776|FG000|Overall Study|Lost to Follow-up|1|||
145384584|NCT02334384|524261777|FG001|Overall Study|Lost to Follow-up|1|||
145384585|NCT00625183|524261778|FG000|Overall Study|Disease Progression|1|||
145384586|NCT02279745|524261779|FG000|Overall Study|Adverse Event|7|||
145384587|NCT02279745|524261779|FG000|Overall Study|Death|6|||
145384588|NCT02279745|524261779|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
145384589|NCT02279745|524261779|FG000|Overall Study|Withdrawal by Subject|2|||
145384590|NCT02279745|524261779|FG000|Overall Study|Pregnancy|1|||
145384591|NCT02279745|524261779|FG000|Overall Study|Study Non-compliance|1|||
145384592|NCT02279745|524261779|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
145384593|NCT02670382|524261783|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
145384594|NCT02670382|524261784|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
145384595|NCT03244618|524261787|FG000|Overall Study|Lost to Follow-up|3|||
145728756|NCT04356183|525525097|FG001|Overall Study|Withdrawal by Subject|1|||
145728757|NCT00402363|525525098|FG000|Overall Study|Adverse Event|9|||
145384596|NCT03244618|524261788|FG001|Overall Study|Lost to Follow-up|4|||
145728758|NCT00402363|525525099|FG001|Overall Study|Adverse Event|14|||
145384597|NCT03244618|524261787|FG000|Overall Study|Protocol Violation|4|||
145384598|NCT03244618|524261788|FG001|Overall Study|Protocol Violation|3|||
145728759|NCT00402363|525525100|FG002|Overall Study|Adverse Event|2|||
145728760|NCT00402363|525525101|FG003|Overall Study|Adverse Event|2|||
145728761|NCT00402363|525525098|FG000|Overall Study|Withdrew Consent|10|||
145384599|NCT03244618|524261787|FG000|Overall Study|Withdrawal by Subject|0|||
145384600|NCT03244618|524261788|FG001|Overall Study|Withdrawal by Subject|2|||
145384601|NCT04424914|524261792|FG000|Overall Study|Other|0|||
145384602|NCT04424914|524261793|FG001|Overall Study|Other|0|||
145384603|NCT04424914|524261794|FG002|Overall Study|Other|28|||
145384604|NCT04424914|524261792|FG000|Overall Study|Withdrawal by Subject|3|||
145384605|NCT04424914|524261793|FG001|Overall Study|Withdrawal by Subject|0|||
145384606|NCT04424914|524261794|FG002|Overall Study|Withdrawal by Subject|0|||
145384607|NCT04424914|524261792|FG000|Overall Study|Study terminated by sponsor|23|||
145384608|NCT04424914|524261793|FG001|Overall Study|Study terminated by sponsor|7|||
145384609|NCT04424914|524261794|FG002|Overall Study|Study terminated by sponsor|0|||
145384610|NCT04424914|524261792|FG000|Overall Study|Lost to Follow-up|0|||
145384611|NCT04424914|524261793|FG001|Overall Study|Lost to Follow-up|0|||
145384612|NCT04424914|524261794|FG002|Overall Study|Lost to Follow-up|1|||
145384613|NCT04424914|524261792|FG000|Overall Study|Death|3|||
145384614|NCT04424914|524261793|FG001|Overall Study|Death|1|||
145384615|NCT04424914|524261794|FG002|Overall Study|Death|0|||
145384616|NCT01156051|524261801|FG000|Overall Study|Lost to Follow-up|1|||
145384617|NCT01156051|524261802|FG001|Overall Study|Lost to Follow-up|0|||
145384618|NCT01156051|524261801|FG000|Overall Study|patient not compliant with protocol|0|||
145384619|NCT01156051|524261802|FG001|Overall Study|patient not compliant with protocol|1|||
145384620|NCT00793546|524261805|FG000|Overall Study|Death|3|||
145384621|NCT00793546|524261806|FG001|Overall Study|Death|0|||
145384622|NCT00793546|524261805|FG000|Overall Study|Lost to Follow-up|1|||
145384623|NCT00793546|524261806|FG001|Overall Study|Lost to Follow-up|0|||
145384624|NCT00793546|524261805|FG000|Overall Study|Withdrawal by Subject|1|||
145384625|NCT00793546|524261806|FG001|Overall Study|Withdrawal by Subject|1|||
145384626|NCT00793546|524261805|FG000|Overall Study|Study Terminated by Sponsor|8|||
145384627|NCT00793546|524261806|FG001|Overall Study|Study Terminated by Sponsor|27|||
145384628|NCT00793546|524261805|FG000|Overall Study|Other|1|||
145384629|NCT00793546|524261806|FG001|Overall Study|Other|0|||
145384630|NCT00350779|524261807|FG000|Overall Study|Adverse Event|4|||
145384631|NCT00350779|524261808|FG001|Overall Study|Adverse Event|2|||
145384632|NCT00350779|524261807|FG000|Overall Study|Lack of Efficacy|0|||
145384633|NCT00350779|524261808|FG001|Overall Study|Lack of Efficacy|4|||
145384634|NCT00350779|524261807|FG000|Overall Study|Lost to Follow-up|2|||
145384635|NCT00350779|524261808|FG001|Overall Study|Lost to Follow-up|0|||
145384636|NCT00350779|524261807|FG000|Overall Study|Physician Decision|2|||
145384637|NCT00350779|524261808|FG001|Overall Study|Physician Decision|4|||
145384638|NCT00350779|524261807|FG000|Overall Study|Protocol Violation|3|||
145384639|NCT00350779|524261808|FG001|Overall Study|Protocol Violation|1|||
145384640|NCT00350779|524261807|FG000|Overall Study|Withdrawal by Subject|9|||
145384641|NCT00350779|524261808|FG001|Overall Study|Withdrawal by Subject|8|||
145384642|NCT00350779|524261807|FG000|Overall Study|Patient Moved|2|||
145384643|NCT00350779|524261808|FG001|Overall Study|Patient Moved|1|||
145384644|NCT00350779|524261807|FG000|Overall Study|Non-compliance with study procedures|0|||
145384645|NCT00350779|524261808|FG001|Overall Study|Non-compliance with study procedures|1|||
145384646|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
145384647|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384648|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384649|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384650|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384651|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384652|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384653|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384654|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
145384655|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145384656|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
145384657|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
145384658|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
145384659|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145384660|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
145728762|NCT00402363|525525099|FG001|Overall Study|Withdrew Consent|5|||
145728763|NCT00402363|525525100|FG002|Overall Study|Withdrew Consent|2|||
145728764|NCT00402363|525525101|FG003|Overall Study|Withdrew Consent|1|||
145728765|NCT00402363|525525098|FG000|Overall Study|Protocol Violation|3|||
145728766|NCT00402363|525525099|FG001|Overall Study|Protocol Violation|5|||
145384661|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
145384662|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145384663|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
145384664|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
145384665|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
145384666|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
145384667|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
145384668|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
145384669|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
145728767|NCT00402363|525525100|FG002|Overall Study|Protocol Violation|0|||
145495018|NCT02234843|524670276|FG009|Overall Study|Patient convenience|0|||
145384670|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
145384671|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
145384672|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
145384673|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
145384674|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
145384675|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
145384676|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145384677|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145384678|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
145384679|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
145384680|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
145384681|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
145384682|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384683|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384684|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384685|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
145384686|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384687|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
145384688|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384689|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384690|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
145384691|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145384692|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384693|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145384694|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384695|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384696|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
145384697|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384698|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384699|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
145384700|NCT00528372|524261809|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
145384701|NCT00528372|524261810|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384702|NCT00528372|524261811|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384703|NCT00528372|524261812|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
145384704|NCT00528372|524261813|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384705|NCT00528372|524261814|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384706|NCT00528372|524261815|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384707|NCT00528372|524261816|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
145384708|NCT00528372|524261817|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
145384709|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
145384710|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
145384711|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
145384712|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145384713|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145384714|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
145384715|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
145384716|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
145384717|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
145384718|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
145384719|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
145384720|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
145384721|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145384722|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
145384723|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
145384724|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
145384725|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145384726|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
145384727|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
145384728|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
145605889|NCT00633932|525073035|FG001|Overall Study|Lost to Follow-up|0|||
145728768|NCT00402363|525525101|FG003|Overall Study|Protocol Violation|3|||
145728769|NCT00402363|525525098|FG000|Overall Study|Lost to Follow-up|5|||
145728770|NCT00402363|525525099|FG001|Overall Study|Lost to Follow-up|4|||
145728771|NCT00402363|525525100|FG002|Overall Study|Lost to Follow-up|0|||
145728772|NCT00402363|525525101|FG003|Overall Study|Lost to Follow-up|2|||
145728773|NCT00402363|525525098|FG000|Overall Study|"Captured as Other"|6|||
145728774|NCT00402363|525525099|FG001|Overall Study|"Captured as Other"|2|||
145728775|NCT00402363|525525100|FG002|Overall Study|"Captured as Other"|2|||
145728776|NCT00402363|525525101|FG003|Overall Study|"Captured as Other"|2|||
145728777|NCT00667355|525525111|FG000|Overall Study|Adverse Event|5|||
145384729|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
145384730|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
145384731|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
145384732|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
145384733|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
145384734|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
145384735|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
145384736|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
145384737|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
145384738|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145384739|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145384740|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
145384741|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
145384742|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
145384743|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
145384744|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
145384745|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145384746|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145384747|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145384748|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145384749|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145384750|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145384751|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
145384752|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145384753|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
145384754|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384755|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384756|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384757|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384758|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
145384759|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
145384760|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384761|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384762|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
145384763|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384764|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145384765|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384766|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384767|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384768|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384769|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145384770|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
145384771|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
145384772|NCT00528372|524261809|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145384773|NCT00528372|524261810|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145384774|NCT00528372|524261811|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
145384775|NCT00528372|524261812|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
145384776|NCT00528372|524261813|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
145384777|NCT00528372|524261814|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
145384778|NCT00528372|524261815|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
145384779|NCT00528372|524261816|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
145384780|NCT00528372|524261817|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
145384781|NCT02432144|524261822|FG000|Overall Study|Participant Non-Compliance|1|||
145384782|NCT01483599|524261823|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
145384783|NCT01483599|524261824|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384784|NCT01483599|524261825|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384785|NCT01483599|524261826|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
145384786|NCT01483599|524261827|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
145384787|NCT01483599|524261828|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
145384788|NCT01483599|524261829|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
145384789|NCT01483599|524261830|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384790|NCT01483599|524261831|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384791|NCT01483599|524261832|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384792|NCT01483599|524261833|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384793|NCT01483599|524261834|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384794|NCT01483599|524261835|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384795|NCT01483599|524261836|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
145384796|NCT01483599|524261823|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384797|NCT01483599|524261824|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145384798|NCT01483599|524261825|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384799|NCT01483599|524261826|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145384800|NCT01483599|524261827|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384801|NCT01483599|524261828|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384802|NCT01483599|524261829|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
145384803|NCT01483599|524261830|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384804|NCT01483599|524261831|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384805|NCT01483599|524261832|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384806|NCT01483599|524261833|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384807|NCT01483599|524261834|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384808|NCT01483599|524261835|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384809|NCT01483599|524261836|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
145384810|NCT01483599|524261823|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
145384811|NCT01483599|524261824|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384812|NCT01483599|524261825|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384813|NCT01483599|524261826|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384814|NCT01483599|524261827|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384815|NCT01483599|524261828|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384816|NCT01483599|524261829|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384817|NCT01483599|524261830|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384818|NCT01483599|524261831|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384819|NCT01483599|524261832|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384820|NCT01483599|524261833|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384821|NCT01483599|524261834|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384822|NCT01483599|524261835|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384823|NCT01483599|524261836|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
145384824|NCT01483599|524261823|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
145384825|NCT01483599|524261824|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
145384826|NCT01483599|524261825|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
145384827|NCT01483599|524261826|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
145384828|NCT01483599|524261827|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
145384829|NCT01483599|524261828|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
145384830|NCT01483599|524261829|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
145384831|NCT01483599|524261830|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
145384832|NCT01483599|524261831|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
145384833|NCT01483599|524261832|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
145384834|NCT01483599|524261833|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
145384835|NCT01483599|524261834|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
145384836|NCT01483599|524261835|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
145384837|NCT01483599|524261836|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
145384838|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
145384839|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
145384840|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
145384841|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
145384842|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
145384843|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
145384844|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
145384845|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
145384846|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
145384847|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
145384848|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
145384849|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
145384850|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
145384851|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
145384852|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384853|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145728778|NCT00667355|525525111|FG000|Overall Study|Lost to Follow-up|1|||
145384854|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384855|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384856|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384857|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384858|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384859|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145384860|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145384861|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384862|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384863|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
145384864|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145384865|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
145384866|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384867|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384868|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384869|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384870|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384871|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384872|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384873|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384874|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145384875|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384876|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384877|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145384878|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
145384879|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
145384880|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384881|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384882|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384883|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384884|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384885|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384886|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384887|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384888|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
145384889|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384890|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
145384891|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384892|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
145384893|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
145384894|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384895|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384896|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384897|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384898|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384899|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384900|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384901|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384902|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
145384903|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384904|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384905|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
145384906|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
145384907|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
145384908|NCT01483599|524261823|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
145384909|NCT01483599|524261824|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
145384910|NCT01483599|524261825|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
145384911|NCT01483599|524261826|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
145384912|NCT01483599|524261827|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
145384913|NCT01483599|524261828|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
145384914|NCT01483599|524261829|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
145384915|NCT01483599|524261830|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
145384916|NCT01483599|524261831|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
145495019|NCT02234843|524670267|FG000|Overall Study|Withdrawal by Subject|5|||
145495020|NCT02234843|524670268|FG001|Overall Study|Withdrawal by Subject|1|||
145495021|NCT02234843|524670269|FG002|Overall Study|Withdrawal by Subject|1|||
145495022|NCT02234843|524670270|FG003|Overall Study|Withdrawal by Subject|0|||
145495023|NCT02234843|524670271|FG004|Overall Study|Withdrawal by Subject|0|||
145384917|NCT01483599|524261832|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
145384918|NCT01483599|524261833|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
145384919|NCT01483599|524261834|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
145384920|NCT01483599|524261835|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
145384921|NCT01483599|524261836|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
145384922|NCT02109445|524261837|FG000|Overall Study|Symptomatic deterioration|2|||
145384923|NCT02109445|524261837|FG000|Overall Study|Adverse Event|1|||
145384924|NCT00958412|524261838|FG000|Overall Study|Study prematurely terminated|18|||
145384925|NCT03488563|524263312|FG000|Overall Study|Lost to Follow-up|7|||
145384926|NCT03488563|524263313|FG001|Overall Study|Lost to Follow-up|6|||
145384927|NCT03488563|524263314|FG002|Overall Study|Lost to Follow-up|7|||
145384928|NCT03488563|524263312|FG000|Overall Study|Withdrawal by Subject|8|||
145384929|NCT03488563|524263313|FG001|Overall Study|Withdrawal by Subject|7|||
145384930|NCT03488563|524263314|FG002|Overall Study|Withdrawal by Subject|7|||
145384931|NCT03488563|524263312|FG000|Overall Study|Physician Decision|0|||
145384932|NCT03488563|524263313|FG001|Overall Study|Physician Decision|0|||
145384933|NCT03488563|524263314|FG002|Overall Study|Physician Decision|1|||
145384934|NCT03488563|524263312|FG000|Overall Study|Protocol Violation|3|||
145384935|NCT03488563|524263313|FG001|Overall Study|Protocol Violation|2|||
145384936|NCT03488563|524263314|FG002|Overall Study|Protocol Violation|6|||
145384937|NCT03488563|524263312|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
145384938|NCT03488563|524263313|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
145384939|NCT03488563|524263314|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
145384940|NCT03488563|524263312|FG000|Overall Study|Use of prohibited medication|2|||
145384941|NCT03488563|524263313|FG001|Overall Study|Use of prohibited medication|0|||
145384942|NCT03488563|524263314|FG002|Overall Study|Use of prohibited medication|0|||
145384943|NCT03488563|524263312|FG000|Overall Study|Adverse Event|1|||
145384944|NCT03488563|524263313|FG001|Overall Study|Adverse Event|0|||
145384945|NCT03488563|524263314|FG002|Overall Study|Adverse Event|1|||
145384946|NCT03488563|524263312|FG000|Overall Study|Subject returned for ET visit|0|||
145384947|NCT03488563|524263313|FG001|Overall Study|Subject returned for ET visit|1|||
145384948|NCT03488563|524263314|FG002|Overall Study|Subject returned for ET visit|0|||
145384949|NCT03488563|524263312|FG000|Overall Study|Sponsor's decision|0|||
145384950|NCT03488563|524263313|FG001|Overall Study|Sponsor's decision|0|||
145384951|NCT03488563|524263314|FG002|Overall Study|Sponsor's decision|1|||
145384952|NCT00582426|524263315|FG000|Overall Study|Lost to Follow-up|0|||
145384953|NCT00582426|524263316|FG001|Overall Study|Lost to Follow-up|2|||
145384954|NCT00582426|524263315|FG000|Overall Study|Adverse Event|4|||
145384955|NCT00582426|524263316|FG001|Overall Study|Adverse Event|2|||
145384956|NCT00582426|524263315|FG000|Overall Study|Protocol Violation|6|||
145384957|NCT00582426|524263316|FG001|Overall Study|Protocol Violation|2|||
145384958|NCT00582426|524263315|FG000|Overall Study|Death|4|||
145384959|NCT00582426|524263316|FG001|Overall Study|Death|3|||
145384960|NCT00582426|524263315|FG000|Overall Study|Withdrawal by Subject|3|||
145384961|NCT00582426|524263316|FG001|Overall Study|Withdrawal by Subject|2|||
145384962|NCT00582426|524263315|FG000|Overall Study|Disease Progression|2|||
145384963|NCT00582426|524263316|FG001|Overall Study|Disease Progression|2|||
145384964|NCT00582426|524263315|FG000|Overall Study|Use of illicit drugs|1|||
145384965|NCT00582426|524263316|FG001|Overall Study|Use of illicit drugs|0|||
145384966|NCT03084302|524263317|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
145384967|NCT03084302|524263317|FG000|Overall Study|No valid objective monitor data|6|||
145384968|NCT01411319|524263318|FG000|Overall Study|Lost to Follow-up|1|||
145384969|NCT02499263|524263319|FG000|Overall Study|Lost to Follow-up|9|||
145384970|NCT02499263|524263319|FG000|Overall Study|Participant's withdrawal of consent|4|||
145384971|NCT02499263|524263319|FG000|Overall Study|Lack of Efficacy|22|||
145384972|NCT02499263|524263319|FG000|Overall Study|investigator's judgment|12|||
145384973|NCT02499263|524263319|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
145384974|NCT02499263|524263319|FG000|Overall Study|Participant's decision|3|||
145384975|NCT02499263|524263319|FG000|Overall Study|Pregnancy|1|||
145384976|NCT04126317|524263336|FG000|Overall Study|Adverse Event|0|||
145384977|NCT04126317|524263337|FG001|Overall Study|Adverse Event|1|||
145384978|NCT04126317|524263336|FG000|Overall Study|Withdrawal by Subject|4|||
145384979|NCT04126317|524263337|FG001|Overall Study|Withdrawal by Subject|1|||
145384980|NCT03297021|524263340|FG000|Overall Study|Incomplete/illegible data sheet|4|||
145495024|NCT02234843|524670272|FG005|Overall Study|Withdrawal by Subject|7|||
145384981|NCT03297021|524263341|FG001|Overall Study|Incomplete/illegible data sheet|2|||
145384982|NCT03297021|524263342|FG002|Overall Study|Incomplete/illegible data sheet|3|||
145384983|NCT03297021|524263340|FG000|Overall Study|Missing Post-Op Data|1|||
145384984|NCT03297021|524263341|FG001|Overall Study|Missing Post-Op Data|2|||
145384985|NCT03297021|524263342|FG002|Overall Study|Missing Post-Op Data|1|||
145384986|NCT02734862|524263344|FG000|Part A|Death|3|||
145384987|NCT02734862|524263345|FG001|Part A|Death|4|||
145384988|NCT02734862|524263346|FG002|Part A|Death|6|||
145384989|NCT02734862|524263344|FG000|Part A|Lost to Follow-up|2|||
145384990|NCT02734862|524263345|FG001|Part A|Lost to Follow-up|1|||
145384991|NCT02734862|524263346|FG002|Part A|Lost to Follow-up|1|||
145384992|NCT02734862|524263344|FG000|Part A|Withdrawal by Subject|1|||
145384993|NCT02734862|524263345|FG001|Part A|Withdrawal by Subject|1|||
145384994|NCT02734862|524263346|FG002|Part A|Withdrawal by Subject|2|||
145384995|NCT02734862|524263344|FG000|Part A|Physician Decision|2|||
145384996|NCT02734862|524263345|FG001|Part A|Physician Decision|0|||
145384997|NCT02734862|524263346|FG002|Part A|Physician Decision|1|||
145384998|NCT02734862|524263344|FG000|Part A|Adverse Event|2|||
145384999|NCT02734862|524263345|FG001|Part A|Adverse Event|0|||
145385000|NCT02734862|524263346|FG002|Part A|Adverse Event|1|||
145385001|NCT02734862|524263344|FG000|Part A|Noncompliance|1|||
145385002|NCT02734862|524263345|FG001|Part A|Noncompliance|1|||
145385003|NCT02734862|524263346|FG002|Part A|Noncompliance|0|||
145385004|NCT02734862|524263344|FG000|Part A|Other|1|||
145385005|NCT02734862|524263345|FG001|Part A|Other|1|||
145385006|NCT02734862|524263346|FG002|Part A|Other|3|||
145385007|NCT02734862|524263344|FG000|Part B|Death|8|||
145385008|NCT02734862|524263345|FG001|Part B|Death|3|||
145385009|NCT02734862|524263346|FG002|Part B|Death|5|||
145385010|NCT02734862|524263344|FG000|Part B|Lost to Follow-up|2|||
145385011|NCT02734862|524263345|FG001|Part B|Lost to Follow-up|2|||
145385012|NCT02734862|524263346|FG002|Part B|Lost to Follow-up|0|||
145385013|NCT02734862|524263344|FG000|Part B|Withdrawal by Subject|3|||
145385014|NCT02734862|524263345|FG001|Part B|Withdrawal by Subject|1|||
145385015|NCT02734862|524263346|FG002|Part B|Withdrawal by Subject|0|||
145385016|NCT02734862|524263344|FG000|Part B|Other|0|||
145385017|NCT02734862|524263345|FG001|Part B|Other|1|||
145385018|NCT02734862|524263346|FG002|Part B|Other|0|||
145385019|NCT04854057|524263347|FG000|Overall Study|Adverse Event|0|||
145385020|NCT04854057|524263348|FG001|Overall Study|Adverse Event|1|||
145385021|NCT01951573|524263351|FG000|Washout Period|Adverse Event|0|||
145385022|NCT01951573|524263352|FG001|Washout Period|Adverse Event|1|||
145385023|NCT02087943|524263372|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
145385024|NCT02087943|524263373|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
145385025|NCT02087943|524263374|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
145385026|NCT02087943|524263375|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
145385027|NCT02087943|524263376|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
145385028|NCT02087943|524263372|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
145385029|NCT02087943|524263373|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
145385030|NCT02087943|524263374|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
145385031|NCT02087943|524263375|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
145385032|NCT02087943|524263376|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
145385033|NCT02087943|524263372|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
145385034|NCT02087943|524263373|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
145385035|NCT02087943|524263374|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
145385036|NCT02087943|524263375|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
145385037|NCT02087943|524263376|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
145385038|NCT02087943|524263372|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
145385039|NCT02087943|524263373|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145385040|NCT02087943|524263374|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
145385041|NCT02087943|524263375|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145385042|NCT02087943|524263376|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
145385043|NCT02087943|524263372|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145385044|NCT02087943|524263373|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
145385045|NCT02087943|524263374|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145385046|NCT02087943|524263375|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145385047|NCT02087943|524263376|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
145385048|NCT02087943|524263372|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
145385049|NCT02087943|524263373|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
145385050|NCT02087943|524263374|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
145385051|NCT02087943|524263375|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
145385052|NCT02087943|524263376|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
145385053|NCT02087943|524263372|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
145385054|NCT02087943|524263373|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
145385055|NCT02087943|524263374|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
145385056|NCT02087943|524263375|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
145385057|NCT02087943|524263376|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
145385058|NCT02087943|524263372|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145385059|NCT02087943|524263373|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145385060|NCT02087943|524263374|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
145385061|NCT02087943|524263375|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145385062|NCT02087943|524263376|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
145385063|NCT02087943|524263372|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145385064|NCT02087943|524263373|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145385065|NCT02087943|524263374|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145385066|NCT02087943|524263375|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
145385067|NCT02087943|524263376|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
145385068|NCT02087943|524263372|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
145385069|NCT02087943|524263373|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
145385070|NCT02087943|524263374|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
145385071|NCT02087943|524263375|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
145385072|NCT02087943|524263376|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
145385073|NCT02886884|524263382|FG000|Follow-up|Withdrawal by Subject|0|||
145385074|NCT02886884|524263383|FG001|Follow-up|Withdrawal by Subject|0|||
145385075|NCT02886884|524263384|FG002|Follow-up|Withdrawal by Subject|0|||
145385076|NCT02886884|524263385|FG003|Follow-up|Withdrawal by Subject|1|||
145385077|NCT02697734|524263391|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
145385078|NCT02697734|524263392|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
145385079|NCT02697734|524263391|FG000|Core Phase - up to Week 48|Adverse Event|1|||
145385080|NCT02697734|524263392|FG001|Core Phase - up to Week 48|Adverse Event|2|||
145385081|NCT02697734|524263391|FG000|Core Phase - up to Week 48|Physician Decision|1|||
145385082|NCT02697734|524263392|FG001|Core Phase - up to Week 48|Physician Decision|0|||
145385083|NCT02697734|524263391|FG000|Optional Extension Phase|Adverse Event|5|||
145385084|NCT02697734|524263392|FG001|Optional Extension Phase|Adverse Event|1|||
145385085|NCT02697734|524263391|FG000|Optional Extension Phase|Physician Decision|0|||
145385086|NCT02697734|524263392|FG001|Optional Extension Phase|Physician Decision|1|||
145385087|NCT02324699|524263393|FG000|Overall Study|study terminated|1|||
145385088|NCT03970200|524263394|FG000|Overall Study|Death|2|||
145385089|NCT03970200|524263395|FG001|Overall Study|Death|2|||
145385090|NCT03970200|524263396|FG002|Overall Study|Death|1|||
145385091|NCT03970200|524263394|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
145385092|NCT03970200|524263395|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
145385093|NCT03970200|524263396|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
145385094|NCT01607346|524263397|FG000|Overall Study|Adverse Event|3|||
145385095|NCT01098162|524263398|FG000|Overall Study|Adverse Event|37|||
145385096|NCT01098162|524263398|FG000|Overall Study|Lack of Efficacy|4|||
145385097|NCT01098162|524263398|FG000|Overall Study|Wish of Patient|7|||
145385098|NCT01098162|524263398|FG000|Overall Study|Lost to Follow-up|9|||
145385099|NCT01098162|524263398|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
145385100|NCT01098162|524263398|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
145385101|NCT01098162|524263398|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
145385102|NCT01098162|524263398|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
145385103|NCT01098162|524263398|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
145385104|NCT01098162|524263398|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
145385105|NCT01098162|524263398|FG000|Overall Study|Other Reason|1|||
145385106|NCT01098162|524263398|FG000|Overall Study|Reason Unknown|26|||
145385107|NCT01605825|524263399|FG000|Overall Study|Adverse Event|4|||
145385108|NCT01605825|524263400|FG001|Overall Study|Adverse Event|2|||
145385109|NCT01605825|524263399|FG000|Overall Study|Withdrawal by Subject|0|||
145385110|NCT01605825|524263400|FG001|Overall Study|Withdrawal by Subject|1|||
145385111|NCT01605825|524263399|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
145385112|NCT01605825|524263400|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
145385113|NCT01605825|524263399|FG000|Overall Study|Non-Compliance with Protocol|3|||
145385114|NCT01605825|524263400|FG001|Overall Study|Non-Compliance with Protocol|0|||
145385115|NCT00830518|524263401|FG000|Overall Study|Progressive Disease|18|||
145728779|NCT00667355|525525111|FG000|Overall Study|Other reason was not specified|5|||
145728780|NCT02175004|525525112|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
145728781|NCT02175004|525525113|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
145728782|NCT02175004|525525112|FG000|Overall Study|Investigator Judgment|1|||
145728783|NCT02175004|525525113|FG001|Overall Study|Investigator Judgment|4|||
145728784|NCT02175004|525525112|FG000|Overall Study|Voluntary Withdrawal|6|||
145728785|NCT02175004|525525113|FG001|Overall Study|Voluntary Withdrawal|19|||
145728786|NCT02175004|525525112|FG000|Overall Study|Liver Transplant|1|||
145728787|NCT02175004|525525113|FG001|Overall Study|Liver Transplant|0|||
145728788|NCT02175004|525525112|FG000|Overall Study|Disease Progression|1|||
145728789|NCT02175004|525525113|FG001|Overall Study|Disease Progression|0|||
145728790|NCT02175004|525525112|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
145385116|NCT00830518|524263402|FG001|Overall Study|Progressive Disease|8|||
145385117|NCT00830518|524263401|FG000|Overall Study|Symptomatic Deterioration|4|||
145385118|NCT00830518|524263402|FG001|Overall Study|Symptomatic Deterioration|1|||
145385119|NCT00830518|524263401|FG000|Overall Study|Adverse Event|14|||
145728791|NCT02175004|525525113|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
145728792|NCT00162032|525525114|FG000|Overall Study|Lost to Follow-up|4|||
145728793|NCT00162032|525525115|FG001|Overall Study|Lost to Follow-up|2|||
145385120|NCT00830518|524263402|FG001|Overall Study|Adverse Event|1|||
145385121|NCT00830518|524263401|FG000|Overall Study|Withdrawal by Patient|2|||
145385122|NCT00830518|524263402|FG001|Overall Study|Withdrawal by Patient|0|||
145385123|NCT00830518|524263401|FG000|Overall Study|Reason not Specified|8|||
145385124|NCT00830518|524263402|FG001|Overall Study|Reason not Specified|1|||
145385125|NCT03469999|524263405|FG000|Overall Study|Lost to Follow-up|2|||
145385126|NCT02155322|524263406|FG000|Overall Study|Adverse Event|1|||
145385127|NCT02155322|524263406|FG000|Overall Study|Physician Decision|1|||
145385128|NCT02155322|524263406|FG000|Overall Study|Relapse/Recurrence|8|||
145385129|NCT02155322|524263406|FG000|Overall Study|Withdrawal by Subject|4|||
145385130|NCT00460746|524263409|FG000|Overall Study|Adverse Event|1|||
145385131|NCT00460746|524263409|FG000|Overall Study|Lost to Follow-up|1|||
145385132|NCT01778751|524263412|FG000|Overall Study|Lost to Follow-up|1|||
145385133|NCT01778751|524263413|FG001|Overall Study|Lost to Follow-up|0|||
145385134|NCT01778751|524263412|FG000|Overall Study|Withdrawal by Subject|0|||
145385135|NCT01778751|524263413|FG001|Overall Study|Withdrawal by Subject|2|||
145385136|NCT01778751|524263412|FG000|Overall Study|Transfered care|1|||
145385137|NCT01778751|524263413|FG001|Overall Study|Transfered care|0|||
145385138|NCT02791438|524263418|FG000|Treatment Period|Adverse Event|1|||
145385139|NCT02791438|524263419|FG001|Treatment Period|Adverse Event|0|||
145385140|NCT02791438|524263418|FG000|Treatment Period|Withdrawal by Subject|0|||
145385141|NCT02791438|524263419|FG001|Treatment Period|Withdrawal by Subject|1|||
145385142|NCT02791438|524263418|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
145385143|NCT02791438|524263419|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
145385144|NCT01603394|524263420|FG000|Overall Study|Adverse Event|1|||
145385145|NCT02669667|524263421|FG000|Overall Study|Lost to Follow-up|0|||
145385146|NCT02669667|524263422|FG001|Overall Study|Lost to Follow-up|0|||
145385147|NCT02669667|524263423|FG002|Overall Study|Lost to Follow-up|0|||
145385148|NCT02669667|524263424|FG003|Overall Study|Lost to Follow-up|0|||
145385149|NCT02669667|524263425|FG004|Overall Study|Lost to Follow-up|0|||
145385150|NCT02669667|524263426|FG005|Overall Study|Lost to Follow-up|1|||
145385151|NCT02669667|524263427|FG006|Overall Study|Lost to Follow-up|0|||
145385152|NCT01215435|524263428|FG000|Overall Study|Adverse Event|1|||
145385153|NCT01215435|524263429|FG001|Overall Study|Adverse Event|0|||
145385154|NCT01215435|524263428|FG000|Overall Study|Protocol Violation|2|||
145385155|NCT01215435|524263429|FG001|Overall Study|Protocol Violation|0|||
145385156|NCT01215435|524263428|FG000|Overall Study|Withdrawal Criteria|8|||
145385157|NCT01215435|524263429|FG001|Overall Study|Withdrawal Criteria|11|||
145385158|NCT01215435|524263428|FG000|Overall Study|Lost to Follow-up|3|||
145385159|NCT01215435|524263429|FG001|Overall Study|Lost to Follow-up|0|||
145385160|NCT01215435|524263428|FG000|Overall Study|Unclassified|5|||
145385161|NCT01215435|524263429|FG001|Overall Study|Unclassified|5|||
145385162|NCT00840034|524263430|FG000|Acute Treatment Phase|Adverse Event|6|||
145385163|NCT00840034|524263431|FG001|Acute Treatment Phase|Adverse Event|8|||
145385164|NCT00840034|524263430|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
145385165|NCT00840034|524263431|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
145385166|NCT00840034|524263430|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
145385167|NCT00840034|524263431|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
145385168|NCT00840034|524263430|FG000|Acute Treatment Phase|Physician Decision|0|||
145385169|NCT00840034|524263431|FG001|Acute Treatment Phase|Physician Decision|1|||
145385170|NCT00840034|524263430|FG000|Acute Treatment Phase|Protocol Violation|2|||
145385171|NCT00840034|524263431|FG001|Acute Treatment Phase|Protocol Violation|4|||
145385172|NCT00840034|524263430|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
145385173|NCT00840034|524263431|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
145385174|NCT00840034|524263430|FG000|Taper Phase|Adverse Event|1|||
145385175|NCT00840034|524263431|FG001|Taper Phase|Adverse Event|0|||
145385176|NCT00840034|524263430|FG000|Taper Phase|Lost to Follow-up|1|||
145385177|NCT00840034|524263431|FG001|Taper Phase|Lost to Follow-up|1|||
145385178|NCT00840034|524263430|FG000|Taper Phase|Withdrawal by Subject|1|||
145385179|NCT00840034|524263431|FG001|Taper Phase|Withdrawal by Subject|1|||
145385180|NCT03383692|524263438|FG000|Overall Study|Progressive disease as per RECIST|3|||
145385181|NCT03383692|524263439|FG001|Overall Study|Progressive disease as per RECIST|3|||
145495025|NCT02234843|524670273|FG006|Overall Study|Withdrawal by Subject|0|||
145495026|NCT02234843|524670274|FG007|Overall Study|Withdrawal by Subject|0|||
145495027|NCT02234843|524670275|FG008|Overall Study|Withdrawal by Subject|0|||
145385182|NCT03383692|524263438|FG000|Overall Study|Clinical progression|0|||
145385183|NCT03383692|524263439|FG001|Overall Study|Clinical progression|1|||
145385184|NCT03383692|524263438|FG000|Overall Study|Adverse Event|3|||
145385185|NCT03383692|524263439|FG001|Overall Study|Adverse Event|0|||
145385186|NCT00586898|524263444|FG000|Overall Study|Adverse Event|1|||
145385187|NCT00586898|524263444|FG000|Overall Study|Patiemt Non-compliance|1|||
145495028|NCT02234843|524670276|FG009|Overall Study|Withdrawal by Subject|0|||
145385188|NCT00586898|524263444|FG000|Overall Study|Evaluable for Toxicity Only|5|||
145385189|NCT02101359|524263445|FG000|Overall Study|Not included|23|||
145385190|NCT02101359|524263446|FG001|Overall Study|Not included|13|||
145385191|NCT02101359|524263445|FG000|Overall Study|Withdrawal by Subject|5|||
145385192|NCT02101359|524263446|FG001|Overall Study|Withdrawal by Subject|4|||
145385193|NCT02101359|524263445|FG000|Overall Study|Lost to Follow-up|1|||
145385194|NCT02101359|524263446|FG001|Overall Study|Lost to Follow-up|0|||
145385195|NCT02101359|524263445|FG000|Overall Study|Protocol Violation|0|||
145385196|NCT02101359|524263446|FG001|Overall Study|Protocol Violation|2|||
145385197|NCT00742027|524263447|FG000|Overall Study|Disease Progression|76|||
145385198|NCT00742027|524263447|FG000|Overall Study|New Cancer Therapy|19|||
145385199|NCT00742027|524263447|FG000|Overall Study|Withdrawal by Subject|18|||
145385200|NCT00742027|524263447|FG000|Overall Study|Death|7|||
145385201|NCT00742027|524263447|FG000|Overall Study|Lost to Follow-up|4|||
145385202|NCT00742027|524263447|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
145385203|NCT00742027|524263447|FG000|Overall Study|Missing|2|||
145385204|NCT00742027|524263447|FG000|Overall Study|Administrative Problems|1|||
145385205|NCT01994902|524263448|FG000|Test Period 1|Withdrawal by Subject|3|||
145385206|NCT01994902|524263449|FG001|Test Period 1|Withdrawal by Subject|0|||
145385207|NCT01994902|524263448|FG000|Test Period 1|device deficiency with adverse event|0|||
145385208|NCT01994902|524263449|FG001|Test Period 1|device deficiency with adverse event|1|||
145385209|NCT01994902|524263448|FG000|Test Period 1|Adverse Event|2|||
145385210|NCT01994902|524263449|FG001|Test Period 1|Adverse Event|1|||
145385211|NCT01994902|524263448|FG000|Test Period 1|Lack of Efficacy|0|||
145385212|NCT01994902|524263449|FG001|Test Period 1|Lack of Efficacy|1|||
145385213|NCT01994902|524263448|FG000|Test Period 1|bag too small|1|||
145385214|NCT01994902|524263449|FG001|Test Period 1|bag too small|0|||
145385215|NCT01994902|524263448|FG000|Test Period 2|Withdrawal by Subject|0|||
145385216|NCT01994902|524263449|FG001|Test Period 2|Withdrawal by Subject|2|||
145385217|NCT01994902|524263448|FG000|Test Period 2|Lack of Efficacy|0|||
145385218|NCT01994902|524263449|FG001|Test Period 2|Lack of Efficacy|1|||
145385219|NCT01994902|524263448|FG000|Test Period 2|Other|0|||
145385220|NCT01994902|524263449|FG001|Test Period 2|Other|3|||
145385221|NCT01180049|524263450|FG000|Overall Study|Other|9|||
145385222|NCT01180049|524263451|FG001|Overall Study|Other|7|||
145385223|NCT01180049|524263450|FG000|Overall Study|Lost to Follow-up|8|||
145385224|NCT01180049|524263451|FG001|Overall Study|Lost to Follow-up|6|||
145385225|NCT01180049|524263450|FG000|Overall Study|Death|36|||
145385226|NCT01180049|524263451|FG001|Overall Study|Death|35|||
145385227|NCT01738191|524263454|FG000|Overall Study|Withdrawal by Subject|4|||
145385228|NCT01738191|524263455|FG001|Overall Study|Withdrawal by Subject|1|||
145385229|NCT02483572|524263456|FG000|Overall Study|Withdrawal by Subject|1|||
145385230|NCT02483572|524263457|FG001|Overall Study|Withdrawal by Subject|0|||
145385231|NCT02483572|524263456|FG000|Overall Study|Lost to Follow-up|1|||
145385232|NCT02483572|524263457|FG001|Overall Study|Lost to Follow-up|0|||
145385233|NCT02483572|524263456|FG000|Overall Study|Physician Decision|0|||
145385234|NCT02483572|524263457|FG001|Overall Study|Physician Decision|1|||
145385235|NCT00966355|524263464|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
145385236|NCT00966355|524263465|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
145385237|NCT00966355|524263466|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
145385238|NCT00966355|524263464|FG000|Overall Study|newly diagnosed advanced HCC|11|||
145385239|NCT00966355|524263465|FG001|Overall Study|newly diagnosed advanced HCC|12|||
145385240|NCT00966355|524263466|FG002|Overall Study|newly diagnosed advanced HCC|10|||
145385241|NCT00966355|524263464|FG000|Overall Study|Lost to Follow-up|5|||
145385242|NCT00966355|524263465|FG001|Overall Study|Lost to Follow-up|4|||
145385243|NCT00966355|524263466|FG002|Overall Study|Lost to Follow-up|3|||
145385244|NCT02552888|524263467|FG000|Overall Study|Lost to Follow-up|1|||
145385245|NCT02552888|524263468|FG001|Overall Study|Lost to Follow-up|1|||
145385246|NCT00385827|524265073|FG000|Part 1|Adverse Event|1|||
145728794|NCT00162032|525525114|FG000|Overall Study|Reason not specified|1|||
145728795|NCT00162032|525525115|FG001|Overall Study|Reason not specified|0|||
145385247|NCT00385827|524265074|FG001|Part 1|Adverse Event|0|||
145385248|NCT00385827|524265075|FG002|Part 1|Adverse Event|0|||
145385249|NCT00385827|524265073|FG000|Part 1|Death|2|||
145385250|NCT00385827|524265074|FG001|Part 1|Death|0|||
145385251|NCT00385827|524265075|FG002|Part 1|Death|0|||
145385252|NCT00385827|524265073|FG000|Part 1|Lack of Efficacy|5|||
145385253|NCT00385827|524265074|FG001|Part 1|Lack of Efficacy|0|||
145385254|NCT00385827|524265075|FG002|Part 1|Lack of Efficacy|0|||
145728796|NCT04263909|525525116|FG000|Overall Study|Physician Decision|1|||
145728797|NCT04263909|525525117|FG001|Overall Study|Physician Decision|0|||
145728798|NCT04263909|525525118|FG002|Overall Study|Physician Decision|0|||
145728799|NCT04263909|525525116|FG000|Overall Study|Adverse Event|3|||
145728800|NCT04263909|525525117|FG001|Overall Study|Adverse Event|0|||
145728801|NCT04263909|525525118|FG002|Overall Study|Adverse Event|0|||
145728802|NCT04263909|525525116|FG000|Overall Study|Protocol Violation|5|||
145728803|NCT04263909|525525117|FG001|Overall Study|Protocol Violation|0|||
145728804|NCT04263909|525525118|FG002|Overall Study|Protocol Violation|0|||
145385255|NCT00385827|524265073|FG000|Part 1|Other|1|||
145385256|NCT00385827|524265074|FG001|Part 1|Other|0|||
145728805|NCT05193500|525525119|FG000|Overall Study|Withdrawal by Subject|7|||
145385257|NCT00385827|524265075|FG002|Part 1|Other|0|||
145385258|NCT00385827|524265073|FG000|Part 2|Adverse Event|0|||
145385259|NCT00385827|524265074|FG001|Part 2|Adverse Event|6|||
145385260|NCT00385827|524265075|FG002|Part 2|Adverse Event|10|||
145385261|NCT00385827|524265073|FG000|Part 2|Death|0|||
145385262|NCT00385827|524265074|FG001|Part 2|Death|0|||
145385263|NCT00385827|524265075|FG002|Part 2|Death|2|||
145385264|NCT00385827|524265073|FG000|Part 2|Lack of Efficacy|0|||
145385265|NCT00385827|524265074|FG001|Part 2|Lack of Efficacy|14|||
145385266|NCT00385827|524265075|FG002|Part 2|Lack of Efficacy|13|||
145385267|NCT00385827|524265073|FG000|Part 2|Randomized but not treated|0|||
145385268|NCT00385827|524265074|FG001|Part 2|Randomized but not treated|2|||
145385269|NCT00385827|524265075|FG002|Part 2|Randomized but not treated|2|||
145385270|NCT00385827|524265073|FG000|Part 2|Other|0|||
145385271|NCT00385827|524265074|FG001|Part 2|Other|11|||
145385272|NCT00385827|524265075|FG002|Part 2|Other|21|||
145385273|NCT04227405|524265076|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
145385274|NCT04227405|524265077|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
145385275|NCT04227405|524265076|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
145385276|NCT04227405|524265077|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
145385277|NCT04227405|524265076|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
145385278|NCT04227405|524265077|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
145385279|NCT04985942|524265078|FG000|Overall Study|Adverse Event|14|||
145385280|NCT04985942|524265079|FG001|Overall Study|Adverse Event|2|||
145385281|NCT04985942|524265078|FG000|Overall Study|Lack of Efficacy|0|||
145385282|NCT04985942|524265079|FG001|Overall Study|Lack of Efficacy|3|||
145385283|NCT04985942|524265078|FG000|Overall Study|Lost to Follow-up|1|||
145385284|NCT04985942|524265079|FG001|Overall Study|Lost to Follow-up|1|||
145385285|NCT04985942|524265078|FG000|Overall Study|Protocol Violation|1|||
145385286|NCT04985942|524265079|FG001|Overall Study|Protocol Violation|1|||
145385287|NCT04985942|524265078|FG000|Overall Study|Withdrawal by Subject|5|||
145385288|NCT04985942|524265079|FG001|Overall Study|Withdrawal by Subject|4|||
145385289|NCT03252145|524265080|FG000|Overall Study|Withdrawal by Subject|1|||
145385290|NCT03252145|524265081|FG001|Overall Study|Withdrawal by Subject|0|||
145385291|NCT03252145|524265080|FG000|Overall Study|Complicating Disease|1|||
145385292|NCT03252145|524265081|FG001|Overall Study|Complicating Disease|2|||
145385293|NCT02626000|524265086|FG000|Overall Study|Decision by Sponsor|1|||
145385294|NCT02626000|524265086|FG000|Overall Study|Death|29|||
145385295|NCT00662311|524265087|FG000|Overall Study|Respiratory Infection|1|||
145385296|NCT00662311|524265088|FG001|Overall Study|Respiratory Infection|0|||
145385297|NCT00662311|524265089|FG002|Overall Study|Respiratory Infection|0|||
145385298|NCT02164318|524265090|FG000|Overall Study|Withdrawal by Subject|0|||
145385299|NCT02164318|524265091|FG001|Overall Study|Withdrawal by Subject|1|||
145385300|NCT02164318|524265092|FG002|Overall Study|Withdrawal by Subject|0|||
145385301|NCT02164318|524265093|FG003|Overall Study|Withdrawal by Subject|1|||
145385302|NCT01467271|524265096|FG000|Overall Study|Death|84|||
145385303|NCT01467271|524265096|FG000|Overall Study|Lost to Follow-up|83|||
145385304|NCT01467271|524265096|FG000|Overall Study|Retraction of patient's consent|21|||
145385305|NCT01467271|524265096|FG000|Overall Study|Other reason|14|||
145385306|NCT00424593|524265103|FG000|Acute Double-Blind Period|Adverse Event|16|||
145385307|NCT00424593|524265104|FG001|Acute Double-Blind Period|Adverse Event|7|||
145385308|NCT00424593|524265103|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
145385309|NCT00424593|524265104|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
145385310|NCT00424593|524265103|FG000|Acute Double-Blind Period|Protocol Violation|2|||
145385311|NCT00424593|524265104|FG001|Acute Double-Blind Period|Protocol Violation|2|||
145385312|NCT00424593|524265103|FG000|Acute Double-Blind Period|Physician Decision|1|||
145385313|NCT00424593|524265104|FG001|Acute Double-Blind Period|Physician Decision|2|||
145385314|NCT00424593|524265103|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
145385315|NCT00424593|524265104|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
145385316|NCT00424593|524265103|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
145385317|NCT00424593|524265104|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
145385318|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
145385319|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
145385320|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Adverse Event|18|||
145385321|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Adverse Event|0|||
145385322|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
145385323|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
145385324|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
145385325|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
145385326|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
145385327|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
145385328|NCT00424593|524265103|FG000|Dose-Blind Extension Period|Physician Decision|3|||
145385329|NCT00424593|524265104|FG001|Dose-Blind Extension Period|Physician Decision|0|||
145385330|NCT02985021|524265105|FG000|Overall Study|Inability to comply with study procedures|1|||
145385331|NCT01005901|524265106|FG000|Overall Study|Withdrawal by Subject|38|||
145385332|NCT01005901|524265107|FG001|Overall Study|Withdrawal by Subject|14|||
145385333|NCT01005901|524265106|FG000|Overall Study|Adverse Event|30|||
145385334|NCT01005901|524265107|FG001|Overall Study|Adverse Event|16|||
145385335|NCT01005901|524265106|FG000|Overall Study|Administrative problems|21|||
145385336|NCT01005901|524265107|FG001|Overall Study|Administrative problems|13|||
145385337|NCT01005901|524265106|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145385338|NCT01005901|524265107|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
145385339|NCT01005901|524265106|FG000|Overall Study|Protocol Violation|4|||
145385340|NCT01005901|524265107|FG001|Overall Study|Protocol Violation|3|||
145385341|NCT01005901|524265106|FG000|Overall Study|Death|2|||
145385342|NCT01005901|524265107|FG001|Overall Study|Death|3|||
145385343|NCT01005901|524265106|FG000|Overall Study|Lost to Follow-up|1|||
145385344|NCT01005901|524265107|FG001|Overall Study|Lost to Follow-up|2|||
145385345|NCT01005901|524265106|FG000|Overall Study|Patient's inability to use the device|1|||
145385346|NCT01005901|524265107|FG001|Overall Study|Patient's inability to use the device|1|||
145385347|NCT01005901|524265106|FG000|Overall Study|No longer requires study drug|0|||
145385348|NCT01005901|524265107|FG001|Overall Study|No longer requires study drug|1|||
145385349|NCT00760487|524265108|FG000|Overall Study|Unilateral implantation|3|||
145385350|NCT04217317|524265113|FG000|Overall Study|Lack of Efficacy|4|||
145385351|NCT04217317|524265113|FG000|Overall Study|Physician Decision|1|||
145385352|NCT03836209|524265114|FG000|Overall Study|Adverse Event|5|||
145385353|NCT03836209|524265115|FG001|Overall Study|Adverse Event|2|||
145385354|NCT03836209|524265114|FG000|Overall Study|Death|4|||
145385355|NCT03836209|524265115|FG001|Overall Study|Death|1|||
145385356|NCT03836209|524265114|FG000|Overall Study|Lack of Efficacy|7|||
145385357|NCT03836209|524265115|FG001|Overall Study|Lack of Efficacy|10|||
145385358|NCT03836209|524265114|FG000|Overall Study|Physician Decision|7|||
145385359|NCT03836209|524265115|FG001|Overall Study|Physician Decision|11|||
145385360|NCT03836209|524265114|FG000|Overall Study|Protocol Violation|0|||
145385361|NCT03836209|524265115|FG001|Overall Study|Protocol Violation|3|||
145385362|NCT03836209|524265114|FG000|Overall Study|Withdrawal by Subject|2|||
145385363|NCT03836209|524265115|FG001|Overall Study|Withdrawal by Subject|10|||
145385364|NCT03836209|524265114|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
145385365|NCT03836209|524265115|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
145385366|NCT03739710|524265116|FG000|Overall Study|Screen Failed|81|||
145385367|NCT01753115|524265117|FG000|Overall Study|Lost to Follow-up|3|||
145385368|NCT01753115|524265118|FG001|Overall Study|Lost to Follow-up|6|||
145385369|NCT01753115|524265119|FG002|Overall Study|Lost to Follow-up|8|||
145385370|NCT01753115|524265117|FG000|Overall Study|Withdrawal by Subject|6|||
145385371|NCT01753115|524265118|FG001|Overall Study|Withdrawal by Subject|5|||
145385372|NCT01753115|524265119|FG002|Overall Study|Withdrawal by Subject|6|||
145385373|NCT01753115|524265117|FG000|Overall Study|Subject non-compliant|3|||
145385374|NCT01753115|524265118|FG001|Overall Study|Subject non-compliant|3|||
145385375|NCT01753115|524265119|FG002|Overall Study|Subject non-compliant|0|||
145385376|NCT01753115|524265117|FG000|Overall Study|Used excluded drug|0|||
145385377|NCT01753115|524265118|FG001|Overall Study|Used excluded drug|1|||
145385378|NCT01753115|524265119|FG002|Overall Study|Used excluded drug|0|||
145385379|NCT04313400|524265125|FG000|Overall Study|Withdrawal by Subject|0|||
145385380|NCT04313400|524265126|FG001|Overall Study|Withdrawal by Subject|0|||
145385381|NCT04313400|524265127|FG002|Overall Study|Withdrawal by Subject|0|||
145385382|NCT04313400|524265128|FG003|Overall Study|Withdrawal by Subject|0|||
145385383|NCT04313400|524265129|FG004|Overall Study|Withdrawal by Subject|0|||
145385384|NCT04313400|524265130|FG005|Overall Study|Withdrawal by Subject|4|||
145385385|NCT04313400|524265131|FG006|Overall Study|Withdrawal by Subject|1|||
145385386|NCT04313400|524265125|FG000|Overall Study|Adverse Event|0|||
145385387|NCT04313400|524265126|FG001|Overall Study|Adverse Event|0|||
145385388|NCT04313400|524265127|FG002|Overall Study|Adverse Event|0|||
145385389|NCT04313400|524265128|FG003|Overall Study|Adverse Event|0|||
145385390|NCT04313400|524265129|FG004|Overall Study|Adverse Event|0|||
145385391|NCT04313400|524265130|FG005|Overall Study|Adverse Event|1|||
145385392|NCT04313400|524265131|FG006|Overall Study|Adverse Event|0|||
145385393|NCT04313400|524265125|FG000|Overall Study|Lost to Follow-up|0|||
145385394|NCT04313400|524265126|FG001|Overall Study|Lost to Follow-up|0|||
145385395|NCT04313400|524265127|FG002|Overall Study|Lost to Follow-up|0|||
145385396|NCT04313400|524265128|FG003|Overall Study|Lost to Follow-up|0|||
145385397|NCT04313400|524265129|FG004|Overall Study|Lost to Follow-up|0|||
145385398|NCT04313400|524265130|FG005|Overall Study|Lost to Follow-up|1|||
145385399|NCT04313400|524265131|FG006|Overall Study|Lost to Follow-up|0|||
145385400|NCT03224624|524265140|FG000|Overall Study|Lost to Follow-up|9|||
145385401|NCT03224624|524265141|FG001|Overall Study|Lost to Follow-up|4|||
145385402|NCT03224624|524265140|FG000|Overall Study|Death|1|||
145385403|NCT03224624|524265141|FG001|Overall Study|Death|0|||
145385404|NCT04318132|524265142|FG000|Overall Study|Protocol Violation|0|||
145385405|NCT04318132|524265143|FG001|Overall Study|Protocol Violation|0|||
145385406|NCT04318132|524265144|FG002|Overall Study|Protocol Violation|3|||
145728806|NCT05193500|525525120|FG001|Overall Study|Withdrawal by Subject|4|||
145728807|NCT05193500|525525121|FG002|Overall Study|Withdrawal by Subject|3|||
145728808|NCT05193500|525525122|FG003|Overall Study|Withdrawal by Subject|5|||
145728809|NCT01106404|525525126|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
145728810|NCT01106404|525525127|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
145728811|NCT01106404|525525126|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
145728812|NCT01106404|525525127|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
145728813|NCT01106404|525525126|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
145728814|NCT01106404|525525127|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
145728815|NCT01106404|525525126|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
145728816|NCT01106404|525525127|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
145728817|NCT00752622|525525128|FG000|Induction Phase|Adverse Event|3|||
145728818|NCT00752622|525525128|FG000|Induction Phase|Other|3|||
145728819|NCT00752622|525525128|FG000|Induction Phase|Non-responder|14|||
145728820|NCT00752622|525525128|FG000|Induction Phase|Withdrawal by Subject|1|||
145728821|NCT00752622|525525128|FG000|Induction Phase|Premature study termination|14|||
145728822|NCT00752622|525525128|FG000|Observational Phase|Premature Study Termination|36|||
145728823|NCT00752622|525525128|FG000|Observational Phase|Non-responder|2|||
145728824|NCT00752622|525525128|FG000|Observational Phase|Withdrawal by Subject|2|||
145728825|NCT00752622|525525128|FG000|Observational Phase|Adverse Event|1|||
145728826|NCT00752622|525525128|FG000|Observational Phase|Other|2|||
145728827|NCT00752622|525525128|FG000|Interventional Phase|Non-responder|2|||
145728828|NCT00752622|525525128|FG000|Interventional Phase|Physician Decision|1|||
145728829|NCT00752622|525525128|FG000|Interventional Phase|Premature Study Termination|5|||
145728830|NCT00576836|525525129|FG000|Overall Study|Death|0|||
145728831|NCT00576836|525525130|FG001|Overall Study|Death|1|||
145728832|NCT00576836|525525129|FG000|Overall Study|Physician Decision|0|||
145728833|NCT00576836|525525130|FG001|Overall Study|Physician Decision|1|||
145728834|NCT03267940|525525133|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
145728835|NCT03267940|525525134|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
145728836|NCT03267940|525525135|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
145728837|NCT03267940|525525136|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
145728838|NCT03267940|525525137|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
145728839|NCT03267940|525525138|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
145728840|NCT03267940|525525133|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
145728841|NCT03267940|525525134|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
145728842|NCT03267940|525525135|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
145728843|NCT03267940|525525136|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
145728844|NCT03267940|525525137|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
145728845|NCT03267940|525525138|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
145385407|NCT04318132|524265145|FG003|Overall Study|Protocol Violation|0|||
145385408|NCT00073008|524265146|FG000|Overall Study|Missing|6|||
145385409|NCT00073008|524265147|FG001|Overall Study|Missing|6|||
145385410|NCT00073008|524265146|FG000|Overall Study|Withdrawal by Subject|2|||
145385411|NCT00073008|524265147|FG001|Overall Study|Withdrawal by Subject|2|||
145385412|NCT00073008|524265146|FG000|Overall Study|Lost to Follow-up|1|||
145385413|NCT00073008|524265147|FG001|Overall Study|Lost to Follow-up|3|||
145385414|NCT00073008|524265146|FG000|Overall Study|Death|46|||
145385415|NCT00073008|524265147|FG001|Overall Study|Death|47|||
145385416|NCT00073008|524265146|FG000|Overall Study|"Other selected on Case Report Form"|7|||
145385417|NCT00073008|524265147|FG001|Overall Study|"Other selected on Case Report Form"|5|||
145385418|NCT00636961|524265159|FG000|Period 1|Administrative problems|1|||
145385419|NCT00636961|524265160|FG001|Period 1|Administrative problems|1|||
145385420|NCT00636961|524265159|FG000|Period 2|Adverse Event|1|||
145385421|NCT00636961|524265160|FG001|Period 2|Adverse Event|0|||
145385422|NCT01926197|524265162|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
145385423|NCT01926197|524265163|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
145385424|NCT01926197|524265162|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
145385425|NCT01926197|524265163|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
145385426|NCT03628716|524265164|FG000|Overall Study|Adverse Event|1|||
145385427|NCT03628716|524265165|FG001|Overall Study|Adverse Event|1|||
145385428|NCT03628716|524265164|FG000|Overall Study|Death|1|||
145385429|NCT03628716|524265165|FG001|Overall Study|Death|0|||
145385430|NCT03628716|524265164|FG000|Overall Study|Lack of Efficacy|15|||
145385431|NCT03628716|524265165|FG001|Overall Study|Lack of Efficacy|20|||
145385432|NCT03628716|524265164|FG000|Overall Study|Withdrawal by Subject|1|||
145385433|NCT03628716|524265165|FG001|Overall Study|Withdrawal by Subject|2|||
145385434|NCT03628716|524265164|FG000|Overall Study|Study Terminated by Sponsor|1|||
145385435|NCT03628716|524265165|FG001|Overall Study|Study Terminated by Sponsor|0|||
145385436|NCT00856843|524265166|FG000|Overall Study|Withdrawal by Subject|1|||
145385437|NCT00856843|524265167|FG001|Overall Study|Withdrawal by Subject|5|||
145385438|NCT00856843|524265166|FG000|Overall Study|Lack of Efficacy|1|||
145385439|NCT00856843|524265167|FG001|Overall Study|Lack of Efficacy|0|||
145385440|NCT02179749|524265168|FG000|Overall Study|Adverse Event|0|||
145385441|NCT02179749|524265169|FG001|Overall Study|Adverse Event|0|||
145385442|NCT02179749|524265170|FG002|Overall Study|Adverse Event|1|||
145385443|NCT02179749|524265168|FG000|Overall Study|Withdrawal by Subject|0|||
145385444|NCT02179749|524265169|FG001|Overall Study|Withdrawal by Subject|0|||
145385445|NCT02179749|524265170|FG002|Overall Study|Withdrawal by Subject|1|||
145385446|NCT01841567|524265171|FG000|Overall Study|Adverse Event|3|||
145385447|NCT01573754|524265176|FG000|Overall Study|Noncompliance or remission not achieved|3|||
145385448|NCT01573754|524265177|FG001|Overall Study|Noncompliance or remission not achieved|15|||
145385449|NCT00829829|524265178|FG000|Overall Study|Protocol Violation|0|||
145385450|NCT00829829|524265179|FG001|Overall Study|Protocol Violation|3|||
145385451|NCT00829829|524265180|FG002|Overall Study|Protocol Violation|0|||
145385452|NCT00829829|524265178|FG000|Overall Study|Adverse Event|4|||
145385453|NCT00829829|524265179|FG001|Overall Study|Adverse Event|4|||
145385454|NCT00829829|524265180|FG002|Overall Study|Adverse Event|3|||
145385455|NCT00829829|524265178|FG000|Overall Study|Withdrawal by Subject|8|||
145385456|NCT00829829|524265179|FG001|Overall Study|Withdrawal by Subject|4|||
145385457|NCT00829829|524265180|FG002|Overall Study|Withdrawal by Subject|2|||
145385458|NCT00829829|524265178|FG000|Overall Study|Decision by the Sponsor|1|||
145385459|NCT00829829|524265179|FG001|Overall Study|Decision by the Sponsor|0|||
145385460|NCT00829829|524265180|FG002|Overall Study|Decision by the Sponsor|2|||
145385461|NCT00829829|524265178|FG000|Overall Study|Lost to Follow-up|7|||
145385462|NCT00829829|524265179|FG001|Overall Study|Lost to Follow-up|3|||
145385463|NCT00829829|524265180|FG002|Overall Study|Lost to Follow-up|3|||
145385464|NCT00829829|524265178|FG000|Overall Study|Other than specified above|2|||
145385465|NCT00829829|524265179|FG001|Overall Study|Other than specified above|2|||
145385466|NCT00829829|524265180|FG002|Overall Study|Other than specified above|1|||
145385467|NCT02984267|524265181|FG000|Overall Study|Protocol Violation|1|||
145385468|NCT02984267|524265182|FG001|Overall Study|Protocol Violation|0|||
145728846|NCT03267940|525525133|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
145385469|NCT02984267|524265181|FG000|Overall Study|Withdrawal by Subject|0|||
145385470|NCT02984267|524265182|FG001|Overall Study|Withdrawal by Subject|1|||
145385471|NCT02685072|524265183|FG000|Treatment Period|Lost to Follow-up|12|||
145385472|NCT02685072|524265184|FG001|Treatment Period|Lost to Follow-up|6|||
145385473|NCT02685072|524265183|FG000|Treatment Period|Withdrawal by Subject|1|||
145385474|NCT02685072|524265184|FG001|Treatment Period|Withdrawal by Subject|3|||
145385475|NCT02685072|524265183|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
145385476|NCT02685072|524265184|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
145385477|NCT02634710|524265185|FG000|Overall Study|Death|4|||
145385478|NCT01249833|524265187|FG000|Overall Study|Lost to Follow-up|0|||
145385479|NCT01249833|524265188|FG001|Overall Study|Lost to Follow-up|1|||
145385480|NCT03796676|524265189|FG000|Overall Study|Adverse Event|2|||
145385481|NCT03796676|524265190|FG001|Overall Study|Adverse Event|1|||
145385482|NCT03796676|524265191|FG002|Overall Study|Adverse Event|2|||
145385483|NCT03796676|524265189|FG000|Overall Study|Lost to Follow-up|2|||
145385484|NCT03796676|524265190|FG001|Overall Study|Lost to Follow-up|1|||
145385485|NCT03796676|524265191|FG002|Overall Study|Lost to Follow-up|0|||
145385486|NCT03796676|524265189|FG000|Overall Study|Protocol Violation|0|||
145385487|NCT03796676|524265190|FG001|Overall Study|Protocol Violation|0|||
145385488|NCT03796676|524265191|FG002|Overall Study|Protocol Violation|1|||
145385489|NCT03796676|524265189|FG000|Overall Study|Withdrawal by Subject|1|||
145385490|NCT03796676|524265190|FG001|Overall Study|Withdrawal by Subject|1|||
145385491|NCT03796676|524265191|FG002|Overall Study|Withdrawal by Subject|0|||
145385492|NCT03796676|524265189|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
145385493|NCT03796676|524265190|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
145385494|NCT03796676|524265191|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
145385495|NCT01085084|524265195|FG000|Overall Study|Withdrawal by Subject|1|||
145385496|NCT01085084|524265196|FG001|Overall Study|Withdrawal by Subject|0|||
145385497|NCT01085084|524265197|FG002|Overall Study|Withdrawal by Subject|0|||
145385498|NCT01085084|524265195|FG000|Overall Study|Lost to Follow-up|2|||
145385499|NCT01085084|524265196|FG001|Overall Study|Lost to Follow-up|1|||
145385500|NCT01085084|524265197|FG002|Overall Study|Lost to Follow-up|1|||
145385501|NCT01085084|524265195|FG000|Overall Study|Adverse Event|4|||
145385502|NCT01085084|524265196|FG001|Overall Study|Adverse Event|3|||
145385503|NCT01085084|524265197|FG002|Overall Study|Adverse Event|6|||
145385504|NCT01085084|524265195|FG000|Overall Study|Treatment Failure|0|||
145385505|NCT01085084|524265196|FG001|Overall Study|Treatment Failure|1|||
145385506|NCT01085084|524265197|FG002|Overall Study|Treatment Failure|2|||
145385507|NCT02749799|524265198|FG000|Overall Study|Adverse Event|2|||
145385508|NCT02749799|524265198|FG000|Overall Study|Lost to Follow-up|4|||
145385509|NCT02749799|524265198|FG000|Overall Study|Protocol Violation|1|||
145385510|NCT02749799|524265198|FG000|Overall Study|Withdrawal by Subject|1|||
145385511|NCT02070978|524265199|FG000|Overall Study|Adverse Event|6|||
145385512|NCT02070978|524265200|FG001|Overall Study|Adverse Event|2|||
145385513|NCT02070978|524265201|FG002|Overall Study|Adverse Event|0|||
145385514|NCT02070978|524265199|FG000|Overall Study|Lost to Follow-up|1|||
145385515|NCT02070978|524265200|FG001|Overall Study|Lost to Follow-up|3|||
145385516|NCT02070978|524265201|FG002|Overall Study|Lost to Follow-up|4|||
145385517|NCT02070978|524265199|FG000|Overall Study|Withdrawal by Subject|3|||
145385518|NCT02070978|524265200|FG001|Overall Study|Withdrawal by Subject|5|||
145385519|NCT02070978|524265201|FG002|Overall Study|Withdrawal by Subject|3|||
145385520|NCT02070978|524265199|FG000|Overall Study|Protocol Violation|1|||
145385521|NCT02070978|524265200|FG001|Overall Study|Protocol Violation|0|||
145385522|NCT02070978|524265201|FG002|Overall Study|Protocol Violation|3|||
145385523|NCT02070978|524265199|FG000|Overall Study|Lack of Efficacy|0|||
145385524|NCT02070978|524265200|FG001|Overall Study|Lack of Efficacy|1|||
145385525|NCT02070978|524265201|FG002|Overall Study|Lack of Efficacy|0|||
145385526|NCT02070978|524265199|FG000|Overall Study|Death|0|||
145385527|NCT02070978|524265200|FG001|Overall Study|Death|0|||
145385528|NCT02070978|524265201|FG002|Overall Study|Death|2|||
145385529|NCT02070978|524265199|FG000|Overall Study|Un-specified|3|||
145385530|NCT02070978|524265200|FG001|Overall Study|Un-specified|2|||
145385531|NCT02070978|524265201|FG002|Overall Study|Un-specified|2|||
145385532|NCT02070978|524265199|FG000|Overall Study|Terminated by Sponsor|33|||
145385533|NCT02070978|524265200|FG001|Overall Study|Terminated by Sponsor|40|||
145385534|NCT02070978|524265201|FG002|Overall Study|Terminated by Sponsor|39|||
145385535|NCT03951753|524265202|FG000|Overall Study|Adverse Event|1|||
145385536|NCT03951753|524265203|FG001|Overall Study|Adverse Event|0|||
145385537|NCT03951753|524265204|FG002|Overall Study|Adverse Event|3|||
145385538|NCT03951753|524265202|FG000|Overall Study|Withdrawal by Subject|3|||
145385539|NCT03951753|524265203|FG001|Overall Study|Withdrawal by Subject|1|||
145385540|NCT03951753|524265204|FG002|Overall Study|Withdrawal by Subject|0|||
145385541|NCT03951753|524265202|FG000|Overall Study|Lost to Follow-up|0|||
145385542|NCT03951753|524265203|FG001|Overall Study|Lost to Follow-up|0|||
145385543|NCT03951753|524265204|FG002|Overall Study|Lost to Follow-up|1|||
145385544|NCT01905592|524265207|FG000|Overall Study|Disease Progression|51|||
145385545|NCT01905592|524265208|FG001|Overall Study|Disease Progression|110|||
145385546|NCT01905592|524265207|FG000|Overall Study|Toxicity|1|||
145385547|NCT01905592|524265208|FG001|Overall Study|Toxicity|16|||
145385548|NCT01905592|524265207|FG000|Overall Study|Physician Decision|0|||
145385549|NCT01905592|524265208|FG001|Overall Study|Physician Decision|2|||
145385550|NCT01905592|524265207|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
145385551|NCT01905592|524265208|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
145385552|NCT01905592|524265207|FG000|Overall Study|Protocol Violation|0|||
145385553|NCT01905592|524265208|FG001|Overall Study|Protocol Violation|1|||
145385554|NCT01905592|524265207|FG000|Overall Study|Sponsor's decision|1|||
145385555|NCT01905592|524265208|FG001|Overall Study|Sponsor's decision|1|||
145385556|NCT01905592|524265207|FG000|Overall Study|Not treated|7|||
145385557|NCT01905592|524265208|FG001|Overall Study|Not treated|3|||
145385558|NCT01905592|524265207|FG000|Overall Study|Withdrawal by Subject|10|||
145385559|NCT01905592|524265208|FG001|Overall Study|Withdrawal by Subject|2|||
145385560|NCT02669043|524265211|FG000|Overall Study|Didn't meet I/E criteria|4|||
145385561|NCT00467558|524265214|FG000|Overall Study|Lost to Follow-up|2|||
145385562|NCT00467558|524265215|FG001|Overall Study|Lost to Follow-up|0|||
145385563|NCT02636439|524265217|FG000|Overall Study|Adverse Event|2|||
145385564|NCT02636439|524265218|FG001|Overall Study|Adverse Event|2|||
145385565|NCT02636439|524265217|FG000|Overall Study|Lost to Follow-up|1|||
145385566|NCT02636439|524265218|FG001|Overall Study|Lost to Follow-up|0|||
145385567|NCT02636439|524265217|FG000|Overall Study|Non-compliance|1|||
145385568|NCT02636439|524265218|FG001|Overall Study|Non-compliance|1|||
145385569|NCT02636439|524265217|FG000|Overall Study|Personal reasons|2|||
145385570|NCT02636439|524265218|FG001|Overall Study|Personal reasons|0|||
145385571|NCT00314808|524266861|FG000|Overall Study|Disease Progression without AE|4|||
145385572|NCT00314808|524266861|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
145385573|NCT04304508|524266862|FG000|Overall Study|Subject Decision|29|||
145385574|NCT04304508|524266863|FG001|Overall Study|Subject Decision|39|||
145385575|NCT04304508|524266864|FG002|Overall Study|Subject Decision|37|||
145385576|NCT04304508|524266865|FG003|Overall Study|Subject Decision|48|||
145385577|NCT04304508|524266862|FG000|Overall Study|Death|6|||
145385578|NCT04304508|524266863|FG001|Overall Study|Death|1|||
145385579|NCT04304508|524266864|FG002|Overall Study|Death|8|||
145385580|NCT04304508|524266865|FG003|Overall Study|Death|5|||
145385581|NCT04304508|524266862|FG000|Overall Study|Non-compliance With Study Drug|3|||
145385582|NCT04304508|524266863|FG001|Overall Study|Non-compliance With Study Drug|1|||
145385583|NCT04304508|524266864|FG002|Overall Study|Non-compliance With Study Drug|2|||
145385584|NCT04304508|524266865|FG003|Overall Study|Non-compliance With Study Drug|0|||
145385585|NCT04304508|524266862|FG000|Overall Study|Switching To Other Therapy|1|||
145385586|NCT04304508|524266863|FG001|Overall Study|Switching To Other Therapy|1|||
145385587|NCT04304508|524266864|FG002|Overall Study|Switching To Other Therapy|1|||
145385588|NCT04304508|524266865|FG003|Overall Study|Switching To Other Therapy|2|||
145385589|NCT04304508|524266862|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
145385590|NCT04304508|524266863|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
145385591|NCT04304508|524266864|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
145385592|NCT04304508|524266865|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
145385593|NCT04304508|524266862|FG000|Overall Study|Withdrawal by Subject|7|||
145385594|NCT04304508|524266863|FG001|Overall Study|Withdrawal by Subject|5|||
145385595|NCT04304508|524266864|FG002|Overall Study|Withdrawal by Subject|11|||
145385596|NCT04304508|524266865|FG003|Overall Study|Withdrawal by Subject|6|||
145385597|NCT04304508|524266862|FG000|Overall Study|Logistical Difficulties|2|||
145385598|NCT04304508|524266863|FG001|Overall Study|Logistical Difficulties|2|||
145385599|NCT04304508|524266864|FG002|Overall Study|Logistical Difficulties|3|||
145385600|NCT04304508|524266865|FG003|Overall Study|Logistical Difficulties|2|||
145385601|NCT04304508|524266862|FG000|Overall Study|Missing Information|1|||
145385602|NCT04304508|524266863|FG001|Overall Study|Missing Information|2|||
145385603|NCT04304508|524266864|FG002|Overall Study|Missing Information|1|||
145385604|NCT04304508|524266865|FG003|Overall Study|Missing Information|3|||
145385605|NCT04304508|524266862|FG000|Overall Study|Other|7|||
145385606|NCT04304508|524266863|FG001|Overall Study|Other|6|||
145385607|NCT04304508|524266864|FG002|Overall Study|Other|5|||
145385608|NCT04304508|524266865|FG003|Overall Study|Other|4|||
145385609|NCT04304508|524266862|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
145385610|NCT04304508|524266863|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145385611|NCT04304508|524266864|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145385612|NCT04304508|524266865|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
145385613|NCT04304508|524266862|FG000|Overall Study|Physician Decision|3|||
145385614|NCT04304508|524266863|FG001|Overall Study|Physician Decision|4|||
145385615|NCT04304508|524266864|FG002|Overall Study|Physician Decision|9|||
145385616|NCT04304508|524266865|FG003|Overall Study|Physician Decision|7|||
145385617|NCT04304508|524266862|FG000|Overall Study|Study drug never administered|10|||
145385618|NCT04304508|524266863|FG001|Overall Study|Study drug never administered|4|||
145385619|NCT04304508|524266864|FG002|Overall Study|Study drug never administered|4|||
145385620|NCT04304508|524266865|FG003|Overall Study|Study drug never administered|4|||
145385621|NCT04304508|524266862|FG000|Overall Study|Adverse Event|49|||
145728847|NCT03267940|525525134|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
145728848|NCT03267940|525525135|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
145728849|NCT03267940|525525136|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
145728850|NCT03267940|525525137|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
145728851|NCT03267940|525525138|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
145728852|NCT03267940|525525133|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
145728853|NCT03267940|525525134|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
145728854|NCT03267940|525525135|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
145385622|NCT04304508|524266863|FG001|Overall Study|Adverse Event|50|||
145385623|NCT04304508|524266864|FG002|Overall Study|Adverse Event|51|||
145385624|NCT04304508|524266865|FG003|Overall Study|Adverse Event|56|||
145385625|NCT04304508|524266862|FG000|Overall Study|Lost to Follow-up|1|||
145385626|NCT04304508|524266863|FG001|Overall Study|Lost to Follow-up|5|||
145385627|NCT04304508|524266864|FG002|Overall Study|Lost to Follow-up|2|||
145385628|NCT04304508|524266865|FG003|Overall Study|Lost to Follow-up|3|||
145728855|NCT03267940|525525136|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
145385629|NCT02688764|524266872|FG000|Overall Study|Adverse Event|3|||
145385630|NCT02688764|524266873|FG001|Overall Study|Adverse Event|3|||
145385631|NCT02688764|524266872|FG000|Overall Study|AE/Kidney transplant|1|||
145385632|NCT02688764|524266873|FG001|Overall Study|AE/Kidney transplant|0|||
145385633|NCT02688764|524266872|FG000|Overall Study|AE/Lack of efficacy|1|||
145385634|NCT02688764|524266873|FG001|Overall Study|AE/Lack of efficacy|0|||
145385635|NCT02688764|524266872|FG000|Overall Study|AE/Non-compl.|1|||
145385636|NCT02688764|524266873|FG001|Overall Study|AE/Non-compl.|0|||
145385637|NCT02688764|524266872|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
145385638|NCT02688764|524266873|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
145385639|NCT02688764|524266872|FG000|Overall Study|AE/Other|0|||
145385640|NCT02688764|524266873|FG001|Overall Study|AE/Other|1|||
145385641|NCT02688764|524266872|FG000|Overall Study|AE/Physician decision|1|||
145385642|NCT02688764|524266873|FG001|Overall Study|AE/Physician decision|0|||
145385643|NCT02688764|524266872|FG000|Overall Study|AE/Withd. parent|3|||
145385644|NCT02688764|524266873|FG001|Overall Study|AE/Withd. parent|0|||
145385645|NCT02688764|524266872|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
145385646|NCT02688764|524266873|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
145385647|NCT02688764|524266872|FG000|Overall Study|AE/Withd. subject|1|||
145385648|NCT02688764|524266873|FG001|Overall Study|AE/Withd. subject|0|||
145385649|NCT02688764|524266872|FG000|Overall Study|Kidney transplant|10|||
145385650|NCT02688764|524266873|FG001|Overall Study|Kidney transplant|4|||
145385651|NCT02688764|524266872|FG000|Overall Study|Lack of Efficacy|3|||
145385652|NCT02688764|524266873|FG001|Overall Study|Lack of Efficacy|2|||
145385653|NCT02688764|524266872|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
145385654|NCT02688764|524266873|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
145385655|NCT02688764|524266872|FG000|Overall Study|Non-compliance with study drug|4|||
145385656|NCT02688764|524266873|FG001|Overall Study|Non-compliance with study drug|0|||
145385657|NCT02688764|524266872|FG000|Overall Study|Non-compl./Physician decision|2|||
145385658|NCT02688764|524266873|FG001|Overall Study|Non-compl./Physician decision|0|||
145385659|NCT02688764|524266872|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
145385660|NCT02688764|524266873|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
145385661|NCT02688764|524266872|FG000|Overall Study|Non-compl./Withd. subject|0|||
145385662|NCT02688764|524266873|FG001|Overall Study|Non-compl./Withd. subject|2|||
145385663|NCT02688764|524266872|FG000|Overall Study|Phosphorus level outside safe range|0|||
145385664|NCT02688764|524266873|FG001|Overall Study|Phosphorus level outside safe range|1|||
145385665|NCT02688764|524266872|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
145385666|NCT02688764|524266873|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
145385667|NCT02688764|524266872|FG000|Overall Study|Study drug taste/Withd. parent|1|||
145385668|NCT02688764|524266873|FG001|Overall Study|Study drug taste/Withd. parent|0|||
145385669|NCT02688764|524266872|FG000|Overall Study|Subject moving out|2|||
145385670|NCT02688764|524266873|FG001|Overall Study|Subject moving out|0|||
145385671|NCT02688764|524266872|FG000|Overall Study|Subject taken off dialysis|1|||
145385672|NCT02688764|524266873|FG001|Overall Study|Subject taken off dialysis|0|||
145385673|NCT02688764|524266872|FG000|Overall Study|Withdrawal by parent|3|||
145385674|NCT02688764|524266873|FG001|Overall Study|Withdrawal by parent|0|||
145385675|NCT02113007|524266874|FG000|Overall Study|Progressive disease|2|||
145385676|NCT00885378|524266875|FG000|Overall Study|Lack of Efficacy|2|||
145385677|NCT00885378|524266876|FG001|Overall Study|Lack of Efficacy|2|||
145385678|NCT00885378|524266875|FG000|Overall Study|Withdrawal by Subject|1|||
145385679|NCT00885378|524266876|FG001|Overall Study|Withdrawal by Subject|2|||
145385680|NCT00885378|524266875|FG000|Overall Study|Lost to Follow-up|1|||
145385681|NCT00885378|524266876|FG001|Overall Study|Lost to Follow-up|2|||
145385682|NCT00885378|524266875|FG000|Overall Study|Poor/Noncompliance|2|||
145385683|NCT00885378|524266876|FG001|Overall Study|Poor/Noncompliance|2|||
145385684|NCT00885378|524266875|FG000|Overall Study|Protocol Violation|2|||
145385685|NCT00885378|524266876|FG001|Overall Study|Protocol Violation|0|||
145385686|NCT04750278|524266877|FG000|Overall Study|Death|9|||
145385687|NCT04750278|524266878|FG001|Overall Study|Death|10|||
145385688|NCT04750278|524266879|FG002|Overall Study|Death|10|||
145385689|NCT04750278|524266877|FG000|Overall Study|Withdrawal by Subject|4|||
145385690|NCT04750278|524266878|FG001|Overall Study|Withdrawal by Subject|1|||
145385691|NCT04750278|524266879|FG002|Overall Study|Withdrawal by Subject|2|||
145385692|NCT04750278|524266877|FG000|Overall Study|Lost to Follow-up|1|||
145385693|NCT04750278|524266878|FG001|Overall Study|Lost to Follow-up|1|||
145385694|NCT04750278|524266879|FG002|Overall Study|Lost to Follow-up|1|||
145385695|NCT04750278|524266877|FG000|Overall Study|Pregnancy|1|||
145385696|NCT04750278|524266878|FG001|Overall Study|Pregnancy|0|||
145385697|NCT04750278|524266879|FG002|Overall Study|Pregnancy|0|||
145385698|NCT04750278|524266877|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
145385699|NCT04750278|524266878|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
145385700|NCT04750278|524266879|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
145385701|NCT04750278|524266877|FG000|Overall Study|Non-compliance|0|||
145385702|NCT04750278|524266878|FG001|Overall Study|Non-compliance|0|||
145385703|NCT04750278|524266879|FG002|Overall Study|Non-compliance|1|||
145385704|NCT04750278|524266877|FG000|Overall Study|Transfer to Outside Facility|0|||
145385705|NCT04750278|524266878|FG001|Overall Study|Transfer to Outside Facility|2|||
145385706|NCT04750278|524266879|FG002|Overall Study|Transfer to Outside Facility|1|||
145385707|NCT04750278|524266877|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
145385708|NCT04750278|524266878|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
145385709|NCT04750278|524266879|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
145385710|NCT04750278|524266877|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
145385711|NCT04750278|524266878|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
145385712|NCT04750278|524266879|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
145385713|NCT01775787|524266880|FG000|First 7-10 Days|Adverse Event|0|||
145385714|NCT01775787|524266881|FG001|First 7-10 Days|Adverse Event|1|||
145385715|NCT01775787|524266880|FG000|First 7-10 Days|family emergency|0|||
145385716|NCT01775787|524266881|FG001|First 7-10 Days|family emergency|1|||
145385717|NCT01775787|524266880|FG000|First 7-10 Days|time commitment|0|||
145385718|NCT01775787|524266881|FG001|First 7-10 Days|time commitment|2|||
145385719|NCT01775787|524266880|FG000|First 7-10 Days|concerns with using IV|1|||
145385720|NCT01775787|524266881|FG001|First 7-10 Days|concerns with using IV|2|||
145385721|NCT01775787|524266880|FG000|Second 7-10 Days|time commitment|0|||
145385722|NCT01775787|524266881|FG001|Second 7-10 Days|time commitment|1|||
145385723|NCT01775787|524266880|FG000|Second 7-10 Days|concerns with using IV|0|||
145385724|NCT01775787|524266881|FG001|Second 7-10 Days|concerns with using IV|1|||
145385725|NCT01299896|524266882|FG000|Overall Study|Withdrawal by Subject|1|||
145385726|NCT01299896|524266883|FG001|Overall Study|Withdrawal by Subject|7|||
145385727|NCT01299896|524266882|FG000|Overall Study|Lost to Follow-up|0|||
145385728|NCT01299896|524266883|FG001|Overall Study|Lost to Follow-up|11|||
145385729|NCT03026283|524266886|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
145385730|NCT03026283|524266887|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
145385731|NCT03026283|524266888|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
145385732|NCT03026283|524266889|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
145385733|NCT03026283|524266890|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
145385734|NCT03026283|524266891|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
145385735|NCT03026283|524266892|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
145385736|NCT03026283|524266893|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
145385737|NCT03026283|524266886|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
145385738|NCT03026283|524266887|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
145385739|NCT03026283|524266888|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
145385740|NCT03026283|524266889|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
145385741|NCT03026283|524266890|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
145385742|NCT03026283|524266891|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
145385743|NCT03026283|524266892|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
145385744|NCT03026283|524266893|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
145385745|NCT03026283|524266886|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385746|NCT03026283|524266887|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
145385747|NCT03026283|524266888|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385748|NCT03026283|524266889|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385749|NCT03026283|524266890|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385750|NCT03026283|524266891|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385751|NCT03026283|524266892|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385752|NCT03026283|524266893|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
145385753|NCT03026283|524266886|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385754|NCT03026283|524266887|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385755|NCT03026283|524266888|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
145385756|NCT03026283|524266889|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385757|NCT03026283|524266890|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385758|NCT03026283|524266891|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385759|NCT03026283|524266892|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385760|NCT03026283|524266893|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
145385761|NCT03026283|524266886|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385762|NCT03026283|524266887|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385763|NCT03026283|524266888|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385764|NCT03026283|524266889|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
145385765|NCT03026283|524266890|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
145385766|NCT03026283|524266891|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385767|NCT03026283|524266892|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385768|NCT03026283|524266893|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
145385769|NCT03026283|524266886|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145728856|NCT03267940|525525137|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
145728857|NCT03267940|525525138|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
145385770|NCT03026283|524266887|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145385771|NCT03026283|524266888|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145385772|NCT03026283|524266889|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
145385773|NCT03026283|524266890|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
145385774|NCT03026283|524266891|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
145385775|NCT03026283|524266892|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145385776|NCT03026283|524266893|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
145385777|NCT03026283|524266886|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385778|NCT03026283|524266887|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385779|NCT03026283|524266888|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385780|NCT03026283|524266889|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
145385781|NCT03026283|524266890|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385782|NCT03026283|524266891|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
145385783|NCT03026283|524266892|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385784|NCT03026283|524266893|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
145385785|NCT03026283|524266886|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385786|NCT03026283|524266887|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385787|NCT03026283|524266888|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385788|NCT03026283|524266889|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
145385789|NCT03026283|524266890|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385790|NCT03026283|524266891|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385791|NCT03026283|524266892|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385792|NCT03026283|524266893|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
145385793|NCT03026283|524266886|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385794|NCT03026283|524266887|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385795|NCT03026283|524266888|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385796|NCT03026283|524266889|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385797|NCT03026283|524266890|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
145385798|NCT03026283|524266891|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
145385799|NCT03026283|524266892|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385800|NCT03026283|524266893|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
145385801|NCT04076319|524266898|FG000|Overall Study|Withdrawal by Subject|2|||
145385802|NCT04076319|524266899|FG001|Overall Study|Withdrawal by Subject|0|||
145385803|NCT04076319|524266898|FG000|Overall Study|Death|1|||
145385804|NCT04076319|524266899|FG001|Overall Study|Death|0|||
145385805|NCT01054222|524266900|FG000|Overall Study|Lack of Efficacy|1|||
145385806|NCT01054222|524266900|FG000|Overall Study|Lost to Follow-up|4|||
145385807|NCT01054222|524266900|FG000|Overall Study|Withdrawal by Subject|6|||
145385808|NCT00824655|524266901|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
145385809|NCT00824655|524266902|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
145385810|NCT00824655|524266901|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
145385811|NCT00824655|524266902|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
145385812|NCT03782571|524266903|FG000|Period 1|Withdrawal by Subject|1|||
145385813|NCT03782571|524266904|FG001|Period 1|Withdrawal by Subject|0|||
145385814|NCT03782571|524266905|FG002|Period 1|Withdrawal by Subject|0|||
145385815|NCT03782571|524266906|FG003|Period 1|Withdrawal by Subject|0|||
145385816|NCT03782571|524266903|FG000|Period 3|Subject Unable to Attend V5|1|||
145385817|NCT03782571|524266904|FG001|Period 3|Subject Unable to Attend V5|0|||
145385818|NCT03782571|524266905|FG002|Period 3|Subject Unable to Attend V5|0|||
145385819|NCT03782571|524266906|FG003|Period 3|Subject Unable to Attend V5|0|||
145385820|NCT03782571|524266903|FG000|Period 3|Adverse Event|1|||
145385821|NCT03782571|524266904|FG001|Period 3|Adverse Event|0|||
145385822|NCT03782571|524266905|FG002|Period 3|Adverse Event|0|||
145385823|NCT03782571|524266906|FG003|Period 3|Adverse Event|0|||
145385824|NCT03504189|524266907|FG000|Overall Study|Withdrawal by Subject|1|||
145385825|NCT03504189|524266907|FG000|Overall Study|Screening Failure|1|||
145385826|NCT03504189|524266907|FG000|Overall Study|Device Failure|2|||
145385827|NCT03091738|524266908|FG000|Overall Study|Adverse Event|1|||
145385828|NCT03091738|524266908|FG000|Overall Study|Lost to Follow-up|1|||
145385829|NCT00199849|524266915|FG000|Overall Study|Unrelated illness or complication|0|||
145385830|NCT00199849|524266916|FG001|Overall Study|Unrelated illness or complication|1|||
145385831|NCT00199849|524266917|FG002|Overall Study|Unrelated illness or complication|0|||
145385832|NCT00199849|524266915|FG000|Overall Study|Progressive disease requiring intervention|0|||
145385833|NCT00199849|524266916|FG001|Overall Study|Progressive disease requiring intervention|0|||
145385834|NCT00199849|524266917|FG002|Overall Study|Progressive disease requiring intervention|1|||
145385835|NCT00199849|524266915|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
145385836|NCT00199849|524266916|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
145385837|NCT00199849|524266917|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
145385838|NCT04727528|524266918|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
145385839|NCT04727528|524266919|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
145385840|NCT04727528|524266918|FG000|Open-label Period|Randomized who did not receive treatment|1|||
145385841|NCT04727528|524266919|FG001|Open-label Period|Randomized who did not receive treatment|0|||
145385842|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145385843|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Adverse Event|1|||
145385844|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Death|0|||
145385845|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Death|1|||
145385846|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
145385847|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
145385848|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
145385849|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
145385850|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Physician Decision|0|||
145385851|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Physician Decision|1|||
145385852|NCT04727528|524266918|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
145385853|NCT04727528|524266919|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145385854|NCT01826981|524266933|FG000|Overall Study|Lack of Efficacy|0|||
145385855|NCT01826981|524266934|FG001|Overall Study|Lack of Efficacy|1|||
145385856|NCT01826981|524266935|FG002|Overall Study|Lack of Efficacy|0|||
145728858|NCT03267940|525525133|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
145728859|NCT03267940|525525134|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
145728860|NCT03267940|525525135|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
145385857|NCT01826981|524266936|FG003|Overall Study|Lack of Efficacy|0|||
145385858|NCT01826981|524266937|FG004|Overall Study|Lack of Efficacy|5|||
145385859|NCT01826981|524266938|FG005|Overall Study|Lack of Efficacy|0|||
145385860|NCT01826981|524266939|FG006|Overall Study|Lack of Efficacy|0|||
145385861|NCT01826981|524266940|FG007|Overall Study|Lack of Efficacy|8|||
145385862|NCT01826981|524266941|FG008|Overall Study|Lack of Efficacy|7|||
145385863|NCT01826981|524266942|FG009|Overall Study|Lack of Efficacy|0|||
145385864|NCT01826981|524266943|FG010|Overall Study|Lack of Efficacy|1|||
145385865|NCT01826981|524266944|FG011|Overall Study|Lack of Efficacy|0|||
145385866|NCT01826981|524266945|FG012|Overall Study|Lack of Efficacy|0|||
145385867|NCT01826981|524266946|FG013|Overall Study|Lack of Efficacy|3|||
145385868|NCT01826981|524266947|FG014|Overall Study|Lack of Efficacy|0|||
145385869|NCT01826981|524266933|FG000|Overall Study|Lost to Follow-up|0|||
145385870|NCT01826981|524266934|FG001|Overall Study|Lost to Follow-up|0|||
145385871|NCT01826981|524266935|FG002|Overall Study|Lost to Follow-up|0|||
145385872|NCT01826981|524266936|FG003|Overall Study|Lost to Follow-up|0|||
145385873|NCT01826981|524266937|FG004|Overall Study|Lost to Follow-up|1|||
145385874|NCT01826981|524266938|FG005|Overall Study|Lost to Follow-up|1|||
145385875|NCT01826981|524266939|FG006|Overall Study|Lost to Follow-up|0|||
145385876|NCT01826981|524266940|FG007|Overall Study|Lost to Follow-up|1|||
145385877|NCT01826981|524266941|FG008|Overall Study|Lost to Follow-up|0|||
145385878|NCT01826981|524266942|FG009|Overall Study|Lost to Follow-up|1|||
145385879|NCT01826981|524266943|FG010|Overall Study|Lost to Follow-up|1|||
145385880|NCT01826981|524266944|FG011|Overall Study|Lost to Follow-up|1|||
145385881|NCT01826981|524266945|FG012|Overall Study|Lost to Follow-up|1|||
145385882|NCT01826981|524266946|FG013|Overall Study|Lost to Follow-up|0|||
145385883|NCT01826981|524266947|FG014|Overall Study|Lost to Follow-up|0|||
145385884|NCT01826981|524266933|FG000|Overall Study|Withdrew Consent|0|||
145385885|NCT01826981|524266934|FG001|Overall Study|Withdrew Consent|0|||
145385886|NCT01826981|524266935|FG002|Overall Study|Withdrew Consent|0|||
145385887|NCT01826981|524266936|FG003|Overall Study|Withdrew Consent|0|||
145385888|NCT01826981|524266937|FG004|Overall Study|Withdrew Consent|0|||
145385889|NCT01826981|524266938|FG005|Overall Study|Withdrew Consent|0|||
145385890|NCT01826981|524266939|FG006|Overall Study|Withdrew Consent|1|||
145385891|NCT01826981|524266940|FG007|Overall Study|Withdrew Consent|1|||
145728861|NCT03267940|525525136|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
145728862|NCT03267940|525525137|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
145728863|NCT03267940|525525138|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
145728864|NCT03267940|525525133|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
145728865|NCT03267940|525525134|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
145728866|NCT03267940|525525135|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
145728867|NCT03267940|525525136|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
145728868|NCT03267940|525525137|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
145385892|NCT01826981|524266941|FG008|Overall Study|Withdrew Consent|0|||
145385893|NCT01826981|524266942|FG009|Overall Study|Withdrew Consent|0|||
145385894|NCT01826981|524266943|FG010|Overall Study|Withdrew Consent|0|||
145385895|NCT01826981|524266944|FG011|Overall Study|Withdrew Consent|1|||
145385896|NCT01826981|524266945|FG012|Overall Study|Withdrew Consent|0|||
145385897|NCT01826981|524266946|FG013|Overall Study|Withdrew Consent|1|||
145385898|NCT01826981|524266947|FG014|Overall Study|Withdrew Consent|0|||
145385899|NCT01826981|524266933|FG000|Overall Study|Adverse Event|0|||
145385900|NCT01826981|524266934|FG001|Overall Study|Adverse Event|0|||
145385901|NCT01826981|524266935|FG002|Overall Study|Adverse Event|0|||
145385902|NCT01826981|524266936|FG003|Overall Study|Adverse Event|0|||
145385903|NCT01826981|524266937|FG004|Overall Study|Adverse Event|1|||
145385904|NCT01826981|524266938|FG005|Overall Study|Adverse Event|0|||
145385905|NCT01826981|524266939|FG006|Overall Study|Adverse Event|0|||
145385906|NCT01826981|524266940|FG007|Overall Study|Adverse Event|0|||
145385907|NCT01826981|524266941|FG008|Overall Study|Adverse Event|0|||
145385908|NCT01826981|524266942|FG009|Overall Study|Adverse Event|0|||
145385909|NCT01826981|524266943|FG010|Overall Study|Adverse Event|0|||
145385910|NCT01826981|524266944|FG011|Overall Study|Adverse Event|0|||
145385911|NCT01826981|524266945|FG012|Overall Study|Adverse Event|0|||
145385912|NCT01826981|524266946|FG013|Overall Study|Adverse Event|0|||
145385913|NCT01826981|524266947|FG014|Overall Study|Adverse Event|0|||
145385914|NCT01826981|524266933|FG000|Overall Study|Upper G-I Haemorrhage|0|||
145385915|NCT01826981|524266934|FG001|Overall Study|Upper G-I Haemorrhage|0|||
145385916|NCT01826981|524266935|FG002|Overall Study|Upper G-I Haemorrhage|0|||
145385917|NCT01826981|524266936|FG003|Overall Study|Upper G-I Haemorrhage|0|||
145385918|NCT01826981|524266937|FG004|Overall Study|Upper G-I Haemorrhage|0|||
145385919|NCT01826981|524266938|FG005|Overall Study|Upper G-I Haemorrhage|0|||
145385920|NCT01826981|524266939|FG006|Overall Study|Upper G-I Haemorrhage|0|||
145385921|NCT01826981|524266940|FG007|Overall Study|Upper G-I Haemorrhage|0|||
145385922|NCT01826981|524266941|FG008|Overall Study|Upper G-I Haemorrhage|0|||
145385923|NCT01826981|524266942|FG009|Overall Study|Upper G-I Haemorrhage|0|||
145385924|NCT01826981|524266943|FG010|Overall Study|Upper G-I Haemorrhage|0|||
145385925|NCT01826981|524266944|FG011|Overall Study|Upper G-I Haemorrhage|0|||
145385926|NCT01826981|524266945|FG012|Overall Study|Upper G-I Haemorrhage|0|||
145385927|NCT01826981|524266946|FG013|Overall Study|Upper G-I Haemorrhage|1|||
145385928|NCT01826981|524266947|FG014|Overall Study|Upper G-I Haemorrhage|0|||
145385929|NCT01826981|524266933|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385930|NCT01826981|524266934|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385931|NCT01826981|524266935|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385932|NCT01826981|524266936|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385933|NCT01826981|524266937|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385934|NCT01826981|524266938|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385935|NCT01826981|524266939|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385936|NCT01826981|524266940|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
145728869|NCT03267940|525525138|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
145728870|NCT03267940|525525133|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
145728871|NCT03267940|525525134|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
145728872|NCT03267940|525525135|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
145728873|NCT03267940|525525136|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
145728874|NCT03267940|525525137|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
145728875|NCT03267940|525525138|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
145385937|NCT01826981|524266941|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385938|NCT01826981|524266942|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385939|NCT01826981|524266943|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385940|NCT01826981|524266944|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385941|NCT01826981|524266945|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385942|NCT01826981|524266946|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385943|NCT01826981|524266947|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
145385944|NCT03479008|524266952|FG000|Overall Study|Withdrawal by Subject|3|||
145385945|NCT01796301|524266953|FG000|Overall Study|Withdrawal by Subject|15|||
145385946|NCT01796301|524266954|FG001|Overall Study|Withdrawal by Subject|15|||
145385947|NCT01796301|524266953|FG000|Overall Study|Lost to Follow-up|3|||
145385948|NCT01796301|524266954|FG001|Overall Study|Lost to Follow-up|3|||
145385949|NCT01796301|524266953|FG000|Overall Study|Death|0|||
145385950|NCT01796301|524266954|FG001|Overall Study|Death|1|||
145728876|NCT03267940|525525133|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
145728877|NCT03267940|525525134|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
145728878|NCT03267940|525525135|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
145728879|NCT03267940|525525136|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
145728880|NCT03267940|525525137|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
145728881|NCT03267940|525525138|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
145728882|NCT03267940|525525133|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
145728883|NCT03267940|525525134|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
145728884|NCT03267940|525525135|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
145728885|NCT03267940|525525136|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
145728886|NCT03267940|525525137|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
145728887|NCT03267940|525525138|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
145728888|NCT00388154|525525145|FG000|Overall Study|Withdrawal by Subject|1|||
145728889|NCT01074216|525525146|FG000|Overall Study|Physician Decision|1|||
145385951|NCT01796301|524266953|FG000|Overall Study|Decision by Sponsor|0|||
145385952|NCT01796301|524266954|FG001|Overall Study|Decision by Sponsor|1|||
145385953|NCT01704755|524266955|FG000|Overall Study|Adverse Event|4|||
145385954|NCT01704755|524266956|FG001|Overall Study|Adverse Event|1|||
145385955|NCT01704755|524266955|FG000|Overall Study|Lost to Follow-up|3|||
145385956|NCT01704755|524266956|FG001|Overall Study|Lost to Follow-up|4|||
145385957|NCT01704755|524266955|FG000|Overall Study|Withdrew consent|1|||
145385958|NCT01704755|524266956|FG001|Overall Study|Withdrew consent|1|||
145385959|NCT01704755|524266955|FG000|Overall Study|Other (not specified)|3|||
145385960|NCT01704755|524266956|FG001|Overall Study|Other (not specified)|1|||
145385961|NCT01704755|524266955|FG000|Overall Study|Withdrew consent and personal issues|1|||
145385962|NCT01704755|524266956|FG001|Overall Study|Withdrew consent and personal issues|0|||
145385963|NCT00667563|524266957|FG000|Overall Study|Protocol Violation|24|||
145385964|NCT00660595|524266960|FG000|Overall Study|Lost to Follow-up|0|||
145385965|NCT00660595|524266961|FG001|Overall Study|Lost to Follow-up|1|||
145385966|NCT00660595|524266960|FG000|Overall Study|Did not consent to participate in study|12|||
145385967|NCT00660595|524266961|FG001|Overall Study|Did not consent to participate in study|8|||
145385968|NCT00660595|524266960|FG000|Overall Study|Participant left hospital|1|||
145385969|NCT00660595|524266961|FG001|Overall Study|Participant left hospital|0|||
145385970|NCT00660595|524266960|FG000|Overall Study|Non Specified reasons|5|||
145385971|NCT00660595|524266961|FG001|Overall Study|Non Specified reasons|0|||
145385972|NCT01148459|524266976|FG000|Overall Study|Serious Adverse Event|5|||
145385973|NCT01148459|524266977|FG001|Overall Study|Serious Adverse Event|4|||
145385974|NCT01148459|524266976|FG000|Overall Study|Withdrawal by Subject|1|||
145385975|NCT01148459|524266977|FG001|Overall Study|Withdrawal by Subject|0|||
145385976|NCT01148459|524266976|FG000|Overall Study|Migrated/moved from study area|3|||
145385977|NCT01148459|524266977|FG001|Overall Study|Migrated/moved from study area|6|||
145385978|NCT01148459|524266976|FG000|Overall Study|Lost to Follow-up|2|||
145385979|NCT01148459|524266977|FG001|Overall Study|Lost to Follow-up|0|||
145385980|NCT01148459|524266976|FG000|Overall Study|Refusal|1|||
145385981|NCT01148459|524266977|FG001|Overall Study|Refusal|0|||
145385982|NCT01148459|524266976|FG000|Overall Study|Failure to comply with study procedures|0|||
145385983|NCT01148459|524266977|FG001|Overall Study|Failure to comply with study procedures|1|||
145385984|NCT00264290|524266978|FG000|Intervention (8 Weeks)|Adverse Event|1|||
145385985|NCT00264290|524266979|FG001|Intervention (8 Weeks)|Adverse Event|0|||
145385986|NCT04399889|524266986|FG000|Overall Study|Death|5|||
145385987|NCT04399889|524266987|FG001|Overall Study|Death|1|||
145385988|NCT04399889|524266988|FG002|Overall Study|Death|1|||
145385989|NCT01152996|524266992|FG000|Overall Study|Withdrawal by Subject|142|||
145385990|NCT01152996|524266992|FG000|Overall Study|Adverse Event|115|||
145385991|NCT01152996|524266992|FG000|Overall Study|Lost to Follow-up|112|||
145385992|NCT01152996|524266992|FG000|Overall Study|Lack of Efficacy|68|||
145385993|NCT01152996|524266992|FG000|Overall Study|Noncompliance|41|||
145385994|NCT01152996|524266992|FG000|Overall Study|Other|36|||
145385995|NCT01152996|524266992|FG000|Overall Study|Protocol Violation|22|||
145385996|NCT01152996|524266992|FG000|Overall Study|Elevated liver enzymes|1|||
145385997|NCT03077607|524266994|FG000|Period 1 (15 Days)|Adverse Event|1|||
145385998|NCT03077607|524266995|FG001|Period 1 (15 Days)|Adverse Event|0|||
145385999|NCT03077607|524266994|FG000|Period 1 (15 Days)|Death|1|||
145386000|NCT03077607|524266995|FG001|Period 1 (15 Days)|Death|0|||
145386001|NCT03077607|524266994|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
145386002|NCT03077607|524266995|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
145386003|NCT03077607|524266994|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
145386004|NCT03077607|524266995|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
145386005|NCT00460239|524266996|FG000|Overall Study|Physician Decision|0|||
145386006|NCT00460239|524266997|FG001|Overall Study|Physician Decision|1|||
145386007|NCT00460239|524266998|FG002|Overall Study|Physician Decision|0|||
145386008|NCT00460239|524266999|FG003|Overall Study|Physician Decision|0|||
145386009|NCT00460239|524267000|FG004|Overall Study|Physician Decision|0|||
145386010|NCT00460239|524267001|FG005|Overall Study|Physician Decision|2|||
145386011|NCT00460239|524267002|FG006|Overall Study|Physician Decision|0|||
145386012|NCT00460239|524267003|FG007|Overall Study|Physician Decision|0|||
145386013|NCT00460239|524267004|FG008|Overall Study|Physician Decision|0|||
145386014|NCT00460239|524266996|FG000|Overall Study|Withdrawal by Subject|0|||
145728890|NCT01074216|525525146|FG000|Overall Study|Not Treated|12|||
145728891|NCT03291587|525525147|FG000|Overall Study|Lost to Follow-up|62|||
145386015|NCT00460239|524266997|FG001|Overall Study|Withdrawal by Subject|0|||
145386016|NCT00460239|524266998|FG002|Overall Study|Withdrawal by Subject|0|||
145386017|NCT00460239|524266999|FG003|Overall Study|Withdrawal by Subject|0|||
145386018|NCT00460239|524267000|FG004|Overall Study|Withdrawal by Subject|0|||
145386019|NCT00460239|524267001|FG005|Overall Study|Withdrawal by Subject|1|||
145386020|NCT00460239|524267002|FG006|Overall Study|Withdrawal by Subject|0|||
145386021|NCT00460239|524267003|FG007|Overall Study|Withdrawal by Subject|0|||
145386022|NCT00460239|524267004|FG008|Overall Study|Withdrawal by Subject|0|||
145386023|NCT00329745|524267008|FG000|Overall Study|Protocol Violation|1|||
145386024|NCT00329745|524267009|FG001|Overall Study|Protocol Violation|0|||
145386025|NCT00329745|524267008|FG000|Overall Study|Withdrawal by Subject|0|||
145386026|NCT00329745|524267009|FG001|Overall Study|Withdrawal by Subject|1|||
145386027|NCT00329745|524267008|FG000|Overall Study|Lost to Follow-up|86|||
145386028|NCT00329745|524267009|FG001|Overall Study|Lost to Follow-up|101|||
145386029|NCT01884545|524267010|FG000|Overall Study|Lost to Follow-up|6|||
145386030|NCT01884545|524267011|FG001|Overall Study|Lost to Follow-up|4|||
145386031|NCT01884545|524267012|FG002|Overall Study|Lost to Follow-up|9|||
145386032|NCT01884545|524267013|FG003|Overall Study|Lost to Follow-up|4|||
145386033|NCT01884545|524267010|FG000|Overall Study|Patient withdrawn|7|||
145386034|NCT01884545|524267011|FG001|Overall Study|Patient withdrawn|12|||
145386035|NCT01884545|524267012|FG002|Overall Study|Patient withdrawn|5|||
145386036|NCT01884545|524267013|FG003|Overall Study|Patient withdrawn|5|||
145386037|NCT01884545|524267010|FG000|Overall Study|Non-adherence|0|||
145386038|NCT01884545|524267011|FG001|Overall Study|Non-adherence|2|||
145386039|NCT01884545|524267012|FG002|Overall Study|Non-adherence|0|||
145386040|NCT01884545|524267013|FG003|Overall Study|Non-adherence|0|||
145386041|NCT01424241|524267014|FG000|Overall Study|Withdrawal by Subject|1|||
145386042|NCT01424241|524267014|FG000|Overall Study|Time constraints|2|||
145386043|NCT02782377|524267015|FG000|Overall Study|Physician Decision|5|||
145386044|NCT02347072|524267022|FG000|Overall Study|Adverse Event|2|||
145386045|NCT02347072|524267022|FG000|Overall Study|Withdrawal by Subject|6|||
145386046|NCT02347072|524267022|FG000|Overall Study|Physician Decision|1|||
145386047|NCT02347072|524267022|FG000|Overall Study|Lost to Follow-up|2|||
145386048|NCT02347072|524267022|FG000|Overall Study|Protocol Violation|1|||
145386049|NCT02347072|524267022|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
145386050|NCT01808222|524267023|FG000|Overall Study|mpMR scan was not performed|1|||
145386051|NCT01146561|524267024|FG000|Overall Study|Withdrawal by Subject|1|||
145386052|NCT01146561|524267024|FG000|Overall Study|Lost to Follow-up|1|||
145386053|NCT00723697|524267030|FG000|Overall Study|Physician questionnaires not received|2|||
145386054|NCT00723697|524267030|FG000|Overall Study|Missing Informed Consent Form|10|||
145386055|NCT00723697|524267030|FG000|Overall Study|Other exclusion criteria applied|6|||
145386056|NCT02774005|524267031|FG000|Overall Study|Adverse Event|8|||
145386057|NCT02774005|524267031|FG000|Overall Study|Withdrawal by Subject|23|||
145386058|NCT02774005|524267031|FG000|Overall Study|Lost to Follow-up|7|||
145386059|NCT02774005|524267031|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
145386060|NCT02774005|524267031|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
145386061|NCT02774005|524267031|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
145386062|NCT02774005|524267031|FG000|Overall Study|Death|1|||
145386063|NCT02774005|524267031|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
145386064|NCT02774005|524267031|FG000|Overall Study|Lack of compliance with study medication|4|||
145386065|NCT02774005|524267031|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
145386066|NCT02774005|524267031|FG000|Overall Study|another study|1|||
145386067|NCT02774005|524267031|FG000|Overall Study|cardiologist imposed travel restriction|1|||
145386068|NCT01289574|524267032|FG000|Overall Study|Lack of Efficacy|4|||
145386069|NCT01289574|524267033|FG001|Overall Study|Lack of Efficacy|0|||
145386070|NCT01289574|524267034|FG002|Overall Study|Lack of Efficacy|1|||
145386071|NCT01289574|524267032|FG000|Overall Study|Lost to Follow-up|2|||
145386072|NCT01289574|524267033|FG001|Overall Study|Lost to Follow-up|0|||
145386073|NCT01289574|524267034|FG002|Overall Study|Lost to Follow-up|1|||
145386074|NCT01289574|524267032|FG000|Overall Study|Withdrawal by Subject|1|||
145386075|NCT01289574|524267033|FG001|Overall Study|Withdrawal by Subject|1|||
145386076|NCT01289574|524267034|FG002|Overall Study|Withdrawal by Subject|1|||
145386077|NCT01289574|524267032|FG000|Overall Study|Adverse Event|0|||
145386078|NCT01289574|524267033|FG001|Overall Study|Adverse Event|1|||
145386079|NCT01289574|524267034|FG002|Overall Study|Adverse Event|0|||
145386080|NCT01289574|524267032|FG000|Overall Study|Subject wanted alternate treatment|0|||
145386081|NCT01289574|524267033|FG001|Overall Study|Subject wanted alternate treatment|1|||
145386082|NCT01289574|524267034|FG002|Overall Study|Subject wanted alternate treatment|0|||
145386083|NCT00262002|524267035|FG000|Overall Study|Adverse Event|2|||
145386084|NCT00262002|524267036|FG001|Overall Study|Adverse Event|1|||
145386085|NCT00262002|524267037|FG002|Overall Study|Adverse Event|0|||
145386086|NCT00262002|524267038|FG003|Overall Study|Adverse Event|0|||
145386087|NCT00262002|524267039|FG004|Overall Study|Adverse Event|0|||
145386088|NCT00262002|524267040|FG005|Overall Study|Adverse Event|1|||
145386089|NCT00262002|524267041|FG006|Overall Study|Adverse Event|0|||
145386090|NCT00262002|524267035|FG000|Overall Study|Withdrawal by Subject|4|||
145386091|NCT00262002|524267036|FG001|Overall Study|Withdrawal by Subject|2|||
145386092|NCT00262002|524267037|FG002|Overall Study|Withdrawal by Subject|0|||
145386093|NCT00262002|524267038|FG003|Overall Study|Withdrawal by Subject|1|||
145386094|NCT00262002|524267039|FG004|Overall Study|Withdrawal by Subject|2|||
145386095|NCT00262002|524267040|FG005|Overall Study|Withdrawal by Subject|2|||
145386096|NCT00262002|524267041|FG006|Overall Study|Withdrawal by Subject|2|||
145386097|NCT00262002|524267035|FG000|Overall Study|Lost to Follow-up|2|||
145386098|NCT00262002|524267036|FG001|Overall Study|Lost to Follow-up|0|||
145386099|NCT00262002|524267037|FG002|Overall Study|Lost to Follow-up|0|||
145386100|NCT00262002|524267038|FG003|Overall Study|Lost to Follow-up|2|||
145386101|NCT00262002|524267039|FG004|Overall Study|Lost to Follow-up|0|||
145386102|NCT00262002|524267040|FG005|Overall Study|Lost to Follow-up|1|||
145386103|NCT00262002|524267041|FG006|Overall Study|Lost to Follow-up|0|||
145386104|NCT00262002|524267035|FG000|Overall Study|Inapropriate enrollment|0|||
145386105|NCT00262002|524267036|FG001|Overall Study|Inapropriate enrollment|1|||
145386106|NCT00262002|524267037|FG002|Overall Study|Inapropriate enrollment|0|||
145386107|NCT00262002|524267038|FG003|Overall Study|Inapropriate enrollment|0|||
145386108|NCT00262002|524267039|FG004|Overall Study|Inapropriate enrollment|0|||
145386109|NCT00262002|524267040|FG005|Overall Study|Inapropriate enrollment|0|||
145386110|NCT00262002|524267041|FG006|Overall Study|Inapropriate enrollment|0|||
145386111|NCT00262002|524267035|FG000|Overall Study|Protocol Violation|3|||
145386112|NCT00262002|524267036|FG001|Overall Study|Protocol Violation|2|||
145386113|NCT00262002|524267037|FG002|Overall Study|Protocol Violation|0|||
145386114|NCT00262002|524267038|FG003|Overall Study|Protocol Violation|2|||
145386115|NCT00262002|524267039|FG004|Overall Study|Protocol Violation|5|||
145386116|NCT00262002|524267040|FG005|Overall Study|Protocol Violation|3|||
145386117|NCT00262002|524267041|FG006|Overall Study|Protocol Violation|2|||
145386118|NCT00262002|524267035|FG000|Overall Study|Unable to classify|0|||
145386119|NCT00262002|524267036|FG001|Overall Study|Unable to classify|0|||
145386120|NCT00262002|524267037|FG002|Overall Study|Unable to classify|0|||
145386121|NCT00262002|524267038|FG003|Overall Study|Unable to classify|0|||
145386122|NCT00262002|524267039|FG004|Overall Study|Unable to classify|0|||
145386123|NCT00262002|524267040|FG005|Overall Study|Unable to classify|0|||
145386124|NCT00262002|524267041|FG006|Overall Study|Unable to classify|2|||
145386125|NCT03885999|524267042|FG000|Overall Study|Adverse Event|1|||
145386126|NCT02452554|524267043|FG000|Overall Study|Death|2|||
145386127|NCT02452554|524267044|FG001|Overall Study|Death|1|||
145386128|NCT02452554|524267045|FG002|Overall Study|Death|0|||
145386129|NCT02452554|524267046|FG003|Overall Study|Death|0|||
145386130|NCT02452554|524267047|FG004|Overall Study|Death|0|||
145386131|NCT02452554|524267048|FG005|Overall Study|Death|0|||
145386132|NCT02452554|524267043|FG000|Overall Study|Lack of Efficacy|13|||
145386133|NCT02452554|524267044|FG001|Overall Study|Lack of Efficacy|14|||
145386134|NCT02452554|524267045|FG002|Overall Study|Lack of Efficacy|9|||
145386135|NCT02452554|524267046|FG003|Overall Study|Lack of Efficacy|1|||
145386136|NCT02452554|524267047|FG004|Overall Study|Lack of Efficacy|5|||
145386137|NCT02452554|524267048|FG005|Overall Study|Lack of Efficacy|8|||
145386138|NCT02452554|524267043|FG000|Overall Study|Physician Decision|0|||
145386139|NCT02452554|524267044|FG001|Overall Study|Physician Decision|1|||
145386140|NCT02452554|524267045|FG002|Overall Study|Physician Decision|0|||
145386141|NCT02452554|524267046|FG003|Overall Study|Physician Decision|0|||
145386142|NCT02452554|524267047|FG004|Overall Study|Physician Decision|0|||
145386143|NCT02452554|524267048|FG005|Overall Study|Physician Decision|0|||
145386144|NCT02452554|524267043|FG000|Overall Study|Withdrawal by Subject|1|||
145386145|NCT02452554|524267044|FG001|Overall Study|Withdrawal by Subject|0|||
145386146|NCT02452554|524267045|FG002|Overall Study|Withdrawal by Subject|2|||
145386147|NCT02452554|524267046|FG003|Overall Study|Withdrawal by Subject|0|||
145386148|NCT02452554|524267047|FG004|Overall Study|Withdrawal by Subject|0|||
145386149|NCT02452554|524267048|FG005|Overall Study|Withdrawal by Subject|1|||
145386150|NCT02452554|524267043|FG000|Overall Study|Ineligible|0|||
145386151|NCT02452554|524267044|FG001|Overall Study|Ineligible|1|||
145386152|NCT02452554|524267045|FG002|Overall Study|Ineligible|0|||
145386153|NCT02452554|524267046|FG003|Overall Study|Ineligible|0|||
145386154|NCT02452554|524267047|FG004|Overall Study|Ineligible|0|||
145386155|NCT02452554|524267048|FG005|Overall Study|Ineligible|0|||
145386156|NCT02452554|524267043|FG000|Overall Study|Never Received Treatment|1|||
145386157|NCT02452554|524267044|FG001|Overall Study|Never Received Treatment|0|||
145386158|NCT02452554|524267045|FG002|Overall Study|Never Received Treatment|0|||
145386159|NCT02452554|524267046|FG003|Overall Study|Never Received Treatment|0|||
145386160|NCT02452554|524267047|FG004|Overall Study|Never Received Treatment|0|||
145386161|NCT02452554|524267048|FG005|Overall Study|Never Received Treatment|0|||
145386162|NCT02494401|524267049|FG000|Overall Study|Lost to Follow-up|22|||
145386163|NCT02494401|524267050|FG001|Overall Study|Lost to Follow-up|25|||
145386164|NCT02494401|524267049|FG000|Overall Study|Withdrawal by Subject|3|||
145386165|NCT02494401|524267050|FG001|Overall Study|Withdrawal by Subject|2|||
145386166|NCT04378569|524268563|FG000|Overall Study|Adverse Event|0|||
145386167|NCT04378569|524268564|FG001|Overall Study|Adverse Event|0|||
145386168|NCT04378569|524268565|FG002|Overall Study|Adverse Event|2|||
145386169|NCT04378569|524268566|FG003|Overall Study|Adverse Event|0|||
145386170|NCT04378569|524268567|FG004|Overall Study|Adverse Event|3|||
145386171|NCT04378569|524268568|FG005|Overall Study|Adverse Event|3|||
145386172|NCT04378569|524268563|FG000|Overall Study|Lost to Follow-up|0|||
145386173|NCT04378569|524268564|FG001|Overall Study|Lost to Follow-up|3|||
145386174|NCT04378569|524268565|FG002|Overall Study|Lost to Follow-up|1|||
145386175|NCT04378569|524268566|FG003|Overall Study|Lost to Follow-up|0|||
145386176|NCT04378569|524268567|FG004|Overall Study|Lost to Follow-up|1|||
145386177|NCT04378569|524268568|FG005|Overall Study|Lost to Follow-up|1|||
145386178|NCT04378569|524268563|FG000|Overall Study|Protocol Violation|0|||
145386179|NCT04378569|524268564|FG001|Overall Study|Protocol Violation|0|||
145386180|NCT04378569|524268565|FG002|Overall Study|Protocol Violation|0|||
145386181|NCT04378569|524268566|FG003|Overall Study|Protocol Violation|0|||
145386182|NCT04378569|524268567|FG004|Overall Study|Protocol Violation|0|||
145386183|NCT04378569|524268568|FG005|Overall Study|Protocol Violation|1|||
145386184|NCT04378569|524268563|FG000|Overall Study|Withdrawal by Subject|0|||
145386185|NCT04378569|524268564|FG001|Overall Study|Withdrawal by Subject|6|||
145386186|NCT04378569|524268565|FG002|Overall Study|Withdrawal by Subject|7|||
145386187|NCT04378569|524268566|FG003|Overall Study|Withdrawal by Subject|4|||
145386188|NCT04378569|524268567|FG004|Overall Study|Withdrawal by Subject|5|||
145386189|NCT04378569|524268568|FG005|Overall Study|Withdrawal by Subject|4|||
145386190|NCT04378569|524268563|FG000|Overall Study|Lack of response|0|||
145386191|NCT04378569|524268564|FG001|Overall Study|Lack of response|0|||
145386192|NCT04378569|524268565|FG002|Overall Study|Lack of response|1|||
145386193|NCT04378569|524268566|FG003|Overall Study|Lack of response|0|||
145386194|NCT04378569|524268567|FG004|Overall Study|Lack of response|1|||
145386195|NCT04378569|524268568|FG005|Overall Study|Lack of response|1|||
145386196|NCT01844817|524268569|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
145386197|NCT01844817|524268570|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
145386198|NCT01844817|524268569|FG000|Treatment|Progressive Disease|27|||
145386199|NCT01844817|524268570|FG001|Treatment|Progressive Disease|36|||
145386200|NCT01844817|524268569|FG000|Treatment|Adverse Event|17|||
145386201|NCT01844817|524268570|FG001|Treatment|Adverse Event|9|||
145386202|NCT01844817|524268569|FG000|Treatment|Withdrawal by Subject|10|||
145386203|NCT01844817|524268570|FG001|Treatment|Withdrawal by Subject|6|||
145386204|NCT01844817|524268569|FG000|Treatment|Death|10|||
145386205|NCT01844817|524268570|FG001|Treatment|Death|8|||
145386206|NCT01844817|524268569|FG000|Treatment|Lost to Follow-up|0|||
145386207|NCT01844817|524268570|FG001|Treatment|Lost to Follow-up|1|||
145386208|NCT01844817|524268569|FG000|Treatment|Other|0|||
145386209|NCT01844817|524268570|FG001|Treatment|Other|3|||
145386210|NCT02207400|524268571|FG000|Overall Study|Adverse Event|1|||
145386211|NCT02207400|524268572|FG001|Overall Study|Adverse Event|1|||
145386212|NCT02207400|524268571|FG000|Overall Study|Lost to Follow-up|6|||
145386213|NCT02207400|524268572|FG001|Overall Study|Lost to Follow-up|7|||
145386214|NCT02207400|524268571|FG000|Overall Study|Protocol Violation|1|||
145386215|NCT02207400|524268572|FG001|Overall Study|Protocol Violation|1|||
145386216|NCT02207400|524268571|FG000|Overall Study|Withdrawal by Subject|8|||
145386217|NCT02207400|524268572|FG001|Overall Study|Withdrawal by Subject|4|||
145386218|NCT02207400|524268571|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
145386219|NCT02207400|524268572|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
145386220|NCT03630705|524268573|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
145386221|NCT03630705|524268574|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
145386222|NCT03630705|524268575|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145386223|NCT03630705|524268576|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145386224|NCT03630705|524268573|FG000|Overall Study|Lost to Follow-up|1|||
145386225|NCT03630705|524268574|FG001|Overall Study|Lost to Follow-up|2|||
145386226|NCT03630705|524268575|FG002|Overall Study|Lost to Follow-up|0|||
145386227|NCT03630705|524268576|FG003|Overall Study|Lost to Follow-up|0|||
145386228|NCT03638466|524268579|FG000|Overall Study|Early Termination|0|||
145386229|NCT03638466|524268580|FG001|Overall Study|Early Termination|1|||
145386230|NCT01128400|524268581|FG000|Overall Study|Lost to Follow-up|1|||
145386231|NCT01128400|524268582|FG001|Overall Study|Lost to Follow-up|0|||
145386232|NCT01128400|524268583|FG002|Overall Study|Lost to Follow-up|1|||
145386233|NCT01128400|524268581|FG000|Overall Study|Screening failure|1|||
145386234|NCT01128400|524268582|FG001|Overall Study|Screening failure|0|||
145386235|NCT01128400|524268583|FG002|Overall Study|Screening failure|0|||
145386236|NCT01128400|524268581|FG000|Overall Study|were not invited to participate on taste|0|||
145386237|NCT01128400|524268582|FG001|Overall Study|were not invited to participate on taste|0|||
145386238|NCT01128400|524268583|FG002|Overall Study|were not invited to participate on taste|15|||
145386239|NCT01128400|524268581|FG000|Overall Study|Excluded due to sinus problems|0|||
145386240|NCT01128400|524268582|FG001|Overall Study|Excluded due to sinus problems|1|||
145386241|NCT01128400|524268583|FG002|Overall Study|Excluded due to sinus problems|0|||
145386242|NCT02362425|524268584|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
145386243|NCT02362425|524268585|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
145386244|NCT02362425|524268586|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
145386245|NCT02362425|524268587|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
145386246|NCT02362425|524268584|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
145386247|NCT02362425|524268585|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145386248|NCT02362425|524268586|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145386249|NCT02362425|524268587|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
145386250|NCT02362425|524268584|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
145386251|NCT02362425|524268585|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
145386252|NCT02362425|524268586|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
145386253|NCT02362425|524268587|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
145386254|NCT02362425|524268584|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
145386255|NCT02362425|524268585|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
145386256|NCT02362425|524268586|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
145386257|NCT02362425|524268587|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
145386258|NCT02362425|524268584|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
145386259|NCT02362425|524268585|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
145386260|NCT02362425|524268586|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
145386261|NCT02362425|524268587|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
145386262|NCT02362425|524268584|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145386263|NCT02362425|524268585|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145386264|NCT02362425|524268586|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
145386265|NCT02362425|524268587|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
145386266|NCT02362425|524268584|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145386267|NCT02362425|524268585|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145386268|NCT02362425|524268586|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
145386269|NCT02362425|524268587|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
145386270|NCT02362425|524268584|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145386271|NCT02362425|524268585|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145386272|NCT02362425|524268586|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
145386273|NCT02362425|524268587|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
145386274|NCT02155309|524268590|FG000|Overall Study|Protocol Violation|0|||
145386275|NCT02155309|524268591|FG001|Overall Study|Protocol Violation|0|||
145386276|NCT02155309|524268592|FG002|Overall Study|Protocol Violation|1|||
145386277|NCT01502956|524268601|FG000|Overall Study|Death|0|||
145386278|NCT01502956|524268602|FG001|Overall Study|Death|2|||
145386279|NCT01502956|524268601|FG000|Overall Study|Lost to Follow-up|14|||
145386280|NCT01502956|524268602|FG001|Overall Study|Lost to Follow-up|11|||
145386281|NCT01502956|524268601|FG000|Overall Study|Physician Decision|2|||
145386282|NCT01502956|524268602|FG001|Overall Study|Physician Decision|3|||
145386283|NCT01502956|524268601|FG000|Overall Study|Withdrawal by Subject|8|||
145386284|NCT01502956|524268602|FG001|Overall Study|Withdrawal by Subject|10|||
145386285|NCT01616758|524268603|FG000|Overall Study|Adverse Event|1|||
145386286|NCT01616758|524268603|FG000|Overall Study|Withdrawal by Subject|2|||
145386287|NCT01616758|524268603|FG000|Overall Study|Disease progression|18|||
145386288|NCT01616758|524268603|FG000|Overall Study|Study termination by Sponsor|1|||
145386289|NCT03746405|524268608|FG000|Overall Study|Withdrawal by Subject|3|||
145386290|NCT03746405|524268609|FG001|Overall Study|Withdrawal by Subject|0|||
145386291|NCT03746405|524268608|FG000|Overall Study|technical difficulties|0|||
145386292|NCT03746405|524268609|FG001|Overall Study|technical difficulties|2|||
145386293|NCT02753816|524268610|FG000|Overall Study|Protocol Violation|0|||
145386294|NCT02753816|524268611|FG001|Overall Study|Protocol Violation|1|||
145386295|NCT02753816|524268612|FG002|Overall Study|Protocol Violation|0|||
145386296|NCT02372383|524268616|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
145386297|NCT02372383|524268617|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
145386298|NCT02372383|524268618|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
145386299|NCT04472494|524268619|FG000|Pre-treatment|Other reasons|2|||
145386300|NCT04472494|524268620|FG001|Pre-treatment|Other reasons|0|||
145386301|NCT04472494|524268619|FG000|Treatment|Death|5|||
145386302|NCT04472494|524268620|FG001|Treatment|Death|2|||
145386303|NCT04472494|524268619|FG000|Treatment|Hospital discharge|1|||
145386304|NCT04472494|524268620|FG001|Treatment|Hospital discharge|1|||
145386305|NCT00707980|524268621|FG000|Overall Study|Adverse Event|49|||
145386306|NCT00707980|524268621|FG000|Overall Study|Lack of Efficacy|35|||
145386307|NCT00707980|524268621|FG000|Overall Study|Non-Compliance with Study Drug|28|||
145386308|NCT00707980|524268621|FG000|Overall Study|Protocol Deviations|19|||
145386309|NCT00707980|524268621|FG000|Overall Study|Withdrawal of Consent|81|||
145386310|NCT00707980|524268621|FG000|Overall Study|Lost to Follow-up|59|||
145386311|NCT00707980|524268621|FG000|Overall Study|Other|39|||
145386312|NCT02768792|524268628|FG000|Overall Study|Adverse Event|1|||
145386313|NCT01188668|524268629|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
145386314|NCT01188668|524268629|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
145386315|NCT01188668|524268629|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
145386316|NCT00303472|524268630|FG000|Treatment Period|Adverse Event|0|||
145386317|NCT00303472|524268631|FG001|Treatment Period|Adverse Event|0|||
145386318|NCT00303472|524268632|FG002|Treatment Period|Adverse Event|0|||
145728892|NCT03291587|525525148|FG001|Overall Study|Lost to Follow-up|43|||
145728893|NCT03291587|525525147|FG000|Overall Study|Refused to Answer|5|||
145728894|NCT03291587|525525148|FG001|Overall Study|Refused to Answer|2|||
145386319|NCT00303472|524268633|FG003|Treatment Period|Adverse Event|0|||
145386320|NCT00303472|524268634|FG004|Treatment Period|Adverse Event|1|||
145386321|NCT00303472|524268635|FG005|Treatment Period|Adverse Event|0|||
145386322|NCT00303472|524268636|FG006|Treatment Period|Adverse Event|0|||
145386323|NCT00303472|524268630|FG000|Treatment Period|Death|0|||
145386324|NCT00303472|524268631|FG001|Treatment Period|Death|0|||
145386325|NCT00303472|524268632|FG002|Treatment Period|Death|0|||
145386326|NCT00303472|524268633|FG003|Treatment Period|Death|1|||
145386327|NCT00303472|524268634|FG004|Treatment Period|Death|0|||
145386328|NCT00303472|524268635|FG005|Treatment Period|Death|0|||
145386329|NCT00303472|524268636|FG006|Treatment Period|Death|1|||
145386330|NCT00303472|524268630|FG000|Treatment Period|Withdrawal by Subject|0|||
145386331|NCT00303472|524268631|FG001|Treatment Period|Withdrawal by Subject|0|||
145386332|NCT00303472|524268632|FG002|Treatment Period|Withdrawal by Subject|0|||
145386333|NCT00303472|524268633|FG003|Treatment Period|Withdrawal by Subject|1|||
145386334|NCT00303472|524268634|FG004|Treatment Period|Withdrawal by Subject|0|||
145386335|NCT00303472|524268635|FG005|Treatment Period|Withdrawal by Subject|1|||
145386336|NCT00303472|524268636|FG006|Treatment Period|Withdrawal by Subject|0|||
145386337|NCT00303472|524268630|FG000|Treatment Period|Other|0|||
145386338|NCT00303472|524268631|FG001|Treatment Period|Other|0|||
145386339|NCT00303472|524268632|FG002|Treatment Period|Other|0|||
145386340|NCT00303472|524268633|FG003|Treatment Period|Other|0|||
145386341|NCT00303472|524268634|FG004|Treatment Period|Other|1|||
145386342|NCT00303472|524268635|FG005|Treatment Period|Other|0|||
145386343|NCT00303472|524268636|FG006|Treatment Period|Other|1|||
145386344|NCT00303472|524268630|FG000|Treatment Period|Disease Progression (to AML)|0|||
145386345|NCT00303472|524268631|FG001|Treatment Period|Disease Progression (to AML)|0|||
145386346|NCT00303472|524268632|FG002|Treatment Period|Disease Progression (to AML)|0|||
145386347|NCT00303472|524268633|FG003|Treatment Period|Disease Progression (to AML)|0|||
145386348|NCT00303472|524268634|FG004|Treatment Period|Disease Progression (to AML)|1|||
145386349|NCT00303472|524268635|FG005|Treatment Period|Disease Progression (to AML)|0|||
145386350|NCT00303472|524268636|FG006|Treatment Period|Disease Progression (to AML)|0|||
145386351|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Adverse Event|1|||
145386352|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Adverse Event|0|||
145386353|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Adverse Event|1|||
145386354|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Adverse Event|0|||
145386355|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Adverse Event|0|||
145386356|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Adverse Event|0|||
145386357|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Adverse Event|0|||
145386358|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Death|2|||
145386359|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Death|0|||
145386360|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Death|1|||
145386361|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Death|0|||
145386362|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Death|0|||
145386363|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Death|0|||
145386364|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Death|0|||
145386365|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386366|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386367|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386368|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
145386369|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386370|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386371|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
145386372|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Physician Decision|0|||
145386373|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Physician Decision|4|||
145386374|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Physician Decision|2|||
145386375|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Physician Decision|3|||
145386376|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Physician Decision|2|||
145386377|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Physician Decision|0|||
145386378|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Physician Decision|0|||
145386379|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145386380|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145386381|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145386382|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
145386383|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
145386384|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145386385|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
145386386|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Other|0|||
145386387|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Other|2|||
145386388|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Other|4|||
145386389|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Other|2|||
145386390|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Other|1|||
145495029|NCT02234843|524670267|FG000|Overall Study|Recovery|1|||
145495030|NCT02234843|524670268|FG001|Overall Study|Recovery|0|||
145386391|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Other|0|||
145386392|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Other|0|||
145386393|NCT00303472|524268630|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
145386394|NCT00303472|524268631|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145386395|NCT00303472|524268632|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145495031|NCT02234843|524670269|FG002|Overall Study|Recovery|0|||
145495032|NCT02234843|524670270|FG003|Overall Study|Recovery|0|||
145495033|NCT02234843|524670271|FG004|Overall Study|Recovery|0|||
145495034|NCT02234843|524670272|FG005|Overall Study|Recovery|0|||
145386396|NCT00303472|524268633|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145386397|NCT00303472|524268634|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145386398|NCT00303472|524268635|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
145386399|NCT00303472|524268636|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
145386400|NCT02937636|524268641|FG000|Overall Study|Other (Not specified)|3|||
145386401|NCT02937636|524268642|FG001|Overall Study|Other (Not specified)|2|||
145386402|NCT00770913|524268644|FG000|Overall Study|Adverse Event|1|||
145386403|NCT00770913|524268645|FG001|Overall Study|Adverse Event|3|||
145386404|NCT00770913|524268646|FG002|Overall Study|Adverse Event|6|||
145386405|NCT00770913|524268644|FG000|Overall Study|Refusal to continue participation|6|||
145386406|NCT00770913|524268645|FG001|Overall Study|Refusal to continue participation|4|||
145386407|NCT00770913|524268646|FG002|Overall Study|Refusal to continue participation|5|||
145386408|NCT00770913|524268644|FG000|Overall Study|Physician Decision|0|||
145386409|NCT00770913|524268645|FG001|Overall Study|Physician Decision|1|||
145386410|NCT00770913|524268646|FG002|Overall Study|Physician Decision|1|||
145386411|NCT00770913|524268644|FG000|Overall Study|Protocol Violation|3|||
145386412|NCT00770913|524268645|FG001|Overall Study|Protocol Violation|0|||
145386413|NCT00770913|524268646|FG002|Overall Study|Protocol Violation|1|||
145386414|NCT00770913|524268644|FG000|Overall Study|Incorrect drug was allocated|1|||
145386415|NCT00770913|524268645|FG001|Overall Study|Incorrect drug was allocated|0|||
145386416|NCT00770913|524268646|FG002|Overall Study|Incorrect drug was allocated|0|||
145386417|NCT00359294|524268650|FG000|Overall Study|Progressive disease|1|||
145386418|NCT00359294|524268651|FG001|Overall Study|Progressive disease|1|||
145386419|NCT00359294|524268652|FG002|Overall Study|Progressive disease|2|||
145386420|NCT00359294|524268653|FG003|Overall Study|Progressive disease|3|||
145386421|NCT00359294|524268654|FG004|Overall Study|Progressive disease|2|||
145386422|NCT00359294|524268650|FG000|Overall Study|Withdrawal by Subject|0|||
145386423|NCT00359294|524268651|FG001|Overall Study|Withdrawal by Subject|0|||
145386424|NCT00359294|524268652|FG002|Overall Study|Withdrawal by Subject|0|||
145386425|NCT00359294|524268653|FG003|Overall Study|Withdrawal by Subject|0|||
145386426|NCT00359294|524268654|FG004|Overall Study|Withdrawal by Subject|1|||
145386427|NCT00359294|524268650|FG000|Overall Study|Not treated|0|||
145386428|NCT00359294|524268651|FG001|Overall Study|Not treated|0|||
145386429|NCT00359294|524268652|FG002|Overall Study|Not treated|0|||
145386430|NCT00359294|524268653|FG003|Overall Study|Not treated|1|||
145386431|NCT00359294|524268654|FG004|Overall Study|Not treated|0|||
145386432|NCT00359294|524268650|FG000|Overall Study|Physician Decision|0|||
145386433|NCT00359294|524268651|FG001|Overall Study|Physician Decision|0|||
145386434|NCT00359294|524268652|FG002|Overall Study|Physician Decision|1|||
145386435|NCT00359294|524268653|FG003|Overall Study|Physician Decision|0|||
145386436|NCT00359294|524268654|FG004|Overall Study|Physician Decision|0|||
145386437|NCT03882957|524268655|FG000|Overall Study|Did not complete all three arms|1|||
145386438|NCT01134393|524268656|FG000|Overall Study|Adverse Event|18|||
145386439|NCT01134393|524268656|FG000|Overall Study|Lack of Efficacy|2|||
145386440|NCT01134393|524268656|FG000|Overall Study|Protocol Violation|12|||
145386441|NCT01134393|524268656|FG000|Overall Study|Lost to Follow-up|3|||
145386442|NCT01134393|524268656|FG000|Overall Study|Withdrawal by Subject|11|||
145386443|NCT01134393|524268656|FG000|Overall Study|Other|6|||
145386444|NCT01658904|524268657|FG000|Overall Study|Principal Investigator discretion|2|||
145386445|NCT01658904|524268658|FG001|Overall Study|Principal Investigator discretion|0|||
145386446|NCT01658904|524268659|FG002|Overall Study|Principal Investigator discretion|0|||
145386447|NCT00524680|524268660|FG000|Overall Study|progression|0|||
145386448|NCT00524680|524268661|FG001|Overall Study|progression|0|||
145386449|NCT00524680|524268662|FG002|Overall Study|progression|0|||
145386450|NCT00524680|524268663|FG003|Overall Study|progression|1|||
145386451|NCT00524680|524268660|FG000|Overall Study|Adverse Event|2|||
145386452|NCT00524680|524268661|FG001|Overall Study|Adverse Event|0|||
145386453|NCT00524680|524268662|FG002|Overall Study|Adverse Event|0|||
145386454|NCT00524680|524268663|FG003|Overall Study|Adverse Event|1|||
145386455|NCT00524680|524268660|FG000|Overall Study|Other|0|||
145386456|NCT00524680|524268661|FG001|Overall Study|Other|1|||
145386457|NCT00524680|524268662|FG002|Overall Study|Other|2|||
145386458|NCT00524680|524268663|FG003|Overall Study|Other|3|||
145386459|NCT00524680|524268660|FG000|Overall Study|Withdrawal by Subject|1|||
145386460|NCT00524680|524268661|FG001|Overall Study|Withdrawal by Subject|0|||
145386461|NCT00524680|524268662|FG002|Overall Study|Withdrawal by Subject|1|||
145386462|NCT00524680|524268663|FG003|Overall Study|Withdrawal by Subject|1|||
145386463|NCT04399538|524268667|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
145386464|NCT04399538|524268668|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
145386465|NCT04399538|524268669|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
145386466|NCT04399538|524268670|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
145386467|NCT04399538|524268671|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
145386468|NCT04399538|524268667|FG000|Double-Blind Treatment|Adverse Event|0|||
145386469|NCT04399538|524268668|FG001|Double-Blind Treatment|Adverse Event|0|||
145386470|NCT04399538|524268669|FG002|Double-Blind Treatment|Adverse Event|0|||
145386471|NCT04399538|524268670|FG003|Double-Blind Treatment|Adverse Event|0|||
145386472|NCT04399538|524268671|FG004|Double-Blind Treatment|Adverse Event|1|||
145386473|NCT04399538|524268667|FG000|Follow-Up|Adverse Event|0|||
145386474|NCT04399538|524268668|FG001|Follow-Up|Adverse Event|0|||
145386475|NCT04399538|524268669|FG002|Follow-Up|Adverse Event|0|||
145386476|NCT04399538|524268670|FG003|Follow-Up|Adverse Event|0|||
145386477|NCT04399538|524268671|FG004|Follow-Up|Adverse Event|1|||
145386478|NCT04399538|524268667|FG000|Follow-Up|Withdrawal by Subject|0|||
145386479|NCT04399538|524268668|FG001|Follow-Up|Withdrawal by Subject|0|||
145386480|NCT04399538|524268669|FG002|Follow-Up|Withdrawal by Subject|0|||
145386481|NCT04399538|524268670|FG003|Follow-Up|Withdrawal by Subject|2|||
145386482|NCT04399538|524268671|FG004|Follow-Up|Withdrawal by Subject|0|||
145386483|NCT02756364|524268673|FG000|Overall Study|Site Terminated by Sponsor|24|||
145386484|NCT02756364|524268674|FG001|Overall Study|Site Terminated by Sponsor|30|||
145386485|NCT02756364|524268675|FG002|Overall Study|Site Terminated by Sponsor|21|||
145386486|NCT02756364|524268673|FG000|Overall Study|Death|20|||
145386487|NCT02756364|524268674|FG001|Overall Study|Death|15|||
145386488|NCT02756364|524268675|FG002|Overall Study|Death|18|||
145386489|NCT02756364|524268673|FG000|Overall Study|Withdrawal by Patient|2|||
145386490|NCT02756364|524268674|FG001|Overall Study|Withdrawal by Patient|1|||
145386491|NCT02756364|524268675|FG002|Overall Study|Withdrawal by Patient|8|||
145386492|NCT02756364|524268673|FG000|Overall Study|Lost to Follow-up|0|||
145386493|NCT02756364|524268674|FG001|Overall Study|Lost to Follow-up|1|||
145386494|NCT02756364|524268675|FG002|Overall Study|Lost to Follow-up|1|||
145386495|NCT02223364|524268676|FG000|Overall Study|Protocol Violation|3|||
145386496|NCT02223364|524268677|FG001|Overall Study|Protocol Violation|0|||
145386497|NCT02223364|524268678|FG002|Overall Study|Protocol Violation|3|||
145386498|NCT02223364|524268676|FG000|Overall Study|subject expired before surgery|1|||
145386499|NCT02223364|524268677|FG001|Overall Study|subject expired before surgery|0|||
145386500|NCT02223364|524268678|FG002|Overall Study|subject expired before surgery|0|||
145386501|NCT02223364|524268676|FG000|Overall Study|Physician Decision|1|||
145386502|NCT02223364|524268677|FG001|Overall Study|Physician Decision|0|||
145386503|NCT02223364|524268678|FG002|Overall Study|Physician Decision|0|||
145386504|NCT01416155|524268679|FG000|Overall Study|Adverse Event|8|||
145386505|NCT01416155|524268679|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
145386506|NCT01416155|524268679|FG000|Overall Study|Withdrawal by Subject|33|||
145386507|NCT01416155|524268679|FG000|Overall Study|Investigator decision|8|||
145386508|NCT01416155|524268679|FG000|Overall Study|Other|7|||
145386509|NCT04811664|524268682|FG000|Overall Study|Lost to Follow-up|78|||
145386510|NCT04811664|524268683|FG001|Overall Study|Lost to Follow-up|125|||
145386511|NCT04811664|524268684|FG002|Overall Study|Lost to Follow-up|46|||
145386512|NCT04811664|524268682|FG000|Overall Study|Withdrawal by Subject|39|||
145386513|NCT04811664|524268683|FG001|Overall Study|Withdrawal by Subject|76|||
145386514|NCT04811664|524268684|FG002|Overall Study|Withdrawal by Subject|12|||
145386515|NCT04811664|524268682|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
145386516|NCT04811664|524268683|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
145386517|NCT04811664|524268684|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
145386518|NCT04811664|524268682|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
145386519|NCT04811664|524268683|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
145386520|NCT04811664|524268684|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
145386521|NCT04811664|524268682|FG000|Overall Study|Protocol Violation|0|||
145386522|NCT04811664|524268683|FG001|Overall Study|Protocol Violation|5|||
145386523|NCT04811664|524268684|FG002|Overall Study|Protocol Violation|11|||
145386524|NCT04811664|524268682|FG000|Overall Study|Study Terminated by Sponsor|4|||
145386525|NCT04811664|524268683|FG001|Overall Study|Study Terminated by Sponsor|3|||
145386526|NCT04811664|524268684|FG002|Overall Study|Study Terminated by Sponsor|34|||
145386527|NCT04811664|524268682|FG000|Overall Study|Early Study Closure|3|||
145386528|NCT04811664|524268683|FG001|Overall Study|Early Study Closure|7|||
145386529|NCT04811664|524268684|FG002|Overall Study|Early Study Closure|79|||
145386530|NCT04811664|524268682|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
145386531|NCT04811664|524268683|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
145386532|NCT04811664|524268684|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
145386533|NCT00248833|524268687|FG000|Overall Study|Adverse Event|2|||
145386534|NCT00248833|524268688|FG001|Overall Study|Adverse Event|0|||
145386535|NCT00248833|524268689|FG002|Overall Study|Adverse Event|0|||
145386536|NCT00248833|524268687|FG000|Overall Study|Withdrawal by Subject|0|||
145386537|NCT00248833|524268688|FG001|Overall Study|Withdrawal by Subject|1|||
145728895|NCT03291587|525525147|FG000|Overall Study|Death|2|||
145728896|NCT03291587|525525148|FG001|Overall Study|Death|4|||
145386538|NCT00248833|524268689|FG002|Overall Study|Withdrawal by Subject|1|||
145386539|NCT00248833|524268687|FG000|Overall Study|Lost to Follow-up|1|||
145386540|NCT00248833|524268688|FG001|Overall Study|Lost to Follow-up|1|||
145386541|NCT00248833|524268689|FG002|Overall Study|Lost to Follow-up|1|||
145386542|NCT00248833|524268687|FG000|Overall Study|Other|0|||
145386543|NCT00248833|524268688|FG001|Overall Study|Other|1|||
145728897|NCT03291587|525525147|FG000|Overall Study|Not interested in participating|8|||
145386544|NCT00248833|524268689|FG002|Overall Study|Other|0|||
145386545|NCT01900899|524268690|FG000|Overall Study|Withdrawal by Subject|7|||
145386546|NCT01900899|524268691|FG001|Overall Study|Withdrawal by Subject|1|||
145386547|NCT01900899|524268690|FG000|Overall Study|Migrated from study area|2|||
145386548|NCT01900899|524268691|FG001|Overall Study|Migrated from study area|0|||
145386549|NCT02772809|524268692|FG000|Overall Study|not completed some tasks|6|||
145386550|NCT00534105|524268695|FG000|Overall Study|Lost to Follow-up|23|||
145386551|NCT00534105|524268696|FG001|Overall Study|Lost to Follow-up|39|||
145386552|NCT00978341|524268697|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
145386553|NCT00978341|524268698|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
145386554|NCT01402986|524268699|FG000|Overall Study|Withdrawal by Subject|7|||
145386555|NCT01402986|524268700|FG001|Overall Study|Withdrawal by Subject|10|||
145386556|NCT01402986|524268701|FG002|Overall Study|Withdrawal by Subject|7|||
145386557|NCT01402986|524268702|FG003|Overall Study|Withdrawal by Subject|13|||
145386558|NCT01402986|524268699|FG000|Overall Study|Death|0|||
145386559|NCT01402986|524268700|FG001|Overall Study|Death|0|||
145386560|NCT01402986|524268701|FG002|Overall Study|Death|0|||
145386561|NCT01402986|524268702|FG003|Overall Study|Death|2|||
145386562|NCT01402986|524268699|FG000|Overall Study|Lost to Follow-up|0|||
145386563|NCT01402986|524268700|FG001|Overall Study|Lost to Follow-up|0|||
145386564|NCT01402986|524268701|FG002|Overall Study|Lost to Follow-up|0|||
145386565|NCT01402986|524268702|FG003|Overall Study|Lost to Follow-up|1|||
145386566|NCT01402986|524268699|FG000|Overall Study|Other|2|||
145386567|NCT01402986|524268700|FG001|Overall Study|Other|5|||
145386568|NCT01402986|524268701|FG002|Overall Study|Other|1|||
145386569|NCT01402986|524268702|FG003|Overall Study|Other|6|||
145386570|NCT02427802|524268703|FG000|Overall Study|Adverse Event|11|||
145386571|NCT02427802|524268704|FG001|Overall Study|Adverse Event|3|||
145386572|NCT02427802|524268705|FG002|Overall Study|Adverse Event|7|||
145386573|NCT02427802|524268703|FG000|Overall Study|Death|0|||
145386574|NCT02427802|524268704|FG001|Overall Study|Death|4|||
145386575|NCT02427802|524268705|FG002|Overall Study|Death|1|||
145386576|NCT02427802|524268703|FG000|Overall Study|Lost to Follow-up|13|||
145386577|NCT02427802|524268704|FG001|Overall Study|Lost to Follow-up|8|||
145386578|NCT02427802|524268705|FG002|Overall Study|Lost to Follow-up|8|||
145386579|NCT02427802|524268703|FG000|Overall Study|Physician Decision|4|||
145386580|NCT02427802|524268704|FG001|Overall Study|Physician Decision|2|||
145386581|NCT02427802|524268705|FG002|Overall Study|Physician Decision|4|||
145386582|NCT02427802|524268703|FG000|Overall Study|Withdrawal by Subject|10|||
145386583|NCT02427802|524268704|FG001|Overall Study|Withdrawal by Subject|5|||
145386584|NCT02427802|524268705|FG002|Overall Study|Withdrawal by Subject|11|||
145386585|NCT02427802|524268703|FG000|Overall Study|Protocol Violation|3|||
145386586|NCT02427802|524268704|FG001|Overall Study|Protocol Violation|1|||
145386587|NCT02427802|524268705|FG002|Overall Study|Protocol Violation|1|||
145386588|NCT02427802|524268703|FG000|Overall Study|protocol specific treatment unrelated|18|||
145386589|NCT02427802|524268704|FG001|Overall Study|protocol specific treatment unrelated|11|||
145386590|NCT02427802|524268705|FG002|Overall Study|protocol specific treatment unrelated|11|||
145386591|NCT02634983|524268706|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
145386592|NCT02634983|524268707|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
145386593|NCT00520767|524268709|FG000|Overall Study|Death|2|||
145386594|NCT01048944|524271025|FG000|Overall Study|Protocol Violation|8|||
145386595|NCT01048944|524271026|FG001|Overall Study|Protocol Violation|10|||
145386596|NCT01048944|524271027|FG002|Overall Study|Protocol Violation|10|||
145386597|NCT01048944|524271028|FG003|Overall Study|Protocol Violation|2|||
145386598|NCT00376532|524271029|FG000|Overall Study|Lack sufficient blood sample|6|||
145386599|NCT00376532|524271030|FG001|Overall Study|Lack sufficient blood sample|6|||
145386600|NCT01133704|524271031|FG000|Overall Study|Death|44|||
145386601|NCT01133704|524271032|FG001|Overall Study|Death|26|||
145386602|NCT01133704|524271031|FG000|Overall Study|Patient refused to continue|4|||
145386603|NCT01133704|524271032|FG001|Overall Study|Patient refused to continue|0|||
145386604|NCT01133704|524271031|FG000|Overall Study|Study Closure|1|||
145386605|NCT01133704|524271032|FG001|Overall Study|Study Closure|0|||
145386606|NCT03396822|524271033|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
145386607|NCT03396822|524271033|FG000|Overall Study|Physician Decision|1|||
145386608|NCT02849704|524271036|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
145386609|NCT02849704|524271037|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
145386610|NCT02849704|524271036|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
145386611|NCT02849704|524271037|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
145386612|NCT02849704|524271036|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
145386613|NCT02849704|524271037|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
145386614|NCT03251482|524271038|FG000|Overall Study|Withdrawal by Subject|0|||
145386615|NCT03251482|524271039|FG001|Overall Study|Withdrawal by Subject|1|||
145386616|NCT03251482|524271040|FG002|Overall Study|Withdrawal by Subject|0|||
145386617|NCT03251482|524271041|FG003|Overall Study|Withdrawal by Subject|0|||
145386618|NCT03251482|524271042|FG004|Overall Study|Withdrawal by Subject|0|||
145386619|NCT02447328|524271045|FG000|Overall Study|Withdrawal by Subject|1|||
145386620|NCT04336475|524271052|FG000|Overall Study|pain|1|||
145386621|NCT04336475|524271053|FG001|Overall Study|pain|0|||
145386622|NCT04336475|524271052|FG000|Overall Study|upper respiratory infection|1|||
145386623|NCT04336475|524271053|FG001|Overall Study|upper respiratory infection|0|||
145386624|NCT04336475|524271052|FG000|Overall Study|Lost to Follow-up|0|||
145386625|NCT04336475|524271053|FG001|Overall Study|Lost to Follow-up|2|||
145386626|NCT01990573|524271056|FG000|Overall Study|Physician Decision|0|||
145386627|NCT01990573|524271057|FG001|Overall Study|Physician Decision|0|||
145386628|NCT01990573|524271058|FG002|Overall Study|Physician Decision|1|||
145386629|NCT01763827|524271063|FG000|Overall Study|Withdrawal by Subject|1|||
145386630|NCT01763827|524271064|FG001|Overall Study|Withdrawal by Subject|0|||
145386631|NCT01763827|524271065|FG002|Overall Study|Withdrawal by Subject|0|||
145386632|NCT01763827|524271066|FG003|Overall Study|Withdrawal by Subject|0|||
145386633|NCT01763827|524271067|FG004|Overall Study|Withdrawal by Subject|2|||
145386634|NCT01763827|524271068|FG005|Overall Study|Withdrawal by Subject|0|||
145386635|NCT01763827|524271063|FG000|Overall Study|Decision by sponsor|2|||
145386636|NCT01763827|524271064|FG001|Overall Study|Decision by sponsor|0|||
145386637|NCT01763827|524271065|FG002|Overall Study|Decision by sponsor|3|||
145386638|NCT01763827|524271066|FG003|Overall Study|Decision by sponsor|0|||
145386639|NCT01763827|524271067|FG004|Overall Study|Decision by sponsor|2|||
145386640|NCT01763827|524271068|FG005|Overall Study|Decision by sponsor|1|||
145386641|NCT01763827|524271063|FG000|Overall Study|Lost to Follow-up|0|||
145386642|NCT01763827|524271064|FG001|Overall Study|Lost to Follow-up|1|||
145386643|NCT01763827|524271065|FG002|Overall Study|Lost to Follow-up|1|||
145386644|NCT01763827|524271066|FG003|Overall Study|Lost to Follow-up|1|||
145386645|NCT01763827|524271067|FG004|Overall Study|Lost to Follow-up|2|||
145386646|NCT01763827|524271068|FG005|Overall Study|Lost to Follow-up|1|||
145386647|NCT02030119|524271069|FG000|Overall Study|Withdrawal by Subject|3|||
145386648|NCT02030119|524271070|FG001|Overall Study|Withdrawal by Subject|1|||
145386649|NCT02030119|524271071|FG002|Overall Study|Withdrawal by Subject|5|||
145386650|NCT02030119|524271072|FG003|Overall Study|Withdrawal by Subject|3|||
145386651|NCT02030119|524271069|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
145386652|NCT02030119|524271070|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
145386653|NCT02030119|524271071|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
145386654|NCT02030119|524271072|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
145386655|NCT00412932|524271075|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
145386656|NCT00412932|524271075|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
145386657|NCT00412932|524271075|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
145386658|NCT00412932|524271075|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
145386659|NCT00412932|524271075|FG000|Olmesartan (Olm) 20 mg|Other|1|||
145386660|NCT00412932|524271075|FG000|Olmesartan 40 mg|Adverse Event|4|||
145386661|NCT00412932|524271075|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
145386662|NCT00412932|524271075|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
145386663|NCT00412932|524271075|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
145386664|NCT00412932|524271075|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
145386665|NCT00412932|524271075|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
145386666|NCT00412932|524271075|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
145386667|NCT02259400|524271082|FG000|Overall Study|Death|0|||
145386668|NCT02259400|524271083|FG001|Overall Study|Death|2|||
145386669|NCT03498313|524271085|FG000|Experimental Period 1|Adverse Event|1|||
145386670|NCT03498313|524271086|FG001|Experimental Period 1|Adverse Event|0|||
145386671|NCT03498313|524271087|FG002|Experimental Period 1|Adverse Event|0|||
145386672|NCT03498313|524271088|FG003|Experimental Period 1|Adverse Event|1|||
145386673|NCT03498313|524271089|FG004|Experimental Period 1|Adverse Event|0|||
145386674|NCT03498313|524271090|FG005|Experimental Period 1|Adverse Event|0|||
145386675|NCT03498313|524271085|FG000|Experimental Period 1|Withdrawal by Subject|0|||
145386676|NCT03498313|524271086|FG001|Experimental Period 1|Withdrawal by Subject|1|||
145386677|NCT03498313|524271087|FG002|Experimental Period 1|Withdrawal by Subject|0|||
145386678|NCT03498313|524271088|FG003|Experimental Period 1|Withdrawal by Subject|0|||
145386679|NCT03498313|524271089|FG004|Experimental Period 1|Withdrawal by Subject|0|||
145386680|NCT03498313|524271090|FG005|Experimental Period 1|Withdrawal by Subject|0|||
145386681|NCT03498313|524271085|FG000|Washout Period 1|Anovulation|1|||
145728898|NCT03291587|525525148|FG001|Overall Study|Not interested in participating|6|||
145728899|NCT03291587|525525147|FG000|Overall Study|Too busy to participate|4|||
145728900|NCT03291587|525525148|FG001|Overall Study|Too busy to participate|2|||
145728901|NCT00796120|525525149|FG000|Overall Study|Death|3|||
145728902|NCT00796120|525525150|FG001|Overall Study|Death|0|||
145728903|NCT00796120|525525149|FG000|Overall Study|Adverse Event|11|||
145728904|NCT00796120|525525150|FG001|Overall Study|Adverse Event|6|||
145386682|NCT03498313|524271086|FG001|Washout Period 1|Anovulation|0|||
145386683|NCT03498313|524271087|FG002|Washout Period 1|Anovulation|0|||
145386684|NCT03498313|524271088|FG003|Washout Period 1|Anovulation|0|||
145386685|NCT03498313|524271089|FG004|Washout Period 1|Anovulation|0|||
145386686|NCT03498313|524271090|FG005|Washout Period 1|Anovulation|0|||
145386687|NCT03498313|524271085|FG000|Washout Period 1|Withdrawal by Subject|0|||
145386688|NCT03498313|524271086|FG001|Washout Period 1|Withdrawal by Subject|3|||
145386689|NCT03498313|524271087|FG002|Washout Period 1|Withdrawal by Subject|0|||
145495035|NCT02234843|524670273|FG006|Overall Study|Recovery|0|||
145728905|NCT00796120|525525149|FG000|Overall Study|Progressive disease|22|||
145728906|NCT00796120|525525150|FG001|Overall Study|Progressive disease|13|||
145386690|NCT03498313|524271088|FG003|Washout Period 1|Withdrawal by Subject|1|||
145386691|NCT03498313|524271089|FG004|Washout Period 1|Withdrawal by Subject|0|||
145386692|NCT03498313|524271090|FG005|Washout Period 1|Withdrawal by Subject|1|||
145386693|NCT03498313|524271085|FG000|Experimental Period 2|Adverse Event|0|||
145386694|NCT03498313|524271086|FG001|Experimental Period 2|Adverse Event|0|||
145386695|NCT03498313|524271087|FG002|Experimental Period 2|Adverse Event|0|||
145386696|NCT03498313|524271088|FG003|Experimental Period 2|Adverse Event|0|||
145386697|NCT03498313|524271089|FG004|Experimental Period 2|Adverse Event|1|||
145386698|NCT03498313|524271090|FG005|Experimental Period 2|Adverse Event|2|||
145386699|NCT03498313|524271085|FG000|Washout Period 2|Physician Decision|1|||
145386700|NCT03498313|524271086|FG001|Washout Period 2|Physician Decision|0|||
145386701|NCT03498313|524271087|FG002|Washout Period 2|Physician Decision|0|||
145386702|NCT03498313|524271088|FG003|Washout Period 2|Physician Decision|1|||
145386703|NCT03498313|524271089|FG004|Washout Period 2|Physician Decision|0|||
145386704|NCT03498313|524271090|FG005|Washout Period 2|Physician Decision|1|||
145386705|NCT03498313|524271085|FG000|Washout Period 2|Withdrawal by Subject|3|||
145386706|NCT03498313|524271086|FG001|Washout Period 2|Withdrawal by Subject|2|||
145386707|NCT03498313|524271087|FG002|Washout Period 2|Withdrawal by Subject|0|||
145386708|NCT03498313|524271088|FG003|Washout Period 2|Withdrawal by Subject|0|||
145386709|NCT03498313|524271089|FG004|Washout Period 2|Withdrawal by Subject|2|||
145386710|NCT03498313|524271090|FG005|Washout Period 2|Withdrawal by Subject|0|||
145386711|NCT03498313|524271085|FG000|Washout Period 2|Anovulation|0|||
145386712|NCT03498313|524271086|FG001|Washout Period 2|Anovulation|0|||
145386713|NCT03498313|524271087|FG002|Washout Period 2|Anovulation|0|||
145386714|NCT03498313|524271088|FG003|Washout Period 2|Anovulation|0|||
145386715|NCT03498313|524271089|FG004|Washout Period 2|Anovulation|0|||
145386716|NCT03498313|524271090|FG005|Washout Period 2|Anovulation|1|||
145386717|NCT02630563|524271093|FG000|Overall Study|Administrative|1|||
145386718|NCT02239640|524271094|FG000|Overall Study|Withdrawal by Subject|3|||
145386719|NCT02239640|524271094|FG000|Overall Study|Lost to Follow-up|72|||
145386720|NCT02239640|524271094|FG000|Overall Study|Death|142|||
145386721|NCT00929994|524271095|FG000|Overall Study|Withdrawal by Subject|1|||
145386722|NCT00929994|524271095|FG000|Overall Study|medical issue unrelated to intervention|4|||
145386723|NCT00929994|524271095|FG000|Overall Study|employment|1|||
145386724|NCT02061813|524271098|FG000|Overall Study|Withdrawal by Subject|1|||
145386725|NCT02061813|524271098|FG000|Overall Study|Protocol Violation|2|||
145386726|NCT00206427|524271099|FG000|Overall Study|Adverse Event|2|||
145386727|NCT03130959|524271103|FG000|Overall Study|Disease progression|19|||
145386728|NCT03130959|524271104|FG001|Overall Study|Disease progression|7|||
145386729|NCT03130959|524271105|FG002|Overall Study|Disease progression|12|||
145386730|NCT03130959|524271106|FG003|Overall Study|Disease progression|7|||
145386731|NCT03130959|524271107|FG004|Overall Study|Disease progression|12|||
145386732|NCT03130959|524271108|FG005|Overall Study|Disease progression|3|||
145386733|NCT03130959|524271109|FG006|Overall Study|Disease progression|6|||
145386734|NCT03130959|524271110|FG007|Overall Study|Disease progression|3|||
145386735|NCT03130959|524271111|FG008|Overall Study|Disease progression|15|||
145386736|NCT03130959|524271112|FG009|Overall Study|Disease progression|8|||
145386737|NCT03130959|524271103|FG000|Overall Study|Study drug toxicity|2|||
145386738|NCT03130959|524271104|FG001|Overall Study|Study drug toxicity|2|||
145386739|NCT03130959|524271105|FG002|Overall Study|Study drug toxicity|1|||
145386740|NCT03130959|524271106|FG003|Overall Study|Study drug toxicity|2|||
145386741|NCT03130959|524271107|FG004|Overall Study|Study drug toxicity|1|||
145386742|NCT03130959|524271108|FG005|Overall Study|Study drug toxicity|1|||
145386743|NCT03130959|524271109|FG006|Overall Study|Study drug toxicity|3|||
145386744|NCT03130959|524271110|FG007|Overall Study|Study drug toxicity|0|||
145386745|NCT03130959|524271111|FG008|Overall Study|Study drug toxicity|3|||
145386746|NCT03130959|524271112|FG009|Overall Study|Study drug toxicity|3|||
145386747|NCT03130959|524271103|FG000|Overall Study|Other reasons|0|||
145386748|NCT03130959|524271104|FG001|Overall Study|Other reasons|0|||
145386749|NCT03130959|524271105|FG002|Overall Study|Other reasons|0|||
145386750|NCT03130959|524271106|FG003|Overall Study|Other reasons|0|||
145386751|NCT03130959|524271107|FG004|Overall Study|Other reasons|0|||
145495036|NCT02234843|524670274|FG007|Overall Study|Recovery|0|||
145386752|NCT03130959|524271108|FG005|Overall Study|Other reasons|1|||
145386753|NCT03130959|524271109|FG006|Overall Study|Other reasons|1|||
145386754|NCT03130959|524271110|FG007|Overall Study|Other reasons|0|||
145386755|NCT03130959|524271111|FG008|Overall Study|Other reasons|0|||
145386756|NCT03130959|524271112|FG009|Overall Study|Other reasons|0|||
145386757|NCT03130959|524271103|FG000|Overall Study|Subject request to discontinue therapy|0|||
145386758|NCT03130959|524271104|FG001|Overall Study|Subject request to discontinue therapy|0|||
145386759|NCT03130959|524271105|FG002|Overall Study|Subject request to discontinue therapy|1|||
145386760|NCT03130959|524271106|FG003|Overall Study|Subject request to discontinue therapy|1|||
145495037|NCT02234843|524670275|FG008|Overall Study|Recovery|0|||
145495038|NCT02234843|524670276|FG009|Overall Study|Recovery|0|||
145386761|NCT03130959|524271107|FG004|Overall Study|Subject request to discontinue therapy|0|||
145386762|NCT03130959|524271108|FG005|Overall Study|Subject request to discontinue therapy|0|||
145386763|NCT03130959|524271109|FG006|Overall Study|Subject request to discontinue therapy|1|||
145495039|NCT02234843|524670267|FG000|Overall Study|Other|0|||
145386764|NCT03130959|524271110|FG007|Overall Study|Subject request to discontinue therapy|1|||
145386765|NCT03130959|524271111|FG008|Overall Study|Subject request to discontinue therapy|0|||
145386766|NCT03130959|524271112|FG009|Overall Study|Subject request to discontinue therapy|0|||
145386767|NCT03130959|524271103|FG000|Overall Study|Not reported|0|||
145386768|NCT03130959|524271104|FG001|Overall Study|Not reported|0|||
145386769|NCT03130959|524271105|FG002|Overall Study|Not reported|0|||
145386770|NCT03130959|524271106|FG003|Overall Study|Not reported|1|||
145386771|NCT03130959|524271107|FG004|Overall Study|Not reported|0|||
145386772|NCT03130959|524271108|FG005|Overall Study|Not reported|1|||
145386773|NCT03130959|524271109|FG006|Overall Study|Not reported|0|||
145386774|NCT03130959|524271110|FG007|Overall Study|Not reported|0|||
145386775|NCT03130959|524271111|FG008|Overall Study|Not reported|0|||
145386776|NCT03130959|524271112|FG009|Overall Study|Not reported|1|||
145386777|NCT03130959|524271103|FG000|Overall Study|Adverse Event unrelated to drug|0|||
145386778|NCT03130959|524271104|FG001|Overall Study|Adverse Event unrelated to drug|0|||
145386779|NCT03130959|524271105|FG002|Overall Study|Adverse Event unrelated to drug|1|||
145386780|NCT03130959|524271106|FG003|Overall Study|Adverse Event unrelated to drug|1|||
145386781|NCT03130959|524271107|FG004|Overall Study|Adverse Event unrelated to drug|1|||
145386782|NCT03130959|524271108|FG005|Overall Study|Adverse Event unrelated to drug|0|||
145386783|NCT03130959|524271109|FG006|Overall Study|Adverse Event unrelated to drug|1|||
145386784|NCT03130959|524271110|FG007|Overall Study|Adverse Event unrelated to drug|0|||
145386785|NCT03130959|524271111|FG008|Overall Study|Adverse Event unrelated to drug|1|||
145386786|NCT03130959|524271112|FG009|Overall Study|Adverse Event unrelated to drug|1|||
145386787|NCT03130959|524271103|FG000|Overall Study|Participant withdrew consent|0|||
145386788|NCT03130959|524271104|FG001|Overall Study|Participant withdrew consent|1|||
145386789|NCT03130959|524271105|FG002|Overall Study|Participant withdrew consent|0|||
145386790|NCT03130959|524271106|FG003|Overall Study|Participant withdrew consent|2|||
145386791|NCT03130959|524271107|FG004|Overall Study|Participant withdrew consent|1|||
145386792|NCT03130959|524271108|FG005|Overall Study|Participant withdrew consent|0|||
145386793|NCT03130959|524271109|FG006|Overall Study|Participant withdrew consent|0|||
145386794|NCT03130959|524271110|FG007|Overall Study|Participant withdrew consent|0|||
145386795|NCT03130959|524271111|FG008|Overall Study|Participant withdrew consent|0|||
145386796|NCT03130959|524271112|FG009|Overall Study|Participant withdrew consent|2|||
145386797|NCT03130959|524271103|FG000|Overall Study|Administrative reason by sponsor|1|||
145386798|NCT03130959|524271104|FG001|Overall Study|Administrative reason by sponsor|0|||
145386799|NCT03130959|524271105|FG002|Overall Study|Administrative reason by sponsor|1|||
145386800|NCT03130959|524271106|FG003|Overall Study|Administrative reason by sponsor|0|||
145386801|NCT03130959|524271107|FG004|Overall Study|Administrative reason by sponsor|0|||
145386802|NCT03130959|524271108|FG005|Overall Study|Administrative reason by sponsor|0|||
145386803|NCT03130959|524271109|FG006|Overall Study|Administrative reason by sponsor|0|||
145386804|NCT03130959|524271110|FG007|Overall Study|Administrative reason by sponsor|0|||
145386805|NCT03130959|524271111|FG008|Overall Study|Administrative reason by sponsor|0|||
145386806|NCT03130959|524271112|FG009|Overall Study|Administrative reason by sponsor|0|||
145386807|NCT03130959|524271103|FG000|Overall Study|Lost to Follow-up|1|||
145386808|NCT03130959|524271104|FG001|Overall Study|Lost to Follow-up|0|||
145386809|NCT03130959|524271105|FG002|Overall Study|Lost to Follow-up|0|||
145386810|NCT03130959|524271106|FG003|Overall Study|Lost to Follow-up|0|||
145386811|NCT03130959|524271107|FG004|Overall Study|Lost to Follow-up|0|||
145386812|NCT03130959|524271108|FG005|Overall Study|Lost to Follow-up|0|||
145386813|NCT03130959|524271109|FG006|Overall Study|Lost to Follow-up|0|||
145386814|NCT03130959|524271110|FG007|Overall Study|Lost to Follow-up|0|||
145386815|NCT03130959|524271111|FG008|Overall Study|Lost to Follow-up|0|||
145386816|NCT03130959|524271112|FG009|Overall Study|Lost to Follow-up|0|||
145386817|NCT01909973|524271114|FG000|Overall Study|Lost to Follow-up|1|||
145386818|NCT01909973|524271115|FG001|Overall Study|Lost to Follow-up|0|||
145386819|NCT00809094|524271116|FG000|Overall Study|Lost to Follow-up|0|||
145386820|NCT00809094|524271117|FG001|Overall Study|Lost to Follow-up|1|||
145386821|NCT01690299|524271119|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
145386822|NCT01690299|524271120|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
145386823|NCT01690299|524271121|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
145386824|NCT01690299|524271122|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145386825|NCT01690299|524271123|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145386826|NCT01690299|524271124|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
145386827|NCT01690299|524271119|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
145386828|NCT01690299|524271120|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145386829|NCT01690299|524271121|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145386830|NCT01690299|524271122|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145386831|NCT01690299|524271123|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145386832|NCT01690299|524271124|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145386833|NCT01690299|524271119|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
145386834|NCT01690299|524271120|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
145386835|NCT01690299|524271121|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145386836|NCT01690299|524271122|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145386837|NCT01690299|524271123|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145386838|NCT01690299|524271124|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145386839|NCT01690299|524271119|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
145386840|NCT01690299|524271120|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
145386841|NCT01690299|524271121|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
145386842|NCT01690299|524271122|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145386843|NCT01690299|524271123|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145386844|NCT01690299|524271124|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
145386845|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145386846|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145386847|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
145386848|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
145386849|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
145386850|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
145386851|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145386852|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145386853|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
145386854|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
145386855|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
145386856|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
145386857|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145386858|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145386859|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145386860|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
145386861|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
145386862|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
145386863|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145386864|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145386865|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
145386866|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
145386867|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
145386868|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
145386869|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145386870|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145386871|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
145386872|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
145386873|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
145386874|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
145386875|NCT01690299|524271119|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145386876|NCT01690299|524271120|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145386877|NCT01690299|524271121|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145386878|NCT01690299|524271122|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145386879|NCT01690299|524271123|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
145386880|NCT01690299|524271124|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
145386881|NCT04676724|524271127|FG000|Overall Study|Adverse Event|2|||
145386882|NCT04676724|524271128|FG001|Overall Study|Adverse Event|0|||
145386883|NCT04676724|524271127|FG000|Overall Study|Lost to Follow-up|1|||
145386884|NCT04676724|524271128|FG001|Overall Study|Lost to Follow-up|0|||
145386885|NCT04676724|524271127|FG000|Overall Study|Physician Decision|0|||
145386886|NCT04676724|524271128|FG001|Overall Study|Physician Decision|1|||
145386887|NCT04676724|524271127|FG000|Overall Study|Withdrawal by Subject|3|||
145386888|NCT04676724|524271128|FG001|Overall Study|Withdrawal by Subject|2|||
145386889|NCT02521792|524271132|FG000|Overall Study|Study Terminated|6|||
145386890|NCT00398047|524271133|FG000|Overall Study|all patient progressed before completion|3|||
145386891|NCT01151345|524271135|FG000|First Intervention Period|Protocol Violation|0|||
145386892|NCT01151345|524271136|FG001|First Intervention Period|Protocol Violation|1|||
145386893|NCT04208412|524271139|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
145386894|NCT04208412|524271140|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
145386895|NCT04208412|524271139|FG000|Overall Study|Withdrawal by Subject|1|||
145386896|NCT04208412|524271140|FG001|Overall Study|Withdrawal by Subject|0|||
145386897|NCT04208412|524271139|FG000|Overall Study|Lost to Follow-up|0|||
145386898|NCT04208412|524271140|FG001|Overall Study|Lost to Follow-up|1|||
145386899|NCT03853291|524271143|FG000|Overall Study|Lost to Follow-up|1|||
145386900|NCT03853291|524271144|FG001|Overall Study|Lost to Follow-up|2|||
145386901|NCT03853291|524271145|FG002|Overall Study|Lost to Follow-up|0|||
145386902|NCT03853291|524271146|FG003|Overall Study|Lost to Follow-up|0|||
145386903|NCT03853291|524271147|FG004|Overall Study|Lost to Follow-up|0|||
145386904|NCT03853291|524271148|FG005|Overall Study|Lost to Follow-up|0|||
145386905|NCT03853291|524271143|FG000|Overall Study|Determined to be ineligible|1|||
145386906|NCT03853291|524271144|FG001|Overall Study|Determined to be ineligible|1|||
145386907|NCT03853291|524271145|FG002|Overall Study|Determined to be ineligible|0|||
145386908|NCT03853291|524271146|FG003|Overall Study|Determined to be ineligible|0|||
145386909|NCT03853291|524271147|FG004|Overall Study|Determined to be ineligible|0|||
145386910|NCT03853291|524271148|FG005|Overall Study|Determined to be ineligible|0|||
145386911|NCT03883477|524271149|FG000|Overall Study|Death|1|||
145386912|NCT03883477|524271150|FG001|Overall Study|Death|0|||
145386913|NCT03883477|524271149|FG000|Overall Study|Protocol Violation|0|||
145386914|NCT03883477|524271150|FG001|Overall Study|Protocol Violation|1|||
145386915|NCT03301831|524271160|FG000|Overall Study|Lost to Follow-up|5|||
145386916|NCT03301831|524271161|FG001|Overall Study|Lost to Follow-up|3|||
145386917|NCT03301831|524271160|FG000|Overall Study|Protocol Violation|4|||
145386918|NCT03301831|524271161|FG001|Overall Study|Protocol Violation|0|||
145386919|NCT03301831|524271160|FG000|Overall Study|Withdrawal by Subject|11|||
145386920|NCT03301831|524271161|FG001|Overall Study|Withdrawal by Subject|0|||
145386921|NCT00913770|524271166|FG000|Overall Study|Unable to contact|24|||
145386922|NCT00913770|524271167|FG001|Overall Study|Unable to contact|19|||
145386923|NCT00913770|524271168|FG002|Overall Study|Unable to contact|13|||
145386924|NCT00913770|524271166|FG000|Overall Study|Refused|11|||
145386925|NCT00913770|524271167|FG001|Overall Study|Refused|10|||
145386926|NCT00913770|524271168|FG002|Overall Study|Refused|8|||
145386927|NCT03337048|524271169|FG000|Overall Study|Withdrawal by Subject|2|||
145386928|NCT03337048|524271170|FG001|Overall Study|Withdrawal by Subject|0|||
145386929|NCT03337048|524271171|FG002|Overall Study|Withdrawal by Subject|0|||
145386930|NCT02348008|524271172|FG000|Overall Study|Adverse Event|2|||
145386931|NCT02348008|524271173|FG001|Overall Study|Adverse Event|3|||
145386932|NCT02348008|524271174|FG002|Overall Study|Adverse Event|3|||
145386933|NCT02348008|524271172|FG000|Overall Study|Disease Progression|1|||
145386934|NCT02348008|524271173|FG001|Overall Study|Disease Progression|5|||
145386935|NCT02348008|524271174|FG002|Overall Study|Disease Progression|16|||
145386936|NCT02348008|524271172|FG000|Overall Study|Withdrawal by Subject|0|||
145386937|NCT02348008|524271173|FG001|Overall Study|Withdrawal by Subject|1|||
145386938|NCT02348008|524271174|FG002|Overall Study|Withdrawal by Subject|0|||
145386939|NCT02348008|524271172|FG000|Overall Study|Symptomatic Deterioration|0|||
145386940|NCT02348008|524271173|FG001|Overall Study|Symptomatic Deterioration|1|||
145386941|NCT02348008|524271174|FG002|Overall Study|Symptomatic Deterioration|0|||
145386942|NCT00893971|524271179|FG000|Overall Study|Physician Decision|3|||
145386943|NCT03268005|524271180|FG000|Overall Study|Death|2|||
145386944|NCT03268005|524271181|FG001|Overall Study|Death|1|||
145386945|NCT03268005|524271180|FG000|Overall Study|Lost to Follow-up|2|||
145386946|NCT03268005|524271181|FG001|Overall Study|Lost to Follow-up|2|||
145386947|NCT03268005|524271180|FG000|Overall Study|Withdrawal by Subject|11|||
145386948|NCT03268005|524271181|FG001|Overall Study|Withdrawal by Subject|11|||
145386949|NCT00492232|524271182|FG000|Placebo Run-in|Adverse Event|0|||
145386950|NCT00492232|524271183|FG001|Placebo Run-in|Adverse Event|2|||
145386951|NCT00492232|524271182|FG000|Placebo Run-in|Protocol Violation|0|||
145386952|NCT00492232|524271183|FG001|Placebo Run-in|Protocol Violation|3|||
145386953|NCT00492232|524271182|FG000|Placebo Run-in|Lost to Follow-up|0|||
145386954|NCT00492232|524271183|FG001|Placebo Run-in|Lost to Follow-up|3|||
145386955|NCT00492232|524271182|FG000|Placebo Run-in|Withdrawal by Subject|0|||
145386956|NCT00492232|524271183|FG001|Placebo Run-in|Withdrawal by Subject|8|||
145386957|NCT00492232|524271182|FG000|Placebo Run-in|Pregnancy|0|||
145386958|NCT00492232|524271183|FG001|Placebo Run-in|Pregnancy|1|||
145386959|NCT00492232|524271182|FG000|Placebo Run-in|Entrance criteria not met|0|||
145386960|NCT00492232|524271183|FG001|Placebo Run-in|Entrance criteria not met|45|||
145386961|NCT00492232|524271182|FG000|Placebo Run-in|Other|0|||
145386962|NCT00492232|524271183|FG001|Placebo Run-in|Other|6|||
145386963|NCT00492232|524271182|FG000|Placebo Run-in|Missing|0|||
145386964|NCT00492232|524271183|FG001|Placebo Run-in|Missing|2|||
145386965|NCT00492232|524271182|FG000|Double-Blind Treatment|Adverse Event|1|||
145386966|NCT00492232|524271183|FG001|Double-Blind Treatment|Adverse Event|2|||
145386967|NCT00492232|524271182|FG000|Double-Blind Treatment|Protocol Violation|3|||
145386968|NCT00492232|524271183|FG001|Double-Blind Treatment|Protocol Violation|7|||
145386969|NCT00492232|524271182|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
145386970|NCT00492232|524271183|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
145386971|NCT00492232|524271182|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
145386972|NCT00492232|524271183|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
145386973|NCT00492232|524271182|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
145386974|NCT00492232|524271183|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
145386975|NCT00492232|524271182|FG000|Double-Blind Treatment|Other|6|||
145495040|NCT02234843|524670268|FG001|Overall Study|Other|2|||
145386976|NCT00492232|524271183|FG001|Double-Blind Treatment|Other|5|||
145386977|NCT00492232|524271182|FG000|Double-Blind Treatment|Randomized not treated|1|||
145386978|NCT00492232|524271183|FG001|Double-Blind Treatment|Randomized not treated|0|||
145386979|NCT00492232|524271182|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
145386980|NCT00492232|524271183|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
145386981|NCT03597139|524271187|FG000|Overall Study|Adverse Event|3|||
145386982|NCT03597139|524271188|FG001|Overall Study|Adverse Event|0|||
145386983|NCT03597139|524271187|FG000|Overall Study|Protocol Non-compliance|1|||
145386984|NCT03597139|524271188|FG001|Overall Study|Protocol Non-compliance|0|||
145386985|NCT02717442|524271189|FG000|Overall Study|Study Terminated by Sponsor|31|||
145386986|NCT02717442|524271190|FG001|Overall Study|Study Terminated by Sponsor|29|||
145386987|NCT02717442|524271189|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
145386988|NCT02717442|524271190|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
145386989|NCT02717442|524271189|FG000|Overall Study|Other - Not Specified|2|||
145386990|NCT02717442|524271190|FG001|Overall Study|Other - Not Specified|0|||
145386991|NCT00382109|524271191|FG000|Overall Study|Adverse Event|3|||
145386992|NCT00382109|524271192|FG001|Overall Study|Adverse Event|0|||
145386993|NCT00382109|524271191|FG000|Overall Study|Physician Decision|6|||
145386994|NCT00382109|524271192|FG001|Overall Study|Physician Decision|1|||
145386995|NCT00382109|524271191|FG000|Overall Study|Withdrawal by Subject|1|||
145386996|NCT00382109|524271192|FG001|Overall Study|Withdrawal by Subject|0|||
145386997|NCT00382109|524271191|FG000|Overall Study|ineligible|2|||
145386998|NCT00382109|524271192|FG001|Overall Study|ineligible|0|||
145386999|NCT00382109|524271191|FG000|Overall Study|Other|0|||
145387000|NCT00382109|524271192|FG001|Overall Study|Other|2|||
145387001|NCT00382109|524271191|FG000|Overall Study|consent withdrawal|0|||
145387002|NCT00382109|524271192|FG001|Overall Study|consent withdrawal|1|||
145387003|NCT05052697|524271193|FG000|Substudy A|Lost to Follow-up|0|||
145387004|NCT05052697|524271194|FG001|Substudy A|Lost to Follow-up|0|||
145387005|NCT05052697|524271195|FG002|Substudy A|Lost to Follow-up|0|||
145387006|NCT05052697|524271196|FG003|Substudy A|Lost to Follow-up|0|||
145387007|NCT05052697|524271197|FG004|Substudy A|Lost to Follow-up|0|||
145387008|NCT05052697|524271198|FG005|Substudy A|Lost to Follow-up|1|||
145387009|NCT05052697|524271199|FG006|Substudy A|Lost to Follow-up|0|||
145387010|NCT05052697|524271200|FG007|Substudy A|Lost to Follow-up|0|||
145387011|NCT05052697|524271201|FG008|Substudy A|Lost to Follow-up|0|||
145387012|NCT05052697|524271202|FG009|Substudy A|Lost to Follow-up|0|||
145387013|NCT05052697|524271203|FG010|Substudy A|Lost to Follow-up|0|||
145387014|NCT05052697|524271204|FG011|Substudy A|Lost to Follow-up|0|||
145387015|NCT05052697|524271205|FG012|Substudy A|Lost to Follow-up|0|||
145387016|NCT05052697|524271206|FG013|Substudy A|Lost to Follow-up|0|||
145387017|NCT05052697|524271207|FG014|Substudy A|Lost to Follow-up|0|||
145387018|NCT05052697|524271208|FG015|Substudy A|Lost to Follow-up|2|||
145387019|NCT05052697|524271209|FG016|Substudy A|Lost to Follow-up|0|||
145387020|NCT05052697|524271210|FG017|Substudy A|Lost to Follow-up|0|||
145387021|NCT05052697|524271211|FG018|Substudy A|Lost to Follow-up|0|||
145387022|NCT05052697|524271212|FG019|Substudy A|Lost to Follow-up|0|||
145387023|NCT05052697|524271213|FG020|Substudy A|Lost to Follow-up|0|||
145387024|NCT05052697|524271214|FG021|Substudy A|Lost to Follow-up|0|||
145387025|NCT05052697|524271215|FG022|Substudy A|Lost to Follow-up|0|||
145387026|NCT05052697|524271216|FG023|Substudy A|Lost to Follow-up|0|||
145387027|NCT05052697|524271217|FG024|Substudy A|Lost to Follow-up|0|||
145387028|NCT05052697|524271218|FG025|Substudy A|Lost to Follow-up|0|||
145387029|NCT05052697|524271219|FG026|Substudy A|Lost to Follow-up|0|||
145387030|NCT05052697|524271220|FG027|Substudy A|Lost to Follow-up|0|||
145387031|NCT05052697|524271221|FG028|Substudy A|Lost to Follow-up|0|||
145387032|NCT05052697|524271222|FG029|Substudy A|Lost to Follow-up|0|||
145387033|NCT05052697|524271223|FG030|Substudy A|Lost to Follow-up|0|||
145387034|NCT05052697|524271224|FG031|Substudy A|Lost to Follow-up|0|||
145387035|NCT05052697|524271225|FG032|Substudy A|Lost to Follow-up|0|||
145387036|NCT05052697|524271226|FG033|Substudy A|Lost to Follow-up|0|||
145387037|NCT05052697|524271193|FG000|Substudy A|No longer met eligibility criteria|0|||
145387038|NCT05052697|524271194|FG001|Substudy A|No longer met eligibility criteria|0|||
145387039|NCT05052697|524271195|FG002|Substudy A|No longer met eligibility criteria|0|||
145387040|NCT05052697|524271196|FG003|Substudy A|No longer met eligibility criteria|0|||
145387041|NCT05052697|524271197|FG004|Substudy A|No longer met eligibility criteria|0|||
145387042|NCT05052697|524271198|FG005|Substudy A|No longer met eligibility criteria|0|||
145387043|NCT05052697|524271199|FG006|Substudy A|No longer met eligibility criteria|0|||
145387044|NCT05052697|524271200|FG007|Substudy A|No longer met eligibility criteria|0|||
145387045|NCT05052697|524271201|FG008|Substudy A|No longer met eligibility criteria|0|||
145387046|NCT05052697|524271202|FG009|Substudy A|No longer met eligibility criteria|0|||
145387047|NCT05052697|524271203|FG010|Substudy A|No longer met eligibility criteria|0|||
145387048|NCT05052697|524271204|FG011|Substudy A|No longer met eligibility criteria|0|||
145387049|NCT05052697|524271205|FG012|Substudy A|No longer met eligibility criteria|0|||
145387050|NCT05052697|524271206|FG013|Substudy A|No longer met eligibility criteria|1|||
145387051|NCT05052697|524271207|FG014|Substudy A|No longer met eligibility criteria|0|||
145387052|NCT05052697|524271208|FG015|Substudy A|No longer met eligibility criteria|0|||
145387053|NCT05052697|524271209|FG016|Substudy A|No longer met eligibility criteria|0|||
145387054|NCT05052697|524271210|FG017|Substudy A|No longer met eligibility criteria|0|||
145387055|NCT05052697|524271211|FG018|Substudy A|No longer met eligibility criteria|0|||
145387056|NCT05052697|524271212|FG019|Substudy A|No longer met eligibility criteria|0|||
145387057|NCT05052697|524271213|FG020|Substudy A|No longer met eligibility criteria|0|||
145387058|NCT05052697|524271214|FG021|Substudy A|No longer met eligibility criteria|0|||
145387059|NCT05052697|524271215|FG022|Substudy A|No longer met eligibility criteria|0|||
145387060|NCT05052697|524271216|FG023|Substudy A|No longer met eligibility criteria|0|||
145387061|NCT05052697|524271217|FG024|Substudy A|No longer met eligibility criteria|0|||
145387062|NCT05052697|524271218|FG025|Substudy A|No longer met eligibility criteria|0|||
145387063|NCT05052697|524271219|FG026|Substudy A|No longer met eligibility criteria|0|||
145387064|NCT05052697|524271220|FG027|Substudy A|No longer met eligibility criteria|0|||
145387065|NCT05052697|524271221|FG028|Substudy A|No longer met eligibility criteria|0|||
145387066|NCT05052697|524271222|FG029|Substudy A|No longer met eligibility criteria|0|||
145387067|NCT05052697|524271223|FG030|Substudy A|No longer met eligibility criteria|0|||
145387068|NCT05052697|524271224|FG031|Substudy A|No longer met eligibility criteria|0|||
145387069|NCT05052697|524271225|FG032|Substudy A|No longer met eligibility criteria|0|||
145387070|NCT05052697|524271226|FG033|Substudy A|No longer met eligibility criteria|0|||
145387071|NCT05052697|524271193|FG000|Substudy A|Not vaccinated|0|||
145387072|NCT05052697|524271194|FG001|Substudy A|Not vaccinated|0|||
145387073|NCT05052697|524271195|FG002|Substudy A|Not vaccinated|0|||
145387074|NCT05052697|524271196|FG003|Substudy A|Not vaccinated|1|||
145387075|NCT05052697|524271197|FG004|Substudy A|Not vaccinated|0|||
145387076|NCT05052697|524271198|FG005|Substudy A|Not vaccinated|0|||
145387077|NCT05052697|524271199|FG006|Substudy A|Not vaccinated|0|||
145387078|NCT05052697|524271200|FG007|Substudy A|Not vaccinated|0|||
145387079|NCT05052697|524271201|FG008|Substudy A|Not vaccinated|1|||
145387080|NCT05052697|524271202|FG009|Substudy A|Not vaccinated|0|||
145387081|NCT05052697|524271203|FG010|Substudy A|Not vaccinated|0|||
145387082|NCT05052697|524271204|FG011|Substudy A|Not vaccinated|0|||
145387083|NCT05052697|524271205|FG012|Substudy A|Not vaccinated|0|||
145387084|NCT05052697|524271206|FG013|Substudy A|Not vaccinated|0|||
145387085|NCT05052697|524271207|FG014|Substudy A|Not vaccinated|0|||
145387086|NCT05052697|524271208|FG015|Substudy A|Not vaccinated|0|||
145387087|NCT05052697|524271209|FG016|Substudy A|Not vaccinated|0|||
145387088|NCT05052697|524271210|FG017|Substudy A|Not vaccinated|0|||
145387089|NCT05052697|524271211|FG018|Substudy A|Not vaccinated|0|||
145387090|NCT05052697|524271212|FG019|Substudy A|Not vaccinated|0|||
145387091|NCT05052697|524271213|FG020|Substudy A|Not vaccinated|0|||
145387092|NCT05052697|524271214|FG021|Substudy A|Not vaccinated|0|||
145387093|NCT05052697|524271215|FG022|Substudy A|Not vaccinated|0|||
145387094|NCT05052697|524271216|FG023|Substudy A|Not vaccinated|0|||
145387095|NCT05052697|524271217|FG024|Substudy A|Not vaccinated|0|||
145387096|NCT05052697|524271218|FG025|Substudy A|Not vaccinated|0|||
145387097|NCT05052697|524271219|FG026|Substudy A|Not vaccinated|0|||
145387098|NCT05052697|524271220|FG027|Substudy A|Not vaccinated|0|||
145387099|NCT05052697|524271221|FG028|Substudy A|Not vaccinated|0|||
145387100|NCT05052697|524271222|FG029|Substudy A|Not vaccinated|0|||
145387101|NCT05052697|524271223|FG030|Substudy A|Not vaccinated|0|||
145387102|NCT05052697|524271224|FG031|Substudy A|Not vaccinated|0|||
145387103|NCT05052697|524271225|FG032|Substudy A|Not vaccinated|0|||
145387104|NCT05052697|524271226|FG033|Substudy A|Not vaccinated|0|||
145387105|NCT05052697|524271193|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387106|NCT05052697|524271194|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387107|NCT05052697|524271195|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387108|NCT05052697|524271196|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387109|NCT05052697|524271197|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387110|NCT05052697|524271198|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387111|NCT05052697|524271199|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387112|NCT05052697|524271200|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387113|NCT05052697|524271201|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387114|NCT05052697|524271202|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387115|NCT05052697|524271203|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387116|NCT05052697|524271204|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145728907|NCT00796120|525525149|FG000|Overall Study|Participant refusal|3|||
145387117|NCT05052697|524271205|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387118|NCT05052697|524271206|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387119|NCT05052697|524271207|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387120|NCT05052697|524271208|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387121|NCT05052697|524271209|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145728908|NCT00796120|525525150|FG001|Overall Study|Participant refusal|4|||
145387122|NCT05052697|524271210|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387123|NCT05052697|524271211|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
145387124|NCT05052697|524271212|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
145387125|NCT05052697|524271213|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145728909|NCT00796120|525525149|FG000|Overall Study|Other|6|||
145387126|NCT05052697|524271214|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
145387127|NCT05052697|524271215|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
145495041|NCT02234843|524670269|FG002|Overall Study|Other|0|||
145387128|NCT05052697|524271216|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387129|NCT05052697|524271217|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387130|NCT05052697|524271218|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387131|NCT05052697|524271219|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387132|NCT05052697|524271220|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387133|NCT05052697|524271221|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387134|NCT05052697|524271222|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387135|NCT05052697|524271223|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387136|NCT05052697|524271224|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387137|NCT05052697|524271225|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387138|NCT05052697|524271226|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
145387139|NCT05052697|524271193|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387140|NCT05052697|524271194|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387141|NCT05052697|524271195|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387142|NCT05052697|524271196|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387143|NCT05052697|524271197|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387144|NCT05052697|524271198|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387145|NCT05052697|524271199|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387146|NCT05052697|524271200|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387147|NCT05052697|524271201|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387148|NCT05052697|524271202|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387149|NCT05052697|524271203|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387150|NCT05052697|524271204|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387151|NCT05052697|524271205|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387152|NCT05052697|524271206|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387153|NCT05052697|524271207|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387154|NCT05052697|524271208|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387155|NCT05052697|524271209|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387156|NCT05052697|524271210|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
145387157|NCT05052697|524271211|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387158|NCT05052697|524271212|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387159|NCT05052697|524271213|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387160|NCT05052697|524271214|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387161|NCT05052697|524271215|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387162|NCT05052697|524271216|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387163|NCT05052697|524271217|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387164|NCT05052697|524271218|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387165|NCT05052697|524271219|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387166|NCT05052697|524271220|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387167|NCT05052697|524271221|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387168|NCT05052697|524271222|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387169|NCT05052697|524271223|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387170|NCT05052697|524271224|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387171|NCT05052697|524271225|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387172|NCT05052697|524271226|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
145387173|NCT05052697|524271193|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387174|NCT05052697|524271194|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387175|NCT05052697|524271195|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387176|NCT05052697|524271196|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387177|NCT05052697|524271197|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387178|NCT05052697|524271198|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387179|NCT05052697|524271199|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387180|NCT05052697|524271200|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387181|NCT05052697|524271201|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387182|NCT05052697|524271202|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387183|NCT05052697|524271203|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387184|NCT05052697|524271204|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387185|NCT05052697|524271205|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387186|NCT05052697|524271206|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387187|NCT05052697|524271207|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387188|NCT05052697|524271208|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387189|NCT05052697|524271209|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387190|NCT05052697|524271210|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387191|NCT05052697|524271211|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387192|NCT05052697|524271212|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
145387193|NCT05052697|524271213|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387194|NCT05052697|524271214|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387195|NCT05052697|524271215|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387196|NCT05052697|524271216|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387197|NCT05052697|524271217|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387198|NCT05052697|524271218|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387199|NCT05052697|524271219|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387200|NCT05052697|524271220|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387201|NCT05052697|524271221|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387202|NCT05052697|524271222|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387203|NCT05052697|524271223|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387204|NCT05052697|524271224|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387205|NCT05052697|524271225|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387206|NCT05052697|524271226|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
145387207|NCT05052697|524271193|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387208|NCT05052697|524271194|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387209|NCT05052697|524271195|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387210|NCT05052697|524271196|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387211|NCT05052697|524271197|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387212|NCT05052697|524271198|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387213|NCT05052697|524271199|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387214|NCT05052697|524271200|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387215|NCT05052697|524271201|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387216|NCT05052697|524271202|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387217|NCT05052697|524271203|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387218|NCT05052697|524271204|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387219|NCT05052697|524271205|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387220|NCT05052697|524271206|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387221|NCT05052697|524271207|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387222|NCT05052697|524271208|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387223|NCT05052697|524271209|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387224|NCT05052697|524271210|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145387225|NCT05052697|524271211|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387226|NCT05052697|524271212|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387227|NCT05052697|524271213|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387228|NCT05052697|524271214|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387229|NCT05052697|524271215|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387230|NCT05052697|524271216|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387231|NCT05052697|524271217|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387232|NCT05052697|524271218|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145387233|NCT05052697|524271219|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387234|NCT05052697|524271220|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
145387235|NCT05052697|524271221|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387236|NCT05052697|524271222|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387237|NCT05052697|524271223|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387238|NCT05052697|524271224|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387239|NCT05052697|524271225|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387240|NCT05052697|524271226|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
145387241|NCT05052697|524271193|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387242|NCT05052697|524271194|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387243|NCT05052697|524271195|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387244|NCT05052697|524271196|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387245|NCT05052697|524271197|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387246|NCT05052697|524271198|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387247|NCT05052697|524271199|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387248|NCT05052697|524271200|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387249|NCT05052697|524271201|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387250|NCT05052697|524271202|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387251|NCT05052697|524271203|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387252|NCT05052697|524271204|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387253|NCT05052697|524271205|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387254|NCT05052697|524271206|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387255|NCT05052697|524271207|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387256|NCT05052697|524271208|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387257|NCT05052697|524271209|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387258|NCT05052697|524271210|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387259|NCT05052697|524271211|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387260|NCT05052697|524271212|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387261|NCT05052697|524271213|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387262|NCT05052697|524271214|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387263|NCT05052697|524271215|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387264|NCT05052697|524271216|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387265|NCT05052697|524271217|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387266|NCT05052697|524271218|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387267|NCT05052697|524271219|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387268|NCT05052697|524271220|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387269|NCT05052697|524271221|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
145387270|NCT05052697|524271222|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387271|NCT05052697|524271223|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145387272|NCT05052697|524271224|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145387273|NCT05052697|524271225|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
145387274|NCT05052697|524271226|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
145387275|NCT05052697|524271193|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387276|NCT05052697|524271194|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387277|NCT05052697|524271195|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387278|NCT05052697|524271196|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387279|NCT05052697|524271197|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387280|NCT05052697|524271198|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387281|NCT05052697|524271199|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387282|NCT05052697|524271200|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387283|NCT05052697|524271201|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387284|NCT05052697|524271202|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387285|NCT05052697|524271203|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387286|NCT05052697|524271204|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387287|NCT05052697|524271205|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387288|NCT05052697|524271206|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387289|NCT05052697|524271207|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387290|NCT05052697|524271208|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145728910|NCT00796120|525525150|FG001|Overall Study|Other|17|||
145728911|NCT00796120|525525149|FG000|Overall Study|Physician Decision|16|||
145728912|NCT00796120|525525150|FG001|Overall Study|Physician Decision|17|||
145728913|NCT00796120|525525149|FG000|Overall Study|Randomized but not treated|0|||
145728914|NCT00796120|525525150|FG001|Overall Study|Randomized but not treated|3|||
145728915|NCT03737474|525525154|FG000|Overall Study|Adverse Event|18|||
145387291|NCT05052697|524271209|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387292|NCT05052697|524271210|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387293|NCT05052697|524271211|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387294|NCT05052697|524271212|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387295|NCT05052697|524271213|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387296|NCT05052697|524271214|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387297|NCT05052697|524271215|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387298|NCT05052697|524271216|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387299|NCT05052697|524271217|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387300|NCT05052697|524271218|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387301|NCT05052697|524271219|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387302|NCT05052697|524271220|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387303|NCT05052697|524271221|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
145387304|NCT05052697|524271222|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
145387305|NCT05052697|524271223|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
145387306|NCT05052697|524271224|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
145387307|NCT05052697|524271225|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
145387308|NCT05052697|524271226|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
145387309|NCT05052697|524271193|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387310|NCT05052697|524271194|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387311|NCT05052697|524271195|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387312|NCT05052697|524271196|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387313|NCT05052697|524271197|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145728916|NCT03737474|525525155|FG001|Overall Study|Adverse Event|48|||
145728917|NCT03737474|525525154|FG000|Overall Study|Lack of Efficacy|1|||
145728918|NCT03737474|525525155|FG001|Overall Study|Lack of Efficacy|3|||
145728919|NCT03737474|525525154|FG000|Overall Study|Protocol Violation|0|||
145728920|NCT03737474|525525155|FG001|Overall Study|Protocol Violation|8|||
145728921|NCT03737474|525525154|FG000|Overall Study|Withdrawal by Subject|5|||
145728922|NCT03737474|525525155|FG001|Overall Study|Withdrawal by Subject|20|||
145387314|NCT05052697|524271198|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387315|NCT05052697|524271199|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387316|NCT05052697|524271200|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387317|NCT05052697|524271201|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387318|NCT05052697|524271202|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145495042|NCT02234843|524670270|FG003|Overall Study|Other|1|||
145728923|NCT03737474|525525154|FG000|Overall Study|Non-compliance With Study Drug|0|||
145387319|NCT05052697|524271203|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387320|NCT05052697|524271204|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387321|NCT05052697|524271205|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387322|NCT05052697|524271206|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387323|NCT05052697|524271207|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387324|NCT05052697|524271208|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387325|NCT05052697|524271209|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387326|NCT05052697|524271210|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387327|NCT05052697|524271211|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387328|NCT05052697|524271212|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387329|NCT05052697|524271213|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387330|NCT05052697|524271214|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387331|NCT05052697|524271215|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387332|NCT05052697|524271216|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387333|NCT05052697|524271217|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387334|NCT05052697|524271218|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387335|NCT05052697|524271219|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387336|NCT05052697|524271220|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387337|NCT05052697|524271221|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387338|NCT05052697|524271222|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387339|NCT05052697|524271223|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387340|NCT05052697|524271224|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387341|NCT05052697|524271225|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
145387342|NCT05052697|524271226|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
145387343|NCT05052697|524271193|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387344|NCT05052697|524271194|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387345|NCT05052697|524271195|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387346|NCT05052697|524271196|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387347|NCT05052697|524271197|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387348|NCT05052697|524271198|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387349|NCT05052697|524271199|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387350|NCT05052697|524271200|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387351|NCT05052697|524271201|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387352|NCT05052697|524271202|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387353|NCT05052697|524271203|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387354|NCT05052697|524271204|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387355|NCT05052697|524271205|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387356|NCT05052697|524271206|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387357|NCT05052697|524271207|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387358|NCT05052697|524271208|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387359|NCT05052697|524271209|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387360|NCT05052697|524271210|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387361|NCT05052697|524271211|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387362|NCT05052697|524271212|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387363|NCT05052697|524271213|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387364|NCT05052697|524271214|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387365|NCT05052697|524271215|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387366|NCT05052697|524271216|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387367|NCT05052697|524271217|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387368|NCT05052697|524271218|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387369|NCT05052697|524271219|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387370|NCT05052697|524271220|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387371|NCT05052697|524271221|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
145387372|NCT05052697|524271222|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
145387373|NCT05052697|524271223|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
145387374|NCT05052697|524271224|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387375|NCT05052697|524271225|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387376|NCT05052697|524271226|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
145387377|NCT03035916|524271227|FG000|Overall Study|Puncture failed|0|||
145387378|NCT03035916|524271228|FG001|Overall Study|Puncture failed|2|||
145387379|NCT03035916|524271229|FG002|Overall Study|Puncture failed|0|||
145387380|NCT01451554|524271230|FG000|Overall Study|Withdrawal by Subject|14|||
145387381|NCT01451554|524271231|FG001|Overall Study|Withdrawal by Subject|9|||
145387382|NCT03178851|524271232|FG000|Overall Study|Death|48|||
145387383|NCT03178851|524271233|FG001|Overall Study|Death|2|||
145387384|NCT03178851|524271234|FG002|Overall Study|Death|25|||
145387385|NCT03178851|524271232|FG000|Overall Study|Withdrawal by Subject|8|||
145387386|NCT03178851|524271233|FG001|Overall Study|Withdrawal by Subject|0|||
145387387|NCT03178851|524271234|FG002|Overall Study|Withdrawal by Subject|0|||
145387388|NCT03178851|524271232|FG000|Overall Study|Lost to Follow-up|5|||
145387389|NCT03178851|524271233|FG001|Overall Study|Lost to Follow-up|2|||
145387390|NCT03178851|524271234|FG002|Overall Study|Lost to Follow-up|0|||
145387391|NCT03178851|524271232|FG000|Overall Study|Adverse Event|0|||
145387392|NCT03178851|524271233|FG001|Overall Study|Adverse Event|0|||
145387393|NCT03178851|524271234|FG002|Overall Study|Adverse Event|1|||
145387394|NCT03178851|524271232|FG000|Overall Study|Study Termination by Sponsor|31|||
145387395|NCT03178851|524271233|FG001|Overall Study|Study Termination by Sponsor|7|||
145387396|NCT03178851|524271234|FG002|Overall Study|Study Termination by Sponsor|26|||
145387397|NCT02226120|524271235|FG000|Overall Study|Adverse Event|60|||
145387398|NCT02226120|524271235|FG000|Overall Study|Death|172|||
145387399|NCT02226120|524271235|FG000|Overall Study|Study terminated by sponsor|1|||
145387400|NCT02226120|524271235|FG000|Overall Study|Technical problems|4|||
145387401|NCT02226120|524271235|FG000|Overall Study|Lost to Follow-up|13|||
145387402|NCT02226120|524271235|FG000|Overall Study|Physician Decision|21|||
145387403|NCT02226120|524271235|FG000|Overall Study|Withdrawal by parent/guardian|36|||
145387404|NCT02226120|524271235|FG000|Overall Study|Non-compliance with study drug|10|||
145387405|NCT02226120|524271235|FG000|Overall Study|Protocol deviation|1|||
145387406|NCT02226120|524271235|FG000|Overall Study|missing treatment disposition pages|2|||
145387407|NCT05188729|524271239|FG000|Overall Study|Withdrawal by Subject|0|||
145387408|NCT05188729|524271240|FG001|Overall Study|Withdrawal by Subject|0|||
145387409|NCT05188729|524271241|FG002|Overall Study|Withdrawal by Subject|0|||
145387410|NCT05188729|524271242|FG003|Overall Study|Withdrawal by Subject|0|||
145387411|NCT05188729|524271243|FG004|Overall Study|Withdrawal by Subject|0|||
145387412|NCT05188729|524271244|FG005|Overall Study|Withdrawal by Subject|0|||
145387413|NCT05188729|524271245|FG006|Overall Study|Withdrawal by Subject|0|||
145387414|NCT05188729|524271246|FG007|Overall Study|Withdrawal by Subject|0|||
145387415|NCT05188729|524271247|FG008|Overall Study|Withdrawal by Subject|0|||
145387416|NCT05188729|524271248|FG009|Overall Study|Withdrawal by Subject|1|||
145387417|NCT05188729|524271249|FG010|Overall Study|Withdrawal by Subject|0|||
145387418|NCT05188729|524271250|FG011|Overall Study|Withdrawal by Subject|0|||
145387419|NCT05188729|524271251|FG012|Overall Study|Withdrawal by Subject|0|||
145387420|NCT05188729|524271239|FG000|Overall Study|Lost to Follow-up|0|||
145387421|NCT05188729|524271240|FG001|Overall Study|Lost to Follow-up|0|||
145387422|NCT05188729|524271241|FG002|Overall Study|Lost to Follow-up|0|||
145387423|NCT05188729|524271242|FG003|Overall Study|Lost to Follow-up|0|||
145387424|NCT05188729|524271243|FG004|Overall Study|Lost to Follow-up|0|||
145387425|NCT05188729|524271244|FG005|Overall Study|Lost to Follow-up|0|||
145387426|NCT05188729|524271245|FG006|Overall Study|Lost to Follow-up|0|||
145387427|NCT05188729|524271246|FG007|Overall Study|Lost to Follow-up|0|||
145387428|NCT05188729|524271247|FG008|Overall Study|Lost to Follow-up|0|||
145387429|NCT05188729|524271248|FG009|Overall Study|Lost to Follow-up|0|||
145387430|NCT05188729|524271249|FG010|Overall Study|Lost to Follow-up|1|||
145387431|NCT05188729|524271250|FG011|Overall Study|Lost to Follow-up|1|||
145387432|NCT05188729|524271251|FG012|Overall Study|Lost to Follow-up|0|||
145387433|NCT00398216|524274248|FG000|Overall Study|Adverse Event|4|||
145387434|NCT00398216|524274249|FG001|Overall Study|Adverse Event|2|||
145387435|NCT00398216|524274250|FG002|Overall Study|Adverse Event|5|||
145387436|NCT00398216|524274251|FG003|Overall Study|Adverse Event|7|||
145387437|NCT00398216|524274252|FG004|Overall Study|Adverse Event|2|||
145387438|NCT00398216|524274248|FG000|Overall Study|Protocol Violation|2|||
145387439|NCT00398216|524274249|FG001|Overall Study|Protocol Violation|4|||
145387440|NCT00398216|524274250|FG002|Overall Study|Protocol Violation|5|||
145387441|NCT00398216|524274251|FG003|Overall Study|Protocol Violation|7|||
145387442|NCT00398216|524274252|FG004|Overall Study|Protocol Violation|5|||
145387443|NCT00398216|524274248|FG000|Overall Study|Lost to Follow-up|1|||
145387444|NCT00398216|524274249|FG001|Overall Study|Lost to Follow-up|6|||
145387445|NCT00398216|524274250|FG002|Overall Study|Lost to Follow-up|4|||
145387446|NCT00398216|524274251|FG003|Overall Study|Lost to Follow-up|4|||
145387447|NCT00398216|524274252|FG004|Overall Study|Lost to Follow-up|1|||
145387448|NCT00398216|524274248|FG000|Overall Study|Death|0|||
145387449|NCT00398216|524274249|FG001|Overall Study|Death|3|||
145387450|NCT00398216|524274250|FG002|Overall Study|Death|0|||
145387451|NCT00398216|524274251|FG003|Overall Study|Death|0|||
145387452|NCT00398216|524274252|FG004|Overall Study|Death|0|||
145387453|NCT00398216|524274248|FG000|Overall Study|Withdrawal by Subject|1|||
145387454|NCT00398216|524274249|FG001|Overall Study|Withdrawal by Subject|0|||
145387455|NCT00398216|524274250|FG002|Overall Study|Withdrawal by Subject|3|||
145387456|NCT00398216|524274251|FG003|Overall Study|Withdrawal by Subject|1|||
145387457|NCT00398216|524274252|FG004|Overall Study|Withdrawal by Subject|2|||
145387458|NCT00398216|524274248|FG000|Overall Study|administrative reasons|3|||
145387459|NCT00398216|524274249|FG001|Overall Study|administrative reasons|4|||
145387460|NCT00398216|524274250|FG002|Overall Study|administrative reasons|4|||
145387461|NCT00398216|524274251|FG003|Overall Study|administrative reasons|3|||
145387462|NCT00398216|524274252|FG004|Overall Study|administrative reasons|3|||
145387463|NCT00398216|524274248|FG000|Overall Study|entrance criteria|0|||
145387464|NCT00398216|524274249|FG001|Overall Study|entrance criteria|0|||
145387465|NCT00398216|524274250|FG002|Overall Study|entrance criteria|0|||
145387466|NCT00398216|524274251|FG003|Overall Study|entrance criteria|0|||
145387467|NCT00398216|524274252|FG004|Overall Study|entrance criteria|2|||
145387468|NCT00802672|524274253|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
145387469|NCT00802672|524274254|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
145387470|NCT00802672|524274255|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
145387471|NCT00802672|524274253|FG000|Overall Study|Adverse Event|1|||
145387472|NCT00802672|524274254|FG001|Overall Study|Adverse Event|1|||
145387473|NCT00802672|524274255|FG002|Overall Study|Adverse Event|1|||
145387474|NCT00802672|524274253|FG000|Overall Study|Protocol Violation|2|||
145387475|NCT00802672|524274254|FG001|Overall Study|Protocol Violation|1|||
145387476|NCT00802672|524274255|FG002|Overall Study|Protocol Violation|1|||
145387477|NCT00802672|524274253|FG000|Overall Study|Lost to Follow-up|5|||
145387478|NCT00802672|524274254|FG001|Overall Study|Lost to Follow-up|5|||
145387479|NCT00802672|524274255|FG002|Overall Study|Lost to Follow-up|3|||
145387480|NCT00802672|524274253|FG000|Overall Study|Withdrawal by Subject|1|||
145387481|NCT00802672|524274254|FG001|Overall Study|Withdrawal by Subject|1|||
145387482|NCT00802672|524274255|FG002|Overall Study|Withdrawal by Subject|2|||
145387483|NCT00802672|524274253|FG000|Overall Study|other|3|||
145387484|NCT00802672|524274254|FG001|Overall Study|other|1|||
145387485|NCT00802672|524274255|FG002|Overall Study|other|2|||
145387486|NCT00759655|524274256|FG000|Overall Study|Termination of the study by sponsor|1|||
145387487|NCT01310127|524274257|FG000|Overall Study|Protocol Violation|1|||
145387488|NCT01310127|524274258|FG001|Overall Study|Protocol Violation|1|||
145387489|NCT01310127|524274257|FG000|Overall Study|advanced psc cataract outlier|1|||
145387490|NCT01310127|524274258|FG001|Overall Study|advanced psc cataract outlier|0|||
145387491|NCT01025284|524274259|FG000|Overall Study|Investigator Decision|0|||
145387492|NCT01025284|524274260|FG001|Overall Study|Investigator Decision|1|||
145387493|NCT01025284|524274261|FG002|Overall Study|Investigator Decision|0|||
145387494|NCT01025284|524274259|FG000|Overall Study|Withdrawal by Subject|0|||
145387495|NCT01025284|524274260|FG001|Overall Study|Withdrawal by Subject|1|||
145387496|NCT01025284|524274261|FG002|Overall Study|Withdrawal by Subject|0|||
145387497|NCT00905567|524274262|FG000|Washout|Withdrawal by Subject|0|||
145387498|NCT00905567|524274263|FG001|Washout|Withdrawal by Subject|1|||
145387499|NCT00547248|524274268|FG000|Overall Study|Protocol Violation|0|||
145387500|NCT00547248|524274269|FG001|Overall Study|Protocol Violation|0|||
145387501|NCT00547248|524274270|FG002|Overall Study|Protocol Violation|1|||
145387502|NCT00547248|524274271|FG003|Overall Study|Protocol Violation|1|||
145387503|NCT00547248|524274268|FG000|Overall Study|Migrated/moved from study area|0|||
145387504|NCT00547248|524274269|FG001|Overall Study|Migrated/moved from study area|0|||
145387505|NCT00547248|524274270|FG002|Overall Study|Migrated/moved from study area|2|||
145387506|NCT00547248|524274271|FG003|Overall Study|Migrated/moved from study area|0|||
145387507|NCT00547248|524274268|FG000|Overall Study|Withdrawal by Subject|0|||
145387508|NCT00547248|524274269|FG001|Overall Study|Withdrawal by Subject|0|||
145387509|NCT00547248|524274270|FG002|Overall Study|Withdrawal by Subject|7|||
145387510|NCT00547248|524274271|FG003|Overall Study|Withdrawal by Subject|1|||
145387511|NCT00534248|524274272|FG000|Overall Study|Adverse Event|19|||
145387512|NCT00534248|524274273|FG001|Overall Study|Adverse Event|29|||
145387513|NCT00534248|524274272|FG000|Overall Study|Lost to Follow-up|353|||
145387514|NCT00534248|524274273|FG001|Overall Study|Lost to Follow-up|375|||
145387515|NCT00534248|524274272|FG000|Overall Study|Other protocol specified criteria|13|||
145387516|NCT00534248|524274273|FG001|Overall Study|Other protocol specified criteria|3|||
145387517|NCT00534248|524274272|FG000|Overall Study|Physician Decision|10|||
145387518|NCT00534248|524274273|FG001|Overall Study|Physician Decision|7|||
145387519|NCT00534248|524274272|FG000|Overall Study|Protocol Violation|3|||
145387520|NCT00534248|524274273|FG001|Overall Study|Protocol Violation|4|||
145387521|NCT00534248|524274272|FG000|Overall Study|Withdrawal by Subject|263|||
145387522|NCT00534248|524274273|FG001|Overall Study|Withdrawal by Subject|255|||
145387523|NCT00697593|524274276|FG000|Overall Study|Adverse Event|3|||
145387524|NCT00697593|524274276|FG000|Overall Study|Protocol Violation|1|||
145387525|NCT00697593|524274276|FG000|Overall Study|Lack of Efficacy|3|||
145387526|NCT00697593|524274276|FG000|Overall Study|Suspension of the study by sponsor|12|||
145387527|NCT02075008|524274285|FG000|Overall Study|Technical problems|1|||
145387528|NCT02075008|524274285|FG000|Overall Study|Pregnancy|1|||
145387529|NCT02075008|524274285|FG000|Overall Study|Physician Decision|1|||
145387530|NCT02075008|524274285|FG000|Overall Study|Lost to Follow-up|1|||
145387531|NCT02075008|524274285|FG000|Overall Study|Lack of Efficacy|1|||
145387532|NCT02075008|524274285|FG000|Overall Study|Death|1|||
145387533|NCT02075008|524274285|FG000|Overall Study|Adverse Event|5|||
145387534|NCT02075008|524274285|FG000|Overall Study|Withdrawal by Subject|6|||
145387535|NCT02075008|524274285|FG000|Overall Study|Study terminated by Sponsor|159|||
145387536|NCT00572455|524274286|FG000|Stage I (14 Days)|Adverse Event|0|||
145387537|NCT00572455|524274287|FG001|Stage I (14 Days)|Adverse Event|0|||
145387538|NCT00572455|524274288|FG002|Stage I (14 Days)|Adverse Event|0|||
145387539|NCT00572455|524274289|FG003|Stage I (14 Days)|Adverse Event|0|||
145387540|NCT00572455|524274290|FG004|Stage I (14 Days)|Adverse Event|0|||
145387541|NCT00572455|524274291|FG005|Stage I (14 Days)|Adverse Event|3|||
145387542|NCT00572455|524274292|FG006|Stage I (14 Days)|Adverse Event|0|||
145387543|NCT00572455|524274293|FG007|Stage I (14 Days)|Adverse Event|0|||
145387544|NCT00572455|524274294|FG008|Stage I (14 Days)|Adverse Event|0|||
145387545|NCT00572455|524274295|FG009|Stage I (14 Days)|Adverse Event|0|||
145387546|NCT00572455|524274296|FG010|Stage I (14 Days)|Adverse Event|0|||
145387547|NCT00572455|524274297|FG011|Stage I (14 Days)|Adverse Event|0|||
145387548|NCT00572455|524274298|FG012|Stage I (14 Days)|Adverse Event|0|||
145387549|NCT00572455|524274299|FG013|Stage I (14 Days)|Adverse Event|0|||
145387550|NCT00572455|524274286|FG000|Stage I (14 Days)|Other|0|||
145387551|NCT00572455|524274287|FG001|Stage I (14 Days)|Other|0|||
145387552|NCT00572455|524274288|FG002|Stage I (14 Days)|Other|0|||
145387553|NCT00572455|524274289|FG003|Stage I (14 Days)|Other|0|||
145387554|NCT00572455|524274290|FG004|Stage I (14 Days)|Other|1|||
145387555|NCT00572455|524274291|FG005|Stage I (14 Days)|Other|0|||
145387556|NCT00572455|524274292|FG006|Stage I (14 Days)|Other|0|||
145387557|NCT00572455|524274293|FG007|Stage I (14 Days)|Other|0|||
145387558|NCT00572455|524274294|FG008|Stage I (14 Days)|Other|0|||
145387559|NCT00572455|524274295|FG009|Stage I (14 Days)|Other|0|||
145387560|NCT00572455|524274296|FG010|Stage I (14 Days)|Other|0|||
145387561|NCT00572455|524274297|FG011|Stage I (14 Days)|Other|0|||
145387562|NCT00572455|524274298|FG012|Stage I (14 Days)|Other|0|||
145387563|NCT00572455|524274299|FG013|Stage I (14 Days)|Other|0|||
145387564|NCT00572455|524274286|FG000|Stage II (28 Days)|Adverse Event|0|||
145387565|NCT00572455|524274287|FG001|Stage II (28 Days)|Adverse Event|0|||
145387566|NCT00572455|524274288|FG002|Stage II (28 Days)|Adverse Event|0|||
145387567|NCT00572455|524274289|FG003|Stage II (28 Days)|Adverse Event|0|||
145387568|NCT00572455|524274290|FG004|Stage II (28 Days)|Adverse Event|0|||
145387569|NCT00572455|524274291|FG005|Stage II (28 Days)|Adverse Event|0|||
145387570|NCT00572455|524274292|FG006|Stage II (28 Days)|Adverse Event|0|||
145387571|NCT00572455|524274293|FG007|Stage II (28 Days)|Adverse Event|0|||
145387572|NCT00572455|524274294|FG008|Stage II (28 Days)|Adverse Event|1|||
145387573|NCT00572455|524274295|FG009|Stage II (28 Days)|Adverse Event|3|||
145387574|NCT00572455|524274296|FG010|Stage II (28 Days)|Adverse Event|3|||
145387575|NCT00572455|524274297|FG011|Stage II (28 Days)|Adverse Event|4|||
145387576|NCT00572455|524274298|FG012|Stage II (28 Days)|Adverse Event|5|||
145387577|NCT00572455|524274299|FG013|Stage II (28 Days)|Adverse Event|1|||
145387578|NCT00572455|524274286|FG000|Stage II (28 Days)|Death|0|||
145387579|NCT00572455|524274287|FG001|Stage II (28 Days)|Death|0|||
145387580|NCT00572455|524274288|FG002|Stage II (28 Days)|Death|0|||
145387581|NCT00572455|524274289|FG003|Stage II (28 Days)|Death|0|||
145387582|NCT00572455|524274290|FG004|Stage II (28 Days)|Death|0|||
145387583|NCT00572455|524274291|FG005|Stage II (28 Days)|Death|0|||
145387584|NCT00572455|524274292|FG006|Stage II (28 Days)|Death|0|||
145387585|NCT00572455|524274293|FG007|Stage II (28 Days)|Death|0|||
145387586|NCT00572455|524274294|FG008|Stage II (28 Days)|Death|1|||
145387587|NCT00572455|524274295|FG009|Stage II (28 Days)|Death|0|||
145387588|NCT00572455|524274296|FG010|Stage II (28 Days)|Death|0|||
145387589|NCT00572455|524274297|FG011|Stage II (28 Days)|Death|0|||
145387590|NCT00572455|524274298|FG012|Stage II (28 Days)|Death|0|||
145387591|NCT00572455|524274299|FG013|Stage II (28 Days)|Death|0|||
145387592|NCT00572455|524274286|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
145387593|NCT00572455|524274287|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
145387594|NCT00572455|524274288|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
145387595|NCT00572455|524274289|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
145387596|NCT00572455|524274290|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
145387597|NCT00572455|524274291|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
145387598|NCT00572455|524274292|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
145387599|NCT00572455|524274293|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
145387600|NCT00572455|524274294|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
145387601|NCT00572455|524274295|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
145387602|NCT00572455|524274296|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
145387603|NCT00572455|524274297|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
145387604|NCT00572455|524274298|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
145387605|NCT00572455|524274299|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
145387606|NCT00572455|524274286|FG000|Stage II (28 Days)|Other|0|||
145387607|NCT00572455|524274287|FG001|Stage II (28 Days)|Other|0|||
145387608|NCT00572455|524274288|FG002|Stage II (28 Days)|Other|0|||
145387609|NCT00572455|524274289|FG003|Stage II (28 Days)|Other|0|||
145387610|NCT00572455|524274290|FG004|Stage II (28 Days)|Other|0|||
145387611|NCT00572455|524274291|FG005|Stage II (28 Days)|Other|0|||
145387612|NCT00572455|524274292|FG006|Stage II (28 Days)|Other|0|||
145387613|NCT00572455|524274293|FG007|Stage II (28 Days)|Other|0|||
145387614|NCT00572455|524274294|FG008|Stage II (28 Days)|Other|1|||
145387615|NCT00572455|524274295|FG009|Stage II (28 Days)|Other|0|||
145387616|NCT00572455|524274296|FG010|Stage II (28 Days)|Other|0|||
145387617|NCT00572455|524274297|FG011|Stage II (28 Days)|Other|0|||
145387618|NCT00572455|524274298|FG012|Stage II (28 Days)|Other|0|||
145387619|NCT00572455|524274299|FG013|Stage II (28 Days)|Other|0|||
145387620|NCT00572455|524274286|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
145387621|NCT00572455|524274287|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
145387622|NCT00572455|524274288|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
145387623|NCT00572455|524274289|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
145387624|NCT00572455|524274290|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
145387625|NCT00572455|524274291|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
145387626|NCT00572455|524274292|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
145387627|NCT00572455|524274293|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
145387628|NCT00572455|524274294|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
145387629|NCT00572455|524274295|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
145387630|NCT00572455|524274296|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
145387631|NCT00572455|524274297|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
145387632|NCT00572455|524274298|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
145387633|NCT00572455|524274299|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
145387634|NCT02384538|524274300|FG000|Overall Study|Adverse Event|1|||
145387635|NCT02384538|524274301|FG001|Overall Study|Adverse Event|4|||
145387636|NCT02384538|524274300|FG000|Overall Study|Lack of Efficacy|4|||
145387637|NCT02384538|524274301|FG001|Overall Study|Lack of Efficacy|4|||
145387638|NCT02384538|524274300|FG000|Overall Study|Withdrew Consent|0|||
145387639|NCT02384538|524274301|FG001|Overall Study|Withdrew Consent|4|||
145387640|NCT02384538|524274300|FG000|Overall Study|Other|1|||
145387641|NCT02384538|524274301|FG001|Overall Study|Other|3|||
145387642|NCT04446429|524274304|FG000|Overall Study|Lost to Follow-up|6|||
145387643|NCT04446429|524274305|FG001|Overall Study|Lost to Follow-up|0|||
145387644|NCT05205005|524274306|FG000|Overall Study|Withdrawal by Subject|1|||
145387645|NCT05205005|524274307|FG001|Overall Study|Withdrawal by Subject|0|||
145387646|NCT05205005|524274306|FG000|Overall Study|Adverse Event|1|||
145387647|NCT05205005|524274307|FG001|Overall Study|Adverse Event|0|||
145387648|NCT02187029|524274311|FG000|Overall Study|Adverse Event|0|||
145387649|NCT02187029|524274312|FG001|Overall Study|Adverse Event|1|||
145387650|NCT02187029|524274313|FG002|Overall Study|Adverse Event|1|||
145387651|NCT02187029|524274314|FG003|Overall Study|Adverse Event|0|||
145387652|NCT02187029|524274311|FG000|Overall Study|Study Terminated by Sponsor|0|||
145387653|NCT02187029|524274312|FG001|Overall Study|Study Terminated by Sponsor|0|||
145387654|NCT02187029|524274313|FG002|Overall Study|Study Terminated by Sponsor|10|||
145387655|NCT02187029|524274314|FG003|Overall Study|Study Terminated by Sponsor|3|||
145387656|NCT02187029|524274311|FG000|Overall Study|Withdrawal by Subject|1|||
145387657|NCT02187029|524274312|FG001|Overall Study|Withdrawal by Subject|0|||
145387658|NCT02187029|524274313|FG002|Overall Study|Withdrawal by Subject|0|||
145387659|NCT02187029|524274314|FG003|Overall Study|Withdrawal by Subject|0|||
145387660|NCT00694356|524274315|FG000|Overall Study|Adverse Event|1|||
145387661|NCT00694356|524274316|FG001|Overall Study|Adverse Event|0|||
145387662|NCT00694356|524274317|FG002|Overall Study|Adverse Event|0|||
145387663|NCT00694356|524274315|FG000|Overall Study|Progressive Disease|2|||
145387664|NCT00694356|524274316|FG001|Overall Study|Progressive Disease|6|||
145387665|NCT00694356|524274317|FG002|Overall Study|Progressive Disease|6|||
145387666|NCT03042910|524274322|FG000|Overall Study|Adverse Event|1|||
145387667|NCT03042910|524274322|FG000|Overall Study|Disease Progression|2|||
145387668|NCT03042910|524274322|FG000|Overall Study|Withdrawal by Subject|3|||
145387669|NCT03042910|524274322|FG000|Overall Study|Enrolled but not treated|1|||
145387670|NCT01763203|524274325|FG000|Overall Study|Death|4|||
145387671|NCT01763203|524274326|FG001|Overall Study|Death|7|||
145387672|NCT01763203|524274325|FG000|Overall Study|Lost to Follow-up|12|||
145387673|NCT01763203|524274326|FG001|Overall Study|Lost to Follow-up|12|||
145387674|NCT01763203|524274325|FG000|Overall Study|Withdrawal by Subject|8|||
145387675|NCT01763203|524274326|FG001|Overall Study|Withdrawal by Subject|12|||
145387676|NCT01763203|524274325|FG000|Overall Study|Moved out of study region|7|||
145387677|NCT01763203|524274326|FG001|Overall Study|Moved out of study region|10|||
145387678|NCT01763203|524274325|FG000|Overall Study|Physician Decision|2|||
145387679|NCT01763203|524274326|FG001|Overall Study|Physician Decision|1|||
145387680|NCT02756819|524274330|FG000|Overall Study|Lost for observation|23|||
145387681|NCT02756819|524274330|FG000|Overall Study|Patient's unwillingness|16|||
145387682|NCT02756819|524274330|FG000|Overall Study|Insufficient efficacy|2|||
145387683|NCT02756819|524274330|FG000|Overall Study|Adverse Event|2|||
145387684|NCT02756819|524274330|FG000|Overall Study|Reason not Specified|9|||
145387685|NCT01491841|524274332|FG000|Overall Study|Screen Failure|10|||
145387686|NCT01491841|524274332|FG000|Overall Study|Withdrawal by Subject|1|||
145387687|NCT02933528|524274333|FG000|Overall Study|Lost to Follow-up|2|||
145387688|NCT00741598|524274334|FG000|Overall Study|Lost to Follow-up|3|||
145387689|NCT00741598|524274335|FG001|Overall Study|Lost to Follow-up|4|||
145387690|NCT00741598|524274334|FG000|Overall Study|Lack of Efficacy|1|||
145387691|NCT00741598|524274335|FG001|Overall Study|Lack of Efficacy|2|||
145387692|NCT00741598|524274334|FG000|Overall Study|Physician Decision|1|||
145387693|NCT00741598|524274335|FG001|Overall Study|Physician Decision|1|||
145387694|NCT00741598|524274334|FG000|Overall Study|Pregnancy|1|||
145387695|NCT00741598|524274335|FG001|Overall Study|Pregnancy|0|||
145387696|NCT00741598|524274334|FG000|Overall Study|Withdrawal by Subject|3|||
145387697|NCT00741598|524274335|FG001|Overall Study|Withdrawal by Subject|2|||
145387698|NCT04105842|524274336|FG000|Overall Study|Withdrawal by Subject|2|||
145387699|NCT01301079|524274339|FG000|Overall Study|Lost to Follow-up|2|||
145387700|NCT01301079|524274340|FG001|Overall Study|Lost to Follow-up|2|||
145387701|NCT00313586|524274341|FG000|Overall Study|Disease progression|14|||
145387702|NCT00313586|524274342|FG001|Overall Study|Disease progression|19|||
145387703|NCT00313586|524274343|FG002|Overall Study|Disease progression|10|||
145387704|NCT00313586|524274344|FG003|Overall Study|Disease progression|3|||
145728924|NCT03737474|525525155|FG001|Overall Study|Non-compliance With Study Drug|1|||
145728925|NCT03737474|525525154|FG000|Overall Study|Physician Decision|1|||
145728926|NCT03737474|525525155|FG001|Overall Study|Physician Decision|4|||
145728927|NCT02513745|525525158|FG000|Overall Study|Criteria at time of surgery not met.|3|||
145728928|NCT02513745|525525159|FG001|Overall Study|Criteria at time of surgery not met.|3|||
145728929|NCT01209143|525525160|FG000|Overall Study|Adverse Event|2|||
145728930|NCT01209143|525525161|FG001|Overall Study|Adverse Event|1|||
145728931|NCT01209143|525525160|FG000|Overall Study|Death|0|||
145728932|NCT01209143|525525161|FG001|Overall Study|Death|1|||
145728933|NCT01209143|525525160|FG000|Overall Study|Physician Decision|3|||
145387705|NCT00313586|524274341|FG000|Overall Study|Adverse Event|12|||
145728934|NCT01209143|525525161|FG001|Overall Study|Physician Decision|1|||
145728935|NCT01209143|525525160|FG000|Overall Study|Lost to Follow-up|1|||
145728936|NCT01209143|525525161|FG001|Overall Study|Lost to Follow-up|0|||
145728937|NCT01209143|525525160|FG000|Overall Study|Withdrawal by Subject|2|||
145728938|NCT01209143|525525161|FG001|Overall Study|Withdrawal by Subject|1|||
145728939|NCT01209143|525525160|FG000|Overall Study|Disease progression|11|||
145728940|NCT01209143|525525161|FG001|Overall Study|Disease progression|16|||
145728941|NCT00381303|525525162|FG000|Overall Study|Lost to Follow-up|25|||
145728942|NCT00381303|525525163|FG001|Overall Study|Lost to Follow-up|9|||
145728943|NCT00381303|525525162|FG000|Overall Study|AE/HIV-related event|22|||
145728944|NCT00381303|525525163|FG001|Overall Study|AE/HIV-related event|6|||
145728945|NCT00381303|525525162|FG000|Overall Study|Non-Adherence|13|||
145728946|NCT00381303|525525163|FG001|Overall Study|Non-Adherence|6|||
145728947|NCT00381303|525525162|FG000|Overall Study|Withdrawal by Subject|13|||
145728948|NCT00381303|525525163|FG001|Overall Study|Withdrawal by Subject|6|||
145728949|NCT00381303|525525162|FG000|Overall Study|Virologic failure|6|||
145728950|NCT00381303|525525163|FG001|Overall Study|Virologic failure|4|||
145728951|NCT00381303|525525162|FG000|Overall Study|Ineligible to continue the trial|2|||
145728952|NCT00381303|525525163|FG001|Overall Study|Ineligible to continue the trial|1|||
145728953|NCT00381303|525525162|FG000|Overall Study|Pregnancy|2|||
145728954|NCT00381303|525525163|FG001|Overall Study|Pregnancy|0|||
145728955|NCT00381303|525525162|FG000|Overall Study|Physician Decision|1|||
145728956|NCT00381303|525525163|FG001|Overall Study|Physician Decision|0|||
145728957|NCT00381303|525525162|FG000|Overall Study|Physician's decision to close the site|3|||
145728958|NCT00381303|525525163|FG001|Overall Study|Physician's decision to close the site|1|||
145728959|NCT00381303|525525162|FG000|Overall Study|Subject moved out of state|2|||
145728960|NCT00381303|525525163|FG001|Overall Study|Subject moved out of state|0|||
145728961|NCT00381303|525525162|FG000|Overall Study|Subject taking too many different meds|1|||
145728962|NCT00381303|525525163|FG001|Overall Study|Subject taking too many different meds|0|||
145728963|NCT00381303|525525162|FG000|Overall Study|No virologic response by week 12|1|||
145728964|NCT00381303|525525163|FG001|Overall Study|No virologic response by week 12|0|||
145728965|NCT00381303|525525162|FG000|Overall Study|Subject was too busy for appointments|1|||
145728966|NCT00381303|525525163|FG001|Overall Study|Subject was too busy for appointments|0|||
145728967|NCT00381303|525525162|FG000|Overall Study|Subject did not continue visits|1|||
145728968|NCT00381303|525525163|FG001|Overall Study|Subject did not continue visits|0|||
145728969|NCT00381303|525525162|FG000|Overall Study|Subject primary physician's decision|1|||
145728970|NCT00381303|525525163|FG001|Overall Study|Subject primary physician's decision|0|||
145728971|NCT01145755|525525166|FG000|Overall Study|Adverse Event|2|||
145728972|NCT01145755|525525167|FG001|Overall Study|Adverse Event|4|||
145728973|NCT01145755|525525168|FG002|Overall Study|Adverse Event|2|||
145728974|NCT01145755|525525166|FG000|Overall Study|Withdrawal by Subject|2|||
145728975|NCT01145755|525525167|FG001|Overall Study|Withdrawal by Subject|2|||
145728976|NCT01145755|525525168|FG002|Overall Study|Withdrawal by Subject|2|||
145387706|NCT00313586|524274342|FG001|Overall Study|Adverse Event|18|||
145387707|NCT00313586|524274343|FG002|Overall Study|Adverse Event|3|||
145387708|NCT00313586|524274344|FG003|Overall Study|Adverse Event|10|||
145387709|NCT00313586|524274341|FG000|Overall Study|Death|11|||
145387710|NCT00313586|524274342|FG001|Overall Study|Death|8|||
145387711|NCT00313586|524274343|FG002|Overall Study|Death|1|||
145387712|NCT00313586|524274344|FG003|Overall Study|Death|7|||
145387713|NCT00313586|524274341|FG000|Overall Study|Withdrawal by Subject|13|||
145387714|NCT00313586|524274342|FG001|Overall Study|Withdrawal by Subject|6|||
145387715|NCT00313586|524274343|FG002|Overall Study|Withdrawal by Subject|6|||
145387716|NCT00313586|524274344|FG003|Overall Study|Withdrawal by Subject|2|||
145387717|NCT00313586|524274341|FG000|Overall Study|Alternative therapy|3|||
145387718|NCT00313586|524274342|FG001|Overall Study|Alternative therapy|6|||
145387719|NCT00313586|524274343|FG002|Overall Study|Alternative therapy|2|||
145728977|NCT01145755|525525166|FG000|Overall Study|Lost to Follow-up|2|||
145728978|NCT01145755|525525167|FG001|Overall Study|Lost to Follow-up|3|||
145728979|NCT01145755|525525168|FG002|Overall Study|Lost to Follow-up|1|||
145728980|NCT01145755|525525166|FG000|Overall Study|Protocol Violation|0|||
145728981|NCT01145755|525525167|FG001|Overall Study|Protocol Violation|3|||
145728982|NCT01145755|525525168|FG002|Overall Study|Protocol Violation|1|||
145728983|NCT01145755|525525166|FG000|Overall Study|Study Closure|14|||
145728984|NCT01145755|525525167|FG001|Overall Study|Study Closure|14|||
145387720|NCT00313586|524274344|FG003|Overall Study|Alternative therapy|0|||
145387721|NCT00313586|524274341|FG000|Overall Study|Other complicating disease|2|||
145387722|NCT00313586|524274342|FG001|Overall Study|Other complicating disease|2|||
145387723|NCT00313586|524274343|FG002|Overall Study|Other complicating disease|0|||
145387724|NCT00313586|524274344|FG003|Overall Study|Other complicating disease|0|||
145387725|NCT00313586|524274341|FG000|Overall Study|Did not achieve HI-major/better response|10|||
145387726|NCT00313586|524274342|FG001|Overall Study|Did not achieve HI-major/better response|7|||
145387727|NCT00313586|524274343|FG002|Overall Study|Did not achieve HI-major/better response|2|||
145387728|NCT00313586|524274344|FG003|Overall Study|Did not achieve HI-major/better response|1|||
145387729|NCT00313586|524274341|FG000|Overall Study|Physician Decision|2|||
145387730|NCT00313586|524274342|FG001|Overall Study|Physician Decision|1|||
145387731|NCT00313586|524274343|FG002|Overall Study|Physician Decision|0|||
145387732|NCT00313586|524274344|FG003|Overall Study|Physician Decision|0|||
145387733|NCT00313586|524274341|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
145387734|NCT00313586|524274342|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
145387735|NCT00313586|524274343|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
145387736|NCT00313586|524274344|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
145387737|NCT00313586|524274341|FG000|Overall Study|Lost insurance|0|||
145387738|NCT00313586|524274342|FG001|Overall Study|Lost insurance|1|||
145387739|NCT00313586|524274343|FG002|Overall Study|Lost insurance|0|||
145387740|NCT00313586|524274344|FG003|Overall Study|Lost insurance|0|||
145387741|NCT00313586|524274341|FG000|Overall Study|Moved|0|||
145387742|NCT00313586|524274342|FG001|Overall Study|Moved|1|||
145387743|NCT00313586|524274343|FG002|Overall Study|Moved|0|||
145387744|NCT00313586|524274344|FG003|Overall Study|Moved|0|||
145387745|NCT00313586|524274341|FG000|Overall Study|Death before starting treatment|1|||
145387746|NCT00313586|524274342|FG001|Overall Study|Death before starting treatment|0|||
145387747|NCT00313586|524274343|FG002|Overall Study|Death before starting treatment|0|||
145387748|NCT00313586|524274344|FG003|Overall Study|Death before starting treatment|0|||
145387749|NCT02087670|524274345|FG000|Overall Study|Withdrawal by Subject|3|||
145387750|NCT02087670|524274346|FG001|Overall Study|Withdrawal by Subject|2|||
145387751|NCT03519919|524274348|FG000|Overall Study|Withdrawal by Subject|1|||
145387752|NCT03519919|524274348|FG000|Overall Study|Lack of Efficacy|1|||
145387753|NCT03519919|524274348|FG000|Overall Study|Screen Failure|1|||
145387754|NCT03076996|524274349|FG000|Overall Study|Withdrawal by Subject|2|||
145387755|NCT03076996|524274349|FG000|Overall Study|Lost to Follow-up|3|||
145387756|NCT03076996|524274349|FG000|Overall Study|Literacy precluded participation|1|||
145387757|NCT02144077|524274353|FG000|Overall Study|Withdrawal by Subject|3|||
145387758|NCT02144077|524274354|FG001|Overall Study|Withdrawal by Subject|3|||
145387759|NCT02144077|524274353|FG000|Overall Study|Adverse Event|2|||
145387760|NCT02144077|524274354|FG001|Overall Study|Adverse Event|3|||
145387761|NCT02144077|524274353|FG000|Overall Study|Lost to Follow-up|2|||
145387762|NCT02144077|524274354|FG001|Overall Study|Lost to Follow-up|2|||
145387763|NCT02144077|524274353|FG000|Overall Study|Protocol Violation|1|||
145387764|NCT02144077|524274354|FG001|Overall Study|Protocol Violation|2|||
145387765|NCT02144077|524274353|FG000|Overall Study|Death|0|||
145387766|NCT02144077|524274354|FG001|Overall Study|Death|1|||
145387767|NCT02144077|524274353|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
145387768|NCT02144077|524274354|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
145387769|NCT00169104|524274355|FG000|Overall Study|Withdrawal by Subject|2|||
145387770|NCT00169104|524274356|FG001|Overall Study|Withdrawal by Subject|0|||
145387771|NCT00169104|524274355|FG000|Overall Study|Protocol Violation|0|||
145387772|NCT00169104|524274356|FG001|Overall Study|Protocol Violation|1|||
145387773|NCT00169104|524274355|FG000|Overall Study|Physician Decision|0|||
145387774|NCT00169104|524274356|FG001|Overall Study|Physician Decision|1|||
145387775|NCT00715299|524274362|FG000|Overall Study|Withdrawal by Subject|1|||
145387776|NCT00715299|524274362|FG000|Overall Study|Adverse Event|3|||
145387777|NCT00715299|524274362|FG000|Overall Study|failed the pre-screen exercise test|2|||
145387778|NCT02020889|524274363|FG000|Overall Study|Adverse Event|0|||
145387779|NCT02020889|524274364|FG001|Overall Study|Adverse Event|1|||
145387780|NCT02020889|524274363|FG000|Overall Study|Lack of Efficacy|1|||
145387781|NCT02020889|524274364|FG001|Overall Study|Lack of Efficacy|0|||
145387782|NCT02020889|524274363|FG000|Overall Study|Lost to Follow-up|1|||
145387783|NCT02020889|524274364|FG001|Overall Study|Lost to Follow-up|0|||
145387784|NCT02020889|524274363|FG000|Overall Study|Physician Decision|2|||
145387785|NCT02020889|524274364|FG001|Overall Study|Physician Decision|0|||
145387786|NCT02020889|524274363|FG000|Overall Study|Withdrawal by Subject|3|||
145387787|NCT02020889|524274364|FG001|Overall Study|Withdrawal by Subject|2|||
145387788|NCT01540981|524274365|FG000|Overall Study|Withdrawal by Subject|1|||
145387789|NCT01540981|524274366|FG001|Overall Study|Withdrawal by Subject|0|||
145387790|NCT01535443|524274368|FG000|Overall Study|Physician Decision|3|||
145387791|NCT00232557|524274369|FG000|Overall Study|Lost to Follow-up|3|||
145387792|NCT00232557|524274370|FG001|Overall Study|Lost to Follow-up|5|||
145387793|NCT02260817|524274371|FG000|Overall Study|Lost to Follow-up|0|||
145387794|NCT02260817|524274372|FG001|Overall Study|Lost to Follow-up|14|||
145387795|NCT02260817|524274371|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
145495043|NCT02234843|524670271|FG004|Overall Study|Other|0|||
145387796|NCT02260817|524274372|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
145387797|NCT02260817|524274371|FG000|Overall Study|Observation, no biopsy|0|||
145387798|NCT02260817|524274372|FG001|Overall Study|Observation, no biopsy|1|||
145387799|NCT02260817|524274371|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
145387800|NCT02260817|524274372|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
145387801|NCT02260817|524274371|FG000|Overall Study|Protocol Violation|0|||
145387802|NCT02260817|524274372|FG001|Overall Study|Protocol Violation|14|||
145387803|NCT04435808|524274375|FG000|Overall Study|Study stopped by DSMB|0|||
145728985|NCT01145755|525525168|FG002|Overall Study|Study Closure|17|||
145728986|NCT01145755|525525166|FG000|Overall Study|Lack of Efficacy|0|||
145728987|NCT01145755|525525167|FG001|Overall Study|Lack of Efficacy|1|||
145728988|NCT01145755|525525168|FG002|Overall Study|Lack of Efficacy|0|||
145728989|NCT01145755|525525166|FG000|Overall Study|Patient could not swollow medication|0|||
145728990|NCT01145755|525525167|FG001|Overall Study|Patient could not swollow medication|0|||
145728991|NCT01145755|525525168|FG002|Overall Study|Patient could not swollow medication|1|||
145728992|NCT01145755|525525166|FG000|Overall Study|Withdrawal by Subject|0|||
145728993|NCT01145755|525525167|FG001|Overall Study|Withdrawal by Subject|0|||
145728994|NCT01145755|525525168|FG002|Overall Study|Withdrawal by Subject|1|||
145728995|NCT01145755|525525166|FG000|Overall Study|Positive urine ethanol|0|||
145728996|NCT01145755|525525167|FG001|Overall Study|Positive urine ethanol|1|||
145728997|NCT01145755|525525168|FG002|Overall Study|Positive urine ethanol|0|||
145728998|NCT01211522|525525169|FG000|Overall Study|Withdrawal by Subject|3|||
145728999|NCT01211522|525525170|FG001|Overall Study|Withdrawal by Subject|7|||
145729000|NCT01211522|525525171|FG002|Overall Study|Withdrawal by Subject|5|||
145729001|NCT01116882|525525178|FG000|30-day|Lost to Follow-up|50|||
145729002|NCT01116882|525525179|FG001|30-day|Lost to Follow-up|21|||
145729003|NCT01116882|525525178|FG000|30-day|Withdrawal by Subject|2|||
145729004|NCT01116882|525525179|FG001|30-day|Withdrawal by Subject|4|||
145729005|NCT01116882|525525178|FG000|30-day|Other Reasons|16|||
145729006|NCT01116882|525525179|FG001|30-day|Other Reasons|6|||
145729007|NCT01116882|525525178|FG000|12-month|Lost to Follow-up|111|||
145729008|NCT01116882|525525179|FG001|12-month|Lost to Follow-up|42|||
145729009|NCT01116882|525525178|FG000|12-month|Other Reasons|151|||
145729010|NCT01116882|525525179|FG001|12-month|Other Reasons|49|||
145729011|NCT01116882|525525178|FG000|12-month|Withdrawal by Subject|5|||
145729012|NCT01116882|525525179|FG001|12-month|Withdrawal by Subject|8|||
145729013|NCT00547365|525525180|FG000|Overall Study|Physician Decision|1|||
145729014|NCT00547365|525525180|FG000|Overall Study|Lost to Follow-up|1|||
145729015|NCT00547365|525525180|FG000|Overall Study|Protocol Violation|2|||
145729016|NCT00547365|525525180|FG000|Overall Study|death (not related to study)|4|||
145729017|NCT01777269|525525183|FG000|Overall Study|Adverse Event|24|||
145729018|NCT01777269|525525184|FG001|Overall Study|Adverse Event|33|||
145729019|NCT01777269|525525183|FG000|Overall Study|Lack of Efficacy|8|||
145729020|NCT01777269|525525184|FG001|Overall Study|Lack of Efficacy|10|||
145729021|NCT01777269|525525183|FG000|Overall Study|Protocol Violation|4|||
145729022|NCT01777269|525525184|FG001|Overall Study|Protocol Violation|4|||
145729023|NCT01777269|525525183|FG000|Overall Study|Participants reached stopping criteria|1|||
145729024|NCT01777269|525525184|FG001|Overall Study|Participants reached stopping criteria|1|||
145729025|NCT01777269|525525183|FG000|Overall Study|Lost to Follow-up|4|||
145729026|NCT01777269|525525184|FG001|Overall Study|Lost to Follow-up|0|||
145729027|NCT01777269|525525183|FG000|Overall Study|Physician Decision|5|||
145387804|NCT04435808|524274376|FG001|Overall Study|Study stopped by DSMB|1|||
145387805|NCT03299101|524274377|FG000|Overall Study|Lost to Follow-up|1|||
145387806|NCT03299101|524274377|FG000|Overall Study|Withdrawal by Subject|5|||
145387807|NCT03299101|524274377|FG000|Overall Study|Surgery was changed|3|||
145387808|NCT03299101|524274377|FG000|Overall Study|Not enough time to complete prehab|1|||
145387809|NCT01882803|524274378|FG000|Overall Study|Disease Progression|1|||
145387810|NCT01882803|524274378|FG000|Overall Study|Withdrawal by Subject|9|||
145387811|NCT01882803|524274378|FG000|Overall Study|Death|68|||
145387812|NCT01882803|524274378|FG000|Overall Study|Physician Decision|3|||
145729028|NCT01777269|525525184|FG001|Overall Study|Physician Decision|2|||
145729029|NCT01777269|525525183|FG000|Overall Study|Withdrawal by Subject|9|||
145729030|NCT01777269|525525184|FG001|Overall Study|Withdrawal by Subject|9|||
145729031|NCT00504881|525525185|FG000|Overall Study|Lack of Efficacy|1|||
145729032|NCT00504881|525525186|FG001|Overall Study|Lack of Efficacy|5|||
145729033|NCT00504881|525525185|FG000|Overall Study|Lost to Follow-up|0|||
145729034|NCT00504881|525525186|FG001|Overall Study|Lost to Follow-up|2|||
145729035|NCT00504881|525525185|FG000|Overall Study|Withdrawal by Subject|1|||
145729036|NCT00504881|525525186|FG001|Overall Study|Withdrawal by Subject|4|||
145387813|NCT01882803|524274378|FG000|Overall Study|Lost to Follow-up|3|||
145387814|NCT01882803|524274378|FG000|Overall Study|Follow-up Completed|39|||
145387815|NCT01882803|524274378|FG000|Overall Study|Study Terminated by the Sponsor|6|||
145729037|NCT00504881|525525185|FG000|Overall Study|Non-Compliance|1|||
145729038|NCT00504881|525525186|FG001|Overall Study|Non-Compliance|0|||
145729039|NCT00504881|525525185|FG000|Overall Study|No Birth Control|0|||
145729040|NCT00504881|525525186|FG001|Overall Study|No Birth Control|1|||
145729041|NCT00504881|525525185|FG000|Overall Study|Safety Visit not performed|0|||
145729042|NCT00504881|525525186|FG001|Overall Study|Safety Visit not performed|1|||
145387816|NCT01563913|524274379|FG000|Overall Study|Physician Decision|1|||
145387817|NCT01563913|524274380|FG001|Overall Study|Physician Decision|0|||
145387818|NCT01563913|524274379|FG000|Overall Study|Spouse Passed Away|1|||
145387819|NCT01563913|524274380|FG001|Overall Study|Spouse Passed Away|0|||
145387820|NCT00551525|524274381|FG000|Overall Study|Protocol Violation|5|||
145387821|NCT00237692|524274384|FG000|Overall Study|Lost to Follow-up|9|||
145387822|NCT00237692|524274385|FG001|Overall Study|Lost to Follow-up|3|||
145387823|NCT00237692|524274386|FG002|Overall Study|Lost to Follow-up|5|||
145387824|NCT00237692|524274387|FG003|Overall Study|Lost to Follow-up|3|||
145387825|NCT00237692|524274384|FG000|Overall Study|Death|1|||
145387826|NCT00237692|524274385|FG001|Overall Study|Death|2|||
145387827|NCT00237692|524274386|FG002|Overall Study|Death|2|||
145387828|NCT00237692|524274387|FG003|Overall Study|Death|3|||
145387829|NCT00237692|524274384|FG000|Overall Study|Excluded - did not meet criteria|4|||
145387830|NCT00237692|524274385|FG001|Overall Study|Excluded - did not meet criteria|3|||
145387831|NCT00237692|524274386|FG002|Overall Study|Excluded - did not meet criteria|5|||
145387832|NCT00237692|524274387|FG003|Overall Study|Excluded - did not meet criteria|9|||
145387833|NCT00237692|524274384|FG000|Overall Study|Withdrawal by Subject|4|||
145387834|NCT00237692|524274385|FG001|Overall Study|Withdrawal by Subject|6|||
145387835|NCT00237692|524274386|FG002|Overall Study|Withdrawal by Subject|10|||
145387836|NCT00237692|524274387|FG003|Overall Study|Withdrawal by Subject|4|||
145387837|NCT00902746|524274388|FG000|Overall Study|Protocol Violation|7|||
145387838|NCT00902746|524274388|FG000|Overall Study|Withdrawal by Subject|16|||
145387839|NCT00902746|524274388|FG000|Overall Study|Adverse Event|8|||
145387840|NCT00902746|524274388|FG000|Overall Study|Lost to Follow-up|3|||
145387841|NCT00902746|524274388|FG000|Overall Study|Physician Decision|2|||
145387842|NCT02081001|524274390|FG000|Overall Study|Adverse Event|0|||
145387843|NCT02081001|524274391|FG001|Overall Study|Adverse Event|0|||
145387844|NCT02081001|524274392|FG002|Overall Study|Adverse Event|0|||
145387845|NCT02081001|524274393|FG003|Overall Study|Adverse Event|0|||
145387846|NCT02081001|524274394|FG004|Overall Study|Adverse Event|1|||
145387847|NCT02081001|524274395|FG005|Overall Study|Adverse Event|0|||
145387848|NCT02081001|524274396|FG006|Overall Study|Adverse Event|0|||
145387849|NCT02081001|524274397|FG007|Overall Study|Adverse Event|0|||
145387850|NCT02081001|524274398|FG008|Overall Study|Adverse Event|0|||
145387851|NCT02081001|524274399|FG009|Overall Study|Adverse Event|0|||
145387852|NCT02081001|524274400|FG010|Overall Study|Adverse Event|0|||
145387853|NCT02081001|524274401|FG011|Overall Study|Adverse Event|0|||
145387854|NCT01765569|524274406|FG000|Period B|Withdrawal by Subject|1|||
145387855|NCT01765569|524274406|FG000|Period C|Death|1|||
145387856|NCT02588092|524274407|FG000|Overall Study|Death|4|||
145387857|NCT02588092|524274408|FG001|Overall Study|Death|3|||
145387858|NCT02588092|524274409|FG002|Overall Study|Death|3|||
145387859|NCT02588092|524274410|FG003|Overall Study|Death|3|||
145387860|NCT02588092|524274411|FG004|Overall Study|Death|2|||
145387861|NCT02588092|524274412|FG005|Overall Study|Death|2|||
145387862|NCT02588092|524274413|FG006|Overall Study|Death|2|||
145387863|NCT02588092|524274414|FG007|Overall Study|Death|1|||
145387864|NCT02588092|524274415|FG008|Overall Study|Death|5|||
145387865|NCT02588092|524274416|FG009|Overall Study|Death|2|||
145387866|NCT02588092|524274407|FG000|Overall Study|Withdrawal by Subject|0|||
145387867|NCT02588092|524274408|FG001|Overall Study|Withdrawal by Subject|0|||
145387868|NCT02588092|524274409|FG002|Overall Study|Withdrawal by Subject|0|||
145387869|NCT02588092|524274410|FG003|Overall Study|Withdrawal by Subject|0|||
145387870|NCT02588092|524274411|FG004|Overall Study|Withdrawal by Subject|0|||
145387871|NCT02588092|524274412|FG005|Overall Study|Withdrawal by Subject|1|||
145387872|NCT02588092|524274413|FG006|Overall Study|Withdrawal by Subject|1|||
145387873|NCT02588092|524274414|FG007|Overall Study|Withdrawal by Subject|2|||
145387874|NCT02588092|524274415|FG008|Overall Study|Withdrawal by Subject|0|||
145387875|NCT02588092|524274416|FG009|Overall Study|Withdrawal by Subject|0|||
145387876|NCT02588092|524274407|FG000|Overall Study|Started Another Treatment|0|||
145387877|NCT02588092|524274408|FG001|Overall Study|Started Another Treatment|0|||
145387878|NCT02588092|524274409|FG002|Overall Study|Started Another Treatment|0|||
145387879|NCT02588092|524274410|FG003|Overall Study|Started Another Treatment|0|||
145387880|NCT02588092|524274411|FG004|Overall Study|Started Another Treatment|1|||
145387881|NCT02588092|524274412|FG005|Overall Study|Started Another Treatment|0|||
145387882|NCT02588092|524274413|FG006|Overall Study|Started Another Treatment|0|||
145387883|NCT02588092|524274414|FG007|Overall Study|Started Another Treatment|1|||
145387884|NCT02588092|524274415|FG008|Overall Study|Started Another Treatment|0|||
145387885|NCT02588092|524274416|FG009|Overall Study|Started Another Treatment|0|||
145387886|NCT02588092|524274407|FG000|Overall Study|Sponsor Decision|0|||
145387887|NCT02588092|524274408|FG001|Overall Study|Sponsor Decision|0|||
145387888|NCT02588092|524274409|FG002|Overall Study|Sponsor Decision|0|||
145387889|NCT02588092|524274410|FG003|Overall Study|Sponsor Decision|0|||
145387890|NCT02588092|524274411|FG004|Overall Study|Sponsor Decision|0|||
145387891|NCT02588092|524274412|FG005|Overall Study|Sponsor Decision|0|||
145387892|NCT02588092|524274413|FG006|Overall Study|Sponsor Decision|0|||
145387893|NCT02588092|524274414|FG007|Overall Study|Sponsor Decision|0|||
145387894|NCT02588092|524274415|FG008|Overall Study|Sponsor Decision|1|||
145387895|NCT02588092|524274416|FG009|Overall Study|Sponsor Decision|1|||
145387896|NCT01348100|524274417|FG000|Overall Study|Subject Withdrew Consent|0|||
145387897|NCT01348100|524274418|FG001|Overall Study|Subject Withdrew Consent|0|||
145387898|NCT01348100|524274419|FG002|Overall Study|Subject Withdrew Consent|2|||
145387899|NCT01348100|524274420|FG003|Overall Study|Subject Withdrew Consent|0|||
145387900|NCT01348100|524274421|FG004|Overall Study|Subject Withdrew Consent|1|||
145387901|NCT01348100|524274422|FG005|Overall Study|Subject Withdrew Consent|0|||
145387902|NCT01348100|524274423|FG006|Overall Study|Subject Withdrew Consent|1|||
145387903|NCT01348100|524274417|FG000|Overall Study|Protocol Deviation|0|||
145387904|NCT01348100|524274418|FG001|Overall Study|Protocol Deviation|0|||
145387905|NCT01348100|524274419|FG002|Overall Study|Protocol Deviation|0|||
145387906|NCT01348100|524274420|FG003|Overall Study|Protocol Deviation|1|||
145387907|NCT01348100|524274421|FG004|Overall Study|Protocol Deviation|0|||
145387908|NCT01348100|524274422|FG005|Overall Study|Protocol Deviation|0|||
145387909|NCT01348100|524274423|FG006|Overall Study|Protocol Deviation|0|||
145387910|NCT01348100|524274417|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387911|NCT01348100|524274418|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387912|NCT01348100|524274419|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387913|NCT01348100|524274420|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387914|NCT01348100|524274421|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387915|NCT01348100|524274422|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145387916|NCT01348100|524274423|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145387917|NCT01348100|524274417|FG000|Overall Study|Lost to Follow-up|0|||
145387918|NCT01348100|524274418|FG001|Overall Study|Lost to Follow-up|0|||
145387919|NCT01348100|524274419|FG002|Overall Study|Lost to Follow-up|0|||
145387920|NCT01348100|524274420|FG003|Overall Study|Lost to Follow-up|0|||
145387921|NCT01348100|524274421|FG004|Overall Study|Lost to Follow-up|0|||
145387922|NCT01348100|524274422|FG005|Overall Study|Lost to Follow-up|0|||
145387923|NCT01348100|524274423|FG006|Overall Study|Lost to Follow-up|1|||
145387924|NCT01348100|524274417|FG000|Overall Study|Administrative Problems|0|||
145387925|NCT01348100|524274418|FG001|Overall Study|Administrative Problems|0|||
145387926|NCT01348100|524274419|FG002|Overall Study|Administrative Problems|0|||
145387927|NCT01348100|524274420|FG003|Overall Study|Administrative Problems|0|||
145387928|NCT01348100|524274421|FG004|Overall Study|Administrative Problems|0|||
145387929|NCT01348100|524274422|FG005|Overall Study|Administrative Problems|1|||
145387930|NCT01348100|524274423|FG006|Overall Study|Administrative Problems|1|||
145387931|NCT00531947|524274426|FG000|Overall Study|Adverse Event|5|||
145387932|NCT00531947|524274427|FG001|Overall Study|Adverse Event|10|||
145387933|NCT00531947|524274426|FG000|Overall Study|Lost to Follow-up|12|||
145387934|NCT00531947|524274427|FG001|Overall Study|Lost to Follow-up|9|||
145387935|NCT00531947|524274426|FG000|Overall Study|Withdrawal by Subject|14|||
145387936|NCT00531947|524274427|FG001|Overall Study|Withdrawal by Subject|19|||
145387937|NCT00531947|524274426|FG000|Overall Study|Protocol Violation|2|||
145387938|NCT00531947|524274427|FG001|Overall Study|Protocol Violation|1|||
145387939|NCT00531947|524274426|FG000|Overall Study|Non-Compliance|4|||
145387940|NCT00531947|524274427|FG001|Overall Study|Non-Compliance|7|||
145387941|NCT00531947|524274426|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
145387942|NCT00531947|524274427|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
145387943|NCT03762681|524274432|FG000|Part 1|Withdrawal by Subject|0|||
145387944|NCT03762681|524274433|FG001|Part 1|Withdrawal by Subject|0|||
145387945|NCT03762681|524274434|FG002|Part 1|Withdrawal by Subject|0|||
145387946|NCT03762681|524274435|FG003|Part 1|Withdrawal by Subject|1|||
145387947|NCT03762681|524274436|FG004|Part 1|Withdrawal by Subject|0|||
145387948|NCT03762681|524274437|FG005|Part 1|Withdrawal by Subject|0|||
145387949|NCT03762681|524274438|FG006|Part 1|Withdrawal by Subject|0|||
145387950|NCT03762681|524274439|FG007|Part 1|Withdrawal by Subject|0|||
145387951|NCT03762681|524274432|FG000|Part 2a|Pandemic Travel Restrictions|0|||
145387952|NCT03762681|524274433|FG001|Part 2a|Pandemic Travel Restrictions|0|||
145387953|NCT03762681|524274434|FG002|Part 2a|Pandemic Travel Restrictions|0|||
145387954|NCT03762681|524274435|FG003|Part 2a|Pandemic Travel Restrictions|0|||
145387955|NCT03762681|524274436|FG004|Part 2a|Pandemic Travel Restrictions|0|||
145387956|NCT03762681|524274437|FG005|Part 2a|Pandemic Travel Restrictions|0|||
145387957|NCT03762681|524274438|FG006|Part 2a|Pandemic Travel Restrictions|0|||
145387958|NCT03762681|524274439|FG007|Part 2a|Pandemic Travel Restrictions|1|||
145387959|NCT03148067|524274442|FG000|Overall Study|Lost to Follow-up|3|||
145387960|NCT03148067|524274442|FG000|Overall Study|Death|1|||
145387961|NCT02383355|524274447|FG000|Overall Study|Adverse Event|2|||
145387962|NCT02383355|524274448|FG001|Overall Study|Adverse Event|0|||
145387963|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
145387964|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
145387965|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
145387966|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
145387967|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
145387968|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
145387969|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
145387970|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
145495044|NCT02234843|524670272|FG005|Overall Study|Other|1|||
145387971|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
145387972|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
145387973|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145387974|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145387975|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145387976|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
145387977|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145387978|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145387979|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
145387980|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
145387981|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145387982|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
145387983|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387984|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387985|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
145387986|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387987|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387988|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387989|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387990|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387991|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387992|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
145387993|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145387994|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145387995|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145387996|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145387997|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145387998|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
145387999|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145388000|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
145388001|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145388002|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
145388003|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145388004|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145388005|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145388006|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145388007|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
145388008|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
145388009|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145388010|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145388011|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145388012|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
145388013|NCT04074330|524274454|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388014|NCT04074330|524274455|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145388015|NCT04074330|524274456|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145388016|NCT04074330|524274457|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145388017|NCT04074330|524274458|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388018|NCT04074330|524274459|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
145388019|NCT04074330|524274460|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388020|NCT04074330|524274461|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388021|NCT04074330|524274462|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388022|NCT04074330|524274463|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
145388023|NCT04074330|524274454|FG000|Dose Expansion (up to 42 Months)|Death|0|||
145388024|NCT04074330|524274455|FG001|Dose Expansion (up to 42 Months)|Death|0|||
145388025|NCT04074330|524274456|FG002|Dose Expansion (up to 42 Months)|Death|0|||
145388026|NCT04074330|524274457|FG003|Dose Expansion (up to 42 Months)|Death|0|||
145388027|NCT04074330|524274458|FG004|Dose Expansion (up to 42 Months)|Death|0|||
145388028|NCT04074330|524274459|FG005|Dose Expansion (up to 42 Months)|Death|0|||
145388029|NCT04074330|524274460|FG006|Dose Expansion (up to 42 Months)|Death|0|||
145388030|NCT04074330|524274461|FG007|Dose Expansion (up to 42 Months)|Death|0|||
145388031|NCT04074330|524274462|FG008|Dose Expansion (up to 42 Months)|Death|1|||
145388032|NCT04074330|524274463|FG009|Dose Expansion (up to 42 Months)|Death|0|||
145388033|NCT04074330|524274454|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388034|NCT04074330|524274455|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388035|NCT04074330|524274456|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388036|NCT04074330|524274457|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145729043|NCT00504881|525525185|FG000|Overall Study|AE, serious fatal|0|||
145729044|NCT00504881|525525186|FG001|Overall Study|AE, serious fatal|1|||
145729045|NCT00504881|525525185|FG000|Overall Study|SAE, non-fatal|2|||
145729046|NCT00504881|525525186|FG001|Overall Study|SAE, non-fatal|6|||
145388037|NCT04074330|524274458|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388038|NCT04074330|524274459|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388039|NCT04074330|524274460|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145495045|NCT02234843|524670273|FG006|Overall Study|Other|0|||
145729047|NCT00504881|525525185|FG000|Overall Study|AE, non-serious non-fatal|4|||
145729048|NCT00504881|525525186|FG001|Overall Study|AE, non-serious non-fatal|14|||
145729049|NCT00504881|525525185|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145729050|NCT00504881|525525186|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
145729051|NCT00504881|525525185|FG000|Overall Study|AE of unknown type|1|||
145729052|NCT00504881|525525186|FG001|Overall Study|AE of unknown type|0|||
145729053|NCT00971243|525525190|FG000|Double Blind Period|Adverse Event|2|||
145729054|NCT00971243|525525191|FG001|Double Blind Period|Adverse Event|3|||
145729055|NCT00971243|525525192|FG002|Double Blind Period|Adverse Event|2|||
145729056|NCT00971243|525525193|FG003|Double Blind Period|Adverse Event|2|||
145729057|NCT00971243|525525194|FG004|Double Blind Period|Adverse Event|3|||
145729058|NCT00971243|525525190|FG000|Double Blind Period|Lost to Follow-up|0|||
145729059|NCT00971243|525525191|FG001|Double Blind Period|Lost to Follow-up|1|||
145729060|NCT00971243|525525192|FG002|Double Blind Period|Lost to Follow-up|1|||
145729061|NCT00971243|525525193|FG003|Double Blind Period|Lost to Follow-up|0|||
145729062|NCT00971243|525525194|FG004|Double Blind Period|Lost to Follow-up|1|||
145729063|NCT00971243|525525190|FG000|Double Blind Period|Physician Decision|10|||
145729064|NCT00971243|525525191|FG001|Double Blind Period|Physician Decision|6|||
145729065|NCT00971243|525525192|FG002|Double Blind Period|Physician Decision|7|||
145729066|NCT00971243|525525193|FG003|Double Blind Period|Physician Decision|6|||
145729067|NCT00971243|525525194|FG004|Double Blind Period|Physician Decision|7|||
145729068|NCT00971243|525525190|FG000|Double Blind Period|Protocol Violation|2|||
145729069|NCT00971243|525525191|FG001|Double Blind Period|Protocol Violation|0|||
145729070|NCT00971243|525525192|FG002|Double Blind Period|Protocol Violation|3|||
145729071|NCT00971243|525525193|FG003|Double Blind Period|Protocol Violation|2|||
145729072|NCT00971243|525525194|FG004|Double Blind Period|Protocol Violation|2|||
145729073|NCT00971243|525525190|FG000|Double Blind Period|Withdrawal by Subject|4|||
145729074|NCT00971243|525525191|FG001|Double Blind Period|Withdrawal by Subject|1|||
145729075|NCT00971243|525525192|FG002|Double Blind Period|Withdrawal by Subject|4|||
145729076|NCT00971243|525525193|FG003|Double Blind Period|Withdrawal by Subject|4|||
145729077|NCT00971243|525525194|FG004|Double Blind Period|Withdrawal by Subject|4|||
145729078|NCT00971243|525525190|FG000|Double Blind Period|Other reasons|1|||
145729079|NCT00971243|525525191|FG001|Double Blind Period|Other reasons|0|||
145729080|NCT00971243|525525192|FG002|Double Blind Period|Other reasons|2|||
145729081|NCT00971243|525525193|FG003|Double Blind Period|Other reasons|0|||
145729082|NCT00971243|525525194|FG004|Double Blind Period|Other reasons|1|||
145729083|NCT00971243|525525190|FG000|Open-label Period|Adverse Event|1|||
145729084|NCT00971243|525525191|FG001|Open-label Period|Adverse Event|0|||
145729085|NCT00971243|525525192|FG002|Open-label Period|Adverse Event|1|||
145729086|NCT00971243|525525193|FG003|Open-label Period|Adverse Event|1|||
145729087|NCT00971243|525525194|FG004|Open-label Period|Adverse Event|0|||
145729088|NCT00971243|525525190|FG000|Open-label Period|Physician Decision|5|||
145729089|NCT00971243|525525191|FG001|Open-label Period|Physician Decision|9|||
145729090|NCT00971243|525525192|FG002|Open-label Period|Physician Decision|3|||
145729091|NCT00971243|525525193|FG003|Open-label Period|Physician Decision|7|||
145729092|NCT00971243|525525194|FG004|Open-label Period|Physician Decision|2|||
145729093|NCT00971243|525525190|FG000|Open-label Period|Protocol Violation|1|||
145729094|NCT00971243|525525191|FG001|Open-label Period|Protocol Violation|1|||
145729095|NCT00971243|525525192|FG002|Open-label Period|Protocol Violation|1|||
145729096|NCT00971243|525525193|FG003|Open-label Period|Protocol Violation|0|||
145388040|NCT04074330|524274461|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
145388041|NCT04074330|524274462|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
145388042|NCT04074330|524274463|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
145388043|NCT03124537|524274464|FG000|Overall Study|Lost to Follow-up|3|||
145388044|NCT03124537|524274465|FG001|Overall Study|Lost to Follow-up|5|||
145388045|NCT03124537|524274464|FG000|Overall Study|App Crash, Incomplete Data|7|||
145388046|NCT03124537|524274465|FG001|Overall Study|App Crash, Incomplete Data|8|||
145388047|NCT03681184|524274466|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
145388048|NCT03681184|524274467|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
145388049|NCT02787083|524274468|FG000|Overall Study|Adverse Event|1|||
145388050|NCT02787083|524274469|FG001|Overall Study|Adverse Event|0|||
145388051|NCT02787083|524274468|FG000|Overall Study|Withdrawal by Subject|2|||
145388052|NCT02787083|524274469|FG001|Overall Study|Withdrawal by Subject|2|||
145388053|NCT03162328|524274470|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
145388054|NCT03162328|524274471|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
145388055|NCT03162328|524274472|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
145388056|NCT03162328|524274470|FG000|Screening Period|Withdrawal by Subject|1|||
145388057|NCT03162328|524274471|FG001|Screening Period|Withdrawal by Subject|0|||
145388058|NCT03162328|524274472|FG002|Screening Period|Withdrawal by Subject|0|||
145388059|NCT03162328|524274470|FG000|Study Period|Withdrawal by Subject|0|||
145388060|NCT03162328|524274471|FG001|Study Period|Withdrawal by Subject|0|||
145388061|NCT03162328|524274472|FG002|Study Period|Withdrawal by Subject|1|||
145388062|NCT03275389|524274474|FG000|Overall Study|Lost to Follow-up|10|||
145388063|NCT03275389|524274475|FG001|Overall Study|Lost to Follow-up|10|||
145388064|NCT03275389|524274476|FG002|Overall Study|Lost to Follow-up|19|||
145495046|NCT02234843|524670274|FG007|Overall Study|Other|1|||
145388065|NCT03275389|524274477|FG003|Overall Study|Lost to Follow-up|12|||
145388066|NCT03275389|524274478|FG004|Overall Study|Lost to Follow-up|11|||
145388067|NCT03275389|524274479|FG005|Overall Study|Lost to Follow-up|12|||
145388068|NCT03275389|524274480|FG006|Overall Study|Lost to Follow-up|21|||
145388069|NCT03275389|524274481|FG007|Overall Study|Lost to Follow-up|15|||
145388070|NCT03275389|524274482|FG008|Overall Study|Lost to Follow-up|12|||
145388071|NCT03275389|524274483|FG009|Overall Study|Lost to Follow-up|14|||
145388072|NCT03275389|524274474|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388073|NCT03275389|524274475|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388074|NCT03275389|524274476|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388075|NCT03275389|524274477|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388076|NCT03275389|524274478|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388077|NCT03275389|524274479|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
145388078|NCT03275389|524274480|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388079|NCT03275389|524274481|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388080|NCT03275389|524274482|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
145388081|NCT03275389|524274483|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
145388082|NCT03275389|524274474|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145388083|NCT03275389|524274475|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145388084|NCT03275389|524274476|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145388085|NCT03275389|524274477|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
145388086|NCT03275389|524274478|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145388087|NCT03275389|524274479|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145388088|NCT03275389|524274480|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145388089|NCT03275389|524274481|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
145388090|NCT03275389|524274482|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145388091|NCT03275389|524274483|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145388092|NCT03275389|524274474|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388093|NCT03275389|524274475|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145388094|NCT03275389|524274476|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388095|NCT03275389|524274477|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
145388096|NCT03275389|524274478|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388097|NCT03275389|524274479|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388098|NCT03275389|524274480|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145388099|NCT03275389|524274481|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388100|NCT03275389|524274482|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388101|NCT03275389|524274483|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145388102|NCT03275389|524274474|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388103|NCT03275389|524274475|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145495047|NCT02234843|524670275|FG008|Overall Study|Other|0|||
145495048|NCT02234843|524670276|FG009|Overall Study|Other|0|||
145495049|NCT02234843|524670267|FG000|Overall Study|Physician Decision|4|||
145388104|NCT03275389|524274476|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145495050|NCT02234843|524670268|FG001|Overall Study|Physician Decision|1|||
145388105|NCT03275389|524274477|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388106|NCT03275389|524274478|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388107|NCT03275389|524274479|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388108|NCT03275389|524274480|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388109|NCT03275389|524274481|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388110|NCT03275389|524274482|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145388111|NCT03275389|524274483|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145388112|NCT03275389|524274474|FG000|Overall Study|Other|0|||
145388113|NCT03275389|524274475|FG001|Overall Study|Other|4|||
145388114|NCT03275389|524274476|FG002|Overall Study|Other|3|||
145388115|NCT03275389|524274477|FG003|Overall Study|Other|2|||
145388116|NCT03275389|524274478|FG004|Overall Study|Other|2|||
145388117|NCT03275389|524274479|FG005|Overall Study|Other|2|||
145388118|NCT03275389|524274480|FG006|Overall Study|Other|0|||
145388119|NCT03275389|524274481|FG007|Overall Study|Other|0|||
145388120|NCT03275389|524274482|FG008|Overall Study|Other|1|||
145388121|NCT03275389|524274483|FG009|Overall Study|Other|0|||
145388122|NCT03749109|524274484|FG000|Overall Study|Adverse Event|2|||
145388123|NCT03749109|524274485|FG001|Overall Study|Adverse Event|0|||
145388124|NCT00401193|524276698|FG000|Overall Study|Adverse Event|1|||
145388125|NCT00401193|524276699|FG001|Overall Study|Adverse Event|3|||
145388126|NCT00401193|524276700|FG002|Overall Study|Adverse Event|1|||
145388127|NCT00401193|524276698|FG000|Overall Study|Protocol Violation|3|||
145388128|NCT00401193|524276699|FG001|Overall Study|Protocol Violation|1|||
145388129|NCT00401193|524276700|FG002|Overall Study|Protocol Violation|1|||
145388130|NCT00401193|524276698|FG000|Overall Study|Lost to Follow-up|6|||
145388131|NCT00401193|524276699|FG001|Overall Study|Lost to Follow-up|5|||
145388132|NCT00401193|524276700|FG002|Overall Study|Lost to Follow-up|1|||
145388133|NCT00401193|524276698|FG000|Overall Study|Withdrawal by Subject|2|||
145388134|NCT00401193|524276699|FG001|Overall Study|Withdrawal by Subject|0|||
145388135|NCT00401193|524276700|FG002|Overall Study|Withdrawal by Subject|1|||
145388136|NCT00401193|524276698|FG000|Overall Study|Other Event|3|||
145388137|NCT00401193|524276699|FG001|Overall Study|Other Event|2|||
145388138|NCT00401193|524276700|FG002|Overall Study|Other Event|2|||
145388139|NCT02526160|524276701|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
145388140|NCT02526160|524276702|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
145388141|NCT02526160|524276701|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
145388142|NCT02526160|524276702|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
145388143|NCT02526160|524276701|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
145388144|NCT02526160|524276702|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
145388145|NCT02526160|524276701|FG000|Open-Label Treatment Extension Period I|Death|0|||
145388146|NCT02526160|524276702|FG001|Open-Label Treatment Extension Period I|Death|1|||
145388147|NCT02526160|524276701|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
145388148|NCT02526160|524276702|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
145388149|NCT02526160|524276701|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
145388150|NCT02526160|524276702|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
145388151|NCT02526160|524276701|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
145388152|NCT02526160|524276702|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
145388153|NCT02526160|524276701|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
145388154|NCT02526160|524276702|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
145388155|NCT01962948|524276705|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
145388156|NCT01962948|524276706|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
145388157|NCT01962948|524276707|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
145388158|NCT01962948|524276708|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
145388159|NCT02576977|524276710|FG000|Overall Study|Adverse Event|13|||
145388160|NCT02576977|524276711|FG001|Overall Study|Adverse Event|2|||
145388161|NCT02576977|524276710|FG000|Overall Study|Death|73|||
145388162|NCT02576977|524276711|FG001|Overall Study|Death|60|||
145495051|NCT02234843|524670269|FG002|Overall Study|Physician Decision|0|||
145495052|NCT02234843|524670270|FG003|Overall Study|Physician Decision|1|||
145495053|NCT02234843|524670271|FG004|Overall Study|Physician Decision|0|||
145495054|NCT02234843|524670272|FG005|Overall Study|Physician Decision|0|||
145388163|NCT02576977|524276710|FG000|Overall Study|Screen failure|1|||
145388164|NCT02576977|524276711|FG001|Overall Study|Screen failure|0|||
145388165|NCT02576977|524276710|FG000|Overall Study|Study Terminated at Selected Sites|27|||
145388166|NCT02576977|524276711|FG001|Overall Study|Study Terminated at Selected Sites|50|||
145388167|NCT02576977|524276710|FG000|Overall Study|Withdrawal by Subject|11|||
145388168|NCT02576977|524276711|FG001|Overall Study|Withdrawal by Subject|11|||
145388169|NCT02576977|524276710|FG000|Overall Study|Final Disposition Unknown|0|||
145388170|NCT02576977|524276711|FG001|Overall Study|Final Disposition Unknown|1|||
145495055|NCT02234843|524670273|FG006|Overall Study|Physician Decision|0|||
145495056|NCT02234843|524670274|FG007|Overall Study|Physician Decision|1|||
145388171|NCT02576977|524276710|FG000|Overall Study|Lost to Follow-up|1|||
145388172|NCT02576977|524276711|FG001|Overall Study|Lost to Follow-up|0|||
145388173|NCT02576977|524276710|FG000|Overall Study|Progressive Disease|0|||
145388174|NCT02576977|524276711|FG001|Overall Study|Progressive Disease|1|||
145388175|NCT02579382|524276716|FG000|Main Study Phase|Lost to Follow-up|0|||
145388176|NCT02579382|524276717|FG001|Main Study Phase|Lost to Follow-up|0|||
145388177|NCT02579382|524276718|FG002|Main Study Phase|Lost to Follow-up|2|||
145388178|NCT02579382|524276719|FG003|Main Study Phase|Lost to Follow-up|0|||
145388179|NCT02579382|524276716|FG000|Main Study Phase|Withdrew Consent|0|||
145388180|NCT02579382|524276717|FG001|Main Study Phase|Withdrew Consent|0|||
145388181|NCT02579382|524276718|FG002|Main Study Phase|Withdrew Consent|0|||
145388182|NCT02579382|524276719|FG003|Main Study Phase|Withdrew Consent|2|||
145388183|NCT02579382|524276716|FG000|Main Study Phase|Lack of Efficacy|0|||
145388184|NCT02579382|524276717|FG001|Main Study Phase|Lack of Efficacy|0|||
145388185|NCT02579382|524276718|FG002|Main Study Phase|Lack of Efficacy|0|||
145388186|NCT02579382|524276719|FG003|Main Study Phase|Lack of Efficacy|1|||
145388187|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
145388188|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
145388189|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
145388190|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
145388191|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
145388192|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
145388193|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
145388194|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
145388195|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
145388196|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145388197|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145388198|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
145388199|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145388200|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
145388201|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145388202|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
145388203|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145388204|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
145388205|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145388206|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
145388207|NCT02579382|524276716|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145388208|NCT02579382|524276717|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
145388209|NCT02579382|524276718|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145388210|NCT02579382|524276719|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
145388211|NCT00667992|524276720|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
145388212|NCT00667992|524276721|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
145388213|NCT00667992|524276720|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
145388214|NCT00667992|524276721|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
145388215|NCT00667992|524276720|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145388216|NCT00667992|524276721|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145388217|NCT00667992|524276720|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
145388218|NCT00667992|524276721|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
145388219|NCT00667992|524276720|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145388220|NCT00667992|524276721|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145388221|NCT00667992|524276720|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
145388222|NCT00667992|524276721|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
145388223|NCT00667992|524276720|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
145388224|NCT00667992|524276721|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
145388225|NCT00667992|524276720|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
145388226|NCT00667992|524276721|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
145388227|NCT00667992|524276720|FG000|Wash-out|Not within one doubling dilution|4|||
145388228|NCT00667992|524276721|FG001|Wash-out|Not within one doubling dilution|3|||
145388229|NCT00667992|524276720|FG000|Wash-out|Failure to wash-out|2|||
145388230|NCT00667992|524276721|FG001|Wash-out|Failure to wash-out|2|||
145388231|NCT00667992|524276720|FG000|Wash-out|Withdrawal by Subject|1|||
145388232|NCT00667992|524276721|FG001|Wash-out|Withdrawal by Subject|0|||
145388233|NCT00667992|524276720|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
145388234|NCT00667992|524276721|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
145388235|NCT00667992|524276720|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
145388236|NCT00667992|524276721|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
145495057|NCT02234843|524670275|FG008|Overall Study|Physician Decision|0|||
145495058|NCT02234843|524670276|FG009|Overall Study|Physician Decision|0|||
145495059|NCT02234843|524670267|FG000|Overall Study|Adverse Event|5|||
145495060|NCT02234843|524670268|FG001|Overall Study|Adverse Event|1|||
145495061|NCT02234843|524670269|FG002|Overall Study|Adverse Event|1|||
145495062|NCT02234843|524670270|FG003|Overall Study|Adverse Event|3|||
145495063|NCT02234843|524670271|FG004|Overall Study|Adverse Event|2|||
145388237|NCT02906579|524276729|FG000|Overall Study|Adverse Event|1|||
145388238|NCT02906579|524276729|FG000|Overall Study|Physician Decision|1|||
145388239|NCT02793947|524276730|FG000|Overall Study|Death|1|||
145388240|NCT02793947|524276731|FG001|Overall Study|Death|0|||
145388241|NCT02793947|524276730|FG000|Overall Study|Physician Decision|1|||
145388242|NCT02793947|524276731|FG001|Overall Study|Physician Decision|5|||
145388243|NCT02213380|524276735|FG000|Underwent Randomization|Withdrawal by Subject|2|||
145388244|NCT02213380|524276736|FG001|Underwent Randomization|Withdrawal by Subject|0|||
145388245|NCT02213380|524276735|FG000|Underwent Randomization|Not treated|3|||
145388246|NCT02213380|524276736|FG001|Underwent Randomization|Not treated|3|||
145388247|NCT02213380|524276735|FG000|Per-protocol Analysis|Protocol Violation|32|||
145388248|NCT02213380|524276736|FG001|Per-protocol Analysis|Protocol Violation|36|||
145388249|NCT01490840|524276739|FG000|Phase 1|Lost to Follow-up|1|||
145388250|NCT01490840|524276740|FG001|Phase 1|Lost to Follow-up|0|||
145388251|NCT01490840|524276739|FG000|Phase 1|Adverse Event|2|||
145388252|NCT01490840|524276740|FG001|Phase 1|Adverse Event|1|||
145388253|NCT01490840|524276739|FG000|Phase 1|Withdrawal by Subject|6|||
145388254|NCT01490840|524276740|FG001|Phase 1|Withdrawal by Subject|5|||
145388255|NCT01490840|524276739|FG000|Phase 1|Visit 6a omitted|1|||
145388256|NCT01490840|524276740|FG001|Phase 1|Visit 6a omitted|0|||
145388257|NCT01490840|524276739|FG000|Phase 2|Withdrawal by Subject|4|||
145388258|NCT01490840|524276740|FG001|Phase 2|Withdrawal by Subject|3|||
145388259|NCT01490840|524276739|FG000|Phase 2|Permanent interruption of fingolimod|0|||
145388260|NCT01490840|524276740|FG001|Phase 2|Permanent interruption of fingolimod|1|||
145388261|NCT01490840|524276739|FG000|Phase 2|Lost to Follow-up|1|||
145388262|NCT01490840|524276740|FG001|Phase 2|Lost to Follow-up|1|||
145388263|NCT01490840|524276739|FG000|Phase 2|Adverse Event|1|||
145388264|NCT01490840|524276740|FG001|Phase 2|Adverse Event|1|||
145388265|NCT01465230|524276744|FG000|Overall Study|Withdrawal by Subject|2|||
145388266|NCT02542397|524276745|FG000|Overall Study|Death|2|||
145388267|NCT02542397|524276745|FG000|Overall Study|Physician Decision|6|||
145388268|NCT02542397|524276745|FG000|Overall Study|Withdrawal by Subject|6|||
145388269|NCT02542397|524276745|FG000|Overall Study|Lost to Follow-up|2|||
145388270|NCT01738919|524276748|FG000|Overall Study|Lost to Follow-up|1|||
145388271|NCT01738919|524276749|FG001|Overall Study|Lost to Follow-up|0|||
145388272|NCT01738919|524276748|FG000|Overall Study|Immigrated|0|||
145388273|NCT01738919|524276749|FG001|Overall Study|Immigrated|1|||
145388274|NCT01738919|524276748|FG000|Overall Study|Withdrawal by Subject|0|||
145388275|NCT01738919|524276749|FG001|Overall Study|Withdrawal by Subject|1|||
145388276|NCT01738919|524276748|FG000|Overall Study|Not treated in accordance to guidelines|0|||
145388277|NCT01738919|524276749|FG001|Overall Study|Not treated in accordance to guidelines|1|||
145388278|NCT01473940|524276753|FG000|Induction Therapy|Death|0|||
145388279|NCT01473940|524276754|FG001|Induction Therapy|Death|0|||
145388280|NCT01473940|524276755|FG002|Induction Therapy|Death|1|||
145388281|NCT01473940|524276756|FG003|Induction Therapy|Death|1|||
145388282|NCT01473940|524276753|FG000|Induction Therapy|Progressive Disease|0|||
145388283|NCT01473940|524276754|FG001|Induction Therapy|Progressive Disease|1|||
145388284|NCT01473940|524276755|FG002|Induction Therapy|Progressive Disease|1|||
145388285|NCT01473940|524276756|FG003|Induction Therapy|Progressive Disease|0|||
145388286|NCT01473940|524276753|FG000|Maintenance Therapy|Progressive Disease|1|||
145388287|NCT01473940|524276754|FG001|Maintenance Therapy|Progressive Disease|2|||
145388288|NCT01473940|524276755|FG002|Maintenance Therapy|Progressive Disease|1|||
145388289|NCT01473940|524276756|FG003|Maintenance Therapy|Progressive Disease|4|||
145495064|NCT02234843|524670272|FG005|Overall Study|Adverse Event|1|||
145495065|NCT02234843|524670273|FG006|Overall Study|Adverse Event|0|||
145495066|NCT02234843|524670274|FG007|Overall Study|Adverse Event|0|||
145388290|NCT02532257|524276757|FG000|Overall Study|Adverse Event|2|||
145388291|NCT02532257|524276757|FG000|Overall Study|Physician Decision|4|||
145388292|NCT02532257|524276757|FG000|Overall Study|Withdrawal by Subject|3|||
145388293|NCT02532257|524276757|FG000|Overall Study|Progressive Disease|10|||
145495067|NCT02234843|524670275|FG008|Overall Study|Adverse Event|1|||
145495068|NCT02234843|524670276|FG009|Overall Study|Adverse Event|0|||
145495069|NCT02234843|524670267|FG000|Overall Study|Non-compliance with study drug|1|||
145495070|NCT02234843|524670268|FG001|Overall Study|Non-compliance with study drug|0|||
145388294|NCT00184002|524276760|FG000|Overall Study|Adverse Event|9|||
145388295|NCT00184002|524276760|FG000|Overall Study|Death|3|||
145388296|NCT00184002|524276760|FG000|Overall Study|Physician Decision|1|||
145388297|NCT00184002|524276760|FG000|Overall Study|Withdrawal by Subject|4|||
145388298|NCT02187861|524276764|FG000|Overall Study|Adverse Event|2|||
145388299|NCT02187861|524276765|FG001|Overall Study|Adverse Event|1|||
145388300|NCT02187861|524276766|FG002|Overall Study|Adverse Event|2|||
145388301|NCT02187861|524276767|FG003|Overall Study|Adverse Event|1|||
145388302|NCT02187861|524276764|FG000|Overall Study|Death|0|||
145388303|NCT02187861|524276765|FG001|Overall Study|Death|3|||
145495071|NCT02234843|524670269|FG002|Overall Study|Non-compliance with study drug|0|||
145495072|NCT02234843|524670270|FG003|Overall Study|Non-compliance with study drug|0|||
145388304|NCT02187861|524276766|FG002|Overall Study|Death|1|||
145388305|NCT02187861|524276767|FG003|Overall Study|Death|2|||
145388306|NCT02187861|524276764|FG000|Overall Study|Physician Decision|0|||
145388307|NCT02187861|524276765|FG001|Overall Study|Physician Decision|1|||
145388308|NCT02187861|524276766|FG002|Overall Study|Physician Decision|0|||
145388309|NCT02187861|524276767|FG003|Overall Study|Physician Decision|3|||
145388310|NCT02187861|524276764|FG000|Overall Study|Progressive Disease|4|||
145388311|NCT02187861|524276765|FG001|Overall Study|Progressive Disease|42|||
145388312|NCT02187861|524276766|FG002|Overall Study|Progressive Disease|19|||
145388313|NCT02187861|524276767|FG003|Overall Study|Progressive Disease|22|||
145388314|NCT02187861|524276764|FG000|Overall Study|Withdrawal by Subject|0|||
145388315|NCT02187861|524276765|FG001|Overall Study|Withdrawal by Subject|0|||
145388316|NCT02187861|524276766|FG002|Overall Study|Withdrawal by Subject|3|||
145388317|NCT02187861|524276767|FG003|Overall Study|Withdrawal by Subject|3|||
145388318|NCT02187861|524276764|FG000|Overall Study|Other|0|||
145388319|NCT02187861|524276765|FG001|Overall Study|Other|1|||
145388320|NCT02187861|524276766|FG002|Overall Study|Other|7|||
145388321|NCT02187861|524276767|FG003|Overall Study|Other|1|||
145388322|NCT01639703|524276768|FG000|Overall Study|Withdrawal by Subject|5|||
145388323|NCT01639703|524276768|FG000|Overall Study|Other reason|7|||
145388324|NCT01308463|524276769|FG000|Overall Study|Study Discontinued|23|||
145388325|NCT01308463|524276769|FG000|Overall Study|Death|4|||
145388326|NCT01308463|524276769|FG000|Overall Study|Revision|2|||
145388327|NCT01042392|524276770|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
145388328|NCT01042392|524276771|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
145388329|NCT01042392|524276772|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
145388330|NCT01042392|524276773|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
145388331|NCT01042392|524276770|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
145388332|NCT01042392|524276771|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
145388333|NCT01042392|524276772|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
145388334|NCT01042392|524276773|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
145388335|NCT01042392|524276770|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
145388336|NCT01042392|524276771|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
145388337|NCT01042392|524276772|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
145388338|NCT01042392|524276773|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
145388339|NCT01042392|524276770|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145388340|NCT01042392|524276771|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145388341|NCT01042392|524276772|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
145388342|NCT01042392|524276773|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
145388343|NCT01042392|524276770|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
145388344|NCT01042392|524276771|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145388345|NCT01042392|524276772|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145388346|NCT01042392|524276773|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
145388347|NCT01042392|524276770|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145388348|NCT01042392|524276771|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145388349|NCT01042392|524276772|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
145388350|NCT01042392|524276773|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
145388351|NCT01042392|524276770|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
145388352|NCT01042392|524276771|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145388353|NCT01042392|524276772|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145388354|NCT01042392|524276773|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
145388355|NCT01042392|524276770|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145495073|NCT02234843|524670271|FG004|Overall Study|Non-compliance with study drug|0|||
145495074|NCT02234843|524670272|FG005|Overall Study|Non-compliance with study drug|1|||
145388356|NCT01042392|524276771|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145388357|NCT01042392|524276772|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
145388358|NCT01042392|524276773|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
145388359|NCT01042392|524276770|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
145388360|NCT01042392|524276771|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145388361|NCT01042392|524276772|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145388362|NCT01042392|524276773|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
145388363|NCT03117361|524276774|FG000|Overall Study|Progressive disease|5|||
145388364|NCT03117361|524276774|FG000|Overall Study|Death|1|||
145388365|NCT03117361|524276774|FG000|Overall Study|Physician Decision|2|||
145388366|NCT03117361|524276774|FG000|Overall Study|On study treatment at the end of study|1|||
145388367|NCT03117361|524276774|FG000|Overall Study|Treatment-related adverse event|1|||
145388368|NCT00587795|524276775|FG000|Overall Study|Withdrawal by Subject|1|||
145388369|NCT00587795|524276776|FG001|Overall Study|Withdrawal by Subject|0|||
145388370|NCT00943592|524276777|FG000|Overall Study|Death|3|||
145388371|NCT02072941|524276778|FG000|Overall Study|Withdrawal by Subject|29|||
145388372|NCT02072941|524276779|FG001|Overall Study|Withdrawal by Subject|21|||
145388373|NCT02072941|524276778|FG000|Overall Study|Lost to Follow-up|4|||
145388374|NCT02072941|524276779|FG001|Overall Study|Lost to Follow-up|4|||
145388375|NCT02072941|524276778|FG000|Overall Study|Death|3|||
145388376|NCT02072941|524276779|FG001|Overall Study|Death|2|||
145388377|NCT02072941|524276778|FG000|Overall Study|Removed by Study Staff|2|||
145388378|NCT02072941|524276779|FG001|Overall Study|Removed by Study Staff|2|||
145388379|NCT01247350|524276780|FG000|Overall Study|Adverse Event|0|||
145388380|NCT01247350|524276781|FG001|Overall Study|Adverse Event|0|||
145388381|NCT01247350|524276782|FG002|Overall Study|Adverse Event|1|||
145388382|NCT01247350|524276783|FG003|Overall Study|Adverse Event|0|||
145388383|NCT01247350|524276784|FG004|Overall Study|Adverse Event|0|||
145388384|NCT01247350|524276780|FG000|Overall Study|Withdrawal by Subject|0|||
145388385|NCT01247350|524276781|FG001|Overall Study|Withdrawal by Subject|0|||
145388386|NCT01247350|524276782|FG002|Overall Study|Withdrawal by Subject|0|||
145388387|NCT01247350|524276783|FG003|Overall Study|Withdrawal by Subject|1|||
145495075|NCT02234843|524670273|FG006|Overall Study|Non-compliance with study drug|1|||
145729097|NCT00971243|525525194|FG004|Open-label Period|Protocol Violation|1|||
145729098|NCT00971243|525525190|FG000|Open-label Period|Withdrawal by Subject|1|||
145729099|NCT00971243|525525191|FG001|Open-label Period|Withdrawal by Subject|0|||
145729100|NCT00971243|525525192|FG002|Open-label Period|Withdrawal by Subject|0|||
145729101|NCT00971243|525525193|FG003|Open-label Period|Withdrawal by Subject|2|||
145729102|NCT00971243|525525194|FG004|Open-label Period|Withdrawal by Subject|1|||
145729103|NCT00971243|525525190|FG000|Open-label Period|Other reason|0|||
145729104|NCT00971243|525525191|FG001|Open-label Period|Other reason|0|||
145729105|NCT00971243|525525192|FG002|Open-label Period|Other reason|0|||
145729106|NCT00971243|525525193|FG003|Open-label Period|Other reason|0|||
145729107|NCT00971243|525525194|FG004|Open-label Period|Other reason|2|||
145729108|NCT00803270|525525195|FG000|Overall Study|Lost to Follow-up|1|||
145729109|NCT00803270|525525196|FG001|Overall Study|Lost to Follow-up|2|||
145729110|NCT01966471|525525199|FG000|Overall Study|Death|44|||
145388388|NCT01247350|524276784|FG004|Overall Study|Withdrawal by Subject|0|||
145495076|NCT02234843|524670274|FG007|Overall Study|Non-compliance with study drug|0|||
145495077|NCT02234843|524670275|FG008|Overall Study|Non-compliance with study drug|0|||
145495078|NCT02234843|524670276|FG009|Overall Study|Non-compliance with study drug|0|||
145495079|NCT02234843|524670267|FG000|Overall Study|Lost to Follow-up|0|||
145495080|NCT02234843|524670268|FG001|Overall Study|Lost to Follow-up|1|||
145495081|NCT02234843|524670269|FG002|Overall Study|Lost to Follow-up|0|||
145495082|NCT02234843|524670270|FG003|Overall Study|Lost to Follow-up|0|||
145495083|NCT02234843|524670271|FG004|Overall Study|Lost to Follow-up|0|||
145495084|NCT02234843|524670272|FG005|Overall Study|Lost to Follow-up|0|||
145495085|NCT02234843|524670273|FG006|Overall Study|Lost to Follow-up|1|||
145495086|NCT02234843|524670274|FG007|Overall Study|Lost to Follow-up|0|||
145495087|NCT02234843|524670275|FG008|Overall Study|Lost to Follow-up|0|||
145495088|NCT02234843|524670276|FG009|Overall Study|Lost to Follow-up|0|||
145495089|NCT00506350|524670279|FG000|Overall Study|Serious Adverse Event|1|||
145495090|NCT00506350|524670280|FG001|Overall Study|Serious Adverse Event|0|||
145495091|NCT00506350|524670281|FG002|Overall Study|Serious Adverse Event|0|||
145495092|NCT00506350|524670282|FG003|Overall Study|Serious Adverse Event|0|||
145495093|NCT00506350|524670283|FG004|Overall Study|Serious Adverse Event|0|||
145495094|NCT00506350|524670284|FG005|Overall Study|Serious Adverse Event|0|||
145495095|NCT00506350|524670285|FG006|Overall Study|Serious Adverse Event|0|||
145729111|NCT01966471|525525200|FG001|Overall Study|Death|56|||
145729112|NCT01966471|525525199|FG000|Overall Study|Lost to Follow-up|46|||
145388389|NCT01247350|524276780|FG000|Overall Study|Entry criteria not met|0|||
145388390|NCT01247350|524276781|FG001|Overall Study|Entry criteria not met|0|||
145495096|NCT00506350|524670286|FG007|Overall Study|Serious Adverse Event|0|||
145495097|NCT00506350|524670287|FG008|Overall Study|Serious Adverse Event|0|||
145495098|NCT00506350|524670279|FG000|Overall Study|Adverse Event|0|||
145495099|NCT00506350|524670280|FG001|Overall Study|Adverse Event|0|||
145495100|NCT00506350|524670281|FG002|Overall Study|Adverse Event|0|||
145388391|NCT01247350|524276782|FG002|Overall Study|Entry criteria not met|0|||
145388392|NCT01247350|524276783|FG003|Overall Study|Entry criteria not met|0|||
145388393|NCT01247350|524276784|FG004|Overall Study|Entry criteria not met|1|||
145388394|NCT02438280|524276787|FG000|Overall Study|Physician Decision|1|||
145388395|NCT02438280|524276788|FG001|Overall Study|Physician Decision|0|||
145388396|NCT02982863|524276789|FG000|Overall Study|Not eligible patients|809|||
145388397|NCT02982863|524276790|FG001|Overall Study|Not eligible patients|4261|||
145388398|NCT02982863|524276791|FG002|Overall Study|Not eligible patients|1852|||
145388399|NCT02982863|524276792|FG003|Overall Study|Not eligible patients|1400|||
145388400|NCT02982863|524276793|FG004|Overall Study|Not eligible patients|492|||
145388401|NCT02457195|524276794|FG000|Overall Study|Adverse Event|3|||
145388402|NCT02457195|524276794|FG000|Overall Study|Protocol Violation|2|||
145388403|NCT02457195|524276794|FG000|Overall Study|Withdrawal by Subject|4|||
145388404|NCT05359952|524276795|FG000|Overall Study|Lost to Follow-up|1|||
145388405|NCT05359952|524276796|FG001|Overall Study|Lost to Follow-up|0|||
145388406|NCT05980013|524276797|FG000|Overall Study|Withdrawal by Subject|0|||
145388407|NCT05980013|524276798|FG001|Overall Study|Withdrawal by Subject|1|||
145388408|NCT05980013|524276797|FG000|Overall Study|Device Error|0|||
145388409|NCT05980013|524276798|FG001|Overall Study|Device Error|1|||
145388410|NCT03066778|524276799|FG000|Overall Study|Death|195|||
145388411|NCT03066778|524276800|FG001|Overall Study|Death|205|||
145388412|NCT03066778|524276799|FG000|Overall Study|Withdrawal by Subject|5|||
145388413|NCT03066778|524276800|FG001|Overall Study|Withdrawal by Subject|7|||
145388414|NCT02091414|524276801|FG000|Overall Study|Withdrawal by Subject|2|||
145388415|NCT02091414|524276801|FG000|Overall Study|Death|2|||
145388416|NCT00435461|524276802|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
145388417|NCT00435461|524276803|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
145388418|NCT00435461|524276804|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
145388419|NCT00435461|524276802|FG000|Overall Study|Protocol Violation|6|||
145388420|NCT00435461|524276803|FG001|Overall Study|Protocol Violation|9|||
145388421|NCT00435461|524276804|FG002|Overall Study|Protocol Violation|10|||
145388422|NCT00435461|524276802|FG000|Overall Study|Participant randomized(inadequate score)|1|||
145388423|NCT00435461|524276803|FG001|Overall Study|Participant randomized(inadequate score)|0|||
145388424|NCT00435461|524276804|FG002|Overall Study|Participant randomized(inadequate score)|0|||
145388425|NCT00435461|524276802|FG000|Overall Study|Compliance less than 80 percent|1|||
145388426|NCT00435461|524276803|FG001|Overall Study|Compliance less than 80 percent|0|||
145388427|NCT00435461|524276804|FG002|Overall Study|Compliance less than 80 percent|0|||
145388428|NCT00435461|524276802|FG000|Overall Study|In error, two study medications switched|1|||
145388429|NCT00435461|524276803|FG001|Overall Study|In error, two study medications switched|0|||
145388430|NCT00435461|524276804|FG002|Overall Study|In error, two study medications switched|0|||
145388431|NCT00435461|524276802|FG000|Overall Study|Lack of Efficacy|2|||
145388432|NCT00435461|524276803|FG001|Overall Study|Lack of Efficacy|1|||
145388433|NCT00435461|524276804|FG002|Overall Study|Lack of Efficacy|0|||
145388434|NCT00435461|524276802|FG000|Overall Study|Withdrawal by Subject|1|||
145388435|NCT00435461|524276803|FG001|Overall Study|Withdrawal by Subject|0|||
145388436|NCT00435461|524276804|FG002|Overall Study|Withdrawal by Subject|2|||
145388437|NCT00435461|524276802|FG000|Overall Study|Randomized in error|1|||
145388438|NCT00435461|524276803|FG001|Overall Study|Randomized in error|0|||
145388439|NCT00435461|524276804|FG002|Overall Study|Randomized in error|0|||
145388440|NCT00435461|524276802|FG000|Overall Study|Participant could not tolerate symptoms|0|||
145388441|NCT00435461|524276803|FG001|Overall Study|Participant could not tolerate symptoms|0|||
145388442|NCT00435461|524276804|FG002|Overall Study|Participant could not tolerate symptoms|1|||
145388443|NCT00435461|524276802|FG000|Overall Study|Participant could not swallow capsule|0|||
145388444|NCT00435461|524276803|FG001|Overall Study|Participant could not swallow capsule|0|||
145388445|NCT00435461|524276804|FG002|Overall Study|Participant could not swallow capsule|1|||
145388446|NCT00435461|524276802|FG000|Overall Study|Pregnancy|2|||
145388447|NCT00435461|524276803|FG001|Overall Study|Pregnancy|0|||
145388448|NCT00435461|524276804|FG002|Overall Study|Pregnancy|0|||
145388449|NCT00435461|524276802|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
145388450|NCT00435461|524276803|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
145388451|NCT00435461|524276804|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
145388452|NCT00435461|524276802|FG000|Overall Study|Participant ended study one day early|1|||
145388453|NCT00435461|524276803|FG001|Overall Study|Participant ended study one day early|0|||
145388454|NCT00435461|524276804|FG002|Overall Study|Participant ended study one day early|0|||
145388455|NCT00435461|524276802|FG000|Overall Study|Noncompliance with study requirements|1|||
145388456|NCT00435461|524276803|FG001|Overall Study|Noncompliance with study requirements|1|||
145388457|NCT00435461|524276804|FG002|Overall Study|Noncompliance with study requirements|1|||
145388458|NCT00435461|524276802|FG000|Overall Study|Adverse Event|1|||
145388459|NCT00435461|524276803|FG001|Overall Study|Adverse Event|2|||
145388460|NCT00435461|524276804|FG002|Overall Study|Adverse Event|6|||
145388461|NCT00435461|524276802|FG000|Overall Study|Non-Compliance of diary|2|||
145388462|NCT00435461|524276803|FG001|Overall Study|Non-Compliance of diary|0|||
145388463|NCT00435461|524276804|FG002|Overall Study|Non-Compliance of diary|1|||
145388464|NCT00435461|524276802|FG000|Overall Study|Lost to Follow-up|1|||
145388465|NCT00435461|524276803|FG001|Overall Study|Lost to Follow-up|1|||
145388466|NCT00435461|524276804|FG002|Overall Study|Lost to Follow-up|2|||
145388467|NCT01768559|524276805|FG000|Overall Study|Randomized but not treated|0|||
145388468|NCT01768559|524276806|FG001|Overall Study|Randomized but not treated|0|||
145495101|NCT00506350|524670282|FG003|Overall Study|Adverse Event|0|||
145388469|NCT01768559|524276807|FG002|Overall Study|Randomized but not treated|1|||
145388470|NCT01768559|524276805|FG000|Overall Study|Adverse Event|15|||
145388471|NCT01768559|524276806|FG001|Overall Study|Adverse Event|2|||
145388472|NCT01768559|524276807|FG002|Overall Study|Adverse Event|5|||
145388473|NCT01768559|524276805|FG000|Overall Study|Lack of Efficacy|6|||
145388474|NCT01768559|524276806|FG001|Overall Study|Lack of Efficacy|4|||
145388475|NCT01768559|524276807|FG002|Overall Study|Lack of Efficacy|0|||
145388476|NCT01768559|524276805|FG000|Overall Study|Poor compliance to protocol|0|||
145388477|NCT01768559|524276806|FG001|Overall Study|Poor compliance to protocol|3|||
145388478|NCT01768559|524276807|FG002|Overall Study|Poor compliance to protocol|2|||
145388479|NCT01768559|524276805|FG000|Overall Study|Other than specified|9|||
145388480|NCT01768559|524276806|FG001|Overall Study|Other than specified|8|||
145388481|NCT01768559|524276807|FG002|Overall Study|Other than specified|5|||
145388482|NCT03146741|524276808|FG000|Overall Study|Txp with non-HCV+ heart|4|||
145388483|NCT03146741|524276808|FG000|Overall Study|Listeted for MOT|2|||
145388484|NCT03146741|524276808|FG000|Overall Study|Physician Decision|2|||
145388485|NCT03146741|524276808|FG000|Overall Study|Awaiting txp|2|||
145388486|NCT00685360|524276812|FG000|Overall Study|Lost to Follow-up|0|||
145388487|NCT00685360|524276813|FG001|Overall Study|Lost to Follow-up|1|||
145388488|NCT00685360|524276814|FG002|Overall Study|Lost to Follow-up|2|||
145388489|NCT00685360|524276812|FG000|Overall Study|Adverse Event|4|||
145388490|NCT00685360|524276813|FG001|Overall Study|Adverse Event|6|||
145388491|NCT00685360|524276814|FG002|Overall Study|Adverse Event|4|||
145388492|NCT00685360|524276812|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
145388493|NCT00685360|524276813|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
145388494|NCT00685360|524276814|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
145388495|NCT00685360|524276812|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
145388496|NCT00685360|524276813|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
145388497|NCT00685360|524276814|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
145388498|NCT00685360|524276812|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
145388499|NCT00685360|524276813|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
145388500|NCT00685360|524276814|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
145388501|NCT00685360|524276812|FG000|Overall Study|Protocol Deviation|0|||
145388502|NCT00685360|524276813|FG001|Overall Study|Protocol Deviation|1|||
145388503|NCT00685360|524276814|FG002|Overall Study|Protocol Deviation|1|||
145388504|NCT01030718|524276821|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
145388505|NCT01030718|524276822|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
145388506|NCT01030718|524276823|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
145388507|NCT01030718|524276821|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
145388508|NCT01030718|524276822|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
145388509|NCT01030718|524276823|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
145388510|NCT01030718|524276821|FG000|Studies CA180-031 and -036 Combined|Death|0|||
145388511|NCT01030718|524276822|FG001|Studies CA180-031 and -036 Combined|Death|1|||
145388512|NCT01030718|524276823|FG002|Studies CA180-031 and -036 Combined|Death|0|||
145388513|NCT01030718|524276821|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
145388514|NCT01030718|524276822|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
145388515|NCT01030718|524276823|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
145388516|NCT01030718|524276821|FG000|Study CA180-036 Only|insufficient effect|1|||
145388517|NCT01030718|524276822|FG001|Study CA180-036 Only|insufficient effect|1|||
145388518|NCT01030718|524276823|FG002|Study CA180-036 Only|insufficient effect|5|||
145388519|NCT01030718|524276821|FG000|Study CA180-036 Only|Adverse Event|2|||
145388520|NCT01030718|524276822|FG001|Study CA180-036 Only|Adverse Event|3|||
145388521|NCT01030718|524276823|FG002|Study CA180-036 Only|Adverse Event|0|||
145388522|NCT01030718|524276821|FG000|Study CA180-036 Only|Death|0|||
145388523|NCT01030718|524276822|FG001|Study CA180-036 Only|Death|1|||
145388524|NCT01030718|524276823|FG002|Study CA180-036 Only|Death|0|||
145388525|NCT01030718|524276821|FG000|Study CA180-036 Only|Other Reasons|0|||
145388526|NCT01030718|524276822|FG001|Study CA180-036 Only|Other Reasons|2|||
145388527|NCT01030718|524276823|FG002|Study CA180-036 Only|Other Reasons|0|||
145388528|NCT00423813|524276824|FG000|Overall Study|Adverse Event|11|||
145388529|NCT00423813|524276825|FG001|Overall Study|Adverse Event|30|||
145388530|NCT00423813|524276826|FG002|Overall Study|Adverse Event|40|||
145388531|NCT00423813|524276824|FG000|Overall Study|Withdrawal by Subject|6|||
145388532|NCT00423813|524276825|FG001|Overall Study|Withdrawal by Subject|8|||
145388533|NCT00423813|524276826|FG002|Overall Study|Withdrawal by Subject|5|||
145388534|NCT00423813|524276824|FG000|Overall Study|Lost to Follow-up|5|||
145388535|NCT00423813|524276825|FG001|Overall Study|Lost to Follow-up|4|||
145388536|NCT00423813|524276826|FG002|Overall Study|Lost to Follow-up|4|||
145388537|NCT00423813|524276824|FG000|Overall Study|Lack of Efficacy|23|||
145388538|NCT00423813|524276825|FG001|Overall Study|Lack of Efficacy|18|||
145388539|NCT00423813|524276826|FG002|Overall Study|Lack of Efficacy|19|||
145388540|NCT00423813|524276824|FG000|Overall Study|Physician Decision|2|||
145388541|NCT00423813|524276825|FG001|Overall Study|Physician Decision|0|||
145388542|NCT00423813|524276826|FG002|Overall Study|Physician Decision|0|||
145388543|NCT00423813|524276824|FG000|Overall Study|Sponsor Decision|0|||
145388544|NCT00423813|524276825|FG001|Overall Study|Sponsor Decision|1|||
145388545|NCT00423813|524276826|FG002|Overall Study|Sponsor Decision|0|||
145388546|NCT00423813|524276824|FG000|Overall Study|Protocol Violation|9|||
145388547|NCT00423813|524276825|FG001|Overall Study|Protocol Violation|4|||
145388548|NCT00423813|524276826|FG002|Overall Study|Protocol Violation|4|||
145388549|NCT00423813|524276824|FG000|Overall Study|Pregnancy|0|||
145388550|NCT00423813|524276825|FG001|Overall Study|Pregnancy|0|||
145388551|NCT00423813|524276826|FG002|Overall Study|Pregnancy|1|||
145388552|NCT00423813|524276824|FG000|Overall Study|Subject started night shift work|1|||
145388553|NCT00423813|524276825|FG001|Overall Study|Subject started night shift work|0|||
145388554|NCT00423813|524276826|FG002|Overall Study|Subject started night shift work|0|||
145388555|NCT00423813|524276824|FG000|Overall Study|Will start exclusionary medications|0|||
145388556|NCT00423813|524276825|FG001|Overall Study|Will start exclusionary medications|1|||
145388557|NCT00423813|524276826|FG002|Overall Study|Will start exclusionary medications|0|||
145388558|NCT00423813|524276824|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
145388559|NCT00423813|524276825|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
145388560|NCT00423813|524276826|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
145388561|NCT01386944|524276827|FG000|Overall Study|Adverse Event|26|||
145388562|NCT01386944|524276827|FG000|Overall Study|Lack of Efficacy|14|||
145388563|NCT01386944|524276827|FG000|Overall Study|Lost to Follow-up|8|||
145388564|NCT01386944|524276827|FG000|Overall Study|Unspecified reason|8|||
145388565|NCT04186221|524276829|FG000|Overall Study|Death|1|||
145388566|NCT01904032|524276830|FG000|Overall Study|Adverse Event|3|||
145388567|NCT01904032|524276831|FG001|Overall Study|Adverse Event|1|||
145388568|NCT01904032|524276830|FG000|Overall Study|Lost to Follow-up|4|||
145388569|NCT01904032|524276831|FG001|Overall Study|Lost to Follow-up|2|||
145388570|NCT00972283|524276841|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
145388571|NCT00972283|524276842|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
145388572|NCT00972283|524276841|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
145388573|NCT00972283|524276842|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
145388574|NCT00972283|524276841|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
145388575|NCT00972283|524276842|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
145388576|NCT00972283|524276841|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
145388577|NCT00972283|524276842|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
145388578|NCT00972283|524276841|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
145388579|NCT00972283|524276842|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
145388580|NCT00972283|524276841|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
145388581|NCT00972283|524276842|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
145388582|NCT00972283|524276841|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
145388583|NCT00972283|524276842|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
145388584|NCT00972283|524276841|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
145388585|NCT00972283|524276842|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
145388586|NCT00972283|524276841|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
145388587|NCT00972283|524276842|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
145388588|NCT00972283|524276841|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
145388589|NCT00972283|524276842|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
145388590|NCT00845676|524276850|FG000|Overall Study|Virologic breakthrough at week 20|1|||
145388591|NCT00845676|524276850|FG000|Overall Study|Adverse Event|1|||
145388592|NCT03373461|524276851|FG000|Part 2|Adverse Event|0|||
145388593|NCT03373461|524276852|FG001|Part 2|Adverse Event|1|||
145388594|NCT03373461|524276853|FG002|Part 2|Adverse Event|0|||
145388595|NCT03373461|524276854|FG003|Part 2|Adverse Event|0|||
145388596|NCT03373461|524276855|FG004|Part 2|Adverse Event|1|||
145388597|NCT01790516|524276856|FG000|Overall Study|Physician Decision|1|||
145388598|NCT01790516|524276857|FG001|Overall Study|Physician Decision|0|||
145388599|NCT03034135|524276858|FG000|Overall Study|Withdrawal by Subject|2|||
145388600|NCT02823470|524278377|FG000|Overall Study|Adverse Event|1|||
145388601|NCT02823470|524278378|FG001|Overall Study|Adverse Event|0|||
145388602|NCT02823470|524278377|FG000|Overall Study|Study terminated by sponsor|8|||
145388603|NCT02823470|524278378|FG001|Overall Study|Study terminated by sponsor|15|||
145388604|NCT01073163|524278380|FG000|Overall Study|Adverse Event|1|||
145388605|NCT01073163|524278380|FG000|Overall Study|Disease Progression|1|||
145388606|NCT01073163|524278380|FG000|Overall Study|Early termination|1|||
145388607|NCT00703677|524278381|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
145388608|NCT04441788|524278382|FG000|Overall Study|Voluntary Withdrawl|0|||
145388609|NCT04441788|524278383|FG001|Overall Study|Voluntary Withdrawl|1|||
145388610|NCT04441788|524278384|FG002|Overall Study|Voluntary Withdrawl|0|||
145388611|NCT04441788|524278382|FG000|Overall Study|Ineligibility|1|||
145388612|NCT04441788|524278383|FG001|Overall Study|Ineligibility|0|||
145388613|NCT04441788|524278384|FG002|Overall Study|Ineligibility|0|||
145388614|NCT04441788|524278382|FG000|Overall Study|Adverse Event|0|||
145388615|NCT04441788|524278383|FG001|Overall Study|Adverse Event|0|||
145388616|NCT04441788|524278384|FG002|Overall Study|Adverse Event|4|||
145388617|NCT04441788|524278382|FG000|Overall Study|Study Terminated by Sponsor|16|||
145388618|NCT04441788|524278383|FG001|Overall Study|Study Terminated by Sponsor|16|||
145388619|NCT04441788|524278384|FG002|Overall Study|Study Terminated by Sponsor|12|||
145388620|NCT03859648|524278387|FG000|Overall Study|Lost to Follow-up|1|||
145495102|NCT00506350|524670283|FG004|Overall Study|Adverse Event|0|||
145495103|NCT00506350|524670284|FG005|Overall Study|Adverse Event|0|||
145495104|NCT00506350|524670285|FG006|Overall Study|Adverse Event|0|||
145495105|NCT00506350|524670286|FG007|Overall Study|Adverse Event|1|||
145495106|NCT00506350|524670287|FG008|Overall Study|Adverse Event|1|||
145495107|NCT00506350|524670279|FG000|Overall Study|Protocol Violation|0|||
145495108|NCT00506350|524670280|FG001|Overall Study|Protocol Violation|0|||
145495109|NCT00506350|524670281|FG002|Overall Study|Protocol Violation|1|||
145495110|NCT00506350|524670282|FG003|Overall Study|Protocol Violation|0|||
145495111|NCT00506350|524670283|FG004|Overall Study|Protocol Violation|0|||
145495112|NCT00506350|524670284|FG005|Overall Study|Protocol Violation|0|||
145495113|NCT00506350|524670285|FG006|Overall Study|Protocol Violation|1|||
145495114|NCT00506350|524670286|FG007|Overall Study|Protocol Violation|0|||
145495115|NCT00506350|524670287|FG008|Overall Study|Protocol Violation|0|||
145495116|NCT00506350|524670279|FG000|Overall Study|Withdrawal by Subject|0|||
145495117|NCT00506350|524670280|FG001|Overall Study|Withdrawal by Subject|1|||
145495118|NCT00506350|524670281|FG002|Overall Study|Withdrawal by Subject|1|||
145495119|NCT00506350|524670282|FG003|Overall Study|Withdrawal by Subject|1|||
145495120|NCT00506350|524670283|FG004|Overall Study|Withdrawal by Subject|4|||
145495121|NCT00506350|524670284|FG005|Overall Study|Withdrawal by Subject|1|||
145495122|NCT00506350|524670285|FG006|Overall Study|Withdrawal by Subject|1|||
145495123|NCT00506350|524670286|FG007|Overall Study|Withdrawal by Subject|2|||
145495124|NCT00506350|524670287|FG008|Overall Study|Withdrawal by Subject|0|||
145495125|NCT00506350|524670279|FG000|Overall Study|Lost to Follow-up|1|||
145495126|NCT00506350|524670280|FG001|Overall Study|Lost to Follow-up|1|||
145495127|NCT00506350|524670281|FG002|Overall Study|Lost to Follow-up|1|||
145495128|NCT00506350|524670282|FG003|Overall Study|Lost to Follow-up|1|||
145495129|NCT00506350|524670283|FG004|Overall Study|Lost to Follow-up|2|||
145495130|NCT00506350|524670284|FG005|Overall Study|Lost to Follow-up|1|||
145495131|NCT00506350|524670285|FG006|Overall Study|Lost to Follow-up|0|||
145495132|NCT00506350|524670286|FG007|Overall Study|Lost to Follow-up|0|||
145495133|NCT00506350|524670287|FG008|Overall Study|Lost to Follow-up|2|||
145495134|NCT00506350|524670279|FG000|Overall Study|Medical Reason|0|||
145495135|NCT00506350|524670280|FG001|Overall Study|Medical Reason|0|||
145495136|NCT00506350|524670281|FG002|Overall Study|Medical Reason|0|||
145495137|NCT00506350|524670282|FG003|Overall Study|Medical Reason|0|||
145495138|NCT00506350|524670283|FG004|Overall Study|Medical Reason|1|||
145495139|NCT00506350|524670284|FG005|Overall Study|Medical Reason|0|||
145495140|NCT00506350|524670285|FG006|Overall Study|Medical Reason|0|||
145495141|NCT00506350|524670286|FG007|Overall Study|Medical Reason|0|||
145495142|NCT00506350|524670287|FG008|Overall Study|Medical Reason|0|||
145495143|NCT00506350|524670279|FG000|Overall Study|Other|1|||
145495144|NCT00506350|524670280|FG001|Overall Study|Other|1|||
145495145|NCT00506350|524670281|FG002|Overall Study|Other|3|||
145495146|NCT00506350|524670282|FG003|Overall Study|Other|0|||
145495147|NCT00506350|524670283|FG004|Overall Study|Other|3|||
145495148|NCT00506350|524670284|FG005|Overall Study|Other|0|||
145495149|NCT00506350|524670285|FG006|Overall Study|Other|0|||
145495150|NCT00506350|524670286|FG007|Overall Study|Other|2|||
145495151|NCT00506350|524670287|FG008|Overall Study|Other|2|||
145388621|NCT03859648|524278387|FG000|Overall Study|Adverse Event|1|||
145495152|NCT01691794|524670288|FG000|Overall Study|Poor/Non-Compliance|1|||
145495153|NCT01691794|524670289|FG001|Overall Study|Poor/Non-Compliance|4|||
145495154|NCT01691794|524670290|FG002|Overall Study|Poor/Non-Compliance|1|||
145495155|NCT01691794|524670288|FG000|Overall Study|Death|0|||
145495156|NCT01691794|524670289|FG001|Overall Study|Death|0|||
145495157|NCT01691794|524670290|FG002|Overall Study|Death|1|||
145495158|NCT01691794|524670288|FG000|Overall Study|Lack of Efficacy|0|||
145495159|NCT01691794|524670289|FG001|Overall Study|Lack of Efficacy|7|||
145495160|NCT01691794|524670290|FG002|Overall Study|Lack of Efficacy|1|||
145495161|NCT01691794|524670288|FG000|Overall Study|Participant request to discontinue|0|||
145495162|NCT01691794|524670289|FG001|Overall Study|Participant request to discontinue|1|||
145495163|NCT01691794|524670290|FG002|Overall Study|Participant request to discontinue|0|||
145495164|NCT01691794|524670288|FG000|Overall Study|Adverse Event|0|||
145388622|NCT02315664|524278388|FG000|Overall Study|Lost to Follow-up|1|||
145388623|NCT02315664|524278389|FG001|Overall Study|Lost to Follow-up|1|||
145388624|NCT02315664|524278388|FG000|Overall Study|Withdrawal by Subject|0|||
145388625|NCT02315664|524278389|FG001|Overall Study|Withdrawal by Subject|3|||
145388626|NCT01677182|524278390|FG000|Overall Study|Adverse Event|2|||
145388627|NCT01677182|524278391|FG001|Overall Study|Adverse Event|1|||
145388628|NCT01677182|524278392|FG002|Overall Study|Adverse Event|8|||
145388629|NCT01677182|524278390|FG000|Overall Study|Protocol Violation|5|||
145388630|NCT01677182|524278391|FG001|Overall Study|Protocol Violation|1|||
145388631|NCT01677182|524278392|FG002|Overall Study|Protocol Violation|4|||
145388632|NCT01677182|524278390|FG000|Overall Study|Lost to Follow-up|4|||
145388633|NCT01677182|524278391|FG001|Overall Study|Lost to Follow-up|0|||
145388634|NCT01677182|524278392|FG002|Overall Study|Lost to Follow-up|3|||
145388635|NCT01677182|524278390|FG000|Overall Study|Withdrawal by Subject|7|||
145388636|NCT01677182|524278391|FG001|Overall Study|Withdrawal by Subject|12|||
145388637|NCT01677182|524278392|FG002|Overall Study|Withdrawal by Subject|10|||
145388638|NCT01677182|524278390|FG000|Overall Study|Study termination|12|||
145388639|NCT01677182|524278391|FG001|Overall Study|Study termination|9|||
145388640|NCT01677182|524278392|FG002|Overall Study|Study termination|11|||
145388641|NCT01677182|524278390|FG000|Overall Study|Lack of Efficacy|3|||
145388642|NCT01677182|524278391|FG001|Overall Study|Lack of Efficacy|0|||
145388643|NCT01677182|524278392|FG002|Overall Study|Lack of Efficacy|1|||
145388644|NCT01677182|524278390|FG000|Overall Study|Other reasons|1|||
145388645|NCT01677182|524278391|FG001|Overall Study|Other reasons|5|||
145388646|NCT01677182|524278392|FG002|Overall Study|Other reasons|2|||
145388647|NCT02501161|524278393|FG000|Overall Study|Adverse Event|2|||
145388648|NCT02501161|524278394|FG001|Overall Study|Adverse Event|6|||
145388649|NCT02501161|524278393|FG000|Overall Study|Lost to Follow-up|7|||
145388650|NCT02501161|524278394|FG001|Overall Study|Lost to Follow-up|4|||
145388651|NCT02501161|524278393|FG000|Overall Study|Withdrawal by Subject|10|||
145388652|NCT02501161|524278394|FG001|Overall Study|Withdrawal by Subject|15|||
145388653|NCT02501161|524278393|FG000|Overall Study|Other|3|||
145388654|NCT02501161|524278394|FG001|Overall Study|Other|0|||
145388655|NCT02489448|524278395|FG000|Overall Study|Death|3|||
145388656|NCT02489448|524278395|FG000|Overall Study|Withdrawal by Subject|2|||
145388657|NCT02849171|524278404|FG000|Overall Study|Withdrawal by Subject|1|||
145388658|NCT02849171|524278404|FG000|Overall Study|Not treated|1|||
145388659|NCT02090283|524278405|FG000|Overall Study|Withdrawal by Subject|6|||
145388660|NCT02090283|524278406|FG001|Overall Study|Withdrawal by Subject|6|||
145388661|NCT02090283|524278407|FG002|Overall Study|Withdrawal by Subject|6|||
145388662|NCT02090283|524278405|FG000|Overall Study|Sponsor Terminated Study|6|||
145388663|NCT02090283|524278406|FG001|Overall Study|Sponsor Terminated Study|6|||
145388664|NCT02090283|524278407|FG002|Overall Study|Sponsor Terminated Study|1|||
145388665|NCT02090283|524278405|FG000|Overall Study|Lost to Follow-up|2|||
145388666|NCT02090283|524278406|FG001|Overall Study|Lost to Follow-up|2|||
145388667|NCT02090283|524278407|FG002|Overall Study|Lost to Follow-up|3|||
145388668|NCT02090283|524278405|FG000|Overall Study|Adverse Event|1|||
145388669|NCT02090283|524278406|FG001|Overall Study|Adverse Event|1|||
145388670|NCT02090283|524278407|FG002|Overall Study|Adverse Event|0|||
145388671|NCT02090283|524278405|FG000|Overall Study|Protocol Violation|2|||
145388672|NCT02090283|524278406|FG001|Overall Study|Protocol Violation|0|||
145388673|NCT02090283|524278407|FG002|Overall Study|Protocol Violation|0|||
145388674|NCT02964338|524278410|FG000|Overall Study|Sponsor terminated study for futility|12|||
145388675|NCT02964338|524278411|FG001|Overall Study|Sponsor terminated study for futility|15|||
145388676|NCT02964338|524278412|FG002|Overall Study|Sponsor terminated study for futility|14|||
145388677|NCT02964338|524278410|FG000|Overall Study|Lack of Efficacy|0|||
145388678|NCT02964338|524278411|FG001|Overall Study|Lack of Efficacy|3|||
145388679|NCT02964338|524278412|FG002|Overall Study|Lack of Efficacy|0|||
145388680|NCT02964338|524278410|FG000|Overall Study|Lost to Follow-up|1|||
145388681|NCT02964338|524278411|FG001|Overall Study|Lost to Follow-up|0|||
145388682|NCT02964338|524278412|FG002|Overall Study|Lost to Follow-up|3|||
145388683|NCT02964338|524278410|FG000|Overall Study|Protocol Violation|0|||
145388684|NCT02964338|524278411|FG001|Overall Study|Protocol Violation|1|||
145388685|NCT02964338|524278412|FG002|Overall Study|Protocol Violation|0|||
145388686|NCT02964338|524278410|FG000|Overall Study|Withdrawal by Subject|1|||
145388687|NCT02964338|524278411|FG001|Overall Study|Withdrawal by Subject|3|||
145388688|NCT02964338|524278412|FG002|Overall Study|Withdrawal by Subject|1|||
145388689|NCT02964338|524278410|FG000|Overall Study|Adverse Event|2|||
145388690|NCT02964338|524278411|FG001|Overall Study|Adverse Event|1|||
145388691|NCT02964338|524278412|FG002|Overall Study|Adverse Event|1|||
145388692|NCT02964338|524278410|FG000|Overall Study|Non-compliant with e-diary|0|||
145388693|NCT02964338|524278411|FG001|Overall Study|Non-compliant with e-diary|1|||
145388694|NCT02964338|524278412|FG002|Overall Study|Non-compliant with e-diary|0|||
145388695|NCT02964338|524278410|FG000|Overall Study|Did not meet criteria|1|||
145388696|NCT02964338|524278411|FG001|Overall Study|Did not meet criteria|0|||
145388697|NCT02964338|524278412|FG002|Overall Study|Did not meet criteria|0|||
145388698|NCT00621257|524278413|FG000|Overall Study|Lost to Follow-up|4|||
145388699|NCT00621257|524278414|FG001|Overall Study|Lost to Follow-up|0|||
145388700|NCT00621257|524278415|FG002|Overall Study|Lost to Follow-up|2|||
145388701|NCT00621257|524278416|FG003|Overall Study|Lost to Follow-up|4|||
145388702|NCT00621257|524278417|FG004|Overall Study|Lost to Follow-up|7|||
145388703|NCT00621257|524278413|FG000|Overall Study|Adverse Event|0|||
145388704|NCT00621257|524278414|FG001|Overall Study|Adverse Event|1|||
145388705|NCT00621257|524278415|FG002|Overall Study|Adverse Event|1|||
145388706|NCT00621257|524278416|FG003|Overall Study|Adverse Event|0|||
145388707|NCT00621257|524278417|FG004|Overall Study|Adverse Event|0|||
145388708|NCT00621257|524278413|FG000|Overall Study|Physician Decision|0|||
145388709|NCT00621257|524278414|FG001|Overall Study|Physician Decision|2|||
145388710|NCT00621257|524278415|FG002|Overall Study|Physician Decision|0|||
145388711|NCT00621257|524278416|FG003|Overall Study|Physician Decision|1|||
145388712|NCT00621257|524278417|FG004|Overall Study|Physician Decision|1|||
145388713|NCT00621257|524278413|FG000|Overall Study|Withdrawal by Subject|0|||
145388714|NCT00621257|524278414|FG001|Overall Study|Withdrawal by Subject|0|||
145388715|NCT00621257|524278415|FG002|Overall Study|Withdrawal by Subject|0|||
145388716|NCT00621257|524278416|FG003|Overall Study|Withdrawal by Subject|1|||
145388717|NCT00621257|524278417|FG004|Overall Study|Withdrawal by Subject|1|||
145388718|NCT01255904|524278421|FG000|Overall Study|Physician Decision|1|||
145388719|NCT01255904|524278422|FG001|Overall Study|Physician Decision|4|||
145388720|NCT02171429|524278424|FG000|Overall Study|Other|0|||
145388721|NCT02171429|524278425|FG001|Overall Study|Other|1|||
145388722|NCT02171429|524278426|FG002|Overall Study|Other|1|||
145388723|NCT02171429|524278424|FG000|Overall Study|Non-Compliance|0|||
145388724|NCT02171429|524278425|FG001|Overall Study|Non-Compliance|0|||
145388725|NCT02171429|524278426|FG002|Overall Study|Non-Compliance|1|||
145388726|NCT02171429|524278424|FG000|Overall Study|Physician Decision|0|||
145388727|NCT02171429|524278425|FG001|Overall Study|Physician Decision|0|||
145388728|NCT02171429|524278426|FG002|Overall Study|Physician Decision|1|||
145388729|NCT02171429|524278424|FG000|Overall Study|Withdrawal by Subject|1|||
145388730|NCT02171429|524278425|FG001|Overall Study|Withdrawal by Subject|1|||
145388731|NCT02171429|524278426|FG002|Overall Study|Withdrawal by Subject|1|||
145388732|NCT02171429|524278424|FG000|Overall Study|Lost to Follow-up|0|||
145388733|NCT02171429|524278425|FG001|Overall Study|Lost to Follow-up|1|||
145388734|NCT02171429|524278426|FG002|Overall Study|Lost to Follow-up|0|||
145388735|NCT02171429|524278424|FG000|Overall Study|Death|0|||
145388736|NCT02171429|524278425|FG001|Overall Study|Death|0|||
145388737|NCT02171429|524278426|FG002|Overall Study|Death|1|||
145388738|NCT01724177|524278429|FG000|Overall Study|Adverse Event|8|||
145388739|NCT01724177|524278429|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
145388740|NCT01724177|524278429|FG000|Overall Study|Nervous participant|1|||
145388741|NCT01724177|524278429|FG000|Overall Study|Serious Adverse Event Related|1|||
145388742|NCT01705080|524278433|FG000|Overall Study|Missed visit|10|||
145388743|NCT01705080|524278434|FG001|Overall Study|Missed visit|4|||
145388744|NCT01705080|524278435|FG002|Overall Study|Missed visit|1|||
145388745|NCT01705080|524278433|FG000|Overall Study|Death|4|||
145388746|NCT01705080|524278434|FG001|Overall Study|Death|4|||
145388747|NCT01705080|524278435|FG002|Overall Study|Death|6|||
145388748|NCT01705080|524278433|FG000|Overall Study|Withdrawal by Subject|61|||
145388749|NCT01705080|524278434|FG001|Overall Study|Withdrawal by Subject|44|||
145388750|NCT01705080|524278435|FG002|Overall Study|Withdrawal by Subject|9|||
145388751|NCT00281697|524278436|FG000|Overall Study|> 60 days since last dose of study drug|4|||
145388752|NCT00281697|524278437|FG001|Overall Study|> 60 days since last dose of study drug|4|||
145388753|NCT00281697|524278436|FG000|Overall Study|Adverse Event|54|||
145388754|NCT00281697|524278437|FG001|Overall Study|Adverse Event|15|||
145388755|NCT00281697|524278436|FG000|Overall Study|Death|8|||
145388756|NCT00281697|524278437|FG001|Overall Study|Death|3|||
145388757|NCT00281697|524278436|FG000|Overall Study|Disease progression|279|||
145388758|NCT00281697|524278437|FG001|Overall Study|Disease progression|149|||
145388759|NCT00281697|524278436|FG000|Overall Study|Other|5|||
145388760|NCT00281697|524278437|FG001|Overall Study|Other|6|||
145388761|NCT00281697|524278436|FG000|Overall Study|Physician's decision to withdraw|15|||
145388762|NCT00281697|524278437|FG001|Overall Study|Physician's decision to withdraw|12|||
145388763|NCT00281697|524278436|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
145388764|NCT00281697|524278437|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
145388765|NCT00281697|524278436|FG000|Overall Study|Did not receive study drug|3|||
145388766|NCT00281697|524278437|FG001|Overall Study|Did not receive study drug|2|||
145388767|NCT00632125|524278438|FG000|Overall Study|Death|82|||
145388768|NCT00632125|524278438|FG000|Overall Study|Withdrawal by Subject|44|||
145388769|NCT00632125|524278438|FG000|Overall Study|Adverse Event|36|||
145388770|NCT00632125|524278438|FG000|Overall Study|Renal transplantation|17|||
145388771|NCT00632125|524278438|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
145388772|NCT00632125|524278438|FG000|Overall Study|Non-compliance|8|||
145388773|NCT00632125|524278438|FG000|Overall Study|Development of uncontrolled hypertension|5|||
145388774|NCT00632125|524278438|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
145388775|NCT02821416|524278445|FG000|Overall Study|Adverse Event|0|||
145388776|NCT02821416|524278446|FG001|Overall Study|Adverse Event|1|||
145388777|NCT02821416|524278445|FG000|Overall Study|Withdrawal by Subject|2|||
145388778|NCT02821416|524278446|FG001|Overall Study|Withdrawal by Subject|0|||
145388779|NCT02821416|524278445|FG000|Overall Study|Lost to Follow-up|1|||
145388780|NCT02821416|524278446|FG001|Overall Study|Lost to Follow-up|0|||
145388781|NCT02256917|524278447|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
145388782|NCT02256917|524278447|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
145388783|NCT02256917|524278447|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
145388784|NCT02256917|524278447|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
145388785|NCT02256917|524278447|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
145388786|NCT04152083|524278448|FG000|Overall Study|Lost to Follow-up|2|||
145388787|NCT04152083|524278449|FG001|Overall Study|Lost to Follow-up|1|||
145388788|NCT04152083|524278448|FG000|Overall Study|Adverse Event|1|||
145388789|NCT04152083|524278449|FG001|Overall Study|Adverse Event|0|||
145388790|NCT04152083|524278448|FG000|Overall Study|Randomized but not treated|3|||
145388791|NCT04152083|524278449|FG001|Overall Study|Randomized but not treated|2|||
145388792|NCT02609386|524278450|FG000|Overall Study|Withdrawal by Subject|6|||
145388793|NCT02609386|524278451|FG001|Overall Study|Withdrawal by Subject|1|||
145388794|NCT02609386|524278450|FG000|Overall Study|Lost to Follow-up|3|||
145388795|NCT02609386|524278451|FG001|Overall Study|Lost to Follow-up|5|||
145388796|NCT02609386|524278450|FG000|Overall Study|Death|19|||
145388797|NCT02609386|524278451|FG001|Overall Study|Death|9|||
145388798|NCT02609386|524278450|FG000|Overall Study|Physician Decision|0|||
145388799|NCT02609386|524278451|FG001|Overall Study|Physician Decision|2|||
145388800|NCT00540644|524278452|FG000|Overall Study|Adverse Event|3|||
145388801|NCT00540644|524278453|FG001|Overall Study|Adverse Event|1|||
145388802|NCT00540644|524278452|FG000|Overall Study|Disease Progression|3|||
145388803|NCT00540644|524278453|FG001|Overall Study|Disease Progression|1|||
145388804|NCT00540644|524278452|FG000|Overall Study|Physician Decision|0|||
145388805|NCT00540644|524278453|FG001|Overall Study|Physician Decision|5|||
145388806|NCT00540644|524278452|FG000|Overall Study|Withdrawal by Subject|2|||
145388807|NCT00540644|524278453|FG001|Overall Study|Withdrawal by Subject|2|||
145388808|NCT00540644|524278452|FG000|Overall Study|Noncomplilance|1|||
145388809|NCT00540644|524278453|FG001|Overall Study|Noncomplilance|0|||
145388810|NCT03280056|524278454|FG000|Overall Study|Withdrawal by Subject|12|||
145388811|NCT03280056|524278455|FG001|Overall Study|Withdrawal by Subject|14|||
145388812|NCT03280056|524278454|FG000|Overall Study|Death|9|||
145388813|NCT03280056|524278455|FG001|Overall Study|Death|2|||
145388814|NCT03280056|524278454|FG000|Overall Study|Adverse Event|1|||
145388815|NCT03280056|524278455|FG001|Overall Study|Adverse Event|3|||
145388816|NCT03280056|524278454|FG000|Overall Study|Lost to Follow-up|1|||
145388817|NCT03280056|524278455|FG001|Overall Study|Lost to Follow-up|1|||
145388818|NCT03280056|524278454|FG000|Overall Study|Physician Decision|0|||
145388819|NCT03280056|524278455|FG001|Overall Study|Physician Decision|1|||
145388820|NCT03280056|524278454|FG000|Overall Study|Early Discontinuation|1|||
145388821|NCT03280056|524278455|FG001|Overall Study|Early Discontinuation|0|||
145388822|NCT01869777|524278456|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
145388823|NCT01135524|524278461|FG000|Overall Study|Withdrawal by Subject|14|||
145388824|NCT01135524|524278461|FG000|Overall Study|Adverse Event|20|||
145388825|NCT01135524|524278461|FG000|Overall Study|Lost to Follow-up|3|||
145388826|NCT01135524|524278461|FG000|Overall Study|Administrative|151|||
145388827|NCT01135524|524278461|FG000|Overall Study|Lack of Efficacy|8|||
145388828|NCT03318003|524278462|FG000|Overall Study|Withdrawal by Subject|1|||
145388829|NCT03318003|524278463|FG001|Overall Study|Withdrawal by Subject|1|||
145388830|NCT03318003|524278462|FG000|Overall Study|fetal loss|0|||
145388831|NCT03318003|524278463|FG001|Overall Study|fetal loss|1|||
145388832|NCT04819438|524278467|FG000|Overall Study|Withdrawal by Subject|1|||
145388833|NCT04819438|524278468|FG001|Overall Study|Withdrawal by Subject|0|||
145388834|NCT04819438|524278467|FG000|Overall Study|Adverse Event|0|||
145388835|NCT04819438|524278468|FG001|Overall Study|Adverse Event|1|||
145388836|NCT04819438|524278467|FG000|Overall Study|Protocol Violation|0|||
145388837|NCT04819438|524278468|FG001|Overall Study|Protocol Violation|1|||
145388838|NCT02869893|524278469|FG000|Overall Study|participant aversion to IV|5|||
145388839|NCT02869893|524278469|FG000|Overall Study|participant fear of MRI scanner|2|||
145388840|NCT02328937|524278470|FG000|Period 1|Lost to Follow-up|0|||
145388841|NCT02328937|524278471|FG001|Period 1|Lost to Follow-up|0|||
145388842|NCT02328937|524278472|FG002|Period 1|Lost to Follow-up|0|||
145388843|NCT02328937|524278473|FG003|Period 1|Lost to Follow-up|1|||
145388844|NCT02328937|524278474|FG004|Period 1|Lost to Follow-up|0|||
145388845|NCT02328937|524278475|FG005|Period 1|Lost to Follow-up|0|||
145388846|NCT02328937|524278470|FG000|Period 2|Adverse Event|0|||
145388847|NCT02328937|524278471|FG001|Period 2|Adverse Event|0|||
145388848|NCT02328937|524278472|FG002|Period 2|Adverse Event|1|||
145388849|NCT02328937|524278473|FG003|Period 2|Adverse Event|0|||
145388850|NCT02328937|524278474|FG004|Period 2|Adverse Event|0|||
145388851|NCT02328937|524278475|FG005|Period 2|Adverse Event|0|||
145388852|NCT03665077|524278478|FG000|Overall Study|Lost to Follow-up|2|||
145388853|NCT03665077|524278478|FG000|Overall Study|Physician Decision|2|||
145388854|NCT00837967|524278481|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
145388855|NCT00837967|524278482|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
145388856|NCT02504320|524278487|FG000|Treatment Period 1|Positive Drug Screen|0|||
145388857|NCT02504320|524278488|FG001|Treatment Period 1|Positive Drug Screen|0|||
145388858|NCT02504320|524278489|FG002|Treatment Period 1|Positive Drug Screen|1|||
145388859|NCT02504320|524278490|FG003|Treatment Period 1|Positive Drug Screen|0|||
145388860|NCT02504320|524278487|FG000|Treatment Period 2|Positive Drug Screen|0|||
145388861|NCT02504320|524278488|FG001|Treatment Period 2|Positive Drug Screen|1|||
145388862|NCT02504320|524278489|FG002|Treatment Period 2|Positive Drug Screen|0|||
145388863|NCT02504320|524278490|FG003|Treatment Period 2|Positive Drug Screen|0|||
145388864|NCT02504320|524278487|FG000|Treatment Period 3|Positive Drug Screen|0|||
145388865|NCT02504320|524278488|FG001|Treatment Period 3|Positive Drug Screen|0|||
145388866|NCT02504320|524278489|FG002|Treatment Period 3|Positive Drug Screen|0|||
145388867|NCT02504320|524278490|FG003|Treatment Period 3|Positive Drug Screen|1|||
145388868|NCT02504320|524278487|FG000|Treatment Period 3|Adverse Event|0|||
145388869|NCT02504320|524278488|FG001|Treatment Period 3|Adverse Event|0|||
145388870|NCT02504320|524278489|FG002|Treatment Period 3|Adverse Event|1|||
145388871|NCT02504320|524278490|FG003|Treatment Period 3|Adverse Event|0|||
145495165|NCT01691794|524670289|FG001|Overall Study|Adverse Event|1|||
145495166|NCT01691794|524670290|FG002|Overall Study|Adverse Event|1|||
145495167|NCT01691794|524670288|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
145495168|NCT01691794|524670289|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
145388872|NCT01737879|524278491|FG000|Overall Study|Death|1|||
145388873|NCT01737879|524278491|FG000|Overall Study|Sponsor decision|40|||
145388874|NCT03293394|524278492|FG000|Follow-up (6 Months)|Adverse Event|4|||
145495169|NCT01691794|524670290|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
145729113|NCT01966471|525525200|FG001|Overall Study|Lost to Follow-up|39|||
145729114|NCT01966471|525525199|FG000|Overall Study|Various reasons|4|||
145729115|NCT01966471|525525200|FG001|Overall Study|Various reasons|4|||
145729116|NCT01966471|525525199|FG000|Overall Study|Physician Decision|7|||
145729117|NCT01966471|525525200|FG001|Overall Study|Physician Decision|5|||
145729118|NCT01966471|525525199|FG000|Overall Study|Study Terminated By Sponsor|758|||
145729119|NCT01966471|525525200|FG001|Overall Study|Study Terminated By Sponsor|773|||
145729120|NCT01966471|525525199|FG000|Overall Study|Withdrawal by Subject|59|||
145729121|NCT01966471|525525200|FG001|Overall Study|Withdrawal by Subject|51|||
145729122|NCT00960531|525525202|FG000|Overall Study|Lack of Efficacy|1|||
145729123|NCT00960531|525525203|FG001|Overall Study|Lack of Efficacy|0|||
145729124|NCT00960531|525525204|FG002|Overall Study|Lack of Efficacy|0|||
145729125|NCT00960531|525525205|FG003|Overall Study|Lack of Efficacy|0|||
145729126|NCT00960531|525525206|FG004|Overall Study|Lack of Efficacy|0|||
145729127|NCT00960531|525525207|FG005|Overall Study|Lack of Efficacy|0|||
145729128|NCT00960531|525525208|FG006|Overall Study|Lack of Efficacy|0|||
145729129|NCT00960531|525525209|FG007|Overall Study|Lack of Efficacy|0|||
145729130|NCT00960531|525525210|FG008|Overall Study|Lack of Efficacy|0|||
145729131|NCT00960531|525525211|FG009|Overall Study|Lack of Efficacy|0|||
145729132|NCT00960531|525525202|FG000|Overall Study|Withdrawal by Subject|1|||
145729133|NCT00960531|525525203|FG001|Overall Study|Withdrawal by Subject|0|||
145729134|NCT00960531|525525204|FG002|Overall Study|Withdrawal by Subject|5|||
145729135|NCT00960531|525525205|FG003|Overall Study|Withdrawal by Subject|2|||
145729136|NCT00960531|525525206|FG004|Overall Study|Withdrawal by Subject|0|||
145729137|NCT00960531|525525207|FG005|Overall Study|Withdrawal by Subject|0|||
145729138|NCT00960531|525525208|FG006|Overall Study|Withdrawal by Subject|2|||
145729139|NCT00960531|525525209|FG007|Overall Study|Withdrawal by Subject|0|||
145729140|NCT00960531|525525210|FG008|Overall Study|Withdrawal by Subject|1|||
145729141|NCT00960531|525525211|FG009|Overall Study|Withdrawal by Subject|0|||
145729142|NCT00960531|525525202|FG000|Overall Study|Caregiver Request|2|||
145729143|NCT00960531|525525203|FG001|Overall Study|Caregiver Request|0|||
145729144|NCT00960531|525525204|FG002|Overall Study|Caregiver Request|6|||
145729145|NCT00960531|525525205|FG003|Overall Study|Caregiver Request|5|||
145388875|NCT03293394|524278493|FG001|Follow-up (6 Months)|Adverse Event|2|||
145388876|NCT02497404|524278494|FG000|Overall Study|Adverse Event|1|||
145388877|NCT04865419|524278497|FG000|Overall Study|Other|1|||
145388878|NCT04865419|524278498|FG001|Overall Study|Other|2|||
145388879|NCT04865419|524278499|FG002|Overall Study|Other|2|||
145388880|NCT04865419|524278500|FG003|Overall Study|Other|1|||
145388881|NCT04865419|524278501|FG004|Overall Study|Other|3|||
145388882|NCT04865419|524278502|FG005|Overall Study|Other|0|||
145388883|NCT04865419|524278503|FG006|Overall Study|Other|0|||
145729146|NCT00960531|525525206|FG004|Overall Study|Caregiver Request|0|||
145495170|NCT01691794|524670288|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
145388884|NCT04865419|524278504|FG007|Overall Study|Other|1|||
145388885|NCT04865419|524278505|FG008|Overall Study|Other|0|||
145388886|NCT04865419|524278506|FG009|Overall Study|Other|0|||
145388887|NCT04865419|524278507|FG010|Overall Study|Other|0|||
145388888|NCT04865419|524278497|FG000|Overall Study|Withdrawal by Subject|0|||
145388889|NCT04865419|524278498|FG001|Overall Study|Withdrawal by Subject|1|||
145388890|NCT04865419|524278499|FG002|Overall Study|Withdrawal by Subject|1|||
145388891|NCT04865419|524278500|FG003|Overall Study|Withdrawal by Subject|0|||
145388892|NCT04865419|524278501|FG004|Overall Study|Withdrawal by Subject|0|||
145388893|NCT04865419|524278502|FG005|Overall Study|Withdrawal by Subject|0|||
145388894|NCT04865419|524278503|FG006|Overall Study|Withdrawal by Subject|0|||
145388895|NCT04865419|524278504|FG007|Overall Study|Withdrawal by Subject|1|||
145388896|NCT04865419|524278505|FG008|Overall Study|Withdrawal by Subject|2|||
145388897|NCT04865419|524278506|FG009|Overall Study|Withdrawal by Subject|1|||
145388898|NCT04865419|524278507|FG010|Overall Study|Withdrawal by Subject|0|||
145388899|NCT04865419|524278497|FG000|Overall Study|Study terminated by Sponsor|0|||
145388900|NCT04865419|524278498|FG001|Overall Study|Study terminated by Sponsor|0|||
145388901|NCT04865419|524278499|FG002|Overall Study|Study terminated by Sponsor|0|||
145388902|NCT04865419|524278500|FG003|Overall Study|Study terminated by Sponsor|2|||
145388903|NCT04865419|524278501|FG004|Overall Study|Study terminated by Sponsor|2|||
145388904|NCT04865419|524278502|FG005|Overall Study|Study terminated by Sponsor|0|||
145388905|NCT04865419|524278503|FG006|Overall Study|Study terminated by Sponsor|0|||
145388906|NCT04865419|524278504|FG007|Overall Study|Study terminated by Sponsor|0|||
145388907|NCT04865419|524278505|FG008|Overall Study|Study terminated by Sponsor|0|||
145388908|NCT04865419|524278506|FG009|Overall Study|Study terminated by Sponsor|0|||
145388909|NCT04865419|524278507|FG010|Overall Study|Study terminated by Sponsor|1|||
145388910|NCT04865419|524278497|FG000|Overall Study|Death|3|||
145388911|NCT04865419|524278498|FG001|Overall Study|Death|1|||
145388912|NCT04865419|524278499|FG002|Overall Study|Death|4|||
145388913|NCT04865419|524278500|FG003|Overall Study|Death|2|||
145388914|NCT04865419|524278501|FG004|Overall Study|Death|5|||
145388915|NCT04865419|524278502|FG005|Overall Study|Death|2|||
145388916|NCT04865419|524278503|FG006|Overall Study|Death|1|||
145388917|NCT04865419|524278504|FG007|Overall Study|Death|1|||
145388918|NCT04865419|524278505|FG008|Overall Study|Death|2|||
145388919|NCT04865419|524278506|FG009|Overall Study|Death|2|||
145388920|NCT04865419|524278507|FG010|Overall Study|Death|1|||
145388921|NCT04865419|524278497|FG000|Overall Study|Lost to Follow-up|0|||
145388922|NCT04865419|524278498|FG001|Overall Study|Lost to Follow-up|0|||
145388923|NCT04865419|524278499|FG002|Overall Study|Lost to Follow-up|0|||
145388924|NCT04865419|524278500|FG003|Overall Study|Lost to Follow-up|0|||
145388925|NCT04865419|524278501|FG004|Overall Study|Lost to Follow-up|0|||
145388926|NCT04865419|524278502|FG005|Overall Study|Lost to Follow-up|0|||
145388927|NCT04865419|524278503|FG006|Overall Study|Lost to Follow-up|0|||
145388928|NCT04865419|524278504|FG007|Overall Study|Lost to Follow-up|0|||
145388929|NCT04865419|524278505|FG008|Overall Study|Lost to Follow-up|0|||
145388930|NCT04865419|524278506|FG009|Overall Study|Lost to Follow-up|1|||
145388931|NCT04865419|524278507|FG010|Overall Study|Lost to Follow-up|0|||
145388932|NCT00334295|524278508|FG000|Overall Study|Patients received fewer than 3 injection|5|||
145388933|NCT00792116|524278511|FG000|Overall Study|Lost to Follow-up|0|||
145388934|NCT00792116|524278512|FG001|Overall Study|Lost to Follow-up|1|||
145388935|NCT00792116|524278511|FG000|Overall Study|Discontnued intervention|1|||
145388936|NCT00792116|524278512|FG001|Overall Study|Discontnued intervention|0|||
145388937|NCT02453256|524278513|FG000|Double Blind Period|Death|1|||
145388938|NCT02453256|524278514|FG001|Double Blind Period|Death|1|||
145388939|NCT02453256|524278513|FG000|Double Blind Period|Adverse Event|3|||
145388940|NCT02453256|524278514|FG001|Double Blind Period|Adverse Event|2|||
145388941|NCT02453256|524278513|FG000|Double Blind Period|Withdrawal by Subject|9|||
145388942|NCT02453256|524278514|FG001|Double Blind Period|Withdrawal by Subject|5|||
145388943|NCT02453256|524278513|FG000|Double Blind Period|Other|0|||
145388944|NCT02453256|524278514|FG001|Double Blind Period|Other|1|||
145388945|NCT02453256|524278513|FG000|Open Label Period|Adverse Event|1|||
145388946|NCT02453256|524278514|FG001|Open Label Period|Adverse Event|3|||
145388947|NCT02453256|524278513|FG000|Open Label Period|Death|0|||
145388948|NCT02453256|524278514|FG001|Open Label Period|Death|1|||
145388949|NCT02453256|524278513|FG000|Open Label Period|Lost to Follow-up|1|||
145388950|NCT02453256|524278514|FG001|Open Label Period|Lost to Follow-up|0|||
145388951|NCT02453256|524278513|FG000|Open Label Period|Other|0|||
145388952|NCT02453256|524278514|FG001|Open Label Period|Other|2|||
145388953|NCT02453256|524278513|FG000|Open Label Period|Withdrawal by Subject|5|||
145388954|NCT02453256|524278514|FG001|Open Label Period|Withdrawal by Subject|1|||
145388955|NCT00980655|524278515|FG000|Overall Study|Adverse Event|13|||
145388956|NCT00980655|524278516|FG001|Overall Study|Adverse Event|31|||
145388957|NCT00980655|524278515|FG000|Overall Study|Death|0|||
145388958|NCT00980655|524278516|FG001|Overall Study|Death|7|||
145388959|NCT00980655|524278515|FG000|Overall Study|Protocol Violation|2|||
145388960|NCT00980655|524278516|FG001|Overall Study|Protocol Violation|7|||
145388961|NCT00980655|524278515|FG000|Overall Study|Withdrawal by Subject|0|||
145388962|NCT00980655|524278516|FG001|Overall Study|Withdrawal by Subject|4|||
145388963|NCT00980655|524278515|FG000|Overall Study|Lost to Follow-up|0|||
145388964|NCT00980655|524278516|FG001|Overall Study|Lost to Follow-up|1|||
145388965|NCT00980655|524278515|FG000|Overall Study|Parent/legal guardian request|1|||
145388966|NCT00980655|524278516|FG001|Overall Study|Parent/legal guardian request|0|||
145388967|NCT00980655|524278515|FG000|Overall Study|Other|0|||
145388968|NCT00980655|524278516|FG001|Overall Study|Other|1|||
145388969|NCT01972464|524278519|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
145388970|NCT01972464|524278520|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
145388971|NCT01972464|524278519|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
145388972|NCT01972464|524278520|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
145388973|NCT01972464|524278519|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
145388974|NCT01972464|524278520|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
145388975|NCT01972464|524278519|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
145388976|NCT01972464|524278520|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
145388977|NCT04530838|524280187|FG000|Overall Study|Other|2|||
145388978|NCT04530838|524280188|FG001|Overall Study|Other|1|||
145388979|NCT04530838|524280189|FG002|Overall Study|Other|0|||
145388980|NCT04530838|524280187|FG000|Overall Study|Physician Decision|0|||
145388981|NCT04530838|524280188|FG001|Overall Study|Physician Decision|0|||
145388982|NCT04530838|524280189|FG002|Overall Study|Physician Decision|1|||
145388983|NCT04530838|524280187|FG000|Overall Study|Death|0|||
145388984|NCT04530838|524280188|FG001|Overall Study|Death|0|||
145388985|NCT04530838|524280189|FG002|Overall Study|Death|1|||
145388986|NCT04530838|524280187|FG000|Overall Study|Adverse Event|0|||
145388987|NCT04530838|524280188|FG001|Overall Study|Adverse Event|1|||
145388988|NCT04530838|524280189|FG002|Overall Study|Adverse Event|0|||
145388989|NCT04530838|524280187|FG000|Overall Study|No longer meets eligibility criteria|1|||
145388990|NCT04530838|524280188|FG001|Overall Study|No longer meets eligibility criteria|0|||
145388991|NCT04530838|524280189|FG002|Overall Study|No longer meets eligibility criteria|2|||
145388992|NCT04530838|524280187|FG000|Overall Study|Withdrawal by parent/guardian|5|||
145388993|NCT04530838|524280188|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145388994|NCT04530838|524280189|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145388995|NCT00762762|524280198|FG000|Overall Study|Did not return for appointments|6|||
145388996|NCT00762762|524280199|FG001|Overall Study|Did not return for appointments|8|||
145388997|NCT02620787|524280204|FG000|Overall Study|Adverse Event|1|||
145388998|NCT02620787|524280205|FG001|Overall Study|Adverse Event|0|||
145388999|NCT02620787|524280204|FG000|Overall Study|Eligibility Criteria Not Met|1|||
145389000|NCT02620787|524280205|FG001|Overall Study|Eligibility Criteria Not Met|0|||
145389001|NCT00807612|524280206|FG000|Overall Study|Death|8|||
145389002|NCT00807612|524280206|FG000|Overall Study|Study early termination|5|||
145389003|NCT00807612|524280206|FG000|Overall Study|Withdrawal by Subject|1|||
145389004|NCT04607135|524280207|FG000|Overall Study|Physician Decision|1|||
145389005|NCT04607135|524280207|FG000|Overall Study|Withdrawal by Subject|1|||
145389006|NCT04607135|524280207|FG000|Overall Study|Equipment not working|3|||
145389007|NCT01210222|524280208|FG000|Overall Study|Ineligible|2|||
145389008|NCT01210222|524280208|FG000|Overall Study|Never treated|1|||
145389009|NCT00941304|524280209|FG000|Overall Study|Lost to Follow-up|1|||
145389010|NCT00941304|524280210|FG001|Overall Study|Lost to Follow-up|0|||
145389011|NCT00941304|524280211|FG002|Overall Study|Lost to Follow-up|0|||
145389012|NCT00941304|524280212|FG003|Overall Study|Lost to Follow-up|0|||
145389013|NCT00941304|524280213|FG004|Overall Study|Lost to Follow-up|0|||
145389014|NCT00784719|524280216|FG000|Overall Study|Adverse Event|0|||
145389015|NCT00784719|524280217|FG001|Overall Study|Adverse Event|2|||
145389016|NCT00784719|524280218|FG002|Overall Study|Adverse Event|0|||
145389017|NCT00784719|524280219|FG003|Overall Study|Adverse Event|0|||
145389018|NCT00784719|524280220|FG004|Overall Study|Adverse Event|1|||
145389019|NCT00784719|524280221|FG005|Overall Study|Adverse Event|1|||
145389020|NCT00784719|524280222|FG006|Overall Study|Adverse Event|1|||
145389021|NCT00784719|524280216|FG000|Overall Study|Lost to Follow-up|0|||
145389022|NCT00784719|524280217|FG001|Overall Study|Lost to Follow-up|0|||
145389023|NCT00784719|524280218|FG002|Overall Study|Lost to Follow-up|0|||
145389024|NCT00784719|524280219|FG003|Overall Study|Lost to Follow-up|0|||
145389025|NCT00784719|524280220|FG004|Overall Study|Lost to Follow-up|1|||
145389026|NCT00784719|524280221|FG005|Overall Study|Lost to Follow-up|1|||
145389027|NCT00784719|524280222|FG006|Overall Study|Lost to Follow-up|0|||
145389028|NCT00784719|524280216|FG000|Overall Study|Other|2|||
145389029|NCT00784719|524280217|FG001|Overall Study|Other|1|||
145389030|NCT00784719|524280218|FG002|Overall Study|Other|1|||
145389031|NCT00784719|524280219|FG003|Overall Study|Other|0|||
145389032|NCT00784719|524280220|FG004|Overall Study|Other|2|||
145389033|NCT00784719|524280221|FG005|Overall Study|Other|1|||
145389034|NCT00784719|524280222|FG006|Overall Study|Other|3|||
145389035|NCT00784719|524280216|FG000|Overall Study|Withdrawal by Subject|1|||
145389036|NCT00784719|524280217|FG001|Overall Study|Withdrawal by Subject|0|||
145389037|NCT00784719|524280218|FG002|Overall Study|Withdrawal by Subject|0|||
145389038|NCT00784719|524280219|FG003|Overall Study|Withdrawal by Subject|0|||
145389039|NCT00784719|524280220|FG004|Overall Study|Withdrawal by Subject|2|||
145389040|NCT00784719|524280221|FG005|Overall Study|Withdrawal by Subject|0|||
145389041|NCT00784719|524280222|FG006|Overall Study|Withdrawal by Subject|1|||
145389042|NCT01408901|524280223|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
145389043|NCT01408901|524280224|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
145389044|NCT01408901|524280225|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
145389045|NCT01408901|524280226|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
145389046|NCT01408901|524280223|FG000|6-Week Follow-Up|Death|1|||
145389047|NCT01408901|524280224|FG001|6-Week Follow-Up|Death|0|||
145389048|NCT01408901|524280225|FG002|6-Week Follow-Up|Death|0|||
145389049|NCT01408901|524280226|FG003|6-Week Follow-Up|Death|0|||
145389050|NCT01408901|524280223|FG000|6-Week Follow-Up|Cancelled visit|0|||
145389051|NCT01408901|524280224|FG001|6-Week Follow-Up|Cancelled visit|1|||
145389052|NCT01408901|524280225|FG002|6-Week Follow-Up|Cancelled visit|0|||
145389053|NCT01408901|524280226|FG003|6-Week Follow-Up|Cancelled visit|2|||
145389054|NCT01408901|524280223|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145389055|NCT01408901|524280224|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145389056|NCT01408901|524280225|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
145389057|NCT01408901|524280226|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
145389058|NCT01408901|524280223|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
145389059|NCT01408901|524280224|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145389060|NCT01408901|524280225|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145389061|NCT01408901|524280226|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
145389062|NCT01408901|524280223|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
145389063|NCT01408901|524280224|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
145389064|NCT01408901|524280225|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
145389065|NCT01408901|524280226|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
145389066|NCT01408901|524280223|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
145389067|NCT01408901|524280224|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
145389068|NCT01408901|524280225|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
145389069|NCT01408901|524280226|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
145389070|NCT01408901|524280223|FG000|26-Week Follow-Up|Death|0|||
145389071|NCT01408901|524280224|FG001|26-Week Follow-Up|Death|1|||
145389072|NCT01408901|524280225|FG002|26-Week Follow-Up|Death|0|||
145389073|NCT01408901|524280226|FG003|26-Week Follow-Up|Death|0|||
145389074|NCT04978337|524280229|FG000|Overall Study|Withdrawal by Subject|0|||
145389075|NCT04978337|524280230|FG001|Overall Study|Withdrawal by Subject|1|||
145389076|NCT01436227|524280234|FG000|Overall Study|Adverse Event|7|||
145389077|NCT01436227|524280234|FG000|Overall Study|Death|1|||
145389078|NCT01436227|524280234|FG000|Overall Study|Lack of Efficacy|1|||
145389079|NCT01436227|524280234|FG000|Overall Study|Lost to Follow-up|3|||
145389080|NCT01436227|524280234|FG000|Overall Study|Physician Decision|1|||
145389081|NCT01436227|524280234|FG000|Overall Study|Withdrawal by Subject|7|||
145389082|NCT01436227|524280234|FG000|Overall Study|Disease progression, relapse|6|||
145389083|NCT05446142|524280237|FG000|Period 2|Adverse Event|1|||
145389084|NCT05446142|524280238|FG001|Period 2|Adverse Event|0|||
145389085|NCT05446142|524280239|FG002|Period 2|Adverse Event|0|||
145389086|NCT05446142|524280240|FG003|Period 2|Adverse Event|0|||
145389087|NCT05446142|524280241|FG004|Period 2|Adverse Event|0|||
145389088|NCT05446142|524280242|FG005|Period 2|Adverse Event|0|||
145389089|NCT02098395|524280247|FG000|Overall Study|Protocol Violation|2|||
145389090|NCT02098395|524280248|FG001|Overall Study|Protocol Violation|2|||
145389091|NCT02098395|524280249|FG002|Overall Study|Protocol Violation|0|||
145389092|NCT02098395|524280250|FG003|Overall Study|Protocol Violation|7|||
145389093|NCT02098395|524280247|FG000|Overall Study|Withdrawal by Subject|10|||
145389094|NCT02098395|524280248|FG001|Overall Study|Withdrawal by Subject|10|||
145389095|NCT02098395|524280249|FG002|Overall Study|Withdrawal by Subject|5|||
145389096|NCT02098395|524280250|FG003|Overall Study|Withdrawal by Subject|13|||
145389097|NCT02098395|524280247|FG000|Overall Study|Adverse Event|12|||
145389098|NCT02098395|524280248|FG001|Overall Study|Adverse Event|19|||
145389099|NCT02098395|524280249|FG002|Overall Study|Adverse Event|34|||
145389100|NCT02098395|524280250|FG003|Overall Study|Adverse Event|2|||
145389101|NCT02098395|524280247|FG000|Overall Study|Lost to Follow-up|2|||
145389102|NCT02098395|524280248|FG001|Overall Study|Lost to Follow-up|1|||
145389103|NCT02098395|524280249|FG002|Overall Study|Lost to Follow-up|0|||
145389104|NCT02098395|524280250|FG003|Overall Study|Lost to Follow-up|3|||
145389105|NCT02098395|524280247|FG000|Overall Study|Unclassified|0|||
145389106|NCT02098395|524280248|FG001|Overall Study|Unclassified|0|||
145389107|NCT02098395|524280249|FG002|Overall Study|Unclassified|3|||
145389108|NCT02098395|524280250|FG003|Overall Study|Unclassified|2|||
145389109|NCT00547157|524280253|FG000|Overall Study|Other|1|||
145389110|NCT00547157|524280254|FG001|Overall Study|Other|0|||
145389111|NCT00547157|524280253|FG000|Overall Study|Death|38|||
145389112|NCT00547157|524280254|FG001|Overall Study|Death|18|||
145389113|NCT00547157|524280253|FG000|Overall Study|Withdrawal by Subject|3|||
145389114|NCT00547157|524280254|FG001|Overall Study|Withdrawal by Subject|1|||
145389115|NCT00547157|524280253|FG000|Overall Study|Administrative decision|3|||
145389116|NCT00547157|524280254|FG001|Overall Study|Administrative decision|2|||
145389117|NCT00547157|524280253|FG000|Overall Study|Lost to Follow-up|4|||
145389118|NCT00547157|524280254|FG001|Overall Study|Lost to Follow-up|2|||
145389119|NCT04633226|524280261|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145389120|NCT04633226|524280261|FG000|Overall Study|Randomized by mistake without study treatment|1|||
145389121|NCT05415462|524280264|FG000|Overall Study|Death|18|||
145389122|NCT05415462|524280265|FG001|Overall Study|Death|10|||
145389123|NCT05415462|524280264|FG000|Overall Study|Lost to Follow-up|72|||
145389124|NCT05415462|524280265|FG001|Overall Study|Lost to Follow-up|64|||
145389125|NCT05415462|524280264|FG000|Overall Study|Physician Decision|5|||
145389126|NCT05415462|524280265|FG001|Overall Study|Physician Decision|5|||
145389127|NCT05415462|524280264|FG000|Overall Study|Protocol Deviation|1|||
145389128|NCT05415462|524280265|FG001|Overall Study|Protocol Deviation|0|||
145389129|NCT05415462|524280264|FG000|Overall Study|Withdrawal by Subject|129|||
145389130|NCT05415462|524280265|FG001|Overall Study|Withdrawal by Subject|101|||
145389131|NCT05415462|524280264|FG000|Overall Study|Other Than Specified|8|||
145389132|NCT05415462|524280265|FG001|Overall Study|Other Than Specified|8|||
145389133|NCT01087203|524280270|FG000|Overall Study|Lost to Follow-up|2|||
145389134|NCT01087203|524280271|FG001|Overall Study|Lost to Follow-up|0|||
145389135|NCT01087203|524280270|FG000|Overall Study|Withdrawal by Subject|2|||
145389136|NCT01087203|524280271|FG001|Overall Study|Withdrawal by Subject|6|||
145389137|NCT01087203|524280270|FG000|Overall Study|Lack of Efficacy|1|||
145389138|NCT01087203|524280271|FG001|Overall Study|Lack of Efficacy|2|||
145389139|NCT01087203|524280270|FG000|Overall Study|Study terminated by sponsor|27|||
145389140|NCT01087203|524280271|FG001|Overall Study|Study terminated by sponsor|27|||
145389141|NCT02559570|524280273|FG000|Overall Study|Adverse Event|0|||
145389142|NCT02559570|524280274|FG001|Overall Study|Adverse Event|2|||
145389143|NCT02559570|524280275|FG002|Overall Study|Adverse Event|0|||
145389144|NCT02559570|524280276|FG003|Overall Study|Adverse Event|1|||
145389145|NCT02559570|524280277|FG004|Overall Study|Adverse Event|0|||
145389146|NCT02559570|524280273|FG000|Overall Study|Withdrawal of Consent|0|||
145389147|NCT02559570|524280274|FG001|Overall Study|Withdrawal of Consent|0|||
145389148|NCT02559570|524280275|FG002|Overall Study|Withdrawal of Consent|1|||
145729147|NCT00960531|525525207|FG005|Overall Study|Caregiver Request|2|||
145729148|NCT00960531|525525208|FG006|Overall Study|Caregiver Request|3|||
145729149|NCT00960531|525525209|FG007|Overall Study|Caregiver Request|1|||
145729150|NCT00960531|525525210|FG008|Overall Study|Caregiver Request|3|||
145729151|NCT00960531|525525211|FG009|Overall Study|Caregiver Request|0|||
145729152|NCT00960531|525525202|FG000|Overall Study|Investigator Request|0|||
145729153|NCT00960531|525525203|FG001|Overall Study|Investigator Request|0|||
145729154|NCT00960531|525525204|FG002|Overall Study|Investigator Request|1|||
145729155|NCT00960531|525525205|FG003|Overall Study|Investigator Request|0|||
145729156|NCT00960531|525525206|FG004|Overall Study|Investigator Request|0|||
145729157|NCT00960531|525525207|FG005|Overall Study|Investigator Request|0|||
145729158|NCT00960531|525525208|FG006|Overall Study|Investigator Request|0|||
145729159|NCT00960531|525525209|FG007|Overall Study|Investigator Request|0|||
145729160|NCT00960531|525525210|FG008|Overall Study|Investigator Request|0|||
145729161|NCT00960531|525525211|FG009|Overall Study|Investigator Request|0|||
145729162|NCT00960531|525525202|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
145729163|NCT00960531|525525203|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145729164|NCT00960531|525525204|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
145729165|NCT00960531|525525205|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145729166|NCT00960531|525525206|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
145729167|NCT00960531|525525207|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
145729168|NCT00960531|525525208|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
145729169|NCT00960531|525525209|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
145729170|NCT00960531|525525210|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
145729171|NCT00960531|525525211|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
145729172|NCT00960531|525525202|FG000|Overall Study|Lost to Follow-up|0|||
145729173|NCT00960531|525525203|FG001|Overall Study|Lost to Follow-up|0|||
145729174|NCT00960531|525525204|FG002|Overall Study|Lost to Follow-up|1|||
145729175|NCT00960531|525525205|FG003|Overall Study|Lost to Follow-up|0|||
145729176|NCT00960531|525525206|FG004|Overall Study|Lost to Follow-up|0|||
145729177|NCT00960531|525525207|FG005|Overall Study|Lost to Follow-up|0|||
145729178|NCT00960531|525525208|FG006|Overall Study|Lost to Follow-up|1|||
145729179|NCT00960531|525525209|FG007|Overall Study|Lost to Follow-up|0|||
145729180|NCT00960531|525525210|FG008|Overall Study|Lost to Follow-up|0|||
145729181|NCT00960531|525525211|FG009|Overall Study|Lost to Follow-up|0|||
145729182|NCT00960531|525525202|FG000|Overall Study|Failed to Return|2|||
145729183|NCT00960531|525525203|FG001|Overall Study|Failed to Return|0|||
145729184|NCT00960531|525525204|FG002|Overall Study|Failed to Return|0|||
145729185|NCT00960531|525525205|FG003|Overall Study|Failed to Return|0|||
145729186|NCT00960531|525525206|FG004|Overall Study|Failed to Return|0|||
145729187|NCT00960531|525525207|FG005|Overall Study|Failed to Return|0|||
145729188|NCT00960531|525525208|FG006|Overall Study|Failed to Return|0|||
145729189|NCT00960531|525525209|FG007|Overall Study|Failed to Return|2|||
145729190|NCT00960531|525525210|FG008|Overall Study|Failed to Return|0|||
145729191|NCT00960531|525525211|FG009|Overall Study|Failed to Return|0|||
145729192|NCT00960531|525525202|FG000|Overall Study|Adverse Event (AE)|2|||
145729193|NCT00960531|525525203|FG001|Overall Study|Adverse Event (AE)|0|||
145729194|NCT00960531|525525204|FG002|Overall Study|Adverse Event (AE)|0|||
145729195|NCT00960531|525525205|FG003|Overall Study|Adverse Event (AE)|0|||
145729196|NCT00960531|525525206|FG004|Overall Study|Adverse Event (AE)|0|||
145729197|NCT00960531|525525207|FG005|Overall Study|Adverse Event (AE)|1|||
145729198|NCT00960531|525525208|FG006|Overall Study|Adverse Event (AE)|2|||
145729199|NCT00960531|525525209|FG007|Overall Study|Adverse Event (AE)|0|||
145729200|NCT00960531|525525210|FG008|Overall Study|Adverse Event (AE)|2|||
145729201|NCT00960531|525525211|FG009|Overall Study|Adverse Event (AE)|0|||
145729202|NCT00960531|525525202|FG000|Overall Study|Reason not Specified|2|||
145729203|NCT00960531|525525203|FG001|Overall Study|Reason not Specified|1|||
145729204|NCT00960531|525525204|FG002|Overall Study|Reason not Specified|13|||
145729205|NCT00960531|525525205|FG003|Overall Study|Reason not Specified|1|||
145729206|NCT00960531|525525206|FG004|Overall Study|Reason not Specified|2|||
145729207|NCT00960531|525525207|FG005|Overall Study|Reason not Specified|0|||
145729208|NCT00960531|525525208|FG006|Overall Study|Reason not Specified|16|||
145729209|NCT00960531|525525209|FG007|Overall Study|Reason not Specified|0|||
145729210|NCT00960531|525525210|FG008|Overall Study|Reason not Specified|8|||
145729211|NCT00960531|525525211|FG009|Overall Study|Reason not Specified|1|||
145729212|NCT03282240|525525212|FG000|Overall Study|Adverse Event|2|||
145729213|NCT03282240|525525213|FG001|Overall Study|Adverse Event|2|||
145729214|NCT03282240|525525214|FG002|Overall Study|Adverse Event|0|||
145729215|NCT03282240|525525212|FG000|Overall Study|Lost to Follow-up|3|||
145729216|NCT03282240|525525213|FG001|Overall Study|Lost to Follow-up|0|||
145729217|NCT03282240|525525214|FG002|Overall Study|Lost to Follow-up|0|||
145729218|NCT03282240|525525212|FG000|Overall Study|Protocol Deviation|4|||
145729219|NCT03282240|525525213|FG001|Overall Study|Protocol Deviation|1|||
145729220|NCT03282240|525525214|FG002|Overall Study|Protocol Deviation|2|||
145729221|NCT03282240|525525212|FG000|Overall Study|Withdrawal by Subject|1|||
145729222|NCT03282240|525525213|FG001|Overall Study|Withdrawal by Subject|0|||
145729223|NCT03282240|525525214|FG002|Overall Study|Withdrawal by Subject|1|||
145729224|NCT01675479|525525215|FG000|Overall Study|Lost to Follow-up|11|||
145389149|NCT02559570|524280276|FG003|Overall Study|Withdrawal of Consent|2|||
145389150|NCT02559570|524280277|FG004|Overall Study|Withdrawal of Consent|1|||
145389151|NCT02559570|524280273|FG000|Overall Study|Lost to Follow-up|1|||
145389152|NCT02559570|524280274|FG001|Overall Study|Lost to Follow-up|0|||
145389153|NCT02559570|524280275|FG002|Overall Study|Lost to Follow-up|0|||
145389154|NCT02559570|524280276|FG003|Overall Study|Lost to Follow-up|0|||
145389155|NCT02559570|524280277|FG004|Overall Study|Lost to Follow-up|0|||
145389156|NCT02559570|524280273|FG000|Overall Study|Protocol Violation|1|||
145389157|NCT02559570|524280274|FG001|Overall Study|Protocol Violation|0|||
145389158|NCT02559570|524280275|FG002|Overall Study|Protocol Violation|0|||
145389159|NCT02559570|524280276|FG003|Overall Study|Protocol Violation|0|||
145389160|NCT02559570|524280277|FG004|Overall Study|Protocol Violation|1|||
145389161|NCT02559570|524280273|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145389162|NCT02559570|524280274|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145389163|NCT02559570|524280275|FG002|Overall Study|Other Miscellaneous Reasons|1|||
145389164|NCT02559570|524280276|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145389165|NCT02559570|524280277|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145389166|NCT05095311|524280284|FG000|Overall Study|Lost to Follow-up|7|||
145389167|NCT05095311|524280285|FG001|Overall Study|Lost to Follow-up|0|||
145389168|NCT05095311|524280286|FG002|Overall Study|Lost to Follow-up|0|||
145389169|NCT02588664|524280289|FG000|Overall Study|Death|56|||
145389170|NCT02588664|524280290|FG001|Overall Study|Death|55|||
145389171|NCT02588664|524280289|FG000|Overall Study|Lost to Follow-up|1305|||
145389172|NCT02588664|524280290|FG001|Overall Study|Lost to Follow-up|990|||
145389173|NCT02500719|524280297|FG000|Overall Study|Lost to Follow-up|2|||
145389174|NCT02500719|524280298|FG001|Overall Study|Lost to Follow-up|3|||
145389175|NCT02500719|524280297|FG000|Overall Study|Trauma history|1|||
145389176|NCT02500719|524280298|FG001|Overall Study|Trauma history|0|||
145389177|NCT02500719|524280297|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
145389178|NCT02500719|524280298|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
145389179|NCT02500719|524280297|FG000|Overall Study|Did not meet criteria for PTSD|0|||
145389180|NCT02500719|524280298|FG001|Overall Study|Did not meet criteria for PTSD|1|||
145389181|NCT02500719|524280297|FG000|Overall Study|Claustrophobia|0|||
145389182|NCT02500719|524280298|FG001|Overall Study|Claustrophobia|1|||
145389183|NCT02500719|524280297|FG000|Overall Study|History of head trauma|0|||
145389184|NCT02500719|524280298|FG001|Overall Study|History of head trauma|1|||
145389185|NCT02710084|524280301|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
145389186|NCT02710084|524280302|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
145389187|NCT00181883|524280303|FG000|Overall Study|Lack of Efficacy|2|||
145389188|NCT00181883|524280303|FG000|Overall Study|Treatment Limiting AEs|3|||
145389189|NCT00181883|524280303|FG000|Overall Study|Withdrawal by Subject|4|||
145389190|NCT00181883|524280303|FG000|Overall Study|Lost to Follow-up|1|||
145389191|NCT05305989|524280304|FG000|Overall Study|Other|3|||
145389192|NCT05305989|524280305|FG001|Overall Study|Other|2|||
145389193|NCT05305989|524280306|FG002|Overall Study|Other|0|||
145729225|NCT03254485|525525216|FG000|Overall Study|Adverse Event|3|||
145729226|NCT03254485|525525217|FG001|Overall Study|Adverse Event|0|||
145729227|NCT03254485|525525218|FG002|Overall Study|Adverse Event|0|||
145729228|NCT03254485|525525219|FG003|Overall Study|Adverse Event|6|||
145729229|NCT03254485|525525216|FG000|Overall Study|Protocol Violation|6|||
145729230|NCT03254485|525525217|FG001|Overall Study|Protocol Violation|0|||
145729231|NCT03254485|525525218|FG002|Overall Study|Protocol Violation|0|||
145729232|NCT03254485|525525219|FG003|Overall Study|Protocol Violation|2|||
145729233|NCT03254485|525525216|FG000|Overall Study|Withdrawal by Subject|1|||
145729234|NCT03254485|525525217|FG001|Overall Study|Withdrawal by Subject|0|||
145729235|NCT03254485|525525218|FG002|Overall Study|Withdrawal by Subject|0|||
145729236|NCT03254485|525525219|FG003|Overall Study|Withdrawal by Subject|4|||
145729237|NCT03254485|525525216|FG000|Overall Study|Death|0|||
145729238|NCT03254485|525525217|FG001|Overall Study|Death|0|||
145729239|NCT03254485|525525218|FG002|Overall Study|Death|0|||
145389194|NCT05305989|524280304|FG000|Overall Study|Sponsor decision|2|||
145389195|NCT05305989|524280305|FG001|Overall Study|Sponsor decision|1|||
145389196|NCT05305989|524280306|FG002|Overall Study|Sponsor decision|0|||
145495171|NCT01691794|524670289|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
145729240|NCT03254485|525525219|FG003|Overall Study|Death|1|||
145389197|NCT05305989|524280304|FG000|Overall Study|Protocol Violation|0|||
145389198|NCT05305989|524280305|FG001|Overall Study|Protocol Violation|1|||
145389199|NCT05305989|524280306|FG002|Overall Study|Protocol Violation|0|||
145389200|NCT05305989|524280304|FG000|Overall Study|Investigator decision|1|||
145389201|NCT05305989|524280305|FG001|Overall Study|Investigator decision|2|||
145389202|NCT05305989|524280306|FG002|Overall Study|Investigator decision|0|||
145389203|NCT05305989|524280304|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
145389204|NCT05305989|524280305|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
145389205|NCT05305989|524280306|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
145729241|NCT03254485|525525216|FG000|Overall Study|Lost to Follow-up|1|||
145729242|NCT03254485|525525217|FG001|Overall Study|Lost to Follow-up|0|||
145389206|NCT05305989|524280304|FG000|Overall Study|Adverse Event|1|||
145389207|NCT05305989|524280305|FG001|Overall Study|Adverse Event|1|||
145389208|NCT05305989|524280306|FG002|Overall Study|Adverse Event|0|||
145389209|NCT05305989|524280304|FG000|Overall Study|Enrolled but never dosed|3|||
145389210|NCT05305989|524280305|FG001|Overall Study|Enrolled but never dosed|2|||
145389211|NCT05305989|524280306|FG002|Overall Study|Enrolled but never dosed|1|||
145389212|NCT00282152|524280307|FG000|Overall Study|Withdrawal by Subject|1|||
145389213|NCT00282152|524280308|FG001|Overall Study|Withdrawal by Subject|0|||
145389214|NCT00585325|524280309|FG000|Overall Study|Withdrawal by Subject|1|||
145389215|NCT00585325|524280310|FG001|Overall Study|Withdrawal by Subject|1|||
145389216|NCT03092791|524280311|FG000|Overall Study|Lost to Follow-up|0|||
145389217|NCT03092791|524280312|FG001|Overall Study|Lost to Follow-up|0|||
145389218|NCT03092791|524280313|FG002|Overall Study|Lost to Follow-up|0|||
145389219|NCT03092791|524280314|FG003|Overall Study|Lost to Follow-up|0|||
145389220|NCT03092791|524280315|FG004|Overall Study|Lost to Follow-up|0|||
145389221|NCT03092791|524280316|FG005|Overall Study|Lost to Follow-up|0|||
145389222|NCT03092791|524280317|FG006|Overall Study|Lost to Follow-up|1|||
145389223|NCT03092791|524280318|FG007|Overall Study|Lost to Follow-up|0|||
145389224|NCT03092791|524280311|FG000|Overall Study|Withdrawal of Consent|0|||
145389225|NCT03092791|524280312|FG001|Overall Study|Withdrawal of Consent|0|||
145389226|NCT03092791|524280313|FG002|Overall Study|Withdrawal of Consent|0|||
145389227|NCT03092791|524280314|FG003|Overall Study|Withdrawal of Consent|0|||
145389228|NCT03092791|524280315|FG004|Overall Study|Withdrawal of Consent|4|||
145389229|NCT03092791|524280316|FG005|Overall Study|Withdrawal of Consent|12|||
145389230|NCT03092791|524280317|FG006|Overall Study|Withdrawal of Consent|6|||
145389231|NCT03092791|524280318|FG007|Overall Study|Withdrawal of Consent|4|||
145389232|NCT03092791|524280311|FG000|Overall Study|Study Termination|0|||
145389233|NCT03092791|524280312|FG001|Overall Study|Study Termination|0|||
145389234|NCT03092791|524280313|FG002|Overall Study|Study Termination|0|||
145389235|NCT03092791|524280314|FG003|Overall Study|Study Termination|0|||
145389236|NCT03092791|524280315|FG004|Overall Study|Study Termination|55|||
145389237|NCT03092791|524280316|FG005|Overall Study|Study Termination|46|||
145389238|NCT03092791|524280317|FG006|Overall Study|Study Termination|53|||
145389239|NCT03092791|524280318|FG007|Overall Study|Study Termination|55|||
145389240|NCT03092791|524280311|FG000|Overall Study|Death|0|||
145389241|NCT03092791|524280312|FG001|Overall Study|Death|0|||
145389242|NCT03092791|524280313|FG002|Overall Study|Death|0|||
145389243|NCT03092791|524280314|FG003|Overall Study|Death|0|||
145389244|NCT03092791|524280315|FG004|Overall Study|Death|0|||
145389245|NCT03092791|524280316|FG005|Overall Study|Death|1|||
145389246|NCT03092791|524280317|FG006|Overall Study|Death|0|||
145389247|NCT03092791|524280318|FG007|Overall Study|Death|1|||
145389248|NCT03092791|524280311|FG000|Overall Study|Reason Not Specified|0|||
145389249|NCT03092791|524280312|FG001|Overall Study|Reason Not Specified|0|||
145389250|NCT03092791|524280313|FG002|Overall Study|Reason Not Specified|0|||
145389251|NCT03092791|524280314|FG003|Overall Study|Reason Not Specified|0|||
145389252|NCT03092791|524280315|FG004|Overall Study|Reason Not Specified|1|||
145389253|NCT03092791|524280316|FG005|Overall Study|Reason Not Specified|1|||
145389254|NCT03092791|524280317|FG006|Overall Study|Reason Not Specified|0|||
145389255|NCT03092791|524280318|FG007|Overall Study|Reason Not Specified|0|||
145389256|NCT02182830|524280319|FG000|Overall Study|Not Treated|1|||
145389257|NCT02182830|524280320|FG001|Overall Study|Not Treated|1|||
145389258|NCT02182830|524280319|FG000|Overall Study|Trial stopped, reason missing|3|||
145389259|NCT02182830|524280320|FG001|Overall Study|Trial stopped, reason missing|3|||
145389260|NCT02182830|524280319|FG000|Overall Study|Consent withdrawn|8|||
145389261|NCT02182830|524280320|FG001|Overall Study|Consent withdrawn|8|||
145389262|NCT02182830|524280319|FG000|Overall Study|Lost to Follow-up|3|||
145389263|NCT02182830|524280320|FG001|Overall Study|Lost to Follow-up|3|||
145389264|NCT01990768|524280321|FG000|Intervention Started|Found to be ineligible|14|||
145389265|NCT01990768|524280322|FG001|Intervention Started|Found to be ineligible|13|||
145389266|NCT01990768|524280323|FG002|Intervention Started|Found to be ineligible|11|||
145389267|NCT01990768|524280321|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
145389268|NCT01990768|524280322|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
145389269|NCT01990768|524280323|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
145389270|NCT01990768|524280321|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
145389271|NCT01990768|524280322|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
145389272|NCT01990768|524280323|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
145389273|NCT01990768|524280321|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
145389274|NCT01990768|524280322|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
145389275|NCT01990768|524280323|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
145389276|NCT01990768|524280321|FG000|Intervention Started|Patient care priority|1|||
145389277|NCT01990768|524280322|FG001|Intervention Started|Patient care priority|2|||
145389278|NCT01990768|524280323|FG002|Intervention Started|Patient care priority|3|||
145389279|NCT01990768|524280321|FG000|Intervention Started|IV lost|2|||
145389280|NCT01990768|524280322|FG001|Intervention Started|IV lost|2|||
145389281|NCT01990768|524280323|FG002|Intervention Started|IV lost|2|||
145389282|NCT01990768|524280321|FG000|Intervention Started|Required CPR|1|||
145389283|NCT01990768|524280322|FG001|Intervention Started|Required CPR|1|||
145389284|NCT01990768|524280323|FG002|Intervention Started|Required CPR|0|||
145389285|NCT01990768|524280321|FG000|Intervention Started|Seizure or hx of seizure|0|||
145389286|NCT01990768|524280322|FG001|Intervention Started|Seizure or hx of seizure|0|||
145389287|NCT01990768|524280323|FG002|Intervention Started|Seizure or hx of seizure|2|||
145389288|NCT01990768|524280321|FG000|Intervention Started|Discovered to be pregnant|0|||
145389289|NCT01990768|524280322|FG001|Intervention Started|Discovered to be pregnant|1|||
145389290|NCT01990768|524280323|FG002|Intervention Started|Discovered to be pregnant|0|||
145729243|NCT03254485|525525218|FG002|Overall Study|Lost to Follow-up|0|||
145729244|NCT03254485|525525219|FG003|Overall Study|Lost to Follow-up|0|||
145729245|NCT03254485|525525216|FG000|Overall Study|Other|1|||
145729246|NCT03254485|525525217|FG001|Overall Study|Other|0|||
145729247|NCT03254485|525525218|FG002|Overall Study|Other|0|||
145729248|NCT03254485|525525219|FG003|Overall Study|Other|2|||
145729249|NCT01572922|525525221|FG000|Overall Study|Adverse Event|1|||
145729250|NCT01572922|525525221|FG000|Overall Study|Protocol Violation|1|||
145729251|NCT01572922|525525221|FG000|Overall Study|Death|1|||
145729252|NCT01335009|525525222|FG000|Overall Study|Too ill to travel to study sites|1|||
145729253|NCT01335009|525525223|FG001|Overall Study|Too ill to travel to study sites|0|||
145729254|NCT01335009|525525222|FG000|Overall Study|Death|28|||
145729255|NCT01335009|525525223|FG001|Overall Study|Death|32|||
145729256|NCT01335009|525525222|FG000|Overall Study|Withdrawal by Subject|1|||
145729257|NCT01335009|525525223|FG001|Overall Study|Withdrawal by Subject|1|||
145389291|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
145389292|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
145389293|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
145729258|NCT01335009|525525222|FG000|Overall Study|Lost to Follow-up|1|||
145729259|NCT01335009|525525223|FG001|Overall Study|Lost to Follow-up|0|||
145389294|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
145389295|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
145389296|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
145389297|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
145389298|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
145389299|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
145389300|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
145389301|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
145389302|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
145389303|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Death|3|||
145389304|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Death|1|||
145389305|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Death|1|||
145389306|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Discharged|2|||
145389307|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Discharged|1|||
145389308|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Discharged|0|||
145389309|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
145389310|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
145389311|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
145389312|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
145389313|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
145389314|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
145389315|NCT01990768|524280321|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
145389316|NCT01990768|524280322|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
145389317|NCT01990768|524280323|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
145389318|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
145389319|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
145389320|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
145389321|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
145389322|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
145389323|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
145389324|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
145389325|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
145389326|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
145389327|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
145389328|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
145389329|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
145389330|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
145389331|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
145389332|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
145389333|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
145389334|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
145389335|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
145389336|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
145389337|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
145389338|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
145389339|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
145389340|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
145389341|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
145389342|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
145389343|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
145389344|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
145389345|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
145389346|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
145389347|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
145389348|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145389349|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145389350|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
145389351|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
145389352|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
145389353|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
145389354|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
145389355|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
145389356|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
145605890|NCT00633932|525073036|FG002|Overall Study|Lost to Follow-up|2|||
145389357|NCT01990768|524280321|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
145389358|NCT01990768|524280322|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
145389359|NCT01990768|524280323|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
145389360|NCT01990768|524280321|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
145389361|NCT01990768|524280322|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
145389362|NCT01990768|524280323|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
145389363|NCT01990768|524280321|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
145389364|NCT01990768|524280322|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
145389365|NCT01990768|524280323|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
145389366|NCT01990768|524280321|FG000|6-Month Follow-up|No contact information|5|||
145389367|NCT01990768|524280322|FG001|6-Month Follow-up|No contact information|6|||
145389368|NCT01990768|524280323|FG002|6-Month Follow-up|No contact information|5|||
145389369|NCT01990768|524280321|FG000|6-Month Follow-up|Homeless|4|||
145389370|NCT01990768|524280322|FG001|6-Month Follow-up|Homeless|3|||
145389371|NCT01990768|524280323|FG002|6-Month Follow-up|Homeless|6|||
145389372|NCT01990768|524280321|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
145389373|NCT01990768|524280322|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
145389374|NCT01990768|524280323|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
145389375|NCT01990768|524280321|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
145389376|NCT01990768|524280322|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
145389377|NCT01990768|524280323|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
145389378|NCT01990768|524280321|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
145389379|NCT01990768|524280322|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
145389380|NCT01990768|524280323|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
145389381|NCT00154375|524280324|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
145389382|NCT00154375|524280325|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
145389383|NCT00154375|524280324|FG000|Overall Study|Adverse Event|18|||
145389384|NCT00154375|524280325|FG001|Overall Study|Adverse Event|20|||
145389385|NCT00154375|524280324|FG000|Overall Study|Withdrawal by Subject|14|||
145389386|NCT00154375|524280325|FG001|Overall Study|Withdrawal by Subject|10|||
145389387|NCT00154375|524280324|FG000|Overall Study|Death|5|||
145389388|NCT00154375|524280325|FG001|Overall Study|Death|13|||
145389389|NCT00154375|524280324|FG000|Overall Study|Study drug no longer required|5|||
145389390|NCT00154375|524280325|FG001|Overall Study|Study drug no longer required|3|||
145389391|NCT00154375|524280324|FG000|Overall Study|Lost to Follow-up|2|||
145389392|NCT00154375|524280325|FG001|Overall Study|Lost to Follow-up|1|||
145389393|NCT00154375|524280324|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145389394|NCT00154375|524280325|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145389395|NCT00154375|524280324|FG000|Overall Study|Protocol Violation|0|||
145389396|NCT00154375|524280325|FG001|Overall Study|Protocol Violation|1|||
145389397|NCT00154375|524280324|FG000|Overall Study|Suspected progression of disease|44|||
145389398|NCT00154375|524280325|FG001|Overall Study|Suspected progression of disease|30|||
145389399|NCT01588405|524280328|FG000|Overall Study|Adverse Event|1|||
145389400|NCT01588405|524280328|FG000|Overall Study|Clinical Worsening|1|||
145389401|NCT00481767|524280329|FG000|Overall Study|Withdrawal by Subject|16|||
145389402|NCT00481767|524280330|FG001|Overall Study|Withdrawal by Subject|11|||
145389403|NCT00481767|524280329|FG000|Overall Study|Lost to Follow-up|16|||
145389404|NCT00481767|524280330|FG001|Overall Study|Lost to Follow-up|10|||
145389405|NCT01554163|524280333|FG000|Overall Study|Adverse Event|3|||
145389406|NCT01554163|524280334|FG001|Overall Study|Adverse Event|0|||
145389407|NCT01554163|524280333|FG000|Overall Study|Lack of Efficacy|1|||
145389408|NCT01554163|524280334|FG001|Overall Study|Lack of Efficacy|0|||
145389409|NCT01554163|524280333|FG000|Overall Study|Lost to Follow-up|1|||
145389410|NCT01554163|524280334|FG001|Overall Study|Lost to Follow-up|0|||
145729260|NCT02818920|525525224|FG000|Overall Study|Unresectable|4|||
145729261|NCT02818920|525525224|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
145729262|NCT02818920|525525224|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
145729263|NCT02818920|525525224|FG000|Overall Study|Adverse Event|3|||
145729264|NCT02818920|525525224|FG000|Overall Study|Developed Other Disease|1|||
145729265|NCT02818920|525525224|FG000|Overall Study|Refused Further Treatment|1|||
145729266|NCT04821869|525525225|FG000|Overall Study|Adverse Event|4|||
145729267|NCT04821869|525525225|FG000|Overall Study|Withdrawal by Subject|2|||
145729268|NCT04821869|525525225|FG000|Overall Study|Did not meet FEV1 criteria|1|||
145729269|NCT04751656|525527430|FG000|Overall Study|Lost to Follow-up|1|||
145729270|NCT03566810|525527431|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
145729271|NCT03566810|525527432|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
145729272|NCT03566810|525527433|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
145729273|NCT03566810|525527434|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
145729274|NCT01103245|525527435|FG000|Overall Study|Withdrawal by Subject|1|||
145729275|NCT01103245|525527436|FG001|Overall Study|Withdrawal by Subject|0|||
145729276|NCT01103245|525527437|FG002|Overall Study|Withdrawal by Subject|3|||
145729277|NCT01103245|525527438|FG003|Overall Study|Withdrawal by Subject|0|||
145729278|NCT01103245|525527435|FG000|Overall Study|Inadequate IV access|1|||
145729279|NCT01103245|525527436|FG001|Overall Study|Inadequate IV access|0|||
145729280|NCT01103245|525527437|FG002|Overall Study|Inadequate IV access|0|||
145389411|NCT01554163|524280333|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145389412|NCT01554163|524280334|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145729281|NCT01103245|525527438|FG003|Overall Study|Inadequate IV access|0|||
145389413|NCT01554163|524280333|FG000|Overall Study|Protocol Violation|0|||
145389414|NCT01554163|524280334|FG001|Overall Study|Protocol Violation|4|||
145389415|NCT01554163|524280333|FG000|Overall Study|Withdrawal by Subject|1|||
145389416|NCT01554163|524280334|FG001|Overall Study|Withdrawal by Subject|5|||
145389417|NCT01554163|524280333|FG000|Overall Study|Not Treated|1|||
145389418|NCT01554163|524280334|FG001|Overall Study|Not Treated|0|||
145389419|NCT02557516|524280336|FG000|Overall Study|Adverse Event|1|||
145729282|NCT01103245|525527435|FG000|Overall Study|Adverse Event|0|||
145729283|NCT01103245|525527436|FG001|Overall Study|Adverse Event|2|||
145389420|NCT02557516|524280337|FG001|Overall Study|Adverse Event|0|||
145389421|NCT02557516|524280338|FG002|Overall Study|Adverse Event|2|||
145389422|NCT02557516|524280339|FG003|Overall Study|Adverse Event|1|||
145389423|NCT02557516|524280336|FG000|Overall Study|Disease progression|0|||
145389424|NCT02557516|524280337|FG001|Overall Study|Disease progression|2|||
145389425|NCT02557516|524280338|FG002|Overall Study|Disease progression|0|||
145389426|NCT02557516|524280339|FG003|Overall Study|Disease progression|0|||
145389427|NCT02557516|524280336|FG000|Overall Study|Physician Decision|0|||
145389428|NCT02557516|524280337|FG001|Overall Study|Physician Decision|2|||
145389429|NCT02557516|524280338|FG002|Overall Study|Physician Decision|0|||
145389430|NCT02557516|524280339|FG003|Overall Study|Physician Decision|0|||
145389431|NCT02557516|524280336|FG000|Overall Study|Sponsor decision|0|||
145389432|NCT02557516|524280337|FG001|Overall Study|Sponsor decision|1|||
145389433|NCT02557516|524280338|FG002|Overall Study|Sponsor decision|2|||
145389434|NCT02557516|524280339|FG003|Overall Study|Sponsor decision|8|||
145389435|NCT00803712|524282026|FG000|Overall Study|Noncompliance|3|||
145389436|NCT00803712|524282027|FG001|Overall Study|Noncompliance|0|||
145389437|NCT00803712|524282026|FG000|Overall Study|Adverse Event|5|||
145389438|NCT00803712|524282027|FG001|Overall Study|Adverse Event|0|||
145389439|NCT00803712|524282026|FG000|Overall Study|Death|8|||
145389440|NCT00803712|524282027|FG001|Overall Study|Death|7|||
145495172|NCT01691794|524670290|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
145495173|NCT00844844|524670291|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
145389441|NCT00803712|524282026|FG000|Overall Study|Lost to Follow-up|3|||
145389442|NCT00803712|524282027|FG001|Overall Study|Lost to Follow-up|1|||
145389443|NCT00803712|524282026|FG000|Overall Study|Withdrawal by Subject|2|||
145389444|NCT00803712|524282027|FG001|Overall Study|Withdrawal by Subject|4|||
145389445|NCT00803712|524282026|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
145389446|NCT00803712|524282027|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
145389447|NCT00803712|524282026|FG000|Overall Study|Protocol criteria (other)|0|||
145389448|NCT00803712|524282027|FG001|Overall Study|Protocol criteria (other)|2|||
145389449|NCT00803712|524282026|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
145389450|NCT00803712|524282027|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
145389451|NCT00803712|524282026|FG000|Overall Study|Administrative decision|2|||
145389452|NCT00803712|524282027|FG001|Overall Study|Administrative decision|3|||
145389453|NCT00803712|524282026|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
145389454|NCT00803712|524282027|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
145389455|NCT02748057|524282028|FG000|Overall Study|Adverse Event|1|||
145389456|NCT02748057|524282029|FG001|Overall Study|Adverse Event|0|||
145389457|NCT02748057|524282028|FG000|Overall Study|Physician Decision|0|||
145389458|NCT02748057|524282029|FG001|Overall Study|Physician Decision|1|||
145389459|NCT02748057|524282028|FG000|Overall Study|Protocol Violation|2|||
145389460|NCT02748057|524282029|FG001|Overall Study|Protocol Violation|1|||
145389461|NCT02748057|524282028|FG000|Overall Study|Participant Moved|1|||
145389462|NCT02748057|524282029|FG001|Overall Study|Participant Moved|0|||
145389463|NCT02748057|524282028|FG000|Overall Study|Withdrawal by Subject|1|||
145389464|NCT02748057|524282029|FG001|Overall Study|Withdrawal by Subject|0|||
145389465|NCT03335813|524282032|FG000|Overall Study|Withdrawal by Subject|1|||
145389466|NCT02861664|524282033|FG000|Overall Study|Withdrawal of Consent|0|||
145389467|NCT02861664|524282034|FG001|Overall Study|Withdrawal of Consent|1|||
145389468|NCT00905632|524282035|FG000|Overall Study|Adverse Event|0|||
145389469|NCT00905632|524282036|FG001|Overall Study|Adverse Event|0|||
145389470|NCT00905632|524282037|FG002|Overall Study|Adverse Event|0|||
145389471|NCT00905632|524282038|FG003|Overall Study|Adverse Event|0|||
145389472|NCT00905632|524282039|FG004|Overall Study|Adverse Event|0|||
145389473|NCT00905632|524282040|FG005|Overall Study|Adverse Event|1|||
145389474|NCT00905632|524282041|FG006|Overall Study|Adverse Event|4|||
145389475|NCT00577772|524282042|FG000|Overall Study|Lost to Follow-up|0|||
145389476|NCT00577772|524282043|FG001|Overall Study|Lost to Follow-up|1|||
145389477|NCT00856999|524282044|FG000|Overall Study|Withdrawal by Subject|5|||
145389478|NCT00610168|524282046|FG000|Overall Study|Withdrawal by Subject|2|||
145389479|NCT00610168|524282047|FG001|Overall Study|Withdrawal by Subject|0|||
145389480|NCT00878800|524282054|FG000|Overall Study|Adverse Event|0|||
145389481|NCT00878800|524282055|FG001|Overall Study|Adverse Event|0|||
145389482|NCT00878800|524282056|FG002|Overall Study|Adverse Event|2|||
145389483|NCT00878800|524282057|FG003|Overall Study|Adverse Event|0|||
145389484|NCT00878800|524282058|FG004|Overall Study|Adverse Event|1|||
145389485|NCT00878800|524282054|FG000|Overall Study|Progressive disease|1|||
145389486|NCT00878800|524282055|FG001|Overall Study|Progressive disease|5|||
145389487|NCT00878800|524282056|FG002|Overall Study|Progressive disease|6|||
145389488|NCT00878800|524282057|FG003|Overall Study|Progressive disease|5|||
145389489|NCT00878800|524282058|FG004|Overall Study|Progressive disease|13|||
145389490|NCT00878800|524282054|FG000|Overall Study|Withdrew consent|1|||
145389491|NCT00878800|524282055|FG001|Overall Study|Withdrew consent|1|||
145389492|NCT00878800|524282056|FG002|Overall Study|Withdrew consent|0|||
145389493|NCT00878800|524282057|FG003|Overall Study|Withdrew consent|1|||
145389494|NCT00878800|524282058|FG004|Overall Study|Withdrew consent|1|||
145389495|NCT00878800|524282054|FG000|Overall Study|Death|0|||
145389496|NCT00878800|524282055|FG001|Overall Study|Death|0|||
145389497|NCT00878800|524282056|FG002|Overall Study|Death|1|||
145389498|NCT00878800|524282057|FG003|Overall Study|Death|0|||
145389499|NCT00878800|524282058|FG004|Overall Study|Death|0|||
145389500|NCT00878800|524282054|FG000|Overall Study|Other|1|||
145389501|NCT00878800|524282055|FG001|Overall Study|Other|1|||
145389502|NCT00878800|524282056|FG002|Overall Study|Other|0|||
145389503|NCT00878800|524282057|FG003|Overall Study|Other|0|||
145389504|NCT00878800|524282058|FG004|Overall Study|Other|1|||
145389505|NCT00613821|524282059|FG000|Overall Study|Withdrawal by Subject|1|||
145389506|NCT00613821|524282060|FG001|Overall Study|Withdrawal by Subject|0|||
145389507|NCT00613821|524282059|FG000|Overall Study|Physician Decision|1|||
145389508|NCT00613821|524282060|FG001|Overall Study|Physician Decision|1|||
145389509|NCT01266824|524282062|FG000|Overall Study|Study terminated prior to completion|2|||
145389510|NCT01266824|524282063|FG001|Overall Study|Study terminated prior to completion|3|||
145389511|NCT02302846|524282064|FG000|Overall Study|Withdrawal by Subject|1|||
145389512|NCT00397189|524282065|FG000|3 Weeks Period|Lost to Follow-up|5|||
145389513|NCT00397189|524282066|FG001|3 Weeks Period|Lost to Follow-up|4|||
145389514|NCT00397189|524282065|FG000|3 Weeks Period|Adverse Event|3|||
145389515|NCT00397189|524282066|FG001|3 Weeks Period|Adverse Event|2|||
145389516|NCT00397189|524282065|FG000|3 Weeks Period|Withdrawal by Subject|13|||
145389517|NCT00397189|524282066|FG001|3 Weeks Period|Withdrawal by Subject|9|||
145389518|NCT00397189|524282065|FG000|3 Weeks Period|Physician Decision|0|||
145389519|NCT00397189|524282066|FG001|3 Weeks Period|Physician Decision|2|||
145389520|NCT00397189|524282065|FG000|3 Weeks Period|Protocol Violation|0|||
145389521|NCT00397189|524282066|FG001|3 Weeks Period|Protocol Violation|3|||
145389522|NCT00397189|524282065|FG000|3 Weeks Period|Other|0|||
145729284|NCT01103245|525527437|FG002|Overall Study|Adverse Event|1|||
145729285|NCT01103245|525527438|FG003|Overall Study|Adverse Event|0|||
145729286|NCT01103245|525527435|FG000|Overall Study|Physician Decision|1|||
145729287|NCT01103245|525527436|FG001|Overall Study|Physician Decision|0|||
145729288|NCT01103245|525527437|FG002|Overall Study|Physician Decision|0|||
145729289|NCT01103245|525527438|FG003|Overall Study|Physician Decision|0|||
145729290|NCT01195545|525527439|FG000|Overall Study|Protocol Violation|4|||
145729291|NCT02425644|525527442|FG000|Overall Study|Lost to Follow-up|2|||
145729292|NCT02425644|525527443|FG001|Overall Study|Lost to Follow-up|3|||
145729293|NCT02425644|525527442|FG000|Overall Study|Withdrawal by Subject|41|||
145729294|NCT02425644|525527443|FG001|Overall Study|Withdrawal by Subject|36|||
145729295|NCT02425644|525527442|FG000|Overall Study|Lack of Efficacy|3|||
145729296|NCT02425644|525527443|FG001|Overall Study|Lack of Efficacy|10|||
145729297|NCT02425644|525527442|FG000|Overall Study|Adverse Event|13|||
145729298|NCT02425644|525527443|FG001|Overall Study|Adverse Event|3|||
145729299|NCT02425644|525527442|FG000|Overall Study|Death|0|||
145729300|NCT02425644|525527443|FG001|Overall Study|Death|2|||
145729301|NCT02425644|525527442|FG000|Overall Study|Other|18|||
145729302|NCT02425644|525527443|FG001|Overall Study|Other|17|||
145729303|NCT02720536|525527444|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
145729304|NCT02720536|525527444|FG000|Overall Study|PR - pregnancy|2|||
145729305|NCT02720536|525527444|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
145729306|NCT02720536|525527444|FG000|Overall Study|PR - death|1|||
145729307|NCT02720536|525527444|FG000|Overall Study|PR - adverse event|1|||
145729308|NCT02720536|525527444|FG000|Overall Study|PR - abnormal lab value(s)|1|||
145729309|NCT02720536|525527444|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
145729310|NCT00300781|525527445|FG000|Overall Study|Disease Progression|55|||
145729311|NCT00300781|525527446|FG001|Overall Study|Disease Progression|52|||
145729312|NCT00300781|525527445|FG000|Overall Study|Adverse Event|5|||
145729313|NCT00300781|525527446|FG001|Overall Study|Adverse Event|6|||
145729314|NCT00300781|525527445|FG000|Overall Study|Withdrawal by Subject|1|||
145729315|NCT00300781|525527446|FG001|Overall Study|Withdrawal by Subject|2|||
145729316|NCT00300781|525527445|FG000|Overall Study|Physician Decision|1|||
145729317|NCT00300781|525527446|FG001|Overall Study|Physician Decision|0|||
145729318|NCT00300781|525527445|FG000|Overall Study|Not Recorded|0|||
145729319|NCT00300781|525527446|FG001|Overall Study|Not Recorded|1|||
145729320|NCT00300781|525527445|FG000|Overall Study|Symptomatic Deterioration|1|||
145729321|NCT00300781|525527446|FG001|Overall Study|Symptomatic Deterioration|0|||
145729322|NCT00300781|525527445|FG000|Overall Study|Lost to Follow-up|0|||
145729323|NCT00300781|525527446|FG001|Overall Study|Lost to Follow-up|1|||
145729324|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
145729325|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
145729326|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
145729327|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
145729328|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
145729329|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
145729330|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
145729331|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
145729332|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
145729333|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
145729334|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
145729335|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
145729336|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Death|3|||
145729337|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Death|1|||
145729338|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
145729339|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
145729340|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Adverse Event|7|||
145729341|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Adverse Event|8|||
145729342|NCT03236246|525527447|FG000|24-Week Dose Titration Period|Captured as Other|1|||
145729343|NCT03236246|525527448|FG001|24-Week Dose Titration Period|Captured as Other|2|||
145729344|NCT03236246|525527447|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
145729345|NCT03236246|525527448|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
145729346|NCT03236246|525527447|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
145729347|NCT03236246|525527448|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
145729348|NCT03236246|525527447|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
145729349|NCT03236246|525527448|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
145729350|NCT03236246|525527447|FG000|24-Week Dose Maintenance Period|Death|0|||
145729351|NCT03236246|525527448|FG001|24-Week Dose Maintenance Period|Death|1|||
145729352|NCT03236246|525527447|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
145729353|NCT03236246|525527448|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
145729354|NCT01794520|525527449|FG000|Overall Study|Adverse events- related to progression|0|||
145729355|NCT01794520|525527450|FG001|Overall Study|Adverse events- related to progression|0|||
145729356|NCT01794520|525527451|FG002|Overall Study|Adverse events- related to progression|1|||
145729357|NCT01794520|525527452|FG003|Overall Study|Adverse events- related to progression|2|||
145729358|NCT01794520|525527453|FG004|Overall Study|Adverse events- related to progression|0|||
145729359|NCT01794520|525527454|FG005|Overall Study|Adverse events- related to progression|1|||
145729360|NCT01794520|525527455|FG006|Overall Study|Adverse events- related to progression|0|||
145729361|NCT01794520|525527449|FG000|Overall Study|Adverse event- not related to progression|1|||
145729362|NCT01794520|525527450|FG001|Overall Study|Adverse event- not related to progression|1|||
145729363|NCT01794520|525527451|FG002|Overall Study|Adverse event- not related to progression|0|||
145729364|NCT01794520|525527452|FG003|Overall Study|Adverse event- not related to progression|0|||
145729365|NCT01794520|525527453|FG004|Overall Study|Adverse event- not related to progression|2|||
145729366|NCT01794520|525527454|FG005|Overall Study|Adverse event- not related to progression|0|||
145729367|NCT01794520|525527455|FG006|Overall Study|Adverse event- not related to progression|0|||
145729368|NCT01794520|525527449|FG000|Overall Study|Progressive disease|5|||
145729369|NCT01794520|525527450|FG001|Overall Study|Progressive disease|6|||
145729370|NCT01794520|525527451|FG002|Overall Study|Progressive disease|2|||
145729371|NCT01794520|525527452|FG003|Overall Study|Progressive disease|5|||
145729372|NCT01794520|525527453|FG004|Overall Study|Progressive disease|27|||
145729373|NCT01794520|525527454|FG005|Overall Study|Progressive disease|18|||
145729374|NCT01794520|525527455|FG006|Overall Study|Progressive disease|0|||
145729375|NCT01794520|525527449|FG000|Overall Study|Withdrew consent|0|||
145729376|NCT01794520|525527450|FG001|Overall Study|Withdrew consent|0|||
145729377|NCT01794520|525527451|FG002|Overall Study|Withdrew consent|1|||
145729378|NCT01794520|525527452|FG003|Overall Study|Withdrew consent|1|||
145729379|NCT01794520|525527453|FG004|Overall Study|Withdrew consent|0|||
145729380|NCT01794520|525527454|FG005|Overall Study|Withdrew consent|0|||
145729381|NCT01794520|525527455|FG006|Overall Study|Withdrew consent|0|||
145729382|NCT01794520|525527449|FG000|Overall Study|Lost to Follow-up|0|||
145729383|NCT01794520|525527450|FG001|Overall Study|Lost to Follow-up|0|||
145729384|NCT01794520|525527451|FG002|Overall Study|Lost to Follow-up|0|||
145729385|NCT01794520|525527452|FG003|Overall Study|Lost to Follow-up|0|||
145729386|NCT01794520|525527453|FG004|Overall Study|Lost to Follow-up|1|||
145729387|NCT01794520|525527454|FG005|Overall Study|Lost to Follow-up|0|||
145729388|NCT01794520|525527455|FG006|Overall Study|Lost to Follow-up|0|||
145729389|NCT01794520|525527449|FG000|Overall Study|Toxicity|0|||
145729390|NCT01794520|525527450|FG001|Overall Study|Toxicity|2|||
145729391|NCT01794520|525527451|FG002|Overall Study|Toxicity|0|||
145729392|NCT01794520|525527452|FG003|Overall Study|Toxicity|0|||
145389523|NCT00397189|524282066|FG001|3 Weeks Period|Other|2|||
145389524|NCT03410992|524282067|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389525|NCT03410992|524282068|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
145389526|NCT03410992|524282069|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389527|NCT03410992|524282070|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389528|NCT03410992|524282071|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389529|NCT03410992|524282072|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389530|NCT03410992|524282073|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389531|NCT03410992|524282074|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389532|NCT03410992|524282075|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389533|NCT03410992|524282076|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389534|NCT03410992|524282077|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
145389535|NCT03410992|524282067|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
145389536|NCT03410992|524282068|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
145389537|NCT03410992|524282069|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389538|NCT03410992|524282070|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389539|NCT03410992|524282071|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389540|NCT03410992|524282072|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389541|NCT03410992|524282073|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389542|NCT03410992|524282074|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389543|NCT03410992|524282075|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389544|NCT03410992|524282076|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389545|NCT03410992|524282077|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
145389546|NCT03410992|524282067|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
145389547|NCT03410992|524282068|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
145389548|NCT03410992|524282069|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389549|NCT03410992|524282070|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389550|NCT03410992|524282071|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389551|NCT03410992|524282072|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389552|NCT03410992|524282073|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389553|NCT03410992|524282074|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389554|NCT03410992|524282075|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389555|NCT03410992|524282076|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389556|NCT03410992|524282077|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
145389557|NCT03410992|524282067|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
145389558|NCT03410992|524282068|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389559|NCT03410992|524282069|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389560|NCT03410992|524282070|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389561|NCT03410992|524282071|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389562|NCT03410992|524282072|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389563|NCT03410992|524282073|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389564|NCT03410992|524282074|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389565|NCT03410992|524282075|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389566|NCT03410992|524282076|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389567|NCT03410992|524282077|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
145389568|NCT03410992|524282067|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
145495174|NCT00844844|524670291|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
145389569|NCT03410992|524282068|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
145389570|NCT03410992|524282069|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389571|NCT03410992|524282070|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389572|NCT03410992|524282071|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389573|NCT03410992|524282072|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389574|NCT03410992|524282073|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389575|NCT03410992|524282074|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389576|NCT03410992|524282075|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389577|NCT03410992|524282076|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389578|NCT03410992|524282077|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
145389579|NCT03410992|524282067|FG000|Week 16 Assessment|Incorrect escapers|0|||
145389580|NCT03410992|524282068|FG001|Week 16 Assessment|Incorrect escapers|6|||
145389581|NCT03410992|524282069|FG002|Week 16 Assessment|Incorrect escapers|0|||
145389582|NCT03410992|524282070|FG003|Week 16 Assessment|Incorrect escapers|0|||
145389583|NCT03410992|524282071|FG004|Week 16 Assessment|Incorrect escapers|0|||
145389584|NCT03410992|524282072|FG005|Week 16 Assessment|Incorrect escapers|0|||
145389585|NCT03410992|524282073|FG006|Week 16 Assessment|Incorrect escapers|0|||
145389586|NCT03410992|524282074|FG007|Week 16 Assessment|Incorrect escapers|0|||
145389587|NCT03410992|524282075|FG008|Week 16 Assessment|Incorrect escapers|0|||
145389588|NCT03410992|524282076|FG009|Week 16 Assessment|Incorrect escapers|0|||
145389589|NCT03410992|524282077|FG010|Week 16 Assessment|Incorrect escapers|0|||
145389590|NCT03410992|524282067|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389591|NCT03410992|524282068|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389592|NCT03410992|524282069|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389593|NCT03410992|524282070|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
145389594|NCT03410992|524282071|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
145389595|NCT03410992|524282072|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389596|NCT03410992|524282073|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389597|NCT03410992|524282074|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389598|NCT03410992|524282075|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389599|NCT03410992|524282076|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389600|NCT03410992|524282077|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
145389601|NCT03410992|524282067|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389602|NCT03410992|524282068|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389603|NCT03410992|524282069|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389604|NCT03410992|524282070|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
145389605|NCT03410992|524282071|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
145389606|NCT03410992|524282072|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
145389607|NCT03410992|524282073|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389608|NCT03410992|524282074|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389609|NCT03410992|524282075|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389610|NCT03410992|524282076|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389611|NCT03410992|524282077|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
145389612|NCT03410992|524282067|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389613|NCT03410992|524282068|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389614|NCT03410992|524282069|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389615|NCT03410992|524282070|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389616|NCT03410992|524282071|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389617|NCT03410992|524282072|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
145389618|NCT03410992|524282073|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389619|NCT03410992|524282074|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389620|NCT03410992|524282075|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389621|NCT03410992|524282076|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389622|NCT03410992|524282077|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
145389623|NCT03410992|524282067|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389624|NCT03410992|524282068|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389625|NCT03410992|524282069|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389626|NCT03410992|524282070|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
145389627|NCT03410992|524282071|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
145389628|NCT03410992|524282072|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
145389629|NCT03410992|524282073|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389630|NCT03410992|524282074|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389631|NCT03410992|524282075|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389632|NCT03410992|524282076|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389633|NCT03410992|524282077|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
145389634|NCT03410992|524282067|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389635|NCT03410992|524282068|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389636|NCT03410992|524282069|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389637|NCT03410992|524282070|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389638|NCT03410992|524282071|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389639|NCT03410992|524282072|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389640|NCT03410992|524282073|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389641|NCT03410992|524282074|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
145389642|NCT03410992|524282075|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389643|NCT03410992|524282076|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389644|NCT03410992|524282077|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
145389645|NCT03410992|524282067|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389646|NCT03410992|524282068|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389647|NCT03410992|524282069|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389648|NCT03410992|524282070|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389649|NCT03410992|524282071|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389650|NCT03410992|524282072|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389651|NCT03410992|524282073|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389652|NCT03410992|524282074|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389653|NCT03410992|524282075|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
145389654|NCT03410992|524282076|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389655|NCT03410992|524282077|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
145389656|NCT01896193|524282079|FG000|Overall Study|Lack of Efficacy|20|||
145389657|NCT01896193|524282080|FG001|Overall Study|Lack of Efficacy|11|||
145389658|NCT01896193|524282079|FG000|Overall Study|Protocol Violation|0|||
145389659|NCT01896193|524282080|FG001|Overall Study|Protocol Violation|1|||
145389660|NCT01896193|524282079|FG000|Overall Study|Withdrew Consent|1|||
145389661|NCT01896193|524282080|FG001|Overall Study|Withdrew Consent|0|||
145389662|NCT03465709|524282083|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
145389663|NCT03465709|524282083|FG000|Overall Study|Withdrawal by Subject|3|||
145389664|NCT04892446|524282084|FG000|Overall Study|Death|4|||
145389665|NCT04892446|524282085|FG001|Overall Study|Death|4|||
145389666|NCT04892446|524282086|FG002|Overall Study|Death|0|||
145389667|NCT04892446|524282084|FG000|Overall Study|Withdrew consent|3|||
145389668|NCT04892446|524282085|FG001|Overall Study|Withdrew consent|0|||
145389669|NCT04892446|524282086|FG002|Overall Study|Withdrew consent|1|||
145389670|NCT04892446|524282084|FG000|Overall Study|Investigator's discretion|1|||
145389671|NCT04892446|524282085|FG001|Overall Study|Investigator's discretion|1|||
145389672|NCT04892446|524282086|FG002|Overall Study|Investigator's discretion|0|||
145389673|NCT04892446|524282084|FG000|Overall Study|Study terminated by sponsor|0|||
145389674|NCT04892446|524282085|FG001|Overall Study|Study terminated by sponsor|0|||
145389675|NCT04892446|524282086|FG002|Overall Study|Study terminated by sponsor|2|||
145389676|NCT03193047|524282088|FG000|Overall Study|Physician Decision|1|||
145389677|NCT03193047|524282089|FG001|Overall Study|Physician Decision|0|||
145389678|NCT03193047|524282088|FG000|Overall Study|Participant Left State|1|||
145389679|NCT03193047|524282089|FG001|Overall Study|Participant Left State|0|||
145729393|NCT01794520|525527453|FG004|Overall Study|Toxicity|0|||
145729394|NCT01794520|525527454|FG005|Overall Study|Toxicity|0|||
145729395|NCT01794520|525527455|FG006|Overall Study|Toxicity|0|||
145729396|NCT01794520|525527449|FG000|Overall Study|Study terminated by sponsor|0|||
145729397|NCT01794520|525527450|FG001|Overall Study|Study terminated by sponsor|0|||
145729398|NCT01794520|525527451|FG002|Overall Study|Study terminated by sponsor|1|||
145729399|NCT01794520|525527452|FG003|Overall Study|Study terminated by sponsor|0|||
145729400|NCT01794520|525527453|FG004|Overall Study|Study terminated by sponsor|1|||
145729401|NCT01794520|525527454|FG005|Overall Study|Study terminated by sponsor|0|||
145729402|NCT01794520|525527455|FG006|Overall Study|Study terminated by sponsor|7|||
145729403|NCT01794520|525527449|FG000|Overall Study|Death|0|||
145729404|NCT01794520|525527450|FG001|Overall Study|Death|0|||
145729405|NCT01794520|525527451|FG002|Overall Study|Death|0|||
145729406|NCT01794520|525527452|FG003|Overall Study|Death|0|||
145729407|NCT01794520|525527453|FG004|Overall Study|Death|1|||
145389680|NCT00705341|524282090|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
145389681|NCT00705341|524282091|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
145389682|NCT00705341|524282092|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
145389683|NCT00705341|524282093|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
145729408|NCT01794520|525527454|FG005|Overall Study|Death|0|||
145729409|NCT01794520|525527455|FG006|Overall Study|Death|22|||
145729410|NCT01794520|525527449|FG000|Overall Study|Other, not specified|0|||
145729411|NCT01794520|525527450|FG001|Overall Study|Other, not specified|0|||
145389684|NCT00705341|524282090|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145605891|NCT00633932|525073034|FG000|Overall Study|Protocol Violation|5|||
145729412|NCT01794520|525527451|FG002|Overall Study|Other, not specified|1|||
145389685|NCT00705341|524282091|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145389686|NCT00705341|524282092|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
145389687|NCT00705341|524282093|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
145389688|NCT02585713|524282097|FG000|Overall Study|Withdrew prior to treatment|2|||
145389689|NCT02585713|524282098|FG001|Overall Study|Withdrew prior to treatment|7|||
145389690|NCT02585713|524282097|FG000|Overall Study|Other|3|||
145389691|NCT02585713|524282098|FG001|Overall Study|Other|1|||
145389692|NCT03173456|524282101|FG000|Baseline|Medication dispensing system malfunction'|0|||
145389693|NCT03173456|524282102|FG001|Baseline|Medication dispensing system malfunction'|1|||
145389694|NCT03173456|524282103|FG002|Baseline|Medication dispensing system malfunction'|0|||
145389695|NCT03173456|524282104|FG003|Baseline|Medication dispensing system malfunction'|0|||
145389696|NCT03173456|524282105|FG004|Baseline|Medication dispensing system malfunction'|2|||
145389697|NCT03173456|524282101|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
145389698|NCT03173456|524282102|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
145389699|NCT03173456|524282103|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
145389700|NCT03173456|524282104|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
145389701|NCT03173456|524282105|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
145389702|NCT01733121|524282106|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
145389703|NCT01733121|524282107|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
145389704|NCT01733121|524282106|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
145389705|NCT01733121|524282107|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
145389706|NCT01733121|524282106|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
145389707|NCT01733121|524282107|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
145389708|NCT01733121|524282106|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
145389709|NCT01733121|524282107|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
145389710|NCT03061188|524282110|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
145389711|NCT03061188|524282111|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
145389712|NCT03061188|524282112|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
145389713|NCT03061188|524282113|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
145389714|NCT03061188|524282110|FG000|On Follow-up for 3 Years|Death|0|||
145389715|NCT03061188|524282111|FG001|On Follow-up for 3 Years|Death|3|||
145389716|NCT03061188|524282112|FG002|On Follow-up for 3 Years|Death|5|||
145389717|NCT03061188|524282113|FG003|On Follow-up for 3 Years|Death|4|||
145389718|NCT03061188|524282110|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
145389719|NCT03061188|524282111|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
145389720|NCT03061188|524282112|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
145389721|NCT03061188|524282113|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
145389722|NCT02609984|524282118|FG000|Overall Study|Death|29|||
145389723|NCT02609984|524282119|FG001|Overall Study|Death|26|||
145389724|NCT02609984|524282118|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
145389725|NCT02609984|524282119|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
145389726|NCT02609984|524282118|FG000|Overall Study|Lost to Follow-up|1|||
145389727|NCT02609984|524282119|FG001|Overall Study|Lost to Follow-up|2|||
145389728|NCT02609984|524282118|FG000|Overall Study|Withdrawal by Subject|0|||
145389729|NCT02609984|524282119|FG001|Overall Study|Withdrawal by Subject|1|||
145389730|NCT02609984|524282118|FG000|Overall Study|Disease Progression|2|||
145389731|NCT02609984|524282119|FG001|Overall Study|Disease Progression|0|||
145389732|NCT02306850|524282122|FG000|Overall Study|Lack of Efficacy|2|||
145389733|NCT02420262|524282123|FG000|Overall Study|Adverse Event|1|||
145389734|NCT02420262|524282124|FG001|Overall Study|Adverse Event|0|||
145389735|NCT02420262|524282123|FG000|Overall Study|Withdrawal by Subject|1|||
145389736|NCT02420262|524282124|FG001|Overall Study|Withdrawal by Subject|4|||
145389737|NCT02420262|524282123|FG000|Overall Study|Unclassified|0|||
145389738|NCT02420262|524282124|FG001|Overall Study|Unclassified|1|||
145729413|NCT01794520|525527452|FG003|Overall Study|Other, not specified|1|||
145729414|NCT01794520|525527453|FG004|Overall Study|Other, not specified|4|||
145729415|NCT01794520|525527454|FG005|Overall Study|Other, not specified|1|||
145729416|NCT01794520|525527455|FG006|Overall Study|Other, not specified|2|||
145729417|NCT00753272|525527465|FG000|Overall Study|Adverse Event|878|||
145729418|NCT00753272|525527466|FG001|Overall Study|Adverse Event|869|||
145729419|NCT00753272|525527465|FG000|Overall Study|Protocol Violation|28|||
145729420|NCT00753272|525527466|FG001|Overall Study|Protocol Violation|46|||
145389739|NCT00436826|524282126|FG000|Double Blind Period (DBP)|Adverse Event|2|||
145389740|NCT00436826|524282127|FG001|Double Blind Period (DBP)|Adverse Event|0|||
145389741|NCT00436826|524282128|FG002|Double Blind Period (DBP)|Adverse Event|0|||
145389742|NCT00436826|524282129|FG003|Double Blind Period (DBP)|Adverse Event|0|||
145729421|NCT00753272|525527465|FG000|Overall Study|Withdrawal by Subject|2481|||
145389743|NCT00436826|524282130|FG004|Double Blind Period (DBP)|Adverse Event|0|||
145389744|NCT00436826|524282131|FG005|Double Blind Period (DBP)|Adverse Event|0|||
145389745|NCT00436826|524282126|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
145389746|NCT00436826|524282127|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
145389747|NCT00436826|524282128|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
145389748|NCT00436826|524282129|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
145389749|NCT00436826|524282130|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
145389750|NCT00436826|524282131|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
145389751|NCT00436826|524282126|FG000|Double Blind Period (DBP)|Other|10|||
145389752|NCT00436826|524282127|FG001|Double Blind Period (DBP)|Other|11|||
145389753|NCT00436826|524282128|FG002|Double Blind Period (DBP)|Other|0|||
145389754|NCT00436826|524282129|FG003|Double Blind Period (DBP)|Other|0|||
145389755|NCT00436826|524282130|FG004|Double Blind Period (DBP)|Other|0|||
145389756|NCT00436826|524282131|FG005|Double Blind Period (DBP)|Other|0|||
145389757|NCT00436826|524282126|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145389758|NCT00436826|524282127|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145389759|NCT00436826|524282128|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145389760|NCT00436826|524282129|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
145389761|NCT00436826|524282130|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145389762|NCT00436826|524282131|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
145389763|NCT00436826|524282126|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145389764|NCT00436826|524282127|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145389765|NCT00436826|524282128|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
145389766|NCT00436826|524282129|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
145389767|NCT00436826|524282130|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145389768|NCT00436826|524282131|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
145389769|NCT00436826|524282126|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145389770|NCT00436826|524282127|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145389771|NCT00436826|524282128|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145389772|NCT00436826|524282129|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
145389773|NCT00436826|524282130|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
145389774|NCT00436826|524282131|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
145389775|NCT00110357|524282137|FG000|Overall Study|Deterioration without progression|2|||
145389776|NCT00110357|524282138|FG001|Overall Study|Deterioration without progression|0|||
145389777|NCT00110357|524282137|FG000|Overall Study|Disease progression/relapse|20|||
145389778|NCT00110357|524282138|FG001|Overall Study|Disease progression/relapse|15|||
145389779|NCT00110357|524282137|FG000|Overall Study|Study Closure|1|||
145389780|NCT00110357|524282138|FG001|Overall Study|Study Closure|0|||
145389781|NCT00110357|524282137|FG000|Overall Study|Study Drug Toxicity|1|||
145389782|NCT00110357|524282138|FG001|Overall Study|Study Drug Toxicity|3|||
145389783|NCT00110357|524282137|FG000|Overall Study|Withdrawal by Subject|3|||
145389784|NCT00110357|524282138|FG001|Overall Study|Withdrawal by Subject|1|||
145389785|NCT04004260|524282139|FG000|Overall Study|Withdrawal by Subject|7|||
145389786|NCT04004260|524282140|FG001|Overall Study|Withdrawal by Subject|3|||
145389787|NCT04004260|524282139|FG000|Overall Study|Lost to Follow-up|22|||
145389788|NCT04004260|524282140|FG001|Overall Study|Lost to Follow-up|12|||
145389789|NCT04004260|524282139|FG000|Overall Study|Did not engage in intervention|13|||
145389790|NCT04004260|524282140|FG001|Overall Study|Did not engage in intervention|17|||
145389791|NCT03382418|524282141|FG000|Overall Study|Withdrawal by Subject|1|||
145389792|NCT03382418|524282142|FG001|Overall Study|Withdrawal by Subject|0|||
145389793|NCT03382418|524282143|FG002|Overall Study|Withdrawal by Subject|0|||
145389794|NCT03382418|524282141|FG000|Overall Study|Lost to Follow-up|2|||
145389795|NCT03382418|524282142|FG001|Overall Study|Lost to Follow-up|3|||
145389796|NCT03382418|524282143|FG002|Overall Study|Lost to Follow-up|0|||
145389797|NCT02360280|524282144|FG000|Overall Study|Withdrawal by Subject|2|||
145389798|NCT02360280|524282145|FG001|Overall Study|Withdrawal by Subject|0|||
145389799|NCT02360280|524282144|FG000|Overall Study|Adverse Event|0|||
145389800|NCT02360280|524282145|FG001|Overall Study|Adverse Event|1|||
145389801|NCT02360280|524282144|FG000|Overall Study|Lost to Follow-up|1|||
145389802|NCT02360280|524282145|FG001|Overall Study|Lost to Follow-up|0|||
145389803|NCT00320788|524282146|FG000|Overall Study|Adverse Event|0|||
145389804|NCT00320788|524282147|FG001|Overall Study|Adverse Event|0|||
145389805|NCT00320788|524282148|FG002|Overall Study|Adverse Event|0|||
145389806|NCT00320788|524282149|FG003|Overall Study|Adverse Event|1|||
145389807|NCT00320788|524282150|FG004|Overall Study|Adverse Event|0|||
145389808|NCT00320788|524282146|FG000|Overall Study|Death|0|||
145389809|NCT00320788|524282147|FG001|Overall Study|Death|0|||
145389810|NCT00320788|524282148|FG002|Overall Study|Death|1|||
145389811|NCT00320788|524282149|FG003|Overall Study|Death|0|||
145389812|NCT00320788|524282150|FG004|Overall Study|Death|1|||
145389813|NCT00320788|524282146|FG000|Overall Study|Lost to Follow-up|0|||
145389814|NCT00320788|524282147|FG001|Overall Study|Lost to Follow-up|2|||
145389815|NCT00320788|524282148|FG002|Overall Study|Lost to Follow-up|1|||
145389816|NCT00320788|524282149|FG003|Overall Study|Lost to Follow-up|0|||
145389817|NCT00320788|524282150|FG004|Overall Study|Lost to Follow-up|0|||
145389818|NCT00320788|524282146|FG000|Overall Study|Decision by the Sponsor|1|||
145389819|NCT00320788|524282147|FG001|Overall Study|Decision by the Sponsor|1|||
145389820|NCT00320788|524282148|FG002|Overall Study|Decision by the Sponsor|0|||
145389821|NCT00320788|524282149|FG003|Overall Study|Decision by the Sponsor|0|||
145389822|NCT00320788|524282150|FG004|Overall Study|Decision by the Sponsor|1|||
145389823|NCT00320788|524282146|FG000|Overall Study|Other|1|||
145389824|NCT00320788|524282147|FG001|Overall Study|Other|2|||
145389825|NCT00320788|524282148|FG002|Overall Study|Other|1|||
145389826|NCT00320788|524282149|FG003|Overall Study|Other|1|||
145389827|NCT00320788|524282150|FG004|Overall Study|Other|1|||
145389828|NCT00320788|524282146|FG000|Overall Study|Physician Decision|1|||
145389829|NCT00320788|524282147|FG001|Overall Study|Physician Decision|1|||
145389830|NCT00320788|524282148|FG002|Overall Study|Physician Decision|0|||
145389831|NCT00320788|524282149|FG003|Overall Study|Physician Decision|0|||
145389832|NCT00320788|524282150|FG004|Overall Study|Physician Decision|0|||
145389833|NCT00320788|524282146|FG000|Overall Study|Protocol Violation|0|||
145389834|NCT00320788|524282147|FG001|Overall Study|Protocol Violation|0|||
145389835|NCT00320788|524282148|FG002|Overall Study|Protocol Violation|0|||
145389836|NCT00320788|524282149|FG003|Overall Study|Protocol Violation|0|||
145389837|NCT00320788|524282150|FG004|Overall Study|Protocol Violation|1|||
145389838|NCT00320788|524282146|FG000|Overall Study|Withdrawal by Subject|3|||
145389839|NCT00320788|524282147|FG001|Overall Study|Withdrawal by Subject|0|||
145389840|NCT00320788|524282148|FG002|Overall Study|Withdrawal by Subject|0|||
145389841|NCT00320788|524282149|FG003|Overall Study|Withdrawal by Subject|3|||
145389842|NCT00320788|524282150|FG004|Overall Study|Withdrawal by Subject|1|||
145389843|NCT00396383|524282154|FG000|Overall Study|Death|2|||
145389844|NCT00396383|524282154|FG000|Overall Study|Lost to Follow-up|1|||
145389845|NCT00534638|524282155|FG000|Overall Study|Withdrawal by Subject|3|||
145389846|NCT00534638|524282156|FG001|Overall Study|Withdrawal by Subject|4|||
145389847|NCT00534638|524282155|FG000|Overall Study|Migrated/moved from study area|13|||
145389848|NCT00534638|524282156|FG001|Overall Study|Migrated/moved from study area|11|||
145389849|NCT00534638|524282155|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
145389850|NCT00534638|524282156|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
145389851|NCT00534638|524282155|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
145389852|NCT00534638|524282156|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
145389853|NCT00534638|524282155|FG000|Overall Study|Other|1685|||
145389854|NCT00534638|524282156|FG001|Overall Study|Other|902|||
145389855|NCT02903420|524282157|FG000|Overall Study|Death|3|||
145389856|NCT01216332|524282160|FG000|Overall Study|Withdrawal by Subject|4|||
145389857|NCT01216332|524282161|FG001|Overall Study|Withdrawal by Subject|0|||
145389858|NCT01066871|524282163|FG000|Overall Study|Lost to Follow-up|0|||
145389859|NCT01066871|524282164|FG001|Overall Study|Lost to Follow-up|2|||
145389860|NCT01066871|524282165|FG002|Overall Study|Lost to Follow-up|2|||
145389861|NCT01066871|524282166|FG003|Overall Study|Lost to Follow-up|0|||
145389862|NCT01066871|524282163|FG000|Overall Study|Protocol Violation|1|||
145389863|NCT01066871|524282164|FG001|Overall Study|Protocol Violation|0|||
145389864|NCT01066871|524282165|FG002|Overall Study|Protocol Violation|3|||
145389865|NCT01066871|524282166|FG003|Overall Study|Protocol Violation|2|||
145389866|NCT01066871|524282163|FG000|Overall Study|Lack of Efficacy|0|||
145389867|NCT01066871|524282164|FG001|Overall Study|Lack of Efficacy|0|||
145389868|NCT01066871|524282165|FG002|Overall Study|Lack of Efficacy|0|||
145389869|NCT01066871|524282166|FG003|Overall Study|Lack of Efficacy|1|||
145389870|NCT01066871|524282163|FG000|Overall Study|Withdrawal by Subject|3|||
145389871|NCT01066871|524282164|FG001|Overall Study|Withdrawal by Subject|1|||
145389872|NCT01066871|524282165|FG002|Overall Study|Withdrawal by Subject|0|||
145389873|NCT01066871|524282166|FG003|Overall Study|Withdrawal by Subject|0|||
145389874|NCT01066871|524282163|FG000|Overall Study|Other|0|||
145389875|NCT01066871|524282164|FG001|Overall Study|Other|2|||
145389876|NCT01066871|524282165|FG002|Overall Study|Other|1|||
145389877|NCT01066871|524282166|FG003|Overall Study|Other|2|||
145389878|NCT04162795|524282169|FG000|Overall Study|Other|16|||
145389879|NCT04162795|524282169|FG000|Overall Study|Screen failures|10|||
145495175|NCT00844844|524670291|FG000|Extension Treatment Period|Adverse Event|2|||
145495176|NCT00844844|524670291|FG000|Post Treatment Period|Withdrawal by Subject|1|||
145495177|NCT00945009|524670292|FG000|Overall Study|Lack of Efficacy|10|||
145495178|NCT00945009|524670293|FG001|Overall Study|Lack of Efficacy|0|||
145495179|NCT00945009|524670294|FG002|Overall Study|Lack of Efficacy|0|||
145495180|NCT00945009|524670292|FG000|Overall Study|Physician Decision|21|||
145495181|NCT00945009|524670293|FG001|Overall Study|Physician Decision|4|||
145495182|NCT00945009|524670294|FG002|Overall Study|Physician Decision|3|||
145495183|NCT00945009|524670292|FG000|Overall Study|Protocol Violation|6|||
145729422|NCT00753272|525527466|FG001|Overall Study|Withdrawal by Subject|2407|||
145389880|NCT02029274|524282172|FG000|Overall Study|Adverse Event|1|||
145495184|NCT00945009|524670293|FG001|Overall Study|Protocol Violation|1|||
145729423|NCT00753272|525527465|FG000|Overall Study|Lost to Follow-up|491|||
145266639|NCT04668066|523825249|FG012|Part 1: Treatment Phase|Other|0|||
145389881|NCT02029274|524282173|FG001|Overall Study|Adverse Event|0|||
145389882|NCT02029274|524282174|FG002|Overall Study|Adverse Event|2|||
145389883|NCT02029274|524282175|FG003|Overall Study|Adverse Event|2|||
145389884|NCT01124292|524282176|FG000|Overall Study|Lost to Follow-up|2|||
145389885|NCT01124292|524282177|FG001|Overall Study|Lost to Follow-up|4|||
145389886|NCT01124292|524282178|FG002|Overall Study|Lost to Follow-up|3|||
145495185|NCT00945009|524670294|FG002|Overall Study|Protocol Violation|0|||
145495186|NCT00945009|524670292|FG000|Overall Study|Withdrawal by Subject|1|||
145605892|NCT00633932|525073035|FG001|Overall Study|Protocol Violation|2|||
145389887|NCT01124292|524282176|FG000|Overall Study|Physician Decision|0|||
145389888|NCT01124292|524282177|FG001|Overall Study|Physician Decision|3|||
145389889|NCT01124292|524282178|FG002|Overall Study|Physician Decision|2|||
145389890|NCT01124292|524282176|FG000|Overall Study|Withdrawal by Subject|0|||
145389891|NCT01124292|524282177|FG001|Overall Study|Withdrawal by Subject|6|||
145389892|NCT01124292|524282178|FG002|Overall Study|Withdrawal by Subject|2|||
145389893|NCT01124292|524282176|FG000|Overall Study|medical issue unrelated to the study|0|||
145389894|NCT01124292|524282177|FG001|Overall Study|medical issue unrelated to the study|0|||
145389895|NCT01124292|524282178|FG002|Overall Study|medical issue unrelated to the study|2|||
145389896|NCT01124292|524282176|FG000|Overall Study|piercing track closed|0|||
145389897|NCT01124292|524282177|FG001|Overall Study|piercing track closed|2|||
145389898|NCT01124292|524282178|FG002|Overall Study|piercing track closed|1|||
145389899|NCT01366638|524282180|FG000|Overall Study|Withdrawal by Subject|0|||
145389900|NCT01366638|524282181|FG001|Overall Study|Withdrawal by Subject|0|||
145389901|NCT01366638|524282182|FG002|Overall Study|Withdrawal by Subject|6|||
145389902|NCT01366638|524282180|FG000|Overall Study|Other|1|||
145389903|NCT01366638|524282181|FG001|Overall Study|Other|0|||
145389904|NCT01366638|524282182|FG002|Overall Study|Other|0|||
145389905|NCT00636636|524282183|FG000|Overall Study|Other reason|4|||
145389906|NCT00636636|524282184|FG001|Overall Study|Other reason|6|||
145389907|NCT00636636|524282183|FG000|Overall Study|Adverse Event|19|||
145389908|NCT00636636|524282184|FG001|Overall Study|Adverse Event|8|||
145389909|NCT00636636|524282183|FG000|Overall Study|Lack of Efficacy|7|||
145389910|NCT00636636|524282184|FG001|Overall Study|Lack of Efficacy|12|||
145389911|NCT00636636|524282183|FG000|Overall Study|Protocol Violation|2|||
145389912|NCT00636636|524282184|FG001|Overall Study|Protocol Violation|2|||
145389913|NCT00636636|524282183|FG000|Overall Study|Lost to Follow-up|0|||
145389914|NCT00636636|524282184|FG001|Overall Study|Lost to Follow-up|1|||
145389915|NCT00636636|524282183|FG000|Overall Study|Death|0|||
145389916|NCT00636636|524282184|FG001|Overall Study|Death|1|||
145389917|NCT00636636|524282183|FG000|Overall Study|Withdrawal by Subject|4|||
145389918|NCT00636636|524282184|FG001|Overall Study|Withdrawal by Subject|9|||
145389919|NCT00524173|524282185|FG000|Overall Study|Lost to Follow-up|0|||
145389920|NCT00524173|524282186|FG001|Overall Study|Lost to Follow-up|1|||
145389921|NCT00524173|524282185|FG000|Overall Study|Death|1|||
145389922|NCT00524173|524282186|FG001|Overall Study|Death|0|||
145389923|NCT00524173|524282185|FG000|Overall Study|Had not reached endpoint at study close|4|||
145389924|NCT00524173|524282186|FG001|Overall Study|Had not reached endpoint at study close|1|||
145389925|NCT01237327|524282187|FG000|Overall Study|Protocol Violation: Core Study|1|||
145389926|NCT01237327|524282188|FG001|Overall Study|Protocol Violation: Core Study|0|||
145389927|NCT01237327|524282187|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
145389928|NCT01237327|524282188|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
145389929|NCT01237327|524282187|FG000|Overall Study|Progression of Disease: Core Study|18|||
145389930|NCT01237327|524282188|FG001|Overall Study|Progression of Disease: Core Study|22|||
145389931|NCT01237327|524282187|FG000|Overall Study|Progression of Disease: Extension Study|15|||
145389932|NCT01237327|524282188|FG001|Overall Study|Progression of Disease: Extension Study|13|||
145389933|NCT01237327|524282187|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
145389934|NCT01237327|524282188|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
145389935|NCT01237327|524282187|FG000|Overall Study|Withdrawal by Subject|1|||
145389936|NCT01237327|524282188|FG001|Overall Study|Withdrawal by Subject|3|||
145389937|NCT01237327|524282187|FG000|Overall Study|Lost to Follow-up|3|||
145389938|NCT01237327|524282188|FG001|Overall Study|Lost to Follow-up|0|||
145389939|NCT03300180|524282189|FG000|Baseline|Withdrawal by Subject|4|||
145389940|NCT03300180|524282190|FG001|Baseline|Withdrawal by Subject|6|||
145389941|NCT03300180|524282191|FG002|Baseline|Withdrawal by Subject|4|||
145389942|NCT03300180|524282189|FG000|6 Month Outcome|Withdrawal by Subject|12|||
145389943|NCT03300180|524282190|FG001|6 Month Outcome|Withdrawal by Subject|12|||
145389944|NCT03300180|524282191|FG002|6 Month Outcome|Withdrawal by Subject|19|||
145389945|NCT03300180|524282189|FG000|6 Month Outcome|Death|2|||
145389946|NCT03300180|524282190|FG001|6 Month Outcome|Death|4|||
145389947|NCT03300180|524282191|FG002|6 Month Outcome|Death|3|||
145389948|NCT03300180|524282189|FG000|6 Month Outcome|Missed Assessment|43|||
145389949|NCT03300180|524282190|FG001|6 Month Outcome|Missed Assessment|52|||
145389950|NCT03300180|524282191|FG002|6 Month Outcome|Missed Assessment|46|||
145389951|NCT03300180|524282189|FG000|12 Month Outcome|Withdrawal by Subject|3|||
145389952|NCT03300180|524282190|FG001|12 Month Outcome|Withdrawal by Subject|6|||
145389953|NCT03300180|524282191|FG002|12 Month Outcome|Withdrawal by Subject|6|||
145389954|NCT03300180|524282189|FG000|12 Month Outcome|Death|9|||
145389955|NCT03300180|524282190|FG001|12 Month Outcome|Death|6|||
145729424|NCT00753272|525527466|FG001|Overall Study|Lost to Follow-up|497|||
145389956|NCT03300180|524282191|FG002|12 Month Outcome|Death|6|||
145389957|NCT03300180|524282189|FG000|12 Month Outcome|Missed Assessment|62|||
145389958|NCT03300180|524282190|FG001|12 Month Outcome|Missed Assessment|59|||
145389959|NCT03300180|524282191|FG002|12 Month Outcome|Missed Assessment|58|||
145389960|NCT03300180|524282189|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
145389961|NCT03300180|524282190|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
145389962|NCT03300180|524282191|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
145389963|NCT03300180|524282189|FG000|18 Month Outcome Assessment|Death|8|||
145389964|NCT03300180|524282190|FG001|18 Month Outcome Assessment|Death|5|||
145389965|NCT03300180|524282191|FG002|18 Month Outcome Assessment|Death|5|||
145389966|NCT03300180|524282189|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
145389967|NCT03300180|524282190|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
145389968|NCT03300180|524282191|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
145389969|NCT03300180|524282189|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
145389970|NCT03300180|524282190|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
145389971|NCT03300180|524282191|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
145389972|NCT03300180|524282189|FG000|24 Month Outcome Assessment|Death|13|||
145389973|NCT03300180|524282190|FG001|24 Month Outcome Assessment|Death|13|||
145389974|NCT03300180|524282191|FG002|24 Month Outcome Assessment|Death|3|||
145389975|NCT03300180|524282189|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
145389976|NCT03300180|524282190|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
145389977|NCT03300180|524282191|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
145389978|NCT01941537|524282194|FG000|Overall Study|Lack of Efficacy|1|||
145389979|NCT01941537|524282195|FG001|Overall Study|Lack of Efficacy|2|||
145389980|NCT01941537|524282194|FG000|Overall Study|Lost to Follow-up|1|||
145389981|NCT01941537|524282195|FG001|Overall Study|Lost to Follow-up|0|||
145389982|NCT01941537|524282194|FG000|Overall Study|Pregnancy|1|||
145389983|NCT01941537|524282195|FG001|Overall Study|Pregnancy|0|||
145389984|NCT01941537|524282194|FG000|Overall Study|Adverse Event|1|||
145389985|NCT01941537|524282195|FG001|Overall Study|Adverse Event|0|||
145389986|NCT01941537|524282194|FG000|Overall Study|Withdrawal by Subject|0|||
145389987|NCT01941537|524282195|FG001|Overall Study|Withdrawal by Subject|1|||
145389988|NCT00669318|524283624|FG000|Overall Study|Withdrawal by Subject|2|||
145389989|NCT01223404|524283625|FG000|First Intervention (1 Day)|Adverse Event|0|||
145389990|NCT01223404|524283626|FG001|First Intervention (1 Day)|Adverse Event|0|||
145389991|NCT01223404|524283627|FG002|First Intervention (1 Day)|Adverse Event|0|||
145389992|NCT01223404|524283628|FG003|First Intervention (1 Day)|Adverse Event|1|||
145389993|NCT01223404|524283629|FG004|First Intervention (1 Day)|Adverse Event|0|||
145389994|NCT01223404|524283630|FG005|First Intervention (1 Day)|Adverse Event|0|||
145729425|NCT00753272|525527465|FG000|Overall Study|Other|1104|||
145729426|NCT00753272|525527466|FG001|Overall Study|Other|1088|||
145729427|NCT02092220|525527467|FG000|Period 1|Unrelated Illness|0|||
145729428|NCT02092220|525527468|FG001|Period 1|Unrelated Illness|2|||
145729429|NCT02092220|525527467|FG000|Period 2|Severe Hypoglycaemia|1|||
145729430|NCT02092220|525527468|FG001|Period 2|Severe Hypoglycaemia|0|||
145729431|NCT02092220|525527467|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
145729432|NCT02092220|525527468|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
145729433|NCT00593957|525527469|FG000|Overall Study|Physician Decision|0|||
145729434|NCT00593957|525527470|FG001|Overall Study|Physician Decision|1|||
145729435|NCT00593957|525527471|FG002|Overall Study|Physician Decision|2|||
145729436|NCT02411578|525527472|FG000|Crossover Trial Phase|Pregnancy|0|||
145729437|NCT02411578|525527473|FG001|Crossover Trial Phase|Pregnancy|1|||
145729438|NCT01193920|525527474|FG000|Overall Study|Withdrawal by Subject|1|||
145729439|NCT01193920|525527475|FG001|Overall Study|Withdrawal by Subject|0|||
145729440|NCT01193920|525527476|FG002|Overall Study|Withdrawal by Subject|5|||
145729441|NCT01193920|525527477|FG003|Overall Study|Withdrawal by Subject|1|||
145729442|NCT01193920|525527478|FG004|Overall Study|Withdrawal by Subject|3|||
145729443|NCT01193920|525527479|FG005|Overall Study|Withdrawal by Subject|1|||
145729444|NCT01193920|525527480|FG006|Overall Study|Withdrawal by Subject|3|||
145729445|NCT01193920|525527481|FG007|Overall Study|Withdrawal by Subject|0|||
145729446|NCT01193920|525527482|FG008|Overall Study|Withdrawal by Subject|1|||
145729447|NCT01193920|525527483|FG009|Overall Study|Withdrawal by Subject|0|||
145729448|NCT01193920|525527474|FG000|Overall Study|Lost to Follow-up|1|||
145729449|NCT01193920|525527475|FG001|Overall Study|Lost to Follow-up|0|||
145729450|NCT01193920|525527476|FG002|Overall Study|Lost to Follow-up|1|||
145729451|NCT01193920|525527477|FG003|Overall Study|Lost to Follow-up|1|||
145729452|NCT01193920|525527478|FG004|Overall Study|Lost to Follow-up|3|||
145389995|NCT01223404|524283625|FG000|Second Intervention (1 Day)|Adverse Event|1|||
145729453|NCT01193920|525527479|FG005|Overall Study|Lost to Follow-up|3|||
145729454|NCT01193920|525527480|FG006|Overall Study|Lost to Follow-up|1|||
145389996|NCT01223404|524283626|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145495187|NCT00945009|524670293|FG001|Overall Study|Withdrawal by Subject|0|||
145729455|NCT01193920|525527481|FG007|Overall Study|Lost to Follow-up|0|||
145389997|NCT01223404|524283627|FG002|Second Intervention (1 Day)|Adverse Event|0|||
145389998|NCT01223404|524283628|FG003|Second Intervention (1 Day)|Adverse Event|0|||
145389999|NCT01223404|524283629|FG004|Second Intervention (1 Day)|Adverse Event|0|||
145390000|NCT01223404|524283630|FG005|Second Intervention (1 Day)|Adverse Event|0|||
145390001|NCT01223404|524283625|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145390002|NCT01223404|524283626|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145605893|NCT00633932|525073036|FG002|Overall Study|Protocol Violation|3|||
145729456|NCT01193920|525527482|FG008|Overall Study|Lost to Follow-up|2|||
145729457|NCT01193920|525527483|FG009|Overall Study|Lost to Follow-up|3|||
145390003|NCT01223404|524283627|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145390004|NCT01223404|524283628|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
145390005|NCT01223404|524283629|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145390006|NCT01223404|524283630|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
145390007|NCT00707057|524283631|FG000|Overall Study|Withdrawal by Subject|8|||
145390008|NCT00707057|524283632|FG001|Overall Study|Withdrawal by Subject|3|||
145390009|NCT00707057|524283631|FG000|Overall Study|Dosed incorrectly|0|||
145390010|NCT00707057|524283632|FG001|Overall Study|Dosed incorrectly|1|||
145390011|NCT02492165|524283633|FG000|Overall Study|Withdrawal by Subject|0|||
145390012|NCT02492165|524283634|FG001|Overall Study|Withdrawal by Subject|1|||
145390013|NCT02492165|524283635|FG002|Overall Study|Withdrawal by Subject|0|||
145390014|NCT02492165|524283636|FG003|Overall Study|Withdrawal by Subject|0|||
145390015|NCT00305227|524283641|FG000|Overall Study|Lost to Follow-up|7|||
145390016|NCT00305227|524283642|FG001|Overall Study|Lost to Follow-up|6|||
145390017|NCT00411450|524283645|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
145390018|NCT01059773|524283646|FG000|Overall Study|Adverse Event|2|||
145390019|NCT01059773|524283647|FG001|Overall Study|Adverse Event|2|||
145390020|NCT01059773|524283646|FG000|Overall Study|Withdrawal by Subject|1|||
145390021|NCT01059773|524283647|FG001|Overall Study|Withdrawal by Subject|5|||
145390022|NCT01059773|524283646|FG000|Overall Study|Lost to Follow-up|1|||
145390023|NCT01059773|524283647|FG001|Overall Study|Lost to Follow-up|1|||
145390024|NCT01059773|524283646|FG000|Overall Study|Pregnancy|1|||
145390025|NCT01059773|524283647|FG001|Overall Study|Pregnancy|1|||
145390026|NCT01059773|524283646|FG000|Overall Study|Protocol Violation|6|||
145390027|NCT01059773|524283647|FG001|Overall Study|Protocol Violation|2|||
145390028|NCT01059773|524283646|FG000|Overall Study|Physician Decision|5|||
145390029|NCT01059773|524283647|FG001|Overall Study|Physician Decision|4|||
145390030|NCT01059773|524283646|FG000|Overall Study|Lack of Efficacy|3|||
145390031|NCT01059773|524283647|FG001|Overall Study|Lack of Efficacy|3|||
145390032|NCT01059773|524283646|FG000|Overall Study|Death|0|||
145390033|NCT01059773|524283647|FG001|Overall Study|Death|1|||
145390034|NCT01059773|524283646|FG000|Overall Study|Malignancy including squamous cell skin|0|||
145390035|NCT01059773|524283647|FG001|Overall Study|Malignancy including squamous cell skin|1|||
145390036|NCT01059773|524283646|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
145390037|NCT01059773|524283647|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
145390038|NCT01059773|524283646|FG000|Overall Study|Other|1|||
145390039|NCT01059773|524283647|FG001|Overall Study|Other|3|||
145390040|NCT00141518|524283650|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
145390041|NCT00141518|524283651|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
145390042|NCT00141518|524283652|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
145390043|NCT00141518|524283650|FG000|Overall Study|Adverse Event|7|||
145390044|NCT00141518|524283651|FG001|Overall Study|Adverse Event|5|||
145390045|NCT00141518|524283652|FG002|Overall Study|Adverse Event|2|||
145390046|NCT00141518|524283650|FG000|Overall Study|Withdrawal by Subject|2|||
145390047|NCT00141518|524283651|FG001|Overall Study|Withdrawal by Subject|0|||
145390048|NCT00141518|524283652|FG002|Overall Study|Withdrawal by Subject|2|||
145390049|NCT00141518|524283650|FG000|Overall Study|Protocol Violation|1|||
145390050|NCT00141518|524283651|FG001|Overall Study|Protocol Violation|1|||
145390051|NCT00141518|524283652|FG002|Overall Study|Protocol Violation|2|||
145390052|NCT00141518|524283650|FG000|Overall Study|Lack of Efficacy|5|||
145390053|NCT00141518|524283651|FG001|Overall Study|Lack of Efficacy|0|||
145390054|NCT00141518|524283652|FG002|Overall Study|Lack of Efficacy|0|||
145390055|NCT01806168|524283654|FG000|Overall Study|Adverse Event|1|||
145390056|NCT01806168|524283655|FG001|Overall Study|Adverse Event|0|||
145390057|NCT01806168|524283656|FG002|Overall Study|Adverse Event|0|||
145390058|NCT01806168|524283654|FG000|Overall Study|Withdrawal by Subject|0|||
145390059|NCT01806168|524283655|FG001|Overall Study|Withdrawal by Subject|1|||
145390060|NCT01806168|524283656|FG002|Overall Study|Withdrawal by Subject|2|||
145390061|NCT01806168|524283654|FG000|Overall Study|Protocol Violation|0|||
145390062|NCT01806168|524283655|FG001|Overall Study|Protocol Violation|0|||
145390063|NCT01806168|524283656|FG002|Overall Study|Protocol Violation|1|||
145390064|NCT01029262|524283659|FG000|Overall Study|Adverse Event|9|||
145390065|NCT01029262|524283660|FG001|Overall Study|Adverse Event|52|||
145390066|NCT01029262|524283659|FG000|Overall Study|Lack of therapeutic effect|57|||
145390067|NCT01029262|524283660|FG001|Overall Study|Lack of therapeutic effect|76|||
145390068|NCT01029262|524283659|FG000|Overall Study|Withdrawal by Subject|10|||
145390069|NCT01029262|524283660|FG001|Overall Study|Withdrawal by Subject|17|||
145390070|NCT01029262|524283659|FG000|Overall Study|Protocol Violation|2|||
145390071|NCT01029262|524283660|FG001|Overall Study|Protocol Violation|3|||
145390072|NCT01029262|524283659|FG000|Overall Study|Miscellaneous|1|||
145390073|NCT01029262|524283660|FG001|Overall Study|Miscellaneous|9|||
145390074|NCT01029262|524283659|FG000|Overall Study|Death|0|||
145390075|NCT01029262|524283660|FG001|Overall Study|Death|3|||
145390076|NCT00614874|524283661|FG000|Overall Study|Protocol Violation|1|||
145390077|NCT00614874|524283661|FG000|Overall Study|Withdrawal by Subject|1|||
145390078|NCT01001910|524283662|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
145390079|NCT03904420|524283663|FG000|Overall Study|Study terminated|2|||
145390080|NCT03904420|524283664|FG001|Overall Study|Study terminated|2|||
145390081|NCT01468454|524283665|FG000|Overall Study|Did not have surgery after PET|9|||
145390082|NCT01462630|524283667|FG000|Overall Study|Did not initiate therapy|3|||
145390083|NCT01462630|524283667|FG000|Overall Study|Death|1|||
145390084|NCT01462630|524283667|FG000|Overall Study|Protocol Violation|2|||
145390085|NCT01462630|524283667|FG000|Overall Study|Adverse Event|1|||
145390086|NCT01048541|524283670|FG000|Overall Study|Withdrawal by Subject|1|||
145390087|NCT01048541|524283671|FG001|Overall Study|Withdrawal by Subject|0|||
145390088|NCT01421641|524283679|FG000|Overall Study|Protocol Violation|2|||
145390089|NCT01421641|524283680|FG001|Overall Study|Protocol Violation|2|||
145390090|NCT02959918|524283682|FG000|Overall Study|Adverse Event|1|||
145390091|NCT02959918|524283683|FG001|Overall Study|Adverse Event|1|||
145390092|NCT02959918|524283684|FG002|Overall Study|Adverse Event|2|||
145390093|NCT02959918|524283685|FG003|Overall Study|Adverse Event|0|||
145390094|NCT02959918|524283686|FG004|Overall Study|Adverse Event|0|||
145390095|NCT02959918|524283687|FG005|Overall Study|Adverse Event|2|||
145390096|NCT02959918|524283688|FG006|Overall Study|Adverse Event|2|||
145390097|NCT02959918|524283689|FG007|Overall Study|Adverse Event|1|||
145390098|NCT02959918|524283690|FG008|Overall Study|Adverse Event|2|||
145390099|NCT02959918|524283691|FG009|Overall Study|Adverse Event|1|||
145390100|NCT02959918|524283692|FG010|Overall Study|Adverse Event|1|||
145390101|NCT02959918|524283693|FG011|Overall Study|Adverse Event|3|||
145390102|NCT02959918|524283694|FG012|Overall Study|Adverse Event|2|||
145390103|NCT02959918|524283695|FG013|Overall Study|Adverse Event|4|||
145390104|NCT02959918|524283682|FG000|Overall Study|Lost to Follow-up|0|||
145390105|NCT02959918|524283683|FG001|Overall Study|Lost to Follow-up|0|||
145390106|NCT02959918|524283684|FG002|Overall Study|Lost to Follow-up|0|||
145390107|NCT02959918|524283685|FG003|Overall Study|Lost to Follow-up|0|||
145390108|NCT02959918|524283686|FG004|Overall Study|Lost to Follow-up|0|||
145390109|NCT02959918|524283687|FG005|Overall Study|Lost to Follow-up|0|||
145390110|NCT02959918|524283688|FG006|Overall Study|Lost to Follow-up|0|||
145390111|NCT02959918|524283689|FG007|Overall Study|Lost to Follow-up|0|||
145390112|NCT02959918|524283690|FG008|Overall Study|Lost to Follow-up|0|||
145390113|NCT02959918|524283691|FG009|Overall Study|Lost to Follow-up|1|||
145390114|NCT02959918|524283692|FG010|Overall Study|Lost to Follow-up|0|||
145390115|NCT02959918|524283693|FG011|Overall Study|Lost to Follow-up|0|||
145390116|NCT02959918|524283694|FG012|Overall Study|Lost to Follow-up|1|||
145390117|NCT02959918|524283695|FG013|Overall Study|Lost to Follow-up|0|||
145390118|NCT02959918|524283682|FG000|Overall Study|Withdrawal by Subject|0|||
145390119|NCT02959918|524283683|FG001|Overall Study|Withdrawal by Subject|0|||
145390120|NCT02959918|524283684|FG002|Overall Study|Withdrawal by Subject|1|||
145390121|NCT02959918|524283685|FG003|Overall Study|Withdrawal by Subject|2|||
145390122|NCT02959918|524283686|FG004|Overall Study|Withdrawal by Subject|0|||
145390123|NCT02959918|524283687|FG005|Overall Study|Withdrawal by Subject|0|||
145390124|NCT02959918|524283688|FG006|Overall Study|Withdrawal by Subject|1|||
145390125|NCT02959918|524283689|FG007|Overall Study|Withdrawal by Subject|0|||
145390126|NCT02959918|524283690|FG008|Overall Study|Withdrawal by Subject|1|||
145390127|NCT02959918|524283691|FG009|Overall Study|Withdrawal by Subject|1|||
145390128|NCT02959918|524283692|FG010|Overall Study|Withdrawal by Subject|2|||
145390129|NCT02959918|524283693|FG011|Overall Study|Withdrawal by Subject|3|||
145390130|NCT02959918|524283694|FG012|Overall Study|Withdrawal by Subject|1|||
145390131|NCT02959918|524283695|FG013|Overall Study|Withdrawal by Subject|1|||
145390132|NCT02959918|524283682|FG000|Overall Study|Protocol Violation|0|||
145390133|NCT02959918|524283683|FG001|Overall Study|Protocol Violation|0|||
145390134|NCT02959918|524283684|FG002|Overall Study|Protocol Violation|1|||
145390135|NCT02959918|524283685|FG003|Overall Study|Protocol Violation|0|||
145390136|NCT02959918|524283686|FG004|Overall Study|Protocol Violation|0|||
145390137|NCT02959918|524283687|FG005|Overall Study|Protocol Violation|1|||
145390138|NCT02959918|524283688|FG006|Overall Study|Protocol Violation|0|||
145390139|NCT02959918|524283689|FG007|Overall Study|Protocol Violation|0|||
145390140|NCT02959918|524283690|FG008|Overall Study|Protocol Violation|2|||
145390141|NCT02959918|524283691|FG009|Overall Study|Protocol Violation|1|||
145390142|NCT02959918|524283692|FG010|Overall Study|Protocol Violation|0|||
145390143|NCT02959918|524283693|FG011|Overall Study|Protocol Violation|1|||
145390144|NCT02959918|524283694|FG012|Overall Study|Protocol Violation|1|||
145390145|NCT02959918|524283695|FG013|Overall Study|Protocol Violation|0|||
145390146|NCT02959918|524283682|FG000|Overall Study|Stopping Rule Met|1|||
145390147|NCT02959918|524283683|FG001|Overall Study|Stopping Rule Met|0|||
145390148|NCT02959918|524283684|FG002|Overall Study|Stopping Rule Met|3|||
145729458|NCT01193920|525527474|FG000|Overall Study|Protocol Violation|1|||
145390149|NCT02959918|524283685|FG003|Overall Study|Stopping Rule Met|4|||
145390150|NCT02959918|524283686|FG004|Overall Study|Stopping Rule Met|5|||
145390151|NCT02959918|524283687|FG005|Overall Study|Stopping Rule Met|3|||
145390152|NCT02959918|524283688|FG006|Overall Study|Stopping Rule Met|2|||
145390153|NCT02959918|524283689|FG007|Overall Study|Stopping Rule Met|4|||
145390154|NCT02959918|524283690|FG008|Overall Study|Stopping Rule Met|1|||
145390155|NCT02959918|524283691|FG009|Overall Study|Stopping Rule Met|1|||
145390156|NCT02959918|524283692|FG010|Overall Study|Stopping Rule Met|3|||
145390157|NCT02959918|524283693|FG011|Overall Study|Stopping Rule Met|5|||
145390158|NCT02959918|524283694|FG012|Overall Study|Stopping Rule Met|2|||
145729459|NCT01193920|525527475|FG001|Overall Study|Protocol Violation|0|||
145390159|NCT02959918|524283695|FG013|Overall Study|Stopping Rule Met|1|||
145390160|NCT02959918|524283682|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
145390161|NCT02959918|524283683|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
145390162|NCT02959918|524283684|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
145390163|NCT02959918|524283685|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
145390164|NCT02959918|524283686|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390165|NCT02959918|524283687|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145495188|NCT00945009|524670294|FG002|Overall Study|Withdrawal by Subject|0|||
145495189|NCT00945009|524670292|FG000|Overall Study|Ineligible|6|||
145495190|NCT00945009|524670293|FG001|Overall Study|Ineligible|1|||
145495191|NCT00945009|524670294|FG002|Overall Study|Ineligible|0|||
145495192|NCT00945009|524670292|FG000|Overall Study|Inevaluable|0|||
145495193|NCT00945009|524670293|FG001|Overall Study|Inevaluable|1|||
145495194|NCT00945009|524670294|FG002|Overall Study|Inevaluable|0|||
145495195|NCT00945009|524670292|FG000|Overall Study|Refusal of further protocol|1|||
145495196|NCT00945009|524670293|FG001|Overall Study|Refusal of further protocol|0|||
145495197|NCT00945009|524670294|FG002|Overall Study|Refusal of further protocol|0|||
145495198|NCT04886154|524670295|FG000|Overall Study|Adverse Event|0|||
145495199|NCT04886154|524670296|FG001|Overall Study|Adverse Event|0|||
145495200|NCT04886154|524670297|FG002|Overall Study|Adverse Event|0|||
145495201|NCT04886154|524670298|FG003|Overall Study|Adverse Event|0|||
145495202|NCT04886154|524670299|FG004|Overall Study|Adverse Event|1|||
145495203|NCT04886154|524670300|FG005|Overall Study|Adverse Event|0|||
145495204|NCT04886154|524670301|FG006|Overall Study|Adverse Event|0|||
145495205|NCT04886154|524670302|FG007|Overall Study|Adverse Event|1|||
145495206|NCT04886154|524670303|FG008|Overall Study|Adverse Event|1|||
145495207|NCT04886154|524670304|FG009|Overall Study|Adverse Event|0|||
145495208|NCT04886154|524670305|FG010|Overall Study|Adverse Event|0|||
145495209|NCT04886154|524670306|FG011|Overall Study|Adverse Event|1|||
145495210|NCT04886154|524670307|FG012|Overall Study|Adverse Event|0|||
145495211|NCT04886154|524670308|FG013|Overall Study|Adverse Event|0|||
145495212|NCT04886154|524670309|FG014|Overall Study|Adverse Event|3|||
145495213|NCT04886154|524670295|FG000|Overall Study|Lost to Follow-up|1|||
145495214|NCT04886154|524670296|FG001|Overall Study|Lost to Follow-up|0|||
145495215|NCT04886154|524670297|FG002|Overall Study|Lost to Follow-up|2|||
145495216|NCT04886154|524670298|FG003|Overall Study|Lost to Follow-up|0|||
145495217|NCT04886154|524670299|FG004|Overall Study|Lost to Follow-up|17|||
145495218|NCT04886154|524670300|FG005|Overall Study|Lost to Follow-up|7|||
145495219|NCT04886154|524670301|FG006|Overall Study|Lost to Follow-up|8|||
145495220|NCT04886154|524670302|FG007|Overall Study|Lost to Follow-up|7|||
145495221|NCT04886154|524670303|FG008|Overall Study|Lost to Follow-up|8|||
145495222|NCT04886154|524670304|FG009|Overall Study|Lost to Follow-up|0|||
145495223|NCT04886154|524670305|FG010|Overall Study|Lost to Follow-up|2|||
145495224|NCT04886154|524670306|FG011|Overall Study|Lost to Follow-up|0|||
145495225|NCT04886154|524670307|FG012|Overall Study|Lost to Follow-up|0|||
145495226|NCT04886154|524670308|FG013|Overall Study|Lost to Follow-up|0|||
145495227|NCT04886154|524670309|FG014|Overall Study|Lost to Follow-up|0|||
145495228|NCT04886154|524670295|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495229|NCT04886154|524670296|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495230|NCT04886154|524670297|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495231|NCT04886154|524670298|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495232|NCT04886154|524670299|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495233|NCT04886154|524670300|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495234|NCT04886154|524670301|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
145495235|NCT04886154|524670302|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495236|NCT04886154|524670303|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495237|NCT04886154|524670304|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495238|NCT04886154|524670305|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495239|NCT04886154|524670306|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495240|NCT04886154|524670307|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495241|NCT04886154|524670308|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495242|NCT04886154|524670309|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
145495243|NCT04886154|524670295|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495244|NCT04886154|524670296|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495245|NCT04886154|524670297|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495246|NCT04886154|524670298|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495247|NCT04886154|524670299|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145495248|NCT04886154|524670300|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495249|NCT04886154|524670301|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145495250|NCT04886154|524670302|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145390166|NCT02959918|524283688|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145495251|NCT04886154|524670303|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495252|NCT04886154|524670304|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145605894|NCT00633932|525073034|FG000|Overall Study|Physician Decision|0|||
145390167|NCT02959918|524283689|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390168|NCT02959918|524283690|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390169|NCT02959918|524283691|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390170|NCT02959918|524283692|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390171|NCT02959918|524283693|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390172|NCT02959918|524283694|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390173|NCT02959918|524283695|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
145390174|NCT02959918|524283682|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390175|NCT02959918|524283683|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390176|NCT02959918|524283684|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390177|NCT02959918|524283685|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390178|NCT02959918|524283686|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390179|NCT02959918|524283687|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390180|NCT02959918|524283688|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390181|NCT02959918|524283689|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
145390182|NCT02959918|524283690|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390183|NCT02959918|524283691|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390184|NCT02959918|524283692|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390185|NCT02959918|524283693|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390186|NCT02959918|524283694|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390187|NCT02959918|524283695|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
145390188|NCT02959918|524283682|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390189|NCT02959918|524283683|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390190|NCT02959918|524283684|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145729460|NCT01193920|525527476|FG002|Overall Study|Protocol Violation|0|||
145729461|NCT01193920|525527477|FG003|Overall Study|Protocol Violation|0|||
145729462|NCT01193920|525527478|FG004|Overall Study|Protocol Violation|0|||
145729463|NCT01193920|525527479|FG005|Overall Study|Protocol Violation|0|||
145729464|NCT01193920|525527480|FG006|Overall Study|Protocol Violation|0|||
145729465|NCT01193920|525527481|FG007|Overall Study|Protocol Violation|0|||
145729466|NCT01193920|525527482|FG008|Overall Study|Protocol Violation|0|||
145729467|NCT01193920|525527483|FG009|Overall Study|Protocol Violation|0|||
145729468|NCT01193920|525527474|FG000|Overall Study|Death|0|||
145729469|NCT01193920|525527475|FG001|Overall Study|Death|0|||
145729470|NCT01193920|525527476|FG002|Overall Study|Death|0|||
145729471|NCT01193920|525527477|FG003|Overall Study|Death|1|||
145729472|NCT01193920|525527478|FG004|Overall Study|Death|0|||
145729473|NCT01193920|525527479|FG005|Overall Study|Death|0|||
145729474|NCT01193920|525527480|FG006|Overall Study|Death|2|||
145729475|NCT01193920|525527481|FG007|Overall Study|Death|3|||
145729476|NCT01193920|525527482|FG008|Overall Study|Death|2|||
145729477|NCT01193920|525527483|FG009|Overall Study|Death|4|||
145729478|NCT01193920|525527474|FG000|Overall Study|Unable to classify|0|||
145729479|NCT01193920|525527475|FG001|Overall Study|Unable to classify|0|||
145729480|NCT01193920|525527476|FG002|Overall Study|Unable to classify|0|||
145729481|NCT01193920|525527477|FG003|Overall Study|Unable to classify|1|||
145729482|NCT01193920|525527478|FG004|Overall Study|Unable to classify|0|||
145729483|NCT01193920|525527479|FG005|Overall Study|Unable to classify|0|||
145729484|NCT01193920|525527480|FG006|Overall Study|Unable to classify|0|||
145729485|NCT01193920|525527481|FG007|Overall Study|Unable to classify|1|||
145729486|NCT01193920|525527482|FG008|Overall Study|Unable to classify|0|||
145729487|NCT01193920|525527483|FG009|Overall Study|Unable to classify|0|||
145729488|NCT00494481|525527484|FG000|Overall Study|Condition under investigation worsened|11|||
145729489|NCT00494481|525527485|FG001|Overall Study|Condition under investigation worsened|13|||
145729490|NCT00494481|525527484|FG000|Overall Study|Adverse Event|15|||
145729491|NCT00494481|525527485|FG001|Overall Study|Adverse Event|11|||
145729492|NCT00494481|525527484|FG000|Overall Study|Other|1|||
145729493|NCT00494481|525527485|FG001|Overall Study|Other|0|||
145729494|NCT00494481|525527484|FG000|Overall Study|Never received IP|2|||
145729495|NCT00494481|525527485|FG001|Overall Study|Never received IP|0|||
145729496|NCT01030198|525527486|FG000|Overall Study|Could not measure efficacy accurately|0|||
145729497|NCT01030198|525527487|FG001|Overall Study|Could not measure efficacy accurately|7|||
145729498|NCT00332189|525527488|FG000|Overall Study|Adverse Event|3|||
145729499|NCT00332189|525527488|FG000|Overall Study|Uncooperative/Noncompliant|3|||
145729500|NCT00332189|525527488|FG000|Overall Study|Withdrawal by Subject|9|||
145729501|NCT00332189|525527488|FG000|Overall Study|Lack of Efficacy|4|||
145729502|NCT00332189|525527488|FG000|Overall Study|Moved out of country|2|||
145729503|NCT02370043|525527489|FG000|Overall Study|Withdrawal by Subject|0|||
145729504|NCT02370043|525527490|FG001|Overall Study|Withdrawal by Subject|0|||
145729505|NCT02370043|525527491|FG002|Overall Study|Withdrawal by Subject|0|||
145729506|NCT02370043|525527492|FG003|Overall Study|Withdrawal by Subject|0|||
145266640|NCT04668066|523825250|FG013|Part 1: Treatment Phase|Other|0|||
145729507|NCT02370043|525527493|FG004|Overall Study|Withdrawal by Subject|1|||
145390191|NCT02959918|524283685|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390192|NCT02959918|524283686|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390193|NCT02959918|524283687|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390194|NCT02959918|524283688|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390195|NCT02959918|524283689|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390196|NCT02959918|524283690|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
145390197|NCT02959918|524283691|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390198|NCT02959918|524283692|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390199|NCT02959918|524283693|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390200|NCT02959918|524283694|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390201|NCT02959918|524283695|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
145390202|NCT02959918|524283682|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390203|NCT02959918|524283683|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390204|NCT02959918|524283684|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390205|NCT02959918|524283685|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390206|NCT02959918|524283686|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390207|NCT02959918|524283687|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390208|NCT02959918|524283688|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390209|NCT02959918|524283689|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390210|NCT02959918|524283690|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390211|NCT02959918|524283691|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
145390212|NCT02959918|524283692|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390213|NCT02959918|524283693|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390214|NCT02959918|524283694|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390215|NCT02959918|524283695|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
145390216|NCT02420119|524283696|FG000|Overall Study|insufficient laboratory data|5|||
145390217|NCT02364388|524283697|FG000|Overall Study|Protocol Violation|1|||
145390218|NCT02364388|524283697|FG000|Overall Study|Technical Failure|3|||
145390219|NCT02364388|524283697|FG000|Overall Study|No OA/US data|2|||
145390220|NCT02364388|524283697|FG000|Overall Study|No Biopsy|2|||
145390221|NCT03231306|524283698|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
145390222|NCT03231306|524283698|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
145390223|NCT03231306|524283698|FG000|Overall Study|Treatment delay > 21 days|2|||
145390224|NCT03231306|524283698|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
145390225|NCT03231306|524283698|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
145390226|NCT03231306|524283698|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
145390227|NCT03231306|524283698|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
145390228|NCT03231306|524283698|FG000|Overall Study|More than 1 Reason|2|||
145390229|NCT05464420|524283702|FG000|Overall Study|Death|0|||
145390230|NCT05464420|524283703|FG001|Overall Study|Death|0|||
145390231|NCT05464420|524283704|FG002|Overall Study|Death|0|||
145390232|NCT05464420|524283705|FG003|Overall Study|Death|1|||
145390233|NCT05464420|524283702|FG000|Overall Study|Lost to Follow-up|16|||
145390234|NCT05464420|524283703|FG001|Overall Study|Lost to Follow-up|11|||
145390235|NCT05464420|524283704|FG002|Overall Study|Lost to Follow-up|11|||
145390236|NCT05464420|524283705|FG003|Overall Study|Lost to Follow-up|11|||
145390237|NCT05464420|524283702|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
145390238|NCT05464420|524283703|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
145390239|NCT05464420|524283704|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
145729508|NCT02370043|525527494|FG005|Overall Study|Withdrawal by Subject|1|||
145729509|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
145729510|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
145729511|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
145729512|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
145729513|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
145729514|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
145729515|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
145729516|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
145729517|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
145729518|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
145729519|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
145729520|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
145390240|NCT05464420|524283705|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
145390241|NCT05464420|524283702|FG000|Overall Study|Withdrawal by Subject|4|||
145390242|NCT05464420|524283703|FG001|Overall Study|Withdrawal by Subject|8|||
145390243|NCT05464420|524283704|FG002|Overall Study|Withdrawal by Subject|3|||
145390244|NCT05464420|524283705|FG003|Overall Study|Withdrawal by Subject|1|||
145390245|NCT05464420|524283702|FG000|Overall Study|Protocol Violation|0|||
145390246|NCT05464420|524283703|FG001|Overall Study|Protocol Violation|0|||
145390247|NCT05464420|524283704|FG002|Overall Study|Protocol Violation|1|||
145390248|NCT05464420|524283705|FG003|Overall Study|Protocol Violation|1|||
145390249|NCT05464420|524283702|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
145390250|NCT05464420|524283703|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
145390251|NCT05464420|524283704|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
145390252|NCT05464420|524283705|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
145390253|NCT01383018|524283706|FG000|Overall Study|Adverse Event|14|||
145390254|NCT01383018|524283706|FG000|Overall Study|Death|10|||
145390255|NCT01383018|524283706|FG000|Overall Study|Lost to Follow-up|5|||
145390256|NCT01383018|524283706|FG000|Overall Study|Physician Decision|5|||
145390257|NCT01383018|524283706|FG000|Overall Study|Withdrawal by Subject|9|||
145390258|NCT01383018|524283706|FG000|Overall Study|Subject not implanted|76|||
145390259|NCT01383018|524283706|FG000|Overall Study|Missed Visit|247|||
145390260|NCT01383018|524283706|FG000|Overall Study|Site closed early-not compliance related|7|||
145390261|NCT01383018|524283706|FG000|Overall Study|Patient moved away from site|1|||
145390262|NCT01383018|524283706|FG000|Overall Study|Subject Incarcerated|1|||
145390263|NCT03414229|524283707|FG000|Overall Study|Adverse Event|1|||
145390264|NCT03414229|524283708|FG001|Overall Study|Adverse Event|0|||
145390265|NCT03414229|524283709|FG002|Overall Study|Adverse Event|2|||
145390266|NCT03414229|524283710|FG003|Overall Study|Adverse Event|1|||
145390267|NCT03414229|524283707|FG000|Overall Study|Lack of Efficacy|7|||
145390268|NCT03414229|524283708|FG001|Overall Study|Lack of Efficacy|4|||
145390269|NCT03414229|524283709|FG002|Overall Study|Lack of Efficacy|1|||
145390270|NCT03414229|524283710|FG003|Overall Study|Lack of Efficacy|9|||
145390271|NCT03414229|524283707|FG000|Overall Study|Change in therapy|1|||
145390272|NCT03414229|524283708|FG001|Overall Study|Change in therapy|0|||
145390273|NCT03414229|524283709|FG002|Overall Study|Change in therapy|0|||
145390274|NCT03414229|524283710|FG003|Overall Study|Change in therapy|0|||
145390275|NCT03414229|524283707|FG000|Overall Study|Pregnancy|0|||
145390276|NCT03414229|524283708|FG001|Overall Study|Pregnancy|0|||
145390277|NCT03414229|524283709|FG002|Overall Study|Pregnancy|1|||
145390278|NCT03414229|524283710|FG003|Overall Study|Pregnancy|0|||
145390279|NCT03414229|524283707|FG000|Overall Study|Withdrawal by Subject|0|||
145390280|NCT03414229|524283708|FG001|Overall Study|Withdrawal by Subject|1|||
145390281|NCT03414229|524283709|FG002|Overall Study|Withdrawal by Subject|1|||
145390282|NCT03414229|524283710|FG003|Overall Study|Withdrawal by Subject|0|||
145390283|NCT04533438|524283714|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
145390284|NCT04533438|524283715|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
145390285|NCT05568797|524283719|FG000|Overall Study|Adverse Event|0|||
145390286|NCT05568797|524283720|FG001|Overall Study|Adverse Event|8|||
145390287|NCT05568797|524283719|FG000|Overall Study|Lost to Follow-up|2|||
145390288|NCT05568797|524283720|FG001|Overall Study|Lost to Follow-up|3|||
145390289|NCT05568797|524283719|FG000|Overall Study|Withdrawal by Subject|1|||
145390290|NCT05568797|524283720|FG001|Overall Study|Withdrawal by Subject|10|||
145729521|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
145729522|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
145729523|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
145729524|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
145729525|NCT01231516|525527495|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
145390291|NCT05568797|524283719|FG000|Overall Study|Other|2|||
145390292|NCT05568797|524283720|FG001|Overall Study|Other|2|||
145390293|NCT00099632|524283721|FG000|Overall Study|Lost to Follow-up|1|||
145390294|NCT00099632|524283722|FG001|Overall Study|Lost to Follow-up|0|||
145390295|NCT00099632|524283723|FG002|Overall Study|Lost to Follow-up|3|||
145390296|NCT00099632|524283724|FG003|Overall Study|Lost to Follow-up|1|||
145390297|NCT00099632|524283725|FG004|Overall Study|Lost to Follow-up|1|||
145390298|NCT00099632|524283726|FG005|Overall Study|Lost to Follow-up|0|||
145729526|NCT01231516|525527496|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
145390299|NCT00099632|524283721|FG000|Overall Study|Withdrawal by Subject|0|||
145390300|NCT00099632|524283722|FG001|Overall Study|Withdrawal by Subject|1|||
145390301|NCT00099632|524283723|FG002|Overall Study|Withdrawal by Subject|0|||
145390302|NCT00099632|524283724|FG003|Overall Study|Withdrawal by Subject|0|||
145390303|NCT00099632|524283725|FG004|Overall Study|Withdrawal by Subject|0|||
145390304|NCT00099632|524283726|FG005|Overall Study|Withdrawal by Subject|1|||
145390305|NCT00099632|524283721|FG000|Overall Study|Protocol Violation|0|||
145390306|NCT00099632|524283722|FG001|Overall Study|Protocol Violation|0|||
145390307|NCT00099632|524283723|FG002|Overall Study|Protocol Violation|0|||
145390308|NCT00099632|524283724|FG003|Overall Study|Protocol Violation|0|||
145390309|NCT00099632|524283725|FG004|Overall Study|Protocol Violation|0|||
145390310|NCT00099632|524283726|FG005|Overall Study|Protocol Violation|1|||
145390311|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
145390312|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
145390313|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
145390314|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
145390315|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
145390316|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
145390317|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
145390318|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
145390319|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
145390320|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
145390321|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
145390322|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
145390323|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
145390324|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
145390325|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
145390326|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
145390327|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
145390328|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145390329|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145390330|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
145390331|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
145390332|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145390333|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145390334|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145390335|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
145390336|NCT02137226|524283749|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
145390337|NCT02137226|524283750|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
145390338|NCT02137226|524283751|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
145390339|NCT02137226|524283752|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
145390340|NCT02137226|524283753|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
145390341|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
145390342|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
145390343|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
145390344|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
145390345|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
145390346|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
145390347|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
145390348|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
145390349|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
145390350|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
145390351|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
145390352|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
145390353|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
145390354|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
145390355|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
145390356|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145390357|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145390358|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
145390359|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145390360|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
145390361|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145390362|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145390363|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
145390364|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145390365|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
145390366|NCT02137226|524283749|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
145390367|NCT02137226|524283750|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
145390368|NCT02137226|524283751|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
145390369|NCT02137226|524283752|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
145390370|NCT02137226|524283753|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
145390371|NCT02998996|524283754|FG000|Overall Study|Lost to Follow-up|0|||
145390372|NCT02998996|524283755|FG001|Overall Study|Lost to Follow-up|0|||
145390373|NCT02998996|524283756|FG002|Overall Study|Lost to Follow-up|1|||
145390374|NCT02998996|524283757|FG003|Overall Study|Lost to Follow-up|0|||
145390375|NCT02998996|524283758|FG004|Overall Study|Lost to Follow-up|0|||
145729527|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
145729528|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
145390376|NCT02998996|524283759|FG005|Overall Study|Lost to Follow-up|0|||
145390377|NCT02998996|524283754|FG000|Overall Study|Pregnancy|0|||
145390378|NCT02998996|524283755|FG001|Overall Study|Pregnancy|1|||
145390379|NCT02998996|524283756|FG002|Overall Study|Pregnancy|0|||
145390380|NCT02998996|524283757|FG003|Overall Study|Pregnancy|0|||
145390381|NCT02998996|524283758|FG004|Overall Study|Pregnancy|0|||
145390382|NCT02998996|524283759|FG005|Overall Study|Pregnancy|0|||
145390383|NCT02998996|524283754|FG000|Overall Study|Family reasons|0|||
145390384|NCT02998996|524283755|FG001|Overall Study|Family reasons|0|||
145390385|NCT02998996|524283756|FG002|Overall Study|Family reasons|0|||
145390386|NCT02998996|524283757|FG003|Overall Study|Family reasons|0|||
145390387|NCT02998996|524283758|FG004|Overall Study|Family reasons|1|||
145390388|NCT02998996|524283759|FG005|Overall Study|Family reasons|0|||
145390389|NCT01398358|524283764|FG000|Overall Study|Lost to Follow-up|11|||
145390390|NCT01398358|524283765|FG001|Overall Study|Lost to Follow-up|21|||
145390391|NCT01398358|524283766|FG002|Overall Study|Lost to Follow-up|18|||
145390392|NCT01398358|524283764|FG000|Overall Study|Withdrawal by Subject|3|||
145390393|NCT01398358|524283765|FG001|Overall Study|Withdrawal by Subject|2|||
145390394|NCT01398358|524283766|FG002|Overall Study|Withdrawal by Subject|2|||
145390395|NCT01398358|524283764|FG000|Overall Study|no longer eligible|1|||
145390396|NCT01398358|524283765|FG001|Overall Study|no longer eligible|0|||
145390397|NCT01398358|524283766|FG002|Overall Study|no longer eligible|1|||
145390398|NCT00003896|524283767|FG000|Overall Study|Adverse Event|16|||
145390399|NCT00003896|524283767|FG000|Overall Study|Withdrawal by Subject|1|||
145390400|NCT00003896|524283767|FG000|Overall Study|Lack of Efficacy|1|||
145390401|NCT00003896|524283767|FG000|Overall Study|Death|3|||
145390402|NCT00003896|524283767|FG000|Overall Study|not protocol specified|3|||
145390403|NCT00003896|524283767|FG000|Overall Study|ineligible|5|||
145390404|NCT00985686|524283768|FG000|Overall Study|Lost to Follow-up|1|||
145390405|NCT00985686|524283769|FG001|Overall Study|Lost to Follow-up|1|||
145390406|NCT00985686|524283770|FG002|Overall Study|Lost to Follow-up|0|||
145390407|NCT00985686|524283771|FG003|Overall Study|Lost to Follow-up|2|||
145390408|NCT01670045|524283772|FG000|Overall Study|Withdrawal by Subject|3|||
145390409|NCT01670045|524283772|FG000|Overall Study|Adverse Event|1|||
145390410|NCT01670045|524283772|FG000|Overall Study|Death|1|||
145390411|NCT01670045|524283772|FG000|Overall Study|Lost to Follow-up|11|||
145390412|NCT03134911|524283773|FG000|Overall Study|Screen failure|31|||
145390413|NCT03134911|524283773|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
145390414|NCT00420628|524283782|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
145390415|NCT00420628|524283783|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
145390416|NCT00420628|524283782|FG000|Overall Study|Lost to Follow-up|3|||
145495253|NCT04886154|524670305|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145390417|NCT00420628|524283783|FG001|Overall Study|Lost to Follow-up|2|||
145390418|NCT00420628|524283782|FG000|Overall Study|Adverse Event|1|||
145390419|NCT00420628|524283783|FG001|Overall Study|Adverse Event|0|||
145390420|NCT00184093|524283790|FG000|Overall Study|Adverse Event|3|||
145390421|NCT00184093|524283790|FG000|Overall Study|Lost to Follow-up|3|||
145390422|NCT00184093|524283790|FG000|Overall Study|Physician Decision|1|||
145390423|NCT00184093|524283790|FG000|Overall Study|Withdrawal by Subject|2|||
145390424|NCT00805129|524283795|FG000|Overall Study|Not treated|1|||
145390425|NCT00571662|524283796|FG000|Overall Study|Withdrawal by Subject|2|||
145390426|NCT00571662|524283796|FG000|Overall Study|psychiatric instability|1|||
145390427|NCT00571662|524283796|FG000|Overall Study|Adverse Event|5|||
145390428|NCT01868165|524283797|FG000|Overall Study|Withdrawal by Subject|36|||
145390429|NCT01868165|524283797|FG000|Overall Study|Physician Decision|2|||
145390430|NCT01868165|524283797|FG000|Overall Study|Lost to Follow-up|3|||
145390431|NCT01868165|524283797|FG000|Overall Study|Death|4|||
145390432|NCT01429298|524283798|FG000|Overall Study|Protocol Violation|4|||
145390433|NCT01429298|524283799|FG001|Overall Study|Protocol Violation|6|||
145390434|NCT01839916|524283800|FG000|Overall Study|Death|9|||
145390435|NCT01839916|524283800|FG000|Overall Study|Physician Decision|17|||
145390436|NCT01839916|524283800|FG000|Overall Study|Relapse|12|||
145390437|NCT01839916|524283800|FG000|Overall Study|GVHD|2|||
145390438|NCT01839916|524283800|FG000|Overall Study|Graft Failure|1|||
145390439|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
145390440|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145390441|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145390442|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
145390443|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
145390444|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145390445|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145390446|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
145390447|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
145390448|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
145390449|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
145390450|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
145390451|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
145390452|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
145390453|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
145390454|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
145390455|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
145390456|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145390457|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145390458|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
145390459|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
145390460|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145390461|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145390462|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
145390463|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
145390464|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145390465|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145390466|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
145390467|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
145390468|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145390469|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145390470|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
145390471|NCT03538691|524283803|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
145390472|NCT03538691|524283804|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
145390473|NCT03538691|524283805|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
145390474|NCT03538691|524283806|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
145390475|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145390476|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
145390477|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145390478|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
145390479|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145390480|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
145390481|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145390482|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
145390483|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145390484|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
145390485|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145390486|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
145390487|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
145390488|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
145390489|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
145390490|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
145390491|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
145390492|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
145390493|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
145390494|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
145390495|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
145390496|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
145390497|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
145390498|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
145390499|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145390500|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
145390501|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145390502|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
145390503|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145390504|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
145390505|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145390506|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
145390507|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145390508|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
145390509|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145390510|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
145390511|NCT03538691|524283803|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145390512|NCT03538691|524283804|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
145390513|NCT03538691|524283805|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145390514|NCT03538691|524283806|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145390515|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
145390516|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
145390517|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
145390518|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
145390519|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
145390520|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
145390521|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
145390522|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
145390523|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
145390524|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
145390525|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
145390526|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
145390527|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
145390528|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
145390529|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
145390530|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
145390531|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
145390532|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
145390533|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
145390534|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
145390535|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145390536|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145729529|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
145729530|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
145729531|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
145729532|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
145729533|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
145729534|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
145729535|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
145729536|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
145729537|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
145729538|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
145729539|NCT01231516|525527495|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
145729540|NCT01231516|525527496|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
145729541|NCT05266586|525527497|FG000|Overall Study|Adverse Event|2|||
145390537|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
145390538|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
145390539|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
145390540|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
145390541|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
145390542|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
145390543|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
145390544|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
145390545|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
145390546|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
145390547|NCT03538691|524283803|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145729542|NCT05266586|525527498|FG001|Overall Study|Adverse Event|2|||
145729543|NCT05266586|525527499|FG002|Overall Study|Adverse Event|1|||
145729544|NCT05266586|525527497|FG000|Overall Study|Withdrawal by Subject|1|||
145729545|NCT05266586|525527498|FG001|Overall Study|Withdrawal by Subject|0|||
145729546|NCT05266586|525527499|FG002|Overall Study|Withdrawal by Subject|1|||
145729547|NCT05266586|525527497|FG000|Overall Study|Non-compliance with study drug|0|||
145729548|NCT05266586|525527498|FG001|Overall Study|Non-compliance with study drug|1|||
145729549|NCT05266586|525527499|FG002|Overall Study|Non-compliance with study drug|0|||
145729550|NCT05266586|525527497|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
145729551|NCT05266586|525527498|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
145729552|NCT05266586|525527499|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
145729553|NCT03707925|525527500|FG000|Overall Study|Inevaluable|1|||
145729554|NCT01117857|525527503|FG000|Overall Study|Lost to Follow-up|4|||
145729555|NCT01117857|525527503|FG000|Overall Study|Withdrawal by Subject|4|||
145729556|NCT01117857|525527503|FG000|Overall Study|Physician Decision|1|||
145729557|NCT02876835|525527504|FG000|Treatment Period (51.1 Month)|Other|1|||
145729558|NCT02876835|525527505|FG001|Treatment Period (51.1 Month)|Other|0|||
145729559|NCT02876835|525527504|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
145729560|NCT02876835|525527505|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
145729561|NCT02876835|525527504|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
145729562|NCT02876835|525527505|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
145729563|NCT02876835|525527504|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
145729564|NCT02876835|525527505|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
145729565|NCT05245097|525527506|FG000|Overall Study|Adverse Event|13|||
145729566|NCT05245097|525527507|FG001|Overall Study|Adverse Event|2|||
145729567|NCT05245097|525527506|FG000|Overall Study|Protocol Violation|8|||
145729568|NCT05245097|525527507|FG001|Overall Study|Protocol Violation|6|||
145729569|NCT05245097|525527506|FG000|Overall Study|Withdrawal by Subject|18|||
145729570|NCT05245097|525527507|FG001|Overall Study|Withdrawal by Subject|0|||
145729571|NCT05245097|525527506|FG000|Overall Study|Death|6|||
145729572|NCT05245097|525527507|FG001|Overall Study|Death|7|||
145729573|NCT05245097|525527506|FG000|Overall Study|Physician Decision|6|||
145729574|NCT05245097|525527507|FG001|Overall Study|Physician Decision|0|||
145729575|NCT05245097|525527506|FG000|Overall Study|Relocation|4|||
145729576|NCT05245097|525527507|FG001|Overall Study|Relocation|3|||
145729577|NCT04683731|525527512|FG000|Overall Study|Withdrawal by Subject|1|||
145729578|NCT04683731|525527513|FG001|Overall Study|Withdrawal by Subject|0|||
145729579|NCT04683731|525527514|FG002|Overall Study|Withdrawal by Subject|3|||
145729580|NCT04683731|525527515|FG003|Overall Study|Withdrawal by Subject|2|||
145729581|NCT04683731|525527512|FG000|Overall Study|Determined patient was not eligible|3|||
145729582|NCT04683731|525527513|FG001|Overall Study|Determined patient was not eligible|3|||
145729583|NCT04683731|525527514|FG002|Overall Study|Determined patient was not eligible|12|||
145729584|NCT04683731|525527515|FG003|Overall Study|Determined patient was not eligible|3|||
145729585|NCT00883051|525527517|FG000|Overall Study|Lost to Follow-up|0|||
145729586|NCT00883051|525527518|FG001|Overall Study|Lost to Follow-up|0|||
145729587|NCT00883051|525527519|FG002|Overall Study|Lost to Follow-up|0|||
145729588|NCT00883051|525527520|FG003|Overall Study|Lost to Follow-up|0|||
145729589|NCT00883051|525527521|FG004|Overall Study|Lost to Follow-up|1|||
145729590|NCT00883051|525527517|FG000|Overall Study|Did not use study medication|24|||
145729591|NCT00883051|525527518|FG001|Overall Study|Did not use study medication|22|||
145729592|NCT00883051|525527519|FG002|Overall Study|Did not use study medication|29|||
145390548|NCT03538691|524283804|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
145729593|NCT00883051|525527520|FG003|Overall Study|Did not use study medication|29|||
145729594|NCT00883051|525527521|FG004|Overall Study|Did not use study medication|17|||
145729595|NCT01411839|525527524|FG000|Overall Study|Lost to Follow-up|4|||
145729596|NCT01411839|525527525|FG001|Overall Study|Lost to Follow-up|3|||
145729597|NCT03604523|525527526|FG000|Overall Study|Physician Decision|1|||
145729598|NCT03604523|525527527|FG001|Overall Study|Physician Decision|0|||
145729599|NCT00810394|525527534|FG000|Overall Study|Withdrawal by Subject|3|||
145729600|NCT00467285|525527535|FG000|Overall Study|Lost to Follow-up|4|||
145390549|NCT03538691|524283805|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
145390550|NCT03538691|524283806|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
145390551|NCT01243177|524283809|FG000|Overall Study|Lack of Efficacy|47|||
145390552|NCT01243177|524283810|FG001|Overall Study|Lack of Efficacy|31|||
145390553|NCT01243177|524283809|FG000|Overall Study|Protocol Violation|11|||
145390554|NCT01243177|524283810|FG001|Overall Study|Protocol Violation|10|||
145390555|NCT01243177|524283809|FG000|Overall Study|Lost to Follow-up|15|||
145390556|NCT01243177|524283810|FG001|Overall Study|Lost to Follow-up|18|||
145390557|NCT01243177|524283809|FG000|Overall Study|Withdrawal by Subject|46|||
145390558|NCT01243177|524283810|FG001|Overall Study|Withdrawal by Subject|38|||
145390559|NCT01243177|524283809|FG000|Overall Study|AE, serious fatal|0|||
145390560|NCT01243177|524283810|FG001|Overall Study|AE, serious fatal|1|||
145390561|NCT01243177|524283809|FG000|Overall Study|SAE, non-fatal|7|||
145390562|NCT01243177|524283810|FG001|Overall Study|SAE, non-fatal|9|||
145390563|NCT01243177|524283809|FG000|Overall Study|AE, non-serious non-fatal|40|||
145729601|NCT00467285|525527536|FG001|Overall Study|Lost to Follow-up|4|||
145729602|NCT03891524|525527537|FG000|Overall Study|Death|0|||
145729603|NCT03891524|525527538|FG001|Overall Study|Death|0|||
145729604|NCT03891524|525527539|FG002|Overall Study|Death|0|||
145729605|NCT03891524|525527540|FG003|Overall Study|Death|0|||
145729606|NCT03891524|525527541|FG004|Overall Study|Death|0|||
145729607|NCT03891524|525527542|FG005|Overall Study|Death|0|||
145729608|NCT03891524|525527543|FG006|Overall Study|Death|0|||
145729609|NCT03891524|525527544|FG007|Overall Study|Death|1|||
145729610|NCT03891524|525527537|FG000|Overall Study|Withdrawal by Subject|0|||
145729611|NCT03891524|525527538|FG001|Overall Study|Withdrawal by Subject|1|||
145729612|NCT03891524|525527539|FG002|Overall Study|Withdrawal by Subject|2|||
145729613|NCT03891524|525527540|FG003|Overall Study|Withdrawal by Subject|1|||
145729614|NCT03891524|525527541|FG004|Overall Study|Withdrawal by Subject|2|||
145729615|NCT03891524|525527542|FG005|Overall Study|Withdrawal by Subject|2|||
145729616|NCT03891524|525527543|FG006|Overall Study|Withdrawal by Subject|2|||
145729617|NCT03891524|525527544|FG007|Overall Study|Withdrawal by Subject|1|||
145729618|NCT03231943|525527547|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729619|NCT03231943|525527548|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
145729620|NCT03231943|525527549|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
145729621|NCT03231943|525527550|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729622|NCT03231943|525527551|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729623|NCT03231943|525527552|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729624|NCT03231943|525527553|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729625|NCT03231943|525527554|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729626|NCT03231943|525527555|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729627|NCT03231943|525527556|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729628|NCT03231943|525527557|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729629|NCT03231943|525527558|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729630|NCT03231943|525527559|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
145729631|NCT03231943|525527547|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729632|NCT03231943|525527548|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
145729633|NCT03231943|525527549|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729634|NCT03231943|525527550|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729635|NCT03231943|525527551|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729636|NCT03231943|525527552|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729637|NCT03231943|525527553|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729638|NCT03231943|525527554|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729639|NCT03231943|525527555|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729640|NCT03231943|525527556|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729641|NCT03231943|525527557|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729642|NCT03231943|525527558|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729643|NCT03231943|525527559|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
145729644|NCT03231943|525527547|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
145729645|NCT03231943|525527548|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729646|NCT03231943|525527549|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729647|NCT03231943|525527550|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145390564|NCT01243177|524283810|FG001|Overall Study|AE, non-serious non-fatal|58|||
145390565|NCT01243177|524283809|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
145390566|NCT01243177|524283810|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
145729648|NCT03231943|525527551|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729649|NCT03231943|525527552|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729650|NCT03231943|525527553|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729651|NCT03231943|525527554|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729652|NCT03231943|525527555|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729653|NCT03231943|525527556|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145390567|NCT01243177|524283809|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145390568|NCT01243177|524283810|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
145390569|NCT01243177|524283809|FG000|Overall Study|Other Reason|11|||
145390570|NCT01243177|524283810|FG001|Overall Study|Other Reason|12|||
145390571|NCT05259163|524285186|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
145390572|NCT05259163|524285187|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
145390573|NCT01239394|524285200|FG000|Overall Study|Adverse Event|1|||
145390574|NCT00524771|524285202|FG000|Overall Study|Protocol Violation|220|||
145390575|NCT00524771|524285203|FG001|Overall Study|Protocol Violation|585|||
145390576|NCT01639144|524285204|FG000|Overall Study|Withdrawal by Subject|4|||
145390577|NCT01639144|524285205|FG001|Overall Study|Withdrawal by Subject|2|||
145390578|NCT01639144|524285204|FG000|Overall Study|Physician Decision|2|||
145390579|NCT01639144|524285205|FG001|Overall Study|Physician Decision|0|||
145390580|NCT01639144|524285204|FG000|Overall Study|Met postoperative exclusion criteria|4|||
145390581|NCT01639144|524285205|FG001|Overall Study|Met postoperative exclusion criteria|3|||
145390582|NCT03492437|524285209|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145390583|NCT03492437|524285210|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145390584|NCT02915159|524285211|FG000|Overall Study|Participant no longer meets criteria|2|||
145390585|NCT02915159|524285212|FG001|Overall Study|Participant no longer meets criteria|0|||
145390586|NCT02915159|524285211|FG000|Overall Study|poor/non-compliance|1|||
145390587|NCT02915159|524285212|FG001|Overall Study|poor/non-compliance|0|||
145390588|NCT02915159|524285211|FG000|Overall Study|Participant withdrew consent|5|||
145390589|NCT02915159|524285212|FG001|Overall Study|Participant withdrew consent|1|||
145390590|NCT02915159|524285211|FG000|Overall Study|Request to discontinue treatment|1|||
145390591|NCT02915159|524285212|FG001|Overall Study|Request to discontinue treatment|2|||
145390592|NCT02915159|524285211|FG000|Overall Study|Adverse Event|2|||
145390593|NCT02915159|524285212|FG001|Overall Study|Adverse Event|2|||
145390594|NCT02915159|524285211|FG000|Overall Study|Lack of Efficacy|0|||
145390595|NCT02915159|524285212|FG001|Overall Study|Lack of Efficacy|3|||
145390596|NCT04534517|524285213|FG000|Overall Study|Adverse Event|1|||
145390597|NCT04534517|524285213|FG000|Overall Study|Withdrawal by Subject|1|||
145390598|NCT04534517|524285213|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145390599|NCT04534517|524285213|FG000|Overall Study|COVID-19 Related|1|||
145390600|NCT03872843|524285214|FG000|Overall Study|Lost to Follow-up|5|||
145390601|NCT03872843|524285215|FG001|Overall Study|Lost to Follow-up|7|||
145390602|NCT05133323|524285216|FG000|Overall Study|Lack of Efficacy|0|||
145390603|NCT05133323|524285217|FG001|Overall Study|Lack of Efficacy|0|||
145390604|NCT05133323|524285218|FG002|Overall Study|Lack of Efficacy|1|||
145390605|NCT05133323|524285216|FG000|Overall Study|Withdrawal by Subject|2|||
145390606|NCT05133323|524285217|FG001|Overall Study|Withdrawal by Subject|1|||
145390607|NCT05133323|524285218|FG002|Overall Study|Withdrawal by Subject|0|||
145390608|NCT01714544|524285219|FG000|Overall Study|Lost to Follow-up|1|||
145390609|NCT01714544|524285219|FG000|Overall Study|Physician Decision|1|||
145390610|NCT01714544|524285219|FG000|Overall Study|Withdrawal by Subject|1|||
145390611|NCT00003483|524285228|FG000|Overall Study|Not evaluable|1|||
145390612|NCT01968811|524285229|FG000|Overall Study|Protocol Violation|4|||
145390613|NCT01968811|524285229|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
145390614|NCT01716663|524285231|FG000|Overall Study|Withdrawn prior to procedure|4|||
145390615|NCT01716663|524285231|FG000|Overall Study|Treated with non-study catheter|2|||
145390616|NCT00872521|524285232|FG000|Completed PAD Induction|Patient choice|0|||
145390617|NCT00872521|524285233|FG001|Completed PAD Induction|Patient choice|1|||
145390618|NCT00872521|524285234|FG002|Completed PAD Induction|Patient choice|0|||
145390619|NCT00872521|524285232|FG000|Completed PAD Induction|Disease progression|0|||
145495254|NCT04886154|524670306|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495255|NCT04886154|524670307|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495256|NCT04886154|524670308|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145495257|NCT04886154|524670309|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145495258|NCT04886154|524670295|FG000|Overall Study|Other, Not Specified|0|||
145495259|NCT04886154|524670296|FG001|Overall Study|Other, Not Specified|0|||
145495260|NCT04886154|524670297|FG002|Overall Study|Other, Not Specified|0|||
145495261|NCT04886154|524670298|FG003|Overall Study|Other, Not Specified|0|||
145495262|NCT04886154|524670299|FG004|Overall Study|Other, Not Specified|11|||
145495263|NCT04886154|524670300|FG005|Overall Study|Other, Not Specified|8|||
145495264|NCT04886154|524670301|FG006|Overall Study|Other, Not Specified|9|||
145495265|NCT04886154|524670302|FG007|Overall Study|Other, Not Specified|10|||
145390620|NCT00872521|524285233|FG001|Completed PAD Induction|Disease progression|2|||
145390621|NCT00872521|524285234|FG002|Completed PAD Induction|Disease progression|0|||
145495266|NCT04886154|524670303|FG008|Overall Study|Other, Not Specified|6|||
145495267|NCT04886154|524670304|FG009|Overall Study|Other, Not Specified|1|||
145495268|NCT04886154|524670305|FG010|Overall Study|Other, Not Specified|1|||
145390622|NCT00872521|524285232|FG000|Completed PAD Induction|Adverse Event|4|||
145495269|NCT04886154|524670306|FG011|Overall Study|Other, Not Specified|2|||
145495270|NCT04886154|524670307|FG012|Overall Study|Other, Not Specified|1|||
145390623|NCT00872521|524285233|FG001|Completed PAD Induction|Adverse Event|0|||
145390624|NCT00872521|524285234|FG002|Completed PAD Induction|Adverse Event|0|||
145390625|NCT00872521|524285232|FG000|Completed PAD Induction|Death|1|||
145390626|NCT00872521|524285233|FG001|Completed PAD Induction|Death|1|||
145390627|NCT00872521|524285234|FG002|Completed PAD Induction|Death|0|||
145390628|NCT00872521|524285232|FG000|Primary Endpoint Analysis|Other|1|||
145390629|NCT00872521|524285233|FG001|Primary Endpoint Analysis|Other|2|||
145390630|NCT00872521|524285234|FG002|Primary Endpoint Analysis|Other|0|||
145390631|NCT00872521|524285232|FG000|Primary Endpoint Analysis|Patient choice|0|||
145390632|NCT00872521|524285233|FG001|Primary Endpoint Analysis|Patient choice|1|||
145390633|NCT00872521|524285234|FG002|Primary Endpoint Analysis|Patient choice|0|||
145390634|NCT00872521|524285232|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
145390635|NCT00872521|524285233|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
145390636|NCT00872521|524285234|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
145390637|NCT00872521|524285232|FG000|Primary Endpoint Analysis|Patient response missing|0|||
145390638|NCT00872521|524285233|FG001|Primary Endpoint Analysis|Patient response missing|0|||
145390639|NCT00872521|524285234|FG002|Primary Endpoint Analysis|Patient response missing|1|||
145390640|NCT00872521|524285232|FG000|Completed 3-month Follow up|Other|0|||
145390641|NCT00872521|524285233|FG001|Completed 3-month Follow up|Other|2|||
145390642|NCT00872521|524285234|FG002|Completed 3-month Follow up|Other|0|||
145390643|NCT00872521|524285232|FG000|Completed 3-month Follow up|Physician Decision|0|||
145390644|NCT00872521|524285233|FG001|Completed 3-month Follow up|Physician Decision|1|||
145390645|NCT00872521|524285234|FG002|Completed 3-month Follow up|Physician Decision|0|||
145390646|NCT00872521|524285232|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
145390647|NCT00872521|524285233|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
145390648|NCT00872521|524285234|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
145390649|NCT03006562|524285235|FG000|Overall Study|Lost to Follow-up|0|||
145390650|NCT03006562|524285236|FG001|Overall Study|Lost to Follow-up|1|||
145390651|NCT01089127|524285241|FG000|Overall Study|Adverse Event|5|||
145390652|NCT01089127|524285242|FG001|Overall Study|Adverse Event|1|||
145390653|NCT01089127|524285243|FG002|Overall Study|Adverse Event|1|||
145390654|NCT01089127|524285244|FG003|Overall Study|Adverse Event|0|||
145390655|NCT01089127|524285245|FG004|Overall Study|Adverse Event|0|||
145390656|NCT01089127|524285246|FG005|Overall Study|Adverse Event|1|||
145390657|NCT01089127|524285241|FG000|Overall Study|Subject withdrew consent|0|||
145390658|NCT01089127|524285242|FG001|Overall Study|Subject withdrew consent|1|||
145390659|NCT01089127|524285243|FG002|Overall Study|Subject withdrew consent|1|||
145390660|NCT01089127|524285244|FG003|Overall Study|Subject withdrew consent|1|||
145390661|NCT01089127|524285245|FG004|Overall Study|Subject withdrew consent|0|||
145390662|NCT01089127|524285246|FG005|Overall Study|Subject withdrew consent|2|||
145390663|NCT01089127|524285241|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145390664|NCT01089127|524285242|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145390665|NCT01089127|524285243|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145729654|NCT03231943|525527557|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145390666|NCT01089127|524285244|FG003|Overall Study|Abnormal test procedure result(s)|0|||
145390667|NCT01089127|524285245|FG004|Overall Study|Abnormal test procedure result(s)|0|||
145390668|NCT01089127|524285246|FG005|Overall Study|Abnormal test procedure result(s)|0|||
145390669|NCT01089127|524285241|FG000|Overall Study|Lost to Follow-up|1|||
145390670|NCT01089127|524285242|FG001|Overall Study|Lost to Follow-up|1|||
145390671|NCT01089127|524285243|FG002|Overall Study|Lost to Follow-up|0|||
145390672|NCT01089127|524285244|FG003|Overall Study|Lost to Follow-up|0|||
145390673|NCT01089127|524285245|FG004|Overall Study|Lost to Follow-up|1|||
145390674|NCT01089127|524285246|FG005|Overall Study|Lost to Follow-up|0|||
145729655|NCT03231943|525527558|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729656|NCT03231943|525527559|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
145729657|NCT03231943|525527547|FG000|Part 2|Adverse Event|0|||
145729658|NCT03231943|525527548|FG001|Part 2|Adverse Event|0|||
145729659|NCT03231943|525527549|FG002|Part 2|Adverse Event|0|||
145729660|NCT03231943|525527550|FG003|Part 2|Adverse Event|0|||
145729661|NCT03231943|525527551|FG004|Part 2|Adverse Event|0|||
145729662|NCT03231943|525527552|FG005|Part 2|Adverse Event|0|||
145266641|NCT04668066|523825251|FG014|Part 1: Treatment Phase|Other|0|||
145390675|NCT01089127|524285241|FG000|Overall Study|Protocol deviation|0|||
145390676|NCT01089127|524285242|FG001|Overall Study|Protocol deviation|1|||
145390677|NCT01089127|524285243|FG002|Overall Study|Protocol deviation|0|||
145390678|NCT01089127|524285244|FG003|Overall Study|Protocol deviation|0|||
145390679|NCT01089127|524285245|FG004|Overall Study|Protocol deviation|1|||
145390680|NCT01089127|524285246|FG005|Overall Study|Protocol deviation|0|||
145390681|NCT00511810|524285250|FG000|Overall Study|Lost to Follow-up|1|||
145390682|NCT00511810|524285251|FG001|Overall Study|Lost to Follow-up|2|||
145390683|NCT00511810|524285250|FG000|Overall Study|Lack of Efficacy|0|||
145729663|NCT03231943|525527553|FG006|Part 2|Adverse Event|0|||
145390684|NCT00511810|524285251|FG001|Overall Study|Lack of Efficacy|2|||
145390685|NCT00511810|524285250|FG000|Overall Study|Refused second scn|0|||
145729664|NCT03231943|525527554|FG007|Part 2|Adverse Event|0|||
145729665|NCT03231943|525527555|FG008|Part 2|Adverse Event|0|||
145729666|NCT03231943|525527556|FG009|Part 2|Adverse Event|0|||
145390686|NCT00511810|524285251|FG001|Overall Study|Refused second scn|1|||
145390687|NCT02427841|524285252|FG000|Overall Study|Lack of Efficacy|5|||
145390688|NCT02427841|524285252|FG000|Overall Study|Physician Decision|2|||
145390689|NCT02427841|524285252|FG000|Overall Study|Withdrawal by Subject|1|||
145390690|NCT02592447|524285255|FG000|Overall Study|Lost to Follow-up|1|||
145390691|NCT02592447|524285256|FG001|Overall Study|Lost to Follow-up|0|||
145390692|NCT02592447|524285255|FG000|Overall Study|Ineligible after randomization|1|||
145390693|NCT02592447|524285256|FG001|Overall Study|Ineligible after randomization|0|||
145390694|NCT02592447|524285255|FG000|Overall Study|Withdrawal by Subject|0|||
145390695|NCT02592447|524285256|FG001|Overall Study|Withdrawal by Subject|1|||
145390696|NCT01096160|524285261|FG000|Overall Study|Adverse Event|0|||
145390697|NCT01096160|524285262|FG001|Overall Study|Adverse Event|0|||
145390698|NCT01096160|524285263|FG002|Overall Study|Adverse Event|1|||
145390699|NCT01096160|524285264|FG003|Overall Study|Adverse Event|0|||
145390700|NCT01096160|524285265|FG004|Overall Study|Adverse Event|0|||
145390701|NCT01096160|524285266|FG005|Overall Study|Adverse Event|0|||
145390702|NCT01096160|524285267|FG006|Overall Study|Adverse Event|0|||
145390703|NCT01096160|524285268|FG007|Overall Study|Adverse Event|0|||
145390704|NCT01096160|524285269|FG008|Overall Study|Adverse Event|0|||
145390705|NCT01096160|524285270|FG009|Overall Study|Adverse Event|1|||
145390706|NCT01096160|524285261|FG000|Overall Study|Met stopping criteria per protocol|0|||
145390707|NCT01096160|524285262|FG001|Overall Study|Met stopping criteria per protocol|0|||
145390708|NCT01096160|524285263|FG002|Overall Study|Met stopping criteria per protocol|0|||
145390709|NCT01096160|524285264|FG003|Overall Study|Met stopping criteria per protocol|0|||
145390710|NCT01096160|524285265|FG004|Overall Study|Met stopping criteria per protocol|1|||
145390711|NCT01096160|524285266|FG005|Overall Study|Met stopping criteria per protocol|0|||
145390712|NCT01096160|524285267|FG006|Overall Study|Met stopping criteria per protocol|2|||
145390713|NCT01096160|524285268|FG007|Overall Study|Met stopping criteria per protocol|0|||
145390714|NCT01096160|524285269|FG008|Overall Study|Met stopping criteria per protocol|2|||
145390715|NCT01096160|524285270|FG009|Overall Study|Met stopping criteria per protocol|0|||
145390716|NCT00627497|524285272|FG000|Overall Study|Lost to Follow-up|1|||
145390717|NCT00627497|524285273|FG001|Overall Study|Lost to Follow-up|1|||
145390718|NCT00627497|524285274|FG002|Overall Study|Lost to Follow-up|0|||
145390719|NCT00627497|524285275|FG003|Overall Study|Lost to Follow-up|0|||
145390720|NCT06060496|524285276|FG000|Overall Study|Withdrawal by Subject|2|||
145390721|NCT06060496|524285276|FG000|Overall Study|Lost to Follow-up|2|||
145390722|NCT02028507|524285277|FG000|Overall Study|Progressive Disease|122|||
145390723|NCT02028507|524285278|FG001|Overall Study|Progressive Disease|90|||
145390724|NCT02028507|524285279|FG002|Overall Study|Progressive Disease|102|||
145390725|NCT02028507|524285280|FG003|Overall Study|Progressive Disease|89|||
145390726|NCT02028507|524285277|FG000|Overall Study|Adverse Event|8|||
145390727|NCT02028507|524285278|FG001|Overall Study|Adverse Event|25|||
145390728|NCT02028507|524285279|FG002|Overall Study|Adverse Event|3|||
145390729|NCT02028507|524285280|FG003|Overall Study|Adverse Event|16|||
145390730|NCT02028507|524285277|FG000|Overall Study|Withdrawal by Subject|6|||
145390731|NCT02028507|524285278|FG001|Overall Study|Withdrawal by Subject|8|||
145390732|NCT02028507|524285279|FG002|Overall Study|Withdrawal by Subject|5|||
145390733|NCT02028507|524285280|FG003|Overall Study|Withdrawal by Subject|9|||
145390734|NCT02028507|524285277|FG000|Overall Study|Protocol Violation|2|||
145390735|NCT02028507|524285278|FG001|Overall Study|Protocol Violation|4|||
145390736|NCT02028507|524285279|FG002|Overall Study|Protocol Violation|1|||
145390737|NCT02028507|524285280|FG003|Overall Study|Protocol Violation|3|||
145390738|NCT02028507|524285277|FG000|Overall Study|Physician Decision|0|||
145390739|NCT02028507|524285278|FG001|Overall Study|Physician Decision|4|||
145729667|NCT03231943|525527557|FG010|Part 2|Adverse Event|1|||
145729668|NCT03231943|525527558|FG011|Part 2|Adverse Event|0|||
145729669|NCT03231943|525527559|FG012|Part 2|Adverse Event|0|||
145729670|NCT03231943|525527547|FG000|Part 2|Withdrawal by Subject|0|||
145729671|NCT03231943|525527548|FG001|Part 2|Withdrawal by Subject|0|||
145729672|NCT03231943|525527549|FG002|Part 2|Withdrawal by Subject|0|||
145729673|NCT03231943|525527550|FG003|Part 2|Withdrawal by Subject|0|||
145729674|NCT03231943|525527551|FG004|Part 2|Withdrawal by Subject|0|||
145729675|NCT03231943|525527552|FG005|Part 2|Withdrawal by Subject|0|||
145729676|NCT03231943|525527553|FG006|Part 2|Withdrawal by Subject|0|||
145729677|NCT03231943|525527554|FG007|Part 2|Withdrawal by Subject|0|||
145729678|NCT03231943|525527555|FG008|Part 2|Withdrawal by Subject|0|||
145729679|NCT03231943|525527556|FG009|Part 2|Withdrawal by Subject|0|||
145729680|NCT03231943|525527557|FG010|Part 2|Withdrawal by Subject|0|||
145729681|NCT03231943|525527558|FG011|Part 2|Withdrawal by Subject|1|||
145729682|NCT03231943|525527559|FG012|Part 2|Withdrawal by Subject|0|||
145729683|NCT00445068|525527560|FG000|Overall Study|Disease progression|26|||
145729684|NCT00445068|525527560|FG000|Overall Study|Adverse Event|5|||
145729685|NCT00445068|525527560|FG000|Overall Study|Abnormal laboratory value|2|||
145729686|NCT00445068|525527560|FG000|Overall Study|Withdrawal by Subject|2|||
145729687|NCT00445068|525527560|FG000|Overall Study|Death|1|||
145729688|NCT04824521|525527561|FG000|Overall Study|Lost to Follow-up|1|||
145729689|NCT03444324|525527562|FG000|Overall Study|Withdrawal by Subject|0|||
145729690|NCT03444324|525527563|FG001|Overall Study|Withdrawal by Subject|1|||
145729691|NCT03444324|525527562|FG000|Overall Study|Lost to Follow-up|4|||
145729692|NCT03444324|525527563|FG001|Overall Study|Lost to Follow-up|2|||
145729693|NCT03444324|525527562|FG000|Overall Study|Protocol Violation|0|||
145729694|NCT03444324|525527563|FG001|Overall Study|Protocol Violation|1|||
145729695|NCT03444324|525527562|FG000|Overall Study|Lack of Trial Compliance|1|||
145729696|NCT03444324|525527563|FG001|Overall Study|Lack of Trial Compliance|1|||
145729697|NCT03444324|525527562|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
145729698|NCT03444324|525527563|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
145729699|NCT01598311|525527564|FG000|Overall Study|Physician Decision|4|||
145729700|NCT01598311|525527565|FG001|Overall Study|Physician Decision|5|||
145729701|NCT01598311|525527564|FG000|Overall Study|Adverse Event|9|||
145729702|NCT01598311|525527565|FG001|Overall Study|Adverse Event|13|||
145729703|NCT01598311|525527564|FG000|Overall Study|Lost to Follow-up|7|||
145729704|NCT01598311|525527565|FG001|Overall Study|Lost to Follow-up|12|||
145729705|NCT01598311|525527564|FG000|Overall Study|Withdrawal by Subject|9|||
145729706|NCT01598311|525527565|FG001|Overall Study|Withdrawal by Subject|13|||
145729707|NCT01598311|525527564|FG000|Overall Study|No reason provided.|0|||
145729708|NCT01598311|525527565|FG001|Overall Study|No reason provided.|5|||
145729709|NCT01598311|525527564|FG000|Overall Study|Randomized but never treated|8|||
145729710|NCT01598311|525527565|FG001|Overall Study|Randomized but never treated|5|||
145729711|NCT01598311|525527564|FG000|Overall Study|Treated but no confirmed CDAD|9|||
145729712|NCT01598311|525527565|FG001|Overall Study|Treated but no confirmed CDAD|8|||
145729713|NCT01598311|525527564|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
145729714|NCT01598311|525527565|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
145729715|NCT00658684|525527566|FG000|Overall Study|Adverse Event|10|||
145729716|NCT00658684|525527567|FG001|Overall Study|Adverse Event|8|||
145729717|NCT00658684|525527568|FG002|Overall Study|Adverse Event|2|||
145729718|NCT00658684|525527569|FG003|Overall Study|Adverse Event|0|||
145729719|NCT00658684|525527566|FG000|Overall Study|Withdrawal by Subject|6|||
145729720|NCT00658684|525527567|FG001|Overall Study|Withdrawal by Subject|4|||
145729721|NCT00658684|525527568|FG002|Overall Study|Withdrawal by Subject|1|||
145729722|NCT00658684|525527569|FG003|Overall Study|Withdrawal by Subject|1|||
145729723|NCT00658684|525527566|FG000|Overall Study|Lack of Efficacy|1|||
145729724|NCT00658684|525527567|FG001|Overall Study|Lack of Efficacy|1|||
145729725|NCT00658684|525527568|FG002|Overall Study|Lack of Efficacy|0|||
145729726|NCT00658684|525527569|FG003|Overall Study|Lack of Efficacy|0|||
145729727|NCT00658684|525527566|FG000|Overall Study|Protocol Violation|1|||
145729728|NCT00658684|525527567|FG001|Overall Study|Protocol Violation|1|||
145390740|NCT02028507|524285279|FG002|Overall Study|Physician Decision|0|||
145390741|NCT02028507|524285280|FG003|Overall Study|Physician Decision|0|||
145390742|NCT02028507|524285277|FG000|Overall Study|Death|1|||
145390743|NCT02028507|524285278|FG001|Overall Study|Death|0|||
145390744|NCT02028507|524285279|FG002|Overall Study|Death|1|||
145729729|NCT00658684|525527568|FG002|Overall Study|Protocol Violation|0|||
145729730|NCT00658684|525527569|FG003|Overall Study|Protocol Violation|0|||
145729731|NCT00658684|525527566|FG000|Overall Study|Pregnancy|1|||
145729732|NCT00658684|525527567|FG001|Overall Study|Pregnancy|1|||
145729733|NCT00658684|525527568|FG002|Overall Study|Pregnancy|0|||
145729734|NCT00658684|525527569|FG003|Overall Study|Pregnancy|0|||
145729735|NCT00688103|525527570|FG000|Overall Study|Adverse Event|4|||
145390745|NCT02028507|524285280|FG003|Overall Study|Death|3|||
145729736|NCT00688103|525527571|FG001|Overall Study|Adverse Event|1|||
145729737|NCT00688103|525527570|FG000|Overall Study|Lack of Efficacy|11|||
145729738|NCT00688103|525527571|FG001|Overall Study|Lack of Efficacy|1|||
145729739|NCT00688103|525527570|FG000|Overall Study|Withdrawal by Subject|4|||
145390746|NCT02028507|524285277|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
145390747|NCT02028507|524285278|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
145390748|NCT02028507|524285279|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
145390749|NCT02028507|524285280|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
145390750|NCT02028507|524285277|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
145390751|NCT02028507|524285278|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
145390752|NCT02028507|524285279|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
145390753|NCT02028507|524285280|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
145390754|NCT02028507|524285277|FG000|Overall Study|Randomized But Not Treated|3|||
145390755|NCT02028507|524285278|FG001|Overall Study|Randomized But Not Treated|6|||
145390756|NCT02028507|524285279|FG002|Overall Study|Randomized But Not Treated|0|||
145390757|NCT02028507|524285280|FG003|Overall Study|Randomized But Not Treated|4|||
145495271|NCT04886154|524670308|FG013|Overall Study|Other, Not Specified|2|||
145495272|NCT04886154|524670309|FG014|Overall Study|Other, Not Specified|3|||
145390758|NCT02028507|524285277|FG000|Overall Study|Enzyme defect|0|||
145390759|NCT02028507|524285278|FG001|Overall Study|Enzyme defect|0|||
145390760|NCT02028507|524285279|FG002|Overall Study|Enzyme defect|0|||
145390761|NCT02028507|524285280|FG003|Overall Study|Enzyme defect|1|||
145390762|NCT02028507|524285277|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145390763|NCT02028507|524285278|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145390764|NCT02028507|524285279|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
145390765|NCT02028507|524285280|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
145390766|NCT02028507|524285277|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
145390767|NCT02028507|524285278|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
145390768|NCT02028507|524285279|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
145390769|NCT02028507|524285280|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
145390770|NCT02258659|524285281|FG000|Overall Study|Withdrawal by Subject|1|||
145390771|NCT03990051|524285282|FG000|Masked Period|Lost to Follow-up|1|||
145390772|NCT03990051|524285283|FG001|Masked Period|Lost to Follow-up|0|||
145390773|NCT03990051|524285282|FG000|Long Term Period|Death|1|||
145390774|NCT03990051|524285283|FG001|Long Term Period|Death|1|||
145390775|NCT03990051|524285282|FG000|Long Term Period|Lost to Follow-up|7|||
145390776|NCT03990051|524285283|FG001|Long Term Period|Lost to Follow-up|2|||
145390777|NCT00272844|524285284|FG000|Overall Study|Withdrawal by Subject|5|||
145390778|NCT00618826|524285285|FG000|Overall Study|Adverse Event|1|||
145390779|NCT01509664|524285287|FG000|Overall Study|Lost to Follow-up|15|||
145390780|NCT01509664|524285288|FG001|Overall Study|Lost to Follow-up|21|||
145390781|NCT01556932|524285291|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
145390782|NCT01556932|524285292|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
145390783|NCT00791700|524285293|FG000|Overall Study|Insufficient clinical response|1|||
145390784|NCT00791700|524285294|FG001|Overall Study|Insufficient clinical response|4|||
145390785|NCT00791700|524285295|FG002|Overall Study|Insufficient clinical response|1|||
145390786|NCT00791700|524285296|FG003|Overall Study|Insufficient clinical response|8|||
145390787|NCT00791700|524285293|FG000|Overall Study|No longer willing to participate|1|||
145390788|NCT00791700|524285294|FG001|Overall Study|No longer willing to participate|1|||
145390789|NCT00791700|524285295|FG002|Overall Study|No longer willing to participate|0|||
145390790|NCT00791700|524285296|FG003|Overall Study|No longer willing to participate|8|||
145390791|NCT00791700|524285293|FG000|Overall Study|Non-compliance with study treatment|0|||
145390792|NCT00791700|524285294|FG001|Overall Study|Non-compliance with study treatment|2|||
145390793|NCT00791700|524285295|FG002|Overall Study|Non-compliance with study treatment|0|||
145390794|NCT00791700|524285296|FG003|Overall Study|Non-compliance with study treatment|4|||
145390795|NCT00791700|524285293|FG000|Overall Study|Withdrawn due to pregnancy|0|||
145390796|NCT00791700|524285294|FG001|Overall Study|Withdrawn due to pregnancy|0|||
145390797|NCT00791700|524285295|FG002|Overall Study|Withdrawn due to pregnancy|0|||
145390798|NCT00791700|524285296|FG003|Overall Study|Withdrawn due to pregnancy|1|||
145390799|NCT00791700|524285293|FG000|Overall Study|Other|0|||
145390800|NCT00791700|524285294|FG001|Overall Study|Other|1|||
145390801|NCT00791700|524285295|FG002|Overall Study|Other|0|||
145390802|NCT00791700|524285296|FG003|Overall Study|Other|1|||
145390803|NCT00791700|524285293|FG000|Overall Study|Death|0|||
145390804|NCT00791700|524285294|FG001|Overall Study|Death|0|||
145390805|NCT00791700|524285295|FG002|Overall Study|Death|0|||
145390806|NCT00791700|524285296|FG003|Overall Study|Death|1|||
145390807|NCT00791700|524285293|FG000|Overall Study|Lost to Follow-up|4|||
145390808|NCT00791700|524285294|FG001|Overall Study|Lost to Follow-up|3|||
145390809|NCT00791700|524285295|FG002|Overall Study|Lost to Follow-up|4|||
145390810|NCT00791700|524285296|FG003|Overall Study|Lost to Follow-up|6|||
145390811|NCT00791700|524285293|FG000|Overall Study|Adverse Event|0|||
145390812|NCT00791700|524285294|FG001|Overall Study|Adverse Event|0|||
145390813|NCT00791700|524285295|FG002|Overall Study|Adverse Event|1|||
145390814|NCT00791700|524285296|FG003|Overall Study|Adverse Event|1|||
145390815|NCT00996034|524285299|FG000|Overall Study|Lost to Follow-up|2|||
145390816|NCT00996034|524285299|FG000|Overall Study|withdrawn by PI|1|||
145390817|NCT01720524|524285300|FG000|Part A|Insufficient Clinical Response|2|||
145390818|NCT01720524|524285301|FG001|Part A|Insufficient Clinical Response|4|||
145390819|NCT01720524|524285300|FG000|Part A|Adverse Event|2|||
145390820|NCT01720524|524285301|FG001|Part A|Adverse Event|2|||
145390821|NCT01720524|524285300|FG000|Part A|Death|2|||
145390822|NCT01720524|524285301|FG001|Part A|Death|1|||
145390823|NCT01720524|524285300|FG000|Part A|Lost to Follow-up|0|||
145390824|NCT01720524|524285301|FG001|Part A|Lost to Follow-up|1|||
145390825|NCT01720524|524285300|FG000|Part A|Missed 28 day follow-up visit|1|||
145390826|NCT01720524|524285301|FG001|Part A|Missed 28 day follow-up visit|1|||
145390827|NCT01720524|524285300|FG000|Part A|Withdrawal by Subject|0|||
145390828|NCT01720524|524285301|FG001|Part A|Withdrawal by Subject|1|||
145390829|NCT01720524|524285300|FG000|Part A|Other|0|||
145390830|NCT01720524|524285301|FG001|Part A|Other|1|||
145390831|NCT01720524|524285300|FG000|Part A|Lost to Follow-up|0|||
145390832|NCT01720524|524285301|FG001|Part A|Lost to Follow-up|1|||
145390833|NCT01720524|524285300|FG000|Part B|No longer willing to participate in study|1|||
145390834|NCT01720524|524285301|FG001|Part B|No longer willing to participate in study|4|||
145390835|NCT01720524|524285300|FG000|Part B|Other|2|||
145390836|NCT01720524|524285301|FG001|Part B|Other|0|||
145390837|NCT01720524|524285300|FG000|Part B|Lost to Follow-up|2|||
145390838|NCT01720524|524285301|FG001|Part B|Lost to Follow-up|3|||
145390839|NCT01720524|524285300|FG000|Part B|Death|0|||
145390840|NCT01720524|524285301|FG001|Part B|Death|2|||
145390841|NCT00158262|524285302|FG000|Overall Study|Lost to Follow-up|1|||
145390842|NCT00158262|524285303|FG001|Overall Study|Lost to Follow-up|1|||
145390843|NCT02105285|524285306|FG000|Overall Study|Adverse Event|1|||
145390844|NCT02105285|524285307|FG001|Overall Study|Adverse Event|1|||
145390845|NCT02105285|524285308|FG002|Overall Study|Adverse Event|0|||
145390846|NCT02105285|524285306|FG000|Overall Study|Protocol Violation|0|||
145390847|NCT02105285|524285307|FG001|Overall Study|Protocol Violation|1|||
145390848|NCT02105285|524285308|FG002|Overall Study|Protocol Violation|0|||
145390849|NCT02105285|524285306|FG000|Overall Study|Withdrawal by Subject|1|||
145390850|NCT02105285|524285307|FG001|Overall Study|Withdrawal by Subject|0|||
145390851|NCT02105285|524285308|FG002|Overall Study|Withdrawal by Subject|0|||
145390852|NCT04501952|524285309|FG000|Overall Study|Adverse Event|0|||
145390853|NCT04501952|524285310|FG001|Overall Study|Adverse Event|3|||
145390854|NCT04501952|524285309|FG000|Overall Study|Investigator's Discretion|0|||
145390855|NCT04501952|524285310|FG001|Overall Study|Investigator's Discretion|1|||
145390856|NCT04501952|524285309|FG000|Overall Study|Protocol Violation|1|||
145390857|NCT04501952|524285310|FG001|Overall Study|Protocol Violation|1|||
145390858|NCT04501952|524285309|FG000|Overall Study|Withdrew Consent|5|||
145390859|NCT04501952|524285310|FG001|Overall Study|Withdrew Consent|4|||
145390860|NCT04501952|524285309|FG000|Overall Study|Lost to Follow-up|7|||
145390861|NCT04501952|524285310|FG001|Overall Study|Lost to Follow-up|2|||
145390862|NCT04501952|524285309|FG000|Overall Study|Randomized and Never Treated|13|||
145390863|NCT04501952|524285310|FG001|Overall Study|Randomized and Never Treated|9|||
145390864|NCT00991289|524285311|FG000|Overall Study|Adverse Event|1|||
145390865|NCT00991289|524285311|FG000|Overall Study|Physician Decision|2|||
145390866|NCT00991289|524285311|FG000|Overall Study|Withdrawal by Subject|3|||
145390867|NCT00991289|524285311|FG000|Overall Study|Lost to Follow-up|4|||
145390868|NCT00991289|524285311|FG000|Overall Study|Protocol Violation|2|||
145390869|NCT02472886|524285312|FG000|Overall Study|Lack of Efficacy|0|||
145390870|NCT02472886|524285313|FG001|Overall Study|Lack of Efficacy|2|||
145390871|NCT02472886|524285314|FG002|Overall Study|Lack of Efficacy|1|||
145390872|NCT02797678|524285316|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
145390873|NCT02797678|524285317|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145390874|NCT02797678|524285318|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145390875|NCT02797678|524285319|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
145390876|NCT02797678|524285316|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
145390877|NCT02797678|524285317|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
145390878|NCT02797678|524285318|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
145390879|NCT02797678|524285319|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
145390880|NCT02797678|524285316|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
145390881|NCT02797678|524285317|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
145390882|NCT02797678|524285318|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
145390883|NCT02797678|524285319|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
145390884|NCT03046953|524285325|FG000|Overall Study|Relapse/progressive disease|21|||
145390885|NCT03046953|524285325|FG000|Overall Study|Death|2|||
145390886|NCT03046953|524285325|FG000|Overall Study|Withdrawal by Subject|3|||
145390887|NCT02716584|524285326|FG000|Overall Study|Lost to Follow-up|8|||
145390888|NCT02716584|524285327|FG001|Overall Study|Lost to Follow-up|5|||
145390889|NCT02385110|524285332|FG000|Overall Study|Early Death|1|||
145390890|NCT02385110|524285333|FG001|Overall Study|Early Death|0|||
145390891|NCT05251233|524287399|FG000|Overall Study|Disease progression - did not start treatment|0|||
145390892|NCT05251233|524287400|FG001|Overall Study|Disease progression - did not start treatment|0|||
145390893|NCT05251233|524287401|FG002|Overall Study|Disease progression - did not start treatment|5|||
145390894|NCT05251233|524287399|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
145390895|NCT05251233|524287400|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
145390896|NCT05251233|524287401|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
145390897|NCT05251233|524287399|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
145390898|NCT05251233|524287400|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
145390899|NCT05251233|524287401|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
145390900|NCT05251233|524287399|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
145390901|NCT05251233|524287400|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
145390902|NCT05251233|524287401|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
145390903|NCT05251233|524287399|FG000|Overall Study|Death - did not start treatment|3|||
145390904|NCT05251233|524287400|FG001|Overall Study|Death - did not start treatment|0|||
145390905|NCT05251233|524287401|FG002|Overall Study|Death - did not start treatment|0|||
145390906|NCT05251233|524287399|FG000|Overall Study|Withdrawal by Subject|2|||
145390907|NCT05251233|524287400|FG001|Overall Study|Withdrawal by Subject|2|||
145390908|NCT05251233|524287401|FG002|Overall Study|Withdrawal by Subject|0|||
145390909|NCT05251233|524287399|FG000|Overall Study|Other complicating disease|2|||
145390910|NCT05251233|524287400|FG001|Overall Study|Other complicating disease|1|||
145390911|NCT05251233|524287401|FG002|Overall Study|Other complicating disease|0|||
145390912|NCT05251233|524287399|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
145390913|NCT05251233|524287400|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
145390914|NCT05251233|524287401|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
145390915|NCT05251233|524287399|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
145390916|NCT05251233|524287400|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
145495273|NCT03919773|524670318|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
145495274|NCT03919773|524670319|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
145495275|NCT03919773|524670318|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
145495276|NCT03919773|524670319|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
145495277|NCT02336282|524670323|FG000|Overall Study|Unrelated illness|1|||
145495278|NCT02336282|524670323|FG000|Overall Study|Uncomfortable with technology|1|||
145495279|NCT02336282|524670323|FG000|Overall Study|Lost to Follow-up|1|||
145495280|NCT02336282|524670323|FG000|Overall Study|Not enough time to complete sessions|2|||
145495281|NCT00904969|524671554|FG000|Overall Study|Lost to Follow-up|4|||
145495282|NCT00904969|524671554|FG000|Overall Study|Withdrawal by Subject|3|||
145495283|NCT00904969|524671554|FG000|Overall Study|Additional Treatments|11|||
145390917|NCT05251233|524287401|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
145390918|NCT00103285|524287402|FG000|Induction|Adverse Event|14|||
145495284|NCT00904969|524671554|FG000|Overall Study|Case Aborted; Subject Exited|1|||
145495285|NCT00755183|524671562|FG000|Overall Study|Adverse Event|5|||
145495286|NCT00755183|524671563|FG001|Overall Study|Adverse Event|2|||
145390919|NCT00103285|524287403|FG001|Induction|Adverse Event|0|||
145390920|NCT00103285|524287404|FG002|Induction|Adverse Event|0|||
145390921|NCT00103285|524287405|FG003|Induction|Adverse Event|0|||
145390922|NCT00103285|524287406|FG004|Induction|Adverse Event|0|||
145390923|NCT00103285|524287407|FG005|Induction|Adverse Event|0|||
145390924|NCT00103285|524287408|FG006|Induction|Adverse Event|0|||
145390925|NCT00103285|524287409|FG007|Induction|Adverse Event|0|||
145390926|NCT00103285|524287402|FG000|Induction|Death|24|||
145390927|NCT00103285|524287403|FG001|Induction|Death|0|||
145390928|NCT00103285|524287404|FG002|Induction|Death|0|||
145390929|NCT00103285|524287405|FG003|Induction|Death|0|||
145390930|NCT00103285|524287406|FG004|Induction|Death|0|||
145495287|NCT00755183|524671562|FG000|Overall Study|Protocol Violation|0|||
145729740|NCT00688103|525527571|FG001|Overall Study|Withdrawal by Subject|2|||
145729741|NCT00688103|525527570|FG000|Overall Study|complex reasons|11|||
145729742|NCT00688103|525527571|FG001|Overall Study|complex reasons|9|||
145729743|NCT01485354|525528970|FG000|Overall Study|Withdrawal by Subject|5|||
145729744|NCT00826111|525528971|FG000|Overall Study|Lost to Follow-up|0|||
145495288|NCT00755183|524671563|FG001|Overall Study|Protocol Violation|1|||
145729745|NCT00826111|525528972|FG001|Overall Study|Lost to Follow-up|1|||
145729746|NCT00826111|525528971|FG000|Overall Study|Protocol Violation|1|||
145390931|NCT00103285|524287407|FG005|Induction|Death|0|||
145390932|NCT00103285|524287408|FG006|Induction|Death|0|||
145390933|NCT00103285|524287409|FG007|Induction|Death|0|||
145390934|NCT00103285|524287402|FG000|Induction|Physician Decision|103|||
145390935|NCT00103285|524287403|FG001|Induction|Physician Decision|0|||
145390936|NCT00103285|524287404|FG002|Induction|Physician Decision|0|||
145390937|NCT00103285|524287405|FG003|Induction|Physician Decision|0|||
145390938|NCT00103285|524287406|FG004|Induction|Physician Decision|0|||
145390939|NCT00103285|524287407|FG005|Induction|Physician Decision|0|||
145390940|NCT00103285|524287408|FG006|Induction|Physician Decision|0|||
145390941|NCT00103285|524287409|FG007|Induction|Physician Decision|0|||
145390942|NCT00103285|524287402|FG000|Induction|Withdrawal by Subject|1|||
145390943|NCT00103285|524287403|FG001|Induction|Withdrawal by Subject|0|||
145390944|NCT00103285|524287404|FG002|Induction|Withdrawal by Subject|0|||
145390945|NCT00103285|524287405|FG003|Induction|Withdrawal by Subject|0|||
145390946|NCT00103285|524287406|FG004|Induction|Withdrawal by Subject|0|||
145390947|NCT00103285|524287407|FG005|Induction|Withdrawal by Subject|0|||
145390948|NCT00103285|524287408|FG006|Induction|Withdrawal by Subject|0|||
145390949|NCT00103285|524287409|FG007|Induction|Withdrawal by Subject|0|||
145390950|NCT00103285|524287402|FG000|Induction|Ineligible|43|||
145390951|NCT00103285|524287403|FG001|Induction|Ineligible|0|||
145390952|NCT00103285|524287404|FG002|Induction|Ineligible|0|||
145390953|NCT00103285|524287405|FG003|Induction|Ineligible|0|||
145390954|NCT00103285|524287406|FG004|Induction|Ineligible|0|||
145390955|NCT00103285|524287407|FG005|Induction|Ineligible|0|||
145390956|NCT00103285|524287408|FG006|Induction|Ineligible|0|||
145390957|NCT00103285|524287409|FG007|Induction|Ineligible|0|||
145390958|NCT00103285|524287402|FG000|Induction|Refusal|906|||
145390959|NCT00103285|524287403|FG001|Induction|Refusal|0|||
145390960|NCT00103285|524287404|FG002|Induction|Refusal|0|||
145390961|NCT00103285|524287405|FG003|Induction|Refusal|0|||
145390962|NCT00103285|524287406|FG004|Induction|Refusal|0|||
145390963|NCT00103285|524287407|FG005|Induction|Refusal|0|||
145390964|NCT00103285|524287408|FG006|Induction|Refusal|0|||
145390965|NCT00103285|524287409|FG007|Induction|Refusal|0|||
145390966|NCT00103285|524287402|FG000|Induction|Other|258|||
145390967|NCT00103285|524287403|FG001|Induction|Other|0|||
145390968|NCT00103285|524287404|FG002|Induction|Other|0|||
145390969|NCT00103285|524287405|FG003|Induction|Other|0|||
145390970|NCT00103285|524287406|FG004|Induction|Other|0|||
145390971|NCT00103285|524287407|FG005|Induction|Other|0|||
145390972|NCT00103285|524287408|FG006|Induction|Other|0|||
145390973|NCT00103285|524287409|FG007|Induction|Other|0|||
145390974|NCT00103285|524287402|FG000|Response Assignment|Adverse Event|0|||
145390975|NCT00103285|524287403|FG001|Response Assignment|Adverse Event|8|||
145390976|NCT00103285|524287404|FG002|Response Assignment|Adverse Event|3|||
145390977|NCT00103285|524287405|FG003|Response Assignment|Adverse Event|2|||
145390978|NCT00103285|524287406|FG004|Response Assignment|Adverse Event|3|||
145729747|NCT00826111|525528972|FG001|Overall Study|Protocol Violation|0|||
145729748|NCT00826111|525528971|FG000|Overall Study|Withdrawal by Subject|5|||
145729749|NCT00826111|525528972|FG001|Overall Study|Withdrawal by Subject|0|||
145729750|NCT00826111|525528971|FG000|Overall Study|Physician Decision|1|||
145729751|NCT00826111|525528972|FG001|Overall Study|Physician Decision|1|||
145729752|NCT02805725|525528973|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
145729753|NCT02805725|525528974|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
145729754|NCT02805725|525528975|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
145729755|NCT02805725|525528976|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
145729756|NCT02805725|525528977|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
145729757|NCT02805725|525528973|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
145729758|NCT02805725|525528974|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
145729759|NCT02805725|525528975|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
145729760|NCT02805725|525528976|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
145729761|NCT02805725|525528977|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
145729762|NCT02805725|525528973|FG000|Phase II|Protocol Violation|0|||
145729763|NCT02805725|525528974|FG001|Phase II|Protocol Violation|0|||
145729764|NCT02805725|525528975|FG002|Phase II|Protocol Violation|0|||
145729765|NCT02805725|525528976|FG003|Phase II|Protocol Violation|0|||
145729766|NCT02805725|525528977|FG004|Phase II|Protocol Violation|6|||
145729767|NCT03511053|525528980|FG000|Overall Study|Withdrawal by Subject|1|||
145729768|NCT01028222|525528983|FG000|Overall Study|Protocol deviation|1|||
145729769|NCT01028222|525528984|FG001|Overall Study|Protocol deviation|0|||
145729770|NCT01028222|525528983|FG000|Overall Study|Disease progression|33|||
145729771|NCT01028222|525528984|FG001|Overall Study|Disease progression|9|||
145729772|NCT01028222|525528983|FG000|Overall Study|Administrative problems|1|||
145729773|NCT01028222|525528984|FG001|Overall Study|Administrative problems|1|||
145729774|NCT01028222|525528983|FG000|Overall Study|Lost to Follow-up|0|||
145729775|NCT01028222|525528984|FG001|Overall Study|Lost to Follow-up|1|||
145390979|NCT00103285|524287407|FG005|Response Assignment|Adverse Event|1|||
145390980|NCT00103285|524287408|FG006|Response Assignment|Adverse Event|1|||
145390981|NCT00103285|524287409|FG007|Response Assignment|Adverse Event|2|||
145495289|NCT00755183|524671562|FG000|Overall Study|Withdrawal by Subject|0|||
145390982|NCT00103285|524287402|FG000|Response Assignment|Death|0|||
145390983|NCT00103285|524287403|FG001|Response Assignment|Death|5|||
145390984|NCT00103285|524287404|FG002|Response Assignment|Death|2|||
145390985|NCT00103285|524287405|FG003|Response Assignment|Death|2|||
145390986|NCT00103285|524287406|FG004|Response Assignment|Death|3|||
145390987|NCT00103285|524287407|FG005|Response Assignment|Death|1|||
145390988|NCT00103285|524287408|FG006|Response Assignment|Death|0|||
145390989|NCT00103285|524287409|FG007|Response Assignment|Death|8|||
145390990|NCT00103285|524287402|FG000|Response Assignment|Lost to Follow-up|0|||
145495290|NCT00755183|524671563|FG001|Overall Study|Withdrawal by Subject|2|||
145729776|NCT01028222|525528983|FG000|Overall Study|Withdrawal by Subject|1|||
145390991|NCT00103285|524287403|FG001|Response Assignment|Lost to Follow-up|9|||
145390992|NCT00103285|524287404|FG002|Response Assignment|Lost to Follow-up|5|||
145390993|NCT00103285|524287405|FG003|Response Assignment|Lost to Follow-up|5|||
145390994|NCT00103285|524287406|FG004|Response Assignment|Lost to Follow-up|1|||
145390995|NCT00103285|524287407|FG005|Response Assignment|Lost to Follow-up|2|||
145390996|NCT00103285|524287408|FG006|Response Assignment|Lost to Follow-up|2|||
145729777|NCT01028222|525528984|FG001|Overall Study|Withdrawal by Subject|0|||
145390997|NCT00103285|524287409|FG007|Response Assignment|Lost to Follow-up|5|||
145390998|NCT00103285|524287402|FG000|Response Assignment|Physician Decision|0|||
145390999|NCT00103285|524287403|FG001|Response Assignment|Physician Decision|13|||
145391000|NCT00103285|524287404|FG002|Response Assignment|Physician Decision|14|||
145391001|NCT00103285|524287405|FG003|Response Assignment|Physician Decision|9|||
145391002|NCT00103285|524287406|FG004|Response Assignment|Physician Decision|13|||
145391003|NCT00103285|524287407|FG005|Response Assignment|Physician Decision|7|||
145391004|NCT00103285|524287408|FG006|Response Assignment|Physician Decision|4|||
145391005|NCT00103285|524287409|FG007|Response Assignment|Physician Decision|35|||
145391006|NCT00103285|524287402|FG000|Response Assignment|Protocol Violation|0|||
145391007|NCT00103285|524287403|FG001|Response Assignment|Protocol Violation|2|||
145391008|NCT00103285|524287404|FG002|Response Assignment|Protocol Violation|0|||
145391009|NCT00103285|524287405|FG003|Response Assignment|Protocol Violation|0|||
145391010|NCT00103285|524287406|FG004|Response Assignment|Protocol Violation|0|||
145391011|NCT00103285|524287407|FG005|Response Assignment|Protocol Violation|0|||
145391012|NCT00103285|524287408|FG006|Response Assignment|Protocol Violation|0|||
145391013|NCT00103285|524287409|FG007|Response Assignment|Protocol Violation|0|||
145391014|NCT00103285|524287402|FG000|Response Assignment|Withdrawal by Subject|0|||
145391015|NCT00103285|524287403|FG001|Response Assignment|Withdrawal by Subject|4|||
145391016|NCT00103285|524287404|FG002|Response Assignment|Withdrawal by Subject|1|||
145391017|NCT00103285|524287405|FG003|Response Assignment|Withdrawal by Subject|1|||
145391018|NCT00103285|524287406|FG004|Response Assignment|Withdrawal by Subject|2|||
145391019|NCT00103285|524287407|FG005|Response Assignment|Withdrawal by Subject|2|||
145391020|NCT00103285|524287408|FG006|Response Assignment|Withdrawal by Subject|0|||
145495291|NCT00755183|524671562|FG000|Overall Study|Administrative|2|||
145495292|NCT00755183|524671563|FG001|Overall Study|Administrative|1|||
145391021|NCT00103285|524287409|FG007|Response Assignment|Withdrawal by Subject|2|||
145391022|NCT00103285|524287402|FG000|Response Assignment|Ineligible|0|||
145391023|NCT00103285|524287403|FG001|Response Assignment|Ineligible|8|||
145391024|NCT00103285|524287404|FG002|Response Assignment|Ineligible|6|||
145391025|NCT00103285|524287405|FG003|Response Assignment|Ineligible|2|||
145391026|NCT00103285|524287406|FG004|Response Assignment|Ineligible|0|||
145391027|NCT00103285|524287407|FG005|Response Assignment|Ineligible|3|||
145391028|NCT00103285|524287408|FG006|Response Assignment|Ineligible|1|||
145391029|NCT00103285|524287409|FG007|Response Assignment|Ineligible|5|||
145391030|NCT00103285|524287402|FG000|Response Assignment|Refusal|0|||
145391031|NCT00103285|524287403|FG001|Response Assignment|Refusal|53|||
145391032|NCT00103285|524287404|FG002|Response Assignment|Refusal|5|||
145391033|NCT00103285|524287405|FG003|Response Assignment|Refusal|3|||
145391034|NCT00103285|524287406|FG004|Response Assignment|Refusal|25|||
145391035|NCT00103285|524287407|FG005|Response Assignment|Refusal|15|||
145391036|NCT00103285|524287408|FG006|Response Assignment|Refusal|30|||
145391037|NCT00103285|524287409|FG007|Response Assignment|Refusal|10|||
145391038|NCT00103285|524287402|FG000|Response Assignment|Other|0|||
145391039|NCT00103285|524287403|FG001|Response Assignment|Other|30|||
145391040|NCT00103285|524287404|FG002|Response Assignment|Other|48|||
145391041|NCT00103285|524287405|FG003|Response Assignment|Other|38|||
145391042|NCT00103285|524287406|FG004|Response Assignment|Other|37|||
145391043|NCT00103285|524287407|FG005|Response Assignment|Other|17|||
145391044|NCT00103285|524287408|FG006|Response Assignment|Other|11|||
145391045|NCT00103285|524287409|FG007|Response Assignment|Other|53|||
145391046|NCT02624947|524287410|FG000|Maternal Participants|Adverse Event|5|||
145391047|NCT02624947|524287411|FG001|Maternal Participants|Adverse Event|0|||
145391048|NCT02624947|524287410|FG000|Maternal Participants|Investigator Decision|5|||
145391049|NCT02624947|524287411|FG001|Maternal Participants|Investigator Decision|3|||
145391050|NCT02624947|524287410|FG000|Maternal Participants|Lost to Follow-up|54|||
145391051|NCT02624947|524287411|FG001|Maternal Participants|Lost to Follow-up|24|||
145391052|NCT02624947|524287410|FG000|Maternal Participants|Non Compliance|8|||
145391053|NCT02624947|524287411|FG001|Maternal Participants|Non Compliance|5|||
145391054|NCT02624947|524287410|FG000|Maternal Participants|Sponsor Request|1|||
145391055|NCT02624947|524287411|FG001|Maternal Participants|Sponsor Request|1|||
145391056|NCT02624947|524287410|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
145391057|NCT02624947|524287411|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
145391058|NCT02624947|524287410|FG000|Maternal Participants|Miscellaneous|23|||
145391059|NCT02624947|524287411|FG001|Maternal Participants|Miscellaneous|15|||
145391060|NCT02624947|524287410|FG000|Infant Participants|Adverse Event|18|||
145391061|NCT02624947|524287411|FG001|Infant Participants|Adverse Event|11|||
145391062|NCT02624947|524287410|FG000|Infant Participants|Investigator Decision|5|||
145391063|NCT02624947|524287411|FG001|Infant Participants|Investigator Decision|4|||
145391064|NCT02624947|524287410|FG000|Infant Participants|Lost to Follow-up|93|||
145391065|NCT02624947|524287411|FG001|Infant Participants|Lost to Follow-up|58|||
145391066|NCT02624947|524287410|FG000|Infant Participants|Non Compliance|17|||
145391067|NCT02624947|524287411|FG001|Infant Participants|Non Compliance|7|||
145391068|NCT02624947|524287410|FG000|Infant Participants|Sponsor Request|0|||
145391069|NCT02624947|524287411|FG001|Infant Participants|Sponsor Request|1|||
145391070|NCT02624947|524287410|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
145391071|NCT02624947|524287411|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
145391072|NCT02624947|524287410|FG000|Infant Participants|Miscellaneous|50|||
145391073|NCT02624947|524287411|FG001|Infant Participants|Miscellaneous|26|||
145391074|NCT03654729|524287412|FG000|Overall Study|Death|9|||
145391075|NCT03654729|524287413|FG001|Overall Study|Death|9|||
145391076|NCT03654729|524287414|FG002|Overall Study|Death|16|||
145391077|NCT03654729|524287412|FG000|Overall Study|Withdrawal by Subject|8|||
145391078|NCT03654729|524287413|FG001|Overall Study|Withdrawal by Subject|6|||
145391079|NCT03654729|524287414|FG002|Overall Study|Withdrawal by Subject|4|||
145391080|NCT03654729|524287412|FG000|Overall Study|Study terminated by Sponsor|3|||
145391081|NCT03654729|524287413|FG001|Overall Study|Study terminated by Sponsor|5|||
145391082|NCT03654729|524287414|FG002|Overall Study|Study terminated by Sponsor|4|||
145391083|NCT03654729|524287412|FG000|Overall Study|Not reported|2|||
145391084|NCT03654729|524287413|FG001|Overall Study|Not reported|4|||
145391085|NCT03654729|524287414|FG002|Overall Study|Not reported|5|||
145391086|NCT03654729|524287412|FG000|Overall Study|Progressive disease|3|||
145391087|NCT03654729|524287413|FG001|Overall Study|Progressive disease|0|||
145391088|NCT03654729|524287414|FG002|Overall Study|Progressive disease|0|||
145495293|NCT00804908|524671565|FG000|Overall Study|Other|115|||
145495294|NCT00804908|524671566|FG001|Overall Study|Other|116|||
145391089|NCT03654729|524287412|FG000|Overall Study|Lost to Follow-up|2|||
145391090|NCT03654729|524287413|FG001|Overall Study|Lost to Follow-up|0|||
145391091|NCT03654729|524287414|FG002|Overall Study|Lost to Follow-up|0|||
145391092|NCT03654729|524287412|FG000|Overall Study|Physician Decision|2|||
145391093|NCT03654729|524287413|FG001|Overall Study|Physician Decision|0|||
145391094|NCT03654729|524287414|FG002|Overall Study|Physician Decision|0|||
145391095|NCT03654729|524287412|FG000|Overall Study|Protocol Violation|1|||
145391096|NCT03654729|524287413|FG001|Overall Study|Protocol Violation|1|||
145391097|NCT03654729|524287414|FG002|Overall Study|Protocol Violation|0|||
145391098|NCT03654729|524287412|FG000|Overall Study|Non-compliance with study drug|0|||
145391099|NCT03654729|524287413|FG001|Overall Study|Non-compliance with study drug|1|||
145391100|NCT03654729|524287414|FG002|Overall Study|Non-compliance with study drug|0|||
145391101|NCT03654729|524287412|FG000|Overall Study|Site terminated by Sponsor|1|||
145391102|NCT03654729|524287413|FG001|Overall Study|Site terminated by Sponsor|0|||
145391103|NCT03654729|524287414|FG002|Overall Study|Site terminated by Sponsor|0|||
145391104|NCT01919164|524287419|FG000|Overall Study|Adverse Event|6|||
145391105|NCT01919164|524287420|FG001|Overall Study|Adverse Event|4|||
145391106|NCT01919164|524287421|FG002|Overall Study|Adverse Event|9|||
145391107|NCT01919164|524287422|FG003|Overall Study|Adverse Event|3|||
145391108|NCT01919164|524287423|FG004|Overall Study|Adverse Event|2|||
145391109|NCT01919164|524287419|FG000|Overall Study|Lost to Follow-up|2|||
145391110|NCT01919164|524287420|FG001|Overall Study|Lost to Follow-up|2|||
145391111|NCT01919164|524287421|FG002|Overall Study|Lost to Follow-up|2|||
145391112|NCT01919164|524287422|FG003|Overall Study|Lost to Follow-up|0|||
145391113|NCT01919164|524287423|FG004|Overall Study|Lost to Follow-up|4|||
145391114|NCT01919164|524287419|FG000|Overall Study|Death|1|||
145391115|NCT01919164|524287420|FG001|Overall Study|Death|0|||
145391116|NCT01919164|524287421|FG002|Overall Study|Death|0|||
145391117|NCT01919164|524287422|FG003|Overall Study|Death|0|||
145391118|NCT01919164|524287423|FG004|Overall Study|Death|0|||
145391119|NCT01919164|524287419|FG000|Overall Study|Protocol Violation|6|||
145391120|NCT01919164|524287420|FG001|Overall Study|Protocol Violation|0|||
145391121|NCT01919164|524287421|FG002|Overall Study|Protocol Violation|3|||
145391122|NCT01919164|524287422|FG003|Overall Study|Protocol Violation|2|||
145391123|NCT01919164|524287423|FG004|Overall Study|Protocol Violation|2|||
145391124|NCT01919164|524287419|FG000|Overall Study|Disease progression|2|||
145391125|NCT01919164|524287420|FG001|Overall Study|Disease progression|2|||
145391126|NCT01919164|524287421|FG002|Overall Study|Disease progression|1|||
145391127|NCT01919164|524287422|FG003|Overall Study|Disease progression|2|||
145391128|NCT01919164|524287423|FG004|Overall Study|Disease progression|1|||
145391129|NCT01919164|524287419|FG000|Overall Study|Withdrew consent|13|||
145391130|NCT01919164|524287420|FG001|Overall Study|Withdrew consent|13|||
145391131|NCT01919164|524287421|FG002|Overall Study|Withdrew consent|14|||
145391132|NCT01919164|524287422|FG003|Overall Study|Withdrew consent|14|||
145391133|NCT01919164|524287423|FG004|Overall Study|Withdrew consent|9|||
145391134|NCT01919164|524287419|FG000|Overall Study|Other Un-specified|13|||
145391135|NCT01919164|524287420|FG001|Overall Study|Other Un-specified|9|||
145391136|NCT01919164|524287421|FG002|Overall Study|Other Un-specified|8|||
145391137|NCT01919164|524287422|FG003|Overall Study|Other Un-specified|7|||
145391138|NCT01919164|524287423|FG004|Overall Study|Other Un-specified|15|||
145391139|NCT00588146|524287424|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
145391140|NCT00588146|524287425|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
145391141|NCT02100839|524287426|FG000|Multiple Ascending Dose|Adverse Event|2|||
145391142|NCT02100839|524287427|FG001|Multiple Ascending Dose|Adverse Event|0|||
145391143|NCT02100839|524287426|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
145391144|NCT02100839|524287427|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
145391145|NCT00463801|524287432|FG000|Overall Study|Protocol Violation|1|||
145391146|NCT00463801|524287432|FG000|Overall Study|Lack of Efficacy|2|||
145391147|NCT00463801|524287432|FG000|Overall Study|Adverse Event|4|||
145391148|NCT00463801|524287432|FG000|Overall Study|Lost to Follow-up|5|||
145391149|NCT00463801|524287432|FG000|Overall Study|No longer require therapy|1|||
145391150|NCT03272347|524287433|FG000|Overall Study|Death|0|||
145391151|NCT03272347|524287434|FG001|Overall Study|Death|0|||
145391152|NCT03272347|524287435|FG002|Overall Study|Death|0|||
145391153|NCT03272347|524287436|FG003|Overall Study|Death|1|||
145391154|NCT03272347|524287433|FG000|Overall Study|Lost to Follow-up|1|||
145391155|NCT03272347|524287434|FG001|Overall Study|Lost to Follow-up|3|||
145391156|NCT03272347|524287435|FG002|Overall Study|Lost to Follow-up|5|||
145391157|NCT03272347|524287436|FG003|Overall Study|Lost to Follow-up|1|||
145391158|NCT03272347|524287433|FG000|Overall Study|Physician Decision|4|||
145391159|NCT03272347|524287434|FG001|Overall Study|Physician Decision|2|||
145391160|NCT03272347|524287435|FG002|Overall Study|Physician Decision|5|||
145391161|NCT03272347|524287436|FG003|Overall Study|Physician Decision|4|||
145391162|NCT03272347|524287433|FG000|Overall Study|Screen Failure|1|||
145391163|NCT03272347|524287434|FG001|Overall Study|Screen Failure|0|||
145391164|NCT03272347|524287435|FG002|Overall Study|Screen Failure|0|||
145391165|NCT03272347|524287436|FG003|Overall Study|Screen Failure|0|||
145391166|NCT03272347|524287433|FG000|Overall Study|Withdrawal by Subject|5|||
145391167|NCT03272347|524287434|FG001|Overall Study|Withdrawal by Subject|1|||
145391168|NCT03272347|524287435|FG002|Overall Study|Withdrawal by Subject|2|||
145391169|NCT03272347|524287436|FG003|Overall Study|Withdrawal by Subject|1|||
145391170|NCT00940888|524287437|FG000|Overall Study|Unsuccessful Implant|4|||
145391171|NCT00940888|524287437|FG000|Overall Study|Death|461|||
145391172|NCT00940888|524287437|FG000|Overall Study|Withdrawn - Non-Death|364|||
145391173|NCT00940888|524287437|FG000|Overall Study|Lost to Follow-up|6|||
145391174|NCT01971567|524287441|FG000|Overall Study|Withdrawal by Subject|3|||
145391175|NCT01971567|524287442|FG001|Overall Study|Withdrawal by Subject|2|||
145391176|NCT01971567|524287441|FG000|Overall Study|Lost to Follow-up|1|||
145391177|NCT01971567|524287442|FG001|Overall Study|Lost to Follow-up|0|||
145391178|NCT00391872|524287443|FG000|Overall Study|Protocol Violation|7|||
145391179|NCT00391872|524287444|FG001|Overall Study|Protocol Violation|2|||
145391180|NCT00391872|524287443|FG000|Overall Study|Withdrawal by Subject|296|||
145391181|NCT00391872|524287444|FG001|Overall Study|Withdrawal by Subject|249|||
145391182|NCT00391872|524287443|FG000|Overall Study|Reason unknown|2|||
145391183|NCT00391872|524287444|FG001|Overall Study|Reason unknown|4|||
145391184|NCT00391872|524287443|FG000|Overall Study|Lost to Follow-up|2|||
145391185|NCT00391872|524287444|FG001|Overall Study|Lost to Follow-up|0|||
145391186|NCT01409915|524287445|FG000|Overall Study|Adverse Event|0|||
145391187|NCT01409915|524287446|FG001|Overall Study|Adverse Event|2|||
145391188|NCT01409915|524287445|FG000|Overall Study|Withdrawal by Subject|0|||
145391189|NCT01409915|524287446|FG001|Overall Study|Withdrawal by Subject|1|||
145391190|NCT01409915|524287445|FG000|Overall Study|Protocol Violation|1|||
145391191|NCT01409915|524287446|FG001|Overall Study|Protocol Violation|0|||
145391192|NCT00215644|524287447|FG000|Overall Study|Disease Progression|28|||
145391193|NCT00215644|524287448|FG001|Overall Study|Disease Progression|10|||
145391194|NCT00215644|524287447|FG000|Overall Study|Adverse Event|2|||
145391195|NCT00215644|524287448|FG001|Overall Study|Adverse Event|9|||
145391196|NCT00215644|524287447|FG000|Overall Study|Death|1|||
145391197|NCT00215644|524287448|FG001|Overall Study|Death|2|||
145391198|NCT00215644|524287447|FG000|Overall Study|Withdrawal by Subject|1|||
145391199|NCT00215644|524287448|FG001|Overall Study|Withdrawal by Subject|0|||
145391200|NCT00215644|524287447|FG000|Overall Study|Other|3|||
145391201|NCT00215644|524287448|FG001|Overall Study|Other|15|||
145391202|NCT00215644|524287447|FG000|Overall Study|Randomized but Not Treated|1|||
145391203|NCT00215644|524287448|FG001|Overall Study|Randomized but Not Treated|0|||
145391204|NCT02250300|524287449|FG000|Expansion Phase|Death|6|||
145391205|NCT02250300|524287450|FG001|Expansion Phase|Death|7|||
145391206|NCT02250300|524287451|FG002|Expansion Phase|Death|0|||
145391207|NCT02250300|524287452|FG003|Expansion Phase|Death|0|||
145391208|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
145391209|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
145391210|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
145391211|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
145391212|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
145391213|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
145391214|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
145391215|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
145391216|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
145391217|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
145391218|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
145391219|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
145391220|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
145391221|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
145391222|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
145391223|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
145391224|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
145391225|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
145391226|NCT03569098|524287456|FG000|Double-Blind Treatment Cycle 1|Other|1|||
145391227|NCT03569098|524287457|FG001|Double-Blind Treatment Cycle 1|Other|0|||
145391228|NCT03569098|524287458|FG002|Double-Blind Treatment Cycle 1|Other|1|||
145391229|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
145495295|NCT00804908|524671567|FG002|Overall Study|Other|114|||
145391230|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
145391231|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
145391232|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
145391233|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
145391234|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
145391235|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
145391236|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
145391237|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
145391238|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
145391239|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
145391240|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
145391241|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
145495296|NCT02177695|524671568|FG000|ITT Analysis|Ineligible|5|||
145391242|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
145391243|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
145391244|NCT03569098|524287456|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
145391245|NCT03569098|524287457|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
145391246|NCT03569098|524287458|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
145391247|NCT01516736|524287465|FG000|Overall Study|Withdrawal by Subject|10|||
145391248|NCT01516736|524287466|FG001|Overall Study|Withdrawal by Subject|4|||
145391249|NCT01516736|524287465|FG000|Overall Study|Adverse Event|4|||
145391250|NCT01516736|524287466|FG001|Overall Study|Adverse Event|5|||
145391251|NCT01516736|524287465|FG000|Overall Study|Death|3|||
145391252|NCT01516736|524287466|FG001|Overall Study|Death|1|||
145391253|NCT01516736|524287465|FG000|Overall Study|Physician Decision|2|||
145391254|NCT01516736|524287466|FG001|Overall Study|Physician Decision|1|||
145391255|NCT01516736|524287465|FG000|Overall Study|Lack of Efficacy|1|||
145391256|NCT01516736|524287466|FG001|Overall Study|Lack of Efficacy|0|||
145391257|NCT01516736|524287465|FG000|Overall Study|Protocol Violation|0|||
145391258|NCT01516736|524287466|FG001|Overall Study|Protocol Violation|1|||
145391259|NCT01516736|524287465|FG000|Overall Study|Other (not specified)|0|||
145391260|NCT01516736|524287466|FG001|Overall Study|Other (not specified)|1|||
145391261|NCT02781818|524287467|FG000|Overall Study|Lost to Follow-up|4|||
145391262|NCT02781818|524287468|FG001|Overall Study|Lost to Follow-up|2|||
145391263|NCT02781818|524287469|FG002|Overall Study|Lost to Follow-up|1|||
145391264|NCT01877668|524287470|FG000|Overall Study|Death|0|||
145391265|NCT01877668|524287471|FG001|Overall Study|Death|0|||
145391266|NCT01877668|524287472|FG002|Overall Study|Death|0|||
145391267|NCT01877668|524287473|FG003|Overall Study|Death|1|||
145391268|NCT01877668|524287474|FG004|Overall Study|Death|0|||
145391269|NCT01877668|524287470|FG000|Overall Study|No longer met study criteria|1|||
145391270|NCT01877668|524287471|FG001|Overall Study|No longer met study criteria|0|||
145391271|NCT01877668|524287472|FG002|Overall Study|No longer met study criteria|1|||
145391272|NCT01877668|524287473|FG003|Overall Study|No longer met study criteria|0|||
145391273|NCT01877668|524287474|FG004|Overall Study|No longer met study criteria|0|||
145391274|NCT01877668|524287470|FG000|Overall Study|Insufficient clinical response|0|||
145391275|NCT01877668|524287471|FG001|Overall Study|Insufficient clinical response|1|||
145391276|NCT01877668|524287472|FG002|Overall Study|Insufficient clinical response|2|||
145391277|NCT01877668|524287473|FG003|Overall Study|Insufficient clinical response|2|||
145391278|NCT01877668|524287474|FG004|Overall Study|Insufficient clinical response|0|||
145391279|NCT01877668|524287470|FG000|Overall Study|Lost to Follow-up|0|||
145391280|NCT01877668|524287471|FG001|Overall Study|Lost to Follow-up|2|||
145391281|NCT01877668|524287472|FG002|Overall Study|Lost to Follow-up|1|||
145391282|NCT01877668|524287473|FG003|Overall Study|Lost to Follow-up|0|||
145391283|NCT01877668|524287474|FG004|Overall Study|Lost to Follow-up|0|||
145391284|NCT01877668|524287470|FG000|Overall Study|Withdrawal by Subject|2|||
145391285|NCT01877668|524287471|FG001|Overall Study|Withdrawal by Subject|0|||
145391286|NCT01877668|524287472|FG002|Overall Study|Withdrawal by Subject|3|||
145391287|NCT01877668|524287473|FG003|Overall Study|Withdrawal by Subject|2|||
145391288|NCT01877668|524287474|FG004|Overall Study|Withdrawal by Subject|2|||
145391289|NCT01877668|524287470|FG000|Overall Study|Other|1|||
145391290|NCT01877668|524287471|FG001|Overall Study|Other|1|||
145391291|NCT01877668|524287472|FG002|Overall Study|Other|1|||
145391292|NCT01877668|524287473|FG003|Overall Study|Other|1|||
145391293|NCT01877668|524287474|FG004|Overall Study|Other|3|||
145391294|NCT01877668|524287470|FG000|Overall Study|Protocol Violation|1|||
145391295|NCT01877668|524287471|FG001|Overall Study|Protocol Violation|1|||
145391296|NCT01877668|524287472|FG002|Overall Study|Protocol Violation|0|||
145391297|NCT01877668|524287473|FG003|Overall Study|Protocol Violation|0|||
145391298|NCT01877668|524287474|FG004|Overall Study|Protocol Violation|3|||
145391299|NCT01877668|524287470|FG000|Overall Study|Adverse event related to study drug|2|||
145391300|NCT01877668|524287471|FG001|Overall Study|Adverse event related to study drug|2|||
145391301|NCT01877668|524287472|FG002|Overall Study|Adverse event related to study drug|2|||
145391302|NCT01877668|524287473|FG003|Overall Study|Adverse event related to study drug|2|||
145391303|NCT01877668|524287474|FG004|Overall Study|Adverse event related to study drug|1|||
145391304|NCT01877668|524287470|FG000|Overall Study|Adverse event unrelated to study drug|4|||
145391305|NCT01877668|524287471|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145391306|NCT01877668|524287472|FG002|Overall Study|Adverse event unrelated to study drug|2|||
145391307|NCT01877668|524287473|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145391308|NCT01877668|524287474|FG004|Overall Study|Adverse event unrelated to study drug|1|||
145391309|NCT01697800|524287475|FG000|Overall Study|Death|0|||
145391310|NCT01697800|524287476|FG001|Overall Study|Death|1|||
145391311|NCT01302418|524287477|FG000|Overall Study|Protocol Violation|9|||
145391312|NCT01302418|524287477|FG000|Overall Study|Non-evaluable|9|||
145391313|NCT01957579|524287483|FG000|Overall Study|Withdrawal of concent|0|||
145391314|NCT01957579|524287484|FG001|Overall Study|Withdrawal of concent|1|||
145391315|NCT01957579|524287485|FG002|Overall Study|Withdrawal of concent|0|||
145391316|NCT01957579|524287486|FG003|Overall Study|Withdrawal of concent|0|||
145391317|NCT01957579|524287483|FG000|Overall Study|Death|0|||
145391318|NCT01957579|524287484|FG001|Overall Study|Death|0|||
145391319|NCT01957579|524287485|FG002|Overall Study|Death|2|||
145391320|NCT01957579|524287486|FG003|Overall Study|Death|0|||
145495297|NCT02177695|524671569|FG001|ITT Analysis|Ineligible|5|||
145391321|NCT01000974|524287487|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
145391322|NCT01000974|524287488|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
145391323|NCT01000974|524287489|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
145391324|NCT01000974|524287487|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
145391325|NCT01000974|524287488|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
145391326|NCT01000974|524287489|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
145391327|NCT01000974|524287487|FG000|Primary Vaccination Phase|Protocol Violation|40|||
145391328|NCT01000974|524287488|FG001|Primary Vaccination Phase|Protocol Violation|3|||
145391329|NCT01000974|524287489|FG002|Primary Vaccination Phase|Protocol Violation|2|||
145391330|NCT01000974|524287487|FG000|Primary Vaccination Phase|Adverse Event|14|||
145391331|NCT01000974|524287488|FG001|Primary Vaccination Phase|Adverse Event|2|||
145391332|NCT01000974|524287489|FG002|Primary Vaccination Phase|Adverse Event|2|||
145391333|NCT01000974|524287487|FG000|Primary Vaccination Phase|Other|4|||
145391334|NCT01000974|524287488|FG001|Primary Vaccination Phase|Other|9|||
145391335|NCT01000974|524287489|FG002|Primary Vaccination Phase|Other|12|||
145391336|NCT01000974|524287487|FG000|Booster Vaccination Phase|Protocol Violation|0|||
145391337|NCT01000974|524287488|FG001|Booster Vaccination Phase|Protocol Violation|0|||
145391338|NCT01000974|524287489|FG002|Booster Vaccination Phase|Protocol Violation|2|||
145391339|NCT01000974|524287487|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
145391340|NCT01000974|524287488|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
145391341|NCT01000974|524287489|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
145391342|NCT01000974|524287487|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
145391343|NCT01000974|524287488|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
145391344|NCT01000974|524287489|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
145391345|NCT01000974|524287487|FG000|Booster Vaccination Phase|Other|24|||
145391346|NCT01000974|524287488|FG001|Booster Vaccination Phase|Other|6|||
145391347|NCT01000974|524287489|FG002|Booster Vaccination Phase|Other|4|||
145391348|NCT03365934|524287491|FG000|Overall Study|Adverse Event|1|||
145391349|NCT03365934|524287491|FG000|Overall Study|Withdrawal by Subject|1|||
145391350|NCT01307891|524287492|FG000|Overall Study|Progressive Disease|3|||
145391351|NCT01307891|524287493|FG001|Overall Study|Progressive Disease|1|||
145391352|NCT02750332|524287494|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145391353|NCT02750332|524287495|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145391354|NCT02937740|524287496|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
145391355|NCT02937740|524287497|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
145391356|NCT02937740|524287496|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
145391357|NCT02937740|524287497|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
145391358|NCT02937740|524287496|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
145391359|NCT02937740|524287497|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
145391360|NCT02937740|524287496|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
145391361|NCT02937740|524287497|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
145391362|NCT02937740|524287496|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
145391363|NCT02937740|524287497|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
145391364|NCT02937740|524287496|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
145391365|NCT02937740|524287497|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
145391366|NCT02485483|524287503|FG000|Overall Study|Depression at baseline|15|||
145391367|NCT02485483|524287504|FG001|Overall Study|Depression at baseline|0|||
145391368|NCT02485483|524287503|FG000|Overall Study|Discontinued after baseline|39|||
145391369|NCT02485483|524287504|FG001|Overall Study|Discontinued after baseline|0|||
145391370|NCT00823264|524287510|FG000|Overall Study|Protocol Violation|2|||
145391371|NCT00823264|524287511|FG001|Overall Study|Protocol Violation|0|||
145391372|NCT02465437|524287518|FG000|Overall Study|Physician Decision|0|||
145391373|NCT02465437|524287519|FG001|Overall Study|Physician Decision|0|||
145391374|NCT02465437|524287520|FG002|Overall Study|Physician Decision|1|||
145391375|NCT02465437|524287521|FG003|Overall Study|Physician Decision|0|||
145391376|NCT02465437|524287518|FG000|Overall Study|Withdrawal by Subject|1|||
145391377|NCT02465437|524287519|FG001|Overall Study|Withdrawal by Subject|0|||
145391378|NCT02465437|524287520|FG002|Overall Study|Withdrawal by Subject|0|||
145391379|NCT02465437|524287521|FG003|Overall Study|Withdrawal by Subject|1|||
145391380|NCT02465437|524287518|FG000|Overall Study|Adverse Event|0|||
145391381|NCT02465437|524287519|FG001|Overall Study|Adverse Event|1|||
145391382|NCT02465437|524287520|FG002|Overall Study|Adverse Event|0|||
145391383|NCT02465437|524287521|FG003|Overall Study|Adverse Event|0|||
145391384|NCT00103662|524287522|FG000|Overall Study|Entered Rescue Procedure|0|||
145391385|NCT00103662|524287523|FG001|Overall Study|Entered Rescue Procedure|7|||
145391386|NCT00103662|524287522|FG000|Overall Study|Death|7|||
145391387|NCT00103662|524287523|FG001|Overall Study|Death|7|||
145391388|NCT00103662|524287522|FG000|Overall Study|Elective Withdrawal|5|||
145391389|NCT00103662|524287523|FG001|Overall Study|Elective Withdrawal|5|||
145391390|NCT00103662|524287522|FG000|Overall Study|Lost to Follow-up|0|||
145391391|NCT00103662|524287523|FG001|Overall Study|Lost to Follow-up|1|||
145391392|NCT00103662|524287522|FG000|Overall Study|Other|6|||
145391393|NCT00103662|524287523|FG001|Overall Study|Other|9|||
145391394|NCT00103662|524287522|FG000|Overall Study|Failed mobilization|0|||
145391395|NCT00103662|524287523|FG001|Overall Study|Failed mobilization|4|||
145391396|NCT00103662|524287522|FG000|Overall Study|Intercurrent illness|1|||
145391397|NCT00103662|524287523|FG001|Overall Study|Intercurrent illness|0|||
145391398|NCT03373760|524287524|FG000|Overall Study|Adverse Event|8|||
145391399|NCT03373760|524287524|FG000|Overall Study|Disease Progression|46|||
145391400|NCT03373760|524287524|FG000|Overall Study|Death|4|||
145391401|NCT01093586|524287525|FG000|Overall Study|Failed to engraft|3|||
145391402|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
145391403|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
145391404|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
145391405|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
145391406|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
145391407|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
145391408|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
145391409|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
145391410|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
145391411|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
145391412|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
145391413|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
145391414|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
145391415|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
145391416|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Death|1|||
145391417|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Death|0|||
145391418|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
145391419|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
145495298|NCT02177695|524671568|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
145729778|NCT01028222|525528983|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
145729779|NCT01028222|525528984|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
145729780|NCT01028222|525528983|FG000|Overall Study|Adverse Event|2|||
145729781|NCT01028222|525528984|FG001|Overall Study|Adverse Event|0|||
145729782|NCT00567268|525528985|FG000|Overall Study|Protocol Violation|7|||
145729783|NCT00567268|525528985|FG000|Overall Study|Lost to Follow-up|36|||
145729784|NCT00567268|525528985|FG000|Overall Study|No Visit After First Day of Treatment|2|||
145729785|NCT00567268|525528985|FG000|Overall Study|No Drug Administration|4|||
145729786|NCT00567268|525528985|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
145729787|NCT02598557|525528986|FG000|Overall Study|Withdrawal by Subject|1|||
145729788|NCT02598557|525528987|FG001|Overall Study|Withdrawal by Subject|0|||
145729789|NCT02598557|525528988|FG002|Overall Study|Withdrawal by Subject|1|||
145729790|NCT02598557|525528986|FG000|Overall Study|Participant did not start treatment|2|||
145729791|NCT02598557|525528987|FG001|Overall Study|Participant did not start treatment|1|||
145729792|NCT02598557|525528988|FG002|Overall Study|Participant did not start treatment|1|||
145729793|NCT02598557|525528986|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
145729794|NCT02598557|525528987|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
145729795|NCT02598557|525528988|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
145729796|NCT02598557|525528986|FG000|Overall Study|Adverse Event|1|||
145729797|NCT02598557|525528987|FG001|Overall Study|Adverse Event|1|||
145729798|NCT02598557|525528988|FG002|Overall Study|Adverse Event|0|||
145391420|NCT00105989|524287526|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
145605895|NCT00633932|525073035|FG001|Overall Study|Physician Decision|0|||
145391421|NCT00105989|524287527|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
145391422|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
145391423|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
145391424|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
145391425|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
145391426|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
145391427|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
145391428|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
145391429|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
145391430|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
145391431|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
145391432|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
145391433|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
145391434|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
145391435|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
145391436|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Death|0|||
145391437|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Death|0|||
145391438|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
145391439|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
145391440|NCT00105989|524287526|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
145391441|NCT00105989|524287527|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
145391442|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
145391443|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
145391444|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
145391445|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
145391446|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
145391447|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
145391448|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
145391449|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
145391450|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
145391451|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
145391452|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
145391453|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
145391454|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
145391455|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
145391456|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
145391457|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
145391458|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
145391459|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
145391460|NCT00105989|524287526|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
145391461|NCT00105989|524287527|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
145391462|NCT01300247|524287528|FG000|Overall Study|Death|1|||
145391463|NCT01300247|524287529|FG001|Overall Study|Death|1|||
145391464|NCT01300247|524287528|FG000|Overall Study|Lost to Follow-up|2|||
145391465|NCT01300247|524287529|FG001|Overall Study|Lost to Follow-up|0|||
145391466|NCT01300247|524287528|FG000|Overall Study|Withdrawal by Subject|1|||
145391467|NCT01300247|524287529|FG001|Overall Study|Withdrawal by Subject|0|||
145391468|NCT01300247|524287528|FG000|Overall Study|Non-Compliance|0|||
145391469|NCT01300247|524287529|FG001|Overall Study|Non-Compliance|1|||
145391470|NCT03060291|524287530|FG000|3-month Follow-up|Declined to respond|8|||
145391471|NCT03060291|524287531|FG001|3-month Follow-up|Declined to respond|10|||
145391472|NCT03060291|524287532|FG002|3-month Follow-up|Declined to respond|2|||
145391473|NCT03060291|524287530|FG000|6-month Follow-up|Declined to respond|7|||
145391474|NCT03060291|524287531|FG001|6-month Follow-up|Declined to respond|13|||
145391475|NCT03060291|524287532|FG002|6-month Follow-up|Declined to respond|4|||
145391476|NCT03060291|524287530|FG000|12-month Follow-up|Declined to respond|7|||
145391477|NCT03060291|524287531|FG001|12-month Follow-up|Declined to respond|16|||
145391478|NCT03060291|524287532|FG002|12-month Follow-up|Declined to respond|6|||
145495299|NCT02177695|524671569|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
145495300|NCT02177695|524671568|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
145495301|NCT02177695|524671569|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
145495302|NCT02177695|524671568|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
145495303|NCT02177695|524671569|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
145495304|NCT00248625|524671572|FG000|Overall Study|Withdrawal by Subject|0|||
145495305|NCT00248625|524671573|FG001|Overall Study|Withdrawal by Subject|2|||
145495306|NCT05176314|524671582|FG000|Overall Study|Lost to Follow-up|2|||
145729799|NCT02072434|525528989|FG000|Overall Study|Protocol Violation|10|||
145495307|NCT05176314|524671582|FG000|Overall Study|Physician Decision|1|||
145495308|NCT05176314|524671582|FG000|Overall Study|Adverse Event|1|||
145495309|NCT02939287|524671590|FG000|Overall Study|met exclusion criteria|1|||
145495310|NCT02939287|524671591|FG001|Overall Study|met exclusion criteria|1|||
145495311|NCT02939287|524671592|FG002|Overall Study|met exclusion criteria|1|||
145495312|NCT02939287|524671590|FG000|Overall Study|Did not complete survey|2|||
145495313|NCT02939287|524671591|FG001|Overall Study|Did not complete survey|2|||
145495314|NCT02939287|524671592|FG002|Overall Study|Did not complete survey|0|||
145391479|NCT03743025|524287533|FG000|Overall Study|Surgery was cancelled|2|||
145391480|NCT03743025|524287534|FG001|Overall Study|Surgery was cancelled|1|||
145391481|NCT03131687|524287539|FG000|Overall Study|Adverse Event|0|||
145495315|NCT02939287|524671590|FG000|Overall Study|Withdrawal by Subject|1|||
145495316|NCT02939287|524671591|FG001|Overall Study|Withdrawal by Subject|1|||
145495317|NCT02939287|524671592|FG002|Overall Study|Withdrawal by Subject|0|||
145495318|NCT00671658|524671597|FG000|Overall Study|Physician Decision|5|||
145495319|NCT01680341|524671602|FG000|Overall Study|Adverse Event|3|||
145495320|NCT01680341|524671603|FG001|Overall Study|Adverse Event|2|||
145495321|NCT01680341|524671602|FG000|Overall Study|Unclassified|18|||
145495322|NCT01680341|524671603|FG001|Overall Study|Unclassified|15|||
145495323|NCT00499486|524671605|FG000|Overall Study|Withdrawal by Subject|16|||
145495324|NCT03796728|524671606|FG000|Overall Study|Lost to Follow-up|8|||
145495325|NCT03796728|524671606|FG000|Overall Study|Reason not Specified|16|||
145495326|NCT00333775|524671608|FG000|Overall Study|Death|144|||
145495327|NCT00333775|524671609|FG001|Overall Study|Death|149|||
145495328|NCT00333775|524671610|FG002|Overall Study|Death|143|||
145495329|NCT00333775|524671608|FG000|Overall Study|In Follow-up When Study Stopped|87|||
145391482|NCT03131687|524287540|FG001|Overall Study|Adverse Event|1|||
145391483|NCT03131687|524287541|FG002|Overall Study|Adverse Event|0|||
145391484|NCT03131687|524287542|FG003|Overall Study|Adverse Event|1|||
145391485|NCT03131687|524287543|FG004|Overall Study|Adverse Event|2|||
145391486|NCT03131687|524287544|FG005|Overall Study|Adverse Event|2|||
145391487|NCT03131687|524287539|FG000|Overall Study|Death|1|||
145391488|NCT03131687|524287540|FG001|Overall Study|Death|0|||
145391489|NCT03131687|524287541|FG002|Overall Study|Death|0|||
145391490|NCT03131687|524287542|FG003|Overall Study|Death|0|||
145391491|NCT03131687|524287543|FG004|Overall Study|Death|0|||
145391492|NCT03131687|524287544|FG005|Overall Study|Death|0|||
145391493|NCT03131687|524287539|FG000|Overall Study|Withdrawal by Subject|3|||
145391494|NCT03131687|524287540|FG001|Overall Study|Withdrawal by Subject|3|||
145391495|NCT03131687|524287541|FG002|Overall Study|Withdrawal by Subject|3|||
145391496|NCT03131687|524287542|FG003|Overall Study|Withdrawal by Subject|1|||
145391497|NCT03131687|524287543|FG004|Overall Study|Withdrawal by Subject|2|||
145391498|NCT03131687|524287544|FG005|Overall Study|Withdrawal by Subject|1|||
145391499|NCT03131687|524287539|FG000|Overall Study|Lost to Follow-up|1|||
145391500|NCT03131687|524287540|FG001|Overall Study|Lost to Follow-up|4|||
145391501|NCT03131687|524287541|FG002|Overall Study|Lost to Follow-up|0|||
145391502|NCT03131687|524287542|FG003|Overall Study|Lost to Follow-up|1|||
145391503|NCT03131687|524287543|FG004|Overall Study|Lost to Follow-up|4|||
145391504|NCT03131687|524287544|FG005|Overall Study|Lost to Follow-up|2|||
145391505|NCT03131687|524287539|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
145391506|NCT03131687|524287540|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
145495330|NCT00333775|524671609|FG001|Overall Study|In Follow-up When Study Stopped|92|||
145495331|NCT00333775|524671610|FG002|Overall Study|In Follow-up When Study Stopped|96|||
145495332|NCT00333775|524671608|FG000|Overall Study|Lost to Follow-up|10|||
145495333|NCT00333775|524671609|FG001|Overall Study|Lost to Follow-up|7|||
145495334|NCT00333775|524671610|FG002|Overall Study|Lost to Follow-up|8|||
145495335|NCT01383928|524671614|FG000|Overall Study|Initiation of ASCT|2|||
145495336|NCT01383928|524671615|FG001|Overall Study|Initiation of ASCT|1|||
145495337|NCT01383928|524671616|FG002|Overall Study|Initiation of ASCT|18|||
145391507|NCT03131687|524287541|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
145391508|NCT03131687|524287542|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
145495338|NCT01383928|524671614|FG000|Overall Study|Adverse Event|1|||
145495339|NCT01383928|524671615|FG001|Overall Study|Adverse Event|2|||
145495340|NCT01383928|524671616|FG002|Overall Study|Adverse Event|8|||
145391509|NCT03131687|524287543|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
145495341|NCT01383928|524671614|FG000|Overall Study|Other|1|||
145391510|NCT03131687|524287544|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
145391511|NCT03131687|524287539|FG000|Overall Study|Principle Investigator Decision|0|||
145391512|NCT03131687|524287540|FG001|Overall Study|Principle Investigator Decision|1|||
145391513|NCT03131687|524287541|FG002|Overall Study|Principle Investigator Decision|0|||
145391514|NCT03131687|524287542|FG003|Overall Study|Principle Investigator Decision|0|||
145391515|NCT03131687|524287543|FG004|Overall Study|Principle Investigator Decision|0|||
145391516|NCT03131687|524287544|FG005|Overall Study|Principle Investigator Decision|0|||
145391517|NCT03131687|524287539|FG000|Overall Study|Inadvertent Enrollment|0|||
145391518|NCT03131687|524287540|FG001|Overall Study|Inadvertent Enrollment|0|||
145391519|NCT03131687|524287541|FG002|Overall Study|Inadvertent Enrollment|0|||
145391520|NCT03131687|524287542|FG003|Overall Study|Inadvertent Enrollment|1|||
145391521|NCT03131687|524287543|FG004|Overall Study|Inadvertent Enrollment|0|||
145391522|NCT03131687|524287544|FG005|Overall Study|Inadvertent Enrollment|0|||
145391523|NCT00869128|524287545|FG000|Overall Study|lack of Compliance|6|||
145391524|NCT00869128|524287546|FG001|Overall Study|lack of Compliance|6|||
145391525|NCT04039204|524287547|FG000|Overall Study|Withdrawal by Subject|0|||
145391526|NCT04039204|524287548|FG001|Overall Study|Withdrawal by Subject|2|||
145391527|NCT00656175|524287549|FG000|Overall Study|Adverse Event|1|||
145391528|NCT00656175|524287550|FG001|Overall Study|Adverse Event|0|||
145391529|NCT00656175|524287549|FG000|Overall Study|Transportation issues|0|||
145391530|NCT00656175|524287550|FG001|Overall Study|Transportation issues|1|||
145391531|NCT01903993|524287553|FG000|Overall Study|Death|118|||
145391532|NCT01903993|524287554|FG001|Overall Study|Death|121|||
145391533|NCT01903993|524287553|FG000|Overall Study|Withdrawal by Subject|15|||
145391534|NCT01903993|524287554|FG001|Overall Study|Withdrawal by Subject|4|||
145391535|NCT01903993|524287553|FG000|Overall Study|Lost to Follow-up|2|||
145391536|NCT01903993|524287554|FG001|Overall Study|Lost to Follow-up|3|||
145391537|NCT01903993|524287553|FG000|Overall Study|Study Terminated by Sponsor|8|||
145391538|NCT01903993|524287554|FG001|Overall Study|Study Terminated by Sponsor|14|||
145391539|NCT01903993|524287553|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
145391540|NCT01903993|524287554|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
145391541|NCT02282163|524287555|FG000|Overall Study|Protocol Violation|1|||
145391542|NCT03472521|524287556|FG000|Overall Study|Lost to Follow-up|3|||
145391543|NCT03472521|524287557|FG001|Overall Study|Lost to Follow-up|2|||
145391544|NCT03472521|524287556|FG000|Overall Study|Discontinued intervention|3|||
145391545|NCT03472521|524287557|FG001|Overall Study|Discontinued intervention|1|||
145391546|NCT00452439|524289513|FG000|Overall Study|Lost to Follow-up|1|||
145391547|NCT00452439|524289514|FG001|Overall Study|Lost to Follow-up|1|||
145391548|NCT00452439|524289513|FG000|Overall Study|Refused Treatment|4|||
145391549|NCT00452439|524289514|FG001|Overall Study|Refused Treatment|3|||
145391550|NCT00452439|524289513|FG000|Overall Study|Death|3|||
145391551|NCT00452439|524289514|FG001|Overall Study|Death|1|||
145391552|NCT00452439|524289513|FG000|Overall Study|Bone Marrow Transplant|0|||
145391553|NCT00452439|524289514|FG001|Overall Study|Bone Marrow Transplant|1|||
145391554|NCT00452439|524289513|FG000|Overall Study|Too Ill to Continue|0|||
145391555|NCT00452439|524289514|FG001|Overall Study|Too Ill to Continue|1|||
145391556|NCT00452439|524289513|FG000|Overall Study|Failed to achieve complete response|2|||
145391557|NCT00452439|524289514|FG001|Overall Study|Failed to achieve complete response|0|||
145391558|NCT00452439|524289513|FG000|Overall Study|Relapse|3|||
145391559|NCT00452439|524289514|FG001|Overall Study|Relapse|0|||
145391560|NCT00452439|524289513|FG000|Overall Study|Fracture|1|||
145391561|NCT00452439|524289514|FG001|Overall Study|Fracture|0|||
145391562|NCT01381926|524289515|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
145391563|NCT01381926|524289516|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
145391564|NCT01381926|524289515|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
145391565|NCT01381926|524289516|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
145391566|NCT04826484|524289533|FG000|Overall Study|Lost to Follow-up|2|||
145391567|NCT04826484|524289534|FG001|Overall Study|Lost to Follow-up|0|||
145391568|NCT03512353|524289537|FG000|Overall Study|Sponsor Decision|3|||
145391569|NCT03512353|524289537|FG000|Overall Study|Death|1|||
145391570|NCT00758498|524289538|FG000|Overall Study|Adverse Event|2|||
145391571|NCT00758498|524289539|FG001|Overall Study|Adverse Event|2|||
145391572|NCT00758498|524289540|FG002|Overall Study|Adverse Event|3|||
145391573|NCT00758498|524289538|FG000|Overall Study|Subject legally detained out of state|1|||
145391574|NCT00758498|524289539|FG001|Overall Study|Subject legally detained out of state|0|||
145495342|NCT01383928|524671615|FG001|Overall Study|Other|3|||
145391575|NCT00758498|524289540|FG002|Overall Study|Subject legally detained out of state|0|||
145391576|NCT00758498|524289538|FG000|Overall Study|Withdrawal by Subject|0|||
145391577|NCT00758498|524289539|FG001|Overall Study|Withdrawal by Subject|0|||
145391578|NCT00758498|524289540|FG002|Overall Study|Withdrawal by Subject|1|||
145391579|NCT00758498|524289538|FG000|Overall Study|Noncompliance to study procedures|0|||
145391580|NCT00758498|524289539|FG001|Overall Study|Noncompliance to study procedures|0|||
145391581|NCT00758498|524289540|FG002|Overall Study|Noncompliance to study procedures|1|||
145391582|NCT02581488|524289544|FG000|Overall Study|Adverse Event|6|||
145391583|NCT02581488|524289545|FG001|Overall Study|Adverse Event|7|||
145495343|NCT01383928|524671616|FG002|Overall Study|Other|4|||
145391584|NCT02581488|524289544|FG000|Overall Study|Lost to Follow-up|1|||
145391585|NCT02581488|524289545|FG001|Overall Study|Lost to Follow-up|0|||
145391586|NCT02581488|524289544|FG000|Overall Study|Withdrawal by Subject|1|||
145391587|NCT02581488|524289545|FG001|Overall Study|Withdrawal by Subject|0|||
145391588|NCT02581488|524289544|FG000|Overall Study|Non-Compliance|1|||
145391589|NCT02581488|524289545|FG001|Overall Study|Non-Compliance|0|||
145391590|NCT02581488|524289544|FG000|Overall Study|Protocol Violation|0|||
145391591|NCT02581488|524289545|FG001|Overall Study|Protocol Violation|4|||
145391592|NCT00954122|524289546|FG000|Overall Study|Withdrawal by Subject|5|||
145391593|NCT00954122|524289546|FG000|Overall Study|Adverse Event|1|||
145391594|NCT00954122|524289546|FG000|Overall Study|Safety Reason|1|||
145391595|NCT03334188|524289553|FG000|Overall Study|Withdrawal by Subject|0|||
145391596|NCT03334188|524289554|FG001|Overall Study|Withdrawal by Subject|1|||
145391597|NCT03334188|524289553|FG000|Overall Study|Death|1|||
145391598|NCT03334188|524289554|FG001|Overall Study|Death|0|||
145391599|NCT03334188|524289553|FG000|Overall Study|Never had qualifying clinic visit|7|||
145391600|NCT03334188|524289554|FG001|Overall Study|Never had qualifying clinic visit|7|||
145391601|NCT03442088|524289561|FG000|Overall Study|Adverse Event|1|||
145391602|NCT03442088|524289561|FG000|Overall Study|Lack of Efficacy|2|||
145391603|NCT03442088|524289561|FG000|Overall Study|Lost to Follow-up|2|||
145391604|NCT01001520|524289562|FG000|Medication Period 1|Withdrawal by Subject|2|||
145391605|NCT01001520|524289563|FG001|Medication Period 1|Withdrawal by Subject|2|||
145391606|NCT01001520|524289562|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
145391607|NCT01001520|524289563|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
145391608|NCT01001520|524289562|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
145391609|NCT01001520|524289563|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
145391610|NCT01001520|524289562|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
145391611|NCT01001520|524289563|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
145391612|NCT01001520|524289562|FG000|Washout Period|Withdrawal by Subject|2|||
145391613|NCT01001520|524289563|FG001|Washout Period|Withdrawal by Subject|1|||
145391614|NCT01001520|524289562|FG000|Medication Period 2|Withdrawal by Subject|0|||
145391615|NCT01001520|524289563|FG001|Medication Period 2|Withdrawal by Subject|3|||
145391616|NCT00357877|524289564|FG000|Overall Study|Death|2|||
145391617|NCT00357877|524289565|FG001|Overall Study|Death|1|||
145391618|NCT00357877|524289564|FG000|Overall Study|Lost to Follow-up|20|||
145391619|NCT00357877|524289565|FG001|Overall Study|Lost to Follow-up|23|||
145391620|NCT00357877|524289564|FG000|Overall Study|Withdrawal by Subject|3|||
145391621|NCT00357877|524289565|FG001|Overall Study|Withdrawal by Subject|3|||
145391622|NCT00357877|524289564|FG000|Overall Study|Administrative withdrawal|1|||
145391623|NCT00357877|524289565|FG001|Overall Study|Administrative withdrawal|1|||
145391624|NCT00357877|524289564|FG000|Overall Study|Other|0|||
145391625|NCT00357877|524289565|FG001|Overall Study|Other|2|||
145391626|NCT04668209|524289568|FG000|Overall Study|Withdrawal by Subject|2|||
145391627|NCT04668209|524289569|FG001|Overall Study|Withdrawal by Subject|2|||
145391628|NCT04668209|524289568|FG000|Overall Study|Lost to Follow-up|3|||
145391629|NCT04668209|524289569|FG001|Overall Study|Lost to Follow-up|4|||
145391630|NCT04668209|524289568|FG000|Overall Study|Subject Expired|2|||
145391631|NCT04668209|524289569|FG001|Overall Study|Subject Expired|0|||
145391632|NCT04668209|524289568|FG000|Overall Study|Withdrawn from study|0|||
145391633|NCT04668209|524289569|FG001|Overall Study|Withdrawn from study|1|||
145391634|NCT04668209|524289568|FG000|Overall Study|Adverse Event|0|||
145391635|NCT04668209|524289569|FG001|Overall Study|Adverse Event|1|||
145391636|NCT00613366|524289579|FG000|Overall Study|Withdrawal by Subject|3|||
145391637|NCT00613366|524289580|FG001|Overall Study|Withdrawal by Subject|2|||
145391638|NCT02907463|524289581|FG000|Overall Study|Lost to Follow-up|17|||
145391639|NCT02907463|524289581|FG000|Overall Study|Death|10|||
145391640|NCT02907463|524289581|FG000|Overall Study|Withdrawal by Subject|4|||
145391641|NCT02907463|524289581|FG000|Overall Study|MIS Approach was not used|2|||
145391642|NCT02907463|524289581|FG000|Overall Study|Not Implanted with Study Device|2|||
145391643|NCT02907463|524289581|FG000|Overall Study|Device Explanted|1|||
145391644|NCT02907463|524289581|FG000|Overall Study|Missing Exit Form|1|||
145391645|NCT04878055|524289582|FG000|Overall Study|Patient transferred in another department|0|||
145391646|NCT04878055|524289583|FG001|Overall Study|Patient transferred in another department|2|||
145391647|NCT04878055|524289582|FG000|Overall Study|Physician Decision|1|||
145391648|NCT04878055|524289583|FG001|Overall Study|Physician Decision|1|||
145391649|NCT04878055|524289582|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
145391650|NCT04878055|524289583|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
145391651|NCT04878055|524289582|FG000|Overall Study|Adverse Event|12|||
145391652|NCT04878055|524289583|FG001|Overall Study|Adverse Event|7|||
145391653|NCT04878055|524289582|FG000|Overall Study|Other|5|||
145391654|NCT04878055|524289583|FG001|Overall Study|Other|0|||
145391655|NCT04878055|524289582|FG000|Overall Study|Withdrawal by Subject|7|||
145391656|NCT04878055|524289583|FG001|Overall Study|Withdrawal by Subject|3|||
145391657|NCT04878055|524289582|FG000|Overall Study|Lost to Follow-up|10|||
145391658|NCT04878055|524289583|FG001|Overall Study|Lost to Follow-up|1|||
145391659|NCT05225558|524289589|FG000|Overall Study|Withdrawal by Subject|4|||
145391660|NCT05225558|524289590|FG001|Overall Study|Withdrawal by Subject|3|||
145391661|NCT05225558|524289589|FG000|Overall Study|Adverse Event|1|||
145391662|NCT05225558|524289590|FG001|Overall Study|Adverse Event|0|||
145391663|NCT05225558|524289589|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
145391664|NCT05225558|524289590|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
145391665|NCT05225558|524289589|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
145391666|NCT05225558|524289590|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
145391667|NCT00970489|524289591|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
145391668|NCT00970489|524289592|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
145391669|NCT02659943|524289593|FG000|Overall Study|Switched to alternative treatment|1|||
145391670|NCT02659943|524289594|FG001|Overall Study|Switched to alternative treatment|1|||
145391671|NCT02659943|524289595|FG002|Overall Study|Switched to alternative treatment|0|||
145391672|NCT02659943|524289596|FG003|Overall Study|Switched to alternative treatment|2|||
145391673|NCT02659943|524289597|FG004|Overall Study|Switched to alternative treatment|1|||
145391674|NCT02659943|524289598|FG005|Overall Study|Switched to alternative treatment|0|||
145391675|NCT02659943|524289599|FG006|Overall Study|Switched to alternative treatment|1|||
145391676|NCT02659943|524289593|FG000|Overall Study|Disease progression on study|0|||
145391677|NCT02659943|524289594|FG001|Overall Study|Disease progression on study|1|||
145391678|NCT02659943|524289595|FG002|Overall Study|Disease progression on study|1|||
145391679|NCT02659943|524289596|FG003|Overall Study|Disease progression on study|1|||
145391680|NCT02659943|524289597|FG004|Overall Study|Disease progression on study|1|||
145391681|NCT02659943|524289598|FG005|Overall Study|Disease progression on study|4|||
145391682|NCT02659943|524289599|FG006|Overall Study|Disease progression on study|0|||
145391683|NCT02659943|524289593|FG000|Overall Study|Patient's condition per principal investigator|0|||
145391684|NCT02659943|524289594|FG001|Overall Study|Patient's condition per principal investigator|0|||
145391685|NCT02659943|524289595|FG002|Overall Study|Patient's condition per principal investigator|0|||
145391686|NCT02659943|524289596|FG003|Overall Study|Patient's condition per principal investigator|0|||
145391687|NCT02659943|524289597|FG004|Overall Study|Patient's condition per principal investigator|0|||
145391688|NCT02659943|524289598|FG005|Overall Study|Patient's condition per principal investigator|1|||
145391689|NCT02659943|524289599|FG006|Overall Study|Patient's condition per principal investigator|0|||
145391690|NCT02659943|524289593|FG000|Overall Study|Ineligible|0|||
145391691|NCT02659943|524289594|FG001|Overall Study|Ineligible|0|||
145391692|NCT02659943|524289595|FG002|Overall Study|Ineligible|0|||
145391693|NCT02659943|524289596|FG003|Overall Study|Ineligible|0|||
145391694|NCT02659943|524289597|FG004|Overall Study|Ineligible|0|||
145391695|NCT02659943|524289598|FG005|Overall Study|Ineligible|0|||
145391696|NCT02659943|524289599|FG006|Overall Study|Ineligible|1|||
145391697|NCT02659943|524289593|FG000|Overall Study|No longer meets eligibility|0|||
145391698|NCT02659943|524289594|FG001|Overall Study|No longer meets eligibility|0|||
145391699|NCT02659943|524289595|FG002|Overall Study|No longer meets eligibility|0|||
145391700|NCT02659943|524289596|FG003|Overall Study|No longer meets eligibility|0|||
145391701|NCT02659943|524289597|FG004|Overall Study|No longer meets eligibility|0|||
145391702|NCT02659943|524289598|FG005|Overall Study|No longer meets eligibility|0|||
145391703|NCT02659943|524289599|FG006|Overall Study|No longer meets eligibility|1|||
145391704|NCT02659943|524289593|FG000|Overall Study|No treatment, per protocol|0|||
145391705|NCT02659943|524289594|FG001|Overall Study|No treatment, per protocol|0|||
145391706|NCT02659943|524289595|FG002|Overall Study|No treatment, per protocol|0|||
145391707|NCT02659943|524289596|FG003|Overall Study|No treatment, per protocol|0|||
145391708|NCT02659943|524289597|FG004|Overall Study|No treatment, per protocol|0|||
145391709|NCT02659943|524289598|FG005|Overall Study|No treatment, per protocol|0|||
145391710|NCT02659943|524289599|FG006|Overall Study|No treatment, per protocol|3|||
145391711|NCT01723072|524289600|FG000|Overall Study|Withdrawal by Subject|7|||
145391712|NCT01723072|524289601|FG001|Overall Study|Withdrawal by Subject|13|||
145391713|NCT01723072|524289600|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
145391714|NCT01723072|524289601|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
145391715|NCT01723072|524289600|FG000|Overall Study|Other|4|||
145391716|NCT01723072|524289601|FG001|Overall Study|Other|3|||
145391717|NCT03428100|524289602|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
145391718|NCT03428100|524289603|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391719|NCT03428100|524289604|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
145391720|NCT03428100|524289605|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
145391721|NCT03428100|524289606|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391722|NCT03428100|524289607|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391723|NCT03428100|524289608|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391724|NCT03428100|524289609|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391725|NCT03428100|524289610|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391726|NCT03428100|524289611|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391727|NCT03428100|524289612|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145495344|NCT01383928|524671614|FG000|Overall Study|Progressive Disease|1|||
145495345|NCT01383928|524671615|FG001|Overall Study|Progressive Disease|1|||
145391728|NCT03428100|524289613|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391729|NCT03428100|524289614|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391730|NCT03428100|524289615|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391731|NCT03428100|524289616|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391732|NCT03428100|524289617|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391733|NCT03428100|524289618|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391734|NCT03428100|524289619|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391735|NCT03428100|524289620|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
145391736|NCT03428100|524289602|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
145391737|NCT03428100|524289603|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
145391738|NCT03428100|524289604|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
145391739|NCT03428100|524289605|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
145391740|NCT03428100|524289606|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391741|NCT03428100|524289607|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391742|NCT03428100|524289608|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391743|NCT03428100|524289609|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391744|NCT03428100|524289610|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391745|NCT03428100|524289611|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391746|NCT03428100|524289612|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391747|NCT03428100|524289613|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391748|NCT03428100|524289614|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391749|NCT03428100|524289615|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391750|NCT03428100|524289616|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391751|NCT03428100|524289617|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391752|NCT03428100|524289618|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391753|NCT03428100|524289619|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391754|NCT03428100|524289620|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
145391755|NCT03428100|524289602|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391756|NCT03428100|524289603|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
145391757|NCT03428100|524289604|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
145391758|NCT03428100|524289605|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391759|NCT03428100|524289606|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391760|NCT03428100|524289607|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391761|NCT03428100|524289608|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391762|NCT03428100|524289609|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391763|NCT03428100|524289610|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391764|NCT03428100|524289611|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391765|NCT03428100|524289612|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391766|NCT03428100|524289613|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391767|NCT03428100|524289614|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391768|NCT03428100|524289615|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391769|NCT03428100|524289616|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391770|NCT03428100|524289617|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391771|NCT03428100|524289618|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391772|NCT03428100|524289619|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391773|NCT03428100|524289620|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
145391774|NCT03428100|524289602|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
145391775|NCT03428100|524289603|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391776|NCT03428100|524289604|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391777|NCT03428100|524289605|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391778|NCT03428100|524289606|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391779|NCT03428100|524289607|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391780|NCT03428100|524289608|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391781|NCT03428100|524289609|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391782|NCT03428100|524289610|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391783|NCT03428100|524289611|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391784|NCT03428100|524289612|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391785|NCT03428100|524289613|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391786|NCT03428100|524289614|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391787|NCT03428100|524289615|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391788|NCT03428100|524289616|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391789|NCT03428100|524289617|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391790|NCT03428100|524289618|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391791|NCT03428100|524289619|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391792|NCT03428100|524289620|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
145391793|NCT03428100|524289602|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391794|NCT03428100|524289603|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
145391795|NCT03428100|524289604|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391796|NCT03428100|524289605|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391797|NCT03428100|524289606|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391798|NCT03428100|524289607|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391799|NCT03428100|524289608|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391800|NCT03428100|524289609|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391801|NCT03428100|524289610|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391802|NCT03428100|524289611|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391803|NCT03428100|524289612|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391804|NCT03428100|524289613|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391805|NCT03428100|524289614|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391806|NCT03428100|524289615|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391807|NCT03428100|524289616|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391808|NCT03428100|524289617|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391809|NCT03428100|524289618|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391810|NCT03428100|524289619|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391811|NCT03428100|524289620|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
145391812|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391813|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391814|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391815|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391816|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391817|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
145391818|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391819|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
145391820|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391821|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391822|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391823|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391824|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
145391825|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391826|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391827|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
145391828|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
145391829|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391830|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
145391831|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
145391832|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
145391833|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
145391834|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
145391835|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
145391836|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
145391837|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
145391838|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
145391839|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
145391840|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
145391841|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
145391842|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
145391843|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
145391844|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
145391845|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
145391846|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
145391847|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
145391848|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
145391849|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
145391850|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391851|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391852|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391853|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391854|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
145391855|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
145391856|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
145391857|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145391858|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391859|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145391860|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145391861|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
145391862|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
145391863|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
145391864|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
145391865|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
145391866|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145391867|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
145391868|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
145391869|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391870|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391871|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391872|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391873|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391874|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391875|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391876|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145391877|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391878|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391879|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391880|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
145391881|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145391882|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391883|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
145391884|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391885|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391886|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
145391887|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
145391888|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
145391889|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
145391890|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
145391891|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
145391892|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
145391893|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
145391894|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
145391895|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
145391896|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
145391897|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
145391898|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
145391899|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
145391900|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
145391901|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
145391902|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
145391903|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
145391904|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
145391905|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
145391906|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
145391907|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391908|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391909|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391910|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391911|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391912|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391913|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
145391914|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391915|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391916|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391917|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391918|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391919|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391920|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391921|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391922|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391923|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391924|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
145391925|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
145391926|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145391927|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145391928|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145391929|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
145391930|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
145391931|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
145391932|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145391933|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145391934|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
145391935|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
145391936|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
145391937|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
145391938|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
145391939|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
145391940|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
145391941|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
145391942|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
145391943|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
145391944|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
145391945|NCT03428100|524289602|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391946|NCT03428100|524289603|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391947|NCT03428100|524289604|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391948|NCT03428100|524289605|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391949|NCT03428100|524289606|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145391950|NCT03428100|524289607|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391951|NCT03428100|524289608|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145391952|NCT03428100|524289609|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145391953|NCT03428100|524289610|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391954|NCT03428100|524289611|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
145391955|NCT03428100|524289612|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
145391956|NCT03428100|524289613|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145391957|NCT03428100|524289614|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145391958|NCT03428100|524289615|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
145391959|NCT03428100|524289616|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
145391960|NCT03428100|524289617|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391961|NCT03428100|524289618|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
145391962|NCT03428100|524289619|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
145391963|NCT03428100|524289620|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
145391964|NCT00922116|524289623|FG000|Overall Study|Adverse Event|4|||
145391965|NCT00922116|524289623|FG000|Overall Study|Death|1|||
145391966|NCT00922116|524289623|FG000|Overall Study|Lost to Follow-up|1|||
145391967|NCT00922116|524289623|FG000|Overall Study|Withdrawal by Subject|4|||
145391968|NCT00922116|524289623|FG000|Overall Study|Other|5|||
145391969|NCT00527826|524289624|FG000|Overall Study|Adverse Event|10|||
145391970|NCT00527826|524289625|FG001|Overall Study|Adverse Event|10|||
145391971|NCT00527826|524289624|FG000|Overall Study|Lost to Follow-up|3|||
145391972|NCT00527826|524289625|FG001|Overall Study|Lost to Follow-up|2|||
145391973|NCT00527826|524289624|FG000|Overall Study|Withdrawal by Subject|5|||
145729800|NCT02072434|525528990|FG001|Overall Study|Protocol Violation|9|||
145729801|NCT02072434|525528989|FG000|Overall Study|Physician Decision|5|||
145729802|NCT02072434|525528990|FG001|Overall Study|Physician Decision|10|||
145729803|NCT02072434|525528989|FG000|Overall Study|Adverse event, serious fatal|1|||
145729804|NCT02072434|525528990|FG001|Overall Study|Adverse event, serious fatal|6|||
145729805|NCT02072434|525528989|FG000|Overall Study|Adverse Event|7|||
145729806|NCT02072434|525528990|FG001|Overall Study|Adverse Event|6|||
145729807|NCT02072434|525528989|FG000|Overall Study|Withdrawal by Subject|17|||
145729808|NCT02072434|525528990|FG001|Overall Study|Withdrawal by Subject|29|||
145729809|NCT02072434|525528989|FG000|Overall Study|Other|14|||
145729810|NCT02072434|525528990|FG001|Overall Study|Other|29|||
145729811|NCT02072434|525528989|FG000|Overall Study|Lost to Follow-up|0|||
145729812|NCT02072434|525528990|FG001|Overall Study|Lost to Follow-up|1|||
145729813|NCT00888433|525528995|FG000|Overall Study|Withdrawal by Subject|1|||
145729814|NCT00888433|525528996|FG001|Overall Study|Withdrawal by Subject|2|||
145729815|NCT00888433|525528995|FG000|Overall Study|Missed Visit|2|||
145729816|NCT00888433|525528996|FG001|Overall Study|Missed Visit|1|||
145729817|NCT04175808|525528997|FG000|Part A|Miscellaneous|2|||
145729818|NCT04175808|525528998|FG001|Part A|Miscellaneous|0|||
145729819|NCT04175808|525528999|FG002|Part A|Miscellaneous|0|||
145729820|NCT04175808|525529000|FG003|Part A|Miscellaneous|0|||
145729821|NCT04175808|525529001|FG004|Part A|Miscellaneous|0|||
145729822|NCT04175808|525529002|FG005|Part A|Miscellaneous|0|||
145729823|NCT04175808|525529003|FG006|Part A|Miscellaneous|0|||
145729824|NCT04796896|525529005|FG000|Overall Study|Adverse Event|1|||
145729825|NCT04796896|525529006|FG001|Overall Study|Adverse Event|0|||
145729826|NCT04796896|525529007|FG002|Overall Study|Adverse Event|0|||
145729827|NCT04796896|525529008|FG003|Overall Study|Adverse Event|0|||
145729828|NCT04796896|525529009|FG004|Overall Study|Adverse Event|0|||
145729829|NCT04796896|525529010|FG005|Overall Study|Adverse Event|1|||
145729830|NCT04796896|525529011|FG006|Overall Study|Adverse Event|1|||
145729831|NCT04796896|525529012|FG007|Overall Study|Adverse Event|0|||
145729832|NCT04796896|525529013|FG008|Overall Study|Adverse Event|1|||
145729833|NCT04796896|525529014|FG009|Overall Study|Adverse Event|1|||
145729834|NCT04796896|525529015|FG010|Overall Study|Adverse Event|1|||
145729835|NCT04796896|525529016|FG011|Overall Study|Adverse Event|0|||
145729836|NCT04796896|525529005|FG000|Overall Study|Lost to Follow-up|24|||
145729837|NCT04796896|525529006|FG001|Overall Study|Lost to Follow-up|15|||
145729838|NCT04796896|525529007|FG002|Overall Study|Lost to Follow-up|6|||
145729839|NCT04796896|525529008|FG003|Overall Study|Lost to Follow-up|4|||
145729840|NCT04796896|525529009|FG004|Overall Study|Lost to Follow-up|21|||
145729841|NCT04796896|525529010|FG005|Overall Study|Lost to Follow-up|55|||
145729842|NCT04796896|525529011|FG006|Overall Study|Lost to Follow-up|237|||
145729843|NCT04796896|525529012|FG007|Overall Study|Lost to Follow-up|52|||
145729844|NCT04796896|525529013|FG008|Overall Study|Lost to Follow-up|221|||
145729845|NCT04796896|525529014|FG009|Overall Study|Lost to Follow-up|43|||
145729846|NCT04796896|525529015|FG010|Overall Study|Lost to Follow-up|142|||
145729847|NCT04796896|525529016|FG011|Overall Study|Lost to Follow-up|18|||
145729848|NCT04796896|525529005|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
145729849|NCT04796896|525529006|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
145729850|NCT04796896|525529007|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
145729851|NCT04796896|525529008|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
145729852|NCT04796896|525529009|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
145729853|NCT04796896|525529010|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
145729854|NCT04796896|525529011|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
145729855|NCT04796896|525529012|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
145729856|NCT04796896|525529013|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
145729857|NCT04796896|525529014|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
145729858|NCT04796896|525529015|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
145729859|NCT04796896|525529016|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
145729860|NCT04796896|525529005|FG000|Overall Study|Physician Decision|1|||
145729861|NCT04796896|525529006|FG001|Overall Study|Physician Decision|0|||
145729862|NCT04796896|525529007|FG002|Overall Study|Physician Decision|0|||
145729863|NCT04796896|525529008|FG003|Overall Study|Physician Decision|0|||
145729864|NCT04796896|525529009|FG004|Overall Study|Physician Decision|0|||
145729865|NCT04796896|525529010|FG005|Overall Study|Physician Decision|3|||
145495346|NCT01383928|524671616|FG002|Overall Study|Progressive Disease|5|||
145495347|NCT01383928|524671614|FG000|Overall Study|Withdrawal by Subject|0|||
145495348|NCT01383928|524671615|FG001|Overall Study|Withdrawal by Subject|0|||
145495349|NCT01383928|524671616|FG002|Overall Study|Withdrawal by Subject|4|||
145495350|NCT01383928|524671614|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
145495351|NCT01383928|524671615|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
145495352|NCT01383928|524671616|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
145495353|NCT03651765|524671618|FG000|Overall Study|Adverse Event|6|||
145495354|NCT03651765|524671618|FG000|Overall Study|Lack of Efficacy|18|||
145495355|NCT03651765|524671618|FG000|Overall Study|Lost to Follow-up|5|||
145495356|NCT03651765|524671618|FG000|Overall Study|Non-Compliance with Study Drug|4|||
145495357|NCT03651765|524671618|FG000|Overall Study|Physician Decision|6|||
145495358|NCT03651765|524671618|FG000|Overall Study|Pregnancy|1|||
145729866|NCT04796896|525529011|FG006|Overall Study|Physician Decision|18|||
145729867|NCT04796896|525529012|FG007|Overall Study|Physician Decision|1|||
145729868|NCT04796896|525529013|FG008|Overall Study|Physician Decision|7|||
145729869|NCT04796896|525529014|FG009|Overall Study|Physician Decision|0|||
145729870|NCT04796896|525529015|FG010|Overall Study|Physician Decision|5|||
145729871|NCT04796896|525529016|FG011|Overall Study|Physician Decision|0|||
145495359|NCT03651765|524671618|FG000|Overall Study|Discontinued by Sponsor|40|||
145729872|NCT04796896|525529005|FG000|Overall Study|Withdrawal by Subject|36|||
145391974|NCT00527826|524289625|FG001|Overall Study|Withdrawal by Subject|8|||
145391975|NCT00527826|524289624|FG000|Overall Study|Inclusion Criteria Not Met|3|||
145391976|NCT00527826|524289625|FG001|Overall Study|Inclusion Criteria Not Met|3|||
145391977|NCT00527826|524289624|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
145391978|NCT00527826|524289625|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
145391979|NCT00527826|524289624|FG000|Overall Study|Additional Intake of Viani forte|0|||
145391980|NCT00527826|524289625|FG001|Overall Study|Additional Intake of Viani forte|1|||
145391981|NCT00527826|524289624|FG000|Overall Study|Participant moved away|0|||
145391982|NCT00527826|524289625|FG001|Overall Study|Participant moved away|1|||
145391983|NCT01808261|524289626|FG000|Overall Study|Physician Decision|0|||
145391984|NCT01808261|524289627|FG001|Overall Study|Physician Decision|2|||
145391985|NCT01808261|524289626|FG000|Overall Study|Study Closed/Terminated|25|||
145391986|NCT01808261|524289627|FG001|Overall Study|Study Closed/Terminated|23|||
145391987|NCT01808261|524289626|FG000|Overall Study|Adverse event, non-fatal|2|||
145391988|NCT01808261|524289627|FG001|Overall Study|Adverse event, non-fatal|0|||
145391989|NCT01808261|524289626|FG000|Overall Study|Consent withdrawn by subject|6|||
145391990|NCT01808261|524289627|FG001|Overall Study|Consent withdrawn by subject|7|||
145391991|NCT01808261|524289626|FG000|Overall Study|Lost to Follow-up|3|||
145391992|NCT01808261|524289627|FG001|Overall Study|Lost to Follow-up|1|||
145391993|NCT02080364|524289628|FG000|Baseline Period|Protocol Violation|2|||
145391994|NCT02080364|524289629|FG001|Baseline Period|Protocol Violation|1|||
145391995|NCT02080364|524289630|FG002|Baseline Period|Protocol Violation|0|||
145391996|NCT02080364|524289631|FG003|Baseline Period|Protocol Violation|0|||
145391997|NCT02080364|524289628|FG000|Baseline Period|Other|0|||
145391998|NCT02080364|524289629|FG001|Baseline Period|Other|1|||
145391999|NCT02080364|524289630|FG002|Baseline Period|Other|1|||
145392000|NCT02080364|524289631|FG003|Baseline Period|Other|0|||
145392001|NCT02080364|524289628|FG000|Treatment Period|Adverse Event|10|||
145392002|NCT02080364|524289629|FG001|Treatment Period|Adverse Event|15|||
145392003|NCT02080364|524289630|FG002|Treatment Period|Adverse Event|11|||
145392004|NCT02080364|524289631|FG003|Treatment Period|Adverse Event|14|||
145392005|NCT02080364|524289628|FG000|Treatment Period|Lost to Follow-up|2|||
145392006|NCT02080364|524289629|FG001|Treatment Period|Lost to Follow-up|3|||
145392007|NCT02080364|524289630|FG002|Treatment Period|Lost to Follow-up|5|||
145392008|NCT02080364|524289631|FG003|Treatment Period|Lost to Follow-up|0|||
145392009|NCT02080364|524289628|FG000|Treatment Period|Protocol Violation|5|||
145392010|NCT02080364|524289629|FG001|Treatment Period|Protocol Violation|3|||
145392011|NCT02080364|524289630|FG002|Treatment Period|Protocol Violation|5|||
145392012|NCT02080364|524289631|FG003|Treatment Period|Protocol Violation|1|||
145392013|NCT02080364|524289628|FG000|Treatment Period|Withdrawal by Subject|16|||
145392014|NCT02080364|524289629|FG001|Treatment Period|Withdrawal by Subject|16|||
145392015|NCT02080364|524289630|FG002|Treatment Period|Withdrawal by Subject|15|||
145392016|NCT02080364|524289631|FG003|Treatment Period|Withdrawal by Subject|10|||
145392017|NCT02080364|524289628|FG000|Treatment Period|Study Terminated by Sponsor|0|||
145392018|NCT02080364|524289629|FG001|Treatment Period|Study Terminated by Sponsor|0|||
145392019|NCT02080364|524289630|FG002|Treatment Period|Study Terminated by Sponsor|180|||
145392020|NCT02080364|524289631|FG003|Treatment Period|Study Terminated by Sponsor|183|||
145392021|NCT02080364|524289628|FG000|Treatment Period|Other|14|||
145392022|NCT02080364|524289629|FG001|Treatment Period|Other|12|||
145392023|NCT02080364|524289630|FG002|Treatment Period|Other|21|||
145392024|NCT02080364|524289631|FG003|Treatment Period|Other|16|||
145392025|NCT02256839|524289632|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
145392026|NCT02256839|524289633|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
145392027|NCT01843803|524289634|FG000|Overall Study|not a Veteran, did not see provider|1|||
145392028|NCT01843803|524289635|FG001|Overall Study|not a Veteran, did not see provider|3|||
145392029|NCT05285787|524289637|FG000|Overall Study|Withdrawal by Subject|1|||
145392030|NCT01051817|524289645|FG000|Overall Study|Adverse Event|0|||
145392031|NCT01051817|524289646|FG001|Overall Study|Adverse Event|2|||
145392032|NCT01051817|524289645|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
145392033|NCT01051817|524289646|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
145392034|NCT01051817|524289645|FG000|Overall Study|Withdrawal by Subject|3|||
145392035|NCT01051817|524289646|FG001|Overall Study|Withdrawal by Subject|5|||
145392036|NCT01051817|524289645|FG000|Overall Study|Protocol Violation|0|||
145392037|NCT01051817|524289646|FG001|Overall Study|Protocol Violation|1|||
145392038|NCT04346199|524289647|FG000|Overall Study|Death|8|||
145392039|NCT04346199|524289648|FG001|Overall Study|Death|9|||
145392040|NCT04346199|524289647|FG000|Overall Study|Lost to Follow-up|0|||
145392041|NCT04346199|524289648|FG001|Overall Study|Lost to Follow-up|1|||
145392042|NCT04346199|524289647|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
145392043|NCT04346199|524289648|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
145392044|NCT04346199|524289647|FG000|Overall Study|Withdrawal by Subject|5|||
145392045|NCT04346199|524289648|FG001|Overall Study|Withdrawal by Subject|1|||
145392046|NCT00627926|524289649|FG000|Overall Study|Adverse Event|26|||
145392047|NCT00627926|524289650|FG001|Overall Study|Adverse Event|37|||
145392048|NCT00627926|524289651|FG002|Overall Study|Adverse Event|36|||
145392049|NCT00627926|524289649|FG000|Overall Study|Death|1|||
145392050|NCT00627926|524289650|FG001|Overall Study|Death|0|||
145392051|NCT00627926|524289651|FG002|Overall Study|Death|0|||
145392052|NCT00627926|524289649|FG000|Overall Study|Lost to Follow-up|4|||
145392053|NCT00627926|524289650|FG001|Overall Study|Lost to Follow-up|3|||
145392054|NCT00627926|524289651|FG002|Overall Study|Lost to Follow-up|4|||
145392055|NCT00627926|524289649|FG000|Overall Study|Withdrawal by Subject|2|||
145392056|NCT00627926|524289650|FG001|Overall Study|Withdrawal by Subject|1|||
145392057|NCT00627926|524289651|FG002|Overall Study|Withdrawal by Subject|0|||
145392058|NCT00627926|524289649|FG000|Overall Study|Lack of Efficacy|118|||
145392059|NCT00627926|524289650|FG001|Overall Study|Lack of Efficacy|40|||
145392060|NCT00627926|524289651|FG002|Overall Study|Lack of Efficacy|38|||
145392061|NCT00627926|524289649|FG000|Overall Study|Noncompliance/unspecified|8|||
145392062|NCT00627926|524289650|FG001|Overall Study|Noncompliance/unspecified|23|||
145392063|NCT00627926|524289651|FG002|Overall Study|Noncompliance/unspecified|17|||
145392064|NCT02401035|524289652|FG000|Overall Study|Withdrawal by Subject|1|||
145392065|NCT02401035|524289653|FG001|Overall Study|Withdrawal by Subject|0|||
145392066|NCT01118663|524289655|FG000|Overall Study|Adverse Event|2|||
145392067|NCT01118663|524289656|FG001|Overall Study|Adverse Event|1|||
145392068|NCT01118663|524289655|FG000|Overall Study|Withdrawal by Subject|0|||
145392069|NCT01118663|524289656|FG001|Overall Study|Withdrawal by Subject|1|||
145392070|NCT01189461|524289657|FG000|Overall Study|Lack of Efficacy|13|||
145392071|NCT01189461|524289657|FG000|Overall Study|Lost to Follow-up|1|||
145392072|NCT01189461|524289657|FG000|Overall Study|Withdrawal by Subject|6|||
145392073|NCT01189461|524289657|FG000|Overall Study|Protocol Violation|1|||
145392074|NCT01189461|524289657|FG000|Overall Study|Adverse Event|2|||
145392075|NCT01189461|524289657|FG000|Overall Study|Did not meet entrance criteria|3|||
145392076|NCT01189461|524289657|FG000|Overall Study|Other|8|||
145392077|NCT03283930|524289658|FG000|Overall Study|Scheduling conflict|8|||
145392078|NCT03283930|524289659|FG001|Overall Study|Scheduling conflict|10|||
145392079|NCT03283930|524289658|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
145392080|NCT03283930|524289659|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
145392081|NCT03283930|524289658|FG000|Overall Study|Technical software issue|2|||
145392082|NCT03283930|524289659|FG001|Overall Study|Technical software issue|2|||
145392083|NCT02106351|524289666|FG000|Treatment Cycle 1|Adverse Event|2|||
145392084|NCT02106351|524289667|FG001|Treatment Cycle 1|Adverse Event|0|||
145392085|NCT02106351|524289668|FG002|Treatment Cycle 1|Adverse Event|0|||
145392086|NCT02106351|524289666|FG000|Treatment Cycle 1|Consent withdrawn|1|||
145392087|NCT02106351|524289667|FG001|Treatment Cycle 1|Consent withdrawn|0|||
145392088|NCT02106351|524289668|FG002|Treatment Cycle 1|Consent withdrawn|2|||
145392089|NCT02106351|524289666|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
145392090|NCT02106351|524289667|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
145392091|NCT02106351|524289668|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
145392092|NCT02106351|524289666|FG000|Treatment Cycle 1|Other|0|||
145392093|NCT02106351|524289667|FG001|Treatment Cycle 1|Other|3|||
145392094|NCT02106351|524289668|FG002|Treatment Cycle 1|Other|1|||
145392095|NCT02106351|524289666|FG000|Treatment Cycle 1|Randomised but not treated|1|||
145392096|NCT02106351|524289667|FG001|Treatment Cycle 1|Randomised but not treated|0|||
145392097|NCT02106351|524289668|FG002|Treatment Cycle 1|Randomised but not treated|1|||
145392098|NCT02106351|524289666|FG000|Treatment Cycle 2|Adverse Event|0|||
145392099|NCT02106351|524289667|FG001|Treatment Cycle 2|Adverse Event|2|||
145392100|NCT02106351|524289668|FG002|Treatment Cycle 2|Adverse Event|0|||
145392101|NCT02106351|524289666|FG000|Treatment Cycle 2|Consent withdrawn|0|||
145392102|NCT02106351|524289667|FG001|Treatment Cycle 2|Consent withdrawn|1|||
145392103|NCT02106351|524289668|FG002|Treatment Cycle 2|Consent withdrawn|1|||
145392104|NCT02106351|524289666|FG000|Treatment Cycle 2|Other|0|||
145392105|NCT02106351|524289667|FG001|Treatment Cycle 2|Other|2|||
145392106|NCT02106351|524289668|FG002|Treatment Cycle 2|Other|2|||
145392107|NCT02106351|524289666|FG000|Treatment Cycle 3|Adverse Event|0|||
145392108|NCT02106351|524289667|FG001|Treatment Cycle 3|Adverse Event|1|||
145392109|NCT02106351|524289668|FG002|Treatment Cycle 3|Adverse Event|0|||
145392110|NCT02106351|524289666|FG000|Treatment Cycle 3|Consent withdrawn|0|||
145392111|NCT02106351|524289667|FG001|Treatment Cycle 3|Consent withdrawn|0|||
145392112|NCT02106351|524289668|FG002|Treatment Cycle 3|Consent withdrawn|2|||
145392113|NCT02106351|524289666|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
145392114|NCT02106351|524289667|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
145495360|NCT03651765|524671618|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
145495361|NCT03651765|524671618|FG000|Overall Study|Withdrawal by Subject|24|||
145392115|NCT02106351|524289668|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
145392116|NCT02106351|524289666|FG000|Treatment Cycle 3|Other|0|||
145392117|NCT02106351|524289667|FG001|Treatment Cycle 3|Other|2|||
145392118|NCT02106351|524289668|FG002|Treatment Cycle 3|Other|3|||
145392119|NCT02106351|524289666|FG000|Treatment Cycle 4|Consent withdrawn|0|||
145392120|NCT02106351|524289667|FG001|Treatment Cycle 4|Consent withdrawn|0|||
145392121|NCT02106351|524289668|FG002|Treatment Cycle 4|Consent withdrawn|2|||
145392122|NCT02106351|524289666|FG000|Treatment Cycle 4|Other|0|||
145392123|NCT02106351|524289667|FG001|Treatment Cycle 4|Other|1|||
145392124|NCT02106351|524289668|FG002|Treatment Cycle 4|Other|0|||
145392125|NCT00069823|524289673|FG000|Overall Study|Did not have follow-up diary cards|6|||
145392126|NCT00069823|524289674|FG001|Overall Study|Did not have follow-up diary cards|3|||
145392127|NCT03560869|524289675|FG000|Overall Study|Withdrawal by Subject|3|||
145392128|NCT03560869|524289676|FG001|Overall Study|Withdrawal by Subject|4|||
145392129|NCT03560869|524289675|FG000|Overall Study|Screening failure|4|||
145392130|NCT03560869|524289676|FG001|Overall Study|Screening failure|4|||
145392131|NCT03560869|524289675|FG000|Overall Study|Withdrawal by PI|0|||
145392132|NCT03560869|524289676|FG001|Overall Study|Withdrawal by PI|1|||
145392133|NCT01801111|524289677|FG000|Overall Study|Adverse Event|12|||
145392134|NCT01801111|524289677|FG000|Overall Study|Death|8|||
145392135|NCT01801111|524289677|FG000|Overall Study|Physician Decision|5|||
145392136|NCT01801111|524289677|FG000|Overall Study|Other|1|||
145392137|NCT01801111|524289677|FG000|Overall Study|Withdrawal by Subject|4|||
145392138|NCT01801111|524289677|FG000|Overall Study|Study Terminated by Sponsor|27|||
145392139|NCT01801111|524289677|FG000|Overall Study|Progressive Disease|81|||
145392140|NCT01210482|524289678|FG000|Overall Study|Protocol Violation|1|||
145392141|NCT01210482|524289678|FG000|Overall Study|Case Report Forms were not collected|18|||
145392142|NCT01210482|524289678|FG000|Overall Study|Duplicated|2|||
145392143|NCT01210482|524289678|FG000|Overall Study|No Drug Administration|28|||
145392144|NCT01223937|524289679|FG000|Overall Study|Withdrawal by Subject|3|||
145392145|NCT01223937|524289680|FG001|Overall Study|Withdrawal by Subject|2|||
145392146|NCT01223937|524289679|FG000|Overall Study|Lost to Follow-up|1|||
145392147|NCT01223937|524289680|FG001|Overall Study|Lost to Follow-up|4|||
145392148|NCT01223937|524289679|FG000|Overall Study|Adverse Event|1|||
145392149|NCT01223937|524289680|FG001|Overall Study|Adverse Event|4|||
145392150|NCT01223937|524289679|FG000|Overall Study|Protocol Violation|8|||
145392151|NCT01223937|524289680|FG001|Overall Study|Protocol Violation|7|||
145392152|NCT01223937|524289679|FG000|Overall Study|Other|4|||
145392153|NCT01223937|524289680|FG001|Overall Study|Other|1|||
145392154|NCT00765817|524289681|FG000|Overall Study|Adverse Event|13|||
145392155|NCT00765817|524289682|FG001|Overall Study|Adverse Event|1|||
145392156|NCT00765817|524289681|FG000|Overall Study|Death|0|||
145392157|NCT00765817|524289682|FG001|Overall Study|Death|1|||
145392158|NCT00765817|524289681|FG000|Overall Study|Entry criteria not met|2|||
145392159|NCT00765817|524289682|FG001|Overall Study|Entry criteria not met|2|||
145392160|NCT00765817|524289681|FG000|Overall Study|Loss of glucose control|0|||
145392161|NCT00765817|524289682|FG001|Overall Study|Loss of glucose control|2|||
145392162|NCT00765817|524289681|FG000|Overall Study|Lost to Follow-up|1|||
145392163|NCT00765817|524289682|FG001|Overall Study|Lost to Follow-up|3|||
145392164|NCT00765817|524289681|FG000|Overall Study|Physician Decision|2|||
145392165|NCT00765817|524289682|FG001|Overall Study|Physician Decision|1|||
145392166|NCT00765817|524289681|FG000|Overall Study|Protocol Violation|1|||
145392167|NCT00765817|524289682|FG001|Overall Study|Protocol Violation|1|||
145392168|NCT00765817|524289681|FG000|Overall Study|Subject decision|7|||
145392169|NCT00765817|524289682|FG001|Overall Study|Subject decision|11|||
145392170|NCT06597084|524289683|FG000|Overall Study|Withdrawal by Subject|4|||
145392171|NCT06597084|524289684|FG001|Overall Study|Withdrawal by Subject|9|||
145392172|NCT06597084|524289683|FG000|Overall Study|Consent was not given by the patient until V2|0|||
145392173|NCT06597084|524289684|FG001|Overall Study|Consent was not given by the patient until V2|3|||
145392174|NCT06597084|524289683|FG000|Overall Study|Physician Decision|1|||
145392175|NCT06597084|524289684|FG001|Overall Study|Physician Decision|0|||
145392176|NCT06597084|524289683|FG000|Overall Study|Adverse Event|3|||
145392177|NCT06597084|524289684|FG001|Overall Study|Adverse Event|2|||
145392178|NCT06597084|524289683|FG000|Overall Study|Death|4|||
145729873|NCT04796896|525529006|FG001|Overall Study|Withdrawal by Subject|31|||
145729874|NCT04796896|525529007|FG002|Overall Study|Withdrawal by Subject|11|||
145729875|NCT04796896|525529008|FG003|Overall Study|Withdrawal by Subject|8|||
145729876|NCT04796896|525529009|FG004|Overall Study|Withdrawal by Subject|16|||
145729877|NCT04796896|525529010|FG005|Overall Study|Withdrawal by Subject|162|||
145729878|NCT04796896|525529011|FG006|Overall Study|Withdrawal by Subject|299|||
145729879|NCT04796896|525529012|FG007|Overall Study|Withdrawal by Subject|149|||
145729880|NCT04796896|525529013|FG008|Overall Study|Withdrawal by Subject|303|||
145729881|NCT04796896|525529014|FG009|Overall Study|Withdrawal by Subject|94|||
145729882|NCT04796896|525529015|FG010|Overall Study|Withdrawal by Subject|192|||
145729883|NCT04796896|525529016|FG011|Overall Study|Withdrawal by Subject|16|||
145729884|NCT04796896|525529005|FG000|Overall Study|Other Than Specified|6|||
145729885|NCT04796896|525529006|FG001|Overall Study|Other Than Specified|5|||
145729886|NCT04796896|525529007|FG002|Overall Study|Other Than Specified|3|||
145392179|NCT06597084|524289684|FG001|Overall Study|Death|0|||
145392180|NCT06597084|524289683|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
145392181|NCT06597084|524289684|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
145392182|NCT06597084|524289683|FG000|Overall Study|Lost to Follow-up|4|||
145392183|NCT06597084|524289684|FG001|Overall Study|Lost to Follow-up|2|||
145729887|NCT04796896|525529008|FG003|Overall Study|Other Than Specified|2|||
145392184|NCT06597084|524289683|FG000|Overall Study|Other. Not specified|1|||
145392185|NCT06597084|524289684|FG001|Overall Study|Other. Not specified|0|||
145392186|NCT00255164|524289689|FG000|Overall Study|Adverse Event|10|||
145392187|NCT00255164|524289690|FG001|Overall Study|Adverse Event|6|||
145392188|NCT00255164|524289691|FG002|Overall Study|Adverse Event|9|||
145392189|NCT00255164|524289689|FG000|Overall Study|Lost to Follow-up|4|||
145392190|NCT00255164|524289690|FG001|Overall Study|Lost to Follow-up|3|||
145392191|NCT00255164|524289691|FG002|Overall Study|Lost to Follow-up|4|||
145392192|NCT00255164|524289689|FG000|Overall Study|Withdrawal by Subject|18|||
145392193|NCT00255164|524289690|FG001|Overall Study|Withdrawal by Subject|17|||
145392194|NCT00255164|524289691|FG002|Overall Study|Withdrawal by Subject|8|||
145392195|NCT00255164|524289689|FG000|Overall Study|Noncompliance|0|||
145392196|NCT00255164|524289690|FG001|Overall Study|Noncompliance|1|||
145392197|NCT00255164|524289691|FG002|Overall Study|Noncompliance|2|||
145392198|NCT00255164|524289689|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
145392199|NCT00255164|524289690|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
145392200|NCT00255164|524289691|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
145392201|NCT00255164|524289689|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
145392202|NCT00255164|524289690|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
145392203|NCT00255164|524289691|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
145392204|NCT00255164|524289689|FG000|Overall Study|Possible Barrett's Esophagus|1|||
145392205|NCT00255164|524289690|FG001|Overall Study|Possible Barrett's Esophagus|3|||
145392206|NCT00255164|524289691|FG002|Overall Study|Possible Barrett's Esophagus|8|||
145392207|NCT00255164|524289689|FG000|Overall Study|Esophageal Stricture|0|||
145392208|NCT00255164|524289690|FG001|Overall Study|Esophageal Stricture|0|||
145392209|NCT00255164|524289691|FG002|Overall Study|Esophageal Stricture|1|||
145392210|NCT00255164|524289689|FG000|Overall Study|Therapeutic Failure|11|||
145392211|NCT00255164|524289690|FG001|Overall Study|Therapeutic Failure|2|||
145392212|NCT00255164|524289691|FG002|Overall Study|Therapeutic Failure|3|||
145392213|NCT03677869|524289692|FG000|Overall Study|Withdrawal by Subject|1|||
145392214|NCT01845597|524291581|FG000|Overall Study|Death|8|||
145392215|NCT01845597|524291581|FG000|Overall Study|Lost to Follow-up|22|||
145392216|NCT04194489|524291583|FG000|Overall Study|Withdrawal by Subject|5|||
145392217|NCT04194489|524291583|FG000|Overall Study|Lost to Follow-up|48|||
145392218|NCT02291029|524291589|FG000|Overall Study|Withdrawal by Subject|0|||
145392219|NCT02291029|524291590|FG001|Overall Study|Withdrawal by Subject|0|||
145392220|NCT02291029|524291591|FG002|Overall Study|Withdrawal by Subject|1|||
145392221|NCT02291029|524291592|FG003|Overall Study|Withdrawal by Subject|0|||
145392222|NCT02291029|524291593|FG004|Overall Study|Withdrawal by Subject|0|||
145392223|NCT02291029|524291594|FG005|Overall Study|Withdrawal by Subject|0|||
145392224|NCT02291029|524291589|FG000|Overall Study|Adverse Event|0|||
145392225|NCT02291029|524291590|FG001|Overall Study|Adverse Event|1|||
145392226|NCT02291029|524291591|FG002|Overall Study|Adverse Event|0|||
145392227|NCT02291029|524291592|FG003|Overall Study|Adverse Event|0|||
145392228|NCT02291029|524291593|FG004|Overall Study|Adverse Event|0|||
145392229|NCT02291029|524291594|FG005|Overall Study|Adverse Event|0|||
145392230|NCT00377637|524291595|FG000|Induction Phase|Adverse Event|12|||
145392231|NCT00377637|524291596|FG001|Induction Phase|Adverse Event|21|||
145392232|NCT00377637|524291597|FG002|Induction Phase|Adverse Event|0|||
145392233|NCT00377637|524291598|FG003|Induction Phase|Adverse Event|0|||
145392234|NCT00377637|524291595|FG000|Induction Phase|Deterioration/serum creatinine|2|||
145392235|NCT00377637|524291596|FG001|Induction Phase|Deterioration/serum creatinine|0|||
145392236|NCT00377637|524291597|FG002|Induction Phase|Deterioration/serum creatinine|0|||
145392237|NCT00377637|524291598|FG003|Induction Phase|Deterioration/serum creatinine|0|||
145392238|NCT00377637|524291595|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145392239|NCT00377637|524291596|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
145392240|NCT00377637|524291597|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145392241|NCT00377637|524291598|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
145392242|NCT00377637|524291595|FG000|Induction Phase|Lost to Follow-up|2|||
145392243|NCT00377637|524291596|FG001|Induction Phase|Lost to Follow-up|1|||
145392244|NCT00377637|524291597|FG002|Induction Phase|Lost to Follow-up|0|||
145392245|NCT00377637|524291598|FG003|Induction Phase|Lost to Follow-up|0|||
145392246|NCT00377637|524291595|FG000|Induction Phase|Death|1|||
145392247|NCT00377637|524291596|FG001|Induction Phase|Death|3|||
145392248|NCT00377637|524291597|FG002|Induction Phase|Death|0|||
145392249|NCT00377637|524291598|FG003|Induction Phase|Death|0|||
145392250|NCT00377637|524291595|FG000|Induction Phase|Withdrawal by Subject|5|||
145495362|NCT03651765|524671618|FG000|Overall Study|Miscellaneous|6|||
145495363|NCT00551759|524671619|FG000|Overall Study|Adverse Event|7|||
145392251|NCT00377637|524291596|FG001|Induction Phase|Withdrawal by Subject|6|||
145392252|NCT00377637|524291597|FG002|Induction Phase|Withdrawal by Subject|0|||
145392253|NCT00377637|524291598|FG003|Induction Phase|Withdrawal by Subject|0|||
145392254|NCT00377637|524291595|FG000|Induction Phase|Physician Decision|3|||
145392255|NCT00377637|524291596|FG001|Induction Phase|Physician Decision|1|||
145392256|NCT00377637|524291597|FG002|Induction Phase|Physician Decision|0|||
145392257|NCT00377637|524291598|FG003|Induction Phase|Physician Decision|0|||
145392258|NCT00377637|524291595|FG000|Induction Phase|Sponsor decision|1|||
145392259|NCT00377637|524291596|FG001|Induction Phase|Sponsor decision|2|||
145392260|NCT00377637|524291597|FG002|Induction Phase|Sponsor decision|0|||
145495364|NCT00551759|524671619|FG000|Overall Study|Death|5|||
145729888|NCT04796896|525529009|FG004|Overall Study|Other Than Specified|6|||
145392261|NCT00377637|524291598|FG003|Induction Phase|Sponsor decision|0|||
145392262|NCT00377637|524291595|FG000|Induction Phase|Non-Compliance|1|||
145392263|NCT00377637|524291596|FG001|Induction Phase|Non-Compliance|0|||
145392264|NCT00377637|524291597|FG002|Induction Phase|Non-Compliance|0|||
145392265|NCT00377637|524291598|FG003|Induction Phase|Non-Compliance|0|||
145392266|NCT00377637|524291595|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
145392267|NCT00377637|524291596|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
145392268|NCT00377637|524291597|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
145392269|NCT00377637|524291598|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
145392270|NCT00377637|524291595|FG000|Maintenance Phase|Adverse Event|0|||
145392271|NCT00377637|524291596|FG001|Maintenance Phase|Adverse Event|0|||
145392272|NCT00377637|524291597|FG002|Maintenance Phase|Adverse Event|29|||
145392273|NCT00377637|524291598|FG003|Maintenance Phase|Adverse Event|43|||
145392274|NCT00377637|524291595|FG000|Maintenance Phase|Physician Decision|0|||
145392275|NCT00377637|524291596|FG001|Maintenance Phase|Physician Decision|0|||
145392276|NCT00377637|524291597|FG002|Maintenance Phase|Physician Decision|5|||
145392277|NCT00377637|524291598|FG003|Maintenance Phase|Physician Decision|4|||
145392278|NCT00377637|524291595|FG000|Maintenance Phase|Lost to Follow-up|0|||
145392279|NCT00377637|524291596|FG001|Maintenance Phase|Lost to Follow-up|0|||
145392280|NCT00377637|524291597|FG002|Maintenance Phase|Lost to Follow-up|3|||
145392281|NCT00377637|524291598|FG003|Maintenance Phase|Lost to Follow-up|1|||
145392282|NCT00377637|524291595|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145392283|NCT00377637|524291596|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145392284|NCT00377637|524291597|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145392285|NCT00377637|524291598|FG003|Maintenance Phase|Withdrawal by Subject|3|||
145392286|NCT00377637|524291595|FG000|Maintenance Phase|Sponsor decision|0|||
145392287|NCT00377637|524291596|FG001|Maintenance Phase|Sponsor decision|0|||
145392288|NCT00377637|524291597|FG002|Maintenance Phase|Sponsor decision|2|||
145392289|NCT00377637|524291598|FG003|Maintenance Phase|Sponsor decision|3|||
145392290|NCT00377637|524291595|FG000|Maintenance Phase|Non-compliance|0|||
145392291|NCT00377637|524291596|FG001|Maintenance Phase|Non-compliance|0|||
145392292|NCT00377637|524291597|FG002|Maintenance Phase|Non-compliance|1|||
145392293|NCT00377637|524291598|FG003|Maintenance Phase|Non-compliance|1|||
145392294|NCT00377637|524291595|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
145392295|NCT00377637|524291596|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
145392296|NCT00377637|524291597|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
145392297|NCT00377637|524291598|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
145392298|NCT00377637|524291595|FG000|Maintenance Phase|Death|0|||
145392299|NCT00377637|524291596|FG001|Maintenance Phase|Death|0|||
145392300|NCT00377637|524291597|FG002|Maintenance Phase|Death|0|||
145392301|NCT00377637|524291598|FG003|Maintenance Phase|Death|1|||
145392302|NCT00522548|524291599|FG000|Overall Study|Adverse Event|2|||
145392303|NCT00522548|524291600|FG001|Overall Study|Adverse Event|2|||
145392304|NCT00522548|524291599|FG000|Overall Study|Withdrawal by Subject|0|||
145392305|NCT00522548|524291600|FG001|Overall Study|Withdrawal by Subject|2|||
145392306|NCT00493012|524291601|FG000|Overall Study|Lost to Follow-up|18|||
145392307|NCT00493012|524291602|FG001|Overall Study|Lost to Follow-up|17|||
145392308|NCT04147247|524291603|FG000|Overall Study|Progressive disease|3|||
145392309|NCT04147247|524291604|FG001|Overall Study|Progressive disease|3|||
145392310|NCT04147247|524291605|FG002|Overall Study|Progressive disease|4|||
145392311|NCT04147247|524291606|FG003|Overall Study|Progressive disease|4|||
145392312|NCT04147247|524291607|FG004|Overall Study|Progressive disease|3|||
145392313|NCT04147247|524291603|FG000|Overall Study|Physician Decision|0|||
145392314|NCT04147247|524291604|FG001|Overall Study|Physician Decision|1|||
145392315|NCT04147247|524291605|FG002|Overall Study|Physician Decision|0|||
145392316|NCT04147247|524291606|FG003|Overall Study|Physician Decision|0|||
145392317|NCT04147247|524291607|FG004|Overall Study|Physician Decision|0|||
145392318|NCT04147247|524291603|FG000|Overall Study|Clinical Disease Progression|0|||
145392319|NCT04147247|524291604|FG001|Overall Study|Clinical Disease Progression|0|||
145392320|NCT04147247|524291605|FG002|Overall Study|Clinical Disease Progression|0|||
145392321|NCT04147247|524291606|FG003|Overall Study|Clinical Disease Progression|0|||
145392322|NCT04147247|524291607|FG004|Overall Study|Clinical Disease Progression|1|||
145392323|NCT04147247|524291603|FG000|Overall Study|Adverse Event|0|||
145392324|NCT04147247|524291604|FG001|Overall Study|Adverse Event|0|||
145392325|NCT04147247|524291605|FG002|Overall Study|Adverse Event|1|||
145392326|NCT04147247|524291606|FG003|Overall Study|Adverse Event|0|||
145392327|NCT04147247|524291607|FG004|Overall Study|Adverse Event|1|||
145392328|NCT00327340|524291608|FG000|Overall Study|Withdrawal by Subject|1|||
145392329|NCT00327340|524291609|FG001|Overall Study|Withdrawal by Subject|5|||
145392330|NCT00327340|524291608|FG000|Overall Study|Physician Decision|1|||
145392331|NCT00327340|524291609|FG001|Overall Study|Physician Decision|1|||
145392332|NCT00327340|524291608|FG000|Overall Study|Disease Progression|10|||
145392333|NCT00327340|524291609|FG001|Overall Study|Disease Progression|19|||
145392334|NCT00327340|524291608|FG000|Overall Study|Symptomatic Disease|0|||
145392335|NCT00327340|524291609|FG001|Overall Study|Symptomatic Disease|2|||
145392336|NCT00327340|524291608|FG000|Overall Study|Adverse Event|3|||
145392337|NCT00327340|524291609|FG001|Overall Study|Adverse Event|3|||
145392338|NCT04085601|524291610|FG000|Overall Study|Lost to Follow-up|1|||
145392339|NCT04085601|524291611|FG001|Overall Study|Lost to Follow-up|0|||
145392340|NCT04085601|524291610|FG000|Overall Study|Death|1|||
145392341|NCT04085601|524291611|FG001|Overall Study|Death|1|||
145392342|NCT00956839|524291612|FG000|Overall Study|Lost to Follow-up|3|||
145392343|NCT00956839|524291613|FG001|Overall Study|Lost to Follow-up|0|||
145392344|NCT00956839|524291614|FG002|Overall Study|Lost to Follow-up|3|||
145392345|NCT02121795|524291615|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
145392346|NCT02121795|524291616|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
145392347|NCT02121795|524291615|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
145392348|NCT02121795|524291616|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
145392349|NCT02121795|524291615|FG000|Double-Blind Phase|Lost to Follow-up|7|||
145392350|NCT02121795|524291616|FG001|Double-Blind Phase|Lost to Follow-up|4|||
145392351|NCT02121795|524291615|FG000|Double-Blind Phase|Physician Decision|2|||
145392352|NCT02121795|524291616|FG001|Double-Blind Phase|Physician Decision|5|||
145392353|NCT02121795|524291615|FG000|Double-Blind Phase|Adverse Event|5|||
145729889|NCT04796896|525529010|FG005|Overall Study|Other Than Specified|31|||
145729890|NCT04796896|525529011|FG006|Overall Study|Other Than Specified|86|||
145729891|NCT04796896|525529012|FG007|Overall Study|Other Than Specified|66|||
145729892|NCT04796896|525529013|FG008|Overall Study|Other Than Specified|388|||
145729893|NCT04796896|525529014|FG009|Overall Study|Other Than Specified|48|||
145729894|NCT04796896|525529015|FG010|Overall Study|Other Than Specified|258|||
145729895|NCT04796896|525529016|FG011|Overall Study|Other Than Specified|4|||
145729896|NCT04796896|525529005|FG000|Overall Study|Protocol Deviation|0|||
145729897|NCT04796896|525529006|FG001|Overall Study|Protocol Deviation|0|||
145729898|NCT04796896|525529007|FG002|Overall Study|Protocol Deviation|0|||
145729899|NCT04796896|525529008|FG003|Overall Study|Protocol Deviation|1|||
145729900|NCT04796896|525529009|FG004|Overall Study|Protocol Deviation|1|||
145729901|NCT04796896|525529010|FG005|Overall Study|Protocol Deviation|2|||
145729902|NCT04796896|525529011|FG006|Overall Study|Protocol Deviation|2|||
145729903|NCT04796896|525529012|FG007|Overall Study|Protocol Deviation|2|||
145729904|NCT04796896|525529013|FG008|Overall Study|Protocol Deviation|2|||
145729905|NCT04796896|525529014|FG009|Overall Study|Protocol Deviation|1|||
145729906|NCT04796896|525529015|FG010|Overall Study|Protocol Deviation|0|||
145729907|NCT04796896|525529016|FG011|Overall Study|Protocol Deviation|0|||
145729908|NCT04796896|525529005|FG000|Overall Study|Missing|0|||
145729909|NCT04796896|525529006|FG001|Overall Study|Missing|0|||
145729910|NCT04796896|525529007|FG002|Overall Study|Missing|0|||
145729911|NCT04796896|525529008|FG003|Overall Study|Missing|0|||
145729912|NCT04796896|525529009|FG004|Overall Study|Missing|0|||
145729913|NCT04796896|525529010|FG005|Overall Study|Missing|0|||
145729914|NCT04796896|525529011|FG006|Overall Study|Missing|2|||
145729915|NCT04796896|525529012|FG007|Overall Study|Missing|1|||
145729916|NCT04796896|525529013|FG008|Overall Study|Missing|2|||
145729917|NCT04796896|525529014|FG009|Overall Study|Missing|1|||
145729918|NCT04796896|525529015|FG010|Overall Study|Missing|1|||
145729919|NCT04796896|525529016|FG011|Overall Study|Missing|0|||
145729920|NCT04796896|525529005|FG000|Overall Study|Death|0|||
145729921|NCT04796896|525529006|FG001|Overall Study|Death|0|||
145729922|NCT04796896|525529007|FG002|Overall Study|Death|0|||
145729923|NCT04796896|525529008|FG003|Overall Study|Death|0|||
145729924|NCT04796896|525529009|FG004|Overall Study|Death|0|||
145729925|NCT04796896|525529010|FG005|Overall Study|Death|0|||
145729926|NCT04796896|525529011|FG006|Overall Study|Death|0|||
145729927|NCT04796896|525529012|FG007|Overall Study|Death|0|||
145729928|NCT04796896|525529013|FG008|Overall Study|Death|1|||
145729929|NCT04796896|525529014|FG009|Overall Study|Death|0|||
145729930|NCT04796896|525529015|FG010|Overall Study|Death|0|||
145729931|NCT04796896|525529016|FG011|Overall Study|Death|0|||
145729932|NCT02021292|525529017|FG000|Overall Study|Physician Decision|0|||
145729933|NCT02021292|525529018|FG001|Overall Study|Physician Decision|1|||
145729934|NCT02021292|525529017|FG000|Overall Study|Lost to Follow-up|0|||
145729935|NCT02021292|525529018|FG001|Overall Study|Lost to Follow-up|1|||
145729936|NCT02021292|525529017|FG000|Overall Study|Death|0|||
145729937|NCT02021292|525529018|FG001|Overall Study|Death|1|||
145729938|NCT05972733|525529021|FG000|Overall Study|Lost to Follow-up|2|||
145392354|NCT02121795|524291616|FG001|Double-Blind Phase|Adverse Event|0|||
145392355|NCT02121795|524291615|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
145392356|NCT02121795|524291616|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
145729939|NCT05972733|525529021|FG000|Overall Study|Withdrawal by Subject|1|||
145392357|NCT02121795|524291615|FG000|Double-Blind Phase|Protocol Violation|0|||
145729940|NCT01177787|525529024|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
145729941|NCT01177787|525529024|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
145729942|NCT01177787|525529024|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
145729943|NCT00568321|525529029|FG000|Overall Study|Adverse Event|1|||
145729944|NCT00568321|525529030|FG001|Overall Study|Adverse Event|0|||
145729945|NCT00568321|525529031|FG002|Overall Study|Adverse Event|0|||
145729946|NCT00568321|525529029|FG000|Overall Study|Lack of Efficacy|8|||
145729947|NCT00568321|525529030|FG001|Overall Study|Lack of Efficacy|5|||
145729948|NCT00568321|525529031|FG002|Overall Study|Lack of Efficacy|6|||
145729949|NCT00568321|525529029|FG000|Overall Study|Lost to Follow-up|0|||
145729950|NCT00568321|525529030|FG001|Overall Study|Lost to Follow-up|0|||
145495365|NCT00551759|524671619|FG000|Overall Study|Ineligible|1|||
145495366|NCT03521570|524671620|FG000|Overall Study|Not eligible|11|||
145495367|NCT03279081|524671621|FG000|Overall Study|Withdrawal by Subject|12|||
145495368|NCT03279081|524671622|FG001|Overall Study|Withdrawal by Subject|20|||
145495369|NCT03279081|524671621|FG000|Overall Study|Physician Decision|4|||
145495370|NCT03279081|524671622|FG001|Overall Study|Physician Decision|1|||
145495371|NCT03279081|524671621|FG000|Overall Study|Lost to Follow-up|8|||
145495372|NCT03279081|524671622|FG001|Overall Study|Lost to Follow-up|8|||
145495373|NCT03279081|524671621|FG000|Overall Study|Death|0|||
145495374|NCT03279081|524671622|FG001|Overall Study|Death|1|||
145495375|NCT03279081|524671621|FG000|Overall Study|Adverse Event|1|||
145495376|NCT03279081|524671622|FG001|Overall Study|Adverse Event|0|||
145495377|NCT03279081|524671621|FG000|Overall Study|Reason not Specified|14|||
145495378|NCT03279081|524671622|FG001|Overall Study|Reason not Specified|4|||
145495379|NCT01521117|524671624|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
145495380|NCT01521117|524671625|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
145495381|NCT01521117|524671624|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
145495382|NCT01521117|524671625|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
145495383|NCT01521117|524671624|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
145495384|NCT01521117|524671625|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
145495385|NCT00784563|524671626|FG000|Years 1 & 2|Withdrawal by Subject|3|||
145495386|NCT00784563|524671627|FG001|Years 1 & 2|Withdrawal by Subject|2|||
145495387|NCT00784563|524671628|FG002|Years 1 & 2|Withdrawal by Subject|0|||
145495388|NCT00784563|524671626|FG000|Years 1 & 2|Adverse Event|0|||
145495389|NCT00784563|524671627|FG001|Years 1 & 2|Adverse Event|3|||
145392358|NCT02121795|524291616|FG001|Double-Blind Phase|Protocol Violation|3|||
145392359|NCT02121795|524291615|FG000|Double-Blind Phase|Death|1|||
145392360|NCT02121795|524291616|FG001|Double-Blind Phase|Death|1|||
145392361|NCT02121795|524291615|FG000|Open-Label Phase|Physician Decision|8|||
145392362|NCT02121795|524291616|FG001|Open-Label Phase|Physician Decision|8|||
145392363|NCT02121795|524291615|FG000|Open-Label Phase|Withdrawal by Subject|3|||
145392364|NCT02121795|524291616|FG001|Open-Label Phase|Withdrawal by Subject|2|||
145392365|NCT02121795|524291615|FG000|Open-Label Phase|Lost to Follow-up|1|||
145392366|NCT02121795|524291616|FG001|Open-Label Phase|Lost to Follow-up|0|||
145392367|NCT04155463|524291617|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
145392368|NCT04155463|524291618|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
145392369|NCT00113295|524291619|FG000|Overall Study|Adverse Event|4|||
145392370|NCT00113295|524291620|FG001|Overall Study|Adverse Event|1|||
145392371|NCT00113295|524291619|FG000|Overall Study|Unrelated Medical Illness|1|||
145392372|NCT00113295|524291620|FG001|Overall Study|Unrelated Medical Illness|0|||
145392373|NCT00994110|524291621|FG000|Overall Study|Withdrawal by Subject|9|||
145392374|NCT00994110|524291622|FG001|Overall Study|Withdrawal by Subject|9|||
145392375|NCT00994110|524291621|FG000|Overall Study|Not Treated|4|||
145392376|NCT00994110|524291622|FG001|Overall Study|Not Treated|8|||
145392377|NCT00994110|524291621|FG000|Overall Study|Adverse Event|1|||
145392378|NCT00994110|524291622|FG001|Overall Study|Adverse Event|0|||
145392379|NCT00994110|524291621|FG000|Overall Study|Patient not resected|41|||
145392380|NCT00994110|524291622|FG001|Overall Study|Patient not resected|52|||
145392381|NCT00994110|524291621|FG000|Overall Study|Pt not eligible|10|||
145392382|NCT00994110|524291622|FG001|Overall Study|Pt not eligible|5|||
145392383|NCT01914393|524291623|FG000|Overall Study|Protocol Violation|11|||
145392384|NCT01914393|524291624|FG001|Overall Study|Protocol Violation|3|||
145392385|NCT01914393|524291625|FG002|Overall Study|Protocol Violation|19|||
145392386|NCT01914393|524291623|FG000|Overall Study|Lack of Efficacy|11|||
145392387|NCT01914393|524291624|FG001|Overall Study|Lack of Efficacy|16|||
145392388|NCT01914393|524291625|FG002|Overall Study|Lack of Efficacy|5|||
145392389|NCT01914393|524291623|FG000|Overall Study|no reason given|14|||
145392390|NCT01914393|524291624|FG001|Overall Study|no reason given|8|||
145392391|NCT01914393|524291625|FG002|Overall Study|no reason given|16|||
145392392|NCT01914393|524291623|FG000|Overall Study|Adverse Event|29|||
145392393|NCT01914393|524291624|FG001|Overall Study|Adverse Event|18|||
145392394|NCT01914393|524291625|FG002|Overall Study|Adverse Event|31|||
145392395|NCT01914393|524291623|FG000|Overall Study|Withdrawal by Subject|38|||
145392396|NCT01914393|524291624|FG001|Overall Study|Withdrawal by Subject|20|||
145392397|NCT01914393|524291625|FG002|Overall Study|Withdrawal by Subject|47|||
145392398|NCT01914393|524291623|FG000|Overall Study|Lost to Follow-up|12|||
145392399|NCT01914393|524291624|FG001|Overall Study|Lost to Follow-up|6|||
145392400|NCT01914393|524291625|FG002|Overall Study|Lost to Follow-up|19|||
145392401|NCT01914393|524291623|FG000|Overall Study|subject never dosed|0|||
145392402|NCT01914393|524291624|FG001|Overall Study|subject never dosed|0|||
145392403|NCT01914393|524291625|FG002|Overall Study|subject never dosed|1|||
145495390|NCT00784563|524671628|FG002|Years 1 & 2|Adverse Event|0|||
145495391|NCT00784563|524671626|FG000|Year 3|Withdrawal by Subject|0|||
145392404|NCT00666211|524291626|FG000|Overall Study|Withdrawal by Subject|10|||
145392405|NCT00666211|524291627|FG001|Overall Study|Withdrawal by Subject|13|||
145495392|NCT00784563|524671627|FG001|Year 3|Withdrawal by Subject|0|||
145495393|NCT00784563|524671628|FG002|Year 3|Withdrawal by Subject|2|||
145495394|NCT00784563|524671626|FG000|Year 3|Adverse Event|0|||
145495395|NCT00784563|524671627|FG001|Year 3|Adverse Event|0|||
145392406|NCT00666211|524291626|FG000|Overall Study|went off medication, no more pain|1|||
145392407|NCT00666211|524291627|FG001|Overall Study|went off medication, no more pain|0|||
145392408|NCT00666211|524291626|FG000|Overall Study|patient non-compliant|6|||
145392409|NCT00666211|524291627|FG001|Overall Study|patient non-compliant|6|||
145392410|NCT00666211|524291626|FG000|Overall Study|disease progression|1|||
145392411|NCT00666211|524291627|FG001|Overall Study|disease progression|8|||
145392412|NCT00666211|524291626|FG000|Overall Study|Lost to Follow-up|2|||
145392413|NCT00666211|524291627|FG001|Overall Study|Lost to Follow-up|0|||
145392414|NCT00666211|524291626|FG000|Overall Study|toxicity|0|||
145392415|NCT00666211|524291627|FG001|Overall Study|toxicity|2|||
145392416|NCT00666211|524291626|FG000|Overall Study|hospital admission|0|||
145392417|NCT00666211|524291627|FG001|Overall Study|hospital admission|5|||
145392418|NCT00666211|524291626|FG000|Overall Study|Death|0|||
145392419|NCT00666211|524291627|FG001|Overall Study|Death|2|||
145392420|NCT00666211|524291626|FG000|Overall Study|off tx for other complicating disease|0|||
145392421|NCT00666211|524291627|FG001|Overall Study|off tx for other complicating disease|1|||
145392422|NCT00666211|524291626|FG000|Overall Study|Physician Decision|0|||
145392423|NCT00666211|524291627|FG001|Overall Study|Physician Decision|1|||
145392424|NCT02999789|524291630|FG000|Overall Study|Withdrawal by Subject|0|||
145392425|NCT02999789|524291631|FG001|Overall Study|Withdrawal by Subject|1|||
145392426|NCT02999789|524291630|FG000|Overall Study|Became ineligible|1|||
145392427|NCT02999789|524291631|FG001|Overall Study|Became ineligible|2|||
145392428|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
145392429|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145392430|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145392431|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145392432|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
145392433|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
145392434|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145392435|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145392436|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145392437|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
145392438|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
145392439|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145392440|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145392441|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145392442|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
145392443|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
145392444|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145392445|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145392446|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145392447|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
145392448|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
145392449|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145392450|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145392451|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145392452|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
145392453|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
145392454|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145392455|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145392456|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145392457|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
145392458|NCT01111565|524291632|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
145392459|NCT01111565|524291633|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145392460|NCT01111565|524291634|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145392461|NCT01111565|524291635|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145392462|NCT01111565|524291636|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
145392463|NCT01111565|524291632|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145392464|NCT01111565|524291633|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145392465|NCT01111565|524291634|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145392466|NCT01111565|524291635|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
145392467|NCT01111565|524291636|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145392468|NCT01111565|524291632|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145392469|NCT01111565|524291633|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145392470|NCT01111565|524291634|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
145392471|NCT01111565|524291635|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145392472|NCT01111565|524291636|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145392473|NCT01111565|524291632|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
145392474|NCT01111565|524291633|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
145392475|NCT01111565|524291634|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
145392476|NCT01111565|524291635|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
145495396|NCT00784563|524671628|FG002|Year 3|Adverse Event|1|||
145495397|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
145495398|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
145495399|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
145495400|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
145495401|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
145495402|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
145495403|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
145495404|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
145495405|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
145495406|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
145495407|NCT01668784|524671629|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
145495408|NCT01668784|524671630|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
145495409|NCT01668784|524671629|FG000|Treatment Period|Disease Progression|316|||
145495410|NCT01668784|524671630|FG001|Treatment Period|Disease Progression|293|||
145495411|NCT01668784|524671629|FG000|Treatment Period|Study Drug Toxicity|46|||
145495412|NCT01668784|524671630|FG001|Treatment Period|Study Drug Toxicity|53|||
145495413|NCT01668784|524671629|FG000|Treatment Period|Death|1|||
145495414|NCT01668784|524671630|FG001|Treatment Period|Death|1|||
145495415|NCT01668784|524671629|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
145495416|NCT01668784|524671630|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
145495417|NCT01668784|524671629|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
145495418|NCT01668784|524671630|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
145495419|NCT01668784|524671629|FG000|Treatment Period|Withdrawal by Subject|5|||
145392477|NCT01111565|524291636|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
145392478|NCT01111565|524291632|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145392479|NCT01111565|524291633|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145392480|NCT01111565|524291634|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145392481|NCT01111565|524291635|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
145392482|NCT01111565|524291636|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
145392483|NCT01111565|524291632|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145392484|NCT01111565|524291633|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145392485|NCT01111565|524291634|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145392486|NCT01111565|524291635|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
145392487|NCT01111565|524291636|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
145392488|NCT02824224|524291637|FG000|Overall Study|Discontinued, IUS expulsion|0|||
145392489|NCT02824224|524291638|FG001|Overall Study|Discontinued, IUS expulsion|1|||
145392490|NCT02824224|524291637|FG000|Overall Study|Did not show up for allocation visit|2|||
145392491|NCT02824224|524291638|FG001|Overall Study|Did not show up for allocation visit|0|||
145392492|NCT02683239|524291639|FG000|Overall Study|Protocol Violation|35|||
145392493|NCT02683239|524291640|FG001|Overall Study|Protocol Violation|23|||
145392494|NCT02683239|524291641|FG002|Overall Study|Protocol Violation|26|||
145392495|NCT02683239|524291642|FG003|Overall Study|Protocol Violation|4|||
145392496|NCT02683239|524291643|FG004|Overall Study|Protocol Violation|35|||
145392497|NCT02683239|524291644|FG005|Overall Study|Protocol Violation|4|||
145392498|NCT02683239|524291645|FG006|Overall Study|Protocol Violation|5|||
145392499|NCT02683239|524291639|FG000|Overall Study|Adverse Event|64|||
145392500|NCT02683239|524291640|FG001|Overall Study|Adverse Event|39|||
145392501|NCT02683239|524291641|FG002|Overall Study|Adverse Event|42|||
145392502|NCT02683239|524291642|FG003|Overall Study|Adverse Event|16|||
145392503|NCT02683239|524291643|FG004|Overall Study|Adverse Event|189|||
145392504|NCT02683239|524291644|FG005|Overall Study|Adverse Event|9|||
145392505|NCT02683239|524291645|FG006|Overall Study|Adverse Event|9|||
145392506|NCT02683239|524291639|FG000|Overall Study|Physician Decision|38|||
145392507|NCT02683239|524291640|FG001|Overall Study|Physician Decision|19|||
145392508|NCT02683239|524291641|FG002|Overall Study|Physician Decision|14|||
145392509|NCT02683239|524291642|FG003|Overall Study|Physician Decision|73|||
145392510|NCT02683239|524291643|FG004|Overall Study|Physician Decision|143|||
145392511|NCT02683239|524291644|FG005|Overall Study|Physician Decision|14|||
145392512|NCT02683239|524291645|FG006|Overall Study|Physician Decision|15|||
145392513|NCT02683239|524291639|FG000|Overall Study|Withdrawal by Subject|187|||
145392514|NCT02683239|524291640|FG001|Overall Study|Withdrawal by Subject|99|||
145392515|NCT02683239|524291641|FG002|Overall Study|Withdrawal by Subject|91|||
145392516|NCT02683239|524291642|FG003|Overall Study|Withdrawal by Subject|18|||
145392517|NCT02683239|524291643|FG004|Overall Study|Withdrawal by Subject|248|||
145392518|NCT02683239|524291644|FG005|Overall Study|Withdrawal by Subject|22|||
145495420|NCT01668784|524671630|FG001|Treatment Period|Withdrawal by Subject|3|||
145495421|NCT01668784|524671629|FG000|Treatment Period|Maximal Clinical Benefit|3|||
145392519|NCT02683239|524291645|FG006|Overall Study|Withdrawal by Subject|28|||
145392520|NCT02683239|524291639|FG000|Overall Study|Lost to Follow-up|77|||
145495422|NCT01668784|524671630|FG001|Treatment Period|Maximal Clinical Benefit|3|||
145392521|NCT02683239|524291640|FG001|Overall Study|Lost to Follow-up|24|||
145495423|NCT01668784|524671629|FG000|Treatment Period|Other|2|||
145495424|NCT01668784|524671630|FG001|Treatment Period|Other|8|||
145495425|NCT01668784|524671629|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
145495426|NCT01668784|524671630|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
145495427|NCT05135871|524671633|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
145495428|NCT05135871|524671634|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
145495429|NCT05135871|524671635|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
145495430|NCT05135871|524671636|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
145495431|NCT00374140|524671641|FG000|Overall Study|Lost to Follow-up|1|||
145495432|NCT00374140|524671641|FG000|Overall Study|Protocol Violation|1|||
145495433|NCT00617734|524671642|FG000|Overall Study|Withdrew Consent|2|||
145495434|NCT00617734|524671643|FG001|Overall Study|Withdrew Consent|0|||
145495435|NCT00617734|524671642|FG000|Overall Study|Adverse Event|4|||
145495436|NCT00617734|524671643|FG001|Overall Study|Adverse Event|1|||
145495437|NCT00617734|524671642|FG000|Overall Study|Protocol Violation|1|||
145495438|NCT00617734|524671643|FG001|Overall Study|Protocol Violation|0|||
145495439|NCT00617734|524671642|FG000|Overall Study|Found Ineligible After Randomization|1|||
145495440|NCT00617734|524671643|FG001|Overall Study|Found Ineligible After Randomization|4|||
145495441|NCT00617734|524671642|FG000|Overall Study|Lost to Follow-up|0|||
145495442|NCT00617734|524671643|FG001|Overall Study|Lost to Follow-up|1|||
145495443|NCT02485691|524671644|FG000|Overall Study|Adverse Event|25|||
145495444|NCT02485691|524671645|FG001|Overall Study|Adverse Event|11|||
145495445|NCT02485691|524671644|FG000|Overall Study|Poor compliance to protocol|0|||
145392522|NCT02683239|524291641|FG002|Overall Study|Lost to Follow-up|25|||
145392523|NCT02683239|524291642|FG003|Overall Study|Lost to Follow-up|7|||
145392524|NCT02683239|524291643|FG004|Overall Study|Lost to Follow-up|88|||
145392525|NCT02683239|524291644|FG005|Overall Study|Lost to Follow-up|8|||
145392526|NCT02683239|524291645|FG006|Overall Study|Lost to Follow-up|11|||
145392527|NCT02683239|524291639|FG000|Overall Study|Death|9|||
145392528|NCT02683239|524291640|FG001|Overall Study|Death|5|||
145392529|NCT02683239|524291641|FG002|Overall Study|Death|8|||
145392530|NCT02683239|524291642|FG003|Overall Study|Death|0|||
145392531|NCT02683239|524291643|FG004|Overall Study|Death|12|||
145392532|NCT02683239|524291644|FG005|Overall Study|Death|1|||
145392533|NCT02683239|524291645|FG006|Overall Study|Death|0|||
145392534|NCT02683239|524291639|FG000|Overall Study|Lack of Efficacy|50|||
145392535|NCT02683239|524291640|FG001|Overall Study|Lack of Efficacy|23|||
145392536|NCT02683239|524291641|FG002|Overall Study|Lack of Efficacy|12|||
145392537|NCT02683239|524291642|FG003|Overall Study|Lack of Efficacy|2|||
145392538|NCT02683239|524291643|FG004|Overall Study|Lack of Efficacy|29|||
145392539|NCT02683239|524291644|FG005|Overall Study|Lack of Efficacy|2|||
145392540|NCT02683239|524291645|FG006|Overall Study|Lack of Efficacy|3|||
145392541|NCT02683239|524291639|FG000|Overall Study|Missing data|0|||
145392542|NCT02683239|524291640|FG001|Overall Study|Missing data|1|||
145392543|NCT02683239|524291641|FG002|Overall Study|Missing data|1|||
145392544|NCT02683239|524291642|FG003|Overall Study|Missing data|0|||
145392545|NCT02683239|524291643|FG004|Overall Study|Missing data|1|||
145392546|NCT02683239|524291644|FG005|Overall Study|Missing data|0|||
145392547|NCT02683239|524291645|FG006|Overall Study|Missing data|0|||
145392548|NCT00368108|524291648|FG000|Overall Study|Adverse Event|38|||
145392549|NCT00368108|524291649|FG001|Overall Study|Adverse Event|26|||
145392550|NCT00368108|524291650|FG002|Overall Study|Adverse Event|44|||
145392551|NCT00368108|524291648|FG000|Overall Study|Abnormal Laboratory Value|0|||
145392552|NCT00368108|524291649|FG001|Overall Study|Abnormal Laboratory Value|0|||
145392553|NCT00368108|524291650|FG002|Overall Study|Abnormal Laboratory Value|3|||
145392554|NCT00368108|524291648|FG000|Overall Study|Protocol Violation|5|||
145495446|NCT02485691|524671645|FG001|Overall Study|Poor compliance to protocol|1|||
145495447|NCT02485691|524671644|FG000|Overall Study|Disease progression|57|||
145392555|NCT00368108|524291649|FG001|Overall Study|Protocol Violation|9|||
145392556|NCT00368108|524291650|FG002|Overall Study|Protocol Violation|9|||
145392557|NCT00368108|524291648|FG000|Overall Study|Withdrawal by Subject|9|||
145495448|NCT02485691|524671645|FG001|Overall Study|Disease progression|92|||
145495449|NCT02485691|524671644|FG000|Overall Study|Investigator's decision|23|||
145392558|NCT00368108|524291649|FG001|Overall Study|Withdrawal by Subject|3|||
145392559|NCT00368108|524291650|FG002|Overall Study|Withdrawal by Subject|5|||
145392560|NCT00368108|524291648|FG000|Overall Study|Lack of Efficacy|7|||
145392561|NCT00368108|524291649|FG001|Overall Study|Lack of Efficacy|8|||
145392562|NCT00368108|524291650|FG002|Overall Study|Lack of Efficacy|5|||
145392563|NCT00368108|524291648|FG000|Overall Study|Physician Decision|2|||
145392564|NCT00368108|524291649|FG001|Overall Study|Physician Decision|0|||
145392565|NCT00368108|524291650|FG002|Overall Study|Physician Decision|1|||
145392566|NCT00368108|524291648|FG000|Overall Study|Other|3|||
145495450|NCT02485691|524671645|FG001|Overall Study|Investigator's decision|5|||
145495451|NCT02485691|524671644|FG000|Overall Study|Participant's request|13|||
145495452|NCT02485691|524671645|FG001|Overall Study|Participant's request|6|||
145495453|NCT02485691|524671644|FG000|Overall Study|Other reason|8|||
145495454|NCT02485691|524671645|FG001|Overall Study|Other reason|9|||
145495455|NCT02485691|524671644|FG000|Overall Study|Randomized and not treated|3|||
145495456|NCT02485691|524671645|FG001|Overall Study|Randomized and not treated|2|||
145495457|NCT00604565|524671646|FG000|Overall Study|Study terminated|0|||
145495458|NCT00604565|524671647|FG001|Overall Study|Study terminated|3|||
145495459|NCT04292535|524671649|FG000|Overall Study|Withdrawal by Subject|0|||
145495460|NCT04292535|524671650|FG001|Overall Study|Withdrawal by Subject|0|||
145495461|NCT04292535|524671651|FG002|Overall Study|Withdrawal by Subject|0|||
145495462|NCT04292535|524671652|FG003|Overall Study|Withdrawal by Subject|0|||
145495463|NCT04292535|524671653|FG004|Overall Study|Withdrawal by Subject|0|||
145495464|NCT04292535|524671654|FG005|Overall Study|Withdrawal by Subject|0|||
145495465|NCT04292535|524671655|FG006|Overall Study|Withdrawal by Subject|0|||
145495466|NCT04292535|524671656|FG007|Overall Study|Withdrawal by Subject|1|||
145495467|NCT04292535|524671657|FG008|Overall Study|Withdrawal by Subject|0|||
145495468|NCT04292535|524671658|FG009|Overall Study|Withdrawal by Subject|0|||
145495469|NCT04292535|524671659|FG010|Overall Study|Withdrawal by Subject|0|||
145495470|NCT04292535|524671660|FG011|Overall Study|Withdrawal by Subject|0|||
145495471|NCT04292535|524671661|FG012|Overall Study|Withdrawal by Subject|0|||
145495472|NCT04292535|524671662|FG013|Overall Study|Withdrawal by Subject|0|||
145495473|NCT04292535|524671649|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495474|NCT04292535|524671650|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495475|NCT04292535|524671651|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495476|NCT04292535|524671652|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495477|NCT04292535|524671653|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495478|NCT04292535|524671654|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495479|NCT04292535|524671655|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495480|NCT04292535|524671656|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
145495481|NCT04292535|524671657|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495482|NCT04292535|524671658|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495483|NCT04292535|524671659|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495484|NCT04292535|524671660|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
145495485|NCT04292535|524671661|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
145495486|NCT04292535|524671662|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
145495487|NCT04292535|524671649|FG000|Overall Study|Report of Dizziness|0|||
145495488|NCT04292535|524671650|FG001|Overall Study|Report of Dizziness|0|||
145495489|NCT04292535|524671651|FG002|Overall Study|Report of Dizziness|0|||
145495490|NCT04292535|524671652|FG003|Overall Study|Report of Dizziness|0|||
145495491|NCT04292535|524671653|FG004|Overall Study|Report of Dizziness|0|||
145495492|NCT04292535|524671654|FG005|Overall Study|Report of Dizziness|0|||
145495493|NCT04292535|524671655|FG006|Overall Study|Report of Dizziness|0|||
145495494|NCT04292535|524671656|FG007|Overall Study|Report of Dizziness|0|||
145495495|NCT04292535|524671657|FG008|Overall Study|Report of Dizziness|0|||
145495496|NCT04292535|524671658|FG009|Overall Study|Report of Dizziness|0|||
145392567|NCT00368108|524291649|FG001|Overall Study|Other|7|||
145392568|NCT00368108|524291650|FG002|Overall Study|Other|1|||
145392569|NCT04131712|524291651|FG000|Overall Study|COVID related|0|||
145392570|NCT04131712|524291652|FG001|Overall Study|COVID related|0|||
145392571|NCT04131712|524291653|FG002|Overall Study|COVID related|2|||
145392572|NCT04131712|524291654|FG003|Overall Study|COVID related|0|||
145392573|NCT04131712|524291651|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145392574|NCT04131712|524291652|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145392575|NCT04131712|524291653|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
145392576|NCT04131712|524291654|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
145392577|NCT01719380|524291663|FG000|Overall Study|Adverse Event|0|||
145392578|NCT01719380|524291664|FG001|Overall Study|Adverse Event|0|||
145392579|NCT01719380|524291665|FG002|Overall Study|Adverse Event|1|||
145392580|NCT01719380|524291666|FG003|Overall Study|Adverse Event|2|||
145392581|NCT01719380|524291667|FG004|Overall Study|Adverse Event|0|||
145392582|NCT01719380|524291668|FG005|Overall Study|Adverse Event|1|||
145392583|NCT01719380|524291669|FG006|Overall Study|Adverse Event|0|||
145392584|NCT01719380|524291670|FG007|Overall Study|Adverse Event|1|||
145392585|NCT01719380|524291671|FG008|Overall Study|Adverse Event|4|||
145392586|NCT01719380|524291672|FG009|Overall Study|Adverse Event|3|||
145392587|NCT01719380|524291663|FG000|Overall Study|Death|0|||
145392588|NCT01719380|524291664|FG001|Overall Study|Death|1|||
145392589|NCT01719380|524291665|FG002|Overall Study|Death|0|||
145392590|NCT01719380|524291666|FG003|Overall Study|Death|0|||
145392591|NCT01719380|524291667|FG004|Overall Study|Death|0|||
145392592|NCT01719380|524291668|FG005|Overall Study|Death|0|||
145392593|NCT01719380|524291669|FG006|Overall Study|Death|0|||
145392594|NCT01719380|524291670|FG007|Overall Study|Death|0|||
145392595|NCT01719380|524291671|FG008|Overall Study|Death|3|||
145392596|NCT01719380|524291672|FG009|Overall Study|Death|3|||
145392597|NCT01719380|524291663|FG000|Overall Study|Participant/Guardian Decision|0|||
145495497|NCT04292535|524671659|FG010|Overall Study|Report of Dizziness|0|||
145495498|NCT04292535|524671660|FG011|Overall Study|Report of Dizziness|0|||
145495499|NCT04292535|524671661|FG012|Overall Study|Report of Dizziness|0|||
145495500|NCT04292535|524671662|FG013|Overall Study|Report of Dizziness|1|||
145495501|NCT04292535|524671649|FG000|Overall Study|Equipment Failure|0|||
145495502|NCT04292535|524671650|FG001|Overall Study|Equipment Failure|0|||
145495503|NCT04292535|524671651|FG002|Overall Study|Equipment Failure|0|||
145495504|NCT04292535|524671652|FG003|Overall Study|Equipment Failure|0|||
145495505|NCT04292535|524671653|FG004|Overall Study|Equipment Failure|0|||
145495506|NCT04292535|524671654|FG005|Overall Study|Equipment Failure|0|||
145495507|NCT04292535|524671655|FG006|Overall Study|Equipment Failure|0|||
145495508|NCT04292535|524671656|FG007|Overall Study|Equipment Failure|0|||
145495509|NCT04292535|524671657|FG008|Overall Study|Equipment Failure|0|||
145495510|NCT04292535|524671658|FG009|Overall Study|Equipment Failure|0|||
145495511|NCT04292535|524671659|FG010|Overall Study|Equipment Failure|0|||
145495512|NCT04292535|524671660|FG011|Overall Study|Equipment Failure|1|||
145495513|NCT04292535|524671661|FG012|Overall Study|Equipment Failure|0|||
145495514|NCT04292535|524671662|FG013|Overall Study|Equipment Failure|0|||
145495515|NCT01420861|524671663|FG000|Overall Study|Adverse Event|2|||
145495516|NCT01420861|524671663|FG000|Overall Study|Study terminated by Sponsor|7|||
145495517|NCT01420861|524671663|FG000|Overall Study|Screen failure|7|||
145495518|NCT01420861|524671663|FG000|Overall Study|Randomized not Treated|2|||
145495519|NCT03474588|524671664|FG000|Overall Study|Withdrawal by Subject|4|||
145495520|NCT03474588|524671665|FG001|Overall Study|Withdrawal by Subject|3|||
145495521|NCT03474588|524671664|FG000|Overall Study|Death|0|||
145495522|NCT03474588|524671665|FG001|Overall Study|Death|1|||
145495523|NCT04659044|524671669|FG000|Induction|Physician Decision|1|||
145495524|NCT04659044|524671669|FG000|Induction|Adverse Event|2|||
145495525|NCT04966013|524671670|FG000|Overall Study|Withdrawal by Subject|0|||
145495526|NCT04966013|524671671|FG001|Overall Study|Withdrawal by Subject|2|||
145495527|NCT04966013|524671672|FG002|Overall Study|Withdrawal by Subject|1|||
145495528|NCT04966013|524671670|FG000|Overall Study|Adverse Event|2|||
145495529|NCT04966013|524671671|FG001|Overall Study|Adverse Event|1|||
145495530|NCT04966013|524671672|FG002|Overall Study|Adverse Event|1|||
145495531|NCT04875975|524671688|FG000|Overall Study|Adverse Event|1|||
145495532|NCT04875975|524671689|FG001|Overall Study|Adverse Event|2|||
145495533|NCT04875975|524671688|FG000|Overall Study|Lack of Efficacy|2|||
145495534|NCT04875975|524671689|FG001|Overall Study|Lack of Efficacy|2|||
145495535|NCT04875975|524671688|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
145495536|NCT04875975|524671689|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
145495537|NCT04875975|524671688|FG000|Overall Study|Relapse With Insults|0|||
145495538|NCT04875975|524671689|FG001|Overall Study|Relapse With Insults|1|||
145495539|NCT04875975|524671688|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
145495540|NCT04875975|524671689|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
145495541|NCT05472090|524671690|FG000|Overall Study|Adverse Event|2|||
145495542|NCT05472090|524671691|FG001|Overall Study|Adverse Event|3|||
145495543|NCT05472090|524671690|FG000|Overall Study|Lack of Efficacy|1|||
145495544|NCT05472090|524671691|FG001|Overall Study|Lack of Efficacy|0|||
145495545|NCT05472090|524671690|FG000|Overall Study|Physician Decision|1|||
145495546|NCT05472090|524671691|FG001|Overall Study|Physician Decision|0|||
145495547|NCT05472090|524671690|FG000|Overall Study|Withdrawal by Subject|2|||
145495548|NCT05472090|524671691|FG001|Overall Study|Withdrawal by Subject|0|||
145495549|NCT05472090|524671690|FG000|Overall Study|Lost to Follow-up|0|||
145392598|NCT01719380|524291664|FG001|Overall Study|Participant/Guardian Decision|0|||
145392599|NCT01719380|524291665|FG002|Overall Study|Participant/Guardian Decision|1|||
145392600|NCT01719380|524291666|FG003|Overall Study|Participant/Guardian Decision|0|||
145392601|NCT01719380|524291667|FG004|Overall Study|Participant/Guardian Decision|0|||
145392602|NCT01719380|524291668|FG005|Overall Study|Participant/Guardian Decision|0|||
145392603|NCT01719380|524291669|FG006|Overall Study|Participant/Guardian Decision|0|||
145392604|NCT01719380|524291670|FG007|Overall Study|Participant/Guardian Decision|0|||
145392605|NCT01719380|524291671|FG008|Overall Study|Participant/Guardian Decision|2|||
145495550|NCT05472090|524671691|FG001|Overall Study|Lost to Follow-up|3|||
145495551|NCT01775501|524673735|FG000|Overall Study|Discontinued prior to treatment|1|||
145495552|NCT01702311|524673736|FG000|Overall Study|Withdrawal by Subject|3|||
145495553|NCT01702311|524673737|FG001|Overall Study|Withdrawal by Subject|2|||
145495554|NCT01702311|524673736|FG000|Overall Study|Discharge less than 24 hours|10|||
145495555|NCT01702311|524673737|FG001|Overall Study|Discharge less than 24 hours|7|||
145495556|NCT01702311|524673736|FG000|Overall Study|Physician Decision|3|||
145495557|NCT01702311|524673737|FG001|Overall Study|Physician Decision|4|||
145495558|NCT02326155|524673743|FG000|Overall Study|Adverse Event|21|||
145495559|NCT02326155|524673744|FG001|Overall Study|Adverse Event|5|||
145495560|NCT02326155|524673743|FG000|Overall Study|Death|3|||
145495561|NCT02326155|524673744|FG001|Overall Study|Death|0|||
145495562|NCT02326155|524673743|FG000|Overall Study|Lack of Efficacy|49|||
145392606|NCT01719380|524291672|FG009|Overall Study|Participant/Guardian Decision|2|||
145495563|NCT02326155|524673744|FG001|Overall Study|Lack of Efficacy|5|||
145392607|NCT01719380|524291663|FG000|Overall Study|Physician Decision|0|||
145392608|NCT01719380|524291664|FG001|Overall Study|Physician Decision|0|||
145392609|NCT01719380|524291665|FG002|Overall Study|Physician Decision|2|||
145392610|NCT01719380|524291666|FG003|Overall Study|Physician Decision|0|||
145392611|NCT01719380|524291667|FG004|Overall Study|Physician Decision|0|||
145392612|NCT01719380|524291668|FG005|Overall Study|Physician Decision|0|||
145392613|NCT01719380|524291669|FG006|Overall Study|Physician Decision|0|||
145392614|NCT01719380|524291670|FG007|Overall Study|Physician Decision|0|||
145392615|NCT01719380|524291671|FG008|Overall Study|Physician Decision|1|||
145392616|NCT01719380|524291672|FG009|Overall Study|Physician Decision|1|||
145392617|NCT01719380|524291663|FG000|Overall Study|Lack of Efficacy|2|||
145392618|NCT01719380|524291664|FG001|Overall Study|Lack of Efficacy|6|||
145392619|NCT01719380|524291665|FG002|Overall Study|Lack of Efficacy|5|||
145392620|NCT01719380|524291666|FG003|Overall Study|Lack of Efficacy|6|||
145392621|NCT01719380|524291667|FG004|Overall Study|Lack of Efficacy|3|||
145392622|NCT01719380|524291668|FG005|Overall Study|Lack of Efficacy|7|||
145392623|NCT01719380|524291669|FG006|Overall Study|Lack of Efficacy|10|||
145392624|NCT01719380|524291670|FG007|Overall Study|Lack of Efficacy|6|||
145392625|NCT01719380|524291671|FG008|Overall Study|Lack of Efficacy|39|||
145392626|NCT01719380|524291672|FG009|Overall Study|Lack of Efficacy|42|||
145392627|NCT01719380|524291663|FG000|Overall Study|Progressive Disease|0|||
145392628|NCT01719380|524291664|FG001|Overall Study|Progressive Disease|0|||
145392629|NCT01719380|524291665|FG002|Overall Study|Progressive Disease|0|||
145392630|NCT01719380|524291666|FG003|Overall Study|Progressive Disease|0|||
145392631|NCT01719380|524291667|FG004|Overall Study|Progressive Disease|0|||
145392632|NCT01719380|524291668|FG005|Overall Study|Progressive Disease|0|||
145392633|NCT01719380|524291669|FG006|Overall Study|Progressive Disease|0|||
145392634|NCT01719380|524291670|FG007|Overall Study|Progressive Disease|0|||
145392635|NCT01719380|524291671|FG008|Overall Study|Progressive Disease|1|||
145392636|NCT01719380|524291672|FG009|Overall Study|Progressive Disease|0|||
145392637|NCT00447772|524291673|FG000|Overall Study|Lack of Efficacy|3|||
145392638|NCT00447772|524291673|FG000|Overall Study|Insufficient compliance|6|||
145392639|NCT00447772|524291673|FG000|Overall Study|Discontinuation of drug therapy|1|||
145392640|NCT00447772|524291673|FG000|Overall Study|Lost to Follow-up|9|||
145392641|NCT00447772|524291673|FG000|Overall Study|Withdrawal by Subject|1|||
145392642|NCT00447772|524291673|FG000|Overall Study|Unable to attend all study visits|2|||
145392643|NCT00447772|524291673|FG000|Overall Study|Adverse Event|1|||
145392644|NCT00447772|524291673|FG000|Overall Study|Patient relocated|1|||
145392645|NCT00447772|524291673|FG000|Overall Study|Incomplete documentation at visit 1|1|||
145392646|NCT00447772|524291673|FG000|Overall Study|Chemotherapy for lung cancer|1|||
145392647|NCT00447772|524291673|FG000|Overall Study|Premature re-injection required|1|||
145392648|NCT00716456|524291674|FG000|Overall Study|Adverse Event|0|||
145392649|NCT00716456|524291675|FG001|Overall Study|Adverse Event|2|||
145392650|NCT00716456|524291676|FG002|Overall Study|Adverse Event|0|||
145392651|NCT00875563|524291681|FG000|Overall Study|Death|4|||
145392652|NCT00875563|524291681|FG000|Overall Study|Withdrawal by Subject|7|||
145392653|NCT00875563|524291681|FG000|Overall Study|No long-term (3-5 year) consent|6|||
145392654|NCT00875563|524291681|FG000|Overall Study|Still be eligible for follow-up|7|||
145392655|NCT02896569|524291682|FG000|Overall Study|Lost to Follow-up|2|||
145392656|NCT02896569|524291683|FG001|Overall Study|Lost to Follow-up|1|||
145392657|NCT02896569|524291682|FG000|Overall Study|Physician Decision|1|||
145392658|NCT02896569|524291683|FG001|Overall Study|Physician Decision|3|||
145392659|NCT02896569|524291682|FG000|Overall Study|Adverse Event|0|||
145392660|NCT02896569|524291683|FG001|Overall Study|Adverse Event|1|||
145392661|NCT02896569|524291682|FG000|Overall Study|Withdrawal by Subject|1|||
145392662|NCT02896569|524291683|FG001|Overall Study|Withdrawal by Subject|0|||
145392663|NCT03257436|524291684|FG000|Overall Study|Withdrawal by Subject|76|||
145392664|NCT03257436|524291684|FG000|Overall Study|Death|19|||
145392665|NCT01841970|524291689|FG000|Overall Study|Withdrawal by Subject|1|||
145392666|NCT01841970|524291689|FG000|Overall Study|Physician Decision|2|||
145392667|NCT01841970|524291689|FG000|Overall Study|Lost to Follow-up|8|||
145392668|NCT03478371|524291690|FG000|Overall Study|non-compliance|1|||
145392669|NCT03478371|524291690|FG000|Overall Study|Lost to Follow-up|4|||
145392670|NCT03874013|524291696|FG000|Overall Study|Adverse Event|0|||
145392671|NCT03874013|524291697|FG001|Overall Study|Adverse Event|1|||
145266642|NCT04668066|523825252|FG015|Part 1: Treatment Phase|Other|0|||
145392672|NCT00327717|524291700|FG000|Overall Study|Adverse Event|6|||
145392673|NCT00327717|524291701|FG001|Overall Study|Adverse Event|6|||
145392674|NCT00327717|524291700|FG000|Overall Study|Lack of Efficacy|0|||
145392675|NCT00327717|524291701|FG001|Overall Study|Lack of Efficacy|1|||
145392676|NCT00327717|524291700|FG000|Overall Study|Withdrawal by Subject|3|||
145392677|NCT00327717|524291701|FG001|Overall Study|Withdrawal by Subject|7|||
145392678|NCT01502033|524291702|FG000|Overall Study|1 participant had scalp discomfort|1|||
145392679|NCT01502033|524291702|FG000|Overall Study|1 participant had worsening depression|1|||
145392680|NCT01502033|524291702|FG000|Overall Study|1 participant went back to school|1|||
145392681|NCT03804268|524291703|FG000|Overall Study|Adverse Event|2|||
145392682|NCT03804268|524291704|FG001|Overall Study|Adverse Event|2|||
145392683|NCT03804268|524291703|FG000|Overall Study|Withdrawal by Subject|2|||
145392684|NCT03804268|524291704|FG001|Overall Study|Withdrawal by Subject|0|||
145392685|NCT03804268|524291703|FG000|Overall Study|Lost to Follow-up|1|||
145392686|NCT03804268|524291704|FG001|Overall Study|Lost to Follow-up|0|||
145392687|NCT03804268|524291703|FG000|Overall Study|Physician Decision|2|||
145392688|NCT03804268|524291704|FG001|Overall Study|Physician Decision|0|||
145392689|NCT03311841|524291707|FG000|14-day Wash-out|Adverse Event|0|||
145392690|NCT03311841|524291708|FG001|14-day Wash-out|Adverse Event|1|||
145392691|NCT03311841|524291709|FG002|14-day Wash-out|Adverse Event|0|||
145392692|NCT03311841|524291710|FG003|14-day Wash-out|Adverse Event|0|||
145392693|NCT03311841|524291711|FG004|14-day Wash-out|Adverse Event|0|||
145392694|NCT03311841|524291707|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
145729951|NCT00568321|525529031|FG002|Overall Study|Lost to Follow-up|1|||
145729952|NCT00568321|525529029|FG000|Overall Study|Withdrawal by Subject|2|||
145729953|NCT00568321|525529030|FG001|Overall Study|Withdrawal by Subject|0|||
145729954|NCT00568321|525529031|FG002|Overall Study|Withdrawal by Subject|0|||
145729955|NCT00568321|525529029|FG000|Overall Study|Protocol Violation|0|||
145729956|NCT00568321|525529030|FG001|Overall Study|Protocol Violation|0|||
145729957|NCT00568321|525529031|FG002|Overall Study|Protocol Violation|1|||
145729958|NCT00568321|525529029|FG000|Overall Study|Randomized, not treated|2|||
145729959|NCT00568321|525529030|FG001|Overall Study|Randomized, not treated|0|||
145729960|NCT00568321|525529031|FG002|Overall Study|Randomized, not treated|1|||
145729961|NCT00823901|525529032|FG000|Overall Study|Adverse Event|1|||
145729962|NCT00823901|525529033|FG001|Overall Study|Adverse Event|1|||
145729963|NCT00823901|525529032|FG000|Overall Study|Lack of Efficacy|1|||
145729964|NCT00823901|525529033|FG001|Overall Study|Lack of Efficacy|0|||
145729965|NCT00823901|525529032|FG000|Overall Study|Lost to Follow-up|2|||
145729966|NCT00823901|525529033|FG001|Overall Study|Lost to Follow-up|1|||
145729967|NCT01369511|525529034|FG000|Overall Study|Adverse Event|1|||
145729968|NCT01369511|525529035|FG001|Overall Study|Adverse Event|1|||
145729969|NCT01369511|525529036|FG002|Overall Study|Adverse Event|5|||
145729970|NCT01369511|525529037|FG003|Overall Study|Adverse Event|0|||
145729971|NCT01369511|525529034|FG000|Overall Study|Entry criteria not met|2|||
145729972|NCT01369511|525529035|FG001|Overall Study|Entry criteria not met|0|||
145729973|NCT01369511|525529036|FG002|Overall Study|Entry criteria not met|0|||
145729974|NCT01369511|525529037|FG003|Overall Study|Entry criteria not met|1|||
145729975|NCT01369511|525529034|FG000|Overall Study|Lost to Follow-up|0|||
145729976|NCT01369511|525529035|FG001|Overall Study|Lost to Follow-up|1|||
145729977|NCT01369511|525529036|FG002|Overall Study|Lost to Follow-up|1|||
145729978|NCT01369511|525529037|FG003|Overall Study|Lost to Follow-up|2|||
145729979|NCT01369511|525529034|FG000|Overall Study|Protocol Violation|0|||
145729980|NCT01369511|525529035|FG001|Overall Study|Protocol Violation|1|||
145729981|NCT01369511|525529036|FG002|Overall Study|Protocol Violation|0|||
145729982|NCT01369511|525529037|FG003|Overall Study|Protocol Violation|2|||
145729983|NCT01369511|525529034|FG000|Overall Study|Physician Decision|3|||
145729984|NCT01369511|525529035|FG001|Overall Study|Physician Decision|4|||
145729985|NCT01369511|525529036|FG002|Overall Study|Physician Decision|0|||
145729986|NCT01369511|525529037|FG003|Overall Study|Physician Decision|0|||
145729987|NCT01369511|525529034|FG000|Overall Study|Sponsor decision|2|||
145729988|NCT01369511|525529035|FG001|Overall Study|Sponsor decision|0|||
145729989|NCT01369511|525529036|FG002|Overall Study|Sponsor decision|1|||
145729990|NCT01369511|525529037|FG003|Overall Study|Sponsor decision|0|||
145729991|NCT01369511|525529034|FG000|Overall Study|Withdrawal by Subject|5|||
145729992|NCT01369511|525529035|FG001|Overall Study|Withdrawal by Subject|6|||
145729993|NCT01369511|525529036|FG002|Overall Study|Withdrawal by Subject|4|||
145729994|NCT01369511|525529037|FG003|Overall Study|Withdrawal by Subject|6|||
145729995|NCT01180998|525529039|FG000|Overall Study|Poor Vision|0|||
145729996|NCT01180998|525529040|FG001|Overall Study|Poor Vision|2|||
145729997|NCT01180998|525529041|FG002|Overall Study|Poor Vision|2|||
145729998|NCT01180998|525529039|FG000|Overall Study|Lost to Follow-up|0|||
145729999|NCT01180998|525529040|FG001|Overall Study|Lost to Follow-up|0|||
145730000|NCT01180998|525529041|FG002|Overall Study|Lost to Follow-up|1|||
145730001|NCT01180998|525529039|FG000|Overall Study|Protocol Violation|1|||
145730002|NCT01180998|525529040|FG001|Overall Study|Protocol Violation|2|||
145730003|NCT01180998|525529041|FG002|Overall Study|Protocol Violation|0|||
145730004|NCT01180998|525529039|FG000|Overall Study|Withdrawal by Subject|0|||
145730005|NCT01180998|525529040|FG001|Overall Study|Withdrawal by Subject|0|||
145730006|NCT01180998|525529041|FG002|Overall Study|Withdrawal by Subject|1|||
145730007|NCT01180998|525529039|FG000|Overall Study|Poor comfort|3|||
145730008|NCT01180998|525529040|FG001|Overall Study|Poor comfort|0|||
145730009|NCT01180998|525529041|FG002|Overall Study|Poor comfort|4|||
145730010|NCT01180998|525529039|FG000|Overall Study|Poor lens handling|0|||
145730011|NCT01180998|525529040|FG001|Overall Study|Poor lens handling|0|||
145730012|NCT01180998|525529041|FG002|Overall Study|Poor lens handling|2|||
145730013|NCT01376349|525529042|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
145730014|NCT01376349|525529043|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
145730015|NCT01376349|525529044|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
145730016|NCT01376349|525529042|FG000|Raondomized Treatment|Adverse Event|13|||
145266643|NCT04668066|523825253|FG016|Part 1: Treatment Phase|Other|0|||
145730017|NCT01376349|525529043|FG001|Raondomized Treatment|Adverse Event|17|||
145730018|NCT01376349|525529044|FG002|Raondomized Treatment|Adverse Event|14|||
145495564|NCT02326155|524673743|FG000|Overall Study|Lost to Follow-up|14|||
145495565|NCT02326155|524673744|FG001|Overall Study|Lost to Follow-up|3|||
145495566|NCT02326155|524673743|FG000|Overall Study|Protocol Violation|2|||
145495567|NCT02326155|524673744|FG001|Overall Study|Protocol Violation|0|||
145495568|NCT02326155|524673743|FG000|Overall Study|Withdrawal by Subject|34|||
145495569|NCT02326155|524673744|FG001|Overall Study|Withdrawal by Subject|11|||
145495570|NCT02326155|524673743|FG000|Overall Study|Disease progression|37|||
145495571|NCT02326155|524673744|FG001|Overall Study|Disease progression|4|||
145495572|NCT02326155|524673743|FG000|Overall Study|Study close|188|||
145495573|NCT02326155|524673744|FG001|Overall Study|Study close|21|||
145495574|NCT02326155|524673743|FG000|Overall Study|except for study close|46|||
145495575|NCT02326155|524673744|FG001|Overall Study|except for study close|13|||
145495576|NCT05024032|524673745|FG000|Overall Study|Withdrawal by Subject|0|||
145495577|NCT05024032|524673746|FG001|Overall Study|Withdrawal by Subject|3|||
145495578|NCT05024032|524673747|FG002|Overall Study|Withdrawal by Subject|4|||
145495579|NCT05024032|524673745|FG000|Overall Study|Adverse Event|0|||
145495580|NCT05024032|524673746|FG001|Overall Study|Adverse Event|1|||
145495581|NCT05024032|524673747|FG002|Overall Study|Adverse Event|0|||
145495582|NCT05024032|524673745|FG000|Overall Study|Protocol Deviation|1|||
145495583|NCT05024032|524673746|FG001|Overall Study|Protocol Deviation|0|||
145495584|NCT05024032|524673747|FG002|Overall Study|Protocol Deviation|0|||
145495585|NCT01209689|524673750|FG000|Overall Study|Insufficient Therapeutic Response|7|||
145495586|NCT01209689|524673751|FG001|Overall Study|Insufficient Therapeutic Response|2|||
145495587|NCT01209689|524673750|FG000|Overall Study|Refused Treatment|8|||
145495588|NCT01209689|524673751|FG001|Overall Study|Refused Treatment|3|||
145495589|NCT01209689|524673750|FG000|Overall Study|Adverse Event|4|||
145495590|NCT01209689|524673751|FG001|Overall Study|Adverse Event|0|||
145495591|NCT01209689|524673750|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
145495592|NCT01209689|524673751|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
145495593|NCT01209689|524673750|FG000|Overall Study|Failure to Return|3|||
145495594|NCT01209689|524673751|FG001|Overall Study|Failure to Return|0|||
145495595|NCT01209689|524673750|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
145495596|NCT01209689|524673751|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
145495597|NCT03780244|524673752|FG000|Overall Study|Lost to Follow-up|1|||
145495598|NCT03780244|524673753|FG001|Overall Study|Lost to Follow-up|0|||
145495599|NCT03175367|524673754|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
145495600|NCT03175367|524673755|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
145495601|NCT03175367|524673756|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
145495602|NCT03175367|524673757|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
145495603|NCT03175367|524673758|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
145495604|NCT03175367|524673759|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
145495605|NCT03175367|524673760|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
145495606|NCT03175367|524673754|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
145495607|NCT03175367|524673755|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
145495608|NCT03175367|524673756|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
145495609|NCT03175367|524673757|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
145495610|NCT03175367|524673758|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
145495611|NCT03175367|524673759|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
145495612|NCT03175367|524673760|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
145495613|NCT03175367|524673754|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145495614|NCT03175367|524673755|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145495615|NCT03175367|524673756|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
145495616|NCT03175367|524673757|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
145495617|NCT03175367|524673758|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145495618|NCT03175367|524673759|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145495619|NCT03175367|524673760|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145392695|NCT03311841|524291708|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
145392696|NCT03311841|524291709|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
145392697|NCT03311841|524291710|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
145392698|NCT03311841|524291711|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
145392699|NCT01026948|524291717|FG000|Overall Study|Physician Decision|8|||
145392700|NCT02989402|524291719|FG000|Overall Study|Adverse event, or serious adverse event|4|||
145392701|NCT02989402|524291719|FG000|Overall Study|Death|2|||
145392702|NCT02989402|524291719|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
145392703|NCT02989402|524291719|FG000|Overall Study|Lost to Follow-up|8|||
145495620|NCT03175367|524673754|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
145495621|NCT03175367|524673755|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
145495622|NCT03175367|524673756|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
145495623|NCT03175367|524673757|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
145495624|NCT03175367|524673758|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
145495625|NCT03175367|524673759|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
145392704|NCT02989402|524291719|FG000|Overall Study|Patient no longer on monotherapy|1|||
145392705|NCT02989402|524291719|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
145392706|NCT02989402|524291719|FG000|Overall Study|Withdrawal by Subject|7|||
145392707|NCT02989402|524291719|FG000|Overall Study|Other|2|||
145392708|NCT00672633|524291734|FG000|Overall Study|Withdrawal by Subject|0|||
145392709|NCT00672633|524291735|FG001|Overall Study|Withdrawal by Subject|1|||
145392710|NCT02824627|524291736|FG000|Overall Study|Adverse Event|1|||
145392711|NCT02824627|524291737|FG001|Overall Study|Adverse Event|2|||
145392712|NCT02824627|524291736|FG000|Overall Study|Lost to Follow-up|2|||
145392713|NCT02824627|524291737|FG001|Overall Study|Lost to Follow-up|1|||
145392714|NCT01938846|524291738|FG000|Overall Study|Progressive disease|26|||
145392715|NCT01938846|524291739|FG001|Overall Study|Progressive disease|18|||
145392716|NCT01938846|524291740|FG002|Overall Study|Progressive disease|16|||
145392717|NCT01938846|524291738|FG000|Overall Study|Adverse Event|8|||
145392718|NCT01938846|524291739|FG001|Overall Study|Adverse Event|4|||
145392719|NCT01938846|524291740|FG002|Overall Study|Adverse Event|3|||
145392720|NCT01938846|524291738|FG000|Overall Study|Withdrawal by Subject|2|||
145392721|NCT01938846|524291739|FG001|Overall Study|Withdrawal by Subject|2|||
145392722|NCT01938846|524291740|FG002|Overall Study|Withdrawal by Subject|1|||
145392723|NCT01938846|524291738|FG000|Overall Study|Other than listed|5|||
145392724|NCT01938846|524291739|FG001|Overall Study|Other than listed|1|||
145392725|NCT01938846|524291740|FG002|Overall Study|Other than listed|4|||
145392726|NCT02499120|524291741|FG000|Overall Study|Death|52|||
145392727|NCT02499120|524291742|FG001|Overall Study|Death|43|||
145392728|NCT02499120|524291741|FG000|Overall Study|Lost to Follow-up|1|||
145392729|NCT02499120|524291742|FG001|Overall Study|Lost to Follow-up|2|||
145392730|NCT02499120|524291741|FG000|Overall Study|Participant refused further follow-up|1|||
145392731|NCT02499120|524291742|FG001|Overall Study|Participant refused further follow-up|0|||
145392732|NCT02499120|524291741|FG000|Overall Study|Withdrawal by Subject|2|||
145392733|NCT02499120|524291742|FG001|Overall Study|Withdrawal by Subject|5|||
145392734|NCT02499120|524291741|FG000|Overall Study|Other|9|||
145392735|NCT02499120|524291742|FG001|Overall Study|Other|10|||
145392736|NCT00964028|524291747|FG000|Overall Study|Withdrawal by Subject|0|||
145392737|NCT00964028|524291748|FG001|Overall Study|Withdrawal by Subject|1|||
145730019|NCT01376349|525529042|FG000|Raondomized Treatment|Unkown|1|||
145730020|NCT01376349|525529043|FG001|Raondomized Treatment|Unkown|2|||
145730021|NCT01376349|525529044|FG002|Raondomized Treatment|Unkown|1|||
145730022|NCT01376349|525529042|FG000|Raondomized Treatment|Alternative Treatment|0|||
145730023|NCT01376349|525529043|FG001|Raondomized Treatment|Alternative Treatment|0|||
145730024|NCT01376349|525529044|FG002|Raondomized Treatment|Alternative Treatment|1|||
145730025|NCT00718640|525529045|FG000|Overall Study|Adverse Event|4|||
145730026|NCT00718640|525529045|FG000|Overall Study|Death|1|||
145730027|NCT00718640|525529045|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
145730028|NCT00068588|525529048|FG000|Overall Study|Adverse Event|0|||
145730029|NCT00068588|525529049|FG001|Overall Study|Adverse Event|0|||
145730030|NCT00068588|525529050|FG002|Overall Study|Adverse Event|2|||
145730031|NCT00068588|525529048|FG000|Overall Study|Withdrawal by Subject|0|||
145730032|NCT00068588|525529049|FG001|Overall Study|Withdrawal by Subject|0|||
145730033|NCT00068588|525529050|FG002|Overall Study|Withdrawal by Subject|1|||
145730034|NCT00068588|525529048|FG000|Overall Study|Poor KPS|0|||
145730035|NCT00068588|525529049|FG001|Overall Study|Poor KPS|0|||
145730036|NCT00068588|525529050|FG002|Overall Study|Poor KPS|1|||
145730037|NCT04098068|525529051|FG000|Overall Study|Disease Progression|7|||
145730038|NCT04098068|525529051|FG000|Overall Study|Withdrawal by Subject|2|||
145730039|NCT04098068|525529051|FG000|Overall Study|New Cancer Diagnosis|1|||
145730040|NCT03871829|525529052|FG000|Overall Study|Lost to Follow-up|0|||
145730041|NCT03871829|525529053|FG001|Overall Study|Lost to Follow-up|1|||
145730042|NCT03871829|525529052|FG000|Overall Study|Withdrawal by Subject|1|||
145730043|NCT03871829|525529053|FG001|Overall Study|Withdrawal by Subject|1|||
145730044|NCT03871829|525529052|FG000|Overall Study|Death|12|||
145730045|NCT03871829|525529053|FG001|Overall Study|Death|8|||
145730046|NCT03871829|525529052|FG000|Overall Study|Study terminated by sponsor|31|||
145730047|NCT03871829|525529053|FG001|Overall Study|Study terminated by sponsor|34|||
145730048|NCT05458479|525529058|FG000|Overall Study|Lost to Follow-up|1|||
145730049|NCT02465463|525529065|FG000|Overall Study|Lost to Follow-up|2|||
145392738|NCT01603407|524291749|FG000|Overall Study|Adverse Event|1|||
145392739|NCT01603407|524291750|FG001|Overall Study|Adverse Event|1|||
145495626|NCT03175367|524673760|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
145730050|NCT02465463|525529066|FG001|Overall Study|Lost to Follow-up|1|||
145730051|NCT02465463|525529065|FG000|Overall Study|Death|1|||
145730052|NCT02465463|525529066|FG001|Overall Study|Death|0|||
145730053|NCT02465463|525529065|FG000|Overall Study|Protocol Violation|1|||
145730054|NCT02465463|525529066|FG001|Overall Study|Protocol Violation|0|||
145392740|NCT01603407|524291751|FG002|Overall Study|Adverse Event|1|||
145392741|NCT01603407|524291749|FG000|Overall Study|Protocol Violation|2|||
145392742|NCT01603407|524291750|FG001|Overall Study|Protocol Violation|2|||
145392743|NCT01603407|524291751|FG002|Overall Study|Protocol Violation|0|||
145392744|NCT01603407|524291749|FG000|Overall Study|Withdrawal by Subject|8|||
145730055|NCT01139658|525529073|FG000|Overall Study|Adverse Event|10|||
145495627|NCT03175367|524673754|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145495628|NCT03175367|524673755|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145495629|NCT03175367|524673756|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
145495630|NCT03175367|524673757|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145495631|NCT03175367|524673758|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
145495632|NCT03175367|524673759|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145495633|NCT03175367|524673760|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145495634|NCT03175367|524673754|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495635|NCT03175367|524673755|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495636|NCT03175367|524673756|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495637|NCT03175367|524673757|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495638|NCT03175367|524673758|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495639|NCT03175367|524673759|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
145495640|NCT03175367|524673760|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
145495641|NCT03175367|524673754|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145495642|NCT03175367|524673755|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145495643|NCT03175367|524673756|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145495644|NCT03175367|524673757|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145495645|NCT03175367|524673758|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145495646|NCT03175367|524673759|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
145495647|NCT03175367|524673760|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
145495648|NCT01280903|524673762|FG000|Overall Study|Lost to Follow-up|23|||
145495649|NCT01280903|524673763|FG001|Overall Study|Lost to Follow-up|16|||
145495650|NCT03453164|524673764|FG000|Overall Study|Lack of Efficacy|16|||
145495651|NCT03453164|524673764|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
145392745|NCT01603407|524291750|FG001|Overall Study|Withdrawal by Subject|5|||
145392746|NCT01603407|524291751|FG002|Overall Study|Withdrawal by Subject|7|||
145392747|NCT01603407|524291749|FG000|Overall Study|Lost to Follow-up|0|||
145392748|NCT01603407|524291750|FG001|Overall Study|Lost to Follow-up|3|||
145392749|NCT01603407|524291751|FG002|Overall Study|Lost to Follow-up|2|||
145392750|NCT02299388|524293162|FG000|Overall Study|Withdrawal by Subject|0|||
145392751|NCT02299388|524293163|FG001|Overall Study|Withdrawal by Subject|1|||
145392752|NCT00130689|524293165|FG000|Overall Study|Progressive Disease|29|||
145392753|NCT00130689|524293165|FG000|Overall Study|Death|1|||
145392754|NCT00130689|524293165|FG000|Overall Study|Clinical Deterioration|4|||
145392755|NCT00130689|524293165|FG000|Overall Study|Withdrawal by Subject|3|||
145392756|NCT00130689|524293165|FG000|Overall Study|Ineligible|6|||
145392757|NCT00766597|524293166|FG000|Overall Study|Unexpected closure of study|4|||
145392758|NCT00766597|524293166|FG000|Overall Study|Without CCR5-tropic virus|5|||
145392759|NCT00943397|524293167|FG000|Overall Study|Adverse Event|0|||
145392760|NCT00943397|524293168|FG001|Overall Study|Adverse Event|6|||
145392761|NCT00943397|524293167|FG000|Overall Study|Lost to Follow-up|0|||
145392762|NCT00943397|524293168|FG001|Overall Study|Lost to Follow-up|4|||
145392763|NCT00943397|524293167|FG000|Overall Study|Protocol Violation|2|||
145392764|NCT00943397|524293168|FG001|Overall Study|Protocol Violation|5|||
145392765|NCT00943397|524293167|FG000|Overall Study|Withdrawal by Subject|1|||
145392766|NCT00943397|524293168|FG001|Overall Study|Withdrawal by Subject|1|||
145392767|NCT00943397|524293167|FG000|Overall Study|Site terminated and other|12|||
145392768|NCT00943397|524293168|FG001|Overall Study|Site terminated and other|56|||
145392769|NCT01254656|524293169|FG000|Overall Study|Discontinued due to termination of study|40|||
145392770|NCT01254656|524293170|FG001|Overall Study|Discontinued due to termination of study|39|||
145392771|NCT01254656|524293171|FG002|Overall Study|Discontinued due to termination of study|13|||
145392772|NCT01254656|524293169|FG000|Overall Study|Lack of Efficacy|3|||
145392773|NCT01254656|524293170|FG001|Overall Study|Lack of Efficacy|0|||
145392774|NCT01254656|524293171|FG002|Overall Study|Lack of Efficacy|0|||
145392775|NCT01254656|524293169|FG000|Overall Study|Lost to Follow-up|1|||
145392776|NCT01254656|524293170|FG001|Overall Study|Lost to Follow-up|0|||
145392777|NCT01254656|524293171|FG002|Overall Study|Lost to Follow-up|2|||
145392778|NCT01254656|524293169|FG000|Overall Study|Withdrawal by Subject|2|||
145392779|NCT01254656|524293170|FG001|Overall Study|Withdrawal by Subject|2|||
145392780|NCT01254656|524293171|FG002|Overall Study|Withdrawal by Subject|1|||
145392781|NCT01254656|524293169|FG000|Overall Study|Pregnancy|0|||
145392782|NCT01254656|524293170|FG001|Overall Study|Pregnancy|0|||
145392783|NCT01254656|524293171|FG002|Overall Study|Pregnancy|2|||
145392784|NCT01254656|524293169|FG000|Overall Study|Adverse Event|1|||
145392785|NCT01254656|524293170|FG001|Overall Study|Adverse Event|1|||
145392786|NCT01254656|524293171|FG002|Overall Study|Adverse Event|0|||
145392787|NCT01254656|524293169|FG000|Overall Study|Death|0|||
145392788|NCT01254656|524293170|FG001|Overall Study|Death|1|||
145392789|NCT01254656|524293171|FG002|Overall Study|Death|0|||
145392790|NCT02948829|524293172|FG000|Overall Study|Lost to Follow-up|2|||
145392791|NCT02948829|524293172|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
145266644|NCT04668066|523825254|FG017|Part 1: Treatment Phase|Other|0|||
145495652|NCT01074502|524673765|FG000|Overall Study|Withdrawal by Subject|1|||
145495653|NCT02220920|524673773|FG000|Overall Study|Adverse Event|1|||
145495654|NCT02220920|524673774|FG001|Overall Study|Adverse Event|0|||
145495655|NCT02220920|524673773|FG000|Overall Study|Lack of Efficacy|0|||
145495656|NCT02220920|524673774|FG001|Overall Study|Lack of Efficacy|1|||
145495657|NCT02220920|524673773|FG000|Overall Study|Withdrawal by Subject|1|||
145495658|NCT02220920|524673774|FG001|Overall Study|Withdrawal by Subject|0|||
145495659|NCT02220920|524673773|FG000|Overall Study|Conflict with the stopping criteria|1|||
145495660|NCT02220920|524673774|FG001|Overall Study|Conflict with the stopping criteria|2|||
145495661|NCT04945733|524673775|FG000|Overall Study|Physician Decision|1|||
145495662|NCT04945733|524673776|FG001|Overall Study|Physician Decision|3|||
145495663|NCT04945733|524673777|FG002|Overall Study|Physician Decision|0|||
145495664|NCT04945733|524673775|FG000|Overall Study|Withdrawal by Subject|3|||
145495665|NCT04945733|524673776|FG001|Overall Study|Withdrawal by Subject|3|||
145495666|NCT04945733|524673777|FG002|Overall Study|Withdrawal by Subject|0|||
145495667|NCT00726063|524673778|FG000|Overall Study|Adverse Event|9|||
145495668|NCT00726063|524673779|FG001|Overall Study|Adverse Event|7|||
145495669|NCT02007096|524673780|FG000|Overall Study|medication not available|2|||
145495670|NCT02007096|524673781|FG001|Overall Study|medication not available|0|||
145495671|NCT02007096|524673780|FG000|Overall Study|did not inject saline|0|||
145495672|NCT02007096|524673781|FG001|Overall Study|did not inject saline|3|||
145495673|NCT02007096|524673780|FG000|Overall Study|did not follow postoperative protocol|8|||
145495674|NCT02007096|524673781|FG001|Overall Study|did not follow postoperative protocol|11|||
145495675|NCT02007096|524673780|FG000|Overall Study|converted to open surgery|1|||
145495676|NCT02007096|524673781|FG001|Overall Study|converted to open surgery|1|||
145495677|NCT02007096|524673780|FG000|Overall Study|no mesh placed|0|||
145495678|NCT02007096|524673781|FG001|Overall Study|no mesh placed|1|||
145495679|NCT01231984|524673782|FG000|Study Period 1|Withdrawal by Subject|0|||
145495680|NCT01231984|524673783|FG001|Study Period 1|Withdrawal by Subject|0|||
145495681|NCT01231984|524673784|FG002|Study Period 1|Withdrawal by Subject|0|||
145495682|NCT01231984|524673785|FG003|Study Period 1|Withdrawal by Subject|1|||
145495683|NCT01231984|524673782|FG000|Study Period 1|Lost to Follow-up|1|||
145495684|NCT01231984|524673783|FG001|Study Period 1|Lost to Follow-up|1|||
145495685|NCT01231984|524673784|FG002|Study Period 1|Lost to Follow-up|1|||
145495686|NCT01231984|524673785|FG003|Study Period 1|Lost to Follow-up|0|||
145495687|NCT01231984|524673782|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
145495688|NCT01231984|524673783|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
145495689|NCT01231984|524673784|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
145495690|NCT01231984|524673785|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
145495691|NCT01231984|524673782|FG000|Study Period 1|Screen Failure|0|||
145495692|NCT01231984|524673783|FG001|Study Period 1|Screen Failure|0|||
145495693|NCT01231984|524673784|FG002|Study Period 1|Screen Failure|0|||
145495694|NCT01231984|524673785|FG003|Study Period 1|Screen Failure|1|||
145495695|NCT01231984|524673782|FG000|Study Period 1|Non-compliance with study requirements|5|||
145495696|NCT01231984|524673783|FG001|Study Period 1|Non-compliance with study requirements|0|||
145495697|NCT01231984|524673784|FG002|Study Period 1|Non-compliance with study requirements|2|||
145495698|NCT01231984|524673785|FG003|Study Period 1|Non-compliance with study requirements|1|||
145495699|NCT01231984|524673782|FG000|Study Period 1|Protocol Violation|3|||
145495700|NCT01231984|524673783|FG001|Study Period 1|Protocol Violation|4|||
145495701|NCT01231984|524673784|FG002|Study Period 1|Protocol Violation|2|||
145495702|NCT01231984|524673785|FG003|Study Period 1|Protocol Violation|3|||
145495703|NCT01231984|524673782|FG000|Study Period 1|Adverse Event|1|||
145495704|NCT01231984|524673783|FG001|Study Period 1|Adverse Event|0|||
145495705|NCT01231984|524673784|FG002|Study Period 1|Adverse Event|0|||
145495706|NCT01231984|524673785|FG003|Study Period 1|Adverse Event|0|||
145495707|NCT01231984|524673782|FG000|Study Period 1|Other|0|||
145392792|NCT02948829|524293172|FG000|Overall Study|Pregnancy|1|||
145392793|NCT02948829|524293172|FG000|Overall Study|Other: Reason not Specified|8|||
145392794|NCT00369915|524293173|FG000|Overall Study|expected side effects|2|||
145392795|NCT00369915|524293174|FG001|Overall Study|expected side effects|1|||
145392796|NCT00369915|524293173|FG000|Overall Study|Withdrawal by Subject|4|||
145392797|NCT00369915|524293174|FG001|Overall Study|Withdrawal by Subject|1|||
145392798|NCT00369915|524293173|FG000|Overall Study|W/drawl by investigators|0|||
145392799|NCT00369915|524293174|FG001|Overall Study|W/drawl by investigators|1|||
145392800|NCT00268983|524293182|FG000|Overall Study|Death|3|||
145392801|NCT00268983|524293183|FG001|Overall Study|Death|0|||
145495708|NCT01231984|524673783|FG001|Study Period 1|Other|0|||
145495709|NCT01231984|524673784|FG002|Study Period 1|Other|0|||
145495710|NCT01231984|524673785|FG003|Study Period 1|Other|1|||
145495711|NCT01231984|524673782|FG000|Study Period 2|Withdrawal by Subject|1|||
145495712|NCT01231984|524673783|FG001|Study Period 2|Withdrawal by Subject|1|||
145495713|NCT01231984|524673784|FG002|Study Period 2|Withdrawal by Subject|0|||
145495714|NCT01231984|524673785|FG003|Study Period 2|Withdrawal by Subject|0|||
145495715|NCT01231984|524673782|FG000|Study Period 2|Lost to Follow-up|1|||
145495716|NCT01231984|524673783|FG001|Study Period 2|Lost to Follow-up|0|||
145392802|NCT01348139|524293188|FG000|Period 1|Adverse Event|1|||
145495717|NCT01231984|524673784|FG002|Study Period 2|Lost to Follow-up|0|||
145495718|NCT01231984|524673785|FG003|Study Period 2|Lost to Follow-up|3|||
145495719|NCT01231984|524673782|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
145495720|NCT01231984|524673783|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
145495721|NCT01231984|524673784|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
145495722|NCT01231984|524673785|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
145495723|NCT02182895|524673788|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
145495724|NCT02182895|524673789|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
145495725|NCT03103542|524673790|FG000|Overall Study|Physician Decision|2|||
145495726|NCT03103542|524673790|FG000|Overall Study|Adverse Event|2|||
145495727|NCT03103542|524673790|FG000|Overall Study|Other|2|||
145495728|NCT03103542|524673790|FG000|Overall Study|Withdrawal by Subject|1|||
145495729|NCT03566511|524673792|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
145495730|NCT03566511|524673793|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
145495731|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
145495732|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
145495733|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145495734|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
145392803|NCT01348139|524293189|FG001|Period 1|Adverse Event|0|||
145392804|NCT01348139|524293190|FG002|Period 1|Adverse Event|0|||
145392805|NCT01348139|524293191|FG003|Period 1|Adverse Event|0|||
145392806|NCT01348139|524293192|FG004|Period 1|Adverse Event|0|||
145392807|NCT01348139|524293193|FG005|Period 1|Adverse Event|0|||
145392808|NCT02254772|524293194|FG000|Overall Study|Ineligible|1|||
145392809|NCT02254772|524293194|FG000|Overall Study|Withdrawal by Subject|1|||
145392810|NCT03200548|524293195|FG000|Overall Study|Withdrawal by Subject|5|||
145392811|NCT03200548|524293196|FG001|Overall Study|Withdrawal by Subject|11|||
145392812|NCT03200548|524293197|FG002|Overall Study|Withdrawal by Subject|7|||
145392813|NCT03200548|524293198|FG003|Overall Study|Withdrawal by Subject|6|||
145392814|NCT00313846|524293199|FG000|Overall Study|Withdrawal by Subject|2|||
145392815|NCT00313846|524293200|FG001|Overall Study|Withdrawal by Subject|0|||
145392816|NCT00313846|524293199|FG000|Overall Study|Adverse Event|1|||
145392817|NCT00313846|524293200|FG001|Overall Study|Adverse Event|8|||
145392818|NCT00313846|524293199|FG000|Overall Study|Administrative|2|||
145392819|NCT00313846|524293200|FG001|Overall Study|Administrative|3|||
145392820|NCT04556760|524293201|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145392821|NCT04556760|524293202|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
145392822|NCT04556760|524293203|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145392823|NCT04556760|524293204|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145392824|NCT04556760|524293205|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145392825|NCT04556760|524293206|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
145392826|NCT04556760|524293201|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145392827|NCT04556760|524293202|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145392828|NCT04556760|524293203|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145392829|NCT04556760|524293204|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
145392830|NCT04556760|524293205|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145392831|NCT04556760|524293206|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
145392832|NCT02849743|524293207|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
145392833|NCT02849743|524293208|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
145392834|NCT02849743|524293207|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
145392835|NCT02849743|524293208|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145392836|NCT01411852|524293211|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
145392837|NCT01411852|524293212|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
145392838|NCT01411852|524293211|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
145392839|NCT01411852|524293212|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
145392840|NCT01411852|524293211|FG000|Prehospital Intervention Phase|Found to be under age|0|||
145392841|NCT01411852|524293212|FG001|Prehospital Intervention Phase|Found to be under age|1|||
145392842|NCT01411852|524293211|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
145392843|NCT01411852|524293212|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
145392844|NCT01411852|524293211|FG000|Hospital Intervention Phase|Severe head injury|5|||
145392845|NCT01411852|524293212|FG001|Hospital Intervention Phase|Severe head injury|4|||
145392846|NCT01411852|524293211|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
145392847|NCT01411852|524293212|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
145392848|NCT01411852|524293211|FG000|Hospital Intervention Phase|Miscommunication error|1|||
145392849|NCT01411852|524293212|FG001|Hospital Intervention Phase|Miscommunication error|2|||
145392850|NCT01411852|524293211|FG000|Hospital Intervention Phase|CPR administered|3|||
145392851|NCT01411852|524293212|FG001|Hospital Intervention Phase|CPR administered|1|||
145495735|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
145495736|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
145495737|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
145495738|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
145495739|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
145495740|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145495741|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145495742|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145495743|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
145495744|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
145495745|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
145495746|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
145495747|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
145495748|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
145495749|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
145495750|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
145495751|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
145495752|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
145495753|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145495754|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145495755|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
145495756|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
145495757|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
145495758|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
145495759|NCT04026113|524673794|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
145495760|NCT04026113|524673795|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
145495761|NCT04026113|524673796|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
145495762|NCT04026113|524673797|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
145495763|NCT04026113|524673794|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
145495764|NCT04026113|524673795|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
145495765|NCT04026113|524673796|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
145495766|NCT04026113|524673797|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
145495767|NCT04613362|524673798|FG000|3 Month Follow-up|Lost to Follow-up|1|||
145495768|NCT04613362|524673799|FG001|3 Month Follow-up|Lost to Follow-up|2|||
145495769|NCT04613362|524673798|FG000|6 Month Follow-up|Lost to Follow-up|0|||
145495770|NCT04613362|524673799|FG001|6 Month Follow-up|Lost to Follow-up|1|||
145495771|NCT02218372|524673800|FG000|Overall Study|Adverse Event|1|||
145495772|NCT02218372|524673801|FG001|Overall Study|Adverse Event|1|||
145495773|NCT02218372|524673800|FG000|Overall Study|Miscellaneous|2|||
145495774|NCT02218372|524673801|FG001|Overall Study|Miscellaneous|1|||
145495775|NCT02218372|524673800|FG000|Overall Study|Randomized but did not receive treatment|2|||
145495776|NCT02218372|524673801|FG001|Overall Study|Randomized but did not receive treatment|3|||
145495777|NCT02218372|524673800|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145495778|NCT02218372|524673801|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145495779|NCT03406780|524673802|FG000|Overall Study|Withdrawal by Subject|1|||
145495780|NCT03406780|524673803|FG001|Overall Study|Withdrawal by Subject|1|||
145495781|NCT03406780|524673802|FG000|Overall Study|Other|0|||
145495782|NCT03406780|524673803|FG001|Overall Study|Other|2|||
145495783|NCT01488045|524673805|FG000|Overall Study|Withdrawal by Subject|6|||
145495784|NCT01488045|524673806|FG001|Overall Study|Withdrawal by Subject|11|||
145495785|NCT01488045|524673805|FG000|Overall Study|Failure to present for colonoscopy|3|||
145495786|NCT01488045|524673806|FG001|Overall Study|Failure to present for colonoscopy|6|||
145495787|NCT01488045|524673805|FG000|Overall Study|Failure to report exclusion criteria|0|||
145495788|NCT01488045|524673806|FG001|Overall Study|Failure to report exclusion criteria|1|||
145495789|NCT05365217|524673808|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145495790|NCT05365217|524673809|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145495791|NCT01527149|524673810|FG000|Overall Study|Death|2|||
145495792|NCT02230410|524673811|FG000|Overall Study|Screen Failure|3|||
145495793|NCT04558125|524673815|FG000|Overall Study|Death|1|||
145495794|NCT03199976|524673816|FG000|Overall Study|Lack of Efficacy|3|||
145495795|NCT03199976|524673817|FG001|Overall Study|Lack of Efficacy|6|||
145495796|NCT03199976|524673818|FG002|Overall Study|Lack of Efficacy|13|||
145495797|NCT03199976|524673816|FG000|Overall Study|Withdrawal by Subject|1|||
145495798|NCT03199976|524673817|FG001|Overall Study|Withdrawal by Subject|0|||
145495799|NCT03199976|524673818|FG002|Overall Study|Withdrawal by Subject|0|||
145495800|NCT03199976|524673816|FG000|Overall Study|Lost to Follow-up|0|||
145495801|NCT03199976|524673817|FG001|Overall Study|Lost to Follow-up|1|||
145495802|NCT03199976|524673818|FG002|Overall Study|Lost to Follow-up|1|||
145495803|NCT01761877|524673819|FG000|Overall Study|Adverse Event|7|||
145495804|NCT01761877|524673820|FG001|Overall Study|Adverse Event|0|||
145266645|NCT04668066|523825255|FG018|Part 1: Treatment Phase|Other|0|||
145392852|NCT01411852|524293211|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
145730056|NCT01139658|525529074|FG001|Overall Study|Adverse Event|27|||
145730057|NCT01139658|525529073|FG000|Overall Study|Lack of Efficacy|15|||
145730058|NCT01139658|525529074|FG001|Overall Study|Lack of Efficacy|7|||
145730059|NCT01139658|525529073|FG000|Overall Study|Withdrawal by Subject|2|||
145730060|NCT01139658|525529074|FG001|Overall Study|Withdrawal by Subject|4|||
145730061|NCT01139658|525529073|FG000|Overall Study|No documentation of treatment|1|||
145730062|NCT01139658|525529074|FG001|Overall Study|No documentation of treatment|0|||
145730063|NCT01139658|525529073|FG000|Overall Study|Other|28|||
145730064|NCT01139658|525529074|FG001|Overall Study|Other|75|||
145730065|NCT01119001|525529080|FG000|Overall Study|Withdrawal by Subject|2|||
145730066|NCT04343248|525529081|FG000|Overall Study|Withdrawal by Subject|5|||
145730067|NCT04343248|525529082|FG001|Overall Study|Withdrawal by Subject|6|||
145730068|NCT04343248|525529081|FG000|Overall Study|Death|1|||
145730069|NCT04343248|525529082|FG001|Overall Study|Death|2|||
145730070|NCT04343248|525529081|FG000|Overall Study|Lost to Follow-up|9|||
145730071|NCT04343248|525529082|FG001|Overall Study|Lost to Follow-up|6|||
145730072|NCT04343248|525529081|FG000|Overall Study|Physician Decision|0|||
145730073|NCT04343248|525529082|FG001|Overall Study|Physician Decision|1|||
145730074|NCT04343248|525529081|FG000|Overall Study|Adverse Event|1|||
145730075|NCT04343248|525529082|FG001|Overall Study|Adverse Event|0|||
145730076|NCT02708095|525529083|FG000|Overall Study|Adverse Event|4|||
145730077|NCT02708095|525529084|FG001|Overall Study|Adverse Event|10|||
145730078|NCT02708095|525529085|FG002|Overall Study|Adverse Event|11|||
145730079|NCT02708095|525529083|FG000|Overall Study|Lack of Efficacy|9|||
145730080|NCT02708095|525529084|FG001|Overall Study|Lack of Efficacy|3|||
145730081|NCT02708095|525529085|FG002|Overall Study|Lack of Efficacy|0|||
145730082|NCT02708095|525529083|FG000|Overall Study|Lost to Follow-up|2|||
145730083|NCT02708095|525529084|FG001|Overall Study|Lost to Follow-up|0|||
145730084|NCT02708095|525529085|FG002|Overall Study|Lost to Follow-up|0|||
145730085|NCT02708095|525529083|FG000|Overall Study|Physician Decision|2|||
145730086|NCT02708095|525529084|FG001|Overall Study|Physician Decision|3|||
145730087|NCT02708095|525529085|FG002|Overall Study|Physician Decision|2|||
145730088|NCT02708095|525529083|FG000|Overall Study|Protocol Violation|0|||
145730089|NCT02708095|525529084|FG001|Overall Study|Protocol Violation|0|||
145730090|NCT02708095|525529085|FG002|Overall Study|Protocol Violation|1|||
145730091|NCT02708095|525529083|FG000|Overall Study|Withdrawal by Subject|5|||
145730092|NCT02708095|525529084|FG001|Overall Study|Withdrawal by Subject|3|||
145730093|NCT02708095|525529085|FG002|Overall Study|Withdrawal by Subject|4|||
145730094|NCT05066724|525529098|FG000|Overall Study|Adverse Event|1|||
145730095|NCT05066724|525529098|FG000|Overall Study|Non-Compliance With Study Drug|5|||
145730096|NCT05066724|525529098|FG000|Overall Study|Withdrawal by Subject|6|||
145730097|NCT05066724|525529098|FG000|Overall Study|Physician Decision|2|||
145730098|NCT00475033|525529113|FG000|Infant Series|Failed to return|3|||
145730099|NCT00475033|525529114|FG001|Infant Series|Failed to return|4|||
145730100|NCT00475033|525529113|FG000|Infant Series|Parent or legal guardian request|1|||
145730101|NCT00475033|525529114|FG001|Infant Series|Parent or legal guardian request|5|||
145730102|NCT00475033|525529113|FG000|Infant Series|Protocol Violation|1|||
145730103|NCT00475033|525529114|FG001|Infant Series|Protocol Violation|2|||
145730104|NCT00475033|525529113|FG000|Infant Series|Lost to Follow-up|2|||
145730105|NCT00475033|525529114|FG001|Infant Series|Lost to Follow-up|0|||
145730106|NCT00475033|525529113|FG000|Infant Series|Adverse Event|0|||
145730107|NCT00475033|525529114|FG001|Infant Series|Adverse Event|2|||
145730108|NCT00475033|525529113|FG000|After the Infant Series|Adverse Event|0|||
145730109|NCT00475033|525529114|FG001|After the Infant Series|Adverse Event|4|||
145730110|NCT00475033|525529113|FG000|After the Infant Series|Parent or legal guardian request|2|||
145730111|NCT00475033|525529114|FG001|After the Infant Series|Parent or legal guardian request|2|||
145730112|NCT00475033|525529113|FG000|After the Infant Series|Failed to return|2|||
145730113|NCT00475033|525529114|FG001|After the Infant Series|Failed to return|1|||
145730114|NCT00475033|525529113|FG000|After the Infant Series|Protocol Violation|1|||
145730115|NCT00475033|525529114|FG001|After the Infant Series|Protocol Violation|0|||
145730116|NCT00475033|525529113|FG000|After the Infant Series|Lost to Follow-up|1|||
145730117|NCT00475033|525529114|FG001|After the Infant Series|Lost to Follow-up|0|||
145730118|NCT00475033|525529113|FG000|After the Infant Series|Other|0|||
145730119|NCT00475033|525529114|FG001|After the Infant Series|Other|1|||
145730120|NCT00475033|525529113|FG000|Toddler Dose|Parent or legal guardian request|2|||
145730121|NCT00475033|525529114|FG001|Toddler Dose|Parent or legal guardian request|0|||
145730122|NCT00475033|525529113|FG000|Toddler Dose|Failed to return|1|||
145730123|NCT00475033|525529114|FG001|Toddler Dose|Failed to return|0|||
145730124|NCT00475033|525529113|FG000|Toddler Dose|Lost to Follow-up|1|||
145730125|NCT00475033|525529114|FG001|Toddler Dose|Lost to Follow-up|0|||
145730126|NCT01696942|525529115|FG000|Overall Study|Withdrawal by Subject|1|||
145730127|NCT01696942|525529116|FG001|Overall Study|Withdrawal by Subject|0|||
145730128|NCT01696942|525529115|FG000|Overall Study|Protocol Violation|1|||
145730129|NCT01696942|525529116|FG001|Overall Study|Protocol Violation|2|||
145605896|NCT00633932|525073036|FG002|Overall Study|Physician Decision|1|||
145730130|NCT01696942|525529115|FG000|Overall Study|screen failure|0|||
145730131|NCT01696942|525529116|FG001|Overall Study|screen failure|1|||
145495805|NCT01761877|524673819|FG000|Overall Study|Withdrawal by Subject|6|||
145392853|NCT01411852|524293212|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
145392854|NCT01411852|524293211|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
145392855|NCT01411852|524293212|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
145392856|NCT01411852|524293211|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
145392857|NCT01411852|524293212|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
145392858|NCT01411852|524293211|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
145392859|NCT01411852|524293212|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
145392860|NCT01411852|524293211|FG000|Hospital Intervention Phase|Other ineligible|2|||
145392861|NCT01411852|524293212|FG001|Hospital Intervention Phase|Other ineligible|2|||
145392862|NCT01411852|524293211|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
145392863|NCT01411852|524293212|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
145392864|NCT01411852|524293211|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
145392865|NCT01411852|524293212|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
145392866|NCT01411852|524293211|FG000|Hospital Intervention Phase|Vascular access failed|1|||
145730132|NCT03144804|525529117|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
145730133|NCT03769181|525530567|FG000|Overall Study|Adverse Event|1|||
145730134|NCT03769181|525530568|FG001|Overall Study|Adverse Event|0|||
145730135|NCT03769181|525530569|FG002|Overall Study|Adverse Event|2|||
145730136|NCT03769181|525530570|FG003|Overall Study|Adverse Event|4|||
145730137|NCT03769181|525530567|FG000|Overall Study|Withdrawal by Subject|1|||
145730138|NCT03769181|525530568|FG001|Overall Study|Withdrawal by Subject|0|||
145730139|NCT03769181|525530569|FG002|Overall Study|Withdrawal by Subject|2|||
145730140|NCT03769181|525530570|FG003|Overall Study|Withdrawal by Subject|1|||
145730141|NCT03769181|525530567|FG000|Overall Study|Progressive disease|9|||
145730142|NCT03769181|525530568|FG001|Overall Study|Progressive disease|7|||
145730143|NCT03769181|525530569|FG002|Overall Study|Progressive disease|13|||
145730144|NCT03769181|525530570|FG003|Overall Study|Progressive disease|6|||
145730145|NCT03769181|525530567|FG000|Overall Study|Other - Unspecified|2|||
145730146|NCT03769181|525530568|FG001|Overall Study|Other - Unspecified|1|||
145730147|NCT03769181|525530569|FG002|Overall Study|Other - Unspecified|0|||
145730148|NCT03769181|525530570|FG003|Overall Study|Other - Unspecified|0|||
145730149|NCT03971422|525530571|FG000|Overall Study|Lost to Follow-up|0|||
145730150|NCT03971422|525530572|FG001|Overall Study|Lost to Follow-up|1|||
145730151|NCT03971422|525530573|FG002|Overall Study|Lost to Follow-up|0|||
145730152|NCT03971422|525530571|FG000|Overall Study|Lack of Efficacy|5|||
145730153|NCT03971422|525530572|FG001|Overall Study|Lack of Efficacy|1|||
145730154|NCT03971422|525530573|FG002|Overall Study|Lack of Efficacy|1|||
145730155|NCT03971422|525530571|FG000|Overall Study|Adverse event, not fatal|2|||
145730156|NCT03971422|525530572|FG001|Overall Study|Adverse event, not fatal|2|||
145730157|NCT03971422|525530573|FG002|Overall Study|Adverse event, not fatal|5|||
145730158|NCT03971422|525530571|FG000|Overall Study|Worsening of MG Symptoms|1|||
145730159|NCT03971422|525530572|FG001|Overall Study|Worsening of MG Symptoms|4|||
145730160|NCT03971422|525530573|FG002|Overall Study|Worsening of MG Symptoms|2|||
145730161|NCT03971422|525530571|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
145730162|NCT03971422|525530572|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
145730163|NCT03971422|525530573|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
145730164|NCT03971422|525530571|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
145730165|NCT03971422|525530572|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
145730166|NCT03971422|525530573|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
145730167|NCT03971422|525530571|FG000|Overall Study|Due to COVID-19 pandemic|0|||
145730168|NCT03971422|525530572|FG001|Overall Study|Due to COVID-19 pandemic|1|||
145730169|NCT03971422|525530573|FG002|Overall Study|Due to COVID-19 pandemic|1|||
145730170|NCT01128361|525530575|FG000|Overall Study|Lost to Follow-up|0|||
145730171|NCT01128361|525530576|FG001|Overall Study|Lost to Follow-up|1|||
145730172|NCT01128361|525530575|FG000|Overall Study|Withdrawal by Subject|5|||
145730173|NCT01128361|525530576|FG001|Overall Study|Withdrawal by Subject|2|||
145730174|NCT01929980|525530577|FG000|Overall Study|Physician Decision|1|||
145730175|NCT04082429|525530578|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
145730176|NCT04082429|525530579|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
145730177|NCT04082429|525530580|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
145730178|NCT04082429|525530581|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
145730179|NCT04082429|525530582|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
145730180|NCT04082429|525530583|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
145392867|NCT01411852|524293212|FG001|Hospital Intervention Phase|Vascular access failed|0|||
145495806|NCT01761877|524673820|FG001|Overall Study|Withdrawal by Subject|4|||
145605897|NCT00633932|525073034|FG000|Overall Study|Doctor's judgement|1|||
145730181|NCT04082429|525530584|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
145730182|NCT04082429|525530585|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
145730183|NCT04082429|525530586|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
145730184|NCT04082429|525530578|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145495807|NCT01761877|524673819|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
145495808|NCT01761877|524673820|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
145495809|NCT01761877|524673819|FG000|Overall Study|Death|0|||
145495810|NCT01761877|524673820|FG001|Overall Study|Death|1|||
145495811|NCT01761877|524673819|FG000|Overall Study|MRI intolerant|1|||
145495812|NCT01761877|524673820|FG001|Overall Study|MRI intolerant|6|||
145495813|NCT04739982|524673821|FG000|Overall Study|Lost to Follow-up|176|||
145495814|NCT04739982|524673822|FG001|Overall Study|Lost to Follow-up|65|||
145495815|NCT04739982|524673821|FG000|Overall Study|Withdrawal by Subject|19|||
145495816|NCT04739982|524673822|FG001|Overall Study|Withdrawal by Subject|0|||
145495817|NCT04739982|524673821|FG000|Overall Study|Protocol Violation|0|||
145495818|NCT04739982|524673822|FG001|Overall Study|Protocol Violation|5|||
145495819|NCT00322881|524673824|FG000|Overall Study|Death|2|||
145495820|NCT00322881|524673824|FG000|Overall Study|Adverse Event|1|||
145495821|NCT00322881|524673824|FG000|Overall Study|Disease Progression|2|||
145495822|NCT04842747|524673827|FG000|Overall Study|Withdrawal by Subject|6|||
145495823|NCT04842747|524673828|FG001|Overall Study|Withdrawal by Subject|2|||
145495824|NCT04842747|524673827|FG000|Overall Study|Lost to Follow-up|1|||
145495825|NCT04842747|524673828|FG001|Overall Study|Lost to Follow-up|2|||
145495826|NCT04842747|524673827|FG000|Overall Study|Physician Decision|1|||
145495827|NCT04842747|524673828|FG001|Overall Study|Physician Decision|0|||
145495828|NCT04842747|524673827|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
145495829|NCT04842747|524673828|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
145495830|NCT00468169|524673832|FG000|Overall Study|Withdrawal by Subject|1|||
145495831|NCT00468169|524673833|FG001|Overall Study|Withdrawal by Subject|0|||
145495832|NCT01126749|524673838|FG000|Phase 1b|Other|0|||
145495833|NCT01126749|524673839|FG001|Phase 1b|Other|1|||
145495834|NCT01126749|524673840|FG002|Phase 1b|Other|0|||
145495835|NCT01126749|524673841|FG003|Phase 1b|Other|0|||
145495836|NCT01126749|524673838|FG000|Phase 1b|Withdrawal by Subject|0|||
145495837|NCT01126749|524673839|FG001|Phase 1b|Withdrawal by Subject|1|||
145495838|NCT01126749|524673840|FG002|Phase 1b|Withdrawal by Subject|0|||
145495839|NCT01126749|524673841|FG003|Phase 1b|Withdrawal by Subject|0|||
145495840|NCT01126749|524673838|FG000|Phase 1b|Death|3|||
145495841|NCT01126749|524673839|FG001|Phase 1b|Death|4|||
145495842|NCT01126749|524673840|FG002|Phase 1b|Death|0|||
145495843|NCT01126749|524673841|FG003|Phase 1b|Death|0|||
145495844|NCT01126749|524673838|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
145495845|NCT01126749|524673839|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
145495846|NCT01126749|524673840|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
145495847|NCT01126749|524673841|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
145495848|NCT01126749|524673838|FG000|Phase 2|Study Termination by Sponsor|0|||
145495849|NCT01126749|524673839|FG001|Phase 2|Study Termination by Sponsor|0|||
145495850|NCT01126749|524673840|FG002|Phase 2|Study Termination by Sponsor|12|||
145495851|NCT01126749|524673841|FG003|Phase 2|Study Termination by Sponsor|6|||
145495852|NCT01126749|524673838|FG000|Phase 2|Other|0|||
145495853|NCT01126749|524673839|FG001|Phase 2|Other|0|||
145495854|NCT01126749|524673840|FG002|Phase 2|Other|4|||
145495855|NCT01126749|524673841|FG003|Phase 2|Other|2|||
145495856|NCT01126749|524673838|FG000|Phase 2|Withdrawal by Subject|0|||
145495857|NCT01126749|524673839|FG001|Phase 2|Withdrawal by Subject|0|||
145495858|NCT01126749|524673840|FG002|Phase 2|Withdrawal by Subject|0|||
145495859|NCT01126749|524673841|FG003|Phase 2|Withdrawal by Subject|2|||
145392868|NCT00321906|524293213|FG000|Overall Study|Adverse Event|36|||
145392869|NCT00321906|524293214|FG001|Overall Study|Adverse Event|44|||
145392870|NCT00321906|524293213|FG000|Overall Study|Death|9|||
145392871|NCT00321906|524293214|FG001|Overall Study|Death|6|||
145392872|NCT00321906|524293213|FG000|Overall Study|Lost to Follow-up|1|||
145392873|NCT00321906|524293214|FG001|Overall Study|Lost to Follow-up|2|||
145392874|NCT00321906|524293213|FG000|Overall Study|Withdrawal by Subject|0|||
145730185|NCT04082429|525530579|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730186|NCT04082429|525530580|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145392875|NCT00321906|524293214|FG001|Overall Study|Withdrawal by Subject|4|||
145730187|NCT04082429|525530581|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730188|NCT04082429|525530582|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
145730189|NCT04082429|525530583|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730190|NCT04082429|525530584|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730191|NCT04082429|525530585|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730192|NCT04082429|525530586|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
145730193|NCT04082429|525530578|FG000|Main Part (After the Treatment Pause)|Death|0|||
145392876|NCT03489343|524293222|FG000|Overall Study|Documented progressive disease|1|||
145495860|NCT01126749|524673838|FG000|Phase 2|Lost to Follow-up|0|||
145495861|NCT01126749|524673839|FG001|Phase 2|Lost to Follow-up|0|||
145392877|NCT03489343|524293223|FG001|Overall Study|Documented progressive disease|0|||
145495862|NCT01126749|524673840|FG002|Phase 2|Lost to Follow-up|0|||
145392878|NCT03489343|524293224|FG002|Overall Study|Documented progressive disease|3|||
145495863|NCT01126749|524673841|FG003|Phase 2|Lost to Follow-up|1|||
145495864|NCT01126749|524673838|FG000|Phase 2|Death|0|||
145730194|NCT04082429|525530579|FG001|Main Part (After the Treatment Pause)|Death|0|||
145730195|NCT04082429|525530580|FG002|Main Part (After the Treatment Pause)|Death|0|||
145730196|NCT04082429|525530581|FG003|Main Part (After the Treatment Pause)|Death|0|||
145730197|NCT04082429|525530582|FG004|Main Part (After the Treatment Pause)|Death|1|||
145730198|NCT04082429|525530583|FG005|Main Part (After the Treatment Pause)|Death|0|||
145730199|NCT04082429|525530584|FG006|Main Part (After the Treatment Pause)|Death|0|||
145730200|NCT04082429|525530585|FG007|Main Part (After the Treatment Pause)|Death|0|||
145730201|NCT04082429|525530586|FG008|Main Part (After the Treatment Pause)|Death|0|||
145730202|NCT04082429|525530578|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730203|NCT04082429|525530579|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730204|NCT04082429|525530580|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730205|NCT04082429|525530581|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
145730206|NCT04082429|525530582|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730207|NCT04082429|525530583|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
145730208|NCT04082429|525530584|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730209|NCT04082429|525530585|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730210|NCT04082429|525530586|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
145730211|NCT04082429|525530578|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145730212|NCT04082429|525530579|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145730213|NCT04082429|525530580|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
145730214|NCT04082429|525530581|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
145730215|NCT04082429|525530582|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145730216|NCT04082429|525530583|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145730217|NCT04082429|525530584|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
145730218|NCT04082429|525530585|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
145730219|NCT04082429|525530586|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
145730220|NCT04082429|525530578|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
145730221|NCT04082429|525530579|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730222|NCT04082429|525530580|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730223|NCT04082429|525530581|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730224|NCT04082429|525530582|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730225|NCT04082429|525530583|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
145730226|NCT04082429|525530584|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730227|NCT04082429|525530585|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730228|NCT04082429|525530586|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
145730229|NCT04082429|525530578|FG000|Extension Part|Ongoing|0|||
145730230|NCT04082429|525530579|FG001|Extension Part|Ongoing|7|||
145730231|NCT04082429|525530580|FG002|Extension Part|Ongoing|17|||
145730232|NCT04082429|525530581|FG003|Extension Part|Ongoing|6|||
145730233|NCT04082429|525530582|FG004|Extension Part|Ongoing|45|||
145392879|NCT03489343|524293225|FG003|Overall Study|Documented progressive disease|1|||
145392880|NCT03489343|524293226|FG004|Overall Study|Documented progressive disease|3|||
145392881|NCT03489343|524293227|FG005|Overall Study|Documented progressive disease|5|||
145392882|NCT03489343|524293228|FG006|Overall Study|Documented progressive disease|4|||
145392883|NCT03489343|524293222|FG000|Overall Study|Adverse Event|0|||
145392884|NCT03489343|524293223|FG001|Overall Study|Adverse Event|1|||
145392885|NCT03489343|524293224|FG002|Overall Study|Adverse Event|0|||
145392886|NCT03489343|524293225|FG003|Overall Study|Adverse Event|0|||
145392887|NCT03489343|524293226|FG004|Overall Study|Adverse Event|0|||
145392888|NCT03489343|524293227|FG005|Overall Study|Adverse Event|1|||
145392889|NCT03489343|524293228|FG006|Overall Study|Adverse Event|0|||
145392890|NCT03489343|524293222|FG000|Overall Study|Withdrawal by Subject|0|||
145392891|NCT03489343|524293223|FG001|Overall Study|Withdrawal by Subject|0|||
145392892|NCT03489343|524293224|FG002|Overall Study|Withdrawal by Subject|0|||
145392893|NCT03489343|524293225|FG003|Overall Study|Withdrawal by Subject|1|||
145392894|NCT03489343|524293226|FG004|Overall Study|Withdrawal by Subject|0|||
145392895|NCT03489343|524293227|FG005|Overall Study|Withdrawal by Subject|1|||
145392896|NCT03489343|524293228|FG006|Overall Study|Withdrawal by Subject|1|||
145392897|NCT03489343|524293222|FG000|Overall Study|Clinical progression|0|||
145392898|NCT03489343|524293223|FG001|Overall Study|Clinical progression|0|||
145392899|NCT03489343|524293224|FG002|Overall Study|Clinical progression|0|||
145392900|NCT03489343|524293225|FG003|Overall Study|Clinical progression|1|||
145730234|NCT04082429|525530583|FG005|Extension Part|Ongoing|0|||
145730235|NCT04082429|525530584|FG006|Extension Part|Ongoing|10|||
145730236|NCT04082429|525530585|FG007|Extension Part|Ongoing|23|||
145730237|NCT04082429|525530586|FG008|Extension Part|Ongoing|25|||
145730238|NCT02824263|525530589|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
145730239|NCT02824263|525530590|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
145392901|NCT03489343|524293226|FG004|Overall Study|Clinical progression|0|||
145392902|NCT03489343|524293227|FG005|Overall Study|Clinical progression|0|||
145392903|NCT03489343|524293228|FG006|Overall Study|Clinical progression|1|||
145392904|NCT01630135|524293230|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
145392905|NCT01630135|524293231|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
145392906|NCT04767373|524293233|FG000|Overall Study|Death|6|||
145392907|NCT04767373|524293234|FG001|Overall Study|Death|3|||
145392908|NCT04767373|524293233|FG000|Overall Study|Lost to Follow-up|67|||
145392909|NCT04767373|524293234|FG001|Overall Study|Lost to Follow-up|35|||
145392910|NCT04767373|524293233|FG000|Overall Study|Physician Decision|15|||
145392911|NCT04767373|524293234|FG001|Overall Study|Physician Decision|4|||
145392912|NCT04767373|524293233|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145392913|NCT04767373|524293234|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145392914|NCT04767373|524293233|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
145392915|NCT04767373|524293234|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
145392916|NCT04767373|524293233|FG000|Overall Study|Other|1|||
145392917|NCT04767373|524293234|FG001|Overall Study|Other|2|||
145392918|NCT02658669|524293235|FG000|Overall Study|Lost to Follow-up|7|||
145392919|NCT02658669|524293236|FG001|Overall Study|Lost to Follow-up|5|||
145392920|NCT00186485|524293237|FG000|Overall Study|Lost to Follow-up|3|||
145392921|NCT00838097|524293250|FG000|Overall Study|Ineligibility determined|6|||
145392922|NCT00838097|524293250|FG000|Overall Study|Adverse Event|2|||
145392923|NCT00838097|524293250|FG000|Overall Study|Withdrawal by Subject|3|||
145392924|NCT00838097|524293250|FG000|Overall Study|Requirement for alternative therapy|2|||
145392925|NCT00838097|524293250|FG000|Overall Study|Physician Decision|4|||
145392926|NCT00838097|524293250|FG000|Overall Study|Lost to Follow-up|11|||
145392927|NCT00838097|524293250|FG000|Overall Study|Death|6|||
145392928|NCT00838097|524293250|FG000|Overall Study|Protocol-specified criteria|142|||
145392929|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
145392930|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
145392931|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Adverse Event|57|||
145392932|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Adverse Event|49|||
145392933|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
145392934|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
145392935|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Site closure|3|||
145392936|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Site closure|2|||
145392937|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
145392938|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
145392939|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Physician Decision|48|||
145392940|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Physician Decision|38|||
145392941|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
145392942|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
145392943|NCT01705977|524293265|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
145392944|NCT01705977|524293266|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
145392945|NCT01705977|524293265|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
145392946|NCT01705977|524293266|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
145392947|NCT01705977|524293265|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
145392948|NCT01705977|524293266|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
145392949|NCT01705977|524293265|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
145392950|NCT01705977|524293266|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
145392951|NCT01705977|524293265|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
145392952|NCT01705977|524293266|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
145392953|NCT01462110|524293273|FG000|Overall Study|Adverse Event|1|||
145392954|NCT01462110|524293274|FG001|Overall Study|Adverse Event|0|||
145392955|NCT00753675|524293275|FG000|Overall Study|other reason|11|||
145392956|NCT00753675|524293276|FG001|Overall Study|other reason|12|||
145392957|NCT00753675|524293277|FG002|Overall Study|other reason|13|||
145392958|NCT00753675|524293275|FG000|Overall Study|Death|1|||
145392959|NCT00753675|524293276|FG001|Overall Study|Death|2|||
145392960|NCT00753675|524293277|FG002|Overall Study|Death|4|||
145392961|NCT00753675|524293275|FG000|Overall Study|Adverse Event|11|||
145392962|NCT00753675|524293276|FG001|Overall Study|Adverse Event|9|||
145392963|NCT00753675|524293277|FG002|Overall Study|Adverse Event|4|||
145392964|NCT00753675|524293275|FG000|Overall Study|Objective progression of disease|35|||
145392965|NCT00753675|524293276|FG001|Overall Study|Objective progression of disease|35|||
145392966|NCT00753675|524293277|FG002|Overall Study|Objective progression of disease|35|||
145392967|NCT00753675|524293275|FG000|Overall Study|Withdrawal by Subject|0|||
145392968|NCT00753675|524293276|FG001|Overall Study|Withdrawal by Subject|1|||
145392969|NCT00753675|524293277|FG002|Overall Study|Withdrawal by Subject|0|||
145392970|NCT00753675|524293275|FG000|Overall Study|Lost to Follow-up|1|||
145392971|NCT00753675|524293276|FG001|Overall Study|Lost to Follow-up|0|||
145392972|NCT00753675|524293277|FG002|Overall Study|Lost to Follow-up|0|||
145392973|NCT05279131|524293279|FG000|Overall Study|Lost to Follow-up|1|||
145392974|NCT05279131|524293279|FG000|Overall Study|Death|1|||
145392975|NCT05279131|524293279|FG000|Overall Study|Physician Decision|1|||
145392976|NCT02149264|524293285|FG000|Overall Study|Withdrawal by Subject|9|||
145392977|NCT02149264|524293285|FG000|Overall Study|Adverse Event|7|||
145392978|NCT02149264|524293285|FG000|Overall Study|Physician Decision|3|||
145392979|NCT02149264|524293285|FG000|Overall Study|Protocol Violation|1|||
145495865|NCT01126749|524673839|FG001|Phase 2|Death|0|||
145495866|NCT01126749|524673840|FG002|Phase 2|Death|22|||
145495867|NCT01126749|524673841|FG003|Phase 2|Death|22|||
145495868|NCT01126749|524673838|FG000|Phase 2|Adverse Event|0|||
145495869|NCT01126749|524673839|FG001|Phase 2|Adverse Event|0|||
145495870|NCT01126749|524673840|FG002|Phase 2|Adverse Event|0|||
145495871|NCT01126749|524673841|FG003|Phase 2|Adverse Event|1|||
145495872|NCT00976274|524673843|FG000|Overall Study|Lost to Follow-up|5|||
145495873|NCT00976274|524673844|FG001|Overall Study|Lost to Follow-up|5|||
145495874|NCT00976274|524673843|FG000|Overall Study|Withdrawal by Subject|1|||
145495875|NCT00976274|524673844|FG001|Overall Study|Withdrawal by Subject|1|||
145495876|NCT00976274|524673843|FG000|Overall Study|Physician Decision|1|||
145495877|NCT00976274|524673844|FG001|Overall Study|Physician Decision|2|||
145495878|NCT00627393|524673845|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
145495879|NCT00627393|524673846|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
145495880|NCT00627393|524673845|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
145495881|NCT00627393|524673846|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
145495882|NCT00627393|524673845|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
145495883|NCT00627393|524673846|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
145495884|NCT00627393|524673845|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
145495885|NCT00627393|524673846|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
145495886|NCT02183675|524673847|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
145495887|NCT02183675|524673848|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
145495888|NCT02183675|524673849|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
145495889|NCT02183675|524673850|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
145495890|NCT02183675|524673851|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
145495891|NCT02183675|524673852|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
145495892|NCT03337308|524673853|FG000|Overall Study|Adverse Event|2|||
145495893|NCT03337308|524673854|FG001|Overall Study|Adverse Event|3|||
145495894|NCT03337308|524673855|FG002|Overall Study|Adverse Event|3|||
145495895|NCT03337308|524673856|FG003|Overall Study|Adverse Event|1|||
145495896|NCT03337308|524673853|FG000|Overall Study|Lost to Follow-up|1|||
145495897|NCT03337308|524673854|FG001|Overall Study|Lost to Follow-up|2|||
145495898|NCT03337308|524673855|FG002|Overall Study|Lost to Follow-up|0|||
145495899|NCT03337308|524673856|FG003|Overall Study|Lost to Follow-up|0|||
145495900|NCT03337308|524673853|FG000|Overall Study|Withdrawal by Subject|2|||
145495901|NCT03337308|524673854|FG001|Overall Study|Withdrawal by Subject|1|||
145495902|NCT03337308|524673855|FG002|Overall Study|Withdrawal by Subject|2|||
145495903|NCT03337308|524673856|FG003|Overall Study|Withdrawal by Subject|1|||
145495904|NCT03337308|524673853|FG000|Overall Study|Protocol Violation|0|||
145495905|NCT03337308|524673854|FG001|Overall Study|Protocol Violation|1|||
145495906|NCT03337308|524673855|FG002|Overall Study|Protocol Violation|0|||
145392980|NCT00520039|524293292|FG000|Overall Study|Exclusion criteria met at first visit|7|||
145392981|NCT00520039|524293293|FG001|Overall Study|Exclusion criteria met at first visit|5|||
145392982|NCT05176717|524293294|FG000|Overall Study|Sponsor Decision|1|||
145392983|NCT05176717|524293295|FG001|Overall Study|Sponsor Decision|2|||
145392984|NCT05176717|524293296|FG002|Overall Study|Sponsor Decision|2|||
145392985|NCT03284853|524293297|FG000|Overall Study|Adverse Event|40|||
145392986|NCT03284853|524293298|FG001|Overall Study|Adverse Event|4|||
145392987|NCT03284853|524293297|FG000|Overall Study|Withdrawal by Subject|5|||
145392988|NCT03284853|524293298|FG001|Overall Study|Withdrawal by Subject|1|||
145392989|NCT03284853|524293297|FG000|Overall Study|Lost to Follow-up|1|||
145392990|NCT03284853|524293298|FG001|Overall Study|Lost to Follow-up|0|||
145495907|NCT03337308|524673856|FG003|Overall Study|Protocol Violation|0|||
145495908|NCT01056822|524673857|FG000|Overall Study|Adverse Event|0|||
145495909|NCT01056822|524673858|FG001|Overall Study|Adverse Event|1|||
145495910|NCT01056822|524673857|FG000|Overall Study|Protocol Violation|6|||
145495911|NCT01056822|524673858|FG001|Overall Study|Protocol Violation|5|||
145495912|NCT01056822|524673857|FG000|Overall Study|Withdrawal by Subject|1|||
145495913|NCT01056822|524673858|FG001|Overall Study|Withdrawal by Subject|1|||
145495914|NCT01056822|524673857|FG000|Overall Study|Lost to Follow-up|1|||
145495915|NCT01056822|524673858|FG001|Overall Study|Lost to Follow-up|0|||
145495916|NCT01614249|524673862|FG000|Overall Study|Lost to Follow-up|11|||
145495917|NCT01614249|524673863|FG001|Overall Study|Lost to Follow-up|23|||
145495918|NCT02946580|524673875|FG000|Overall Study|Withdrawal by Subject|1|||
145495919|NCT02946580|524673876|FG001|Overall Study|Withdrawal by Subject|2|||
145495920|NCT02946580|524673875|FG000|Overall Study|Adverse Event|0|||
145495921|NCT02946580|524673876|FG001|Overall Study|Adverse Event|2|||
145495922|NCT02946580|524673875|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
145495923|NCT02946580|524673876|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
145495924|NCT02761330|524673877|FG000|Treatment Week 1|Withdrawal by Subject|0|||
145495925|NCT02761330|524673878|FG001|Treatment Week 1|Withdrawal by Subject|0|||
145495926|NCT02761330|524673879|FG002|Treatment Week 1|Withdrawal by Subject|0|||
145495927|NCT02761330|524673880|FG003|Treatment Week 1|Withdrawal by Subject|1|||
145495928|NCT02761330|524673881|FG004|Treatment Week 1|Withdrawal by Subject|0|||
145495929|NCT02761330|524673882|FG005|Treatment Week 1|Withdrawal by Subject|1|||
145495930|NCT00888134|524673883|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
145495931|NCT00888134|524673883|FG000|Follow-up|being followed for long-term survival|1|||
145495932|NCT03043313|524673884|FG000|Overall Study|Withdrawal by Subject|5|||
145495933|NCT03043313|524673885|FG001|Overall Study|Withdrawal by Subject|1|||
145495934|NCT03043313|524673886|FG002|Overall Study|Withdrawal by Subject|1|||
145495935|NCT03043313|524673884|FG000|Overall Study|Lost to Follow-up|1|||
145495936|NCT03043313|524673885|FG001|Overall Study|Lost to Follow-up|1|||
145495937|NCT03043313|524673886|FG002|Overall Study|Lost to Follow-up|0|||
145495938|NCT03043313|524673884|FG000|Overall Study|Death|28|||
145495939|NCT03043313|524673885|FG001|Overall Study|Death|26|||
145495940|NCT03043313|524673886|FG002|Overall Study|Death|17|||
145495941|NCT03043313|524673884|FG000|Overall Study|Participation terminated by sponsor|11|||
145495942|NCT03043313|524673885|FG001|Overall Study|Participation terminated by sponsor|13|||
145495943|NCT03043313|524673886|FG002|Overall Study|Participation terminated by sponsor|13|||
145495944|NCT02657889|524673887|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
145495945|NCT02657889|524673888|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
145495946|NCT02657889|524673889|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
145495947|NCT02657889|524673890|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
145495948|NCT02657889|524673887|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
145495949|NCT02657889|524673888|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
145495950|NCT02657889|524673889|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
145495951|NCT02657889|524673890|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
145495952|NCT02657889|524673887|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
145495953|NCT02657889|524673888|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
145495954|NCT02657889|524673889|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
145495955|NCT02657889|524673890|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
145495956|NCT02657889|524673887|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
145495957|NCT02657889|524673888|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
145495958|NCT02657889|524673889|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
145495959|NCT02657889|524673890|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
145495960|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
145495961|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
145495962|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
145495963|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
145495964|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
145495965|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
145495966|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
145495967|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
145495968|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
145495969|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
145495970|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
145495971|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
145495972|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
145495973|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
145495974|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
145495975|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
145495976|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
145495977|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
145495978|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
145495979|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
145495980|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
145495981|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
145495982|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
145495983|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
145495984|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
145495985|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
145495986|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
145495987|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
145495988|NCT02657889|524673887|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
145495989|NCT02657889|524673888|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
145495990|NCT02657889|524673889|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
145495991|NCT02657889|524673890|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
145495992|NCT00795535|524673891|FG000|Overall Study|incomplete data and technical problems|20|||
145495993|NCT03341299|524673896|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
145495994|NCT03341299|524673897|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
145495995|NCT03341299|524673898|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
145495996|NCT03341299|524673899|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
145495997|NCT02702492|524673910|FG000|Overall Study|Disease progression|3|||
145495998|NCT02702492|524673911|FG001|Overall Study|Disease progression|3|||
145495999|NCT02702492|524673912|FG002|Overall Study|Disease progression|2|||
145496000|NCT02702492|524673913|FG003|Overall Study|Disease progression|4|||
145496001|NCT02702492|524673914|FG004|Overall Study|Disease progression|4|||
145496002|NCT02702492|524673915|FG005|Overall Study|Disease progression|1|||
145496003|NCT02702492|524673916|FG006|Overall Study|Disease progression|2|||
145496004|NCT02702492|524673917|FG007|Overall Study|Disease progression|8|||
145496005|NCT02702492|524673918|FG008|Overall Study|Disease progression|5|||
145496006|NCT02702492|524673919|FG009|Overall Study|Disease progression|1|||
145496007|NCT02702492|524673920|FG010|Overall Study|Disease progression|0|||
145496008|NCT02702492|524673921|FG011|Overall Study|Disease progression|3|||
145496009|NCT02702492|524673922|FG012|Overall Study|Disease progression|2|||
145496010|NCT02702492|524673910|FG000|Overall Study|Clinical progression|0|||
145496011|NCT02702492|524673911|FG001|Overall Study|Clinical progression|0|||
145496012|NCT02702492|524673912|FG002|Overall Study|Clinical progression|2|||
145496013|NCT02702492|524673913|FG003|Overall Study|Clinical progression|1|||
145496014|NCT02702492|524673914|FG004|Overall Study|Clinical progression|0|||
145496015|NCT02702492|524673915|FG005|Overall Study|Clinical progression|2|||
145496016|NCT02702492|524673916|FG006|Overall Study|Clinical progression|1|||
145496017|NCT02702492|524673917|FG007|Overall Study|Clinical progression|4|||
145496018|NCT02702492|524673918|FG008|Overall Study|Clinical progression|0|||
145496019|NCT02702492|524673919|FG009|Overall Study|Clinical progression|0|||
145496020|NCT02702492|524673920|FG010|Overall Study|Clinical progression|1|||
145496021|NCT02702492|524673921|FG011|Overall Study|Clinical progression|2|||
145496022|NCT02702492|524673922|FG012|Overall Study|Clinical progression|0|||
145496023|NCT02702492|524673910|FG000|Overall Study|Adverse Event|0|||
145496024|NCT02702492|524673911|FG001|Overall Study|Adverse Event|0|||
145496025|NCT02702492|524673912|FG002|Overall Study|Adverse Event|1|||
145496026|NCT02702492|524673913|FG003|Overall Study|Adverse Event|2|||
145496027|NCT02702492|524673914|FG004|Overall Study|Adverse Event|1|||
145496028|NCT02702492|524673915|FG005|Overall Study|Adverse Event|0|||
145496029|NCT02702492|524673916|FG006|Overall Study|Adverse Event|1|||
145496030|NCT02702492|524673917|FG007|Overall Study|Adverse Event|0|||
145496031|NCT02702492|524673918|FG008|Overall Study|Adverse Event|2|||
145496032|NCT02702492|524673919|FG009|Overall Study|Adverse Event|0|||
145496033|NCT02702492|524673920|FG010|Overall Study|Adverse Event|0|||
145496034|NCT02702492|524673921|FG011|Overall Study|Adverse Event|0|||
145496035|NCT02702492|524673922|FG012|Overall Study|Adverse Event|1|||
145496036|NCT02702492|524673910|FG000|Overall Study|Other|0|||
145496037|NCT02702492|524673911|FG001|Overall Study|Other|0|||
145496038|NCT02702492|524673912|FG002|Overall Study|Other|0|||
145496039|NCT02702492|524673913|FG003|Overall Study|Other|0|||
145496040|NCT02702492|524673914|FG004|Overall Study|Other|0|||
145496041|NCT02702492|524673915|FG005|Overall Study|Other|0|||
145496042|NCT02702492|524673916|FG006|Overall Study|Other|0|||
145496043|NCT02702492|524673917|FG007|Overall Study|Other|0|||
145496044|NCT02702492|524673918|FG008|Overall Study|Other|0|||
145496045|NCT02702492|524673919|FG009|Overall Study|Other|0|||
145496046|NCT02702492|524673920|FG010|Overall Study|Other|0|||
145496047|NCT02702492|524673921|FG011|Overall Study|Other|0|||
145496048|NCT02702492|524673922|FG012|Overall Study|Other|1|||
145496049|NCT02458313|524675532|FG000|Overall Study|Withdrawal by Subject|6|||
145496050|NCT02458313|524675533|FG001|Overall Study|Withdrawal by Subject|8|||
145496051|NCT02458313|524675532|FG000|Overall Study|Excluded for motion during MRI|1|||
145496052|NCT02458313|524675533|FG001|Overall Study|Excluded for motion during MRI|2|||
145496053|NCT00199381|524675534|FG000|Overall Study|Withdrawal by Subject|38|||
145496054|NCT00199381|524675534|FG000|Overall Study|Adverse Event|73|||
145496055|NCT00199381|524675534|FG000|Overall Study|Protocol Violation|6|||
145496056|NCT00199381|524675534|FG000|Overall Study|Lack of Efficacy|27|||
145496057|NCT00199381|524675534|FG000|Overall Study|Not including due to early termination|37|||
145496058|NCT00199381|524675534|FG000|Overall Study|Study termination by Sponsor|323|||
145496059|NCT03414983|524675536|FG000|Pre-Treatment|Other reasons|1|||
145496060|NCT03414983|524675537|FG001|Pre-Treatment|Other reasons|0|||
145496061|NCT03414983|524675536|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
145496062|NCT03414983|524675537|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
145496063|NCT03414983|524675536|FG000|Pre-Treatment|Participant withdrew consent|1|||
145496064|NCT03414983|524675537|FG001|Pre-Treatment|Participant withdrew consent|3|||
145496065|NCT03414983|524675536|FG000|Treatment|Participant withdrew consent|4|||
145496066|NCT03414983|524675537|FG001|Treatment|Participant withdrew consent|3|||
145496067|NCT03414983|524675536|FG000|Treatment|Participant request to discontinue study treatment|8|||
145496068|NCT03414983|524675537|FG001|Treatment|Participant request to discontinue study treatment|10|||
145496069|NCT03414983|524675536|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
145496070|NCT03414983|524675537|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
145496071|NCT03414983|524675536|FG000|Treatment|Death|0|||
145496072|NCT03414983|524675537|FG001|Treatment|Death|1|||
145496073|NCT03414983|524675536|FG000|Treatment|Study Drug Toxicity|10|||
145496074|NCT03414983|524675537|FG001|Treatment|Study Drug Toxicity|5|||
145496075|NCT03414983|524675536|FG000|Treatment|Disease Progression|75|||
145496076|NCT03414983|524675537|FG001|Treatment|Disease Progression|29|||
145496077|NCT03414983|524675536|FG000|Treatment|Not reported|1|||
145496078|NCT03414983|524675537|FG001|Treatment|Not reported|0|||
145392991|NCT03284853|524293297|FG000|Overall Study|Lack of Efficacy|1|||
145392992|NCT03284853|524293298|FG001|Overall Study|Lack of Efficacy|0|||
145392993|NCT03284853|524293297|FG000|Overall Study|Disallowed Concurrent Medication|1|||
145392994|NCT03284853|524293298|FG001|Overall Study|Disallowed Concurrent Medication|1|||
145496079|NCT03414983|524675536|FG000|Treatment|Other reasons|3|||
145496080|NCT03414983|524675537|FG001|Treatment|Other reasons|2|||
145496081|NCT03414983|524675536|FG000|Treatment|Poor/non-compliance|2|||
145496082|NCT03414983|524675537|FG001|Treatment|Poor/non-compliance|0|||
145496083|NCT03414983|524675536|FG000|Treatment|Maximum clinical benefit|5|||
145496084|NCT03414983|524675537|FG001|Treatment|Maximum clinical benefit|9|||
145496085|NCT03414983|524675536|FG000|Treatment|Lost to Follow-up|0|||
145496086|NCT03414983|524675537|FG001|Treatment|Lost to Follow-up|1|||
145496087|NCT03414983|524675536|FG000|Treatment|Administrative reasons by sponsor|1|||
145496088|NCT03414983|524675537|FG001|Treatment|Administrative reasons by sponsor|0|||
145496089|NCT02608684|524675538|FG000|Overall Study|Physician Decision|2|||
145496090|NCT02608684|524675538|FG000|Overall Study|Withdrawal by Subject|1|||
145496091|NCT00751296|524675539|FG000|Overall Study|Adverse Event|2|||
145496092|NCT02318706|524675542|FG000|Double-blind Phase|Adverse Event|7|||
145496093|NCT02318706|524675543|FG001|Double-blind Phase|Adverse Event|4|||
145496094|NCT02318706|524675544|FG002|Double-blind Phase|Adverse Event|3|||
145496095|NCT02318706|524675545|FG003|Double-blind Phase|Adverse Event|10|||
145496096|NCT02318706|524675546|FG004|Double-blind Phase|Adverse Event|0|||
145496097|NCT02318706|524675542|FG000|Double-blind Phase|Lost to Follow-up|1|||
145496098|NCT02318706|524675543|FG001|Double-blind Phase|Lost to Follow-up|0|||
145496099|NCT02318706|524675544|FG002|Double-blind Phase|Lost to Follow-up|0|||
145496100|NCT02318706|524675545|FG003|Double-blind Phase|Lost to Follow-up|0|||
145496101|NCT02318706|524675546|FG004|Double-blind Phase|Lost to Follow-up|0|||
145496102|NCT02318706|524675542|FG000|Double-blind Phase|Protocol Violation|4|||
145496103|NCT02318706|524675543|FG001|Double-blind Phase|Protocol Violation|2|||
145496104|NCT02318706|524675544|FG002|Double-blind Phase|Protocol Violation|4|||
145496105|NCT02318706|524675545|FG003|Double-blind Phase|Protocol Violation|3|||
145496106|NCT02318706|524675546|FG004|Double-blind Phase|Protocol Violation|0|||
145496107|NCT02318706|524675542|FG000|Double-blind Phase|Withdrawal by Subject|9|||
145496108|NCT02318706|524675543|FG001|Double-blind Phase|Withdrawal by Subject|5|||
145496109|NCT02318706|524675544|FG002|Double-blind Phase|Withdrawal by Subject|7|||
145496110|NCT02318706|524675545|FG003|Double-blind Phase|Withdrawal by Subject|10|||
145496111|NCT02318706|524675546|FG004|Double-blind Phase|Withdrawal by Subject|0|||
145496112|NCT02318706|524675542|FG000|Double-blind Phase|Other|4|||
145496113|NCT02318706|524675543|FG001|Double-blind Phase|Other|1|||
145496114|NCT02318706|524675544|FG002|Double-blind Phase|Other|2|||
145496115|NCT02318706|524675545|FG003|Double-blind Phase|Other|1|||
145496116|NCT02318706|524675546|FG004|Double-blind Phase|Other|0|||
145496117|NCT02318706|524675542|FG000|Double-blind Phase|Death|0|||
145496118|NCT02318706|524675543|FG001|Double-blind Phase|Death|0|||
145496119|NCT02318706|524675544|FG002|Double-blind Phase|Death|2|||
145496120|NCT02318706|524675545|FG003|Double-blind Phase|Death|0|||
145496121|NCT02318706|524675546|FG004|Double-blind Phase|Death|0|||
145392995|NCT03284853|524293297|FG000|Overall Study|Protocol Violation|3|||
145392996|NCT03284853|524293298|FG001|Overall Study|Protocol Violation|3|||
145392997|NCT03284853|524293297|FG000|Overall Study|Death|0|||
145392998|NCT03284853|524293298|FG001|Overall Study|Death|1|||
145392999|NCT03284853|524293297|FG000|Overall Study|Other - Reason not reported in CSR|4|||
145393000|NCT03284853|524293298|FG001|Overall Study|Other - Reason not reported in CSR|3|||
145393001|NCT02143024|524293300|FG000|Overall Study|Lost to Follow-up|1|||
145393002|NCT02143024|524293301|FG001|Overall Study|Lost to Follow-up|1|||
145393003|NCT02143024|524293300|FG000|Overall Study|Withdrawal by Subject|1|||
145393004|NCT02143024|524293301|FG001|Overall Study|Withdrawal by Subject|0|||
145393005|NCT02308228|524293302|FG000|Overall Study|Adverse Event|3|||
145393006|NCT02308228|524293303|FG001|Overall Study|Adverse Event|4|||
145393007|NCT02308228|524293302|FG000|Overall Study|Withdrawal by Subject|5|||
145393008|NCT02308228|524293303|FG001|Overall Study|Withdrawal by Subject|3|||
145393009|NCT03999749|524293308|FG000|Overall Study|Toxicity|16|||
145393010|NCT03999749|524293308|FG000|Overall Study|Withdrawal by Subject|3|||
145393011|NCT03999749|524293308|FG000|Overall Study|Disease progression|26|||
145393012|NCT03999749|524293308|FG000|Overall Study|Physician Decision|4|||
145496122|NCT02318706|524675542|FG000|Open-label Extension Phase|Adverse Event|0|||
145496123|NCT02318706|524675543|FG001|Open-label Extension Phase|Adverse Event|0|||
145496124|NCT02318706|524675544|FG002|Open-label Extension Phase|Adverse Event|0|||
145496125|NCT02318706|524675545|FG003|Open-label Extension Phase|Adverse Event|0|||
145496126|NCT02318706|524675546|FG004|Open-label Extension Phase|Adverse Event|21|||
145496127|NCT02318706|524675542|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
145393013|NCT03999749|524293308|FG000|Overall Study|Death|5|||
145496128|NCT02318706|524675543|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
145496129|NCT02318706|524675544|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
145393014|NCT03999749|524293308|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
145393015|NCT05219968|524293309|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
145393016|NCT05219968|524293310|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145393017|NCT05219968|524293311|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145393018|NCT05219968|524293312|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145393019|NCT05219968|524293313|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
145393020|NCT05219968|524293309|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
145393021|NCT05219968|524293310|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
145393022|NCT05219968|524293311|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
145393023|NCT05219968|524293312|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
145393024|NCT05219968|524293313|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
145393025|NCT05219968|524293309|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
145393026|NCT05219968|524293310|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
145393027|NCT05219968|524293311|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
145393028|NCT05219968|524293312|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
145393029|NCT05219968|524293313|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
145393030|NCT05219968|524293309|FG000|Week 24 Treatment Period|Adverse Event|3|||
145393031|NCT05219968|524293310|FG001|Week 24 Treatment Period|Adverse Event|0|||
145393032|NCT05219968|524293311|FG002|Week 24 Treatment Period|Adverse Event|0|||
145393033|NCT05219968|524293312|FG003|Week 24 Treatment Period|Adverse Event|0|||
145393034|NCT05219968|524293313|FG004|Week 24 Treatment Period|Adverse Event|0|||
145393035|NCT05219968|524293309|FG000|Week 24 Treatment Period|Physician Decision|0|||
145393036|NCT05219968|524293310|FG001|Week 24 Treatment Period|Physician Decision|1|||
145393037|NCT05219968|524293311|FG002|Week 24 Treatment Period|Physician Decision|0|||
145393038|NCT05219968|524293312|FG003|Week 24 Treatment Period|Physician Decision|0|||
145393039|NCT05219968|524293313|FG004|Week 24 Treatment Period|Physician Decision|0|||
145393040|NCT05219968|524293309|FG000|Week 24 Treatment Period|Other, not specified|3|||
145393041|NCT05219968|524293310|FG001|Week 24 Treatment Period|Other, not specified|0|||
145393042|NCT05219968|524293311|FG002|Week 24 Treatment Period|Other, not specified|0|||
145393043|NCT05219968|524293312|FG003|Week 24 Treatment Period|Other, not specified|0|||
145393044|NCT05219968|524293313|FG004|Week 24 Treatment Period|Other, not specified|0|||
145393045|NCT05219968|524293309|FG000|Safety Extension Period|Treatment administration failure|0|||
145393046|NCT05219968|524293310|FG001|Safety Extension Period|Treatment administration failure|0|||
145393047|NCT05219968|524293311|FG002|Safety Extension Period|Treatment administration failure|0|||
145393048|NCT05219968|524293312|FG003|Safety Extension Period|Treatment administration failure|1|||
145393049|NCT05219968|524293313|FG004|Safety Extension Period|Treatment administration failure|4|||
145393050|NCT05219968|524293309|FG000|Safety Extension Period|Bilateral dislodgement|0|||
145393051|NCT05219968|524293310|FG001|Safety Extension Period|Bilateral dislodgement|0|||
145393052|NCT05219968|524293311|FG002|Safety Extension Period|Bilateral dislodgement|4|||
145393053|NCT05219968|524293312|FG003|Safety Extension Period|Bilateral dislodgement|0|||
145393054|NCT05219968|524293313|FG004|Safety Extension Period|Bilateral dislodgement|1|||
145393055|NCT05219968|524293309|FG000|Safety Extension Period|Withdrawal by Subject|0|||
145393056|NCT05219968|524293310|FG001|Safety Extension Period|Withdrawal by Subject|0|||
145393057|NCT05219968|524293311|FG002|Safety Extension Period|Withdrawal by Subject|2|||
145393058|NCT05219968|524293312|FG003|Safety Extension Period|Withdrawal by Subject|0|||
145393059|NCT05219968|524293313|FG004|Safety Extension Period|Withdrawal by Subject|4|||
145393060|NCT05219968|524293309|FG000|Safety Extension Period|Adverse Event|0|||
145393061|NCT05219968|524293310|FG001|Safety Extension Period|Adverse Event|0|||
145393062|NCT05219968|524293311|FG002|Safety Extension Period|Adverse Event|2|||
145393063|NCT05219968|524293312|FG003|Safety Extension Period|Adverse Event|1|||
145393064|NCT05219968|524293313|FG004|Safety Extension Period|Adverse Event|1|||
145393065|NCT05219968|524293309|FG000|Safety Extension Period|Lost to Follow-up|0|||
145393066|NCT05219968|524293310|FG001|Safety Extension Period|Lost to Follow-up|0|||
145393067|NCT05219968|524293311|FG002|Safety Extension Period|Lost to Follow-up|0|||
145393068|NCT05219968|524293312|FG003|Safety Extension Period|Lost to Follow-up|1|||
145393069|NCT05219968|524293313|FG004|Safety Extension Period|Lost to Follow-up|0|||
145393070|NCT04587336|524293316|FG000|Overall Study|Lost to Follow-up|1|||
145393071|NCT04587336|524293317|FG001|Overall Study|Lost to Follow-up|0|||
145393072|NCT02358031|524294792|FG000|Overall Study|Death|253|||
145393073|NCT02358031|524294793|FG001|Overall Study|Death|237|||
145393074|NCT02358031|524294794|FG002|Overall Study|Death|266|||
145393075|NCT02358031|524294792|FG000|Overall Study|Lost to Follow-up|1|||
145393076|NCT02358031|524294793|FG001|Overall Study|Lost to Follow-up|1|||
145393077|NCT02358031|524294794|FG002|Overall Study|Lost to Follow-up|0|||
145393078|NCT02358031|524294792|FG000|Overall Study|Withdrawal by Subject|19|||
145393079|NCT02358031|524294793|FG001|Overall Study|Withdrawal by Subject|14|||
145393080|NCT02358031|524294794|FG002|Overall Study|Withdrawal by Subject|18|||
145393081|NCT02358031|524294792|FG000|Overall Study|Sponsor Decision|26|||
145393082|NCT02358031|524294793|FG001|Overall Study|Sponsor Decision|28|||
145393083|NCT02358031|524294794|FG002|Overall Study|Sponsor Decision|16|||
145393084|NCT01212094|524294795|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
145393085|NCT01212094|524294796|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
145393086|NCT01212094|524294797|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
145393087|NCT01212094|524294795|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
145393088|NCT01212094|524294796|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
145393089|NCT01212094|524294797|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
145393090|NCT01212094|524294795|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
145393091|NCT01212094|524294796|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
145393092|NCT01212094|524294797|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
145393093|NCT01212094|524294795|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
145393094|NCT01212094|524294796|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
145393095|NCT01212094|524294797|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
145393096|NCT01212094|524294795|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
145393097|NCT01212094|524294796|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
145393098|NCT01212094|524294797|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
145393099|NCT01212094|524294795|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
145393100|NCT01212094|524294796|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
145393101|NCT01212094|524294797|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
145393102|NCT05664581|524294799|FG000|Overall Study|Withdrawal by Subject|2|||
145393103|NCT03101150|524294800|FG000|Overall Study|Lost to Follow-up|2|||
145393104|NCT03101150|524294801|FG001|Overall Study|Lost to Follow-up|4|||
145393105|NCT03101150|524294800|FG000|Overall Study|Miscarriage|3|||
145393106|NCT03101150|524294801|FG001|Overall Study|Miscarriage|6|||
145393107|NCT01128296|524294803|FG000|Overall Study|Physician Decision|0|||
145393108|NCT01128296|524294804|FG001|Overall Study|Physician Decision|0|||
145393109|NCT01128296|524294805|FG002|Overall Study|Physician Decision|0|||
145393110|NCT01128296|524294806|FG003|Overall Study|Physician Decision|0|||
145393111|NCT01128296|524294807|FG004|Overall Study|Physician Decision|0|||
145393112|NCT01128296|524294808|FG005|Overall Study|Physician Decision|3|||
145393113|NCT01128296|524294803|FG000|Overall Study|Withdrawal by Subject|0|||
145393114|NCT01128296|524294804|FG001|Overall Study|Withdrawal by Subject|0|||
145393115|NCT01128296|524294805|FG002|Overall Study|Withdrawal by Subject|0|||
145393116|NCT01128296|524294806|FG003|Overall Study|Withdrawal by Subject|0|||
145393117|NCT01128296|524294807|FG004|Overall Study|Withdrawal by Subject|0|||
145393118|NCT01128296|524294808|FG005|Overall Study|Withdrawal by Subject|2|||
145393119|NCT03316586|524294813|FG000|Overall Study|Adverse Event|2|||
145393120|NCT03316586|524294813|FG000|Overall Study|Physician Decision|3|||
145393121|NCT03316586|524294813|FG000|Overall Study|Lack of Efficacy|10|||
145393122|NCT03316586|524294813|FG000|Overall Study|still on treatment|1|||
145393123|NCT03316586|524294813|FG000|Overall Study|Patient needed radiation therapy|1|||
145393124|NCT03316586|524294813|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
145393125|NCT04547140|524294817|FG000|Overall Study|Adverse Event|0|||
145393126|NCT04547140|524294818|FG001|Overall Study|Adverse Event|1|||
145393127|NCT04547140|524294817|FG000|Overall Study|Withdrawal by Subject|0|||
145393128|NCT04547140|524294818|FG001|Overall Study|Withdrawal by Subject|1|||
145393129|NCT04547140|524294817|FG000|Overall Study|Lost to Follow-up|3|||
145393130|NCT04547140|524294818|FG001|Overall Study|Lost to Follow-up|1|||
145393131|NCT04547140|524294817|FG000|Overall Study|Death|2|||
145393132|NCT04547140|524294818|FG001|Overall Study|Death|1|||
145393133|NCT04547140|524294817|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
145393134|NCT04547140|524294818|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
145393135|NCT04547140|524294817|FG000|Overall Study|Pregnancy|1|||
145730240|NCT02824263|525530589|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
145730241|NCT02824263|525530590|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
145730242|NCT01676909|525530592|FG000|Overall Study|Withdrawal by Subject|3|||
145730243|NCT01676909|525530593|FG001|Overall Study|Withdrawal by Subject|5|||
145730244|NCT01676909|525530592|FG000|Overall Study|Lost to Follow-up|15|||
145730245|NCT01676909|525530593|FG001|Overall Study|Lost to Follow-up|9|||
145393136|NCT04547140|524294818|FG001|Overall Study|Pregnancy|0|||
145393137|NCT04547140|524294817|FG000|Overall Study|Reason Not Specified|4|||
145393138|NCT04547140|524294818|FG001|Overall Study|Reason Not Specified|1|||
145393139|NCT00873730|524294819|FG000|Overall Study|Protocol Deviation|5|||
145393140|NCT00873730|524294820|FG001|Overall Study|Protocol Deviation|2|||
145393141|NCT00873730|524294819|FG000|Overall Study|Adverse Event|0|||
145730246|NCT02076113|525530594|FG000|Overall Study|Lost to Follow-up|4|||
145730247|NCT02076113|525530595|FG001|Overall Study|Lost to Follow-up|1|||
145730248|NCT02076113|525530594|FG000|Overall Study|Withdrawal by Subject|2|||
145393142|NCT00873730|524294820|FG001|Overall Study|Adverse Event|2|||
145393143|NCT00873730|524294819|FG000|Overall Study|Withdrawal by Subject|0|||
145393144|NCT00873730|524294820|FG001|Overall Study|Withdrawal by Subject|1|||
145393145|NCT00873730|524294819|FG000|Overall Study|Sponsor decision|1|||
145393146|NCT00873730|524294820|FG001|Overall Study|Sponsor decision|0|||
145393147|NCT04613739|524294821|FG000|Overall Study|Lost to Follow-up|6|||
145393148|NCT04613739|524294822|FG001|Overall Study|Lost to Follow-up|9|||
145393149|NCT04613739|524294821|FG000|Overall Study|potentially duplicative/fraudulent|1|||
145730249|NCT02076113|525530595|FG001|Overall Study|Withdrawal by Subject|3|||
145496130|NCT02318706|524675545|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
145496131|NCT02318706|524675546|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
145496132|NCT02318706|524675542|FG000|Open-label Extension Phase|Death|0|||
145496133|NCT02318706|524675543|FG001|Open-label Extension Phase|Death|0|||
145496134|NCT02318706|524675544|FG002|Open-label Extension Phase|Death|0|||
145496135|NCT02318706|524675545|FG003|Open-label Extension Phase|Death|0|||
145496136|NCT02318706|524675546|FG004|Open-label Extension Phase|Death|1|||
145496137|NCT02318706|524675542|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
145496138|NCT02318706|524675543|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
145496139|NCT02318706|524675544|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
145496140|NCT02318706|524675545|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
145496141|NCT02318706|524675546|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
145496142|NCT04106557|524675547|FG000|Overall Study|Physician Decision|0|||
145496143|NCT04106557|524675548|FG001|Overall Study|Physician Decision|1|||
145496144|NCT04106557|524675549|FG002|Overall Study|Physician Decision|0|||
145496145|NCT04106557|524675547|FG000|Overall Study|Protocol Violation|0|||
145496146|NCT04106557|524675548|FG001|Overall Study|Protocol Violation|1|||
145496147|NCT04106557|524675549|FG002|Overall Study|Protocol Violation|0|||
145496148|NCT03714672|524675554|FG000|Overall Study|Adverse Event|0|||
145496149|NCT03714672|524675555|FG001|Overall Study|Adverse Event|0|||
145496150|NCT03714672|524675556|FG002|Overall Study|Adverse Event|3|||
145496151|NCT03714672|524675557|FG003|Overall Study|Adverse Event|0|||
145496152|NCT03714672|524675554|FG000|Overall Study|Physician Decision|0|||
145496153|NCT03714672|524675555|FG001|Overall Study|Physician Decision|1|||
145496154|NCT03714672|524675556|FG002|Overall Study|Physician Decision|0|||
145496155|NCT03714672|524675557|FG003|Overall Study|Physician Decision|0|||
145496156|NCT03714672|524675554|FG000|Overall Study|Other Reason|1|||
145496157|NCT03714672|524675555|FG001|Overall Study|Other Reason|2|||
145496158|NCT03714672|524675556|FG002|Overall Study|Other Reason|1|||
145496159|NCT03714672|524675557|FG003|Overall Study|Other Reason|1|||
145496160|NCT03714672|524675554|FG000|Overall Study|Lost to Follow-up|1|||
145496161|NCT03714672|524675555|FG001|Overall Study|Lost to Follow-up|1|||
145496162|NCT03714672|524675556|FG002|Overall Study|Lost to Follow-up|0|||
145496163|NCT03714672|524675557|FG003|Overall Study|Lost to Follow-up|0|||
145496164|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
145496165|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496166|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496167|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496168|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496169|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496170|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145496171|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
145496172|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496173|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496174|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496175|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496176|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496177|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
145496178|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
145496179|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496180|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496181|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496182|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496183|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496184|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145496185|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
145496186|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496187|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496188|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496189|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496190|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496191|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145496192|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
145496193|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496194|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496195|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496196|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496197|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496198|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
145496199|NCT01054885|524675559|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
145605898|NCT00633932|525073035|FG001|Overall Study|Doctor's judgement|0|||
145393150|NCT04613739|524294822|FG001|Overall Study|potentially duplicative/fraudulent|3|||
145393151|NCT00003537|524294823|FG000|Overall Study|Not evalauable|1|||
145393152|NCT01051557|524294824|FG000|Overall Study|Physician Decision|1|||
145393153|NCT01051557|524294825|FG001|Overall Study|Physician Decision|0|||
145393154|NCT01051557|524294826|FG002|Overall Study|Physician Decision|0|||
145393155|NCT01051557|524294827|FG003|Overall Study|Physician Decision|0|||
145393156|NCT01051557|524294828|FG004|Overall Study|Physician Decision|0|||
145393157|NCT01051557|524294829|FG005|Overall Study|Physician Decision|0|||
145393158|NCT01051557|524294830|FG006|Overall Study|Physician Decision|0|||
145393159|NCT01051557|524294824|FG000|Overall Study|disease progression|3|||
145393160|NCT01051557|524294825|FG001|Overall Study|disease progression|3|||
145393161|NCT01051557|524294826|FG002|Overall Study|disease progression|5|||
145393162|NCT01051557|524294827|FG003|Overall Study|disease progression|2|||
145393163|NCT01051557|524294828|FG004|Overall Study|disease progression|4|||
145393164|NCT01051557|524294829|FG005|Overall Study|disease progression|3|||
145393165|NCT01051557|524294830|FG006|Overall Study|disease progression|1|||
145393166|NCT01051557|524294824|FG000|Overall Study|Withdrawal by Subject|0|||
145393167|NCT01051557|524294825|FG001|Overall Study|Withdrawal by Subject|0|||
145393168|NCT01051557|524294826|FG002|Overall Study|Withdrawal by Subject|1|||
145393169|NCT01051557|524294827|FG003|Overall Study|Withdrawal by Subject|0|||
145393170|NCT01051557|524294828|FG004|Overall Study|Withdrawal by Subject|2|||
145393171|NCT01051557|524294829|FG005|Overall Study|Withdrawal by Subject|0|||
145393172|NCT01051557|524294830|FG006|Overall Study|Withdrawal by Subject|1|||
145393173|NCT01051557|524294824|FG000|Overall Study|Adverse Event|0|||
145393174|NCT01051557|524294825|FG001|Overall Study|Adverse Event|0|||
145393175|NCT01051557|524294826|FG002|Overall Study|Adverse Event|0|||
145393176|NCT01051557|524294827|FG003|Overall Study|Adverse Event|1|||
145393177|NCT01051557|524294828|FG004|Overall Study|Adverse Event|1|||
145393178|NCT01051557|524294829|FG005|Overall Study|Adverse Event|3|||
145393179|NCT01051557|524294830|FG006|Overall Study|Adverse Event|4|||
145393180|NCT01178125|524294831|FG000|Overall Study|Lost to Follow-up|397|||
145393181|NCT01178125|524294831|FG000|Overall Study|Adverse Event|244|||
145393182|NCT01178125|524294831|FG000|Overall Study|Withdrawal by Subject|209|||
145393183|NCT01178125|524294831|FG000|Overall Study|Noncompliance|184|||
145393184|NCT01178125|524294831|FG000|Overall Study|Pregnancy|55|||
145393185|NCT01178125|524294831|FG000|Overall Study|Other Reason|39|||
145393186|NCT01178125|524294831|FG000|Overall Study|Sponsor Decision|28|||
145393187|NCT01178125|524294831|FG000|Overall Study|Protocol Violation|17|||
145393188|NCT01178125|524294831|FG000|Overall Study|Investigator Decision|5|||
145393189|NCT01004978|524294832|FG000|Overall Study|Disease progression|31|||
145393190|NCT01004978|524294833|FG001|Overall Study|Disease progression|48|||
145393191|NCT01004978|524294832|FG000|Overall Study|Adverse Event|42|||
145393192|NCT01004978|524294833|FG001|Overall Study|Adverse Event|22|||
145393193|NCT01004978|524294832|FG000|Overall Study|Death|3|||
145393194|NCT01004978|524294833|FG001|Overall Study|Death|2|||
145393195|NCT01004978|524294832|FG000|Overall Study|Withdrawal by Subject|16|||
145393196|NCT01004978|524294833|FG001|Overall Study|Withdrawal by Subject|16|||
145393197|NCT01004978|524294832|FG000|Overall Study|Alternative therapy|4|||
145393198|NCT01004978|524294833|FG001|Overall Study|Alternative therapy|8|||
145393199|NCT01004978|524294832|FG000|Overall Study|Physician Decision|6|||
145393200|NCT01004978|524294833|FG001|Overall Study|Physician Decision|3|||
145393201|NCT01004978|524294832|FG000|Overall Study|Other complicating disease|2|||
145393202|NCT01004978|524294833|FG001|Overall Study|Other complicating disease|2|||
145393203|NCT01004978|524294832|FG000|Overall Study|Protocol Violation|2|||
145393204|NCT01004978|524294833|FG001|Overall Study|Protocol Violation|3|||
145393205|NCT01004978|524294832|FG000|Overall Study|Non-compliance|3|||
145393206|NCT01004978|524294833|FG001|Overall Study|Non-compliance|2|||
145393207|NCT01004978|524294832|FG000|Overall Study|Ineligible|1|||
145496200|NCT01054885|524675560|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145496201|NCT01054885|524675561|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145496202|NCT01054885|524675562|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145605899|NCT00633932|525073036|FG002|Overall Study|Doctor's judgement|0|||
145393208|NCT01004978|524294833|FG001|Overall Study|Ineligible|0|||
145393209|NCT01004978|524294832|FG000|Overall Study|Unblinded|0|||
145393210|NCT01004978|524294833|FG001|Overall Study|Unblinded|1|||
145393211|NCT01004978|524294832|FG000|Overall Study|Performance status worsening|0|||
145393212|NCT01004978|524294833|FG001|Overall Study|Performance status worsening|1|||
145393213|NCT01004978|524294832|FG000|Overall Study|Never started treatment|8|||
145393214|NCT01004978|524294833|FG001|Overall Study|Never started treatment|9|||
145393215|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393216|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
145393217|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
145393218|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393219|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393220|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393221|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393222|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393223|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145496203|NCT01054885|524675563|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145496204|NCT01054885|524675564|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145496205|NCT01054885|524675565|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145496206|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
145496207|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
145496208|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
145496209|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
145496210|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
145496211|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
145496212|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
145496213|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145496214|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145496215|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
145496216|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
145496217|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145496218|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
145496219|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145496220|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
145496221|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
145496222|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
145496223|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
145496224|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
145496225|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
145496226|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
145496227|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
145496228|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
145496229|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
145496230|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
145496231|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
145393224|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393225|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393226|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145496232|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
145496233|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
145496234|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
145393227|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393228|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393229|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145393230|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
145393231|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
145393232|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393233|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393234|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393235|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393236|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393237|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393238|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393239|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393240|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393241|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393242|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393243|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393244|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145393245|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
145393246|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
145393247|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
145393248|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393249|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393250|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393251|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393252|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393253|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393254|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393255|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393256|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393257|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393258|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393259|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145393260|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393261|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393262|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
145393263|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393264|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393265|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393266|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393267|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393268|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393269|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393270|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393271|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393272|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393273|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393274|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
145393275|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393276|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393277|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
145393278|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393279|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393280|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393281|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393282|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393283|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393284|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393285|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393286|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393287|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393288|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393289|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
145393290|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393291|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393292|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
145393293|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393294|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393295|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393296|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393297|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393298|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393299|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393300|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393301|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393302|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393303|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393304|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
145393305|NCT02326272|524294834|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393306|NCT02326272|524294835|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393307|NCT02326272|524294836|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
145393308|NCT02326272|524294837|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393309|NCT02326272|524294838|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393310|NCT02326272|524294839|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393311|NCT02326272|524294840|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145496235|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
145496236|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
145496237|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
145496238|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
145496239|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
145496240|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
145496241|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
145496242|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
145496243|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
145496244|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
145496245|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
145496246|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
145496247|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
145496248|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145496249|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
145496250|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
145496251|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145496252|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145496253|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
145496254|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
145496255|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
145496256|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
145496257|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
145496258|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
145496259|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
145496260|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
145496261|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
145496262|NCT01054885|524675559|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145496263|NCT01054885|524675560|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
145496264|NCT01054885|524675561|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
145496265|NCT01054885|524675562|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
145496266|NCT01054885|524675563|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
145496267|NCT01054885|524675564|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
145496268|NCT01054885|524675565|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
145496269|NCT03085095|524675569|FG000|Overall Study|Adverse Event|23|||
145496270|NCT03085095|524675570|FG001|Overall Study|Adverse Event|8|||
145496271|NCT03085095|524675569|FG000|Overall Study|Protocol Violation|0|||
145496272|NCT03085095|524675570|FG001|Overall Study|Protocol Violation|1|||
145496273|NCT03085095|524675569|FG000|Overall Study|Lost to Follow-up|2|||
145496274|NCT03085095|524675570|FG001|Overall Study|Lost to Follow-up|1|||
145496275|NCT03085095|524675569|FG000|Overall Study|Withdrawal by Subject|17|||
145496276|NCT03085095|524675570|FG001|Overall Study|Withdrawal by Subject|6|||
145605900|NCT00633932|525073034|FG000|Overall Study|Moved Away|1|||
145605901|NCT00633932|525073035|FG001|Overall Study|Moved Away|0|||
145605902|NCT00633932|525073036|FG002|Overall Study|Moved Away|0|||
145605903|NCT00482274|525073037|FG000|Overall Study|Adverse Event|1|||
145605904|NCT04836858|525073038|FG000|Overall Study|Adverse Event|0|||
145605905|NCT04836858|525073039|FG001|Overall Study|Adverse Event|0|||
145605906|NCT04836858|525073040|FG002|Overall Study|Adverse Event|0|||
145605907|NCT04836858|525073041|FG003|Overall Study|Adverse Event|1|||
145605908|NCT04836858|525073038|FG000|Overall Study|Lost to Follow-up|1|||
145605909|NCT04836858|525073039|FG001|Overall Study|Lost to Follow-up|0|||
145605910|NCT04836858|525073040|FG002|Overall Study|Lost to Follow-up|0|||
145605911|NCT04836858|525073041|FG003|Overall Study|Lost to Follow-up|0|||
145605912|NCT04836858|525073038|FG000|Overall Study|Subject/Guardian decision|3|||
145605913|NCT04836858|525073039|FG001|Overall Study|Subject/Guardian decision|0|||
145605914|NCT04836858|525073040|FG002|Overall Study|Subject/Guardian decision|0|||
145605915|NCT04836858|525073041|FG003|Overall Study|Subject/Guardian decision|1|||
145605916|NCT04836858|525073038|FG000|Overall Study|Randomized but not treated|4|||
145605917|NCT04836858|525073039|FG001|Overall Study|Randomized but not treated|0|||
145605918|NCT04836858|525073040|FG002|Overall Study|Randomized but not treated|0|||
145605919|NCT04836858|525073041|FG003|Overall Study|Randomized but not treated|0|||
145605920|NCT04887948|525073045|FG000|Overall Study|Death|1|||
145605921|NCT04887948|525073046|FG001|Overall Study|Death|0|||
145605922|NCT04887948|525073047|FG002|Overall Study|Death|0|||
145605923|NCT04887948|525073045|FG000|Overall Study|Lost to Follow-up|1|||
145605924|NCT04887948|525073046|FG001|Overall Study|Lost to Follow-up|0|||
145605925|NCT04887948|525073047|FG002|Overall Study|Lost to Follow-up|3|||
145605926|NCT04887948|525073045|FG000|Overall Study|Physician Decision|0|||
145605927|NCT04887948|525073046|FG001|Overall Study|Physician Decision|4|||
145605928|NCT04887948|525073047|FG002|Overall Study|Physician Decision|1|||
145605929|NCT04887948|525073045|FG000|Overall Study|Protocol Violation|1|||
145605930|NCT04887948|525073046|FG001|Overall Study|Protocol Violation|1|||
145605931|NCT04887948|525073047|FG002|Overall Study|Protocol Violation|0|||
145605932|NCT04887948|525073045|FG000|Overall Study|Withdrawal by Subject|0|||
145393312|NCT02326272|524294841|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393313|NCT02326272|524294842|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393314|NCT02326272|524294843|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393315|NCT02326272|524294844|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393316|NCT02326272|524294845|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393317|NCT02326272|524294846|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393318|NCT02326272|524294847|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393319|NCT02326272|524294848|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
145393320|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393321|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393322|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393323|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393324|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145393325|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
145393326|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
145393327|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145393328|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145393329|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393330|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393331|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393332|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393333|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393334|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145393335|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393336|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393337|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393338|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393339|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393340|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
145393341|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145393342|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393343|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145393344|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145393345|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393346|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393347|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393348|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393349|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145393350|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393351|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393352|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393353|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393354|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393355|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145393356|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393357|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145393358|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393359|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393360|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393361|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393362|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393363|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393364|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145393365|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393366|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393367|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393368|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145393369|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393370|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
145393371|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145393372|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145393373|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393374|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145393375|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393376|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393377|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393378|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393379|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145393380|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393381|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393382|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393383|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393384|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393385|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393386|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393387|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
145393388|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393389|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393390|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393391|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393392|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393393|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393394|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
145393395|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393396|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393397|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393398|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393399|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393400|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393401|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
145393402|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393403|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393404|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393405|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393406|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393407|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145496277|NCT03085095|524675569|FG000|Overall Study|Physician Decision|9|||
145496278|NCT03085095|524675570|FG001|Overall Study|Physician Decision|3|||
145496279|NCT03085095|524675569|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
145496280|NCT03085095|524675570|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
145496281|NCT03085095|524675569|FG000|Overall Study|Did not Receive Study Drug|2|||
145496282|NCT03085095|524675570|FG001|Overall Study|Did not Receive Study Drug|2|||
145393408|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393409|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145393410|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393411|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393412|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393413|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393414|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145496283|NCT03085095|524675569|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
145496284|NCT03085095|524675570|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
145496285|NCT03459079|524675572|FG000|Overall Study|Adverse Event|4|||
145496286|NCT03459079|524675573|FG001|Overall Study|Adverse Event|2|||
145496287|NCT03459079|524675574|FG002|Overall Study|Adverse Event|0|||
145496288|NCT03459079|524675572|FG000|Overall Study|Withdrawal by Subject|2|||
145496289|NCT03459079|524675573|FG001|Overall Study|Withdrawal by Subject|2|||
145496290|NCT03459079|524675574|FG002|Overall Study|Withdrawal by Subject|0|||
145496291|NCT03363841|524675575|FG000|Overall Study|Adverse Event|1|||
145496292|NCT03363841|524675575|FG000|Overall Study|Withdrawal by Subject|1|||
145496293|NCT03363841|524675575|FG000|Overall Study|Death|7|||
145496294|NCT03363841|524675575|FG000|Overall Study|Physician Decision|1|||
145496295|NCT02156076|524675578|FG000|Treatment Period|no longer meets study criteria|0|||
145496296|NCT02156076|524675579|FG001|Treatment Period|no longer meets study criteria|0|||
145496297|NCT02156076|524675580|FG002|Treatment Period|no longer meets study criteria|1|||
145496298|NCT02156076|524675581|FG003|Treatment Period|no longer meets study criteria|0|||
145496299|NCT02156076|524675578|FG000|Treatment Period|Poor/non-compliance|0|||
145496300|NCT02156076|524675579|FG001|Treatment Period|Poor/non-compliance|1|||
145496301|NCT02156076|524675580|FG002|Treatment Period|Poor/non-compliance|0|||
145496302|NCT02156076|524675581|FG003|Treatment Period|Poor/non-compliance|0|||
145496303|NCT02156076|524675578|FG000|Treatment Period|Lost to Follow-up|0|||
145496304|NCT02156076|524675579|FG001|Treatment Period|Lost to Follow-up|0|||
145496305|NCT02156076|524675580|FG002|Treatment Period|Lost to Follow-up|0|||
145496306|NCT02156076|524675581|FG003|Treatment Period|Lost to Follow-up|1|||
145496307|NCT02156076|524675578|FG000|Treatment Period|Withdrawal by Subject|0|||
145496308|NCT02156076|524675579|FG001|Treatment Period|Withdrawal by Subject|0|||
145496309|NCT02156076|524675580|FG002|Treatment Period|Withdrawal by Subject|1|||
145496310|NCT02156076|524675581|FG003|Treatment Period|Withdrawal by Subject|0|||
145496311|NCT02156076|524675578|FG000|Treatment Period|Subject request to discontinue treatment|0|||
145496312|NCT02156076|524675579|FG001|Treatment Period|Subject request to discontinue treatment|1|||
145496313|NCT02156076|524675580|FG002|Treatment Period|Subject request to discontinue treatment|0|||
145496314|NCT02156076|524675581|FG003|Treatment Period|Subject request to discontinue treatment|0|||
145496315|NCT02156076|524675578|FG000|Treatment Period|Adverse Event|0|||
145496316|NCT02156076|524675579|FG001|Treatment Period|Adverse Event|0|||
145496317|NCT02156076|524675580|FG002|Treatment Period|Adverse Event|0|||
145496318|NCT02156076|524675581|FG003|Treatment Period|Adverse Event|1|||
145496319|NCT02156076|524675578|FG000|Follow-up Period|Withdrawal by Subject|1|||
145496320|NCT02156076|524675579|FG001|Follow-up Period|Withdrawal by Subject|0|||
145496321|NCT02156076|524675580|FG002|Follow-up Period|Withdrawal by Subject|0|||
145496322|NCT02156076|524675581|FG003|Follow-up Period|Withdrawal by Subject|0|||
145496323|NCT06271993|524675582|FG000|Overall Study|Not reactive to histamine|5|||
145496324|NCT06271993|524675583|FG001|Overall Study|Not reactive to histamine|5|||
145496325|NCT06271993|524675584|FG002|Overall Study|Not reactive to histamine|5|||
145496326|NCT00687596|524675585|FG000|Overall Study|Adverse Event (AE)|10|||
145496327|NCT00687596|524675586|FG001|Overall Study|Adverse Event (AE)|3|||
145496328|NCT00687596|524675585|FG000|Overall Study|Radiological Disease Progression|6|||
145496329|NCT00687596|524675586|FG001|Overall Study|Radiological Disease Progression|2|||
145496330|NCT00687596|524675585|FG000|Overall Study|Clinical Disease Progression|1|||
145496331|NCT00687596|524675586|FG001|Overall Study|Clinical Disease Progression|3|||
145496332|NCT00687596|524675585|FG000|Overall Study|Investigator Discretion|3|||
145496333|NCT00687596|524675586|FG001|Overall Study|Investigator Discretion|1|||
145496334|NCT00687596|524675585|FG000|Overall Study|Sponsor Terminated Study|6|||
145496335|NCT00687596|524675586|FG001|Overall Study|Sponsor Terminated Study|17|||
145496336|NCT03331315|524675594|FG000|Overall Study|Physician Decision|18|||
145496337|NCT03331315|524675595|FG001|Overall Study|Physician Decision|14|||
145496338|NCT02558894|524675598|FG000|Overall Study|Death; any cause, entire study duration|28|||
145496339|NCT02558894|524675599|FG001|Overall Study|Death; any cause, entire study duration|31|||
145496340|NCT02558894|524675598|FG000|Overall Study|Withdrawal by Subject|2|||
145496341|NCT02558894|524675599|FG001|Overall Study|Withdrawal by Subject|1|||
145496342|NCT02558894|524675598|FG000|Overall Study|Closure of Part A|2|||
145496343|NCT02558894|524675599|FG001|Overall Study|Closure of Part A|1|||
145496344|NCT02992288|524675600|FG000|Overall Study|Adverse Event|8|||
145496345|NCT02992288|524675601|FG001|Overall Study|Adverse Event|2|||
145496346|NCT02992288|524675602|FG002|Overall Study|Adverse Event|2|||
145496347|NCT02992288|524675603|FG003|Overall Study|Adverse Event|2|||
145496348|NCT02992288|524675604|FG004|Overall Study|Adverse Event|2|||
145496349|NCT02992288|524675605|FG005|Overall Study|Adverse Event|7|||
145496350|NCT02992288|524675600|FG000|Overall Study|Non-compliance with study drug|0|||
145496351|NCT02992288|524675601|FG001|Overall Study|Non-compliance with study drug|1|||
145730250|NCT02076113|525530594|FG000|Overall Study|Death|1|||
145730251|NCT02076113|525530595|FG001|Overall Study|Death|3|||
145393415|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393416|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393417|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393418|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
145393419|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393420|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393421|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393422|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393423|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393424|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
145393425|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393426|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393427|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393428|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393429|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393430|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
145393431|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
145393432|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
145496352|NCT02992288|524675602|FG002|Overall Study|Non-compliance with study drug|1|||
145730252|NCT01176968|525530599|FG000|Overall Study|Adverse Event|10|||
145730253|NCT01176968|525530600|FG001|Overall Study|Adverse Event|11|||
145730254|NCT01176968|525530599|FG000|Overall Study|Death|2|||
145730255|NCT01176968|525530600|FG001|Overall Study|Death|3|||
145393433|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
145393434|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393435|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393436|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393437|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393438|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393439|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145393440|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393441|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393442|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393443|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393444|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393445|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
145393446|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393447|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393448|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393449|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393450|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393451|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393452|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393453|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393454|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
145393455|NCT02326272|524294834|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393456|NCT02326272|524294835|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393457|NCT02326272|524294836|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393458|NCT02326272|524294837|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393459|NCT02326272|524294838|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393460|NCT02326272|524294839|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393461|NCT02326272|524294840|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
145393462|NCT02326272|524294841|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393463|NCT02326272|524294842|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393464|NCT02326272|524294843|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393465|NCT02326272|524294844|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393466|NCT02326272|524294845|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393467|NCT02326272|524294846|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393468|NCT02326272|524294847|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393469|NCT02326272|524294848|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
145393470|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
145393471|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
145393472|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
145393473|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
145393474|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
145393475|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
145393476|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
145393477|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
145393478|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
145393479|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
145393480|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
145393481|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
145393482|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
145393483|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
145393484|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
145393485|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393486|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393487|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393488|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393489|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393490|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393491|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393492|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145496353|NCT02992288|524675603|FG003|Overall Study|Non-compliance with study drug|0|||
145496354|NCT02992288|524675604|FG004|Overall Study|Non-compliance with study drug|1|||
145496355|NCT02992288|524675605|FG005|Overall Study|Non-compliance with study drug|0|||
145496356|NCT02992288|524675600|FG000|Overall Study|Physician Decision|3|||
145496357|NCT02992288|524675601|FG001|Overall Study|Physician Decision|0|||
145496358|NCT02992288|524675602|FG002|Overall Study|Physician Decision|1|||
145496359|NCT02992288|524675603|FG003|Overall Study|Physician Decision|0|||
145496360|NCT02992288|524675604|FG004|Overall Study|Physician Decision|0|||
145496361|NCT02992288|524675605|FG005|Overall Study|Physician Decision|1|||
145496362|NCT02992288|524675600|FG000|Overall Study|Death|2|||
145496363|NCT02992288|524675601|FG001|Overall Study|Death|0|||
145496364|NCT02992288|524675602|FG002|Overall Study|Death|2|||
145496365|NCT02992288|524675603|FG003|Overall Study|Death|1|||
145496366|NCT02992288|524675604|FG004|Overall Study|Death|2|||
145496367|NCT02992288|524675605|FG005|Overall Study|Death|0|||
145496368|NCT02992288|524675600|FG000|Overall Study|Lost to Follow-up|0|||
145496369|NCT02992288|524675601|FG001|Overall Study|Lost to Follow-up|0|||
145496370|NCT02992288|524675602|FG002|Overall Study|Lost to Follow-up|0|||
145496371|NCT02992288|524675603|FG003|Overall Study|Lost to Follow-up|1|||
145496372|NCT02992288|524675604|FG004|Overall Study|Lost to Follow-up|0|||
145496373|NCT02992288|524675605|FG005|Overall Study|Lost to Follow-up|0|||
145496374|NCT02992288|524675600|FG000|Overall Study|Protocol Violation|0|||
145496375|NCT02992288|524675601|FG001|Overall Study|Protocol Violation|0|||
145496376|NCT02992288|524675602|FG002|Overall Study|Protocol Violation|0|||
145496377|NCT02992288|524675603|FG003|Overall Study|Protocol Violation|0|||
145496378|NCT02992288|524675604|FG004|Overall Study|Protocol Violation|0|||
145496379|NCT02992288|524675605|FG005|Overall Study|Protocol Violation|1|||
145496380|NCT02992288|524675600|FG000|Overall Study|Withdrawal by Subject|4|||
145496381|NCT02992288|524675601|FG001|Overall Study|Withdrawal by Subject|2|||
145496382|NCT02992288|524675602|FG002|Overall Study|Withdrawal by Subject|1|||
145496383|NCT02992288|524675603|FG003|Overall Study|Withdrawal by Subject|5|||
145496384|NCT02992288|524675604|FG004|Overall Study|Withdrawal by Subject|3|||
145496385|NCT02992288|524675605|FG005|Overall Study|Withdrawal by Subject|4|||
145496386|NCT00656513|524675606|FG000|Overall Study|Protocol Violation|1|||
145496387|NCT00656513|524675607|FG001|Overall Study|Protocol Violation|0|||
145496388|NCT00656513|524675608|FG002|Overall Study|Protocol Violation|2|||
145496389|NCT00656513|524675606|FG000|Overall Study|Withdrawal by Subject|0|||
145496390|NCT00656513|524675607|FG001|Overall Study|Withdrawal by Subject|11|||
145496391|NCT00656513|524675608|FG002|Overall Study|Withdrawal by Subject|4|||
145496392|NCT00656513|524675606|FG000|Overall Study|Death|0|||
145496393|NCT00656513|524675607|FG001|Overall Study|Death|0|||
145496394|NCT00656513|524675608|FG002|Overall Study|Death|1|||
145496395|NCT00656513|524675606|FG000|Overall Study|Missing data|0|||
145496396|NCT00656513|524675607|FG001|Overall Study|Missing data|11|||
145496397|NCT00656513|524675608|FG002|Overall Study|Missing data|9|||
145496398|NCT00656513|524675606|FG000|Overall Study|Incomplete treatment|3|||
145496399|NCT00656513|524675607|FG001|Overall Study|Incomplete treatment|0|||
145496400|NCT00656513|524675608|FG002|Overall Study|Incomplete treatment|0|||
145496401|NCT00656513|524675606|FG000|Overall Study|Treatment completed outside of timeframe|0|||
145496402|NCT00656513|524675607|FG001|Overall Study|Treatment completed outside of timeframe|3|||
145496403|NCT00656513|524675608|FG002|Overall Study|Treatment completed outside of timeframe|1|||
145496404|NCT00656513|524675606|FG000|Overall Study|Missing baseline form|0|||
145496405|NCT00656513|524675607|FG001|Overall Study|Missing baseline form|5|||
145496406|NCT00656513|524675608|FG002|Overall Study|Missing baseline form|5|||
145496407|NCT03379818|524675609|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
145496408|NCT03379818|524675610|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
145496409|NCT03379818|524675609|FG000|Overall Study|Withdrawal by Subject|2|||
145496410|NCT03379818|524675610|FG001|Overall Study|Withdrawal by Subject|3|||
145496411|NCT03379818|524675609|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
145496412|NCT03379818|524675610|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
145496413|NCT01867671|524675614|FG000|Overall Study|Adverse Event|5|||
145496414|NCT01867671|524675615|FG001|Overall Study|Adverse Event|3|||
145496415|NCT01867671|524675614|FG000|Overall Study|Anaphylaxis|0|||
145496416|NCT01867671|524675615|FG001|Overall Study|Anaphylaxis|1|||
145496417|NCT01867671|524675614|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
145496418|NCT01867671|524675615|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
145496419|NCT01867671|524675614|FG000|Overall Study|Lost to Follow-up|0|||
145496420|NCT01867671|524675615|FG001|Overall Study|Lost to Follow-up|1|||
145496421|NCT01867671|524675614|FG000|Overall Study|Non-compliance with Study Drug|1|||
145496422|NCT01867671|524675615|FG001|Overall Study|Non-compliance with Study Drug|2|||
145496423|NCT01867671|524675614|FG000|Overall Study|Withdrawal by Subject|21|||
145496424|NCT01867671|524675615|FG001|Overall Study|Withdrawal by Subject|21|||
145496425|NCT05236270|524675618|FG000|Overall Study|Lost to Follow-up|3|||
145496426|NCT05236270|524675619|FG001|Overall Study|Lost to Follow-up|2|||
145496427|NCT05236270|524675620|FG002|Overall Study|Lost to Follow-up|0|||
145496428|NCT05236270|524675621|FG003|Overall Study|Lost to Follow-up|0|||
145496429|NCT05236270|524675622|FG004|Overall Study|Lost to Follow-up|2|||
145496430|NCT05236270|524675623|FG005|Overall Study|Lost to Follow-up|0|||
145730256|NCT01176968|525530599|FG000|Overall Study|Lack of Efficacy|0|||
145730257|NCT01176968|525530600|FG001|Overall Study|Lack of Efficacy|1|||
145730258|NCT01176968|525530599|FG000|Overall Study|Lost to Follow-up|16|||
145730259|NCT01176968|525530600|FG001|Overall Study|Lost to Follow-up|14|||
145730260|NCT01176968|525530599|FG000|Overall Study|Withdrawal by Subject|48|||
145730261|NCT01176968|525530600|FG001|Overall Study|Withdrawal by Subject|48|||
145730262|NCT01176968|525530599|FG000|Overall Study|Protocol Violation|2|||
145730263|NCT01176968|525530600|FG001|Overall Study|Protocol Violation|1|||
145730264|NCT01176968|525530599|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145730265|NCT01176968|525530600|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
145730266|NCT01176968|525530599|FG000|Overall Study|Study terminated by sponsor|0|||
145730267|NCT01176968|525530600|FG001|Overall Study|Study terminated by sponsor|1|||
145730268|NCT01176968|525530599|FG000|Overall Study|Reason not defined|5|||
145730269|NCT01176968|525530600|FG001|Overall Study|Reason not defined|3|||
145730270|NCT02993523|525530603|FG000|Overall Study|Withdrew Consent|0|||
145730271|NCT02993523|525530604|FG001|Overall Study|Withdrew Consent|0|||
145730272|NCT02993523|525530605|FG002|Overall Study|Withdrew Consent|2|||
145730273|NCT02993523|525530606|FG003|Overall Study|Withdrew Consent|9|||
145730274|NCT02993523|525530607|FG004|Overall Study|Withdrew Consent|0|||
145730275|NCT02993523|525530603|FG000|Overall Study|Lost to Follow-up|0|||
145730276|NCT02993523|525530604|FG001|Overall Study|Lost to Follow-up|0|||
145730277|NCT02993523|525530605|FG002|Overall Study|Lost to Follow-up|3|||
145730278|NCT02993523|525530606|FG003|Overall Study|Lost to Follow-up|6|||
145730279|NCT02993523|525530607|FG004|Overall Study|Lost to Follow-up|0|||
145730280|NCT02993523|525530603|FG000|Overall Study|Death|1|||
145730281|NCT02993523|525530604|FG001|Overall Study|Death|1|||
145730282|NCT02993523|525530605|FG002|Overall Study|Death|138|||
145730283|NCT02993523|525530606|FG003|Overall Study|Death|222|||
145730284|NCT02993523|525530607|FG004|Overall Study|Death|6|||
145730285|NCT02993523|525530603|FG000|Overall Study|Reason not Specified|0|||
145730286|NCT02993523|525530604|FG001|Overall Study|Reason not Specified|0|||
145730287|NCT02993523|525530605|FG002|Overall Study|Reason not Specified|1|||
145292701|NCT00337077|523922214|FG001|Overall Study|Progressive disease|37|||
145292702|NCT00337077|523922215|FG002|Overall Study|Progressive disease|19|||
145292703|NCT00337077|523922213|FG000|Overall Study|Adverse Event|7|||
145292704|NCT00337077|523922214|FG001|Overall Study|Adverse Event|7|||
145292705|NCT00337077|523922215|FG002|Overall Study|Adverse Event|1|||
145292706|NCT00337077|523922213|FG000|Overall Study|Death|0|||
145292707|NCT00337077|523922214|FG001|Overall Study|Death|1|||
145292708|NCT00337077|523922215|FG002|Overall Study|Death|0|||
145292709|NCT00337077|523922213|FG000|Overall Study|Withdrawal by Subject|7|||
145292710|NCT00337077|523922214|FG001|Overall Study|Withdrawal by Subject|2|||
145292711|NCT00337077|523922215|FG002|Overall Study|Withdrawal by Subject|2|||
145292712|NCT00337077|523922213|FG000|Overall Study|Alternative therapy|1|||
145292713|NCT00337077|523922214|FG001|Overall Study|Alternative therapy|0|||
145292714|NCT00337077|523922215|FG002|Overall Study|Alternative therapy|0|||
145292715|NCT00337077|523922213|FG000|Overall Study|Physician Decision|1|||
145292716|NCT00337077|523922214|FG001|Overall Study|Physician Decision|4|||
145292717|NCT00337077|523922215|FG002|Overall Study|Physician Decision|2|||
145292718|NCT00337077|523922213|FG000|Overall Study|Never started treatment|1|||
145292719|NCT00337077|523922214|FG001|Overall Study|Never started treatment|1|||
145292720|NCT00337077|523922215|FG002|Overall Study|Never started treatment|0|||
145292721|NCT00337077|523922213|FG000|Overall Study|Ineligible|1|||
145292722|NCT00337077|523922214|FG001|Overall Study|Ineligible|1|||
145292723|NCT00337077|523922215|FG002|Overall Study|Ineligible|1|||
145292724|NCT01492400|523922220|FG000|Overall Study|Miscellaneous Reasons|2|||
145292725|NCT01492400|523922221|FG001|Overall Study|Miscellaneous Reasons|3|||
145292726|NCT01492400|523922220|FG000|Overall Study|Personal Reasons|0|||
145292727|NCT01492400|523922221|FG001|Overall Study|Personal Reasons|5|||
145292728|NCT01492400|523922220|FG000|Overall Study|Lost to Follow-up|3|||
145292729|NCT01492400|523922221|FG001|Overall Study|Lost to Follow-up|1|||
145292730|NCT01492400|523922220|FG000|Overall Study|Pregnancy|0|||
145292731|NCT01492400|523922221|FG001|Overall Study|Pregnancy|1|||
145292732|NCT01492400|523922220|FG000|Overall Study|Lack of Efficacy|1|||
145292733|NCT01492400|523922221|FG001|Overall Study|Lack of Efficacy|1|||
145292734|NCT01492400|523922220|FG000|Overall Study|Adverse Event|10|||
145292735|NCT01492400|523922221|FG001|Overall Study|Adverse Event|5|||
145292736|NCT00659607|523922222|FG000|Overall Study|No blood pressure recorded|147|||
145292737|NCT00659607|523922222|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
145292738|NCT00659607|523922222|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
145292739|NCT00659607|523922222|FG000|Overall Study|No recorded efficacy data|15|||
145292740|NCT00659607|523922222|FG000|Overall Study|Inconsistent BP measuring date|2|||
145292741|NCT02899338|523922224|FG000|Overall Study|Adverse Event|1|||
145292742|NCT02899338|523922225|FG001|Overall Study|Adverse Event|2|||
145292743|NCT02899338|523922224|FG000|Overall Study|Withdrawal by Subject|2|||
145292744|NCT02899338|523922225|FG001|Overall Study|Withdrawal by Subject|0|||
145292745|NCT06179108|523922226|FG000|Overall Study|Withdrawal by Subject|16|||
145496431|NCT05236270|524675624|FG006|Overall Study|Lost to Follow-up|1|||
145496432|NCT05236270|524675625|FG007|Overall Study|Lost to Follow-up|3|||
145496433|NCT01743469|524675634|FG000|Active Treatment Phase|Adverse Event|10|||
145496434|NCT01743469|524675635|FG001|Active Treatment Phase|Adverse Event|5|||
145496435|NCT01743469|524675636|FG002|Active Treatment Phase|Adverse Event|8|||
145496436|NCT01743469|524675637|FG003|Active Treatment Phase|Adverse Event|1|||
145496437|NCT01743469|524675634|FG000|Active Treatment Phase|Disease Progression|40|||
145496438|NCT01743469|524675635|FG001|Active Treatment Phase|Disease Progression|47|||
145496439|NCT01743469|524675636|FG002|Active Treatment Phase|Disease Progression|30|||
145496440|NCT01743469|524675637|FG003|Active Treatment Phase|Disease Progression|20|||
145496441|NCT01743469|524675634|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
145496442|NCT01743469|524675635|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
145496443|NCT01743469|524675636|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
145496444|NCT01743469|524675637|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
145496445|NCT01743469|524675634|FG000|Active Treatment Phase|Missing|1|||
145496446|NCT01743469|524675635|FG001|Active Treatment Phase|Missing|0|||
145496447|NCT01743469|524675636|FG002|Active Treatment Phase|Missing|0|||
145496448|NCT01743469|524675637|FG003|Active Treatment Phase|Missing|0|||
145496449|NCT01743469|524675634|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
145496450|NCT01743469|524675635|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
145496451|NCT01743469|524675636|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
145496452|NCT01743469|524675637|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
145496453|NCT01743469|524675634|FG000|Follow-up Period - Post-Treatment|Death|43|||
145496454|NCT01743469|524675635|FG001|Follow-up Period - Post-Treatment|Death|47|||
145496455|NCT01743469|524675636|FG002|Follow-up Period - Post-Treatment|Death|22|||
145496456|NCT01743469|524675637|FG003|Follow-up Period - Post-Treatment|Death|16|||
145496457|NCT01743469|524675634|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
145496458|NCT01743469|524675635|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
145496459|NCT01743469|524675636|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
145496460|NCT01743469|524675637|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
145496461|NCT02718898|524675638|FG000|Blinded Treatment Period|Adverse Event|5|||
145496462|NCT02718898|524675639|FG001|Blinded Treatment Period|Adverse Event|1|||
145496463|NCT02718898|524675640|FG002|Blinded Treatment Period|Adverse Event|0|||
145496464|NCT02718898|524675641|FG003|Blinded Treatment Period|Adverse Event|0|||
145496465|NCT02718898|524675642|FG004|Blinded Treatment Period|Adverse Event|0|||
145496466|NCT02718898|524675643|FG005|Blinded Treatment Period|Adverse Event|0|||
145496467|NCT02718898|524675644|FG006|Blinded Treatment Period|Adverse Event|0|||
145496468|NCT02718898|524675638|FG000|Blinded Treatment Period|Physician Decision|1|||
145496469|NCT02718898|524675639|FG001|Blinded Treatment Period|Physician Decision|0|||
145496470|NCT02718898|524675640|FG002|Blinded Treatment Period|Physician Decision|0|||
145496471|NCT02718898|524675641|FG003|Blinded Treatment Period|Physician Decision|0|||
145496472|NCT02718898|524675642|FG004|Blinded Treatment Period|Physician Decision|0|||
145496473|NCT02718898|524675643|FG005|Blinded Treatment Period|Physician Decision|0|||
145496474|NCT02718898|524675644|FG006|Blinded Treatment Period|Physician Decision|0|||
145496475|NCT02718898|524675638|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
145496476|NCT02718898|524675639|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
145496477|NCT02718898|524675640|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
145496478|NCT02718898|524675641|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
145496479|NCT02718898|524675642|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
145496480|NCT02718898|524675643|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
145496481|NCT02718898|524675644|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
145496482|NCT02718898|524675638|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
145496483|NCT02718898|524675639|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
145496484|NCT02718898|524675640|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
145496485|NCT02718898|524675641|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
145496486|NCT02718898|524675642|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
145496487|NCT02718898|524675643|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
145496488|NCT02718898|524675644|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
145496489|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
145496490|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
145496491|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
145496492|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
145496493|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
145496494|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
145496495|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
145496496|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145496497|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145496498|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145496499|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
145496500|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145496501|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145393493|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393494|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393495|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
145393496|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
145393497|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
145393498|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145393499|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
145730288|NCT02993523|525530606|FG003|Overall Study|Reason not Specified|1|||
145730289|NCT02993523|525530607|FG004|Overall Study|Reason not Specified|0|||
145730290|NCT03694418|525530608|FG000|Overall Study|Lost to Follow-up|115|||
145730291|NCT03694418|525530609|FG001|Overall Study|Lost to Follow-up|23|||
145730292|NCT03694418|525530610|FG002|Overall Study|Lost to Follow-up|12|||
145730293|NCT03694418|525530611|FG003|Overall Study|Lost to Follow-up|12|||
145730294|NCT03694418|525530612|FG004|Overall Study|Lost to Follow-up|13|||
145730295|NCT04288778|525530613|FG000|Overall Study|Withdrawal by Subject|2|||
145730296|NCT04288778|525530613|FG000|Overall Study|Adverse Event|5|||
145730297|NCT04288778|525530613|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145730298|NCT04288778|525530613|FG000|Overall Study|Other|1|||
145730299|NCT04288778|525530613|FG000|Overall Study|Started but not treated|2|||
145730300|NCT04485104|525530614|FG000|Overall Study|Physician Decision|2|||
145730301|NCT04485104|525530615|FG001|Overall Study|Physician Decision|0|||
145730302|NCT04485104|525530614|FG000|Overall Study|Decision by sponsor|0|||
145730303|NCT04485104|525530615|FG001|Overall Study|Decision by sponsor|1|||
145730304|NCT05057247|525530616|FG000|Overall Study|Death|4|||
145730305|NCT05057247|525530616|FG000|Overall Study|Physician Decision|3|||
145730306|NCT05057247|525530616|FG000|Overall Study|Progressive Disease|7|||
145730307|NCT05057247|525530616|FG000|Overall Study|Withdrawal by Subject|3|||
145730308|NCT05057247|525530616|FG000|Overall Study|Adverse Event|6|||
145730309|NCT05057247|525530616|FG000|Overall Study|Subject Non-Compliance|1|||
145730310|NCT05057247|525530616|FG000|Overall Study|On treatment|2|||
145730311|NCT01386658|525530617|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
145730312|NCT01386658|525530618|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
145730313|NCT01386658|525530617|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
145730314|NCT01386658|525530618|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
145730315|NCT01067326|525530621|FG000|Overall Study|Adverse Event|0|||
145730316|NCT01067326|525530622|FG001|Overall Study|Adverse Event|2|||
145730317|NCT01067326|525530621|FG000|Overall Study|Withdrawal by Subject|1|||
145730318|NCT01067326|525530622|FG001|Overall Study|Withdrawal by Subject|0|||
145730319|NCT01067326|525530621|FG000|Overall Study|Early Study Termination|1|||
145730320|NCT01067326|525530622|FG001|Overall Study|Early Study Termination|1|||
145730321|NCT00769860|525530623|FG000|Overall Study|Withdrawal by Subject|2|||
145730322|NCT00769860|525530624|FG001|Overall Study|Withdrawal by Subject|0|||
145730323|NCT03170154|525530626|FG000|Overall Study|Lost to Follow-up|4|||
145730324|NCT03170154|525530626|FG000|Overall Study|Death|2|||
145730325|NCT03170154|525530626|FG000|Overall Study|Withdrawal by Subject|2|||
145730326|NCT02279862|525530627|FG000|Overall Study|Study drug toxicity|3|||
145730327|NCT02279862|525530628|FG001|Overall Study|Study drug toxicity|6|||
145730328|NCT02279862|525530627|FG000|Overall Study|No longer meets criteria|0|||
145730329|NCT02279862|525530628|FG001|Overall Study|No longer meets criteria|1|||
145730330|NCT02279862|525530627|FG000|Overall Study|Administrative reason by sponsor|0|||
145730331|NCT02279862|525530628|FG001|Overall Study|Administrative reason by sponsor|1|||
145730332|NCT02279862|525530627|FG000|Overall Study|Disease progression|5|||
145730333|NCT02279862|525530628|FG001|Overall Study|Disease progression|2|||
145730334|NCT02279862|525530627|FG000|Overall Study|Study closed by sponsor|16|||
145730335|NCT02279862|525530628|FG001|Overall Study|Study closed by sponsor|13|||
145730336|NCT02279862|525530627|FG000|Overall Study|Other|1|||
145730337|NCT02279862|525530628|FG001|Overall Study|Other|2|||
145730338|NCT02279862|525530627|FG000|Overall Study|Withdrawal by Subject|1|||
145730339|NCT02279862|525530628|FG001|Overall Study|Withdrawal by Subject|0|||
145730340|NCT03431857|525530629|FG000|Overall Study|Death|6|||
145730341|NCT03431857|525530629|FG000|Overall Study|Lost to Follow-up|41|||
145730342|NCT03431857|525530629|FG000|Overall Study|Adverse Event|6|||
145730343|NCT03431857|525530629|FG000|Overall Study|Withdrawal by Subject|1|||
145730344|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
145730345|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
145730346|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
145730347|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
145730348|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
145730349|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
145730350|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
145730351|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
145730352|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
145730353|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
145730354|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
145393500|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393501|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393502|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393503|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393504|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393505|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393506|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393507|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393508|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393509|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393510|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145393511|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393512|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145393513|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393514|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145393515|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393516|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393517|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393518|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393519|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393520|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393521|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393522|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393523|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393524|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393525|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393526|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
145393527|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393528|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393529|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145393530|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393531|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393532|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393533|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393534|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393535|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393536|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393537|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393538|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393539|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393540|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
145393541|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393542|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
145393543|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145393544|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
145393545|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393546|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393547|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393548|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393549|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393550|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393551|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393552|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393553|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393554|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393555|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393556|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
145393557|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393558|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145393559|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
145393560|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393561|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393562|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145496502|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
145496503|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145496504|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145496505|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
145496506|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
145496507|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145393563|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393564|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393565|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393566|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393567|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393568|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393569|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393570|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145393571|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
145393572|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145393573|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145730355|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
145730356|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
145730357|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
145730358|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
145730359|NCT01323621|525530630|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
145730360|NCT01323621|525530631|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
145730361|NCT01323621|525530632|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
145730362|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
145730363|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
145730364|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
145730365|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
145393574|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145496508|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145496509|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145393575|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393576|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393577|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393578|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393579|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393580|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393581|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393582|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393583|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393584|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393585|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393586|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
145393587|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393588|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393589|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
145393590|NCT02326272|524294834|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393591|NCT02326272|524294835|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393592|NCT02326272|524294836|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393593|NCT02326272|524294837|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393594|NCT02326272|524294838|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393595|NCT02326272|524294839|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393596|NCT02326272|524294840|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393597|NCT02326272|524294841|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393598|NCT02326272|524294842|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393599|NCT02326272|524294843|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393600|NCT02326272|524294844|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393601|NCT02326272|524294845|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393602|NCT02326272|524294846|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
145393603|NCT02326272|524294847|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393604|NCT02326272|524294848|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
145393605|NCT01447407|524294863|FG000|Overall Study|Withdrawal by Subject|2|||
145393606|NCT01447407|524294864|FG001|Overall Study|Withdrawal by Subject|0|||
145393607|NCT01447407|524294865|FG002|Overall Study|Withdrawal by Subject|0|||
145393608|NCT01447407|524294866|FG003|Overall Study|Withdrawal by Subject|1|||
145393609|NCT01447407|524294863|FG000|Overall Study|Physician Decision|0|||
145496510|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
145496511|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
145496512|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
145496513|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
145496514|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
145496515|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
145496516|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
145496517|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496518|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496519|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496520|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
145496521|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496522|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496523|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
145496524|NCT02718898|524675638|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496525|NCT02718898|524675639|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496526|NCT02718898|524675640|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496527|NCT02718898|524675641|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
145496528|NCT02718898|524675642|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496529|NCT02718898|524675643|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496530|NCT02718898|524675644|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
145496531|NCT02718898|524675638|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
145496532|NCT02718898|524675639|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
145496533|NCT02718898|524675640|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
145496534|NCT02718898|524675641|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
145496535|NCT02718898|524675642|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
145496536|NCT02718898|524675643|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
145496537|NCT02718898|524675644|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
145496538|NCT02718898|524675638|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
145496539|NCT02718898|524675639|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
145496540|NCT02718898|524675640|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
145496541|NCT02718898|524675641|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
145496542|NCT02718898|524675642|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
145496543|NCT02718898|524675643|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
145496544|NCT02718898|524675644|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
145496545|NCT02718898|524675638|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145496546|NCT02718898|524675639|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145496547|NCT02718898|524675640|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145496548|NCT02718898|524675641|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145496549|NCT02718898|524675642|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145496550|NCT02718898|524675643|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
145496551|NCT02718898|524675644|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
145496552|NCT02559622|524675648|FG000|Overall Study|Progressive disease|0|||
145496553|NCT02559622|524675649|FG001|Overall Study|Progressive disease|1|||
145496554|NCT02559622|524675650|FG002|Overall Study|Progressive disease|0|||
145496555|NCT02559622|524675651|FG003|Overall Study|Progressive disease|0|||
145496556|NCT02559622|524675648|FG000|Overall Study|Adverse Event|0|||
145496557|NCT02559622|524675649|FG001|Overall Study|Adverse Event|2|||
145496558|NCT02559622|524675650|FG002|Overall Study|Adverse Event|2|||
145496559|NCT02559622|524675651|FG003|Overall Study|Adverse Event|2|||
145496560|NCT02559622|524675648|FG000|Overall Study|Patient/guardian decision|1|||
145496561|NCT02559622|524675649|FG001|Overall Study|Patient/guardian decision|2|||
145496562|NCT02559622|524675650|FG002|Overall Study|Patient/guardian decision|0|||
145393610|NCT01447407|524294864|FG001|Overall Study|Physician Decision|0|||
145730366|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
145730367|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
145393611|NCT01447407|524294865|FG002|Overall Study|Physician Decision|1|||
145393612|NCT01447407|524294866|FG003|Overall Study|Physician Decision|1|||
145393613|NCT00735943|524294871|FG000|Overall Study|Lost to Follow-up|1|||
145393614|NCT00735943|524294871|FG000|Overall Study|Adverse Event|1|||
145393615|NCT01265394|524294872|FG000|Overall Study|Subjects withdrawn|37|||
145393616|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
145393617|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
145393618|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
145393619|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Death|0|||
145393620|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Death|1|||
145393621|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Death|0|||
145393622|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
145393623|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
145393624|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
145393625|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
145393626|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
145393627|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
145393628|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145393629|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145393630|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145393631|NCT01064414|524294873|FG000|Core Period: Baseline to Week 26|Other|4|||
145393632|NCT01064414|524294874|FG001|Core Period: Baseline to Week 26|Other|7|||
145393633|NCT01064414|524294875|FG002|Core Period: Baseline to Week 26|Other|2|||
145393634|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145393635|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145393636|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145393637|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Death|0|||
145393638|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Death|1|||
145393639|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145393640|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
145393641|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145393642|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145393643|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
145393644|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145393645|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145393646|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145393647|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145393648|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145393649|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
145393650|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145393651|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145393652|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145393653|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145393654|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145393655|NCT01064414|524294873|FG000|Extension Period: Week 26 to Week 52|Other|5|||
145393656|NCT01064414|524294874|FG001|Extension Period: Week 26 to Week 52|Other|2|||
145393657|NCT01064414|524294875|FG002|Extension Period: Week 26 to Week 52|Other|1|||
145393658|NCT02185417|524294876|FG000|Overall Study|Death|448|||
145393659|NCT02185417|524294877|FG001|Overall Study|Death|446|||
145496563|NCT02559622|524675651|FG003|Overall Study|Patient/guardian decision|1|||
145496564|NCT02163538|524675652|FG000|Overall Study|Protocol Violation|1|||
145393660|NCT02185417|524294878|FG002|Overall Study|Death|0|||
145393661|NCT02185417|524294876|FG000|Overall Study|Withdrawal by Subject|7|||
145393662|NCT02185417|524294877|FG001|Overall Study|Withdrawal by Subject|12|||
145393663|NCT02185417|524294878|FG002|Overall Study|Withdrawal by Subject|0|||
145393664|NCT03131167|524294886|FG000|Overall Study|Other (Unspecified)|0|||
145393665|NCT03131167|524294887|FG001|Overall Study|Other (Unspecified)|0|||
145393666|NCT03131167|524294888|FG002|Overall Study|Other (Unspecified)|0|||
145393667|NCT03131167|524294889|FG003|Overall Study|Other (Unspecified)|0|||
145393668|NCT03131167|524294890|FG004|Overall Study|Other (Unspecified)|0|||
145393669|NCT03131167|524294891|FG005|Overall Study|Other (Unspecified)|1|||
145393670|NCT03131167|524294892|FG006|Overall Study|Other (Unspecified)|0|||
145393671|NCT03131167|524294893|FG007|Overall Study|Other (Unspecified)|0|||
145393672|NCT03131167|524294894|FG008|Overall Study|Other (Unspecified)|0|||
145393673|NCT03131167|524294895|FG009|Overall Study|Other (Unspecified)|0|||
145393674|NCT03131167|524294896|FG010|Overall Study|Other (Unspecified)|0|||
145496565|NCT02163538|524675653|FG001|Overall Study|Protocol Violation|0|||
145730368|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
145393675|NCT03131167|524294897|FG011|Overall Study|Other (Unspecified)|0|||
145393676|NCT03131167|524294898|FG012|Overall Study|Other (Unspecified)|0|||
145393677|NCT02532374|524294899|FG000|Overall Study|Withdrawal by Subject|1|||
145393678|NCT02532374|524294899|FG000|Overall Study|Physician Decision|1|||
145393679|NCT02762084|524294900|FG000|Overall Study|Withdrawal by Subject|1|||
145393680|NCT02762084|524294901|FG001|Overall Study|Withdrawal by Subject|0|||
145393681|NCT02762084|524294902|FG002|Overall Study|Withdrawal by Subject|0|||
145393682|NCT02762084|524294900|FG000|Overall Study|Adverse Event|0|||
145393683|NCT02762084|524294901|FG001|Overall Study|Adverse Event|0|||
145393684|NCT02762084|524294902|FG002|Overall Study|Adverse Event|1|||
145393685|NCT01781962|524294903|FG000|Overall Study|Other Miscellaneous Reasons|5|||
145393686|NCT01765296|524294904|FG000|Overall Study|Protocol Violation|0|||
145393687|NCT01765296|524294905|FG001|Overall Study|Protocol Violation|5|||
145393688|NCT01765296|524294906|FG002|Overall Study|Protocol Violation|4|||
145393689|NCT01765296|524294904|FG000|Overall Study|Withdrawal by Subject|4|||
145393690|NCT01765296|524294905|FG001|Overall Study|Withdrawal by Subject|2|||
145730369|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
145730370|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
145730371|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145730372|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
145730373|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145730374|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
145730375|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
145730376|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
145730377|NCT01323621|525530630|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145730378|NCT01323621|525530631|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
145730379|NCT01323621|525530632|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
145730380|NCT00651157|525530633|FG000|Overall Study|Death|1|||
145730381|NCT00651157|525530633|FG000|Overall Study|Protocol Violation|1|||
145730382|NCT01163721|525530638|FG000|Overall Study|Adverse Event|5|||
145730383|NCT01163721|525530639|FG001|Overall Study|Adverse Event|6|||
145730384|NCT01163721|525530638|FG000|Overall Study|Withdrawal by Subject|3|||
145730385|NCT01163721|525530639|FG001|Overall Study|Withdrawal by Subject|4|||
145730386|NCT01163721|525530638|FG000|Overall Study|Lost to Follow-up|0|||
145730387|NCT01163721|525530639|FG001|Overall Study|Lost to Follow-up|1|||
145730388|NCT01163721|525530638|FG000|Overall Study|Physician Decision|0|||
145730389|NCT01163721|525530639|FG001|Overall Study|Physician Decision|1|||
145730390|NCT00688181|525530640|FG000|Overall Study|Lost to Follow-up|17|||
145730391|NCT00688181|525530640|FG000|Overall Study|Unknown Reason|4|||
145730392|NCT00688181|525530640|FG000|Overall Study|Non-clinical Reason|2|||
145730393|NCT01050205|525530641|FG000|Overall Study|Lost to Follow-up|7|||
145730394|NCT01050205|525530642|FG001|Overall Study|Lost to Follow-up|1|||
145730395|NCT01050205|525530641|FG000|Overall Study|Withdrawal by Subject|1|||
145730396|NCT01050205|525530642|FG001|Overall Study|Withdrawal by Subject|1|||
145730397|NCT01050205|525530641|FG000|Overall Study|Relocated from area|1|||
145730398|NCT01050205|525530642|FG001|Overall Study|Relocated from area|2|||
145730399|NCT01050205|525530641|FG000|Overall Study|Discontinued Intervention|2|||
145730400|NCT01050205|525530642|FG001|Overall Study|Discontinued Intervention|0|||
145730401|NCT01295281|525530645|FG000|First Intervention (7 Days)|Death|0|||
145730402|NCT01295281|525530646|FG001|First Intervention (7 Days)|Death|1|||
145730403|NCT00292461|525530647|FG000|Overall Study|Adverse Event|4|||
145730404|NCT00292461|525530648|FG001|Overall Study|Adverse Event|2|||
145730405|NCT00292461|525530647|FG000|Overall Study|Lack of Efficacy|1|||
145730406|NCT00292461|525530648|FG001|Overall Study|Lack of Efficacy|0|||
145730407|NCT00292461|525530647|FG000|Overall Study|Withdrawal by Subject|0|||
145730408|NCT00292461|525530648|FG001|Overall Study|Withdrawal by Subject|1|||
145730409|NCT00292461|525530647|FG000|Overall Study|Protocol Violation|4|||
145730410|NCT00292461|525530648|FG001|Overall Study|Protocol Violation|3|||
145730411|NCT00292461|525530647|FG000|Overall Study|Lost to Follow-up|1|||
145730412|NCT00292461|525530648|FG001|Overall Study|Lost to Follow-up|0|||
145730413|NCT00954421|525530649|FG000|Screening|screen failures|3|||
145730414|NCT00954421|525530649|FG000|6 Months of DBS|Withdrawal by Subject|1|||
145730415|NCT00954421|525530649|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
145730416|NCT01891721|525530650|FG000|Overall Study|Lost to Follow-up|10|||
145730417|NCT01891721|525530651|FG001|Overall Study|Lost to Follow-up|5|||
145730418|NCT01891721|525530652|FG002|Overall Study|Lost to Follow-up|1|||
145730419|NCT00633061|525530653|FG000|Overall Study|Study closed|86|||
145730420|NCT00633061|525530654|FG001|Overall Study|Study closed|0|||
145730421|NCT05125679|525530659|FG000|Overall Study|Study Terminated by Sponsor|2|||
145730422|NCT05125679|525530660|FG001|Overall Study|Study Terminated by Sponsor|5|||
145730423|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
145730424|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
145730425|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
145730426|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
145730427|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
145730428|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
145730429|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
145730430|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
145730431|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
145730432|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
145730433|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
145730434|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
145730435|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
145730436|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
145730437|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
145393691|NCT01765296|524294906|FG002|Overall Study|Withdrawal by Subject|2|||
145393692|NCT01765296|524294904|FG000|Overall Study|Adverse Event|1|||
145730438|NCT04908189|525530665|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
145730439|NCT04908189|525530666|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
145730440|NCT04908189|525530667|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
145730441|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
145730442|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
145730443|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
145730444|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
145730445|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
145730446|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
145730447|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
145730448|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
145730449|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
145730450|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
145730451|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
145730452|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
145730453|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
145730454|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
145730455|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
145730456|NCT04908189|525530665|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
145730457|NCT04908189|525530666|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
145730458|NCT04908189|525530667|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
145730459|NCT00607022|525530669|FG000|Overall Study|Withdrawal by Subject|1|||
145730460|NCT00607022|525530670|FG001|Overall Study|Withdrawal by Subject|0|||
145730461|NCT00607022|525530671|FG002|Overall Study|Withdrawal by Subject|0|||
145730462|NCT04540133|525530672|FG000|Overall Study|Lost to Follow-up|1|||
145730463|NCT04540133|525530673|FG001|Overall Study|Lost to Follow-up|0|||
145730464|NCT00458341|525530674|FG000|Cycle 1|Adverse Event|1|||
145730465|NCT00458341|525530675|FG001|Cycle 1|Adverse Event|0|||
145730466|NCT05461794|525530676|FG000|Overall Study|Withdrawal by Subject|1|||
145730467|NCT05461794|525530677|FG001|Overall Study|Withdrawal by Subject|1|||
145730468|NCT05461794|525530678|FG002|Overall Study|Withdrawal by Subject|3|||
145730469|NCT05461794|525530676|FG000|Overall Study|Study Terminated By Sponsor|18|||
145730470|NCT05461794|525530677|FG001|Overall Study|Study Terminated By Sponsor|13|||
145730471|NCT05461794|525530678|FG002|Overall Study|Study Terminated By Sponsor|16|||
145730472|NCT05461794|525530676|FG000|Overall Study|Death|20|||
145730473|NCT05461794|525530677|FG001|Overall Study|Death|5|||
145730474|NCT05461794|525530678|FG002|Overall Study|Death|19|||
145393693|NCT01765296|524294905|FG001|Overall Study|Adverse Event|13|||
145393694|NCT01765296|524294906|FG002|Overall Study|Adverse Event|5|||
145393695|NCT01765296|524294904|FG000|Overall Study|Lack of Efficacy|0|||
145393696|NCT01765296|524294905|FG001|Overall Study|Lack of Efficacy|0|||
145393697|NCT01765296|524294906|FG002|Overall Study|Lack of Efficacy|2|||
145393698|NCT01619852|524294907|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
145393699|NCT01619852|524294908|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
145393700|NCT01619852|524294907|FG000|3 Month Follow up|Lost to Follow-up|31|||
145393701|NCT01619852|524294908|FG001|3 Month Follow up|Lost to Follow-up|34|||
145393702|NCT03933449|524294909|FG000|Overall Study|Adverse Event|6|||
145393703|NCT03933449|524294910|FG001|Overall Study|Adverse Event|4|||
145393704|NCT03933449|524294909|FG000|Overall Study|Death|55|||
145393705|NCT03933449|524294910|FG001|Overall Study|Death|57|||
145393706|NCT03933449|524294909|FG000|Overall Study|Sponsor Decision|1|||
145393707|NCT03933449|524294910|FG001|Overall Study|Sponsor Decision|0|||
145393708|NCT03075267|524294916|FG000|Overall Study|Protocol Violation|1|||
145393709|NCT03075267|524294917|FG001|Overall Study|Protocol Violation|0|||
145393710|NCT03075267|524294918|FG002|Overall Study|Protocol Violation|0|||
145393711|NCT02168491|524294919|FG000|Overall Study|Withdrawal by Subject|1|||
145393712|NCT00809445|524294920|FG000|1 Month Follow-up|Lost contact|1|||
145393713|NCT00809445|524294921|FG001|1 Month Follow-up|Lost contact|2|||
145393714|NCT00809445|524294922|FG002|1 Month Follow-up|Lost contact|1|||
145393715|NCT00809445|524294920|FG000|1 Month Follow-up|Withdrew consent|1|||
145393716|NCT00809445|524294921|FG001|1 Month Follow-up|Withdrew consent|1|||
145393717|NCT00809445|524294922|FG002|1 Month Follow-up|Withdrew consent|1|||
145496566|NCT02163538|524675652|FG000|Overall Study|Physician Decision|0|||
145730475|NCT02958267|525530682|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
145730476|NCT02958267|525530683|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
145393718|NCT00809445|524294920|FG000|1 Month Follow-up|Death|0|||
145393719|NCT00809445|524294921|FG001|1 Month Follow-up|Death|1|||
145393720|NCT00809445|524294922|FG002|1 Month Follow-up|Death|1|||
145393721|NCT00809445|524294920|FG000|1 Month Follow-up|Incarcerated|0|||
145393722|NCT00809445|524294921|FG001|1 Month Follow-up|Incarcerated|0|||
145393723|NCT00809445|524294922|FG002|1 Month Follow-up|Incarcerated|1|||
145393724|NCT00809445|524294920|FG000|6 Month Follow-up|Lost contact|16|||
145393725|NCT00809445|524294921|FG001|6 Month Follow-up|Lost contact|14|||
145393726|NCT00809445|524294922|FG002|6 Month Follow-up|Lost contact|14|||
145393727|NCT00809445|524294920|FG000|6 Month Follow-up|Death|2|||
145393728|NCT00809445|524294921|FG001|6 Month Follow-up|Death|1|||
145393729|NCT00809445|524294922|FG002|6 Month Follow-up|Death|1|||
145393730|NCT00809445|524294920|FG000|6 Month Follow-up|Incarcerated|6|||
145393731|NCT00809445|524294921|FG001|6 Month Follow-up|Incarcerated|8|||
145393732|NCT00809445|524294922|FG002|6 Month Follow-up|Incarcerated|8|||
145393733|NCT00809445|524294920|FG000|6 Month Follow-up|Withdrew consent|0|||
145393734|NCT00809445|524294921|FG001|6 Month Follow-up|Withdrew consent|0|||
145393735|NCT00809445|524294922|FG002|6 Month Follow-up|Withdrew consent|1|||
145730477|NCT02958267|525530682|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
145730478|NCT02958267|525530683|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
145730479|NCT02958267|525530682|FG000|Follow-up Visits|Additional treatment pursued|2|||
145730480|NCT02958267|525530683|FG001|Follow-up Visits|Additional treatment pursued|1|||
145730481|NCT01210118|525530684|FG000|Overall Study|Lost to Follow-up|1|||
145730482|NCT01210118|525530685|FG001|Overall Study|Lost to Follow-up|1|||
145730483|NCT01210118|525530684|FG000|Overall Study|Protocol Violation|1|||
145730484|NCT01210118|525530685|FG001|Overall Study|Protocol Violation|1|||
145730485|NCT01210118|525530684|FG000|Overall Study|Spontaneous abortion|1|||
145730486|NCT01210118|525530685|FG001|Overall Study|Spontaneous abortion|3|||
145730487|NCT00777946|525530686|FG000|Overall Study|Adverse Event|11|||
145730488|NCT00777946|525530687|FG001|Overall Study|Adverse Event|1|||
145730489|NCT00777946|525530688|FG002|Overall Study|Adverse Event|3|||
145730490|NCT00777946|525530686|FG000|Overall Study|Lack of Efficacy|0|||
145730491|NCT00777946|525530687|FG001|Overall Study|Lack of Efficacy|0|||
145730492|NCT00777946|525530688|FG002|Overall Study|Lack of Efficacy|9|||
145730493|NCT00777946|525530686|FG000|Overall Study|Condition no longer required study drug|1|||
145730494|NCT00777946|525530687|FG001|Overall Study|Condition no longer required study drug|0|||
145730495|NCT00777946|525530688|FG002|Overall Study|Condition no longer required study drug|0|||
145730496|NCT00777946|525530686|FG000|Overall Study|Patient withdrew consent|3|||
145730497|NCT00777946|525530687|FG001|Overall Study|Patient withdrew consent|2|||
145730498|NCT00777946|525530688|FG002|Overall Study|Patient withdrew consent|3|||
145730499|NCT00777946|525530686|FG000|Overall Study|Lost to Follow-up|3|||
145730500|NCT00777946|525530687|FG001|Overall Study|Lost to Follow-up|1|||
145730501|NCT00777946|525530688|FG002|Overall Study|Lost to Follow-up|0|||
145730502|NCT00777946|525530686|FG000|Overall Study|Protocol deviation|2|||
145730503|NCT00777946|525530687|FG001|Overall Study|Protocol deviation|1|||
145730504|NCT00777946|525530688|FG002|Overall Study|Protocol deviation|1|||
145730505|NCT00777946|525530686|FG000|Overall Study|Randomized in error|1|||
145393736|NCT01566604|524294924|FG000|Overall Study|Patient's inability to use the device|1|||
145393737|NCT01566604|524294925|FG001|Overall Study|Patient's inability to use the device|0|||
145393738|NCT01566604|524294924|FG000|Overall Study|Administrative problems|1|||
145393739|NCT01566604|524294925|FG001|Overall Study|Administrative problems|0|||
145730506|NCT00777946|525530687|FG001|Overall Study|Randomized in error|1|||
145496567|NCT02163538|524675653|FG001|Overall Study|Physician Decision|1|||
145393740|NCT01566604|524294924|FG000|Overall Study|Lack of Efficacy|1|||
145393741|NCT01566604|524294925|FG001|Overall Study|Lack of Efficacy|2|||
145393742|NCT01566604|524294924|FG000|Overall Study|Protocol deviation|2|||
145393743|NCT01566604|524294925|FG001|Overall Study|Protocol deviation|0|||
145393744|NCT01566604|524294924|FG000|Overall Study|Abnormal laboratory value|2|||
145393745|NCT01566604|524294925|FG001|Overall Study|Abnormal laboratory value|0|||
145393746|NCT01566604|524294924|FG000|Overall Study|Death|4|||
145393747|NCT01566604|524294925|FG001|Overall Study|Death|1|||
145393748|NCT01566604|524294924|FG000|Overall Study|Adverse Event|4|||
145496568|NCT04484961|524675656|FG000|Overall Study|Lost to Follow-up|9|||
145393749|NCT01566604|524294925|FG001|Overall Study|Adverse Event|2|||
145393750|NCT01566604|524294924|FG000|Overall Study|Withdrawal by Subject|9|||
145393751|NCT01566604|524294925|FG001|Overall Study|Withdrawal by Subject|6|||
145393752|NCT01610037|524294927|FG000|All Patients|Adverse Event|27|||
145393753|NCT01610037|524294928|FG001|All Patients|Adverse Event|22|||
145496569|NCT04484961|524675657|FG001|Overall Study|Lost to Follow-up|9|||
145496570|NCT00388349|524675658|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
145496571|NCT00388349|524675659|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
145393754|NCT01610037|524294929|FG002|All Patients|Adverse Event|26|||
145393755|NCT01610037|524294927|FG000|All Patients|Withdrawal by Subject|12|||
145393756|NCT01610037|524294928|FG001|All Patients|Withdrawal by Subject|10|||
145393757|NCT01610037|524294929|FG002|All Patients|Withdrawal by Subject|20|||
145393758|NCT01610037|524294927|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
145393759|NCT01610037|524294928|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
145393760|NCT01610037|524294929|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
145393761|NCT01610037|524294927|FG000|All Patients|Death|4|||
145393762|NCT01610037|524294928|FG001|All Patients|Death|2|||
145393763|NCT01610037|524294929|FG002|All Patients|Death|1|||
145393764|NCT01610037|524294927|FG000|All Patients|Protocol deviation|4|||
145393765|NCT01610037|524294928|FG001|All Patients|Protocol deviation|3|||
145393766|NCT01610037|524294929|FG002|All Patients|Protocol deviation|3|||
145393767|NCT01610037|524294927|FG000|All Patients|Abnormal laboratory value|1|||
145393768|NCT01610037|524294928|FG001|All Patients|Abnormal laboratory value|1|||
145393769|NCT01610037|524294929|FG002|All Patients|Abnormal laboratory value|0|||
145393770|NCT01610037|524294927|FG000|All Patients|Administrative problems|1|||
145393771|NCT01610037|524294928|FG001|All Patients|Administrative problems|4|||
145393772|NCT01610037|524294929|FG002|All Patients|Administrative problems|4|||
145393773|NCT01610037|524294927|FG000|All Patients|Lost to Follow-up|1|||
145393774|NCT01610037|524294928|FG001|All Patients|Lost to Follow-up|0|||
145393775|NCT01610037|524294929|FG002|All Patients|Lost to Follow-up|0|||
145393776|NCT01610037|524294927|FG000|All Patients|Abnormal test procedure result(s)|0|||
145393777|NCT01610037|524294928|FG001|All Patients|Abnormal test procedure result(s)|1|||
145393778|NCT01610037|524294929|FG002|All Patients|Abnormal test procedure result(s)|3|||
145393779|NCT01610037|524294927|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
145393780|NCT01610037|524294928|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
145393781|NCT01610037|524294929|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
145393782|NCT01610037|524294927|FG000|Treatment and Follow up Period|Death|10|||
145393783|NCT01610037|524294928|FG001|Treatment and Follow up Period|Death|5|||
145393784|NCT01610037|524294929|FG002|Treatment and Follow up Period|Death|4|||
145393785|NCT01610037|524294927|FG000|Treatment and Follow up Period|Administrative problems|1|||
145393786|NCT01610037|524294928|FG001|Treatment and Follow up Period|Administrative problems|3|||
145393787|NCT01610037|524294929|FG002|Treatment and Follow up Period|Administrative problems|2|||
145393788|NCT01610037|524294927|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
145393789|NCT01610037|524294928|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
145393790|NCT01610037|524294929|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
145393791|NCT00705757|524294931|FG000|Overall Study|Lack of Efficacy|5|||
145393792|NCT00705757|524294932|FG001|Overall Study|Lack of Efficacy|1|||
145393793|NCT00705757|524294933|FG002|Overall Study|Lack of Efficacy|3|||
145393794|NCT00705757|524294931|FG000|Overall Study|Lost to Follow-up|7|||
145393795|NCT00705757|524294932|FG001|Overall Study|Lost to Follow-up|6|||
145393796|NCT00705757|524294933|FG002|Overall Study|Lost to Follow-up|6|||
145393797|NCT00705757|524294931|FG000|Overall Study|Withdrawal by Subject|1|||
145393798|NCT00705757|524294932|FG001|Overall Study|Withdrawal by Subject|1|||
145393799|NCT00705757|524294933|FG002|Overall Study|Withdrawal by Subject|2|||
145393800|NCT00661089|524294934|FG000|Overall Study|1 subject withdrawal|0|||
145393801|NCT00661089|524294935|FG001|Overall Study|1 subject withdrawal|1|||
145393802|NCT00661089|524294934|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
145393803|NCT00661089|524294935|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
145393804|NCT01443858|524294942|FG000|Overall Study|Withdrawal by Subject|9|||
145393805|NCT01443858|524294943|FG001|Overall Study|Withdrawal by Subject|8|||
145393806|NCT01443858|524294944|FG002|Overall Study|Withdrawal by Subject|5|||
145393807|NCT01443858|524294942|FG000|Overall Study|Lack of Efficacy|1|||
145393808|NCT01443858|524294943|FG001|Overall Study|Lack of Efficacy|0|||
145393809|NCT01443858|524294944|FG002|Overall Study|Lack of Efficacy|0|||
145393810|NCT01443858|524294942|FG000|Overall Study|Lost to Follow-up|5|||
145393811|NCT01443858|524294943|FG001|Overall Study|Lost to Follow-up|5|||
145393812|NCT01443858|524294944|FG002|Overall Study|Lost to Follow-up|2|||
145393813|NCT03361306|524294948|FG000|Overall Study|Death|6|||
145496572|NCT01345240|524675663|FG000|Overall Study|Adverse Event|3|||
145393814|NCT01272908|524294950|FG000|Initial Treatment Period|Adverse Event|1|||
145393815|NCT01272908|524294950|FG000|Initial Treatment Period|Lack of Efficacy|5|||
145393816|NCT01272908|524294950|FG000|Initial Treatment Period|Protocol Violation|1|||
145393817|NCT01272908|524294950|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
145393818|NCT01272908|524294950|FG000|Re-Treatment Period|Adverse Event|2|||
145393819|NCT01272908|524294950|FG000|Re-Treatment Period|Lack of Efficacy|3|||
145393820|NCT01272908|524294950|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
145393821|NCT02221648|524294951|FG000|Overall Study|Withdrawal by Subject|3|||
145393822|NCT02221648|524294952|FG001|Overall Study|Withdrawal by Subject|3|||
145393823|NCT00149396|524294953|FG000|Overall Study|Death|15|||
145393824|NCT00149396|524294953|FG000|Overall Study|Withdrawal by Subject|1|||
145393825|NCT00149396|524294953|FG000|Overall Study|Subject noncompliance|2|||
145393826|NCT00149396|524294953|FG000|Overall Study|other treatment|5|||
145393827|NCT00807885|524294954|FG000|Overall Study|Lost to Follow-up|0|||
145393828|NCT00807885|524294955|FG001|Overall Study|Lost to Follow-up|0|||
145393829|NCT00807885|524294956|FG002|Overall Study|Lost to Follow-up|0|||
145393830|NCT00807885|524294957|FG003|Overall Study|Lost to Follow-up|0|||
145393831|NCT00807885|524294958|FG004|Overall Study|Lost to Follow-up|0|||
145393832|NCT00807885|524294959|FG005|Overall Study|Lost to Follow-up|1|||
145393833|NCT00807885|524294960|FG006|Overall Study|Lost to Follow-up|0|||
145393834|NCT00807885|524294961|FG007|Overall Study|Lost to Follow-up|0|||
145393835|NCT00807885|524294962|FG008|Overall Study|Lost to Follow-up|0|||
145393836|NCT00810069|524294963|FG000|Lead-in Period I|Adverse Event|43|||
145393837|NCT00810069|524294964|FG001|Lead-in Period I|Adverse Event|0|||
145393838|NCT00810069|524294965|FG002|Lead-in Period I|Adverse Event|0|||
145393839|NCT00810069|524294963|FG000|Lead-in Period I|Lack of Efficacy|1|||
145393840|NCT00810069|524294964|FG001|Lead-in Period I|Lack of Efficacy|0|||
145393841|NCT00810069|524294965|FG002|Lead-in Period I|Lack of Efficacy|0|||
145393842|NCT00810069|524294963|FG000|Lead-in Period I|Lost to Follow-up|19|||
145393843|NCT00810069|524294964|FG001|Lead-in Period I|Lost to Follow-up|0|||
145393844|NCT00810069|524294965|FG002|Lead-in Period I|Lost to Follow-up|0|||
145393845|NCT00810069|524294963|FG000|Lead-in Period I|Physician Decision|1|||
145393846|NCT00810069|524294964|FG001|Lead-in Period I|Physician Decision|0|||
145393847|NCT00810069|524294965|FG002|Lead-in Period I|Physician Decision|0|||
145393848|NCT00810069|524294963|FG000|Lead-in Period I|Protocol Violation|1|||
145393849|NCT00810069|524294964|FG001|Lead-in Period I|Protocol Violation|0|||
145393850|NCT00810069|524294965|FG002|Lead-in Period I|Protocol Violation|0|||
145393851|NCT00810069|524294963|FG000|Lead-in Period I|Withdrawal by Subject|46|||
145393852|NCT00810069|524294964|FG001|Lead-in Period I|Withdrawal by Subject|0|||
145393853|NCT00810069|524294965|FG002|Lead-in Period I|Withdrawal by Subject|0|||
145393854|NCT00810069|524294963|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
145393855|NCT00810069|524294964|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
145393856|NCT00810069|524294965|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
145393857|NCT00810069|524294963|FG000|Lead-in Period I|Randomization criteria not met|158|||
145393858|NCT00810069|524294964|FG001|Lead-in Period I|Randomization criteria not met|0|||
145393859|NCT00810069|524294965|FG002|Lead-in Period I|Randomization criteria not met|0|||
145393860|NCT00810069|524294963|FG000|Double-Blind Period II|Adverse Event|0|||
145393861|NCT00810069|524294964|FG001|Double-Blind Period II|Adverse Event|9|||
145393862|NCT00810069|524294965|FG002|Double-Blind Period II|Adverse Event|8|||
145393863|NCT00810069|524294963|FG000|Double-Blind Period II|Lack of Efficacy|0|||
145393864|NCT00810069|524294964|FG001|Double-Blind Period II|Lack of Efficacy|7|||
145393865|NCT00810069|524294965|FG002|Double-Blind Period II|Lack of Efficacy|12|||
145393866|NCT00810069|524294963|FG000|Double-Blind Period II|Lost to Follow-up|0|||
145393867|NCT00810069|524294964|FG001|Double-Blind Period II|Lost to Follow-up|9|||
145393868|NCT00810069|524294965|FG002|Double-Blind Period II|Lost to Follow-up|9|||
145393869|NCT00810069|524294963|FG000|Double-Blind Period II|Physician Decision|0|||
145393870|NCT00810069|524294964|FG001|Double-Blind Period II|Physician Decision|0|||
145393871|NCT00810069|524294965|FG002|Double-Blind Period II|Physician Decision|1|||
145393872|NCT00810069|524294963|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
145393873|NCT00810069|524294964|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
145393874|NCT00810069|524294965|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
145393875|NCT00810069|524294963|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
145496573|NCT01345240|524675664|FG001|Overall Study|Adverse Event|5|||
145393876|NCT00810069|524294964|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
145393877|NCT00810069|524294965|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
145393878|NCT00810069|524294963|FG000|Double-Blind Period II|Clinical relapse|0|||
145393879|NCT00810069|524294964|FG001|Double-Blind Period II|Clinical relapse|3|||
145393880|NCT00810069|524294965|FG002|Double-Blind Period II|Clinical relapse|0|||
145393881|NCT00810069|524294963|FG000|Double-Blind Period II|Protocol Violation|0|||
145393882|NCT00810069|524294964|FG001|Double-Blind Period II|Protocol Violation|7|||
145393883|NCT00810069|524294965|FG002|Double-Blind Period II|Protocol Violation|6|||
145730507|NCT00777946|525530688|FG002|Overall Study|Randomized in error|0|||
145730508|NCT02673619|525530692|FG000|Overall Study|Lost to Follow-up|1|||
145730509|NCT02673619|525530693|FG001|Overall Study|Lost to Follow-up|0|||
145730510|NCT02673619|525530694|FG002|Overall Study|Lost to Follow-up|0|||
145730511|NCT02673619|525530695|FG003|Overall Study|Lost to Follow-up|0|||
145730512|NCT02673619|525530692|FG000|Overall Study|Withdrawal by Subject|1|||
145730513|NCT02673619|525530693|FG001|Overall Study|Withdrawal by Subject|1|||
145730514|NCT02673619|525530694|FG002|Overall Study|Withdrawal by Subject|1|||
145730515|NCT02673619|525530695|FG003|Overall Study|Withdrawal by Subject|0|||
145730516|NCT02673619|525530692|FG000|Overall Study|Adverse Event|0|||
145730517|NCT02673619|525530693|FG001|Overall Study|Adverse Event|0|||
145393884|NCT01951417|524294966|FG000|Overall Study|Withdrawal by Subject|1|||
145393885|NCT01951417|524294966|FG000|Overall Study|Protocol Violation|2|||
145393886|NCT01951417|524294966|FG000|Overall Study|Lost to Follow-up|6|||
145393887|NCT00977613|524294967|FG000|Overall Study|Lost to Follow-up|16|||
145393888|NCT02039778|524294972|FG000|Overall Study|Death|2|||
145393889|NCT02039778|524294972|FG000|Overall Study|Withdrawal by Subject|1|||
145730518|NCT02673619|525530694|FG002|Overall Study|Adverse Event|1|||
145730519|NCT02673619|525530695|FG003|Overall Study|Adverse Event|0|||
145730520|NCT02673619|525530692|FG000|Overall Study|Lack of Efficacy|0|||
145730521|NCT02673619|525530693|FG001|Overall Study|Lack of Efficacy|0|||
145730522|NCT02673619|525530694|FG002|Overall Study|Lack of Efficacy|1|||
145730523|NCT02673619|525530695|FG003|Overall Study|Lack of Efficacy|0|||
145730524|NCT01313117|525530697|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
145730525|NCT01313117|525530697|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
145730526|NCT03602261|525530702|FG000|Overall Study|Adverse Event|5|||
145730527|NCT03602261|525530703|FG001|Overall Study|Adverse Event|1|||
145730528|NCT03602261|525530702|FG000|Overall Study|Physician Decision|1|||
145730529|NCT03602261|525530703|FG001|Overall Study|Physician Decision|0|||
145730530|NCT03602261|525530702|FG000|Overall Study|Withdrawal by Subject|1|||
145730531|NCT03602261|525530703|FG001|Overall Study|Withdrawal by Subject|1|||
145730532|NCT03602261|525530702|FG000|Overall Study|Lack of Efficacy|0|||
145730533|NCT03602261|525530703|FG001|Overall Study|Lack of Efficacy|1|||
145730534|NCT03602261|525530702|FG000|Overall Study|Subject moving out of state|1|||
145730535|NCT03602261|525530703|FG001|Overall Study|Subject moving out of state|0|||
145730536|NCT01444651|525532086|FG000|Overall Study|Adverse Event|3|||
145730537|NCT01444651|525532087|FG001|Overall Study|Adverse Event|2|||
145730538|NCT01444651|525532086|FG000|Overall Study|Lost to Follow-up|5|||
145730539|NCT01444651|525532087|FG001|Overall Study|Lost to Follow-up|5|||
145730540|NCT01444651|525532086|FG000|Overall Study|Non-fasting|2|||
145730541|NCT01444651|525532087|FG001|Overall Study|Non-fasting|1|||
145730542|NCT01444651|525532086|FG000|Overall Study|Missing data|1|||
145730543|NCT01444651|525532087|FG001|Overall Study|Missing data|1|||
145730544|NCT01955122|525532088|FG000|Overall Study|Physician Decision|5|||
145730545|NCT01955122|525532089|FG001|Overall Study|Physician Decision|5|||
145730546|NCT01672788|525532090|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
145730547|NCT01672788|525532091|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
145730548|NCT01672788|525532092|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
145730549|NCT01672788|525532093|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
145730550|NCT03338192|525532094|FG000|Year One to Year Two|High Blood Pressure|7|||
145730551|NCT03338192|525532095|FG001|Year One to Year Two|High Blood Pressure|1|||
145730552|NCT03338192|525532094|FG000|Year One to Year Two|HIV +|1|||
145730553|NCT03338192|525532095|FG001|Year One to Year Two|HIV +|0|||
145730554|NCT03338192|525532094|FG000|Year Two to Year Four|High Blood Pressure|1|||
145730555|NCT03338192|525532095|FG001|Year Two to Year Four|High Blood Pressure|0|||
145730556|NCT03338192|525532094|FG000|Year Two to Year Four|HIV +|2|||
145730557|NCT03338192|525532095|FG001|Year Two to Year Four|HIV +|0|||
145730558|NCT03338192|525532094|FG000|Year Four to Year Six|High Blood Pressure|2|||
145730559|NCT03338192|525532095|FG001|Year Four to Year Six|High Blood Pressure|1|||
145730560|NCT03329196|525532098|FG000|Overall Study|Adverse Event|10|||
145730561|NCT03329196|525532099|FG001|Overall Study|Adverse Event|5|||
145730562|NCT03329196|525532098|FG000|Overall Study|Physician Decision|2|||
145393890|NCT02039778|524294972|FG000|Overall Study|Never started the protocol treatment|1|||
145393891|NCT01317641|524296655|FG000|Overall Study|Not treated|0|||
145393892|NCT01317641|524296656|FG001|Overall Study|Not treated|0|||
145730563|NCT03329196|525532099|FG001|Overall Study|Physician Decision|2|||
145730564|NCT03329196|525532098|FG000|Overall Study|Withdrawal by Subject|11|||
145730565|NCT03329196|525532099|FG001|Overall Study|Withdrawal by Subject|3|||
145393893|NCT01317641|524296657|FG002|Overall Study|Not treated|0|||
145393894|NCT01317641|524296658|FG003|Overall Study|Not treated|0|||
145393895|NCT01317641|524296659|FG004|Overall Study|Not treated|0|||
145393896|NCT01317641|524296660|FG005|Overall Study|Not treated|0|||
145393897|NCT01317641|524296661|FG006|Overall Study|Not treated|0|||
145393898|NCT01317641|524296662|FG007|Overall Study|Not treated|1|||
145393899|NCT01317641|524296663|FG008|Overall Study|Not treated|1|||
145393900|NCT01317641|524296655|FG000|Overall Study|Adverse Event|0|||
145393901|NCT01317641|524296656|FG001|Overall Study|Adverse Event|1|||
145393902|NCT01317641|524296657|FG002|Overall Study|Adverse Event|0|||
145393903|NCT01317641|524296658|FG003|Overall Study|Adverse Event|1|||
145393904|NCT01317641|524296659|FG004|Overall Study|Adverse Event|0|||
145393905|NCT01317641|524296660|FG005|Overall Study|Adverse Event|0|||
145393906|NCT01317641|524296661|FG006|Overall Study|Adverse Event|2|||
145393907|NCT01317641|524296662|FG007|Overall Study|Adverse Event|1|||
145393908|NCT01317641|524296663|FG008|Overall Study|Adverse Event|0|||
145393909|NCT01317641|524296655|FG000|Overall Study|Protocol Violation|1|||
145393910|NCT01317641|524296656|FG001|Overall Study|Protocol Violation|0|||
145393911|NCT01317641|524296657|FG002|Overall Study|Protocol Violation|0|||
145393912|NCT01317641|524296658|FG003|Overall Study|Protocol Violation|0|||
145393913|NCT01317641|524296659|FG004|Overall Study|Protocol Violation|0|||
145393914|NCT01317641|524296660|FG005|Overall Study|Protocol Violation|0|||
145393915|NCT01317641|524296661|FG006|Overall Study|Protocol Violation|0|||
145393916|NCT01317641|524296662|FG007|Overall Study|Protocol Violation|0|||
145393917|NCT01317641|524296663|FG008|Overall Study|Protocol Violation|0|||
145393918|NCT01317641|524296655|FG000|Overall Study|Disease progression|0|||
145393919|NCT01317641|524296656|FG001|Overall Study|Disease progression|0|||
145393920|NCT01317641|524296657|FG002|Overall Study|Disease progression|0|||
145393921|NCT01317641|524296658|FG003|Overall Study|Disease progression|0|||
145393922|NCT01317641|524296659|FG004|Overall Study|Disease progression|0|||
145393923|NCT01317641|524296660|FG005|Overall Study|Disease progression|0|||
145393924|NCT01317641|524296661|FG006|Overall Study|Disease progression|0|||
145393925|NCT01317641|524296662|FG007|Overall Study|Disease progression|3|||
145393926|NCT01317641|524296663|FG008|Overall Study|Disease progression|4|||
145393927|NCT01317641|524296655|FG000|Overall Study|Withdrawal by Subject|0|||
145393928|NCT01317641|524296656|FG001|Overall Study|Withdrawal by Subject|0|||
145393929|NCT01317641|524296657|FG002|Overall Study|Withdrawal by Subject|0|||
145393930|NCT01317641|524296658|FG003|Overall Study|Withdrawal by Subject|0|||
145393931|NCT01317641|524296659|FG004|Overall Study|Withdrawal by Subject|0|||
145393932|NCT01317641|524296660|FG005|Overall Study|Withdrawal by Subject|0|||
145393933|NCT01317641|524296661|FG006|Overall Study|Withdrawal by Subject|1|||
145393934|NCT01317641|524296662|FG007|Overall Study|Withdrawal by Subject|0|||
145393935|NCT01317641|524296663|FG008|Overall Study|Withdrawal by Subject|0|||
145393936|NCT00715559|524296664|FG000|Overall Study|medication not tolerated - nausea|1|||
145393937|NCT02019550|524296665|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145393938|NCT02019550|524296666|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
145393939|NCT02787304|524296669|FG000|Overall Study|Adverse Event|9|||
145393940|NCT02787304|524296670|FG001|Overall Study|Adverse Event|3|||
145393941|NCT02787304|524296671|FG002|Overall Study|Adverse Event|8|||
145393942|NCT02787304|524296672|FG003|Overall Study|Adverse Event|1|||
145393943|NCT02787304|524296669|FG000|Overall Study|Withdrawal by Subject|1|||
145393944|NCT02787304|524296670|FG001|Overall Study|Withdrawal by Subject|4|||
145393945|NCT02787304|524296671|FG002|Overall Study|Withdrawal by Subject|0|||
145393946|NCT02787304|524296672|FG003|Overall Study|Withdrawal by Subject|0|||
145393947|NCT02787304|524296669|FG000|Overall Study|Lost to Follow-up|1|||
145393948|NCT02787304|524296670|FG001|Overall Study|Lost to Follow-up|0|||
145393949|NCT02787304|524296671|FG002|Overall Study|Lost to Follow-up|0|||
145393950|NCT02787304|524296672|FG003|Overall Study|Lost to Follow-up|1|||
145393951|NCT02787304|524296669|FG000|Overall Study|Noncompliance with study drug|0|||
145393952|NCT02787304|524296670|FG001|Overall Study|Noncompliance with study drug|0|||
145393953|NCT02787304|524296671|FG002|Overall Study|Noncompliance with study drug|1|||
145393954|NCT02787304|524296672|FG003|Overall Study|Noncompliance with study drug|0|||
145393955|NCT02787304|524296669|FG000|Overall Study|Physician Decision|0|||
145393956|NCT02787304|524296670|FG001|Overall Study|Physician Decision|0|||
145393957|NCT02787304|524296671|FG002|Overall Study|Physician Decision|1|||
145393958|NCT02787304|524296672|FG003|Overall Study|Physician Decision|0|||
145393959|NCT02787304|524296669|FG000|Overall Study|Study terminated by sponsor|25|||
145393960|NCT02787304|524296670|FG001|Overall Study|Study terminated by sponsor|31|||
145393961|NCT02787304|524296671|FG002|Overall Study|Study terminated by sponsor|31|||
145393962|NCT02787304|524296672|FG003|Overall Study|Study terminated by sponsor|32|||
145393963|NCT04771013|524296674|FG000|Overall Study|Withdrawal by Subject|2|||
145393964|NCT04771013|524296675|FG001|Overall Study|Withdrawal by Subject|0|||
145393965|NCT04771013|524296674|FG000|Overall Study|Death|0|||
145393966|NCT04771013|524296675|FG001|Overall Study|Death|5|||
145393967|NCT04771013|524296674|FG000|Overall Study|Referred to another hospital before day 20|0|||
145393968|NCT04771013|524296675|FG001|Overall Study|Referred to another hospital before day 20|1|||
145393969|NCT00823134|524296676|FG000|Overall Study|Invalid measurement|1|||
145393970|NCT00419757|524296680|FG000|Overall Study|Adverse Event|1|||
145393971|NCT00419757|524296681|FG001|Overall Study|Adverse Event|4|||
145393972|NCT00419757|524296680|FG000|Overall Study|Lost to Follow-up|1|||
145393973|NCT00419757|524296681|FG001|Overall Study|Lost to Follow-up|4|||
145393974|NCT00419757|524296680|FG000|Overall Study|Withdrawal by Subject|7|||
145393975|NCT00419757|524296681|FG001|Overall Study|Withdrawal by Subject|1|||
145393976|NCT00419757|524296680|FG000|Overall Study|Protocol Violation|2|||
145393977|NCT00419757|524296681|FG001|Overall Study|Protocol Violation|3|||
145393978|NCT00419757|524296680|FG000|Overall Study|Study specific discontinuation criteria|4|||
145393979|NCT00419757|524296681|FG001|Overall Study|Study specific discontinuation criteria|8|||
145393980|NCT00419757|524296680|FG000|Overall Study|Multiple reasons|3|||
145393981|NCT00419757|524296681|FG001|Overall Study|Multiple reasons|1|||
145393982|NCT00379834|524296686|FG000|Overall Study|Time constraints|2|||
145393983|NCT01519817|524296687|FG000|Overall Study|Withdrawal by Subject|1|||
145730566|NCT03329196|525532098|FG000|Overall Study|Hepatic function abnormalities|0|||
145730567|NCT03329196|525532099|FG001|Overall Study|Hepatic function abnormalities|1|||
145730568|NCT03329196|525532098|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
145730569|NCT03329196|525532099|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
145730570|NCT03329196|525532098|FG000|Overall Study|Difficult to control Hb|2|||
145730571|NCT03329196|525532099|FG001|Overall Study|Difficult to control Hb|3|||
145730572|NCT03329196|525532098|FG000|Overall Study|Dialysis or renal transplant|13|||
145393984|NCT01519817|524296688|FG001|Overall Study|Withdrawal by Subject|0|||
145393985|NCT01519817|524296689|FG002|Overall Study|Withdrawal by Subject|0|||
145393986|NCT01519817|524296690|FG003|Overall Study|Withdrawal by Subject|0|||
145393987|NCT01519817|524296687|FG000|Overall Study|Off study due to infection|0|||
145393988|NCT01519817|524296688|FG001|Overall Study|Off study due to infection|0|||
145393989|NCT01519817|524296689|FG002|Overall Study|Off study due to infection|0|||
145393990|NCT01519817|524296690|FG003|Overall Study|Off study due to infection|1|||
145393991|NCT02922153|524296691|FG000|Overall Study|Death|8|||
145393992|NCT02922153|524296692|FG001|Overall Study|Death|1|||
145393993|NCT02922153|524296691|FG000|Overall Study|Lost to Follow-up|1|||
145393994|NCT02922153|524296692|FG001|Overall Study|Lost to Follow-up|0|||
145393995|NCT02922153|524296691|FG000|Overall Study|Physician Decision|1|||
145393996|NCT02922153|524296692|FG001|Overall Study|Physician Decision|1|||
145393997|NCT01325350|524296695|FG000|Overall Study|Adverse Event|3|||
145496574|NCT01345240|524675665|FG002|Overall Study|Adverse Event|4|||
145496575|NCT01345240|524675666|FG003|Overall Study|Adverse Event|2|||
145393998|NCT01325350|524296696|FG001|Overall Study|Adverse Event|3|||
145393999|NCT01325350|524296697|FG002|Overall Study|Adverse Event|3|||
145496576|NCT01345240|524675667|FG004|Overall Study|Adverse Event|1|||
145496577|NCT01345240|524675663|FG000|Overall Study|Lost to Follow-up|8|||
145496578|NCT01345240|524675664|FG001|Overall Study|Lost to Follow-up|9|||
145730573|NCT03329196|525532099|FG001|Overall Study|Dialysis or renal transplant|15|||
145394000|NCT01325350|524296698|FG003|Overall Study|Adverse Event|1|||
145394001|NCT01325350|524296699|FG004|Overall Study|Adverse Event|2|||
145394002|NCT01325350|524296695|FG000|Overall Study|Pregnancy|0|||
145394003|NCT01325350|524296696|FG001|Overall Study|Pregnancy|0|||
145394004|NCT01325350|524296697|FG002|Overall Study|Pregnancy|1|||
145394005|NCT01325350|524296698|FG003|Overall Study|Pregnancy|0|||
145394006|NCT01325350|524296699|FG004|Overall Study|Pregnancy|1|||
145394007|NCT01325350|524296695|FG000|Overall Study|Lost to Follow-up|1|||
145496579|NCT01345240|524675665|FG002|Overall Study|Lost to Follow-up|14|||
145496580|NCT01345240|524675666|FG003|Overall Study|Lost to Follow-up|7|||
145730574|NCT02464228|525532100|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
145730575|NCT02464228|525532101|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
145730576|NCT02464228|525532102|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
145394008|NCT01325350|524296696|FG001|Overall Study|Lost to Follow-up|0|||
145394009|NCT01325350|524296697|FG002|Overall Study|Lost to Follow-up|5|||
145394010|NCT01325350|524296698|FG003|Overall Study|Lost to Follow-up|1|||
145394011|NCT01325350|524296699|FG004|Overall Study|Lost to Follow-up|5|||
145394012|NCT01325350|524296695|FG000|Overall Study|Personal Reasons|2|||
145394013|NCT01325350|524296696|FG001|Overall Study|Personal Reasons|1|||
145394014|NCT01325350|524296697|FG002|Overall Study|Personal Reasons|6|||
145394015|NCT01325350|524296698|FG003|Overall Study|Personal Reasons|5|||
145394016|NCT01325350|524296699|FG004|Overall Study|Personal Reasons|3|||
145394017|NCT01325350|524296695|FG000|Overall Study|Protocol Violation|0|||
145394018|NCT01325350|524296696|FG001|Overall Study|Protocol Violation|0|||
145394019|NCT01325350|524296697|FG002|Overall Study|Protocol Violation|0|||
145394020|NCT01325350|524296698|FG003|Overall Study|Protocol Violation|1|||
145394021|NCT01325350|524296699|FG004|Overall Study|Protocol Violation|0|||
145394022|NCT01325350|524296695|FG000|Overall Study|Withdrawal by Subject|0|||
145394023|NCT01325350|524296696|FG001|Overall Study|Withdrawal by Subject|0|||
145394024|NCT01325350|524296697|FG002|Overall Study|Withdrawal by Subject|1|||
145394025|NCT01325350|524296698|FG003|Overall Study|Withdrawal by Subject|1|||
145496581|NCT01345240|524675667|FG004|Overall Study|Lost to Follow-up|9|||
145496582|NCT04011540|524675668|FG000|Overall Study|Lost to Follow-up|9|||
145496583|NCT04011540|524675669|FG001|Overall Study|Lost to Follow-up|6|||
145496584|NCT01502293|524675670|FG000|Overall Study|Progressive Disease|20|||
145496585|NCT01502293|524675671|FG001|Overall Study|Progressive Disease|12|||
145496586|NCT01502293|524675672|FG002|Overall Study|Progressive Disease|2|||
145496587|NCT01502293|524675670|FG000|Overall Study|Withdrawal by Subject|3|||
145496588|NCT01502293|524675671|FG001|Overall Study|Withdrawal by Subject|3|||
145496589|NCT01502293|524675672|FG002|Overall Study|Withdrawal by Subject|1|||
145394026|NCT01325350|524296699|FG004|Overall Study|Withdrawal by Subject|0|||
145394027|NCT01325350|524296695|FG000|Overall Study|Did Not Receive Treatment|0|||
145394028|NCT01325350|524296696|FG001|Overall Study|Did Not Receive Treatment|1|||
145394029|NCT01325350|524296697|FG002|Overall Study|Did Not Receive Treatment|1|||
145394030|NCT01325350|524296698|FG003|Overall Study|Did Not Receive Treatment|0|||
145394031|NCT01325350|524296699|FG004|Overall Study|Did Not Receive Treatment|1|||
145394032|NCT01716806|524296706|FG000|Overall Study|Patient withdrawal of consent|4|||
145394033|NCT01716806|524296707|FG001|Overall Study|Patient withdrawal of consent|2|||
145394034|NCT01716806|524296708|FG002|Overall Study|Patient withdrawal of consent|4|||
145394035|NCT01716806|524296709|FG003|Overall Study|Patient withdrawal of consent|3|||
145394036|NCT01716806|524296710|FG004|Overall Study|Patient withdrawal of consent|2|||
145394037|NCT01716806|524296711|FG005|Overall Study|Patient withdrawal of consent|0|||
145394038|NCT01716806|524296706|FG000|Overall Study|Lost to Follow-up|3|||
145394039|NCT01716806|524296707|FG001|Overall Study|Lost to Follow-up|3|||
145394040|NCT01716806|524296708|FG002|Overall Study|Lost to Follow-up|0|||
145394041|NCT01716806|524296709|FG003|Overall Study|Lost to Follow-up|2|||
145394042|NCT01716806|524296710|FG004|Overall Study|Lost to Follow-up|1|||
145394043|NCT01716806|524296711|FG005|Overall Study|Lost to Follow-up|0|||
145394044|NCT01716806|524296706|FG000|Overall Study|Death|13|||
145394045|NCT01716806|524296707|FG001|Overall Study|Death|9|||
145394046|NCT01716806|524296708|FG002|Overall Study|Death|12|||
145394047|NCT01716806|524296709|FG003|Overall Study|Death|4|||
145394048|NCT01716806|524296710|FG004|Overall Study|Death|10|||
145394049|NCT01716806|524296711|FG005|Overall Study|Death|5|||
145394050|NCT01716806|524296706|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145394051|NCT01716806|524296707|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145394052|NCT01716806|524296708|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145394053|NCT01716806|524296709|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
145394054|NCT01716806|524296710|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
145394055|NCT01716806|524296711|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
145394056|NCT01716806|524296706|FG000|Overall Study|PI decision|0|||
145394057|NCT01716806|524296707|FG001|Overall Study|PI decision|0|||
145394058|NCT01716806|524296708|FG002|Overall Study|PI decision|0|||
145394059|NCT01716806|524296709|FG003|Overall Study|PI decision|0|||
145394060|NCT01716806|524296710|FG004|Overall Study|PI decision|1|||
145394061|NCT01716806|524296711|FG005|Overall Study|PI decision|0|||
145496590|NCT01502293|524675670|FG000|Overall Study|Adverse Event|0|||
145605933|NCT04887948|525073046|FG001|Overall Study|Withdrawal by Subject|6|||
145605934|NCT04887948|525073047|FG002|Overall Study|Withdrawal by Subject|1|||
145605935|NCT04887948|525073045|FG000|Overall Study|No longer met eligibility criteria|1|||
145605936|NCT04887948|525073046|FG001|Overall Study|No longer met eligibility criteria|2|||
145605937|NCT04887948|525073047|FG002|Overall Study|No longer met eligibility criteria|1|||
145605938|NCT04887948|525073045|FG000|Overall Study|Other|2|||
145605939|NCT04887948|525073046|FG001|Overall Study|Other|1|||
145605940|NCT04887948|525073047|FG002|Overall Study|Other|1|||
145605941|NCT00787319|525073048|FG000|Overall Study|Lost to Follow-up|2|||
145605942|NCT00787319|525073048|FG000|Overall Study|Withdrawal by Subject|15|||
145605943|NCT00787319|525073048|FG000|Overall Study|Adverse Event|3|||
145605944|NCT00787319|525073048|FG000|Overall Study|Objective progression or relapse|30|||
145605945|NCT00787319|525073048|FG000|Overall Study|Lack of Efficacy|1|||
145605946|NCT00787319|525073048|FG000|Overall Study|Budget exhausted/exceeded|1|||
145394062|NCT01716806|524296706|FG000|Overall Study|Change in performance status|1|||
145394063|NCT01716806|524296707|FG001|Overall Study|Change in performance status|0|||
145394064|NCT01716806|524296708|FG002|Overall Study|Change in performance status|0|||
145496591|NCT01502293|524675671|FG001|Overall Study|Adverse Event|2|||
145496592|NCT01502293|524675672|FG002|Overall Study|Adverse Event|0|||
145496593|NCT01502293|524675670|FG000|Overall Study|Reason Not Specified|2|||
145496594|NCT01502293|524675671|FG001|Overall Study|Reason Not Specified|0|||
145496595|NCT01502293|524675672|FG002|Overall Study|Reason Not Specified|0|||
145496596|NCT01502293|524675670|FG000|Overall Study|Physician Decision|0|||
145496597|NCT01502293|524675671|FG001|Overall Study|Physician Decision|0|||
145496598|NCT01502293|524675672|FG002|Overall Study|Physician Decision|1|||
145496599|NCT01339832|524675678|FG000|Overall Study|Lost to Follow-up|3|||
145496600|NCT01339832|524675678|FG000|Overall Study|Death|11|||
145496601|NCT00231816|524675679|FG000|Overall Study|Adverse Event|1|||
145496602|NCT00231816|524675680|FG001|Overall Study|Adverse Event|0|||
145496603|NCT00231816|524675679|FG000|Overall Study|Lost to Follow-up|8|||
145496604|NCT00231816|524675680|FG001|Overall Study|Lost to Follow-up|5|||
145496605|NCT00231816|524675679|FG000|Overall Study|Protocol Violation|2|||
145496606|NCT00231816|524675680|FG001|Overall Study|Protocol Violation|3|||
145496607|NCT00231816|524675679|FG000|Overall Study|Withdrawal by Subject|3|||
145496608|NCT00231816|524675680|FG001|Overall Study|Withdrawal by Subject|3|||
145496609|NCT00231816|524675679|FG000|Overall Study|Other|2|||
145496610|NCT00231816|524675680|FG001|Overall Study|Other|1|||
145496611|NCT00774046|524675681|FG000|Screening|Not eligible|56|||
145496612|NCT00774046|524675681|FG000|Enrollment|Desired other therapy/refused|28|||
145730577|NCT02464228|525532103|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
145730578|NCT02464228|525532100|FG000|Overall Study|Physician Decision|2|||
145394065|NCT01716806|524296709|FG003|Overall Study|Change in performance status|0|||
145394066|NCT01716806|524296710|FG004|Overall Study|Change in performance status|0|||
145394067|NCT01716806|524296711|FG005|Overall Study|Change in performance status|0|||
145394068|NCT01716806|524296706|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
145394069|NCT01716806|524296707|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
145394070|NCT01716806|524296708|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
145394071|NCT01716806|524296709|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
145394072|NCT01716806|524296710|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
145394073|NCT01716806|524296711|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
145394074|NCT01716806|524296706|FG000|Overall Study|Sponsor direction|7|||
145394075|NCT01716806|524296707|FG001|Overall Study|Sponsor direction|8|||
145394076|NCT01716806|524296708|FG002|Overall Study|Sponsor direction|5|||
145394077|NCT01716806|524296709|FG003|Overall Study|Sponsor direction|12|||
145394078|NCT01716806|524296710|FG004|Overall Study|Sponsor direction|16|||
145394079|NCT01716806|524296711|FG005|Overall Study|Sponsor direction|1|||
145394080|NCT02692586|524296712|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
145394081|NCT02692586|524296712|FG000|Overall Study|Received adjunctive thrombolytics|2|||
145394082|NCT03506438|524296716|FG000|Overall Study|Lost to Follow-up|8|||
145394083|NCT03506438|524296717|FG001|Overall Study|Lost to Follow-up|7|||
145394084|NCT03506438|524296718|FG002|Overall Study|Lost to Follow-up|8|||
145394085|NCT03506438|524296719|FG003|Overall Study|Lost to Follow-up|7|||
145394086|NCT03506438|524296720|FG004|Overall Study|Lost to Follow-up|0|||
145394087|NCT03506438|524296721|FG005|Overall Study|Lost to Follow-up|0|||
145394088|NCT03934216|524296724|FG000|Overall Study|Other Reasons|5|||
145394089|NCT03934216|524296725|FG001|Overall Study|Other Reasons|5|||
145394090|NCT03934216|524296724|FG000|Overall Study|Adverse Event|22|||
145394091|NCT03934216|524296725|FG001|Overall Study|Adverse Event|11|||
145394092|NCT03934216|524296724|FG000|Overall Study|Lack of Efficacy|8|||
145394093|NCT03934216|524296725|FG001|Overall Study|Lack of Efficacy|7|||
145394094|NCT03934216|524296724|FG000|Overall Study|Lost to Follow-up|2|||
145394095|NCT03934216|524296725|FG001|Overall Study|Lost to Follow-up|0|||
145394096|NCT03934216|524296724|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145394097|NCT03934216|524296725|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145394098|NCT03934216|524296724|FG000|Overall Study|Pregnancy|1|||
145394099|NCT03934216|524296725|FG001|Overall Study|Pregnancy|0|||
145394100|NCT03934216|524296724|FG000|Overall Study|Withdrawal by Subject|18|||
145394101|NCT03934216|524296725|FG001|Overall Study|Withdrawal by Subject|6|||
145394102|NCT03934216|524296724|FG000|Overall Study|Randomized but not treated|1|||
145394103|NCT03934216|524296725|FG001|Overall Study|Randomized but not treated|1|||
145394104|NCT01053741|524296728|FG000|2nd Study Intervention|Physician Decision|0|||
145394105|NCT01053741|524296729|FG001|2nd Study Intervention|Physician Decision|1|||
145394106|NCT01396083|524296730|FG000|Overall Study|Adverse Event|2|||
145394107|NCT01396083|524296731|FG001|Overall Study|Adverse Event|28|||
145496613|NCT00774046|524675681|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
145496614|NCT05498649|524675682|FG000|Overall Study|Lost to Follow-up|1|||
145496615|NCT04607005|524675683|FG000|Overall Study|Adverse Event|0|||
145730579|NCT02464228|525532101|FG001|Overall Study|Physician Decision|0|||
145394108|NCT01396083|524296730|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145394109|NCT01396083|524296731|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145394110|NCT01396083|524296730|FG000|Overall Study|Consent withdrawn|4|||
145394111|NCT01396083|524296731|FG001|Overall Study|Consent withdrawn|5|||
145394112|NCT01396083|524296730|FG000|Overall Study|Protocol deviation(s)|0|||
145394113|NCT01396083|524296731|FG001|Overall Study|Protocol deviation(s)|1|||
145496616|NCT04607005|524675684|FG001|Overall Study|Adverse Event|1|||
145496617|NCT04607005|524675683|FG000|Overall Study|Lack of Efficacy|1|||
145496618|NCT04607005|524675684|FG001|Overall Study|Lack of Efficacy|6|||
145394114|NCT01396083|524296730|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145394115|NCT01396083|524296731|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145394116|NCT01396083|524296730|FG000|Overall Study|Administrative problems|1|||
145394117|NCT01396083|524296731|FG001|Overall Study|Administrative problems|0|||
145394118|NCT01396083|524296730|FG000|Overall Study|Lost to Follow-up|1|||
145394119|NCT01396083|524296731|FG001|Overall Study|Lost to Follow-up|0|||
145394120|NCT00619827|524296732|FG000|Overall Study|Adverse Event|1|||
145394121|NCT00619827|524296733|FG001|Overall Study|Adverse Event|2|||
145394122|NCT00619827|524296732|FG000|Overall Study|Withdrawal by Subject|2|||
145394123|NCT00619827|524296733|FG001|Overall Study|Withdrawal by Subject|2|||
145394124|NCT02806713|524296734|FG000|Overall Study|Urethral injury during procedure|1|||
145730580|NCT02464228|525532102|FG002|Overall Study|Physician Decision|1|||
145730581|NCT02464228|525532103|FG003|Overall Study|Physician Decision|0|||
145730582|NCT02464228|525532100|FG000|Overall Study|Miscellaneous|1|||
145730583|NCT02464228|525532101|FG001|Overall Study|Miscellaneous|0|||
145730584|NCT02464228|525532102|FG002|Overall Study|Miscellaneous|1|||
145730585|NCT02464228|525532103|FG003|Overall Study|Miscellaneous|0|||
145730586|NCT02464228|525532100|FG000|Overall Study|Adverse Event|9|||
145730587|NCT02464228|525532101|FG001|Overall Study|Adverse Event|0|||
145730588|NCT02464228|525532102|FG002|Overall Study|Adverse Event|3|||
145730589|NCT02464228|525532103|FG003|Overall Study|Adverse Event|0|||
145730590|NCT02464228|525532100|FG000|Overall Study|Withdrawal by Subject|1|||
145730591|NCT02464228|525532101|FG001|Overall Study|Withdrawal by Subject|1|||
145730592|NCT02464228|525532102|FG002|Overall Study|Withdrawal by Subject|1|||
145730593|NCT02464228|525532103|FG003|Overall Study|Withdrawal by Subject|0|||
145730594|NCT02464228|525532100|FG000|Overall Study|Disease Progression|22|||
145730595|NCT02464228|525532101|FG001|Overall Study|Disease Progression|12|||
145730596|NCT02464228|525532102|FG002|Overall Study|Disease Progression|5|||
145730597|NCT02464228|525532103|FG003|Overall Study|Disease Progression|2|||
145730598|NCT01117454|525532106|FG000|Overall Study|Pregnancy|0|||
145730599|NCT01117454|525532107|FG001|Overall Study|Pregnancy|1|||
145730600|NCT01637623|525532116|FG000|Overall Study|Lost to Follow-up|0|||
145730601|NCT01637623|525532117|FG001|Overall Study|Lost to Follow-up|0|||
145730602|NCT01637623|525532118|FG002|Overall Study|Lost to Follow-up|2|||
145730603|NCT01637623|525532116|FG000|Overall Study|Physician Decision|1|||
145730604|NCT01637623|525532117|FG001|Overall Study|Physician Decision|0|||
145730605|NCT01637623|525532118|FG002|Overall Study|Physician Decision|1|||
145730606|NCT00784693|525532136|FG000|Overall Study|Lost to Follow-up|0|||
145730607|NCT00784693|525532137|FG001|Overall Study|Lost to Follow-up|1|||
145730608|NCT00784693|525532136|FG000|Overall Study|Lack of Efficacy|1|||
145730609|NCT00784693|525532137|FG001|Overall Study|Lack of Efficacy|1|||
145730610|NCT00784693|525532136|FG000|Overall Study|Withdrawal by Subject|0|||
145730611|NCT00784693|525532137|FG001|Overall Study|Withdrawal by Subject|4|||
145730612|NCT00784693|525532136|FG000|Overall Study|Randomized but not Treated|1|||
145730613|NCT00784693|525532137|FG001|Overall Study|Randomized but not Treated|0|||
145730614|NCT00784693|525532136|FG000|Overall Study|Other|1|||
145730615|NCT00784693|525532137|FG001|Overall Study|Other|0|||
145730616|NCT00528866|525532138|FG000|Overall Study|Protocol Violation|6|||
145730617|NCT00993915|525532139|FG000|Overall Study|Insufficient clinical response|3|||
145730618|NCT00993915|525532139|FG000|Overall Study|Withdrawal by Subject|2|||
145730619|NCT00993915|525532139|FG000|Overall Study|Other|1|||
145730620|NCT00993915|525532139|FG000|Overall Study|Ongoing|3|||
145730621|NCT02430051|525532140|FG000|Overall Study|Withdrawal by Subject|6|||
145730622|NCT02430051|525532141|FG001|Overall Study|Withdrawal by Subject|3|||
145730623|NCT02430051|525532140|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
145730624|NCT02430051|525532141|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
145730625|NCT02430051|525532140|FG000|Overall Study|Protocol Violation|1|||
145730626|NCT02430051|525532141|FG001|Overall Study|Protocol Violation|0|||
145730627|NCT02030405|525532146|FG000|Overall Study|Withdrawal by Subject|1|||
145730628|NCT02030405|525532146|FG000|Overall Study|Lost to Follow-up|1|||
145730629|NCT00132496|525532147|FG000|Overall Study|Withdrawal by Subject|1|||
145394125|NCT02806713|524296735|FG001|Overall Study|Urethral injury during procedure|0|||
145730630|NCT00132496|525532148|FG001|Overall Study|Withdrawal by Subject|2|||
145730631|NCT00132496|525532147|FG000|Overall Study|Physician Decision|1|||
145730632|NCT00132496|525532148|FG001|Overall Study|Physician Decision|0|||
145730633|NCT04526197|525532149|FG000|Period 1|Adverse Event|0|||
145730634|NCT04526197|525532150|FG001|Period 1|Adverse Event|1|||
145730635|NCT04526197|525532149|FG000|Period 1|Withdrawal by Subject|1|||
145730636|NCT04526197|525532150|FG001|Period 1|Withdrawal by Subject|0|||
145730637|NCT04526197|525532149|FG000|Period 2|Adverse Event|0|||
145730638|NCT04526197|525532150|FG001|Period 2|Adverse Event|1|||
145394126|NCT02806713|524296734|FG000|Overall Study|cancelled surgery|1|||
145394127|NCT02806713|524296735|FG001|Overall Study|cancelled surgery|2|||
145394128|NCT00735709|524296736|FG000|Overall Study|Adverse Event|2|||
145730639|NCT04526197|525532149|FG000|Period 2|Withdrawal by Subject|0|||
145730640|NCT04526197|525532150|FG001|Period 2|Withdrawal by Subject|1|||
145730641|NCT01136811|525532151|FG000|Overall Study|Physician Decision|11|||
145496619|NCT04607005|524675683|FG000|Overall Study|Withdrawal by Subject|4|||
145496620|NCT04607005|524675684|FG001|Overall Study|Withdrawal by Subject|9|||
145496621|NCT04607005|524675683|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
145496622|NCT04607005|524675684|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
145496623|NCT00668148|524675685|FG000|Overall Study|Adverse Event|5|||
145496624|NCT00668148|524675685|FG000|Overall Study|Subject Non-compliance|1|||
145496625|NCT00668148|524675685|FG000|Overall Study|Progressive Disease Before Treatment|2|||
145496626|NCT00668148|524675685|FG000|Overall Study|Withdrawal of Consent|2|||
145496627|NCT00781768|524677379|FG000|Overall Study|Not transplanted.|0|||
145496628|NCT00781768|524677380|FG001|Overall Study|Not transplanted.|2|||
145496629|NCT02892344|524677383|FG000|Overall Study|Protocol deviation|3|||
145496630|NCT02892344|524677384|FG001|Overall Study|Protocol deviation|4|||
145496631|NCT02892344|524677383|FG000|Overall Study|Adverse Event|1|||
145496632|NCT02892344|524677384|FG001|Overall Study|Adverse Event|8|||
145496633|NCT02892344|524677383|FG000|Overall Study|Lost to Follow-up|0|||
145496634|NCT02892344|524677384|FG001|Overall Study|Lost to Follow-up|1|||
145496635|NCT02892344|524677383|FG000|Overall Study|Non-compliance with study treatment|0|||
145496636|NCT02892344|524677384|FG001|Overall Study|Non-compliance with study treatment|1|||
145496637|NCT02892344|524677383|FG000|Overall Study|Physician Decision|0|||
145496638|NCT02892344|524677384|FG001|Overall Study|Physician Decision|2|||
145496639|NCT02892344|524677383|FG000|Overall Study|Subject/guardian decision|0|||
145496640|NCT02892344|524677384|FG001|Overall Study|Subject/guardian decision|4|||
145496641|NCT02892344|524677383|FG000|Overall Study|Technical problems|0|||
145496642|NCT02892344|524677384|FG001|Overall Study|Technical problems|1|||
145496643|NCT04944992|524677385|FG000|Overall Study|Lost to Follow-up|1|||
145394129|NCT00735709|524296737|FG001|Overall Study|Adverse Event|3|||
145394130|NCT00735709|524296738|FG002|Overall Study|Adverse Event|1|||
145394131|NCT00735709|524296739|FG003|Overall Study|Adverse Event|5|||
145394132|NCT00735709|524296736|FG000|Overall Study|Lack of Efficacy|8|||
145394133|NCT00735709|524296737|FG001|Overall Study|Lack of Efficacy|4|||
145394134|NCT00735709|524296738|FG002|Overall Study|Lack of Efficacy|2|||
145394135|NCT00735709|524296739|FG003|Overall Study|Lack of Efficacy|3|||
145394136|NCT00735709|524296736|FG000|Overall Study|Noncompliance|0|||
145394137|NCT00735709|524296737|FG001|Overall Study|Noncompliance|0|||
145394138|NCT00735709|524296738|FG002|Overall Study|Noncompliance|1|||
145394139|NCT00735709|524296739|FG003|Overall Study|Noncompliance|0|||
145394140|NCT00735709|524296736|FG000|Overall Study|Protocol deviations|1|||
145394141|NCT00735709|524296737|FG001|Overall Study|Protocol deviations|2|||
145394142|NCT00735709|524296738|FG002|Overall Study|Protocol deviations|1|||
145394143|NCT00735709|524296739|FG003|Overall Study|Protocol deviations|1|||
145394144|NCT00735709|524296736|FG000|Overall Study|Voluntary Withdrawal|1|||
145394145|NCT00735709|524296737|FG001|Overall Study|Voluntary Withdrawal|3|||
145394146|NCT00735709|524296738|FG002|Overall Study|Voluntary Withdrawal|5|||
145394147|NCT00735709|524296739|FG003|Overall Study|Voluntary Withdrawal|7|||
145394148|NCT00735709|524296736|FG000|Overall Study|Lost to Follow-up|0|||
145394149|NCT00735709|524296737|FG001|Overall Study|Lost to Follow-up|1|||
145394150|NCT00735709|524296738|FG002|Overall Study|Lost to Follow-up|1|||
145394151|NCT00735709|524296739|FG003|Overall Study|Lost to Follow-up|1|||
145394152|NCT00735709|524296736|FG000|Overall Study|Excluded medication|1|||
145394153|NCT00735709|524296737|FG001|Overall Study|Excluded medication|0|||
145394154|NCT00735709|524296738|FG002|Overall Study|Excluded medication|0|||
145394155|NCT00735709|524296739|FG003|Overall Study|Excluded medication|1|||
145394156|NCT00521365|524296759|FG000|Overall Study|Adverse Event|3|||
145394157|NCT00521365|524296759|FG000|Overall Study|Lost to Follow-up|6|||
145394158|NCT00521365|524296759|FG000|Overall Study|Protocol deviation|2|||
145394159|NCT00521365|524296759|FG000|Overall Study|Drug compliance|3|||
145394160|NCT00521365|524296759|FG000|Overall Study|Usage of not allowed drugs|6|||
145394161|NCT03150082|524296760|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
145394162|NCT03150082|524296761|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
145394163|NCT01158261|524296762|FG000|Overall Study|Lost to Follow-up|9|||
145394164|NCT01158261|524296762|FG000|Overall Study|Death|7|||
145394165|NCT01158261|524296762|FG000|Overall Study|Withdrawal by Subject|1|||
145394166|NCT02899065|524296765|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
145394167|NCT02899065|524296766|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
145394168|NCT02899065|524296765|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
145394169|NCT02899065|524296766|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
145394170|NCT02899065|524296765|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
145394171|NCT02899065|524296766|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
145496644|NCT04944992|524677386|FG001|Overall Study|Lost to Follow-up|1|||
145496645|NCT04944992|524677385|FG000|Overall Study|Physician Decision|1|||
145496646|NCT04944992|524677386|FG001|Overall Study|Physician Decision|0|||
145394172|NCT00971867|524296767|FG000|Overall Study|Adverse Event|4|||
145394173|NCT00971867|524296767|FG000|Overall Study|Participant Withdrew Consent|1|||
145394174|NCT00971867|524296767|FG000|Overall Study|Disease Progression|6|||
145394175|NCT02983045|524296769|FG000|Overall Study|Withdrawal by Subject|0|||
145394176|NCT02983045|524296770|FG001|Overall Study|Withdrawal by Subject|1|||
145394177|NCT02983045|524296771|FG002|Overall Study|Withdrawal by Subject|0|||
145394178|NCT02983045|524296772|FG003|Overall Study|Withdrawal by Subject|5|||
145394179|NCT02983045|524296773|FG004|Overall Study|Withdrawal by Subject|0|||
145394180|NCT02983045|524296774|FG005|Overall Study|Withdrawal by Subject|72|||
145394181|NCT02983045|524296775|FG006|Overall Study|Withdrawal by Subject|0|||
145394182|NCT02983045|524296776|FG007|Overall Study|Withdrawal by Subject|0|||
145394183|NCT02983045|524296777|FG008|Overall Study|Withdrawal by Subject|0|||
145394184|NCT02983045|524296778|FG009|Overall Study|Withdrawal by Subject|2|||
145496647|NCT04944992|524677385|FG000|Overall Study|Withdrawal by Subject|6|||
145496648|NCT04944992|524677386|FG001|Overall Study|Withdrawal by Subject|1|||
145496649|NCT01295814|524677387|FG000|Overall Study|Lack of Efficacy|0|||
145496650|NCT01295814|524677388|FG001|Overall Study|Lack of Efficacy|2|||
145496651|NCT01295814|524677387|FG000|Overall Study|Withdrawal by Subject|2|||
145730642|NCT00372385|525532152|FG000|Overall Study|Adverse Event|6|||
145730643|NCT00372385|525532153|FG001|Overall Study|Adverse Event|11|||
145730644|NCT00372385|525532154|FG002|Overall Study|Adverse Event|9|||
145730645|NCT00372385|525532155|FG003|Overall Study|Adverse Event|7|||
145730646|NCT00372385|525532152|FG000|Overall Study|Noncompliance|0|||
145730647|NCT00372385|525532153|FG001|Overall Study|Noncompliance|1|||
145730648|NCT00372385|525532154|FG002|Overall Study|Noncompliance|1|||
145730649|NCT00372385|525532155|FG003|Overall Study|Noncompliance|1|||
145730650|NCT00372385|525532152|FG000|Overall Study|Physician Decision|1|||
145730651|NCT00372385|525532153|FG001|Overall Study|Physician Decision|0|||
145730652|NCT00372385|525532154|FG002|Overall Study|Physician Decision|0|||
145730653|NCT00372385|525532155|FG003|Overall Study|Physician Decision|0|||
145730654|NCT00372385|525532152|FG000|Overall Study|Lost to Follow-up|2|||
145730655|NCT00372385|525532153|FG001|Overall Study|Lost to Follow-up|0|||
145730656|NCT00372385|525532154|FG002|Overall Study|Lost to Follow-up|0|||
145730657|NCT00372385|525532155|FG003|Overall Study|Lost to Follow-up|0|||
145730658|NCT00372385|525532152|FG000|Overall Study|Withdrawal by Subject|2|||
145730659|NCT00372385|525532153|FG001|Overall Study|Withdrawal by Subject|1|||
145730660|NCT00372385|525532154|FG002|Overall Study|Withdrawal by Subject|0|||
145730661|NCT00372385|525532155|FG003|Overall Study|Withdrawal by Subject|0|||
145394185|NCT02983045|524296769|FG000|Overall Study|Lost to Follow-up|0|||
145394186|NCT02983045|524296770|FG001|Overall Study|Lost to Follow-up|0|||
145394187|NCT02983045|524296771|FG002|Overall Study|Lost to Follow-up|0|||
145394188|NCT02983045|524296772|FG003|Overall Study|Lost to Follow-up|0|||
145394189|NCT02983045|524296773|FG004|Overall Study|Lost to Follow-up|0|||
145394190|NCT02983045|524296774|FG005|Overall Study|Lost to Follow-up|10|||
145394191|NCT02983045|524296775|FG006|Overall Study|Lost to Follow-up|0|||
145394192|NCT02983045|524296776|FG007|Overall Study|Lost to Follow-up|0|||
145394193|NCT02983045|524296777|FG008|Overall Study|Lost to Follow-up|0|||
145394194|NCT02983045|524296778|FG009|Overall Study|Lost to Follow-up|0|||
145394195|NCT00905424|524296779|FG000|Overall Study|Lost to Follow-up|3|||
145394196|NCT00905424|524296780|FG001|Overall Study|Lost to Follow-up|3|||
145394197|NCT00905424|524296779|FG000|Overall Study|Withdrawal by Subject|1|||
145394198|NCT00905424|524296780|FG001|Overall Study|Withdrawal by Subject|2|||
145394199|NCT00905424|524296779|FG000|Overall Study|Adverse Event|4|||
145394200|NCT00905424|524296780|FG001|Overall Study|Adverse Event|2|||
145394201|NCT00905424|524296779|FG000|Overall Study|Non-compliance with study medication|2|||
145394202|NCT00905424|524296780|FG001|Overall Study|Non-compliance with study medication|0|||
145394203|NCT00905424|524296779|FG000|Overall Study|Sponsor decision|1|||
145394204|NCT00905424|524296780|FG001|Overall Study|Sponsor decision|0|||
145394205|NCT00905424|524296779|FG000|Overall Study|Positive urine drug screen|0|||
145394206|NCT00905424|524296780|FG001|Overall Study|Positive urine drug screen|1|||
145394207|NCT00905424|524296779|FG000|Overall Study|Non-adherence to visit schedule|0|||
145394208|NCT00905424|524296780|FG001|Overall Study|Non-adherence to visit schedule|1|||
145394209|NCT00379899|524296783|FG000|Overall Study|Adverse Event|7|||
145394210|NCT00379899|524296784|FG001|Overall Study|Adverse Event|3|||
145394211|NCT00379899|524296783|FG000|Overall Study|Death|10|||
145394212|NCT00379899|524296784|FG001|Overall Study|Death|10|||
145394213|NCT00379899|524296783|FG000|Overall Study|Lost to Follow-up|2|||
145394214|NCT00379899|524296784|FG001|Overall Study|Lost to Follow-up|4|||
145394215|NCT00379899|524296783|FG000|Overall Study|Physician Decision|3|||
145394216|NCT00379899|524296784|FG001|Overall Study|Physician Decision|4|||
145394217|NCT00379899|524296783|FG000|Overall Study|Withdrawal by Subject|5|||
145394218|NCT00379899|524296784|FG001|Overall Study|Withdrawal by Subject|5|||
145394219|NCT00379899|524296783|FG000|Overall Study|Ineligibility determined|0|||
145394220|NCT00379899|524296784|FG001|Overall Study|Ineligibility determined|1|||
145394221|NCT00379899|524296783|FG000|Overall Study|Noncompliance|1|||
145394222|NCT00379899|524296784|FG001|Overall Study|Noncompliance|1|||
145394223|NCT00379899|524296783|FG000|Overall Study|Parathyroidectomy|0|||
145394224|NCT00379899|524296784|FG001|Overall Study|Parathyroidectomy|2|||
145394225|NCT00379899|524296783|FG000|Overall Study|Renal transplantation|5|||
145394226|NCT00379899|524296784|FG001|Overall Study|Renal transplantation|4|||
145394227|NCT00379899|524296783|FG000|Overall Study|Coronary artery bypass graft|1|||
145730662|NCT00372385|525532152|FG000|Overall Study|Refusal of Treatment|3|||
145730663|NCT00372385|525532153|FG001|Overall Study|Refusal of Treatment|6|||
145730664|NCT00372385|525532154|FG002|Overall Study|Refusal of Treatment|0|||
145730665|NCT00372385|525532155|FG003|Overall Study|Refusal of Treatment|0|||
145730666|NCT00372385|525532152|FG000|Overall Study|No Response|1|||
145730667|NCT00372385|525532153|FG001|Overall Study|No Response|1|||
145730668|NCT00372385|525532154|FG002|Overall Study|No Response|0|||
145730669|NCT00372385|525532155|FG003|Overall Study|No Response|0|||
145730670|NCT00372385|525532152|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
145394228|NCT00379899|524296784|FG001|Overall Study|Coronary artery bypass graft|1|||
145394229|NCT00379899|524296783|FG000|Overall Study|Other protocol-specified criteria|3|||
145394230|NCT00379899|524296784|FG001|Overall Study|Other protocol-specified criteria|4|||
145394231|NCT00379899|524296783|FG000|Overall Study|Other|3|||
145394232|NCT00379899|524296784|FG001|Overall Study|Other|1|||
145394233|NCT01922258|524296785|FG000|Overall Study|Lost to Follow-up|1|||
145394234|NCT01922258|524296786|FG001|Overall Study|Lost to Follow-up|1|||
145394235|NCT01922258|524296785|FG000|Overall Study|Adverse Event|9|||
145394236|NCT01922258|524296786|FG001|Overall Study|Adverse Event|2|||
145394237|NCT01922258|524296785|FG000|Overall Study|Met Withdrawal Criteria|0|||
145605947|NCT00787319|525073048|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
145730671|NCT00372385|525532153|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
145730672|NCT00372385|525532154|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
145730673|NCT00372385|525532155|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
145730674|NCT00372385|525532152|FG000|Overall Study|Virologic Stopping Rule|17|||
145730675|NCT00372385|525532153|FG001|Overall Study|Virologic Stopping Rule|0|||
145730676|NCT00372385|525532154|FG002|Overall Study|Virologic Stopping Rule|0|||
145730677|NCT00372385|525532155|FG003|Overall Study|Virologic Stopping Rule|0|||
145730678|NCT02973048|525532157|FG000|Overall Study|Epidural catheter insertion failure|1|||
145730679|NCT02973048|525532158|FG001|Overall Study|Epidural catheter insertion failure|0|||
145730680|NCT02973048|525532157|FG000|Overall Study|Withdrawal by Subject|0|||
145730681|NCT02973048|525532158|FG001|Overall Study|Withdrawal by Subject|3|||
145730682|NCT01906346|525532162|FG000|Overall Study|AEs|1|||
145730683|NCT00364156|525532165|FG000|Overall Study|Withdrawal by Subject|73|||
145730684|NCT00364156|525532166|FG001|Overall Study|Withdrawal by Subject|80|||
145730685|NCT00364156|525532165|FG000|Overall Study|Protocol Violation|6|||
145730686|NCT00364156|525532166|FG001|Overall Study|Protocol Violation|1|||
145730687|NCT02511678|525532167|FG000|Overall Study|Withdrawal by Subject|2|||
145730688|NCT02511678|525532167|FG000|Overall Study|Lost to Follow-up|4|||
145730689|NCT02511678|525532167|FG000|Overall Study|Death|19|||
145730690|NCT02511678|525532167|FG000|Overall Study|Adverse Event|1|||
145730691|NCT02511678|525532167|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
145730692|NCT02511678|525532167|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
145730693|NCT02511678|525532167|FG000|Overall Study|Required Radiofrequency Ablation|1|||
145730694|NCT02511678|525532167|FG000|Overall Study|Biopsy was Negative|1|||
145730695|NCT02511678|525532167|FG000|Overall Study|Protocol Violation|1|||
145730696|NCT02511678|525532167|FG000|Overall Study|Received Radiation Treatment|1|||
145730697|NCT02730598|525532173|FG000|Overall Study|Withdrawal by Subject|3|||
145730698|NCT02730598|525532174|FG001|Overall Study|Withdrawal by Subject|3|||
145730699|NCT02730598|525532173|FG000|Overall Study|Protocol Violation|0|||
145730700|NCT02730598|525532174|FG001|Overall Study|Protocol Violation|1|||
145730701|NCT02730598|525532173|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
145730702|NCT02730598|525532174|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
145730703|NCT03049735|525532179|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
145730704|NCT03049735|525532180|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
145730705|NCT03049735|525532181|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
145730706|NCT03049735|525532179|FG000|Overall Study|Other|5|||
145730707|NCT03049735|525532180|FG001|Overall Study|Other|3|||
145730708|NCT03049735|525532181|FG002|Overall Study|Other|1|||
145730709|NCT03049735|525532179|FG000|Overall Study|Lack of Efficacy|4|||
145730710|NCT03049735|525532180|FG001|Overall Study|Lack of Efficacy|0|||
145730711|NCT03049735|525532181|FG002|Overall Study|Lack of Efficacy|3|||
145730712|NCT03049735|525532179|FG000|Overall Study|Protocol deviation|1|||
145730713|NCT03049735|525532180|FG001|Overall Study|Protocol deviation|0|||
145730714|NCT03049735|525532181|FG002|Overall Study|Protocol deviation|0|||
145730715|NCT03049735|525532179|FG000|Overall Study|Pregnancy|0|||
145730716|NCT03049735|525532180|FG001|Overall Study|Pregnancy|0|||
145730717|NCT03049735|525532181|FG002|Overall Study|Pregnancy|1|||
145730718|NCT03049735|525532179|FG000|Overall Study|Adverse Event|7|||
145730719|NCT03049735|525532180|FG001|Overall Study|Adverse Event|18|||
145730720|NCT03049735|525532181|FG002|Overall Study|Adverse Event|5|||
145730721|NCT03049735|525532179|FG000|Overall Study|Withdrawal by Subject|10|||
145394238|NCT01922258|524296786|FG001|Overall Study|Met Withdrawal Criteria|4|||
145394239|NCT01922258|524296785|FG000|Overall Study|Withdrawn by the Investigator|1|||
145394240|NCT01922258|524296786|FG001|Overall Study|Withdrawn by the Investigator|4|||
145394241|NCT01922258|524296785|FG000|Overall Study|Withdrawal by participant|5|||
145394242|NCT01922258|524296786|FG001|Overall Study|Withdrawal by participant|5|||
145394243|NCT05225389|524296787|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
145394244|NCT01585246|524296788|FG000|Overall Study|Lost to Follow-up|0|||
145266646|NCT04668066|523825237|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266647|NCT04668066|523825238|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266648|NCT04668066|523825239|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145394245|NCT01585246|524296789|FG001|Overall Study|Lost to Follow-up|0|||
145394246|NCT01585246|524296790|FG002|Overall Study|Lost to Follow-up|2|||
145394247|NCT01585246|524296791|FG003|Overall Study|Lost to Follow-up|1|||
145266649|NCT04668066|523825240|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145394248|NCT01585246|524296792|FG004|Overall Study|Lost to Follow-up|0|||
145730722|NCT03049735|525532180|FG001|Overall Study|Withdrawal by Subject|3|||
145730723|NCT03049735|525532181|FG002|Overall Study|Withdrawal by Subject|7|||
145730724|NCT03049735|525532179|FG000|Overall Study|Lost to Follow-up|1|||
145730725|NCT03049735|525532180|FG001|Overall Study|Lost to Follow-up|5|||
145730726|NCT03049735|525532181|FG002|Overall Study|Lost to Follow-up|5|||
145730727|NCT02146326|525532182|FG000|Overall Study|Lost to Follow-up|3|||
145730728|NCT02146326|525532183|FG001|Overall Study|Lost to Follow-up|3|||
145730729|NCT02146326|525532184|FG002|Overall Study|Lost to Follow-up|11|||
145730730|NCT02146326|525532185|FG003|Overall Study|Lost to Follow-up|19|||
145730731|NCT02146326|525532182|FG000|Overall Study|Withdrawal by Subject|2|||
145730732|NCT02146326|525532183|FG001|Overall Study|Withdrawal by Subject|1|||
145730733|NCT02146326|525532184|FG002|Overall Study|Withdrawal by Subject|15|||
145730734|NCT02146326|525532185|FG003|Overall Study|Withdrawal by Subject|11|||
145730735|NCT02146326|525532182|FG000|Overall Study|Separated from mental health center|23|||
145730736|NCT02146326|525532183|FG001|Overall Study|Separated from mental health center|33|||
145730737|NCT02146326|525532184|FG002|Overall Study|Separated from mental health center|0|||
145730738|NCT02146326|525532185|FG003|Overall Study|Separated from mental health center|0|||
145730739|NCT02146326|525532182|FG000|Overall Study|Incarcerated|0|||
145730740|NCT02146326|525532183|FG001|Overall Study|Incarcerated|0|||
145730741|NCT02146326|525532184|FG002|Overall Study|Incarcerated|3|||
145730742|NCT02146326|525532185|FG003|Overall Study|Incarcerated|8|||
145730743|NCT02146326|525532182|FG000|Overall Study|Death|0|||
145730744|NCT02146326|525532183|FG001|Overall Study|Death|0|||
145730745|NCT02146326|525532184|FG002|Overall Study|Death|4|||
145730746|NCT02146326|525532185|FG003|Overall Study|Death|4|||
145730747|NCT02146326|525532182|FG000|Overall Study|Unable to complete interview|0|||
145730748|NCT02146326|525532183|FG001|Overall Study|Unable to complete interview|0|||
145730749|NCT02146326|525532184|FG002|Overall Study|Unable to complete interview|10|||
145730750|NCT02146326|525532185|FG003|Overall Study|Unable to complete interview|6|||
145730751|NCT03153111|525532186|FG000|Overall Study|Death|2|||
145730752|NCT03153111|525532187|FG001|Overall Study|Death|5|||
145730753|NCT03153111|525532186|FG000|Overall Study|Lost to Follow-up|1|||
145730754|NCT03153111|525532187|FG001|Overall Study|Lost to Follow-up|0|||
145730755|NCT03153111|525532186|FG000|Overall Study|Physician Decision|5|||
145730756|NCT03153111|525532187|FG001|Overall Study|Physician Decision|1|||
145730757|NCT03153111|525532186|FG000|Overall Study|Withdrawal by Subject|3|||
145730758|NCT03153111|525532187|FG001|Overall Study|Withdrawal by Subject|3|||
145730759|NCT01079130|525532190|FG000|Overall Study|Adverse Event|1|||
145730760|NCT01079130|525532191|FG001|Overall Study|Adverse Event|1|||
145730761|NCT01079130|525532192|FG002|Overall Study|Adverse Event|0|||
145730762|NCT01079130|525532193|FG003|Overall Study|Adverse Event|1|||
145730763|NCT01079130|525532194|FG004|Overall Study|Adverse Event|5|||
145730764|NCT01079130|525532195|FG005|Overall Study|Adverse Event|1|||
145730765|NCT01079130|525532190|FG000|Overall Study|Administrative problems|1|||
145730766|NCT01079130|525532191|FG001|Overall Study|Administrative problems|3|||
145730767|NCT01079130|525532192|FG002|Overall Study|Administrative problems|0|||
145730768|NCT01079130|525532193|FG003|Overall Study|Administrative problems|0|||
145730769|NCT01079130|525532194|FG004|Overall Study|Administrative problems|0|||
145730770|NCT01079130|525532195|FG005|Overall Study|Administrative problems|1|||
145730771|NCT01079130|525532190|FG000|Overall Study|Withdrawal by Subject|0|||
145730772|NCT01079130|525532191|FG001|Overall Study|Withdrawal by Subject|1|||
145730773|NCT01079130|525532192|FG002|Overall Study|Withdrawal by Subject|0|||
145730774|NCT01079130|525532193|FG003|Overall Study|Withdrawal by Subject|0|||
145730775|NCT01079130|525532194|FG004|Overall Study|Withdrawal by Subject|1|||
145730776|NCT01079130|525532195|FG005|Overall Study|Withdrawal by Subject|3|||
145730777|NCT01079130|525532190|FG000|Overall Study|Protocol deviation|0|||
145730778|NCT01079130|525532191|FG001|Overall Study|Protocol deviation|2|||
145730779|NCT01079130|525532192|FG002|Overall Study|Protocol deviation|1|||
145730780|NCT01079130|525532193|FG003|Overall Study|Protocol deviation|2|||
145730781|NCT01079130|525532194|FG004|Overall Study|Protocol deviation|0|||
145730782|NCT01079130|525532195|FG005|Overall Study|Protocol deviation|0|||
145730783|NCT01079130|525532190|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145730784|NCT01079130|525532191|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145730785|NCT01079130|525532192|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145730786|NCT01079130|525532193|FG003|Overall Study|Abnormal test procedure result(s)|0|||
145730787|NCT01079130|525532194|FG004|Overall Study|Abnormal test procedure result(s)|1|||
145730788|NCT01079130|525532195|FG005|Overall Study|Abnormal test procedure result(s)|0|||
145730789|NCT01079130|525532190|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145730790|NCT01079130|525532191|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145730791|NCT01079130|525532192|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145730792|NCT01079130|525532193|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
145730793|NCT01079130|525532194|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
145730794|NCT01079130|525532195|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
145730795|NCT01079130|525532190|FG000|Overall Study|Lost to Follow-up|0|||
145730796|NCT01079130|525532191|FG001|Overall Study|Lost to Follow-up|0|||
145730797|NCT01079130|525532192|FG002|Overall Study|Lost to Follow-up|0|||
145730798|NCT01079130|525532193|FG003|Overall Study|Lost to Follow-up|0|||
145394249|NCT01585246|524296788|FG000|Overall Study|Protocol Violation|0|||
145605948|NCT00787319|525073048|FG000|Overall Study|No health insurance reimbursement|2|||
145394250|NCT01585246|524296789|FG001|Overall Study|Protocol Violation|0|||
145394251|NCT01585246|524296790|FG002|Overall Study|Protocol Violation|0|||
145394252|NCT01585246|524296791|FG003|Overall Study|Protocol Violation|0|||
145394253|NCT01585246|524296792|FG004|Overall Study|Protocol Violation|1|||
145394254|NCT01585246|524296788|FG000|Overall Study|Withdrawal by Subject|0|||
145394255|NCT01585246|524296789|FG001|Overall Study|Withdrawal by Subject|0|||
145394256|NCT01585246|524296790|FG002|Overall Study|Withdrawal by Subject|1|||
145394257|NCT01585246|524296791|FG003|Overall Study|Withdrawal by Subject|2|||
145394258|NCT01585246|524296792|FG004|Overall Study|Withdrawal by Subject|1|||
145394259|NCT01585246|524296788|FG000|Overall Study|Other|0|||
145394260|NCT01585246|524296789|FG001|Overall Study|Other|1|||
145394261|NCT01585246|524296790|FG002|Overall Study|Other|1|||
145394262|NCT01585246|524296791|FG003|Overall Study|Other|1|||
145394263|NCT01585246|524296792|FG004|Overall Study|Other|0|||
145394264|NCT04552132|524296793|FG000|Overall Study|Lost to Follow-up|4|||
145394265|NCT04552132|524296794|FG001|Overall Study|Lost to Follow-up|3|||
145394266|NCT04552132|524296793|FG000|Overall Study|Protocol Violation|1|||
145605949|NCT00787319|525073048|FG000|Overall Study|Stabilized disease findings|3|||
145394267|NCT04552132|524296794|FG001|Overall Study|Protocol Violation|0|||
145394268|NCT01657162|524296795|FG000|Overall Study|Adverse Event|26|||
145394269|NCT01657162|524296796|FG001|Overall Study|Adverse Event|36|||
145394270|NCT01657162|524296795|FG000|Overall Study|Withdrawal by Subject|13|||
145394271|NCT01657162|524296796|FG001|Overall Study|Withdrawal by Subject|13|||
145394272|NCT01657162|524296795|FG000|Overall Study|Continuing Significant Deterioration|9|||
145394273|NCT01657162|524296796|FG001|Overall Study|Continuing Significant Deterioration|3|||
145394274|NCT01657162|524296795|FG000|Overall Study|Refusal of Treatment|4|||
145394275|NCT01657162|524296796|FG001|Overall Study|Refusal of Treatment|6|||
145394276|NCT01657162|524296795|FG000|Overall Study|Lost to Follow-up|3|||
145394277|NCT01657162|524296796|FG001|Overall Study|Lost to Follow-up|4|||
145394278|NCT01657162|524296795|FG000|Overall Study|Death|2|||
145394279|NCT01657162|524296796|FG001|Overall Study|Death|3|||
145394280|NCT01657162|524296795|FG000|Overall Study|Inability to Complete Study Procedures|1|||
145394281|NCT01657162|524296796|FG001|Overall Study|Inability to Complete Study Procedures|7|||
145394282|NCT01657162|524296795|FG000|Overall Study|Protocol Violation|1|||
145394283|NCT01657162|524296796|FG001|Overall Study|Protocol Violation|0|||
145394284|NCT01657162|524296795|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
145394285|NCT01657162|524296796|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
145394286|NCT01657162|524296795|FG000|Overall Study|Other than Specified|0|||
145394287|NCT01657162|524296796|FG001|Overall Study|Other than Specified|2|||
145394288|NCT01598610|524296799|FG000|Overall Study|Adverse Event|1|||
145394289|NCT03360019|524296800|FG000|Overall Study|Withdrawal by Subject|2|||
145394290|NCT03360019|524296801|FG001|Overall Study|Withdrawal by Subject|0|||
145394291|NCT03360019|524296802|FG002|Overall Study|Withdrawal by Subject|0|||
145394292|NCT03360019|524296800|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
145394293|NCT03360019|524296801|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
145394294|NCT03360019|524296802|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
145496652|NCT01295814|524677388|FG001|Overall Study|Withdrawal by Subject|0|||
145730799|NCT01079130|525532194|FG004|Overall Study|Lost to Follow-up|1|||
145730800|NCT01079130|525532195|FG005|Overall Study|Lost to Follow-up|0|||
145730801|NCT01853982|525532196|FG000|Overall Study|Withdrawal by Subject|1|||
145730802|NCT01853982|525532197|FG001|Overall Study|Withdrawal by Subject|0|||
145730803|NCT01853982|525532196|FG000|Overall Study|Death|1|||
145730804|NCT01853982|525532197|FG001|Overall Study|Death|0|||
145730805|NCT01853982|525532196|FG000|Overall Study|Lost to Follow-up|0|||
145730806|NCT01853982|525532197|FG001|Overall Study|Lost to Follow-up|1|||
145730807|NCT00390910|525532198|FG000|Overall Study|Adverse Event|1|||
145730808|NCT00390910|525532199|FG001|Overall Study|Adverse Event|0|||
145730809|NCT00390910|525532200|FG002|Overall Study|Adverse Event|0|||
145496653|NCT00303069|524677389|FG000|Overall Study|Lost to Follow-up|1|||
145496654|NCT00303069|524677390|FG001|Overall Study|Lost to Follow-up|0|||
145496655|NCT00303069|524677391|FG002|Overall Study|Lost to Follow-up|0|||
145496656|NCT00303069|524677392|FG003|Overall Study|Lost to Follow-up|2|||
145496657|NCT00303069|524677389|FG000|Overall Study|subject moved|1|||
145496658|NCT00303069|524677390|FG001|Overall Study|subject moved|0|||
145496659|NCT00303069|524677391|FG002|Overall Study|subject moved|0|||
145496660|NCT00303069|524677392|FG003|Overall Study|subject moved|0|||
145496661|NCT00303069|524677389|FG000|Overall Study|Recruitment into Army Reserves|0|||
145496662|NCT00303069|524677390|FG001|Overall Study|Recruitment into Army Reserves|0|||
145496663|NCT00303069|524677391|FG002|Overall Study|Recruitment into Army Reserves|1|||
145496664|NCT00303069|524677392|FG003|Overall Study|Recruitment into Army Reserves|0|||
145496665|NCT01972217|524677395|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
145496666|NCT01972217|524677396|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
145496667|NCT01972217|524677397|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
145496668|NCT01972217|524677398|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
145496669|NCT01972217|524677395|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
145730810|NCT00390910|525532198|FG000|Overall Study|Lost to Follow-up|0|||
145730811|NCT00390910|525532199|FG001|Overall Study|Lost to Follow-up|1|||
145730812|NCT00390910|525532200|FG002|Overall Study|Lost to Follow-up|5|||
145730813|NCT00390910|525532198|FG000|Overall Study|Withdrawal by Subject|1|||
145496670|NCT01972217|524677396|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
145496671|NCT01972217|524677397|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
145605950|NCT00787319|525073048|FG000|Overall Study|Inactive disease|5|||
145730814|NCT00390910|525532199|FG001|Overall Study|Withdrawal by Subject|3|||
145730815|NCT00390910|525532200|FG002|Overall Study|Withdrawal by Subject|2|||
145730816|NCT00390910|525532198|FG000|Overall Study|Migrated/moved from study area|0|||
145730817|NCT00390910|525532199|FG001|Overall Study|Migrated/moved from study area|0|||
145730818|NCT00390910|525532200|FG002|Overall Study|Migrated/moved from study area|3|||
145730819|NCT01839487|525532201|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
145730820|NCT01839487|525532202|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
145730821|NCT01839487|525532203|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
145730822|NCT01839487|525532204|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
145730823|NCT01839487|525532205|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
145730824|NCT01839487|525532206|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
145730825|NCT01839487|525532201|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
145730826|NCT01839487|525532202|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
145730827|NCT01839487|525532203|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
145730828|NCT01839487|525532204|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
145730829|NCT01839487|525532205|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
145730830|NCT01839487|525532206|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
145730831|NCT01839487|525532201|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
145730832|NCT01839487|525532202|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
145730833|NCT01839487|525532203|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
145730834|NCT01839487|525532204|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
145730835|NCT01839487|525532205|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
145730836|NCT01839487|525532206|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
145730837|NCT01839487|525532201|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
145394295|NCT01691378|524296805|FG000|Overall Study|Withdrawal by Subject|2|||
145394296|NCT01691378|524296806|FG001|Overall Study|Withdrawal by Subject|0|||
145394297|NCT01691378|524296805|FG000|Overall Study|Lost to Follow-up|5|||
145394298|NCT01691378|524296806|FG001|Overall Study|Lost to Follow-up|2|||
145394299|NCT02329327|524296811|FG000|Overall Study|Death|78|||
145394300|NCT02329327|524296812|FG001|Overall Study|Death|0|||
145394301|NCT02329327|524296811|FG000|Overall Study|Withdrawal by Subject|3|||
145730838|NCT01839487|525532202|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
145730839|NCT01839487|525532203|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
145730840|NCT01839487|525532204|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
145730841|NCT01839487|525532205|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
145730842|NCT01839487|525532206|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
145730843|NCT01839487|525532201|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
145730844|NCT01839487|525532202|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
145730845|NCT01839487|525532203|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
145730846|NCT01839487|525532204|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
145730847|NCT01839487|525532205|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
145730848|NCT01839487|525532206|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
145730849|NCT01839487|525532201|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
145730850|NCT01839487|525532202|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
145730851|NCT01839487|525532203|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
145730852|NCT01839487|525532204|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
145730853|NCT01839487|525532205|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
145730854|NCT01839487|525532206|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
145730855|NCT01839487|525532201|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
145730856|NCT01839487|525532202|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
145730857|NCT01839487|525532203|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
145730858|NCT01839487|525532204|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
145730859|NCT01839487|525532205|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
145730860|NCT01839487|525532206|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
145730861|NCT01839487|525532201|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
145730862|NCT01839487|525532202|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
145730863|NCT01839487|525532203|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
145730864|NCT01839487|525532204|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
145730865|NCT01839487|525532205|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
145730866|NCT01839487|525532206|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
145730867|NCT01839487|525532201|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
145730868|NCT01839487|525532202|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
145730869|NCT01839487|525532203|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
145730870|NCT01839487|525532204|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
145730871|NCT01839487|525532205|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
145730872|NCT01839487|525532206|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
145730873|NCT01658826|525532212|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
145730874|NCT01658826|525532213|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
145730875|NCT01658826|525532212|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
145730876|NCT01658826|525532213|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
145730877|NCT01658826|525532212|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
145730878|NCT01658826|525532213|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
145730879|NCT01658826|525532212|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
145730880|NCT01658826|525532213|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
145730881|NCT01658826|525532212|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
145730882|NCT01658826|525532213|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
145730883|NCT01658826|525532212|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
145730884|NCT01658826|525532213|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
145730885|NCT01658826|525532212|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
145730886|NCT01658826|525532213|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
145730887|NCT01658826|525532212|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
145730888|NCT01658826|525532213|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
145730889|NCT01658826|525532212|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
145730890|NCT01658826|525532213|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
145730891|NCT01422850|525532217|FG000|Overall Study|Physician Decision|3|||
145730892|NCT04484831|525532218|FG000|Overall Study|Withdrawal by Subject|1|||
145730893|NCT04484831|525532219|FG001|Overall Study|Withdrawal by Subject|0|||
145394302|NCT02329327|524296812|FG001|Overall Study|Withdrawal by Subject|0|||
145730894|NCT02244996|525532220|FG000|Overall Study|Lack of Efficacy|2|||
145730895|NCT02244996|525532221|FG001|Overall Study|Lack of Efficacy|6|||
145730896|NCT00174265|525532222|FG000|Overall Study|Adverse Event|7|||
145730897|NCT00174265|525532223|FG001|Overall Study|Adverse Event|4|||
145730898|NCT00174265|525532222|FG000|Overall Study|Lack of Efficacy|2|||
145730899|NCT00174265|525532223|FG001|Overall Study|Lack of Efficacy|2|||
145730900|NCT00174265|525532222|FG000|Overall Study|Withdrawal by Subject|3|||
145730901|NCT00174265|525532223|FG001|Overall Study|Withdrawal by Subject|5|||
145730902|NCT00174265|525532222|FG000|Overall Study|Lost to Follow-up|1|||
145730903|NCT00174265|525532223|FG001|Overall Study|Lost to Follow-up|0|||
145730904|NCT00174265|525532222|FG000|Overall Study|Other (Not specified)|16|||
145730905|NCT00174265|525532223|FG001|Overall Study|Other (Not specified)|10|||
145730906|NCT03471871|525532225|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
145730907|NCT03471871|525532226|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
145730908|NCT03471871|525532227|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
145730909|NCT03471871|525532228|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
145730910|NCT03471871|525532229|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
145730911|NCT03471871|525532225|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
145730912|NCT03471871|525532226|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
145730913|NCT03471871|525532227|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
145730914|NCT03471871|525532228|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
145730915|NCT03471871|525532229|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
145730916|NCT03471871|525532225|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
145730917|NCT03471871|525532226|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
145730918|NCT03471871|525532227|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
145730919|NCT03471871|525532228|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
145730920|NCT03471871|525532229|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
145730921|NCT03471871|525532225|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145730922|NCT03471871|525532226|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145730923|NCT03471871|525532227|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145730924|NCT03471871|525532228|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
145730925|NCT03471871|525532229|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
145730926|NCT03471871|525532225|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
145605951|NCT02312856|525073049|FG000|Overall Study|Death|1|||
145496672|NCT01972217|524677398|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
145496673|NCT01972217|524677395|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
145496674|NCT01972217|524677396|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
145496675|NCT01972217|524677397|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
145496676|NCT01972217|524677398|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
145496677|NCT01972217|524677395|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
145496678|NCT01972217|524677396|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
145496679|NCT01972217|524677397|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
145496680|NCT01972217|524677398|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
145496681|NCT01972217|524677395|FG000|Part B Double-blind, Randomised Period|Death|0|||
145496682|NCT01972217|524677396|FG001|Part B Double-blind, Randomised Period|Death|0|||
145496683|NCT01972217|524677397|FG002|Part B Double-blind, Randomised Period|Death|43|||
145496684|NCT01972217|524677398|FG003|Part B Double-blind, Randomised Period|Death|44|||
145496685|NCT01972217|524677395|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
145496686|NCT01972217|524677396|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
145496687|NCT01972217|524677397|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
145496688|NCT01972217|524677398|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
145496689|NCT01972217|524677395|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
145496690|NCT01972217|524677396|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
145496691|NCT01972217|524677397|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
145496692|NCT01972217|524677398|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
145496693|NCT01972217|524677395|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
145496694|NCT01972217|524677396|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
145496695|NCT01972217|524677397|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
145496696|NCT01972217|524677398|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
145496697|NCT01972217|524677395|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
145496698|NCT01972217|524677396|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
145496699|NCT01972217|524677397|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
145496700|NCT01972217|524677398|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
145496701|NCT00335777|524677400|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
145496702|NCT00335777|524677400|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
145496703|NCT00335777|524677400|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
145496704|NCT00335777|524677400|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
145496705|NCT00335777|524677400|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
145496706|NCT00939393|524677408|FG000|Overall Study|Withdrawal by Subject|1|||
145496707|NCT00939393|524677409|FG001|Overall Study|Withdrawal by Subject|0|||
145496708|NCT00939393|524677408|FG000|Overall Study|Lost to Follow-up|3|||
145496709|NCT00939393|524677409|FG001|Overall Study|Lost to Follow-up|0|||
145496710|NCT02851615|524677410|FG000|Overall Study|Cognitive Issue|1|||
145496711|NCT02851615|524677411|FG001|Overall Study|Cognitive Issue|0|||
145496712|NCT02851615|524677410|FG000|Overall Study|Lost to Follow-up|0|||
145496713|NCT02851615|524677411|FG001|Overall Study|Lost to Follow-up|4|||
145496714|NCT00313014|524677412|FG000|Overall Study|Withdrawal by Subject|11|||
145496715|NCT00313014|524677413|FG001|Overall Study|Withdrawal by Subject|7|||
145496716|NCT00313014|524677414|FG002|Overall Study|Withdrawal by Subject|5|||
145496717|NCT00313014|524677412|FG000|Overall Study|Adverse Event|14|||
145496718|NCT00313014|524677413|FG001|Overall Study|Adverse Event|29|||
145496719|NCT00313014|524677414|FG002|Overall Study|Adverse Event|16|||
145496720|NCT00313014|524677412|FG000|Overall Study|Lost to Follow-up|7|||
145496721|NCT00313014|524677413|FG001|Overall Study|Lost to Follow-up|6|||
145496722|NCT00313014|524677414|FG002|Overall Study|Lost to Follow-up|10|||
145496723|NCT00313014|524677412|FG000|Overall Study|Administrative|9|||
145496724|NCT00313014|524677413|FG001|Overall Study|Administrative|6|||
145496725|NCT00313014|524677414|FG002|Overall Study|Administrative|14|||
145496726|NCT00313014|524677412|FG000|Overall Study|Lack of Efficacy|52|||
145496727|NCT00313014|524677413|FG001|Overall Study|Lack of Efficacy|25|||
145496728|NCT00313014|524677414|FG002|Overall Study|Lack of Efficacy|16|||
145496729|NCT00371150|524677416|FG000|Overall Study|Lost to Follow-up|3|||
145496730|NCT00371150|524677417|FG001|Overall Study|Lost to Follow-up|2|||
145496731|NCT00408317|524677419|FG000|First Intervention Period|Adverse Event|0|||
145496732|NCT00408317|524677420|FG001|First Intervention Period|Adverse Event|1|||
145496733|NCT00408317|524677419|FG000|Second Intervention Period|Adverse Event|2|||
145496734|NCT00408317|524677420|FG001|Second Intervention Period|Adverse Event|0|||
145496735|NCT00408317|524677419|FG000|Second Intervention Period|Protocol Violation|0|||
145496736|NCT00408317|524677420|FG001|Second Intervention Period|Protocol Violation|1|||
145496737|NCT00408317|524677419|FG000|Second Intervention Period|Withdrawal of consent|0|||
145496738|NCT00408317|524677420|FG001|Second Intervention Period|Withdrawal of consent|1|||
145496739|NCT00473564|524677421|FG000|Overall Study|robot surgery aborted in OR|23|||
145496740|NCT00674817|524677422|FG000|Period 1|Withdrawal by Subject|2|||
145496741|NCT00674817|524677422|FG000|Period 1|Protocol Violation|1|||
145496742|NCT00674817|524677422|FG000|Period 3|Adverse Event|1|||
145496743|NCT00674817|524677422|FG000|Period 3|Protocol Violation|1|||
145496744|NCT00674817|524677422|FG000|Period 4|Adverse Event|1|||
145496745|NCT02379728|524677423|FG000|Overall Study|Lost to Follow-up|1|||
145496746|NCT02379728|524677424|FG001|Overall Study|Lost to Follow-up|0|||
145496747|NCT02379728|524677425|FG002|Overall Study|Lost to Follow-up|3|||
145496748|NCT02379728|524677426|FG003|Overall Study|Lost to Follow-up|0|||
145394303|NCT02329327|524296811|FG000|Overall Study|Lost to Follow-up|4|||
145394304|NCT02329327|524296812|FG001|Overall Study|Lost to Follow-up|0|||
145394305|NCT00325819|524296814|FG000|Overall Study|Study product lost in mail|2|||
145394306|NCT00325819|524296815|FG001|Overall Study|Study product lost in mail|1|||
145394307|NCT00325819|524296814|FG000|Overall Study|Did not take a dose of study product|4|||
145394308|NCT00325819|524296815|FG001|Overall Study|Did not take a dose of study product|9|||
145394309|NCT00325819|524296814|FG000|Overall Study|Lost to Follow-up|3|||
145394310|NCT00325819|524296815|FG001|Overall Study|Lost to Follow-up|3|||
145394311|NCT04888494|524296818|FG000|Overall Study|Lost to Follow-up|2|||
145394312|NCT04888494|524296819|FG001|Overall Study|Lost to Follow-up|3|||
145394313|NCT04888494|524296818|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
145394314|NCT04888494|524296819|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
145394315|NCT03430856|524296820|FG000|Overall Study|Adverse Event|0|||
145394316|NCT03430856|524296821|FG001|Overall Study|Adverse Event|1|||
145394317|NCT03430856|524296822|FG002|Overall Study|Adverse Event|0|||
145394318|NCT03430856|524296820|FG000|Overall Study|Rescue criteria|1|||
145394319|NCT03430856|524296821|FG001|Overall Study|Rescue criteria|1|||
145394320|NCT03430856|524296822|FG002|Overall Study|Rescue criteria|0|||
145394321|NCT03430856|524296820|FG000|Overall Study|Voluntary withdrawal of consent|1|||
145394322|NCT03430856|524296821|FG001|Overall Study|Voluntary withdrawal of consent|1|||
145394323|NCT03430856|524296822|FG002|Overall Study|Voluntary withdrawal of consent|1|||
145394324|NCT00565604|524296826|FG000|Overall Study|Failure to treat|2|||
145394325|NCT00565604|524296826|FG000|Overall Study|Lost to Follow-up|2|||
145394326|NCT04754542|524296827|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
145394327|NCT04754542|524296828|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
145394328|NCT01718483|524298703|FG000|Overall Study|Withdrawal by Subject|14|||
145496749|NCT02379728|524677423|FG000|Overall Study|Withdrawal by Subject|5|||
145496750|NCT02379728|524677424|FG001|Overall Study|Withdrawal by Subject|0|||
145496751|NCT02379728|524677425|FG002|Overall Study|Withdrawal by Subject|5|||
145496752|NCT02379728|524677426|FG003|Overall Study|Withdrawal by Subject|3|||
145496753|NCT02379728|524677423|FG000|Overall Study|Protocol Violation|0|||
145496754|NCT02379728|524677424|FG001|Overall Study|Protocol Violation|0|||
145496755|NCT02379728|524677425|FG002|Overall Study|Protocol Violation|2|||
145496756|NCT02379728|524677426|FG003|Overall Study|Protocol Violation|0|||
145496757|NCT01112917|524677427|FG000|Overall Study|Death|2|||
145496758|NCT01112917|524677428|FG001|Overall Study|Death|11|||
145496759|NCT01112917|524677427|FG000|Overall Study|Lost to Follow-up|1|||
145496760|NCT01112917|524677428|FG001|Overall Study|Lost to Follow-up|1|||
145496761|NCT01112917|524677427|FG000|Overall Study|Withdrawal by Subject|1|||
145496762|NCT01112917|524677428|FG001|Overall Study|Withdrawal by Subject|3|||
145496763|NCT01112917|524677427|FG000|Overall Study|Unable to Convert Filter|3|||
145496764|NCT01112917|524677428|FG001|Overall Study|Unable to Convert Filter|0|||
145496765|NCT05101122|524677429|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
145496766|NCT05101122|524677429|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
145496767|NCT05101122|524677429|FG000|AD313 80/5|Withdrawal by Subject|1|||
145496768|NCT05101122|524677429|FG000|AD313 80/10|Physician Decision|1|||
145496769|NCT03131219|524677431|FG000|Initial Evaluation Period|Adverse Event|2|||
145496770|NCT03131219|524677432|FG001|Initial Evaluation Period|Adverse Event|0|||
145496771|NCT03131219|524677431|FG000|Initial Evaluation Period|Protocol Violation|1|||
145730927|NCT03471871|525532226|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
145730928|NCT03471871|525532227|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
145730929|NCT03471871|525532228|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
145730930|NCT03471871|525532229|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
145730931|NCT00047320|525532230|FG000|Overall Study|Lack of Efficacy|8|||
145730932|NCT00047320|525532230|FG000|Overall Study|Lost to Follow-up|1|||
145730933|NCT00047320|525532230|FG000|Overall Study|Physician Decision|8|||
145730934|NCT00047320|525532230|FG000|Overall Study|Withdrawal by Subject|9|||
145730935|NCT00047320|525532230|FG000|Overall Study|Ineligible|2|||
145730936|NCT03040622|525532232|FG000|Overall Study|unable to implant device|3|||
145496772|NCT03131219|524677432|FG001|Initial Evaluation Period|Protocol Violation|0|||
145496773|NCT03131219|524677431|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
145730937|NCT03078907|525533541|FG000|Overall Study|Adverse Event|2|||
145730938|NCT03078907|525533542|FG001|Overall Study|Adverse Event|0|||
145730939|NCT03078907|525533541|FG000|Overall Study|Other|1|||
145496774|NCT03131219|524677432|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
145496775|NCT03131219|524677431|FG000|Initial Evaluation Period|Physician Decision|1|||
145496776|NCT03131219|524677432|FG001|Initial Evaluation Period|Physician Decision|0|||
145496777|NCT03131219|524677431|FG000|Extension Period|Physician Decision|1|||
145730940|NCT03078907|525533542|FG001|Overall Study|Other|0|||
145730941|NCT03078907|525533541|FG000|Overall Study|Protocol Violation|0|||
145730942|NCT03078907|525533542|FG001|Overall Study|Protocol Violation|1|||
145730943|NCT00985166|525533543|FG000|Overall Study|Lost to Follow-up|3|||
145730944|NCT00985166|525533544|FG001|Overall Study|Lost to Follow-up|2|||
145730945|NCT00985166|525533545|FG002|Overall Study|Lost to Follow-up|2|||
145730946|NCT00985166|525533543|FG000|Overall Study|Withdrawal by Subject|3|||
145730947|NCT00985166|525533544|FG001|Overall Study|Withdrawal by Subject|2|||
145730948|NCT00985166|525533545|FG002|Overall Study|Withdrawal by Subject|0|||
145730949|NCT00985166|525533543|FG000|Overall Study|Test not done|2|||
145730950|NCT00985166|525533544|FG001|Overall Study|Test not done|0|||
145730951|NCT00985166|525533545|FG002|Overall Study|Test not done|4|||
145730952|NCT00985166|525533543|FG000|Overall Study|Other|1|||
145730953|NCT00985166|525533544|FG001|Overall Study|Other|0|||
145730954|NCT00985166|525533545|FG002|Overall Study|Other|1|||
145730955|NCT00909792|525533552|FG000|Period 1|Did not meet inclusion criteria|0|||
145730956|NCT00909792|525533553|FG001|Period 1|Did not meet inclusion criteria|1|||
145730957|NCT00909792|525533552|FG000|Period 2|Biomicroscopy|1|||
145730958|NCT00909792|525533553|FG001|Period 2|Biomicroscopy|0|||
145730959|NCT00909792|525533552|FG000|Period 2|Lost to Follow-up|0|||
145730960|NCT00909792|525533553|FG001|Period 2|Lost to Follow-up|1|||
145730961|NCT03434353|525533554|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
145730962|NCT03434353|525533555|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
145730963|NCT03434353|525533556|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
145730964|NCT03434353|525533557|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
145730965|NCT03434353|525533558|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
145730966|NCT03434353|525533554|FG000|Overall Study|Withdrew consent|1|||
145730967|NCT03434353|525533555|FG001|Overall Study|Withdrew consent|0|||
145730968|NCT03434353|525533556|FG002|Overall Study|Withdrew consent|3|||
145730969|NCT03434353|525533557|FG003|Overall Study|Withdrew consent|0|||
145730970|NCT03434353|525533558|FG004|Overall Study|Withdrew consent|0|||
145730971|NCT03434353|525533554|FG000|Overall Study|Adverse Event|1|||
145730972|NCT03434353|525533555|FG001|Overall Study|Adverse Event|0|||
145394329|NCT01718483|524298704|FG001|Overall Study|Withdrawal by Subject|12|||
145394330|NCT01718483|524298703|FG000|Overall Study|Adverse Event|5|||
145394331|NCT01718483|524298704|FG001|Overall Study|Adverse Event|12|||
145394332|NCT01718483|524298703|FG000|Overall Study|Lost to Follow-up|8|||
145394333|NCT01718483|524298704|FG001|Overall Study|Lost to Follow-up|3|||
145496778|NCT03131219|524677432|FG001|Extension Period|Physician Decision|0|||
145496779|NCT00616759|524677433|FG000|Overall Study|Physician Decision|2|||
145496780|NCT00616759|524677434|FG001|Overall Study|Physician Decision|0|||
145496781|NCT00616759|524677433|FG000|Overall Study|Withdrawal by Subject|1|||
145496782|NCT00616759|524677434|FG001|Overall Study|Withdrawal by Subject|2|||
145496783|NCT00981656|524677448|FG000|Overall Study|Protocol Violation|1|||
145496784|NCT00981656|524677448|FG000|Overall Study|Did not start protocol treatment|2|||
145496785|NCT02903771|524677449|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
145496786|NCT02903771|524677450|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
145496787|NCT02903771|524677451|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
145496788|NCT02903771|524677452|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
145496789|NCT02903771|524677453|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
145496790|NCT02903771|524677454|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
145496791|NCT02903771|524677455|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
145496792|NCT02903771|524677449|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496793|NCT02903771|524677450|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
145496794|NCT02903771|524677451|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496795|NCT02903771|524677452|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496796|NCT02903771|524677453|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496797|NCT02903771|524677454|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496798|NCT02903771|524677455|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
145496799|NCT02903771|524677449|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
145496800|NCT02903771|524677450|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
145496801|NCT02903771|524677451|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
145496802|NCT02903771|524677452|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
145496803|NCT02903771|524677453|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
145496804|NCT02903771|524677454|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
145496805|NCT02903771|524677455|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
145496806|NCT02903771|524677449|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145496807|NCT02903771|524677450|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145496808|NCT02903771|524677451|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145730973|NCT03434353|525533556|FG002|Overall Study|Adverse Event|0|||
145730974|NCT03434353|525533557|FG003|Overall Study|Adverse Event|0|||
145730975|NCT03434353|525533558|FG004|Overall Study|Adverse Event|1|||
145730976|NCT03434353|525533554|FG000|Overall Study|Lost to Follow-up|2|||
145496809|NCT02903771|524677452|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145496810|NCT02903771|524677453|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
145496811|NCT02903771|524677454|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145496812|NCT02903771|524677455|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
145496813|NCT02903771|524677449|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496814|NCT02903771|524677450|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496815|NCT02903771|524677451|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496816|NCT02903771|524677452|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496817|NCT02903771|524677453|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496818|NCT02903771|524677454|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
145496819|NCT02903771|524677455|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
145496820|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496821|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496822|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496823|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496824|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
145496825|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496826|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
145496827|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145496828|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145496829|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145496830|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145605952|NCT02312856|525073049|FG000|Overall Study|Lost to Follow-up|3|||
145496831|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
145496832|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145496833|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
145496834|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145496835|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145730977|NCT03434353|525533555|FG001|Overall Study|Lost to Follow-up|0|||
145730978|NCT03434353|525533556|FG002|Overall Study|Lost to Follow-up|0|||
145730979|NCT03434353|525533557|FG003|Overall Study|Lost to Follow-up|0|||
145730980|NCT03434353|525533558|FG004|Overall Study|Lost to Follow-up|0|||
145730981|NCT01990534|525533559|FG000|Overall Study|Death|22|||
145730982|NCT01990534|525533559|FG000|Overall Study|Progressive disease|3|||
145730983|NCT01990534|525533559|FG000|Overall Study|Protocol Violation|1|||
145730984|NCT01990534|525533559|FG000|Overall Study|Withdrawal of Informed Consent|2|||
145394334|NCT01718483|524298703|FG000|Overall Study|Protocol Violation|4|||
145394335|NCT01718483|524298704|FG001|Overall Study|Protocol Violation|2|||
145394336|NCT01718483|524298703|FG000|Overall Study|Other|1|||
145394337|NCT01718483|524298704|FG001|Overall Study|Other|4|||
145394338|NCT01718483|524298703|FG000|Overall Study|Pregnancy|1|||
145394339|NCT01718483|524298704|FG001|Overall Study|Pregnancy|1|||
145394340|NCT01718483|524298703|FG000|Overall Study|Lack of Efficacy|1|||
145394341|NCT01718483|524298704|FG001|Overall Study|Lack of Efficacy|0|||
145394342|NCT02119299|524298705|FG000|Overall Study|Withdrawal by Subject|7|||
145394343|NCT02119299|524298705|FG000|Overall Study|Lack of Efficacy|1|||
145394344|NCT02119299|524298705|FG000|Overall Study|Pregnancy|1|||
145394345|NCT04110314|524298706|FG000|Overall Study|Did not meet inclusion criteria|35255|||
145394346|NCT04110314|524298707|FG001|Overall Study|Did not meet inclusion criteria|35104|||
145394347|NCT04110314|524298708|FG002|Overall Study|Did not meet inclusion criteria|35636|||
145394348|NCT04110314|524298709|FG003|Overall Study|Did not meet inclusion criteria|35135|||
145394349|NCT04110314|524298710|FG004|Overall Study|Did not meet inclusion criteria|35247|||
145394350|NCT04110314|524298711|FG005|Overall Study|Did not meet inclusion criteria|35727|||
145394351|NCT00115778|524298713|FG000|Overall Study|Withdrawal by Subject|0|||
145394352|NCT00115778|524298714|FG001|Overall Study|Withdrawal by Subject|1|||
145394353|NCT00249873|524298719|FG000|Overall Study|Not treated|7|||
145394354|NCT00249873|524298720|FG001|Overall Study|Not treated|8|||
145394355|NCT00249873|524298719|FG000|Overall Study|Significant thrombocytopenia|9|||
145394356|NCT00249873|524298720|FG001|Overall Study|Significant thrombocytopenia|8|||
145394357|NCT00249873|524298719|FG000|Overall Study|Severe allergic reaction|8|||
145394358|NCT00249873|524298720|FG001|Overall Study|Severe allergic reaction|1|||
145394359|NCT00249873|524298719|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
145394360|NCT00249873|524298720|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
145394361|NCT00249873|524298719|FG000|Overall Study|Other Serious Adverse Event|86|||
145394362|NCT00249873|524298720|FG001|Overall Study|Other Serious Adverse Event|97|||
145394363|NCT00249873|524298719|FG000|Overall Study|Qualifying condition not present|20|||
145394364|NCT00249873|524298720|FG001|Overall Study|Qualifying condition not present|23|||
145394365|NCT00249873|524298719|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
145394366|NCT00249873|524298720|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
145394367|NCT00249873|524298719|FG000|Overall Study|Withdrawal by Subject|504|||
145394368|NCT00249873|524298720|FG001|Overall Study|Withdrawal by Subject|466|||
145394369|NCT00249873|524298719|FG000|Overall Study|Lost to Follow-up|4|||
145394370|NCT00249873|524298720|FG001|Overall Study|Lost to Follow-up|7|||
145394371|NCT00249873|524298719|FG000|Overall Study|Minor bleeding|99|||
145394372|NCT00249873|524298720|FG001|Overall Study|Minor bleeding|37|||
145394373|NCT00249873|524298719|FG000|Overall Study|Non-compliance|41|||
145394374|NCT00249873|524298720|FG001|Overall Study|Non-compliance|46|||
145394375|NCT00249873|524298719|FG000|Overall Study|Other non serious Adverse Event|112|||
145394376|NCT00249873|524298720|FG001|Overall Study|Other non serious Adverse Event|108|||
145605953|NCT01932294|525073050|FG000|Overall Study|Death|43|||
145730985|NCT01990534|525533559|FG000|Overall Study|Symptomatic Deterioration|1|||
145730986|NCT01990534|525533559|FG000|Overall Study|Withdrawal by Subject|3|||
145730987|NCT01990534|525533559|FG000|Overall Study|Reason not Specified|2|||
145730988|NCT01990534|525533559|FG000|Overall Study|Lost to Follow-up|1|||
145730989|NCT00234494|525533560|FG000|Overall Study|Protocol Violation|2|||
145730990|NCT01831544|525533563|FG000|Overall Study|Death|1|||
145730991|NCT01831544|525533563|FG000|Overall Study|Still on original MVAD device|2|||
145730992|NCT01681628|525533566|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
145730993|NCT01681628|525533567|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
145730994|NCT01681628|525533566|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
145730995|NCT01681628|525533567|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
145730996|NCT01681628|525533566|FG000|19 Months Follow-up|Death|1|||
145730997|NCT01681628|525533567|FG001|19 Months Follow-up|Death|0|||
145730998|NCT01681628|525533566|FG000|19 Months Follow-up|Lost to Follow-up|61|||
145730999|NCT01681628|525533567|FG001|19 Months Follow-up|Lost to Follow-up|43|||
145731000|NCT01521897|525533568|FG000|Overall Study|Protocol Violation|18|||
145731001|NCT01521897|525533568|FG000|Overall Study|Lost to Follow-up|5|||
145731002|NCT02194062|525533570|FG000|Overall Study|Lost to Follow-up|2|||
145731003|NCT02194062|525533571|FG001|Overall Study|Lost to Follow-up|2|||
145605954|NCT01932294|525073050|FG000|Overall Study|Lost to Follow-up|8|||
145394377|NCT00249873|524298719|FG000|Overall Study|Other contraindicated medication|1|||
145394378|NCT00249873|524298720|FG001|Overall Study|Other contraindicated medication|0|||
145394379|NCT00249873|524298719|FG000|Overall Study|Patient not wish to continue after May08|3|||
145394380|NCT00249873|524298720|FG001|Overall Study|Patient not wish to continue after May08|4|||
145394381|NCT00249873|524298719|FG000|Overall Study|Physician withdrew consent|59|||
145394382|NCT00249873|524298720|FG001|Overall Study|Physician withdrew consent|60|||
145394383|NCT00249873|524298719|FG000|Overall Study|Open label clopidogrel required|31|||
145394384|NCT00249873|524298720|FG001|Overall Study|Open label clopidogrel required|42|||
145394385|NCT00249873|524298719|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
145394386|NCT00249873|524298720|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
145394387|NCT00249873|524298719|FG000|Overall Study|Oral anticoagulant required|159|||
145394388|NCT00249873|524298720|FG001|Overall Study|Oral anticoagulant required|157|||
145394389|NCT00249873|524298719|FG000|Overall Study|Study drug intolerance|5|||
145394390|NCT00249873|524298720|FG001|Overall Study|Study drug intolerance|0|||
145394391|NCT00249873|524298719|FG000|Overall Study|Surgery/ procedure|9|||
145394392|NCT00249873|524298720|FG001|Overall Study|Surgery/ procedure|9|||
145394393|NCT00249873|524298719|FG000|Overall Study|Event related to cardiac condition|12|||
145394394|NCT00249873|524298720|FG001|Overall Study|Event related to cardiac condition|21|||
145394395|NCT00249873|524298719|FG000|Overall Study|Thromboembolic/outcome event|82|||
145394396|NCT00249873|524298720|FG001|Overall Study|Thromboembolic/outcome event|122|||
145394397|NCT00974311|524298721|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
145394398|NCT00974311|524298722|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
145394399|NCT00974311|524298721|FG000|DB Phase (up to 24 Months)|Death|561|||
145394400|NCT00974311|524298722|FG001|DB Phase (up to 24 Months)|Death|298|||
145394401|NCT00974311|524298721|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
145394402|NCT00974311|524298722|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
145394403|NCT00974311|524298721|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
145394404|NCT00974311|524298722|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
145394405|NCT00974311|524298721|FG000|DB Phase (up to 24 Months)|Other|1|||
145394406|NCT00974311|524298722|FG001|DB Phase (up to 24 Months)|Other|0|||
145394407|NCT00974311|524298721|FG000|OLE Phase (up to 77 Months)|Death|14|||
145394408|NCT00974311|524298722|FG001|OLE Phase (up to 77 Months)|Death|21|||
145394409|NCT00974311|524298721|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
145394410|NCT00974311|524298722|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
145394411|NCT00974311|524298721|FG000|OLE Phase (up to 77 Months)|Other|15|||
145394412|NCT00974311|524298722|FG001|OLE Phase (up to 77 Months)|Other|2|||
145394413|NCT00974311|524298721|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
145394414|NCT00974311|524298722|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
145394415|NCT00165503|524298725|FG000|Overall Study|Death|1|||
145731004|NCT02194062|525533572|FG002|Overall Study|Lost to Follow-up|5|||
145731005|NCT02502266|525533573|FG000|Overall Study|Adverse Event|0|||
145731006|NCT02502266|525533574|FG001|Overall Study|Adverse Event|0|||
145731007|NCT02502266|525533575|FG002|Overall Study|Adverse Event|0|||
145731008|NCT02502266|525533576|FG003|Overall Study|Adverse Event|0|||
145731009|NCT02502266|525533577|FG004|Overall Study|Adverse Event|1|||
145731010|NCT02502266|525533578|FG005|Overall Study|Adverse Event|1|||
145731011|NCT02502266|525533579|FG006|Overall Study|Adverse Event|1|||
145731012|NCT02502266|525533573|FG000|Overall Study|Withdrawal by Subject|30|||
145731013|NCT02502266|525533574|FG001|Overall Study|Withdrawal by Subject|15|||
145731014|NCT02502266|525533575|FG002|Overall Study|Withdrawal by Subject|16|||
145731015|NCT02502266|525533576|FG003|Overall Study|Withdrawal by Subject|0|||
145731016|NCT02502266|525533577|FG004|Overall Study|Withdrawal by Subject|0|||
145731017|NCT02502266|525533578|FG005|Overall Study|Withdrawal by Subject|0|||
145731018|NCT02502266|525533579|FG006|Overall Study|Withdrawal by Subject|0|||
145731019|NCT02502266|525533573|FG000|Overall Study|Still on Treatment|0|||
145731020|NCT02502266|525533574|FG001|Overall Study|Still on Treatment|0|||
145731021|NCT02502266|525533575|FG002|Overall Study|Still on Treatment|1|||
145731022|NCT02502266|525533576|FG003|Overall Study|Still on Treatment|0|||
145731023|NCT02502266|525533577|FG004|Overall Study|Still on Treatment|0|||
145731024|NCT02502266|525533578|FG005|Overall Study|Still on Treatment|0|||
145731025|NCT02502266|525533579|FG006|Overall Study|Still on Treatment|0|||
145731026|NCT02502266|525533573|FG000|Overall Study|Other Reasons|19|||
145731027|NCT02502266|525533574|FG001|Overall Study|Other Reasons|6|||
145731028|NCT02502266|525533575|FG002|Overall Study|Other Reasons|14|||
145731029|NCT02502266|525533576|FG003|Overall Study|Other Reasons|0|||
145731030|NCT02502266|525533577|FG004|Overall Study|Other Reasons|1|||
145731031|NCT02502266|525533578|FG005|Overall Study|Other Reasons|1|||
145731032|NCT02502266|525533579|FG006|Overall Study|Other Reasons|0|||
145731033|NCT02502266|525533573|FG000|Overall Study|Arm 4 Discontinued|0|||
145731034|NCT02502266|525533574|FG001|Overall Study|Arm 4 Discontinued|0|||
145731035|NCT02502266|525533575|FG002|Overall Study|Arm 4 Discontinued|0|||
145731036|NCT02502266|525533576|FG003|Overall Study|Arm 4 Discontinued|52|||
145731037|NCT02502266|525533577|FG004|Overall Study|Arm 4 Discontinued|0|||
145731038|NCT02502266|525533578|FG005|Overall Study|Arm 4 Discontinued|0|||
145731039|NCT02502266|525533579|FG006|Overall Study|Arm 4 Discontinued|0|||
145731040|NCT02502266|525533573|FG000|Overall Study|Never treated|0|||
145731041|NCT02502266|525533574|FG001|Overall Study|Never treated|0|||
145731042|NCT02502266|525533575|FG002|Overall Study|Never treated|0|||
145731043|NCT02502266|525533576|FG003|Overall Study|Never treated|0|||
145731044|NCT02502266|525533577|FG004|Overall Study|Never treated|0|||
145731045|NCT02502266|525533578|FG005|Overall Study|Never treated|1|||
145731046|NCT02502266|525533579|FG006|Overall Study|Never treated|0|||
145731047|NCT02634346|525533582|FG000|Overall Study|Withdrawal by Subject|8|||
145731048|NCT02634346|525533583|FG001|Overall Study|Withdrawal by Subject|9|||
145731049|NCT02634346|525533584|FG002|Overall Study|Withdrawal by Subject|8|||
145731050|NCT02634346|525533582|FG000|Overall Study|Adverse Event|2|||
145731051|NCT02634346|525533583|FG001|Overall Study|Adverse Event|2|||
145731052|NCT02634346|525533584|FG002|Overall Study|Adverse Event|7|||
145731053|NCT02634346|525533582|FG000|Overall Study|Lack of Efficacy|1|||
145731054|NCT02634346|525533583|FG001|Overall Study|Lack of Efficacy|2|||
145731055|NCT02634346|525533584|FG002|Overall Study|Lack of Efficacy|8|||
145731056|NCT02634346|525533582|FG000|Overall Study|Lost to Follow-up|1|||
145731057|NCT02634346|525533583|FG001|Overall Study|Lost to Follow-up|0|||
145731058|NCT02634346|525533584|FG002|Overall Study|Lost to Follow-up|0|||
145731059|NCT02634346|525533582|FG000|Overall Study|Protocol Violation|0|||
145731060|NCT02634346|525533583|FG001|Overall Study|Protocol Violation|1|||
145731061|NCT02634346|525533584|FG002|Overall Study|Protocol Violation|0|||
145731062|NCT00992511|525533586|FG000|Overall Study|Migrated/moved from study area|1|||
145731063|NCT00992511|525533587|FG001|Overall Study|Migrated/moved from study area|0|||
145731064|NCT00992511|525533588|FG002|Overall Study|Migrated/moved from study area|1|||
145731065|NCT00992511|525533589|FG003|Overall Study|Migrated/moved from study area|2|||
145731066|NCT00992511|525533586|FG000|Overall Study|Lost to Follow-up|1|||
145731067|NCT00992511|525533587|FG001|Overall Study|Lost to Follow-up|0|||
145731068|NCT00992511|525533588|FG002|Overall Study|Lost to Follow-up|0|||
145394416|NCT00165503|524298725|FG000|Overall Study|Lost to Follow-up|12|||
145731069|NCT00992511|525533589|FG003|Overall Study|Lost to Follow-up|2|||
145731070|NCT00992511|525533586|FG000|Overall Study|Withdrawal by Subject|0|||
145731071|NCT00992511|525533587|FG001|Overall Study|Withdrawal by Subject|0|||
145731072|NCT00992511|525533588|FG002|Overall Study|Withdrawal by Subject|1|||
145731073|NCT00992511|525533589|FG003|Overall Study|Withdrawal by Subject|1|||
145731074|NCT04498169|525533590|FG000|Study Completion|Adverse Event|1|||
145731075|NCT04498169|525533591|FG001|Study Completion|Adverse Event|1|||
145731076|NCT04615247|525533592|FG000|Overall Study|Adverse Event|0|||
145731077|NCT04615247|525533593|FG001|Overall Study|Adverse Event|2|||
145731078|NCT04615247|525533592|FG000|Overall Study|Withdrawal by Subject|1|||
145731079|NCT04615247|525533593|FG001|Overall Study|Withdrawal by Subject|1|||
145731080|NCT00221195|525533598|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
145731081|NCT00221195|525533599|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
145731082|NCT00221195|525533598|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
145731083|NCT00221195|525533599|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
145731084|NCT00221195|525533598|FG000|Washout Period (Months 7-9)|Death|0|||
145731085|NCT00221195|525533599|FG001|Washout Period (Months 7-9)|Death|1|||
145731086|NCT00221195|525533598|FG000|Therapy 2 (Months 10-15)|Death|1|||
145731087|NCT00221195|525533599|FG001|Therapy 2 (Months 10-15)|Death|0|||
145731088|NCT00221195|525533598|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
145731089|NCT00221195|525533599|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
145731090|NCT00216203|525533601|FG000|Overall Study|Withdrawal by Subject|2|||
145394417|NCT00165503|524298725|FG000|Overall Study|Unresectable|3|||
145394418|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Death|20|||
145394419|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Death|26|||
145394420|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
145394421|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
145394422|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
145394423|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
145394424|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
145394425|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
145394426|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
145394427|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
145394428|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
145394429|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
145394430|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
145394431|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
145394432|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
145394433|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
145394434|NCT00643201|524298726|FG000|Randomized, Completed 6 Months of Study|Other|107|||
145394435|NCT00643201|524298727|FG001|Randomized, Completed 6 Months of Study|Other|107|||
145394436|NCT00643201|524298726|FG000|Completed Study Follow Up|Death|28|||
145394437|NCT00643201|524298727|FG001|Completed Study Follow Up|Death|34|||
145394438|NCT00643201|524298726|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
145394439|NCT00643201|524298727|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
145394440|NCT00643201|524298726|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
145394441|NCT00643201|524298727|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
145394442|NCT00643201|524298726|FG000|Completed Study Follow Up|non-specified|1|||
145394443|NCT00643201|524298727|FG001|Completed Study Follow Up|non-specified|0|||
145394444|NCT02346708|524298728|FG000|Overall Study|Adverse Event|2|||
145394445|NCT02346708|524298729|FG001|Overall Study|Adverse Event|0|||
145394446|NCT02346708|524298728|FG000|Overall Study|Protocol Violation|0|||
145394447|NCT02346708|524298729|FG001|Overall Study|Protocol Violation|1|||
145394448|NCT02976519|524298730|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394449|NCT02976519|524298731|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
145394450|NCT02976519|524298732|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394451|NCT02976519|524298733|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394452|NCT02976519|524298734|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394453|NCT02976519|524298735|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394454|NCT02976519|524298736|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
145394455|NCT02976519|524298730|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394456|NCT02976519|524298731|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394457|NCT02976519|524298732|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394458|NCT02976519|524298733|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
145394459|NCT02976519|524298734|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394460|NCT02976519|524298735|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394461|NCT02976519|524298736|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
145394462|NCT02976519|524298730|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394463|NCT02976519|524298731|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394464|NCT02976519|524298732|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394465|NCT02976519|524298733|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394466|NCT02976519|524298734|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394467|NCT02976519|524298735|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
145394468|NCT02976519|524298736|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
145394469|NCT02976519|524298730|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145394470|NCT02976519|524298731|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145394471|NCT02976519|524298732|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145605955|NCT01932294|525073050|FG000|Overall Study|VAD Implantation|20|||
145731091|NCT02596620|525533602|FG000|Overall Study|Lost to Follow-up|1|||
145731092|NCT02596620|525533603|FG001|Overall Study|Lost to Follow-up|1|||
145731093|NCT04658186|525533604|FG000|Overall Study|Adverse Event|4|||
145394472|NCT02976519|524298733|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145394473|NCT02976519|524298734|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145394474|NCT02976519|524298735|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
145394475|NCT02976519|524298736|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
145394476|NCT02976519|524298730|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394477|NCT02976519|524298731|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394478|NCT02976519|524298732|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394479|NCT02976519|524298733|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394480|NCT02976519|524298734|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394481|NCT02976519|524298735|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
145394482|NCT02976519|524298736|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
145394483|NCT00928434|524298739|FG000|Overall Study|Adverse Event|14|||
145394484|NCT00928434|524298740|FG001|Overall Study|Adverse Event|5|||
145394485|NCT00928434|524298741|FG002|Overall Study|Adverse Event|18|||
145394486|NCT00928434|524298739|FG000|Overall Study|Protocol Violation|5|||
145394487|NCT00928434|524298740|FG001|Overall Study|Protocol Violation|0|||
145394488|NCT00928434|524298741|FG002|Overall Study|Protocol Violation|8|||
145394489|NCT00928434|524298739|FG000|Overall Study|Physician Decision|2|||
145394490|NCT00928434|524298740|FG001|Overall Study|Physician Decision|0|||
145394491|NCT00928434|524298741|FG002|Overall Study|Physician Decision|3|||
145394492|NCT00928434|524298739|FG000|Overall Study|Lost to Follow-up|1|||
145394493|NCT00928434|524298740|FG001|Overall Study|Lost to Follow-up|0|||
145394494|NCT00928434|524298741|FG002|Overall Study|Lost to Follow-up|3|||
145394495|NCT00928434|524298739|FG000|Overall Study|Withdrawal by Subject|5|||
145394496|NCT00928434|524298740|FG001|Overall Study|Withdrawal by Subject|3|||
145394497|NCT00928434|524298741|FG002|Overall Study|Withdrawal by Subject|2|||
145394498|NCT00928434|524298739|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
145394499|NCT00928434|524298740|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
145394500|NCT00928434|524298741|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
145394501|NCT00928434|524298739|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
145394502|NCT00928434|524298740|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
145394503|NCT00928434|524298741|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
145394504|NCT00928434|524298739|FG000|Overall Study|Other (not meeting above criteria)|5|||
145394505|NCT00928434|524298740|FG001|Overall Study|Other (not meeting above criteria)|1|||
145394506|NCT00928434|524298741|FG002|Overall Study|Other (not meeting above criteria)|2|||
145394507|NCT01278342|524298744|FG000|Overall Study|Physician Decision|0|||
145394508|NCT01278342|524298745|FG001|Overall Study|Physician Decision|1|||
145394509|NCT01278342|524298746|FG002|Overall Study|Physician Decision|0|||
145394510|NCT01278342|524298744|FG000|Overall Study|Lost to Follow-up|1|||
145394511|NCT01278342|524298745|FG001|Overall Study|Lost to Follow-up|0|||
145394512|NCT01278342|524298746|FG002|Overall Study|Lost to Follow-up|0|||
145394513|NCT01278342|524298744|FG000|Overall Study|Administrative problems|2|||
145394514|NCT01278342|524298745|FG001|Overall Study|Administrative problems|0|||
145394515|NCT01278342|524298746|FG002|Overall Study|Administrative problems|0|||
145394516|NCT01278342|524298744|FG000|Overall Study|Other|1|||
145394517|NCT01278342|524298745|FG001|Overall Study|Other|0|||
145394518|NCT01278342|524298746|FG002|Overall Study|Other|0|||
145394519|NCT05417412|524298758|FG000|Overall Study|Lost to Follow-up|2|||
145394520|NCT01576575|524298759|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
145394521|NCT01576575|524298759|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
145394522|NCT01576575|524298759|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
145394523|NCT02157519|524298763|FG000|Overall Study|Death|3|||
145605956|NCT01932294|525073050|FG000|Overall Study|Heart Transplantation|16|||
145731094|NCT04658186|525533605|FG001|Overall Study|Adverse Event|18|||
145731095|NCT04658186|525533606|FG002|Overall Study|Adverse Event|15|||
145731096|NCT04658186|525533604|FG000|Overall Study|Lack of Efficacy|1|||
145731097|NCT04658186|525533605|FG001|Overall Study|Lack of Efficacy|1|||
145731098|NCT04658186|525533606|FG002|Overall Study|Lack of Efficacy|0|||
145731099|NCT04658186|525533604|FG000|Overall Study|Protocol Violation|0|||
145731100|NCT04658186|525533605|FG001|Overall Study|Protocol Violation|0|||
145731101|NCT04658186|525533606|FG002|Overall Study|Protocol Violation|1|||
145731102|NCT04658186|525533604|FG000|Overall Study|Lost to Follow-up|0|||
145731103|NCT04658186|525533605|FG001|Overall Study|Lost to Follow-up|0|||
145731104|NCT04658186|525533606|FG002|Overall Study|Lost to Follow-up|2|||
145731105|NCT04658186|525533604|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
145731106|NCT04658186|525533605|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
145731107|NCT04658186|525533606|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
145731108|NCT04658186|525533604|FG000|Overall Study|Participant is Moving in Another Province|0|||
145731109|NCT04658186|525533605|FG001|Overall Study|Participant is Moving in Another Province|1|||
145731110|NCT04658186|525533606|FG002|Overall Study|Participant is Moving in Another Province|0|||
145731111|NCT04658186|525533604|FG000|Overall Study|Non-Compliance|0|||
145731112|NCT04658186|525533605|FG001|Overall Study|Non-Compliance|1|||
145731113|NCT04658186|525533606|FG002|Overall Study|Non-Compliance|1|||
145731114|NCT04658186|525533604|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
145394524|NCT02157519|524298764|FG001|Overall Study|Death|1|||
145394525|NCT02157519|524298763|FG000|Overall Study|Withdrawal by Subject|7|||
145394526|NCT02157519|524298764|FG001|Overall Study|Withdrawal by Subject|0|||
145394527|NCT02157519|524298763|FG000|Overall Study|Lost to Follow-up|1|||
145394528|NCT02157519|524298764|FG001|Overall Study|Lost to Follow-up|0|||
145394529|NCT01656395|524298765|FG000|Overall Study|Adverse Event|1|||
145394530|NCT01656395|524298766|FG001|Overall Study|Adverse Event|14|||
145394531|NCT01656395|524298767|FG002|Overall Study|Adverse Event|5|||
145394532|NCT01656395|524298768|FG003|Overall Study|Adverse Event|4|||
145394533|NCT01656395|524298769|FG004|Overall Study|Adverse Event|5|||
145394534|NCT01656395|524298770|FG005|Overall Study|Adverse Event|7|||
145394535|NCT01656395|524298771|FG006|Overall Study|Adverse Event|0|||
145394536|NCT01656395|524298772|FG007|Overall Study|Adverse Event|0|||
145394537|NCT01656395|524298765|FG000|Overall Study|Lack of Efficacy|1|||
145394538|NCT01656395|524298766|FG001|Overall Study|Lack of Efficacy|8|||
145394539|NCT01656395|524298767|FG002|Overall Study|Lack of Efficacy|6|||
145394540|NCT01656395|524298768|FG003|Overall Study|Lack of Efficacy|1|||
145394541|NCT01656395|524298769|FG004|Overall Study|Lack of Efficacy|1|||
145394542|NCT01656395|524298770|FG005|Overall Study|Lack of Efficacy|6|||
145394543|NCT01656395|524298771|FG006|Overall Study|Lack of Efficacy|0|||
145394544|NCT01656395|524298772|FG007|Overall Study|Lack of Efficacy|0|||
145394545|NCT01656395|524298765|FG000|Overall Study|Lost to Follow-up|1|||
145394546|NCT01656395|524298766|FG001|Overall Study|Lost to Follow-up|0|||
145394547|NCT01656395|524298767|FG002|Overall Study|Lost to Follow-up|0|||
145394548|NCT01656395|524298768|FG003|Overall Study|Lost to Follow-up|0|||
145394549|NCT01656395|524298769|FG004|Overall Study|Lost to Follow-up|0|||
145394550|NCT01656395|524298770|FG005|Overall Study|Lost to Follow-up|0|||
145394551|NCT01656395|524298771|FG006|Overall Study|Lost to Follow-up|0|||
145394552|NCT01656395|524298772|FG007|Overall Study|Lost to Follow-up|0|||
145394553|NCT01656395|524298765|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145394554|NCT01656395|524298766|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145394555|NCT01656395|524298767|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145394556|NCT01656395|524298768|FG003|Overall Study|Non-Compliance with Study Drug|0|||
145394557|NCT01656395|524298769|FG004|Overall Study|Non-Compliance with Study Drug|1|||
145394558|NCT01656395|524298770|FG005|Overall Study|Non-Compliance with Study Drug|1|||
145394559|NCT01656395|524298771|FG006|Overall Study|Non-Compliance with Study Drug|0|||
145394560|NCT01656395|524298772|FG007|Overall Study|Non-Compliance with Study Drug|0|||
145394561|NCT01656395|524298765|FG000|Overall Study|Other|0|||
145394562|NCT01656395|524298766|FG001|Overall Study|Other|0|||
145394563|NCT01656395|524298767|FG002|Overall Study|Other|1|||
145394564|NCT01656395|524298768|FG003|Overall Study|Other|0|||
145394565|NCT01656395|524298769|FG004|Overall Study|Other|0|||
145394566|NCT01656395|524298770|FG005|Overall Study|Other|1|||
145394567|NCT01656395|524298771|FG006|Overall Study|Other|0|||
145394568|NCT01656395|524298772|FG007|Overall Study|Other|0|||
145394569|NCT01656395|524298765|FG000|Overall Study|Physician Decision|2|||
145394570|NCT01656395|524298766|FG001|Overall Study|Physician Decision|3|||
145394571|NCT01656395|524298767|FG002|Overall Study|Physician Decision|3|||
145394572|NCT01656395|524298768|FG003|Overall Study|Physician Decision|2|||
145394573|NCT01656395|524298769|FG004|Overall Study|Physician Decision|3|||
145394574|NCT01656395|524298770|FG005|Overall Study|Physician Decision|3|||
145394575|NCT01656395|524298771|FG006|Overall Study|Physician Decision|0|||
145394576|NCT01656395|524298772|FG007|Overall Study|Physician Decision|0|||
145394577|NCT01656395|524298765|FG000|Overall Study|Pregnancy|0|||
145394578|NCT01656395|524298766|FG001|Overall Study|Pregnancy|0|||
145394579|NCT01656395|524298767|FG002|Overall Study|Pregnancy|1|||
145394580|NCT01656395|524298768|FG003|Overall Study|Pregnancy|0|||
145394581|NCT01656395|524298769|FG004|Overall Study|Pregnancy|0|||
145394582|NCT01656395|524298770|FG005|Overall Study|Pregnancy|0|||
145394583|NCT01656395|524298771|FG006|Overall Study|Pregnancy|0|||
145394584|NCT01656395|524298772|FG007|Overall Study|Pregnancy|0|||
145394585|NCT01656395|524298765|FG000|Overall Study|Progressive Disease|0|||
145394586|NCT01656395|524298766|FG001|Overall Study|Progressive Disease|0|||
145394587|NCT01656395|524298767|FG002|Overall Study|Progressive Disease|0|||
145394588|NCT01656395|524298768|FG003|Overall Study|Progressive Disease|0|||
145394589|NCT01656395|524298769|FG004|Overall Study|Progressive Disease|0|||
145394590|NCT01656395|524298770|FG005|Overall Study|Progressive Disease|1|||
145394591|NCT01656395|524298771|FG006|Overall Study|Progressive Disease|0|||
145394592|NCT01656395|524298772|FG007|Overall Study|Progressive Disease|0|||
145394593|NCT01656395|524298765|FG000|Overall Study|Protocol Violation|6|||
145394594|NCT01656395|524298766|FG001|Overall Study|Protocol Violation|6|||
145394595|NCT01656395|524298767|FG002|Overall Study|Protocol Violation|9|||
145394596|NCT01656395|524298768|FG003|Overall Study|Protocol Violation|2|||
145394597|NCT01656395|524298769|FG004|Overall Study|Protocol Violation|4|||
145394598|NCT01656395|524298770|FG005|Overall Study|Protocol Violation|10|||
145394599|NCT01656395|524298771|FG006|Overall Study|Protocol Violation|0|||
145394600|NCT01656395|524298772|FG007|Overall Study|Protocol Violation|0|||
145394601|NCT01656395|524298765|FG000|Overall Study|Screen Failure|2|||
145394602|NCT01656395|524298766|FG001|Overall Study|Screen Failure|1|||
145394603|NCT01656395|524298767|FG002|Overall Study|Screen Failure|7|||
145394604|NCT01656395|524298768|FG003|Overall Study|Screen Failure|1|||
145394605|NCT01656395|524298769|FG004|Overall Study|Screen Failure|0|||
145394606|NCT01656395|524298770|FG005|Overall Study|Screen Failure|8|||
145394607|NCT01656395|524298771|FG006|Overall Study|Screen Failure|0|||
145394608|NCT01656395|524298772|FG007|Overall Study|Screen Failure|0|||
145394609|NCT01656395|524298765|FG000|Overall Study|Withdrawal by Subject|3|||
145394610|NCT01656395|524298766|FG001|Overall Study|Withdrawal by Subject|1|||
145394611|NCT01656395|524298767|FG002|Overall Study|Withdrawal by Subject|4|||
145394612|NCT01656395|524298768|FG003|Overall Study|Withdrawal by Subject|2|||
145394613|NCT01656395|524298769|FG004|Overall Study|Withdrawal by Subject|0|||
145394614|NCT01656395|524298770|FG005|Overall Study|Withdrawal by Subject|3|||
145394615|NCT01656395|524298771|FG006|Overall Study|Withdrawal by Subject|0|||
145394616|NCT01656395|524298772|FG007|Overall Study|Withdrawal by Subject|0|||
145394617|NCT02048722|524298785|FG000|2 Cycles of Treatment|Adverse Event|2|||
145394618|NCT02048722|524298785|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
145394619|NCT02048722|524298785|FG000|2 Cycles of Treatment|Progressive Disease|2|||
145394620|NCT02048722|524298785|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
145394621|NCT02048722|524298785|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
145394622|NCT02048722|524298785|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
145394623|NCT00274742|524298786|FG000|Overall Study|Adverse Event|0|||
145394624|NCT00274742|524298787|FG001|Overall Study|Adverse Event|4|||
145394625|NCT00274742|524298788|FG002|Overall Study|Adverse Event|1|||
145394626|NCT00274742|524298789|FG003|Overall Study|Adverse Event|4|||
145394627|NCT00274742|524298790|FG004|Overall Study|Adverse Event|12|||
145394628|NCT00274742|524298791|FG005|Overall Study|Adverse Event|3|||
145394629|NCT00274742|524298786|FG000|Overall Study|Lost to Follow-up|0|||
145394630|NCT00274742|524298787|FG001|Overall Study|Lost to Follow-up|0|||
145394631|NCT00274742|524298788|FG002|Overall Study|Lost to Follow-up|0|||
145394632|NCT00274742|524298789|FG003|Overall Study|Lost to Follow-up|0|||
145394633|NCT00274742|524298790|FG004|Overall Study|Lost to Follow-up|1|||
145394634|NCT00274742|524298791|FG005|Overall Study|Lost to Follow-up|0|||
145394635|NCT00274742|524298786|FG000|Overall Study|End of Study|0|||
145394636|NCT00274742|524298787|FG001|Overall Study|End of Study|0|||
145394637|NCT00274742|524298788|FG002|Overall Study|End of Study|0|||
145394638|NCT00274742|524298789|FG003|Overall Study|End of Study|1|||
145394639|NCT00274742|524298790|FG004|Overall Study|End of Study|0|||
145394640|NCT00274742|524298791|FG005|Overall Study|End of Study|0|||
145394641|NCT00274742|524298786|FG000|Overall Study|Disease Progression|0|||
145496836|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145496837|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145496838|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
145496839|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145496840|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
145496841|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496842|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496843|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496844|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496845|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
145496846|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496847|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
145496848|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496849|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496850|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496851|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496852|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
145496853|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496854|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
145496855|NCT02903771|524677449|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496856|NCT02903771|524677450|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496857|NCT02903771|524677451|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496858|NCT02903771|524677452|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496859|NCT02903771|524677453|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
145496860|NCT02903771|524677454|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496861|NCT02903771|524677455|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
145496862|NCT01709721|524677456|FG000|Open Label Phase|Withdrawal by Subject|0|||
145496863|NCT01709721|524677457|FG001|Open Label Phase|Withdrawal by Subject|0|||
145496864|NCT01709721|524677458|FG002|Open Label Phase|Withdrawal by Subject|5|||
145496865|NCT01709721|524677456|FG000|Open Label Phase|Adverse Event|0|||
145496866|NCT01709721|524677457|FG001|Open Label Phase|Adverse Event|0|||
145496867|NCT01709721|524677458|FG002|Open Label Phase|Adverse Event|8|||
145496868|NCT01709721|524677456|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
145496869|NCT01709721|524677457|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
145496870|NCT01709721|524677458|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
145496871|NCT01709721|524677456|FG000|Open Label Phase|Investigator Decision|0|||
145496872|NCT01709721|524677457|FG001|Open Label Phase|Investigator Decision|0|||
145496873|NCT01709721|524677458|FG002|Open Label Phase|Investigator Decision|1|||
145496874|NCT01709721|524677456|FG000|Open Label Phase|Sponsor Decision|0|||
145731115|NCT04658186|525533605|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
145731116|NCT04658186|525533606|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
145731117|NCT04658186|525533604|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
145731118|NCT04658186|525533605|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
145731119|NCT04658186|525533606|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
145731120|NCT04658186|525533604|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
145731121|NCT04658186|525533605|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
145731122|NCT04658186|525533606|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
145731123|NCT04658186|525533604|FG000|Overall Study|PI Decision due to Participant Safety|0|||
145731124|NCT04658186|525533605|FG001|Overall Study|PI Decision due to Participant Safety|0|||
145731125|NCT04658186|525533606|FG002|Overall Study|PI Decision due to Participant Safety|1|||
145731126|NCT04658186|525533604|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
145731127|NCT04658186|525533605|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
145731128|NCT04658186|525533606|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
145731129|NCT03801902|525533607|FG000|Overall Study|Did not receive protocol treatment.|1|||
145731130|NCT03801902|525533608|FG001|Overall Study|Did not receive protocol treatment.|0|||
145731131|NCT03801902|525533609|FG002|Overall Study|Did not receive protocol treatment.|0|||
145731132|NCT03801902|525533610|FG003|Overall Study|Did not receive protocol treatment.|0|||
145731133|NCT00908232|525533611|FG000|Cycle 1 to 4|Death|5|||
145731134|NCT00908232|525533612|FG001|Cycle 1 to 4|Death|0|||
145731135|NCT00908232|525533613|FG002|Cycle 1 to 4|Death|0|||
145731136|NCT00908232|525533614|FG003|Cycle 1 to 4|Death|0|||
145731137|NCT00908232|525533611|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
145731138|NCT00908232|525533612|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
145731139|NCT00908232|525533613|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
145394642|NCT00274742|524298787|FG001|Overall Study|Disease Progression|1|||
145394643|NCT00274742|524298788|FG002|Overall Study|Disease Progression|1|||
145394644|NCT00274742|524298789|FG003|Overall Study|Disease Progression|0|||
145394645|NCT00274742|524298790|FG004|Overall Study|Disease Progression|1|||
145394646|NCT00274742|524298791|FG005|Overall Study|Disease Progression|0|||
145394647|NCT00274742|524298786|FG000|Overall Study|Other|0|||
145394648|NCT00274742|524298787|FG001|Overall Study|Other|3|||
145394649|NCT00274742|524298788|FG002|Overall Study|Other|0|||
145394650|NCT00274742|524298789|FG003|Overall Study|Other|0|||
145394651|NCT00274742|524298790|FG004|Overall Study|Other|2|||
145394652|NCT00274742|524298791|FG005|Overall Study|Other|0|||
145394653|NCT04742673|524298795|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
145394654|NCT04742673|524298796|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
145394655|NCT04073303|524298799|FG000|Overall Study|Adverse Event|0|||
145394656|NCT04073303|524298800|FG001|Overall Study|Adverse Event|2|||
145394657|NCT04073303|524298799|FG000|Overall Study|Withdrawal by Subject|16|||
145394658|NCT04073303|524298800|FG001|Overall Study|Withdrawal by Subject|36|||
145394659|NCT04073303|524298799|FG000|Overall Study|Lost to Follow-up|6|||
145394660|NCT04073303|524298800|FG001|Overall Study|Lost to Follow-up|1|||
145394661|NCT04073303|524298799|FG000|Overall Study|Protocol Deviation|0|||
145394662|NCT04073303|524298800|FG001|Overall Study|Protocol Deviation|4|||
145394663|NCT04073303|524298799|FG000|Overall Study|Other|1|||
145394664|NCT04073303|524298800|FG001|Overall Study|Other|1|||
145394665|NCT03126786|524298808|FG000|Overall Study|Adverse Event|3|||
145394666|NCT03126786|524298809|FG001|Overall Study|Adverse Event|0|||
145394667|NCT03126786|524298808|FG000|Overall Study|Lost to Follow-up|0|||
145394668|NCT03126786|524298809|FG001|Overall Study|Lost to Follow-up|1|||
145394669|NCT03126786|524298808|FG000|Overall Study|Withdrawal by Subject|3|||
145394670|NCT03126786|524298809|FG001|Overall Study|Withdrawal by Subject|1|||
145394671|NCT03113968|524298810|FG000|Overall Study|Withdrawal by Subject|31|||
145394672|NCT03113968|524298811|FG001|Overall Study|Withdrawal by Subject|4|||
145394673|NCT04805671|524298812|FG000|Overall Study|Death|2|||
145394674|NCT04805671|524298813|FG001|Overall Study|Death|7|||
145394675|NCT04805671|524298812|FG000|Overall Study|Lost to Follow-up|1|||
145394676|NCT04805671|524298813|FG001|Overall Study|Lost to Follow-up|0|||
145394677|NCT04805671|524298812|FG000|Overall Study|Withdrawal by Subject|9|||
145394678|NCT04805671|524298813|FG001|Overall Study|Withdrawal by Subject|7|||
145394679|NCT04805671|524298812|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
145394680|NCT04805671|524298813|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
145394681|NCT00096538|524298814|FG000|Overall Study|Withdrawal by Subject|1|||
145394682|NCT02686164|524298816|FG000|Overall Study|Adverse Event|1|||
145394683|NCT02686164|524298816|FG000|Overall Study|Withdrawal of consent|1|||
145394684|NCT02686164|524298816|FG000|Overall Study|Clinical progression|1|||
145394685|NCT02324361|524298817|FG000|Overall Study|Lost to Follow-up|5|||
145394686|NCT02324361|524298818|FG001|Overall Study|Lost to Follow-up|2|||
145394687|NCT04235504|524298822|FG000|Study Phase|Withdrawal by Subject|5|||
145394688|NCT04235504|524298823|FG001|Study Phase|Withdrawal by Subject|2|||
145394689|NCT04235504|524298824|FG002|Study Phase|Withdrawal by Subject|0|||
145394690|NCT04235504|524298825|FG003|Study Phase|Withdrawal by Subject|0|||
145394691|NCT04235504|524298822|FG000|Continuation Phase|Withdrawal by Subject|0|||
145394692|NCT04235504|524298823|FG001|Continuation Phase|Withdrawal by Subject|4|||
145394693|NCT04235504|524298824|FG002|Continuation Phase|Withdrawal by Subject|0|||
145394694|NCT04235504|524298825|FG003|Continuation Phase|Withdrawal by Subject|0|||
145394695|NCT04235504|524298822|FG000|Continuation Phase|Adverse Event|0|||
145394696|NCT04235504|524298823|FG001|Continuation Phase|Adverse Event|1|||
145394697|NCT04235504|524298824|FG002|Continuation Phase|Adverse Event|0|||
145394698|NCT04235504|524298825|FG003|Continuation Phase|Adverse Event|0|||
145394699|NCT04235504|524298822|FG000|Continuation Phase|Physician Decision|1|||
145394700|NCT04235504|524298823|FG001|Continuation Phase|Physician Decision|2|||
145394701|NCT04235504|524298824|FG002|Continuation Phase|Physician Decision|1|||
145394702|NCT04235504|524298825|FG003|Continuation Phase|Physician Decision|0|||
145394703|NCT04001803|524298832|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
145394704|NCT04001803|524298832|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
145394705|NCT04001803|524298832|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
145394706|NCT04001803|524298832|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
145394707|NCT04001803|524298832|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
145394708|NCT04001803|524298832|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
145394709|NCT04001803|524298832|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
145394710|NCT04001803|524298832|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
145394711|NCT04001803|524298832|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
145394712|NCT04001803|524298832|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
145394713|NCT01931397|524298833|FG000|Overall Study|Physician Decision|2|||
145394714|NCT01931397|524298833|FG000|Overall Study|Withdrawal by Subject|8|||
145394715|NCT01931397|524298833|FG000|Overall Study|moved out of state|1|||
145394716|NCT02493517|524298837|FG000|Overall Study|Protocol Violation|1|||
145496875|NCT01709721|524677457|FG001|Open Label Phase|Sponsor Decision|0|||
145496876|NCT01709721|524677458|FG002|Open Label Phase|Sponsor Decision|2|||
145496877|NCT01709721|524677456|FG000|Open Label Phase|Protocol Violation|0|||
145496878|NCT01709721|524677457|FG001|Open Label Phase|Protocol Violation|0|||
145496879|NCT01709721|524677458|FG002|Open Label Phase|Protocol Violation|1|||
145731140|NCT00908232|525533614|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
145731141|NCT00908232|525533611|FG000|Cycle 1 to 4|Progressive Disease|6|||
145731142|NCT00908232|525533612|FG001|Cycle 1 to 4|Progressive Disease|0|||
145731143|NCT00908232|525533613|FG002|Cycle 1 to 4|Progressive Disease|0|||
145731144|NCT00908232|525533614|FG003|Cycle 1 to 4|Progressive Disease|0|||
145731145|NCT00908232|525533611|FG000|Cycle 1 to 4|Adverse Event|12|||
145731146|NCT00908232|525533612|FG001|Cycle 1 to 4|Adverse Event|0|||
145731147|NCT00908232|525533613|FG002|Cycle 1 to 4|Adverse Event|0|||
145731148|NCT00908232|525533614|FG003|Cycle 1 to 4|Adverse Event|0|||
145731149|NCT00908232|525533611|FG000|Cycle 1 to 4|Other|1|||
145731150|NCT00908232|525533612|FG001|Cycle 1 to 4|Other|0|||
145731151|NCT00908232|525533613|FG002|Cycle 1 to 4|Other|0|||
145731152|NCT00908232|525533614|FG003|Cycle 1 to 4|Other|0|||
145731153|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
145731154|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
145731155|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
145731156|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
145731157|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
145731158|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
145731159|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
145731160|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
145731161|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
145731162|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
145731163|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
145731164|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
145731165|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
145731166|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
145731167|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
145731168|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
145731169|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
145731170|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
145731171|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
145731172|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
145731173|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
145731174|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
145731175|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
145731176|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
145731177|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
145731178|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
145731179|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
145731180|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
145496880|NCT01709721|524677456|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
145731181|NCT00908232|525533611|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
145731182|NCT00908232|525533612|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
145731183|NCT00908232|525533613|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
145731184|NCT00908232|525533614|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
145394717|NCT02493517|524298838|FG001|Overall Study|Protocol Violation|2|||
145394718|NCT02493517|524298837|FG000|Overall Study|Withdrawal by Subject|1|||
145394719|NCT02493517|524298838|FG001|Overall Study|Withdrawal by Subject|2|||
145394720|NCT02493517|524298837|FG000|Overall Study|Adverse Event|0|||
145394721|NCT02493517|524298838|FG001|Overall Study|Adverse Event|2|||
145394722|NCT02493517|524298837|FG000|Overall Study|Missed study visit|0|||
145394723|NCT02493517|524298838|FG001|Overall Study|Missed study visit|1|||
145394724|NCT01367249|524298839|FG000|Overall Study|Withdrawal by Subject|6|||
145394725|NCT01367249|524298840|FG001|Overall Study|Withdrawal by Subject|6|||
145394726|NCT01367249|524298839|FG000|Overall Study|Other|3|||
145394727|NCT01367249|524298840|FG001|Overall Study|Other|10|||
145394728|NCT05404711|524298841|FG000|Completed Study Visit|Withdrawal by Subject|1|||
145394729|NCT05404711|524298841|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
145394730|NCT05404711|524298841|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
145394731|NCT05404711|524298841|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
145394732|NCT05404711|524298841|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
145394733|NCT05404711|524298841|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
145394734|NCT02058589|524298842|FG000|Overall Study|Serious Adverse Event|1|||
145394735|NCT02058589|524298843|FG001|Overall Study|Serious Adverse Event|1|||
145394736|NCT02058589|524298842|FG000|Overall Study|Non-Serious Adverse Event|1|||
145394737|NCT02058589|524298843|FG001|Overall Study|Non-Serious Adverse Event|0|||
145394738|NCT02058589|524298842|FG000|Overall Study|Withdrawal by Subject|0|||
145394739|NCT02058589|524298843|FG001|Overall Study|Withdrawal by Subject|1|||
145394740|NCT02346877|524298844|FG000|Overall Study|Adverse Event|1|||
145394741|NCT02346877|524298845|FG001|Overall Study|Adverse Event|0|||
145394742|NCT02346877|524298844|FG000|Overall Study|Administrative Decision|1|||
145394743|NCT02346877|524298845|FG001|Overall Study|Administrative Decision|0|||
145394744|NCT02346877|524298844|FG000|Overall Study|Sponsor Decision|12|||
145394745|NCT02346877|524298845|FG001|Overall Study|Sponsor Decision|0|||
145394746|NCT02346877|524298844|FG000|Overall Study|Missing|5|||
145394747|NCT02346877|524298845|FG001|Overall Study|Missing|0|||
145394748|NCT00490971|524298847|FG000|Acute/Continuation|Adverse Event|62|||
145394749|NCT00490971|524298848|FG001|Acute/Continuation|Adverse Event|13|||
145394750|NCT00490971|524298849|FG002|Acute/Continuation|Adverse Event|0|||
145394751|NCT00490971|524298850|FG003|Acute/Continuation|Adverse Event|0|||
145394752|NCT00490971|524298851|FG004|Acute/Continuation|Adverse Event|0|||
145394753|NCT00490971|524298847|FG000|Acute/Continuation|Death|2|||
145394754|NCT00490971|524298848|FG001|Acute/Continuation|Death|0|||
145394755|NCT00490971|524298849|FG002|Acute/Continuation|Death|0|||
145394756|NCT00490971|524298850|FG003|Acute/Continuation|Death|0|||
145394757|NCT00490971|524298851|FG004|Acute/Continuation|Death|0|||
145394758|NCT00490971|524298847|FG000|Acute/Continuation|Lack of Efficacy|106|||
145394759|NCT00490971|524298848|FG001|Acute/Continuation|Lack of Efficacy|12|||
145394760|NCT00490971|524298849|FG002|Acute/Continuation|Lack of Efficacy|0|||
145394761|NCT00490971|524298850|FG003|Acute/Continuation|Lack of Efficacy|0|||
145394762|NCT00490971|524298851|FG004|Acute/Continuation|Lack of Efficacy|0|||
145394763|NCT00490971|524298847|FG000|Acute/Continuation|Lost to Follow-up|23|||
145394764|NCT00490971|524298848|FG001|Acute/Continuation|Lost to Follow-up|7|||
145394765|NCT00490971|524298849|FG002|Acute/Continuation|Lost to Follow-up|0|||
145394766|NCT00490971|524298850|FG003|Acute/Continuation|Lost to Follow-up|0|||
145394767|NCT00490971|524298851|FG004|Acute/Continuation|Lost to Follow-up|0|||
145394768|NCT00490971|524298847|FG000|Acute/Continuation|Protocol Violation|10|||
145394769|NCT00490971|524298848|FG001|Acute/Continuation|Protocol Violation|2|||
145394770|NCT00490971|524298849|FG002|Acute/Continuation|Protocol Violation|0|||
145394771|NCT00490971|524298850|FG003|Acute/Continuation|Protocol Violation|0|||
145394772|NCT00490971|524298851|FG004|Acute/Continuation|Protocol Violation|0|||
145394773|NCT00490971|524298847|FG000|Acute/Continuation|Withdrawal by Subject|92|||
145394774|NCT00490971|524298848|FG001|Acute/Continuation|Withdrawal by Subject|24|||
145394775|NCT00490971|524298849|FG002|Acute/Continuation|Withdrawal by Subject|0|||
145394776|NCT00490971|524298850|FG003|Acute/Continuation|Withdrawal by Subject|0|||
145394777|NCT00490971|524298851|FG004|Acute/Continuation|Withdrawal by Subject|0|||
145394778|NCT00490971|524298847|FG000|Acute/Continuation|Other|11|||
145394779|NCT00490971|524298848|FG001|Acute/Continuation|Other|4|||
145394780|NCT00490971|524298849|FG002|Acute/Continuation|Other|0|||
145394781|NCT00490971|524298850|FG003|Acute/Continuation|Other|0|||
145394782|NCT00490971|524298851|FG004|Acute/Continuation|Other|0|||
145394783|NCT00490971|524298847|FG000|Maintenance|Adverse Event|0|||
145394784|NCT00490971|524298848|FG001|Maintenance|Adverse Event|0|||
145394785|NCT00490971|524298849|FG002|Maintenance|Adverse Event|4|||
145394786|NCT00490971|524298850|FG003|Maintenance|Adverse Event|5|||
145394787|NCT00490971|524298851|FG004|Maintenance|Adverse Event|7|||
145394788|NCT00490971|524298847|FG000|Maintenance|Death|0|||
145394789|NCT00490971|524298848|FG001|Maintenance|Death|0|||
145394790|NCT00490971|524298849|FG002|Maintenance|Death|0|||
145394791|NCT00490971|524298850|FG003|Maintenance|Death|2|||
145394792|NCT00490971|524298851|FG004|Maintenance|Death|0|||
145394793|NCT00490971|524298847|FG000|Maintenance|Lost to Follow-up|0|||
145394794|NCT00490971|524298848|FG001|Maintenance|Lost to Follow-up|0|||
145394795|NCT00490971|524298849|FG002|Maintenance|Lost to Follow-up|5|||
145394796|NCT00490971|524298850|FG003|Maintenance|Lost to Follow-up|8|||
145394797|NCT00490971|524298851|FG004|Maintenance|Lost to Follow-up|10|||
145394798|NCT00490971|524298847|FG000|Maintenance|Pregnancy|0|||
145394799|NCT00490971|524298848|FG001|Maintenance|Pregnancy|0|||
145394800|NCT00490971|524298849|FG002|Maintenance|Pregnancy|1|||
145394801|NCT00490971|524298850|FG003|Maintenance|Pregnancy|0|||
145394802|NCT00490971|524298851|FG004|Maintenance|Pregnancy|0|||
145394803|NCT00490971|524298847|FG000|Maintenance|Protocol Violation|0|||
145394804|NCT00490971|524298848|FG001|Maintenance|Protocol Violation|0|||
145394805|NCT00490971|524298849|FG002|Maintenance|Protocol Violation|4|||
145394806|NCT00490971|524298850|FG003|Maintenance|Protocol Violation|1|||
145394807|NCT00490971|524298851|FG004|Maintenance|Protocol Violation|1|||
145731185|NCT02260882|525533615|FG000|Overall Study|Protocol Violation|0|||
145394808|NCT00490971|524298847|FG000|Maintenance|Withdrawal by Subject|0|||
145394809|NCT00490971|524298848|FG001|Maintenance|Withdrawal by Subject|0|||
145394810|NCT00490971|524298849|FG002|Maintenance|Withdrawal by Subject|26|||
145394811|NCT00490971|524298850|FG003|Maintenance|Withdrawal by Subject|28|||
145394812|NCT00490971|524298851|FG004|Maintenance|Withdrawal by Subject|18|||
145394813|NCT00490971|524298847|FG000|Maintenance|Other|0|||
145394814|NCT00490971|524298848|FG001|Maintenance|Other|0|||
145394815|NCT00490971|524298849|FG002|Maintenance|Other|11|||
145394816|NCT00490971|524298850|FG003|Maintenance|Other|9|||
145394817|NCT00490971|524298851|FG004|Maintenance|Other|3|||
145731186|NCT02260882|525533616|FG001|Overall Study|Protocol Violation|1|||
145394818|NCT04980014|524300674|FG000|Overall Study|Participants who are Duplicated|1|||
145394819|NCT04980014|524300674|FG000|Overall Study|Follow-up Failure|13|||
145731187|NCT02119325|525533617|FG000|Washout Period 1|Adverse Event|0|||
145731188|NCT02119325|525533618|FG001|Washout Period 1|Adverse Event|1|||
145731189|NCT01601847|525533619|FG000|Overall Study|Death|1|||
145731190|NCT01601847|525533620|FG001|Overall Study|Death|0|||
145731191|NCT01601847|525533619|FG000|Overall Study|Withdrawal by Subject|11|||
145731192|NCT01601847|525533620|FG001|Overall Study|Withdrawal by Subject|7|||
145731193|NCT01601847|525533619|FG000|Overall Study|Lost to Follow-up|1|||
145394820|NCT04980014|524300674|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
145394821|NCT04980014|524300674|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
145394822|NCT04980014|524300674|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
145394823|NCT02317991|524300675|FG000|Overall Study|Adverse Event|12|||
145394824|NCT02317991|524300675|FG000|Overall Study|Death|4|||
145394825|NCT02317991|524300675|FG000|Overall Study|Withdrawal by Subject|8|||
145394826|NCT02317991|524300675|FG000|Overall Study|Progressive Disease|41|||
145394827|NCT01051921|524300677|FG000|Overall Study|Physician Decision|9|||
145394828|NCT01051921|524300677|FG000|Overall Study|Adverse Event|8|||
145394829|NCT01051921|524300677|FG000|Overall Study|Withdrawal by Subject|7|||
145394830|NCT01051921|524300677|FG000|Overall Study|Lost to Follow-up|4|||
145394831|NCT01051921|524300677|FG000|Overall Study|virological failure|1|||
145394832|NCT01051921|524300677|FG000|Overall Study|patient moved|1|||
145394833|NCT01001429|524300678|FG000|Overall Study|surgery cancelled|0|||
145394834|NCT01001429|524300679|FG001|Overall Study|surgery cancelled|1|||
145394835|NCT01063855|524300680|FG000|Overall Study|Adverse Event|4|||
145394836|NCT01063855|524300681|FG001|Overall Study|Adverse Event|4|||
145394837|NCT01063855|524300680|FG000|Overall Study|Death|0|||
145394838|NCT01063855|524300681|FG001|Overall Study|Death|1|||
145394839|NCT01063855|524300680|FG000|Overall Study|Lost to Follow-up|8|||
145394840|NCT01063855|524300681|FG001|Overall Study|Lost to Follow-up|4|||
145394841|NCT01063855|524300680|FG000|Overall Study|Pregnancy|1|||
145394842|NCT01063855|524300681|FG001|Overall Study|Pregnancy|0|||
145394843|NCT01063855|524300680|FG000|Overall Study|Lack of Efficacy|0|||
145394844|NCT01063855|524300681|FG001|Overall Study|Lack of Efficacy|1|||
145394845|NCT01063855|524300680|FG000|Overall Study|Withdrawal by Subject|11|||
145394846|NCT01063855|524300681|FG001|Overall Study|Withdrawal by Subject|8|||
145394847|NCT01063855|524300680|FG000|Overall Study|Reason not specified|13|||
145394848|NCT01063855|524300681|FG001|Overall Study|Reason not specified|11|||
145394849|NCT01165307|524300682|FG000|Overall Study|Lost to Follow-up|11|||
145394850|NCT01165307|524300683|FG001|Overall Study|Lost to Follow-up|3|||
145394851|NCT01165307|524300682|FG000|Overall Study|Withdrawal by Subject|2|||
145394852|NCT01165307|524300683|FG001|Overall Study|Withdrawal by Subject|0|||
145394853|NCT01165307|524300682|FG000|Overall Study|Subject not available for contact|1|||
145394854|NCT01165307|524300683|FG001|Overall Study|Subject not available for contact|0|||
145394855|NCT03627832|524300688|FG000|Overall Study|Withdrawal by Subject|10|||
145394856|NCT03627832|524300689|FG001|Overall Study|Withdrawal by Subject|1|||
145394857|NCT00048035|524300690|FG000|Core Period|Early Withdrawals|4|||
145394858|NCT00048035|524300691|FG001|Core Period|Early Withdrawals|2|||
145394859|NCT00048035|524300692|FG002|Core Period|Early Withdrawals|1|||
145394860|NCT00048035|524300693|FG003|Core Period|Early Withdrawals|1|||
145394861|NCT00048035|524300694|FG004|Core Period|Early Withdrawals|1|||
145394862|NCT00048035|524300695|FG005|Core Period|Early Withdrawals|1|||
145394863|NCT00048035|524300696|FG006|Core Period|Early Withdrawals|0|||
145394864|NCT00048035|524300697|FG007|Core Period|Early Withdrawals|0|||
145394865|NCT00048035|524300690|FG000|Extension Year 1|Early Withdrawals|0|||
145394866|NCT00048035|524300691|FG001|Extension Year 1|Early Withdrawals|0|||
145394867|NCT00048035|524300692|FG002|Extension Year 1|Early Withdrawals|0|||
145394868|NCT00048035|524300693|FG003|Extension Year 1|Early Withdrawals|0|||
145394869|NCT00048035|524300694|FG004|Extension Year 1|Early Withdrawals|0|||
145394870|NCT00048035|524300695|FG005|Extension Year 1|Early Withdrawals|0|||
145394871|NCT00048035|524300696|FG006|Extension Year 1|Early Withdrawals|11|||
145394872|NCT00048035|524300697|FG007|Extension Year 1|Early Withdrawals|11|||
145394873|NCT00048035|524300690|FG000|Extension Year 2|Early Withdrawals|0|||
145394874|NCT00048035|524300691|FG001|Extension Year 2|Early Withdrawals|0|||
145394875|NCT00048035|524300692|FG002|Extension Year 2|Early Withdrawals|0|||
145394876|NCT00048035|524300693|FG003|Extension Year 2|Early Withdrawals|0|||
145394877|NCT00048035|524300694|FG004|Extension Year 2|Early Withdrawals|0|||
145394878|NCT00048035|524300695|FG005|Extension Year 2|Early Withdrawals|0|||
145394879|NCT00048035|524300696|FG006|Extension Year 2|Early Withdrawals|3|||
145394880|NCT00048035|524300697|FG007|Extension Year 2|Early Withdrawals|3|||
145394881|NCT05137717|524300698|FG000|Overall Study|Death|2|||
145394882|NCT05137717|524300698|FG000|Overall Study|Withdrawal by Subject|6|||
145394883|NCT00509899|524300699|FG000|Overall Study|Progressive disease|1|||
145394884|NCT00509899|524300700|FG001|Overall Study|Progressive disease|3|||
145731194|NCT01601847|525533620|FG001|Overall Study|Lost to Follow-up|3|||
145394885|NCT00509899|524300701|FG002|Overall Study|Progressive disease|5|||
145394886|NCT00509899|524300702|FG003|Overall Study|Progressive disease|1|||
145394887|NCT00509899|524300703|FG004|Overall Study|Progressive disease|0|||
145394888|NCT00509899|524300704|FG005|Overall Study|Progressive disease|1|||
145394889|NCT00509899|524300705|FG006|Overall Study|Progressive disease|0|||
145731195|NCT00954174|525533626|FG000|Overall Study|Adverse Event|28|||
145496881|NCT01709721|524677457|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
145496882|NCT01709721|524677458|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
145496883|NCT01709721|524677456|FG000|Open Label Phase|Inadequate Pain Control|0|||
145496884|NCT01709721|524677457|FG001|Open Label Phase|Inadequate Pain Control|0|||
145496885|NCT01709721|524677458|FG002|Open Label Phase|Inadequate Pain Control|37|||
145496886|NCT01709721|524677456|FG000|Open Label Phase|Other, Specify in text field in database|0|||
145496887|NCT01709721|524677457|FG001|Open Label Phase|Other, Specify in text field in database|0|||
145496888|NCT01709721|524677458|FG002|Open Label Phase|Other, Specify in text field in database|14|||
145496889|NCT01709721|524677456|FG000|Randomized Phase|Adverse Event|0|||
145496890|NCT01709721|524677457|FG001|Randomized Phase|Adverse Event|1|||
145496891|NCT01709721|524677458|FG002|Randomized Phase|Adverse Event|0|||
145496892|NCT01709721|524677456|FG000|Randomized Phase|Lost to Follow-up|1|||
145496893|NCT01709721|524677457|FG001|Randomized Phase|Lost to Follow-up|0|||
145496894|NCT01709721|524677458|FG002|Randomized Phase|Lost to Follow-up|0|||
145496895|NCT01709721|524677456|FG000|Randomized Phase|Inadequate Pain Control|1|||
145496896|NCT01709721|524677457|FG001|Randomized Phase|Inadequate Pain Control|2|||
145496897|NCT01709721|524677458|FG002|Randomized Phase|Inadequate Pain Control|0|||
145496898|NCT01709721|524677456|FG000|Randomized Phase|Other, Specify text field in database|1|||
145496899|NCT01709721|524677457|FG001|Randomized Phase|Other, Specify text field in database|3|||
145496900|NCT01709721|524677458|FG002|Randomized Phase|Other, Specify text field in database|0|||
145496901|NCT01310777|524677459|FG000|Overall Study|Adverse Event|23|||
145496902|NCT01310777|524677460|FG001|Overall Study|Adverse Event|1|||
145496903|NCT01310777|524677461|FG002|Overall Study|Adverse Event|15|||
145496904|NCT01310777|524677459|FG000|Overall Study|Lost to Follow-up|0|||
145496905|NCT01310777|524677460|FG001|Overall Study|Lost to Follow-up|4|||
145496906|NCT01310777|524677461|FG002|Overall Study|Lost to Follow-up|1|||
145496907|NCT01310777|524677459|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
145496908|NCT01310777|524677460|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
145496909|NCT01310777|524677461|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
145496910|NCT01310777|524677459|FG000|Overall Study|Inadequate Control of IOP|5|||
145496911|NCT01310777|524677460|FG001|Overall Study|Inadequate Control of IOP|7|||
145496912|NCT01310777|524677461|FG002|Overall Study|Inadequate Control of IOP|10|||
145496913|NCT01310777|524677459|FG000|Overall Study|Other|4|||
145496914|NCT01310777|524677460|FG001|Overall Study|Other|1|||
145496915|NCT01310777|524677461|FG002|Overall Study|Other|2|||
145496916|NCT03697252|524677468|FG000|Overall Study|Adverse Event|3|||
145496917|NCT03697252|524677469|FG001|Overall Study|Adverse Event|2|||
145496918|NCT03697252|524677468|FG000|Overall Study|Withdrawal by Subject|14|||
145496919|NCT03697252|524677469|FG001|Overall Study|Withdrawal by Subject|14|||
145496920|NCT03697252|524677468|FG000|Overall Study|Lost to Follow-up|0|||
145496921|NCT03697252|524677469|FG001|Overall Study|Lost to Follow-up|1|||
145496922|NCT03697252|524677468|FG000|Overall Study|Physician Decision|1|||
145496923|NCT03697252|524677469|FG001|Overall Study|Physician Decision|1|||
145496924|NCT03697252|524677468|FG000|Overall Study|Other|0|||
145496925|NCT03697252|524677469|FG001|Overall Study|Other|1|||
145496926|NCT03125395|524677470|FG000|Overall Study|Adverse Event|2|||
145496927|NCT03125395|524677470|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145394890|NCT00509899|524300706|FG007|Overall Study|Progressive disease|0|||
145394891|NCT00509899|524300699|FG000|Overall Study|Unacceptable Toxicity|1|||
145394892|NCT00509899|524300700|FG001|Overall Study|Unacceptable Toxicity|0|||
145394893|NCT00509899|524300701|FG002|Overall Study|Unacceptable Toxicity|0|||
145394894|NCT00509899|524300702|FG003|Overall Study|Unacceptable Toxicity|2|||
145394895|NCT00509899|524300703|FG004|Overall Study|Unacceptable Toxicity|0|||
145394896|NCT00509899|524300704|FG005|Overall Study|Unacceptable Toxicity|0|||
145394897|NCT00509899|524300705|FG006|Overall Study|Unacceptable Toxicity|0|||
145394898|NCT00509899|524300706|FG007|Overall Study|Unacceptable Toxicity|0|||
145394899|NCT00509899|524300699|FG000|Overall Study|Withdrawal by Subject|6|||
145394900|NCT00509899|524300700|FG001|Overall Study|Withdrawal by Subject|2|||
145394901|NCT00509899|524300701|FG002|Overall Study|Withdrawal by Subject|3|||
145394902|NCT00509899|524300702|FG003|Overall Study|Withdrawal by Subject|0|||
145394903|NCT00509899|524300703|FG004|Overall Study|Withdrawal by Subject|3|||
145496928|NCT03125395|524677470|FG000|Overall Study|Physician Decision|2|||
145496929|NCT03125395|524677470|FG000|Overall Study|Commercial drug is available|5|||
145496930|NCT00106704|524677471|FG000|Overall Study|Adverse Event|10|||
145496931|NCT00106704|524677472|FG001|Overall Study|Adverse Event|7|||
145496932|NCT00106704|524677471|FG000|Overall Study|Death|2|||
145496933|NCT00106704|524677472|FG001|Overall Study|Death|1|||
145496934|NCT00106704|524677471|FG000|Overall Study|Lack of Efficacy|67|||
145496935|NCT00106704|524677472|FG001|Overall Study|Lack of Efficacy|69|||
145496936|NCT00106704|524677471|FG000|Overall Study|Lost to Follow-up|7|||
145496937|NCT00106704|524677472|FG001|Overall Study|Lost to Follow-up|3|||
145496938|NCT00106704|524677471|FG000|Overall Study|Pregnancy|1|||
145496939|NCT00106704|524677472|FG001|Overall Study|Pregnancy|0|||
145496940|NCT00106704|524677471|FG000|Overall Study|Protocol Violation|4|||
145496941|NCT00106704|524677472|FG001|Overall Study|Protocol Violation|7|||
145496942|NCT00106704|524677471|FG000|Overall Study|Withdrawal by Subject|14|||
145496943|NCT00106704|524677472|FG001|Overall Study|Withdrawal by Subject|21|||
145496944|NCT00106704|524677471|FG000|Overall Study|Patient moved|1|||
145731196|NCT00954174|525533627|FG001|Overall Study|Adverse Event|23|||
145731197|NCT00954174|525533628|FG002|Overall Study|Adverse Event|4|||
145731198|NCT00954174|525533629|FG003|Overall Study|Adverse Event|9|||
145496945|NCT00106704|524677472|FG001|Overall Study|Patient moved|0|||
145496946|NCT00106704|524677471|FG000|Overall Study|Site terminated|0|||
145496947|NCT00106704|524677472|FG001|Overall Study|Site terminated|1|||
145496948|NCT00106704|524677471|FG000|Overall Study|Planned major surgery|1|||
145496949|NCT00106704|524677472|FG001|Overall Study|Planned major surgery|0|||
145496950|NCT00106704|524677471|FG000|Overall Study|Patient Received Glycemic Medication|22|||
145496951|NCT00106704|524677472|FG001|Overall Study|Patient Received Glycemic Medication|41|||
145496952|NCT00106704|524677471|FG000|Overall Study|Unable to re-enter US|1|||
145496953|NCT00106704|524677472|FG001|Overall Study|Unable to re-enter US|0|||
145496954|NCT00106704|524677471|FG000|Overall Study|Laboratory test|1|||
145496955|NCT00106704|524677472|FG001|Overall Study|Laboratory test|1|||
145496956|NCT01780506|524677473|FG000|Double-Blind Phase|Randomized but not Treated|3|||
145496957|NCT01780506|524677474|FG001|Double-Blind Phase|Randomized but not Treated|2|||
145496958|NCT01780506|524677473|FG000|Double-Blind Phase|Adverse Event|4|||
145496959|NCT01780506|524677474|FG001|Double-Blind Phase|Adverse Event|14|||
145496960|NCT01780506|524677473|FG000|Double-Blind Phase|Death|1|||
145496961|NCT01780506|524677474|FG001|Double-Blind Phase|Death|2|||
145496962|NCT01780506|524677473|FG000|Double-Blind Phase|Pregnancy|2|||
145731199|NCT00954174|525533626|FG000|Overall Study|Death|4|||
145731200|NCT00954174|525533627|FG001|Overall Study|Death|2|||
145731201|NCT00954174|525533628|FG002|Overall Study|Death|0|||
145731202|NCT00954174|525533629|FG003|Overall Study|Death|0|||
145731203|NCT00954174|525533626|FG000|Overall Study|Lack of Efficacy|32|||
145731204|NCT00954174|525533627|FG001|Overall Study|Lack of Efficacy|22|||
145731205|NCT00954174|525533628|FG002|Overall Study|Lack of Efficacy|8|||
145731206|NCT00954174|525533629|FG003|Overall Study|Lack of Efficacy|6|||
145731207|NCT00954174|525533626|FG000|Overall Study|Withdrawal by Subject|14|||
145731208|NCT00954174|525533627|FG001|Overall Study|Withdrawal by Subject|10|||
145731209|NCT00954174|525533628|FG002|Overall Study|Withdrawal by Subject|4|||
145731210|NCT00954174|525533629|FG003|Overall Study|Withdrawal by Subject|3|||
145731211|NCT00954174|525533626|FG000|Overall Study|Medical Reason|4|||
145496963|NCT01780506|524677474|FG001|Double-Blind Phase|Pregnancy|1|||
145496964|NCT01780506|524677473|FG000|Double-Blind Phase|Lack of Efficacy|1|||
145496965|NCT01780506|524677474|FG001|Double-Blind Phase|Lack of Efficacy|1|||
145496966|NCT01780506|524677473|FG000|Double-Blind Phase|Investigator's Discretion|5|||
145496967|NCT01780506|524677474|FG001|Double-Blind Phase|Investigator's Discretion|2|||
145496968|NCT01780506|524677473|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
145496969|NCT01780506|524677474|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
145496970|NCT01780506|524677473|FG000|Double-Blind Phase|Protocol Violation|4|||
145496971|NCT01780506|524677474|FG001|Double-Blind Phase|Protocol Violation|3|||
145496972|NCT01780506|524677473|FG000|Double-Blind Phase|Withdrew Consent|23|||
145496973|NCT01780506|524677474|FG001|Double-Blind Phase|Withdrew Consent|24|||
145496974|NCT01780506|524677473|FG000|Double-Blind Phase|Lost to Follow-up|23|||
145496975|NCT01780506|524677474|FG001|Double-Blind Phase|Lost to Follow-up|26|||
145496976|NCT01780506|524677473|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
145496977|NCT01780506|524677474|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
145496978|NCT03486912|524677478|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
145496979|NCT03486912|524677479|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
145496980|NCT03486912|524677480|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
145496981|NCT03486912|524677481|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
145496982|NCT03486912|524677478|FG000|Treatment Period|Withdrawal by Subject|3|||
145496983|NCT03486912|524677479|FG001|Treatment Period|Withdrawal by Subject|3|||
145496984|NCT03486912|524677480|FG002|Treatment Period|Withdrawal by Subject|3|||
145731212|NCT00954174|525533627|FG001|Overall Study|Medical Reason|2|||
145731213|NCT00954174|525533628|FG002|Overall Study|Medical Reason|1|||
145731214|NCT00954174|525533629|FG003|Overall Study|Medical Reason|0|||
145731215|NCT00954174|525533626|FG000|Overall Study|Ineligible|40|||
145731216|NCT00954174|525533627|FG001|Overall Study|Ineligible|47|||
145731217|NCT00954174|525533628|FG002|Overall Study|Ineligible|7|||
145731218|NCT00954174|525533629|FG003|Overall Study|Ineligible|4|||
145731219|NCT00954174|525533626|FG000|Overall Study|Never Treated|4|||
145731220|NCT00954174|525533627|FG001|Overall Study|Never Treated|17|||
145731221|NCT00954174|525533628|FG002|Overall Study|Never Treated|0|||
145731222|NCT00954174|525533629|FG003|Overall Study|Never Treated|3|||
145731223|NCT02234323|525533630|FG000|All Enrolled|Not Treated: Completed study in database|2|||
145731224|NCT02234323|525533630|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
145731225|NCT02234323|525533630|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
145731226|NCT02234323|525533630|FG000|All Treated|Death|1|||
145731227|NCT02234323|525533630|FG000|All Treated|Physician Decision|5|||
145731228|NCT02234323|525533630|FG000|All Treated|Lack of Efficacy|3|||
145731229|NCT02234323|525533630|FG000|All Treated|Exceeded lab value limit|2|||
145731230|NCT02234323|525533630|FG000|All Treated|Other|7|||
145731231|NCT04209621|525533631|FG000|Overall Study|Death|1|||
145731232|NCT04209621|525533631|FG000|Overall Study|Study Terminated Early|2|||
145731233|NCT02249767|525533632|FG000|Overall Study|Did not use medication|8|||
145731234|NCT02249767|525533633|FG001|Overall Study|Did not use medication|9|||
145731235|NCT02249767|525533634|FG002|Overall Study|Did not use medication|8|||
145731236|NCT01372410|525533635|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
145731237|NCT01372410|525533636|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
145731238|NCT01372410|525533637|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
145731239|NCT01372410|525533638|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
145731240|NCT01372410|525533639|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
145731241|NCT01372410|525533640|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
145731242|NCT01372410|525533641|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
145731243|NCT01372410|525533642|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
145731244|NCT01372410|525533635|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731245|NCT01372410|525533636|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
145731246|NCT01372410|525533637|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731247|NCT01372410|525533638|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731248|NCT01372410|525533639|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731249|NCT01372410|525533640|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731250|NCT01372410|525533641|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
145731251|NCT01372410|525533642|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
145731252|NCT01372410|525533635|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731253|NCT01372410|525533636|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731254|NCT01372410|525533637|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731255|NCT01372410|525533638|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731256|NCT01372410|525533639|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
145731257|NCT01372410|525533640|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731258|NCT01372410|525533641|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731259|NCT01372410|525533642|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145731260|NCT01372410|525533635|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731261|NCT01372410|525533636|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731262|NCT01372410|525533637|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731263|NCT01372410|525533638|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731264|NCT01372410|525533639|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731265|NCT01372410|525533640|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731266|NCT01372410|525533641|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
145731267|NCT01372410|525533642|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
145731268|NCT01372410|525533635|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
145731269|NCT01372410|525533636|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731270|NCT01372410|525533637|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731271|NCT01372410|525533638|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731272|NCT01372410|525533639|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731273|NCT01372410|525533640|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731274|NCT01372410|525533641|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
145731275|NCT01372410|525533642|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
145731276|NCT01372410|525533635|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731277|NCT01372410|525533636|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731278|NCT01372410|525533637|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731279|NCT01372410|525533638|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731280|NCT01372410|525533639|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
145731281|NCT01372410|525533640|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731282|NCT01372410|525533641|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731283|NCT01372410|525533642|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
145731284|NCT01372410|525533635|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
145731285|NCT01372410|525533636|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
145731286|NCT01372410|525533637|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
145731287|NCT01372410|525533638|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
145731288|NCT01372410|525533639|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
145731289|NCT01372410|525533640|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
145731290|NCT01372410|525533641|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
145731291|NCT01372410|525533642|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
145731292|NCT01372410|525533635|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731293|NCT01372410|525533636|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731294|NCT01372410|525533637|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731295|NCT01372410|525533638|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731296|NCT01372410|525533639|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731297|NCT01372410|525533640|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731298|NCT01372410|525533641|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
145731299|NCT01372410|525533642|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
145731300|NCT01372410|525533635|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731301|NCT01372410|525533636|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731302|NCT01372410|525533637|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
145731303|NCT01372410|525533638|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731304|NCT01372410|525533639|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731305|NCT01372410|525533640|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731306|NCT01372410|525533641|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731307|NCT01372410|525533642|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
145731308|NCT01372410|525533635|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731309|NCT01372410|525533636|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731310|NCT01372410|525533637|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731311|NCT01372410|525533638|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731312|NCT01372410|525533639|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731313|NCT01372410|525533640|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
145731314|NCT01372410|525533641|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145731315|NCT01372410|525533642|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
145496985|NCT03486912|524677481|FG003|Treatment Period|Withdrawal by Subject|2|||
145496986|NCT03486912|524677478|FG000|Treatment Period|Other Reasons|0|||
145496987|NCT03486912|524677479|FG001|Treatment Period|Other Reasons|2|||
145496988|NCT03486912|524677480|FG002|Treatment Period|Other Reasons|1|||
145496989|NCT03486912|524677481|FG003|Treatment Period|Other Reasons|1|||
145496990|NCT03486912|524677478|FG000|Treatment Period|Adverse Event|0|||
145496991|NCT03486912|524677479|FG001|Treatment Period|Adverse Event|1|||
145496992|NCT03486912|524677480|FG002|Treatment Period|Adverse Event|1|||
145496993|NCT03486912|524677481|FG003|Treatment Period|Adverse Event|0|||
145496994|NCT03486912|524677478|FG000|Treatment Period|Lost to Follow-up|1|||
145496995|NCT03486912|524677479|FG001|Treatment Period|Lost to Follow-up|0|||
145496996|NCT03486912|524677480|FG002|Treatment Period|Lost to Follow-up|0|||
145496997|NCT03486912|524677481|FG003|Treatment Period|Lost to Follow-up|2|||
145496998|NCT00412984|524677483|FG000|Overall Study|Death|331|||
145496999|NCT00412984|524677484|FG001|Overall Study|Death|349|||
145497000|NCT00412984|524677483|FG000|Overall Study|Adverse Event|679|||
145497001|NCT00412984|524677484|FG001|Overall Study|Adverse Event|738|||
145497002|NCT00412984|524677483|FG000|Overall Study|Withdrawal by Subject|921|||
145497003|NCT00412984|524677484|FG001|Overall Study|Withdrawal by Subject|989|||
145497004|NCT00412984|524677483|FG000|Overall Study|Lost to Follow-up|51|||
145497005|NCT00412984|524677484|FG001|Overall Study|Lost to Follow-up|39|||
145497006|NCT00412984|524677483|FG000|Overall Study|Poor/Noncompliance|57|||
145497007|NCT00412984|524677484|FG001|Overall Study|Poor/Noncompliance|77|||
145497008|NCT00412984|524677483|FG000|Overall Study|Pregnancy|1|||
145497009|NCT00412984|524677484|FG001|Overall Study|Pregnancy|0|||
145497010|NCT00412984|524677483|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
145497011|NCT00412984|524677484|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
145497012|NCT00412984|524677483|FG000|Overall Study|Administrative Reason by Sponsor|11|||
145497013|NCT00412984|524677484|FG001|Overall Study|Administrative Reason by Sponsor|8|||
145497014|NCT00412984|524677483|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
145497015|NCT00412984|524677484|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
145497016|NCT00412984|524677483|FG000|Overall Study|Other Reason|80|||
145497017|NCT00412984|524677484|FG001|Overall Study|Other Reason|92|||
145497018|NCT00412984|524677483|FG000|Overall Study|Not Reported|11|||
145497019|NCT00412984|524677484|FG001|Overall Study|Not Reported|12|||
145497020|NCT01499940|524677485|FG000|Overall Study|Study was withdrawn before completion.|9|||
145497021|NCT02435212|524677486|FG000|Core Phase|Adverse Event|8|||
145497022|NCT02435212|524677487|FG001|Core Phase|Adverse Event|5|||
145497023|NCT02435212|524677486|FG000|Core Phase|Withdrawal by Subject|3|||
145497024|NCT02435212|524677487|FG001|Core Phase|Withdrawal by Subject|0|||
145497025|NCT02435212|524677486|FG000|Core Phase|Withdrawal by parent/guardian|9|||
145497026|NCT02435212|524677487|FG001|Core Phase|Withdrawal by parent/guardian|4|||
145497027|NCT02435212|524677486|FG000|Core Phase|Protocol Violation|1|||
145497028|NCT02435212|524677487|FG001|Core Phase|Protocol Violation|2|||
145497029|NCT02435212|524677486|FG000|Core Phase|Physician Decision|3|||
145497030|NCT02435212|524677487|FG001|Core Phase|Physician Decision|0|||
145497031|NCT02435212|524677486|FG000|Core Phase|Lost to Follow-up|0|||
145497032|NCT02435212|524677487|FG001|Core Phase|Lost to Follow-up|1|||
145497033|NCT02435212|524677486|FG000|Core Phase|Lack of Efficacy|0|||
145497034|NCT02435212|524677487|FG001|Core Phase|Lack of Efficacy|1|||
145497035|NCT02435212|524677486|FG000|Core Phase|Recovery|1|||
145497036|NCT02435212|524677487|FG001|Core Phase|Recovery|0|||
145497037|NCT02435212|524677486|FG000|Optional Extension Phase|Adverse Event|3|||
145497038|NCT02435212|524677487|FG001|Optional Extension Phase|Adverse Event|9|||
145497039|NCT02435212|524677486|FG000|Optional Extension Phase|Physician Decision|6|||
145497040|NCT02435212|524677487|FG001|Optional Extension Phase|Physician Decision|8|||
145497041|NCT02435212|524677486|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
145497042|NCT02435212|524677487|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
145497043|NCT02435212|524677486|FG000|Optional Extension Phase|Lack of Efficacy|2|||
145497044|NCT02435212|524677487|FG001|Optional Extension Phase|Lack of Efficacy|3|||
145497045|NCT02435212|524677486|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
145497046|NCT02435212|524677487|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
145497047|NCT02435212|524677486|FG000|Optional Extension Phase|Protocol Violation|0|||
145497048|NCT02435212|524677487|FG001|Optional Extension Phase|Protocol Violation|1|||
145497049|NCT02435212|524677486|FG000|Optional Extension Phase|Recovery|1|||
145497050|NCT02435212|524677487|FG001|Optional Extension Phase|Recovery|1|||
145497051|NCT02435212|524677486|FG000|Optional Extension Phase|Death|1|||
145497052|NCT02435212|524677487|FG001|Optional Extension Phase|Death|0|||
145497053|NCT02435212|524677486|FG000|Optional Extension Phase|Technical problems|2|||
145497054|NCT02435212|524677487|FG001|Optional Extension Phase|Technical problems|0|||
145497055|NCT04711850|524677488|FG000|Overall Study|Graft loss|2|||
145497056|NCT04711850|524677489|FG001|Overall Study|Graft loss|1|||
145497057|NCT04711850|524677488|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
145497058|NCT04711850|524677489|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
145497059|NCT04711850|524677488|FG000|Overall Study|Study terminated by sponsor|5|||
145497060|NCT04711850|524677489|FG001|Overall Study|Study terminated by sponsor|3|||
145497061|NCT04711850|524677488|FG000|Overall Study|Sponsor decision|0|||
145497062|NCT04711850|524677489|FG001|Overall Study|Sponsor decision|2|||
145497063|NCT04531176|524677499|FG000|Overall Study|Study was stopped early|24|||
145497064|NCT04531176|524677500|FG001|Overall Study|Study was stopped early|26|||
145497065|NCT04531176|524677501|FG002|Overall Study|Study was stopped early|24|||
145497066|NCT00561652|524677506|FG000|Overall Study|Withdrawal by Subject|0|||
145497067|NCT00561652|524677507|FG001|Overall Study|Withdrawal by Subject|1|||
145497068|NCT00317473|524677508|FG000|Overall Study|Withdrawal by Subject|2|||
145497069|NCT00317473|524677509|FG001|Overall Study|Withdrawal by Subject|1|||
145497070|NCT00317473|524677510|FG002|Overall Study|Withdrawal by Subject|2|||
145497071|NCT00317473|524677511|FG003|Overall Study|Withdrawal by Subject|1|||
145497072|NCT00317473|524677512|FG004|Overall Study|Withdrawal by Subject|3|||
145497073|NCT00317473|524677513|FG005|Overall Study|Withdrawal by Subject|1|||
145497074|NCT00317473|524677508|FG000|Overall Study|Relocation|1|||
145497075|NCT00317473|524677509|FG001|Overall Study|Relocation|0|||
145497076|NCT00317473|524677510|FG002|Overall Study|Relocation|1|||
145497077|NCT00317473|524677511|FG003|Overall Study|Relocation|1|||
145497078|NCT00317473|524677512|FG004|Overall Study|Relocation|5|||
145497079|NCT00317473|524677513|FG005|Overall Study|Relocation|2|||
145497080|NCT00317473|524677508|FG000|Overall Study|Death|1|||
145497081|NCT00317473|524677509|FG001|Overall Study|Death|0|||
145497082|NCT00317473|524677510|FG002|Overall Study|Death|0|||
145497083|NCT00317473|524677511|FG003|Overall Study|Death|0|||
145497084|NCT00317473|524677512|FG004|Overall Study|Death|0|||
145497085|NCT00317473|524677513|FG005|Overall Study|Death|0|||
145497086|NCT00317473|524677508|FG000|Overall Study|Other|0|||
145497087|NCT00317473|524677509|FG001|Overall Study|Other|2|||
145497088|NCT00317473|524677510|FG002|Overall Study|Other|0|||
145497089|NCT00317473|524677511|FG003|Overall Study|Other|0|||
145497090|NCT00317473|524677512|FG004|Overall Study|Other|0|||
145497091|NCT00317473|524677513|FG005|Overall Study|Other|0|||
145497092|NCT02285855|524677514|FG000|Overall Study|Withdrawal by Subject|2|||
145497093|NCT02285855|524677515|FG001|Overall Study|Withdrawal by Subject|1|||
145497094|NCT00528112|524677516|FG000|Treatment up to 3 Years|Adverse Event|313|||
145497095|NCT00528112|524677517|FG001|Treatment up to 3 Years|Adverse Event|278|||
145497096|NCT00528112|524677516|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
145497097|NCT00528112|524677517|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
145497098|NCT00528112|524677516|FG000|Treatment up to 3 Years|Protocol Violation|16|||
145497099|NCT00528112|524677517|FG001|Treatment up to 3 Years|Protocol Violation|16|||
145497100|NCT00528112|524677516|FG000|Treatment up to 3 Years|Death|0|||
145497101|NCT00528112|524677517|FG001|Treatment up to 3 Years|Death|1|||
145497102|NCT00528112|524677516|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
145497103|NCT00528112|524677517|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
145497104|NCT00528112|524677516|FG000|Treatment up to 3 Years|Pregnancy|9|||
145497105|NCT00528112|524677517|FG001|Treatment up to 3 Years|Pregnancy|10|||
145497106|NCT00528112|524677516|FG000|Treatment up to 3 Years|Other reasons|186|||
145731316|NCT00867113|525533643|FG000|Treatment Period|Adverse Event|15|||
145497107|NCT00528112|524677517|FG001|Treatment up to 3 Years|Other reasons|186|||
145497108|NCT00528112|524677516|FG000|Extension Phase|Withdrawal by Subject|0|||
145497109|NCT00528112|524677517|FG001|Extension Phase|Withdrawal by Subject|3|||
145731317|NCT00867113|525533643|FG000|Treatment Period|Death|2|||
145731318|NCT00867113|525533643|FG000|Treatment Period|Withdrawal by Subject|19|||
145731319|NCT00867113|525533643|FG000|Treatment Period|Lost to Follow-up|3|||
145731320|NCT00867113|525533643|FG000|Treatment Period|Administrative problems|1|||
145731321|NCT00867113|525533643|FG000|Treatment Period|Disease progression/relapse|1|||
145731322|NCT00867113|525533643|FG000|Treatment Period|Protocol Violation|4|||
145731323|NCT00867113|525533643|FG000|Post Treatment After Survival Follow-up|Death|1|||
145731324|NCT00867113|525533643|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
145731325|NCT00867113|525533643|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
145731326|NCT00867113|525533643|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
145731327|NCT04585646|525533644|FG000|First Intervention|Physician Decision|1|||
145731328|NCT04585646|525533645|FG001|First Intervention|Physician Decision|0|||
145731329|NCT04585646|525533644|FG000|First Intervention|Lost to Follow-up|0|||
145731330|NCT04585646|525533645|FG001|First Intervention|Lost to Follow-up|3|||
145731331|NCT04585646|525533644|FG000|First Intervention|Withdrawal by Subject|0|||
145731332|NCT04585646|525533645|FG001|First Intervention|Withdrawal by Subject|1|||
145731333|NCT01886313|525533646|FG000|Overall Study|Adverse Event|1|||
145731334|NCT01886313|525533647|FG001|Overall Study|Adverse Event|1|||
145731335|NCT04614662|525533648|FG000|Overall Study|Withdrawal by Subject|0|||
145731336|NCT04614662|525533649|FG001|Overall Study|Withdrawal by Subject|1|||
145731337|NCT01230788|525533656|FG000|Overall Study|Prescribed exclusion drug|1|||
145731338|NCT01717768|525533658|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731339|NCT01717768|525533659|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
145731340|NCT01717768|525533660|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731341|NCT01717768|525533661|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731342|NCT01717768|525533662|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731343|NCT01717768|525533663|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731344|NCT01717768|525533664|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731345|NCT01717768|525533665|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731346|NCT01717768|525533666|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731347|NCT01717768|525533667|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731348|NCT01717768|525533668|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731349|NCT01717768|525533669|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
145731350|NCT01717768|525533658|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731351|NCT01717768|525533659|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731352|NCT01717768|525533660|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731353|NCT01717768|525533661|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731354|NCT01717768|525533662|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731355|NCT01717768|525533663|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731356|NCT01717768|525533664|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731357|NCT01717768|525533665|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731358|NCT01717768|525533666|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731359|NCT01717768|525533667|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731360|NCT01717768|525533668|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
145731361|NCT01717768|525533669|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
145731362|NCT01717768|525533658|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731363|NCT01717768|525533659|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731364|NCT01717768|525533660|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731365|NCT01717768|525533661|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731366|NCT01717768|525533662|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731367|NCT01717768|525533663|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731368|NCT01717768|525533664|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731369|NCT01717768|525533665|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
145731370|NCT01717768|525533666|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731371|NCT01717768|525533667|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731372|NCT01717768|525533668|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731373|NCT01717768|525533669|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
145731374|NCT01717768|525533658|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731375|NCT01717768|525533659|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731376|NCT01717768|525533660|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731377|NCT01717768|525533661|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731378|NCT01717768|525533662|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731379|NCT01717768|525533663|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731380|NCT01717768|525533664|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731381|NCT01717768|525533665|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731382|NCT01717768|525533666|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731383|NCT01717768|525533667|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
145731384|NCT01717768|525533668|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145731385|NCT01717768|525533669|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
145497110|NCT00528112|524677516|FG000|Extension Phase|Other reasons|0|||
145497111|NCT00528112|524677517|FG001|Extension Phase|Other reasons|100|||
145497112|NCT00528112|524677516|FG000|Extension Phase|Pregnancy|0|||
145497113|NCT00528112|524677517|FG001|Extension Phase|Pregnancy|3|||
145497114|NCT00528112|524677516|FG000|Extension Phase|Lost to Follow-up|0|||
145497115|NCT00528112|524677517|FG001|Extension Phase|Lost to Follow-up|12|||
145497116|NCT00528112|524677516|FG000|Extension Phase|Death|0|||
145497117|NCT00528112|524677517|FG001|Extension Phase|Death|1|||
145497118|NCT00528112|524677516|FG000|Extension Phase|Adverse Event|0|||
145497119|NCT00528112|524677517|FG001|Extension Phase|Adverse Event|36|||
145497120|NCT00528112|524677516|FG000|Extension Phase|Protocol Violation|0|||
145497121|NCT00528112|524677517|FG001|Extension Phase|Protocol Violation|2|||
145497122|NCT01451606|524677522|FG000|Overall Study|Withdrawal by Subject|4|||
145497123|NCT01451606|524677523|FG001|Overall Study|Withdrawal by Subject|3|||
145497124|NCT04609319|524677524|FG000|Overall Study|Death|64|||
145497125|NCT04609319|524677525|FG001|Overall Study|Death|49|||
145497126|NCT04609319|524677526|FG002|Overall Study|Death|1|||
145497127|NCT04609319|524677524|FG000|Overall Study|Withdrawal of consent|15|||
145497128|NCT04609319|524677525|FG001|Overall Study|Withdrawal of consent|3|||
145497129|NCT04609319|524677526|FG002|Overall Study|Withdrawal of consent|0|||
145497130|NCT04609319|524677524|FG000|Overall Study|Lost to Follow-up|20|||
145497131|NCT04609319|524677525|FG001|Overall Study|Lost to Follow-up|33|||
145497132|NCT04609319|524677526|FG002|Overall Study|Lost to Follow-up|0|||
145497133|NCT04609319|524677524|FG000|Overall Study|Alive until end of follow-up|60|||
145497134|NCT04609319|524677525|FG001|Overall Study|Alive until end of follow-up|53|||
145497135|NCT04609319|524677526|FG002|Overall Study|Alive until end of follow-up|1|||
145497136|NCT03804528|524677527|FG000|Overall Study|Time Commitment|18|||
145497137|NCT03804528|524677527|FG000|Overall Study|Health Reasons|5|||
145497138|NCT02331134|524677530|FG000|Overall Study|Withdrawal by Subject|1|||
145497139|NCT04825574|524677531|FG000|Overall Study|Commercial treatment became available|1|||
145497140|NCT04825574|524677531|FG000|Overall Study|Disease progression|1|||
145497141|NCT03518086|524677532|FG000|Overall Study|Adverse Event|23|||
145497142|NCT03518086|524677533|FG001|Overall Study|Adverse Event|15|||
145497143|NCT03518086|524677534|FG002|Overall Study|Adverse Event|3|||
145497144|NCT03518086|524677535|FG003|Overall Study|Adverse Event|2|||
145497145|NCT03518086|524677532|FG000|Overall Study|Withdrawal by Subject|8|||
145497146|NCT03518086|524677533|FG001|Overall Study|Withdrawal by Subject|5|||
145497147|NCT03518086|524677534|FG002|Overall Study|Withdrawal by Subject|1|||
145497148|NCT03518086|524677535|FG003|Overall Study|Withdrawal by Subject|0|||
145497149|NCT03518086|524677532|FG000|Overall Study|Lack of Efficacy|5|||
145497150|NCT03518086|524677533|FG001|Overall Study|Lack of Efficacy|5|||
145497151|NCT03518086|524677534|FG002|Overall Study|Lack of Efficacy|0|||
145497152|NCT03518086|524677535|FG003|Overall Study|Lack of Efficacy|2|||
145497153|NCT03518086|524677532|FG000|Overall Study|Protocol Violation|1|||
145497154|NCT03518086|524677533|FG001|Overall Study|Protocol Violation|5|||
145497155|NCT03518086|524677534|FG002|Overall Study|Protocol Violation|1|||
145497156|NCT03518086|524677535|FG003|Overall Study|Protocol Violation|3|||
145497157|NCT03518086|524677532|FG000|Overall Study|Lost to Follow-up|0|||
145497158|NCT03518086|524677533|FG001|Overall Study|Lost to Follow-up|3|||
145497159|NCT03518086|524677534|FG002|Overall Study|Lost to Follow-up|0|||
145497160|NCT03518086|524677535|FG003|Overall Study|Lost to Follow-up|0|||
145497161|NCT03518086|524677532|FG000|Overall Study|Insufficient Diary Data|0|||
145497162|NCT03518086|524677533|FG001|Overall Study|Insufficient Diary Data|2|||
145497163|NCT03518086|524677534|FG002|Overall Study|Insufficient Diary Data|0|||
145394904|NCT00509899|524300704|FG005|Overall Study|Withdrawal by Subject|2|||
145394905|NCT00509899|524300705|FG006|Overall Study|Withdrawal by Subject|0|||
145394906|NCT00509899|524300706|FG007|Overall Study|Withdrawal by Subject|0|||
145394907|NCT00509899|524300699|FG000|Overall Study|Physician Decision|4|||
145394908|NCT00509899|524300700|FG001|Overall Study|Physician Decision|2|||
145394909|NCT00509899|524300701|FG002|Overall Study|Physician Decision|7|||
145394910|NCT00509899|524300702|FG003|Overall Study|Physician Decision|0|||
145394911|NCT00509899|524300703|FG004|Overall Study|Physician Decision|1|||
145394912|NCT00509899|524300704|FG005|Overall Study|Physician Decision|4|||
145394913|NCT00509899|524300705|FG006|Overall Study|Physician Decision|0|||
145394914|NCT00509899|524300706|FG007|Overall Study|Physician Decision|0|||
145394915|NCT00509899|524300699|FG000|Overall Study|Intercurrent Illness|1|||
145394916|NCT00509899|524300700|FG001|Overall Study|Intercurrent Illness|0|||
145394917|NCT00509899|524300701|FG002|Overall Study|Intercurrent Illness|0|||
145394918|NCT00509899|524300702|FG003|Overall Study|Intercurrent Illness|1|||
145394919|NCT00509899|524300703|FG004|Overall Study|Intercurrent Illness|0|||
145394920|NCT00509899|524300704|FG005|Overall Study|Intercurrent Illness|1|||
145394921|NCT00509899|524300705|FG006|Overall Study|Intercurrent Illness|0|||
145394922|NCT00509899|524300706|FG007|Overall Study|Intercurrent Illness|0|||
145394923|NCT00509899|524300699|FG000|Overall Study|Death|2|||
145394924|NCT00509899|524300700|FG001|Overall Study|Death|2|||
145394925|NCT00509899|524300701|FG002|Overall Study|Death|3|||
145394926|NCT00509899|524300702|FG003|Overall Study|Death|0|||
145394927|NCT00509899|524300703|FG004|Overall Study|Death|1|||
145394928|NCT00509899|524300704|FG005|Overall Study|Death|1|||
145394929|NCT00509899|524300705|FG006|Overall Study|Death|1|||
145394930|NCT00509899|524300706|FG007|Overall Study|Death|1|||
145394931|NCT00509899|524300699|FG000|Overall Study|Lack of Efficacy|1|||
145394932|NCT00509899|524300700|FG001|Overall Study|Lack of Efficacy|0|||
145394933|NCT00509899|524300701|FG002|Overall Study|Lack of Efficacy|2|||
145394934|NCT00509899|524300702|FG003|Overall Study|Lack of Efficacy|0|||
145394935|NCT00509899|524300703|FG004|Overall Study|Lack of Efficacy|0|||
145394936|NCT00509899|524300704|FG005|Overall Study|Lack of Efficacy|1|||
145394937|NCT00509899|524300705|FG006|Overall Study|Lack of Efficacy|0|||
145394938|NCT00509899|524300706|FG007|Overall Study|Lack of Efficacy|0|||
145394939|NCT01711983|524300711|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
145394940|NCT01711983|524300711|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
145394941|NCT01711983|524300711|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
145394942|NCT01711983|524300711|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
145394943|NCT00737100|524300712|FG000|Overall Study|Adverse Event|6|||
145394944|NCT00737100|524300713|FG001|Overall Study|Adverse Event|5|||
145394945|NCT00737100|524300714|FG002|Overall Study|Adverse Event|3|||
145394946|NCT00737100|524300712|FG000|Overall Study|Lost to Follow-up|0|||
145394947|NCT00737100|524300713|FG001|Overall Study|Lost to Follow-up|1|||
145394948|NCT00737100|524300714|FG002|Overall Study|Lost to Follow-up|0|||
145394949|NCT00737100|524300712|FG000|Overall Study|Withdrawal by Subject|0|||
145394950|NCT00737100|524300713|FG001|Overall Study|Withdrawal by Subject|0|||
145394951|NCT00737100|524300714|FG002|Overall Study|Withdrawal by Subject|3|||
145394952|NCT00737100|524300712|FG000|Overall Study|Reason discontinued not explained above|1|||
145394953|NCT00737100|524300713|FG001|Overall Study|Reason discontinued not explained above|1|||
145394954|NCT00737100|524300714|FG002|Overall Study|Reason discontinued not explained above|1|||
145394955|NCT02595502|524300717|FG000|Period 1|Adverse Event|0|||
145394956|NCT02595502|524300718|FG001|Period 1|Adverse Event|1|||
145394957|NCT02595502|524300717|FG000|Period 1|Withdrawal by Subject|1|||
145394958|NCT02595502|524300718|FG001|Period 1|Withdrawal by Subject|0|||
145394959|NCT02595502|524300717|FG000|Period 1|Lost to Follow-up|0|||
145394960|NCT02595502|524300718|FG001|Period 1|Lost to Follow-up|1|||
145394961|NCT02595502|524300717|FG000|Period 2|Adverse Event|1|||
145394962|NCT02595502|524300718|FG001|Period 2|Adverse Event|1|||
145394963|NCT02595502|524300717|FG000|Period 2|Received incorrect lens at Period 1|0|||
145394964|NCT02595502|524300718|FG001|Period 2|Received incorrect lens at Period 1|1|||
145497164|NCT03518086|524677535|FG003|Overall Study|Insufficient Diary Data|0|||
145497165|NCT03518086|524677532|FG000|Overall Study|Non- compliance to Protocol|0|||
145497166|NCT03518086|524677533|FG001|Overall Study|Non- compliance to Protocol|1|||
145497167|NCT03518086|524677534|FG002|Overall Study|Non- compliance to Protocol|0|||
145497168|NCT03518086|524677535|FG003|Overall Study|Non- compliance to Protocol|0|||
145497169|NCT03518086|524677532|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
145497170|NCT03518086|524677533|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
145497171|NCT03518086|524677534|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
145497172|NCT03518086|524677535|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
145497173|NCT03518086|524677532|FG000|Overall Study|Site Terminated by Sponsor|0|||
145497174|NCT03518086|524677533|FG001|Overall Study|Site Terminated by Sponsor|1|||
145497175|NCT03518086|524677534|FG002|Overall Study|Site Terminated by Sponsor|0|||
145497176|NCT03518086|524677535|FG003|Overall Study|Site Terminated by Sponsor|0|||
145497177|NCT03518086|524677532|FG000|Overall Study|Pregnancy|0|||
145497178|NCT03518086|524677533|FG001|Overall Study|Pregnancy|0|||
145497179|NCT03518086|524677534|FG002|Overall Study|Pregnancy|0|||
145497180|NCT03518086|524677535|FG003|Overall Study|Pregnancy|2|||
145497181|NCT04328077|524679528|FG000|Overall Study|Lost to Follow-up|0|||
145497182|NCT04328077|524679529|FG001|Overall Study|Lost to Follow-up|1|||
145497183|NCT04328077|524679530|FG002|Overall Study|Lost to Follow-up|0|||
145497184|NCT04328077|524679531|FG003|Overall Study|Lost to Follow-up|0|||
145497185|NCT04328077|524679528|FG000|Overall Study|Withdrawal by Subject|0|||
145497186|NCT04328077|524679529|FG001|Overall Study|Withdrawal by Subject|1|||
145497187|NCT04328077|524679530|FG002|Overall Study|Withdrawal by Subject|1|||
145497188|NCT04328077|524679531|FG003|Overall Study|Withdrawal by Subject|3|||
145497189|NCT01456039|524679532|FG000|Phase 1 (First Step)|Disease Progression|1|||
145497190|NCT01456039|524679533|FG001|Phase 1 (First Step)|Disease Progression|1|||
145497191|NCT01456039|524679534|FG002|Phase 1 (First Step)|Disease Progression|0|||
145497192|NCT01456039|524679532|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
145497193|NCT01456039|524679533|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
145497194|NCT01456039|524679534|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
145497195|NCT01456039|524679532|FG000|Phase 1 (First Step)|Adverse Event|0|||
145497196|NCT01456039|524679533|FG001|Phase 1 (First Step)|Adverse Event|3|||
145497197|NCT01456039|524679534|FG002|Phase 1 (First Step)|Adverse Event|0|||
145497198|NCT01456039|524679532|FG000|Phase 1 (First Step)|Other|0|||
145497199|NCT01456039|524679533|FG001|Phase 1 (First Step)|Other|1|||
145497200|NCT01456039|524679534|FG002|Phase 1 (First Step)|Other|0|||
145497201|NCT01456039|524679532|FG000|Phase 2 (Second Step)|Disease Progression|0|||
145497202|NCT01456039|524679533|FG001|Phase 2 (Second Step)|Disease Progression|0|||
145497203|NCT01456039|524679534|FG002|Phase 2 (Second Step)|Disease Progression|17|||
145497204|NCT01456039|524679532|FG000|Phase 2 (Second Step)|Adverse Event|0|||
145497205|NCT01456039|524679533|FG001|Phase 2 (Second Step)|Adverse Event|0|||
145497206|NCT01456039|524679534|FG002|Phase 2 (Second Step)|Adverse Event|10|||
145497207|NCT01456039|524679532|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
145497208|NCT01456039|524679533|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
145497209|NCT01456039|524679534|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
145497210|NCT01456039|524679532|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
145497211|NCT01456039|524679533|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
145497212|NCT01456039|524679534|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
145497213|NCT01456039|524679532|FG000|Phase 2 (Second Step)|Other|0|||
145497214|NCT01456039|524679533|FG001|Phase 2 (Second Step)|Other|0|||
145497215|NCT01456039|524679534|FG002|Phase 2 (Second Step)|Other|1|||
145497216|NCT02345070|524679537|FG000|Overall Study|Adverse Event|12|||
145497217|NCT02345070|524679538|FG001|Overall Study|Adverse Event|8|||
145497218|NCT02345070|524679539|FG002|Overall Study|Adverse Event|16|||
145497219|NCT02345070|524679537|FG000|Overall Study|Poor compliance to protocol|2|||
145497220|NCT02345070|524679538|FG001|Overall Study|Poor compliance to protocol|0|||
145497221|NCT02345070|524679539|FG002|Overall Study|Poor compliance to protocol|0|||
145497222|NCT02345070|524679537|FG000|Overall Study|Other than specified above|6|||
145497223|NCT02345070|524679538|FG001|Overall Study|Other than specified above|3|||
145497224|NCT02345070|524679539|FG002|Overall Study|Other than specified above|7|||
145497225|NCT02151058|524679540|FG000|Overall Study|Withdrawal by Subject|1|||
145497226|NCT02151058|524679541|FG001|Overall Study|Withdrawal by Subject|1|||
145394965|NCT02595502|524300717|FG000|Period 3|Protocol Violation|0|||
145394966|NCT02595502|524300718|FG001|Period 3|Protocol Violation|1|||
145394967|NCT02595502|524300717|FG000|Period 3|Lost to Follow-up|1|||
145394968|NCT02595502|524300718|FG001|Period 3|Lost to Follow-up|0|||
145394969|NCT02595502|524300717|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
145394970|NCT02595502|524300718|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
145394971|NCT03286218|524300719|FG000|Qualification Phase Period 1|Adverse Event|1|||
145394972|NCT03286218|524300720|FG001|Qualification Phase Period 1|Adverse Event|0|||
145394973|NCT03286218|524300721|FG002|Qualification Phase Period 1|Adverse Event|0|||
145394974|NCT03286218|524300722|FG003|Qualification Phase Period 1|Adverse Event|0|||
145394975|NCT03286218|524300723|FG004|Qualification Phase Period 1|Adverse Event|0|||
145394976|NCT03286218|524300724|FG005|Qualification Phase Period 1|Adverse Event|0|||
145394977|NCT03286218|524300725|FG006|Qualification Phase Period 1|Adverse Event|0|||
145394978|NCT03286218|524300726|FG007|Qualification Phase Period 1|Adverse Event|0|||
145497227|NCT02151058|524679542|FG002|Overall Study|Withdrawal by Subject|3|||
145497228|NCT02151058|524679540|FG000|Overall Study|Lost to Follow-up|1|||
145497229|NCT02151058|524679541|FG001|Overall Study|Lost to Follow-up|0|||
145497230|NCT02151058|524679542|FG002|Overall Study|Lost to Follow-up|2|||
145497231|NCT00124943|524679545|FG000|Phase II|Adverse Event|0|||
145497232|NCT00124943|524679546|FG001|Phase II|Adverse Event|2|||
145497233|NCT00124943|524679547|FG002|Phase II|Adverse Event|0|||
145497234|NCT00124943|524679548|FG003|Phase II|Adverse Event|1|||
145497235|NCT00124943|524679545|FG000|Phase II|Protocol Violation|0|||
145497236|NCT00124943|524679546|FG001|Phase II|Protocol Violation|0|||
145497237|NCT00124943|524679547|FG002|Phase II|Protocol Violation|0|||
145497238|NCT00124943|524679548|FG003|Phase II|Protocol Violation|1|||
145497239|NCT00124943|524679545|FG000|Phase II|Lost to Follow-up|0|||
145497240|NCT00124943|524679546|FG001|Phase II|Lost to Follow-up|0|||
145497241|NCT00124943|524679547|FG002|Phase II|Lost to Follow-up|0|||
145497242|NCT00124943|524679548|FG003|Phase II|Lost to Follow-up|1|||
145497243|NCT00124943|524679545|FG000|Phase II|Withdrawal by Subject|0|||
145497244|NCT00124943|524679546|FG001|Phase II|Withdrawal by Subject|0|||
145497245|NCT00124943|524679547|FG002|Phase II|Withdrawal by Subject|0|||
145497246|NCT00124943|524679548|FG003|Phase II|Withdrawal by Subject|2|||
145497247|NCT03829228|524679549|FG000|Overall Study|Protocol Violation|1|||
145497248|NCT03337477|524679550|FG000|Overall Study|not categorized into the listed ones|11|||
145497249|NCT03337477|524679551|FG001|Overall Study|not categorized into the listed ones|9|||
145497250|NCT03337477|524679550|FG000|Overall Study|Withdrawal by Subject|0|||
145497251|NCT03337477|524679551|FG001|Overall Study|Withdrawal by Subject|1|||
145497252|NCT03337477|524679550|FG000|Overall Study|Death|0|||
145497253|NCT03337477|524679551|FG001|Overall Study|Death|1|||
145497254|NCT03337477|524679550|FG000|Overall Study|Lost to Follow-up|0|||
145497255|NCT03337477|524679551|FG001|Overall Study|Lost to Follow-up|2|||
145497256|NCT02443688|524679554|FG000|Overall Study|Adverse Event|2|||
145497257|NCT02443688|524679555|FG001|Overall Study|Adverse Event|3|||
145497258|NCT02443688|524679556|FG002|Overall Study|Adverse Event|2|||
145497259|NCT02443688|524679554|FG000|Overall Study|Lost to Follow-up|1|||
145497260|NCT02443688|524679555|FG001|Overall Study|Lost to Follow-up|0|||
145497261|NCT02443688|524679556|FG002|Overall Study|Lost to Follow-up|0|||
145497262|NCT02443688|524679554|FG000|Overall Study|Physician Decision|3|||
145497263|NCT02443688|524679555|FG001|Overall Study|Physician Decision|0|||
145497264|NCT02443688|524679556|FG002|Overall Study|Physician Decision|1|||
145497265|NCT02443688|524679554|FG000|Overall Study|Pregnancy|0|||
145497266|NCT02443688|524679555|FG001|Overall Study|Pregnancy|0|||
145497267|NCT02443688|524679556|FG002|Overall Study|Pregnancy|1|||
145497268|NCT02443688|524679554|FG000|Overall Study|Withdrawal by Subject|3|||
145497269|NCT02443688|524679555|FG001|Overall Study|Withdrawal by Subject|3|||
145497270|NCT02443688|524679556|FG002|Overall Study|Withdrawal by Subject|4|||
145497271|NCT02443688|524679554|FG000|Overall Study|Non-compliance with study drug|1|||
145497272|NCT02443688|524679555|FG001|Overall Study|Non-compliance with study drug|2|||
145497273|NCT02443688|524679556|FG002|Overall Study|Non-compliance with study drug|4|||
145497274|NCT02443688|524679554|FG000|Overall Study|Sponsor Request|2|||
145497275|NCT02443688|524679555|FG001|Overall Study|Sponsor Request|1|||
145497276|NCT02443688|524679556|FG002|Overall Study|Sponsor Request|0|||
145497277|NCT02177123|524679558|FG000|Overall Study|Lost to Follow-up|6|||
145497278|NCT02177123|524679558|FG000|Overall Study|Withdrawal by Subject|4|||
145497279|NCT02177123|524679558|FG000|Overall Study|Adverse Event|4|||
145497280|NCT02177123|524679558|FG000|Overall Study|Physician Decision|3|||
145497281|NCT02177123|524679558|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
145497282|NCT02177123|524679558|FG000|Overall Study|Excluded for medical reasons|2|||
145497283|NCT02177123|524679558|FG000|Overall Study|Death|1|||
145497284|NCT02177123|524679558|FG000|Overall Study|Other|1|||
145731386|NCT01774084|525533670|FG000|Overall Study|Personal reasons|1|||
145731387|NCT01774084|525533671|FG001|Overall Study|Personal reasons|0|||
145731388|NCT04226833|525533679|FG000|Overall Study|Death|0|||
145731389|NCT04226833|525533680|FG001|Overall Study|Death|0|||
145731390|NCT04226833|525533681|FG002|Overall Study|Death|1|||
145731391|NCT04226833|525533682|FG003|Overall Study|Death|0|||
145731392|NCT01472380|525533683|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
145731393|NCT01472380|525533683|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
145731394|NCT06071754|525533684|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
145731395|NCT05028517|525533685|FG000|Overall Study|Lost to Follow-up|13|||
145731396|NCT05028517|525533686|FG001|Overall Study|Lost to Follow-up|20|||
145731397|NCT05028517|525533687|FG002|Overall Study|Lost to Follow-up|12|||
145731398|NCT05028517|525533685|FG000|Overall Study|Withdrawal by Subject|0|||
145731399|NCT05028517|525533686|FG001|Overall Study|Withdrawal by Subject|0|||
145731400|NCT05028517|525533687|FG002|Overall Study|Withdrawal by Subject|1|||
145731401|NCT03055013|525535848|FG000|Overall Study|Adverse Event|78|||
145731402|NCT03055013|525535849|FG001|Overall Study|Adverse Event|0|||
145731403|NCT03055013|525535848|FG000|Overall Study|Death|6|||
145731404|NCT03055013|525535849|FG001|Overall Study|Death|0|||
145731405|NCT03055013|525535848|FG000|Overall Study|Disease relapse|33|||
145731406|NCT03055013|525535849|FG001|Overall Study|Disease relapse|0|||
145731407|NCT03055013|525535848|FG000|Overall Study|Withdrawal by Subject|28|||
145731408|NCT03055013|525535849|FG001|Overall Study|Withdrawal by Subject|0|||
145731409|NCT03055013|525535848|FG000|Overall Study|Other complicating disease|5|||
145731410|NCT03055013|525535849|FG001|Overall Study|Other complicating disease|0|||
145731411|NCT03055013|525535848|FG000|Overall Study|Physician Decision|1|||
145731412|NCT03055013|525535849|FG001|Overall Study|Physician Decision|0|||
145731413|NCT03055013|525535848|FG000|Overall Study|Benign mass/non-RCC|4|||
145731414|NCT03055013|525535849|FG001|Overall Study|Benign mass/non-RCC|0|||
145731415|NCT03055013|525535848|FG000|Overall Study|Enrolled in another trial|1|||
145731416|NCT03055013|525535849|FG001|Overall Study|Enrolled in another trial|0|||
145731417|NCT03055013|525535848|FG000|Overall Study|Non-protocol therapy|1|||
145731418|NCT03055013|525535849|FG001|Overall Study|Non-protocol therapy|0|||
145731419|NCT03055013|525535848|FG000|Overall Study|Incompliance|1|||
145731420|NCT03055013|525535849|FG001|Overall Study|Incompliance|0|||
145394979|NCT03286218|524300727|FG008|Qualification Phase Period 1|Adverse Event|0|||
145394980|NCT03286218|524300728|FG009|Qualification Phase Period 1|Adverse Event|0|||
145394981|NCT03286218|524300729|FG010|Qualification Phase Period 1|Adverse Event|0|||
145394982|NCT03286218|524300730|FG011|Qualification Phase Period 1|Adverse Event|0|||
145394983|NCT03286218|524300719|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394984|NCT03286218|524300720|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
145394985|NCT03286218|524300721|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394986|NCT03286218|524300722|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394987|NCT03286218|524300723|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394988|NCT03286218|524300724|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394989|NCT03286218|524300725|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394990|NCT03286218|524300726|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394991|NCT03286218|524300727|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394992|NCT03286218|524300728|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394993|NCT03286218|524300729|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394994|NCT03286218|524300730|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
145394995|NCT03286218|524300719|FG000|Qualification Phase Period 2|Adverse Event|0|||
145394996|NCT03286218|524300720|FG001|Qualification Phase Period 2|Adverse Event|1|||
145394997|NCT03286218|524300721|FG002|Qualification Phase Period 2|Adverse Event|0|||
145394998|NCT03286218|524300722|FG003|Qualification Phase Period 2|Adverse Event|0|||
145394999|NCT03286218|524300723|FG004|Qualification Phase Period 2|Adverse Event|0|||
145395000|NCT03286218|524300724|FG005|Qualification Phase Period 2|Adverse Event|0|||
145395001|NCT03286218|524300725|FG006|Qualification Phase Period 2|Adverse Event|0|||
145395002|NCT03286218|524300726|FG007|Qualification Phase Period 2|Adverse Event|0|||
145395003|NCT03286218|524300727|FG008|Qualification Phase Period 2|Adverse Event|0|||
145395004|NCT03286218|524300728|FG009|Qualification Phase Period 2|Adverse Event|0|||
145395005|NCT03286218|524300729|FG010|Qualification Phase Period 2|Adverse Event|0|||
145395006|NCT03286218|524300730|FG011|Qualification Phase Period 2|Adverse Event|0|||
145395007|NCT03286218|524300719|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
145395008|NCT03286218|524300720|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
145395009|NCT03286218|524300721|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395010|NCT03286218|524300722|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395011|NCT03286218|524300723|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395012|NCT03286218|524300724|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395013|NCT03286218|524300725|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395014|NCT03286218|524300726|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395015|NCT03286218|524300727|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395016|NCT03286218|524300728|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395017|NCT03286218|524300729|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395018|NCT03286218|524300730|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
145395019|NCT03286218|524300719|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
145395020|NCT03286218|524300720|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
145395021|NCT03286218|524300721|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
145395022|NCT03286218|524300722|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
145395023|NCT03286218|524300723|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
145395024|NCT03286218|524300724|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
145395025|NCT03286218|524300725|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
145395026|NCT03286218|524300726|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
145395027|NCT03286218|524300727|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
145395028|NCT03286218|524300728|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
145395029|NCT03286218|524300729|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
145395030|NCT03286218|524300730|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
145395031|NCT03286218|524300719|FG000|Qualification Phase Period 2|Protocol Violation|2|||
145395032|NCT03286218|524300720|FG001|Qualification Phase Period 2|Protocol Violation|0|||
145395033|NCT03286218|524300721|FG002|Qualification Phase Period 2|Protocol Violation|0|||
145395034|NCT03286218|524300722|FG003|Qualification Phase Period 2|Protocol Violation|0|||
145395035|NCT03286218|524300723|FG004|Qualification Phase Period 2|Protocol Violation|0|||
145395036|NCT03286218|524300724|FG005|Qualification Phase Period 2|Protocol Violation|0|||
145395037|NCT03286218|524300725|FG006|Qualification Phase Period 2|Protocol Violation|0|||
145395038|NCT03286218|524300726|FG007|Qualification Phase Period 2|Protocol Violation|0|||
145395039|NCT03286218|524300727|FG008|Qualification Phase Period 2|Protocol Violation|0|||
145395040|NCT03286218|524300728|FG009|Qualification Phase Period 2|Protocol Violation|0|||
145395041|NCT03286218|524300729|FG010|Qualification Phase Period 2|Protocol Violation|0|||
145395042|NCT03286218|524300730|FG011|Qualification Phase Period 2|Protocol Violation|0|||
145395043|NCT03286218|524300719|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
145395044|NCT03286218|524300720|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
145395045|NCT03286218|524300721|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395046|NCT03286218|524300722|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395047|NCT03286218|524300723|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395048|NCT03286218|524300724|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395049|NCT03286218|524300725|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395050|NCT03286218|524300726|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395051|NCT03286218|524300727|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
145497285|NCT02177123|524679558|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
145497286|NCT05660577|524679559|FG000|Overall Study|Discontinued|9|||
145497287|NCT00481832|524679564|FG000|Enrollment|Physician Decision|8|||
145497288|NCT00481832|524679564|FG000|Enrollment|Unable to collect enough stem cells|2|||
145497289|NCT00481832|524679564|FG000|Inter-transplant Period|Adverse Event|4|||
145497290|NCT00481832|524679564|FG000|Inter-transplant Period|Death|3|||
145497291|NCT00481832|524679564|FG000|Inter-transplant Period|Physician Decision|4|||
145497292|NCT00481832|524679564|FG000|Inter-transplant Period|Disease relapse|11|||
145497293|NCT00481832|524679564|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
145497294|NCT00581308|524679565|FG000|Pre Discharge|Lost to Follow-up|1|||
145497295|NCT00581308|524679565|FG000|Pre Discharge|Device Removed|1|||
145497296|NCT00581308|524679565|FG000|Month 1|Lost to Follow-up|3|||
145497297|NCT00581308|524679565|FG000|Month 1|Withdrawal by Subject|2|||
145497298|NCT00581308|524679565|FG000|Month 1|Device Removed|2|||
145497299|NCT00581308|524679565|FG000|Month 1|Uknown|1|||
145497300|NCT00581308|524679565|FG000|Month 6|Lost to Follow-up|1|||
145497301|NCT00581308|524679565|FG000|Month 6|Withdrawal by Subject|2|||
145497302|NCT00581308|524679565|FG000|Month 12|Death|1|||
145497303|NCT00581308|524679565|FG000|Month 12|Lost to Follow-up|14|||
145497304|NCT00581308|524679565|FG000|Month 12|Withdrawal by Subject|3|||
145497305|NCT00581308|524679565|FG000|Month 12|Device Removed|1|||
145497306|NCT00581308|524679565|FG000|Month 12|Other|1|||
145497307|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
145497308|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
145497309|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
145497310|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
145497311|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
145497312|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
145497313|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
145497314|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
145731421|NCT03055013|525535848|FG000|Overall Study|Insurance issues|1|||
145731422|NCT03055013|525535849|FG001|Overall Study|Insurance issues|0|||
145731423|NCT03055013|525535848|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
145731424|NCT03055013|525535849|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
145731425|NCT03055013|525535848|FG000|Overall Study|Did not receive nivolumab|10|||
145731426|NCT03055013|525535849|FG001|Overall Study|Did not receive nivolumab|0|||
145731427|NCT03055013|525535848|FG000|Overall Study|Did not receive surgery|0|||
145731428|NCT03055013|525535849|FG001|Overall Study|Did not receive surgery|28|||
145731429|NCT03422172|525535853|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
145731430|NCT03422172|525535853|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
145731431|NCT03422172|525535853|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
145731432|NCT05736211|525535855|FG000|Overall Study|Lost to Follow-up|6|||
145731433|NCT05736211|525535856|FG001|Overall Study|Lost to Follow-up|0|||
145731434|NCT00293722|525535857|FG000|Overall Study|Other|427|||
145731435|NCT04982588|525535861|FG000|Overall Study|Withdrawal by Subject|2|||
145731436|NCT02170389|525535862|FG000|Overall Study|Study terminated prior to start of treat|1|||
145731437|NCT01008696|525535863|FG000|Overall Study|Participant's evasion of hospital visit|5|||
145731438|NCT01008696|525535864|FG001|Overall Study|Participant's evasion of hospital visit|4|||
145731439|NCT01008696|525535863|FG000|Overall Study|Withdrawal by Subject|2|||
145731440|NCT01008696|525535864|FG001|Overall Study|Withdrawal by Subject|4|||
145731441|NCT01008696|525535863|FG000|Overall Study|Physician Decision|5|||
145731442|NCT01008696|525535864|FG001|Overall Study|Physician Decision|1|||
145731443|NCT01008696|525535863|FG000|Overall Study|Adverse Event|1|||
145731444|NCT01008696|525535864|FG001|Overall Study|Adverse Event|0|||
145731445|NCT01008696|525535863|FG000|Overall Study|Participants' non-cooperation|2|||
145731446|NCT01008696|525535864|FG001|Overall Study|Participants' non-cooperation|3|||
145731447|NCT01008696|525535863|FG000|Overall Study|Other|2|||
145731448|NCT01008696|525535864|FG001|Overall Study|Other|3|||
145731449|NCT01008696|525535863|FG000|Overall Study|Other|0|||
145731450|NCT01008696|525535864|FG001|Overall Study|Other|2|||
145731451|NCT02366728|525535865|FG000|Overall Study|Death|0|||
145731452|NCT02366728|525535866|FG001|Overall Study|Death|0|||
145731453|NCT02366728|525535867|FG002|Overall Study|Death|1|||
145731454|NCT02366728|525535865|FG000|Overall Study|Adverse Event|1|||
145731455|NCT02366728|525535866|FG001|Overall Study|Adverse Event|0|||
145731456|NCT02366728|525535867|FG002|Overall Study|Adverse Event|0|||
145731457|NCT02366728|525535865|FG000|Overall Study|Screen Failure|2|||
145731458|NCT02366728|525535866|FG001|Overall Study|Screen Failure|1|||
145731459|NCT02366728|525535867|FG002|Overall Study|Screen Failure|0|||
145731460|NCT02366728|525535865|FG000|Overall Study|Only yielded 2 vaccines|1|||
145731461|NCT02366728|525535866|FG001|Overall Study|Only yielded 2 vaccines|0|||
145731462|NCT02366728|525535867|FG002|Overall Study|Only yielded 2 vaccines|0|||
145731463|NCT02960854|525535868|FG000|Overall Study|Not Disclosed|2|||
145731464|NCT02960854|525535869|FG001|Overall Study|Not Disclosed|2|||
145731465|NCT02960854|525535868|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
145497315|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
145497316|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
145497317|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
145497318|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
145497319|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
145497320|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
145497321|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
145605957|NCT01932294|525073050|FG000|Overall Study|Transferred to other hospitals|12|||
145497322|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Other|1|||
145497323|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Other|5|||
145497324|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Other|0|||
145497325|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Other|2|||
145395052|NCT03286218|524300728|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395053|NCT03286218|524300729|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395054|NCT03286218|524300730|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
145395055|NCT03286218|524300719|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395056|NCT03286218|524300720|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395057|NCT03286218|524300721|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
145395058|NCT03286218|524300722|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
145395059|NCT03286218|524300723|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395060|NCT03286218|524300724|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
145395061|NCT03286218|524300725|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395062|NCT03286218|524300726|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395063|NCT03286218|524300727|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395064|NCT03286218|524300728|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395065|NCT03286218|524300729|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
145395066|NCT03286218|524300730|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
145395067|NCT03286218|524300719|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395068|NCT03286218|524300720|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395069|NCT03286218|524300721|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395070|NCT03286218|524300722|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395071|NCT03286218|524300723|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395072|NCT03286218|524300724|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395073|NCT03286218|524300725|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395074|NCT03286218|524300726|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395075|NCT03286218|524300727|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395076|NCT03286218|524300728|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395077|NCT03286218|524300729|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
145395078|NCT03286218|524300730|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
145395079|NCT00227539|524300733|FG000|Overall Study|Protocol Violation|1|||
145395080|NCT01166750|524300734|FG000|Overall Study|Lost to Follow-up|1|||
145395081|NCT01166750|524300735|FG001|Overall Study|Lost to Follow-up|0|||
145395082|NCT02111174|524300736|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
145395083|NCT02111174|524300737|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
145395084|NCT02111174|524300736|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
145395085|NCT02111174|524300737|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
145395086|NCT02111174|524300736|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
145395087|NCT02111174|524300737|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
145395088|NCT02111174|524300736|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
145395089|NCT02111174|524300737|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
145395090|NCT00901342|524300738|FG000|Overall Study|Adverse Event|1|||
145395091|NCT00901342|524300738|FG000|Overall Study|Death|4|||
145395092|NCT00901342|524300738|FG000|Overall Study|Disease progression|1|||
145395093|NCT00901342|524300738|FG000|Overall Study|Withdrawal by Subject|9|||
145395094|NCT02716779|524300739|FG000|Monotherapy|Adverse Event|0|||
145395095|NCT02716779|524300740|FG001|Monotherapy|Adverse Event|1|||
145497326|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Other|3|||
145497327|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
145731466|NCT02960854|525535869|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
145731467|NCT02960854|525535868|FG000|Overall Study|Subject Withdrew Consent|0|||
145731468|NCT02960854|525535869|FG001|Overall Study|Subject Withdrew Consent|1|||
145731469|NCT02960854|525535868|FG000|Overall Study|Death|4|||
145731470|NCT02960854|525535869|FG001|Overall Study|Death|6|||
145731471|NCT00833911|525535870|FG000|Titration|Adverse Event|18|||
145731472|NCT00833911|525535870|FG000|Titration|Withdrawal by Subject|3|||
145731473|NCT00833911|525535870|FG000|Maintenance Phase I|Adverse Event|73|||
145731474|NCT00833911|525535870|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
145731475|NCT00833911|525535870|FG000|Maintenance Phase I|Physician Decision|10|||
145731476|NCT00833911|525535870|FG000|Maintenance Phase I|Lack of Efficacy|4|||
145731477|NCT00833911|525535870|FG000|Maintenance Phase II|Adverse Event|6|||
145731478|NCT00833911|525535870|FG000|Maintenance Phase II|Physician Decision|2|||
145731479|NCT00833911|525535870|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
145731480|NCT00833911|525535870|FG000|Maintenance Phase II|Lack of Efficacy|1|||
145731481|NCT01383161|525535871|FG000|Overall Study|Adverse Event|5|||
145731482|NCT01383161|525535872|FG001|Overall Study|Adverse Event|1|||
145731483|NCT01383161|525535871|FG000|Overall Study|Withdrawal by Subject|0|||
145731484|NCT01383161|525535872|FG001|Overall Study|Withdrawal by Subject|2|||
145731485|NCT01383161|525535871|FG000|Overall Study|Lack of Efficacy|0|||
145731486|NCT01383161|525535872|FG001|Overall Study|Lack of Efficacy|1|||
145731487|NCT03942406|525535881|FG000|Overall Study|Lost to Follow-up|4|||
145731488|NCT03942406|525535882|FG001|Overall Study|Lost to Follow-up|5|||
145731489|NCT03942406|525535883|FG002|Overall Study|Lost to Follow-up|3|||
145731490|NCT03942406|525535884|FG003|Overall Study|Lost to Follow-up|7|||
145731491|NCT03942406|525535885|FG004|Overall Study|Lost to Follow-up|1|||
145395096|NCT02716779|524300741|FG002|Monotherapy|Adverse Event|1|||
145395097|NCT02716779|524300739|FG000|Combination Therapy|Adverse Event|0|||
145395098|NCT02716779|524300740|FG001|Combination Therapy|Adverse Event|2|||
145395099|NCT02716779|524300741|FG002|Combination Therapy|Adverse Event|1|||
145395100|NCT01261390|524300746|FG000|Overall Study|Significant Concurrent Illness|1|||
145395101|NCT01261390|524300747|FG001|Overall Study|Significant Concurrent Illness|0|||
145395102|NCT01261390|524300748|FG002|Overall Study|Significant Concurrent Illness|1|||
145395103|NCT01261390|524300749|FG003|Overall Study|Significant Concurrent Illness|0|||
145395104|NCT01261390|524300746|FG000|Overall Study|Dissatisfaction with Treatment|2|||
145395105|NCT01261390|524300747|FG001|Overall Study|Dissatisfaction with Treatment|1|||
145395106|NCT01261390|524300748|FG002|Overall Study|Dissatisfaction with Treatment|1|||
145395107|NCT01261390|524300749|FG003|Overall Study|Dissatisfaction with Treatment|2|||
145395108|NCT01261390|524300746|FG000|Overall Study|Relocation|0|||
145395109|NCT01261390|524300747|FG001|Overall Study|Relocation|1|||
145395110|NCT01261390|524300748|FG002|Overall Study|Relocation|0|||
145395111|NCT01261390|524300749|FG003|Overall Study|Relocation|0|||
145395112|NCT01261390|524300746|FG000|Overall Study|Loss of Interest in the Study|3|||
145395113|NCT01261390|524300747|FG001|Overall Study|Loss of Interest in the Study|1|||
145395114|NCT01261390|524300748|FG002|Overall Study|Loss of Interest in the Study|0|||
145395115|NCT01261390|524300749|FG003|Overall Study|Loss of Interest in the Study|0|||
145395116|NCT01261390|524300746|FG000|Overall Study|Lost to Follow-up|1|||
145395117|NCT01261390|524300747|FG001|Overall Study|Lost to Follow-up|6|||
145395118|NCT01261390|524300748|FG002|Overall Study|Lost to Follow-up|5|||
145395119|NCT01261390|524300749|FG003|Overall Study|Lost to Follow-up|6|||
145395120|NCT03421379|524300751|FG000|Period 1|Withdrawal by Subject|0|||
145395121|NCT03421379|524300752|FG001|Period 1|Withdrawal by Subject|1|||
145395122|NCT03421379|524300751|FG000|Period 1|Physician Decision|1|||
145395123|NCT03421379|524300752|FG001|Period 1|Physician Decision|1|||
145395124|NCT03421379|524300751|FG000|Period 1|Did not receive treatment|1|||
145395125|NCT03421379|524300752|FG001|Period 1|Did not receive treatment|2|||
145395126|NCT01497067|524300754|FG000|Overall Study|Lost to Follow-up|56|||
145395127|NCT01497067|524300754|FG000|Overall Study|Adverse Event|3|||
145395128|NCT01497067|524300754|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
145395129|NCT01497067|524300754|FG000|Overall Study|Other|13|||
145395130|NCT03771963|524300755|FG000|Overall Study|Lost to Follow-up|22|||
145395131|NCT03771963|524300755|FG000|Overall Study|Withdrawal of Consent|10|||
145395132|NCT03066830|524300756|FG000|Overall Study|At the Participant's own Request|16|||
145395133|NCT03066830|524300757|FG001|Overall Study|At the Participant's own Request|17|||
145395134|NCT03066830|524300756|FG000|Overall Study|Other|3|||
145395135|NCT03066830|524300757|FG001|Overall Study|Other|0|||
145395136|NCT03066830|524300756|FG000|Overall Study|Poor Compliance to Protocol|1|||
145395137|NCT03066830|524300757|FG001|Overall Study|Poor Compliance to Protocol|0|||
145395138|NCT03066830|524300756|FG000|Overall Study|Adverse Event|2|||
145395139|NCT03066830|524300757|FG001|Overall Study|Adverse Event|2|||
145395140|NCT03066830|524300756|FG000|Overall Study|Lost to Follow-up|11|||
145395141|NCT03066830|524300757|FG001|Overall Study|Lost to Follow-up|3|||
145395142|NCT01827592|524300765|FG000|Overall Study|Adverse Event|11|||
145395143|NCT01827592|524300766|FG001|Overall Study|Adverse Event|9|||
145395144|NCT01827592|524300767|FG002|Overall Study|Adverse Event|2|||
145395145|NCT01827592|524300765|FG000|Overall Study|Physician Decision|0|||
145395146|NCT01827592|524300766|FG001|Overall Study|Physician Decision|2|||
145395147|NCT01827592|524300767|FG002|Overall Study|Physician Decision|1|||
145395148|NCT01827592|524300765|FG000|Overall Study|Protocol Violation|2|||
145395149|NCT01827592|524300766|FG001|Overall Study|Protocol Violation|1|||
145395150|NCT01827592|524300767|FG002|Overall Study|Protocol Violation|0|||
145395151|NCT01827592|524300765|FG000|Overall Study|Lost to Follow-up|1|||
145395152|NCT01827592|524300766|FG001|Overall Study|Lost to Follow-up|2|||
145395153|NCT01827592|524300767|FG002|Overall Study|Lost to Follow-up|2|||
145395154|NCT01827592|524300765|FG000|Overall Study|Withdrawal by Subject|12|||
145395155|NCT01827592|524300766|FG001|Overall Study|Withdrawal by Subject|11|||
145395156|NCT01827592|524300767|FG002|Overall Study|Withdrawal by Subject|11|||
145395157|NCT01827592|524300765|FG000|Overall Study|Patient's substantial non-compliance|1|||
145395158|NCT01827592|524300766|FG001|Overall Study|Patient's substantial non-compliance|1|||
145395159|NCT01827592|524300767|FG002|Overall Study|Patient's substantial non-compliance|6|||
145395160|NCT01827592|524300765|FG000|Overall Study|Trial terminated by Sponsor|47|||
145395161|NCT01827592|524300766|FG001|Overall Study|Trial terminated by Sponsor|53|||
145497328|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
145497329|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
145497330|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
145497331|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
145497332|NCT02006472|524679569|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
145497333|NCT02006472|524679570|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
145497334|NCT02006472|524679571|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
145497335|NCT02006472|524679572|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
145497336|NCT02006472|524679573|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
145497337|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
145497338|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
145497339|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
145497340|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
145497341|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
145497342|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
145497343|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
145497344|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
145497345|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
145497346|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
145497347|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
145497348|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
145497349|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
145497350|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
145497351|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
145497352|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Other|0|||
145497353|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Other|1|||
145497354|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Other|0|||
145497355|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Other|1|||
145497356|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Other|0|||
145497357|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Not treated|0|||
145497358|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Not treated|0|||
145497359|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Not treated|2|||
145497360|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Not treated|0|||
145497361|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Not treated|0|||
145497362|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
145497363|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
145497364|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
145497365|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
145605958|NCT04415151|525073051|FG000|Overall Study|Death|1|||
145731492|NCT03942406|525535886|FG005|Overall Study|Lost to Follow-up|0|||
145731493|NCT03942406|525535887|FG006|Overall Study|Lost to Follow-up|0|||
145731494|NCT03942406|525535881|FG000|Overall Study|Withdrawal by Subject|3|||
145731495|NCT03942406|525535882|FG001|Overall Study|Withdrawal by Subject|1|||
145731496|NCT03942406|525535883|FG002|Overall Study|Withdrawal by Subject|1|||
145731497|NCT03942406|525535884|FG003|Overall Study|Withdrawal by Subject|3|||
145731498|NCT03942406|525535885|FG004|Overall Study|Withdrawal by Subject|0|||
145731499|NCT03942406|525535886|FG005|Overall Study|Withdrawal by Subject|0|||
145731500|NCT03942406|525535887|FG006|Overall Study|Withdrawal by Subject|0|||
145731501|NCT03942406|525535881|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
145731502|NCT03942406|525535882|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
145731503|NCT03942406|525535883|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
145731504|NCT03942406|525535884|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
145731505|NCT03942406|525535885|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
145731506|NCT03942406|525535886|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
145731507|NCT03942406|525535887|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
145731508|NCT01207596|525535888|FG000|Overall Study|Physician Decision|4|||
145731509|NCT01207596|525535888|FG000|Overall Study|Lack of Efficacy|1|||
145731510|NCT01207596|525535888|FG000|Overall Study|Adverse Event|3|||
145731511|NCT01207596|525535888|FG000|Overall Study|Withdrawal by Subject|1|||
145731512|NCT01054144|525535891|FG000|Overall Study|Death|2|||
145731513|NCT02748018|525535892|FG000|Study Period|Adverse Event|1|||
145731514|NCT02748018|525535893|FG001|Study Period|Adverse Event|3|||
145731515|NCT02748018|525535894|FG002|Study Period|Adverse Event|4|||
145731516|NCT02748018|525535895|FG003|Study Period|Adverse Event|0|||
145731517|NCT02748018|525535896|FG004|Study Period|Adverse Event|3|||
145731518|NCT02748018|525535897|FG005|Study Period|Adverse Event|3|||
145731519|NCT02748018|525535892|FG000|Study Period|Withdrawal by Subject|7|||
145731520|NCT02748018|525535893|FG001|Study Period|Withdrawal by Subject|4|||
145731521|NCT02748018|525535894|FG002|Study Period|Withdrawal by Subject|4|||
145731522|NCT02748018|525535895|FG003|Study Period|Withdrawal by Subject|11|||
145731523|NCT02748018|525535896|FG004|Study Period|Withdrawal by Subject|12|||
145731524|NCT02748018|525535897|FG005|Study Period|Withdrawal by Subject|10|||
145731525|NCT02748018|525535892|FG000|Study Period|Pregnancy|0|||
145731526|NCT02748018|525535893|FG001|Study Period|Pregnancy|1|||
145395162|NCT01827592|524300767|FG002|Overall Study|Trial terminated by Sponsor|51|||
145395163|NCT01827592|524300765|FG000|Overall Study|Others|0|||
145395164|NCT01827592|524300766|FG001|Overall Study|Others|1|||
145395165|NCT01827592|524300767|FG002|Overall Study|Others|3|||
145395166|NCT00003471|524300772|FG000|Overall Study|Not evaluable|4|||
145395167|NCT00808067|524300773|FG000|Overall Study|Major/minor bleed|30|||
145395168|NCT00808067|524300774|FG001|Overall Study|Major/minor bleed|44|||
145395169|NCT00808067|524300773|FG000|Overall Study|Outcome event - other|33|||
145395170|NCT00808067|524300774|FG001|Overall Study|Outcome event - other|25|||
145395171|NCT00808067|524300773|FG000|Overall Study|Adverse Event|111|||
145395172|NCT00808067|524300774|FG001|Overall Study|Adverse Event|121|||
145395173|NCT00808067|524300773|FG000|Overall Study|Hospitalization (not including surgery)|18|||
145395174|NCT00808067|524300774|FG001|Overall Study|Hospitalization (not including surgery)|17|||
145395175|NCT00808067|524300773|FG000|Overall Study|Hospitalization due to surgery|37|||
145395176|NCT00808067|524300774|FG001|Overall Study|Hospitalization due to surgery|40|||
145395177|NCT00808067|524300773|FG000|Overall Study|Reduced creatinine clearance|53|||
145395178|NCT00808067|524300774|FG001|Overall Study|Reduced creatinine clearance|55|||
145395179|NCT00808067|524300773|FG000|Overall Study|Elevated LFT results|7|||
145395180|NCT00808067|524300774|FG001|Overall Study|Elevated LFT results|3|||
145395181|NCT00808067|524300773|FG000|Overall Study|Patient refused to take study medication|65|||
145395182|NCT00808067|524300774|FG001|Overall Study|Patient refused to take study medication|76|||
145395183|NCT00808067|524300773|FG000|Overall Study|Missing|1|||
145395184|NCT00808067|524300774|FG001|Overall Study|Missing|0|||
145395185|NCT00808067|524300773|FG000|Overall Study|Death|1|||
145395186|NCT00808067|524300774|FG001|Overall Study|Death|1|||
145395187|NCT00808067|524300773|FG000|Overall Study|Procedure|6|||
145395188|NCT00808067|524300774|FG001|Overall Study|Procedure|7|||
145395189|NCT00808067|524300773|FG000|Overall Study|Withdrawal by Subject|21|||
145395190|NCT00808067|524300774|FG001|Overall Study|Withdrawal by Subject|25|||
145395191|NCT00808067|524300773|FG000|Overall Study|Site closed|4|||
145395192|NCT00808067|524300774|FG001|Overall Study|Site closed|3|||
145395193|NCT00808067|524300773|FG000|Overall Study|Physician Decision|47|||
145395194|NCT00808067|524300774|FG001|Overall Study|Physician Decision|38|||
145395195|NCT00808067|524300773|FG000|Overall Study|Protocol Violation|3|||
145395196|NCT00808067|524300774|FG001|Overall Study|Protocol Violation|11|||
145395197|NCT00808067|524300773|FG000|Overall Study|Patient elected|7|||
145395198|NCT00808067|524300774|FG001|Overall Study|Patient elected|9|||
145395199|NCT00808067|524300773|FG000|Overall Study|Site closed for cause|19|||
145395200|NCT00808067|524300774|FG001|Overall Study|Site closed for cause|19|||
145395201|NCT00808067|524300773|FG000|Overall Study|Other reason not defined above|5|||
145395202|NCT00808067|524300774|FG001|Overall Study|Other reason not defined above|5|||
145395203|NCT00808067|524300773|FG000|Overall Study|Excluded from analysis|13|||
145395204|NCT00808067|524300774|FG001|Overall Study|Excluded from analysis|19|||
145395205|NCT00689338|524300775|FG000|Overall Study|Death|65|||
145395206|NCT00689338|524300775|FG000|Overall Study|Adverse Event|13|||
145395207|NCT00689338|524300775|FG000|Overall Study|Insufficient Clinical Response|1|||
145395208|NCT00689338|524300775|FG000|Overall Study|Lack of Efficacy|6|||
145395209|NCT00689338|524300775|FG000|Overall Study|Other|8|||
145395210|NCT00689338|524300775|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
145395211|NCT00689338|524300775|FG000|Overall Study|Lost to Follow-up|5|||
145395212|NCT00689338|524300775|FG000|Overall Study|Withdrawal by Subject|3|||
145395213|NCT00689338|524300775|FG000|Overall Study|Protocol Violation|15|||
145395214|NCT00715403|524300780|FG000|Overall Study|Progressive disease|0|||
145395215|NCT00715403|524300781|FG001|Overall Study|Progressive disease|1|||
145395216|NCT00715403|524300782|FG002|Overall Study|Progressive disease|3|||
145395217|NCT00715403|524300783|FG003|Overall Study|Progressive disease|9|||
145395218|NCT00715403|524300784|FG004|Overall Study|Progressive disease|5|||
145395219|NCT00715403|524300785|FG005|Overall Study|Progressive disease|14|||
145395220|NCT00715403|524300786|FG006|Overall Study|Progressive disease|1|||
145395221|NCT00715403|524300780|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
145395222|NCT00715403|524300781|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
145395223|NCT00715403|524300782|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
145395224|NCT00715403|524300783|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
145605959|NCT04415151|525073052|FG001|Overall Study|Death|1|||
145395225|NCT00715403|524300784|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
145395226|NCT00715403|524300785|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
145395227|NCT00715403|524300786|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
145731527|NCT02748018|525535894|FG002|Study Period|Pregnancy|0|||
145731528|NCT02748018|525535895|FG003|Study Period|Pregnancy|0|||
145731529|NCT02748018|525535896|FG004|Study Period|Pregnancy|1|||
145731530|NCT02748018|525535897|FG005|Study Period|Pregnancy|0|||
145731531|NCT02748018|525535892|FG000|Study Period|Physician Decision|2|||
145731532|NCT02748018|525535893|FG001|Study Period|Physician Decision|2|||
145731533|NCT02748018|525535894|FG002|Study Period|Physician Decision|1|||
145731534|NCT02748018|525535895|FG003|Study Period|Physician Decision|0|||
145731535|NCT02748018|525535896|FG004|Study Period|Physician Decision|2|||
145731536|NCT02748018|525535897|FG005|Study Period|Physician Decision|0|||
145731537|NCT02748018|525535892|FG000|Study Period|Lost to Follow-up|0|||
145497366|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
145497367|NCT02006472|524679569|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
145497368|NCT02006472|524679570|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
145497369|NCT02006472|524679571|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
145497370|NCT02006472|524679572|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
145497371|NCT02006472|524679573|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
145497372|NCT00886379|524679574|FG000|Overall Study|Transferred Schools|0|||
145497373|NCT00886379|524679575|FG001|Overall Study|Transferred Schools|0|||
145497374|NCT00886379|524679576|FG002|Overall Study|Transferred Schools|2|||
145497375|NCT00886379|524679577|FG003|Overall Study|Transferred Schools|1|||
145497376|NCT00886379|524679578|FG004|Overall Study|Transferred Schools|1|||
145497377|NCT00886379|524679574|FG000|Overall Study|Final blood draw not obtained|3|||
145497378|NCT00886379|524679575|FG001|Overall Study|Final blood draw not obtained|3|||
145497379|NCT00886379|524679576|FG002|Overall Study|Final blood draw not obtained|4|||
145497380|NCT00886379|524679577|FG003|Overall Study|Final blood draw not obtained|2|||
145497381|NCT00886379|524679578|FG004|Overall Study|Final blood draw not obtained|2|||
145497382|NCT03219723|524679579|FG000|Overall Study|Case Report Forms Uncollected|6|||
145497383|NCT03219723|524679579|FG000|Overall Study|Protocol Deviation|4|||
145497384|NCT03137381|524679580|FG000|Overall Study|Adverse Event|3|||
145395228|NCT00715403|524300780|FG000|Overall Study|Other Adverse Event than DLT|1|||
145395229|NCT00715403|524300781|FG001|Overall Study|Other Adverse Event than DLT|0|||
145395230|NCT00715403|524300782|FG002|Overall Study|Other Adverse Event than DLT|0|||
145395231|NCT00715403|524300783|FG003|Overall Study|Other Adverse Event than DLT|0|||
145395232|NCT00715403|524300784|FG004|Overall Study|Other Adverse Event than DLT|0|||
145395233|NCT00715403|524300785|FG005|Overall Study|Other Adverse Event than DLT|2|||
145395234|NCT00715403|524300786|FG006|Overall Study|Other Adverse Event than DLT|0|||
145395235|NCT00715403|524300780|FG000|Overall Study|Protocol Violation|0|||
145395236|NCT00715403|524300781|FG001|Overall Study|Protocol Violation|0|||
145395237|NCT00715403|524300782|FG002|Overall Study|Protocol Violation|0|||
145395238|NCT00715403|524300783|FG003|Overall Study|Protocol Violation|0|||
145395239|NCT00715403|524300784|FG004|Overall Study|Protocol Violation|0|||
145395240|NCT00715403|524300785|FG005|Overall Study|Protocol Violation|1|||
145395241|NCT00715403|524300786|FG006|Overall Study|Protocol Violation|0|||
145395242|NCT00715403|524300780|FG000|Overall Study|Other reason not defined above|0|||
145395243|NCT00715403|524300781|FG001|Overall Study|Other reason not defined above|0|||
145395244|NCT00715403|524300782|FG002|Overall Study|Other reason not defined above|1|||
145395245|NCT00715403|524300783|FG003|Overall Study|Other reason not defined above|0|||
145395246|NCT00715403|524300784|FG004|Overall Study|Other reason not defined above|1|||
145395247|NCT00715403|524300785|FG005|Overall Study|Other reason not defined above|1|||
145395248|NCT00715403|524300786|FG006|Overall Study|Other reason not defined above|0|||
145395249|NCT02104895|524300787|FG000|Overall Study|Withdrawal by Subject|0|||
145395250|NCT02104895|524300788|FG001|Overall Study|Withdrawal by Subject|14|||
145395251|NCT00101868|524300790|FG000|Overall Study|Death|10|||
145395252|NCT00101868|524300791|FG001|Overall Study|Death|10|||
145395253|NCT00101868|524300790|FG000|Overall Study|Withdrawal by Subject|8|||
145395254|NCT00101868|524300791|FG001|Overall Study|Withdrawal by Subject|9|||
145395255|NCT00101868|524300790|FG000|Overall Study|Protocol Violation|3|||
145395256|NCT00101868|524300791|FG001|Overall Study|Protocol Violation|0|||
145395257|NCT00101868|524300790|FG000|Overall Study|Lost to Follow-up|8|||
145395258|NCT00101868|524300791|FG001|Overall Study|Lost to Follow-up|13|||
145395259|NCT03839394|524300792|FG000|Overall Study|Lost to Follow-up|6|||
145395260|NCT03839394|524300793|FG001|Overall Study|Lost to Follow-up|8|||
145395261|NCT03839394|524300792|FG000|Overall Study|Withdrawal by Subject|0|||
145395262|NCT03839394|524300793|FG001|Overall Study|Withdrawal by Subject|2|||
145395263|NCT03718429|524300796|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
145395264|NCT03718429|524300797|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
145395265|NCT03718429|524300798|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
145395266|NCT03718429|524300799|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
145395267|NCT02532283|524300804|FG000|Overall Study|Adverse Event|0|||
145395268|NCT02532283|524300805|FG001|Overall Study|Adverse Event|1|||
145395269|NCT02532283|524300804|FG000|Overall Study|Death|1|||
145395270|NCT02532283|524300805|FG001|Overall Study|Death|0|||
145395271|NCT02532283|524300804|FG000|Overall Study|Lost to Follow-up|0|||
145395272|NCT02532283|524300805|FG001|Overall Study|Lost to Follow-up|1|||
145395273|NCT02532283|524300804|FG000|Overall Study|Withdrawal by Subject|8|||
145395274|NCT02532283|524300805|FG001|Overall Study|Withdrawal by Subject|3|||
145395275|NCT01945944|524300806|FG000|Overall Study|Adverse Event|0|||
145395276|NCT01945944|524300807|FG001|Overall Study|Adverse Event|2|||
145605960|NCT04415151|525073051|FG000|Overall Study|Withdrawal by Subject|1|||
145395277|NCT01945944|524300806|FG000|Overall Study|Physician Decision|1|||
145395278|NCT01945944|524300807|FG001|Overall Study|Physician Decision|0|||
145395279|NCT01945944|524300806|FG000|Overall Study|Withdrawal by Subject|0|||
145395280|NCT01945944|524300807|FG001|Overall Study|Withdrawal by Subject|1|||
145395281|NCT01817075|524300808|FG000|Overall Study|Adverse Event|7|||
145395282|NCT01817075|524300809|FG001|Overall Study|Adverse Event|5|||
145395283|NCT01817075|524300808|FG000|Overall Study|Physician Decision|9|||
145395284|NCT01817075|524300809|FG001|Overall Study|Physician Decision|12|||
145395285|NCT01817075|524300808|FG000|Overall Study|Withdrawal by Subject|31|||
145395286|NCT01817075|524300809|FG001|Overall Study|Withdrawal by Subject|15|||
145395287|NCT01817075|524300808|FG000|Overall Study|Received Sorafenib after enrollment|0|||
145395288|NCT01817075|524300809|FG001|Overall Study|Received Sorafenib after enrollment|1|||
145395289|NCT01817075|524300808|FG000|Overall Study|Ineligible|0|||
145395290|NCT01817075|524300809|FG001|Overall Study|Ineligible|2|||
145395291|NCT04376515|524300812|FG000|Overall Study|Found to have been vaccinated before study start|6|||
145395292|NCT04376515|524300813|FG001|Overall Study|Found to have been vaccinated before study start|6|||
145395293|NCT01683604|524300814|FG000|Overall Study|Adverse Event|2|||
145497385|NCT03137381|524679581|FG001|Overall Study|Adverse Event|0|||
145497386|NCT03137381|524679582|FG002|Overall Study|Adverse Event|2|||
145497387|NCT03137381|524679583|FG003|Overall Study|Adverse Event|0|||
145497388|NCT03137381|524679580|FG000|Overall Study|Lost to Follow-up|2|||
145497389|NCT03137381|524679581|FG001|Overall Study|Lost to Follow-up|1|||
145497390|NCT03137381|524679582|FG002|Overall Study|Lost to Follow-up|1|||
145497391|NCT03137381|524679583|FG003|Overall Study|Lost to Follow-up|0|||
145497392|NCT03137381|524679580|FG000|Overall Study|Protocol deviation|1|||
145497393|NCT03137381|524679581|FG001|Overall Study|Protocol deviation|1|||
145497394|NCT03137381|524679582|FG002|Overall Study|Protocol deviation|0|||
145497395|NCT03137381|524679583|FG003|Overall Study|Protocol deviation|1|||
145497396|NCT03137381|524679580|FG000|Overall Study|Withdrawal by Investigator|0|||
145497397|NCT03137381|524679581|FG001|Overall Study|Withdrawal by Investigator|1|||
145497398|NCT03137381|524679582|FG002|Overall Study|Withdrawal by Investigator|1|||
145497399|NCT03137381|524679583|FG003|Overall Study|Withdrawal by Investigator|0|||
145497400|NCT03137381|524679580|FG000|Overall Study|Withdrawal by Subject|3|||
145497401|NCT03137381|524679581|FG001|Overall Study|Withdrawal by Subject|4|||
145497402|NCT03137381|524679582|FG002|Overall Study|Withdrawal by Subject|3|||
145497403|NCT03137381|524679583|FG003|Overall Study|Withdrawal by Subject|0|||
145497404|NCT03137381|524679580|FG000|Overall Study|Pregnancy|0|||
145395294|NCT01683604|524300814|FG000|Overall Study|Lack of Efficacy|1|||
145395295|NCT01683604|524300814|FG000|Overall Study|Other|2|||
145395296|NCT01395810|524300817|FG000|Overall Study|Adverse Event|0|||
145395297|NCT01395810|524300818|FG001|Overall Study|Adverse Event|1|||
145395298|NCT01395810|524300819|FG002|Overall Study|Adverse Event|0|||
145395299|NCT01395810|524300820|FG003|Overall Study|Adverse Event|0|||
145395300|NCT01395810|524300817|FG000|Overall Study|Lack of Efficacy|0|||
145395301|NCT01395810|524300818|FG001|Overall Study|Lack of Efficacy|1|||
145395302|NCT01395810|524300819|FG002|Overall Study|Lack of Efficacy|0|||
145395303|NCT01395810|524300820|FG003|Overall Study|Lack of Efficacy|0|||
145395304|NCT01395810|524300817|FG000|Overall Study|Withdrawal criteria|0|||
145395305|NCT01395810|524300818|FG001|Overall Study|Withdrawal criteria|2|||
145395306|NCT01395810|524300819|FG002|Overall Study|Withdrawal criteria|0|||
145395307|NCT01395810|524300820|FG003|Overall Study|Withdrawal criteria|0|||
145395308|NCT01395810|524300817|FG000|Overall Study|Unclassified|2|||
145395309|NCT01395810|524300818|FG001|Overall Study|Unclassified|0|||
145395310|NCT01395810|524300819|FG002|Overall Study|Unclassified|0|||
145497405|NCT03137381|524679581|FG001|Overall Study|Pregnancy|0|||
145497406|NCT03137381|524679582|FG002|Overall Study|Pregnancy|1|||
145395311|NCT01395810|524300820|FG003|Overall Study|Unclassified|0|||
145395312|NCT03877224|524300824|FG000|Overall Study|Death|3|||
145395313|NCT03877224|524300825|FG001|Overall Study|Death|2|||
145395314|NCT03877224|524300824|FG000|Overall Study|Withdrawal by Subject|1|||
145395315|NCT03877224|524300825|FG001|Overall Study|Withdrawal by Subject|6|||
145497407|NCT03137381|524679583|FG003|Overall Study|Pregnancy|0|||
145497408|NCT00459316|524679588|FG000|Steps 1 & 2|Other eligibility failure|1|||
145497409|NCT00459316|524679589|FG001|Steps 1 & 2|Other eligibility failure|1|||
145497410|NCT00459316|524679590|FG002|Steps 1 & 2|Other eligibility failure|0|||
145497411|NCT00459316|524679588|FG000|Steps 1 & 2|Death|1|||
145497412|NCT00459316|524679589|FG001|Steps 1 & 2|Death|1|||
145497413|NCT00459316|524679590|FG002|Steps 1 & 2|Death|0|||
145497414|NCT00459316|524679588|FG000|Steps 1 & 2|Not able to get to clinic|7|||
145497415|NCT00459316|524679589|FG001|Steps 1 & 2|Not able to get to clinic|4|||
145497416|NCT00459316|524679590|FG002|Steps 1 & 2|Not able to get to clinic|0|||
145497417|NCT00459316|524679588|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
145497418|NCT00459316|524679589|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
145497419|NCT00459316|524679590|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
145497420|NCT00459316|524679588|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
145497421|NCT00459316|524679589|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
145497422|NCT00459316|524679590|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
145497423|NCT00459316|524679588|FG000|Steps 1 & 2|Lost to Follow-up|5|||
145497424|NCT00459316|524679589|FG001|Steps 1 & 2|Lost to Follow-up|0|||
145497425|NCT00459316|524679590|FG002|Steps 1 & 2|Lost to Follow-up|2|||
145497426|NCT00459316|524679588|FG000|Step 3|Withdrawal by Subject|3|||
145497427|NCT00459316|524679589|FG001|Step 3|Withdrawal by Subject|0|||
145497428|NCT00459316|524679590|FG002|Step 3|Withdrawal by Subject|1|||
145497429|NCT01980017|524679591|FG000|Overall Study|Lost to Follow-up|30|||
145497430|NCT01980017|524679592|FG001|Overall Study|Lost to Follow-up|21|||
145497431|NCT01980017|524679591|FG000|Overall Study|Death|0|||
145497432|NCT01980017|524679592|FG001|Overall Study|Death|1|||
145497433|NCT03044106|524679594|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
145497434|NCT03044106|524679595|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
145497435|NCT01207414|524679596|FG000|Overall Study|Adverse Event|25|||
145395316|NCT03877224|524300824|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
145395317|NCT03877224|524300825|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
145395318|NCT03234036|524302254|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
145395319|NCT03234036|524302255|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
145395320|NCT03234036|524302256|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
145395321|NCT03234036|524302257|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
145395322|NCT02163395|524302258|FG000|Overall Study|Withdrawal by Subject|1|||
145395323|NCT02163395|524302258|FG000|Overall Study|Lost to Follow-up|3|||
145395324|NCT02163395|524302258|FG000|Overall Study|Adverse Event|1|||
145395325|NCT01145482|524302262|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
145395326|NCT01145482|524302263|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
145395327|NCT02619617|524302271|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
145395328|NCT02619617|524302272|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
145395329|NCT02619617|524302271|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
145395330|NCT02619617|524302272|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
145395331|NCT02735980|524302273|FG000|Overall Study|Adverse Event|0|||
145395332|NCT02735980|524302274|FG001|Overall Study|Adverse Event|4|||
145395333|NCT02735980|524302275|FG002|Overall Study|Adverse Event|1|||
145395334|NCT02735980|524302273|FG000|Overall Study|Death|5|||
145395335|NCT02735980|524302274|FG001|Overall Study|Death|4|||
145395336|NCT02735980|524302275|FG002|Overall Study|Death|0|||
145395337|NCT02735980|524302273|FG000|Overall Study|Physician Decision|3|||
145497436|NCT01207414|524679597|FG001|Overall Study|Adverse Event|39|||
145497437|NCT01207414|524679596|FG000|Overall Study|Abnormal test procedure results|0|||
145497438|NCT01207414|524679597|FG001|Overall Study|Abnormal test procedure results|1|||
145497439|NCT01207414|524679596|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145497440|NCT01207414|524679597|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145497441|NCT01207414|524679596|FG000|Overall Study|Patient withdrew consent|14|||
145497442|NCT01207414|524679597|FG001|Overall Study|Patient withdrew consent|11|||
145497443|NCT01207414|524679596|FG000|Overall Study|Lost to Follow-up|15|||
145497444|NCT01207414|524679597|FG001|Overall Study|Lost to Follow-up|17|||
145497445|NCT01207414|524679596|FG000|Overall Study|Administrative problems|1|||
145497446|NCT01207414|524679597|FG001|Overall Study|Administrative problems|1|||
145497447|NCT01207414|524679596|FG000|Overall Study|Protocol deviation|12|||
145497448|NCT01207414|524679597|FG001|Overall Study|Protocol deviation|9|||
145497449|NCT01207414|524679596|FG000|Overall Study|Randomized in error|1|||
145497450|NCT01207414|524679597|FG001|Overall Study|Randomized in error|0|||
145497451|NCT01748292|524679598|FG000|Overall Study|Adverse Event|2|||
145497452|NCT01748292|524679599|FG001|Overall Study|Adverse Event|4|||
145497453|NCT01748292|524679598|FG000|Overall Study|Lost to Follow-up|0|||
145497454|NCT01748292|524679599|FG001|Overall Study|Lost to Follow-up|3|||
145497455|NCT01748292|524679598|FG000|Overall Study|Death|0|||
145497456|NCT01748292|524679599|FG001|Overall Study|Death|3|||
145497457|NCT01748292|524679598|FG000|Overall Study|Withdrawal by Subject|0|||
145497458|NCT01748292|524679599|FG001|Overall Study|Withdrawal by Subject|2|||
145497459|NCT02057250|524679600|FG000|AID Assessment Phase|Adverse Event|3|||
145497460|NCT02057250|524679601|FG001|AID Assessment Phase|Adverse Event|2|||
145497461|NCT02057250|524679602|FG002|AID Assessment Phase|Adverse Event|6|||
145497462|NCT02057250|524679603|FG003|AID Assessment Phase|Adverse Event|1|||
145497463|NCT02057250|524679604|FG004|AID Assessment Phase|Adverse Event|0|||
145497464|NCT02057250|524679600|FG000|AID Assessment Phase|Other than specified above|1|||
145497465|NCT02057250|524679601|FG001|AID Assessment Phase|Other than specified above|1|||
145497466|NCT02057250|524679602|FG002|AID Assessment Phase|Other than specified above|1|||
145497467|NCT02057250|524679603|FG003|AID Assessment Phase|Other than specified above|1|||
145497468|NCT02057250|524679604|FG004|AID Assessment Phase|Other than specified above|0|||
145497469|NCT02057250|524679600|FG000|Extension Phase|Adverse Event|0|||
145497470|NCT02057250|524679601|FG001|Extension Phase|Adverse Event|0|||
145497471|NCT02057250|524679602|FG002|Extension Phase|Adverse Event|0|||
145497472|NCT02057250|524679603|FG003|Extension Phase|Adverse Event|0|||
145497473|NCT02057250|524679604|FG004|Extension Phase|Adverse Event|15|||
145497474|NCT02057250|524679600|FG000|Extension Phase|Lack of Efficacy|0|||
145497475|NCT02057250|524679601|FG001|Extension Phase|Lack of Efficacy|0|||
145497476|NCT02057250|524679602|FG002|Extension Phase|Lack of Efficacy|0|||
145497477|NCT02057250|524679603|FG003|Extension Phase|Lack of Efficacy|0|||
145497478|NCT02057250|524679604|FG004|Extension Phase|Lack of Efficacy|10|||
145497479|NCT02057250|524679600|FG000|Extension Phase|Entered in this period but not treated|0|||
145497480|NCT02057250|524679601|FG001|Extension Phase|Entered in this period but not treated|0|||
145497481|NCT02057250|524679602|FG002|Extension Phase|Entered in this period but not treated|0|||
145497482|NCT02057250|524679603|FG003|Extension Phase|Entered in this period but not treated|0|||
145497483|NCT02057250|524679604|FG004|Extension Phase|Entered in this period but not treated|4|||
145497484|NCT02057250|524679600|FG000|Extension Phase|Other than specified above|0|||
145497485|NCT02057250|524679601|FG001|Extension Phase|Other than specified above|0|||
145497486|NCT02057250|524679602|FG002|Extension Phase|Other than specified above|0|||
145497487|NCT02057250|524679603|FG003|Extension Phase|Other than specified above|0|||
145497488|NCT02057250|524679604|FG004|Extension Phase|Other than specified above|7|||
145497489|NCT01435382|524679607|FG000|Overall Study|Lost to Follow-up|1|||
145497490|NCT01435382|524679608|FG001|Overall Study|Lost to Follow-up|0|||
145497491|NCT01435382|524679609|FG002|Overall Study|Lost to Follow-up|1|||
145497492|NCT01435382|524679610|FG003|Overall Study|Lost to Follow-up|0|||
145497493|NCT01435382|524679607|FG000|Overall Study|Withdrawal by Subject|0|||
145497494|NCT01435382|524679608|FG001|Overall Study|Withdrawal by Subject|2|||
145395338|NCT02735980|524302274|FG001|Overall Study|Physician Decision|1|||
145395339|NCT02735980|524302275|FG002|Overall Study|Physician Decision|0|||
145395340|NCT02735980|524302273|FG000|Overall Study|Screen failure|1|||
145395341|NCT02735980|524302274|FG001|Overall Study|Screen failure|0|||
145395342|NCT02735980|524302275|FG002|Overall Study|Screen failure|0|||
145395343|NCT02735980|524302273|FG000|Overall Study|Withdrawal by Subject|1|||
145395344|NCT02735980|524302274|FG001|Overall Study|Withdrawal by Subject|2|||
145395345|NCT02735980|524302275|FG002|Overall Study|Withdrawal by Subject|0|||
145395346|NCT03713684|524302276|FG000|Overall Study|Adverse Event|1|||
145395347|NCT03713684|524302277|FG001|Overall Study|Adverse Event|3|||
145395348|NCT03713684|524302278|FG002|Overall Study|Adverse Event|1|||
145395349|NCT03713684|524302279|FG003|Overall Study|Adverse Event|0|||
145395350|NCT03713684|524302276|FG000|Overall Study|Poor compliance to protocol|2|||
145395351|NCT03713684|524302277|FG001|Overall Study|Poor compliance to protocol|1|||
145395352|NCT03713684|524302278|FG002|Overall Study|Poor compliance to protocol|0|||
145395353|NCT03713684|524302279|FG003|Overall Study|Poor compliance to protocol|1|||
145395354|NCT03713684|524302276|FG000|Overall Study|Withdrawal by Subject|14|||
145395355|NCT03713684|524302277|FG001|Overall Study|Withdrawal by Subject|6|||
145395356|NCT03713684|524302278|FG002|Overall Study|Withdrawal by Subject|14|||
145395357|NCT03713684|524302279|FG003|Overall Study|Withdrawal by Subject|16|||
145395358|NCT03713684|524302276|FG000|Overall Study|Other than specified|69|||
145395359|NCT03713684|524302277|FG001|Overall Study|Other than specified|77|||
145395360|NCT03713684|524302278|FG002|Overall Study|Other than specified|73|||
145395361|NCT03713684|524302279|FG003|Overall Study|Other than specified|70|||
145395362|NCT00528424|524302280|FG000|Overall Study|Lost to Follow-up|13|||
145395363|NCT00528424|524302280|FG000|Overall Study|Withdrew consent|2|||
145395364|NCT00528424|524302280|FG000|Overall Study|Administrative reason|2|||
145395365|NCT00528424|524302280|FG000|Overall Study|Other|12|||
145395366|NCT02515630|524302281|FG000|Overall Study|Withdrawal by Subject|5|||
145395367|NCT02515630|524302281|FG000|Overall Study|Adverse Event|4|||
145395368|NCT02515630|524302281|FG000|Overall Study|Physician Decision|4|||
145395369|NCT02515630|524302281|FG000|Overall Study|Death|2|||
145395370|NCT02515630|524302281|FG000|Overall Study|Disease Progression|1|||
145395371|NCT00458003|524302282|FG000|Overall Study|Non protocol spinal anesthesia|1|||
145395372|NCT00458003|524302283|FG001|Overall Study|Non protocol spinal anesthesia|1|||
145395373|NCT02154139|524302288|FG000|Overall Study|Injection not administered|2|||
145395374|NCT02154139|524302288|FG000|Overall Study|Other|2|||
145395375|NCT02154139|524302288|FG000|Overall Study|Investigator transferred|3|||
145395376|NCT00473655|524302289|FG000|Overall Study|Lost to Follow-up|9|||
145395377|NCT00473655|524302290|FG001|Overall Study|Lost to Follow-up|5|||
145395378|NCT00473655|524302291|FG002|Overall Study|Lost to Follow-up|8|||
145395379|NCT02087774|524302293|FG000|Overall Study|Were absent day of data collection|8|||
145395380|NCT02087774|524302294|FG001|Overall Study|Were absent day of data collection|20|||
145395381|NCT01529606|524302304|FG000|Overall Study|Lost to Follow-up|21|||
145395382|NCT01529606|524302305|FG001|Overall Study|Lost to Follow-up|18|||
145395383|NCT05209880|524302306|FG000|1-Month Follow-up|Spoke with Doctor|5|||
145395384|NCT05209880|524302307|FG001|1-Month Follow-up|Spoke with Doctor|5|||
145395385|NCT05209880|524302306|FG000|1-Month Follow-up|Lost to Follow-up|7|||
145395386|NCT05209880|524302307|FG001|1-Month Follow-up|Lost to Follow-up|9|||
145395387|NCT05209880|524302306|FG000|1-Month Follow-up|Discontinued|0|||
145395388|NCT05209880|524302307|FG001|1-Month Follow-up|Discontinued|1|||
145395389|NCT05209880|524302306|FG000|3-Month Follow-up|Spoke with Doctor|17|||
145395390|NCT05209880|524302307|FG001|3-Month Follow-up|Spoke with Doctor|7|||
145395391|NCT05209880|524302306|FG000|3-Month Follow-up|Lost to Follow-up|8|||
145395392|NCT05209880|524302307|FG001|3-Month Follow-up|Lost to Follow-up|10|||
145395393|NCT05209880|524302306|FG000|3-Month Follow-up|Discontinued|1|||
145395394|NCT05209880|524302307|FG001|3-Month Follow-up|Discontinued|3|||
145395395|NCT05209880|524302306|FG000|6-Month Follow-up|Spoke with Doctor|25|||
145395396|NCT05209880|524302307|FG001|6-Month Follow-up|Spoke with Doctor|14|||
145395397|NCT05209880|524302306|FG000|6-Month Follow-up|Lost to Follow-up|9|||
145395398|NCT05209880|524302307|FG001|6-Month Follow-up|Lost to Follow-up|14|||
145395399|NCT05209880|524302306|FG000|6-Month Follow-up|Discontinued|1|||
145395400|NCT05209880|524302307|FG001|6-Month Follow-up|Discontinued|3|||
145395401|NCT05635045|524302308|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145395402|NCT05635045|524302309|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145395403|NCT05635045|524302310|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
145395404|NCT05635045|524302311|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
145395405|NCT03143101|524302312|FG000|Overall Study|Withdrawal by Subject|0|||
145395406|NCT03143101|524302313|FG001|Overall Study|Withdrawal by Subject|1|||
145395407|NCT03143101|524302314|FG002|Overall Study|Withdrawal by Subject|0|||
145395408|NCT03143101|524302312|FG000|Overall Study|Lost to Follow-up|2|||
145395409|NCT03143101|524302313|FG001|Overall Study|Lost to Follow-up|2|||
145395410|NCT03143101|524302314|FG002|Overall Study|Lost to Follow-up|0|||
145395411|NCT05227118|524302317|FG000|Overall Study|Adverse Event|0|||
145395412|NCT05227118|524302318|FG001|Overall Study|Adverse Event|0|||
145395413|NCT05227118|524302319|FG002|Overall Study|Adverse Event|1|||
145395414|NCT05227118|524302320|FG003|Overall Study|Adverse Event|0|||
145395415|NCT05227118|524302317|FG000|Overall Study|Withdrawal by Subject|0|||
145395416|NCT05227118|524302318|FG001|Overall Study|Withdrawal by Subject|0|||
145395417|NCT05227118|524302319|FG002|Overall Study|Withdrawal by Subject|2|||
145395418|NCT05227118|524302320|FG003|Overall Study|Withdrawal by Subject|0|||
145395419|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
145395420|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
145395421|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
145395422|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
145395423|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
145395424|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
145395425|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
145395426|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
145395427|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
145395428|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
145395429|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
145395430|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
145395431|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
145395432|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145395433|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145395434|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145395435|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145395436|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145395437|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
145395438|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145395439|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145395440|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145395441|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145395442|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145395443|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
145395444|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395445|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395446|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395447|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395448|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395449|NCT01435759|524302321|FG000|Antidepressant Lead-in Phase|Other|119|||
145395450|NCT01435759|524302322|FG001|Antidepressant Lead-in Phase|Other|0|||
145395451|NCT01435759|524302323|FG002|Antidepressant Lead-in Phase|Other|0|||
145395452|NCT01435759|524302324|FG003|Antidepressant Lead-in Phase|Other|0|||
145395453|NCT01435759|524302325|FG004|Antidepressant Lead-in Phase|Other|0|||
145395454|NCT01435759|524302326|FG005|Antidepressant Lead-in Phase|Other|0|||
145497495|NCT01435382|524679609|FG002|Overall Study|Withdrawal by Subject|0|||
145497496|NCT01435382|524679610|FG003|Overall Study|Withdrawal by Subject|1|||
145497497|NCT00423579|524679612|FG000|Overall Study|Lost to Follow-up|3|||
145497498|NCT00423579|524679613|FG001|Overall Study|Lost to Follow-up|0|||
145497499|NCT00423579|524679612|FG000|Overall Study|Protocol Violation|1|||
145497500|NCT00423579|524679613|FG001|Overall Study|Protocol Violation|3|||
145497501|NCT00423579|524679612|FG000|Overall Study|Diagnosis of diabetes|0|||
145497502|NCT00423579|524679613|FG001|Overall Study|Diagnosis of diabetes|1|||
145497503|NCT03962491|524679618|FG000|Overall Study|Lost to Follow-up|4|||
145497504|NCT03962491|524679619|FG001|Overall Study|Lost to Follow-up|5|||
145497505|NCT02383576|524679620|FG000|Overall Study|Death|53|||
145497506|NCT02383576|524679621|FG001|Overall Study|Death|33|||
145497507|NCT02383576|524679620|FG000|Overall Study|Lost to Follow-up|7|||
145497508|NCT02383576|524679621|FG001|Overall Study|Lost to Follow-up|1|||
145497509|NCT02383576|524679620|FG000|Overall Study|Withdrew Consent|1|||
145731538|NCT02748018|525535893|FG001|Study Period|Lost to Follow-up|0|||
145497510|NCT02383576|524679621|FG001|Overall Study|Withdrew Consent|6|||
145731539|NCT02748018|525535894|FG002|Study Period|Lost to Follow-up|0|||
145731540|NCT02748018|525535895|FG003|Study Period|Lost to Follow-up|2|||
145731541|NCT02748018|525535896|FG004|Study Period|Lost to Follow-up|0|||
145731542|NCT02748018|525535897|FG005|Study Period|Lost to Follow-up|1|||
145731543|NCT02748018|525535892|FG000|Continuation Period|Adverse Event|2|||
145731544|NCT02748018|525535893|FG001|Continuation Period|Adverse Event|0|||
145731545|NCT02748018|525535894|FG002|Continuation Period|Adverse Event|1|||
145731546|NCT02748018|525535895|FG003|Continuation Period|Adverse Event|1|||
145731547|NCT02748018|525535896|FG004|Continuation Period|Adverse Event|1|||
145731548|NCT02748018|525535897|FG005|Continuation Period|Adverse Event|4|||
145731549|NCT02748018|525535892|FG000|Continuation Period|Withdrawal by Subject|3|||
145731550|NCT02748018|525535893|FG001|Continuation Period|Withdrawal by Subject|5|||
145731551|NCT02748018|525535894|FG002|Continuation Period|Withdrawal by Subject|3|||
145731552|NCT02748018|525535895|FG003|Continuation Period|Withdrawal by Subject|9|||
145731553|NCT02748018|525535896|FG004|Continuation Period|Withdrawal by Subject|11|||
145731554|NCT02748018|525535897|FG005|Continuation Period|Withdrawal by Subject|1|||
145731555|NCT02748018|525535892|FG000|Continuation Period|Lost to Follow-up|0|||
145731556|NCT02748018|525535893|FG001|Continuation Period|Lost to Follow-up|2|||
145731557|NCT02748018|525535894|FG002|Continuation Period|Lost to Follow-up|1|||
145731558|NCT02748018|525535895|FG003|Continuation Period|Lost to Follow-up|0|||
145731559|NCT02748018|525535896|FG004|Continuation Period|Lost to Follow-up|1|||
145731560|NCT02748018|525535897|FG005|Continuation Period|Lost to Follow-up|0|||
145731561|NCT02748018|525535892|FG000|Continuation Period|Pregnancy|1|||
145731562|NCT02748018|525535893|FG001|Continuation Period|Pregnancy|2|||
145731563|NCT02748018|525535894|FG002|Continuation Period|Pregnancy|0|||
145731564|NCT02748018|525535895|FG003|Continuation Period|Pregnancy|0|||
145731565|NCT02748018|525535896|FG004|Continuation Period|Pregnancy|0|||
145731566|NCT02748018|525535897|FG005|Continuation Period|Pregnancy|0|||
145731567|NCT02748018|525535892|FG000|Continuation Period|Physician Decision|0|||
145731568|NCT02748018|525535893|FG001|Continuation Period|Physician Decision|1|||
145731569|NCT02748018|525535894|FG002|Continuation Period|Physician Decision|2|||
145731570|NCT02748018|525535895|FG003|Continuation Period|Physician Decision|0|||
145731571|NCT02748018|525535896|FG004|Continuation Period|Physician Decision|2|||
145731572|NCT02748018|525535897|FG005|Continuation Period|Physician Decision|1|||
145731573|NCT02748018|525535892|FG000|Continuation Period|Protocol Violation|0|||
145731574|NCT02748018|525535893|FG001|Continuation Period|Protocol Violation|1|||
145731575|NCT02748018|525535894|FG002|Continuation Period|Protocol Violation|0|||
145731576|NCT02748018|525535895|FG003|Continuation Period|Protocol Violation|0|||
145731577|NCT02748018|525535896|FG004|Continuation Period|Protocol Violation|0|||
145731578|NCT02748018|525535897|FG005|Continuation Period|Protocol Violation|0|||
145731579|NCT05628285|525535898|FG000|Overall Study|Lost to Follow-up|1|||
145731580|NCT06069778|525535899|FG000|Overall Study|Withdrawal by Subject|1|||
145731581|NCT02856893|525535900|FG000|Overall Study|Lack of Efficacy|27|||
145731582|NCT02856893|525535901|FG001|Overall Study|Lack of Efficacy|15|||
145731583|NCT02856893|525535902|FG002|Overall Study|Lack of Efficacy|19|||
145731584|NCT02856893|525535900|FG000|Overall Study|Death|1|||
145731585|NCT02856893|525535901|FG001|Overall Study|Death|0|||
145731586|NCT02856893|525535902|FG002|Overall Study|Death|0|||
145731587|NCT02856893|525535900|FG000|Overall Study|Adverse Event|2|||
145731588|NCT02856893|525535901|FG001|Overall Study|Adverse Event|0|||
145731589|NCT02856893|525535902|FG002|Overall Study|Adverse Event|0|||
145731590|NCT02856893|525535900|FG000|Overall Study|Physician Decision|0|||
145731591|NCT02856893|525535901|FG001|Overall Study|Physician Decision|2|||
145731592|NCT02856893|525535902|FG002|Overall Study|Physician Decision|3|||
145731593|NCT02856893|525535900|FG000|Overall Study|Withdrawal by Subject|1|||
145497511|NCT02383576|524679620|FG000|Overall Study|Investigator's Decision|0|||
145497512|NCT02383576|524679621|FG001|Overall Study|Investigator's Decision|1|||
145497513|NCT02383576|524679620|FG000|Overall Study|Administrative/Other|2|||
145497514|NCT02383576|524679621|FG001|Overall Study|Administrative/Other|4|||
145497515|NCT04097678|524679622|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
145497516|NCT04097678|524679623|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
145497517|NCT03694678|524679624|FG000|Overall Study|Withdrawal by Subject|2|||
145497518|NCT03694678|524679625|FG001|Overall Study|Withdrawal by Subject|0|||
145497519|NCT03694678|524679624|FG000|Overall Study|Lost to Follow-up|2|||
145497520|NCT03694678|524679625|FG001|Overall Study|Lost to Follow-up|3|||
145497521|NCT04852302|524679637|FG000|Overall Study|Withdrawal by Subject|2|||
145497522|NCT04852302|524679637|FG000|Overall Study|Did not complete CALM therapy.|2|||
145497523|NCT03267277|524679638|FG000|Overall Study|Withdrawal by Subject|1|||
145497524|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
145497525|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
145497526|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
145497527|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
145497528|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
145497529|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
145497530|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
145497531|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145497532|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
145497533|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
145497534|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145497535|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
145497536|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
145497537|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
145497538|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
145497539|NCT01436149|524679639|FG000|Antidepressant Lead-in Phase|Other|119|||
145497540|NCT01436149|524679640|FG001|Antidepressant Lead-in Phase|Other|0|||
145497541|NCT01436149|524679641|FG002|Antidepressant Lead-in Phase|Other|0|||
145497542|NCT01436149|524679639|FG000|Randomized Phase|Adverse Event|9|||
145497543|NCT01436149|524679640|FG001|Randomized Phase|Adverse Event|10|||
145497544|NCT01436149|524679641|FG002|Randomized Phase|Adverse Event|11|||
145497545|NCT01436149|524679639|FG000|Randomized Phase|Protocol Violation|4|||
145497546|NCT01436149|524679640|FG001|Randomized Phase|Protocol Violation|5|||
145497547|NCT01436149|524679641|FG002|Randomized Phase|Protocol Violation|0|||
145497548|NCT01436149|524679639|FG000|Randomized Phase|Withdrawal by Subject|16|||
145497549|NCT01436149|524679640|FG001|Randomized Phase|Withdrawal by Subject|10|||
145497550|NCT01436149|524679641|FG002|Randomized Phase|Withdrawal by Subject|10|||
145497551|NCT01436149|524679639|FG000|Randomized Phase|Lost to Follow-up|34|||
145497552|NCT01436149|524679640|FG001|Randomized Phase|Lost to Follow-up|5|||
145497553|NCT01436149|524679641|FG002|Randomized Phase|Lost to Follow-up|6|||
145497554|NCT01436149|524679639|FG000|Randomized Phase|Lack of Efficacy|0|||
145497555|NCT01436149|524679640|FG001|Randomized Phase|Lack of Efficacy|0|||
145395455|NCT01435759|524302321|FG000|Double-blind Phase|Adverse Event|7|||
145395456|NCT01435759|524302322|FG001|Double-blind Phase|Adverse Event|0|||
145395457|NCT01435759|524302323|FG002|Double-blind Phase|Adverse Event|1|||
145395458|NCT01435759|524302324|FG003|Double-blind Phase|Adverse Event|1|||
145395459|NCT01435759|524302325|FG004|Double-blind Phase|Adverse Event|1|||
145395460|NCT01435759|524302326|FG005|Double-blind Phase|Adverse Event|3|||
145395461|NCT01435759|524302321|FG000|Double-blind Phase|Protocol Violation|2|||
145395462|NCT01435759|524302322|FG001|Double-blind Phase|Protocol Violation|0|||
145395463|NCT01435759|524302323|FG002|Double-blind Phase|Protocol Violation|1|||
145395464|NCT01435759|524302324|FG003|Double-blind Phase|Protocol Violation|2|||
145395465|NCT01435759|524302325|FG004|Double-blind Phase|Protocol Violation|0|||
145395466|NCT01435759|524302326|FG005|Double-blind Phase|Protocol Violation|1|||
145395467|NCT01435759|524302321|FG000|Double-blind Phase|Withdrawal by Subject|17|||
145395468|NCT01435759|524302322|FG001|Double-blind Phase|Withdrawal by Subject|4|||
145395469|NCT01435759|524302323|FG002|Double-blind Phase|Withdrawal by Subject|3|||
145395470|NCT01435759|524302324|FG003|Double-blind Phase|Withdrawal by Subject|4|||
145395471|NCT01435759|524302325|FG004|Double-blind Phase|Withdrawal by Subject|2|||
145395472|NCT01435759|524302326|FG005|Double-blind Phase|Withdrawal by Subject|2|||
145395473|NCT01435759|524302321|FG000|Double-blind Phase|Lost to Follow-up|31|||
145395474|NCT01435759|524302322|FG001|Double-blind Phase|Lost to Follow-up|1|||
145395475|NCT01435759|524302323|FG002|Double-blind Phase|Lost to Follow-up|2|||
145395476|NCT01435759|524302324|FG003|Double-blind Phase|Lost to Follow-up|0|||
145395477|NCT01435759|524302325|FG004|Double-blind Phase|Lost to Follow-up|3|||
145395478|NCT01435759|524302326|FG005|Double-blind Phase|Lost to Follow-up|3|||
145395479|NCT01435759|524302321|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
145731594|NCT02856893|525535901|FG001|Overall Study|Withdrawal by Subject|1|||
145731595|NCT02856893|525535902|FG002|Overall Study|Withdrawal by Subject|0|||
145731596|NCT02856893|525535900|FG000|Overall Study|Other reasons|2|||
145731597|NCT02856893|525535901|FG001|Overall Study|Other reasons|1|||
145731598|NCT02856893|525535902|FG002|Overall Study|Other reasons|2|||
145731599|NCT02310672|525535903|FG000|Overall Study|Death|1|||
145731600|NCT02310672|525535903|FG000|Overall Study|Lost to Follow-up|1|||
145731601|NCT02310672|525535903|FG000|Overall Study|Withdrawal by Subject|1|||
145731602|NCT02310672|525535903|FG000|Overall Study|Sponsor's decision|12|||
145731603|NCT04704336|525535907|FG000|Overall Study|Death|2|||
145731604|NCT04704336|525535908|FG001|Overall Study|Death|2|||
145731605|NCT04704336|525535907|FG000|Overall Study|Lost to Follow-up|33|||
145731606|NCT04704336|525535908|FG001|Overall Study|Lost to Follow-up|40|||
145731607|NCT03118674|525535916|FG000|Overall Study|Lost to Follow-up|2|||
145731608|NCT03118674|525535916|FG000|Overall Study|Screen Faliure|8|||
145731609|NCT03118674|525535916|FG000|Overall Study|Withdrawal by Subject|5|||
145731610|NCT01324323|525535917|FG000|Overall Study|Withdrawal by Subject|1|||
145731611|NCT00537485|525535918|FG000|Overall Study|Adverse Event|10|||
145731612|NCT00537485|525535919|FG001|Overall Study|Adverse Event|5|||
145731613|NCT00537485|525535918|FG000|Overall Study|Withdrawal by Subject|3|||
145731614|NCT00537485|525535919|FG001|Overall Study|Withdrawal by Subject|2|||
145731615|NCT00537485|525535918|FG000|Overall Study|Withdrawal by Subject|1|||
145731616|NCT00537485|525535919|FG001|Overall Study|Withdrawal by Subject|3|||
145731617|NCT00537485|525535918|FG000|Overall Study|Physician Decision|1|||
145731618|NCT00537485|525535919|FG001|Overall Study|Physician Decision|0|||
145731619|NCT03153137|525535920|FG000|Overall Study|Lost to Follow-up|1|||
145731620|NCT03153137|525535921|FG001|Overall Study|Lost to Follow-up|0|||
145731621|NCT03153137|525535920|FG000|Overall Study|Withdrawal by Subject|2|||
145731622|NCT03153137|525535921|FG001|Overall Study|Withdrawal by Subject|1|||
145731623|NCT03153137|525535920|FG000|Overall Study|Physician Decision|0|||
145731624|NCT03153137|525535921|FG001|Overall Study|Physician Decision|3|||
145731625|NCT01284062|525535931|FG000|Overall Study|Adverse Event|4|||
145731626|NCT01284062|525535932|FG001|Overall Study|Adverse Event|5|||
145731627|NCT01284062|525535933|FG002|Overall Study|Adverse Event|0|||
145731628|NCT01284062|525535934|FG003|Overall Study|Adverse Event|5|||
145731629|NCT01284062|525535931|FG000|Overall Study|Lack of Efficacy|3|||
145731630|NCT01284062|525535932|FG001|Overall Study|Lack of Efficacy|2|||
145731631|NCT01284062|525535933|FG002|Overall Study|Lack of Efficacy|2|||
145731632|NCT01284062|525535934|FG003|Overall Study|Lack of Efficacy|1|||
145731633|NCT01284062|525535931|FG000|Overall Study|Medication error without adverse event|0|||
145731634|NCT01284062|525535932|FG001|Overall Study|Medication error without adverse event|0|||
145731635|NCT01284062|525535933|FG002|Overall Study|Medication error without adverse event|1|||
145731636|NCT01284062|525535934|FG003|Overall Study|Medication error without adverse event|0|||
145731637|NCT01284062|525535931|FG000|Overall Study|Protocol Violation|1|||
145731638|NCT01284062|525535932|FG001|Overall Study|Protocol Violation|0|||
145731639|NCT01284062|525535933|FG002|Overall Study|Protocol Violation|0|||
145731640|NCT01284062|525535934|FG003|Overall Study|Protocol Violation|2|||
145731641|NCT01284062|525535931|FG000|Overall Study|Withdrawal by Subject|3|||
145731642|NCT01284062|525535932|FG001|Overall Study|Withdrawal by Subject|1|||
145731643|NCT01284062|525535933|FG002|Overall Study|Withdrawal by Subject|2|||
145731644|NCT01284062|525535934|FG003|Overall Study|Withdrawal by Subject|5|||
145731645|NCT01284062|525535931|FG000|Overall Study|Other|0|||
145731646|NCT01284062|525535932|FG001|Overall Study|Other|0|||
145731647|NCT01284062|525535933|FG002|Overall Study|Other|0|||
145731648|NCT01284062|525535934|FG003|Overall Study|Other|1|||
145731649|NCT01284062|525535931|FG000|Overall Study|Site Closed|0|||
145731650|NCT01284062|525535932|FG001|Overall Study|Site Closed|0|||
145731651|NCT01284062|525535933|FG002|Overall Study|Site Closed|1|||
145731652|NCT01284062|525535934|FG003|Overall Study|Site Closed|0|||
145731653|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
145395480|NCT01435759|524302322|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395481|NCT01435759|524302323|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395482|NCT01435759|524302324|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395483|NCT01435759|524302325|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
145395484|NCT01435759|524302326|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
145395485|NCT01435759|524302321|FG000|Double-blind Phase|Other|8|||
145395486|NCT01435759|524302322|FG001|Double-blind Phase|Other|2|||
145395487|NCT01435759|524302323|FG002|Double-blind Phase|Other|0|||
145395488|NCT01435759|524302324|FG003|Double-blind Phase|Other|2|||
145395489|NCT01435759|524302325|FG004|Double-blind Phase|Other|0|||
145395490|NCT01435759|524302326|FG005|Double-blind Phase|Other|0|||
145395491|NCT03727841|524302332|FG000|Overall Study|Physician Decision|3|||
145395492|NCT03727841|524302333|FG001|Overall Study|Physician Decision|1|||
145395493|NCT01601496|524302334|FG000|Overall Study|Physician Decision|1|||
145395494|NCT01601496|524302334|FG000|Overall Study|Withdrawal by Subject|1|||
145395495|NCT01601496|524302334|FG000|Overall Study|Lost to Follow-up|6|||
145395496|NCT01601496|524302334|FG000|Overall Study|Death|4|||
145395497|NCT01601496|524302334|FG000|Overall Study|Other: patient refusal to continue|3|||
145395498|NCT03243305|524302335|FG000|Overall Study|Lost to Follow-up|250|||
145395499|NCT03243305|524302335|FG000|Overall Study|Withdrawal by Subject|170|||
145395500|NCT03243305|524302335|FG000|Overall Study|Pregnancy|104|||
145395501|NCT03243305|524302335|FG000|Overall Study|Non-Compliance with Study Drug|38|||
145395502|NCT03243305|524302335|FG000|Overall Study|Adverse Event|23|||
145395503|NCT03243305|524302335|FG000|Overall Study|No sexually active|26|||
145395504|NCT03243305|524302335|FG000|Overall Study|Physician Decision|22|||
145395505|NCT03243305|524302335|FG000|Overall Study|Protocol Violation|22|||
145395506|NCT03243305|524302335|FG000|Overall Study|Study method no longer primary method|12|||
145395507|NCT03243305|524302335|FG000|Overall Study|Study Terminated by Sponsor|1|||
145395508|NCT03243305|524302335|FG000|Overall Study|Early terminations|267|||
145395509|NCT02689804|524302336|FG000|Overall Study|Withdrawal by Subject|2|||
145395510|NCT02689804|524302337|FG001|Overall Study|Withdrawal by Subject|0|||
145395511|NCT00426764|524302339|FG000|Overall Study|Protocol Violation|1|||
145395512|NCT00426764|524302339|FG000|Overall Study|Withdrawal by Subject|4|||
145395513|NCT00426764|524302339|FG000|Overall Study|Physician Decision|6|||
145395514|NCT00426764|524302339|FG000|Overall Study|Compassionate Use|1|||
145395515|NCT00426764|524302339|FG000|Overall Study|Progressive Disease|83|||
145395516|NCT00426764|524302339|FG000|Overall Study|Adverse Event|24|||
145395517|NCT00426764|524302339|FG000|Overall Study|Other|1|||
145395518|NCT00426764|524302339|FG000|Overall Study|Death|1|||
145395519|NCT00426764|524302339|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
145497556|NCT01436149|524679641|FG002|Randomized Phase|Lack of Efficacy|1|||
145497557|NCT01436149|524679639|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
145497558|NCT01436149|524679640|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
145497559|NCT01436149|524679641|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
145497560|NCT01436149|524679639|FG000|Randomized Phase|Other|12|||
145497561|NCT01436149|524679640|FG001|Randomized Phase|Other|5|||
145497562|NCT01436149|524679641|FG002|Randomized Phase|Other|11|||
145497563|NCT04849364|524679643|FG000|Overall Study|Eligibility criteria not meet|0|||
145497564|NCT04849364|524679644|FG001|Overall Study|Eligibility criteria not meet|1|||
145497565|NCT04849364|524679645|FG002|Overall Study|Eligibility criteria not meet|0|||
145497566|NCT02738801|524679654|FG000|Overall Study|Adverse Event|1|||
145497567|NCT02738801|524679655|FG001|Overall Study|Adverse Event|1|||
145497568|NCT02738801|524679654|FG000|Overall Study|Withdrawal by Subject|0|||
145497569|NCT02738801|524679655|FG001|Overall Study|Withdrawal by Subject|1|||
145497570|NCT01643668|524679656|FG000|Overall Study|Death|1|||
145497571|NCT03253796|524679667|FG000|Period 1: Run-In|Adverse Event|4|||
145497572|NCT03253796|524679668|FG001|Period 1: Run-In|Adverse Event|0|||
145497573|NCT03253796|524679669|FG002|Period 1: Run-In|Adverse Event|0|||
145497574|NCT03253796|524679670|FG003|Period 1: Run-In|Adverse Event|0|||
145497575|NCT03253796|524679671|FG004|Period 1: Run-In|Adverse Event|0|||
145497576|NCT03253796|524679667|FG000|Period 1: Run-In|Lack of Efficacy|1|||
145497577|NCT03253796|524679668|FG001|Period 1: Run-In|Lack of Efficacy|0|||
145497578|NCT03253796|524679669|FG002|Period 1: Run-In|Lack of Efficacy|0|||
145497579|NCT03253796|524679670|FG003|Period 1: Run-In|Lack of Efficacy|0|||
145497580|NCT03253796|524679671|FG004|Period 1: Run-In|Lack of Efficacy|0|||
145497581|NCT03253796|524679667|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
145497582|NCT03253796|524679668|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
145497583|NCT03253796|524679669|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
145497584|NCT03253796|524679670|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
145497585|NCT03253796|524679671|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
145497586|NCT03253796|524679667|FG000|Period 1: Run-In|Protocol Violation|5|||
145497587|NCT03253796|524679668|FG001|Period 1: Run-In|Protocol Violation|0|||
145497588|NCT03253796|524679669|FG002|Period 1: Run-In|Protocol Violation|0|||
145497589|NCT03253796|524679670|FG003|Period 1: Run-In|Protocol Violation|0|||
145497590|NCT03253796|524679671|FG004|Period 1: Run-In|Protocol Violation|0|||
145497591|NCT03253796|524679667|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
145497592|NCT03253796|524679668|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
145497593|NCT03253796|524679669|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
145497594|NCT03253796|524679670|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
145497595|NCT03253796|524679671|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
145395520|NCT00673257|524302340|FG000|Overall Study|Withdrawal by Subject|4|||
145395521|NCT00673257|524302340|FG000|Overall Study|Unable to obtain specimen|1|||
145395522|NCT04396626|524302347|FG000|Overall Study|Premature termination of study|975|||
145395523|NCT02417753|524302350|FG000|Overall Study|Death|1|||
145395524|NCT02849587|524302353|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
145395525|NCT02849587|524302354|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
145395526|NCT02849587|524302355|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
145395527|NCT02849587|524302353|FG000|Overall Study|Withdrawal by Subject|0|||
145395528|NCT02849587|524302354|FG001|Overall Study|Withdrawal by Subject|1|||
145395529|NCT02849587|524302355|FG002|Overall Study|Withdrawal by Subject|0|||
145395530|NCT00871234|524302356|FG000|Overall Study|Adverse Event|2|||
145395531|NCT00871234|524302356|FG000|Overall Study|Lost to Follow-up|3|||
145395532|NCT03380377|524302359|FG000|Overall Study|Physician Decision|1|||
145395533|NCT03380377|524302359|FG000|Overall Study|Withdrawal by Subject|1|||
145395534|NCT02600923|524302360|FG000|Overall Study|Death|10|||
145395535|NCT02600923|524302360|FG000|Overall Study|Adverse Event|3|||
145395536|NCT02600923|524302360|FG000|Overall Study|Global deterioration of health status|2|||
145395537|NCT02600923|524302360|FG000|Overall Study|Insufficient clinical response|6|||
145395538|NCT02600923|524302360|FG000|Overall Study|Lost to Follow-up|1|||
145395539|NCT02600923|524302360|FG000|Overall Study|Withdrawal by Subject|5|||
145395540|NCT02600923|524302360|FG000|Overall Study|Objective progression or relapse|50|||
145395541|NCT02600923|524302360|FG000|Overall Study|Study terminated by Sponsor|53|||
145395542|NCT02600923|524302360|FG000|Overall Study|Not treated|1|||
145395543|NCT00792909|524302361|FG000|Overall Study|Withdrawal by Subject|0|||
145395544|NCT00792909|524302362|FG001|Overall Study|Withdrawal by Subject|1|||
145395545|NCT00792909|524302363|FG002|Overall Study|Withdrawal by Subject|0|||
145395546|NCT00385918|524302367|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
145395547|NCT00385918|524302368|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
145395548|NCT00385918|524302369|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
145395549|NCT00385918|524302367|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
145395550|NCT00385918|524302368|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
145395551|NCT00385918|524302369|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
145395552|NCT00385918|524302367|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
145395553|NCT00385918|524302368|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
145395554|NCT00385918|524302369|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
145395555|NCT00385918|524302367|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
145395556|NCT00385918|524302368|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
145395557|NCT00385918|524302369|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
145395558|NCT00385918|524302367|FG000|Intervention Phase After Randomization|Physician Decision|1|||
145395559|NCT00385918|524302368|FG001|Intervention Phase After Randomization|Physician Decision|0|||
145395560|NCT00385918|524302369|FG002|Intervention Phase After Randomization|Physician Decision|0|||
145395561|NCT00385918|524302367|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
145395562|NCT00385918|524302368|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
145395563|NCT00385918|524302369|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
145395564|NCT00128661|524302370|FG000|Overall Study|Adverse Event|14|||
145395565|NCT00128661|524302371|FG001|Overall Study|Adverse Event|11|||
145395566|NCT00128661|524302370|FG000|Overall Study|Lost to Follow-up|10|||
145395567|NCT00128661|524302371|FG001|Overall Study|Lost to Follow-up|7|||
145395568|NCT00128661|524302370|FG000|Overall Study|Withdrawal by Subject|243|||
145395569|NCT00128661|524302371|FG001|Overall Study|Withdrawal by Subject|232|||
145395570|NCT00128661|524302370|FG000|Overall Study|Other|7|||
145395571|NCT00128661|524302371|FG001|Overall Study|Other|8|||
145395572|NCT02782741|524302373|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
145395573|NCT02782741|524302374|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
145395574|NCT02782741|524302375|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
145395575|NCT02782741|524302373|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
145395576|NCT02782741|524302374|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
145395577|NCT02782741|524302375|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
145395578|NCT02782741|524302373|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
145395579|NCT02782741|524302374|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
145395580|NCT02782741|524302375|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
145395581|NCT02782741|524302373|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
145395582|NCT02782741|524302374|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
145395583|NCT02782741|524302375|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
145395584|NCT02782741|524302373|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
145395585|NCT02782741|524302374|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
145395586|NCT02782741|524302375|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
145395587|NCT04157088|524302376|FG000|Overall Study|Study terminated by sponsor|23|||
145395588|NCT04157088|524302376|FG000|Overall Study|Withdrawal by Subject|4|||
145395589|NCT04157088|524302376|FG000|Overall Study|Lost to Follow-up|2|||
145395590|NCT04157088|524302376|FG000|Overall Study|Death|1|||
145395591|NCT02421419|524302377|FG000|Overall Study|Physician Decision|0|||
145395592|NCT02421419|524302378|FG001|Overall Study|Physician Decision|0|||
145395593|NCT02421419|524302379|FG002|Overall Study|Physician Decision|1|||
145395594|NCT01676701|524302381|FG000|Overall Study|Protocol Violation|1|||
145395595|NCT01676701|524302382|FG001|Overall Study|Protocol Violation|0|||
145395596|NCT01676701|524302381|FG000|Overall Study|Sponsor Decision|3|||
145395597|NCT01676701|524302382|FG001|Overall Study|Sponsor Decision|4|||
145395598|NCT02115607|524302383|FG000|Overall Study|Withdrawal by Subject|1|||
145395599|NCT00196105|524302387|FG000|Overall Study|Lost to Follow-up|4|||
145395600|NCT00196105|524302388|FG001|Overall Study|Lost to Follow-up|5|||
145395601|NCT00196105|524302389|FG002|Overall Study|Lost to Follow-up|7|||
145395602|NCT04863872|524302390|FG000|Overall Study|Withdrawal by Subject|4|||
145395603|NCT04863872|524302391|FG001|Overall Study|Withdrawal by Subject|15|||
145395604|NCT04863872|524302390|FG000|Overall Study|Death|5|||
145395605|NCT04863872|524302391|FG001|Overall Study|Death|2|||
145395606|NCT04863872|524302390|FG000|Overall Study|Lost to Follow-up|2|||
145395607|NCT04863872|524302391|FG001|Overall Study|Lost to Follow-up|1|||
145395608|NCT01275144|524302392|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
145395609|NCT01275144|524302393|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
145395610|NCT05607576|524302395|FG000|Overall Study|immediate sensor error|2|||
145395611|NCT05607576|524302395|FG000|Overall Study|Physician Decision|2|||
145266650|NCT04668066|523825241|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266651|NCT04668066|523825242|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266652|NCT04668066|523825243|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266653|NCT04668066|523825244|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266654|NCT04668066|523825245|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266655|NCT04668066|523825246|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266656|NCT04668066|523825247|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266657|NCT04668066|523825248|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266658|NCT04668066|523825249|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
145266659|NCT04668066|523825250|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266660|NCT04668066|523825251|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266661|NCT04668066|523825252|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
145266662|NCT04668066|523825253|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266663|NCT04668066|523825254|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266664|NCT04668066|523825255|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
145266665|NCT04668066|523825237|FG000|Part 1: Follow-Up|Adverse Event|0|||
145266666|NCT04668066|523825238|FG001|Part 1: Follow-Up|Adverse Event|0|||
145266667|NCT04668066|523825239|FG002|Part 1: Follow-Up|Adverse Event|0|||
145266668|NCT04668066|523825240|FG003|Part 1: Follow-Up|Adverse Event|0|||
145266669|NCT04668066|523825241|FG004|Part 1: Follow-Up|Adverse Event|0|||
145266670|NCT04668066|523825242|FG005|Part 1: Follow-Up|Adverse Event|0|||
145395612|NCT02998151|524302396|FG000|Overall Study|Withdrawal by Subject|3|||
145395613|NCT02998151|524302396|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
145395614|NCT02998151|524302396|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
145395615|NCT03811821|524302402|FG000|Overall Study|Adverse Event|1|||
145395616|NCT03811821|524302403|FG001|Overall Study|Adverse Event|1|||
145395617|NCT03811821|524302402|FG000|Overall Study|Withdrawal by Subject|5|||
145395618|NCT03811821|524302403|FG001|Overall Study|Withdrawal by Subject|4|||
145395619|NCT03811821|524302402|FG000|Overall Study|Lost to Follow-up|2|||
145395620|NCT03811821|524302403|FG001|Overall Study|Lost to Follow-up|2|||
145395621|NCT03811821|524302402|FG000|Overall Study|Contraindication for treatment|0|||
145395622|NCT03811821|524302403|FG001|Overall Study|Contraindication for treatment|1|||
145395623|NCT03811821|524302402|FG000|Overall Study|Tolerability|0|||
145395624|NCT03811821|524302403|FG001|Overall Study|Tolerability|3|||
145395625|NCT03811821|524302402|FG000|Overall Study|Comorbidities|0|||
145395626|NCT03811821|524302403|FG001|Overall Study|Comorbidities|2|||
145395627|NCT05027815|524302407|FG000|Overall Study|Death|2|||
145395628|NCT05027815|524302408|FG001|Overall Study|Death|1|||
145395629|NCT03110354|524304822|FG000|Overall Study|Death|1|||
145395630|NCT03110354|524304823|FG001|Overall Study|Death|0|||
145395631|NCT03110354|524304824|FG002|Overall Study|Death|0|||
145395632|NCT03110354|524304825|FG003|Overall Study|Death|1|||
145395633|NCT03110354|524304826|FG004|Overall Study|Death|0|||
145395634|NCT03110354|524304822|FG000|Overall Study|Start of new therapy|0|||
145395635|NCT03110354|524304823|FG001|Overall Study|Start of new therapy|0|||
145395636|NCT03110354|524304824|FG002|Overall Study|Start of new therapy|0|||
145395637|NCT03110354|524304825|FG003|Overall Study|Start of new therapy|0|||
145395638|NCT03110354|524304826|FG004|Overall Study|Start of new therapy|1|||
145395639|NCT03110354|524304822|FG000|Overall Study|Failure to achieve response|2|||
145395640|NCT03110354|524304823|FG001|Overall Study|Failure to achieve response|3|||
145395641|NCT03110354|524304824|FG002|Overall Study|Failure to achieve response|0|||
145395642|NCT03110354|524304825|FG003|Overall Study|Failure to achieve response|2|||
145395643|NCT03110354|524304826|FG004|Overall Study|Failure to achieve response|1|||
145395644|NCT03110354|524304822|FG000|Overall Study|Progressive disease|1|||
145395645|NCT03110354|524304823|FG001|Overall Study|Progressive disease|1|||
145395646|NCT03110354|524304824|FG002|Overall Study|Progressive disease|3|||
145395647|NCT03110354|524304825|FG003|Overall Study|Progressive disease|4|||
145395648|NCT03110354|524304826|FG004|Overall Study|Progressive disease|2|||
145395649|NCT03110354|524304822|FG000|Overall Study|Adverse Event|0|||
145395650|NCT03110354|524304823|FG001|Overall Study|Adverse Event|0|||
145395651|NCT03110354|524304824|FG002|Overall Study|Adverse Event|0|||
145395652|NCT03110354|524304825|FG003|Overall Study|Adverse Event|2|||
145395653|NCT03110354|524304826|FG004|Overall Study|Adverse Event|2|||
145395654|NCT03110354|524304822|FG000|Overall Study|Other|0|||
145395655|NCT03110354|524304823|FG001|Overall Study|Other|0|||
145395656|NCT03110354|524304824|FG002|Overall Study|Other|0|||
145395657|NCT03110354|524304825|FG003|Overall Study|Other|1|||
145395658|NCT03110354|524304826|FG004|Overall Study|Other|1|||
145395659|NCT01298700|524304827|FG000|Overall Study|Adverse Event|50|||
145395660|NCT01298700|524304828|FG001|Overall Study|Adverse Event|51|||
145395661|NCT01298700|524304827|FG000|Overall Study|Lack of Efficacy|9|||
145395662|NCT01298700|524304828|FG001|Overall Study|Lack of Efficacy|14|||
145395663|NCT01298700|524304827|FG000|Overall Study|Lost to Follow-up|5|||
145395664|NCT01298700|524304828|FG001|Overall Study|Lost to Follow-up|2|||
145395665|NCT01298700|524304827|FG000|Overall Study|Withdrawal by Subject|12|||
145395666|NCT01298700|524304828|FG001|Overall Study|Withdrawal by Subject|9|||
145395667|NCT01298700|524304827|FG000|Overall Study|Protocol Violation|6|||
145395668|NCT01298700|524304828|FG001|Overall Study|Protocol Violation|4|||
145395669|NCT01298700|524304827|FG000|Overall Study|Other Miscellaneous Reasons|16|||
145395670|NCT01298700|524304828|FG001|Overall Study|Other Miscellaneous Reasons|15|||
145395671|NCT01298700|524304827|FG000|Overall Study|Did not Receive Study Drug|3|||
145395672|NCT01298700|524304828|FG001|Overall Study|Did not Receive Study Drug|5|||
145395673|NCT04006145|524304829|FG000|Overall Study|Lost to Follow-up|0|||
145395674|NCT04006145|524304830|FG001|Overall Study|Lost to Follow-up|1|||
145395675|NCT04006145|524304829|FG000|Overall Study|Other|1|||
145395676|NCT04006145|524304830|FG001|Overall Study|Other|2|||
145395677|NCT00010257|524304833|FG000|Overall Study|Withdrawal by Subject|1|||
145395678|NCT00010257|524304834|FG001|Overall Study|Withdrawal by Subject|0|||
145395679|NCT02063672|524304835|FG000|Overall Study|Ongoing Follow-up|27|||
145395680|NCT02063672|524304836|FG001|Overall Study|Ongoing Follow-up|14|||
145395681|NCT02063672|524304835|FG000|Overall Study|Death|5|||
145395682|NCT02063672|524304836|FG001|Overall Study|Death|3|||
145395683|NCT02063672|524304835|FG000|Overall Study|Lost to Follow-up|1|||
145395684|NCT02063672|524304836|FG001|Overall Study|Lost to Follow-up|3|||
145395685|NCT02063672|524304835|FG000|Overall Study|Withdrawal by Subject|2|||
145395686|NCT02063672|524304836|FG001|Overall Study|Withdrawal by Subject|2|||
145395687|NCT01307787|524304838|FG000|Overall Study|Withdrawal by Subject|2|||
145395688|NCT01307787|524304839|FG001|Overall Study|Withdrawal by Subject|0|||
145497596|NCT03253796|524679667|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
145266671|NCT04668066|523825243|FG006|Part 1: Follow-Up|Adverse Event|0|||
145395689|NCT01965327|524304840|FG000|Overall Study|Physician Decision|2|||
145395690|NCT02498678|524304841|FG000|Overall Study|interference from the surgical team|0|||
145395691|NCT02498678|524304842|FG001|Overall Study|interference from the surgical team|2|||
145395692|NCT01405560|524304843|FG000|Overall Study|Physician Decision|1|||
145395693|NCT01484951|524304847|FG000|Overall Study|Adverse Event|3|||
145395694|NCT01484951|524304847|FG000|Overall Study|Personal Reasons|1|||
145395695|NCT01484951|524304847|FG000|Overall Study|Non-Compliance|1|||
145395696|NCT02169505|524304848|FG000|Overall Study|Withdrawal by Subject|1|||
145395697|NCT02035553|524304849|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
145395698|NCT02035553|524304850|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
145395699|NCT02035553|524304849|FG000|Overall Study|Adverse Event|10|||
145395700|NCT02035553|524304850|FG001|Overall Study|Adverse Event|6|||
145395701|NCT02035553|524304849|FG000|Overall Study|Physician Decision|3|||
145395702|NCT02035553|524304850|FG001|Overall Study|Physician Decision|2|||
145395703|NCT02035553|524304849|FG000|Overall Study|Lack of Efficacy|1|||
145395704|NCT02035553|524304850|FG001|Overall Study|Lack of Efficacy|1|||
145395705|NCT02035553|524304849|FG000|Overall Study|Withdrawal by Subject|4|||
145395706|NCT02035553|524304850|FG001|Overall Study|Withdrawal by Subject|7|||
145395707|NCT02035553|524304849|FG000|Overall Study|Non-compliance with Study Drug|0|||
145395708|NCT02035553|524304850|FG001|Overall Study|Non-compliance with Study Drug|1|||
145395709|NCT02035553|524304849|FG000|Overall Study|Lost to Follow-up|0|||
145395710|NCT02035553|524304850|FG001|Overall Study|Lost to Follow-up|1|||
145395711|NCT02035553|524304849|FG000|Overall Study|Other Reason|0|||
145395712|NCT02035553|524304850|FG001|Overall Study|Other Reason|4|||
145395713|NCT01854697|524304851|FG000|Overall Study|Adverse Event|1|||
145395714|NCT01854697|524304852|FG001|Overall Study|Adverse Event|0|||
145395715|NCT01854697|524304853|FG002|Overall Study|Adverse Event|0|||
145395716|NCT01854697|524304854|FG003|Overall Study|Adverse Event|0|||
145395717|NCT01854697|524304855|FG004|Overall Study|Adverse Event|1|||
145395718|NCT01854697|524304851|FG000|Overall Study|Lost to Follow-up|4|||
145395719|NCT01854697|524304852|FG001|Overall Study|Lost to Follow-up|1|||
145395720|NCT01854697|524304853|FG002|Overall Study|Lost to Follow-up|1|||
145395721|NCT01854697|524304854|FG003|Overall Study|Lost to Follow-up|2|||
145395722|NCT01854697|524304855|FG004|Overall Study|Lost to Follow-up|0|||
145395723|NCT01854697|524304851|FG000|Overall Study|To enter another AbbVie study|1|||
145395724|NCT01854697|524304852|FG001|Overall Study|To enter another AbbVie study|0|||
145395725|NCT01854697|524304853|FG002|Overall Study|To enter another AbbVie study|0|||
145395726|NCT01854697|524304854|FG003|Overall Study|To enter another AbbVie study|0|||
145395727|NCT01854697|524304855|FG004|Overall Study|To enter another AbbVie study|1|||
145395728|NCT01854697|524304851|FG000|Overall Study|Withdrew Consent|0|||
145395729|NCT01854697|524304852|FG001|Overall Study|Withdrew Consent|1|||
145395730|NCT01854697|524304853|FG002|Overall Study|Withdrew Consent|0|||
145395731|NCT01854697|524304854|FG003|Overall Study|Withdrew Consent|1|||
145395732|NCT01854697|524304855|FG004|Overall Study|Withdrew Consent|0|||
145395733|NCT01854697|524304851|FG000|Overall Study|Other|0|||
145395734|NCT01854697|524304852|FG001|Overall Study|Other|1|||
145395735|NCT01854697|524304853|FG002|Overall Study|Other|1|||
145395736|NCT01854697|524304854|FG003|Overall Study|Other|0|||
145395737|NCT01854697|524304855|FG004|Overall Study|Other|0|||
145395738|NCT00243919|524304861|FG000|Overall Study|Death|3|||
145395739|NCT00243919|524304862|FG001|Overall Study|Death|4|||
145395740|NCT00243919|524304863|FG002|Overall Study|Death|6|||
145395741|NCT00243919|524304861|FG000|Overall Study|Withdrawal by Subject|6|||
145395742|NCT00243919|524304862|FG001|Overall Study|Withdrawal by Subject|6|||
145395743|NCT00243919|524304863|FG002|Overall Study|Withdrawal by Subject|2|||
145395744|NCT00243919|524304861|FG000|Overall Study|Lost to Follow-up|6|||
145395745|NCT00243919|524304862|FG001|Overall Study|Lost to Follow-up|7|||
145395746|NCT00243919|524304863|FG002|Overall Study|Lost to Follow-up|3|||
145395747|NCT00243919|524304861|FG000|Overall Study|Administrative Error|1|||
145395748|NCT00243919|524304862|FG001|Overall Study|Administrative Error|0|||
145395749|NCT00243919|524304863|FG002|Overall Study|Administrative Error|0|||
145395750|NCT00243919|524304861|FG000|Overall Study|Physician Decision|1|||
145395751|NCT00243919|524304862|FG001|Overall Study|Physician Decision|1|||
145395752|NCT00243919|524304863|FG002|Overall Study|Physician Decision|0|||
145266672|NCT04668066|523825244|FG007|Part 1: Follow-Up|Adverse Event|0|||
145395753|NCT04176939|524304868|FG000|Overall Study|Withdrawal by Subject|5|||
145395754|NCT04176939|524304868|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
145395755|NCT04176939|524304868|FG000|Overall Study|Lost to Follow-up|2|||
145395756|NCT04176939|524304868|FG000|Overall Study|Unspecified reason|4|||
145395757|NCT04176939|524304868|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
145395758|NCT04919317|524304869|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
145395759|NCT04919317|524304870|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
145395760|NCT04919317|524304869|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
145395761|NCT04919317|524304870|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
145395762|NCT02869789|524304871|FG000|Overall Study|Disease progression|184|||
145395763|NCT02869789|524304872|FG001|Overall Study|Disease progression|109|||
145395764|NCT02869789|524304873|FG002|Overall Study|Disease progression|260|||
145395765|NCT02869789|524304874|FG003|Overall Study|Disease progression|19|||
145395766|NCT02869789|524304871|FG000|Overall Study|Study drug toxicity|90|||
145395767|NCT02869789|524304872|FG001|Overall Study|Study drug toxicity|32|||
145395768|NCT02869789|524304873|FG002|Overall Study|Study drug toxicity|55|||
145395769|NCT02869789|524304874|FG003|Overall Study|Study drug toxicity|14|||
145395770|NCT02869789|524304871|FG000|Overall Study|Death|7|||
145395771|NCT02869789|524304872|FG001|Overall Study|Death|3|||
145395772|NCT02869789|524304873|FG002|Overall Study|Death|5|||
145395773|NCT02869789|524304874|FG003|Overall Study|Death|1|||
145395774|NCT02869789|524304871|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
145395775|NCT02869789|524304872|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
145395776|NCT02869789|524304873|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
145395777|NCT02869789|524304874|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
145395778|NCT02869789|524304871|FG000|Overall Study|Participant request to discontinue study treatment|10|||
145395779|NCT02869789|524304872|FG001|Overall Study|Participant request to discontinue study treatment|5|||
145395780|NCT02869789|524304873|FG002|Overall Study|Participant request to discontinue study treatment|5|||
145395781|NCT02869789|524304874|FG003|Overall Study|Participant request to discontinue study treatment|3|||
145395782|NCT02869789|524304871|FG000|Overall Study|Withdrawal by Subject|5|||
145395783|NCT02869789|524304872|FG001|Overall Study|Withdrawal by Subject|2|||
145395784|NCT02869789|524304873|FG002|Overall Study|Withdrawal by Subject|7|||
145395785|NCT02869789|524304874|FG003|Overall Study|Withdrawal by Subject|2|||
145731654|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
145731655|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
145731656|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
145731657|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
145731658|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
145731659|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
145731660|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
145731661|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Death|1|||
145731662|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Death|1|||
145731663|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
145731664|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
145731665|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
145731666|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
145731667|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
145731668|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
145731669|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
145731670|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
145731671|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
145731672|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
145731673|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
145731674|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
145731675|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
145731676|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
145731677|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
145731678|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
145731679|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
145731680|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
145731681|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
145731682|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
145731683|NCT00559585|525535937|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
145731684|NCT00559585|525535938|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
145731685|NCT00559585|525535937|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
145731686|NCT00559585|525535938|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
145731687|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
145731688|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
145731689|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
145731690|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
145731691|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
145731692|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
145731693|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
145731694|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
145731695|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
145731696|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
145731697|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
145731698|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
145395786|NCT02869789|524304871|FG000|Overall Study|Lost to Follow-up|0|||
145395787|NCT02869789|524304872|FG001|Overall Study|Lost to Follow-up|0|||
145395788|NCT02869789|524304873|FG002|Overall Study|Lost to Follow-up|2|||
145395789|NCT02869789|524304874|FG003|Overall Study|Lost to Follow-up|0|||
145395790|NCT02869789|524304871|FG000|Overall Study|Maximum clinical benefit|5|||
145395791|NCT02869789|524304872|FG001|Overall Study|Maximum clinical benefit|2|||
145731699|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
145731700|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
145731701|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
145731702|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
145731703|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
145731704|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
145731705|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
145731706|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
145731707|NCT00559585|525535937|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
145731708|NCT00559585|525535938|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
145731709|NCT02644941|525535939|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
145731710|NCT02644941|525535940|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
145731711|NCT01145495|525535941|FG000|Overall Study|Adverse Event|6|||
145731712|NCT01145495|525535941|FG000|Overall Study|Withdrawal by Subject|6|||
145731713|NCT01145495|525535941|FG000|Overall Study|Disease progression after respone|2|||
145731714|NCT01862640|525535948|FG000|Overall Study|Adverse Event|4|||
145731715|NCT01862640|525535949|FG001|Overall Study|Adverse Event|10|||
145731716|NCT01862640|525535950|FG002|Overall Study|Adverse Event|6|||
145731717|NCT01862640|525535951|FG003|Overall Study|Adverse Event|8|||
145731718|NCT01862640|525535948|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
145731719|NCT01862640|525535949|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
145731720|NCT01862640|525535950|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
145731721|NCT01862640|525535951|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
145731722|NCT01862640|525535948|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
145731723|NCT01862640|525535949|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
145731724|NCT01862640|525535950|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
145731725|NCT01862640|525535951|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
145731726|NCT01862640|525535948|FG000|Overall Study|Withdrawal by Subject|2|||
145731727|NCT01862640|525535949|FG001|Overall Study|Withdrawal by Subject|4|||
145731728|NCT01862640|525535950|FG002|Overall Study|Withdrawal by Subject|8|||
145731729|NCT01862640|525535951|FG003|Overall Study|Withdrawal by Subject|5|||
145731730|NCT01862640|525535948|FG000|Overall Study|Protocol Deviation|0|||
145731731|NCT01862640|525535949|FG001|Overall Study|Protocol Deviation|0|||
145731732|NCT01862640|525535950|FG002|Overall Study|Protocol Deviation|1|||
145731733|NCT01862640|525535951|FG003|Overall Study|Protocol Deviation|0|||
145731734|NCT01019317|525535954|FG000|Overall Study|Not Eligible|4|||
145731735|NCT02178553|525535955|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
145731736|NCT02178553|525535956|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
145731737|NCT02178553|525535955|FG000|Overall Study|Physician Decision|0|||
145731738|NCT02178553|525535956|FG001|Overall Study|Physician Decision|4|||
145731739|NCT02178553|525535955|FG000|Overall Study|Technical problem with injection|1|||
145731740|NCT02178553|525535956|FG001|Overall Study|Technical problem with injection|3|||
145731741|NCT01699789|525535958|FG000|Overall Study|Withdrawal by Subject|18|||
145731742|NCT01699789|525535959|FG001|Overall Study|Withdrawal by Subject|23|||
145731743|NCT01699789|525535958|FG000|Overall Study|Death|1|||
145731744|NCT01699789|525535959|FG001|Overall Study|Death|2|||
145497597|NCT03253796|524679668|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
145497598|NCT03253796|524679669|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
145497599|NCT03253796|524679670|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
145497600|NCT03253796|524679671|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
145497601|NCT03253796|524679667|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
145497602|NCT03253796|524679668|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
145497603|NCT03253796|524679669|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
145497604|NCT03253796|524679670|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
145497605|NCT03253796|524679671|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
145497606|NCT03253796|524679667|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
145497607|NCT03253796|524679668|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
145497608|NCT03253796|524679669|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
145497609|NCT03253796|524679670|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
145497610|NCT03253796|524679671|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
145497611|NCT03253796|524679667|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
145497612|NCT03253796|524679668|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
145497613|NCT03253796|524679669|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
145497614|NCT03253796|524679670|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
145497615|NCT03253796|524679671|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
145497616|NCT03253796|524679667|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
145497617|NCT03253796|524679668|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
145497618|NCT03253796|524679669|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
145497619|NCT03253796|524679670|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
145497620|NCT03253796|524679671|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
145497621|NCT03253796|524679667|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
145497622|NCT03253796|524679668|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
145497623|NCT03253796|524679669|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
145497624|NCT03253796|524679670|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
145497625|NCT03253796|524679671|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
145497626|NCT00894803|524679672|FG000|Overall Study|Death|20|||
145497627|NCT00894803|524679673|FG001|Overall Study|Death|4|||
145497628|NCT00894803|524679672|FG000|Overall Study|Lost to Follow-up|0|||
145497629|NCT00894803|524679673|FG001|Overall Study|Lost to Follow-up|1|||
145497630|NCT01075243|524679675|FG000|Overall Study|Lost to Follow-up|5|||
145497631|NCT01075243|524679676|FG001|Overall Study|Lost to Follow-up|2|||
145497632|NCT01075243|524679677|FG002|Overall Study|Lost to Follow-up|0|||
145497633|NCT01075243|524679675|FG000|Overall Study|Withdrawal by Subject|1|||
145497634|NCT01075243|524679676|FG001|Overall Study|Withdrawal by Subject|1|||
145497635|NCT01075243|524679677|FG002|Overall Study|Withdrawal by Subject|0|||
145497636|NCT03094416|524679683|FG000|Run-in|Screening failure|8|||
145497637|NCT03094416|524679683|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
145497638|NCT03094416|524679683|FG000|Run-in|Withdrawal by Subject|3|||
145497639|NCT03094416|524679683|FG000|Treatment Period|Withdrawal by Subject|2|||
145497640|NCT03050801|524679686|FG000|Experiment 1|Lost to Follow-up|0|||
145497641|NCT03050801|524679687|FG001|Experiment 1|Lost to Follow-up|1|||
145497642|NCT03050801|524679688|FG002|Experiment 1|Lost to Follow-up|0|||
145497643|NCT03050801|524679689|FG003|Experiment 1|Lost to Follow-up|0|||
145497644|NCT03050801|524679690|FG004|Experiment 1|Lost to Follow-up|0|||
145497645|NCT03050801|524679691|FG005|Experiment 1|Lost to Follow-up|0|||
145497646|NCT03050801|524679686|FG000|Experiment 1|Physician Decision|0|||
145497647|NCT03050801|524679687|FG001|Experiment 1|Physician Decision|3|||
145497648|NCT03050801|524679688|FG002|Experiment 1|Physician Decision|0|||
145497649|NCT03050801|524679689|FG003|Experiment 1|Physician Decision|0|||
145497650|NCT03050801|524679690|FG004|Experiment 1|Physician Decision|0|||
145497651|NCT03050801|524679691|FG005|Experiment 1|Physician Decision|0|||
145497652|NCT03050801|524679686|FG000|Experiment 1|Change of experimental design|0|||
145497653|NCT03050801|524679687|FG001|Experiment 1|Change of experimental design|3|||
145497654|NCT03050801|524679688|FG002|Experiment 1|Change of experimental design|0|||
145497655|NCT03050801|524679689|FG003|Experiment 1|Change of experimental design|0|||
145497656|NCT03050801|524679690|FG004|Experiment 1|Change of experimental design|0|||
145497657|NCT03050801|524679691|FG005|Experiment 1|Change of experimental design|0|||
145497658|NCT03050801|524679686|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
145497659|NCT03050801|524679687|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
145731745|NCT01699789|525535958|FG000|Overall Study|Lost to Follow-up|83|||
145731746|NCT01699789|525535959|FG001|Overall Study|Lost to Follow-up|101|||
145497660|NCT03050801|524679688|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
145497661|NCT03050801|524679689|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
145497662|NCT03050801|524679690|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
145497663|NCT03050801|524679691|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
145497664|NCT03050801|524679686|FG000|Experiment 2|Lost to Follow-up|0|||
145497665|NCT03050801|524679687|FG001|Experiment 2|Lost to Follow-up|0|||
145497666|NCT03050801|524679688|FG002|Experiment 2|Lost to Follow-up|0|||
145731747|NCT02554903|525535960|FG000|Overall Study|Death|1|||
145731748|NCT02554903|525535961|FG001|Overall Study|Death|1|||
145731749|NCT02554903|525535960|FG000|Overall Study|Physician Decision|2|||
145731750|NCT02554903|525535961|FG001|Overall Study|Physician Decision|2|||
145731751|NCT02554903|525535960|FG000|Overall Study|Heart Transplant|1|||
145731752|NCT02554903|525535961|FG001|Overall Study|Heart Transplant|2|||
145731753|NCT00639223|525535962|FG000|Overall Study|Lost to Follow-up|0|||
145731754|NCT00639223|525535963|FG001|Overall Study|Lost to Follow-up|2|||
145731755|NCT02540538|525535965|FG000|Overall Study|Pregnancy|0|||
145731756|NCT02540538|525535966|FG001|Overall Study|Pregnancy|1|||
145731757|NCT02540538|525535967|FG002|Overall Study|Pregnancy|0|||
145731758|NCT01557348|525535971|FG000|Overall Study|Adverse Event|6|||
145731759|NCT01557348|525535972|FG001|Overall Study|Adverse Event|16|||
145731760|NCT01557348|525535971|FG000|Overall Study|Infusion reaction event|5|||
145731761|NCT01557348|525535972|FG001|Overall Study|Infusion reaction event|5|||
145731762|NCT01557348|525535971|FG000|Overall Study|Death|7|||
145731763|NCT01557348|525535972|FG001|Overall Study|Death|4|||
145731764|NCT01557348|525535971|FG000|Overall Study|Insufficient Therapeutic Response|13|||
145731765|NCT01557348|525535972|FG001|Overall Study|Insufficient Therapeutic Response|28|||
145731766|NCT01557348|525535971|FG000|Overall Study|Withdrawal by Subject|5|||
145731767|NCT01557348|525535972|FG001|Overall Study|Withdrawal by Subject|4|||
145731768|NCT01557348|525535971|FG000|Overall Study|Lost to Follow-up|26|||
145731769|NCT01557348|525535972|FG001|Overall Study|Lost to Follow-up|22|||
145731770|NCT01557348|525535971|FG000|Overall Study|Administrative|18|||
145731771|NCT01557348|525535972|FG001|Overall Study|Administrative|11|||
145395792|NCT02869789|524304873|FG002|Overall Study|Maximum clinical benefit|1|||
145497667|NCT03050801|524679689|FG003|Experiment 2|Lost to Follow-up|1|||
145497668|NCT03050801|524679690|FG004|Experiment 2|Lost to Follow-up|1|||
145497669|NCT03050801|524679691|FG005|Experiment 2|Lost to Follow-up|0|||
145497670|NCT03050801|524679686|FG000|Experiment 2|Physician Decision|0|||
145497671|NCT03050801|524679687|FG001|Experiment 2|Physician Decision|0|||
145497672|NCT03050801|524679688|FG002|Experiment 2|Physician Decision|0|||
145497673|NCT03050801|524679689|FG003|Experiment 2|Physician Decision|0|||
145497674|NCT03050801|524679690|FG004|Experiment 2|Physician Decision|1|||
145731772|NCT00403754|525535973|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
145731773|NCT00403754|525535974|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
145731774|NCT00403754|525535975|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
145731775|NCT00403754|525535976|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
145731776|NCT00403754|525535973|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
145731777|NCT00403754|525535974|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
145731778|NCT00403754|525535975|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
145731779|NCT00403754|525535976|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
145731780|NCT02000427|525535981|FG000|Overall Study|Death|22|||
145731781|NCT03829319|525535982|FG000|Overall Study|Sponsor's Decision|4|||
145731782|NCT03829319|525535983|FG001|Overall Study|Sponsor's Decision|90|||
145731783|NCT03829319|525535984|FG002|Overall Study|Sponsor's Decision|102|||
145731784|NCT03829319|525535982|FG000|Overall Study|Withdrawal by Subject|1|||
145731785|NCT03829319|525535983|FG001|Overall Study|Withdrawal by Subject|5|||
145731786|NCT03829319|525535984|FG002|Overall Study|Withdrawal by Subject|4|||
145731787|NCT03829319|525535982|FG000|Overall Study|Physician Decision|0|||
145731788|NCT03829319|525535983|FG001|Overall Study|Physician Decision|3|||
145731789|NCT03829319|525535984|FG002|Overall Study|Physician Decision|0|||
145731790|NCT03829319|525535982|FG000|Overall Study|Lost to Follow-up|0|||
145731791|NCT03829319|525535983|FG001|Overall Study|Lost to Follow-up|0|||
145731792|NCT03829319|525535984|FG002|Overall Study|Lost to Follow-up|1|||
145731793|NCT03829319|525535982|FG000|Overall Study|Death|8|||
145731794|NCT03829319|525535983|FG001|Overall Study|Death|277|||
145731795|NCT03829319|525535984|FG002|Overall Study|Death|266|||
145731796|NCT02846532|525535985|FG000|Overall Study|Lost to Follow-up|0|||
145731797|NCT02846532|525535986|FG001|Overall Study|Lost to Follow-up|1|||
145731798|NCT02846532|525535987|FG002|Overall Study|Lost to Follow-up|1|||
145731799|NCT02846532|525535985|FG000|Overall Study|Withdrawal by Subject|1|||
145731800|NCT02846532|525535986|FG001|Overall Study|Withdrawal by Subject|2|||
145731801|NCT02846532|525535987|FG002|Overall Study|Withdrawal by Subject|0|||
145731802|NCT04484259|525535988|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
145731803|NCT04484259|525535989|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
145731804|NCT04484259|525535990|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
145731805|NCT04484259|525535991|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
145731806|NCT04484259|525535992|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
145731807|NCT04484259|525535988|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
145731808|NCT04484259|525535989|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
145731809|NCT04484259|525535990|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
145731810|NCT04484259|525535991|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
145731811|NCT04484259|525535992|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
145731812|NCT04484259|525535988|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
145731813|NCT04484259|525535989|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
145731814|NCT04484259|525535990|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
145731815|NCT04484259|525535991|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
145731816|NCT04484259|525535992|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
145731817|NCT04484259|525535988|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
145731818|NCT04484259|525535989|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
145731819|NCT04484259|525535990|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
145731820|NCT04484259|525535991|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
145731821|NCT04484259|525535992|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
145731822|NCT04484259|525535988|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
145731823|NCT04484259|525535989|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
145731824|NCT04484259|525535990|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
145731825|NCT04484259|525535991|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
145731826|NCT04484259|525535992|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
145731827|NCT04484259|525535988|FG000|Randomized Treatment|Withdrawal by Subject|1|||
145731828|NCT04484259|525535989|FG001|Randomized Treatment|Withdrawal by Subject|0|||
145731829|NCT04484259|525535990|FG002|Randomized Treatment|Withdrawal by Subject|0|||
145731830|NCT04484259|525535991|FG003|Randomized Treatment|Withdrawal by Subject|0|||
145731831|NCT04484259|525535992|FG004|Randomized Treatment|Withdrawal by Subject|0|||
145731832|NCT03951220|525535993|FG000|Overall Study|Withdrawal by Subject|9|||
145731833|NCT03951220|525535994|FG001|Overall Study|Withdrawal by Subject|2|||
145731834|NCT03951220|525535995|FG002|Overall Study|Withdrawal by Subject|0|||
145731835|NCT04498832|525535996|FG000|Overall Study|Adverse Event|1|||
145731836|NCT04498832|525535997|FG001|Overall Study|Adverse Event|3|||
145731837|NCT04498832|525535996|FG000|Overall Study|Withdrawal by Subject|0|||
145731838|NCT04498832|525535997|FG001|Overall Study|Withdrawal by Subject|1|||
145731839|NCT05359003|525535998|FG000|Overall Study|Withdrawal by Subject|1|||
145731840|NCT05359003|525535999|FG001|Overall Study|Withdrawal by Subject|3|||
145731841|NCT01313650|525536003|FG000|Overall Study|Adverse Event|9|||
145266673|NCT04668066|523825245|FG008|Part 1: Follow-Up|Adverse Event|0|||
145731842|NCT01313650|525536004|FG001|Overall Study|Adverse Event|34|||
145731843|NCT01313650|525536005|FG002|Overall Study|Adverse Event|24|||
145731844|NCT01313650|525536006|FG003|Overall Study|Adverse Event|23|||
145266674|NCT04668066|523825246|FG009|Part 1: Follow-Up|Adverse Event|0|||
145731845|NCT01313650|525536003|FG000|Overall Study|Lack of Efficacy|37|||
145731846|NCT01313650|525536004|FG001|Overall Study|Lack of Efficacy|20|||
145731847|NCT01313650|525536005|FG002|Overall Study|Lack of Efficacy|32|||
145731848|NCT01313650|525536006|FG003|Overall Study|Lack of Efficacy|20|||
145731849|NCT01313650|525536003|FG000|Overall Study|Lost to Follow-up|1|||
145731850|NCT01313650|525536004|FG001|Overall Study|Lost to Follow-up|0|||
145731851|NCT01313650|525536005|FG002|Overall Study|Lost to Follow-up|3|||
145731852|NCT01313650|525536006|FG003|Overall Study|Lost to Follow-up|2|||
145731853|NCT01313650|525536003|FG000|Overall Study|Withdrawal by Subject|16|||
145731854|NCT01313650|525536004|FG001|Overall Study|Withdrawal by Subject|20|||
145731855|NCT01313650|525536005|FG002|Overall Study|Withdrawal by Subject|15|||
145731856|NCT01313650|525536006|FG003|Overall Study|Withdrawal by Subject|15|||
145731857|NCT01313650|525536003|FG000|Overall Study|Protocol Violation|4|||
145731858|NCT01313650|525536004|FG001|Overall Study|Protocol Violation|7|||
145731859|NCT01313650|525536005|FG002|Overall Study|Protocol Violation|5|||
145731860|NCT01313650|525536006|FG003|Overall Study|Protocol Violation|6|||
145731861|NCT01313650|525536003|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
145731862|NCT01313650|525536004|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
145731863|NCT01313650|525536005|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
145731864|NCT01313650|525536006|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
145731865|NCT05393037|525536009|FG000|Part A|Death|1|||
145731866|NCT05393037|525536010|FG001|Part A|Death|0|||
145731867|NCT05393037|525536009|FG000|Part A|Lost to Follow-up|1|||
145731868|NCT05393037|525536010|FG001|Part A|Lost to Follow-up|1|||
145731869|NCT05393037|525536009|FG000|Part A|Withdrawal by Subject|2|||
145731870|NCT05393037|525536010|FG001|Part A|Withdrawal by Subject|4|||
145731871|NCT05393037|525536009|FG000|Part B|Lost to Follow-up|1|||
145731872|NCT05393037|525536010|FG001|Part B|Lost to Follow-up|0|||
145731873|NCT01012739|525536011|FG000|Treatment Period 1|Adverse Event|0|||
145731874|NCT01012739|525536012|FG001|Treatment Period 1|Adverse Event|0|||
145731875|NCT01012739|525536013|FG002|Treatment Period 1|Adverse Event|0|||
145731876|NCT01012739|525536014|FG003|Treatment Period 1|Adverse Event|1|||
145731877|NCT01012739|525536011|FG000|Treatment Period 2|Abnormal test procedure results|0|||
145731878|NCT01012739|525536012|FG001|Treatment Period 2|Abnormal test procedure results|0|||
145731879|NCT01012739|525536013|FG002|Treatment Period 2|Abnormal test procedure results|0|||
145731880|NCT01012739|525536014|FG003|Treatment Period 2|Abnormal test procedure results|1|||
145731881|NCT02466971|525536015|FG000|Overall Study|eligible and never treated|14|||
145731882|NCT02466971|525536016|FG001|Overall Study|eligible and never treated|20|||
145731883|NCT02466971|525536015|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
145731884|NCT02466971|525536016|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
145731885|NCT02466971|525536015|FG000|Overall Study|ineligible and treated|1|||
145731886|NCT02466971|525536016|FG001|Overall Study|ineligible and treated|0|||
145731887|NCT02466971|525536015|FG000|Overall Study|ineligible and never treated|0|||
145731888|NCT02466971|525536016|FG001|Overall Study|ineligible and never treated|1|||
145731889|NCT06268288|525536017|FG000|Overall Study|Withdrawal by Subject|1|||
145731890|NCT06268288|525536018|FG001|Overall Study|Withdrawal by Subject|2|||
145731891|NCT02684357|525536023|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
145731892|NCT02684357|525536024|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
145731893|NCT02684357|525536025|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
145731894|NCT02684357|525536026|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
145731895|NCT02684357|525536027|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
145731896|NCT02684357|525536028|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
145731897|NCT02684357|525536023|FG000|Part A|Lost to Follow-up|0|||
145731898|NCT02684357|525536024|FG001|Part A|Lost to Follow-up|2|||
145731899|NCT02684357|525536025|FG002|Part A|Lost to Follow-up|2|||
145731900|NCT02684357|525536026|FG003|Part A|Lost to Follow-up|0|||
145731901|NCT02684357|525536027|FG004|Part A|Lost to Follow-up|0|||
145731902|NCT02684357|525536028|FG005|Part A|Lost to Follow-up|0|||
145731903|NCT02684357|525536023|FG000|Part A|Withdrawal by Subject|3|||
145731904|NCT02684357|525536024|FG001|Part A|Withdrawal by Subject|0|||
145731905|NCT02684357|525536025|FG002|Part A|Withdrawal by Subject|0|||
145731906|NCT02684357|525536026|FG003|Part A|Withdrawal by Subject|0|||
145731907|NCT02684357|525536027|FG004|Part A|Withdrawal by Subject|0|||
145731908|NCT02684357|525536028|FG005|Part A|Withdrawal by Subject|0|||
145731909|NCT02684357|525536023|FG000|Part A|Other|0|||
145731910|NCT02684357|525536024|FG001|Part A|Other|1|||
145731911|NCT02684357|525536025|FG002|Part A|Other|0|||
145731912|NCT02684357|525536026|FG003|Part A|Other|0|||
145731913|NCT02684357|525536027|FG004|Part A|Other|0|||
145731914|NCT02684357|525536028|FG005|Part A|Other|0|||
145731915|NCT02684357|525536023|FG000|Part B|Adverse Event (Other)|0|||
145731916|NCT02684357|525536024|FG001|Part B|Adverse Event (Other)|0|||
145731917|NCT02684357|525536025|FG002|Part B|Adverse Event (Other)|0|||
145731918|NCT02684357|525536026|FG003|Part B|Adverse Event (Other)|1|||
145731919|NCT02684357|525536027|FG004|Part B|Adverse Event (Other)|1|||
145731920|NCT02684357|525536028|FG005|Part B|Adverse Event (Other)|1|||
145731921|NCT02684357|525536023|FG000|Part B|Lost to Follow-up|0|||
145731922|NCT02684357|525536024|FG001|Part B|Lost to Follow-up|0|||
145731923|NCT02684357|525536025|FG002|Part B|Lost to Follow-up|0|||
145731924|NCT02684357|525536026|FG003|Part B|Lost to Follow-up|1|||
145731925|NCT02684357|525536027|FG004|Part B|Lost to Follow-up|1|||
145731926|NCT02684357|525536028|FG005|Part B|Lost to Follow-up|7|||
145731927|NCT02684357|525536023|FG000|Part B|Withdrawal by Subject|0|||
145731928|NCT02684357|525536024|FG001|Part B|Withdrawal by Subject|0|||
145731929|NCT02684357|525536025|FG002|Part B|Withdrawal by Subject|0|||
145731930|NCT02684357|525536026|FG003|Part B|Withdrawal by Subject|0|||
145731931|NCT02684357|525536027|FG004|Part B|Withdrawal by Subject|2|||
145731932|NCT02684357|525536028|FG005|Part B|Withdrawal by Subject|4|||
145731933|NCT02684357|525536023|FG000|Part B|Other|0|||
145731934|NCT02684357|525536024|FG001|Part B|Other|0|||
145731935|NCT02684357|525536025|FG002|Part B|Other|0|||
145731936|NCT02684357|525536026|FG003|Part B|Other|1|||
145731937|NCT02684357|525536027|FG004|Part B|Other|0|||
145731938|NCT02684357|525536028|FG005|Part B|Other|1|||
145731939|NCT04567615|525536029|FG000|Randomization|Participant withdrew consent|1|||
145731940|NCT04567615|525536030|FG001|Randomization|Participant withdrew consent|0|||
145731941|NCT04567615|525536031|FG002|Randomization|Participant withdrew consent|0|||
145731942|NCT04567615|525536029|FG000|Randomization|Adverse event unrelated to study drug|0|||
145731943|NCT04567615|525536030|FG001|Randomization|Adverse event unrelated to study drug|1|||
145731944|NCT04567615|525536031|FG002|Randomization|Adverse event unrelated to study drug|0|||
145731945|NCT04567615|525536029|FG000|Treatment Period|Participant Withdrew Consent|2|||
145731946|NCT04567615|525536030|FG001|Treatment Period|Participant Withdrew Consent|5|||
145731947|NCT04567615|525536031|FG002|Treatment Period|Participant Withdrew Consent|1|||
145731948|NCT04567615|525536029|FG000|Treatment Period|Death|1|||
145731949|NCT04567615|525536030|FG001|Treatment Period|Death|2|||
145731950|NCT04567615|525536031|FG002|Treatment Period|Death|0|||
145731951|NCT04567615|525536029|FG000|Treatment Period|Lost to Follow-up|0|||
145731952|NCT04567615|525536030|FG001|Treatment Period|Lost to Follow-up|1|||
145731953|NCT04567615|525536031|FG002|Treatment Period|Lost to Follow-up|0|||
145731954|NCT04567615|525536029|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
145731955|NCT04567615|525536030|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
145731956|NCT04567615|525536031|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
145731957|NCT04567615|525536029|FG000|Treatment Period|Disease Progression|85|||
145731958|NCT04567615|525536030|FG001|Treatment Period|Disease Progression|63|||
145731959|NCT04567615|525536031|FG002|Treatment Period|Disease Progression|16|||
145731960|NCT04567615|525536029|FG000|Treatment Period|Study Drug Toxicity|3|||
145731961|NCT04567615|525536030|FG001|Treatment Period|Study Drug Toxicity|10|||
145731962|NCT04567615|525536031|FG002|Treatment Period|Study Drug Toxicity|4|||
145731963|NCT04567615|525536029|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
145731964|NCT04567615|525536030|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
145731965|NCT04567615|525536031|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
145731966|NCT04567615|525536029|FG000|Treatment Period|Other Reasons|1|||
145731967|NCT04567615|525536030|FG001|Treatment Period|Other Reasons|2|||
145731968|NCT04567615|525536031|FG002|Treatment Period|Other Reasons|0|||
145731969|NCT04567615|525536029|FG000|Treatment Period|Still On-going Treatment|21|||
145731970|NCT04567615|525536030|FG001|Treatment Period|Still On-going Treatment|22|||
145731971|NCT04567615|525536031|FG002|Treatment Period|Still On-going Treatment|2|||
145731972|NCT01306890|525537504|FG000|Overall Study|Adverse Event|2|||
145731973|NCT01306890|525537504|FG000|Overall Study|Death|1223|||
145731974|NCT01306890|525537504|FG000|Overall Study|Lost to Follow-up|58|||
145731975|NCT01306890|525537504|FG000|Overall Study|Withdrawal by Subject|88|||
145731976|NCT01306890|525537504|FG000|Overall Study|Unspecified reasons|104|||
145731977|NCT01306890|525537504|FG000|Overall Study|Study Termination|3|||
145731978|NCT01306890|525537504|FG000|Overall Study|No discontinuation documentation|41|||
145731979|NCT02217436|525537505|FG000|Overall Study|Protocol Violation|1|||
145731980|NCT02217436|525537506|FG001|Overall Study|Protocol Violation|1|||
145731981|NCT02217436|525537505|FG000|Overall Study|Incomplete data|0|||
145731982|NCT02217436|525537506|FG001|Overall Study|Incomplete data|1|||
145731983|NCT01890148|525537507|FG000|Overall Study|Adverse Event|1|||
145731984|NCT01215175|525537508|FG000|Overall Study|Lost to Follow-up|0|||
145731985|NCT01215175|525537509|FG001|Overall Study|Lost to Follow-up|1|||
145731986|NCT01215175|525537510|FG002|Overall Study|Lost to Follow-up|0|||
145731987|NCT01215175|525537511|FG003|Overall Study|Lost to Follow-up|1|||
145731988|NCT01215175|525537512|FG004|Overall Study|Lost to Follow-up|0|||
145731989|NCT01678209|525537513|FG000|Overall Study|could not scan twice|1|||
145731990|NCT01678209|525537514|FG001|Overall Study|could not scan twice|1|||
145395793|NCT02869789|524304874|FG003|Overall Study|Maximum clinical benefit|0|||
145731991|NCT01678209|525537515|FG002|Overall Study|could not scan twice|1|||
145731992|NCT01678209|525537513|FG000|Overall Study|scheduling conflicts|0|||
145731993|NCT01678209|525537514|FG001|Overall Study|scheduling conflicts|0|||
145731994|NCT01678209|525537515|FG002|Overall Study|scheduling conflicts|1|||
145731995|NCT01678209|525537513|FG000|Overall Study|screen fail|16|||
145731996|NCT01678209|525537514|FG001|Overall Study|screen fail|17|||
145731997|NCT01678209|525537515|FG002|Overall Study|screen fail|16|||
145731998|NCT03739762|525537516|FG000|Overall Study|Lost to Follow-up|1|||
145731999|NCT03739762|525537517|FG001|Overall Study|Lost to Follow-up|1|||
145732000|NCT03739762|525537516|FG000|Overall Study|Withdrawal by Subject|2|||
145732001|NCT03739762|525537517|FG001|Overall Study|Withdrawal by Subject|6|||
145732002|NCT00607880|525537518|FG000|Overall Study|Unable to place port due to occlusion|1|||
145732003|NCT00607880|525537519|FG001|Overall Study|Unable to place port due to occlusion|0|||
145732004|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
145732005|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
145732006|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Death|0|||
145732007|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Death|1|||
145732008|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
145732009|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
145732010|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
145732011|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
145732012|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
145732013|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
145732014|NCT00323297|525537522|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
145732015|NCT00323297|525537523|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
145732016|NCT00323297|525537522|FG000|Part B (Open-label)|Death|0|||
145732017|NCT00323297|525537523|FG001|Part B (Open-label)|Death|1|||
145732018|NCT00323297|525537522|FG000|Part B (Open-label)|Reason unspecified|0|||
145732019|NCT00323297|525537523|FG001|Part B (Open-label)|Reason unspecified|1|||
145732020|NCT00323297|525537522|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
145732021|NCT00323297|525537523|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
145732022|NCT00323297|525537522|FG000|Part B (Open-label)|Lack of Efficacy|3|||
145732023|NCT00323297|525537523|FG001|Part B (Open-label)|Lack of Efficacy|1|||
145732024|NCT00323297|525537522|FG000|Part B (Open-label)|Adverse Event|5|||
145732025|NCT00323297|525537523|FG001|Part B (Open-label)|Adverse Event|5|||
145732026|NCT00323297|525537522|FG000|Part B (Open-label)|Protocol Violation|0|||
145732027|NCT00323297|525537523|FG001|Part B (Open-label)|Protocol Violation|1|||
145732028|NCT01603082|525537525|FG000|Overall Study|Adverse Event|0|||
145732029|NCT01603082|525537526|FG001|Overall Study|Adverse Event|1|||
145732030|NCT01603082|525537525|FG000|Overall Study|Withdrawal by Subject|1|||
145732031|NCT01603082|525537526|FG001|Overall Study|Withdrawal by Subject|0|||
145732032|NCT01603082|525537525|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
145732033|NCT01603082|525537526|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
145732034|NCT01026142|525537529|FG000|Overall Study|Death|136|||
145732035|NCT01026142|525537530|FG001|Overall Study|Death|134|||
145732036|NCT01026142|525537529|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
145732037|NCT01026142|525537530|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
145732038|NCT00634010|525537532|FG000|Overall Study|Adverse Event|2|||
145732039|NCT00634010|525537533|FG001|Overall Study|Adverse Event|5|||
145732040|NCT00634010|525537532|FG000|Overall Study|Withdrawal by Subject|5|||
145732041|NCT00634010|525537533|FG001|Overall Study|Withdrawal by Subject|6|||
145732042|NCT00634010|525537532|FG000|Overall Study|Physician Decision|1|||
145732043|NCT00634010|525537533|FG001|Overall Study|Physician Decision|1|||
145732044|NCT00634010|525537532|FG000|Overall Study|Disease Progression|1|||
145732045|NCT00634010|525537533|FG001|Overall Study|Disease Progression|1|||
145732046|NCT00634010|525537532|FG000|Overall Study|Non-Compliant|1|||
145732047|NCT00634010|525537533|FG001|Overall Study|Non-Compliant|1|||
145732048|NCT05085665|525537537|FG000|Overall Study|Physician Decision|2|||
145732049|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145732050|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145732051|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
145732052|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
145732053|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
145732054|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
145732055|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
145732056|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
145732057|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
145732058|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
145732059|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
145732060|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
145395794|NCT02869789|524304871|FG000|Overall Study|Poor/Non-compliance|0|||
145395795|NCT02869789|524304872|FG001|Overall Study|Poor/Non-compliance|2|||
145395796|NCT02869789|524304873|FG002|Overall Study|Poor/Non-compliance|1|||
145395797|NCT02869789|524304874|FG003|Overall Study|Poor/Non-compliance|0|||
145395798|NCT02869789|524304871|FG000|Overall Study|Participant no longer meets study criteria|0|||
145605961|NCT04415151|525073052|FG001|Overall Study|Withdrawal by Subject|0|||
145732061|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
145732062|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
145732063|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
145732064|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
145732065|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
145732066|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
145732067|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
145732068|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
145732069|NCT01641809|525537538|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
145732070|NCT01641809|525537539|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
145732071|NCT01641809|525537540|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
145732072|NCT01641809|525537541|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
145732073|NCT01641809|525537538|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
145732074|NCT01641809|525537539|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
145732075|NCT01641809|525537540|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
145732076|NCT01641809|525537541|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
145732077|NCT01641809|525537538|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
145732078|NCT01641809|525537539|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
145732079|NCT01641809|525537540|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
145732080|NCT01641809|525537541|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
145732081|NCT01641809|525537538|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
145732082|NCT01641809|525537539|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
145732083|NCT01641809|525537540|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
145732084|NCT01641809|525537541|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
145732085|NCT01641809|525537538|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
145732086|NCT01641809|525537539|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
145732087|NCT01641809|525537540|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
145732088|NCT01641809|525537541|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
145732089|NCT01641809|525537538|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
145732090|NCT01641809|525537539|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
145732091|NCT01641809|525537540|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
145732092|NCT01641809|525537541|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
145732093|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
145732094|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
145732095|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
145732096|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
145732097|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
145732098|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
145732099|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
145732100|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
145732101|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
145732102|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
145732103|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
145732104|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
145732105|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
145732106|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
145732107|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
145732108|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
145497675|NCT03050801|524679691|FG005|Experiment 2|Physician Decision|0|||
145266675|NCT04668066|523825247|FG010|Part 1: Follow-Up|Adverse Event|0|||
145732109|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
145732110|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
145732111|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
145732112|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
145732113|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
145732114|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
145732115|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
145732116|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
145732117|NCT01641809|525537538|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
145732118|NCT01641809|525537539|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
145732119|NCT01641809|525537540|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
145732120|NCT01641809|525537541|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
145732121|NCT03294109|525537544|FG000|Overall Study|Withdrawal by Subject|6|||
145732122|NCT03294109|525537545|FG001|Overall Study|Withdrawal by Subject|5|||
145732123|NCT03690141|525537546|FG000|Overall Study|Adverse Event|5|||
145732124|NCT03690141|525537546|FG000|Overall Study|Withdrawal by Subject|3|||
145732125|NCT03690141|525537546|FG000|Overall Study|Physician Decision|4|||
145732126|NCT03690141|525537546|FG000|Overall Study|Disease progression|4|||
145732127|NCT04744285|525537547|FG000|Overall Study|Withdrawal by Subject|1|||
145732128|NCT04744285|525537548|FG001|Overall Study|Withdrawal by Subject|1|||
145732129|NCT04744285|525537549|FG002|Overall Study|Withdrawal by Subject|2|||
145732130|NCT04744285|525537550|FG003|Overall Study|Withdrawal by Subject|1|||
145732131|NCT00448435|525537551|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
145732132|NCT00448435|525537552|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
145732133|NCT04195581|525537555|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
145732134|NCT04195581|525537555|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
145732135|NCT04195581|525537555|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
145732136|NCT04195581|525537555|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
145732137|NCT04195581|525537555|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
145732138|NCT04195581|525537555|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
145732139|NCT00821431|525537556|FG000|Overall Study|Adverse Event|6|||
145732140|NCT00821431|525537557|FG001|Overall Study|Adverse Event|3|||
145732141|NCT00821431|525537556|FG000|Overall Study|Withdrawal by Subject|5|||
145732142|NCT00821431|525537557|FG001|Overall Study|Withdrawal by Subject|0|||
145732143|NCT00821431|525537556|FG000|Overall Study|Lost to Follow-up|1|||
145732144|NCT00821431|525537557|FG001|Overall Study|Lost to Follow-up|0|||
145732145|NCT00821431|525537556|FG000|Overall Study|Protocol Violation|3|||
145732146|NCT00821431|525537557|FG001|Overall Study|Protocol Violation|1|||
145732147|NCT00821431|525537556|FG000|Overall Study|Physician Decision|0|||
145732148|NCT00821431|525537557|FG001|Overall Study|Physician Decision|1|||
145732149|NCT01387230|525537558|FG000|Overall Study|Adverse Event|0|||
145732150|NCT01387230|525537559|FG001|Overall Study|Adverse Event|1|||
145732151|NCT01387230|525537560|FG002|Overall Study|Adverse Event|3|||
145732152|NCT01387230|525537558|FG000|Overall Study|Lack of Efficacy|8|||
145732153|NCT01387230|525537559|FG001|Overall Study|Lack of Efficacy|5|||
145732154|NCT01387230|525537560|FG002|Overall Study|Lack of Efficacy|4|||
145732155|NCT01387230|525537558|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
145732156|NCT01387230|525537559|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
145732157|NCT01387230|525537560|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
145732158|NCT01387230|525537558|FG000|Overall Study|Lost to Follow-up|0|||
145732159|NCT01387230|525537559|FG001|Overall Study|Lost to Follow-up|0|||
145732160|NCT01387230|525537560|FG002|Overall Study|Lost to Follow-up|1|||
145732161|NCT01387230|525537558|FG000|Overall Study|Withdrawal by Subject|4|||
145732162|NCT01387230|525537559|FG001|Overall Study|Withdrawal by Subject|1|||
145732163|NCT01387230|525537560|FG002|Overall Study|Withdrawal by Subject|0|||
145732164|NCT03026127|525537563|FG000|CRISP R61|Adverse Event|5|||
145732165|NCT03026127|525537564|FG001|CRISP R61|Adverse Event|0|||
145732166|NCT03026127|525537565|FG002|CRISP R61|Adverse Event|0|||
145732167|NCT03026127|525537563|FG000|CRISP R61|Lost to Follow-up|2|||
145732168|NCT03026127|525537564|FG001|CRISP R61|Lost to Follow-up|0|||
145732169|NCT03026127|525537565|FG002|CRISP R61|Lost to Follow-up|0|||
145732170|NCT03026127|525537563|FG000|CRISP R61|Dropped before therapy|5|||
145732171|NCT03026127|525537564|FG001|CRISP R61|Dropped before therapy|0|||
145732172|NCT03026127|525537565|FG002|CRISP R61|Dropped before therapy|0|||
145732173|NCT03026127|525537563|FG000|CRISP R33|Lost to Follow-up|0|||
145732174|NCT03026127|525537564|FG001|CRISP R33|Lost to Follow-up|5|||
145732175|NCT03026127|525537565|FG002|CRISP R33|Lost to Follow-up|4|||
145732176|NCT03026127|525537563|FG000|CRISP R33|Adverse Event|0|||
145732177|NCT03026127|525537564|FG001|CRISP R33|Adverse Event|9|||
145732178|NCT03026127|525537565|FG002|CRISP R33|Adverse Event|5|||
145732179|NCT03026127|525537563|FG000|CRISP R33|Withdrawal by Subject|0|||
145732180|NCT03026127|525537564|FG001|CRISP R33|Withdrawal by Subject|9|||
145732181|NCT03026127|525537565|FG002|CRISP R33|Withdrawal by Subject|1|||
145732182|NCT03026127|525537563|FG000|CRISP R33|Lack of Efficacy|0|||
145732183|NCT03026127|525537564|FG001|CRISP R33|Lack of Efficacy|3|||
145732184|NCT03026127|525537565|FG002|CRISP R33|Lack of Efficacy|2|||
145395799|NCT02869789|524304872|FG001|Overall Study|Participant no longer meets study criteria|1|||
145497676|NCT03050801|524679686|FG000|Experiment 2|Pregnancy|0|||
145497677|NCT03050801|524679687|FG001|Experiment 2|Pregnancy|0|||
145497678|NCT03050801|524679688|FG002|Experiment 2|Pregnancy|0|||
145497679|NCT03050801|524679689|FG003|Experiment 2|Pregnancy|0|||
145732185|NCT03026127|525537563|FG000|CRISP R33|Physician Decision|0|||
145497680|NCT03050801|524679690|FG004|Experiment 2|Pregnancy|1|||
145732186|NCT03026127|525537564|FG001|CRISP R33|Physician Decision|3|||
145732187|NCT03026127|525537565|FG002|CRISP R33|Physician Decision|1|||
145732188|NCT03026127|525537563|FG000|CRISP R33|Transportation|0|||
145732189|NCT03026127|525537564|FG001|CRISP R33|Transportation|2|||
145732190|NCT03026127|525537565|FG002|CRISP R33|Transportation|1|||
145732191|NCT01182766|525537569|FG000|Overall Study|Lost to Follow-up|32|||
145732192|NCT01182766|525537570|FG001|Overall Study|Lost to Follow-up|36|||
145732193|NCT01182766|525537571|FG002|Overall Study|Lost to Follow-up|29|||
145732194|NCT01182766|525537569|FG000|Overall Study|Withdrawal by Subject|14|||
145732195|NCT01182766|525537570|FG001|Overall Study|Withdrawal by Subject|3|||
145732196|NCT01182766|525537571|FG002|Overall Study|Withdrawal by Subject|6|||
145732197|NCT01182766|525537569|FG000|Overall Study|Physician Decision|1|||
145732198|NCT01182766|525537570|FG001|Overall Study|Physician Decision|0|||
145497681|NCT03050801|524679691|FG005|Experiment 2|Pregnancy|0|||
145732199|NCT01182766|525537571|FG002|Overall Study|Physician Decision|0|||
145732200|NCT01182766|525537569|FG000|Overall Study|Non-compliance|1|||
145732201|NCT01182766|525537570|FG001|Overall Study|Non-compliance|1|||
145732202|NCT01182766|525537571|FG002|Overall Study|Non-compliance|1|||
145732203|NCT03027557|525537572|FG000|Overall Study|Adverse Event|1|||
145732204|NCT03027557|525537573|FG001|Overall Study|Adverse Event|0|||
145732205|NCT03027557|525537574|FG002|Overall Study|Adverse Event|0|||
145732206|NCT02510560|525537575|FG000|Overall Study|Discontinued from Treatment|27|||
145732207|NCT02510560|525537576|FG001|Overall Study|Discontinued from Treatment|18|||
145732208|NCT02510560|525537577|FG002|Overall Study|Discontinued from Treatment|19|||
145732209|NCT02510560|525537575|FG000|Overall Study|Other|4|||
145732210|NCT02510560|525537576|FG001|Overall Study|Other|4|||
145732211|NCT02510560|525537577|FG002|Overall Study|Other|3|||
145732212|NCT04427501|525537578|FG000|Overall Study|Death|0|||
145732213|NCT04427501|525537579|FG001|Overall Study|Death|0|||
145732214|NCT04427501|525537580|FG002|Overall Study|Death|0|||
145732215|NCT04427501|525537581|FG003|Overall Study|Death|0|||
145732216|NCT04427501|525537582|FG004|Overall Study|Death|0|||
145732217|NCT04427501|525537583|FG005|Overall Study|Death|15|||
145266676|NCT04668066|523825248|FG011|Part 1: Follow-Up|Adverse Event|1|||
145395800|NCT02869789|524304873|FG002|Overall Study|Participant no longer meets study criteria|1|||
145395801|NCT02869789|524304874|FG003|Overall Study|Participant no longer meets study criteria|0|||
145395802|NCT02869789|524304871|FG000|Overall Study|Administrative reason by sponsor|0|||
145395803|NCT02869789|524304872|FG001|Overall Study|Administrative reason by sponsor|0|||
145395804|NCT02869789|524304873|FG002|Overall Study|Administrative reason by sponsor|1|||
145395805|NCT02869789|524304874|FG003|Overall Study|Administrative reason by sponsor|0|||
145395806|NCT02869789|524304871|FG000|Overall Study|Other reasons|4|||
145395807|NCT02869789|524304872|FG001|Overall Study|Other reasons|8|||
145395808|NCT02869789|524304873|FG002|Overall Study|Other reasons|6|||
145732218|NCT04427501|525537584|FG006|Overall Study|Death|0|||
145732219|NCT04427501|525537585|FG007|Overall Study|Death|0|||
145732220|NCT04427501|525537586|FG008|Overall Study|Death|0|||
145732221|NCT04427501|525537587|FG009|Overall Study|Death|0|||
145732222|NCT04427501|525537588|FG010|Overall Study|Death|0|||
145732223|NCT04427501|525537589|FG011|Overall Study|Death|0|||
145732224|NCT04427501|525537578|FG000|Overall Study|Lost to Follow-up|5|||
145732225|NCT04427501|525537579|FG001|Overall Study|Lost to Follow-up|1|||
145732226|NCT04427501|525537580|FG002|Overall Study|Lost to Follow-up|2|||
145732227|NCT04427501|525537581|FG003|Overall Study|Lost to Follow-up|0|||
145732228|NCT04427501|525537582|FG004|Overall Study|Lost to Follow-up|2|||
145732229|NCT04427501|525537583|FG005|Overall Study|Lost to Follow-up|11|||
145732230|NCT04427501|525537584|FG006|Overall Study|Lost to Follow-up|10|||
145732231|NCT04427501|525537585|FG007|Overall Study|Lost to Follow-up|10|||
145732232|NCT04427501|525537586|FG008|Overall Study|Lost to Follow-up|2|||
145732233|NCT04427501|525537587|FG009|Overall Study|Lost to Follow-up|5|||
145732234|NCT04427501|525537588|FG010|Overall Study|Lost to Follow-up|2|||
145732235|NCT04427501|525537589|FG011|Overall Study|Lost to Follow-up|0|||
145732236|NCT04427501|525537578|FG000|Overall Study|Physician Decision|0|||
145732237|NCT04427501|525537579|FG001|Overall Study|Physician Decision|3|||
145732238|NCT04427501|525537580|FG002|Overall Study|Physician Decision|0|||
145732239|NCT04427501|525537581|FG003|Overall Study|Physician Decision|0|||
145732240|NCT04427501|525537582|FG004|Overall Study|Physician Decision|0|||
145732241|NCT04427501|525537583|FG005|Overall Study|Physician Decision|0|||
145732242|NCT04427501|525537584|FG006|Overall Study|Physician Decision|2|||
145732243|NCT04427501|525537585|FG007|Overall Study|Physician Decision|0|||
145732244|NCT04427501|525537586|FG008|Overall Study|Physician Decision|0|||
145732245|NCT04427501|525537587|FG009|Overall Study|Physician Decision|0|||
145732246|NCT04427501|525537588|FG010|Overall Study|Physician Decision|0|||
145732247|NCT04427501|525537589|FG011|Overall Study|Physician Decision|0|||
145732248|NCT04427501|525537578|FG000|Overall Study|Withdrawal by Subject|9|||
145732249|NCT04427501|525537579|FG001|Overall Study|Withdrawal by Subject|2|||
145732250|NCT04427501|525537580|FG002|Overall Study|Withdrawal by Subject|2|||
145732251|NCT04427501|525537581|FG003|Overall Study|Withdrawal by Subject|3|||
145732252|NCT04427501|525537582|FG004|Overall Study|Withdrawal by Subject|7|||
145395809|NCT02869789|524304874|FG003|Overall Study|Other reasons|0|||
145395810|NCT00230048|524304875|FG000|Overall Study|Lost to Follow-up|13|||
145395811|NCT00230048|524304876|FG001|Overall Study|Lost to Follow-up|18|||
145395812|NCT00676403|524304877|FG000|Overall Study|Adverse Event|1|||
145395813|NCT00676403|524304878|FG001|Overall Study|Adverse Event|2|||
145395814|NCT00676403|524304879|FG002|Overall Study|Adverse Event|0|||
145395815|NCT00676403|524304880|FG003|Overall Study|Adverse Event|5|||
145395816|NCT00676403|524304881|FG004|Overall Study|Adverse Event|1|||
145395817|NCT00676403|524304882|FG005|Overall Study|Adverse Event|2|||
145395818|NCT00676403|524304877|FG000|Overall Study|Lost to Follow-up|0|||
145395819|NCT00676403|524304878|FG001|Overall Study|Lost to Follow-up|0|||
145395820|NCT00676403|524304879|FG002|Overall Study|Lost to Follow-up|0|||
145395821|NCT00676403|524304880|FG003|Overall Study|Lost to Follow-up|0|||
145395822|NCT00676403|524304881|FG004|Overall Study|Lost to Follow-up|0|||
145395823|NCT00676403|524304882|FG005|Overall Study|Lost to Follow-up|1|||
145395824|NCT00676403|524304877|FG000|Overall Study|Reason Unspecified|1|||
145395825|NCT00676403|524304878|FG001|Overall Study|Reason Unspecified|0|||
145395826|NCT00676403|524304879|FG002|Overall Study|Reason Unspecified|1|||
145395827|NCT00676403|524304880|FG003|Overall Study|Reason Unspecified|0|||
145395828|NCT00676403|524304881|FG004|Overall Study|Reason Unspecified|0|||
145395829|NCT00676403|524304882|FG005|Overall Study|Reason Unspecified|1|||
145395830|NCT00676403|524304877|FG000|Overall Study|Withdrawal by Subject|0|||
145395831|NCT00676403|524304878|FG001|Overall Study|Withdrawal by Subject|0|||
145395832|NCT00676403|524304879|FG002|Overall Study|Withdrawal by Subject|0|||
145395833|NCT00676403|524304880|FG003|Overall Study|Withdrawal by Subject|0|||
145395834|NCT00676403|524304881|FG004|Overall Study|Withdrawal by Subject|0|||
145395835|NCT00676403|524304882|FG005|Overall Study|Withdrawal by Subject|1|||
145395836|NCT03225170|524304883|FG000|Overall Study|Lost to Follow-up|4|||
145395837|NCT03225170|524304884|FG001|Overall Study|Lost to Follow-up|4|||
145395838|NCT03225170|524304885|FG002|Overall Study|Lost to Follow-up|0|||
145395839|NCT03225170|524304883|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
145395840|NCT03225170|524304884|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
145395841|NCT03225170|524304885|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
145395842|NCT01746862|524304886|FG000|Overall Study|Withdrawal by Subject|1|||
145395843|NCT01746862|524304887|FG001|Overall Study|Withdrawal by Subject|1|||
145395844|NCT01746862|524304886|FG000|Overall Study|Protocol Violation|1|||
145395845|NCT01746862|524304887|FG001|Overall Study|Protocol Violation|0|||
145395846|NCT01746862|524304886|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
145395847|NCT01746862|524304887|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
145395848|NCT01746862|524304886|FG000|Overall Study|Entered puberty during the study|1|||
145732253|NCT04427501|525537583|FG005|Overall Study|Withdrawal by Subject|25|||
145732254|NCT04427501|525537584|FG006|Overall Study|Withdrawal by Subject|15|||
145732255|NCT04427501|525537585|FG007|Overall Study|Withdrawal by Subject|7|||
145732256|NCT04427501|525537586|FG008|Overall Study|Withdrawal by Subject|4|||
145732257|NCT04427501|525537587|FG009|Overall Study|Withdrawal by Subject|1|||
145732258|NCT04427501|525537588|FG010|Overall Study|Withdrawal by Subject|4|||
145732259|NCT04427501|525537589|FG011|Overall Study|Withdrawal by Subject|0|||
145732260|NCT04427501|525537578|FG000|Overall Study|Other - as reported by the investigator|1|||
145732261|NCT04427501|525537579|FG001|Overall Study|Other - as reported by the investigator|0|||
145732262|NCT04427501|525537580|FG002|Overall Study|Other - as reported by the investigator|0|||
145732263|NCT04427501|525537581|FG003|Overall Study|Other - as reported by the investigator|0|||
145732264|NCT04427501|525537582|FG004|Overall Study|Other - as reported by the investigator|0|||
145732265|NCT04427501|525537583|FG005|Overall Study|Other - as reported by the investigator|6|||
145732266|NCT04427501|525537584|FG006|Overall Study|Other - as reported by the investigator|6|||
145732267|NCT04427501|525537585|FG007|Overall Study|Other - as reported by the investigator|0|||
145732268|NCT04427501|525537586|FG008|Overall Study|Other - as reported by the investigator|0|||
145732269|NCT04427501|525537587|FG009|Overall Study|Other - as reported by the investigator|0|||
145732270|NCT04427501|525537588|FG010|Overall Study|Other - as reported by the investigator|0|||
145732271|NCT04427501|525537589|FG011|Overall Study|Other - as reported by the investigator|0|||
145732272|NCT04427501|525537578|FG000|Overall Study|Other|0|||
145732273|NCT04427501|525537579|FG001|Overall Study|Other|0|||
145732274|NCT04427501|525537580|FG002|Overall Study|Other|0|||
145732275|NCT04427501|525537581|FG003|Overall Study|Other|0|||
145732276|NCT04427501|525537582|FG004|Overall Study|Other|0|||
145732277|NCT04427501|525537583|FG005|Overall Study|Other|0|||
145732278|NCT04427501|525537584|FG006|Overall Study|Other|0|||
145732279|NCT04427501|525537585|FG007|Overall Study|Other|0|||
145732280|NCT04427501|525537586|FG008|Overall Study|Other|0|||
145732281|NCT04427501|525537587|FG009|Overall Study|Other|0|||
145732282|NCT04427501|525537588|FG010|Overall Study|Other|0|||
145732283|NCT04427501|525537589|FG011|Overall Study|Other|1|||
145732284|NCT04936841|525537590|FG000|Overall Study|Death|1|||
145732285|NCT04598477|525537591|FG000|Overall Study|Adverse Event|2|||
145732286|NCT04598477|525537592|FG001|Overall Study|Adverse Event|0|||
145497682|NCT03050801|524679686|FG000|Experiment 2|Withdrawal by Subject|0|||
145497683|NCT03050801|524679687|FG001|Experiment 2|Withdrawal by Subject|0|||
145497684|NCT03050801|524679688|FG002|Experiment 2|Withdrawal by Subject|0|||
145497685|NCT03050801|524679689|FG003|Experiment 2|Withdrawal by Subject|1|||
145497686|NCT03050801|524679690|FG004|Experiment 2|Withdrawal by Subject|0|||
145497687|NCT03050801|524679691|FG005|Experiment 2|Withdrawal by Subject|0|||
145497688|NCT03050801|524679686|FG000|Experiment 2|Poor data quality|0|||
145497689|NCT03050801|524679687|FG001|Experiment 2|Poor data quality|0|||
145497690|NCT03050801|524679688|FG002|Experiment 2|Poor data quality|0|||
145497691|NCT03050801|524679689|FG003|Experiment 2|Poor data quality|4|||
145497692|NCT03050801|524679690|FG004|Experiment 2|Poor data quality|1|||
145497693|NCT03050801|524679691|FG005|Experiment 2|Poor data quality|0|||
145497694|NCT03050801|524679686|FG000|Experiment 2|Discomfort during stimulation|0|||
145497695|NCT03050801|524679687|FG001|Experiment 2|Discomfort during stimulation|0|||
145497696|NCT03050801|524679688|FG002|Experiment 2|Discomfort during stimulation|0|||
145497697|NCT03050801|524679689|FG003|Experiment 2|Discomfort during stimulation|0|||
145497698|NCT03050801|524679690|FG004|Experiment 2|Discomfort during stimulation|0|||
145497699|NCT03050801|524679691|FG005|Experiment 2|Discomfort during stimulation|2|||
145497700|NCT02246530|524679692|FG000|Overall Study|Lost to Follow-up|4|||
145497701|NCT02246530|524679693|FG001|Overall Study|Lost to Follow-up|0|||
145497702|NCT01506596|524679694|FG000|Overall Study|ineligible pathology|1|||
145497703|NCT01488890|524679697|FG000|Overall Study|Serious adverse event|2|||
145497704|NCT01488890|524679698|FG001|Overall Study|Serious adverse event|0|||
145497705|NCT01488890|524679699|FG002|Overall Study|Serious adverse event|0|||
145605962|NCT00638235|525073058|FG000|Overall Study|Lost to Follow-up|31|||
145497706|NCT01488890|524679700|FG003|Overall Study|Serious adverse event|0|||
145497707|NCT01488890|524679697|FG000|Overall Study|Protocol Violation|3|||
145497708|NCT01488890|524679698|FG001|Overall Study|Protocol Violation|0|||
145497709|NCT01488890|524679699|FG002|Overall Study|Protocol Violation|4|||
145497710|NCT01488890|524679700|FG003|Overall Study|Protocol Violation|0|||
145497711|NCT01488890|524679697|FG000|Overall Study|Lost to Follow-up|13|||
145497712|NCT01488890|524679698|FG001|Overall Study|Lost to Follow-up|10|||
145497713|NCT01488890|524679699|FG002|Overall Study|Lost to Follow-up|20|||
145497714|NCT01488890|524679700|FG003|Overall Study|Lost to Follow-up|3|||
145497715|NCT01488890|524679697|FG000|Overall Study|Withdrawal by Subject|14|||
145497716|NCT01488890|524679698|FG001|Overall Study|Withdrawal by Subject|10|||
145497717|NCT01488890|524679699|FG002|Overall Study|Withdrawal by Subject|11|||
145497718|NCT01488890|524679700|FG003|Overall Study|Withdrawal by Subject|2|||
145497719|NCT05712460|524679701|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497720|NCT05712460|524679702|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497721|NCT05712460|524679703|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497722|NCT05712460|524679704|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497723|NCT05712460|524679705|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497724|NCT05712460|524679706|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145732287|NCT04598477|525537591|FG000|Overall Study|Death|0|||
145497725|NCT05712460|524679707|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497726|NCT05712460|524679708|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
145497727|NCT05712460|524679709|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497728|NCT05712460|524679710|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497729|NCT05712460|524679711|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497730|NCT05712460|524679712|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
145497731|NCT04366349|524679715|FG000|Overall Study|Withdrawal by Subject|1|||
145497732|NCT04366349|524679716|FG001|Overall Study|Withdrawal by Subject|0|||
145497733|NCT04366349|524679717|FG002|Overall Study|Withdrawal by Subject|0|||
145497734|NCT04366349|524679718|FG003|Overall Study|Withdrawal by Subject|0|||
145497735|NCT04366349|524679719|FG004|Overall Study|Withdrawal by Subject|0|||
145497736|NCT04366349|524679720|FG005|Overall Study|Withdrawal by Subject|0|||
145497737|NCT01350999|524679725|FG000|Overall Study|Adverse Event|4|||
145497738|NCT01350999|524679726|FG001|Overall Study|Adverse Event|9|||
145497739|NCT01350999|524679727|FG002|Overall Study|Adverse Event|10|||
145497740|NCT01350999|524679725|FG000|Overall Study|Voluntary withdrawal|3|||
145497741|NCT01350999|524679726|FG001|Overall Study|Voluntary withdrawal|4|||
145497742|NCT01350999|524679727|FG002|Overall Study|Voluntary withdrawal|6|||
145497743|NCT01350999|524679725|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
145497744|NCT01350999|524679726|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
145497745|NCT01350999|524679727|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
145497746|NCT00079417|524681884|FG000|Overall Study|Physician Decision|2|||
145497747|NCT00079417|524681884|FG000|Overall Study|Ineligible|7|||
145497748|NCT01615939|524681885|FG000|Overall Study|Lost to Follow-up|5|||
145497749|NCT01615939|524681886|FG001|Overall Study|Lost to Follow-up|0|||
145497750|NCT02121535|524681890|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
145497751|NCT02121535|524681891|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
145497752|NCT02121535|524681890|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
145497753|NCT02121535|524681891|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
145497754|NCT00092417|524681892|FG000|Overall Study|Lost to Follow-up|2|||
145732288|NCT04598477|525537592|FG001|Overall Study|Death|1|||
145732289|NCT04598477|525537591|FG000|Overall Study|Lost to Follow-up|1|||
145732290|NCT04598477|525537592|FG001|Overall Study|Lost to Follow-up|0|||
145732291|NCT04598477|525537591|FG000|Overall Study|Physician Decision|7|||
145732292|NCT04598477|525537592|FG001|Overall Study|Physician Decision|2|||
145732293|NCT04598477|525537591|FG000|Overall Study|Pregnancy|0|||
145732294|NCT04598477|525537592|FG001|Overall Study|Pregnancy|1|||
145732295|NCT04598477|525537591|FG000|Overall Study|Requires Prohibited Medication|0|||
145732296|NCT04598477|525537592|FG001|Overall Study|Requires Prohibited Medication|1|||
145732297|NCT04598477|525537591|FG000|Overall Study|Study Terminated by Sponsor|18|||
145732298|NCT04598477|525537592|FG001|Overall Study|Study Terminated by Sponsor|12|||
145732299|NCT04598477|525537591|FG000|Overall Study|Withdrawal by Subject|16|||
145732300|NCT04598477|525537592|FG001|Overall Study|Withdrawal by Subject|12|||
145732301|NCT04598477|525537591|FG000|Overall Study|Other|15|||
145732302|NCT04598477|525537592|FG001|Overall Study|Other|8|||
145732303|NCT05579990|525537598|FG000|Overall Study|Lost to Follow-up|3|||
145732304|NCT05118204|525537599|FG000|Overall Study|Lost to Follow-up|3|||
145732305|NCT05118204|525537600|FG001|Overall Study|Lost to Follow-up|2|||
145732306|NCT05118204|525537599|FG000|Overall Study|Withdrawal by Subject|0|||
145732307|NCT05118204|525537600|FG001|Overall Study|Withdrawal by Subject|2|||
145732308|NCT04029480|525537601|FG000|Overall Study|Physician Decision|0|||
145732309|NCT04029480|525537602|FG001|Overall Study|Physician Decision|0|||
145732310|NCT04029480|525537603|FG002|Overall Study|Physician Decision|2|||
145732311|NCT04029480|525537604|FG003|Overall Study|Physician Decision|1|||
145732312|NCT04029480|525537601|FG000|Overall Study|Withdrawal by Subject|2|||
145732313|NCT04029480|525537602|FG001|Overall Study|Withdrawal by Subject|0|||
145732314|NCT04029480|525537603|FG002|Overall Study|Withdrawal by Subject|1|||
145732315|NCT04029480|525537604|FG003|Overall Study|Withdrawal by Subject|1|||
145732316|NCT04786119|525537605|FG000|Overall Study|Withdrawal by Subject|4|||
145732317|NCT04786119|525537606|FG001|Overall Study|Withdrawal by Subject|5|||
145732318|NCT04786119|525537605|FG000|Overall Study|Lost to Follow-up|5|||
145732319|NCT04786119|525537606|FG001|Overall Study|Lost to Follow-up|5|||
145732320|NCT04786119|525537605|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
145395849|NCT01746862|524304887|FG001|Overall Study|Entered puberty during the study|0|||
145395850|NCT00731822|524304894|FG000|Overall Study|Adverse Event|2|||
145395851|NCT00731822|524304895|FG001|Overall Study|Adverse Event|1|||
145395852|NCT00731822|524304894|FG000|Overall Study|Protocol Violation|1|||
145395853|NCT00731822|524304895|FG001|Overall Study|Protocol Violation|0|||
145395854|NCT00731822|524304894|FG000|Overall Study|Lost to Follow-up|1|||
145395855|NCT00731822|524304895|FG001|Overall Study|Lost to Follow-up|0|||
145395856|NCT04144322|524304902|FG000|Overall Study|Lack of Efficacy|2|||
145395857|NCT04144322|524304903|FG001|Overall Study|Lack of Efficacy|2|||
145395858|NCT04817332|524304904|FG000|Overall Study|Lost to Follow-up|3|||
145395859|NCT04817332|524304905|FG001|Overall Study|Lost to Follow-up|3|||
145395860|NCT04817332|524304904|FG000|Overall Study|Protocol Violation|2|||
145395861|NCT04817332|524304905|FG001|Overall Study|Protocol Violation|0|||
145395862|NCT02131064|524304911|FG000|Overall Study|Death|5|||
145395863|NCT02131064|524304912|FG001|Overall Study|Death|6|||
145395864|NCT02131064|524304911|FG000|Overall Study|Lost to Follow-up|4|||
145395865|NCT02131064|524304912|FG001|Overall Study|Lost to Follow-up|8|||
145395866|NCT02131064|524304911|FG000|Overall Study|Withdrawal by Subject|14|||
145395867|NCT02131064|524304912|FG001|Overall Study|Withdrawal by Subject|18|||
145395868|NCT02131064|524304911|FG000|Overall Study|Other|2|||
145395869|NCT02131064|524304912|FG001|Overall Study|Other|2|||
145395870|NCT00549549|524304913|FG000|Overall Study|Adverse Event|5|||
145395871|NCT00549549|524304914|FG001|Overall Study|Adverse Event|3|||
145395872|NCT00549549|524304915|FG002|Overall Study|Adverse Event|1|||
145395873|NCT00549549|524304916|FG003|Overall Study|Adverse Event|9|||
145395874|NCT00549549|524304913|FG000|Overall Study|Lack of Efficacy|9|||
145395875|NCT00549549|524304914|FG001|Overall Study|Lack of Efficacy|6|||
145395876|NCT00549549|524304915|FG002|Overall Study|Lack of Efficacy|4|||
145395877|NCT00549549|524304916|FG003|Overall Study|Lack of Efficacy|2|||
145395878|NCT00549549|524304913|FG000|Overall Study|Lost to Follow-up|1|||
145395879|NCT00549549|524304914|FG001|Overall Study|Lost to Follow-up|0|||
145395880|NCT00549549|524304915|FG002|Overall Study|Lost to Follow-up|1|||
145395881|NCT00549549|524304916|FG003|Overall Study|Lost to Follow-up|2|||
145395882|NCT00549549|524304913|FG000|Overall Study|Withdrawal by Subject|0|||
145395883|NCT00549549|524304914|FG001|Overall Study|Withdrawal by Subject|4|||
145395884|NCT00549549|524304915|FG002|Overall Study|Withdrawal by Subject|1|||
145395885|NCT00549549|524304916|FG003|Overall Study|Withdrawal by Subject|0|||
145395886|NCT00549549|524304913|FG000|Overall Study|Other|9|||
145395887|NCT00549549|524304914|FG001|Overall Study|Other|9|||
145395888|NCT00549549|524304915|FG002|Overall Study|Other|9|||
145395889|NCT00549549|524304916|FG003|Overall Study|Other|11|||
145395890|NCT00549549|524304913|FG000|Overall Study|Randomized but not treated|0|||
145395891|NCT00549549|524304914|FG001|Overall Study|Randomized but not treated|0|||
145395892|NCT00549549|524304915|FG002|Overall Study|Randomized but not treated|1|||
145395893|NCT00549549|524304916|FG003|Overall Study|Randomized but not treated|1|||
145395894|NCT02227784|524304920|FG000|Double-Blind Phase|Adverse Event|3|||
145395895|NCT02227784|524304921|FG001|Double-Blind Phase|Adverse Event|2|||
145395896|NCT02227784|524304922|FG002|Double-Blind Phase|Adverse Event|1|||
145395897|NCT02227784|524304923|FG003|Double-Blind Phase|Adverse Event|3|||
145395898|NCT02227784|524304924|FG004|Double-Blind Phase|Adverse Event|0|||
145395899|NCT02227784|524304920|FG000|Double-Blind Phase|Physician Decision|1|||
145395900|NCT02227784|524304921|FG001|Double-Blind Phase|Physician Decision|0|||
145395901|NCT02227784|524304922|FG002|Double-Blind Phase|Physician Decision|0|||
145395902|NCT02227784|524304923|FG003|Double-Blind Phase|Physician Decision|1|||
145395903|NCT02227784|524304924|FG004|Double-Blind Phase|Physician Decision|0|||
145395904|NCT02227784|524304920|FG000|Double-Blind Phase|Protocol Violation|0|||
145395905|NCT02227784|524304921|FG001|Double-Blind Phase|Protocol Violation|0|||
145395906|NCT02227784|524304922|FG002|Double-Blind Phase|Protocol Violation|1|||
145395907|NCT02227784|524304923|FG003|Double-Blind Phase|Protocol Violation|1|||
145395908|NCT02227784|524304924|FG004|Double-Blind Phase|Protocol Violation|0|||
145395909|NCT02227784|524304920|FG000|Double-Blind Phase|Sponsor Decision|34|||
145732321|NCT04786119|525537606|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
145732322|NCT02593786|525537607|FG000|Overall Study|Disease progression|12|||
145732323|NCT02593786|525537608|FG001|Overall Study|Disease progression|16|||
145732324|NCT02593786|525537609|FG002|Overall Study|Disease progression|10|||
145732325|NCT02593786|525537610|FG003|Overall Study|Disease progression|7|||
145732326|NCT02593786|525537607|FG000|Overall Study|Study drug toxicity|1|||
145732327|NCT02593786|525537608|FG001|Overall Study|Study drug toxicity|0|||
145732328|NCT02593786|525537609|FG002|Overall Study|Study drug toxicity|0|||
145732329|NCT02593786|525537610|FG003|Overall Study|Study drug toxicity|0|||
145732330|NCT02593786|525537607|FG000|Overall Study|Adverse event unrelated to study drug|1|||
145732331|NCT02593786|525537608|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145732332|NCT02593786|525537609|FG002|Overall Study|Adverse event unrelated to study drug|1|||
145732333|NCT02593786|525537610|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145732334|NCT02593786|525537607|FG000|Overall Study|Participant request to discontinue study therapy|0|||
145732335|NCT02593786|525537608|FG001|Overall Study|Participant request to discontinue study therapy|2|||
145732336|NCT02593786|525537609|FG002|Overall Study|Participant request to discontinue study therapy|0|||
145732337|NCT02593786|525537610|FG003|Overall Study|Participant request to discontinue study therapy|0|||
145732338|NCT02593786|525537607|FG000|Overall Study|Other reasons|1|||
145732339|NCT02593786|525537608|FG001|Overall Study|Other reasons|1|||
145732340|NCT02593786|525537609|FG002|Overall Study|Other reasons|0|||
145732341|NCT02593786|525537610|FG003|Overall Study|Other reasons|5|||
145732342|NCT01019980|525537611|FG000|Overall Study|Drug not available.|2|||
145732343|NCT01019980|525537612|FG001|Overall Study|Drug not available.|0|||
145732344|NCT03901053|525537622|FG000|Overall Study|Lost to Follow-up|6|||
145732345|NCT03901053|525537623|FG001|Overall Study|Lost to Follow-up|2|||
145732346|NCT03901053|525537622|FG000|Overall Study|Withdrawal by Subject|4|||
145732347|NCT03901053|525537623|FG001|Overall Study|Withdrawal by Subject|3|||
145732348|NCT03901053|525537622|FG000|Overall Study|Unsatisfactory Device|1|||
145732349|NCT03901053|525537623|FG001|Overall Study|Unsatisfactory Device|2|||
145732350|NCT03901053|525537622|FG000|Overall Study|No longer meets study criteria|1|||
145732351|NCT03901053|525537623|FG001|Overall Study|No longer meets study criteria|3|||
145732352|NCT03901053|525537622|FG000|Overall Study|Subject's Medical Status|0|||
145732353|NCT03901053|525537623|FG001|Overall Study|Subject's Medical Status|1|||
145732354|NCT03901053|525537622|FG000|Overall Study|Screening Failure|1|||
145732355|NCT03901053|525537623|FG001|Overall Study|Screening Failure|0|||
145732356|NCT04600336|525537624|FG000|Initial Treatment|Withdrawal by Subject|1|||
145732357|NCT04600336|525537625|FG001|Initial Treatment|Withdrawal by Subject|2|||
145732358|NCT04600336|525537626|FG002|Initial Treatment|Withdrawal by Subject|0|||
145732359|NCT04600336|525537627|FG003|Initial Treatment|Withdrawal by Subject|0|||
145732360|NCT04600336|525537624|FG000|Initial Treatment|Adverse Event|0|||
145732361|NCT04600336|525537625|FG001|Initial Treatment|Adverse Event|2|||
145732362|NCT04600336|525537626|FG002|Initial Treatment|Adverse Event|0|||
145732363|NCT04600336|525537627|FG003|Initial Treatment|Adverse Event|0|||
145732364|NCT04600336|525537624|FG000|Initial Treatment|Other complicating disease|0|||
145732365|NCT04600336|525537625|FG001|Initial Treatment|Other complicating disease|0|||
145732366|NCT04600336|525537626|FG002|Initial Treatment|Other complicating disease|1|||
145732367|NCT04600336|525537627|FG003|Initial Treatment|Other complicating disease|0|||
145732368|NCT04600336|525537624|FG000|Crossover Treatment|Withdrawal by Subject|0|||
145732369|NCT04600336|525537625|FG001|Crossover Treatment|Withdrawal by Subject|0|||
145732370|NCT04600336|525537626|FG002|Crossover Treatment|Withdrawal by Subject|2|||
145732371|NCT04600336|525537627|FG003|Crossover Treatment|Withdrawal by Subject|1|||
145732372|NCT04600336|525537624|FG000|Crossover Treatment|Adverse Event|0|||
145732373|NCT04600336|525537625|FG001|Crossover Treatment|Adverse Event|0|||
145732374|NCT04600336|525537626|FG002|Crossover Treatment|Adverse Event|1|||
145732375|NCT04600336|525537627|FG003|Crossover Treatment|Adverse Event|1|||
145497755|NCT00092417|524681893|FG001|Overall Study|Lost to Follow-up|0|||
145497756|NCT00092417|524681892|FG000|Overall Study|Withdrawal by Subject|2|||
145497757|NCT00092417|524681893|FG001|Overall Study|Withdrawal by Subject|1|||
145266677|NCT04668066|523825249|FG012|Part 1: Follow-Up|Adverse Event|0|||
145497758|NCT00092417|524681892|FG000|Overall Study|Other|1|||
145497759|NCT00092417|524681893|FG001|Overall Study|Other|0|||
145497760|NCT01520506|524681894|FG000|Overall Study|Missed Visit|4|||
145497761|NCT01520506|524681894|FG000|Overall Study|Lost to Follow-up|1|||
145497762|NCT01520506|524681894|FG000|Overall Study|Withdrawal by Subject|1|||
145497763|NCT00425269|524681895|FG000|Overall Study|Pregnancy|5|||
145497764|NCT00425269|524681896|FG001|Overall Study|Pregnancy|7|||
145497765|NCT00425269|524681895|FG000|Overall Study|Lost to Follow-up|9|||
145497766|NCT00425269|524681896|FG001|Overall Study|Lost to Follow-up|9|||
145497767|NCT00425269|524681895|FG000|Overall Study|moved or medical reason|5|||
145497768|NCT00425269|524681896|FG001|Overall Study|moved or medical reason|4|||
145395910|NCT02227784|524304921|FG001|Double-Blind Phase|Sponsor Decision|15|||
145395911|NCT02227784|524304922|FG002|Double-Blind Phase|Sponsor Decision|14|||
145395912|NCT02227784|524304923|FG003|Double-Blind Phase|Sponsor Decision|32|||
145395913|NCT02227784|524304924|FG004|Double-Blind Phase|Sponsor Decision|0|||
145395914|NCT02227784|524304920|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
145395915|NCT02227784|524304921|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
145395916|NCT02227784|524304922|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
145395917|NCT02227784|524304923|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
145395918|NCT02227784|524304924|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145395919|NCT02227784|524304920|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145395920|NCT02227784|524304921|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145395921|NCT02227784|524304922|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145395922|NCT02227784|524304923|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
145395923|NCT02227784|524304924|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
145395924|NCT02227784|524304920|FG000|Open-Label Extension Phase (OLE)|Death|0|||
145395925|NCT02227784|524304921|FG001|Open-Label Extension Phase (OLE)|Death|0|||
145395926|NCT02227784|524304922|FG002|Open-Label Extension Phase (OLE)|Death|0|||
145395927|NCT02227784|524304923|FG003|Open-Label Extension Phase (OLE)|Death|0|||
145395928|NCT02227784|524304924|FG004|Open-Label Extension Phase (OLE)|Death|1|||
145395929|NCT02227784|524304920|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145395930|NCT02227784|524304921|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145395931|NCT02227784|524304922|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145395932|NCT02227784|524304923|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145395933|NCT02227784|524304924|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
145395934|NCT02227784|524304920|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145395935|NCT02227784|524304921|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145395936|NCT02227784|524304922|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145497769|NCT01084655|524681899|FG000|Overall Study|Radiographic disease progression|3|||
145497770|NCT01084655|524681900|FG001|Overall Study|Radiographic disease progression|2|||
145497771|NCT01084655|524681901|FG002|Overall Study|Radiographic disease progression|8|||
145497772|NCT01084655|524681899|FG000|Overall Study|Withdrawal by Subject|1|||
145497773|NCT01084655|524681900|FG001|Overall Study|Withdrawal by Subject|0|||
145497774|NCT01084655|524681901|FG002|Overall Study|Withdrawal by Subject|4|||
145732376|NCT04739800|525537628|FG000|Overall Study|Adverse Event|2|||
145732377|NCT04739800|525537629|FG001|Overall Study|Adverse Event|1|||
145497775|NCT01084655|524681899|FG000|Overall Study|Adverse Event|2|||
145732378|NCT04739800|525537630|FG002|Overall Study|Adverse Event|4|||
145732379|NCT04739800|525537631|FG003|Overall Study|Adverse Event|5|||
145732380|NCT04739800|525537628|FG000|Overall Study|Never Treated|2|||
145732381|NCT04739800|525537629|FG001|Overall Study|Never Treated|0|||
145732382|NCT04739800|525537630|FG002|Overall Study|Never Treated|1|||
145732383|NCT04739800|525537631|FG003|Overall Study|Never Treated|1|||
145732384|NCT04739800|525537628|FG000|Overall Study|On Treatment|5|||
145732385|NCT04739800|525537629|FG001|Overall Study|On Treatment|9|||
145732386|NCT04739800|525537630|FG002|Overall Study|On Treatment|9|||
145732387|NCT04739800|525537631|FG003|Overall Study|On Treatment|9|||
145732388|NCT04739800|525537628|FG000|Overall Study|Symptomatic Deterioration|1|||
145732389|NCT04739800|525537629|FG001|Overall Study|Symptomatic Deterioration|1|||
145732390|NCT04739800|525537630|FG002|Overall Study|Symptomatic Deterioration|3|||
145732391|NCT04739800|525537631|FG003|Overall Study|Symptomatic Deterioration|0|||
145732392|NCT04739800|525537628|FG000|Overall Study|Withdrawal by Subject|1|||
145732393|NCT04739800|525537629|FG001|Overall Study|Withdrawal by Subject|2|||
145732394|NCT04739800|525537630|FG002|Overall Study|Withdrawal by Subject|1|||
145732395|NCT04739800|525537631|FG003|Overall Study|Withdrawal by Subject|3|||
145732396|NCT04739800|525537628|FG000|Overall Study|Other Reason|1|||
145732397|NCT04739800|525537629|FG001|Overall Study|Other Reason|3|||
145732398|NCT04739800|525537630|FG002|Overall Study|Other Reason|5|||
145732399|NCT04739800|525537631|FG003|Overall Study|Other Reason|4|||
145732400|NCT03808688|525539159|FG000|Overall Study|Adverse Event|13|||
145732401|NCT03808688|525539160|FG001|Overall Study|Adverse Event|17|||
145732402|NCT03808688|525539159|FG000|Overall Study|Lack of Efficacy|2|||
145732403|NCT03808688|525539160|FG001|Overall Study|Lack of Efficacy|0|||
145732404|NCT03808688|525539159|FG000|Overall Study|Lost to Follow-up|0|||
145732405|NCT03808688|525539160|FG001|Overall Study|Lost to Follow-up|2|||
145732406|NCT03808688|525539159|FG000|Overall Study|Withdrawal by Subject|1|||
145732407|NCT03808688|525539160|FG001|Overall Study|Withdrawal by Subject|0|||
145732408|NCT03808688|525539159|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
145732409|NCT03808688|525539160|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
145732410|NCT03808688|525539159|FG000|Overall Study|IOP Too High|1|||
145732411|NCT03808688|525539160|FG001|Overall Study|IOP Too High|1|||
145732412|NCT03808688|525539159|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
145732413|NCT03808688|525539160|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
145732414|NCT03808688|525539159|FG000|Overall Study|Visit Out of Window|0|||
145732415|NCT03808688|525539160|FG001|Overall Study|Visit Out of Window|1|||
145732416|NCT03808688|525539159|FG000|Overall Study|Medication Non-Compliance|0|||
145732417|NCT03808688|525539160|FG001|Overall Study|Medication Non-Compliance|1|||
145732418|NCT01940354|525539171|FG000|Overall Study|Withdrawal by Subject|4|||
145732419|NCT01940354|525539172|FG001|Overall Study|Withdrawal by Subject|2|||
145732420|NCT03756350|525539173|FG000|Overall Study|Lost to Follow-up|1|||
145732421|NCT01524133|525539176|FG000|Treatment Phase|Withdrawal by Subject|13|||
145732422|NCT01524133|525539177|FG001|Treatment Phase|Withdrawal by Subject|28|||
145732423|NCT01524133|525539178|FG002|Treatment Phase|Withdrawal by Subject|31|||
145732424|NCT01524133|525539176|FG000|Treatment Phase|Physician Decision|6|||
145732425|NCT01524133|525539177|FG001|Treatment Phase|Physician Decision|3|||
145732426|NCT01524133|525539178|FG002|Treatment Phase|Physician Decision|3|||
145732427|NCT01524133|525539176|FG000|Treatment Phase|Lost to Follow-up|0|||
145732428|NCT01524133|525539177|FG001|Treatment Phase|Lost to Follow-up|1|||
145732429|NCT01524133|525539178|FG002|Treatment Phase|Lost to Follow-up|2|||
145732430|NCT01524133|525539176|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
145732431|NCT01524133|525539177|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
145732432|NCT01524133|525539178|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
145732433|NCT01524133|525539176|FG000|Overall Study 52 Weeks|Physician Decision|1|||
145732434|NCT01524133|525539177|FG001|Overall Study 52 Weeks|Physician Decision|0|||
145732435|NCT01524133|525539178|FG002|Overall Study 52 Weeks|Physician Decision|2|||
145732436|NCT01524133|525539176|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
145732437|NCT01524133|525539177|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
145732438|NCT01524133|525539178|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
145732439|NCT04964960|525539179|FG000|Overall Study|Withdrawal by Subject|1|||
145732440|NCT04964960|525539179|FG000|Overall Study|Did not complete cycles|1|||
145732441|NCT01423812|525539180|FG000|Overall Study|Lost to Follow-up|2|||
145732442|NCT01423812|525539181|FG001|Overall Study|Lost to Follow-up|2|||
145497776|NCT01084655|524681900|FG001|Overall Study|Adverse Event|1|||
145497777|NCT01084655|524681901|FG002|Overall Study|Adverse Event|2|||
145497778|NCT01084655|524681899|FG000|Overall Study|Other|0|||
145497779|NCT01084655|524681900|FG001|Overall Study|Other|3|||
145497780|NCT01084655|524681901|FG002|Overall Study|Other|2|||
145497781|NCT01084655|524681899|FG000|Overall Study|Symptomatic deterioration|0|||
145497782|NCT01084655|524681900|FG001|Overall Study|Symptomatic deterioration|0|||
145497783|NCT01084655|524681901|FG002|Overall Study|Symptomatic deterioration|2|||
145497784|NCT01084655|524681899|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
145497785|NCT01084655|524681900|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
145497786|NCT01084655|524681901|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
145497787|NCT01256788|524681902|FG000|Overall Study|Lost to Follow-up|5|||
145497788|NCT01256788|524681903|FG001|Overall Study|Lost to Follow-up|8|||
145497789|NCT01256788|524681904|FG002|Overall Study|Lost to Follow-up|3|||
145497790|NCT00906204|524681905|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
145497791|NCT00906204|524681906|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
145497792|NCT00906204|524681905|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
145497793|NCT00906204|524681906|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
145497794|NCT00906204|524681905|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
145497795|NCT00906204|524681906|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
145497796|NCT00906204|524681905|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
145497797|NCT00906204|524681906|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
145497798|NCT00906204|524681905|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
145497799|NCT00906204|524681906|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
145497800|NCT00744497|524681907|FG000|Overall Study|Withdrawal by Subject|21|||
145732443|NCT01423812|525539180|FG000|Overall Study|Withdrawal by Subject|1|||
145732444|NCT01423812|525539181|FG001|Overall Study|Withdrawal by Subject|2|||
145732445|NCT03155373|525539182|FG000|Overall Study|No longer required surgery|1|||
145732446|NCT03155373|525539182|FG000|Overall Study|Protocol Violation|1|||
145732447|NCT03155373|525539182|FG000|Overall Study|Death|2|||
145732448|NCT03155373|525539182|FG000|Overall Study|Withdrawal by Subject|3|||
145732449|NCT02616614|525539183|FG000|Overall Study|Withdrawal by Subject|10|||
145732450|NCT02616614|525539184|FG001|Overall Study|Withdrawal by Subject|5|||
145732451|NCT02616614|525539185|FG002|Overall Study|Withdrawal by Subject|6|||
145732452|NCT02616614|525539183|FG000|Overall Study|Physician Decision|2|||
145732453|NCT02616614|525539184|FG001|Overall Study|Physician Decision|1|||
145732454|NCT02616614|525539185|FG002|Overall Study|Physician Decision|0|||
145732455|NCT02616614|525539183|FG000|Overall Study|Adverse Event|1|||
145732456|NCT02616614|525539184|FG001|Overall Study|Adverse Event|4|||
145732457|NCT02616614|525539185|FG002|Overall Study|Adverse Event|1|||
145732458|NCT02616614|525539183|FG000|Overall Study|Protocol Violation|0|||
145732459|NCT02616614|525539184|FG001|Overall Study|Protocol Violation|3|||
145732460|NCT02616614|525539185|FG002|Overall Study|Protocol Violation|1|||
145732461|NCT02616614|525539183|FG000|Overall Study|Prohibited Medication|12|||
145732462|NCT02616614|525539184|FG001|Overall Study|Prohibited Medication|9|||
145732463|NCT02616614|525539185|FG002|Overall Study|Prohibited Medication|5|||
145732464|NCT02616614|525539183|FG000|Overall Study|More than 3 applications missed|6|||
145732465|NCT02616614|525539184|FG001|Overall Study|More than 3 applications missed|8|||
145732466|NCT02616614|525539185|FG002|Overall Study|More than 3 applications missed|1|||
145732467|NCT02616614|525539183|FG000|Overall Study|Lost to Follow-up|31|||
145732468|NCT02616614|525539184|FG001|Overall Study|Lost to Follow-up|28|||
145732469|NCT02616614|525539185|FG002|Overall Study|Lost to Follow-up|13|||
145732470|NCT02616614|525539183|FG000|Overall Study|Pregnancy|2|||
145732471|NCT02616614|525539184|FG001|Overall Study|Pregnancy|0|||
145732472|NCT02616614|525539185|FG002|Overall Study|Pregnancy|1|||
145732473|NCT02616614|525539183|FG000|Overall Study|Other|1|||
145732474|NCT02616614|525539184|FG001|Overall Study|Other|2|||
145732475|NCT02616614|525539185|FG002|Overall Study|Other|1|||
145732476|NCT01214187|525539188|FG000|Overall Study|Adverse Event|6|||
145732477|NCT01214187|525539189|FG001|Overall Study|Adverse Event|2|||
145732478|NCT01214187|525539188|FG000|Overall Study|Death|1|||
145732479|NCT01214187|525539189|FG001|Overall Study|Death|1|||
145732480|NCT01214187|525539188|FG000|Overall Study|Withdrawal by Subject|0|||
145732481|NCT01214187|525539189|FG001|Overall Study|Withdrawal by Subject|3|||
145732482|NCT01233869|525539190|FG000|Initial Treatment Period (24 Months)|Death|1|||
145732483|NCT01233869|525539191|FG001|Initial Treatment Period (24 Months)|Death|0|||
145732484|NCT01233869|525539192|FG002|Initial Treatment Period (24 Months)|Death|0|||
145732485|NCT01233869|525539193|FG003|Initial Treatment Period (24 Months)|Death|0|||
145732486|NCT01233869|525539190|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
145732487|NCT01233869|525539191|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
145732488|NCT01233869|525539192|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
145732489|NCT01233869|525539193|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
145732490|NCT01233869|525539190|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
145732491|NCT01233869|525539191|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
145497801|NCT00744497|524681908|FG001|Overall Study|Withdrawal by Subject|18|||
145497802|NCT00744497|524681907|FG000|Overall Study|Death|11|||
145497803|NCT00744497|524681908|FG001|Overall Study|Death|9|||
145497804|NCT00744497|524681907|FG000|Overall Study|Lost to Follow-up|4|||
145497805|NCT00744497|524681908|FG001|Overall Study|Lost to Follow-up|2|||
145497806|NCT00744497|524681907|FG000|Overall Study|Poor compliance/noncompliance|9|||
145497807|NCT00744497|524681908|FG001|Overall Study|Poor compliance/noncompliance|5|||
145497808|NCT00744497|524681907|FG000|Overall Study|No longer meets study criteria|7|||
145497809|NCT00744497|524681908|FG001|Overall Study|No longer meets study criteria|3|||
145497810|NCT00744497|524681907|FG000|Overall Study|Administrative Reason By Sponsor|25|||
145497811|NCT00744497|524681908|FG001|Overall Study|Administrative Reason By Sponsor|8|||
145497812|NCT00744497|524681907|FG000|Overall Study|Disease progression|312|||
145497813|NCT00744497|524681908|FG001|Overall Study|Disease progression|219|||
145497814|NCT00744497|524681907|FG000|Overall Study|Study drug toxicity|68|||
145497815|NCT00744497|524681908|FG001|Overall Study|Study drug toxicity|141|||
145497816|NCT00744497|524681907|FG000|Overall Study|Adverse event unrelated to study drug|78|||
145497817|NCT00744497|524681908|FG001|Overall Study|Adverse event unrelated to study drug|122|||
145497818|NCT00744497|524681907|FG000|Overall Study|Patient requested to stop study drug|65|||
145497819|NCT00744497|524681908|FG001|Overall Study|Patient requested to stop study drug|80|||
145497820|NCT00744497|524681907|FG000|Overall Study|Maximum clinical benefit|141|||
145497821|NCT00744497|524681908|FG001|Overall Study|Maximum clinical benefit|142|||
145497822|NCT00744497|524681907|FG000|Overall Study|Not defined|19|||
145497823|NCT00744497|524681908|FG001|Overall Study|Not defined|13|||
145497824|NCT03182374|524681913|FG000|Overall Study|Lost to Follow-up|3|||
145497825|NCT03182374|524681914|FG001|Overall Study|Lost to Follow-up|2|||
145497826|NCT03182374|524681913|FG000|Overall Study|Lack of Efficacy|8|||
145497827|NCT03182374|524681914|FG001|Overall Study|Lack of Efficacy|14|||
145497828|NCT03182374|524681913|FG000|Overall Study|Withdrawal by Subject|1|||
145497829|NCT03182374|524681914|FG001|Overall Study|Withdrawal by Subject|1|||
145497830|NCT03182374|524681913|FG000|Overall Study|exit for non-compliance|1|||
145497831|NCT03182374|524681914|FG001|Overall Study|exit for non-compliance|1|||
145497832|NCT03182374|524681913|FG000|Overall Study|one subject was randomized but not treated|1|||
145497833|NCT03182374|524681914|FG001|Overall Study|one subject was randomized but not treated|0|||
145497834|NCT03182374|524681913|FG000|Overall Study|Other reasons|0|||
145497835|NCT03182374|524681914|FG001|Overall Study|Other reasons|3|||
145497836|NCT03198715|524681918|FG000|Overall Study|Death|0|||
145497837|NCT03198715|524681919|FG001|Overall Study|Death|0|||
145497838|NCT03198715|524681920|FG002|Overall Study|Death|1|||
145497839|NCT03198715|524681921|FG003|Overall Study|Death|0|||
145395937|NCT02227784|524304923|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
145395938|NCT02227784|524304924|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
145395939|NCT02155699|524304925|FG000|Overall Study|Withdrawal by Subject|0|||
145395940|NCT02155699|524304926|FG001|Overall Study|Withdrawal by Subject|3|||
145395941|NCT02155699|524304927|FG002|Overall Study|Withdrawal by Subject|6|||
145395942|NCT02155699|524304928|FG003|Overall Study|Withdrawal by Subject|1|||
145395943|NCT02155699|524304925|FG000|Overall Study|Lost to Follow-up|0|||
145395944|NCT02155699|524304926|FG001|Overall Study|Lost to Follow-up|0|||
145395945|NCT02155699|524304927|FG002|Overall Study|Lost to Follow-up|0|||
145395946|NCT02155699|524304928|FG003|Overall Study|Lost to Follow-up|3|||
145395947|NCT02155699|524304925|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
145395948|NCT02155699|524304926|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
145395949|NCT02155699|524304927|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
145395950|NCT02155699|524304928|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
145395951|NCT04058028|524304929|FG000|Overall Study|Withdrawal of Consent from Study|12|||
145395952|NCT04058028|524304930|FG001|Overall Study|Withdrawal of Consent from Study|8|||
145395953|NCT04058028|524304931|FG002|Overall Study|Withdrawal of Consent from Study|6|||
145395954|NCT04058028|524304932|FG003|Overall Study|Withdrawal of Consent from Study|7|||
145395955|NCT04058028|524304929|FG000|Overall Study|Decision by Sponsor|13|||
145395956|NCT04058028|524304930|FG001|Overall Study|Decision by Sponsor|4|||
145395957|NCT04058028|524304931|FG002|Overall Study|Decision by Sponsor|1|||
145395958|NCT04058028|524304932|FG003|Overall Study|Decision by Sponsor|35|||
145395959|NCT04058028|524304929|FG000|Overall Study|Lost to Follow-up|1|||
145395960|NCT04058028|524304930|FG001|Overall Study|Lost to Follow-up|1|||
145395961|NCT04058028|524304931|FG002|Overall Study|Lost to Follow-up|1|||
145395962|NCT04058028|524304932|FG003|Overall Study|Lost to Follow-up|0|||
145395963|NCT04058028|524304929|FG000|Overall Study|Death|0|||
145395964|NCT04058028|524304930|FG001|Overall Study|Death|1|||
145395965|NCT04058028|524304931|FG002|Overall Study|Death|0|||
145395966|NCT04058028|524304932|FG003|Overall Study|Death|0|||
145395967|NCT04010461|524304933|FG000|Overall Study|COVID based withdrawal|5|||
145395968|NCT04010461|524304933|FG000|Overall Study|Withdrawal by Subject|5|||
145395969|NCT04010461|524304933|FG000|Overall Study|Adverse Event|1|||
145395970|NCT04010461|524304933|FG000|Overall Study|No Motor Threshold obtainable|1|||
145395971|NCT04010461|524304933|FG000|Overall Study|Physician Decision|1|||
145395972|NCT00485069|524304934|FG000|Overall Study|Adverse Event|10|||
145395973|NCT00485069|524304935|FG001|Overall Study|Adverse Event|4|||
145395974|NCT00485069|524304934|FG000|Overall Study|Lack of Efficacy|2|||
145395975|NCT00485069|524304935|FG001|Overall Study|Lack of Efficacy|1|||
145395976|NCT00485069|524304934|FG000|Overall Study|Protocol Violation|0|||
145395977|NCT00485069|524304935|FG001|Overall Study|Protocol Violation|1|||
145395978|NCT00485069|524304934|FG000|Overall Study|Withdrawal by Subject|6|||
145395979|NCT00485069|524304935|FG001|Overall Study|Withdrawal by Subject|6|||
145395980|NCT00102596|524304936|FG000|Part A|Screen failures|6|||
145395981|NCT00102596|524304937|FG001|Part A|Screen failures|0|||
145395982|NCT00102596|524304936|FG000|Part A|Adverse Event|1|||
145395983|NCT00102596|524304937|FG001|Part A|Adverse Event|0|||
145395984|NCT02688933|524304938|FG000|Overall Study|Adverse Event|3|||
145395985|NCT02688933|524304939|FG001|Overall Study|Adverse Event|1|||
145395986|NCT02688933|524304938|FG000|Overall Study|Lack of Efficacy|2|||
145395987|NCT02688933|524304939|FG001|Overall Study|Lack of Efficacy|2|||
145395988|NCT02688933|524304938|FG000|Overall Study|Poor compliance to protocol|7|||
145395989|NCT02688933|524304939|FG001|Overall Study|Poor compliance to protocol|4|||
145395990|NCT02688933|524304938|FG000|Overall Study|Hypoglycemia|2|||
145395991|NCT02688933|524304939|FG001|Overall Study|Hypoglycemia|0|||
145395992|NCT02688933|524304938|FG000|Overall Study|Other than Specified|14|||
145395993|NCT02688933|524304939|FG001|Overall Study|Other than Specified|25|||
145395994|NCT02688933|524304938|FG000|Overall Study|Lost to Follow-up|1|||
145395995|NCT02688933|524304939|FG001|Overall Study|Lost to Follow-up|5|||
145395996|NCT01365130|524304942|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
145395997|NCT05547386|524304943|FG000|Overall Study|Withdrawal by Subject|7|||
145395998|NCT04622969|524304944|FG000|Overall Study|Withdrawal by Subject|2|||
145395999|NCT04622969|524304945|FG001|Overall Study|Withdrawal by Subject|3|||
145396000|NCT05616013|524304946|FG000|Overall Study|Adverse Event|6|||
145732492|NCT01233869|525539192|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
145732493|NCT01233869|525539193|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
145732494|NCT01233869|525539190|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
145732495|NCT01233869|525539191|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
145732496|NCT01233869|525539192|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
145732497|NCT01233869|525539193|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
145732498|NCT01233869|525539190|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
145732499|NCT01233869|525539191|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
145732500|NCT01233869|525539192|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
145732501|NCT01233869|525539193|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
145732502|NCT01233869|525539190|FG000|Extended Treatment Period (46 Months)|Other|3|||
145732503|NCT01233869|525539191|FG001|Extended Treatment Period (46 Months)|Other|0|||
145732504|NCT01233869|525539192|FG002|Extended Treatment Period (46 Months)|Other|0|||
145497840|NCT03198715|524681922|FG004|Overall Study|Death|2|||
145497841|NCT03198715|524681918|FG000|Overall Study|Other|0|||
145497842|NCT03198715|524681919|FG001|Overall Study|Other|1|||
145497843|NCT03198715|524681920|FG002|Overall Study|Other|1|||
145497844|NCT03198715|524681921|FG003|Overall Study|Other|0|||
145497845|NCT03198715|524681922|FG004|Overall Study|Other|0|||
145497846|NCT00914316|524681927|FG000|Phase 1|Physician Decision|4|||
145497847|NCT00914316|524681928|FG001|Phase 1|Physician Decision|0|||
145497848|NCT00914316|524681929|FG002|Phase 1|Physician Decision|1|||
145497849|NCT00914316|524681930|FG003|Phase 1|Physician Decision|2|||
145497850|NCT00914316|524681927|FG000|Phase 1|Withdrawal by Subject|0|||
145497851|NCT00914316|524681928|FG001|Phase 1|Withdrawal by Subject|2|||
145497852|NCT00914316|524681929|FG002|Phase 1|Withdrawal by Subject|4|||
145497853|NCT00914316|524681930|FG003|Phase 1|Withdrawal by Subject|0|||
145497854|NCT00914316|524681927|FG000|Phase 1|Adverse Event|1|||
145497855|NCT00914316|524681928|FG001|Phase 1|Adverse Event|0|||
145497856|NCT00914316|524681929|FG002|Phase 1|Adverse Event|0|||
145497857|NCT00914316|524681930|FG003|Phase 1|Adverse Event|0|||
145497858|NCT00914316|524681927|FG000|Phase 2|Withdrawal by Subject|1|||
145497859|NCT00914316|524681928|FG001|Phase 2|Withdrawal by Subject|0|||
145497860|NCT00914316|524681929|FG002|Phase 2|Withdrawal by Subject|1|||
145497861|NCT00914316|524681930|FG003|Phase 2|Withdrawal by Subject|0|||
145497862|NCT02399163|524681934|FG000|Overall Study|Adverse Event|2|||
145497863|NCT02399163|524681934|FG000|Overall Study|Protocol Deviation|2|||
145497864|NCT02399163|524681934|FG000|Overall Study|Withdrawal by Participant|5|||
145497865|NCT01391546|524681940|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
145497866|NCT01391546|524681941|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
145497867|NCT04225897|524681947|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497868|NCT04225897|524681948|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
145497869|NCT04225897|524681949|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497870|NCT04225897|524681950|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497871|NCT04225897|524681951|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145396001|NCT05616013|524304947|FG001|Overall Study|Adverse Event|12|||
145396002|NCT05616013|524304948|FG002|Overall Study|Adverse Event|8|||
145396003|NCT05616013|524304949|FG003|Overall Study|Adverse Event|4|||
145396004|NCT05616013|524304950|FG004|Overall Study|Adverse Event|6|||
145396005|NCT05616013|524304951|FG005|Overall Study|Adverse Event|8|||
145396006|NCT05616013|524304952|FG006|Overall Study|Adverse Event|3|||
145396007|NCT05616013|524304953|FG007|Overall Study|Adverse Event|6|||
145497872|NCT04225897|524681952|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497873|NCT04225897|524681953|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497874|NCT04225897|524681954|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497875|NCT04225897|524681955|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497876|NCT04225897|524681956|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145396008|NCT05616013|524304954|FG008|Overall Study|Adverse Event|1|||
145266678|NCT04668066|523825250|FG013|Part 1: Follow-Up|Adverse Event|0|||
145396009|NCT05616013|524304946|FG000|Overall Study|Lost to Follow-up|5|||
145396010|NCT05616013|524304947|FG001|Overall Study|Lost to Follow-up|4|||
145396011|NCT05616013|524304948|FG002|Overall Study|Lost to Follow-up|3|||
145396012|NCT05616013|524304949|FG003|Overall Study|Lost to Follow-up|2|||
145396013|NCT05616013|524304950|FG004|Overall Study|Lost to Follow-up|0|||
145396014|NCT05616013|524304951|FG005|Overall Study|Lost to Follow-up|5|||
145396015|NCT05616013|524304952|FG006|Overall Study|Lost to Follow-up|2|||
145396016|NCT05616013|524304953|FG007|Overall Study|Lost to Follow-up|1|||
145396017|NCT05616013|524304954|FG008|Overall Study|Lost to Follow-up|2|||
145396018|NCT05616013|524304946|FG000|Overall Study|Non-compliance with study requirements|2|||
145396019|NCT05616013|524304947|FG001|Overall Study|Non-compliance with study requirements|2|||
145396020|NCT05616013|524304948|FG002|Overall Study|Non-compliance with study requirements|2|||
145396021|NCT05616013|524304949|FG003|Overall Study|Non-compliance with study requirements|3|||
145396022|NCT05616013|524304950|FG004|Overall Study|Non-compliance with study requirements|0|||
145396023|NCT05616013|524304951|FG005|Overall Study|Non-compliance with study requirements|2|||
145396024|NCT05616013|524304952|FG006|Overall Study|Non-compliance with study requirements|1|||
145396025|NCT05616013|524304953|FG007|Overall Study|Non-compliance with study requirements|1|||
145396026|NCT05616013|524304954|FG008|Overall Study|Non-compliance with study requirements|4|||
145396027|NCT05616013|524304946|FG000|Overall Study|Withdrawal by Subject|11|||
145396028|NCT05616013|524304947|FG001|Overall Study|Withdrawal by Subject|9|||
145396029|NCT05616013|524304948|FG002|Overall Study|Withdrawal by Subject|8|||
145396030|NCT05616013|524304949|FG003|Overall Study|Withdrawal by Subject|6|||
145396031|NCT05616013|524304950|FG004|Overall Study|Withdrawal by Subject|3|||
145396032|NCT05616013|524304951|FG005|Overall Study|Withdrawal by Subject|4|||
145396033|NCT05616013|524304952|FG006|Overall Study|Withdrawal by Subject|6|||
145396034|NCT05616013|524304953|FG007|Overall Study|Withdrawal by Subject|5|||
145396035|NCT05616013|524304954|FG008|Overall Study|Withdrawal by Subject|4|||
145396036|NCT05616013|524304946|FG000|Overall Study|Physician Decision|0|||
145396037|NCT05616013|524304947|FG001|Overall Study|Physician Decision|0|||
145396038|NCT05616013|524304948|FG002|Overall Study|Physician Decision|1|||
145396039|NCT05616013|524304949|FG003|Overall Study|Physician Decision|0|||
145396040|NCT05616013|524304950|FG004|Overall Study|Physician Decision|0|||
145396041|NCT05616013|524304951|FG005|Overall Study|Physician Decision|1|||
145396042|NCT05616013|524304952|FG006|Overall Study|Physician Decision|3|||
145396043|NCT05616013|524304953|FG007|Overall Study|Physician Decision|0|||
145396044|NCT05616013|524304954|FG008|Overall Study|Physician Decision|0|||
145396045|NCT05616013|524304946|FG000|Overall Study|Protocol Violation|0|||
145396046|NCT05616013|524304947|FG001|Overall Study|Protocol Violation|0|||
145396047|NCT05616013|524304948|FG002|Overall Study|Protocol Violation|0|||
145396048|NCT05616013|524304949|FG003|Overall Study|Protocol Violation|0|||
145396049|NCT05616013|524304950|FG004|Overall Study|Protocol Violation|0|||
145396050|NCT05616013|524304951|FG005|Overall Study|Protocol Violation|0|||
145396051|NCT05616013|524304952|FG006|Overall Study|Protocol Violation|1|||
145396052|NCT05616013|524304953|FG007|Overall Study|Protocol Violation|0|||
145396053|NCT05616013|524304954|FG008|Overall Study|Protocol Violation|2|||
145396054|NCT05616013|524304946|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
145396055|NCT05616013|524304947|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396056|NCT05616013|524304948|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396057|NCT05616013|524304949|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396058|NCT05616013|524304950|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396059|NCT05616013|524304951|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396060|NCT05616013|524304952|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396061|NCT05616013|524304953|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396062|NCT05616013|524304954|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
145396063|NCT05616013|524304946|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
145396064|NCT05616013|524304947|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396065|NCT05616013|524304948|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396066|NCT05616013|524304949|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396067|NCT05616013|524304950|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396068|NCT05616013|524304951|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396069|NCT05616013|524304952|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396070|NCT05616013|524304953|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396071|NCT05616013|524304954|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
145396072|NCT05616013|524304946|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
145396073|NCT05616013|524304947|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396074|NCT05616013|524304948|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396075|NCT05616013|524304949|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396076|NCT05616013|524304950|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396077|NCT05616013|524304951|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396078|NCT05616013|524304952|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396079|NCT05616013|524304953|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396080|NCT05616013|524304954|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
145396081|NCT05616013|524304946|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396082|NCT05616013|524304947|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
145396083|NCT05616013|524304948|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396084|NCT05616013|524304949|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396085|NCT05616013|524304950|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396086|NCT05616013|524304951|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396087|NCT05616013|524304952|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145732505|NCT01233869|525539193|FG003|Extended Treatment Period (46 Months)|Other|3|||
145732506|NCT01233869|525539190|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
145732507|NCT01233869|525539191|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
145732508|NCT01233869|525539192|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
145732509|NCT01233869|525539193|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
145732510|NCT01975428|525539197|FG000|Overall Study|Lost to Follow-up|17|||
145732511|NCT01975428|525539198|FG001|Overall Study|Lost to Follow-up|4|||
145732512|NCT01975428|525539197|FG000|Overall Study|Withdrawal by Subject|3|||
145732513|NCT01975428|525539198|FG001|Overall Study|Withdrawal by Subject|10|||
145732514|NCT00628251|525539199|FG000|Randomised Part|Withdrawal by Subject|0|||
145732515|NCT00628251|525539200|FG001|Randomised Part|Withdrawal by Subject|0|||
145732516|NCT00628251|525539201|FG002|Randomised Part|Withdrawal by Subject|1|||
145732517|NCT00628251|525539199|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
145732518|NCT00628251|525539200|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
145732519|NCT00628251|525539201|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
145732520|NCT00628251|525539199|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
145732521|NCT00628251|525539200|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
145732522|NCT00628251|525539201|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
145732523|NCT00628251|525539199|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
145732524|NCT00628251|525539200|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
145732525|NCT00628251|525539201|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
145732526|NCT00628251|525539199|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
145732527|NCT00628251|525539200|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
145732528|NCT00628251|525539201|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
145732529|NCT00628251|525539199|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
145732530|NCT00628251|525539200|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
145732531|NCT00628251|525539201|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
145732532|NCT01237340|525539208|FG000|Overall Study|Adverse Event|3|||
145732533|NCT01237340|525539208|FG000|Overall Study|Withdrawal by Subject|1|||
145732534|NCT01237340|525539208|FG000|Overall Study|Early termination of the trial|36|||
145732535|NCT01610687|525539209|FG000|Overall Study|Lack of Efficacy|26|||
145732536|NCT01610687|525539209|FG000|Overall Study|Adverse Event|18|||
145732537|NCT01610687|525539209|FG000|Overall Study|Moved out of area|6|||
145732538|NCT01610687|525539209|FG000|Overall Study|Withdrawal by Subject|7|||
145732539|NCT01610687|525539209|FG000|Overall Study|Lost to Follow-up|4|||
145732540|NCT01610687|525539209|FG000|Overall Study|Symptom control without study medication|2|||
145732541|NCT01610687|525539209|FG000|Overall Study|Unable to make journey|1|||
145732542|NCT01610687|525539209|FG000|Overall Study|Death|1|||
145732543|NCT01610687|525539209|FG000|Overall Study|Cannabis affecting job|1|||
145732544|NCT01610687|525539209|FG000|Overall Study|Felt more alter without study medication|1|||
145732545|NCT03836807|525539210|FG000|Overall Study|Physician Decision|1|||
145732546|NCT03836807|525539211|FG001|Overall Study|Physician Decision|0|||
145732547|NCT01272947|525539212|FG000|Overall Study|Abnormal Laboratory Value|2|||
145732548|NCT01272947|525539213|FG001|Overall Study|Abnormal Laboratory Value|2|||
145732549|NCT02019420|525539216|FG000|Overall Study|Did not receive study drug|2|||
145732550|NCT02019420|525539217|FG001|Overall Study|Did not receive study drug|2|||
145732551|NCT02019420|525539216|FG000|Overall Study|Withdrawal by Subject|1|||
145732552|NCT02019420|525539217|FG001|Overall Study|Withdrawal by Subject|3|||
145732553|NCT02019420|525539216|FG000|Overall Study|At request of sponsor or investigator|0|||
145732554|NCT02019420|525539217|FG001|Overall Study|At request of sponsor or investigator|1|||
145732555|NCT02019420|525539216|FG000|Overall Study|Death|104|||
145732556|NCT02019420|525539217|FG001|Overall Study|Death|99|||
145732557|NCT02019420|525539216|FG000|Overall Study|Transferred to other care facility|1|||
145732558|NCT02019420|525539217|FG001|Overall Study|Transferred to other care facility|1|||
145732559|NCT00882310|525539222|FG000|Overall Study|Screen Failure|10|||
145732560|NCT00882310|525539222|FG000|Overall Study|Never received treatment|1|||
145732561|NCT00882310|525539222|FG000|Overall Study|Death|6|||
145732562|NCT00882310|525539222|FG000|Overall Study|Progression of disease|4|||
145732563|NCT00882310|525539222|FG000|Overall Study|Adverse Event|1|||
145732564|NCT01093625|525539223|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
145732565|NCT01093625|525539224|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
145732566|NCT01093625|525539223|FG000|2-Week Visit|Withdrawal by Subject|1|||
145732567|NCT01093625|525539224|FG001|2-Week Visit|Withdrawal by Subject|0|||
145732568|NCT01093625|525539223|FG000|1-Month Visit|Lost to Follow-up|2|||
145732569|NCT01093625|525539224|FG001|1-Month Visit|Lost to Follow-up|0|||
145732570|NCT01093625|525539223|FG000|3-Month Visit|Lost to Follow-up|2|||
145732571|NCT01093625|525539224|FG001|3-Month Visit|Lost to Follow-up|0|||
145732572|NCT01093625|525539223|FG000|6-Month Visit|Withdrawal by Subject|6|||
145732573|NCT01093625|525539224|FG001|6-Month Visit|Withdrawal by Subject|7|||
145732574|NCT01093625|525539223|FG000|6-Month Visit|Lost to Follow-up|2|||
145497877|NCT04225897|524681957|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497878|NCT04225897|524681958|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
145497879|NCT04225897|524681947|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497880|NCT04225897|524681948|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497881|NCT04225897|524681949|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
145497882|NCT04225897|524681950|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497883|NCT04225897|524681951|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497884|NCT04225897|524681952|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497885|NCT04225897|524681953|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145605963|NCT00638235|525073059|FG001|Overall Study|Lost to Follow-up|3|||
145732575|NCT01093625|525539224|FG001|6-Month Visit|Lost to Follow-up|2|||
145732576|NCT01093625|525539223|FG000|1-Year Visit|Lost to Follow-up|5|||
145732577|NCT01093625|525539224|FG001|1-Year Visit|Lost to Follow-up|3|||
145732578|NCT04233164|525539229|FG000|Overall Study|Unable to obtain specimen|0|||
145732579|NCT04233164|525539230|FG001|Overall Study|Unable to obtain specimen|1|||
145732580|NCT01843218|525539235|FG000|Overall Study|Withdrawal by Subject|5|||
145732581|NCT01431534|525539236|FG000|Treatment Phase|Adverse Event|0|||
145732582|NCT01431534|525539237|FG001|Treatment Phase|Adverse Event|0|||
145732583|NCT01431534|525539238|FG002|Treatment Phase|Adverse Event|1|||
145732584|NCT01431534|525539236|FG000|Treatment Phase|Progressive Disease|4|||
145732585|NCT01431534|525539237|FG001|Treatment Phase|Progressive Disease|3|||
145732586|NCT01431534|525539238|FG002|Treatment Phase|Progressive Disease|10|||
145732587|NCT01009554|525539239|FG000|Overall Study|Adverse Event|1|||
145732588|NCT01009554|525539240|FG001|Overall Study|Adverse Event|1|||
145732589|NCT01009554|525539239|FG000|Overall Study|Withdrawal by Subject|1|||
145732590|NCT01009554|525539240|FG001|Overall Study|Withdrawal by Subject|3|||
145732591|NCT01009554|525539239|FG000|Overall Study|Noncompliant with Study Product|0|||
145732592|NCT01009554|525539240|FG001|Overall Study|Noncompliant with Study Product|3|||
145732593|NCT01605253|525539241|FG000|Overall Study|Physician Decision|3|||
145732594|NCT01605253|525539242|FG001|Overall Study|Physician Decision|2|||
145732595|NCT01605253|525539241|FG000|Overall Study|Lost to Follow-up|3|||
145732596|NCT01605253|525539242|FG001|Overall Study|Lost to Follow-up|1|||
145732597|NCT00835120|525539249|FG000|Overall Study|Lack of Efficacy|1|||
145732598|NCT00835120|525539249|FG000|Overall Study|Lost to Follow-up|3|||
145732599|NCT00835120|525539249|FG000|Overall Study|Adverse Event|2|||
145732600|NCT00835120|525539249|FG000|Overall Study|Withdrawal by Subject|2|||
145732601|NCT00708175|525539258|FG000|Overall Study|Adverse Event|4|||
145732602|NCT00708175|525539259|FG001|Overall Study|Adverse Event|5|||
145732603|NCT00708175|525539258|FG000|Overall Study|Protocol Violation|2|||
145732604|NCT00708175|525539259|FG001|Overall Study|Protocol Violation|3|||
145732605|NCT00708175|525539258|FG000|Overall Study|Lost to Follow-up|5|||
145732606|NCT00708175|525539259|FG001|Overall Study|Lost to Follow-up|3|||
145732607|NCT00708175|525539258|FG000|Overall Study|Withdrawal by Subject|5|||
145732608|NCT00708175|525539259|FG001|Overall Study|Withdrawal by Subject|7|||
145732609|NCT00708175|525539258|FG000|Overall Study|BMD loss >7%|2|||
145732610|NCT00708175|525539259|FG001|Overall Study|BMD loss >7%|3|||
145732611|NCT02038920|525539261|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
145732612|NCT02038920|525539262|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
145732613|NCT02038920|525539263|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
145732614|NCT02038920|525539264|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
145732615|NCT02038920|525539265|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
145732616|NCT02038920|525539266|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
145732617|NCT02038920|525539261|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
145732618|NCT02038920|525539262|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145732619|NCT02038920|525539263|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145732620|NCT02038920|525539264|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145732621|NCT02038920|525539265|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145732622|NCT02038920|525539266|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
145732623|NCT02038920|525539261|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
145732624|NCT02038920|525539262|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
145732625|NCT02038920|525539263|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145732626|NCT02038920|525539264|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145732627|NCT02038920|525539265|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145732628|NCT02038920|525539266|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
145732629|NCT02038920|525539261|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
145732630|NCT02038920|525539262|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
145732631|NCT02038920|525539263|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
145732632|NCT02038920|525539264|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
145732633|NCT02038920|525539265|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
145497886|NCT04225897|524681954|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497887|NCT04225897|524681955|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497888|NCT04225897|524681956|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497889|NCT04225897|524681957|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497890|NCT04225897|524681958|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
145497891|NCT04225897|524681947|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497892|NCT04225897|524681948|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497893|NCT04225897|524681949|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
145497894|NCT04225897|524681950|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497895|NCT04225897|524681951|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497896|NCT04225897|524681952|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497897|NCT04225897|524681953|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497898|NCT04225897|524681954|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497899|NCT04225897|524681955|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497900|NCT04225897|524681956|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497901|NCT04225897|524681957|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497902|NCT04225897|524681958|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
145497903|NCT04225897|524681947|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497904|NCT04225897|524681948|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497905|NCT04225897|524681949|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497906|NCT04225897|524681950|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497907|NCT04225897|524681951|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497908|NCT04225897|524681952|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497909|NCT04225897|524681953|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497910|NCT04225897|524681954|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
145497911|NCT04225897|524681955|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497912|NCT04225897|524681956|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497913|NCT04225897|524681957|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497914|NCT04225897|524681958|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
145497915|NCT00074711|524681960|FG000|Overall Study|Withdrawal by Subject|1|||
145497916|NCT00074711|524681961|FG001|Overall Study|Withdrawal by Subject|1|||
145497917|NCT00074711|524681960|FG000|Overall Study|Lost to Follow-up|10|||
145497918|NCT00074711|524681961|FG001|Overall Study|Lost to Follow-up|8|||
145497919|NCT00074711|524681960|FG000|Overall Study|Participant stopped study drug|4|||
145497920|NCT00074711|524681961|FG001|Overall Study|Participant stopped study drug|6|||
145497921|NCT03466658|524681962|FG000|Overall Study|Withdrawal by Subject|3|||
145497922|NCT00837434|524681963|FG000|Overall Study|Physician Decision|3|||
145497923|NCT00837434|524681964|FG001|Overall Study|Physician Decision|0|||
145497924|NCT00837434|524681963|FG000|Overall Study|Lost to Follow-up|1|||
145497925|NCT00837434|524681964|FG001|Overall Study|Lost to Follow-up|1|||
145497926|NCT00837434|524681963|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
145497927|NCT00837434|524681964|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
145497928|NCT00837434|524681963|FG000|Overall Study|Noncompliant|2|||
145497929|NCT00837434|524681964|FG001|Overall Study|Noncompliant|0|||
145497930|NCT00837434|524681963|FG000|Overall Study|Baseline assessments not done in time|1|||
145497931|NCT00837434|524681964|FG001|Overall Study|Baseline assessments not done in time|0|||
145497932|NCT00837434|524681963|FG000|Overall Study|Unable to obtain study drug|1|||
145497933|NCT00837434|524681964|FG001|Overall Study|Unable to obtain study drug|0|||
145497934|NCT01921205|524681965|FG000|Overall Study|Adverse Event|12|||
145497935|NCT01921205|524681966|FG001|Overall Study|Adverse Event|7|||
145497936|NCT01921205|524681965|FG000|Overall Study|Lack of Efficacy|1|||
145497937|NCT01921205|524681966|FG001|Overall Study|Lack of Efficacy|0|||
145497938|NCT01921205|524681965|FG000|Overall Study|Protocol Violation|1|||
145497939|NCT01921205|524681966|FG001|Overall Study|Protocol Violation|3|||
145497940|NCT01921205|524681965|FG000|Overall Study|Lost to Follow-up|1|||
145497941|NCT01921205|524681966|FG001|Overall Study|Lost to Follow-up|1|||
145497942|NCT01921205|524681965|FG000|Overall Study|Withdrawal by Subject|6|||
145497943|NCT01921205|524681966|FG001|Overall Study|Withdrawal by Subject|5|||
145497944|NCT01921205|524681965|FG000|Overall Study|Use Of Prohibited Medication|0|||
145497945|NCT01921205|524681966|FG001|Overall Study|Use Of Prohibited Medication|1|||
145497946|NCT01921205|524681965|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
145497947|NCT01921205|524681966|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
145497948|NCT01921205|524681965|FG000|Overall Study|Non Compliance Of The Parent|0|||
145497949|NCT01921205|524681966|FG001|Overall Study|Non Compliance Of The Parent|1|||
145497950|NCT01921205|524681965|FG000|Overall Study|Non Compliance Of Child|0|||
145497951|NCT01921205|524681966|FG001|Overall Study|Non Compliance Of Child|1|||
145497952|NCT00360230|524681967|FG000|Overall Study|Withdrawal by Subject|1|||
145497953|NCT00360230|524681968|FG001|Overall Study|Withdrawal by Subject|1|||
145497954|NCT00360230|524681969|FG002|Overall Study|Withdrawal by Subject|0|||
145497955|NCT00360230|524681970|FG003|Overall Study|Withdrawal by Subject|1|||
145497956|NCT00360230|524681971|FG004|Overall Study|Withdrawal by Subject|1|||
145497957|NCT00360230|524681972|FG005|Overall Study|Withdrawal by Subject|1|||
145497958|NCT00360230|524681973|FG006|Overall Study|Withdrawal by Subject|0|||
145497959|NCT00360230|524681967|FG000|Overall Study|Migrated|4|||
145497960|NCT00360230|524681968|FG001|Overall Study|Migrated|1|||
145497961|NCT00360230|524681969|FG002|Overall Study|Migrated|3|||
145497962|NCT00360230|524681970|FG003|Overall Study|Migrated|1|||
145497963|NCT00360230|524681971|FG004|Overall Study|Migrated|4|||
145497964|NCT00360230|524681972|FG005|Overall Study|Migrated|1|||
145497965|NCT00360230|524681973|FG006|Overall Study|Migrated|1|||
145497966|NCT00360230|524681967|FG000|Overall Study|Other|1|||
145497967|NCT00360230|524681968|FG001|Overall Study|Other|0|||
145497968|NCT00360230|524681969|FG002|Overall Study|Other|0|||
145497969|NCT00360230|524681970|FG003|Overall Study|Other|0|||
145497970|NCT00360230|524681971|FG004|Overall Study|Other|0|||
145497971|NCT00360230|524681972|FG005|Overall Study|Other|0|||
145497972|NCT00360230|524681973|FG006|Overall Study|Other|0|||
145497973|NCT00360230|524681967|FG000|Overall Study|Protocol Violation|0|||
145497974|NCT00360230|524681968|FG001|Overall Study|Protocol Violation|0|||
145497975|NCT00360230|524681969|FG002|Overall Study|Protocol Violation|0|||
145497976|NCT00360230|524681970|FG003|Overall Study|Protocol Violation|0|||
145497977|NCT00360230|524681971|FG004|Overall Study|Protocol Violation|0|||
145497978|NCT00360230|524681972|FG005|Overall Study|Protocol Violation|1|||
145497979|NCT00360230|524681973|FG006|Overall Study|Protocol Violation|0|||
145497980|NCT00360230|524681967|FG000|Overall Study|Death|0|||
145497981|NCT00360230|524681968|FG001|Overall Study|Death|1|||
145497982|NCT00360230|524681969|FG002|Overall Study|Death|0|||
145497983|NCT00360230|524681970|FG003|Overall Study|Death|0|||
145497984|NCT00360230|524681971|FG004|Overall Study|Death|0|||
145497985|NCT00360230|524681972|FG005|Overall Study|Death|1|||
145497986|NCT00360230|524681973|FG006|Overall Study|Death|1|||
145497987|NCT00456846|524681974|FG000|Overall Study|Adverse Event|2|||
145497988|NCT00456846|524681975|FG001|Overall Study|Adverse Event|15|||
145497989|NCT00456846|524681974|FG000|Overall Study|Physician Decision|11|||
145497990|NCT00456846|524681975|FG001|Overall Study|Physician Decision|6|||
145497991|NCT00456846|524681974|FG000|Overall Study|Protocol Deviation|2|||
145497992|NCT00456846|524681975|FG001|Overall Study|Protocol Deviation|0|||
145497993|NCT00456846|524681974|FG000|Overall Study|Participant Discretion|1|||
145497994|NCT00456846|524681975|FG001|Overall Study|Participant Discretion|5|||
145497995|NCT00456846|524681974|FG000|Overall Study|Other|0|||
145497996|NCT00456846|524681975|FG001|Overall Study|Other|2|||
145497997|NCT00910650|524681976|FG000|Overall Study|Death|2|||
145497998|NCT03367793|524681977|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
145497999|NCT03367793|524681978|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
145498000|NCT03367793|524681979|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
145498001|NCT03367793|524681980|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
145498002|NCT03367793|524681981|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
145498003|NCT03367793|524681982|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
145498004|NCT00260533|524681983|FG000|Overall Study|Other|3|||
145498005|NCT00260533|524681984|FG001|Overall Study|Other|3|||
145498006|NCT00003475|524681985|FG000|Overall Study|Not evaluable|13|||
145498007|NCT04682366|524681986|FG000|Overall Study|Lost to Follow-up|1|||
145498008|NCT04682366|524681987|FG001|Overall Study|Lost to Follow-up|1|||
145498009|NCT02224560|524681992|FG000|Overall Study|Protocol Deviation|1|||
145498010|NCT02224560|524681993|FG001|Overall Study|Protocol Deviation|0|||
145498011|NCT02224560|524681994|FG002|Overall Study|Protocol Deviation|0|||
145498012|NCT02224560|524681992|FG000|Overall Study|Withdrawal by Subject|2|||
145498013|NCT02224560|524681993|FG001|Overall Study|Withdrawal by Subject|0|||
145498014|NCT02224560|524681994|FG002|Overall Study|Withdrawal by Subject|1|||
145498015|NCT02224560|524681992|FG000|Overall Study|Met Withdrawal Criteria|1|||
145498016|NCT02224560|524681993|FG001|Overall Study|Met Withdrawal Criteria|0|||
145498017|NCT02224560|524681994|FG002|Overall Study|Met Withdrawal Criteria|0|||
145498018|NCT02224560|524681992|FG000|Overall Study|Adverse Event|4|||
145498019|NCT02224560|524681993|FG001|Overall Study|Adverse Event|1|||
145498020|NCT02224560|524681994|FG002|Overall Study|Adverse Event|1|||
145498021|NCT02224560|524681992|FG000|Overall Study|Withdrawn by Investigator|1|||
145498022|NCT02224560|524681993|FG001|Overall Study|Withdrawn by Investigator|1|||
145498023|NCT02224560|524681994|FG002|Overall Study|Withdrawn by Investigator|0|||
145498024|NCT04543279|524681995|FG000|Overall Study|Withdrawal by Subject|1|||
145498025|NCT04543279|524681996|FG001|Overall Study|Withdrawal by Subject|0|||
145498026|NCT04543279|524681995|FG000|Overall Study|Adverse Event|1|||
145498027|NCT04543279|524681996|FG001|Overall Study|Adverse Event|0|||
145498028|NCT04543279|524681995|FG000|Overall Study|Physician Decision|1|||
145498029|NCT04543279|524681996|FG001|Overall Study|Physician Decision|0|||
145498030|NCT00929695|524681998|FG000|Overall Study|Death|2|||
145498031|NCT00929695|524681999|FG001|Overall Study|Death|1|||
145498032|NCT00929695|524681998|FG000|Overall Study|Withdrawal by Subject|0|||
145498033|NCT00929695|524681999|FG001|Overall Study|Withdrawal by Subject|2|||
145498034|NCT00929695|524681998|FG000|Overall Study|discharge home|4|||
145396088|NCT05616013|524304953|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396089|NCT05616013|524304954|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
145396090|NCT05616013|524304946|FG000|Overall Study|Participant Decision, Time Constraints|0|||
145396091|NCT05616013|524304947|FG001|Overall Study|Participant Decision, Time Constraints|1|||
145396092|NCT05616013|524304948|FG002|Overall Study|Participant Decision, Time Constraints|0|||
145396093|NCT05616013|524304949|FG003|Overall Study|Participant Decision, Time Constraints|0|||
145396094|NCT05616013|524304950|FG004|Overall Study|Participant Decision, Time Constraints|0|||
145396095|NCT05616013|524304951|FG005|Overall Study|Participant Decision, Time Constraints|0|||
145396096|NCT05616013|524304952|FG006|Overall Study|Participant Decision, Time Constraints|0|||
145396097|NCT05616013|524304953|FG007|Overall Study|Participant Decision, Time Constraints|0|||
145396098|NCT05616013|524304954|FG008|Overall Study|Participant Decision, Time Constraints|0|||
145396099|NCT05616013|524304946|FG000|Overall Study|Prohibited Concomitant Medication|0|||
145396100|NCT05616013|524304947|FG001|Overall Study|Prohibited Concomitant Medication|0|||
145396101|NCT05616013|524304948|FG002|Overall Study|Prohibited Concomitant Medication|1|||
145396102|NCT05616013|524304949|FG003|Overall Study|Prohibited Concomitant Medication|0|||
145396103|NCT05616013|524304950|FG004|Overall Study|Prohibited Concomitant Medication|0|||
145396104|NCT05616013|524304951|FG005|Overall Study|Prohibited Concomitant Medication|0|||
145396105|NCT05616013|524304952|FG006|Overall Study|Prohibited Concomitant Medication|0|||
145396106|NCT05616013|524304953|FG007|Overall Study|Prohibited Concomitant Medication|0|||
145396107|NCT05616013|524304954|FG008|Overall Study|Prohibited Concomitant Medication|0|||
145396108|NCT05616013|524304946|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396109|NCT05616013|524304947|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396110|NCT05616013|524304948|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
145396111|NCT05616013|524304949|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396112|NCT05616013|524304950|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396113|NCT05616013|524304951|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396114|NCT05616013|524304952|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396115|NCT05616013|524304953|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396116|NCT05616013|524304954|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
145396117|NCT05616013|524304946|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396118|NCT05616013|524304947|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396119|NCT05616013|524304948|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396120|NCT05616013|524304949|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
145396121|NCT05616013|524304950|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396122|NCT05616013|524304951|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396123|NCT05616013|524304952|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396124|NCT05616013|524304953|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396125|NCT05616013|524304954|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
145396126|NCT05616013|524304946|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396127|NCT05616013|524304947|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396128|NCT05616013|524304948|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396129|NCT05616013|524304949|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396130|NCT05616013|524304950|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396131|NCT05616013|524304951|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396132|NCT05616013|524304952|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
145396133|NCT05616013|524304953|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396134|NCT05616013|524304954|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
145396135|NCT05616013|524304946|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396136|NCT05616013|524304947|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396137|NCT05616013|524304948|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396138|NCT05616013|524304949|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396139|NCT05616013|524304950|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396140|NCT05616013|524304951|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396141|NCT05616013|524304952|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396142|NCT05616013|524304953|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
145396143|NCT05616013|524304954|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
145396144|NCT05616013|524304946|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396145|NCT05616013|524304947|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
145732634|NCT02038920|525539266|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
145498035|NCT00929695|524681999|FG001|Overall Study|discharge home|3|||
145498036|NCT00929695|524681998|FG000|Overall Study|incorrect stratification|2|||
145498037|NCT00929695|524681999|FG001|Overall Study|incorrect stratification|0|||
145498038|NCT04030143|524682000|FG000|Overall Study|Adverse Event|5|||
145498039|NCT04030143|524682001|FG001|Overall Study|Adverse Event|10|||
145498040|NCT04030143|524682000|FG000|Overall Study|Lost to Follow-up|3|||
145498041|NCT04030143|524682001|FG001|Overall Study|Lost to Follow-up|7|||
145498042|NCT04030143|524682000|FG000|Overall Study|Protocol Deviation|2|||
145498043|NCT04030143|524682001|FG001|Overall Study|Protocol Deviation|2|||
145498044|NCT04030143|524682000|FG000|Overall Study|Withdrawal by Subject|16|||
145498045|NCT04030143|524682001|FG001|Overall Study|Withdrawal by Subject|18|||
145498046|NCT04030143|524682000|FG000|Overall Study|Physician Decision|1|||
145498047|NCT04030143|524682001|FG001|Overall Study|Physician Decision|1|||
145498048|NCT04030143|524682000|FG000|Overall Study|Due to Covid-19|2|||
145498049|NCT04030143|524682001|FG001|Overall Study|Due to Covid-19|3|||
145498050|NCT04030143|524682000|FG000|Overall Study|Not Due to Covid-19|1|||
145498051|NCT04030143|524682001|FG001|Overall Study|Not Due to Covid-19|1|||
145498052|NCT04218240|524682002|FG000|Overall Study|Withdrawal by Subject|6|||
145498053|NCT04218240|524682003|FG001|Overall Study|Withdrawal by Subject|0|||
145498054|NCT04218240|524682002|FG000|Overall Study|Lack of Efficacy|24|||
145498055|NCT04218240|524682003|FG001|Overall Study|Lack of Efficacy|19|||
145498056|NCT04218240|524682002|FG000|Overall Study|Physician Decision|0|||
145498057|NCT04218240|524682003|FG001|Overall Study|Physician Decision|1|||
145498058|NCT04218240|524682002|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
145498059|NCT04218240|524682003|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
145498060|NCT05966142|524682007|FG000|Overall Study|Death|3|||
145498061|NCT05966142|524682008|FG001|Overall Study|Death|3|||
145498062|NCT05966142|524682007|FG000|Overall Study|Lost to Follow-up|55|||
145498063|NCT05966142|524682008|FG001|Overall Study|Lost to Follow-up|52|||
145498064|NCT05966142|524682007|FG000|Overall Study|Physician Decision|1|||
145498065|NCT05966142|524682008|FG001|Overall Study|Physician Decision|0|||
145498066|NCT05966142|524682007|FG000|Overall Study|Withdrawal by Subject|9|||
145498067|NCT05966142|524682008|FG001|Overall Study|Withdrawal by Subject|8|||
145498068|NCT05966142|524682007|FG000|Overall Study|Duplicate Enrollment|1|||
145498069|NCT05966142|524682008|FG001|Overall Study|Duplicate Enrollment|0|||
145498070|NCT05966142|524682007|FG000|Overall Study|Study Logistical Reason|1|||
145498071|NCT05966142|524682008|FG001|Overall Study|Study Logistical Reason|0|||
145498072|NCT05966142|524682007|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
145498073|NCT05966142|524682008|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
145498074|NCT05249582|524682009|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
145498075|NCT05249582|524682010|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
145498076|NCT05249582|524682009|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
145498077|NCT05249582|524682010|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
145498078|NCT05249582|524682009|FG000|Overall Study|Declined to use virtual reality headset|1|||
145498079|NCT05249582|524682010|FG001|Overall Study|Declined to use virtual reality headset|0|||
145498080|NCT05386329|524682011|FG000|Overall Study|Lost to Follow-up|3|||
145498081|NCT03600909|524682014|FG000|Overall Study|Not treated|0|||
145498082|NCT03600909|524682015|FG001|Overall Study|Not treated|3|||
145498083|NCT03600909|524682016|FG002|Overall Study|Not treated|0|||
145498084|NCT00521079|524682017|FG000|Overall Study|Adverse Event|7|||
145498085|NCT00521079|524682018|FG001|Overall Study|Adverse Event|1|||
145498086|NCT00521079|524682017|FG000|Overall Study|Lost to Follow-up|2|||
145498087|NCT00521079|524682018|FG001|Overall Study|Lost to Follow-up|1|||
145498088|NCT00521079|524682017|FG000|Overall Study|Withdrawal by Subject|5|||
145498089|NCT00521079|524682018|FG001|Overall Study|Withdrawal by Subject|3|||
145498090|NCT04408989|524682019|FG000|Overall Study|Lost to Follow-up|0|||
145498091|NCT04408989|524682020|FG001|Overall Study|Lost to Follow-up|0|||
145498092|NCT04408989|524682021|FG002|Overall Study|Lost to Follow-up|1|||
145498093|NCT04408989|524682019|FG000|Overall Study|Withdrawal by Subject|0|||
145498094|NCT04408989|524682020|FG001|Overall Study|Withdrawal by Subject|0|||
145498095|NCT04408989|524682021|FG002|Overall Study|Withdrawal by Subject|2|||
145498096|NCT05135767|524682022|FG000|Baseline|Lost to Follow-up|1|||
145498097|NCT05135767|524682023|FG001|Baseline|Lost to Follow-up|1|||
145498098|NCT05135767|524682022|FG000|Baseline|Withdrawal by Subject|0|||
145498099|NCT05135767|524682023|FG001|Baseline|Withdrawal by Subject|2|||
145498100|NCT05135767|524682022|FG000|Active Study Phase|Lost to Follow-up|2|||
145498101|NCT05135767|524682023|FG001|Active Study Phase|Lost to Follow-up|0|||
145498102|NCT02694185|524682024|FG000|Overall Study|Withdrawal by Subject|45|||
145498103|NCT02694185|524682025|FG001|Overall Study|Withdrawal by Subject|0|||
145732635|NCT02038920|525539261|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145498104|NCT05082857|524682026|FG000|Overall Study|participants relocated and could not continue|2|||
145498105|NCT05082857|524682027|FG001|Overall Study|participants relocated and could not continue|1|||
145732636|NCT02038920|525539262|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145498106|NCT05082857|524682026|FG000|Overall Study|Lost to Follow-up|1|||
145498107|NCT05082857|524682027|FG001|Overall Study|Lost to Follow-up|3|||
145498108|NCT04363320|524682028|FG000|Overall Study|Lost to Follow-up|43|||
145498109|NCT04363320|524682029|FG001|Overall Study|Lost to Follow-up|42|||
145498110|NCT04363320|524682030|FG002|Overall Study|Lost to Follow-up|24|||
145498111|NCT04363320|524682031|FG003|Overall Study|Lost to Follow-up|29|||
145498112|NCT04363320|524682028|FG000|Overall Study|Death|0|||
145498113|NCT04363320|524682029|FG001|Overall Study|Death|0|||
145498114|NCT04363320|524682030|FG002|Overall Study|Death|1|||
145498115|NCT04363320|524682031|FG003|Overall Study|Death|0|||
145498116|NCT02260934|524682041|FG000|Overall Study|Lost to Follow-up|2|||
145498117|NCT02260934|524682042|FG001|Overall Study|Lost to Follow-up|1|||
145498118|NCT02260934|524682041|FG000|Overall Study|Withdrawal by Subject|0|||
145498119|NCT02260934|524682042|FG001|Overall Study|Withdrawal by Subject|2|||
145498120|NCT02260934|524682041|FG000|Overall Study|Participant Relocated|1|||
145498121|NCT02260934|524682042|FG001|Overall Study|Participant Relocated|0|||
145498122|NCT02260934|524682041|FG000|Overall Study|Site error|0|||
145498123|NCT02260934|524682042|FG001|Overall Study|Site error|1|||
145498124|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
145498125|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
145498126|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
145498127|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
145498128|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
145498129|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
145498130|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
145498131|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
145498132|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
145498133|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
145498134|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
145498135|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
145498136|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
145498137|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
145498138|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
145498139|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
145498140|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
145498141|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
145498142|NCT03605667|524682045|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
145498143|NCT03605667|524682046|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
145498144|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
145498145|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
145498146|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Other|6|||
145498147|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Other|8|||
145498148|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
145498149|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
145498150|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
145498151|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
145498152|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
145498153|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
145498154|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
145498155|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
145498156|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
145498157|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
145498158|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
145498159|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
145498160|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Death|0|||
145498161|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Death|2|||
145498162|NCT03605667|524682045|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
145498163|NCT03605667|524682046|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
145498164|NCT05632211|524682047|FG000|Overall Study|Withdrawal by Subject|2|||
145498165|NCT05632211|524682048|FG001|Overall Study|Withdrawal by Subject|0|||
145498166|NCT05632211|524682049|FG002|Overall Study|Withdrawal by Subject|2|||
145498167|NCT05632211|524682047|FG000|Overall Study|Other reasons|1|||
145498168|NCT05632211|524682048|FG001|Overall Study|Other reasons|1|||
145732637|NCT02038920|525539263|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
145498169|NCT05632211|524682049|FG002|Overall Study|Other reasons|1|||
145498170|NCT02532517|524682056|FG000|Overall Study|Did not complete 24-Month visit|4|||
145498171|NCT02532517|524682056|FG000|Overall Study|Failed Angiographic eligibility|1|||
145498172|NCT02532517|524682056|FG000|Overall Study|Lost to Follow-up|4|||
145498173|NCT02532517|524682056|FG000|Overall Study|Withdrawal by Subject|4|||
145498174|NCT02532517|524682056|FG000|Overall Study|Death|4|||
145498175|NCT00400179|524682057|FG000|Overall Study|Adverse Event|2|||
145498176|NCT00400179|524682058|FG001|Overall Study|Adverse Event|2|||
145498177|NCT00400179|524682057|FG000|Overall Study|Death|1|||
145498178|NCT00400179|524682058|FG001|Overall Study|Death|2|||
145498179|NCT00400179|524682057|FG000|Overall Study|Withdrew Consent|1|||
145498180|NCT00400179|524682058|FG001|Overall Study|Withdrew Consent|5|||
145498181|NCT00400179|524682057|FG000|Overall Study|Disease progression|1|||
145498182|NCT00400179|524682058|FG001|Overall Study|Disease progression|1|||
145498183|NCT00400179|524682057|FG000|Overall Study|Intercurrent illness|0|||
145498184|NCT00400179|524682058|FG001|Overall Study|Intercurrent illness|1|||
145498185|NCT00400179|524682057|FG000|Overall Study|Investigator judgment|0|||
145498186|NCT00400179|524682058|FG001|Overall Study|Investigator judgment|1|||
145498187|NCT00400179|524682057|FG000|Overall Study|Randomization error/patient ineligible|1|||
145498188|NCT00400179|524682058|FG001|Overall Study|Randomization error/patient ineligible|6|||
145498189|NCT04780061|524682059|FG000|Overall Study|Withdrawal by Subject|5|||
145498190|NCT04780061|524682060|FG001|Overall Study|Withdrawal by Subject|8|||
145498191|NCT04780061|524682059|FG000|Overall Study|Adverse Event|2|||
145498192|NCT04780061|524682060|FG001|Overall Study|Adverse Event|2|||
145498193|NCT04780061|524682059|FG000|Overall Study|Lost to Follow-up|1|||
145498194|NCT04780061|524682060|FG001|Overall Study|Lost to Follow-up|5|||
145498195|NCT00734149|524682061|FG000|Overall Study|Withdrawal by Subject|1|||
145498196|NCT05138653|524682062|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
145498197|NCT05138653|524682063|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498198|NCT05138653|524682064|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498199|NCT05138653|524682065|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498200|NCT05138653|524682066|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498201|NCT05138653|524682067|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498202|NCT05138653|524682068|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498203|NCT05138653|524682069|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498204|NCT05138653|524682070|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498205|NCT05138653|524682071|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498206|NCT05138653|524682072|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498207|NCT05138653|524682073|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498208|NCT05138653|524682074|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498209|NCT05138653|524682075|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498210|NCT05138653|524682076|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498211|NCT05138653|524682077|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
145498212|NCT05138653|524682062|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498213|NCT05138653|524682063|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
145498214|NCT05138653|524682064|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498215|NCT05138653|524682065|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498216|NCT05138653|524682066|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498217|NCT05138653|524682067|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498218|NCT05138653|524682068|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498219|NCT05138653|524682069|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498220|NCT05138653|524682070|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
145498221|NCT05138653|524682071|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498222|NCT05138653|524682072|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498223|NCT05138653|524682073|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498224|NCT05138653|524682074|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498225|NCT05138653|524682075|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498226|NCT05138653|524682076|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498227|NCT05138653|524682077|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
145498228|NCT05138653|524682062|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498229|NCT05138653|524682063|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
145498230|NCT05138653|524682064|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498231|NCT05138653|524682065|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498232|NCT05138653|524682066|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
145498233|NCT05138653|524682067|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498234|NCT05138653|524682068|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498235|NCT05138653|524682069|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498236|NCT05138653|524682070|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498237|NCT05138653|524682071|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498238|NCT05138653|524682072|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498239|NCT05138653|524682073|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498240|NCT05138653|524682074|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498241|NCT05138653|524682075|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498242|NCT05138653|524682076|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498243|NCT05138653|524682077|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
145498244|NCT05138653|524682062|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498245|NCT05138653|524682063|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498246|NCT05138653|524682064|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498247|NCT05138653|524682065|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498248|NCT05138653|524682066|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498249|NCT05138653|524682067|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498250|NCT05138653|524682068|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
145498251|NCT05138653|524682069|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498252|NCT05138653|524682070|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498253|NCT05138653|524682071|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498254|NCT05138653|524682072|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498255|NCT05138653|524682073|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498256|NCT05138653|524682074|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498257|NCT05138653|524682075|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498258|NCT05138653|524682076|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498259|NCT05138653|524682077|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
145498260|NCT05138653|524682062|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498261|NCT05138653|524682063|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498262|NCT05138653|524682064|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498263|NCT05138653|524682065|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498264|NCT05138653|524682066|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498265|NCT05138653|524682067|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498266|NCT05138653|524682068|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498267|NCT05138653|524682069|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498268|NCT05138653|524682070|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498269|NCT05138653|524682071|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498270|NCT05138653|524682072|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
145498271|NCT05138653|524682073|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498272|NCT05138653|524682074|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
145498273|NCT05138653|524682075|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498274|NCT05138653|524682076|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
145498275|NCT05138653|524682077|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
145498276|NCT05138653|524682062|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498277|NCT05138653|524682063|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498278|NCT05138653|524682064|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498279|NCT05138653|524682065|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498280|NCT05138653|524682066|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145396146|NCT05616013|524304948|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396147|NCT05616013|524304949|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396148|NCT05616013|524304950|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396149|NCT05616013|524304951|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396150|NCT05616013|524304952|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396151|NCT05616013|524304953|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
145396152|NCT05616013|524304954|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
145396153|NCT05116202|524304955|FG000|Overall Study|Study Terminated by Sponsor|21|||
145396154|NCT05116202|524304956|FG001|Overall Study|Study Terminated by Sponsor|38|||
145396155|NCT05116202|524304957|FG002|Overall Study|Study Terminated by Sponsor|17|||
145396156|NCT05116202|524304958|FG003|Overall Study|Study Terminated by Sponsor|18|||
145396157|NCT05116202|524304959|FG004|Overall Study|Study Terminated by Sponsor|0|||
145396158|NCT05116202|524304955|FG000|Overall Study|Withdrawal by Subject|0|||
145396159|NCT05116202|524304956|FG001|Overall Study|Withdrawal by Subject|1|||
145396160|NCT05116202|524304957|FG002|Overall Study|Withdrawal by Subject|1|||
145396161|NCT05116202|524304958|FG003|Overall Study|Withdrawal by Subject|1|||
145396162|NCT05116202|524304959|FG004|Overall Study|Withdrawal by Subject|1|||
145396163|NCT05116202|524304955|FG000|Overall Study|Lost to Follow-up|0|||
145396164|NCT05116202|524304956|FG001|Overall Study|Lost to Follow-up|0|||
145396165|NCT05116202|524304957|FG002|Overall Study|Lost to Follow-up|0|||
145396166|NCT05116202|524304958|FG003|Overall Study|Lost to Follow-up|0|||
145396167|NCT05116202|524304959|FG004|Overall Study|Lost to Follow-up|2|||
145396168|NCT05116202|524304955|FG000|Overall Study|Death|1|||
145396169|NCT05116202|524304956|FG001|Overall Study|Death|1|||
145396170|NCT05116202|524304957|FG002|Overall Study|Death|2|||
145396171|NCT05116202|524304958|FG003|Overall Study|Death|1|||
145396172|NCT05116202|524304959|FG004|Overall Study|Death|5|||
145498281|NCT05138653|524682067|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145605964|NCT00638235|525073060|FG002|Overall Study|Lost to Follow-up|18|||
145396173|NCT05067972|524304960|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
145396174|NCT05067972|524304961|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
145396175|NCT05067972|524304962|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
145396176|NCT05067972|524304963|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
145396177|NCT05067972|524304964|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
145396178|NCT05067972|524304965|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
145396179|NCT05067972|524304966|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
145396180|NCT05067972|524304960|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
145396181|NCT05067972|524304961|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
145396182|NCT05067972|524304962|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
145396183|NCT05067972|524304963|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
145396184|NCT05067972|524304964|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
145396185|NCT05067972|524304965|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
145396186|NCT05067972|524304966|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
145396187|NCT05067972|524304960|FG000|Part 1: Treatment|Progressive Disease|3|||
145396188|NCT05067972|524304961|FG001|Part 1: Treatment|Progressive Disease|3|||
145396189|NCT05067972|524304962|FG002|Part 1: Treatment|Progressive Disease|4|||
145396190|NCT05067972|524304963|FG003|Part 1: Treatment|Progressive Disease|2|||
145396191|NCT05067972|524304964|FG004|Part 1: Treatment|Progressive Disease|3|||
145396192|NCT05067972|524304965|FG005|Part 1: Treatment|Progressive Disease|0|||
145396193|NCT05067972|524304966|FG006|Part 1: Treatment|Progressive Disease|2|||
145396194|NCT05067972|524304960|FG000|Part 1: Treatment|Physician Decision|0|||
145396195|NCT05067972|524304961|FG001|Part 1: Treatment|Physician Decision|0|||
145396196|NCT05067972|524304962|FG002|Part 1: Treatment|Physician Decision|0|||
145396197|NCT05067972|524304963|FG003|Part 1: Treatment|Physician Decision|1|||
145396198|NCT05067972|524304964|FG004|Part 1: Treatment|Physician Decision|0|||
145396199|NCT05067972|524304965|FG005|Part 1: Treatment|Physician Decision|0|||
145396200|NCT05067972|524304966|FG006|Part 1: Treatment|Physician Decision|0|||
145396201|NCT05067972|524304960|FG000|Part 1: Treatment|Death|0|||
145396202|NCT05067972|524304961|FG001|Part 1: Treatment|Death|0|||
145396203|NCT05067972|524304962|FG002|Part 1: Treatment|Death|0|||
145396204|NCT05067972|524304963|FG003|Part 1: Treatment|Death|2|||
145396205|NCT05067972|524304964|FG004|Part 1: Treatment|Death|0|||
145396206|NCT05067972|524304965|FG005|Part 1: Treatment|Death|0|||
145396207|NCT05067972|524304966|FG006|Part 1: Treatment|Death|0|||
145396208|NCT05067972|524304960|FG000|Part 1: Treatment|Adverse Event|0|||
145396209|NCT05067972|524304961|FG001|Part 1: Treatment|Adverse Event|0|||
145396210|NCT05067972|524304962|FG002|Part 1: Treatment|Adverse Event|0|||
145396211|NCT05067972|524304963|FG003|Part 1: Treatment|Adverse Event|0|||
145396212|NCT05067972|524304964|FG004|Part 1: Treatment|Adverse Event|0|||
145396213|NCT05067972|524304965|FG005|Part 1: Treatment|Adverse Event|2|||
145396214|NCT05067972|524304966|FG006|Part 1: Treatment|Adverse Event|1|||
145396215|NCT05067972|524304960|FG000|Part 1: Follow-up|Adverse Event|0|||
145396216|NCT05067972|524304961|FG001|Part 1: Follow-up|Adverse Event|0|||
145396217|NCT05067972|524304962|FG002|Part 1: Follow-up|Adverse Event|0|||
145396218|NCT05067972|524304963|FG003|Part 1: Follow-up|Adverse Event|0|||
145396219|NCT05067972|524304964|FG004|Part 1: Follow-up|Adverse Event|0|||
145396220|NCT05067972|524304965|FG005|Part 1: Follow-up|Adverse Event|1|||
145396221|NCT05067972|524304966|FG006|Part 1: Follow-up|Adverse Event|0|||
145396222|NCT05067972|524304960|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
145396223|NCT05067972|524304961|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
145396224|NCT05067972|524304962|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
145396225|NCT05067972|524304963|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
145396226|NCT05067972|524304964|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
145396227|NCT05067972|524304965|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
145396228|NCT05067972|524304966|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
145396229|NCT05067972|524304960|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396230|NCT05067972|524304961|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396231|NCT05067972|524304962|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396232|NCT05067972|524304963|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396233|NCT05067972|524304964|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396234|NCT05067972|524304965|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
145396235|NCT05067972|524304966|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
145396236|NCT05067972|524304960|FG000|Part 1: Follow-up|Physician Decision|0|||
145396237|NCT05067972|524304961|FG001|Part 1: Follow-up|Physician Decision|0|||
145396238|NCT05067972|524304962|FG002|Part 1: Follow-up|Physician Decision|0|||
145396239|NCT05067972|524304963|FG003|Part 1: Follow-up|Physician Decision|1|||
145396240|NCT05067972|524304964|FG004|Part 1: Follow-up|Physician Decision|0|||
145396241|NCT05067972|524304965|FG005|Part 1: Follow-up|Physician Decision|0|||
145396242|NCT05067972|524304966|FG006|Part 1: Follow-up|Physician Decision|0|||
145396243|NCT05067972|524304960|FG000|Part 1: Follow-up|Death|1|||
145396244|NCT05067972|524304961|FG001|Part 1: Follow-up|Death|2|||
145396245|NCT05067972|524304962|FG002|Part 1: Follow-up|Death|1|||
145396246|NCT05067972|524304963|FG003|Part 1: Follow-up|Death|0|||
145396247|NCT05067972|524304964|FG004|Part 1: Follow-up|Death|1|||
145396248|NCT05067972|524304965|FG005|Part 1: Follow-up|Death|0|||
145396249|NCT05067972|524304966|FG006|Part 1: Follow-up|Death|1|||
145396250|NCT04391842|524304967|FG000|Overall Study|Withdrawal by Subject|2|||
145396251|NCT00810199|524304968|FG000|Overall Study|Adverse Event|24|||
145396252|NCT00810199|524304969|FG001|Overall Study|Adverse Event|26|||
145396253|NCT00810199|524304968|FG000|Overall Study|Death|4|||
145396254|NCT00810199|524304969|FG001|Overall Study|Death|6|||
145396255|NCT00810199|524304968|FG000|Overall Study|Withdrew consent|9|||
145396256|NCT00810199|524304969|FG001|Overall Study|Withdrew consent|12|||
145396257|NCT00810199|524304968|FG000|Overall Study|Insufficient therapeutic response|5|||
145396258|NCT00810199|524304969|FG001|Overall Study|Insufficient therapeutic response|14|||
145396259|NCT00810199|524304968|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
145396260|NCT00810199|524304969|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
145396261|NCT00810199|524304968|FG000|Overall Study|Administrative/Other|5|||
145396262|NCT00810199|524304969|FG001|Overall Study|Administrative/Other|6|||
145396263|NCT00810199|524304968|FG000|Overall Study|Protocol Violation|2|||
145396264|NCT00810199|524304969|FG001|Overall Study|Protocol Violation|6|||
145396265|NCT00810199|524304968|FG000|Overall Study|Failure to return|1|||
145396266|NCT00810199|524304969|FG001|Overall Study|Failure to return|4|||
145396267|NCT00810199|524304968|FG000|Overall Study|Did not receive study drug|2|||
145396268|NCT00810199|524304969|FG001|Overall Study|Did not receive study drug|1|||
145396269|NCT00992017|524304971|FG000|Overall Study|Lost to Follow-up|2|||
145396270|NCT00992017|524304971|FG000|Overall Study|Withdrawal by Subject|2|||
145396271|NCT00992017|524304971|FG000|Overall Study|Unable to get to clinic|5|||
145396272|NCT00992017|524304971|FG000|Overall Study|Not adhere to study requirements|1|||
145396273|NCT02864407|524304972|FG000|Overall Study|Protocol Violation|3|||
145396274|NCT02864407|524304972|FG000|Overall Study|Lost to Follow-up|115|||
145396275|NCT02864407|524304972|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
145396276|NCT02864407|524304972|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
145396277|NCT02864407|524304972|FG000|Overall Study|Consent prior to the contract date|1|||
145396278|NCT02287038|524304982|FG000|Overall Study|Stopped attending appointments|3|||
145396279|NCT02287038|524304983|FG001|Overall Study|Stopped attending appointments|2|||
145396280|NCT02287038|524304982|FG000|Overall Study|Anxiety after starting medication|0|||
145396281|NCT02287038|524304983|FG001|Overall Study|Anxiety after starting medication|1|||
145396282|NCT02287038|524304982|FG000|Overall Study|Nausea after starting medication|1|||
145396283|NCT02287038|524304983|FG001|Overall Study|Nausea after starting medication|0|||
145396284|NCT02287038|524304982|FG000|Overall Study|Abnormal ECG after starting medication|1|||
145396285|NCT02287038|524304983|FG001|Overall Study|Abnormal ECG after starting medication|0|||
145396286|NCT05502302|524304991|FG000|Overall Study|Lost to Follow-up|6|||
145396287|NCT05502302|524304991|FG000|Overall Study|Death|2|||
145396288|NCT02155985|524305003|FG000|Overall Study|Withdrawal by Subject|0|||
145396289|NCT02155985|524305004|FG001|Overall Study|Withdrawal by Subject|0|||
145396290|NCT02155985|524305005|FG002|Overall Study|Withdrawal by Subject|1|||
145396291|NCT02155985|524305003|FG000|Overall Study|Lost to Follow-up|1|||
145396292|NCT02155985|524305004|FG001|Overall Study|Lost to Follow-up|0|||
145396293|NCT02155985|524305005|FG002|Overall Study|Lost to Follow-up|0|||
145396294|NCT02573259|524305006|FG000|Overall Study|Death|1|||
145396295|NCT02573259|524305007|FG001|Overall Study|Death|6|||
145396296|NCT02573259|524305008|FG002|Overall Study|Death|5|||
145396297|NCT02573259|524305009|FG003|Overall Study|Death|6|||
145396298|NCT02573259|524305010|FG004|Overall Study|Death|9|||
145396299|NCT02573259|524305011|FG005|Overall Study|Death|32|||
145396300|NCT02573259|524305012|FG006|Overall Study|Death|21|||
145396301|NCT02573259|524305006|FG000|Overall Study|Lost to Follow-up|0|||
145396302|NCT02573259|524305007|FG001|Overall Study|Lost to Follow-up|0|||
145396303|NCT02573259|524305008|FG002|Overall Study|Lost to Follow-up|0|||
145396304|NCT02573259|524305009|FG003|Overall Study|Lost to Follow-up|0|||
145396305|NCT02573259|524305010|FG004|Overall Study|Lost to Follow-up|0|||
145396306|NCT02573259|524305011|FG005|Overall Study|Lost to Follow-up|2|||
145396307|NCT02573259|524305012|FG006|Overall Study|Lost to Follow-up|1|||
145396308|NCT02573259|524305006|FG000|Overall Study|Participant refused further follow-up|0|||
145396309|NCT02573259|524305007|FG001|Overall Study|Participant refused further follow-up|2|||
145396310|NCT02573259|524305008|FG002|Overall Study|Participant refused further follow-up|1|||
145396311|NCT02573259|524305009|FG003|Overall Study|Participant refused further follow-up|0|||
145396312|NCT02573259|524305010|FG004|Overall Study|Participant refused further follow-up|3|||
145396313|NCT02573259|524305011|FG005|Overall Study|Participant refused further follow-up|20|||
145396314|NCT02573259|524305012|FG006|Overall Study|Participant refused further follow-up|7|||
145396315|NCT02573259|524305006|FG000|Overall Study|Other|0|||
145396316|NCT02573259|524305007|FG001|Overall Study|Other|0|||
145396317|NCT02573259|524305008|FG002|Overall Study|Other|0|||
145396318|NCT02573259|524305009|FG003|Overall Study|Other|0|||
145396319|NCT02573259|524305010|FG004|Overall Study|Other|1|||
145396320|NCT02573259|524305011|FG005|Overall Study|Other|4|||
145396321|NCT02573259|524305012|FG006|Overall Study|Other|5|||
145396322|NCT00751140|524305013|FG000|Overall Study|benign angioma excluded from analysis|1|||
145396323|NCT02667301|524305014|FG000|Overall Study|Adverse Event|1|||
145396324|NCT02667301|524305014|FG000|Overall Study|Lack of Efficacy|1|||
145396325|NCT00735007|524305015|FG000|Overall Study|Adverse Event|4|||
145396326|NCT00735007|524305015|FG000|Overall Study|Protocol Violation|1|||
145498282|NCT05138653|524682068|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498283|NCT05138653|524682069|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145396327|NCT01883895|524305019|FG000|Overall Study|Lost to Follow-up|2|||
145396328|NCT02895295|524305020|FG000|Overall Study|Survey Non-response|71|||
145396329|NCT02895295|524305021|FG001|Overall Study|Survey Non-response|94|||
145396330|NCT02895295|524305022|FG002|Overall Study|Survey Non-response|92|||
145396331|NCT04414787|524305027|FG000|Overall Study|Patient Death|18|||
145396332|NCT04414787|524305028|FG001|Overall Study|Patient Death|18|||
145396333|NCT04414787|524305029|FG002|Overall Study|Patient Death|15|||
145396334|NCT04414787|524305030|FG003|Overall Study|Patient Death|15|||
145396335|NCT04414787|524305027|FG000|Overall Study|Patient Hospitalization|1|||
145396336|NCT04414787|524305028|FG001|Overall Study|Patient Hospitalization|1|||
145396337|NCT04414787|524305029|FG002|Overall Study|Patient Hospitalization|2|||
145396338|NCT04414787|524305030|FG003|Overall Study|Patient Hospitalization|2|||
145396339|NCT04414787|524305027|FG000|Overall Study|Lost to Follow-up|7|||
145396340|NCT04414787|524305028|FG001|Overall Study|Lost to Follow-up|7|||
145396341|NCT04414787|524305029|FG002|Overall Study|Lost to Follow-up|5|||
145396342|NCT04414787|524305030|FG003|Overall Study|Lost to Follow-up|5|||
145396343|NCT04414787|524305027|FG000|Overall Study|Residence in post-acute care facility|3|||
145396344|NCT04414787|524305028|FG001|Overall Study|Residence in post-acute care facility|3|||
145396345|NCT04414787|524305029|FG002|Overall Study|Residence in post-acute care facility|5|||
145396346|NCT04414787|524305030|FG003|Overall Study|Residence in post-acute care facility|5|||
145396347|NCT00490919|524305031|FG000|Open-label Run-in Period|Adverse Event|239|||
145396348|NCT00490919|524305032|FG001|Open-label Run-in Period|Adverse Event|0|||
145396349|NCT00490919|524305033|FG002|Open-label Run-in Period|Adverse Event|0|||
145396350|NCT00490919|524305031|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
145396351|NCT00490919|524305032|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
145396352|NCT00490919|524305033|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
145396353|NCT00490919|524305031|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
145396354|NCT00490919|524305032|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
145396355|NCT00490919|524305033|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
145396356|NCT00490919|524305031|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
145396357|NCT00490919|524305032|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
145396358|NCT00490919|524305033|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
145396359|NCT00490919|524305031|FG000|Open-label Run-in Period|Administrative|40|||
145396360|NCT00490919|524305032|FG001|Open-label Run-in Period|Administrative|0|||
145396361|NCT00490919|524305033|FG002|Open-label Run-in Period|Administrative|0|||
145396362|NCT00490919|524305031|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
145396363|NCT00490919|524305032|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
145396364|NCT00490919|524305033|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
145396365|NCT00490919|524305031|FG000|Double-blind Phase|Adverse Event|0|||
145396366|NCT00490919|524305032|FG001|Double-blind Phase|Adverse Event|40|||
145396367|NCT00490919|524305033|FG002|Double-blind Phase|Adverse Event|20|||
145396368|NCT00490919|524305031|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145396369|NCT00490919|524305032|FG001|Double-blind Phase|Withdrawal by Subject|10|||
145396370|NCT00490919|524305033|FG002|Double-blind Phase|Withdrawal by Subject|11|||
145396371|NCT00490919|524305031|FG000|Double-blind Phase|Lost to Follow-up|0|||
145396372|NCT00490919|524305032|FG001|Double-blind Phase|Lost to Follow-up|8|||
145396373|NCT00490919|524305033|FG002|Double-blind Phase|Lost to Follow-up|11|||
145396374|NCT00490919|524305031|FG000|Double-blind Phase|Lack of Efficacy|0|||
145396375|NCT00490919|524305032|FG001|Double-blind Phase|Lack of Efficacy|22|||
145396376|NCT00490919|524305033|FG002|Double-blind Phase|Lack of Efficacy|36|||
145396377|NCT00490919|524305031|FG000|Double-blind Phase|Administrative|0|||
145396378|NCT00490919|524305032|FG001|Double-blind Phase|Administrative|6|||
145396379|NCT00490919|524305033|FG002|Double-blind Phase|Administrative|6|||
145396380|NCT00447902|524305034|FG000|Overall Study|Adverse Event|0|||
145396381|NCT00447902|524305035|FG001|Overall Study|Adverse Event|3|||
145396382|NCT00447902|524305034|FG000|Overall Study|Protocol Violation|1|||
145396383|NCT00447902|524305035|FG001|Overall Study|Protocol Violation|0|||
145396384|NCT00447902|524305034|FG000|Overall Study|Withdrawal by Subject|0|||
145396385|NCT00447902|524305035|FG001|Overall Study|Withdrawal by Subject|1|||
145396386|NCT00447902|524305034|FG000|Overall Study|included patients who discontinued|1|||
145396387|NCT00447902|524305035|FG001|Overall Study|included patients who discontinued|1|||
145396388|NCT00447902|524305034|FG000|Overall Study|Lack of Efficacy|2|||
145396389|NCT00447902|524305035|FG001|Overall Study|Lack of Efficacy|1|||
145396390|NCT04113694|524306434|FG000|Overall Study|Adverse Event|2|||
145396391|NCT04113694|524306434|FG000|Overall Study|Lost to Follow-up|2|||
145396392|NCT04113694|524306434|FG000|Overall Study|Withdrawal by Subject|6|||
145396393|NCT04113694|524306434|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
145396394|NCT01228591|524306435|FG000|Baseline|Lack of Efficacy|1|||
145396395|NCT01228591|524306436|FG001|Baseline|Lack of Efficacy|2|||
145396396|NCT02723188|524306437|FG000|Overall Study|Withdrawal by Subject|1|||
145396397|NCT02723188|524306438|FG001|Overall Study|Withdrawal by Subject|0|||
145396398|NCT02723188|524306439|FG002|Overall Study|Withdrawal by Subject|0|||
145396399|NCT01095835|524306440|FG000|Overall Study|Adverse Event|8|||
145396400|NCT01095835|524306441|FG001|Overall Study|Adverse Event|6|||
145396401|NCT01095835|524306442|FG002|Overall Study|Adverse Event|6|||
145396402|NCT01095835|524306440|FG000|Overall Study|Lack of Efficacy|0|||
145396403|NCT01095835|524306441|FG001|Overall Study|Lack of Efficacy|1|||
145396404|NCT01095835|524306442|FG002|Overall Study|Lack of Efficacy|0|||
145396405|NCT01095835|524306440|FG000|Overall Study|Physician Decision|0|||
145396406|NCT01095835|524306441|FG001|Overall Study|Physician Decision|0|||
145396407|NCT01095835|524306442|FG002|Overall Study|Physician Decision|1|||
145396408|NCT01095835|524306440|FG000|Overall Study|Withdrawal by Subject|1|||
145396409|NCT01095835|524306441|FG001|Overall Study|Withdrawal by Subject|3|||
145396410|NCT01095835|524306442|FG002|Overall Study|Withdrawal by Subject|0|||
145396411|NCT01095835|524306440|FG000|Overall Study|Non study compliance|0|||
145396412|NCT01095835|524306441|FG001|Overall Study|Non study compliance|0|||
145396413|NCT01095835|524306442|FG002|Overall Study|Non study compliance|1|||
145396414|NCT01095835|524306440|FG000|Overall Study|Protocol Violation|1|||
145396415|NCT01095835|524306441|FG001|Overall Study|Protocol Violation|2|||
145396416|NCT01095835|524306442|FG002|Overall Study|Protocol Violation|0|||
145396417|NCT00116688|524306450|FG000|Overall Study|Protocol deviation|1|||
145396418|NCT00116688|524306451|FG001|Overall Study|Protocol deviation|0|||
145396419|NCT00116688|524306450|FG000|Overall Study|Noncompliance|3|||
145396420|NCT00116688|524306451|FG001|Overall Study|Noncompliance|1|||
145396421|NCT00116688|524306450|FG000|Overall Study|Adverse Event|11|||
145396422|NCT00116688|524306451|FG001|Overall Study|Adverse Event|0|||
145396423|NCT00116688|524306450|FG000|Overall Study|Withdrawal by Subject|26|||
145396424|NCT00116688|524306451|FG001|Overall Study|Withdrawal by Subject|2|||
145396425|NCT00116688|524306450|FG000|Overall Study|Requirement for alternative therapy|11|||
145396426|NCT00116688|524306451|FG001|Overall Study|Requirement for alternative therapy|1|||
145396427|NCT00116688|524306450|FG000|Overall Study|Physician Decision|7|||
145396428|NCT00116688|524306451|FG001|Overall Study|Physician Decision|0|||
145396429|NCT00116688|524306450|FG000|Overall Study|Lost to Follow-up|3|||
145396430|NCT00116688|524306451|FG001|Overall Study|Lost to Follow-up|0|||
145396431|NCT00116688|524306450|FG000|Overall Study|Death|15|||
145396432|NCT00116688|524306451|FG001|Overall Study|Death|0|||
145396433|NCT00116688|524306450|FG000|Overall Study|Protocol-specified criteria|3|||
145396434|NCT00116688|524306451|FG001|Overall Study|Protocol-specified criteria|0|||
145396435|NCT00116688|524306450|FG000|Overall Study|Pregnancy|1|||
145396436|NCT00116688|524306451|FG001|Overall Study|Pregnancy|0|||
145396437|NCT00116688|524306450|FG000|Overall Study|Other|11|||
145396438|NCT00116688|524306451|FG001|Overall Study|Other|0|||
145396439|NCT01775670|524306455|FG000|Overall Study|Lost to Follow-up|1|||
145396440|NCT01775670|524306456|FG001|Overall Study|Lost to Follow-up|1|||
145396441|NCT00789321|524306458|FG000|Overall Study|Adverse Event|0|||
145396442|NCT00789321|524306459|FG001|Overall Study|Adverse Event|1|||
145396443|NCT00104052|524306460|FG000|Overall Study|Adverse Event|1|||
145396444|NCT00104052|524306460|FG000|Overall Study|Lack of Efficacy|26|||
145396445|NCT00104052|524306460|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
145396446|NCT03652818|524306461|FG000|Overall Study|Adverse Event|1|||
145396447|NCT03652818|524306462|FG001|Overall Study|Adverse Event|0|||
145396448|NCT03652818|524306463|FG002|Overall Study|Adverse Event|0|||
145396449|NCT03652818|524306464|FG003|Overall Study|Adverse Event|0|||
145396450|NCT03652818|524306465|FG004|Overall Study|Adverse Event|0|||
145396451|NCT03652818|524306461|FG000|Overall Study|Physician Decision|1|||
145396452|NCT03652818|524306462|FG001|Overall Study|Physician Decision|0|||
145396453|NCT03652818|524306463|FG002|Overall Study|Physician Decision|0|||
145396454|NCT03652818|524306464|FG003|Overall Study|Physician Decision|0|||
145396455|NCT03652818|524306465|FG004|Overall Study|Physician Decision|0|||
145396456|NCT03652818|524306461|FG000|Overall Study|Lost to Follow-up|0|||
145396457|NCT03652818|524306462|FG001|Overall Study|Lost to Follow-up|1|||
145396458|NCT03652818|524306463|FG002|Overall Study|Lost to Follow-up|2|||
145498284|NCT05138653|524682070|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145396459|NCT03652818|524306464|FG003|Overall Study|Lost to Follow-up|1|||
145396460|NCT03652818|524306465|FG004|Overall Study|Lost to Follow-up|1|||
145396461|NCT03964207|524306466|FG000|First Treatment|Withdrawal by Subject|1|||
145396462|NCT03964207|524306467|FG001|First Treatment|Withdrawal by Subject|2|||
145396463|NCT03964207|524306466|FG000|First Treatment|Protocol Violation|1|||
145396464|NCT03964207|524306467|FG001|First Treatment|Protocol Violation|0|||
145396465|NCT03964207|524306466|FG000|First Treatment|Lost to Follow-up|1|||
145396466|NCT03964207|524306467|FG001|First Treatment|Lost to Follow-up|0|||
145396467|NCT03964207|524306466|FG000|Second Treatment|Lost to Follow-up|0|||
145396468|NCT03964207|524306467|FG001|Second Treatment|Lost to Follow-up|1|||
145396469|NCT03964207|524306466|FG000|Second Treatment|Adverse Event|1|||
145396470|NCT03964207|524306467|FG001|Second Treatment|Adverse Event|2|||
145396471|NCT00830219|524306468|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145396472|NCT00830219|524306469|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145396473|NCT01294423|524306474|FG000|Overall Study|Adverse Event|1|||
145396474|NCT01294423|524306475|FG001|Overall Study|Adverse Event|2|||
145498285|NCT05138653|524682071|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498286|NCT05138653|524682072|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498287|NCT05138653|524682073|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498288|NCT05138653|524682074|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498289|NCT05138653|524682075|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498290|NCT05138653|524682076|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
145498291|NCT05138653|524682077|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
145498292|NCT05138653|524682062|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498293|NCT05138653|524682063|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498294|NCT05138653|524682064|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498295|NCT05138653|524682065|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498296|NCT05138653|524682066|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498297|NCT05138653|524682067|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498298|NCT05138653|524682068|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498299|NCT05138653|524682069|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498300|NCT05138653|524682070|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498301|NCT05138653|524682071|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498302|NCT05138653|524682072|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498303|NCT05138653|524682073|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498304|NCT05138653|524682074|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498305|NCT05138653|524682075|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
145498306|NCT05138653|524682076|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498307|NCT05138653|524682077|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
145498308|NCT05967260|524682078|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
145498309|NCT05967260|524682079|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
145498310|NCT00626106|524682080|FG000|Overall Study|Withdrawal by Subject|2|||
145498311|NCT00626106|524682081|FG001|Overall Study|Withdrawal by Subject|1|||
145498312|NCT00626106|524682080|FG000|Overall Study|Lost to Follow-up|1|||
145498313|NCT00626106|524682081|FG001|Overall Study|Lost to Follow-up|4|||
145498314|NCT00626106|524682080|FG000|Overall Study|Death|64|||
145498315|NCT00626106|524682081|FG001|Overall Study|Death|19|||
145498316|NCT03253393|524682082|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
145498317|NCT03253393|524682083|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
145498318|NCT03253393|524682084|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
145498319|NCT03204188|524682085|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
145498320|NCT03204188|524682085|FG000|Immunotherapy Phase (1 Year)|Death|1|||
145498321|NCT03204188|524682085|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
145498322|NCT03204188|524682085|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
145498323|NCT04639245|524683595|FG000|Overall Study|Death|1|||
145498324|NCT00535496|524683596|FG000|Overall Study|Lost to Follow-up|0|||
145498325|NCT00535496|524683597|FG001|Overall Study|Lost to Follow-up|1|||
145498326|NCT00535496|524683598|FG002|Overall Study|Lost to Follow-up|0|||
145498327|NCT00535496|524683599|FG003|Overall Study|Lost to Follow-up|0|||
145498328|NCT00535496|524683596|FG000|Overall Study|Not treated with sugammadex|0|||
145498329|NCT00535496|524683597|FG001|Overall Study|Not treated with sugammadex|1|||
145498330|NCT00535496|524683598|FG002|Overall Study|Not treated with sugammadex|0|||
145498331|NCT00535496|524683599|FG003|Overall Study|Not treated with sugammadex|0|||
145498332|NCT03591406|524683603|FG000|Overall Study|Adverse Event|5|||
145498333|NCT03591406|524683604|FG001|Overall Study|Adverse Event|3|||
145498334|NCT03591406|524683603|FG000|Overall Study|Protocol Violation|2|||
145498335|NCT03591406|524683604|FG001|Overall Study|Protocol Violation|1|||
145498336|NCT03591406|524683603|FG000|Overall Study|Withdrawal by Subject|0|||
145498337|NCT03591406|524683604|FG001|Overall Study|Withdrawal by Subject|5|||
145498338|NCT01083771|524683605|FG000|Overall Study|non-compliant|2|||
145498339|NCT01083771|524683605|FG000|Overall Study|Withdrawal by Subject|3|||
145498340|NCT00321620|524683608|FG000|Overall Study|Death|269|||
145396475|NCT01294423|524306476|FG002|Overall Study|Adverse Event|3|||
145396476|NCT01294423|524306474|FG000|Overall Study|Withdrawal by Subject|1|||
145396477|NCT01294423|524306475|FG001|Overall Study|Withdrawal by Subject|2|||
145396478|NCT01294423|524306476|FG002|Overall Study|Withdrawal by Subject|2|||
145396479|NCT01294423|524306474|FG000|Overall Study|subject no longer meets study criteria|2|||
145396480|NCT01294423|524306475|FG001|Overall Study|subject no longer meets study criteria|5|||
145396481|NCT01294423|524306476|FG002|Overall Study|subject no longer meets study criteria|2|||
145396482|NCT01294423|524306474|FG000|Overall Study|poor/non-compliance|1|||
145396483|NCT01294423|524306475|FG001|Overall Study|poor/non-compliance|0|||
145396484|NCT01294423|524306476|FG002|Overall Study|poor/non-compliance|1|||
145396485|NCT01241279|524306477|FG000|Overall Study|Lost to Follow-up|0|||
145396486|NCT01241279|524306478|FG001|Overall Study|Lost to Follow-up|1|||
145396487|NCT00239720|524306482|FG000|Overall Study|Adverse Event|1|||
145396488|NCT00239720|524306483|FG001|Overall Study|Adverse Event|0|||
145396489|NCT00239720|524306482|FG000|Overall Study|Lost to Follow-up|0|||
145396490|NCT00239720|524306483|FG001|Overall Study|Lost to Follow-up|1|||
145396491|NCT01811732|524306484|FG000|Overall Study|Lost to Follow-up|24|||
145396492|NCT01811732|524306485|FG001|Overall Study|Lost to Follow-up|30|||
145396493|NCT01811732|524306484|FG000|Overall Study|Withdrawal by Subject|16|||
145396494|NCT01811732|524306485|FG001|Overall Study|Withdrawal by Subject|10|||
145396495|NCT01811732|524306484|FG000|Overall Study|Adverse Event|3|||
145396496|NCT01811732|524306485|FG001|Overall Study|Adverse Event|9|||
145396497|NCT01811732|524306484|FG000|Overall Study|Lack of Efficacy|3|||
145396498|NCT01811732|524306485|FG001|Overall Study|Lack of Efficacy|1|||
145396499|NCT01811732|524306484|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
145396500|NCT01811732|524306485|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
145396501|NCT01811732|524306484|FG000|Overall Study|Physician Decision|2|||
145396502|NCT01811732|524306485|FG001|Overall Study|Physician Decision|0|||
145396503|NCT01811732|524306484|FG000|Overall Study|Death|1|||
145396504|NCT01811732|524306485|FG001|Overall Study|Death|1|||
145396505|NCT01811732|524306484|FG000|Overall Study|Insufficient venous access|0|||
145396506|NCT01811732|524306485|FG001|Overall Study|Insufficient venous access|1|||
145396507|NCT01811732|524306484|FG000|Overall Study|Protocol Violation|0|||
145396508|NCT01811732|524306485|FG001|Overall Study|Protocol Violation|1|||
145396509|NCT01811732|524306484|FG000|Overall Study|Subject incarcerated|1|||
145396510|NCT01811732|524306485|FG001|Overall Study|Subject incarcerated|2|||
145396511|NCT01811732|524306484|FG000|Overall Study|Admitted to another facility|1|||
145396512|NCT01811732|524306485|FG001|Overall Study|Admitted to another facility|0|||
145396513|NCT01811732|524306484|FG000|Overall Study|Correct study drug not available on site|1|||
145396514|NCT01811732|524306485|FG001|Overall Study|Correct study drug not available on site|0|||
145396515|NCT01607593|524306488|FG000|Overall Study|Adverse Event|15|||
145396516|NCT01607593|524306488|FG000|Overall Study|Lack of Efficacy|16|||
145396517|NCT01607593|524306488|FG000|Overall Study|Lost to Follow-up|25|||
145396518|NCT01607593|524306488|FG000|Overall Study|Continuation|33|||
145396519|NCT01607593|524306488|FG000|Overall Study|Other|4|||
145396520|NCT00483652|524306491|FG000|Double-blind Treatment Period|Protocol Violation|2|||
145396521|NCT00483652|524306492|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145396522|NCT00483652|524306491|FG000|Double-blind Treatment Period|Adverse Event|3|||
145396523|NCT00483652|524306492|FG001|Double-blind Treatment Period|Adverse Event|4|||
145396524|NCT00483652|524306491|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
145396525|NCT00483652|524306492|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
145396526|NCT00483652|524306491|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
145396527|NCT00483652|524306492|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
145396528|NCT00126594|524306494|FG000|Overall Study|Ineligible|2|||
145396529|NCT00126594|524306495|FG001|Overall Study|Ineligible|0|||
145396530|NCT00126594|524306494|FG000|Overall Study|Withdrawal by Subject|0|||
145396531|NCT00126594|524306495|FG001|Overall Study|Withdrawal by Subject|4|||
145396532|NCT00126594|524306494|FG000|Overall Study|Physician Decision|1|||
145396533|NCT00126594|524306495|FG001|Overall Study|Physician Decision|3|||
145396534|NCT00126594|524306494|FG000|Overall Study|Adverse Event|7|||
145396535|NCT00126594|524306495|FG001|Overall Study|Adverse Event|5|||
145396536|NCT00126594|524306494|FG000|Overall Study|Non-compliance|0|||
145396537|NCT00126594|524306495|FG001|Overall Study|Non-compliance|1|||
145396538|NCT00126594|524306494|FG000|Overall Study|Disease Progression|29|||
145396539|NCT00126594|524306495|FG001|Overall Study|Disease Progression|24|||
145396540|NCT00468585|524306496|FG000|Overall Study|Patient not treated|1|||
145396541|NCT00468585|524306497|FG001|Overall Study|Patient not treated|0|||
145396542|NCT00468585|524306498|FG002|Overall Study|Patient not treated|1|||
145396543|NCT00468585|524306499|FG003|Overall Study|Patient not treated|0|||
145396544|NCT00468585|524306496|FG000|Overall Study|Patient found to be ineligible|0|||
145396545|NCT00468585|524306497|FG001|Overall Study|Patient found to be ineligible|0|||
145396546|NCT00468585|524306498|FG002|Overall Study|Patient found to be ineligible|1|||
145396547|NCT00468585|524306499|FG003|Overall Study|Patient found to be ineligible|0|||
145396548|NCT00468585|524306496|FG000|Overall Study|Adverse Event|0|||
145396549|NCT00468585|524306497|FG001|Overall Study|Adverse Event|0|||
145396550|NCT00468585|524306498|FG002|Overall Study|Adverse Event|1|||
145396551|NCT00468585|524306499|FG003|Overall Study|Adverse Event|0|||
145396552|NCT00468585|524306496|FG000|Overall Study|Withdrawal by Subject|0|||
145396553|NCT00468585|524306497|FG001|Overall Study|Withdrawal by Subject|0|||
145396554|NCT00468585|524306498|FG002|Overall Study|Withdrawal by Subject|2|||
145396555|NCT00468585|524306499|FG003|Overall Study|Withdrawal by Subject|1|||
145396556|NCT01290718|524306504|FG000|Overall Study|Early termination of the study|4|||
145396557|NCT00891813|524306507|FG000|Overall Study|Adverse Event|3|||
145396558|NCT00891813|524306507|FG000|Overall Study|Withdrawal by Subject|1|||
145396559|NCT00891813|524306507|FG000|Overall Study|Patient Noncompliance|6|||
145396560|NCT00891813|524306507|FG000|Overall Study|Protocol Violation|2|||
145396561|NCT02513550|524306508|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
145396562|NCT02513550|524306509|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
145396563|NCT02513550|524306510|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
145396564|NCT02513550|524306511|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
145396565|NCT02513550|524306512|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
145396566|NCT02513550|524306513|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
145396567|NCT02513550|524306508|FG000|Double Blind Treatment Period|Adverse Event|5|||
145396568|NCT02513550|524306509|FG001|Double Blind Treatment Period|Adverse Event|13|||
145396569|NCT02513550|524306510|FG002|Double Blind Treatment Period|Adverse Event|17|||
145396570|NCT02513550|524306511|FG003|Double Blind Treatment Period|Adverse Event|0|||
145396571|NCT02513550|524306512|FG004|Double Blind Treatment Period|Adverse Event|1|||
145396572|NCT02513550|524306513|FG005|Double Blind Treatment Period|Adverse Event|0|||
145396573|NCT02513550|524306508|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
145396574|NCT02513550|524306509|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
145396575|NCT02513550|524306510|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
145396576|NCT02513550|524306511|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
145396577|NCT02513550|524306512|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
145396578|NCT02513550|524306513|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
145396579|NCT02513550|524306508|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
145396580|NCT02513550|524306509|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
145396581|NCT02513550|524306510|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
145396582|NCT02513550|524306511|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
145396583|NCT02513550|524306512|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
145396584|NCT02513550|524306513|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
145396585|NCT02513550|524306508|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145396586|NCT02513550|524306509|FG001|Double Blind Treatment Period|Protocol Violation|1|||
145396587|NCT02513550|524306510|FG002|Double Blind Treatment Period|Protocol Violation|4|||
145396588|NCT02513550|524306511|FG003|Double Blind Treatment Period|Protocol Violation|0|||
145396589|NCT02513550|524306512|FG004|Double Blind Treatment Period|Protocol Violation|0|||
145396590|NCT02513550|524306513|FG005|Double Blind Treatment Period|Protocol Violation|0|||
145396591|NCT02513550|524306508|FG000|Double Blind Treatment Period|Physician Decision|2|||
145396592|NCT02513550|524306509|FG001|Double Blind Treatment Period|Physician Decision|0|||
145396593|NCT02513550|524306510|FG002|Double Blind Treatment Period|Physician Decision|4|||
145396594|NCT02513550|524306511|FG003|Double Blind Treatment Period|Physician Decision|0|||
145396595|NCT02513550|524306512|FG004|Double Blind Treatment Period|Physician Decision|0|||
145396596|NCT02513550|524306513|FG005|Double Blind Treatment Period|Physician Decision|0|||
145396597|NCT02513550|524306508|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
145396598|NCT02513550|524306509|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
145396599|NCT02513550|524306510|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
145396600|NCT02513550|524306511|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
145396601|NCT02513550|524306512|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
145396602|NCT02513550|524306513|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
145396603|NCT02513550|524306508|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145498341|NCT00321620|524683609|FG001|Overall Study|Death|294|||
145498342|NCT00321620|524683608|FG000|Overall Study|Withdrawal by Subject|164|||
145498343|NCT00321620|524683609|FG001|Overall Study|Withdrawal by Subject|147|||
145498344|NCT00321620|524683608|FG000|Overall Study|Disease progression|113|||
145498345|NCT00321620|524683609|FG001|Overall Study|Disease progression|117|||
145498346|NCT00321620|524683608|FG000|Overall Study|Adverse Event|43|||
145498347|NCT00321620|524683609|FG001|Overall Study|Adverse Event|56|||
145498348|NCT00321620|524683608|FG000|Overall Study|Lost to Follow-up|13|||
145498349|NCT00321620|524683609|FG001|Overall Study|Lost to Follow-up|9|||
145498350|NCT00321620|524683608|FG000|Overall Study|Physician Decision|4|||
145498351|NCT00321620|524683609|FG001|Overall Study|Physician Decision|1|||
145498352|NCT00321620|524683608|FG000|Overall Study|Noncompliance|14|||
145498353|NCT00321620|524683609|FG001|Overall Study|Noncompliance|7|||
145498354|NCT00321620|524683608|FG000|Overall Study|Protocol deviation|4|||
145498355|NCT00321620|524683609|FG001|Overall Study|Protocol deviation|3|||
145498356|NCT00321620|524683608|FG000|Overall Study|Ineligibility determined|2|||
145498357|NCT00321620|524683609|FG001|Overall Study|Ineligibility determined|3|||
145498358|NCT00321620|524683608|FG000|Overall Study|Participant request|75|||
145498359|NCT00321620|524683609|FG001|Overall Study|Participant request|52|||
145498360|NCT00321620|524683608|FG000|Overall Study|Other|42|||
145498361|NCT00321620|524683609|FG001|Overall Study|Other|33|||
145498362|NCT03181932|524683610|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
145498363|NCT03181932|524683611|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
145498364|NCT03181932|524683610|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
145498365|NCT03181932|524683611|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
145498366|NCT03181932|524683610|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
145498367|NCT03181932|524683611|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
145498368|NCT03181932|524683610|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
145498369|NCT03181932|524683611|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
145498370|NCT03181932|524683610|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
145498371|NCT03181932|524683611|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
145498372|NCT03181932|524683610|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
145498373|NCT03181932|524683611|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
145498374|NCT03181932|524683610|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
145498375|NCT03181932|524683611|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
145498376|NCT03181932|524683610|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
145498377|NCT03181932|524683611|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
145498378|NCT03181932|524683610|FG000|Period 2 (Open-label Period)|Reason missing|2|||
145498379|NCT03181932|524683611|FG001|Period 2 (Open-label Period)|Reason missing|0|||
145498380|NCT03304626|524683612|FG000|Overall Study|Adverse Event|1|||
145498381|NCT03304626|524683613|FG001|Overall Study|Adverse Event|0|||
145498382|NCT03304626|524683612|FG000|Overall Study|Lack of Efficacy|1|||
145498383|NCT03304626|524683613|FG001|Overall Study|Lack of Efficacy|1|||
145498384|NCT01462370|524683617|FG000|Overall Study|Lack of Qualifying Event|1|||
145498385|NCT01462370|524683618|FG001|Overall Study|Lack of Qualifying Event|1|||
145498386|NCT01462370|524683617|FG000|Overall Study|Physician Decision|0|||
145498387|NCT01462370|524683618|FG001|Overall Study|Physician Decision|1|||
145498388|NCT01462370|524683617|FG000|Overall Study|Withdrawal by Subject|0|||
145498389|NCT01462370|524683618|FG001|Overall Study|Withdrawal by Subject|3|||
145498390|NCT01747876|524683619|FG000|Overall Study|Adverse Event|1|||
145498391|NCT01747876|524683620|FG001|Overall Study|Adverse Event|0|||
145498392|NCT01747876|524683621|FG002|Overall Study|Adverse Event|2|||
145498393|NCT01747876|524683619|FG000|Overall Study|Withdrawal by Subject|0|||
145498394|NCT01747876|524683620|FG001|Overall Study|Withdrawal by Subject|1|||
145498395|NCT01747876|524683621|FG002|Overall Study|Withdrawal by Subject|1|||
145498396|NCT01747876|524683619|FG000|Overall Study|Disease progression|4|||
145498397|NCT01747876|524683620|FG001|Overall Study|Disease progression|13|||
145498398|NCT01747876|524683621|FG002|Overall Study|Disease progression|8|||
145498399|NCT01747876|524683619|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
145498400|NCT01747876|524683620|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
145498401|NCT01747876|524683621|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
145498402|NCT00853307|524683622|FG000|Overall Study|Adverse Event|1|||
145498403|NCT00853307|524683623|FG001|Overall Study|Adverse Event|2|||
145498404|NCT00853307|524683622|FG000|Overall Study|Withdrawal by Subject|1|||
145498405|NCT00853307|524683623|FG001|Overall Study|Withdrawal by Subject|2|||
145498406|NCT00853307|524683622|FG000|Overall Study|Reason Not Specified|0|||
145498407|NCT00853307|524683623|FG001|Overall Study|Reason Not Specified|1|||
145498408|NCT02703597|524683648|FG000|Assignment to Baseline|Lost to Follow-up|17|||
145498409|NCT02703597|524683649|FG001|Assignment to Baseline|Lost to Follow-up|16|||
145498410|NCT02703597|524683648|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
145498411|NCT02703597|524683649|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
145498412|NCT02703597|524683648|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
145498413|NCT02703597|524683649|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
145498414|NCT02703597|524683648|FG000|First Post-test to First Follow-up|Site drop out|0|||
145498415|NCT02703597|524683649|FG001|First Post-test to First Follow-up|Site drop out|58|||
145498416|NCT02703597|524683648|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
145498417|NCT02703597|524683649|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
145498418|NCT02703597|524683648|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
145498419|NCT02703597|524683649|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
145498420|NCT02703597|524683648|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
145498421|NCT02703597|524683649|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
145498422|NCT02461758|524683650|FG000|Overall Study|Lost to Follow-up|0|||
145498423|NCT02461758|524683651|FG001|Overall Study|Lost to Follow-up|1|||
145498424|NCT02461758|524683652|FG002|Overall Study|Lost to Follow-up|1|||
145498425|NCT02461758|524683653|FG003|Overall Study|Lost to Follow-up|0|||
145498426|NCT03216226|524683654|FG000|Overall Study|Adverse Event|3|||
145498427|NCT03216226|524683655|FG001|Overall Study|Adverse Event|0|||
145498428|NCT03216226|524683654|FG000|Overall Study|Protocol Violation|1|||
145498429|NCT03216226|524683655|FG001|Overall Study|Protocol Violation|3|||
145498430|NCT03216226|524683654|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
145498431|NCT03216226|524683655|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
145498432|NCT03216226|524683654|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
145498433|NCT03216226|524683655|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
145498434|NCT03216226|524683654|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
145498435|NCT03216226|524683655|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
145498436|NCT02158442|524683663|FG000|Overall Study|Withdrawal by Subject|1|||
145498437|NCT02158442|524683664|FG001|Overall Study|Withdrawal by Subject|0|||
145498438|NCT02158442|524683663|FG000|Overall Study|Perfusion staff not available|1|||
145498439|NCT02158442|524683664|FG001|Overall Study|Perfusion staff not available|0|||
145498440|NCT01409707|524683665|FG000|Overall Study|Withdrawal by Subject|5|||
145498441|NCT01409707|524683666|FG001|Overall Study|Withdrawal by Subject|17|||
145498442|NCT01409707|524683667|FG002|Overall Study|Withdrawal by Subject|16|||
145498443|NCT01217229|524683668|FG000|Overall Study|Adverse Event|1|||
145498444|NCT01217229|524683668|FG000|Overall Study|Disease progression, deterioration|2|||
145498445|NCT01217229|524683668|FG000|Overall Study|Disease progression, Cheson criteria|14|||
145498446|NCT01217229|524683668|FG000|Overall Study|Protocol Violation|1|||
145498447|NCT01217229|524683668|FG000|Overall Study|Disease progression not confirmed|2|||
145498448|NCT02651675|524683671|FG000|Overall Study|Death|0|||
145498449|NCT02651675|524683672|FG001|Overall Study|Death|0|||
145498450|NCT02651675|524683673|FG002|Overall Study|Death|1|||
145498451|NCT05194124|524683677|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498452|NCT05194124|524683678|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498453|NCT05194124|524683679|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498454|NCT05194124|524683680|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
145498455|NCT05194124|524683681|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498456|NCT05194124|524683682|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
145498457|NCT05194124|524683683|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498458|NCT05194124|524683684|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498459|NCT05194124|524683685|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498460|NCT05194124|524683686|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
145498461|NCT05194124|524683677|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498462|NCT05194124|524683678|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498463|NCT05194124|524683679|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498464|NCT05194124|524683680|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498465|NCT05194124|524683681|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498466|NCT05194124|524683682|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498467|NCT05194124|524683683|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498468|NCT05194124|524683684|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498469|NCT05194124|524683685|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
145498470|NCT05194124|524683686|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
145498471|NCT03642873|524683687|FG000|Third Intervention (1 Day)|Screen failure|0|||
145498472|NCT03642873|524683688|FG001|Third Intervention (1 Day)|Screen failure|0|||
145498473|NCT03642873|524683689|FG002|Third Intervention (1 Day)|Screen failure|0|||
145498474|NCT03642873|524683690|FG003|Third Intervention (1 Day)|Screen failure|0|||
145498475|NCT03642873|524683691|FG004|Third Intervention (1 Day)|Screen failure|1|||
145498476|NCT03642873|524683692|FG005|Third Intervention (1 Day)|Screen failure|0|||
145498477|NCT01253291|524683693|FG000|Overall Study|Withdrawal by Subject|1|||
145498478|NCT01253291|524683694|FG001|Overall Study|Withdrawal by Subject|1|||
145498479|NCT01253291|524683695|FG002|Overall Study|Withdrawal by Subject|0|||
145498480|NCT01253291|524683696|FG003|Overall Study|Withdrawal by Subject|0|||
145498481|NCT01253291|524683697|FG004|Overall Study|Withdrawal by Subject|0|||
145498482|NCT01253291|524683693|FG000|Overall Study|Adverse Event|0|||
145498483|NCT01253291|524683694|FG001|Overall Study|Adverse Event|1|||
145396604|NCT02513550|524306509|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145396605|NCT02513550|524306510|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
145396606|NCT02513550|524306511|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145396607|NCT02513550|524306512|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145396608|NCT02513550|524306513|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
145396609|NCT02513550|524306508|FG000|Double Blind Treatment Period|Due to personal business|2|||
145396610|NCT02513550|524306509|FG001|Double Blind Treatment Period|Due to personal business|0|||
145396611|NCT02513550|524306510|FG002|Double Blind Treatment Period|Due to personal business|1|||
145396612|NCT02513550|524306511|FG003|Double Blind Treatment Period|Due to personal business|0|||
145396613|NCT02513550|524306512|FG004|Double Blind Treatment Period|Due to personal business|0|||
145396614|NCT02513550|524306513|FG005|Double Blind Treatment Period|Due to personal business|0|||
145396615|NCT02513550|524306508|FG000|Double Blind Treatment Period|Death|1|||
145396616|NCT02513550|524306509|FG001|Double Blind Treatment Period|Death|0|||
145396617|NCT02513550|524306510|FG002|Double Blind Treatment Period|Death|2|||
145396618|NCT02513550|524306511|FG003|Double Blind Treatment Period|Death|0|||
145396619|NCT02513550|524306512|FG004|Double Blind Treatment Period|Death|0|||
145396620|NCT02513550|524306513|FG005|Double Blind Treatment Period|Death|0|||
145396621|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
145396622|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
145396623|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
145396624|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145396625|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145396626|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
145396627|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
145396628|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
145396629|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
145396630|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
145396631|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
145396632|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
145396633|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
145396634|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
145396635|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
145396636|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145396637|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145396638|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
145396639|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
145396640|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
145396641|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
145396642|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
145396643|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
145396644|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
145396645|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
145396646|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
145396647|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
145396648|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
145396649|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
145396650|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
145396651|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Death|0|||
145396652|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Death|0|||
145396653|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Death|1|||
145396654|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Death|0|||
145396655|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Death|0|||
145396656|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Death|0|||
145396657|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
145396658|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
145396659|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
145396660|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
145396661|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
145396662|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
145396663|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145396664|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145396665|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
145498484|NCT01253291|524683695|FG002|Overall Study|Adverse Event|0|||
145396666|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145396667|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145396668|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
145396669|NCT02513550|524306508|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
145396670|NCT02513550|524306509|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
145396671|NCT02513550|524306510|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
145396672|NCT02513550|524306511|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
145396673|NCT02513550|524306512|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
145396674|NCT02513550|524306513|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
145396675|NCT02059239|524306514|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
145396676|NCT02059239|524306515|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
145396677|NCT02059239|524306514|FG000|Overall Study|Physician Decision|1|||
145396678|NCT02059239|524306515|FG001|Overall Study|Physician Decision|0|||
145396679|NCT01268267|524306517|FG000|Overall Study|Protocol Violation|1|||
145396680|NCT01222104|524306518|FG000|Overall Study|Lost to Follow-up|37|||
145396681|NCT01222104|524306518|FG000|Overall Study|Death|10|||
145396682|NCT01418339|524306519|FG000|Overall Study|Adverse Event|5|||
145396683|NCT01418339|524306520|FG001|Overall Study|Adverse Event|2|||
145396684|NCT01418339|524306519|FG000|Overall Study|Subject Withdrew Consent|1|||
145396685|NCT01418339|524306520|FG001|Overall Study|Subject Withdrew Consent|2|||
145396686|NCT01418339|524306519|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
145396687|NCT01418339|524306520|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
145396688|NCT02204917|524306523|FG000|Overall Study|Protocol Violation|1|||
145396689|NCT00909844|524306524|FG000|Overall Study|Adverse Event|1|||
145396690|NCT00909844|524306524|FG000|Overall Study|Withdrawal by Subject|1|||
145396691|NCT00909844|524306524|FG000|Overall Study|Lost to Follow-up|2|||
145396692|NCT02219685|524306525|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
145396693|NCT02219685|524306526|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
145396694|NCT02219685|524306525|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
145396695|NCT02219685|524306526|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
145396696|NCT00698815|524306527|FG000|Overall Study|Death|1|||
145396697|NCT00698815|524306528|FG001|Overall Study|Death|2|||
145396698|NCT00698815|524306529|FG002|Overall Study|Death|4|||
145396699|NCT00698815|524306527|FG000|Overall Study|Withdrawal by Subject|6|||
145396700|NCT00698815|524306528|FG001|Overall Study|Withdrawal by Subject|3|||
145396701|NCT00698815|524306529|FG002|Overall Study|Withdrawal by Subject|2|||
145396702|NCT00698815|524306527|FG000|Overall Study|MD discretion|2|||
145396703|NCT00698815|524306528|FG001|Overall Study|MD discretion|7|||
145396704|NCT00698815|524306529|FG002|Overall Study|MD discretion|2|||
145396705|NCT00698815|524306527|FG000|Overall Study|Did not receive protocol treatment|1|||
145396706|NCT00698815|524306528|FG001|Overall Study|Did not receive protocol treatment|2|||
145396707|NCT00698815|524306529|FG002|Overall Study|Did not receive protocol treatment|2|||
145396708|NCT00706004|524306530|FG000|Overall Study|Did not meet eligibility criteria|2|||
145396709|NCT00297648|524306532|FG000|Overall Study|Adverse Event|13|||
145396710|NCT00297648|524306532|FG000|Overall Study|Lack of Efficacy|18|||
145732638|NCT02038920|525539264|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145732639|NCT02038920|525539265|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145732640|NCT02038920|525539266|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
145732641|NCT02038920|525539261|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
145732642|NCT02038920|525539262|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
145732643|NCT02038920|525539263|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
145732644|NCT02038920|525539264|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
145732645|NCT02038920|525539265|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
145266679|NCT04668066|523825251|FG014|Part 1: Follow-Up|Adverse Event|0|||
145396711|NCT00297648|524306532|FG000|Overall Study|Lost to Follow-up|1|||
145396712|NCT00297648|524306532|FG000|Overall Study|Withdrawal by Subject|3|||
145266680|NCT04668066|523825252|FG015|Part 1: Follow-Up|Adverse Event|0|||
145396713|NCT00297648|524306532|FG000|Overall Study|Other: Incompliance|1|||
145498485|NCT01253291|524683696|FG003|Overall Study|Adverse Event|0|||
145498486|NCT01253291|524683697|FG004|Overall Study|Adverse Event|0|||
145498487|NCT01253291|524683693|FG000|Overall Study|Lack of Efficacy|1|||
145498488|NCT01253291|524683694|FG001|Overall Study|Lack of Efficacy|0|||
145498489|NCT01253291|524683695|FG002|Overall Study|Lack of Efficacy|0|||
145498490|NCT01253291|524683696|FG003|Overall Study|Lack of Efficacy|0|||
145498491|NCT01253291|524683697|FG004|Overall Study|Lack of Efficacy|0|||
145498492|NCT01253291|524683693|FG000|Overall Study|Physician Decision|2|||
145498493|NCT01253291|524683694|FG001|Overall Study|Physician Decision|0|||
145498494|NCT01253291|524683695|FG002|Overall Study|Physician Decision|0|||
145498495|NCT01253291|524683696|FG003|Overall Study|Physician Decision|0|||
145498496|NCT01253291|524683697|FG004|Overall Study|Physician Decision|2|||
145498497|NCT01838395|524683701|FG000|Overall Study|Withdrawal by Subject|0|||
145498498|NCT01838395|524683702|FG001|Overall Study|Withdrawal by Subject|0|||
145498499|NCT01838395|524683703|FG002|Overall Study|Withdrawal by Subject|0|||
145498500|NCT01838395|524683704|FG003|Overall Study|Withdrawal by Subject|0|||
145498501|NCT01838395|524683705|FG004|Overall Study|Withdrawal by Subject|1|||
145498502|NCT01838395|524683706|FG005|Overall Study|Withdrawal by Subject|0|||
145396714|NCT03575702|524306537|FG000|Overall Study|Withdrawal by Subject|1|||
145396715|NCT03575702|524306538|FG001|Overall Study|Withdrawal by Subject|1|||
145396716|NCT03575702|524306537|FG000|Overall Study|Lost to Follow-up|1|||
145396717|NCT03575702|524306538|FG001|Overall Study|Lost to Follow-up|2|||
145396718|NCT03575702|524306537|FG000|Overall Study|Protocol Violation|0|||
145396719|NCT03575702|524306538|FG001|Overall Study|Protocol Violation|1|||
145396720|NCT03575702|524306537|FG000|Overall Study|Patient non compliance|4|||
145396721|NCT03575702|524306538|FG001|Overall Study|Patient non compliance|0|||
145396722|NCT01545388|524306539|FG000|Overall Study|Adverse Event|2|||
145396723|NCT01545388|524306540|FG001|Overall Study|Adverse Event|4|||
145396724|NCT01545388|524306541|FG002|Overall Study|Adverse Event|1|||
145396725|NCT01545388|524306539|FG000|Overall Study|Lack of Efficacy|3|||
145396726|NCT01545388|524306540|FG001|Overall Study|Lack of Efficacy|2|||
145396727|NCT01545388|524306541|FG002|Overall Study|Lack of Efficacy|5|||
145396728|NCT01545388|524306539|FG000|Overall Study|Participant moved or relocated|1|||
145396729|NCT01545388|524306540|FG001|Overall Study|Participant moved or relocated|0|||
145396730|NCT01545388|524306541|FG002|Overall Study|Participant moved or relocated|0|||
145396731|NCT01545388|524306539|FG000|Overall Study|Withdrawal by Subject|1|||
145396732|NCT01545388|524306540|FG001|Overall Study|Withdrawal by Subject|4|||
145396733|NCT01545388|524306541|FG002|Overall Study|Withdrawal by Subject|2|||
145396734|NCT01545388|524306539|FG000|Overall Study|Other|1|||
145396735|NCT01545388|524306540|FG001|Overall Study|Other|1|||
145396736|NCT01545388|524306541|FG002|Overall Study|Other|0|||
145396737|NCT01900444|524306542|FG000|Overall Study|Protocol Violation|2|||
145396738|NCT01900444|524306542|FG000|Overall Study|Lost to Follow-up|1|||
145396739|NCT00072384|524306544|FG000|Overall Study|Physician Decision|1|||
145396740|NCT00072384|524306544|FG000|Overall Study|Ineligible|8|||
145396741|NCT01825200|524306545|FG000|Overall Study|Lost to Follow-up|5|||
145396742|NCT01825200|524306546|FG001|Overall Study|Lost to Follow-up|6|||
145396743|NCT01825200|524306545|FG000|Overall Study|Withdrawal by Subject|0|||
145396744|NCT01825200|524306546|FG001|Overall Study|Withdrawal by Subject|1|||
145396745|NCT01255163|524306547|FG000|Overall Study|Withdrawal by Subject|1|||
145396746|NCT01255163|524306548|FG001|Overall Study|Withdrawal by Subject|0|||
145396747|NCT01255163|524306547|FG000|Overall Study|Lost to Follow-up|2|||
145396748|NCT01255163|524306548|FG001|Overall Study|Lost to Follow-up|0|||
145396749|NCT01255163|524306547|FG000|Overall Study|Adverse Event|0|||
145396750|NCT01255163|524306548|FG001|Overall Study|Adverse Event|2|||
145396751|NCT01255163|524306547|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
145396752|NCT01255163|524306548|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
145396753|NCT02127658|524306553|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
145396754|NCT02127658|524306554|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
145396755|NCT02127658|524306553|FG000|Overall Study|Withdrawal by Subject|0|||
145396756|NCT02127658|524306554|FG001|Overall Study|Withdrawal by Subject|2|||
145396757|NCT02127658|524306553|FG000|Overall Study|Physician Decision|0|||
145396758|NCT02127658|524306554|FG001|Overall Study|Physician Decision|1|||
145498503|NCT01838395|524683701|FG000|Overall Study|Death|0|||
145498504|NCT01838395|524683702|FG001|Overall Study|Death|0|||
145498505|NCT01838395|524683703|FG002|Overall Study|Death|1|||
145498506|NCT01838395|524683704|FG003|Overall Study|Death|0|||
145498507|NCT01838395|524683705|FG004|Overall Study|Death|0|||
145396759|NCT03834493|524306555|FG000|Overall Study|Participants Ongoing|311|||
145396760|NCT03834493|524306556|FG001|Overall Study|Participants Ongoing|324|||
145396761|NCT03834493|524306555|FG000|Overall Study|Withdrawal by Subject|20|||
145396762|NCT03834493|524306556|FG001|Overall Study|Withdrawal by Subject|17|||
145396763|NCT03834493|524306555|FG000|Overall Study|Physician Decision|1|||
145396764|NCT03834493|524306556|FG001|Overall Study|Physician Decision|0|||
145396765|NCT03834493|524306555|FG000|Overall Study|Death|289|||
145396766|NCT03834493|524306556|FG001|Overall Study|Death|282|||
145396767|NCT02277028|524306559|FG000|Overall Study|Lost to Follow-up|1|||
145396768|NCT02277028|524306560|FG001|Overall Study|Lost to Follow-up|0|||
145498508|NCT01838395|524683706|FG005|Overall Study|Death|0|||
145396769|NCT02277028|524306559|FG000|Overall Study|Withdrawal by Subject|0|||
145396770|NCT02277028|524306560|FG001|Overall Study|Withdrawal by Subject|1|||
145396771|NCT02718911|524306561|FG000|Overall Study|Adverse Event|0|||
145396772|NCT02718911|524306562|FG001|Overall Study|Adverse Event|0|||
145396773|NCT02718911|524306563|FG002|Overall Study|Adverse Event|0|||
145396774|NCT02718911|524306564|FG003|Overall Study|Adverse Event|0|||
145396775|NCT02718911|524306565|FG004|Overall Study|Adverse Event|0|||
145396776|NCT02718911|524306566|FG005|Overall Study|Adverse Event|0|||
145396777|NCT02718911|524306567|FG006|Overall Study|Adverse Event|0|||
145396778|NCT02718911|524306568|FG007|Overall Study|Adverse Event|0|||
145396779|NCT02718911|524306569|FG008|Overall Study|Adverse Event|0|||
145396780|NCT02718911|524306570|FG009|Overall Study|Adverse Event|2|||
145396781|NCT02718911|524306561|FG000|Overall Study|Death|2|||
145396782|NCT02718911|524306562|FG001|Overall Study|Death|3|||
145396783|NCT02718911|524306563|FG002|Overall Study|Death|1|||
145396784|NCT02718911|524306564|FG003|Overall Study|Death|0|||
145396785|NCT02718911|524306565|FG004|Overall Study|Death|1|||
145396786|NCT02718911|524306566|FG005|Overall Study|Death|3|||
145396787|NCT02718911|524306567|FG006|Overall Study|Death|1|||
145396788|NCT02718911|524306568|FG007|Overall Study|Death|1|||
145396789|NCT02718911|524306569|FG008|Overall Study|Death|4|||
145396790|NCT02718911|524306570|FG009|Overall Study|Death|3|||
145396791|NCT02718911|524306561|FG000|Overall Study|Lost to Follow-up|0|||
145396792|NCT02718911|524306562|FG001|Overall Study|Lost to Follow-up|0|||
145396793|NCT02718911|524306563|FG002|Overall Study|Lost to Follow-up|0|||
145396794|NCT02718911|524306564|FG003|Overall Study|Lost to Follow-up|0|||
145396795|NCT02718911|524306565|FG004|Overall Study|Lost to Follow-up|0|||
145396796|NCT02718911|524306566|FG005|Overall Study|Lost to Follow-up|0|||
145396797|NCT02718911|524306567|FG006|Overall Study|Lost to Follow-up|0|||
145396798|NCT02718911|524306568|FG007|Overall Study|Lost to Follow-up|0|||
145396799|NCT02718911|524306569|FG008|Overall Study|Lost to Follow-up|1|||
145396800|NCT02718911|524306570|FG009|Overall Study|Lost to Follow-up|0|||
145396801|NCT02718911|524306561|FG000|Overall Study|Physician Decision|2|||
145396802|NCT02718911|524306562|FG001|Overall Study|Physician Decision|0|||
145396803|NCT02718911|524306563|FG002|Overall Study|Physician Decision|1|||
145396804|NCT02718911|524306564|FG003|Overall Study|Physician Decision|1|||
145396805|NCT02718911|524306565|FG004|Overall Study|Physician Decision|0|||
145396806|NCT02718911|524306566|FG005|Overall Study|Physician Decision|0|||
145396807|NCT02718911|524306567|FG006|Overall Study|Physician Decision|0|||
145396808|NCT02718911|524306568|FG007|Overall Study|Physician Decision|1|||
145396809|NCT02718911|524306569|FG008|Overall Study|Physician Decision|2|||
145396810|NCT02718911|524306570|FG009|Overall Study|Physician Decision|1|||
145396811|NCT02718911|524306561|FG000|Overall Study|Withdrawal by Subject|0|||
145396812|NCT02718911|524306562|FG001|Overall Study|Withdrawal by Subject|0|||
145396813|NCT02718911|524306563|FG002|Overall Study|Withdrawal by Subject|0|||
145396814|NCT02718911|524306564|FG003|Overall Study|Withdrawal by Subject|0|||
145396815|NCT02718911|524306565|FG004|Overall Study|Withdrawal by Subject|1|||
145396816|NCT02718911|524306566|FG005|Overall Study|Withdrawal by Subject|0|||
145396817|NCT02718911|524306567|FG006|Overall Study|Withdrawal by Subject|0|||
145396818|NCT02718911|524306568|FG007|Overall Study|Withdrawal by Subject|0|||
145396819|NCT02718911|524306569|FG008|Overall Study|Withdrawal by Subject|1|||
145396820|NCT02718911|524306570|FG009|Overall Study|Withdrawal by Subject|4|||
145732646|NCT02038920|525539266|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
145396821|NCT02718911|524306561|FG000|Overall Study|Reason Not Collected|0|||
145396822|NCT02718911|524306562|FG001|Overall Study|Reason Not Collected|0|||
145396823|NCT02718911|524306563|FG002|Overall Study|Reason Not Collected|1|||
145396824|NCT02718911|524306564|FG003|Overall Study|Reason Not Collected|0|||
145732647|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145396825|NCT02718911|524306565|FG004|Overall Study|Reason Not Collected|0|||
145396826|NCT02718911|524306566|FG005|Overall Study|Reason Not Collected|0|||
145396827|NCT02718911|524306567|FG006|Overall Study|Reason Not Collected|2|||
145396828|NCT02718911|524306568|FG007|Overall Study|Reason Not Collected|1|||
145396829|NCT02718911|524306569|FG008|Overall Study|Reason Not Collected|4|||
145732648|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145732649|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145732650|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145732651|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
145732652|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
145732653|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145732654|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145732655|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145732656|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145732657|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
145732658|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
145498509|NCT01838395|524683701|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
145498510|NCT01838395|524683702|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
145498511|NCT01838395|524683703|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
145498512|NCT01838395|524683704|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
145498513|NCT01838395|524683705|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
145498514|NCT01838395|524683706|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
145498515|NCT03312231|524683707|FG000|Overall Study|Lost to Follow-up|2|||
145498516|NCT03312231|524683708|FG001|Overall Study|Lost to Follow-up|6|||
145498517|NCT03312231|524683709|FG002|Overall Study|Lost to Follow-up|1|||
145498518|NCT03312231|524683710|FG003|Overall Study|Lost to Follow-up|3|||
145498519|NCT03312231|524683711|FG004|Overall Study|Lost to Follow-up|1|||
145498520|NCT03312231|524683707|FG000|Overall Study|Withdrawal by Subject|0|||
145498521|NCT03312231|524683708|FG001|Overall Study|Withdrawal by Subject|3|||
145498522|NCT03312231|524683709|FG002|Overall Study|Withdrawal by Subject|1|||
145498523|NCT03312231|524683710|FG003|Overall Study|Withdrawal by Subject|0|||
145498524|NCT03312231|524683711|FG004|Overall Study|Withdrawal by Subject|0|||
145498525|NCT03312231|524683707|FG000|Overall Study|Death|0|||
145498526|NCT03312231|524683708|FG001|Overall Study|Death|1|||
145498527|NCT03312231|524683709|FG002|Overall Study|Death|1|||
145498528|NCT03312231|524683710|FG003|Overall Study|Death|0|||
145498529|NCT03312231|524683711|FG004|Overall Study|Death|0|||
145498530|NCT03312231|524683707|FG000|Overall Study|Study Vaccination not Received|1|||
145498531|NCT03312231|524683708|FG001|Overall Study|Study Vaccination not Received|1|||
145498532|NCT03312231|524683709|FG002|Overall Study|Study Vaccination not Received|1|||
145498533|NCT03312231|524683710|FG003|Overall Study|Study Vaccination not Received|0|||
145498534|NCT03312231|524683711|FG004|Overall Study|Study Vaccination not Received|0|||
145498535|NCT03157830|524683716|FG000|Overall Study|Lost to Follow-up|1|||
145498536|NCT03157830|524683716|FG000|Overall Study|Withdrawal by Subject|1|||
145498537|NCT03694353|524683720|FG000|Overall Study|Withdrawal by Subject|1|||
145498538|NCT03694353|524683720|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
145498539|NCT05720897|524683722|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
145498540|NCT05720897|524683723|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
145498541|NCT05565742|524683729|FG000|Overall Study|Withdrawal by Subject|0|||
145498542|NCT05565742|524683730|FG001|Overall Study|Withdrawal by Subject|0|||
145498543|NCT05565742|524683731|FG002|Overall Study|Withdrawal by Subject|2|||
145498544|NCT05565742|524683732|FG003|Overall Study|Withdrawal by Subject|2|||
145498545|NCT05565742|524683733|FG004|Overall Study|Withdrawal by Subject|2|||
145498546|NCT05565742|524683729|FG000|Overall Study|Death|1|||
145498547|NCT05565742|524683730|FG001|Overall Study|Death|0|||
145498548|NCT05565742|524683731|FG002|Overall Study|Death|0|||
145498549|NCT05565742|524683732|FG003|Overall Study|Death|0|||
145498550|NCT05565742|524683733|FG004|Overall Study|Death|0|||
145498551|NCT05565742|524683729|FG000|Overall Study|Participant Travelled Abroad|0|||
145498552|NCT05565742|524683730|FG001|Overall Study|Participant Travelled Abroad|0|||
145498553|NCT05565742|524683731|FG002|Overall Study|Participant Travelled Abroad|0|||
145498554|NCT05565742|524683732|FG003|Overall Study|Participant Travelled Abroad|0|||
145498555|NCT05565742|524683733|FG004|Overall Study|Participant Travelled Abroad|1|||
145498556|NCT04163341|524683734|FG000|Overall Study|Withdrawal by Subject|2|||
145498557|NCT04163341|524683735|FG001|Overall Study|Withdrawal by Subject|0|||
145498558|NCT04163341|524683734|FG000|Overall Study|Lost to Follow-up|3|||
145498559|NCT04163341|524683735|FG001|Overall Study|Lost to Follow-up|4|||
145498560|NCT05417438|524683736|FG000|Overall Study|Withdrawal by Subject|3|||
145498561|NCT04272242|524683737|FG000|Overall Study|Withdrawal by Subject|3|||
145498562|NCT04272242|524683737|FG000|Overall Study|Lost to Follow-up|1|||
145498563|NCT04272242|524683737|FG000|Overall Study|Adverse Event|1|||
145498564|NCT02681523|524683740|FG000|Overall Study|Adverse Event|1|||
145498565|NCT02681523|524683740|FG000|Overall Study|Patient Non-compliance|1|||
145498566|NCT01586364|524685213|FG000|Overall Study|Withdrawal by Subject|40|||
145498567|NCT01586364|524685213|FG000|Overall Study|Adverse Event|37|||
145396830|NCT02718911|524306570|FG009|Overall Study|Reason Not Collected|9|||
145396831|NCT01867008|524306571|FG000|Overall Study|Withdrawal by Subject|1|||
145396832|NCT00983372|524306572|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
145396833|NCT00983372|524306572|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
145396834|NCT00983372|524306572|FG000|Diltiazem ER Alone|Adverse Event|1|||
145396835|NCT00791999|524306580|FG000|Overall Study|Protocol planed withdrawal|14|||
145396836|NCT00791999|524306581|FG001|Overall Study|Protocol planed withdrawal|11|||
145396837|NCT00791999|524306582|FG002|Overall Study|Protocol planed withdrawal|11|||
145396838|NCT00791999|524306583|FG003|Overall Study|Protocol planed withdrawal|45|||
145396839|NCT00791999|524306580|FG000|Overall Study|Withdrawal by Subject|0|||
145396840|NCT00791999|524306581|FG001|Overall Study|Withdrawal by Subject|1|||
145396841|NCT00791999|524306582|FG002|Overall Study|Withdrawal by Subject|0|||
145396842|NCT00791999|524306583|FG003|Overall Study|Withdrawal by Subject|2|||
145396843|NCT00791999|524306580|FG000|Overall Study|Protocol Violation|3|||
145396844|NCT00791999|524306581|FG001|Overall Study|Protocol Violation|0|||
145396845|NCT00791999|524306582|FG002|Overall Study|Protocol Violation|1|||
145396846|NCT00791999|524306583|FG003|Overall Study|Protocol Violation|0|||
145396847|NCT00791999|524306580|FG000|Overall Study|Adverse Event|3|||
145396848|NCT00791999|524306581|FG001|Overall Study|Adverse Event|3|||
145396849|NCT00791999|524306582|FG002|Overall Study|Adverse Event|7|||
145396850|NCT00791999|524306583|FG003|Overall Study|Adverse Event|3|||
145396851|NCT00791999|524306580|FG000|Overall Study|Lack of Efficacy|0|||
145396852|NCT00791999|524306581|FG001|Overall Study|Lack of Efficacy|1|||
145396853|NCT00791999|524306582|FG002|Overall Study|Lack of Efficacy|0|||
145396854|NCT00791999|524306583|FG003|Overall Study|Lack of Efficacy|2|||
145396855|NCT00791999|524306580|FG000|Overall Study|Reason other than those above|1|||
145396856|NCT00791999|524306581|FG001|Overall Study|Reason other than those above|0|||
145396857|NCT00791999|524306582|FG002|Overall Study|Reason other than those above|1|||
145396858|NCT00791999|524306583|FG003|Overall Study|Reason other than those above|0|||
145396859|NCT00570401|524306588|FG000|Overall Study|Adverse Event|2|||
145396860|NCT01710020|524306589|FG000|Period 1|Protocol Violation|1|||
145396861|NCT01764841|524306590|FG000|Overall Study|Logistical Difficulties|0|||
145396862|NCT01764841|524306591|FG001|Overall Study|Logistical Difficulties|1|||
145396863|NCT01764841|524306592|FG002|Overall Study|Logistical Difficulties|0|||
145396864|NCT01764841|524306593|FG003|Overall Study|Logistical Difficulties|0|||
145396865|NCT01764841|524306590|FG000|Overall Study|Death|3|||
145396866|NCT01764841|524306591|FG001|Overall Study|Death|0|||
145396867|NCT01764841|524306592|FG002|Overall Study|Death|1|||
145396868|NCT01764841|524306593|FG003|Overall Study|Death|4|||
145396869|NCT01764841|524306590|FG000|Overall Study|No Follow Up|1|||
145396870|NCT01764841|524306591|FG001|Overall Study|No Follow Up|0|||
145396871|NCT01764841|524306592|FG002|Overall Study|No Follow Up|1|||
145396872|NCT01764841|524306593|FG003|Overall Study|No Follow Up|0|||
145396873|NCT01764841|524306590|FG000|Overall Study|Protocol Violation|0|||
145396874|NCT01764841|524306591|FG001|Overall Study|Protocol Violation|1|||
145396875|NCT01764841|524306592|FG002|Overall Study|Protocol Violation|0|||
145396876|NCT01764841|524306593|FG003|Overall Study|Protocol Violation|0|||
145396877|NCT01764841|524306590|FG000|Overall Study|Withdrawal by Subject|16|||
145396878|NCT01764841|524306591|FG001|Overall Study|Withdrawal by Subject|24|||
145396879|NCT01764841|524306592|FG002|Overall Study|Withdrawal by Subject|11|||
145396880|NCT01764841|524306593|FG003|Overall Study|Withdrawal by Subject|15|||
145396881|NCT01764841|524306590|FG000|Overall Study|Lost to Follow-up|3|||
145396882|NCT01764841|524306591|FG001|Overall Study|Lost to Follow-up|0|||
145396883|NCT01764841|524306592|FG002|Overall Study|Lost to Follow-up|1|||
145396884|NCT01764841|524306593|FG003|Overall Study|Lost to Follow-up|0|||
145396885|NCT00248651|524306594|FG000|Overall Study|Withdrawal by Subject|28|||
145396886|NCT00248651|524306595|FG001|Overall Study|Withdrawal by Subject|40|||
145396887|NCT00248651|524306596|FG002|Overall Study|Withdrawal by Subject|32|||
145396888|NCT00828113|524306597|FG000|Overall Study|Withdrawal by Subject|27|||
145396889|NCT00828113|524306598|FG001|Overall Study|Withdrawal by Subject|26|||
145396890|NCT00828113|524306597|FG000|Overall Study|Lost to Follow-up|3|||
145396891|NCT00828113|524306598|FG001|Overall Study|Lost to Follow-up|5|||
145396892|NCT02481050|524309154|FG000|Overall Study|Adverse Event|1|||
145396893|NCT02481050|524309154|FG000|Overall Study|Disease Progression|47|||
145396894|NCT02481050|524309154|FG000|Overall Study|Withdrawal by Subject|7|||
145396895|NCT02481050|524309154|FG000|Overall Study|Other|3|||
145396896|NCT01386606|524309155|FG000|Overall Study|Adverse Event|0|||
145396897|NCT01386606|524309156|FG001|Overall Study|Adverse Event|1|||
145396898|NCT01386606|524309157|FG002|Overall Study|Adverse Event|0|||
145498568|NCT01586364|524685213|FG000|Overall Study|Lost to Follow-up|17|||
145498569|NCT01586364|524685213|FG000|Overall Study|Protocol Violation|16|||
145498570|NCT01586364|524685213|FG000|Overall Study|Lack of Efficacy|1|||
145498571|NCT01586364|524685213|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
145498572|NCT01586364|524685213|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
145498573|NCT01586364|524685213|FG000|Overall Study|Other-Site closure due to PI illness|1|||
145498574|NCT01586364|524685213|FG000|Overall Study|Other-PI discretion, site closing|2|||
145498575|NCT01586364|524685213|FG000|Overall Study|Other-Not specified|1|||
145498576|NCT00091949|524685214|FG000|Overall Study|Withdrawal by Subject|117|||
145498577|NCT00091949|524685215|FG001|Overall Study|Withdrawal by Subject|110|||
145498578|NCT00091949|524685214|FG000|Overall Study|Lost to Follow-up|58|||
145498579|NCT00091949|524685215|FG001|Overall Study|Lost to Follow-up|41|||
145498580|NCT05366738|524685216|FG000|Overall Study|Adverse Event|0|||
145498581|NCT05366738|524685217|FG001|Overall Study|Adverse Event|1|||
145498582|NCT05366738|524685218|FG002|Overall Study|Adverse Event|0|||
145498583|NCT05291520|524685219|FG000|Overall Study|Lost to Follow-up|0|||
145498584|NCT05291520|524685220|FG001|Overall Study|Lost to Follow-up|0|||
145498585|NCT05291520|524685221|FG002|Overall Study|Lost to Follow-up|1|||
145498586|NCT01347112|524685222|FG000|Overall Study|Withdrawal by Subject|1|||
145498587|NCT01347112|524685223|FG001|Overall Study|Withdrawal by Subject|7|||
145498588|NCT01347112|524685222|FG000|Overall Study|Lost to Follow-up|3|||
145498589|NCT01347112|524685223|FG001|Overall Study|Lost to Follow-up|5|||
145498590|NCT00696072|524685224|FG000|Overall Study|continuing active treatment|10|||
145498591|NCT00696072|524685225|FG001|Overall Study|continuing active treatment|13|||
145498592|NCT00696072|524685224|FG000|Overall Study|Adverse Event|10|||
145498593|NCT00696072|524685225|FG001|Overall Study|Adverse Event|6|||
145498594|NCT00696072|524685224|FG000|Overall Study|Patient Request|3|||
145498595|NCT00696072|524685225|FG001|Overall Study|Patient Request|7|||
145498596|NCT00696072|524685224|FG000|Overall Study|Investigator Request|1|||
145498597|NCT00696072|524685225|FG001|Overall Study|Investigator Request|4|||
145498598|NCT00696072|524685224|FG000|Overall Study|Sponsor Request|0|||
145498599|NCT00696072|524685225|FG001|Overall Study|Sponsor Request|1|||
145498600|NCT00696072|524685224|FG000|Overall Study|Disease Progression|32|||
145498601|NCT00696072|524685225|FG001|Overall Study|Disease Progression|30|||
145498602|NCT00696072|524685224|FG000|Overall Study|Non-specified|1|||
145498603|NCT00696072|524685225|FG001|Overall Study|Non-specified|2|||
145498604|NCT01597596|524685226|FG000|Overall Study|Study terminated by sponsor|1|||
145498605|NCT01597596|524685227|FG001|Overall Study|Study terminated by sponsor|0|||
145498606|NCT01597596|524685226|FG000|Overall Study|Physician Decision|0|||
145498607|NCT01597596|524685227|FG001|Overall Study|Physician Decision|1|||
145498608|NCT00992108|524685234|FG000|Overall Study|Lost to Follow-up|0|||
145498609|NCT00992108|524685235|FG001|Overall Study|Lost to Follow-up|1|||
145498610|NCT02419001|524685238|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
145498611|NCT02419001|524685239|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
145498612|NCT01614886|524685250|FG000|Overall Study|Adverse Event|15|||
145498613|NCT01614886|524685251|FG001|Overall Study|Adverse Event|20|||
145498614|NCT01614886|524685250|FG000|Overall Study|Withdrawal by Subject|4|||
145498615|NCT01614886|524685251|FG001|Overall Study|Withdrawal by Subject|4|||
145498616|NCT01614886|524685250|FG000|Overall Study|Death|1|||
145498617|NCT01614886|524685251|FG001|Overall Study|Death|0|||
145498618|NCT01614886|524685250|FG000|Overall Study|Protocol deviation|0|||
145498619|NCT01614886|524685251|FG001|Overall Study|Protocol deviation|2|||
145498620|NCT01523366|524685252|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145498621|NCT01523366|524685253|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145498622|NCT01523366|524685252|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
145498623|NCT01523366|524685253|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
145498624|NCT01352715|524685254|FG000|Overall Study|Death|3|||
145498625|NCT01352715|524685255|FG001|Overall Study|Death|3|||
145498626|NCT01352715|524685254|FG000|Overall Study|Lost to Follow-up|5|||
145498627|NCT01352715|524685255|FG001|Overall Study|Lost to Follow-up|7|||
145498628|NCT01352715|524685254|FG000|Overall Study|Withdrawal by Subject|4|||
145498629|NCT01352715|524685255|FG001|Overall Study|Withdrawal by Subject|8|||
145498630|NCT01352715|524685254|FG000|Overall Study|site closure|16|||
145498631|NCT01352715|524685255|FG001|Overall Study|site closure|15|||
145498632|NCT01352715|524685254|FG000|Overall Study|no final visit in closeout period|15|||
145498633|NCT01352715|524685255|FG001|Overall Study|no final visit in closeout period|12|||
145498634|NCT01352715|524685254|FG000|Overall Study|major ineligibility|2|||
145498635|NCT01352715|524685255|FG001|Overall Study|major ineligibility|1|||
145605965|NCT00638235|525073061|FG003|Overall Study|Lost to Follow-up|10|||
145498636|NCT04596267|524685256|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
145498637|NCT04596267|524685257|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
145498638|NCT04596267|524685256|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
145498639|NCT04596267|524685257|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
145498640|NCT00071058|524685258|FG000|Overall Study|brain tumor-removed from study|1|||
145498641|NCT01710345|524685259|FG000|Overall Study|Adverse Event|0|||
145498642|NCT01710345|524685260|FG001|Overall Study|Adverse Event|2|||
145498643|NCT01710345|524685261|FG002|Overall Study|Adverse Event|0|||
145498644|NCT01710345|524685259|FG000|Overall Study|Lack of Efficacy|2|||
145498645|NCT01710345|524685260|FG001|Overall Study|Lack of Efficacy|3|||
145498646|NCT01710345|524685261|FG002|Overall Study|Lack of Efficacy|1|||
145498647|NCT01710345|524685259|FG000|Overall Study|Drug Dosing Error|1|||
145498648|NCT01710345|524685260|FG001|Overall Study|Drug Dosing Error|0|||
145498649|NCT01710345|524685261|FG002|Overall Study|Drug Dosing Error|0|||
145498650|NCT00449696|524685263|FG000|Overall Study|Other Treatment Required|6|||
145498651|NCT00449696|524685264|FG001|Overall Study|Other Treatment Required|1|||
145498652|NCT00449696|524685263|FG000|Overall Study|Withdrawal by Subject|5|||
145498653|NCT00449696|524685264|FG001|Overall Study|Withdrawal by Subject|5|||
145498654|NCT00449696|524685263|FG000|Overall Study|Lost to Follow-up|2|||
145498655|NCT00449696|524685264|FG001|Overall Study|Lost to Follow-up|3|||
145498656|NCT00449696|524685263|FG000|Overall Study|Others|7|||
145498657|NCT00449696|524685264|FG001|Overall Study|Others|0|||
145498658|NCT01033019|524685265|FG000|Overall Study|Withdrawal by Subject|1|||
145498659|NCT01033019|524685266|FG001|Overall Study|Withdrawal by Subject|0|||
145498660|NCT00551642|524685269|FG000|Treatment Period|Protocol Deviation|6|||
145498661|NCT00551642|524685270|FG001|Treatment Period|Protocol Deviation|11|||
145498662|NCT00551642|524685269|FG000|Treatment Period|Delivery device failure|1|||
145498663|NCT00551642|524685270|FG001|Treatment Period|Delivery device failure|3|||
145498664|NCT00551642|524685269|FG000|Treatment Period|Physician Decision|0|||
145498665|NCT00551642|524685270|FG001|Treatment Period|Physician Decision|1|||
145498666|NCT00551642|524685269|FG000|Treatment Period|Death|33|||
145498667|NCT00551642|524685270|FG001|Treatment Period|Death|31|||
145498668|NCT00551642|524685269|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
145498669|NCT00551642|524685270|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
145498670|NCT00551642|524685269|FG000|Treatment Period|Adverse Event|15|||
145498671|NCT00551642|524685270|FG001|Treatment Period|Adverse Event|12|||
145498672|NCT00551642|524685269|FG000|Treatment Period|Withdrawal by Subject|2|||
145498673|NCT00551642|524685270|FG001|Treatment Period|Withdrawal by Subject|1|||
145498674|NCT03011099|524685271|FG000|Overall Study|Withdrawal by Subject|0|||
145498675|NCT03011099|524685272|FG001|Overall Study|Withdrawal by Subject|2|||
145732659|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145498676|NCT00283296|524685276|FG000|Overall Study|in-home trial not completed|5|||
145498677|NCT01353898|524685277|FG000|Overall Study|Study site terminated|0|||
145732660|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145732661|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145732662|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145732663|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
145732664|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
145732665|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145732666|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145732667|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145732668|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145732669|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
145732670|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
145732671|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145732672|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145732673|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145732674|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145732675|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
145732676|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
145732677|NCT02038920|525539261|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
145732678|NCT02038920|525539262|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
145732679|NCT02038920|525539263|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
145732680|NCT02038920|525539264|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
145732681|NCT02038920|525539265|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
145732682|NCT02038920|525539266|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
145732683|NCT02383589|525539267|FG000|Treatment Period|Adverse Event|1|||
145732684|NCT02383589|525539268|FG001|Treatment Period|Adverse Event|3|||
145732685|NCT02383589|525539267|FG000|Treatment Period|Lost to Follow-up|0|||
145732686|NCT02383589|525539268|FG001|Treatment Period|Lost to Follow-up|1|||
145732687|NCT02383589|525539267|FG000|Treatment Period|Withdrawal by Subject|0|||
145732688|NCT02383589|525539268|FG001|Treatment Period|Withdrawal by Subject|5|||
145396899|NCT01386606|524309158|FG003|Overall Study|Adverse Event|0|||
145396900|NCT01386606|524309155|FG000|Overall Study|Withdrawal by Subject|0|||
145396901|NCT01386606|524309156|FG001|Overall Study|Withdrawal by Subject|1|||
145396902|NCT01386606|524309157|FG002|Overall Study|Withdrawal by Subject|1|||
145396903|NCT01386606|524309158|FG003|Overall Study|Withdrawal by Subject|0|||
145396904|NCT01386606|524309155|FG000|Overall Study|Protocol Violation|1|||
145396905|NCT01386606|524309156|FG001|Overall Study|Protocol Violation|0|||
145396906|NCT01386606|524309157|FG002|Overall Study|Protocol Violation|1|||
145732689|NCT02383589|525539267|FG000|Treatment Period|Non-compliance with study drug|0|||
145396907|NCT01386606|524309158|FG003|Overall Study|Protocol Violation|1|||
145396908|NCT01386606|524309155|FG000|Overall Study|Lost to Follow-up|2|||
145396909|NCT01386606|524309156|FG001|Overall Study|Lost to Follow-up|0|||
145732690|NCT02383589|525539268|FG001|Treatment Period|Non-compliance with study drug|1|||
145732691|NCT02383589|525539267|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
145732692|NCT02383589|525539268|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
145732693|NCT02383589|525539267|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
145732694|NCT02383589|525539268|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
145732695|NCT02383589|525539267|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
145732696|NCT02383589|525539268|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
145732697|NCT00866697|525539269|FG000|Overall Study|Study closed/terminated|156|||
145732698|NCT00866697|525539270|FG001|Overall Study|Study closed/terminated|138|||
145732699|NCT00866697|525539269|FG000|Overall Study|Lost to Follow-up|22|||
145732700|NCT00866697|525539270|FG001|Overall Study|Lost to Follow-up|28|||
145732701|NCT00866697|525539269|FG000|Overall Study|Physician Decision|3|||
145732702|NCT00866697|525539270|FG001|Overall Study|Physician Decision|5|||
145732703|NCT00866697|525539269|FG000|Overall Study|Withdrawal by Subject|33|||
145732704|NCT00866697|525539270|FG001|Overall Study|Withdrawal by Subject|57|||
145732705|NCT02906787|525539274|FG000|Overall Study|Withdrawal by Subject|12|||
145732706|NCT02906787|525539275|FG001|Overall Study|Withdrawal by Subject|10|||
145732707|NCT02906787|525539274|FG000|Overall Study|Missed|24|||
145732708|NCT02906787|525539275|FG001|Overall Study|Missed|22|||
145732709|NCT04275297|525539276|FG000|Overall Study|Lost to Follow-up|1|||
145732710|NCT04275297|525539277|FG001|Overall Study|Lost to Follow-up|1|||
145732711|NCT00447382|525539278|FG000|Overall Study|Adverse Event|1|||
145732712|NCT00447382|525539279|FG001|Overall Study|Adverse Event|1|||
145732713|NCT00447382|525539278|FG000|Overall Study|Lack of Efficacy|1|||
145732714|NCT00447382|525539279|FG001|Overall Study|Lack of Efficacy|0|||
145732715|NCT00447382|525539278|FG000|Overall Study|Protocol Violation|2|||
145732716|NCT00447382|525539279|FG001|Overall Study|Protocol Violation|0|||
145732717|NCT00447382|525539278|FG000|Overall Study|Unclassified|2|||
145732718|NCT00447382|525539279|FG001|Overall Study|Unclassified|5|||
145732719|NCT04225806|525539286|FG000|Overall Study|Trial termination|15|||
145732720|NCT02408861|525539287|FG000|Overall Study|Death|0|||
145732721|NCT02408861|525539288|FG001|Overall Study|Death|3|||
145732722|NCT02408861|525539289|FG002|Overall Study|Death|1|||
145732723|NCT02408861|525539290|FG003|Overall Study|Death|2|||
145732724|NCT02408861|525539291|FG004|Overall Study|Death|4|||
145732725|NCT02408861|525539292|FG005|Overall Study|Death|1|||
145732726|NCT02408861|525539293|FG006|Overall Study|Death|0|||
145732727|NCT02408861|525539287|FG000|Overall Study|Lost to Follow-up|0|||
145732728|NCT02408861|525539288|FG001|Overall Study|Lost to Follow-up|0|||
145732729|NCT02408861|525539289|FG002|Overall Study|Lost to Follow-up|1|||
145732730|NCT02408861|525539290|FG003|Overall Study|Lost to Follow-up|1|||
145732731|NCT02408861|525539291|FG004|Overall Study|Lost to Follow-up|4|||
145732732|NCT02408861|525539292|FG005|Overall Study|Lost to Follow-up|2|||
145732733|NCT02408861|525539293|FG006|Overall Study|Lost to Follow-up|1|||
145732734|NCT02408861|525539287|FG000|Overall Study|Disease Progression|0|||
145732735|NCT02408861|525539288|FG001|Overall Study|Disease Progression|0|||
145732736|NCT02408861|525539289|FG002|Overall Study|Disease Progression|1|||
145732737|NCT02408861|525539290|FG003|Overall Study|Disease Progression|0|||
145732738|NCT02408861|525539291|FG004|Overall Study|Disease Progression|3|||
145732739|NCT02408861|525539292|FG005|Overall Study|Disease Progression|1|||
145732740|NCT02408861|525539293|FG006|Overall Study|Disease Progression|1|||
145732741|NCT02408861|525539287|FG000|Overall Study|Adverse Event|1|||
145732742|NCT02408861|525539288|FG001|Overall Study|Adverse Event|0|||
145732743|NCT02408861|525539289|FG002|Overall Study|Adverse Event|1|||
145732744|NCT02408861|525539290|FG003|Overall Study|Adverse Event|0|||
145732745|NCT02408861|525539291|FG004|Overall Study|Adverse Event|2|||
145732746|NCT02408861|525539292|FG005|Overall Study|Adverse Event|0|||
145732747|NCT02408861|525539293|FG006|Overall Study|Adverse Event|0|||
145732748|NCT02408861|525539287|FG000|Overall Study|Physician Decision|1|||
145732749|NCT02408861|525539288|FG001|Overall Study|Physician Decision|1|||
145732750|NCT02408861|525539289|FG002|Overall Study|Physician Decision|1|||
145732751|NCT02408861|525539290|FG003|Overall Study|Physician Decision|0|||
145732752|NCT02408861|525539291|FG004|Overall Study|Physician Decision|0|||
145732753|NCT02408861|525539292|FG005|Overall Study|Physician Decision|1|||
145732754|NCT02408861|525539293|FG006|Overall Study|Physician Decision|0|||
145732755|NCT02408861|525539287|FG000|Overall Study|Protocol Violation|1|||
145498678|NCT01353898|524685278|FG001|Overall Study|Study site terminated|0|||
145498679|NCT01353898|524685279|FG002|Overall Study|Study site terminated|0|||
145498680|NCT01353898|524685280|FG003|Overall Study|Study site terminated|0|||
145498681|NCT01353898|524685281|FG004|Overall Study|Study site terminated|0|||
145498682|NCT01353898|524685282|FG005|Overall Study|Study site terminated|1|||
145498683|NCT02668653|524685283|FG000|Overall Study|Refractory disease|41|||
145498684|NCT02668653|524685284|FG001|Overall Study|Refractory disease|70|||
145498685|NCT02668653|524685283|FG000|Overall Study|Relapse|44|||
145498686|NCT02668653|524685284|FG001|Overall Study|Relapse|65|||
145498687|NCT02668653|524685283|FG000|Overall Study|Adverse Event|58|||
145498688|NCT02668653|524685284|FG001|Overall Study|Adverse Event|23|||
145498689|NCT02668653|524685283|FG000|Overall Study|Subject decision to stop study drug|25|||
145498690|NCT02668653|524685284|FG001|Overall Study|Subject decision to stop study drug|23|||
145498691|NCT02668653|524685283|FG000|Overall Study|Other reasons not specified|16|||
145498692|NCT02668653|524685284|FG001|Overall Study|Other reasons not specified|11|||
145498693|NCT02668653|524685283|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
145498694|NCT02668653|524685284|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
145498695|NCT02668653|524685283|FG000|Overall Study|Investigator decision|10|||
145498696|NCT02668653|524685284|FG001|Overall Study|Investigator decision|7|||
145498697|NCT02668653|524685283|FG000|Overall Study|Failure to meet continuation criteria|5|||
145498698|NCT02668653|524685284|FG001|Overall Study|Failure to meet continuation criteria|12|||
145498699|NCT02668653|524685283|FG000|Overall Study|Lost to Follow-up|1|||
145498700|NCT02668653|524685284|FG001|Overall Study|Lost to Follow-up|0|||
145498701|NCT02668653|524685283|FG000|Overall Study|Pregnancy|0|||
145498702|NCT02668653|524685284|FG001|Overall Study|Pregnancy|1|||
145498703|NCT02668653|524685283|FG000|Overall Study|Death|0|||
145498704|NCT02668653|524685284|FG001|Overall Study|Death|1|||
145498705|NCT03558737|524685285|FG000|Overall Study|Death|1|||
145498706|NCT03558737|524685286|FG001|Overall Study|Death|1|||
145498707|NCT01294553|524685287|FG000|Overall Study|Duplicated Participants|1|||
145498708|NCT01294553|524685287|FG000|Overall Study|Protocol Violation|268|||
145498709|NCT03041181|524685290|FG000|Overall Study|Disease Progression|1|||
145498710|NCT03041181|524685291|FG001|Overall Study|Disease Progression|2|||
145498711|NCT03224819|524685292|FG000|Overall Study|Withdrawal by Subject|0|||
145498712|NCT03224819|524685293|FG001|Overall Study|Withdrawal by Subject|0|||
145498713|NCT03224819|524685294|FG002|Overall Study|Withdrawal by Subject|0|||
145732756|NCT02408861|525539288|FG001|Overall Study|Protocol Violation|0|||
145732757|NCT02408861|525539289|FG002|Overall Study|Protocol Violation|0|||
145732758|NCT02408861|525539290|FG003|Overall Study|Protocol Violation|0|||
145732759|NCT02408861|525539291|FG004|Overall Study|Protocol Violation|0|||
145732760|NCT02408861|525539292|FG005|Overall Study|Protocol Violation|0|||
145732761|NCT02408861|525539293|FG006|Overall Study|Protocol Violation|0|||
145732762|NCT02408861|525539287|FG000|Overall Study|Withdrawal by Subject|0|||
145732763|NCT02408861|525539288|FG001|Overall Study|Withdrawal by Subject|0|||
145732764|NCT02408861|525539289|FG002|Overall Study|Withdrawal by Subject|0|||
145732765|NCT02408861|525539290|FG003|Overall Study|Withdrawal by Subject|0|||
145732766|NCT02408861|525539291|FG004|Overall Study|Withdrawal by Subject|1|||
145732767|NCT02408861|525539292|FG005|Overall Study|Withdrawal by Subject|1|||
145732768|NCT02408861|525539293|FG006|Overall Study|Withdrawal by Subject|0|||
145732769|NCT02408861|525539287|FG000|Overall Study|Other Treatment|0|||
145732770|NCT02408861|525539288|FG001|Overall Study|Other Treatment|0|||
145732771|NCT02408861|525539289|FG002|Overall Study|Other Treatment|0|||
145732772|NCT02408861|525539290|FG003|Overall Study|Other Treatment|0|||
145732773|NCT02408861|525539291|FG004|Overall Study|Other Treatment|0|||
145732774|NCT02408861|525539292|FG005|Overall Study|Other Treatment|1|||
145732775|NCT02408861|525539293|FG006|Overall Study|Other Treatment|1|||
145732776|NCT04091451|525539294|FG000|Overall Study|Adverse Event|15|||
145732777|NCT04091451|525539295|FG001|Overall Study|Adverse Event|10|||
145732778|NCT04091451|525539294|FG000|Overall Study|Lost to Follow-up|8|||
145732779|NCT04091451|525539295|FG001|Overall Study|Lost to Follow-up|8|||
145732780|NCT04091451|525539294|FG000|Overall Study|Protocol Violation|5|||
145732781|NCT04091451|525539295|FG001|Overall Study|Protocol Violation|4|||
145732782|NCT04091451|525539294|FG000|Overall Study|Withdrawal by Subject|21|||
145498714|NCT03224819|524685295|FG003|Overall Study|Withdrawal by Subject|0|||
145498715|NCT03224819|524685296|FG004|Overall Study|Withdrawal by Subject|0|||
145498716|NCT03224819|524685297|FG005|Overall Study|Withdrawal by Subject|0|||
145498717|NCT03224819|524685298|FG006|Overall Study|Withdrawal by Subject|0|||
145498718|NCT03224819|524685299|FG007|Overall Study|Withdrawal by Subject|0|||
145498719|NCT03224819|524685300|FG008|Overall Study|Withdrawal by Subject|0|||
145498720|NCT03224819|524685301|FG009|Overall Study|Withdrawal by Subject|0|||
145498721|NCT03224819|524685302|FG010|Overall Study|Withdrawal by Subject|0|||
145498722|NCT03224819|524685303|FG011|Overall Study|Withdrawal by Subject|0|||
145605966|NCT00638235|525073062|FG004|Overall Study|Lost to Follow-up|13|||
145732783|NCT04091451|525539295|FG001|Overall Study|Withdrawal by Subject|27|||
145732784|NCT04091451|525539294|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
145732785|NCT04091451|525539295|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
145732786|NCT04091451|525539294|FG000|Overall Study|Migrated/moved from the study area|3|||
145396910|NCT01386606|524309157|FG002|Overall Study|Lost to Follow-up|0|||
145396911|NCT01386606|524309158|FG003|Overall Study|Lost to Follow-up|0|||
145396912|NCT01386606|524309155|FG000|Overall Study|Subject incarcerated|0|||
145396913|NCT01386606|524309156|FG001|Overall Study|Subject incarcerated|1|||
145396914|NCT01386606|524309157|FG002|Overall Study|Subject incarcerated|0|||
145396915|NCT01386606|524309158|FG003|Overall Study|Subject incarcerated|0|||
145396916|NCT01386606|524309155|FG000|Overall Study|Unable to draw PK|1|||
145396917|NCT01386606|524309156|FG001|Overall Study|Unable to draw PK|0|||
145396918|NCT01386606|524309157|FG002|Overall Study|Unable to draw PK|0|||
145396919|NCT01386606|524309158|FG003|Overall Study|Unable to draw PK|0|||
145396920|NCT01386606|524309155|FG000|Overall Study|T levels too high|0|||
145396921|NCT01386606|524309156|FG001|Overall Study|T levels too high|1|||
145396922|NCT01386606|524309157|FG002|Overall Study|T levels too high|1|||
145396923|NCT01386606|524309158|FG003|Overall Study|T levels too high|0|||
145396924|NCT02357459|524309161|FG000|Overall Study|Adverse Event|0|||
145396925|NCT02357459|524309162|FG001|Overall Study|Adverse Event|1|||
145396926|NCT02357459|524309163|FG002|Overall Study|Adverse Event|1|||
145396927|NCT02357459|524309161|FG000|Overall Study|Withdrawal by Subject|5|||
145396928|NCT02357459|524309162|FG001|Overall Study|Withdrawal by Subject|3|||
145396929|NCT02357459|524309163|FG002|Overall Study|Withdrawal by Subject|3|||
145396930|NCT02357459|524309161|FG000|Overall Study|Physician Decision|0|||
145396931|NCT02357459|524309162|FG001|Overall Study|Physician Decision|2|||
145396932|NCT02357459|524309163|FG002|Overall Study|Physician Decision|0|||
145396933|NCT02357459|524309161|FG000|Overall Study|Protocol Violation|1|||
145396934|NCT02357459|524309162|FG001|Overall Study|Protocol Violation|1|||
145396935|NCT02357459|524309163|FG002|Overall Study|Protocol Violation|0|||
145396936|NCT02357459|524309161|FG000|Overall Study|Lost to Follow-up|1|||
145396937|NCT02357459|524309162|FG001|Overall Study|Lost to Follow-up|3|||
145396938|NCT02357459|524309163|FG002|Overall Study|Lost to Follow-up|0|||
145396939|NCT02357459|524309161|FG000|Overall Study|Lack of Efficacy|7|||
145396940|NCT02357459|524309162|FG001|Overall Study|Lack of Efficacy|4|||
145396941|NCT02357459|524309163|FG002|Overall Study|Lack of Efficacy|4|||
145396942|NCT02357459|524309161|FG000|Overall Study|Patient Relocated|2|||
145396943|NCT02357459|524309162|FG001|Overall Study|Patient Relocated|0|||
145396944|NCT02357459|524309163|FG002|Overall Study|Patient Relocated|0|||
145396945|NCT02357459|524309161|FG000|Overall Study|Instruction from PCP|1|||
145396946|NCT02357459|524309162|FG001|Overall Study|Instruction from PCP|0|||
145396947|NCT02357459|524309163|FG002|Overall Study|Instruction from PCP|0|||
145396948|NCT02357459|524309161|FG000|Overall Study|Incarceration|0|||
145396949|NCT02357459|524309162|FG001|Overall Study|Incarceration|0|||
145396950|NCT02357459|524309163|FG002|Overall Study|Incarceration|1|||
145396951|NCT02357459|524309161|FG000|Overall Study|Pre-planned Knee surgery|0|||
145396952|NCT02357459|524309162|FG001|Overall Study|Pre-planned Knee surgery|0|||
145396953|NCT02357459|524309163|FG002|Overall Study|Pre-planned Knee surgery|2|||
145396954|NCT02357459|524309161|FG000|Overall Study|Job Commitments|0|||
145396955|NCT02357459|524309162|FG001|Overall Study|Job Commitments|0|||
145396956|NCT02357459|524309163|FG002|Overall Study|Job Commitments|1|||
145396957|NCT03246347|524309164|FG000|Overall Study|On Study|23|||
145396958|NCT02188160|524309165|FG000|Overall Study|Adverse Event|1|||
145396959|NCT02188160|524309166|FG001|Overall Study|Adverse Event|0|||
145396960|NCT02188160|524309165|FG000|Overall Study|Use of an excluded medication|0|||
145396961|NCT02188160|524309166|FG001|Overall Study|Use of an excluded medication|1|||
145396962|NCT00916578|524309169|FG000|Overall Study|Physician Decision|2|||
145396963|NCT00916578|524309169|FG000|Overall Study|Withdrawal by Subject|3|||
145396964|NCT00916578|524309169|FG000|Overall Study|Insurance Denial|2|||
145396965|NCT01022203|524309174|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
145396966|NCT01022203|524309175|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
145396967|NCT01022203|524309174|FG000|Post Treatment Assessment|Physician Decision|2|||
145396968|NCT01022203|524309175|FG001|Post Treatment Assessment|Physician Decision|0|||
145396969|NCT01022203|524309174|FG000|Post Treatment Assessment|Adverse Event|0|||
145396970|NCT01022203|524309175|FG001|Post Treatment Assessment|Adverse Event|2|||
145396971|NCT01022203|524309174|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
145396972|NCT01022203|524309175|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
145396973|NCT00611806|524309177|FG000|Overall Study|Withdrawal by Subject|8|||
145396974|NCT00611806|524309178|FG001|Overall Study|Withdrawal by Subject|2|||
145396975|NCT00611806|524309177|FG000|Overall Study|Adverse Event|2|||
145396976|NCT00611806|524309178|FG001|Overall Study|Adverse Event|1|||
145396977|NCT00611806|524309177|FG000|Overall Study|Lost to Follow-up|6|||
145396978|NCT00611806|524309178|FG001|Overall Study|Lost to Follow-up|0|||
145396979|NCT00903201|524309179|FG000|Overall Study|Adverse Event|1|||
145396980|NCT00903201|524309180|FG001|Overall Study|Adverse Event|4|||
145396981|NCT00903201|524309181|FG002|Overall Study|Adverse Event|0|||
145396982|NCT00903201|524309179|FG000|Overall Study|Protocol Violation|2|||
145396983|NCT00903201|524309180|FG001|Overall Study|Protocol Violation|1|||
145396984|NCT00903201|524309181|FG002|Overall Study|Protocol Violation|0|||
145396985|NCT00903201|524309179|FG000|Overall Study|Lost to Follow-up|0|||
145266681|NCT04668066|523825253|FG016|Part 1: Follow-Up|Adverse Event|0|||
145396986|NCT00903201|524309180|FG001|Overall Study|Lost to Follow-up|1|||
145396987|NCT00903201|524309181|FG002|Overall Study|Lost to Follow-up|0|||
145396988|NCT00903201|524309179|FG000|Overall Study|Physician Decision|1|||
145396989|NCT00903201|524309180|FG001|Overall Study|Physician Decision|0|||
145396990|NCT00903201|524309181|FG002|Overall Study|Physician Decision|1|||
145396991|NCT00903201|524309179|FG000|Overall Study|Withdrawal by Subject|1|||
145396992|NCT00903201|524309180|FG001|Overall Study|Withdrawal by Subject|0|||
145396993|NCT00903201|524309181|FG002|Overall Study|Withdrawal by Subject|1|||
145396994|NCT01094288|524309184|FG000|Overall Study|Adverse Event|0|||
145396995|NCT01094288|524309185|FG001|Overall Study|Adverse Event|3|||
145396996|NCT01094288|524309186|FG002|Overall Study|Adverse Event|1|||
145396997|NCT01094288|524309187|FG003|Overall Study|Adverse Event|1|||
145396998|NCT01094288|524309188|FG004|Overall Study|Adverse Event|0|||
145396999|NCT01094288|524309189|FG005|Overall Study|Adverse Event|0|||
145397000|NCT01094288|524309190|FG006|Overall Study|Adverse Event|0|||
145397001|NCT01094288|524309191|FG007|Overall Study|Adverse Event|0|||
145397002|NCT01094288|524309184|FG000|Overall Study|Withdrawal by Subject|0|||
145397003|NCT01094288|524309185|FG001|Overall Study|Withdrawal by Subject|1|||
145397004|NCT01094288|524309186|FG002|Overall Study|Withdrawal by Subject|2|||
145397005|NCT01094288|524309187|FG003|Overall Study|Withdrawal by Subject|0|||
145397006|NCT01094288|524309188|FG004|Overall Study|Withdrawal by Subject|0|||
145397007|NCT01094288|524309189|FG005|Overall Study|Withdrawal by Subject|0|||
145397008|NCT01094288|524309190|FG006|Overall Study|Withdrawal by Subject|0|||
145397009|NCT01094288|524309191|FG007|Overall Study|Withdrawal by Subject|2|||
145397010|NCT01094288|524309184|FG000|Overall Study|Initiation of Alternative Therapy|0|||
145397011|NCT01094288|524309185|FG001|Overall Study|Initiation of Alternative Therapy|0|||
145397012|NCT01094288|524309186|FG002|Overall Study|Initiation of Alternative Therapy|1|||
145397013|NCT01094288|524309187|FG003|Overall Study|Initiation of Alternative Therapy|0|||
145397014|NCT01094288|524309188|FG004|Overall Study|Initiation of Alternative Therapy|0|||
145397015|NCT01094288|524309189|FG005|Overall Study|Initiation of Alternative Therapy|0|||
145397016|NCT01094288|524309190|FG006|Overall Study|Initiation of Alternative Therapy|0|||
145397017|NCT01094288|524309191|FG007|Overall Study|Initiation of Alternative Therapy|0|||
145397018|NCT01094288|524309184|FG000|Overall Study|Reason not Specified|2|||
145397019|NCT01094288|524309185|FG001|Overall Study|Reason not Specified|3|||
145397020|NCT01094288|524309186|FG002|Overall Study|Reason not Specified|0|||
145397021|NCT01094288|524309187|FG003|Overall Study|Reason not Specified|1|||
145397022|NCT01094288|524309188|FG004|Overall Study|Reason not Specified|0|||
145397023|NCT01094288|524309189|FG005|Overall Study|Reason not Specified|0|||
145397024|NCT01094288|524309190|FG006|Overall Study|Reason not Specified|0|||
145397025|NCT01094288|524309191|FG007|Overall Study|Reason not Specified|0|||
145397026|NCT01094288|524309184|FG000|Overall Study|Ongoing Participants|0|||
145397027|NCT01094288|524309185|FG001|Overall Study|Ongoing Participants|3|||
145397028|NCT01094288|524309186|FG002|Overall Study|Ongoing Participants|0|||
145397029|NCT01094288|524309187|FG003|Overall Study|Ongoing Participants|0|||
145397030|NCT01094288|524309188|FG004|Overall Study|Ongoing Participants|0|||
145397031|NCT01094288|524309189|FG005|Overall Study|Ongoing Participants|0|||
145397032|NCT01094288|524309190|FG006|Overall Study|Ongoing Participants|0|||
145397033|NCT01094288|524309191|FG007|Overall Study|Ongoing Participants|0|||
145397034|NCT02611882|524309192|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
145397035|NCT02611882|524309193|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
145397036|NCT02611882|524309194|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
145397037|NCT00643760|524309203|FG000|Overall Study|Adverse Event|11|||
145397038|NCT00643760|524309204|FG001|Overall Study|Adverse Event|5|||
145397039|NCT00643760|524309205|FG002|Overall Study|Adverse Event|12|||
145397040|NCT00643760|524309206|FG003|Overall Study|Adverse Event|21|||
145397041|NCT00643760|524309207|FG004|Overall Study|Adverse Event|6|||
145397042|NCT00643760|524309203|FG000|Overall Study|Lack of Efficacy|3|||
145397043|NCT00643760|524309204|FG001|Overall Study|Lack of Efficacy|1|||
145397044|NCT00643760|524309205|FG002|Overall Study|Lack of Efficacy|0|||
145397045|NCT00643760|524309206|FG003|Overall Study|Lack of Efficacy|4|||
145397046|NCT00643760|524309207|FG004|Overall Study|Lack of Efficacy|3|||
145397047|NCT00643760|524309203|FG000|Overall Study|Protocol Violation|7|||
145397048|NCT00643760|524309204|FG001|Overall Study|Protocol Violation|6|||
145397049|NCT00643760|524309205|FG002|Overall Study|Protocol Violation|4|||
145397050|NCT00643760|524309206|FG003|Overall Study|Protocol Violation|4|||
145397051|NCT00643760|524309207|FG004|Overall Study|Protocol Violation|6|||
145397052|NCT00643760|524309203|FG000|Overall Study|Lost to Follow-up|6|||
145397053|NCT00643760|524309204|FG001|Overall Study|Lost to Follow-up|2|||
145397054|NCT00643760|524309205|FG002|Overall Study|Lost to Follow-up|1|||
145397055|NCT00643760|524309206|FG003|Overall Study|Lost to Follow-up|3|||
145397056|NCT00643760|524309207|FG004|Overall Study|Lost to Follow-up|3|||
145498723|NCT03224819|524685304|FG012|Overall Study|Withdrawal by Subject|1|||
145498724|NCT03224819|524685305|FG013|Overall Study|Withdrawal by Subject|0|||
145498725|NCT03224819|524685292|FG000|Overall Study|Sponsor Decision|0|||
145498726|NCT03224819|524685293|FG001|Overall Study|Sponsor Decision|0|||
145498727|NCT03224819|524685294|FG002|Overall Study|Sponsor Decision|0|||
145498728|NCT03224819|524685295|FG003|Overall Study|Sponsor Decision|1|||
145498729|NCT03224819|524685296|FG004|Overall Study|Sponsor Decision|1|||
145498730|NCT03224819|524685297|FG005|Overall Study|Sponsor Decision|2|||
145498731|NCT03224819|524685298|FG006|Overall Study|Sponsor Decision|1|||
145498732|NCT03224819|524685299|FG007|Overall Study|Sponsor Decision|1|||
145498733|NCT03224819|524685300|FG008|Overall Study|Sponsor Decision|1|||
145498734|NCT03224819|524685301|FG009|Overall Study|Sponsor Decision|2|||
145498735|NCT03224819|524685302|FG010|Overall Study|Sponsor Decision|1|||
145498736|NCT03224819|524685303|FG011|Overall Study|Sponsor Decision|1|||
145498737|NCT03224819|524685304|FG012|Overall Study|Sponsor Decision|1|||
145498738|NCT03224819|524685305|FG013|Overall Study|Sponsor Decision|0|||
145498739|NCT03224819|524685292|FG000|Overall Study|Lost to Follow-up|0|||
145498740|NCT03224819|524685293|FG001|Overall Study|Lost to Follow-up|0|||
145498741|NCT03224819|524685294|FG002|Overall Study|Lost to Follow-up|0|||
145498742|NCT03224819|524685295|FG003|Overall Study|Lost to Follow-up|0|||
145498743|NCT03224819|524685296|FG004|Overall Study|Lost to Follow-up|0|||
145498744|NCT03224819|524685297|FG005|Overall Study|Lost to Follow-up|0|||
145498745|NCT03224819|524685298|FG006|Overall Study|Lost to Follow-up|0|||
145498746|NCT03224819|524685299|FG007|Overall Study|Lost to Follow-up|0|||
145605967|NCT00638235|525073063|FG005|Overall Study|Lost to Follow-up|26|||
145498747|NCT03224819|524685300|FG008|Overall Study|Lost to Follow-up|1|||
145498748|NCT03224819|524685301|FG009|Overall Study|Lost to Follow-up|0|||
145498749|NCT03224819|524685302|FG010|Overall Study|Lost to Follow-up|0|||
145397057|NCT00643760|524309203|FG000|Overall Study|Investigator Discretion|0|||
145397058|NCT00643760|524309204|FG001|Overall Study|Investigator Discretion|0|||
145397059|NCT00643760|524309205|FG002|Overall Study|Investigator Discretion|0|||
145397060|NCT00643760|524309206|FG003|Overall Study|Investigator Discretion|2|||
145397061|NCT00643760|524309207|FG004|Overall Study|Investigator Discretion|0|||
145397062|NCT00643760|524309203|FG000|Overall Study|Withdrawal by Subject|3|||
145397063|NCT00643760|524309204|FG001|Overall Study|Withdrawal by Subject|1|||
145397064|NCT00643760|524309205|FG002|Overall Study|Withdrawal by Subject|2|||
145397065|NCT00643760|524309206|FG003|Overall Study|Withdrawal by Subject|4|||
145397066|NCT00643760|524309207|FG004|Overall Study|Withdrawal by Subject|1|||
145397067|NCT03353792|524309217|FG000|Overall Study|Lost to Follow-up|1|||
145397068|NCT03353792|524309218|FG001|Overall Study|Lost to Follow-up|0|||
145397069|NCT03353792|524309217|FG000|Overall Study|Participant Unable to Manage Device|1|||
145397070|NCT03353792|524309218|FG001|Overall Study|Participant Unable to Manage Device|0|||
145397071|NCT01699750|524309222|FG000|Overall Study|Withdrew Consent|0|||
145397072|NCT01699750|524309223|FG001|Overall Study|Withdrew Consent|1|||
145397073|NCT01699750|524309222|FG000|Overall Study|Other|0|||
145397074|NCT01699750|524309223|FG001|Overall Study|Other|2|||
145397075|NCT02452047|524309224|FG000|Overall Study|Adverse Event|0|||
145397076|NCT02452047|524309225|FG001|Overall Study|Adverse Event|1|||
145397077|NCT02452047|524309226|FG002|Overall Study|Adverse Event|1|||
145397078|NCT02452047|524309224|FG000|Overall Study|Death|1|||
145397079|NCT02452047|524309225|FG001|Overall Study|Death|3|||
145397080|NCT02452047|524309226|FG002|Overall Study|Death|1|||
145397081|NCT02452047|524309224|FG000|Overall Study|Physician Decision|1|||
145397082|NCT02452047|524309225|FG001|Overall Study|Physician Decision|0|||
145397083|NCT02452047|524309226|FG002|Overall Study|Physician Decision|0|||
145397084|NCT02452047|524309224|FG000|Overall Study|Lost to Follow-up|1|||
145397085|NCT02452047|524309225|FG001|Overall Study|Lost to Follow-up|1|||
145397086|NCT02452047|524309226|FG002|Overall Study|Lost to Follow-up|0|||
145397087|NCT02452047|524309224|FG000|Overall Study|Withdrawal by Subject|1|||
145397088|NCT02452047|524309225|FG001|Overall Study|Withdrawal by Subject|0|||
145397089|NCT02452047|524309226|FG002|Overall Study|Withdrawal by Subject|0|||
145397090|NCT01868646|524309228|FG000|Overall Study|Do not meet inclusion criteria|3|||
145397091|NCT01868646|524309229|FG001|Overall Study|Do not meet inclusion criteria|5|||
145397092|NCT01831427|524309230|FG000|Overall Study|Adverse Event|0|||
145397093|NCT01831427|524309231|FG001|Overall Study|Adverse Event|1|||
145397094|NCT01831427|524309232|FG002|Overall Study|Adverse Event|0|||
145397095|NCT01831427|524309233|FG003|Overall Study|Adverse Event|0|||
145397096|NCT01831427|524309234|FG004|Overall Study|Adverse Event|0|||
145397097|NCT01831427|524309235|FG005|Overall Study|Adverse Event|1|||
145397098|NCT01831427|524309236|FG006|Overall Study|Adverse Event|0|||
145397099|NCT01831427|524309237|FG007|Overall Study|Adverse Event|1|||
145397100|NCT01831427|524309238|FG008|Overall Study|Adverse Event|0|||
145397101|NCT01831427|524309239|FG009|Overall Study|Adverse Event|0|||
145397102|NCT01831427|524309240|FG010|Overall Study|Adverse Event|2|||
145397103|NCT01831427|524309230|FG000|Overall Study|Investigator's Discretion|0|||
145397104|NCT01831427|524309231|FG001|Overall Study|Investigator's Discretion|0|||
145397105|NCT01831427|524309232|FG002|Overall Study|Investigator's Discretion|0|||
145397106|NCT01831427|524309233|FG003|Overall Study|Investigator's Discretion|1|||
145397107|NCT01831427|524309234|FG004|Overall Study|Investigator's Discretion|0|||
145397108|NCT01831427|524309235|FG005|Overall Study|Investigator's Discretion|0|||
145397109|NCT01831427|524309236|FG006|Overall Study|Investigator's Discretion|0|||
145397110|NCT01831427|524309237|FG007|Overall Study|Investigator's Discretion|0|||
145397111|NCT01831427|524309238|FG008|Overall Study|Investigator's Discretion|0|||
145397112|NCT01831427|524309239|FG009|Overall Study|Investigator's Discretion|0|||
145397113|NCT01831427|524309240|FG010|Overall Study|Investigator's Discretion|0|||
145397114|NCT01831427|524309230|FG000|Overall Study|Withdrew Consent|0|||
145397115|NCT01831427|524309231|FG001|Overall Study|Withdrew Consent|0|||
145397116|NCT01831427|524309232|FG002|Overall Study|Withdrew Consent|0|||
145397117|NCT01831427|524309233|FG003|Overall Study|Withdrew Consent|0|||
145397118|NCT01831427|524309234|FG004|Overall Study|Withdrew Consent|0|||
145498750|NCT03224819|524685303|FG011|Overall Study|Lost to Follow-up|0|||
145498751|NCT03224819|524685304|FG012|Overall Study|Lost to Follow-up|0|||
145397119|NCT01831427|524309235|FG005|Overall Study|Withdrew Consent|0|||
145397120|NCT01831427|524309236|FG006|Overall Study|Withdrew Consent|2|||
145397121|NCT01831427|524309237|FG007|Overall Study|Withdrew Consent|0|||
145397122|NCT01831427|524309238|FG008|Overall Study|Withdrew Consent|0|||
145397123|NCT01831427|524309239|FG009|Overall Study|Withdrew Consent|1|||
145397124|NCT01831427|524309240|FG010|Overall Study|Withdrew Consent|1|||
145397125|NCT00536510|524309241|FG000|Overall Study|Adverse Event|27|||
145397126|NCT00536510|524309242|FG001|Overall Study|Adverse Event|4|||
145397127|NCT00536510|524309241|FG000|Overall Study|Lost to Follow-up|11|||
145397128|NCT00536510|524309242|FG001|Overall Study|Lost to Follow-up|8|||
145397129|NCT00536510|524309241|FG000|Overall Study|Protocol Violation|4|||
145397130|NCT00536510|524309242|FG001|Overall Study|Protocol Violation|5|||
145397131|NCT00536510|524309241|FG000|Overall Study|Withdrawal by Subject|16|||
145498752|NCT03224819|524685305|FG013|Overall Study|Lost to Follow-up|0|||
145498753|NCT03224819|524685292|FG000|Overall Study|Death|0|||
145498754|NCT03224819|524685293|FG001|Overall Study|Death|1|||
145498755|NCT03224819|524685294|FG002|Overall Study|Death|0|||
145498756|NCT03224819|524685295|FG003|Overall Study|Death|0|||
145498757|NCT03224819|524685296|FG004|Overall Study|Death|0|||
145498758|NCT03224819|524685297|FG005|Overall Study|Death|0|||
145498759|NCT03224819|524685298|FG006|Overall Study|Death|0|||
145498760|NCT03224819|524685299|FG007|Overall Study|Death|1|||
145498761|NCT03224819|524685300|FG008|Overall Study|Death|0|||
145498762|NCT03224819|524685301|FG009|Overall Study|Death|0|||
145498763|NCT03224819|524685302|FG010|Overall Study|Death|0|||
145498764|NCT03224819|524685303|FG011|Overall Study|Death|1|||
145498765|NCT03224819|524685304|FG012|Overall Study|Death|0|||
145498766|NCT03224819|524685305|FG013|Overall Study|Death|0|||
145498767|NCT01903460|524685308|FG000|Overall Study|Adverse Event|0|||
145498768|NCT01903460|524685309|FG001|Overall Study|Adverse Event|0|||
145498769|NCT01903460|524685310|FG002|Overall Study|Adverse Event|0|||
145498770|NCT01903460|524685311|FG003|Overall Study|Adverse Event|1|||
145498771|NCT03104868|524685312|FG000|6 Week Follow up|Lost to Follow-up|5|||
145498772|NCT03104868|524685313|FG001|6 Week Follow up|Lost to Follow-up|8|||
145498773|NCT03104868|524685312|FG000|6 Week Follow up|Death|1|||
145498774|NCT03104868|524685313|FG001|6 Week Follow up|Death|1|||
145498775|NCT03104868|524685312|FG000|6 Week Follow up|Withdrawal by Subject|7|||
145498776|NCT03104868|524685313|FG001|6 Week Follow up|Withdrawal by Subject|6|||
145498777|NCT03104868|524685312|FG000|6 Week Follow up|Completed Later Timepoint|24|||
145498778|NCT03104868|524685313|FG001|6 Week Follow up|Completed Later Timepoint|22|||
145498779|NCT03104868|524685312|FG000|6 Month Follow up|Lost to Follow-up|2|||
145498780|NCT03104868|524685313|FG001|6 Month Follow up|Lost to Follow-up|2|||
145498781|NCT03104868|524685312|FG000|6 Month Follow up|Death|0|||
145498782|NCT03104868|524685313|FG001|6 Month Follow up|Death|1|||
145498783|NCT03104868|524685312|FG000|6 Month Follow up|Completed Later Timepoint|22|||
145498784|NCT03104868|524685313|FG001|6 Month Follow up|Completed Later Timepoint|32|||
145498785|NCT03104868|524685312|FG000|12 Month Follow up|Lost to Follow-up|1|||
145498786|NCT03104868|524685313|FG001|12 Month Follow up|Lost to Follow-up|2|||
145498787|NCT03104868|524685312|FG000|12 Month Follow up|Death|0|||
145498788|NCT03104868|524685313|FG001|12 Month Follow up|Death|1|||
145498789|NCT03104868|524685312|FG000|12 Month Follow up|Withdrawal by Subject|0|||
145498790|NCT03104868|524685313|FG001|12 Month Follow up|Withdrawal by Subject|3|||
145498791|NCT03104868|524685312|FG000|12 Month Follow up|Completed Later Timepoint|32|||
145498792|NCT03104868|524685313|FG001|12 Month Follow up|Completed Later Timepoint|29|||
145498793|NCT03104868|524685312|FG000|18 Month Follow up|Lost to Follow-up|7|||
145498794|NCT03104868|524685313|FG001|18 Month Follow up|Lost to Follow-up|11|||
145498795|NCT03104868|524685312|FG000|18 Month Follow up|Death|2|||
145498796|NCT03104868|524685313|FG001|18 Month Follow up|Death|1|||
145498797|NCT03104868|524685312|FG000|18 Month Follow up|Withdrawal by Subject|1|||
145498798|NCT03104868|524685313|FG001|18 Month Follow up|Withdrawal by Subject|2|||
145498799|NCT03104868|524685312|FG000|18 Month Follow up|Graft Loss|1|||
145498800|NCT03104868|524685313|FG001|18 Month Follow up|Graft Loss|1|||
145498801|NCT03104868|524685312|FG000|18 Month Follow up|Completed Later Timepoint|19|||
145498802|NCT03104868|524685313|FG001|18 Month Follow up|Completed Later Timepoint|20|||
145498803|NCT03104868|524685312|FG000|24 Month Follow up|Lost to Follow-up|15|||
145498804|NCT03104868|524685313|FG001|24 Month Follow up|Lost to Follow-up|16|||
145498805|NCT03104868|524685312|FG000|24 Month Follow up|Death|3|||
145498806|NCT03104868|524685313|FG001|24 Month Follow up|Death|2|||
145498807|NCT03104868|524685312|FG000|24 Month Follow up|Withdrawal by Subject|1|||
145498808|NCT03104868|524685313|FG001|24 Month Follow up|Withdrawal by Subject|0|||
145498809|NCT03104868|524685312|FG000|24 Month Follow up|Graft Loss|2|||
145498810|NCT03104868|524685313|FG001|24 Month Follow up|Graft Loss|0|||
145498811|NCT00005780|524685314|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
145498812|NCT00829426|524685315|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145498813|NCT00829426|524685316|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145498814|NCT03597347|524685320|FG000|Overall Study|Withdrawal by Subject|1|||
145498815|NCT03597347|524685321|FG001|Overall Study|Withdrawal by Subject|1|||
145498816|NCT03597347|524685322|FG002|Overall Study|Withdrawal by Subject|0|||
145498817|NCT03597347|524685320|FG000|Overall Study|Withdrawal due to Covid-19|3|||
145498818|NCT03597347|524685321|FG001|Overall Study|Withdrawal due to Covid-19|0|||
145498819|NCT03597347|524685322|FG002|Overall Study|Withdrawal due to Covid-19|0|||
145732787|NCT04091451|525539295|FG001|Overall Study|Migrated/moved from the study area|5|||
145498820|NCT03597347|524685320|FG000|Overall Study|Sponsor decision to terminate study|3|||
145498821|NCT03597347|524685321|FG001|Overall Study|Sponsor decision to terminate study|2|||
145498822|NCT03597347|524685322|FG002|Overall Study|Sponsor decision to terminate study|4|||
145498823|NCT04606134|524685323|FG000|Overall Study|Adverse Event|0|||
145498824|NCT04606134|524685324|FG001|Overall Study|Adverse Event|1|||
145498825|NCT00107653|524685325|FG000|Overall Study|Adverse Event|24|||
145498826|NCT00107653|524685326|FG001|Overall Study|Adverse Event|43|||
145732788|NCT04091451|525539294|FG000|Overall Study|Suspected HZ episode|1|||
145498827|NCT00107653|524685325|FG000|Overall Study|Insufficient Therapeutic Response|25|||
145498828|NCT00107653|524685326|FG001|Overall Study|Insufficient Therapeutic Response|11|||
145498829|NCT00107653|524685325|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
145498830|NCT00107653|524685326|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145498831|NCT00107653|524685325|FG000|Overall Study|Protocol Violation|1|||
145498832|NCT00107653|524685326|FG001|Overall Study|Protocol Violation|0|||
145498833|NCT00107653|524685325|FG000|Overall Study|Withdrawal by Subject|12|||
145498834|NCT00107653|524685326|FG001|Overall Study|Withdrawal by Subject|13|||
145498835|NCT00107653|524685325|FG000|Overall Study|Lost to Follow-up|13|||
145498836|NCT00107653|524685326|FG001|Overall Study|Lost to Follow-up|5|||
145498837|NCT00107653|524685325|FG000|Overall Study|Administrative Reasons|3|||
145498838|NCT00107653|524685326|FG001|Overall Study|Administrative Reasons|3|||
145498839|NCT02018562|524685330|FG000|Overall Study|Withdrawal by Subject|2|||
145498840|NCT02018562|524685331|FG001|Overall Study|Withdrawal by Subject|0|||
145498841|NCT02018562|524685330|FG000|Overall Study|Discharged prior to study completion|1|||
145498842|NCT02018562|524685331|FG001|Overall Study|Discharged prior to study completion|0|||
145498843|NCT04050553|524685333|FG000|Period 1|Physician Decision|2|||
145498844|NCT04050553|524685334|FG001|Period 1|Physician Decision|2|||
145397132|NCT00536510|524309242|FG001|Overall Study|Withdrawal by Subject|9|||
145397133|NCT00536510|524309241|FG000|Overall Study|Flushing with Product|20|||
145397134|NCT00536510|524309242|FG001|Overall Study|Flushing with Product|0|||
145397135|NCT00536510|524309241|FG000|Overall Study|Laboratory Adverse Event|2|||
145397136|NCT00536510|524309242|FG001|Overall Study|Laboratory Adverse Event|1|||
145397137|NCT00536510|524309241|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
145397138|NCT00536510|524309242|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
145397139|NCT01249417|524309243|FG000|Randomised Population|Study treatment not received|0|||
145397140|NCT01249417|524309244|FG001|Randomised Population|Study treatment not received|0|||
145397141|NCT01249417|524309245|FG002|Randomised Population|Study treatment not received|2|||
145397142|NCT01249417|524309243|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
145397143|NCT01249417|524309244|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
145397144|NCT01249417|524309245|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
145397145|NCT01249417|524309243|FG000|Treatment Phase - ITT Population|Other|0|||
145397146|NCT01249417|524309244|FG001|Treatment Phase - ITT Population|Other|0|||
145397147|NCT01249417|524309245|FG002|Treatment Phase - ITT Population|Other|1|||
145397148|NCT01249417|524309243|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
145397149|NCT01249417|524309244|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
145397150|NCT01249417|524309245|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
145397151|NCT01249417|524309243|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
145397152|NCT01249417|524309244|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
145397153|NCT01249417|524309245|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
145498845|NCT04050553|524685333|FG000|Period 1|Adverse Event|1|||
145498846|NCT04050553|524685334|FG001|Period 1|Adverse Event|1|||
145498847|NCT04050553|524685333|FG000|Period 1|Withdrawal by Subject|0|||
145498848|NCT04050553|524685334|FG001|Period 1|Withdrawal by Subject|1|||
145732789|NCT04091451|525539295|FG001|Overall Study|Suspected HZ episode|0|||
145397154|NCT01249417|524309243|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
145397155|NCT01249417|524309244|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
145498849|NCT04050553|524685333|FG000|Wash-out|Adverse Event|0|||
145732790|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
145732791|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
145732792|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
145732793|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
145266682|NCT04668066|523825254|FG017|Part 1: Follow-Up|Adverse Event|0|||
145732794|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
145732795|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
145732796|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
145732797|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
145732798|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
145732799|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
145732800|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
145732801|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
145732802|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
145732803|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
145732804|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
145732805|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
145732806|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
145732807|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
145732808|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
145732809|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
145498850|NCT04050553|524685334|FG001|Wash-out|Adverse Event|1|||
145498851|NCT04050553|524685333|FG000|Wash-out|Withdrawal by Subject|0|||
145498852|NCT04050553|524685334|FG001|Wash-out|Withdrawal by Subject|1|||
145498853|NCT05430854|524685335|FG000|Overall Study|Trial terminated by Sponsor|39|||
145498854|NCT05430854|524685336|FG001|Overall Study|Trial terminated by Sponsor|50|||
145498855|NCT05430854|524685337|FG002|Overall Study|Trial terminated by Sponsor|46|||
145498856|NCT05430854|524685335|FG000|Overall Study|Withdrawal by Subject|0|||
145498857|NCT05430854|524685336|FG001|Overall Study|Withdrawal by Subject|3|||
145498858|NCT05430854|524685337|FG002|Overall Study|Withdrawal by Subject|0|||
145498859|NCT04314284|524685338|FG000|Overall Study|Withdrawal by Subject|4|||
145498860|NCT04314284|524685339|FG001|Overall Study|Withdrawal by Subject|7|||
145498861|NCT04314284|524685338|FG000|Overall Study|Consented but did not complete survey|0|||
145498862|NCT04314284|524685339|FG001|Overall Study|Consented but did not complete survey|6|||
145498863|NCT01652235|524685343|FG000|Overall Study|Death|9|||
145498864|NCT01652235|524685343|FG000|Overall Study|Lost to Follow-up|5|||
145498865|NCT01652235|524685343|FG000|Overall Study|Withdrawal by Subject|2|||
145498866|NCT02023086|524685344|FG000|Overall Study|Withdrawal by Subject|2|||
145498867|NCT02023086|524685345|FG001|Overall Study|Withdrawal by Subject|0|||
145498868|NCT03589859|524685348|FG000|Overall Study|Withdrawal by Subject|0|||
145498869|NCT03589859|524685349|FG001|Overall Study|Withdrawal by Subject|6|||
145498870|NCT03472885|524685351|FG000|24-Week Treatment Period|Adverse Event|1|||
145498871|NCT02201953|524685352|FG000|Overall Study|Randomized but Never Treated|1|||
145498872|NCT02201953|524685353|FG001|Overall Study|Randomized but Never Treated|5|||
145498873|NCT02201953|524685352|FG000|Overall Study|Lack of Efficacy|9|||
145498874|NCT02201953|524685353|FG001|Overall Study|Lack of Efficacy|30|||
145498875|NCT02201953|524685352|FG000|Overall Study|Lost to Follow-up|8|||
145498876|NCT02201953|524685353|FG001|Overall Study|Lost to Follow-up|8|||
145498877|NCT02201953|524685352|FG000|Overall Study|Withdrew Consent|2|||
145498878|NCT02201953|524685353|FG001|Overall Study|Withdrew Consent|5|||
145498879|NCT02201953|524685352|FG000|Overall Study|Adverse Event|0|||
145498880|NCT02201953|524685353|FG001|Overall Study|Adverse Event|5|||
145498881|NCT02201953|524685352|FG000|Overall Study|Death|0|||
145498882|NCT02201953|524685353|FG001|Overall Study|Death|3|||
145498883|NCT02638220|524685354|FG000|Overall Study|Lost to Follow-up|6|||
145498884|NCT02638220|524685354|FG000|Overall Study|Withdrawal by Subject|3|||
145498885|NCT02638220|524685354|FG000|Overall Study|Physician Decision|1|||
145498886|NCT02638220|524685354|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
145498887|NCT01198795|524687732|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
145498888|NCT01198795|524687732|FG000|Overall Study|Withdrawal by Subject|17|||
145498889|NCT01198795|524687732|FG000|Overall Study|Lost to Follow-up|15|||
145498890|NCT01198795|524687732|FG000|Overall Study|Adverse Event|9|||
145498891|NCT01198795|524687732|FG000|Overall Study|Lack of Efficacy|5|||
145498892|NCT01198795|524687732|FG000|Overall Study|Protocol Violation|2|||
145498893|NCT01198795|524687732|FG000|Overall Study|Other Reason|4|||
145498894|NCT00129402|524687734|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
145498895|NCT00129402|524687735|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
145498896|NCT00129402|524687736|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
145498897|NCT00129402|524687737|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
145498898|NCT00129402|524687738|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
145498899|NCT00129402|524687739|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
145498900|NCT00129402|524687740|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
145498901|NCT00129402|524687734|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498902|NCT00129402|524687735|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498903|NCT00129402|524687736|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498904|NCT00129402|524687737|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498905|NCT00129402|524687738|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498906|NCT00129402|524687739|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
145498907|NCT00129402|524687740|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
145498908|NCT00129402|524687734|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145498909|NCT00129402|524687735|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145732810|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
145732811|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
145498910|NCT00129402|524687736|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145498911|NCT00129402|524687737|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
145498912|NCT00129402|524687738|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145498913|NCT00129402|524687739|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145498914|NCT00129402|524687740|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
145732812|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
145732813|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
145498915|NCT00129402|524687734|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
145732814|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
145498916|NCT00129402|524687735|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
145498917|NCT00129402|524687736|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
145498918|NCT00129402|524687737|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
145498919|NCT00129402|524687738|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
145498920|NCT00129402|524687739|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
145498921|NCT00129402|524687740|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
145498922|NCT00129402|524687734|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498923|NCT00129402|524687735|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498924|NCT00129402|524687736|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
145498925|NCT00129402|524687737|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498926|NCT00129402|524687738|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498927|NCT00129402|524687739|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498928|NCT00129402|524687740|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
145498929|NCT00129402|524687734|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
145498930|NCT00129402|524687735|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
145498931|NCT00129402|524687736|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
145498932|NCT00129402|524687737|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
145498933|NCT00129402|524687738|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
145498934|NCT00129402|524687739|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
145498935|NCT00129402|524687740|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
145498936|NCT00129402|524687734|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498937|NCT00129402|524687735|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498938|NCT00129402|524687736|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
145498939|NCT00129402|524687737|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498940|NCT00129402|524687738|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498941|NCT00129402|524687739|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498942|NCT00129402|524687740|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
145498943|NCT00129402|524687734|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
145498944|NCT00129402|524687735|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
145498945|NCT00129402|524687736|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
145498946|NCT00129402|524687737|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
145498947|NCT00129402|524687738|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
145498948|NCT00129402|524687739|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
145498949|NCT00129402|524687740|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
145498950|NCT00129402|524687734|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
145498951|NCT00129402|524687735|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
145498952|NCT00129402|524687736|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
145498953|NCT00129402|524687737|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
145498954|NCT00129402|524687738|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
145498955|NCT00129402|524687739|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
145498956|NCT00129402|524687740|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
145498957|NCT00129402|524687734|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498958|NCT00129402|524687735|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498959|NCT00129402|524687736|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498960|NCT00129402|524687737|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498961|NCT00129402|524687738|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498962|NCT00129402|524687739|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
145498963|NCT00129402|524687740|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
145498964|NCT00129402|524687734|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498965|NCT00129402|524687735|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498966|NCT00129402|524687736|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498967|NCT00129402|524687737|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498968|NCT00129402|524687738|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498969|NCT00129402|524687739|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
145498970|NCT00129402|524687740|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
145498971|NCT00129402|524687734|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498972|NCT00129402|524687735|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498973|NCT00129402|524687736|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498974|NCT00129402|524687737|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498975|NCT00129402|524687738|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498976|NCT00129402|524687739|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
145498977|NCT00129402|524687740|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
145498978|NCT00129402|524687734|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498979|NCT00129402|524687735|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498980|NCT00129402|524687736|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498981|NCT00129402|524687737|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498982|NCT00129402|524687738|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498983|NCT00129402|524687739|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
145498984|NCT00129402|524687740|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
145498985|NCT03041038|524687741|FG000|Overall Study|Withdrawal by Subject|4|||
145498986|NCT03041038|524687742|FG001|Overall Study|Withdrawal by Subject|0|||
145498987|NCT03041038|524687741|FG000|Overall Study|Lost to Follow-up|1|||
145498988|NCT03041038|524687742|FG001|Overall Study|Lost to Follow-up|1|||
145498989|NCT03041038|524687741|FG000|Overall Study|Protocol Violation|1|||
145498990|NCT03041038|524687742|FG001|Overall Study|Protocol Violation|1|||
145498991|NCT02131259|524687743|FG000|Overall Study|Progressive disease|751|||
145498992|NCT02131259|524687743|FG000|Overall Study|Adverse Event|341|||
145498993|NCT02131259|524687743|FG000|Overall Study|Lost to Follow-up|7|||
145498994|NCT02131259|524687743|FG000|Overall Study|Relocation|32|||
145498995|NCT02131259|524687743|FG000|Overall Study|Other|63|||
145498996|NCT02131259|524687743|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
145498997|NCT02131259|524687743|FG000|Overall Study|Progressive disease/relocation|1|||
145498998|NCT02131259|524687743|FG000|Overall Study|Progressive disease/other|2|||
145498999|NCT02131259|524687743|FG000|Overall Study|AE/lost to follow-up|1|||
145499000|NCT02131259|524687743|FG000|Overall Study|AE/other|1|||
145499001|NCT02131259|524687743|FG000|Overall Study|Progressive disease/AE/other|1|||
145499002|NCT02131259|524687743|FG000|Overall Study|Missing|3|||
145499003|NCT02796170|524687744|FG000|Overall Study|Lost to Follow-up|3|||
145499004|NCT02796170|524687745|FG001|Overall Study|Lost to Follow-up|0|||
145499005|NCT01527370|524687746|FG000|Overall Study|Withdrawal by Subject|4|||
145499006|NCT01527370|524687746|FG000|Overall Study|Physician Decision|1|||
145499007|NCT01527370|524687746|FG000|Overall Study|Death|1|||
145499008|NCT01472289|524687750|FG000|Overall Study|Death|2|||
145499009|NCT02435992|524687751|FG000|Overall Study|non compliance with protocol|2|||
145499010|NCT02435992|524687752|FG001|Overall Study|non compliance with protocol|0|||
145499011|NCT02435992|524687753|FG002|Overall Study|non compliance with protocol|1|||
145499012|NCT02435992|524687754|FG003|Overall Study|non compliance with protocol|0|||
145499013|NCT02435992|524687755|FG004|Overall Study|non compliance with protocol|0|||
145499014|NCT02435992|524687751|FG000|Overall Study|Adverse Event|11|||
145499015|NCT02435992|524687752|FG001|Overall Study|Adverse Event|6|||
145499016|NCT02435992|524687753|FG002|Overall Study|Adverse Event|12|||
145499017|NCT02435992|524687754|FG003|Overall Study|Adverse Event|0|||
145499018|NCT02435992|524687755|FG004|Overall Study|Adverse Event|0|||
145499019|NCT02435992|524687751|FG000|Overall Study|Lack of Efficacy|4|||
145499020|NCT02435992|524687752|FG001|Overall Study|Lack of Efficacy|10|||
145499021|NCT02435992|524687753|FG002|Overall Study|Lack of Efficacy|9|||
145499022|NCT02435992|524687754|FG003|Overall Study|Lack of Efficacy|0|||
145499023|NCT02435992|524687755|FG004|Overall Study|Lack of Efficacy|0|||
145499024|NCT02435992|524687751|FG000|Overall Study|Withdrawal by Subject|10|||
145499025|NCT02435992|524687752|FG001|Overall Study|Withdrawal by Subject|8|||
145499026|NCT02435992|524687753|FG002|Overall Study|Withdrawal by Subject|20|||
145499027|NCT02435992|524687754|FG003|Overall Study|Withdrawal by Subject|0|||
145499028|NCT02435992|524687755|FG004|Overall Study|Withdrawal by Subject|0|||
145499029|NCT02435992|524687751|FG000|Overall Study|Other Reason|1|||
145499030|NCT02435992|524687752|FG001|Overall Study|Other Reason|0|||
145499031|NCT02435992|524687753|FG002|Overall Study|Other Reason|0|||
145499032|NCT02435992|524687754|FG003|Overall Study|Other Reason|0|||
145499033|NCT02435992|524687755|FG004|Overall Study|Other Reason|0|||
145499034|NCT02435992|524687751|FG000|Overall Study|Physician Decision|0|||
145499035|NCT02435992|524687752|FG001|Overall Study|Physician Decision|0|||
145499036|NCT02435992|524687753|FG002|Overall Study|Physician Decision|1|||
145499037|NCT02435992|524687754|FG003|Overall Study|Physician Decision|0|||
145499038|NCT02435992|524687755|FG004|Overall Study|Physician Decision|0|||
145499039|NCT03873116|524687756|FG000|Part 1|Study drug discontinuation due to rash|0|||
145605968|NCT00638235|525073064|FG006|Overall Study|Lost to Follow-up|0|||
145499040|NCT03873116|524687757|FG001|Part 1|Study drug discontinuation due to rash|0|||
145499041|NCT03873116|524687758|FG002|Part 1|Study drug discontinuation due to rash|0|||
145499042|NCT03873116|524687759|FG003|Part 1|Study drug discontinuation due to rash|0|||
145499043|NCT03873116|524687760|FG004|Part 1|Study drug discontinuation due to rash|0|||
145499044|NCT03873116|524687761|FG005|Part 1|Study drug discontinuation due to rash|1|||
145499045|NCT03873116|524687756|FG000|Part 2|Withdrawal by Subject|0|||
145499046|NCT03873116|524687757|FG001|Part 2|Withdrawal by Subject|0|||
145499047|NCT03873116|524687758|FG002|Part 2|Withdrawal by Subject|1|||
145499048|NCT03873116|524687759|FG003|Part 2|Withdrawal by Subject|0|||
145499049|NCT03873116|524687760|FG004|Part 2|Withdrawal by Subject|0|||
145499050|NCT03873116|524687761|FG005|Part 2|Withdrawal by Subject|0|||
145499051|NCT03873116|524687756|FG000|Part 2|Lab abnormality or AE|0|||
145499052|NCT03873116|524687757|FG001|Part 2|Lab abnormality or AE|0|||
145499053|NCT03873116|524687758|FG002|Part 2|Lab abnormality or AE|0|||
145499054|NCT03873116|524687759|FG003|Part 2|Lab abnormality or AE|0|||
145499055|NCT03873116|524687760|FG004|Part 2|Lab abnormality or AE|1|||
145499056|NCT03873116|524687761|FG005|Part 2|Lab abnormality or AE|0|||
145499057|NCT03873116|524687756|FG000|Part 3|Withdrawal by Subject|0|||
145499058|NCT03873116|524687757|FG001|Part 3|Withdrawal by Subject|0|||
145499059|NCT03873116|524687758|FG002|Part 3|Withdrawal by Subject|0|||
145499060|NCT03873116|524687759|FG003|Part 3|Withdrawal by Subject|0|||
145499061|NCT03873116|524687760|FG004|Part 3|Withdrawal by Subject|1|||
145499062|NCT03873116|524687761|FG005|Part 3|Withdrawal by Subject|0|||
145499063|NCT02531802|524687762|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
145499064|NCT02531802|524687763|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
145499065|NCT02531802|524687764|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
145499066|NCT02531802|524687765|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
145499067|NCT02531802|524687766|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
145499068|NCT02531802|524687767|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
145499069|NCT02531802|524687768|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
145499070|NCT02531802|524687769|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
145499071|NCT02531802|524687770|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
145499072|NCT02531802|524687771|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
145499073|NCT02531802|524687772|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
145499074|NCT02531802|524687773|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
145499075|NCT02531802|524687774|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
145499076|NCT02531802|524687775|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
145499077|NCT02531802|524687776|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
145499078|NCT02531802|524687777|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
145499079|NCT02531802|524687778|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
145499080|NCT02531802|524687779|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
145499081|NCT02531802|524687780|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
145499082|NCT02531802|524687781|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
145499083|NCT02531802|524687782|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
145499084|NCT02531802|524687762|FG000|Received Vaccination 2|Physician Decision|0|||
145499085|NCT02531802|524687763|FG001|Received Vaccination 2|Physician Decision|0|||
145499086|NCT02531802|524687764|FG002|Received Vaccination 2|Physician Decision|0|||
145499087|NCT02531802|524687765|FG003|Received Vaccination 2|Physician Decision|0|||
145499088|NCT02531802|524687766|FG004|Received Vaccination 2|Physician Decision|0|||
145499089|NCT02531802|524687767|FG005|Received Vaccination 2|Physician Decision|1|||
145499090|NCT02531802|524687768|FG006|Received Vaccination 2|Physician Decision|0|||
145499091|NCT02531802|524687769|FG007|Received Vaccination 2|Physician Decision|0|||
145499092|NCT02531802|524687770|FG008|Received Vaccination 2|Physician Decision|0|||
145499093|NCT02531802|524687771|FG009|Received Vaccination 2|Physician Decision|2|||
145499094|NCT02531802|524687772|FG010|Received Vaccination 2|Physician Decision|0|||
145499095|NCT02531802|524687773|FG011|Received Vaccination 2|Physician Decision|0|||
145732815|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
145732816|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
145732817|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
145732818|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
145732819|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
145732820|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
145499096|NCT02531802|524687774|FG012|Received Vaccination 2|Physician Decision|0|||
145499097|NCT02531802|524687775|FG013|Received Vaccination 2|Physician Decision|1|||
145499098|NCT02531802|524687776|FG014|Received Vaccination 2|Physician Decision|0|||
145499099|NCT02531802|524687777|FG015|Received Vaccination 2|Physician Decision|0|||
145499100|NCT02531802|524687778|FG016|Received Vaccination 2|Physician Decision|0|||
145499101|NCT02531802|524687779|FG017|Received Vaccination 2|Physician Decision|1|||
145499102|NCT02531802|524687780|FG018|Received Vaccination 2|Physician Decision|0|||
145499103|NCT02531802|524687781|FG019|Received Vaccination 2|Physician Decision|0|||
145499104|NCT02531802|524687782|FG020|Received Vaccination 2|Physician Decision|0|||
145499105|NCT02531802|524687762|FG000|Received Vaccination 2|Adverse Event|0|||
145499106|NCT02531802|524687763|FG001|Received Vaccination 2|Adverse Event|0|||
145499107|NCT02531802|524687764|FG002|Received Vaccination 2|Adverse Event|0|||
145499108|NCT02531802|524687765|FG003|Received Vaccination 2|Adverse Event|0|||
145499109|NCT02531802|524687766|FG004|Received Vaccination 2|Adverse Event|0|||
145499110|NCT02531802|524687767|FG005|Received Vaccination 2|Adverse Event|2|||
145499111|NCT02531802|524687768|FG006|Received Vaccination 2|Adverse Event|0|||
145499112|NCT02531802|524687769|FG007|Received Vaccination 2|Adverse Event|0|||
145499113|NCT02531802|524687770|FG008|Received Vaccination 2|Adverse Event|0|||
145499114|NCT02531802|524687771|FG009|Received Vaccination 2|Adverse Event|0|||
145499115|NCT02531802|524687772|FG010|Received Vaccination 2|Adverse Event|0|||
145499116|NCT02531802|524687773|FG011|Received Vaccination 2|Adverse Event|0|||
145499117|NCT02531802|524687774|FG012|Received Vaccination 2|Adverse Event|0|||
145499118|NCT02531802|524687775|FG013|Received Vaccination 2|Adverse Event|0|||
145499119|NCT02531802|524687776|FG014|Received Vaccination 2|Adverse Event|0|||
145499120|NCT02531802|524687777|FG015|Received Vaccination 2|Adverse Event|0|||
145499121|NCT02531802|524687778|FG016|Received Vaccination 2|Adverse Event|0|||
145499122|NCT02531802|524687779|FG017|Received Vaccination 2|Adverse Event|2|||
145499123|NCT02531802|524687780|FG018|Received Vaccination 2|Adverse Event|1|||
145499124|NCT02531802|524687781|FG019|Received Vaccination 2|Adverse Event|0|||
145499125|NCT02531802|524687782|FG020|Received Vaccination 2|Adverse Event|1|||
145499126|NCT02531802|524687762|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
145499127|NCT02531802|524687763|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
145499128|NCT02531802|524687764|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
145499129|NCT02531802|524687765|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
145499130|NCT02531802|524687766|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
145499131|NCT02531802|524687767|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
145499132|NCT02531802|524687768|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
145499133|NCT02531802|524687769|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
145499134|NCT02531802|524687770|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
145499135|NCT02531802|524687771|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
145499136|NCT02531802|524687772|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
145499137|NCT02531802|524687773|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
145499138|NCT02531802|524687774|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
145499139|NCT02531802|524687775|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
145499140|NCT02531802|524687776|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
145499141|NCT02531802|524687777|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
145499142|NCT02531802|524687778|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
145499143|NCT02531802|524687779|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
145499144|NCT02531802|524687780|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
145499145|NCT02531802|524687781|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
145499146|NCT02531802|524687782|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
145499147|NCT02000440|524687791|FG000|Overall Study|Adverse Event|3|||
145499148|NCT02000440|524687791|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
145499149|NCT04109547|524687792|FG000|Overall Study|Withdrawal by Subject|3|||
145499150|NCT04109547|524687793|FG001|Overall Study|Withdrawal by Subject|2|||
145499151|NCT04109547|524687794|FG002|Overall Study|Withdrawal by Subject|6|||
145499152|NCT04109547|524687795|FG003|Overall Study|Withdrawal by Subject|6|||
145499153|NCT04109547|524687792|FG000|Overall Study|Lost to Follow-up|0|||
145397156|NCT01249417|524309245|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
145397157|NCT00917124|524309246|FG000|Overall Study|Protocol Violation|4|||
145397158|NCT00917124|524309247|FG001|Overall Study|Protocol Violation|6|||
145397159|NCT01783743|524309252|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
145397160|NCT01783743|524309253|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
145397161|NCT01783743|524309252|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
145397162|NCT01783743|524309253|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
145397163|NCT01783743|524309252|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
145397164|NCT01783743|524309253|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
145397165|NCT02771275|524309255|FG000|Overall Study|Reoperation|3|||
145397166|NCT02771275|524309255|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
145397167|NCT05556148|524309256|FG000|Overall Study|Early Termination|29|||
145397168|NCT05556148|524309256|FG000|Overall Study|Baseline Tasks Expired|4|||
145499154|NCT04109547|524687793|FG001|Overall Study|Lost to Follow-up|0|||
145499155|NCT04109547|524687794|FG002|Overall Study|Lost to Follow-up|0|||
145499156|NCT04109547|524687795|FG003|Overall Study|Lost to Follow-up|1|||
145499157|NCT04109547|524687792|FG000|Overall Study|Physician Decision|1|||
145499158|NCT04109547|524687793|FG001|Overall Study|Physician Decision|2|||
145397169|NCT05556148|524309256|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
145499159|NCT04109547|524687794|FG002|Overall Study|Physician Decision|0|||
145499160|NCT04109547|524687795|FG003|Overall Study|Physician Decision|0|||
145499161|NCT00871975|524687796|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
145499162|NCT00871975|524687796|FG000|Overall Study|Catheters could not be inserted|1|||
145499163|NCT00871975|524687796|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
145499164|NCT00871975|524687796|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
145499165|NCT01690143|524687797|FG000|Overall Study|Withdrawal by Subject|1|||
145499166|NCT01210313|524687801|FG000|Overall Study|Withdrawal by Subject|3|||
145499167|NCT01210313|524687801|FG000|Overall Study|Adverse Event|2|||
145499168|NCT01210313|524687801|FG000|Overall Study|Distant recurrence|4|||
145499169|NCT01210313|524687801|FG000|Overall Study|Non-compliance|7|||
145499170|NCT03113487|524687804|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
145499171|NCT04189952|524687807|FG000|Follow-up Period|Death|1|||
145499172|NCT04189952|524687807|FG000|Follow-up Period|Withdrawal by Subject|1|||
145499173|NCT00870740|524687808|FG000|Overall Study|Adverse Event|2|||
145499174|NCT00870740|524687809|FG001|Overall Study|Adverse Event|1|||
145499175|NCT00870740|524687810|FG002|Overall Study|Adverse Event|3|||
145499176|NCT00870740|524687811|FG003|Overall Study|Adverse Event|2|||
145499177|NCT00870740|524687812|FG004|Overall Study|Adverse Event|1|||
145499178|NCT00870740|524687813|FG005|Overall Study|Adverse Event|6|||
145499179|NCT00870740|524687808|FG000|Overall Study|Consent Withdrawn|6|||
145499180|NCT00870740|524687809|FG001|Overall Study|Consent Withdrawn|3|||
145499181|NCT00870740|524687810|FG002|Overall Study|Consent Withdrawn|4|||
145499182|NCT00870740|524687811|FG003|Overall Study|Consent Withdrawn|6|||
145499183|NCT00870740|524687812|FG004|Overall Study|Consent Withdrawn|6|||
145499184|NCT00870740|524687813|FG005|Overall Study|Consent Withdrawn|5|||
145499185|NCT00870740|524687808|FG000|Overall Study|Investigator Decision|2|||
145499186|NCT00870740|524687809|FG001|Overall Study|Investigator Decision|0|||
145499187|NCT00870740|524687810|FG002|Overall Study|Investigator Decision|1|||
145499188|NCT00870740|524687811|FG003|Overall Study|Investigator Decision|0|||
145499189|NCT00870740|524687812|FG004|Overall Study|Investigator Decision|0|||
145499190|NCT00870740|524687813|FG005|Overall Study|Investigator Decision|0|||
145499191|NCT00870740|524687808|FG000|Overall Study|Subject Non-compliance|0|||
145499192|NCT00870740|524687809|FG001|Overall Study|Subject Non-compliance|0|||
145499193|NCT00870740|524687810|FG002|Overall Study|Subject Non-compliance|0|||
145499194|NCT00870740|524687811|FG003|Overall Study|Subject Non-compliance|0|||
145499195|NCT00870740|524687812|FG004|Overall Study|Subject Non-compliance|0|||
145499196|NCT00870740|524687813|FG005|Overall Study|Subject Non-compliance|1|||
145499197|NCT00870740|524687808|FG000|Overall Study|Death|0|||
145499198|NCT00870740|524687809|FG001|Overall Study|Death|0|||
145499199|NCT00870740|524687810|FG002|Overall Study|Death|0|||
145499200|NCT00870740|524687811|FG003|Overall Study|Death|0|||
145499201|NCT00870740|524687812|FG004|Overall Study|Death|1|||
145499202|NCT00870740|524687813|FG005|Overall Study|Death|0|||
145499203|NCT00870740|524687808|FG000|Overall Study|Other|2|||
145499204|NCT00870740|524687809|FG001|Overall Study|Other|5|||
145499205|NCT00870740|524687810|FG002|Overall Study|Other|2|||
145499206|NCT00870740|524687811|FG003|Overall Study|Other|4|||
145499207|NCT00870740|524687812|FG004|Overall Study|Other|3|||
145499208|NCT00870740|524687813|FG005|Overall Study|Other|5|||
145499209|NCT04298697|524687820|FG000|Overall Study|Lost to Follow-up|5|||
145499210|NCT04298697|524687821|FG001|Overall Study|Lost to Follow-up|5|||
145499211|NCT04298697|524687822|FG002|Overall Study|Lost to Follow-up|1|||
145499212|NCT04298697|524687823|FG003|Overall Study|Lost to Follow-up|0|||
145499213|NCT04298697|524687820|FG000|Overall Study|Withdrawal by Subject|0|||
145499214|NCT04298697|524687821|FG001|Overall Study|Withdrawal by Subject|3|||
145499215|NCT04298697|524687822|FG002|Overall Study|Withdrawal by Subject|2|||
145499216|NCT04298697|524687823|FG003|Overall Study|Withdrawal by Subject|3|||
145499217|NCT01498068|524687826|FG000|Overall Study|Withdrawal by Subject|1|||
145499218|NCT01498068|524687827|FG001|Overall Study|Withdrawal by Subject|1|||
145499219|NCT00198822|524687829|FG000|Overall Study|Lost to Follow-up|14|||
145499220|NCT00198822|524687830|FG001|Overall Study|Lost to Follow-up|20|||
145499221|NCT00198822|524687831|FG002|Overall Study|Lost to Follow-up|21|||
145499222|NCT04973449|524687834|FG000|Overall Study|Withdrawal by Subject|3|||
145499223|NCT04973449|524687835|FG001|Overall Study|Withdrawal by Subject|3|||
145499224|NCT04973449|524687836|FG002|Overall Study|Withdrawal by Subject|2|||
145499225|NCT04973449|524687837|FG003|Overall Study|Withdrawal by Subject|5|||
145499226|NCT04973449|524687838|FG004|Overall Study|Withdrawal by Subject|5|||
145499227|NCT04973449|524687839|FG005|Overall Study|Withdrawal by Subject|4|||
145499228|NCT04973449|524687840|FG006|Overall Study|Withdrawal by Subject|7|||
145499229|NCT04973449|524687841|FG007|Overall Study|Withdrawal by Subject|5|||
145499230|NCT04973449|524687834|FG000|Overall Study|Lost to Follow-up|15|||
145499231|NCT04973449|524687835|FG001|Overall Study|Lost to Follow-up|16|||
145499232|NCT04973449|524687836|FG002|Overall Study|Lost to Follow-up|16|||
145499233|NCT04973449|524687837|FG003|Overall Study|Lost to Follow-up|13|||
145499234|NCT04973449|524687838|FG004|Overall Study|Lost to Follow-up|5|||
145499235|NCT04973449|524687839|FG005|Overall Study|Lost to Follow-up|6|||
145499236|NCT04973449|524687840|FG006|Overall Study|Lost to Follow-up|10|||
145499237|NCT04973449|524687841|FG007|Overall Study|Lost to Follow-up|6|||
145499238|NCT04973449|524687834|FG000|Overall Study|Death|1|||
145499239|NCT04973449|524687835|FG001|Overall Study|Death|0|||
145499240|NCT04973449|524687836|FG002|Overall Study|Death|0|||
145397170|NCT05556148|524309256|FG000|Overall Study|No Longer Wished to Participate|1|||
145397171|NCT05556148|524309256|FG000|Overall Study|Bacterial Conjunctivitis|1|||
145397172|NCT03191799|524309257|FG000|Overall Study|Withdrawal by Subject|4|||
145397173|NCT03191799|524309257|FG000|Overall Study|Physician Decision|2|||
145397174|NCT03191799|524309257|FG000|Overall Study|Lost to Follow-up|1|||
145397175|NCT03191799|524309257|FG000|Overall Study|Death|2|||
145397176|NCT00728494|524309270|FG000|Overall Study|Adverse Event|7|||
145397177|NCT00728494|524309271|FG001|Overall Study|Adverse Event|0|||
145397178|NCT00728494|524309270|FG000|Overall Study|Withdrawal by Subject|0|||
145397179|NCT00728494|524309271|FG001|Overall Study|Withdrawal by Subject|2|||
145397180|NCT00728494|524309270|FG000|Overall Study|Lack of Efficacy|2|||
145397181|NCT00728494|524309271|FG001|Overall Study|Lack of Efficacy|4|||
145397182|NCT00728494|524309270|FG000|Overall Study|No data available|0|||
145397183|NCT00728494|524309271|FG001|Overall Study|No data available|1|||
145397184|NCT03769649|524309272|FG000|Overall Study|Lost to Follow-up|4|||
145397185|NCT00853762|524309273|FG000|Overall Study|Premature Termination|16|||
145397186|NCT00853762|524309274|FG001|Overall Study|Premature Termination|15|||
145397187|NCT00853762|524309275|FG002|Overall Study|Premature Termination|14|||
145397188|NCT00853762|524309276|FG003|Overall Study|Premature Termination|21|||
145397189|NCT00853762|524309273|FG000|Overall Study|Protocol Violation|0|||
145397190|NCT00853762|524309274|FG001|Overall Study|Protocol Violation|0|||
145397191|NCT00853762|524309275|FG002|Overall Study|Protocol Violation|0|||
145397192|NCT00853762|524309276|FG003|Overall Study|Protocol Violation|1|||
145397193|NCT00853762|524309273|FG000|Overall Study|Withdrawal by Subject|0|||
145397194|NCT00853762|524309274|FG001|Overall Study|Withdrawal by Subject|0|||
145397195|NCT00853762|524309275|FG002|Overall Study|Withdrawal by Subject|1|||
145397196|NCT00853762|524309276|FG003|Overall Study|Withdrawal by Subject|0|||
145397197|NCT00853762|524309273|FG000|Overall Study|Other|0|||
145397198|NCT00853762|524309274|FG001|Overall Study|Other|2|||
145397199|NCT00853762|524309275|FG002|Overall Study|Other|0|||
145397200|NCT00853762|524309276|FG003|Overall Study|Other|0|||
145397201|NCT00853762|524309273|FG000|Overall Study|Randomised but not Treated|0|||
145397202|NCT00853762|524309274|FG001|Overall Study|Randomised but not Treated|2|||
145397203|NCT00853762|524309275|FG002|Overall Study|Randomised but not Treated|2|||
145397204|NCT00853762|524309276|FG003|Overall Study|Randomised but not Treated|0|||
145397205|NCT00748241|524309278|FG000|Overall Study|Implant failure|1|||
145397206|NCT00748241|524309278|FG000|Overall Study|Lost to Follow-up|5|||
145397207|NCT00748241|524309278|FG000|Overall Study|Death|2|||
145397208|NCT02456727|524309281|FG000|Overall Study|Lost to Follow-up|63|||
145397209|NCT02456727|524309282|FG001|Overall Study|Lost to Follow-up|65|||
145397210|NCT02456727|524309281|FG000|Overall Study|Death|2|||
145397211|NCT02456727|524309282|FG001|Overall Study|Death|1|||
145397212|NCT02456727|524309281|FG000|Overall Study|Withdrawal by Subject|1|||
145397213|NCT02456727|524309282|FG001|Overall Study|Withdrawal by Subject|10|||
145397214|NCT02456727|524309281|FG000|Overall Study|Never Initiated Treatment|43|||
145397215|NCT02456727|524309282|FG001|Overall Study|Never Initiated Treatment|30|||
145397216|NCT01408706|524309286|FG000|Overall Study|Physician Decision|1|||
145397217|NCT01408706|524309287|FG001|Overall Study|Physician Decision|0|||
145397218|NCT00888654|524309288|FG000|Overall Study|Problems swallowing oral meds.|1|||
145397219|NCT00888654|524309288|FG000|Overall Study|Not enough oral meds before surgery|3|||
145397220|NCT00888654|524309288|FG000|Overall Study|Surgery aborted|2|||
145397221|NCT00888654|524309288|FG000|Overall Study|Withdrawal by Subject|1|||
145397222|NCT00888654|524309288|FG000|Overall Study|Inelig. due to contraindication of med|1|||
145397223|NCT00888654|524309288|FG000|Overall Study|Change in surg date|1|||
145397224|NCT00888654|524309288|FG000|Overall Study|Stopped meds due to headaches|1|||
145397225|NCT02974868|524309289|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
145397226|NCT02974868|524309290|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
145397227|NCT02974868|524309291|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
145397228|NCT02974868|524309292|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
145397229|NCT02974868|524309289|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
145397230|NCT02974868|524309290|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
145397231|NCT02974868|524309291|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
145397232|NCT02974868|524309292|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
145397233|NCT02974868|524309289|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
145397234|NCT02974868|524309290|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
145397235|NCT02974868|524309291|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
145397236|NCT02974868|524309292|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
145397237|NCT02974868|524309289|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
145397238|NCT02974868|524309290|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
145397239|NCT02974868|524309291|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
145397240|NCT02974868|524309292|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
145397241|NCT02674516|524309293|FG000|Overall Study|Lost to Follow-up|3|||
145499241|NCT04973449|524687837|FG003|Overall Study|Death|0|||
145499242|NCT04973449|524687838|FG004|Overall Study|Death|0|||
145499243|NCT04973449|524687839|FG005|Overall Study|Death|1|||
145499244|NCT04973449|524687840|FG006|Overall Study|Death|0|||
145499245|NCT04973449|524687841|FG007|Overall Study|Death|0|||
145499246|NCT04973449|524687834|FG000|Overall Study|Other|1|||
145499247|NCT04973449|524687835|FG001|Overall Study|Other|1|||
145499248|NCT04973449|524687836|FG002|Overall Study|Other|2|||
145499249|NCT04973449|524687837|FG003|Overall Study|Other|1|||
145499250|NCT04973449|524687838|FG004|Overall Study|Other|4|||
145499251|NCT04973449|524687839|FG005|Overall Study|Other|0|||
145499252|NCT04973449|524687840|FG006|Overall Study|Other|2|||
145499253|NCT04973449|524687841|FG007|Overall Study|Other|2|||
145499254|NCT00888173|524687842|FG000|Overall Study|Wrong Primary|1|||
145499255|NCT00888173|524687842|FG000|Overall Study|Ineligible: required test not done|1|||
145499256|NCT00737672|524687849|FG000|Overall Study|Graft Abandonment|48|||
145499257|NCT00737672|524687850|FG001|Overall Study|Graft Abandonment|56|||
145499258|NCT00737672|524687849|FG000|Overall Study|Death|23|||
145499259|NCT00737672|524687850|FG001|Overall Study|Death|22|||
145499260|NCT00737672|524687849|FG000|Overall Study|Withdrawal by Subject|1|||
145499261|NCT00737672|524687850|FG001|Overall Study|Withdrawal by Subject|2|||
145499262|NCT00737672|524687849|FG000|Overall Study|Lost to Follow-up|1|||
145499263|NCT00737672|524687850|FG001|Overall Study|Lost to Follow-up|0|||
145499264|NCT00737672|524687849|FG000|Overall Study|Miscellaneous|7|||
145499265|NCT00737672|524687850|FG001|Overall Study|Miscellaneous|1|||
145499266|NCT00737672|524687849|FG000|Overall Study|Physician Decision|0|||
145499267|NCT00737672|524687850|FG001|Overall Study|Physician Decision|2|||
145499268|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
145499269|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
145499270|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
145499271|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
145499272|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Adverse Event|2|||
145499273|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Adverse Event|5|||
145499274|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Adverse Event|1|||
145499275|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Adverse Event|2|||
145499276|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Death|13|||
145499277|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Death|17|||
145499278|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Death|1|||
145499279|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Death|0|||
145499280|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
145605969|NCT00638235|525073065|FG007|Overall Study|Lost to Follow-up|1|||
145397242|NCT02674516|524309294|FG001|Overall Study|Lost to Follow-up|0|||
145397243|NCT02674516|524309293|FG000|Overall Study|Protocol Violation|0|||
145397244|NCT02674516|524309294|FG001|Overall Study|Protocol Violation|4|||
145397245|NCT02674516|524309293|FG000|Overall Study|Knowledge of study hypothesis|1|||
145397246|NCT02674516|524309294|FG001|Overall Study|Knowledge of study hypothesis|0|||
145397247|NCT00490035|524309295|FG000|Overall Study|AE, non-serious non-fatal|3|||
145397248|NCT00490035|524309296|FG001|Overall Study|AE, non-serious non-fatal|4|||
145397249|NCT00490035|524309297|FG002|Overall Study|AE, non-serious non-fatal|4|||
145397250|NCT00490035|524309298|FG003|Overall Study|AE, non-serious non-fatal|5|||
145397251|NCT00490035|524309295|FG000|Overall Study|Lost to Follow-up|2|||
145397252|NCT00490035|524309296|FG001|Overall Study|Lost to Follow-up|0|||
145397253|NCT00490035|524309297|FG002|Overall Study|Lost to Follow-up|1|||
145397254|NCT00490035|524309298|FG003|Overall Study|Lost to Follow-up|0|||
145397255|NCT00490035|524309295|FG000|Overall Study|Withdrawal by Subject|2|||
145397256|NCT00490035|524309296|FG001|Overall Study|Withdrawal by Subject|1|||
145397257|NCT00490035|524309297|FG002|Overall Study|Withdrawal by Subject|1|||
145397258|NCT00490035|524309298|FG003|Overall Study|Withdrawal by Subject|0|||
145397259|NCT00490035|524309295|FG000|Overall Study|Other reason|0|||
145397260|NCT00490035|524309296|FG001|Overall Study|Other reason|1|||
145397261|NCT00490035|524309297|FG002|Overall Study|Other reason|3|||
145397262|NCT00490035|524309298|FG003|Overall Study|Other reason|1|||
145397263|NCT00490035|524309295|FG000|Overall Study|AE, serious fatal|1|||
145397264|NCT00490035|524309296|FG001|Overall Study|AE, serious fatal|0|||
145397265|NCT00490035|524309297|FG002|Overall Study|AE, serious fatal|0|||
145397266|NCT00490035|524309298|FG003|Overall Study|AE, serious fatal|0|||
145397267|NCT00490035|524309295|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
145397268|NCT00490035|524309296|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
145397269|NCT00490035|524309297|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
145397270|NCT00490035|524309298|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
145397271|NCT00490035|524309295|FG000|Overall Study|AE of unknown type|0|||
145499281|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
145499282|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
145499283|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
145499284|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Disease Progression|2|||
145499285|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Disease Progression|0|||
145499286|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Disease Progression|0|||
145499287|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Disease Progression|0|||
145397272|NCT00490035|524309296|FG001|Overall Study|AE of unknown type|0|||
145397273|NCT00490035|524309297|FG002|Overall Study|AE of unknown type|2|||
145397274|NCT00490035|524309298|FG003|Overall Study|AE of unknown type|0|||
145397275|NCT06058390|524309299|FG000|Overall Study|Lost to Follow-up|0|||
145397276|NCT06058390|524309300|FG001|Overall Study|Lost to Follow-up|0|||
145397277|NCT06058390|524309301|FG002|Overall Study|Lost to Follow-up|2|||
145397278|NCT06058390|524309302|FG003|Overall Study|Lost to Follow-up|1|||
145397279|NCT06058390|524309299|FG000|Overall Study|Physician Decision|0|||
145397280|NCT06058390|524309300|FG001|Overall Study|Physician Decision|0|||
145397281|NCT06058390|524309301|FG002|Overall Study|Physician Decision|0|||
145397282|NCT06058390|524309302|FG003|Overall Study|Physician Decision|1|||
145397283|NCT06058390|524309299|FG000|Overall Study|Participants did not receive any study intervention|0|||
145397284|NCT06058390|524309300|FG001|Overall Study|Participants did not receive any study intervention|0|||
145397285|NCT06058390|524309301|FG002|Overall Study|Participants did not receive any study intervention|0|||
145397286|NCT06058390|524309302|FG003|Overall Study|Participants did not receive any study intervention|1|||
145397287|NCT03589807|524309305|FG000|Overall Study|Lost to Follow-up|0|||
145397288|NCT03589807|524309306|FG001|Overall Study|Lost to Follow-up|2|||
145397289|NCT03589807|524309307|FG002|Overall Study|Lost to Follow-up|2|||
145397290|NCT03589807|524309308|FG003|Overall Study|Lost to Follow-up|3|||
145397291|NCT03589807|524309309|FG004|Overall Study|Lost to Follow-up|1|||
145397292|NCT03589807|524309310|FG005|Overall Study|Lost to Follow-up|1|||
145397293|NCT03589807|524309305|FG000|Overall Study|Withdrawal by Subject|0|||
145397294|NCT03589807|524309306|FG001|Overall Study|Withdrawal by Subject|5|||
145397295|NCT03589807|524309307|FG002|Overall Study|Withdrawal by Subject|0|||
145397296|NCT03589807|524309308|FG003|Overall Study|Withdrawal by Subject|0|||
145397297|NCT03589807|524309309|FG004|Overall Study|Withdrawal by Subject|0|||
145397298|NCT03589807|524309310|FG005|Overall Study|Withdrawal by Subject|0|||
145397299|NCT03589807|524309305|FG000|Overall Study|Protocol Violation|0|||
145397300|NCT03589807|524309306|FG001|Overall Study|Protocol Violation|0|||
145397301|NCT03589807|524309307|FG002|Overall Study|Protocol Violation|0|||
145397302|NCT03589807|524309308|FG003|Overall Study|Protocol Violation|1|||
145397303|NCT03589807|524309309|FG004|Overall Study|Protocol Violation|0|||
145397304|NCT03589807|524309310|FG005|Overall Study|Protocol Violation|0|||
145397305|NCT03589807|524309305|FG000|Overall Study|Enrolled but treatment not administered|0|||
145397306|NCT03589807|524309306|FG001|Overall Study|Enrolled but treatment not administered|0|||
145397307|NCT03589807|524309307|FG002|Overall Study|Enrolled but treatment not administered|0|||
145397308|NCT03589807|524309308|FG003|Overall Study|Enrolled but treatment not administered|0|||
145397309|NCT03589807|524309309|FG004|Overall Study|Enrolled but treatment not administered|1|||
145397310|NCT03589807|524309310|FG005|Overall Study|Enrolled but treatment not administered|0|||
145397311|NCT01534273|524309311|FG000|Period 1|Physician Decision|0|||
145397312|NCT01534273|524309312|FG001|Period 1|Physician Decision|0|||
145397313|NCT01534273|524309313|FG002|Period 1|Physician Decision|0|||
145397314|NCT01534273|524309314|FG003|Period 1|Physician Decision|1|||
145397315|NCT01534273|524309315|FG004|Period 1|Physician Decision|0|||
145397316|NCT01534273|524309316|FG005|Period 1|Physician Decision|0|||
145397317|NCT01534273|524309317|FG006|Period 1|Physician Decision|0|||
145397318|NCT01619865|524309318|FG000|Overall Study|Adverse Event|1|||
145397319|NCT01619865|524309318|FG000|Overall Study|Death|2|||
145397320|NCT01619865|524309318|FG000|Overall Study|subject not able to comply|1|||
145397321|NCT03586050|524309319|FG000|Overall Study|Death|3|||
145397322|NCT03586050|524309319|FG000|Overall Study|Withdrawal by Subject|2|||
145397323|NCT01494818|524309320|FG000|Overall Study|Relocation|1|||
145397324|NCT01494818|524309321|FG001|Overall Study|Relocation|2|||
145397325|NCT01494818|524309320|FG000|Overall Study|Lost to Follow-up|1|||
145397326|NCT01494818|524309321|FG001|Overall Study|Lost to Follow-up|0|||
145397327|NCT00593918|524309322|FG000|Overall Study|Withdrawal by Subject|5|||
145397328|NCT00593918|524309323|FG001|Overall Study|Withdrawal by Subject|24|||
145397329|NCT01211145|524309327|FG000|Overall Study|Reason not specified|3|||
145397330|NCT01211145|524309328|FG001|Overall Study|Reason not specified|2|||
145397331|NCT01211145|524309329|FG002|Overall Study|Reason not specified|2|||
145397332|NCT01211145|524309330|FG003|Overall Study|Reason not specified|1|||
145397333|NCT01211145|524309327|FG000|Overall Study|Lost to Follow-up|3|||
145397334|NCT01211145|524309328|FG001|Overall Study|Lost to Follow-up|2|||
145397335|NCT01211145|524309329|FG002|Overall Study|Lost to Follow-up|1|||
145397336|NCT01211145|524309330|FG003|Overall Study|Lost to Follow-up|2|||
145397337|NCT01211145|524309327|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145397338|NCT01211145|524309328|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145397339|NCT01211145|524309329|FG002|Overall Study|Study-specific withdrawal criteria|0|||
145397340|NCT01211145|524309330|FG003|Overall Study|Study-specific withdrawal criteria|0|||
145397341|NCT01211145|524309327|FG000|Overall Study|Severe noncompliance to protocol|1|||
145397342|NCT01211145|524309328|FG001|Overall Study|Severe noncompliance to protocol|0|||
145397343|NCT01211145|524309329|FG002|Overall Study|Severe noncompliance to protocol|0|||
145397344|NCT01211145|524309330|FG003|Overall Study|Severe noncompliance to protocol|0|||
145397345|NCT01211145|524309327|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
145397346|NCT01211145|524309328|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
145397347|NCT01211145|524309329|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
145499288|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
145499289|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
145499290|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
145499291|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
145499292|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
145499293|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
145499294|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
145499295|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
145499296|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
145499297|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
145499298|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
145499299|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
145499300|NCT03955146|524687856|FG000|DB Period (48 Weeks)|Participant Decision|9|||
145499301|NCT03955146|524687857|FG001|DB Period (48 Weeks)|Participant Decision|12|||
145499302|NCT03955146|524687858|FG002|DB Period (48 Weeks)|Participant Decision|1|||
145499303|NCT03955146|524687859|FG003|DB Period (48 Weeks)|Participant Decision|1|||
145499304|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
145499305|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
145499306|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
145499307|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
145499308|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
145499309|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
145499310|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
145499311|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
145499312|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
145499313|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
145499314|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
145499315|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
145499316|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
145499317|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
145499318|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
145499319|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
145499320|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
145499321|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
145499322|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
145499323|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
145499324|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
145499325|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
145499326|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
145499327|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
145499328|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
145499329|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
145499330|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
145499331|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
145499332|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
145499333|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
145499334|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
145499335|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
145499336|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
145499337|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
145499338|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
145499339|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
145499340|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
145499341|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
145499342|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
145499343|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
145499344|NCT03955146|524687856|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
145499345|NCT03955146|524687857|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
145499346|NCT03955146|524687858|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
145499347|NCT03955146|524687859|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
145499348|NCT02002598|524687864|FG000|Dose Level 1|Withdrawal by Subject|1|||
145499349|NCT02002598|524687865|FG001|Dose Level 1|Withdrawal by Subject|0|||
145499350|NCT02002598|524687866|FG002|Dose Level 1|Withdrawal by Subject|0|||
145499351|NCT02002598|524687867|FG003|Dose Level 1|Withdrawal by Subject|0|||
145499352|NCT02002598|524687868|FG004|Dose Level 1|Withdrawal by Subject|0|||
145499353|NCT02628873|524687869|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
145605970|NCT00638235|525073066|FG008|Overall Study|Lost to Follow-up|18|||
145499354|NCT02628873|524687870|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
145499355|NCT02628873|524687869|FG000|Second Test (1 Hour)|Physician Decision|1|||
145499356|NCT02628873|524687870|FG001|Second Test (1 Hour)|Physician Decision|0|||
145499357|NCT04672239|524687871|FG000|Week 2 Survey|Failed survey check items|1|||
145499358|NCT04672239|524687872|FG001|Week 2 Survey|Failed survey check items|2|||
145499359|NCT04672239|524687873|FG002|Week 2 Survey|Failed survey check items|3|||
145499360|NCT04672239|524687871|FG000|Week 2 Survey|Partially completed survey|7|||
145499361|NCT04672239|524687872|FG001|Week 2 Survey|Partially completed survey|1|||
145499362|NCT04672239|524687873|FG002|Week 2 Survey|Partially completed survey|4|||
145499363|NCT04672239|524687871|FG000|Week 2 Survey|Withdrawal by Subject|0|||
145499364|NCT04672239|524687872|FG001|Week 2 Survey|Withdrawal by Subject|1|||
145499365|NCT04672239|524687873|FG002|Week 2 Survey|Withdrawal by Subject|0|||
145499366|NCT04672239|524687871|FG000|Week 2 Survey|Lost to Follow-up|3|||
145499367|NCT04672239|524687872|FG001|Week 2 Survey|Lost to Follow-up|2|||
145499368|NCT04672239|524687873|FG002|Week 2 Survey|Lost to Follow-up|5|||
145499369|NCT04672239|524687871|FG000|Week 6 Survey|Failed survey check items|2|||
145499370|NCT04672239|524687872|FG001|Week 6 Survey|Failed survey check items|2|||
145499371|NCT04672239|524687873|FG002|Week 6 Survey|Failed survey check items|2|||
145499372|NCT04672239|524687871|FG000|Week 6 Survey|Partially completed survey|3|||
145499373|NCT04672239|524687872|FG001|Week 6 Survey|Partially completed survey|3|||
145499374|NCT04672239|524687873|FG002|Week 6 Survey|Partially completed survey|2|||
145499375|NCT04672239|524687871|FG000|Week 6 Survey|Withdrawal by Subject|1|||
145499376|NCT04672239|524687872|FG001|Week 6 Survey|Withdrawal by Subject|1|||
145499377|NCT04672239|524687873|FG002|Week 6 Survey|Withdrawal by Subject|1|||
145499378|NCT04672239|524687871|FG000|Week 6 Survey|Withdrawn by PI|0|||
145499379|NCT04672239|524687872|FG001|Week 6 Survey|Withdrawn by PI|1|||
145499380|NCT04672239|524687873|FG002|Week 6 Survey|Withdrawn by PI|0|||
145499381|NCT04672239|524687871|FG000|Week 6 Survey|Lost to Follow-up|12|||
145499382|NCT04672239|524687872|FG001|Week 6 Survey|Lost to Follow-up|2|||
145499383|NCT04672239|524687873|FG002|Week 6 Survey|Lost to Follow-up|5|||
145499384|NCT04672239|524687871|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
145499385|NCT04672239|524687872|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
145499386|NCT04672239|524687873|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
145499387|NCT04672239|524687871|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
145499388|NCT04672239|524687872|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
145499389|NCT04672239|524687873|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
145499390|NCT04672239|524687871|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
145499391|NCT04672239|524687872|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
145499392|NCT04672239|524687873|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
145499393|NCT04672239|524687871|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
145499394|NCT04672239|524687872|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
145499395|NCT04672239|524687873|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
145499396|NCT04672239|524687871|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
145499397|NCT04672239|524687872|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
145499398|NCT04672239|524687873|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
145499399|NCT04672239|524687871|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
145499400|NCT04672239|524687872|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
145499401|NCT04672239|524687873|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
145499402|NCT04672239|524687871|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
145499403|NCT04672239|524687872|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
145499404|NCT04672239|524687873|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
145499405|NCT00541658|524687874|FG000|Overall Study|Adverse Event|28|||
145499406|NCT00541658|524687875|FG001|Overall Study|Adverse Event|37|||
145499407|NCT00541658|524687876|FG002|Overall Study|Adverse Event|25|||
145499408|NCT00541658|524687874|FG000|Overall Study|Physician Decision|0|||
145499409|NCT00541658|524687875|FG001|Overall Study|Physician Decision|0|||
145499410|NCT00541658|524687876|FG002|Overall Study|Physician Decision|4|||
145499411|NCT00541658|524687874|FG000|Overall Study|Lost to Follow-up|3|||
145499412|NCT00541658|524687875|FG001|Overall Study|Lost to Follow-up|3|||
145499413|NCT00541658|524687876|FG002|Overall Study|Lost to Follow-up|6|||
145499414|NCT00541658|524687874|FG000|Overall Study|Protocol Violation|0|||
145499415|NCT00541658|524687875|FG001|Overall Study|Protocol Violation|1|||
145499416|NCT00541658|524687876|FG002|Overall Study|Protocol Violation|1|||
145499417|NCT00541658|524687874|FG000|Overall Study|Withdrawal by Subject|28|||
145499418|NCT00541658|524687875|FG001|Overall Study|Withdrawal by Subject|32|||
145499419|NCT00541658|524687876|FG002|Overall Study|Withdrawal by Subject|32|||
145499420|NCT00541658|524687874|FG000|Overall Study|Took No Study Drug|1|||
145499421|NCT00541658|524687875|FG001|Overall Study|Took No Study Drug|0|||
145499422|NCT00541658|524687876|FG002|Overall Study|Took No Study Drug|0|||
145499423|NCT01099267|524687877|FG000|MDS-003 Study|Adverse Event|37|||
145499424|NCT01099267|524687877|FG000|MDS-003 Study|Lack of Efficacy|52|||
145499425|NCT01099267|524687877|FG000|MDS-003 Study|Withdrawal by Subject|8|||
145499426|NCT01099267|524687877|FG000|MDS-003 Study|Lost to Follow-up|1|||
145499427|NCT01099267|524687877|FG000|MDS-003 Study|Death|11|||
145499428|NCT01099267|524687877|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
145499429|NCT01099267|524687877|FG000|MDS-003 Study|Disease Progression|7|||
145499430|NCT01099267|524687877|FG000|MDS-003 Study|Investigator Decision|2|||
145499431|NCT01099267|524687877|FG000|MDS-003 Study|Non-Compliance|2|||
145499432|NCT01099267|524687877|FG000|MDS-003 Study|Loss of Response|1|||
145499433|NCT01099267|524687877|FG000|MDS-003 Study|Secondary Malign Disease|1|||
145499434|NCT04986904|524687878|FG000|Overall Study|Lost to Follow-up|11|||
145499435|NCT04986904|524687878|FG000|Overall Study|Withdrawal by Subject|1|||
145499436|NCT04123470|524687883|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
145499437|NCT04123470|524687884|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
145499438|NCT04123470|524687883|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
145499439|NCT04123470|524687884|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
145499440|NCT04123470|524687883|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
145499441|NCT04123470|524687884|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
145499442|NCT04123470|524687883|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
145499443|NCT04123470|524687884|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
145499444|NCT05972993|524687898|FG000|Overall Study|Lost to Follow-up|2|||
145499445|NCT05972993|524687899|FG001|Overall Study|Lost to Follow-up|0|||
145499446|NCT05972993|524687900|FG002|Overall Study|Lost to Follow-up|1|||
145499447|NCT05972993|524687901|FG003|Overall Study|Lost to Follow-up|0|||
145499448|NCT05972993|524687902|FG004|Overall Study|Lost to Follow-up|0|||
145499449|NCT05972993|524687903|FG005|Overall Study|Lost to Follow-up|0|||
145499450|NCT05972993|524687904|FG006|Overall Study|Lost to Follow-up|0|||
145499451|NCT05972993|524687905|FG007|Overall Study|Lost to Follow-up|2|||
145499452|NCT05972993|524687906|FG008|Overall Study|Lost to Follow-up|0|||
145499453|NCT03866577|524687909|FG000|Overall Study|Protocol Violation|0|||
145499454|NCT03866577|524687910|FG001|Overall Study|Protocol Violation|0|||
145499455|NCT03866577|524687911|FG002|Overall Study|Protocol Violation|0|||
145499456|NCT03866577|524687912|FG003|Overall Study|Protocol Violation|0|||
145499457|NCT03866577|524687913|FG004|Overall Study|Protocol Violation|0|||
145499458|NCT03866577|524687914|FG005|Overall Study|Protocol Violation|0|||
145499459|NCT03866577|524687915|FG006|Overall Study|Protocol Violation|0|||
145499460|NCT03866577|524687916|FG007|Overall Study|Protocol Violation|0|||
145499461|NCT03866577|524687917|FG008|Overall Study|Protocol Violation|0|||
145499462|NCT03866577|524687918|FG009|Overall Study|Protocol Violation|0|||
145499463|NCT03866577|524687919|FG010|Overall Study|Protocol Violation|0|||
145499464|NCT03866577|524687920|FG011|Overall Study|Protocol Violation|1|||
145499465|NCT03866577|524687921|FG012|Overall Study|Protocol Violation|0|||
145499466|NCT03866577|524687909|FG000|Overall Study|Withdrawal by Subject|0|||
145499467|NCT03866577|524687910|FG001|Overall Study|Withdrawal by Subject|0|||
145499468|NCT03866577|524687911|FG002|Overall Study|Withdrawal by Subject|0|||
145499469|NCT03866577|524687912|FG003|Overall Study|Withdrawal by Subject|0|||
145499470|NCT03866577|524687913|FG004|Overall Study|Withdrawal by Subject|0|||
145499471|NCT03866577|524687914|FG005|Overall Study|Withdrawal by Subject|0|||
145499472|NCT03866577|524687915|FG006|Overall Study|Withdrawal by Subject|0|||
145499473|NCT03866577|524687916|FG007|Overall Study|Withdrawal by Subject|0|||
145499474|NCT03866577|524687917|FG008|Overall Study|Withdrawal by Subject|1|||
145499475|NCT03866577|524687918|FG009|Overall Study|Withdrawal by Subject|1|||
145499476|NCT03866577|524687919|FG010|Overall Study|Withdrawal by Subject|0|||
145499477|NCT03866577|524687920|FG011|Overall Study|Withdrawal by Subject|0|||
145499478|NCT03866577|524687921|FG012|Overall Study|Withdrawal by Subject|0|||
145499479|NCT03866577|524687909|FG000|Overall Study|Not qualified for IVIg infusion|0|||
145499480|NCT03866577|524687910|FG001|Overall Study|Not qualified for IVIg infusion|0|||
145499481|NCT03866577|524687911|FG002|Overall Study|Not qualified for IVIg infusion|0|||
145499482|NCT03866577|524687912|FG003|Overall Study|Not qualified for IVIg infusion|0|||
145499483|NCT03866577|524687913|FG004|Overall Study|Not qualified for IVIg infusion|0|||
145499484|NCT03866577|524687914|FG005|Overall Study|Not qualified for IVIg infusion|0|||
145499485|NCT03866577|524687915|FG006|Overall Study|Not qualified for IVIg infusion|0|||
145499486|NCT03866577|524687916|FG007|Overall Study|Not qualified for IVIg infusion|0|||
145499487|NCT03866577|524687917|FG008|Overall Study|Not qualified for IVIg infusion|0|||
145499488|NCT03866577|524687918|FG009|Overall Study|Not qualified for IVIg infusion|1|||
145499489|NCT03866577|524687919|FG010|Overall Study|Not qualified for IVIg infusion|0|||
145499490|NCT03866577|524687920|FG011|Overall Study|Not qualified for IVIg infusion|0|||
145499491|NCT03866577|524687921|FG012|Overall Study|Not qualified for IVIg infusion|0|||
145499492|NCT05523089|524687923|FG000|Overall Study|Withdrawal by Subject|1|||
145499493|NCT05523089|524687924|FG001|Overall Study|Withdrawal by Subject|0|||
145499494|NCT05523089|524687925|FG002|Overall Study|Withdrawal by Subject|0|||
145499495|NCT05523089|524687923|FG000|Overall Study|Lost to Follow-up|1|||
145499496|NCT05523089|524687924|FG001|Overall Study|Lost to Follow-up|0|||
145499497|NCT05523089|524687925|FG002|Overall Study|Lost to Follow-up|0|||
145499498|NCT02514083|524687926|FG000|Overall Study|Adverse Event|1|||
145499499|NCT01899040|524687927|FG000|Overall Study|Randomized in error|0|||
145499500|NCT01899040|524687928|FG001|Overall Study|Randomized in error|1|||
145499501|NCT01899040|524687929|FG002|Overall Study|Randomized in error|1|||
145499502|NCT01899040|524687927|FG000|Overall Study|Adverse Event|3|||
145499503|NCT01899040|524687928|FG001|Overall Study|Adverse Event|1|||
145499504|NCT01899040|524687929|FG002|Overall Study|Adverse Event|2|||
145499505|NCT01899040|524687927|FG000|Overall Study|Unspecified reasons|4|||
145499506|NCT01899040|524687928|FG001|Overall Study|Unspecified reasons|4|||
145499507|NCT01899040|524687929|FG002|Overall Study|Unspecified reasons|0|||
145499508|NCT01899040|524687927|FG000|Overall Study|Compliance issues|1|||
145499509|NCT01899040|524687928|FG001|Overall Study|Compliance issues|2|||
145499510|NCT01899040|524687929|FG002|Overall Study|Compliance issues|0|||
145499511|NCT01710501|524689949|FG000|Overall Study|Lost to Follow-up|2|||
145499512|NCT01710501|524689950|FG001|Overall Study|Lost to Follow-up|0|||
145499513|NCT01710501|524689951|FG002|Overall Study|Lost to Follow-up|0|||
145499514|NCT02536976|524689952|FG000|Overall Study|Physician Decision|0|||
145499515|NCT02536976|524689953|FG001|Overall Study|Physician Decision|1|||
145499516|NCT02144610|524689956|FG000|Overall Study|Physician Decision|1|||
145499517|NCT02144610|524689957|FG001|Overall Study|Physician Decision|0|||
145499518|NCT02144610|524689956|FG000|Overall Study|Withdrawal by Subject|1|||
145499519|NCT02144610|524689957|FG001|Overall Study|Withdrawal by Subject|5|||
145499520|NCT02144610|524689956|FG000|Overall Study|Death|2|||
145499521|NCT02144610|524689957|FG001|Overall Study|Death|2|||
145499522|NCT02144610|524689956|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
145499523|NCT02144610|524689957|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
145499524|NCT02144610|524689956|FG000|Overall Study|Other|0|||
145499525|NCT02144610|524689957|FG001|Overall Study|Other|1|||
145499526|NCT01432730|524689959|FG000|Period 1|Adverse Event|2|||
145499527|NCT01432730|524689960|FG001|Period 1|Adverse Event|0|||
145499528|NCT01432730|524689959|FG000|Period 2|Adverse Event|0|||
145499529|NCT01432730|524689960|FG001|Period 2|Adverse Event|4|||
145499530|NCT03038100|524689974|FG000|Overall Study|Death|289|||
145499531|NCT03038100|524689975|FG001|Overall Study|Death|272|||
145499532|NCT03038100|524689974|FG000|Overall Study|Lost to Follow-up|9|||
145499533|NCT03038100|524689975|FG001|Overall Study|Lost to Follow-up|10|||
145499534|NCT03038100|524689974|FG000|Overall Study|Protocol Deviation|1|||
145499535|NCT03038100|524689975|FG001|Overall Study|Protocol Deviation|4|||
145499536|NCT03038100|524689974|FG000|Overall Study|Withdrawal by Subject|45|||
145499537|NCT03038100|524689975|FG001|Overall Study|Withdrawal by Subject|51|||
145499538|NCT03038100|524689974|FG000|Overall Study|Study Terminated By Sponsor|305|||
145499539|NCT03038100|524689975|FG001|Overall Study|Study Terminated By Sponsor|311|||
145499540|NCT03038100|524689974|FG000|Overall Study|Physician Decision|1|||
145499541|NCT03038100|524689975|FG001|Overall Study|Physician Decision|3|||
145499542|NCT03250273|524689976|FG000|Overall Study|Disease Progression|2|||
145499543|NCT03250273|524689977|FG001|Overall Study|Disease Progression|11|||
145499544|NCT03250273|524689976|FG000|Overall Study|Death|0|||
145499545|NCT03250273|524689977|FG001|Overall Study|Death|1|||
145499546|NCT02392624|524689978|FG000|Overall Study|Withdrawal by Subject|15|||
145499547|NCT02392624|524689979|FG001|Overall Study|Withdrawal by Subject|12|||
145499548|NCT02392624|524689980|FG002|Overall Study|Withdrawal by Subject|9|||
145499549|NCT02392624|524689978|FG000|Overall Study|Adverse Event|4|||
145499550|NCT02392624|524689979|FG001|Overall Study|Adverse Event|1|||
145499551|NCT02392624|524689980|FG002|Overall Study|Adverse Event|2|||
145499552|NCT02392624|524689978|FG000|Overall Study|Pregnancy|1|||
145499553|NCT02392624|524689979|FG001|Overall Study|Pregnancy|0|||
145499554|NCT02392624|524689980|FG002|Overall Study|Pregnancy|0|||
145499555|NCT02392624|524689978|FG000|Overall Study|Protocol Violation|0|||
145499556|NCT02392624|524689979|FG001|Overall Study|Protocol Violation|0|||
145499557|NCT02392624|524689980|FG002|Overall Study|Protocol Violation|1|||
145499558|NCT02392624|524689978|FG000|Overall Study|Sponsor/Investigator Decision|2|||
145499559|NCT02392624|524689979|FG001|Overall Study|Sponsor/Investigator Decision|1|||
145499560|NCT02392624|524689980|FG002|Overall Study|Sponsor/Investigator Decision|0|||
145499561|NCT02392624|524689978|FG000|Overall Study|Other|49|||
145499562|NCT02392624|524689979|FG001|Overall Study|Other|1|||
145499563|NCT02392624|524689980|FG002|Overall Study|Other|1|||
145499564|NCT00936715|524689981|FG000|Overall Study|Investigators Discretion|1|||
145499565|NCT00936715|524689981|FG000|Overall Study|Protocol Violation|1|||
145499566|NCT00936715|524689981|FG000|Overall Study|Safety or Tolerability Reasons|4|||
145499567|NCT03877510|524689982|FG000|Overall Study|Death|6|||
145499568|NCT03877510|524689982|FG000|Overall Study|Lost to Follow-up|2|||
145499569|NCT03877510|524689982|FG000|Overall Study|Non-compliance with study drug|2|||
145499570|NCT03877510|524689982|FG000|Overall Study|Lack of Efficacy|14|||
145499571|NCT03877510|524689982|FG000|Overall Study|Adverse Event|20|||
145499572|NCT03877510|524689982|FG000|Overall Study|Withdrawal by Subject|22|||
145499573|NCT03877510|524689982|FG000|Overall Study|Miscellaneous|1|||
145499574|NCT01744977|524689989|FG000|Overall Study|Withdrawal by Subject|1|||
145499575|NCT01744977|524689990|FG001|Overall Study|Withdrawal by Subject|2|||
145499576|NCT01744977|524689989|FG000|Overall Study|Death|2|||
145499577|NCT01744977|524689990|FG001|Overall Study|Death|3|||
145499578|NCT01744977|524689989|FG000|Overall Study|Lost to Follow-up|2|||
145499579|NCT01744977|524689990|FG001|Overall Study|Lost to Follow-up|0|||
145499580|NCT01744977|524689989|FG000|Overall Study|No longer meets inclusion|6|||
145499581|NCT01744977|524689990|FG001|Overall Study|No longer meets inclusion|0|||
145499582|NCT04004988|524689993|FG000|Period 1|Physician Decision|2|||
145499583|NCT04004988|524689994|FG001|Period 1|Physician Decision|0|||
145499584|NCT04004988|524689993|FG000|Period 1|Withdrawal by Subject|0|||
145499585|NCT04004988|524689994|FG001|Period 1|Withdrawal by Subject|1|||
145499586|NCT04004988|524689993|FG000|Period 1|Adverse Event|1|||
145499587|NCT04004988|524689994|FG001|Period 1|Adverse Event|2|||
145499588|NCT00912808|524689995|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
145499589|NCT00912808|524689996|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
145499590|NCT00912808|524689995|FG000|Washout|Withdrawal by Subject|0|||
145499591|NCT00912808|524689996|FG001|Washout|Withdrawal by Subject|1|||
145499592|NCT00912808|524689995|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
145499593|NCT00912808|524689996|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
145499594|NCT00912808|524689995|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
145499595|NCT00912808|524689996|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
145499596|NCT03345784|524690001|FG000|Overall Study|Withdrawal by Subject|2|||
145499597|NCT03345784|524690002|FG001|Overall Study|Withdrawal by Subject|1|||
145499598|NCT00482053|524690007|FG000|Inter-treatment Period|Disease progression|1|||
145499599|NCT01055197|524690017|FG000|Overall Study|Protocol Violation|7|||
145499600|NCT01055197|524690018|FG001|Overall Study|Protocol Violation|2|||
145499601|NCT01055197|524690017|FG000|Overall Study|Withdrawal by Subject|2|||
145499602|NCT01055197|524690018|FG001|Overall Study|Withdrawal by Subject|0|||
145499603|NCT00538902|524690019|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
145499604|NCT00538902|524690020|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
145499605|NCT00538902|524690021|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
145499606|NCT00538902|524690019|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
145499607|NCT00538902|524690020|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
145499608|NCT00538902|524690021|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
145499609|NCT00538902|524690019|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
145499610|NCT00538902|524690020|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
145499611|NCT00538902|524690021|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
145499612|NCT00538902|524690019|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
145499613|NCT00538902|524690020|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
145499614|NCT00538902|524690021|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
145499615|NCT00538902|524690019|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
145499616|NCT00538902|524690020|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
145499617|NCT00538902|524690021|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
145499618|NCT00538902|524690019|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
145499619|NCT00538902|524690020|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
145499620|NCT00538902|524690021|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
145499621|NCT00538902|524690019|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
145499622|NCT00538902|524690020|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
145499623|NCT00538902|524690021|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
145499624|NCT00538902|524690019|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
145499625|NCT00538902|524690020|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
145499626|NCT00538902|524690021|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
145499627|NCT03131570|524690022|FG000|Overall Study|Adverse Event|1|||
145499628|NCT03131570|524690023|FG001|Overall Study|Adverse Event|0|||
145397348|NCT01211145|524309330|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
145397349|NCT01211145|524309327|FG000|Overall Study|Patient decision|2|||
145397350|NCT01211145|524309328|FG001|Overall Study|Patient decision|1|||
145397351|NCT01211145|524309329|FG002|Overall Study|Patient decision|0|||
145397352|NCT01211145|524309330|FG003|Overall Study|Patient decision|2|||
145397353|NCT00427908|524309331|FG000|Primary Phase|Lost to Follow-up|4|||
145397354|NCT00427908|524309332|FG001|Primary Phase|Lost to Follow-up|0|||
145397355|NCT00427908|524309333|FG002|Primary Phase|Lost to Follow-up|2|||
145397356|NCT00427908|524309334|FG003|Primary Phase|Lost to Follow-up|0|||
145397357|NCT00427908|524309331|FG000|Primary Phase|Withdrawal by Subject|1|||
145397358|NCT00427908|524309332|FG001|Primary Phase|Withdrawal by Subject|2|||
145397359|NCT00427908|524309333|FG002|Primary Phase|Withdrawal by Subject|1|||
145397360|NCT00427908|524309334|FG003|Primary Phase|Withdrawal by Subject|0|||
145397361|NCT00427908|524309331|FG000|Primary Phase|Adverse Event|0|||
145397362|NCT00427908|524309332|FG001|Primary Phase|Adverse Event|1|||
145397363|NCT00427908|524309333|FG002|Primary Phase|Adverse Event|0|||
145397364|NCT00427908|524309334|FG003|Primary Phase|Adverse Event|0|||
145397365|NCT04202497|524309338|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
145397366|NCT04202497|524309339|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145397367|NCT04202497|524309340|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145397368|NCT04202497|524309341|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
145397369|NCT04344301|524309342|FG000|Overall Study|Withdrawal by Subject|1|||
145397370|NCT04344301|524309343|FG001|Overall Study|Withdrawal by Subject|0|||
145397371|NCT04344301|524309342|FG000|Overall Study|Death|0|||
145397372|NCT04344301|524309343|FG001|Overall Study|Death|1|||
145397373|NCT01548599|524311451|FG000|Overall Study|Lost to Follow-up|0|||
145397374|NCT01548599|524311452|FG001|Overall Study|Lost to Follow-up|1|||
145397375|NCT01548599|524311451|FG000|Overall Study|Withdrawal by Subject|4|||
145397376|NCT01548599|524311452|FG001|Overall Study|Withdrawal by Subject|0|||
145397377|NCT01548599|524311451|FG000|Overall Study|Death|2|||
145397378|NCT01548599|524311452|FG001|Overall Study|Death|1|||
145397379|NCT03163446|524311455|FG000|Overall Study|Unable to return for Day 180 visit|2|||
145397380|NCT03163446|524311456|FG001|Overall Study|Unable to return for Day 180 visit|0|||
145397381|NCT03163446|524311455|FG000|Overall Study|Withdrawal by Subject|2|||
145397382|NCT03163446|524311456|FG001|Overall Study|Withdrawal by Subject|6|||
145397383|NCT03163446|524311455|FG000|Overall Study|Death|16|||
145397384|NCT03163446|524311456|FG001|Overall Study|Death|5|||
145397385|NCT03163446|524311455|FG000|Overall Study|Lost to Follow-up|6|||
145397386|NCT03163446|524311456|FG001|Overall Study|Lost to Follow-up|5|||
145397387|NCT03163446|524311455|FG000|Overall Study|Physician Decision|1|||
145397388|NCT03163446|524311456|FG001|Overall Study|Physician Decision|1|||
145397389|NCT03163446|524311455|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
145397390|NCT03163446|524311456|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
145397391|NCT03638128|524311457|FG000|Overall Study|Withdrawal by Subject|1|||
145397392|NCT03638128|524311458|FG001|Overall Study|Withdrawal by Subject|7|||
145397393|NCT03638128|524311459|FG002|Overall Study|Withdrawal by Subject|6|||
145397394|NCT03638128|524311457|FG000|Overall Study|Sponsor Decision|15|||
145397395|NCT03638128|524311458|FG001|Overall Study|Sponsor Decision|12|||
145397396|NCT03638128|524311459|FG002|Overall Study|Sponsor Decision|19|||
145397397|NCT03638128|524311457|FG000|Overall Study|Lost to Follow-up|0|||
145397398|NCT03638128|524311458|FG001|Overall Study|Lost to Follow-up|0|||
145397399|NCT03638128|524311459|FG002|Overall Study|Lost to Follow-up|1|||
145397400|NCT00329108|524311460|FG000|Overall Study|Adverse Event|2|||
145397401|NCT00329108|524311461|FG001|Overall Study|Adverse Event|2|||
145397402|NCT00329108|524311460|FG000|Overall Study|Lack of Efficacy|3|||
145397403|NCT00329108|524311461|FG001|Overall Study|Lack of Efficacy|3|||
145397404|NCT00329108|524311460|FG000|Overall Study|Withdrawal by Subject|0|||
145397405|NCT00329108|524311461|FG001|Overall Study|Withdrawal by Subject|2|||
145397406|NCT00329108|524311460|FG000|Overall Study|symptomatic deterioration|1|||
145397407|NCT00329108|524311461|FG001|Overall Study|symptomatic deterioration|1|||
145397408|NCT00329108|524311460|FG000|Overall Study|Subject no longer willing to participate|2|||
145397409|NCT00329108|524311461|FG001|Overall Study|Subject no longer willing to participate|2|||
145397410|NCT00329108|524311460|FG000|Overall Study|study terminated by sponsor|1|||
145397411|NCT00329108|524311461|FG001|Overall Study|study terminated by sponsor|0|||
145397412|NCT00329108|524311460|FG000|Overall Study|withdrew patient after SAE resolved|1|||
145397413|NCT00329108|524311461|FG001|Overall Study|withdrew patient after SAE resolved|0|||
145397414|NCT00329108|524311460|FG000|Overall Study|Protocol Violation|0|||
145397415|NCT00329108|524311461|FG001|Overall Study|Protocol Violation|2|||
145397416|NCT01389232|524311462|FG000|Overall Study|Had scaffold removed|15|||
145397417|NCT01389232|524311462|FG000|Overall Study|Personal reasons|2|||
145397418|NCT01389232|524311462|FG000|Overall Study|Adverse Event|1|||
145397419|NCT01389232|524311462|FG000|Overall Study|Death|1|||
145397420|NCT01317940|524311463|FG000|Overall Study|Death|1|||
145499629|NCT01550003|524690026|FG000|Overall Study|Adverse Event|0|||
145499630|NCT01550003|524690027|FG001|Overall Study|Adverse Event|9|||
145499631|NCT01550003|524690028|FG002|Overall Study|Adverse Event|15|||
145499632|NCT01550003|524690026|FG000|Overall Study|Lack of Efficacy|4|||
145499633|NCT01550003|524690027|FG001|Overall Study|Lack of Efficacy|11|||
145499634|NCT01550003|524690028|FG002|Overall Study|Lack of Efficacy|15|||
145499635|NCT01550003|524690026|FG000|Overall Study|Protocol Violation|0|||
145499636|NCT01550003|524690027|FG001|Overall Study|Protocol Violation|3|||
145499637|NCT01550003|524690028|FG002|Overall Study|Protocol Violation|2|||
145499638|NCT01550003|524690026|FG000|Overall Study|Lost to Follow-up|1|||
145499639|NCT01550003|524690027|FG001|Overall Study|Lost to Follow-up|4|||
145499640|NCT01550003|524690028|FG002|Overall Study|Lost to Follow-up|8|||
145499641|NCT01550003|524690026|FG000|Overall Study|Consent withdrawn|2|||
145499642|NCT01550003|524690027|FG001|Overall Study|Consent withdrawn|11|||
145499643|NCT01550003|524690028|FG002|Overall Study|Consent withdrawn|23|||
145499644|NCT01550003|524690026|FG000|Overall Study|Missing|1|||
145499645|NCT01550003|524690027|FG001|Overall Study|Missing|0|||
145499646|NCT01550003|524690028|FG002|Overall Study|Missing|2|||
145499647|NCT01550003|524690026|FG000|Overall Study|Study closure as announced by sponsor|7|||
145499648|NCT01550003|524690027|FG001|Overall Study|Study closure as announced by sponsor|6|||
145499649|NCT01550003|524690028|FG002|Overall Study|Study closure as announced by sponsor|24|||
145499650|NCT01550003|524690026|FG000|Overall Study|Protocol Noncompliance|1|||
145499651|NCT01550003|524690027|FG001|Overall Study|Protocol Noncompliance|0|||
145499652|NCT01550003|524690028|FG002|Overall Study|Protocol Noncompliance|0|||
145499653|NCT01550003|524690026|FG000|Overall Study|Study closure|0|||
145499654|NCT01550003|524690027|FG001|Overall Study|Study closure|1|||
145499655|NCT01550003|524690028|FG002|Overall Study|Study closure|1|||
145499656|NCT01550003|524690026|FG000|Overall Study|Patient reached adulthood|0|||
145499657|NCT01550003|524690027|FG001|Overall Study|Patient reached adulthood|1|||
145499658|NCT01550003|524690028|FG002|Overall Study|Patient reached adulthood|0|||
145499659|NCT01550003|524690026|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
145499660|NCT01550003|524690027|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
145499661|NCT01550003|524690028|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
145499662|NCT01550003|524690026|FG000|Overall Study|Sponsor's order|0|||
145499663|NCT01550003|524690027|FG001|Overall Study|Sponsor's order|3|||
145499664|NCT01550003|524690028|FG002|Overall Study|Sponsor's order|3|||
145499665|NCT01550003|524690026|FG000|Overall Study|Sponsor's decision|1|||
145499666|NCT01550003|524690027|FG001|Overall Study|Sponsor's decision|5|||
145499667|NCT01550003|524690028|FG002|Overall Study|Sponsor's decision|4|||
145499668|NCT01550003|524690026|FG000|Overall Study|Subject mother passed away|0|||
145499669|NCT01550003|524690027|FG001|Overall Study|Subject mother passed away|1|||
145499670|NCT01550003|524690028|FG002|Overall Study|Subject mother passed away|0|||
145499671|NCT01550003|524690026|FG000|Overall Study|Discontinuation|0|||
145499672|NCT01550003|524690027|FG001|Overall Study|Discontinuation|1|||
145499673|NCT01550003|524690028|FG002|Overall Study|Discontinuation|0|||
145499674|NCT01550003|524690026|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
145499675|NCT01550003|524690027|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
145499676|NCT01550003|524690028|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
145499677|NCT01550003|524690026|FG000|Overall Study|Site closure|0|||
145499678|NCT01550003|524690027|FG001|Overall Study|Site closure|2|||
145499679|NCT01550003|524690028|FG002|Overall Study|Site closure|0|||
145499680|NCT01550003|524690026|FG000|Overall Study|Pregnancy|0|||
145499681|NCT01550003|524690027|FG001|Overall Study|Pregnancy|1|||
145499682|NCT01550003|524690028|FG002|Overall Study|Pregnancy|0|||
145499683|NCT01550003|524690026|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
145499684|NCT01550003|524690027|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
145499685|NCT01550003|524690028|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
145499686|NCT01550003|524690026|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
145499687|NCT01550003|524690027|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
145499688|NCT01550003|524690028|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
145499689|NCT01550003|524690026|FG000|Overall Study|Switching to adult rheumatologist|0|||
145499690|NCT01550003|524690027|FG001|Overall Study|Switching to adult rheumatologist|0|||
145499691|NCT01550003|524690028|FG002|Overall Study|Switching to adult rheumatologist|1|||
145499692|NCT01550003|524690026|FG000|Overall Study|Patient transition to adult care|0|||
145499693|NCT01550003|524690027|FG001|Overall Study|Patient transition to adult care|0|||
145499694|NCT01550003|524690028|FG002|Overall Study|Patient transition to adult care|1|||
145499695|NCT01550003|524690026|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
145499696|NCT01550003|524690027|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
145499697|NCT01550003|524690028|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
145499698|NCT01550003|524690026|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
145499699|NCT01550003|524690027|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
145499700|NCT01550003|524690028|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
145499701|NCT01550003|524690026|FG000|Overall Study|Per Sponsor request|1|||
145605971|NCT01473381|525073071|FG000|Overall Study|Adverse Event|8|||
145499702|NCT01550003|524690027|FG001|Overall Study|Per Sponsor request|0|||
145499703|NCT01550003|524690028|FG002|Overall Study|Per Sponsor request|1|||
145499704|NCT01550003|524690026|FG000|Overall Study|Patient not compliance|0|||
145499705|NCT01550003|524690027|FG001|Overall Study|Patient not compliance|0|||
145499706|NCT01550003|524690028|FG002|Overall Study|Patient not compliance|1|||
145499707|NCT01550003|524690026|FG000|Overall Study|Non-compliance|0|||
145499708|NCT01550003|524690027|FG001|Overall Study|Non-compliance|0|||
145499709|NCT01550003|524690028|FG002|Overall Study|Non-compliance|1|||
145499710|NCT01550003|524690026|FG000|Overall Study|Study closed|0|||
145499711|NCT01550003|524690027|FG001|Overall Study|Study closed|1|||
145499712|NCT01550003|524690028|FG002|Overall Study|Study closed|0|||
145499713|NCT01550003|524690026|FG000|Overall Study|Transitioned to adult rheumatology|0|||
145499714|NCT01550003|524690027|FG001|Overall Study|Transitioned to adult rheumatology|0|||
145499715|NCT01550003|524690028|FG002|Overall Study|Transitioned to adult rheumatology|1|||
145499716|NCT00001959|524690029|FG000|Overall Study|newly diagnosed colon cancer|1|||
145499717|NCT00001959|524690029|FG000|Overall Study|disabling sedation|1|||
145499718|NCT00001959|524690029|FG000|Overall Study|non-compliance|1|||
145499719|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
145499720|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
145499721|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
145499722|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
145499723|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
145499724|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
145499725|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
145499726|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
145499727|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
145499728|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
145499729|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
145499730|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
145499731|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
145499732|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
145499733|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
145499734|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
145499735|NCT03773978|524690032|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
145499736|NCT03773978|524690033|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
145499737|NCT03773978|524690032|FG000|DBW Period|Adverse Event|2|||
145499738|NCT03773978|524690033|FG001|DBW Period|Adverse Event|2|||
145499739|NCT03773978|524690032|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
145499740|NCT03773978|524690033|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
145499741|NCT03773978|524690032|FG000|DBW Period|Withdrawal by Subject|2|||
145499742|NCT03773978|524690033|FG001|DBW Period|Withdrawal by Subject|1|||
145499743|NCT03773978|524690032|FG000|DBW Period|Due to epidemic or pandemic|5|||
145499744|NCT03773978|524690033|FG001|DBW Period|Due to epidemic or pandemic|6|||
145499745|NCT03773978|524690032|FG000|DBW Period|Study team decision|1|||
145499746|NCT03773978|524690033|FG001|DBW Period|Study team decision|0|||
145499747|NCT03777982|524690034|FG000|Overall Study|Physician Decision|0|||
145499748|NCT03777982|524690035|FG001|Overall Study|Physician Decision|1|||
145499749|NCT03995368|524690038|FG000|Overall Study|Lost to Follow-up|1|||
145499750|NCT03995368|524690039|FG001|Overall Study|Lost to Follow-up|4|||
145499751|NCT03995368|524690040|FG002|Overall Study|Lost to Follow-up|1|||
145499752|NCT03995368|524690038|FG000|Overall Study|Did not meet inclusion criteria|1|||
145499753|NCT03995368|524690039|FG001|Overall Study|Did not meet inclusion criteria|6|||
145499754|NCT03995368|524690040|FG002|Overall Study|Did not meet inclusion criteria|3|||
145499755|NCT03995368|524690038|FG000|Overall Study|Withdrawal by Subject|0|||
145499756|NCT03995368|524690039|FG001|Overall Study|Withdrawal by Subject|1|||
145499757|NCT03995368|524690040|FG002|Overall Study|Withdrawal by Subject|1|||
145499758|NCT03592186|524690041|FG000|Overall Study|Withdrawal by Subject|1|||
145499759|NCT03592186|524690042|FG001|Overall Study|Withdrawal by Subject|0|||
145499760|NCT03592186|524690041|FG000|Overall Study|Lost to Follow-up|16|||
145499761|NCT03592186|524690042|FG001|Overall Study|Lost to Follow-up|11|||
145499762|NCT03755934|524690043|FG000|Overall Study|Adverse Event|4|||
145499763|NCT03755934|524690044|FG001|Overall Study|Adverse Event|1|||
145499764|NCT03755934|524690045|FG002|Overall Study|Adverse Event|1|||
145499765|NCT03755934|524690046|FG003|Overall Study|Adverse Event|3|||
145499766|NCT03755934|524690043|FG000|Overall Study|Physician Decision|2|||
145499767|NCT03755934|524690044|FG001|Overall Study|Physician Decision|0|||
145499768|NCT03755934|524690045|FG002|Overall Study|Physician Decision|0|||
145499769|NCT03755934|524690046|FG003|Overall Study|Physician Decision|1|||
145499770|NCT03755934|524690043|FG000|Overall Study|Withdrawal by Subject|5|||
145499771|NCT03755934|524690044|FG001|Overall Study|Withdrawal by Subject|0|||
145499772|NCT03755934|524690045|FG002|Overall Study|Withdrawal by Subject|0|||
145499773|NCT03755934|524690046|FG003|Overall Study|Withdrawal by Subject|1|||
145499774|NCT03755934|524690043|FG000|Overall Study|Other|3|||
145499775|NCT03755934|524690044|FG001|Overall Study|Other|1|||
145499776|NCT03755934|524690045|FG002|Overall Study|Other|3|||
145499777|NCT03755934|524690046|FG003|Overall Study|Other|1|||
145499778|NCT01052493|524690047|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
145499779|NCT01052493|524690048|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
145499780|NCT01052493|524690049|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
145499781|NCT00307801|524690050|FG000|Overall Study|Adverse Event|12|||
145499782|NCT00307801|524690051|FG001|Overall Study|Adverse Event|4|||
145499783|NCT00307801|524690050|FG000|Overall Study|Withdrawal by Subject|9|||
145499784|NCT00307801|524690051|FG001|Overall Study|Withdrawal by Subject|4|||
145499785|NCT00307801|524690050|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
145499786|NCT00307801|524690051|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
145499787|NCT00307801|524690050|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
145499788|NCT00307801|524690051|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
145499789|NCT00307801|524690050|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
145499790|NCT00307801|524690051|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
145499791|NCT00307801|524690050|FG000|Overall Study|Wrong Randomization|1|||
145499792|NCT00307801|524690051|FG001|Overall Study|Wrong Randomization|0|||
145499793|NCT00307801|524690050|FG000|Overall Study|Lack of Efficacy|0|||
145499794|NCT00307801|524690051|FG001|Overall Study|Lack of Efficacy|2|||
145499795|NCT00307801|524690050|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
145499796|NCT00307801|524690051|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
145499797|NCT00307801|524690050|FG000|Overall Study|Frustration with e-diary|1|||
145499798|NCT00307801|524690051|FG001|Overall Study|Frustration with e-diary|0|||
145499799|NCT00307801|524690050|FG000|Overall Study|Protocol Violation|3|||
145499800|NCT00307801|524690051|FG001|Overall Study|Protocol Violation|2|||
145499801|NCT00307801|524690050|FG000|Overall Study|No reason specified|2|||
145499802|NCT00307801|524690051|FG001|Overall Study|No reason specified|0|||
145499803|NCT00307801|524690050|FG000|Overall Study|Pregnancy|0|||
145499804|NCT00307801|524690051|FG001|Overall Study|Pregnancy|1|||
145499805|NCT03944577|524690054|FG000|Overall Study|Adverse Event|3|||
145499806|NCT03058146|524690060|FG000|Overall Study|Withdrawal by Subject|4|||
145499807|NCT03058146|524690061|FG001|Overall Study|Withdrawal by Subject|1|||
145499808|NCT03058146|524690060|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
145499809|NCT03058146|524690061|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
145499810|NCT00632229|524690062|FG000|Overall Study|Adverse Event|6|||
145499811|NCT00632229|524690063|FG001|Overall Study|Adverse Event|0|||
145499812|NCT00632229|524690062|FG000|Overall Study|Lost to Follow-up|0|||
145499813|NCT00632229|524690063|FG001|Overall Study|Lost to Follow-up|3|||
145499814|NCT00632229|524690062|FG000|Overall Study|Lack of Efficacy|0|||
145499815|NCT00632229|524690063|FG001|Overall Study|Lack of Efficacy|2|||
145499816|NCT00632229|524690062|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
145499817|NCT00632229|524690063|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
145499818|NCT00577889|524690065|FG000|Overall Study|Withdrawal by Subject|1|||
145499819|NCT00577889|524690066|FG001|Overall Study|Withdrawal by Subject|0|||
145499820|NCT00577889|524690067|FG002|Overall Study|Withdrawal by Subject|0|||
145499821|NCT00993967|524690071|FG000|Overall Study|Adverse Event|8|||
145732821|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
145499822|NCT00993967|524690071|FG000|Overall Study|Death|1|||
145499823|NCT00993967|524690071|FG000|Overall Study|Lost to Follow-up|14|||
145499824|NCT00993967|524690071|FG000|Overall Study|Withdrawal by Subject|36|||
145499825|NCT00993967|524690071|FG000|Overall Study|Protocol Violation|2|||
145499826|NCT01467960|524690072|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
145499827|NCT01467960|524690073|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
145732822|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
145732823|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
145732824|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
145732825|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
145732826|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
145732827|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
145732828|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
145732829|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
145732830|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
145732831|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
145732832|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
145732833|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
145732834|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
145499828|NCT01467960|524690074|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
145499829|NCT01467960|524690075|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
145499830|NCT01467960|524690076|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
145499831|NCT01467960|524690077|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
145499832|NCT04825678|524690080|FG000|Overall Study|Decision by Sponsor|2|||
145499833|NCT04825678|524690081|FG001|Overall Study|Decision by Sponsor|3|||
145499834|NCT04825678|524690080|FG000|Overall Study|Withdrawal of Consent From Study|7|||
145499835|NCT04825678|524690081|FG001|Overall Study|Withdrawal of Consent From Study|9|||
145499836|NCT04825678|524690080|FG000|Overall Study|Lost to Follow-up|3|||
145499837|NCT04825678|524690081|FG001|Overall Study|Lost to Follow-up|4|||
145499838|NCT04825678|524690080|FG000|Overall Study|Never Received Investigational Product|1|||
145499839|NCT04825678|524690081|FG001|Overall Study|Never Received Investigational Product|1|||
145499840|NCT05530252|524690082|FG000|Overall Study|Lost to Follow-up|1|||
145499841|NCT05530252|524690083|FG001|Overall Study|Lost to Follow-up|1|||
145499842|NCT05530252|524690084|FG002|Overall Study|Lost to Follow-up|1|||
145499843|NCT00651742|524690089|FG000|Overall Study|Objective Disease Progression|22|||
145499844|NCT00651742|524690089|FG000|Overall Study|Toxicity|3|||
145499845|NCT00651742|524690089|FG000|Overall Study|Investigator Judgment|1|||
145499846|NCT00651742|524690089|FG000|Overall Study|Withdrawal of Consent|1|||
145499847|NCT00651742|524690089|FG000|Overall Study|Enrolled but not treated|1|||
145499848|NCT01535040|524690091|FG000|Overall Study|Physician Decision|0|||
145499849|NCT01535040|524690092|FG001|Overall Study|Physician Decision|1|||
145499850|NCT01535040|524690091|FG000|Overall Study|Withdrawal by Subject|13|||
145499851|NCT01535040|524690092|FG001|Overall Study|Withdrawal by Subject|10|||
145499852|NCT01535040|524690091|FG000|Overall Study|Never Started|9|||
145499853|NCT01535040|524690092|FG001|Overall Study|Never Started|4|||
145499854|NCT01535040|524690091|FG000|Overall Study|Toxicity|7|||
145499855|NCT01535040|524690092|FG001|Overall Study|Toxicity|5|||
145499856|NCT01535040|524690091|FG000|Overall Study|Multiple Reasons|1|||
145499857|NCT01535040|524690092|FG001|Overall Study|Multiple Reasons|1|||
145499858|NCT01074970|524690093|FG000|Overall Study|Never Treated|0|||
145499859|NCT01074970|524690094|FG001|Overall Study|Never Treated|0|||
145499860|NCT01074970|524690095|FG002|Overall Study|Never Treated|8|||
145499861|NCT01074970|524690096|FG003|Overall Study|Never Treated|1|||
145499862|NCT01074970|524690093|FG000|Overall Study|Adverse Event|1|||
145499863|NCT01074970|524690094|FG001|Overall Study|Adverse Event|0|||
145499864|NCT01074970|524690095|FG002|Overall Study|Adverse Event|4|||
145499865|NCT01074970|524690096|FG003|Overall Study|Adverse Event|3|||
145499866|NCT01074970|524690093|FG000|Overall Study|Disease progression during treatment|3|||
145499867|NCT01074970|524690094|FG001|Overall Study|Disease progression during treatment|1|||
145499868|NCT01074970|524690095|FG002|Overall Study|Disease progression during treatment|2|||
145499869|NCT01074970|524690096|FG003|Overall Study|Disease progression during treatment|9|||
145499870|NCT01074970|524690093|FG000|Overall Study|Lost to Follow-up|0|||
145499871|NCT01074970|524690094|FG001|Overall Study|Lost to Follow-up|0|||
145499872|NCT01074970|524690095|FG002|Overall Study|Lost to Follow-up|1|||
145499873|NCT01074970|524690096|FG003|Overall Study|Lost to Follow-up|0|||
145499874|NCT01074970|524690093|FG000|Overall Study|Withdrawal by Subject|0|||
145499875|NCT01074970|524690094|FG001|Overall Study|Withdrawal by Subject|0|||
145499876|NCT01074970|524690095|FG002|Overall Study|Withdrawal by Subject|6|||
145499877|NCT01074970|524690096|FG003|Overall Study|Withdrawal by Subject|4|||
145499878|NCT00911170|524690099|FG000|Treatment Period|Randomized in error|1|||
145499879|NCT00911170|524690100|FG001|Treatment Period|Randomized in error|1|||
145499880|NCT00911170|524690099|FG000|Treatment Period|Ineligibility determined|1|||
145397421|NCT01317940|524311464|FG001|Overall Study|Death|0|||
145397422|NCT01317940|524311465|FG002|Overall Study|Death|1|||
145397423|NCT01317940|524311466|FG003|Overall Study|Death|0|||
145397424|NCT01317940|524311467|FG004|Overall Study|Death|0|||
145397425|NCT01317940|524311468|FG005|Overall Study|Death|0|||
145397426|NCT01317940|524311463|FG000|Overall Study|Lost to Follow-up|0|||
145397427|NCT01317940|524311464|FG001|Overall Study|Lost to Follow-up|0|||
145397428|NCT01317940|524311465|FG002|Overall Study|Lost to Follow-up|1|||
145499881|NCT00911170|524690100|FG001|Treatment Period|Ineligibility determined|3|||
145499882|NCT00911170|524690099|FG000|Treatment Period|Protocol deviation|1|||
145499883|NCT00911170|524690100|FG001|Treatment Period|Protocol deviation|2|||
145499884|NCT00911170|524690099|FG000|Treatment Period|Adverse Event|9|||
145397429|NCT01317940|524311466|FG003|Overall Study|Lost to Follow-up|1|||
145397430|NCT01317940|524311467|FG004|Overall Study|Lost to Follow-up|1|||
145499885|NCT00911170|524690100|FG001|Treatment Period|Adverse Event|10|||
145499886|NCT00911170|524690099|FG000|Treatment Period|Withdrawal by Subject|4|||
145397431|NCT01317940|524311468|FG005|Overall Study|Lost to Follow-up|0|||
145397432|NCT01317940|524311463|FG000|Overall Study|Change in therapy plan|0|||
145499887|NCT00911170|524690100|FG001|Treatment Period|Withdrawal by Subject|4|||
145499888|NCT00911170|524690099|FG000|Treatment Period|Disease progression|0|||
145499889|NCT00911170|524690100|FG001|Treatment Period|Disease progression|2|||
145499890|NCT00911170|524690099|FG000|Treatment Period|Physician Decision|5|||
145499891|NCT00911170|524690100|FG001|Treatment Period|Physician Decision|5|||
145499892|NCT00911170|524690099|FG000|Treatment Period|Lost to Follow-up|0|||
145499893|NCT00911170|524690100|FG001|Treatment Period|Lost to Follow-up|1|||
145499894|NCT00911170|524690099|FG000|Treatment Period|Death|6|||
145499895|NCT00911170|524690100|FG001|Treatment Period|Death|9|||
145499896|NCT00911170|524690099|FG000|Long Term Follow-Up|Continuing in study|274|||
145499897|NCT00911170|524690100|FG001|Long Term Follow-Up|Continuing in study|269|||
145499898|NCT00911170|524690099|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
145499899|NCT00911170|524690100|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
145499900|NCT00911170|524690099|FG000|Long Term Follow-Up|Physician Decision|5|||
145499901|NCT00911170|524690100|FG001|Long Term Follow-Up|Physician Decision|4|||
145499902|NCT00911170|524690099|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
145499903|NCT00911170|524690100|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
145499904|NCT00911170|524690099|FG000|Long Term Follow-Up|Death|116|||
145499905|NCT00911170|524690100|FG001|Long Term Follow-Up|Death|121|||
145499906|NCT02594124|524690101|FG000|Overall Study|Adverse Event|0|||
145499907|NCT02594124|524690102|FG001|Overall Study|Adverse Event|5|||
145499908|NCT02594124|524690103|FG002|Overall Study|Adverse Event|8|||
145499909|NCT02594124|524690104|FG003|Overall Study|Adverse Event|1|||
145499910|NCT02594124|524690105|FG004|Overall Study|Adverse Event|0|||
145499911|NCT02594124|524690106|FG005|Overall Study|Adverse Event|0|||
145499912|NCT02594124|524690107|FG006|Overall Study|Adverse Event|2|||
145499913|NCT02594124|524690108|FG007|Overall Study|Adverse Event|2|||
145499914|NCT02594124|524690109|FG008|Overall Study|Adverse Event|0|||
145499915|NCT02594124|524690101|FG000|Overall Study|Withdrawal by Subject|2|||
145499916|NCT02594124|524690102|FG001|Overall Study|Withdrawal by Subject|3|||
145499917|NCT02594124|524690103|FG002|Overall Study|Withdrawal by Subject|5|||
145499918|NCT02594124|524690104|FG003|Overall Study|Withdrawal by Subject|1|||
145499919|NCT02594124|524690105|FG004|Overall Study|Withdrawal by Subject|8|||
145499920|NCT02594124|524690106|FG005|Overall Study|Withdrawal by Subject|4|||
145499921|NCT02594124|524690107|FG006|Overall Study|Withdrawal by Subject|13|||
145397433|NCT01317940|524311464|FG001|Overall Study|Change in therapy plan|0|||
145397434|NCT01317940|524311465|FG002|Overall Study|Change in therapy plan|3|||
145397435|NCT01317940|524311466|FG003|Overall Study|Change in therapy plan|0|||
145397436|NCT01317940|524311467|FG004|Overall Study|Change in therapy plan|0|||
145397437|NCT01317940|524311468|FG005|Overall Study|Change in therapy plan|0|||
145397438|NCT00945243|524311470|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
145397439|NCT03256578|524311471|FG000|Overall Study|Excluded Post Randomization|66|||
145397440|NCT03256578|524311472|FG001|Overall Study|Excluded Post Randomization|56|||
145397441|NCT02371616|524311473|FG000|Overall Study|Protocol Violation|2|||
145397442|NCT02371616|524311474|FG001|Overall Study|Protocol Violation|1|||
145397443|NCT02371616|524311473|FG000|Overall Study|Adverse Event|0|||
145397444|NCT02371616|524311474|FG001|Overall Study|Adverse Event|1|||
145397445|NCT02371616|524311473|FG000|Overall Study|Withdrawal of Consent|1|||
145397446|NCT02371616|524311474|FG001|Overall Study|Withdrawal of Consent|0|||
145397447|NCT02371616|524311473|FG000|Overall Study|Other (Not specified)|1|||
145397448|NCT02371616|524311474|FG001|Overall Study|Other (Not specified)|5|||
145397449|NCT00754741|524311477|FG000|Overall Study|Died or disenrolled|57|||
145397450|NCT00754741|524311478|FG001|Overall Study|Died or disenrolled|69|||
145397451|NCT00754741|524311479|FG002|Overall Study|Died or disenrolled|54|||
145397452|NCT04152200|524311481|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
145397453|NCT04152200|524311482|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
145499922|NCT02594124|524690108|FG007|Overall Study|Withdrawal by Subject|19|||
145499923|NCT02594124|524690109|FG008|Overall Study|Withdrawal by Subject|0|||
145499924|NCT02594124|524690101|FG000|Overall Study|Physician Decision|0|||
145499925|NCT02594124|524690102|FG001|Overall Study|Physician Decision|2|||
145499926|NCT02594124|524690103|FG002|Overall Study|Physician Decision|0|||
145499927|NCT02594124|524690104|FG003|Overall Study|Physician Decision|0|||
145499928|NCT02594124|524690105|FG004|Overall Study|Physician Decision|0|||
145499929|NCT02594124|524690106|FG005|Overall Study|Physician Decision|0|||
145499930|NCT02594124|524690107|FG006|Overall Study|Physician Decision|0|||
145499931|NCT02594124|524690108|FG007|Overall Study|Physician Decision|1|||
145499932|NCT02594124|524690109|FG008|Overall Study|Physician Decision|0|||
145499933|NCT02594124|524690101|FG000|Overall Study|Commercial drug|0|||
145499934|NCT02594124|524690102|FG001|Overall Study|Commercial drug|1|||
145499935|NCT02594124|524690103|FG002|Overall Study|Commercial drug|6|||
145499936|NCT02594124|524690104|FG003|Overall Study|Commercial drug|3|||
145499937|NCT02594124|524690105|FG004|Overall Study|Commercial drug|0|||
145499938|NCT02594124|524690106|FG005|Overall Study|Commercial drug|0|||
145499939|NCT02594124|524690107|FG006|Overall Study|Commercial drug|7|||
145499940|NCT02594124|524690108|FG007|Overall Study|Commercial drug|11|||
145499941|NCT02594124|524690109|FG008|Overall Study|Commercial drug|2|||
145499942|NCT02594124|524690101|FG000|Overall Study|Reason Not Specified|1|||
145499943|NCT02594124|524690102|FG001|Overall Study|Reason Not Specified|3|||
145499944|NCT02594124|524690103|FG002|Overall Study|Reason Not Specified|4|||
145499945|NCT02594124|524690104|FG003|Overall Study|Reason Not Specified|0|||
145499946|NCT02594124|524690105|FG004|Overall Study|Reason Not Specified|0|||
145499947|NCT02594124|524690106|FG005|Overall Study|Reason Not Specified|1|||
145499948|NCT02594124|524690107|FG006|Overall Study|Reason Not Specified|1|||
145499949|NCT02594124|524690108|FG007|Overall Study|Reason Not Specified|6|||
145499950|NCT02594124|524690109|FG008|Overall Study|Reason Not Specified|1|||
145499951|NCT01824836|524690110|FG000|Overall Study|Adverse Event|48|||
145499952|NCT01824836|524690110|FG000|Overall Study|Withdrawal by Subject|63|||
145499953|NCT01824836|524690110|FG000|Overall Study|Other complicating disease|116|||
145499954|NCT01824836|524690110|FG000|Overall Study|Disease progression|5|||
145499955|NCT01824836|524690110|FG000|Overall Study|Alternative therapy|2|||
145499956|NCT01824836|524690110|FG000|Overall Study|Depression|1|||
145499957|NCT01824836|524690110|FG000|Overall Study|Non-compliance|3|||
145499958|NCT01824836|524690110|FG000|Overall Study|Patient regained ovarian function|3|||
145499959|NCT01824836|524690110|FG000|Overall Study|Lost to Follow-up|8|||
145499960|NCT01824836|524690110|FG000|Overall Study|Physician Decision|2|||
145499961|NCT01824836|524690110|FG000|Overall Study|Research office was closed|3|||
145499962|NCT01824836|524690110|FG000|Overall Study|Relocation|3|||
145499963|NCT01824836|524690110|FG000|Overall Study|Insurance-related issue|1|||
145499964|NCT01824836|524690110|FG000|Overall Study|Transportation issue|1|||
145499965|NCT01824836|524690110|FG000|Overall Study|Patient transferred care|1|||
145499966|NCT01824836|524690110|FG000|Overall Study|Unknown reasons|4|||
145499967|NCT01824836|524690110|FG000|Overall Study|Never started treatment|16|||
145499968|NCT04323124|524690113|FG000|Overall Study|Adverse Event|0|||
145499969|NCT04323124|524690114|FG001|Overall Study|Adverse Event|0|||
145499970|NCT04323124|524690115|FG002|Overall Study|Adverse Event|0|||
145499971|NCT04323124|524690116|FG003|Overall Study|Adverse Event|0|||
145499972|NCT04323124|524690117|FG004|Overall Study|Adverse Event|0|||
145499973|NCT04323124|524690118|FG005|Overall Study|Adverse Event|1|||
145499974|NCT04323124|524690119|FG006|Overall Study|Adverse Event|0|||
145499975|NCT04323124|524690120|FG007|Overall Study|Adverse Event|1|||
145499976|NCT04323124|524690121|FG008|Overall Study|Adverse Event|1|||
145499977|NCT04323124|524690122|FG009|Overall Study|Adverse Event|0|||
145499978|NCT04323124|524690123|FG010|Overall Study|Adverse Event|0|||
145499979|NCT04323124|524690124|FG011|Overall Study|Adverse Event|0|||
145499980|NCT04323124|524690125|FG012|Overall Study|Adverse Event|0|||
145499981|NCT04323124|524690126|FG013|Overall Study|Adverse Event|0|||
145499982|NCT04323124|524690127|FG014|Overall Study|Adverse Event|0|||
145499983|NCT04323124|524690113|FG000|Overall Study|Other|0|||
145499984|NCT04323124|524690114|FG001|Overall Study|Other|0|||
145499985|NCT04323124|524690115|FG002|Overall Study|Other|0|||
145499986|NCT04323124|524690116|FG003|Overall Study|Other|0|||
145499987|NCT04323124|524690117|FG004|Overall Study|Other|1|||
145499988|NCT04323124|524690118|FG005|Overall Study|Other|0|||
145499989|NCT04323124|524690119|FG006|Overall Study|Other|0|||
145499990|NCT04323124|524690120|FG007|Overall Study|Other|0|||
145499991|NCT04323124|524690121|FG008|Overall Study|Other|1|||
145499992|NCT04323124|524690122|FG009|Overall Study|Other|0|||
145499993|NCT04323124|524690123|FG010|Overall Study|Other|0|||
145499994|NCT04323124|524690124|FG011|Overall Study|Other|0|||
145499995|NCT04323124|524690125|FG012|Overall Study|Other|0|||
145499996|NCT04323124|524690126|FG013|Overall Study|Other|0|||
145499997|NCT04323124|524690127|FG014|Overall Study|Other|0|||
145499998|NCT04323124|524690113|FG000|Overall Study|Coming from a red zone (COVID)|0|||
145499999|NCT04323124|524690114|FG001|Overall Study|Coming from a red zone (COVID)|0|||
145500000|NCT04323124|524690115|FG002|Overall Study|Coming from a red zone (COVID)|0|||
145500001|NCT04323124|524690116|FG003|Overall Study|Coming from a red zone (COVID)|0|||
145500002|NCT04323124|524690117|FG004|Overall Study|Coming from a red zone (COVID)|1|||
145500003|NCT04323124|524690118|FG005|Overall Study|Coming from a red zone (COVID)|1|||
145500004|NCT04323124|524690119|FG006|Overall Study|Coming from a red zone (COVID)|0|||
145500005|NCT04323124|524690120|FG007|Overall Study|Coming from a red zone (COVID)|0|||
145500006|NCT04323124|524690121|FG008|Overall Study|Coming from a red zone (COVID)|0|||
145500007|NCT04323124|524690122|FG009|Overall Study|Coming from a red zone (COVID)|0|||
145500008|NCT04323124|524690123|FG010|Overall Study|Coming from a red zone (COVID)|0|||
145500009|NCT04323124|524690124|FG011|Overall Study|Coming from a red zone (COVID)|0|||
145500010|NCT04323124|524690125|FG012|Overall Study|Coming from a red zone (COVID)|0|||
145500011|NCT04323124|524690126|FG013|Overall Study|Coming from a red zone (COVID)|0|||
145500012|NCT04323124|524690127|FG014|Overall Study|Coming from a red zone (COVID)|0|||
145500013|NCT04323124|524690113|FG000|Overall Study|No longer meets eligibility criteria|0|||
145500014|NCT04323124|524690114|FG001|Overall Study|No longer meets eligibility criteria|0|||
145500015|NCT04323124|524690115|FG002|Overall Study|No longer meets eligibility criteria|0|||
145500016|NCT04323124|524690116|FG003|Overall Study|No longer meets eligibility criteria|0|||
145500017|NCT04323124|524690117|FG004|Overall Study|No longer meets eligibility criteria|0|||
145500018|NCT04323124|524690118|FG005|Overall Study|No longer meets eligibility criteria|0|||
145500019|NCT04323124|524690119|FG006|Overall Study|No longer meets eligibility criteria|0|||
145500020|NCT04323124|524690120|FG007|Overall Study|No longer meets eligibility criteria|1|||
145500021|NCT04323124|524690121|FG008|Overall Study|No longer meets eligibility criteria|0|||
145500022|NCT04323124|524690122|FG009|Overall Study|No longer meets eligibility criteria|0|||
145500023|NCT04323124|524690123|FG010|Overall Study|No longer meets eligibility criteria|0|||
145500024|NCT04323124|524690124|FG011|Overall Study|No longer meets eligibility criteria|0|||
145500025|NCT04323124|524690125|FG012|Overall Study|No longer meets eligibility criteria|0|||
145500026|NCT04323124|524690126|FG013|Overall Study|No longer meets eligibility criteria|1|||
145500027|NCT04323124|524690127|FG014|Overall Study|No longer meets eligibility criteria|1|||
145500028|NCT04323124|524690113|FG000|Overall Study|Study terminated by sponsor|0|||
145500029|NCT04323124|524690114|FG001|Overall Study|Study terminated by sponsor|0|||
145500030|NCT04323124|524690115|FG002|Overall Study|Study terminated by sponsor|0|||
145500031|NCT04323124|524690116|FG003|Overall Study|Study terminated by sponsor|0|||
145500032|NCT04323124|524690117|FG004|Overall Study|Study terminated by sponsor|0|||
145500033|NCT04323124|524690118|FG005|Overall Study|Study terminated by sponsor|0|||
145500034|NCT04323124|524690119|FG006|Overall Study|Study terminated by sponsor|0|||
145500035|NCT04323124|524690120|FG007|Overall Study|Study terminated by sponsor|0|||
145500036|NCT04323124|524690121|FG008|Overall Study|Study terminated by sponsor|0|||
145500037|NCT04323124|524690122|FG009|Overall Study|Study terminated by sponsor|0|||
145500038|NCT04323124|524690123|FG010|Overall Study|Study terminated by sponsor|0|||
145500039|NCT04323124|524690124|FG011|Overall Study|Study terminated by sponsor|2|||
145500040|NCT04323124|524690125|FG012|Overall Study|Study terminated by sponsor|1|||
145500041|NCT04323124|524690126|FG013|Overall Study|Study terminated by sponsor|0|||
145500042|NCT04323124|524690127|FG014|Overall Study|Study terminated by sponsor|0|||
145500043|NCT02083354|524691848|FG000|Overall Study|Withdrawal by Subject|9|||
145500044|NCT02083354|524691848|FG000|Overall Study|Lost to Follow-up|1|||
145500045|NCT02083354|524691848|FG000|Overall Study|Adverse Event|3|||
145500046|NCT02083354|524691848|FG000|Overall Study|Disease progression|46|||
145500047|NCT02083354|524691848|FG000|Overall Study|Study closed/terminated|5|||
145500048|NCT02066181|524691863|FG000|Overall Study|Withdrawal by Subject|1|||
145500049|NCT02066181|524691864|FG001|Overall Study|Withdrawal by Subject|1|||
145500050|NCT02141295|524691868|FG000|Overall Study|Adverse Event|1|||
145500051|NCT02141295|524691869|FG001|Overall Study|Adverse Event|18|||
145500052|NCT02141295|524691870|FG002|Overall Study|Adverse Event|11|||
145500053|NCT02141295|524691868|FG000|Overall Study|Physician Decision|2|||
145500054|NCT02141295|524691869|FG001|Overall Study|Physician Decision|19|||
145500055|NCT02141295|524691870|FG002|Overall Study|Physician Decision|14|||
145500056|NCT02141295|524691868|FG000|Overall Study|Study terminated by sponsor|0|||
145500057|NCT02141295|524691869|FG001|Overall Study|Study terminated by sponsor|6|||
145500058|NCT02141295|524691870|FG002|Overall Study|Study terminated by sponsor|6|||
145500059|NCT02141295|524691868|FG000|Overall Study|Non-compliance|0|||
145500060|NCT02141295|524691869|FG001|Overall Study|Non-compliance|1|||
145500061|NCT02141295|524691870|FG002|Overall Study|Non-compliance|0|||
145500062|NCT02141295|524691868|FG000|Overall Study|Progressive disease|3|||
145500063|NCT02141295|524691869|FG001|Overall Study|Progressive disease|32|||
145500064|NCT02141295|524691870|FG002|Overall Study|Progressive disease|50|||
145500065|NCT02141295|524691868|FG000|Overall Study|Reason not specified|0|||
145500066|NCT02141295|524691869|FG001|Overall Study|Reason not specified|9|||
145500067|NCT02141295|524691870|FG002|Overall Study|Reason not specified|10|||
145500068|NCT02141295|524691868|FG000|Overall Study|Withdrawal by Subject|0|||
145500069|NCT02141295|524691869|FG001|Overall Study|Withdrawal by Subject|9|||
145500070|NCT02141295|524691870|FG002|Overall Study|Withdrawal by Subject|4|||
145500071|NCT01389596|524691871|FG000|Overall Study|Protocol Violation|3|||
145500072|NCT01389596|524691872|FG001|Overall Study|Protocol Violation|4|||
145500073|NCT01389596|524691873|FG002|Overall Study|Protocol Violation|3|||
145500074|NCT01389596|524691871|FG000|Overall Study|Withdrawal by Subject|1|||
145500075|NCT01389596|524691872|FG001|Overall Study|Withdrawal by Subject|2|||
145500076|NCT01389596|524691873|FG002|Overall Study|Withdrawal by Subject|2|||
145500077|NCT01389596|524691871|FG000|Overall Study|Insufficient Clinical Response|3|||
145500078|NCT01389596|524691872|FG001|Overall Study|Insufficient Clinical Response|4|||
145500079|NCT01389596|524691873|FG002|Overall Study|Insufficient Clinical Response|5|||
145500080|NCT01389596|524691871|FG000|Overall Study|Adverse Event|1|||
145500081|NCT01389596|524691872|FG001|Overall Study|Adverse Event|4|||
145500082|NCT01389596|524691873|FG002|Overall Study|Adverse Event|0|||
145500083|NCT01389596|524691871|FG000|Overall Study|Death|0|||
145500084|NCT01389596|524691872|FG001|Overall Study|Death|1|||
145500085|NCT01389596|524691873|FG002|Overall Study|Death|0|||
145500086|NCT01389596|524691871|FG000|Overall Study|Other Unspecified|2|||
145500087|NCT01389596|524691872|FG001|Overall Study|Other Unspecified|1|||
145500088|NCT01389596|524691873|FG002|Overall Study|Other Unspecified|0|||
145500089|NCT01671319|524691874|FG000|Overall Study|Withdrawal by Subject|1|||
145500090|NCT00214201|524691875|FG000|Overall Study|Withdrawal by Subject|2|||
145500091|NCT00214201|524691876|FG001|Overall Study|Withdrawal by Subject|0|||
145500092|NCT00214201|524691875|FG000|Overall Study|Death|0|||
145500093|NCT00214201|524691876|FG001|Overall Study|Death|2|||
145500094|NCT01354899|524691877|FG000|Overall Study|discharge from the hospital|2|||
145500095|NCT01354899|524691877|FG000|Overall Study|Protocol Violation|1|||
145500096|NCT00463567|524691878|FG000|Overall Study|Adverse Event|29|||
145500097|NCT00463567|524691879|FG001|Overall Study|Adverse Event|26|||
145500098|NCT00463567|524691880|FG002|Overall Study|Adverse Event|17|||
145500099|NCT00463567|524691881|FG003|Overall Study|Adverse Event|46|||
145500100|NCT00463567|524691882|FG004|Overall Study|Adverse Event|10|||
145500101|NCT00463567|524691883|FG005|Overall Study|Adverse Event|10|||
145500102|NCT00463567|524691884|FG006|Overall Study|Adverse Event|4|||
145500103|NCT00463567|524691878|FG000|Overall Study|Withdrawal by Subject|29|||
145500104|NCT00463567|524691879|FG001|Overall Study|Withdrawal by Subject|22|||
145500105|NCT00463567|524691880|FG002|Overall Study|Withdrawal by Subject|20|||
145500106|NCT00463567|524691881|FG003|Overall Study|Withdrawal by Subject|37|||
145500107|NCT00463567|524691882|FG004|Overall Study|Withdrawal by Subject|6|||
145500108|NCT00463567|524691883|FG005|Overall Study|Withdrawal by Subject|5|||
145500109|NCT00463567|524691884|FG006|Overall Study|Withdrawal by Subject|1|||
145500110|NCT00463567|524691878|FG000|Overall Study|Protocol Deviation|13|||
145500111|NCT00463567|524691879|FG001|Overall Study|Protocol Deviation|9|||
145500112|NCT00463567|524691880|FG002|Overall Study|Protocol Deviation|14|||
145500113|NCT00463567|524691881|FG003|Overall Study|Protocol Deviation|11|||
145500114|NCT00463567|524691882|FG004|Overall Study|Protocol Deviation|1|||
145500115|NCT00463567|524691883|FG005|Overall Study|Protocol Deviation|1|||
145500116|NCT00463567|524691884|FG006|Overall Study|Protocol Deviation|2|||
145500117|NCT00463567|524691878|FG000|Overall Study|Lost to Follow-up|12|||
145500118|NCT00463567|524691879|FG001|Overall Study|Lost to Follow-up|6|||
145500119|NCT00463567|524691880|FG002|Overall Study|Lost to Follow-up|13|||
145500120|NCT00463567|524691881|FG003|Overall Study|Lost to Follow-up|8|||
145500121|NCT00463567|524691882|FG004|Overall Study|Lost to Follow-up|1|||
145500122|NCT00463567|524691883|FG005|Overall Study|Lost to Follow-up|1|||
145500123|NCT00463567|524691884|FG006|Overall Study|Lost to Follow-up|1|||
145500124|NCT00463567|524691878|FG000|Overall Study|Administrative problems|5|||
145500125|NCT00463567|524691879|FG001|Overall Study|Administrative problems|3|||
145500126|NCT00463567|524691880|FG002|Overall Study|Administrative problems|6|||
145500127|NCT00463567|524691881|FG003|Overall Study|Administrative problems|9|||
145500128|NCT00463567|524691882|FG004|Overall Study|Administrative problems|3|||
145500129|NCT00463567|524691883|FG005|Overall Study|Administrative problems|2|||
145500130|NCT00463567|524691884|FG006|Overall Study|Administrative problems|2|||
145500131|NCT00463567|524691878|FG000|Overall Study|Lack of Efficacy|4|||
145500132|NCT00463567|524691879|FG001|Overall Study|Lack of Efficacy|9|||
145500133|NCT00463567|524691880|FG002|Overall Study|Lack of Efficacy|9|||
145500134|NCT00463567|524691881|FG003|Overall Study|Lack of Efficacy|17|||
145500135|NCT00463567|524691882|FG004|Overall Study|Lack of Efficacy|1|||
145500136|NCT00463567|524691883|FG005|Overall Study|Lack of Efficacy|0|||
145500137|NCT00463567|524691884|FG006|Overall Study|Lack of Efficacy|1|||
145500138|NCT00463567|524691878|FG000|Overall Study|Abnormal lab value(s)|1|||
145500139|NCT00463567|524691879|FG001|Overall Study|Abnormal lab value(s)|1|||
145500140|NCT00463567|524691880|FG002|Overall Study|Abnormal lab value(s)|2|||
145500141|NCT00463567|524691881|FG003|Overall Study|Abnormal lab value(s)|1|||
145500142|NCT00463567|524691882|FG004|Overall Study|Abnormal lab value(s)|1|||
145605972|NCT01473381|525073072|FG001|Overall Study|Adverse Event|20|||
145500143|NCT00463567|524691883|FG005|Overall Study|Abnormal lab value(s)|0|||
145500144|NCT00463567|524691884|FG006|Overall Study|Abnormal lab value(s)|0|||
145500145|NCT00463567|524691878|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145500146|NCT00463567|524691879|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145500147|NCT00463567|524691880|FG002|Overall Study|Abnormal test procedure result(s)|6|||
145500148|NCT00463567|524691881|FG003|Overall Study|Abnormal test procedure result(s)|2|||
145500149|NCT00463567|524691882|FG004|Overall Study|Abnormal test procedure result(s)|0|||
145500150|NCT00463567|524691883|FG005|Overall Study|Abnormal test procedure result(s)|2|||
145500151|NCT00463567|524691884|FG006|Overall Study|Abnormal test procedure result(s)|0|||
145500152|NCT00463567|524691878|FG000|Overall Study|Death|1|||
145500153|NCT00463567|524691879|FG001|Overall Study|Death|0|||
145500154|NCT00463567|524691880|FG002|Overall Study|Death|2|||
145500155|NCT00463567|524691881|FG003|Overall Study|Death|0|||
145500156|NCT00463567|524691882|FG004|Overall Study|Death|0|||
145500157|NCT00463567|524691883|FG005|Overall Study|Death|0|||
145500158|NCT00463567|524691884|FG006|Overall Study|Death|0|||
145500159|NCT01124006|524691885|FG000|Overall Study|Withdrawal by Subject|2|||
145500160|NCT01124006|524691886|FG001|Overall Study|Withdrawal by Subject|2|||
145500161|NCT01124006|524691887|FG002|Overall Study|Withdrawal by Subject|0|||
145500162|NCT01124006|524691885|FG000|Overall Study|Lost to Follow-up|1|||
145500163|NCT01124006|524691886|FG001|Overall Study|Lost to Follow-up|0|||
145500164|NCT01124006|524691887|FG002|Overall Study|Lost to Follow-up|1|||
145500165|NCT01124006|524691885|FG000|Overall Study|Other|0|||
145500166|NCT01124006|524691886|FG001|Overall Study|Other|0|||
145500167|NCT01124006|524691887|FG002|Overall Study|Other|1|||
145500168|NCT01803607|524691889|FG000|Overall Study|Adverse Event|5|||
145500169|NCT01803607|524691890|FG001|Overall Study|Adverse Event|3|||
145500170|NCT01803607|524691889|FG000|Overall Study|Lack of Efficacy|0|||
145500171|NCT01803607|524691890|FG001|Overall Study|Lack of Efficacy|1|||
145500172|NCT01803607|524691889|FG000|Overall Study|Protocol Violation|3|||
145500173|NCT01803607|524691890|FG001|Overall Study|Protocol Violation|2|||
145500174|NCT01803607|524691889|FG000|Overall Study|Study terminated by sponsor|54|||
145500175|NCT01803607|524691890|FG001|Overall Study|Study terminated by sponsor|56|||
145500176|NCT01803607|524691889|FG000|Overall Study|Withdrawal by Subject|6|||
145500177|NCT01803607|524691890|FG001|Overall Study|Withdrawal by Subject|5|||
145500178|NCT04154904|524691929|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
145500179|NCT04154904|524691930|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
145500180|NCT04154904|524691931|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
145500181|NCT00706238|524691932|FG000|Overall Study|Disease progression|4|||
145500182|NCT00706238|524691932|FG000|Overall Study|Other|1|||
145500183|NCT03819114|524691933|FG000|Overall Study|Protocol Violation|0|||
145500184|NCT03819114|524691934|FG001|Overall Study|Protocol Violation|1|||
145500185|NCT03819114|524691935|FG002|Overall Study|Protocol Violation|1|||
145500186|NCT03819114|524691936|FG003|Overall Study|Protocol Violation|0|||
145500187|NCT03819114|524691933|FG000|Overall Study|Lost to Follow-up|0|||
145500188|NCT03819114|524691934|FG001|Overall Study|Lost to Follow-up|0|||
145500189|NCT03819114|524691935|FG002|Overall Study|Lost to Follow-up|1|||
145500190|NCT03819114|524691936|FG003|Overall Study|Lost to Follow-up|0|||
145500191|NCT03841604|524691937|FG000|Overall Study|Withdrawal by Subject|3|||
145500192|NCT03841604|524691938|FG001|Overall Study|Withdrawal by Subject|1|||
145500193|NCT03841604|524691937|FG000|Overall Study|Adverse Event|4|||
145500194|NCT03841604|524691938|FG001|Overall Study|Adverse Event|2|||
145500195|NCT03841604|524691937|FG000|Overall Study|Physician Decision|1|||
145500196|NCT03841604|524691938|FG001|Overall Study|Physician Decision|0|||
145500197|NCT02492763|524691939|FG000|Overall Study|Withdrawal by Subject|0|||
145500198|NCT02492763|524691940|FG001|Overall Study|Withdrawal by Subject|2|||
145500199|NCT02492763|524691941|FG002|Overall Study|Withdrawal by Subject|1|||
145500200|NCT02492763|524691942|FG003|Overall Study|Withdrawal by Subject|0|||
145500201|NCT02492763|524691939|FG000|Overall Study|Adverse Event|3|||
145500202|NCT02492763|524691940|FG001|Overall Study|Adverse Event|1|||
145500203|NCT02492763|524691941|FG002|Overall Study|Adverse Event|1|||
145500204|NCT02492763|524691942|FG003|Overall Study|Adverse Event|2|||
145500205|NCT02492763|524691939|FG000|Overall Study|Death|0|||
145500206|NCT02492763|524691940|FG001|Overall Study|Death|0|||
145500207|NCT02492763|524691941|FG002|Overall Study|Death|1|||
145500208|NCT02492763|524691942|FG003|Overall Study|Death|0|||
145500209|NCT02492763|524691939|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
145500210|NCT02492763|524691940|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
145500211|NCT02492763|524691941|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
145500212|NCT02492763|524691942|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
145500213|NCT02492763|524691939|FG000|Overall Study|Lost to Follow-up|0|||
145500214|NCT02492763|524691940|FG001|Overall Study|Lost to Follow-up|0|||
145500215|NCT02492763|524691941|FG002|Overall Study|Lost to Follow-up|1|||
145500216|NCT02492763|524691942|FG003|Overall Study|Lost to Follow-up|0|||
145500217|NCT02492763|524691939|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145605973|NCT01473381|525073073|FG002|Overall Study|Adverse Event|25|||
145500218|NCT02492763|524691940|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145500219|NCT02492763|524691941|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145500220|NCT02492763|524691942|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145500221|NCT02492763|524691939|FG000|Overall Study|Screen Failure|0|||
145500222|NCT02492763|524691940|FG001|Overall Study|Screen Failure|0|||
145500223|NCT02492763|524691941|FG002|Overall Study|Screen Failure|0|||
145500224|NCT02492763|524691942|FG003|Overall Study|Screen Failure|1|||
145500225|NCT02492763|524691939|FG000|Overall Study|Study Terminated by Sponsor|13|||
145500226|NCT02492763|524691940|FG001|Overall Study|Study Terminated by Sponsor|10|||
145500227|NCT02492763|524691941|FG002|Overall Study|Study Terminated by Sponsor|6|||
145500228|NCT02492763|524691942|FG003|Overall Study|Study Terminated by Sponsor|10|||
145500229|NCT01337960|524691943|FG000|Overall Study|Lost to Follow-up|1|||
145500230|NCT01337960|524691944|FG001|Overall Study|Lost to Follow-up|0|||
145500231|NCT01337960|524691945|FG002|Overall Study|Lost to Follow-up|0|||
145500232|NCT01337960|524691943|FG000|Overall Study|Withdrawal by Subject|1|||
145500233|NCT01337960|524691944|FG001|Overall Study|Withdrawal by Subject|0|||
145500234|NCT01337960|524691945|FG002|Overall Study|Withdrawal by Subject|0|||
145500235|NCT02085161|524691947|FG000|Overall Study|Not Treated|1|||
145500236|NCT02085161|524691948|FG001|Overall Study|Not Treated|0|||
145500237|NCT02085161|524691949|FG002|Overall Study|Not Treated|0|||
145500238|NCT02085161|524691950|FG003|Overall Study|Not Treated|0|||
145500239|NCT02085161|524691947|FG000|Overall Study|Adverse Event|8|||
145500240|NCT02085161|524691948|FG001|Overall Study|Adverse Event|5|||
145500241|NCT02085161|524691949|FG002|Overall Study|Adverse Event|4|||
145500242|NCT02085161|524691950|FG003|Overall Study|Adverse Event|5|||
145500243|NCT02085161|524691947|FG000|Overall Study|Protocol Violation|0|||
145500244|NCT02085161|524691948|FG001|Overall Study|Protocol Violation|1|||
145500245|NCT02085161|524691949|FG002|Overall Study|Protocol Violation|0|||
145500246|NCT02085161|524691950|FG003|Overall Study|Protocol Violation|1|||
145500247|NCT02085161|524691947|FG000|Overall Study|Withdrawal by Subject|2|||
145500248|NCT02085161|524691948|FG001|Overall Study|Withdrawal by Subject|4|||
145500249|NCT02085161|524691949|FG002|Overall Study|Withdrawal by Subject|0|||
145500250|NCT02085161|524691950|FG003|Overall Study|Withdrawal by Subject|3|||
145500251|NCT02085161|524691947|FG000|Overall Study|Other Reason|1|||
145500252|NCT02085161|524691948|FG001|Overall Study|Other Reason|0|||
145500253|NCT02085161|524691949|FG002|Overall Study|Other Reason|1|||
145500254|NCT02085161|524691950|FG003|Overall Study|Other Reason|1|||
145500255|NCT01936870|524691953|FG000|Overall Study|No Visit After Treatment|176|||
145500256|NCT01936870|524691953|FG000|Overall Study|Protocol Violation|12|||
145500257|NCT01936870|524691953|FG000|Overall Study|No Drug Administration|1|||
145500258|NCT00628108|524691956|FG000|Overall Study|Adverse Event|0|||
145500259|NCT00628108|524691957|FG001|Overall Study|Adverse Event|3|||
145500260|NCT00628108|524691956|FG000|Overall Study|Withdrawal by Subject|1|||
145500261|NCT00628108|524691957|FG001|Overall Study|Withdrawal by Subject|0|||
145500262|NCT03848832|524691958|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
145500263|NCT03848832|524691959|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
145500264|NCT03848832|524691960|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
145500265|NCT03848832|524691958|FG000|Overall Study|Withdrawal by Subject|0|||
145500266|NCT03848832|524691959|FG001|Overall Study|Withdrawal by Subject|0|||
145500267|NCT03848832|524691960|FG002|Overall Study|Withdrawal by Subject|1|||
145500268|NCT03848832|524691958|FG000|Overall Study|Withdrawal (Covid-19)|0|||
145500269|NCT03848832|524691959|FG001|Overall Study|Withdrawal (Covid-19)|2|||
145500270|NCT03848832|524691960|FG002|Overall Study|Withdrawal (Covid-19)|0|||
145500271|NCT03848832|524691958|FG000|Overall Study|Physician Decision|2|||
145500272|NCT03848832|524691959|FG001|Overall Study|Physician Decision|1|||
145500273|NCT03848832|524691960|FG002|Overall Study|Physician Decision|3|||
145500274|NCT03848832|524691958|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
145500275|NCT03848832|524691959|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
145500276|NCT03848832|524691960|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
145500277|NCT03848832|524691958|FG000|Overall Study|Adverse Event|1|||
145500278|NCT03848832|524691959|FG001|Overall Study|Adverse Event|0|||
145500279|NCT03848832|524691960|FG002|Overall Study|Adverse Event|0|||
145500280|NCT00719472|524691962|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
145500281|NCT00719472|524691962|FG000|Enrolled in Study|Subject decision to withdraw|8|||
145500282|NCT00719472|524691962|FG000|Enrolled in Study|Various Reasons|17|||
145500283|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
145500284|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Death|5|||
145500285|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
145500286|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
145500287|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
145500288|NCT00719472|524691962|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
145500289|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
145500290|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Death|6|||
145500291|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Disease progression|3|||
145500292|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
145500293|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
145500294|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
145500295|NCT00719472|524691962|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
145500296|NCT00711191|524691965|FG000|Overall Study|Adverse Event|1|||
145500297|NCT00711191|524691966|FG001|Overall Study|Adverse Event|1|||
145500298|NCT00711191|524691967|FG002|Overall Study|Adverse Event|2|||
145500299|NCT00711191|524691965|FG000|Overall Study|Objective progression or relapse|2|||
145500300|NCT00711191|524691966|FG001|Overall Study|Objective progression or relapse|3|||
145500301|NCT00711191|524691967|FG002|Overall Study|Objective progression or relapse|7|||
145500302|NCT00711191|524691965|FG000|Overall Study|Withdrawal by Subject|0|||
145500303|NCT00711191|524691966|FG001|Overall Study|Withdrawal by Subject|1|||
145397454|NCT04969289|524311483|FG000|Overall Study|Lost to Follow-up|13|||
145397455|NCT04969289|524311484|FG001|Overall Study|Lost to Follow-up|9|||
145397456|NCT00593814|524311485|FG000|Overall Study|Death|7|||
145397457|NCT00593814|524311486|FG001|Overall Study|Death|0|||
145397458|NCT00593814|524311485|FG000|Overall Study|Withdrawal by Subject|7|||
145397459|NCT00593814|524311486|FG001|Overall Study|Withdrawal by Subject|0|||
145397460|NCT00593814|524311485|FG000|Overall Study|Lost to Follow-up|7|||
145397461|NCT00593814|524311486|FG001|Overall Study|Lost to Follow-up|0|||
145397462|NCT00593814|524311485|FG000|Overall Study|Physician Decision|3|||
145397463|NCT00593814|524311486|FG001|Overall Study|Physician Decision|0|||
145397464|NCT02699996|524311487|FG000|Overall Study|Withdrawal by Subject|5|||
145397465|NCT02699996|524311488|FG001|Overall Study|Withdrawal by Subject|2|||
145397466|NCT01921517|524311489|FG000|Overall Study|Lost to Follow-up|5|||
145397467|NCT01921517|524311490|FG001|Overall Study|Lost to Follow-up|0|||
145397468|NCT01921517|524311489|FG000|Overall Study|Newly diagnosed health concern|2|||
145397469|NCT01921517|524311490|FG001|Overall Study|Newly diagnosed health concern|0|||
145397470|NCT01921517|524311489|FG000|Overall Study|Physician Decision|0|||
145397471|NCT01921517|524311490|FG001|Overall Study|Physician Decision|2|||
145397472|NCT01921517|524311489|FG000|Overall Study|Withdrawal by Subject|7|||
145397473|NCT01921517|524311490|FG001|Overall Study|Withdrawal by Subject|3|||
145397474|NCT01921517|524311489|FG000|Overall Study|Subject missed final imaging|1|||
145397475|NCT01921517|524311490|FG001|Overall Study|Subject missed final imaging|4|||
145397476|NCT04069715|524311493|FG000|Overall Study|Lost to Follow-up|1|||
145397477|NCT04069715|524311494|FG001|Overall Study|Lost to Follow-up|1|||
145397478|NCT04069715|524311493|FG000|Overall Study|Physician Decision|1|||
145397479|NCT04069715|524311494|FG001|Overall Study|Physician Decision|1|||
145397480|NCT04069715|524311493|FG000|Overall Study|Withdrawal by Subject|3|||
145397481|NCT04069715|524311494|FG001|Overall Study|Withdrawal by Subject|3|||
145397482|NCT03205150|524311495|FG000|Overall Study|Protocol deviation|1|||
145397483|NCT03205150|524311496|FG001|Overall Study|Protocol deviation|3|||
145397484|NCT03205150|524311497|FG002|Overall Study|Protocol deviation|0|||
145397485|NCT03205150|524311495|FG000|Overall Study|Patient/guardian decision|0|||
145397486|NCT03205150|524311496|FG001|Overall Study|Patient/guardian decision|3|||
145397487|NCT03205150|524311497|FG002|Overall Study|Patient/guardian decision|0|||
145397488|NCT03205150|524311495|FG000|Overall Study|Adverse Event|1|||
145397489|NCT03205150|524311496|FG001|Overall Study|Adverse Event|1|||
145397490|NCT03205150|524311497|FG002|Overall Study|Adverse Event|1|||
145397491|NCT03205150|524311495|FG000|Overall Study|Lost to Follow-up|0|||
145397492|NCT03205150|524311496|FG001|Overall Study|Lost to Follow-up|0|||
145397493|NCT03205150|524311497|FG002|Overall Study|Lost to Follow-up|1|||
145397494|NCT02486692|524311500|FG000|Overall Study|did not login for randomization|4|||
145397495|NCT02486692|524311501|FG001|Overall Study|did not login for randomization|7|||
145397496|NCT03028142|524311502|FG000|Overall Study|Adverse Event|1|||
145397497|NCT03028142|524311503|FG001|Overall Study|Adverse Event|1|||
145397498|NCT03028142|524311504|FG002|Overall Study|Adverse Event|0|||
145397499|NCT03028142|524311505|FG003|Overall Study|Adverse Event|0|||
145397500|NCT03028142|524311506|FG004|Overall Study|Adverse Event|0|||
145397501|NCT03028142|524311507|FG005|Overall Study|Adverse Event|1|||
145397502|NCT03028142|524311502|FG000|Overall Study|Withdrawal by Subject|0|||
145397503|NCT03028142|524311503|FG001|Overall Study|Withdrawal by Subject|0|||
145397504|NCT03028142|524311504|FG002|Overall Study|Withdrawal by Subject|0|||
145397505|NCT03028142|524311505|FG003|Overall Study|Withdrawal by Subject|0|||
145397506|NCT03028142|524311506|FG004|Overall Study|Withdrawal by Subject|1|||
145397507|NCT03028142|524311507|FG005|Overall Study|Withdrawal by Subject|0|||
145397508|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
145397509|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
145397510|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
145397511|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
145397512|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
145397513|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
145397514|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
145397515|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
145397516|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
145397517|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
145397518|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
145397519|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
145397520|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
145397521|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
145397522|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
145397523|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
145397524|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
145397525|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
145397526|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
145397527|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
145397528|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
145397529|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
145397530|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
145397531|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
145397532|NCT01198002|524311508|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
145397533|NCT01198002|524311509|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
145397534|NCT01198002|524311510|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
145397535|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
145397536|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
145397537|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
145397538|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
145397539|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
145397540|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
145397541|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
145397542|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
145397543|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
145397544|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
145397545|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
145397546|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
145397547|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
145397548|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
145397549|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
145397550|NCT01198002|524311508|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
145397551|NCT01198002|524311509|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
145397552|NCT01198002|524311510|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
145397553|NCT03102762|524311511|FG000|Overall Study|Lost to Follow-up|1|||
145397554|NCT03102762|524311512|FG001|Overall Study|Lost to Follow-up|0|||
145397555|NCT04456686|524311513|FG000|Overall Study|Adverse Event|2|||
145397556|NCT04456686|524311514|FG001|Overall Study|Adverse Event|1|||
145397557|NCT04456686|524311513|FG000|Overall Study|Lack of Efficacy|3|||
145397558|NCT04456686|524311514|FG001|Overall Study|Lack of Efficacy|1|||
145397559|NCT04456686|524311513|FG000|Overall Study|Withdrew consent|3|||
145397560|NCT04456686|524311514|FG001|Overall Study|Withdrew consent|1|||
145397561|NCT04456686|524311513|FG000|Overall Study|Physician Decision|2|||
145397562|NCT04456686|524311514|FG001|Overall Study|Physician Decision|2|||
145397563|NCT04456686|524311513|FG000|Overall Study|Withdrawal by Subject|5|||
145397564|NCT04456686|524311514|FG001|Overall Study|Withdrawal by Subject|1|||
145397565|NCT04456686|524311513|FG000|Overall Study|Protocol Violation|0|||
145397566|NCT04456686|524311514|FG001|Overall Study|Protocol Violation|1|||
145397567|NCT02858401|524311517|FG000|Overall Study|Withdrew Consent|0|||
145397568|NCT02858401|524311518|FG001|Overall Study|Withdrew Consent|0|||
145397569|NCT02858401|524311519|FG002|Overall Study|Withdrew Consent|0|||
145397570|NCT02858401|524311520|FG003|Overall Study|Withdrew Consent|0|||
145397571|NCT02858401|524311521|FG004|Overall Study|Withdrew Consent|0|||
145397572|NCT02858401|524311522|FG005|Overall Study|Withdrew Consent|1|||
145397573|NCT02858401|524311523|FG006|Overall Study|Withdrew Consent|0|||
145397574|NCT02858401|524311517|FG000|Overall Study|Lost to Follow-up|0|||
145397575|NCT02858401|524311518|FG001|Overall Study|Lost to Follow-up|1|||
145397576|NCT02858401|524311519|FG002|Overall Study|Lost to Follow-up|0|||
145397577|NCT02858401|524311520|FG003|Overall Study|Lost to Follow-up|0|||
145397578|NCT02858401|524311521|FG004|Overall Study|Lost to Follow-up|0|||
145397579|NCT02858401|524311522|FG005|Overall Study|Lost to Follow-up|0|||
145397580|NCT02858401|524311523|FG006|Overall Study|Lost to Follow-up|0|||
145397581|NCT01064479|524311524|FG000|Overall Study|Death|10|||
145397582|NCT01064479|524311525|FG001|Overall Study|Death|11|||
145397583|NCT01064479|524311524|FG000|Overall Study|Withdrawal by Subject|2|||
145397584|NCT01064479|524311525|FG001|Overall Study|Withdrawal by Subject|2|||
145397585|NCT01064479|524311524|FG000|Overall Study|Disease progression|1|||
145397586|NCT01064479|524311525|FG001|Overall Study|Disease progression|1|||
145397587|NCT01064479|524311524|FG000|Overall Study|Toxicity|1|||
145397588|NCT01064479|524311525|FG001|Overall Study|Toxicity|1|||
145500304|NCT00711191|524691967|FG002|Overall Study|Withdrawal by Subject|3|||
145500305|NCT04646044|524691968|FG000|Overall Study|Lost to Follow-up|0|||
145500306|NCT04646044|524691969|FG001|Overall Study|Lost to Follow-up|0|||
145500307|NCT04646044|524691970|FG002|Overall Study|Lost to Follow-up|1|||
145500308|NCT04646044|524691971|FG003|Overall Study|Lost to Follow-up|0|||
145500309|NCT04646044|524691968|FG000|Overall Study|Withdrawal by Subject|0|||
145500310|NCT04646044|524691969|FG001|Overall Study|Withdrawal by Subject|1|||
145500311|NCT04646044|524691970|FG002|Overall Study|Withdrawal by Subject|0|||
145500312|NCT04646044|524691971|FG003|Overall Study|Withdrawal by Subject|0|||
145500313|NCT03038880|524691977|FG000|Overall Study|Death|1|||
145500314|NCT03038880|524691978|FG001|Overall Study|Death|2|||
145500315|NCT03038880|524691979|FG002|Overall Study|Death|0|||
145500316|NCT03038880|524691977|FG000|Overall Study|Physician Decision|2|||
145500317|NCT03038880|524691978|FG001|Overall Study|Physician Decision|1|||
145500318|NCT03038880|524691979|FG002|Overall Study|Physician Decision|0|||
145500319|NCT02803580|524691980|FG000|Overall Study|Death|13|||
145500320|NCT02803580|524691980|FG000|Overall Study|Lost to Follow-up|19|||
145500321|NCT02803580|524691980|FG000|Overall Study|Withdrawal by Subject|3|||
145500322|NCT02803580|524691980|FG000|Overall Study|Inclusion in clinical trial|1|||
145500323|NCT03879772|524691981|FG000|Overall Study|Adverse Event|2|||
145500324|NCT03879772|524691982|FG001|Overall Study|Adverse Event|2|||
145500325|NCT03879772|524691983|FG002|Overall Study|Adverse Event|3|||
145500326|NCT03879772|524691984|FG003|Overall Study|Adverse Event|4|||
145500327|NCT03879772|524691985|FG004|Overall Study|Adverse Event|3|||
145500328|NCT03879772|524691981|FG000|Overall Study|Treatment Failure|1|||
145500329|NCT03879772|524691982|FG001|Overall Study|Treatment Failure|0|||
145500330|NCT03879772|524691983|FG002|Overall Study|Treatment Failure|0|||
145500331|NCT03879772|524691984|FG003|Overall Study|Treatment Failure|2|||
145500332|NCT03879772|524691985|FG004|Overall Study|Treatment Failure|1|||
145500333|NCT03879772|524691981|FG000|Overall Study|Lost to Follow-up|0|||
145500334|NCT03879772|524691982|FG001|Overall Study|Lost to Follow-up|0|||
145500335|NCT03879772|524691983|FG002|Overall Study|Lost to Follow-up|0|||
145500336|NCT03879772|524691984|FG003|Overall Study|Lost to Follow-up|0|||
145500337|NCT03879772|524691985|FG004|Overall Study|Lost to Follow-up|1|||
145500338|NCT03879772|524691981|FG000|Overall Study|Withdrawal by Subject|0|||
145500339|NCT03879772|524691982|FG001|Overall Study|Withdrawal by Subject|1|||
145500340|NCT03879772|524691983|FG002|Overall Study|Withdrawal by Subject|3|||
145500341|NCT03879772|524691984|FG003|Overall Study|Withdrawal by Subject|1|||
145500342|NCT03879772|524691985|FG004|Overall Study|Withdrawal by Subject|1|||
145500343|NCT03879772|524691981|FG000|Overall Study|Protocol Violation|0|||
145500344|NCT03879772|524691982|FG001|Overall Study|Protocol Violation|0|||
145500345|NCT03879772|524691983|FG002|Overall Study|Protocol Violation|3|||
145500346|NCT03879772|524691984|FG003|Overall Study|Protocol Violation|1|||
145500347|NCT03879772|524691985|FG004|Overall Study|Protocol Violation|2|||
145500348|NCT03879772|524691981|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
145500349|NCT03879772|524691982|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
145500350|NCT03879772|524691983|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
145500351|NCT03879772|524691984|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
145500352|NCT03879772|524691985|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
145500353|NCT01598532|524691986|FG000|Overall Study|Lost to Follow-up|3|||
145500354|NCT01598532|524691986|FG000|Overall Study|Did not meet inclusion criteria|8|||
145500355|NCT00702221|524691987|FG000|Overall Study|Adverse Event|4|||
145500356|NCT00702221|524691988|FG001|Overall Study|Adverse Event|3|||
145500357|NCT04798196|524691992|FG000|Overall Study|Lost to Follow-up|3|||
145500358|NCT04798196|524691993|FG001|Overall Study|Lost to Follow-up|1|||
145500359|NCT04798196|524691994|FG002|Overall Study|Lost to Follow-up|3|||
145500360|NCT01249261|524691995|FG000|Overall Study|Withdrawal by Subject|1|||
145500361|NCT01249261|524691996|FG001|Overall Study|Withdrawal by Subject|0|||
145500362|NCT00728689|524691998|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
145500363|NCT00728689|524691999|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
145500364|NCT00389610|524692002|FG000|Overall Study|Disease Progression|0|||
145500365|NCT00389610|524692003|FG001|Overall Study|Disease Progression|19|||
145500366|NCT00389610|524692002|FG000|Overall Study|Death|0|||
145500367|NCT00389610|524692003|FG001|Overall Study|Death|1|||
145500368|NCT00389610|524692002|FG000|Overall Study|Physician Decision|0|||
145500369|NCT00389610|524692003|FG001|Overall Study|Physician Decision|1|||
145500370|NCT00389610|524692002|FG000|Overall Study|Withdrawal by Subject|0|||
145500371|NCT00389610|524692003|FG001|Overall Study|Withdrawal by Subject|1|||
145500372|NCT00887809|524692004|FG000|Overall Study|Patient Not Treated|3|||
145500373|NCT00887809|524692005|FG001|Overall Study|Patient Not Treated|0|||
145500374|NCT00887809|524692004|FG000|Overall Study|Death|1|||
145500375|NCT00887809|524692005|FG001|Overall Study|Death|0|||
145500376|NCT05567783|524692006|FG000|Overall Study|Death|2|||
145500377|NCT05567783|524692007|FG001|Overall Study|Death|3|||
145500378|NCT05567783|524692008|FG002|Overall Study|Death|0|||
145500379|NCT05567783|524692006|FG000|Overall Study|Lost to Follow-up|25|||
145500380|NCT05567783|524692007|FG001|Overall Study|Lost to Follow-up|19|||
145500381|NCT05567783|524692008|FG002|Overall Study|Lost to Follow-up|17|||
145500382|NCT05567783|524692006|FG000|Overall Study|Physician Decision|10|||
145500383|NCT05567783|524692007|FG001|Overall Study|Physician Decision|7|||
145500384|NCT05567783|524692008|FG002|Overall Study|Physician Decision|9|||
145500385|NCT05567783|524692006|FG000|Overall Study|Study Terminated by Sponsor|924|||
145500386|NCT05567783|524692007|FG001|Overall Study|Study Terminated by Sponsor|937|||
145500387|NCT05567783|524692008|FG002|Overall Study|Study Terminated by Sponsor|941|||
145500388|NCT05567783|524692006|FG000|Overall Study|Withdrawal by Subject|23|||
145500389|NCT05567783|524692007|FG001|Overall Study|Withdrawal by Subject|27|||
145500390|NCT05567783|524692008|FG002|Overall Study|Withdrawal by Subject|24|||
145500391|NCT05567783|524692006|FG000|Overall Study|Incarcerated|1|||
145500392|NCT05567783|524692007|FG001|Overall Study|Incarcerated|0|||
145500393|NCT05567783|524692008|FG002|Overall Study|Incarcerated|0|||
145500394|NCT05567783|524692006|FG000|Overall Study|Participant randomized in error|4|||
145500395|NCT05567783|524692007|FG001|Overall Study|Participant randomized in error|2|||
145500396|NCT05567783|524692008|FG002|Overall Study|Participant randomized in error|2|||
145500397|NCT03675126|524692011|FG000|Overall Study|Study Terminated by Sponsor|9|||
145500398|NCT03675126|524692011|FG000|Overall Study|Death|2|||
145500399|NCT03675126|524692011|FG000|Overall Study|Withdrawal by Subject|4|||
145500400|NCT00391586|524692014|FG000|Overall Study|Progressive disease|13|||
145500401|NCT00391586|524692014|FG000|Overall Study|Adverse Event|5|||
145500402|NCT00391586|524692014|FG000|Overall Study|Physician Decision|2|||
145500403|NCT00391586|524692014|FG000|Overall Study|Death|4|||
145500404|NCT00453206|524692016|FG000|Overall Study|Death|1|||
145500405|NCT01352793|524692021|FG000|Overall Study|Lost to Follow-up|289|||
145500406|NCT01352793|524692022|FG001|Overall Study|Lost to Follow-up|125|||
145500407|NCT01352793|524692021|FG000|Overall Study|Withdrawal by Subject|120|||
145500408|NCT01352793|524692022|FG001|Overall Study|Withdrawal by Subject|55|||
145500409|NCT01352793|524692021|FG000|Overall Study|Protocol Violation|44|||
145500410|NCT01352793|524692022|FG001|Overall Study|Protocol Violation|23|||
145500411|NCT01352793|524692021|FG000|Overall Study|Adverse Event|44|||
145500412|NCT01352793|524692022|FG001|Overall Study|Adverse Event|10|||
145500413|NCT01352793|524692021|FG000|Overall Study|Physician Decision|1|||
145500414|NCT01352793|524692022|FG001|Overall Study|Physician Decision|0|||
145500415|NCT01352793|524692021|FG000|Overall Study|Pregnancy|26|||
145500416|NCT01352793|524692022|FG001|Overall Study|Pregnancy|8|||
145500417|NCT01352793|524692021|FG000|Overall Study|Other|25|||
145500418|NCT01352793|524692022|FG001|Overall Study|Other|7|||
145500419|NCT01352793|524692021|FG000|Overall Study|Medication error|2|||
145500420|NCT01352793|524692022|FG001|Overall Study|Medication error|2|||
145500421|NCT01352793|524692021|FG000|Overall Study|Death|1|||
145500422|NCT01352793|524692022|FG001|Overall Study|Death|0|||
145500423|NCT01352793|524692021|FG000|Overall Study|Randomized but not vaccinated|8|||
145500424|NCT01352793|524692022|FG001|Overall Study|Randomized but not vaccinated|0|||
145500425|NCT01352793|524692021|FG000|Overall Study|No longer meets eligibility criteria|25|||
145500426|NCT01352793|524692022|FG001|Overall Study|No longer meets eligibility criteria|15|||
145500427|NCT01929317|524692025|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
145500428|NCT01929317|524692026|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
145500429|NCT01929317|524692025|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
145500430|NCT01929317|524692026|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
145500431|NCT01929317|524692025|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
145500432|NCT01929317|524692026|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
145500433|NCT01929317|524692025|FG000|Long-term Phase|Adverse Event|5|||
145500434|NCT01929317|524692026|FG001|Long-term Phase|Adverse Event|1|||
145500435|NCT01929317|524692025|FG000|Long-term Phase|Physician Decision|3|||
145500436|NCT01929317|524692026|FG001|Long-term Phase|Physician Decision|0|||
145500437|NCT01929317|524692025|FG000|Long-term Phase|Withdrawal by Subject|4|||
145500438|NCT01929317|524692026|FG001|Long-term Phase|Withdrawal by Subject|0|||
145500439|NCT01929317|524692025|FG000|Long-term Phase|Protocol Violation|1|||
145500440|NCT01929317|524692026|FG001|Long-term Phase|Protocol Violation|0|||
145500441|NCT01929317|524692025|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
145500442|NCT01929317|524692026|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
145500443|NCT01929317|524692025|FG000|Long-term Phase|Study Closed/Terminated|5|||
145500444|NCT01929317|524692026|FG001|Long-term Phase|Study Closed/Terminated|3|||
145500445|NCT02667119|524692027|FG000|Overall Study|Lost to Follow-up|3|||
145500446|NCT02667119|524692028|FG001|Overall Study|Lost to Follow-up|0|||
145500447|NCT03783078|524692029|FG000|Overall Study|Death|31|||
145500448|NCT03783078|524692029|FG000|Overall Study|Sponsor Decision|23|||
145500449|NCT03783078|524692029|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145500450|NCT02059278|524692030|FG000|Overall Study|Adverse Event|1|||
145500451|NCT02059278|524692031|FG001|Overall Study|Adverse Event|1|||
145500452|NCT02059278|524692030|FG000|Overall Study|Lost to Follow-up|1|||
145500453|NCT02059278|524692031|FG001|Overall Study|Lost to Follow-up|0|||
145500454|NCT02059278|524692030|FG000|Overall Study|Withdrawal by Subject|0|||
145500455|NCT02059278|524692031|FG001|Overall Study|Withdrawal by Subject|3|||
145500456|NCT02059278|524692030|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
145500457|NCT02059278|524692031|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
145500458|NCT03043794|524692034|FG000|Overall Study|Lost to Follow-up|1|||
145500459|NCT03205423|524692037|FG000|Overall Study|Personal|1|||
145500460|NCT03205423|524692038|FG001|Overall Study|Personal|1|||
145500461|NCT03205423|524692037|FG000|Overall Study|Physician Decision|0|||
145500462|NCT03205423|524692038|FG001|Overall Study|Physician Decision|2|||
145500463|NCT04467905|524692039|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
145500464|NCT04467905|524692040|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
145500465|NCT04467905|524692041|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
145500466|NCT04467905|524692039|FG000|Overall Study|Conversion to SR|0|||
145500467|NCT04467905|524692040|FG001|Overall Study|Conversion to SR|0|||
145500468|NCT04467905|524692041|FG002|Overall Study|Conversion to SR|3|||
145500469|NCT04467905|524692039|FG000|Overall Study|Technical issue with Holter ECG|0|||
145500470|NCT04467905|524692040|FG001|Overall Study|Technical issue with Holter ECG|0|||
145500471|NCT04467905|524692041|FG002|Overall Study|Technical issue with Holter ECG|3|||
145500472|NCT04467905|524692039|FG000|Overall Study|Hemodynamic instability|0|||
145500473|NCT04467905|524692040|FG001|Overall Study|Hemodynamic instability|0|||
145500474|NCT04467905|524692041|FG002|Overall Study|Hemodynamic instability|1|||
145500475|NCT04467905|524692039|FG000|Overall Study|Site misinterpretation of protocol|0|||
145500476|NCT04467905|524692040|FG001|Overall Study|Site misinterpretation of protocol|0|||
145500477|NCT04467905|524692041|FG002|Overall Study|Site misinterpretation of protocol|1|||
145500478|NCT04145349|524693907|FG000|Overall Study|Withdrawal by Subject|3|||
145500479|NCT04145349|524693908|FG001|Overall Study|Withdrawal by Subject|0|||
145500480|NCT04145349|524693907|FG000|Overall Study|Lost to Follow-up|0|||
145500481|NCT04145349|524693908|FG001|Overall Study|Lost to Follow-up|1|||
145500482|NCT04145349|524693907|FG000|Overall Study|On study treatment (Ongoing)|0|||
145500483|NCT04145349|524693908|FG001|Overall Study|On study treatment (Ongoing)|1|||
145500484|NCT01772316|524693916|FG000|Overall Study|Serious adverse event|1|||
145500485|NCT01772316|524693916|FG000|Overall Study|Inform consent withdrawn|1|||
145500486|NCT01772316|524693916|FG000|Overall Study|Withdrawn by sponsor decision|5|||
145500487|NCT01774721|524693918|FG000|Overall Study|Death|133|||
145500488|NCT01774721|524693919|FG001|Overall Study|Death|152|||
145500489|NCT01774721|524693918|FG000|Overall Study|Withdrawal by Subject|20|||
145500490|NCT01774721|524693919|FG001|Overall Study|Withdrawal by Subject|14|||
145500491|NCT01774721|524693918|FG000|Overall Study|Lost to Follow-up|6|||
145500492|NCT01774721|524693919|FG001|Overall Study|Lost to Follow-up|7|||
145500493|NCT01774721|524693918|FG000|Overall Study|Did not meet eligibility criteria|0|||
145500494|NCT01774721|524693919|FG001|Overall Study|Did not meet eligibility criteria|3|||
145500495|NCT01774721|524693918|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
145500496|NCT01774721|524693919|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
145500497|NCT01774721|524693918|FG000|Overall Study|Study terminated by sponsor|5|||
145500498|NCT01774721|524693919|FG001|Overall Study|Study terminated by sponsor|0|||
145500499|NCT01774721|524693918|FG000|Overall Study|Disease progression|5|||
145500500|NCT01774721|524693919|FG001|Overall Study|Disease progression|0|||
145500501|NCT02453321|524693923|FG000|Overall Study|Weakness|1|||
145500502|NCT02453321|524693924|FG001|Overall Study|Weakness|1|||
145500503|NCT02453321|524693925|FG002|Overall Study|Weakness|2|||
145500504|NCT02453321|524693923|FG000|Overall Study|Deep Venous Thrombosis|0|||
145500505|NCT02453321|524693924|FG001|Overall Study|Deep Venous Thrombosis|1|||
145500506|NCT02453321|524693925|FG002|Overall Study|Deep Venous Thrombosis|0|||
145500507|NCT02054104|524693927|FG000|Overall Study|Did not want to continue due to college classes|1|||
145500508|NCT02054104|524693928|FG001|Overall Study|Did not want to continue due to college classes|0|||
145500509|NCT02054104|524693927|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
145500510|NCT02054104|524693928|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
145500511|NCT02054104|524693927|FG000|Overall Study|No evidence of immunologic response|2|||
145500512|NCT02054104|524693928|FG001|Overall Study|No evidence of immunologic response|2|||
145500513|NCT02054104|524693927|FG000|Overall Study|Disease Progression On Study|4|||
145500514|NCT02054104|524693928|FG001|Overall Study|Disease Progression On Study|5|||
145500515|NCT02054104|524693927|FG000|Overall Study|Diagnosis of lymphoma|0|||
145500516|NCT02054104|524693928|FG001|Overall Study|Diagnosis of lymphoma|1|||
145500517|NCT02054104|524693927|FG000|Overall Study|Inconclusive response|0|||
145500518|NCT02054104|524693928|FG001|Overall Study|Inconclusive response|1|||
145500519|NCT02633306|524693932|FG000|Overall Study|Withdrawal by Subject|3|||
145500520|NCT03910244|524693933|FG000|Overall Study|Adverse Event|14|||
145500521|NCT03910244|524693934|FG001|Overall Study|Adverse Event|0|||
145500522|NCT03910244|524693933|FG000|Overall Study|Death|1|||
145500523|NCT03910244|524693934|FG001|Overall Study|Death|0|||
145500524|NCT03910244|524693933|FG000|Overall Study|Lost to Follow-up|0|||
145500525|NCT03910244|524693934|FG001|Overall Study|Lost to Follow-up|2|||
145500526|NCT03910244|524693933|FG000|Overall Study|Joint withdrawal decision|1|||
145500527|NCT03910244|524693934|FG001|Overall Study|Joint withdrawal decision|0|||
145500528|NCT03910244|524693933|FG000|Overall Study|Study Terminated by Sponsor|7|||
145500529|NCT03910244|524693934|FG001|Overall Study|Study Terminated by Sponsor|4|||
145500530|NCT03910244|524693933|FG000|Overall Study|Physician Decision|1|||
145397589|NCT01064479|524311524|FG000|Overall Study|Other|1|||
145397590|NCT01064479|524311525|FG001|Overall Study|Other|2|||
145397591|NCT01663402|524311529|FG000|Overall Study|Randomized but not treated|19|||
145397592|NCT01663402|524311530|FG001|Overall Study|Randomized but not treated|11|||
145397593|NCT01663402|524311529|FG000|Overall Study|Adverse Event|347|||
145397594|NCT01663402|524311530|FG001|Overall Study|Adverse Event|362|||
145397595|NCT01663402|524311529|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
145397596|NCT01663402|524311530|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
145397597|NCT01663402|524311529|FG000|Overall Study|Poor compliance to protocol|529|||
145397598|NCT01663402|524311530|FG001|Overall Study|Poor compliance to protocol|454|||
145397599|NCT01663402|524311529|FG000|Overall Study|Physician Decision|77|||
145397600|NCT01663402|524311530|FG001|Overall Study|Physician Decision|62|||
145397601|NCT01663402|524311529|FG000|Overall Study|Site terminated by sponsor|1|||
145397602|NCT01663402|524311530|FG001|Overall Study|Site terminated by sponsor|3|||
145397603|NCT01663402|524311529|FG000|Overall Study|Participant moved|139|||
145397604|NCT01663402|524311530|FG001|Overall Study|Participant moved|104|||
145397605|NCT01663402|524311529|FG000|Overall Study|Withdrawal by Subject|118|||
145397606|NCT01663402|524311530|FG001|Overall Study|Withdrawal by Subject|91|||
145397607|NCT01663402|524311529|FG000|Overall Study|Related to study drug administration|96|||
145397608|NCT01663402|524311530|FG001|Overall Study|Related to study drug administration|105|||
145397609|NCT01663402|524311529|FG000|Overall Study|Lost to Follow-up|17|||
145397610|NCT01663402|524311530|FG001|Overall Study|Lost to Follow-up|15|||
145397611|NCT01663402|524311529|FG000|Overall Study|Other than specified above|172|||
145397612|NCT01663402|524311530|FG001|Overall Study|Other than specified above|147|||
145397613|NCT03903172|524311533|FG000|Overall Study|screen fail|4|||
145397614|NCT03903172|524311534|FG001|Overall Study|screen fail|1|||
145397615|NCT02495389|524311535|FG000|Overall Study|Withdrawal by Subject|40|||
145397616|NCT01802385|524311539|FG000|Overall Study|Death|106|||
145397617|NCT01802385|524311540|FG001|Overall Study|Death|120|||
145397618|NCT05559905|524311541|FG000|Overall Study|Withdrawal by Subject|1|||
145397619|NCT05559905|524311542|FG001|Overall Study|Withdrawal by Subject|0|||
145397620|NCT05559905|524311543|FG002|Overall Study|Withdrawal by Subject|0|||
145397621|NCT05559905|524311541|FG000|Overall Study|Not Reported|1|||
145397622|NCT05559905|524311542|FG001|Overall Study|Not Reported|0|||
145397623|NCT05559905|524311543|FG002|Overall Study|Not Reported|0|||
145397624|NCT04003103|524311544|FG000|Overall Study|Death|1|||
145397625|NCT04003103|524311545|FG001|Overall Study|Death|0|||
145397626|NCT04003103|524311546|FG002|Overall Study|Death|0|||
145397627|NCT04003103|524311544|FG000|Overall Study|Lost to Follow-up|4|||
145397628|NCT04003103|524311545|FG001|Overall Study|Lost to Follow-up|3|||
145397629|NCT04003103|524311546|FG002|Overall Study|Lost to Follow-up|2|||
145397630|NCT04003103|524311544|FG000|Overall Study|Withdrawal by Subject|10|||
145397631|NCT04003103|524311545|FG001|Overall Study|Withdrawal by Subject|1|||
145397632|NCT04003103|524311546|FG002|Overall Study|Withdrawal by Subject|1|||
145397633|NCT04003103|524311544|FG000|Overall Study|Status not recorded|0|||
145397634|NCT04003103|524311545|FG001|Overall Study|Status not recorded|2|||
145397635|NCT04003103|524311546|FG002|Overall Study|Status not recorded|0|||
145397636|NCT05518539|524311547|FG000|Overall Study|Lost to Follow-up|6|||
145397637|NCT00338741|524311550|FG000|Overall Study|Lost to Follow-up|2|||
145397638|NCT00338741|524311551|FG001|Overall Study|Lost to Follow-up|0|||
145397639|NCT00617357|524311552|FG000|Overall Study|Lost to Follow-up|7|||
145397640|NCT00617357|524311552|FG000|Overall Study|Death|5|||
145397641|NCT00617357|524311552|FG000|Overall Study|insurance concerns|2|||
145397642|NCT00617357|524311552|FG000|Overall Study|Withdrawal by Subject|1|||
145397643|NCT00617357|524311552|FG000|Overall Study|Physician Decision|1|||
145397644|NCT01747499|524311553|FG000|Overall Study|Steroid refractory aGvHD|1|||
145397645|NCT01747499|524311554|FG001|Overall Study|Steroid refractory aGvHD|0|||
145397646|NCT01747499|524311555|FG002|Overall Study|Steroid refractory aGvHD|0|||
145397647|NCT01747499|524311556|FG003|Overall Study|Steroid refractory aGvHD|1|||
145397648|NCT01747499|524311557|FG004|Overall Study|Steroid refractory aGvHD|4|||
145397649|NCT01747499|524311553|FG000|Overall Study|Physician Decision|0|||
145397650|NCT01747499|524311554|FG001|Overall Study|Physician Decision|1|||
145397651|NCT01747499|524311555|FG002|Overall Study|Physician Decision|0|||
145397652|NCT01747499|524311556|FG003|Overall Study|Physician Decision|0|||
145397653|NCT01747499|524311557|FG004|Overall Study|Physician Decision|2|||
145397654|NCT01747499|524311553|FG000|Overall Study|Death|0|||
145397655|NCT01747499|524311554|FG001|Overall Study|Death|0|||
145397656|NCT01747499|524311555|FG002|Overall Study|Death|0|||
145397657|NCT01747499|524311556|FG003|Overall Study|Death|1|||
145397658|NCT01747499|524311557|FG004|Overall Study|Death|1|||
145397659|NCT01747499|524311553|FG000|Overall Study|Withdrawal by Subject|0|||
145397660|NCT01747499|524311554|FG001|Overall Study|Withdrawal by Subject|0|||
145397661|NCT01747499|524311555|FG002|Overall Study|Withdrawal by Subject|0|||
145397662|NCT01747499|524311556|FG003|Overall Study|Withdrawal by Subject|0|||
145397663|NCT01747499|524311557|FG004|Overall Study|Withdrawal by Subject|6|||
145397664|NCT01747499|524311553|FG000|Overall Study|Developed AML and death|0|||
145397665|NCT01747499|524311554|FG001|Overall Study|Developed AML and death|0|||
145397666|NCT01747499|524311555|FG002|Overall Study|Developed AML and death|0|||
145397667|NCT01747499|524311556|FG003|Overall Study|Developed AML and death|0|||
145397668|NCT01747499|524311557|FG004|Overall Study|Developed AML and death|1|||
145397669|NCT01747499|524311553|FG000|Overall Study|Determined not to be eligible|0|||
145397670|NCT01747499|524311554|FG001|Overall Study|Determined not to be eligible|0|||
145397671|NCT01747499|524311555|FG002|Overall Study|Determined not to be eligible|0|||
145397672|NCT01747499|524311556|FG003|Overall Study|Determined not to be eligible|0|||
145397673|NCT01747499|524311557|FG004|Overall Study|Determined not to be eligible|1|||
145397674|NCT00072410|524311558|FG000|Overall Study|Progressive disease|0|||
145397675|NCT00072410|524311559|FG001|Overall Study|Progressive disease|3|||
145397676|NCT03834506|524311564|FG000|Overall Study|Death|336|||
145397677|NCT03834506|524311565|FG001|Overall Study|Death|326|||
145397678|NCT03834506|524311564|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145397679|NCT03834506|524311565|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145397680|NCT03834506|524311564|FG000|Overall Study|Withdrawal by Subject|10|||
145397681|NCT03834506|524311565|FG001|Overall Study|Withdrawal by Subject|8|||
145397682|NCT03834506|524311564|FG000|Overall Study|Sponsor decision|165|||
145397683|NCT03834506|524311565|FG001|Overall Study|Sponsor decision|178|||
145397684|NCT03834506|524311564|FG000|Overall Study|Physician Decision|3|||
145397685|NCT03834506|524311565|FG001|Overall Study|Physician Decision|1|||
145397686|NCT03834506|524311564|FG000|Overall Study|Lost to Follow-up|0|||
145397687|NCT03834506|524311565|FG001|Overall Study|Lost to Follow-up|1|||
145397688|NCT01819727|524311568|FG000|Overall Study|Adverse Event|8|||
145397689|NCT01819727|524311569|FG001|Overall Study|Adverse Event|9|||
145397690|NCT01819727|524311568|FG000|Overall Study|Death|1|||
145397691|NCT01819727|524311569|FG001|Overall Study|Death|0|||
145397692|NCT01819727|524311568|FG000|Overall Study|Lost to Follow-up|1|||
145397693|NCT01819727|524311569|FG001|Overall Study|Lost to Follow-up|1|||
145397694|NCT01819727|524311568|FG000|Overall Study|Physician Decision|3|||
145397695|NCT01819727|524311569|FG001|Overall Study|Physician Decision|2|||
145397696|NCT01819727|524311568|FG000|Overall Study|Pregnancy|1|||
145397697|NCT01819727|524311569|FG001|Overall Study|Pregnancy|0|||
145397698|NCT01819727|524311568|FG000|Overall Study|Protocol Violation|0|||
145397699|NCT01819727|524311569|FG001|Overall Study|Protocol Violation|2|||
145397700|NCT01819727|524311568|FG000|Overall Study|Study Terminated by Sponsor|0|||
145397701|NCT01819727|524311569|FG001|Overall Study|Study Terminated by Sponsor|1|||
145397702|NCT01819727|524311568|FG000|Overall Study|Withdrawal by Subject|6|||
145500531|NCT03910244|524693934|FG001|Overall Study|Physician Decision|0|||
145500532|NCT03910244|524693933|FG000|Overall Study|Protocol Violation|1|||
145500533|NCT03910244|524693934|FG001|Overall Study|Protocol Violation|0|||
145397703|NCT01819727|524311569|FG001|Overall Study|Withdrawal by Subject|11|||
145397704|NCT01819727|524311568|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
145397705|NCT01819727|524311569|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
145397706|NCT01819727|524311568|FG000|Overall Study|Quit due to lack of health benifits|0|||
145605974|NCT01473381|525073074|FG003|Overall Study|Adverse Event|17|||
145397707|NCT01819727|524311569|FG001|Overall Study|Quit due to lack of health benifits|1|||
145397708|NCT03644017|524311570|FG000|Overall Study|Access Abandonment|5|||
145397709|NCT03644017|524311570|FG000|Overall Study|Kidney Transplant|2|||
145397710|NCT02700048|524311571|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
145397711|NCT02700048|524311572|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
145397712|NCT02175225|524311573|FG000|Overall Study|Withdrawal by Subject|1|||
145397713|NCT02175225|524311574|FG001|Overall Study|Withdrawal by Subject|2|||
145397714|NCT02175225|524311573|FG000|Overall Study|Lost to Follow-up|6|||
145397715|NCT02175225|524311574|FG001|Overall Study|Lost to Follow-up|7|||
145397716|NCT02175225|524311573|FG000|Overall Study|Study drug not administered|1|||
145397717|NCT02175225|524311574|FG001|Overall Study|Study drug not administered|2|||
145397718|NCT02340000|524311575|FG000|Time Period 1|Withdrawal by Subject|6|||
145397719|NCT02340000|524311576|FG001|Time Period 1|Withdrawal by Subject|8|||
145397720|NCT02340000|524311575|FG000|Time Period 1|Lost to Follow-up|6|||
145397721|NCT02340000|524311576|FG001|Time Period 1|Lost to Follow-up|7|||
145397722|NCT02340000|524311575|FG000|Time Period 2|Withdrawal by Subject|9|||
145397723|NCT02340000|524311576|FG001|Time Period 2|Withdrawal by Subject|7|||
145397724|NCT02340000|524311575|FG000|Time Period 2|Lost to Follow-up|10|||
145397725|NCT02340000|524311576|FG001|Time Period 2|Lost to Follow-up|8|||
145397726|NCT00969228|524311581|FG000|Overall Study|Adverse Event|1|||
145397727|NCT00969228|524311582|FG001|Overall Study|Adverse Event|0|||
145397728|NCT00969228|524311581|FG000|Overall Study|Withdrawal by Subject|4|||
145397729|NCT00969228|524311582|FG001|Overall Study|Withdrawal by Subject|0|||
145397730|NCT00969228|524311581|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
145397731|NCT00969228|524311582|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
145397732|NCT03311945|524311584|FG000|Overall Study|Adverse Event|2|||
145397733|NCT03311945|524311584|FG000|Overall Study|Lack of Efficacy|1|||
145397734|NCT01107925|524311585|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
145397735|NCT01107925|524311586|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145397736|NCT01107925|524311587|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145397737|NCT01107925|524311588|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145397738|NCT01107925|524311589|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
145397739|NCT01107925|524311590|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
145397740|NCT01107925|524311585|FG000|Period 2|Withdrawal by Subject|0|||
145397741|NCT01107925|524311586|FG001|Period 2|Withdrawal by Subject|1|||
145397742|NCT01107925|524311587|FG002|Period 2|Withdrawal by Subject|0|||
145397743|NCT01107925|524311588|FG003|Period 2|Withdrawal by Subject|0|||
145397744|NCT01107925|524311589|FG004|Period 2|Withdrawal by Subject|0|||
145397745|NCT01107925|524311590|FG005|Period 2|Withdrawal by Subject|1|||
145397746|NCT04877990|524311591|FG000|Treatment|Other reasons|3|||
145397747|NCT04877990|524311592|FG001|Treatment|Other reasons|1|||
145397748|NCT04877990|524311591|FG000|Treatment|Administrative reasons by sponsor|17|||
145397749|NCT04877990|524311592|FG001|Treatment|Administrative reasons by sponsor|33|||
145397750|NCT04877990|524311591|FG000|Treatment|Withdrawal by Subject|2|||
145397751|NCT04877990|524311592|FG001|Treatment|Withdrawal by Subject|6|||
145397752|NCT04877990|524311591|FG000|Treatment|Adverse Event|2|||
145397753|NCT04877990|524311592|FG001|Treatment|Adverse Event|1|||
145397754|NCT01619878|524311593|FG000|6 Week Follow-up Phase|Adverse Event|1|||
145397755|NCT01619878|524311593|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
145397756|NCT01619878|524311593|FG000|Follow-up at 12 Months of Age|Death|2|||
145397757|NCT01305564|524311594|FG000|Overall Study|Death|21|||
145397758|NCT01305564|524311594|FG000|Overall Study|Lost to Follow-up|12|||
145397759|NCT01305564|524311594|FG000|Overall Study|Withdrawal by Subject|1|||
145397760|NCT01305564|524311594|FG000|Overall Study|Physician Decision|3|||
145397761|NCT01949142|524311607|FG000|Overall Study|Withdrawal of consent|1|||
145397762|NCT01949142|524311608|FG001|Overall Study|Withdrawal of consent|0|||
145397763|NCT01949142|524311607|FG000|Overall Study|Lost to Follow-up|1|||
145397764|NCT01949142|524311608|FG001|Overall Study|Lost to Follow-up|1|||
145397765|NCT01949142|524311607|FG000|Overall Study|Parent changed their mind|1|||
145397766|NCT01949142|524311608|FG001|Overall Study|Parent changed their mind|0|||
145397767|NCT00960804|524311609|FG000|Overall Study|Adverse Event|1|||
145397768|NCT00960804|524311610|FG001|Overall Study|Adverse Event|0|||
145397769|NCT00960804|524311611|FG002|Overall Study|Adverse Event|0|||
145397770|NCT00960804|524311609|FG000|Overall Study|Withdrawal by Subject|1|||
145397771|NCT00960804|524311610|FG001|Overall Study|Withdrawal by Subject|0|||
145397772|NCT00960804|524311611|FG002|Overall Study|Withdrawal by Subject|0|||
145397773|NCT00960804|524311609|FG000|Overall Study|Study terminated by the sponsor|5|||
145397774|NCT00960804|524311610|FG001|Overall Study|Study terminated by the sponsor|4|||
145397775|NCT00960804|524311611|FG002|Overall Study|Study terminated by the sponsor|10|||
145397776|NCT02007720|524311612|FG000|Overall Study|Withdrawal by Subject|9|||
145397777|NCT02007720|524311613|FG001|Overall Study|Withdrawal by Subject|11|||
145397778|NCT02007720|524311612|FG000|Overall Study|study terminated by sponsor|58|||
145397779|NCT02007720|524311613|FG001|Overall Study|study terminated by sponsor|54|||
145397780|NCT02007720|524311612|FG000|Overall Study|technical problem|4|||
145500534|NCT03910244|524693933|FG000|Overall Study|Withdrawal by Subject|7|||
145500535|NCT03910244|524693934|FG001|Overall Study|Withdrawal by Subject|2|||
145500536|NCT01213472|524693935|FG000|Overall Study|Recurrence/Progressive disease|25|||
145500537|NCT01213472|524693935|FG000|Overall Study|Withdrawal by Subject|1|||
145500538|NCT01213472|524693935|FG000|Overall Study|Physician Decision|1|||
145500539|NCT03774576|524693938|FG000|Period 2|Adverse Event|1|||
145500540|NCT01746901|524693939|FG000|Naloxone Challenge Phase|Adverse Event|2|||
145500541|NCT01746901|524693940|FG001|Naloxone Challenge Phase|Adverse Event|0|||
145500542|NCT01746901|524693941|FG002|Naloxone Challenge Phase|Adverse Event|0|||
145500543|NCT01746901|524693942|FG003|Naloxone Challenge Phase|Adverse Event|0|||
145500544|NCT01746901|524693943|FG004|Naloxone Challenge Phase|Adverse Event|0|||
145500545|NCT01746901|524693944|FG005|Naloxone Challenge Phase|Adverse Event|0|||
145500546|NCT01746901|524693945|FG006|Naloxone Challenge Phase|Adverse Event|0|||
145500547|NCT01746901|524693946|FG007|Naloxone Challenge Phase|Adverse Event|0|||
145500548|NCT01746901|524693947|FG008|Naloxone Challenge Phase|Adverse Event|0|||
145500549|NCT01746901|524693939|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
145500550|NCT01746901|524693940|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500551|NCT01746901|524693941|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500552|NCT01746901|524693942|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500553|NCT01746901|524693943|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500554|NCT01746901|524693944|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500555|NCT01746901|524693945|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500556|NCT01746901|524693946|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500557|NCT01746901|524693947|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
145500558|NCT01746901|524693939|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500559|NCT01746901|524693940|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
145500560|NCT01746901|524693941|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500561|NCT01746901|524693942|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145397781|NCT02007720|524311613|FG001|Overall Study|technical problem|2|||
145397782|NCT02007720|524311612|FG000|Overall Study|patient followd less than 165 days|11|||
145397783|NCT02007720|524311613|FG001|Overall Study|patient followd less than 165 days|5|||
145397784|NCT01573000|524313314|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
145397785|NCT01573000|524313315|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
145397786|NCT01573000|524313314|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
145397787|NCT01573000|524313315|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
145397788|NCT01573000|524313314|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
145397789|NCT01573000|524313315|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
145397790|NCT01573000|524313314|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
145397791|NCT01573000|524313315|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
145397792|NCT01573000|524313314|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
145397793|NCT01573000|524313315|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
145397794|NCT01573000|524313314|FG000|Crossover Phase|Lack of Efficacy|0|||
145397795|NCT01573000|524313315|FG001|Crossover Phase|Lack of Efficacy|13|||
145397796|NCT01573000|524313314|FG000|Crossover Phase|Lost to Follow-up|0|||
145397797|NCT01573000|524313315|FG001|Crossover Phase|Lost to Follow-up|2|||
145397798|NCT01573000|524313314|FG000|Crossover Phase|Death|0|||
145397799|NCT01573000|524313315|FG001|Crossover Phase|Death|3|||
145397800|NCT01573000|524313314|FG000|Long-Term Follow-Up|Death|3|||
145397801|NCT01573000|524313315|FG001|Long-Term Follow-Up|Death|0|||
145397802|NCT01573000|524313314|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
145397803|NCT01573000|524313315|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
145397804|NCT01100853|524313319|FG000|Overall Study|Lost to Follow-up|11|||
145397805|NCT01100853|524313320|FG001|Overall Study|Lost to Follow-up|6|||
145397806|NCT01100853|524313319|FG000|Overall Study|Received <4 study injections|10|||
145397807|NCT01100853|524313320|FG001|Overall Study|Received <4 study injections|13|||
145397808|NCT01100853|524313319|FG000|Overall Study|Withdrawal by Subject|6|||
145397809|NCT01100853|524313320|FG001|Overall Study|Withdrawal by Subject|4|||
145397810|NCT01384877|524313321|FG000|Treatment 2|Lost to Follow-up|2|||
145397811|NCT01384877|524313322|FG001|Treatment 2|Lost to Follow-up|2|||
145397812|NCT04161391|524313323|FG000|Overall Study|Adverse Event|0|||
145397813|NCT04161391|524313324|FG001|Overall Study|Adverse Event|1|||
145397814|NCT04161391|524313325|FG002|Overall Study|Adverse Event|0|||
145397815|NCT04161391|524313326|FG003|Overall Study|Adverse Event|1|||
145397816|NCT04161391|524313327|FG004|Overall Study|Adverse Event|0|||
145397817|NCT04161391|524313328|FG005|Overall Study|Adverse Event|0|||
145397818|NCT04161391|524313329|FG006|Overall Study|Adverse Event|0|||
145397819|NCT04161391|524313330|FG007|Overall Study|Adverse Event|3|||
145397820|NCT04161391|524313331|FG008|Overall Study|Adverse Event|0|||
145397821|NCT04161391|524313323|FG000|Overall Study|Death|0|||
145397822|NCT04161391|524313324|FG001|Overall Study|Death|0|||
145397823|NCT04161391|524313325|FG002|Overall Study|Death|0|||
145397824|NCT04161391|524313326|FG003|Overall Study|Death|0|||
145397825|NCT04161391|524313327|FG004|Overall Study|Death|0|||
145397826|NCT04161391|524313328|FG005|Overall Study|Death|0|||
145397827|NCT04161391|524313329|FG006|Overall Study|Death|0|||
145397828|NCT04161391|524313330|FG007|Overall Study|Death|1|||
145397829|NCT04161391|524313331|FG008|Overall Study|Death|0|||
145397830|NCT04161391|524313323|FG000|Overall Study|Physician Decision|0|||
145397831|NCT04161391|524313324|FG001|Overall Study|Physician Decision|0|||
145397832|NCT04161391|524313325|FG002|Overall Study|Physician Decision|1|||
145397833|NCT04161391|524313326|FG003|Overall Study|Physician Decision|2|||
145397834|NCT04161391|524313327|FG004|Overall Study|Physician Decision|0|||
145397835|NCT04161391|524313328|FG005|Overall Study|Physician Decision|0|||
145397836|NCT04161391|524313329|FG006|Overall Study|Physician Decision|2|||
145397837|NCT04161391|524313330|FG007|Overall Study|Physician Decision|0|||
145397838|NCT04161391|524313331|FG008|Overall Study|Physician Decision|0|||
145397839|NCT04161391|524313323|FG000|Overall Study|Progressive Disease|4|||
145397840|NCT04161391|524313324|FG001|Overall Study|Progressive Disease|3|||
145397841|NCT04161391|524313325|FG002|Overall Study|Progressive Disease|3|||
145397842|NCT04161391|524313326|FG003|Overall Study|Progressive Disease|5|||
145397843|NCT04161391|524313327|FG004|Overall Study|Progressive Disease|3|||
145397844|NCT04161391|524313328|FG005|Overall Study|Progressive Disease|3|||
145397845|NCT04161391|524313329|FG006|Overall Study|Progressive Disease|5|||
145397846|NCT04161391|524313330|FG007|Overall Study|Progressive Disease|2|||
145397847|NCT04161391|524313331|FG008|Overall Study|Progressive Disease|2|||
145397848|NCT01162343|524313334|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
145397849|NCT01162343|524313334|FG000|Overall Study|Refused psychiatrist assessment|12|||
145397850|NCT00641056|524313335|FG000|Overall Study|Adverse Event|12|||
145397851|NCT00641056|524313336|FG001|Overall Study|Adverse Event|2|||
145397852|NCT00641056|524313335|FG000|Overall Study|Lost to Follow-up|2|||
145397853|NCT00641056|524313336|FG001|Overall Study|Lost to Follow-up|1|||
145397854|NCT00641056|524313335|FG000|Overall Study|Physician Decision|3|||
145397855|NCT00641056|524313336|FG001|Overall Study|Physician Decision|1|||
145500562|NCT01746901|524693943|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500563|NCT01746901|524693944|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500564|NCT01746901|524693945|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500565|NCT01746901|524693946|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500566|NCT01746901|524693947|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145500567|NCT01746901|524693939|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500568|NCT01746901|524693940|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
145500569|NCT01746901|524693941|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
145500570|NCT01746901|524693942|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500571|NCT01746901|524693943|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500572|NCT01746901|524693944|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500573|NCT01746901|524693945|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500574|NCT01746901|524693946|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500575|NCT01746901|524693947|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
145500576|NCT01746901|524693939|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500577|NCT01746901|524693940|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
145500578|NCT01746901|524693941|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
145500579|NCT01746901|524693942|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500580|NCT01746901|524693943|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500581|NCT01746901|524693944|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500582|NCT01746901|524693945|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500583|NCT01746901|524693946|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500584|NCT01746901|524693947|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
145500585|NCT01746901|524693939|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500586|NCT01746901|524693940|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
145500587|NCT01746901|524693941|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
145500588|NCT01746901|524693942|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500589|NCT01746901|524693943|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500590|NCT01746901|524693944|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500591|NCT01746901|524693945|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500592|NCT01746901|524693946|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500593|NCT01746901|524693947|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145500594|NCT01746901|524693939|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
145500595|NCT01746901|524693940|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
145500596|NCT01746901|524693941|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
145500597|NCT01746901|524693942|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
145500598|NCT01746901|524693943|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
145500599|NCT01746901|524693944|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
145500600|NCT01746901|524693945|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
145500601|NCT01746901|524693946|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
145500602|NCT01746901|524693947|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
145500603|NCT01746901|524693939|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500604|NCT01746901|524693940|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500605|NCT01746901|524693941|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500606|NCT01746901|524693942|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500607|NCT01746901|524693943|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500608|NCT01746901|524693944|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500609|NCT01746901|524693945|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500610|NCT01746901|524693946|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
145500611|NCT01746901|524693947|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
145500612|NCT01746901|524693939|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500613|NCT01746901|524693940|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500614|NCT01746901|524693941|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500615|NCT01746901|524693942|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500616|NCT01746901|524693943|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500617|NCT01746901|524693944|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
145500618|NCT01746901|524693945|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
145500619|NCT01746901|524693946|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500620|NCT01746901|524693947|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
145500621|NCT01746901|524693939|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500622|NCT01746901|524693940|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500623|NCT01746901|524693941|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500624|NCT01746901|524693942|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
145500625|NCT01746901|524693943|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145605975|NCT01473381|525073071|FG000|Overall Study|Insufficient Therapeutic Response|10|||
145500626|NCT01746901|524693944|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500627|NCT01746901|524693945|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500628|NCT01746901|524693946|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500629|NCT01746901|524693947|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
145500630|NCT01746901|524693939|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500631|NCT01746901|524693940|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500632|NCT01746901|524693941|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500633|NCT01746901|524693942|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500634|NCT01746901|524693943|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500635|NCT01746901|524693944|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
145500636|NCT01746901|524693945|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500637|NCT01746901|524693946|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
145500638|NCT01746901|524693947|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
145500639|NCT01746901|524693939|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500640|NCT01746901|524693940|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500641|NCT01746901|524693941|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500642|NCT01746901|524693942|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500643|NCT01746901|524693943|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500644|NCT01746901|524693944|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500645|NCT01746901|524693945|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
145500646|NCT01746901|524693946|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
145500647|NCT01746901|524693947|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
145500648|NCT03594110|524693951|FG000|Interventional Part|Participant concerned about study treatment|23|||
145500649|NCT03594110|524693952|FG001|Interventional Part|Participant concerned about study treatment|28|||
145500650|NCT03594110|524693951|FG000|Interventional Part|Doctor advice|38|||
145500651|NCT03594110|524693952|FG001|Interventional Part|Doctor advice|40|||
145500652|NCT03594110|524693951|FG000|Interventional Part|Participants' wish|89|||
145500653|NCT03594110|524693952|FG001|Interventional Part|Participants' wish|68|||
145500654|NCT03594110|524693951|FG000|Interventional Part|Adverse event-non-fatal events|119|||
145500655|NCT03594110|524693952|FG001|Interventional Part|Adverse event-non-fatal events|116|||
145500656|NCT03594110|524693951|FG000|Interventional Part|Study drug stopped, reason missing|336|||
145500657|NCT03594110|524693952|FG001|Interventional Part|Study drug stopped, reason missing|294|||
145500658|NCT03594110|524693951|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
145500659|NCT03594110|524693952|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
145500660|NCT03594110|524693951|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
145500661|NCT03594110|524693952|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
145500662|NCT03594110|524693951|FG000|Interventional Part|Contraindicated drug started|32|||
145500663|NCT03594110|524693952|FG001|Interventional Part|Contraindicated drug started|18|||
145500664|NCT03594110|524693951|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
145500665|NCT03594110|524693952|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
145500666|NCT03594110|524693951|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
145500667|NCT03594110|524693952|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
145500668|NCT03594110|524693951|FG000|Non-interventional Part|Withdrawal by Subject|3|||
145500669|NCT03594110|524693952|FG001|Non-interventional Part|Withdrawal by Subject|4|||
145500670|NCT03594110|524693951|FG000|Non-interventional Part|Lost to Follow-up|45|||
145397856|NCT00641056|524313335|FG000|Overall Study|Protocol Violation|2|||
145397857|NCT00641056|524313336|FG001|Overall Study|Protocol Violation|0|||
145397858|NCT00641056|524313335|FG000|Overall Study|Entry Criteria Not Met|3|||
145397859|NCT00641056|524313336|FG001|Overall Study|Entry Criteria Not Met|0|||
145397860|NCT00641056|524313335|FG000|Overall Study|Subject Decision|6|||
145397861|NCT00641056|524313336|FG001|Overall Study|Subject Decision|19|||
145397862|NCT00641056|524313335|FG000|Overall Study|Sponsor Decision|1|||
145397863|NCT00641056|524313336|FG001|Overall Study|Sponsor Decision|2|||
145397864|NCT00896493|524313339|FG000|Overall Study|Early disease relapse|3|||
145397865|NCT02026141|524313342|FG000|Overall Study|Protocol Violation|0|||
145397866|NCT02026141|524313343|FG001|Overall Study|Protocol Violation|1|||
145397867|NCT03074695|524313346|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
145397868|NCT03074695|524313347|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
145397869|NCT03074695|524313346|FG000|Overall Study|Research staff not available|1|||
145397870|NCT03074695|524313347|FG001|Overall Study|Research staff not available|2|||
145397871|NCT03074695|524313346|FG000|Overall Study|Did not receive neuraxial block|2|||
145397872|NCT03074695|524313347|FG001|Overall Study|Did not receive neuraxial block|2|||
145397873|NCT01774981|524313348|FG000|Overall Study|Adverse Event|0|||
145397874|NCT01774981|524313349|FG001|Overall Study|Adverse Event|0|||
145397875|NCT01774981|524313350|FG002|Overall Study|Adverse Event|0|||
145397876|NCT01774981|524313351|FG003|Overall Study|Adverse Event|0|||
145500671|NCT03594110|524693952|FG001|Non-interventional Part|Lost to Follow-up|41|||
145500672|NCT02085460|524693954|FG000|Overall Study|Adverse Event|2|||
145500673|NCT02085460|524693955|FG001|Overall Study|Adverse Event|2|||
145500674|NCT02085460|524693956|FG002|Overall Study|Adverse Event|1|||
145500675|NCT02085460|524693954|FG000|Overall Study|Physician Decision|1|||
145500676|NCT02085460|524693955|FG001|Overall Study|Physician Decision|1|||
145500677|NCT02085460|524693956|FG002|Overall Study|Physician Decision|2|||
145500678|NCT02085460|524693954|FG000|Overall Study|Withdrawal by Subject|11|||
145500679|NCT02085460|524693955|FG001|Overall Study|Withdrawal by Subject|5|||
145500680|NCT02085460|524693956|FG002|Overall Study|Withdrawal by Subject|7|||
145500681|NCT00763035|524693957|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
145500682|NCT00763035|524693958|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
145500683|NCT00763035|524693957|FG000|First Intervention|Adverse Event|0|||
145500684|NCT00763035|524693958|FG001|First Intervention|Adverse Event|1|||
145500685|NCT00763035|524693957|FG000|Second Intervention|Adverse Event|1|||
145500686|NCT00763035|524693958|FG001|Second Intervention|Adverse Event|0|||
145500687|NCT00763035|524693957|FG000|Second Intervention|Physician Decision|2|||
145500688|NCT00763035|524693958|FG001|Second Intervention|Physician Decision|0|||
145500689|NCT00907335|524693961|FG000|Overall Study|Withdrawal by Subject|2|||
145500690|NCT00907335|524693962|FG001|Overall Study|Withdrawal by Subject|0|||
145500691|NCT00907335|524693961|FG000|Overall Study|Adverse Event|4|||
145500692|NCT00907335|524693962|FG001|Overall Study|Adverse Event|1|||
145500693|NCT00907335|524693961|FG000|Overall Study|Lost to Follow-up|2|||
145500694|NCT00907335|524693962|FG001|Overall Study|Lost to Follow-up|0|||
145500695|NCT00930046|524693963|FG000|Overall Study|Wound catheter malfunctioned|1|||
145500696|NCT00930046|524693964|FG001|Overall Study|Wound catheter malfunctioned|2|||
145500697|NCT01967940|524693966|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
145500698|NCT01967940|524693967|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
145500699|NCT01967940|524693968|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
145500700|NCT01967940|524693969|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
145500701|NCT01967940|524693966|FG000|Part 2|Adverse Event|0|||
145500702|NCT01967940|524693967|FG001|Part 2|Adverse Event|0|||
145500703|NCT01967940|524693968|FG002|Part 2|Adverse Event|0|||
145500704|NCT01967940|524693969|FG003|Part 2|Adverse Event|1|||
145500705|NCT01967940|524693966|FG000|Part 2|Unknown Reason|0|||
145500706|NCT01967940|524693967|FG001|Part 2|Unknown Reason|0|||
145500707|NCT01967940|524693968|FG002|Part 2|Unknown Reason|0|||
145500708|NCT01967940|524693969|FG003|Part 2|Unknown Reason|1|||
145500709|NCT00361296|524693975|FG000|Overall Study|Physician Decision|1|||
145500710|NCT00361296|524693975|FG000|Overall Study|Lack of Efficacy|2|||
145500711|NCT00904982|524693977|FG000|Overall Study|Withdrawal by Subject|2|||
145500712|NCT00904982|524693978|FG001|Overall Study|Withdrawal by Subject|0|||
145500713|NCT00904982|524693979|FG002|Overall Study|Withdrawal by Subject|0|||
145500714|NCT00904982|524693980|FG003|Overall Study|Withdrawal by Subject|0|||
145500715|NCT02072668|524693985|FG000|Second Intervention|Lost to Follow-up|1|||
145500716|NCT02072668|524693986|FG001|Second Intervention|Lost to Follow-up|0|||
145500717|NCT02420821|524693991|FG000|Overall Study|Lost to Follow-up|6|||
145500718|NCT02420821|524693992|FG001|Overall Study|Lost to Follow-up|6|||
145500719|NCT02420821|524693991|FG000|Overall Study|Non-compliance|0|||
145500720|NCT02420821|524693992|FG001|Overall Study|Non-compliance|2|||
145500721|NCT02420821|524693991|FG000|Overall Study|Physician Decision|6|||
145500722|NCT02420821|524693992|FG001|Overall Study|Physician Decision|2|||
145500723|NCT02420821|524693991|FG000|Overall Study|Withdrawal by Subject|32|||
145500724|NCT02420821|524693992|FG001|Overall Study|Withdrawal by Subject|25|||
145500725|NCT02420821|524693991|FG000|Overall Study|Death|270|||
145500726|NCT02420821|524693992|FG001|Overall Study|Death|263|||
145732835|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
145732836|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
145500727|NCT02420821|524693991|FG000|Overall Study|Study Terminated By Sponsor|145|||
145500728|NCT02420821|524693992|FG001|Overall Study|Study Terminated By Sponsor|149|||
145500729|NCT02420821|524693991|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
145500730|NCT02420821|524693992|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
145266683|NCT04668066|523825255|FG018|Part 1: Follow-Up|Adverse Event|0|||
145500731|NCT02420821|524693991|FG000|Overall Study|Adverse Event|0|||
145500732|NCT02420821|524693992|FG001|Overall Study|Adverse Event|1|||
145500733|NCT02420821|524693991|FG000|Overall Study|Protinuria|0|||
145500734|NCT02420821|524693992|FG001|Overall Study|Protinuria|1|||
145500735|NCT02420821|524693991|FG000|Overall Study|Progressive Disease|1|||
145500736|NCT02420821|524693992|FG001|Overall Study|Progressive Disease|1|||
145500737|NCT02420821|524693991|FG000|Overall Study|Disease Progression|0|||
145500738|NCT02420821|524693992|FG001|Overall Study|Disease Progression|1|||
145500739|NCT02420821|524693991|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
145732837|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
145397877|NCT01774981|524313352|FG004|Overall Study|Adverse Event|0|||
145397878|NCT01774981|524313353|FG005|Overall Study|Adverse Event|1|||
145397879|NCT01774981|524313354|FG006|Overall Study|Adverse Event|0|||
145397880|NCT01774981|524313355|FG007|Overall Study|Adverse Event|0|||
145397881|NCT01774981|524313348|FG000|Overall Study|Withdrawal by Subject|0|||
145397882|NCT01774981|524313349|FG001|Overall Study|Withdrawal by Subject|0|||
145397883|NCT01774981|524313350|FG002|Overall Study|Withdrawal by Subject|0|||
145397884|NCT01774981|524313351|FG003|Overall Study|Withdrawal by Subject|0|||
145397885|NCT01774981|524313352|FG004|Overall Study|Withdrawal by Subject|0|||
145397886|NCT01774981|524313353|FG005|Overall Study|Withdrawal by Subject|0|||
145397887|NCT01774981|524313354|FG006|Overall Study|Withdrawal by Subject|0|||
145397888|NCT01774981|524313355|FG007|Overall Study|Withdrawal by Subject|1|||
145397889|NCT01774981|524313348|FG000|Overall Study|Death|0|||
145397890|NCT01774981|524313349|FG001|Overall Study|Death|0|||
145397891|NCT01774981|524313350|FG002|Overall Study|Death|0|||
145397892|NCT01774981|524313351|FG003|Overall Study|Death|0|||
145397893|NCT01774981|524313352|FG004|Overall Study|Death|1|||
145397894|NCT01774981|524313353|FG005|Overall Study|Death|0|||
145397895|NCT01774981|524313354|FG006|Overall Study|Death|0|||
145397896|NCT01774981|524313355|FG007|Overall Study|Death|0|||
145397897|NCT00902577|524313360|FG000|Overall Study|Withdrawal by Subject|6|||
145397898|NCT00902577|524313360|FG000|Overall Study|FMISO production failure|2|||
145397899|NCT01232790|524313363|FG000|Randomization|Withdrawal by Subject|2|||
145397900|NCT01232790|524313364|FG001|Randomization|Withdrawal by Subject|0|||
145397901|NCT01232790|524313363|FG000|Randomization|Protocol Violation|0|||
145397902|NCT01232790|524313364|FG001|Randomization|Protocol Violation|1|||
145397903|NCT01232790|524313363|FG000|Randomization|Physician Decision|0|||
145397904|NCT01232790|524313364|FG001|Randomization|Physician Decision|1|||
145397905|NCT01232790|524313363|FG000|Initial Assessment|Withdrawal by Subject|0|||
145397906|NCT01232790|524313364|FG001|Initial Assessment|Withdrawal by Subject|1|||
145397907|NCT01232790|524313363|FG000|First Crossover|Withdrawal by Subject|1|||
145397908|NCT01232790|524313364|FG001|First Crossover|Withdrawal by Subject|0|||
145397909|NCT01232790|524313363|FG000|Second Crossover|Withdrawal by Subject|1|||
145397910|NCT01232790|524313364|FG001|Second Crossover|Withdrawal by Subject|2|||
145397911|NCT03322293|524313365|FG000|Overall Study|Lost to Follow-up|0|||
145397912|NCT03322293|524313366|FG001|Overall Study|Lost to Follow-up|0|||
145397913|NCT03322293|524313367|FG002|Overall Study|Lost to Follow-up|1|||
145397914|NCT00083915|524313368|FG000|Overall Study|Death|6|||
145397915|NCT00083915|524313369|FG001|Overall Study|Death|3|||
145397916|NCT00083915|524313368|FG000|Overall Study|Physician Decision|11|||
145397917|NCT00083915|524313369|FG001|Overall Study|Physician Decision|6|||
145397918|NCT00083915|524313368|FG000|Overall Study|Withdrawal by Subject|8|||
145397919|NCT00083915|524313369|FG001|Overall Study|Withdrawal by Subject|3|||
145397920|NCT00083915|524313368|FG000|Overall Study|disease progression|18|||
145397921|NCT00083915|524313369|FG001|Overall Study|disease progression|23|||
145397922|NCT00083915|524313368|FG000|Overall Study|Failure to collect|3|||
145397923|NCT00083915|524313369|FG001|Overall Study|Failure to collect|0|||
145397924|NCT00083915|524313368|FG000|Overall Study|No response|3|||
145397925|NCT00083915|524313369|FG001|Overall Study|No response|1|||
145397926|NCT00083915|524313368|FG000|Overall Study|Insurance issues|1|||
145397927|NCT00083915|524313369|FG001|Overall Study|Insurance issues|1|||
145397928|NCT01239797|524313370|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
145397929|NCT01239797|524313371|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
145397930|NCT01239797|524313370|FG000|Randomized Participants|Participant withdrew consent|1|||
145397931|NCT01239797|524313371|FG001|Randomized Participants|Participant withdrew consent|7|||
145397932|NCT01239797|524313370|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
145397933|NCT01239797|524313371|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
145397934|NCT01239797|524313370|FG000|Treated Participants|Disease progression|185|||
145500740|NCT02420821|524693992|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
145500741|NCT01658436|524693993|FG000|Overall Study|Adverse Event|6|||
145500742|NCT01658436|524693994|FG001|Overall Study|Adverse Event|5|||
145500743|NCT01658436|524693993|FG000|Overall Study|Physician Decision|1|||
145500744|NCT01658436|524693994|FG001|Overall Study|Physician Decision|0|||
145500745|NCT01658436|524693993|FG000|Overall Study|Progressive disease|12|||
145500746|NCT01658436|524693994|FG001|Overall Study|Progressive disease|4|||
145500747|NCT01658436|524693993|FG000|Overall Study|Study terminated by sponsor|0|||
145500748|NCT01658436|524693994|FG001|Overall Study|Study terminated by sponsor|1|||
145500749|NCT01658436|524693993|FG000|Overall Study|Subject/guardian decision|0|||
145500750|NCT01658436|524693994|FG001|Overall Study|Subject/guardian decision|1|||
145500751|NCT01658436|524693993|FG000|Overall Study|Death|1|||
145500752|NCT01658436|524693994|FG001|Overall Study|Death|0|||
145500753|NCT00686712|524693995|FG000|Overall Study|Protocol Violation|8|||
145500754|NCT00686712|524693996|FG001|Overall Study|Protocol Violation|8|||
145500755|NCT00686712|524693997|FG002|Overall Study|Protocol Violation|10|||
145500756|NCT00686712|524693995|FG000|Overall Study|Lost to Follow-up|1|||
145500757|NCT00686712|524693996|FG001|Overall Study|Lost to Follow-up|2|||
145500758|NCT00686712|524693997|FG002|Overall Study|Lost to Follow-up|3|||
145500759|NCT00686712|524693995|FG000|Overall Study|Adverse Event|1|||
145500760|NCT00686712|524693996|FG001|Overall Study|Adverse Event|1|||
145500761|NCT00686712|524693997|FG002|Overall Study|Adverse Event|0|||
145500762|NCT01318915|524694000|FG000|Overall Study|Lost to Follow-up|1|||
145500763|NCT00926237|524694001|FG000|Overall Study|Withdrawal by Subject|2|||
145500764|NCT00926237|524694002|FG001|Overall Study|Withdrawal by Subject|1|||
145500765|NCT04119414|524694003|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
145500766|NCT04322526|524694005|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
145500767|NCT04322526|524694006|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
145500768|NCT04322526|524694005|FG000|Washout (1 Week)|Lost to Follow-up|1|||
145500769|NCT04322526|524694006|FG001|Washout (1 Week)|Lost to Follow-up|2|||
145500770|NCT01716234|524694007|FG000|Overall Study|Protocol Violation|0|||
145500771|NCT01716234|524694008|FG001|Overall Study|Protocol Violation|0|||
145500772|NCT01716234|524694009|FG002|Overall Study|Protocol Violation|0|||
145500773|NCT01716234|524694010|FG003|Overall Study|Protocol Violation|1|||
145500774|NCT01716234|524694011|FG004|Overall Study|Protocol Violation|1|||
145500775|NCT01716234|524694012|FG005|Overall Study|Protocol Violation|1|||
145500776|NCT01716234|524694013|FG006|Overall Study|Protocol Violation|0|||
145500777|NCT01716234|524694007|FG000|Overall Study|Lack of Efficacy|0|||
145500778|NCT01716234|524694008|FG001|Overall Study|Lack of Efficacy|0|||
145500779|NCT01716234|524694009|FG002|Overall Study|Lack of Efficacy|0|||
145500780|NCT01716234|524694010|FG003|Overall Study|Lack of Efficacy|1|||
145500781|NCT01716234|524694011|FG004|Overall Study|Lack of Efficacy|0|||
145500782|NCT01716234|524694012|FG005|Overall Study|Lack of Efficacy|0|||
145500783|NCT01716234|524694013|FG006|Overall Study|Lack of Efficacy|0|||
145500784|NCT01716234|524694007|FG000|Overall Study|Did not meet protocol eligibility|0|||
145500785|NCT01716234|524694008|FG001|Overall Study|Did not meet protocol eligibility|0|||
145500786|NCT01716234|524694009|FG002|Overall Study|Did not meet protocol eligibility|1|||
145500787|NCT01716234|524694010|FG003|Overall Study|Did not meet protocol eligibility|0|||
145500788|NCT01716234|524694011|FG004|Overall Study|Did not meet protocol eligibility|0|||
145500789|NCT01716234|524694012|FG005|Overall Study|Did not meet protocol eligibility|4|||
145500790|NCT01716234|524694013|FG006|Overall Study|Did not meet protocol eligibility|0|||
145500791|NCT01716234|524694007|FG000|Overall Study|Adverse Event|7|||
145500792|NCT01716234|524694008|FG001|Overall Study|Adverse Event|10|||
145500793|NCT01716234|524694009|FG002|Overall Study|Adverse Event|2|||
145500794|NCT01716234|524694010|FG003|Overall Study|Adverse Event|8|||
145500795|NCT01716234|524694011|FG004|Overall Study|Adverse Event|3|||
145500796|NCT01716234|524694012|FG005|Overall Study|Adverse Event|6|||
145500797|NCT01716234|524694013|FG006|Overall Study|Adverse Event|0|||
145500798|NCT01716234|524694007|FG000|Overall Study|Withdrawal by Subject|3|||
145500799|NCT01716234|524694008|FG001|Overall Study|Withdrawal by Subject|0|||
145500800|NCT01716234|524694009|FG002|Overall Study|Withdrawal by Subject|2|||
145500801|NCT01716234|524694010|FG003|Overall Study|Withdrawal by Subject|2|||
145500802|NCT01716234|524694011|FG004|Overall Study|Withdrawal by Subject|1|||
145500803|NCT01716234|524694012|FG005|Overall Study|Withdrawal by Subject|3|||
145500804|NCT01716234|524694013|FG006|Overall Study|Withdrawal by Subject|0|||
145500805|NCT01523756|524694014|FG000|Baseline Period|Adverse Event|0|||
145500806|NCT01523756|524694015|FG001|Baseline Period|Adverse Event|1|||
145500807|NCT01523756|524694014|FG000|Test Period 1|Adverse Event|1|||
145500808|NCT01523756|524694015|FG001|Test Period 1|Adverse Event|0|||
145500809|NCT01523756|524694014|FG000|Test Period 2|Withdrawal by Subject|0|||
145500810|NCT01523756|524694015|FG001|Test Period 2|Withdrawal by Subject|1|||
145500811|NCT00474812|524694019|FG000|Overall Study|Withdrawal by Subject|5|||
145500812|NCT00474812|524694019|FG000|Overall Study|No Initiation of treatment|2|||
145500813|NCT05408429|524694024|FG000|Overall Study|Lost to Follow-up|1|||
145500814|NCT05408429|524694025|FG001|Overall Study|Lost to Follow-up|1|||
145500815|NCT05408429|524694026|FG002|Overall Study|Lost to Follow-up|0|||
145500816|NCT05408429|524694024|FG000|Overall Study|Withdrawal by Subject|5|||
145500817|NCT05408429|524694025|FG001|Overall Study|Withdrawal by Subject|0|||
145500818|NCT05408429|524694026|FG002|Overall Study|Withdrawal by Subject|1|||
145500819|NCT03435211|524694027|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
145500820|NCT02195518|524694028|FG000|Overall Study|Adverse Event|1|||
145500821|NCT02195518|524694028|FG000|Overall Study|Protocol Violation|4|||
145500822|NCT02195518|524694028|FG000|Overall Study|Pregnancy|2|||
145500823|NCT02195518|524694028|FG000|Overall Study|Withdrawal by Subject|1|||
145500824|NCT02195518|524694028|FG000|Overall Study|Lost to Follow-up|1|||
145500825|NCT03818256|524694029|FG000|Overall Study|Withdrawal by Subject|2|||
145500826|NCT03818256|524694030|FG001|Overall Study|Withdrawal by Subject|2|||
145500827|NCT03818256|524694029|FG000|Overall Study|Adverse Event|3|||
145500828|NCT03818256|524694030|FG001|Overall Study|Adverse Event|1|||
145500829|NCT03818256|524694029|FG000|Overall Study|Lost to Follow-up|0|||
145500830|NCT03818256|524694030|FG001|Overall Study|Lost to Follow-up|5|||
145500831|NCT03818256|524694029|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
145732838|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
145732839|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
145500832|NCT03818256|524694030|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
145500833|NCT03818256|524694029|FG000|Overall Study|Not reporting for scheduled visits|1|||
145500834|NCT03818256|524694030|FG001|Overall Study|Not reporting for scheduled visits|0|||
145500835|NCT03818256|524694029|FG000|Overall Study|Non-compliant with investigational product|1|||
145500836|NCT03818256|524694030|FG001|Overall Study|Non-compliant with investigational product|0|||
145500837|NCT01342211|524694031|FG000|Overall Study|Lost to Follow-up|0|||
145500838|NCT01342211|524694032|FG001|Overall Study|Lost to Follow-up|0|||
145500839|NCT01342211|524694033|FG002|Overall Study|Lost to Follow-up|0|||
145500840|NCT01342211|524694034|FG003|Overall Study|Lost to Follow-up|1|||
145500841|NCT01342211|524694035|FG004|Overall Study|Lost to Follow-up|0|||
145500842|NCT01342211|524694031|FG000|Overall Study|Adverse Event|0|||
145500843|NCT01342211|524694032|FG001|Overall Study|Adverse Event|0|||
145500844|NCT01342211|524694033|FG002|Overall Study|Adverse Event|0|||
145500845|NCT01342211|524694034|FG003|Overall Study|Adverse Event|0|||
145500846|NCT01342211|524694035|FG004|Overall Study|Adverse Event|1|||
145500847|NCT01342211|524694031|FG000|Overall Study|Withdrawal by Subject|0|||
145500848|NCT01342211|524694032|FG001|Overall Study|Withdrawal by Subject|0|||
145500849|NCT01342211|524694033|FG002|Overall Study|Withdrawal by Subject|0|||
145500850|NCT01342211|524694034|FG003|Overall Study|Withdrawal by Subject|1|||
145500851|NCT01342211|524694035|FG004|Overall Study|Withdrawal by Subject|0|||
145500852|NCT01342211|524694031|FG000|Overall Study|Randomized, but not Treated|0|||
145500853|NCT01342211|524694032|FG001|Overall Study|Randomized, but not Treated|2|||
145500854|NCT01342211|524694033|FG002|Overall Study|Randomized, but not Treated|0|||
145500855|NCT01342211|524694034|FG003|Overall Study|Randomized, but not Treated|0|||
145500856|NCT01342211|524694035|FG004|Overall Study|Randomized, but not Treated|1|||
145500857|NCT01588522|524694038|FG000|Overall Study|Withdrawal by Subject|1|||
145500858|NCT01588522|524694039|FG001|Overall Study|Withdrawal by Subject|5|||
145500859|NCT01588522|524694040|FG002|Overall Study|Withdrawal by Subject|3|||
145500860|NCT01588522|524694041|FG003|Overall Study|Withdrawal by Subject|1|||
145500861|NCT01588522|524694042|FG004|Overall Study|Withdrawal by Subject|2|||
145500862|NCT01588522|524694043|FG005|Overall Study|Withdrawal by Subject|0|||
145500863|NCT01588522|524694038|FG000|Overall Study|Lack of Efficacy|0|||
145500864|NCT01588522|524694039|FG001|Overall Study|Lack of Efficacy|0|||
145500865|NCT01588522|524694040|FG002|Overall Study|Lack of Efficacy|0|||
145500866|NCT01588522|524694041|FG003|Overall Study|Lack of Efficacy|0|||
145500867|NCT01588522|524694042|FG004|Overall Study|Lack of Efficacy|1|||
145500868|NCT01588522|524694043|FG005|Overall Study|Lack of Efficacy|0|||
145500869|NCT01588522|524694038|FG000|Overall Study|Adverse Event|0|||
145500870|NCT01588522|524694039|FG001|Overall Study|Adverse Event|0|||
145500871|NCT01588522|524694040|FG002|Overall Study|Adverse Event|0|||
145500872|NCT01588522|524694041|FG003|Overall Study|Adverse Event|1|||
145500873|NCT01588522|524694042|FG004|Overall Study|Adverse Event|0|||
145500874|NCT01588522|524694043|FG005|Overall Study|Adverse Event|0|||
145500875|NCT01588522|524694038|FG000|Overall Study|Grade 2 alopecia|1|||
145500876|NCT01588522|524694039|FG001|Overall Study|Grade 2 alopecia|0|||
145500877|NCT01588522|524694040|FG002|Overall Study|Grade 2 alopecia|0|||
145500878|NCT01588522|524694041|FG003|Overall Study|Grade 2 alopecia|0|||
145500879|NCT01588522|524694042|FG004|Overall Study|Grade 2 alopecia|0|||
145500880|NCT01588522|524694043|FG005|Overall Study|Grade 2 alopecia|0|||
145500881|NCT01588522|524694038|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
145500882|NCT01588522|524694039|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
145500883|NCT01588522|524694040|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
145500884|NCT01588522|524694041|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
145500885|NCT01588522|524694042|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
145500886|NCT01588522|524694043|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
145500887|NCT01588522|524694038|FG000|Overall Study|Taken off taxane-based regimen|0|||
145500888|NCT01588522|524694039|FG001|Overall Study|Taken off taxane-based regimen|0|||
145500889|NCT01588522|524694040|FG002|Overall Study|Taken off taxane-based regimen|0|||
145500890|NCT01588522|524694041|FG003|Overall Study|Taken off taxane-based regimen|1|||
145500891|NCT01588522|524694042|FG004|Overall Study|Taken off taxane-based regimen|0|||
145500892|NCT01588522|524694043|FG005|Overall Study|Taken off taxane-based regimen|0|||
145500893|NCT01588522|524694038|FG000|Overall Study|Did not initiate chemotherapy|0|||
145500894|NCT01588522|524694039|FG001|Overall Study|Did not initiate chemotherapy|0|||
145500895|NCT01588522|524694040|FG002|Overall Study|Did not initiate chemotherapy|0|||
145500896|NCT01588522|524694041|FG003|Overall Study|Did not initiate chemotherapy|0|||
145500897|NCT01588522|524694042|FG004|Overall Study|Did not initiate chemotherapy|1|||
145500898|NCT01588522|524694043|FG005|Overall Study|Did not initiate chemotherapy|0|||
145500899|NCT02749422|524694048|FG000|Overall Study|Lost to Follow-up|0|||
145500900|NCT02749422|524694049|FG001|Overall Study|Lost to Follow-up|2|||
145500901|NCT02749422|524694048|FG000|Overall Study|Ineligible|0|||
145500902|NCT02749422|524694049|FG001|Overall Study|Ineligible|1|||
145500903|NCT05786651|524694050|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
145500904|NCT02855125|524694051|FG000|Overall Study|Withdrawal by Subject|2|||
145500905|NCT02855125|524694052|FG001|Overall Study|Withdrawal by Subject|2|||
145500906|NCT02855125|524694051|FG000|Overall Study|Clinical Disease Progression|5|||
145500907|NCT02855125|524694052|FG001|Overall Study|Clinical Disease Progression|4|||
145500908|NCT02855125|524694051|FG000|Overall Study|Radiologic Disease Progression|36|||
145500909|NCT02855125|524694052|FG001|Overall Study|Radiologic Disease Progression|39|||
145500910|NCT02855125|524694051|FG000|Overall Study|Adverse Event|11|||
145397935|NCT01239797|524313371|FG001|Treated Participants|Disease progression|185|||
145397936|NCT01239797|524313370|FG000|Treated Participants|Study drug toxicity|39|||
145397937|NCT01239797|524313371|FG001|Treated Participants|Study drug toxicity|45|||
145397938|NCT01239797|524313370|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
145397939|NCT01239797|524313371|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
145397940|NCT01239797|524313370|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
145397941|NCT01239797|524313371|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
145397942|NCT01239797|524313370|FG000|Treated Participants|Administrative reason by sponsor|13|||
145397943|NCT01239797|524313371|FG001|Treated Participants|Administrative reason by sponsor|4|||
145397944|NCT01239797|524313370|FG000|Treated Participants|Other reasons|14|||
145397945|NCT01239797|524313371|FG001|Treated Participants|Other reasons|14|||
145397946|NCT01239797|524313370|FG000|Treated Participants|Participant withdrew consent|6|||
145397947|NCT01239797|524313371|FG001|Treated Participants|Participant withdrew consent|11|||
145397948|NCT01239797|524313370|FG000|Treated Participants|Death|1|||
145397949|NCT01239797|524313371|FG001|Treated Participants|Death|1|||
145397950|NCT01239797|524313370|FG000|Treated Participants|Participant no longer meets study criteria|1|||
145397951|NCT01239797|524313371|FG001|Treated Participants|Participant no longer meets study criteria|1|||
145397952|NCT01239797|524313370|FG000|Treated Participants|Poor/non-compliance|0|||
145397953|NCT01239797|524313371|FG001|Treated Participants|Poor/non-compliance|1|||
145397954|NCT02000921|524313372|FG000|Overall Study|Withdrawal by Subject|3|||
145397955|NCT02000921|524313373|FG001|Overall Study|Withdrawal by Subject|10|||
145397956|NCT02000921|524313374|FG002|Overall Study|Withdrawal by Subject|5|||
145397957|NCT02000921|524313372|FG000|Overall Study|Lost to Follow-up|2|||
145397958|NCT02000921|524313373|FG001|Overall Study|Lost to Follow-up|4|||
145397959|NCT02000921|524313374|FG002|Overall Study|Lost to Follow-up|5|||
145397960|NCT02000921|524313372|FG000|Overall Study|Physician Decision|0|||
145397961|NCT02000921|524313373|FG001|Overall Study|Physician Decision|2|||
145397962|NCT02000921|524313374|FG002|Overall Study|Physician Decision|0|||
145397963|NCT02914834|524313379|FG000|Overall Study|Study halted due to COVID|1|||
145397964|NCT02914834|524313380|FG001|Overall Study|Study halted due to COVID|1|||
145397965|NCT02914834|524313379|FG000|Overall Study|1 subject withdrew|0|||
145500911|NCT02855125|524694052|FG001|Overall Study|Adverse Event|7|||
145500912|NCT02855125|524694051|FG000|Overall Study|Physician Decision|1|||
145500913|NCT02855125|524694052|FG001|Overall Study|Physician Decision|0|||
145500914|NCT02855125|524694051|FG000|Overall Study|On Treatment|9|||
145500915|NCT02855125|524694052|FG001|Overall Study|On Treatment|11|||
145500916|NCT02855125|524694051|FG000|Overall Study|Randomized but not treated|0|||
145500917|NCT02855125|524694052|FG001|Overall Study|Randomized but not treated|1|||
145500918|NCT04586205|524694062|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
145500919|NCT04586205|524694063|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
145500920|NCT03312634|524695595|FG000|Overall Study|Adverse Event|11|||
145500921|NCT03312634|524695596|FG001|Overall Study|Adverse Event|0|||
145500922|NCT03312634|524695595|FG000|Overall Study|Sponsor request|2|||
145500923|NCT03312634|524695596|FG001|Overall Study|Sponsor request|0|||
145500924|NCT03312634|524695595|FG000|Overall Study|Withdrawal by Subject|31|||
145500925|NCT03312634|524695596|FG001|Overall Study|Withdrawal by Subject|9|||
145500926|NCT03312634|524695595|FG000|Overall Study|Enrolled in an interventional study|0|||
145500927|NCT03312634|524695596|FG001|Overall Study|Enrolled in an interventional study|52|||
145500928|NCT03312634|524695595|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
145500929|NCT03312634|524695596|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
145500930|NCT03312634|524695595|FG000|Overall Study|Death|0|||
145500931|NCT03312634|524695596|FG001|Overall Study|Death|1|||
145500932|NCT03312634|524695595|FG000|Overall Study|Non-compliance|0|||
145500933|NCT03312634|524695596|FG001|Overall Study|Non-compliance|2|||
145500934|NCT03312634|524695595|FG000|Overall Study|Lost to Follow-up|0|||
145500935|NCT03312634|524695596|FG001|Overall Study|Lost to Follow-up|1|||
145500936|NCT03312634|524695595|FG000|Overall Study|Enrolled into non-interventional study|0|||
145500937|NCT03312634|524695596|FG001|Overall Study|Enrolled into non-interventional study|5|||
145500938|NCT03312634|524695595|FG000|Overall Study|Worsening clinical condition|0|||
145500939|NCT03312634|524695596|FG001|Overall Study|Worsening clinical condition|1|||
145500940|NCT03312634|524695595|FG000|Overall Study|Participant did not want to travel|0|||
145500941|NCT03312634|524695596|FG001|Overall Study|Participant did not want to travel|1|||
145500942|NCT03312634|524695595|FG000|Overall Study|Physician Decision|1|||
145500943|NCT03312634|524695596|FG001|Overall Study|Physician Decision|0|||
145500944|NCT03312634|524695595|FG000|Overall Study|Other|13|||
145500945|NCT03312634|524695596|FG001|Overall Study|Other|0|||
145500946|NCT01148979|524695605|FG000|Overall Study|Lost to Follow-up|0|||
145500947|NCT01148979|524695606|FG001|Overall Study|Lost to Follow-up|1|||
145500948|NCT00777153|524695607|FG000|Overall Study|Lost to Follow-up|1|||
145500949|NCT00777153|524695608|FG001|Overall Study|Lost to Follow-up|1|||
145500950|NCT00777153|524695609|FG002|Overall Study|Lost to Follow-up|0|||
145500951|NCT00777153|524695607|FG000|Overall Study|Death|85|||
145500952|NCT00777153|524695608|FG001|Overall Study|Death|73|||
145500953|NCT00777153|524695609|FG002|Overall Study|Death|33|||
145500954|NCT00777153|524695607|FG000|Overall Study|Withdrawal by Subject|3|||
145500955|NCT00777153|524695608|FG001|Overall Study|Withdrawal by Subject|4|||
145500956|NCT00777153|524695609|FG002|Overall Study|Withdrawal by Subject|3|||
145500957|NCT00777153|524695607|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
145500958|NCT00777153|524695608|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
145500959|NCT00777153|524695609|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
145500960|NCT00554216|524695610|FG000|Overall Study|Lost to Follow-up|92|||
145500961|NCT00554216|524695611|FG001|Overall Study|Lost to Follow-up|31|||
145500962|NCT00554216|524695612|FG002|Overall Study|Lost to Follow-up|63|||
145500963|NCT00554216|524695610|FG000|Overall Study|Adverse Event|16|||
145500964|NCT00554216|524695611|FG001|Overall Study|Adverse Event|16|||
145500965|NCT00554216|524695612|FG002|Overall Study|Adverse Event|36|||
145500966|NCT00554216|524695610|FG000|Overall Study|Withdrawal by Subject|92|||
145500967|NCT00554216|524695611|FG001|Overall Study|Withdrawal by Subject|31|||
145500968|NCT00554216|524695612|FG002|Overall Study|Withdrawal by Subject|43|||
145500969|NCT00554216|524695610|FG000|Overall Study|Non compliance|10|||
145500970|NCT00554216|524695611|FG001|Overall Study|Non compliance|4|||
145500971|NCT00554216|524695612|FG002|Overall Study|Non compliance|5|||
145500972|NCT00554216|524695610|FG000|Overall Study|Pregnancy|2|||
145500973|NCT00554216|524695611|FG001|Overall Study|Pregnancy|1|||
145500974|NCT00554216|524695612|FG002|Overall Study|Pregnancy|14|||
145500975|NCT00554216|524695610|FG000|Overall Study|Restricted med|3|||
145500976|NCT00554216|524695611|FG001|Overall Study|Restricted med|1|||
145500977|NCT00554216|524695612|FG002|Overall Study|Restricted med|1|||
145500978|NCT00554216|524695610|FG000|Overall Study|Other|12|||
145500979|NCT00554216|524695611|FG001|Overall Study|Other|7|||
145500980|NCT00554216|524695612|FG002|Overall Study|Other|10|||
145500981|NCT00554216|524695610|FG000|Overall Study|Lack of Efficacy|15|||
145500982|NCT00554216|524695611|FG001|Overall Study|Lack of Efficacy|3|||
145500983|NCT00554216|524695612|FG002|Overall Study|Lack of Efficacy|0|||
145500984|NCT05462756|524695615|FG000|Treatment Period|Adverse Event|3|||
145500985|NCT05462756|524695616|FG001|Treatment Period|Adverse Event|0|||
145500986|NCT05462756|524695615|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
145500987|NCT05462756|524695616|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
145500988|NCT05462756|524695615|FG000|Treatment Period|Death|0|||
145500989|NCT05462756|524695616|FG001|Treatment Period|Death|1|||
145500990|NCT05462756|524695615|FG000|Treatment Period|Lost to Follow-up|2|||
145500991|NCT05462756|524695616|FG001|Treatment Period|Lost to Follow-up|1|||
145500992|NCT05462756|524695615|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
145500993|NCT05462756|524695616|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
145500994|NCT05462756|524695615|FG000|Treatment Period|Physician Decision|2|||
145500995|NCT05462756|524695616|FG001|Treatment Period|Physician Decision|0|||
145500996|NCT05462756|524695615|FG000|Treatment Period|Protocol Violation|0|||
145500997|NCT05462756|524695616|FG001|Treatment Period|Protocol Violation|1|||
145500998|NCT05462756|524695615|FG000|Treatment Period|Withdrawal by Subject|5|||
145500999|NCT05462756|524695616|FG001|Treatment Period|Withdrawal by Subject|12|||
145501000|NCT05462756|524695615|FG000|Follow-Up Period|Adverse Event|1|||
145501001|NCT05462756|524695616|FG001|Follow-Up Period|Adverse Event|0|||
145501002|NCT05462756|524695615|FG000|Follow-Up Period|Death|1|||
145501003|NCT05462756|524695616|FG001|Follow-Up Period|Death|0|||
145501004|NCT05462756|524695615|FG000|Follow-Up Period|Lost to Follow-up|3|||
145501005|NCT05462756|524695616|FG001|Follow-Up Period|Lost to Follow-up|1|||
145501006|NCT05462756|524695615|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145501007|NCT05462756|524695616|FG001|Follow-Up Period|Withdrawal by Subject|4|||
145501008|NCT02079246|524695617|FG000|OLEX|Withdrawal before treatment|1|||
145501009|NCT02079246|524695618|FG001|OLEX|Withdrawal before treatment|0|||
145501010|NCT02079246|524695617|FG000|OLEX|Death|11|||
145501011|NCT02079246|524695618|FG001|OLEX|Death|0|||
145501012|NCT02079246|524695617|FG000|OLEX|Adverse Event|66|||
145501013|NCT02079246|524695618|FG001|OLEX|Adverse Event|0|||
145501014|NCT02079246|524695617|FG000|OLEX|Withdrawal by Subject|60|||
145501015|NCT02079246|524695618|FG001|OLEX|Withdrawal by Subject|0|||
145501016|NCT02079246|524695617|FG000|OLEX|Lost to Follow-up|6|||
145501017|NCT02079246|524695618|FG001|OLEX|Lost to Follow-up|0|||
145501018|NCT02079246|524695617|FG000|OLEX|Protocol Violation|6|||
145501019|NCT02079246|524695618|FG001|OLEX|Protocol Violation|0|||
145501020|NCT02079246|524695617|FG000|OLEX|Lack of Efficacy|3|||
145501021|NCT02079246|524695618|FG001|OLEX|Lack of Efficacy|0|||
145501022|NCT02079246|524695617|FG000|OLEX|Results of the lead-in studies|58|||
145501023|NCT02079246|524695618|FG001|OLEX|Results of the lead-in studies|0|||
145501024|NCT02079246|524695617|FG000|OLEX|Other: Disallowed medication|8|||
145501025|NCT02079246|524695618|FG001|OLEX|Other: Disallowed medication|0|||
145501026|NCT02079246|524695617|FG000|OLEX|Other: Insufficient compliance|2|||
145501027|NCT02079246|524695618|FG001|OLEX|Other: Insufficient compliance|0|||
145501028|NCT02079246|524695617|FG000|OLEX|Other: Caregiver unavailable|3|||
145501029|NCT02079246|524695618|FG001|OLEX|Other: Caregiver unavailable|0|||
145501030|NCT02079246|524695617|FG000|OLEX|Other: Coordinator decision|1|||
145501031|NCT02079246|524695618|FG001|OLEX|Other: Coordinator decision|0|||
145501032|NCT02079246|524695617|FG000|OLEX|Other: Worsening of condition|1|||
145501033|NCT02079246|524695618|FG001|OLEX|Other: Worsening of condition|0|||
145501034|NCT02079246|524695617|FG000|OLEX|Other: Moved to nursing home|1|||
145501035|NCT02079246|524695618|FG001|OLEX|Other: Moved to nursing home|0|||
145501036|NCT02079246|524695617|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
145501037|NCT02079246|524695618|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
145501038|NCT02079246|524695617|FG000|OLEX-MEM|Adverse Event|0|||
145501039|NCT02079246|524695618|FG001|OLEX-MEM|Adverse Event|6|||
145501040|NCT02079246|524695617|FG000|OLEX-MEM|Withdrawal by Subject|0|||
145501041|NCT02079246|524695618|FG001|OLEX-MEM|Withdrawal by Subject|7|||
145501042|NCT02079246|524695617|FG000|OLEX-MEM|Protocol Violation|0|||
145501043|NCT02079246|524695618|FG001|OLEX-MEM|Protocol Violation|2|||
145501044|NCT02079246|524695617|FG000|OLEX-MEM|Lost to Follow-up|0|||
145501045|NCT02079246|524695618|FG001|OLEX-MEM|Lost to Follow-up|1|||
145501046|NCT02079246|524695617|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
145501047|NCT02079246|524695618|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
145501048|NCT04040933|524695623|FG000|Overall Study|Protocol Violation|1|||
145501049|NCT04040933|524695623|FG000|Overall Study|Withdrawal by Subject|2|||
145501050|NCT00775190|524695624|FG000|Overall Study|Lost to Follow-up|2|||
145501051|NCT00775190|524695625|FG001|Overall Study|Lost to Follow-up|3|||
145501052|NCT00775190|524695624|FG000|Overall Study|Withdrawal by Subject|1|||
145501053|NCT00775190|524695625|FG001|Overall Study|Withdrawal by Subject|2|||
145501054|NCT00775190|524695624|FG000|Overall Study|Protocol Violation|1|||
145501055|NCT00775190|524695625|FG001|Overall Study|Protocol Violation|0|||
145732840|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
145501056|NCT01709084|524695626|FG000|Overall Study|Lost to Follow-up|4|||
145501057|NCT01709084|524695627|FG001|Overall Study|Lost to Follow-up|7|||
145501058|NCT01709084|524695626|FG000|Overall Study|Withdrawal by Subject|2|||
145501059|NCT01709084|524695627|FG001|Overall Study|Withdrawal by Subject|2|||
145501060|NCT01709084|524695626|FG000|Overall Study|Adverse Event|5|||
145501061|NCT01709084|524695627|FG001|Overall Study|Adverse Event|0|||
145501062|NCT01709084|524695626|FG000|Overall Study|Other|5|||
145501063|NCT01709084|524695627|FG001|Overall Study|Other|3|||
145501064|NCT01709084|524695626|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
145501065|NCT01709084|524695627|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
145501066|NCT01709084|524695626|FG000|Overall Study|Not Treated|0|||
145501067|NCT01709084|524695627|FG001|Overall Study|Not Treated|2|||
145501068|NCT00641667|524695633|FG000|Overall Study|Withdrawal by Subject|1|||
145501069|NCT00641667|524695633|FG000|Overall Study|Adverse Event|1|||
145397966|NCT02914834|524313380|FG001|Overall Study|1 subject withdrew|1|||
145397967|NCT02631941|524313385|FG000|Overall Study|Physician Decision|0|||
145397968|NCT02631941|524313386|FG001|Overall Study|Physician Decision|1|||
145397969|NCT02631941|524313387|FG002|Overall Study|Physician Decision|0|||
145397970|NCT02631941|524313388|FG003|Overall Study|Physician Decision|0|||
145397971|NCT02631941|524313389|FG004|Overall Study|Physician Decision|0|||
145397972|NCT02631941|524313390|FG005|Overall Study|Physician Decision|0|||
145397973|NCT02631941|524313391|FG006|Overall Study|Physician Decision|0|||
145397974|NCT02631941|524313392|FG007|Overall Study|Physician Decision|0|||
145397975|NCT02631941|524313393|FG008|Overall Study|Physician Decision|0|||
145397976|NCT02631941|524313394|FG009|Overall Study|Physician Decision|0|||
145397977|NCT02631941|524313385|FG000|Overall Study|Adverse Event|0|||
145397978|NCT02631941|524313386|FG001|Overall Study|Adverse Event|1|||
145397979|NCT02631941|524313387|FG002|Overall Study|Adverse Event|0|||
145397980|NCT02631941|524313388|FG003|Overall Study|Adverse Event|0|||
145397981|NCT02631941|524313389|FG004|Overall Study|Adverse Event|0|||
145397982|NCT02631941|524313390|FG005|Overall Study|Adverse Event|0|||
145397983|NCT02631941|524313391|FG006|Overall Study|Adverse Event|0|||
145397984|NCT02631941|524313392|FG007|Overall Study|Adverse Event|0|||
145397985|NCT02631941|524313393|FG008|Overall Study|Adverse Event|0|||
145397986|NCT02631941|524313394|FG009|Overall Study|Adverse Event|0|||
145397987|NCT02631941|524313385|FG000|Overall Study|Withdrawal by Subject|0|||
145397988|NCT02631941|524313386|FG001|Overall Study|Withdrawal by Subject|0|||
145397989|NCT02631941|524313387|FG002|Overall Study|Withdrawal by Subject|0|||
145397990|NCT02631941|524313388|FG003|Overall Study|Withdrawal by Subject|0|||
145397991|NCT02631941|524313389|FG004|Overall Study|Withdrawal by Subject|1|||
145397992|NCT02631941|524313390|FG005|Overall Study|Withdrawal by Subject|0|||
145397993|NCT02631941|524313391|FG006|Overall Study|Withdrawal by Subject|0|||
145397994|NCT02631941|524313392|FG007|Overall Study|Withdrawal by Subject|1|||
145397995|NCT02631941|524313393|FG008|Overall Study|Withdrawal by Subject|0|||
145397996|NCT02631941|524313394|FG009|Overall Study|Withdrawal by Subject|0|||
145397997|NCT02631941|524313385|FG000|Overall Study|Lost to Follow-up|0|||
145397998|NCT02631941|524313386|FG001|Overall Study|Lost to Follow-up|0|||
145397999|NCT02631941|524313387|FG002|Overall Study|Lost to Follow-up|0|||
145501070|NCT00641667|524695633|FG000|Overall Study|Physician Decision|1|||
145501071|NCT00641667|524695633|FG000|Overall Study|Worsening of underlying disease|3|||
145501072|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
145501073|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
145501074|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
145501075|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
145501076|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
145501077|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
145501078|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
145501079|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
145501080|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
145501081|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
145501082|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
145501083|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
145501084|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
145501085|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
145501086|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
145501087|NCT01235741|524695634|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
145501088|NCT01235741|524695635|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
145501089|NCT01235741|524695636|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
145501090|NCT01235741|524695634|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
145501091|NCT01235741|524695635|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
145501092|NCT01235741|524695636|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
145501093|NCT01235741|524695634|FG000|Randomized to Treatment|Adverse Event|0|||
145501094|NCT01235741|524695635|FG001|Randomized to Treatment|Adverse Event|1|||
145501095|NCT01235741|524695636|FG002|Randomized to Treatment|Adverse Event|1|||
145501096|NCT01235741|524695634|FG000|Randomized to Treatment|Sponsor terminated study|0|||
145501097|NCT01235741|524695635|FG001|Randomized to Treatment|Sponsor terminated study|35|||
145501098|NCT01235741|524695636|FG002|Randomized to Treatment|Sponsor terminated study|34|||
145501099|NCT01235741|524695634|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
145501100|NCT01235741|524695635|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
145501101|NCT01235741|524695636|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
145501102|NCT01235741|524695634|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
145501103|NCT01235741|524695635|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
145501104|NCT01235741|524695636|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
145501105|NCT01235741|524695634|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
145501106|NCT01235741|524695635|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
145501107|NCT01235741|524695636|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
145501108|NCT01421719|524695637|FG000|Overall Study|Withdrawal by Subject|4|||
145501109|NCT01712399|524695644|FG000|Overall Study|Lost to Follow-up|1|||
145501110|NCT01712399|524695644|FG000|Overall Study|Withdrawal by Subject|39|||
145501111|NCT01712399|524695644|FG000|Overall Study|Death|1|||
145501112|NCT01712399|524695644|FG000|Overall Study|Adverse Event|11|||
145501113|NCT01712399|524695644|FG000|Overall Study|Study closure|345|||
145501114|NCT01357850|524695645|FG000|Overall Study|Lost to Follow-up|1|||
145501115|NCT01357850|524695646|FG001|Overall Study|Lost to Follow-up|0|||
145501116|NCT01357850|524695647|FG002|Overall Study|Lost to Follow-up|0|||
145501117|NCT01357850|524695648|FG003|Overall Study|Lost to Follow-up|0|||
145501118|NCT04610281|524695649|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
145501119|NCT04610281|524695650|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
145501120|NCT01942837|524695651|FG000|Overall Study|Death|1|||
145501121|NCT01942837|524695651|FG000|Overall Study|Symptomatic or radiographic progression|49|||
145501122|NCT01942837|524695651|FG000|Overall Study|Adverse Event|6|||
145501123|NCT01942837|524695651|FG000|Overall Study|Physician Decision|3|||
145501124|NCT01942837|524695651|FG000|Overall Study|Withdrawal by Subject|2|||
145501125|NCT01942837|524695651|FG000|Overall Study|Intercurrent Illness|1|||
145501126|NCT01942837|524695651|FG000|Overall Study|On treatment|3|||
145501127|NCT01942837|524695651|FG000|Overall Study|Never initiate the treatment|2|||
145501128|NCT01298648|524695652|FG000|Overall Study|Withdrawal by Subject|2|||
145501129|NCT01298648|524695652|FG000|Overall Study|Lost to Follow-up|21|||
145501130|NCT03077412|524695656|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
145501131|NCT03077412|524695657|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
145501132|NCT03077412|524695658|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
145501133|NCT03077412|524695656|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
145501134|NCT03077412|524695657|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
145501135|NCT03077412|524695658|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
145501136|NCT03077412|524695656|FG000|Overall Study|Adverse Event|1|||
145501137|NCT03077412|524695657|FG001|Overall Study|Adverse Event|2|||
145501138|NCT03077412|524695658|FG002|Overall Study|Adverse Event|2|||
145501139|NCT03077412|524695656|FG000|Overall Study|Investigator's Discretion|0|||
145501140|NCT03077412|524695657|FG001|Overall Study|Investigator's Discretion|1|||
145501141|NCT03077412|524695658|FG002|Overall Study|Investigator's Discretion|1|||
145501142|NCT03077412|524695656|FG000|Overall Study|Withdrew Consent|0|||
145501143|NCT03077412|524695657|FG001|Overall Study|Withdrew Consent|2|||
145501144|NCT03077412|524695658|FG002|Overall Study|Withdrew Consent|0|||
145501145|NCT02266888|524695660|FG000|Overall Study|Death|2|||
145501146|NCT02266888|524695661|FG001|Overall Study|Death|2|||
145501147|NCT02266888|524695662|FG002|Overall Study|Death|4|||
145501148|NCT02266888|524695663|FG003|Overall Study|Death|2|||
145501149|NCT02266888|524695660|FG000|Overall Study|Physician Decision|0|||
145501150|NCT02266888|524695661|FG001|Overall Study|Physician Decision|1|||
145501151|NCT02266888|524695662|FG002|Overall Study|Physician Decision|2|||
145501152|NCT02266888|524695663|FG003|Overall Study|Physician Decision|2|||
145501153|NCT02266888|524695660|FG000|Overall Study|Study Terminated|5|||
145501154|NCT02266888|524695661|FG001|Overall Study|Study Terminated|1|||
145501155|NCT02266888|524695662|FG002|Overall Study|Study Terminated|0|||
145501156|NCT02266888|524695663|FG003|Overall Study|Study Terminated|0|||
145501157|NCT02266888|524695660|FG000|Overall Study|No Longer Eligible|0|||
145501158|NCT02266888|524695661|FG001|Overall Study|No Longer Eligible|0|||
145501159|NCT02266888|524695662|FG002|Overall Study|No Longer Eligible|0|||
145501160|NCT02266888|524695663|FG003|Overall Study|No Longer Eligible|2|||
145501161|NCT02266888|524695660|FG000|Overall Study|Randomization Closed|0|||
145501162|NCT02266888|524695661|FG001|Overall Study|Randomization Closed|0|||
145501163|NCT02266888|524695662|FG002|Overall Study|Randomization Closed|4|||
145501164|NCT02266888|524695663|FG003|Overall Study|Randomization Closed|0|||
145501165|NCT02266888|524695660|FG000|Overall Study|Personnel unavailable at transplant|0|||
145501166|NCT02266888|524695661|FG001|Overall Study|Personnel unavailable at transplant|0|||
145501167|NCT02266888|524695662|FG002|Overall Study|Personnel unavailable at transplant|0|||
145501168|NCT02266888|524695663|FG003|Overall Study|Personnel unavailable at transplant|1|||
145501169|NCT02266888|524695660|FG000|Overall Study|Transfer of care|0|||
145501170|NCT02266888|524695661|FG001|Overall Study|Transfer of care|0|||
145501171|NCT02266888|524695662|FG002|Overall Study|Transfer of care|1|||
145501172|NCT02266888|524695663|FG003|Overall Study|Transfer of care|0|||
145501173|NCT02351856|524695664|FG000|Overall Study|Adverse Event|2|||
145501174|NCT02351856|524695664|FG000|Overall Study|Physician Decision|5|||
145501175|NCT02351856|524695664|FG000|Overall Study|Study terminated by sponsor|1|||
145501176|NCT01458392|524695665|FG000|Overall Study|Death|2|||
145501177|NCT01458392|524695666|FG001|Overall Study|Death|11|||
145501178|NCT01458392|524695667|FG002|Overall Study|Death|22|||
145501179|NCT01458392|524695665|FG000|Overall Study|At the discretion of the sponsor|0|||
145501180|NCT01458392|524695666|FG001|Overall Study|At the discretion of the sponsor|2|||
145501181|NCT01458392|524695667|FG002|Overall Study|At the discretion of the sponsor|7|||
145501182|NCT01458392|524695665|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
145501183|NCT01458392|524695666|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
145501184|NCT01458392|524695667|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
145501185|NCT01281124|524695670|FG000|Overall Study|Death|1|||
145501186|NCT02038933|524695671|FG000|Overall Study|Disease progression|104|||
145501187|NCT02038933|524695671|FG000|Overall Study|Study drug toxicity|6|||
145501188|NCT02038933|524695671|FG000|Overall Study|Adverse event unrelated to study drug|6|||
145501189|NCT02038933|524695671|FG000|Overall Study|Participant request to discontinue treatment|2|||
145501190|NCT02038933|524695671|FG000|Overall Study|Lost to Follow-up|1|||
145501191|NCT02038933|524695671|FG000|Overall Study|Other reasons|2|||
145501192|NCT00753506|524695672|FG000|Overall Study|Withdrawal by Subject|4|||
145501193|NCT00753506|524695673|FG001|Overall Study|Withdrawal by Subject|1|||
145501194|NCT00753506|524695672|FG000|Overall Study|Lost to Follow-up|2|||
145501195|NCT00753506|524695673|FG001|Overall Study|Lost to Follow-up|0|||
145501196|NCT00753506|524695672|FG000|Overall Study|Other reason|1|||
145501197|NCT00753506|524695673|FG001|Overall Study|Other reason|1|||
145501198|NCT04226742|524695676|FG000|Overall Study|Lost to Follow-up|16|||
145501199|NCT04226742|524695677|FG001|Overall Study|Lost to Follow-up|13|||
145501200|NCT04226742|524695676|FG000|Overall Study|Withdrawal by Subject|5|||
145501201|NCT04226742|524695677|FG001|Overall Study|Withdrawal by Subject|3|||
145501202|NCT01193244|524695680|FG000|Overall Study|Withdrawal by Subject|79|||
145501203|NCT01193244|524695681|FG001|Overall Study|Withdrawal by Subject|97|||
145501204|NCT01193244|524695680|FG000|Overall Study|Other|303|||
145501205|NCT01193244|524695681|FG001|Overall Study|Other|278|||
145501206|NCT01193244|524695680|FG000|Overall Study|Lost to Follow-up|6|||
145501207|NCT01193244|524695681|FG001|Overall Study|Lost to Follow-up|15|||
145501208|NCT01417377|524695682|FG000|Overall Study|Lost to Follow-up|12|||
145501209|NCT01417377|524695682|FG000|Overall Study|Enrolled, but not treated|1|||
145501210|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
145501211|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
145501212|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
145501213|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
145501214|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
145501215|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
145501216|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
145501217|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
145501218|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
145501219|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
145501220|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
145501221|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
145501222|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
145501223|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
145501224|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
145501225|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
145501226|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
145501227|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
145501228|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
145501229|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
145501230|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
145501231|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
145501232|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
145501233|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
145501234|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
145501235|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
145501236|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
145501237|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
145501238|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501239|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501240|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501241|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501242|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501243|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501244|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
145501245|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501246|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501247|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501248|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501249|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501250|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501251|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
145501252|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Transplant|0|||
145501253|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Transplant|1|||
145501254|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Transplant|0|||
145501255|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Transplant|0|||
145501256|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Transplant|0|||
145501257|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Transplant|1|||
145501258|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Transplant|0|||
145501259|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Transplant|0|||
145501260|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Transplant|0|||
145501261|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Transplant|0|||
145501262|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Transplant|0|||
145501263|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Transplant|0|||
145501264|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Transplant|0|||
145501265|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Transplant|0|||
145501266|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
145501267|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
145501268|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
145501269|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
145501270|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
145501271|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
145501272|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
145501273|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
145501274|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
145501275|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
145501276|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
145501277|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
145501278|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
145501279|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
145501280|NCT02113982|524695683|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
145501281|NCT02113982|524695684|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
145501282|NCT02113982|524695685|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
145501283|NCT02113982|524695686|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
145501284|NCT02113982|524695687|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
145501285|NCT02113982|524695688|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
145501286|NCT02113982|524695689|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
145501287|NCT02113982|524695690|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
145501288|NCT02113982|524695691|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
145501289|NCT02113982|524695692|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
145501290|NCT02113982|524695693|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
145501291|NCT02113982|524695694|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
145501292|NCT02113982|524695695|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
145501293|NCT02113982|524695696|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
145501294|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
145501295|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
145501296|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
145501297|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
145501298|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
145501299|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
145501300|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
145501301|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
145501302|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
145501303|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
145501304|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
145501305|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
145501306|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
145501307|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
145501308|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
145501309|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
145501310|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
145501311|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
145501312|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
145501313|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
145501314|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
145501315|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
145501316|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
145501317|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
145501318|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
145501319|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
145501320|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
145501321|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
145501322|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501323|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501324|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501325|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501326|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501327|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501328|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501329|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
145501330|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501331|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
145501332|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
145501333|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501334|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501335|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
145501336|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501337|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501338|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501339|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501340|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501341|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501342|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501343|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
145501344|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501345|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
145501346|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501347|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501348|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501349|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
145501350|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501351|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501352|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501353|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501354|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501355|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501356|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501357|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
145501358|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501359|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501360|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501361|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501362|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501363|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
145501364|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Transplant|0|||
145501365|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Transplant|0|||
145501366|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Transplant|0|||
145501367|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Transplant|0|||
145501368|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Transplant|0|||
145501369|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Transplant|0|||
145501370|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Transplant|0|||
145501371|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Transplant|0|||
145501372|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Transplant|0|||
145501373|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Transplant|4|||
145501374|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Transplant|2|||
145501375|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Transplant|0|||
145501376|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Transplant|0|||
145501377|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Transplant|0|||
145501378|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
145501379|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
145501380|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
145501381|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
145501382|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
145501383|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
145501384|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
145501385|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
145501386|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
145501387|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
145501388|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
145501389|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
145501390|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
145501391|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
145501392|NCT02113982|524695683|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
145501393|NCT02113982|524695684|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
145501394|NCT02113982|524695685|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
145501395|NCT02113982|524695686|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
145501396|NCT02113982|524695687|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
145501397|NCT02113982|524695688|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
145501398|NCT02113982|524695689|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
145501399|NCT02113982|524695690|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
145501400|NCT02113982|524695691|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
145501401|NCT02113982|524695692|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
145501402|NCT02113982|524695693|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
145501403|NCT02113982|524695694|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
145266684|NCT04668066|523825237|FG000|Part 1: Follow-Up|Other|0|||
145501404|NCT02113982|524695695|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
145501405|NCT02113982|524695696|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
145501406|NCT02113982|524695683|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501407|NCT02113982|524695684|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501408|NCT02113982|524695685|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501409|NCT02113982|524695686|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501410|NCT02113982|524695687|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501411|NCT02113982|524695688|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501412|NCT02113982|524695689|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501413|NCT02113982|524695690|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501414|NCT02113982|524695691|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501415|NCT02113982|524695692|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501416|NCT02113982|524695693|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501417|NCT02113982|524695694|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
145501418|NCT02113982|524695695|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501419|NCT02113982|524695696|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
145501420|NCT02113982|524695683|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501421|NCT02113982|524695684|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501422|NCT02113982|524695685|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501423|NCT02113982|524695686|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501424|NCT02113982|524695687|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501425|NCT02113982|524695688|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501426|NCT02113982|524695689|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501427|NCT02113982|524695690|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501428|NCT02113982|524695691|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501429|NCT02113982|524695692|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501430|NCT02113982|524695693|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501431|NCT02113982|524695694|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
145501432|NCT02113982|524695695|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501433|NCT02113982|524695696|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
145501434|NCT02113982|524695683|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501435|NCT02113982|524695684|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501436|NCT02113982|524695685|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501437|NCT02113982|524695686|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501438|NCT02113982|524695687|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501439|NCT02113982|524695688|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501440|NCT02113982|524695689|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501441|NCT02113982|524695690|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501442|NCT02113982|524695691|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501443|NCT02113982|524695692|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501444|NCT02113982|524695693|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145732841|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
145501445|NCT02113982|524695694|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
145501446|NCT02113982|524695695|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501447|NCT02113982|524695696|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
145501448|NCT02113982|524695683|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
145398000|NCT02631941|524313388|FG003|Overall Study|Lost to Follow-up|0|||
145398001|NCT02631941|524313389|FG004|Overall Study|Lost to Follow-up|0|||
145398002|NCT02631941|524313390|FG005|Overall Study|Lost to Follow-up|0|||
145398003|NCT02631941|524313391|FG006|Overall Study|Lost to Follow-up|0|||
145398004|NCT02631941|524313392|FG007|Overall Study|Lost to Follow-up|0|||
145398005|NCT02631941|524313393|FG008|Overall Study|Lost to Follow-up|1|||
145398006|NCT02631941|524313394|FG009|Overall Study|Lost to Follow-up|0|||
145398007|NCT03722576|524313400|FG000|Overall Study|Withdrawal by Subject|3|||
145398008|NCT03722576|524313400|FG000|Overall Study|Adverse Event|2|||
145398009|NCT03722576|524313400|FG000|Overall Study|Physician Decision|1|||
145398010|NCT03722576|524313400|FG000|Overall Study|Lost to Follow-up|1|||
145398011|NCT01240382|524313401|FG000|Overall Study|Adverse Event|2|||
145398012|NCT01240382|524313402|FG001|Overall Study|Adverse Event|1|||
145398013|NCT01240382|524313401|FG000|Overall Study|Lack of Efficacy|0|||
145398014|NCT01240382|524313402|FG001|Overall Study|Lack of Efficacy|2|||
145398015|NCT01240382|524313401|FG000|Overall Study|Fear of adverse events|0|||
145398016|NCT01240382|524313402|FG001|Overall Study|Fear of adverse events|1|||
145398017|NCT03885908|524313404|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
145398018|NCT03885908|524313405|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
145398019|NCT03885908|524313404|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
145398020|NCT03885908|524313405|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
145398021|NCT03885908|524313404|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
145398022|NCT03885908|524313405|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
145398023|NCT03885908|524313404|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
145501449|NCT02113982|524695684|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
145501450|NCT02113982|524695685|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
145501451|NCT02113982|524695686|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
145501452|NCT02113982|524695687|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
145501453|NCT02113982|524695688|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
145501454|NCT02113982|524695689|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
145501455|NCT02113982|524695690|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
145501456|NCT02113982|524695691|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
145501457|NCT02113982|524695692|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
145501458|NCT02113982|524695693|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
145501459|NCT02113982|524695694|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
145501460|NCT02113982|524695695|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
145501461|NCT02113982|524695696|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
145501462|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501463|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145266685|NCT04668066|523825238|FG001|Part 1: Follow-Up|Other|0|||
145501464|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145398024|NCT03885908|524313405|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
145398025|NCT03669549|524313406|FG000|Overall Study|Adverse Event|4|||
145398026|NCT03669549|524313406|FG000|Overall Study|Withdrawal by Subject|1|||
145398027|NCT03669549|524313406|FG000|Overall Study|Study terminated by the Sponsor|1|||
145398028|NCT03585270|524313410|FG000|Overall Study|Withdrawal by Subject|2|||
145398029|NCT03585270|524313411|FG001|Overall Study|Withdrawal by Subject|6|||
145398030|NCT03585270|524313410|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
145398031|NCT03585270|524313411|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
145398032|NCT03585270|524313410|FG000|Overall Study|Adverse Event|5|||
145398033|NCT03585270|524313411|FG001|Overall Study|Adverse Event|2|||
145398034|NCT03585270|524313410|FG000|Overall Study|Lost to Follow-up|1|||
145398035|NCT03585270|524313411|FG001|Overall Study|Lost to Follow-up|4|||
145398036|NCT03585270|524313410|FG000|Overall Study|Death|5|||
145398037|NCT03585270|524313411|FG001|Overall Study|Death|3|||
145398038|NCT03585270|524313410|FG000|Overall Study|Other reasons|2|||
145398039|NCT03585270|524313411|FG001|Overall Study|Other reasons|2|||
145398040|NCT02053493|524313412|FG000|Overall Study|Withdrawal by Subject|1|||
145398041|NCT02053493|524313413|FG001|Overall Study|Withdrawal by Subject|1|||
145398042|NCT01791985|524313416|FG000|Overall Study|Adverse Event|7|||
145398043|NCT01791985|524313416|FG000|Overall Study|Withdrawal by Subject|1|||
145398044|NCT05214118|524313428|FG000|Overall Study|Lost to Follow-up|0|||
145398045|NCT05214118|524313429|FG001|Overall Study|Lost to Follow-up|2|||
145398046|NCT05214118|524313428|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
145398047|NCT05214118|524313429|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
145398048|NCT05214118|524313428|FG000|Overall Study|moved|1|||
145398049|NCT05214118|524313429|FG001|Overall Study|moved|0|||
145398050|NCT03217591|524313430|FG000|Overall Study|Adverse Event|1|||
145398051|NCT03217591|524313431|FG001|Overall Study|Adverse Event|2|||
145398052|NCT03217591|524313432|FG002|Overall Study|Adverse Event|6|||
145398053|NCT03217591|524313430|FG000|Overall Study|Withdrawal by Subject|0|||
145398054|NCT03217591|524313431|FG001|Overall Study|Withdrawal by Subject|1|||
145398055|NCT03217591|524313432|FG002|Overall Study|Withdrawal by Subject|3|||
145398056|NCT03217591|524313430|FG000|Overall Study|Lost to Follow-up|1|||
145398057|NCT03217591|524313431|FG001|Overall Study|Lost to Follow-up|0|||
145398058|NCT03217591|524313432|FG002|Overall Study|Lost to Follow-up|0|||
145398059|NCT03217591|524313430|FG000|Overall Study|Protocol Violation|1|||
145398060|NCT03217591|524313431|FG001|Overall Study|Protocol Violation|0|||
145398061|NCT03217591|524313432|FG002|Overall Study|Protocol Violation|1|||
145398062|NCT04467515|524313435|FG000|Overall Study|Lost to Follow-up|1|||
145398063|NCT04467515|524313436|FG001|Overall Study|Lost to Follow-up|0|||
145398064|NCT04467515|524313437|FG002|Overall Study|Lost to Follow-up|0|||
145398065|NCT04467515|524313435|FG000|Overall Study|Withdrawal by Subject|1|||
145398066|NCT04467515|524313436|FG001|Overall Study|Withdrawal by Subject|0|||
145398067|NCT04467515|524313437|FG002|Overall Study|Withdrawal by Subject|1|||
145398068|NCT04467515|524313435|FG000|Overall Study|Progressive Disease|0|||
145398069|NCT04467515|524313436|FG001|Overall Study|Progressive Disease|1|||
145398070|NCT04467515|524313437|FG002|Overall Study|Progressive Disease|3|||
145398071|NCT04467515|524313435|FG000|Overall Study|Death|0|||
145398072|NCT04467515|524313436|FG001|Overall Study|Death|1|||
145398073|NCT04467515|524313437|FG002|Overall Study|Death|0|||
145398074|NCT03014206|524313440|FG000|Overall Study|Registration Violation|12|||
145398075|NCT01091246|524313441|FG000|Overall Study|Lost to Follow-up|23|||
145398076|NCT01091246|524313442|FG001|Overall Study|Lost to Follow-up|11|||
145398077|NCT01091246|524313443|FG002|Overall Study|Lost to Follow-up|7|||
145398078|NCT01091246|524313441|FG000|Overall Study|Adverse Event|1|||
145398079|NCT01091246|524313442|FG001|Overall Study|Adverse Event|0|||
145398080|NCT01091246|524313443|FG002|Overall Study|Adverse Event|1|||
145398081|NCT01091246|524313441|FG000|Overall Study|Withdrawal by Subject|9|||
145398082|NCT01091246|524313442|FG001|Overall Study|Withdrawal by Subject|5|||
145398083|NCT01091246|524313443|FG002|Overall Study|Withdrawal by Subject|4|||
145398084|NCT01091246|524313441|FG000|Overall Study|Subject not dosed|2|||
145398085|NCT01091246|524313442|FG001|Overall Study|Subject not dosed|0|||
145398086|NCT01091246|524313443|FG002|Overall Study|Subject not dosed|1|||
145398087|NCT04577794|524313444|FG000|Overall Study|Adverse Event|1|||
145398088|NCT04577794|524313445|FG001|Overall Study|Adverse Event|1|||
145398089|NCT01676012|524313447|FG000|Overall Study|Adverse Event|2|||
145398090|NCT01676012|524313447|FG000|Overall Study|incomplete set of videos|1|||
145398091|NCT02849080|524313448|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
145398092|NCT02849080|524313449|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
145398093|NCT02849080|524313450|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
145398094|NCT02849080|524313451|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
145398095|NCT02849080|524313448|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
145398096|NCT02849080|524313449|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
145398097|NCT02849080|524313450|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
145398098|NCT02849080|524313451|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
145398099|NCT02849080|524313448|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
145398100|NCT02849080|524313449|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
145501465|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501466|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501467|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501468|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501469|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501470|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501471|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501472|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501473|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501474|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
145501475|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
145501476|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501477|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501478|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501479|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501480|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501481|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501482|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501483|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501484|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501485|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501486|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501487|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
145501488|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
145501489|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
145501490|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501491|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501492|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501493|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501494|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501495|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501496|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501497|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501498|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501499|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501500|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501501|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
145501502|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
145501503|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
145501504|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501505|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501506|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501507|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501508|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501509|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501510|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501511|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501512|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501513|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501514|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501515|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
145501516|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
145501517|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
145501518|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501519|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501520|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501521|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501522|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501523|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501524|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501525|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501526|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501527|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501528|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145266686|NCT04668066|523825239|FG002|Part 1: Follow-Up|Other|0|||
145398101|NCT02849080|524313450|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
145398102|NCT02849080|524313451|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
145398103|NCT02849080|524313448|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
145398104|NCT02849080|524313449|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145398105|NCT02849080|524313450|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145398106|NCT02849080|524313451|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
145398107|NCT02849080|524313448|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
145398108|NCT02849080|524313449|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
145398109|NCT02849080|524313450|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
145398110|NCT02849080|524313451|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
145398111|NCT02849080|524313448|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
145398112|NCT02849080|524313449|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145398113|NCT02849080|524313450|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145398114|NCT02849080|524313451|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
145398115|NCT04460326|524313462|FG000|Completed at Least 4 Meals|Early discharge|5|||
145398116|NCT04460326|524313463|FG001|Completed at Least 4 Meals|Early discharge|5|||
145398117|NCT04460326|524313462|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
145398118|NCT04460326|524313463|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
145398119|NCT04460326|524313462|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
145398120|NCT04460326|524313463|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
145398121|NCT04460326|524313462|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
145398122|NCT04460326|524313463|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
145398123|NCT04460326|524313462|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
145398124|NCT04460326|524313463|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
145398125|NCT04460326|524313462|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
145398126|NCT04460326|524313463|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
145398127|NCT03160716|524313464|FG000|Overall Study|Lost to Follow-up|1|||
145398128|NCT01628848|524313466|FG000|Overall Study|Adverse Event|9|||
145398129|NCT01628848|524313467|FG001|Overall Study|Adverse Event|7|||
145398130|NCT01628848|524313466|FG000|Overall Study|Lack of Efficacy|0|||
145398131|NCT01628848|524313467|FG001|Overall Study|Lack of Efficacy|4|||
145398132|NCT01628848|524313466|FG000|Overall Study|Withdrawal by Subject|0|||
145398133|NCT01628848|524313467|FG001|Overall Study|Withdrawal by Subject|2|||
145398134|NCT01628848|524313466|FG000|Overall Study|Physician Decision|3|||
145398135|NCT01628848|524313467|FG001|Overall Study|Physician Decision|1|||
145398136|NCT04794751|524313470|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
145398137|NCT04794751|524313471|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
145398138|NCT04794751|524313470|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
145398139|NCT04794751|524313471|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
145398140|NCT04794751|524313470|FG000|Period 1|Protocol Violation|0|||
145266687|NCT04668066|523825240|FG003|Part 1: Follow-Up|Other|0|||
145266688|NCT04668066|523825241|FG004|Part 1: Follow-Up|Other|0|||
145398141|NCT04794751|524313471|FG001|Period 1|Protocol Violation|2|||
145398142|NCT04794751|524313470|FG000|Period 1|Withdrawal by Subject|0|||
145398143|NCT04794751|524313471|FG001|Period 1|Withdrawal by Subject|1|||
145398144|NCT04794751|524313470|FG000|Period 2|Withdrawal by Subject|0|||
145398145|NCT04794751|524313471|FG001|Period 2|Withdrawal by Subject|1|||
145398146|NCT04794751|524313470|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
145398147|NCT04794751|524313471|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
145398148|NCT04794751|524313470|FG000|Period 2|Protocol Violation|1|||
145398149|NCT04794751|524313471|FG001|Period 2|Protocol Violation|0|||
145501529|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145398150|NCT02283658|524313472|FG000|Overall Study|Withdrawal by Subject|1|||
145398151|NCT03528551|524313474|FG000|Overall Study|Lost to Follow-up|0|||
145398152|NCT03528551|524313475|FG001|Overall Study|Lost to Follow-up|1|||
145398153|NCT03528551|524313476|FG002|Overall Study|Lost to Follow-up|0|||
145398154|NCT03528551|524313474|FG000|Overall Study|Transferred to other arm/group|2|||
145398155|NCT03528551|524313475|FG001|Overall Study|Transferred to other arm/group|3|||
145398156|NCT03528551|524313476|FG002|Overall Study|Transferred to other arm/group|0|||
145501530|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
145501531|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
145501532|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501533|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501534|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501535|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501536|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501537|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501538|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501539|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501540|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501541|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501542|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501543|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501544|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
145501545|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
145501546|NCT02113982|524695683|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501547|NCT02113982|524695684|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501548|NCT02113982|524695685|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501549|NCT02113982|524695686|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501550|NCT02113982|524695687|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501551|NCT02113982|524695688|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501552|NCT02113982|524695689|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501553|NCT02113982|524695690|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501554|NCT02113982|524695691|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501555|NCT02113982|524695692|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501556|NCT02113982|524695693|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501557|NCT02113982|524695694|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501558|NCT02113982|524695695|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
145501559|NCT02113982|524695696|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
145501560|NCT03763877|524695705|FG000|Overall Study|Withdrawal by Subject|3|||
145501561|NCT03763877|524695706|FG001|Overall Study|Withdrawal by Subject|1|||
145501562|NCT03763877|524695707|FG002|Overall Study|Withdrawal by Subject|3|||
145501563|NCT03763877|524695708|FG003|Overall Study|Withdrawal by Subject|4|||
145501564|NCT03763877|524695705|FG000|Overall Study|Adverse Event|1|||
145501565|NCT03763877|524695706|FG001|Overall Study|Adverse Event|1|||
145501566|NCT03763877|524695707|FG002|Overall Study|Adverse Event|3|||
145501567|NCT03763877|524695708|FG003|Overall Study|Adverse Event|1|||
145501568|NCT03763877|524695705|FG000|Overall Study|Protocol Violation|1|||
145501569|NCT03763877|524695706|FG001|Overall Study|Protocol Violation|1|||
145501570|NCT03763877|524695707|FG002|Overall Study|Protocol Violation|0|||
145501571|NCT03763877|524695708|FG003|Overall Study|Protocol Violation|0|||
145501572|NCT03763877|524695705|FG000|Overall Study|Lost to Follow-up|0|||
145501573|NCT03763877|524695706|FG001|Overall Study|Lost to Follow-up|1|||
145501574|NCT03763877|524695707|FG002|Overall Study|Lost to Follow-up|1|||
145501575|NCT03763877|524695708|FG003|Overall Study|Lost to Follow-up|0|||
145501576|NCT03040336|524695709|FG000|Overall Study|Death|1|||
145501577|NCT03040336|524695710|FG001|Overall Study|Death|0|||
145501578|NCT03040336|524695709|FG000|Overall Study|Withdrawal by Subject|2|||
145501579|NCT03040336|524695710|FG001|Overall Study|Withdrawal by Subject|3|||
145501580|NCT01600716|524695715|FG000|Overall Study|Other Reasons|3|||
145501581|NCT01600716|524695716|FG001|Overall Study|Other Reasons|1|||
145501582|NCT01600716|524695715|FG000|Overall Study|Personal Reasons|0|||
145501583|NCT01600716|524695716|FG001|Overall Study|Personal Reasons|2|||
145501584|NCT01600716|524695715|FG000|Overall Study|Lost to Follow-up|0|||
145501585|NCT01600716|524695716|FG001|Overall Study|Lost to Follow-up|2|||
145501586|NCT01600716|524695715|FG000|Overall Study|Pregnancy|1|||
145501587|NCT01600716|524695716|FG001|Overall Study|Pregnancy|0|||
145501588|NCT01600716|524695715|FG000|Overall Study|Lack of Efficacy|2|||
145501589|NCT01600716|524695716|FG001|Overall Study|Lack of Efficacy|1|||
145266689|NCT04668066|523825242|FG005|Part 1: Follow-Up|Other|0|||
145501590|NCT01600716|524695715|FG000|Overall Study|Adverse Event|1|||
145501591|NCT01600716|524695716|FG001|Overall Study|Adverse Event|1|||
145501592|NCT01759446|524695721|FG000|Overall Study|Protocol Violation|1|||
145501593|NCT01759446|524695722|FG001|Overall Study|Protocol Violation|0|||
145501594|NCT01759446|524695723|FG002|Overall Study|Protocol Violation|1|||
145501595|NCT01759446|524695724|FG003|Overall Study|Protocol Violation|0|||
145398157|NCT03528551|524313474|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145398158|NCT03528551|524313475|FG001|Overall Study|Withdrawal by parent/guardian|5|||
145398159|NCT03528551|524313476|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145398160|NCT03528551|524313474|FG000|Overall Study|Protocol Violation|0|||
145398161|NCT03528551|524313475|FG001|Overall Study|Protocol Violation|3|||
145398162|NCT03528551|524313476|FG002|Overall Study|Protocol Violation|0|||
145398163|NCT03528551|524313474|FG000|Overall Study|Withdrawal by Subject|0|||
145398164|NCT03528551|524313475|FG001|Overall Study|Withdrawal by Subject|7|||
145398165|NCT03528551|524313476|FG002|Overall Study|Withdrawal by Subject|0|||
145398166|NCT01939314|524313479|FG000|Overall Study|Withdrawal by Subject|3|||
145398167|NCT01939314|524313480|FG001|Overall Study|Withdrawal by Subject|1|||
145398168|NCT01939314|524313479|FG000|Overall Study|Protocol Violation|1|||
145398169|NCT01939314|524313480|FG001|Overall Study|Protocol Violation|0|||
145398170|NCT01939314|524313479|FG000|Overall Study|Pregnancy|0|||
145398171|NCT01939314|524313480|FG001|Overall Study|Pregnancy|1|||
145398172|NCT01939314|524313479|FG000|Overall Study|Lost to Follow-up|5|||
145398173|NCT01939314|524313480|FG001|Overall Study|Lost to Follow-up|6|||
145398174|NCT01789047|524313481|FG000|Overall Study|Adverse Event|3|||
145398175|NCT01789047|524313482|FG001|Overall Study|Adverse Event|2|||
145398176|NCT01789047|524313481|FG000|Overall Study|Withdrawal by Subject|1|||
145398177|NCT01789047|524313482|FG001|Overall Study|Withdrawal by Subject|2|||
145398178|NCT02668640|524313483|FG000|Overall Study|Lost to Follow-up|13|||
145398179|NCT02668640|524313483|FG000|Overall Study|Other, not specified|1|||
145398180|NCT02322749|524313486|FG000|Period 2|Adverse Event|0|||
145398181|NCT02322749|524313487|FG001|Period 2|Adverse Event|0|||
145398182|NCT02322749|524313488|FG002|Period 2|Adverse Event|0|||
145398183|NCT02322749|524313489|FG003|Period 2|Adverse Event|1|||
145398184|NCT02322749|524313490|FG004|Period 2|Adverse Event|0|||
145398185|NCT02322749|524313491|FG005|Period 2|Adverse Event|0|||
145398186|NCT02322749|524313486|FG000|Period 2|Withdrawal by Subject|0|||
145398187|NCT02322749|524313487|FG001|Period 2|Withdrawal by Subject|0|||
145398188|NCT02322749|524313488|FG002|Period 2|Withdrawal by Subject|0|||
145398189|NCT02322749|524313489|FG003|Period 2|Withdrawal by Subject|1|||
145398190|NCT02322749|524313490|FG004|Period 2|Withdrawal by Subject|0|||
145398191|NCT02322749|524313491|FG005|Period 2|Withdrawal by Subject|0|||
145398192|NCT02322749|524313486|FG000|Period 3|Withdrawal by Subject|0|||
145398193|NCT02322749|524313487|FG001|Period 3|Withdrawal by Subject|0|||
145398194|NCT02322749|524313488|FG002|Period 3|Withdrawal by Subject|1|||
145398195|NCT02322749|524313489|FG003|Period 3|Withdrawal by Subject|0|||
145398196|NCT02322749|524313490|FG004|Period 3|Withdrawal by Subject|0|||
145398197|NCT02322749|524313491|FG005|Period 3|Withdrawal by Subject|0|||
145398198|NCT00073918|524313492|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
145398199|NCT00073918|524313492|FG000|Overall Study|Rapid disease progression|2|||
145398200|NCT00073918|524313492|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
145398201|NCT01190813|524313493|FG000|Overall Study|Lost to Follow-up|1|||
145398202|NCT01190813|524313494|FG001|Overall Study|Lost to Follow-up|2|||
145398203|NCT01190813|524313493|FG000|Overall Study|Withdrawal by Subject|2|||
145398204|NCT01190813|524313494|FG001|Overall Study|Withdrawal by Subject|1|||
145398205|NCT01190813|524313493|FG000|Overall Study|Refused study treatment after randomized|1|||
145398206|NCT01190813|524313494|FG001|Overall Study|Refused study treatment after randomized|0|||
145398207|NCT01190813|524313493|FG000|Overall Study|Adverse Event|0|||
145398208|NCT01190813|524313494|FG001|Overall Study|Adverse Event|1|||
145398209|NCT04821830|524313497|FG000|Overall Study|Withdrawal by Subject|1|||
145398210|NCT04821830|524313498|FG001|Overall Study|Withdrawal by Subject|0|||
145398211|NCT00919633|524313499|FG000|Overall Study|Adverse Event|1|||
145398212|NCT00919633|524313500|FG001|Overall Study|Adverse Event|9|||
145398213|NCT00919633|524313501|FG002|Overall Study|Adverse Event|12|||
145398214|NCT00919633|524313502|FG003|Overall Study|Adverse Event|10|||
145398215|NCT00919633|524313499|FG000|Overall Study|Death|0|||
145398216|NCT00919633|524313500|FG001|Overall Study|Death|0|||
145398217|NCT00919633|524313501|FG002|Overall Study|Death|2|||
145398218|NCT00919633|524313502|FG003|Overall Study|Death|0|||
145398219|NCT00919633|524313499|FG000|Overall Study|Lack of Efficacy|17|||
145398220|NCT00919633|524313500|FG001|Overall Study|Lack of Efficacy|3|||
145398221|NCT00919633|524313501|FG002|Overall Study|Lack of Efficacy|2|||
145398222|NCT00919633|524313502|FG003|Overall Study|Lack of Efficacy|3|||
145398223|NCT00919633|524313499|FG000|Overall Study|Withdrawal by Subject|1|||
145398224|NCT00919633|524313500|FG001|Overall Study|Withdrawal by Subject|2|||
145398225|NCT00919633|524313501|FG002|Overall Study|Withdrawal by Subject|4|||
145398226|NCT00919633|524313502|FG003|Overall Study|Withdrawal by Subject|3|||
145501596|NCT01759446|524695725|FG004|Overall Study|Protocol Violation|0|||
145501597|NCT01759446|524695721|FG000|Overall Study|Withdrawal by Subject|0|||
145501598|NCT01759446|524695722|FG001|Overall Study|Withdrawal by Subject|1|||
145501599|NCT01759446|524695723|FG002|Overall Study|Withdrawal by Subject|0|||
145501600|NCT01759446|524695724|FG003|Overall Study|Withdrawal by Subject|1|||
145501601|NCT01759446|524695725|FG004|Overall Study|Withdrawal by Subject|0|||
145501602|NCT01760733|524695726|FG000|Waiting List|Death|18|||
145501603|NCT01760733|524695726|FG000|Waiting List|Removed from waiting list|41|||
145501604|NCT01760733|524695726|FG000|Waiting List|Not received a transplant yet|13|||
145501605|NCT01760733|524695726|FG000|Transplanted|Not reached 10 years post transplant|184|||
145501606|NCT01760733|524695726|FG000|Transplanted|Death|26|||
145501607|NCT01760733|524695726|FG000|Transplanted|Graft loss|7|||
145501608|NCT00815659|524695727|FG000|Overall Study|Adverse Event|9|||
145501609|NCT00815659|524695727|FG000|Overall Study|Withdrawal by Subject|9|||
145501610|NCT00815659|524695727|FG000|Overall Study|Lost to Follow-up|4|||
145501611|NCT00815659|524695727|FG000|Overall Study|Protocol Violation|1|||
145501612|NCT02395471|524695728|FG000|Overall Study|Lost to Follow-up|2|||
145501613|NCT02395471|524695729|FG001|Overall Study|Lost to Follow-up|0|||
145501614|NCT02395471|524695728|FG000|Overall Study|Withdrawal by Subject|2|||
145501615|NCT02395471|524695729|FG001|Overall Study|Withdrawal by Subject|1|||
145501616|NCT02395471|524695728|FG000|Overall Study|Physician Decision|1|||
145501617|NCT02395471|524695729|FG001|Overall Study|Physician Decision|0|||
145501618|NCT02395471|524695728|FG000|Overall Study|Protocol Violation|0|||
145501619|NCT02395471|524695729|FG001|Overall Study|Protocol Violation|1|||
145501620|NCT02395471|524695728|FG000|Overall Study|Failure to swollow sponge twice|1|||
145501621|NCT02395471|524695729|FG001|Overall Study|Failure to swollow sponge twice|0|||
145501622|NCT02395471|524695728|FG000|Overall Study|Patient did not return for procedure|0|||
145501623|NCT02395471|524695729|FG001|Overall Study|Patient did not return for procedure|1|||
145501624|NCT02395471|524695728|FG000|Overall Study|Subject not eligible|1|||
145501625|NCT02395471|524695729|FG001|Overall Study|Subject not eligible|0|||
145501626|NCT03847896|524695730|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
145501627|NCT03847896|524695731|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
145501628|NCT03847896|524695732|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
145501629|NCT03847896|524695733|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
145501630|NCT03847896|524695734|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
145501631|NCT03847896|524695730|FG000|Overall Study|Withdrawal by Subject|2|||
145501632|NCT03847896|524695731|FG001|Overall Study|Withdrawal by Subject|10|||
145501633|NCT03847896|524695732|FG002|Overall Study|Withdrawal by Subject|5|||
145501634|NCT03847896|524695733|FG003|Overall Study|Withdrawal by Subject|9|||
145501635|NCT03847896|524695734|FG004|Overall Study|Withdrawal by Subject|8|||
145501636|NCT03847896|524695730|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145501637|NCT03847896|524695731|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145501638|NCT03847896|524695732|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145501639|NCT03847896|524695733|FG003|Overall Study|Withdrawal by parent/guardian|0|||
145501640|NCT03847896|524695734|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145501641|NCT03847896|524695730|FG000|Overall Study|Adverse Event|2|||
145501642|NCT03847896|524695731|FG001|Overall Study|Adverse Event|1|||
145501643|NCT03847896|524695732|FG002|Overall Study|Adverse Event|3|||
145501644|NCT03847896|524695733|FG003|Overall Study|Adverse Event|2|||
145501645|NCT03847896|524695734|FG004|Overall Study|Adverse Event|4|||
145501646|NCT03847896|524695730|FG000|Overall Study|A severe exacerbation event|0|||
145501647|NCT03847896|524695731|FG001|Overall Study|A severe exacerbation event|0|||
145501648|NCT03847896|524695732|FG002|Overall Study|A severe exacerbation event|0|||
145501649|NCT03847896|524695733|FG003|Overall Study|A severe exacerbation event|0|||
145501650|NCT03847896|524695734|FG004|Overall Study|A severe exacerbation event|3|||
145501651|NCT03847896|524695730|FG000|Overall Study|Protocol Violation|0|||
145501652|NCT03847896|524695731|FG001|Overall Study|Protocol Violation|2|||
145501653|NCT03847896|524695732|FG002|Overall Study|Protocol Violation|1|||
145501654|NCT03847896|524695733|FG003|Overall Study|Protocol Violation|0|||
145501655|NCT03847896|524695734|FG004|Overall Study|Protocol Violation|2|||
145501656|NCT03847896|524695730|FG000|Overall Study|Lost to Follow-up|0|||
145501657|NCT03847896|524695731|FG001|Overall Study|Lost to Follow-up|0|||
145501658|NCT03847896|524695732|FG002|Overall Study|Lost to Follow-up|0|||
145501659|NCT03847896|524695733|FG003|Overall Study|Lost to Follow-up|1|||
145501660|NCT03847896|524695734|FG004|Overall Study|Lost to Follow-up|0|||
145501661|NCT03847896|524695730|FG000|Overall Study|Condition under investigation worsened|0|||
145501662|NCT03847896|524695731|FG001|Overall Study|Condition under investigation worsened|0|||
145501663|NCT03847896|524695732|FG002|Overall Study|Condition under investigation worsened|0|||
145501664|NCT03847896|524695733|FG003|Overall Study|Condition under investigation worsened|1|||
145501665|NCT03847896|524695734|FG004|Overall Study|Condition under investigation worsened|1|||
145501666|NCT03847896|524695730|FG000|Overall Study|Lack of Efficacy|0|||
145501667|NCT03847896|524695731|FG001|Overall Study|Lack of Efficacy|0|||
145501668|NCT03847896|524695732|FG002|Overall Study|Lack of Efficacy|0|||
145501669|NCT03847896|524695733|FG003|Overall Study|Lack of Efficacy|2|||
145501670|NCT03847896|524695734|FG004|Overall Study|Lack of Efficacy|2|||
145501671|NCT03847896|524695730|FG000|Overall Study|Other reasons|3|||
145501672|NCT03847896|524695731|FG001|Overall Study|Other reasons|3|||
145501673|NCT03847896|524695732|FG002|Overall Study|Other reasons|1|||
145501674|NCT03847896|524695733|FG003|Overall Study|Other reasons|2|||
145501675|NCT03847896|524695734|FG004|Overall Study|Other reasons|1|||
145501676|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
145501677|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
145501678|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Adverse Event|31|||
145501679|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Adverse Event|21|||
145501680|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
145501681|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
145501682|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
145501683|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
145501684|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
145501685|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
145501686|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
145501687|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
145501688|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Administrative problems|3|||
145501689|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Administrative problems|3|||
145501690|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Death|5|||
145501691|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Death|8|||
145501692|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Disease progression|139|||
145501693|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Disease progression|119|||
145501694|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
145501695|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
145501696|NCT00785785|524695735|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
145501697|NCT00785785|524695736|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
145501698|NCT00785785|524695735|FG000|Optional Extension Phase|Adverse Event|4|||
145501699|NCT00785785|524695736|FG001|Optional Extension Phase|Adverse Event|5|||
145501700|NCT00785785|524695735|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
145501701|NCT00785785|524695736|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
145501702|NCT00785785|524695735|FG000|Optional Extension Phase|Lost to Follow-up|1|||
145501703|NCT00785785|524695736|FG001|Optional Extension Phase|Lost to Follow-up|0|||
145501704|NCT00785785|524695735|FG000|Optional Extension Phase|Administrative problems|2|||
145501705|NCT00785785|524695736|FG001|Optional Extension Phase|Administrative problems|0|||
145501706|NCT00785785|524695735|FG000|Optional Extension Phase|Death|1|||
145501707|NCT00785785|524695736|FG001|Optional Extension Phase|Death|5|||
145501708|NCT00785785|524695735|FG000|Optional Extension Phase|Disease progression|22|||
145501709|NCT00785785|524695736|FG001|Optional Extension Phase|Disease progression|70|||
145501710|NCT00785785|524695735|FG000|Optional Extension Phase|Protocol deviation|0|||
145501711|NCT00785785|524695736|FG001|Optional Extension Phase|Protocol deviation|2|||
145501712|NCT00785785|524695735|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
145501713|NCT00785785|524695736|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
145501714|NCT01244893|524695737|FG000|Baseline|Protocol Violation|0|||
145501715|NCT01244893|524695738|FG001|Baseline|Protocol Violation|1|||
145501716|NCT01244893|524695737|FG000|1-Week Follow Up|Lost to Follow-up|1|||
145501717|NCT01244893|524695738|FG001|1-Week Follow Up|Lost to Follow-up|0|||
145501718|NCT00357552|524695739|FG000|Screening|Did not meet eligibility criteria|84|||
145501719|NCT00357552|524695739|FG000|Weeks 0 to 24|Death|1|||
145501720|NCT00357552|524695739|FG000|Weeks 24 to 104|Death|3|||
145501721|NCT00357552|524695739|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
145501722|NCT00882557|524695746|FG000|Overall Study|Withdrawal by Subject|1|||
145501723|NCT00882557|524695747|FG001|Overall Study|Withdrawal by Subject|0|||
145501724|NCT00882557|524695746|FG000|Overall Study|Trouble with Vein Access|1|||
145501725|NCT00882557|524695747|FG001|Overall Study|Trouble with Vein Access|0|||
145501726|NCT00882557|524695746|FG000|Overall Study|Randomized Not Treated|0|||
145501727|NCT00882557|524695747|FG001|Overall Study|Randomized Not Treated|1|||
145501728|NCT00823615|524695752|FG000|Period 2|Lost to Follow-up|2|||
145501729|NCT00823615|524695753|FG001|Period 2|Lost to Follow-up|0|||
145501730|NCT00823615|524695752|FG000|Period 2|Time/Job Conflict|1|||
145501731|NCT00823615|524695753|FG001|Period 2|Time/Job Conflict|2|||
145501732|NCT02404025|524695754|FG000|Overall Study|Adverse Event|1|||
145501733|NCT02404025|524695754|FG000|Overall Study|Lack of Efficacy|3|||
145501734|NCT00905164|524695760|FG000|Period 1|Protocol Violation|0|||
145501735|NCT00905164|524695761|FG001|Period 1|Protocol Violation|1|||
145501736|NCT01646125|524697962|FG000|Overall Study|Untreated|2|||
145501737|NCT01646125|524697963|FG001|Overall Study|Untreated|5|||
145501738|NCT01646125|524697962|FG000|Overall Study|Adverse Event|2|||
145501739|NCT01646125|524697963|FG001|Overall Study|Adverse Event|1|||
145501740|NCT01646125|524697962|FG000|Overall Study|Death|1|||
145501741|NCT01646125|524697963|FG001|Overall Study|Death|1|||
145501742|NCT01646125|524697962|FG000|Overall Study|Physician Decision|1|||
145501743|NCT01646125|524697963|FG001|Overall Study|Physician Decision|3|||
145501744|NCT01646125|524697962|FG000|Overall Study|Progressive disease|22|||
145501745|NCT01646125|524697963|FG001|Overall Study|Progressive disease|16|||
145501746|NCT01646125|524697962|FG000|Overall Study|Study terminated by sponsor|2|||
145501747|NCT01646125|524697963|FG001|Overall Study|Study terminated by sponsor|1|||
145501748|NCT01646125|524697962|FG000|Overall Study|Subject/Guardian decision|1|||
145501749|NCT01646125|524697963|FG001|Overall Study|Subject/Guardian decision|1|||
145501750|NCT00918255|524697968|FG000|Overall Study|Adverse Event|1|||
145501751|NCT00918255|524697969|FG001|Overall Study|Adverse Event|0|||
145501752|NCT00918255|524697970|FG002|Overall Study|Adverse Event|0|||
145501753|NCT00918255|524697968|FG000|Overall Study|Withdrawal by Subject|1|||
145501754|NCT00918255|524697969|FG001|Overall Study|Withdrawal by Subject|0|||
145501755|NCT00918255|524697970|FG002|Overall Study|Withdrawal by Subject|2|||
145501756|NCT00918255|524697968|FG000|Overall Study|Lack of Efficacy|1|||
145501757|NCT00918255|524697969|FG001|Overall Study|Lack of Efficacy|0|||
145501758|NCT00918255|524697970|FG002|Overall Study|Lack of Efficacy|0|||
145501759|NCT00918255|524697968|FG000|Overall Study|Lost to Follow-up|1|||
145501760|NCT00918255|524697969|FG001|Overall Study|Lost to Follow-up|0|||
145501761|NCT00918255|524697970|FG002|Overall Study|Lost to Follow-up|2|||
145501762|NCT00918255|524697968|FG000|Overall Study|Exceeded allowed number of interventions|0|||
145501763|NCT00918255|524697969|FG001|Overall Study|Exceeded allowed number of interventions|0|||
145501764|NCT00918255|524697970|FG002|Overall Study|Exceeded allowed number of interventions|1|||
145501765|NCT00918255|524697968|FG000|Overall Study|Non-compliance|1|||
145501766|NCT00918255|524697969|FG001|Overall Study|Non-compliance|0|||
145501767|NCT00918255|524697970|FG002|Overall Study|Non-compliance|0|||
145501768|NCT00918255|524697968|FG000|Overall Study|Investigator discretion|1|||
145501769|NCT00918255|524697969|FG001|Overall Study|Investigator discretion|0|||
145501770|NCT00918255|524697970|FG002|Overall Study|Investigator discretion|0|||
145501771|NCT00068692|524697972|FG000|Step 1: Registration|Disese progression/relapse|5|||
145501772|NCT00068692|524697973|FG001|Step 1: Registration|Disese progression/relapse|0|||
145501773|NCT00068692|524697974|FG002|Step 1: Registration|Disese progression/relapse|0|||
145501774|NCT00068692|524697975|FG003|Step 1: Registration|Disese progression/relapse|0|||
145501775|NCT00068692|524697976|FG004|Step 1: Registration|Disese progression/relapse|0|||
145501776|NCT00068692|524697977|FG005|Step 1: Registration|Disese progression/relapse|0|||
145501777|NCT00068692|524697978|FG006|Step 1: Registration|Disese progression/relapse|0|||
145501778|NCT00068692|524697979|FG007|Step 1: Registration|Disese progression/relapse|0|||
145501779|NCT00068692|524697972|FG000|Step 1: Registration|Adverse Event|7|||
145501780|NCT00068692|524697973|FG001|Step 1: Registration|Adverse Event|0|||
145501781|NCT00068692|524697974|FG002|Step 1: Registration|Adverse Event|0|||
145501782|NCT00068692|524697975|FG003|Step 1: Registration|Adverse Event|0|||
145501783|NCT00068692|524697976|FG004|Step 1: Registration|Adverse Event|0|||
145501784|NCT00068692|524697977|FG005|Step 1: Registration|Adverse Event|0|||
145501785|NCT00068692|524697978|FG006|Step 1: Registration|Adverse Event|0|||
145501786|NCT00068692|524697979|FG007|Step 1: Registration|Adverse Event|0|||
145501787|NCT00068692|524697972|FG000|Step 1: Registration|Death|1|||
145501788|NCT00068692|524697973|FG001|Step 1: Registration|Death|0|||
145501789|NCT00068692|524697974|FG002|Step 1: Registration|Death|0|||
145501790|NCT00068692|524697975|FG003|Step 1: Registration|Death|0|||
145501791|NCT00068692|524697976|FG004|Step 1: Registration|Death|0|||
145501792|NCT00068692|524697977|FG005|Step 1: Registration|Death|0|||
145501793|NCT00068692|524697978|FG006|Step 1: Registration|Death|0|||
145501794|NCT00068692|524697979|FG007|Step 1: Registration|Death|0|||
145501795|NCT00068692|524697972|FG000|Step 1: Registration|Withdrawal by Subject|11|||
145501796|NCT00068692|524697973|FG001|Step 1: Registration|Withdrawal by Subject|0|||
145501797|NCT00068692|524697974|FG002|Step 1: Registration|Withdrawal by Subject|0|||
145501798|NCT00068692|524697975|FG003|Step 1: Registration|Withdrawal by Subject|0|||
145501799|NCT00068692|524697976|FG004|Step 1: Registration|Withdrawal by Subject|0|||
145501800|NCT00068692|524697977|FG005|Step 1: Registration|Withdrawal by Subject|0|||
145501801|NCT00068692|524697978|FG006|Step 1: Registration|Withdrawal by Subject|0|||
145501802|NCT00068692|524697979|FG007|Step 1: Registration|Withdrawal by Subject|0|||
145501803|NCT00068692|524697972|FG000|Step 1: Registration|Alternative therapy|2|||
145501804|NCT00068692|524697973|FG001|Step 1: Registration|Alternative therapy|0|||
145501805|NCT00068692|524697974|FG002|Step 1: Registration|Alternative therapy|0|||
145501806|NCT00068692|524697975|FG003|Step 1: Registration|Alternative therapy|0|||
145501807|NCT00068692|524697976|FG004|Step 1: Registration|Alternative therapy|0|||
145501808|NCT00068692|524697977|FG005|Step 1: Registration|Alternative therapy|0|||
145501809|NCT00068692|524697978|FG006|Step 1: Registration|Alternative therapy|0|||
145501810|NCT00068692|524697979|FG007|Step 1: Registration|Alternative therapy|0|||
145398227|NCT00919633|524313499|FG000|Overall Study|Lost to Follow-up|3|||
145398228|NCT00919633|524313500|FG001|Overall Study|Lost to Follow-up|1|||
145398229|NCT00919633|524313501|FG002|Overall Study|Lost to Follow-up|0|||
145398230|NCT00919633|524313502|FG003|Overall Study|Lost to Follow-up|2|||
145398231|NCT00919633|524313499|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
145398232|NCT00919633|524313500|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
145398233|NCT00919633|524313501|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
145398234|NCT00919633|524313502|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
145398235|NCT00919633|524313499|FG000|Overall Study|Protocol Violation|0|||
145398236|NCT00919633|524313500|FG001|Overall Study|Protocol Violation|0|||
145398237|NCT00919633|524313501|FG002|Overall Study|Protocol Violation|0|||
145398238|NCT00919633|524313502|FG003|Overall Study|Protocol Violation|1|||
145398239|NCT00919633|524313499|FG000|Overall Study|Physician Decision|0|||
145398240|NCT00919633|524313500|FG001|Overall Study|Physician Decision|0|||
145398241|NCT00919633|524313501|FG002|Overall Study|Physician Decision|0|||
145398242|NCT00919633|524313502|FG003|Overall Study|Physician Decision|1|||
145398243|NCT00919633|524313499|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
145398244|NCT00919633|524313500|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
145398245|NCT00919633|524313501|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
145398246|NCT00919633|524313502|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
145398247|NCT00919633|524313499|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
145398248|NCT00919633|524313500|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
145398249|NCT00919633|524313501|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
145398250|NCT00919633|524313502|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
145398251|NCT05630196|524314698|FG000|Overall Study|Adverse Event|2|||
145398252|NCT05630196|524314699|FG001|Overall Study|Adverse Event|1|||
145398253|NCT05630196|524314698|FG000|Overall Study|Lost to Follow-up|1|||
145398254|NCT05630196|524314699|FG001|Overall Study|Lost to Follow-up|1|||
145398255|NCT05630196|524314698|FG000|Overall Study|Protocol Violation|2|||
145398256|NCT05630196|524314699|FG001|Overall Study|Protocol Violation|3|||
145398257|NCT05630196|524314698|FG000|Overall Study|Physician Decision|1|||
145398258|NCT05630196|524314699|FG001|Overall Study|Physician Decision|0|||
145398259|NCT05630196|524314698|FG000|Overall Study|Withdrawal by Subject|3|||
145398260|NCT05630196|524314699|FG001|Overall Study|Withdrawal by Subject|4|||
145398261|NCT01655901|524314703|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145398262|NCT01655901|524314704|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145398263|NCT01655901|524314705|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145398264|NCT01655901|524314706|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
145398265|NCT01655901|524314707|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
145398266|NCT01655901|524314708|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
145398267|NCT00352118|524314709|FG000|Overall Study|Physician Decision|4|||
145398268|NCT00870727|524314710|FG000|Overall Study|Lost to Follow-up|0|||
145398269|NCT00870727|524314711|FG001|Overall Study|Lost to Follow-up|1|||
145398270|NCT00870727|524314710|FG000|Overall Study|Lack of Efficacy|1|||
145398271|NCT00870727|524314711|FG001|Overall Study|Lack of Efficacy|3|||
145398272|NCT00870727|524314710|FG000|Overall Study|Adverse Event|0|||
145398273|NCT00870727|524314711|FG001|Overall Study|Adverse Event|1|||
145398274|NCT00557466|524314712|FG000|Overall Study|Adverse Event|3|||
145398275|NCT00557466|524314713|FG001|Overall Study|Adverse Event|1|||
145398276|NCT00557466|524314714|FG002|Overall Study|Adverse Event|4|||
145398277|NCT00557466|524314715|FG003|Overall Study|Adverse Event|1|||
145398278|NCT00557466|524314716|FG004|Overall Study|Adverse Event|2|||
145398279|NCT00557466|524314717|FG005|Overall Study|Adverse Event|4|||
145398280|NCT00557466|524314712|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145398281|NCT00557466|524314713|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145398282|NCT00557466|524314714|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145398283|NCT00557466|524314715|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145398284|NCT00557466|524314716|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145398285|NCT00557466|524314717|FG005|Overall Study|Abnormal laboratory value(s)|0|||
145398286|NCT00557466|524314712|FG000|Overall Study|Protocol deviation|0|||
145398287|NCT00557466|524314713|FG001|Overall Study|Protocol deviation|1|||
145398288|NCT00557466|524314714|FG002|Overall Study|Protocol deviation|0|||
145398289|NCT00557466|524314715|FG003|Overall Study|Protocol deviation|2|||
145398290|NCT00557466|524314716|FG004|Overall Study|Protocol deviation|0|||
145398291|NCT00557466|524314717|FG005|Overall Study|Protocol deviation|0|||
145398292|NCT00557466|524314712|FG000|Overall Study|Subject withdrew consent|0|||
145398293|NCT00557466|524314713|FG001|Overall Study|Subject withdrew consent|0|||
145398294|NCT00557466|524314714|FG002|Overall Study|Subject withdrew consent|0|||
145398295|NCT00557466|524314715|FG003|Overall Study|Subject withdrew consent|0|||
145398296|NCT00557466|524314716|FG004|Overall Study|Subject withdrew consent|1|||
145398297|NCT00557466|524314717|FG005|Overall Study|Subject withdrew consent|2|||
145398298|NCT00557466|524314712|FG000|Overall Study|Administrative problems|0|||
145501811|NCT00068692|524697972|FG000|Step 1: Registration|Complicating disease|2|||
145501812|NCT00068692|524697973|FG001|Step 1: Registration|Complicating disease|0|||
145501813|NCT00068692|524697974|FG002|Step 1: Registration|Complicating disease|0|||
145501814|NCT00068692|524697975|FG003|Step 1: Registration|Complicating disease|0|||
145501815|NCT00068692|524697976|FG004|Step 1: Registration|Complicating disease|0|||
145501816|NCT00068692|524697977|FG005|Step 1: Registration|Complicating disease|0|||
145501817|NCT00068692|524697978|FG006|Step 1: Registration|Complicating disease|0|||
145501818|NCT00068692|524697979|FG007|Step 1: Registration|Complicating disease|0|||
145501819|NCT00068692|524697972|FG000|Step 1: Registration|Protocol Violation|1|||
145501820|NCT00068692|524697973|FG001|Step 1: Registration|Protocol Violation|0|||
145501821|NCT00068692|524697974|FG002|Step 1: Registration|Protocol Violation|0|||
145501822|NCT00068692|524697975|FG003|Step 1: Registration|Protocol Violation|0|||
145501823|NCT00068692|524697976|FG004|Step 1: Registration|Protocol Violation|0|||
145501824|NCT00068692|524697977|FG005|Step 1: Registration|Protocol Violation|0|||
145501825|NCT00068692|524697978|FG006|Step 1: Registration|Protocol Violation|0|||
145501826|NCT00068692|524697979|FG007|Step 1: Registration|Protocol Violation|0|||
145501827|NCT00068692|524697972|FG000|Step 1: Registration|Not eligible|6|||
145501828|NCT00068692|524697973|FG001|Step 1: Registration|Not eligible|0|||
145501829|NCT00068692|524697974|FG002|Step 1: Registration|Not eligible|0|||
145501830|NCT00068692|524697975|FG003|Step 1: Registration|Not eligible|0|||
145501831|NCT00068692|524697976|FG004|Step 1: Registration|Not eligible|0|||
145501832|NCT00068692|524697977|FG005|Step 1: Registration|Not eligible|0|||
145501833|NCT00068692|524697978|FG006|Step 1: Registration|Not eligible|0|||
145501834|NCT00068692|524697979|FG007|Step 1: Registration|Not eligible|0|||
145501835|NCT00068692|524697972|FG000|Step 1: Registration|Other|2|||
145501836|NCT00068692|524697973|FG001|Step 1: Registration|Other|0|||
145501837|NCT00068692|524697974|FG002|Step 1: Registration|Other|0|||
145501838|NCT00068692|524697975|FG003|Step 1: Registration|Other|0|||
145501839|NCT00068692|524697976|FG004|Step 1: Registration|Other|0|||
145501840|NCT00068692|524697977|FG005|Step 1: Registration|Other|0|||
145501841|NCT00068692|524697978|FG006|Step 1: Registration|Other|0|||
145501842|NCT00068692|524697979|FG007|Step 1: Registration|Other|0|||
145501843|NCT00068692|524697972|FG000|Step 1: Registration|Not start protocol therapy|3|||
145501844|NCT00068692|524697973|FG001|Step 1: Registration|Not start protocol therapy|0|||
145501845|NCT00068692|524697974|FG002|Step 1: Registration|Not start protocol therapy|0|||
145501846|NCT00068692|524697975|FG003|Step 1: Registration|Not start protocol therapy|0|||
145501847|NCT00068692|524697976|FG004|Step 1: Registration|Not start protocol therapy|0|||
145501848|NCT00068692|524697977|FG005|Step 1: Registration|Not start protocol therapy|0|||
145501849|NCT00068692|524697978|FG006|Step 1: Registration|Not start protocol therapy|0|||
145501850|NCT00068692|524697979|FG007|Step 1: Registration|Not start protocol therapy|0|||
145501851|NCT00068692|524697972|FG000|Step 1: Registration|Registered but not randomized|0|||
145501852|NCT00068692|524697973|FG001|Step 1: Registration|Registered but not randomized|1|||
145501853|NCT00068692|524697974|FG002|Step 1: Registration|Registered but not randomized|0|||
145501854|NCT00068692|524697975|FG003|Step 1: Registration|Registered but not randomized|0|||
145501855|NCT00068692|524697976|FG004|Step 1: Registration|Registered but not randomized|0|||
145501856|NCT00068692|524697977|FG005|Step 1: Registration|Registered but not randomized|0|||
145501857|NCT00068692|524697978|FG006|Step 1: Registration|Registered but not randomized|0|||
145501858|NCT00068692|524697979|FG007|Step 1: Registration|Registered but not randomized|0|||
145501859|NCT00068692|524697972|FG000|Step 2: Randomization|Disesae progression/replase|0|||
145501860|NCT00068692|524697973|FG001|Step 2: Randomization|Disesae progression/replase|0|||
145501861|NCT00068692|524697974|FG002|Step 2: Randomization|Disesae progression/replase|1|||
145501862|NCT00068692|524697975|FG003|Step 2: Randomization|Disesae progression/replase|1|||
145501863|NCT00068692|524697976|FG004|Step 2: Randomization|Disesae progression/replase|0|||
145501864|NCT00068692|524697977|FG005|Step 2: Randomization|Disesae progression/replase|0|||
145501865|NCT00068692|524697978|FG006|Step 2: Randomization|Disesae progression/replase|0|||
145501866|NCT00068692|524697979|FG007|Step 2: Randomization|Disesae progression/replase|0|||
145501867|NCT00068692|524697972|FG000|Step 2: Randomization|Adverse Event|0|||
145501868|NCT00068692|524697973|FG001|Step 2: Randomization|Adverse Event|0|||
145501869|NCT00068692|524697974|FG002|Step 2: Randomization|Adverse Event|4|||
145501870|NCT00068692|524697975|FG003|Step 2: Randomization|Adverse Event|2|||
145501871|NCT00068692|524697976|FG004|Step 2: Randomization|Adverse Event|2|||
145501872|NCT00068692|524697977|FG005|Step 2: Randomization|Adverse Event|3|||
145501873|NCT00068692|524697978|FG006|Step 2: Randomization|Adverse Event|4|||
145501874|NCT00068692|524697979|FG007|Step 2: Randomization|Adverse Event|4|||
145501875|NCT00068692|524697972|FG000|Step 2: Randomization|Death|0|||
145501876|NCT00068692|524697973|FG001|Step 2: Randomization|Death|0|||
145501877|NCT00068692|524697974|FG002|Step 2: Randomization|Death|0|||
145501878|NCT00068692|524697975|FG003|Step 2: Randomization|Death|0|||
145501879|NCT00068692|524697976|FG004|Step 2: Randomization|Death|1|||
145501880|NCT00068692|524697977|FG005|Step 2: Randomization|Death|0|||
145501881|NCT00068692|524697978|FG006|Step 2: Randomization|Death|0|||
145501882|NCT00068692|524697979|FG007|Step 2: Randomization|Death|1|||
145501883|NCT00068692|524697972|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
145501884|NCT00068692|524697973|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
145266690|NCT04668066|523825243|FG006|Part 1: Follow-Up|Other|0|||
145398299|NCT00557466|524314713|FG001|Overall Study|Administrative problems|1|||
145398300|NCT00557466|524314714|FG002|Overall Study|Administrative problems|1|||
145398301|NCT00557466|524314715|FG003|Overall Study|Administrative problems|0|||
145398302|NCT00557466|524314716|FG004|Overall Study|Administrative problems|0|||
145398303|NCT00557466|524314717|FG005|Overall Study|Administrative problems|0|||
145398304|NCT00557466|524314712|FG000|Overall Study|Abnormal test procedure results|0|||
145398305|NCT00557466|524314713|FG001|Overall Study|Abnormal test procedure results|0|||
145398306|NCT00557466|524314714|FG002|Overall Study|Abnormal test procedure results|1|||
145398307|NCT00557466|524314715|FG003|Overall Study|Abnormal test procedure results|0|||
145398308|NCT00557466|524314716|FG004|Overall Study|Abnormal test procedure results|0|||
145398309|NCT00557466|524314717|FG005|Overall Study|Abnormal test procedure results|0|||
145398310|NCT00557466|524314712|FG000|Overall Study|Lost to Follow-up|0|||
145398311|NCT00557466|524314713|FG001|Overall Study|Lost to Follow-up|0|||
145398312|NCT00557466|524314714|FG002|Overall Study|Lost to Follow-up|0|||
145398313|NCT00557466|524314715|FG003|Overall Study|Lost to Follow-up|1|||
145398314|NCT00557466|524314716|FG004|Overall Study|Lost to Follow-up|0|||
145398315|NCT00557466|524314717|FG005|Overall Study|Lost to Follow-up|0|||
145398316|NCT01712516|524314718|FG000|Overall Study|Technical problems|0|||
145398317|NCT01712516|524314719|FG001|Overall Study|Technical problems|0|||
145398318|NCT01712516|524314720|FG002|Overall Study|Technical problems|0|||
145398319|NCT01712516|524314721|FG003|Overall Study|Technical problems|2|||
145398320|NCT01712516|524314718|FG000|Overall Study|Lost to Follow-up|0|||
145398321|NCT01712516|524314719|FG001|Overall Study|Lost to Follow-up|0|||
145398322|NCT01712516|524314720|FG002|Overall Study|Lost to Follow-up|2|||
145398323|NCT01712516|524314721|FG003|Overall Study|Lost to Follow-up|1|||
145398324|NCT01712516|524314718|FG000|Overall Study|Death|0|||
145398325|NCT01712516|524314719|FG001|Overall Study|Death|1|||
145398326|NCT01712516|524314720|FG002|Overall Study|Death|0|||
145398327|NCT01712516|524314721|FG003|Overall Study|Death|0|||
145398328|NCT01712516|524314718|FG000|Overall Study|Protocol deviation|1|||
145398329|NCT01712516|524314719|FG001|Overall Study|Protocol deviation|0|||
145398330|NCT01712516|524314720|FG002|Overall Study|Protocol deviation|1|||
145501885|NCT00068692|524697974|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
145501886|NCT00068692|524697975|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
145501887|NCT00068692|524697976|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
145501888|NCT00068692|524697977|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
145501889|NCT00068692|524697978|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
145501890|NCT00068692|524697979|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
145501891|NCT00068692|524697972|FG000|Step 2: Randomization|alternative therapy|0|||
145501892|NCT00068692|524697973|FG001|Step 2: Randomization|alternative therapy|0|||
145501893|NCT00068692|524697974|FG002|Step 2: Randomization|alternative therapy|0|||
145501894|NCT00068692|524697975|FG003|Step 2: Randomization|alternative therapy|1|||
145501895|NCT00068692|524697976|FG004|Step 2: Randomization|alternative therapy|1|||
145501896|NCT00068692|524697977|FG005|Step 2: Randomization|alternative therapy|0|||
145501897|NCT00068692|524697978|FG006|Step 2: Randomization|alternative therapy|0|||
145501898|NCT00068692|524697979|FG007|Step 2: Randomization|alternative therapy|0|||
145501899|NCT00068692|524697972|FG000|Step 2: Randomization|Physician Decision|0|||
145501900|NCT00068692|524697973|FG001|Step 2: Randomization|Physician Decision|0|||
145501901|NCT00068692|524697974|FG002|Step 2: Randomization|Physician Decision|0|||
145501902|NCT00068692|524697975|FG003|Step 2: Randomization|Physician Decision|1|||
145501903|NCT00068692|524697976|FG004|Step 2: Randomization|Physician Decision|1|||
145501904|NCT00068692|524697977|FG005|Step 2: Randomization|Physician Decision|0|||
145501905|NCT00068692|524697978|FG006|Step 2: Randomization|Physician Decision|0|||
145501906|NCT00068692|524697979|FG007|Step 2: Randomization|Physician Decision|0|||
145501907|NCT00068692|524697972|FG000|Step 2: Randomization|Other|0|||
145501908|NCT00068692|524697973|FG001|Step 2: Randomization|Other|0|||
145501909|NCT00068692|524697974|FG002|Step 2: Randomization|Other|0|||
145501910|NCT00068692|524697975|FG003|Step 2: Randomization|Other|1|||
145501911|NCT00068692|524697976|FG004|Step 2: Randomization|Other|0|||
145501912|NCT00068692|524697977|FG005|Step 2: Randomization|Other|1|||
145501913|NCT00068692|524697978|FG006|Step 2: Randomization|Other|0|||
145501914|NCT00068692|524697979|FG007|Step 2: Randomization|Other|0|||
145501915|NCT00068692|524697972|FG000|Step 2: Randomization|never start protocol therapy|0|||
145501916|NCT00068692|524697973|FG001|Step 2: Randomization|never start protocol therapy|0|||
145501917|NCT00068692|524697974|FG002|Step 2: Randomization|never start protocol therapy|1|||
145501918|NCT00068692|524697975|FG003|Step 2: Randomization|never start protocol therapy|0|||
145501919|NCT00068692|524697976|FG004|Step 2: Randomization|never start protocol therapy|1|||
145501920|NCT00068692|524697977|FG005|Step 2: Randomization|never start protocol therapy|0|||
145501921|NCT00068692|524697978|FG006|Step 2: Randomization|never start protocol therapy|0|||
145501922|NCT00068692|524697979|FG007|Step 2: Randomization|never start protocol therapy|0|||
145501923|NCT00248040|524697981|FG000|Overall Study|transplantectomy|2|||
145501924|NCT00248040|524697982|FG001|Overall Study|transplantectomy|1|||
145501925|NCT00248040|524697983|FG002|Overall Study|transplantectomy|3|||
145501926|NCT00248040|524697981|FG000|Overall Study|transplant cancelled post treat start|1|||
145501927|NCT00248040|524697982|FG001|Overall Study|transplant cancelled post treat start|0|||
145501928|NCT00248040|524697983|FG002|Overall Study|transplant cancelled post treat start|0|||
145501929|NCT00248040|524697981|FG000|Overall Study|Death|0|||
145501930|NCT00248040|524697982|FG001|Overall Study|Death|0|||
145501931|NCT00248040|524697983|FG002|Overall Study|Death|1|||
145501932|NCT03557034|524697986|FG000|Overall Study|Withdrawal by Subject|1|||
145501933|NCT03557034|524697987|FG001|Overall Study|Withdrawal by Subject|0|||
145501934|NCT00865566|524697988|FG000|Overall Study|Death|1|||
145501935|NCT00865566|524697989|FG001|Overall Study|Death|11|||
145501936|NCT00865566|524697988|FG000|Overall Study|Lost to Follow-up|314|||
145501937|NCT00865566|524697989|FG001|Overall Study|Lost to Follow-up|315|||
145501938|NCT00865566|524697988|FG000|Overall Study|Withdrawal by Subject|45|||
145501939|NCT00865566|524697989|FG001|Overall Study|Withdrawal by Subject|65|||
145501940|NCT00865566|524697988|FG000|Overall Study|Physician Decision|0|||
145501941|NCT00865566|524697989|FG001|Overall Study|Physician Decision|1|||
145501942|NCT00865566|524697988|FG000|Overall Study|Participant relocated|78|||
145501943|NCT00865566|524697989|FG001|Overall Study|Participant relocated|107|||
145501944|NCT00865566|524697988|FG000|Overall Study|Participant unable to adhere|27|||
145501945|NCT00865566|524697989|FG001|Overall Study|Participant unable to adhere|42|||
145501946|NCT00865566|524697988|FG000|Overall Study|Other; N=245 due to early study closure|154|||
145501947|NCT00865566|524697989|FG001|Overall Study|Other; N=245 due to early study closure|139|||
145501948|NCT00865566|524697988|FG000|Overall Study|HIV infection|5|||
145501949|NCT00865566|524697989|FG001|Overall Study|HIV infection|7|||
145501950|NCT00118417|524697992|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
145501951|NCT00118417|524697993|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
145501952|NCT00118417|524697992|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
145501953|NCT00118417|524697993|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
145501954|NCT00118417|524697992|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
145501955|NCT00118417|524697993|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
145501956|NCT00118417|524697992|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
145501957|NCT00118417|524697993|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
145501958|NCT00118417|524697992|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
145501959|NCT00118417|524697993|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
145501960|NCT02978781|524697994|FG000|Part A|Adverse Event|1|||
145501961|NCT02978781|524697995|FG001|Part A|Adverse Event|1|||
145501962|NCT02978781|524697996|FG002|Part A|Adverse Event|0|||
145501963|NCT02978781|524697997|FG003|Part A|Adverse Event|0|||
145501964|NCT02978781|524697998|FG004|Part A|Adverse Event|0|||
145501965|NCT02978781|524697994|FG000|Part A|Withdrawal by Subject|0|||
145501966|NCT02978781|524697995|FG001|Part A|Withdrawal by Subject|1|||
145501967|NCT02978781|524697996|FG002|Part A|Withdrawal by Subject|0|||
145501968|NCT02978781|524697997|FG003|Part A|Withdrawal by Subject|0|||
145501969|NCT02978781|524697998|FG004|Part A|Withdrawal by Subject|0|||
145501970|NCT02978781|524697994|FG000|Part B|Withdrawal by Subject|0|||
145501971|NCT02978781|524697995|FG001|Part B|Withdrawal by Subject|0|||
145501972|NCT02978781|524697996|FG002|Part B|Withdrawal by Subject|0|||
145501973|NCT02978781|524697997|FG003|Part B|Withdrawal by Subject|1|||
145501974|NCT02978781|524697998|FG004|Part B|Withdrawal by Subject|0|||
145501975|NCT02978781|524697994|FG000|Part C|Adverse Event|0|||
145501976|NCT02978781|524697995|FG001|Part C|Adverse Event|0|||
145501977|NCT02978781|524697996|FG002|Part C|Adverse Event|0|||
145501978|NCT02978781|524697997|FG003|Part C|Adverse Event|0|||
145501979|NCT02978781|524697998|FG004|Part C|Adverse Event|2|||
145501980|NCT02978781|524697994|FG000|Part C|Withdrawal by Subject|0|||
145501981|NCT02978781|524697995|FG001|Part C|Withdrawal by Subject|0|||
145501982|NCT02978781|524697996|FG002|Part C|Withdrawal by Subject|0|||
145501983|NCT02978781|524697997|FG003|Part C|Withdrawal by Subject|0|||
145501984|NCT02978781|524697998|FG004|Part C|Withdrawal by Subject|1|||
145501985|NCT02978781|524697994|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
145501986|NCT02978781|524697995|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
145501987|NCT02978781|524697996|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
145501988|NCT02978781|524697997|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
145501989|NCT02978781|524697998|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
145501990|NCT02282605|524697999|FG000|Overall Study|negative SA result on Day -1|3|||
145501991|NCT02282605|524698000|FG001|Overall Study|negative SA result on Day -1|0|||
145501992|NCT02282605|524698001|FG002|Overall Study|negative SA result on Day -1|0|||
145501993|NCT01528969|524698004|FG000|Overall Study|absent from the school at baseline|2|||
145501994|NCT01528969|524698005|FG001|Overall Study|absent from the school at baseline|0|||
145501995|NCT01383356|524698006|FG000|Period 1|Adverse Event|5|||
145501996|NCT01383356|524698007|FG001|Period 1|Adverse Event|3|||
145501997|NCT01383356|524698006|FG000|Period 1|Non-compliance|3|||
145501998|NCT01383356|524698007|FG001|Period 1|Non-compliance|0|||
145501999|NCT01383356|524698006|FG000|Period 1|Out of Range Mid-study-Test|0|||
145398331|NCT01712516|524314721|FG003|Overall Study|Protocol deviation|0|||
145398332|NCT01712516|524314718|FG000|Overall Study|Physician Decision|2|||
145398333|NCT01712516|524314719|FG001|Overall Study|Physician Decision|0|||
145398334|NCT01712516|524314720|FG002|Overall Study|Physician Decision|0|||
145398335|NCT01712516|524314721|FG003|Overall Study|Physician Decision|1|||
145398336|NCT01712516|524314718|FG000|Overall Study|Withdrawal by Subject|3|||
145398337|NCT01712516|524314719|FG001|Overall Study|Withdrawal by Subject|9|||
145398338|NCT01712516|524314720|FG002|Overall Study|Withdrawal by Subject|3|||
145398339|NCT01712516|524314721|FG003|Overall Study|Withdrawal by Subject|9|||
145398340|NCT01251952|524314722|FG000|Overall Study|Adverse Event|1|||
145398341|NCT00496769|524314723|FG000|Double Blind|>=1 reason assigned per patient|558|||
145398342|NCT00496769|524314724|FG001|Double Blind|>=1 reason assigned per patient|649|||
145398343|NCT00496769|524314725|FG002|Double Blind|>=1 reason assigned per patient|0|||
145398344|NCT00496769|524314723|FG000|Open Label|>=1 reason assigned per patient|0|||
145398345|NCT00496769|524314724|FG001|Open Label|>=1 reason assigned per patient|0|||
145398346|NCT00496769|524314725|FG002|Open Label|>=1 reason assigned per patient|1011|||
145398347|NCT02810418|524314731|FG000|Arm A Dose Escalation|Adverse Event|2|||
145398348|NCT02810418|524314732|FG001|Arm A Dose Escalation|Adverse Event|1|||
145398349|NCT02810418|524314733|FG002|Arm A Dose Escalation|Adverse Event|0|||
145398350|NCT02810418|524314734|FG003|Arm A Dose Escalation|Adverse Event|0|||
145398351|NCT02810418|524314735|FG004|Arm A Dose Escalation|Adverse Event|0|||
145398352|NCT02810418|524314736|FG005|Arm A Dose Escalation|Adverse Event|0|||
145398353|NCT02810418|524314737|FG006|Arm A Dose Escalation|Adverse Event|0|||
145398354|NCT02810418|524314731|FG000|Dose Expansion|Adverse Event|0|||
145398355|NCT02810418|524314732|FG001|Dose Expansion|Adverse Event|1|||
145398356|NCT02810418|524314733|FG002|Dose Expansion|Adverse Event|1|||
145398357|NCT02810418|524314734|FG003|Dose Expansion|Adverse Event|0|||
145398358|NCT02810418|524314735|FG004|Dose Expansion|Adverse Event|0|||
145398359|NCT02810418|524314736|FG005|Dose Expansion|Adverse Event|0|||
145398360|NCT02810418|524314737|FG006|Dose Expansion|Adverse Event|0|||
145398361|NCT02810418|524314731|FG000|Dose Expansion|Physician Decision|0|||
145398362|NCT02810418|524314732|FG001|Dose Expansion|Physician Decision|0|||
145398363|NCT02810418|524314733|FG002|Dose Expansion|Physician Decision|2|||
145398364|NCT02810418|524314734|FG003|Dose Expansion|Physician Decision|0|||
145398365|NCT02810418|524314735|FG004|Dose Expansion|Physician Decision|0|||
145398366|NCT02810418|524314736|FG005|Dose Expansion|Physician Decision|0|||
145398367|NCT02810418|524314737|FG006|Dose Expansion|Physician Decision|0|||
145398368|NCT02810418|524314731|FG000|Arm B Dose Escalation|Adverse Event|0|||
145398369|NCT02810418|524314732|FG001|Arm B Dose Escalation|Adverse Event|0|||
145398370|NCT02810418|524314733|FG002|Arm B Dose Escalation|Adverse Event|0|||
145398371|NCT02810418|524314734|FG003|Arm B Dose Escalation|Adverse Event|0|||
145398372|NCT02810418|524314735|FG004|Arm B Dose Escalation|Adverse Event|1|||
145398373|NCT02810418|524314736|FG005|Arm B Dose Escalation|Adverse Event|2|||
145398374|NCT02810418|524314737|FG006|Arm B Dose Escalation|Adverse Event|0|||
145398375|NCT02224625|524314738|FG000|Irritation|Adverse Event|6|||
145398376|NCT02224625|524314738|FG000|Sensitization|Adverse Event|55|||
145398377|NCT01130272|524314741|FG000|Overall Study|Adverse Event|2|||
145398378|NCT01130272|524314742|FG001|Overall Study|Adverse Event|5|||
145398379|NCT01130272|524314743|FG002|Overall Study|Adverse Event|6|||
145398380|NCT01130272|524314744|FG003|Overall Study|Adverse Event|22|||
145398381|NCT01130272|524314745|FG004|Overall Study|Adverse Event|7|||
145398382|NCT01130272|524314741|FG000|Overall Study|IVRS-confirmed constipation|0|||
145398383|NCT01130272|524314742|FG001|Overall Study|IVRS-confirmed constipation|1|||
145398384|NCT01130272|524314743|FG002|Overall Study|IVRS-confirmed constipation|1|||
145398385|NCT01130272|524314744|FG003|Overall Study|IVRS-confirmed constipation|2|||
145398386|NCT01130272|524314745|FG004|Overall Study|IVRS-confirmed constipation|0|||
145502000|NCT01383356|524698007|FG001|Period 1|Out of Range Mid-study-Test|1|||
145398387|NCT01130272|524314741|FG000|Overall Study|Rescue medications due to diarrhea|3|||
145398388|NCT01130272|524314742|FG001|Overall Study|Rescue medications due to diarrhea|5|||
145398389|NCT01130272|524314743|FG002|Overall Study|Rescue medications due to diarrhea|8|||
145398390|NCT01130272|524314744|FG003|Overall Study|Rescue medications due to diarrhea|8|||
145398391|NCT01130272|524314745|FG004|Overall Study|Rescue medications due to diarrhea|6|||
145398392|NCT01130272|524314741|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
145502001|NCT01383356|524698006|FG000|Period 1|Personal|0|||
145502002|NCT01383356|524698007|FG001|Period 1|Personal|2|||
145502003|NCT03584789|524698008|FG000|Overall Study|refused EHR permission|19|||
145502004|NCT03584789|524698009|FG001|Overall Study|refused EHR permission|28|||
145502005|NCT03584789|524698010|FG002|Overall Study|refused EHR permission|23|||
145502006|NCT03584789|524698008|FG000|Overall Study|patients tied to a provider who retired|0|||
145502007|NCT03584789|524698009|FG001|Overall Study|patients tied to a provider who retired|0|||
145502008|NCT03584789|524698010|FG002|Overall Study|patients tied to a provider who retired|3|||
145502009|NCT02035267|524698011|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
145502010|NCT02035267|524698012|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
145502011|NCT02035267|524698013|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
145502012|NCT02035267|524698014|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
145502013|NCT02035267|524698011|FG000|Overall Study|Adverse Event|0|||
145502014|NCT02035267|524698012|FG001|Overall Study|Adverse Event|0|||
145502015|NCT02035267|524698013|FG002|Overall Study|Adverse Event|1|||
145502016|NCT02035267|524698014|FG003|Overall Study|Adverse Event|0|||
145502017|NCT02035267|524698011|FG000|Overall Study|Lost to Follow-up|0|||
145502018|NCT02035267|524698012|FG001|Overall Study|Lost to Follow-up|0|||
145502019|NCT02035267|524698013|FG002|Overall Study|Lost to Follow-up|0|||
145502020|NCT02035267|524698014|FG003|Overall Study|Lost to Follow-up|1|||
145502021|NCT02035267|524698011|FG000|Overall Study|Other unspecified|0|||
145502022|NCT02035267|524698012|FG001|Overall Study|Other unspecified|1|||
145502023|NCT02035267|524698013|FG002|Overall Study|Other unspecified|0|||
145502024|NCT02035267|524698014|FG003|Overall Study|Other unspecified|0|||
145502025|NCT00602472|524698015|FG000|Overall Study|Adverse Event|5|||
145502026|NCT00602472|524698016|FG001|Overall Study|Adverse Event|23|||
145502027|NCT00602472|524698015|FG000|Overall Study|Protocol Violation|4|||
145502028|NCT00602472|524698016|FG001|Overall Study|Protocol Violation|19|||
145502029|NCT00602472|524698015|FG000|Overall Study|Withdrawal by Subject|8|||
145502030|NCT00602472|524698016|FG001|Overall Study|Withdrawal by Subject|14|||
145502031|NCT00602472|524698015|FG000|Overall Study|Other incl. lack of efficacy|4|||
145502032|NCT00602472|524698016|FG001|Overall Study|Other incl. lack of efficacy|2|||
145502033|NCT00084136|524698017|FG000|PI Comparison|Death|10|||
145502034|NCT00084136|524698018|FG001|PI Comparison|Death|9|||
145502035|NCT00084136|524698019|FG002|PI Comparison|Death|0|||
145502036|NCT00084136|524698017|FG000|PI Comparison|Lost to Follow-up|11|||
145502037|NCT00084136|524698018|FG001|PI Comparison|Lost to Follow-up|8|||
145502038|NCT00084136|524698019|FG002|PI Comparison|Lost to Follow-up|0|||
145502039|NCT00084136|524698017|FG000|PI Comparison|Withdrawal by Subject|33|||
145502040|NCT00084136|524698018|FG001|PI Comparison|Withdrawal by Subject|30|||
145502041|NCT00084136|524698019|FG002|PI Comparison|Withdrawal by Subject|0|||
145502042|NCT00084136|524698017|FG000|PI Comparison|Clinic site closed|1|||
145502043|NCT00084136|524698018|FG001|PI Comparison|Clinic site closed|0|||
145502044|NCT00084136|524698019|FG002|PI Comparison|Clinic site closed|0|||
145502045|NCT00084136|524698017|FG000|NRTI Comparison|Death|20|||
145502046|NCT00084136|524698018|FG001|NRTI Comparison|Death|0|||
145502047|NCT00084136|524698019|FG002|NRTI Comparison|Death|18|||
145502048|NCT00084136|524698017|FG000|NRTI Comparison|Lost to Follow-up|14|||
145502049|NCT00084136|524698018|FG001|NRTI Comparison|Lost to Follow-up|0|||
145502050|NCT00084136|524698019|FG002|NRTI Comparison|Lost to Follow-up|12|||
145502051|NCT00084136|524698017|FG000|NRTI Comparison|Withdrawal by Subject|54|||
145502052|NCT00084136|524698018|FG001|NRTI Comparison|Withdrawal by Subject|0|||
145502053|NCT00084136|524698019|FG002|NRTI Comparison|Withdrawal by Subject|38|||
145502054|NCT00084136|524698017|FG000|NRTI Comparison|Clinic site closed|12|||
145502055|NCT00084136|524698018|FG001|NRTI Comparison|Clinic site closed|0|||
145502056|NCT00084136|524698019|FG002|NRTI Comparison|Clinic site closed|14|||
145502057|NCT00084136|524698017|FG000|NRTI Comparison|Not reason above|1|||
145502058|NCT00084136|524698018|FG001|NRTI Comparison|Not reason above|0|||
145502059|NCT00084136|524698019|FG002|NRTI Comparison|Not reason above|0|||
145502060|NCT02230670|524698020|FG000|Overall Study|Adverse Event|1|||
145502061|NCT02230670|524698021|FG001|Overall Study|Adverse Event|2|||
145502062|NCT02230670|524698020|FG000|Overall Study|Withdrawal by Subject|2|||
145502063|NCT02230670|524698021|FG001|Overall Study|Withdrawal by Subject|2|||
145502064|NCT02230670|524698020|FG000|Overall Study|Physician Decision|0|||
145502065|NCT02230670|524698021|FG001|Overall Study|Physician Decision|1|||
145502066|NCT02230670|524698020|FG000|Overall Study|Protocol Violation|0|||
145502067|NCT02230670|524698021|FG001|Overall Study|Protocol Violation|1|||
145502068|NCT02230670|524698020|FG000|Overall Study|Progression to Child-Pugh C|1|||
145502069|NCT02230670|524698021|FG001|Overall Study|Progression to Child-Pugh C|2|||
145502070|NCT03938259|524698024|FG000|Overall Study|unable to establish baseline for ventilation|1|||
145502071|NCT03938259|524698025|FG001|Overall Study|unable to establish baseline for ventilation|1|||
145502072|NCT01907854|524698026|FG000|Overall Study|Protocol Violation|1|||
145502073|NCT01907854|524698027|FG001|Overall Study|Protocol Violation|1|||
145502074|NCT01907854|524698026|FG000|Overall Study|Withdrawal by Subject|9|||
145502075|NCT01907854|524698027|FG001|Overall Study|Withdrawal by Subject|7|||
145502076|NCT01907854|524698026|FG000|Overall Study|Lost to Follow-up|2|||
145502077|NCT01907854|524698027|FG001|Overall Study|Lost to Follow-up|2|||
145502078|NCT01907854|524698026|FG000|Overall Study|Unclassified|4|||
145502079|NCT01907854|524698027|FG001|Overall Study|Unclassified|3|||
145502080|NCT01657019|524698028|FG000|Overall Study|Withdrawal by Subject|65|||
145502081|NCT01657019|524698028|FG000|Overall Study|Adverse Event|55|||
145502082|NCT01657019|524698028|FG000|Overall Study|Lost to Follow-up|48|||
145502083|NCT01657019|524698028|FG000|Overall Study|Protocol Violation|6|||
145502084|NCT01657019|524698028|FG000|Overall Study|Lack of Efficacy|3|||
145502085|NCT01657019|524698028|FG000|Overall Study|Other|58|||
145502086|NCT00956007|524698029|FG000|Overall Study|Protocol Violation|27|||
145502087|NCT00956007|524698030|FG001|Overall Study|Protocol Violation|23|||
145502088|NCT01750229|524698031|FG000|Randomized Crossover Phase|Adverse Event|1|||
145502089|NCT01750229|524698031|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
145502090|NCT01750229|524698031|FG000|Long-term Follow-up Phase|Adverse Event|2|||
145502091|NCT01750229|524698031|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
145502092|NCT01285323|524698034|FG000|Overall Study|Adverse Event|9|||
145502093|NCT01285323|524698035|FG001|Overall Study|Adverse Event|8|||
145502094|NCT01285323|524698034|FG000|Overall Study|Lack of Efficacy|4|||
145502095|NCT01285323|524698035|FG001|Overall Study|Lack of Efficacy|2|||
145502096|NCT01285323|524698034|FG000|Overall Study|Withdrawal by Subject|15|||
145502097|NCT01285323|524698035|FG001|Overall Study|Withdrawal by Subject|11|||
145502098|NCT01285323|524698034|FG000|Overall Study|Protocol Violation|1|||
145502099|NCT01285323|524698035|FG001|Overall Study|Protocol Violation|2|||
145502100|NCT01285323|524698034|FG000|Overall Study|Non-compliance with study procedures|2|||
145502101|NCT01285323|524698035|FG001|Overall Study|Non-compliance with study procedures|3|||
145502102|NCT01285323|524698034|FG000|Overall Study|Lost to Follow-up|1|||
145502103|NCT01285323|524698035|FG001|Overall Study|Lost to Follow-up|1|||
145502104|NCT01285323|524698034|FG000|Overall Study|Other|1|||
145502105|NCT01285323|524698035|FG001|Overall Study|Other|3|||
145502106|NCT02606643|524698036|FG000|Overall Study|did not meet inclusion criteria|1|||
145502107|NCT02606643|524698037|FG001|Overall Study|did not meet inclusion criteria|3|||
145502108|NCT00803569|524698040|FG000|Overall Study|Progressive Disease|3|||
145502109|NCT00803569|524698040|FG000|Overall Study|Noncompliance|1|||
145502110|NCT02900378|524698048|FG000|Randomization (Visit 2)|Adverse Event|14|||
145502111|NCT02900378|524698049|FG001|Randomization (Visit 2)|Adverse Event|11|||
145502112|NCT02900378|524698048|FG000|Randomization (Visit 2)|Death|1|||
145502113|NCT02900378|524698049|FG001|Randomization (Visit 2)|Death|4|||
145502114|NCT02900378|524698048|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
145502115|NCT02900378|524698049|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
145502116|NCT02900378|524698048|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
145502117|NCT02900378|524698049|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
145502118|NCT02900378|524698048|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
145502119|NCT02900378|524698049|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
145502120|NCT02900378|524698048|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
145502121|NCT02900378|524698049|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
145502122|NCT02900378|524698048|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
145502123|NCT02900378|524698049|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
145502124|NCT03818321|524698050|FG000|Overall Study|Withdrawal by Subject|1|||
145502125|NCT03818321|524698051|FG001|Overall Study|Withdrawal by Subject|2|||
145502126|NCT01134055|524698052|FG000|Overall Study|Adverse Event|5|||
145502127|NCT01134055|524698053|FG001|Overall Study|Adverse Event|2|||
145502128|NCT01134055|524698054|FG002|Overall Study|Adverse Event|2|||
145502129|NCT01134055|524698055|FG003|Overall Study|Adverse Event|2|||
145502130|NCT01134055|524698056|FG004|Overall Study|Adverse Event|5|||
145502131|NCT01134055|524698057|FG005|Overall Study|Adverse Event|7|||
145502132|NCT01134055|524698058|FG006|Overall Study|Adverse Event|2|||
145502133|NCT01134055|524698052|FG000|Overall Study|Lost to Follow-up|0|||
145502134|NCT01134055|524698053|FG001|Overall Study|Lost to Follow-up|1|||
145502135|NCT01134055|524698054|FG002|Overall Study|Lost to Follow-up|0|||
145502136|NCT01134055|524698055|FG003|Overall Study|Lost to Follow-up|1|||
145502137|NCT01134055|524698056|FG004|Overall Study|Lost to Follow-up|0|||
145502138|NCT01134055|524698057|FG005|Overall Study|Lost to Follow-up|0|||
145502139|NCT01134055|524698058|FG006|Overall Study|Lost to Follow-up|0|||
145502140|NCT01134055|524698052|FG000|Overall Study|Withdrawal by Subject|3|||
145502141|NCT01134055|524698053|FG001|Overall Study|Withdrawal by Subject|3|||
145502142|NCT01134055|524698054|FG002|Overall Study|Withdrawal by Subject|1|||
145502143|NCT01134055|524698055|FG003|Overall Study|Withdrawal by Subject|2|||
145502144|NCT01134055|524698056|FG004|Overall Study|Withdrawal by Subject|0|||
145502145|NCT01134055|524698057|FG005|Overall Study|Withdrawal by Subject|0|||
145502146|NCT01134055|524698058|FG006|Overall Study|Withdrawal by Subject|8|||
145502147|NCT01134055|524698052|FG000|Overall Study|Protocol Violation|0|||
145502148|NCT01134055|524698053|FG001|Overall Study|Protocol Violation|0|||
145502149|NCT01134055|524698054|FG002|Overall Study|Protocol Violation|0|||
145502150|NCT01134055|524698055|FG003|Overall Study|Protocol Violation|1|||
145502151|NCT01134055|524698056|FG004|Overall Study|Protocol Violation|1|||
145502152|NCT01134055|524698057|FG005|Overall Study|Protocol Violation|0|||
145502153|NCT01134055|524698058|FG006|Overall Study|Protocol Violation|0|||
145502154|NCT01134055|524698052|FG000|Overall Study|Physician Decision|0|||
145502155|NCT01134055|524698053|FG001|Overall Study|Physician Decision|0|||
145502156|NCT01134055|524698054|FG002|Overall Study|Physician Decision|0|||
145502157|NCT01134055|524698055|FG003|Overall Study|Physician Decision|0|||
145502158|NCT01134055|524698056|FG004|Overall Study|Physician Decision|0|||
145502159|NCT01134055|524698057|FG005|Overall Study|Physician Decision|0|||
145502160|NCT01134055|524698058|FG006|Overall Study|Physician Decision|1|||
145502161|NCT05038982|524698059|FG000|Overall Study|Withdrawal by Subject|0|||
145502162|NCT05038982|524698060|FG001|Overall Study|Withdrawal by Subject|2|||
145502163|NCT01454102|524698062|FG000|Overall Study|Continuing in the treatment period|0|||
145502164|NCT01454102|524698063|FG001|Overall Study|Continuing in the treatment period|0|||
145502165|NCT01454102|524698064|FG002|Overall Study|Continuing in the treatment period|0|||
145502166|NCT01454102|524698065|FG003|Overall Study|Continuing in the treatment period|0|||
145502167|NCT01454102|524698066|FG004|Overall Study|Continuing in the treatment period|3|||
145502168|NCT01454102|524698067|FG005|Overall Study|Continuing in the treatment period|3|||
145398393|NCT01130272|524314742|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
145398394|NCT01130272|524314743|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
145398395|NCT01130272|524314744|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
145398396|NCT01130272|524314745|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
145398397|NCT01130272|524314741|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145398398|NCT01130272|524314742|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145398399|NCT01130272|524314743|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145398400|NCT01130272|524314744|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
145398401|NCT01130272|524314745|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
145398402|NCT01130272|524314741|FG000|Overall Study|Protocol Violation|0|||
145398403|NCT01130272|524314742|FG001|Overall Study|Protocol Violation|0|||
145398404|NCT01130272|524314743|FG002|Overall Study|Protocol Violation|3|||
145398405|NCT01130272|524314744|FG003|Overall Study|Protocol Violation|5|||
145398406|NCT01130272|524314745|FG004|Overall Study|Protocol Violation|5|||
145398407|NCT01130272|524314741|FG000|Overall Study|Lost to Follow-up|4|||
145398408|NCT01130272|524314742|FG001|Overall Study|Lost to Follow-up|3|||
145398409|NCT01130272|524314743|FG002|Overall Study|Lost to Follow-up|4|||
145398410|NCT01130272|524314744|FG003|Overall Study|Lost to Follow-up|7|||
145398411|NCT01130272|524314745|FG004|Overall Study|Lost to Follow-up|6|||
145398412|NCT01130272|524314741|FG000|Overall Study|Withdrawal by Subject|4|||
145398413|NCT01130272|524314742|FG001|Overall Study|Withdrawal by Subject|11|||
145398414|NCT01130272|524314743|FG002|Overall Study|Withdrawal by Subject|10|||
145398415|NCT01130272|524314744|FG003|Overall Study|Withdrawal by Subject|9|||
145398416|NCT01130272|524314745|FG004|Overall Study|Withdrawal by Subject|8|||
145398417|NCT01130272|524314741|FG000|Overall Study|Physician Decision|1|||
145398418|NCT01130272|524314742|FG001|Overall Study|Physician Decision|1|||
145398419|NCT01130272|524314743|FG002|Overall Study|Physician Decision|0|||
145398420|NCT01130272|524314744|FG003|Overall Study|Physician Decision|1|||
145398421|NCT01130272|524314745|FG004|Overall Study|Physician Decision|2|||
145398422|NCT01130272|524314741|FG000|Overall Study|Sponsor decision|6|||
145398423|NCT01130272|524314742|FG001|Overall Study|Sponsor decision|15|||
145398424|NCT01130272|524314743|FG002|Overall Study|Sponsor decision|16|||
145398425|NCT01130272|524314744|FG003|Overall Study|Sponsor decision|13|||
145398426|NCT01130272|524314745|FG004|Overall Study|Sponsor decision|16|||
145398427|NCT01130272|524314741|FG000|Overall Study|Study arm discontinued|38|||
145398428|NCT01130272|524314742|FG001|Overall Study|Study arm discontinued|0|||
145398429|NCT01130272|524314743|FG002|Overall Study|Study arm discontinued|0|||
145398430|NCT01130272|524314744|FG003|Overall Study|Study arm discontinued|0|||
145398431|NCT01130272|524314745|FG004|Overall Study|Study arm discontinued|0|||
145398432|NCT01548404|524314746|FG000|Overall Study|Adverse Event|3|||
145398433|NCT01548404|524314747|FG001|Overall Study|Adverse Event|1|||
145398434|NCT01548404|524314746|FG000|Overall Study|Physician Decision|2|||
145398435|NCT01548404|524314747|FG001|Overall Study|Physician Decision|1|||
145398436|NCT01548404|524314746|FG000|Overall Study|Inadequate response to study treatment|23|||
145398437|NCT01548404|524314747|FG001|Overall Study|Inadequate response to study treatment|7|||
145398438|NCT01548404|524314746|FG000|Overall Study|Lost to Follow-up|2|||
145398439|NCT01548404|524314747|FG001|Overall Study|Lost to Follow-up|0|||
145398440|NCT01548404|524314746|FG000|Overall Study|Withdrawal by Subject|0|||
145398441|NCT01548404|524314747|FG001|Overall Study|Withdrawal by Subject|3|||
145398442|NCT01548404|524314746|FG000|Overall Study|Other than specified above|0|||
145398443|NCT01548404|524314747|FG001|Overall Study|Other than specified above|2|||
145398444|NCT00301834|524314748|FG000|Overall Study|Death|1|||
145398445|NCT02870868|524314749|FG000|Overall Study|Withdrawal by Subject|2|||
145398446|NCT02870868|524314750|FG001|Overall Study|Withdrawal by Subject|1|||
145398447|NCT01674725|524314755|FG000|Overall Study|Adverse Event|1|||
145398448|NCT01674725|524314756|FG001|Overall Study|Adverse Event|0|||
145398449|NCT01674725|524314755|FG000|Overall Study|Did not receive study drug|1|||
145398450|NCT01674725|524314756|FG001|Overall Study|Did not receive study drug|0|||
145398451|NCT01674725|524314755|FG000|Overall Study|Withdrawal by Subject|1|||
145398452|NCT01674725|524314756|FG001|Overall Study|Withdrawal by Subject|0|||
145398453|NCT01674725|524314755|FG000|Overall Study|Lost to Follow-up|0|||
145398454|NCT01674725|524314756|FG001|Overall Study|Lost to Follow-up|1|||
145398455|NCT00960193|524314761|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
145398456|NCT01324102|524314762|FG000|Overall Study|illness|1|||
145398457|NCT01324102|524314763|FG001|Overall Study|illness|6|||
145398458|NCT03238417|524314764|FG000|Overall|non-response|955|||
145398459|NCT03238417|524314765|FG001|Overall|non-response|1920|||
145398460|NCT03238417|524314764|FG000|Overall|partial completion|48|||
145398461|NCT03238417|524314765|FG001|Overall|partial completion|68|||
145398462|NCT03238417|524314764|FG000|Baseline|Partial completion|17|||
145398463|NCT03238417|524314765|FG001|Baseline|Partial completion|48|||
145398464|NCT03238417|524314764|FG000|Baseline|non-response|372|||
145398465|NCT03238417|524314765|FG001|Baseline|non-response|669|||
145398466|NCT03238417|524314764|FG000|12-month|non-response|296|||
145398467|NCT03238417|524314765|FG001|12-month|non-response|669|||
145398468|NCT03238417|524314764|FG000|12-month|partial completion|23|||
145398469|NCT03238417|524314765|FG001|12-month|partial completion|37|||
145398470|NCT03238417|524314764|FG000|24-month|non-response|287|||
145398471|NCT03238417|524314765|FG001|24-month|non-response|594|||
145398472|NCT03238417|524314764|FG000|24-month|partial completion|8|||
145398473|NCT03238417|524314765|FG001|24-month|partial completion|31|||
145398474|NCT01249131|524314766|FG000|Washout Period of 10 Days|Adverse Event|0|||
145398475|NCT01249131|524314767|FG001|Washout Period of 10 Days|Adverse Event|0|||
145398476|NCT01249131|524314768|FG002|Washout Period of 10 Days|Adverse Event|0|||
145398477|NCT01249131|524314769|FG003|Washout Period of 10 Days|Adverse Event|0|||
145398478|NCT01249131|524314770|FG004|Washout Period of 10 Days|Adverse Event|1|||
145398479|NCT01249131|524314771|FG005|Washout Period of 10 Days|Adverse Event|0|||
145398480|NCT00719901|524314772|FG000|Overall Study|Adverse Event|5|||
145398481|NCT00719901|524314772|FG000|Overall Study|Withdrawal by Subject|1|||
145398482|NCT00719901|524314772|FG000|Overall Study|Alternate Treatment|1|||
145398483|NCT00719901|524314772|FG000|Overall Study|Disease Progression|3|||
145398484|NCT00719901|524314772|FG000|Overall Study|Availability of Study Drug|1|||
145398485|NCT00192114|524314773|FG000|Overall Study|Objective Tumor Progression|19|||
145398486|NCT00192114|524314773|FG000|Overall Study|Adverse Event|2|||
145398487|NCT00192114|524314773|FG000|Overall Study|Clinical Progression|2|||
145398488|NCT00192114|524314773|FG000|Overall Study|Death|1|||
145398489|NCT00492297|524314774|FG000|Treatment|Death|2|||
145398490|NCT00492297|524314774|FG000|Treatment|Study terminated by sponsor|3|||
145398491|NCT00492297|524314774|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
145398492|NCT00492297|524314774|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
145398493|NCT00492297|524314774|FG000|Survival Only Follow-up|Death|46|||
145398494|NCT00492297|524314774|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
145398495|NCT00492297|524314774|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
145398496|NCT00113607|524314775|FG000|Overall Study|Adverse Event|40|||
145398497|NCT00113607|524314776|FG001|Overall Study|Adverse Event|71|||
145398498|NCT00113607|524314775|FG000|Overall Study|Death|8|||
145398499|NCT00113607|524314776|FG001|Overall Study|Death|8|||
145398500|NCT00113607|524314775|FG000|Overall Study|Withdrawal by Subject|50|||
145398501|NCT00113607|524314776|FG001|Overall Study|Withdrawal by Subject|58|||
145398502|NCT00113607|524314775|FG000|Overall Study|Lost to Follow-up|0|||
145398503|NCT00113607|524314776|FG001|Overall Study|Lost to Follow-up|2|||
145398504|NCT00113607|524314775|FG000|Overall Study|Disease Progression|180|||
145398505|NCT00113607|524314776|FG001|Overall Study|Disease Progression|142|||
145398506|NCT00113607|524314775|FG000|Overall Study|Complete Response (Confirmed)|14|||
145398507|NCT00113607|524314776|FG001|Overall Study|Complete Response (Confirmed)|24|||
145398508|NCT00113607|524314775|FG000|Overall Study|Other|43|||
145398509|NCT00113607|524314776|FG001|Overall Study|Other|32|||
145398510|NCT00749398|524314778|FG000|Overall Study|Lack of Efficacy|7|||
145398511|NCT00749398|524314778|FG000|Overall Study|Adverse Event|4|||
145398512|NCT00749398|524314778|FG000|Overall Study|Serious adverse event|11|||
145398513|NCT00749398|524314778|FG000|Overall Study|Withdrawal by Subject|17|||
145398514|NCT00749398|524314778|FG000|Overall Study|Lost to Follow-up|11|||
145398515|NCT00749398|524314778|FG000|Overall Study|Reason not specified|2|||
145398516|NCT00749398|524314778|FG000|Overall Study|Unknown reason|1|||
145398517|NCT05002972|524314784|FG000|Overall Study|Withdrawal by Subject|2|||
145398518|NCT01664091|524314785|FG000|Overall Study|Death|1|||
145398519|NCT01664091|524314785|FG000|Overall Study|Disease Progression|2|||
145398520|NCT01664091|524314785|FG000|Overall Study|Lost to Follow-up|2|||
145398521|NCT01664091|524314785|FG000|Overall Study|Withdrawal by Subject|1|||
145398522|NCT01172873|524314788|FG000|Overall Study|Withdrawal by Subject|3|||
145398523|NCT01172873|524314789|FG001|Overall Study|Withdrawal by Subject|2|||
145398524|NCT04613518|524314792|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
145398525|NCT04613518|524314793|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
145398526|NCT04613518|524314794|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
145398527|NCT04613518|524314792|FG000|Double-Blind Treatment Period|Adverse Event|2|||
145398528|NCT04613518|524314793|FG001|Double-Blind Treatment Period|Adverse Event|0|||
145398529|NCT04613518|524314794|FG002|Double-Blind Treatment Period|Adverse Event|1|||
145398530|NCT04613518|524314792|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
145398531|NCT04613518|524314793|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
145398532|NCT04613518|524314794|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
145398533|NCT04613518|524314792|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
145398534|NCT04613518|524314793|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
145502169|NCT01454102|524698068|FG006|Overall Study|Continuing in the treatment period|2|||
145502170|NCT01454102|524698069|FG007|Overall Study|Continuing in the treatment period|0|||
145502171|NCT01454102|524698070|FG008|Overall Study|Continuing in the treatment period|1|||
145502172|NCT01454102|524698071|FG009|Overall Study|Continuing in the treatment period|0|||
145502173|NCT01454102|524698072|FG010|Overall Study|Continuing in the treatment period|0|||
145502174|NCT01454102|524698073|FG011|Overall Study|Continuing in the treatment period|4|||
145502175|NCT01454102|524698074|FG012|Overall Study|Continuing in the treatment period|7|||
145502176|NCT01454102|524698075|FG013|Overall Study|Continuing in the treatment period|4|||
145502177|NCT01454102|524698076|FG014|Overall Study|Continuing in the treatment period|3|||
145502178|NCT01454102|524698077|FG015|Overall Study|Continuing in the treatment period|1|||
145502179|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
145502180|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
145502181|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
145502182|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
145502183|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145502184|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
145502185|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
145502186|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
145502187|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
145502188|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
145502189|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
145502190|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
145502191|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
145502192|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
145502193|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
145502194|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
145502195|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
145502196|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
145502197|NCT03739203|524698078|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
145502198|NCT03739203|524698079|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
145502199|NCT03739203|524698080|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
145502200|NCT03739203|524698078|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
145502201|NCT03739203|524698079|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
145502202|NCT03739203|524698080|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
145502203|NCT03739203|524698078|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
145502204|NCT03739203|524698079|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
145502205|NCT03739203|524698080|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
145502206|NCT03739203|524698078|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
145502207|NCT03739203|524698079|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
145502208|NCT03739203|524698080|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
145502209|NCT03739203|524698078|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
145502210|NCT03739203|524698079|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
145502211|NCT03739203|524698080|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
145502212|NCT01782378|524698081|FG000|First Series|Lost to Follow-up|7|||
145502213|NCT01782378|524698082|FG001|First Series|Lost to Follow-up|8|||
145502214|NCT01782378|524698081|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
145502215|NCT01782378|524698082|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
145502216|NCT01782378|524698081|FG000|Second Series|Lost to Follow-up|8|||
145502217|NCT01782378|524698082|FG001|Second Series|Lost to Follow-up|7|||
145502218|NCT01782378|524698081|FG000|Second Series|Did not choose to complete S2 Optional|18|||
145502219|NCT01782378|524698082|FG001|Second Series|Did not choose to complete S2 Optional|0|||
145502220|NCT01663103|524698085|FG000|Overall Study|Withdrawal by Subject|1|||
145502221|NCT01663103|524698086|FG001|Overall Study|Withdrawal by Subject|2|||
145502222|NCT01663103|524698085|FG000|Overall Study|Adverse Event|1|||
145502223|NCT01663103|524698086|FG001|Overall Study|Adverse Event|0|||
145502224|NCT01663103|524698085|FG000|Overall Study|dog bite|1|||
145502225|NCT01663103|524698086|FG001|Overall Study|dog bite|0|||
145502226|NCT01656408|524698087|FG000|Overall Study|Adverse Event|0|||
145502227|NCT01656408|524698088|FG001|Overall Study|Adverse Event|0|||
145502228|NCT01656408|524698089|FG002|Overall Study|Adverse Event|1|||
145502229|NCT01656408|524698090|FG003|Overall Study|Adverse Event|0|||
145502230|NCT01656408|524698091|FG004|Overall Study|Adverse Event|0|||
145502231|NCT01656408|524698092|FG005|Overall Study|Adverse Event|1|||
145502232|NCT01656408|524698093|FG006|Overall Study|Adverse Event|1|||
145502233|NCT01656408|524698094|FG007|Overall Study|Adverse Event|0|||
145502234|NCT01656408|524698095|FG008|Overall Study|Adverse Event|1|||
145502235|NCT01656408|524698096|FG009|Overall Study|Adverse Event|0|||
145502236|NCT01656408|524698087|FG000|Overall Study|Physician Decision|1|||
145502237|NCT01656408|524698088|FG001|Overall Study|Physician Decision|0|||
145502238|NCT01656408|524698089|FG002|Overall Study|Physician Decision|1|||
145502239|NCT01656408|524698090|FG003|Overall Study|Physician Decision|0|||
145502240|NCT01656408|524698091|FG004|Overall Study|Physician Decision|1|||
145502241|NCT01656408|524698092|FG005|Overall Study|Physician Decision|1|||
145502242|NCT01656408|524698093|FG006|Overall Study|Physician Decision|0|||
145502243|NCT01656408|524698094|FG007|Overall Study|Physician Decision|1|||
145502244|NCT01656408|524698095|FG008|Overall Study|Physician Decision|1|||
145502245|NCT01656408|524698096|FG009|Overall Study|Physician Decision|3|||
145502246|NCT00888940|524698107|FG000|Overall Study|Adverse Event|12|||
145502247|NCT00888940|524698108|FG001|Overall Study|Adverse Event|3|||
145502248|NCT00888940|524698107|FG000|Overall Study|Lost to Follow-up|5|||
145502249|NCT00888940|524698108|FG001|Overall Study|Lost to Follow-up|5|||
145502250|NCT00888940|524698107|FG000|Overall Study|Randomized Not Treated|11|||
145502251|NCT00888940|524698108|FG001|Overall Study|Randomized Not Treated|13|||
145502252|NCT03815929|524698113|FG000|Overall Study|Lost to Follow-up|2|||
145502253|NCT03815929|524698114|FG001|Overall Study|Lost to Follow-up|1|||
145502254|NCT03815929|524698115|FG002|Overall Study|Lost to Follow-up|0|||
145502255|NCT03815929|524698113|FG000|Overall Study|Physician Decision|2|||
145502256|NCT03815929|524698114|FG001|Overall Study|Physician Decision|2|||
145502257|NCT03815929|524698115|FG002|Overall Study|Physician Decision|0|||
145502258|NCT03815929|524698113|FG000|Overall Study|Withdrawal by Subject|0|||
145502259|NCT03815929|524698114|FG001|Overall Study|Withdrawal by Subject|0|||
145502260|NCT03815929|524698115|FG002|Overall Study|Withdrawal by Subject|1|||
145502261|NCT03313037|524698116|FG000|Overall Study|Protocol Violation|4|||
145502262|NCT03313037|524698117|FG001|Overall Study|Protocol Violation|1|||
145502263|NCT03313037|524698116|FG000|Overall Study|Other|1|||
145502264|NCT03313037|524698117|FG001|Overall Study|Other|1|||
145502265|NCT03313037|524698116|FG000|Overall Study|Withdrawal by Subject|4|||
145502266|NCT03313037|524698117|FG001|Overall Study|Withdrawal by Subject|3|||
145502267|NCT03313037|524698116|FG000|Overall Study|No longer meets eligibility criteria|1|||
145502268|NCT03313037|524698117|FG001|Overall Study|No longer meets eligibility criteria|7|||
145502269|NCT03313037|524698116|FG000|Overall Study|Lost to Follow-up|9|||
145502270|NCT03313037|524698117|FG001|Overall Study|Lost to Follow-up|8|||
145502271|NCT03313037|524698116|FG000|Overall Study|Randomized but not treated|1|||
145502272|NCT03313037|524698117|FG001|Overall Study|Randomized but not treated|0|||
145502273|NCT02760498|524698118|FG000|Overall Study|Adverse Event|3|||
145502274|NCT02760498|524698119|FG001|Overall Study|Adverse Event|3|||
145502275|NCT02760498|524698120|FG002|Overall Study|Adverse Event|1|||
145502276|NCT02760498|524698121|FG003|Overall Study|Adverse Event|1|||
145502277|NCT02760498|524698122|FG004|Overall Study|Adverse Event|0|||
145502278|NCT02760498|524698123|FG005|Overall Study|Adverse Event|6|||
145502279|NCT02760498|524698118|FG000|Overall Study|Death|7|||
145502280|NCT02760498|524698119|FG001|Overall Study|Death|5|||
145502281|NCT02760498|524698120|FG002|Overall Study|Death|5|||
145502282|NCT02760498|524698121|FG003|Overall Study|Death|7|||
145502283|NCT02760498|524698122|FG004|Overall Study|Death|0|||
145502284|NCT02760498|524698123|FG005|Overall Study|Death|23|||
145502285|NCT02760498|524698118|FG000|Overall Study|Lost to Follow-up|0|||
145502286|NCT02760498|524698119|FG001|Overall Study|Lost to Follow-up|0|||
145502287|NCT02760498|524698120|FG002|Overall Study|Lost to Follow-up|0|||
145502288|NCT02760498|524698121|FG003|Overall Study|Lost to Follow-up|0|||
145502289|NCT02760498|524698122|FG004|Overall Study|Lost to Follow-up|0|||
145502290|NCT02760498|524698123|FG005|Overall Study|Lost to Follow-up|3|||
145502291|NCT02760498|524698118|FG000|Overall Study|Non-compliance with study drug|0|||
145502292|NCT02760498|524698119|FG001|Overall Study|Non-compliance with study drug|2|||
145502293|NCT02760498|524698120|FG002|Overall Study|Non-compliance with study drug|0|||
145502294|NCT02760498|524698121|FG003|Overall Study|Non-compliance with study drug|0|||
145502295|NCT02760498|524698122|FG004|Overall Study|Non-compliance with study drug|0|||
145502296|NCT02760498|524698123|FG005|Overall Study|Non-compliance with study drug|0|||
145502297|NCT02760498|524698118|FG000|Overall Study|Participant decision|1|||
145502298|NCT02760498|524698119|FG001|Overall Study|Participant decision|4|||
145502299|NCT02760498|524698120|FG002|Overall Study|Participant decision|2|||
145502300|NCT02760498|524698121|FG003|Overall Study|Participant decision|2|||
145502301|NCT02760498|524698122|FG004|Overall Study|Participant decision|1|||
145502302|NCT02760498|524698123|FG005|Overall Study|Participant decision|6|||
145502303|NCT02760498|524698118|FG000|Overall Study|Sponsor decision|0|||
145502304|NCT02760498|524698119|FG001|Overall Study|Sponsor decision|0|||
145502305|NCT02760498|524698120|FG002|Overall Study|Sponsor decision|0|||
145502306|NCT02760498|524698121|FG003|Overall Study|Sponsor decision|3|||
145502307|NCT02760498|524698122|FG004|Overall Study|Sponsor decision|0|||
145502308|NCT02760498|524698123|FG005|Overall Study|Sponsor decision|0|||
145502309|NCT02760498|524698118|FG000|Overall Study|Physician Decision|3|||
145502310|NCT02760498|524698119|FG001|Overall Study|Physician Decision|4|||
145502311|NCT02760498|524698120|FG002|Overall Study|Physician Decision|1|||
145502312|NCT02760498|524698121|FG003|Overall Study|Physician Decision|4|||
145502313|NCT02760498|524698122|FG004|Overall Study|Physician Decision|0|||
145502314|NCT02760498|524698123|FG005|Overall Study|Physician Decision|2|||
145502315|NCT02760498|524698118|FG000|Overall Study|Disease progression|21|||
145502316|NCT02760498|524698119|FG001|Overall Study|Disease progression|19|||
145502317|NCT02760498|524698120|FG002|Overall Study|Disease progression|20|||
145398535|NCT04613518|524314794|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
145398536|NCT04613518|524314792|FG000|Double-Blind Treatment Period|Other Reasons|2|||
145398537|NCT04613518|524314793|FG001|Double-Blind Treatment Period|Other Reasons|0|||
145398538|NCT04613518|524314794|FG002|Double-Blind Treatment Period|Other Reasons|0|||
145398539|NCT04613518|524314792|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
145398540|NCT04613518|524314793|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
145398541|NCT04613518|524314794|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
145398542|NCT04613518|524314792|FG000|Open-Label Treatment Period|Adverse Event|1|||
145398543|NCT04613518|524314793|FG001|Open-Label Treatment Period|Adverse Event|0|||
145398544|NCT04613518|524314794|FG002|Open-Label Treatment Period|Adverse Event|3|||
145398545|NCT04613518|524314792|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
145398546|NCT04613518|524314793|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
145398547|NCT04613518|524314794|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
145398548|NCT04613518|524314792|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
145398549|NCT04613518|524314793|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
145398550|NCT04613518|524314794|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
145398551|NCT04613518|524314792|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
145398552|NCT04613518|524314793|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
145398553|NCT04613518|524314794|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
145398554|NCT04613518|524314792|FG000|Open-Label Treatment Period|Other reasons|1|||
145398555|NCT04613518|524314793|FG001|Open-Label Treatment Period|Other reasons|0|||
145398556|NCT04613518|524314794|FG002|Open-Label Treatment Period|Other reasons|0|||
145398557|NCT01076543|524314796|FG000|Overall Study|Withdrawal by Subject|2|||
145398558|NCT01076543|524314797|FG001|Overall Study|Withdrawal by Subject|0|||
145398559|NCT01076543|524314798|FG002|Overall Study|Withdrawal by Subject|0|||
145398560|NCT01076543|524314799|FG003|Overall Study|Withdrawal by Subject|0|||
145398561|NCT01076543|524314800|FG004|Overall Study|Withdrawal by Subject|0|||
145398562|NCT01076543|524314801|FG005|Overall Study|Withdrawal by Subject|0|||
145398563|NCT01077323|524314802|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
145398564|NCT01077323|524314803|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
145398565|NCT01077323|524314804|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
145398566|NCT01077323|524314802|FG000|Overall Study|Dispensing of drug in baseline period|0|||
145398567|NCT01077323|524314803|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
145398568|NCT01077323|524314804|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
145398569|NCT01077323|524314802|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
145398570|NCT01077323|524314803|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
145398571|NCT01077323|524314804|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
145398572|NCT02616783|524314805|FG000|Overall Study|Randomized but Not Treated|1|||
145398573|NCT02616783|524314806|FG001|Overall Study|Randomized but Not Treated|0|||
145398574|NCT02616783|524314805|FG000|Overall Study|Adverse Event|1|||
145398575|NCT02616783|524314806|FG001|Overall Study|Adverse Event|0|||
145398576|NCT02616783|524314805|FG000|Overall Study|Death|1|||
145398577|NCT02616783|524314806|FG001|Overall Study|Death|0|||
145398578|NCT02616783|524314805|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145398579|NCT02616783|524314806|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145398580|NCT02616783|524314805|FG000|Overall Study|Protocol Violation|1|||
145398581|NCT02616783|524314806|FG001|Overall Study|Protocol Violation|1|||
145398582|NCT02616783|524314805|FG000|Overall Study|Withdrew Consent|1|||
145398583|NCT02616783|524314806|FG001|Overall Study|Withdrew Consent|1|||
145398584|NCT00372424|524314807|FG000|Overall Study|Adverse Event|2|||
145398585|NCT00372424|524314807|FG000|Overall Study|Withdrawal by Subject|1|||
145398586|NCT00372424|524314807|FG000|Overall Study|Death|1|||
145398587|NCT00372424|524314807|FG000|Overall Study|Objective Progression or Relapse|14|||
145398588|NCT00372424|524314807|FG000|Overall Study|Other|7|||
145398589|NCT00372424|524314807|FG000|Overall Study|Enrolled, Not Treated|1|||
145398590|NCT03797898|524314811|FG000|Overall Study|Lost to Follow-up|60|||
145398591|NCT03797898|524314812|FG001|Overall Study|Lost to Follow-up|69|||
145398592|NCT03797898|524314811|FG000|Overall Study|Withdrawal by Subject|9|||
145398593|NCT03797898|524314812|FG001|Overall Study|Withdrawal by Subject|7|||
145398594|NCT03797898|524314811|FG000|Overall Study|Became ineligible|5|||
145398595|NCT03797898|524314812|FG001|Overall Study|Became ineligible|2|||
145398596|NCT01614470|524314813|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
145398597|NCT01614470|524314814|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145398598|NCT01614470|524314815|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145398599|NCT01614470|524314813|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
145398600|NCT01614470|524314814|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
145398601|NCT01614470|524314815|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
145398602|NCT00086190|524314816|FG000|Overall Study|Adverse Event|6|||
145398603|NCT00086190|524314817|FG001|Overall Study|Adverse Event|2|||
145398604|NCT00086190|524314818|FG002|Overall Study|Adverse Event|2|||
145398605|NCT00086190|524314816|FG000|Overall Study|Withdrawal by Subject|0|||
145502318|NCT02760498|524698121|FG003|Overall Study|Disease progression|18|||
145502319|NCT02760498|524698122|FG004|Overall Study|Disease progression|4|||
145502320|NCT02760498|524698123|FG005|Overall Study|Disease progression|55|||
145502321|NCT02760498|524698118|FG000|Overall Study|Withdrawal by Subject|4|||
145502322|NCT02760498|524698119|FG001|Overall Study|Withdrawal by Subject|7|||
145502323|NCT02760498|524698120|FG002|Overall Study|Withdrawal by Subject|5|||
145502324|NCT02760498|524698121|FG003|Overall Study|Withdrawal by Subject|1|||
145502325|NCT02760498|524698122|FG004|Overall Study|Withdrawal by Subject|0|||
145502326|NCT02760498|524698123|FG005|Overall Study|Withdrawal by Subject|6|||
145502327|NCT02760498|524698118|FG000|Overall Study|Other than specified|1|||
145502328|NCT02760498|524698119|FG001|Overall Study|Other than specified|6|||
145502329|NCT02760498|524698120|FG002|Overall Study|Other than specified|0|||
145502330|NCT02760498|524698121|FG003|Overall Study|Other than specified|3|||
145502331|NCT02760498|524698122|FG004|Overall Study|Other than specified|1|||
145502332|NCT02760498|524698123|FG005|Overall Study|Other than specified|0|||
145502333|NCT02760498|524698118|FG000|Overall Study|Not treated|0|||
145502334|NCT02760498|524698119|FG001|Overall Study|Not treated|0|||
145502335|NCT02760498|524698120|FG002|Overall Study|Not treated|0|||
145502336|NCT02760498|524698121|FG003|Overall Study|Not treated|0|||
145502337|NCT02760498|524698122|FG004|Overall Study|Not treated|0|||
145502338|NCT02760498|524698123|FG005|Overall Study|Not treated|2|||
145502339|NCT02205736|524698124|FG000|Overall Study|Lost to Follow-up|106|||
145502340|NCT03326713|524698125|FG000|Overall Study|Death|2|||
145502341|NCT03326713|524698126|FG001|Overall Study|Death|1|||
145502342|NCT03326713|524698127|FG002|Overall Study|Death|0|||
145502343|NCT03326713|524698125|FG000|Overall Study|Lost to Follow-up|20|||
145502344|NCT03326713|524698126|FG001|Overall Study|Lost to Follow-up|21|||
145502345|NCT03326713|524698127|FG002|Overall Study|Lost to Follow-up|33|||
145502346|NCT03326713|524698125|FG000|Overall Study|Withdrawal by Subject|1|||
145502347|NCT03326713|524698126|FG001|Overall Study|Withdrawal by Subject|2|||
145502348|NCT03326713|524698127|FG002|Overall Study|Withdrawal by Subject|11|||
145502349|NCT03326713|524698125|FG000|Overall Study|Found Ineligible|11|||
145398606|NCT00086190|524314817|FG001|Overall Study|Withdrawal by Subject|2|||
145398607|NCT00086190|524314818|FG002|Overall Study|Withdrawal by Subject|2|||
145398608|NCT00086190|524314816|FG000|Overall Study|Protocol Violation|1|||
145398609|NCT00086190|524314817|FG001|Overall Study|Protocol Violation|0|||
145398610|NCT00086190|524314818|FG002|Overall Study|Protocol Violation|0|||
145398611|NCT00086190|524314816|FG000|Overall Study|Moved|1|||
145398612|NCT00086190|524314817|FG001|Overall Study|Moved|0|||
145398613|NCT00086190|524314818|FG002|Overall Study|Moved|0|||
145398614|NCT00086190|524314816|FG000|Overall Study|Worsening depression|0|||
145398615|NCT00086190|524314817|FG001|Overall Study|Worsening depression|0|||
145398616|NCT00086190|524314818|FG002|Overall Study|Worsening depression|2|||
145398617|NCT03902613|524314819|FG000|Overall Study|Physician Decision|1|||
145398618|NCT01526785|524314821|FG000|Overall Study|Study Terminated by Sponsor|8|||
145398619|NCT01526785|524314821|FG000|Overall Study|Death|2|||
145398620|NCT01526785|524314821|FG000|Overall Study|Physician Decision|1|||
145398621|NCT01526785|524314821|FG000|Overall Study|Withdrawal by Subject|2|||
145398622|NCT04265261|524314825|FG000|Overall Study|Adverse Event|2|||
145398623|NCT04265261|524314826|FG001|Overall Study|Adverse Event|0|||
145398624|NCT04265261|524314827|FG002|Overall Study|Adverse Event|0|||
145398625|NCT04265261|524314825|FG000|Overall Study|Death|1|||
145398626|NCT04265261|524314826|FG001|Overall Study|Death|0|||
145398627|NCT04265261|524314827|FG002|Overall Study|Death|0|||
145398628|NCT04265261|524314825|FG000|Overall Study|Lost to Follow-up|4|||
145398629|NCT04265261|524314826|FG001|Overall Study|Lost to Follow-up|1|||
145398630|NCT04265261|524314827|FG002|Overall Study|Lost to Follow-up|3|||
145398631|NCT04265261|524314825|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145398632|NCT04265261|524314826|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145398633|NCT04265261|524314827|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145502350|NCT03326713|524698126|FG001|Overall Study|Found Ineligible|11|||
145502351|NCT03326713|524698127|FG002|Overall Study|Found Ineligible|8|||
145502352|NCT00771758|524698128|FG000|Overall Study|Adverse Event|2|||
145502353|NCT00771758|524698129|FG001|Overall Study|Adverse Event|8|||
145502354|NCT00771758|524698130|FG002|Overall Study|Adverse Event|1|||
145502355|NCT00771758|524698128|FG000|Overall Study|Lack of Efficacy|0|||
145502356|NCT00771758|524698129|FG001|Overall Study|Lack of Efficacy|2|||
145398634|NCT04265261|524314825|FG000|Overall Study|Physician Decision|0|||
145502357|NCT00771758|524698130|FG002|Overall Study|Lack of Efficacy|1|||
145502358|NCT00771758|524698128|FG000|Overall Study|Lost to Follow-up|1|||
145502359|NCT00771758|524698129|FG001|Overall Study|Lost to Follow-up|0|||
145502360|NCT00771758|524698130|FG002|Overall Study|Lost to Follow-up|0|||
145502361|NCT00771758|524698128|FG000|Overall Study|Protocol Violation|1|||
145502362|NCT00771758|524698129|FG001|Overall Study|Protocol Violation|0|||
145502363|NCT00771758|524698130|FG002|Overall Study|Protocol Violation|0|||
145502364|NCT00771758|524698128|FG000|Overall Study|Withdrawal by Subject|1|||
145502365|NCT00771758|524698129|FG001|Overall Study|Withdrawal by Subject|0|||
145502366|NCT00771758|524698130|FG002|Overall Study|Withdrawal by Subject|0|||
145502367|NCT00771758|524698128|FG000|Overall Study|Other|3|||
145502368|NCT00771758|524698129|FG001|Overall Study|Other|2|||
145502369|NCT00771758|524698130|FG002|Overall Study|Other|0|||
145502370|NCT03067077|524698131|FG000|Overall Study|Did not receive surgery|4|||
145502371|NCT03067077|524698132|FG001|Overall Study|Did not receive surgery|5|||
145502372|NCT03067077|524698131|FG000|Overall Study|Lost to Follow-up|3|||
145502373|NCT03067077|524698132|FG001|Overall Study|Lost to Follow-up|2|||
145502374|NCT00935584|524698135|FG000|Overall Study|Withdrawal by Subject|9|||
145502375|NCT00935584|524698136|FG001|Overall Study|Withdrawal by Subject|0|||
145502376|NCT00935584|524698135|FG000|Overall Study|Death|3|||
145502377|NCT00935584|524698136|FG001|Overall Study|Death|0|||
145502378|NCT00935584|524698135|FG000|Overall Study|Lost to Follow-up|8|||
145502379|NCT00935584|524698136|FG001|Overall Study|Lost to Follow-up|0|||
145502380|NCT00935584|524698135|FG000|Overall Study|No show|9|||
145502381|NCT00935584|524698136|FG001|Overall Study|No show|0|||
145502382|NCT00935584|524698135|FG000|Overall Study|Relocated|3|||
145502383|NCT00935584|524698136|FG001|Overall Study|Relocated|0|||
145502384|NCT00935584|524698135|FG000|Overall Study|Patient changed provider|3|||
145502385|NCT00935584|524698136|FG001|Overall Study|Patient changed provider|0|||
145502386|NCT00935584|524698135|FG000|Overall Study|Provider dropped out of study|14|||
145502387|NCT00935584|524698136|FG001|Overall Study|Provider dropped out of study|4|||
145502388|NCT00174187|524698143|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
145502389|NCT00174187|524698144|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
145502390|NCT00174187|524698145|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
145502391|NCT00174187|524698143|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
145502392|NCT00174187|524698144|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
145502393|NCT00174187|524698145|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
145502394|NCT00174187|524698143|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
145502395|NCT00174187|524698144|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
145502396|NCT00174187|524698145|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
145502397|NCT00174187|524698143|FG000|Period 1 (up to 3 Years)|Other|0|||
145502398|NCT00174187|524698144|FG001|Period 1 (up to 3 Years)|Other|1|||
145502399|NCT00174187|524698145|FG002|Period 1 (up to 3 Years)|Other|0|||
145502400|NCT00174187|524698143|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
145502401|NCT00174187|524698144|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
145502402|NCT00174187|524698145|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
145502403|NCT00174187|524698143|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
145502404|NCT00174187|524698144|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
145502405|NCT00174187|524698145|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
145502406|NCT00174187|524698143|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
145502407|NCT00174187|524698144|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
145502408|NCT00174187|524698145|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
145502409|NCT00174187|524698143|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
145502410|NCT00174187|524698144|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
145502411|NCT00174187|524698145|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
145502412|NCT00174187|524698143|FG000|Period 2 (After 3 Years)|Other|0|||
145502413|NCT00174187|524698144|FG001|Period 2 (After 3 Years)|Other|0|||
145502414|NCT00174187|524698145|FG002|Period 2 (After 3 Years)|Other|5|||
145502415|NCT01198977|524698147|FG000|Overall Study|Lost to Follow-up|1|||
145502416|NCT01198977|524698148|FG001|Overall Study|Lost to Follow-up|0|||
145502417|NCT01285557|524698149|FG000|Overall Study|Death|173|||
145502418|NCT01285557|524698150|FG001|Overall Study|Death|90|||
145502419|NCT01285557|524698149|FG000|Overall Study|Lost to Follow-up|6|||
145502420|NCT01285557|524698150|FG001|Overall Study|Lost to Follow-up|2|||
145502421|NCT01285557|524698149|FG000|Overall Study|Withdrew Consent|6|||
145502422|NCT01285557|524698150|FG001|Overall Study|Withdrew Consent|1|||
145502423|NCT01285557|524698149|FG000|Overall Study|Sponsor Study Termination|23|||
145502424|NCT01285557|524698150|FG001|Overall Study|Sponsor Study Termination|13|||
145502425|NCT01285557|524698149|FG000|Overall Study|Randomized but not treated|1|||
145502426|NCT01285557|524698150|FG001|Overall Study|Randomized but not treated|1|||
145502427|NCT01285557|524698149|FG000|Overall Study|Study follow-up ongoing|28|||
145502428|NCT01285557|524698150|FG001|Overall Study|Study follow-up ongoing|14|||
145502429|NCT01285557|524698149|FG000|Overall Study|Sponsor Decision|2|||
145502430|NCT01285557|524698150|FG001|Overall Study|Sponsor Decision|1|||
145502431|NCT01648751|524698157|FG000|Overall Study|Withdrawal by Subject|2|||
145502432|NCT01648751|524698158|FG001|Overall Study|Withdrawal by Subject|3|||
145502433|NCT02484391|524698163|FG000|Overall Study|Lack of Efficacy|15|||
145502434|NCT02484391|524698164|FG001|Overall Study|Lack of Efficacy|14|||
145502435|NCT02484391|524698165|FG002|Overall Study|Lack of Efficacy|3|||
145502436|NCT02484391|524698163|FG000|Overall Study|Lost to Follow-up|0|||
145502437|NCT02484391|524698164|FG001|Overall Study|Lost to Follow-up|0|||
145502438|NCT02484391|524698165|FG002|Overall Study|Lost to Follow-up|2|||
145502439|NCT02484391|524698163|FG000|Overall Study|Physician Decision|1|||
145502440|NCT02484391|524698164|FG001|Overall Study|Physician Decision|3|||
145502441|NCT02484391|524698165|FG002|Overall Study|Physician Decision|0|||
145502442|NCT02484391|524698163|FG000|Overall Study|Went to Transplant|5|||
145502443|NCT02484391|524698164|FG001|Overall Study|Went to Transplant|3|||
145502444|NCT02484391|524698165|FG002|Overall Study|Went to Transplant|2|||
145502445|NCT00904033|524699950|FG000|Overall Study|Withdrawal by Subject|1|||
145502446|NCT00904033|524699951|FG001|Overall Study|Withdrawal by Subject|1|||
145502447|NCT00904033|524699952|FG002|Overall Study|Withdrawal by Subject|0|||
145502448|NCT00904033|524699953|FG003|Overall Study|Withdrawal by Subject|0|||
145502449|NCT00904033|524699950|FG000|Overall Study|Physician Decision|0|||
145502450|NCT00904033|524699951|FG001|Overall Study|Physician Decision|0|||
145502451|NCT00904033|524699952|FG002|Overall Study|Physician Decision|1|||
145502452|NCT00904033|524699953|FG003|Overall Study|Physician Decision|0|||
145502453|NCT00904033|524699950|FG000|Overall Study|Unable to obtain final blood draw|0|||
145502454|NCT00904033|524699951|FG001|Overall Study|Unable to obtain final blood draw|0|||
145502455|NCT00904033|524699952|FG002|Overall Study|Unable to obtain final blood draw|0|||
145502456|NCT00904033|524699953|FG003|Overall Study|Unable to obtain final blood draw|2|||
145502457|NCT03252925|524699954|FG000|Overall Study|Withdrawal by Subject|1|||
145502458|NCT03252925|524699955|FG001|Overall Study|Withdrawal by Subject|0|||
145502459|NCT03252925|524699954|FG000|Overall Study|Protocol Violation|6|||
145502460|NCT03252925|524699955|FG001|Overall Study|Protocol Violation|0|||
145502461|NCT03252925|524699954|FG000|Overall Study|Adverse Event|1|||
145502462|NCT03252925|524699955|FG001|Overall Study|Adverse Event|0|||
145502463|NCT03252925|524699954|FG000|Overall Study|Lost to Follow-up|6|||
145502464|NCT03252925|524699955|FG001|Overall Study|Lost to Follow-up|6|||
145502465|NCT00521404|524699956|FG000|Overall Study|Adverse Event|13|||
145502466|NCT00521404|524699956|FG000|Overall Study|Disease Progression|33|||
145502467|NCT00521404|524699956|FG000|Overall Study|Investigator decision|5|||
145502468|NCT00521404|524699956|FG000|Overall Study|Withdrawal of consent|3|||
145502469|NCT00521404|524699956|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
145502470|NCT00521404|524699956|FG000|Overall Study|Other|7|||
145502471|NCT01908803|524699963|FG000|Overall Study|Adverse Event|1|||
145502472|NCT01908803|524699964|FG001|Overall Study|Adverse Event|0|||
145502473|NCT01908803|524699963|FG000|Overall Study|Physician Decision|0|||
145502474|NCT01908803|524699964|FG001|Overall Study|Physician Decision|1|||
145502475|NCT01908803|524699963|FG000|Overall Study|Withdrawal by Subject|1|||
145502476|NCT01908803|524699964|FG001|Overall Study|Withdrawal by Subject|0|||
145502477|NCT01908803|524699963|FG000|Overall Study|Randomization Error|1|||
145502478|NCT01908803|524699964|FG001|Overall Study|Randomization Error|0|||
145502479|NCT01908803|524699963|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
145502480|NCT01908803|524699964|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
145502481|NCT00098813|524699965|FG000|Overall Study|Death|8|||
145502482|NCT00098813|524699965|FG000|Overall Study|Protocol Violation|1|||
145502483|NCT00098813|524699965|FG000|Overall Study|Withdrawal by Subject|7|||
145502484|NCT00098813|524699965|FG000|Overall Study|Progression of Disease|1|||
145502485|NCT00098813|524699965|FG000|Overall Study|Other complicating disease|1|||
145502486|NCT00098813|524699965|FG000|Overall Study|Reversal of RAI resistance|1|||
145502487|NCT03926611|524699966|FG000|Overall Study|Adverse Event|0|||
145502488|NCT03926611|524699967|FG001|Overall Study|Adverse Event|0|||
145502489|NCT03926611|524699968|FG002|Overall Study|Adverse Event|0|||
145502490|NCT03926611|524699969|FG003|Overall Study|Adverse Event|3|||
145502491|NCT03926611|524699970|FG004|Overall Study|Adverse Event|1|||
145502492|NCT03926611|524699971|FG005|Overall Study|Adverse Event|3|||
145502493|NCT03926611|524699972|FG006|Overall Study|Adverse Event|0|||
145502494|NCT03926611|524699966|FG000|Overall Study|Lack of Efficacy|1|||
145502495|NCT03926611|524699967|FG001|Overall Study|Lack of Efficacy|2|||
145502496|NCT03926611|524699968|FG002|Overall Study|Lack of Efficacy|0|||
145502497|NCT03926611|524699969|FG003|Overall Study|Lack of Efficacy|0|||
145502498|NCT03926611|524699970|FG004|Overall Study|Lack of Efficacy|1|||
145502499|NCT03926611|524699971|FG005|Overall Study|Lack of Efficacy|0|||
145502500|NCT03926611|524699972|FG006|Overall Study|Lack of Efficacy|1|||
145502501|NCT03926611|524699966|FG000|Overall Study|Physician Decision|0|||
145502502|NCT03926611|524699967|FG001|Overall Study|Physician Decision|0|||
145502503|NCT03926611|524699968|FG002|Overall Study|Physician Decision|0|||
145502504|NCT03926611|524699969|FG003|Overall Study|Physician Decision|0|||
145502505|NCT03926611|524699970|FG004|Overall Study|Physician Decision|0|||
145502506|NCT03926611|524699971|FG005|Overall Study|Physician Decision|1|||
145502507|NCT03926611|524699972|FG006|Overall Study|Physician Decision|0|||
145502508|NCT03926611|524699966|FG000|Overall Study|Protocol Violation|1|||
145502509|NCT03926611|524699967|FG001|Overall Study|Protocol Violation|0|||
145502510|NCT03926611|524699968|FG002|Overall Study|Protocol Violation|0|||
145502511|NCT03926611|524699969|FG003|Overall Study|Protocol Violation|1|||
145502512|NCT03926611|524699970|FG004|Overall Study|Protocol Violation|1|||
145502513|NCT03926611|524699971|FG005|Overall Study|Protocol Violation|1|||
145502514|NCT03926611|524699972|FG006|Overall Study|Protocol Violation|1|||
145502515|NCT03926611|524699966|FG000|Overall Study|Technical problems|0|||
145502516|NCT03926611|524699967|FG001|Overall Study|Technical problems|0|||
145502517|NCT03926611|524699968|FG002|Overall Study|Technical problems|0|||
145502518|NCT03926611|524699969|FG003|Overall Study|Technical problems|0|||
145502519|NCT03926611|524699970|FG004|Overall Study|Technical problems|0|||
145502520|NCT03926611|524699971|FG005|Overall Study|Technical problems|1|||
145502521|NCT03926611|524699972|FG006|Overall Study|Technical problems|0|||
145502522|NCT03926611|524699966|FG000|Overall Study|Withdrawal by Subject|1|||
145502523|NCT03926611|524699967|FG001|Overall Study|Withdrawal by Subject|1|||
145502524|NCT03926611|524699968|FG002|Overall Study|Withdrawal by Subject|1|||
145502525|NCT03926611|524699969|FG003|Overall Study|Withdrawal by Subject|0|||
145502526|NCT03926611|524699970|FG004|Overall Study|Withdrawal by Subject|0|||
145502527|NCT03926611|524699971|FG005|Overall Study|Withdrawal by Subject|1|||
145502528|NCT03926611|524699972|FG006|Overall Study|Withdrawal by Subject|3|||
145502529|NCT03926611|524699966|FG000|Overall Study|Covid-19 pandemic|0|||
145502530|NCT03926611|524699967|FG001|Overall Study|Covid-19 pandemic|0|||
145502531|NCT03926611|524699968|FG002|Overall Study|Covid-19 pandemic|1|||
145502532|NCT03926611|524699969|FG003|Overall Study|Covid-19 pandemic|0|||
145502533|NCT03926611|524699970|FG004|Overall Study|Covid-19 pandemic|1|||
145502534|NCT03926611|524699971|FG005|Overall Study|Covid-19 pandemic|2|||
145502535|NCT03926611|524699972|FG006|Overall Study|Covid-19 pandemic|0|||
145502536|NCT01524796|524699975|FG000|Overall Study|Adverse Event|13|||
145502537|NCT01524796|524699975|FG000|Overall Study|Lack of Efficacy|3|||
145502538|NCT01524796|524699975|FG000|Overall Study|Lost to Follow-up|1|||
145502539|NCT01524796|524699975|FG000|Overall Study|The price|1|||
145502540|NCT01524796|524699975|FG000|Overall Study|Withdrawal by Subject|4|||
145502541|NCT01524796|524699975|FG000|Overall Study|Move|1|||
145502542|NCT01524796|524699975|FG000|Overall Study|Deterioration of pains|1|||
145502543|NCT01524796|524699975|FG000|Overall Study|Gall stone surgery|1|||
145502544|NCT01524796|524699975|FG000|Overall Study|Nervous about confidentiality|1|||
145502545|NCT01524796|524699975|FG000|Overall Study|Switch to carbamazapine|1|||
145502546|NCT01524796|524699975|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
145502547|NCT00836693|524699976|FG000|Overall Study|Adverse Event|4|||
145502548|NCT00836693|524699977|FG001|Overall Study|Adverse Event|1|||
145502549|NCT00836693|524699976|FG000|Overall Study|Sponsor Decision|0|||
145502550|NCT00836693|524699977|FG001|Overall Study|Sponsor Decision|1|||
145502551|NCT00836693|524699976|FG000|Overall Study|Physician Decision|2|||
145502552|NCT00836693|524699977|FG001|Overall Study|Physician Decision|0|||
145502553|NCT00836693|524699976|FG000|Overall Study|Withdrawal by Subject|9|||
145502554|NCT00836693|524699977|FG001|Overall Study|Withdrawal by Subject|4|||
145502555|NCT00836693|524699976|FG000|Overall Study|Protocol Violation|1|||
145502556|NCT00836693|524699977|FG001|Overall Study|Protocol Violation|0|||
145502557|NCT00836693|524699976|FG000|Overall Study|Lost to Follow-up|1|||
145502558|NCT00836693|524699977|FG001|Overall Study|Lost to Follow-up|0|||
145502559|NCT02612779|524699978|FG000|Overall Study|Administrative reason by sponsor|4|||
145502560|NCT02612779|524699979|FG001|Overall Study|Administrative reason by sponsor|1|||
145266691|NCT04668066|523825244|FG007|Part 1: Follow-Up|Other|0|||
145502561|NCT02612779|524699978|FG000|Overall Study|No longer meet study criteria|0|||
145502562|NCT02612779|524699979|FG001|Overall Study|No longer meet study criteria|1|||
145502563|NCT02612779|524699978|FG000|Overall Study|Disease progression|29|||
145502564|NCT02612779|524699979|FG001|Overall Study|Disease progression|2|||
145502565|NCT02612779|524699978|FG000|Overall Study|Study drug toxicity|10|||
145502566|NCT02612779|524699979|FG001|Overall Study|Study drug toxicity|1|||
145398635|NCT04265261|524314826|FG001|Overall Study|Physician Decision|0|||
145398636|NCT04265261|524314827|FG002|Overall Study|Physician Decision|1|||
145398637|NCT04265261|524314825|FG000|Overall Study|Protocol Deviation|0|||
145398638|NCT04265261|524314826|FG001|Overall Study|Protocol Deviation|2|||
145398639|NCT04265261|524314827|FG002|Overall Study|Protocol Deviation|0|||
145398640|NCT04265261|524314825|FG000|Overall Study|Withdrawal by Subject|2|||
145398641|NCT04265261|524314826|FG001|Overall Study|Withdrawal by Subject|1|||
145398642|NCT04265261|524314827|FG002|Overall Study|Withdrawal by Subject|4|||
145398643|NCT02990000|524316443|FG000|Overall Study|Failed to provide data beyond baseline|36|||
145398644|NCT02990000|524316444|FG001|Overall Study|Failed to provide data beyond baseline|34|||
145398645|NCT00922636|524316445|FG000|Overall Study|Adverse Event|3|||
145398646|NCT00922636|524316446|FG001|Overall Study|Adverse Event|3|||
145398647|NCT00922636|524316447|FG002|Overall Study|Adverse Event|2|||
145398648|NCT00922636|524316448|FG003|Overall Study|Adverse Event|3|||
145398649|NCT00922636|524316449|FG004|Overall Study|Adverse Event|2|||
145398650|NCT00922636|524316445|FG000|Overall Study|Lack of Efficacy|1|||
145398651|NCT00922636|524316446|FG001|Overall Study|Lack of Efficacy|7|||
145398652|NCT00922636|524316447|FG002|Overall Study|Lack of Efficacy|3|||
145398653|NCT00922636|524316448|FG003|Overall Study|Lack of Efficacy|2|||
145398654|NCT00922636|524316449|FG004|Overall Study|Lack of Efficacy|4|||
145398655|NCT00922636|524316445|FG000|Overall Study|Sponsor Decision|0|||
145398656|NCT00922636|524316446|FG001|Overall Study|Sponsor Decision|0|||
145398657|NCT00922636|524316447|FG002|Overall Study|Sponsor Decision|2|||
145398658|NCT00922636|524316448|FG003|Overall Study|Sponsor Decision|0|||
145398659|NCT00922636|524316449|FG004|Overall Study|Sponsor Decision|0|||
145398660|NCT00922636|524316445|FG000|Overall Study|Withdrawal by Subject|0|||
145398661|NCT00922636|524316446|FG001|Overall Study|Withdrawal by Subject|0|||
145398662|NCT00922636|524316447|FG002|Overall Study|Withdrawal by Subject|5|||
145398663|NCT00922636|524316448|FG003|Overall Study|Withdrawal by Subject|2|||
145398664|NCT00922636|524316449|FG004|Overall Study|Withdrawal by Subject|4|||
145398665|NCT00922636|524316445|FG000|Overall Study|Protocol Violation|0|||
145398666|NCT00922636|524316446|FG001|Overall Study|Protocol Violation|0|||
145398667|NCT00922636|524316447|FG002|Overall Study|Protocol Violation|2|||
145398668|NCT00922636|524316448|FG003|Overall Study|Protocol Violation|2|||
145398669|NCT00922636|524316449|FG004|Overall Study|Protocol Violation|0|||
145398670|NCT00922636|524316445|FG000|Overall Study|Entry Criteria Not Met|0|||
145398671|NCT00922636|524316446|FG001|Overall Study|Entry Criteria Not Met|0|||
145398672|NCT00922636|524316447|FG002|Overall Study|Entry Criteria Not Met|1|||
145398673|NCT00922636|524316448|FG003|Overall Study|Entry Criteria Not Met|1|||
145398674|NCT00922636|524316449|FG004|Overall Study|Entry Criteria Not Met|0|||
145398675|NCT00922636|524316445|FG000|Overall Study|Parent/Caregiver Decision|2|||
145398676|NCT00922636|524316446|FG001|Overall Study|Parent/Caregiver Decision|4|||
145398677|NCT00922636|524316447|FG002|Overall Study|Parent/Caregiver Decision|3|||
145398678|NCT00922636|524316448|FG003|Overall Study|Parent/Caregiver Decision|5|||
145398679|NCT00922636|524316449|FG004|Overall Study|Parent/Caregiver Decision|2|||
145398680|NCT00922636|524316445|FG000|Overall Study|Lost to Follow-up|1|||
145398681|NCT00922636|524316446|FG001|Overall Study|Lost to Follow-up|2|||
145398682|NCT00922636|524316447|FG002|Overall Study|Lost to Follow-up|2|||
145398683|NCT00922636|524316448|FG003|Overall Study|Lost to Follow-up|2|||
145398684|NCT00922636|524316449|FG004|Overall Study|Lost to Follow-up|4|||
145398685|NCT02308046|524316452|FG000|Overall Study|Negative yeast culture at Baseline|32|||
145398686|NCT02308046|524316453|FG001|Overall Study|Negative yeast culture at Baseline|33|||
145398687|NCT02308046|524316452|FG000|Overall Study|Positive for STD at Baseline|1|||
145398688|NCT02308046|524316453|FG001|Overall Study|Positive for STD at Baseline|2|||
145398689|NCT02308046|524316452|FG000|Overall Study|Lost to Follow-up|1|||
145398690|NCT02308046|524316453|FG001|Overall Study|Lost to Follow-up|3|||
145398691|NCT01181167|524316454|FG000|Overall Study|Adverse Event|11|||
145398692|NCT01181167|524316455|FG001|Overall Study|Adverse Event|21|||
145398693|NCT01181167|524316454|FG000|Overall Study|Lost to Follow-up|1|||
145398694|NCT01181167|524316455|FG001|Overall Study|Lost to Follow-up|0|||
145398695|NCT01181167|524316454|FG000|Overall Study|Physician Decision|2|||
145398696|NCT01181167|524316455|FG001|Overall Study|Physician Decision|3|||
145398697|NCT01181167|524316454|FG000|Overall Study|Protocol Violation|3|||
145398698|NCT01181167|524316455|FG001|Overall Study|Protocol Violation|0|||
145398699|NCT01181167|524316454|FG000|Overall Study|Withdrawal by Subject|6|||
145398700|NCT01181167|524316455|FG001|Overall Study|Withdrawal by Subject|8|||
145398701|NCT00161213|524316456|FG000|Overall Study|Withdrawal by Subject|1|||
145398702|NCT00161213|524316456|FG000|Overall Study|Evaluable for toxicity but not response|1|||
145398703|NCT01433159|524316458|FG000|Overall Study|Adverse Event|1|||
145398704|NCT01433159|524316459|FG001|Overall Study|Adverse Event|0|||
145398705|NCT01433159|524316458|FG000|Overall Study|Physician Decision|1|||
145398706|NCT01433159|524316459|FG001|Overall Study|Physician Decision|0|||
145398707|NCT01433159|524316458|FG000|Overall Study|Protocol Violation|0|||
145398708|NCT01433159|524316459|FG001|Overall Study|Protocol Violation|1|||
145398709|NCT02579629|524316471|FG000|Overall Study|Withdrawal by Subject|0|||
145398710|NCT02579629|524316472|FG001|Overall Study|Withdrawal by Subject|1|||
145398711|NCT02579629|524316473|FG002|Overall Study|Withdrawal by Subject|0|||
145398712|NCT02579629|524316471|FG000|Overall Study|Screen Failure|2|||
145398713|NCT02579629|524316472|FG001|Overall Study|Screen Failure|0|||
145398714|NCT02579629|524316473|FG002|Overall Study|Screen Failure|2|||
145398715|NCT01930539|524316474|FG000|Overall Study|Withdrawal by Subject|2|||
145398716|NCT01930539|524316475|FG001|Overall Study|Withdrawal by Subject|2|||
145398717|NCT01190891|524316478|FG000|Overall Study|Protocol Violation|1|||
145398718|NCT01190891|524316479|FG001|Overall Study|Protocol Violation|0|||
145398719|NCT01190891|524316478|FG000|Overall Study|Withdrawal by Subject|5|||
145398720|NCT01190891|524316479|FG001|Overall Study|Withdrawal by Subject|0|||
145398721|NCT01926028|524316480|FG000|Overall Study|Lost to Follow-up|7|||
145398722|NCT01926028|524316481|FG001|Overall Study|Lost to Follow-up|6|||
145398723|NCT01926028|524316482|FG002|Overall Study|Lost to Follow-up|0|||
145398724|NCT01926028|524316480|FG000|Overall Study|Physician Decision|1|||
145398725|NCT01926028|524316481|FG001|Overall Study|Physician Decision|5|||
145398726|NCT01926028|524316482|FG002|Overall Study|Physician Decision|0|||
145398727|NCT01926028|524316480|FG000|Overall Study|Withdrawal by Subject|9|||
145398728|NCT01926028|524316481|FG001|Overall Study|Withdrawal by Subject|9|||
145398729|NCT01926028|524316482|FG002|Overall Study|Withdrawal by Subject|2|||
145398730|NCT01926028|524316480|FG000|Overall Study|Non compliance or other reasons|4|||
145398731|NCT01926028|524316481|FG001|Overall Study|Non compliance or other reasons|2|||
145398732|NCT01926028|524316482|FG002|Overall Study|Non compliance or other reasons|0|||
145398733|NCT00737048|524316483|FG000|Overall Study|Physician Decision|0|||
145398734|NCT00737048|524316484|FG001|Overall Study|Physician Decision|0|||
145398735|NCT00737048|524316485|FG002|Overall Study|Physician Decision|1|||
145502567|NCT02612779|524699978|FG000|Overall Study|Death|1|||
145398736|NCT00737048|524316483|FG000|Overall Study|Adverse Event|0|||
145398737|NCT00737048|524316484|FG001|Overall Study|Adverse Event|1|||
145398738|NCT00737048|524316485|FG002|Overall Study|Adverse Event|0|||
145398739|NCT00737048|524316483|FG000|Overall Study|Worsening of the symptoms|3|||
145398740|NCT00737048|524316484|FG001|Overall Study|Worsening of the symptoms|5|||
145398741|NCT00737048|524316485|FG002|Overall Study|Worsening of the symptoms|3|||
145398742|NCT00744939|524316486|FG000|Overall Study|Withdrawal by Subject|9|||
145398743|NCT00744939|524316486|FG000|Overall Study|Protocol Violation|13|||
145398744|NCT00744939|524316486|FG000|Overall Study|Death|24|||
145398745|NCT00744939|524316486|FG000|Overall Study|distance|4|||
145398746|NCT00744939|524316486|FG000|Overall Study|Lost to Follow-up|12|||
145398747|NCT00744939|524316486|FG000|Overall Study|Medical history exclusionary|1|||
145398748|NCT00744939|524316486|FG000|Overall Study|Did not receive Magnevist|7|||
145398749|NCT00744939|524316486|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
145398750|NCT00744939|524316486|FG000|Overall Study|coma|1|||
145398751|NCT00744939|524316486|FG000|Overall Study|incorrect race|1|||
145398752|NCT04040439|524316487|FG000|Overall Study|Invalid registration|11|||
145398753|NCT04040439|524316487|FG000|Overall Study|No IC* on publication of study results|2|||
145398754|NCT01248455|524316490|FG000|Overall Study|switched to alternate treatment|1|||
145398755|NCT00426270|524316491|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
145398756|NCT00426270|524316491|FG000|Overall Study|Adverse Event|5|||
145398757|NCT01587885|524316492|FG000|Treatment Period 1|Failure to Return|0|||
145398758|NCT01587885|524316493|FG001|Treatment Period 1|Failure to Return|1|||
145398759|NCT01587885|524316492|FG000|Treatment Period 1|Protocol Violation|0|||
145398760|NCT01587885|524316493|FG001|Treatment Period 1|Protocol Violation|2|||
145398761|NCT01117870|524316495|FG000|Overall Study|Inability to place needle|1|||
145398762|NCT01117870|524316496|FG001|Overall Study|Inability to place needle|0|||
145398763|NCT01309386|524316497|FG000|Overall Study|Other|2|||
145398764|NCT01309386|524316498|FG001|Overall Study|Other|0|||
145398765|NCT01309386|524316497|FG000|Overall Study|Withdrawal by Subject|2|||
145398766|NCT01309386|524316498|FG001|Overall Study|Withdrawal by Subject|0|||
145398767|NCT01309386|524316497|FG000|Overall Study|Progressive disease|9|||
145398768|NCT01309386|524316498|FG001|Overall Study|Progressive disease|11|||
145398769|NCT01309386|524316497|FG000|Overall Study|Physician Decision|1|||
145398770|NCT01309386|524316498|FG001|Overall Study|Physician Decision|1|||
145398771|NCT01309386|524316497|FG000|Overall Study|Lack of Efficacy|3|||
145398772|NCT01309386|524316498|FG001|Overall Study|Lack of Efficacy|1|||
145398773|NCT01309386|524316497|FG000|Overall Study|Adverse Event|5|||
145398774|NCT01309386|524316498|FG001|Overall Study|Adverse Event|8|||
145398775|NCT02062437|524316499|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
145398776|NCT02062437|524316499|FG000|Overall Study|Patient not available for the 2y visit|18|||
145398777|NCT02062437|524316499|FG000|Overall Study|Death|2|||
145398778|NCT02062437|524316499|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
145398779|NCT00723229|524316500|FG000|First Intervention|Lost to Follow-up|7|||
145398780|NCT00723229|524316501|FG001|First Intervention|Lost to Follow-up|3|||
145398781|NCT02900352|524316502|FG000|Overall Study|Lost to Follow-up|28|||
145398782|NCT02900352|524316503|FG001|Overall Study|Lost to Follow-up|17|||
145398783|NCT02089347|524316504|FG000|Overall Study|Protocol Violation|1|||
145398784|NCT02089347|524316505|FG001|Overall Study|Protocol Violation|0|||
145398785|NCT00001566|524316506|FG000|Overall Study|patients' choice to discontinue protocol|3|||
145398786|NCT00001566|524316506|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
145398787|NCT00001566|524316506|FG000|Overall Study|Death|13|||
145398788|NCT00001566|524316506|FG000|Overall Study|Lost to Follow-up|1|||
145398789|NCT00001566|524316506|FG000|Overall Study|unable to complete initial apheresis|1|||
145398790|NCT03439137|524316511|FG000|Overall Study|Adverse Event|16|||
145398791|NCT03439137|524316512|FG001|Overall Study|Adverse Event|12|||
145398792|NCT03439137|524316511|FG000|Overall Study|Physician Decision|0|||
145398793|NCT03439137|524316512|FG001|Overall Study|Physician Decision|5|||
145398794|NCT03439137|524316511|FG000|Overall Study|Withdrawal by Subject|14|||
145398795|NCT03439137|524316512|FG001|Overall Study|Withdrawal by Subject|4|||
145266692|NCT04668066|523825245|FG008|Part 1: Follow-Up|Other|0|||
145398796|NCT03439137|524316511|FG000|Overall Study|Conducting rescue therapy|2|||
145502568|NCT02612779|524699979|FG001|Overall Study|Death|0|||
145502569|NCT02612779|524699978|FG000|Overall Study|Adverse event unrelated to study drug|5|||
145502570|NCT02612779|524699979|FG001|Overall Study|Adverse event unrelated to study drug|0|||
145502571|NCT02612779|524699978|FG000|Overall Study|Participant withdrew consent|4|||
145502572|NCT02612779|524699979|FG001|Overall Study|Participant withdrew consent|0|||
145502573|NCT02612779|524699978|FG000|Overall Study|Lost to Follow-up|1|||
145502574|NCT02612779|524699979|FG001|Overall Study|Lost to Follow-up|0|||
145502575|NCT02612779|524699978|FG000|Overall Study|Maximum clinical benefit|10|||
145502576|NCT02612779|524699979|FG001|Overall Study|Maximum clinical benefit|1|||
145502577|NCT02612779|524699978|FG000|Overall Study|Other reasons|4|||
145502578|NCT02612779|524699979|FG001|Overall Study|Other reasons|0|||
145502579|NCT01002339|524699980|FG000|Overall Study|Withdrawal by Subject|0|||
145502580|NCT01002339|524699981|FG001|Overall Study|Withdrawal by Subject|1|||
145502581|NCT01002339|524699982|FG002|Overall Study|Withdrawal by Subject|0|||
145502582|NCT01002339|524699980|FG000|Overall Study|Incorrect treatment assignment|0|||
145502583|NCT01002339|524699981|FG001|Overall Study|Incorrect treatment assignment|0|||
145502584|NCT01002339|524699982|FG002|Overall Study|Incorrect treatment assignment|1|||
145502585|NCT01002339|524699980|FG000|Overall Study|Protocol Violation|0|||
145502586|NCT01002339|524699981|FG001|Overall Study|Protocol Violation|0|||
145502587|NCT01002339|524699982|FG002|Overall Study|Protocol Violation|2|||
145502588|NCT01002339|524699980|FG000|Overall Study|Lung cancer detected before transplant|0|||
145502589|NCT01002339|524699981|FG001|Overall Study|Lung cancer detected before transplant|0|||
145502590|NCT01002339|524699982|FG002|Overall Study|Lung cancer detected before transplant|1|||
145502591|NCT01002339|524699980|FG000|Overall Study|Randomized. Not transplanted|0|||
145502592|NCT01002339|524699981|FG001|Overall Study|Randomized. Not transplanted|0|||
145502593|NCT01002339|524699982|FG002|Overall Study|Randomized. Not transplanted|1|||
145502594|NCT02215252|524699983|FG000|Overall Study|Adverse Event|1|||
145502595|NCT02215252|524699984|FG001|Overall Study|Adverse Event|5|||
145502596|NCT02215252|524699985|FG002|Overall Study|Adverse Event|2|||
145502597|NCT02215252|524699983|FG000|Overall Study|Lost to Follow-up|0|||
145502598|NCT02215252|524699984|FG001|Overall Study|Lost to Follow-up|0|||
145502599|NCT02215252|524699985|FG002|Overall Study|Lost to Follow-up|1|||
145502600|NCT02215252|524699983|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
145502601|NCT02215252|524699984|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
145502602|NCT02215252|524699985|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
145502603|NCT02215252|524699983|FG000|Overall Study|Protocol Violation|0|||
145502604|NCT02215252|524699984|FG001|Overall Study|Protocol Violation|1|||
145502605|NCT02215252|524699985|FG002|Overall Study|Protocol Violation|0|||
145502606|NCT02215252|524699983|FG000|Overall Study|Withdrawal by Subject|1|||
145502607|NCT02215252|524699984|FG001|Overall Study|Withdrawal by Subject|0|||
145502608|NCT02215252|524699985|FG002|Overall Study|Withdrawal by Subject|0|||
145502609|NCT02215252|524699983|FG000|Overall Study|Other|0|||
145502610|NCT02215252|524699984|FG001|Overall Study|Other|1|||
145502611|NCT02215252|524699985|FG002|Overall Study|Other|1|||
145502612|NCT00892099|524699986|FG000|Overall Study|Death|1|||
145502613|NCT00892099|524699987|FG001|Overall Study|Death|0|||
145502614|NCT00892099|524699988|FG002|Overall Study|Death|1|||
145502615|NCT00892099|524699986|FG000|Overall Study|Adverse Event|1|||
145502616|NCT00892099|524699987|FG001|Overall Study|Adverse Event|0|||
145502617|NCT00892099|524699988|FG002|Overall Study|Adverse Event|0|||
145502618|NCT00892099|524699986|FG000|Overall Study|replocated|1|||
145502619|NCT00892099|524699987|FG001|Overall Study|replocated|0|||
145502620|NCT00892099|524699988|FG002|Overall Study|replocated|2|||
145502621|NCT00892099|524699986|FG000|Overall Study|Prolonged hospitalization|1|||
145502622|NCT00892099|524699987|FG001|Overall Study|Prolonged hospitalization|0|||
145502623|NCT00892099|524699988|FG002|Overall Study|Prolonged hospitalization|1|||
145502624|NCT00892099|524699986|FG000|Overall Study|no further details|1|||
145502625|NCT00892099|524699987|FG001|Overall Study|no further details|0|||
145502626|NCT00892099|524699988|FG002|Overall Study|no further details|1|||
145502627|NCT00892099|524699986|FG000|Overall Study|kidney function recovered|0|||
145502628|NCT00892099|524699987|FG001|Overall Study|kidney function recovered|1|||
145502629|NCT00892099|524699988|FG002|Overall Study|kidney function recovered|0|||
145502630|NCT00892099|524699986|FG000|Overall Study|investigator decision|0|||
145502631|NCT00892099|524699987|FG001|Overall Study|investigator decision|0|||
145502632|NCT00892099|524699988|FG002|Overall Study|investigator decision|1|||
145502633|NCT00892099|524699986|FG000|Overall Study|Lost to Follow-up|0|||
145502634|NCT00892099|524699987|FG001|Overall Study|Lost to Follow-up|0|||
145502635|NCT00892099|524699988|FG002|Overall Study|Lost to Follow-up|1|||
145502636|NCT02346721|524699989|FG000|Overall Study|Withdrew Consent|3|||
145502637|NCT02346721|524699989|FG000|Overall Study|Lack of Efficacy|1|||
145502638|NCT00790842|524699990|FG000|Dose Level 1|Adverse Event|1|||
145502639|NCT00790842|524699991|FG001|Dose Level 1|Adverse Event|0|||
145502640|NCT00790842|524699992|FG002|Dose Level 1|Adverse Event|0|||
145502641|NCT00790842|524699993|FG003|Dose Level 1|Adverse Event|2|||
145502642|NCT00790842|524699994|FG004|Dose Level 1|Adverse Event|0|||
145502643|NCT00790842|524699995|FG005|Dose Level 1|Adverse Event|0|||
145502644|NCT00790842|524699996|FG006|Dose Level 1|Adverse Event|0|||
145502645|NCT00790842|524699997|FG007|Dose Level 1|Adverse Event|1|||
145502646|NCT00790842|524699998|FG008|Dose Level 1|Adverse Event|0|||
145502647|NCT00790842|524699999|FG009|Dose Level 1|Adverse Event|0|||
145502648|NCT00790842|524700000|FG010|Dose Level 1|Adverse Event|0|||
145502649|NCT00790842|524699990|FG000|Dose Level 1|Physician Decision|1|||
145502650|NCT00790842|524699991|FG001|Dose Level 1|Physician Decision|0|||
145502651|NCT00790842|524699992|FG002|Dose Level 1|Physician Decision|0|||
145502652|NCT00790842|524699993|FG003|Dose Level 1|Physician Decision|0|||
145502653|NCT00790842|524699994|FG004|Dose Level 1|Physician Decision|0|||
145502654|NCT00790842|524699995|FG005|Dose Level 1|Physician Decision|0|||
145502655|NCT00790842|524699996|FG006|Dose Level 1|Physician Decision|0|||
145502656|NCT00790842|524699997|FG007|Dose Level 1|Physician Decision|1|||
145502657|NCT00790842|524699998|FG008|Dose Level 1|Physician Decision|0|||
145502658|NCT00790842|524699999|FG009|Dose Level 1|Physician Decision|0|||
145502659|NCT00790842|524700000|FG010|Dose Level 1|Physician Decision|0|||
145502660|NCT00790842|524699990|FG000|Dose Level 1|Withdrawal by Subject|1|||
145502661|NCT00790842|524699991|FG001|Dose Level 1|Withdrawal by Subject|0|||
145502662|NCT00790842|524699992|FG002|Dose Level 1|Withdrawal by Subject|0|||
145502663|NCT00790842|524699993|FG003|Dose Level 1|Withdrawal by Subject|0|||
145502664|NCT00790842|524699994|FG004|Dose Level 1|Withdrawal by Subject|0|||
145502665|NCT00790842|524699995|FG005|Dose Level 1|Withdrawal by Subject|0|||
145502666|NCT00790842|524699996|FG006|Dose Level 1|Withdrawal by Subject|0|||
145502667|NCT00790842|524699997|FG007|Dose Level 1|Withdrawal by Subject|0|||
145502668|NCT00790842|524699998|FG008|Dose Level 1|Withdrawal by Subject|0|||
145502669|NCT00790842|524699999|FG009|Dose Level 1|Withdrawal by Subject|0|||
145502670|NCT00790842|524700000|FG010|Dose Level 1|Withdrawal by Subject|0|||
145502671|NCT00790842|524699990|FG000|Dose Level 2|Death|0|||
145502672|NCT00790842|524699991|FG001|Dose Level 2|Death|1|||
145502673|NCT00790842|524699992|FG002|Dose Level 2|Death|0|||
145502674|NCT00790842|524699993|FG003|Dose Level 2|Death|0|||
145502675|NCT00790842|524699994|FG004|Dose Level 2|Death|1|||
145502676|NCT00790842|524699995|FG005|Dose Level 2|Death|0|||
145502677|NCT00790842|524699996|FG006|Dose Level 2|Death|0|||
145502678|NCT00790842|524699997|FG007|Dose Level 2|Death|0|||
145502679|NCT00790842|524699998|FG008|Dose Level 2|Death|0|||
145502680|NCT00790842|524699999|FG009|Dose Level 2|Death|0|||
145502681|NCT00790842|524700000|FG010|Dose Level 2|Death|0|||
145502682|NCT00790842|524699990|FG000|Dose Level 2|Physician Decision|0|||
145502683|NCT00790842|524699991|FG001|Dose Level 2|Physician Decision|1|||
145502684|NCT00790842|524699992|FG002|Dose Level 2|Physician Decision|0|||
145502685|NCT00790842|524699993|FG003|Dose Level 2|Physician Decision|0|||
145502686|NCT00790842|524699994|FG004|Dose Level 2|Physician Decision|0|||
145502687|NCT00790842|524699995|FG005|Dose Level 2|Physician Decision|0|||
145502688|NCT00790842|524699996|FG006|Dose Level 2|Physician Decision|0|||
145502689|NCT00790842|524699997|FG007|Dose Level 2|Physician Decision|0|||
145502690|NCT00790842|524699998|FG008|Dose Level 2|Physician Decision|0|||
145502691|NCT00790842|524699999|FG009|Dose Level 2|Physician Decision|0|||
145502692|NCT00790842|524700000|FG010|Dose Level 2|Physician Decision|0|||
145502693|NCT00790842|524699990|FG000|Dose Level 2|Withdrawal by Subject|0|||
145502694|NCT00790842|524699991|FG001|Dose Level 2|Withdrawal by Subject|1|||
145502695|NCT00790842|524699992|FG002|Dose Level 2|Withdrawal by Subject|0|||
145502696|NCT00790842|524699993|FG003|Dose Level 2|Withdrawal by Subject|0|||
145502697|NCT00790842|524699994|FG004|Dose Level 2|Withdrawal by Subject|0|||
145502698|NCT00790842|524699995|FG005|Dose Level 2|Withdrawal by Subject|0|||
145502699|NCT00790842|524699996|FG006|Dose Level 2|Withdrawal by Subject|0|||
145502700|NCT00790842|524699997|FG007|Dose Level 2|Withdrawal by Subject|0|||
145502701|NCT00790842|524699998|FG008|Dose Level 2|Withdrawal by Subject|0|||
145502702|NCT00790842|524699999|FG009|Dose Level 2|Withdrawal by Subject|0|||
145502703|NCT00790842|524700000|FG010|Dose Level 2|Withdrawal by Subject|0|||
145502704|NCT00790842|524699990|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145732842|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
145502705|NCT00790842|524699991|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502706|NCT00790842|524699992|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502707|NCT00790842|524699993|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502708|NCT00790842|524699994|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502709|NCT00790842|524699995|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502710|NCT00790842|524699996|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502711|NCT00790842|524699997|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502712|NCT00790842|524699998|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
145502713|NCT00790842|524699999|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502714|NCT00790842|524700000|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
145502715|NCT00790842|524699990|FG000|Dose Level 3|Adverse Event|0|||
145502716|NCT00790842|524699991|FG001|Dose Level 3|Adverse Event|0|||
145502717|NCT00790842|524699992|FG002|Dose Level 3|Adverse Event|1|||
145398797|NCT03439137|524316512|FG001|Overall Study|Conducting rescue therapy|1|||
145398798|NCT03439137|524316511|FG000|Overall Study|Difficult to control Hb|10|||
145398799|NCT03439137|524316512|FG001|Overall Study|Difficult to control Hb|2|||
145398800|NCT03439137|524316511|FG000|Overall Study|Initiation of a renal transplant|0|||
145398801|NCT03439137|524316512|FG001|Overall Study|Initiation of a renal transplant|2|||
145398802|NCT01225549|524316517|FG000|Period 4 - Washout|Disallowed medication|0|||
145398803|NCT01225549|524316518|FG001|Period 4 - Washout|Disallowed medication|1|||
145398804|NCT01225549|524316519|FG002|Period 4 - Washout|Disallowed medication|0|||
145398805|NCT01225549|524316520|FG003|Period 4 - Washout|Disallowed medication|0|||
145398806|NCT01225549|524316521|FG004|Period 4 - Washout|Disallowed medication|0|||
145398807|NCT01225549|524316522|FG005|Period 4 - Washout|Disallowed medication|0|||
145398808|NCT01225549|524316523|FG006|Period 4 - Washout|Disallowed medication|0|||
145398809|NCT01225549|524316524|FG007|Period 4 - Washout|Disallowed medication|0|||
145398810|NCT01225549|524316525|FG008|Period 4 - Washout|Disallowed medication|0|||
145398811|NCT01225549|524316526|FG009|Period 4 - Washout|Disallowed medication|0|||
145398812|NCT01225549|524316517|FG000|Period 6 - Washout|Disallowed medication|0|||
145398813|NCT01225549|524316518|FG001|Period 6 - Washout|Disallowed medication|0|||
145398814|NCT01225549|524316519|FG002|Period 6 - Washout|Disallowed medication|0|||
145398815|NCT01225549|524316520|FG003|Period 6 - Washout|Disallowed medication|1|||
145398816|NCT01225549|524316521|FG004|Period 6 - Washout|Disallowed medication|0|||
145398817|NCT01225549|524316522|FG005|Period 6 - Washout|Disallowed medication|0|||
145398818|NCT01225549|524316523|FG006|Period 6 - Washout|Disallowed medication|0|||
145398819|NCT01225549|524316524|FG007|Period 6 - Washout|Disallowed medication|0|||
145398820|NCT01225549|524316525|FG008|Period 6 - Washout|Disallowed medication|0|||
145398821|NCT01225549|524316526|FG009|Period 6 - Washout|Disallowed medication|0|||
145398822|NCT00473083|524316529|FG000|Overall Study|Adverse Event|1|||
145398823|NCT00473083|524316530|FG001|Overall Study|Adverse Event|0|||
145398824|NCT00473083|524316531|FG002|Overall Study|Adverse Event|0|||
145398825|NCT02915835|524316532|FG000|Overall Study|Physician Decision|1|||
145398826|NCT02915835|524316533|FG001|Overall Study|Physician Decision|0|||
145398827|NCT02915835|524316532|FG000|Overall Study|Withdrawal by Subject|0|||
145398828|NCT02915835|524316533|FG001|Overall Study|Withdrawal by Subject|1|||
145398829|NCT01184872|524316534|FG000|Overall Study|Adverse Event|3|||
145398830|NCT01184872|524316535|FG001|Overall Study|Adverse Event|4|||
145398831|NCT01184872|524316534|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145398832|NCT01184872|524316535|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145398833|NCT01184872|524316534|FG000|Overall Study|Withdrawal by Subject|2|||
145398834|NCT01184872|524316535|FG001|Overall Study|Withdrawal by Subject|0|||
145398835|NCT01184872|524316534|FG000|Overall Study|Lost to Follow-up|0|||
145398836|NCT01184872|524316535|FG001|Overall Study|Lost to Follow-up|1|||
145398837|NCT01184872|524316534|FG000|Overall Study|Administrative problems|1|||
145398838|NCT01184872|524316535|FG001|Overall Study|Administrative problems|1|||
145398839|NCT01184872|524316534|FG000|Overall Study|Protocol deviation|1|||
145398840|NCT01184872|524316535|FG001|Overall Study|Protocol deviation|0|||
145398841|NCT03426345|524316536|FG000|Overall Study|Adverse Event|4|||
145502718|NCT00790842|524699993|FG003|Dose Level 3|Adverse Event|0|||
145502719|NCT00790842|524699994|FG004|Dose Level 3|Adverse Event|0|||
145398842|NCT03426345|524316537|FG001|Overall Study|Adverse Event|4|||
145398843|NCT03426345|524316536|FG000|Overall Study|Lack of Efficacy|1|||
145398844|NCT03426345|524316537|FG001|Overall Study|Lack of Efficacy|0|||
145398845|NCT03426345|524316536|FG000|Overall Study|Withdrawal by Subject|5|||
145398846|NCT03426345|524316537|FG001|Overall Study|Withdrawal by Subject|6|||
145398847|NCT03426345|524316536|FG000|Overall Study|Lost to Follow-up|3|||
145398848|NCT03426345|524316537|FG001|Overall Study|Lost to Follow-up|1|||
145398849|NCT03426345|524316536|FG000|Overall Study|Protocol Deviation|3|||
145398850|NCT03426345|524316537|FG001|Overall Study|Protocol Deviation|4|||
145398851|NCT03426345|524316536|FG000|Overall Study|Reason Not Specified|1|||
145398852|NCT03426345|524316537|FG001|Overall Study|Reason Not Specified|2|||
145398853|NCT03426345|524316536|FG000|Overall Study|Missing Completion Status|1|||
145398854|NCT03426345|524316537|FG001|Overall Study|Missing Completion Status|0|||
145398855|NCT00433836|524316538|FG000|Overall Study|Adverse Event|7|||
145398856|NCT00433836|524316539|FG001|Overall Study|Adverse Event|0|||
145398857|NCT00433836|524316538|FG000|Overall Study|Lost to Follow-up|3|||
145398858|NCT00433836|524316539|FG001|Overall Study|Lost to Follow-up|0|||
145398859|NCT00433836|524316538|FG000|Overall Study|Withdrawal by Subject|2|||
145398860|NCT00433836|524316539|FG001|Overall Study|Withdrawal by Subject|1|||
145398861|NCT00433836|524316538|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145398862|NCT00433836|524316539|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145398863|NCT00433836|524316538|FG000|Overall Study|Protocol Violation|0|||
145398864|NCT00433836|524316539|FG001|Overall Study|Protocol Violation|2|||
145398865|NCT00433836|524316538|FG000|Overall Study|Condition no longer requires study drug|0|||
145398866|NCT00433836|524316539|FG001|Overall Study|Condition no longer requires study drug|1|||
145398867|NCT00433836|524316538|FG000|Overall Study|Abnormal laboratory values|0|||
145398868|NCT00433836|524316539|FG001|Overall Study|Abnormal laboratory values|1|||
145398869|NCT02446691|524316540|FG000|Overall Study|Withdrawal by Subject|2|||
145398870|NCT02446691|524316540|FG000|Overall Study|Lost to Follow-up|8|||
145398871|NCT02446691|524316540|FG000|Overall Study|Protocol Violation|1|||
145398872|NCT02643693|524316541|FG000|Overall Study|Physician Decision|0|||
145398873|NCT02643693|524316542|FG001|Overall Study|Physician Decision|1|||
145398874|NCT02643693|524316543|FG002|Overall Study|Physician Decision|0|||
145398875|NCT02643693|524316544|FG003|Overall Study|Physician Decision|0|||
145398876|NCT02643693|524316545|FG004|Overall Study|Physician Decision|0|||
145398877|NCT02643693|524316546|FG005|Overall Study|Physician Decision|0|||
145398878|NCT02643693|524316541|FG000|Overall Study|Withdrawal by Subject|0|||
145398879|NCT02643693|524316542|FG001|Overall Study|Withdrawal by Subject|1|||
145398880|NCT02643693|524316543|FG002|Overall Study|Withdrawal by Subject|0|||
145398881|NCT02643693|524316544|FG003|Overall Study|Withdrawal by Subject|0|||
145398882|NCT02643693|524316545|FG004|Overall Study|Withdrawal by Subject|0|||
145398883|NCT02643693|524316546|FG005|Overall Study|Withdrawal by Subject|0|||
145398884|NCT02643693|524316541|FG000|Overall Study|Protocol Adherence Issues|2|||
145398885|NCT02643693|524316542|FG001|Overall Study|Protocol Adherence Issues|0|||
145398886|NCT02643693|524316543|FG002|Overall Study|Protocol Adherence Issues|1|||
145398887|NCT02643693|524316544|FG003|Overall Study|Protocol Adherence Issues|0|||
145398888|NCT02643693|524316545|FG004|Overall Study|Protocol Adherence Issues|0|||
145398889|NCT02643693|524316546|FG005|Overall Study|Protocol Adherence Issues|1|||
145398890|NCT02153918|524316549|FG000|Overall Study|Refused further treatment|1|||
145398891|NCT02144701|524316550|FG000|Overall Study|development of relapse, GVHD or death|9|||
145398892|NCT02144701|524316551|FG001|Overall Study|development of relapse, GVHD or death|3|||
145398893|NCT01103323|524316552|FG000|Without/Before Drug Switch|Adverse Event|50|||
145398894|NCT01103323|524316553|FG001|Without/Before Drug Switch|Adverse Event|7|||
145398895|NCT01103323|524316552|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
145398896|NCT01103323|524316553|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
145398897|NCT01103323|524316552|FG000|Without/Before Drug Switch|Protocol Violation|2|||
145398898|NCT01103323|524316553|FG001|Without/Before Drug Switch|Protocol Violation|0|||
145398899|NCT01103323|524316552|FG000|Without/Before Drug Switch|Physician Decision|2|||
145398900|NCT01103323|524316553|FG001|Without/Before Drug Switch|Physician Decision|0|||
145398901|NCT01103323|524316552|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
145398902|NCT01103323|524316553|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
145398903|NCT01103323|524316552|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
145398904|NCT01103323|524316553|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
145398905|NCT01103323|524316552|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
145398906|NCT01103323|524316553|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
145398907|NCT02314728|524316559|FG000|Overall Study|Protocol Violation|1|||
145398908|NCT02314728|524316560|FG001|Overall Study|Protocol Violation|0|||
145398909|NCT02314728|524316559|FG000|Overall Study|Lost to Follow-up|0|||
145398910|NCT02314728|524316560|FG001|Overall Study|Lost to Follow-up|1|||
145398911|NCT00249834|524316561|FG000|Overall Study|Ovarian stimulation failed|1|||
145398912|NCT00249834|524316562|FG001|Overall Study|Ovarian stimulation failed|0|||
145398913|NCT00249834|524316563|FG002|Overall Study|Ovarian stimulation failed|0|||
145732843|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
145398914|NCT00249834|524316564|FG003|Overall Study|Ovarian stimulation failed|0|||
145398915|NCT00249834|524316565|FG004|Overall Study|Ovarian stimulation failed|0|||
145502720|NCT00790842|524699995|FG005|Dose Level 3|Adverse Event|0|||
145502721|NCT00790842|524699996|FG006|Dose Level 3|Adverse Event|0|||
145502722|NCT00790842|524699997|FG007|Dose Level 3|Adverse Event|0|||
145502723|NCT00790842|524699998|FG008|Dose Level 3|Adverse Event|0|||
145502724|NCT00790842|524699999|FG009|Dose Level 3|Adverse Event|0|||
145502725|NCT00790842|524700000|FG010|Dose Level 3|Adverse Event|0|||
145502726|NCT00790842|524699990|FG000|Dose Level 3|Withdrawal by Subject|0|||
145502727|NCT00790842|524699991|FG001|Dose Level 3|Withdrawal by Subject|0|||
145502728|NCT00790842|524699992|FG002|Dose Level 3|Withdrawal by Subject|3|||
145502729|NCT00790842|524699993|FG003|Dose Level 3|Withdrawal by Subject|0|||
145502730|NCT00790842|524699994|FG004|Dose Level 3|Withdrawal by Subject|0|||
145502731|NCT00790842|524699995|FG005|Dose Level 3|Withdrawal by Subject|0|||
145502732|NCT00790842|524699996|FG006|Dose Level 3|Withdrawal by Subject|0|||
145502733|NCT00790842|524699997|FG007|Dose Level 3|Withdrawal by Subject|0|||
145502734|NCT00790842|524699998|FG008|Dose Level 3|Withdrawal by Subject|0|||
145502735|NCT00790842|524699999|FG009|Dose Level 3|Withdrawal by Subject|2|||
145502736|NCT00790842|524700000|FG010|Dose Level 3|Withdrawal by Subject|0|||
145502737|NCT00790842|524699990|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502738|NCT00790842|524699991|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502739|NCT00790842|524699992|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502740|NCT00790842|524699993|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502741|NCT00790842|524699994|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502742|NCT00790842|524699995|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
145502743|NCT00790842|524699996|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502744|NCT00790842|524699997|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502745|NCT00790842|524699998|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502746|NCT00790842|524699999|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502747|NCT00790842|524700000|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
145502748|NCT00790842|524699990|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502749|NCT00790842|524699991|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502750|NCT00790842|524699992|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
145502751|NCT00790842|524699993|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502752|NCT00790842|524699994|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502753|NCT00790842|524699995|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502754|NCT00790842|524699996|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502755|NCT00790842|524699997|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502756|NCT00790842|524699998|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502757|NCT00790842|524699999|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502758|NCT00790842|524700000|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
145502759|NCT00790842|524699990|FG000|Dose Level 4|Adverse Event|0|||
145502760|NCT00790842|524699991|FG001|Dose Level 4|Adverse Event|0|||
145502761|NCT00790842|524699992|FG002|Dose Level 4|Adverse Event|0|||
145502762|NCT00790842|524699993|FG003|Dose Level 4|Adverse Event|0|||
145502763|NCT00790842|524699994|FG004|Dose Level 4|Adverse Event|0|||
145502764|NCT00790842|524699995|FG005|Dose Level 4|Adverse Event|0|||
145502765|NCT00790842|524699996|FG006|Dose Level 4|Adverse Event|1|||
145502766|NCT00790842|524699997|FG007|Dose Level 4|Adverse Event|0|||
145502767|NCT00790842|524699998|FG008|Dose Level 4|Adverse Event|0|||
145502768|NCT00790842|524699999|FG009|Dose Level 4|Adverse Event|0|||
145502769|NCT00790842|524700000|FG010|Dose Level 4|Adverse Event|0|||
145502770|NCT00790842|524699990|FG000|Dose Level 4|Physician Decision|0|||
145502771|NCT00790842|524699991|FG001|Dose Level 4|Physician Decision|0|||
145502772|NCT00790842|524699992|FG002|Dose Level 4|Physician Decision|0|||
145502773|NCT00790842|524699993|FG003|Dose Level 4|Physician Decision|0|||
145502774|NCT00790842|524699994|FG004|Dose Level 4|Physician Decision|0|||
145502775|NCT00790842|524699995|FG005|Dose Level 4|Physician Decision|0|||
145502776|NCT00790842|524699996|FG006|Dose Level 4|Physician Decision|1|||
145502777|NCT00790842|524699997|FG007|Dose Level 4|Physician Decision|0|||
145502778|NCT00790842|524699998|FG008|Dose Level 4|Physician Decision|0|||
145502779|NCT00790842|524699999|FG009|Dose Level 4|Physician Decision|0|||
145502780|NCT00790842|524700000|FG010|Dose Level 4|Physician Decision|1|||
145502781|NCT00790842|524699990|FG000|Dose Level 4|Withdrawal by Subject|0|||
145502782|NCT00790842|524699991|FG001|Dose Level 4|Withdrawal by Subject|0|||
145502783|NCT00790842|524699992|FG002|Dose Level 4|Withdrawal by Subject|0|||
145502784|NCT00790842|524699993|FG003|Dose Level 4|Withdrawal by Subject|0|||
145502785|NCT00790842|524699994|FG004|Dose Level 4|Withdrawal by Subject|0|||
145502786|NCT00790842|524699995|FG005|Dose Level 4|Withdrawal by Subject|0|||
145502787|NCT00790842|524699996|FG006|Dose Level 4|Withdrawal by Subject|0|||
145502788|NCT00790842|524699997|FG007|Dose Level 4|Withdrawal by Subject|0|||
145502789|NCT00790842|524699998|FG008|Dose Level 4|Withdrawal by Subject|0|||
145502790|NCT00790842|524699999|FG009|Dose Level 4|Withdrawal by Subject|0|||
145502791|NCT00790842|524700000|FG010|Dose Level 4|Withdrawal by Subject|1|||
145502792|NCT00790842|524699990|FG000|Expansion Cohort|Adverse Event|0|||
145502793|NCT00790842|524699991|FG001|Expansion Cohort|Adverse Event|0|||
145502794|NCT00790842|524699992|FG002|Expansion Cohort|Adverse Event|0|||
145398916|NCT00249834|524316566|FG005|Overall Study|Ovarian stimulation failed|0|||
145398917|NCT00249834|524316567|FG006|Overall Study|Ovarian stimulation failed|0|||
145398918|NCT00249834|524316568|FG007|Overall Study|Ovarian stimulation failed|0|||
145398919|NCT00249834|524316561|FG000|Overall Study|Failure of down-regulation|0|||
145398920|NCT00249834|524316562|FG001|Overall Study|Failure of down-regulation|0|||
145398921|NCT00249834|524316563|FG002|Overall Study|Failure of down-regulation|0|||
145398922|NCT00249834|524316564|FG003|Overall Study|Failure of down-regulation|0|||
145398923|NCT00249834|524316565|FG004|Overall Study|Failure of down-regulation|0|||
145398924|NCT00249834|524316566|FG005|Overall Study|Failure of down-regulation|0|||
145398925|NCT00249834|524316567|FG006|Overall Study|Failure of down-regulation|1|||
145398926|NCT00249834|524316568|FG007|Overall Study|Failure of down-regulation|0|||
145398927|NCT00249834|524316561|FG000|Overall Study|Protocol Violation|0|||
145398928|NCT00249834|524316562|FG001|Overall Study|Protocol Violation|19|||
145398929|NCT00249834|524316563|FG002|Overall Study|Protocol Violation|14|||
145398930|NCT00249834|524316564|FG003|Overall Study|Protocol Violation|8|||
145502795|NCT00790842|524699993|FG003|Expansion Cohort|Adverse Event|0|||
145502796|NCT00790842|524699994|FG004|Expansion Cohort|Adverse Event|0|||
145398931|NCT00249834|524316565|FG004|Overall Study|Protocol Violation|5|||
145398932|NCT00249834|524316566|FG005|Overall Study|Protocol Violation|2|||
145398933|NCT00249834|524316567|FG006|Overall Study|Protocol Violation|0|||
145398934|NCT00249834|524316568|FG007|Overall Study|Protocol Violation|0|||
145502797|NCT00790842|524699995|FG005|Expansion Cohort|Adverse Event|0|||
145502798|NCT00790842|524699996|FG006|Expansion Cohort|Adverse Event|1|||
145502799|NCT00790842|524699997|FG007|Expansion Cohort|Adverse Event|0|||
145502800|NCT00790842|524699998|FG008|Expansion Cohort|Adverse Event|0|||
145502801|NCT00790842|524699999|FG009|Expansion Cohort|Adverse Event|0|||
145502802|NCT00790842|524700000|FG010|Expansion Cohort|Adverse Event|0|||
145502803|NCT00790842|524699990|FG000|Expansion Cohort|Death|0|||
145502804|NCT00790842|524699991|FG001|Expansion Cohort|Death|0|||
145502805|NCT00790842|524699992|FG002|Expansion Cohort|Death|2|||
145502806|NCT00790842|524699993|FG003|Expansion Cohort|Death|0|||
145502807|NCT00790842|524699994|FG004|Expansion Cohort|Death|0|||
145502808|NCT00790842|524699995|FG005|Expansion Cohort|Death|0|||
145502809|NCT00790842|524699996|FG006|Expansion Cohort|Death|0|||
145502810|NCT00790842|524699997|FG007|Expansion Cohort|Death|0|||
145502811|NCT00790842|524699998|FG008|Expansion Cohort|Death|0|||
145502812|NCT00790842|524699999|FG009|Expansion Cohort|Death|0|||
145502813|NCT00790842|524700000|FG010|Expansion Cohort|Death|0|||
145502814|NCT00790842|524699990|FG000|Expansion Cohort|Physician Decision|0|||
145502815|NCT00790842|524699991|FG001|Expansion Cohort|Physician Decision|0|||
145502816|NCT00790842|524699992|FG002|Expansion Cohort|Physician Decision|1|||
145502817|NCT00790842|524699993|FG003|Expansion Cohort|Physician Decision|0|||
145502818|NCT00790842|524699994|FG004|Expansion Cohort|Physician Decision|0|||
145502819|NCT00790842|524699995|FG005|Expansion Cohort|Physician Decision|0|||
145502820|NCT00790842|524699996|FG006|Expansion Cohort|Physician Decision|0|||
145502821|NCT00790842|524699997|FG007|Expansion Cohort|Physician Decision|0|||
145502822|NCT00790842|524699998|FG008|Expansion Cohort|Physician Decision|0|||
145502823|NCT00790842|524699999|FG009|Expansion Cohort|Physician Decision|0|||
145502824|NCT00790842|524700000|FG010|Expansion Cohort|Physician Decision|0|||
145502825|NCT00790842|524699990|FG000|Expansion Cohort|Withdrawal by Subject|0|||
145502826|NCT00790842|524699991|FG001|Expansion Cohort|Withdrawal by Subject|0|||
145502827|NCT00790842|524699992|FG002|Expansion Cohort|Withdrawal by Subject|3|||
145502828|NCT00790842|524699993|FG003|Expansion Cohort|Withdrawal by Subject|0|||
145502829|NCT00790842|524699994|FG004|Expansion Cohort|Withdrawal by Subject|0|||
145502830|NCT00790842|524699995|FG005|Expansion Cohort|Withdrawal by Subject|0|||
145502831|NCT00790842|524699996|FG006|Expansion Cohort|Withdrawal by Subject|0|||
145502832|NCT00790842|524699997|FG007|Expansion Cohort|Withdrawal by Subject|0|||
145502833|NCT00790842|524699998|FG008|Expansion Cohort|Withdrawal by Subject|0|||
145502834|NCT00790842|524699999|FG009|Expansion Cohort|Withdrawal by Subject|0|||
145502835|NCT00790842|524700000|FG010|Expansion Cohort|Withdrawal by Subject|0|||
145502836|NCT00790842|524699990|FG000|Expansion Cohort|Study Closure|0|||
145502837|NCT00790842|524699991|FG001|Expansion Cohort|Study Closure|0|||
145502838|NCT00790842|524699992|FG002|Expansion Cohort|Study Closure|1|||
145502839|NCT00790842|524699993|FG003|Expansion Cohort|Study Closure|0|||
145502840|NCT00790842|524699994|FG004|Expansion Cohort|Study Closure|0|||
145502841|NCT00790842|524699995|FG005|Expansion Cohort|Study Closure|0|||
145502842|NCT00790842|524699996|FG006|Expansion Cohort|Study Closure|0|||
145502843|NCT00790842|524699997|FG007|Expansion Cohort|Study Closure|0|||
145502844|NCT00790842|524699998|FG008|Expansion Cohort|Study Closure|0|||
145502845|NCT00790842|524699999|FG009|Expansion Cohort|Study Closure|0|||
145502846|NCT00790842|524700000|FG010|Expansion Cohort|Study Closure|0|||
145502847|NCT02968004|524700001|FG000|Main Study Phase|Adverse Event|1|||
145502848|NCT02968004|524700002|FG001|Main Study Phase|Adverse Event|0|||
145502849|NCT02968004|524700001|FG000|Main Study Phase|Withdrawal by Subject|0|||
145502850|NCT02968004|524700002|FG001|Main Study Phase|Withdrawal by Subject|1|||
145502851|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
145502852|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
145502853|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
145502854|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
145502855|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
145502856|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
145502857|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
145502858|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
145502859|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
145502860|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
145502861|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
145502862|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
145502863|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
145502864|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
145502865|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
145502866|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
145502867|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
145502868|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
145502869|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
145502870|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
145502871|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
145502872|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
145502873|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
145502874|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
145502875|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
145502876|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
145502877|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
145502878|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
145502879|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
145502880|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
145502881|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
145502882|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
145502883|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
145502884|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
145502885|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
145502886|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
145502887|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
145502888|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
145502889|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
145502890|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
145502891|NCT02968004|524700001|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
145502892|NCT02968004|524700002|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
145502893|NCT00419952|524700003|FG000|Overall Study|Adverse Event|8|||
145502894|NCT00419952|524700004|FG001|Overall Study|Adverse Event|10|||
145502895|NCT00419952|524700003|FG000|Overall Study|Withdrawal by Subject|44|||
145502896|NCT00419952|524700004|FG001|Overall Study|Withdrawal by Subject|43|||
145502897|NCT00419952|524700003|FG000|Overall Study|Lost to Follow-up|43|||
145502898|NCT00419952|524700004|FG001|Overall Study|Lost to Follow-up|34|||
145502899|NCT00419952|524700003|FG000|Overall Study|Protocol Violation|32|||
145502900|NCT00419952|524700004|FG001|Overall Study|Protocol Violation|24|||
145502901|NCT00419952|524700003|FG000|Overall Study|Pregnancy|4|||
145502902|NCT00419952|524700004|FG001|Overall Study|Pregnancy|2|||
145502903|NCT00419952|524700003|FG000|Overall Study|Physician Decision|1|||
145502904|NCT00419952|524700004|FG001|Overall Study|Physician Decision|3|||
145502905|NCT00419952|524700003|FG000|Overall Study|Incorrectly enrolled|10|||
145502906|NCT00419952|524700004|FG001|Overall Study|Incorrectly enrolled|3|||
145502907|NCT00419952|524700003|FG000|Overall Study|Intake of prohibited medication|2|||
145502908|NCT00419952|524700004|FG001|Overall Study|Intake of prohibited medication|2|||
145502909|NCT00419952|524700003|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
145398935|NCT00069264|524316573|FG000|Overall Study|Adverse Event|3|||
145398936|NCT00069264|524316573|FG000|Overall Study|Progressive Disease|23|||
145398937|NCT00069264|524316573|FG000|Overall Study|Withdrawal by Subject|3|||
145398938|NCT00069264|524316573|FG000|Overall Study|Discon Therapy|3|||
145398939|NCT02848664|524316574|FG000|Overall Study|Withdrawal by Subject|2|||
145398940|NCT02848664|524316574|FG000|Overall Study|Adverse Event|1|||
145398941|NCT02848664|524316574|FG000|Overall Study|no assistance for device training|1|||
145398942|NCT00732069|524316577|FG000|Washout After First Study Drug|Adverse Event|1|||
145398943|NCT00732069|524316578|FG001|Washout After First Study Drug|Adverse Event|0|||
145398944|NCT00732069|524316579|FG002|Washout After First Study Drug|Adverse Event|0|||
145398945|NCT00732069|524316580|FG003|Washout After First Study Drug|Adverse Event|0|||
145398946|NCT00732069|524316581|FG004|Washout After First Study Drug|Adverse Event|0|||
145398947|NCT00732069|524316582|FG005|Washout After First Study Drug|Adverse Event|0|||
145398948|NCT00577317|524316583|FG000|Overall Study|Study Terminated|0|||
145398949|NCT00577317|524316584|FG001|Overall Study|Study Terminated|2|||
145398950|NCT01405898|524316588|FG000|Overall Study|Withdrawal by Subject|2|||
145398951|NCT01405898|524316589|FG001|Overall Study|Withdrawal by Subject|2|||
145398952|NCT01687218|524316590|FG000|Overall Study|Withdrawal by Subject|2|||
145398953|NCT01687218|524316591|FG001|Overall Study|Withdrawal by Subject|3|||
145398954|NCT01687218|524316592|FG002|Overall Study|Withdrawal by Subject|0|||
145398955|NCT01687218|524316593|FG003|Overall Study|Withdrawal by Subject|1|||
145398956|NCT01687218|524316594|FG004|Overall Study|Withdrawal by Subject|1|||
145398957|NCT01687218|524316595|FG005|Overall Study|Withdrawal by Subject|0|||
145398958|NCT01687218|524316590|FG000|Overall Study|Relocated, no follow-up planned|1|||
145398959|NCT01687218|524316591|FG001|Overall Study|Relocated, no follow-up planned|0|||
145398960|NCT01687218|524316592|FG002|Overall Study|Relocated, no follow-up planned|1|||
145398961|NCT01687218|524316593|FG003|Overall Study|Relocated, no follow-up planned|1|||
145398962|NCT01687218|524316594|FG004|Overall Study|Relocated, no follow-up planned|0|||
145398963|NCT01687218|524316595|FG005|Overall Study|Relocated, no follow-up planned|0|||
145398964|NCT00846586|524316603|FG000|Overall Study|Adverse Event|20|||
145398965|NCT00846586|524316604|FG001|Overall Study|Adverse Event|10|||
145398966|NCT00846586|524316603|FG000|Overall Study|Subject withdrew consent|8|||
145398967|NCT00846586|524316604|FG001|Overall Study|Subject withdrew consent|10|||
145398968|NCT00846586|524316603|FG000|Overall Study|Administrative problems|5|||
145398969|NCT00846586|524316604|FG001|Overall Study|Administrative problems|4|||
145398970|NCT00846586|524316603|FG000|Overall Study|Death|2|||
145398971|NCT00846586|524316604|FG001|Overall Study|Death|0|||
145398972|NCT00846586|524316603|FG000|Overall Study|Protocol deviation|2|||
145398973|NCT00846586|524316604|FG001|Overall Study|Protocol deviation|6|||
145398974|NCT00846586|524316603|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145398975|NCT00846586|524316604|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145398976|NCT00846586|524316603|FG000|Overall Study|Lost to Follow-up|1|||
145398977|NCT00846586|524316604|FG001|Overall Study|Lost to Follow-up|4|||
145398978|NCT00846586|524316603|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145398979|NCT00846586|524316604|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145398980|NCT00875810|524316605|FG000|Overall Study|Withdrawal by Subject|1|||
145398981|NCT00875810|524316605|FG000|Overall Study|Physician Decision|3|||
145398982|NCT00875810|524316605|FG000|Overall Study|Lost to Follow-up|39|||
145398983|NCT00875810|524316605|FG000|Overall Study|Patient enroled but not implanted|2|||
145398984|NCT00875810|524316605|FG000|Overall Study|Device explanted|1|||
145398985|NCT00780975|524316606|FG000|Overall Study|Progressive disease|3|||
145398986|NCT00780975|524316606|FG000|Overall Study|Toxicity|5|||
145398987|NCT01061606|524316607|FG000|Overall Study|Adverse Event|1|||
145398988|NCT01061606|524316607|FG000|Overall Study|Death|1|||
145398989|NCT01061606|524316607|FG000|Overall Study|Disease Progression|4|||
145398990|NCT01061606|524316607|FG000|Overall Study|alternative therapy|2|||
145398991|NCT01204671|524316608|FG000|Overall Study|Adverse Event|4|||
145398992|NCT01204671|524316609|FG001|Overall Study|Adverse Event|3|||
145398993|NCT01204671|524316610|FG002|Overall Study|Adverse Event|3|||
145398994|NCT01204671|524316611|FG003|Overall Study|Adverse Event|3|||
145398995|NCT01204671|524316612|FG004|Overall Study|Adverse Event|1|||
145398996|NCT01204671|524316608|FG000|Overall Study|Withdrawal by Subject|2|||
145398997|NCT01204671|524316609|FG001|Overall Study|Withdrawal by Subject|3|||
145398998|NCT01204671|524316610|FG002|Overall Study|Withdrawal by Subject|4|||
145398999|NCT01204671|524316611|FG003|Overall Study|Withdrawal by Subject|5|||
145266693|NCT04668066|523825246|FG009|Part 1: Follow-Up|Other|0|||
145732844|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
145399000|NCT01204671|524316612|FG004|Overall Study|Withdrawal by Subject|3|||
145399001|NCT01204671|524316608|FG000|Overall Study|Lost to Follow-up|7|||
145399002|NCT01204671|524316609|FG001|Overall Study|Lost to Follow-up|8|||
145399003|NCT01204671|524316610|FG002|Overall Study|Lost to Follow-up|6|||
145399004|NCT01204671|524316611|FG003|Overall Study|Lost to Follow-up|4|||
145399005|NCT01204671|524316612|FG004|Overall Study|Lost to Follow-up|0|||
145399006|NCT01204671|524316608|FG000|Overall Study|Unknown Completion Status|1|||
145399007|NCT01204671|524316609|FG001|Overall Study|Unknown Completion Status|1|||
145399008|NCT01204671|524316610|FG002|Overall Study|Unknown Completion Status|0|||
145399009|NCT01204671|524316611|FG003|Overall Study|Unknown Completion Status|0|||
145399010|NCT01204671|524316612|FG004|Overall Study|Unknown Completion Status|0|||
145399011|NCT01204671|524316608|FG000|Overall Study|Physician Decision|0|||
145399012|NCT01204671|524316609|FG001|Overall Study|Physician Decision|0|||
145399013|NCT01204671|524316610|FG002|Overall Study|Physician Decision|0|||
145399014|NCT01204671|524316611|FG003|Overall Study|Physician Decision|1|||
145399015|NCT01204671|524316612|FG004|Overall Study|Physician Decision|0|||
145399016|NCT03106077|524316615|FG000|Overall Study|Screen Failure|94|||
145399017|NCT03106077|524316616|FG001|Overall Study|Screen Failure|0|||
145399018|NCT01274533|524316617|FG000|Overall Study|Withdrawal by Subject|1|||
145399019|NCT01274533|524316617|FG000|Overall Study|Non-compliance|1|||
145399020|NCT01274533|524316617|FG000|Overall Study|Disease progression|2|||
145399021|NCT03669588|524316618|FG000|Overall Study|Adverse Event|1|||
145399022|NCT03669588|524316619|FG001|Overall Study|Adverse Event|0|||
145399023|NCT03669588|524316618|FG000|Overall Study|Physician Decision|0|||
145399024|NCT03669588|524316619|FG001|Overall Study|Physician Decision|1|||
145399025|NCT03669588|524316618|FG000|Overall Study|Protocol Violation|1|||
145399026|NCT03669588|524316619|FG001|Overall Study|Protocol Violation|0|||
145399027|NCT03669588|524316618|FG000|Overall Study|Sponsor Decision|1|||
145399028|NCT03669588|524316619|FG001|Overall Study|Sponsor Decision|1|||
145399029|NCT03669588|524316618|FG000|Overall Study|Withdrawal by Subject|1|||
145399030|NCT03669588|524316619|FG001|Overall Study|Withdrawal by Subject|4|||
145399031|NCT03669588|524316618|FG000|Overall Study|Rescue Therapy Needed|0|||
145399032|NCT03669588|524316619|FG001|Overall Study|Rescue Therapy Needed|1|||
145502910|NCT00419952|524700004|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
145502911|NCT00419952|524700003|FG000|Overall Study|Diary or medication non-compliance|2|||
145502912|NCT00419952|524700004|FG001|Overall Study|Diary or medication non-compliance|4|||
145502913|NCT00419952|524700003|FG000|Overall Study|Abnormal ECG|1|||
145502914|NCT00419952|524700004|FG001|Overall Study|Abnormal ECG|0|||
145502915|NCT02158546|524700011|FG000|Overall Study|Physician Decision|0|||
145502916|NCT02158546|524700012|FG001|Overall Study|Physician Decision|1|||
145502917|NCT02158546|524700013|FG002|Overall Study|Physician Decision|0|||
145502918|NCT02158546|524700014|FG003|Overall Study|Physician Decision|0|||
145502919|NCT02158546|524700011|FG000|Overall Study|Non-compliance|0|||
145502920|NCT02158546|524700012|FG001|Overall Study|Non-compliance|1|||
145502921|NCT02158546|524700013|FG002|Overall Study|Non-compliance|0|||
145502922|NCT02158546|524700014|FG003|Overall Study|Non-compliance|1|||
145502923|NCT02158546|524700011|FG000|Overall Study|Failure to meet eligibility criteria|0|||
145502924|NCT02158546|524700012|FG001|Overall Study|Failure to meet eligibility criteria|1|||
145502925|NCT02158546|524700013|FG002|Overall Study|Failure to meet eligibility criteria|0|||
145502926|NCT02158546|524700014|FG003|Overall Study|Failure to meet eligibility criteria|0|||
145502927|NCT02158546|524700011|FG000|Overall Study|Lack of Efficacy|1|||
145502928|NCT02158546|524700012|FG001|Overall Study|Lack of Efficacy|1|||
145502929|NCT02158546|524700013|FG002|Overall Study|Lack of Efficacy|0|||
145502930|NCT02158546|524700014|FG003|Overall Study|Lack of Efficacy|0|||
145502931|NCT02158546|524700011|FG000|Overall Study|Adverse Event|2|||
145502932|NCT02158546|524700012|FG001|Overall Study|Adverse Event|2|||
145502933|NCT02158546|524700013|FG002|Overall Study|Adverse Event|0|||
145502934|NCT02158546|524700014|FG003|Overall Study|Adverse Event|0|||
145502935|NCT02158546|524700011|FG000|Overall Study|Withdrawal by Subject|6|||
145502936|NCT02158546|524700012|FG001|Overall Study|Withdrawal by Subject|2|||
145502937|NCT02158546|524700013|FG002|Overall Study|Withdrawal by Subject|1|||
145502938|NCT02158546|524700014|FG003|Overall Study|Withdrawal by Subject|0|||
145502939|NCT02158546|524700011|FG000|Overall Study|Lost to Follow-up|5|||
145502940|NCT02158546|524700012|FG001|Overall Study|Lost to Follow-up|4|||
145502941|NCT02158546|524700013|FG002|Overall Study|Lost to Follow-up|0|||
145502942|NCT02158546|524700014|FG003|Overall Study|Lost to Follow-up|1|||
145502943|NCT02158546|524700011|FG000|Overall Study|Site Excluded|5|||
145502944|NCT02158546|524700012|FG001|Overall Study|Site Excluded|5|||
145502945|NCT02158546|524700013|FG002|Overall Study|Site Excluded|3|||
145502946|NCT02158546|524700014|FG003|Overall Study|Site Excluded|4|||
145502947|NCT00885170|524700017|FG000|Overall Study|Adverse Event|12|||
145502948|NCT00885170|524700018|FG001|Overall Study|Adverse Event|4|||
145502949|NCT00885170|524700017|FG000|Overall Study|Excessive bone loss|6|||
145502950|NCT00885170|524700018|FG001|Overall Study|Excessive bone loss|3|||
145502951|NCT00885170|524700017|FG000|Overall Study|Lost to Follow-up|2|||
145502952|NCT00885170|524700018|FG001|Overall Study|Lost to Follow-up|1|||
145502953|NCT00885170|524700017|FG000|Overall Study|Physician Decision|2|||
145502954|NCT00885170|524700018|FG001|Overall Study|Physician Decision|1|||
145502955|NCT00885170|524700017|FG000|Overall Study|Protocol Violation|3|||
145502956|NCT00885170|524700018|FG001|Overall Study|Protocol Violation|1|||
145502957|NCT00885170|524700017|FG000|Overall Study|Withdrawal by Subject|13|||
145502958|NCT00885170|524700018|FG001|Overall Study|Withdrawal by Subject|13|||
145502959|NCT01208207|524700021|FG000|Part I|Adverse Event|19|||
145502960|NCT01208207|524700022|FG001|Part I|Adverse Event|2|||
145502961|NCT01208207|524700023|FG002|Part I|Adverse Event|6|||
145502962|NCT01208207|524700024|FG003|Part I|Adverse Event|0|||
145502963|NCT01208207|524700025|FG004|Part I|Adverse Event|0|||
145502964|NCT01208207|524700026|FG005|Part I|Adverse Event|0|||
145502965|NCT01208207|524700027|FG006|Part I|Adverse Event|0|||
145502966|NCT01208207|524700021|FG000|Part I|Lack of Efficacy|21|||
145502967|NCT01208207|524700022|FG001|Part I|Lack of Efficacy|3|||
145502968|NCT01208207|524700023|FG002|Part I|Lack of Efficacy|2|||
145502969|NCT01208207|524700024|FG003|Part I|Lack of Efficacy|0|||
145502970|NCT01208207|524700025|FG004|Part I|Lack of Efficacy|0|||
145502971|NCT01208207|524700026|FG005|Part I|Lack of Efficacy|0|||
145502972|NCT01208207|524700027|FG006|Part I|Lack of Efficacy|0|||
145502973|NCT01208207|524700021|FG000|Part I|Lost to Follow-up|6|||
145502974|NCT01208207|524700022|FG001|Part I|Lost to Follow-up|1|||
145502975|NCT01208207|524700023|FG002|Part I|Lost to Follow-up|0|||
145502976|NCT01208207|524700024|FG003|Part I|Lost to Follow-up|0|||
145502977|NCT01208207|524700025|FG004|Part I|Lost to Follow-up|0|||
145502978|NCT01208207|524700026|FG005|Part I|Lost to Follow-up|0|||
145502979|NCT01208207|524700027|FG006|Part I|Lost to Follow-up|0|||
145502980|NCT01208207|524700021|FG000|Part I|Non-Compliance With Study Drug|1|||
145502981|NCT01208207|524700022|FG001|Part I|Non-Compliance With Study Drug|0|||
145502982|NCT01208207|524700023|FG002|Part I|Non-Compliance With Study Drug|1|||
145399033|NCT02008526|524316620|FG000|Overall Study|Death|0|||
145399034|NCT02008526|524316621|FG001|Overall Study|Death|2|||
145399035|NCT02008526|524316622|FG002|Overall Study|Death|1|||
145399036|NCT02008526|524316620|FG000|Overall Study|Withdrawal by Subject|3|||
145399037|NCT02008526|524316621|FG001|Overall Study|Withdrawal by Subject|3|||
145399038|NCT02008526|524316622|FG002|Overall Study|Withdrawal by Subject|2|||
145399039|NCT02008526|524316620|FG000|Overall Study|Lost to Follow-up|5|||
145399040|NCT02008526|524316621|FG001|Overall Study|Lost to Follow-up|9|||
145399041|NCT02008526|524316622|FG002|Overall Study|Lost to Follow-up|6|||
145399042|NCT00492726|524316623|FG000|Overall Study|Adverse Event|10|||
145502983|NCT01208207|524700024|FG003|Part I|Non-Compliance With Study Drug|0|||
145502984|NCT01208207|524700025|FG004|Part I|Non-Compliance With Study Drug|0|||
145502985|NCT01208207|524700026|FG005|Part I|Non-Compliance With Study Drug|0|||
145502986|NCT01208207|524700027|FG006|Part I|Non-Compliance With Study Drug|0|||
145502987|NCT01208207|524700021|FG000|Part I|Physician Decision|0|||
145502988|NCT01208207|524700022|FG001|Part I|Physician Decision|1|||
145502989|NCT01208207|524700023|FG002|Part I|Physician Decision|0|||
145502990|NCT01208207|524700024|FG003|Part I|Physician Decision|0|||
145502991|NCT01208207|524700025|FG004|Part I|Physician Decision|0|||
145502992|NCT01208207|524700026|FG005|Part I|Physician Decision|0|||
145502993|NCT01208207|524700027|FG006|Part I|Physician Decision|0|||
145502994|NCT01208207|524700021|FG000|Part I|Progressive Disease|1|||
145502995|NCT01208207|524700022|FG001|Part I|Progressive Disease|0|||
145502996|NCT01208207|524700023|FG002|Part I|Progressive Disease|0|||
145502997|NCT01208207|524700024|FG003|Part I|Progressive Disease|0|||
145502998|NCT01208207|524700025|FG004|Part I|Progressive Disease|0|||
145502999|NCT01208207|524700026|FG005|Part I|Progressive Disease|0|||
145503000|NCT01208207|524700027|FG006|Part I|Progressive Disease|0|||
145503001|NCT01208207|524700021|FG000|Part I|Protocol Violation|8|||
145503002|NCT01208207|524700022|FG001|Part I|Protocol Violation|0|||
145503003|NCT01208207|524700023|FG002|Part I|Protocol Violation|2|||
145503004|NCT01208207|524700024|FG003|Part I|Protocol Violation|0|||
145503005|NCT01208207|524700025|FG004|Part I|Protocol Violation|0|||
145503006|NCT01208207|524700026|FG005|Part I|Protocol Violation|0|||
145503007|NCT01208207|524700027|FG006|Part I|Protocol Violation|0|||
145503008|NCT01208207|524700021|FG000|Part I|Withdrawal by Subject|14|||
145503009|NCT01208207|524700022|FG001|Part I|Withdrawal by Subject|4|||
145503010|NCT01208207|524700023|FG002|Part I|Withdrawal by Subject|4|||
145503011|NCT01208207|524700024|FG003|Part I|Withdrawal by Subject|0|||
145503012|NCT01208207|524700025|FG004|Part I|Withdrawal by Subject|0|||
145503013|NCT01208207|524700026|FG005|Part I|Withdrawal by Subject|0|||
145503014|NCT01208207|524700027|FG006|Part I|Withdrawal by Subject|0|||
145503015|NCT01208207|524700021|FG000|Part II|Withdrawal by Subject|0|||
145503016|NCT01208207|524700022|FG001|Part II|Withdrawal by Subject|0|||
145503017|NCT01208207|524700023|FG002|Part II|Withdrawal by Subject|0|||
145503018|NCT01208207|524700024|FG003|Part II|Withdrawal by Subject|10|||
145503019|NCT01208207|524700025|FG004|Part II|Withdrawal by Subject|9|||
145503020|NCT01208207|524700026|FG005|Part II|Withdrawal by Subject|3|||
145503021|NCT01208207|524700027|FG006|Part II|Withdrawal by Subject|5|||
145503022|NCT01208207|524700021|FG000|Part II|Adverse Event|0|||
145503023|NCT01208207|524700022|FG001|Part II|Adverse Event|0|||
145503024|NCT01208207|524700023|FG002|Part II|Adverse Event|0|||
145503025|NCT01208207|524700024|FG003|Part II|Adverse Event|5|||
145503026|NCT01208207|524700025|FG004|Part II|Adverse Event|9|||
145503027|NCT01208207|524700026|FG005|Part II|Adverse Event|4|||
145503028|NCT01208207|524700027|FG006|Part II|Adverse Event|2|||
145503029|NCT01208207|524700021|FG000|Part II|Lack of Efficacy|0|||
145503030|NCT01208207|524700022|FG001|Part II|Lack of Efficacy|0|||
145503031|NCT01208207|524700023|FG002|Part II|Lack of Efficacy|0|||
145503032|NCT01208207|524700024|FG003|Part II|Lack of Efficacy|6|||
145503033|NCT01208207|524700025|FG004|Part II|Lack of Efficacy|4|||
145503034|NCT01208207|524700026|FG005|Part II|Lack of Efficacy|3|||
145503035|NCT01208207|524700027|FG006|Part II|Lack of Efficacy|3|||
145503036|NCT01208207|524700021|FG000|Part II|Lost to Follow-up|0|||
145503037|NCT01208207|524700022|FG001|Part II|Lost to Follow-up|0|||
145503038|NCT01208207|524700023|FG002|Part II|Lost to Follow-up|0|||
145503039|NCT01208207|524700024|FG003|Part II|Lost to Follow-up|4|||
145503040|NCT01208207|524700025|FG004|Part II|Lost to Follow-up|0|||
145503041|NCT01208207|524700026|FG005|Part II|Lost to Follow-up|2|||
145503042|NCT01208207|524700027|FG006|Part II|Lost to Follow-up|1|||
145503043|NCT01208207|524700021|FG000|Part II|Non-Compliance With Study Drug|0|||
145503044|NCT01208207|524700022|FG001|Part II|Non-Compliance With Study Drug|0|||
145503045|NCT01208207|524700023|FG002|Part II|Non-Compliance With Study Drug|0|||
145503046|NCT01208207|524700024|FG003|Part II|Non-Compliance With Study Drug|4|||
145503047|NCT01208207|524700025|FG004|Part II|Non-Compliance With Study Drug|1|||
145503048|NCT01208207|524700026|FG005|Part II|Non-Compliance With Study Drug|1|||
145503049|NCT01208207|524700027|FG006|Part II|Non-Compliance With Study Drug|0|||
145503050|NCT01208207|524700021|FG000|Part II|Physician Decision|0|||
145503051|NCT01208207|524700022|FG001|Part II|Physician Decision|0|||
145503052|NCT01208207|524700023|FG002|Part II|Physician Decision|0|||
145503053|NCT01208207|524700024|FG003|Part II|Physician Decision|1|||
145503054|NCT01208207|524700025|FG004|Part II|Physician Decision|0|||
145503055|NCT01208207|524700026|FG005|Part II|Physician Decision|2|||
145503056|NCT01208207|524700027|FG006|Part II|Physician Decision|0|||
145503057|NCT01208207|524700021|FG000|Part II|Protocol Violation|0|||
145503058|NCT01208207|524700022|FG001|Part II|Protocol Violation|0|||
145503059|NCT01208207|524700023|FG002|Part II|Protocol Violation|0|||
145503060|NCT01208207|524700024|FG003|Part II|Protocol Violation|1|||
145503061|NCT01208207|524700025|FG004|Part II|Protocol Violation|0|||
145503062|NCT01208207|524700026|FG005|Part II|Protocol Violation|0|||
145503063|NCT01208207|524700027|FG006|Part II|Protocol Violation|0|||
145503064|NCT01208207|524700021|FG000|Part II|Technical Problems|0|||
145503065|NCT01208207|524700022|FG001|Part II|Technical Problems|0|||
145503066|NCT01208207|524700023|FG002|Part II|Technical Problems|0|||
145503067|NCT01208207|524700024|FG003|Part II|Technical Problems|1|||
145503068|NCT01208207|524700025|FG004|Part II|Technical Problems|0|||
145503069|NCT01208207|524700026|FG005|Part II|Technical Problems|1|||
145503070|NCT01208207|524700027|FG006|Part II|Technical Problems|0|||
145503071|NCT04041414|524700028|FG000|Overall Study|Lost to Follow-up|1|||
145503072|NCT04041414|524700029|FG001|Overall Study|Lost to Follow-up|2|||
145503073|NCT00665652|524700030|FG000|Overall Study|Adverse Event|4|||
145503074|NCT00665652|524700030|FG000|Overall Study|Death|1|||
145503075|NCT00665652|524700030|FG000|Overall Study|No longer met inclusion criteria.|1|||
145503076|NCT00380367|524700044|FG000|Overall Study|Lost to Follow-up|1|||
145503077|NCT00380367|524700044|FG000|Overall Study|Withdrawal by Subject|1|||
145503078|NCT01605799|524700045|FG000|Overall Study|Withdrawal by Subject|2|||
145503079|NCT01605799|524700046|FG001|Overall Study|Withdrawal by Subject|1|||
145503080|NCT00830440|524700055|FG000|Overall Study|Protocol Violation|1|||
145503081|NCT00830440|524700056|FG001|Overall Study|Protocol Violation|0|||
145503082|NCT00830440|524700055|FG000|Overall Study|Withdrawal by Subject|1|||
145503083|NCT00830440|524700056|FG001|Overall Study|Withdrawal by Subject|0|||
145503084|NCT00830440|524700055|FG000|Overall Study|unsuccessful procedure|4|||
145503085|NCT00830440|524700056|FG001|Overall Study|unsuccessful procedure|0|||
145503086|NCT00830440|524700055|FG000|Overall Study|Adverse Event|2|||
145503087|NCT00830440|524700056|FG001|Overall Study|Adverse Event|0|||
145503088|NCT02592798|524700057|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
145503089|NCT02592798|524700058|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
145503090|NCT02592798|524700057|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
145503091|NCT02592798|524700058|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
145503092|NCT02592798|524700057|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
145503093|NCT02592798|524700058|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
145503094|NCT02592798|524700057|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
145503095|NCT02592798|524700058|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
145503096|NCT02592798|524700057|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
145503097|NCT02592798|524700058|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
145503098|NCT02592798|524700057|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
145503099|NCT02592798|524700058|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
145503100|NCT02592798|524700057|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
145503101|NCT02592798|524700058|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
145503102|NCT02592798|524700057|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
145503103|NCT02592798|524700058|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
145503104|NCT02592798|524700057|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
145503105|NCT02592798|524700058|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
145503106|NCT02592798|524700057|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
145503107|NCT02592798|524700058|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
145503108|NCT02592798|524700057|FG000|Transition From DB2 to OLE|Other reasons|1|||
145503109|NCT02592798|524700058|FG001|Transition From DB2 to OLE|Other reasons|0|||
145503110|NCT02592798|524700057|FG000|Open Label Period (OLE)|Other reasons|0|||
145503111|NCT02592798|524700058|FG001|Open Label Period (OLE)|Other reasons|2|||
145503112|NCT02592798|524700057|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
145503113|NCT02592798|524700058|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
145503114|NCT02592798|524700057|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
145503115|NCT02592798|524700058|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
145503116|NCT02592798|524700057|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
145503117|NCT02592798|524700058|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
145503118|NCT02592798|524700057|FG000|Open Label Period (OLE)|Adverse Event|0|||
145503119|NCT02592798|524700058|FG001|Open Label Period (OLE)|Adverse Event|1|||
145503120|NCT00942604|524700059|FG000|Overall Study|Protocol Violation|1|||
145503121|NCT00942604|524700060|FG001|Overall Study|Protocol Violation|1|||
145503122|NCT00942604|524700059|FG000|Overall Study|Adverse Event|0|||
145503123|NCT00942604|524700060|FG001|Overall Study|Adverse Event|1|||
145503124|NCT00942604|524700059|FG000|Overall Study|Withdrawal by Subject|0|||
145503125|NCT00942604|524700060|FG001|Overall Study|Withdrawal by Subject|1|||
145503126|NCT00942604|524700059|FG000|Overall Study|Patient relocation|1|||
145503127|NCT00942604|524700060|FG001|Overall Study|Patient relocation|1|||
145503128|NCT01143246|524700061|FG000|Overall Study|Adverse Event|24|||
145503129|NCT01143246|524700062|FG001|Overall Study|Adverse Event|28|||
145503130|NCT01143246|524700061|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
145503131|NCT01143246|524700062|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
145503132|NCT01143246|524700061|FG000|Overall Study|Lost to Follow-up|0|||
145503133|NCT01143246|524700062|FG001|Overall Study|Lost to Follow-up|1|||
145503134|NCT01143246|524700061|FG000|Overall Study|Death|16|||
145503135|NCT01143246|524700062|FG001|Overall Study|Death|15|||
145503136|NCT01143246|524700061|FG000|Overall Study|Reason not Specified|3|||
145503137|NCT01143246|524700062|FG001|Overall Study|Reason not Specified|5|||
145503138|NCT03987503|524700064|FG000|Overall Study|Lost to Follow-up|20|||
145503139|NCT03987503|524700064|FG000|Overall Study|Withdrawal by Subject|2|||
145503140|NCT03486834|524700066|FG000|Overall Study|Withdrawal by Subject|46|||
145503141|NCT03486834|524700067|FG001|Overall Study|Withdrawal by Subject|46|||
145503142|NCT03486834|524700068|FG002|Overall Study|Withdrawal by Subject|52|||
145503143|NCT03486834|524700066|FG000|Overall Study|Adverse Event|8|||
145503144|NCT03486834|524700067|FG001|Overall Study|Adverse Event|7|||
145503145|NCT03486834|524700068|FG002|Overall Study|Adverse Event|0|||
145503146|NCT03486834|524700066|FG000|Overall Study|Lost to Follow-up|41|||
145503147|NCT03486834|524700067|FG001|Overall Study|Lost to Follow-up|24|||
145503148|NCT03486834|524700068|FG002|Overall Study|Lost to Follow-up|39|||
145503149|NCT03486834|524700066|FG000|Overall Study|Non-compliance with Study Drug|2|||
145503150|NCT03486834|524700067|FG001|Overall Study|Non-compliance with Study Drug|2|||
145503151|NCT03486834|524700068|FG002|Overall Study|Non-compliance with Study Drug|0|||
145503152|NCT03486834|524700066|FG000|Overall Study|Physician Decision|5|||
145503153|NCT03486834|524700067|FG001|Overall Study|Physician Decision|2|||
145503154|NCT03486834|524700068|FG002|Overall Study|Physician Decision|3|||
145503155|NCT03486834|524700066|FG000|Overall Study|Pregnancy|10|||
145503156|NCT03486834|524700067|FG001|Overall Study|Pregnancy|12|||
145503157|NCT03486834|524700068|FG002|Overall Study|Pregnancy|12|||
145503158|NCT03486834|524700066|FG000|Overall Study|Protocol Deviation|2|||
145503159|NCT03486834|524700067|FG001|Overall Study|Protocol Deviation|3|||
145266694|NCT04668066|523825247|FG010|Part 1: Follow-Up|Other|0|||
145503160|NCT03486834|524700068|FG002|Overall Study|Protocol Deviation|3|||
145503161|NCT03486834|524700066|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145503162|NCT03486834|524700067|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145503163|NCT03486834|524700068|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145503164|NCT03486834|524700066|FG000|Overall Study|Randomized but not treated|4|||
145503165|NCT03486834|524700067|FG001|Overall Study|Randomized but not treated|4|||
145503166|NCT03486834|524700068|FG002|Overall Study|Randomized but not treated|1|||
145503167|NCT02745119|524700070|FG000|Overall Study|Adverse Event|1|||
145503168|NCT02745119|524700071|FG001|Overall Study|Adverse Event|0|||
145503169|NCT02745119|524700072|FG002|Overall Study|Adverse Event|1|||
145503170|NCT02745119|524700073|FG003|Overall Study|Adverse Event|3|||
145503171|NCT02745119|524700070|FG000|Overall Study|Death|3|||
145503172|NCT02745119|524700071|FG001|Overall Study|Death|3|||
145503173|NCT02745119|524700072|FG002|Overall Study|Death|0|||
145503174|NCT02745119|524700073|FG003|Overall Study|Death|4|||
145503175|NCT02745119|524700070|FG000|Overall Study|Lost to Follow-up|0|||
145503176|NCT02745119|524700071|FG001|Overall Study|Lost to Follow-up|0|||
145503177|NCT02745119|524700072|FG002|Overall Study|Lost to Follow-up|0|||
145503178|NCT02745119|524700073|FG003|Overall Study|Lost to Follow-up|1|||
145503179|NCT02745119|524700070|FG000|Overall Study|Protocol Deviation|0|||
145503180|NCT02745119|524700071|FG001|Overall Study|Protocol Deviation|0|||
145503181|NCT02745119|524700072|FG002|Overall Study|Protocol Deviation|0|||
145503182|NCT02745119|524700073|FG003|Overall Study|Protocol Deviation|1|||
145503183|NCT02745119|524700070|FG000|Overall Study|Withdrawal by Subject|7|||
145503184|NCT02745119|524700071|FG001|Overall Study|Withdrawal by Subject|15|||
145503185|NCT02745119|524700072|FG002|Overall Study|Withdrawal by Subject|8|||
145503186|NCT02745119|524700073|FG003|Overall Study|Withdrawal by Subject|14|||
145503187|NCT02745119|524700070|FG000|Overall Study|Study Terminated by Sponsor|134|||
145503188|NCT02745119|524700071|FG001|Overall Study|Study Terminated by Sponsor|252|||
145503189|NCT02745119|524700072|FG002|Overall Study|Study Terminated by Sponsor|135|||
145503190|NCT02745119|524700073|FG003|Overall Study|Study Terminated by Sponsor|251|||
145503191|NCT02745119|524700070|FG000|Overall Study|Physician Decision|0|||
145503192|NCT02745119|524700071|FG001|Overall Study|Physician Decision|2|||
145503193|NCT02745119|524700072|FG002|Overall Study|Physician Decision|2|||
145503194|NCT02745119|524700073|FG003|Overall Study|Physician Decision|2|||
145503195|NCT02745119|524700070|FG000|Overall Study|Reason Not Specified|0|||
145503196|NCT02745119|524700071|FG001|Overall Study|Reason Not Specified|2|||
145503197|NCT02745119|524700072|FG002|Overall Study|Reason Not Specified|0|||
145503198|NCT02745119|524700073|FG003|Overall Study|Reason Not Specified|1|||
145503199|NCT00687193|524700077|FG000|Overall Study|Adverse Event|0|||
145503200|NCT00687193|524700078|FG001|Overall Study|Adverse Event|1|||
145503201|NCT00687193|524700079|FG002|Overall Study|Adverse Event|2|||
145503202|NCT00687193|524700080|FG003|Overall Study|Adverse Event|3|||
145503203|NCT00687193|524700081|FG004|Overall Study|Adverse Event|0|||
145503204|NCT00687193|524700082|FG005|Overall Study|Adverse Event|2|||
145503205|NCT00687193|524700077|FG000|Overall Study|Lack of Efficacy|1|||
145503206|NCT00687193|524700078|FG001|Overall Study|Lack of Efficacy|1|||
145503207|NCT00687193|524700079|FG002|Overall Study|Lack of Efficacy|0|||
145503208|NCT00687193|524700080|FG003|Overall Study|Lack of Efficacy|0|||
145503209|NCT00687193|524700081|FG004|Overall Study|Lack of Efficacy|0|||
145503210|NCT00687193|524700082|FG005|Overall Study|Lack of Efficacy|2|||
145503211|NCT00687193|524700077|FG000|Overall Study|Protocol Violation|1|||
145503212|NCT00687193|524700078|FG001|Overall Study|Protocol Violation|2|||
145503213|NCT00687193|524700079|FG002|Overall Study|Protocol Violation|0|||
145503214|NCT00687193|524700080|FG003|Overall Study|Protocol Violation|1|||
145503215|NCT00687193|524700081|FG004|Overall Study|Protocol Violation|2|||
145503216|NCT00687193|524700082|FG005|Overall Study|Protocol Violation|0|||
145503217|NCT02447003|524700083|FG000|Overall Study|Other|0|||
145503218|NCT02447003|524700084|FG001|Overall Study|Other|4|||
145503219|NCT02447003|524700083|FG000|Overall Study|Site discontinued|0|||
145503220|NCT02447003|524700084|FG001|Overall Study|Site discontinued|2|||
145503221|NCT02447003|524700083|FG000|Overall Study|Physician Decision|0|||
145503222|NCT02447003|524700084|FG001|Overall Study|Physician Decision|1|||
145503223|NCT02447003|524700083|FG000|Overall Study|Withdrawal by Subject|4|||
145503224|NCT02447003|524700084|FG001|Overall Study|Withdrawal by Subject|3|||
145503225|NCT02447003|524700083|FG000|Overall Study|Sponsor Decision|6|||
145503226|NCT02447003|524700084|FG001|Overall Study|Sponsor Decision|11|||
145503227|NCT02447003|524700083|FG000|Overall Study|Progressive Disease|1|||
145503228|NCT02447003|524700084|FG001|Overall Study|Progressive Disease|0|||
145503229|NCT02447003|524700083|FG000|Overall Study|Lost to Follow-up|5|||
145503230|NCT02447003|524700084|FG001|Overall Study|Lost to Follow-up|0|||
145503231|NCT02447003|524700083|FG000|Overall Study|Death|154|||
145503232|NCT02447003|524700084|FG001|Overall Study|Death|63|||
145503233|NCT01394016|524700085|FG000|Overall Study|Progressive Disease|2|||
145503234|NCT01394016|524700086|FG001|Overall Study|Progressive Disease|0|||
145503235|NCT01394016|524700087|FG002|Overall Study|Progressive Disease|0|||
145503236|NCT01394016|524700088|FG003|Overall Study|Progressive Disease|0|||
145503237|NCT01394016|524700089|FG004|Overall Study|Progressive Disease|0|||
145503238|NCT01394016|524700090|FG005|Overall Study|Progressive Disease|0|||
145503239|NCT01394016|524700091|FG006|Overall Study|Progressive Disease|0|||
145503240|NCT01394016|524700092|FG007|Overall Study|Progressive Disease|0|||
145503241|NCT01394016|524700093|FG008|Overall Study|Progressive Disease|0|||
145503242|NCT01394016|524700094|FG009|Overall Study|Progressive Disease|0|||
145503243|NCT01394016|524700095|FG010|Overall Study|Progressive Disease|0|||
145503244|NCT01394016|524700096|FG011|Overall Study|Progressive Disease|0|||
145503245|NCT01394016|524700097|FG012|Overall Study|Progressive Disease|0|||
145503246|NCT01394016|524700098|FG013|Overall Study|Progressive Disease|0|||
145503247|NCT01394016|524700099|FG014|Overall Study|Progressive Disease|0|||
145503248|NCT01394016|524700100|FG015|Overall Study|Progressive Disease|0|||
145503249|NCT01394016|524700101|FG016|Overall Study|Progressive Disease|0|||
145503250|NCT01394016|524700102|FG017|Overall Study|Progressive Disease|0|||
145503251|NCT01394016|524700103|FG018|Overall Study|Progressive Disease|0|||
145503252|NCT01394016|524700085|FG000|Overall Study|Withdrawal by Subject|0|||
145503253|NCT01394016|524700086|FG001|Overall Study|Withdrawal by Subject|0|||
145503254|NCT01394016|524700087|FG002|Overall Study|Withdrawal by Subject|0|||
145503255|NCT01394016|524700088|FG003|Overall Study|Withdrawal by Subject|0|||
145503256|NCT01394016|524700089|FG004|Overall Study|Withdrawal by Subject|0|||
145503257|NCT01394016|524700090|FG005|Overall Study|Withdrawal by Subject|0|||
145503258|NCT01394016|524700091|FG006|Overall Study|Withdrawal by Subject|0|||
145503259|NCT01394016|524700092|FG007|Overall Study|Withdrawal by Subject|1|||
145503260|NCT01394016|524700093|FG008|Overall Study|Withdrawal by Subject|1|||
145503261|NCT01394016|524700094|FG009|Overall Study|Withdrawal by Subject|1|||
145503262|NCT01394016|524700095|FG010|Overall Study|Withdrawal by Subject|4|||
145503263|NCT01394016|524700096|FG011|Overall Study|Withdrawal by Subject|0|||
145503264|NCT01394016|524700097|FG012|Overall Study|Withdrawal by Subject|0|||
145503265|NCT01394016|524700098|FG013|Overall Study|Withdrawal by Subject|3|||
145503266|NCT01394016|524700099|FG014|Overall Study|Withdrawal by Subject|1|||
145503267|NCT01394016|524700100|FG015|Overall Study|Withdrawal by Subject|3|||
145503268|NCT01394016|524700101|FG016|Overall Study|Withdrawal by Subject|1|||
145503269|NCT01394016|524700102|FG017|Overall Study|Withdrawal by Subject|1|||
145503270|NCT01394016|524700103|FG018|Overall Study|Withdrawal by Subject|2|||
145503271|NCT01394016|524700085|FG000|Overall Study|Adverse Event|0|||
145503272|NCT01394016|524700086|FG001|Overall Study|Adverse Event|0|||
145503273|NCT01394016|524700087|FG002|Overall Study|Adverse Event|0|||
145503274|NCT01394016|524700088|FG003|Overall Study|Adverse Event|0|||
145503275|NCT01394016|524700089|FG004|Overall Study|Adverse Event|0|||
145503276|NCT01394016|524700090|FG005|Overall Study|Adverse Event|0|||
145503277|NCT01394016|524700091|FG006|Overall Study|Adverse Event|0|||
145503278|NCT01394016|524700092|FG007|Overall Study|Adverse Event|0|||
145503279|NCT01394016|524700093|FG008|Overall Study|Adverse Event|0|||
145503280|NCT01394016|524700094|FG009|Overall Study|Adverse Event|1|||
145503281|NCT01394016|524700095|FG010|Overall Study|Adverse Event|0|||
145503282|NCT01394016|524700096|FG011|Overall Study|Adverse Event|0|||
145503283|NCT01394016|524700097|FG012|Overall Study|Adverse Event|0|||
145503284|NCT01394016|524700098|FG013|Overall Study|Adverse Event|0|||
145503285|NCT01394016|524700099|FG014|Overall Study|Adverse Event|0|||
145503286|NCT01394016|524700100|FG015|Overall Study|Adverse Event|0|||
145503287|NCT01394016|524700101|FG016|Overall Study|Adverse Event|1|||
145503288|NCT01394016|524700102|FG017|Overall Study|Adverse Event|1|||
145503289|NCT01394016|524700103|FG018|Overall Study|Adverse Event|0|||
145503290|NCT01394016|524700085|FG000|Overall Study|Sponsor Decision|0|||
145503291|NCT01394016|524700086|FG001|Overall Study|Sponsor Decision|0|||
145503292|NCT01394016|524700087|FG002|Overall Study|Sponsor Decision|0|||
145503293|NCT01394016|524700088|FG003|Overall Study|Sponsor Decision|0|||
145503294|NCT01394016|524700089|FG004|Overall Study|Sponsor Decision|0|||
145503295|NCT01394016|524700090|FG005|Overall Study|Sponsor Decision|0|||
145503296|NCT01394016|524700091|FG006|Overall Study|Sponsor Decision|0|||
145503297|NCT01394016|524700092|FG007|Overall Study|Sponsor Decision|0|||
145503298|NCT01394016|524700093|FG008|Overall Study|Sponsor Decision|0|||
145503299|NCT01394016|524700094|FG009|Overall Study|Sponsor Decision|0|||
145503300|NCT01394016|524700095|FG010|Overall Study|Sponsor Decision|0|||
145503301|NCT01394016|524700096|FG011|Overall Study|Sponsor Decision|0|||
145503302|NCT01394016|524700097|FG012|Overall Study|Sponsor Decision|1|||
145503303|NCT01394016|524700098|FG013|Overall Study|Sponsor Decision|0|||
145503304|NCT01394016|524700099|FG014|Overall Study|Sponsor Decision|0|||
145503305|NCT01394016|524700100|FG015|Overall Study|Sponsor Decision|0|||
145503306|NCT01394016|524700101|FG016|Overall Study|Sponsor Decision|0|||
145503307|NCT01394016|524700102|FG017|Overall Study|Sponsor Decision|0|||
145503308|NCT01394016|524700103|FG018|Overall Study|Sponsor Decision|0|||
145503309|NCT01394016|524700085|FG000|Overall Study|Lost to Follow-up|0|||
145503310|NCT01394016|524700086|FG001|Overall Study|Lost to Follow-up|0|||
145503311|NCT01394016|524700087|FG002|Overall Study|Lost to Follow-up|0|||
145503312|NCT01394016|524700088|FG003|Overall Study|Lost to Follow-up|0|||
145503313|NCT01394016|524700089|FG004|Overall Study|Lost to Follow-up|0|||
145503314|NCT01394016|524700090|FG005|Overall Study|Lost to Follow-up|0|||
145503315|NCT01394016|524700091|FG006|Overall Study|Lost to Follow-up|0|||
145503316|NCT01394016|524700092|FG007|Overall Study|Lost to Follow-up|0|||
145503317|NCT01394016|524700093|FG008|Overall Study|Lost to Follow-up|0|||
145503318|NCT01394016|524700094|FG009|Overall Study|Lost to Follow-up|0|||
145503319|NCT01394016|524700095|FG010|Overall Study|Lost to Follow-up|0|||
145503320|NCT01394016|524700096|FG011|Overall Study|Lost to Follow-up|0|||
145503321|NCT01394016|524700097|FG012|Overall Study|Lost to Follow-up|0|||
145503322|NCT01394016|524700098|FG013|Overall Study|Lost to Follow-up|0|||
145503323|NCT01394016|524700099|FG014|Overall Study|Lost to Follow-up|0|||
145503324|NCT01394016|524700100|FG015|Overall Study|Lost to Follow-up|0|||
145503325|NCT01394016|524700101|FG016|Overall Study|Lost to Follow-up|0|||
145503326|NCT01394016|524700102|FG017|Overall Study|Lost to Follow-up|0|||
145503327|NCT01394016|524700103|FG018|Overall Study|Lost to Follow-up|1|||
145503328|NCT03534804|524700104|FG000|Overall Study|Withdrawal by Subject|1|||
145503329|NCT04161157|524700105|FG000|Overall Study|Lost to Follow-up|4|||
145503330|NCT04161157|524700105|FG000|Overall Study|Death|3|||
145503331|NCT04161157|524700105|FG000|Overall Study|Ineligible|2|||
145503332|NCT04161157|524700105|FG000|Overall Study|Withdrawal by Subject|4|||
145503333|NCT04922216|524700112|FG000|Overall Study|Withdrawal by Subject|0|||
145503334|NCT04922216|524700113|FG001|Overall Study|Withdrawal by Subject|1|||
145503335|NCT04922216|524700114|FG002|Overall Study|Withdrawal by Subject|0|||
145503336|NCT04922216|524700115|FG003|Overall Study|Withdrawal by Subject|0|||
145503337|NCT04922216|524700116|FG004|Overall Study|Withdrawal by Subject|0|||
145503338|NCT04922216|524700117|FG005|Overall Study|Withdrawal by Subject|0|||
145503339|NCT04922216|524700118|FG006|Overall Study|Withdrawal by Subject|0|||
145503340|NCT04922216|524700119|FG007|Overall Study|Withdrawal by Subject|2|||
145503341|NCT04922216|524700120|FG008|Overall Study|Withdrawal by Subject|0|||
145503342|NCT04922216|524700121|FG009|Overall Study|Withdrawal by Subject|0|||
145503343|NCT04922216|524700122|FG010|Overall Study|Withdrawal by Subject|0|||
145503344|NCT04922216|524700123|FG011|Overall Study|Withdrawal by Subject|0|||
145503345|NCT04922216|524700124|FG012|Overall Study|Withdrawal by Subject|1|||
145503346|NCT04922216|524700125|FG013|Overall Study|Withdrawal by Subject|1|||
145503347|NCT04922216|524700126|FG014|Overall Study|Withdrawal by Subject|1|||
145503348|NCT04922216|524700127|FG015|Overall Study|Withdrawal by Subject|0|||
145503349|NCT04922216|524700128|FG016|Overall Study|Withdrawal by Subject|0|||
145503350|NCT04922216|524700129|FG017|Overall Study|Withdrawal by Subject|1|||
145503351|NCT04922216|524700130|FG018|Overall Study|Withdrawal by Subject|1|||
145503352|NCT04922216|524700131|FG019|Overall Study|Withdrawal by Subject|1|||
145503353|NCT04922216|524700132|FG020|Overall Study|Withdrawal by Subject|1|||
145503354|NCT04922216|524700133|FG021|Overall Study|Withdrawal by Subject|0|||
145503355|NCT04922216|524700134|FG022|Overall Study|Withdrawal by Subject|0|||
145503356|NCT04922216|524700135|FG023|Overall Study|Withdrawal by Subject|2|||
145503357|NCT04922216|524700136|FG024|Overall Study|Withdrawal by Subject|0|||
145503358|NCT04922216|524700137|FG025|Overall Study|Withdrawal by Subject|0|||
145503359|NCT04922216|524700138|FG026|Overall Study|Withdrawal by Subject|1|||
145503360|NCT04922216|524700139|FG027|Overall Study|Withdrawal by Subject|0|||
145503361|NCT04922216|524700140|FG028|Overall Study|Withdrawal by Subject|0|||
145503362|NCT04922216|524700141|FG029|Overall Study|Withdrawal by Subject|0|||
145503363|NCT04922216|524700142|FG030|Overall Study|Withdrawal by Subject|1|||
145503364|NCT04922216|524700143|FG031|Overall Study|Withdrawal by Subject|0|||
145503365|NCT04922216|524700112|FG000|Overall Study|Lost to Follow-up|1|||
145503366|NCT04922216|524700113|FG001|Overall Study|Lost to Follow-up|0|||
145503367|NCT04922216|524700114|FG002|Overall Study|Lost to Follow-up|2|||
145503368|NCT04922216|524700115|FG003|Overall Study|Lost to Follow-up|0|||
145503369|NCT04922216|524700116|FG004|Overall Study|Lost to Follow-up|0|||
145503370|NCT04922216|524700117|FG005|Overall Study|Lost to Follow-up|2|||
145503371|NCT04922216|524700118|FG006|Overall Study|Lost to Follow-up|0|||
145503372|NCT04922216|524700119|FG007|Overall Study|Lost to Follow-up|1|||
145503373|NCT04922216|524700120|FG008|Overall Study|Lost to Follow-up|1|||
145503374|NCT04922216|524700121|FG009|Overall Study|Lost to Follow-up|2|||
145503375|NCT04922216|524700122|FG010|Overall Study|Lost to Follow-up|2|||
145503376|NCT04922216|524700123|FG011|Overall Study|Lost to Follow-up|1|||
145503377|NCT04922216|524700124|FG012|Overall Study|Lost to Follow-up|1|||
145503378|NCT04922216|524700125|FG013|Overall Study|Lost to Follow-up|0|||
145503379|NCT04922216|524700126|FG014|Overall Study|Lost to Follow-up|1|||
145503380|NCT04922216|524700127|FG015|Overall Study|Lost to Follow-up|0|||
145503381|NCT04922216|524700128|FG016|Overall Study|Lost to Follow-up|0|||
145503382|NCT04922216|524700129|FG017|Overall Study|Lost to Follow-up|2|||
145503383|NCT04922216|524700130|FG018|Overall Study|Lost to Follow-up|1|||
145503384|NCT04922216|524700131|FG019|Overall Study|Lost to Follow-up|0|||
145503385|NCT04922216|524700132|FG020|Overall Study|Lost to Follow-up|1|||
145503386|NCT04922216|524700133|FG021|Overall Study|Lost to Follow-up|0|||
145503387|NCT04922216|524700134|FG022|Overall Study|Lost to Follow-up|2|||
145503388|NCT04922216|524700135|FG023|Overall Study|Lost to Follow-up|1|||
145503389|NCT04922216|524700136|FG024|Overall Study|Lost to Follow-up|0|||
145503390|NCT04922216|524700137|FG025|Overall Study|Lost to Follow-up|2|||
145503391|NCT04922216|524700138|FG026|Overall Study|Lost to Follow-up|0|||
145503392|NCT04922216|524700139|FG027|Overall Study|Lost to Follow-up|0|||
145503393|NCT04922216|524700140|FG028|Overall Study|Lost to Follow-up|1|||
145503394|NCT04922216|524700141|FG029|Overall Study|Lost to Follow-up|0|||
145503395|NCT04922216|524700142|FG030|Overall Study|Lost to Follow-up|2|||
145503396|NCT04922216|524700143|FG031|Overall Study|Lost to Follow-up|1|||
145503397|NCT04721977|524700144|FG000|Overall Study|Death|15|||
145503398|NCT04721977|524700144|FG000|Overall Study|Ongoing|51|||
145503399|NCT03278249|524700145|FG000|Overall Study|Withdrawal by Subject|2|||
145503400|NCT03278249|524700145|FG000|Overall Study|Lost to Follow-up|1|||
145503401|NCT02017405|524700146|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
145503402|NCT02017405|524700147|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
145503403|NCT02017405|524700148|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
145503404|NCT02017405|524700149|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
145503405|NCT02017405|524700150|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
145503406|NCT02017405|524700151|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
145503407|NCT02017405|524700146|FG000|Open-label Phase|Adverse Event|1|||
145503408|NCT02017405|524700147|FG001|Open-label Phase|Adverse Event|1|||
145503409|NCT02017405|524700148|FG002|Open-label Phase|Adverse Event|0|||
145503410|NCT02017405|524700149|FG003|Open-label Phase|Adverse Event|0|||
145503411|NCT02017405|524700150|FG004|Open-label Phase|Adverse Event|0|||
145503412|NCT02017405|524700151|FG005|Open-label Phase|Adverse Event|0|||
145503413|NCT02864394|524700153|FG000|Overall Study|Death|184|||
145503414|NCT02864394|524700154|FG001|Overall Study|Death|189|||
145503415|NCT02864394|524700153|FG000|Overall Study|Lost to Follow-up|0|||
145503416|NCT02864394|524700154|FG001|Overall Study|Lost to Follow-up|2|||
145503417|NCT02864394|524700153|FG000|Overall Study|Sponsor Decision|26|||
145503418|NCT02864394|524700154|FG001|Overall Study|Sponsor Decision|11|||
145503419|NCT02864394|524700153|FG000|Overall Study|Withdrawal by Subject|3|||
145503420|NCT02864394|524700154|FG001|Overall Study|Withdrawal by Subject|10|||
145503421|NCT02374450|524700155|FG000|Overall Study|Protocol Violation|0|||
145503422|NCT02374450|524700156|FG001|Overall Study|Protocol Violation|1|||
145503423|NCT02374450|524700157|FG002|Overall Study|Protocol Violation|0|||
145503424|NCT02374450|524700155|FG000|Overall Study|Withdrawal by Subject|91|||
145503425|NCT02374450|524700156|FG001|Overall Study|Withdrawal by Subject|110|||
145503426|NCT02374450|524700157|FG002|Overall Study|Withdrawal by Subject|4|||
145503427|NCT02374450|524700155|FG000|Overall Study|Lost to Follow-up|168|||
145503428|NCT02374450|524700156|FG001|Overall Study|Lost to Follow-up|194|||
145503429|NCT02374450|524700157|FG002|Overall Study|Lost to Follow-up|138|||
145503430|NCT02374450|524700155|FG000|Overall Study|Death|173|||
145503431|NCT02374450|524700156|FG001|Overall Study|Death|185|||
145503432|NCT02374450|524700157|FG002|Overall Study|Death|81|||
145503433|NCT02374450|524700155|FG000|Overall Study|Migrated from the study area|538|||
145503434|NCT02374450|524700156|FG001|Overall Study|Migrated from the study area|648|||
145503435|NCT02374450|524700157|FG002|Overall Study|Migrated from the study area|181|||
145503436|NCT02374450|524700155|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
145503437|NCT02374450|524700156|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
145503438|NCT02374450|524700157|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
145503439|NCT02374450|524700155|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
145503440|NCT02374450|524700156|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
145503441|NCT02374450|524700157|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
145503442|NCT02374450|524700155|FG000|Overall Study|Other|0|||
145503443|NCT02374450|524700156|FG001|Overall Study|Other|21|||
145503444|NCT02374450|524700157|FG002|Overall Study|Other|79|||
145503445|NCT04730804|524700158|FG000|Overall Study|Physician Decision|0|||
145399043|NCT00492726|524316624|FG001|Overall Study|Adverse Event|6|||
145399044|NCT00492726|524316623|FG000|Overall Study|Death|7|||
145399045|NCT00492726|524316624|FG001|Overall Study|Death|2|||
145399046|NCT00492726|524316623|FG000|Overall Study|Lack of Efficacy|0|||
145399047|NCT00492726|524316624|FG001|Overall Study|Lack of Efficacy|2|||
145399048|NCT00492726|524316623|FG000|Overall Study|Lost to Follow-up|27|||
145399049|NCT00492726|524316624|FG001|Overall Study|Lost to Follow-up|19|||
145399050|NCT00492726|524316623|FG000|Overall Study|Physician Decision|0|||
145399051|NCT00492726|524316624|FG001|Overall Study|Physician Decision|1|||
145399052|NCT00492726|524316623|FG000|Overall Study|Withdrawal by Subject|6|||
145399053|NCT00492726|524316624|FG001|Overall Study|Withdrawal by Subject|3|||
145399054|NCT00492726|524316623|FG000|Overall Study|Non compliant with study medication|0|||
145399055|NCT00492726|524316624|FG001|Overall Study|Non compliant with study medication|3|||
145399056|NCT04386902|524316625|FG000|Overall Study|Withdrawal by Subject|5|||
145399057|NCT04386902|524316625|FG000|Overall Study|Technical problems in the recording|5|||
145399058|NCT01100502|524316626|FG000|Overall Study|Withdrawal by Subject|18|||
145399059|NCT01100502|524316627|FG001|Overall Study|Withdrawal by Subject|25|||
145399060|NCT01100502|524316626|FG000|Overall Study|Lost to Follow-up|13|||
145399061|NCT01100502|524316627|FG001|Overall Study|Lost to Follow-up|28|||
145399062|NCT01100502|524316626|FG000|Overall Study|Site request to end participation in study|0|||
145399063|NCT01100502|524316627|FG001|Overall Study|Site request to end participation in study|1|||
145399064|NCT01100502|524316626|FG000|Overall Study|Death|45|||
145399065|NCT01100502|524316627|FG001|Overall Study|Death|40|||
145399066|NCT00721799|524316628|FG000|Overall Study|Withdrawal by Subject|7|||
145399067|NCT00721799|524316628|FG000|Overall Study|withdraw by subject after scan 1|1|||
145399068|NCT05158140|524316630|FG000|Overall Study|Death|0|||
145399069|NCT05158140|524316631|FG001|Overall Study|Death|0|||
145399070|NCT05158140|524316632|FG002|Overall Study|Death|0|||
145399071|NCT05158140|524316633|FG003|Overall Study|Death|1|||
145399072|NCT05158140|524316630|FG000|Overall Study|Lost to Follow-up|3|||
145399073|NCT05158140|524316631|FG001|Overall Study|Lost to Follow-up|6|||
145399074|NCT05158140|524316632|FG002|Overall Study|Lost to Follow-up|4|||
145399075|NCT05158140|524316633|FG003|Overall Study|Lost to Follow-up|3|||
145399076|NCT05158140|524316630|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145399077|NCT05158140|524316631|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145399078|NCT05158140|524316632|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
145399079|NCT05158140|524316633|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145399080|NCT05158140|524316630|FG000|Overall Study|Withdrawal by Subject|3|||
145399081|NCT05158140|524316631|FG001|Overall Study|Withdrawal by Subject|7|||
145399082|NCT05158140|524316632|FG002|Overall Study|Withdrawal by Subject|3|||
145399083|NCT05158140|524316633|FG003|Overall Study|Withdrawal by Subject|7|||
145399084|NCT00807365|524316637|FG000|Overall Study|Study Terminated|5|||
145399085|NCT01121263|524316639|FG000|Overall Study|Death|3|||
145399086|NCT01121263|524316640|FG001|Overall Study|Death|2|||
145399087|NCT01121263|524316639|FG000|Overall Study|Lost to Follow-up|22|||
145399088|NCT01121263|524316640|FG001|Overall Study|Lost to Follow-up|12|||
145399089|NCT01121263|524316639|FG000|Overall Study|Withdrawal by Subject|0|||
145399090|NCT01121263|524316640|FG001|Overall Study|Withdrawal by Subject|1|||
145399091|NCT03810456|524316641|FG000|Treatment|Urgent Family Matters|3|||
145399092|NCT03810456|524316642|FG001|Treatment|Urgent Family Matters|0|||
145399093|NCT03810456|524316643|FG002|Treatment|Urgent Family Matters|0|||
145399094|NCT03810456|524316641|FG000|Treatment|Scheduling Conflicts|0|||
145399095|NCT03810456|524316642|FG001|Treatment|Scheduling Conflicts|11|||
145399096|NCT03810456|524316643|FG002|Treatment|Scheduling Conflicts|0|||
145399097|NCT03810456|524316641|FG000|Treatment|No Longer Interested|0|||
145399098|NCT03810456|524316642|FG001|Treatment|No Longer Interested|12|||
145399099|NCT03810456|524316643|FG002|Treatment|No Longer Interested|0|||
145399100|NCT03810456|524316641|FG000|Treatment|Transportation Issues|0|||
145399101|NCT03810456|524316642|FG001|Treatment|Transportation Issues|1|||
145399102|NCT03810456|524316643|FG002|Treatment|Transportation Issues|0|||
145399103|NCT03810456|524316641|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
145399104|NCT03810456|524316642|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
145399105|NCT03810456|524316643|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
145399106|NCT03810456|524316641|FG000|1 Month Follow-Up|Relocated to Different State|1|||
145399107|NCT03810456|524316642|FG001|1 Month Follow-Up|Relocated to Different State|0|||
145399108|NCT03810456|524316643|FG002|1 Month Follow-Up|Relocated to Different State|1|||
145399109|NCT03810456|524316641|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
145399110|NCT03810456|524316642|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
145399111|NCT03810456|524316643|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
145399112|NCT03810456|524316641|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
145399113|NCT03810456|524316642|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
145399114|NCT03810456|524316643|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
145399115|NCT03810456|524316641|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
145399116|NCT03810456|524316642|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
145399117|NCT03810456|524316643|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
145399118|NCT03810456|524316641|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
145399119|NCT03810456|524316642|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
145399120|NCT03810456|524316643|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
145399121|NCT03810456|524316641|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
145399122|NCT03810456|524316642|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
145399123|NCT03810456|524316643|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
145399124|NCT02100124|524316648|FG000|Overall Study|Lost to Follow-up|5|||
145399125|NCT02100124|524316649|FG001|Overall Study|Lost to Follow-up|11|||
145399126|NCT02100124|524316650|FG002|Overall Study|Lost to Follow-up|3|||
145399127|NCT02100124|524316648|FG000|Overall Study|Withdrawal by Subject|1|||
145399128|NCT02100124|524316649|FG001|Overall Study|Withdrawal by Subject|0|||
145399129|NCT02100124|524316650|FG002|Overall Study|Withdrawal by Subject|0|||
145399130|NCT04350827|524316651|FG000|Overall Study|Lost to Follow-up|1|||
145399131|NCT04350827|524316652|FG001|Overall Study|Lost to Follow-up|2|||
145399132|NCT02812186|524318236|FG000|Period 1|Post randomization screen failure|5|||
145399133|NCT02812186|524318237|FG001|Period 1|Post randomization screen failure|9|||
145399134|NCT02812186|524318236|FG000|Period 1|nonevaluable data sets|6|||
145399135|NCT02812186|524318237|FG001|Period 1|nonevaluable data sets|6|||
145399136|NCT03103503|524318238|FG000|Overall Study|Death|64|||
145399137|NCT03103503|524318238|FG000|Overall Study|Physician Decision|57|||
145399138|NCT03103503|524318238|FG000|Overall Study|Withdrawal by Subject|10|||
145399139|NCT03103503|524318238|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
145399140|NCT03103503|524318238|FG000|Overall Study|Lost to Follow-up|3|||
145399141|NCT03103503|524318238|FG000|Overall Study|Study Closure|757|||
145399142|NCT03342001|524318242|FG000|Overall Study|Adverse Event|1|||
145399143|NCT03342001|524318242|FG000|Overall Study|Lost to Follow-up|1|||
145399144|NCT04635839|524318245|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
145399145|NCT04635839|524318246|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
145399146|NCT02737358|524318247|FG000|Overall Study|Withdrawal by Subject|7|||
145399147|NCT02737358|524318248|FG001|Overall Study|Withdrawal by Subject|12|||
145399148|NCT02737358|524318247|FG000|Overall Study|Lost to Follow-up|2|||
145399149|NCT02737358|524318248|FG001|Overall Study|Lost to Follow-up|3|||
145399150|NCT01739335|524318250|FG000|Overall Study|Lost to Follow-up|7|||
145399151|NCT01739335|524318251|FG001|Overall Study|Lost to Follow-up|4|||
145399152|NCT01739335|524318250|FG000|Overall Study|Ineligible patient randomized|0|||
145399153|NCT01739335|524318251|FG001|Overall Study|Ineligible patient randomized|1|||
145399154|NCT00288912|524318252|FG000|Overall Study|Developed exclusion criterion|4|||
145399155|NCT00288912|524318253|FG001|Overall Study|Developed exclusion criterion|6|||
145399156|NCT00288912|524318254|FG002|Overall Study|Developed exclusion criterion|7|||
145399157|NCT00288912|524318252|FG000|Overall Study|Lost to Follow-up|9|||
145399158|NCT00288912|524318253|FG001|Overall Study|Lost to Follow-up|6|||
145399159|NCT00288912|524318254|FG002|Overall Study|Lost to Follow-up|9|||
145399160|NCT00288912|524318252|FG000|Overall Study|Withdrawal by Subject|4|||
145399161|NCT00288912|524318253|FG001|Overall Study|Withdrawal by Subject|5|||
145399162|NCT00288912|524318254|FG002|Overall Study|Withdrawal by Subject|12|||
145399163|NCT00386334|524318259|FG000|Double Blind Period|Adverse Event|9|||
145399164|NCT00386334|524318260|FG001|Double Blind Period|Adverse Event|14|||
145399165|NCT00386334|524318259|FG000|Double Blind Period|Protocol Violation|1|||
145399166|NCT00386334|524318260|FG001|Double Blind Period|Protocol Violation|1|||
145399167|NCT00386334|524318259|FG000|Double Blind Period|Withdrawal by Subject|9|||
145399168|NCT00386334|524318260|FG001|Double Blind Period|Withdrawal by Subject|13|||
145399169|NCT00386334|524318259|FG000|Double Blind Period|Lack of Efficacy|20|||
145399170|NCT00386334|524318260|FG001|Double Blind Period|Lack of Efficacy|11|||
145399171|NCT00386334|524318259|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
145399172|NCT00386334|524318260|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
145399173|NCT00386334|524318259|FG000|Double Blind Period|Other|3|||
145399174|NCT00386334|524318260|FG001|Double Blind Period|Other|3|||
145399175|NCT00386334|524318259|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
145399176|NCT00386334|524318260|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
145399177|NCT01245101|524318264|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
145399178|NCT01245101|524318265|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
145399179|NCT01245101|524318264|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
145399180|NCT01245101|524318265|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
145399181|NCT01245101|524318264|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
145399182|NCT01245101|524318265|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
145399183|NCT01122173|524318266|FG000|Overall Study|Lost to Follow-up|3|||
145399184|NCT01122173|524318266|FG000|Overall Study|Withdrawal by Subject|3|||
145399185|NCT01122173|524318266|FG000|Overall Study|Left study for other reasons|3|||
145399186|NCT02133508|524318267|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
145399187|NCT02133508|524318267|FG000|Overall Study|Death|12|||
145399188|NCT02133508|524318267|FG000|Overall Study|Lost to Follow-up|2|||
145399189|NCT03093181|524318270|FG000|Overall Study|Withdrawal by Subject|2|||
145399190|NCT03093181|524318271|FG001|Overall Study|Withdrawal by Subject|1|||
145503446|NCT04730804|524700159|FG001|Overall Study|Physician Decision|0|||
145503447|NCT04730804|524700160|FG002|Overall Study|Physician Decision|0|||
145503448|NCT04730804|524700161|FG003|Overall Study|Physician Decision|0|||
145503449|NCT04730804|524700162|FG004|Overall Study|Physician Decision|0|||
145503450|NCT04730804|524700163|FG005|Overall Study|Physician Decision|1|||
145503451|NCT04730804|524700158|FG000|Overall Study|Withdrawal by Subject|0|||
145503452|NCT04730804|524700159|FG001|Overall Study|Withdrawal by Subject|0|||
145503453|NCT04730804|524700160|FG002|Overall Study|Withdrawal by Subject|0|||
145503454|NCT04730804|524700161|FG003|Overall Study|Withdrawal by Subject|0|||
145503455|NCT04730804|524700162|FG004|Overall Study|Withdrawal by Subject|1|||
145503456|NCT04730804|524700163|FG005|Overall Study|Withdrawal by Subject|2|||
145503457|NCT02202759|524701414|FG000|Overall Study|Study Terminated by Sponsor|3|||
145503458|NCT02202759|524701415|FG001|Overall Study|Study Terminated by Sponsor|3|||
145503459|NCT02202759|524701416|FG002|Overall Study|Study Terminated by Sponsor|3|||
145503460|NCT02202759|524701414|FG000|Overall Study|Withdrawal by Subject|2|||
145503461|NCT02202759|524701415|FG001|Overall Study|Withdrawal by Subject|1|||
145503462|NCT02202759|524701416|FG002|Overall Study|Withdrawal by Subject|1|||
145503463|NCT02202759|524701414|FG000|Overall Study|Reason not Specified|4|||
145503464|NCT02202759|524701415|FG001|Overall Study|Reason not Specified|11|||
145503465|NCT02202759|524701416|FG002|Overall Study|Reason not Specified|10|||
145503466|NCT05029362|524701420|FG000|Overall Study|Lost to Follow-up|9|||
145503467|NCT03126591|524701421|FG000|Overall Study|Death|6|||
145503468|NCT03126591|524701422|FG001|Overall Study|Death|3|||
145503469|NCT03126591|524701423|FG002|Overall Study|Death|17|||
145503470|NCT03126591|524701421|FG000|Overall Study|Progressive Disease|0|||
145503471|NCT03126591|524701422|FG001|Overall Study|Progressive Disease|1|||
145503472|NCT03126591|524701423|FG002|Overall Study|Progressive Disease|2|||
145503473|NCT03126591|524701421|FG000|Overall Study|Terminated by Sponsor|0|||
145503474|NCT03126591|524701422|FG001|Overall Study|Terminated by Sponsor|1|||
145503475|NCT03126591|524701423|FG002|Overall Study|Terminated by Sponsor|4|||
145503476|NCT03126591|524701421|FG000|Overall Study|Withdrawal by Subject|1|||
145503477|NCT03126591|524701422|FG001|Overall Study|Withdrawal by Subject|1|||
145503478|NCT03126591|524701423|FG002|Overall Study|Withdrawal by Subject|4|||
145503479|NCT03722238|524701426|FG000|Overall Study|Protocol Violation|1|||
145503480|NCT03722238|524701427|FG001|Overall Study|Protocol Violation|0|||
145503481|NCT03722238|524701426|FG000|Overall Study|Physician Decision|1|||
145503482|NCT03722238|524701427|FG001|Overall Study|Physician Decision|0|||
145503483|NCT03722238|524701426|FG000|Overall Study|Death|1|||
145503484|NCT03722238|524701427|FG001|Overall Study|Death|0|||
145503485|NCT03722238|524701426|FG000|Overall Study|Lost to Follow-up|6|||
145503486|NCT03722238|524701427|FG001|Overall Study|Lost to Follow-up|0|||
145503487|NCT03722238|524701426|FG000|Overall Study|Partial missing data|44|||
145503488|NCT03722238|524701427|FG001|Overall Study|Partial missing data|1|||
145503489|NCT03722238|524701426|FG000|Overall Study|Withdrawal by Subject|2|||
145503490|NCT03722238|524701427|FG001|Overall Study|Withdrawal by Subject|0|||
145503491|NCT03722238|524701426|FG000|Overall Study|Other|4|||
145503492|NCT03722238|524701427|FG001|Overall Study|Other|0|||
145503493|NCT03722238|524701426|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
145503494|NCT03722238|524701427|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
145503495|NCT03722238|524701426|FG000|Overall Study|Did not meet risk classification group criteria|90|||
145503496|NCT03722238|524701427|FG001|Overall Study|Did not meet risk classification group criteria|0|||
145503497|NCT03722238|524701426|FG000|Overall Study|Did not sign consent|17|||
145503498|NCT03722238|524701427|FG001|Overall Study|Did not sign consent|0|||
145503499|NCT03722238|524701426|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
145503500|NCT03722238|524701427|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
145503501|NCT03722238|524701426|FG000|Overall Study|Not willing to purchase study medication|142|||
145503502|NCT03722238|524701427|FG001|Overall Study|Not willing to purchase study medication|0|||
145503503|NCT03722238|524701426|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
145503504|NCT03722238|524701427|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
145503505|NCT02351817|524701428|FG000|Period 1|Adverse Event|1|||
145503506|NCT02351817|524701429|FG001|Period 1|Adverse Event|2|||
145503507|NCT02351817|524701428|FG000|Period 1|Lack of Efficacy|0|||
145503508|NCT02351817|524701429|FG001|Period 1|Lack of Efficacy|1|||
145503509|NCT02351817|524701428|FG000|Period 2|Adverse Event|0|||
145503510|NCT02351817|524701429|FG001|Period 2|Adverse Event|2|||
145503511|NCT02351817|524701428|FG000|Period 2|Protocol Violation|1|||
145503512|NCT02351817|524701429|FG001|Period 2|Protocol Violation|0|||
145503513|NCT02488915|524701432|FG000|Overall Study|Death|21|||
145503514|NCT02488915|524701432|FG000|Overall Study|Lost to Follow-up|4|||
145503515|NCT02488915|524701432|FG000|Overall Study|Withdrawal by Subject|1|||
145503516|NCT03771664|524701433|FG000|Overall Study|Adverse Event|1|||
145503517|NCT03771664|524701434|FG001|Overall Study|Adverse Event|0|||
145503518|NCT03771664|524701433|FG000|Overall Study|Lost to Follow-up|1|||
145503519|NCT03771664|524701434|FG001|Overall Study|Lost to Follow-up|0|||
145503520|NCT03771664|524701433|FG000|Overall Study|Withdrawal by Participant|1|||
145503521|NCT03771664|524701434|FG001|Overall Study|Withdrawal by Participant|4|||
145503522|NCT03771664|524701433|FG000|Overall Study|Randomized but not Treated|0|||
145503523|NCT03771664|524701434|FG001|Overall Study|Randomized but not Treated|1|||
145503524|NCT00561925|524701435|FG000|14 Day Lead-In Period|Adverse Event|38|||
145503525|NCT00561925|524701436|FG001|14 Day Lead-In Period|Adverse Event|0|||
145503526|NCT00561925|524701437|FG002|14 Day Lead-In Period|Adverse Event|0|||
145503527|NCT00561925|524701438|FG003|14 Day Lead-In Period|Adverse Event|0|||
145503528|NCT00561925|524701439|FG004|14 Day Lead-In Period|Adverse Event|0|||
145503529|NCT00561925|524701435|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
145503530|NCT00561925|524701436|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
145503531|NCT00561925|524701437|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
145503532|NCT00561925|524701438|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
145503533|NCT00561925|524701439|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
145503534|NCT00561925|524701435|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
145503535|NCT00561925|524701436|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
145503536|NCT00561925|524701437|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
145503537|NCT00561925|524701438|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
145503538|NCT00561925|524701439|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
145503539|NCT00561925|524701435|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
145503540|NCT00561925|524701436|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
145503541|NCT00561925|524701437|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
145503542|NCT00561925|524701438|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
145503543|NCT00561925|524701439|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
145503544|NCT00561925|524701435|FG000|14 Day Lead-In Period|Other|5|||
145503545|NCT00561925|524701436|FG001|14 Day Lead-In Period|Other|0|||
145503546|NCT00561925|524701437|FG002|14 Day Lead-In Period|Other|0|||
145503547|NCT00561925|524701438|FG003|14 Day Lead-In Period|Other|0|||
145503548|NCT00561925|524701439|FG004|14 Day Lead-In Period|Other|0|||
145503549|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
145503550|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
145503551|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
145503552|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
145503553|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
145503554|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
145503555|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
145503556|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
145503557|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
145503558|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
145503559|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
145503560|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
145503561|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
145503562|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
145503563|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
145503564|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
145503565|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
145503566|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
145503567|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
145503568|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
145503569|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
145503570|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
145503571|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
145503572|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
145503573|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
145503574|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
145503575|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
145503576|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
145503577|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
145503578|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
145503579|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Death|0|||
145503580|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Death|6|||
145503581|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Death|3|||
145503582|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Death|0|||
145503583|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Death|0|||
145503584|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
145503585|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
145503586|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
145503587|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
145503588|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
145503589|NCT00561925|524701435|FG000|144-week Double-blind, Double-dummy|Other|0|||
145503590|NCT00561925|524701436|FG001|144-week Double-blind, Double-dummy|Other|8|||
145503591|NCT00561925|524701437|FG002|144-week Double-blind, Double-dummy|Other|11|||
145503592|NCT00561925|524701438|FG003|144-week Double-blind, Double-dummy|Other|0|||
145503593|NCT00561925|524701439|FG004|144-week Double-blind, Double-dummy|Other|0|||
145503594|NCT00561925|524701435|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
145503595|NCT00561925|524701436|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
145503596|NCT00561925|524701437|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
145503597|NCT00561925|524701438|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
145503598|NCT00561925|524701439|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
145503599|NCT00684021|524701442|FG000|Overall Study|MRI Contraindicated|1|||
145503600|NCT00684021|524701443|FG001|Overall Study|MRI Contraindicated|1|||
145503601|NCT00684021|524701444|FG002|Overall Study|MRI Contraindicated|1|||
145503602|NCT00684021|524701445|FG003|Overall Study|MRI Contraindicated|0|||
145503603|NCT00684021|524701442|FG000|Overall Study|MRI not performed|0|||
145503604|NCT00684021|524701443|FG001|Overall Study|MRI not performed|1|||
145503605|NCT00684021|524701444|FG002|Overall Study|MRI not performed|1|||
145503606|NCT00684021|524701445|FG003|Overall Study|MRI not performed|2|||
145503607|NCT00684021|524701442|FG000|Overall Study|Death|1|||
145503608|NCT00684021|524701443|FG001|Overall Study|Death|0|||
145503609|NCT00684021|524701444|FG002|Overall Study|Death|0|||
145503610|NCT00684021|524701445|FG003|Overall Study|Death|0|||
145503611|NCT00891904|524701446|FG000|Overall Study|Death|1|||
145503612|NCT00891904|524701446|FG000|Overall Study|Adverse Event|1|||
145503613|NCT02976038|524701447|FG000|Overall Study|Physician Decision|22|||
145503614|NCT02976038|524701447|FG000|Overall Study|Withdrawal by Subject|3|||
145503615|NCT02976038|524701447|FG000|Overall Study|Lost to Follow-up|2|||
145503616|NCT02976038|524701447|FG000|Overall Study|Adverse Event|1|||
145503617|NCT01046396|524701448|FG000|Overall Study|Withdrawal by Subject|5|||
145503618|NCT00724698|524701449|FG000|Overall Study|Adverse Event|9|||
145503619|NCT00724698|524701449|FG000|Overall Study|Failure of Therapy|4|||
145503620|NCT00724698|524701449|FG000|Overall Study|Poor Compliance|16|||
145503621|NCT00724698|524701449|FG000|Overall Study|Lost to Follow-up|36|||
145503622|NCT00724698|524701449|FG000|Overall Study|No Info|25|||
145503623|NCT02177032|524701452|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
145503624|NCT02177032|524701453|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
145503625|NCT02177032|524701454|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
145503626|NCT02177032|524701455|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
145503627|NCT02177032|524701452|FG000|Overall Study|Lost to Follow-up|0|||
145503628|NCT02177032|524701453|FG001|Overall Study|Lost to Follow-up|2|||
145503629|NCT02177032|524701454|FG002|Overall Study|Lost to Follow-up|0|||
145503630|NCT02177032|524701455|FG003|Overall Study|Lost to Follow-up|0|||
145503631|NCT02177032|524701452|FG000|Overall Study|OTHER|2|||
145503632|NCT02177032|524701453|FG001|Overall Study|OTHER|0|||
145503633|NCT02177032|524701454|FG002|Overall Study|OTHER|1|||
145503634|NCT02177032|524701455|FG003|Overall Study|OTHER|0|||
145503635|NCT02177032|524701452|FG000|Overall Study|Withdrawal by Subject|1|||
145503636|NCT02177032|524701453|FG001|Overall Study|Withdrawal by Subject|0|||
145503637|NCT02177032|524701454|FG002|Overall Study|Withdrawal by Subject|1|||
145503638|NCT02177032|524701455|FG003|Overall Study|Withdrawal by Subject|0|||
145503639|NCT02161016|524701456|FG000|Overall Study|withdrawn by IRB|1|||
145503640|NCT02556177|524701459|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
145503641|NCT02556177|524701460|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
145503642|NCT00658359|524701461|FG000|Overall Study|Death|3|||
145503643|NCT00658359|524701462|FG001|Overall Study|Death|1|||
145503644|NCT00658359|524701463|FG002|Overall Study|Death|2|||
145503645|NCT00658359|524701461|FG000|Overall Study|Adverse Event|13|||
145503646|NCT00658359|524701462|FG001|Overall Study|Adverse Event|6|||
145503647|NCT00658359|524701463|FG002|Overall Study|Adverse Event|9|||
145503648|NCT00658359|524701461|FG000|Overall Study|Protocol Violation|1|||
145503649|NCT00658359|524701462|FG001|Overall Study|Protocol Violation|0|||
145503650|NCT00658359|524701463|FG002|Overall Study|Protocol Violation|0|||
145503651|NCT00658359|524701461|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
145503652|NCT00658359|524701462|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
145503653|NCT00658359|524701463|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
145503654|NCT00658359|524701461|FG000|Overall Study|Withdrawal by Subject|7|||
145503655|NCT00658359|524701462|FG001|Overall Study|Withdrawal by Subject|4|||
145503656|NCT00658359|524701463|FG002|Overall Study|Withdrawal by Subject|2|||
145503657|NCT00658359|524701461|FG000|Overall Study|Lost to Follow-up|2|||
145503658|NCT00658359|524701462|FG001|Overall Study|Lost to Follow-up|2|||
145503659|NCT00658359|524701463|FG002|Overall Study|Lost to Follow-up|4|||
145503660|NCT00658359|524701461|FG000|Overall Study|Lack of Efficacy|0|||
145503661|NCT00658359|524701462|FG001|Overall Study|Lack of Efficacy|1|||
145503662|NCT00658359|524701463|FG002|Overall Study|Lack of Efficacy|0|||
145503663|NCT00734539|524701467|FG000|Main Study|Death|33|||
145503664|NCT00734539|524701468|FG001|Main Study|Death|32|||
145503665|NCT00734539|524701467|FG000|Main Study|Physician Decision|2|||
145503666|NCT00734539|524701468|FG001|Main Study|Physician Decision|0|||
145503667|NCT00734539|524701467|FG000|Main Study|Withdrawal by Subject|1|||
145503668|NCT00734539|524701468|FG001|Main Study|Withdrawal by Subject|3|||
145503669|NCT00734539|524701467|FG000|Main Study|Enrolled in error; ineligible|1|||
145503670|NCT00734539|524701468|FG001|Main Study|Enrolled in error; ineligible|0|||
145503671|NCT02504151|524701471|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
145503672|NCT02504151|524701472|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
145503673|NCT02504151|524701471|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
145503674|NCT02504151|524701472|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
145503675|NCT02504151|524701471|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145503676|NCT02504151|524701472|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145503677|NCT02504151|524701471|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
145503678|NCT02504151|524701472|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
145399191|NCT03093181|524318272|FG002|Overall Study|Withdrawal by Subject|2|||
145399192|NCT03093181|524318270|FG000|Overall Study|Other (Not specified)|1|||
145399193|NCT03093181|524318271|FG001|Overall Study|Other (Not specified)|0|||
145399194|NCT03093181|524318272|FG002|Overall Study|Other (Not specified)|0|||
145399195|NCT03093181|524318270|FG000|Overall Study|Adverse Event|0|||
145399196|NCT03093181|524318271|FG001|Overall Study|Adverse Event|1|||
145399197|NCT03093181|524318272|FG002|Overall Study|Adverse Event|0|||
145399198|NCT03093181|524318270|FG000|Overall Study|Other (Protocol violation)|0|||
145399199|NCT03093181|524318271|FG001|Overall Study|Other (Protocol violation)|0|||
145399200|NCT03093181|524318272|FG002|Overall Study|Other (Protocol violation)|1|||
145399201|NCT04210986|524318275|FG000|Overall Study|Lost to Follow-up|5|||
145399202|NCT04210986|524318276|FG001|Overall Study|Lost to Follow-up|2|||
145399203|NCT04210986|524318275|FG000|Overall Study|Withdrawal by Subject|3|||
145399204|NCT04210986|524318276|FG001|Overall Study|Withdrawal by Subject|1|||
145503679|NCT00705016|524701473|FG000|Overall Study|Adverse Event|6|||
145503680|NCT00705016|524701474|FG001|Overall Study|Adverse Event|11|||
145503681|NCT00705016|524701475|FG002|Overall Study|Adverse Event|10|||
145503682|NCT00705016|524701473|FG000|Overall Study|Death|5|||
145503683|NCT00705016|524701474|FG001|Overall Study|Death|7|||
145503684|NCT00705016|524701475|FG002|Overall Study|Death|5|||
145503685|NCT00705016|524701473|FG000|Overall Study|Protocol Violation|0|||
145503686|NCT00705016|524701474|FG001|Overall Study|Protocol Violation|1|||
145503687|NCT00705016|524701475|FG002|Overall Study|Protocol Violation|1|||
145503688|NCT00705016|524701473|FG000|Overall Study|Withdrawal by Subject|4|||
145503689|NCT00705016|524701474|FG001|Overall Study|Withdrawal by Subject|3|||
145503690|NCT00705016|524701475|FG002|Overall Study|Withdrawal by Subject|2|||
145503691|NCT00705016|524701473|FG000|Overall Study|Progressive Disease|33|||
145503692|NCT00705016|524701474|FG001|Overall Study|Progressive Disease|29|||
145503693|NCT00705016|524701475|FG002|Overall Study|Progressive Disease|33|||
145503694|NCT00705016|524701473|FG000|Overall Study|Symptomatic Deterioration|3|||
145503695|NCT00705016|524701474|FG001|Overall Study|Symptomatic Deterioration|1|||
145503696|NCT00705016|524701475|FG002|Overall Study|Symptomatic Deterioration|1|||
145503697|NCT00705016|524701473|FG000|Overall Study|Other|9|||
145503698|NCT00705016|524701474|FG001|Overall Study|Other|6|||
145503699|NCT00705016|524701475|FG002|Overall Study|Other|6|||
145503700|NCT01188343|524701476|FG000|Overall Study|Not vaccinated|0|||
145503701|NCT01188343|524701477|FG001|Overall Study|Not vaccinated|2|||
145503702|NCT01188343|524701478|FG002|Overall Study|Not vaccinated|1|||
145503703|NCT01188343|524701476|FG000|Overall Study|Withdrawal by Subject|1|||
145399205|NCT04210986|524318275|FG000|Overall Study|Protocol Violation|1|||
145399206|NCT04210986|524318276|FG001|Overall Study|Protocol Violation|1|||
145399207|NCT04210986|524318275|FG000|Overall Study|Physician Decision|0|||
145399208|NCT04210986|524318276|FG001|Overall Study|Physician Decision|1|||
145399209|NCT02378662|524318277|FG000|Overall Study|Early Discontinuation|2|||
145399210|NCT02378662|524318278|FG001|Overall Study|Early Discontinuation|0|||
145399211|NCT01159574|524318279|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
145399212|NCT01159574|524318279|FG000|Treatment Phase|Adverse Event|3|||
145399213|NCT01159574|524318279|FG000|Treatment Phase|Death|6|||
145399214|NCT01159574|524318279|FG000|Treatment Phase|Physician Decision|2|||
145399215|NCT01159574|524318279|FG000|Treatment Phase|Withdrawal by Subject|7|||
145399216|NCT01159574|524318279|FG000|Treatment Phase|still on treatment|2|||
145399217|NCT01159574|524318279|FG000|Follow Up Phase|Lost to Follow-up|2|||
145399218|NCT01159574|524318279|FG000|Follow Up Phase|still being followed for overall surviva|18|||
145399219|NCT03555149|524318280|FG000|Overall Study|Death|18|||
145399220|NCT03555149|524318281|FG001|Overall Study|Death|15|||
145399221|NCT03555149|524318282|FG002|Overall Study|Death|15|||
145399222|NCT03555149|524318283|FG003|Overall Study|Death|4|||
145399223|NCT03555149|524318284|FG004|Overall Study|Death|4|||
145399224|NCT03555149|524318285|FG005|Overall Study|Death|11|||
145399225|NCT03555149|524318286|FG006|Overall Study|Death|12|||
145399226|NCT03555149|524318287|FG007|Overall Study|Death|1|||
145399227|NCT03555149|524318280|FG000|Overall Study|Lost to Follow-up|1|||
145503704|NCT01188343|524701477|FG001|Overall Study|Withdrawal by Subject|24|||
145503705|NCT01188343|524701478|FG002|Overall Study|Withdrawal by Subject|0|||
145503706|NCT02536963|524701481|FG000|Overall Study|Withdrawal by Subject|18|||
145503707|NCT00515619|524701486|FG000|Overall Study|Adverse Event|34|||
145503708|NCT00515619|524701486|FG000|Overall Study|Lack of Efficacy|92|||
145503709|NCT00515619|524701486|FG000|Overall Study|Withdrawal by Subject|66|||
145503710|NCT00515619|524701486|FG000|Overall Study|Protocol Violation|3|||
145503711|NCT00515619|524701486|FG000|Overall Study|Lost to Follow-up|4|||
145503712|NCT00515619|524701486|FG000|Overall Study|Unsatisfactory compliance|6|||
145503713|NCT00515619|524701486|FG000|Overall Study|Other: Site discontinuing trials|2|||
145503714|NCT00515619|524701486|FG000|Overall Study|Other: Subject cannot attend visits|2|||
145503715|NCT00515619|524701486|FG000|Overall Study|Other: Subject required surgery|1|||
145503716|NCT00515619|524701486|FG000|Overall Study|Other: Subject moved to another country|1|||
145503717|NCT00515619|524701486|FG000|Overall Study|Other: Investigator decision|1|||
145503718|NCT00515619|524701486|FG000|Overall Study|Other: Subject became pregnant|1|||
145503719|NCT00515619|524701486|FG000|Overall Study|Other: Request from sponsor|1|||
145503720|NCT00515619|524701486|FG000|Overall Study|Other: Drug available on license|1|||
145503721|NCT00515619|524701486|FG000|Overall Study|Other: Subject interested in other AED|1|||
145503722|NCT02379091|524701487|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145503723|NCT02379091|524701488|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
145503724|NCT02379091|524701489|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145503725|NCT02379091|524701490|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
145503726|NCT02379091|524701487|FG000|Overall Study|Principal Investigator Discretion|0|||
145399228|NCT03555149|524318281|FG001|Overall Study|Lost to Follow-up|0|||
145399229|NCT03555149|524318282|FG002|Overall Study|Lost to Follow-up|0|||
145399230|NCT03555149|524318283|FG003|Overall Study|Lost to Follow-up|0|||
145399231|NCT03555149|524318284|FG004|Overall Study|Lost to Follow-up|0|||
145399232|NCT03555149|524318285|FG005|Overall Study|Lost to Follow-up|1|||
145399233|NCT03555149|524318286|FG006|Overall Study|Lost to Follow-up|0|||
145399234|NCT03555149|524318287|FG007|Overall Study|Lost to Follow-up|0|||
145399235|NCT03555149|524318280|FG000|Overall Study|Physician Decision|1|||
145399236|NCT03555149|524318281|FG001|Overall Study|Physician Decision|0|||
145399237|NCT03555149|524318282|FG002|Overall Study|Physician Decision|0|||
145399238|NCT03555149|524318283|FG003|Overall Study|Physician Decision|0|||
145399239|NCT03555149|524318284|FG004|Overall Study|Physician Decision|0|||
145399240|NCT03555149|524318285|FG005|Overall Study|Physician Decision|0|||
145399241|NCT03555149|524318286|FG006|Overall Study|Physician Decision|0|||
145399242|NCT03555149|524318287|FG007|Overall Study|Physician Decision|0|||
145399243|NCT03555149|524318280|FG000|Overall Study|Study Terminated By Sponsor|1|||
145399244|NCT03555149|524318281|FG001|Overall Study|Study Terminated By Sponsor|0|||
145399245|NCT03555149|524318282|FG002|Overall Study|Study Terminated By Sponsor|0|||
145399246|NCT03555149|524318283|FG003|Overall Study|Study Terminated By Sponsor|0|||
145399247|NCT03555149|524318284|FG004|Overall Study|Study Terminated By Sponsor|0|||
145399248|NCT03555149|524318285|FG005|Overall Study|Study Terminated By Sponsor|2|||
145399249|NCT03555149|524318286|FG006|Overall Study|Study Terminated By Sponsor|3|||
145399250|NCT03555149|524318287|FG007|Overall Study|Study Terminated By Sponsor|1|||
145399251|NCT03555149|524318280|FG000|Overall Study|Withdrawal by Subject|3|||
145399252|NCT03555149|524318281|FG001|Overall Study|Withdrawal by Subject|0|||
145399253|NCT03555149|524318282|FG002|Overall Study|Withdrawal by Subject|0|||
145399254|NCT03555149|524318283|FG003|Overall Study|Withdrawal by Subject|2|||
145399255|NCT03555149|524318284|FG004|Overall Study|Withdrawal by Subject|0|||
145399256|NCT03555149|524318285|FG005|Overall Study|Withdrawal by Subject|1|||
145399257|NCT03555149|524318286|FG006|Overall Study|Withdrawal by Subject|0|||
145399258|NCT03555149|524318287|FG007|Overall Study|Withdrawal by Subject|0|||
145399259|NCT02666222|524318291|FG000|Overall Study|Death|2|||
145399260|NCT01474486|524318300|FG000|Overall Study|Death|2|||
145399261|NCT01474486|524318300|FG000|Overall Study|Withdrawal by Subject|4|||
145399262|NCT01474486|524318300|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
145399263|NCT03863353|524318301|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
145399264|NCT03863353|524318302|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
145399265|NCT04079790|524318303|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
145399266|NCT04079790|524318304|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145399267|NCT04079790|524318305|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145399268|NCT04079790|524318306|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
145399269|NCT04079790|524318303|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145399270|NCT04079790|524318304|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145399271|NCT04079790|524318305|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
145399272|NCT04079790|524318306|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
145399273|NCT04079790|524318303|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145399274|NCT04079790|524318304|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145399275|NCT04079790|524318305|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
145399276|NCT04079790|524318306|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
145399277|NCT05817669|524318307|FG000|Overall Study|Prohibited medication used|1|||
145399278|NCT05817669|524318308|FG001|Overall Study|Prohibited medication used|2|||
145399279|NCT05817669|524318307|FG000|Overall Study|Adverse Event|1|||
145399280|NCT05817669|524318308|FG001|Overall Study|Adverse Event|0|||
145399281|NCT05817669|524318307|FG000|Overall Study|Withdrawal by Subject|1|||
145399282|NCT05817669|524318308|FG001|Overall Study|Withdrawal by Subject|2|||
145399283|NCT03810183|524318310|FG000|Overall Study|Study terminated by Sponsor|2|||
145399284|NCT03810183|524318311|FG001|Overall Study|Study terminated by Sponsor|1|||
145399285|NCT00323063|524318313|FG000|Overall Study|Adverse Event|1|||
145503727|NCT02379091|524701488|FG001|Overall Study|Principal Investigator Discretion|1|||
145399286|NCT00323063|524318314|FG001|Overall Study|Adverse Event|0|||
145399287|NCT00323063|524318313|FG000|Overall Study|brain mets discovered prior to treatment|1|||
145399288|NCT00323063|524318314|FG001|Overall Study|brain mets discovered prior to treatment|0|||
145503728|NCT02379091|524701489|FG002|Overall Study|Principal Investigator Discretion|0|||
145503729|NCT02379091|524701490|FG003|Overall Study|Principal Investigator Discretion|0|||
145503730|NCT02379091|524701487|FG000|Overall Study|Lost to Follow-up|0|||
145503731|NCT02379091|524701488|FG001|Overall Study|Lost to Follow-up|0|||
145503732|NCT02379091|524701489|FG002|Overall Study|Lost to Follow-up|0|||
145503733|NCT02379091|524701490|FG003|Overall Study|Lost to Follow-up|1|||
145503734|NCT02379091|524701487|FG000|Overall Study|Voluntary Withdrawal|2|||
145503735|NCT02379091|524701488|FG001|Overall Study|Voluntary Withdrawal|5|||
145503736|NCT02379091|524701489|FG002|Overall Study|Voluntary Withdrawal|2|||
145503737|NCT02379091|524701490|FG003|Overall Study|Voluntary Withdrawal|4|||
145503738|NCT02379091|524701487|FG000|Overall Study|Study Termination|7|||
145503739|NCT02379091|524701488|FG001|Overall Study|Study Termination|2|||
145503740|NCT02379091|524701489|FG002|Overall Study|Study Termination|5|||
145503741|NCT02379091|524701490|FG003|Overall Study|Study Termination|8|||
145503742|NCT02379091|524701487|FG000|Overall Study|Lack of Efficacy|3|||
145503743|NCT02379091|524701488|FG001|Overall Study|Lack of Efficacy|0|||
145503744|NCT02379091|524701489|FG002|Overall Study|Lack of Efficacy|0|||
145503745|NCT02379091|524701490|FG003|Overall Study|Lack of Efficacy|0|||
145503746|NCT02129699|524701492|FG000|Overall Study|Did not start treatment|3|||
145503747|NCT02129699|524701493|FG001|Overall Study|Did not start treatment|2|||
145503748|NCT00670748|524701499|FG000|Overall Study|Death during treatment|1|||
145503749|NCT00670748|524701500|FG001|Overall Study|Death during treatment|1|||
145503750|NCT00670748|524701501|FG002|Overall Study|Death during treatment|1|||
145503751|NCT00670748|524701502|FG003|Overall Study|Death during treatment|0|||
145503752|NCT00670748|524701499|FG000|Overall Study|Not off study|2|||
145503753|NCT00670748|524701500|FG001|Overall Study|Not off study|1|||
145503754|NCT00670748|524701501|FG002|Overall Study|Not off study|1|||
145503755|NCT00670748|524701502|FG003|Overall Study|Not off study|1|||
145503756|NCT03863080|524701507|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
145503757|NCT03863080|524701508|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
145503758|NCT03863080|524701509|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
145503759|NCT03863080|524701510|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
145503760|NCT03863080|524701507|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
145503761|NCT03863080|524701508|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
145503762|NCT03863080|524701509|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
145503763|NCT03863080|524701510|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
145503764|NCT03863080|524701507|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
145503765|NCT03863080|524701508|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
145503766|NCT03863080|524701509|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
145503767|NCT03863080|524701510|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
145503768|NCT02991768|524701520|FG000|Overall Study|Physician Decision|4|||
145503769|NCT03467750|524701521|FG000|Overall Study|Surgery canceled|1|||
145503770|NCT03467750|524701522|FG001|Overall Study|Surgery canceled|0|||
145503771|NCT03467750|524701521|FG000|Overall Study|Protocol Violation|1|||
145399289|NCT04275336|524318315|FG000|Overall Study|First venipuncture failed|4|||
145399290|NCT04275336|524318316|FG001|Overall Study|First venipuncture failed|6|||
145399291|NCT04275336|524318317|FG002|Overall Study|First venipuncture failed|5|||
145399292|NCT04275336|524318315|FG000|Overall Study|Unscheduled venipuncture|9|||
145399293|NCT04275336|524318316|FG001|Overall Study|Unscheduled venipuncture|13|||
145399294|NCT04275336|524318317|FG002|Overall Study|Unscheduled venipuncture|7|||
145399295|NCT04275336|524318315|FG000|Overall Study|Failed specimen of saliva|4|||
145399296|NCT04275336|524318316|FG001|Overall Study|Failed specimen of saliva|3|||
145399297|NCT04275336|524318317|FG002|Overall Study|Failed specimen of saliva|4|||
145399298|NCT03055936|524318318|FG000|Overall Study|Adverse Event|0|||
145399299|NCT03055936|524318319|FG001|Overall Study|Adverse Event|1|||
145399300|NCT03055936|524318320|FG002|Overall Study|Adverse Event|1|||
145399301|NCT03055936|524318321|FG003|Overall Study|Adverse Event|1|||
145399302|NCT03055936|524318318|FG000|Overall Study|Personal reason|2|||
145399303|NCT03055936|524318319|FG001|Overall Study|Personal reason|0|||
145399304|NCT03055936|524318320|FG002|Overall Study|Personal reason|1|||
145399305|NCT03055936|524318321|FG003|Overall Study|Personal reason|0|||
145399306|NCT03167242|524318325|FG000|Overall Study|Patient/Guardian Decision|0|||
145399307|NCT03167242|524318326|FG001|Overall Study|Patient/Guardian Decision|1|||
145399308|NCT03167242|524318327|FG002|Overall Study|Patient/Guardian Decision|2|||
145399309|NCT03167242|524318328|FG003|Overall Study|Patient/Guardian Decision|1|||
145399310|NCT03167242|524318329|FG004|Overall Study|Patient/Guardian Decision|1|||
145399311|NCT03167242|524318330|FG005|Overall Study|Patient/Guardian Decision|1|||
145399312|NCT03167242|524318331|FG006|Overall Study|Patient/Guardian Decision|0|||
145399313|NCT03167242|524318332|FG007|Overall Study|Patient/Guardian Decision|0|||
145399314|NCT03167242|524318333|FG008|Overall Study|Patient/Guardian Decision|0|||
145399315|NCT03167242|524318334|FG009|Overall Study|Patient/Guardian Decision|0|||
145399316|NCT03167242|524318335|FG010|Overall Study|Patient/Guardian Decision|1|||
145399317|NCT03167242|524318336|FG011|Overall Study|Patient/Guardian Decision|0|||
145399318|NCT03167242|524318325|FG000|Overall Study|Lost to Follow-up|0|||
145399319|NCT03167242|524318326|FG001|Overall Study|Lost to Follow-up|0|||
145399320|NCT03167242|524318327|FG002|Overall Study|Lost to Follow-up|1|||
145399321|NCT03167242|524318328|FG003|Overall Study|Lost to Follow-up|0|||
145399322|NCT03167242|524318329|FG004|Overall Study|Lost to Follow-up|0|||
145503772|NCT03467750|524701522|FG001|Overall Study|Protocol Violation|1|||
145399323|NCT03167242|524318330|FG005|Overall Study|Lost to Follow-up|1|||
145399324|NCT03167242|524318331|FG006|Overall Study|Lost to Follow-up|2|||
145503773|NCT03467750|524701521|FG000|Overall Study|Withdrawal by Subject|0|||
145503774|NCT03467750|524701522|FG001|Overall Study|Withdrawal by Subject|1|||
145503775|NCT05673876|524701523|FG000|Overall Study|Death|3|||
145399325|NCT03167242|524318332|FG007|Overall Study|Lost to Follow-up|1|||
145399326|NCT03167242|524318333|FG008|Overall Study|Lost to Follow-up|0|||
145503776|NCT05673876|524701524|FG001|Overall Study|Death|1|||
145503777|NCT05673876|524701523|FG000|Overall Study|Study Terminated by Sponsor|0|||
145503778|NCT05673876|524701524|FG001|Overall Study|Study Terminated by Sponsor|1|||
145503779|NCT05673876|524701523|FG000|Overall Study|Physician Decision|0|||
145503780|NCT05673876|524701524|FG001|Overall Study|Physician Decision|1|||
145503781|NCT03529422|524701525|FG000|Overall Study|Withdrawal by Subject|1|||
145503782|NCT03529422|524701525|FG000|Overall Study|Protocol Violation|1|||
145503783|NCT03529422|524701525|FG000|Overall Study|Disease progression|2|||
145503784|NCT02000115|524701528|FG000|Overall Study|Death|56|||
145503785|NCT02000115|524701529|FG001|Overall Study|Death|45|||
145503786|NCT02000115|524701530|FG002|Overall Study|Death|0|||
145503787|NCT02000115|524701531|FG003|Overall Study|Death|0|||
145503788|NCT02000115|524701528|FG000|Overall Study|Missed Visit|6|||
145503789|NCT02000115|524701529|FG001|Overall Study|Missed Visit|8|||
145503790|NCT02000115|524701530|FG002|Overall Study|Missed Visit|1|||
145503791|NCT02000115|524701531|FG003|Overall Study|Missed Visit|0|||
145503792|NCT02000115|524701528|FG000|Overall Study|Protocol Violation|2|||
145732845|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
145732846|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
145503793|NCT02000115|524701529|FG001|Overall Study|Protocol Violation|1|||
145503794|NCT02000115|524701530|FG002|Overall Study|Protocol Violation|0|||
145503795|NCT02000115|524701531|FG003|Overall Study|Protocol Violation|0|||
145503796|NCT02000115|524701528|FG000|Overall Study|Physician Decision|2|||
145503797|NCT02000115|524701529|FG001|Overall Study|Physician Decision|0|||
145503798|NCT02000115|524701530|FG002|Overall Study|Physician Decision|0|||
145503799|NCT02000115|524701531|FG003|Overall Study|Physician Decision|0|||
145503800|NCT02000115|524701528|FG000|Overall Study|Withdrawal by Subject|11|||
145503801|NCT02000115|524701529|FG001|Overall Study|Withdrawal by Subject|11|||
145503802|NCT02000115|524701530|FG002|Overall Study|Withdrawal by Subject|0|||
145503803|NCT02000115|524701531|FG003|Overall Study|Withdrawal by Subject|0|||
145503804|NCT02000115|524701528|FG000|Overall Study|Lost to Follow-up|0|||
145503805|NCT02000115|524701529|FG001|Overall Study|Lost to Follow-up|1|||
145503806|NCT02000115|524701530|FG002|Overall Study|Lost to Follow-up|0|||
145503807|NCT02000115|524701531|FG003|Overall Study|Lost to Follow-up|0|||
145503808|NCT02000115|524701528|FG000|Overall Study|Non-compliance|2|||
145503809|NCT02000115|524701529|FG001|Overall Study|Non-compliance|1|||
145503810|NCT02000115|524701530|FG002|Overall Study|Non-compliance|0|||
145503811|NCT02000115|524701531|FG003|Overall Study|Non-compliance|0|||
145503812|NCT02000115|524701528|FG000|Overall Study|Withdrawn on day of randomization|0|||
145503813|NCT02000115|524701529|FG001|Overall Study|Withdrawn on day of randomization|1|||
145503814|NCT02000115|524701530|FG002|Overall Study|Withdrawn on day of randomization|0|||
145503815|NCT02000115|524701531|FG003|Overall Study|Withdrawn on day of randomization|0|||
145503816|NCT02000115|524701528|FG000|Overall Study|Still on Study|0|||
145503817|NCT02000115|524701529|FG001|Overall Study|Still on Study|0|||
145503818|NCT02000115|524701530|FG002|Overall Study|Still on Study|0|||
145503819|NCT02000115|524701531|FG003|Overall Study|Still on Study|53|||
145503820|NCT04988477|524701534|FG000|Overall Study|Death|1|||
145503821|NCT04988477|524701535|FG001|Overall Study|Death|0|||
145503822|NCT04988477|524701536|FG002|Overall Study|Death|0|||
145503823|NCT04988477|524701534|FG000|Overall Study|Lost to Follow-up|5|||
145503824|NCT04988477|524701535|FG001|Overall Study|Lost to Follow-up|2|||
145503825|NCT04988477|524701536|FG002|Overall Study|Lost to Follow-up|0|||
145503826|NCT04988477|524701534|FG000|Overall Study|Withdrawal by Subject|2|||
145503827|NCT04988477|524701535|FG001|Overall Study|Withdrawal by Subject|0|||
145503828|NCT04988477|524701536|FG002|Overall Study|Withdrawal by Subject|0|||
145503829|NCT01987453|524702739|FG000|Overall Study|Death|0|||
145503830|NCT01987453|524702740|FG001|Overall Study|Death|0|||
145503831|NCT01987453|524702741|FG002|Overall Study|Death|1|||
145503832|NCT01987453|524702739|FG000|Overall Study|Lack of Efficacy|1|||
145503833|NCT01987453|524702740|FG001|Overall Study|Lack of Efficacy|12|||
145399327|NCT03167242|524318334|FG009|Overall Study|Lost to Follow-up|0|||
145399328|NCT03167242|524318335|FG010|Overall Study|Lost to Follow-up|1|||
145399329|NCT03167242|524318336|FG011|Overall Study|Lost to Follow-up|1|||
145399330|NCT03167242|524318325|FG000|Overall Study|Reason not provided|0|||
145399331|NCT03167242|524318326|FG001|Overall Study|Reason not provided|0|||
145399332|NCT03167242|524318327|FG002|Overall Study|Reason not provided|0|||
145399333|NCT03167242|524318328|FG003|Overall Study|Reason not provided|0|||
145399334|NCT03167242|524318329|FG004|Overall Study|Reason not provided|0|||
145399335|NCT03167242|524318330|FG005|Overall Study|Reason not provided|0|||
145399336|NCT03167242|524318331|FG006|Overall Study|Reason not provided|0|||
145399337|NCT03167242|524318332|FG007|Overall Study|Reason not provided|0|||
145399338|NCT03167242|524318333|FG008|Overall Study|Reason not provided|1|||
145399339|NCT03167242|524318334|FG009|Overall Study|Reason not provided|0|||
145399340|NCT03167242|524318335|FG010|Overall Study|Reason not provided|0|||
145399341|NCT03167242|524318336|FG011|Overall Study|Reason not provided|0|||
145399342|NCT01038687|524318342|FG000|Overall Study|Adverse Event|0|||
145399343|NCT01038687|524318343|FG001|Overall Study|Adverse Event|2|||
145399344|NCT01038687|524318344|FG002|Overall Study|Adverse Event|1|||
145399345|NCT05222880|524318345|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145399346|NCT05222880|524318345|FG000|Overall Study|Withdrew Consent during Study|1|||
145399347|NCT05222880|524318345|FG000|Overall Study|COVID-19 Related|1|||
145399348|NCT05401565|524318346|FG000|Overall Study|Lost to Follow-up|1|||
145399349|NCT05401565|524318347|FG001|Overall Study|Lost to Follow-up|0|||
145399350|NCT05401565|524318346|FG000|Overall Study|Adverse Event|2|||
145399351|NCT05401565|524318347|FG001|Overall Study|Adverse Event|0|||
145399352|NCT02984982|524318352|FG000|Overall Study|Adverse Event|2|||
145399353|NCT02984982|524318353|FG001|Overall Study|Adverse Event|5|||
145399354|NCT02984982|524318352|FG000|Overall Study|Poor Compliance to Protocol|4|||
145399355|NCT02984982|524318353|FG001|Overall Study|Poor Compliance to Protocol|4|||
145399356|NCT02984982|524318352|FG000|Overall Study|Withdrawal by Subject|2|||
145399357|NCT02984982|524318353|FG001|Overall Study|Withdrawal by Subject|0|||
145399358|NCT02984982|524318352|FG000|Overall Study|Randomized but not treated|0|||
145399359|NCT02984982|524318353|FG001|Overall Study|Randomized but not treated|1|||
145399360|NCT03327324|524318354|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399361|NCT03327324|524318355|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145399362|NCT03327324|524318356|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399363|NCT03327324|524318357|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145399364|NCT03327324|524318358|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399365|NCT03327324|524318359|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
145399366|NCT03327324|524318354|FG000|Baseline (Month 0-Month 3)|Refused|0|||
145399367|NCT03327324|524318355|FG001|Baseline (Month 0-Month 3)|Refused|0|||
145399368|NCT03327324|524318356|FG002|Baseline (Month 0-Month 3)|Refused|0|||
145399369|NCT03327324|524318357|FG003|Baseline (Month 0-Month 3)|Refused|0|||
145399370|NCT03327324|524318358|FG004|Baseline (Month 0-Month 3)|Refused|1|||
145399371|NCT03327324|524318359|FG005|Baseline (Month 0-Month 3)|Refused|0|||
145399372|NCT03327324|524318354|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145399373|NCT03327324|524318355|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
145399374|NCT03327324|524318356|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145399375|NCT03327324|524318357|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145399376|NCT03327324|524318358|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145399377|NCT03327324|524318359|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
145399378|NCT03327324|524318354|FG000|Baseline (Month 0-Month 3)|Death|0|||
145399379|NCT03327324|524318355|FG001|Baseline (Month 0-Month 3)|Death|0|||
145399380|NCT03327324|524318356|FG002|Baseline (Month 0-Month 3)|Death|0|||
145399381|NCT03327324|524318357|FG003|Baseline (Month 0-Month 3)|Death|0|||
145399382|NCT03327324|524318358|FG004|Baseline (Month 0-Month 3)|Death|1|||
145399383|NCT03327324|524318359|FG005|Baseline (Month 0-Month 3)|Death|0|||
145399384|NCT03327324|524318354|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399385|NCT03327324|524318355|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399386|NCT03327324|524318356|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399387|NCT03327324|524318357|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145407497|NCT01143324|524347018|FG000|Overall Study|Withdrawal by Subject|4|||
145399388|NCT03327324|524318358|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399389|NCT03327324|524318359|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
145399390|NCT03327324|524318354|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145732847|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
145732848|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
145732849|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
145732850|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
145732851|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
145732852|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
145732853|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
145732854|NCT00217737|525539300|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
145732855|NCT00217737|525539301|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
145732856|NCT00217737|525539302|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
145732857|NCT00217737|525539303|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
145732858|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
145732859|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
145732860|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
145732861|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
145732862|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
145732863|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
145732864|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
145732865|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
145732866|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Study suspension|0|||
145732867|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Study suspension|45|||
145399391|NCT03327324|524318355|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399392|NCT03327324|524318356|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145399393|NCT03327324|524318357|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399394|NCT03327324|524318358|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399395|NCT03327324|524318359|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399396|NCT03327324|524318354|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
145399397|NCT03327324|524318355|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145399398|NCT03327324|524318356|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145399399|NCT03327324|524318357|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
145399400|NCT03327324|524318358|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
145399401|NCT03327324|524318359|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
145399402|NCT03327324|524318354|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
145399403|NCT03327324|524318355|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145399404|NCT03327324|524318356|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145399405|NCT03327324|524318357|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145399406|NCT03327324|524318358|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145399407|NCT03327324|524318359|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
145399408|NCT03327324|524318354|FG000|Intervention (Month 3-Month 6)|Death|1|||
145399409|NCT03327324|524318355|FG001|Intervention (Month 3-Month 6)|Death|0|||
145399410|NCT03327324|524318356|FG002|Intervention (Month 3-Month 6)|Death|1|||
145503834|NCT01987453|524702741|FG002|Overall Study|Lack of Efficacy|0|||
145503835|NCT01590888|524702742|FG000|Overall Study|Adverse Event|3|||
145503836|NCT01590888|524702743|FG001|Overall Study|Adverse Event|0|||
145503837|NCT01590888|524702744|FG002|Overall Study|Adverse Event|1|||
145503838|NCT01590888|524702742|FG000|Overall Study|Lost to Follow-up|1|||
145503839|NCT01590888|524702743|FG001|Overall Study|Lost to Follow-up|0|||
145503840|NCT01590888|524702744|FG002|Overall Study|Lost to Follow-up|0|||
145503841|NCT04953728|524702745|FG000|Overall Study|Withdrawal by Subject|3|||
145503842|NCT04953728|524702745|FG000|Overall Study|Physician Decision|1|||
145503843|NCT02105662|524702746|FG000|Overall Study|Lost to Follow-up|5|||
145503844|NCT02105662|524702746|FG000|Overall Study|Withdrawal by Subject|1|||
145503845|NCT02331277|524702747|FG000|Overall Study|Withdrawal by Subject|1|||
145503846|NCT02331277|524702748|FG001|Overall Study|Withdrawal by Subject|0|||
145503847|NCT00990704|524702751|FG000|Overall Study|Adverse Event|1|||
145503848|NCT00990704|524702752|FG001|Overall Study|Adverse Event|1|||
145503849|NCT00990704|524702751|FG000|Overall Study|Physician Decision|0|||
145503850|NCT00990704|524702752|FG001|Overall Study|Physician Decision|1|||
145503851|NCT01399372|524702753|FG000|Overall Study|Protocol Violation|3|||
145503852|NCT01399372|524702754|FG001|Overall Study|Protocol Violation|1|||
145503853|NCT01376804|524702755|FG000|Treatment Period|Withdrawal by Subject|1|||
145503854|NCT01376804|524702755|FG000|Treatment Period|Adverse Event|6|||
145503855|NCT01376804|524702755|FG000|Treatment Period|Patient did not receive study drug|1|||
145503856|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
145503857|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
145503858|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Patient requirement|20|||
145503859|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Death|5|||
145399411|NCT03327324|524318357|FG003|Intervention (Month 3-Month 6)|Death|1|||
145399412|NCT03327324|524318358|FG004|Intervention (Month 3-Month 6)|Death|1|||
145399413|NCT03327324|524318359|FG005|Intervention (Month 3-Month 6)|Death|0|||
145399414|NCT03327324|524318354|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399415|NCT03327324|524318355|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399416|NCT03327324|524318356|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399417|NCT03327324|524318357|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399418|NCT03327324|524318358|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399419|NCT03327324|524318359|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
145399420|NCT03327324|524318354|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
145399421|NCT03327324|524318355|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399422|NCT03327324|524318356|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399423|NCT03327324|524318357|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399424|NCT03327324|524318358|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399425|NCT03327324|524318359|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
145399426|NCT03327324|524318354|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
145399427|NCT03327324|524318355|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
145399428|NCT03327324|524318356|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145399429|NCT03327324|524318357|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145399430|NCT03327324|524318358|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145399431|NCT03327324|524318359|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
145399432|NCT03327324|524318354|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145399433|NCT03327324|524318355|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145399434|NCT03327324|524318356|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
145399435|NCT03327324|524318357|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145399436|NCT03327324|524318358|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145399437|NCT03327324|524318359|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
145399438|NCT03327324|524318354|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399439|NCT03327324|524318355|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399440|NCT03327324|524318356|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399441|NCT03327324|524318357|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
145399442|NCT03327324|524318358|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
145399443|NCT03327324|524318359|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
145399444|NCT03327324|524318354|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
145399445|NCT03327324|524318355|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145399446|NCT03327324|524318356|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145399447|NCT03327324|524318357|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145503860|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Change of therapy|6|||
145503861|NCT01071798|524702756|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
145503862|NCT01071798|524702756|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
145503863|NCT01071798|524702756|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
145503864|NCT01071798|524702756|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
145503865|NCT01071798|524702756|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
145503866|NCT01705509|524702763|FG000|Inclusion CPET|Screen Failure|5|||
145503867|NCT01705509|524702763|FG000|Inclusion CPET|Withdrawal by Subject|2|||
145503868|NCT01705509|524702763|FG000|CPET w/ Ranexa|Screen Failure|2|||
145503869|NCT02736890|524702764|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
145503870|NCT02736890|524702765|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
145503871|NCT02736890|524702764|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
145503872|NCT02736890|524702765|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
145503873|NCT02904954|524702766|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
145503874|NCT02904954|524702767|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
145503875|NCT02904954|524702766|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
145503876|NCT02904954|524702767|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
145503877|NCT02904954|524702766|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
145503878|NCT02904954|524702767|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
145503879|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Recurrence|2|||
145503880|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Recurrence|0|||
145503881|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Adverse Event|2|||
145503882|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Adverse Event|6|||
145503883|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Participant wishes|12|||
145503884|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Participant wishes|7|||
145503885|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Physician Decision|2|||
145503886|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Physician Decision|1|||
145503887|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
145503888|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
145503889|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Death|0|||
145503890|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Death|1|||
145503891|NCT02904954|524702766|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
145503892|NCT02904954|524702767|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
145399448|NCT03327324|524318358|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145399449|NCT03327324|524318359|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
145399450|NCT03327324|524318354|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
145399451|NCT03327324|524318355|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145732868|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Study suspension|0|||
145732869|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Study suspension|0|||
145732870|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
145732871|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
145732872|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
145732873|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
145732874|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Death|2|||
145732875|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Death|3|||
145399452|NCT03327324|524318356|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145399453|NCT03327324|524318357|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145399454|NCT03327324|524318358|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145399455|NCT03327324|524318359|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
145399456|NCT03177148|524318370|FG000|Overall Study|Lost to Follow-up|50|||
145399457|NCT03177148|524318371|FG001|Overall Study|Lost to Follow-up|1|||
145399458|NCT03177148|524318370|FG000|Overall Study|Death|1|||
145399459|NCT03177148|524318371|FG001|Overall Study|Death|0|||
145399460|NCT02563899|524318372|FG000|Overall Study|Protocol Violation|1|||
145503893|NCT05097963|524702768|FG000|Overall Study|Protocol Violation|13|||
145503894|NCT05097963|524702768|FG000|Overall Study|Withdrawal by Subject|21|||
145503895|NCT03349034|524702771|FG000|Overall Study|catheters dislodged during transport|2|||
145732876|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Death|0|||
145732877|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Death|0|||
145732878|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
145732879|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
145732880|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
145732881|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
145732882|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
145732883|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
145732884|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
145732885|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
145732886|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
145732887|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
145732888|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
145732889|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
145732890|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
145732891|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
145732892|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
145399461|NCT02563899|524318373|FG001|Overall Study|Protocol Violation|0|||
145399462|NCT02563899|524318374|FG002|Overall Study|Protocol Violation|0|||
145399463|NCT02563899|524318375|FG003|Overall Study|Protocol Violation|0|||
145399464|NCT02563899|524318372|FG000|Overall Study|Withdrawal by Subject|0|||
145399465|NCT02563899|524318373|FG001|Overall Study|Withdrawal by Subject|0|||
145399466|NCT02563899|524318374|FG002|Overall Study|Withdrawal by Subject|1|||
145503896|NCT03349034|524702772|FG001|Overall Study|catheters dislodged during transport|0|||
145399467|NCT02563899|524318375|FG003|Overall Study|Withdrawal by Subject|0|||
145399468|NCT02033759|524318384|FG000|Overall Study|Withdrawal by Subject|2|||
145399469|NCT02033759|524318385|FG001|Overall Study|Withdrawal by Subject|1|||
145399470|NCT02033759|524318384|FG000|Overall Study|Protocol Violation|1|||
145399471|NCT02033759|524318385|FG001|Overall Study|Protocol Violation|1|||
145399472|NCT02997163|524321023|FG000|Overall Study|Adverse Event|1|||
145399473|NCT02997163|524321024|FG001|Overall Study|Adverse Event|0|||
145399474|NCT02997163|524321025|FG002|Overall Study|Adverse Event|0|||
145399475|NCT02997163|524321026|FG003|Overall Study|Adverse Event|1|||
145399476|NCT02337764|524321027|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
145503897|NCT03349034|524702771|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
145503898|NCT03349034|524702772|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
145503899|NCT03349034|524702771|FG000|Overall Study|soft tissue flap used|1|||
145503900|NCT03349034|524702772|FG001|Overall Study|soft tissue flap used|0|||
145503901|NCT03349034|524702771|FG000|Overall Study|Other|0|||
145503902|NCT03349034|524702772|FG001|Overall Study|Other|1|||
145503903|NCT01039376|524702773|FG000|Overall Study|Lost to Follow-up|5|||
145503904|NCT01039376|524702774|FG001|Overall Study|Lost to Follow-up|12|||
145503905|NCT01039376|524702773|FG000|Overall Study|Physician Decision|15|||
145503906|NCT01039376|524702774|FG001|Overall Study|Physician Decision|10|||
145503907|NCT01039376|524702773|FG000|Overall Study|Withdrawal by Subject|20|||
145503908|NCT01039376|524702774|FG001|Overall Study|Withdrawal by Subject|32|||
145503909|NCT01039376|524702773|FG000|Overall Study|Study terminated by Sponsor|90|||
145503910|NCT01039376|524702774|FG001|Overall Study|Study terminated by Sponsor|72|||
145503911|NCT00123422|524702775|FG000|Overall Study|Physician Decision|2|||
145503912|NCT00123422|524702776|FG001|Overall Study|Physician Decision|2|||
145503913|NCT00123422|524702777|FG002|Overall Study|Physician Decision|6|||
145503914|NCT00123422|524702775|FG000|Overall Study|Withdrawal by Subject|1|||
145503915|NCT00123422|524702776|FG001|Overall Study|Withdrawal by Subject|2|||
145503916|NCT00123422|524702777|FG002|Overall Study|Withdrawal by Subject|2|||
145503917|NCT00123422|524702775|FG000|Overall Study|Lost to Follow-up|1|||
145503918|NCT00123422|524702776|FG001|Overall Study|Lost to Follow-up|2|||
145503919|NCT00123422|524702777|FG002|Overall Study|Lost to Follow-up|2|||
145503920|NCT01554241|524702778|FG000|Overall Study|Death|3|||
145503921|NCT01554241|524702779|FG001|Overall Study|Death|1|||
145503922|NCT01554241|524702780|FG002|Overall Study|Death|1|||
145503923|NCT01554241|524702781|FG003|Overall Study|Death|0|||
145503924|NCT01554241|524702778|FG000|Overall Study|protocol specified renal stone|0|||
145503925|NCT01554241|524702779|FG001|Overall Study|protocol specified renal stone|0|||
145503926|NCT01554241|524702780|FG002|Overall Study|protocol specified renal stone|0|||
145503927|NCT01554241|524702781|FG003|Overall Study|protocol specified renal stone|1|||
145503928|NCT01554241|524702778|FG000|Overall Study|protocol specified change in eGFR|0|||
145503929|NCT01554241|524702779|FG001|Overall Study|protocol specified change in eGFR|0|||
145503930|NCT01554241|524702780|FG002|Overall Study|protocol specified change in eGFR|1|||
145503931|NCT01554241|524702781|FG003|Overall Study|protocol specified change in eGFR|0|||
145503932|NCT01554241|524702778|FG000|Overall Study|Withdrawal by Subject|0|||
145503933|NCT01554241|524702779|FG001|Overall Study|Withdrawal by Subject|0|||
145503934|NCT01554241|524702780|FG002|Overall Study|Withdrawal by Subject|2|||
145503935|NCT01554241|524702781|FG003|Overall Study|Withdrawal by Subject|0|||
145503936|NCT02118961|524702782|FG000|Overall Study|Withdrawal by Subject|1|||
145503937|NCT02118961|524702783|FG001|Overall Study|Withdrawal by Subject|0|||
145503938|NCT03809104|524702786|FG000|Overall Study|Withdrawal by Subject|3|||
145503939|NCT01532986|524702787|FG000|Overall Study|Death|9|||
145503940|NCT01532986|524702788|FG001|Overall Study|Death|9|||
145503941|NCT01532986|524702787|FG000|Overall Study|Withdrawal by Subject|7|||
145503942|NCT01532986|524702788|FG001|Overall Study|Withdrawal by Subject|10|||
145503943|NCT01532986|524702787|FG000|Overall Study|Physician Decision|7|||
145503944|NCT01532986|524702788|FG001|Overall Study|Physician Decision|5|||
145503945|NCT02120898|524702789|FG000|Overall Study|Withdrawal by Subject|4|||
145503946|NCT02120898|524702790|FG001|Overall Study|Withdrawal by Subject|2|||
145503947|NCT02120898|524702791|FG002|Overall Study|Withdrawal by Subject|2|||
145503948|NCT02120898|524702789|FG000|Overall Study|Non-compliance with study drug|3|||
145503949|NCT02120898|524702790|FG001|Overall Study|Non-compliance with study drug|0|||
145503950|NCT02120898|524702791|FG002|Overall Study|Non-compliance with study drug|0|||
145503951|NCT02120898|524702789|FG000|Overall Study|Adverse Event|1|||
145503952|NCT02120898|524702790|FG001|Overall Study|Adverse Event|2|||
145503953|NCT02120898|524702791|FG002|Overall Study|Adverse Event|1|||
145503954|NCT02120898|524702789|FG000|Overall Study|Protocol Violation|1|||
145503955|NCT02120898|524702790|FG001|Overall Study|Protocol Violation|2|||
145503956|NCT02120898|524702791|FG002|Overall Study|Protocol Violation|0|||
145503957|NCT02120898|524702789|FG000|Overall Study|Lost to Follow-up|0|||
145503958|NCT02120898|524702790|FG001|Overall Study|Lost to Follow-up|0|||
145503959|NCT02120898|524702791|FG002|Overall Study|Lost to Follow-up|1|||
145503960|NCT04313244|524702792|FG000|Overall Study|Withdrawal of Consent|3|||
145503961|NCT04313244|524702793|FG001|Overall Study|Withdrawal of Consent|3|||
145399477|NCT02337764|524321027|FG000|Overall Study|Voluntary Withdrawal|12|||
145399478|NCT02337764|524321027|FG000|Overall Study|Lack of Efficacy|2|||
145399479|NCT00183430|524321038|FG000|Overall Study|Adverse Event|1|||
145399480|NCT00183430|524321039|FG001|Overall Study|Adverse Event|0|||
145399481|NCT00183430|524321038|FG000|Overall Study|Lost to Follow-up|3|||
145399482|NCT00183430|524321039|FG001|Overall Study|Lost to Follow-up|0|||
145399483|NCT00183430|524321038|FG000|Overall Study|did not meet inclusion criteria|1|||
145399484|NCT00183430|524321039|FG001|Overall Study|did not meet inclusion criteria|0|||
145399485|NCT00183430|524321038|FG000|Overall Study|Withdrawal by Subject|1|||
145399486|NCT00183430|524321039|FG001|Overall Study|Withdrawal by Subject|0|||
145399487|NCT00883181|524321046|FG000|Overall Study|Hematological Adverse Event|26|||
145399488|NCT00883181|524321046|FG000|Overall Study|Non-hematological Adverse Event|55|||
145399489|NCT00883181|524321046|FG000|Overall Study|Disease Progression|94|||
145399490|NCT00883181|524321046|FG000|Overall Study|Administrative Reason|24|||
145399491|NCT00883181|524321046|FG000|Overall Study|Withdrawal by Subject|4|||
145399492|NCT00883181|524321046|FG000|Overall Study|Death|31|||
145399493|NCT00883181|524321046|FG000|Overall Study|Other|38|||
145399494|NCT00883181|524321046|FG000|Overall Study|Protocol Deviation|3|||
145399495|NCT00883181|524321046|FG000|Overall Study|Noncompliance|3|||
145399496|NCT01218308|524321047|FG000|Overall Study|Adverse Event|1|||
145399497|NCT01218308|524321048|FG001|Overall Study|Adverse Event|2|||
145399498|NCT01218308|524321047|FG000|Overall Study|Protocol Violation|0|||
145399499|NCT01218308|524321048|FG001|Overall Study|Protocol Violation|2|||
145399500|NCT01218308|524321047|FG000|Overall Study|Withdrawal by Subject|61|||
145399501|NCT01218308|524321048|FG001|Overall Study|Withdrawal by Subject|64|||
145399502|NCT01218308|524321047|FG000|Overall Study|Lost to Follow-up|27|||
145399503|NCT01218308|524321048|FG001|Overall Study|Lost to Follow-up|31|||
145399504|NCT01218308|524321047|FG000|Overall Study|Other|14|||
145399505|NCT01218308|524321048|FG001|Overall Study|Other|21|||
145399506|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
145399507|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145399508|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145399509|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145399510|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
145399511|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
145399512|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145399513|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145399514|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145399515|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
145399516|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
145399517|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145399518|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145399519|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145399520|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
145399521|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
145399522|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145399523|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145399524|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145399525|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
145399526|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
145399527|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145399528|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145399529|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145399530|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
145399531|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
145399532|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145399533|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145399534|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145399535|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
145399536|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
145399537|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145399538|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145399539|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145399540|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
145399541|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
145399542|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145399543|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145399544|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145399545|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
145503962|NCT04313244|524702792|FG000|Overall Study|Met Exclusion Criteria|1|||
145503963|NCT04313244|524702793|FG001|Overall Study|Met Exclusion Criteria|0|||
145503964|NCT04313244|524702792|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
145503965|NCT04313244|524702793|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
145399546|NCT02709746|524321049|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
145399547|NCT02709746|524321050|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145399548|NCT02709746|524321051|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145399549|NCT02709746|524321052|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145399550|NCT02709746|524321053|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
145399551|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145399552|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
145399553|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145399554|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
145399555|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
145399556|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
145399557|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
145399558|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
145399559|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
145399560|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
145399561|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
145399562|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
145399563|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
145399564|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
145399565|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
145399566|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
145399567|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
145399568|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
145399569|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
145399570|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
145399571|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
145399572|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
145399573|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
145399574|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
145399575|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
145399576|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
145399577|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145399578|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145399579|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
145399580|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
145399581|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145399582|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145399583|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
145399584|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145399585|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
145399586|NCT02709746|524321049|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
145399587|NCT02709746|524321050|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
145399588|NCT02709746|524321051|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
145399589|NCT02709746|524321052|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
145399590|NCT02709746|524321053|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
145399591|NCT00752089|524321054|FG000|Overall Study|Adverse Event|1|||
145399592|NCT00752089|524321054|FG000|Overall Study|Protocol Deviation|2|||
145399593|NCT00752089|524321054|FG000|Overall Study|Could not attend visit 9|1|||
145399594|NCT00752089|524321054|FG000|Overall Study|Not capable of wearing partial denture|1|||
145399595|NCT00752089|524321054|FG000|Overall Study|Cannot continue the study|1|||
145399596|NCT03154086|524321063|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399597|NCT03154086|524321064|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399598|NCT03154086|524321065|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399599|NCT03154086|524321066|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
145399600|NCT03154086|524321067|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399601|NCT03154086|524321068|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399602|NCT03154086|524321069|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399603|NCT03154086|524321070|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145503966|NCT00927953|524702794|FG000|Overall Study|Death|2|||
145503967|NCT00927953|524702795|FG001|Overall Study|Death|1|||
145503968|NCT05021978|524702796|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
145503969|NCT05021978|524702797|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
145503970|NCT05021978|524702798|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
145503971|NCT05021978|524702799|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
145503972|NCT05021978|524702796|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
145503973|NCT05021978|524702797|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
145503974|NCT05021978|524702798|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
145503975|NCT05021978|524702799|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
145503976|NCT00043979|524702800|FG000|Period 1|recipient with progressive disease|7|||
145503977|NCT00043979|524702801|FG001|Period 1|recipient with progressive disease|4|||
145503978|NCT00043979|524702802|FG002|Period 1|recipient with progressive disease|3|||
145503979|NCT04614974|524702807|FG000|Overall Study|Lost to Follow-up|14|||
145503980|NCT04614974|524702808|FG001|Overall Study|Lost to Follow-up|11|||
145503981|NCT02754440|524702810|FG000|Overall Study|Protocol Violation|3|||
145503982|NCT02754440|524702811|FG001|Overall Study|Protocol Violation|2|||
145503983|NCT02754440|524702812|FG002|Overall Study|Protocol Violation|2|||
145503984|NCT02754440|524702813|FG003|Overall Study|Protocol Violation|6|||
145503985|NCT02754440|524702810|FG000|Overall Study|Adverse Event|3|||
145503986|NCT02754440|524702811|FG001|Overall Study|Adverse Event|1|||
145503987|NCT02754440|524702812|FG002|Overall Study|Adverse Event|0|||
145503988|NCT02754440|524702813|FG003|Overall Study|Adverse Event|9|||
145503989|NCT02754440|524702810|FG000|Overall Study|Withdrawal by Subject|0|||
145503990|NCT02754440|524702811|FG001|Overall Study|Withdrawal by Subject|0|||
145503991|NCT02754440|524702812|FG002|Overall Study|Withdrawal by Subject|0|||
145503992|NCT02754440|524702813|FG003|Overall Study|Withdrawal by Subject|1|||
145503993|NCT02754440|524702810|FG000|Overall Study|Equipment failure|0|||
145503994|NCT02754440|524702811|FG001|Overall Study|Equipment failure|5|||
145503995|NCT02754440|524702812|FG002|Overall Study|Equipment failure|5|||
145503996|NCT02754440|524702813|FG003|Overall Study|Equipment failure|7|||
145503997|NCT02754440|524702810|FG000|Overall Study|Subject issues not resulting in AE|0|||
145503998|NCT02754440|524702811|FG001|Overall Study|Subject issues not resulting in AE|0|||
145503999|NCT02754440|524702812|FG002|Overall Study|Subject issues not resulting in AE|0|||
145504000|NCT02754440|524702813|FG003|Overall Study|Subject issues not resulting in AE|12|||
145504001|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Adverse Event|9|||
145504002|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Adverse Event|3|||
145504003|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Death|7|||
145504004|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Death|7|||
145504005|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
145504006|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
145504007|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Physician Decision|1|||
145504008|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Physician Decision|0|||
145504009|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
145504010|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
145504011|NCT02558296|524702814|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
145504012|NCT02558296|524702815|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
145504013|NCT02558296|524702814|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
145504014|NCT02558296|524702815|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
145504015|NCT02558296|524702814|FG000|Completed the Study|Adverse Event|14|||
145504016|NCT02558296|524702815|FG001|Completed the Study|Adverse Event|5|||
145504017|NCT02558296|524702814|FG000|Completed the Study|Death|39|||
145504018|NCT02558296|524702815|FG001|Completed the Study|Death|25|||
145504019|NCT02558296|524702814|FG000|Completed the Study|Lost to Follow-up|31|||
145504020|NCT02558296|524702815|FG001|Completed the Study|Lost to Follow-up|23|||
145504021|NCT02558296|524702814|FG000|Completed the Study|Physician Decision|6|||
145504022|NCT02558296|524702815|FG001|Completed the Study|Physician Decision|0|||
145504023|NCT02558296|524702814|FG000|Completed the Study|Protocol Violation|2|||
145504024|NCT02558296|524702815|FG001|Completed the Study|Protocol Violation|1|||
145504025|NCT02558296|524702814|FG000|Completed the Study|Withdrawal by Subject|53|||
145504026|NCT02558296|524702815|FG001|Completed the Study|Withdrawal by Subject|31|||
145504027|NCT02558296|524702814|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
145399604|NCT03154086|524321071|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399605|NCT03154086|524321072|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399606|NCT03154086|524321073|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399607|NCT03154086|524321074|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399608|NCT03154086|524321075|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399609|NCT03154086|524321076|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145504028|NCT02558296|524702815|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
145399610|NCT03154086|524321077|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
145399611|NCT03154086|524321063|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145266695|NCT04668066|523825248|FG011|Part 1: Follow-Up|Other|1|||
145399612|NCT03154086|524321064|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
145399613|NCT03154086|524321065|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399614|NCT03154086|524321066|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399615|NCT03154086|524321067|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399616|NCT03154086|524321068|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399617|NCT03154086|524321069|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399618|NCT03154086|524321070|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399619|NCT03154086|524321071|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399620|NCT03154086|524321072|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399621|NCT03154086|524321073|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399622|NCT03154086|524321074|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399623|NCT03154086|524321075|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399624|NCT03154086|524321076|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399625|NCT03154086|524321077|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
145399626|NCT03154086|524321063|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399627|NCT03154086|524321064|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399628|NCT03154086|524321065|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
145399629|NCT03154086|524321066|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399630|NCT03154086|524321067|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399631|NCT03154086|524321068|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399632|NCT03154086|524321069|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399633|NCT03154086|524321070|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399634|NCT03154086|524321071|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399635|NCT03154086|524321072|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399636|NCT03154086|524321073|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399637|NCT03154086|524321074|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399638|NCT03154086|524321075|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399639|NCT03154086|524321076|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399640|NCT03154086|524321077|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
145399641|NCT03154086|524321063|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
145399642|NCT03154086|524321064|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399643|NCT03154086|524321065|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399644|NCT03154086|524321066|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399645|NCT03154086|524321067|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399646|NCT03154086|524321068|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399647|NCT03154086|524321069|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399648|NCT03154086|524321070|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399649|NCT03154086|524321071|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399650|NCT03154086|524321072|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399651|NCT03154086|524321073|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399652|NCT03154086|524321074|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399653|NCT03154086|524321075|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399654|NCT03154086|524321076|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399655|NCT03154086|524321077|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
145399656|NCT03154086|524321063|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399657|NCT03154086|524321064|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399658|NCT03154086|524321065|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399659|NCT03154086|524321066|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399660|NCT03154086|524321067|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399661|NCT03154086|524321068|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399662|NCT03154086|524321069|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399663|NCT03154086|524321070|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399664|NCT03154086|524321071|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
145399665|NCT03154086|524321072|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399666|NCT03154086|524321073|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399667|NCT03154086|524321074|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399668|NCT03154086|524321075|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399669|NCT03154086|524321076|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399670|NCT03154086|524321077|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
145399671|NCT03154086|524321063|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399672|NCT03154086|524321064|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399673|NCT03154086|524321065|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399674|NCT03154086|524321066|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145504029|NCT02919995|524702819|FG000|Overall Study|Adverse Event|0|||
145504030|NCT02919995|524702820|FG001|Overall Study|Adverse Event|0|||
145399675|NCT03154086|524321067|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145504031|NCT02919995|524702821|FG002|Overall Study|Adverse Event|0|||
145504032|NCT02919995|524702822|FG003|Overall Study|Adverse Event|0|||
145504033|NCT02919995|524702823|FG004|Overall Study|Adverse Event|0|||
145504034|NCT02919995|524702824|FG005|Overall Study|Adverse Event|1|||
145504035|NCT01821118|524702825|FG000|Overall Study|Death|0|||
145504036|NCT01821118|524702826|FG001|Overall Study|Death|1|||
145504037|NCT02557139|524702827|FG000|Overall Study|Significant liver elevation|1|||
145504038|NCT02557139|524702828|FG001|Overall Study|Significant liver elevation|0|||
145504039|NCT02557139|524702829|FG002|Overall Study|Significant liver elevation|1|||
145504040|NCT02557139|524702827|FG000|Overall Study|Withdrawal by Subject|1|||
145504041|NCT02557139|524702828|FG001|Overall Study|Withdrawal by Subject|0|||
145504042|NCT02557139|524702829|FG002|Overall Study|Withdrawal by Subject|0|||
145504043|NCT02557139|524702827|FG000|Overall Study|Illness of prohibited medication|0|||
145504044|NCT02557139|524702828|FG001|Overall Study|Illness of prohibited medication|0|||
145504045|NCT02557139|524702829|FG002|Overall Study|Illness of prohibited medication|1|||
145504046|NCT01146795|524702831|FG000|Overall Study|Withdrawal by Subject|4|||
145504047|NCT01146795|524702831|FG000|Overall Study|Adverse Event|6|||
145504048|NCT01146795|524702831|FG000|Overall Study|Still in treatment at study closure|10|||
145504049|NCT05375760|524702832|FG000|Overall Study|Adverse Event|1|||
145504050|NCT05375760|524702833|FG001|Overall Study|Adverse Event|0|||
145504051|NCT05375760|524702832|FG000|Overall Study|Death|0|||
145504052|NCT05375760|524702833|FG001|Overall Study|Death|1|||
145504053|NCT05375760|524702832|FG000|Overall Study|Lost to Follow-up|6|||
145504054|NCT05375760|524702833|FG001|Overall Study|Lost to Follow-up|6|||
145504055|NCT05375760|524702832|FG000|Overall Study|Withdrawal by Subject|17|||
145504056|NCT05375760|524702833|FG001|Overall Study|Withdrawal by Subject|19|||
145504057|NCT05375760|524702832|FG000|Overall Study|Dosing halted by FDA|96|||
145504058|NCT05375760|524702833|FG001|Overall Study|Dosing halted by FDA|100|||
145504059|NCT05375760|524702832|FG000|Overall Study|Not compliant with study visit|2|||
145504060|NCT05375760|524702833|FG001|Overall Study|Not compliant with study visit|0|||
145504061|NCT05375760|524702832|FG000|Overall Study|Physician Decision|1|||
145504062|NCT05375760|524702833|FG001|Overall Study|Physician Decision|0|||
145504063|NCT05375760|524702832|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
145504064|NCT05375760|524702833|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
145504065|NCT05375760|524702832|FG000|Overall Study|Participant moved|1|||
145504066|NCT05375760|524702833|FG001|Overall Study|Participant moved|0|||
145504067|NCT00363480|524702834|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
145504068|NCT00363480|524702834|FG000|Overall Study|Adverse Event|4|||
145504069|NCT00363480|524702834|FG000|Overall Study|Lost to Follow-up|5|||
145504070|NCT00363480|524702834|FG000|Overall Study|Withdrawal by Subject|5|||
145504071|NCT00363480|524702834|FG000|Overall Study|Non-compliance of subject|1|||
145504072|NCT00363480|524702834|FG000|Overall Study|Participant discontinued on its own|1|||
145504073|NCT03853109|524702835|FG000|Overall Study|Withdrawal by Subject|0|||
145504074|NCT03853109|524702836|FG001|Overall Study|Withdrawal by Subject|0|||
145504075|NCT03853109|524702837|FG002|Overall Study|Withdrawal by Subject|1|||
145504076|NCT03853109|524702838|FG003|Overall Study|Withdrawal by Subject|2|||
145504077|NCT03853109|524702839|FG004|Overall Study|Withdrawal by Subject|1|||
145504078|NCT03853109|524702840|FG005|Overall Study|Withdrawal by Subject|4|||
145504079|NCT03853109|524702841|FG006|Overall Study|Withdrawal by Subject|5|||
145504080|NCT03853109|524702842|FG007|Overall Study|Withdrawal by Subject|3|||
145504081|NCT03853109|524702835|FG000|Overall Study|Decision by Sponsor|0|||
145504082|NCT03853109|524702836|FG001|Overall Study|Decision by Sponsor|0|||
145504083|NCT03853109|524702837|FG002|Overall Study|Decision by Sponsor|1|||
145504084|NCT03853109|524702838|FG003|Overall Study|Decision by Sponsor|0|||
145504085|NCT03853109|524702839|FG004|Overall Study|Decision by Sponsor|1|||
145504086|NCT03853109|524702840|FG005|Overall Study|Decision by Sponsor|1|||
145504087|NCT03853109|524702841|FG006|Overall Study|Decision by Sponsor|10|||
145504088|NCT03853109|524702842|FG007|Overall Study|Decision by Sponsor|2|||
145504089|NCT03853109|524702835|FG000|Overall Study|Lost to Follow-up|0|||
145504090|NCT03853109|524702836|FG001|Overall Study|Lost to Follow-up|0|||
145504091|NCT03853109|524702837|FG002|Overall Study|Lost to Follow-up|0|||
145504092|NCT03853109|524702838|FG003|Overall Study|Lost to Follow-up|0|||
145504093|NCT03853109|524702839|FG004|Overall Study|Lost to Follow-up|1|||
145504094|NCT03853109|524702840|FG005|Overall Study|Lost to Follow-up|3|||
145504095|NCT03853109|524702841|FG006|Overall Study|Lost to Follow-up|0|||
145504096|NCT03853109|524702842|FG007|Overall Study|Lost to Follow-up|0|||
145504097|NCT03853109|524702835|FG000|Overall Study|Death|2|||
145732893|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
145504098|NCT03853109|524702836|FG001|Overall Study|Death|5|||
145504099|NCT03853109|524702837|FG002|Overall Study|Death|8|||
145504100|NCT03853109|524702838|FG003|Overall Study|Death|10|||
145504101|NCT03853109|524702839|FG004|Overall Study|Death|3|||
145504102|NCT03853109|524702840|FG005|Overall Study|Death|20|||
145504103|NCT03853109|524702841|FG006|Overall Study|Death|10|||
145504104|NCT03853109|524702842|FG007|Overall Study|Death|5|||
145504105|NCT04634253|524702843|FG000|Overall Study|Adverse Event|1|||
145504106|NCT04634253|524702844|FG001|Overall Study|Adverse Event|1|||
145504107|NCT04634253|524702845|FG002|Overall Study|Adverse Event|0|||
145504108|NCT04634253|524702843|FG000|Overall Study|Physician Decision|0|||
145504109|NCT04634253|524702844|FG001|Overall Study|Physician Decision|1|||
145504110|NCT04634253|524702845|FG002|Overall Study|Physician Decision|0|||
145504111|NCT04634253|524702843|FG000|Overall Study|Withdrawal by Subject|1|||
145504112|NCT04634253|524702844|FG001|Overall Study|Withdrawal by Subject|0|||
145732894|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
145732895|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
145732896|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
145732897|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
145732898|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
145732899|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
145732900|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
145732901|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
145732902|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
145732903|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
145732904|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
145732905|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
145732906|NCT00217737|525539300|FG000|Step 2 Randomization/Registration|Other|1|||
145732907|NCT00217737|525539301|FG001|Step 2 Randomization/Registration|Other|2|||
145732908|NCT00217737|525539302|FG002|Step 2 Randomization/Registration|Other|0|||
145732909|NCT00217737|525539303|FG003|Step 2 Randomization/Registration|Other|0|||
145504113|NCT04634253|524702845|FG002|Overall Study|Withdrawal by Subject|3|||
145504114|NCT01499355|524702846|FG000|Run-In Period|Study Termination|15|||
145504115|NCT01499355|524702847|FG001|Run-In Period|Study Termination|0|||
145504116|NCT01499355|524702848|FG002|Run-In Period|Study Termination|0|||
145504117|NCT01499355|524702849|FG003|Run-In Period|Study Termination|0|||
145504118|NCT01499355|524702846|FG000|Run-In Period|Other|3|||
145504119|NCT01499355|524702847|FG001|Run-In Period|Other|0|||
145504120|NCT01499355|524702848|FG002|Run-In Period|Other|0|||
145504121|NCT01499355|524702849|FG003|Run-In Period|Other|0|||
145504122|NCT01499355|524702846|FG000|Run-In Period|Death|2|||
145504123|NCT01499355|524702847|FG001|Run-In Period|Death|0|||
145504124|NCT01499355|524702848|FG002|Run-In Period|Death|0|||
145504125|NCT01499355|524702849|FG003|Run-In Period|Death|0|||
145504126|NCT01499355|524702846|FG000|Run-In Period|Investigator Decision|2|||
145504127|NCT01499355|524702847|FG001|Run-In Period|Investigator Decision|0|||
145504128|NCT01499355|524702848|FG002|Run-In Period|Investigator Decision|0|||
145504129|NCT01499355|524702849|FG003|Run-In Period|Investigator Decision|0|||
145504130|NCT01499355|524702846|FG000|Run-In Period|Consent Withdrawn|1|||
145504131|NCT01499355|524702847|FG001|Run-In Period|Consent Withdrawn|0|||
145504132|NCT01499355|524702848|FG002|Run-In Period|Consent Withdrawn|0|||
145504133|NCT01499355|524702849|FG003|Run-In Period|Consent Withdrawn|0|||
145504134|NCT01499355|524702846|FG000|Run-In Period|Adverse Event|8|||
145504135|NCT01499355|524702847|FG001|Run-In Period|Adverse Event|0|||
145504136|NCT01499355|524702848|FG002|Run-In Period|Adverse Event|0|||
145504137|NCT01499355|524702849|FG003|Run-In Period|Adverse Event|0|||
145504138|NCT01499355|524702846|FG000|Double-Blind Period|Adverse Event|0|||
145504139|NCT01499355|524702847|FG001|Double-Blind Period|Adverse Event|2|||
145504140|NCT01499355|524702848|FG002|Double-Blind Period|Adverse Event|3|||
145504141|NCT01499355|524702849|FG003|Double-Blind Period|Adverse Event|2|||
145504142|NCT01499355|524702846|FG000|Double-Blind Period|Study Termination|0|||
145504143|NCT01499355|524702847|FG001|Double-Blind Period|Study Termination|18|||
145504144|NCT01499355|524702848|FG002|Double-Blind Period|Study Termination|16|||
145504145|NCT01499355|524702849|FG003|Double-Blind Period|Study Termination|14|||
145504146|NCT01499355|524702846|FG000|Double-Blind Period|Other|0|||
145504147|NCT01499355|524702847|FG001|Double-Blind Period|Other|1|||
145504148|NCT01499355|524702848|FG002|Double-Blind Period|Other|2|||
145504149|NCT01499355|524702849|FG003|Double-Blind Period|Other|2|||
145504150|NCT01499355|524702846|FG000|Double-Blind Period|Death|0|||
145504151|NCT01499355|524702847|FG001|Double-Blind Period|Death|1|||
145504152|NCT01499355|524702848|FG002|Double-Blind Period|Death|0|||
145504153|NCT01499355|524702849|FG003|Double-Blind Period|Death|0|||
145504154|NCT01499355|524702846|FG000|Double-Blind Period|Investigator Decision|0|||
145504155|NCT01499355|524702847|FG001|Double-Blind Period|Investigator Decision|0|||
145732910|NCT04890054|525540845|FG000|Overall Study|Lost to Follow-up|202|||
145504156|NCT01499355|524702848|FG002|Double-Blind Period|Investigator Decision|3|||
145504157|NCT01499355|524702849|FG003|Double-Blind Period|Investigator Decision|3|||
145504158|NCT01499355|524702846|FG000|Double-Blind Period|Consent Withdrawn|0|||
145504159|NCT01499355|524702847|FG001|Double-Blind Period|Consent Withdrawn|0|||
145504160|NCT01499355|524702848|FG002|Double-Blind Period|Consent Withdrawn|1|||
145504161|NCT01499355|524702849|FG003|Double-Blind Period|Consent Withdrawn|2|||
145504162|NCT01499355|524702846|FG000|Double-Blind Period|Lost to Follow-up|0|||
145504163|NCT01499355|524702847|FG001|Double-Blind Period|Lost to Follow-up|1|||
145504164|NCT01499355|524702848|FG002|Double-Blind Period|Lost to Follow-up|0|||
145504165|NCT01499355|524702849|FG003|Double-Blind Period|Lost to Follow-up|0|||
145504166|NCT01457703|524702852|FG000|Overall Study|Screen Failure|5|||
145504167|NCT01457703|524702853|FG001|Overall Study|Screen Failure|7|||
145504168|NCT01457703|524702852|FG000|Overall Study|Withdrawal by Subject|1|||
145504169|NCT01457703|524702853|FG001|Overall Study|Withdrawal by Subject|4|||
145504170|NCT03133793|524702858|FG000|Overall Study|Withdrawal by Subject|0|||
145504171|NCT03133793|524702859|FG001|Overall Study|Withdrawal by Subject|4|||
145504172|NCT03133793|524702860|FG002|Overall Study|Withdrawal by Subject|2|||
145504173|NCT03133793|524702861|FG003|Overall Study|Withdrawal by Subject|4|||
145504174|NCT03133793|524702858|FG000|Overall Study|Lost to Follow-up|1|||
145504175|NCT03133793|524702859|FG001|Overall Study|Lost to Follow-up|0|||
145504176|NCT03133793|524702860|FG002|Overall Study|Lost to Follow-up|2|||
145504177|NCT03133793|524702861|FG003|Overall Study|Lost to Follow-up|0|||
145504178|NCT03133793|524702858|FG000|Overall Study|Death|0|||
145504179|NCT03133793|524702859|FG001|Overall Study|Death|0|||
145504180|NCT03133793|524702860|FG002|Overall Study|Death|0|||
145504181|NCT03133793|524702861|FG003|Overall Study|Death|1|||
145504182|NCT00432172|524702863|FG000|Overall Study|Physician Decision|0|||
145504183|NCT00432172|524702864|FG001|Overall Study|Physician Decision|0|||
145504184|NCT00432172|524702865|FG002|Overall Study|Physician Decision|2|||
145504185|NCT00432172|524702866|FG003|Overall Study|Physician Decision|0|||
145504186|NCT00432172|524702863|FG000|Overall Study|Adverse Event|4|||
145504187|NCT00432172|524702864|FG001|Overall Study|Adverse Event|2|||
145504188|NCT00432172|524702865|FG002|Overall Study|Adverse Event|4|||
145504189|NCT00432172|524702866|FG003|Overall Study|Adverse Event|3|||
145504190|NCT00432172|524702863|FG000|Overall Study|Disease progression|0|||
145504191|NCT00432172|524702864|FG001|Overall Study|Disease progression|2|||
145504192|NCT00432172|524702865|FG002|Overall Study|Disease progression|5|||
145504193|NCT00432172|524702866|FG003|Overall Study|Disease progression|1|||
145504194|NCT00432172|524702863|FG000|Overall Study|Withdrawal by Subject|0|||
145504195|NCT00432172|524702864|FG001|Overall Study|Withdrawal by Subject|1|||
145504196|NCT00432172|524702865|FG002|Overall Study|Withdrawal by Subject|0|||
145504197|NCT00432172|524702866|FG003|Overall Study|Withdrawal by Subject|2|||
145504198|NCT00432172|524702863|FG000|Overall Study|No treatment received|2|||
145504199|NCT00432172|524702864|FG001|Overall Study|No treatment received|2|||
145504200|NCT00432172|524702865|FG002|Overall Study|No treatment received|0|||
145504201|NCT00432172|524702866|FG003|Overall Study|No treatment received|1|||
145504202|NCT02141204|524702867|FG000|Overall Study|Lost to Follow-up|2|||
145504203|NCT02141204|524702868|FG001|Overall Study|Lost to Follow-up|1|||
145504204|NCT02141204|524702867|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
145504205|NCT02141204|524702868|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
145504206|NCT02141204|524702867|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
145504207|NCT02141204|524702868|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
145504208|NCT02141204|524702867|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
145504209|NCT02141204|524702868|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
145504210|NCT05006573|524702873|FG000|Double-blind Treatment Period|Physician Decision|2|||
145504211|NCT05006573|524702874|FG001|Double-blind Treatment Period|Physician Decision|0|||
145504212|NCT05006573|524702873|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
145504213|NCT05006573|524702874|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
145504214|NCT05006573|524702873|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
145504215|NCT05006573|524702874|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145504216|NCT05006573|524702873|FG000|Double-blind Treatment Period|Protocol Violation|2|||
145504217|NCT05006573|524702874|FG001|Double-blind Treatment Period|Protocol Violation|0|||
145504218|NCT05006573|524702873|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
145504219|NCT05006573|524702874|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
145504220|NCT05006573|524702873|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
145504221|NCT05006573|524702874|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
145504222|NCT04949490|524702875|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
145504223|NCT04949490|524702876|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
145504224|NCT04949490|524702877|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
145504225|NCT04949490|524702878|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
145504226|NCT04949490|524702879|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
145504227|NCT04949490|524702880|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
145504228|NCT04949490|524702875|FG000|Group A and Group B|Withdrawal by Subject|0|||
145504229|NCT04949490|524702876|FG001|Group A and Group B|Withdrawal by Subject|0|||
145732911|NCT04890054|525540846|FG001|Overall Study|Lost to Follow-up|219|||
145732912|NCT02113579|525540850|FG000|Overall Study|Adverse Event|1|||
145399676|NCT03154086|524321068|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399677|NCT03154086|524321069|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399678|NCT03154086|524321070|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
145399679|NCT03154086|524321071|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399680|NCT03154086|524321072|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399681|NCT03154086|524321073|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399682|NCT03154086|524321074|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399683|NCT03154086|524321075|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399684|NCT03154086|524321076|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399685|NCT03154086|524321077|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
145399686|NCT03154086|524321063|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
145399687|NCT03154086|524321064|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
145399688|NCT03154086|524321065|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
145399689|NCT03154086|524321066|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
145399690|NCT03154086|524321067|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
145399691|NCT03154086|524321068|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
145399692|NCT03154086|524321069|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
145399693|NCT03154086|524321070|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
145399694|NCT03154086|524321071|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
145399695|NCT03154086|524321072|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
145399696|NCT03154086|524321073|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
145399697|NCT03154086|524321074|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
145399698|NCT03154086|524321075|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
145399699|NCT03154086|524321076|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
145399700|NCT03154086|524321077|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
145399701|NCT03504917|524321081|FG000|Blinded Treatment Period|Protocol Violation|1|||
145399702|NCT03504917|524321082|FG001|Blinded Treatment Period|Protocol Violation|0|||
145399703|NCT03504917|524321081|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
145399704|NCT03504917|524321082|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
145399705|NCT03504917|524321081|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
145399706|NCT03504917|524321082|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
145399707|NCT03504917|524321081|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
145399708|NCT03504917|524321082|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
145399709|NCT03504917|524321081|FG000|Blinded Treatment Period|Adverse Event|4|||
145399710|NCT03504917|524321082|FG001|Blinded Treatment Period|Adverse Event|4|||
145399711|NCT03504917|524321081|FG000|Blinded Treatment Period|Physician Decision|1|||
145399712|NCT03504917|524321082|FG001|Blinded Treatment Period|Physician Decision|0|||
145399713|NCT03504917|524321081|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
145504230|NCT04949490|524702877|FG002|Group A and Group B|Withdrawal by Subject|1|||
145504231|NCT04949490|524702878|FG003|Group A and Group B|Withdrawal by Subject|0|||
145504232|NCT04949490|524702879|FG004|Group A and Group B|Withdrawal by Subject|0|||
145504233|NCT04949490|524702880|FG005|Group A and Group B|Withdrawal by Subject|0|||
145504234|NCT04949490|524702875|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
145504235|NCT04949490|524702876|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
145504236|NCT04949490|524702877|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
145504237|NCT04949490|524702878|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
145504238|NCT04949490|524702879|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
145504239|NCT04949490|524702880|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
145504240|NCT04949490|524702875|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
145504241|NCT04949490|524702876|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
145504242|NCT04949490|524702877|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
145504243|NCT04949490|524702878|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
145504244|NCT04949490|524702879|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
145504245|NCT04949490|524702880|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
145504246|NCT01177397|524704714|FG000|Overall Study|Protocol Violation|0|||
145504247|NCT01177397|524704715|FG001|Overall Study|Protocol Violation|0|||
145504248|NCT01177397|524704716|FG002|Overall Study|Protocol Violation|0|||
145504249|NCT01177397|524704717|FG003|Overall Study|Protocol Violation|0|||
145504250|NCT01177397|524704718|FG004|Overall Study|Protocol Violation|0|||
145504251|NCT01177397|524704719|FG005|Overall Study|Protocol Violation|1|||
145504252|NCT01177397|524704720|FG006|Overall Study|Protocol Violation|0|||
145504253|NCT01177397|524704721|FG007|Overall Study|Protocol Violation|0|||
145504254|NCT01177397|524704722|FG008|Overall Study|Protocol Violation|0|||
145504255|NCT01177397|524704723|FG009|Overall Study|Protocol Violation|0|||
145504256|NCT01177397|524704724|FG010|Overall Study|Protocol Violation|0|||
145504257|NCT01177397|524704725|FG011|Overall Study|Protocol Violation|0|||
145504258|NCT01177397|524704714|FG000|Overall Study|Lost to Follow-up|0|||
145504259|NCT01177397|524704715|FG001|Overall Study|Lost to Follow-up|0|||
145504260|NCT01177397|524704716|FG002|Overall Study|Lost to Follow-up|0|||
145504261|NCT01177397|524704717|FG003|Overall Study|Lost to Follow-up|0|||
145504262|NCT01177397|524704718|FG004|Overall Study|Lost to Follow-up|1|||
145504263|NCT01177397|524704719|FG005|Overall Study|Lost to Follow-up|0|||
145504264|NCT01177397|524704720|FG006|Overall Study|Lost to Follow-up|0|||
145504265|NCT01177397|524704721|FG007|Overall Study|Lost to Follow-up|2|||
145504266|NCT01177397|524704722|FG008|Overall Study|Lost to Follow-up|0|||
145504267|NCT01177397|524704723|FG009|Overall Study|Lost to Follow-up|0|||
145504268|NCT01177397|524704724|FG010|Overall Study|Lost to Follow-up|0|||
145504269|NCT01177397|524704725|FG011|Overall Study|Lost to Follow-up|0|||
145504270|NCT01177397|524704714|FG000|Overall Study|Death|0|||
145504271|NCT01177397|524704715|FG001|Overall Study|Death|0|||
145504272|NCT01177397|524704716|FG002|Overall Study|Death|1|||
145504273|NCT01177397|524704717|FG003|Overall Study|Death|1|||
145504274|NCT01177397|524704718|FG004|Overall Study|Death|0|||
145504275|NCT01177397|524704719|FG005|Overall Study|Death|0|||
145504276|NCT01177397|524704720|FG006|Overall Study|Death|0|||
145504277|NCT01177397|524704721|FG007|Overall Study|Death|5|||
145504278|NCT01177397|524704722|FG008|Overall Study|Death|2|||
145504279|NCT01177397|524704723|FG009|Overall Study|Death|1|||
145504280|NCT01177397|524704724|FG010|Overall Study|Death|0|||
145504281|NCT01177397|524704725|FG011|Overall Study|Death|0|||
145504282|NCT01177397|524704714|FG000|Overall Study|Withdrawal by Subject|0|||
145504283|NCT01177397|524704715|FG001|Overall Study|Withdrawal by Subject|0|||
145504284|NCT01177397|524704716|FG002|Overall Study|Withdrawal by Subject|1|||
145504285|NCT01177397|524704717|FG003|Overall Study|Withdrawal by Subject|1|||
145504286|NCT01177397|524704718|FG004|Overall Study|Withdrawal by Subject|1|||
145504287|NCT01177397|524704719|FG005|Overall Study|Withdrawal by Subject|2|||
145504288|NCT01177397|524704720|FG006|Overall Study|Withdrawal by Subject|0|||
145504289|NCT01177397|524704721|FG007|Overall Study|Withdrawal by Subject|5|||
145504290|NCT01177397|524704722|FG008|Overall Study|Withdrawal by Subject|9|||
145504291|NCT01177397|524704723|FG009|Overall Study|Withdrawal by Subject|1|||
145504292|NCT01177397|524704724|FG010|Overall Study|Withdrawal by Subject|1|||
145504293|NCT01177397|524704725|FG011|Overall Study|Withdrawal by Subject|0|||
145504294|NCT01177397|524704714|FG000|Overall Study|Adverse Event|0|||
145504295|NCT01177397|524704715|FG001|Overall Study|Adverse Event|0|||
145504296|NCT01177397|524704716|FG002|Overall Study|Adverse Event|1|||
145504297|NCT01177397|524704717|FG003|Overall Study|Adverse Event|2|||
145504298|NCT01177397|524704718|FG004|Overall Study|Adverse Event|0|||
145504299|NCT01177397|524704719|FG005|Overall Study|Adverse Event|12|||
145504300|NCT01177397|524704720|FG006|Overall Study|Adverse Event|1|||
145504301|NCT01177397|524704721|FG007|Overall Study|Adverse Event|14|||
145504302|NCT01177397|524704722|FG008|Overall Study|Adverse Event|8|||
145504303|NCT01177397|524704723|FG009|Overall Study|Adverse Event|6|||
145504304|NCT01177397|524704724|FG010|Overall Study|Adverse Event|3|||
145504305|NCT01177397|524704725|FG011|Overall Study|Adverse Event|7|||
145504306|NCT01177397|524704714|FG000|Overall Study|Disease progression|1|||
145504307|NCT01177397|524704715|FG001|Overall Study|Disease progression|2|||
145504308|NCT01177397|524704716|FG002|Overall Study|Disease progression|5|||
145504309|NCT01177397|524704717|FG003|Overall Study|Disease progression|5|||
145504310|NCT01177397|524704718|FG004|Overall Study|Disease progression|4|||
145504311|NCT01177397|524704719|FG005|Overall Study|Disease progression|10|||
145504312|NCT01177397|524704720|FG006|Overall Study|Disease progression|10|||
145504313|NCT01177397|524704721|FG007|Overall Study|Disease progression|21|||
145504314|NCT01177397|524704722|FG008|Overall Study|Disease progression|18|||
145504315|NCT01177397|524704723|FG009|Overall Study|Disease progression|12|||
145504316|NCT01177397|524704724|FG010|Overall Study|Disease progression|10|||
145504317|NCT01177397|524704725|FG011|Overall Study|Disease progression|8|||
145504318|NCT01177397|524704714|FG000|Overall Study|Other reasons|0|||
145504319|NCT01177397|524704715|FG001|Overall Study|Other reasons|0|||
145504320|NCT01177397|524704716|FG002|Overall Study|Other reasons|1|||
145504321|NCT01177397|524704717|FG003|Overall Study|Other reasons|0|||
145504322|NCT01177397|524704718|FG004|Overall Study|Other reasons|1|||
145504323|NCT01177397|524704719|FG005|Overall Study|Other reasons|1|||
145504324|NCT01177397|524704720|FG006|Overall Study|Other reasons|2|||
145504325|NCT01177397|524704721|FG007|Overall Study|Other reasons|6|||
145504326|NCT01177397|524704722|FG008|Overall Study|Other reasons|10|||
145504327|NCT01177397|524704723|FG009|Overall Study|Other reasons|8|||
145504328|NCT01177397|524704724|FG010|Overall Study|Other reasons|0|||
145504329|NCT01177397|524704725|FG011|Overall Study|Other reasons|2|||
145504330|NCT04555616|524704726|FG000|Overall Study|Death|1|||
145504331|NCT04555616|524704727|FG001|Overall Study|Death|0|||
145504332|NCT04555616|524704728|FG002|Overall Study|Death|1|||
145504333|NCT04555616|524704726|FG000|Overall Study|Withdrawal by Subject|2|||
145504334|NCT04555616|524704727|FG001|Overall Study|Withdrawal by Subject|1|||
145504335|NCT04555616|524704728|FG002|Overall Study|Withdrawal by Subject|0|||
145504336|NCT02446899|524704729|FG000|Overall Study|Adverse Event|4|||
145504337|NCT02446899|524704730|FG001|Overall Study|Adverse Event|7|||
145504338|NCT02446899|524704729|FG000|Overall Study|Condition Under Investigation Worsened|1|||
145504339|NCT02446899|524704730|FG001|Overall Study|Condition Under Investigation Worsened|4|||
145504340|NCT02446899|524704729|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
145504341|NCT02446899|524704730|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
145504342|NCT02446899|524704729|FG000|Overall Study|Lack of Efficacy|2|||
145504343|NCT02446899|524704730|FG001|Overall Study|Lack of Efficacy|8|||
145504344|NCT02446899|524704729|FG000|Overall Study|Lost to Follow-up|1|||
145504345|NCT02446899|524704730|FG001|Overall Study|Lost to Follow-up|3|||
145504346|NCT02446899|524704729|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
145504347|NCT02446899|524704730|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
145504348|NCT02446899|524704729|FG000|Overall Study|Withdrawal by Subject|11|||
145504349|NCT02446899|524704730|FG001|Overall Study|Withdrawal by Subject|19|||
145504350|NCT02446899|524704729|FG000|Overall Study|Miscellaneous|5|||
145504351|NCT02446899|524704730|FG001|Overall Study|Miscellaneous|4|||
145504352|NCT02446899|524704729|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145504353|NCT02446899|524704730|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
145504354|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
145504355|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
145504356|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
145504357|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
145504358|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
145504359|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
145504360|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
145504361|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
145504362|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
145504363|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
145504364|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
145399714|NCT03504917|524321082|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
145399715|NCT03504917|524321081|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
145399716|NCT03504917|524321082|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
145399717|NCT03504917|524321081|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
145399718|NCT03504917|524321082|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
145399719|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
145399720|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
145399721|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
145399722|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
145399723|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
145399724|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
145399725|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
145399726|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
145399727|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
145399728|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
145399729|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
145732913|NCT02113579|525540851|FG001|Overall Study|Adverse Event|0|||
145399730|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
145399731|NCT03504917|524321081|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
145399732|NCT03504917|524321082|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
145399733|NCT04219189|524321083|FG000|Overall Study|Withdrawal by Subject|1|||
145399734|NCT04219189|524321084|FG001|Overall Study|Withdrawal by Subject|2|||
145399735|NCT04219189|524321083|FG000|Overall Study|Protocol Violation|0|||
145399736|NCT04219189|524321084|FG001|Overall Study|Protocol Violation|1|||
145399737|NCT04219189|524321083|FG000|Overall Study|Lost to Follow-up|0|||
145399738|NCT04219189|524321084|FG001|Overall Study|Lost to Follow-up|1|||
145504365|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
145504366|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
145504367|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
145504368|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
145504369|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145504370|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145504371|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145504372|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
145504373|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145504374|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145504375|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
145399739|NCT04219189|524321083|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
145399740|NCT04219189|524321084|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
145399741|NCT01299584|524321085|FG000|Overall Study|Protocol Violation|9|||
145399742|NCT00572832|524321086|FG000|Overall Study|Lost to Follow-up|0|||
145399743|NCT00572832|524321087|FG001|Overall Study|Lost to Follow-up|11|||
145399744|NCT00572832|524321086|FG000|Overall Study|Pregnancy|0|||
145399745|NCT00572832|524321087|FG001|Overall Study|Pregnancy|1|||
145399746|NCT00324155|524321091|FG000|Enrolled and Randomized|No longer met study criteria|3|||
145399747|NCT00324155|524321092|FG001|Enrolled and Randomized|No longer met study criteria|0|||
145399748|NCT00324155|524321091|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
145399749|NCT00324155|524321092|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
145399750|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
145504376|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145504377|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145504378|NCT01106690|524704736|FG000|Core Period: Baseline to Week 26|Other|10|||
145504379|NCT01106690|524704737|FG001|Core Period: Baseline to Week 26|Other|2|||
145504380|NCT01106690|524704738|FG002|Core Period: Baseline to Week 26|Other|6|||
145504381|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145504382|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145504383|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145504384|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145504385|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145504386|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145504387|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145504388|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145504389|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145504390|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145504391|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
145504392|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
145504393|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145504394|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145504395|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145504396|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Other|8|||
145504397|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Other|3|||
145504398|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Other|4|||
145399751|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
145399752|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
145399753|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
145399754|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Death|8|||
145399755|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Death|15|||
145399756|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
145399757|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
145399758|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
145399759|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
145399760|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
145399761|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
145399762|NCT00324155|524321091|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
145399763|NCT00324155|524321092|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
145399764|NCT00324155|524321091|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
145399765|NCT00324155|524321092|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
145399766|NCT00324155|524321091|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
145399767|NCT00324155|524321092|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
145399768|NCT00324155|524321091|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
145399769|NCT00324155|524321092|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
145399770|NCT00324155|524321091|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
145399771|NCT00324155|524321092|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
145399772|NCT00324155|524321091|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
145399773|NCT00324155|524321092|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
145399774|NCT00324155|524321091|FG000|Follow-up Phase|On-going participants still on drug|11|||
145399775|NCT00324155|524321092|FG001|Follow-up Phase|On-going participants still on drug|6|||
145399776|NCT00390689|524321093|FG000|Overall Study|Adverse Event|2|||
145399777|NCT00390689|524321094|FG001|Overall Study|Adverse Event|5|||
145399778|NCT00390689|524321095|FG002|Overall Study|Adverse Event|2|||
145399779|NCT00390689|524321093|FG000|Overall Study|Lack of Efficacy|0|||
145399780|NCT00390689|524321094|FG001|Overall Study|Lack of Efficacy|0|||
145399781|NCT00390689|524321095|FG002|Overall Study|Lack of Efficacy|1|||
145399782|NCT00390689|524321093|FG000|Overall Study|Protocol Violation|1|||
145399783|NCT00390689|524321094|FG001|Overall Study|Protocol Violation|0|||
145399784|NCT00390689|524321095|FG002|Overall Study|Protocol Violation|0|||
145399785|NCT00390689|524321093|FG000|Overall Study|Investigator's judgement|2|||
145399786|NCT00390689|524321094|FG001|Overall Study|Investigator's judgement|0|||
145399787|NCT00390689|524321095|FG002|Overall Study|Investigator's judgement|0|||
145399788|NCT01253161|524321096|FG000|Overall Study|Adverse Event|1|||
145399789|NCT03101020|524321098|FG000|Overall Study|Lack of time to participate|1|||
145399790|NCT03101020|524321099|FG001|Overall Study|Lack of time to participate|0|||
145399791|NCT03101020|524321098|FG000|Overall Study|Ran over by a car|0|||
145399792|NCT03101020|524321099|FG001|Overall Study|Ran over by a car|1|||
145399793|NCT03101020|524321098|FG000|Overall Study|Withdrawal by Subject|0|||
145399794|NCT03101020|524321099|FG001|Overall Study|Withdrawal by Subject|2|||
145399795|NCT01924533|524321100|FG000|Overall Study|Death|181|||
145399796|NCT01924533|524321101|FG001|Overall Study|Death|200|||
145399797|NCT01924533|524321100|FG000|Overall Study|Lost to Follow-up|0|||
145399798|NCT01924533|524321101|FG001|Overall Study|Lost to Follow-up|1|||
145399799|NCT01924533|524321100|FG000|Overall Study|Withdrawal by Subject|7|||
145399800|NCT01924533|524321101|FG001|Overall Study|Withdrawal by Subject|3|||
145399801|NCT01924533|524321100|FG000|Overall Study|Other Eligibility criteria|1|||
145399802|NCT01924533|524321101|FG001|Overall Study|Other Eligibility criteria|1|||
145399803|NCT04233879|524321102|FG000|Overall Study|Death|2|||
145399804|NCT04233879|524321103|FG001|Overall Study|Death|0|||
145399805|NCT04233879|524321102|FG000|Overall Study|Lost to Follow-up|3|||
145399806|NCT04233879|524321103|FG001|Overall Study|Lost to Follow-up|8|||
145399807|NCT04233879|524321102|FG000|Overall Study|Physician Decision|4|||
145399808|NCT04233879|524321103|FG001|Overall Study|Physician Decision|4|||
145399809|NCT04233879|524321102|FG000|Overall Study|Withdrawal by Subject|7|||
145399810|NCT04233879|524321103|FG001|Overall Study|Withdrawal by Subject|10|||
145399811|NCT04233879|524321102|FG000|Overall Study|Other|281|||
145399812|NCT04233879|524321103|FG001|Overall Study|Other|279|||
145399813|NCT03292016|524321104|FG000|Second Washout|Adverse Event|0|||
145399814|NCT03292016|524321105|FG001|Second Washout|Adverse Event|1|||
145399815|NCT03292016|524321106|FG002|Second Washout|Adverse Event|0|||
145399816|NCT03292016|524321107|FG003|Second Washout|Adverse Event|0|||
145399817|NCT03292016|524321108|FG004|Second Washout|Adverse Event|0|||
145399818|NCT03292016|524321109|FG005|Second Washout|Adverse Event|0|||
145399819|NCT01909804|524321110|FG000|Overall Study|Randomized but Never Treated|0|||
145399820|NCT01909804|524321111|FG001|Overall Study|Randomized but Never Treated|0|||
145399821|NCT01909804|524321112|FG002|Overall Study|Randomized but Never Treated|0|||
145399822|NCT01909804|524321113|FG003|Overall Study|Randomized but Never Treated|0|||
145399823|NCT01909804|524321114|FG004|Overall Study|Randomized but Never Treated|0|||
145399824|NCT01909804|524321115|FG005|Overall Study|Randomized but Never Treated|0|||
145399825|NCT01909804|524321116|FG006|Overall Study|Randomized but Never Treated|1|||
145399826|NCT01909804|524321117|FG007|Overall Study|Randomized but Never Treated|0|||
145399827|NCT01909804|524321118|FG008|Overall Study|Randomized but Never Treated|0|||
145399828|NCT01909804|524321119|FG009|Overall Study|Randomized but Never Treated|0|||
145399829|NCT01909804|524321120|FG010|Overall Study|Randomized but Never Treated|0|||
145399830|NCT01909804|524321121|FG011|Overall Study|Randomized but Never Treated|1|||
145399831|NCT01909804|524321110|FG000|Overall Study|Death|0|||
145399832|NCT01909804|524321111|FG001|Overall Study|Death|0|||
145399833|NCT01909804|524321112|FG002|Overall Study|Death|0|||
145399834|NCT01909804|524321113|FG003|Overall Study|Death|0|||
145399835|NCT01909804|524321114|FG004|Overall Study|Death|0|||
145399836|NCT01909804|524321115|FG005|Overall Study|Death|0|||
145399837|NCT01909804|524321116|FG006|Overall Study|Death|0|||
145399838|NCT01909804|524321117|FG007|Overall Study|Death|0|||
145399839|NCT01909804|524321118|FG008|Overall Study|Death|0|||
145399840|NCT01909804|524321119|FG009|Overall Study|Death|0|||
145399841|NCT01909804|524321120|FG010|Overall Study|Death|1|||
145399842|NCT01909804|524321121|FG011|Overall Study|Death|0|||
145399843|NCT01909804|524321110|FG000|Overall Study|Lack of Efficacy|4|||
145399844|NCT01909804|524321111|FG001|Overall Study|Lack of Efficacy|1|||
145504399|NCT01106690|524704736|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
145504400|NCT01106690|524704737|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145504401|NCT01106690|524704738|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145504402|NCT00998296|524704739|FG000|Overall Study|Progressive disease|0|||
145504403|NCT00998296|524704740|FG001|Overall Study|Progressive disease|1|||
145504404|NCT00998296|524704741|FG002|Overall Study|Progressive disease|0|||
145504405|NCT00998296|524704742|FG003|Overall Study|Progressive disease|0|||
145504406|NCT00998296|524704743|FG004|Overall Study|Progressive disease|0|||
145504407|NCT00998296|524704744|FG005|Overall Study|Progressive disease|0|||
145504408|NCT00998296|524704745|FG006|Overall Study|Progressive disease|1|||
145504409|NCT00998296|524704746|FG007|Overall Study|Progressive disease|0|||
145504410|NCT00998296|524704747|FG008|Overall Study|Progressive disease|0|||
145399845|NCT01909804|524321112|FG002|Overall Study|Lack of Efficacy|0|||
145399846|NCT01909804|524321113|FG003|Overall Study|Lack of Efficacy|0|||
145399847|NCT01909804|524321114|FG004|Overall Study|Lack of Efficacy|7|||
145399848|NCT01909804|524321115|FG005|Overall Study|Lack of Efficacy|3|||
145399849|NCT01909804|524321116|FG006|Overall Study|Lack of Efficacy|1|||
145399850|NCT01909804|524321117|FG007|Overall Study|Lack of Efficacy|1|||
145399851|NCT01909804|524321118|FG008|Overall Study|Lack of Efficacy|0|||
145399852|NCT01909804|524321119|FG009|Overall Study|Lack of Efficacy|1|||
145504411|NCT00998296|524704748|FG009|Overall Study|Progressive disease|14|||
145504412|NCT00998296|524704749|FG010|Overall Study|Progressive disease|5|||
145504413|NCT00998296|524704739|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504414|NCT00998296|524704740|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504415|NCT00998296|524704741|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504416|NCT00998296|524704742|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504417|NCT00998296|524704743|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
145504418|NCT00998296|524704744|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
145399853|NCT01909804|524321120|FG010|Overall Study|Lack of Efficacy|0|||
145399854|NCT01909804|524321121|FG011|Overall Study|Lack of Efficacy|1|||
145399855|NCT01909804|524321110|FG000|Overall Study|Withdrew Consent|0|||
145399856|NCT01909804|524321111|FG001|Overall Study|Withdrew Consent|0|||
145399857|NCT01909804|524321112|FG002|Overall Study|Withdrew Consent|0|||
145399858|NCT01909804|524321113|FG003|Overall Study|Withdrew Consent|0|||
145399859|NCT01909804|524321114|FG004|Overall Study|Withdrew Consent|1|||
145399860|NCT01909804|524321115|FG005|Overall Study|Withdrew Consent|1|||
145504419|NCT00998296|524704745|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504420|NCT00998296|524704746|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
145504421|NCT00998296|524704747|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
145504422|NCT00998296|524704748|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504423|NCT00998296|524704749|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
145504424|NCT00998296|524704739|FG000|Overall Study|Other adverse event|0|||
145504425|NCT00998296|524704740|FG001|Overall Study|Other adverse event|0|||
145504426|NCT00998296|524704741|FG002|Overall Study|Other adverse event|0|||
145504427|NCT00998296|524704742|FG003|Overall Study|Other adverse event|0|||
145504428|NCT00998296|524704743|FG004|Overall Study|Other adverse event|1|||
145504429|NCT00998296|524704744|FG005|Overall Study|Other adverse event|0|||
145504430|NCT00998296|524704745|FG006|Overall Study|Other adverse event|0|||
145504431|NCT00998296|524704746|FG007|Overall Study|Other adverse event|0|||
145504432|NCT00998296|524704747|FG008|Overall Study|Other adverse event|0|||
145504433|NCT00998296|524704748|FG009|Overall Study|Other adverse event|1|||
145504434|NCT00998296|524704749|FG010|Overall Study|Other adverse event|2|||
145504435|NCT00998296|524704739|FG000|Overall Study|Refused to continue taking trial med.|0|||
145504436|NCT00998296|524704740|FG001|Overall Study|Refused to continue taking trial med.|0|||
145504437|NCT00998296|524704741|FG002|Overall Study|Refused to continue taking trial med.|0|||
145504438|NCT00998296|524704742|FG003|Overall Study|Refused to continue taking trial med.|0|||
145504439|NCT00998296|524704743|FG004|Overall Study|Refused to continue taking trial med.|0|||
145504440|NCT00998296|524704744|FG005|Overall Study|Refused to continue taking trial med.|0|||
145504441|NCT00998296|524704745|FG006|Overall Study|Refused to continue taking trial med.|0|||
145399861|NCT01909804|524321116|FG006|Overall Study|Withdrew Consent|0|||
145399862|NCT01909804|524321117|FG007|Overall Study|Withdrew Consent|0|||
145399863|NCT01909804|524321118|FG008|Overall Study|Withdrew Consent|0|||
145266696|NCT04668066|523825249|FG012|Part 1: Follow-Up|Other|1|||
145504442|NCT00998296|524704746|FG007|Overall Study|Refused to continue taking trial med.|0|||
145504443|NCT00998296|524704747|FG008|Overall Study|Refused to continue taking trial med.|0|||
145504444|NCT00998296|524704748|FG009|Overall Study|Refused to continue taking trial med.|2|||
145504445|NCT00998296|524704749|FG010|Overall Study|Refused to continue taking trial med.|0|||
145504446|NCT00998296|524704739|FG000|Overall Study|Reason other than those specified above|0|||
145504447|NCT00998296|524704740|FG001|Overall Study|Reason other than those specified above|0|||
145504448|NCT00998296|524704741|FG002|Overall Study|Reason other than those specified above|0|||
145504449|NCT00998296|524704742|FG003|Overall Study|Reason other than those specified above|0|||
145504450|NCT00998296|524704743|FG004|Overall Study|Reason other than those specified above|0|||
145504451|NCT00998296|524704744|FG005|Overall Study|Reason other than those specified above|0|||
145504452|NCT00998296|524704745|FG006|Overall Study|Reason other than those specified above|0|||
145504453|NCT00998296|524704746|FG007|Overall Study|Reason other than those specified above|0|||
145504454|NCT00998296|524704747|FG008|Overall Study|Reason other than those specified above|0|||
145504455|NCT00998296|524704748|FG009|Overall Study|Reason other than those specified above|1|||
145504456|NCT00998296|524704749|FG010|Overall Study|Reason other than those specified above|0|||
145504457|NCT04396639|524704750|FG000|Overall Study|Withdrawal by Subject|1|||
145504458|NCT04396639|524704750|FG000|Overall Study|Other|1|||
145504459|NCT01544335|524704751|FG000|Overall Study|Lost to Follow-up|27|||
145504460|NCT01544335|524704751|FG000|Overall Study|Death|4|||
145504461|NCT01544335|524704751|FG000|Overall Study|Disease progression|3|||
145504462|NCT01544335|524704751|FG000|Overall Study|Baseline Measurements not Available|19|||
145504463|NCT03219528|524704758|FG000|Overall Study|Lost to Follow-up|5|||
145504464|NCT03219528|524704759|FG001|Overall Study|Lost to Follow-up|4|||
145504465|NCT03219528|524704758|FG000|Overall Study|Withdrawal by Subject|4|||
145504466|NCT03219528|524704759|FG001|Overall Study|Withdrawal by Subject|4|||
145504467|NCT00241839|524704760|FG000|Overall Study|Withdrawal by Subject|18|||
145504468|NCT00241839|524704761|FG001|Overall Study|Withdrawal by Subject|17|||
145504469|NCT00241839|524704760|FG000|Overall Study|Adverse Event|1|||
145504470|NCT00241839|524704761|FG001|Overall Study|Adverse Event|1|||
145504471|NCT00196313|524704766|FG000|Overall Study|Protocol Violation|2|||
145399864|NCT01909804|524321119|FG009|Overall Study|Withdrew Consent|0|||
145399865|NCT01909804|524321120|FG010|Overall Study|Withdrew Consent|0|||
145399866|NCT01909804|524321121|FG011|Overall Study|Withdrew Consent|0|||
145399867|NCT01909804|524321110|FG000|Overall Study|Protocol Violation|0|||
145399868|NCT01909804|524321111|FG001|Overall Study|Protocol Violation|0|||
145399869|NCT01909804|524321112|FG002|Overall Study|Protocol Violation|0|||
145399870|NCT01909804|524321113|FG003|Overall Study|Protocol Violation|0|||
145399871|NCT01909804|524321114|FG004|Overall Study|Protocol Violation|0|||
145399872|NCT01909804|524321115|FG005|Overall Study|Protocol Violation|0|||
145399873|NCT01909804|524321116|FG006|Overall Study|Protocol Violation|0|||
145399874|NCT01909804|524321117|FG007|Overall Study|Protocol Violation|0|||
145399875|NCT01909804|524321118|FG008|Overall Study|Protocol Violation|0|||
145399876|NCT01909804|524321119|FG009|Overall Study|Protocol Violation|0|||
145399877|NCT01909804|524321120|FG010|Overall Study|Protocol Violation|0|||
145399878|NCT01909804|524321121|FG011|Overall Study|Protocol Violation|1|||
145399879|NCT02895347|524321122|FG000|Overall Study|Withdrawal by Subject|3|||
145399880|NCT02895347|524321123|FG001|Overall Study|Withdrawal by Subject|1|||
145399881|NCT01673178|524321127|FG000|Overall Study|Lost to Follow-up|0|||
145399882|NCT01673178|524321128|FG001|Overall Study|Lost to Follow-up|1|||
145399883|NCT01673178|524321129|FG002|Overall Study|Lost to Follow-up|0|||
145399884|NCT01673178|524321130|FG003|Overall Study|Lost to Follow-up|0|||
145399885|NCT01673178|524321131|FG004|Overall Study|Lost to Follow-up|0|||
145399886|NCT01673178|524321127|FG000|Overall Study|Withdrawal by Subject|0|||
145732914|NCT02113579|525540850|FG000|Overall Study|Withdrawal by Subject|3|||
145732915|NCT02113579|525540851|FG001|Overall Study|Withdrawal by Subject|2|||
145399887|NCT01673178|524321128|FG001|Overall Study|Withdrawal by Subject|0|||
145399888|NCT01673178|524321129|FG002|Overall Study|Withdrawal by Subject|1|||
145399889|NCT01673178|524321130|FG003|Overall Study|Withdrawal by Subject|4|||
145399890|NCT01673178|524321131|FG004|Overall Study|Withdrawal by Subject|2|||
145399891|NCT01673178|524321127|FG000|Overall Study|Protocol Violation|1|||
145399892|NCT01673178|524321128|FG001|Overall Study|Protocol Violation|1|||
145399893|NCT01673178|524321129|FG002|Overall Study|Protocol Violation|0|||
145399894|NCT01673178|524321130|FG003|Overall Study|Protocol Violation|1|||
145399895|NCT01673178|524321131|FG004|Overall Study|Protocol Violation|0|||
145399896|NCT01673178|524321127|FG000|Overall Study|Adverse Event|1|||
145399897|NCT01673178|524321128|FG001|Overall Study|Adverse Event|0|||
145399898|NCT01673178|524321129|FG002|Overall Study|Adverse Event|0|||
145399899|NCT01673178|524321130|FG003|Overall Study|Adverse Event|2|||
145399900|NCT01673178|524321131|FG004|Overall Study|Adverse Event|0|||
145399901|NCT01673178|524321127|FG000|Overall Study|Other|1|||
145399902|NCT01673178|524321128|FG001|Overall Study|Other|0|||
145399903|NCT01673178|524321129|FG002|Overall Study|Other|2|||
145399904|NCT01673178|524321130|FG003|Overall Study|Other|1|||
145399905|NCT01673178|524321131|FG004|Overall Study|Other|0|||
145399906|NCT00931632|524321133|FG000|Overall Study|Withdrawal by Subject|2|||
145399907|NCT00931632|524321134|FG001|Overall Study|Withdrawal by Subject|3|||
145399908|NCT00931632|524321133|FG000|Overall Study|Adverse Event|19|||
145399909|NCT00931632|524321134|FG001|Overall Study|Adverse Event|15|||
145399910|NCT01419314|524321135|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
145399911|NCT01419314|524321136|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
145399912|NCT01419314|524321135|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
145399913|NCT01419314|524321136|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
145399914|NCT01419314|524321135|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
145399915|NCT01419314|524321136|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
145399916|NCT00402727|524321140|FG000|Overall Study|Adverse Event|10|||
145399917|NCT00402727|524321141|FG001|Overall Study|Adverse Event|6|||
145399918|NCT00402727|524321140|FG000|Overall Study|Death|1|||
145399919|NCT00402727|524321141|FG001|Overall Study|Death|0|||
145399920|NCT00402727|524321140|FG000|Overall Study|Lack of Efficacy|1|||
145399921|NCT00402727|524321141|FG001|Overall Study|Lack of Efficacy|3|||
145399922|NCT00402727|524321140|FG000|Overall Study|Lost to Follow-up|24|||
145399923|NCT00402727|524321141|FG001|Overall Study|Lost to Follow-up|11|||
145399924|NCT00402727|524321140|FG000|Overall Study|Physician Decision|1|||
145399925|NCT00402727|524321141|FG001|Overall Study|Physician Decision|1|||
145399926|NCT00402727|524321140|FG000|Overall Study|Protocol Violation|0|||
145399927|NCT00402727|524321141|FG001|Overall Study|Protocol Violation|4|||
145504472|NCT00196313|524704767|FG001|Overall Study|Protocol Violation|3|||
145504473|NCT00196313|524704766|FG000|Overall Study|Withdrawal by Subject|3|||
145399928|NCT00402727|524321140|FG000|Overall Study|Withdrawal by Subject|3|||
145399929|NCT00402727|524321141|FG001|Overall Study|Withdrawal by Subject|7|||
145399930|NCT00402727|524321140|FG000|Overall Study|supply problems|2|||
145399931|NCT00402727|524321141|FG001|Overall Study|supply problems|1|||
145399932|NCT00402727|524321140|FG000|Overall Study|non-compliance|0|||
145399933|NCT00402727|524321141|FG001|Overall Study|non-compliance|1|||
145399934|NCT03372798|524321142|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
145399935|NCT03372798|524321143|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
145399936|NCT03372798|524321142|FG000|Overall Study|Failure of imaging probe|0|||
145399937|NCT03372798|524321143|FG001|Overall Study|Failure of imaging probe|1|||
145399938|NCT03139552|524321160|FG000|Overall Study|unable to attend tasting due to schedule|3|||
145399939|NCT00887484|524321177|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
145399940|NCT00887484|524321177|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
145399941|NCT00887484|524321177|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
145399942|NCT01316224|524321178|FG000|Overall Study|Protocol Violation|3|||
145399943|NCT01316224|524321178|FG000|Overall Study|Adverse Event|3|||
145399944|NCT01316224|524321178|FG000|Overall Study|Lack of Efficacy|1|||
145399945|NCT01316224|524321178|FG000|Overall Study|Withdrawal by Subject|1|||
145504474|NCT00196313|524704767|FG001|Overall Study|Withdrawal by Subject|1|||
145399946|NCT01316224|524321178|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
145504475|NCT00196313|524704766|FG000|Overall Study|Adverse Event|3|||
145504476|NCT00196313|524704767|FG001|Overall Study|Adverse Event|1|||
145504477|NCT00196313|524704766|FG000|Overall Study|Subject Pregnant|1|||
145504478|NCT00196313|524704767|FG001|Overall Study|Subject Pregnant|1|||
145504479|NCT00196313|524704766|FG000|Overall Study|Lost to Follow-up|2|||
145266697|NCT04668066|523825250|FG013|Part 1: Follow-Up|Other|0|||
145504480|NCT00196313|524704767|FG001|Overall Study|Lost to Follow-up|2|||
145504481|NCT03096288|524704768|FG000|Overall Study|Withdrawal by Subject|0|||
145504482|NCT03096288|524704769|FG001|Overall Study|Withdrawal by Subject|1|||
145504483|NCT03096288|524704770|FG002|Overall Study|Withdrawal by Subject|0|||
145504484|NCT03096288|524704771|FG003|Overall Study|Withdrawal by Subject|1|||
145504485|NCT01411891|524704774|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
145504486|NCT01411891|524704775|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
145504487|NCT02004093|524704776|FG000|Overall Study|Death|2|||
145504488|NCT02004093|524704777|FG001|Overall Study|Death|1|||
145504489|NCT02004093|524704776|FG000|Overall Study|Lack of Efficacy|66|||
145504490|NCT02004093|524704777|FG001|Overall Study|Lack of Efficacy|62|||
145504491|NCT02004093|524704776|FG000|Overall Study|Protocol Violation|0|||
145504492|NCT02004093|524704777|FG001|Overall Study|Protocol Violation|1|||
145504493|NCT02004093|524704776|FG000|Overall Study|Lost to Follow-up|0|||
145504494|NCT02004093|524704777|FG001|Overall Study|Lost to Follow-up|1|||
145504495|NCT02004093|524704776|FG000|Overall Study|Withdrawal by Subject|3|||
145504496|NCT02004093|524704777|FG001|Overall Study|Withdrawal by Subject|7|||
145504497|NCT02004093|524704776|FG000|Overall Study|Other|3|||
145504498|NCT02004093|524704777|FG001|Overall Study|Other|1|||
145504499|NCT04085289|524704778|FG000|Overall Study|Withdrawal by Subject|0|||
145504500|NCT04085289|524704779|FG001|Overall Study|Withdrawal by Subject|0|||
145504501|NCT04085289|524704780|FG002|Overall Study|Withdrawal by Subject|1|||
145504502|NCT00414596|524704781|FG000|Overall Study|Protocol Violation|2|||
145504503|NCT04639258|524704782|FG000|Overall Study|Screen failure|5|||
145504504|NCT04639258|524704782|FG000|Overall Study|Physician Decision|2|||
145504505|NCT04639258|524704782|FG000|Overall Study|Early study termination|3|||
145504506|NCT04639258|524704782|FG000|Overall Study|Withdrawal by Subject|1|||
145504507|NCT01635153|524704784|FG000|Overall Study|Lost to Follow-up|40|||
145504508|NCT01635153|524704785|FG001|Overall Study|Lost to Follow-up|43|||
145732916|NCT02113579|525540850|FG000|Overall Study|Lost to Follow-up|6|||
145732917|NCT02113579|525540851|FG001|Overall Study|Lost to Follow-up|2|||
145732918|NCT03872453|525540855|FG000|Overall Study|Adverse Event|1|||
145399947|NCT01316224|524321178|FG000|Overall Study|Other|1|||
145399948|NCT00264147|524321179|FG000|Treatment I Period|Adverse Event|3|||
145399949|NCT00264147|524321180|FG001|Treatment I Period|Adverse Event|6|||
145399950|NCT00264147|524321181|FG002|Treatment I Period|Adverse Event|3|||
145399951|NCT00264147|524321182|FG003|Treatment I Period|Adverse Event|5|||
145504509|NCT02560558|524704786|FG000|Overall Study|Adverse Event|1|||
145504510|NCT02560558|524704787|FG001|Overall Study|Adverse Event|0|||
145399952|NCT00264147|524321183|FG004|Treatment I Period|Adverse Event|7|||
145399953|NCT00264147|524321184|FG005|Treatment I Period|Adverse Event|0|||
145399954|NCT00264147|524321179|FG000|Treatment I Period|Laboratory Adverse Event|0|||
145399955|NCT00264147|524321180|FG001|Treatment I Period|Laboratory Adverse Event|0|||
145504511|NCT02560558|524704786|FG000|Overall Study|Death|0|||
145504512|NCT02560558|524704787|FG001|Overall Study|Death|2|||
145504513|NCT02560558|524704786|FG000|Overall Study|Lost to Follow-up|0|||
145504514|NCT02560558|524704787|FG001|Overall Study|Lost to Follow-up|4|||
145504515|NCT02560558|524704786|FG000|Overall Study|Protocol Violation|3|||
145504516|NCT02560558|524704787|FG001|Overall Study|Protocol Violation|0|||
145399956|NCT00264147|524321181|FG002|Treatment I Period|Laboratory Adverse Event|0|||
145399957|NCT00264147|524321182|FG003|Treatment I Period|Laboratory Adverse Event|1|||
145504517|NCT02560558|524704786|FG000|Overall Study|Withdrawal by Subject|3|||
145504518|NCT02560558|524704787|FG001|Overall Study|Withdrawal by Subject|0|||
145504519|NCT00297258|524704798|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
145399958|NCT00264147|524321183|FG004|Treatment I Period|Laboratory Adverse Event|0|||
145399959|NCT00264147|524321184|FG005|Treatment I Period|Laboratory Adverse Event|0|||
145399960|NCT00264147|524321179|FG000|Treatment I Period|Lack of Efficacy|6|||
145399961|NCT00264147|524321180|FG001|Treatment I Period|Lack of Efficacy|2|||
145399962|NCT00264147|524321181|FG002|Treatment I Period|Lack of Efficacy|8|||
145399963|NCT00264147|524321182|FG003|Treatment I Period|Lack of Efficacy|0|||
145399964|NCT00264147|524321183|FG004|Treatment I Period|Lack of Efficacy|1|||
145399965|NCT00264147|524321184|FG005|Treatment I Period|Lack of Efficacy|0|||
145399966|NCT00264147|524321179|FG000|Treatment I Period|Lost to Follow-up|1|||
145399967|NCT00264147|524321180|FG001|Treatment I Period|Lost to Follow-up|0|||
145399968|NCT00264147|524321181|FG002|Treatment I Period|Lost to Follow-up|0|||
145399969|NCT00264147|524321182|FG003|Treatment I Period|Lost to Follow-up|1|||
145399970|NCT00264147|524321183|FG004|Treatment I Period|Lost to Follow-up|1|||
145399971|NCT00264147|524321184|FG005|Treatment I Period|Lost to Follow-up|0|||
145399972|NCT00264147|524321179|FG000|Treatment I Period|Protocol Violation|2|||
145399973|NCT00264147|524321180|FG001|Treatment I Period|Protocol Violation|2|||
145399974|NCT00264147|524321181|FG002|Treatment I Period|Protocol Violation|0|||
145399975|NCT00264147|524321182|FG003|Treatment I Period|Protocol Violation|0|||
145399976|NCT00264147|524321183|FG004|Treatment I Period|Protocol Violation|0|||
145399977|NCT00264147|524321184|FG005|Treatment I Period|Protocol Violation|0|||
145399978|NCT00264147|524321179|FG000|Treatment I Period|Withdrawal by Subject|2|||
145399979|NCT00264147|524321180|FG001|Treatment I Period|Withdrawal by Subject|0|||
145399980|NCT00264147|524321181|FG002|Treatment I Period|Withdrawal by Subject|0|||
145399981|NCT00264147|524321182|FG003|Treatment I Period|Withdrawal by Subject|2|||
145399982|NCT00264147|524321183|FG004|Treatment I Period|Withdrawal by Subject|2|||
145399983|NCT00264147|524321184|FG005|Treatment I Period|Withdrawal by Subject|0|||
145399984|NCT00264147|524321179|FG000|Treatment I Period|Patient out of town for an extended time|0|||
145399985|NCT00264147|524321180|FG001|Treatment I Period|Patient out of town for an extended time|1|||
145399986|NCT00264147|524321181|FG002|Treatment I Period|Patient out of town for an extended time|0|||
145399987|NCT00264147|524321182|FG003|Treatment I Period|Patient out of town for an extended time|0|||
145399988|NCT00264147|524321183|FG004|Treatment I Period|Patient out of town for an extended time|0|||
145399989|NCT00264147|524321184|FG005|Treatment I Period|Patient out of town for an extended time|0|||
145399990|NCT00264147|524321179|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145399991|NCT00264147|524321180|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145399992|NCT00264147|524321181|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
145399993|NCT00264147|524321182|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145399994|NCT00264147|524321183|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145399995|NCT00264147|524321184|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
145399996|NCT00264147|524321179|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
145399997|NCT00264147|524321180|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
145399998|NCT00264147|524321181|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
145399999|NCT00264147|524321182|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
145400000|NCT00264147|524321183|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
145400001|NCT00264147|524321184|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
145400002|NCT00264147|524321179|FG000|Treatment II Period|Adverse Event|0|||
145400003|NCT00264147|524321180|FG001|Treatment II Period|Adverse Event|0|||
145400004|NCT00264147|524321181|FG002|Treatment II Period|Adverse Event|0|||
145400005|NCT00264147|524321182|FG003|Treatment II Period|Adverse Event|0|||
145400006|NCT00264147|524321183|FG004|Treatment II Period|Adverse Event|9|||
145400007|NCT00264147|524321184|FG005|Treatment II Period|Adverse Event|9|||
145400008|NCT00264147|524321179|FG000|Treatment II Period|Laboratory Adverse Event|0|||
145400009|NCT00264147|524321180|FG001|Treatment II Period|Laboratory Adverse Event|0|||
145400010|NCT00264147|524321181|FG002|Treatment II Period|Laboratory Adverse Event|0|||
145400011|NCT00264147|524321182|FG003|Treatment II Period|Laboratory Adverse Event|0|||
145400012|NCT00264147|524321183|FG004|Treatment II Period|Laboratory Adverse Event|0|||
145400013|NCT00264147|524321184|FG005|Treatment II Period|Laboratory Adverse Event|1|||
145400014|NCT00264147|524321179|FG000|Treatment II Period|Lack of Efficacy|0|||
145400015|NCT00264147|524321180|FG001|Treatment II Period|Lack of Efficacy|0|||
145400016|NCT00264147|524321181|FG002|Treatment II Period|Lack of Efficacy|0|||
145400017|NCT00264147|524321182|FG003|Treatment II Period|Lack of Efficacy|0|||
145400018|NCT00264147|524321183|FG004|Treatment II Period|Lack of Efficacy|20|||
145400019|NCT00264147|524321184|FG005|Treatment II Period|Lack of Efficacy|19|||
145400020|NCT00264147|524321179|FG000|Treatment II Period|Lost to Follow-up|0|||
145400021|NCT00264147|524321180|FG001|Treatment II Period|Lost to Follow-up|0|||
145400022|NCT00264147|524321181|FG002|Treatment II Period|Lost to Follow-up|0|||
145400023|NCT00264147|524321182|FG003|Treatment II Period|Lost to Follow-up|0|||
145400024|NCT00264147|524321183|FG004|Treatment II Period|Lost to Follow-up|1|||
145400025|NCT00264147|524321184|FG005|Treatment II Period|Lost to Follow-up|1|||
145400026|NCT00264147|524321179|FG000|Treatment II Period|Withdrawal by Subject|0|||
145400027|NCT00264147|524321180|FG001|Treatment II Period|Withdrawal by Subject|0|||
145400028|NCT00264147|524321181|FG002|Treatment II Period|Withdrawal by Subject|0|||
145400029|NCT00264147|524321182|FG003|Treatment II Period|Withdrawal by Subject|0|||
145400030|NCT00264147|524321183|FG004|Treatment II Period|Withdrawal by Subject|3|||
145400031|NCT00264147|524321184|FG005|Treatment II Period|Withdrawal by Subject|2|||
145400032|NCT00264147|524321179|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
145400033|NCT00264147|524321180|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
145400034|NCT00264147|524321181|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
145400035|NCT00264147|524321182|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
145400036|NCT00264147|524321183|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
145400037|NCT00264147|524321184|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
145400038|NCT00449163|524321185|FG000|Overall Study|Physician Decision|3|||
145400039|NCT02949947|524321195|FG000|Overall Study|Non Compliance|0|||
145400040|NCT02949947|524321196|FG001|Overall Study|Non Compliance|1|||
145400041|NCT02949947|524321195|FG000|Overall Study|Insurance change|1|||
145400042|NCT02949947|524321196|FG001|Overall Study|Insurance change|0|||
145504520|NCT00297258|524704798|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
145400043|NCT02230891|524321200|FG000|Baseline|Did not meet inclusion|0|||
145400044|NCT02230891|524321201|FG001|Baseline|Did not meet inclusion|1|||
145400045|NCT02230891|524321202|FG002|Baseline|Did not meet inclusion|1|||
145400046|NCT02230891|524321200|FG000|2 Week|Withdrawal by Subject|2|||
145400047|NCT02230891|524321201|FG001|2 Week|Withdrawal by Subject|2|||
145400048|NCT02230891|524321202|FG002|2 Week|Withdrawal by Subject|0|||
145400049|NCT02230891|524321200|FG000|2 Week|Consent withdrawn|1|||
145400050|NCT02230891|524321201|FG001|2 Week|Consent withdrawn|0|||
145400051|NCT02230891|524321202|FG002|2 Week|Consent withdrawn|0|||
145400052|NCT02230891|524321200|FG000|6 Month|Withdrawal by Subject|1|||
145400053|NCT02230891|524321201|FG001|6 Month|Withdrawal by Subject|1|||
145400054|NCT02230891|524321202|FG002|6 Month|Withdrawal by Subject|1|||
145504521|NCT00297258|524704798|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
145504522|NCT00297258|524704798|FG000|Overall Study|Intercurrent Illness|3|||
145504523|NCT00297258|524704798|FG000|Overall Study|Intercurrent Death|2|||
145504524|NCT00297258|524704798|FG000|Overall Study|Deteriorization of General Condition|1|||
145504525|NCT00297258|524704798|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
145504526|NCT00297258|524704798|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
145504527|NCT00297258|524704798|FG000|Overall Study|Switch to Commercial Treatment|1|||
145504528|NCT00297258|524704798|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
145504529|NCT01263197|524704800|FG000|First Intervention (Period 1)|Adverse Event|0|||
145504530|NCT01263197|524704801|FG001|First Intervention (Period 1)|Adverse Event|0|||
145504531|NCT01263197|524704802|FG002|First Intervention (Period 1)|Adverse Event|0|||
145504532|NCT01263197|524704803|FG003|First Intervention (Period 1)|Adverse Event|0|||
145504533|NCT01263197|524704804|FG004|First Intervention (Period 1)|Adverse Event|0|||
145504534|NCT01263197|524704805|FG005|First Intervention (Period 1)|Adverse Event|1|||
145400055|NCT02230891|524321200|FG000|6 Month|Physician Decision|0|||
145400056|NCT02230891|524321201|FG001|6 Month|Physician Decision|2|||
145400057|NCT02230891|524321202|FG002|6 Month|Physician Decision|0|||
145400058|NCT02230891|524321200|FG000|12 Month|Death|1|||
145400059|NCT02230891|524321201|FG001|12 Month|Death|0|||
145400060|NCT02230891|524321202|FG002|12 Month|Death|0|||
145400061|NCT02230891|524321200|FG000|12 Month|Lost to Follow-up|0|||
145400062|NCT02230891|524321201|FG001|12 Month|Lost to Follow-up|1|||
145400063|NCT02230891|524321202|FG002|12 Month|Lost to Follow-up|0|||
145400064|NCT02230891|524321200|FG000|12 Month|Withdrawal by Subject|0|||
145400065|NCT02230891|524321201|FG001|12 Month|Withdrawal by Subject|2|||
145400066|NCT02230891|524321202|FG002|12 Month|Withdrawal by Subject|0|||
145400067|NCT02230891|524321200|FG000|18 Month End of Study|Death|0|||
145400068|NCT02230891|524321201|FG001|18 Month End of Study|Death|0|||
145400069|NCT02230891|524321202|FG002|18 Month End of Study|Death|1|||
145400070|NCT02230891|524321200|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
145400071|NCT02230891|524321201|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
145400072|NCT02230891|524321202|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
145400073|NCT04158219|524321203|FG000|Overall Study|Lost to Follow-up|1|||
145400074|NCT01814007|524321204|FG000|Overall Study|Withdrawal by Subject|1|||
145400075|NCT04194814|524321206|FG000|Overall Study|Physician Decision|3|||
145400076|NCT04194814|524321207|FG001|Overall Study|Physician Decision|0|||
145400077|NCT04194814|524321206|FG000|Overall Study|Withdrawal by Subject|0|||
145400078|NCT04194814|524321207|FG001|Overall Study|Withdrawal by Subject|2|||
145400079|NCT00434252|524322800|FG000|Overall Study|Lack of Efficacy|50|||
145400080|NCT00434252|524322801|FG001|Overall Study|Lack of Efficacy|100|||
145400081|NCT00434252|524322800|FG000|Overall Study|Adverse Event|6|||
145400082|NCT00434252|524322801|FG001|Overall Study|Adverse Event|13|||
145400083|NCT00434252|524322800|FG000|Overall Study|Death|1|||
145400084|NCT00434252|524322801|FG001|Overall Study|Death|2|||
145400085|NCT00434252|524322800|FG000|Overall Study|Lost to Follow-up|0|||
145400086|NCT00434252|524322801|FG001|Overall Study|Lost to Follow-up|1|||
145400087|NCT00434252|524322800|FG000|Overall Study|Physician Decision|4|||
145400088|NCT00434252|524322801|FG001|Overall Study|Physician Decision|8|||
145400089|NCT00434252|524322800|FG000|Overall Study|Withdrawal by Subject|3|||
145400090|NCT00434252|524322801|FG001|Overall Study|Withdrawal by Subject|7|||
145400091|NCT00720278|524322815|FG000|Overall Study|Adverse Event|5|||
145400092|NCT00720278|524322816|FG001|Overall Study|Adverse Event|3|||
145400093|NCT00720278|524322817|FG002|Overall Study|Adverse Event|4|||
145400094|NCT00720278|524322815|FG000|Overall Study|Withdrawal by Subject|0|||
145400095|NCT00720278|524322816|FG001|Overall Study|Withdrawal by Subject|1|||
145400096|NCT00720278|524322817|FG002|Overall Study|Withdrawal by Subject|0|||
145400097|NCT00720278|524322815|FG000|Overall Study|Lost to Follow-up|0|||
145400098|NCT00720278|524322816|FG001|Overall Study|Lost to Follow-up|0|||
145400099|NCT00720278|524322817|FG002|Overall Study|Lost to Follow-up|1|||
145400100|NCT00720278|524322815|FG000|Overall Study|Non-compliance|1|||
145400101|NCT00720278|524322816|FG001|Overall Study|Non-compliance|0|||
145400102|NCT00720278|524322817|FG002|Overall Study|Non-compliance|0|||
145400103|NCT00720278|524322815|FG000|Overall Study|eligibility criteria violation|1|||
145400104|NCT00720278|524322816|FG001|Overall Study|eligibility criteria violation|0|||
145400105|NCT00720278|524322817|FG002|Overall Study|eligibility criteria violation|1|||
145504535|NCT01263197|524704800|FG000|Washout Period 1|Protocol Violation|0|||
145400106|NCT03630393|524322823|FG000|Overall Study|Death|1|||
145266698|NCT04668066|523825251|FG014|Part 1: Follow-Up|Other|0|||
145732919|NCT03872453|525540856|FG001|Overall Study|Adverse Event|1|||
145400107|NCT03630393|524322824|FG001|Overall Study|Death|0|||
145400108|NCT00408499|524322825|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145400109|NCT00408499|524322826|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145400110|NCT00408499|524322827|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
145400111|NCT00408499|524322828|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145400112|NCT00408499|524322829|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
145400113|NCT00408499|524322825|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
145400114|NCT00408499|524322826|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
145400115|NCT00408499|524322827|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
145400116|NCT00408499|524322828|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
145400117|NCT00408499|524322829|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
145504536|NCT01263197|524704801|FG001|Washout Period 1|Protocol Violation|0|||
145504537|NCT01263197|524704802|FG002|Washout Period 1|Protocol Violation|0|||
145504538|NCT01263197|524704803|FG003|Washout Period 1|Protocol Violation|0|||
145504539|NCT01263197|524704804|FG004|Washout Period 1|Protocol Violation|1|||
145504540|NCT01263197|524704805|FG005|Washout Period 1|Protocol Violation|0|||
145504541|NCT01263197|524704800|FG000|Washout Period 2|Physician Decision|0|||
145504542|NCT01263197|524704801|FG001|Washout Period 2|Physician Decision|0|||
145504543|NCT01263197|524704802|FG002|Washout Period 2|Physician Decision|0|||
145504544|NCT01263197|524704803|FG003|Washout Period 2|Physician Decision|0|||
145504545|NCT01263197|524704804|FG004|Washout Period 2|Physician Decision|0|||
145504546|NCT01263197|524704805|FG005|Washout Period 2|Physician Decision|1|||
145504547|NCT01263197|524704800|FG000|Washout Period 2|Protocol Violation|0|||
145504548|NCT01263197|524704801|FG001|Washout Period 2|Protocol Violation|0|||
145504549|NCT01263197|524704802|FG002|Washout Period 2|Protocol Violation|0|||
145504550|NCT01263197|524704803|FG003|Washout Period 2|Protocol Violation|1|||
145504551|NCT01263197|524704804|FG004|Washout Period 2|Protocol Violation|0|||
145504552|NCT01263197|524704805|FG005|Washout Period 2|Protocol Violation|0|||
145504553|NCT01263197|524704800|FG000|Third Intervention (Period 3)|Adverse Event|0|||
145504554|NCT01263197|524704801|FG001|Third Intervention (Period 3)|Adverse Event|1|||
145504555|NCT01263197|524704802|FG002|Third Intervention (Period 3)|Adverse Event|0|||
145504556|NCT01263197|524704803|FG003|Third Intervention (Period 3)|Adverse Event|0|||
145504557|NCT01263197|524704804|FG004|Third Intervention (Period 3)|Adverse Event|0|||
145504558|NCT01263197|524704805|FG005|Third Intervention (Period 3)|Adverse Event|0|||
145504559|NCT01470326|524704806|FG000|Overall Study|Protocol Violation|32|||
145504560|NCT01470326|524704806|FG000|Overall Study|No Drug Administration Information|2|||
145504561|NCT01470326|524704806|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
145504562|NCT01967576|524704807|FG000|Overall Study|Withdrawal by Subject|3|||
145400118|NCT00408499|524322825|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
145400119|NCT00408499|524322826|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
145400120|NCT00408499|524322827|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
145400121|NCT00408499|524322828|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
145400122|NCT00408499|524322829|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
145400123|NCT00408499|524322825|FG000|Phase II- MTD Expansion|Adverse Event|0|||
145400124|NCT00408499|524322826|FG001|Phase II- MTD Expansion|Adverse Event|0|||
145400125|NCT00408499|524322827|FG002|Phase II- MTD Expansion|Adverse Event|0|||
145400126|NCT00408499|524322828|FG003|Phase II- MTD Expansion|Adverse Event|0|||
145400127|NCT00408499|524322829|FG004|Phase II- MTD Expansion|Adverse Event|9|||
145400128|NCT00408499|524322825|FG000|Phase II- MTD Expansion|Death|0|||
145400129|NCT00408499|524322826|FG001|Phase II- MTD Expansion|Death|0|||
145400130|NCT00408499|524322827|FG002|Phase II- MTD Expansion|Death|0|||
145400131|NCT00408499|524322828|FG003|Phase II- MTD Expansion|Death|0|||
145400132|NCT00408499|524322829|FG004|Phase II- MTD Expansion|Death|2|||
145400133|NCT00408499|524322825|FG000|Phase II- MTD Expansion|Physician Decision|0|||
145400134|NCT00408499|524322826|FG001|Phase II- MTD Expansion|Physician Decision|0|||
145400135|NCT00408499|524322827|FG002|Phase II- MTD Expansion|Physician Decision|0|||
145400136|NCT00408499|524322828|FG003|Phase II- MTD Expansion|Physician Decision|0|||
145400137|NCT00408499|524322829|FG004|Phase II- MTD Expansion|Physician Decision|1|||
145400138|NCT00408499|524322825|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145400139|NCT00408499|524322826|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145400140|NCT00408499|524322827|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145400141|NCT00408499|524322828|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
145400142|NCT00408499|524322829|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
145400143|NCT00408499|524322825|FG000|Phase II- MTD Expansion|treatment delay|0|||
145400144|NCT00408499|524322826|FG001|Phase II- MTD Expansion|treatment delay|0|||
145400145|NCT00408499|524322827|FG002|Phase II- MTD Expansion|treatment delay|0|||
145400146|NCT00408499|524322828|FG003|Phase II- MTD Expansion|treatment delay|0|||
145400147|NCT00408499|524322829|FG004|Phase II- MTD Expansion|treatment delay|3|||
145400148|NCT00997334|524322831|FG000|Overall Study|still on therapy|12|||
145400149|NCT00997334|524322831|FG000|Overall Study|Adverse Event|3|||
145400150|NCT00997334|524322831|FG000|Overall Study|Patient non-compliance|1|||
145266699|NCT04668066|523825252|FG015|Part 1: Follow-Up|Other|0|||
145400151|NCT00997334|524322831|FG000|Overall Study|Withdrawal by Subject|3|||
145400152|NCT00997334|524322831|FG000|Overall Study|Death|2|||
145400153|NCT00997334|524322831|FG000|Overall Study|Urgent Palliative Care|2|||
145400154|NCT00997334|524322831|FG000|Overall Study|No lesion amenable|1|||
145400155|NCT00997334|524322831|FG000|Overall Study|Ineligible|1|||
145400156|NCT01586195|524322834|FG000|Overall Study|Death|11|||
145732920|NCT03872453|525540857|FG002|Overall Study|Adverse Event|0|||
145732921|NCT03872453|525540858|FG003|Overall Study|Adverse Event|0|||
145266700|NCT04668066|523825253|FG016|Part 1: Follow-Up|Other|0|||
145732922|NCT03872453|525540855|FG000|Overall Study|Lost to Follow-up|8|||
145400157|NCT01586195|524322834|FG000|Overall Study|Withdrawal of Consent|5|||
145400158|NCT01586195|524322834|FG000|Overall Study|Started new anti-melanoma therapy|1|||
145400159|NCT01586195|524322834|FG000|Overall Study|Reason not specified|9|||
145400160|NCT03499795|524322841|FG000|Overall Study|Adverse Event|1|||
145400161|NCT03499795|524322841|FG000|Overall Study|Lost to Follow-up|1|||
145400162|NCT04748718|524322844|FG000|Overall Study|Lost to Follow-up|50|||
145400163|NCT01450813|524322845|FG000|Overall Study|Physician Decision|1|||
145400164|NCT01450813|524322846|FG001|Overall Study|Physician Decision|1|||
145400165|NCT01450813|524322847|FG002|Overall Study|Physician Decision|0|||
145400166|NCT01450813|524322848|FG003|Overall Study|Physician Decision|3|||
145400167|NCT01935089|524322850|FG000|Overall Study|Adverse Event|2|||
145400168|NCT01935089|524322850|FG000|Overall Study|Withdrawal by Subject|1|||
145400169|NCT01483118|524322851|FG000|Overall Study|Lost to Follow-up|12|||
145400170|NCT01483118|524322852|FG001|Overall Study|Lost to Follow-up|16|||
145400171|NCT00785356|524322853|FG000|Overall Study|Study prematurely terminated|8|||
145400172|NCT01079780|524322855|FG000|Overall Study|Disease progression|43|||
145400173|NCT01079780|524322856|FG001|Overall Study|Disease progression|7|||
145400174|NCT01079780|524322857|FG002|Overall Study|Disease progression|31|||
145400175|NCT01079780|524322855|FG000|Overall Study|Adverse Event|13|||
145400176|NCT01079780|524322856|FG001|Overall Study|Adverse Event|5|||
145400177|NCT01079780|524322857|FG002|Overall Study|Adverse Event|7|||
145400178|NCT01079780|524322855|FG000|Overall Study|Death|2|||
145400179|NCT01079780|524322856|FG001|Overall Study|Death|0|||
145400180|NCT01079780|524322857|FG002|Overall Study|Death|2|||
145400181|NCT01079780|524322855|FG000|Overall Study|Withdrawal by Subject|6|||
145400182|NCT01079780|524322856|FG001|Overall Study|Withdrawal by Subject|4|||
145400183|NCT01079780|524322857|FG002|Overall Study|Withdrawal by Subject|4|||
145400184|NCT01079780|524322855|FG000|Overall Study|Alternative therapy|2|||
145400185|NCT01079780|524322856|FG001|Overall Study|Alternative therapy|0|||
145400186|NCT01079780|524322857|FG002|Overall Study|Alternative therapy|2|||
145400187|NCT01079780|524322855|FG000|Overall Study|Physician Decision|1|||
145400188|NCT01079780|524322856|FG001|Overall Study|Physician Decision|0|||
145400189|NCT01079780|524322857|FG002|Overall Study|Physician Decision|1|||
145400190|NCT01079780|524322855|FG000|Overall Study|Error made in lesion measurement|1|||
145400191|NCT01079780|524322856|FG001|Overall Study|Error made in lesion measurement|0|||
145400192|NCT01079780|524322857|FG002|Overall Study|Error made in lesion measurement|0|||
145400193|NCT01079780|524322855|FG000|Overall Study|Patient had surgery|1|||
145400194|NCT01079780|524322856|FG001|Overall Study|Patient had surgery|0|||
145400195|NCT01079780|524322857|FG002|Overall Study|Patient had surgery|0|||
145400196|NCT01079780|524322855|FG000|Overall Study|Treatment cycle delay|0|||
145400197|NCT01079780|524322856|FG001|Overall Study|Treatment cycle delay|0|||
145400198|NCT01079780|524322857|FG002|Overall Study|Treatment cycle delay|1|||
145400199|NCT01079780|524322855|FG000|Overall Study|Never started treatment|1|||
145400200|NCT01079780|524322856|FG001|Overall Study|Never started treatment|0|||
145400201|NCT01079780|524322857|FG002|Overall Study|Never started treatment|2|||
145400202|NCT01178294|524322863|FG000|Overall Study|Adverse Event|4|||
145400203|NCT01178294|524322863|FG000|Overall Study|Lost to Follow-up|2|||
145400204|NCT01178294|524322863|FG000|Overall Study|Lack of Efficacy|1|||
145400205|NCT01178294|524322863|FG000|Overall Study|Death|1|||
145400206|NCT01178294|524322863|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
145400207|NCT01178294|524322863|FG000|Overall Study|Subject status is terminal|1|||
145400208|NCT01178294|524322863|FG000|Overall Study|Completion status could not be verified|1|||
145400209|NCT02783066|524322864|FG000|Overall Study|Withdrawal by Subject|13|||
145400210|NCT02051296|524322865|FG000|Overall Study|Lost to Follow-up|1|||
145400211|NCT02051296|524322866|FG001|Overall Study|Lost to Follow-up|2|||
145400212|NCT02051296|524322865|FG000|Overall Study|withdraw prior to treatment|7|||
145400213|NCT02051296|524322866|FG001|Overall Study|withdraw prior to treatment|7|||
145400214|NCT00975416|524322867|FG000|Overall Study|early discharge from tx|3|||
145400215|NCT00975416|524322868|FG001|Overall Study|early discharge from tx|5|||
145400216|NCT05379920|524322869|FG000|Overall Study|Lost to Follow-up|0|||
145400217|NCT05379920|524322870|FG001|Overall Study|Lost to Follow-up|5|||
145400218|NCT05379920|524322871|FG002|Overall Study|Lost to Follow-up|0|||
145400219|NCT05379920|524322872|FG003|Overall Study|Lost to Follow-up|0|||
145400220|NCT03176771|524322875|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
145400221|NCT03176771|524322876|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
145400222|NCT03176771|524322877|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
145400223|NCT03176771|524322878|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
145400224|NCT03176771|524322879|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
145504563|NCT01967576|524704807|FG000|Overall Study|Progressed/Removed from treatment|1|||
145504564|NCT01967576|524704807|FG000|Overall Study|Study closing at site|1|||
145504565|NCT01967576|524704807|FG000|Overall Study|Adverse Event|1|||
145504566|NCT01967576|524704807|FG000|Overall Study|Refused further treatment|1|||
145504567|NCT03967444|524704810|FG000|Overall Study|Lost to Follow-up|1|||
145504568|NCT03967444|524704811|FG001|Overall Study|Lost to Follow-up|2|||
145504569|NCT00345358|524704817|FG000|Primary Vaccination Phase|Other|0|||
145504570|NCT00345358|524704818|FG001|Primary Vaccination Phase|Other|1|||
145504571|NCT00345358|524704819|FG002|Primary Vaccination Phase|Other|1|||
145504572|NCT00345358|524704820|FG003|Primary Vaccination Phase|Other|0|||
145504573|NCT00345358|524704817|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
145504574|NCT00345358|524704818|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
145504575|NCT00345358|524704819|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
145504576|NCT00345358|524704820|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
145504577|NCT00345358|524704817|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
145504578|NCT00345358|524704818|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
145504579|NCT00345358|524704819|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
145504580|NCT00345358|524704820|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
145504581|NCT00345358|524704817|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
145504582|NCT00345358|524704818|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
145504583|NCT00345358|524704819|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
145504584|NCT00345358|524704820|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
145504585|NCT00345358|524704817|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
145504586|NCT00345358|524704818|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
145504587|NCT00345358|524704819|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
145504588|NCT00345358|524704820|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
145732923|NCT03872453|525540856|FG001|Overall Study|Lost to Follow-up|7|||
145504589|NCT00345358|524704817|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
145504590|NCT00345358|524704818|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
145504591|NCT00345358|524704819|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
145504592|NCT00345358|524704820|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
145504593|NCT02892448|524704822|FG000|Overall Study|Screening failure|2|||
145504594|NCT02892448|524704823|FG001|Overall Study|Screening failure|2|||
145504595|NCT02892448|524704824|FG002|Overall Study|Screening failure|1|||
145504596|NCT00346697|524704825|FG000|Overall Study|Lost to Follow-up|0|||
145504597|NCT00346697|524704826|FG001|Overall Study|Lost to Follow-up|1|||
145504598|NCT00499083|524704827|FG000|Overall Study|Not evaluable|3|||
145504599|NCT00318643|524704830|FG000|Overall Study|Adverse Event|0|||
145504600|NCT00318643|524704831|FG001|Overall Study|Adverse Event|0|||
145504601|NCT00318643|524704832|FG002|Overall Study|Adverse Event|0|||
145504602|NCT00318643|524704833|FG003|Overall Study|Adverse Event|0|||
145504603|NCT00318643|524704834|FG004|Overall Study|Adverse Event|1|||
145504604|NCT00318643|524704830|FG000|Overall Study|Participant's Decision|0|||
145504605|NCT00318643|524704831|FG001|Overall Study|Participant's Decision|0|||
145504606|NCT00318643|524704832|FG002|Overall Study|Participant's Decision|0|||
145504607|NCT00318643|524704833|FG003|Overall Study|Participant's Decision|0|||
145504608|NCT00318643|524704834|FG004|Overall Study|Participant's Decision|1|||
145504609|NCT00318643|524704830|FG000|Overall Study|Investigator's Decision|0|||
145504610|NCT00318643|524704831|FG001|Overall Study|Investigator's Decision|0|||
145504611|NCT00318643|524704832|FG002|Overall Study|Investigator's Decision|0|||
145504612|NCT00318643|524704833|FG003|Overall Study|Investigator's Decision|0|||
145504613|NCT00318643|524704834|FG004|Overall Study|Investigator's Decision|1|||
145504614|NCT01812252|524704837|FG000|Overall Study|Persistent Disease|1|||
145504615|NCT01812252|524704838|FG001|Overall Study|Persistent Disease|0|||
145504616|NCT01812252|524704837|FG000|Overall Study|Not transplanted|11|||
145504617|NCT01812252|524704838|FG001|Overall Study|Not transplanted|11|||
145504618|NCT01812252|524704837|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
145504619|NCT01812252|524704838|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
145504620|NCT01812252|524704837|FG000|Overall Study|Withdrawal by Subject|1|||
145504621|NCT01812252|524704838|FG001|Overall Study|Withdrawal by Subject|1|||
145504622|NCT01812252|524704837|FG000|Overall Study|Screen Failure|1|||
145504623|NCT01812252|524704838|FG001|Overall Study|Screen Failure|0|||
145504624|NCT01519921|524704842|FG000|Overall Study|Adverse Event|10|||
145504625|NCT01519921|524704843|FG001|Overall Study|Adverse Event|9|||
145504626|NCT01519921|524704842|FG000|Overall Study|Lack of Efficacy|4|||
145504627|NCT01519921|524704843|FG001|Overall Study|Lack of Efficacy|3|||
145504628|NCT01519921|524704842|FG000|Overall Study|Withdrawal by Subject|3|||
145504629|NCT01519921|524704843|FG001|Overall Study|Withdrawal by Subject|0|||
145504630|NCT01519921|524704842|FG000|Overall Study|Lost to Follow-up|2|||
145504631|NCT01519921|524704843|FG001|Overall Study|Lost to Follow-up|1|||
145504632|NCT01519921|524704842|FG000|Overall Study|Treatment refusal|2|||
145504633|NCT01519921|524704843|FG001|Overall Study|Treatment refusal|1|||
145504634|NCT01519921|524704842|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
145504635|NCT01519921|524704843|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
145504636|NCT04269889|524704844|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
145504637|NCT01721044|524704845|FG000|Treatment Period|Adverse Event|7|||
145504638|NCT01721044|524704846|FG001|Treatment Period|Adverse Event|7|||
145504639|NCT01721044|524704847|FG002|Treatment Period|Adverse Event|10|||
145504640|NCT01721044|524704845|FG000|Treatment Period|Death|0|||
145504641|NCT01721044|524704846|FG001|Treatment Period|Death|0|||
145504642|NCT01721044|524704847|FG002|Treatment Period|Death|1|||
145504643|NCT01721044|524704845|FG000|Treatment Period|Lack of Efficacy|16|||
145504644|NCT01721044|524704846|FG001|Treatment Period|Lack of Efficacy|4|||
145504645|NCT01721044|524704847|FG002|Treatment Period|Lack of Efficacy|4|||
145504646|NCT01721044|524704845|FG000|Treatment Period|Lost to Follow-up|0|||
145504647|NCT01721044|524704846|FG001|Treatment Period|Lost to Follow-up|0|||
145504648|NCT01721044|524704847|FG002|Treatment Period|Lost to Follow-up|1|||
145504649|NCT01721044|524704845|FG000|Treatment Period|Physician Decision|1|||
145504650|NCT01721044|524704846|FG001|Treatment Period|Physician Decision|0|||
145504651|NCT01721044|524704847|FG002|Treatment Period|Physician Decision|2|||
145504652|NCT01721044|524704845|FG000|Treatment Period|Protocol Violation|1|||
145504653|NCT01721044|524704846|FG001|Treatment Period|Protocol Violation|0|||
145504654|NCT01721044|524704847|FG002|Treatment Period|Protocol Violation|0|||
145504655|NCT01721044|524704845|FG000|Treatment Period|Withdrawal by Subject|7|||
145504656|NCT01721044|524704846|FG001|Treatment Period|Withdrawal by Subject|6|||
145504657|NCT01721044|524704847|FG002|Treatment Period|Withdrawal by Subject|1|||
145504658|NCT03155841|524704850|FG000|Overall Study|Protocol Violation|3|||
145504659|NCT03155841|524704851|FG001|Overall Study|Protocol Violation|4|||
145504660|NCT01526733|524704852|FG000|Phase 1|Protocol Violation|1|||
145504661|NCT01526733|524704853|FG001|Phase 1|Protocol Violation|0|||
145504662|NCT01526733|524704852|FG000|Phase 1|Withdrawal by Subject|1|||
145504663|NCT01526733|524704853|FG001|Phase 1|Withdrawal by Subject|1|||
145504664|NCT04032093|524704854|FG000|Overall Study|Lost to Follow-up|7|||
145504665|NCT04032093|524704855|FG001|Overall Study|Lost to Follow-up|7|||
145504666|NCT04032093|524704856|FG002|Overall Study|Lost to Follow-up|6|||
145504667|NCT04032093|524704857|FG003|Overall Study|Lost to Follow-up|10|||
145504668|NCT04032093|524704858|FG004|Overall Study|Lost to Follow-up|13|||
145504669|NCT04032093|524704859|FG005|Overall Study|Lost to Follow-up|7|||
145504670|NCT04032093|524704860|FG006|Overall Study|Lost to Follow-up|7|||
145504671|NCT04032093|524704861|FG007|Overall Study|Lost to Follow-up|5|||
145504672|NCT04032093|524704862|FG008|Overall Study|Lost to Follow-up|9|||
145504673|NCT04032093|524704863|FG009|Overall Study|Lost to Follow-up|12|||
145504674|NCT04032093|524704854|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504675|NCT04032093|524704855|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504676|NCT04032093|524704856|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504677|NCT04032093|524704857|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
145504678|NCT04032093|524704858|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
145504679|NCT04032093|524704859|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504680|NCT04032093|524704860|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504681|NCT04032093|524704861|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
145504682|NCT04032093|524704862|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
145504683|NCT04032093|524704863|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
145504684|NCT04032093|524704854|FG000|Overall Study|Other|1|||
145504685|NCT04032093|524704855|FG001|Overall Study|Other|0|||
145504686|NCT04032093|524704856|FG002|Overall Study|Other|0|||
145504687|NCT04032093|524704857|FG003|Overall Study|Other|1|||
145504688|NCT04032093|524704858|FG004|Overall Study|Other|1|||
145504689|NCT04032093|524704859|FG005|Overall Study|Other|0|||
145504690|NCT04032093|524704860|FG006|Overall Study|Other|0|||
145504691|NCT04032093|524704861|FG007|Overall Study|Other|0|||
145504692|NCT04032093|524704862|FG008|Overall Study|Other|0|||
145504693|NCT04032093|524704863|FG009|Overall Study|Other|1|||
145504694|NCT04032093|524704854|FG000|Overall Study|Withdrawal by Subject|1|||
145504695|NCT04032093|524704855|FG001|Overall Study|Withdrawal by Subject|3|||
145504696|NCT04032093|524704856|FG002|Overall Study|Withdrawal by Subject|2|||
145504697|NCT04032093|524704857|FG003|Overall Study|Withdrawal by Subject|2|||
145504698|NCT04032093|524704858|FG004|Overall Study|Withdrawal by Subject|3|||
145504699|NCT04032093|524704859|FG005|Overall Study|Withdrawal by Subject|0|||
145504700|NCT04032093|524704860|FG006|Overall Study|Withdrawal by Subject|0|||
145504701|NCT04032093|524704861|FG007|Overall Study|Withdrawal by Subject|0|||
145504702|NCT04032093|524704862|FG008|Overall Study|Withdrawal by Subject|0|||
145504703|NCT04032093|524704863|FG009|Overall Study|Withdrawal by Subject|0|||
145504704|NCT04032093|524704854|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145504705|NCT04032093|524704855|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145504706|NCT04032093|524704856|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145504707|NCT04032093|524704857|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145504708|NCT04032093|524704858|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145504709|NCT04032093|524704859|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145504710|NCT04032093|524704860|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
145504711|NCT04032093|524704861|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
145504712|NCT04032093|524704862|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
145504713|NCT04032093|524704863|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
145504714|NCT04032093|524704854|FG000|Overall Study|Adverse Event|0|||
145504715|NCT04032093|524704855|FG001|Overall Study|Adverse Event|0|||
145504716|NCT04032093|524704856|FG002|Overall Study|Adverse Event|0|||
145504717|NCT04032093|524704857|FG003|Overall Study|Adverse Event|0|||
145504718|NCT04032093|524704858|FG004|Overall Study|Adverse Event|0|||
145504719|NCT04032093|524704859|FG005|Overall Study|Adverse Event|0|||
145504720|NCT04032093|524704860|FG006|Overall Study|Adverse Event|0|||
145504721|NCT04032093|524704861|FG007|Overall Study|Adverse Event|0|||
145504722|NCT04032093|524704862|FG008|Overall Study|Adverse Event|0|||
145504723|NCT04032093|524704863|FG009|Overall Study|Adverse Event|1|||
145504724|NCT04032093|524704854|FG000|Overall Study|Physician Decision|0|||
145504725|NCT04032093|524704855|FG001|Overall Study|Physician Decision|0|||
145504726|NCT04032093|524704856|FG002|Overall Study|Physician Decision|0|||
145504727|NCT04032093|524704857|FG003|Overall Study|Physician Decision|0|||
145504728|NCT04032093|524704858|FG004|Overall Study|Physician Decision|0|||
145504729|NCT04032093|524704859|FG005|Overall Study|Physician Decision|1|||
145504730|NCT04032093|524704860|FG006|Overall Study|Physician Decision|0|||
145504731|NCT04032093|524704861|FG007|Overall Study|Physician Decision|0|||
145504732|NCT04032093|524704862|FG008|Overall Study|Physician Decision|0|||
145504733|NCT04032093|524704863|FG009|Overall Study|Physician Decision|0|||
145504734|NCT00949702|524704869|FG000|Overall Study|Death|40|||
145504735|NCT00949702|524704869|FG000|Overall Study|Disease progression|7|||
145504736|NCT00949702|524704869|FG000|Overall Study|Withdrawal of consent|1|||
145504737|NCT01654302|524704870|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
145504738|NCT01654302|524704871|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
145504739|NCT02377817|524704879|FG000|Overall Study|Transportation/childcare barriers.|2|||
145400225|NCT03176771|524322875|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145400226|NCT03176771|524322876|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
145400227|NCT03176771|524322877|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145400228|NCT03176771|524322878|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145400229|NCT03176771|524322879|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
145400230|NCT03176771|524322875|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
145400231|NCT03176771|524322876|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
145400232|NCT03176771|524322877|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
145400233|NCT03176771|524322878|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
145400234|NCT03176771|524322879|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
145400235|NCT03176771|524322875|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145400236|NCT03176771|524322876|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145400237|NCT03176771|524322877|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
145400238|NCT03176771|524322878|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145400239|NCT03176771|524322879|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
145400240|NCT03176771|524322875|FG000|Double-Blind Extension Period|Adverse Event|0|||
145400241|NCT03176771|524322876|FG001|Double-Blind Extension Period|Adverse Event|0|||
145400242|NCT03176771|524322877|FG002|Double-Blind Extension Period|Adverse Event|0|||
145400243|NCT03176771|524322878|FG003|Double-Blind Extension Period|Adverse Event|15|||
145400244|NCT03176771|524322879|FG004|Double-Blind Extension Period|Adverse Event|18|||
145400245|NCT03176771|524322875|FG000|Double-Blind Extension Period|Death|0|||
145400246|NCT03176771|524322876|FG001|Double-Blind Extension Period|Death|0|||
145400247|NCT03176771|524322877|FG002|Double-Blind Extension Period|Death|0|||
145400248|NCT03176771|524322878|FG003|Double-Blind Extension Period|Death|3|||
145400249|NCT03176771|524322879|FG004|Double-Blind Extension Period|Death|4|||
145400250|NCT03176771|524322875|FG000|Double-Blind Extension Period|Physician Decision|0|||
145400251|NCT03176771|524322876|FG001|Double-Blind Extension Period|Physician Decision|0|||
145400252|NCT03176771|524322877|FG002|Double-Blind Extension Period|Physician Decision|0|||
145400253|NCT03176771|524322878|FG003|Double-Blind Extension Period|Physician Decision|3|||
145400254|NCT03176771|524322879|FG004|Double-Blind Extension Period|Physician Decision|1|||
145400255|NCT03176771|524322875|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
145400256|NCT03176771|524322876|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
145400257|NCT03176771|524322877|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
145400258|NCT03176771|524322878|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
145400259|NCT03176771|524322879|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
145400260|NCT00106002|524322881|FG000|Overall Study|Did not take any study drug|1|||
145400261|NCT00106002|524322881|FG000|Overall Study|Ineligible after Registration|1|||
145400262|NCT02265510|524322885|FG000|Overall Study|Withdrawal by Subject|1|||
145400263|NCT02265510|524322886|FG001|Overall Study|Withdrawal by Subject|1|||
145400264|NCT02265510|524322887|FG002|Overall Study|Withdrawal by Subject|2|||
145400265|NCT02265510|524322888|FG003|Overall Study|Withdrawal by Subject|1|||
145400266|NCT02265510|524322889|FG004|Overall Study|Withdrawal by Subject|0|||
145400267|NCT02265510|524322890|FG005|Overall Study|Withdrawal by Subject|2|||
145400268|NCT02265510|524322891|FG006|Overall Study|Withdrawal by Subject|0|||
145400269|NCT02265510|524322892|FG007|Overall Study|Withdrawal by Subject|2|||
145400270|NCT02265510|524322893|FG008|Overall Study|Withdrawal by Subject|0|||
145400271|NCT02265510|524322894|FG009|Overall Study|Withdrawal by Subject|0|||
145400272|NCT02265510|524322895|FG010|Overall Study|Withdrawal by Subject|0|||
145400273|NCT02265510|524322896|FG011|Overall Study|Withdrawal by Subject|0|||
145400274|NCT02265510|524322897|FG012|Overall Study|Withdrawal by Subject|1|||
145400275|NCT02265510|524322898|FG013|Overall Study|Withdrawal by Subject|0|||
145400276|NCT02265510|524322885|FG000|Overall Study|Disease Progression|0|||
145400277|NCT02265510|524322886|FG001|Overall Study|Disease Progression|1|||
145400278|NCT02265510|524322887|FG002|Overall Study|Disease Progression|2|||
145400279|NCT02265510|524322888|FG003|Overall Study|Disease Progression|1|||
145400280|NCT02265510|524322889|FG004|Overall Study|Disease Progression|1|||
145400281|NCT02265510|524322890|FG005|Overall Study|Disease Progression|0|||
145400282|NCT02265510|524322891|FG006|Overall Study|Disease Progression|0|||
145400283|NCT02265510|524322892|FG007|Overall Study|Disease Progression|0|||
145400284|NCT02265510|524322893|FG008|Overall Study|Disease Progression|0|||
145400285|NCT02265510|524322894|FG009|Overall Study|Disease Progression|0|||
145400286|NCT02265510|524322895|FG010|Overall Study|Disease Progression|0|||
145400287|NCT02265510|524322896|FG011|Overall Study|Disease Progression|0|||
145400288|NCT02265510|524322897|FG012|Overall Study|Disease Progression|0|||
145400289|NCT02265510|524322898|FG013|Overall Study|Disease Progression|0|||
145400290|NCT02265510|524322885|FG000|Overall Study|Death|2|||
145400291|NCT02265510|524322886|FG001|Overall Study|Death|0|||
145400292|NCT02265510|524322887|FG002|Overall Study|Death|2|||
145400293|NCT02265510|524322888|FG003|Overall Study|Death|2|||
145400294|NCT02265510|524322889|FG004|Overall Study|Death|1|||
145400295|NCT02265510|524322890|FG005|Overall Study|Death|3|||
145400296|NCT02265510|524322891|FG006|Overall Study|Death|2|||
145400297|NCT02265510|524322892|FG007|Overall Study|Death|1|||
145400298|NCT02265510|524322893|FG008|Overall Study|Death|3|||
145400299|NCT02265510|524322894|FG009|Overall Study|Death|3|||
145400300|NCT02265510|524322895|FG010|Overall Study|Death|4|||
145400301|NCT02265510|524322896|FG011|Overall Study|Death|12|||
145400302|NCT02265510|524322897|FG012|Overall Study|Death|7|||
145400303|NCT02265510|524322898|FG013|Overall Study|Death|6|||
145400304|NCT02265510|524322885|FG000|Overall Study|Lost to Follow-up|0|||
145400305|NCT02265510|524322886|FG001|Overall Study|Lost to Follow-up|0|||
145400306|NCT02265510|524322887|FG002|Overall Study|Lost to Follow-up|0|||
145400307|NCT02265510|524322888|FG003|Overall Study|Lost to Follow-up|0|||
145504740|NCT02377817|524704880|FG001|Overall Study|Transportation/childcare barriers.|0|||
145504741|NCT02377817|524704879|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
145504742|NCT02377817|524704880|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
145504743|NCT02839200|524704881|FG000|Overall Study|Withdrawal by Subject|2|||
145504744|NCT02839200|524704882|FG001|Overall Study|Withdrawal by Subject|0|||
145504745|NCT02839200|524704883|FG002|Overall Study|Withdrawal by Subject|1|||
145504746|NCT02839200|524704884|FG003|Overall Study|Withdrawal by Subject|0|||
145504747|NCT02839200|524704885|FG004|Overall Study|Withdrawal by Subject|0|||
145504748|NCT02839200|524704886|FG005|Overall Study|Withdrawal by Subject|1|||
145504749|NCT02839200|524704881|FG000|Overall Study|Lost to Follow-up|2|||
145504750|NCT02839200|524704882|FG001|Overall Study|Lost to Follow-up|0|||
145504751|NCT02839200|524704883|FG002|Overall Study|Lost to Follow-up|0|||
145504752|NCT02839200|524704884|FG003|Overall Study|Lost to Follow-up|0|||
145504753|NCT02839200|524704885|FG004|Overall Study|Lost to Follow-up|1|||
145504754|NCT02839200|524704886|FG005|Overall Study|Lost to Follow-up|0|||
145504755|NCT02839200|524704881|FG000|Overall Study|Adverse Event|0|||
145504756|NCT02839200|524704882|FG001|Overall Study|Adverse Event|0|||
145504757|NCT02839200|524704883|FG002|Overall Study|Adverse Event|0|||
145504758|NCT02839200|524704884|FG003|Overall Study|Adverse Event|0|||
145504759|NCT02839200|524704885|FG004|Overall Study|Adverse Event|1|||
145504760|NCT02839200|524704886|FG005|Overall Study|Adverse Event|0|||
145504761|NCT02839200|524704881|FG000|Overall Study|Randomized in error|0|||
145504762|NCT02839200|524704882|FG001|Overall Study|Randomized in error|1|||
145504763|NCT02839200|524704883|FG002|Overall Study|Randomized in error|0|||
145504764|NCT02839200|524704884|FG003|Overall Study|Randomized in error|0|||
145504765|NCT02839200|524704885|FG004|Overall Study|Randomized in error|0|||
145504766|NCT02839200|524704886|FG005|Overall Study|Randomized in error|0|||
145504767|NCT03614156|524704903|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
145504768|NCT03614156|524704904|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
145504769|NCT03614156|524704905|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
145504770|NCT03614156|524704906|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
145504771|NCT03614156|524704903|FG000|Open-Label Treatment Period|Adverse Event|7|||
145504772|NCT03614156|524704904|FG001|Open-Label Treatment Period|Adverse Event|0|||
145504773|NCT03614156|524704905|FG002|Open-Label Treatment Period|Adverse Event|0|||
145504774|NCT03614156|524704906|FG003|Open-Label Treatment Period|Adverse Event|0|||
145504775|NCT03614156|524704903|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
145504776|NCT03614156|524704904|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
145504777|NCT03614156|524704905|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
145504778|NCT03614156|524704906|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
145504779|NCT03614156|524704903|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
145504780|NCT03614156|524704904|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
145504781|NCT03614156|524704905|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
145504782|NCT03614156|524704906|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
145504783|NCT03614156|524704903|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
145504784|NCT03614156|524704904|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
145504785|NCT03614156|524704905|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
145504786|NCT03614156|524704906|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
145504787|NCT03614156|524704903|FG000|Open-Label Treatment Period|Protocol Violation|2|||
145504788|NCT03614156|524704904|FG001|Open-Label Treatment Period|Protocol Violation|0|||
145504789|NCT03614156|524704905|FG002|Open-Label Treatment Period|Protocol Violation|0|||
145504790|NCT03614156|524704906|FG003|Open-Label Treatment Period|Protocol Violation|0|||
145504791|NCT03614156|524704903|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
145504792|NCT03614156|524704904|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
145504793|NCT03614156|524704905|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
145504794|NCT03614156|524704906|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
145504795|NCT03614156|524704903|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
145504796|NCT03614156|524704904|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
145504797|NCT03614156|524704905|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
145504798|NCT03614156|524704906|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
145504799|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
145504800|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
145504801|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
145504802|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
145504803|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145504804|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
145504805|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145504806|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145504807|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145504808|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145504809|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
145504810|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
145504811|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
145504812|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
145504813|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
145504814|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
145504815|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
145732924|NCT03872453|525540857|FG002|Overall Study|Lost to Follow-up|4|||
145400308|NCT02265510|524322889|FG004|Overall Study|Lost to Follow-up|1|||
145400309|NCT02265510|524322890|FG005|Overall Study|Lost to Follow-up|0|||
145400310|NCT02265510|524322891|FG006|Overall Study|Lost to Follow-up|0|||
145400311|NCT02265510|524322892|FG007|Overall Study|Lost to Follow-up|0|||
145400312|NCT02265510|524322893|FG008|Overall Study|Lost to Follow-up|0|||
145400313|NCT02265510|524322894|FG009|Overall Study|Lost to Follow-up|2|||
145400314|NCT02265510|524322895|FG010|Overall Study|Lost to Follow-up|0|||
145400315|NCT02265510|524322896|FG011|Overall Study|Lost to Follow-up|0|||
145400316|NCT02265510|524322897|FG012|Overall Study|Lost to Follow-up|0|||
145400317|NCT02265510|524322898|FG013|Overall Study|Lost to Follow-up|2|||
145400318|NCT02265510|524322885|FG000|Overall Study|Other|0|||
145400319|NCT02265510|524322886|FG001|Overall Study|Other|1|||
145400320|NCT02265510|524322887|FG002|Overall Study|Other|0|||
145400321|NCT02265510|524322888|FG003|Overall Study|Other|0|||
145400322|NCT02265510|524322889|FG004|Overall Study|Other|0|||
145400323|NCT02265510|524322890|FG005|Overall Study|Other|0|||
145400324|NCT02265510|524322891|FG006|Overall Study|Other|0|||
145400325|NCT02265510|524322892|FG007|Overall Study|Other|0|||
145400326|NCT02265510|524322893|FG008|Overall Study|Other|0|||
145400327|NCT02265510|524322894|FG009|Overall Study|Other|0|||
145400328|NCT02265510|524322895|FG010|Overall Study|Other|0|||
145400329|NCT02265510|524322896|FG011|Overall Study|Other|0|||
145400330|NCT02265510|524322897|FG012|Overall Study|Other|0|||
145400331|NCT02265510|524322898|FG013|Overall Study|Other|0|||
145400332|NCT02265510|524322885|FG000|Overall Study|Study Terminated by Sponsor|0|||
145400333|NCT02265510|524322886|FG001|Overall Study|Study Terminated by Sponsor|0|||
145400334|NCT02265510|524322887|FG002|Overall Study|Study Terminated by Sponsor|0|||
145400335|NCT02265510|524322888|FG003|Overall Study|Study Terminated by Sponsor|0|||
145400336|NCT02265510|524322889|FG004|Overall Study|Study Terminated by Sponsor|0|||
145400337|NCT02265510|524322890|FG005|Overall Study|Study Terminated by Sponsor|1|||
145400338|NCT02265510|524322891|FG006|Overall Study|Study Terminated by Sponsor|1|||
145400339|NCT02265510|524322892|FG007|Overall Study|Study Terminated by Sponsor|1|||
145400340|NCT02265510|524322893|FG008|Overall Study|Study Terminated by Sponsor|1|||
145400341|NCT02265510|524322894|FG009|Overall Study|Study Terminated by Sponsor|2|||
145400342|NCT02265510|524322895|FG010|Overall Study|Study Terminated by Sponsor|1|||
145400343|NCT02265510|524322896|FG011|Overall Study|Study Terminated by Sponsor|4|||
145400344|NCT02265510|524322897|FG012|Overall Study|Study Terminated by Sponsor|1|||
145400345|NCT02265510|524322898|FG013|Overall Study|Study Terminated by Sponsor|2|||
145400346|NCT01004614|524322899|FG000|Washout|Withdrawal by Subject|0|||
145400347|NCT01004614|524322900|FG001|Washout|Withdrawal by Subject|1|||
145400348|NCT01004614|524322901|FG002|Washout|Withdrawal by Subject|0|||
145400349|NCT01004614|524322902|FG003|Washout|Withdrawal by Subject|0|||
145400350|NCT02530385|524322903|FG000|Overall Study|Withdrawal by Subject|0|||
145400351|NCT02530385|524322904|FG001|Overall Study|Withdrawal by Subject|1|||
145400352|NCT01569022|524322906|FG000|First Intervention|Lost to Follow-up|2|||
145400353|NCT01569022|524322907|FG001|First Intervention|Lost to Follow-up|1|||
145400354|NCT01569022|524322906|FG000|Second Intervention|Lost to Follow-up|2|||
145400355|NCT01569022|524322907|FG001|Second Intervention|Lost to Follow-up|2|||
145400356|NCT02111083|524322912|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
145400357|NCT02111083|524322913|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
145400358|NCT00116142|524322914|FG000|Overall Study|Adverse Event|8|||
145400359|NCT00116142|524322915|FG001|Overall Study|Adverse Event|7|||
145400360|NCT00116142|524322914|FG000|Overall Study|Protocol Violation|2|||
145400361|NCT00116142|524322915|FG001|Overall Study|Protocol Violation|1|||
145400362|NCT00116142|524322914|FG000|Overall Study|Withdrawal by Subject|5|||
145400363|NCT00116142|524322915|FG001|Overall Study|Withdrawal by Subject|5|||
145400364|NCT00116142|524322914|FG000|Overall Study|Physician Decision|3|||
145400365|NCT00116142|524322915|FG001|Overall Study|Physician Decision|1|||
145400366|NCT00116142|524322914|FG000|Overall Study|Delayed Radiation Therapy|1|||
145400367|NCT00116142|524322915|FG001|Overall Study|Delayed Radiation Therapy|0|||
145400368|NCT00116142|524322914|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
145400369|NCT00116142|524322915|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
145400370|NCT00116142|524322914|FG000|Overall Study|Patient stopped due to depression|0|||
145400371|NCT00116142|524322915|FG001|Overall Study|Patient stopped due to depression|1|||
145400372|NCT00116142|524322914|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
145400373|NCT00116142|524322915|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
145400374|NCT00116142|524322914|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
145400375|NCT00116142|524322915|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
145400376|NCT00116142|524322914|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
145400377|NCT00116142|524322915|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
145400378|NCT00644059|524322916|FG000|Overall Study|Lost to Follow-up|37|||
145400379|NCT00644059|524322917|FG001|Overall Study|Lost to Follow-up|34|||
145400380|NCT00644059|524322918|FG002|Overall Study|Lost to Follow-up|16|||
145400381|NCT00644059|524322916|FG000|Overall Study|Withdrawal by Subject|52|||
145400382|NCT00644059|524322917|FG001|Overall Study|Withdrawal by Subject|60|||
145400383|NCT00644059|524322918|FG002|Overall Study|Withdrawal by Subject|30|||
145400384|NCT00644059|524322916|FG000|Overall Study|Adverse Event|8|||
145504816|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
145504817|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
145504818|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
145504819|NCT03614156|524704903|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
145504820|NCT03614156|524704904|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
145504821|NCT03614156|524704905|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
145266701|NCT04668066|523825254|FG017|Part 1: Follow-Up|Other|0|||
145400385|NCT00644059|524322917|FG001|Overall Study|Adverse Event|5|||
145400386|NCT00644059|524322918|FG002|Overall Study|Adverse Event|1|||
145400387|NCT00644059|524322916|FG000|Overall Study|Inappropriate Enrollment|1|||
145400388|NCT00644059|524322917|FG001|Overall Study|Inappropriate Enrollment|3|||
145400389|NCT00644059|524322918|FG002|Overall Study|Inappropriate Enrollment|0|||
145400390|NCT00644059|524322916|FG000|Overall Study|Protocol Deviation/violation|20|||
145400391|NCT00644059|524322917|FG001|Overall Study|Protocol Deviation/violation|19|||
145400392|NCT00644059|524322918|FG002|Overall Study|Protocol Deviation/violation|15|||
145400393|NCT00644059|524322916|FG000|Overall Study|Unable to classify|6|||
145400394|NCT00644059|524322917|FG001|Overall Study|Unable to classify|2|||
145400395|NCT00644059|524322918|FG002|Overall Study|Unable to classify|3|||
145400396|NCT01462942|524322920|FG000|Overall Study|Adverse Event|7|||
145400397|NCT01462942|524322921|FG001|Overall Study|Adverse Event|12|||
145400398|NCT01462942|524322922|FG002|Overall Study|Adverse Event|10|||
145504822|NCT03614156|524704906|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
145504823|NCT03614156|524704903|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
145504824|NCT03614156|524704904|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
145504825|NCT03614156|524704905|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
145504826|NCT03614156|524704906|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
145504827|NCT03614156|524704903|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
145504828|NCT03614156|524704904|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
145504829|NCT03614156|524704905|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
145504830|NCT03614156|524704906|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
145504831|NCT03614156|524704903|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
145504832|NCT03614156|524704904|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
145504833|NCT03614156|524704905|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
145504834|NCT03614156|524704906|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
145504835|NCT03207763|524706626|FG000|Overall Study|Lost to Follow-up|1|||
145504836|NCT03207763|524706627|FG001|Overall Study|Lost to Follow-up|0|||
145504837|NCT03751657|524706628|FG000|Overall Study|Physician Decision|0|||
145504838|NCT03751657|524706629|FG001|Overall Study|Physician Decision|1|||
145504839|NCT03751657|524706628|FG000|Overall Study|Withdrawal by Subject|1|||
145504840|NCT03751657|524706629|FG001|Overall Study|Withdrawal by Subject|1|||
145504841|NCT03751657|524706628|FG000|Overall Study|Lost to Follow-up|2|||
145504842|NCT03751657|524706629|FG001|Overall Study|Lost to Follow-up|1|||
145504843|NCT01938716|524706634|FG000|Overall Study|Physician Decision|2|||
145400399|NCT01462942|524322923|FG003|Overall Study|Adverse Event|11|||
145400400|NCT01462942|524322924|FG004|Overall Study|Adverse Event|11|||
145400401|NCT01462942|524322920|FG000|Overall Study|Other, including COPD exacerbation|3|||
145400402|NCT01462942|524322921|FG001|Overall Study|Other, including COPD exacerbation|5|||
145400403|NCT01462942|524322922|FG002|Overall Study|Other, including COPD exacerbation|2|||
145400404|NCT01462942|524322923|FG003|Overall Study|Other, including COPD exacerbation|8|||
145400405|NCT01462942|524322924|FG004|Overall Study|Other, including COPD exacerbation|5|||
145400406|NCT01462942|524322920|FG000|Overall Study|Withdrawal by Subject|14|||
145400407|NCT01462942|524322921|FG001|Overall Study|Withdrawal by Subject|10|||
145400408|NCT01462942|524322922|FG002|Overall Study|Withdrawal by Subject|14|||
145400409|NCT01462942|524322923|FG003|Overall Study|Withdrawal by Subject|16|||
145400410|NCT01462942|524322924|FG004|Overall Study|Withdrawal by Subject|19|||
145400411|NCT01462942|524322920|FG000|Overall Study|Lack of Efficacy|6|||
145400412|NCT01462942|524322921|FG001|Overall Study|Lack of Efficacy|0|||
145400413|NCT01462942|524322922|FG002|Overall Study|Lack of Efficacy|4|||
145400414|NCT01462942|524322923|FG003|Overall Study|Lack of Efficacy|5|||
145400415|NCT01462942|524322924|FG004|Overall Study|Lack of Efficacy|3|||
145400416|NCT01462942|524322920|FG000|Overall Study|Lost to Follow-up|0|||
145400417|NCT01462942|524322921|FG001|Overall Study|Lost to Follow-up|1|||
145400418|NCT01462942|524322922|FG002|Overall Study|Lost to Follow-up|1|||
145400419|NCT01462942|524322923|FG003|Overall Study|Lost to Follow-up|1|||
145400420|NCT01462942|524322924|FG004|Overall Study|Lost to Follow-up|1|||
145400421|NCT01462942|524322920|FG000|Overall Study|Protocol Violation|4|||
145400422|NCT01462942|524322921|FG001|Overall Study|Protocol Violation|6|||
145400423|NCT01462942|524322922|FG002|Overall Study|Protocol Violation|9|||
145400424|NCT01462942|524322923|FG003|Overall Study|Protocol Violation|9|||
145400425|NCT01462942|524322924|FG004|Overall Study|Protocol Violation|6|||
145400426|NCT01026493|524322925|FG000|Overall Study|Protocol Violation|0|||
145400427|NCT01026493|524322926|FG001|Overall Study|Protocol Violation|1|||
145400428|NCT01026493|524322927|FG002|Overall Study|Protocol Violation|0|||
145400429|NCT01026493|524322928|FG003|Overall Study|Protocol Violation|0|||
145400430|NCT01026493|524322929|FG004|Overall Study|Protocol Violation|2|||
145400431|NCT01026493|524322930|FG005|Overall Study|Protocol Violation|3|||
145400432|NCT01026493|524322931|FG006|Overall Study|Protocol Violation|4|||
145400433|NCT01026493|524322932|FG007|Overall Study|Protocol Violation|1|||
145400434|NCT04076917|524322936|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
145504844|NCT01938716|524706634|FG000|Overall Study|Withdrawal by Subject|2|||
145504845|NCT01358721|524706635|FG000|Overall Study|Withdrawal by Subject|0|||
145504846|NCT01358721|524706636|FG001|Overall Study|Withdrawal by Subject|0|||
145504847|NCT01358721|524706637|FG002|Overall Study|Withdrawal by Subject|0|||
145504848|NCT01358721|524706638|FG003|Overall Study|Withdrawal by Subject|1|||
145504849|NCT01358721|524706635|FG000|Overall Study|Death|0|||
145504850|NCT01358721|524706636|FG001|Overall Study|Death|2|||
145504851|NCT01358721|524706637|FG002|Overall Study|Death|0|||
145504852|NCT01358721|524706638|FG003|Overall Study|Death|0|||
145504853|NCT01358721|524706635|FG000|Overall Study|Study Drug Toxicity|1|||
145504854|NCT01358721|524706636|FG001|Overall Study|Study Drug Toxicity|3|||
145504855|NCT01358721|524706637|FG002|Overall Study|Study Drug Toxicity|4|||
145504856|NCT01358721|524706638|FG003|Overall Study|Study Drug Toxicity|5|||
145504857|NCT01358721|524706635|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
145504858|NCT01358721|524706636|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
145504859|NCT01358721|524706637|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
145504860|NCT01358721|524706638|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
145504861|NCT01358721|524706635|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
145400435|NCT04076917|524322936|FG000|Overall Study|Study closure|13|||
145400436|NCT04076917|524322936|FG000|Overall Study|Physician Decision|3|||
145400437|NCT04076917|524322936|FG000|Overall Study|Death|1|||
145400438|NCT04076917|524322936|FG000|Overall Study|Lost to Follow-up|1|||
145400439|NCT04076917|524322936|FG000|Overall Study|Withdrawal by Subject|1|||
145400440|NCT04076917|524322936|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
145400441|NCT01701245|524322942|FG000|Overall Study|Protocol Violation|1|||
145400442|NCT01701245|524322943|FG001|Overall Study|Protocol Violation|3|||
145400443|NCT01701245|524322942|FG000|Overall Study|Did not complete the open label period|11|||
145400444|NCT01701245|524322943|FG001|Overall Study|Did not complete the open label period|12|||
145400445|NCT00630916|524322948|FG000|Overall Study|Death|110|||
145400446|NCT00630916|524322948|FG000|Overall Study|Explant|8|||
145400447|NCT00630916|524322948|FG000|Overall Study|Lost to Follow-up|5|||
145400448|NCT00630916|524322948|FG000|Overall Study|Withdrawal by Subject|30|||
145400449|NCT00630916|524322948|FG000|Overall Study|Protocol Violation|7|||
145400450|NCT00630916|524322948|FG000|Overall Study|Physician Decision|47|||
145400451|NCT00630916|524322948|FG000|Overall Study|Lack of Efficacy|3|||
145400452|NCT02295644|524322949|FG000|Overall Study|Did not meet inclusion criterion|0|||
145400453|NCT02295644|524322950|FG001|Overall Study|Did not meet inclusion criterion|0|||
145400454|NCT02295644|524322951|FG002|Overall Study|Did not meet inclusion criterion|1|||
145400455|NCT02295644|524322952|FG003|Overall Study|Did not meet inclusion criterion|2|||
145400456|NCT02147626|524322954|FG000|Overall Study|Lost to Follow-up|4|||
145400457|NCT02147626|524322955|FG001|Overall Study|Lost to Follow-up|4|||
145400458|NCT02147626|524322954|FG000|Overall Study|Pregnancy|1|||
145400459|NCT02147626|524322955|FG001|Overall Study|Pregnancy|2|||
145400460|NCT02147626|524322954|FG000|Overall Study|Withdrawal by Subject|0|||
145400461|NCT02147626|524322955|FG001|Overall Study|Withdrawal by Subject|1|||
145400462|NCT03786380|524322956|FG000|Overall Study|Adverse Event|1|||
145400463|NCT03786380|524322957|FG001|Overall Study|Adverse Event|0|||
145400464|NCT03786380|524322958|FG002|Overall Study|Adverse Event|0|||
145400465|NCT03786380|524322959|FG003|Overall Study|Adverse Event|3|||
145400466|NCT03786380|524322960|FG004|Overall Study|Adverse Event|1|||
145400467|NCT03786380|524322956|FG000|Overall Study|Lack of Efficacy|0|||
145400468|NCT03786380|524322957|FG001|Overall Study|Lack of Efficacy|0|||
145400469|NCT03786380|524322958|FG002|Overall Study|Lack of Efficacy|0|||
145400470|NCT03786380|524322959|FG003|Overall Study|Lack of Efficacy|0|||
145400471|NCT03786380|524322960|FG004|Overall Study|Lack of Efficacy|1|||
145400472|NCT03786380|524322956|FG000|Overall Study|Withdrawal by Subject|1|||
145400473|NCT03786380|524322957|FG001|Overall Study|Withdrawal by Subject|2|||
145400474|NCT03786380|524322958|FG002|Overall Study|Withdrawal by Subject|2|||
145400475|NCT03786380|524322959|FG003|Overall Study|Withdrawal by Subject|1|||
145400476|NCT03786380|524322960|FG004|Overall Study|Withdrawal by Subject|2|||
145400477|NCT03786380|524322956|FG000|Overall Study|Lost to Follow-up|3|||
145400478|NCT03786380|524322957|FG001|Overall Study|Lost to Follow-up|0|||
145400479|NCT03786380|524322958|FG002|Overall Study|Lost to Follow-up|1|||
145400480|NCT03786380|524322959|FG003|Overall Study|Lost to Follow-up|2|||
145400481|NCT03786380|524322960|FG004|Overall Study|Lost to Follow-up|0|||
145400482|NCT03786380|524322956|FG000|Overall Study|Physician Decision|0|||
145400483|NCT03786380|524322957|FG001|Overall Study|Physician Decision|0|||
145400484|NCT03786380|524322958|FG002|Overall Study|Physician Decision|1|||
145400485|NCT03786380|524322959|FG003|Overall Study|Physician Decision|0|||
145400486|NCT03786380|524322960|FG004|Overall Study|Physician Decision|0|||
145400487|NCT03786380|524322956|FG000|Overall Study|Study Terminated by the Sponsor|30|||
145400488|NCT03786380|524322957|FG001|Overall Study|Study Terminated by the Sponsor|20|||
145400489|NCT03786380|524322958|FG002|Overall Study|Study Terminated by the Sponsor|50|||
145400490|NCT03786380|524322959|FG003|Overall Study|Study Terminated by the Sponsor|57|||
145400491|NCT03786380|524322960|FG004|Overall Study|Study Terminated by the Sponsor|23|||
145400492|NCT03786380|524322956|FG000|Overall Study|Reason Not Specified|0|||
145400493|NCT03786380|524322957|FG001|Overall Study|Reason Not Specified|0|||
145400494|NCT03786380|524322958|FG002|Overall Study|Reason Not Specified|0|||
145400495|NCT03786380|524322959|FG003|Overall Study|Reason Not Specified|0|||
145400496|NCT03786380|524322960|FG004|Overall Study|Reason Not Specified|1|||
145400497|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
145400498|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145400499|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145400500|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145732925|NCT03872453|525540858|FG003|Overall Study|Lost to Follow-up|4|||
145504862|NCT01358721|524706636|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
145504863|NCT01358721|524706637|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
145504864|NCT01358721|524706638|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
145504865|NCT01358721|524706635|FG000|Overall Study|Adverse Event related to study drug|1|||
145504866|NCT01358721|524706636|FG001|Overall Study|Adverse Event related to study drug|0|||
145504867|NCT01358721|524706637|FG002|Overall Study|Adverse Event related to study drug|0|||
145504868|NCT01358721|524706638|FG003|Overall Study|Adverse Event related to study drug|1|||
145504869|NCT01358721|524706635|FG000|Overall Study|Disease Progression|19|||
145504870|NCT01358721|524706636|FG001|Overall Study|Disease Progression|15|||
145504871|NCT01358721|524706637|FG002|Overall Study|Disease Progression|17|||
145504872|NCT01358721|524706638|FG003|Overall Study|Disease Progression|15|||
145504873|NCT01358721|524706635|FG000|Overall Study|Out of State/Unmet Criteria|0|||
145504874|NCT01358721|524706636|FG001|Overall Study|Out of State/Unmet Criteria|0|||
145504875|NCT01358721|524706637|FG002|Overall Study|Out of State/Unmet Criteria|1|||
145504876|NCT01358721|524706638|FG003|Overall Study|Out of State/Unmet Criteria|0|||
145504877|NCT04730271|524706644|FG000|Overall Study|Adverse Event|0|||
145504878|NCT04730271|524706645|FG001|Overall Study|Adverse Event|2|||
145504879|NCT04730271|524706644|FG000|Overall Study|Withdrawal by Subject|1|||
145504880|NCT04730271|524706645|FG001|Overall Study|Withdrawal by Subject|1|||
145504881|NCT04730271|524706644|FG000|Overall Study|Protocol Violation|7|||
145504882|NCT04730271|524706645|FG001|Overall Study|Protocol Violation|13|||
145504883|NCT04730271|524706644|FG000|Overall Study|Lost to Follow-up|3|||
145504884|NCT04730271|524706645|FG001|Overall Study|Lost to Follow-up|3|||
145504885|NCT04730271|524706644|FG000|Overall Study|Death|1|||
145504886|NCT04730271|524706645|FG001|Overall Study|Death|0|||
145504887|NCT02223858|524706650|FG000|Overall Study|Death|1|||
145504888|NCT02223858|524706651|FG001|Overall Study|Death|1|||
145504889|NCT02223858|524706650|FG000|Overall Study|Lost to Follow-up|6|||
145504890|NCT02223858|524706651|FG001|Overall Study|Lost to Follow-up|11|||
145504891|NCT02223858|524706650|FG000|Overall Study|Withdrawal by Subject|8|||
145504892|NCT02223858|524706651|FG001|Overall Study|Withdrawal by Subject|5|||
145504893|NCT02223858|524706650|FG000|Overall Study|Refused|9|||
145504894|NCT02223858|524706651|FG001|Overall Study|Refused|9|||
145504895|NCT04455815|524706652|FG000|Randomisation Phase|Adverse Event|1|||
145504896|NCT04455815|524706653|FG001|Randomisation Phase|Adverse Event|0|||
145504897|NCT04455815|524706652|FG000|Treatment Phase|Adverse Event|0|||
145504898|NCT04455815|524706653|FG001|Treatment Phase|Adverse Event|1|||
145504899|NCT04455815|524706652|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
145504900|NCT04455815|524706653|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
145504901|NCT04455815|524706652|FG000|Treatment Phase|Withdrawal by Subject|1|||
145504902|NCT04455815|524706653|FG001|Treatment Phase|Withdrawal by Subject|1|||
145504903|NCT02106390|524706654|FG000|Overall Study|Withdrawal by Subject|15|||
145504904|NCT02106390|524706655|FG001|Overall Study|Withdrawal by Subject|16|||
145504905|NCT02106390|524706656|FG002|Overall Study|Withdrawal by Subject|15|||
145504906|NCT02106390|524706654|FG000|Overall Study|Lost to Follow-up|25|||
145504907|NCT02106390|524706655|FG001|Overall Study|Lost to Follow-up|20|||
145504908|NCT02106390|524706656|FG002|Overall Study|Lost to Follow-up|13|||
145504909|NCT02106390|524706654|FG000|Overall Study|Other: Administrative Reason|8|||
145504910|NCT02106390|524706655|FG001|Overall Study|Other: Administrative Reason|5|||
145504911|NCT02106390|524706656|FG002|Overall Study|Other: Administrative Reason|12|||
145504912|NCT02106390|524706654|FG000|Overall Study|Other: Unspecified|1|||
145504913|NCT02106390|524706655|FG001|Overall Study|Other: Unspecified|4|||
145504914|NCT02106390|524706656|FG002|Overall Study|Other: Unspecified|2|||
145504915|NCT02106390|524706654|FG000|Overall Study|Adverse Event|0|||
145504916|NCT02106390|524706655|FG001|Overall Study|Adverse Event|2|||
145504917|NCT02106390|524706656|FG002|Overall Study|Adverse Event|1|||
145504918|NCT02106390|524706654|FG000|Overall Study|Protocol Violation|0|||
145504919|NCT02106390|524706655|FG001|Overall Study|Protocol Violation|1|||
145504920|NCT02106390|524706656|FG002|Overall Study|Protocol Violation|0|||
145504921|NCT01189032|524706657|FG000|Overall Study|Adverse Event|1|||
145504922|NCT01189032|524706658|FG001|Overall Study|Adverse Event|3|||
145504923|NCT01189032|524706659|FG002|Overall Study|Adverse Event|4|||
145504924|NCT01189032|524706657|FG000|Overall Study|Lack of Efficacy|2|||
145504925|NCT01189032|524706658|FG001|Overall Study|Lack of Efficacy|3|||
145504926|NCT01189032|524706659|FG002|Overall Study|Lack of Efficacy|0|||
145504927|NCT01189032|524706657|FG000|Overall Study|Withdrawal by Subject|1|||
145504928|NCT01189032|524706658|FG001|Overall Study|Withdrawal by Subject|0|||
145504929|NCT01189032|524706659|FG002|Overall Study|Withdrawal by Subject|1|||
145504930|NCT01189032|524706657|FG000|Overall Study|Protocol Violation|1|||
145504931|NCT01189032|524706658|FG001|Overall Study|Protocol Violation|1|||
145504932|NCT01189032|524706659|FG002|Overall Study|Protocol Violation|1|||
145504933|NCT00473382|524706660|FG000|Core Study|Adverse Event|3|||
145504934|NCT00473382|524706661|FG001|Core Study|Adverse Event|1|||
145504935|NCT00473382|524706662|FG002|Core Study|Adverse Event|1|||
145504936|NCT00473382|524706660|FG000|Core Study|Death|3|||
145504937|NCT00473382|524706661|FG001|Core Study|Death|5|||
145504938|NCT00473382|524706662|FG002|Core Study|Death|10|||
145504939|NCT00473382|524706660|FG000|Core Study|Lost to Follow-up|3|||
145504940|NCT00473382|524706661|FG001|Core Study|Lost to Follow-up|3|||
145504941|NCT00473382|524706662|FG002|Core Study|Lost to Follow-up|3|||
145504942|NCT00473382|524706660|FG000|Core Study|Physician Decision|1|||
145504943|NCT00473382|524706661|FG001|Core Study|Physician Decision|2|||
145504944|NCT00473382|524706662|FG002|Core Study|Physician Decision|2|||
145504945|NCT00473382|524706660|FG000|Core Study|Subject non-compliance|5|||
145504946|NCT00473382|524706661|FG001|Core Study|Subject non-compliance|2|||
145504947|NCT00473382|524706662|FG002|Core Study|Subject non-compliance|1|||
145504948|NCT00473382|524706660|FG000|Core Study|Subject needed other treatment|1|||
145504949|NCT00473382|524706661|FG001|Core Study|Subject needed other treatment|3|||
145504950|NCT00473382|524706662|FG002|Core Study|Subject needed other treatment|2|||
145504951|NCT00473382|524706660|FG000|Core Study|Subject's decision|12|||
145504952|NCT00473382|524706661|FG001|Core Study|Subject's decision|11|||
145504953|NCT00473382|524706662|FG002|Core Study|Subject's decision|10|||
145504954|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
145504955|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
145504956|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
145504957|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Death|1|||
145504958|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Death|3|||
145504959|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Death|3|||
145504960|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
145504961|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
145504962|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
145504963|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
145504964|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
145504965|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
145504966|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
145504967|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
145504968|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
145504969|NCT00473382|524706660|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
145504970|NCT00473382|524706661|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
145504971|NCT00473382|524706662|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
145504972|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
145504973|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
145504974|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
145504975|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Death|1|||
145504976|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Death|7|||
145504977|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Death|4|||
145504978|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
145504979|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
145504980|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
145504981|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
145504982|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
145504983|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
145504984|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
145504985|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
145504986|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
145504987|NCT00473382|524706660|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
145504988|NCT00473382|524706661|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
145504989|NCT00473382|524706662|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
145504990|NCT01166282|524706663|FG000|Open-label Period|Adverse Event|0|||
145504991|NCT01166282|524706664|FG001|Open-label Period|Adverse Event|0|||
145504992|NCT01166282|524706665|FG002|Open-label Period|Adverse Event|6|||
145504993|NCT01166282|524706663|FG000|Open-label Period|Withdrawal by Subject|0|||
145504994|NCT01166282|524706664|FG001|Open-label Period|Withdrawal by Subject|0|||
145504995|NCT01166282|524706665|FG002|Open-label Period|Withdrawal by Subject|4|||
145504996|NCT01166282|524706663|FG000|Open-label Period|Lack of Efficacy|0|||
145504997|NCT01166282|524706664|FG001|Open-label Period|Lack of Efficacy|0|||
145504998|NCT01166282|524706665|FG002|Open-label Period|Lack of Efficacy|2|||
145504999|NCT01166282|524706663|FG000|Open-label Period|Remission|0|||
145505000|NCT01166282|524706664|FG001|Open-label Period|Remission|0|||
145732926|NCT03872453|525540855|FG000|Overall Study|Never Treated Migraine|19|||
145732927|NCT03872453|525540856|FG001|Overall Study|Never Treated Migraine|17|||
145732928|NCT03872453|525540857|FG002|Overall Study|Never Treated Migraine|13|||
145732929|NCT03872453|525540858|FG003|Overall Study|Never Treated Migraine|12|||
145505001|NCT01166282|524706665|FG002|Open-label Period|Remission|4|||
145505002|NCT01166282|524706663|FG000|Open-label Period|Irregular Compliance|0|||
145505003|NCT01166282|524706664|FG001|Open-label Period|Irregular Compliance|0|||
145505004|NCT01166282|524706665|FG002|Open-label Period|Irregular Compliance|1|||
145505005|NCT02577718|524706666|FG000|Overall Study|Death|6|||
145505006|NCT02577718|524706666|FG000|Overall Study|Withdrawal by Subject|2|||
145505007|NCT01995838|524706667|FG000|Overall Study|Lost to Follow-up|0|||
145505008|NCT01995838|524706668|FG001|Overall Study|Lost to Follow-up|1|||
145505009|NCT01995838|524706669|FG002|Overall Study|Lost to Follow-up|0|||
145505010|NCT01995838|524706670|FG003|Overall Study|Lost to Follow-up|0|||
145505011|NCT01995838|524706671|FG004|Overall Study|Lost to Follow-up|0|||
145505012|NCT01995838|524706672|FG005|Overall Study|Lost to Follow-up|0|||
145505013|NCT01995838|524706673|FG006|Overall Study|Lost to Follow-up|1|||
145505014|NCT01995838|524706667|FG000|Overall Study|Participant choice|2|||
145505015|NCT01995838|524706668|FG001|Overall Study|Participant choice|0|||
145505016|NCT01995838|524706669|FG002|Overall Study|Participant choice|0|||
145505017|NCT01995838|524706670|FG003|Overall Study|Participant choice|0|||
145505018|NCT01995838|524706671|FG004|Overall Study|Participant choice|0|||
145505019|NCT01995838|524706672|FG005|Overall Study|Participant choice|1|||
145505020|NCT01995838|524706673|FG006|Overall Study|Participant choice|1|||
145505021|NCT01995838|524706667|FG000|Overall Study|Adverse Event|0|||
145505022|NCT01995838|524706668|FG001|Overall Study|Adverse Event|0|||
145505023|NCT01995838|524706669|FG002|Overall Study|Adverse Event|0|||
145505024|NCT01995838|524706670|FG003|Overall Study|Adverse Event|0|||
145505025|NCT01995838|524706671|FG004|Overall Study|Adverse Event|0|||
145505026|NCT01995838|524706672|FG005|Overall Study|Adverse Event|0|||
145505027|NCT01995838|524706673|FG006|Overall Study|Adverse Event|1|||
145505028|NCT01995838|524706667|FG000|Overall Study|Withdrawal by Subject|0|||
145505029|NCT01995838|524706668|FG001|Overall Study|Withdrawal by Subject|0|||
145505030|NCT01995838|524706669|FG002|Overall Study|Withdrawal by Subject|0|||
145505031|NCT01995838|524706670|FG003|Overall Study|Withdrawal by Subject|0|||
145505032|NCT01995838|524706671|FG004|Overall Study|Withdrawal by Subject|1|||
145505033|NCT01995838|524706672|FG005|Overall Study|Withdrawal by Subject|0|||
145400501|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145400502|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145400503|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
145400504|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
145400505|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400506|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400507|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400508|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400509|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400510|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
145400511|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400512|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
145400513|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400514|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400515|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400516|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400517|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
145400518|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145400519|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145400520|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
145400521|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145400522|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145400523|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145505034|NCT01995838|524706673|FG006|Overall Study|Withdrawal by Subject|0|||
145505035|NCT01995838|524706667|FG000|Overall Study|Other|3|||
145505036|NCT01995838|524706668|FG001|Overall Study|Other|1|||
145505037|NCT01995838|524706669|FG002|Overall Study|Other|0|||
145505038|NCT01995838|524706670|FG003|Overall Study|Other|2|||
145505039|NCT01995838|524706671|FG004|Overall Study|Other|1|||
145505040|NCT01995838|524706672|FG005|Overall Study|Other|1|||
145505041|NCT01995838|524706673|FG006|Overall Study|Other|2|||
145732930|NCT03872453|525540855|FG000|Overall Study|Pregnancy|1|||
145505042|NCT00275509|524706678|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
145505043|NCT00275509|524706679|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
145505044|NCT03196349|524706680|FG000|Overall Study|Did not receive study drug|0|||
145505045|NCT03196349|524706681|FG001|Overall Study|Did not receive study drug|1|||
145505046|NCT03196349|524706682|FG002|Overall Study|Did not receive study drug|2|||
145505047|NCT03196349|524706680|FG000|Overall Study|No data entered|2|||
145505048|NCT03196349|524706681|FG001|Overall Study|No data entered|4|||
145505049|NCT03196349|524706682|FG002|Overall Study|No data entered|0|||
145505050|NCT03196349|524706680|FG000|Overall Study|Study Terminated early|15|||
145505051|NCT03196349|524706681|FG001|Overall Study|Study Terminated early|9|||
145505052|NCT03196349|524706682|FG002|Overall Study|Study Terminated early|11|||
145505053|NCT02819804|524706683|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
145505054|NCT03388164|524706688|FG000|Overall Study|Withdrawal by Subject|3|||
145505055|NCT03388164|524706689|FG001|Overall Study|Withdrawal by Subject|1|||
145505056|NCT00686686|524706691|FG000|Overall Study|Non-compliance|1|||
145505057|NCT00686686|524706691|FG000|Overall Study|Adverse Event|2|||
145505058|NCT00686686|524706691|FG000|Overall Study|Lost to Follow-up|3|||
145505059|NCT01012440|524706692|FG000|Overall Study|Withdrawal by Subject|2|||
145505060|NCT00131248|524706694|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
145505061|NCT00131248|524706695|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
145505062|NCT00477386|524706703|FG000|Overall Study|Adverse Event|4|||
145505063|NCT00477386|524706704|FG001|Overall Study|Adverse Event|8|||
145505064|NCT00477386|524706703|FG000|Overall Study|Disease progression, relapse|3|||
145505065|NCT00477386|524706704|FG001|Overall Study|Disease progression, relapse|4|||
145505066|NCT00477386|524706703|FG000|Overall Study|Disease progression, refractory|1|||
145505067|NCT00477386|524706704|FG001|Overall Study|Disease progression, refractory|3|||
145505068|NCT00477386|524706703|FG000|Overall Study|Other|1|||
145505069|NCT00477386|524706704|FG001|Overall Study|Other|2|||
145505070|NCT00477386|524706703|FG000|Overall Study|Physician Decision|1|||
145505071|NCT00477386|524706704|FG001|Overall Study|Physician Decision|0|||
145505072|NCT00477386|524706703|FG000|Overall Study|Withdrawal by Subject|1|||
145505073|NCT00477386|524706704|FG001|Overall Study|Withdrawal by Subject|0|||
145505074|NCT01254422|524706705|FG000|Overall Study|Protocol Violation|1|||
145505075|NCT01254422|524706706|FG001|Overall Study|Protocol Violation|0|||
145505076|NCT01254422|524706705|FG000|Overall Study|Adverse Event|1|||
145505077|NCT01254422|524706706|FG001|Overall Study|Adverse Event|0|||
145505078|NCT01254422|524706705|FG000|Overall Study|Serious adverse event|0|||
145505079|NCT01254422|524706706|FG001|Overall Study|Serious adverse event|1|||
145505080|NCT01254422|524706705|FG000|Overall Study|Lost to Follow-up|1|||
145505081|NCT01254422|524706706|FG001|Overall Study|Lost to Follow-up|0|||
145505082|NCT02207088|524706707|FG000|Overall Study|Adverse Event|2|||
145505083|NCT00643162|524706708|FG000|Overall Study|Withdrawal by Subject|1|||
145505084|NCT00643162|524706709|FG001|Overall Study|Withdrawal by Subject|1|||
145505085|NCT02691507|524706710|FG000|Overall Study|Missed Visit 3|0|||
145505086|NCT02691507|524706711|FG001|Overall Study|Missed Visit 3|1|||
145505087|NCT03023397|524706712|FG000|Run-In|Failed screening allergen challenge|1|||
145505088|NCT03023397|524706713|FG001|Run-In|Failed screening allergen challenge|0|||
145505089|NCT03023397|524706714|FG002|Run-In|Failed screening allergen challenge|0|||
145505090|NCT03023397|524706712|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
145505091|NCT03023397|524706713|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
145505092|NCT03023397|524706714|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
145505093|NCT01216189|524706716|FG000|Overall Study|Lost to Follow-up|21|||
145505094|NCT01216189|524706717|FG001|Overall Study|Lost to Follow-up|3|||
145505095|NCT01216189|524706716|FG000|Overall Study|Death|4|||
145505096|NCT01216189|524706717|FG001|Overall Study|Death|2|||
145505097|NCT00541385|524706718|FG000|Overall Study|Adverse Event|6|||
145505098|NCT00541385|524706719|FG001|Overall Study|Adverse Event|3|||
145505099|NCT00541385|524706718|FG000|Overall Study|Withdrawal by Subject|2|||
145505100|NCT00541385|524706719|FG001|Overall Study|Withdrawal by Subject|2|||
145505101|NCT00541385|524706718|FG000|Overall Study|Lost to Follow-up|6|||
145505102|NCT00541385|524706719|FG001|Overall Study|Lost to Follow-up|1|||
145505103|NCT00541385|524706718|FG000|Overall Study|Parasite reappearance/malaria|67|||
145505104|NCT00541385|524706719|FG001|Overall Study|Parasite reappearance/malaria|32|||
145505105|NCT01733680|524706720|FG000|Overall Study|Withdrawal by Subject|0|||
145505106|NCT01733680|524706721|FG001|Overall Study|Withdrawal by Subject|1|||
145505107|NCT02699749|524706723|FG000|Overall Study|Other|0|||
145505108|NCT02699749|524706724|FG001|Overall Study|Other|0|||
145505109|NCT02699749|524706725|FG002|Overall Study|Other|2|||
145505110|NCT02699749|524706726|FG003|Overall Study|Other|0|||
145505111|NCT02699749|524706727|FG004|Overall Study|Other|0|||
145505112|NCT02699749|524706728|FG005|Overall Study|Other|1|||
145505113|NCT02699749|524706729|FG006|Overall Study|Other|1|||
145505114|NCT02699749|524706730|FG007|Overall Study|Other|0|||
145505115|NCT02699749|524706731|FG008|Overall Study|Other|0|||
145505116|NCT02699749|524706732|FG009|Overall Study|Other|0|||
145505117|NCT02699749|524706733|FG010|Overall Study|Other|1|||
145505118|NCT02699749|524706734|FG011|Overall Study|Other|0|||
145505119|NCT02699749|524706735|FG012|Overall Study|Other|0|||
145505120|NCT02699749|524706736|FG013|Overall Study|Other|0|||
145505121|NCT02699749|524706723|FG000|Overall Study|Progressive Disease|3|||
145505122|NCT02699749|524706724|FG001|Overall Study|Progressive Disease|3|||
145505123|NCT02699749|524706725|FG002|Overall Study|Progressive Disease|14|||
145505124|NCT02699749|524706726|FG003|Overall Study|Progressive Disease|3|||
145505125|NCT02699749|524706727|FG004|Overall Study|Progressive Disease|3|||
145505126|NCT02699749|524706728|FG005|Overall Study|Progressive Disease|7|||
145505127|NCT02699749|524706729|FG006|Overall Study|Progressive Disease|5|||
145505128|NCT02699749|524706730|FG007|Overall Study|Progressive Disease|5|||
145505129|NCT02699749|524706731|FG008|Overall Study|Progressive Disease|6|||
145505130|NCT02699749|524706732|FG009|Overall Study|Progressive Disease|6|||
145505131|NCT02699749|524706733|FG010|Overall Study|Progressive Disease|5|||
145505132|NCT02699749|524706734|FG011|Overall Study|Progressive Disease|4|||
145400524|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
145400525|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400526|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400527|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
145400528|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400529|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400530|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400531|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
145400532|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400533|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400534|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
145400535|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400536|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400537|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400538|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
145400539|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400540|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400541|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400542|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
145400543|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400544|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400545|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
145400546|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145400547|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145400548|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145400549|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
145400550|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145505133|NCT02699749|524706735|FG012|Overall Study|Progressive Disease|3|||
145505134|NCT02699749|524706736|FG013|Overall Study|Progressive Disease|5|||
145505135|NCT02699749|524706723|FG000|Overall Study|Death|0|||
145505136|NCT02699749|524706724|FG001|Overall Study|Death|0|||
145505137|NCT02699749|524706725|FG002|Overall Study|Death|0|||
145505138|NCT02699749|524706726|FG003|Overall Study|Death|0|||
145505139|NCT02699749|524706727|FG004|Overall Study|Death|0|||
145505140|NCT02699749|524706728|FG005|Overall Study|Death|0|||
145505141|NCT02699749|524706729|FG006|Overall Study|Death|0|||
145505142|NCT02699749|524706730|FG007|Overall Study|Death|0|||
145505143|NCT02699749|524706731|FG008|Overall Study|Death|0|||
145505144|NCT02699749|524706732|FG009|Overall Study|Death|0|||
145505145|NCT02699749|524706733|FG010|Overall Study|Death|0|||
145505146|NCT02699749|524706734|FG011|Overall Study|Death|0|||
145505147|NCT02699749|524706735|FG012|Overall Study|Death|0|||
145505148|NCT02699749|524706736|FG013|Overall Study|Death|1|||
145505149|NCT02699749|524706723|FG000|Overall Study|Lost to Follow-up|0|||
145505150|NCT02699749|524706724|FG001|Overall Study|Lost to Follow-up|0|||
145505151|NCT02699749|524706725|FG002|Overall Study|Lost to Follow-up|0|||
145505152|NCT02699749|524706726|FG003|Overall Study|Lost to Follow-up|0|||
145505153|NCT02699749|524706727|FG004|Overall Study|Lost to Follow-up|0|||
145505154|NCT02699749|524706728|FG005|Overall Study|Lost to Follow-up|1|||
145505155|NCT02699749|524706729|FG006|Overall Study|Lost to Follow-up|0|||
145505156|NCT02699749|524706730|FG007|Overall Study|Lost to Follow-up|1|||
145505157|NCT02699749|524706731|FG008|Overall Study|Lost to Follow-up|0|||
145505158|NCT02699749|524706732|FG009|Overall Study|Lost to Follow-up|0|||
145505159|NCT02699749|524706733|FG010|Overall Study|Lost to Follow-up|0|||
145505160|NCT02699749|524706734|FG011|Overall Study|Lost to Follow-up|0|||
145505161|NCT02699749|524706735|FG012|Overall Study|Lost to Follow-up|0|||
145505162|NCT02699749|524706736|FG013|Overall Study|Lost to Follow-up|0|||
145505163|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
145505164|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
145505165|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
145505166|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
145505167|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
145505168|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
145505169|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
145505170|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
145505171|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
145505172|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
145505173|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
145505174|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
145505175|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
145505176|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
145505177|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
145505178|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
145505179|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
145505180|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
145505181|NCT02952820|524706737|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
145505182|NCT02952820|524706738|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
145505183|NCT02952820|524706739|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
145505184|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
145505185|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
145505186|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
145505187|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
145505188|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
145505189|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
145505190|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
145505191|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
145505192|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
145505193|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
145505194|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
145505195|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
145505196|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
145505197|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
145505198|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
145505199|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
145505200|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
145505201|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
145505202|NCT02952820|524706737|FG000|Active Treatment Period (6 Months)|Not treated|0|||
145505203|NCT02952820|524706738|FG001|Active Treatment Period (6 Months)|Not treated|0|||
145505204|NCT02952820|524706739|FG002|Active Treatment Period (6 Months)|Not treated|1|||
145505205|NCT04139018|524706740|FG000|Overall Study|Screen fail|1|||
145505206|NCT04139018|524706741|FG001|Overall Study|Screen fail|0|||
145505207|NCT04139018|524706740|FG000|Overall Study|Withdrawal by Subject|2|||
145505208|NCT04139018|524706741|FG001|Overall Study|Withdrawal by Subject|0|||
145505209|NCT04139018|524706740|FG000|Overall Study|Lost to Follow-up|0|||
145505210|NCT04139018|524706741|FG001|Overall Study|Lost to Follow-up|1|||
145505211|NCT02565108|524706742|FG000|Overall Study|Adverse Event|1|||
145505212|NCT02565108|524706743|FG001|Overall Study|Adverse Event|0|||
145505213|NCT02565108|524706742|FG000|Overall Study|Withdrew Consent|1|||
145505214|NCT02565108|524706743|FG001|Overall Study|Withdrew Consent|0|||
145505215|NCT01310075|524706744|FG000|Overall Study|Lost to Follow-up|1|||
145505216|NCT01310075|524706745|FG001|Overall Study|Lost to Follow-up|0|||
145505217|NCT01310075|524706744|FG000|Overall Study|Physician Decision|10|||
145505218|NCT01310075|524706745|FG001|Overall Study|Physician Decision|7|||
145505219|NCT01310075|524706744|FG000|Overall Study|Protocol Violation|2|||
145505220|NCT01310075|524706745|FG001|Overall Study|Protocol Violation|2|||
145505221|NCT01310075|524706744|FG000|Overall Study|Withdrawal by Subject|1|||
145505222|NCT01310075|524706745|FG001|Overall Study|Withdrawal by Subject|1|||
145505223|NCT01094119|524706746|FG000|Overall Study|Lack of Efficacy|2|||
145505224|NCT01094119|524706747|FG001|Overall Study|Lack of Efficacy|4|||
145505225|NCT01587924|524706748|FG000|Overall Study|Adverse Event|0|||
145505226|NCT01587924|524706749|FG001|Overall Study|Adverse Event|2|||
145505227|NCT01587924|524706750|FG002|Overall Study|Adverse Event|0|||
145505228|NCT01587924|524706751|FG003|Overall Study|Adverse Event|0|||
145505229|NCT01587924|524706748|FG000|Overall Study|Protocol Violation|2|||
145505230|NCT01587924|524706749|FG001|Overall Study|Protocol Violation|1|||
145505231|NCT01587924|524706750|FG002|Overall Study|Protocol Violation|2|||
145505232|NCT01587924|524706751|FG003|Overall Study|Protocol Violation|1|||
145505233|NCT01587924|524706748|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
145505234|NCT01587924|524706749|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
145505235|NCT01587924|524706750|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
145505236|NCT01587924|524706751|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
145505237|NCT01587924|524706748|FG000|Overall Study|Withdrawal by Subject|0|||
145505238|NCT01587924|524706749|FG001|Overall Study|Withdrawal by Subject|1|||
145505239|NCT01587924|524706750|FG002|Overall Study|Withdrawal by Subject|1|||
145505240|NCT01587924|524706751|FG003|Overall Study|Withdrawal by Subject|0|||
145505241|NCT01696188|524706752|FG000|Overall Study|Protocol Violation|1|||
145505242|NCT01696188|524706753|FG001|Overall Study|Protocol Violation|1|||
145505243|NCT00960999|524706754|FG000|Overall Study|Withdrawal by Subject|1|||
145505244|NCT00960999|524706755|FG001|Overall Study|Withdrawal by Subject|0|||
145505245|NCT00960999|524706754|FG000|Overall Study|Protocol Violation|5|||
145505246|NCT00960999|524706755|FG001|Overall Study|Protocol Violation|2|||
145505247|NCT00960999|524706754|FG000|Overall Study|RT dose constraints not met|2|||
145505248|NCT00960999|524706755|FG001|Overall Study|RT dose constraints not met|0|||
145505249|NCT02668393|524706756|FG000|Overall Study|Progressive disease|6|||
145505250|NCT02668393|524706757|FG001|Overall Study|Progressive disease|3|||
145505251|NCT02668393|524706756|FG000|Overall Study|Adverse Event|0|||
145505252|NCT02668393|524706757|FG001|Overall Study|Adverse Event|2|||
145505253|NCT02668393|524706756|FG000|Overall Study|Withdrawal from the trial|0|||
145505254|NCT02668393|524706757|FG001|Overall Study|Withdrawal from the trial|1|||
145732931|NCT03872453|525540856|FG001|Overall Study|Pregnancy|0|||
145732932|NCT03872453|525540857|FG002|Overall Study|Pregnancy|0|||
145266702|NCT04668066|523825255|FG018|Part 1: Follow-Up|Other|0|||
145505255|NCT02668393|524706756|FG000|Overall Study|Lack of benefit and side effects|1|||
145505256|NCT02668393|524706757|FG001|Overall Study|Lack of benefit and side effects|0|||
145505257|NCT00606593|524706758|FG000|Overall Study|Adverse Event|0|||
145505258|NCT00606593|524706759|FG001|Overall Study|Adverse Event|0|||
145505259|NCT00606593|524706760|FG002|Overall Study|Adverse Event|0|||
145505260|NCT00606593|524706761|FG003|Overall Study|Adverse Event|1|||
145505261|NCT00606593|524706762|FG004|Overall Study|Adverse Event|1|||
145505262|NCT00606593|524706763|FG005|Overall Study|Adverse Event|0|||
145505263|NCT00606593|524706764|FG006|Overall Study|Adverse Event|1|||
145505264|NCT00606593|524706765|FG007|Overall Study|Adverse Event|2|||
145505265|NCT00606593|524706766|FG008|Overall Study|Adverse Event|1|||
145505266|NCT00606593|524706767|FG009|Overall Study|Adverse Event|0|||
145505267|NCT00606593|524706758|FG000|Overall Study|Withdrawal of consent|1|||
145505268|NCT00606593|524706759|FG001|Overall Study|Withdrawal of consent|0|||
145505269|NCT00606593|524706760|FG002|Overall Study|Withdrawal of consent|1|||
145505270|NCT00606593|524706761|FG003|Overall Study|Withdrawal of consent|0|||
145505271|NCT00606593|524706762|FG004|Overall Study|Withdrawal of consent|0|||
145505272|NCT00606593|524706763|FG005|Overall Study|Withdrawal of consent|0|||
145505273|NCT00606593|524706764|FG006|Overall Study|Withdrawal of consent|0|||
145505274|NCT00606593|524706765|FG007|Overall Study|Withdrawal of consent|0|||
145505275|NCT00606593|524706766|FG008|Overall Study|Withdrawal of consent|0|||
145505276|NCT00606593|524706767|FG009|Overall Study|Withdrawal of consent|0|||
145505277|NCT00606593|524706758|FG000|Overall Study|Administrative/Other|0|||
145505278|NCT00606593|524706759|FG001|Overall Study|Administrative/Other|0|||
145505279|NCT00606593|524706760|FG002|Overall Study|Administrative/Other|1|||
145505280|NCT00606593|524706761|FG003|Overall Study|Administrative/Other|0|||
145505281|NCT00606593|524706762|FG004|Overall Study|Administrative/Other|0|||
145505282|NCT00606593|524706763|FG005|Overall Study|Administrative/Other|0|||
145505283|NCT00606593|524706764|FG006|Overall Study|Administrative/Other|0|||
145505284|NCT00606593|524706765|FG007|Overall Study|Administrative/Other|0|||
145505285|NCT00606593|524706766|FG008|Overall Study|Administrative/Other|0|||
145505286|NCT00606593|524706767|FG009|Overall Study|Administrative/Other|0|||
145505287|NCT03181529|524706768|FG000|Overall Study|Withdrawal by Subject|1|||
145505288|NCT03181529|524706769|FG001|Overall Study|Withdrawal by Subject|1|||
145505289|NCT03181529|524706768|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
145505290|NCT03181529|524706769|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
145505291|NCT00787644|524706770|FG000|Overall Study|Lost to Follow-up|1|||
145505292|NCT00787644|524706771|FG001|Overall Study|Lost to Follow-up|1|||
145505293|NCT00787644|524706770|FG000|Overall Study|Withdrawal by Subject|1|||
145505294|NCT00787644|524706771|FG001|Overall Study|Withdrawal by Subject|1|||
145505295|NCT00759941|524706772|FG000|Overall Study|Use of medication|1|||
145505296|NCT00759941|524706773|FG001|Overall Study|Use of medication|0|||
145505297|NCT00759941|524706772|FG000|Overall Study|Adverse Event|1|||
145505298|NCT00759941|524706773|FG001|Overall Study|Adverse Event|0|||
145505299|NCT00759941|524706772|FG000|Overall Study|Exited in error by site|1|||
145505300|NCT00759941|524706773|FG001|Overall Study|Exited in error by site|1|||
145505301|NCT05615922|524706775|FG000|Overall Study|Lost to Follow-up|1|||
145505302|NCT06083506|524706776|FG000|Overall Study|Physician Decision|2|||
145505303|NCT06083506|524706776|FG000|Overall Study|Lack of Efficacy|1|||
145505304|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
145505305|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
145505306|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
145505307|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
145505308|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
145505309|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
145505310|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
145505311|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
145505312|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
145505313|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
145505314|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
145505315|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
145505316|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
145505317|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
145505318|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
145732933|NCT03872453|525540858|FG003|Overall Study|Pregnancy|0|||
145732934|NCT03872453|525540855|FG000|Overall Study|Protocol Deviation|2|||
145505319|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
145505320|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
145505321|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
145505322|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
145505323|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
145505324|NCT05307692|524706778|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
145505325|NCT05307692|524706779|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
145505326|NCT05307692|524706780|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
145505327|NCT05307692|524706781|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
145505328|NCT05307692|524706778|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
145505329|NCT05307692|524706779|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
145505330|NCT05307692|524706780|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
145505331|NCT05307692|524706781|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
145505332|NCT05307692|524706778|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
145505333|NCT05307692|524706779|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
145505334|NCT05307692|524706780|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
145505335|NCT05307692|524706781|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
145505336|NCT04500158|524706782|FG000|Overall Study|Physician Decision|17|||
145505337|NCT04500158|524706783|FG001|Overall Study|Physician Decision|11|||
145505338|NCT03493464|524706788|FG000|Overall Study|Surgery not performed|1|||
145505339|NCT04774094|524706794|FG000|Overall Study|Other|2|||
145505340|NCT04774094|524706794|FG000|Overall Study|Withdrawal by Subject|9|||
145505341|NCT04774094|524706794|FG000|Overall Study|Lost to Follow-up|7|||
145505342|NCT04774094|524706794|FG000|Overall Study|Lack of Efficacy|5|||
145505343|NCT04774094|524706794|FG000|Overall Study|Death|17|||
145505344|NCT04774094|524706794|FG000|Overall Study|Adverse Event|4|||
145505345|NCT05232682|524706797|FG000|Overall Study|Lost to Follow-up|2|||
145505346|NCT03894813|524707946|FG000|Overall Study|Adverse Event|1|||
145505347|NCT03894813|524707947|FG001|Overall Study|Adverse Event|1|||
145505348|NCT03894813|524707946|FG000|Overall Study|Lack of Efficacy|3|||
145505349|NCT03894813|524707947|FG001|Overall Study|Lack of Efficacy|3|||
145505350|NCT03894813|524707946|FG000|Overall Study|Lost to Follow-up|1|||
145505351|NCT03894813|524707947|FG001|Overall Study|Lost to Follow-up|0|||
145505352|NCT03894813|524707946|FG000|Overall Study|Pregnancy|2|||
145505353|NCT03894813|524707947|FG001|Overall Study|Pregnancy|1|||
145505354|NCT03894813|524707946|FG000|Overall Study|Protocol Violation|3|||
145505355|NCT03894813|524707947|FG001|Overall Study|Protocol Violation|7|||
145505356|NCT03894813|524707946|FG000|Overall Study|Withdrawal by Subject|1|||
145505357|NCT03894813|524707947|FG001|Overall Study|Withdrawal by Subject|3|||
145505358|NCT03894813|524707946|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
145505359|NCT03894813|524707947|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
145505360|NCT00831181|524707953|FG000|Overall Study|Adverse Event|12|||
145505361|NCT02863419|524707954|FG000|Overall Study|Lost to Follow-up|0|||
145505362|NCT02863419|524707955|FG001|Overall Study|Lost to Follow-up|1|||
145505363|NCT02863419|524707956|FG002|Overall Study|Lost to Follow-up|4|||
145505364|NCT02863419|524707954|FG000|Overall Study|Withdrawal by Subject|5|||
145505365|NCT02863419|524707955|FG001|Overall Study|Withdrawal by Subject|5|||
145505366|NCT02863419|524707956|FG002|Overall Study|Withdrawal by Subject|3|||
145505367|NCT02863419|524707954|FG000|Overall Study|Died|3|||
145505368|NCT02863419|524707955|FG001|Overall Study|Died|4|||
145505369|NCT02863419|524707956|FG002|Overall Study|Died|1|||
145505370|NCT02362282|524707957|FG000|Overall Study|Withdrawal by Subject|1|||
145505371|NCT02362282|524707958|FG001|Overall Study|Withdrawal by Subject|0|||
145505372|NCT02284243|524707965|FG000|Overall Study|Lack of Efficacy|3|||
145505373|NCT02284243|524707966|FG001|Overall Study|Lack of Efficacy|3|||
145505374|NCT02284243|524707965|FG000|Overall Study|Adverse Event|1|||
145505375|NCT02284243|524707966|FG001|Overall Study|Adverse Event|0|||
145505376|NCT01932437|524707967|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
145505377|NCT01932437|524707968|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
145505378|NCT01932437|524707969|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
145505379|NCT01932437|524707970|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
145505380|NCT01932437|524707971|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
145505381|NCT01932437|524707972|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
145505382|NCT00074490|524707973|FG000|Overall Study|Progressive malignancy|0|||
145505383|NCT00074490|524707974|FG001|Overall Study|Progressive malignancy|7|||
145505384|NCT00074490|524707975|FG002|Overall Study|Progressive malignancy|0|||
145505385|NCT00074490|524707976|FG003|Overall Study|Progressive malignancy|0|||
145505386|NCT00074490|524707977|FG004|Overall Study|Progressive malignancy|3|||
145505387|NCT00074490|524707978|FG005|Overall Study|Progressive malignancy|0|||
145505388|NCT04411667|524707981|FG000|Overall Study|Physician Decision|1|||
145505389|NCT04411667|524707982|FG001|Overall Study|Physician Decision|0|||
145505390|NCT04287517|524707985|FG000|Overall Study|Withdrawal by Subject|1|||
145505391|NCT04287517|524707986|FG001|Overall Study|Withdrawal by Subject|1|||
145505392|NCT03857867|524707987|FG000|Overall Study|Physician Decision|1|||
145505393|NCT02425943|524707988|FG000|Overall Study|Adverse Event|3|||
145505394|NCT02425943|524707989|FG001|Overall Study|Adverse Event|1|||
145505395|NCT02425943|524707988|FG000|Overall Study|Lost to Follow-up|59|||
145505396|NCT02425943|524707989|FG001|Overall Study|Lost to Follow-up|37|||
145505397|NCT02425943|524707988|FG000|Overall Study|Protocol Violation|4|||
145505398|NCT02425943|524707989|FG001|Overall Study|Protocol Violation|1|||
145505399|NCT02425943|524707988|FG000|Overall Study|Withdrawal by Subject|64|||
145505400|NCT02425943|524707989|FG001|Overall Study|Withdrawal by Subject|31|||
145505401|NCT02425943|524707988|FG000|Overall Study|Other|6|||
145505402|NCT02425943|524707989|FG001|Overall Study|Other|0|||
145505403|NCT01106248|524707992|FG000|Overall Study|Adverse Event|1|||
145505404|NCT01106248|524707992|FG000|Overall Study|Administrative|2|||
145505405|NCT00357903|524707993|FG000|Overall Study|Adverse Event|87|||
145505406|NCT00357903|524707994|FG001|Overall Study|Adverse Event|4|||
145505407|NCT00357903|524707993|FG000|Overall Study|Death|33|||
145505408|NCT00357903|524707994|FG001|Overall Study|Death|0|||
145505409|NCT00357903|524707993|FG000|Overall Study|Lost to Follow-up|23|||
145505410|NCT00357903|524707994|FG001|Overall Study|Lost to Follow-up|4|||
145505411|NCT00357903|524707993|FG000|Overall Study|Physician Decision|39|||
145505412|NCT00357903|524707994|FG001|Overall Study|Physician Decision|5|||
145505413|NCT00357903|524707993|FG000|Overall Study|Withdrawal by Subject|57|||
145505414|NCT00357903|524707994|FG001|Overall Study|Withdrawal by Subject|7|||
145505415|NCT00357903|524707993|FG000|Overall Study|Completed month 12 only|0|||
145505416|NCT00357903|524707994|FG001|Overall Study|Completed month 12 only|1|||
145505417|NCT00357903|524707993|FG000|Overall Study|Protocol issues|14|||
145505418|NCT00357903|524707994|FG001|Overall Study|Protocol issues|3|||
145505419|NCT00357903|524707993|FG000|Overall Study|Response status|61|||
145505420|NCT00357903|524707994|FG001|Overall Study|Response status|9|||
145505421|NCT00357903|524707993|FG000|Overall Study|Other|49|||
145505422|NCT00357903|524707994|FG001|Overall Study|Other|10|||
145505423|NCT01780974|524707995|FG000|Overall Study|Death|1|||
145505424|NCT01780974|524707996|FG001|Overall Study|Death|0|||
145505425|NCT01780974|524707995|FG000|Overall Study|Adverse Event|1|||
145505426|NCT01780974|524707996|FG001|Overall Study|Adverse Event|3|||
145505427|NCT03848728|524707999|FG000|Overall Study|Death|16|||
145505428|NCT03848728|524708000|FG001|Overall Study|Death|13|||
145505429|NCT03848728|524707999|FG000|Overall Study|Outmigrated to non-study community|98|||
145505430|NCT03848728|524708000|FG001|Overall Study|Outmigrated to non-study community|106|||
145505431|NCT03848728|524707999|FG000|Overall Study|Transfered to non-study clinic|32|||
145505432|NCT03848728|524708000|FG001|Overall Study|Transfered to non-study clinic|48|||
145505433|NCT03848728|524707999|FG000|Overall Study|Withdrawal by Subject|1|||
145505434|NCT03848728|524708000|FG001|Overall Study|Withdrawal by Subject|0|||
145505435|NCT00536744|524708003|FG000|Overall Study|Adverse Event|13|||
145732935|NCT03872453|525540856|FG001|Overall Study|Protocol Deviation|0|||
145505436|NCT00536744|524708004|FG001|Overall Study|Adverse Event|10|||
145505437|NCT00536744|524708003|FG000|Overall Study|Death|2|||
145505438|NCT00536744|524708004|FG001|Overall Study|Death|1|||
145505439|NCT00536744|524708003|FG000|Overall Study|Physician Decision|3|||
145505440|NCT00536744|524708004|FG001|Overall Study|Physician Decision|1|||
145505441|NCT00536744|524708003|FG000|Overall Study|Lost to Follow-up|3|||
145505442|NCT00536744|524708004|FG001|Overall Study|Lost to Follow-up|5|||
145505443|NCT00536744|524708003|FG000|Overall Study|Withdrawal by Subject|7|||
145732936|NCT03872453|525540857|FG002|Overall Study|Protocol Deviation|0|||
145505444|NCT00536744|524708004|FG001|Overall Study|Withdrawal by Subject|8|||
145505445|NCT00536744|524708003|FG000|Overall Study|PI tried alternative treatment|1|||
145732937|NCT03872453|525540858|FG003|Overall Study|Protocol Deviation|2|||
145505446|NCT00536744|524708004|FG001|Overall Study|PI tried alternative treatment|3|||
145505447|NCT01642589|524708008|FG000|Overall Study|Withdrawal by Subject|1|||
145505448|NCT01642589|524708009|FG001|Overall Study|Withdrawal by Subject|1|||
145505449|NCT01108185|524708014|FG000|Overall Study|Non-compliance|15|||
145505450|NCT01108185|524708014|FG000|Overall Study|Lost to Follow-up|12|||
145505451|NCT02581410|524708015|FG000|Vaccination Phase|Adverse Event|2|||
145505452|NCT02581410|524708016|FG001|Vaccination Phase|Adverse Event|1|||
145505453|NCT02581410|524708015|FG000|Vaccination Phase|Withdrawal by Subject|0|||
145505454|NCT02581410|524708016|FG001|Vaccination Phase|Withdrawal by Subject|1|||
145505455|NCT02581410|524708015|FG000|Vaccination Phase|Migrated/moved from study area|0|||
145505456|NCT02581410|524708016|FG001|Vaccination Phase|Migrated/moved from study area|1|||
145505457|NCT02581410|524708015|FG000|End of Study Phase|Adverse Event|4|||
145505458|NCT02581410|524708016|FG001|End of Study Phase|Adverse Event|3|||
145505459|NCT02581410|524708015|FG000|End of Study Phase|Withdrawal by Subject|1|||
145400551|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145400552|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
145400553|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400554|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400555|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400556|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400557|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
145400558|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400559|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
145400560|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400561|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400562|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400563|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400564|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
145400565|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400566|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
145400567|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400568|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400569|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400570|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400571|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
145400572|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400573|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
145400574|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400575|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400576|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400577|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400578|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
145400579|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400580|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
145400581|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400582|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400583|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400584|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400585|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400586|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
145400587|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
145400588|NCT01791595|524322965|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400589|NCT01791595|524322966|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400590|NCT01791595|524322967|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400591|NCT01791595|524322968|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400592|NCT01791595|524322969|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400593|NCT01791595|524322970|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
145400594|NCT01791595|524322971|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
145400595|NCT01791595|524322965|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400596|NCT01791595|524322966|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400597|NCT01791595|524322967|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400598|NCT01791595|524322968|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400599|NCT01791595|524322969|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400600|NCT01791595|524322970|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
145400601|NCT01791595|524322971|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
145400602|NCT01791595|524322965|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400603|NCT01791595|524322966|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400604|NCT01791595|524322967|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400605|NCT01791595|524322968|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400606|NCT01791595|524322969|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400607|NCT01791595|524322970|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
145400608|NCT01791595|524322971|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
145400609|NCT01791595|524322965|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400610|NCT01791595|524322966|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400611|NCT01791595|524322967|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400612|NCT01791595|524322968|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400613|NCT01791595|524322969|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400614|NCT01791595|524322970|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
145400615|NCT01791595|524322971|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
145400616|NCT01791595|524322965|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400617|NCT01791595|524322966|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400618|NCT01791595|524322967|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400619|NCT01791595|524322968|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400620|NCT01791595|524322969|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400621|NCT01791595|524322970|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
145400622|NCT01791595|524322971|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
145400623|NCT03118934|524322972|FG000|Overall Study|Adverse Event|0|||
145400624|NCT03118934|524322973|FG001|Overall Study|Adverse Event|0|||
145400625|NCT03118934|524322974|FG002|Overall Study|Adverse Event|0|||
145400626|NCT03118934|524322975|FG003|Overall Study|Adverse Event|0|||
145400627|NCT03118934|524322976|FG004|Overall Study|Adverse Event|0|||
145400628|NCT03118934|524322977|FG005|Overall Study|Adverse Event|1|||
145400629|NCT03118934|524322972|FG000|Overall Study|Physician Decision|0|||
145400630|NCT03118934|524322973|FG001|Overall Study|Physician Decision|0|||
145400631|NCT03118934|524322974|FG002|Overall Study|Physician Decision|0|||
145400632|NCT03118934|524322975|FG003|Overall Study|Physician Decision|0|||
145400633|NCT03118934|524322976|FG004|Overall Study|Physician Decision|0|||
145400634|NCT03118934|524322977|FG005|Overall Study|Physician Decision|1|||
145400635|NCT03118934|524322972|FG000|Overall Study|Discontinued prior to exposure|0|||
145400636|NCT03118934|524322973|FG001|Overall Study|Discontinued prior to exposure|1|||
145400637|NCT03118934|524322974|FG002|Overall Study|Discontinued prior to exposure|1|||
145400638|NCT03118934|524322975|FG003|Overall Study|Discontinued prior to exposure|1|||
145400639|NCT03118934|524322976|FG004|Overall Study|Discontinued prior to exposure|2|||
145400640|NCT03118934|524322977|FG005|Overall Study|Discontinued prior to exposure|0|||
145400641|NCT03080935|524322978|FG000|Overall Study|Death|34|||
145400642|NCT03080935|524322979|FG001|Overall Study|Death|50|||
145400643|NCT03080935|524322978|FG000|Overall Study|Lost to Follow-up|5|||
145400644|NCT03080935|524322979|FG001|Overall Study|Lost to Follow-up|4|||
145505460|NCT02581410|524708016|FG001|End of Study Phase|Withdrawal by Subject|2|||
145505461|NCT02581410|524708015|FG000|End of Study Phase|Migrated/moved from study area|0|||
145505462|NCT02581410|524708016|FG001|End of Study Phase|Migrated/moved from study area|3|||
145505463|NCT02581410|524708015|FG000|End of Study Phase|Lost to Follow-up|0|||
145505464|NCT02581410|524708016|FG001|End of Study Phase|Lost to Follow-up|2|||
145505465|NCT02581410|524708015|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
145505466|NCT02581410|524708016|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
145505467|NCT02908672|524708019|FG000|Run-in Period|Death|12|||
145505468|NCT02908672|524708020|FG001|Run-in Period|Death|10|||
145505469|NCT02908672|524708021|FG002|Run-in Period|Death|0|||
145505470|NCT02908672|524708022|FG003|Run-in Period|Death|0|||
145505471|NCT02908672|524708019|FG000|Run-in Period|Lost to Follow-up|1|||
145505472|NCT02908672|524708020|FG001|Run-in Period|Lost to Follow-up|1|||
145505473|NCT02908672|524708021|FG002|Run-in Period|Lost to Follow-up|0|||
145505474|NCT02908672|524708022|FG003|Run-in Period|Lost to Follow-up|0|||
145505475|NCT02908672|524708019|FG000|Run-in Period|Reason Not Specified|2|||
145505476|NCT02908672|524708020|FG001|Run-in Period|Reason Not Specified|0|||
145505477|NCT02908672|524708021|FG002|Run-in Period|Reason Not Specified|0|||
145505478|NCT02908672|524708022|FG003|Run-in Period|Reason Not Specified|0|||
145505479|NCT02908672|524708019|FG000|Run-in Period|Protocol Violation|1|||
145505480|NCT02908672|524708020|FG001|Run-in Period|Protocol Violation|1|||
145505481|NCT02908672|524708021|FG002|Run-in Period|Protocol Violation|0|||
145505482|NCT02908672|524708022|FG003|Run-in Period|Protocol Violation|0|||
145505483|NCT02908672|524708019|FG000|Run-in Period|Study Ended by Sponsor|5|||
145505484|NCT02908672|524708020|FG001|Run-in Period|Study Ended by Sponsor|1|||
145505485|NCT02908672|524708021|FG002|Run-in Period|Study Ended by Sponsor|0|||
145505486|NCT02908672|524708022|FG003|Run-in Period|Study Ended by Sponsor|0|||
145505487|NCT02908672|524708019|FG000|Run-in Period|Withdrawal by Subject|3|||
145505488|NCT02908672|524708020|FG001|Run-in Period|Withdrawal by Subject|9|||
145505489|NCT02908672|524708021|FG002|Run-in Period|Withdrawal by Subject|0|||
145505490|NCT02908672|524708022|FG003|Run-in Period|Withdrawal by Subject|0|||
145505491|NCT02908672|524708019|FG000|Triple Combination Period|Death|0|||
145505492|NCT02908672|524708020|FG001|Triple Combination Period|Death|0|||
145505493|NCT02908672|524708021|FG002|Triple Combination Period|Death|150|||
145505494|NCT02908672|524708022|FG003|Triple Combination Period|Death|127|||
145505495|NCT02908672|524708019|FG000|Triple Combination Period|Lost to Follow-up|0|||
145505496|NCT02908672|524708020|FG001|Triple Combination Period|Lost to Follow-up|0|||
145505497|NCT02908672|524708021|FG002|Triple Combination Period|Lost to Follow-up|6|||
145505498|NCT02908672|524708022|FG003|Triple Combination Period|Lost to Follow-up|8|||
145505499|NCT02908672|524708019|FG000|Triple Combination Period|Reason Not Specified|0|||
145505500|NCT02908672|524708020|FG001|Triple Combination Period|Reason Not Specified|0|||
145505501|NCT02908672|524708021|FG002|Triple Combination Period|Reason Not Specified|0|||
145505502|NCT02908672|524708022|FG003|Triple Combination Period|Reason Not Specified|1|||
145505503|NCT02908672|524708019|FG000|Triple Combination Period|Physician Decision|0|||
145505504|NCT02908672|524708020|FG001|Triple Combination Period|Physician Decision|0|||
145505505|NCT02908672|524708021|FG002|Triple Combination Period|Physician Decision|1|||
145505506|NCT02908672|524708022|FG003|Triple Combination Period|Physician Decision|1|||
145505507|NCT02908672|524708019|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
145505508|NCT02908672|524708020|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
145505509|NCT02908672|524708021|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
145505510|NCT02908672|524708022|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
145505511|NCT02908672|524708019|FG000|Triple Combination Period|Withdrawal by Subject|0|||
145505512|NCT02908672|524708020|FG001|Triple Combination Period|Withdrawal by Subject|0|||
145505513|NCT02908672|524708021|FG002|Triple Combination Period|Withdrawal by Subject|13|||
145505514|NCT02908672|524708022|FG003|Triple Combination Period|Withdrawal by Subject|16|||
145505515|NCT01185080|524708026|FG000|Overall Study|Adverse Event|1|||
145505516|NCT01185080|524708027|FG001|Overall Study|Adverse Event|1|||
145505517|NCT01185080|524708028|FG002|Overall Study|Adverse Event|0|||
145505518|NCT01185080|524708026|FG000|Overall Study|Personal reasons|0|||
145505519|NCT01185080|524708027|FG001|Overall Study|Personal reasons|0|||
145505520|NCT01185080|524708028|FG002|Overall Study|Personal reasons|1|||
145505521|NCT02876601|524708029|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
145505522|NCT02876601|524708030|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
145505523|NCT02876601|524708031|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
145505524|NCT02876601|524708032|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
145505525|NCT01967238|524708035|FG000|Overall Study|Adverse Event|1|||
145505526|NCT01967238|524708036|FG001|Overall Study|Adverse Event|1|||
145505527|NCT01967238|524708037|FG002|Overall Study|Adverse Event|0|||
145505528|NCT01967238|524708035|FG000|Overall Study|Lost to Follow-up|1|||
145505529|NCT01967238|524708036|FG001|Overall Study|Lost to Follow-up|0|||
145505530|NCT01967238|524708037|FG002|Overall Study|Lost to Follow-up|1|||
145505531|NCT01967238|524708035|FG000|Overall Study|Withdrawal by Subject|0|||
145505532|NCT01967238|524708036|FG001|Overall Study|Withdrawal by Subject|0|||
145505533|NCT01967238|524708037|FG002|Overall Study|Withdrawal by Subject|1|||
145505534|NCT02807402|524708042|FG000|Overall Study|Failure to Return|1|||
145505535|NCT02807402|524708042|FG000|Overall Study|Death|3|||
145505536|NCT02807402|524708042|FG000|Overall Study|Other|2|||
145505537|NCT01442103|524709561|FG000|Overall Study|Lost to Follow-up|2|||
145505538|NCT02605122|524709563|FG000|Overall Study|Withdrawal by Subject|4|||
145505539|NCT02605122|524709564|FG001|Overall Study|Withdrawal by Subject|1|||
145505540|NCT02605122|524709563|FG000|Overall Study|Lost to Follow-up|1|||
145505541|NCT02605122|524709564|FG001|Overall Study|Lost to Follow-up|1|||
145505542|NCT00807001|524709565|FG000|Overall Study|Non-compliance|0|||
145505543|NCT00807001|524709566|FG001|Overall Study|Non-compliance|1|||
145505544|NCT00807001|524709567|FG002|Overall Study|Non-compliance|0|||
145505545|NCT00807001|524709568|FG003|Overall Study|Non-compliance|0|||
145505546|NCT00807001|524709569|FG004|Overall Study|Non-compliance|0|||
145505547|NCT02139592|524709583|FG000|Overall Study|Case Report Forms Uncollected|8|||
145505548|NCT01255436|524709593|FG000|Overall Study|Lost to Follow-up|178|||
145505549|NCT01255436|524709594|FG001|Overall Study|Lost to Follow-up|191|||
145505550|NCT01255436|524709593|FG000|Overall Study|Death, stroke, or MI|4|||
145505551|NCT01255436|524709594|FG001|Overall Study|Death, stroke, or MI|3|||
145505552|NCT00867815|524709600|FG000|Overall Study|Lost to Follow-up|1|||
145505553|NCT04050202|524709601|FG000|Overall Study|Lost to Follow-up|2|||
145505554|NCT00001213|524709602|FG000|Overall Study|Death|18|||
145505555|NCT03534180|524709605|FG000|Overall Study|Withdrawal by Subject|1|||
145505556|NCT00220636|524709606|FG000|Overall Study|Withdrawal by Subject|4|||
145505557|NCT05661409|524709607|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
145505558|NCT05661409|524709608|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
145505559|NCT05661409|524709609|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
145505560|NCT05661409|524709610|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
145505561|NCT05661409|524709611|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
145505562|NCT05661409|524709612|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
145505563|NCT05661409|524709607|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
145505564|NCT05661409|524709608|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
145505565|NCT05661409|524709609|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
145505566|NCT05661409|524709610|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
145505567|NCT05661409|524709611|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
145505568|NCT05661409|524709612|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
145505569|NCT05661409|524709607|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
145505570|NCT05661409|524709608|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
145505571|NCT05661409|524709609|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
145505572|NCT05661409|524709610|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
145505573|NCT05661409|524709611|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
145505574|NCT05661409|524709612|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
145505575|NCT05661409|524709607|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
145505576|NCT05661409|524709608|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
145505577|NCT05661409|524709609|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
145505578|NCT05661409|524709610|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
145505579|NCT05661409|524709611|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
145505580|NCT05661409|524709612|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
145505581|NCT05661409|524709607|FG000|Overall Study|Miscommu-nication about administration|0|||
145505582|NCT05661409|524709608|FG001|Overall Study|Miscommu-nication about administration|0|||
145505583|NCT05661409|524709609|FG002|Overall Study|Miscommu-nication about administration|0|||
145505584|NCT05661409|524709610|FG003|Overall Study|Miscommu-nication about administration|0|||
145505585|NCT05661409|524709611|FG004|Overall Study|Miscommu-nication about administration|0|||
145505586|NCT05661409|524709612|FG005|Overall Study|Miscommu-nication about administration|1|||
145505587|NCT02636595|524709613|FG000|Overall Study|Lost to Follow-up|1|||
145505588|NCT02636595|524709613|FG000|Overall Study|Other|1|||
145505589|NCT02015637|524709617|FG000|Overall Study|Lost to Follow-up|3|||
145505590|NCT02015637|524709618|FG001|Overall Study|Lost to Follow-up|5|||
145505591|NCT02015637|524709617|FG000|Overall Study|Adverse Event|3|||
145505592|NCT02015637|524709618|FG001|Overall Study|Adverse Event|0|||
145505593|NCT02015637|524709617|FG000|Overall Study|Did not take study drug|2|||
145505594|NCT02015637|524709618|FG001|Overall Study|Did not take study drug|0|||
145400645|NCT03080935|524322978|FG000|Overall Study|Withdrawal by Subject|11|||
145400646|NCT03080935|524322979|FG001|Overall Study|Withdrawal by Subject|15|||
145400647|NCT02175121|524322980|FG000|Overall Study|Lack of Efficacy|1|||
145400648|NCT02175121|524322981|FG001|Overall Study|Lack of Efficacy|0|||
145400649|NCT02175121|524322982|FG002|Overall Study|Lack of Efficacy|0|||
145400650|NCT02175121|524322983|FG003|Overall Study|Lack of Efficacy|0|||
145400651|NCT02175121|524322984|FG004|Overall Study|Lack of Efficacy|0|||
145400652|NCT02175121|524322980|FG000|Overall Study|Lost to Follow-up|0|||
145400653|NCT02175121|524322981|FG001|Overall Study|Lost to Follow-up|1|||
145400654|NCT02175121|524322982|FG002|Overall Study|Lost to Follow-up|0|||
145400655|NCT02175121|524322983|FG003|Overall Study|Lost to Follow-up|1|||
145400656|NCT02175121|524322984|FG004|Overall Study|Lost to Follow-up|0|||
145400657|NCT02175121|524322980|FG000|Overall Study|Personal emergency|0|||
145400658|NCT02175121|524322981|FG001|Overall Study|Personal emergency|0|||
145400659|NCT02175121|524322982|FG002|Overall Study|Personal emergency|0|||
145400660|NCT02175121|524322983|FG003|Overall Study|Personal emergency|0|||
145400661|NCT02175121|524322984|FG004|Overall Study|Personal emergency|1|||
145400662|NCT02175121|524322980|FG000|Overall Study|Schedule conflict|0|||
145400663|NCT02175121|524322981|FG001|Overall Study|Schedule conflict|0|||
145400664|NCT02175121|524322982|FG002|Overall Study|Schedule conflict|1|||
145400665|NCT02175121|524322983|FG003|Overall Study|Schedule conflict|0|||
145400666|NCT02175121|524322984|FG004|Overall Study|Schedule conflict|0|||
145400667|NCT02175121|524322980|FG000|Overall Study|Time issues|0|||
145400668|NCT02175121|524322981|FG001|Overall Study|Time issues|0|||
145400669|NCT02175121|524322982|FG002|Overall Study|Time issues|1|||
145400670|NCT02175121|524322983|FG003|Overall Study|Time issues|0|||
145400671|NCT02175121|524322984|FG004|Overall Study|Time issues|0|||
145400672|NCT02027025|524322989|FG000|Overall Study|Adverse Event|0|||
145400673|NCT02027025|524322990|FG001|Overall Study|Adverse Event|1|||
145400674|NCT02027025|524322991|FG002|Overall Study|Adverse Event|1|||
145400675|NCT02027025|524322989|FG000|Overall Study|Protocol Violation|1|||
145400676|NCT02027025|524322990|FG001|Overall Study|Protocol Violation|0|||
145400677|NCT02027025|524322991|FG002|Overall Study|Protocol Violation|0|||
145400678|NCT02027025|524322989|FG000|Overall Study|Lost to Follow-up|0|||
145400679|NCT02027025|524322990|FG001|Overall Study|Lost to Follow-up|2|||
145400680|NCT02027025|524322991|FG002|Overall Study|Lost to Follow-up|0|||
145400681|NCT02027025|524322989|FG000|Overall Study|Withdrawal by Subject|0|||
145400682|NCT02027025|524322990|FG001|Overall Study|Withdrawal by Subject|1|||
145400683|NCT02027025|524322991|FG002|Overall Study|Withdrawal by Subject|0|||
145400684|NCT02027025|524322989|FG000|Overall Study|Sponsor's decision|0|||
145400685|NCT02027025|524322990|FG001|Overall Study|Sponsor's decision|1|||
145400686|NCT02027025|524322991|FG002|Overall Study|Sponsor's decision|0|||
145400687|NCT03886272|524322994|FG000|Period 1|Withdrawal by Subject|0|||
145400688|NCT03886272|524322995|FG001|Period 1|Withdrawal by Subject|0|||
145400689|NCT03886272|524322996|FG002|Period 1|Withdrawal by Subject|0|||
145400690|NCT03886272|524322997|FG003|Period 1|Withdrawal by Subject|0|||
145400691|NCT03886272|524322998|FG004|Period 1|Withdrawal by Subject|0|||
145400692|NCT03886272|524322999|FG005|Period 1|Withdrawal by Subject|1|||
145400693|NCT03886272|524323000|FG006|Period 1|Withdrawal by Subject|0|||
145400694|NCT03044314|524323004|FG000|Overall Study|Physician Decision|2|||
145400695|NCT03044314|524323004|FG000|Overall Study|Withdrawal by Subject|1|||
145400696|NCT03044314|524323004|FG000|Overall Study|Connector tubing not available|1|||
145400697|NCT03234465|524323005|FG000|Overall Study|Adverse Event|4|||
145400698|NCT03234465|524323006|FG001|Overall Study|Adverse Event|2|||
145400699|NCT03234465|524323005|FG000|Overall Study|Death|0|||
145400700|NCT03234465|524323006|FG001|Overall Study|Death|1|||
145400701|NCT03234465|524323005|FG000|Overall Study|Lost to Follow-up|1|||
145400702|NCT03234465|524323006|FG001|Overall Study|Lost to Follow-up|1|||
145400703|NCT03234465|524323005|FG000|Overall Study|Withdrawal by Subject|12|||
145400704|NCT03234465|524323006|FG001|Overall Study|Withdrawal by Subject|27|||
145400705|NCT03234465|524323005|FG000|Overall Study|Symptomatic deterioration|0|||
145400706|NCT03234465|524323006|FG001|Overall Study|Symptomatic deterioration|1|||
145505595|NCT03198507|524709619|FG000|Overall Study|Withdrawal by Subject|1|||
145400707|NCT03234465|524323005|FG000|Overall Study|Non-compliance|2|||
145400708|NCT03234465|524323006|FG001|Overall Study|Non-compliance|0|||
145400709|NCT03234465|524323005|FG000|Overall Study|Other|14|||
145400710|NCT03234465|524323006|FG001|Overall Study|Other|8|||
145400711|NCT01973218|524323020|FG000|Overall Study|Adverse Event|1|||
145400712|NCT01973218|524323021|FG001|Overall Study|Adverse Event|0|||
145400713|NCT01973218|524323020|FG000|Overall Study|Withdrawal by Subject|1|||
145400714|NCT01973218|524323021|FG001|Overall Study|Withdrawal by Subject|0|||
145400715|NCT02247466|524323022|FG000|Overall Study|Procedure changed to open surgery|0|||
145505596|NCT03198507|524709620|FG001|Overall Study|Withdrawal by Subject|0|||
145400716|NCT02247466|524323023|FG001|Overall Study|Procedure changed to open surgery|3|||
145400717|NCT01324947|524323025|FG000|Overall Study|Adverse Event|7|||
145400718|NCT01324947|524323025|FG000|Overall Study|Death|10|||
145400719|NCT01324947|524323025|FG000|Overall Study|Other|3|||
145400720|NCT01324947|524323025|FG000|Overall Study|Progressive Disease|50|||
145400721|NCT01324947|524323025|FG000|Overall Study|Withdrawal by Subject|3|||
145400722|NCT01324947|524323025|FG000|Overall Study|1 discontinued before starting drug|1|||
145400723|NCT02873689|524324653|FG000|Overall Study|Lack of Efficacy|1|||
145400724|NCT02873689|524324654|FG001|Overall Study|Lack of Efficacy|0|||
145400725|NCT02873689|524324653|FG000|Overall Study|Withdrawal by Subject|2|||
145400726|NCT02873689|524324654|FG001|Overall Study|Withdrawal by Subject|2|||
145400727|NCT02873689|524324653|FG000|Overall Study|Protocol Violation|1|||
145400728|NCT02873689|524324654|FG001|Overall Study|Protocol Violation|0|||
145400729|NCT02873689|524324653|FG000|Overall Study|Adverse Event|2|||
145400730|NCT02873689|524324654|FG001|Overall Study|Adverse Event|2|||
145400731|NCT02873689|524324653|FG000|Overall Study|Randomized but not Treated|1|||
145400732|NCT02873689|524324654|FG001|Overall Study|Randomized but not Treated|1|||
145400733|NCT00350545|524324655|FG000|Overall Study|Withdrawal by Subject|2|||
145400734|NCT00266708|524324672|FG000|Overall Study|No renal function|1|||
145400735|NCT00266708|524324673|FG001|Overall Study|No renal function|1|||
145400736|NCT00266708|524324672|FG000|Overall Study|Refused biopsy|3|||
145400737|NCT00266708|524324673|FG001|Overall Study|Refused biopsy|6|||
145400738|NCT00266708|524324672|FG000|Overall Study|Asthma|0|||
145400739|NCT00266708|524324673|FG001|Overall Study|Asthma|2|||
145400740|NCT02791269|524324674|FG000|Overall Study|Lost to Follow-up|0|||
145400741|NCT02791269|524324675|FG001|Overall Study|Lost to Follow-up|1|||
145400742|NCT02351934|524324676|FG000|Allocation|POD weight<pre-op weight|3|||
145400743|NCT02351934|524324677|FG001|Allocation|POD weight<pre-op weight|0|||
145400744|NCT02351934|524324676|FG000|Allocation|Hypotension preventing administration|2|||
145400745|NCT02351934|524324677|FG001|Allocation|Hypotension preventing administration|0|||
145400746|NCT02351934|524324676|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
145400747|NCT02351934|524324677|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
145400748|NCT02351934|524324676|FG000|Follow-Up|POD weight<pre-op weight|3|||
145400749|NCT02351934|524324677|FG001|Follow-Up|POD weight<pre-op weight|0|||
145400750|NCT02351934|524324676|FG000|Follow-Up|Acute Kidney Injury|1|||
145400751|NCT02351934|524324677|FG001|Follow-Up|Acute Kidney Injury|0|||
145400752|NCT02351934|524324676|FG000|Follow-Up|Early dismissal|3|||
145400753|NCT02351934|524324677|FG001|Follow-Up|Early dismissal|0|||
145400754|NCT02351934|524324676|FG000|Follow-Up|Hypotension|3|||
145400755|NCT02351934|524324677|FG001|Follow-Up|Hypotension|0|||
145400756|NCT02351934|524324676|FG000|Follow-Up|No documentation|2|||
145400757|NCT02351934|524324677|FG001|Follow-Up|No documentation|0|||
145400758|NCT02351934|524324676|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
145400759|NCT02351934|524324677|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
145400760|NCT02351934|524324676|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
145400761|NCT02351934|524324677|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
145400762|NCT02683109|524324678|FG000|Overall Study|Adverse Event|1|||
145400763|NCT02683109|524324679|FG001|Overall Study|Adverse Event|0|||
145400764|NCT00368251|524324680|FG000|Overall Study|SAE, non-fatal|1|||
145400765|NCT00368251|524324681|FG001|Overall Study|SAE, non-fatal|0|||
145400766|NCT00368251|524324682|FG002|Overall Study|SAE, non-fatal|0|||
145400767|NCT00368251|524324680|FG000|Overall Study|AE, non-serious non-fatal|0|||
145400768|NCT00368251|524324681|FG001|Overall Study|AE, non-serious non-fatal|0|||
145400769|NCT00368251|524324682|FG002|Overall Study|AE, non-serious non-fatal|1|||
145400770|NCT01373164|524324684|FG000|Overall Study|Lost to Follow-up|0|||
145400771|NCT01373164|524324685|FG001|Overall Study|Lost to Follow-up|0|||
145505597|NCT02454517|524709621|FG000|Overall Study|Withdrawal by Subject|3|||
145505598|NCT02454517|524709622|FG001|Overall Study|Withdrawal by Subject|0|||
145505599|NCT02454517|524709621|FG000|Overall Study|Lost to Follow-up|4|||
145505600|NCT02454517|524709622|FG001|Overall Study|Lost to Follow-up|7|||
145505601|NCT02454517|524709621|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
145505602|NCT02454517|524709622|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
145505603|NCT02194985|524709623|FG000|Overall Study|Adverse Event|1|||
145505604|NCT02194985|524709623|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
145505605|NCT02194985|524709623|FG000|Overall Study|Physician Decision|4|||
145505606|NCT02194985|524709623|FG000|Overall Study|Lost to Follow-up|1|||
145505607|NCT02194985|524709623|FG000|Overall Study|Withdrawal by Subject|2|||
145505608|NCT02304367|524709630|FG000|Overall Study|Lack of Response to Bruosumab|1|||
145505609|NCT02304367|524709630|FG000|Overall Study|Sponsor Decision|3|||
145505610|NCT02304367|524709630|FG000|Overall Study|Death|2|||
145505611|NCT02304367|524709630|FG000|Overall Study|Physician Decision|1|||
145732938|NCT03872453|525540855|FG000|Overall Study|Withdrawal by Subject|0|||
145400772|NCT01373164|524324686|FG002|Overall Study|Lost to Follow-up|1|||
145400773|NCT01373164|524324687|FG003|Overall Study|Lost to Follow-up|2|||
145400774|NCT01373164|524324688|FG004|Overall Study|Lost to Follow-up|0|||
145400775|NCT01373164|524324684|FG000|Overall Study|Withdrawal by Subject|0|||
145400776|NCT01373164|524324685|FG001|Overall Study|Withdrawal by Subject|1|||
145400777|NCT01373164|524324686|FG002|Overall Study|Withdrawal by Subject|0|||
145400778|NCT01373164|524324687|FG003|Overall Study|Withdrawal by Subject|10|||
145400779|NCT01373164|524324688|FG004|Overall Study|Withdrawal by Subject|2|||
145400780|NCT02669849|524324689|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145400781|NCT02669849|524324690|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145400782|NCT02669849|524324691|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
145400783|NCT02669849|524324689|FG000|Overall Study|Lost to Follow-up|1|||
145400784|NCT02669849|524324690|FG001|Overall Study|Lost to Follow-up|0|||
145400785|NCT02669849|524324691|FG002|Overall Study|Lost to Follow-up|3|||
145400786|NCT02669849|524324689|FG000|Overall Study|Death|1|||
145400787|NCT02669849|524324690|FG001|Overall Study|Death|1|||
145400788|NCT02669849|524324691|FG002|Overall Study|Death|2|||
145400789|NCT02669849|524324689|FG000|Overall Study|Study terminated by sponsor|16|||
145400790|NCT02669849|524324690|FG001|Overall Study|Study terminated by sponsor|1|||
145400791|NCT02669849|524324691|FG002|Overall Study|Study terminated by sponsor|14|||
145400792|NCT02669849|524324689|FG000|Overall Study|Other|0|||
145400793|NCT02669849|524324690|FG001|Overall Study|Other|0|||
145400794|NCT02669849|524324691|FG002|Overall Study|Other|2|||
145400795|NCT03408899|524324694|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
145400796|NCT04745351|524324695|FG000|Overall Study|Death|51|||
145400797|NCT04745351|524324696|FG001|Overall Study|Death|25|||
145400798|NCT04745351|524324695|FG000|Overall Study|Lost to Follow-up|9|||
145400799|NCT04745351|524324696|FG001|Overall Study|Lost to Follow-up|3|||
145400800|NCT04745351|524324695|FG000|Overall Study|Randomized but Never Treated|3|||
145400801|NCT04745351|524324696|FG001|Overall Study|Randomized but Never Treated|3|||
145400802|NCT04745351|524324695|FG000|Overall Study|Adverse Event|4|||
145400803|NCT04745351|524324696|FG001|Overall Study|Adverse Event|0|||
145400804|NCT04745351|524324695|FG000|Overall Study|Withdrew Consent|1|||
145400805|NCT04745351|524324696|FG001|Overall Study|Withdrew Consent|2|||
145400806|NCT04745351|524324695|FG000|Overall Study|Investigator's Discretion|2|||
145400807|NCT04745351|524324696|FG001|Overall Study|Investigator's Discretion|0|||
145400808|NCT04745351|524324695|FG000|Overall Study|Protocol Violation|1|||
145400809|NCT04745351|524324696|FG001|Overall Study|Protocol Violation|0|||
145400810|NCT01863771|524324697|FG000|Induction Phase|Adverse Event|9|||
145400811|NCT01863771|524324698|FG001|Induction Phase|Adverse Event|0|||
145400812|NCT01863771|524324699|FG002|Induction Phase|Adverse Event|0|||
145400813|NCT01863771|524324700|FG003|Induction Phase|Adverse Event|0|||
145400814|NCT01863771|524324697|FG000|Induction Phase|Lack of Efficacy|10|||
145400815|NCT01863771|524324698|FG001|Induction Phase|Lack of Efficacy|0|||
145400816|NCT01863771|524324699|FG002|Induction Phase|Lack of Efficacy|0|||
145400817|NCT01863771|524324700|FG003|Induction Phase|Lack of Efficacy|0|||
145400818|NCT01863771|524324697|FG000|Induction Phase|Withdrawal by Subject|2|||
145400819|NCT01863771|524324698|FG001|Induction Phase|Withdrawal by Subject|0|||
145400820|NCT01863771|524324699|FG002|Induction Phase|Withdrawal by Subject|0|||
145400821|NCT01863771|524324700|FG003|Induction Phase|Withdrawal by Subject|0|||
145400822|NCT01863771|524324697|FG000|Maintenance Phase|Adverse Event|0|||
145400823|NCT01863771|524324698|FG001|Maintenance Phase|Adverse Event|0|||
145400824|NCT01863771|524324699|FG002|Maintenance Phase|Adverse Event|1|||
145400825|NCT01863771|524324700|FG003|Maintenance Phase|Adverse Event|1|||
145400826|NCT01863771|524324697|FG000|Maintenance Phase|Lack of Efficacy|0|||
145400827|NCT01863771|524324698|FG001|Maintenance Phase|Lack of Efficacy|3|||
145400828|NCT01863771|524324699|FG002|Maintenance Phase|Lack of Efficacy|7|||
145400829|NCT01863771|524324700|FG003|Maintenance Phase|Lack of Efficacy|38|||
145400830|NCT01863771|524324697|FG000|Maintenance Phase|Physician Decision|0|||
145400831|NCT01863771|524324698|FG001|Maintenance Phase|Physician Decision|0|||
145505612|NCT02304367|524709630|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
145505613|NCT04139798|524709635|FG000|Overall Study|Withdrawal by Subject|6|||
145505614|NCT04139798|524709636|FG001|Overall Study|Withdrawal by Subject|5|||
145505615|NCT04139798|524709635|FG000|Overall Study|Lost to Follow-up|2|||
145505616|NCT04139798|524709636|FG001|Overall Study|Lost to Follow-up|5|||
145505617|NCT04139798|524709635|FG000|Overall Study|Discontinued|4|||
145505618|NCT04139798|524709636|FG001|Overall Study|Discontinued|2|||
145505619|NCT04139798|524709635|FG000|Overall Study|Adverse Event|1|||
145505620|NCT04139798|524709636|FG001|Overall Study|Adverse Event|3|||
145505621|NCT04139798|524709635|FG000|Overall Study|Protocol Violation|1|||
145505622|NCT04139798|524709636|FG001|Overall Study|Protocol Violation|0|||
145505623|NCT03895840|524709639|FG000|Overall Study|Withdrawal by Subject|21|||
145505624|NCT01931566|524709640|FG000|Overall Study|Randomized But Not Treated|6|||
145505625|NCT01931566|524709641|FG001|Overall Study|Randomized But Not Treated|9|||
145505626|NCT01931566|524709642|FG002|Overall Study|Randomized But Not Treated|14|||
145505627|NCT01931566|524709640|FG000|Overall Study|Adverse Event|37|||
145505628|NCT01931566|524709641|FG001|Overall Study|Adverse Event|167|||
145505629|NCT01931566|524709642|FG002|Overall Study|Adverse Event|132|||
145505630|NCT01931566|524709640|FG000|Overall Study|Major Protocol Deviation|5|||
145505631|NCT01931566|524709641|FG001|Overall Study|Major Protocol Deviation|14|||
145505632|NCT01931566|524709642|FG002|Overall Study|Major Protocol Deviation|21|||
145505633|NCT01931566|524709640|FG000|Overall Study|Lost to Follow-up|3|||
145505634|NCT01931566|524709641|FG001|Overall Study|Lost to Follow-up|26|||
145505635|NCT01931566|524709642|FG002|Overall Study|Lost to Follow-up|23|||
145505636|NCT01931566|524709640|FG000|Overall Study|Voluntary Withdrawal|78|||
145505637|NCT01931566|524709641|FG001|Overall Study|Voluntary Withdrawal|245|||
145505638|NCT01931566|524709642|FG002|Overall Study|Voluntary Withdrawal|225|||
145505639|NCT01931566|524709640|FG000|Overall Study|Study Termination|289|||
145505640|NCT01931566|524709641|FG001|Overall Study|Study Termination|968|||
145505641|NCT01931566|524709642|FG002|Overall Study|Study Termination|1037|||
145505642|NCT01931566|524709640|FG000|Overall Study|Reason Not Specified|11|||
145505643|NCT01931566|524709641|FG001|Overall Study|Reason Not Specified|47|||
145505644|NCT01931566|524709642|FG002|Overall Study|Reason Not Specified|53|||
145505645|NCT01931566|524709640|FG000|Overall Study|Missing|0|||
145505646|NCT01931566|524709641|FG001|Overall Study|Missing|0|||
145505647|NCT01931566|524709642|FG002|Overall Study|Missing|1|||
145505648|NCT01599637|524709643|FG000|Overall Study|administrative problems|0|||
145505649|NCT01599637|524709644|FG001|Overall Study|administrative problems|2|||
145505650|NCT01599637|524709645|FG002|Overall Study|administrative problems|0|||
145505651|NCT01599637|524709643|FG000|Overall Study|Adverse Event|1|||
145505652|NCT01599637|524709644|FG001|Overall Study|Adverse Event|0|||
145505653|NCT01599637|524709645|FG002|Overall Study|Adverse Event|0|||
145505654|NCT00760617|524709647|FG000|Overall Study|Adverse Event|5|||
145505655|NCT00760617|524709648|FG001|Overall Study|Adverse Event|2|||
145505656|NCT00760617|524709649|FG002|Overall Study|Adverse Event|0|||
145505657|NCT00760617|524709647|FG000|Overall Study|Lost to Follow-up|0|||
145505658|NCT00760617|524709648|FG001|Overall Study|Lost to Follow-up|0|||
145505659|NCT00760617|524709649|FG002|Overall Study|Lost to Follow-up|5|||
145505660|NCT04476797|524709650|FG000|Overall Study|Withdrawal by Subject|1|||
145505661|NCT04476797|524709651|FG001|Overall Study|Withdrawal by Subject|0|||
145505662|NCT04476797|524709652|FG002|Overall Study|Withdrawal by Subject|0|||
145505663|NCT04476797|524709650|FG000|Overall Study|Death|0|||
145505664|NCT04476797|524709651|FG001|Overall Study|Death|1|||
145505665|NCT04476797|524709652|FG002|Overall Study|Death|2|||
145505666|NCT04476797|524709650|FG000|Overall Study|Sponsor Terminated Study|0|||
145505667|NCT04476797|524709651|FG001|Overall Study|Sponsor Terminated Study|18|||
145505668|NCT04476797|524709652|FG002|Overall Study|Sponsor Terminated Study|17|||
145505669|NCT02395081|524709653|FG000|Overall Study|Withdrawal by Subject|1|||
145505670|NCT02395081|524709654|FG001|Overall Study|Withdrawal by Subject|1|||
145505671|NCT02395081|524709655|FG002|Overall Study|Withdrawal by Subject|0|||
145505672|NCT02395081|524709653|FG000|Overall Study|Moved where blood couldn't be collected|4|||
145505673|NCT02395081|524709654|FG001|Overall Study|Moved where blood couldn't be collected|1|||
145505674|NCT02395081|524709655|FG002|Overall Study|Moved where blood couldn't be collected|3|||
145505675|NCT02395081|524709653|FG000|Overall Study|Fetal Loss|2|||
145505676|NCT02395081|524709654|FG001|Overall Study|Fetal Loss|3|||
145505677|NCT02395081|524709655|FG002|Overall Study|Fetal Loss|1|||
145505678|NCT04625101|524709658|FG000|Overall Study|Withdrawal by Subject|0|||
145505679|NCT04625101|524709659|FG001|Overall Study|Withdrawal by Subject|1|||
145505680|NCT04625101|524709658|FG000|Overall Study|Protocol Deviation|1|||
145505681|NCT04625101|524709659|FG001|Overall Study|Protocol Deviation|0|||
145505682|NCT02991040|524709660|FG000|Overall Study|Withdrawal by Subject|2|||
145505683|NCT02991040|524709660|FG000|Overall Study|Lost to Follow-up|2|||
145505684|NCT02721966|524709662|FG000|Overall Study|Protocol Violation|1|||
145505685|NCT02721966|524709663|FG001|Overall Study|Protocol Violation|0|||
145505686|NCT02721966|524709664|FG002|Overall Study|Protocol Violation|0|||
145505687|NCT02721966|524709665|FG003|Overall Study|Protocol Violation|0|||
145505688|NCT02721966|524709666|FG004|Overall Study|Protocol Violation|0|||
145505689|NCT02721966|524709662|FG000|Overall Study|Withdrawal by Subject|9|||
145505690|NCT02721966|524709663|FG001|Overall Study|Withdrawal by Subject|2|||
145505691|NCT02721966|524709664|FG002|Overall Study|Withdrawal by Subject|3|||
145400832|NCT01863771|524324699|FG002|Maintenance Phase|Physician Decision|2|||
145400833|NCT01863771|524324700|FG003|Maintenance Phase|Physician Decision|1|||
145400834|NCT01863771|524324697|FG000|Maintenance Phase|Pregnancy|0|||
145400835|NCT01863771|524324698|FG001|Maintenance Phase|Pregnancy|1|||
145400836|NCT01863771|524324699|FG002|Maintenance Phase|Pregnancy|0|||
145400837|NCT01863771|524324700|FG003|Maintenance Phase|Pregnancy|0|||
145400838|NCT01863771|524324697|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145400839|NCT01863771|524324698|FG001|Maintenance Phase|Withdrawal by Subject|1|||
145400840|NCT01863771|524324699|FG002|Maintenance Phase|Withdrawal by Subject|2|||
145400841|NCT01863771|524324700|FG003|Maintenance Phase|Withdrawal by Subject|3|||
145400842|NCT03636256|524324701|FG000|Overall Study|Lost to Follow-up|3|||
145400843|NCT03636256|524324702|FG001|Overall Study|Lost to Follow-up|0|||
145400844|NCT03636256|524324703|FG002|Overall Study|Lost to Follow-up|2|||
145400845|NCT03636256|524324704|FG003|Overall Study|Lost to Follow-up|1|||
145400846|NCT03636256|524324705|FG004|Overall Study|Lost to Follow-up|0|||
145400847|NCT03636256|524324706|FG005|Overall Study|Lost to Follow-up|4|||
145400848|NCT03636256|524324707|FG006|Overall Study|Lost to Follow-up|2|||
145400849|NCT03636256|524324708|FG007|Overall Study|Lost to Follow-up|0|||
145400850|NCT03636256|524324709|FG008|Overall Study|Lost to Follow-up|4|||
145400851|NCT03636256|524324701|FG000|Overall Study|Withdrawal by Subject|0|||
145400852|NCT03636256|524324702|FG001|Overall Study|Withdrawal by Subject|0|||
145400853|NCT03636256|524324703|FG002|Overall Study|Withdrawal by Subject|0|||
145400854|NCT03636256|524324704|FG003|Overall Study|Withdrawal by Subject|0|||
145400855|NCT03636256|524324705|FG004|Overall Study|Withdrawal by Subject|0|||
145400856|NCT03636256|524324706|FG005|Overall Study|Withdrawal by Subject|0|||
145400857|NCT03636256|524324707|FG006|Overall Study|Withdrawal by Subject|0|||
145400858|NCT03636256|524324708|FG007|Overall Study|Withdrawal by Subject|0|||
145400859|NCT03636256|524324709|FG008|Overall Study|Withdrawal by Subject|1|||
145400860|NCT02426684|524324710|FG000|Overall Study|Physician Decision|1|||
145400861|NCT01118299|524324711|FG000|Overall Study|Death|7|||
145400862|NCT01118299|524324712|FG001|Overall Study|Death|5|||
145400863|NCT01118299|524324711|FG000|Overall Study|Withdrawal by Subject|8|||
145400864|NCT01118299|524324712|FG001|Overall Study|Withdrawal by Subject|8|||
145400865|NCT01118299|524324711|FG000|Overall Study|Lost to Follow-up|2|||
145400866|NCT01118299|524324712|FG001|Overall Study|Lost to Follow-up|1|||
145400867|NCT01118299|524324711|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
145400868|NCT01118299|524324712|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
145400869|NCT02932943|524324713|FG000|Overall Study|Lost to Follow-up|0|||
145400870|NCT02932943|524324714|FG001|Overall Study|Lost to Follow-up|2|||
145400871|NCT02932943|524324713|FG000|Overall Study|Adverse Event|2|||
145400872|NCT02932943|524324714|FG001|Overall Study|Adverse Event|2|||
145400873|NCT02932943|524324713|FG000|Overall Study|Withdrawal by Subject|3|||
145400874|NCT02932943|524324714|FG001|Overall Study|Withdrawal by Subject|3|||
145400875|NCT02337491|524324715|FG000|Overall Study|Death|1|||
145400876|NCT02337491|524324716|FG001|Overall Study|Death|1|||
145400877|NCT02337491|524324715|FG000|Overall Study|Adverse Event|0|||
145400878|NCT02337491|524324716|FG001|Overall Study|Adverse Event|1|||
145400879|NCT02337491|524324715|FG000|Overall Study|Withdrawal by Subject|3|||
145400880|NCT02337491|524324716|FG001|Overall Study|Withdrawal by Subject|0|||
145400881|NCT02337491|524324715|FG000|Overall Study|Progressive Disease|44|||
145400882|NCT02337491|524324716|FG001|Overall Study|Progressive Disease|28|||
145400883|NCT02337491|524324715|FG000|Overall Study|On Treatment|2|||
145400884|NCT02337491|524324716|FG001|Overall Study|On Treatment|0|||
145400885|NCT00551369|524324718|FG000|Overall Study|Protocol Violation|5|||
145400886|NCT00551369|524324718|FG000|Overall Study|Withdrawal by Subject|1|||
145400887|NCT00551369|524324718|FG000|Overall Study|Not treated per protocol and re|1|||
145400888|NCT02251275|524324719|FG000|Overall Study|Adverse Event|23|||
145400889|NCT02251275|524324720|FG001|Overall Study|Adverse Event|60|||
145400890|NCT02251275|524324721|FG002|Overall Study|Adverse Event|28|||
145400891|NCT02251275|524324722|FG003|Overall Study|Adverse Event|0|||
145400892|NCT02251275|524324723|FG004|Overall Study|Adverse Event|0|||
145400893|NCT02251275|524324719|FG000|Overall Study|Lost to Follow-up|5|||
145400894|NCT02251275|524324720|FG001|Overall Study|Lost to Follow-up|6|||
145400895|NCT02251275|524324721|FG002|Overall Study|Lost to Follow-up|4|||
145400896|NCT02251275|524324722|FG003|Overall Study|Lost to Follow-up|0|||
145400897|NCT02251275|524324723|FG004|Overall Study|Lost to Follow-up|0|||
145400898|NCT02251275|524324719|FG000|Overall Study|Physician Decision|19|||
145400899|NCT02251275|524324720|FG001|Overall Study|Physician Decision|30|||
145400900|NCT02251275|524324721|FG002|Overall Study|Physician Decision|26|||
145505692|NCT02721966|524709665|FG003|Overall Study|Withdrawal by Subject|7|||
145505693|NCT02721966|524709666|FG004|Overall Study|Withdrawal by Subject|0|||
145505694|NCT02721966|524709662|FG000|Overall Study|Adverse Event|4|||
145505695|NCT02721966|524709663|FG001|Overall Study|Adverse Event|4|||
145505696|NCT02721966|524709664|FG002|Overall Study|Adverse Event|3|||
145505697|NCT02721966|524709665|FG003|Overall Study|Adverse Event|0|||
145505698|NCT02721966|524709666|FG004|Overall Study|Adverse Event|0|||
145505699|NCT02721966|524709662|FG000|Overall Study|Death|1|||
145505700|NCT02721966|524709663|FG001|Overall Study|Death|0|||
145505701|NCT02721966|524709664|FG002|Overall Study|Death|0|||
145505702|NCT02721966|524709665|FG003|Overall Study|Death|0|||
145505703|NCT02721966|524709666|FG004|Overall Study|Death|0|||
145505704|NCT02721966|524709662|FG000|Overall Study|Lack of Efficacy|7|||
145505705|NCT02721966|524709663|FG001|Overall Study|Lack of Efficacy|4|||
145505706|NCT02721966|524709664|FG002|Overall Study|Lack of Efficacy|0|||
145505707|NCT02721966|524709665|FG003|Overall Study|Lack of Efficacy|0|||
145505708|NCT02721966|524709666|FG004|Overall Study|Lack of Efficacy|0|||
145505709|NCT02721966|524709662|FG000|Overall Study|Lost to Follow-up|0|||
145505710|NCT02721966|524709663|FG001|Overall Study|Lost to Follow-up|0|||
145505711|NCT02721966|524709664|FG002|Overall Study|Lost to Follow-up|3|||
145505712|NCT02721966|524709665|FG003|Overall Study|Lost to Follow-up|0|||
145505713|NCT02721966|524709666|FG004|Overall Study|Lost to Follow-up|0|||
145505714|NCT02721966|524709662|FG000|Overall Study|Physician Decision|1|||
145505715|NCT02721966|524709663|FG001|Overall Study|Physician Decision|1|||
145505716|NCT02721966|524709664|FG002|Overall Study|Physician Decision|0|||
145505717|NCT02721966|524709665|FG003|Overall Study|Physician Decision|0|||
145505718|NCT02721966|524709666|FG004|Overall Study|Physician Decision|0|||
145505719|NCT02721966|524709662|FG000|Overall Study|Pregnancy|1|||
145505720|NCT02721966|524709663|FG001|Overall Study|Pregnancy|0|||
145505721|NCT02721966|524709664|FG002|Overall Study|Pregnancy|0|||
145505722|NCT02721966|524709665|FG003|Overall Study|Pregnancy|0|||
145505723|NCT02721966|524709666|FG004|Overall Study|Pregnancy|0|||
145505724|NCT02721966|524709662|FG000|Overall Study|Did not continue to period 2|5|||
145505725|NCT02721966|524709663|FG001|Overall Study|Did not continue to period 2|12|||
145505726|NCT02721966|524709664|FG002|Overall Study|Did not continue to period 2|0|||
145505727|NCT02721966|524709665|FG003|Overall Study|Did not continue to period 2|0|||
145505728|NCT02721966|524709666|FG004|Overall Study|Did not continue to period 2|5|||
145505729|NCT03070964|524709667|FG000|Overall Study|Progressive disease|8|||
145505730|NCT03070964|524709667|FG000|Overall Study|Treatment-unrelated adverse event|2|||
145505731|NCT03070964|524709667|FG000|Overall Study|Never treated|1|||
145505732|NCT03070964|524709667|FG000|Overall Study|Physician Decision|1|||
145505733|NCT03070964|524709667|FG000|Overall Study|Withdrawal by Subject|1|||
145505734|NCT03070964|524709667|FG000|Overall Study|Adverse Event|1|||
145505735|NCT01869764|524709668|FG000|Overall Study|Withdrawal by Subject|0|||
145505736|NCT01869764|524709669|FG001|Overall Study|Withdrawal by Subject|2|||
145505737|NCT01286480|524709670|FG000|Overall Study|Withdrawal by Subject|5|||
145505738|NCT01286480|524709671|FG001|Overall Study|Withdrawal by Subject|3|||
145505739|NCT00834093|524709672|FG000|Overall Study|Progressive Disease|3|||
145505740|NCT00834093|524709672|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
145505741|NCT01626872|524709673|FG000|Overall Study|Physician Decision|13|||
145505742|NCT01626872|524709674|FG001|Overall Study|Physician Decision|9|||
145505743|NCT01626872|524709675|FG002|Overall Study|Physician Decision|6|||
145505744|NCT01626872|524709673|FG000|Overall Study|Withdrawal by Subject|19|||
145505745|NCT01626872|524709674|FG001|Overall Study|Withdrawal by Subject|27|||
145505746|NCT01626872|524709675|FG002|Overall Study|Withdrawal by Subject|8|||
145505747|NCT01626872|524709673|FG000|Overall Study|Adverse Event (including Death)|20|||
145505748|NCT01626872|524709674|FG001|Overall Study|Adverse Event (including Death)|28|||
145505749|NCT01626872|524709675|FG002|Overall Study|Adverse Event (including Death)|8|||
145505750|NCT01626872|524709673|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
145505751|NCT01626872|524709674|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
145505752|NCT01626872|524709675|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
145505753|NCT01578486|524709676|FG000|Overall Study|Physician Decision|3|||
145505754|NCT01578486|524709676|FG000|Overall Study|Withdrawal by Subject|2|||
145505755|NCT01209325|524709679|FG000|Overall Study|Lost to Follow-up|24|||
145505756|NCT01209325|524709679|FG000|Overall Study|Adverse Event|1|||
145505757|NCT01209325|524709679|FG000|Overall Study|Relocated|3|||
145505758|NCT01209325|524709679|FG000|Overall Study|Refusal after starting therapy|8|||
145505759|NCT01209325|524709679|FG000|Overall Study|Protocol Violation|4|||
145505760|NCT01209325|524709679|FG000|Overall Study|Refusal prior to therapy|1|||
145505761|NCT01209325|524709679|FG000|Overall Study|Incarceration|2|||
145505762|NCT00607373|524709680|FG000|Treatment Period|Adverse Event|0|||
145505763|NCT00607373|524709681|FG001|Treatment Period|Adverse Event|4|||
145505764|NCT00607373|524709680|FG000|Treatment Period|Physician Decision|0|||
145505765|NCT00607373|524709681|FG001|Treatment Period|Physician Decision|1|||
145505766|NCT00607373|524709680|FG000|Treatment Period|Withdrawal by Subject|0|||
145505767|NCT00607373|524709681|FG001|Treatment Period|Withdrawal by Subject|1|||
145505768|NCT00607373|524709680|FG000|Follow-up Period|Other|0|||
145505769|NCT00607373|524709681|FG001|Follow-up Period|Other|1|||
145505770|NCT00607373|524709680|FG000|Follow-up Period|Protocol Violation|0|||
145505771|NCT00607373|524709681|FG001|Follow-up Period|Protocol Violation|1|||
145505772|NCT00607373|524709680|FG000|Follow-up Period|Withdrawal by Subject|1|||
145505773|NCT00607373|524709681|FG001|Follow-up Period|Withdrawal by Subject|3|||
145505774|NCT01918306|524709682|FG000|Overall Study|progresive disease|4|||
145505775|NCT01918306|524709683|FG001|Overall Study|progresive disease|0|||
145505776|NCT01918306|524709684|FG002|Overall Study|progresive disease|1|||
145505777|NCT01918306|524709685|FG003|Overall Study|progresive disease|1|||
145505778|NCT01918306|524709682|FG000|Overall Study|Withdrawal by Subject|0|||
145505779|NCT01918306|524709683|FG001|Overall Study|Withdrawal by Subject|0|||
145505780|NCT01918306|524709684|FG002|Overall Study|Withdrawal by Subject|0|||
145505781|NCT01918306|524709685|FG003|Overall Study|Withdrawal by Subject|2|||
145505782|NCT01918306|524709682|FG000|Overall Study|neutropenia|1|||
145505783|NCT01918306|524709683|FG001|Overall Study|neutropenia|0|||
145505784|NCT01918306|524709684|FG002|Overall Study|neutropenia|0|||
145505785|NCT01918306|524709685|FG003|Overall Study|neutropenia|0|||
145505786|NCT01918306|524709682|FG000|Overall Study|Lack of Efficacy|1|||
145505787|NCT01918306|524709683|FG001|Overall Study|Lack of Efficacy|0|||
145505788|NCT01918306|524709684|FG002|Overall Study|Lack of Efficacy|0|||
145505789|NCT01918306|524709685|FG003|Overall Study|Lack of Efficacy|0|||
145505790|NCT01918306|524709682|FG000|Overall Study|progress disease, crossover|0|||
145505791|NCT01918306|524709683|FG001|Overall Study|progress disease, crossover|0|||
145400901|NCT02251275|524324722|FG003|Overall Study|Physician Decision|0|||
145400902|NCT02251275|524324723|FG004|Overall Study|Physician Decision|1|||
145400903|NCT02251275|524324719|FG000|Overall Study|Protocol Deviation|0|||
145400904|NCT02251275|524324720|FG001|Overall Study|Protocol Deviation|0|||
145400905|NCT02251275|524324721|FG002|Overall Study|Protocol Deviation|1|||
145400906|NCT02251275|524324722|FG003|Overall Study|Protocol Deviation|0|||
145400907|NCT02251275|524324723|FG004|Overall Study|Protocol Deviation|0|||
145400908|NCT02251275|524324719|FG000|Overall Study|Withdrawal by Subject|25|||
145400909|NCT02251275|524324720|FG001|Overall Study|Withdrawal by Subject|51|||
145400910|NCT02251275|524324721|FG002|Overall Study|Withdrawal by Subject|35|||
145400911|NCT02251275|524324722|FG003|Overall Study|Withdrawal by Subject|1|||
145400912|NCT02251275|524324723|FG004|Overall Study|Withdrawal by Subject|0|||
145400913|NCT01302899|524324728|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
145400914|NCT01302899|524324729|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
145400915|NCT01302899|524324728|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
145400916|NCT01302899|524324729|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
145400917|NCT02497469|524324730|FG000|Overall Study|Randomized but not Treated|0|||
145400918|NCT02497469|524324731|FG001|Overall Study|Randomized but not Treated|2|||
145400919|NCT02497469|524324730|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
145400920|NCT02497469|524324731|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
145400921|NCT02497469|524324730|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
145400922|NCT02497469|524324731|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
145400923|NCT02497469|524324730|FG000|Overall Study|Significant Protocol Deviation|4|||
145400924|NCT02497469|524324731|FG001|Overall Study|Significant Protocol Deviation|5|||
145400925|NCT02497469|524324730|FG000|Overall Study|Lost to Follow-up|14|||
145400926|NCT02497469|524324731|FG001|Overall Study|Lost to Follow-up|4|||
145400927|NCT02497469|524324730|FG000|Overall Study|Voluntary Withdrawal|39|||
145400928|NCT02497469|524324731|FG001|Overall Study|Voluntary Withdrawal|41|||
145400929|NCT02497469|524324730|FG000|Overall Study|Pregnancy|1|||
145400930|NCT02497469|524324731|FG001|Overall Study|Pregnancy|1|||
145400931|NCT02497469|524324730|FG000|Overall Study|Lack of Efficacy|86|||
145400932|NCT02497469|524324731|FG001|Overall Study|Lack of Efficacy|40|||
145400933|NCT02497469|524324730|FG000|Overall Study|Reason not Specified|6|||
145400934|NCT02497469|524324731|FG001|Overall Study|Reason not Specified|6|||
145400935|NCT03558516|524324732|FG000|Overall Study|Protocol Violation|2|||
145400936|NCT03558516|524324733|FG001|Overall Study|Protocol Violation|2|||
145400937|NCT00472420|524324734|FG000|Induction Treatment Period|Physician Decision|9|||
145400938|NCT00472420|524324734|FG000|Induction Treatment Period|Adverse Event|3|||
145400939|NCT00472420|524324734|FG000|Induction Treatment Period|Non-compliance|1|||
145400940|NCT00472420|524324734|FG000|Induction Treatment Period|Death|3|||
145400941|NCT00472420|524324734|FG000|Follow-up Period|Death|5|||
145400942|NCT00472420|524324734|FG000|Follow-up Period|Physician Decision|9|||
145400943|NCT00472420|524324734|FG000|Follow-up Period|Lost to Follow-up|2|||
145400944|NCT00472420|524324734|FG000|Follow-up Period|Protocol Violation|1|||
145400945|NCT02737722|524324738|FG000|Overall Study|Physician Decision|0|||
145400946|NCT02737722|524324739|FG001|Overall Study|Physician Decision|0|||
145400947|NCT02737722|524324740|FG002|Overall Study|Physician Decision|1|||
145400948|NCT02737722|524324741|FG003|Overall Study|Physician Decision|0|||
145400949|NCT02662569|524324744|FG000|Overall Study|Withdrawal by Subject|6|||
145400950|NCT02662569|524324745|FG001|Overall Study|Withdrawal by Subject|1|||
145400951|NCT02662569|524324746|FG002|Overall Study|Withdrawal by Subject|6|||
145400952|NCT02662569|524324747|FG003|Overall Study|Withdrawal by Subject|4|||
145505792|NCT01918306|524709684|FG002|Overall Study|progress disease, crossover|1|||
145505793|NCT01918306|524709685|FG003|Overall Study|progress disease, crossover|0|||
145505794|NCT01160822|524709690|FG000|Overall Study|Adverse Event|0|||
145505795|NCT01160822|524709691|FG001|Overall Study|Adverse Event|0|||
145505796|NCT01160822|524709692|FG002|Overall Study|Adverse Event|0|||
145505797|NCT01160822|524709693|FG003|Overall Study|Adverse Event|0|||
145505798|NCT01160822|524709694|FG004|Overall Study|Adverse Event|1|||
145505799|NCT01160822|524709695|FG005|Overall Study|Adverse Event|2|||
145505800|NCT01160822|524709696|FG006|Overall Study|Adverse Event|5|||
145505801|NCT01160822|524709690|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145505802|NCT01160822|524709691|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145505803|NCT01160822|524709692|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145400953|NCT02662569|524324744|FG000|Overall Study|Lost to Follow-up|1|||
145400954|NCT02662569|524324745|FG001|Overall Study|Lost to Follow-up|0|||
145400955|NCT02662569|524324746|FG002|Overall Study|Lost to Follow-up|0|||
145400956|NCT02662569|524324747|FG003|Overall Study|Lost to Follow-up|0|||
145400957|NCT01774591|524324748|FG000|Overall Study|Physician Decision|1|||
145400958|NCT01774591|524324749|FG001|Overall Study|Physician Decision|1|||
145400959|NCT01774591|524324748|FG000|Overall Study|Withdrawal by Subject|0|||
145400960|NCT01774591|524324749|FG001|Overall Study|Withdrawal by Subject|1|||
145400961|NCT01774591|524324748|FG000|Overall Study|Adverse Event|0|||
145400962|NCT01774591|524324749|FG001|Overall Study|Adverse Event|2|||
145400963|NCT02785939|524324755|FG000|Overall Study|Progression|25|||
145400964|NCT02785939|524324756|FG001|Overall Study|Progression|8|||
145400965|NCT02785939|524324755|FG000|Overall Study|Adverse Event|3|||
145400966|NCT02785939|524324756|FG001|Overall Study|Adverse Event|1|||
145400967|NCT02785939|524324755|FG000|Overall Study|Death|1|||
145400968|NCT02785939|524324756|FG001|Overall Study|Death|0|||
145400969|NCT02785939|524324755|FG000|Overall Study|Refusal|1|||
145400970|NCT02785939|524324756|FG001|Overall Study|Refusal|0|||
145400971|NCT02785939|524324755|FG000|Overall Study|Deteriorating health|1|||
145400972|NCT02785939|524324756|FG001|Overall Study|Deteriorating health|0|||
145400973|NCT02785939|524324755|FG000|Overall Study|Not protocol specified|0|||
145400974|NCT02785939|524324756|FG001|Overall Study|Not protocol specified|1|||
145400975|NCT01787552|524324759|FG000|Overall Study|Withdrawal by Subject|2|||
145400976|NCT01787552|524324760|FG001|Overall Study|Withdrawal by Subject|0|||
145400977|NCT01787552|524324761|FG002|Overall Study|Withdrawal by Subject|0|||
145400978|NCT01787552|524324762|FG003|Overall Study|Withdrawal by Subject|4|||
145400979|NCT01787552|524324759|FG000|Overall Study|Physician Decision|2|||
145400980|NCT01787552|524324760|FG001|Overall Study|Physician Decision|2|||
145400981|NCT01787552|524324761|FG002|Overall Study|Physician Decision|1|||
145400982|NCT01787552|524324762|FG003|Overall Study|Physician Decision|2|||
145400983|NCT01787552|524324759|FG000|Overall Study|Death|0|||
145400984|NCT01787552|524324760|FG001|Overall Study|Death|0|||
145400985|NCT01787552|524324761|FG002|Overall Study|Death|0|||
145400986|NCT01787552|524324762|FG003|Overall Study|Death|1|||
145400987|NCT01787552|524324759|FG000|Overall Study|Adverse Event|2|||
145400988|NCT01787552|524324760|FG001|Overall Study|Adverse Event|5|||
145400989|NCT01787552|524324761|FG002|Overall Study|Adverse Event|2|||
145400990|NCT01787552|524324762|FG003|Overall Study|Adverse Event|16|||
145400991|NCT01787552|524324759|FG000|Overall Study|Study terminated by Sponsor|0|||
145400992|NCT01787552|524324760|FG001|Overall Study|Study terminated by Sponsor|0|||
145400993|NCT01787552|524324761|FG002|Overall Study|Study terminated by Sponsor|1|||
145400994|NCT01787552|524324762|FG003|Overall Study|Study terminated by Sponsor|3|||
145400995|NCT01787552|524324759|FG000|Overall Study|Progressive Disease|2|||
145400996|NCT01787552|524324760|FG001|Overall Study|Progressive Disease|2|||
145400997|NCT01787552|524324761|FG002|Overall Study|Progressive Disease|1|||
145400998|NCT01787552|524324762|FG003|Overall Study|Progressive Disease|1|||
145400999|NCT04249427|524324772|FG000|Overall Study|Adverse Event|3|||
145401000|NCT04249427|524324773|FG001|Overall Study|Adverse Event|1|||
145401001|NCT04249427|524324772|FG000|Overall Study|Lack of Efficacy|0|||
145401002|NCT04249427|524324773|FG001|Overall Study|Lack of Efficacy|1|||
145401003|NCT04249427|524324772|FG000|Overall Study|Withdrawal by Subject|1|||
145401004|NCT04249427|524324773|FG001|Overall Study|Withdrawal by Subject|2|||
145401005|NCT02557399|524324774|FG000|Overall Study|Adverse Event|6|||
145401006|NCT02557399|524324775|FG001|Overall Study|Adverse Event|5|||
145401007|NCT02557399|524324774|FG000|Overall Study|Protocol Violation|0|||
145401008|NCT02557399|524324775|FG001|Overall Study|Protocol Violation|1|||
145401009|NCT02557399|524324774|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145401010|NCT02557399|524324775|FG001|Overall Study|Protocol-defined stopping criteria|1|||
145401011|NCT02557399|524324774|FG000|Overall Study|Withdrawal by Subject|1|||
145401012|NCT02557399|524324775|FG001|Overall Study|Withdrawal by Subject|1|||
145401013|NCT03608826|524324776|FG000|Overall Study|Death|3|||
145401014|NCT03608826|524324776|FG000|Overall Study|Heart Transplant|3|||
145401015|NCT03608826|524324776|FG000|Overall Study|Physician Decision|4|||
145401016|NCT03122171|524324777|FG000|Overall Study|Withdrawal by Subject|1|||
145505804|NCT01160822|524709693|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145505805|NCT01160822|524709694|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
145505806|NCT01160822|524709695|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
145505807|NCT01160822|524709696|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
145505808|NCT01160822|524709690|FG000|Overall Study|Withdrawal by Subject|0|||
145505809|NCT01160822|524709691|FG001|Overall Study|Withdrawal by Subject|0|||
145505810|NCT01160822|524709692|FG002|Overall Study|Withdrawal by Subject|0|||
145505811|NCT01160822|524709693|FG003|Overall Study|Withdrawal by Subject|0|||
145505812|NCT01160822|524709694|FG004|Overall Study|Withdrawal by Subject|0|||
145505813|NCT01160822|524709695|FG005|Overall Study|Withdrawal by Subject|0|||
145505814|NCT01160822|524709696|FG006|Overall Study|Withdrawal by Subject|1|||
145505815|NCT01160822|524709690|FG000|Overall Study|Lost to Follow-up|0|||
145505816|NCT01160822|524709691|FG001|Overall Study|Lost to Follow-up|0|||
145505817|NCT01160822|524709692|FG002|Overall Study|Lost to Follow-up|0|||
145505818|NCT01160822|524709693|FG003|Overall Study|Lost to Follow-up|0|||
145505819|NCT01160822|524709694|FG004|Overall Study|Lost to Follow-up|1|||
145505820|NCT01160822|524709695|FG005|Overall Study|Lost to Follow-up|0|||
145505821|NCT01160822|524709696|FG006|Overall Study|Lost to Follow-up|0|||
145505822|NCT01160822|524709690|FG000|Overall Study|Administrative problems|0|||
145505823|NCT01160822|524709691|FG001|Overall Study|Administrative problems|0|||
145505824|NCT01160822|524709692|FG002|Overall Study|Administrative problems|0|||
145505825|NCT01160822|524709693|FG003|Overall Study|Administrative problems|0|||
145505826|NCT01160822|524709694|FG004|Overall Study|Administrative problems|1|||
145505827|NCT01160822|524709695|FG005|Overall Study|Administrative problems|0|||
145505828|NCT01160822|524709696|FG006|Overall Study|Administrative problems|0|||
145505829|NCT01160822|524709690|FG000|Overall Study|Protocol deviation|0|||
145505830|NCT01160822|524709691|FG001|Overall Study|Protocol deviation|0|||
145505831|NCT01160822|524709692|FG002|Overall Study|Protocol deviation|0|||
145505832|NCT01160822|524709693|FG003|Overall Study|Protocol deviation|0|||
145505833|NCT01160822|524709694|FG004|Overall Study|Protocol deviation|2|||
145505834|NCT01160822|524709695|FG005|Overall Study|Protocol deviation|0|||
145505835|NCT01160822|524709696|FG006|Overall Study|Protocol deviation|0|||
145505836|NCT02506244|524709697|FG000|Overall Study|Did not undergo active monitoring|458|||
145505837|NCT02506244|524709698|FG001|Overall Study|Did not undergo active monitoring|459|||
145505838|NCT02506244|524709699|FG002|Overall Study|Did not undergo active monitoring|0|||
145505839|NCT00314795|524709703|FG000|Overall Study|Adverse Event|8|||
145505840|NCT00314795|524709703|FG000|Overall Study|Death|4|||
145505841|NCT00314795|524709703|FG000|Overall Study|Reason not Specified|3|||
145505842|NCT00314795|524709703|FG000|Overall Study|Renal Transplant|3|||
145505843|NCT00314795|524709703|FG000|Overall Study|Participants Withdrew Consent|2|||
145505844|NCT04717336|524709704|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
145505845|NCT04717336|524709705|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
145505846|NCT04717336|524709704|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
145505847|NCT04717336|524709705|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
145505848|NCT02039843|524709710|FG000|Randomization and Observation Period|Adverse Event|2|||
145505849|NCT02039843|524709711|FG001|Randomization and Observation Period|Adverse Event|0|||
145505850|NCT02039843|524709710|FG000|Randomization and Observation Period|Death|1|||
145505851|NCT02039843|524709711|FG001|Randomization and Observation Period|Death|0|||
145505852|NCT02039843|524709710|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
145505853|NCT02039843|524709711|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
145505854|NCT02039843|524709710|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
145505855|NCT02039843|524709711|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
145505856|NCT02039843|524709710|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
145505857|NCT02039843|524709711|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
145505858|NCT02039843|524709710|FG000|Pairing With a Study Dog|Death|1|||
145505859|NCT02039843|524709711|FG001|Pairing With a Study Dog|Death|0|||
145505860|NCT02039843|524709710|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
145505861|NCT02039843|524709711|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
145505862|NCT02039843|524709710|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
145505863|NCT02039843|524709711|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
145505864|NCT02039843|524709710|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
145505865|NCT02039843|524709711|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
145505866|NCT02170077|524709712|FG000|Overall Study|Withdrawal by Subject|3|||
145505867|NCT02170077|524709713|FG001|Overall Study|Withdrawal by Subject|4|||
145505868|NCT02170077|524709714|FG002|Overall Study|Withdrawal by Subject|2|||
145505869|NCT02170077|524709712|FG000|Overall Study|Adverse Event|4|||
145505870|NCT02170077|524709713|FG001|Overall Study|Adverse Event|4|||
145505871|NCT02170077|524709714|FG002|Overall Study|Adverse Event|4|||
145505872|NCT02170077|524709712|FG000|Overall Study|Lost to Follow-up|0|||
145505873|NCT02170077|524709713|FG001|Overall Study|Lost to Follow-up|1|||
145505874|NCT02170077|524709714|FG002|Overall Study|Lost to Follow-up|0|||
145505875|NCT02170077|524709712|FG000|Overall Study|Exclusion criteria|2|||
145505876|NCT02170077|524709713|FG001|Overall Study|Exclusion criteria|2|||
145505877|NCT02170077|524709714|FG002|Overall Study|Exclusion criteria|5|||
145505878|NCT02170077|524709712|FG000|Overall Study|Exacerbation of seizures|0|||
145505879|NCT02170077|524709713|FG001|Overall Study|Exacerbation of seizures|2|||
145505880|NCT02170077|524709714|FG002|Overall Study|Exacerbation of seizures|1|||
145505881|NCT01958164|524709715|FG000|Overall Study|Adverse Event|0|||
145505882|NCT01958164|524709716|FG001|Overall Study|Adverse Event|2|||
145505883|NCT01958164|524709715|FG000|Overall Study|Lost to Follow-up|2|||
145505884|NCT01958164|524709716|FG001|Overall Study|Lost to Follow-up|3|||
145505885|NCT01724346|524709721|FG000|Overall Study|Death|42|||
145505886|NCT01724346|524709722|FG001|Overall Study|Death|42|||
145505887|NCT01724346|524709721|FG000|Overall Study|Lost to Follow-up|5|||
145505888|NCT01724346|524709722|FG001|Overall Study|Lost to Follow-up|1|||
145505889|NCT01724346|524709721|FG000|Overall Study|Withdrawal by Subject|27|||
145505890|NCT01724346|524709722|FG001|Overall Study|Withdrawal by Subject|19|||
145505891|NCT01724346|524709721|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
145505892|NCT01724346|524709722|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
145505893|NCT00525161|524709723|FG000|Overall Study|Adverse Event|1|||
145505894|NCT01076361|524709724|FG000|Overall Study|22 leads were excluded from analysis|21|||
145505895|NCT00750438|524709729|FG000|Overall Study|Protocol Violation|4|||
145505896|NCT00750438|524709730|FG001|Overall Study|Protocol Violation|1|||
145505897|NCT00750438|524709729|FG000|Overall Study|Physician Decision|2|||
145505898|NCT00750438|524709730|FG001|Overall Study|Physician Decision|2|||
145505899|NCT00750438|524709729|FG000|Overall Study|Withdrawal by Subject|1|||
145505900|NCT00750438|524709730|FG001|Overall Study|Withdrawal by Subject|1|||
145505901|NCT00256997|524709733|FG000|Overall Study|Protocol Violation|1|||
145505902|NCT00256997|524709734|FG001|Overall Study|Protocol Violation|4|||
145505903|NCT00256997|524709733|FG000|Overall Study|Lack of Efficacy|1|||
145505904|NCT00256997|524709734|FG001|Overall Study|Lack of Efficacy|4|||
145505905|NCT00256997|524709733|FG000|Overall Study|Death|2|||
145505906|NCT00256997|524709734|FG001|Overall Study|Death|0|||
145505907|NCT00256997|524709733|FG000|Overall Study|Adverse Event|4|||
145505908|NCT00256997|524709734|FG001|Overall Study|Adverse Event|0|||
145505909|NCT00256997|524709733|FG000|Overall Study|Lost to Follow-up|3|||
145505910|NCT00256997|524709734|FG001|Overall Study|Lost to Follow-up|5|||
145505911|NCT00256997|524709733|FG000|Overall Study|Withdrawal by Subject|13|||
145505912|NCT00256997|524709734|FG001|Overall Study|Withdrawal by Subject|3|||
145505913|NCT00256997|524709733|FG000|Overall Study|Started but not treated|2|||
145505914|NCT00256997|524709734|FG001|Overall Study|Started but not treated|0|||
145505915|NCT00256997|524709733|FG000|Overall Study|Other|5|||
145505916|NCT00256997|524709734|FG001|Overall Study|Other|8|||
145505917|NCT00256997|524709733|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
145505918|NCT00256997|524709734|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
145505919|NCT00256997|524709733|FG000|Overall Study|Participant Non-compliant|3|||
145505920|NCT00256997|524709734|FG001|Overall Study|Participant Non-compliant|6|||
145505921|NCT00256997|524709733|FG000|Overall Study|Investigator Withdrew Participant|2|||
145505922|NCT00256997|524709734|FG001|Overall Study|Investigator Withdrew Participant|1|||
145505923|NCT02736578|524709735|FG000|Overall Study|Adverse Event|1|||
145505924|NCT02736578|524709736|FG001|Overall Study|Adverse Event|0|||
145505925|NCT00354432|524709737|FG000|Overall Study|Adverse Event|3|||
145505926|NCT00354432|524709738|FG001|Overall Study|Adverse Event|1|||
145505927|NCT00354432|524709739|FG002|Overall Study|Adverse Event|5|||
145505928|NCT00354432|524709740|FG003|Overall Study|Adverse Event|5|||
145505929|NCT00354432|524709737|FG000|Overall Study|Off/Toxicity|3|||
145505930|NCT00354432|524709738|FG001|Overall Study|Off/Toxicity|7|||
145505931|NCT00354432|524709739|FG002|Overall Study|Off/Toxicity|5|||
145505932|NCT00354432|524709740|FG003|Overall Study|Off/Toxicity|5|||
145505933|NCT00802945|524709741|FG000|Overall Study|Death|27|||
145505934|NCT00802945|524709742|FG001|Overall Study|Death|23|||
145505935|NCT00802945|524709741|FG000|Overall Study|Terminated by sponsor|8|||
145505936|NCT00802945|524709742|FG001|Overall Study|Terminated by sponsor|12|||
145505937|NCT01104311|524709743|FG000|Overall Study|Withdrawal by Subject|6|||
145505938|NCT01104311|524709744|FG001|Overall Study|Withdrawal by Subject|6|||
145505939|NCT01104311|524709743|FG000|Overall Study|Protocol Violation|0|||
145505940|NCT01104311|524709744|FG001|Overall Study|Protocol Violation|1|||
145505941|NCT01104311|524709743|FG000|Overall Study|Physician Decision|2|||
145505942|NCT01104311|524709744|FG001|Overall Study|Physician Decision|2|||
145505943|NCT01104311|524709743|FG000|Overall Study|low compliance|1|||
145505944|NCT01104311|524709744|FG001|Overall Study|low compliance|1|||
145505945|NCT01104311|524709743|FG000|Overall Study|Adverse Event|1|||
145505946|NCT01104311|524709744|FG001|Overall Study|Adverse Event|2|||
145505947|NCT02873702|524711254|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
145505948|NCT02873702|524711255|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
145505949|NCT02873702|524711256|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
145505950|NCT02873702|524711257|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
145505951|NCT02873702|524711254|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
145505952|NCT02873702|524711255|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
145505953|NCT02873702|524711256|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
145505954|NCT02873702|524711257|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
145505955|NCT02873702|524711254|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
145505956|NCT02873702|524711255|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
145505957|NCT02873702|524711256|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
145505958|NCT02873702|524711257|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
145505959|NCT02873702|524711254|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
145505960|NCT02873702|524711255|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
145505961|NCT02873702|524711256|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
145505962|NCT02873702|524711257|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
145505963|NCT02873702|524711254|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
145505964|NCT02873702|524711255|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
145505965|NCT02873702|524711256|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
145505966|NCT02873702|524711257|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
145505967|NCT04816669|524711260|FG000|Part 1|Adverse Event|1|||
145505968|NCT04816669|524711261|FG001|Part 1|Adverse Event|1|||
145505969|NCT04816669|524711262|FG002|Part 1|Adverse Event|0|||
145505970|NCT04816669|524711263|FG003|Part 1|Adverse Event|0|||
145505971|NCT04816669|524711260|FG000|Part 1|Lost to Follow-up|2|||
145505972|NCT04816669|524711261|FG001|Part 1|Lost to Follow-up|2|||
145505973|NCT04816669|524711262|FG002|Part 1|Lost to Follow-up|0|||
145505974|NCT04816669|524711263|FG003|Part 1|Lost to Follow-up|0|||
145505975|NCT04816669|524711260|FG000|Part 1|Protocol Violation|0|||
145505976|NCT04816669|524711261|FG001|Part 1|Protocol Violation|1|||
145505977|NCT04816669|524711262|FG002|Part 1|Protocol Violation|0|||
145505978|NCT04816669|524711263|FG003|Part 1|Protocol Violation|0|||
145505979|NCT04816669|524711260|FG000|Part 1|Withdrawal by Subject|1|||
145505980|NCT04816669|524711261|FG001|Part 1|Withdrawal by Subject|2|||
145505981|NCT04816669|524711262|FG002|Part 1|Withdrawal by Subject|0|||
145505982|NCT04816669|524711263|FG003|Part 1|Withdrawal by Subject|0|||
145505983|NCT04816669|524711260|FG000|Part 2|Other|0|||
145505984|NCT04816669|524711261|FG001|Part 2|Other|0|||
145505985|NCT04816669|524711262|FG002|Part 2|Other|1|||
145505986|NCT04816669|524711263|FG003|Part 2|Other|0|||
145505987|NCT04816669|524711260|FG000|Part 2|Withdrawal by Subject|0|||
145505988|NCT04816669|524711261|FG001|Part 2|Withdrawal by Subject|0|||
145505989|NCT04816669|524711262|FG002|Part 2|Withdrawal by Subject|0|||
145505990|NCT04816669|524711263|FG003|Part 2|Withdrawal by Subject|1|||
145505991|NCT04816669|524711260|FG000|Part 2|Lost to Follow-up|0|||
145505992|NCT04816669|524711261|FG001|Part 2|Lost to Follow-up|0|||
145505993|NCT04816669|524711262|FG002|Part 2|Lost to Follow-up|1|||
145505994|NCT04816669|524711263|FG003|Part 2|Lost to Follow-up|0|||
145505995|NCT01229267|524711264|FG000|Overall Study|Adverse Event|4|||
145505996|NCT01229267|524711265|FG001|Overall Study|Adverse Event|6|||
145505997|NCT01229267|524711266|FG002|Overall Study|Adverse Event|3|||
145505998|NCT01229267|524711267|FG003|Overall Study|Adverse Event|2|||
145505999|NCT01229267|524711268|FG004|Overall Study|Adverse Event|10|||
145506000|NCT01229267|524711264|FG000|Overall Study|Death|40|||
145506001|NCT01229267|524711265|FG001|Overall Study|Death|37|||
145506002|NCT01229267|524711266|FG002|Overall Study|Death|35|||
145506003|NCT01229267|524711267|FG003|Overall Study|Death|13|||
145506004|NCT01229267|524711268|FG004|Overall Study|Death|103|||
145506005|NCT01229267|524711264|FG000|Overall Study|Withdrawal by Subject|23|||
145506006|NCT01229267|524711265|FG001|Overall Study|Withdrawal by Subject|22|||
145506007|NCT01229267|524711266|FG002|Overall Study|Withdrawal by Subject|32|||
145506008|NCT01229267|524711267|FG003|Overall Study|Withdrawal by Subject|14|||
145506009|NCT01229267|524711268|FG004|Overall Study|Withdrawal by Subject|59|||
145506010|NCT01229267|524711264|FG000|Overall Study|Protocol Violation|0|||
145506011|NCT01229267|524711265|FG001|Overall Study|Protocol Violation|1|||
145506012|NCT01229267|524711266|FG002|Overall Study|Protocol Violation|0|||
145506013|NCT01229267|524711267|FG003|Overall Study|Protocol Violation|0|||
145506014|NCT01229267|524711268|FG004|Overall Study|Protocol Violation|0|||
145506015|NCT01229267|524711264|FG000|Overall Study|Progressive disease|0|||
145506016|NCT01229267|524711265|FG001|Overall Study|Progressive disease|0|||
145506017|NCT01229267|524711266|FG002|Overall Study|Progressive disease|0|||
145506018|NCT01229267|524711267|FG003|Overall Study|Progressive disease|0|||
145506019|NCT01229267|524711268|FG004|Overall Study|Progressive disease|1|||
145506020|NCT01229267|524711264|FG000|Overall Study|Physician Decision|8|||
145506021|NCT01229267|524711265|FG001|Overall Study|Physician Decision|11|||
145506022|NCT01229267|524711266|FG002|Overall Study|Physician Decision|8|||
145506023|NCT01229267|524711267|FG003|Overall Study|Physician Decision|3|||
145506024|NCT01229267|524711268|FG004|Overall Study|Physician Decision|25|||
145506025|NCT01229267|524711264|FG000|Overall Study|Lost to Follow-up|6|||
145506026|NCT01229267|524711265|FG001|Overall Study|Lost to Follow-up|5|||
145506027|NCT01229267|524711266|FG002|Overall Study|Lost to Follow-up|8|||
145506028|NCT01229267|524711267|FG003|Overall Study|Lost to Follow-up|3|||
145506029|NCT01229267|524711268|FG004|Overall Study|Lost to Follow-up|22|||
145506030|NCT01499277|524711271|FG000|Overall Study|Adverse Event|3|||
145506031|NCT01499277|524711272|FG001|Overall Study|Adverse Event|6|||
145506032|NCT01499277|524711271|FG000|Overall Study|Death|3|||
145506033|NCT01499277|524711272|FG001|Overall Study|Death|2|||
145506034|NCT01499277|524711271|FG000|Overall Study|Lost to Follow-up|15|||
145506035|NCT01499277|524711272|FG001|Overall Study|Lost to Follow-up|8|||
145506036|NCT01499277|524711271|FG000|Overall Study|Protocol Violation|2|||
145506037|NCT01499277|524711272|FG001|Overall Study|Protocol Violation|3|||
145506038|NCT01499277|524711271|FG000|Overall Study|Withdrawal by Subject|16|||
145506039|NCT01499277|524711272|FG001|Overall Study|Withdrawal by Subject|6|||
145506040|NCT01499277|524711271|FG000|Overall Study|Lack of therapeutic response and other|8|||
145506041|NCT01499277|524711272|FG001|Overall Study|Lack of therapeutic response and other|7|||
145506042|NCT00372593|524711273|FG000|Overall Study|Adverse Event|43|||
145506043|NCT00372593|524711274|FG001|Overall Study|Adverse Event|45|||
145506044|NCT00372593|524711275|FG002|Overall Study|Adverse Event|0|||
145506045|NCT00372593|524711273|FG000|Overall Study|Death|16|||
145506046|NCT00372593|524711274|FG001|Overall Study|Death|20|||
145506047|NCT00372593|524711275|FG002|Overall Study|Death|1|||
145506048|NCT00372593|524711273|FG000|Overall Study|Lack of Efficacy|82|||
145506049|NCT00372593|524711274|FG001|Overall Study|Lack of Efficacy|71|||
145506050|NCT00372593|524711275|FG002|Overall Study|Lack of Efficacy|2|||
145506051|NCT00372593|524711273|FG000|Overall Study|Lost to Follow-up|1|||
145506052|NCT00372593|524711274|FG001|Overall Study|Lost to Follow-up|0|||
145506053|NCT00372593|524711275|FG002|Overall Study|Lost to Follow-up|0|||
145506054|NCT00372593|524711273|FG000|Overall Study|Physician Decision|42|||
145506055|NCT00372593|524711274|FG001|Overall Study|Physician Decision|41|||
145506056|NCT00372593|524711275|FG002|Overall Study|Physician Decision|0|||
145506057|NCT00372593|524711273|FG000|Overall Study|Ineligible|20|||
145506058|NCT00372593|524711274|FG001|Overall Study|Ineligible|21|||
145506059|NCT00372593|524711275|FG002|Overall Study|Ineligible|1|||
145506060|NCT02974543|524711276|FG000|Overall Study|Withdrawal by Subject|1|||
145732939|NCT03872453|525540856|FG001|Overall Study|Withdrawal by Subject|1|||
145732940|NCT03872453|525540857|FG002|Overall Study|Withdrawal by Subject|2|||
145506061|NCT02974543|524711277|FG001|Overall Study|Withdrawal by Subject|0|||
145506062|NCT00742235|524711278|FG000|Overall Study|Lost to Follow-up|0|||
145506063|NCT00742235|524711279|FG001|Overall Study|Lost to Follow-up|31|||
145506064|NCT00433004|524711280|FG000|Overall Study|Lost to Follow-up|5|||
145506065|NCT00433004|524711281|FG001|Overall Study|Lost to Follow-up|7|||
145506066|NCT01237899|524711284|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
145506067|NCT01237899|524711285|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
145506068|NCT01237899|524711286|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
145506069|NCT01237899|524711287|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
145506070|NCT01237899|524711288|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
145506071|NCT01237899|524711289|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
145506072|NCT01237899|524711290|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
145506073|NCT01237899|524711291|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
145506074|NCT01237899|524711292|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
145506075|NCT01237899|524711293|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
145506076|NCT01237899|524711294|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
145506077|NCT00790088|524711295|FG000|Overall Study|Protocol Violation|11|||
145506078|NCT00790088|524711295|FG000|Overall Study|Withdrawal by Subject|17|||
145506079|NCT00790088|524711295|FG000|Overall Study|Lost to Follow-up|7|||
145506080|NCT00790088|524711295|FG000|Overall Study|Physician Decision|4|||
145506081|NCT05782179|524711300|FG000|Overall Study|Adverse Event|0|||
145506082|NCT05782179|524711301|FG001|Overall Study|Adverse Event|0|||
145506083|NCT05782179|524711302|FG002|Overall Study|Adverse Event|2|||
145506084|NCT05782179|524711303|FG003|Overall Study|Adverse Event|0|||
145506085|NCT05782179|524711304|FG004|Overall Study|Adverse Event|0|||
145506086|NCT05782179|524711305|FG005|Overall Study|Adverse Event|0|||
145506087|NCT06170242|524711306|FG000|Overall Study|Lost to Follow-up|0|||
145506088|NCT06170242|524711307|FG001|Overall Study|Lost to Follow-up|0|||
145506089|NCT06170242|524711308|FG002|Overall Study|Lost to Follow-up|1|||
145506090|NCT06170242|524711309|FG003|Overall Study|Lost to Follow-up|1|||
145506091|NCT03682770|524711319|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506092|NCT03682770|524711320|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
145506093|NCT03682770|524711321|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506094|NCT03682770|524711322|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506095|NCT03682770|524711323|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506096|NCT03682770|524711324|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506097|NCT03682770|524711325|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
145506098|NCT03682770|524711319|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
145506099|NCT03682770|524711320|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
145506100|NCT03682770|524711321|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
145506101|NCT03682770|524711322|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
145506102|NCT03682770|524711323|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
145506103|NCT03682770|524711324|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
145506104|NCT03682770|524711325|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
145506105|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
145506106|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
145506107|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
145506108|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
145506109|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
145506110|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
145506111|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
145506112|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506113|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506114|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506115|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
145506116|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506117|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506118|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
145506119|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
145506120|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
145506121|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
145506122|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
145506123|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
145506124|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
145506125|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
145506126|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506127|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506128|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
145506129|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506130|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506131|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506132|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
145506133|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506134|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506135|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
145506136|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506137|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506138|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506139|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
145506140|NCT03682770|524711319|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506141|NCT03682770|524711320|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506142|NCT03682770|524711321|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506143|NCT03682770|524711322|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
145506144|NCT03682770|524711323|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506145|NCT03682770|524711324|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506146|NCT03682770|524711325|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
145506147|NCT03682770|524711319|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
145506148|NCT03682770|524711320|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
145506149|NCT03682770|524711321|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
145506150|NCT03682770|524711322|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
145506151|NCT03682770|524711323|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
145506152|NCT03682770|524711324|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
145506153|NCT03682770|524711325|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
145506154|NCT03682770|524711319|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506155|NCT03682770|524711320|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506156|NCT03682770|524711321|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506157|NCT03682770|524711322|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506158|NCT03682770|524711323|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
145506159|NCT03682770|524711324|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506160|NCT03682770|524711325|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
145506161|NCT03682770|524711319|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506162|NCT03682770|524711320|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506163|NCT03682770|524711321|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506164|NCT03682770|524711322|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506165|NCT03682770|524711323|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506166|NCT03682770|524711324|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
145506167|NCT03682770|524711325|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
145506168|NCT03682770|524711319|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
145506169|NCT03682770|524711320|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
145506170|NCT03682770|524711321|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
145506171|NCT03682770|524711322|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
145506172|NCT03682770|524711323|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
145506173|NCT03682770|524711324|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
145506174|NCT03682770|524711325|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
145506175|NCT01491607|524711326|FG000|Overall Study|Lost to Follow-up|7|||
145506176|NCT01491607|524711326|FG000|Overall Study|Withdrawal by Subject|3|||
145506177|NCT01317277|524711327|FG000|Overall Study|Lost to Follow-up|3|||
145506178|NCT01317277|524711328|FG001|Overall Study|Lost to Follow-up|1|||
145506179|NCT01317277|524711327|FG000|Overall Study|Lost MEMS|1|||
145506180|NCT01317277|524711328|FG001|Overall Study|Lost MEMS|1|||
145506181|NCT01317277|524711327|FG000|Overall Study|Unable to comply with intervention|1|||
145506182|NCT01317277|524711328|FG001|Overall Study|Unable to comply with intervention|0|||
145506183|NCT01317277|524711327|FG000|Overall Study|Withdrawal by Subject|1|||
145506184|NCT01317277|524711328|FG001|Overall Study|Withdrawal by Subject|0|||
145506185|NCT01317277|524711327|FG000|Overall Study|Adverse Event|1|||
145506186|NCT01317277|524711328|FG001|Overall Study|Adverse Event|0|||
145506187|NCT00774566|524711329|FG000|Overall Study|Protocol Violation|18|||
145506188|NCT00774566|524711330|FG001|Overall Study|Protocol Violation|15|||
145506189|NCT04896073|524711337|FG000|Overall Study|Screen failure|0|||
145506190|NCT04896073|524711338|FG001|Overall Study|Screen failure|2|||
145506191|NCT04896073|524711337|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
145506192|NCT04896073|524711338|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
145506193|NCT03565497|524711340|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
145506194|NCT03565497|524711341|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
145506195|NCT03565497|524711342|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
145506196|NCT03565497|524711340|FG000|Overall Study|Lost to Follow-up|1|||
145506197|NCT03565497|524711341|FG001|Overall Study|Lost to Follow-up|1|||
145506198|NCT03565497|524711342|FG002|Overall Study|Lost to Follow-up|2|||
145506199|NCT03565497|524711340|FG000|Overall Study|Withdrawal by Subject|1|||
145401017|NCT00606307|524324780|FG000|Overall Study|Adverse Event|2|||
145401018|NCT00606307|524324780|FG000|Overall Study|Withdrawal by Subject|2|||
145401019|NCT00606307|524324780|FG000|Overall Study|Disease progression|6|||
145401020|NCT00606307|524324780|FG000|Overall Study|QTc prolongation|1|||
145401021|NCT03368807|524324781|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
145401022|NCT03368807|524324781|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
145401023|NCT03368807|524324781|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
145401024|NCT03368807|524324781|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
145401025|NCT01118052|524324787|FG000|Overall Study|Never treated|2|||
145401026|NCT00843492|524324788|FG000|Overall Study|Adverse Event|0|||
145401027|NCT00843492|524324789|FG001|Overall Study|Adverse Event|3|||
145401028|NCT00843492|524324788|FG000|Overall Study|Lost to Follow-up|4|||
145401029|NCT00843492|524324789|FG001|Overall Study|Lost to Follow-up|4|||
145401030|NCT00843492|524324788|FG000|Overall Study|Withdrawal by Subject|0|||
145401031|NCT00843492|524324789|FG001|Overall Study|Withdrawal by Subject|4|||
145401032|NCT00843492|524324788|FG000|Overall Study|Immobilization Stopped|1|||
145401033|NCT00843492|524324789|FG001|Overall Study|Immobilization Stopped|0|||
145401034|NCT00843492|524324788|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
145401035|NCT00843492|524324789|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
145401036|NCT00843492|524324788|FG000|Overall Study|Orthopedic Surgery|0|||
145401037|NCT00843492|524324789|FG001|Overall Study|Orthopedic Surgery|2|||
145401038|NCT00843492|524324788|FG000|Overall Study|Visit Not Performed|1|||
145401039|NCT00843492|524324789|FG001|Overall Study|Visit Not Performed|0|||
145401040|NCT00843492|524324788|FG000|Overall Study|Deep-vein Thrombosis|1|||
145401041|NCT00843492|524324789|FG001|Overall Study|Deep-vein Thrombosis|0|||
145401042|NCT00794664|524324790|FG000|Treatment Period|Withdrawal by Subject|0|||
145401043|NCT00794664|524324791|FG001|Treatment Period|Withdrawal by Subject|2|||
145401044|NCT00794664|524324790|FG000|Treatment Period|Protocol non-compliance|0|||
145401045|NCT00794664|524324791|FG001|Treatment Period|Protocol non-compliance|1|||
145401046|NCT00794664|524324790|FG000|Treatment Period|Other|0|||
145401047|NCT00794664|524324791|FG001|Treatment Period|Other|1|||
145401048|NCT00794664|524324790|FG000|Treatment Period|Adverse Event|1|||
145401049|NCT00794664|524324791|FG001|Treatment Period|Adverse Event|8|||
145401050|NCT00794664|524324790|FG000|Follow-up Period|Other|1|||
145401051|NCT00794664|524324791|FG001|Follow-up Period|Other|2|||
145401052|NCT00794664|524324790|FG000|Follow-up Period|Withdrawal by Subject|0|||
145401053|NCT00794664|524324791|FG001|Follow-up Period|Withdrawal by Subject|2|||
145401054|NCT00794664|524324790|FG000|Follow-up Period|Protocol non-compliance|0|||
145401055|NCT00794664|524324791|FG001|Follow-up Period|Protocol non-compliance|1|||
145401056|NCT01677741|524324792|FG000|Overall Study|Death|0|||
145401057|NCT01677741|524324793|FG001|Overall Study|Death|0|||
145401058|NCT01677741|524324794|FG002|Overall Study|Death|0|||
145401059|NCT01677741|524324795|FG003|Overall Study|Death|1|||
145401060|NCT01677741|524324796|FG004|Overall Study|Death|0|||
145401061|NCT01677741|524324797|FG005|Overall Study|Death|1|||
145401062|NCT01677741|524324798|FG006|Overall Study|Death|0|||
145401063|NCT01677741|524324799|FG007|Overall Study|Death|0|||
145401064|NCT01677741|524324792|FG000|Overall Study|Withdrawal by Subject|2|||
145401065|NCT01677741|524324793|FG001|Overall Study|Withdrawal by Subject|7|||
145401066|NCT01677741|524324794|FG002|Overall Study|Withdrawal by Subject|5|||
145401067|NCT01677741|524324795|FG003|Overall Study|Withdrawal by Subject|4|||
145401068|NCT01677741|524324796|FG004|Overall Study|Withdrawal by Subject|11|||
145401069|NCT01677741|524324797|FG005|Overall Study|Withdrawal by Subject|20|||
145401070|NCT01677741|524324798|FG006|Overall Study|Withdrawal by Subject|4|||
145401071|NCT01677741|524324799|FG007|Overall Study|Withdrawal by Subject|2|||
145401072|NCT01677741|524324792|FG000|Overall Study|Enrolled in a rollover study|0|||
145401073|NCT01677741|524324793|FG001|Overall Study|Enrolled in a rollover study|3|||
145401074|NCT01677741|524324794|FG002|Overall Study|Enrolled in a rollover study|2|||
145401075|NCT01677741|524324795|FG003|Overall Study|Enrolled in a rollover study|1|||
145401076|NCT01677741|524324796|FG004|Overall Study|Enrolled in a rollover study|6|||
145401077|NCT01677741|524324797|FG005|Overall Study|Enrolled in a rollover study|6|||
145401078|NCT01677741|524324798|FG006|Overall Study|Enrolled in a rollover study|7|||
145401079|NCT01677741|524324799|FG007|Overall Study|Enrolled in a rollover study|0|||
145401080|NCT01677741|524324792|FG000|Overall Study|Progressive disease|1|||
145401081|NCT01677741|524324793|FG001|Overall Study|Progressive disease|0|||
145401082|NCT01677741|524324794|FG002|Overall Study|Progressive disease|1|||
145401083|NCT01677741|524324795|FG003|Overall Study|Progressive disease|0|||
145401084|NCT01677741|524324796|FG004|Overall Study|Progressive disease|0|||
145401085|NCT01677741|524324797|FG005|Overall Study|Progressive disease|1|||
145401086|NCT01677741|524324798|FG006|Overall Study|Progressive disease|0|||
145401087|NCT01677741|524324799|FG007|Overall Study|Progressive disease|0|||
145401088|NCT00720499|524324800|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
145506200|NCT03565497|524711341|FG001|Overall Study|Withdrawal by Subject|1|||
145506201|NCT03565497|524711342|FG002|Overall Study|Withdrawal by Subject|1|||
145506202|NCT02999672|524711343|FG000|Overall Study|Death|0|||
145506203|NCT02999672|524711344|FG001|Overall Study|Death|1|||
145506204|NCT02999672|524711343|FG000|Overall Study|Study Terminated by Sponsor|0|||
145506205|NCT02999672|524711344|FG001|Overall Study|Study Terminated by Sponsor|1|||
145506206|NCT02999672|524711343|FG000|Overall Study|Progressive Disease|9|||
145506207|NCT02999672|524711344|FG001|Overall Study|Progressive Disease|5|||
145506208|NCT02999672|524711343|FG000|Overall Study|Adverse Event|4|||
145506209|NCT02999672|524711344|FG001|Overall Study|Adverse Event|0|||
145506210|NCT01385176|524711345|FG000|Randomization Phase|Death|1|||
145506211|NCT01385176|524711346|FG001|Randomization Phase|Death|2|||
145506212|NCT01385176|524711345|FG000|6-18 Month All VNS Active|Death|1|||
145506213|NCT01385176|524711346|FG001|6-18 Month All VNS Active|Death|2|||
145506214|NCT01385176|524711345|FG000|6-18 Month All VNS Active|Physician Decision|0|||
145506215|NCT01385176|524711346|FG001|6-18 Month All VNS Active|Physician Decision|1|||
145506216|NCT01385176|524711345|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
145506217|NCT01385176|524711346|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
145506218|NCT01385176|524711345|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
145506219|NCT01385176|524711346|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
145506220|NCT01075685|524711347|FG000|Overall Study|Protocol Violation|9|||
145506221|NCT01075685|524711348|FG001|Overall Study|Protocol Violation|1|||
145506222|NCT01075685|524711347|FG000|Overall Study|Withdrawal by Subject|20|||
145506223|NCT01075685|524711348|FG001|Overall Study|Withdrawal by Subject|5|||
145506224|NCT01075685|524711347|FG000|Overall Study|Lost to Follow-up|563|||
145506225|NCT01075685|524711348|FG001|Overall Study|Lost to Follow-up|220|||
145506226|NCT02858362|524711351|FG000|Overall Study|Protocol Violation|0|||
145506227|NCT02858362|524711352|FG001|Overall Study|Protocol Violation|1|||
145506228|NCT02858362|524711353|FG002|Overall Study|Protocol Violation|0|||
145506229|NCT02858362|524711351|FG000|Overall Study|Withdrawal by Subject|1|||
145506230|NCT02858362|524711352|FG001|Overall Study|Withdrawal by Subject|0|||
145506231|NCT02858362|524711353|FG002|Overall Study|Withdrawal by Subject|0|||
145506232|NCT02858362|524711351|FG000|Overall Study|Early Study Termination|0|||
145506233|NCT02858362|524711352|FG001|Overall Study|Early Study Termination|0|||
145506234|NCT02858362|524711353|FG002|Overall Study|Early Study Termination|3|||
145506235|NCT02858362|524711351|FG000|Overall Study|Lost to Follow-up|1|||
145506236|NCT02858362|524711352|FG001|Overall Study|Lost to Follow-up|0|||
145506237|NCT02858362|524711353|FG002|Overall Study|Lost to Follow-up|0|||
145506238|NCT00392769|524711357|FG000|Overall Study|Clinical Deterioration|9|||
145506239|NCT00392769|524711357|FG000|Overall Study|Adverse Event|1|||
145506240|NCT02561832|524711358|FG000|Overall Study|Withdrawal by Subject|1|||
145506241|NCT02561832|524711359|FG001|Overall Study|Withdrawal by Subject|1|||
145506242|NCT02561832|524711358|FG000|Overall Study|Adverse Event|3|||
145506243|NCT02561832|524711359|FG001|Overall Study|Adverse Event|0|||
145506244|NCT02561832|524711358|FG000|Overall Study|Disease progression|3|||
145506245|NCT02561832|524711359|FG001|Overall Study|Disease progression|3|||
145506246|NCT00439517|524711361|FG000|Overall Study|Subject on treatment|1|||
145506247|NCT00439517|524711362|FG001|Overall Study|Subject on treatment|0|||
145506248|NCT00439517|524711361|FG000|Overall Study|Subject in survival follow-up|1|||
145506249|NCT00439517|524711362|FG001|Overall Study|Subject in survival follow-up|0|||
145506250|NCT00594815|524711365|FG000|Overall Study|Never Treated|3|||
145506251|NCT00594815|524711365|FG000|Overall Study|Withdrawal by Subject|2|||
145506252|NCT00594815|524711365|FG000|Overall Study|Toxicity|4|||
145506253|NCT03599089|524711366|FG000|Overall Study|Lost to Follow-up|1|||
145506254|NCT03599089|524711367|FG001|Overall Study|Lost to Follow-up|0|||
145506255|NCT03599089|524711368|FG002|Overall Study|Lost to Follow-up|0|||
145506256|NCT03599089|524711369|FG003|Overall Study|Lost to Follow-up|0|||
145506257|NCT03599089|524711366|FG000|Overall Study|Withdrawal by Subject|2|||
145506258|NCT03599089|524711367|FG001|Overall Study|Withdrawal by Subject|1|||
145506259|NCT03599089|524711368|FG002|Overall Study|Withdrawal by Subject|0|||
145506260|NCT03599089|524711369|FG003|Overall Study|Withdrawal by Subject|0|||
145506261|NCT03599089|524711366|FG000|Overall Study|Lack of Efficacy|0|||
145506262|NCT03599089|524711367|FG001|Overall Study|Lack of Efficacy|0|||
145506263|NCT03599089|524711368|FG002|Overall Study|Lack of Efficacy|1|||
145506264|NCT03599089|524711369|FG003|Overall Study|Lack of Efficacy|2|||
145506265|NCT03214666|524711370|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
145506266|NCT03214666|524711371|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
145506267|NCT03214666|524711372|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
145506268|NCT03214666|524711373|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
145506269|NCT03214666|524711374|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
145506270|NCT03214666|524711375|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
145506271|NCT02500797|524711378|FG000|Overall Study|Cancel (rapid disease progression)|0|||
145506272|NCT02500797|524711379|FG001|Overall Study|Cancel (rapid disease progression)|0|||
145506273|NCT02500797|524711380|FG002|Overall Study|Cancel (rapid disease progression)|0|||
145506274|NCT02500797|524711381|FG003|Overall Study|Cancel (rapid disease progression)|0|||
145506275|NCT02500797|524711382|FG004|Overall Study|Cancel (rapid disease progression)|1|||
145506276|NCT02500797|524711383|FG005|Overall Study|Cancel (rapid disease progression)|1|||
145506277|NCT02500797|524711384|FG006|Overall Study|Cancel (rapid disease progression)|0|||
145506278|NCT02500797|524711385|FG007|Overall Study|Cancel (rapid disease progression)|0|||
145506279|NCT02500797|524711378|FG000|Overall Study|Withdrawal by Subject|1|||
145506280|NCT02500797|524711379|FG001|Overall Study|Withdrawal by Subject|0|||
145506281|NCT02500797|524711380|FG002|Overall Study|Withdrawal by Subject|0|||
145506282|NCT02500797|524711381|FG003|Overall Study|Withdrawal by Subject|0|||
145506283|NCT02500797|524711382|FG004|Overall Study|Withdrawal by Subject|0|||
145506284|NCT02500797|524711383|FG005|Overall Study|Withdrawal by Subject|0|||
145506285|NCT02500797|524711384|FG006|Overall Study|Withdrawal by Subject|0|||
145506286|NCT02500797|524711385|FG007|Overall Study|Withdrawal by Subject|0|||
145506287|NCT00060840|524711386|FG000|Overall Study|Change in surgical plan|2|||
145506288|NCT00060840|524711387|FG001|Overall Study|Change in surgical plan|6|||
145506289|NCT00060840|524711386|FG000|Overall Study|Death|0|||
145506290|NCT00060840|524711387|FG001|Overall Study|Death|1|||
145506291|NCT00060840|524711386|FG000|Overall Study|Withdrawal by Subject|0|||
145506292|NCT00060840|524711387|FG001|Overall Study|Withdrawal by Subject|1|||
145506293|NCT00060840|524711386|FG000|Overall Study|Subinvestigator unavailable|0|||
145506294|NCT00060840|524711387|FG001|Overall Study|Subinvestigator unavailable|1|||
145506295|NCT00060840|524711386|FG000|Overall Study|Physician Decision|1|||
145506296|NCT00060840|524711387|FG001|Overall Study|Physician Decision|0|||
145506297|NCT00060840|524711386|FG000|Overall Study|Other|1|||
145506298|NCT00060840|524711387|FG001|Overall Study|Other|0|||
145506299|NCT00357006|524711388|FG000|Overall Study|Lost to Follow-up|1|||
145506300|NCT00357006|524711389|FG001|Overall Study|Lost to Follow-up|2|||
145506301|NCT00357006|524711390|FG002|Overall Study|Lost to Follow-up|1|||
145506302|NCT00357006|524711388|FG000|Overall Study|Withdrawal by Subject|1|||
145506303|NCT00357006|524711389|FG001|Overall Study|Withdrawal by Subject|3|||
145506304|NCT00357006|524711390|FG002|Overall Study|Withdrawal by Subject|2|||
145506305|NCT00976560|524711391|FG000|Overall Study|Adverse Event|5|||
145506306|NCT00976560|524711392|FG001|Overall Study|Adverse Event|5|||
145506307|NCT00976560|524711391|FG000|Overall Study|Lack of Efficacy|3|||
145506308|NCT00976560|524711392|FG001|Overall Study|Lack of Efficacy|5|||
145506309|NCT00976560|524711391|FG000|Overall Study|Protocol Violation|1|||
145506310|NCT00976560|524711392|FG001|Overall Study|Protocol Violation|0|||
145506311|NCT00976560|524711391|FG000|Overall Study|Lost to Follow-up|1|||
145506312|NCT00976560|524711392|FG001|Overall Study|Lost to Follow-up|0|||
145506313|NCT00976560|524711391|FG000|Overall Study|Physician Decision|2|||
145506314|NCT00976560|524711392|FG001|Overall Study|Physician Decision|0|||
145506315|NCT00976560|524711391|FG000|Overall Study|Withdrawal by Subject|2|||
145506316|NCT00976560|524711392|FG001|Overall Study|Withdrawal by Subject|3|||
145506317|NCT03710161|524711393|FG000|Overall Study|Study halted due to COVID pandemic|3|||
145506318|NCT03710161|524711394|FG001|Overall Study|Study halted due to COVID pandemic|2|||
145506319|NCT05340478|524711399|FG000|Overall Study|Scheduling Issues|10|||
145506320|NCT05340478|524711400|FG001|Overall Study|Scheduling Issues|4|||
145506321|NCT05340478|524711399|FG000|Overall Study|Neither member of dyad started treatment|2|||
145506322|NCT05340478|524711400|FG001|Overall Study|Neither member of dyad started treatment|2|||
145506323|NCT05340478|524711399|FG000|Overall Study|Withdrawn from study|2|||
145506324|NCT05340478|524711400|FG001|Overall Study|Withdrawn from study|2|||
145506325|NCT05340478|524711399|FG000|Overall Study|Lost to Follow-up|1|||
145506326|NCT05340478|524711400|FG001|Overall Study|Lost to Follow-up|4|||
145506327|NCT00092443|524711401|FG000|Overall Study|Adverse Event|9|||
145506328|NCT00092443|524711402|FG001|Overall Study|Adverse Event|13|||
145506329|NCT00092443|524711401|FG000|Overall Study|Lost to Follow-up|7|||
145506330|NCT00092443|524711402|FG001|Overall Study|Lost to Follow-up|3|||
145506331|NCT00092443|524711401|FG000|Overall Study|Protocol Violation|11|||
145506332|NCT00092443|524711402|FG001|Overall Study|Protocol Violation|9|||
145506333|NCT00092443|524711401|FG000|Overall Study|Withdrawal by Subject|9|||
145506334|NCT00092443|524711402|FG001|Overall Study|Withdrawal by Subject|11|||
145506335|NCT00092443|524711401|FG000|Overall Study|Moved|5|||
145506336|NCT00092443|524711402|FG001|Overall Study|Moved|5|||
145506337|NCT00092443|524711401|FG000|Overall Study|Other|17|||
145506338|NCT00092443|524711402|FG001|Overall Study|Other|13|||
145506339|NCT02963506|524711404|FG000|Double-Blind Period|Adverse Event|0|||
145506340|NCT02963506|524711405|FG001|Double-Blind Period|Adverse Event|0|||
145506341|NCT02963506|524711406|FG002|Double-Blind Period|Adverse Event|1|||
145506342|NCT02963506|524711407|FG003|Double-Blind Period|Adverse Event|0|||
145506343|NCT02963506|524711408|FG004|Double-Blind Period|Adverse Event|0|||
145506344|NCT02963506|524711409|FG005|Double-Blind Period|Adverse Event|0|||
145506345|NCT02963506|524711410|FG006|Double-Blind Period|Adverse Event|0|||
145506346|NCT02963506|524711411|FG007|Double-Blind Period|Adverse Event|0|||
145506347|NCT02963506|524711412|FG008|Double-Blind Period|Adverse Event|0|||
145506348|NCT02963506|524711413|FG009|Double-Blind Period|Adverse Event|0|||
145506349|NCT02963506|524711414|FG010|Double-Blind Period|Adverse Event|0|||
145506350|NCT02963506|524711415|FG011|Double-Blind Period|Adverse Event|0|||
145506351|NCT02963506|524711416|FG012|Double-Blind Period|Adverse Event|0|||
145506352|NCT02963506|524711404|FG000|Double-Blind Period|Death|0|||
145506353|NCT02963506|524711405|FG001|Double-Blind Period|Death|0|||
145506354|NCT02963506|524711406|FG002|Double-Blind Period|Death|0|||
145506355|NCT02963506|524711407|FG003|Double-Blind Period|Death|1|||
145506356|NCT02963506|524711408|FG004|Double-Blind Period|Death|0|||
145506357|NCT02963506|524711409|FG005|Double-Blind Period|Death|0|||
145506358|NCT02963506|524711410|FG006|Double-Blind Period|Death|0|||
145506359|NCT02963506|524711411|FG007|Double-Blind Period|Death|0|||
145506360|NCT02963506|524711412|FG008|Double-Blind Period|Death|0|||
145506361|NCT02963506|524711413|FG009|Double-Blind Period|Death|0|||
145506362|NCT02963506|524711414|FG010|Double-Blind Period|Death|0|||
145506363|NCT02963506|524711415|FG011|Double-Blind Period|Death|0|||
145506364|NCT02963506|524711416|FG012|Double-Blind Period|Death|0|||
145506365|NCT02963506|524711404|FG000|Double-Blind Period|Lost to Follow-up|0|||
145506366|NCT02963506|524711405|FG001|Double-Blind Period|Lost to Follow-up|1|||
145506367|NCT02963506|524711406|FG002|Double-Blind Period|Lost to Follow-up|0|||
145506368|NCT02963506|524711407|FG003|Double-Blind Period|Lost to Follow-up|0|||
145506369|NCT02963506|524711408|FG004|Double-Blind Period|Lost to Follow-up|0|||
145506370|NCT02963506|524711409|FG005|Double-Blind Period|Lost to Follow-up|0|||
145506371|NCT02963506|524711410|FG006|Double-Blind Period|Lost to Follow-up|0|||
145506372|NCT02963506|524711411|FG007|Double-Blind Period|Lost to Follow-up|0|||
145506373|NCT02963506|524711412|FG008|Double-Blind Period|Lost to Follow-up|0|||
145506374|NCT02963506|524711413|FG009|Double-Blind Period|Lost to Follow-up|0|||
145506375|NCT02963506|524711414|FG010|Double-Blind Period|Lost to Follow-up|0|||
145506376|NCT02963506|524711415|FG011|Double-Blind Period|Lost to Follow-up|0|||
145506377|NCT02963506|524711416|FG012|Double-Blind Period|Lost to Follow-up|0|||
145506378|NCT02963506|524711404|FG000|Double-Blind Period|Withdrawal by Subject|0|||
145506379|NCT02963506|524711405|FG001|Double-Blind Period|Withdrawal by Subject|0|||
145506380|NCT02963506|524711406|FG002|Double-Blind Period|Withdrawal by Subject|1|||
145506381|NCT02963506|524711407|FG003|Double-Blind Period|Withdrawal by Subject|1|||
145506382|NCT02963506|524711408|FG004|Double-Blind Period|Withdrawal by Subject|0|||
145506383|NCT02963506|524711409|FG005|Double-Blind Period|Withdrawal by Subject|0|||
145506384|NCT02963506|524711410|FG006|Double-Blind Period|Withdrawal by Subject|0|||
145506385|NCT02963506|524711411|FG007|Double-Blind Period|Withdrawal by Subject|0|||
145506386|NCT02963506|524711412|FG008|Double-Blind Period|Withdrawal by Subject|0|||
145506387|NCT02963506|524711413|FG009|Double-Blind Period|Withdrawal by Subject|0|||
145506388|NCT02963506|524711414|FG010|Double-Blind Period|Withdrawal by Subject|0|||
145506389|NCT02963506|524711415|FG011|Double-Blind Period|Withdrawal by Subject|0|||
145506390|NCT02963506|524711416|FG012|Double-Blind Period|Withdrawal by Subject|0|||
145506391|NCT02963506|524711404|FG000|Double-Blind Period|No compliance|0|||
145506392|NCT02963506|524711405|FG001|Double-Blind Period|No compliance|1|||
145506393|NCT02963506|524711406|FG002|Double-Blind Period|No compliance|0|||
145506394|NCT02963506|524711407|FG003|Double-Blind Period|No compliance|0|||
145506395|NCT02963506|524711408|FG004|Double-Blind Period|No compliance|0|||
145506396|NCT02963506|524711409|FG005|Double-Blind Period|No compliance|0|||
145506397|NCT02963506|524711410|FG006|Double-Blind Period|No compliance|0|||
145506398|NCT02963506|524711411|FG007|Double-Blind Period|No compliance|0|||
145506399|NCT02963506|524711412|FG008|Double-Blind Period|No compliance|0|||
145506400|NCT02963506|524711413|FG009|Double-Blind Period|No compliance|0|||
145506401|NCT02963506|524711414|FG010|Double-Blind Period|No compliance|0|||
145506402|NCT02963506|524711415|FG011|Double-Blind Period|No compliance|0|||
145506403|NCT02963506|524711416|FG012|Double-Blind Period|No compliance|0|||
145506404|NCT02963506|524711404|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506405|NCT02963506|524711405|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
145506406|NCT02963506|524711406|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506407|NCT02963506|524711407|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506408|NCT02963506|524711408|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506409|NCT02963506|524711409|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506410|NCT02963506|524711410|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506411|NCT02963506|524711411|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506412|NCT02963506|524711412|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506413|NCT02963506|524711413|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506414|NCT02963506|524711414|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506415|NCT02963506|524711415|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506416|NCT02963506|524711416|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
145506417|NCT02963506|524711404|FG000|Dose-Blind Period|Adverse Event|0|||
145506418|NCT02963506|524711405|FG001|Dose-Blind Period|Adverse Event|0|||
145506419|NCT02963506|524711406|FG002|Dose-Blind Period|Adverse Event|0|||
145506420|NCT02963506|524711407|FG003|Dose-Blind Period|Adverse Event|0|||
145506421|NCT02963506|524711408|FG004|Dose-Blind Period|Adverse Event|0|||
145506422|NCT02963506|524711409|FG005|Dose-Blind Period|Adverse Event|1|||
145506423|NCT02963506|524711410|FG006|Dose-Blind Period|Adverse Event|3|||
145506424|NCT02963506|524711411|FG007|Dose-Blind Period|Adverse Event|2|||
145506425|NCT02963506|524711412|FG008|Dose-Blind Period|Adverse Event|2|||
145506426|NCT02963506|524711413|FG009|Dose-Blind Period|Adverse Event|2|||
145506427|NCT02963506|524711414|FG010|Dose-Blind Period|Adverse Event|1|||
145506428|NCT02963506|524711415|FG011|Dose-Blind Period|Adverse Event|1|||
145506429|NCT02963506|524711416|FG012|Dose-Blind Period|Adverse Event|6|||
145506430|NCT02963506|524711404|FG000|Dose-Blind Period|Lack of Efficacy|0|||
145506431|NCT02963506|524711405|FG001|Dose-Blind Period|Lack of Efficacy|0|||
145506432|NCT02963506|524711406|FG002|Dose-Blind Period|Lack of Efficacy|0|||
145506433|NCT02963506|524711407|FG003|Dose-Blind Period|Lack of Efficacy|0|||
145506434|NCT02963506|524711408|FG004|Dose-Blind Period|Lack of Efficacy|0|||
145506435|NCT02963506|524711409|FG005|Dose-Blind Period|Lack of Efficacy|0|||
145506436|NCT02963506|524711410|FG006|Dose-Blind Period|Lack of Efficacy|0|||
145506437|NCT02963506|524711411|FG007|Dose-Blind Period|Lack of Efficacy|1|||
145506438|NCT02963506|524711412|FG008|Dose-Blind Period|Lack of Efficacy|0|||
145506439|NCT02963506|524711413|FG009|Dose-Blind Period|Lack of Efficacy|1|||
145506440|NCT02963506|524711414|FG010|Dose-Blind Period|Lack of Efficacy|0|||
145506441|NCT02963506|524711415|FG011|Dose-Blind Period|Lack of Efficacy|0|||
145506442|NCT02963506|524711416|FG012|Dose-Blind Period|Lack of Efficacy|0|||
145506443|NCT02963506|524711404|FG000|Dose-Blind Period|Lost to Follow-up|0|||
145506444|NCT02963506|524711405|FG001|Dose-Blind Period|Lost to Follow-up|0|||
145506445|NCT02963506|524711406|FG002|Dose-Blind Period|Lost to Follow-up|0|||
145506446|NCT02963506|524711407|FG003|Dose-Blind Period|Lost to Follow-up|0|||
145506447|NCT02963506|524711408|FG004|Dose-Blind Period|Lost to Follow-up|0|||
145506448|NCT02963506|524711409|FG005|Dose-Blind Period|Lost to Follow-up|1|||
145506449|NCT02963506|524711410|FG006|Dose-Blind Period|Lost to Follow-up|0|||
145506450|NCT02963506|524711411|FG007|Dose-Blind Period|Lost to Follow-up|0|||
145506451|NCT02963506|524711412|FG008|Dose-Blind Period|Lost to Follow-up|1|||
145506452|NCT02963506|524711413|FG009|Dose-Blind Period|Lost to Follow-up|0|||
145506453|NCT02963506|524711414|FG010|Dose-Blind Period|Lost to Follow-up|0|||
145506454|NCT02963506|524711415|FG011|Dose-Blind Period|Lost to Follow-up|1|||
145506455|NCT02963506|524711416|FG012|Dose-Blind Period|Lost to Follow-up|0|||
145506456|NCT02963506|524711404|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
145506457|NCT02963506|524711405|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
145506458|NCT02963506|524711406|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
145506459|NCT02963506|524711407|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
145506460|NCT02963506|524711408|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
145506461|NCT02963506|524711409|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
145506462|NCT02963506|524711410|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
145506463|NCT02963506|524711411|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
145506464|NCT02963506|524711412|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
145506465|NCT02963506|524711413|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
145506466|NCT02963506|524711414|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
145506467|NCT02963506|524711415|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
145506468|NCT02963506|524711416|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
145506469|NCT02963506|524711404|FG000|Dose-Blind Period|Sponsor decision|0|||
145506470|NCT02963506|524711405|FG001|Dose-Blind Period|Sponsor decision|0|||
145506471|NCT02963506|524711406|FG002|Dose-Blind Period|Sponsor decision|0|||
145506472|NCT02963506|524711407|FG003|Dose-Blind Period|Sponsor decision|0|||
145506473|NCT02963506|524711408|FG004|Dose-Blind Period|Sponsor decision|0|||
145506474|NCT02963506|524711409|FG005|Dose-Blind Period|Sponsor decision|1|||
145506475|NCT02963506|524711410|FG006|Dose-Blind Period|Sponsor decision|0|||
145506476|NCT02963506|524711411|FG007|Dose-Blind Period|Sponsor decision|0|||
145506477|NCT02963506|524711412|FG008|Dose-Blind Period|Sponsor decision|0|||
145506478|NCT02963506|524711413|FG009|Dose-Blind Period|Sponsor decision|0|||
145506479|NCT02963506|524711414|FG010|Dose-Blind Period|Sponsor decision|0|||
145506480|NCT02963506|524711415|FG011|Dose-Blind Period|Sponsor decision|0|||
145506481|NCT02963506|524711416|FG012|Dose-Blind Period|Sponsor decision|0|||
145506482|NCT02963506|524711404|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506483|NCT02963506|524711405|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506484|NCT02963506|524711406|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506485|NCT02963506|524711407|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506486|NCT02963506|524711408|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506487|NCT02963506|524711409|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506488|NCT02963506|524711410|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506489|NCT02963506|524711411|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506490|NCT02963506|524711412|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506491|NCT02963506|524711413|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506492|NCT02963506|524711414|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506493|NCT02963506|524711415|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
145506494|NCT02963506|524711416|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
145506495|NCT00630838|524711419|FG000|Overall Study|Death|0|||
145506496|NCT00630838|524711420|FG001|Overall Study|Death|1|||
145506497|NCT00630838|524711419|FG000|Overall Study|Lost to Follow-up|0|||
145506498|NCT00630838|524711420|FG001|Overall Study|Lost to Follow-up|1|||
145506499|NCT00928408|524711421|FG000|Overall Study|Other|2|||
145506500|NCT00928408|524711421|FG000|Overall Study|Withdrawal by Subject|4|||
145506501|NCT00928408|524711421|FG000|Overall Study|Death|5|||
145506502|NCT00928408|524711421|FG000|Overall Study|Lost to Follow-up|12|||
145506503|NCT03843541|524711422|FG000|Overall Study|Adverse Event|4|||
145506504|NCT03843541|524711423|FG001|Overall Study|Adverse Event|2|||
145506505|NCT03843541|524711424|FG002|Overall Study|Adverse Event|3|||
145506506|NCT03843541|524711422|FG000|Overall Study|Death|1|||
145506507|NCT03843541|524711423|FG001|Overall Study|Death|0|||
145506508|NCT03843541|524711424|FG002|Overall Study|Death|0|||
145506509|NCT03843541|524711422|FG000|Overall Study|Lack of adherence to study medication|0|||
145506510|NCT03843541|524711423|FG001|Overall Study|Lack of adherence to study medication|0|||
145506511|NCT03843541|524711424|FG002|Overall Study|Lack of adherence to study medication|1|||
145506512|NCT03843541|524711422|FG000|Overall Study|Physician Decision|1|||
145506513|NCT03843541|524711423|FG001|Overall Study|Physician Decision|2|||
145506514|NCT03843541|524711424|FG002|Overall Study|Physician Decision|2|||
145506515|NCT03843541|524711422|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
145506516|NCT03843541|524711423|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
145506517|NCT03843541|524711424|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
145506518|NCT03843541|524711422|FG000|Overall Study|Withdrawal by Subject|6|||
145506519|NCT03843541|524711423|FG001|Overall Study|Withdrawal by Subject|9|||
145506520|NCT03843541|524711424|FG002|Overall Study|Withdrawal by Subject|7|||
145506521|NCT03843541|524711422|FG000|Overall Study|Administration of rescue mucolytic|0|||
145506522|NCT03843541|524711423|FG001|Overall Study|Administration of rescue mucolytic|0|||
145506523|NCT03843541|524711424|FG002|Overall Study|Administration of rescue mucolytic|1|||
145506524|NCT03843541|524711422|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
145506525|NCT03843541|524711423|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
145506526|NCT03843541|524711424|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
145506527|NCT04163016|524711426|FG000|Enrollment|Adverse Event|1|||
145506528|NCT04163016|524711427|FG001|Enrollment|Adverse Event|0|||
145506529|NCT04163016|524711428|FG002|Enrollment|Adverse Event|0|||
145506530|NCT04163016|524711429|FG003|Enrollment|Adverse Event|0|||
145506531|NCT04163016|524711426|FG000|Treatment|Adverse Event|0|||
145506532|NCT04163016|524711427|FG001|Treatment|Adverse Event|1|||
145506533|NCT04163016|524711428|FG002|Treatment|Adverse Event|0|||
145506534|NCT04163016|524711429|FG003|Treatment|Adverse Event|0|||
145506535|NCT04163016|524711426|FG000|Treatment|Withdrawal by Subject|0|||
145506536|NCT04163016|524711427|FG001|Treatment|Withdrawal by Subject|2|||
145506537|NCT04163016|524711428|FG002|Treatment|Withdrawal by Subject|0|||
145506538|NCT04163016|524711429|FG003|Treatment|Withdrawal by Subject|0|||
145506539|NCT04163016|524711426|FG000|Treatment|Indeterminate TB-test|0|||
145506540|NCT04163016|524711427|FG001|Treatment|Indeterminate TB-test|0|||
145506541|NCT04163016|524711428|FG002|Treatment|Indeterminate TB-test|0|||
145506542|NCT04163016|524711429|FG003|Treatment|Indeterminate TB-test|1|||
145506543|NCT04163016|524711426|FG000|Treatment|Participant did not want to continue in study|0|||
145506544|NCT04163016|524711427|FG001|Treatment|Participant did not want to continue in study|0|||
145506545|NCT04163016|524711428|FG002|Treatment|Participant did not want to continue in study|0|||
145506546|NCT04163016|524711429|FG003|Treatment|Participant did not want to continue in study|1|||
145506547|NCT02930018|524711433|FG000|Overall Study|Lost to Follow-up|1|||
145506548|NCT02930018|524711434|FG001|Overall Study|Lost to Follow-up|1|||
145506549|NCT02930018|524711433|FG000|Overall Study|Withdrawal by Subject|5|||
145506550|NCT02930018|524711434|FG001|Overall Study|Withdrawal by Subject|2|||
145506551|NCT02102204|524713189|FG000|Overall Study|Withdrawal by Subject|137|||
145506552|NCT02102204|524713189|FG000|Overall Study|Death|92|||
145506553|NCT02102204|524713189|FG000|Overall Study|Lost to Follow-up|65|||
145506554|NCT02102204|524713189|FG000|Overall Study|Sponsor Decision|5|||
145506555|NCT02102204|524713189|FG000|Overall Study|Ongoing|5|||
145506556|NCT02656693|524713191|FG000|Overall Study|Pregnancy|1|||
145506557|NCT02656693|524713192|FG001|Overall Study|Pregnancy|1|||
145506558|NCT02656693|524713193|FG002|Overall Study|Pregnancy|1|||
145506559|NCT02656693|524713191|FG000|Overall Study|Bariatric surgery|0|||
145506560|NCT02656693|524713192|FG001|Overall Study|Bariatric surgery|1|||
145506561|NCT02656693|524713193|FG002|Overall Study|Bariatric surgery|2|||
145506562|NCT02269267|524713195|FG000|Overall Study|Death|5|||
145506563|NCT03773796|524713196|FG000|Overall Study|Adverse Event|1|||
145506564|NCT03773796|524713196|FG000|Overall Study|Withdrawal by Subject|1|||
145506565|NCT03773796|524713196|FG000|Overall Study|Lack of Efficacy|1|||
145506566|NCT03805659|524713198|FG000|Overall Study|Withdrawal by Subject|0|||
145506567|NCT03805659|524713199|FG001|Overall Study|Withdrawal by Subject|1|||
145506568|NCT02273596|524713202|FG000|24-Week Treatment Period|Adverse Event|3|||
145506569|NCT02273596|524713202|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
145506570|NCT02273596|524713202|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
145506571|NCT02273596|524713202|FG000|24-Week Treatment Period|Physician Decision|1|||
145506572|NCT02273596|524713202|FG000|24-Week Treatment Period|Protocol Deviation|1|||
145506573|NCT02273596|524713202|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
145506574|NCT02273596|524713202|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
145506575|NCT02273596|524713202|FG000|Extension Period|Lost to Follow-up|1|||
145506576|NCT02273596|524713202|FG000|Extension Period|Protocol Deviation|1|||
145506577|NCT02604160|524713204|FG000|Overall Study|Protocol Violation|0|||
145506578|NCT02604160|524713205|FG001|Overall Study|Protocol Violation|1|||
145506579|NCT02604160|524713204|FG000|Overall Study|Physician Decision|0|||
145506580|NCT02604160|524713205|FG001|Overall Study|Physician Decision|1|||
145506581|NCT01596062|524713206|FG000|Overall Study|Adverse Event|1|||
145506582|NCT01596062|524713207|FG001|Overall Study|Adverse Event|0|||
145506583|NCT01596062|524713208|FG002|Overall Study|Adverse Event|2|||
145506584|NCT01596062|524713206|FG000|Overall Study|Lack of Efficacy|0|||
145506585|NCT01596062|524713207|FG001|Overall Study|Lack of Efficacy|0|||
145506586|NCT01596062|524713208|FG002|Overall Study|Lack of Efficacy|1|||
145506587|NCT02255435|524713209|FG000|Overall Study|Patient's Limited Time Availability|0|||
145506588|NCT02255435|524713210|FG001|Overall Study|Patient's Limited Time Availability|0|||
145506589|NCT02255435|524713211|FG002|Overall Study|Patient's Limited Time Availability|0|||
145506590|NCT02255435|524713212|FG003|Overall Study|Patient's Limited Time Availability|0|||
145506591|NCT02255435|524713213|FG004|Overall Study|Patient's Limited Time Availability|0|||
145506592|NCT02255435|524713214|FG005|Overall Study|Patient's Limited Time Availability|0|||
145506593|NCT02255435|524713215|FG006|Overall Study|Patient's Limited Time Availability|0|||
145506594|NCT02255435|524713216|FG007|Overall Study|Patient's Limited Time Availability|1|||
145506595|NCT02255435|524713217|FG008|Overall Study|Patient's Limited Time Availability|0|||
145506596|NCT02255435|524713218|FG009|Overall Study|Patient's Limited Time Availability|0|||
145506597|NCT02255435|524713209|FG000|Overall Study|Withdrawal by Subject|0|||
145506598|NCT02255435|524713210|FG001|Overall Study|Withdrawal by Subject|0|||
145506599|NCT02255435|524713211|FG002|Overall Study|Withdrawal by Subject|0|||
145506600|NCT02255435|524713212|FG003|Overall Study|Withdrawal by Subject|0|||
145506601|NCT02255435|524713213|FG004|Overall Study|Withdrawal by Subject|0|||
145506602|NCT02255435|524713214|FG005|Overall Study|Withdrawal by Subject|0|||
145506603|NCT02255435|524713215|FG006|Overall Study|Withdrawal by Subject|0|||
145506604|NCT02255435|524713216|FG007|Overall Study|Withdrawal by Subject|0|||
145506605|NCT02255435|524713217|FG008|Overall Study|Withdrawal by Subject|1|||
145506606|NCT02255435|524713218|FG009|Overall Study|Withdrawal by Subject|4|||
145506607|NCT02255435|524713209|FG000|Overall Study|Administrative reasons|0|||
145506608|NCT02255435|524713210|FG001|Overall Study|Administrative reasons|0|||
145506609|NCT02255435|524713211|FG002|Overall Study|Administrative reasons|0|||
145506610|NCT02255435|524713212|FG003|Overall Study|Administrative reasons|0|||
145506611|NCT02255435|524713213|FG004|Overall Study|Administrative reasons|0|||
145506612|NCT02255435|524713214|FG005|Overall Study|Administrative reasons|0|||
145506613|NCT02255435|524713215|FG006|Overall Study|Administrative reasons|0|||
145506614|NCT02255435|524713216|FG007|Overall Study|Administrative reasons|0|||
145506615|NCT02255435|524713217|FG008|Overall Study|Administrative reasons|0|||
145506616|NCT02255435|524713218|FG009|Overall Study|Administrative reasons|2|||
145506617|NCT01069900|524713221|FG000|Overall Study|Technical problems|0|||
145506618|NCT01069900|524713222|FG001|Overall Study|Technical problems|1|||
145506619|NCT01069900|524713221|FG000|Overall Study|Lost to Follow-up|7|||
145506620|NCT01069900|524713222|FG001|Overall Study|Lost to Follow-up|1|||
145506621|NCT01069900|524713221|FG000|Overall Study|Withdrawal by Subject|6|||
145506622|NCT01069900|524713222|FG001|Overall Study|Withdrawal by Subject|1|||
145506623|NCT01069900|524713221|FG000|Overall Study|Protocol Violation|4|||
145506624|NCT01069900|524713222|FG001|Overall Study|Protocol Violation|1|||
145506625|NCT01069900|524713221|FG000|Overall Study|Insufficient Therapeutic effect|1|||
145506626|NCT01069900|524713222|FG001|Overall Study|Insufficient Therapeutic effect|0|||
145506627|NCT00145158|524713223|FG000|Overall Study|premature withdrawal|2|||
145506628|NCT00145158|524713224|FG001|Overall Study|premature withdrawal|3|||
145506629|NCT02687191|524713225|FG000|Overall Study|Death|0|||
145506630|NCT02687191|524713226|FG001|Overall Study|Death|1|||
145506631|NCT02687191|524713227|FG002|Overall Study|Death|1|||
145506632|NCT02687191|524713228|FG003|Overall Study|Death|0|||
145506633|NCT02687191|524713229|FG004|Overall Study|Death|1|||
145506634|NCT02687191|524713230|FG005|Overall Study|Death|1|||
145506635|NCT02687191|524713225|FG000|Overall Study|Withdrawal by Subject|0|||
145506636|NCT02687191|524713226|FG001|Overall Study|Withdrawal by Subject|0|||
145506637|NCT02687191|524713227|FG002|Overall Study|Withdrawal by Subject|0|||
145506638|NCT02687191|524713228|FG003|Overall Study|Withdrawal by Subject|1|||
145506639|NCT02687191|524713229|FG004|Overall Study|Withdrawal by Subject|0|||
145506640|NCT02687191|524713230|FG005|Overall Study|Withdrawal by Subject|0|||
145506641|NCT01227018|524713231|FG000|Overall Study|Disease progression|9|||
145506642|NCT01227018|524713231|FG000|Overall Study|Toxicity|2|||
145506643|NCT01227018|524713231|FG000|Overall Study|Withdrew after beginning treatment|4|||
145506644|NCT02948634|524713232|FG000|Overall Study|Lack of efficacy and study suspended|10|||
145506645|NCT02948634|524713233|FG001|Overall Study|Lack of efficacy and study suspended|2|||
145506646|NCT01413204|524713236|FG000|Overall Study|Adverse Event|1|||
145506647|NCT01413204|524713237|FG001|Overall Study|Adverse Event|2|||
145506648|NCT01413204|524713238|FG002|Overall Study|Adverse Event|2|||
145506649|NCT01413204|524713236|FG000|Overall Study|Physician Decision|3|||
145506650|NCT01413204|524713237|FG001|Overall Study|Physician Decision|0|||
145506651|NCT01413204|524713238|FG002|Overall Study|Physician Decision|2|||
145506652|NCT01413204|524713236|FG000|Overall Study|Withdrawal by Subject|1|||
145506653|NCT01413204|524713237|FG001|Overall Study|Withdrawal by Subject|4|||
145506654|NCT01413204|524713238|FG002|Overall Study|Withdrawal by Subject|4|||
145506655|NCT01413204|524713236|FG000|Overall Study|Clearly not eligible for the study|0|||
145506656|NCT01413204|524713237|FG001|Overall Study|Clearly not eligible for the study|0|||
145506657|NCT01413204|524713238|FG002|Overall Study|Clearly not eligible for the study|1|||
145506658|NCT01413204|524713236|FG000|Overall Study|Fasting plasma glucose level increased|1|||
145506659|NCT01413204|524713237|FG001|Overall Study|Fasting plasma glucose level increased|0|||
145506660|NCT01413204|524713238|FG002|Overall Study|Fasting plasma glucose level increased|10|||
145506661|NCT00753649|524713239|FG000|Overall Study|Migrated/moved from study area|1|||
145506662|NCT00753649|524713240|FG001|Overall Study|Migrated/moved from study area|0|||
145506663|NCT00753649|524713239|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
145506664|NCT00753649|524713240|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
145506665|NCT00753649|524713239|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
145506666|NCT00753649|524713240|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
145506667|NCT00753649|524713239|FG000|Overall Study|Protocol Violation|2|||
145506668|NCT00753649|524713240|FG001|Overall Study|Protocol Violation|0|||
145506669|NCT00499616|524713241|FG000|Overall Study|Death|1|||
145506670|NCT00499616|524713242|FG001|Overall Study|Death|5|||
145506671|NCT00499616|524713243|FG002|Overall Study|Death|3|||
145506672|NCT00499616|524713244|FG003|Overall Study|Death|1|||
145506673|NCT00499616|524713241|FG000|Overall Study|Lack of Efficacy|5|||
145506674|NCT00499616|524713242|FG001|Overall Study|Lack of Efficacy|0|||
145506675|NCT00499616|524713243|FG002|Overall Study|Lack of Efficacy|19|||
145506676|NCT00499616|524713244|FG003|Overall Study|Lack of Efficacy|0|||
145506677|NCT00499616|524713241|FG000|Overall Study|Lost to Follow-up|0|||
145506678|NCT00499616|524713242|FG001|Overall Study|Lost to Follow-up|0|||
145506679|NCT00499616|524713243|FG002|Overall Study|Lost to Follow-up|1|||
145506680|NCT00499616|524713244|FG003|Overall Study|Lost to Follow-up|0|||
145506681|NCT00499616|524713241|FG000|Overall Study|Physician Decision|6|||
145506682|NCT00499616|524713242|FG001|Overall Study|Physician Decision|16|||
145506683|NCT00499616|524713243|FG002|Overall Study|Physician Decision|9|||
145506684|NCT00499616|524713244|FG003|Overall Study|Physician Decision|0|||
145506685|NCT00499616|524713241|FG000|Overall Study|Withdrawal by Subject|1|||
145506686|NCT00499616|524713242|FG001|Overall Study|Withdrawal by Subject|0|||
145506687|NCT00499616|524713243|FG002|Overall Study|Withdrawal by Subject|1|||
145506688|NCT00499616|524713244|FG003|Overall Study|Withdrawal by Subject|0|||
145506689|NCT00499616|524713241|FG000|Overall Study|Ineligible|1|||
145506690|NCT00499616|524713242|FG001|Overall Study|Ineligible|2|||
145506691|NCT00499616|524713243|FG002|Overall Study|Ineligible|0|||
145506692|NCT00499616|524713244|FG003|Overall Study|Ineligible|15|||
145506693|NCT00499616|524713241|FG000|Overall Study|Not evaluable|0|||
145506694|NCT00499616|524713242|FG001|Overall Study|Not evaluable|0|||
145506695|NCT00499616|524713243|FG002|Overall Study|Not evaluable|0|||
145506696|NCT00499616|524713244|FG003|Overall Study|Not evaluable|41|||
145506697|NCT00499616|524713241|FG000|Overall Study|Patient/Parent Refusal|1|||
145506698|NCT00499616|524713242|FG001|Overall Study|Patient/Parent Refusal|5|||
145506699|NCT00499616|524713243|FG002|Overall Study|Patient/Parent Refusal|3|||
145506700|NCT00499616|524713244|FG003|Overall Study|Patient/Parent Refusal|0|||
145506701|NCT03085797|524713246|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
145506702|NCT03085797|524713247|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
145506703|NCT03085797|524713246|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
145506704|NCT03085797|524713247|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
145506705|NCT03085797|524713246|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
145506706|NCT03085797|524713247|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
145506707|NCT01864603|524713248|FG000|Stage 2|DSMB design modification|86056|||
145506708|NCT01864603|524713249|FG001|Stage 2|DSMB design modification|92558|||
145506709|NCT00330967|524713251|FG000|Overall Study|Withdrawal by Subject|0|||
145506710|NCT00330967|524713252|FG001|Overall Study|Withdrawal by Subject|5|||
145506711|NCT00330967|524713251|FG000|Overall Study|Physician Decision|0|||
145506712|NCT00330967|524713252|FG001|Overall Study|Physician Decision|9|||
145506713|NCT00859456|524713253|FG000|Overall Study|Adverse Event|3|||
145506714|NCT00859456|524713253|FG000|Overall Study|Progressive disease|2|||
145506715|NCT00859456|524713253|FG000|Overall Study|Non-compliance|3|||
145506716|NCT00337675|524713254|FG000|Overall Study|Adverse Event|10|||
145506717|NCT00337675|524713255|FG001|Overall Study|Adverse Event|9|||
145506718|NCT00337675|524713256|FG002|Overall Study|Adverse Event|19|||
145506719|NCT00337675|524713254|FG000|Overall Study|Lack of Efficacy|10|||
145506720|NCT00337675|524713255|FG001|Overall Study|Lack of Efficacy|7|||
145506721|NCT00337675|524713256|FG002|Overall Study|Lack of Efficacy|9|||
145506722|NCT00337675|524713254|FG000|Overall Study|Lost to Follow-up|22|||
145506723|NCT00337675|524713255|FG001|Overall Study|Lost to Follow-up|19|||
145506724|NCT00337675|524713256|FG002|Overall Study|Lost to Follow-up|17|||
145506725|NCT00337675|524713254|FG000|Overall Study|Physician Decision|9|||
145506726|NCT00337675|524713255|FG001|Overall Study|Physician Decision|17|||
145506727|NCT00337675|524713256|FG002|Overall Study|Physician Decision|14|||
145506728|NCT00337675|524713254|FG000|Overall Study|Protocol Violation|21|||
145506729|NCT00337675|524713255|FG001|Overall Study|Protocol Violation|24|||
145506730|NCT00337675|524713256|FG002|Overall Study|Protocol Violation|19|||
145506731|NCT00337675|524713254|FG000|Overall Study|Withdrawal by Subject|25|||
145506732|NCT00337675|524713255|FG001|Overall Study|Withdrawal by Subject|25|||
145506733|NCT00337675|524713256|FG002|Overall Study|Withdrawal by Subject|19|||
145506734|NCT00337675|524713254|FG000|Overall Study|Progressive Disease|0|||
145506735|NCT00337675|524713255|FG001|Overall Study|Progressive Disease|2|||
145506736|NCT00337675|524713256|FG002|Overall Study|Progressive Disease|0|||
145506737|NCT00337675|524713254|FG000|Overall Study|Trial Terminated|0|||
145506738|NCT00337675|524713255|FG001|Overall Study|Trial Terminated|0|||
145506739|NCT00337675|524713256|FG002|Overall Study|Trial Terminated|2|||
145506740|NCT02578706|524713259|FG000|Overall Study|Withdrawal by Subject|1|||
145506741|NCT02578706|524713260|FG001|Overall Study|Withdrawal by Subject|0|||
145506742|NCT02578706|524713261|FG002|Overall Study|Withdrawal by Subject|0|||
145506743|NCT02578706|524713259|FG000|Overall Study|Lost to Follow-up|0|||
145506744|NCT02578706|524713260|FG001|Overall Study|Lost to Follow-up|4|||
145506745|NCT02578706|524713261|FG002|Overall Study|Lost to Follow-up|0|||
145506746|NCT02578706|524713259|FG000|Overall Study|Physician Decision|0|||
145506747|NCT02578706|524713260|FG001|Overall Study|Physician Decision|1|||
145506748|NCT02578706|524713261|FG002|Overall Study|Physician Decision|0|||
145506749|NCT02910986|524713269|FG000|Overall Study|non-Latina|14|||
145506750|NCT02910986|524713270|FG001|Overall Study|non-Latina|13|||
145506751|NCT02910986|524713271|FG002|Overall Study|non-Latina|12|||
145506752|NCT02910986|524713269|FG000|Overall Study|Failure to return T! survey|72|||
145506753|NCT02910986|524713270|FG001|Overall Study|Failure to return T! survey|84|||
145506754|NCT02910986|524713271|FG002|Overall Study|Failure to return T! survey|72|||
145506755|NCT02910986|524713269|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
145506756|NCT02910986|524713270|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
145506757|NCT02910986|524713271|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
145506758|NCT02910986|524713269|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
145506759|NCT02910986|524713270|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
145506760|NCT02910986|524713271|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
145506761|NCT03306173|524713277|FG000|Overall Study|Lost to Follow-up|16|||
145506762|NCT03306173|524713278|FG001|Overall Study|Lost to Follow-up|23|||
145506763|NCT03306173|524713277|FG000|Overall Study|Withdrawal by Subject|4|||
145506764|NCT03306173|524713278|FG001|Overall Study|Withdrawal by Subject|3|||
145506765|NCT03306173|524713277|FG000|Overall Study|Discontinued|4|||
145506766|NCT03306173|524713278|FG001|Overall Study|Discontinued|4|||
145506767|NCT01339052|524713285|FG000|Overall Study|Disease progression|13|||
145506768|NCT01339052|524713286|FG001|Overall Study|Disease progression|46|||
145506769|NCT01339052|524713285|FG000|Overall Study|Adverse Event|1|||
145506770|NCT01339052|524713286|FG001|Overall Study|Adverse Event|1|||
145506771|NCT01339052|524713285|FG000|Overall Study|Withdrawal by Subject|0|||
145506772|NCT01339052|524713286|FG001|Overall Study|Withdrawal by Subject|3|||
145506773|NCT01339052|524713285|FG000|Overall Study|Physician Decision|1|||
145506774|NCT01339052|524713286|FG001|Overall Study|Physician Decision|0|||
145506775|NCT02637037|524713287|FG000|Overall Study|Positive drug screen at admission|1|||
145506776|NCT02637037|524713288|FG001|Overall Study|Positive drug screen at admission|0|||
145506777|NCT02637037|524713287|FG000|Overall Study|Withdrawal by Subject|2|||
145506778|NCT02637037|524713288|FG001|Overall Study|Withdrawal by Subject|1|||
145506779|NCT02637037|524713287|FG000|Overall Study|Adverse Event|1|||
145506780|NCT02637037|524713288|FG001|Overall Study|Adverse Event|0|||
145506781|NCT02023697|524713291|FG000|Treatment Period|Radiological progression|13|||
145506782|NCT02023697|524713292|FG001|Treatment Period|Radiological progression|17|||
145506783|NCT02023697|524713293|FG002|Treatment Period|Radiological progression|26|||
145506784|NCT02023697|524713291|FG000|Treatment Period|Never Treated|5|||
145506785|NCT02023697|524713292|FG001|Treatment Period|Never Treated|6|||
145506786|NCT02023697|524713293|FG002|Treatment Period|Never Treated|10|||
145506787|NCT02023697|524713291|FG000|Treatment Period|Adverse Event|13|||
145506788|NCT02023697|524713292|FG001|Treatment Period|Adverse Event|25|||
145506789|NCT02023697|524713293|FG002|Treatment Period|Adverse Event|23|||
145506790|NCT02023697|524713291|FG000|Treatment Period|Logistical difficulties|1|||
145506791|NCT02023697|524713292|FG001|Treatment Period|Logistical difficulties|1|||
145506792|NCT02023697|524713293|FG002|Treatment Period|Logistical difficulties|1|||
145506793|NCT02023697|524713291|FG000|Treatment Period|Clinical progression|10|||
145506794|NCT02023697|524713292|FG001|Treatment Period|Clinical progression|8|||
145506795|NCT02023697|524713293|FG002|Treatment Period|Clinical progression|28|||
145506796|NCT02023697|524713291|FG000|Treatment Period|Withdrawal by Subject|4|||
145506797|NCT02023697|524713292|FG001|Treatment Period|Withdrawal by Subject|5|||
145506798|NCT02023697|524713293|FG002|Treatment Period|Withdrawal by Subject|13|||
145506799|NCT02023697|524713291|FG000|Treatment Period|Safety outcome reached|0|||
145506800|NCT02023697|524713292|FG001|Treatment Period|Safety outcome reached|1|||
145506801|NCT02023697|524713293|FG002|Treatment Period|Safety outcome reached|0|||
145506802|NCT02023697|524713291|FG000|Treatment Period|Physician Decision|0|||
145506803|NCT02023697|524713292|FG001|Treatment Period|Physician Decision|0|||
145506804|NCT02023697|524713293|FG002|Treatment Period|Physician Decision|1|||
145506805|NCT02023697|524713291|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
145506806|NCT02023697|524713292|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
145506807|NCT02023697|524713293|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
145506808|NCT02023697|524713291|FG000|Active Follow-up Period|Lost to Follow-up|1|||
145506809|NCT02023697|524713292|FG001|Active Follow-up Period|Lost to Follow-up|1|||
145506810|NCT02023697|524713293|FG002|Active Follow-up Period|Lost to Follow-up|1|||
145506811|NCT02023697|524713291|FG000|Active Follow-up Period|Deterioration of general condition|1|||
145506812|NCT02023697|524713292|FG001|Active Follow-up Period|Deterioration of general condition|1|||
145506813|NCT02023697|524713293|FG002|Active Follow-up Period|Deterioration of general condition|1|||
145506814|NCT02023697|524713291|FG000|Active Follow-up Period|Other unspecified|2|||
145506815|NCT02023697|524713292|FG001|Active Follow-up Period|Other unspecified|0|||
145506816|NCT02023697|524713293|FG002|Active Follow-up Period|Other unspecified|1|||
145506817|NCT02023697|524713291|FG000|Active Follow-up Period|Clinical progression|0|||
145506818|NCT02023697|524713292|FG001|Active Follow-up Period|Clinical progression|2|||
145506819|NCT02023697|524713293|FG002|Active Follow-up Period|Clinical progression|1|||
145506820|NCT02023697|524713291|FG000|Active Follow-up Period|Radiological progression|0|||
145506821|NCT02023697|524713292|FG001|Active Follow-up Period|Radiological progression|0|||
145506822|NCT02023697|524713293|FG002|Active Follow-up Period|Radiological progression|1|||
145506823|NCT02023697|524713291|FG000|Active Follow-up Period|Death|83|||
145506824|NCT02023697|524713292|FG001|Active Follow-up Period|Death|82|||
145506825|NCT02023697|524713293|FG002|Active Follow-up Period|Death|87|||
145506826|NCT02023697|524713291|FG000|Long-term Follow-up Period|Death|9|||
145506827|NCT02023697|524713292|FG001|Long-term Follow-up Period|Death|6|||
145506828|NCT02023697|524713293|FG002|Long-term Follow-up Period|Death|4|||
145506829|NCT02023697|524713291|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
145506830|NCT02023697|524713292|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
145506831|NCT02023697|524713293|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
145506832|NCT02023697|524713291|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
145506833|NCT02023697|524713292|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
145506834|NCT02023697|524713293|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
145506835|NCT02023697|524713291|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
145506836|NCT02023697|524713292|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
145506837|NCT02023697|524713293|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
145506838|NCT02023697|524713291|FG000|Long-term Follow-up Period|Technical problems|0|||
145506839|NCT02023697|524713292|FG001|Long-term Follow-up Period|Technical problems|0|||
145506840|NCT02023697|524713293|FG002|Long-term Follow-up Period|Technical problems|1|||
145506841|NCT02023697|524713291|FG000|Long-term Follow-up Period|Other unspecified|6|||
145506842|NCT02023697|524713292|FG001|Long-term Follow-up Period|Other unspecified|3|||
145506843|NCT02023697|524713293|FG002|Long-term Follow-up Period|Other unspecified|5|||
145506844|NCT01469377|524713299|FG000|Overall Study|Protocol Deviation|7|||
145506845|NCT01469377|524713300|FG001|Overall Study|Protocol Deviation|10|||
145506846|NCT01469377|524713301|FG002|Overall Study|Protocol Deviation|10|||
145506847|NCT01469377|524713299|FG000|Overall Study|Lost to Follow-up|3|||
145506848|NCT01469377|524713300|FG001|Overall Study|Lost to Follow-up|2|||
145506849|NCT01469377|524713301|FG002|Overall Study|Lost to Follow-up|5|||
145506850|NCT01469377|524713299|FG000|Overall Study|Withdrawal of Consent|12|||
145506851|NCT01469377|524713300|FG001|Overall Study|Withdrawal of Consent|14|||
145506852|NCT01469377|524713301|FG002|Overall Study|Withdrawal of Consent|15|||
145506853|NCT01469377|524713299|FG000|Overall Study|Adverse Event|8|||
145506854|NCT01469377|524713300|FG001|Overall Study|Adverse Event|18|||
145506855|NCT01469377|524713301|FG002|Overall Study|Adverse Event|36|||
145506856|NCT01469377|524713299|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145506857|NCT01469377|524713300|FG001|Overall Study|Insufficient Therapeutic Response|4|||
145506858|NCT01469377|524713301|FG002|Overall Study|Insufficient Therapeutic Response|0|||
145506859|NCT01469377|524713299|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145506860|NCT01469377|524713300|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145506861|NCT01469377|524713301|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145506862|NCT00714870|524713303|FG000|Overall Study|Lost to Follow-up|22|||
145506863|NCT00714870|524713304|FG001|Overall Study|Lost to Follow-up|5|||
145506864|NCT00714870|524713303|FG000|Overall Study|patient unable to come b/c back pain|1|||
145506865|NCT00714870|524713304|FG001|Overall Study|patient unable to come b/c back pain|0|||
145506866|NCT00714870|524713303|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
145506867|NCT00714870|524713304|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
145506868|NCT03399552|524713305|FG000|Overall Study|No evidence of disease|1|||
145506869|NCT03399552|524713305|FG000|Overall Study|Unevaluable|1|||
145506870|NCT02357368|524713306|FG000|Overall Study|Lost to Follow-up|0|||
145506871|NCT02357368|524713307|FG001|Overall Study|Lost to Follow-up|0|||
145506872|NCT02357368|524713308|FG002|Overall Study|Lost to Follow-up|0|||
145506873|NCT02357368|524713309|FG003|Overall Study|Lost to Follow-up|1|||
145506874|NCT02357368|524713306|FG000|Overall Study|Pregnancy|3|||
145506875|NCT02357368|524713307|FG001|Overall Study|Pregnancy|2|||
145506876|NCT02357368|524713308|FG002|Overall Study|Pregnancy|0|||
145506877|NCT02357368|524713309|FG003|Overall Study|Pregnancy|0|||
145506878|NCT02357368|524713306|FG000|Overall Study|Withdrawal by Subject|3|||
145506879|NCT02357368|524713307|FG001|Overall Study|Withdrawal by Subject|1|||
145506880|NCT02357368|524713308|FG002|Overall Study|Withdrawal by Subject|1|||
145506881|NCT02357368|524713309|FG003|Overall Study|Withdrawal by Subject|2|||
145506882|NCT00611026|524713312|FG000|Randomized to Double-blind Treatment|Not treated|2|||
145506883|NCT00611026|524713313|FG001|Randomized to Double-blind Treatment|Not treated|1|||
145506884|NCT00611026|524713314|FG002|Randomized to Double-blind Treatment|Not treated|3|||
145506885|NCT00611026|524713312|FG000|Double-blind Treatment Period|Death|1|||
145506886|NCT00611026|524713313|FG001|Double-blind Treatment Period|Death|0|||
145506887|NCT00611026|524713314|FG002|Double-blind Treatment Period|Death|0|||
145506888|NCT00611026|524713312|FG000|Double-blind Treatment Period|Adverse Event|9|||
145506889|NCT00611026|524713313|FG001|Double-blind Treatment Period|Adverse Event|28|||
145506890|NCT00611026|524713314|FG002|Double-blind Treatment Period|Adverse Event|46|||
145506891|NCT00611026|524713312|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
145506892|NCT00611026|524713313|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
145506893|NCT00611026|524713314|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
145506894|NCT00611026|524713312|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
145506895|NCT00611026|524713313|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
145506896|NCT00611026|524713314|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
145506897|NCT00611026|524713312|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
145506898|NCT00611026|524713313|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
145506899|NCT00611026|524713314|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
145506900|NCT00611026|524713312|FG000|Double-blind Treatment Period|Other|13|||
145506901|NCT00611026|524713313|FG001|Double-blind Treatment Period|Other|20|||
145506902|NCT00611026|524713314|FG002|Double-blind Treatment Period|Other|18|||
145506903|NCT01147874|524713316|FG000|Overall Study|Adverse Event|5|||
145506904|NCT01147874|524713316|FG000|Overall Study|Investigator's Request|1|||
145506905|NCT01147874|524713316|FG000|Overall Study|Lost to Follow-up|25|||
145506906|NCT01147874|524713316|FG000|Overall Study|Other|5|||
145506907|NCT01147874|524713316|FG000|Overall Study|Protocol Violation|5|||
145506908|NCT01147874|524713316|FG000|Overall Study|Sponsor's Decision|2|||
145506909|NCT01147874|524713316|FG000|Overall Study|Withdrawal by Subject|24|||
145506910|NCT02175030|524713324|FG000|Overall Study|Failed screen after consent|7|||
145506911|NCT02175030|524713325|FG001|Overall Study|Failed screen after consent|6|||
145506912|NCT02175030|524713324|FG000|Overall Study|Failed IUD Insertion|20|||
145506913|NCT02175030|524713325|FG001|Overall Study|Failed IUD Insertion|21|||
145506914|NCT02175030|524713324|FG000|Overall Study|Physician Decision|1|||
145506915|NCT02175030|524713325|FG001|Overall Study|Physician Decision|1|||
145506916|NCT02175030|524713324|FG000|Overall Study|Lost to Follow-up|6|||
145506917|NCT02175030|524713325|FG001|Overall Study|Lost to Follow-up|6|||
145506918|NCT02175030|524713324|FG000|Overall Study|Withdrawal by Subject|1|||
145506919|NCT02175030|524713325|FG001|Overall Study|Withdrawal by Subject|4|||
145506920|NCT02533453|524713326|FG000|Overall Study|Adverse Event|6|||
145506921|NCT02533453|524713326|FG000|Overall Study|Protocol Violation|1|||
145506922|NCT02533453|524713326|FG000|Overall Study|Withdrawal by Subject|2|||
145506923|NCT03892967|524713331|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
145506924|NCT03892967|524713332|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
145506925|NCT03892967|524713333|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
145506926|NCT03892967|524713334|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
145506927|NCT03892967|524713335|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
145506928|NCT03892967|524713331|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
145506929|NCT03892967|524713332|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
145506930|NCT03892967|524713333|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
145506931|NCT03892967|524713334|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
145506932|NCT03892967|524713335|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
145506933|NCT03892967|524713331|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
145506934|NCT03892967|524713332|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
145506935|NCT03892967|524713333|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
145506936|NCT03892967|524713334|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
145506937|NCT03892967|524713335|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
145506938|NCT03892967|524713331|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
145506939|NCT03892967|524713332|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
145506940|NCT03892967|524713333|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
145506941|NCT03892967|524713334|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
145506942|NCT03892967|524713335|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
145506943|NCT03892967|524713331|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
145506944|NCT03892967|524713332|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
145506945|NCT03892967|524713333|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
145506946|NCT03892967|524713334|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
145506947|NCT03892967|524713335|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
145506948|NCT03892967|524713331|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
145506949|NCT03892967|524713332|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
145506950|NCT03892967|524713333|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
145506951|NCT03892967|524713334|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
145506952|NCT03892967|524713335|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
145506953|NCT04434937|524713336|FG000|Overall Study|Death|4|||
145506954|NCT04434937|524713336|FG000|Overall Study|Withdrawal by Subject|1|||
145506955|NCT04434937|524713336|FG000|Overall Study|Transitioned to Rollover Study|19|||
145506956|NCT04434937|524713336|FG000|Overall Study|Progressive Disease|18|||
145506957|NCT03387085|524713341|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
145506958|NCT04193189|524713342|FG000|Overall Study|Lost to Follow-up|9|||
145506959|NCT04193189|524713343|FG001|Overall Study|Lost to Follow-up|7|||
145506960|NCT04193189|524713344|FG002|Overall Study|Lost to Follow-up|9|||
145506961|NCT04193189|524713345|FG003|Overall Study|Lost to Follow-up|0|||
145506962|NCT04193189|524713342|FG000|Overall Study|Withdrawal by Subject|1|||
145506963|NCT04193189|524713343|FG001|Overall Study|Withdrawal by Subject|2|||
145506964|NCT04193189|524713344|FG002|Overall Study|Withdrawal by Subject|2|||
145506965|NCT04193189|524713345|FG003|Overall Study|Withdrawal by Subject|0|||
145506966|NCT04193189|524713342|FG000|Overall Study|Death|1|||
145506967|NCT04193189|524713343|FG001|Overall Study|Death|1|||
145506968|NCT04193189|524713344|FG002|Overall Study|Death|0|||
145506969|NCT04193189|524713345|FG003|Overall Study|Death|0|||
145506970|NCT04193189|524713342|FG000|Overall Study|Protocol Violation|0|||
145506971|NCT04193189|524713343|FG001|Overall Study|Protocol Violation|0|||
145506972|NCT04193189|524713344|FG002|Overall Study|Protocol Violation|0|||
145506973|NCT04193189|524713345|FG003|Overall Study|Protocol Violation|1|||
145506974|NCT03180840|524715042|FG000|Overall Study|Withdrawal by Subject|1|||
145506975|NCT00476008|524715045|FG000|Overall Study|Adverse Event|4|||
145506976|NCT00476008|524715046|FG001|Overall Study|Adverse Event|4|||
145506977|NCT00476008|524715045|FG000|Overall Study|Placebo concerns|2|||
145506978|NCT00476008|524715046|FG001|Overall Study|Placebo concerns|2|||
145506979|NCT00476008|524715045|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
145506980|NCT00476008|524715046|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
145506981|NCT00476008|524715045|FG000|Overall Study|Withdrawal by Subject|0|||
145506982|NCT00476008|524715046|FG001|Overall Study|Withdrawal by Subject|1|||
145506983|NCT00476008|524715045|FG000|Overall Study|Death|1|||
145506984|NCT00476008|524715046|FG001|Overall Study|Death|0|||
145506985|NCT01788358|524715050|FG000|Overall Study|Other|11|||
145506986|NCT01788358|524715050|FG000|Overall Study|Logistical difficulties|1|||
145506987|NCT01788358|524715050|FG000|Overall Study|Lost to Follow-up|5|||
145506988|NCT01788358|524715050|FG000|Overall Study|Protocol Violation|3|||
145506989|NCT01788358|524715050|FG000|Overall Study|Withdrawal by Subject|26|||
145506990|NCT01788358|524715050|FG000|Overall Study|Lack of Efficacy|1|||
145506991|NCT01788358|524715050|FG000|Overall Study|Adverse Event|51|||
145506992|NCT01168219|524715051|FG000|Overall Study|off study before starting treatment|2|||
145506993|NCT01168219|524715051|FG000|Overall Study|withdrew before transplant|1|||
145506994|NCT01168219|524715051|FG000|Overall Study|ineligible due to CML|2|||
145506995|NCT02563067|524715054|FG000|Overall Study|Subject/guardian decision|14|||
145506996|NCT02563067|524715055|FG001|Overall Study|Subject/guardian decision|20|||
145506997|NCT02563067|524715056|FG002|Overall Study|Subject/guardian decision|16|||
145506998|NCT02563067|524715054|FG000|Overall Study|Physician Decision|0|||
145506999|NCT02563067|524715055|FG001|Overall Study|Physician Decision|1|||
145507000|NCT02563067|524715056|FG002|Overall Study|Physician Decision|3|||
145507001|NCT02563067|524715054|FG000|Overall Study|Lost to Follow-up|1|||
145507002|NCT02563067|524715055|FG001|Overall Study|Lost to Follow-up|2|||
145507003|NCT02563067|524715056|FG002|Overall Study|Lost to Follow-up|0|||
145507004|NCT02563067|524715054|FG000|Overall Study|Technical problems|0|||
145507005|NCT02563067|524715055|FG001|Overall Study|Technical problems|1|||
145507006|NCT02563067|524715056|FG002|Overall Study|Technical problems|0|||
145507007|NCT02563067|524715054|FG000|Overall Study|Lack of Efficacy|1|||
145507008|NCT02563067|524715055|FG001|Overall Study|Lack of Efficacy|0|||
145507009|NCT02563067|524715056|FG002|Overall Study|Lack of Efficacy|0|||
145507010|NCT02563067|524715054|FG000|Overall Study|Death|0|||
145507011|NCT02563067|524715055|FG001|Overall Study|Death|1|||
145507012|NCT02563067|524715056|FG002|Overall Study|Death|1|||
145507013|NCT02563067|524715054|FG000|Overall Study|Adverse Event|2|||
145507014|NCT02563067|524715055|FG001|Overall Study|Adverse Event|1|||
145507015|NCT02563067|524715056|FG002|Overall Study|Adverse Event|0|||
145507016|NCT02563067|524715054|FG000|Overall Study|Death post Treatment/safety period|1|||
145507017|NCT02563067|524715055|FG001|Overall Study|Death post Treatment/safety period|0|||
145507018|NCT02563067|524715056|FG002|Overall Study|Death post Treatment/safety period|0|||
145507019|NCT01039519|524715061|FG000|Treatment|Progressive disease|20|||
145507020|NCT01039519|524715061|FG000|Treatment|Treatment failure|2|||
145507021|NCT01039519|524715061|FG000|Treatment|Adverse Event|3|||
145507022|NCT01039519|524715061|FG000|Treatment|Physician Decision|2|||
145507023|NCT01039519|524715061|FG000|Survival Follow-up|Death|23|||
145507024|NCT01039519|524715061|FG000|Survival Follow-up|Sponsor decision|4|||
145507025|NCT00808080|524715065|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
145507026|NCT00423917|524715068|FG000|Overall Study|Cancel|2|||
145507027|NCT00423917|524715068|FG000|Overall Study|Ineligible|1|||
145507028|NCT00243269|524715069|FG000|Overall Study|Protocol Violation|2|||
145507029|NCT00243269|524715070|FG001|Overall Study|Protocol Violation|1|||
145507030|NCT00243269|524715071|FG002|Overall Study|Protocol Violation|0|||
145507031|NCT00243269|524715072|FG003|Overall Study|Protocol Violation|1|||
145507032|NCT00243269|524715069|FG000|Overall Study|Lost to Follow-up|1|||
145507033|NCT00243269|524715070|FG001|Overall Study|Lost to Follow-up|0|||
145507034|NCT00243269|524715071|FG002|Overall Study|Lost to Follow-up|1|||
145507035|NCT00243269|524715072|FG003|Overall Study|Lost to Follow-up|3|||
145507036|NCT01837823|524715073|FG000|Overall Study|Lost to Follow-up|6|||
145507037|NCT03052400|524715074|FG000|Overall Study|Lost to Follow-up|1|||
145507038|NCT03052400|524715075|FG001|Overall Study|Lost to Follow-up|0|||
145507039|NCT03052400|524715074|FG000|Overall Study|Withdrawal by Subject|0|||
145507040|NCT03052400|524715075|FG001|Overall Study|Withdrawal by Subject|1|||
145507041|NCT00555061|524715076|FG000|Overall Study|Adverse Event|3|||
145507042|NCT00555061|524715076|FG000|Overall Study|Protocol Violation|1|||
145507043|NCT00555061|524715076|FG000|Overall Study|Lost to Follow-up|2|||
145507044|NCT00555061|524715076|FG000|Overall Study|Withdrawal by Subject|2|||
145507045|NCT00555061|524715076|FG000|Overall Study|Participant enrolled, but never treated|1|||
145507046|NCT03830892|524715079|FG000|Overall Study|Physician Decision|2|||
145507047|NCT03830892|524715080|FG001|Overall Study|Physician Decision|3|||
145507048|NCT03830892|524715079|FG000|Overall Study|Study terminated due to COVID|4|||
145507049|NCT03830892|524715080|FG001|Overall Study|Study terminated due to COVID|0|||
145507050|NCT03830892|524715079|FG000|Overall Study|Protocol Violation|0|||
145507051|NCT03830892|524715080|FG001|Overall Study|Protocol Violation|1|||
145507052|NCT03830892|524715079|FG000|Overall Study|Withdrawal by Subject|0|||
145507053|NCT03830892|524715080|FG001|Overall Study|Withdrawal by Subject|2|||
145507054|NCT04269265|524715081|FG000|Overall Study|Physician Decision|1|||
145507055|NCT04269265|524715081|FG000|Overall Study|Withdrawal by Subject|1|||
145507056|NCT04269265|524715081|FG000|Overall Study|Overenrolled (sample size reached)|4|||
145507057|NCT04439136|524715082|FG000|Overall Study|Ineligible|1|||
145507058|NCT04439136|524715082|FG000|Overall Study|Never Started Treatment|2|||
145507059|NCT04439136|524715082|FG000|Overall Study|Adverse Event|4|||
145507060|NCT04439136|524715082|FG000|Overall Study|Death|3|||
145507061|NCT04439136|524715082|FG000|Overall Study|Disease Progression|27|||
145507062|NCT04439136|524715082|FG000|Overall Study|Alternative Therapy|1|||
145507063|NCT04439136|524715082|FG000|Overall Study|Increased Tumor Burden|1|||
145507064|NCT04439136|524715082|FG000|Overall Study|Symptomatic Detrioration|1|||
145507065|NCT04849559|524715083|FG000|Overall Study|Withdrawal by Subject|2|||
145507066|NCT04849559|524715084|FG001|Overall Study|Withdrawal by Subject|1|||
145507067|NCT01662102|524715088|FG000|Overall Study|Sponsor's decision|1|||
145507068|NCT01662102|524715089|FG001|Overall Study|Sponsor's decision|0|||
145507069|NCT02586207|524715090|FG000|Overall Study|Physician Decision|1|||
145507070|NCT02586207|524715090|FG000|Overall Study|Withdrawal by Subject|1|||
145507071|NCT03527732|524715091|FG000|Overall Study|Lost to Follow-up|21|||
145507072|NCT03527732|524715092|FG001|Overall Study|Lost to Follow-up|23|||
145507073|NCT03527732|524715093|FG002|Overall Study|Lost to Follow-up|80|||
145507074|NCT03527732|524715094|FG003|Overall Study|Lost to Follow-up|62|||
145507075|NCT03527732|524715095|FG004|Overall Study|Lost to Follow-up|12|||
145507076|NCT03527732|524715096|FG005|Overall Study|Lost to Follow-up|20|||
145507077|NCT01262989|524715097|FG000|Period 1|Lost to Follow-up|1|||
145507078|NCT01262989|524715098|FG001|Period 1|Lost to Follow-up|1|||
145507079|NCT01262989|524715097|FG000|Period 1|Intercurrent disease|0|||
145507080|NCT01262989|524715098|FG001|Period 1|Intercurrent disease|1|||
145507081|NCT01262989|524715097|FG000|Period 1|Positive answer for exclusion criteria|0|||
145507082|NCT01262989|524715098|FG001|Period 1|Positive answer for exclusion criteria|1|||
145507083|NCT01262989|524715097|FG000|Period 2|Intercurrent disease|0|||
145507084|NCT01262989|524715098|FG001|Period 2|Intercurrent disease|1|||
145507085|NCT02306161|524715099|FG000|Overall Study|Death|1|||
145507086|NCT02306161|524715100|FG001|Overall Study|Death|3|||
145507087|NCT02306161|524715099|FG000|Overall Study|Lack of Efficacy|20|||
145507088|NCT02306161|524715100|FG001|Overall Study|Lack of Efficacy|43|||
145507089|NCT02306161|524715099|FG000|Overall Study|Physician Decision|30|||
145507090|NCT02306161|524715100|FG001|Overall Study|Physician Decision|18|||
145507091|NCT02306161|524715099|FG000|Overall Study|Withdrawal by Subject|4|||
145507092|NCT02306161|524715100|FG001|Overall Study|Withdrawal by Subject|0|||
145507093|NCT02306161|524715099|FG000|Overall Study|Ineligible|9|||
145507094|NCT02306161|524715100|FG001|Overall Study|Ineligible|5|||
145507095|NCT00470275|524715101|FG000|Overall Study|Death|1|||
145507096|NCT00470275|524715101|FG000|Overall Study|Lack of Efficacy|7|||
145507097|NCT00470275|524715101|FG000|Overall Study|Withdrawal by Subject|2|||
145507098|NCT03048578|524715102|FG000|Overall Study|Withdrawal by Subject|5|||
145507099|NCT03048578|524715103|FG001|Overall Study|Withdrawal by Subject|6|||
145507100|NCT03048578|524715102|FG000|Overall Study|Lost to Follow-up|22|||
145507101|NCT03048578|524715103|FG001|Overall Study|Lost to Follow-up|10|||
145507102|NCT03048578|524715102|FG000|Overall Study|Adverse Event|1|||
145507103|NCT03048578|524715103|FG001|Overall Study|Adverse Event|2|||
145507104|NCT03048578|524715102|FG000|Overall Study|Terminated|3|||
145507105|NCT03048578|524715103|FG001|Overall Study|Terminated|2|||
145507106|NCT00526071|524715104|FG000|Overall Study|Adverse Event|1|||
145507107|NCT00526071|524715104|FG000|Overall Study|Withdrawal by Subject|1|||
145507108|NCT00526071|524715104|FG000|Overall Study|Lack of Response to Study Drug|4|||
145507109|NCT04995419|524715105|FG000|Overall Study|Withdrawal by Subject|3|||
145507110|NCT04995419|524715105|FG000|Overall Study|Progressive Disease|19|||
145507111|NCT04995419|524715105|FG000|Overall Study|Adverse Event|2|||
145507112|NCT04995419|524715105|FG000|Overall Study|Ongoing|16|||
145507113|NCT00573144|524715108|FG000|Overall Study|Withdrawal by Subject|2|||
145507114|NCT00573144|524715109|FG001|Overall Study|Withdrawal by Subject|3|||
145507115|NCT00125164|524715110|FG000|Overall Study|Adverse Event|0|||
145507116|NCT00125164|524715111|FG001|Overall Study|Adverse Event|0|||
145507117|NCT00125164|524715112|FG002|Overall Study|Adverse Event|2|||
145507118|NCT00125164|524715113|FG003|Overall Study|Adverse Event|4|||
145507119|NCT00125164|524715110|FG000|Overall Study|Lost to Follow-up|0|||
145507120|NCT00125164|524715111|FG001|Overall Study|Lost to Follow-up|0|||
145507121|NCT00125164|524715112|FG002|Overall Study|Lost to Follow-up|1|||
145507122|NCT00125164|524715113|FG003|Overall Study|Lost to Follow-up|1|||
145507123|NCT00125164|524715110|FG000|Overall Study|Withdrawal by Subject|2|||
145507124|NCT00125164|524715111|FG001|Overall Study|Withdrawal by Subject|0|||
145507125|NCT00125164|524715112|FG002|Overall Study|Withdrawal by Subject|1|||
145507126|NCT00125164|524715113|FG003|Overall Study|Withdrawal by Subject|1|||
145507127|NCT04939415|524715120|FG000|Overall Study|Withdrawal by Subject|1|||
145507128|NCT04939415|524715121|FG001|Overall Study|Withdrawal by Subject|3|||
145507129|NCT04939415|524715120|FG000|Overall Study|Lost to Follow-up|0|||
145507130|NCT04939415|524715121|FG001|Overall Study|Lost to Follow-up|2|||
145507131|NCT04308291|524715122|FG000|Run-In Phase|Withdrawal by Subject|4|||
145507132|NCT04308291|524715122|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
145507133|NCT04308291|524715122|FG000|Study Phase 6-M|Physician Decision|2|||
145507134|NCT04308291|524715122|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
145507135|NCT04308291|524715122|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
145507136|NCT04308291|524715122|FG000|Study Phase 12-M|Physician Decision|2|||
145507137|NCT04308291|524715122|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
145507138|NCT03610269|524715124|FG000|Overall Study|Physician Decision|10|||
145507139|NCT03610269|524715124|FG000|Overall Study|Protocol Violation|1|||
145507140|NCT03610269|524715124|FG000|Overall Study|Unable to draw blood|1|||
145507141|NCT03610269|524715124|FG000|Overall Study|Screen fail|4|||
145507142|NCT00067002|524715127|FG000|Overall Study|Early Death|1|||
145507143|NCT00067002|524715128|FG001|Overall Study|Early Death|2|||
145507144|NCT00067002|524715127|FG000|Overall Study|Delayed|1|||
145507145|NCT00067002|524715128|FG001|Overall Study|Delayed|1|||
145507146|NCT00067002|524715127|FG000|Overall Study|Graft Failure|5|||
145507147|NCT00067002|524715128|FG001|Overall Study|Graft Failure|6|||
145507148|NCT01354314|524715129|FG000|Overall Study|Lost to Follow-up|1|||
145507149|NCT01354314|524715130|FG001|Overall Study|Lost to Follow-up|0|||
145507150|NCT01354314|524715131|FG002|Overall Study|Lost to Follow-up|1|||
145507151|NCT01354314|524715132|FG003|Overall Study|Lost to Follow-up|1|||
145507152|NCT01354314|524715129|FG000|Overall Study|Withdrawal by Subject|0|||
145507153|NCT01354314|524715130|FG001|Overall Study|Withdrawal by Subject|0|||
145507154|NCT01354314|524715131|FG002|Overall Study|Withdrawal by Subject|1|||
145507155|NCT01354314|524715132|FG003|Overall Study|Withdrawal by Subject|0|||
145507156|NCT01354314|524715129|FG000|Overall Study|Adverse Event|0|||
145507157|NCT01354314|524715130|FG001|Overall Study|Adverse Event|0|||
145507158|NCT01354314|524715131|FG002|Overall Study|Adverse Event|0|||
145507159|NCT01354314|524715132|FG003|Overall Study|Adverse Event|1|||
145507160|NCT01354314|524715129|FG000|Overall Study|Protocol Violation|1|||
145507161|NCT01354314|524715130|FG001|Overall Study|Protocol Violation|1|||
145507162|NCT01354314|524715131|FG002|Overall Study|Protocol Violation|0|||
145507163|NCT01354314|524715132|FG003|Overall Study|Protocol Violation|0|||
145507164|NCT01354314|524715129|FG000|Overall Study|Less than 90% Adherence|4|||
145507165|NCT01354314|524715130|FG001|Overall Study|Less than 90% Adherence|2|||
145507166|NCT01354314|524715131|FG002|Overall Study|Less than 90% Adherence|6|||
145507167|NCT01354314|524715132|FG003|Overall Study|Less than 90% Adherence|4|||
145507168|NCT00478023|524715133|FG000|Overall Study|Adverse Event|11|||
145507169|NCT00478023|524715134|FG001|Overall Study|Adverse Event|7|||
145507170|NCT00478023|524715135|FG002|Overall Study|Adverse Event|8|||
145507171|NCT00478023|524715136|FG003|Overall Study|Adverse Event|14|||
145507172|NCT00478023|524715137|FG004|Overall Study|Adverse Event|6|||
145507173|NCT00478023|524715133|FG000|Overall Study|Death|1|||
145507174|NCT00478023|524715134|FG001|Overall Study|Death|0|||
145507175|NCT00478023|524715135|FG002|Overall Study|Death|0|||
145507176|NCT00478023|524715136|FG003|Overall Study|Death|0|||
145507177|NCT00478023|524715137|FG004|Overall Study|Death|0|||
145507178|NCT00478023|524715133|FG000|Overall Study|Lack of Efficacy|11|||
145507179|NCT00478023|524715134|FG001|Overall Study|Lack of Efficacy|10|||
145507180|NCT00478023|524715135|FG002|Overall Study|Lack of Efficacy|4|||
145507181|NCT00478023|524715136|FG003|Overall Study|Lack of Efficacy|5|||
145507182|NCT00478023|524715137|FG004|Overall Study|Lack of Efficacy|41|||
145507183|NCT00478023|524715133|FG000|Overall Study|Lost to Follow-up|3|||
145507184|NCT00478023|524715134|FG001|Overall Study|Lost to Follow-up|1|||
145507185|NCT00478023|524715135|FG002|Overall Study|Lost to Follow-up|1|||
145507186|NCT00478023|524715136|FG003|Overall Study|Lost to Follow-up|1|||
145507187|NCT00478023|524715137|FG004|Overall Study|Lost to Follow-up|0|||
145507188|NCT00478023|524715133|FG000|Overall Study|Withdrawal by Subject|2|||
145507189|NCT00478023|524715134|FG001|Overall Study|Withdrawal by Subject|3|||
145507190|NCT00478023|524715135|FG002|Overall Study|Withdrawal by Subject|2|||
145507191|NCT00478023|524715136|FG003|Overall Study|Withdrawal by Subject|4|||
145507192|NCT00478023|524715137|FG004|Overall Study|Withdrawal by Subject|5|||
145507193|NCT00478023|524715133|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
145507194|NCT00478023|524715134|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
145507195|NCT00478023|524715135|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
145507196|NCT00478023|524715136|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
145507197|NCT00478023|524715137|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
145507198|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
145507199|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
145507200|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
145507201|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
145507202|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507203|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507204|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507205|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
145507206|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
145507207|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507208|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
145507209|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507210|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507211|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507212|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
145507213|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
145507214|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
145507215|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
145507216|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507217|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507218|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507219|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
145507220|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
145507221|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
145507222|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
145507223|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
145507224|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
145507225|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
145507226|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
145507227|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
145507228|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
145507229|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
145507230|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
145507231|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
145507232|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
145507233|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
145507234|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507235|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507236|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507237|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145401089|NCT00720499|524324801|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145401090|NCT00720499|524324800|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
145401091|NCT00720499|524324801|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
145401092|NCT00720499|524324800|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
145401093|NCT00720499|524324801|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
145401094|NCT01618968|524324802|FG000|Overall Study|Adverse Event|1|||
145401095|NCT01618968|524324803|FG001|Overall Study|Adverse Event|0|||
145401096|NCT01618968|524324804|FG002|Overall Study|Adverse Event|0|||
145401097|NCT01618968|524324805|FG003|Overall Study|Adverse Event|0|||
145401098|NCT01618968|524324802|FG000|Overall Study|Death|0|||
145401099|NCT01618968|524324803|FG001|Overall Study|Death|0|||
145401100|NCT01618968|524324804|FG002|Overall Study|Death|0|||
145401101|NCT01618968|524324805|FG003|Overall Study|Death|1|||
145401102|NCT03087058|524324811|FG000|Overall Study|Withdrawal by Subject|2|||
145401103|NCT03087058|524324812|FG001|Overall Study|Withdrawal by Subject|0|||
145401104|NCT03087058|524324813|FG002|Overall Study|Withdrawal by Subject|0|||
145401105|NCT01441973|524324818|FG000|Overall Study|Disease progression|8|||
145401106|NCT01441973|524324819|FG001|Overall Study|Disease progression|6|||
145401107|NCT01441973|524324818|FG000|Overall Study|Adverse event unrelated to study drug|3|||
145401108|NCT01441973|524324819|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145401109|NCT01441973|524324818|FG000|Overall Study|Participant request to discontinue|1|||
145401110|NCT01441973|524324819|FG001|Overall Study|Participant request to discontinue|1|||
145401111|NCT01441973|524324818|FG000|Overall Study|Poor compliance/noncompliance|0|||
145401112|NCT01441973|524324819|FG001|Overall Study|Poor compliance/noncompliance|1|||
145401113|NCT01441973|524324818|FG000|Overall Study|Administrative reason by sponsor|3|||
145401114|NCT01441973|524324819|FG001|Overall Study|Administrative reason by sponsor|5|||
145401115|NCT01441973|524324818|FG000|Overall Study|Participant withdrew consent|0|||
145401116|NCT01441973|524324819|FG001|Overall Study|Participant withdrew consent|1|||
145401117|NCT04356937|524324820|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
145401118|NCT04356937|524324821|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
145401119|NCT03312738|524326415|FG000|Overall Study|Progressive disease|58|||
145401120|NCT03312738|524326416|FG001|Overall Study|Progressive disease|67|||
145401121|NCT03312738|524326415|FG000|Overall Study|Patient/guardian decision|13|||
145401122|NCT03312738|524326416|FG001|Overall Study|Patient/guardian decision|5|||
145401123|NCT03312738|524326415|FG000|Overall Study|Adverse Event|5|||
145401124|NCT03312738|524326416|FG001|Overall Study|Adverse Event|3|||
145401125|NCT03312738|524326415|FG000|Overall Study|Protocol deviation|2|||
145401126|NCT03312738|524326416|FG001|Overall Study|Protocol deviation|0|||
145401127|NCT03312738|524326415|FG000|Overall Study|Technical problems|0|||
145401128|NCT03312738|524326416|FG001|Overall Study|Technical problems|1|||
145401129|NCT03312738|524326415|FG000|Overall Study|Physician Decision|2|||
145401130|NCT03312738|524326416|FG001|Overall Study|Physician Decision|3|||
145401131|NCT02466399|524326420|FG000|Overall Study|Adverse Event|1|||
145401132|NCT02466399|524326421|FG001|Overall Study|Adverse Event|0|||
145401133|NCT02466399|524326420|FG000|Overall Study|Early exit due to family emergency|1|||
145401134|NCT02466399|524326421|FG001|Overall Study|Early exit due to family emergency|0|||
145401135|NCT00607893|524326422|FG000|Overall Study|Lost to Follow-up|4|||
145401136|NCT00607893|524326423|FG001|Overall Study|Lost to Follow-up|0|||
145401137|NCT00607893|524326422|FG000|Overall Study|withdrew due to loss of interest|0|||
145401138|NCT00607893|524326423|FG001|Overall Study|withdrew due to loss of interest|1|||
145401139|NCT00607893|524326422|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
145401140|NCT00607893|524326423|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
145401141|NCT00607893|524326422|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
145401142|NCT00607893|524326423|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
145401143|NCT00607893|524326422|FG000|Overall Study|Declined to be treated|1|||
145401144|NCT00607893|524326423|FG001|Overall Study|Declined to be treated|0|||
145401145|NCT00607893|524326422|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
145401146|NCT00607893|524326423|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
145401147|NCT02014272|524326426|FG000|Intervention Period 1|Withdrawal by Subject|1|||
145401148|NCT02014272|524326427|FG001|Intervention Period 1|Withdrawal by Subject|0|||
145401149|NCT02014272|524326426|FG000|Intervention Period 1|Adverse Event|0|||
145401150|NCT02014272|524326427|FG001|Intervention Period 1|Adverse Event|1|||
145401151|NCT00958074|524326428|FG000|Overall Study|Withdrawal by Subject|0|||
145401152|NCT00958074|524326429|FG001|Overall Study|Withdrawal by Subject|1|||
145401153|NCT03712280|524326432|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
145401154|NCT03712280|524326433|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
145401155|NCT03712280|524326434|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
145401156|NCT03712280|524326435|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
145401157|NCT03712280|524326432|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
145401158|NCT03712280|524326433|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
145401159|NCT03712280|524326434|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
145401160|NCT03712280|524326435|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
145401161|NCT03712280|524326432|FG000|Overall Study|Adverse Event|0|||
145507238|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507239|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507240|NCT05019521|524715141|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
145507241|NCT05019521|524715142|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507242|NCT05019521|524715143|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
145507243|NCT05019521|524715144|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
145507244|NCT05019521|524715145|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507245|NCT05019521|524715146|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507246|NCT05019521|524715147|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507247|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
145507248|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
145507249|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
145507250|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507251|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507252|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
145507253|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
145507254|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
145507255|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
145507256|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
145507257|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507258|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507259|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
145507260|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
145507261|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
145507262|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507263|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507264|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
145507265|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
145507266|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
145507267|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
145507268|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
145507269|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
145507270|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
145507271|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
145507272|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
145507273|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
145507274|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
145507275|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
145507276|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
145507277|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
145507278|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
145507279|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
145507280|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
145507281|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
145507282|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507283|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507284|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507285|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507286|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507287|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
145507288|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
145507289|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
145507290|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
145507291|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
145507292|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507293|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507294|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
145507295|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
145507296|NCT05019521|524715141|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
145507297|NCT05019521|524715142|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
145732941|NCT03872453|525540858|FG003|Overall Study|Withdrawal by Subject|0|||
145732942|NCT03872453|525540855|FG000|Overall Study|Other Than Specified|1|||
145507298|NCT05019521|524715143|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
145507299|NCT05019521|524715144|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
145507300|NCT05019521|524715145|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
145507301|NCT05019521|524715146|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
145507302|NCT05019521|524715147|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
145507303|NCT02453711|524715148|FG000|Overall Study|Withdrawal by Subject|5|||
145507304|NCT02453711|524715149|FG001|Overall Study|Withdrawal by Subject|4|||
145507305|NCT02453711|524715150|FG002|Overall Study|Withdrawal by Subject|6|||
145507306|NCT02453711|524715151|FG003|Overall Study|Withdrawal by Subject|4|||
145507307|NCT02453711|524715152|FG004|Overall Study|Withdrawal by Subject|1|||
145507308|NCT02453711|524715153|FG005|Overall Study|Withdrawal by Subject|1|||
145507309|NCT02453711|524715154|FG006|Overall Study|Withdrawal by Subject|0|||
145507310|NCT02453711|524715155|FG007|Overall Study|Withdrawal by Subject|1|||
145507311|NCT02453711|524715156|FG008|Overall Study|Withdrawal by Subject|7|||
145507312|NCT02453711|524715148|FG000|Overall Study|Lost to Follow-up|5|||
145507313|NCT02453711|524715149|FG001|Overall Study|Lost to Follow-up|3|||
145507314|NCT02453711|524715150|FG002|Overall Study|Lost to Follow-up|2|||
145507315|NCT02453711|524715151|FG003|Overall Study|Lost to Follow-up|3|||
145507316|NCT02453711|524715152|FG004|Overall Study|Lost to Follow-up|1|||
145507317|NCT02453711|524715153|FG005|Overall Study|Lost to Follow-up|5|||
145507318|NCT02453711|524715154|FG006|Overall Study|Lost to Follow-up|2|||
145507319|NCT02453711|524715155|FG007|Overall Study|Lost to Follow-up|6|||
145507320|NCT02453711|524715156|FG008|Overall Study|Lost to Follow-up|6|||
145507321|NCT02453711|524715148|FG000|Overall Study|Death|0|||
145507322|NCT02453711|524715149|FG001|Overall Study|Death|0|||
145507323|NCT02453711|524715150|FG002|Overall Study|Death|0|||
145507324|NCT02453711|524715151|FG003|Overall Study|Death|0|||
145507325|NCT02453711|524715152|FG004|Overall Study|Death|0|||
145507326|NCT02453711|524715153|FG005|Overall Study|Death|0|||
145507327|NCT02453711|524715154|FG006|Overall Study|Death|1|||
145507328|NCT02453711|524715155|FG007|Overall Study|Death|0|||
145507329|NCT02453711|524715156|FG008|Overall Study|Death|0|||
145507330|NCT02453711|524715148|FG000|Overall Study|Unclassified|1|||
145507331|NCT02453711|524715149|FG001|Overall Study|Unclassified|0|||
145507332|NCT02453711|524715150|FG002|Overall Study|Unclassified|1|||
145507333|NCT02453711|524715151|FG003|Overall Study|Unclassified|0|||
145507334|NCT02453711|524715152|FG004|Overall Study|Unclassified|0|||
145507335|NCT02453711|524715153|FG005|Overall Study|Unclassified|0|||
145507336|NCT02453711|524715154|FG006|Overall Study|Unclassified|0|||
145507337|NCT02453711|524715155|FG007|Overall Study|Unclassified|0|||
145507338|NCT02453711|524715156|FG008|Overall Study|Unclassified|0|||
145507339|NCT03695367|524715158|FG000|Overall Study|Missed the Day 28 visit.|1|||
145507340|NCT03695367|524715159|FG001|Overall Study|Missed the Day 28 visit.|0|||
145507341|NCT03695367|524715158|FG000|Overall Study|Lost to Follow-up|0|||
145507342|NCT03695367|524715159|FG001|Overall Study|Lost to Follow-up|1|||
145507343|NCT03695367|524715158|FG000|Overall Study|Withdrawal by Subject|0|||
145507344|NCT03695367|524715159|FG001|Overall Study|Withdrawal by Subject|1|||
145507345|NCT03695367|524715158|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
145507346|NCT03695367|524715159|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
145507347|NCT00068419|524715160|FG000|Overall Study|Adverse Event|3|||
145507348|NCT00068419|524715160|FG000|Overall Study|Lack of Efficacy|24|||
145507349|NCT00068419|524715160|FG000|Overall Study|Lost to Follow-up|1|||
145507350|NCT00068419|524715160|FG000|Overall Study|Physician Decision|7|||
145507351|NCT00068419|524715160|FG000|Overall Study|Withdrawal by Subject|14|||
145507352|NCT00068419|524715160|FG000|Overall Study|Ineligible|11|||
145507353|NCT00396253|524715171|FG000|Overall Study|Protocol Violation|1|||
145507354|NCT00396253|524715171|FG000|Overall Study|Withdrawal by Subject|7|||
145507355|NCT00396253|524715171|FG000|Overall Study|Death|3|||
145507356|NCT00396253|524715171|FG000|Overall Study|Physician Decision|1|||
145507357|NCT00396253|524715171|FG000|Overall Study|Change in eligibility status|1|||
145507358|NCT04672655|524715182|FG000|Overall Study|Lost to Follow-up|12|||
145507359|NCT04672655|524715183|FG001|Overall Study|Lost to Follow-up|17|||
145507360|NCT04672655|524715182|FG000|Overall Study|Withdrawal by Subject|1|||
145507361|NCT04672655|524715183|FG001|Overall Study|Withdrawal by Subject|0|||
145507362|NCT04672655|524715182|FG000|Overall Study|Withdrawal by Study|1|||
145507363|NCT04672655|524715183|FG001|Overall Study|Withdrawal by Study|0|||
145507364|NCT01077050|524716886|FG000|Overall Study|Subjects signed ICF could not be located|1|||
145507365|NCT01077050|524716886|FG000|Overall Study|Screen failure|8|||
145507366|NCT01006291|524716892|FG000|Overall Study|Adverse Event|2|||
145507367|NCT01006291|524716893|FG001|Overall Study|Adverse Event|1|||
145507368|NCT01006291|524716894|FG002|Overall Study|Adverse Event|2|||
145507369|NCT01006291|524716892|FG000|Overall Study|Lack of Efficacy|2|||
145507370|NCT01006291|524716893|FG001|Overall Study|Lack of Efficacy|2|||
145507371|NCT01006291|524716894|FG002|Overall Study|Lack of Efficacy|1|||
145507372|NCT01006291|524716892|FG000|Overall Study|Protocol Violation|3|||
145507373|NCT01006291|524716893|FG001|Overall Study|Protocol Violation|3|||
145507374|NCT01006291|524716894|FG002|Overall Study|Protocol Violation|3|||
145507375|NCT01006291|524716892|FG000|Overall Study|Withdrawal criteria|5|||
145507376|NCT01006291|524716893|FG001|Overall Study|Withdrawal criteria|4|||
145507377|NCT01006291|524716894|FG002|Overall Study|Withdrawal criteria|4|||
145507378|NCT01006291|524716892|FG000|Overall Study|Other|14|||
145507379|NCT01006291|524716893|FG001|Overall Study|Other|14|||
145507380|NCT01006291|524716894|FG002|Overall Study|Other|17|||
145507381|NCT00684060|524716895|FG000|Overall Study|Lost to Follow-up|1|||
145507382|NCT00684060|524716896|FG001|Overall Study|Lost to Follow-up|0|||
145507383|NCT00684060|524716895|FG000|Overall Study|New stenosis identified|1|||
145507384|NCT00684060|524716896|FG001|Overall Study|New stenosis identified|0|||
145507385|NCT00684060|524716895|FG000|Overall Study|Unable to collect MRI|1|||
145507386|NCT00684060|524716896|FG001|Overall Study|Unable to collect MRI|2|||
145507387|NCT00684060|524716895|FG000|Overall Study|Death|0|||
145507388|NCT00684060|524716896|FG001|Overall Study|Death|1|||
145507389|NCT00702715|524716901|FG000|Overall Study|Lost to Follow-up|1|||
145507390|NCT00702715|524716902|FG001|Overall Study|Lost to Follow-up|0|||
145507391|NCT01865552|524716903|FG000|Period 1|Adverse Event|1|||
145507392|NCT01865552|524716904|FG001|Period 1|Adverse Event|0|||
145507393|NCT01865552|524716905|FG002|Period 1|Adverse Event|0|||
145507394|NCT01865552|524716906|FG003|Period 1|Adverse Event|1|||
145507395|NCT01865552|524716907|FG004|Period 1|Adverse Event|1|||
145507396|NCT01865552|524716908|FG005|Period 1|Adverse Event|1|||
145507397|NCT01865552|524716903|FG000|Period 1|Pathological lab|0|||
145507398|NCT01865552|524716904|FG001|Period 1|Pathological lab|0|||
145507399|NCT01865552|524716905|FG002|Period 1|Pathological lab|0|||
145401162|NCT03712280|524326433|FG001|Overall Study|Adverse Event|0|||
145401163|NCT03712280|524326434|FG002|Overall Study|Adverse Event|1|||
145401164|NCT03712280|524326435|FG003|Overall Study|Adverse Event|0|||
145401165|NCT03530293|524326439|FG000|Pre-randomization|Adverse Event|12|||
145401166|NCT03530293|524326440|FG001|Pre-randomization|Adverse Event|0|||
145401167|NCT03530293|524326441|FG002|Pre-randomization|Adverse Event|0|||
145401168|NCT03530293|524326439|FG000|Pre-randomization|Protocol Violation|2|||
145401169|NCT03530293|524326440|FG001|Pre-randomization|Protocol Violation|0|||
145401170|NCT03530293|524326441|FG002|Pre-randomization|Protocol Violation|0|||
145401171|NCT03530293|524326439|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
145401172|NCT03530293|524326440|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
145401173|NCT03530293|524326441|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
145401174|NCT03530293|524326439|FG000|Pre-randomization|Withdrawal by Subject|5|||
145401175|NCT03530293|524326440|FG001|Pre-randomization|Withdrawal by Subject|0|||
145401176|NCT03530293|524326441|FG002|Pre-randomization|Withdrawal by Subject|0|||
145401177|NCT03530293|524326439|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
145401178|NCT03530293|524326440|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
145401179|NCT03530293|524326441|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
145401180|NCT03530293|524326439|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
145401181|NCT03530293|524326440|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
145401182|NCT03530293|524326441|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
145401183|NCT03530293|524326439|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
145401184|NCT03530293|524326440|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
145401185|NCT03530293|524326441|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
145401186|NCT03530293|524326439|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
145401187|NCT03530293|524326440|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
145401188|NCT03530293|524326441|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
145401189|NCT03530293|524326439|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
145401190|NCT03530293|524326440|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
145401191|NCT03530293|524326441|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
145401192|NCT01663623|524326442|FG000|Overall Study|Adverse Event|3|||
145401193|NCT01663623|524326443|FG001|Overall Study|Adverse Event|7|||
145401194|NCT01663623|524326442|FG000|Overall Study|Lack of Efficacy|5|||
145401195|NCT01663623|524326443|FG001|Overall Study|Lack of Efficacy|6|||
145401196|NCT01663623|524326442|FG000|Overall Study|Protocol Violation|0|||
145401197|NCT01663623|524326443|FG001|Overall Study|Protocol Violation|1|||
145401198|NCT01663623|524326442|FG000|Overall Study|Other-Study closed/terminated|1|||
145401199|NCT01663623|524326443|FG001|Overall Study|Other-Study closed/terminated|1|||
145401200|NCT01663623|524326442|FG000|Overall Study|Physician Decision|1|||
145401201|NCT01663623|524326443|FG001|Overall Study|Physician Decision|4|||
145401202|NCT01663623|524326442|FG000|Overall Study|Withdrawal by Subject|2|||
145507400|NCT01865552|524716906|FG003|Period 1|Pathological lab|0|||
145507401|NCT01865552|524716907|FG004|Period 1|Pathological lab|1|||
145507402|NCT01865552|524716908|FG005|Period 1|Pathological lab|0|||
145507403|NCT01865552|524716903|FG000|Period 1|Other|0|||
145507404|NCT01865552|524716904|FG001|Period 1|Other|0|||
145507405|NCT01865552|524716905|FG002|Period 1|Other|0|||
145507406|NCT01865552|524716906|FG003|Period 1|Other|0|||
145507407|NCT01865552|524716907|FG004|Period 1|Other|1|||
145507408|NCT01865552|524716908|FG005|Period 1|Other|0|||
145507409|NCT03079102|524716911|FG000|Overall Study|Physician Decision|0|||
145507410|NCT03079102|524716912|FG001|Overall Study|Physician Decision|1|||
145507411|NCT02923921|524716913|FG000|Overall Study|Sponsor Decision|39|||
145507412|NCT02923921|524716914|FG001|Overall Study|Sponsor Decision|38|||
145507413|NCT02923921|524716913|FG000|Overall Study|Lost to Follow-up|1|||
145507414|NCT02923921|524716914|FG001|Overall Study|Lost to Follow-up|0|||
145507415|NCT02923921|524716913|FG000|Overall Study|Withdrawal by Subject|6|||
145507416|NCT02923921|524716914|FG001|Overall Study|Withdrawal by Subject|13|||
145507417|NCT02923921|524716913|FG000|Overall Study|Unknown, Not Collected|7|||
145507418|NCT02923921|524716914|FG001|Overall Study|Unknown, Not Collected|6|||
145507419|NCT00854113|524716915|FG000|Overall Study|Adverse Event|0|||
145507420|NCT00854113|524716916|FG001|Overall Study|Adverse Event|0|||
145507421|NCT00854113|524716917|FG002|Overall Study|Adverse Event|0|||
145507422|NCT00854113|524716918|FG003|Overall Study|Adverse Event|0|||
145507423|NCT00854113|524716919|FG004|Overall Study|Adverse Event|0|||
145507424|NCT00854113|524716920|FG005|Overall Study|Adverse Event|0|||
145507425|NCT00854113|524716921|FG006|Overall Study|Adverse Event|0|||
145401203|NCT01663623|524326443|FG001|Overall Study|Withdrawal by Subject|1|||
145401204|NCT02152007|524326444|FG000|Overall Study|Withdrawal by Subject|1|||
145401205|NCT05412134|524326445|FG000|Overall Study|Lost to Follow-up|2|||
145401206|NCT05412134|524326446|FG001|Overall Study|Lost to Follow-up|0|||
145401207|NCT01704261|524326447|FG000|Overall Study|Withdrawal by Subject|12|||
145401208|NCT01704261|524326448|FG001|Overall Study|Withdrawal by Subject|15|||
145401209|NCT01704261|524326447|FG000|Overall Study|Lost to Follow-up|1|||
145401210|NCT01704261|524326448|FG001|Overall Study|Lost to Follow-up|0|||
145401211|NCT00423046|524326449|FG000|Overall Study|Other|340|||
145401212|NCT00423046|524326450|FG001|Overall Study|Other|345|||
145401213|NCT02722967|524326451|FG000|Overall Study|Adverse Event|1|||
145401214|NCT02722967|524326452|FG001|Overall Study|Adverse Event|0|||
145401215|NCT02722967|524326453|FG002|Overall Study|Adverse Event|0|||
145401216|NCT02722967|524326451|FG000|Overall Study|Lost to Follow-up|0|||
145401217|NCT02722967|524326452|FG001|Overall Study|Lost to Follow-up|1|||
145401218|NCT02722967|524326453|FG002|Overall Study|Lost to Follow-up|0|||
145401219|NCT02722967|524326451|FG000|Overall Study|Non-compliance with patch wearing|2|||
145401220|NCT02722967|524326452|FG001|Overall Study|Non-compliance with patch wearing|1|||
145401221|NCT02722967|524326453|FG002|Overall Study|Non-compliance with patch wearing|1|||
145401222|NCT02722967|524326451|FG000|Overall Study|Withdrawal by Subject|1|||
145401223|NCT02722967|524326452|FG001|Overall Study|Withdrawal by Subject|0|||
145507426|NCT00854113|524716922|FG007|Overall Study|Adverse Event|2|||
145507427|NCT00854113|524716923|FG008|Overall Study|Adverse Event|0|||
145507428|NCT00854113|524716924|FG009|Overall Study|Adverse Event|0|||
145507429|NCT00854113|524716925|FG010|Overall Study|Adverse Event|0|||
145507430|NCT00854113|524716915|FG000|Overall Study|Withdrawal by Subject|0|||
145507431|NCT00854113|524716916|FG001|Overall Study|Withdrawal by Subject|0|||
145507432|NCT00854113|524716917|FG002|Overall Study|Withdrawal by Subject|0|||
145507433|NCT00854113|524716918|FG003|Overall Study|Withdrawal by Subject|0|||
145507434|NCT00854113|524716919|FG004|Overall Study|Withdrawal by Subject|0|||
145507435|NCT00854113|524716920|FG005|Overall Study|Withdrawal by Subject|0|||
145507436|NCT00854113|524716921|FG006|Overall Study|Withdrawal by Subject|0|||
145507437|NCT00854113|524716922|FG007|Overall Study|Withdrawal by Subject|1|||
145507438|NCT00854113|524716923|FG008|Overall Study|Withdrawal by Subject|1|||
145507439|NCT00854113|524716924|FG009|Overall Study|Withdrawal by Subject|0|||
145507440|NCT00854113|524716925|FG010|Overall Study|Withdrawal by Subject|0|||
145507441|NCT00796419|524716927|FG000|Overall Study|Death|0|||
145507442|NCT00796419|524716928|FG001|Overall Study|Death|1|||
145507443|NCT01250145|524716931|FG000|Overall Study|Adverse Event|2|||
145507444|NCT01250145|524716932|FG001|Overall Study|Adverse Event|1|||
145507445|NCT01250145|524716931|FG000|Overall Study|Withdrawal by Subject|0|||
145507446|NCT01250145|524716932|FG001|Overall Study|Withdrawal by Subject|4|||
145507447|NCT02840799|524716933|FG000|Phase 1|Physician Decision|1|||
145507448|NCT02840799|524716934|FG001|Phase 1|Physician Decision|3|||
145507449|NCT02840799|524716933|FG000|Phase 1|Withdrawal by Subject|4|||
145507450|NCT02840799|524716934|FG001|Phase 1|Withdrawal by Subject|0|||
145507451|NCT02840799|524716933|FG000|Phase 2 (Crossover)|Adverse Event|0|||
145507452|NCT02840799|524716934|FG001|Phase 2 (Crossover)|Adverse Event|1|||
145401224|NCT02722967|524326453|FG002|Overall Study|Withdrawal by Subject|1|||
145401225|NCT02722967|524326451|FG000|Overall Study|Physician Decision|1|||
145507453|NCT02840799|524716933|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
145507454|NCT02840799|524716934|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
145401226|NCT02722967|524326452|FG001|Overall Study|Physician Decision|0|||
145507455|NCT02565784|524716935|FG000|First Treatment|Adverse Event|1|||
145401227|NCT02722967|524326453|FG002|Overall Study|Physician Decision|0|||
145507456|NCT02565784|524716935|FG000|First Treatment|Withdrawal by Subject|1|||
145507457|NCT02565784|524716935|FG000|Second Treatment|Withdrawal by Subject|2|||
145507458|NCT02741518|524716937|FG000|Overall Study|Withdrawal by Subject|1|||
145507459|NCT02741518|524716938|FG001|Overall Study|Withdrawal by Subject|1|||
145507460|NCT01349049|524716941|FG000|Overall Study|Disease progression|3|||
145507461|NCT01349049|524716942|FG001|Overall Study|Disease progression|5|||
145507462|NCT01349049|524716943|FG002|Overall Study|Disease progression|3|||
145507463|NCT01349049|524716944|FG003|Overall Study|Disease progression|2|||
145401228|NCT02722967|524326451|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
145401229|NCT02722967|524326452|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
145507464|NCT01349049|524716945|FG004|Overall Study|Disease progression|2|||
145507465|NCT01349049|524716946|FG005|Overall Study|Disease progression|2|||
145507466|NCT01349049|524716947|FG006|Overall Study|Disease progression|3|||
145507467|NCT01349049|524716948|FG007|Overall Study|Disease progression|2|||
145507468|NCT01349049|524716949|FG008|Overall Study|Disease progression|33|||
145507469|NCT01349049|524716941|FG000|Overall Study|Adverse Event|0|||
145507470|NCT01349049|524716942|FG001|Overall Study|Adverse Event|1|||
145507471|NCT01349049|524716943|FG002|Overall Study|Adverse Event|0|||
145507472|NCT01349049|524716944|FG003|Overall Study|Adverse Event|0|||
145507473|NCT01349049|524716945|FG004|Overall Study|Adverse Event|0|||
145507474|NCT01349049|524716946|FG005|Overall Study|Adverse Event|3|||
145507475|NCT01349049|524716947|FG006|Overall Study|Adverse Event|1|||
145507476|NCT01349049|524716948|FG007|Overall Study|Adverse Event|0|||
145507477|NCT01349049|524716949|FG008|Overall Study|Adverse Event|4|||
145507478|NCT01349049|524716941|FG000|Overall Study|Physician Decision|0|||
145507479|NCT01349049|524716942|FG001|Overall Study|Physician Decision|1|||
145507480|NCT01349049|524716943|FG002|Overall Study|Physician Decision|0|||
145507481|NCT01349049|524716944|FG003|Overall Study|Physician Decision|0|||
145507482|NCT01349049|524716945|FG004|Overall Study|Physician Decision|0|||
145507483|NCT01349049|524716946|FG005|Overall Study|Physician Decision|0|||
145507484|NCT01349049|524716947|FG006|Overall Study|Physician Decision|0|||
145507485|NCT01349049|524716948|FG007|Overall Study|Physician Decision|0|||
145507486|NCT01349049|524716949|FG008|Overall Study|Physician Decision|2|||
145507487|NCT01349049|524716941|FG000|Overall Study|Protocol Violation|0|||
145507488|NCT01349049|524716942|FG001|Overall Study|Protocol Violation|0|||
145507489|NCT01349049|524716943|FG002|Overall Study|Protocol Violation|0|||
145507490|NCT01349049|524716944|FG003|Overall Study|Protocol Violation|0|||
145507491|NCT01349049|524716945|FG004|Overall Study|Protocol Violation|0|||
145507492|NCT01349049|524716946|FG005|Overall Study|Protocol Violation|0|||
145401230|NCT02722967|524326453|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
145401231|NCT02783911|524326457|FG000|Overall Study|Lost to Follow-up|3|||
145401232|NCT02783911|524326458|FG001|Overall Study|Lost to Follow-up|32|||
145401233|NCT01218802|524326462|FG000|Overall Study|Lost to Follow-up|5|||
145401234|NCT01218802|524326463|FG001|Overall Study|Lost to Follow-up|6|||
145401235|NCT01218802|524326462|FG000|Overall Study|Withdrawal by Subject|3|||
145401236|NCT01218802|524326463|FG001|Overall Study|Withdrawal by Subject|10|||
145401237|NCT01218802|524326462|FG000|Overall Study|Adverse Event|0|||
145401238|NCT01218802|524326463|FG001|Overall Study|Adverse Event|2|||
145401239|NCT01218802|524326462|FG000|Overall Study|Incarcerated|2|||
145401240|NCT01218802|524326463|FG001|Overall Study|Incarcerated|0|||
145401241|NCT01041859|524326469|FG000|Open-Label Titration|Adverse Event|69|||
145401242|NCT01041859|524326470|FG001|Open-Label Titration|Adverse Event|0|||
145401243|NCT01041859|524326471|FG002|Open-Label Titration|Adverse Event|0|||
145401244|NCT01041859|524326469|FG000|Open-Label Titration|Lack of Efficacy|3|||
145401245|NCT01041859|524326470|FG001|Open-Label Titration|Lack of Efficacy|0|||
145401246|NCT01041859|524326471|FG002|Open-Label Titration|Lack of Efficacy|0|||
145401247|NCT01041859|524326469|FG000|Open-Label Titration|Lost to Follow-up|1|||
145401248|NCT01041859|524326470|FG001|Open-Label Titration|Lost to Follow-up|0|||
145401249|NCT01041859|524326471|FG002|Open-Label Titration|Lost to Follow-up|0|||
145401250|NCT01041859|524326469|FG000|Open-Label Titration|Physician Decision|1|||
145401251|NCT01041859|524326470|FG001|Open-Label Titration|Physician Decision|0|||
145401252|NCT01041859|524326471|FG002|Open-Label Titration|Physician Decision|0|||
145401253|NCT01041859|524326469|FG000|Open-Label Titration|Protocol Violation|1|||
145401254|NCT01041859|524326470|FG001|Open-Label Titration|Protocol Violation|0|||
145401255|NCT01041859|524326471|FG002|Open-Label Titration|Protocol Violation|0|||
145401256|NCT01041859|524326469|FG000|Open-Label Titration|Other|7|||
145401257|NCT01041859|524326470|FG001|Open-Label Titration|Other|0|||
145401258|NCT01041859|524326471|FG002|Open-Label Titration|Other|0|||
145401259|NCT01041859|524326469|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
145401260|NCT01041859|524326470|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
145401261|NCT01041859|524326471|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
145401262|NCT01041859|524326469|FG000|Open-Label Titration|Withdrawal by Subject|11|||
145401263|NCT01041859|524326470|FG001|Open-Label Titration|Withdrawal by Subject|0|||
145401264|NCT01041859|524326471|FG002|Open-Label Titration|Withdrawal by Subject|0|||
145401265|NCT01041859|524326469|FG000|Double-Blind Maintenance|Adverse Event|0|||
145401266|NCT01041859|524326470|FG001|Double-Blind Maintenance|Adverse Event|23|||
145401267|NCT01041859|524326471|FG002|Double-Blind Maintenance|Adverse Event|13|||
145401268|NCT01041859|524326469|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
145401269|NCT01041859|524326470|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
145507493|NCT01349049|524716947|FG006|Overall Study|Protocol Violation|0|||
145507494|NCT01349049|524716948|FG007|Overall Study|Protocol Violation|0|||
145507495|NCT01349049|524716949|FG008|Overall Study|Protocol Violation|1|||
145507496|NCT01349049|524716941|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
145507497|NCT01349049|524716942|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
145507498|NCT01349049|524716943|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
145507499|NCT01349049|524716944|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
145507500|NCT01349049|524716945|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
145507501|NCT01349049|524716946|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
145507502|NCT01349049|524716947|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
145507503|NCT01349049|524716948|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
145507504|NCT01349049|524716949|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
145507505|NCT01349049|524716941|FG000|Overall Study|Other|0|||
145507506|NCT01349049|524716942|FG001|Overall Study|Other|0|||
145507507|NCT01349049|524716943|FG002|Overall Study|Other|0|||
145507508|NCT01349049|524716944|FG003|Overall Study|Other|0|||
145507509|NCT01349049|524716945|FG004|Overall Study|Other|0|||
145507510|NCT01349049|524716946|FG005|Overall Study|Other|1|||
145507511|NCT01349049|524716947|FG006|Overall Study|Other|0|||
145507512|NCT01349049|524716948|FG007|Overall Study|Other|0|||
145507513|NCT01349049|524716949|FG008|Overall Study|Other|4|||
145507514|NCT01349049|524716941|FG000|Overall Study|Death|0|||
145507515|NCT01349049|524716942|FG001|Overall Study|Death|0|||
145507516|NCT01349049|524716943|FG002|Overall Study|Death|0|||
145507517|NCT01349049|524716944|FG003|Overall Study|Death|0|||
145507518|NCT01349049|524716945|FG004|Overall Study|Death|0|||
145507519|NCT01349049|524716946|FG005|Overall Study|Death|0|||
145507520|NCT01349049|524716947|FG006|Overall Study|Death|0|||
145507521|NCT01349049|524716948|FG007|Overall Study|Death|1|||
145507522|NCT01349049|524716949|FG008|Overall Study|Death|5|||
145507523|NCT01349049|524716941|FG000|Overall Study|Non-compliance|0|||
145507524|NCT01349049|524716942|FG001|Overall Study|Non-compliance|0|||
145507525|NCT01349049|524716943|FG002|Overall Study|Non-compliance|0|||
145507526|NCT01349049|524716944|FG003|Overall Study|Non-compliance|1|||
145507527|NCT01349049|524716945|FG004|Overall Study|Non-compliance|0|||
145507528|NCT01349049|524716946|FG005|Overall Study|Non-compliance|0|||
145507529|NCT01349049|524716947|FG006|Overall Study|Non-compliance|0|||
145507530|NCT01349049|524716948|FG007|Overall Study|Non-compliance|0|||
145507531|NCT01349049|524716949|FG008|Overall Study|Non-compliance|0|||
145507532|NCT01349049|524716941|FG000|Overall Study|Withdrawal by Subject|0|||
145507533|NCT01349049|524716942|FG001|Overall Study|Withdrawal by Subject|0|||
145507534|NCT01349049|524716943|FG002|Overall Study|Withdrawal by Subject|0|||
145507535|NCT01349049|524716944|FG003|Overall Study|Withdrawal by Subject|0|||
145507536|NCT01349049|524716945|FG004|Overall Study|Withdrawal by Subject|0|||
145507537|NCT01349049|524716946|FG005|Overall Study|Withdrawal by Subject|0|||
145507538|NCT01349049|524716947|FG006|Overall Study|Withdrawal by Subject|0|||
145507539|NCT01349049|524716948|FG007|Overall Study|Withdrawal by Subject|0|||
145507540|NCT01349049|524716949|FG008|Overall Study|Withdrawal by Subject|6|||
145507541|NCT00552188|524716952|FG000|Overall Study|Adverse Event|0|||
145507542|NCT00552188|524716953|FG001|Overall Study|Adverse Event|2|||
145507543|NCT00552188|524716952|FG000|Overall Study|Lost to Follow-up|2|||
145507544|NCT00552188|524716953|FG001|Overall Study|Lost to Follow-up|1|||
145507545|NCT00552188|524716952|FG000|Overall Study|Withdrawal of consent|0|||
145507546|NCT00552188|524716953|FG001|Overall Study|Withdrawal of consent|1|||
145507547|NCT00552188|524716952|FG000|Overall Study|Subject returned to home country|0|||
145507548|NCT00552188|524716953|FG001|Overall Study|Subject returned to home country|1|||
145507549|NCT03887702|524716954|FG000|Overall Study|Study terminated|0|||
145507550|NCT03887702|524716955|FG001|Overall Study|Study terminated|0|||
145507551|NCT03887702|524716956|FG002|Overall Study|Study terminated|2|||
145507552|NCT03887702|524716957|FG003|Overall Study|Study terminated|2|||
145507553|NCT01193257|524716960|FG000|Overall Study|Death|202|||
145507554|NCT01193257|524716961|FG001|Overall Study|Death|391|||
145507555|NCT01193257|524716960|FG000|Overall Study|Study termination by sponsor|0|||
145507556|NCT01193257|524716961|FG001|Overall Study|Study termination by sponsor|3|||
145507557|NCT01193257|524716960|FG000|Overall Study|Withdrawal by Subject|26|||
145507558|NCT01193257|524716961|FG001|Overall Study|Withdrawal by Subject|86|||
145507559|NCT01193257|524716960|FG000|Overall Study|Lost to Follow-up|2|||
145507560|NCT01193257|524716961|FG001|Overall Study|Lost to Follow-up|3|||
145507561|NCT01193257|524716960|FG000|Overall Study|Unblinded due to futility|135|||
145507562|NCT01193257|524716961|FG001|Overall Study|Unblinded due to futility|251|||
145507563|NCT01675544|524716972|FG000|Overall Study|Withdrawal by Subject|2|||
145507564|NCT03544333|524716973|FG000|Overall Study|Withdrawal by Subject|1|||
145507565|NCT03544333|524716974|FG001|Overall Study|Withdrawal by Subject|0|||
145507566|NCT02813577|524716975|FG000|Overall Study|Study terminated|4|||
145507567|NCT01388335|524716976|FG000|Period 1|Progressive Disease|1|||
145507568|NCT01388335|524716976|FG000|Period 2|Progressive Disease|2|||
145507569|NCT01388335|524716976|FG000|Period 2|Sponsor Decision|1|||
145507570|NCT01388335|524716976|FG000|Safety Extension|Progressive Disease|7|||
145507571|NCT00885534|524716978|FG000|Overall Study|Patient deemed ineligible|1|||
145507572|NCT01032889|524716979|FG000|Overall Study|Adverse Event|2|||
145507573|NCT01032889|524716980|FG001|Overall Study|Adverse Event|2|||
145507574|NCT01032889|524716981|FG002|Overall Study|Adverse Event|0|||
145507575|NCT01032889|524716979|FG000|Overall Study|Withdrawal of Consent|1|||
145507576|NCT01032889|524716980|FG001|Overall Study|Withdrawal of Consent|2|||
145507577|NCT01032889|524716981|FG002|Overall Study|Withdrawal of Consent|1|||
145507578|NCT01032889|524716979|FG000|Overall Study|Patient Request|0|||
145507579|NCT01032889|524716980|FG001|Overall Study|Patient Request|1|||
145507580|NCT01032889|524716981|FG002|Overall Study|Patient Request|0|||
145507581|NCT01032889|524716979|FG000|Overall Study|Lost to Follow-up|1|||
145507582|NCT01032889|524716980|FG001|Overall Study|Lost to Follow-up|1|||
145507583|NCT01032889|524716981|FG002|Overall Study|Lost to Follow-up|0|||
145507584|NCT01032889|524716979|FG000|Overall Study|Lack of Submental Fat|2|||
145507585|NCT01032889|524716980|FG001|Overall Study|Lack of Submental Fat|8|||
145507586|NCT01032889|524716981|FG002|Overall Study|Lack of Submental Fat|1|||
145507587|NCT01032889|524716979|FG000|Overall Study|Miscellaneous Reasons|2|||
145507588|NCT01032889|524716980|FG001|Overall Study|Miscellaneous Reasons|1|||
145507589|NCT01032889|524716981|FG002|Overall Study|Miscellaneous Reasons|1|||
145507590|NCT01500720|524716983|FG000|Overall Study|Randomized But Not Treated|1|||
145507591|NCT01500720|524716984|FG001|Overall Study|Randomized But Not Treated|1|||
145507592|NCT01500720|524716983|FG000|Overall Study|Other|4|||
145507593|NCT01500720|524716984|FG001|Overall Study|Other|8|||
145507594|NCT00740857|524716985|FG000|Overall Study|Withdrawal by Subject|1|||
145507595|NCT00740857|524716986|FG001|Overall Study|Withdrawal by Subject|0|||
145507596|NCT00740857|524716987|FG002|Overall Study|Withdrawal by Subject|0|||
145507597|NCT03532451|524716988|FG000|Overall Study|Withdrawal by Subject|0|||
145507598|NCT03532451|524716989|FG001|Overall Study|Withdrawal by Subject|1|||
145507599|NCT03532451|524716988|FG000|Overall Study|Did not undergo surgery|1|||
145507600|NCT03532451|524716989|FG001|Overall Study|Did not undergo surgery|1|||
145507601|NCT02527421|524716990|FG000|Overall Study|Withdrawal by Subject|1|||
145507602|NCT02527421|524716991|FG001|Overall Study|Withdrawal by Subject|0|||
145507603|NCT02541604|524716992|FG000|Overall Study|Death|6|||
145507604|NCT02541604|524716993|FG001|Overall Study|Death|5|||
145507605|NCT02541604|524716994|FG002|Overall Study|Death|7|||
145507606|NCT02541604|524716995|FG003|Overall Study|Death|2|||
145507607|NCT02541604|524716996|FG004|Overall Study|Death|9|||
145507608|NCT02541604|524716997|FG005|Overall Study|Death|8|||
145507609|NCT02541604|524716998|FG006|Overall Study|Death|9|||
145507610|NCT02541604|524716999|FG007|Overall Study|Death|9|||
145507611|NCT02541604|524717000|FG008|Overall Study|Death|3|||
145507612|NCT02541604|524717001|FG009|Overall Study|Death|4|||
145507613|NCT02541604|524717002|FG010|Overall Study|Death|2|||
145507614|NCT02541604|524717003|FG011|Overall Study|Death|3|||
145507615|NCT02541604|524716992|FG000|Overall Study|Lost to Follow-up|2|||
145507616|NCT02541604|524716993|FG001|Overall Study|Lost to Follow-up|0|||
145507617|NCT02541604|524716994|FG002|Overall Study|Lost to Follow-up|1|||
145507618|NCT02541604|524716995|FG003|Overall Study|Lost to Follow-up|0|||
145507619|NCT02541604|524716996|FG004|Overall Study|Lost to Follow-up|0|||
145507620|NCT02541604|524716997|FG005|Overall Study|Lost to Follow-up|1|||
145507621|NCT02541604|524716998|FG006|Overall Study|Lost to Follow-up|1|||
145507622|NCT02541604|524716999|FG007|Overall Study|Lost to Follow-up|0|||
145507623|NCT02541604|524717000|FG008|Overall Study|Lost to Follow-up|0|||
145507624|NCT02541604|524717001|FG009|Overall Study|Lost to Follow-up|0|||
145507625|NCT02541604|524717002|FG010|Overall Study|Lost to Follow-up|0|||
145507626|NCT02541604|524717003|FG011|Overall Study|Lost to Follow-up|0|||
145507627|NCT02541604|524716992|FG000|Overall Study|Withdrawal by Subject|2|||
145507628|NCT02541604|524716993|FG001|Overall Study|Withdrawal by Subject|0|||
145507629|NCT02541604|524716994|FG002|Overall Study|Withdrawal by Subject|1|||
145507630|NCT02541604|524716995|FG003|Overall Study|Withdrawal by Subject|0|||
145507631|NCT02541604|524716996|FG004|Overall Study|Withdrawal by Subject|1|||
145507632|NCT02541604|524716997|FG005|Overall Study|Withdrawal by Subject|1|||
145507633|NCT02541604|524716998|FG006|Overall Study|Withdrawal by Subject|0|||
145507634|NCT02541604|524716999|FG007|Overall Study|Withdrawal by Subject|0|||
145507635|NCT02541604|524717000|FG008|Overall Study|Withdrawal by Subject|1|||
145507636|NCT02541604|524717001|FG009|Overall Study|Withdrawal by Subject|0|||
145507637|NCT02541604|524717002|FG010|Overall Study|Withdrawal by Subject|0|||
145507638|NCT02541604|524717003|FG011|Overall Study|Withdrawal by Subject|0|||
145507639|NCT02541604|524716992|FG000|Overall Study|Study Terminated by Sponsor|1|||
145507640|NCT02541604|524716993|FG001|Overall Study|Study Terminated by Sponsor|4|||
145507641|NCT02541604|524716994|FG002|Overall Study|Study Terminated by Sponsor|2|||
145507642|NCT02541604|524716995|FG003|Overall Study|Study Terminated by Sponsor|1|||
145507643|NCT02541604|524716996|FG004|Overall Study|Study Terminated by Sponsor|0|||
145507644|NCT02541604|524716997|FG005|Overall Study|Study Terminated by Sponsor|0|||
145507645|NCT02541604|524716998|FG006|Overall Study|Study Terminated by Sponsor|0|||
145507646|NCT02541604|524716999|FG007|Overall Study|Study Terminated by Sponsor|0|||
145507647|NCT02541604|524717000|FG008|Overall Study|Study Terminated by Sponsor|0|||
145507648|NCT02541604|524717001|FG009|Overall Study|Study Terminated by Sponsor|0|||
145507649|NCT02541604|524717002|FG010|Overall Study|Study Terminated by Sponsor|0|||
145507650|NCT02541604|524717003|FG011|Overall Study|Study Terminated by Sponsor|0|||
145507651|NCT02541604|524716992|FG000|Overall Study|Medical condition may jeopardize safety|0|||
145507652|NCT02541604|524716993|FG001|Overall Study|Medical condition may jeopardize safety|0|||
145507653|NCT02541604|524716994|FG002|Overall Study|Medical condition may jeopardize safety|0|||
145507654|NCT02541604|524716995|FG003|Overall Study|Medical condition may jeopardize safety|0|||
145507655|NCT02541604|524716996|FG004|Overall Study|Medical condition may jeopardize safety|0|||
145507656|NCT02541604|524716997|FG005|Overall Study|Medical condition may jeopardize safety|0|||
145507657|NCT02541604|524716998|FG006|Overall Study|Medical condition may jeopardize safety|0|||
145507658|NCT02541604|524716999|FG007|Overall Study|Medical condition may jeopardize safety|1|||
145507659|NCT02541604|524717000|FG008|Overall Study|Medical condition may jeopardize safety|0|||
145507660|NCT02541604|524717001|FG009|Overall Study|Medical condition may jeopardize safety|0|||
145507661|NCT02541604|524717002|FG010|Overall Study|Medical condition may jeopardize safety|0|||
145507662|NCT02541604|524717003|FG011|Overall Study|Medical condition may jeopardize safety|0|||
145507663|NCT01615029|524717004|FG000|Overall Study|Adverse Event|0|||
145507664|NCT01615029|524717005|FG001|Overall Study|Adverse Event|0|||
145507665|NCT01615029|524717006|FG002|Overall Study|Adverse Event|0|||
145507666|NCT01615029|524717007|FG003|Overall Study|Adverse Event|0|||
145507667|NCT01615029|524717008|FG004|Overall Study|Adverse Event|1|||
145507668|NCT01615029|524717004|FG000|Overall Study|Death|0|||
145507669|NCT01615029|524717005|FG001|Overall Study|Death|0|||
145507670|NCT01615029|524717006|FG002|Overall Study|Death|0|||
145507671|NCT01615029|524717007|FG003|Overall Study|Death|0|||
145507672|NCT01615029|524717008|FG004|Overall Study|Death|1|||
145507673|NCT01615029|524717004|FG000|Overall Study|Lost to Follow-up|0|||
145507674|NCT01615029|524717005|FG001|Overall Study|Lost to Follow-up|0|||
145507675|NCT01615029|524717006|FG002|Overall Study|Lost to Follow-up|0|||
145507676|NCT01615029|524717007|FG003|Overall Study|Lost to Follow-up|0|||
145507677|NCT01615029|524717008|FG004|Overall Study|Lost to Follow-up|1|||
145507678|NCT01615029|524717004|FG000|Overall Study|Progressive disease|2|||
145507679|NCT01615029|524717005|FG001|Overall Study|Progressive disease|1|||
145507680|NCT01615029|524717006|FG002|Overall Study|Progressive disease|1|||
145507681|NCT01615029|524717007|FG003|Overall Study|Progressive disease|1|||
145507682|NCT01615029|524717008|FG004|Overall Study|Progressive disease|5|||
145507683|NCT01615029|524717004|FG000|Overall Study|Physician Decision|0|||
145507684|NCT01615029|524717005|FG001|Overall Study|Physician Decision|0|||
145507685|NCT01615029|524717006|FG002|Overall Study|Physician Decision|0|||
145507686|NCT01615029|524717007|FG003|Overall Study|Physician Decision|0|||
145507687|NCT01615029|524717008|FG004|Overall Study|Physician Decision|1|||
145507688|NCT01615029|524717004|FG000|Overall Study|Ongoing|1|||
145507689|NCT01615029|524717005|FG001|Overall Study|Ongoing|2|||
145507690|NCT01615029|524717006|FG002|Overall Study|Ongoing|3|||
145507691|NCT01615029|524717007|FG003|Overall Study|Ongoing|2|||
145507692|NCT01615029|524717008|FG004|Overall Study|Ongoing|23|||
145507693|NCT05064358|524717009|FG000|Overall Study|Death|23|||
145507694|NCT05064358|524717010|FG001|Overall Study|Death|23|||
145507695|NCT05064358|524717011|FG002|Overall Study|Death|25|||
145507696|NCT05064358|524717012|FG003|Overall Study|Death|21|||
145507697|NCT05064358|524717013|FG004|Overall Study|Death|5|||
145507698|NCT05064358|524717009|FG000|Overall Study|Lost to Follow-up|1|||
145507699|NCT05064358|524717010|FG001|Overall Study|Lost to Follow-up|2|||
145507700|NCT05064358|524717011|FG002|Overall Study|Lost to Follow-up|0|||
145507701|NCT05064358|524717012|FG003|Overall Study|Lost to Follow-up|2|||
145507702|NCT05064358|524717013|FG004|Overall Study|Lost to Follow-up|0|||
145507703|NCT05064358|524717009|FG000|Overall Study|Physician Decision|1|||
145507704|NCT05064358|524717010|FG001|Overall Study|Physician Decision|1|||
145507705|NCT05064358|524717011|FG002|Overall Study|Physician Decision|2|||
145507706|NCT05064358|524717012|FG003|Overall Study|Physician Decision|0|||
145507707|NCT05064358|524717013|FG004|Overall Study|Physician Decision|0|||
145507708|NCT05064358|524717009|FG000|Overall Study|Withdrawal by Subject|4|||
145507709|NCT05064358|524717010|FG001|Overall Study|Withdrawal by Subject|5|||
145507710|NCT05064358|524717011|FG002|Overall Study|Withdrawal by Subject|3|||
145507711|NCT05064358|524717012|FG003|Overall Study|Withdrawal by Subject|6|||
145507712|NCT05064358|524717013|FG004|Overall Study|Withdrawal by Subject|3|||
145507713|NCT05064358|524717009|FG000|Overall Study|Ongoing at the time of analysis|1|||
145507714|NCT05064358|524717010|FG001|Overall Study|Ongoing at the time of analysis|2|||
145507715|NCT05064358|524717011|FG002|Overall Study|Ongoing at the time of analysis|2|||
145507716|NCT05064358|524717012|FG003|Overall Study|Ongoing at the time of analysis|2|||
145507717|NCT05064358|524717013|FG004|Overall Study|Ongoing at the time of analysis|2|||
145507718|NCT01287741|524717014|FG000|Overall Study|Withdrawal by Subject|35|||
145507719|NCT01287741|524717015|FG001|Overall Study|Withdrawal by Subject|38|||
145507720|NCT01287741|524717014|FG000|Overall Study|Protocol Violation|2|||
145507721|NCT01287741|524717015|FG001|Overall Study|Protocol Violation|0|||
145507722|NCT01287741|524717014|FG000|Overall Study|Physician Decision|15|||
145507723|NCT01287741|524717015|FG001|Overall Study|Physician Decision|23|||
145507724|NCT01287741|524717014|FG000|Overall Study|Non-compliance|8|||
145507725|NCT01287741|524717015|FG001|Overall Study|Non-compliance|6|||
145507726|NCT01287741|524717014|FG000|Overall Study|Lost to Follow-up|10|||
145507727|NCT01287741|524717015|FG001|Overall Study|Lost to Follow-up|8|||
145507728|NCT01287741|524717014|FG000|Overall Study|Death|32|||
145507729|NCT01287741|524717015|FG001|Overall Study|Death|44|||
145507730|NCT01287741|524717014|FG000|Overall Study|Adverse Event|4|||
145507731|NCT01287741|524717015|FG001|Overall Study|Adverse Event|6|||
145507732|NCT01287741|524717014|FG000|Overall Study|Study terminated by Sponsor|307|||
145507733|NCT01287741|524717015|FG001|Overall Study|Study terminated by Sponsor|315|||
145507734|NCT01287741|524717014|FG000|Overall Study|Progressive disease|190|||
145507735|NCT01287741|524717015|FG001|Overall Study|Progressive disease|166|||
145507736|NCT01287741|524717014|FG000|Overall Study|Reason not specified|23|||
145507737|NCT01287741|524717015|FG001|Overall Study|Reason not specified|9|||
145507738|NCT04421027|524717016|FG000|Treatment Period|Adverse Event|5|||
145507739|NCT04421027|524717017|FG001|Treatment Period|Adverse Event|3|||
145507740|NCT04421027|524717018|FG002|Treatment Period|Adverse Event|0|||
145507741|NCT04421027|524717019|FG003|Treatment Period|Adverse Event|0|||
145507742|NCT04421027|524717016|FG000|Treatment Period|Death|98|||
145507743|NCT04421027|524717017|FG001|Treatment Period|Death|61|||
145507744|NCT04421027|524717018|FG002|Treatment Period|Death|0|||
145507745|NCT04421027|524717019|FG003|Treatment Period|Death|0|||
145507746|NCT04421027|524717016|FG000|Treatment Period|Lost to Follow-up|22|||
145507747|NCT04421027|524717017|FG001|Treatment Period|Lost to Follow-up|20|||
145507748|NCT04421027|524717018|FG002|Treatment Period|Lost to Follow-up|0|||
145507749|NCT04421027|524717019|FG003|Treatment Period|Lost to Follow-up|0|||
145507750|NCT04421027|524717016|FG000|Treatment Period|Other-Unknown|15|||
145507751|NCT04421027|524717017|FG001|Treatment Period|Other-Unknown|9|||
145507752|NCT04421027|524717018|FG002|Treatment Period|Other-Unknown|0|||
145507753|NCT04421027|524717019|FG003|Treatment Period|Other-Unknown|0|||
145507754|NCT04421027|524717016|FG000|Treatment Period|Physician Decision|1|||
145507755|NCT04421027|524717017|FG001|Treatment Period|Physician Decision|1|||
145507756|NCT04421027|524717018|FG002|Treatment Period|Physician Decision|0|||
145507757|NCT04421027|524717019|FG003|Treatment Period|Physician Decision|0|||
145507758|NCT04421027|524717016|FG000|Treatment Period|Withdrawal by Subject|7|||
145507759|NCT04421027|524717017|FG001|Treatment Period|Withdrawal by Subject|12|||
145507760|NCT04421027|524717018|FG002|Treatment Period|Withdrawal by Subject|0|||
145507761|NCT04421027|524717019|FG003|Treatment Period|Withdrawal by Subject|0|||
145507762|NCT04421027|524717016|FG000|Treatment Period|Randomized Not Dosed|9|||
145507763|NCT04421027|524717017|FG001|Treatment Period|Randomized Not Dosed|14|||
145507764|NCT04421027|524717018|FG002|Treatment Period|Randomized Not Dosed|0|||
145507765|NCT04421027|524717019|FG003|Treatment Period|Randomized Not Dosed|0|||
145507766|NCT04421027|524717016|FG000|Follow-Up Period|Adverse Event|0|||
145507767|NCT04421027|524717017|FG001|Follow-Up Period|Adverse Event|0|||
145507768|NCT04421027|524717018|FG002|Follow-Up Period|Adverse Event|0|||
145507769|NCT04421027|524717019|FG003|Follow-Up Period|Adverse Event|3|||
145507770|NCT04421027|524717016|FG000|Follow-Up Period|Death|0|||
145507771|NCT04421027|524717017|FG001|Follow-Up Period|Death|0|||
145507772|NCT04421027|524717018|FG002|Follow-Up Period|Death|16|||
145507773|NCT04421027|524717019|FG003|Follow-Up Period|Death|17|||
145507774|NCT04421027|524717016|FG000|Follow-Up Period|Lost to Follow-up|0|||
145507775|NCT04421027|524717017|FG001|Follow-Up Period|Lost to Follow-up|0|||
145507776|NCT04421027|524717018|FG002|Follow-Up Period|Lost to Follow-up|7|||
145507777|NCT04421027|524717019|FG003|Follow-Up Period|Lost to Follow-up|7|||
145507778|NCT04421027|524717016|FG000|Follow-Up Period|Protocol Deviation|0|||
145507779|NCT04421027|524717017|FG001|Follow-Up Period|Protocol Deviation|0|||
145507780|NCT04421027|524717018|FG002|Follow-Up Period|Protocol Deviation|1|||
145507781|NCT04421027|524717019|FG003|Follow-Up Period|Protocol Deviation|0|||
145507782|NCT04421027|524717016|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
145507783|NCT04421027|524717017|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
145507784|NCT04421027|524717018|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
145507785|NCT04421027|524717019|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
145507786|NCT04421027|524717016|FG000|Follow-Up Period|Left message, participant did not call back|0|||
145507787|NCT04421027|524717017|FG001|Follow-Up Period|Left message, participant did not call back|0|||
145507788|NCT04421027|524717018|FG002|Follow-Up Period|Left message, participant did not call back|0|||
145507789|NCT04421027|524717019|FG003|Follow-Up Period|Left message, participant did not call back|1|||
145507790|NCT04421027|524717016|FG000|Follow-Up Period|Participant died|0|||
145507791|NCT04421027|524717017|FG001|Follow-Up Period|Participant died|0|||
145507792|NCT04421027|524717018|FG002|Follow-Up Period|Participant died|0|||
145507793|NCT04421027|524717019|FG003|Follow-Up Period|Participant died|1|||
145507794|NCT04421027|524717016|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
145507795|NCT04421027|524717017|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
145507796|NCT04421027|524717018|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
145507797|NCT04421027|524717019|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
145507798|NCT05767749|524717029|FG000|Overall Study|Withdrawal by Subject|0|||
145507799|NCT05767749|524717030|FG001|Overall Study|Withdrawal by Subject|0|||
145507800|NCT05767749|524717031|FG002|Overall Study|Withdrawal by Subject|2|||
145507801|NCT05767749|524717032|FG003|Overall Study|Withdrawal by Subject|2|||
145507802|NCT05767749|524717033|FG004|Overall Study|Withdrawal by Subject|2|||
145507803|NCT05767749|524717034|FG005|Overall Study|Withdrawal by Subject|2|||
145507804|NCT03083873|524718536|FG000|Overall Study|Death|6|||
145507805|NCT03083873|524718537|FG001|Overall Study|Death|15|||
145507806|NCT03083873|524718538|FG002|Overall Study|Death|13|||
145507807|NCT03083873|524718539|FG003|Overall Study|Death|9|||
145507808|NCT03083873|524718540|FG004|Overall Study|Death|0|||
145507809|NCT03083873|524718536|FG000|Overall Study|Sponsor Terminated Study|0|||
145507810|NCT03083873|524718537|FG001|Overall Study|Sponsor Terminated Study|1|||
145507811|NCT03083873|524718538|FG002|Overall Study|Sponsor Terminated Study|2|||
145507812|NCT03083873|524718539|FG003|Overall Study|Sponsor Terminated Study|3|||
145507813|NCT03083873|524718540|FG004|Overall Study|Sponsor Terminated Study|0|||
145507814|NCT03083873|524718536|FG000|Overall Study|Lost to Follow-up|0|||
145507815|NCT03083873|524718537|FG001|Overall Study|Lost to Follow-up|1|||
145507816|NCT03083873|524718538|FG002|Overall Study|Lost to Follow-up|1|||
145507817|NCT03083873|524718539|FG003|Overall Study|Lost to Follow-up|0|||
145507818|NCT03083873|524718540|FG004|Overall Study|Lost to Follow-up|0|||
145507819|NCT03083873|524718536|FG000|Overall Study|Withdrawal by Subject|2|||
145507820|NCT03083873|524718537|FG001|Overall Study|Withdrawal by Subject|0|||
145507821|NCT03083873|524718538|FG002|Overall Study|Withdrawal by Subject|0|||
145507822|NCT03083873|524718539|FG003|Overall Study|Withdrawal by Subject|0|||
145507823|NCT03083873|524718540|FG004|Overall Study|Withdrawal by Subject|0|||
145507824|NCT03083873|524718536|FG000|Overall Study|Did Not Receive TIL|2|||
145507825|NCT03083873|524718537|FG001|Overall Study|Did Not Receive TIL|5|||
145507826|NCT03083873|524718538|FG002|Overall Study|Did Not Receive TIL|3|||
145507827|NCT03083873|524718539|FG003|Overall Study|Did Not Receive TIL|1|||
145507828|NCT03083873|524718540|FG004|Overall Study|Did Not Receive TIL|0|||
145507829|NCT01677377|524718541|FG000|Overall Study|Protocol Violation|1|||
145507830|NCT01677377|524718542|FG001|Overall Study|Protocol Violation|0|||
145507831|NCT01677377|524718543|FG002|Overall Study|Protocol Violation|0|||
145507832|NCT01677377|524718541|FG000|Overall Study|Lost to Follow-up|0|||
145507833|NCT01677377|524718542|FG001|Overall Study|Lost to Follow-up|1|||
145507834|NCT01677377|524718543|FG002|Overall Study|Lost to Follow-up|1|||
145507835|NCT01677377|524718541|FG000|Overall Study|Withdrawal by Subject|0|||
145507836|NCT01677377|524718542|FG001|Overall Study|Withdrawal by Subject|0|||
145507837|NCT01677377|524718543|FG002|Overall Study|Withdrawal by Subject|3|||
145507838|NCT01677377|524718541|FG000|Overall Study|Lack of Efficacy|0|||
145507839|NCT01677377|524718542|FG001|Overall Study|Lack of Efficacy|0|||
145507840|NCT01677377|524718543|FG002|Overall Study|Lack of Efficacy|1|||
145507841|NCT01677377|524718541|FG000|Overall Study|Pregnancy|0|||
145507842|NCT01677377|524718542|FG001|Overall Study|Pregnancy|0|||
145507843|NCT01677377|524718543|FG002|Overall Study|Pregnancy|1|||
145507844|NCT00479687|524718544|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
145507845|NCT00479687|524718545|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
145507846|NCT00479687|524718546|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
145507847|NCT00479687|524718544|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
145507848|NCT00479687|524718545|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
145507849|NCT00479687|524718546|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
145507850|NCT00479687|524718544|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
145507851|NCT00479687|524718545|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
145507852|NCT00479687|524718546|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
145507853|NCT00479687|524718544|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
145507854|NCT00479687|524718545|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
145507855|NCT00479687|524718546|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
145507856|NCT00479687|524718544|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
145507857|NCT00479687|524718545|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
145507858|NCT00479687|524718546|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
145507859|NCT00479687|524718544|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
145507860|NCT00479687|524718545|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
145507861|NCT00479687|524718546|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
145507862|NCT00479687|524718544|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
145507863|NCT00479687|524718545|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
145507864|NCT00479687|524718546|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
145507865|NCT00479687|524718544|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
145507866|NCT00479687|524718545|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
145507867|NCT00479687|524718546|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
145507868|NCT00479687|524718544|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
145507869|NCT00479687|524718545|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
145507870|NCT00479687|524718546|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
145507871|NCT00295880|524718547|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
145507872|NCT00295880|524718547|FG000|Overall Study|Unit randomization did not occur|1|||
145507873|NCT01474239|524718548|FG000|Overall Study|Disease Progression|37|||
145507874|NCT01474239|524718549|FG001|Overall Study|Disease Progression|25|||
145507875|NCT01474239|524718548|FG000|Overall Study|Adverse Event|12|||
145507876|NCT01474239|524718549|FG001|Overall Study|Adverse Event|3|||
145507877|NCT01474239|524718548|FG000|Overall Study|Withdrawal by Subject|1|||
145401270|NCT01041859|524326471|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
145401271|NCT01041859|524326469|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
145401272|NCT01041859|524326470|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
145401273|NCT01041859|524326471|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
145401274|NCT01041859|524326469|FG000|Double-Blind Maintenance|Physician Decision|0|||
145401275|NCT01041859|524326470|FG001|Double-Blind Maintenance|Physician Decision|2|||
145401276|NCT01041859|524326471|FG002|Double-Blind Maintenance|Physician Decision|1|||
145401277|NCT01041859|524326469|FG000|Double-Blind Maintenance|Protocol Violation|0|||
145401278|NCT01041859|524326470|FG001|Double-Blind Maintenance|Protocol Violation|1|||
145401279|NCT01041859|524326471|FG002|Double-Blind Maintenance|Protocol Violation|3|||
145401280|NCT01041859|524326469|FG000|Double-Blind Maintenance|Other|0|||
145401281|NCT01041859|524326470|FG001|Double-Blind Maintenance|Other|6|||
145401282|NCT01041859|524326471|FG002|Double-Blind Maintenance|Other|2|||
145401283|NCT01041859|524326469|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
145401284|NCT01041859|524326470|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
145401285|NCT01041859|524326471|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
145401286|NCT01041859|524326469|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
145401287|NCT01041859|524326470|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
145401288|NCT01041859|524326471|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
145401289|NCT03329885|524326474|FG000|Overall Study|Sponsor discontinued the study early|0|||
145401290|NCT03329885|524326475|FG001|Overall Study|Sponsor discontinued the study early|0|||
145401291|NCT03329885|524326476|FG002|Overall Study|Sponsor discontinued the study early|0|||
145401292|NCT03329885|524326477|FG003|Overall Study|Sponsor discontinued the study early|0|||
145401293|NCT03329885|524326478|FG004|Overall Study|Sponsor discontinued the study early|0|||
145401294|NCT03329885|524326479|FG005|Overall Study|Sponsor discontinued the study early|0|||
145401295|NCT03329885|524326480|FG006|Overall Study|Sponsor discontinued the study early|1|||
145401296|NCT03329885|524326481|FG007|Overall Study|Sponsor discontinued the study early|1|||
145401297|NCT03329885|524326482|FG008|Overall Study|Sponsor discontinued the study early|0|||
145401298|NCT00369343|524326488|FG000|Double-blind Phase|Adverse Event|19|||
145401299|NCT00369343|524326489|FG001|Double-blind Phase|Adverse Event|4|||
145401300|NCT00369343|524326488|FG000|Double-blind Phase|Failed to return|2|||
145401301|NCT00369343|524326489|FG001|Double-blind Phase|Failed to return|0|||
145401302|NCT00369343|524326488|FG000|Double-blind Phase|Lost to Follow-up|9|||
145401303|NCT00369343|524326489|FG001|Double-blind Phase|Lost to Follow-up|2|||
145401304|NCT00369343|524326488|FG000|Double-blind Phase|Protocol Violation|2|||
145401305|NCT00369343|524326489|FG001|Double-blind Phase|Protocol Violation|0|||
145401306|NCT00369343|524326488|FG000|Double-blind Phase|Withdrawal by Subject|8|||
145401307|NCT00369343|524326489|FG001|Double-blind Phase|Withdrawal by Subject|6|||
145401308|NCT00369343|524326488|FG000|Double-blind Phase|Lack of Efficacy|0|||
145401309|NCT00369343|524326489|FG001|Double-blind Phase|Lack of Efficacy|4|||
145401310|NCT00369343|524326488|FG000|Double-blind Phase|Protocol deviation|4|||
145401311|NCT00369343|524326489|FG001|Double-blind Phase|Protocol deviation|0|||
145401312|NCT00369343|524326488|FG000|Open-label Phase|Adverse Event|19|||
145401313|NCT00369343|524326489|FG001|Open-label Phase|Adverse Event|7|||
145401314|NCT00369343|524326488|FG000|Open-label Phase|Failed to return|4|||
145401315|NCT00369343|524326489|FG001|Open-label Phase|Failed to return|0|||
145401316|NCT00369343|524326488|FG000|Open-label Phase|Physician Decision|2|||
145401317|NCT00369343|524326489|FG001|Open-label Phase|Physician Decision|0|||
145401318|NCT00369343|524326488|FG000|Open-label Phase|Lost to Follow-up|5|||
145401319|NCT00369343|524326489|FG001|Open-label Phase|Lost to Follow-up|3|||
145401320|NCT00369343|524326488|FG000|Open-label Phase|inadvertently reported study completers|3|||
145401321|NCT00369343|524326489|FG001|Open-label Phase|inadvertently reported study completers|2|||
145401322|NCT00369343|524326488|FG000|Open-label Phase|Protocol Violation|1|||
145401323|NCT00369343|524326489|FG001|Open-label Phase|Protocol Violation|3|||
145401324|NCT00369343|524326488|FG000|Open-label Phase|Withdrawal by Subject|15|||
145401325|NCT00369343|524326489|FG001|Open-label Phase|Withdrawal by Subject|6|||
145401326|NCT00369343|524326488|FG000|Open-label Phase|Lack of Efficacy|4|||
145401327|NCT00369343|524326489|FG001|Open-label Phase|Lack of Efficacy|3|||
145401328|NCT00369343|524326488|FG000|Open-label Phase|Lack of continuance tolerability|3|||
145401329|NCT00369343|524326489|FG001|Open-label Phase|Lack of continuance tolerability|4|||
145401330|NCT00369343|524326488|FG000|Open-label Phase|did not take study drug|1|||
145401331|NCT00369343|524326489|FG001|Open-label Phase|did not take study drug|2|||
145401332|NCT00828711|524326493|FG000|Overall Study|Lost to Follow-up|1|||
145401333|NCT00828711|524326494|FG001|Overall Study|Lost to Follow-up|0|||
145401334|NCT00828711|524326495|FG002|Overall Study|Lost to Follow-up|0|||
145401335|NCT03883386|524326496|FG000|First Assignment|Lost to Follow-up|1|||
145401336|NCT03883386|524326497|FG001|First Assignment|Lost to Follow-up|0|||
145401337|NCT03883386|524326496|FG000|First Assignment|Withdrawal by Subject|1|||
145401338|NCT03883386|524326497|FG001|First Assignment|Withdrawal by Subject|1|||
145401339|NCT01326871|524326498|FG000|Overall Study|Major surgery|0|||
145401340|NCT01326871|524326499|FG001|Overall Study|Major surgery|1|||
145401341|NCT01326871|524326500|FG002|Overall Study|Major surgery|0|||
145401342|NCT01326871|524326498|FG000|Overall Study|SAE and death|0|||
145507878|NCT01474239|524718549|FG001|Overall Study|Withdrawal by Subject|2|||
145507879|NCT01474239|524718548|FG000|Overall Study|Death|1|||
145507880|NCT01474239|524718549|FG001|Overall Study|Death|1|||
145507881|NCT01474239|524718548|FG000|Overall Study|Clinical Disease Progression|7|||
145507882|NCT01474239|524718549|FG001|Overall Study|Clinical Disease Progression|1|||
145507883|NCT01474239|524718548|FG000|Overall Study|Withdrawal for Economic Reason|1|||
145507884|NCT01474239|524718549|FG001|Overall Study|Withdrawal for Economic Reason|0|||
145507885|NCT02260180|524718553|FG000|Overall Study|Adverse Event|2|||
145507886|NCT02260180|524718554|FG001|Overall Study|Adverse Event|0|||
145507887|NCT02260180|524718555|FG002|Overall Study|Adverse Event|1|||
145507888|NCT03126344|524718562|FG000|Overall Study|Lost to Follow-up|0|||
145507889|NCT03126344|524718563|FG001|Overall Study|Lost to Follow-up|0|||
145507890|NCT03126344|524718564|FG002|Overall Study|Lost to Follow-up|5|||
145507891|NCT01027273|524718565|FG000|Overall Study|Lost to Follow-up|57|||
145507892|NCT01027273|524718566|FG001|Overall Study|Lost to Follow-up|31|||
145507893|NCT01027273|524718565|FG000|Overall Study|Death|2|||
145507894|NCT01027273|524718566|FG001|Overall Study|Death|2|||
145507895|NCT01330108|524718573|FG000|Overall Study|Withdrawal by Subject|4|||
145507896|NCT00485134|524718574|FG000|Overall Study|Lost to Follow-up|1|||
145507897|NCT00485134|524718575|FG001|Overall Study|Lost to Follow-up|0|||
145507898|NCT00485134|524718576|FG002|Overall Study|Lost to Follow-up|0|||
145507899|NCT00485134|524718577|FG003|Overall Study|Lost to Follow-up|0|||
145507900|NCT00485134|524718578|FG004|Overall Study|Lost to Follow-up|0|||
145507901|NCT00485134|524718579|FG005|Overall Study|Lost to Follow-up|0|||
145507902|NCT00485134|524718580|FG006|Overall Study|Lost to Follow-up|0|||
145507903|NCT00485134|524718581|FG007|Overall Study|Lost to Follow-up|0|||
145507904|NCT00485134|524718574|FG000|Overall Study|Withdrawal by Subject|0|||
145507905|NCT00485134|524718575|FG001|Overall Study|Withdrawal by Subject|1|||
145507906|NCT00485134|524718576|FG002|Overall Study|Withdrawal by Subject|0|||
145507907|NCT00485134|524718577|FG003|Overall Study|Withdrawal by Subject|0|||
145507908|NCT00485134|524718578|FG004|Overall Study|Withdrawal by Subject|0|||
145507909|NCT00485134|524718579|FG005|Overall Study|Withdrawal by Subject|0|||
145507910|NCT00485134|524718580|FG006|Overall Study|Withdrawal by Subject|0|||
145507911|NCT00485134|524718581|FG007|Overall Study|Withdrawal by Subject|0|||
145507912|NCT00485134|524718574|FG000|Overall Study|Change in health status|0|||
145507913|NCT00485134|524718575|FG001|Overall Study|Change in health status|1|||
145507914|NCT00485134|524718576|FG002|Overall Study|Change in health status|2|||
145507915|NCT00485134|524718577|FG003|Overall Study|Change in health status|1|||
145507916|NCT00485134|524718578|FG004|Overall Study|Change in health status|0|||
145507917|NCT00485134|524718579|FG005|Overall Study|Change in health status|1|||
145507918|NCT00485134|524718580|FG006|Overall Study|Change in health status|0|||
145507919|NCT00485134|524718581|FG007|Overall Study|Change in health status|0|||
145507920|NCT00485134|524718574|FG000|Overall Study|Withdrew for adverse event|0|||
145507921|NCT00485134|524718575|FG001|Overall Study|Withdrew for adverse event|0|||
145507922|NCT00485134|524718576|FG002|Overall Study|Withdrew for adverse event|1|||
145507923|NCT00485134|524718577|FG003|Overall Study|Withdrew for adverse event|0|||
145507924|NCT00485134|524718578|FG004|Overall Study|Withdrew for adverse event|0|||
145507925|NCT00485134|524718579|FG005|Overall Study|Withdrew for adverse event|0|||
145507926|NCT00485134|524718580|FG006|Overall Study|Withdrew for adverse event|0|||
145507927|NCT00485134|524718581|FG007|Overall Study|Withdrew for adverse event|0|||
145507928|NCT00485134|524718574|FG000|Overall Study|Positive drug test|0|||
145507929|NCT00485134|524718575|FG001|Overall Study|Positive drug test|0|||
145507930|NCT00485134|524718576|FG002|Overall Study|Positive drug test|0|||
145507931|NCT00485134|524718577|FG003|Overall Study|Positive drug test|0|||
145507932|NCT00485134|524718578|FG004|Overall Study|Positive drug test|2|||
145507933|NCT00485134|524718579|FG005|Overall Study|Positive drug test|1|||
145507934|NCT00485134|524718580|FG006|Overall Study|Positive drug test|0|||
145507935|NCT00485134|524718581|FG007|Overall Study|Positive drug test|0|||
145507936|NCT00485134|524718574|FG000|Overall Study|Non-compliance|0|||
145507937|NCT00485134|524718575|FG001|Overall Study|Non-compliance|0|||
145507938|NCT00485134|524718576|FG002|Overall Study|Non-compliance|0|||
145507939|NCT00485134|524718577|FG003|Overall Study|Non-compliance|0|||
145507940|NCT00485134|524718578|FG004|Overall Study|Non-compliance|1|||
145507941|NCT00485134|524718579|FG005|Overall Study|Non-compliance|2|||
145507942|NCT00485134|524718580|FG006|Overall Study|Non-compliance|2|||
145507943|NCT00485134|524718581|FG007|Overall Study|Non-compliance|0|||
145507944|NCT00485134|524718574|FG000|Overall Study|Unable to comply with study schedule|0|||
145507945|NCT00485134|524718575|FG001|Overall Study|Unable to comply with study schedule|0|||
145507946|NCT00485134|524718576|FG002|Overall Study|Unable to comply with study schedule|0|||
145507947|NCT00485134|524718577|FG003|Overall Study|Unable to comply with study schedule|0|||
145507948|NCT00485134|524718578|FG004|Overall Study|Unable to comply with study schedule|0|||
145507949|NCT00485134|524718579|FG005|Overall Study|Unable to comply with study schedule|0|||
145507950|NCT00485134|524718580|FG006|Overall Study|Unable to comply with study schedule|0|||
145507951|NCT00485134|524718581|FG007|Overall Study|Unable to comply with study schedule|1|||
145507952|NCT00485134|524718574|FG000|Overall Study|Pregnancy|0|||
145507953|NCT00485134|524718575|FG001|Overall Study|Pregnancy|0|||
145507954|NCT00485134|524718576|FG002|Overall Study|Pregnancy|0|||
145507955|NCT00485134|524718577|FG003|Overall Study|Pregnancy|0|||
145507956|NCT00485134|524718578|FG004|Overall Study|Pregnancy|0|||
145507957|NCT00485134|524718579|FG005|Overall Study|Pregnancy|0|||
145507958|NCT00485134|524718580|FG006|Overall Study|Pregnancy|1|||
145507959|NCT00485134|524718581|FG007|Overall Study|Pregnancy|0|||
145507960|NCT00970684|524718582|FG000|Overall Study|Lack of Efficacy|5|||
145507961|NCT00970684|524718582|FG000|Overall Study|Adverse Event|4|||
145507962|NCT00970684|524718582|FG000|Overall Study|Withdrawal by Subject|1|||
145507963|NCT03656562|524718585|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
145507964|NCT03656562|524718586|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
145507965|NCT03656562|524718587|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
145507966|NCT03656562|524718588|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
145507967|NCT03656562|524718585|FG000|Overall Study|Physician Decision|1|||
145507968|NCT03656562|524718586|FG001|Overall Study|Physician Decision|2|||
145507969|NCT03656562|524718587|FG002|Overall Study|Physician Decision|0|||
145507970|NCT03656562|524718588|FG003|Overall Study|Physician Decision|0|||
145507971|NCT03656562|524718585|FG000|Overall Study|Subject Decision|3|||
145507972|NCT03656562|524718586|FG001|Overall Study|Subject Decision|5|||
145507973|NCT03656562|524718587|FG002|Overall Study|Subject Decision|0|||
145507974|NCT03656562|524718588|FG003|Overall Study|Subject Decision|2|||
145507975|NCT00905645|524718589|FG000|Overall Study|Death (not device related)|10|||
145507976|NCT00905645|524718590|FG001|Overall Study|Death (not device related)|4|||
145507977|NCT00905645|524718591|FG002|Overall Study|Death (not device related)|15|||
145507978|NCT00905645|524718592|FG003|Overall Study|Death (not device related)|8|||
145507979|NCT00905645|524718589|FG000|Overall Study|Explantation of study device(s)|78|||
145507980|NCT00905645|524718590|FG001|Overall Study|Explantation of study device(s)|47|||
145507981|NCT00905645|524718591|FG002|Overall Study|Explantation of study device(s)|28|||
145507982|NCT00905645|524718592|FG003|Overall Study|Explantation of study device(s)|21|||
145507983|NCT00905645|524718589|FG000|Overall Study|Subject Request|41|||
145507984|NCT00905645|524718590|FG001|Overall Study|Subject Request|17|||
145507985|NCT00905645|524718591|FG002|Overall Study|Subject Request|13|||
145507986|NCT00905645|524718592|FG003|Overall Study|Subject Request|11|||
145507987|NCT00905645|524718589|FG000|Overall Study|Lost to Follow-up|299|||
145507988|NCT00905645|524718590|FG001|Overall Study|Lost to Follow-up|103|||
145507989|NCT00905645|524718591|FG002|Overall Study|Lost to Follow-up|51|||
145507990|NCT00905645|524718592|FG003|Overall Study|Lost to Follow-up|12|||
145507991|NCT04881942|524718593|FG000|Overall Study|Adverse Event|0|||
145507992|NCT04881942|524718594|FG001|Overall Study|Adverse Event|0|||
145507993|NCT04881942|524718595|FG002|Overall Study|Adverse Event|0|||
145507994|NCT04881942|524718596|FG003|Overall Study|Adverse Event|0|||
145507995|NCT04881942|524718597|FG004|Overall Study|Adverse Event|1|||
145507996|NCT04881942|524718593|FG000|Overall Study|Alternates|0|||
145507997|NCT04881942|524718594|FG001|Overall Study|Alternates|0|||
145507998|NCT04881942|524718595|FG002|Overall Study|Alternates|0|||
145507999|NCT04881942|524718596|FG003|Overall Study|Alternates|0|||
145508000|NCT04881942|524718597|FG004|Overall Study|Alternates|2|||
145508001|NCT02136069|524718598|FG000|Overall Study|UC flare-up|1|||
145508002|NCT02136069|524718599|FG001|Overall Study|UC flare-up|0|||
145508003|NCT02136069|524718598|FG000|Overall Study|Adverse Event|6|||
145508004|NCT02136069|524718599|FG001|Overall Study|Adverse Event|8|||
145508005|NCT02136069|524718598|FG000|Overall Study|Death|0|||
145508006|NCT02136069|524718599|FG001|Overall Study|Death|1|||
145508007|NCT02136069|524718598|FG000|Overall Study|Lack of Efficacy|10|||
145508008|NCT02136069|524718599|FG001|Overall Study|Lack of Efficacy|4|||
145508009|NCT02136069|524718598|FG000|Overall Study|Lost to Follow-up|1|||
145508010|NCT02136069|524718599|FG001|Overall Study|Lost to Follow-up|0|||
145508011|NCT02136069|524718598|FG000|Overall Study|Non-Compliance|1|||
145508012|NCT02136069|524718599|FG001|Overall Study|Non-Compliance|0|||
145508013|NCT02136069|524718598|FG000|Overall Study|Physician Decision|5|||
145508014|NCT02136069|524718599|FG001|Overall Study|Physician Decision|4|||
145508015|NCT02136069|524718598|FG000|Overall Study|Withdrawal by Subject|10|||
145508016|NCT02136069|524718599|FG001|Overall Study|Withdrawal by Subject|11|||
145508017|NCT04693234|524718600|FG000|Overall Study|Death|79|||
145508018|NCT04693234|524718601|FG001|Overall Study|Death|19|||
145508019|NCT04693234|524718600|FG000|Overall Study|Sponsor Ended Study|47|||
145508020|NCT04693234|524718601|FG001|Overall Study|Sponsor Ended Study|18|||
145508021|NCT04693234|524718600|FG000|Overall Study|Withdrawal by Subject|10|||
145508022|NCT04693234|524718601|FG001|Overall Study|Withdrawal by Subject|2|||
145508023|NCT04693234|524718600|FG000|Overall Study|Lost to Follow-up|2|||
145508024|NCT04693234|524718601|FG001|Overall Study|Lost to Follow-up|1|||
145508025|NCT00578292|524718602|FG000|Overall Study|Death|1|||
145508026|NCT00578292|524718602|FG000|Overall Study|Graft failure|2|||
145508027|NCT00459186|524718603|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
145508028|NCT00459186|524718603|FG000|PET Imaging and Assessment|Adverse Event|3|||
145508029|NCT02920242|524718604|FG000|Overall Study|Withdrawal by Subject|1|||
145508030|NCT02920242|524718605|FG001|Overall Study|Withdrawal by Subject|0|||
145508031|NCT02920242|524718606|FG002|Overall Study|Withdrawal by Subject|1|||
145508032|NCT02920242|524718604|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
145508033|NCT02920242|524718605|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
145508034|NCT02920242|524718606|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
145508035|NCT00441064|524718607|FG000|Overall Study|Adverse Event|1|||
145508036|NCT00441064|524718608|FG001|Overall Study|Adverse Event|0|||
145508037|NCT00441064|524718607|FG000|Overall Study|Abnormal laboratory values|0|||
145508038|NCT00441064|524718608|FG001|Overall Study|Abnormal laboratory values|2|||
145508039|NCT00441064|524718607|FG000|Overall Study|Abnormal test procedure results|0|||
145508040|NCT00441064|524718608|FG001|Overall Study|Abnormal test procedure results|1|||
145508041|NCT00441064|524718607|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145508042|NCT00441064|524718608|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145508043|NCT00441064|524718607|FG000|Overall Study|Protocol Deviation|3|||
145508044|NCT00441064|524718608|FG001|Overall Study|Protocol Deviation|2|||
145508045|NCT00441064|524718607|FG000|Overall Study|Patient withdrew consent|5|||
145508046|NCT00441064|524718608|FG001|Overall Study|Patient withdrew consent|2|||
145508047|NCT03051178|524718609|FG000|Overall Study|Withdrawal by Subject|5|||
145508048|NCT00953056|524718610|FG000|Overall Study|Withdrew Consent|0|||
145508049|NCT00953056|524718611|FG001|Overall Study|Withdrew Consent|0|||
145508050|NCT00953056|524718612|FG002|Overall Study|Withdrew Consent|0|||
145508051|NCT00953056|524718613|FG003|Overall Study|Withdrew Consent|0|||
145508052|NCT00953056|524718614|FG004|Overall Study|Withdrew Consent|2|||
145508053|NCT00953056|524718615|FG005|Overall Study|Withdrew Consent|3|||
145508054|NCT00953056|524718610|FG000|Overall Study|Serious Adverse Event|0|||
145508055|NCT00953056|524718611|FG001|Overall Study|Serious Adverse Event|0|||
145508056|NCT00953056|524718612|FG002|Overall Study|Serious Adverse Event|0|||
145508057|NCT00953056|524718613|FG003|Overall Study|Serious Adverse Event|0|||
145508058|NCT00953056|524718614|FG004|Overall Study|Serious Adverse Event|0|||
145508059|NCT00953056|524718615|FG005|Overall Study|Serious Adverse Event|1|||
145508060|NCT03962504|524718616|FG000|Overall Study|Other|11|||
145508061|NCT03962504|524718617|FG001|Overall Study|Other|32|||
145508062|NCT03339219|524718618|FG000|Overall Study|Death|12|||
145508063|NCT03339219|524718618|FG000|Overall Study|Site Terminated by Sponsor|22|||
145508064|NCT03339219|524718618|FG000|Overall Study|Withdrawal by Subject|1|||
145508065|NCT00845897|524718621|FG000|Overall Study|Lost to Follow-up|1|||
145508066|NCT00845897|524718622|FG001|Overall Study|Lost to Follow-up|1|||
145508067|NCT00845897|524718623|FG002|Overall Study|Lost to Follow-up|0|||
145508068|NCT00845897|524718621|FG000|Overall Study|Withdrawal by Subject|0|||
145508069|NCT00845897|524718622|FG001|Overall Study|Withdrawal by Subject|3|||
145508070|NCT00845897|524718623|FG002|Overall Study|Withdrawal by Subject|2|||
145508071|NCT00845897|524718621|FG000|Overall Study|Ulcer did not heal|1|||
145508072|NCT00845897|524718622|FG001|Overall Study|Ulcer did not heal|0|||
145508073|NCT00845897|524718623|FG002|Overall Study|Ulcer did not heal|1|||
145508074|NCT00845897|524718621|FG000|Overall Study|Too ill to participate|0|||
145508075|NCT00845897|524718622|FG001|Overall Study|Too ill to participate|1|||
145508076|NCT00845897|524718623|FG002|Overall Study|Too ill to participate|0|||
145508077|NCT02722499|524718624|FG000|Overall Study|Lost to Follow-up|2|||
145508078|NCT02722499|524718625|FG001|Overall Study|Lost to Follow-up|0|||
145508079|NCT02722499|524718626|FG002|Overall Study|Lost to Follow-up|1|||
145508080|NCT02817464|524718636|FG000|Overall Study|Lost to Follow-up|1|||
145508081|NCT02817464|524718637|FG001|Overall Study|Lost to Follow-up|0|||
145508082|NCT02817464|524718636|FG000|Overall Study|Discontinued early due to personal decision|1|||
145508083|NCT02817464|524718637|FG001|Overall Study|Discontinued early due to personal decision|1|||
145508084|NCT01273519|524718639|FG000|Overall Study|Adverse Event|3|||
145508085|NCT01273519|524718640|FG001|Overall Study|Adverse Event|0|||
145508086|NCT01273519|524718641|FG002|Overall Study|Adverse Event|0|||
145508087|NCT01273519|524718639|FG000|Overall Study|Lost to Follow-up|2|||
145508088|NCT01273519|524718640|FG001|Overall Study|Lost to Follow-up|1|||
145508089|NCT01273519|524718641|FG002|Overall Study|Lost to Follow-up|3|||
145508090|NCT01273519|524718639|FG000|Overall Study|Lack of Efficacy|8|||
145508091|NCT01273519|524718640|FG001|Overall Study|Lack of Efficacy|3|||
145508092|NCT01273519|524718641|FG002|Overall Study|Lack of Efficacy|4|||
145508093|NCT01273519|524718639|FG000|Overall Study|Other|6|||
145508094|NCT01273519|524718640|FG001|Overall Study|Other|1|||
145508095|NCT01273519|524718641|FG002|Overall Study|Other|1|||
145508096|NCT04292899|524718642|FG000|Overall Study|Death|21|||
145508097|NCT04292899|524718643|FG001|Overall Study|Death|28|||
145508098|NCT04292899|524718644|FG002|Overall Study|Death|188|||
145508099|NCT04292899|524718645|FG003|Overall Study|Death|371|||
145508100|NCT04292899|524718642|FG000|Overall Study|Lost to Follow-up|8|||
145508101|NCT04292899|524718643|FG001|Overall Study|Lost to Follow-up|4|||
145508102|NCT04292899|524718644|FG002|Overall Study|Lost to Follow-up|22|||
145508103|NCT04292899|524718645|FG003|Overall Study|Lost to Follow-up|235|||
145508104|NCT04292899|524718642|FG000|Overall Study|Withdrew consent|1|||
145508105|NCT04292899|524718643|FG001|Overall Study|Withdrew consent|0|||
145508106|NCT04292899|524718644|FG002|Overall Study|Withdrew consent|11|||
145508107|NCT04292899|524718645|FG003|Overall Study|Withdrew consent|32|||
145508108|NCT04292899|524718642|FG000|Overall Study|Adverse Event|2|||
145508109|NCT04292899|524718643|FG001|Overall Study|Adverse Event|1|||
145508110|NCT04292899|524718644|FG002|Overall Study|Adverse Event|2|||
145508111|NCT04292899|524718645|FG003|Overall Study|Adverse Event|2|||
145508112|NCT04292899|524718642|FG000|Overall Study|Investigator's Discretion|0|||
145508113|NCT04292899|524718643|FG001|Overall Study|Investigator's Discretion|0|||
145508114|NCT04292899|524718644|FG002|Overall Study|Investigator's Discretion|0|||
145508115|NCT04292899|524718645|FG003|Overall Study|Investigator's Discretion|3|||
145508116|NCT04292899|524718642|FG000|Overall Study|Non-compliance With Study Drug|0|||
145508117|NCT04292899|524718643|FG001|Overall Study|Non-compliance With Study Drug|0|||
145508118|NCT04292899|524718644|FG002|Overall Study|Non-compliance With Study Drug|0|||
145508119|NCT04292899|524718645|FG003|Overall Study|Non-compliance With Study Drug|1|||
145508120|NCT04292899|524718642|FG000|Overall Study|Protocol Violation|0|||
145508121|NCT04292899|524718643|FG001|Overall Study|Protocol Violation|0|||
145508122|NCT04292899|524718644|FG002|Overall Study|Protocol Violation|0|||
145508123|NCT04292899|524718645|FG003|Overall Study|Protocol Violation|1|||
145508124|NCT00828204|524718650|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
145508125|NCT00828204|524718651|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
145508126|NCT00828204|524718650|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
145508127|NCT00828204|524718651|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
145508128|NCT00828204|524718650|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
145508129|NCT00828204|524718651|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
145508130|NCT00828204|524718650|FG000|Main Study: After Study Restart|Adverse Event|0|||
145508131|NCT00828204|524718651|FG001|Main Study: After Study Restart|Adverse Event|2|||
145508132|NCT00828204|524718650|FG000|Main Study: After Study Restart|Noncompliance|0|||
145508133|NCT00828204|524718651|FG001|Main Study: After Study Restart|Noncompliance|1|||
145508134|NCT00828204|524718650|FG000|Extension Study|Lost to Follow-up|0|||
145508135|NCT00828204|524718651|FG001|Extension Study|Lost to Follow-up|1|||
145508136|NCT00828204|524718650|FG000|Extension Study|Physician Decision|0|||
145508137|NCT00828204|524718651|FG001|Extension Study|Physician Decision|2|||
145508138|NCT01704599|524718658|FG000|Overall Study|Adverse Event|1|||
145508139|NCT02840461|524718659|FG000|Overall Study|Adverse Event|1|||
145508140|NCT02840461|524718660|FG001|Overall Study|Adverse Event|5|||
145508141|NCT02840461|524718661|FG002|Overall Study|Adverse Event|3|||
145508142|NCT02840461|524718659|FG000|Overall Study|Lost to Follow-up|10|||
145508143|NCT02840461|524718660|FG001|Overall Study|Lost to Follow-up|7|||
145508144|NCT02840461|524718661|FG002|Overall Study|Lost to Follow-up|6|||
145508145|NCT02840461|524718659|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
145508146|NCT02840461|524718660|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
145508147|NCT02840461|524718661|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
145508148|NCT02840461|524718659|FG000|Overall Study|Protocol Violation|2|||
145508149|NCT02840461|524718660|FG001|Overall Study|Protocol Violation|3|||
145508150|NCT02840461|524718661|FG002|Overall Study|Protocol Violation|1|||
145508151|NCT02840461|524718659|FG000|Overall Study|Withdrawal by Subject|10|||
145508152|NCT02840461|524718660|FG001|Overall Study|Withdrawal by Subject|6|||
145508153|NCT02840461|524718661|FG002|Overall Study|Withdrawal by Subject|2|||
145508154|NCT02840461|524718659|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
145508155|NCT02840461|524718660|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
145508156|NCT02840461|524718661|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
145508157|NCT01737502|524718664|FG000|Phase I|Disease progression|2|||
145508158|NCT01737502|524718665|FG001|Phase I|Disease progression|3|||
145508159|NCT01737502|524718664|FG000|Phase I|Complicating disease|1|||
145508160|NCT01737502|524718665|FG001|Phase I|Complicating disease|0|||
145508161|NCT01737502|524718664|FG000|Phase II|Adverse Event|0|||
145508162|NCT01737502|524718665|FG001|Phase II|Adverse Event|3|||
145508163|NCT01737502|524718664|FG000|Phase II|Disease progression|0|||
145508164|NCT01737502|524718665|FG001|Phase II|Disease progression|18|||
145508165|NCT01737502|524718664|FG000|Phase II|Death|0|||
145508166|NCT01737502|524718665|FG001|Phase II|Death|1|||
145508167|NCT01737502|524718664|FG000|Phase II|Transition to hospice care|0|||
145508168|NCT01737502|524718665|FG001|Phase II|Transition to hospice care|1|||
145508169|NCT02003924|524718676|FG000|Double-blind Phase|Lost to Follow-up|2|||
145508170|NCT02003924|524718677|FG001|Double-blind Phase|Lost to Follow-up|1|||
145508171|NCT02003924|524718678|FG002|Double-blind Phase|Lost to Follow-up|0|||
145508172|NCT02003924|524718676|FG000|Double-blind Phase|Protocol Violation|1|||
145508173|NCT02003924|524718677|FG001|Double-blind Phase|Protocol Violation|2|||
145508174|NCT02003924|524718678|FG002|Double-blind Phase|Protocol Violation|0|||
145508175|NCT02003924|524718676|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
145508176|NCT02003924|524718677|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
145508177|NCT02003924|524718678|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
145508178|NCT02003924|524718676|FG000|Double-blind Phase|Disease Progression|229|||
145508179|NCT02003924|524718677|FG001|Double-blind Phase|Disease Progression|247|||
145508180|NCT02003924|524718678|FG002|Double-blind Phase|Disease Progression|0|||
145508181|NCT02003924|524718676|FG000|Double-blind Phase|Adverse Event|120|||
145508182|NCT02003924|524718677|FG001|Double-blind Phase|Adverse Event|31|||
145508183|NCT02003924|524718678|FG002|Double-blind Phase|Adverse Event|0|||
145508184|NCT02003924|524718676|FG000|Double-blind Phase|Randomized But not Treated|3|||
145508185|NCT02003924|524718677|FG001|Double-blind Phase|Randomized But not Treated|3|||
145508186|NCT02003924|524718678|FG002|Double-blind Phase|Randomized But not Treated|0|||
145508187|NCT02003924|524718676|FG000|Double-blind Phase|Other|29|||
145508188|NCT02003924|524718677|FG001|Double-blind Phase|Other|50|||
145508189|NCT02003924|524718678|FG002|Double-blind Phase|Other|0|||
145508190|NCT02003924|524718676|FG000|Open-label Phase|Lost to Follow-up|0|||
145508191|NCT02003924|524718677|FG001|Open-label Phase|Lost to Follow-up|0|||
145508192|NCT02003924|524718678|FG002|Open-label Phase|Lost to Follow-up|1|||
145508193|NCT02003924|524718676|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
145508194|NCT02003924|524718677|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
145508195|NCT02003924|524718678|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
145508196|NCT02003924|524718676|FG000|Open-label Phase|Disease Progression|59|||
145508197|NCT02003924|524718677|FG001|Open-label Phase|Disease Progression|0|||
145508198|NCT02003924|524718678|FG002|Open-label Phase|Disease Progression|5|||
145508199|NCT02003924|524718676|FG000|Open-label Phase|Adverse Event|25|||
145508200|NCT02003924|524718677|FG001|Open-label Phase|Adverse Event|0|||
145508201|NCT02003924|524718678|FG002|Open-label Phase|Adverse Event|10|||
145508202|NCT02003924|524718676|FG000|Open-label Phase|Other|7|||
145508203|NCT02003924|524718677|FG001|Open-label Phase|Other|0|||
145508204|NCT02003924|524718678|FG002|Open-label Phase|Other|0|||
145508205|NCT02003924|524718676|FG000|Long-term Follow-up Phase|Death|288|||
145508206|NCT02003924|524718677|FG001|Long-term Follow-up Phase|Death|174|||
145508207|NCT02003924|524718678|FG002|Long-term Follow-up Phase|Death|4|||
145508208|NCT02003924|524718676|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
145508209|NCT02003924|524718677|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
145508210|NCT02003924|524718678|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
145508211|NCT02003924|524718676|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
145508212|NCT02003924|524718677|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
145508213|NCT02003924|524718678|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
145508214|NCT02003924|524718676|FG000|Long-term Follow-up Phase|Other|5|||
145508215|NCT02003924|524718677|FG001|Long-term Follow-up Phase|Other|2|||
145508216|NCT02003924|524718678|FG002|Long-term Follow-up Phase|Other|1|||
145508217|NCT00124306|524718682|FG000|Overall Study|Adverse Event|7|||
145508218|NCT00124306|524718683|FG001|Overall Study|Adverse Event|2|||
145508219|NCT00124306|524718682|FG000|Overall Study|Lost to Follow-up|10|||
145508220|NCT00124306|524718683|FG001|Overall Study|Lost to Follow-up|6|||
145508221|NCT00124306|524718682|FG000|Overall Study|Lack of Efficacy|3|||
145508222|NCT00124306|524718683|FG001|Overall Study|Lack of Efficacy|6|||
145508223|NCT00124306|524718682|FG000|Overall Study|Personal constraints|0|||
145508224|NCT00124306|524718683|FG001|Overall Study|Personal constraints|2|||
145508225|NCT00124306|524718682|FG000|Overall Study|Use of unacceptable medication|1|||
145508226|NCT00124306|524718683|FG001|Overall Study|Use of unacceptable medication|0|||
145508227|NCT00124306|524718682|FG000|Overall Study|Abnormal lab result|0|||
145508228|NCT00124306|524718683|FG001|Overall Study|Abnormal lab result|1|||
145508229|NCT00124306|524718682|FG000|Overall Study|Other|2|||
145508230|NCT00124306|524718683|FG001|Overall Study|Other|0|||
145508231|NCT00560352|524718685|FG000|Overall Study|Adverse event unrelated to study drug|2|||
145508232|NCT00560352|524718686|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145508233|NCT00560352|524718687|FG002|Overall Study|Adverse event unrelated to study drug|1|||
145508234|NCT00560352|524718685|FG000|Overall Study|Study drug toxicity|3|||
145508235|NCT00560352|524718686|FG001|Overall Study|Study drug toxicity|0|||
145508236|NCT00560352|524718687|FG002|Overall Study|Study drug toxicity|1|||
145508237|NCT00560352|524718685|FG000|Overall Study|Disease progression|0|||
145508238|NCT00560352|524718686|FG001|Overall Study|Disease progression|1|||
145508239|NCT00560352|524718687|FG002|Overall Study|Disease progression|1|||
145508240|NCT00560352|524718685|FG000|Overall Study|Withdrawal by Subject|1|||
145508241|NCT00560352|524718686|FG001|Overall Study|Withdrawal by Subject|1|||
145508242|NCT00560352|524718687|FG002|Overall Study|Withdrawal by Subject|1|||
145508243|NCT00560352|524718685|FG000|Overall Study|Maximum clinical benefit|1|||
145508244|NCT00560352|524718686|FG001|Overall Study|Maximum clinical benefit|0|||
145508245|NCT00560352|524718687|FG002|Overall Study|Maximum clinical benefit|0|||
145508246|NCT00114517|524718688|FG000|Overall Study|Adverse Event|6|||
145508247|NCT00114517|524718689|FG001|Overall Study|Adverse Event|1|||
145508248|NCT00114517|524718690|FG002|Overall Study|Adverse Event|6|||
145508249|NCT00114517|524718691|FG003|Overall Study|Adverse Event|3|||
145508250|NCT00114517|524718688|FG000|Overall Study|Lost to Follow-up|2|||
145508251|NCT00114517|524718689|FG001|Overall Study|Lost to Follow-up|2|||
145508252|NCT00114517|524718690|FG002|Overall Study|Lost to Follow-up|2|||
145508253|NCT00114517|524718691|FG003|Overall Study|Lost to Follow-up|1|||
145508254|NCT00114517|524718688|FG000|Overall Study|Too busy|3|||
145508255|NCT00114517|524718689|FG001|Overall Study|Too busy|1|||
145508256|NCT00114517|524718690|FG002|Overall Study|Too busy|1|||
145508257|NCT00114517|524718691|FG003|Overall Study|Too busy|2|||
145508258|NCT00114517|524718688|FG000|Overall Study|Moved from area|0|||
145508259|NCT00114517|524718689|FG001|Overall Study|Moved from area|3|||
145508260|NCT00114517|524718690|FG002|Overall Study|Moved from area|2|||
145508261|NCT00114517|524718691|FG003|Overall Study|Moved from area|1|||
145508262|NCT00114517|524718688|FG000|Overall Study|Did not want estradiol|1|||
145508263|NCT00114517|524718689|FG001|Overall Study|Did not want estradiol|1|||
145508264|NCT00114517|524718690|FG002|Overall Study|Did not want estradiol|0|||
145508265|NCT00114517|524718691|FG003|Overall Study|Did not want estradiol|0|||
145508266|NCT00114517|524718688|FG000|Overall Study|Armed-services duty|0|||
145508267|NCT00114517|524718689|FG001|Overall Study|Armed-services duty|1|||
145508268|NCT00114517|524718690|FG002|Overall Study|Armed-services duty|0|||
145508269|NCT00114517|524718691|FG003|Overall Study|Armed-services duty|1|||
145508270|NCT00114517|524718688|FG000|Overall Study|Competing family issue|0|||
145508271|NCT00114517|524718689|FG001|Overall Study|Competing family issue|1|||
145508272|NCT00114517|524718690|FG002|Overall Study|Competing family issue|0|||
145508273|NCT00114517|524718691|FG003|Overall Study|Competing family issue|1|||
145508274|NCT00114517|524718688|FG000|Overall Study|Physician Decision|0|||
145508275|NCT00114517|524718689|FG001|Overall Study|Physician Decision|1|||
145508276|NCT00114517|524718690|FG002|Overall Study|Physician Decision|0|||
145508277|NCT00114517|524718691|FG003|Overall Study|Physician Decision|0|||
145508278|NCT00114517|524718688|FG000|Overall Study|Lost interest|0|||
145508279|NCT00114517|524718689|FG001|Overall Study|Lost interest|0|||
145508280|NCT00114517|524718690|FG002|Overall Study|Lost interest|1|||
145508281|NCT00114517|524718691|FG003|Overall Study|Lost interest|0|||
145508282|NCT00114517|524718688|FG000|Overall Study|Weight increase|0|||
145508283|NCT00114517|524718689|FG001|Overall Study|Weight increase|0|||
145508284|NCT00114517|524718690|FG002|Overall Study|Weight increase|1|||
145508285|NCT00114517|524718691|FG003|Overall Study|Weight increase|0|||
145508286|NCT00114517|524718688|FG000|Overall Study|Concern about blood clots|0|||
145508287|NCT00114517|524718689|FG001|Overall Study|Concern about blood clots|0|||
145508288|NCT00114517|524718690|FG002|Overall Study|Concern about blood clots|1|||
145508289|NCT00114517|524718691|FG003|Overall Study|Concern about blood clots|0|||
145508290|NCT00114517|524718688|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
145508291|NCT00114517|524718689|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
145508292|NCT00114517|524718690|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
145508293|NCT00114517|524718691|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
145508294|NCT00539864|524720235|FG000|Overall Study|Lost to Follow-up|0|||
145508295|NCT00539864|524720236|FG001|Overall Study|Lost to Follow-up|1|||
145508296|NCT00539864|524720235|FG000|Overall Study|Withdrawal by Subject|1|||
145508297|NCT00539864|524720236|FG001|Overall Study|Withdrawal by Subject|1|||
145508298|NCT00943072|524720242|FG000|Overall Study|Adverse Event|0|||
145508299|NCT00943072|524720243|FG001|Overall Study|Adverse Event|3|||
145508300|NCT00943072|524720242|FG000|Overall Study|Death|0|||
145508301|NCT00943072|524720243|FG001|Overall Study|Death|2|||
145508302|NCT00943072|524720242|FG000|Overall Study|Withdrawal by Subject|3|||
145508303|NCT00943072|524720243|FG001|Overall Study|Withdrawal by Subject|1|||
145508304|NCT00943072|524720242|FG000|Overall Study|Protocol Violation|0|||
145508305|NCT00943072|524720243|FG001|Overall Study|Protocol Violation|1|||
145508306|NCT00943072|524720242|FG000|Overall Study|Lost to Follow-up|1|||
145508307|NCT00943072|524720243|FG001|Overall Study|Lost to Follow-up|2|||
145508308|NCT00943072|524720242|FG000|Overall Study|Lack of Efficacy|0|||
145508309|NCT00943072|524720243|FG001|Overall Study|Lack of Efficacy|4|||
145508310|NCT00943072|524720242|FG000|Overall Study|Other|1|||
145508311|NCT00943072|524720243|FG001|Overall Study|Other|1|||
145508312|NCT03860818|524720249|FG000|Overall Study|Death|144|||
145508313|NCT03860818|524720250|FG001|Overall Study|Death|195|||
145508314|NCT03860818|524720249|FG000|Overall Study|Graft Loss|32|||
145508315|NCT03860818|524720250|FG001|Overall Study|Graft Loss|45|||
145508316|NCT00792571|524720251|FG000|Overall Study|Death|1|||
145508317|NCT00792571|524720251|FG000|Overall Study|Adverse Event|4|||
145508318|NCT00792571|524720251|FG000|Overall Study|Withdrawal by Subject|1|||
145508319|NCT00792571|524720251|FG000|Overall Study|Other|4|||
145508320|NCT02600819|524720252|FG000|GEN Phase|Adverse Event|2|||
145508321|NCT02600819|524720253|FG001|GEN Phase|Adverse Event|0|||
145508322|NCT02600819|524720252|FG000|GEN Phase|Death|2|||
145508323|NCT02600819|524720253|FG001|GEN Phase|Death|0|||
145508324|NCT02600819|524720252|FG000|GEN Phase|Investigator's Discretion|4|||
145508325|NCT02600819|524720253|FG001|GEN Phase|Investigator's Discretion|0|||
145508326|NCT02600819|524720252|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
145508327|NCT02600819|524720253|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
145508328|NCT02600819|524720252|FG000|GEN Phase|Withdrew Consent|5|||
145508329|NCT02600819|524720253|FG001|GEN Phase|Withdrew Consent|0|||
145508330|NCT02600819|524720252|FG000|GEN Phase|Lost to Follow-up|2|||
145508331|NCT02600819|524720253|FG001|GEN Phase|Lost to Follow-up|0|||
145508332|NCT01715857|524720254|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
145508333|NCT00505778|524720255|FG000|Overall Study|Adverse Event|2|||
145508334|NCT00505778|524720256|FG001|Overall Study|Adverse Event|7|||
145508335|NCT00505778|524720255|FG000|Overall Study|Physician Decision|8|||
145508336|NCT00505778|524720256|FG001|Overall Study|Physician Decision|14|||
145508337|NCT00505778|524720255|FG000|Overall Study|Lost to Follow-up|17|||
145508338|NCT00505778|524720256|FG001|Overall Study|Lost to Follow-up|23|||
145508339|NCT00505778|524720255|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
145508340|NCT00505778|524720256|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
145508341|NCT00505778|524720255|FG000|Overall Study|Protocol Violation|7|||
145508342|NCT00505778|524720256|FG001|Overall Study|Protocol Violation|9|||
145508343|NCT00505778|524720255|FG000|Overall Study|Withdrawal by Subject|29|||
145508344|NCT00505778|524720256|FG001|Overall Study|Withdrawal by Subject|14|||
145508345|NCT00505778|524720255|FG000|Overall Study|Relapse|65|||
145508346|NCT00505778|524720256|FG001|Overall Study|Relapse|65|||
145508347|NCT00505778|524720255|FG000|Overall Study|Took No Study Drug|2|||
145508348|NCT00505778|524720256|FG001|Overall Study|Took No Study Drug|2|||
145508349|NCT03790696|524720259|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
145508350|NCT03790696|524720260|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
145508351|NCT00481091|524720267|FG000|Overall Study|Withdrawal by Subject|0|||
145508352|NCT00481091|524720268|FG001|Overall Study|Withdrawal by Subject|1|||
145508353|NCT00481091|524720269|FG002|Overall Study|Withdrawal by Subject|1|||
145508354|NCT00481091|524720270|FG003|Overall Study|Withdrawal by Subject|0|||
145508355|NCT00481091|524720271|FG004|Overall Study|Withdrawal by Subject|0|||
145508356|NCT00481091|524720272|FG005|Overall Study|Withdrawal by Subject|0|||
145508357|NCT00481091|524720273|FG006|Overall Study|Withdrawal by Subject|0|||
145508358|NCT00481091|524720274|FG007|Overall Study|Withdrawal by Subject|0|||
145508359|NCT00481091|524720275|FG008|Overall Study|Withdrawal by Subject|1|||
145508360|NCT00481091|524720276|FG009|Overall Study|Withdrawal by Subject|6|||
145508361|NCT00481091|524720267|FG000|Overall Study|Other, Not Specified|0|||
145508362|NCT00481091|524720268|FG001|Overall Study|Other, Not Specified|1|||
145508363|NCT00481091|524720269|FG002|Overall Study|Other, Not Specified|1|||
145508364|NCT00481091|524720270|FG003|Overall Study|Other, Not Specified|0|||
145508365|NCT00481091|524720271|FG004|Overall Study|Other, Not Specified|0|||
145508366|NCT00481091|524720272|FG005|Overall Study|Other, Not Specified|1|||
145508367|NCT00481091|524720273|FG006|Overall Study|Other, Not Specified|0|||
145508368|NCT00481091|524720274|FG007|Overall Study|Other, Not Specified|0|||
145508369|NCT00481091|524720275|FG008|Overall Study|Other, Not Specified|0|||
145508370|NCT00481091|524720276|FG009|Overall Study|Other, Not Specified|4|||
145508371|NCT00481091|524720267|FG000|Overall Study|Adverse Event|1|||
145508372|NCT00481091|524720268|FG001|Overall Study|Adverse Event|2|||
145508373|NCT00481091|524720269|FG002|Overall Study|Adverse Event|0|||
145508374|NCT00481091|524720270|FG003|Overall Study|Adverse Event|1|||
145508375|NCT00481091|524720271|FG004|Overall Study|Adverse Event|1|||
145508376|NCT00481091|524720272|FG005|Overall Study|Adverse Event|1|||
145508377|NCT00481091|524720273|FG006|Overall Study|Adverse Event|2|||
145508378|NCT00481091|524720274|FG007|Overall Study|Adverse Event|1|||
145508379|NCT00481091|524720275|FG008|Overall Study|Adverse Event|1|||
145508380|NCT00481091|524720276|FG009|Overall Study|Adverse Event|6|||
145508381|NCT00481091|524720267|FG000|Overall Study|Progressive disease clinical|0|||
145508382|NCT00481091|524720268|FG001|Overall Study|Progressive disease clinical|0|||
145508383|NCT00481091|524720269|FG002|Overall Study|Progressive disease clinical|0|||
145508384|NCT00481091|524720270|FG003|Overall Study|Progressive disease clinical|0|||
145508385|NCT00481091|524720271|FG004|Overall Study|Progressive disease clinical|0|||
145508386|NCT00481091|524720272|FG005|Overall Study|Progressive disease clinical|0|||
145508387|NCT00481091|524720273|FG006|Overall Study|Progressive disease clinical|0|||
145508388|NCT00481091|524720274|FG007|Overall Study|Progressive disease clinical|0|||
145508389|NCT00481091|524720275|FG008|Overall Study|Progressive disease clinical|1|||
145508390|NCT00481091|524720276|FG009|Overall Study|Progressive disease clinical|7|||
145508391|NCT00481091|524720267|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
145508392|NCT00481091|524720268|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
145508393|NCT00481091|524720269|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508394|NCT00481091|524720270|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508395|NCT00481091|524720271|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508396|NCT00481091|524720272|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
145508397|NCT00481091|524720273|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508398|NCT00481091|524720274|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508399|NCT00481091|524720275|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508400|NCT00481091|524720276|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
145508401|NCT00481091|524720267|FG000|Overall Study|Progressive disease other|1|||
145508402|NCT00481091|524720268|FG001|Overall Study|Progressive disease other|1|||
145508403|NCT00481091|524720269|FG002|Overall Study|Progressive disease other|0|||
145508404|NCT00481091|524720270|FG003|Overall Study|Progressive disease other|1|||
145508405|NCT00481091|524720271|FG004|Overall Study|Progressive disease other|1|||
145508406|NCT00481091|524720272|FG005|Overall Study|Progressive disease other|1|||
145508407|NCT00481091|524720273|FG006|Overall Study|Progressive disease other|0|||
145508408|NCT00481091|524720274|FG007|Overall Study|Progressive disease other|2|||
145508409|NCT00481091|524720275|FG008|Overall Study|Progressive disease other|0|||
145508410|NCT00481091|524720276|FG009|Overall Study|Progressive disease other|0|||
145508411|NCT00481091|524720267|FG000|Overall Study|No reason given|0|||
145508412|NCT00481091|524720268|FG001|Overall Study|No reason given|0|||
145508413|NCT00481091|524720269|FG002|Overall Study|No reason given|1|||
145508414|NCT00481091|524720270|FG003|Overall Study|No reason given|1|||
145508415|NCT00481091|524720271|FG004|Overall Study|No reason given|1|||
145508416|NCT00481091|524720272|FG005|Overall Study|No reason given|0|||
145508417|NCT00481091|524720273|FG006|Overall Study|No reason given|1|||
145508418|NCT00481091|524720274|FG007|Overall Study|No reason given|1|||
145508419|NCT00481091|524720275|FG008|Overall Study|No reason given|1|||
145508420|NCT00481091|524720276|FG009|Overall Study|No reason given|4|||
145508421|NCT00475306|524720277|FG000|Overall Study|Protocol Violation|1|||
145508422|NCT00475306|524720278|FG001|Overall Study|Protocol Violation|1|||
145508423|NCT00475306|524720279|FG002|Overall Study|Protocol Violation|0|||
145508424|NCT00475306|524720280|FG003|Overall Study|Protocol Violation|1|||
145508425|NCT04294680|524720281|FG000|Overall Study|Withdrawal by Subject|2|||
145508426|NCT04294680|524720282|FG001|Overall Study|Withdrawal by Subject|1|||
145508427|NCT04294680|524720281|FG000|Overall Study|Follow-up visits completed outside of window|1|||
145508428|NCT04294680|524720282|FG001|Overall Study|Follow-up visits completed outside of window|0|||
145508429|NCT02881567|524720283|FG000|Overall Study|Adverse Event|1|||
145508430|NCT02881567|524720283|FG000|Overall Study|Lost to Follow-up|3|||
145508431|NCT02881567|524720283|FG000|Overall Study|Consent withdrawn|1|||
145508432|NCT02881567|524720283|FG000|Overall Study|Investigator decision|1|||
145401343|NCT01326871|524326499|FG001|Overall Study|SAE and death|2|||
145401344|NCT01326871|524326500|FG002|Overall Study|SAE and death|0|||
145401345|NCT01326871|524326498|FG000|Overall Study|Physician decision and decreased performance status|0|||
145401346|NCT01326871|524326499|FG001|Overall Study|Physician decision and decreased performance status|1|||
145401347|NCT01326871|524326500|FG002|Overall Study|Physician decision and decreased performance status|0|||
145401348|NCT01326871|524326498|FG000|Overall Study|Disease progression|0|||
145401349|NCT01326871|524326499|FG001|Overall Study|Disease progression|11|||
145401350|NCT01326871|524326500|FG002|Overall Study|Disease progression|5|||
145401351|NCT01326871|524326498|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
145401352|NCT01326871|524326499|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
145401353|NCT01326871|524326500|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
145401354|NCT01326871|524326498|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
145401355|NCT01326871|524326499|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
145401356|NCT01326871|524326500|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
145401357|NCT01326871|524326498|FG000|Overall Study|Withdrawal by Subject|0|||
145401358|NCT01326871|524326499|FG001|Overall Study|Withdrawal by Subject|1|||
145401359|NCT01326871|524326500|FG002|Overall Study|Withdrawal by Subject|0|||
145401360|NCT01326871|524326498|FG000|Overall Study|DLT|0|||
145401361|NCT01326871|524326499|FG001|Overall Study|DLT|2|||
145401362|NCT01326871|524326500|FG002|Overall Study|DLT|0|||
145401363|NCT01326871|524326498|FG000|Overall Study|SAE, disease progression and subject decision|0|||
145401364|NCT01326871|524326499|FG001|Overall Study|SAE, disease progression and subject decision|1|||
145401365|NCT01326871|524326500|FG002|Overall Study|SAE, disease progression and subject decision|0|||
145401366|NCT01326871|524326498|FG000|Overall Study|Death|0|||
145401367|NCT01326871|524326499|FG001|Overall Study|Death|1|||
145401368|NCT01326871|524326500|FG002|Overall Study|Death|0|||
145401369|NCT01326871|524326498|FG000|Overall Study|Other|0|||
145401370|NCT01326871|524326499|FG001|Overall Study|Other|3|||
145401371|NCT01326871|524326500|FG002|Overall Study|Other|0|||
145401372|NCT01326871|524326498|FG000|Overall Study|SAE and disease progression|0|||
145401373|NCT01326871|524326499|FG001|Overall Study|SAE and disease progression|0|||
145401374|NCT01326871|524326500|FG002|Overall Study|SAE and disease progression|1|||
145401375|NCT01326871|524326498|FG000|Overall Study|SAE and physician decision|0|||
145401376|NCT01326871|524326499|FG001|Overall Study|SAE and physician decision|0|||
145401377|NCT01326871|524326500|FG002|Overall Study|SAE and physician decision|1|||
145401378|NCT01326871|524326498|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
145401379|NCT01326871|524326499|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
145401380|NCT01326871|524326500|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
145401381|NCT01326871|524326498|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
145401382|NCT01326871|524326499|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
145401383|NCT01326871|524326500|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
145401384|NCT01326871|524326498|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
145401385|NCT01326871|524326499|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
145401386|NCT01326871|524326500|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
145401387|NCT01326871|524326498|FG000|Overall Study|Physician Decision|0|||
145401388|NCT01326871|524326499|FG001|Overall Study|Physician Decision|0|||
145401389|NCT01326871|524326500|FG002|Overall Study|Physician Decision|1|||
145401390|NCT01326871|524326498|FG000|Overall Study|SAE|0|||
145401391|NCT01326871|524326499|FG001|Overall Study|SAE|0|||
145401392|NCT01326871|524326500|FG002|Overall Study|SAE|1|||
145401393|NCT01326871|524326498|FG000|Overall Study|Disease progression and death|0|||
145401394|NCT01326871|524326499|FG001|Overall Study|Disease progression and death|0|||
145401395|NCT01326871|524326500|FG002|Overall Study|Disease progression and death|1|||
145401396|NCT01326871|524326498|FG000|Overall Study|Subject decision|0|||
145401397|NCT01326871|524326499|FG001|Overall Study|Subject decision|0|||
145401398|NCT01326871|524326500|FG002|Overall Study|Subject decision|1|||
145401399|NCT00251758|524326501|FG000|Overall Study|Adverse Event|7|||
145508433|NCT02881567|524720283|FG000|Overall Study|Study terminated by sponsor|9|||
145508434|NCT02881567|524720283|FG000|Overall Study|Reason not Specified|3|||
145508435|NCT02405442|524720284|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
145508436|NCT02405442|524720285|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
145508437|NCT02405442|524720286|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
145508438|NCT02405442|524720287|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
145508439|NCT02405442|524720284|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
145508440|NCT02405442|524720285|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
145508441|NCT02405442|524720286|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
145508442|NCT02405442|524720287|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
145508443|NCT02405442|524720284|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
145508444|NCT02405442|524720285|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
145508445|NCT02405442|524720286|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
145508446|NCT02405442|524720287|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
145508447|NCT02405442|524720284|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
145508448|NCT02405442|524720285|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
145508449|NCT02405442|524720286|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
145508450|NCT02405442|524720287|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
145508451|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
145508452|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
145508453|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
145508454|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
145508455|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
145508456|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
145508457|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
145508458|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
145508459|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
145508460|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
145508461|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
145508462|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
145508463|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
145508464|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
145508465|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
145508466|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
145508467|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
145508468|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
145508469|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
145508470|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
145508471|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
145508472|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
145508473|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
145508474|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
145508475|NCT02405442|524720284|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
145508476|NCT02405442|524720285|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
145508477|NCT02405442|524720286|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
145508478|NCT02405442|524720287|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
145508479|NCT02405442|524720284|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
145508480|NCT02405442|524720285|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
145508481|NCT02405442|524720286|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
145508482|NCT02405442|524720287|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
145508483|NCT02405442|524720284|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
145508484|NCT02405442|524720285|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
145508485|NCT02405442|524720286|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
145508486|NCT02405442|524720287|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
145401400|NCT00251758|524326502|FG001|Overall Study|Adverse Event|9|||
145401401|NCT00251758|524326503|FG002|Overall Study|Adverse Event|11|||
145401402|NCT00251758|524326501|FG000|Overall Study|Lost to Follow-up|4|||
145401403|NCT00251758|524326502|FG001|Overall Study|Lost to Follow-up|2|||
145401404|NCT00251758|524326503|FG002|Overall Study|Lost to Follow-up|5|||
145401405|NCT00251758|524326501|FG000|Overall Study|Withdrawal by Subject|13|||
145401406|NCT00251758|524326502|FG001|Overall Study|Withdrawal by Subject|7|||
145401407|NCT00251758|524326503|FG002|Overall Study|Withdrawal by Subject|3|||
145401408|NCT00251758|524326501|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145401409|NCT00251758|524326502|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
145401410|NCT00251758|524326503|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
145401411|NCT00251758|524326501|FG000|Overall Study|Lack of Efficacy|3|||
145401412|NCT00251758|524326502|FG001|Overall Study|Lack of Efficacy|0|||
145401413|NCT00251758|524326503|FG002|Overall Study|Lack of Efficacy|0|||
145401414|NCT00251758|524326501|FG000|Overall Study|Noncompliant|0|||
145401415|NCT00251758|524326502|FG001|Overall Study|Noncompliant|2|||
145401416|NCT00251758|524326503|FG002|Overall Study|Noncompliant|2|||
145401417|NCT00251758|524326501|FG000|Overall Study|Pregnancy|0|||
145401418|NCT00251758|524326502|FG001|Overall Study|Pregnancy|1|||
145401419|NCT00251758|524326503|FG002|Overall Study|Pregnancy|0|||
145401420|NCT00251758|524326501|FG000|Overall Study|Per Subject Request|0|||
145401421|NCT00251758|524326502|FG001|Overall Study|Per Subject Request|0|||
145401422|NCT00251758|524326503|FG002|Overall Study|Per Subject Request|1|||
145401423|NCT00251758|524326501|FG000|Overall Study|Per Investigator Request|1|||
145401424|NCT00251758|524326502|FG001|Overall Study|Per Investigator Request|0|||
145401425|NCT00251758|524326503|FG002|Overall Study|Per Investigator Request|0|||
145401426|NCT01387269|524326505|FG000|Overall Study|Death|38|||
145401427|NCT01387269|524326506|FG001|Overall Study|Death|20|||
145401428|NCT01387269|524326505|FG000|Overall Study|Other|8|||
145401429|NCT01387269|524326506|FG001|Overall Study|Other|7|||
145401430|NCT01387269|524326505|FG000|Overall Study|Unrelated AE|12|||
145401431|NCT01387269|524326506|FG001|Overall Study|Unrelated AE|3|||
145401432|NCT01387269|524326505|FG000|Overall Study|Withdrawal by patient|32|||
145401433|NCT01387269|524326506|FG001|Overall Study|Withdrawal by patient|10|||
145401434|NCT01387269|524326505|FG000|Overall Study|Study drug-related AE|1|||
145401435|NCT01387269|524326506|FG001|Overall Study|Study drug-related AE|0|||
145401436|NCT01387269|524326505|FG000|Overall Study|Lost to Follow-up|1|||
145401437|NCT01387269|524326506|FG001|Overall Study|Lost to Follow-up|0|||
145401438|NCT01200329|524326507|FG000|Overall Study|Lack of financial coverage|2|||
145401439|NCT01200329|524326507|FG000|Overall Study|Progressive disease|1|||
145401440|NCT03641508|524326510|FG000|First Injection|Lost to Follow-up|2|||
145401441|NCT03641508|524326511|FG001|First Injection|Lost to Follow-up|0|||
145401442|NCT02404545|524326512|FG000|Overall Study|Sponsor Termination|6|||
145401443|NCT02404545|524326513|FG001|Overall Study|Sponsor Termination|6|||
145401444|NCT02577029|524326516|FG000|Overall Study|Adverse Event|1|||
145401445|NCT02577029|524326517|FG001|Overall Study|Adverse Event|0|||
145401446|NCT02577029|524326518|FG002|Overall Study|Adverse Event|2|||
145401447|NCT02577029|524326519|FG003|Overall Study|Adverse Event|0|||
145401448|NCT02577029|524326520|FG004|Overall Study|Adverse Event|1|||
145508487|NCT02405442|524720284|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
145508488|NCT02405442|524720285|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
145508489|NCT02405442|524720286|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
145508490|NCT02405442|524720287|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
145508491|NCT00373113|524720288|FG000|Overall Study|Death|1|||
145508492|NCT00373113|524720289|FG001|Overall Study|Death|7|||
145508493|NCT00373113|524720288|FG000|Overall Study|Adverse Event|38|||
145508494|NCT00373113|524720289|FG001|Overall Study|Adverse Event|24|||
145401449|NCT02577029|524326521|FG005|Overall Study|Adverse Event|0|||
145401450|NCT02577029|524326522|FG006|Overall Study|Adverse Event|0|||
145401451|NCT02577029|524326523|FG007|Overall Study|Adverse Event|0|||
145401452|NCT02577029|524326516|FG000|Overall Study|Withdrawal by Subject|0|||
145401453|NCT02577029|524326517|FG001|Overall Study|Withdrawal by Subject|0|||
145401454|NCT02577029|524326518|FG002|Overall Study|Withdrawal by Subject|0|||
145401455|NCT02577029|524326519|FG003|Overall Study|Withdrawal by Subject|0|||
145401456|NCT02577029|524326520|FG004|Overall Study|Withdrawal by Subject|0|||
145401457|NCT02577029|524326521|FG005|Overall Study|Withdrawal by Subject|1|||
145401458|NCT02577029|524326522|FG006|Overall Study|Withdrawal by Subject|0|||
145401459|NCT02577029|524326523|FG007|Overall Study|Withdrawal by Subject|0|||
145401460|NCT02577029|524326516|FG000|Overall Study|Sponsor Termination of the Study|9|||
145401461|NCT02577029|524326517|FG001|Overall Study|Sponsor Termination of the Study|2|||
145401462|NCT02577029|524326518|FG002|Overall Study|Sponsor Termination of the Study|5|||
145401463|NCT02577029|524326519|FG003|Overall Study|Sponsor Termination of the Study|12|||
145401464|NCT02577029|524326520|FG004|Overall Study|Sponsor Termination of the Study|10|||
145401465|NCT02577029|524326521|FG005|Overall Study|Sponsor Termination of the Study|12|||
145401466|NCT02577029|524326522|FG006|Overall Study|Sponsor Termination of the Study|12|||
145401467|NCT02577029|524326523|FG007|Overall Study|Sponsor Termination of the Study|12|||
145401468|NCT02078817|524326524|FG000|Overall Study|Withdrawal by Subject|1|||
145401469|NCT00855218|524326525|FG000|Overall Study|Adverse Event|43|||
145401470|NCT00855218|524326526|FG001|Overall Study|Adverse Event|27|||
145401471|NCT00855218|524326525|FG000|Overall Study|Withdrawal by Subject|10|||
145401472|NCT00855218|524326526|FG001|Overall Study|Withdrawal by Subject|6|||
145401473|NCT00855218|524326525|FG000|Overall Study|Physician Decision|18|||
145401474|NCT00855218|524326526|FG001|Overall Study|Physician Decision|11|||
145401475|NCT00855218|524326525|FG000|Overall Study|Lost to Follow-up|0|||
145401476|NCT00855218|524326526|FG001|Overall Study|Lost to Follow-up|1|||
145401477|NCT00855218|524326525|FG000|Overall Study|Protocol Violation|5|||
145401478|NCT00855218|524326526|FG001|Overall Study|Protocol Violation|9|||
145401479|NCT00855218|524326525|FG000|Overall Study|non-compliant with study drug|3|||
145401480|NCT00855218|524326526|FG001|Overall Study|non-compliant with study drug|1|||
145401481|NCT00855218|524326525|FG000|Overall Study|patient convenience|2|||
145401482|NCT00855218|524326526|FG001|Overall Study|patient convenience|0|||
145401483|NCT00855218|524326525|FG000|Overall Study|technical problems|2|||
145401484|NCT00855218|524326526|FG001|Overall Study|technical problems|1|||
145401485|NCT00855218|524326525|FG000|Overall Study|Still treated with study medication|0|||
145401486|NCT00855218|524326526|FG001|Overall Study|Still treated with study medication|1|||
145401487|NCT00855218|524326525|FG000|Overall Study|Untreatable disease progression|54|||
145401488|NCT00855218|524326526|FG001|Overall Study|Untreatable disease progression|67|||
145401489|NCT00855218|524326525|FG000|Overall Study|Second malignancy|0|||
145401490|NCT00855218|524326526|FG001|Overall Study|Second malignancy|1|||
145401491|NCT00855218|524326525|FG000|Overall Study|Progression measurement proven|7|||
145401492|NCT00855218|524326526|FG001|Overall Study|Progression measurement proven|15|||
145401493|NCT00855218|524326525|FG000|Overall Study|Clinical endpoint reached|10|||
145401494|NCT00855218|524326526|FG001|Overall Study|Clinical endpoint reached|13|||
145401495|NCT00769561|524326528|FG000|Overall Study|Withdrawal by Subject|2|||
145401496|NCT00769561|524326529|FG001|Overall Study|Withdrawal by Subject|2|||
145401497|NCT00769561|524326528|FG000|Overall Study|Lost to Follow-up|1|||
145401498|NCT00769561|524326529|FG001|Overall Study|Lost to Follow-up|3|||
145401499|NCT03824561|524326537|FG000|Overall Study|Protocol Violation|19|||
145401500|NCT03191552|524326538|FG000|Overall Study|Lost to Follow-up|1|||
145401501|NCT03191552|524326539|FG001|Overall Study|Lost to Follow-up|0|||
145401502|NCT03191552|524326540|FG002|Overall Study|Lost to Follow-up|0|||
145401503|NCT03191552|524326538|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
145401504|NCT03191552|524326539|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
145401505|NCT03191552|524326540|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
145401506|NCT02370511|524326541|FG000|Overall Study|Death|10|||
145401507|NCT02370511|524326542|FG001|Overall Study|Death|7|||
145401508|NCT02370511|524326543|FG002|Overall Study|Death|1|||
145401509|NCT02370511|524326541|FG000|Overall Study|Withdrawal by Subject|2|||
145401510|NCT02370511|524326542|FG001|Overall Study|Withdrawal by Subject|0|||
145401511|NCT02370511|524326543|FG002|Overall Study|Withdrawal by Subject|0|||
145401512|NCT02370511|524326541|FG000|Overall Study|Lost to Follow-up|0|||
145401513|NCT02370511|524326542|FG001|Overall Study|Lost to Follow-up|4|||
145401514|NCT02370511|524326543|FG002|Overall Study|Lost to Follow-up|0|||
145401515|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
145401516|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145401517|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145401518|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
145508495|NCT00373113|524720288|FG000|Overall Study|Study terminated by sponsor|9|||
145508496|NCT00373113|524720289|FG001|Overall Study|Study terminated by sponsor|1|||
145508497|NCT00373113|524720288|FG000|Overall Study|Global deterioration of health status|10|||
145508498|NCT00373113|524720289|FG001|Overall Study|Global deterioration of health status|7|||
145508499|NCT00373113|524720288|FG000|Overall Study|Lost to Follow-up|1|||
145508500|NCT00373113|524720289|FG001|Overall Study|Lost to Follow-up|3|||
145508501|NCT00373113|524720288|FG000|Overall Study|Objective progression or relapse|150|||
145508502|NCT00373113|524720289|FG001|Overall Study|Objective progression or relapse|169|||
145508503|NCT00373113|524720288|FG000|Overall Study|Other|14|||
145508504|NCT00373113|524720289|FG001|Overall Study|Other|17|||
145508505|NCT00373113|524720288|FG000|Overall Study|Protocol Violation|5|||
145508506|NCT00373113|524720289|FG001|Overall Study|Protocol Violation|1|||
145508507|NCT00373113|524720288|FG000|Overall Study|Withdrawal by Subject|10|||
145508508|NCT00373113|524720289|FG001|Overall Study|Withdrawal by Subject|15|||
145508509|NCT02078960|524720290|FG000|Treatment Period|Other|0|||
145508510|NCT02078960|524720291|FG001|Treatment Period|Other|0|||
145508511|NCT02078960|524720292|FG002|Treatment Period|Other|1|||
145508512|NCT02078960|524720290|FG000|Treatment Period|Lack of Efficacy|0|||
145508513|NCT02078960|524720291|FG001|Treatment Period|Lack of Efficacy|1|||
145508514|NCT02078960|524720292|FG002|Treatment Period|Lack of Efficacy|0|||
145508515|NCT02078960|524720290|FG000|Treatment Period|Disease progression - accelerated phase|0|||
145508516|NCT02078960|524720291|FG001|Treatment Period|Disease progression - accelerated phase|1|||
145508517|NCT02078960|524720292|FG002|Treatment Period|Disease progression - accelerated phase|0|||
145508518|NCT02078960|524720290|FG000|Treatment Period|Disease progression - blast phase|1|||
145508519|NCT02078960|524720291|FG001|Treatment Period|Disease progression - blast phase|0|||
145508520|NCT02078960|524720292|FG002|Treatment Period|Disease progression - blast phase|0|||
145508521|NCT02078960|524720290|FG000|Treatment Period|Withdrawal by Subject|0|||
145508522|NCT02078960|524720291|FG001|Treatment Period|Withdrawal by Subject|1|||
145508523|NCT02078960|524720292|FG002|Treatment Period|Withdrawal by Subject|1|||
145508524|NCT02078960|524720290|FG000|Treatment Period|Adverse Event|1|||
145508525|NCT02078960|524720291|FG001|Treatment Period|Adverse Event|0|||
145508526|NCT02078960|524720292|FG002|Treatment Period|Adverse Event|0|||
145508527|NCT02078960|524720290|FG000|Treatment Period|Death|0|||
145508528|NCT02078960|524720291|FG001|Treatment Period|Death|0|||
145508529|NCT02078960|524720292|FG002|Treatment Period|Death|1|||
145508530|NCT02078960|524720290|FG000|Follow-up Period|Death|2|||
145508531|NCT02078960|524720291|FG001|Follow-up Period|Death|0|||
145508532|NCT02078960|524720292|FG002|Follow-up Period|Death|0|||
145508533|NCT02078960|524720290|FG000|Follow-up Period|Lost to Follow-up|0|||
145508534|NCT02078960|524720291|FG001|Follow-up Period|Lost to Follow-up|1|||
145508535|NCT02078960|524720292|FG002|Follow-up Period|Lost to Follow-up|0|||
145508536|NCT03275350|524720293|FG000|Overall Study|Lost to Follow-up|4|||
145508537|NCT03275350|524720294|FG001|Overall Study|Lost to Follow-up|6|||
145508538|NCT03275350|524720293|FG000|Overall Study|Death|2|||
145508539|NCT03275350|524720294|FG001|Overall Study|Death|1|||
145508540|NCT03275350|524720293|FG000|Overall Study|Physician Decision|1|||
145508541|NCT03275350|524720294|FG001|Overall Study|Physician Decision|0|||
145508542|NCT03275350|524720293|FG000|Overall Study|Incarcerated|1|||
145508543|NCT03275350|524720294|FG001|Overall Study|Incarcerated|1|||
145508544|NCT04661579|524720297|FG000|Overall Study|Lost to Follow-up|19|||
145508545|NCT04661579|524720298|FG001|Overall Study|Lost to Follow-up|10|||
145508546|NCT04661579|524720299|FG002|Overall Study|Lost to Follow-up|2|||
145508547|NCT04661579|524720300|FG003|Overall Study|Lost to Follow-up|7|||
145508548|NCT04661579|524720301|FG004|Overall Study|Lost to Follow-up|11|||
145508549|NCT04661579|524720297|FG000|Overall Study|Physician Decision|2|||
145508550|NCT04661579|524720298|FG001|Overall Study|Physician Decision|0|||
145508551|NCT04661579|524720299|FG002|Overall Study|Physician Decision|0|||
145508552|NCT04661579|524720300|FG003|Overall Study|Physician Decision|1|||
145508553|NCT04661579|524720301|FG004|Overall Study|Physician Decision|0|||
145508554|NCT04661579|524720297|FG000|Overall Study|Withdrawal by Subject|1|||
145508555|NCT04661579|524720298|FG001|Overall Study|Withdrawal by Subject|4|||
145508556|NCT04661579|524720299|FG002|Overall Study|Withdrawal by Subject|0|||
145508557|NCT04661579|524720300|FG003|Overall Study|Withdrawal by Subject|2|||
145508558|NCT04661579|524720301|FG004|Overall Study|Withdrawal by Subject|0|||
145508559|NCT04661579|524720297|FG000|Overall Study|Death|1|||
145508560|NCT04661579|524720298|FG001|Overall Study|Death|0|||
145508561|NCT04661579|524720299|FG002|Overall Study|Death|0|||
145508562|NCT04661579|524720300|FG003|Overall Study|Death|0|||
145508563|NCT04661579|524720301|FG004|Overall Study|Death|0|||
145508564|NCT04661579|524720297|FG000|Overall Study|Other|1|||
145508565|NCT04661579|524720298|FG001|Overall Study|Other|2|||
145508566|NCT04661579|524720299|FG002|Overall Study|Other|1|||
145508567|NCT04661579|524720300|FG003|Overall Study|Other|1|||
145508568|NCT04661579|524720301|FG004|Overall Study|Other|1|||
145401519|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
145401520|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145401521|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145401522|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
145401523|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
145401524|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145401525|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145401526|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145401527|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
145401528|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
145401529|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
145401530|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
145401531|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
145401532|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145401533|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145401534|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145401535|NCT01149655|524326544|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
145401536|NCT01149655|524326545|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145401537|NCT01149655|524326546|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145401538|NCT01149655|524326547|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
145401539|NCT01149655|524326544|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145401540|NCT01149655|524326545|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
145401541|NCT01149655|524326546|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145401542|NCT01149655|524326547|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
145401543|NCT01149655|524326544|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145401544|NCT01149655|524326545|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
145401545|NCT01149655|524326546|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145401546|NCT01149655|524326547|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
145508569|NCT04661579|524720297|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
145508570|NCT04661579|524720298|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
145508571|NCT04661579|524720299|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
145508572|NCT04661579|524720300|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
145508573|NCT04661579|524720301|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
145508574|NCT01396447|524720302|FG000|Overall Study|Did Not Receive Treatment|3|||
145508575|NCT01396447|524720303|FG001|Overall Study|Did Not Receive Treatment|2|||
145508576|NCT01396447|524720304|FG002|Overall Study|Did Not Receive Treatment|1|||
145508577|NCT01396447|524720305|FG003|Overall Study|Did Not Receive Treatment|0|||
145508578|NCT01396447|524720302|FG000|Overall Study|Adverse Event|15|||
145508579|NCT01396447|524720303|FG001|Overall Study|Adverse Event|12|||
145508580|NCT01396447|524720304|FG002|Overall Study|Adverse Event|12|||
145508581|NCT01396447|524720305|FG003|Overall Study|Adverse Event|17|||
145508582|NCT01396447|524720302|FG000|Overall Study|Insufficient Therapeutic Response|5|||
145508583|NCT01396447|524720303|FG001|Overall Study|Insufficient Therapeutic Response|5|||
145508584|NCT01396447|524720304|FG002|Overall Study|Insufficient Therapeutic Response|2|||
145508585|NCT01396447|524720305|FG003|Overall Study|Insufficient Therapeutic Response|4|||
145508586|NCT01396447|524720302|FG000|Overall Study|Protocol Violation|5|||
145508587|NCT01396447|524720303|FG001|Overall Study|Protocol Violation|2|||
145508588|NCT01396447|524720304|FG002|Overall Study|Protocol Violation|3|||
145508589|NCT01396447|524720305|FG003|Overall Study|Protocol Violation|7|||
145508590|NCT01396447|524720302|FG000|Overall Study|Withdrawal of Consent|11|||
145508591|NCT01396447|524720303|FG001|Overall Study|Withdrawal of Consent|9|||
145508592|NCT01396447|524720304|FG002|Overall Study|Withdrawal of Consent|4|||
145508593|NCT01396447|524720305|FG003|Overall Study|Withdrawal of Consent|15|||
145508594|NCT01396447|524720302|FG000|Overall Study|Lost to Follow-up|4|||
145508595|NCT01396447|524720303|FG001|Overall Study|Lost to Follow-up|8|||
145508596|NCT01396447|524720304|FG002|Overall Study|Lost to Follow-up|7|||
145508597|NCT01396447|524720305|FG003|Overall Study|Lost to Follow-up|9|||
145508598|NCT01396447|524720302|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145508599|NCT01396447|524720303|FG001|Overall Study|Other Miscellaneous Reasons|2|||
145508600|NCT01396447|524720304|FG002|Overall Study|Other Miscellaneous Reasons|1|||
145508601|NCT01396447|524720305|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145508602|NCT01402102|524720307|FG000|Overall Study|Protocol Violation|1|||
145508603|NCT01402102|524720308|FG001|Overall Study|Protocol Violation|0|||
145508604|NCT01402102|524720307|FG000|Overall Study|Insufficiency of compliance|1|||
145508605|NCT01402102|524720308|FG001|Overall Study|Insufficiency of compliance|1|||
145508606|NCT01402102|524720307|FG000|Overall Study|Withdrawal by Subject|0|||
145508607|NCT01402102|524720308|FG001|Overall Study|Withdrawal by Subject|2|||
145508608|NCT01386970|524720309|FG000|Overall Study|Withdrawal by Subject|0|||
145508609|NCT01386970|524720310|FG001|Overall Study|Withdrawal by Subject|1|||
145508610|NCT01386970|524720309|FG000|Overall Study|Adverse Event|4|||
145508611|NCT01386970|524720310|FG001|Overall Study|Adverse Event|1|||
145508612|NCT02423902|524720312|FG000|Overall Study|Disease progression|1|||
145508613|NCT02423902|524720313|FG001|Overall Study|Disease progression|4|||
145508614|NCT04329806|524720314|FG000|Overall Study|Physician Decision|3|||
145508615|NCT04329806|524720315|FG001|Overall Study|Physician Decision|4|||
145508616|NCT04838626|524720316|FG000|Overall Study|Adverse Event|2|||
145508617|NCT04838626|524720316|FG000|Overall Study|Physician Decision|6|||
145508618|NCT04838626|524720316|FG000|Overall Study|Protocol Violation|3|||
145508619|NCT04838626|524720316|FG000|Overall Study|Withdrawal by Subject|9|||
145508620|NCT04838626|524720316|FG000|Overall Study|Technical Problems|2|||
145508621|NCT02867384|524720317|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
145508622|NCT02867384|524720318|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
145508623|NCT02867384|524720319|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
145508624|NCT02867384|524720317|FG000|Overall Study|Progression/ Relapse|15|||
145508625|NCT02867384|524720318|FG001|Overall Study|Progression/ Relapse|19|||
145508626|NCT02867384|524720319|FG002|Overall Study|Progression/ Relapse|0|||
145508627|NCT02867384|524720317|FG000|Overall Study|Adverse Event|13|||
145508628|NCT02867384|524720318|FG001|Overall Study|Adverse Event|1|||
145508629|NCT02867384|524720319|FG002|Overall Study|Adverse Event|0|||
145508630|NCT02867384|524720317|FG000|Overall Study|Withdrawal by Subject|6|||
145508631|NCT02867384|524720318|FG001|Overall Study|Withdrawal by Subject|5|||
145508632|NCT02867384|524720319|FG002|Overall Study|Withdrawal by Subject|0|||
145508633|NCT02867384|524720317|FG000|Overall Study|Physician Decision|1|||
145508634|NCT02867384|524720318|FG001|Overall Study|Physician Decision|2|||
145508635|NCT02867384|524720319|FG002|Overall Study|Physician Decision|0|||
145508636|NCT02867384|524720317|FG000|Overall Study|Patient compliance|1|||
145508637|NCT02867384|524720318|FG001|Overall Study|Patient compliance|0|||
145508638|NCT02867384|524720319|FG002|Overall Study|Patient compliance|0|||
145508639|NCT02867384|524720317|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
145508640|NCT02867384|524720318|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
145508641|NCT02867384|524720319|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
145508642|NCT02867384|524720317|FG000|Overall Study|Never start treatment|3|||
145508643|NCT02867384|524720318|FG001|Overall Study|Never start treatment|0|||
145508644|NCT02867384|524720319|FG002|Overall Study|Never start treatment|0|||
145508645|NCT03901469|524720320|FG000|Overall Study|Radiographic Progression|4|||
145508646|NCT03901469|524720321|FG001|Overall Study|Radiographic Progression|6|||
145508647|NCT03901469|524720322|FG002|Overall Study|Radiographic Progression|3|||
145508648|NCT03901469|524720323|FG003|Overall Study|Radiographic Progression|30|||
145508649|NCT03901469|524720324|FG004|Overall Study|Radiographic Progression|7|||
145508650|NCT03901469|524720325|FG005|Overall Study|Radiographic Progression|2|||
145508651|NCT03901469|524720326|FG006|Overall Study|Radiographic Progression|11|||
145508652|NCT03901469|524720320|FG000|Overall Study|Clinical Progression|0|||
145508653|NCT03901469|524720321|FG001|Overall Study|Clinical Progression|2|||
145508654|NCT03901469|524720322|FG002|Overall Study|Clinical Progression|0|||
145508655|NCT03901469|524720323|FG003|Overall Study|Clinical Progression|7|||
145508656|NCT03901469|524720324|FG004|Overall Study|Clinical Progression|6|||
145508657|NCT03901469|524720325|FG005|Overall Study|Clinical Progression|0|||
145508658|NCT03901469|524720326|FG006|Overall Study|Clinical Progression|2|||
145508659|NCT03901469|524720320|FG000|Overall Study|Adverse Event|1|||
145508660|NCT03901469|524720321|FG001|Overall Study|Adverse Event|0|||
145508661|NCT03901469|524720322|FG002|Overall Study|Adverse Event|0|||
145508662|NCT03901469|524720323|FG003|Overall Study|Adverse Event|0|||
145508663|NCT03901469|524720324|FG004|Overall Study|Adverse Event|0|||
145508664|NCT03901469|524720325|FG005|Overall Study|Adverse Event|0|||
145508665|NCT03901469|524720326|FG006|Overall Study|Adverse Event|9|||
145508666|NCT03901469|524720320|FG000|Overall Study|Physician Decision|0|||
145508667|NCT03901469|524720321|FG001|Overall Study|Physician Decision|0|||
145508668|NCT03901469|524720322|FG002|Overall Study|Physician Decision|0|||
145508669|NCT03901469|524720323|FG003|Overall Study|Physician Decision|1|||
145508670|NCT03901469|524720324|FG004|Overall Study|Physician Decision|0|||
145508671|NCT03901469|524720325|FG005|Overall Study|Physician Decision|0|||
145508672|NCT03901469|524720326|FG006|Overall Study|Physician Decision|0|||
145508673|NCT03901469|524720320|FG000|Overall Study|Withdrawal by Subject|0|||
145508674|NCT03901469|524720321|FG001|Overall Study|Withdrawal by Subject|0|||
145508675|NCT03901469|524720322|FG002|Overall Study|Withdrawal by Subject|0|||
145508676|NCT03901469|524720323|FG003|Overall Study|Withdrawal by Subject|0|||
145508677|NCT03901469|524720324|FG004|Overall Study|Withdrawal by Subject|2|||
145508678|NCT03901469|524720325|FG005|Overall Study|Withdrawal by Subject|0|||
145508679|NCT03901469|524720326|FG006|Overall Study|Withdrawal by Subject|8|||
145508680|NCT03901469|524720320|FG000|Overall Study|Death|0|||
145508681|NCT03901469|524720321|FG001|Overall Study|Death|0|||
145508682|NCT03901469|524720322|FG002|Overall Study|Death|0|||
145508683|NCT03901469|524720323|FG003|Overall Study|Death|3|||
145508684|NCT03901469|524720324|FG004|Overall Study|Death|5|||
145508685|NCT03901469|524720325|FG005|Overall Study|Death|0|||
145508686|NCT03901469|524720326|FG006|Overall Study|Death|1|||
145508687|NCT03901469|524720320|FG000|Overall Study|Termination of study by sponsor|0|||
145508688|NCT03901469|524720321|FG001|Overall Study|Termination of study by sponsor|0|||
145508689|NCT03901469|524720322|FG002|Overall Study|Termination of study by sponsor|0|||
145508690|NCT03901469|524720323|FG003|Overall Study|Termination of study by sponsor|0|||
145508691|NCT03901469|524720324|FG004|Overall Study|Termination of study by sponsor|1|||
145508692|NCT03901469|524720325|FG005|Overall Study|Termination of study by sponsor|1|||
145508693|NCT03901469|524720326|FG006|Overall Study|Termination of study by sponsor|0|||
145508694|NCT03901469|524720320|FG000|Overall Study|Not Reported|1|||
145508695|NCT03901469|524720321|FG001|Overall Study|Not Reported|0|||
145508696|NCT03901469|524720322|FG002|Overall Study|Not Reported|0|||
145508697|NCT03901469|524720323|FG003|Overall Study|Not Reported|1|||
145508698|NCT03901469|524720324|FG004|Overall Study|Not Reported|0|||
145401547|NCT01149655|524326544|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
145401548|NCT01149655|524326545|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
145401549|NCT01149655|524326546|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
145401550|NCT01149655|524326547|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
145401551|NCT01149655|524326544|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
145401552|NCT01149655|524326545|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
145401553|NCT01149655|524326546|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
145401554|NCT01149655|524326547|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
145401555|NCT01149655|524326544|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145401556|NCT01149655|524326545|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
145401557|NCT01149655|524326546|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145401558|NCT01149655|524326547|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
145401559|NCT01149655|524326544|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
145401560|NCT01149655|524326545|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
145401561|NCT01149655|524326546|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
145401562|NCT01149655|524326547|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
145401563|NCT01149655|524326544|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
145401564|NCT01149655|524326545|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
145401565|NCT01149655|524326546|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
145401566|NCT01149655|524326547|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
145401567|NCT01149655|524326544|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
145401568|NCT01149655|524326545|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
145401569|NCT01149655|524326546|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
145401570|NCT01149655|524326547|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
145401571|NCT01149655|524326544|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
145401572|NCT01149655|524326545|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
145401573|NCT01149655|524326546|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
145401574|NCT01149655|524326547|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
145401575|NCT01149655|524326544|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
145401576|NCT01149655|524326545|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
145401577|NCT01149655|524326546|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
145401578|NCT01149655|524326547|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
145401579|NCT01265498|524326550|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
145401580|NCT01265498|524326551|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
145401581|NCT00617279|524326556|FG000|Overall Study|Study terminated by Sponsor|10|||
145401582|NCT00617279|524326557|FG001|Overall Study|Study terminated by Sponsor|15|||
145401583|NCT00617279|524326556|FG000|Overall Study|Graft abandonment|2|||
145401584|NCT00617279|524326557|FG001|Overall Study|Graft abandonment|0|||
145401585|NCT00617279|524326556|FG000|Overall Study|Lost to Follow-up|1|||
145401586|NCT00617279|524326557|FG001|Overall Study|Lost to Follow-up|0|||
145401587|NCT00617279|524326556|FG000|Overall Study|Death|1|||
145401588|NCT00617279|524326557|FG001|Overall Study|Death|2|||
145401589|NCT00921024|524326560|FG000|Overall Study|Lost to Follow-up|2|||
145401590|NCT00921024|524326561|FG001|Overall Study|Lost to Follow-up|0|||
145401591|NCT00921024|524326560|FG000|Overall Study|Received concomittant therapy|2|||
145401592|NCT00921024|524326561|FG001|Overall Study|Received concomittant therapy|0|||
145401593|NCT00921024|524326560|FG000|Overall Study|Withdrawal by Subject|0|||
145401594|NCT00921024|524326561|FG001|Overall Study|Withdrawal by Subject|3|||
145401595|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Other than specified|2|||
145401596|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Other than specified|4|||
145401597|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
145401598|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
145401599|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Pregnancy|0|||
145401600|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Pregnancy|2|||
145401601|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Physician Decision|1|||
145401602|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Physician Decision|1|||
145401603|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
145401604|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
145508699|NCT03901469|524720325|FG005|Overall Study|Not Reported|0|||
145508700|NCT03901469|524720326|FG006|Overall Study|Not Reported|1|||
145508701|NCT03710083|524720327|FG000|Overall Study|Withdrawal by Subject|2|||
145508702|NCT03710083|524720327|FG000|Overall Study|Unsuccessful Procedure|1|||
145508703|NCT01727024|524720328|FG000|Period 1|Lost to Follow-up|1|||
145508704|NCT01727024|524720329|FG001|Period 1|Lost to Follow-up|1|||
145508705|NCT01727024|524720328|FG000|Period 1|Withdrawal by Subject|2|||
145508706|NCT01727024|524720329|FG001|Period 1|Withdrawal by Subject|3|||
145508707|NCT01485172|524720330|FG000|Overall Study|Adverse Event|2|||
145508708|NCT01485172|524720331|FG001|Overall Study|Adverse Event|1|||
145508709|NCT01485172|524720332|FG002|Overall Study|Adverse Event|2|||
145508710|NCT01485172|524720333|FG003|Overall Study|Adverse Event|2|||
145508711|NCT01485172|524720334|FG004|Overall Study|Adverse Event|1|||
145508712|NCT01485172|524720335|FG005|Overall Study|Adverse Event|2|||
145508713|NCT01485172|524720330|FG000|Overall Study|Lack of Efficacy|2|||
145508714|NCT01485172|524720331|FG001|Overall Study|Lack of Efficacy|0|||
145508715|NCT01485172|524720332|FG002|Overall Study|Lack of Efficacy|0|||
145508716|NCT01485172|524720333|FG003|Overall Study|Lack of Efficacy|0|||
145508717|NCT01485172|524720334|FG004|Overall Study|Lack of Efficacy|0|||
145508718|NCT01485172|524720335|FG005|Overall Study|Lack of Efficacy|0|||
145508719|NCT01485172|524720330|FG000|Overall Study|Protocol Violation|0|||
145508720|NCT01485172|524720331|FG001|Overall Study|Protocol Violation|0|||
145508721|NCT01485172|524720332|FG002|Overall Study|Protocol Violation|4|||
145508722|NCT01485172|524720333|FG003|Overall Study|Protocol Violation|5|||
145508723|NCT01485172|524720334|FG004|Overall Study|Protocol Violation|1|||
145508724|NCT01485172|524720335|FG005|Overall Study|Protocol Violation|0|||
145508725|NCT01485172|524720330|FG000|Overall Study|Protocol defined stopping criteria|1|||
145508726|NCT01485172|524720331|FG001|Overall Study|Protocol defined stopping criteria|0|||
145508727|NCT01485172|524720332|FG002|Overall Study|Protocol defined stopping criteria|0|||
145508728|NCT01485172|524720333|FG003|Overall Study|Protocol defined stopping criteria|0|||
145508729|NCT01485172|524720334|FG004|Overall Study|Protocol defined stopping criteria|1|||
145508730|NCT01485172|524720335|FG005|Overall Study|Protocol defined stopping criteria|0|||
145508731|NCT01485172|524720330|FG000|Overall Study|Lost to Follow-up|0|||
145508732|NCT01485172|524720331|FG001|Overall Study|Lost to Follow-up|0|||
145508733|NCT01485172|524720332|FG002|Overall Study|Lost to Follow-up|1|||
145508734|NCT01485172|524720333|FG003|Overall Study|Lost to Follow-up|0|||
145508735|NCT01485172|524720334|FG004|Overall Study|Lost to Follow-up|0|||
145508736|NCT01485172|524720335|FG005|Overall Study|Lost to Follow-up|1|||
145508737|NCT01485172|524720330|FG000|Overall Study|Physician Decision|0|||
145508738|NCT01485172|524720331|FG001|Overall Study|Physician Decision|0|||
145508739|NCT01485172|524720332|FG002|Overall Study|Physician Decision|0|||
145508740|NCT01485172|524720333|FG003|Overall Study|Physician Decision|0|||
145508741|NCT01485172|524720334|FG004|Overall Study|Physician Decision|1|||
145508742|NCT01485172|524720335|FG005|Overall Study|Physician Decision|0|||
145508743|NCT01485172|524720330|FG000|Overall Study|Withdrawal by Subject|2|||
145508744|NCT01485172|524720331|FG001|Overall Study|Withdrawal by Subject|0|||
145508745|NCT01485172|524720332|FG002|Overall Study|Withdrawal by Subject|0|||
145508746|NCT01485172|524720333|FG003|Overall Study|Withdrawal by Subject|1|||
145508747|NCT01485172|524720334|FG004|Overall Study|Withdrawal by Subject|1|||
145508748|NCT01485172|524720335|FG005|Overall Study|Withdrawal by Subject|1|||
145508749|NCT01587014|524720336|FG000|Overall Study|Death|2|||
145508750|NCT02948088|524720340|FG000|Overall Study|Lost to Follow-up|8|||
145508751|NCT02948088|524720340|FG000|Overall Study|Death|1|||
145508752|NCT02948088|524720340|FG000|Overall Study|Withdrawal by Subject|4|||
145508753|NCT02948088|524720340|FG000|Overall Study|Other|2|||
145508754|NCT01409811|524720341|FG000|Overall Study|Insurance denial|1|||
145508755|NCT00634101|524720342|FG000|Overall Study|Study Terminated|3|||
145508756|NCT00634101|524720343|FG001|Overall Study|Study Terminated|3|||
145508757|NCT00634101|524720342|FG000|Overall Study|Lost to Follow-up|2|||
145508758|NCT00634101|524720343|FG001|Overall Study|Lost to Follow-up|0|||
145508759|NCT00838513|524720345|FG000|Screening Period|Screen Failure|3|||
145508760|NCT00838513|524720345|FG000|Extension Treatment Period|Death|1|||
145508761|NCT00838513|524720345|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
145508762|NCT00139477|524720349|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
145508763|NCT00139477|524720350|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
145508764|NCT00139477|524720349|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
145508765|NCT00139477|524720350|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
145508766|NCT00139477|524720349|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
145508767|NCT00139477|524720350|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
145508768|NCT00139477|524720349|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
145508769|NCT00139477|524720350|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
145508770|NCT00139477|524720349|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
145508771|NCT00139477|524720350|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
145508772|NCT00139477|524720349|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
145508773|NCT00139477|524720350|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
145508774|NCT00139477|524720349|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
145508775|NCT00139477|524720350|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
145508776|NCT00975780|524720351|FG000|Follow Up|Death|88|||
145508777|NCT00975780|524720352|FG001|Follow Up|Death|122|||
145508778|NCT00975780|524720351|FG000|Follow Up|Facility Withdrawal|7|||
145508779|NCT00975780|524720352|FG001|Follow Up|Facility Withdrawal|23|||
145508780|NCT00975780|524720351|FG000|Follow Up|Discharged from Facility|7|||
145508781|NCT00975780|524720352|FG001|Follow Up|Discharged from Facility|12|||
145508782|NCT01077076|524720355|FG000|First Intervention|Withdrawal by Subject|1|||
145508783|NCT01077076|524720356|FG001|First Intervention|Withdrawal by Subject|0|||
145508784|NCT01077076|524720357|FG002|First Intervention|Withdrawal by Subject|0|||
145508785|NCT01077076|524720358|FG003|First Intervention|Withdrawal by Subject|0|||
145508786|NCT01077076|524720359|FG004|First Intervention|Withdrawal by Subject|0|||
145508787|NCT01077076|524720360|FG005|First Intervention|Withdrawal by Subject|0|||
145508788|NCT01077076|524720355|FG000|Third Intervention|Death in the participant's family|0|||
145508789|NCT01077076|524720356|FG001|Third Intervention|Death in the participant's family|0|||
145508790|NCT01077076|524720357|FG002|Third Intervention|Death in the participant's family|0|||
145508791|NCT01077076|524720358|FG003|Third Intervention|Death in the participant's family|0|||
145508792|NCT01077076|524720359|FG004|Third Intervention|Death in the participant's family|0|||
145508793|NCT01077076|524720360|FG005|Third Intervention|Death in the participant's family|1|||
145508794|NCT01976741|524720363|FG000|Overall Study|Withdrawal by Subject|1|||
145508795|NCT01976741|524720364|FG001|Overall Study|Withdrawal by Subject|0|||
145508796|NCT01976741|524720365|FG002|Overall Study|Withdrawal by Subject|1|||
145508797|NCT01976741|524720366|FG003|Overall Study|Withdrawal by Subject|1|||
145508798|NCT01976741|524720367|FG004|Overall Study|Withdrawal by Subject|0|||
145508799|NCT01976741|524720368|FG005|Overall Study|Withdrawal by Subject|0|||
145508800|NCT01976741|524720369|FG006|Overall Study|Withdrawal by Subject|1|||
145508801|NCT01976741|524720370|FG007|Overall Study|Withdrawal by Subject|4|||
145508802|NCT01976741|524720371|FG008|Overall Study|Withdrawal by Subject|0|||
145508803|NCT01976741|524720372|FG009|Overall Study|Withdrawal by Subject|0|||
145508804|NCT01976741|524720363|FG000|Overall Study|Adverse Event|0|||
145508805|NCT01976741|524720364|FG001|Overall Study|Adverse Event|0|||
145508806|NCT01976741|524720365|FG002|Overall Study|Adverse Event|2|||
145508807|NCT01976741|524720366|FG003|Overall Study|Adverse Event|0|||
145508808|NCT01976741|524720367|FG004|Overall Study|Adverse Event|0|||
145508809|NCT01976741|524720368|FG005|Overall Study|Adverse Event|0|||
145508810|NCT01976741|524720369|FG006|Overall Study|Adverse Event|3|||
145508811|NCT01976741|524720370|FG007|Overall Study|Adverse Event|8|||
145508812|NCT01976741|524720371|FG008|Overall Study|Adverse Event|1|||
145508813|NCT01976741|524720372|FG009|Overall Study|Adverse Event|4|||
145508814|NCT01415882|524720373|FG000|Overall Study|Ineligible|1|||
145508815|NCT01415882|524720374|FG001|Overall Study|Ineligible|0|||
145508816|NCT01415882|524720375|FG002|Overall Study|Ineligible|0|||
145508817|NCT01415882|524720376|FG003|Overall Study|Ineligible|3|||
145508818|NCT01415882|524720377|FG004|Overall Study|Ineligible|0|||
145508819|NCT01415882|524720373|FG000|Overall Study|Withdrawal by Subject|0|||
145508820|NCT01415882|524720374|FG001|Overall Study|Withdrawal by Subject|1|||
145508821|NCT01415882|524720375|FG002|Overall Study|Withdrawal by Subject|0|||
145508822|NCT01415882|524720376|FG003|Overall Study|Withdrawal by Subject|1|||
145508823|NCT01415882|524720377|FG004|Overall Study|Withdrawal by Subject|0|||
145508824|NCT00670306|524720378|FG000|Overall Study|Adverse Event|8|||
145508825|NCT00670306|524720378|FG000|Overall Study|Lack of Efficacy|10|||
145508826|NCT00670306|524720378|FG000|Overall Study|Withdrawal by Subject|9|||
145508827|NCT00670306|524720378|FG000|Overall Study|Physician Decision|1|||
145508828|NCT00670306|524720378|FG000|Overall Study|Lost to Follow-up|8|||
145508829|NCT00670306|524720378|FG000|Overall Study|incl/excl criterias did not meet|19|||
145508830|NCT01301027|524720379|FG000|Overall Study|Physician Decision|2|||
145508831|NCT01301027|524720380|FG001|Overall Study|Physician Decision|0|||
145508832|NCT01301027|524720379|FG000|Overall Study|Withdrawal by Subject|2|||
145508833|NCT01301027|524720380|FG001|Overall Study|Withdrawal by Subject|3|||
145508834|NCT01301027|524720379|FG000|Overall Study|Adverse Event|0|||
145508835|NCT01301027|524720380|FG001|Overall Study|Adverse Event|2|||
145508836|NCT01301027|524720379|FG000|Overall Study|Fracture|1|||
145508837|NCT01301027|524720380|FG001|Overall Study|Fracture|3|||
145508838|NCT01301027|524720379|FG000|Overall Study|Transplant|0|||
145508839|NCT01301027|524720380|FG001|Overall Study|Transplant|2|||
145508840|NCT01301027|524720379|FG000|Overall Study|Volume Overload|3|||
145508841|NCT01301027|524720380|FG001|Overall Study|Volume Overload|0|||
145508842|NCT03566485|524720381|FG000|Overall Study|Disease progression|5|||
145508843|NCT03566485|524720382|FG001|Overall Study|Disease progression|4|||
145508844|NCT03566485|524720381|FG000|Overall Study|Clinical progression|0|||
145508845|NCT03566485|524720382|FG001|Overall Study|Clinical progression|1|||
145508846|NCT03566485|524720381|FG000|Overall Study|Toxicity|0|||
145508847|NCT03566485|524720382|FG001|Overall Study|Toxicity|2|||
145508848|NCT00369265|524720383|FG000|Overall Study|Study terminated|4|||
145508849|NCT00369265|524720384|FG001|Overall Study|Study terminated|7|||
145508850|NCT01192191|524720385|FG000|Overall Study|Adverse Event|7|||
145508851|NCT01192191|524720386|FG001|Overall Study|Adverse Event|12|||
145508852|NCT01192191|524720385|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
145508853|NCT01192191|524720386|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
145508854|NCT01192191|524720385|FG000|Overall Study|Lost to Follow-up|0|||
145508855|NCT01192191|524720386|FG001|Overall Study|Lost to Follow-up|1|||
145508856|NCT01192191|524720385|FG000|Overall Study|Withdrawal by Subject|1|||
145508857|NCT01192191|524720386|FG001|Overall Study|Withdrawal by Subject|6|||
145508858|NCT00467753|524720387|FG000|Overall Study|Lost to Follow-up|1|||
145508859|NCT00467753|524720388|FG001|Overall Study|Lost to Follow-up|2|||
145508860|NCT00467753|524720387|FG000|Overall Study|Adverse Event|2|||
145508861|NCT00467753|524720388|FG001|Overall Study|Adverse Event|0|||
145508862|NCT00775593|524721929|FG000|Overall Study|Unmet eligibility criteria|6|||
145508863|NCT00775593|524721929|FG000|Overall Study|Death|1|||
145508864|NCT02067676|524721930|FG000|Overall Study|Withdrawal by Subject|1|||
145508865|NCT02067676|524721931|FG001|Overall Study|Withdrawal by Subject|0|||
145508866|NCT02067676|524721932|FG002|Overall Study|Withdrawal by Subject|0|||
145508867|NCT02067676|524721933|FG003|Overall Study|Withdrawal by Subject|0|||
145508868|NCT02067676|524721934|FG004|Overall Study|Withdrawal by Subject|0|||
145508869|NCT02067676|524721935|FG005|Overall Study|Withdrawal by Subject|0|||
145508870|NCT00996333|524721936|FG000|Overall Study|Screen failure|1|||
145508871|NCT00996333|524721936|FG000|Overall Study|Withdrawal by Subject|1|||
145508872|NCT00996333|524721936|FG000|Overall Study|Death|4|||
145508873|NCT00996333|524721936|FG000|Overall Study|Adverse Event|1|||
145508874|NCT00996333|524721936|FG000|Overall Study|Physician Decision|1|||
145508875|NCT00996333|524721936|FG000|Overall Study|Other|5|||
145508876|NCT01327482|524721937|FG000|Overall Study|Adverse Event|1|||
145508877|NCT03865381|524721940|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
145508878|NCT03865381|524721940|FG000|Overall Study|Withdrawal by Subject|2|||
145508879|NCT04999852|524721941|FG000|Overall Study|Withdrawal by Subject|11|||
145508880|NCT04999852|524721942|FG001|Overall Study|Withdrawal by Subject|1|||
145508881|NCT04999852|524721941|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
145508882|NCT04999852|524721942|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
145508883|NCT05626322|524721943|FG000|Overall Study|Death|2|||
145508884|NCT05626322|524721944|FG001|Overall Study|Death|0|||
145508885|NCT05626322|524721945|FG002|Overall Study|Death|0|||
145508886|NCT05626322|524721943|FG000|Overall Study|Physician Decision|1|||
145508887|NCT05626322|524721944|FG001|Overall Study|Physician Decision|0|||
145508888|NCT05626322|524721945|FG002|Overall Study|Physician Decision|0|||
145508889|NCT05626322|524721943|FG000|Overall Study|Progressive Disease|0|||
145508890|NCT05626322|524721944|FG001|Overall Study|Progressive Disease|1|||
145508891|NCT05626322|524721945|FG002|Overall Study|Progressive Disease|1|||
145508892|NCT05626322|524721943|FG000|Overall Study|Study terminated by sponsor|0|||
145508893|NCT05626322|524721944|FG001|Overall Study|Study terminated by sponsor|1|||
145508894|NCT05626322|524721945|FG002|Overall Study|Study terminated by sponsor|0|||
145508895|NCT03776812|524721946|FG000|Overall Study|Death|53|||
145508896|NCT03776812|524721947|FG001|Overall Study|Death|49|||
145508897|NCT03776812|524721948|FG002|Overall Study|Death|56|||
145508898|NCT03776812|524721946|FG000|Overall Study|Withdrawal by Subject|1|||
145508899|NCT03776812|524721947|FG001|Overall Study|Withdrawal by Subject|7|||
145508900|NCT03776812|524721948|FG002|Overall Study|Withdrawal by Subject|2|||
145508901|NCT03776812|524721946|FG000|Overall Study|Lost to Follow-up|1|||
145508902|NCT03776812|524721947|FG001|Overall Study|Lost to Follow-up|1|||
145508903|NCT03776812|524721948|FG002|Overall Study|Lost to Follow-up|0|||
145508904|NCT03776812|524721946|FG000|Overall Study|Did not enter long-term follow-up|3|||
145508905|NCT03776812|524721947|FG001|Overall Study|Did not enter long-term follow-up|3|||
145508906|NCT03776812|524721948|FG002|Overall Study|Did not enter long-term follow-up|2|||
145508907|NCT04758637|524721951|FG000|Overall Study|Lost to Follow-up|0|||
145508908|NCT04758637|524721952|FG001|Overall Study|Lost to Follow-up|1|||
145508909|NCT04758637|524721953|FG002|Overall Study|Lost to Follow-up|0|||
145508910|NCT04758637|524721954|FG003|Overall Study|Lost to Follow-up|0|||
145508911|NCT03350672|524721960|FG000|Overall Study|Withdrawal by Subject|7|||
145508912|NCT03350672|524721961|FG001|Overall Study|Withdrawal by Subject|0|||
145508913|NCT03350672|524721962|FG002|Overall Study|Withdrawal by Subject|0|||
145508914|NCT00048074|524721965|FG000|Overall Study|Adverse Event|46|||
145508915|NCT00048074|524721966|FG001|Overall Study|Adverse Event|41|||
145508916|NCT00048074|524721967|FG002|Overall Study|Adverse Event|53|||
145508917|NCT00048074|524721965|FG000|Overall Study|Death|3|||
145508918|NCT00048074|524721966|FG001|Overall Study|Death|3|||
145508919|NCT00048074|524721967|FG002|Overall Study|Death|2|||
145508920|NCT00048074|524721965|FG000|Overall Study|Lost to Follow-up|2|||
145508921|NCT00048074|524721966|FG001|Overall Study|Lost to Follow-up|6|||
145508922|NCT00048074|524721967|FG002|Overall Study|Lost to Follow-up|6|||
145508923|NCT00048074|524721965|FG000|Overall Study|Withdrawal by Subject|28|||
145508924|NCT00048074|524721966|FG001|Overall Study|Withdrawal by Subject|30|||
145508925|NCT00048074|524721967|FG002|Overall Study|Withdrawal by Subject|35|||
145508926|NCT00048074|524721965|FG000|Overall Study|Protocol Violation|1|||
145508927|NCT00048074|524721966|FG001|Overall Study|Protocol Violation|3|||
145508928|NCT00048074|524721967|FG002|Overall Study|Protocol Violation|0|||
145401605|NCT02003144|524326568|FG000|Open Label Maintenance Phase|Adverse Event|2|||
145508929|NCT00048074|524721965|FG000|Overall Study|Study participation was terminated|0|||
145508930|NCT00048074|524721966|FG001|Overall Study|Study participation was terminated|1|||
145508931|NCT00048074|524721967|FG002|Overall Study|Study participation was terminated|0|||
145508932|NCT00048074|524721965|FG000|Overall Study|Husband ill|0|||
145508933|NCT00048074|524721966|FG001|Overall Study|Husband ill|1|||
145508934|NCT00048074|524721967|FG002|Overall Study|Husband ill|0|||
145508935|NCT00048074|524721965|FG000|Overall Study|Poor compliance|0|||
145508936|NCT00048074|524721966|FG001|Overall Study|Poor compliance|1|||
145508937|NCT00048074|524721967|FG002|Overall Study|Poor compliance|0|||
145508938|NCT00048074|524721965|FG000|Overall Study|Out of station|0|||
145508939|NCT00048074|524721966|FG001|Overall Study|Out of station|1|||
145508940|NCT00048074|524721967|FG002|Overall Study|Out of station|1|||
145508941|NCT00048074|524721965|FG000|Overall Study|Social reasons|1|||
145508942|NCT00048074|524721966|FG001|Overall Study|Social reasons|0|||
145508943|NCT00048074|524721967|FG002|Overall Study|Social reasons|0|||
145508944|NCT02873377|524721968|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
145508945|NCT02873377|524721969|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
145508946|NCT02873377|524721968|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
145508947|NCT02873377|524721969|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
145508948|NCT01583296|524721972|FG000|Overall Study|Withdrawal by Subject|11|||
145508949|NCT01583296|524721973|FG001|Overall Study|Withdrawal by Subject|10|||
145508950|NCT01047553|524721974|FG000|Overall Study|Adverse Event|10|||
145401606|NCT02003144|524326569|FG001|Open Label Maintenance Phase|Adverse Event|1|||
145401607|NCT02034006|524328678|FG000|Overall Study|Withdrawal by Subject|7|||
145401608|NCT02034006|524328678|FG000|Overall Study|Lost to Follow-up|5|||
145401609|NCT02034006|524328678|FG000|Overall Study|Death|1|||
145401610|NCT02034006|524328678|FG000|Overall Study|Pregnancy|1|||
145401611|NCT01855958|524328682|FG000|Overall Study|Withdrawal by Subject|1|||
145401612|NCT01855958|524328683|FG001|Overall Study|Withdrawal by Subject|0|||
145401613|NCT00499122|524328684|FG000|Overall Study|Withdrawal by Subject|2|||
145401614|NCT04539275|524328688|FG000|Overall Study|Death|2|||
145401615|NCT04539275|524328689|FG001|Overall Study|Death|4|||
145401616|NCT04539275|524328688|FG000|Overall Study|Lost to Follow-up|1|||
145401617|NCT04539275|524328689|FG001|Overall Study|Lost to Follow-up|1|||
145401618|NCT04539275|524328688|FG000|Overall Study|Withdrawal by Subject|3|||
145508951|NCT01047553|524721975|FG001|Overall Study|Adverse Event|5|||
145508952|NCT01047553|524721974|FG000|Overall Study|Withdrawal by Subject|4|||
145508953|NCT01047553|524721975|FG001|Overall Study|Withdrawal by Subject|2|||
145508954|NCT01047553|524721974|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
145508955|NCT01047553|524721975|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
145508956|NCT01047553|524721974|FG000|Overall Study|Lost to Follow-up|1|||
145508957|NCT01047553|524721975|FG001|Overall Study|Lost to Follow-up|0|||
145508958|NCT01047553|524721974|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
145508959|NCT01047553|524721975|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
145508960|NCT01047553|524721974|FG000|Overall Study|PI's decision|0|||
145508961|NCT01047553|524721975|FG001|Overall Study|PI's decision|1|||
145508962|NCT01063283|524721976|FG000|Cycle 1|Adverse Event|2|||
145508963|NCT01063283|524721977|FG001|Cycle 1|Adverse Event|0|||
145508964|NCT01063283|524721978|FG002|Cycle 1|Adverse Event|0|||
145508965|NCT01063283|524721976|FG000|Cycle 1|Technical failure in data collection|1|||
145508966|NCT01063283|524721977|FG001|Cycle 1|Technical failure in data collection|0|||
145508967|NCT01063283|524721978|FG002|Cycle 1|Technical failure in data collection|0|||
145508968|NCT03237286|524721981|FG000|Overall Study|Withdrawal by Subject|1|||
145508969|NCT03237286|524721982|FG001|Overall Study|Withdrawal by Subject|0|||
145508970|NCT03237286|524721983|FG002|Overall Study|Withdrawal by Subject|2|||
145508971|NCT03237286|524721981|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
145508972|NCT03237286|524721982|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
145508973|NCT03237286|524721983|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
145508974|NCT00948441|524721984|FG000|Overall Study|no longer meet inclusion criteria|1|||
145508975|NCT00948441|524721985|FG001|Overall Study|no longer meet inclusion criteria|4|||
145508976|NCT02792829|524721986|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508977|NCT02792829|524721987|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
145732943|NCT03872453|525540856|FG001|Overall Study|Other Than Specified|0|||
145508978|NCT02792829|524721988|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508979|NCT02792829|524721989|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508980|NCT02792829|524721990|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508981|NCT02792829|524721991|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508982|NCT02792829|524721992|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508983|NCT02792829|524721993|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
145508984|NCT02792829|524721986|FG000|Treatment Period 2|Adverse Event|0|||
145508985|NCT02792829|524721987|FG001|Treatment Period 2|Adverse Event|0|||
145508986|NCT02792829|524721988|FG002|Treatment Period 2|Adverse Event|0|||
145508987|NCT02792829|524721989|FG003|Treatment Period 2|Adverse Event|0|||
145508988|NCT02792829|524721990|FG004|Treatment Period 2|Adverse Event|1|||
145508989|NCT02792829|524721991|FG005|Treatment Period 2|Adverse Event|0|||
145508990|NCT02792829|524721992|FG006|Treatment Period 2|Adverse Event|1|||
145508991|NCT02792829|524721993|FG007|Treatment Period 2|Adverse Event|1|||
145508992|NCT02792829|524721986|FG000|Treatment Period 2|Use of proscribed medications|0|||
145508993|NCT02792829|524721987|FG001|Treatment Period 2|Use of proscribed medications|0|||
145508994|NCT02792829|524721988|FG002|Treatment Period 2|Use of proscribed medications|0|||
145508995|NCT02792829|524721989|FG003|Treatment Period 2|Use of proscribed medications|0|||
145508996|NCT02792829|524721990|FG004|Treatment Period 2|Use of proscribed medications|0|||
145508997|NCT02792829|524721991|FG005|Treatment Period 2|Use of proscribed medications|0|||
145508998|NCT02792829|524721992|FG006|Treatment Period 2|Use of proscribed medications|0|||
145508999|NCT02792829|524721993|FG007|Treatment Period 2|Use of proscribed medications|1|||
145509000|NCT00104520|524721996|FG000|Overall Study|Unrelated adverse event|34|||
145509001|NCT00104520|524721997|FG001|Overall Study|Unrelated adverse event|47|||
145509002|NCT00104520|524721996|FG000|Overall Study|Study drug intolerance|0|||
145509003|NCT00104520|524721997|FG001|Overall Study|Study drug intolerance|1|||
145509004|NCT00104520|524721996|FG000|Overall Study|Related adverse event|13|||
145509005|NCT00104520|524721997|FG001|Overall Study|Related adverse event|15|||
145509006|NCT00104520|524721996|FG000|Overall Study|Lost to Follow-up|1|||
145509007|NCT00104520|524721997|FG001|Overall Study|Lost to Follow-up|0|||
145509008|NCT00104520|524721996|FG000|Overall Study|Noncompliance|0|||
145509009|NCT00104520|524721997|FG001|Overall Study|Noncompliance|2|||
145509010|NCT00104520|524721996|FG000|Overall Study|Personal/administrative|1|||
145509011|NCT00104520|524721997|FG001|Overall Study|Personal/administrative|1|||
145509012|NCT00104520|524721996|FG000|Overall Study|Other|1|||
145509013|NCT00104520|524721997|FG001|Overall Study|Other|5|||
145509014|NCT01026324|524721999|FG000|Follow up/Survival|Withdrawal by Subject|1|||
145509015|NCT01026324|524722000|FG001|Follow up/Survival|Withdrawal by Subject|0|||
145509016|NCT01026324|524722001|FG002|Follow up/Survival|Withdrawal by Subject|0|||
145509017|NCT02442804|524722004|FG000|Overall Study|Withdrawal by Subject|0|||
145509018|NCT02442804|524722005|FG001|Overall Study|Withdrawal by Subject|1|||
145509019|NCT02442804|524722004|FG000|Overall Study|Adverse Event|1|||
145509020|NCT02442804|524722005|FG001|Overall Study|Adverse Event|0|||
145509021|NCT02624986|524722009|FG000|Overall Study|Death|0|||
145509022|NCT02624986|524722010|FG001|Overall Study|Death|1|||
145509023|NCT02624986|524722011|FG002|Overall Study|Death|2|||
145509024|NCT02624986|524722012|FG003|Overall Study|Death|2|||
145509025|NCT02624986|524722013|FG004|Overall Study|Death|2|||
145509026|NCT02624986|524722014|FG005|Overall Study|Death|0|||
145509027|NCT02624986|524722015|FG006|Overall Study|Death|0|||
145509028|NCT02624986|524722016|FG007|Overall Study|Death|1|||
145509029|NCT02624986|524722009|FG000|Overall Study|Study Terminated by Sponsor|1|||
145509030|NCT02624986|524722010|FG001|Overall Study|Study Terminated by Sponsor|1|||
145509031|NCT02624986|524722011|FG002|Overall Study|Study Terminated by Sponsor|0|||
145509032|NCT02624986|524722012|FG003|Overall Study|Study Terminated by Sponsor|1|||
145509033|NCT02624986|524722013|FG004|Overall Study|Study Terminated by Sponsor|2|||
145509034|NCT02624986|524722014|FG005|Overall Study|Study Terminated by Sponsor|2|||
145509035|NCT02624986|524722015|FG006|Overall Study|Study Terminated by Sponsor|4|||
145509036|NCT02624986|524722016|FG007|Overall Study|Study Terminated by Sponsor|3|||
145509037|NCT02624986|524722009|FG000|Overall Study|Progressive Disease|0|||
145509038|NCT02624986|524722010|FG001|Overall Study|Progressive Disease|1|||
145509039|NCT02624986|524722011|FG002|Overall Study|Progressive Disease|0|||
145509040|NCT02624986|524722012|FG003|Overall Study|Progressive Disease|0|||
145509041|NCT02624986|524722013|FG004|Overall Study|Progressive Disease|0|||
145509042|NCT02624986|524722014|FG005|Overall Study|Progressive Disease|0|||
145509043|NCT02624986|524722015|FG006|Overall Study|Progressive Disease|0|||
145509044|NCT02624986|524722016|FG007|Overall Study|Progressive Disease|0|||
145509045|NCT02624986|524722009|FG000|Overall Study|Protocol Violation|1|||
145509046|NCT02624986|524722010|FG001|Overall Study|Protocol Violation|0|||
145509047|NCT02624986|524722011|FG002|Overall Study|Protocol Violation|0|||
145509048|NCT02624986|524722012|FG003|Overall Study|Protocol Violation|0|||
145509049|NCT02624986|524722013|FG004|Overall Study|Protocol Violation|0|||
145509050|NCT02624986|524722014|FG005|Overall Study|Protocol Violation|0|||
145509051|NCT02624986|524722015|FG006|Overall Study|Protocol Violation|0|||
145509052|NCT02624986|524722016|FG007|Overall Study|Protocol Violation|0|||
145509053|NCT02624986|524722009|FG000|Overall Study|Withdrawal by Subject|0|||
145509054|NCT02624986|524722010|FG001|Overall Study|Withdrawal by Subject|0|||
145509055|NCT02624986|524722011|FG002|Overall Study|Withdrawal by Subject|0|||
145509056|NCT02624986|524722012|FG003|Overall Study|Withdrawal by Subject|0|||
145509057|NCT02624986|524722013|FG004|Overall Study|Withdrawal by Subject|0|||
145509058|NCT02624986|524722014|FG005|Overall Study|Withdrawal by Subject|0|||
145509059|NCT02624986|524722015|FG006|Overall Study|Withdrawal by Subject|0|||
145509060|NCT02624986|524722016|FG007|Overall Study|Withdrawal by Subject|1|||
145509061|NCT02116205|524722017|FG000|Overall Study|Withdrawal by Subject|2|||
145509062|NCT02116205|524722018|FG001|Overall Study|Withdrawal by Subject|4|||
145509063|NCT02116205|524722019|FG002|Overall Study|Withdrawal by Subject|1|||
145509064|NCT02116205|524722020|FG003|Overall Study|Withdrawal by Subject|3|||
145509065|NCT02116205|524722017|FG000|Overall Study|Lost to Follow-up|0|||
145509066|NCT02116205|524722018|FG001|Overall Study|Lost to Follow-up|2|||
145509067|NCT02116205|524722019|FG002|Overall Study|Lost to Follow-up|1|||
145509068|NCT02116205|524722020|FG003|Overall Study|Lost to Follow-up|2|||
145509069|NCT02116205|524722017|FG000|Overall Study|Physician Decision|0|||
145509070|NCT02116205|524722018|FG001|Overall Study|Physician Decision|1|||
145509071|NCT02116205|524722019|FG002|Overall Study|Physician Decision|1|||
145509072|NCT02116205|524722020|FG003|Overall Study|Physician Decision|1|||
145509073|NCT02116205|524722017|FG000|Overall Study|Exclusion criteria|0|||
145509074|NCT02116205|524722018|FG001|Overall Study|Exclusion criteria|0|||
145509075|NCT02116205|524722019|FG002|Overall Study|Exclusion criteria|1|||
145509076|NCT02116205|524722020|FG003|Overall Study|Exclusion criteria|0|||
145509077|NCT04200352|524722026|FG000|Overall Study|Death|1|||
145509078|NCT04200352|524722026|FG000|Overall Study|Adverse Event|6|||
145509079|NCT04200352|524722026|FG000|Overall Study|Withdrawal by parent/guardian|6|||
145509080|NCT04200352|524722026|FG000|Overall Study|Lack of Efficacy|1|||
145509081|NCT04200352|524722026|FG000|Overall Study|Other than specified|6|||
145509082|NCT00806819|524722027|FG000|Overall Study|progressive disease (modified RECIST )|217|||
145509083|NCT00806819|524722028|FG001|Overall Study|progressive disease (modified RECIST )|216|||
145509084|NCT00806819|524722027|FG000|Overall Study|Worsening or AE of underlying disease|18|||
145509085|NCT00806819|524722028|FG001|Overall Study|Worsening or AE of underlying disease|25|||
145732944|NCT03872453|525540857|FG002|Overall Study|Other Than Specified|0|||
145509086|NCT00806819|524722027|FG000|Overall Study|Other AE|38|||
145509087|NCT00806819|524722028|FG001|Overall Study|Other AE|40|||
145509088|NCT00806819|524722027|FG000|Overall Study|Protocol Violation|9|||
145509089|NCT00806819|524722028|FG001|Overall Study|Protocol Violation|4|||
145509090|NCT00806819|524722027|FG000|Overall Study|Lost to Follow-up|1|||
145509091|NCT00806819|524722028|FG001|Overall Study|Lost to Follow-up|0|||
145509092|NCT00806819|524722027|FG000|Overall Study|Withdrawal by Subject|32|||
145509093|NCT00806819|524722028|FG001|Overall Study|Withdrawal by Subject|29|||
145509094|NCT00806819|524722027|FG000|Overall Study|Not treated|6|||
145509095|NCT00806819|524722028|FG001|Overall Study|Not treated|3|||
145509096|NCT00806819|524722027|FG000|Overall Study|Reasons other than stated above|25|||
145509097|NCT00806819|524722028|FG001|Overall Study|Reasons other than stated above|41|||
145509098|NCT02302339|524722031|FG000|Overall Study|Lost to Follow-up|1|||
145509099|NCT02302339|524722032|FG001|Overall Study|Lost to Follow-up|0|||
145509100|NCT02302339|524722033|FG002|Overall Study|Lost to Follow-up|0|||
145509101|NCT02302339|524722034|FG003|Overall Study|Lost to Follow-up|0|||
145509102|NCT02302339|524722031|FG000|Overall Study|Withdrawal by Subject|0|||
145509103|NCT02302339|524722032|FG001|Overall Study|Withdrawal by Subject|2|||
145509104|NCT02302339|524722033|FG002|Overall Study|Withdrawal by Subject|1|||
145509105|NCT02302339|524722034|FG003|Overall Study|Withdrawal by Subject|0|||
145509106|NCT02752165|524722037|FG000|Overall Study|Withdrawal by Subject|6|||
145509107|NCT02752165|524722038|FG001|Overall Study|Withdrawal by Subject|6|||
145509108|NCT02752165|524722037|FG000|Overall Study|Protocol Violation|6|||
145509109|NCT02752165|524722038|FG001|Overall Study|Protocol Violation|5|||
145509110|NCT02752165|524722037|FG000|Overall Study|Lost to Follow-up|33|||
145509111|NCT02752165|524722038|FG001|Overall Study|Lost to Follow-up|38|||
145509112|NCT00912197|524722041|FG000|Overall Study|Withdrawal by Subject|3|||
145509113|NCT00912197|524722042|FG001|Overall Study|Withdrawal by Subject|3|||
145509114|NCT01326104|524722048|FG000|Overall Study|progressed prior to vaccine|0|||
145509115|NCT01326104|524722049|FG001|Overall Study|progressed prior to vaccine|2|||
145509116|NCT01326104|524722048|FG000|Overall Study|unable to make vaccine|0|||
145509117|NCT01326104|524722049|FG001|Overall Study|unable to make vaccine|2|||
145509118|NCT00494676|524722052|FG000|Allocation|Withdrawal by Subject|2|||
145509119|NCT00494676|524722053|FG001|Allocation|Withdrawal by Subject|4|||
145509120|NCT00494676|524722052|FG000|First Intervention|Withdrawal by Subject|1|||
145509121|NCT00494676|524722053|FG001|First Intervention|Withdrawal by Subject|3|||
145509122|NCT00494676|524722052|FG000|Second Intervention|Withdrawal by Subject|1|||
145509123|NCT00494676|524722053|FG001|Second Intervention|Withdrawal by Subject|1|||
145509124|NCT04073225|524722055|FG000|Overall Study|Lost to Follow-up|4|||
145509125|NCT04073225|524722056|FG001|Overall Study|Lost to Follow-up|3|||
145509126|NCT03568461|524722061|FG000|Overall Study|Death|7|||
145509127|NCT03568461|524722061|FG000|Overall Study|Physician Decision|5|||
145509128|NCT03568461|524722061|FG000|Overall Study|Subject decision|5|||
145509129|NCT03568461|524722061|FG000|Overall Study|Lost to Follow-up|1|||
145509130|NCT04695977|524722062|FG000|Overall Study|Sponsor Decision|9|||
145509131|NCT04695977|524722063|FG001|Overall Study|Sponsor Decision|4|||
145509132|NCT04695977|524722062|FG000|Overall Study|Death|2|||
145509133|NCT04695977|524722063|FG001|Overall Study|Death|5|||
145509134|NCT02175199|524723250|FG000|Overall Study|Withdrawal by Subject|1|||
145509135|NCT02175199|524723251|FG001|Overall Study|Withdrawal by Subject|5|||
145509136|NCT02175199|524723250|FG000|Overall Study|Randomized in Error|1|||
145509137|NCT02175199|524723251|FG001|Overall Study|Randomized in Error|0|||
145509138|NCT02175199|524723250|FG000|Overall Study|Sponsor Decision|1|||
145509139|NCT02175199|524723251|FG001|Overall Study|Sponsor Decision|0|||
145509140|NCT03983317|524723254|FG000|Overall Study|Physician Decision|5|||
145509141|NCT01761162|524723255|FG000|Overall Study|Withdrawal by Subject|3|||
145509142|NCT04681352|524723256|FG000|Overall Study|Lost to Follow-up|2|||
145509143|NCT04681352|524723256|FG000|Overall Study|Withdrawal by Subject|22|||
145509144|NCT01643772|524723257|FG000|Overall Study|Protocol Violation|0|||
145509145|NCT01643772|524723258|FG001|Overall Study|Protocol Violation|0|||
145509146|NCT01643772|524723259|FG002|Overall Study|Protocol Violation|0|||
145509147|NCT01643772|524723260|FG003|Overall Study|Protocol Violation|1|||
145509148|NCT01643772|524723257|FG000|Overall Study|Adverse Event|0|||
145509149|NCT01643772|524723258|FG001|Overall Study|Adverse Event|0|||
145509150|NCT01643772|524723259|FG002|Overall Study|Adverse Event|0|||
145509151|NCT01643772|524723260|FG003|Overall Study|Adverse Event|1|||
145509152|NCT04335136|524723261|FG000|Overall Study|Death|8|||
145509153|NCT04335136|524723262|FG001|Overall Study|Death|4|||
145509154|NCT04335136|524723261|FG000|Overall Study|Lost to Follow-up|2|||
145509155|NCT04335136|524723262|FG001|Overall Study|Lost to Follow-up|0|||
145509156|NCT04335136|524723261|FG000|Overall Study|Protocol Violation|1|||
145509157|NCT04335136|524723262|FG001|Overall Study|Protocol Violation|0|||
145509158|NCT04335136|524723261|FG000|Overall Study|Withdrawal by Subject|1|||
145509159|NCT04335136|524723262|FG001|Overall Study|Withdrawal by Subject|1|||
145509160|NCT04335136|524723261|FG000|Overall Study|Health-threatening condition|0|||
145509161|NCT04335136|524723262|FG001|Overall Study|Health-threatening condition|1|||
145509162|NCT04335136|524723261|FG000|Overall Study|Adverse Event|0|||
145509163|NCT04335136|524723262|FG001|Overall Study|Adverse Event|1|||
145509164|NCT04335136|524723261|FG000|Overall Study|Erroneously randomized|2|||
145509165|NCT04335136|524723262|FG001|Overall Study|Erroneously randomized|0|||
145509166|NCT01305577|524723266|FG000|Overall Study|Adverse Event|2|||
145509167|NCT01305577|524723267|FG001|Overall Study|Adverse Event|2|||
145509168|NCT01305577|524723268|FG002|Overall Study|Adverse Event|1|||
145509169|NCT01305577|524723266|FG000|Overall Study|Withdrawal by Subject|7|||
145509170|NCT01305577|524723267|FG001|Overall Study|Withdrawal by Subject|5|||
145509171|NCT01305577|524723268|FG002|Overall Study|Withdrawal by Subject|6|||
145509172|NCT01305577|524723266|FG000|Overall Study|Lost to Follow-up|4|||
145509173|NCT01305577|524723267|FG001|Overall Study|Lost to Follow-up|3|||
145509174|NCT01305577|524723268|FG002|Overall Study|Lost to Follow-up|2|||
145509175|NCT01305577|524723266|FG000|Overall Study|Protocol Deviation|0|||
145509176|NCT01305577|524723267|FG001|Overall Study|Protocol Deviation|1|||
145509177|NCT01305577|524723268|FG002|Overall Study|Protocol Deviation|1|||
145509178|NCT00796978|524723269|FG000|Overall Study|Cardiac adverse event|5|||
145509179|NCT00796978|524723269|FG000|Overall Study|Adverse Event|4|||
145509180|NCT00796978|524723269|FG000|Overall Study|Withdrawal by Subject|3|||
145509181|NCT00622440|524723282|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
145509182|NCT00622440|524723283|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
145509183|NCT00622440|524723282|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
145509184|NCT00622440|524723283|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
145509185|NCT00622440|524723282|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
145509186|NCT00622440|524723283|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
145509187|NCT00622440|524723282|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
145509188|NCT00622440|524723283|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
145509189|NCT01652534|524723284|FG000|Overall Study|Lack of Efficacy|1|||
145509190|NCT01652534|524723285|FG001|Overall Study|Lack of Efficacy|0|||
145509191|NCT00811018|524723286|FG000|Overall Study|Additional Chronic Treatment|31|||
145509192|NCT00811018|524723286|FG000|Overall Study|Adverse Event|79|||
145509193|NCT00811018|524723286|FG000|Overall Study|Death|147|||
145509194|NCT00811018|524723286|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
145509195|NCT00811018|524723286|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
145509196|NCT00811018|524723286|FG000|Overall Study|Investigator Decision|57|||
145509197|NCT00811018|524723286|FG000|Overall Study|Lost to Follow-up|19|||
145509198|NCT00811018|524723286|FG000|Overall Study|Pregnancy|6|||
145509199|NCT00811018|524723286|FG000|Overall Study|Sponsor Decision|450|||
145509200|NCT00811018|524723286|FG000|Overall Study|Withdrawal by Subject|70|||
145509201|NCT00811018|524723286|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
145509202|NCT00811018|524723286|FG000|Overall Study|Other|26|||
145509203|NCT02722304|524723290|FG000|Overall Study|Study Terminated by Sponsor|1|||
145509204|NCT02722304|524723291|FG001|Overall Study|Study Terminated by Sponsor|0|||
145509205|NCT02722304|524723292|FG002|Overall Study|Study Terminated by Sponsor|2|||
145509206|NCT02722304|524723293|FG003|Overall Study|Study Terminated by Sponsor|1|||
145509207|NCT02722304|524723294|FG004|Overall Study|Study Terminated by Sponsor|1|||
145509208|NCT02722304|524723290|FG000|Overall Study|Other|0|||
145509209|NCT02722304|524723291|FG001|Overall Study|Other|0|||
145509210|NCT02722304|524723292|FG002|Overall Study|Other|0|||
145509211|NCT02722304|524723293|FG003|Overall Study|Other|1|||
145509212|NCT02722304|524723294|FG004|Overall Study|Other|1|||
145509213|NCT04380519|524723297|FG000|Overall Study|Withdrawal by Subject|4|||
145509214|NCT04380519|524723298|FG001|Overall Study|Withdrawal by Subject|0|||
145605976|NCT01473381|525073072|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145605977|NCT01473381|525073073|FG002|Overall Study|Insufficient Therapeutic Response|2|||
145605978|NCT01473381|525073074|FG003|Overall Study|Insufficient Therapeutic Response|3|||
145605979|NCT01473381|525073071|FG000|Overall Study|Protocol Violation|17|||
145605980|NCT01473381|525073072|FG001|Overall Study|Protocol Violation|23|||
145605981|NCT01473381|525073073|FG002|Overall Study|Protocol Violation|19|||
145605982|NCT01473381|525073074|FG003|Overall Study|Protocol Violation|17|||
145605983|NCT01473381|525073071|FG000|Overall Study|Withdrawal of Consent|20|||
145605984|NCT01473381|525073072|FG001|Overall Study|Withdrawal of Consent|21|||
145605985|NCT01473381|525073073|FG002|Overall Study|Withdrawal of Consent|20|||
145605986|NCT01473381|525073074|FG003|Overall Study|Withdrawal of Consent|26|||
145605987|NCT01473381|525073071|FG000|Overall Study|Lost to Follow-up|25|||
145605988|NCT01473381|525073072|FG001|Overall Study|Lost to Follow-up|28|||
145605989|NCT01473381|525073073|FG002|Overall Study|Lost to Follow-up|35|||
145605990|NCT01473381|525073074|FG003|Overall Study|Lost to Follow-up|23|||
145605991|NCT01473381|525073071|FG000|Overall Study|Other Reasons|0|||
145605992|NCT01473381|525073072|FG001|Overall Study|Other Reasons|0|||
145605993|NCT01473381|525073073|FG002|Overall Study|Other Reasons|1|||
145605994|NCT01473381|525073074|FG003|Overall Study|Other Reasons|3|||
145605995|NCT00539643|525073075|FG000|Overall Study|Adverse Event|1|||
145605996|NCT00539643|525073076|FG001|Overall Study|Adverse Event|0|||
145605997|NCT00539643|525073075|FG000|Overall Study|Death|2|||
145605998|NCT00539643|525073076|FG001|Overall Study|Death|1|||
145605999|NCT00539643|525073075|FG000|Overall Study|Physician Decision|3|||
145606000|NCT00539643|525073076|FG001|Overall Study|Physician Decision|1|||
145606001|NCT00539643|525073075|FG000|Overall Study|Withdrawal by Subject|0|||
145606002|NCT00539643|525073076|FG001|Overall Study|Withdrawal by Subject|1|||
145606003|NCT02228395|525073077|FG000|First Intervention Period|No longer willing to participate|1|||
145606004|NCT02228395|525073078|FG001|First Intervention Period|No longer willing to participate|0|||
145606005|NCT02228395|525073079|FG002|First Intervention Period|No longer willing to participate|0|||
145606006|NCT02228395|525073077|FG000|First Intervention Period|Unable to comply with study dates|0|||
145606007|NCT02228395|525073078|FG001|First Intervention Period|Unable to comply with study dates|1|||
145606008|NCT02228395|525073079|FG002|First Intervention Period|Unable to comply with study dates|1|||
145606009|NCT02569437|525073083|FG000|Overall Study|Lost to Follow-up|12|||
145606010|NCT02569437|525073084|FG001|Overall Study|Lost to Follow-up|14|||
145606011|NCT02255357|525073085|FG000|Overall Study|Physician Decision|10|||
145606012|NCT02255357|525073086|FG001|Overall Study|Physician Decision|24|||
145606013|NCT01641926|525073087|FG000|Overall Study|Adverse Event|5|||
145606014|NCT01641926|525073088|FG001|Overall Study|Adverse Event|2|||
145606015|NCT01641926|525073089|FG002|Overall Study|Adverse Event|3|||
145606016|NCT01641926|525073090|FG003|Overall Study|Adverse Event|1|||
145606017|NCT01641926|525073087|FG000|Overall Study|Lost to Follow-up|2|||
145606018|NCT01641926|525073088|FG001|Overall Study|Lost to Follow-up|2|||
145606019|NCT01641926|525073089|FG002|Overall Study|Lost to Follow-up|1|||
145606020|NCT01641926|525073090|FG003|Overall Study|Lost to Follow-up|0|||
145606021|NCT01641926|525073087|FG000|Overall Study|Physician Decision|6|||
145606022|NCT01641926|525073088|FG001|Overall Study|Physician Decision|5|||
145606023|NCT01641926|525073089|FG002|Overall Study|Physician Decision|0|||
145606024|NCT01641926|525073090|FG003|Overall Study|Physician Decision|1|||
145606025|NCT01641926|525073087|FG000|Overall Study|Protocol Violation|1|||
145606026|NCT01641926|525073088|FG001|Overall Study|Protocol Violation|0|||
145606027|NCT01641926|525073089|FG002|Overall Study|Protocol Violation|0|||
145606028|NCT01641926|525073090|FG003|Overall Study|Protocol Violation|1|||
145606029|NCT01641926|525073087|FG000|Overall Study|Withdrawal by Subject|13|||
145606030|NCT01641926|525073088|FG001|Overall Study|Withdrawal by Subject|5|||
145606031|NCT01641926|525073089|FG002|Overall Study|Withdrawal by Subject|6|||
145606032|NCT01641926|525073090|FG003|Overall Study|Withdrawal by Subject|1|||
145606033|NCT01641926|525073087|FG000|Overall Study|Not Treated|1|||
145606034|NCT01641926|525073088|FG001|Overall Study|Not Treated|1|||
145606035|NCT01641926|525073089|FG002|Overall Study|Not Treated|1|||
145606036|NCT01641926|525073090|FG003|Overall Study|Not Treated|0|||
145606037|NCT01287520|525073091|FG000|Overall Study|Adverse Event|2|||
145606038|NCT01287520|525073092|FG001|Overall Study|Adverse Event|2|||
145606039|NCT01287520|525073093|FG002|Overall Study|Adverse Event|2|||
145606040|NCT01287520|525073094|FG003|Overall Study|Adverse Event|1|||
145606041|NCT01287520|525073095|FG004|Overall Study|Adverse Event|1|||
145606042|NCT01287520|525073096|FG005|Overall Study|Adverse Event|2|||
145606043|NCT01287520|525073097|FG006|Overall Study|Adverse Event|0|||
145606044|NCT01287520|525073098|FG007|Overall Study|Adverse Event|2|||
145606045|NCT01287520|525073099|FG008|Overall Study|Adverse Event|0|||
145606046|NCT01287520|525073091|FG000|Overall Study|Physician Decision|1|||
145606047|NCT01287520|525073092|FG001|Overall Study|Physician Decision|1|||
145401619|NCT04539275|524328689|FG001|Overall Study|Withdrawal by Subject|0|||
145606048|NCT01287520|525073093|FG002|Overall Study|Physician Decision|2|||
145606049|NCT01287520|525073094|FG003|Overall Study|Physician Decision|0|||
145401620|NCT01799941|524328690|FG000|Overall Study|Adverse Event|34|||
145401621|NCT01799941|524328690|FG000|Overall Study|Withdrawal by Subject|21|||
145401622|NCT01799941|524328690|FG000|Overall Study|Death|2|||
145401623|NCT01799941|524328690|FG000|Overall Study|Investigator Decision|4|||
145401624|NCT01799941|524328690|FG000|Overall Study|Lack of Efficacy|3|||
145401625|NCT01799941|524328690|FG000|Overall Study|Lost to Follow-up|17|||
145401626|NCT01799941|524328690|FG000|Overall Study|Other|15|||
145401627|NCT00606008|524328691|FG000|Overall Study|Adverse Event|1|||
145606050|NCT01287520|525073095|FG004|Overall Study|Physician Decision|1|||
145606051|NCT01287520|525073096|FG005|Overall Study|Physician Decision|1|||
145606052|NCT01287520|525073097|FG006|Overall Study|Physician Decision|0|||
145606053|NCT01287520|525073098|FG007|Overall Study|Physician Decision|1|||
145606054|NCT01287520|525073099|FG008|Overall Study|Physician Decision|0|||
145606055|NCT01287520|525073091|FG000|Overall Study|Progressive disease|0|||
145606056|NCT01287520|525073092|FG001|Overall Study|Progressive disease|4|||
145509215|NCT04380519|524723299|FG002|Overall Study|Withdrawal by Subject|1|||
145509216|NCT04380519|524723297|FG000|Overall Study|Death|14|||
145509217|NCT04380519|524723298|FG001|Overall Study|Death|9|||
145509218|NCT04380519|524723299|FG002|Overall Study|Death|6|||
145509219|NCT04380519|524723297|FG000|Overall Study|Adverse Event|0|||
145509220|NCT04380519|524723298|FG001|Overall Study|Adverse Event|1|||
145509221|NCT04380519|524723299|FG002|Overall Study|Adverse Event|0|||
145509222|NCT04380519|524723297|FG000|Overall Study|relatives' decision|0|||
145509223|NCT04380519|524723298|FG001|Overall Study|relatives' decision|1|||
145509224|NCT04380519|524723299|FG002|Overall Study|relatives' decision|0|||
145606057|NCT01287520|525073093|FG002|Overall Study|Progressive disease|1|||
145606058|NCT01287520|525073094|FG003|Overall Study|Progressive disease|6|||
145606059|NCT01287520|525073095|FG004|Overall Study|Progressive disease|1|||
145606060|NCT01287520|525073096|FG005|Overall Study|Progressive disease|0|||
145606061|NCT01287520|525073097|FG006|Overall Study|Progressive disease|2|||
145606062|NCT01287520|525073098|FG007|Overall Study|Progressive disease|2|||
145606063|NCT01287520|525073099|FG008|Overall Study|Progressive disease|4|||
145606064|NCT01287520|525073091|FG000|Overall Study|Withdrawal by Subject|0|||
145606065|NCT01287520|525073092|FG001|Overall Study|Withdrawal by Subject|0|||
145606066|NCT01287520|525073093|FG002|Overall Study|Withdrawal by Subject|0|||
145606067|NCT01287520|525073094|FG003|Overall Study|Withdrawal by Subject|0|||
145606068|NCT01287520|525073095|FG004|Overall Study|Withdrawal by Subject|0|||
145606069|NCT01287520|525073096|FG005|Overall Study|Withdrawal by Subject|1|||
145606070|NCT01287520|525073097|FG006|Overall Study|Withdrawal by Subject|0|||
145606071|NCT01287520|525073098|FG007|Overall Study|Withdrawal by Subject|0|||
145606072|NCT01287520|525073099|FG008|Overall Study|Withdrawal by Subject|1|||
145606073|NCT03587142|525073100|FG000|Overall Study|Lost to Follow-up|5|||
145606074|NCT03587142|525073101|FG001|Overall Study|Lost to Follow-up|3|||
145606075|NCT03587142|525073100|FG000|Overall Study|Did not complete the f4 visit|3|||
145606076|NCT03587142|525073101|FG001|Overall Study|Did not complete the f4 visit|7|||
145606077|NCT02768662|525073102|FG000|Overall Study|Adverse Event|1|||
145606078|NCT02768662|525073102|FG000|Overall Study|Lost to Follow-up|4|||
145606079|NCT02768662|525073102|FG000|Overall Study|Withdrawal by Subject|3|||
145606080|NCT02768662|525073102|FG000|Overall Study|Study terminated by Sponsor|78|||
145606081|NCT03673462|525073103|FG000|Overall Study|Adverse Event|11|||
145606082|NCT03673462|525073104|FG001|Overall Study|Adverse Event|1|||
145606083|NCT03673462|525073103|FG000|Overall Study|Protocol Violation|25|||
145606084|NCT03673462|525073104|FG001|Overall Study|Protocol Violation|11|||
145606085|NCT03673462|525073103|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
145606086|NCT03673462|525073104|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
145606087|NCT03673462|525073103|FG000|Overall Study|Lost to Follow-up|102|||
145606088|NCT03673462|525073104|FG001|Overall Study|Lost to Follow-up|19|||
145606089|NCT01800201|525073105|FG000|Overall Study|Withdrawal by Subject|2|||
145606090|NCT01800201|525073106|FG001|Overall Study|Withdrawal by Subject|0|||
145606091|NCT01800201|525073105|FG000|Overall Study|patient privacy concerns|1|||
145606092|NCT01800201|525073106|FG001|Overall Study|patient privacy concerns|1|||
145606093|NCT01800201|525073105|FG000|Overall Study|did not want to use device|0|||
145606094|NCT01800201|525073106|FG001|Overall Study|did not want to use device|1|||
145606095|NCT01800201|525073105|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
145606096|NCT01800201|525073106|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
145606097|NCT00708435|525073107|FG000|Overall Study|Death / Serious Adverse Event|10|||
145606098|NCT00708435|525073108|FG001|Overall Study|Death / Serious Adverse Event|5|||
145606099|NCT00708435|525073107|FG000|Overall Study|Lost to Follow-up|9|||
145606100|NCT00708435|525073108|FG001|Overall Study|Lost to Follow-up|4|||
145509225|NCT02147561|524723304|FG000|Overall Study|Lost to Follow-up|3|||
145509226|NCT02147561|524723304|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
145509227|NCT00393861|524723305|FG000|Overall Study|Adverse Event|2|||
145606101|NCT00708435|525073107|FG000|Overall Study|Withdrawal by Subject|3|||
145606102|NCT00708435|525073108|FG001|Overall Study|Withdrawal by Subject|7|||
145606103|NCT00708435|525073107|FG000|Overall Study|Adverse Event|1|||
145606104|NCT00708435|525073108|FG001|Overall Study|Adverse Event|0|||
145606105|NCT00708435|525073107|FG000|Overall Study|Protocol Violation|0|||
145509228|NCT00393861|524723305|FG000|Overall Study|Disease Progression|24|||
145606106|NCT00708435|525073108|FG001|Overall Study|Protocol Violation|1|||
145606107|NCT00708435|525073107|FG000|Overall Study|Intervention by primary care physician|1|||
145606108|NCT00708435|525073108|FG001|Overall Study|Intervention by primary care physician|0|||
145606109|NCT00708435|525073107|FG000|Overall Study|Refused hospitalization|1|||
145509229|NCT05300763|524723306|FG000|Overall Study|Adverse Event|0|||
145509230|NCT05300763|524723307|FG001|Overall Study|Adverse Event|1|||
145509231|NCT05300763|524723306|FG000|Overall Study|Major Protocol Deviation|1|||
145606110|NCT00708435|525073108|FG001|Overall Study|Refused hospitalization|0|||
145606111|NCT05061537|525073116|FG000|Treatment Phase|Progressive disease|0|||
145606112|NCT05061537|525073117|FG001|Treatment Phase|Progressive disease|1|||
145606113|NCT05061537|525073118|FG002|Treatment Phase|Progressive disease|2|||
145606114|NCT05061537|525073119|FG003|Treatment Phase|Progressive disease|0|||
145606115|NCT05061537|525073120|FG004|Treatment Phase|Progressive disease|0|||
145606116|NCT05061537|525073116|FG000|Treatment Phase|Adverse Event|0|||
145606117|NCT05061537|525073117|FG001|Treatment Phase|Adverse Event|0|||
145606118|NCT05061537|525073118|FG002|Treatment Phase|Adverse Event|2|||
145606119|NCT05061537|525073119|FG003|Treatment Phase|Adverse Event|0|||
145606120|NCT05061537|525073120|FG004|Treatment Phase|Adverse Event|0|||
145606121|NCT05061537|525073116|FG000|Treatment Phase|Global deterioration of health status|0|||
145606122|NCT05061537|525073117|FG001|Treatment Phase|Global deterioration of health status|1|||
145606123|NCT05061537|525073118|FG002|Treatment Phase|Global deterioration of health status|0|||
145606124|NCT05061537|525073119|FG003|Treatment Phase|Global deterioration of health status|0|||
145606125|NCT05061537|525073120|FG004|Treatment Phase|Global deterioration of health status|0|||
145606126|NCT05061537|525073116|FG000|Follow up|Other|2|||
145606127|NCT05061537|525073117|FG001|Follow up|Other|0|||
145606128|NCT05061537|525073118|FG002|Follow up|Other|2|||
145606129|NCT05061537|525073119|FG003|Follow up|Other|0|||
145606130|NCT05061537|525073120|FG004|Follow up|Other|0|||
145606131|NCT05061537|525073116|FG000|Follow up|Study terminated by sponsor|0|||
145606132|NCT05061537|525073117|FG001|Follow up|Study terminated by sponsor|0|||
145606133|NCT05061537|525073118|FG002|Follow up|Study terminated by sponsor|2|||
145606134|NCT05061537|525073119|FG003|Follow up|Study terminated by sponsor|0|||
145606135|NCT05061537|525073120|FG004|Follow up|Study terminated by sponsor|0|||
145606136|NCT05061537|525073116|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
145606137|NCT05061537|525073117|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
145606138|NCT05061537|525073118|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
145606139|NCT05061537|525073119|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
145606140|NCT05061537|525073120|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
145606141|NCT05061537|525073116|FG000|Long-term Follow-up|Death|0|||
145606142|NCT05061537|525073117|FG001|Long-term Follow-up|Death|1|||
145606143|NCT05061537|525073118|FG002|Long-term Follow-up|Death|0|||
145606144|NCT05061537|525073119|FG003|Long-term Follow-up|Death|0|||
145606145|NCT05061537|525073120|FG004|Long-term Follow-up|Death|0|||
145606146|NCT02343003|525073121|FG000|Overall Study|Withdrawal by Subject|9|||
145606147|NCT02343003|525073122|FG001|Overall Study|Withdrawal by Subject|4|||
145606148|NCT02343003|525073121|FG000|Overall Study|Lost to Follow-up|5|||
145606149|NCT02343003|525073122|FG001|Overall Study|Lost to Follow-up|1|||
145606150|NCT02343003|525073121|FG000|Overall Study|Protocol Violation|1|||
145606151|NCT02343003|525073122|FG001|Overall Study|Protocol Violation|0|||
145606152|NCT02343003|525073121|FG000|Overall Study|Death|0|||
145606153|NCT02343003|525073122|FG001|Overall Study|Death|1|||
145606154|NCT02343003|525073121|FG000|Overall Study|exclusion criteria met|1|||
145606155|NCT02343003|525073122|FG001|Overall Study|exclusion criteria met|1|||
145606156|NCT02343003|525073121|FG000|Overall Study|terminated by sponsor|2|||
145606157|NCT02343003|525073122|FG001|Overall Study|terminated by sponsor|0|||
145606158|NCT02281760|525073123|FG000|Overall Study|Withdrawal by Subject|1|||
145606159|NCT02635724|525073124|FG000|Overall Study|Withdrawal by Subject|0|||
145606160|NCT02635724|525073125|FG001|Overall Study|Withdrawal by Subject|1|||
145606161|NCT02635724|525073126|FG002|Overall Study|Withdrawal by Subject|0|||
145606162|NCT02387996|525073131|FG000|Overall Study|Disease Progression|167|||
145606163|NCT02387996|525073131|FG000|Overall Study|Study Drug Toxicity|31|||
145606164|NCT02387996|525073131|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
145606165|NCT02387996|525073131|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
145606166|NCT02387996|525073131|FG000|Overall Study|Subject Withdrew Consent|5|||
145606167|NCT02387996|525073131|FG000|Overall Study|Lost to Follow-up|1|||
145606168|NCT02387996|525073131|FG000|Overall Study|Poor/Non-Compliance|1|||
145606169|NCT02387996|525073131|FG000|Overall Study|Other Reasons|5|||
145401628|NCT00606008|524328691|FG000|Overall Study|Withdrawal by Subject|4|||
145401629|NCT00547339|524328702|FG000|Overall Study|Physician Decision|0|||
145606170|NCT02387996|525073131|FG000|Overall Study|Death|1|||
145401630|NCT00547339|524328703|FG001|Overall Study|Physician Decision|0|||
145401631|NCT00547339|524328704|FG002|Overall Study|Physician Decision|1|||
145401632|NCT00547339|524328705|FG003|Overall Study|Physician Decision|0|||
145606171|NCT02424591|525073132|FG000|Overall Study|Protocol Violation|2|||
145606172|NCT02424591|525073133|FG001|Overall Study|Protocol Violation|3|||
145606173|NCT00770432|525073136|FG000|Overall Study|Other|4|||
145606174|NCT00770432|525073137|FG001|Overall Study|Other|6|||
145606175|NCT00770432|525073136|FG000|Overall Study|Non-compliance|0|||
145606176|NCT00770432|525073137|FG001|Overall Study|Non-compliance|1|||
145606177|NCT00312702|525073138|FG000|Immunization Phase|Lost to Follow-up|0|||
145606178|NCT00312702|525073139|FG001|Immunization Phase|Lost to Follow-up|1|||
145606179|NCT00312702|525073140|FG002|Immunization Phase|Lost to Follow-up|0|||
145606180|NCT02756832|525073144|FG000|Overall Study|Lost for Observation after Baseline|6|||
145606181|NCT02756832|525073144|FG000|Overall Study|Lost for Observation|13|||
145606182|NCT02756832|525073144|FG000|Overall Study|Patient's Unwillingness|12|||
145401633|NCT02369653|524328706|FG000|Overall Study|Lost to Follow-up|0|||
145606183|NCT02756832|525073144|FG000|Overall Study|Insufficient Efficacy|2|||
145509232|NCT05300763|524723307|FG001|Overall Study|Major Protocol Deviation|0|||
145509233|NCT05300763|524723306|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
145509234|NCT05300763|524723307|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145509235|NCT02283762|524723308|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
145509236|NCT02283762|524723309|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
145509237|NCT02283762|524723308|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
145509238|NCT02283762|524723309|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
145509239|NCT02283762|524723308|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
145509240|NCT02283762|524723309|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
145509241|NCT02283762|524723308|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
145509242|NCT02283762|524723309|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
145509243|NCT02283762|524723308|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
145509244|NCT02283762|524723309|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
145509245|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
145509246|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
145509247|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
145509248|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
145509249|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
145509250|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
145509251|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
145509252|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
145509253|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
145509254|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
145509255|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
145509256|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
145509257|NCT02283762|524723308|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
145509258|NCT02283762|524723309|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
145509259|NCT02367833|524723313|FG000|Overall Study|Withdrawal by Subject|1|||
145509260|NCT02367833|524723314|FG001|Overall Study|Withdrawal by Subject|1|||
145509261|NCT02367833|524723315|FG002|Overall Study|Withdrawal by Subject|0|||
145509262|NCT00889720|524723318|FG000|Overall Study|Withdrawal by Subject|4|||
145509263|NCT00889720|524723318|FG000|Overall Study|Other|4|||
145509264|NCT00476229|524723319|FG000|Overall Study|Progressive shortness of breath|1|||
145509265|NCT02164461|524723320|FG000|Overall Study|Adverse Event|0|||
145509266|NCT02164461|524723321|FG001|Overall Study|Adverse Event|0|||
145509267|NCT02164461|524723322|FG002|Overall Study|Adverse Event|1|||
145509268|NCT02164461|524723320|FG000|Overall Study|Disease Progression|1|||
145509269|NCT02164461|524723321|FG001|Overall Study|Disease Progression|3|||
145509270|NCT02164461|524723322|FG002|Overall Study|Disease Progression|4|||
145509271|NCT02164461|524723320|FG000|Overall Study|Withdrawal by Subject|0|||
145509272|NCT02164461|524723321|FG001|Overall Study|Withdrawal by Subject|3|||
145509273|NCT02164461|524723322|FG002|Overall Study|Withdrawal by Subject|0|||
145509274|NCT02100696|524723324|FG000|Induction Phase|Adverse Event|0|||
145509275|NCT02100696|524723325|FG001|Induction Phase|Adverse Event|0|||
145509276|NCT02100696|524723326|FG002|Induction Phase|Adverse Event|1|||
145509277|NCT02100696|524723327|FG003|Induction Phase|Adverse Event|0|||
145509278|NCT02100696|524723328|FG004|Induction Phase|Adverse Event|0|||
145509279|NCT02100696|524723329|FG005|Induction Phase|Adverse Event|0|||
145509280|NCT02100696|524723324|FG000|Induction Phase|Lost to Follow-up|1|||
145509281|NCT02100696|524723325|FG001|Induction Phase|Lost to Follow-up|0|||
145509282|NCT02100696|524723326|FG002|Induction Phase|Lost to Follow-up|1|||
145509283|NCT02100696|524723327|FG003|Induction Phase|Lost to Follow-up|0|||
145509284|NCT02100696|524723328|FG004|Induction Phase|Lost to Follow-up|0|||
145509285|NCT02100696|524723329|FG005|Induction Phase|Lost to Follow-up|0|||
145509286|NCT02100696|524723324|FG000|Induction Phase|Protocol Violation|0|||
145509287|NCT02100696|524723325|FG001|Induction Phase|Protocol Violation|1|||
145509288|NCT02100696|524723326|FG002|Induction Phase|Protocol Violation|1|||
145509289|NCT02100696|524723327|FG003|Induction Phase|Protocol Violation|0|||
145509290|NCT02100696|524723328|FG004|Induction Phase|Protocol Violation|0|||
145509291|NCT02100696|524723329|FG005|Induction Phase|Protocol Violation|0|||
145509292|NCT02100696|524723324|FG000|Induction Phase|Withdrawal by Subject|8|||
145509293|NCT02100696|524723325|FG001|Induction Phase|Withdrawal by Subject|2|||
145509294|NCT02100696|524723326|FG002|Induction Phase|Withdrawal by Subject|13|||
145509295|NCT02100696|524723327|FG003|Induction Phase|Withdrawal by Subject|0|||
145509296|NCT02100696|524723328|FG004|Induction Phase|Withdrawal by Subject|0|||
145606184|NCT02756832|525073144|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
145509297|NCT02100696|524723329|FG005|Induction Phase|Withdrawal by Subject|0|||
145509298|NCT02100696|524723324|FG000|Induction Phase|Physician Decision|1|||
145509299|NCT02100696|524723325|FG001|Induction Phase|Physician Decision|0|||
145509300|NCT02100696|524723326|FG002|Induction Phase|Physician Decision|2|||
145509301|NCT02100696|524723327|FG003|Induction Phase|Physician Decision|0|||
145509302|NCT02100696|524723328|FG004|Induction Phase|Physician Decision|0|||
145509303|NCT02100696|524723329|FG005|Induction Phase|Physician Decision|0|||
145606185|NCT02756832|525073144|FG000|Overall Study|Reason not Specified|9|||
145606186|NCT02756832|525073144|FG000|Overall Study|Protocol Deviation|10|||
145606187|NCT03592277|525073148|FG000|Overall Study|Withdrawal by Subject|6|||
145606188|NCT03592277|525073149|FG001|Overall Study|Withdrawal by Subject|8|||
145606189|NCT00954733|525073150|FG000|Overall Study|blood gas machine did not work|1|||
145606190|NCT01346514|525073157|FG000|Overall Study|Lost to Follow-up|19|||
145606191|NCT01346514|525073158|FG001|Overall Study|Lost to Follow-up|30|||
145606192|NCT01346514|525073157|FG000|Overall Study|Withdrawal by Subject|7|||
145606193|NCT01346514|525073158|FG001|Overall Study|Withdrawal by Subject|3|||
145606194|NCT01346514|525073157|FG000|Overall Study|Death|3|||
145606195|NCT01346514|525073158|FG001|Overall Study|Death|4|||
145606196|NCT00909480|525073162|FG000|Overall Study|Adverse Event|5|||
145606197|NCT00909480|525073163|FG001|Overall Study|Adverse Event|3|||
145606198|NCT00909480|525073162|FG000|Overall Study|Protocol Violation|6|||
145606199|NCT00909480|525073163|FG001|Overall Study|Protocol Violation|8|||
145606200|NCT00909480|525073162|FG000|Overall Study|Withdrawal criteria|9|||
145606201|NCT00909480|525073163|FG001|Overall Study|Withdrawal criteria|11|||
145509304|NCT02100696|524723324|FG000|Induction Phase|Multiple Reasons|5|||
145509305|NCT02100696|524723325|FG001|Induction Phase|Multiple Reasons|2|||
145509306|NCT02100696|524723326|FG002|Induction Phase|Multiple Reasons|8|||
145509307|NCT02100696|524723327|FG003|Induction Phase|Multiple Reasons|0|||
145509308|NCT02100696|524723328|FG004|Induction Phase|Multiple Reasons|0|||
145509309|NCT02100696|524723329|FG005|Induction Phase|Multiple Reasons|0|||
145509310|NCT02100696|524723324|FG000|Maintenance Phase|Adverse Event|0|||
145509311|NCT02100696|524723325|FG001|Maintenance Phase|Adverse Event|0|||
145509312|NCT02100696|524723326|FG002|Maintenance Phase|Adverse Event|0|||
145509313|NCT02100696|524723327|FG003|Maintenance Phase|Adverse Event|0|||
145606202|NCT00909480|525073162|FG000|Overall Study|Unclassified|18|||
145606203|NCT00909480|525073163|FG001|Overall Study|Unclassified|19|||
145509314|NCT02100696|524723328|FG004|Maintenance Phase|Adverse Event|0|||
145509315|NCT02100696|524723329|FG005|Maintenance Phase|Adverse Event|2|||
145509316|NCT02100696|524723324|FG000|Maintenance Phase|Lost to Follow-up|0|||
145509317|NCT02100696|524723325|FG001|Maintenance Phase|Lost to Follow-up|0|||
145606204|NCT04772053|525073170|FG000|Overall Study|Physician Decision|2|||
145606205|NCT04772053|525073170|FG000|Overall Study|Withdrawal by Subject|3|||
145606206|NCT04772053|525073170|FG000|Overall Study|Study Terminated by Sponsor|1|||
145606207|NCT04146896|525073171|FG000|Overall Study|Adverse Event|5|||
145606208|NCT04146896|525073172|FG001|Overall Study|Adverse Event|8|||
145606209|NCT04146896|525073171|FG000|Overall Study|Lack of Efficacy|3|||
145606210|NCT04146896|525073172|FG001|Overall Study|Lack of Efficacy|2|||
145606211|NCT04146896|525073171|FG000|Overall Study|Lost to Follow-up|0|||
145606212|NCT04146896|525073172|FG001|Overall Study|Lost to Follow-up|1|||
145606213|NCT04146896|525073171|FG000|Overall Study|Non-compliance|5|||
145606214|NCT04146896|525073172|FG001|Overall Study|Non-compliance|4|||
145606215|NCT04146896|525073171|FG000|Overall Study|Withdrawal by Subject|3|||
145606216|NCT04146896|525073172|FG001|Overall Study|Withdrawal by Subject|5|||
145606217|NCT04146896|525073171|FG000|Overall Study|Randomized in error|1|||
145606218|NCT04146896|525073172|FG001|Overall Study|Randomized in error|2|||
145606219|NCT02118337|525073173|FG000|Overall Study|Other|1|||
145606220|NCT02118337|525073174|FG001|Overall Study|Other|0|||
145606221|NCT02118337|525073175|FG002|Overall Study|Other|0|||
145606222|NCT02118337|525073176|FG003|Overall Study|Other|0|||
145606223|NCT02118337|525073177|FG004|Overall Study|Other|2|||
145606224|NCT02118337|525073178|FG005|Overall Study|Other|3|||
145606225|NCT02118337|525073179|FG006|Overall Study|Other|1|||
145509318|NCT02100696|524723326|FG002|Maintenance Phase|Lost to Follow-up|0|||
145509319|NCT02100696|524723327|FG003|Maintenance Phase|Lost to Follow-up|0|||
145606226|NCT02118337|525073180|FG007|Overall Study|Other|28|||
145606227|NCT02118337|525073181|FG008|Overall Study|Other|15|||
145606228|NCT02118337|525073173|FG000|Overall Study|Lost to Follow-up|0|||
145606229|NCT02118337|525073174|FG001|Overall Study|Lost to Follow-up|0|||
145606230|NCT02118337|525073175|FG002|Overall Study|Lost to Follow-up|0|||
145606231|NCT02118337|525073176|FG003|Overall Study|Lost to Follow-up|0|||
145509320|NCT02100696|524723328|FG004|Maintenance Phase|Lost to Follow-up|1|||
145509321|NCT02100696|524723329|FG005|Maintenance Phase|Lost to Follow-up|0|||
145509322|NCT02100696|524723324|FG000|Maintenance Phase|Protocol Violation|0|||
145509323|NCT02100696|524723325|FG001|Maintenance Phase|Protocol Violation|0|||
145509324|NCT02100696|524723326|FG002|Maintenance Phase|Protocol Violation|0|||
145509325|NCT02100696|524723327|FG003|Maintenance Phase|Protocol Violation|0|||
145509326|NCT02100696|524723328|FG004|Maintenance Phase|Protocol Violation|1|||
145509327|NCT02100696|524723329|FG005|Maintenance Phase|Protocol Violation|0|||
145509328|NCT02100696|524723324|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145606232|NCT02118337|525073177|FG004|Overall Study|Lost to Follow-up|0|||
145606233|NCT02118337|525073178|FG005|Overall Study|Lost to Follow-up|0|||
145509329|NCT02100696|524723325|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145606234|NCT02118337|525073179|FG006|Overall Study|Lost to Follow-up|0|||
145606235|NCT02118337|525073180|FG007|Overall Study|Lost to Follow-up|1|||
145606236|NCT02118337|525073181|FG008|Overall Study|Lost to Follow-up|0|||
145606237|NCT02118337|525073173|FG000|Overall Study|Withdrawal by Subject|1|||
145606238|NCT02118337|525073174|FG001|Overall Study|Withdrawal by Subject|3|||
145606239|NCT02118337|525073175|FG002|Overall Study|Withdrawal by Subject|2|||
145606240|NCT02118337|525073176|FG003|Overall Study|Withdrawal by Subject|1|||
145606241|NCT02118337|525073177|FG004|Overall Study|Withdrawal by Subject|2|||
145606242|NCT02118337|525073178|FG005|Overall Study|Withdrawal by Subject|2|||
145606243|NCT02118337|525073179|FG006|Overall Study|Withdrawal by Subject|1|||
145606244|NCT02118337|525073180|FG007|Overall Study|Withdrawal by Subject|4|||
145606245|NCT02118337|525073181|FG008|Overall Study|Withdrawal by Subject|2|||
145606246|NCT02118337|525073173|FG000|Overall Study|Death|2|||
145606247|NCT02118337|525073174|FG001|Overall Study|Death|2|||
145606248|NCT02118337|525073175|FG002|Overall Study|Death|1|||
145606249|NCT02118337|525073176|FG003|Overall Study|Death|2|||
145606250|NCT02118337|525073177|FG004|Overall Study|Death|5|||
145606251|NCT02118337|525073178|FG005|Overall Study|Death|1|||
145606252|NCT02118337|525073179|FG006|Overall Study|Death|2|||
145606253|NCT02118337|525073180|FG007|Overall Study|Death|9|||
145606254|NCT02118337|525073181|FG008|Overall Study|Death|4|||
145606255|NCT04296890|525073182|FG000|Overall Study|Withdrawal by Subject|1|||
145606256|NCT04296890|525073182|FG000|Overall Study|Death|62|||
145606257|NCT04296890|525073182|FG000|Overall Study|Lost to Follow-up|3|||
145606258|NCT04296890|525073182|FG000|Overall Study|Other than specified|2|||
145606259|NCT00652938|525073191|FG000|Overall Study|Adverse Event|1|||
145606260|NCT00652938|525073192|FG001|Overall Study|Adverse Event|0|||
145606261|NCT00652938|525073193|FG002|Overall Study|Adverse Event|2|||
145606262|NCT00652938|525073191|FG000|Overall Study|Withdrawal by Subject|0|||
145606263|NCT00652938|525073192|FG001|Overall Study|Withdrawal by Subject|6|||
145606264|NCT00652938|525073193|FG002|Overall Study|Withdrawal by Subject|1|||
145606265|NCT00652938|525073191|FG000|Overall Study|Lost to Follow-up|0|||
145606266|NCT00652938|525073192|FG001|Overall Study|Lost to Follow-up|0|||
145606267|NCT00652938|525073193|FG002|Overall Study|Lost to Follow-up|2|||
145606268|NCT00652938|525073191|FG000|Overall Study|fear of blood sampling|0|||
145606269|NCT00652938|525073192|FG001|Overall Study|fear of blood sampling|1|||
145606270|NCT00652938|525073193|FG002|Overall Study|fear of blood sampling|0|||
145606271|NCT00975221|525074981|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
145606272|NCT00975221|525074982|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
145606273|NCT00975221|525074981|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
145606274|NCT00975221|525074982|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
145606275|NCT00975221|525074981|FG000|Titration Phase (Weeks 1-12)|Other|0|||
145606276|NCT00975221|525074982|FG001|Titration Phase (Weeks 1-12)|Other|1|||
145606277|NCT00975221|525074981|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
145606278|NCT00975221|525074982|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
145509330|NCT02100696|524723326|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145509331|NCT02100696|524723327|FG003|Maintenance Phase|Withdrawal by Subject|1|||
145509332|NCT02100696|524723328|FG004|Maintenance Phase|Withdrawal by Subject|4|||
145509333|NCT02100696|524723329|FG005|Maintenance Phase|Withdrawal by Subject|2|||
145509334|NCT02100696|524723324|FG000|Maintenance Phase|Physician Decision|0|||
145509335|NCT02100696|524723325|FG001|Maintenance Phase|Physician Decision|0|||
145509336|NCT02100696|524723326|FG002|Maintenance Phase|Physician Decision|0|||
145509337|NCT02100696|524723327|FG003|Maintenance Phase|Physician Decision|0|||
145509338|NCT02100696|524723328|FG004|Maintenance Phase|Physician Decision|1|||
145509339|NCT02100696|524723329|FG005|Maintenance Phase|Physician Decision|0|||
145509340|NCT02100696|524723324|FG000|Maintenance Phase|Multiple Reasons|0|||
145509341|NCT02100696|524723325|FG001|Maintenance Phase|Multiple Reasons|0|||
145509342|NCT02100696|524723326|FG002|Maintenance Phase|Multiple Reasons|0|||
145509343|NCT02100696|524723327|FG003|Maintenance Phase|Multiple Reasons|0|||
145509344|NCT02100696|524723328|FG004|Maintenance Phase|Multiple Reasons|2|||
145509345|NCT02100696|524723329|FG005|Maintenance Phase|Multiple Reasons|1|||
145509346|NCT01262820|524723331|FG000|Overall Study|Adverse Event|5|||
145509347|NCT01262820|524723331|FG000|Overall Study|Lack of Efficacy|9|||
145509348|NCT01262820|524723331|FG000|Overall Study|Drug held for 21+ days|1|||
145509349|NCT01668589|524723332|FG000|Overall Study|Lost to Follow-up|29|||
145509350|NCT01668589|524723333|FG001|Overall Study|Lost to Follow-up|37|||
145509351|NCT01668589|524723334|FG002|Overall Study|Lost to Follow-up|15|||
145509352|NCT01668589|524723335|FG003|Overall Study|Lost to Follow-up|5|||
145509353|NCT01668589|524723332|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
145509354|NCT01668589|524723333|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
145509355|NCT01668589|524723334|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
145509356|NCT01668589|524723335|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
145509357|NCT01668589|524723332|FG000|Overall Study|Death|12|||
145509358|NCT01668589|524723333|FG001|Overall Study|Death|3|||
145509359|NCT01668589|524723334|FG002|Overall Study|Death|2|||
145509360|NCT01668589|524723335|FG003|Overall Study|Death|11|||
145509361|NCT01668589|524723332|FG000|Overall Study|Other|44|||
145509362|NCT01668589|524723333|FG001|Overall Study|Other|10|||
145509363|NCT01668589|524723334|FG002|Overall Study|Other|7|||
145509364|NCT01668589|524723335|FG003|Overall Study|Other|15|||
145509365|NCT00993148|524723336|FG000|Overall Study|Lost to Follow-up|2|||
145509366|NCT00993148|524723336|FG000|Overall Study|never initiated treatment|1|||
145509367|NCT01120964|524723337|FG000|Overall Study|Did not receive full treatment|1|||
145509368|NCT01120964|524723338|FG001|Overall Study|Did not receive full treatment|0|||
145509369|NCT02621151|524723341|FG000|Overall Study|Not eligible for trial|6|||
145509370|NCT04198714|524723342|FG000|Overall Study|Physician Decision|0|||
145509371|NCT04198714|524723343|FG001|Overall Study|Physician Decision|1|||
145509372|NCT04238819|524723344|FG000|Overall Study|Ongoing Treatment|0|||
145509373|NCT04238819|524723345|FG001|Overall Study|Ongoing Treatment|0|||
145509374|NCT04238819|524723346|FG002|Overall Study|Ongoing Treatment|0|||
145509375|NCT04238819|524723347|FG003|Overall Study|Ongoing Treatment|0|||
145509376|NCT04238819|524723348|FG004|Overall Study|Ongoing Treatment|1|||
145509377|NCT04238819|524723349|FG005|Overall Study|Ongoing Treatment|4|||
145509378|NCT04238819|524723350|FG006|Overall Study|Ongoing Treatment|0|||
145509379|NCT04238819|524723344|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
145509380|NCT04238819|524723345|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
145509381|NCT04238819|524723346|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
145509382|NCT04238819|524723347|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
145509383|NCT04238819|524723348|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
145509384|NCT04238819|524723349|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
145509385|NCT04238819|524723350|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
145509386|NCT02529553|524723351|FG000|Overall Study|Progressive Disease|1|||
145509387|NCT02529553|524723352|FG001|Overall Study|Progressive Disease|0|||
145509388|NCT02529553|524723353|FG002|Overall Study|Progressive Disease|1|||
145509389|NCT02529553|524723354|FG003|Overall Study|Progressive Disease|3|||
145509390|NCT02529553|524723355|FG004|Overall Study|Progressive Disease|2|||
145509391|NCT02529553|524723356|FG005|Overall Study|Progressive Disease|3|||
145509392|NCT02529553|524723357|FG006|Overall Study|Progressive Disease|3|||
145509393|NCT02529553|524723358|FG007|Overall Study|Progressive Disease|5|||
145509394|NCT02529553|524723359|FG008|Overall Study|Progressive Disease|3|||
145509395|NCT02529553|524723351|FG000|Overall Study|Physician Decision|0|||
145509396|NCT02529553|524723352|FG001|Overall Study|Physician Decision|1|||
145509397|NCT02529553|524723353|FG002|Overall Study|Physician Decision|0|||
145509398|NCT02529553|524723354|FG003|Overall Study|Physician Decision|0|||
145509399|NCT02529553|524723355|FG004|Overall Study|Physician Decision|1|||
145509400|NCT02529553|524723356|FG005|Overall Study|Physician Decision|0|||
145509401|NCT02529553|524723357|FG006|Overall Study|Physician Decision|0|||
145509402|NCT02529553|524723358|FG007|Overall Study|Physician Decision|0|||
145509403|NCT02529553|524723359|FG008|Overall Study|Physician Decision|0|||
145509404|NCT02529553|524723351|FG000|Overall Study|Withdrawal by Subject|0|||
145509405|NCT02529553|524723352|FG001|Overall Study|Withdrawal by Subject|0|||
145509406|NCT02529553|524723353|FG002|Overall Study|Withdrawal by Subject|0|||
145509407|NCT02529553|524723354|FG003|Overall Study|Withdrawal by Subject|0|||
145509408|NCT02529553|524723355|FG004|Overall Study|Withdrawal by Subject|0|||
145509409|NCT02529553|524723356|FG005|Overall Study|Withdrawal by Subject|1|||
145509410|NCT02529553|524723357|FG006|Overall Study|Withdrawal by Subject|0|||
145509411|NCT02529553|524723358|FG007|Overall Study|Withdrawal by Subject|1|||
145509412|NCT02529553|524723359|FG008|Overall Study|Withdrawal by Subject|0|||
145509413|NCT02355184|524723361|FG000|Overall Study|Lost to Follow-up|2|||
145509414|NCT02355184|524723361|FG000|Overall Study|Study Terminated|10|||
145509415|NCT00724711|524724880|FG000|Overall Study|Adverse Event|7|||
145509416|NCT00724711|524724881|FG001|Overall Study|Adverse Event|3|||
145509417|NCT00724711|524724880|FG000|Overall Study|Pregnancy|0|||
145509418|NCT00724711|524724881|FG001|Overall Study|Pregnancy|1|||
145509419|NCT00724711|524724880|FG000|Overall Study|Lack of Efficacy|0|||
145509420|NCT00724711|524724881|FG001|Overall Study|Lack of Efficacy|1|||
145509421|NCT00724711|524724880|FG000|Overall Study|Physician Decision|0|||
145509422|NCT00724711|524724881|FG001|Overall Study|Physician Decision|3|||
145509423|NCT00724711|524724880|FG000|Overall Study|Withdrawal by Subject|5|||
145509424|NCT00724711|524724881|FG001|Overall Study|Withdrawal by Subject|4|||
145509425|NCT00724711|524724880|FG000|Overall Study|Lost to Follow-up|4|||
145509426|NCT00724711|524724881|FG001|Overall Study|Lost to Follow-up|5|||
145509427|NCT00724711|524724880|FG000|Overall Study|Protocol Violation|1|||
145509428|NCT00724711|524724881|FG001|Overall Study|Protocol Violation|0|||
145509429|NCT01088048|524724883|FG000|Overall Study|Adverse Event|7|||
145509430|NCT01088048|524724884|FG001|Overall Study|Adverse Event|9|||
145509431|NCT01088048|524724885|FG002|Overall Study|Adverse Event|7|||
145509432|NCT01088048|524724886|FG003|Overall Study|Adverse Event|5|||
145509433|NCT01088048|524724887|FG004|Overall Study|Adverse Event|6|||
145509434|NCT01088048|524724888|FG005|Overall Study|Adverse Event|3|||
145509435|NCT01088048|524724889|FG006|Overall Study|Adverse Event|3|||
145509436|NCT01088048|524724890|FG007|Overall Study|Adverse Event|0|||
145509437|NCT01088048|524724891|FG008|Overall Study|Adverse Event|2|||
145509438|NCT01088048|524724892|FG009|Overall Study|Adverse Event|2|||
145509439|NCT01088048|524724883|FG000|Overall Study|Withdrew Consent|1|||
145509440|NCT01088048|524724884|FG001|Overall Study|Withdrew Consent|1|||
145509441|NCT01088048|524724885|FG002|Overall Study|Withdrew Consent|1|||
145509442|NCT01088048|524724886|FG003|Overall Study|Withdrew Consent|1|||
145509443|NCT01088048|524724887|FG004|Overall Study|Withdrew Consent|2|||
145509444|NCT01088048|524724888|FG005|Overall Study|Withdrew Consent|1|||
145509445|NCT01088048|524724889|FG006|Overall Study|Withdrew Consent|0|||
145509446|NCT01088048|524724890|FG007|Overall Study|Withdrew Consent|2|||
145509447|NCT01088048|524724891|FG008|Overall Study|Withdrew Consent|2|||
145509448|NCT01088048|524724892|FG009|Overall Study|Withdrew Consent|1|||
145509449|NCT01088048|524724883|FG000|Overall Study|Concomitant Medication Prohibited|1|||
145509450|NCT01088048|524724884|FG001|Overall Study|Concomitant Medication Prohibited|0|||
145509451|NCT01088048|524724885|FG002|Overall Study|Concomitant Medication Prohibited|0|||
145509452|NCT01088048|524724886|FG003|Overall Study|Concomitant Medication Prohibited|0|||
145509453|NCT01088048|524724887|FG004|Overall Study|Concomitant Medication Prohibited|0|||
145509454|NCT01088048|524724888|FG005|Overall Study|Concomitant Medication Prohibited|0|||
145509455|NCT01088048|524724889|FG006|Overall Study|Concomitant Medication Prohibited|0|||
145509456|NCT01088048|524724890|FG007|Overall Study|Concomitant Medication Prohibited|0|||
145509457|NCT01088048|524724891|FG008|Overall Study|Concomitant Medication Prohibited|0|||
145509458|NCT01088048|524724892|FG009|Overall Study|Concomitant Medication Prohibited|0|||
145509459|NCT01088048|524724883|FG000|Overall Study|Investigator Request|2|||
145509460|NCT01088048|524724884|FG001|Overall Study|Investigator Request|2|||
145509461|NCT01088048|524724885|FG002|Overall Study|Investigator Request|0|||
145509462|NCT01088048|524724886|FG003|Overall Study|Investigator Request|0|||
145509463|NCT01088048|524724887|FG004|Overall Study|Investigator Request|3|||
145509464|NCT01088048|524724888|FG005|Overall Study|Investigator Request|1|||
145509465|NCT01088048|524724889|FG006|Overall Study|Investigator Request|1|||
145509466|NCT01088048|524724890|FG007|Overall Study|Investigator Request|0|||
145509467|NCT01088048|524724891|FG008|Overall Study|Investigator Request|0|||
145509468|NCT01088048|524724892|FG009|Overall Study|Investigator Request|0|||
145509469|NCT01088048|524724883|FG000|Overall Study|Patient Non-compliance|0|||
145509470|NCT01088048|524724884|FG001|Overall Study|Patient Non-compliance|1|||
145509471|NCT01088048|524724885|FG002|Overall Study|Patient Non-compliance|0|||
145509472|NCT01088048|524724886|FG003|Overall Study|Patient Non-compliance|0|||
145509473|NCT01088048|524724887|FG004|Overall Study|Patient Non-compliance|0|||
145509474|NCT01088048|524724888|FG005|Overall Study|Patient Non-compliance|0|||
145509475|NCT01088048|524724889|FG006|Overall Study|Patient Non-compliance|0|||
145509476|NCT01088048|524724890|FG007|Overall Study|Patient Non-compliance|0|||
145509477|NCT01088048|524724891|FG008|Overall Study|Patient Non-compliance|0|||
145509478|NCT01088048|524724892|FG009|Overall Study|Patient Non-compliance|0|||
145509479|NCT01088048|524724883|FG000|Overall Study|Disease Progression|7|||
145509480|NCT01088048|524724884|FG001|Overall Study|Disease Progression|4|||
145509481|NCT01088048|524724885|FG002|Overall Study|Disease Progression|3|||
145509482|NCT01088048|524724886|FG003|Overall Study|Disease Progression|5|||
145509483|NCT01088048|524724887|FG004|Overall Study|Disease Progression|3|||
145509484|NCT01088048|524724888|FG005|Overall Study|Disease Progression|3|||
145509485|NCT01088048|524724889|FG006|Overall Study|Disease Progression|2|||
145509486|NCT01088048|524724890|FG007|Overall Study|Disease Progression|1|||
145509487|NCT01088048|524724891|FG008|Overall Study|Disease Progression|0|||
145509488|NCT01088048|524724892|FG009|Overall Study|Disease Progression|0|||
145509489|NCT01088048|524724883|FG000|Overall Study|Death|1|||
145509490|NCT01088048|524724884|FG001|Overall Study|Death|5|||
145509491|NCT01088048|524724885|FG002|Overall Study|Death|3|||
145509492|NCT01088048|524724886|FG003|Overall Study|Death|3|||
145509493|NCT01088048|524724887|FG004|Overall Study|Death|1|||
145509494|NCT01088048|524724888|FG005|Overall Study|Death|3|||
145509495|NCT01088048|524724889|FG006|Overall Study|Death|0|||
145509496|NCT01088048|524724890|FG007|Overall Study|Death|0|||
145509497|NCT01088048|524724891|FG008|Overall Study|Death|3|||
145509498|NCT01088048|524724892|FG009|Overall Study|Death|1|||
145509499|NCT01088048|524724883|FG000|Overall Study|Other|3|||
145509500|NCT01088048|524724884|FG001|Overall Study|Other|5|||
145509501|NCT01088048|524724885|FG002|Overall Study|Other|0|||
145509502|NCT01088048|524724886|FG003|Overall Study|Other|0|||
145509503|NCT01088048|524724887|FG004|Overall Study|Other|2|||
145509504|NCT01088048|524724888|FG005|Overall Study|Other|0|||
145509505|NCT01088048|524724889|FG006|Overall Study|Other|0|||
145509506|NCT01088048|524724890|FG007|Overall Study|Other|2|||
145509507|NCT01088048|524724891|FG008|Overall Study|Other|0|||
145509508|NCT01088048|524724892|FG009|Overall Study|Other|0|||
145509509|NCT01621802|524724893|FG000|Overall Study|Protocol Violation|0|||
145509510|NCT01621802|524724894|FG001|Overall Study|Protocol Violation|0|||
145509511|NCT01621802|524724895|FG002|Overall Study|Protocol Violation|0|||
145509512|NCT01621802|524724896|FG003|Overall Study|Protocol Violation|0|||
145509513|NCT01621802|524724897|FG004|Overall Study|Protocol Violation|0|||
145509514|NCT01621802|524724898|FG005|Overall Study|Protocol Violation|1|||
145509515|NCT01621802|524724893|FG000|Overall Study|Withdrawal by Subject|8|||
145509516|NCT01621802|524724894|FG001|Overall Study|Withdrawal by Subject|4|||
145509517|NCT01621802|524724895|FG002|Overall Study|Withdrawal by Subject|4|||
145509518|NCT01621802|524724896|FG003|Overall Study|Withdrawal by Subject|2|||
145509519|NCT01621802|524724897|FG004|Overall Study|Withdrawal by Subject|2|||
145509520|NCT01621802|524724898|FG005|Overall Study|Withdrawal by Subject|0|||
145509521|NCT01621802|524724893|FG000|Overall Study|Migrated/moved from study area|0|||
145509522|NCT01621802|524724894|FG001|Overall Study|Migrated/moved from study area|0|||
145509523|NCT01621802|524724895|FG002|Overall Study|Migrated/moved from study area|2|||
145509524|NCT01621802|524724896|FG003|Overall Study|Migrated/moved from study area|0|||
145509525|NCT01621802|524724897|FG004|Overall Study|Migrated/moved from study area|1|||
145509526|NCT01621802|524724898|FG005|Overall Study|Migrated/moved from study area|0|||
145509527|NCT01621802|524724893|FG000|Overall Study|Others|3|||
145509528|NCT01621802|524724894|FG001|Overall Study|Others|3|||
145509529|NCT01621802|524724895|FG002|Overall Study|Others|3|||
145509530|NCT01621802|524724896|FG003|Overall Study|Others|2|||
145509531|NCT01621802|524724897|FG004|Overall Study|Others|1|||
145509532|NCT01621802|524724898|FG005|Overall Study|Others|0|||
145509533|NCT01621802|524724893|FG000|Overall Study|Lost to Follow-up|36|||
145509534|NCT01621802|524724894|FG001|Overall Study|Lost to Follow-up|16|||
145509535|NCT01621802|524724895|FG002|Overall Study|Lost to Follow-up|24|||
145509536|NCT01621802|524724896|FG003|Overall Study|Lost to Follow-up|7|||
145509537|NCT01621802|524724897|FG004|Overall Study|Lost to Follow-up|31|||
145509538|NCT01621802|524724898|FG005|Overall Study|Lost to Follow-up|11|||
145509539|NCT01149148|524724899|FG000|Overall Study|Lost to Follow-up|1|||
145509540|NCT01149148|524724900|FG001|Overall Study|Lost to Follow-up|2|||
145509541|NCT01149148|524724899|FG000|Overall Study|Death|1|||
145509542|NCT01149148|524724900|FG001|Overall Study|Death|0|||
145509543|NCT03436082|524724901|FG000|Overall Study|Did not undergo procedure|1|||
145509544|NCT03436082|524724902|FG001|Overall Study|Did not undergo procedure|0|||
145509545|NCT00950859|524724903|FG000|Overall Study|Adverse Event|3|||
145509546|NCT00950859|524724904|FG001|Overall Study|Adverse Event|3|||
145509547|NCT00950859|524724903|FG000|Overall Study|Insufficient Viral Load Response|12|||
145509548|NCT00950859|524724904|FG001|Overall Study|Insufficient Viral Load Response|3|||
145509549|NCT00950859|524724903|FG000|Overall Study|Protocol Violation|1|||
145509550|NCT00950859|524724904|FG001|Overall Study|Protocol Violation|1|||
145509551|NCT00950859|524724903|FG000|Overall Study|Lost to Follow-up|0|||
145509552|NCT00950859|524724904|FG001|Overall Study|Lost to Follow-up|3|||
145509553|NCT04896086|524724905|FG000|Overall Study|Lost to Follow-up|0|||
145509554|NCT04896086|524724906|FG001|Overall Study|Lost to Follow-up|2|||
145509555|NCT04896086|524724907|FG002|Overall Study|Lost to Follow-up|1|||
145606279|NCT00975221|525074981|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
145606280|NCT00975221|525074982|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
145606281|NCT00975221|525074981|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
145606282|NCT00975221|525074982|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
145606283|NCT01862991|525074983|FG000|Overall Study|Lost to Follow-up|2|||
145606284|NCT01862991|525074984|FG001|Overall Study|Lost to Follow-up|1|||
145606285|NCT01862991|525074985|FG002|Overall Study|Lost to Follow-up|1|||
145606286|NCT01862991|525074983|FG000|Overall Study|Protocol Violation|1|||
145606287|NCT01862991|525074984|FG001|Overall Study|Protocol Violation|0|||
145606288|NCT01862991|525074985|FG002|Overall Study|Protocol Violation|0|||
145606289|NCT02026232|525074986|FG000|Overall Study|incomplete visit/missing data|3|||
145606290|NCT02026232|525074987|FG001|Overall Study|incomplete visit/missing data|2|||
145606291|NCT00605319|525074988|FG000|Overall Study|Adverse Event|6|||
145606292|NCT02670538|525074989|FG000|Overall Study|Withdrawal of Consent|8|||
145606293|NCT02670538|525074990|FG001|Overall Study|Withdrawal of Consent|6|||
145606294|NCT02670538|525074991|FG002|Overall Study|Withdrawal of Consent|5|||
145606295|NCT02670538|525074989|FG000|Overall Study|Lost to Follow-up|8|||
145606296|NCT02670538|525074990|FG001|Overall Study|Lost to Follow-up|12|||
145606297|NCT02670538|525074991|FG002|Overall Study|Lost to Follow-up|7|||
145606298|NCT02670538|525074989|FG000|Overall Study|Adverse Event|5|||
145606299|NCT02670538|525074990|FG001|Overall Study|Adverse Event|5|||
145606300|NCT02670538|525074991|FG002|Overall Study|Adverse Event|11|||
145606301|NCT02670538|525074989|FG000|Overall Study|Lack of Efficacy|7|||
145606302|NCT02670538|525074990|FG001|Overall Study|Lack of Efficacy|1|||
145606303|NCT02670538|525074991|FG002|Overall Study|Lack of Efficacy|2|||
145606304|NCT02670538|525074989|FG000|Overall Study|Protocol Violation|3|||
145606305|NCT02670538|525074990|FG001|Overall Study|Protocol Violation|4|||
145606306|NCT02670538|525074991|FG002|Overall Study|Protocol Violation|1|||
145606307|NCT02670538|525074989|FG000|Overall Study|Noncompliance with Study Drug|1|||
145606308|NCT02670538|525074990|FG001|Overall Study|Noncompliance with Study Drug|3|||
145606309|NCT02670538|525074991|FG002|Overall Study|Noncompliance with Study Drug|2|||
145606310|NCT02670538|525074989|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145606311|NCT02670538|525074990|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145606312|NCT02670538|525074991|FG002|Overall Study|Other Miscellaneous Reasons|2|||
145606313|NCT02110732|525074996|FG000|Overall Study|Physician Decision|5|||
145606314|NCT02110732|525074997|FG001|Overall Study|Physician Decision|2|||
145606315|NCT02110732|525074996|FG000|Overall Study|Lost to Follow-up|1|||
145606316|NCT02110732|525074997|FG001|Overall Study|Lost to Follow-up|1|||
145606317|NCT01691521|525074998|FG000|Overall Study|Adverse Event|4|||
145606318|NCT01691521|525074999|FG001|Overall Study|Adverse Event|0|||
145606319|NCT01691521|525075000|FG002|Overall Study|Adverse Event|1|||
145606320|NCT01691521|525074998|FG000|Overall Study|Lack of Efficacy|1|||
145606321|NCT01691521|525074999|FG001|Overall Study|Lack of Efficacy|1|||
145606322|NCT01691521|525075000|FG002|Overall Study|Lack of Efficacy|2|||
145606323|NCT01691521|525074998|FG000|Overall Study|Protocol Violation|0|||
145606324|NCT01691521|525074999|FG001|Overall Study|Protocol Violation|3|||
145509556|NCT04896086|524724908|FG003|Overall Study|Lost to Follow-up|0|||
145509557|NCT04896086|524724909|FG004|Overall Study|Lost to Follow-up|0|||
145509558|NCT04896086|524724905|FG000|Overall Study|Physician Decision|0|||
145509559|NCT04896086|524724906|FG001|Overall Study|Physician Decision|1|||
145509560|NCT04896086|524724907|FG002|Overall Study|Physician Decision|0|||
145732945|NCT03872453|525540858|FG003|Overall Study|Other Than Specified|0|||
145606325|NCT01691521|525075000|FG002|Overall Study|Protocol Violation|0|||
145606326|NCT01691521|525074998|FG000|Overall Study|Lost to Follow-up|0|||
145606327|NCT01691521|525074999|FG001|Overall Study|Lost to Follow-up|2|||
145606328|NCT01691521|525075000|FG002|Overall Study|Lost to Follow-up|2|||
145606329|NCT01691521|525074998|FG000|Overall Study|Physician Decision|2|||
145606330|NCT01691521|525074999|FG001|Overall Study|Physician Decision|1|||
145509561|NCT04896086|524724908|FG003|Overall Study|Physician Decision|0|||
145509562|NCT04896086|524724909|FG004|Overall Study|Physician Decision|0|||
145606331|NCT01691521|525075000|FG002|Overall Study|Physician Decision|0|||
145606332|NCT01691521|525074998|FG000|Overall Study|Withdrawal by Subject|5|||
145606333|NCT01691521|525074999|FG001|Overall Study|Withdrawal by Subject|9|||
145606334|NCT01691521|525075000|FG002|Overall Study|Withdrawal by Subject|4|||
145606335|NCT01480596|525075003|FG000|Overall Study|Adverse Event|3|||
145606336|NCT01480596|525075004|FG001|Overall Study|Adverse Event|0|||
145606337|NCT01480596|525075003|FG000|Overall Study|MG exacerbation or change in medication|2|||
145606338|NCT01480596|525075004|FG001|Overall Study|MG exacerbation or change in medication|2|||
145606339|NCT04503096|525075005|FG000|Overall Study|Withdrawal by Subject|3|||
145606340|NCT01153269|525075006|FG000|Overall Study|Withdrawal by Subject|1|||
145606341|NCT01153269|525075006|FG000|Overall Study|Antiretroviral therapy break|1|||
145606342|NCT00100932|525075011|FG000|Overall Study|Adverse Event|11|||
145606343|NCT00100932|525075012|FG001|Overall Study|Adverse Event|2|||
145606344|NCT00100932|525075011|FG000|Overall Study|Withdrawal by Subject|6|||
145606345|NCT00100932|525075012|FG001|Overall Study|Withdrawal by Subject|0|||
145606346|NCT00100932|525075011|FG000|Overall Study|Progressive Disease|44|||
145606347|NCT00100932|525075012|FG001|Overall Study|Progressive Disease|18|||
145606348|NCT00100932|525075011|FG000|Overall Study|Physician Decision|7|||
145606349|NCT00100932|525075012|FG001|Overall Study|Physician Decision|5|||
145606350|NCT00100932|525075011|FG000|Overall Study|Other|5|||
145606351|NCT00100932|525075012|FG001|Overall Study|Other|2|||
145606352|NCT01576367|525075013|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145606353|NCT01576367|525075013|FG000|Overall Study|Moved to commercial use after 6 months|1|||
145606354|NCT01453348|525075014|FG000|Overall Study|Death|0|||
145606355|NCT01453348|525075015|FG001|Overall Study|Death|0|||
145606356|NCT01453348|525075016|FG002|Overall Study|Death|1|||
145606357|NCT01453348|525075014|FG000|Overall Study|Withdrawal by Subject|0|||
145606358|NCT01453348|525075015|FG001|Overall Study|Withdrawal by Subject|1|||
145606359|NCT01453348|525075016|FG002|Overall Study|Withdrawal by Subject|0|||
145606360|NCT01453348|525075014|FG000|Overall Study|Protocol Violation|1|||
145606361|NCT01453348|525075015|FG001|Overall Study|Protocol Violation|0|||
145606362|NCT01453348|525075016|FG002|Overall Study|Protocol Violation|0|||
145606363|NCT00988221|525075017|FG000|Part I|Adverse Event|0|||
145606364|NCT00988221|525075018|FG001|Part I|Adverse Event|1|||
145606365|NCT00988221|525075019|FG002|Part I|Adverse Event|2|||
145606366|NCT00988221|525075020|FG003|Part I|Adverse Event|0|||
145606367|NCT00988221|525075017|FG000|Part I|Insufficient Therapeutic Response|4|||
145606368|NCT00988221|525075018|FG001|Part I|Insufficient Therapeutic Response|6|||
145606369|NCT00988221|525075019|FG002|Part I|Insufficient Therapeutic Response|5|||
145606370|NCT00988221|525075020|FG003|Part I|Insufficient Therapeutic Response|0|||
145401634|NCT02369653|524328707|FG001|Overall Study|Lost to Follow-up|1|||
145401635|NCT02369653|524328706|FG000|Overall Study|Administrative reason by sponsor|0|||
145401636|NCT02369653|524328707|FG001|Overall Study|Administrative reason by sponsor|1|||
145401637|NCT02369653|524328706|FG000|Overall Study|Death|1|||
145401638|NCT02369653|524328707|FG001|Overall Study|Death|2|||
145401639|NCT02369653|524328706|FG000|Overall Study|Participant withdrew consent|13|||
145401640|NCT02369653|524328707|FG001|Overall Study|Participant withdrew consent|3|||
145401641|NCT01458587|524328708|FG000|Overall Study|Withdrawal by Subject|1|||
145401642|NCT01458587|524328709|FG001|Overall Study|Withdrawal by Subject|0|||
145401643|NCT01603602|524328710|FG000|Overall Study|Adverse Event|1|||
145401644|NCT01603602|524328711|FG001|Overall Study|Adverse Event|0|||
145401645|NCT01603602|524328712|FG002|Overall Study|Adverse Event|0|||
145401646|NCT01603602|524328710|FG000|Overall Study|Personal Reasons|1|||
145401647|NCT01603602|524328711|FG001|Overall Study|Personal Reasons|0|||
145401648|NCT01603602|524328712|FG002|Overall Study|Personal Reasons|1|||
145401649|NCT00095979|524328716|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
145401650|NCT04018066|524328717|FG000|Overall Study|participants started taking medications during the study period|3|||
145401651|NCT04018066|524328717|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
145401652|NCT02732639|524328720|FG000|Overall Study|Lost to Follow-up|1|||
145401653|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
145401654|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145401655|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145401656|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
145401657|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
145401658|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145401659|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145401660|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
145401661|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
145401662|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
145401663|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
145401664|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
145401665|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
145401666|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145401667|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145401668|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
145401669|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
145401670|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
145401671|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
145401672|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
145401673|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
145509563|NCT04896086|524724905|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
145509564|NCT04896086|524724906|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
145509565|NCT04896086|524724907|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
145509566|NCT04896086|524724908|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
145509567|NCT04896086|524724909|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
145509568|NCT04896086|524724905|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
145509569|NCT04896086|524724906|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
145509570|NCT04896086|524724907|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
145509571|NCT04896086|524724908|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
145732946|NCT01096342|525540861|FG000|Overall Study|Protocol Violation|1|||
145732947|NCT00929656|525540862|FG000|Overall Study|Lost to Follow-up|0|||
145509572|NCT04896086|524724909|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
145509573|NCT00724867|524724914|FG000|Overall Study|Adverse Event|25|||
145509574|NCT00724867|524724914|FG000|Overall Study|Lack of Efficacy|14|||
145509575|NCT00724867|524724914|FG000|Overall Study|Lost to Follow-up|12|||
145509576|NCT00724867|524724914|FG000|Overall Study|Non-compliance with study drug|6|||
145509577|NCT00724867|524724914|FG000|Overall Study|Physician Decision|17|||
145509578|NCT00724867|524724914|FG000|Overall Study|Protocol Violation|1|||
145509579|NCT00724867|524724914|FG000|Overall Study|Withdrawal by Subject|31|||
145509580|NCT00724867|524724914|FG000|Overall Study|Sponsor decision to end study|14|||
145509581|NCT00724867|524724914|FG000|Overall Study|Subject incarcerated|1|||
145509582|NCT00724867|524724914|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
145509583|NCT00724867|524724914|FG000|Overall Study|Subject moved out of state|1|||
145509584|NCT00724867|524724914|FG000|Overall Study|Elected to exit due to site closure|2|||
145509585|NCT00436345|524724915|FG000|Overall Study|ICU resident beyond follow-up period|3|||
145509586|NCT00436345|524724916|FG001|Overall Study|ICU resident beyond follow-up period|0|||
145509587|NCT01175083|524724917|FG000|Primary Epoch|Withdrawal by Subject|0|||
145509588|NCT01175083|524724918|FG001|Primary Epoch|Withdrawal by Subject|0|||
145509589|NCT01175083|524724919|FG002|Primary Epoch|Withdrawal by Subject|0|||
145509590|NCT01175083|524724920|FG003|Primary Epoch|Withdrawal by Subject|0|||
145509591|NCT01175083|524724921|FG004|Primary Epoch|Withdrawal by Subject|0|||
145509592|NCT01175083|524724922|FG005|Primary Epoch|Withdrawal by Subject|2|||
145509593|NCT01175083|524724917|FG000|Primary Epoch|Lost to Follow-up|0|||
145509594|NCT01175083|524724918|FG001|Primary Epoch|Lost to Follow-up|0|||
145509595|NCT01175083|524724919|FG002|Primary Epoch|Lost to Follow-up|0|||
145509596|NCT01175083|524724920|FG003|Primary Epoch|Lost to Follow-up|0|||
145509597|NCT01175083|524724921|FG004|Primary Epoch|Lost to Follow-up|0|||
145509598|NCT01175083|524724922|FG005|Primary Epoch|Lost to Follow-up|1|||
145509599|NCT01175083|524724917|FG000|Booster Epoch|Death|0|||
145509600|NCT01175083|524724918|FG001|Booster Epoch|Death|0|||
145509601|NCT01175083|524724919|FG002|Booster Epoch|Death|1|||
145509602|NCT01175083|524724920|FG003|Booster Epoch|Death|0|||
145509603|NCT01175083|524724921|FG004|Booster Epoch|Death|0|||
145509604|NCT01175083|524724922|FG005|Booster Epoch|Death|0|||
145509605|NCT01175083|524724917|FG000|Booster Epoch|Withdrawal by Subject|0|||
145509606|NCT01175083|524724918|FG001|Booster Epoch|Withdrawal by Subject|0|||
145509607|NCT01175083|524724919|FG002|Booster Epoch|Withdrawal by Subject|0|||
145509608|NCT01175083|524724920|FG003|Booster Epoch|Withdrawal by Subject|1|||
145509609|NCT01175083|524724921|FG004|Booster Epoch|Withdrawal by Subject|0|||
145509610|NCT01175083|524724922|FG005|Booster Epoch|Withdrawal by Subject|0|||
145509611|NCT01296672|524724923|FG000|Overall Study|Lost to Follow-up|73|||
145509612|NCT01296672|524724924|FG001|Overall Study|Lost to Follow-up|18|||
145509613|NCT01716052|524724925|FG000|Overall Study|Withdrawal of funding|1|||
145509614|NCT01716052|524724926|FG001|Overall Study|Withdrawal of funding|1|||
145509615|NCT04027608|524724929|FG000|Overall Study|Withdrawal by Subject|13|||
145509616|NCT04027608|524724930|FG001|Overall Study|Withdrawal by Subject|2|||
145509617|NCT04027608|524724929|FG000|Overall Study|Protocol Violation|2|||
145509618|NCT04027608|524724930|FG001|Overall Study|Protocol Violation|1|||
145509619|NCT04027608|524724929|FG000|Overall Study|Physician Decision|1|||
145509620|NCT04027608|524724930|FG001|Overall Study|Physician Decision|0|||
145509621|NCT04027608|524724929|FG000|Overall Study|Lost to Follow-up|20|||
145509622|NCT04027608|524724930|FG001|Overall Study|Lost to Follow-up|4|||
145509623|NCT00975689|524724935|FG000|Overall Study|Adverse Event|0|||
145509624|NCT00975689|524724936|FG001|Overall Study|Adverse Event|3|||
145509625|NCT00975689|524724935|FG000|Overall Study|Withdrawal by Subject|1|||
145509626|NCT00975689|524724936|FG001|Overall Study|Withdrawal by Subject|0|||
145509627|NCT00975689|524724935|FG000|Overall Study|Physician Decision|1|||
145509628|NCT00975689|524724936|FG001|Overall Study|Physician Decision|0|||
145509629|NCT01092546|524724940|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
145509630|NCT00771953|524724943|FG000|Overall Study|Adverse Event|5|||
145509631|NCT00771953|524724944|FG001|Overall Study|Adverse Event|3|||
145606371|NCT00988221|525075017|FG000|Part I|Refused Treatment|0|||
145509632|NCT00771953|524724943|FG000|Overall Study|Death|2|||
145509633|NCT00771953|524724944|FG001|Overall Study|Death|2|||
145509634|NCT00771953|524724943|FG000|Overall Study|Progression before active Tx|1|||
145732948|NCT00929656|525540863|FG001|Overall Study|Lost to Follow-up|1|||
145606372|NCT00988221|525075018|FG001|Part I|Refused Treatment|2|||
145606373|NCT00988221|525075019|FG002|Part I|Refused Treatment|1|||
145606374|NCT00988221|525075020|FG003|Part I|Refused Treatment|0|||
145606375|NCT00988221|525075017|FG000|Part I|Lost to Follow-up|0|||
145606376|NCT00988221|525075018|FG001|Part I|Lost to Follow-up|1|||
145606377|NCT00988221|525075019|FG002|Part I|Lost to Follow-up|0|||
145606378|NCT00988221|525075020|FG003|Part I|Lost to Follow-up|0|||
145606379|NCT00988221|525075017|FG000|Part II|Adverse Event|1|||
145606380|NCT00988221|525075018|FG001|Part II|Adverse Event|0|||
145606381|NCT00988221|525075019|FG002|Part II|Adverse Event|0|||
145606382|NCT00988221|525075020|FG003|Part II|Adverse Event|1|||
145606383|NCT00988221|525075017|FG000|Part II|Withdrawal by Subject|0|||
145606384|NCT00988221|525075018|FG001|Part II|Withdrawal by Subject|0|||
145606385|NCT00988221|525075019|FG002|Part II|Withdrawal by Subject|2|||
145606386|NCT00988221|525075020|FG003|Part II|Withdrawal by Subject|2|||
145606387|NCT00988221|525075017|FG000|Part II|Reason not Specified|0|||
145606388|NCT00988221|525075018|FG001|Part II|Reason not Specified|0|||
145606389|NCT00988221|525075019|FG002|Part II|Reason not Specified|1|||
145606390|NCT00988221|525075020|FG003|Part II|Reason not Specified|0|||
145606391|NCT00988221|525075017|FG000|Part III|Adverse Event|1|||
145606392|NCT00988221|525075018|FG001|Part III|Adverse Event|0|||
145606393|NCT00988221|525075019|FG002|Part III|Adverse Event|1|||
145606394|NCT00988221|525075020|FG003|Part III|Adverse Event|0|||
145606395|NCT00988221|525075017|FG000|Part III|Insufficient Therapeutic Response|0|||
145606396|NCT00988221|525075018|FG001|Part III|Insufficient Therapeutic Response|1|||
145606397|NCT00988221|525075019|FG002|Part III|Insufficient Therapeutic Response|1|||
145606398|NCT00988221|525075020|FG003|Part III|Insufficient Therapeutic Response|0|||
145606399|NCT00988221|525075017|FG000|Part III|Refused Treatment|0|||
145509635|NCT00771953|524724944|FG001|Overall Study|Progression before active Tx|2|||
145509636|NCT00771953|524724943|FG000|Overall Study|Sponsor decision|1|||
145509637|NCT00771953|524724944|FG001|Overall Study|Sponsor decision|0|||
145509638|NCT00771953|524724943|FG000|Overall Study|Other complicating disease|1|||
145509639|NCT00771953|524724944|FG001|Overall Study|Other complicating disease|0|||
145606400|NCT00988221|525075018|FG001|Part III|Refused Treatment|0|||
145606401|NCT00988221|525075019|FG002|Part III|Refused Treatment|1|||
145509640|NCT00771953|524724943|FG000|Overall Study|Withdrawal by Subject|0|||
145509641|NCT00771953|524724944|FG001|Overall Study|Withdrawal by Subject|3|||
145606402|NCT00988221|525075020|FG003|Part III|Refused Treatment|0|||
145606403|NCT03528174|525075028|FG000|Overall Study|Adverse Event|1|||
145509642|NCT00947193|524724947|FG000|Overall Study|Lost to Follow-up|1|||
145606404|NCT03528174|525075028|FG000|Overall Study|sensors dislodged|1|||
145606405|NCT03002038|525075029|FG000|Overall Study|Adverse Event|3|||
145509643|NCT00947193|524724948|FG001|Overall Study|Lost to Follow-up|0|||
145606406|NCT03002038|525075030|FG001|Overall Study|Adverse Event|1|||
145606407|NCT03002038|525075029|FG000|Overall Study|Withdrawal by Subject|8|||
145606408|NCT03002038|525075030|FG001|Overall Study|Withdrawal by Subject|4|||
145606409|NCT03002038|525075029|FG000|Overall Study|Immigration to another region|0|||
145606410|NCT03002038|525075030|FG001|Overall Study|Immigration to another region|2|||
145606411|NCT00979602|525075039|FG000|Overall Study|Serious Adverse Event|5|||
145606412|NCT00979602|525075040|FG001|Overall Study|Serious Adverse Event|3|||
145606413|NCT00979602|525075039|FG000|Overall Study|Protocol Violation|3|||
145606414|NCT00979602|525075040|FG001|Overall Study|Protocol Violation|0|||
145606415|NCT00979602|525075039|FG000|Overall Study|Withdrawal by Subject|31|||
145606416|NCT00979602|525075040|FG001|Overall Study|Withdrawal by Subject|25|||
145606417|NCT00979602|525075039|FG000|Overall Study|Lost to Follow-up|100|||
145606418|NCT00979602|525075040|FG001|Overall Study|Lost to Follow-up|96|||
145606419|NCT00979602|525075039|FG000|Overall Study|Migrated/moved from study area|3|||
145606420|NCT00979602|525075040|FG001|Overall Study|Migrated/moved from study area|6|||
145606421|NCT00979602|525075039|FG000|Overall Study|Others|3|||
145606422|NCT00979602|525075040|FG001|Overall Study|Others|3|||
145606423|NCT02904902|525075041|FG000|Overall Study|Withdrawal by Subject|1|||
145606424|NCT02712398|525075045|FG000|Overall Study|Withdrawal by Subject|6|||
145606425|NCT02712398|525075045|FG000|Overall Study|Lost to Follow-up|6|||
145606426|NCT02712398|525075045|FG000|Overall Study|Sponsor Decision|1|||
145606427|NCT02712398|525075045|FG000|Overall Study|Physician Decision|1|||
145606428|NCT02712398|525075045|FG000|Overall Study|Death|2|||
145606429|NCT02712398|525075045|FG000|Overall Study|Re-operation|21|||
145606430|NCT01725386|525075047|FG000|Overall Study|Death|84|||
145606431|NCT01725386|525075048|FG001|Overall Study|Death|40|||
145606432|NCT01725386|525075047|FG000|Overall Study|Lost to Follow-up|81|||
145509644|NCT00947193|524724947|FG000|Overall Study|Withdrawal by Subject|1|||
145509645|NCT00947193|524724948|FG001|Overall Study|Withdrawal by Subject|0|||
145509646|NCT00947193|524724947|FG000|Overall Study|Factor VIII >1%|1|||
145509647|NCT00947193|524724948|FG001|Overall Study|Factor VIII >1%|0|||
145509648|NCT04364984|524724949|FG000|Overall Study|Death|2|||
145509649|NCT04364984|524724950|FG001|Overall Study|Death|2|||
145509650|NCT04364984|524724951|FG002|Overall Study|Death|0|||
145606433|NCT01725386|525075048|FG001|Overall Study|Lost to Follow-up|6|||
145606434|NCT01725386|525075047|FG000|Overall Study|Withdrawal by Subject|10|||
145606435|NCT01725386|525075048|FG001|Overall Study|Withdrawal by Subject|0|||
145606436|NCT00879996|525075056|FG000|Overall Study|Lost to Follow-up|7|||
145606437|NCT00879996|525075057|FG001|Overall Study|Lost to Follow-up|6|||
145606438|NCT00879996|525075056|FG000|Overall Study|non-compliance|6|||
145606439|NCT00879996|525075057|FG001|Overall Study|non-compliance|4|||
145606440|NCT00879996|525075056|FG000|Overall Study|Physician Decision|1|||
145606441|NCT00879996|525075057|FG001|Overall Study|Physician Decision|2|||
145606442|NCT00879996|525075056|FG000|Overall Study|psychiatric problem|0|||
145606443|NCT00879996|525075057|FG001|Overall Study|psychiatric problem|1|||
145606444|NCT00879996|525075056|FG000|Overall Study|put on parole|1|||
145606445|NCT00879996|525075057|FG001|Overall Study|put on parole|0|||
145606446|NCT02002182|525075066|FG000|Overall Study|Withdraw from study|3|||
145606447|NCT02002182|525075067|FG001|Overall Study|Withdraw from study|1|||
145606448|NCT02002182|525075066|FG000|Overall Study|Health Reasons|1|||
145606449|NCT02002182|525075067|FG001|Overall Study|Health Reasons|0|||
145606450|NCT02002182|525075066|FG000|Overall Study|Death|1|||
145606451|NCT02002182|525075067|FG001|Overall Study|Death|0|||
145606452|NCT03787680|525075069|FG000|Overall Study|Physician Decision|2|||
145606453|NCT03787680|525075070|FG001|Overall Study|Physician Decision|3|||
145606454|NCT03787680|525075069|FG000|Overall Study|Adverse Event|7|||
145606455|NCT03787680|525075070|FG001|Overall Study|Adverse Event|3|||
145606456|NCT03787680|525075069|FG000|Overall Study|Withdrawal by Subject|2|||
145606457|NCT03787680|525075070|FG001|Overall Study|Withdrawal by Subject|1|||
145606458|NCT05400746|525075071|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
145606459|NCT05400746|525075072|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
145606460|NCT05400746|525075073|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
145606461|NCT03724396|525075074|FG000|Overall Study|Lost to Follow-up|1|||
145606462|NCT03724396|525075075|FG001|Overall Study|Lost to Follow-up|1|||
145606463|NCT03724396|525075074|FG000|Overall Study|Withdrawal by Subject|1|||
145606464|NCT03724396|525075075|FG001|Overall Study|Withdrawal by Subject|0|||
145606465|NCT01490125|525075076|FG000|Period I|Adverse Event|4|||
145606466|NCT01490125|525075077|FG001|Period I|Adverse Event|1|||
145509651|NCT01349959|524724952|FG000|Overall Study|Adverse Event|7|||
145606467|NCT01490125|525075078|FG002|Period I|Adverse Event|1|||
145606468|NCT01490125|525075079|FG003|Period I|Adverse Event|3|||
145509652|NCT02675634|524724953|FG000|Test Period 1|Adverse Event|0|||
145509653|NCT02675634|524724954|FG001|Test Period 1|Adverse Event|1|||
145509654|NCT02675634|524724955|FG002|Test Period 1|Adverse Event|0|||
145606469|NCT01490125|525075080|FG004|Period I|Adverse Event|2|||
145606470|NCT01490125|525075081|FG005|Period I|Adverse Event|4|||
145509655|NCT02675634|524724956|FG003|Test Period 1|Adverse Event|1|||
145509656|NCT02675634|524724957|FG004|Test Period 1|Adverse Event|0|||
145509657|NCT02675634|524724958|FG005|Test Period 1|Adverse Event|0|||
145509658|NCT02675634|524724953|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
145509659|NCT02675634|524724954|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
145509660|NCT02675634|524724955|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
145509661|NCT02675634|524724956|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
145509662|NCT02675634|524724957|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
145509663|NCT02675634|524724958|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
145509664|NCT02675634|524724953|FG000|Test Period 2|Lack of Efficacy|1|||
145509665|NCT02675634|524724954|FG001|Test Period 2|Lack of Efficacy|0|||
145509666|NCT02675634|524724955|FG002|Test Period 2|Lack of Efficacy|0|||
145509667|NCT02675634|524724956|FG003|Test Period 2|Lack of Efficacy|0|||
145509668|NCT02675634|524724957|FG004|Test Period 2|Lack of Efficacy|0|||
145509669|NCT02675634|524724958|FG005|Test Period 2|Lack of Efficacy|0|||
145509670|NCT02675634|524724953|FG000|Test Period 2|Adverse Event|0|||
145606471|NCT01490125|525075076|FG000|Period I|Protocol Violation|1|||
145509671|NCT02675634|524724954|FG001|Test Period 2|Adverse Event|0|||
145509672|NCT02675634|524724955|FG002|Test Period 2|Adverse Event|0|||
145509673|NCT02675634|524724956|FG003|Test Period 2|Adverse Event|0|||
145509674|NCT02675634|524724957|FG004|Test Period 2|Adverse Event|0|||
145509675|NCT02675634|524724958|FG005|Test Period 2|Adverse Event|1|||
145606472|NCT01490125|525075077|FG001|Period I|Protocol Violation|1|||
145606473|NCT01490125|525075078|FG002|Period I|Protocol Violation|1|||
145606474|NCT01490125|525075079|FG003|Period I|Protocol Violation|1|||
145606475|NCT01490125|525075080|FG004|Period I|Protocol Violation|0|||
145606476|NCT01490125|525075081|FG005|Period I|Protocol Violation|0|||
145606477|NCT01490125|525075076|FG000|Period I|Withdrawal by Subject|1|||
145606478|NCT01490125|525075077|FG001|Period I|Withdrawal by Subject|3|||
145606479|NCT01490125|525075078|FG002|Period I|Withdrawal by Subject|2|||
145606480|NCT01490125|525075079|FG003|Period I|Withdrawal by Subject|1|||
145606481|NCT01490125|525075080|FG004|Period I|Withdrawal by Subject|2|||
145606482|NCT01490125|525075081|FG005|Period I|Withdrawal by Subject|1|||
145606483|NCT01490125|525075076|FG000|Period II|Adverse Event|2|||
145606484|NCT01490125|525075077|FG001|Period II|Adverse Event|3|||
145606485|NCT01490125|525075078|FG002|Period II|Adverse Event|2|||
145606486|NCT01490125|525075079|FG003|Period II|Adverse Event|2|||
145606487|NCT01490125|525075080|FG004|Period II|Adverse Event|4|||
145606488|NCT01490125|525075081|FG005|Period II|Adverse Event|2|||
145606489|NCT01490125|525075076|FG000|Period II|Protocol Violation|0|||
145606490|NCT01490125|525075077|FG001|Period II|Protocol Violation|0|||
145606491|NCT01490125|525075078|FG002|Period II|Protocol Violation|1|||
145606492|NCT01490125|525075079|FG003|Period II|Protocol Violation|1|||
145606493|NCT01490125|525075080|FG004|Period II|Protocol Violation|0|||
145606494|NCT01490125|525075081|FG005|Period II|Protocol Violation|0|||
145606495|NCT01490125|525075076|FG000|Period II|Lost to Follow-up|0|||
145606496|NCT01490125|525075077|FG001|Period II|Lost to Follow-up|1|||
145606497|NCT01490125|525075078|FG002|Period II|Lost to Follow-up|0|||
145606498|NCT01490125|525075079|FG003|Period II|Lost to Follow-up|0|||
145606499|NCT01490125|525075080|FG004|Period II|Lost to Follow-up|0|||
145606500|NCT01490125|525075081|FG005|Period II|Lost to Follow-up|0|||
145606501|NCT01490125|525075076|FG000|Period II|Withdrawal by Subject|1|||
145606502|NCT01490125|525075077|FG001|Period II|Withdrawal by Subject|0|||
145606503|NCT01490125|525075078|FG002|Period II|Withdrawal by Subject|0|||
145606504|NCT01490125|525075079|FG003|Period II|Withdrawal by Subject|0|||
145606505|NCT01490125|525075080|FG004|Period II|Withdrawal by Subject|0|||
145606506|NCT01490125|525075081|FG005|Period II|Withdrawal by Subject|0|||
145606507|NCT01490125|525075076|FG000|Period III|Adverse Event|3|||
145606508|NCT01490125|525075077|FG001|Period III|Adverse Event|1|||
145606509|NCT01490125|525075078|FG002|Period III|Adverse Event|0|||
145606510|NCT01490125|525075079|FG003|Period III|Adverse Event|1|||
145606511|NCT01490125|525075080|FG004|Period III|Adverse Event|0|||
145606512|NCT01490125|525075081|FG005|Period III|Adverse Event|0|||
145606513|NCT01490125|525075076|FG000|Period III|Death|0|||
145606514|NCT01490125|525075077|FG001|Period III|Death|0|||
145606515|NCT01490125|525075078|FG002|Period III|Death|0|||
145509676|NCT01941186|524724959|FG000|Follow-up|Lost to Follow-up|1|||
145606516|NCT01490125|525075079|FG003|Period III|Death|1|||
145509677|NCT01941186|524724960|FG001|Follow-up|Lost to Follow-up|0|||
145509678|NCT02105961|524724961|FG000|Overall Study|Adverse Event|18|||
145606517|NCT01490125|525075080|FG004|Period III|Death|0|||
145606518|NCT01490125|525075081|FG005|Period III|Death|0|||
145606519|NCT01490125|525075076|FG000|Period III|Lack of Efficacy|0|||
145606520|NCT01490125|525075077|FG001|Period III|Lack of Efficacy|0|||
145606521|NCT01490125|525075078|FG002|Period III|Lack of Efficacy|0|||
145509679|NCT02105961|524724962|FG001|Overall Study|Adverse Event|7|||
145509680|NCT02105961|524724963|FG002|Overall Study|Adverse Event|13|||
145606522|NCT01490125|525075079|FG003|Period III|Lack of Efficacy|0|||
145606523|NCT01490125|525075080|FG004|Period III|Lack of Efficacy|1|||
145606524|NCT01490125|525075081|FG005|Period III|Lack of Efficacy|0|||
145606525|NCT04522180|525075082|FG000|Overall Study|Investigator judgement|3|||
145606526|NCT04522180|525075083|FG001|Overall Study|Investigator judgement|4|||
145509681|NCT02105961|524724961|FG000|Overall Study|Lack of Efficacy|3|||
145509682|NCT02105961|524724962|FG001|Overall Study|Lack of Efficacy|0|||
145509683|NCT02105961|524724963|FG002|Overall Study|Lack of Efficacy|3|||
145401674|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145401675|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145401676|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
145401677|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
145401678|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145401679|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145401680|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
145401681|NCT01668797|524328721|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
145401682|NCT01668797|524328722|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145401683|NCT01668797|524328723|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145401684|NCT01668797|524328724|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
145401685|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145401686|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
145401687|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145401688|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
145401689|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145401690|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
145401691|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145401692|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
145401693|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
145401694|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
145401695|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
145401696|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
145401697|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145401698|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
145401699|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145401700|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
145401701|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
145401702|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
145401703|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
145509684|NCT02105961|524724961|FG000|Overall Study|Lost to Follow-up|2|||
145509685|NCT02105961|524724962|FG001|Overall Study|Lost to Follow-up|0|||
145509686|NCT02105961|524724963|FG002|Overall Study|Lost to Follow-up|1|||
145509687|NCT02105961|524724961|FG000|Overall Study|Physician Decision|3|||
145509688|NCT02105961|524724962|FG001|Overall Study|Physician Decision|3|||
145509689|NCT02105961|524724963|FG002|Overall Study|Physician Decision|2|||
145509690|NCT02105961|524724961|FG000|Overall Study|Withdrawal by Subject|15|||
145509691|NCT02105961|524724962|FG001|Overall Study|Withdrawal by Subject|7|||
145509692|NCT02105961|524724963|FG002|Overall Study|Withdrawal by Subject|11|||
145509693|NCT03860259|524724964|FG000|Overall Study|Lost to Follow-up|5|||
145509694|NCT03860259|524724965|FG001|Overall Study|Lost to Follow-up|5|||
145509695|NCT03860259|524724964|FG000|Overall Study|Protocol Violation|1|||
145509696|NCT03860259|524724965|FG001|Overall Study|Protocol Violation|0|||
145509697|NCT00934362|524724966|FG000|Overall Study|Adverse Event|1|||
145509698|NCT00934362|524724967|FG001|Overall Study|Adverse Event|0|||
145509699|NCT04154189|524724968|FG000|Overall Study|Withdrawal by Subject|4|||
145509700|NCT04154189|524724969|FG001|Overall Study|Withdrawal by Subject|6|||
145509701|NCT04154189|524724968|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
145509702|NCT04154189|524724969|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
145509703|NCT04154189|524724968|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
145509704|NCT04154189|524724969|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
145509705|NCT04154189|524724968|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
145509706|NCT04154189|524724969|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
145509707|NCT04154189|524724968|FG000|Overall Study|Death|25|||
145509708|NCT04154189|524724969|FG001|Overall Study|Death|25|||
145509709|NCT02280408|524724970|FG000|Overall Study|Lost to Follow-up|0|||
145509710|NCT02280408|524724971|FG001|Overall Study|Lost to Follow-up|2|||
145509711|NCT02280408|524724972|FG002|Overall Study|Lost to Follow-up|0|||
145509712|NCT02280408|524724973|FG003|Overall Study|Lost to Follow-up|0|||
145509713|NCT01092117|524724974|FG000|Index Procedure to 1 Month|Death|1|||
145509714|NCT01092117|524724974|FG000|1 Month|Death|1|||
145509715|NCT01092117|524724974|FG000|1 Month|Withdrawal by Subject|1|||
145509716|NCT01092117|524724974|FG000|1 Month|Lost to Follow-up|1|||
145509717|NCT01092117|524724974|FG000|6 Months|Death|2|||
145509718|NCT01092117|524724974|FG000|6 Months|Withdrawal by Subject|3|||
145509719|NCT01092117|524724974|FG000|12 Month|Death|11|||
145509720|NCT01092117|524724974|FG000|12 Month|Withdrawal by Subject|2|||
145509721|NCT01092117|524724974|FG000|12 Month|Lost to Follow-up|1|||
145509722|NCT01092117|524724974|FG000|Year 2|Death|5|||
145509723|NCT01092117|524724974|FG000|Year 2|Withdrawal by Subject|4|||
145509724|NCT01092117|524724974|FG000|Year 2|Lost to Follow-up|1|||
145509725|NCT01092117|524724974|FG000|Year 3|Death|7|||
145509726|NCT01092117|524724974|FG000|Year 3|Withdrawal by Subject|9|||
145509727|NCT01092117|524724974|FG000|Year 3|Lost to Follow-up|3|||
145509728|NCT01092117|524724974|FG000|Year 4|Death|8|||
145509729|NCT01092117|524724974|FG000|Year 4|Withdrawal by Subject|4|||
145509730|NCT01092117|524724974|FG000|Year 4|Lost to Follow-up|4|||
145509731|NCT02474069|524724975|FG000|Selection Phase (SP)|Adverse Event|8|||
145509732|NCT02474069|524724976|FG001|Selection Phase (SP)|Adverse Event|0|||
145509733|NCT02474069|524724977|FG002|Selection Phase (SP)|Adverse Event|0|||
145509734|NCT02474069|524724975|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
145509735|NCT02474069|524724976|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
145509736|NCT02474069|524724977|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
145509737|NCT02474069|524724975|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
145509738|NCT02474069|524724976|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
145509739|NCT02474069|524724977|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
145509740|NCT02474069|524724975|FG000|Selection Phase (SP)|Physician Decision|1|||
145509741|NCT02474069|524724976|FG001|Selection Phase (SP)|Physician Decision|0|||
145509742|NCT02474069|524724977|FG002|Selection Phase (SP)|Physician Decision|0|||
145509743|NCT02474069|524724975|FG000|Selection Phase (SP)|Protocol Violation|1|||
145509744|NCT02474069|524724976|FG001|Selection Phase (SP)|Protocol Violation|0|||
145509745|NCT02474069|524724977|FG002|Selection Phase (SP)|Protocol Violation|0|||
145509746|NCT02474069|524724975|FG000|Selection Phase (SP)|No longer requires treatment|1|||
145509747|NCT02474069|524724976|FG001|Selection Phase (SP)|No longer requires treatment|0|||
145509748|NCT02474069|524724977|FG002|Selection Phase (SP)|No longer requires treatment|0|||
145509749|NCT02474069|524724975|FG000|Selection Phase (SP)|Technical Problem|1|||
145509750|NCT02474069|524724976|FG001|Selection Phase (SP)|Technical Problem|0|||
145509751|NCT02474069|524724977|FG002|Selection Phase (SP)|Technical Problem|0|||
145509752|NCT02474069|524724975|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
145509753|NCT02474069|524724976|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
145509754|NCT02474069|524724977|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
145509755|NCT02474069|524724975|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
145509756|NCT02474069|524724976|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
145509757|NCT02474069|524724977|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
145509758|NCT02474069|524724975|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
145509759|NCT02474069|524724976|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
145509760|NCT02474069|524724977|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
145509761|NCT02474069|524724975|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
145509762|NCT02474069|524724976|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
145509763|NCT02474069|524724977|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
145509764|NCT02474069|524724975|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
145509765|NCT02474069|524724976|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
145509766|NCT02474069|524724977|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
145509767|NCT02474069|524724975|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
145509768|NCT02474069|524724976|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
145509769|NCT02474069|524724977|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
145509770|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
145509771|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
145509772|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
145509773|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
145509774|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
145509775|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
145509776|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
145509777|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
145509778|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
145509779|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
145509780|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
145509781|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
145509782|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
145509783|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
145509784|NCT04173494|524724978|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
145509785|NCT04173494|524724979|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
145509786|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
145509787|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
145509788|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
145509789|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
145509790|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
145509791|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
145509792|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
145606527|NCT04522180|525075082|FG000|Overall Study|Voluntary withdrawal|1|||
145606528|NCT04522180|525075083|FG001|Overall Study|Voluntary withdrawal|0|||
145606529|NCT04522180|525075082|FG000|Overall Study|Pregnancy|0|||
145606530|NCT04522180|525075083|FG001|Overall Study|Pregnancy|1|||
145606531|NCT04522180|525075082|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
145606532|NCT04522180|525075083|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
145606533|NCT04522180|525075082|FG000|Overall Study|Reason not specified|8|||
145606534|NCT04522180|525075083|FG001|Overall Study|Reason not specified|5|||
145606535|NCT05807919|525075084|FG000|Overall Study|Received antibiotics - excluded|0|||
145606536|NCT05807919|525075085|FG001|Overall Study|Received antibiotics - excluded|1|||
145606537|NCT05807919|525075084|FG000|Overall Study|Withdrawal by Subject|0|||
145606538|NCT05807919|525075085|FG001|Overall Study|Withdrawal by Subject|3|||
145606539|NCT05807919|525075084|FG000|Overall Study|Adverse Event|1|||
145606540|NCT05807919|525075085|FG001|Overall Study|Adverse Event|1|||
145606541|NCT03635489|525075086|FG000|Overall Study|Death|19|||
145606542|NCT03635489|525075087|FG001|Overall Study|Death|13|||
145606543|NCT03635489|525075086|FG000|Overall Study|Lost to Follow-up|1|||
145606544|NCT03635489|525075087|FG001|Overall Study|Lost to Follow-up|2|||
145606545|NCT03635489|525075086|FG000|Overall Study|Withdrawal by Subject|1|||
145606546|NCT03635489|525075087|FG001|Overall Study|Withdrawal by Subject|2|||
145606547|NCT03635489|525075086|FG000|Overall Study|Study Ended by Sponsor|28|||
145606548|NCT03635489|525075087|FG001|Overall Study|Study Ended by Sponsor|34|||
145606549|NCT00943306|525075092|FG000|Overall Study|Physician Decision|1|||
145606550|NCT00943306|525075092|FG000|Overall Study|Death|1|||
145606551|NCT00943306|525075092|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
145606552|NCT00733980|525075093|FG000|Overall Study|Adverse Event|5|||
145606553|NCT00733980|525075094|FG001|Overall Study|Adverse Event|2|||
145606554|NCT00733980|525075093|FG000|Overall Study|Lack of Efficacy|0|||
145606555|NCT00733980|525075094|FG001|Overall Study|Lack of Efficacy|1|||
145606556|NCT00733980|525075093|FG000|Overall Study|Protocol Violation|2|||
145606557|NCT00733980|525075094|FG001|Overall Study|Protocol Violation|1|||
145606558|NCT00733980|525075093|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
145606559|NCT00733980|525075094|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
145606560|NCT00733980|525075093|FG000|Overall Study|Lost to Follow-up|6|||
145606561|NCT00733980|525075094|FG001|Overall Study|Lost to Follow-up|11|||
145606562|NCT00733980|525075093|FG000|Overall Study|Physician Decision|2|||
145606563|NCT00733980|525075094|FG001|Overall Study|Physician Decision|3|||
145606564|NCT00733980|525075093|FG000|Overall Study|Withdrawal by Subject|6|||
145606565|NCT00733980|525075094|FG001|Overall Study|Withdrawal by Subject|2|||
145606566|NCT01552954|525075095|FG000|Overall Study|Adverse Event|1|||
145606567|NCT01552954|525075096|FG001|Overall Study|Adverse Event|2|||
145606568|NCT01552954|525075095|FG000|Overall Study|Lost to Follow-up|1|||
145606569|NCT01552954|525075096|FG001|Overall Study|Lost to Follow-up|1|||
145606570|NCT01552954|525075095|FG000|Overall Study|Withdrawal by Subject|1|||
145606571|NCT01552954|525075096|FG001|Overall Study|Withdrawal by Subject|1|||
145606572|NCT01552954|525075095|FG000|Overall Study|Protocol Violation|1|||
145606573|NCT01552954|525075096|FG001|Overall Study|Protocol Violation|2|||
145606574|NCT01552954|525075095|FG000|Overall Study|diagnosed DM|1|||
145606575|NCT01552954|525075096|FG001|Overall Study|diagnosed DM|0|||
145606576|NCT00779779|525075098|FG000|Overall Study|Adverse Event|1|||
145606577|NCT00779779|525075098|FG000|Overall Study|Protocol Violation|14|||
145606578|NCT00779779|525075098|FG000|Overall Study|Withdrawal by Subject|4|||
145606579|NCT00779779|525075098|FG000|Overall Study|Lost to Follow-up|5|||
145606580|NCT02404389|525075100|FG000|Overall Study|Adverse Event|1|||
145606581|NCT02404389|525075101|FG001|Overall Study|Adverse Event|0|||
145606582|NCT02404389|525075102|FG002|Overall Study|Adverse Event|1|||
145606583|NCT02404389|525075103|FG003|Overall Study|Adverse Event|0|||
145606584|NCT02404389|525075104|FG004|Overall Study|Adverse Event|2|||
145606585|NCT02404389|525075100|FG000|Overall Study|Subject/guardian decision|1|||
145606586|NCT02404389|525075101|FG001|Overall Study|Subject/guardian decision|0|||
145606587|NCT02404389|525075102|FG002|Overall Study|Subject/guardian decision|0|||
145606588|NCT02404389|525075103|FG003|Overall Study|Subject/guardian decision|1|||
145606589|NCT02404389|525075104|FG004|Overall Study|Subject/guardian decision|1|||
145606590|NCT03300570|525075108|FG000|Overall Study|Adverse Event|0|||
145606591|NCT03300570|525075109|FG001|Overall Study|Adverse Event|1|||
145606592|NCT03300570|525075108|FG000|Overall Study|Withdrawal by Subject|1|||
145606593|NCT03300570|525075109|FG001|Overall Study|Withdrawal by Subject|0|||
145606594|NCT03300570|525075108|FG000|Overall Study|Inadequate bowel prep|1|||
145606595|NCT03300570|525075109|FG001|Overall Study|Inadequate bowel prep|0|||
145606596|NCT00117156|525075112|FG000|Overall Study|Adverse Event|9|||
145606597|NCT00117156|525075112|FG000|Overall Study|Physician Decision|1|||
145606598|NCT00117156|525075112|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
145606599|NCT01987817|525075113|FG000|Overall Study|Adverse Event|4|||
145606600|NCT01987817|525075114|FG001|Overall Study|Adverse Event|0|||
145606601|NCT01987817|525075113|FG000|Overall Study|Withdrawal by Subject|1|||
145606602|NCT01987817|525075114|FG001|Overall Study|Withdrawal by Subject|1|||
145606603|NCT01987817|525075113|FG000|Overall Study|Physician Decision|1|||
145606604|NCT01987817|525075114|FG001|Overall Study|Physician Decision|0|||
145606605|NCT01576718|525075117|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
145606606|NCT01576718|525075118|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145509793|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
145509794|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
145606607|NCT01576718|525075119|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145606608|NCT01576718|525075120|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145606609|NCT01576718|525075121|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145606610|NCT01576718|525075122|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145606611|NCT01576718|525075123|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145606612|NCT01576718|525075117|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
145606613|NCT01576718|525075118|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606614|NCT01576718|525075119|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606615|NCT01576718|525075120|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606616|NCT01576718|525075121|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606617|NCT01576718|525075122|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606618|NCT01576718|525075123|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145606619|NCT01576718|525075117|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
145606620|NCT01576718|525075118|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145606621|NCT01576718|525075119|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145606622|NCT01576718|525075120|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145606623|NCT01576718|525075121|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145606624|NCT01576718|525075122|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145509795|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
145509796|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
145509797|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
145509798|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
145509799|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
145509800|NCT04173494|524724978|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
145509801|NCT04173494|524724979|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
145509802|NCT00202878|524724980|FG000|Overall Study|Death|964|||
145509803|NCT00202878|524724981|FG001|Overall Study|Death|968|||
145509804|NCT00202878|524724980|FG000|Overall Study|Only Vital Status Known|357|||
145509805|NCT00202878|524724981|FG001|Overall Study|Only Vital Status Known|356|||
145509806|NCT00202878|524724980|FG000|Overall Study|Lost to Follow-up|44|||
145509807|NCT00202878|524724981|FG001|Overall Study|Lost to Follow-up|49|||
145509808|NCT00202878|524724980|FG000|Overall Study|Site Closure|39|||
145606625|NCT01576718|525075123|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145606626|NCT01576718|525075117|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
145606627|NCT01576718|525075118|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606628|NCT01576718|525075119|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606629|NCT01576718|525075120|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606630|NCT01576718|525075121|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606631|NCT01576718|525075122|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606632|NCT01576718|525075123|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145606633|NCT01576718|525075117|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
145606634|NCT01576718|525075118|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145606635|NCT01576718|525075119|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145606636|NCT01576718|525075120|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145509809|NCT00202878|524724981|FG001|Overall Study|Site Closure|36|||
145509810|NCT00202878|524724980|FG000|Overall Study|Withdrawal by Subject|795|||
145509811|NCT00202878|524724981|FG001|Overall Study|Withdrawal by Subject|808|||
145509812|NCT02433080|524724983|FG000|Overall Study|Lost to Follow-up|1|||
145606637|NCT01576718|525075121|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145606638|NCT01576718|525075122|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145606639|NCT01576718|525075123|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145606640|NCT01576718|525075117|FG000|Treatment Period|Adverse Event|0|||
145509813|NCT02433080|524724984|FG001|Overall Study|Lost to Follow-up|2|||
145606641|NCT01576718|525075118|FG001|Treatment Period|Adverse Event|1|||
145606642|NCT01576718|525075119|FG002|Treatment Period|Adverse Event|1|||
145606643|NCT01576718|525075120|FG003|Treatment Period|Adverse Event|1|||
145606644|NCT01576718|525075121|FG004|Treatment Period|Adverse Event|1|||
145732949|NCT03308942|525540864|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
145509814|NCT02433080|524724983|FG000|Overall Study|Withdrawal by Subject|0|||
145509815|NCT02433080|524724984|FG001|Overall Study|Withdrawal by Subject|2|||
145509816|NCT03801031|524724985|FG000|Overall Study|Lost to Follow-up|1|||
145509817|NCT03801031|524724986|FG001|Overall Study|Lost to Follow-up|0|||
145509818|NCT03801031|524724985|FG000|Overall Study|Unable to comply|1|||
145509819|NCT03801031|524724986|FG001|Overall Study|Unable to comply|0|||
145509820|NCT03801031|524724985|FG000|Overall Study|Withdrawal by Subject|0|||
145509821|NCT03801031|524724986|FG001|Overall Study|Withdrawal by Subject|1|||
145509822|NCT01598506|524724989|FG000|Overall Study|Withdrawal by Subject|2|||
145509823|NCT02504216|524724990|FG000|Overall Study|Lost to Follow-up|3|||
145509824|NCT02504216|524724991|FG001|Overall Study|Lost to Follow-up|3|||
145509825|NCT02504216|524724990|FG000|Overall Study|Withdrawal by Subject|8|||
145509826|NCT02504216|524724991|FG001|Overall Study|Withdrawal by Subject|12|||
145509827|NCT00223080|524724992|FG000|Overall Study|Withdrawal by Subject|253|||
145509828|NCT00223080|524724993|FG001|Overall Study|Withdrawal by Subject|232|||
145509829|NCT00223080|524724992|FG000|Overall Study|Required contraindicated med|0|||
145509830|NCT00223080|524724993|FG001|Overall Study|Required contraindicated med|1|||
145509831|NCT00223080|524724992|FG000|Overall Study|Non-compliant|7|||
145509832|NCT00223080|524724993|FG001|Overall Study|Non-compliant|7|||
145509833|NCT00223080|524724992|FG000|Overall Study|Moved from study area|37|||
145509834|NCT00223080|524724993|FG001|Overall Study|Moved from study area|47|||
145509835|NCT00223080|524724992|FG000|Overall Study|Lost to Follow-up|259|||
145509836|NCT00223080|524724993|FG001|Overall Study|Lost to Follow-up|284|||
145509837|NCT00223080|524724992|FG000|Overall Study|Death|85|||
145509838|NCT00223080|524724993|FG001|Overall Study|Death|74|||
145509839|NCT00223080|524724992|FG000|Overall Study|Other|14|||
145509840|NCT00223080|524724993|FG001|Overall Study|Other|11|||
145509841|NCT00223080|524724992|FG000|Overall Study|Reason not provided|141|||
145509842|NCT00223080|524724993|FG001|Overall Study|Reason not provided|140|||
145509843|NCT00223080|524724992|FG000|Overall Study|Adverse Event|0|||
145509844|NCT00223080|524724993|FG001|Overall Study|Adverse Event|1|||
145509845|NCT02598583|524724994|FG000|Extension Period|Withdrawal by Subject|1|||
145509846|NCT02598583|524724995|FG001|Extension Period|Withdrawal by Subject|0|||
145509847|NCT00947882|524725003|FG000|Overall Study|Adverse Event|0|||
145509848|NCT00947882|524725004|FG001|Overall Study|Adverse Event|1|||
145509849|NCT00947882|524725005|FG002|Overall Study|Adverse Event|4|||
145509850|NCT00947882|524725006|FG003|Overall Study|Adverse Event|4|||
145509851|NCT00947882|524725003|FG000|Overall Study|Withdrawal by Subject|2|||
145509852|NCT00947882|524725004|FG001|Overall Study|Withdrawal by Subject|0|||
145509853|NCT00947882|524725005|FG002|Overall Study|Withdrawal by Subject|8|||
145509854|NCT00947882|524725006|FG003|Overall Study|Withdrawal by Subject|2|||
145509855|NCT00947882|524725003|FG000|Overall Study|Protocol Violation|0|||
145509856|NCT00947882|524725004|FG001|Overall Study|Protocol Violation|0|||
145509857|NCT00947882|524725005|FG002|Overall Study|Protocol Violation|1|||
145509858|NCT00947882|524725006|FG003|Overall Study|Protocol Violation|0|||
145509859|NCT00947882|524725003|FG000|Overall Study|Lost to Follow-up|0|||
145509860|NCT00947882|524725004|FG001|Overall Study|Lost to Follow-up|2|||
145509861|NCT00947882|524725005|FG002|Overall Study|Lost to Follow-up|1|||
145509862|NCT00947882|524725006|FG003|Overall Study|Lost to Follow-up|0|||
145509863|NCT00947882|524725003|FG000|Overall Study|Other/Unknown|10|||
145509864|NCT00947882|524725004|FG001|Overall Study|Other/Unknown|13|||
145509865|NCT00947882|524725005|FG002|Overall Study|Other/Unknown|3|||
145509866|NCT00947882|524725006|FG003|Overall Study|Other/Unknown|6|||
145509867|NCT00947882|524725003|FG000|Overall Study|Trial Terminated by Sponsor|62|||
145509868|NCT00947882|524725004|FG001|Overall Study|Trial Terminated by Sponsor|61|||
145509869|NCT00947882|524725005|FG002|Overall Study|Trial Terminated by Sponsor|62|||
145509870|NCT00947882|524725006|FG003|Overall Study|Trial Terminated by Sponsor|70|||
145509871|NCT00452361|524725007|FG000|Overall Study|Adverse Event|8|||
145509872|NCT00452361|524725008|FG001|Overall Study|Adverse Event|0|||
145509873|NCT00452361|524725007|FG000|Overall Study|Withdrawal by Subject|0|||
145509874|NCT00452361|524725008|FG001|Overall Study|Withdrawal by Subject|1|||
145509875|NCT00452361|524725007|FG000|Overall Study|Premature termination|13|||
145509876|NCT00452361|524725008|FG001|Overall Study|Premature termination|9|||
145509877|NCT05188053|524725009|FG000|Overall Study|Lost to Follow-up|23|||
145509878|NCT05188053|524725010|FG001|Overall Study|Lost to Follow-up|30|||
145509879|NCT05188053|524725009|FG000|Overall Study|Protocol Violation|16|||
145509880|NCT05188053|524725010|FG001|Overall Study|Protocol Violation|16|||
145509881|NCT05188053|524725009|FG000|Overall Study|Physician Decision|3|||
145509882|NCT05188053|524725010|FG001|Overall Study|Physician Decision|0|||
145509883|NCT05188053|524725009|FG000|Overall Study|Withdrawal by Subject|0|||
145509884|NCT05188053|524725010|FG001|Overall Study|Withdrawal by Subject|1|||
145509885|NCT02087423|524725014|FG000|Overall Study|Withdrawal by Subject|20|||
145509886|NCT02087423|524725015|FG001|Overall Study|Withdrawal by Subject|20|||
145606645|NCT01576718|525075122|FG005|Treatment Period|Adverse Event|1|||
145401704|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
145401705|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145401706|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
145401707|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145401708|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
145401709|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145401710|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
145401711|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145606646|NCT01576718|525075123|FG006|Treatment Period|Adverse Event|0|||
145509887|NCT02087423|524725016|FG002|Overall Study|Withdrawal by Subject|3|||
145509888|NCT02087423|524725014|FG000|Overall Study|Death|68|||
145509889|NCT02087423|524725015|FG001|Overall Study|Death|207|||
145509890|NCT02087423|524725016|FG002|Overall Study|Death|40|||
145509891|NCT02087423|524725014|FG000|Overall Study|Lost to Follow-up|0|||
145509892|NCT02087423|524725015|FG001|Overall Study|Lost to Follow-up|2|||
145509893|NCT02087423|524725016|FG002|Overall Study|Lost to Follow-up|0|||
145509894|NCT02087423|524725014|FG000|Overall Study|Terminated from study at final DCO|23|||
145509895|NCT02087423|524725015|FG001|Overall Study|Terminated from study at final DCO|36|||
145509896|NCT02087423|524725016|FG002|Overall Study|Terminated from study at final DCO|25|||
145509897|NCT01010867|524725017|FG000|Overall Study|< 50% adherence to probiotic|1|||
145509898|NCT02762370|524725020|FG000|Overall Study|Protocol Violation|1|||
145509899|NCT02762370|524725021|FG001|Overall Study|Protocol Violation|0|||
145509900|NCT04393454|524725028|FG000|Overall Study|Death|1|||
145509901|NCT04393454|524725028|FG000|Overall Study|Lost to Follow-up|1|||
145509902|NCT03304249|524725030|FG000|Overall Study|Lost to Follow-up|8|||
145509903|NCT03304249|524725031|FG001|Overall Study|Lost to Follow-up|10|||
145509904|NCT03304249|524725030|FG000|Overall Study|Withdrawal by Subject|12|||
145509905|NCT03304249|524725031|FG001|Overall Study|Withdrawal by Subject|2|||
145509906|NCT03304249|524725030|FG000|Overall Study|Moved Out of District|4|||
145509907|NCT03304249|524725031|FG001|Overall Study|Moved Out of District|2|||
145509908|NCT00924027|524725032|FG000|Overall Study|Lost to Further Follow-Up|4|||
145509909|NCT00924027|524725033|FG001|Overall Study|Lost to Further Follow-Up|0|||
145509910|NCT00924027|524725034|FG002|Overall Study|Lost to Further Follow-Up|0|||
145509911|NCT00924027|524725035|FG003|Overall Study|Lost to Further Follow-Up|0|||
145509912|NCT00924027|524725032|FG000|Overall Study|Physician Decision|1|||
145509913|NCT00924027|524725033|FG001|Overall Study|Physician Decision|0|||
145509914|NCT00924027|524725034|FG002|Overall Study|Physician Decision|0|||
145509915|NCT00924027|524725035|FG003|Overall Study|Physician Decision|1|||
145509916|NCT00924027|524725032|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
145509917|NCT00924027|524725033|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
145509918|NCT00924027|524725034|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
145509919|NCT00924027|524725035|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
145509920|NCT00924027|524725032|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
145509921|NCT00924027|524725033|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
145509922|NCT00924027|524725034|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
145509923|NCT00924027|524725035|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
145509924|NCT00924027|524725032|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
145509925|NCT00924027|524725033|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
145509926|NCT00924027|524725034|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
145509927|NCT00924027|524725035|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
145509928|NCT04549545|524726833|FG000|Initial Period|Withdrawal by Subject|4|||
145509929|NCT04549545|524726834|FG001|Initial Period|Withdrawal by Subject|0|||
145509930|NCT04549545|524726833|FG000|Initial Period|Additional ENT Procedure|3|||
145509931|NCT04549545|524726834|FG001|Initial Period|Additional ENT Procedure|0|||
145509932|NCT04549545|524726833|FG000|Initial Period|Lost to Follow-up|3|||
145509933|NCT04549545|524726834|FG001|Initial Period|Lost to Follow-up|1|||
145509934|NCT04549545|524726833|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
145509935|NCT04549545|524726834|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
145509936|NCT04549545|524726833|FG000|Crossover Period|Additional ENT Procedure|0|||
145509937|NCT04549545|524726834|FG001|Crossover Period|Additional ENT Procedure|6|||
145509938|NCT04549545|524726833|FG000|Crossover Period|Lost to Follow-up|0|||
145509939|NCT04549545|524726834|FG001|Crossover Period|Lost to Follow-up|1|||
145509940|NCT04549545|524726833|FG000|Crossover Period|Withdrawal by Subject|0|||
145509941|NCT04549545|524726834|FG001|Crossover Period|Withdrawal by Subject|4|||
145509942|NCT01395524|524726839|FG000|Overall Study|Non-compliance with study schedule|1|||
145509943|NCT01395524|524726840|FG001|Overall Study|Non-compliance with study schedule|0|||
145509944|NCT01395524|524726841|FG002|Overall Study|Non-compliance with study schedule|1|||
145509945|NCT01395524|524726839|FG000|Overall Study|Lost to Follow-up|3|||
145509946|NCT01395524|524726840|FG001|Overall Study|Lost to Follow-up|1|||
145509947|NCT01395524|524726841|FG002|Overall Study|Lost to Follow-up|1|||
145509948|NCT01395524|524726839|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
145509949|NCT01395524|524726840|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
145509950|NCT01395524|524726841|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
145509951|NCT01395524|524726839|FG000|Overall Study|Severe noncompliance with protocol|1|||
145509952|NCT01395524|524726840|FG001|Overall Study|Severe noncompliance with protocol|0|||
145509953|NCT01395524|524726841|FG002|Overall Study|Severe noncompliance with protocol|0|||
145509954|NCT01395524|524726839|FG000|Overall Study|Adverse Event|4|||
145509955|NCT01395524|524726840|FG001|Overall Study|Adverse Event|4|||
145509956|NCT01395524|524726841|FG002|Overall Study|Adverse Event|3|||
145509957|NCT01395524|524726839|FG000|Overall Study|Death|1|||
145509958|NCT01395524|524726840|FG001|Overall Study|Death|0|||
145509959|NCT01395524|524726841|FG002|Overall Study|Death|0|||
145509960|NCT01395524|524726839|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
145509961|NCT01395524|524726840|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145509962|NCT01395524|524726841|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145509963|NCT01395524|524726839|FG000|Overall Study|Withdrawal by Subject|4|||
145509964|NCT01395524|524726840|FG001|Overall Study|Withdrawal by Subject|8|||
145509965|NCT01395524|524726841|FG002|Overall Study|Withdrawal by Subject|8|||
145509966|NCT01395524|524726839|FG000|Overall Study|Did not receive treatment|1|||
145509967|NCT01395524|524726840|FG001|Overall Study|Did not receive treatment|1|||
145509968|NCT01395524|524726841|FG002|Overall Study|Did not receive treatment|3|||
145509969|NCT01395524|524726839|FG000|Overall Study|Subject had spinal surgery|0|||
145509970|NCT01395524|524726840|FG001|Overall Study|Subject had spinal surgery|0|||
145509971|NCT01395524|524726841|FG002|Overall Study|Subject had spinal surgery|1|||
145509972|NCT01657461|524726842|FG000|Overall Study|Death|9|||
145509973|NCT01657461|524726843|FG001|Overall Study|Death|12|||
145509974|NCT01657461|524726842|FG000|Overall Study|Lost to Follow-up|0|||
145509975|NCT01657461|524726843|FG001|Overall Study|Lost to Follow-up|3|||
145509976|NCT01657461|524726842|FG000|Overall Study|Physician Decision|0|||
145509977|NCT01657461|524726843|FG001|Overall Study|Physician Decision|2|||
145509978|NCT01657461|524726842|FG000|Overall Study|Withdrawal by Subject|1|||
145509979|NCT01657461|524726843|FG001|Overall Study|Withdrawal by Subject|3|||
145509980|NCT01868542|524726844|FG000|Overall Study|Protocol Violation|0|||
145509981|NCT01868542|524726845|FG001|Overall Study|Protocol Violation|1|||
145509982|NCT01868542|524726844|FG000|Overall Study|Unclassified|0|||
145509983|NCT01868542|524726845|FG001|Overall Study|Unclassified|1|||
145509984|NCT00130247|524726846|FG000|Overall Study|Pregnancy|1|||
145401712|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
145401713|NCT01668797|524328721|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145401714|NCT01668797|524328722|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
145401715|NCT01668797|524328723|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145401716|NCT01668797|524328724|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
145401717|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
145401718|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
145401719|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
145401720|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
145401721|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
145401722|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
145401723|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
145401724|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
145401725|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
145401726|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
145509985|NCT00130247|524726847|FG001|Overall Study|Pregnancy|0|||
145509986|NCT00130247|524726846|FG000|Overall Study|Post-randomization exclusion|1|||
145509987|NCT00130247|524726847|FG001|Overall Study|Post-randomization exclusion|2|||
145509988|NCT00130247|524726846|FG000|Overall Study|Not compliant with DOT|0|||
145509989|NCT00130247|524726847|FG001|Overall Study|Not compliant with DOT|2|||
145509990|NCT00843284|524726852|FG000|Overall Study|Adverse Event|39|||
145509991|NCT00843284|524726852|FG000|Overall Study|Lack of Efficacy|5|||
145509992|NCT00843284|524726852|FG000|Overall Study|Lost to Follow-up|11|||
145509993|NCT00843284|524726852|FG000|Overall Study|Other|10|||
145509994|NCT00843284|524726852|FG000|Overall Study|Withdrawal by Subject|4|||
145509995|NCT00843284|524726852|FG000|Overall Study|Death|3|||
145509996|NCT00122980|524726853|FG000|Overall Study|Death|0|||
145509997|NCT00122980|524726854|FG001|Overall Study|Death|1|||
145509998|NCT00122980|524726853|FG000|Overall Study|Physician Decision|2|||
145509999|NCT00122980|524726854|FG001|Overall Study|Physician Decision|0|||
145510000|NCT00122980|524726853|FG000|Overall Study|Protocol Violation|5|||
145510001|NCT00122980|524726854|FG001|Overall Study|Protocol Violation|1|||
145510002|NCT00122980|524726853|FG000|Overall Study|Withdrawal by Subject|2|||
145510003|NCT00122980|524726854|FG001|Overall Study|Withdrawal by Subject|3|||
145510004|NCT00122980|524726853|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
145510005|NCT00122980|524726854|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
145510006|NCT00122980|524726853|FG000|Overall Study|Study termination|27|||
145510007|NCT00122980|524726854|FG001|Overall Study|Study termination|35|||
145510008|NCT01124864|524726855|FG000|Overall Study|Follow up phase competed as per protocol|18|||
145510009|NCT01124864|524726856|FG001|Overall Study|Follow up phase competed as per protocol|22|||
145510010|NCT01124864|524726857|FG002|Overall Study|Follow up phase competed as per protocol|24|||
145510011|NCT01124864|524726858|FG003|Overall Study|Follow up phase competed as per protocol|18|||
145510012|NCT01124864|524726859|FG004|Overall Study|Follow up phase competed as per protocol|26|||
145510013|NCT01124864|524726860|FG005|Overall Study|Follow up phase competed as per protocol|2|||
145510014|NCT01124864|524726855|FG000|Overall Study|Death|6|||
145510015|NCT01124864|524726856|FG001|Overall Study|Death|9|||
145510016|NCT01124864|524726857|FG002|Overall Study|Death|6|||
145510017|NCT01124864|524726858|FG003|Overall Study|Death|2|||
145510018|NCT01124864|524726859|FG004|Overall Study|Death|1|||
145510019|NCT01124864|524726860|FG005|Overall Study|Death|0|||
145510020|NCT01124864|524726855|FG000|Overall Study|Withdrawal by Subject|2|||
145510021|NCT01124864|524726856|FG001|Overall Study|Withdrawal by Subject|3|||
145510022|NCT01124864|524726857|FG002|Overall Study|Withdrawal by Subject|4|||
145510023|NCT01124864|524726858|FG003|Overall Study|Withdrawal by Subject|0|||
145510024|NCT01124864|524726859|FG004|Overall Study|Withdrawal by Subject|2|||
145510025|NCT01124864|524726860|FG005|Overall Study|Withdrawal by Subject|1|||
145510026|NCT01124864|524726855|FG000|Overall Study|Lost to Follow-up|1|||
145510027|NCT01124864|524726856|FG001|Overall Study|Lost to Follow-up|1|||
145510028|NCT01124864|524726857|FG002|Overall Study|Lost to Follow-up|0|||
145510029|NCT01124864|524726858|FG003|Overall Study|Lost to Follow-up|1|||
145510030|NCT01124864|524726859|FG004|Overall Study|Lost to Follow-up|0|||
145510031|NCT01124864|524726860|FG005|Overall Study|Lost to Follow-up|0|||
145510032|NCT01124864|524726855|FG000|Overall Study|Protocol Violation|1|||
145510033|NCT01124864|524726856|FG001|Overall Study|Protocol Violation|0|||
145510034|NCT01124864|524726857|FG002|Overall Study|Protocol Violation|0|||
145510035|NCT01124864|524726858|FG003|Overall Study|Protocol Violation|0|||
145510036|NCT01124864|524726859|FG004|Overall Study|Protocol Violation|1|||
145510037|NCT01124864|524726860|FG005|Overall Study|Protocol Violation|0|||
145510038|NCT01243242|524726861|FG000|Overall Study|Adverse Event|1|||
145510039|NCT01243242|524726862|FG001|Overall Study|Adverse Event|1|||
145510040|NCT01243242|524726861|FG000|Overall Study|Withdrawal by Subject|1|||
145510041|NCT01243242|524726862|FG001|Overall Study|Withdrawal by Subject|1|||
145510042|NCT01243242|524726861|FG000|Overall Study|Physician Decision|0|||
145510043|NCT01243242|524726862|FG001|Overall Study|Physician Decision|1|||
145510044|NCT01243242|524726861|FG000|Overall Study|sponsor decision|0|||
145510045|NCT01243242|524726862|FG001|Overall Study|sponsor decision|1|||
145510046|NCT01243242|524726861|FG000|Overall Study|non compliance|1|||
145510047|NCT01243242|524726862|FG001|Overall Study|non compliance|0|||
145510048|NCT03844945|524726865|FG000|Overall Study|Adverse Event|1|||
145510049|NCT03844945|524726866|FG001|Overall Study|Adverse Event|1|||
145510050|NCT03844945|524726867|FG002|Overall Study|Adverse Event|4|||
145510051|NCT03844945|524726868|FG003|Overall Study|Adverse Event|0|||
145510052|NCT03844945|524726865|FG000|Overall Study|Withdrawal by Subject|0|||
145510053|NCT03844945|524726866|FG001|Overall Study|Withdrawal by Subject|0|||
145510054|NCT03844945|524726867|FG002|Overall Study|Withdrawal by Subject|1|||
145510055|NCT03844945|524726868|FG003|Overall Study|Withdrawal by Subject|0|||
145510056|NCT03844945|524726865|FG000|Overall Study|Lack of Efficacy|0|||
145510057|NCT03844945|524726866|FG001|Overall Study|Lack of Efficacy|0|||
145510058|NCT03844945|524726867|FG002|Overall Study|Lack of Efficacy|0|||
145510059|NCT03844945|524726868|FG003|Overall Study|Lack of Efficacy|1|||
145510060|NCT01256294|524726882|FG000|Overall Study|Adverse Event|1|||
145401727|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
145401728|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
145401729|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
145401730|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
145401731|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
145401732|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
145401733|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145510061|NCT01256294|524726883|FG001|Overall Study|Adverse Event|0|||
145510062|NCT01256294|524726882|FG000|Overall Study|Withdrawal by Subject|1|||
145510063|NCT01256294|524726883|FG001|Overall Study|Withdrawal by Subject|1|||
145510064|NCT01256294|524726882|FG000|Overall Study|Protocol deviation|2|||
145510065|NCT01256294|524726883|FG001|Overall Study|Protocol deviation|1|||
145510066|NCT02160899|524726884|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145510067|NCT02160899|524726885|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145510068|NCT02160899|524726886|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
145510069|NCT02160899|524726887|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
145510070|NCT02160899|524726888|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
145510071|NCT02160899|524726889|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
145510072|NCT04129151|524726890|FG000|Overall Study|Adverse Event|1|||
145510073|NCT04129151|524726890|FG000|Overall Study|Disease Progression|7|||
145510074|NCT04129151|524726890|FG000|Overall Study|Study closure|1|||
145510075|NCT02249832|524726894|FG000|Overall Study|Withdrawal by Subject|3|||
145510076|NCT02249832|524726894|FG000|Overall Study|Lost to Follow-up|10|||
145510077|NCT00545272|524726900|FG000|Overall Study|Protocol deviation|0|||
145510078|NCT00545272|524726901|FG001|Overall Study|Protocol deviation|1|||
145510079|NCT00545272|524726902|FG002|Overall Study|Protocol deviation|0|||
145510080|NCT00545272|524726903|FG003|Overall Study|Protocol deviation|1|||
145510081|NCT00545272|524726904|FG004|Overall Study|Protocol deviation|0|||
145510082|NCT00545272|524726905|FG005|Overall Study|Protocol deviation|1|||
145510083|NCT00545272|524726900|FG000|Overall Study|Adverse Event|0|||
145510084|NCT00545272|524726901|FG001|Overall Study|Adverse Event|0|||
145510085|NCT00545272|524726902|FG002|Overall Study|Adverse Event|1|||
145510086|NCT00545272|524726903|FG003|Overall Study|Adverse Event|0|||
145510087|NCT00545272|524726904|FG004|Overall Study|Adverse Event|0|||
145510088|NCT00545272|524726905|FG005|Overall Study|Adverse Event|1|||
145510089|NCT00545272|524726900|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145510090|NCT00545272|524726901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145510091|NCT00545272|524726902|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145510092|NCT00545272|524726903|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145510093|NCT00545272|524726904|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145510094|NCT00545272|524726905|FG005|Overall Study|Abnormal laboratory value(s)|1|||
145510095|NCT00545272|524726900|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145510096|NCT00545272|524726901|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145510097|NCT00545272|524726902|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145510098|NCT00545272|524726903|FG003|Overall Study|Abnormal test procedure result(s)|0|||
145510099|NCT00545272|524726904|FG004|Overall Study|Abnormal test procedure result(s)|1|||
145510100|NCT00545272|524726905|FG005|Overall Study|Abnormal test procedure result(s)|0|||
145510101|NCT00545272|524726900|FG000|Overall Study|Lost to Follow-up|0|||
145510102|NCT00545272|524726901|FG001|Overall Study|Lost to Follow-up|0|||
145510103|NCT00545272|524726902|FG002|Overall Study|Lost to Follow-up|0|||
145510104|NCT00545272|524726903|FG003|Overall Study|Lost to Follow-up|0|||
145510105|NCT00545272|524726904|FG004|Overall Study|Lost to Follow-up|1|||
145510106|NCT00545272|524726905|FG005|Overall Study|Lost to Follow-up|0|||
145510107|NCT02934503|524726906|FG000|Overall Study|progression of disease|3|||
145510108|NCT02934503|524726906|FG000|Overall Study|Withdrawal by Subject|1|||
145510109|NCT04248491|524726907|FG000|Overall Study|Lost to Follow-up|1|||
145510110|NCT04248491|524726908|FG001|Overall Study|Lost to Follow-up|0|||
145510111|NCT01652469|524726909|FG000|Overall Study|Withdrawal by Subject|1|||
145510112|NCT01652469|524726910|FG001|Overall Study|Withdrawal by Subject|4|||
145510113|NCT01652469|524726909|FG000|Overall Study|Lost to Follow-up|0|||
145510114|NCT01652469|524726910|FG001|Overall Study|Lost to Follow-up|2|||
145510115|NCT02834793|524726911|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
145510116|NCT02834793|524726912|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
145510117|NCT02834793|524726913|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
145510118|NCT02834793|524726914|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
145510119|NCT02834793|524726911|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
145510120|NCT02834793|524726912|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
145510121|NCT02834793|524726913|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
145510122|NCT02834793|524726914|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
145510123|NCT02834793|524726911|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
145510124|NCT02834793|524726912|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
145510125|NCT02834793|524726913|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
145510126|NCT02834793|524726914|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
145510127|NCT02834793|524726911|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
145510128|NCT02834793|524726912|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
145510129|NCT02834793|524726913|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
145510130|NCT02834793|524726914|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
145510131|NCT02834793|524726911|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
145510132|NCT02834793|524726912|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
145510133|NCT02834793|524726913|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
145510134|NCT02834793|524726914|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
145510135|NCT02834793|524726911|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
145401734|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145401735|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
145401736|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
145401737|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
145401738|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
145401739|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
145401740|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
145401741|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
145401742|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
145401743|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
145401744|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
145401745|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
145401746|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
145401747|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
145401748|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
145401749|NCT01668797|524328721|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
145401750|NCT01668797|524328722|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
145401751|NCT01668797|524328723|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
145401752|NCT01668797|524328724|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
145401753|NCT02515227|524328725|FG000|Overall Study|Adverse Event|0|||
145401754|NCT02515227|524328726|FG001|Overall Study|Adverse Event|2|||
145401755|NCT02515227|524328725|FG000|Overall Study|Progressive disease|2|||
145401756|NCT02515227|524328726|FG001|Overall Study|Progressive disease|9|||
145401757|NCT00686972|524328730|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
145401758|NCT03502798|524328731|FG000|Overall Study|equipment failure|0|||
145401759|NCT03502798|524328732|FG001|Overall Study|equipment failure|7|||
145401760|NCT01027845|524328733|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
145401761|NCT01027845|524328734|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
145401762|NCT01027845|524328735|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
145401763|NCT01027845|524328736|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
145401764|NCT01027845|524328733|FG000|Primary Vaccination Phase|Adverse Event|1|||
145401765|NCT01027845|524328734|FG001|Primary Vaccination Phase|Adverse Event|0|||
145401766|NCT01027845|524328735|FG002|Primary Vaccination Phase|Adverse Event|0|||
145401767|NCT01027845|524328736|FG003|Primary Vaccination Phase|Adverse Event|0|||
145401768|NCT01027845|524328733|FG000|Primary Vaccination Phase|Protocol Violation|1|||
145401769|NCT01027845|524328734|FG001|Primary Vaccination Phase|Protocol Violation|0|||
145401770|NCT01027845|524328735|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145401771|NCT01027845|524328736|FG003|Primary Vaccination Phase|Protocol Violation|0|||
145401772|NCT01027845|524328733|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
145401773|NCT01027845|524328734|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
145401774|NCT01027845|524328735|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
145401775|NCT01027845|524328736|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
145401776|NCT01027845|524328733|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
145401777|NCT01027845|524328734|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
145401778|NCT01027845|524328735|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
145401779|NCT01027845|524328736|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
145401780|NCT01027845|524328733|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
145401781|NCT01027845|524328734|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
145401782|NCT01027845|524328735|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
145401783|NCT01027845|524328736|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
145401784|NCT01603277|524328738|FG000|Overall Study|Adverse Event|1|||
145401785|NCT01603277|524328739|FG001|Overall Study|Adverse Event|2|||
145401786|NCT01603277|524328738|FG000|Overall Study|Physician Decision|0|||
145401787|NCT01603277|524328739|FG001|Overall Study|Physician Decision|1|||
145401788|NCT01603277|524328738|FG000|Overall Study|Protocol Violation|6|||
145401789|NCT01603277|524328739|FG001|Overall Study|Protocol Violation|10|||
145401790|NCT01603277|524328738|FG000|Overall Study|Withdrawal by Subject|5|||
145401791|NCT01603277|524328739|FG001|Overall Study|Withdrawal by Subject|4|||
145510136|NCT02834793|524726912|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
145510137|NCT02834793|524726913|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
145510138|NCT02834793|524726914|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
145510139|NCT02834793|524726911|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
145510140|NCT02834793|524726912|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
145510141|NCT02834793|524726913|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
145510142|NCT02834793|524726914|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
145510143|NCT02834793|524726911|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
145510144|NCT02834793|524726912|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
145510145|NCT02834793|524726913|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
145510146|NCT02834793|524726914|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
145510147|NCT02834793|524726911|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
145510148|NCT02834793|524726912|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
145510149|NCT02834793|524726913|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
145510150|NCT02834793|524726914|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
145510151|NCT02834793|524726911|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
145510152|NCT02834793|524726912|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
145510153|NCT02834793|524726913|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
145510154|NCT02834793|524726914|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
145510155|NCT02834793|524726911|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
145510156|NCT02834793|524726912|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
145510157|NCT02834793|524726913|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
145510158|NCT02834793|524726914|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
145510159|NCT02834793|524726911|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
145510160|NCT02834793|524726912|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
145510161|NCT02834793|524726913|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
145510162|NCT02834793|524726914|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
145510163|NCT02834793|524726911|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
145510164|NCT02834793|524726912|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
145510165|NCT02834793|524726913|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
145510166|NCT02834793|524726914|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
145510167|NCT02834793|524726911|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
145510168|NCT02834793|524726912|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
145510169|NCT02834793|524726913|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
145510170|NCT02834793|524726914|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
145510171|NCT02834793|524726911|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
145510172|NCT02834793|524726912|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
145510173|NCT02834793|524726913|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
145510174|NCT02834793|524726914|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
145510175|NCT01731938|524726915|FG000|Preliminary Part I|Withdrawal by Subject|2|||
145510176|NCT01731938|524726916|FG001|Preliminary Part I|Withdrawal by Subject|2|||
145510177|NCT01731938|524726915|FG000|Preliminary Part I|Physician Decision|1|||
145510178|NCT01731938|524726916|FG001|Preliminary Part I|Physician Decision|0|||
145510179|NCT01731938|524726915|FG000|Preliminary Part I|Lost to Follow-up|0|||
145510180|NCT01731938|524726916|FG001|Preliminary Part I|Lost to Follow-up|3|||
145510181|NCT01731938|524726915|FG000|Preliminary Part I|Missed Week 6 visit|0|||
145510182|NCT01731938|524726916|FG001|Preliminary Part I|Missed Week 6 visit|3|||
145510183|NCT01731938|524726915|FG000|Primary Part II|Withdrawal by Subject|5|||
145510184|NCT01731938|524726916|FG001|Primary Part II|Withdrawal by Subject|4|||
145510185|NCT01731938|524726915|FG000|Primary Part II|Lost to Follow-up|4|||
145510186|NCT01731938|524726916|FG001|Primary Part II|Lost to Follow-up|5|||
145510187|NCT01731938|524726915|FG000|Primary Part II|Death|2|||
145510188|NCT01731938|524726916|FG001|Primary Part II|Death|1|||
145510189|NCT01731938|524726915|FG000|Primary Part II|Missed Week 6 visit|2|||
145401792|NCT01603277|524328738|FG000|Overall Study|Non-Compliance|2|||
145510190|NCT01731938|524726916|FG001|Primary Part II|Missed Week 6 visit|3|||
145510191|NCT04931888|524726917|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
145401793|NCT01603277|524328739|FG001|Overall Study|Non-Compliance|1|||
145401794|NCT04465422|524328752|FG000|Overall Study|Lost to Follow-up|0|||
145401795|NCT04465422|524328753|FG001|Overall Study|Lost to Follow-up|2|||
145401796|NCT01692119|524328756|FG000|Overall Study|Protocol Violation|3|||
145401797|NCT01692119|524328757|FG001|Overall Study|Protocol Violation|1|||
145401798|NCT01692119|524328756|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
145401799|NCT01692119|524328757|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
145401800|NCT00112957|524328758|FG000|Overall Study|Progressive disease|18|||
145401801|NCT00112957|524328758|FG000|Overall Study|Physician Decision|1|||
145401802|NCT03307174|524328759|FG000|Overall Study|Unplanned ICU Administrion|5|||
145401803|NCT03307174|524328760|FG001|Overall Study|Unplanned ICU Administrion|3|||
145401804|NCT03307174|524328759|FG000|Overall Study|Aborted Surgery|1|||
145401805|NCT03307174|524328760|FG001|Overall Study|Aborted Surgery|2|||
145401806|NCT03307174|524328759|FG000|Overall Study|Hypotension|6|||
145510192|NCT04931888|524726918|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
145510193|NCT04931888|524726919|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
145510194|NCT04931888|524726920|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
145510195|NCT01049009|524726921|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
145510196|NCT01049009|524726922|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
145510197|NCT01049009|524726921|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145510198|NCT01049009|524726922|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145510199|NCT01049009|524726921|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
145510200|NCT01049009|524726922|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
145510201|NCT01049009|524726921|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
145510202|NCT01049009|524726922|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
145510203|NCT03179202|524726923|FG000|Overall Study|Screen Failure|67|||
145510204|NCT03179202|524726923|FG000|Overall Study|Subject Lost to Follow Up|12|||
145510205|NCT03179202|524726923|FG000|Overall Study|Withdrawal by Subject|7|||
145510206|NCT03179202|524726923|FG000|Overall Study|Adverse Event|3|||
145510207|NCT03179202|524726923|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
145510208|NCT03179202|524726923|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
145510209|NCT00859638|524726924|FG000|Overall Study|Lost to Follow-up|6|||
145510210|NCT00859638|524726925|FG001|Overall Study|Lost to Follow-up|1|||
145510211|NCT00859638|524726924|FG000|Overall Study|Withdrawal by Subject|3|||
145510212|NCT00859638|524726925|FG001|Overall Study|Withdrawal by Subject|2|||
145510213|NCT00859638|524726924|FG000|Overall Study|Ill health|1|||
145510214|NCT00859638|524726925|FG001|Overall Study|Ill health|1|||
145510215|NCT02969408|524726927|FG000|Overall Study|Adverse Event|2|||
145510216|NCT02969408|524726927|FG000|Overall Study|Withdrawal by Subject|8|||
145510217|NCT02969408|524726927|FG000|Overall Study|Lost to Follow-up|4|||
145510218|NCT02969408|524726927|FG000|Overall Study|Protocol Violation|1|||
145510219|NCT02969408|524726927|FG000|Overall Study|Other than specified|1|||
145510220|NCT01068600|524726928|FG000|Overall Study|Withdrawal by Subject|5|||
145510221|NCT01068600|524726929|FG001|Overall Study|Withdrawal by Subject|6|||
145510222|NCT01068600|524726928|FG000|Overall Study|Adverse Event|3|||
145510223|NCT01068600|524726929|FG001|Overall Study|Adverse Event|3|||
145510224|NCT01068600|524726928|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145510225|NCT01068600|524726929|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145510226|NCT01068600|524726928|FG000|Overall Study|Lost to Follow-up|1|||
145510227|NCT01068600|524726929|FG001|Overall Study|Lost to Follow-up|2|||
145510228|NCT01068600|524726928|FG000|Overall Study|Protocol deviation|1|||
145510229|NCT01068600|524726929|FG001|Overall Study|Protocol deviation|1|||
145510230|NCT01068600|524726928|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145510231|NCT01068600|524726929|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145510232|NCT01068600|524726928|FG000|Overall Study|Administrative problems|0|||
145510233|NCT01068600|524726929|FG001|Overall Study|Administrative problems|1|||
145510234|NCT01623050|524726930|FG000|Overall Study|Lost to Follow-up|9|||
145510235|NCT01191762|524726931|FG000|Overall Study|Adverse Event|1|||
145510236|NCT01191762|524726932|FG001|Overall Study|Adverse Event|0|||
145510237|NCT01519869|524726935|FG000|Overall Study|Lost to Follow-up|1|||
145510238|NCT03023813|524726936|FG000|Overall Study|Lost to Follow-up|1|||
145510239|NCT03023813|524726937|FG001|Overall Study|Lost to Follow-up|2|||
145510240|NCT03023813|524726938|FG002|Overall Study|Lost to Follow-up|0|||
145510241|NCT02123472|524726940|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
145510242|NCT02123472|524726941|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
145510243|NCT00126490|524726946|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
145510244|NCT02625909|524726947|FG000|Overall Study|Death|2|||
145510245|NCT02625909|524726948|FG001|Overall Study|Death|0|||
145510246|NCT02625909|524726947|FG000|Overall Study|Lost to Follow-up|3|||
145510247|NCT02625909|524726948|FG001|Overall Study|Lost to Follow-up|5|||
145510248|NCT02625909|524726947|FG000|Overall Study|Lack of Efficacy|9|||
145510249|NCT02625909|524726948|FG001|Overall Study|Lack of Efficacy|2|||
145510250|NCT02625909|524726947|FG000|Overall Study|Reinfection|3|||
145510251|NCT02625909|524726948|FG001|Overall Study|Reinfection|2|||
145510252|NCT00035932|524726955|FG000|Overall Study|Adverse Event|10|||
145510253|NCT00035932|524726956|FG001|Overall Study|Adverse Event|9|||
145510254|NCT00035932|524726957|FG002|Overall Study|Adverse Event|9|||
145510255|NCT00035932|524726955|FG000|Overall Study|Death|0|||
145510256|NCT00035932|524726956|FG001|Overall Study|Death|0|||
145510257|NCT00035932|524726957|FG002|Overall Study|Death|1|||
145510258|NCT00035932|524726955|FG000|Overall Study|Disease Progression / Relapse|1|||
145510259|NCT00035932|524726956|FG001|Overall Study|Disease Progression / Relapse|1|||
145510260|NCT00035932|524726957|FG002|Overall Study|Disease Progression / Relapse|0|||
145510261|NCT00035932|524726955|FG000|Overall Study|Lost to Follow-up|4|||
145510262|NCT00035932|524726956|FG001|Overall Study|Lost to Follow-up|4|||
145510263|NCT00035932|524726957|FG002|Overall Study|Lost to Follow-up|3|||
145510264|NCT00035932|524726955|FG000|Overall Study|Noncompliance|6|||
145510265|NCT00035932|524726956|FG001|Overall Study|Noncompliance|7|||
145510266|NCT00035932|524726957|FG002|Overall Study|Noncompliance|6|||
145510267|NCT00035932|524726955|FG000|Overall Study|Protocol Violation While on Study|0|||
145510268|NCT00035932|524726956|FG001|Overall Study|Protocol Violation While on Study|1|||
145510269|NCT00035932|524726957|FG002|Overall Study|Protocol Violation While on Study|2|||
145510270|NCT00035932|524726955|FG000|Overall Study|Withdrawal by Subject|1|||
145510271|NCT00035932|524726956|FG001|Overall Study|Withdrawal by Subject|5|||
145510272|NCT00035932|524726957|FG002|Overall Study|Withdrawal by Subject|0|||
145510273|NCT00035932|524726955|FG000|Overall Study|Study Termination by Sponsor|1|||
145510274|NCT00035932|524726956|FG001|Overall Study|Study Termination by Sponsor|0|||
145510275|NCT00035932|524726957|FG002|Overall Study|Study Termination by Sponsor|0|||
145510276|NCT00035932|524726955|FG000|Overall Study|Lack of Efficacy|33|||
145510277|NCT00035932|524726956|FG001|Overall Study|Lack of Efficacy|33|||
145510278|NCT00035932|524726957|FG002|Overall Study|Lack of Efficacy|28|||
145510279|NCT04413617|524726958|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
145510280|NCT04413617|524726959|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
145510281|NCT04413617|524726960|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
145510282|NCT04413617|524726961|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
145510283|NCT04413617|524726962|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
145510284|NCT04413617|524726958|FG000|Overall Study|Protocol Violation|0|||
145510285|NCT04413617|524726959|FG001|Overall Study|Protocol Violation|1|||
145510286|NCT04413617|524726960|FG002|Overall Study|Protocol Violation|0|||
145510287|NCT04413617|524726961|FG003|Overall Study|Protocol Violation|0|||
145510288|NCT04413617|524726962|FG004|Overall Study|Protocol Violation|1|||
145510289|NCT04413617|524726958|FG000|Overall Study|Lack of Efficacy|2|||
145510290|NCT04413617|524726959|FG001|Overall Study|Lack of Efficacy|0|||
145510291|NCT04413617|524726960|FG002|Overall Study|Lack of Efficacy|2|||
145510292|NCT04413617|524726961|FG003|Overall Study|Lack of Efficacy|1|||
145510293|NCT04413617|524726962|FG004|Overall Study|Lack of Efficacy|0|||
145510294|NCT04413617|524726958|FG000|Overall Study|Withdrawal by Subject|3|||
145510295|NCT04413617|524726959|FG001|Overall Study|Withdrawal by Subject|4|||
145510296|NCT04413617|524726960|FG002|Overall Study|Withdrawal by Subject|2|||
145510297|NCT04413617|524726961|FG003|Overall Study|Withdrawal by Subject|5|||
145510298|NCT04413617|524726962|FG004|Overall Study|Withdrawal by Subject|3|||
145510299|NCT04413617|524726958|FG000|Overall Study|Death|1|||
145510300|NCT04413617|524726959|FG001|Overall Study|Death|0|||
145510301|NCT04413617|524726960|FG002|Overall Study|Death|0|||
145510302|NCT04413617|524726961|FG003|Overall Study|Death|0|||
145510303|NCT04413617|524726962|FG004|Overall Study|Death|0|||
145510304|NCT04413617|524726958|FG000|Overall Study|Adverse Event|1|||
145510305|NCT04413617|524726959|FG001|Overall Study|Adverse Event|0|||
145510306|NCT04413617|524726960|FG002|Overall Study|Adverse Event|0|||
145510307|NCT04413617|524726961|FG003|Overall Study|Adverse Event|1|||
145510308|NCT04413617|524726962|FG004|Overall Study|Adverse Event|1|||
145510309|NCT04413617|524726958|FG000|Overall Study|COVID-19|0|||
145510310|NCT04413617|524726959|FG001|Overall Study|COVID-19|1|||
145510311|NCT04413617|524726960|FG002|Overall Study|COVID-19|0|||
145510312|NCT04413617|524726961|FG003|Overall Study|COVID-19|0|||
145510313|NCT04413617|524726962|FG004|Overall Study|COVID-19|0|||
145510314|NCT00312195|524726963|FG000|Overall Study|Adverse Event|4|||
145510315|NCT00312195|524726964|FG001|Overall Study|Adverse Event|6|||
145510316|NCT00312195|524726963|FG000|Overall Study|Lost to Follow-up|1|||
145510317|NCT00312195|524726964|FG001|Overall Study|Lost to Follow-up|0|||
145510318|NCT00312195|524726963|FG000|Overall Study|Protocol Violation|1|||
145510319|NCT00312195|524726964|FG001|Overall Study|Protocol Violation|0|||
145510320|NCT02511106|524726967|FG000|Overall Study|Lost to Follow-up|6|||
145510321|NCT02511106|524726968|FG001|Overall Study|Lost to Follow-up|4|||
145510322|NCT02511106|524726967|FG000|Overall Study|Withdrawal by Subject|24|||
145510323|NCT02511106|524726968|FG001|Overall Study|Withdrawal by Subject|21|||
145510324|NCT02511106|524726967|FG000|Overall Study|Death|42|||
145510325|NCT02511106|524726968|FG001|Overall Study|Death|82|||
145510326|NCT02511106|524726967|FG000|Overall Study|Ongoing study at data cut-off|3|||
145510327|NCT02511106|524726968|FG001|Overall Study|Ongoing study at data cut-off|2|||
145510328|NCT02511106|524726967|FG000|Overall Study|Without specified reason|3|||
145510329|NCT02511106|524726968|FG001|Overall Study|Without specified reason|0|||
145510330|NCT01703754|524726971|FG000|Overall Study|Clinically significant disease progression|2|||
145510331|NCT01703754|524726972|FG001|Overall Study|Clinically significant disease progression|2|||
145510332|NCT01703754|524726973|FG002|Overall Study|Clinically significant disease progression|1|||
145510333|NCT01703754|524726971|FG000|Overall Study|Adverse Event|1|||
145510334|NCT01703754|524726972|FG001|Overall Study|Adverse Event|1|||
145510335|NCT01703754|524726973|FG002|Overall Study|Adverse Event|0|||
145510336|NCT01703754|524726971|FG000|Overall Study|Withdrawal by Subject|2|||
145510337|NCT01703754|524726972|FG001|Overall Study|Withdrawal by Subject|0|||
145510338|NCT01703754|524726973|FG002|Overall Study|Withdrawal by Subject|0|||
145510339|NCT01459497|524726977|FG000|Overall Study|Inability to meet trial constraints.|1|||
145510340|NCT01459497|524726978|FG001|Overall Study|Inability to meet trial constraints.|0|||
145510341|NCT01459497|524726977|FG000|Overall Study|Physician Decision|1|||
145510342|NCT01459497|524726978|FG001|Overall Study|Physician Decision|1|||
145510343|NCT01459497|524726977|FG000|Overall Study|Hospitalization.|0|||
145510344|NCT01459497|524726978|FG001|Overall Study|Hospitalization.|3|||
145510345|NCT01459497|524726977|FG000|Overall Study|Disease progression.|0|||
145510346|NCT01459497|524726978|FG001|Overall Study|Disease progression.|1|||
145510347|NCT03530124|524726979|FG000|Overall Study|Withdrawal by Subject|0|||
145401807|NCT03307174|524328760|FG001|Overall Study|Hypotension|0|||
145401808|NCT03307174|524328759|FG000|Overall Study|Nonfunctional epidural|1|||
145401809|NCT03307174|524328760|FG001|Overall Study|Nonfunctional epidural|1|||
145401810|NCT03307174|524328759|FG000|Overall Study|Planned epidural removal|1|||
145401811|NCT03307174|524328760|FG001|Overall Study|Planned epidural removal|0|||
145401812|NCT03307174|524328759|FG000|Overall Study|Intrathecal catheter placement|0|||
145401813|NCT03307174|524328760|FG001|Overall Study|Intrathecal catheter placement|1|||
145401814|NCT03444584|524328763|FG000|Overall Study|Withdrawal by Subject|0|||
145401815|NCT03444584|524328764|FG001|Overall Study|Withdrawal by Subject|1|||
145401816|NCT03444584|524328763|FG000|Overall Study|Other|0|||
145401817|NCT03444584|524328764|FG001|Overall Study|Other|1|||
145401818|NCT03451045|524328765|FG000|Overall Study|Lack of Efficacy|3|||
145401819|NCT03451045|524328766|FG001|Overall Study|Lack of Efficacy|2|||
145401820|NCT03451045|524328767|FG002|Overall Study|Lack of Efficacy|2|||
145401821|NCT03451045|524328765|FG000|Overall Study|Physician Decision|1|||
145401822|NCT03451045|524328766|FG001|Overall Study|Physician Decision|1|||
145401823|NCT03451045|524328767|FG002|Overall Study|Physician Decision|1|||
145401824|NCT03451045|524328765|FG000|Overall Study|Withdrawal by Subject|4|||
145401825|NCT03451045|524328766|FG001|Overall Study|Withdrawal by Subject|0|||
145401826|NCT03451045|524328767|FG002|Overall Study|Withdrawal by Subject|5|||
145401827|NCT03451045|524328765|FG000|Overall Study|Pregnancy|0|||
145401828|NCT03451045|524328766|FG001|Overall Study|Pregnancy|0|||
145401829|NCT03451045|524328767|FG002|Overall Study|Pregnancy|2|||
145401830|NCT03451045|524328765|FG000|Overall Study|Adverse Event|7|||
145401831|NCT03451045|524328766|FG001|Overall Study|Adverse Event|1|||
145401832|NCT03451045|524328767|FG002|Overall Study|Adverse Event|3|||
145401833|NCT03451045|524328765|FG000|Overall Study|Non-compliance with study|2|||
145401834|NCT03451045|524328766|FG001|Overall Study|Non-compliance with study|0|||
145401835|NCT03451045|524328767|FG002|Overall Study|Non-compliance with study|1|||
145401836|NCT03451045|524328765|FG000|Overall Study|any other reason|10|||
145401837|NCT03451045|524328766|FG001|Overall Study|any other reason|2|||
145401838|NCT03451045|524328767|FG002|Overall Study|any other reason|13|||
145401839|NCT00863707|524328768|FG000|Overall Study|Randomized, but drug not received|4|||
145401840|NCT00863707|524328769|FG001|Overall Study|Randomized, but drug not received|3|||
145401841|NCT01142336|524328770|FG000|Overall Study|Adverse Event|1|||
145401842|NCT01142336|524328771|FG001|Overall Study|Adverse Event|1|||
145401843|NCT01142336|524328770|FG000|Overall Study|Lost to Follow-up|0|||
145401844|NCT01142336|524328771|FG001|Overall Study|Lost to Follow-up|1|||
145401845|NCT02391337|524328772|FG000|6 Months Follow-up|Death|5|||
145401846|NCT02391337|524328773|FG001|6 Months Follow-up|Death|4|||
145401847|NCT02391337|524328772|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
145401848|NCT02391337|524328773|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
145401849|NCT02391337|524328772|FG000|12 Months Follow-up|Death|2|||
145401850|NCT02391337|524328773|FG001|12 Months Follow-up|Death|0|||
145401851|NCT02391337|524328772|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
145401852|NCT02391337|524328773|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
145401853|NCT02391337|524328772|FG000|12 Months Follow-up|Lost to Follow-up|0|||
145401854|NCT02391337|524328773|FG001|12 Months Follow-up|Lost to Follow-up|2|||
145401855|NCT01286129|524328774|FG000|Overall Study|Withdrawal by Subject|4|||
145401856|NCT01286129|524328775|FG001|Overall Study|Withdrawal by Subject|1|||
145401857|NCT01286129|524328774|FG000|Overall Study|Could not comply with study requirements|4|||
145401858|NCT01286129|524328775|FG001|Overall Study|Could not comply with study requirements|4|||
145401859|NCT00830128|524328776|FG000|Overall Study|Adverse Event|5|||
145401860|NCT00830128|524328776|FG000|Overall Study|Lack of Efficacy|7|||
145732950|NCT03308942|525540865|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
145732951|NCT03308942|525540866|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
145732952|NCT03308942|525540867|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
145732953|NCT03308942|525540868|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
145732954|NCT03308942|525540864|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
145732955|NCT03308942|525540865|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
145732956|NCT03308942|525540866|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
145732957|NCT03308942|525540867|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
145732958|NCT03308942|525540868|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
145732959|NCT03308942|525540864|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
145732960|NCT03308942|525540865|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
145732961|NCT03308942|525540866|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
145732962|NCT03308942|525540867|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
145732963|NCT03308942|525540868|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
145732964|NCT03308942|525540864|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
145732965|NCT03308942|525540865|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
145732966|NCT03308942|525540866|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
145732967|NCT03308942|525540867|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
145732968|NCT03308942|525540868|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
145732969|NCT03308942|525540864|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
145732970|NCT03308942|525540865|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
145732971|NCT03308942|525540866|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
145732972|NCT03308942|525540867|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
145732973|NCT03308942|525540868|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
145732974|NCT03308942|525540864|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
145732975|NCT03308942|525540865|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
145732976|NCT03308942|525540866|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
145732977|NCT03308942|525540867|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
145732978|NCT03308942|525540868|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
145732979|NCT03308942|525540864|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
145732980|NCT03308942|525540865|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
145732981|NCT03308942|525540866|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
145732982|NCT03308942|525540867|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
145732983|NCT03308942|525540868|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
145732984|NCT01131351|525540869|FG000|Overall Study|Adverse Event|0|||
145732985|NCT01131351|525540870|FG001|Overall Study|Adverse Event|2|||
145732986|NCT01131351|525540869|FG000|Overall Study|Protocol Deviation|0|||
145732987|NCT01131351|525540870|FG001|Overall Study|Protocol Deviation|1|||
145732988|NCT04147234|525540873|FG000|Overall Study|Clinical deterioration|0|||
145732989|NCT04147234|525540874|FG001|Overall Study|Clinical deterioration|0|||
145732990|NCT04147234|525540875|FG002|Overall Study|Clinical deterioration|1|||
145732991|NCT04147234|525540876|FG003|Overall Study|Clinical deterioration|0|||
145732992|NCT04147234|525540877|FG004|Overall Study|Clinical deterioration|0|||
145732993|NCT04147234|525540878|FG005|Overall Study|Clinical deterioration|0|||
145732994|NCT04147234|525540879|FG006|Overall Study|Clinical deterioration|0|||
145732995|NCT04147234|525540873|FG000|Overall Study|Withdrawal by Subject|0|||
145510348|NCT03530124|524726980|FG001|Overall Study|Withdrawal by Subject|1|||
145510349|NCT03530124|524726979|FG000|Overall Study|Protocol Violation|1|||
145510350|NCT03530124|524726980|FG001|Overall Study|Protocol Violation|0|||
145510351|NCT03530124|524726979|FG000|Overall Study|Discharged prior to study completion|1|||
145510352|NCT03530124|524726980|FG001|Overall Study|Discharged prior to study completion|0|||
145510353|NCT03179319|524726981|FG000|Overall Study|Lost to Follow-up|6|||
145510354|NCT03179319|524726982|FG001|Overall Study|Lost to Follow-up|0|||
145510355|NCT01120717|524726983|FG000|Overall Study|Withdrawal by Subject|11|||
145510356|NCT01120717|524726984|FG001|Overall Study|Withdrawal by Subject|6|||
145510357|NCT01120717|524726983|FG000|Overall Study|Adverse Event|10|||
145510358|NCT01120717|524726984|FG001|Overall Study|Adverse Event|6|||
145510359|NCT01120717|524726983|FG000|Overall Study|Protocol Deviation|2|||
145510360|NCT01120717|524726984|FG001|Overall Study|Protocol Deviation|5|||
145510361|NCT01120717|524726983|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145510362|NCT01120717|524726984|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145510363|NCT01120717|524726983|FG000|Overall Study|Lost to Follow-up|2|||
145510364|NCT01120717|524726984|FG001|Overall Study|Lost to Follow-up|3|||
145510365|NCT01120717|524726983|FG000|Overall Study|Death|3|||
145510366|NCT01120717|524726984|FG001|Overall Study|Death|1|||
145510367|NCT01120717|524726983|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
145606647|NCT01576718|525075117|FG000|Treatment Period|Withdrawal by Subject|0|||
145510368|NCT01120717|524726984|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145510369|NCT01309282|524726989|FG000|Overall Study|Lost to Follow-up|1|||
145510370|NCT02445794|524726990|FG000|Overall Study|Adverse Event|0|||
145510371|NCT02445794|524726991|FG001|Overall Study|Adverse Event|0|||
145510372|NCT02445794|524726992|FG002|Overall Study|Adverse Event|2|||
145510373|NCT02445794|524726993|FG003|Overall Study|Adverse Event|0|||
145510374|NCT01136785|524726994|FG000|Overall Study|Protocol Violation|2|||
145510375|NCT01136785|524726995|FG001|Overall Study|Protocol Violation|1|||
145510376|NCT00233064|524726996|FG000|Overall Study|Lost to Follow-up|7|||
145510377|NCT00233064|524726997|FG001|Overall Study|Lost to Follow-up|7|||
145510378|NCT00233064|524726996|FG000|Overall Study|Withdrawal by Subject|5|||
145510379|NCT00233064|524726997|FG001|Overall Study|Withdrawal by Subject|3|||
145510380|NCT00233064|524726996|FG000|Overall Study|Death|0|||
145510381|NCT00233064|524726997|FG001|Overall Study|Death|1|||
145510382|NCT00233064|524726996|FG000|Overall Study|Relocation|0|||
145510383|NCT00233064|524726997|FG001|Overall Study|Relocation|1|||
145510384|NCT00233064|524726996|FG000|Overall Study|Protocol Violation|1|||
145510385|NCT00233064|524726997|FG001|Overall Study|Protocol Violation|0|||
145510386|NCT00233064|524726996|FG000|Overall Study|Moved to Dom. Republic|1|||
145510387|NCT00233064|524726997|FG001|Overall Study|Moved to Dom. Republic|0|||
145510388|NCT04976192|524727000|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510389|NCT04976192|524727001|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
145510390|NCT04976192|524727002|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510391|NCT04976192|524727003|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510392|NCT04976192|524727004|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510393|NCT04976192|524727005|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510394|NCT04976192|524727006|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510395|NCT04976192|524727007|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510396|NCT04976192|524727008|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510397|NCT04976192|524727009|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
145510398|NCT04976192|524727000|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
145510399|NCT04976192|524727001|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
145510400|NCT04976192|524727002|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
145510401|NCT04976192|524727003|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
145510402|NCT04976192|524727004|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510403|NCT04976192|524727005|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510404|NCT04976192|524727006|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510405|NCT04976192|524727007|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510406|NCT04976192|524727008|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510407|NCT04976192|524727009|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510408|NCT04976192|524727000|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
145510409|NCT04976192|524727001|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510410|NCT04976192|524727002|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
145510411|NCT04976192|524727003|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510412|NCT04976192|524727004|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510413|NCT04976192|524727005|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510414|NCT04976192|524727006|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510415|NCT04976192|524727007|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510416|NCT04976192|524727008|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510417|NCT04976192|524727009|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
145510418|NCT04976192|524727000|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510419|NCT04976192|524727001|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510420|NCT04976192|524727002|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145732996|NCT04147234|525540874|FG001|Overall Study|Withdrawal by Subject|1|||
145510421|NCT04976192|524727003|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145510422|NCT04976192|524727004|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
145510423|NCT04976192|524727005|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
145510424|NCT04976192|524727006|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
145510425|NCT04976192|524727007|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
145510426|NCT04976192|524727008|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
145510427|NCT04976192|524727009|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
145510428|NCT04976192|524727000|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510429|NCT04976192|524727001|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510430|NCT04976192|524727002|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145401861|NCT00830128|524328776|FG000|Overall Study|Protocol Violation|1|||
145401862|NCT00830128|524328776|FG000|Overall Study|Withdrawal by Subject|2|||
145401863|NCT00830128|524328776|FG000|Overall Study|Family obligation|1|||
145401864|NCT00830128|524328776|FG000|Overall Study|Relocation|1|||
145401865|NCT00830128|524328776|FG000|Overall Study|Work obligation|1|||
145401866|NCT00830128|524328776|FG000|Overall Study|Operating a vehicle|1|||
145401867|NCT04142242|524328781|FG000|Stage I|Non-compliance with the protocol|1|||
145401868|NCT04142242|524328782|FG001|Stage I|Non-compliance with the protocol|0|||
145401869|NCT04142242|524328783|FG002|Stage I|Non-compliance with the protocol|0|||
145401870|NCT04142242|524328784|FG003|Stage I|Non-compliance with the protocol|0|||
145401871|NCT04142242|524328785|FG004|Stage I|Non-compliance with the protocol|0|||
145401872|NCT04142242|524328786|FG005|Stage I|Non-compliance with the protocol|1|||
145401873|NCT04142242|524328781|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145401874|NCT04142242|524328782|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
145401875|NCT04142242|524328783|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145401876|NCT04142242|524328784|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145401877|NCT04142242|524328785|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145401878|NCT04142242|524328786|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
145401879|NCT04142242|524328781|FG000|Stage II|Non-compliance with the protocol|0|||
145401880|NCT04142242|524328782|FG001|Stage II|Non-compliance with the protocol|0|||
145401881|NCT04142242|524328783|FG002|Stage II|Non-compliance with the protocol|0|||
145401882|NCT04142242|524328784|FG003|Stage II|Non-compliance with the protocol|2|||
145401883|NCT04142242|524328785|FG004|Stage II|Non-compliance with the protocol|0|||
145401884|NCT04142242|524328786|FG005|Stage II|Non-compliance with the protocol|0|||
145401885|NCT04142242|524328781|FG000|Stage II|Lost to Follow-up|0|||
145401886|NCT04142242|524328782|FG001|Stage II|Lost to Follow-up|0|||
145401887|NCT04142242|524328783|FG002|Stage II|Lost to Follow-up|1|||
145401888|NCT04142242|524328784|FG003|Stage II|Lost to Follow-up|2|||
145401889|NCT04142242|524328785|FG004|Stage II|Lost to Follow-up|0|||
145401890|NCT04142242|524328786|FG005|Stage II|Lost to Follow-up|0|||
145401891|NCT04142242|524328781|FG000|Stage II|Withdrawal by Subject|0|||
145401892|NCT04142242|524328782|FG001|Stage II|Withdrawal by Subject|0|||
145401893|NCT04142242|524328783|FG002|Stage II|Withdrawal by Subject|5|||
145401894|NCT04142242|524328784|FG003|Stage II|Withdrawal by Subject|9|||
145401895|NCT04142242|524328785|FG004|Stage II|Withdrawal by Subject|0|||
145401896|NCT04142242|524328786|FG005|Stage II|Withdrawal by Subject|0|||
145401897|NCT00846053|524328789|FG000|Overall Study|Physician Decision|3|||
145401898|NCT00846053|524328790|FG001|Overall Study|Physician Decision|0|||
145401899|NCT00111761|524328791|FG000|Part 1|Physician Decision|0|||
145401900|NCT00111761|524328792|FG001|Part 1|Physician Decision|1|||
145401901|NCT00111761|524328791|FG000|Part 1|Death|0|||
145401902|NCT00111761|524328792|FG001|Part 1|Death|2|||
145401903|NCT00111761|524328791|FG000|Part 1|Other|0|||
145401904|NCT00111761|524328792|FG001|Part 1|Other|1|||
145401905|NCT00111761|524328791|FG000|Part 1|Withdrawal by Subject|0|||
145401906|NCT00111761|524328792|FG001|Part 1|Withdrawal by Subject|1|||
145401907|NCT00111761|524328791|FG000|Part 2|Adverse Event|1|||
145401908|NCT00111761|524328792|FG001|Part 2|Adverse Event|0|||
145401909|NCT00111761|524328791|FG000|Part 2|Physician Decision|1|||
145401910|NCT00111761|524328792|FG001|Part 2|Physician Decision|0|||
145401911|NCT00111761|524328791|FG000|Part 2|Death|1|||
145401912|NCT00111761|524328792|FG001|Part 2|Death|0|||
145401913|NCT00111761|524328791|FG000|Part 2|Disease progression|3|||
145401914|NCT00111761|524328792|FG001|Part 2|Disease progression|0|||
145401915|NCT00111761|524328791|FG000|Part 2|Protocol-specified criteria|1|||
145401916|NCT00111761|524328792|FG001|Part 2|Protocol-specified criteria|0|||
145401917|NCT00111761|524328791|FG000|Part 2|Other|1|||
145401918|NCT00111761|524328792|FG001|Part 2|Other|0|||
145401919|NCT00467519|524328799|FG000|Overall Study|Protocol Violation|8|||
145401920|NCT00467519|524328800|FG001|Overall Study|Protocol Violation|4|||
145401921|NCT00467519|524328799|FG000|Overall Study|Lost to Follow-up|2|||
145401922|NCT00467519|524328800|FG001|Overall Study|Lost to Follow-up|9|||
145401923|NCT00467519|524328799|FG000|Overall Study|Withdrawal by Subject|4|||
145401924|NCT00467519|524328800|FG001|Overall Study|Withdrawal by Subject|10|||
145401925|NCT01123655|524328803|FG000|Overall Study|Medication for RA had to be changed|1|||
145401926|NCT01123655|524328804|FG001|Overall Study|Medication for RA had to be changed|0|||
145401927|NCT01123655|524328805|FG002|Overall Study|Medication for RA had to be changed|0|||
145401928|NCT01123655|524328803|FG000|Overall Study|new illness|0|||
145401929|NCT01123655|524328804|FG001|Overall Study|new illness|1|||
145401930|NCT01123655|524328805|FG002|Overall Study|new illness|0|||
145401931|NCT01123655|524328803|FG000|Overall Study|began prohibitive drug|0|||
145401932|NCT01123655|524328804|FG001|Overall Study|began prohibitive drug|0|||
145401933|NCT01123655|524328805|FG002|Overall Study|began prohibitive drug|1|||
145401934|NCT00062166|524328806|FG000|Overall Study|Withdrawal by Subject|6|||
145401935|NCT01776554|524328809|FG000|Overall Study|Adverse Event|1|||
145401936|NCT01776554|524328810|FG001|Overall Study|Adverse Event|0|||
145401937|NCT01776554|524328809|FG000|Overall Study|Withdrawal by Subject|3|||
145401938|NCT01776554|524328810|FG001|Overall Study|Withdrawal by Subject|8|||
145401939|NCT01776554|524328809|FG000|Overall Study|Lost to Follow-up|6|||
145401940|NCT01776554|524328810|FG001|Overall Study|Lost to Follow-up|9|||
145401941|NCT01776554|524328809|FG000|Overall Study|Administrative Reason|2|||
145401942|NCT01776554|524328810|FG001|Overall Study|Administrative Reason|5|||
145401943|NCT01776554|524328809|FG000|Overall Study|Protocol Violation|1|||
145401944|NCT01776554|524328810|FG001|Overall Study|Protocol Violation|0|||
145401945|NCT01776554|524328809|FG000|Overall Study|Unclassified|4|||
145401946|NCT01776554|524328810|FG001|Overall Study|Unclassified|1|||
145401947|NCT02475369|524328811|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
145401948|NCT02475369|524328812|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
145606648|NCT01576718|525075118|FG001|Treatment Period|Withdrawal by Subject|1|||
145401949|NCT01991795|524328815|FG000|Overall Study|Lost to Follow-up|6|||
145401950|NCT01991795|524328816|FG001|Overall Study|Lost to Follow-up|4|||
145401951|NCT01991795|524328815|FG000|Overall Study|Withdrawal by Subject|117|||
145510431|NCT04976192|524727003|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510432|NCT04976192|524727004|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
145510433|NCT04976192|524727005|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510434|NCT04976192|524727006|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510435|NCT04976192|524727007|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510436|NCT04976192|524727008|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510437|NCT04976192|524727009|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
145510438|NCT04976192|524727000|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510439|NCT04976192|524727001|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510440|NCT04976192|524727002|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510441|NCT04976192|524727003|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510442|NCT04976192|524727004|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510443|NCT04976192|524727005|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145510444|NCT04976192|524727006|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510445|NCT04976192|524727007|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510446|NCT04976192|524727008|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510447|NCT04976192|524727009|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145510448|NCT01925131|524728902|FG000|Overall Study|Death|0|||
145510449|NCT01925131|524728903|FG001|Overall Study|Death|0|||
145510450|NCT01925131|524728904|FG002|Overall Study|Death|1|||
145510451|NCT01925131|524728905|FG003|Overall Study|Death|0|||
145510452|NCT01925131|524728906|FG004|Overall Study|Death|0|||
145510453|NCT01925131|524728907|FG005|Overall Study|Death|0|||
145510454|NCT01925131|524728902|FG000|Overall Study|Progression/Relapse|1|||
145510455|NCT01925131|524728903|FG001|Overall Study|Progression/Relapse|1|||
145510456|NCT01925131|524728904|FG002|Overall Study|Progression/Relapse|4|||
145510457|NCT01925131|524728905|FG003|Overall Study|Progression/Relapse|0|||
145510458|NCT01925131|524728906|FG004|Overall Study|Progression/Relapse|0|||
145510459|NCT01925131|524728907|FG005|Overall Study|Progression/Relapse|1|||
145510460|NCT01925131|524728902|FG000|Overall Study|Patient Refusal|1|||
145510461|NCT01925131|524728903|FG001|Overall Study|Patient Refusal|0|||
145510462|NCT01925131|524728904|FG002|Overall Study|Patient Refusal|0|||
145510463|NCT01925131|524728905|FG003|Overall Study|Patient Refusal|0|||
145510464|NCT01925131|524728906|FG004|Overall Study|Patient Refusal|0|||
145510465|NCT01925131|524728907|FG005|Overall Study|Patient Refusal|0|||
145510466|NCT01925131|524728902|FG000|Overall Study|Adverse Event|0|||
145510467|NCT01925131|524728903|FG001|Overall Study|Adverse Event|0|||
145510468|NCT01925131|524728904|FG002|Overall Study|Adverse Event|2|||
145510469|NCT01925131|524728905|FG003|Overall Study|Adverse Event|0|||
145510470|NCT01925131|524728906|FG004|Overall Study|Adverse Event|1|||
145510471|NCT01925131|524728907|FG005|Overall Study|Adverse Event|3|||
145510472|NCT01925131|524728902|FG000|Overall Study|Other - Not Protocol Specified|3|||
145510473|NCT01925131|524728903|FG001|Overall Study|Other - Not Protocol Specified|1|||
145510474|NCT01925131|524728904|FG002|Overall Study|Other - Not Protocol Specified|2|||
145510475|NCT01925131|524728905|FG003|Overall Study|Other - Not Protocol Specified|5|||
145510476|NCT01925131|524728906|FG004|Overall Study|Other - Not Protocol Specified|10|||
145510477|NCT01925131|524728907|FG005|Overall Study|Other - Not Protocol Specified|6|||
145510478|NCT01139008|524728908|FG000|Overall Study|Withdrawal by Subject|5|||
145510479|NCT01139008|524728908|FG000|Overall Study|Non-compliant, lost product|1|||
145510480|NCT04838977|524728909|FG000|Overall Study|Lost to Follow-up|2|||
145510481|NCT04838977|524728910|FG001|Overall Study|Lost to Follow-up|3|||
145510482|NCT04838977|524728909|FG000|Overall Study|Withdrawal by Subject|1|||
145510483|NCT04838977|524728910|FG001|Overall Study|Withdrawal by Subject|1|||
145510484|NCT00265148|524728911|FG000|Overall Study|Adverse Event|2|||
145510485|NCT00265148|524728912|FG001|Overall Study|Adverse Event|2|||
145510486|NCT00265148|524728911|FG000|Overall Study|Lack of Efficacy|0|||
145510487|NCT00265148|524728912|FG001|Overall Study|Lack of Efficacy|2|||
145510488|NCT00265148|524728911|FG000|Overall Study|Protocol Violation|3|||
145510489|NCT00265148|524728912|FG001|Overall Study|Protocol Violation|2|||
145510490|NCT00265148|524728911|FG000|Overall Study|Lost to Follow-up|0|||
145510491|NCT00265148|524728912|FG001|Overall Study|Lost to Follow-up|1|||
145510492|NCT00265148|524728911|FG000|Overall Study|Withdrawal by Subject|2|||
145510493|NCT00265148|524728912|FG001|Overall Study|Withdrawal by Subject|1|||
145510494|NCT00265148|524728911|FG000|Overall Study|Physician Decision|1|||
145510495|NCT00265148|524728912|FG001|Overall Study|Physician Decision|0|||
145510496|NCT00265148|524728911|FG000|Overall Study|Increasing frailty|0|||
145510497|NCT00265148|524728912|FG001|Overall Study|Increasing frailty|1|||
145510498|NCT00265148|524728911|FG000|Overall Study|Subject chose to change of the dose|1|||
145510499|NCT00265148|524728912|FG001|Overall Study|Subject chose to change of the dose|0|||
145510500|NCT01463007|524728913|FG000|Overall Study|Physician Decision|1|||
145510501|NCT00942994|524728914|FG000|Overall Study|Adverse Event|7|||
145510502|NCT00942994|524728915|FG001|Overall Study|Adverse Event|4|||
145510503|NCT00942994|524728914|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145510504|NCT00942994|524728915|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145510505|NCT00942994|524728914|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145510506|NCT00942994|524728915|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145510507|NCT00942994|524728914|FG000|Overall Study|Patient withdrew consent|5|||
145510508|NCT00942994|524728915|FG001|Overall Study|Patient withdrew consent|8|||
145510509|NCT00942994|524728914|FG000|Overall Study|Lost to Follow-up|1|||
145510510|NCT00942994|524728915|FG001|Overall Study|Lost to Follow-up|4|||
145510511|NCT00942994|524728914|FG000|Overall Study|Protocol deviation|1|||
145510512|NCT00942994|524728915|FG001|Overall Study|Protocol deviation|2|||
145510513|NCT03583385|524728916|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145510514|NCT03583385|524728917|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145510515|NCT03583385|524728916|FG000|Treatment Period 2|Adverse Event|1|||
145510516|NCT03583385|524728917|FG001|Treatment Period 2|Adverse Event|0|||
145510517|NCT00095940|524728918|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
145510518|NCT00095940|524728919|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
145510519|NCT00095940|524728920|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
145510520|NCT00095940|524728921|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
145510521|NCT00095940|524728922|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
145510522|NCT00095940|524728923|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
145510523|NCT00095940|524728924|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
145510524|NCT00095940|524728925|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
145510525|NCT00095940|524728926|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
145510526|NCT00095940|524728918|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
145510527|NCT00095940|524728919|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
145510528|NCT00095940|524728920|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
145510529|NCT00095940|524728921|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
145510530|NCT00095940|524728922|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
145510531|NCT00095940|524728923|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
145510532|NCT00095940|524728924|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
145510533|NCT00095940|524728925|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
145510534|NCT00095940|524728926|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
145510535|NCT00095940|524728918|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510536|NCT00095940|524728919|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510537|NCT00095940|524728920|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510538|NCT00095940|524728921|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510539|NCT00095940|524728922|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510540|NCT00095940|524728923|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510541|NCT00095940|524728924|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510542|NCT00095940|524728925|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
145510543|NCT00095940|524728926|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
145510544|NCT02314637|524728929|FG000|Overall Study|Adverse Event|4|||
145510545|NCT02314637|524728930|FG001|Overall Study|Adverse Event|8|||
145510546|NCT02314637|524728929|FG000|Overall Study|Lack of Efficacy|1|||
145510547|NCT02314637|524728930|FG001|Overall Study|Lack of Efficacy|0|||
145510548|NCT02314637|524728929|FG000|Overall Study|Physician Decision|5|||
145510549|NCT02314637|524728930|FG001|Overall Study|Physician Decision|2|||
145510550|NCT02314637|524728929|FG000|Overall Study|Withdrawal by Subject|5|||
145510551|NCT02314637|524728930|FG001|Overall Study|Withdrawal by Subject|4|||
145510552|NCT02314637|524728929|FG000|Overall Study|Other Reason|1|||
145510553|NCT02314637|524728930|FG001|Overall Study|Other Reason|0|||
145510554|NCT01311024|524728945|FG000|Overall Study|Protocol Violation|35|||
145510555|NCT01311024|524728946|FG001|Overall Study|Protocol Violation|22|||
145510556|NCT02597478|524728951|FG000|Overall Study|Withdrawal by Subject|2|||
145510557|NCT02597478|524728952|FG001|Overall Study|Withdrawal by Subject|0|||
145510558|NCT02597478|524728951|FG000|Overall Study|Change of opioid dose|1|||
145510559|NCT02597478|524728952|FG001|Overall Study|Change of opioid dose|0|||
145510560|NCT02597478|524728951|FG000|Overall Study|Insufficient exertional dyspnea|0|||
145510561|NCT02597478|524728952|FG001|Overall Study|Insufficient exertional dyspnea|1|||
145510562|NCT01256190|524728954|FG000|Overall Study|Lost to Follow-up|2|||
145510563|NCT01256190|524728955|FG001|Overall Study|Lost to Follow-up|0|||
145510564|NCT02364336|524728956|FG000|Overall Study|Adverse Event|0|||
145510565|NCT02364336|524728957|FG001|Overall Study|Adverse Event|1|||
145510566|NCT04643158|524728958|FG000|Overall Study|Study terminated by sponsor|0|||
145510567|NCT04643158|524728959|FG001|Overall Study|Study terminated by sponsor|0|||
145510568|NCT04643158|524728960|FG002|Overall Study|Study terminated by sponsor|1|||
145510569|NCT04643158|524728961|FG003|Overall Study|Study terminated by sponsor|0|||
145510570|NCT04643158|524728962|FG004|Overall Study|Study terminated by sponsor|0|||
145510571|NCT04643158|524728963|FG005|Overall Study|Study terminated by sponsor|1|||
145510572|NCT04643158|524728964|FG006|Overall Study|Study terminated by sponsor|0|||
145510573|NCT04643158|524728958|FG000|Overall Study|Global/country situation|0|||
145510574|NCT04643158|524728959|FG001|Overall Study|Global/country situation|0|||
145510575|NCT04643158|524728960|FG002|Overall Study|Global/country situation|1|||
145510576|NCT04643158|524728961|FG003|Overall Study|Global/country situation|0|||
145510577|NCT04643158|524728962|FG004|Overall Study|Global/country situation|0|||
145510578|NCT04643158|524728963|FG005|Overall Study|Global/country situation|0|||
145510579|NCT04643158|524728964|FG006|Overall Study|Global/country situation|0|||
145510580|NCT04643158|524728958|FG000|Overall Study|Withdrawal by Subject|0|||
145510581|NCT04643158|524728959|FG001|Overall Study|Withdrawal by Subject|0|||
145510582|NCT04643158|524728960|FG002|Overall Study|Withdrawal by Subject|0|||
145510583|NCT04643158|524728961|FG003|Overall Study|Withdrawal by Subject|0|||
145510584|NCT04643158|524728962|FG004|Overall Study|Withdrawal by Subject|0|||
145510585|NCT04643158|524728963|FG005|Overall Study|Withdrawal by Subject|1|||
145510586|NCT04643158|524728964|FG006|Overall Study|Withdrawal by Subject|0|||
145510587|NCT02350478|524728965|FG000|Overall Study|Lost to Follow-up|5|||
145510588|NCT02350478|524728966|FG001|Overall Study|Lost to Follow-up|1|||
145510589|NCT02779556|524728967|FG000|Baseline|Partial baseline interview completed|1|||
145510590|NCT02779556|524728968|FG001|Baseline|Partial baseline interview completed|0|||
145510591|NCT02779556|524728967|FG000|3 Months|Lost to Follow-up|40|||
145510592|NCT02779556|524728968|FG001|3 Months|Lost to Follow-up|29|||
145510593|NCT02779556|524728967|FG000|3 Months|Missed 3 month clinic visit|27|||
145510594|NCT02779556|524728968|FG001|3 Months|Missed 3 month clinic visit|19|||
145510595|NCT02779556|524728967|FG000|6 Month|Lost to Follow-up|33|||
145510596|NCT02779556|524728968|FG001|6 Month|Lost to Follow-up|39|||
145510597|NCT02779556|524728967|FG000|6 Month HbA1c|No value collected during window|69|||
145510598|NCT02779556|524728968|FG001|6 Month HbA1c|No value collected during window|50|||
145510599|NCT02779556|524728967|FG000|12 Month HbA1c|No value collected during window|138|||
145510600|NCT02779556|524728968|FG001|12 Month HbA1c|No value collected during window|102|||
145510601|NCT03110770|524728970|FG000|Overall Study|Death|1|||
145510602|NCT03110770|524728971|FG001|Overall Study|Death|0|||
145510603|NCT03110770|524728972|FG002|Overall Study|Death|0|||
145510604|NCT03110770|524728973|FG003|Overall Study|Death|1|||
145510605|NCT03110770|524728974|FG004|Overall Study|Death|0|||
145510606|NCT03110770|524728970|FG000|Overall Study|Enrolled but did not receive product|0|||
145510607|NCT03110770|524728971|FG001|Overall Study|Enrolled but did not receive product|0|||
145510608|NCT03110770|524728972|FG002|Overall Study|Enrolled but did not receive product|0|||
145510609|NCT03110770|524728973|FG003|Overall Study|Enrolled but did not receive product|8|||
145510610|NCT03110770|524728974|FG004|Overall Study|Enrolled but did not receive product|7|||
145510611|NCT03110770|524728970|FG000|Overall Study|Lost to Follow-up|0|||
145510612|NCT03110770|524728971|FG001|Overall Study|Lost to Follow-up|0|||
145510613|NCT03110770|524728972|FG002|Overall Study|Lost to Follow-up|0|||
145510614|NCT03110770|524728973|FG003|Overall Study|Lost to Follow-up|53|||
145510615|NCT03110770|524728974|FG004|Overall Study|Lost to Follow-up|45|||
145510616|NCT03110770|524728970|FG000|Overall Study|Investigator Decision|0|||
145510617|NCT03110770|524728971|FG001|Overall Study|Investigator Decision|0|||
145510618|NCT03110770|524728972|FG002|Overall Study|Investigator Decision|0|||
145510619|NCT03110770|524728973|FG003|Overall Study|Investigator Decision|5|||
145510620|NCT03110770|524728974|FG004|Overall Study|Investigator Decision|3|||
145510621|NCT03110770|524728970|FG000|Overall Study|Withdrawal by Subject|0|||
145510622|NCT03110770|524728971|FG001|Overall Study|Withdrawal by Subject|0|||
145510623|NCT03110770|524728972|FG002|Overall Study|Withdrawal by Subject|0|||
145510624|NCT03110770|524728973|FG003|Overall Study|Withdrawal by Subject|24|||
145510625|NCT03110770|524728974|FG004|Overall Study|Withdrawal by Subject|24|||
145510626|NCT03110770|524728970|FG000|Overall Study|Moved from area|5|||
145510627|NCT03110770|524728971|FG001|Overall Study|Moved from area|0|||
145510628|NCT03110770|524728972|FG002|Overall Study|Moved from area|2|||
145510629|NCT03110770|524728973|FG003|Overall Study|Moved from area|42|||
145510630|NCT03110770|524728974|FG004|Overall Study|Moved from area|43|||
145510631|NCT03110770|524728970|FG000|Overall Study|Illness/Injury unrelated to product|0|||
145510632|NCT03110770|524728971|FG001|Overall Study|Illness/Injury unrelated to product|0|||
145510633|NCT03110770|524728972|FG002|Overall Study|Illness/Injury unrelated to product|0|||
145510634|NCT03110770|524728973|FG003|Overall Study|Illness/Injury unrelated to product|0|||
145510635|NCT03110770|524728974|FG004|Overall Study|Illness/Injury unrelated to product|1|||
145510636|NCT01667419|524728975|FG000|Overall Study|Reason Not Specified|1|||
145510637|NCT01667419|524728976|FG001|Overall Study|Reason Not Specified|0|||
145732997|NCT04147234|525540875|FG002|Overall Study|Withdrawal by Subject|1|||
145401952|NCT01991795|524328816|FG001|Overall Study|Withdrawal by Subject|94|||
145401953|NCT01991795|524328815|FG000|Overall Study|Site prematurely closed by sponsor|26|||
145401954|NCT01991795|524328816|FG001|Overall Study|Site prematurely closed by sponsor|25|||
145401955|NCT04798027|524328817|FG000|Overall Study|Protocol Violation|0|||
145401956|NCT04798027|524328818|FG001|Overall Study|Protocol Violation|0|||
145401957|NCT04798027|524328819|FG002|Overall Study|Protocol Violation|0|||
145401958|NCT04798027|524328820|FG003|Overall Study|Protocol Violation|0|||
145401959|NCT04798027|524328821|FG004|Overall Study|Protocol Violation|1|||
145401960|NCT04798027|524328822|FG005|Overall Study|Protocol Violation|0|||
145510638|NCT01667419|524728977|FG002|Overall Study|Reason Not Specified|0|||
145510639|NCT01667419|524728978|FG003|Overall Study|Reason Not Specified|0|||
145510640|NCT01667419|524728975|FG000|Overall Study|Withdrawal by Subject|16|||
145510641|NCT01667419|524728976|FG001|Overall Study|Withdrawal by Subject|8|||
145510642|NCT01667419|524728977|FG002|Overall Study|Withdrawal by Subject|9|||
145510643|NCT01667419|524728978|FG003|Overall Study|Withdrawal by Subject|8|||
145510644|NCT01667419|524728975|FG000|Overall Study|Non-compliance|0|||
145510645|NCT01667419|524728976|FG001|Overall Study|Non-compliance|0|||
145510646|NCT01667419|524728977|FG002|Overall Study|Non-compliance|0|||
145510647|NCT01667419|524728978|FG003|Overall Study|Non-compliance|1|||
145510648|NCT01667419|524728975|FG000|Overall Study|Protocol Violation|1|||
145510649|NCT01667419|524728976|FG001|Overall Study|Protocol Violation|0|||
145510650|NCT01667419|524728977|FG002|Overall Study|Protocol Violation|0|||
145510651|NCT01667419|524728978|FG003|Overall Study|Protocol Violation|0|||
145510652|NCT01667419|524728975|FG000|Overall Study|Lost to Follow-up|7|||
145510653|NCT01667419|524728976|FG001|Overall Study|Lost to Follow-up|6|||
145510654|NCT01667419|524728977|FG002|Overall Study|Lost to Follow-up|2|||
145510655|NCT01667419|524728978|FG003|Overall Study|Lost to Follow-up|4|||
145510656|NCT01667419|524728975|FG000|Overall Study|Death|18|||
145510657|NCT01667419|524728976|FG001|Overall Study|Death|33|||
145510658|NCT01667419|524728977|FG002|Overall Study|Death|25|||
145510659|NCT01667419|524728978|FG003|Overall Study|Death|26|||
145510660|NCT00856518|524728979|FG000|Overall Study|Lost to Follow-up|4|||
145510661|NCT00856518|524728980|FG001|Overall Study|Lost to Follow-up|2|||
145510662|NCT02082340|524728982|FG000|Overall Study|Lost to Follow-up|1|||
145510663|NCT02082340|524728983|FG001|Overall Study|Lost to Follow-up|1|||
145510664|NCT02644109|524728990|FG000|Overall Study|Adverse Event|0|||
145510665|NCT02644109|524728991|FG001|Overall Study|Adverse Event|4|||
145510666|NCT04195893|524728994|FG000|Second Intervention|Withdrawal by Subject|1|||
145510667|NCT04195893|524728995|FG001|Second Intervention|Withdrawal by Subject|0|||
145510668|NCT00918736|524728998|FG000|Overall Study|Withdrawal by Subject|4|||
145510669|NCT01474018|524728999|FG000|Overall Study|Lost to Follow-up|0|||
145510670|NCT01474018|524729000|FG001|Overall Study|Lost to Follow-up|1|||
145510671|NCT01474018|524728999|FG000|Overall Study|Withdrawal by Subject|0|||
145510672|NCT01474018|524729000|FG001|Overall Study|Withdrawal by Subject|2|||
145510673|NCT01942733|524729002|FG000|Overall Study|Lost to Follow-up|1|||
145510674|NCT01942733|524729002|FG000|Overall Study|Non-compliance with IMP|1|||
145510675|NCT01942733|524729002|FG000|Overall Study|Administrative|1|||
145510676|NCT00486291|524729006|FG000|Overall Study|Adverse Event|3|||
145510677|NCT00486291|524729007|FG001|Overall Study|Adverse Event|4|||
145510678|NCT00486291|524729006|FG000|Overall Study|Lost to Follow-up|3|||
145510679|NCT00486291|524729007|FG001|Overall Study|Lost to Follow-up|7|||
145510680|NCT00486291|524729006|FG000|Overall Study|protocol non-compliance|10|||
145510681|NCT00486291|524729007|FG001|Overall Study|protocol non-compliance|15|||
145510682|NCT00486291|524729006|FG000|Overall Study|requirement for restricted medication|0|||
145510683|NCT00486291|524729007|FG001|Overall Study|requirement for restricted medication|3|||
145510684|NCT03462511|524729011|FG000|Overall Study|Withdrawal by Subject|2|||
145510685|NCT03462511|524729012|FG001|Overall Study|Withdrawal by Subject|3|||
145510686|NCT02925416|524729013|FG000|Overall Study|Adverse Event|2|||
145510687|NCT02925416|524729014|FG001|Overall Study|Adverse Event|0|||
145510688|NCT00200356|524729015|FG000|Overall Study|Lack of Efficacy|3|||
145510689|NCT00200356|524729016|FG001|Overall Study|Lack of Efficacy|3|||
145510690|NCT00200356|524729015|FG000|Overall Study|Protocol Violation|4|||
145510691|NCT00200356|524729016|FG001|Overall Study|Protocol Violation|4|||
145510692|NCT00200356|524729015|FG000|Overall Study|Nontreatment|1|||
145510693|NCT00200356|524729016|FG001|Overall Study|Nontreatment|0|||
145510694|NCT04080167|524729020|FG000|Overall Study|Lost to Follow-up-Patients|7|||
145510695|NCT04080167|524729021|FG001|Overall Study|Lost to Follow-up-Patients|14|||
145510696|NCT04080167|524729022|FG002|Overall Study|Lost to Follow-up-Patients|0|||
145510697|NCT04080167|524729020|FG000|Overall Study|Lost to Follow-up-Providers|2|||
145510698|NCT04080167|524729021|FG001|Overall Study|Lost to Follow-up-Providers|2|||
145510699|NCT04080167|524729022|FG002|Overall Study|Lost to Follow-up-Providers|0|||
145510700|NCT04080167|524729020|FG000|Overall Study|Withdrawal by Subject|1|||
145510701|NCT04080167|524729021|FG001|Overall Study|Withdrawal by Subject|2|||
145510702|NCT04080167|524729022|FG002|Overall Study|Withdrawal by Subject|0|||
145510703|NCT04080167|524729020|FG000|Overall Study|Withdrawal by Provider|0|||
145510704|NCT04080167|524729021|FG001|Overall Study|Withdrawal by Provider|0|||
145510705|NCT04080167|524729022|FG002|Overall Study|Withdrawal by Provider|4|||
145510706|NCT04080167|524729020|FG000|Overall Study|Death-Patient|2|||
145510707|NCT04080167|524729021|FG001|Overall Study|Death-Patient|1|||
145510708|NCT04080167|524729022|FG002|Overall Study|Death-Patient|0|||
145510709|NCT04080167|524729020|FG000|Overall Study|Hydroxyurea New Starts|0|||
145510710|NCT04080167|524729021|FG001|Overall Study|Hydroxyurea New Starts|0|||
145510711|NCT04080167|524729022|FG002|Overall Study|Hydroxyurea New Starts|1|||
145510712|NCT04080167|524729020|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
145510713|NCT04080167|524729021|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
145510714|NCT04080167|524729022|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
145510715|NCT02167139|524729023|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
145510716|NCT02167139|524729024|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
145510717|NCT02167139|524729025|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
145510718|NCT02167139|524729026|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
145510719|NCT02167139|524729023|FG000|Randomised, Double-blind|Adverse Event|2|||
145510720|NCT02167139|524729024|FG001|Randomised, Double-blind|Adverse Event|9|||
145510721|NCT02167139|524729025|FG002|Randomised, Double-blind|Adverse Event|0|||
145510722|NCT02167139|524729026|FG003|Randomised, Double-blind|Adverse Event|0|||
145510723|NCT02167139|524729023|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
145510724|NCT02167139|524729024|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
145510725|NCT02167139|524729025|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
145510726|NCT02167139|524729026|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
145510727|NCT02167139|524729023|FG000|Randomised, Double-blind|Other|3|||
145510728|NCT02167139|524729024|FG001|Randomised, Double-blind|Other|0|||
145510729|NCT02167139|524729025|FG002|Randomised, Double-blind|Other|0|||
145510730|NCT02167139|524729026|FG003|Randomised, Double-blind|Other|0|||
145510731|NCT02167139|524729023|FG000|Transition-extension|Adverse Event|2|||
145510732|NCT02167139|524729024|FG001|Transition-extension|Adverse Event|0|||
145510733|NCT02167139|524729025|FG002|Transition-extension|Adverse Event|2|||
145510734|NCT02167139|524729026|FG003|Transition-extension|Adverse Event|3|||
145510735|NCT02167139|524729023|FG000|Transition-extension|Withdrawal by Subject|2|||
145510736|NCT02167139|524729024|FG001|Transition-extension|Withdrawal by Subject|0|||
145510737|NCT02167139|524729025|FG002|Transition-extension|Withdrawal by Subject|4|||
145510738|NCT02167139|524729026|FG003|Transition-extension|Withdrawal by Subject|1|||
145510739|NCT02167139|524729023|FG000|Transition-extension|Lack of Efficacy|0|||
145510740|NCT02167139|524729024|FG001|Transition-extension|Lack of Efficacy|0|||
145510741|NCT02167139|524729025|FG002|Transition-extension|Lack of Efficacy|1|||
145510742|NCT02167139|524729026|FG003|Transition-extension|Lack of Efficacy|1|||
145510743|NCT02167139|524729023|FG000|Transition-extension|Other|1|||
145510744|NCT02167139|524729024|FG001|Transition-extension|Other|0|||
145510745|NCT02167139|524729025|FG002|Transition-extension|Other|1|||
145510746|NCT02167139|524729026|FG003|Transition-extension|Other|0|||
145510747|NCT02167139|524729023|FG000|Transition-extension|Lost to Follow-up|1|||
145510748|NCT02167139|524729024|FG001|Transition-extension|Lost to Follow-up|0|||
145510749|NCT02167139|524729025|FG002|Transition-extension|Lost to Follow-up|0|||
145510750|NCT02167139|524729026|FG003|Transition-extension|Lost to Follow-up|0|||
145510751|NCT01297491|524729027|FG000|Overall Study|Adverse Event|11|||
145510752|NCT01297491|524729028|FG001|Overall Study|Adverse Event|6|||
145510753|NCT01297491|524729027|FG000|Overall Study|Physician Decision|3|||
145510754|NCT01297491|524729028|FG001|Overall Study|Physician Decision|2|||
145510755|NCT01297491|524729027|FG000|Overall Study|Progressive disease|11|||
145510756|NCT01297491|524729028|FG001|Overall Study|Progressive disease|20|||
145510757|NCT01297491|524729027|FG000|Overall Study|Patient/Guardian decision|3|||
145510758|NCT01297491|524729028|FG001|Overall Study|Patient/Guardian decision|4|||
145510759|NCT01297491|524729027|FG000|Overall Study|Death|2|||
145510760|NCT01297491|524729028|FG001|Overall Study|Death|1|||
145510761|NCT01015638|524729034|FG000|Overall Study|Withdrawal by Subject|1|||
145510762|NCT01015638|524729035|FG001|Overall Study|Withdrawal by Subject|0|||
145510763|NCT00984620|524729036|FG000|Overall Study|Adverse Event|5|||
145510764|NCT00984620|524729037|FG001|Overall Study|Adverse Event|5|||
145510765|NCT00984620|524729036|FG000|Overall Study|Lost to Follow-up|1|||
145510766|NCT00984620|524729037|FG001|Overall Study|Lost to Follow-up|1|||
145510767|NCT00984620|524729036|FG000|Overall Study|Withdrawal by Subject|0|||
145510768|NCT00984620|524729037|FG001|Overall Study|Withdrawal by Subject|2|||
145510769|NCT00984620|524729036|FG000|Overall Study|reason other than listed above|0|||
145510770|NCT00984620|524729037|FG001|Overall Study|reason other than listed above|4|||
145510771|NCT02379637|524729040|FG000|Overall Study|Protocol Violation|0|||
145510772|NCT02379637|524729041|FG001|Overall Study|Protocol Violation|1|||
145510773|NCT02379637|524729040|FG000|Overall Study|Adverse Event|1|||
145510774|NCT02379637|524729041|FG001|Overall Study|Adverse Event|0|||
145510775|NCT02379637|524729040|FG000|Overall Study|Withdrawal by Subject|1|||
145510776|NCT02379637|524729041|FG001|Overall Study|Withdrawal by Subject|0|||
145510777|NCT02791763|524729042|FG000|Overall Study|Protocol Violation|0|||
145510778|NCT02791763|524729043|FG001|Overall Study|Protocol Violation|0|||
145510779|NCT02791763|524729044|FG002|Overall Study|Protocol Violation|1|||
145510780|NCT02791763|524729042|FG000|Overall Study|Withdrawal by Subject|5|||
145510781|NCT02791763|524729043|FG001|Overall Study|Withdrawal by Subject|1|||
145510782|NCT02791763|524729044|FG002|Overall Study|Withdrawal by Subject|0|||
145510783|NCT02791763|524729042|FG000|Overall Study|Physician Decision|0|||
145510784|NCT02791763|524729043|FG001|Overall Study|Physician Decision|1|||
145510785|NCT02791763|524729044|FG002|Overall Study|Physician Decision|0|||
145510786|NCT02791763|524729042|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
145510787|NCT02791763|524729043|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
145510788|NCT02791763|524729044|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
145510789|NCT02791763|524729042|FG000|Overall Study|Cancer event|1|||
145510790|NCT02791763|524729043|FG001|Overall Study|Cancer event|3|||
145510791|NCT02791763|524729044|FG002|Overall Study|Cancer event|0|||
145510792|NCT02791763|524729042|FG000|Overall Study|Participant had renal transplant|3|||
145510793|NCT02791763|524729043|FG001|Overall Study|Participant had renal transplant|0|||
145510794|NCT02791763|524729044|FG002|Overall Study|Participant had renal transplant|0|||
145510795|NCT02791763|524729042|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
145510796|NCT02791763|524729043|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
145510797|NCT02791763|524729044|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
145510798|NCT02791763|524729042|FG000|Overall Study|Adverse Event|12|||
145510799|NCT02791763|524729043|FG001|Overall Study|Adverse Event|13|||
145510800|NCT02791763|524729044|FG002|Overall Study|Adverse Event|7|||
145510801|NCT01561313|524729051|FG000|Overall Study|Withdrawal by Subject|1|||
145510802|NCT01561313|524729052|FG001|Overall Study|Withdrawal by Subject|0|||
145510803|NCT01561313|524729051|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
145510804|NCT01561313|524729052|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
145510805|NCT04535453|524729053|FG000|Overall Study|Death|0|||
145510806|NCT04535453|524729054|FG001|Overall Study|Death|1|||
145510807|NCT04535453|524729055|FG002|Overall Study|Death|0|||
145510808|NCT04535453|524729056|FG003|Overall Study|Death|0|||
145510809|NCT04535453|524729057|FG004|Overall Study|Death|0|||
145510810|NCT04535453|524729058|FG005|Overall Study|Death|0|||
145510811|NCT04535453|524729059|FG006|Overall Study|Death|0|||
145510812|NCT04535453|524729060|FG007|Overall Study|Death|0|||
145510813|NCT04535453|524729061|FG008|Overall Study|Death|0|||
145510814|NCT04535453|524729062|FG009|Overall Study|Death|0|||
145510815|NCT04535453|524729063|FG010|Overall Study|Death|0|||
145510816|NCT04535453|524729064|FG011|Overall Study|Death|0|||
145510817|NCT04535453|524729053|FG000|Overall Study|Lost to Follow-up|1|||
145510818|NCT04535453|524729054|FG001|Overall Study|Lost to Follow-up|1|||
145510819|NCT04535453|524729055|FG002|Overall Study|Lost to Follow-up|1|||
145510820|NCT04535453|524729056|FG003|Overall Study|Lost to Follow-up|0|||
145510821|NCT04535453|524729057|FG004|Overall Study|Lost to Follow-up|3|||
145510822|NCT04535453|524729058|FG005|Overall Study|Lost to Follow-up|1|||
145510823|NCT04535453|524729059|FG006|Overall Study|Lost to Follow-up|0|||
145510824|NCT04535453|524729060|FG007|Overall Study|Lost to Follow-up|0|||
145510825|NCT04535453|524729061|FG008|Overall Study|Lost to Follow-up|1|||
145510826|NCT04535453|524729062|FG009|Overall Study|Lost to Follow-up|1|||
145510827|NCT04535453|524729063|FG010|Overall Study|Lost to Follow-up|0|||
145510828|NCT04535453|524729064|FG011|Overall Study|Lost to Follow-up|0|||
145510829|NCT04535453|524729053|FG000|Overall Study|Physician Decision|0|||
145510830|NCT04535453|524729054|FG001|Overall Study|Physician Decision|0|||
145510831|NCT04535453|524729055|FG002|Overall Study|Physician Decision|0|||
145510832|NCT04535453|524729056|FG003|Overall Study|Physician Decision|1|||
145510833|NCT04535453|524729057|FG004|Overall Study|Physician Decision|0|||
145510834|NCT04535453|524729058|FG005|Overall Study|Physician Decision|0|||
145510835|NCT04535453|524729059|FG006|Overall Study|Physician Decision|0|||
145510836|NCT04535453|524729060|FG007|Overall Study|Physician Decision|0|||
145510837|NCT04535453|524729061|FG008|Overall Study|Physician Decision|0|||
145510838|NCT04535453|524729062|FG009|Overall Study|Physician Decision|0|||
145510839|NCT04535453|524729063|FG010|Overall Study|Physician Decision|0|||
145510840|NCT04535453|524729064|FG011|Overall Study|Physician Decision|0|||
145510841|NCT04535453|524729053|FG000|Overall Study|Withdrawal by Subject|3|||
145510842|NCT04535453|524729054|FG001|Overall Study|Withdrawal by Subject|6|||
145510843|NCT04535453|524729055|FG002|Overall Study|Withdrawal by Subject|3|||
145510844|NCT04535453|524729056|FG003|Overall Study|Withdrawal by Subject|3|||
145510845|NCT04535453|524729057|FG004|Overall Study|Withdrawal by Subject|2|||
145510846|NCT04535453|524729058|FG005|Overall Study|Withdrawal by Subject|1|||
145510847|NCT04535453|524729059|FG006|Overall Study|Withdrawal by Subject|1|||
145510848|NCT04535453|524729060|FG007|Overall Study|Withdrawal by Subject|1|||
145510849|NCT04535453|524729061|FG008|Overall Study|Withdrawal by Subject|1|||
145510850|NCT04535453|524729062|FG009|Overall Study|Withdrawal by Subject|1|||
145510851|NCT04535453|524729063|FG010|Overall Study|Withdrawal by Subject|0|||
145510852|NCT04535453|524729064|FG011|Overall Study|Withdrawal by Subject|1|||
145510853|NCT04535453|524729053|FG000|Overall Study|Other|0|||
145510854|NCT04535453|524729054|FG001|Overall Study|Other|0|||
145510855|NCT04535453|524729055|FG002|Overall Study|Other|1|||
145510856|NCT04535453|524729056|FG003|Overall Study|Other|0|||
145510857|NCT04535453|524729057|FG004|Overall Study|Other|1|||
145510858|NCT04535453|524729058|FG005|Overall Study|Other|0|||
145510859|NCT04535453|524729059|FG006|Overall Study|Other|1|||
145510860|NCT04535453|524729060|FG007|Overall Study|Other|1|||
145510861|NCT04535453|524729061|FG008|Overall Study|Other|1|||
145510862|NCT04535453|524729062|FG009|Overall Study|Other|0|||
145510863|NCT04535453|524729063|FG010|Overall Study|Other|0|||
145510864|NCT04535453|524729064|FG011|Overall Study|Other|0|||
145510865|NCT01742286|524729065|FG000|Escalation Phase|Administrative problems|1|||
145510866|NCT01742286|524729066|FG001|Escalation Phase|Administrative problems|1|||
145510867|NCT01742286|524729067|FG002|Escalation Phase|Administrative problems|0|||
145510868|NCT01742286|524729068|FG003|Escalation Phase|Administrative problems|0|||
145510869|NCT01742286|524729069|FG004|Escalation Phase|Administrative problems|0|||
145510870|NCT01742286|524729070|FG005|Escalation Phase|Administrative problems|0|||
145510871|NCT01742286|524729071|FG006|Escalation Phase|Administrative problems|2|||
145401961|NCT04798027|524328823|FG006|Overall Study|Protocol Violation|0|||
145401962|NCT04798027|524328824|FG007|Overall Study|Protocol Violation|1|||
145401963|NCT04798027|524328825|FG008|Overall Study|Protocol Violation|0|||
145401964|NCT04798027|524328817|FG000|Overall Study|Withdrawal by Subject|1|||
145401965|NCT04798027|524328818|FG001|Overall Study|Withdrawal by Subject|0|||
145401966|NCT04798027|524328819|FG002|Overall Study|Withdrawal by Subject|1|||
145401967|NCT04798027|524328820|FG003|Overall Study|Withdrawal by Subject|1|||
145401968|NCT04798027|524328821|FG004|Overall Study|Withdrawal by Subject|1|||
145510872|NCT01742286|524729065|FG000|Escalation Phase|Adverse Event|0|||
145510873|NCT01742286|524729066|FG001|Escalation Phase|Adverse Event|1|||
145510874|NCT01742286|524729067|FG002|Escalation Phase|Adverse Event|2|||
145510875|NCT01742286|524729068|FG003|Escalation Phase|Adverse Event|0|||
145510876|NCT01742286|524729069|FG004|Escalation Phase|Adverse Event|0|||
145510877|NCT01742286|524729070|FG005|Escalation Phase|Adverse Event|1|||
145510878|NCT01742286|524729071|FG006|Escalation Phase|Adverse Event|0|||
145510879|NCT01742286|524729065|FG000|Escalation Phase|Disease progression|3|||
145510880|NCT01742286|524729066|FG001|Escalation Phase|Disease progression|7|||
145510881|NCT01742286|524729067|FG002|Escalation Phase|Disease progression|4|||
145510882|NCT01742286|524729068|FG003|Escalation Phase|Disease progression|1|||
145510883|NCT01742286|524729069|FG004|Escalation Phase|Disease progression|4|||
145510884|NCT01742286|524729070|FG005|Escalation Phase|Disease progression|3|||
145510885|NCT01742286|524729071|FG006|Escalation Phase|Disease progression|2|||
145510886|NCT01742286|524729065|FG000|Escalation Phase|Death|0|||
145510887|NCT01742286|524729066|FG001|Escalation Phase|Death|0|||
145510888|NCT01742286|524729067|FG002|Escalation Phase|Death|0|||
145510889|NCT01742286|524729068|FG003|Escalation Phase|Death|0|||
145510890|NCT01742286|524729069|FG004|Escalation Phase|Death|0|||
145510891|NCT01742286|524729070|FG005|Escalation Phase|Death|1|||
145510892|NCT01742286|524729071|FG006|Escalation Phase|Death|0|||
145510893|NCT01742286|524729065|FG000|Escalation Phase|Physician Decision|0|||
145510894|NCT01742286|524729066|FG001|Escalation Phase|Physician Decision|3|||
145510895|NCT01742286|524729067|FG002|Escalation Phase|Physician Decision|0|||
145510896|NCT01742286|524729068|FG003|Escalation Phase|Physician Decision|1|||
145510897|NCT01742286|524729069|FG004|Escalation Phase|Physician Decision|0|||
145510898|NCT01742286|524729070|FG005|Escalation Phase|Physician Decision|0|||
145510899|NCT01742286|524729071|FG006|Escalation Phase|Physician Decision|2|||
145510900|NCT01742286|524729065|FG000|Escalation Phase|Subject/guardian decision|1|||
145510901|NCT01742286|524729066|FG001|Escalation Phase|Subject/guardian decision|0|||
145510902|NCT01742286|524729067|FG002|Escalation Phase|Subject/guardian decision|0|||
145510903|NCT01742286|524729068|FG003|Escalation Phase|Subject/guardian decision|0|||
145510904|NCT01742286|524729069|FG004|Escalation Phase|Subject/guardian decision|0|||
145510905|NCT01742286|524729070|FG005|Escalation Phase|Subject/guardian decision|0|||
145510906|NCT01742286|524729071|FG006|Escalation Phase|Subject/guardian decision|0|||
145510907|NCT01742286|524729065|FG000|Expansion Phase|Administrative problems|0|||
145510908|NCT01742286|524729066|FG001|Expansion Phase|Administrative problems|0|||
145510909|NCT01742286|524729067|FG002|Expansion Phase|Administrative problems|0|||
145510910|NCT01742286|524729068|FG003|Expansion Phase|Administrative problems|0|||
145510911|NCT01742286|524729069|FG004|Expansion Phase|Administrative problems|0|||
145510912|NCT01742286|524729070|FG005|Expansion Phase|Administrative problems|0|||
145510913|NCT01742286|524729071|FG006|Expansion Phase|Administrative problems|5|||
145510914|NCT01742286|524729065|FG000|Expansion Phase|Physician Decision|0|||
145510915|NCT01742286|524729066|FG001|Expansion Phase|Physician Decision|0|||
145510916|NCT01742286|524729067|FG002|Expansion Phase|Physician Decision|4|||
145510917|NCT01742286|524729068|FG003|Expansion Phase|Physician Decision|0|||
145510918|NCT01742286|524729069|FG004|Expansion Phase|Physician Decision|0|||
145510919|NCT01742286|524729070|FG005|Expansion Phase|Physician Decision|0|||
145510920|NCT01742286|524729071|FG006|Expansion Phase|Physician Decision|9|||
145510921|NCT01742286|524729065|FG000|Expansion Phase|Adverse Event|0|||
145510922|NCT01742286|524729066|FG001|Expansion Phase|Adverse Event|0|||
145510923|NCT01742286|524729067|FG002|Expansion Phase|Adverse Event|0|||
145510924|NCT01742286|524729068|FG003|Expansion Phase|Adverse Event|0|||
145510925|NCT01742286|524729069|FG004|Expansion Phase|Adverse Event|0|||
145510926|NCT01742286|524729070|FG005|Expansion Phase|Adverse Event|0|||
145510927|NCT01742286|524729071|FG006|Expansion Phase|Adverse Event|6|||
145510928|NCT01742286|524729065|FG000|Expansion Phase|Disease progression|0|||
145510929|NCT01742286|524729066|FG001|Expansion Phase|Disease progression|0|||
145510930|NCT01742286|524729067|FG002|Expansion Phase|Disease progression|3|||
145510931|NCT01742286|524729068|FG003|Expansion Phase|Disease progression|0|||
145510932|NCT01742286|524729069|FG004|Expansion Phase|Disease progression|0|||
145510933|NCT01742286|524729070|FG005|Expansion Phase|Disease progression|0|||
145510934|NCT01742286|524729071|FG006|Expansion Phase|Disease progression|15|||
145510935|NCT01742286|524729065|FG000|Expansion Phase|Withdrawal by Subject|0|||
145510936|NCT01742286|524729066|FG001|Expansion Phase|Withdrawal by Subject|0|||
145510937|NCT01742286|524729067|FG002|Expansion Phase|Withdrawal by Subject|0|||
145510938|NCT01742286|524729068|FG003|Expansion Phase|Withdrawal by Subject|0|||
145510939|NCT01742286|524729069|FG004|Expansion Phase|Withdrawal by Subject|0|||
145510940|NCT01742286|524729070|FG005|Expansion Phase|Withdrawal by Subject|0|||
145510941|NCT01742286|524729071|FG006|Expansion Phase|Withdrawal by Subject|1|||
145510942|NCT04530136|524729072|FG000|Overall Study|Lost to Follow-up|2|||
145510943|NCT04530136|524729073|FG001|Overall Study|Lost to Follow-up|3|||
145510944|NCT04530136|524729072|FG000|Overall Study|Withdrawal by Subject|1|||
145510945|NCT04530136|524729073|FG001|Overall Study|Withdrawal by Subject|0|||
145510946|NCT04530136|524729072|FG000|Overall Study|Death|0|||
145510947|NCT04530136|524729073|FG001|Overall Study|Death|1|||
145510948|NCT01387542|524729074|FG000|Overall Study|Adverse Event|3|||
145510949|NCT01387542|524729074|FG000|Overall Study|Withdrawal by Subject|1|||
145510950|NCT01387542|524729074|FG000|Overall Study|Changed diagnosis|1|||
145510951|NCT01387542|524729074|FG000|Overall Study|Insufficient response|1|||
145510952|NCT01387542|524729074|FG000|Overall Study|Non-compliant|1|||
145510953|NCT01387542|524729074|FG000|Overall Study|Lost to Follow-up|1|||
145510954|NCT01233232|524729075|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
145510955|NCT01233232|524729076|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
145510956|NCT01233232|524729077|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
145510957|NCT01519167|524729083|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
145510958|NCT01519167|524729084|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
145510959|NCT01519167|524729083|FG000|Overall Study|Adverse Event|0|||
145510960|NCT01519167|524729084|FG001|Overall Study|Adverse Event|1|||
145510961|NCT01519167|524729083|FG000|Overall Study|Lack of Efficacy|0|||
145510962|NCT01519167|524729084|FG001|Overall Study|Lack of Efficacy|1|||
145510963|NCT01519167|524729083|FG000|Overall Study|Medical condition changes&deep sedation|0|||
145510964|NCT01519167|524729084|FG001|Overall Study|Medical condition changes&deep sedation|2|||
145510965|NCT01519167|524729083|FG000|Overall Study|Physician Decision|0|||
145510966|NCT01519167|524729084|FG001|Overall Study|Physician Decision|1|||
145510967|NCT04189224|524729085|FG000|Period 2|Adverse Event|0|||
145510968|NCT04189224|524729086|FG001|Period 2|Adverse Event|1|||
145510969|NCT04236141|524731412|FG000|Overall Study|Death|18|||
145510970|NCT04236141|524731413|FG001|Overall Study|Death|10|||
145510971|NCT04236141|524731412|FG000|Overall Study|Withdrawal by Participant|1|||
145510972|NCT04236141|524731413|FG001|Overall Study|Withdrawal by Participant|0|||
145510973|NCT04236141|524731412|FG000|Overall Study|Reason not Specified|1|||
145510974|NCT04236141|524731413|FG001|Overall Study|Reason not Specified|0|||
145510975|NCT04236141|524731412|FG000|Overall Study|Study terminated by Sponsor|8|||
145510976|NCT04236141|524731413|FG001|Overall Study|Study terminated by Sponsor|4|||
145510977|NCT01217307|524731417|FG000|Overall Study|Withdrawal by Subject|0|||
145510978|NCT01217307|524731418|FG001|Overall Study|Withdrawal by Subject|1|||
145510979|NCT01888432|524731423|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
145510980|NCT01888432|524731424|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
145510981|NCT01888432|524731423|FG000|12-month Analysis (FAS)|Physician Decision|1|||
145510982|NCT01888432|524731424|FG001|12-month Analysis (FAS)|Physician Decision|1|||
145510983|NCT01888432|524731423|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
145510984|NCT01888432|524731424|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
145510985|NCT01888432|524731423|FG000|12-month Analysis (FAS)|Death|4|||
145510986|NCT01888432|524731424|FG001|12-month Analysis (FAS)|Death|3|||
145510987|NCT01888432|524731423|FG000|24-month Analysis (FAS)|Graft loss|0|||
145510988|NCT01888432|524731424|FG001|24-month Analysis (FAS)|Graft loss|1|||
145510989|NCT01888432|524731423|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
145510990|NCT01888432|524731424|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
145510991|NCT01888432|524731423|FG000|24-month Analysis (FAS)|Physician Decision|2|||
145510992|NCT01888432|524731424|FG001|24-month Analysis (FAS)|Physician Decision|4|||
145510993|NCT01888432|524731423|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
145510994|NCT01888432|524731424|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
145510995|NCT01888432|524731423|FG000|24-month Analysis (FAS)|Death|8|||
145510996|NCT01888432|524731424|FG001|24-month Analysis (FAS)|Death|4|||
145510997|NCT01888432|524731423|FG000|36-month Analysis (Extension)|Death|1|||
145510998|NCT01888432|524731424|FG001|36-month Analysis (Extension)|Death|0|||
145510999|NCT01696929|524731427|FG000|Overall Study|Physician Decision|1|||
145511000|NCT04473235|524731430|FG000|Overall Study|Lost to Follow-up|6|||
145511001|NCT04473235|524731431|FG001|Overall Study|Lost to Follow-up|5|||
145511002|NCT04473235|524731430|FG000|Overall Study|Declined continuation|2|||
145511003|NCT04473235|524731431|FG001|Overall Study|Declined continuation|0|||
145511004|NCT04473235|524731430|FG000|Overall Study|Physician Decision|1|||
145511005|NCT04473235|524731431|FG001|Overall Study|Physician Decision|1|||
145511006|NCT04473235|524731430|FG000|Overall Study|Protocol Violation|10|||
145511007|NCT04473235|524731431|FG001|Overall Study|Protocol Violation|6|||
145511008|NCT00798759|524731434|FG000|Overall Study|Adverse Event|3|||
145511009|NCT00798759|524731435|FG001|Overall Study|Adverse Event|3|||
145511010|NCT00798759|524731434|FG000|Overall Study|Lost to Follow-up|1|||
145511011|NCT00798759|524731435|FG001|Overall Study|Lost to Follow-up|1|||
145511012|NCT00798759|524731434|FG000|Overall Study|Protocol Violation|4|||
145511013|NCT00798759|524731435|FG001|Overall Study|Protocol Violation|8|||
145511014|NCT00798759|524731434|FG000|Overall Study|Other|0|||
145511015|NCT00798759|524731435|FG001|Overall Study|Other|1|||
145511016|NCT02156271|524731436|FG000|Overall Study|Physician Decision|4|||
145511017|NCT02156271|524731437|FG001|Overall Study|Physician Decision|3|||
145511018|NCT00955305|524731438|FG000|Overall Study|Disease progression|39|||
145511019|NCT00955305|524731439|FG001|Overall Study|Disease progression|41|||
145511020|NCT00955305|524731438|FG000|Overall Study|Adverse Event|22|||
145511021|NCT00955305|524731439|FG001|Overall Study|Adverse Event|22|||
145511022|NCT00955305|524731438|FG000|Overall Study|Death|2|||
145511023|NCT00955305|524731439|FG001|Overall Study|Death|1|||
145511024|NCT00955305|524731438|FG000|Overall Study|Withdrawal by Subject|5|||
145511025|NCT00955305|524731439|FG001|Overall Study|Withdrawal by Subject|4|||
145511026|NCT00955305|524731438|FG000|Overall Study|Alternative therapy|4|||
145511027|NCT00955305|524731439|FG001|Overall Study|Alternative therapy|0|||
145511028|NCT00955305|524731438|FG000|Overall Study|Other complicating disease|2|||
145511029|NCT00955305|524731439|FG001|Overall Study|Other complicating disease|4|||
145511030|NCT00955305|524731438|FG000|Overall Study|Physician Decision|1|||
145511031|NCT00955305|524731439|FG001|Overall Study|Physician Decision|0|||
145511032|NCT00955305|524731438|FG000|Overall Study|Continued presence of residual disease|0|||
145511033|NCT00955305|524731439|FG001|Overall Study|Continued presence of residual disease|1|||
145511034|NCT00955305|524731438|FG000|Overall Study|Functional decline|2|||
145511035|NCT00955305|524731439|FG001|Overall Study|Functional decline|0|||
145511036|NCT00955305|524731438|FG000|Overall Study|Maximum response achieved|0|||
145511037|NCT00955305|524731439|FG001|Overall Study|Maximum response achieved|1|||
145511038|NCT00955305|524731438|FG000|Overall Study|Lost to Follow-up|0|||
145511039|NCT00955305|524731439|FG001|Overall Study|Lost to Follow-up|1|||
145511040|NCT00955305|524731438|FG000|Overall Study|No off-treatment reason submitted|1|||
145511041|NCT00955305|524731439|FG001|Overall Study|No off-treatment reason submitted|0|||
145511042|NCT00955305|524731438|FG000|Overall Study|Never started protocol treatment|5|||
145511043|NCT00955305|524731439|FG001|Overall Study|Never started protocol treatment|5|||
145511044|NCT00955305|524731438|FG000|Overall Study|Ineligible|5|||
145511045|NCT00955305|524731439|FG001|Overall Study|Ineligible|7|||
145511046|NCT03387111|524731440|FG000|Overall Study|Progressive Disease|3|||
145511047|NCT03387111|524731440|FG000|Overall Study|Other|1|||
145511048|NCT01945710|524731444|FG000|Overall Study|Progressive Disease|5|||
145511049|NCT01945710|524731445|FG001|Overall Study|Progressive Disease|4|||
145511050|NCT01945710|524731446|FG002|Overall Study|Progressive Disease|3|||
145511051|NCT01945710|524731447|FG003|Overall Study|Progressive Disease|2|||
145511052|NCT01945710|524731448|FG004|Overall Study|Progressive Disease|7|||
145511053|NCT01945710|524731449|FG005|Overall Study|Progressive Disease|3|||
145511054|NCT01945710|524731450|FG006|Overall Study|Progressive Disease|19|||
145511055|NCT01945710|524731444|FG000|Overall Study|Adverse Event|0|||
145511056|NCT01945710|524731445|FG001|Overall Study|Adverse Event|1|||
145511057|NCT01945710|524731446|FG002|Overall Study|Adverse Event|0|||
145511058|NCT01945710|524731447|FG003|Overall Study|Adverse Event|0|||
145511059|NCT01945710|524731448|FG004|Overall Study|Adverse Event|0|||
145511060|NCT01945710|524731449|FG005|Overall Study|Adverse Event|0|||
145511061|NCT01945710|524731450|FG006|Overall Study|Adverse Event|0|||
145511062|NCT01945710|524731444|FG000|Overall Study|Other|2|||
145511063|NCT01945710|524731445|FG001|Overall Study|Other|0|||
145511064|NCT01945710|524731446|FG002|Overall Study|Other|3|||
145511065|NCT01945710|524731447|FG003|Overall Study|Other|1|||
145511066|NCT01945710|524731448|FG004|Overall Study|Other|1|||
145511067|NCT01945710|524731449|FG005|Overall Study|Other|0|||
145511068|NCT01945710|524731450|FG006|Overall Study|Other|4|||
145511069|NCT01945710|524731444|FG000|Overall Study|Withdrawal by Subject|0|||
145511070|NCT01945710|524731445|FG001|Overall Study|Withdrawal by Subject|1|||
145511071|NCT01945710|524731446|FG002|Overall Study|Withdrawal by Subject|1|||
145511072|NCT01945710|524731447|FG003|Overall Study|Withdrawal by Subject|0|||
145511073|NCT01945710|524731448|FG004|Overall Study|Withdrawal by Subject|1|||
145511074|NCT01945710|524731449|FG005|Overall Study|Withdrawal by Subject|0|||
145511075|NCT01945710|524731450|FG006|Overall Study|Withdrawal by Subject|0|||
145511076|NCT02730195|524731451|FG000|Overall Study|Withdrawal by Subject|1|||
145511077|NCT00375609|524731452|FG000|Overall Study|Did not receive treatment|1|||
145511078|NCT00375609|524731453|FG001|Overall Study|Did not receive treatment|0|||
145511079|NCT00375609|524731454|FG002|Overall Study|Did not receive treatment|0|||
145511080|NCT00375609|524731452|FG000|Overall Study|Adverse Event|0|||
145511081|NCT00375609|524731453|FG001|Overall Study|Adverse Event|3|||
145511082|NCT00375609|524731454|FG002|Overall Study|Adverse Event|0|||
145511083|NCT00375609|524731452|FG000|Overall Study|Lost to Follow-up|1|||
145511084|NCT00375609|524731453|FG001|Overall Study|Lost to Follow-up|0|||
145511085|NCT00375609|524731454|FG002|Overall Study|Lost to Follow-up|0|||
145511086|NCT00375609|524731452|FG000|Overall Study|Physician Decision|0|||
145511087|NCT00375609|524731453|FG001|Overall Study|Physician Decision|0|||
145511088|NCT00375609|524731454|FG002|Overall Study|Physician Decision|1|||
145511089|NCT00375609|524731452|FG000|Overall Study|Withdrawal by Subject|1|||
145511090|NCT00375609|524731453|FG001|Overall Study|Withdrawal by Subject|4|||
145511091|NCT00375609|524731454|FG002|Overall Study|Withdrawal by Subject|0|||
145511092|NCT00375609|524731452|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
145511093|NCT00375609|524731453|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
145511094|NCT00375609|524731454|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
145511095|NCT01368562|524731455|FG000|Overall Study|Adverse Event|1|||
145511096|NCT01368562|524731455|FG000|Overall Study|Disease progression|1|||
145511097|NCT01368562|524731455|FG000|Overall Study|Lost to Follow-up|1|||
145511098|NCT01368562|524731455|FG000|Overall Study|Death|6|||
145511099|NCT01368562|524731455|FG000|Overall Study|Unresponsive to treatment|5|||
145511100|NCT01368562|524731455|FG000|Overall Study|Other|3|||
145511101|NCT01368562|524731455|FG000|Overall Study|Other than specified|2|||
145511102|NCT02810444|524731457|FG000|Overall Study|Screen Failures|14|||
145511103|NCT02810444|524731457|FG000|Overall Study|Withdrawal by Subject|4|||
145511104|NCT02810444|524731457|FG000|Overall Study|Adverse Event|3|||
145511105|NCT01754727|524731460|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
145511106|NCT02785770|524731461|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
145511107|NCT02785770|524731462|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
145511108|NCT02785770|524731463|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
145511109|NCT02785770|524731464|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
145511110|NCT02785770|524731461|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
145511111|NCT02785770|524731462|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
145511112|NCT02785770|524731463|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
145511113|NCT02785770|524731464|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
145511114|NCT02785770|524731461|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
145511115|NCT02785770|524731462|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
145511116|NCT02785770|524731463|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
145511117|NCT02785770|524731464|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
145511118|NCT02891070|524731477|FG000|Overall Study|Adverse Event|1|||
145511119|NCT02891070|524731478|FG001|Overall Study|Adverse Event|0|||
145511120|NCT02891070|524731477|FG000|Overall Study|Physician Decision|0|||
145511121|NCT02891070|524731478|FG001|Overall Study|Physician Decision|1|||
145511122|NCT02891070|524731477|FG000|Overall Study|Lost to Follow-up|4|||
145511123|NCT02891070|524731478|FG001|Overall Study|Lost to Follow-up|4|||
145511124|NCT02891070|524731477|FG000|Overall Study|Other|1|||
145511125|NCT02891070|524731478|FG001|Overall Study|Other|0|||
145511126|NCT02891070|524731477|FG000|Overall Study|Protocol Violation|0|||
145511127|NCT02891070|524731478|FG001|Overall Study|Protocol Violation|1|||
145511128|NCT02891070|524731477|FG000|Overall Study|Withdrawal by Subject|1|||
145511129|NCT02891070|524731478|FG001|Overall Study|Withdrawal by Subject|2|||
145511130|NCT02891070|524731477|FG000|Overall Study|Death|3|||
145511131|NCT02891070|524731478|FG001|Overall Study|Death|0|||
145511132|NCT04491604|524731483|FG000|Overall Study|Withdrawal by Subject|3|||
145511133|NCT02888119|524731488|FG000|Overall Study|Lost to Follow-up|5|||
145511134|NCT02888119|524731489|FG001|Overall Study|Lost to Follow-up|4|||
145511135|NCT02888119|524731490|FG002|Overall Study|Lost to Follow-up|0|||
145511136|NCT01767142|524731491|FG000|Overall Study|Lost to Follow-up|3|||
145511137|NCT00926029|524731492|FG000|Overall Study|Lost to Follow-up|2|||
145511138|NCT00926029|524731493|FG001|Overall Study|Lost to Follow-up|1|||
145511139|NCT00926029|524731494|FG002|Overall Study|Lost to Follow-up|1|||
145511140|NCT03206788|524731495|FG000|Overall Study|Withdrawal by Subject|0|||
145511141|NCT03206788|524731496|FG001|Overall Study|Withdrawal by Subject|1|||
145511142|NCT03206788|524731495|FG000|Overall Study|Adverse Event|0|||
145511143|NCT03206788|524731496|FG001|Overall Study|Adverse Event|1|||
145511144|NCT03206788|524731495|FG000|Overall Study|Physician Decision|0|||
145511145|NCT03206788|524731496|FG001|Overall Study|Physician Decision|1|||
145511146|NCT05246514|524731497|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
145511147|NCT05246514|524731497|FG000|Overall Study|Withdrawal by Subject|1|||
145511148|NCT05246514|524731497|FG000|Overall Study|Death|13|||
145511149|NCT01802073|524731500|FG000|Overall Study|Lost to Follow-up|0|||
145511150|NCT01802073|524731501|FG001|Overall Study|Lost to Follow-up|1|||
145511151|NCT01802073|524731500|FG000|Overall Study|Non-compliant|4|||
145511152|NCT01802073|524731501|FG001|Overall Study|Non-compliant|2|||
145511153|NCT01802073|524731500|FG000|Overall Study|Withdrawal by Subject|1|||
145511154|NCT01802073|524731501|FG001|Overall Study|Withdrawal by Subject|1|||
145511155|NCT01802073|524731500|FG000|Overall Study|Physician Decision|0|||
145511156|NCT01802073|524731501|FG001|Overall Study|Physician Decision|7|||
145511157|NCT02657408|524731505|FG000|Overall Study|Adverse Event|3|||
145511158|NCT02657408|524731506|FG001|Overall Study|Adverse Event|7|||
145511159|NCT00324961|524731507|FG000|Overall Study|Adverse Event|5|||
145511160|NCT00324961|524731507|FG000|Overall Study|Consent Withdrawn|11|||
145511161|NCT00324961|524731507|FG000|Overall Study|Lost to Follow-up|22|||
145511162|NCT00324961|524731507|FG000|Overall Study|Protocol Violation|3|||
145511163|NCT00324961|524731507|FG000|Overall Study|Other|2|||
145511164|NCT00344487|524731508|FG000|Overall Study|immunologic failure|1|||
145511165|NCT02447302|524731512|FG000|Overall Study|Physician Decision|1|||
145511166|NCT02447302|524731513|FG001|Overall Study|Physician Decision|0|||
145511167|NCT02447302|524731514|FG002|Overall Study|Physician Decision|0|||
145511168|NCT02447302|524731512|FG000|Overall Study|Adverse Event|4|||
145511169|NCT02447302|524731513|FG001|Overall Study|Adverse Event|3|||
145511170|NCT02447302|524731514|FG002|Overall Study|Adverse Event|0|||
145511171|NCT02447302|524731512|FG000|Overall Study|Withdrawal by Subject|0|||
145511172|NCT02447302|524731513|FG001|Overall Study|Withdrawal by Subject|1|||
145511173|NCT02447302|524731514|FG002|Overall Study|Withdrawal by Subject|5|||
145511174|NCT02447302|524731512|FG000|Overall Study|Sponsor Decision|0|||
145511175|NCT02447302|524731513|FG001|Overall Study|Sponsor Decision|0|||
145511176|NCT02447302|524731514|FG002|Overall Study|Sponsor Decision|1|||
145511177|NCT05334212|524731519|FG000|Overall Study|Study terminated prematurely|7|||
145511178|NCT00910299|524731520|FG000|Overall Study|Withdrawal by Subject|16|||
145511179|NCT00910299|524731521|FG001|Overall Study|Withdrawal by Subject|13|||
145511180|NCT00910299|524731520|FG000|Overall Study|Sponsor Decision|58|||
145511181|NCT00910299|524731521|FG001|Overall Study|Sponsor Decision|60|||
145511182|NCT00910299|524731520|FG000|Overall Study|Didn't receive any study drug|2|||
145511183|NCT00910299|524731521|FG001|Overall Study|Didn't receive any study drug|1|||
145511184|NCT01456897|524731522|FG000|Overall Study|Adverse Event|19|||
145511185|NCT01456897|524731523|FG001|Overall Study|Adverse Event|22|||
145511186|NCT01456897|524731522|FG000|Overall Study|Protocol Violation|3|||
145511187|NCT01456897|524731523|FG001|Overall Study|Protocol Violation|4|||
145511188|NCT01456897|524731522|FG000|Overall Study|Physician Decision|5|||
145511189|NCT01456897|524731523|FG001|Overall Study|Physician Decision|3|||
145511190|NCT01456897|524731522|FG000|Overall Study|Withdrawal by Subject|44|||
145511191|NCT01456897|524731523|FG001|Overall Study|Withdrawal by Subject|17|||
145511192|NCT01456897|524731522|FG000|Overall Study|Lack of Efficacy|4|||
145511193|NCT01456897|524731523|FG001|Overall Study|Lack of Efficacy|11|||
145511194|NCT01396070|524731524|FG000|Overall Study|Withdrawal by Subject|2|||
145511195|NCT01396070|524731524|FG000|Overall Study|Death|2|||
145511196|NCT01396070|524731524|FG000|Overall Study|Adverse Event|8|||
145511197|NCT01396070|524731524|FG000|Overall Study|Physician Decision|3|||
145511198|NCT01396070|524731524|FG000|Overall Study|Lack of Efficacy|4|||
145511199|NCT04254913|524731526|FG000|Overall Study|Adverse Event|1|||
145511200|NCT01396057|524731527|FG000|Overall Study|Adverse Event|2|||
145511201|NCT01396057|524731528|FG001|Overall Study|Adverse Event|6|||
145511202|NCT01396057|524731527|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145511203|NCT01396057|524731528|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
145511204|NCT01396057|524731527|FG000|Overall Study|Protocol deviation|4|||
145511205|NCT01396057|524731528|FG001|Overall Study|Protocol deviation|4|||
145511206|NCT01396057|524731527|FG000|Overall Study|Consent withdrawn|3|||
145511207|NCT01396057|524731528|FG001|Overall Study|Consent withdrawn|2|||
145511208|NCT02695420|524731529|FG000|Overall Study|Death|0|||
145511209|NCT02695420|524731530|FG001|Overall Study|Death|1|||
145511210|NCT02695420|524731531|FG002|Overall Study|Death|0|||
145511211|NCT02695420|524731532|FG003|Overall Study|Death|0|||
145511212|NCT00916929|524731535|FG000|Overall Study|Lost to Follow-up|1|||
145511213|NCT00916929|524731536|FG001|Overall Study|Lost to Follow-up|3|||
145511214|NCT00916929|524731535|FG000|Overall Study|Death|5|||
145511215|NCT00916929|524731536|FG001|Overall Study|Death|10|||
145511216|NCT00916929|524731535|FG000|Overall Study|Withdrawal by Subject|1|||
145511217|NCT00916929|524731536|FG001|Overall Study|Withdrawal by Subject|5|||
145511218|NCT00916929|524731535|FG000|Overall Study|Left ventricular epicardial lead|1|||
145511219|NCT00916929|524731536|FG001|Overall Study|Left ventricular epicardial lead|2|||
145511220|NCT00916929|524731535|FG000|Overall Study|Transferred to hospice care|1|||
145511221|NCT00916929|524731536|FG001|Overall Study|Transferred to hospice care|1|||
145511222|NCT00916929|524731535|FG000|Overall Study|System explant|1|||
145511223|NCT00916929|524731536|FG001|Overall Study|System explant|0|||
145511224|NCT00916929|524731535|FG000|Overall Study|Moved to another state|0|||
145511225|NCT00916929|524731536|FG001|Overall Study|Moved to another state|1|||
145511226|NCT00916929|524731535|FG000|Overall Study|Device unable to process impedance data|0|||
145511227|NCT00916929|524731536|FG001|Overall Study|Device unable to process impedance data|7|||
145511228|NCT02929407|524731537|FG000|Overall Study|Adverse Event|1|||
145511229|NCT02878798|524731540|FG000|Overall Study|Withdrawal by Subject|5|||
145511230|NCT02878798|524731541|FG001|Overall Study|Withdrawal by Subject|4|||
145511231|NCT02878798|524731540|FG000|Overall Study|Lost to Follow-up|2|||
145511232|NCT02878798|524731541|FG001|Overall Study|Lost to Follow-up|2|||
145511233|NCT02878798|524731540|FG000|Overall Study|Protocol Violation|0|||
145511234|NCT02878798|524731541|FG001|Overall Study|Protocol Violation|1|||
145511235|NCT03500224|524731542|FG000|Overall Study|Withdrawal by Subject|2|||
145511236|NCT01324401|524731543|FG000|Overall Study|Withdrawn before any treatment|0|||
145511237|NCT01324401|524731544|FG001|Overall Study|Withdrawn before any treatment|3|||
145511238|NCT01324401|524731543|FG000|Overall Study|Adverse Event|1|||
145511239|NCT01324401|524731544|FG001|Overall Study|Adverse Event|3|||
145511240|NCT01708902|524731546|FG000|Overall Study|Adverse Event|3|||
145511241|NCT01708902|524731547|FG001|Overall Study|Adverse Event|4|||
145511242|NCT01708902|524731548|FG002|Overall Study|Adverse Event|9|||
145511243|NCT01708902|524731549|FG003|Overall Study|Adverse Event|2|||
145511244|NCT01708902|524731550|FG004|Overall Study|Adverse Event|7|||
145511245|NCT01708902|524731551|FG005|Overall Study|Adverse Event|3|||
145511246|NCT01708902|524731552|FG006|Overall Study|Adverse Event|5|||
145511247|NCT01708902|524731546|FG000|Overall Study|Lack of Efficacy|3|||
145511248|NCT01708902|524731547|FG001|Overall Study|Lack of Efficacy|1|||
145511249|NCT01708902|524731548|FG002|Overall Study|Lack of Efficacy|0|||
145511250|NCT01708902|524731549|FG003|Overall Study|Lack of Efficacy|0|||
145511251|NCT01708902|524731550|FG004|Overall Study|Lack of Efficacy|0|||
145511252|NCT01708902|524731551|FG005|Overall Study|Lack of Efficacy|1|||
145511253|NCT01708902|524731552|FG006|Overall Study|Lack of Efficacy|0|||
145511254|NCT01708902|524731546|FG000|Overall Study|Non compliance with protocol|0|||
145511255|NCT01708902|524731547|FG001|Overall Study|Non compliance with protocol|2|||
145511256|NCT01708902|524731548|FG002|Overall Study|Non compliance with protocol|1|||
145511257|NCT01708902|524731549|FG003|Overall Study|Non compliance with protocol|3|||
145511258|NCT01708902|524731550|FG004|Overall Study|Non compliance with protocol|0|||
145511259|NCT01708902|524731551|FG005|Overall Study|Non compliance with protocol|0|||
145511260|NCT01708902|524731552|FG006|Overall Study|Non compliance with protocol|0|||
145511261|NCT01708902|524731546|FG000|Overall Study|Lost to Follow-up|2|||
145511262|NCT01708902|524731547|FG001|Overall Study|Lost to Follow-up|1|||
145511263|NCT01708902|524731548|FG002|Overall Study|Lost to Follow-up|2|||
145511264|NCT01708902|524731549|FG003|Overall Study|Lost to Follow-up|2|||
145511265|NCT01708902|524731550|FG004|Overall Study|Lost to Follow-up|0|||
145511266|NCT01708902|524731551|FG005|Overall Study|Lost to Follow-up|0|||
145511267|NCT01708902|524731552|FG006|Overall Study|Lost to Follow-up|1|||
145511268|NCT01708902|524731546|FG000|Overall Study|Refused to continue trial medication|8|||
145511269|NCT01708902|524731547|FG001|Overall Study|Refused to continue trial medication|0|||
145511270|NCT01708902|524731548|FG002|Overall Study|Refused to continue trial medication|4|||
145511271|NCT01708902|524731549|FG003|Overall Study|Refused to continue trial medication|2|||
145511272|NCT01708902|524731550|FG004|Overall Study|Refused to continue trial medication|8|||
145511273|NCT01708902|524731551|FG005|Overall Study|Refused to continue trial medication|1|||
145511274|NCT01708902|524731552|FG006|Overall Study|Refused to continue trial medication|1|||
145511275|NCT01708902|524731546|FG000|Overall Study|Other Reason|1|||
145511276|NCT01708902|524731547|FG001|Overall Study|Other Reason|0|||
145511277|NCT01708902|524731548|FG002|Overall Study|Other Reason|1|||
145511278|NCT01708902|524731549|FG003|Overall Study|Other Reason|1|||
145511279|NCT01708902|524731550|FG004|Overall Study|Other Reason|1|||
145511280|NCT01708902|524731551|FG005|Overall Study|Other Reason|2|||
145511281|NCT01708902|524731552|FG006|Overall Study|Other Reason|0|||
145511282|NCT00499590|524731555|FG000|Overall Study|Study Terminated|112|||
145511283|NCT00499590|524731556|FG001|Overall Study|Study Terminated|112|||
145511284|NCT00499590|524731557|FG002|Overall Study|Study Terminated|112|||
145511285|NCT00499590|524731555|FG000|Overall Study|Not treated|1|||
145511286|NCT00499590|524731556|FG001|Overall Study|Not treated|0|||
145511287|NCT00499590|524731557|FG002|Overall Study|Not treated|1|||
145511288|NCT02633020|524731561|FG000|Overall Study|Adverse Event|1|||
145511289|NCT02633020|524731562|FG001|Overall Study|Adverse Event|0|||
145511290|NCT00934440|524731563|FG000|Overall Study|Lost to Follow-up|1|||
145511291|NCT02152956|524731564|FG000|Overall Study|Adverse Event|0|||
145511292|NCT02152956|524731565|FG001|Overall Study|Adverse Event|0|||
145511293|NCT02152956|524731566|FG002|Overall Study|Adverse Event|0|||
145511294|NCT02152956|524731567|FG003|Overall Study|Adverse Event|0|||
145511295|NCT02152956|524731568|FG004|Overall Study|Adverse Event|0|||
145511296|NCT02152956|524731569|FG005|Overall Study|Adverse Event|0|||
145511297|NCT02152956|524731570|FG006|Overall Study|Adverse Event|0|||
145511298|NCT02152956|524731571|FG007|Overall Study|Adverse Event|0|||
145511299|NCT02152956|524731572|FG008|Overall Study|Adverse Event|0|||
145511300|NCT02152956|524731573|FG009|Overall Study|Adverse Event|0|||
145511301|NCT02152956|524731574|FG010|Overall Study|Adverse Event|0|||
145511302|NCT02152956|524731575|FG011|Overall Study|Adverse Event|4|||
145511303|NCT02152956|524731576|FG012|Overall Study|Adverse Event|0|||
145511304|NCT02152956|524731564|FG000|Overall Study|Death|0|||
145511305|NCT02152956|524731565|FG001|Overall Study|Death|3|||
145511306|NCT02152956|524731566|FG002|Overall Study|Death|3|||
145511307|NCT02152956|524731567|FG003|Overall Study|Death|4|||
145511308|NCT02152956|524731568|FG004|Overall Study|Death|1|||
145511309|NCT02152956|524731569|FG005|Overall Study|Death|2|||
145511310|NCT02152956|524731570|FG006|Overall Study|Death|6|||
145511311|NCT02152956|524731571|FG007|Overall Study|Death|6|||
145511312|NCT02152956|524731572|FG008|Overall Study|Death|4|||
145511313|NCT02152956|524731573|FG009|Overall Study|Death|5|||
145511314|NCT02152956|524731574|FG010|Overall Study|Death|3|||
145511315|NCT02152956|524731575|FG011|Overall Study|Death|143|||
145511316|NCT02152956|524731576|FG012|Overall Study|Death|12|||
145511317|NCT02152956|524731564|FG000|Overall Study|Lost to Follow-up|0|||
145511318|NCT02152956|524731565|FG001|Overall Study|Lost to Follow-up|1|||
145511319|NCT02152956|524731566|FG002|Overall Study|Lost to Follow-up|0|||
145511320|NCT02152956|524731567|FG003|Overall Study|Lost to Follow-up|0|||
145511321|NCT02152956|524731568|FG004|Overall Study|Lost to Follow-up|0|||
145511322|NCT02152956|524731569|FG005|Overall Study|Lost to Follow-up|0|||
145511323|NCT02152956|524731570|FG006|Overall Study|Lost to Follow-up|0|||
145511324|NCT02152956|524731571|FG007|Overall Study|Lost to Follow-up|0|||
145511325|NCT02152956|524731572|FG008|Overall Study|Lost to Follow-up|0|||
145511326|NCT02152956|524731573|FG009|Overall Study|Lost to Follow-up|0|||
145511327|NCT02152956|524731574|FG010|Overall Study|Lost to Follow-up|0|||
145511328|NCT02152956|524731575|FG011|Overall Study|Lost to Follow-up|3|||
145511329|NCT02152956|524731576|FG012|Overall Study|Lost to Follow-up|0|||
145511330|NCT02152956|524731564|FG000|Overall Study|Withdrawal by Subject|1|||
145511331|NCT02152956|524731565|FG001|Overall Study|Withdrawal by Subject|0|||
145511332|NCT02152956|524731566|FG002|Overall Study|Withdrawal by Subject|1|||
145511333|NCT02152956|524731567|FG003|Overall Study|Withdrawal by Subject|0|||
145511334|NCT02152956|524731568|FG004|Overall Study|Withdrawal by Subject|2|||
145511335|NCT02152956|524731569|FG005|Overall Study|Withdrawal by Subject|2|||
145511336|NCT02152956|524731570|FG006|Overall Study|Withdrawal by Subject|0|||
145511337|NCT02152956|524731571|FG007|Overall Study|Withdrawal by Subject|0|||
145511338|NCT02152956|524731572|FG008|Overall Study|Withdrawal by Subject|1|||
145511339|NCT02152956|524731573|FG009|Overall Study|Withdrawal by Subject|0|||
145511340|NCT02152956|524731574|FG010|Overall Study|Withdrawal by Subject|0|||
145511341|NCT02152956|524731575|FG011|Overall Study|Withdrawal by Subject|4|||
145511342|NCT02152956|524731576|FG012|Overall Study|Withdrawal by Subject|0|||
145511343|NCT02152956|524731564|FG000|Overall Study|Physician Decision|0|||
145511344|NCT02152956|524731565|FG001|Overall Study|Physician Decision|0|||
145511345|NCT02152956|524731566|FG002|Overall Study|Physician Decision|0|||
145511346|NCT02152956|524731567|FG003|Overall Study|Physician Decision|0|||
145511347|NCT02152956|524731568|FG004|Overall Study|Physician Decision|0|||
145511348|NCT02152956|524731569|FG005|Overall Study|Physician Decision|0|||
145511349|NCT02152956|524731570|FG006|Overall Study|Physician Decision|0|||
145511350|NCT02152956|524731571|FG007|Overall Study|Physician Decision|0|||
145511351|NCT02152956|524731572|FG008|Overall Study|Physician Decision|0|||
145511352|NCT02152956|524731573|FG009|Overall Study|Physician Decision|0|||
145511353|NCT02152956|524731574|FG010|Overall Study|Physician Decision|0|||
145511354|NCT02152956|524731575|FG011|Overall Study|Physician Decision|1|||
145511355|NCT02152956|524731576|FG012|Overall Study|Physician Decision|0|||
145511356|NCT02152956|524731564|FG000|Overall Study|Study terminated by sponsor|0|||
145511357|NCT02152956|524731565|FG001|Overall Study|Study terminated by sponsor|0|||
145511358|NCT02152956|524731566|FG002|Overall Study|Study terminated by sponsor|0|||
145511359|NCT02152956|524731567|FG003|Overall Study|Study terminated by sponsor|0|||
145511360|NCT02152956|524731568|FG004|Overall Study|Study terminated by sponsor|0|||
145511361|NCT02152956|524731569|FG005|Overall Study|Study terminated by sponsor|0|||
145511362|NCT02152956|524731570|FG006|Overall Study|Study terminated by sponsor|0|||
145511363|NCT02152956|524731571|FG007|Overall Study|Study terminated by sponsor|0|||
145511364|NCT02152956|524731572|FG008|Overall Study|Study terminated by sponsor|0|||
145511365|NCT02152956|524731573|FG009|Overall Study|Study terminated by sponsor|0|||
145511366|NCT02152956|524731574|FG010|Overall Study|Study terminated by sponsor|0|||
145511367|NCT02152956|524731575|FG011|Overall Study|Study terminated by sponsor|29|||
145511368|NCT02152956|524731576|FG012|Overall Study|Study terminated by sponsor|0|||
145511369|NCT02152956|524731564|FG000|Overall Study|progressive disease|0|||
145511370|NCT02152956|524731565|FG001|Overall Study|progressive disease|0|||
145511371|NCT02152956|524731566|FG002|Overall Study|progressive disease|0|||
145511372|NCT02152956|524731567|FG003|Overall Study|progressive disease|0|||
145511373|NCT02152956|524731568|FG004|Overall Study|progressive disease|0|||
145511374|NCT02152956|524731569|FG005|Overall Study|progressive disease|0|||
145511375|NCT02152956|524731570|FG006|Overall Study|progressive disease|0|||
145511376|NCT02152956|524731571|FG007|Overall Study|progressive disease|0|||
145511377|NCT02152956|524731572|FG008|Overall Study|progressive disease|1|||
145511378|NCT02152956|524731573|FG009|Overall Study|progressive disease|0|||
145511379|NCT02152956|524731574|FG010|Overall Study|progressive disease|0|||
145511380|NCT02152956|524731575|FG011|Overall Study|progressive disease|1|||
145511381|NCT02152956|524731576|FG012|Overall Study|progressive disease|0|||
145511382|NCT00530816|524731577|FG000|Overall Study|Progressive Disease|16|||
145511383|NCT00530816|524731578|FG001|Overall Study|Progressive Disease|24|||
145511384|NCT00530816|524731579|FG002|Overall Study|Progressive Disease|24|||
145511385|NCT00530816|524731577|FG000|Overall Study|Adverse Event|6|||
145511386|NCT00530816|524731578|FG001|Overall Study|Adverse Event|13|||
145511387|NCT00530816|524731579|FG002|Overall Study|Adverse Event|7|||
145511388|NCT00530816|524731577|FG000|Overall Study|Other|3|||
145511389|NCT00530816|524731578|FG001|Overall Study|Other|3|||
145511390|NCT00530816|524731579|FG002|Overall Study|Other|4|||
145511391|NCT00530816|524731577|FG000|Overall Study|Withdrawal by Subject|1|||
145511392|NCT00530816|524731578|FG001|Overall Study|Withdrawal by Subject|2|||
145511393|NCT00530816|524731579|FG002|Overall Study|Withdrawal by Subject|6|||
145511394|NCT05661851|524731580|FG000|Overall Study|Protocol Violation|1|||
145511395|NCT05661851|524731581|FG001|Overall Study|Protocol Violation|1|||
145511396|NCT05661851|524731580|FG000|Overall Study|Covid-19 Related|3|||
145511397|NCT05661851|524731581|FG001|Overall Study|Covid-19 Related|4|||
145511398|NCT05661851|524731580|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
145511399|NCT05661851|524731581|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
145511400|NCT05661851|524731580|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
145511401|NCT05661851|524731581|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
145511402|NCT01014910|524731582|FG000|Overall Study|Withdrawal by Subject|0|||
145511403|NCT01014910|524731583|FG001|Overall Study|Withdrawal by Subject|2|||
145511404|NCT01388985|524731584|FG000|Overall Study|Death|0|||
145511405|NCT01388985|524731585|FG001|Overall Study|Death|1|||
145511406|NCT01388985|524731584|FG000|Overall Study|Lost to Follow-up|30|||
145511407|NCT01388985|524731585|FG001|Overall Study|Lost to Follow-up|30|||
145511408|NCT01388985|524731584|FG000|Overall Study|Withdrawal by Subject|13|||
145511409|NCT01388985|524731585|FG001|Overall Study|Withdrawal by Subject|4|||
145511410|NCT01388985|524731584|FG000|Overall Study|Subject unavailable|1|||
145511411|NCT01388985|524731585|FG001|Overall Study|Subject unavailable|1|||
145511412|NCT01388985|524731584|FG000|Overall Study|Other (no reason)|0|||
145511413|NCT01388985|524731585|FG001|Overall Study|Other (no reason)|1|||
145511414|NCT01388985|524731584|FG000|Overall Study|Error of nurse|5|||
145511415|NCT01388985|524731585|FG001|Overall Study|Error of nurse|1|||
145511416|NCT01057589|524731586|FG000|Overall Study|Disease Progression|35|||
145511417|NCT01057589|524731586|FG000|Overall Study|Adverse Event|10|||
145511418|NCT01057589|524731586|FG000|Overall Study|Physician Decision|8|||
145511419|NCT01057589|524731586|FG000|Overall Study|Withdrawal by Subject|3|||
145511420|NCT01057589|524731586|FG000|Overall Study|Sponsor Decision|1|||
145511421|NCT01057589|524731586|FG000|Overall Study|Death|8|||
145511422|NCT01057589|524731586|FG000|Overall Study|Lost to Follow-up|1|||
145511423|NCT02954172|524731589|FG000|Overall Study|Protocol Violation|3|||
145511424|NCT02954172|524731590|FG001|Overall Study|Protocol Violation|0|||
145511425|NCT02954172|524731589|FG000|Overall Study|allergic reaction|2|||
145511426|NCT02954172|524731590|FG001|Overall Study|allergic reaction|1|||
145511427|NCT02954172|524731589|FG000|Overall Study|non-measurable lesions at baseline|1|||
145511428|NCT02954172|524731590|FG001|Overall Study|non-measurable lesions at baseline|2|||
145511429|NCT00870584|524731591|FG000|Overall Study|Adverse Event|3|||
145511430|NCT00870584|524731592|FG001|Overall Study|Adverse Event|3|||
145511431|NCT00870584|524731591|FG000|Overall Study|Withdrawal by Subject|6|||
145511432|NCT00870584|524731592|FG001|Overall Study|Withdrawal by Subject|7|||
145511433|NCT00870584|524731591|FG000|Overall Study|Lost to Follow-up|5|||
145511434|NCT00870584|524731592|FG001|Overall Study|Lost to Follow-up|1|||
145511435|NCT00870584|524731591|FG000|Overall Study|Protocol Deviation|2|||
145511436|NCT00870584|524731592|FG001|Overall Study|Protocol Deviation|2|||
145511437|NCT01497366|524731593|FG000|Overall Study|Virologic failure|2|||
145511438|NCT01497366|524731594|FG001|Overall Study|Virologic failure|50|||
145511439|NCT01497366|524731593|FG000|Overall Study|Lost to Follow-up|11|||
145511440|NCT01497366|524731594|FG001|Overall Study|Lost to Follow-up|10|||
145511441|NCT01497366|524731593|FG000|Overall Study|Withdrawal by Subject|6|||
145511442|NCT01497366|524731594|FG001|Overall Study|Withdrawal by Subject|6|||
145511443|NCT01497366|524731593|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
145511444|NCT01497366|524731594|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
145511445|NCT01497366|524731593|FG000|Overall Study|Other|5|||
145511446|NCT01497366|524731594|FG001|Overall Study|Other|0|||
145511447|NCT01497366|524731593|FG000|Overall Study|Death|1|||
145511448|NCT01497366|524731594|FG001|Overall Study|Death|1|||
145511449|NCT01497366|524731593|FG000|Overall Study|Randomized but not treated|7|||
145511450|NCT01497366|524731594|FG001|Overall Study|Randomized but not treated|21|||
145511451|NCT00472030|524731606|FG000|Overall Study|Physician Decision|1|||
145511452|NCT00472030|524731607|FG001|Overall Study|Physician Decision|0|||
145511453|NCT00829504|524731608|FG000|First Intervention|Adverse Event|1|||
145511454|NCT00829504|524731609|FG001|First Intervention|Adverse Event|0|||
145511455|NCT00829504|524731608|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145511456|NCT00829504|524731609|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145511457|NCT00829504|524731608|FG000|Second Intervention|Physician Decision|1|||
145511458|NCT00829504|524731609|FG001|Second Intervention|Physician Decision|0|||
145511459|NCT02338882|524733379|FG000|Overall Study|Death|1|||
145511460|NCT02338882|524733380|FG001|Overall Study|Death|0|||
145511461|NCT02338882|524733379|FG000|Overall Study|Lost to Follow-up|6|||
145511462|NCT02338882|524733380|FG001|Overall Study|Lost to Follow-up|3|||
145511463|NCT01904773|524733381|FG000|Screen|Screen failure|3|||
145511464|NCT01904773|524733382|FG001|Screen|Screen failure|0|||
145511465|NCT01904773|524733383|FG002|Screen|Screen failure|0|||
145511466|NCT01904773|524733384|FG003|Screen|Screen failure|0|||
145511467|NCT01904773|524733385|FG004|Screen|Screen failure|0|||
145511468|NCT01904773|524733386|FG005|Screen|Screen failure|0|||
145511469|NCT01904773|524733387|FG006|Screen|Screen failure|0|||
145511470|NCT01904773|524733388|FG007|Screen|Screen failure|0|||
145511471|NCT01904773|524733389|FG008|Screen|Screen failure|0|||
145511472|NCT01904773|524733381|FG000|Screen|Withdrawal by Subject|1|||
145511473|NCT01904773|524733382|FG001|Screen|Withdrawal by Subject|0|||
145511474|NCT01904773|524733383|FG002|Screen|Withdrawal by Subject|0|||
145511475|NCT01904773|524733384|FG003|Screen|Withdrawal by Subject|0|||
145511476|NCT01904773|524733385|FG004|Screen|Withdrawal by Subject|0|||
145511477|NCT01904773|524733386|FG005|Screen|Withdrawal by Subject|0|||
145511478|NCT01904773|524733387|FG006|Screen|Withdrawal by Subject|0|||
145511479|NCT01904773|524733388|FG007|Screen|Withdrawal by Subject|0|||
145511480|NCT01904773|524733389|FG008|Screen|Withdrawal by Subject|0|||
145511481|NCT01904773|524733381|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
145511482|NCT01904773|524733382|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511483|NCT01904773|524733383|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511484|NCT01904773|524733384|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511485|NCT01904773|524733385|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511486|NCT01904773|524733386|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511487|NCT01904773|524733387|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511488|NCT01904773|524733388|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511489|NCT01904773|524733389|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
145511490|NCT01904773|524733381|FG000|First Intervention|Adverse Event|0|||
145511491|NCT01904773|524733382|FG001|First Intervention|Adverse Event|0|||
145511492|NCT01904773|524733383|FG002|First Intervention|Adverse Event|0|||
145511493|NCT01904773|524733384|FG003|First Intervention|Adverse Event|0|||
145511494|NCT01904773|524733385|FG004|First Intervention|Adverse Event|0|||
145511495|NCT01904773|524733386|FG005|First Intervention|Adverse Event|0|||
145511496|NCT01904773|524733387|FG006|First Intervention|Adverse Event|1|||
145511497|NCT01904773|524733388|FG007|First Intervention|Adverse Event|0|||
145511498|NCT01904773|524733389|FG008|First Intervention|Adverse Event|0|||
145511499|NCT01904773|524733381|FG000|Placebo Washout First Intervention|Condition worsened|0|||
145511500|NCT01904773|524733382|FG001|Placebo Washout First Intervention|Condition worsened|1|||
145511501|NCT01904773|524733383|FG002|Placebo Washout First Intervention|Condition worsened|0|||
145511502|NCT01904773|524733384|FG003|Placebo Washout First Intervention|Condition worsened|0|||
145511503|NCT01904773|524733385|FG004|Placebo Washout First Intervention|Condition worsened|0|||
145511504|NCT01904773|524733386|FG005|Placebo Washout First Intervention|Condition worsened|0|||
145511505|NCT01904773|524733387|FG006|Placebo Washout First Intervention|Condition worsened|0|||
145511506|NCT01904773|524733388|FG007|Placebo Washout First Intervention|Condition worsened|0|||
145511507|NCT01904773|524733389|FG008|Placebo Washout First Intervention|Condition worsened|0|||
145511508|NCT01904773|524733381|FG000|Fifth Intervention|Adverse Event|0|||
145511509|NCT01904773|524733382|FG001|Fifth Intervention|Adverse Event|0|||
145511510|NCT01904773|524733383|FG002|Fifth Intervention|Adverse Event|0|||
145511511|NCT01904773|524733384|FG003|Fifth Intervention|Adverse Event|0|||
145511512|NCT01904773|524733385|FG004|Fifth Intervention|Adverse Event|0|||
145511513|NCT01904773|524733386|FG005|Fifth Intervention|Adverse Event|0|||
145511514|NCT01904773|524733387|FG006|Fifth Intervention|Adverse Event|0|||
145511515|NCT01904773|524733388|FG007|Fifth Intervention|Adverse Event|1|||
145511516|NCT01904773|524733389|FG008|Fifth Intervention|Adverse Event|0|||
145511517|NCT01904773|524733381|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511518|NCT01904773|524733382|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
145511519|NCT01904773|524733383|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511520|NCT01904773|524733384|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511521|NCT01904773|524733385|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511522|NCT01904773|524733386|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511523|NCT01904773|524733387|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511524|NCT01904773|524733388|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511525|NCT01904773|524733389|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
145511526|NCT04518995|524733390|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
145511527|NCT04518995|524733391|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
145511528|NCT04518995|524733392|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
145511529|NCT04518995|524733390|FG000|Overall Study|Lack of Efficacy|2|||
145511530|NCT04518995|524733391|FG001|Overall Study|Lack of Efficacy|1|||
145511531|NCT04518995|524733392|FG002|Overall Study|Lack of Efficacy|0|||
145511532|NCT04518995|524733390|FG000|Overall Study|Non-compliance With Study Drug|0|||
145511533|NCT04518995|524733391|FG001|Overall Study|Non-compliance With Study Drug|3|||
145511534|NCT04518995|524733392|FG002|Overall Study|Non-compliance With Study Drug|2|||
145511535|NCT04518995|524733390|FG000|Overall Study|Pregnancy|0|||
145511536|NCT04518995|524733391|FG001|Overall Study|Pregnancy|0|||
145511537|NCT04518995|524733392|FG002|Overall Study|Pregnancy|1|||
145511538|NCT04518995|524733390|FG000|Overall Study|Protocol Violation|2|||
145511539|NCT04518995|524733391|FG001|Overall Study|Protocol Violation|0|||
145511540|NCT04518995|524733392|FG002|Overall Study|Protocol Violation|1|||
145511541|NCT04518995|524733390|FG000|Overall Study|Reason not Specified|4|||
145511542|NCT04518995|524733391|FG001|Overall Study|Reason not Specified|11|||
145511543|NCT04518995|524733392|FG002|Overall Study|Reason not Specified|2|||
145511544|NCT04518995|524733390|FG000|Overall Study|Lost to Follow-up|1|||
145511545|NCT04518995|524733391|FG001|Overall Study|Lost to Follow-up|10|||
145511546|NCT04518995|524733392|FG002|Overall Study|Lost to Follow-up|6|||
145511547|NCT00669409|524733395|FG000|Part 2|Withdrawal by Subject|0|||
145511548|NCT00669409|524733396|FG001|Part 2|Withdrawal by Subject|0|||
145511549|NCT00669409|524733397|FG002|Part 2|Withdrawal by Subject|0|||
145511550|NCT00669409|524733398|FG003|Part 2|Withdrawal by Subject|0|||
145511551|NCT00669409|524733399|FG004|Part 2|Withdrawal by Subject|0|||
145511552|NCT00669409|524733400|FG005|Part 2|Withdrawal by Subject|0|||
145511553|NCT00669409|524733401|FG006|Part 2|Withdrawal by Subject|0|||
145511554|NCT00669409|524733402|FG007|Part 2|Withdrawal by Subject|0|||
145511555|NCT00669409|524733403|FG008|Part 2|Withdrawal by Subject|0|||
145511556|NCT00669409|524733404|FG009|Part 2|Withdrawal by Subject|1|||
145511557|NCT00669409|524733405|FG010|Part 2|Withdrawal by Subject|0|||
145511558|NCT00813943|524733406|FG000|Overall Study|Ongoing at cut-off date|5|||
145511559|NCT00813943|524733407|FG001|Overall Study|Ongoing at cut-off date|5|||
145511560|NCT00813943|524733408|FG002|Overall Study|Ongoing at cut-off date|3|||
145511561|NCT05367492|524733409|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
145511562|NCT05367492|524733410|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
145511563|NCT05367492|524733411|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
145511564|NCT05367492|524733409|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
145511565|NCT05367492|524733410|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
145511566|NCT05367492|524733411|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
145511567|NCT05367492|524733409|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
145511568|NCT05367492|524733410|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
145511569|NCT05367492|524733411|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
145511570|NCT05367492|524733409|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
145511571|NCT05367492|524733410|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
145511572|NCT05367492|524733411|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
145511573|NCT01523275|524733414|FG000|Overall Study|Lost to Follow-up|1|||
145511574|NCT01523275|524733415|FG001|Overall Study|Lost to Follow-up|2|||
145511575|NCT01523275|524733414|FG000|Overall Study|Withdrawal by Subject|1|||
145511576|NCT01523275|524733415|FG001|Overall Study|Withdrawal by Subject|0|||
145511577|NCT02471612|524733425|FG000|Overall Study|Lost to Follow-up|2|||
145511578|NCT05573386|524733426|FG000|Overall Study|Withdrawal by Subject|3|||
145511579|NCT05573386|524733427|FG001|Overall Study|Withdrawal by Subject|2|||
145511580|NCT03646123|524733428|FG000|Overall Study|Withdrawal by Subject|2|||
145511581|NCT03646123|524733429|FG001|Overall Study|Withdrawal by Subject|2|||
145511582|NCT03646123|524733430|FG002|Overall Study|Withdrawal by Subject|3|||
145511583|NCT03646123|524733428|FG000|Overall Study|Study termination by sponsor|0|||
145511584|NCT03646123|524733429|FG001|Overall Study|Study termination by sponsor|45|||
145511585|NCT03646123|524733430|FG002|Overall Study|Study termination by sponsor|139|||
145511586|NCT03646123|524733428|FG000|Overall Study|Lost to Follow-up|4|||
145511587|NCT03646123|524733429|FG001|Overall Study|Lost to Follow-up|10|||
145511588|NCT03646123|524733430|FG002|Overall Study|Lost to Follow-up|10|||
145511589|NCT03646123|524733428|FG000|Overall Study|Death|2|||
145511590|NCT03646123|524733429|FG001|Overall Study|Death|1|||
145511591|NCT03646123|524733430|FG002|Overall Study|Death|1|||
145511592|NCT03646123|524733428|FG000|Overall Study|Other|2|||
145511593|NCT03646123|524733429|FG001|Overall Study|Other|0|||
145511594|NCT03646123|524733430|FG002|Overall Study|Other|2|||
145511595|NCT05343624|524733431|FG000|Overall Study|Chart review not completed|1|||
145511596|NCT00329797|524733432|FG000|Overall Study|Protocol Violation|1|||
145511597|NCT00329797|524733433|FG001|Overall Study|Protocol Violation|0|||
145511598|NCT00329797|524733432|FG000|Overall Study|Withdrawal by Subject|6|||
145511599|NCT00329797|524733433|FG001|Overall Study|Withdrawal by Subject|6|||
145511600|NCT01761240|524733442|FG000|Overall Study|Progressive disease:radiology assessment|3|||
145511601|NCT01761240|524733443|FG001|Overall Study|Progressive disease:radiology assessment|3|||
145511602|NCT01761240|524733444|FG002|Overall Study|Progressive disease:radiology assessment|0|||
145511603|NCT01761240|524733445|FG003|Overall Study|Progressive disease:radiology assessment|0|||
145511604|NCT01761240|524733446|FG004|Overall Study|Progressive disease:radiology assessment|0|||
145511605|NCT01761240|524733442|FG000|Overall Study|Progressive disease:clinical assessment|0|||
145511606|NCT01761240|524733443|FG001|Overall Study|Progressive disease:clinical assessment|0|||
145511607|NCT01761240|524733444|FG002|Overall Study|Progressive disease:clinical assessment|3|||
145511608|NCT01761240|524733445|FG003|Overall Study|Progressive disease:clinical assessment|1|||
145511609|NCT01761240|524733446|FG004|Overall Study|Progressive disease:clinical assessment|0|||
145511610|NCT01761240|524733442|FG000|Overall Study|Withdrawal by Subject|0|||
145511611|NCT01761240|524733443|FG001|Overall Study|Withdrawal by Subject|0|||
145511612|NCT01761240|524733444|FG002|Overall Study|Withdrawal by Subject|0|||
145511613|NCT01761240|524733445|FG003|Overall Study|Withdrawal by Subject|3|||
145511614|NCT01761240|524733446|FG004|Overall Study|Withdrawal by Subject|1|||
145511615|NCT01761240|524733442|FG000|Overall Study|Adverse Event|0|||
145511616|NCT01761240|524733443|FG001|Overall Study|Adverse Event|0|||
145511617|NCT01761240|524733444|FG002|Overall Study|Adverse Event|0|||
145511618|NCT01761240|524733445|FG003|Overall Study|Adverse Event|1|||
145511619|NCT01761240|524733446|FG004|Overall Study|Adverse Event|6|||
145511620|NCT01761240|524733442|FG000|Overall Study|Death|0|||
145511621|NCT01761240|524733443|FG001|Overall Study|Death|1|||
145511622|NCT01761240|524733444|FG002|Overall Study|Death|1|||
145511623|NCT01761240|524733445|FG003|Overall Study|Death|2|||
145511624|NCT01761240|524733446|FG004|Overall Study|Death|1|||
145511625|NCT01761240|524733442|FG000|Overall Study|Non-compliance|0|||
145511626|NCT01761240|524733443|FG001|Overall Study|Non-compliance|0|||
145511627|NCT01761240|524733444|FG002|Overall Study|Non-compliance|1|||
145511628|NCT01761240|524733445|FG003|Overall Study|Non-compliance|0|||
145511629|NCT01761240|524733446|FG004|Overall Study|Non-compliance|0|||
145511630|NCT02055118|524733452|FG000|Overall Study|Withdrawal by Subject|0|||
145511631|NCT02055118|524733453|FG001|Overall Study|Withdrawal by Subject|2|||
145511632|NCT02055118|524733454|FG002|Overall Study|Withdrawal by Subject|0|||
145511633|NCT02281383|524733456|FG000|Overall Study|Progressive Disease|1|||
145511634|NCT02281383|524733456|FG000|Overall Study|Withdrawal by Subject|6|||
145511635|NCT02281383|524733456|FG000|Overall Study|Protocol Violation|2|||
145511636|NCT02281383|524733456|FG000|Overall Study|Death|1|||
145401969|NCT04798027|524328822|FG005|Overall Study|Withdrawal by Subject|1|||
145401970|NCT04798027|524328823|FG006|Overall Study|Withdrawal by Subject|3|||
145401971|NCT04798027|524328824|FG007|Overall Study|Withdrawal by Subject|2|||
145401972|NCT04798027|524328825|FG008|Overall Study|Withdrawal by Subject|2|||
145401973|NCT04798027|524328817|FG000|Overall Study|Lost to Follow-up|1|||
145401974|NCT04798027|524328818|FG001|Overall Study|Lost to Follow-up|3|||
145401975|NCT04798027|524328819|FG002|Overall Study|Lost to Follow-up|0|||
145401976|NCT04798027|524328820|FG003|Overall Study|Lost to Follow-up|0|||
145401977|NCT04798027|524328821|FG004|Overall Study|Lost to Follow-up|0|||
145401978|NCT04798027|524328822|FG005|Overall Study|Lost to Follow-up|1|||
145401979|NCT04798027|524328823|FG006|Overall Study|Lost to Follow-up|0|||
145401980|NCT04798027|524328824|FG007|Overall Study|Lost to Follow-up|0|||
145401981|NCT04798027|524328825|FG008|Overall Study|Lost to Follow-up|1|||
145401982|NCT04798027|524328817|FG000|Overall Study|Withdrawal by Sponsor|8|||
145401983|NCT04798027|524328818|FG001|Overall Study|Withdrawal by Sponsor|22|||
145401984|NCT04798027|524328819|FG002|Overall Study|Withdrawal by Sponsor|9|||
145401985|NCT04798027|524328820|FG003|Overall Study|Withdrawal by Sponsor|26|||
145401986|NCT04798027|524328821|FG004|Overall Study|Withdrawal by Sponsor|24|||
145401987|NCT04798027|524328822|FG005|Overall Study|Withdrawal by Sponsor|11|||
145401988|NCT04798027|524328823|FG006|Overall Study|Withdrawal by Sponsor|25|||
145401989|NCT04798027|524328824|FG007|Overall Study|Withdrawal by Sponsor|26|||
145401990|NCT04798027|524328825|FG008|Overall Study|Withdrawal by Sponsor|11|||
145401991|NCT00885118|524328826|FG000|Overall Study|Adverse Event|1|||
145401992|NCT00885118|524328827|FG001|Overall Study|Adverse Event|0|||
145401993|NCT00885118|524328828|FG002|Overall Study|Adverse Event|0|||
145401994|NCT00885118|524328829|FG003|Overall Study|Adverse Event|0|||
145401995|NCT00885118|524328830|FG004|Overall Study|Adverse Event|0|||
145511637|NCT02281383|524733456|FG000|Overall Study|Adverse Event|2|||
145401996|NCT00885118|524328826|FG000|Overall Study|Withdrawal by Subject|0|||
145401997|NCT00885118|524328827|FG001|Overall Study|Withdrawal by Subject|0|||
145401998|NCT00885118|524328828|FG002|Overall Study|Withdrawal by Subject|0|||
145401999|NCT00885118|524328829|FG003|Overall Study|Withdrawal by Subject|0|||
145402000|NCT00885118|524328830|FG004|Overall Study|Withdrawal by Subject|1|||
145402001|NCT00885118|524328826|FG000|Overall Study|Other reason not defined above|0|||
145402002|NCT00885118|524328827|FG001|Overall Study|Other reason not defined above|0|||
145402003|NCT00885118|524328828|FG002|Overall Study|Other reason not defined above|1|||
145402004|NCT00885118|524328829|FG003|Overall Study|Other reason not defined above|0|||
145402005|NCT00885118|524328830|FG004|Overall Study|Other reason not defined above|0|||
145402006|NCT03642990|524328831|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
145402007|NCT03642990|524328831|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
145402008|NCT00094445|524328832|FG000|Overall Study|Withdrawal by Subject|3|||
145402009|NCT00094445|524328832|FG000|Overall Study|Lost to Follow-up|1|||
145402010|NCT00094445|524328832|FG000|Overall Study|Progressive Disease|2|||
145402011|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
145402012|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
145402013|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
145402014|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
145402015|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
145402016|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
145402017|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
145402018|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145402019|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145402020|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145402021|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
145402022|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
145402023|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145402024|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145402025|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
145402026|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
145402027|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
145402028|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145402029|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145402030|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145402031|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
145402032|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
145402033|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145402034|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145402035|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145402036|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
145402037|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
145402038|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145402039|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145402040|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
145402041|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
145402042|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
145402043|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145402044|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145402045|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
145402046|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
145402047|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
145402048|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145402049|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145402050|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
145402051|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
145402052|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145402053|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145402054|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145402055|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
145402056|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
145402057|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
145511638|NCT01215097|524733458|FG000|Overall Study|Adverse Event|1|||
145511639|NCT01215097|524733459|FG001|Overall Study|Adverse Event|3|||
145511640|NCT01215097|524733458|FG000|Overall Study|Protocol Violation|0|||
145511641|NCT01215097|524733459|FG001|Overall Study|Protocol Violation|2|||
145511642|NCT01215097|524733458|FG000|Overall Study|Lost to Follow-up|2|||
145511643|NCT01215097|524733459|FG001|Overall Study|Lost to Follow-up|0|||
145511644|NCT01215097|524733458|FG000|Overall Study|Withdrawal by Subject|6|||
145511645|NCT01215097|524733459|FG001|Overall Study|Withdrawal by Subject|3|||
145511646|NCT01215097|524733458|FG000|Overall Study|Lack of Efficacy|0|||
145511647|NCT01215097|524733459|FG001|Overall Study|Lack of Efficacy|3|||
145511648|NCT01215097|524733458|FG000|Overall Study|patient's refusal to come|2|||
145511649|NCT01215097|524733459|FG001|Overall Study|patient's refusal to come|2|||
145511650|NCT01215097|524733458|FG000|Overall Study|patient's private reason|1|||
145511651|NCT01215097|524733459|FG001|Overall Study|patient's private reason|1|||
145511652|NCT02252939|524733461|FG000|Overall Study|Lost to Follow-up|3|||
145511653|NCT01516034|524733462|FG000|Overall Study|Physician Decision|1|||
145511654|NCT01516034|524733462|FG000|Overall Study|Lack of Efficacy|7|||
145511655|NCT01033448|524733463|FG000|Overall Study|Withdrawal by Subject|4|||
145511656|NCT01033448|524733463|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
145511657|NCT01033448|524733463|FG000|Overall Study|Lost to Follow-up|3|||
145511658|NCT01033448|524733463|FG000|Overall Study|Withdrew due to other reasons|3|||
145511659|NCT01033448|524733463|FG000|Overall Study|Unknown disposition|1|||
145511660|NCT02560025|524733469|FG000|Overall Study|Ineligible after consent/ registration|3|||
145511661|NCT02703337|524733472|FG000|Period One (Part A)|Withdrawal by Subject|0|||
145511662|NCT02703337|524733473|FG001|Period One (Part A)|Withdrawal by Subject|0|||
145511663|NCT02703337|524733474|FG002|Period One (Part A)|Withdrawal by Subject|0|||
145511664|NCT02703337|524733475|FG003|Period One (Part A)|Withdrawal by Subject|0|||
145511665|NCT02703337|524733476|FG004|Period One (Part A)|Withdrawal by Subject|1|||
145511666|NCT02703337|524733477|FG005|Period One (Part A)|Withdrawal by Subject|0|||
145511667|NCT02703337|524733478|FG006|Period One (Part A)|Withdrawal by Subject|0|||
145511668|NCT02703337|524733479|FG007|Period One (Part A)|Withdrawal by Subject|0|||
145511669|NCT00282308|524733484|FG000|Treatment Period|Lost to Follow-up|1|||
145511670|NCT00282308|524733485|FG001|Treatment Period|Lost to Follow-up|0|||
145511671|NCT00282308|524733486|FG002|Treatment Period|Lost to Follow-up|0|||
145511672|NCT00282308|524733484|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
145511673|NCT00282308|524733485|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
145511674|NCT00282308|524733486|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
145511675|NCT00282308|524733484|FG000|Treatment Period|Adverse Event|0|||
145511676|NCT00282308|524733485|FG001|Treatment Period|Adverse Event|2|||
145511677|NCT00282308|524733486|FG002|Treatment Period|Adverse Event|0|||
145511678|NCT00282308|524733484|FG000|Treatment Period|Not Treated with Study Drug|1|||
145511679|NCT00282308|524733485|FG001|Treatment Period|Not Treated with Study Drug|0|||
145511680|NCT00282308|524733486|FG002|Treatment Period|Not Treated with Study Drug|0|||
145511681|NCT00282308|524733484|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
145511682|NCT00282308|524733485|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
145511683|NCT00282308|524733486|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
145511684|NCT00282308|524733484|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
145511685|NCT00282308|524733485|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
145511686|NCT00282308|524733486|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
145511687|NCT00282308|524733484|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
145511688|NCT00282308|524733485|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
145511689|NCT00282308|524733486|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
145511690|NCT00282308|524733484|FG000|Safety Follow-up Period|Adverse Event|0|||
145511691|NCT00282308|524733485|FG001|Safety Follow-up Period|Adverse Event|0|||
145511692|NCT00282308|524733486|FG002|Safety Follow-up Period|Adverse Event|1|||
145511693|NCT00282308|524733484|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
145511694|NCT00282308|524733485|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
145511695|NCT00282308|524733486|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
145511696|NCT00282308|524733484|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
145511697|NCT00282308|524733485|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
145511698|NCT00282308|524733486|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
145511699|NCT00282308|524733484|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
145511700|NCT00282308|524733485|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
145511701|NCT00282308|524733486|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
145511702|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
145511703|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
145511704|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
145511705|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
145511706|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
145511707|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
145511708|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
145511709|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
145511710|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
145511711|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
145511712|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
145511713|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
145511714|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
145511715|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
145511716|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
145511717|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
145511718|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
145511719|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
145511720|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
145511721|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
145511722|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
145511723|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
145511724|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
145511725|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
145511726|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
145511727|NCT01584440|524733488|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
145511728|NCT01584440|524733489|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
145511729|NCT01584440|524733490|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
145511730|NCT01584440|524733491|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
145511731|NCT01584440|524733492|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
145511732|NCT01584440|524733488|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
145511733|NCT01584440|524733489|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
145511734|NCT01584440|524733490|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
145511735|NCT01584440|524733491|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
145511736|NCT01584440|524733492|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
145511737|NCT01584440|524733488|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
145511738|NCT01584440|524733489|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
145511739|NCT01584440|524733490|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
145511740|NCT01584440|524733491|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
145511741|NCT01584440|524733492|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
145511742|NCT01584440|524733488|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
145511743|NCT01584440|524733489|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
145511744|NCT01584440|524733490|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
145511745|NCT01584440|524733491|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
145511746|NCT01584440|524733492|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
145511747|NCT04237116|524733493|FG000|Overall Study|Adverse Event|0|||
145511748|NCT04237116|524733494|FG001|Overall Study|Adverse Event|1|||
145511749|NCT04237116|524733493|FG000|Overall Study|Study terminated by Sponsor|4|||
145511750|NCT04237116|524733494|FG001|Overall Study|Study terminated by Sponsor|1|||
145511751|NCT03212144|524733495|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
145511752|NCT03212144|524733496|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
145511753|NCT03212144|524733495|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
145511754|NCT03212144|524733496|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
145511755|NCT00899431|524733497|FG000|Overall Study|Physician Decision|1|||
145511756|NCT00899431|524733498|FG001|Overall Study|Physician Decision|0|||
145511757|NCT00899431|524733499|FG002|Overall Study|Physician Decision|0|||
145511758|NCT00661427|524733500|FG000|Overall Study|Adverse Event|5|||
145511759|NCT00661427|524733501|FG001|Overall Study|Adverse Event|5|||
145511760|NCT00661427|524733500|FG000|Overall Study|Patient not treated|0|||
145511761|NCT00661427|524733501|FG001|Overall Study|Patient not treated|2|||
145511762|NCT00599339|524733502|FG000|Overall Study|Adverse Event|79|||
145511763|NCT00599339|524733502|FG000|Overall Study|Withdrawal by Subject|137|||
145511764|NCT00599339|524733502|FG000|Overall Study|Other Reason|179|||
145511765|NCT00599339|524733502|FG000|Overall Study|Lost to Follow-up|221|||
145511766|NCT00599339|524733502|FG000|Overall Study|No valid data consent|36|||
145511767|NCT00599339|524733502|FG000|Overall Study|Study Termination Status Unknown|12|||
145511768|NCT05564052|524733503|FG000|Overall Study|Withdrawal by Subject|0|||
145511769|NCT05564052|524733504|FG001|Overall Study|Withdrawal by Subject|0|||
145511770|NCT05564052|524733505|FG002|Overall Study|Withdrawal by Subject|0|||
145511771|NCT05564052|524733506|FG003|Overall Study|Withdrawal by Subject|1|||
145511772|NCT01821560|524733507|FG000|Overall Study|Lost to Follow-up|5|||
145511773|NCT01821560|524733508|FG001|Overall Study|Lost to Follow-up|5|||
145511774|NCT01821560|524733507|FG000|Overall Study|Withdrawal by Subject|1|||
145511775|NCT01821560|524733508|FG001|Overall Study|Withdrawal by Subject|1|||
145511776|NCT01821560|524733507|FG000|Overall Study|Protocol Violation|0|||
145511777|NCT01821560|524733508|FG001|Overall Study|Protocol Violation|1|||
145511778|NCT00531427|524733509|FG000|Overall Study|Withdrawal by Subject|7|||
145511779|NCT00531427|524733510|FG001|Overall Study|Withdrawal by Subject|13|||
145511780|NCT00531427|524733509|FG000|Overall Study|Adverse Event|44|||
145511781|NCT00531427|524733510|FG001|Overall Study|Adverse Event|30|||
145511782|NCT00531427|524733509|FG000|Overall Study|Lost to Follow-up|4|||
145511783|NCT00531427|524733510|FG001|Overall Study|Lost to Follow-up|3|||
145511784|NCT00531427|524733509|FG000|Overall Study|Lack of Efficacy|14|||
145511785|NCT00531427|524733510|FG001|Overall Study|Lack of Efficacy|39|||
145511786|NCT00531427|524733509|FG000|Overall Study|Administrative|4|||
145511787|NCT00531427|524733510|FG001|Overall Study|Administrative|9|||
145511788|NCT01338298|524733511|FG000|Overall Study|Withdrawal by Subject|1|||
145511789|NCT01338298|524733512|FG001|Overall Study|Withdrawal by Subject|1|||
145511790|NCT01338298|524733511|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
145511791|NCT01338298|524733512|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
145511792|NCT01338298|524733511|FG000|Overall Study|Administrative error|0|||
145511793|NCT01338298|524733512|FG001|Overall Study|Administrative error|1|||
145511794|NCT01338298|524733511|FG000|Overall Study|Positive symptom worsening|1|||
145511795|NCT01338298|524733512|FG001|Overall Study|Positive symptom worsening|0|||
145511796|NCT01338298|524733511|FG000|Overall Study|Depressive symptoms and nausea|1|||
145511797|NCT01338298|524733512|FG001|Overall Study|Depressive symptoms and nausea|0|||
145511798|NCT01338298|524733511|FG000|Overall Study|Non-adherence|1|||
145511799|NCT01338298|524733512|FG001|Overall Study|Non-adherence|0|||
145511800|NCT02872285|524733513|FG000|Overall Study|Withdrawal by Subject|2|||
145511801|NCT02872285|524733514|FG001|Overall Study|Withdrawal by Subject|0|||
145511802|NCT02872285|524733513|FG000|Overall Study|Lost to Follow-up|2|||
145511803|NCT02872285|524733514|FG001|Overall Study|Lost to Follow-up|2|||
145511804|NCT02872285|524733513|FG000|Overall Study|Discontinued due to back surgery|1|||
145511805|NCT02872285|524733514|FG001|Overall Study|Discontinued due to back surgery|0|||
145511806|NCT02660983|524733516|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
145511807|NCT02660983|524733517|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
145511808|NCT02660983|524733516|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
145511809|NCT02660983|524733517|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
145511810|NCT02660983|524733516|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
145511811|NCT02660983|524733517|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
145511812|NCT02660983|524733516|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
145511813|NCT02660983|524733517|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
145511814|NCT02660983|524733516|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
145511815|NCT02660983|524733517|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
145511816|NCT02660983|524733516|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
145511817|NCT02660983|524733517|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
145511818|NCT02660983|524733516|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
145511819|NCT02660983|524733517|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
145511820|NCT01253577|524733521|FG000|Overall Study|Lost to Follow-up|3|||
145511821|NCT00721968|524733522|FG000|Overall Study|Lost to Follow-up|2|||
145511822|NCT00721968|524733523|FG001|Overall Study|Lost to Follow-up|0|||
145511823|NCT05601544|524733524|FG000|Phase 2 Period 1|Adverse Event|0|||
145511824|NCT05601544|524733525|FG001|Phase 2 Period 1|Adverse Event|1|||
145511825|NCT05601544|524733526|FG002|Phase 2 Period 1|Adverse Event|0|||
145511826|NCT05601544|524733527|FG003|Phase 2 Period 1|Adverse Event|0|||
145511827|NCT05601544|524733528|FG004|Phase 2 Period 1|Adverse Event|0|||
145511828|NCT05601544|524733529|FG005|Phase 2 Period 1|Adverse Event|0|||
145511829|NCT01064947|524733530|FG000|Overall Study|negative culture|41|||
145511830|NCT06457204|524733531|FG000|Washout|Adverse Event|0|||
145511831|NCT06457204|524733532|FG001|Washout|Adverse Event|2|||
145511832|NCT01601652|524733534|FG000|Overall Study|Death|1|||
145511833|NCT00488683|524733541|FG000|Overall Study|Withdrawal by Subject|1|||
145511834|NCT00488683|524733542|FG001|Overall Study|Withdrawal by Subject|2|||
145511835|NCT00488683|524733543|FG002|Overall Study|Withdrawal by Subject|2|||
145511836|NCT00488683|524733541|FG000|Overall Study|Lost to Follow-up|5|||
145511837|NCT00488683|524733542|FG001|Overall Study|Lost to Follow-up|3|||
145511838|NCT00488683|524733543|FG002|Overall Study|Lost to Follow-up|0|||
145511839|NCT00488683|524733541|FG000|Overall Study|Protocol Violation|5|||
145511840|NCT00488683|524733542|FG001|Overall Study|Protocol Violation|1|||
145511841|NCT00488683|524733543|FG002|Overall Study|Protocol Violation|0|||
145511842|NCT00488683|524733541|FG000|Overall Study|Unable to Classify|1|||
145511843|NCT00488683|524733542|FG001|Overall Study|Unable to Classify|0|||
145511844|NCT00488683|524733543|FG002|Overall Study|Unable to Classify|0|||
145511845|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
145511846|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
145511847|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
145511848|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
145511849|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
145511850|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
145511851|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
145511852|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
145511853|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
145511854|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
145511855|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
145511856|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
145511857|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
145511858|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
145511859|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
145511860|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
145511861|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
145511862|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
145511863|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
145511864|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
145511865|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
145511866|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
145511867|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
145511868|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
145511869|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
145511870|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
145511871|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
145732998|NCT04147234|525540876|FG003|Overall Study|Withdrawal by Subject|0|||
145732999|NCT04147234|525540877|FG004|Overall Study|Withdrawal by Subject|0|||
145733000|NCT04147234|525540878|FG005|Overall Study|Withdrawal by Subject|0|||
145733001|NCT04147234|525540879|FG006|Overall Study|Withdrawal by Subject|0|||
145733002|NCT04147234|525540873|FG000|Overall Study|Clinical disease progression|1|||
145733003|NCT04147234|525540874|FG001|Overall Study|Clinical disease progression|3|||
145733004|NCT04147234|525540875|FG002|Overall Study|Clinical disease progression|1|||
145733005|NCT04147234|525540876|FG003|Overall Study|Clinical disease progression|1|||
145733006|NCT04147234|525540877|FG004|Overall Study|Clinical disease progression|0|||
145733007|NCT04147234|525540878|FG005|Overall Study|Clinical disease progression|1|||
145733008|NCT04147234|525540879|FG006|Overall Study|Clinical disease progression|0|||
145733009|NCT04147234|525540873|FG000|Overall Study|Objective disease progression|6|||
145733010|NCT04147234|525540874|FG001|Overall Study|Objective disease progression|4|||
145733011|NCT04147234|525540875|FG002|Overall Study|Objective disease progression|3|||
145733012|NCT04147234|525540876|FG003|Overall Study|Objective disease progression|3|||
145733013|NCT04147234|525540877|FG004|Overall Study|Objective disease progression|5|||
145733014|NCT04147234|525540878|FG005|Overall Study|Objective disease progression|2|||
145733015|NCT04147234|525540879|FG006|Overall Study|Objective disease progression|3|||
145733016|NCT04147234|525540873|FG000|Overall Study|Adverse Event|0|||
145733017|NCT04147234|525540874|FG001|Overall Study|Adverse Event|0|||
145733018|NCT04147234|525540875|FG002|Overall Study|Adverse Event|0|||
145733019|NCT04147234|525540876|FG003|Overall Study|Adverse Event|0|||
145733020|NCT04147234|525540877|FG004|Overall Study|Adverse Event|1|||
145733021|NCT04147234|525540878|FG005|Overall Study|Adverse Event|0|||
145733022|NCT04147234|525540879|FG006|Overall Study|Adverse Event|0|||
145733023|NCT05104476|525540882|FG000|Overall Study|Randomized But Not Treated|1|||
145733024|NCT05104476|525540883|FG001|Overall Study|Randomized But Not Treated|2|||
145733025|NCT05104476|525540882|FG000|Overall Study|Adverse Event|2|||
145733026|NCT05104476|525540883|FG001|Overall Study|Adverse Event|2|||
145733027|NCT05104476|525540882|FG000|Overall Study|Withdrawal by Subject|3|||
145733028|NCT05104476|525540883|FG001|Overall Study|Withdrawal by Subject|3|||
145511872|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
145511873|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
145511874|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
145511875|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
145511876|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
145511877|NCT03818035|524733545|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
145511878|NCT03818035|524733546|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
145511879|NCT03818035|524733547|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
145511880|NCT03818035|524733548|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
145511881|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
145511882|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
145511883|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
145511884|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
145511885|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
145511886|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
145511887|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
145511888|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
145511889|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
145511890|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
145511891|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
145511892|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
145511893|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
145511894|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
145511895|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
145511896|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
145511897|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
145511898|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
145511899|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
145511900|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
145511901|NCT03818035|524733545|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
145511902|NCT03818035|524733546|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
145511903|NCT03818035|524733547|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
145511904|NCT03818035|524733548|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
145511905|NCT03374202|524733551|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
145511906|NCT03374202|524733552|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
145511907|NCT03374202|524733553|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
145511908|NCT03374202|524733551|FG000|Five Year Long Term Follow Up|Death|0|||
145511909|NCT03374202|524733552|FG001|Five Year Long Term Follow Up|Death|1|||
145511910|NCT03374202|524733553|FG002|Five Year Long Term Follow Up|Death|0|||
145511911|NCT01794338|524735263|FG000|Overall Study|Death|2|||
145511912|NCT01794338|524735264|FG001|Overall Study|Death|0|||
145511913|NCT01794338|524735263|FG000|Overall Study|Lost to Follow-up|6|||
145511914|NCT01794338|524735264|FG001|Overall Study|Lost to Follow-up|9|||
145511915|NCT01754402|524735265|FG000|Overall Study|Death|0|||
145511916|NCT01754402|524735266|FG001|Overall Study|Death|0|||
145511917|NCT01754402|524735267|FG002|Overall Study|Death|1|||
145511918|NCT01754402|524735265|FG000|Overall Study|Adverse Event|2|||
145511919|NCT01754402|524735266|FG001|Overall Study|Adverse Event|2|||
145511920|NCT01754402|524735267|FG002|Overall Study|Adverse Event|1|||
145511921|NCT01754402|524735265|FG000|Overall Study|Withdrawal by Subject|0|||
145511922|NCT01754402|524735266|FG001|Overall Study|Withdrawal by Subject|0|||
145511923|NCT01754402|524735267|FG002|Overall Study|Withdrawal by Subject|1|||
145511924|NCT01754402|524735265|FG000|Overall Study|Lack of Efficacy|0|||
145511925|NCT01754402|524735266|FG001|Overall Study|Lack of Efficacy|0|||
145511926|NCT01754402|524735267|FG002|Overall Study|Lack of Efficacy|1|||
145511927|NCT01282463|524735268|FG000|Overall Study|Lost to Follow-up|1|||
145511928|NCT01282463|524735269|FG001|Overall Study|Lost to Follow-up|0|||
145511929|NCT01282463|524735270|FG002|Overall Study|Lost to Follow-up|0|||
145511930|NCT01282463|524735268|FG000|Overall Study|Withdrawal by Subject|6|||
145511931|NCT01282463|524735269|FG001|Overall Study|Withdrawal by Subject|2|||
145511932|NCT01282463|524735270|FG002|Overall Study|Withdrawal by Subject|3|||
145511933|NCT01282463|524735268|FG000|Overall Study|"Never Treated Death"|0|||
145511934|NCT01282463|524735269|FG001|Overall Study|"Never Treated Death"|1|||
145511935|NCT01282463|524735270|FG002|Overall Study|"Never Treated Death"|0|||
145511936|NCT01282463|524735268|FG000|Overall Study|"Never Treated PD"|0|||
145511937|NCT01282463|524735269|FG001|Overall Study|"Never Treated PD"|1|||
145511938|NCT01282463|524735270|FG002|Overall Study|"Never Treated PD"|0|||
145511939|NCT01282463|524735268|FG000|Overall Study|Protocol Violation|0|||
145733029|NCT05104476|525540882|FG000|Overall Study|Other Than Specified|0|||
145733030|NCT05104476|525540883|FG001|Overall Study|Other Than Specified|3|||
145511940|NCT01282463|524735269|FG001|Overall Study|Protocol Violation|0|||
145511941|NCT01282463|524735270|FG002|Overall Study|Protocol Violation|1|||
145511942|NCT01282463|524735268|FG000|Overall Study|Physician Decision|1|||
145511943|NCT01282463|524735269|FG001|Overall Study|Physician Decision|0|||
145511944|NCT01282463|524735270|FG002|Overall Study|Physician Decision|0|||
145511945|NCT01954927|524735271|FG000|Overall Study|Withdrawal by Subject|3|||
145511946|NCT01954927|524735272|FG001|Overall Study|Withdrawal by Subject|1|||
145511947|NCT03320824|524735273|FG000|Overall Study|Withdrawal by Subject|8|||
145511948|NCT03320824|524735274|FG001|Overall Study|Withdrawal by Subject|1|||
145511949|NCT03320824|524735273|FG000|Overall Study|Lost to Follow-up|10|||
145511950|NCT03320824|524735274|FG001|Overall Study|Lost to Follow-up|1|||
145511951|NCT03320824|524735273|FG000|Overall Study|moved out of state|0|||
145511952|NCT03320824|524735274|FG001|Overall Study|moved out of state|1|||
145511953|NCT03320824|524735273|FG000|Overall Study|could not complete final visit|0|||
145511954|NCT03320824|524735274|FG001|Overall Study|could not complete final visit|1|||
145511955|NCT00109590|524735275|FG000|Overall Study|Lost to Follow-up|1|||
145511956|NCT00109590|524735276|FG001|Overall Study|Lost to Follow-up|0|||
145511957|NCT00109590|524735277|FG002|Overall Study|Lost to Follow-up|1|||
145511958|NCT00109590|524735275|FG000|Overall Study|Never Started Treatment|1|||
145511959|NCT00109590|524735276|FG001|Overall Study|Never Started Treatment|2|||
145511960|NCT00109590|524735277|FG002|Overall Study|Never Started Treatment|3|||
145511961|NCT02123251|524735278|FG000|Overall Study|Death|1|||
145511962|NCT02123251|524735279|FG001|Overall Study|Death|1|||
145511963|NCT02123251|524735278|FG000|Overall Study|Withdrawal by Subject|0|||
145511964|NCT02123251|524735279|FG001|Overall Study|Withdrawal by Subject|3|||
145511965|NCT02123251|524735278|FG000|Overall Study|Lost Medicaid eligibility|29|||
145511966|NCT02123251|524735279|FG001|Overall Study|Lost Medicaid eligibility|22|||
145511967|NCT02123251|524735278|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
145511968|NCT02123251|524735279|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
145511969|NCT01221285|524735280|FG000|Overall Study|Withdrawal by Subject|1|||
145511970|NCT00727441|524735283|FG000|Overall Study|Disease Progression|11|||
145511971|NCT00727441|524735284|FG001|Overall Study|Disease Progression|14|||
145511972|NCT00727441|524735285|FG002|Overall Study|Disease Progression|17|||
145511973|NCT00727441|524735283|FG000|Overall Study|Eligibility|7|||
145511974|NCT00727441|524735284|FG001|Overall Study|Eligibility|5|||
145511975|NCT00727441|524735285|FG002|Overall Study|Eligibility|7|||
145511976|NCT00727441|524735283|FG000|Overall Study|Death|0|||
145511977|NCT00727441|524735284|FG001|Overall Study|Death|1|||
145511978|NCT00727441|524735285|FG002|Overall Study|Death|1|||
145511979|NCT00727441|524735283|FG000|Overall Study|Physician Decision|0|||
145511980|NCT00727441|524735284|FG001|Overall Study|Physician Decision|1|||
145511981|NCT00727441|524735285|FG002|Overall Study|Physician Decision|0|||
145511982|NCT00727441|524735283|FG000|Overall Study|Withdrawal by Subject|0|||
145511983|NCT00727441|524735284|FG001|Overall Study|Withdrawal by Subject|1|||
145511984|NCT00727441|524735285|FG002|Overall Study|Withdrawal by Subject|0|||
145511985|NCT01239992|524735286|FG000|Overall Study|Withdrawal by Subject|2|||
145511986|NCT00535288|524735287|FG000|Overall Study|Adverse Event|20|||
145511987|NCT00535288|524735288|FG001|Overall Study|Adverse Event|19|||
145511988|NCT00535288|524735289|FG002|Overall Study|Adverse Event|25|||
145511989|NCT00535288|524735290|FG003|Overall Study|Adverse Event|20|||
145511990|NCT00535288|524735291|FG004|Overall Study|Adverse Event|30|||
145511991|NCT00535288|524735287|FG000|Overall Study|Lost to Follow-up|0|||
145511992|NCT00535288|524735288|FG001|Overall Study|Lost to Follow-up|3|||
145511993|NCT00535288|524735289|FG002|Overall Study|Lost to Follow-up|0|||
145511994|NCT00535288|524735290|FG003|Overall Study|Lost to Follow-up|0|||
145511995|NCT00535288|524735291|FG004|Overall Study|Lost to Follow-up|0|||
145511996|NCT00535288|524735287|FG000|Overall Study|Lack of Efficacy|26|||
145511997|NCT00535288|524735288|FG001|Overall Study|Lack of Efficacy|3|||
145511998|NCT00535288|524735289|FG002|Overall Study|Lack of Efficacy|4|||
145511999|NCT00535288|524735290|FG003|Overall Study|Lack of Efficacy|4|||
145512000|NCT00535288|524735291|FG004|Overall Study|Lack of Efficacy|7|||
145512001|NCT00535288|524735287|FG000|Overall Study|Unwilling to cooperate|6|||
145512002|NCT00535288|524735288|FG001|Overall Study|Unwilling to cooperate|6|||
145512003|NCT00535288|524735289|FG002|Overall Study|Unwilling to cooperate|3|||
145512004|NCT00535288|524735290|FG003|Overall Study|Unwilling to cooperate|3|||
145512005|NCT00535288|524735291|FG004|Overall Study|Unwilling to cooperate|4|||
145512006|NCT00535288|524735287|FG000|Overall Study|Other|2|||
145512007|NCT00535288|524735288|FG001|Overall Study|Other|1|||
145512008|NCT00535288|524735289|FG002|Overall Study|Other|1|||
145512009|NCT00535288|524735290|FG003|Overall Study|Other|2|||
145512010|NCT00535288|524735291|FG004|Overall Study|Other|1|||
145512011|NCT00745849|524735292|FG000|First Intervention|Withdrawal by Subject|0|||
145512012|NCT00745849|524735293|FG001|First Intervention|Withdrawal by Subject|1|||
145512013|NCT00745849|524735292|FG000|First Intervention|Lost to Follow-up|1|||
145512014|NCT00745849|524735293|FG001|First Intervention|Lost to Follow-up|1|||
145512015|NCT00745849|524735292|FG000|Second Intervention|Lost to Follow-up|2|||
145512016|NCT00745849|524735293|FG001|Second Intervention|Lost to Follow-up|1|||
145512017|NCT01129583|524735294|FG000|Overall Study|Death|1|||
145512018|NCT01129583|524735295|FG001|Overall Study|Death|0|||
145512019|NCT01129583|524735294|FG000|Overall Study|Lost to Follow-up|1|||
145512020|NCT01129583|524735295|FG001|Overall Study|Lost to Follow-up|1|||
145512021|NCT01129583|524735294|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
145512022|NCT01129583|524735295|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
145512023|NCT02848729|524735303|FG000|Overall Study|Withdrawal by Subject|1|||
145512024|NCT02848729|524735304|FG001|Overall Study|Withdrawal by Subject|0|||
145512025|NCT02848729|524735303|FG000|Overall Study|Emesis|15|||
145512026|NCT02848729|524735304|FG001|Overall Study|Emesis|11|||
145512027|NCT02617485|524735305|FG000|Treatment and Observation Period|Adverse Event|9|||
145512028|NCT02617485|524735306|FG001|Treatment and Observation Period|Adverse Event|1|||
145512029|NCT02617485|524735305|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
145512030|NCT02617485|524735306|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
145512031|NCT02617485|524735305|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
145512032|NCT02617485|524735306|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
145512033|NCT02617485|524735305|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
145512034|NCT02617485|524735306|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
145512035|NCT02617485|524735305|FG000|Treatment and Observation Period|Physician Decision|0|||
145512036|NCT02617485|524735306|FG001|Treatment and Observation Period|Physician Decision|1|||
145512037|NCT02617485|524735305|FG000|Follow-up Period|Adverse Event|1|||
145512038|NCT02617485|524735306|FG001|Follow-up Period|Adverse Event|0|||
145512039|NCT02617485|524735305|FG000|Follow-up Period|Withdrawal by Subject|1|||
145512040|NCT02617485|524735306|FG001|Follow-up Period|Withdrawal by Subject|0|||
145512041|NCT02617485|524735305|FG000|Follow-up Period|Disease progression|2|||
145512042|NCT02617485|524735306|FG001|Follow-up Period|Disease progression|1|||
145512043|NCT02617485|524735305|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
145512044|NCT02617485|524735306|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
145512045|NCT02617485|524735305|FG000|Follow-up Period|Patient needed radiotherapy|9|||
145512046|NCT02617485|524735306|FG001|Follow-up Period|Patient needed radiotherapy|5|||
145512047|NCT02617485|524735305|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
145512048|NCT02617485|524735306|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
145512049|NCT00220779|524735310|FG000|Overall Study|Adverse Event|1|||
145512050|NCT00220779|524735311|FG001|Overall Study|Adverse Event|0|||
145512051|NCT00220779|524735312|FG002|Overall Study|Adverse Event|0|||
145512052|NCT00220779|524735310|FG000|Overall Study|Withdrawal by Subject|1|||
145512053|NCT00220779|524735311|FG001|Overall Study|Withdrawal by Subject|4|||
145512054|NCT00220779|524735312|FG002|Overall Study|Withdrawal by Subject|1|||
145512055|NCT00220779|524735310|FG000|Overall Study|Non-compliance|1|||
145512056|NCT00220779|524735311|FG001|Overall Study|Non-compliance|0|||
145512057|NCT00220779|524735312|FG002|Overall Study|Non-compliance|0|||
145512058|NCT00220779|524735310|FG000|Overall Study|Too time consuming|1|||
145512059|NCT00220779|524735311|FG001|Overall Study|Too time consuming|0|||
145512060|NCT00220779|524735312|FG002|Overall Study|Too time consuming|0|||
145512061|NCT00220779|524735310|FG000|Overall Study|Pregnancy|0|||
145512062|NCT00220779|524735311|FG001|Overall Study|Pregnancy|0|||
145512063|NCT00220779|524735312|FG002|Overall Study|Pregnancy|2|||
145512064|NCT00220779|524735310|FG000|Overall Study|Lack of Efficacy|3|||
145512065|NCT00220779|524735311|FG001|Overall Study|Lack of Efficacy|0|||
145512066|NCT00220779|524735312|FG002|Overall Study|Lack of Efficacy|1|||
145512067|NCT00791076|524735313|FG000|Overall Study|Study was terminated,PI left institution|8|||
145512068|NCT02248675|524735320|FG000|Overall Study|Lost to Follow-up|3|||
145512069|NCT02248675|524735321|FG001|Overall Study|Lost to Follow-up|1|||
145512070|NCT03390101|524735324|FG000|Weeks 0-12|Withdrawal by Subject|0|||
145512071|NCT03390101|524735325|FG001|Weeks 0-12|Withdrawal by Subject|1|||
145512072|NCT03390101|524735326|FG002|Weeks 0-12|Withdrawal by Subject|1|||
145512073|NCT03390101|524735324|FG000|Weeks 0-12|Lost to Follow-up|0|||
145512074|NCT03390101|524735325|FG001|Weeks 0-12|Lost to Follow-up|1|||
145512075|NCT03390101|524735326|FG002|Weeks 0-12|Lost to Follow-up|0|||
145512076|NCT03390101|524735324|FG000|Weeks 12-54|Withdrawal by Subject|0|||
145512077|NCT03390101|524735325|FG001|Weeks 12-54|Withdrawal by Subject|3|||
145512078|NCT03390101|524735326|FG002|Weeks 12-54|Withdrawal by Subject|1|||
145512079|NCT03390101|524735324|FG000|Weeks 12-54|Pregnancy|1|||
145512080|NCT03390101|524735325|FG001|Weeks 12-54|Pregnancy|0|||
145512081|NCT03390101|524735326|FG002|Weeks 12-54|Pregnancy|0|||
145512082|NCT03390101|524735324|FG000|Weeks 12-54|Adverse Event|2|||
145512083|NCT03390101|524735325|FG001|Weeks 12-54|Adverse Event|1|||
145512084|NCT03390101|524735326|FG002|Weeks 12-54|Adverse Event|1|||
145512085|NCT01511055|524735327|FG000|Overall Study|Withdrawal by Subject|6|||
145512086|NCT00830869|524735328|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
145512087|NCT00830869|524735329|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
145512088|NCT00830869|524735330|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
145512089|NCT00830869|524735331|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
145512090|NCT00830869|524735332|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
145512091|NCT00830869|524735333|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
145512092|NCT00830869|524735334|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
145512093|NCT00830869|524735335|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
145512094|NCT00830869|524735336|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
145512095|NCT00830869|524735337|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
145512096|NCT00830869|524735338|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
145512097|NCT00830869|524735339|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
145512098|NCT00830869|524735328|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
145512099|NCT00830869|524735329|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
145512100|NCT00830869|524735330|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
145512101|NCT00830869|524735331|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
145512102|NCT00830869|524735332|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
145512103|NCT00830869|524735333|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
145512104|NCT00830869|524735334|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
145512105|NCT00830869|524735335|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
145512106|NCT00830869|524735336|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
145512107|NCT00830869|524735337|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
145512108|NCT00830869|524735338|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
145512109|NCT00830869|524735339|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
145512110|NCT00830869|524735328|FG000|Period 1: Part 1|Adverse Event|0|||
145512111|NCT00830869|524735329|FG001|Period 1: Part 1|Adverse Event|0|||
145512112|NCT00830869|524735330|FG002|Period 1: Part 1|Adverse Event|0|||
145512113|NCT00830869|524735331|FG003|Period 1: Part 1|Adverse Event|0|||
145512114|NCT00830869|524735332|FG004|Period 1: Part 1|Adverse Event|0|||
145512115|NCT00830869|524735333|FG005|Period 1: Part 1|Adverse Event|1|||
145512116|NCT00830869|524735334|FG006|Period 1: Part 1|Adverse Event|1|||
145512117|NCT00830869|524735335|FG007|Period 1: Part 1|Adverse Event|0|||
145512118|NCT00830869|524735336|FG008|Period 1: Part 1|Adverse Event|0|||
145512119|NCT00830869|524735337|FG009|Period 1: Part 1|Adverse Event|0|||
145512120|NCT00830869|524735338|FG010|Period 1: Part 1|Adverse Event|0|||
145512121|NCT00830869|524735339|FG011|Period 1: Part 1|Adverse Event|0|||
145512122|NCT00830869|524735328|FG000|Period 1: Part 1|Progressive disease|1|||
145512123|NCT00830869|524735329|FG001|Period 1: Part 1|Progressive disease|0|||
145512124|NCT00830869|524735330|FG002|Period 1: Part 1|Progressive disease|1|||
145512125|NCT00830869|524735331|FG003|Period 1: Part 1|Progressive disease|6|||
145512126|NCT00830869|524735332|FG004|Period 1: Part 1|Progressive disease|4|||
145512127|NCT00830869|524735333|FG005|Period 1: Part 1|Progressive disease|4|||
145512128|NCT00830869|524735334|FG006|Period 1: Part 1|Progressive disease|1|||
145512129|NCT00830869|524735335|FG007|Period 1: Part 1|Progressive disease|0|||
145512130|NCT00830869|524735336|FG008|Period 1: Part 1|Progressive disease|0|||
145512131|NCT00830869|524735337|FG009|Period 1: Part 1|Progressive disease|0|||
145512132|NCT00830869|524735338|FG010|Period 1: Part 1|Progressive disease|0|||
145512133|NCT00830869|524735339|FG011|Period 1: Part 1|Progressive disease|0|||
145512134|NCT00830869|524735328|FG000|Period 2: Part 2|Protocol Violation|0|||
145512135|NCT00830869|524735329|FG001|Period 2: Part 2|Protocol Violation|0|||
145512136|NCT00830869|524735330|FG002|Period 2: Part 2|Protocol Violation|0|||
145512137|NCT00830869|524735331|FG003|Period 2: Part 2|Protocol Violation|0|||
145512138|NCT00830869|524735332|FG004|Period 2: Part 2|Protocol Violation|0|||
145512139|NCT00830869|524735333|FG005|Period 2: Part 2|Protocol Violation|0|||
145512140|NCT00830869|524735334|FG006|Period 2: Part 2|Protocol Violation|0|||
145512141|NCT00830869|524735335|FG007|Period 2: Part 2|Protocol Violation|1|||
145512142|NCT00830869|524735336|FG008|Period 2: Part 2|Protocol Violation|0|||
145512143|NCT00830869|524735337|FG009|Period 2: Part 2|Protocol Violation|1|||
145512144|NCT00830869|524735338|FG010|Period 2: Part 2|Protocol Violation|0|||
145512145|NCT00830869|524735339|FG011|Period 2: Part 2|Protocol Violation|0|||
145512146|NCT00830869|524735328|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
145512147|NCT00830869|524735329|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
145512148|NCT00830869|524735330|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
145512149|NCT00830869|524735331|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
145512150|NCT00830869|524735332|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
145512151|NCT00830869|524735333|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
145512152|NCT00830869|524735334|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
145512153|NCT00830869|524735335|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
145733031|NCT04606771|525540884|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
145512154|NCT00830869|524735336|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
145512155|NCT00830869|524735337|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
145512156|NCT00830869|524735338|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
145512157|NCT00830869|524735339|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
145512158|NCT00830869|524735328|FG000|Period 2: Part 2|Adverse Event|0|||
145512159|NCT00830869|524735329|FG001|Period 2: Part 2|Adverse Event|0|||
145512160|NCT00830869|524735330|FG002|Period 2: Part 2|Adverse Event|0|||
145512161|NCT00830869|524735331|FG003|Period 2: Part 2|Adverse Event|0|||
145512162|NCT00830869|524735332|FG004|Period 2: Part 2|Adverse Event|0|||
145512163|NCT00830869|524735333|FG005|Period 2: Part 2|Adverse Event|0|||
145512164|NCT00830869|524735334|FG006|Period 2: Part 2|Adverse Event|0|||
145512165|NCT00830869|524735335|FG007|Period 2: Part 2|Adverse Event|4|||
145512166|NCT00830869|524735336|FG008|Period 2: Part 2|Adverse Event|3|||
145512167|NCT00830869|524735337|FG009|Period 2: Part 2|Adverse Event|2|||
145512168|NCT00830869|524735338|FG010|Period 2: Part 2|Adverse Event|2|||
145512169|NCT00830869|524735339|FG011|Period 2: Part 2|Adverse Event|0|||
145512170|NCT00830869|524735328|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
145512171|NCT00830869|524735329|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
145512172|NCT00830869|524735330|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
145512173|NCT00830869|524735331|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
145512174|NCT00830869|524735332|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
145512175|NCT00830869|524735333|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
145512176|NCT00830869|524735334|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
145512177|NCT00830869|524735335|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
145512178|NCT00830869|524735336|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
145512179|NCT00830869|524735337|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
145512180|NCT00830869|524735338|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
145512181|NCT00830869|524735339|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
145512182|NCT00830869|524735328|FG000|Period 2: Part 2|Progressive disease|0|||
145512183|NCT00830869|524735329|FG001|Period 2: Part 2|Progressive disease|0|||
145512184|NCT00830869|524735330|FG002|Period 2: Part 2|Progressive disease|0|||
145512185|NCT00830869|524735331|FG003|Period 2: Part 2|Progressive disease|0|||
145512186|NCT00830869|524735332|FG004|Period 2: Part 2|Progressive disease|0|||
145512187|NCT00830869|524735333|FG005|Period 2: Part 2|Progressive disease|0|||
145512188|NCT00830869|524735334|FG006|Period 2: Part 2|Progressive disease|0|||
145512189|NCT00830869|524735335|FG007|Period 2: Part 2|Progressive disease|14|||
145512190|NCT00830869|524735336|FG008|Period 2: Part 2|Progressive disease|11|||
145512191|NCT00830869|524735337|FG009|Period 2: Part 2|Progressive disease|12|||
145512192|NCT00830869|524735338|FG010|Period 2: Part 2|Progressive disease|8|||
145512193|NCT00830869|524735339|FG011|Period 2: Part 2|Progressive disease|15|||
145512194|NCT00830869|524735328|FG000|Period 2: Part 2|Other|0|||
145512195|NCT00830869|524735329|FG001|Period 2: Part 2|Other|0|||
145512196|NCT00830869|524735330|FG002|Period 2: Part 2|Other|0|||
145512197|NCT00830869|524735331|FG003|Period 2: Part 2|Other|0|||
145512198|NCT00830869|524735332|FG004|Period 2: Part 2|Other|0|||
145512199|NCT00830869|524735333|FG005|Period 2: Part 2|Other|0|||
145512200|NCT00830869|524735334|FG006|Period 2: Part 2|Other|0|||
145512201|NCT00830869|524735335|FG007|Period 2: Part 2|Other|0|||
145512202|NCT00830869|524735336|FG008|Period 2: Part 2|Other|0|||
145512203|NCT00830869|524735337|FG009|Period 2: Part 2|Other|1|||
145512204|NCT00830869|524735338|FG010|Period 2: Part 2|Other|0|||
145512205|NCT00830869|524735339|FG011|Period 2: Part 2|Other|0|||
145512206|NCT00281658|524735345|FG000|Randomized Phase|Adverse Event|0|||
145512207|NCT00281658|524735346|FG001|Randomized Phase|Adverse Event|2|||
145512208|NCT00281658|524735347|FG002|Randomized Phase|Adverse Event|0|||
145512209|NCT00281658|524735348|FG003|Randomized Phase|Adverse Event|0|||
145512210|NCT00281658|524735345|FG000|Randomized Phase|Lost to Follow-up|34|||
145512211|NCT00281658|524735346|FG001|Randomized Phase|Lost to Follow-up|27|||
145512212|NCT00281658|524735347|FG002|Randomized Phase|Lost to Follow-up|0|||
145512213|NCT00281658|524735348|FG003|Randomized Phase|Lost to Follow-up|0|||
145512214|NCT00281658|524735345|FG000|Randomized Phase|Withdrawal by Subject|8|||
145512215|NCT00281658|524735346|FG001|Randomized Phase|Withdrawal by Subject|7|||
145512216|NCT00281658|524735347|FG002|Randomized Phase|Withdrawal by Subject|0|||
145512217|NCT00281658|524735348|FG003|Randomized Phase|Withdrawal by Subject|0|||
145512218|NCT00281658|524735345|FG000|Randomized Phase|Study closed/terminated|1|||
145512219|NCT00281658|524735346|FG001|Randomized Phase|Study closed/terminated|1|||
145512220|NCT00281658|524735347|FG002|Randomized Phase|Study closed/terminated|0|||
145512221|NCT00281658|524735348|FG003|Randomized Phase|Study closed/terminated|0|||
145512222|NCT00281658|524735345|FG000|Randomized Phase|Disease progression|36|||
145512223|NCT00281658|524735346|FG001|Randomized Phase|Disease progression|27|||
145512224|NCT00281658|524735347|FG002|Randomized Phase|Disease progression|0|||
145512225|NCT00281658|524735348|FG003|Randomized Phase|Disease progression|0|||
145512226|NCT00281658|524735345|FG000|Randomized Phase|Physician Decision|1|||
145512227|NCT00281658|524735346|FG001|Randomized Phase|Physician Decision|1|||
145512228|NCT00281658|524735347|FG002|Randomized Phase|Physician Decision|0|||
145512229|NCT00281658|524735348|FG003|Randomized Phase|Physician Decision|0|||
145512230|NCT00281658|524735345|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
145512231|NCT00281658|524735346|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
145512232|NCT00281658|524735347|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
145512233|NCT00281658|524735348|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
145512234|NCT00281658|524735345|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
145512235|NCT00281658|524735346|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
145512236|NCT00281658|524735347|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
145512237|NCT00281658|524735348|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
145512238|NCT00281658|524735345|FG000|Randomized Phase|Treatment ongoing|1|||
145512239|NCT00281658|524735346|FG001|Randomized Phase|Treatment ongoing|0|||
145512240|NCT00281658|524735347|FG002|Randomized Phase|Treatment ongoing|0|||
145512241|NCT00281658|524735348|FG003|Randomized Phase|Treatment ongoing|0|||
145512242|NCT00281658|524735345|FG000|Open Label Phase|Adverse Event|0|||
145512243|NCT00281658|524735346|FG001|Open Label Phase|Adverse Event|0|||
145512244|NCT00281658|524735347|FG002|Open Label Phase|Adverse Event|1|||
145512245|NCT00281658|524735348|FG003|Open Label Phase|Adverse Event|0|||
145512246|NCT00281658|524735345|FG000|Open Label Phase|Lost to Follow-up|0|||
145512247|NCT00281658|524735346|FG001|Open Label Phase|Lost to Follow-up|0|||
145512248|NCT00281658|524735347|FG002|Open Label Phase|Lost to Follow-up|16|||
145512249|NCT00281658|524735348|FG003|Open Label Phase|Lost to Follow-up|2|||
145512250|NCT00281658|524735345|FG000|Open Label Phase|Withdrawal by Subject|0|||
145512251|NCT00281658|524735346|FG001|Open Label Phase|Withdrawal by Subject|0|||
145512252|NCT00281658|524735347|FG002|Open Label Phase|Withdrawal by Subject|3|||
145512253|NCT00281658|524735348|FG003|Open Label Phase|Withdrawal by Subject|2|||
145512254|NCT00281658|524735345|FG000|Open Label Phase|Disease progression|0|||
145512255|NCT00281658|524735346|FG001|Open Label Phase|Disease progression|0|||
145512256|NCT00281658|524735347|FG002|Open Label Phase|Disease progression|18|||
145512257|NCT00281658|524735348|FG003|Open Label Phase|Disease progression|0|||
145512258|NCT00281658|524735345|FG000|Open Label Phase|Physician Decision|0|||
145512259|NCT00281658|524735346|FG001|Open Label Phase|Physician Decision|0|||
145512260|NCT00281658|524735347|FG002|Open Label Phase|Physician Decision|1|||
145512261|NCT00281658|524735348|FG003|Open Label Phase|Physician Decision|0|||
145512262|NCT00281658|524735345|FG000|Open Label Phase|Relocation of patient|0|||
145512263|NCT00281658|524735346|FG001|Open Label Phase|Relocation of patient|0|||
145512264|NCT00281658|524735347|FG002|Open Label Phase|Relocation of patient|1|||
145512265|NCT00281658|524735348|FG003|Open Label Phase|Relocation of patient|0|||
145512266|NCT00281658|524735345|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
145512267|NCT00281658|524735346|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
145512268|NCT00281658|524735347|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
145512269|NCT00281658|524735348|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
145512270|NCT04590248|524735349|FG000|Overall Study|Lost to Follow-up|1|||
145512271|NCT04590248|524735349|FG000|Overall Study|Withdrawal by Subject|16|||
145512272|NCT04590248|524735349|FG000|Overall Study|Other|2|||
145512273|NCT02052414|524735352|FG000|Overall Study|Adverse Event|12|||
145512274|NCT02052414|524735352|FG000|Overall Study|Lack of Efficacy|2|||
145512275|NCT02052414|524735352|FG000|Overall Study|Withdrawal by Subject|3|||
145512276|NCT01343693|524735361|FG000|Overall Study|Lost to Follow-up|9|||
145512277|NCT02704143|524735362|FG000|Overall Study|disease progression|10|||
145733032|NCT04606771|525540885|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
145733033|NCT04606771|525540884|FG000|Overall Study|Death|5|||
145733034|NCT04606771|525540885|FG001|Overall Study|Death|6|||
145733035|NCT04606771|525540884|FG000|Overall Study|Wrong randomisation|0|||
145512278|NCT01235598|524735363|FG000|Overall Study|Adverse Event|0|||
145512279|NCT01235598|524735364|FG001|Overall Study|Adverse Event|3|||
145512280|NCT01235598|524735363|FG000|Overall Study|Lack of Efficacy|0|||
145512281|NCT01235598|524735364|FG001|Overall Study|Lack of Efficacy|1|||
145512282|NCT01235598|524735363|FG000|Overall Study|Withdrawal by Subject|1|||
145733036|NCT04606771|525540885|FG001|Overall Study|Wrong randomisation|1|||
145733037|NCT04464265|525540890|FG000|Overall Study|Physician Decision|2|||
145733038|NCT01438151|525540894|FG000|Overall Study|study terminated|8|||
145733039|NCT02459769|525540898|FG000|Overall Study|Withdrawal by Subject|7|||
145512283|NCT01235598|524735364|FG001|Overall Study|Withdrawal by Subject|0|||
145512284|NCT02551991|524735365|FG000|Overall Study|Death|5|||
145512285|NCT02551991|524735366|FG001|Overall Study|Death|7|||
145512286|NCT02551991|524735367|FG002|Overall Study|Death|8|||
145512287|NCT02551991|524735368|FG003|Overall Study|Death|7|||
145512288|NCT02551991|524735369|FG004|Overall Study|Death|17|||
145512289|NCT02551991|524735365|FG000|Overall Study|Withdrawal by Subject|1|||
145512290|NCT02551991|524735366|FG001|Overall Study|Withdrawal by Subject|0|||
145512291|NCT02551991|524735367|FG002|Overall Study|Withdrawal by Subject|0|||
145512292|NCT02551991|524735368|FG003|Overall Study|Withdrawal by Subject|0|||
145512293|NCT02551991|524735369|FG004|Overall Study|Withdrawal by Subject|2|||
145512294|NCT02551991|524735365|FG000|Overall Study|Lost to Follow-up|0|||
145512295|NCT02551991|524735366|FG001|Overall Study|Lost to Follow-up|0|||
145512296|NCT02551991|524735367|FG002|Overall Study|Lost to Follow-up|1|||
145512297|NCT02551991|524735368|FG003|Overall Study|Lost to Follow-up|0|||
145512298|NCT02551991|524735369|FG004|Overall Study|Lost to Follow-up|0|||
145512299|NCT02551991|524735365|FG000|Overall Study|Sponsor Decision|1|||
145512300|NCT02551991|524735366|FG001|Overall Study|Sponsor Decision|0|||
145512301|NCT02551991|524735367|FG002|Overall Study|Sponsor Decision|1|||
145512302|NCT02551991|524735368|FG003|Overall Study|Sponsor Decision|0|||
145512303|NCT02551991|524735369|FG004|Overall Study|Sponsor Decision|5|||
145512304|NCT02551991|524735365|FG000|Overall Study|Other|0|||
145512305|NCT02551991|524735366|FG001|Overall Study|Other|0|||
145512306|NCT02551991|524735367|FG002|Overall Study|Other|0|||
145512307|NCT02551991|524735368|FG003|Overall Study|Other|0|||
145512308|NCT02551991|524735369|FG004|Overall Study|Other|1|||
145512309|NCT00395343|524735370|FG000|Overall Study|Adverse Event|13|||
145512310|NCT00395343|524735371|FG001|Overall Study|Adverse Event|5|||
145512311|NCT00395343|524735370|FG000|Overall Study|Lack of Efficacy|0|||
145512312|NCT00395343|524735371|FG001|Overall Study|Lack of Efficacy|1|||
145512313|NCT00395343|524735370|FG000|Overall Study|Lost to Follow-up|4|||
145512314|NCT00395343|524735371|FG001|Overall Study|Lost to Follow-up|4|||
145512315|NCT00395343|524735370|FG000|Overall Study|Physician Decision|2|||
145512316|NCT00395343|524735371|FG001|Overall Study|Physician Decision|4|||
145512317|NCT00395343|524735370|FG000|Overall Study|Protocol Violation|6|||
145512318|NCT00395343|524735371|FG001|Overall Study|Protocol Violation|8|||
145512319|NCT00395343|524735370|FG000|Overall Study|Withdrawal by Subject|11|||
145512320|NCT00395343|524735371|FG001|Overall Study|Withdrawal by Subject|12|||
145512321|NCT00395343|524735370|FG000|Overall Study|Other|5|||
145512322|NCT00395343|524735371|FG001|Overall Study|Other|2|||
145512323|NCT00387790|524735374|FG000|Overall Study|Adverse Event|5|||
145512324|NCT00387790|524735374|FG000|Overall Study|Lack of Efficacy|2|||
145512325|NCT00387790|524735374|FG000|Overall Study|Physician Decision|2|||
145512326|NCT00387790|524735374|FG000|Overall Study|Withdrawal by Subject|3|||
145512327|NCT00387790|524735374|FG000|Overall Study|Ineligible for study|2|||
145512328|NCT01874340|524735375|FG000|Overall Study|Study terminated by Sponsor|6|||
145512329|NCT01874340|524735376|FG001|Overall Study|Study terminated by Sponsor|8|||
145512330|NCT01874340|524735377|FG002|Overall Study|Study terminated by Sponsor|8|||
145512331|NCT01874340|524735378|FG003|Overall Study|Study terminated by Sponsor|4|||
145512332|NCT01874340|524735375|FG000|Overall Study|Withdrawal by Subject|0|||
145512333|NCT01874340|524735376|FG001|Overall Study|Withdrawal by Subject|0|||
145512334|NCT01874340|524735377|FG002|Overall Study|Withdrawal by Subject|0|||
145512335|NCT01874340|524735378|FG003|Overall Study|Withdrawal by Subject|1|||
145512336|NCT03539549|524735379|FG000|Overall Study|Adverse Event|12|||
145512337|NCT03539549|524735379|FG000|Overall Study|Lost to Follow-up|1|||
145512338|NCT03539549|524735379|FG000|Overall Study|Death|2|||
145512339|NCT03539549|524735379|FG000|Overall Study|Progressive Disease|1|||
145512340|NCT03539549|524735379|FG000|Overall Study|Reason not Specified|1|||
145512341|NCT02864862|524735381|FG000|Overall Study|Lost to Follow-up|1|||
145512342|NCT02864862|524735382|FG001|Overall Study|Lost to Follow-up|0|||
145512343|NCT02864862|524735383|FG002|Overall Study|Lost to Follow-up|1|||
145512344|NCT02864862|524735381|FG000|Overall Study|Protocol Violation|0|||
145512345|NCT02864862|524735382|FG001|Overall Study|Protocol Violation|0|||
145512346|NCT02864862|524735383|FG002|Overall Study|Protocol Violation|1|||
145512347|NCT03263702|524735384|FG000|Overall Study|Lost to Follow-up|2|||
145512348|NCT03263702|524735385|FG001|Overall Study|Lost to Follow-up|2|||
145512349|NCT03263702|524735384|FG000|Overall Study|Withdrawal by Subject|1|||
145512350|NCT03263702|524735385|FG001|Overall Study|Withdrawal by Subject|2|||
145512351|NCT03598114|524735386|FG000|Overall Study|Staff turnover/left the program|3|||
145512352|NCT03598114|524735387|FG001|Overall Study|Staff turnover/left the program|39|||
145512353|NCT00689117|524735388|FG000|Overall Study|Adverse Event|6|||
145512354|NCT00689117|524735389|FG001|Overall Study|Adverse Event|0|||
145512355|NCT00689117|524735390|FG002|Overall Study|Adverse Event|5|||
145512356|NCT00689117|524735391|FG003|Overall Study|Adverse Event|0|||
145512357|NCT00689117|524735388|FG000|Overall Study|Lost to Follow-up|26|||
145512358|NCT00689117|524735389|FG001|Overall Study|Lost to Follow-up|19|||
145512359|NCT00689117|524735390|FG002|Overall Study|Lost to Follow-up|17|||
145512360|NCT00689117|524735391|FG003|Overall Study|Lost to Follow-up|11|||
145512361|NCT00689117|524735388|FG000|Overall Study|Lack of Efficacy|1|||
145512362|NCT00689117|524735389|FG001|Overall Study|Lack of Efficacy|2|||
145512363|NCT00689117|524735390|FG002|Overall Study|Lack of Efficacy|2|||
145512364|NCT00689117|524735391|FG003|Overall Study|Lack of Efficacy|2|||
145512365|NCT00689117|524735388|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
145512366|NCT00689117|524735389|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
145512367|NCT00689117|524735390|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
145512368|NCT00689117|524735391|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
145512369|NCT00689117|524735388|FG000|Overall Study|Withdrawal by Subject|19|||
145512370|NCT00689117|524735389|FG001|Overall Study|Withdrawal by Subject|18|||
145512371|NCT00689117|524735390|FG002|Overall Study|Withdrawal by Subject|26|||
145512372|NCT00689117|524735391|FG003|Overall Study|Withdrawal by Subject|13|||
145512373|NCT00689117|524735388|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
145512374|NCT00689117|524735389|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
145512375|NCT00689117|524735390|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
145512376|NCT00689117|524735391|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
145512377|NCT00689117|524735388|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145512378|NCT00689117|524735389|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
145512379|NCT00689117|524735390|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145512380|NCT00689117|524735391|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145512381|NCT00689117|524735388|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
145512382|NCT00689117|524735389|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
145512383|NCT00689117|524735390|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
145512384|NCT00689117|524735391|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
145512385|NCT00689117|524735388|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
145512386|NCT00689117|524735389|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
145512387|NCT00689117|524735390|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
145512388|NCT00689117|524735391|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
145512389|NCT00689117|524735388|FG000|Overall Study|Use of Prohibitive Medication|2|||
145512390|NCT00689117|524735389|FG001|Overall Study|Use of Prohibitive Medication|1|||
145512391|NCT00689117|524735390|FG002|Overall Study|Use of Prohibitive Medication|3|||
145512392|NCT00689117|524735391|FG003|Overall Study|Use of Prohibitive Medication|0|||
145512393|NCT00689117|524735388|FG000|Overall Study|Pregnancy|0|||
145512394|NCT00689117|524735389|FG001|Overall Study|Pregnancy|2|||
145512395|NCT00689117|524735390|FG002|Overall Study|Pregnancy|0|||
145512396|NCT00689117|524735391|FG003|Overall Study|Pregnancy|2|||
145512397|NCT00689117|524735388|FG000|Overall Study|Incarceration|2|||
145512398|NCT00689117|524735389|FG001|Overall Study|Incarceration|0|||
145512399|NCT00689117|524735390|FG002|Overall Study|Incarceration|0|||
145512400|NCT00689117|524735391|FG003|Overall Study|Incarceration|0|||
145512401|NCT00689117|524735388|FG000|Overall Study|Fear of Birth Defects|0|||
145512402|NCT00689117|524735389|FG001|Overall Study|Fear of Birth Defects|0|||
145512403|NCT00689117|524735390|FG002|Overall Study|Fear of Birth Defects|1|||
145512404|NCT00689117|524735391|FG003|Overall Study|Fear of Birth Defects|0|||
145512405|NCT00689117|524735388|FG000|Overall Study|Transportation|1|||
145512406|NCT00689117|524735389|FG001|Overall Study|Transportation|0|||
145512407|NCT00689117|524735390|FG002|Overall Study|Transportation|0|||
145512408|NCT00689117|524735391|FG003|Overall Study|Transportation|0|||
145512409|NCT00689117|524735388|FG000|Overall Study|Patient Withdrew from Study|0|||
145512410|NCT00689117|524735389|FG001|Overall Study|Patient Withdrew from Study|0|||
145512411|NCT00689117|524735390|FG002|Overall Study|Patient Withdrew from Study|0|||
145512412|NCT00689117|524735391|FG003|Overall Study|Patient Withdrew from Study|1|||
145512413|NCT00689117|524735388|FG000|Overall Study|Personal Reason|0|||
145512414|NCT00689117|524735389|FG001|Overall Study|Personal Reason|1|||
145512415|NCT00689117|524735390|FG002|Overall Study|Personal Reason|0|||
145512416|NCT00689117|524735391|FG003|Overall Study|Personal Reason|0|||
145512417|NCT00689117|524735388|FG000|Overall Study|Dispensing Error|0|||
145512418|NCT00689117|524735389|FG001|Overall Study|Dispensing Error|1|||
145512419|NCT00689117|524735390|FG002|Overall Study|Dispensing Error|0|||
145512420|NCT00689117|524735391|FG003|Overall Study|Dispensing Error|0|||
145512421|NCT01206322|524735392|FG000|Overall Study|Adverse Event|0|||
145512422|NCT01206322|524735393|FG001|Overall Study|Adverse Event|0|||
145512423|NCT01206322|524735394|FG002|Overall Study|Adverse Event|0|||
145512424|NCT01206322|524735395|FG003|Overall Study|Adverse Event|1|||
145512425|NCT00444678|524735396|FG000|Overall Study|Toxicity|11|||
145512426|NCT00444678|524735396|FG000|Overall Study|Disease Progression|12|||
145512427|NCT00444678|524735396|FG000|Overall Study|Death|3|||
145512428|NCT00444678|524735396|FG000|Overall Study|Physician Decision|3|||
145512429|NCT00444678|524735396|FG000|Overall Study|Withdrawal by Subject|2|||
145512430|NCT00606905|524735402|FG000|Overall Study|No Pregnancy|9|||
145512431|NCT00606905|524735403|FG001|Overall Study|No Pregnancy|6|||
145512432|NCT00606905|524735402|FG000|Overall Study|Non-Index Pregnancy|1|||
145512433|NCT00606905|524735403|FG001|Overall Study|Non-Index Pregnancy|4|||
145512434|NCT00606905|524735402|FG000|Overall Study|Withdrew|5|||
145512435|NCT00606905|524735403|FG001|Overall Study|Withdrew|5|||
145512436|NCT02386189|524735404|FG000|Overall Study|Lost to Follow-up|2|||
145512437|NCT02386189|524735405|FG001|Overall Study|Lost to Follow-up|3|||
145512438|NCT02386189|524735404|FG000|Overall Study|Withdrawal by Subject|1|||
145512439|NCT02386189|524735405|FG001|Overall Study|Withdrawal by Subject|0|||
145512440|NCT02386189|524735404|FG000|Overall Study|Death|1|||
145512441|NCT02386189|524735405|FG001|Overall Study|Death|0|||
145512442|NCT04657666|524735406|FG000|Period 1|Withdrawal of participant consent|2|||
145512443|NCT04657666|524735407|FG001|Period 1|Withdrawal of participant consent|1|||
145512444|NCT04657666|524735406|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
145512445|NCT04657666|524735407|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
145512446|NCT04657666|524735406|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
145512447|NCT04657666|524735407|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
145512448|NCT04657666|524735406|FG000|Period 2|Other|2|||
145512449|NCT04657666|524735407|FG001|Period 2|Other|0|||
145512450|NCT04657666|524735406|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
145512451|NCT04657666|524735407|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
145512452|NCT03120351|524735408|FG000|Overall Study|Physician Decision|1|||
145512453|NCT03120351|524735409|FG001|Overall Study|Physician Decision|1|||
145512454|NCT01022398|524735418|FG000|Overall Study|Study terminated|2|||
145512455|NCT01022398|524735419|FG001|Overall Study|Study terminated|2|||
145512456|NCT03319745|524735421|FG000|Overall Study|Death|1|||
145512457|NCT03319745|524735421|FG000|Overall Study|Toxicity Precluding Surgery|1|||
145512458|NCT01317550|524735422|FG000|Overall Study|Withdrawal by Subject|1|||
145512459|NCT01317550|524735423|FG001|Overall Study|Withdrawal by Subject|0|||
145512460|NCT01317550|524735424|FG002|Overall Study|Withdrawal by Subject|0|||
145512461|NCT01317550|524735425|FG003|Overall Study|Withdrawal by Subject|0|||
145512462|NCT01317550|524735422|FG000|Overall Study|Lack of compliance study med|1|||
145512463|NCT01317550|524735423|FG001|Overall Study|Lack of compliance study med|0|||
145512464|NCT01317550|524735424|FG002|Overall Study|Lack of compliance study med|0|||
145512465|NCT01317550|524735425|FG003|Overall Study|Lack of compliance study med|0|||
145512466|NCT00870103|524735426|FG000|Overall Study|Physician Decision|2|||
145512467|NCT00870103|524735426|FG000|Overall Study|Lost to Follow-up|2|||
145512468|NCT03679754|524735427|FG000|Overall Study|Investigator request|1|||
145512469|NCT00964171|524735428|FG000|Overall Study|Death|5|||
145512470|NCT02872935|524735429|FG000|Overall Study|Other|0|||
145512471|NCT02872935|524735430|FG001|Overall Study|Other|1|||
145512472|NCT03037580|524735434|FG000|Overall Study|Withdrawal by Subject|3|||
145512473|NCT03037580|524735435|FG001|Overall Study|Withdrawal by Subject|0|||
145512474|NCT03037580|524735434|FG000|Overall Study|Adverse Event|1|||
145512475|NCT03037580|524735435|FG001|Overall Study|Adverse Event|0|||
145512476|NCT03037580|524735434|FG000|Overall Study|Study Terminated by Sponsor|12|||
145512477|NCT03037580|524735435|FG001|Overall Study|Study Terminated by Sponsor|15|||
145512478|NCT03037580|524735434|FG000|Overall Study|Death|0|||
145512479|NCT03037580|524735435|FG001|Overall Study|Death|1|||
145512480|NCT02873429|524735436|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
145512481|NCT02873429|524735437|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
145512482|NCT02873429|524735436|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
145512483|NCT02873429|524735437|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
145512484|NCT02873429|524735436|FG000|16 Weeks|Lost to Follow-up|3|||
145512485|NCT02873429|524735437|FG001|16 Weeks|Lost to Follow-up|0|||
145512486|NCT00853567|524735439|FG000|Overall Study|Study prematurely terminated|71|||
145512487|NCT00782834|524735440|FG000|Treatment Phase|fibrous tumor not GIST|1|||
145512488|NCT02259088|524735441|FG000|Overall Study|Adverse Event|6|||
145512489|NCT02259088|524735442|FG001|Overall Study|Adverse Event|4|||
145512490|NCT02259088|524735441|FG000|Overall Study|Lost to Follow-up|2|||
145512491|NCT02259088|524735442|FG001|Overall Study|Lost to Follow-up|0|||
145512492|NCT02259088|524735441|FG000|Overall Study|Death|2|||
145512493|NCT02259088|524735442|FG001|Overall Study|Death|0|||
145512494|NCT02259088|524735441|FG000|Overall Study|Physician Decision|5|||
145512495|NCT02259088|524735442|FG001|Overall Study|Physician Decision|2|||
145512496|NCT02259088|524735441|FG000|Overall Study|Protocol deviation|5|||
145512497|NCT02259088|524735442|FG001|Overall Study|Protocol deviation|0|||
145512498|NCT02259088|524735441|FG000|Overall Study|Subject/guardian decision|8|||
145512499|NCT02259088|524735442|FG001|Overall Study|Subject/guardian decision|8|||
145512500|NCT01818752|524735443|FG000|Overall Study|Adverse Event|64|||
145512501|NCT01818752|524735444|FG001|Overall Study|Adverse Event|74|||
145512502|NCT01818752|524735443|FG000|Overall Study|Death|14|||
145512503|NCT01818752|524735444|FG001|Overall Study|Death|18|||
145512504|NCT01818752|524735443|FG000|Overall Study|Non-compliance|16|||
145512505|NCT01818752|524735444|FG001|Overall Study|Non-compliance|20|||
145512506|NCT01818752|524735443|FG000|Overall Study|Withdrawal by Subject|15|||
145512507|NCT01818752|524735444|FG001|Overall Study|Withdrawal by Subject|14|||
145512508|NCT01818752|524735443|FG000|Overall Study|Physician Decision|9|||
145512509|NCT01818752|524735444|FG001|Overall Study|Physician Decision|8|||
145512510|NCT01818752|524735443|FG000|Overall Study|Disease Progression|54|||
145512511|NCT01818752|524735444|FG001|Overall Study|Disease Progression|48|||
145512512|NCT01818752|524735443|FG000|Overall Study|Other|7|||
145512513|NCT01818752|524735444|FG001|Overall Study|Other|8|||
145512514|NCT01818752|524735443|FG000|Overall Study|Continuing Treatment|1|||
145512515|NCT01818752|524735444|FG001|Overall Study|Continuing Treatment|4|||
145512516|NCT01818752|524735443|FG000|Overall Study|Randomized but not Dosed|7|||
145512517|NCT01818752|524735444|FG001|Overall Study|Randomized but not Dosed|4|||
145512518|NCT04270370|524735445|FG000|Overall Study|Lost to Follow-up|1|||
145512519|NCT04270370|524735446|FG001|Overall Study|Lost to Follow-up|0|||
145512520|NCT04270370|524735447|FG002|Overall Study|Lost to Follow-up|0|||
145512521|NCT04270370|524735448|FG003|Overall Study|Lost to Follow-up|0|||
145512522|NCT04270370|524735449|FG004|Overall Study|Lost to Follow-up|0|||
145512523|NCT04270370|524735450|FG005|Overall Study|Lost to Follow-up|0|||
145512524|NCT04270370|524735451|FG006|Overall Study|Lost to Follow-up|0|||
145512525|NCT04270370|524735452|FG007|Overall Study|Lost to Follow-up|0|||
145512526|NCT04270370|524735453|FG008|Overall Study|Lost to Follow-up|1|||
145512527|NCT04270370|524735454|FG009|Overall Study|Lost to Follow-up|0|||
145512528|NCT04270370|524735455|FG010|Overall Study|Lost to Follow-up|0|||
145512529|NCT04270370|524735456|FG011|Overall Study|Lost to Follow-up|0|||
145512530|NCT01324141|524735457|FG000|Overall Study|Declined to participate before treatment started|1|||
145512531|NCT01324141|524735457|FG000|Overall Study|Disease progression on study|1|||
145512532|NCT02745080|524735458|FG000|Overall Study|Adverse Event|13|||
145512533|NCT02745080|524735459|FG001|Overall Study|Adverse Event|21|||
145512534|NCT02745080|524735458|FG000|Overall Study|Lack of Efficacy|11|||
145512535|NCT02745080|524735459|FG001|Overall Study|Lack of Efficacy|23|||
145512536|NCT02745080|524735458|FG000|Overall Study|Lost to Follow-up|3|||
145512537|NCT02745080|524735459|FG001|Overall Study|Lost to Follow-up|3|||
145512538|NCT02745080|524735458|FG000|Overall Study|Physician Decision|3|||
145512539|NCT02745080|524735459|FG001|Overall Study|Physician Decision|0|||
145512540|NCT02745080|524735458|FG000|Overall Study|Protocol Violation|3|||
145512541|NCT02745080|524735459|FG001|Overall Study|Protocol Violation|1|||
145512542|NCT02745080|524735458|FG000|Overall Study|Withdrawal by Subject|22|||
145512543|NCT02745080|524735459|FG001|Overall Study|Withdrawal by Subject|41|||
145512544|NCT01001325|524735461|FG000|Overall Study|Lost to Follow-up|16|||
145512545|NCT01001325|524735462|FG001|Overall Study|Lost to Follow-up|10|||
145512546|NCT01001325|524735461|FG000|Overall Study|Protocol Violation|2|||
145512547|NCT01001325|524735462|FG001|Overall Study|Protocol Violation|0|||
145512548|NCT02051933|524738315|FG000|Overall Study|Physician Decision|0|||
145512549|NCT02051933|524738316|FG001|Overall Study|Physician Decision|1|||
145512550|NCT03745820|524738318|FG000|Overall Study|Adverse Event|0|||
145512551|NCT03745820|524738319|FG001|Overall Study|Adverse Event|3|||
145512552|NCT03745820|524738320|FG002|Overall Study|Adverse Event|2|||
145512553|NCT03745820|524738318|FG000|Overall Study|Non-Compliance with Study Drug|4|||
145512554|NCT03745820|524738319|FG001|Overall Study|Non-Compliance with Study Drug|3|||
145512555|NCT03745820|524738320|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145512556|NCT03745820|524738318|FG000|Overall Study|Withdrawal by Subject|4|||
145512557|NCT03745820|524738319|FG001|Overall Study|Withdrawal by Subject|4|||
145512558|NCT03745820|524738320|FG002|Overall Study|Withdrawal by Subject|4|||
145512559|NCT03745820|524738318|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
145512560|NCT03745820|524738319|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
145512561|NCT03745820|524738320|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
145512562|NCT03745820|524738318|FG000|Overall Study|Lost to Follow-up|2|||
145512563|NCT03745820|524738319|FG001|Overall Study|Lost to Follow-up|0|||
145512564|NCT03745820|524738320|FG002|Overall Study|Lost to Follow-up|3|||
145512565|NCT03745820|524738318|FG000|Overall Study|Reason not Specified|2|||
145512566|NCT03745820|524738319|FG001|Overall Study|Reason not Specified|4|||
145512567|NCT03745820|524738320|FG002|Overall Study|Reason not Specified|1|||
145512568|NCT00507728|524738321|FG000|Randomization to Month 3|Lost to Follow-up|15|||
145512569|NCT00507728|524738322|FG001|Randomization to Month 3|Lost to Follow-up|14|||
145512570|NCT00507728|524738323|FG002|Randomization to Month 3|Lost to Follow-up|20|||
145512571|NCT00507728|524738321|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
145512572|NCT00507728|524738322|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
145512573|NCT00507728|524738323|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
145512574|NCT02151773|524738324|FG000|Overall Study|Protocol Deviation|64|||
145512575|NCT04605991|524738327|FG000|Overall Study|Adverse Event|5|||
145512576|NCT04605991|524738327|FG000|Overall Study|Lack of Efficacy|1|||
145512577|NCT04605991|524738327|FG000|Overall Study|Lost to Follow-up|8|||
145512578|NCT04605991|524738327|FG000|Overall Study|Physician Decision|4|||
145512579|NCT04605991|524738327|FG000|Overall Study|Withdrawal by Subject|14|||
145512580|NCT04605991|524738327|FG000|Overall Study|Non-compliance with study|1|||
145512581|NCT02527200|524738328|FG000|Overall Study|Withdrawal by Subject|3|||
145512582|NCT02527200|524738329|FG001|Overall Study|Withdrawal by Subject|2|||
145512583|NCT02527200|524738330|FG002|Overall Study|Withdrawal by Subject|1|||
145512584|NCT02527200|524738331|FG003|Overall Study|Withdrawal by Subject|0|||
145512585|NCT02527200|524738328|FG000|Overall Study|Unclassified|0|||
145512586|NCT02527200|524738329|FG001|Overall Study|Unclassified|1|||
145512587|NCT02527200|524738330|FG002|Overall Study|Unclassified|0|||
145512588|NCT02527200|524738331|FG003|Overall Study|Unclassified|0|||
145512589|NCT02527200|524738328|FG000|Overall Study|Lost to Follow-up|0|||
145512590|NCT02527200|524738329|FG001|Overall Study|Lost to Follow-up|0|||
145512591|NCT02527200|524738330|FG002|Overall Study|Lost to Follow-up|1|||
145512592|NCT02527200|524738331|FG003|Overall Study|Lost to Follow-up|0|||
145512593|NCT00966875|524738333|FG000|Part A|Adverse Event|2|||
145512594|NCT00966875|524738334|FG001|Part A|Adverse Event|1|||
145512595|NCT00966875|524738335|FG002|Part A|Adverse Event|0|||
145512596|NCT00966875|524738336|FG003|Part A|Adverse Event|1|||
145733040|NCT02459769|525540899|FG001|Overall Study|Withdrawal by Subject|4|||
145733041|NCT02459769|525540900|FG002|Overall Study|Withdrawal by Subject|8|||
145733042|NCT02459769|525540901|FG003|Overall Study|Withdrawal by Subject|5|||
145733043|NCT02459769|525540898|FG000|Overall Study|Lost to Follow-up|1|||
145733044|NCT02459769|525540899|FG001|Overall Study|Lost to Follow-up|0|||
145733045|NCT02459769|525540900|FG002|Overall Study|Lost to Follow-up|1|||
145733046|NCT02459769|525540901|FG003|Overall Study|Lost to Follow-up|0|||
145733047|NCT02378220|525540902|FG000|Overall Study|Death|6|||
145733048|NCT02378220|525540903|FG001|Overall Study|Death|1|||
145733049|NCT00312221|525540904|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
145512597|NCT00966875|524738337|FG004|Part A|Adverse Event|0|||
145512598|NCT00966875|524738338|FG005|Part A|Adverse Event|1|||
145512599|NCT00966875|524738339|FG006|Part A|Adverse Event|0|||
145512600|NCT00966875|524738340|FG007|Part A|Adverse Event|3|||
145512601|NCT00966875|524738341|FG008|Part A|Adverse Event|3|||
145512602|NCT00966875|524738333|FG000|Part A|Entry Criteria|0|||
145512603|NCT00966875|524738334|FG001|Part A|Entry Criteria|0|||
145512604|NCT00966875|524738335|FG002|Part A|Entry Criteria|0|||
145733050|NCT00312221|525540905|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
145733051|NCT00312221|525540906|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
145733052|NCT00312221|525540907|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
145733053|NCT00312221|525540904|FG000|Open-label Run-in Period|Adverse Event|74|||
145512605|NCT00966875|524738336|FG003|Part A|Entry Criteria|0|||
145512606|NCT00966875|524738337|FG004|Part A|Entry Criteria|0|||
145512607|NCT00966875|524738338|FG005|Part A|Entry Criteria|2|||
145512608|NCT00966875|524738339|FG006|Part A|Entry Criteria|0|||
145512609|NCT00966875|524738340|FG007|Part A|Entry Criteria|0|||
145512610|NCT00966875|524738341|FG008|Part A|Entry Criteria|0|||
145512611|NCT00966875|524738333|FG000|Part A|Lack of Efficacy|0|||
145512612|NCT00966875|524738334|FG001|Part A|Lack of Efficacy|1|||
145512613|NCT00966875|524738335|FG002|Part A|Lack of Efficacy|0|||
145512614|NCT00966875|524738336|FG003|Part A|Lack of Efficacy|0|||
145512615|NCT00966875|524738337|FG004|Part A|Lack of Efficacy|0|||
145512616|NCT00966875|524738338|FG005|Part A|Lack of Efficacy|0|||
145512617|NCT00966875|524738339|FG006|Part A|Lack of Efficacy|4|||
145512618|NCT00966875|524738340|FG007|Part A|Lack of Efficacy|0|||
145512619|NCT00966875|524738341|FG008|Part A|Lack of Efficacy|0|||
145512620|NCT00966875|524738333|FG000|Part A|Lost to Follow-up|2|||
145512621|NCT00966875|524738334|FG001|Part A|Lost to Follow-up|0|||
145512622|NCT00966875|524738335|FG002|Part A|Lost to Follow-up|0|||
145512623|NCT00966875|524738336|FG003|Part A|Lost to Follow-up|0|||
145512624|NCT00966875|524738337|FG004|Part A|Lost to Follow-up|0|||
145733054|NCT00312221|525540905|FG001|Open-label Run-in Period|Adverse Event|0|||
145512625|NCT00966875|524738338|FG005|Part A|Lost to Follow-up|1|||
145512626|NCT00966875|524738339|FG006|Part A|Lost to Follow-up|0|||
145512627|NCT00966875|524738340|FG007|Part A|Lost to Follow-up|0|||
145512628|NCT00966875|524738341|FG008|Part A|Lost to Follow-up|0|||
145512629|NCT00966875|524738333|FG000|Part A|Parent/Caregiver Decision|0|||
145512630|NCT00966875|524738334|FG001|Part A|Parent/Caregiver Decision|0|||
145512631|NCT00966875|524738335|FG002|Part A|Parent/Caregiver Decision|0|||
145512632|NCT00966875|524738336|FG003|Part A|Parent/Caregiver Decision|1|||
145512633|NCT00966875|524738337|FG004|Part A|Parent/Caregiver Decision|0|||
145512634|NCT00966875|524738338|FG005|Part A|Parent/Caregiver Decision|0|||
145512635|NCT00966875|524738339|FG006|Part A|Parent/Caregiver Decision|0|||
145512636|NCT00966875|524738340|FG007|Part A|Parent/Caregiver Decision|0|||
145512637|NCT00966875|524738341|FG008|Part A|Parent/Caregiver Decision|0|||
145512638|NCT00966875|524738333|FG000|Part A|Physician Decision|0|||
145512639|NCT00966875|524738334|FG001|Part A|Physician Decision|0|||
145512640|NCT00966875|524738335|FG002|Part A|Physician Decision|0|||
145512641|NCT00966875|524738336|FG003|Part A|Physician Decision|0|||
145512642|NCT00966875|524738337|FG004|Part A|Physician Decision|1|||
145512643|NCT00966875|524738338|FG005|Part A|Physician Decision|0|||
145512644|NCT00966875|524738339|FG006|Part A|Physician Decision|1|||
145512645|NCT00966875|524738340|FG007|Part A|Physician Decision|0|||
145512646|NCT00966875|524738341|FG008|Part A|Physician Decision|2|||
145512647|NCT00966875|524738333|FG000|Part A|Sponsor Decision|0|||
145512648|NCT00966875|524738334|FG001|Part A|Sponsor Decision|0|||
145512649|NCT00966875|524738335|FG002|Part A|Sponsor Decision|1|||
145512650|NCT00966875|524738336|FG003|Part A|Sponsor Decision|0|||
145512651|NCT00966875|524738337|FG004|Part A|Sponsor Decision|1|||
145512652|NCT00966875|524738338|FG005|Part A|Sponsor Decision|0|||
145512653|NCT00966875|524738339|FG006|Part A|Sponsor Decision|0|||
145512654|NCT00966875|524738340|FG007|Part A|Sponsor Decision|2|||
145512655|NCT00966875|524738341|FG008|Part A|Sponsor Decision|1|||
145512656|NCT00966875|524738333|FG000|Part A|Withdrawal by Subject|2|||
145512657|NCT00966875|524738334|FG001|Part A|Withdrawal by Subject|2|||
145512658|NCT00966875|524738335|FG002|Part A|Withdrawal by Subject|1|||
145512659|NCT00966875|524738336|FG003|Part A|Withdrawal by Subject|1|||
145512660|NCT00966875|524738337|FG004|Part A|Withdrawal by Subject|3|||
145512661|NCT00966875|524738338|FG005|Part A|Withdrawal by Subject|0|||
145512662|NCT00966875|524738339|FG006|Part A|Withdrawal by Subject|5|||
145512663|NCT00966875|524738340|FG007|Part A|Withdrawal by Subject|1|||
145512664|NCT00966875|524738341|FG008|Part A|Withdrawal by Subject|1|||
145512665|NCT00966875|524738333|FG000|Part A|Protocol Violation|0|||
145512666|NCT00966875|524738334|FG001|Part A|Protocol Violation|0|||
145512667|NCT00966875|524738335|FG002|Part A|Protocol Violation|0|||
145512668|NCT00966875|524738336|FG003|Part A|Protocol Violation|0|||
145512669|NCT00966875|524738337|FG004|Part A|Protocol Violation|0|||
145512670|NCT00966875|524738338|FG005|Part A|Protocol Violation|0|||
145512671|NCT00966875|524738339|FG006|Part A|Protocol Violation|2|||
145512672|NCT00966875|524738340|FG007|Part A|Protocol Violation|1|||
145512673|NCT00966875|524738341|FG008|Part A|Protocol Violation|1|||
145512674|NCT00966875|524738333|FG000|Part B|Adverse Event|0|||
145512675|NCT00966875|524738334|FG001|Part B|Adverse Event|1|||
145512676|NCT00966875|524738335|FG002|Part B|Adverse Event|1|||
145512677|NCT00966875|524738336|FG003|Part B|Adverse Event|0|||
145512678|NCT00966875|524738337|FG004|Part B|Adverse Event|1|||
145512679|NCT00966875|524738338|FG005|Part B|Adverse Event|0|||
145512680|NCT00966875|524738339|FG006|Part B|Adverse Event|5|||
145512681|NCT00966875|524738340|FG007|Part B|Adverse Event|2|||
145512682|NCT00966875|524738341|FG008|Part B|Adverse Event|2|||
145512683|NCT00966875|524738333|FG000|Part B|Death|0|||
145512684|NCT00966875|524738334|FG001|Part B|Death|0|||
145512685|NCT00966875|524738335|FG002|Part B|Death|1|||
145512686|NCT00966875|524738336|FG003|Part B|Death|0|||
145512687|NCT00966875|524738337|FG004|Part B|Death|0|||
145512688|NCT00966875|524738338|FG005|Part B|Death|0|||
145512689|NCT00966875|524738339|FG006|Part B|Death|0|||
145512690|NCT00966875|524738340|FG007|Part B|Death|1|||
145512691|NCT00966875|524738341|FG008|Part B|Death|0|||
145512692|NCT00966875|524738333|FG000|Part B|Lack of Efficacy|2|||
145512693|NCT00966875|524738334|FG001|Part B|Lack of Efficacy|1|||
145512694|NCT00966875|524738335|FG002|Part B|Lack of Efficacy|1|||
145512695|NCT00966875|524738336|FG003|Part B|Lack of Efficacy|1|||
145512696|NCT00966875|524738337|FG004|Part B|Lack of Efficacy|2|||
145512697|NCT00966875|524738338|FG005|Part B|Lack of Efficacy|3|||
145512698|NCT00966875|524738339|FG006|Part B|Lack of Efficacy|12|||
145512699|NCT00966875|524738340|FG007|Part B|Lack of Efficacy|9|||
145512700|NCT00966875|524738341|FG008|Part B|Lack of Efficacy|6|||
145512701|NCT00966875|524738333|FG000|Part B|Lost to Follow-up|0|||
145512702|NCT00966875|524738334|FG001|Part B|Lost to Follow-up|0|||
145512703|NCT00966875|524738335|FG002|Part B|Lost to Follow-up|0|||
145512704|NCT00966875|524738336|FG003|Part B|Lost to Follow-up|1|||
145512705|NCT00966875|524738337|FG004|Part B|Lost to Follow-up|0|||
145512706|NCT00966875|524738338|FG005|Part B|Lost to Follow-up|0|||
145512707|NCT00966875|524738339|FG006|Part B|Lost to Follow-up|0|||
145512708|NCT00966875|524738340|FG007|Part B|Lost to Follow-up|0|||
145512709|NCT00966875|524738341|FG008|Part B|Lost to Follow-up|1|||
145512710|NCT00966875|524738333|FG000|Part B|Physician Decision|0|||
145512711|NCT00966875|524738334|FG001|Part B|Physician Decision|0|||
145512712|NCT00966875|524738335|FG002|Part B|Physician Decision|1|||
145512713|NCT00966875|524738336|FG003|Part B|Physician Decision|0|||
145512714|NCT00966875|524738337|FG004|Part B|Physician Decision|2|||
145512715|NCT00966875|524738338|FG005|Part B|Physician Decision|1|||
145512716|NCT00966875|524738339|FG006|Part B|Physician Decision|0|||
145512717|NCT00966875|524738340|FG007|Part B|Physician Decision|0|||
145512718|NCT00966875|524738341|FG008|Part B|Physician Decision|2|||
145512719|NCT00966875|524738333|FG000|Part B|Sponsor Decision|1|||
145512720|NCT00966875|524738334|FG001|Part B|Sponsor Decision|0|||
145512721|NCT00966875|524738335|FG002|Part B|Sponsor Decision|0|||
145512722|NCT00966875|524738336|FG003|Part B|Sponsor Decision|0|||
145512723|NCT00966875|524738337|FG004|Part B|Sponsor Decision|0|||
145512724|NCT00966875|524738338|FG005|Part B|Sponsor Decision|1|||
145512725|NCT00966875|524738339|FG006|Part B|Sponsor Decision|0|||
145512726|NCT00966875|524738340|FG007|Part B|Sponsor Decision|2|||
145512727|NCT00966875|524738341|FG008|Part B|Sponsor Decision|1|||
145512728|NCT00966875|524738333|FG000|Part B|Withdrawal by Subject|2|||
145512729|NCT00966875|524738334|FG001|Part B|Withdrawal by Subject|1|||
145512730|NCT00966875|524738335|FG002|Part B|Withdrawal by Subject|2|||
145512731|NCT00966875|524738336|FG003|Part B|Withdrawal by Subject|1|||
145512732|NCT00966875|524738337|FG004|Part B|Withdrawal by Subject|2|||
145512733|NCT00966875|524738338|FG005|Part B|Withdrawal by Subject|1|||
145512734|NCT00966875|524738339|FG006|Part B|Withdrawal by Subject|4|||
145512735|NCT00966875|524738340|FG007|Part B|Withdrawal by Subject|5|||
145512736|NCT00966875|524738341|FG008|Part B|Withdrawal by Subject|5|||
145512737|NCT00966875|524738333|FG000|Part B|Entry Criteria|0|||
145512738|NCT00966875|524738334|FG001|Part B|Entry Criteria|0|||
145512739|NCT00966875|524738335|FG002|Part B|Entry Criteria|0|||
145512740|NCT00966875|524738336|FG003|Part B|Entry Criteria|0|||
145512741|NCT00966875|524738337|FG004|Part B|Entry Criteria|0|||
145512742|NCT00966875|524738338|FG005|Part B|Entry Criteria|0|||
145512743|NCT00966875|524738339|FG006|Part B|Entry Criteria|1|||
145512744|NCT00966875|524738340|FG007|Part B|Entry Criteria|0|||
145512745|NCT00966875|524738341|FG008|Part B|Entry Criteria|1|||
145512746|NCT01589653|524738344|FG000|Overall Study|Protocol Violation|3|||
145512747|NCT01589653|524738345|FG001|Overall Study|Protocol Violation|1|||
145512748|NCT01589653|524738344|FG000|Overall Study|Withdrawal criteria|4|||
145512749|NCT01589653|524738345|FG001|Overall Study|Withdrawal criteria|7|||
145512750|NCT01589653|524738344|FG000|Overall Study|Unclassified|0|||
145512751|NCT01589653|524738345|FG001|Overall Study|Unclassified|3|||
145512752|NCT01536067|524738346|FG000|Overall Study|Disease Progression|1|||
145512753|NCT04250077|524738347|FG000|Overall Study|Withdrawal by Subject|0|||
145512754|NCT04250077|524738348|FG001|Overall Study|Withdrawal by Subject|1|||
145512755|NCT04250077|524738349|FG002|Overall Study|Withdrawal by Subject|0|||
145512756|NCT04250077|524738347|FG000|Overall Study|Lost to Follow-up|2|||
145512757|NCT04250077|524738348|FG001|Overall Study|Lost to Follow-up|3|||
145512758|NCT04250077|524738349|FG002|Overall Study|Lost to Follow-up|0|||
145512759|NCT03255629|524738350|FG000|Overall Study|Adverse Event|1|||
145512760|NCT03255629|524738351|FG001|Overall Study|Adverse Event|0|||
145512761|NCT03255629|524738350|FG000|Overall Study|did not experience hypoglycemia|2|||
145512762|NCT03255629|524738351|FG001|Overall Study|did not experience hypoglycemia|1|||
145512763|NCT04540198|524738352|FG000|Overall Study|Lost to Follow-up|25|||
145512764|NCT04540198|524738353|FG001|Overall Study|Lost to Follow-up|23|||
145512765|NCT04540198|524738352|FG000|Overall Study|Withdrawal by Subject|15|||
145512766|NCT04540198|524738353|FG001|Overall Study|Withdrawal by Subject|9|||
145512767|NCT04540198|524738352|FG000|Overall Study|Discontinued|1|||
145512768|NCT04540198|524738353|FG001|Overall Study|Discontinued|0|||
145512769|NCT01086358|524738354|FG000|First Intervention|Lost to Follow-up|9|||
145512770|NCT01086358|524738355|FG001|First Intervention|Lost to Follow-up|4|||
145512771|NCT01086358|524738354|FG000|First Intervention|Withdrawal by Subject|0|||
145512772|NCT01086358|524738355|FG001|First Intervention|Withdrawal by Subject|1|||
145512773|NCT01086358|524738354|FG000|Second Intervention|Lost to Follow-up|4|||
145512774|NCT01086358|524738355|FG001|Second Intervention|Lost to Follow-up|4|||
145512775|NCT03330002|524738359|FG000|Overall Study|Lost to Follow-up|15|||
145512776|NCT03330002|524738359|FG000|Overall Study|Death|7|||
145512777|NCT00833417|524738360|FG000|Overall Study|Adverse Event|5|||
145512778|NCT00833417|524738361|FG001|Overall Study|Adverse Event|16|||
145512779|NCT00833417|524738360|FG000|Overall Study|Death|1|||
145512780|NCT00833417|524738361|FG001|Overall Study|Death|3|||
145512781|NCT00833417|524738360|FG000|Overall Study|Lost to Follow-up|1|||
145512782|NCT00833417|524738361|FG001|Overall Study|Lost to Follow-up|2|||
145512783|NCT00833417|524738360|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
145512784|NCT00833417|524738361|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
145512785|NCT00833417|524738360|FG000|Overall Study|Patient Decision to Withdraw|4|||
145512786|NCT00833417|524738361|FG001|Overall Study|Patient Decision to Withdraw|23|||
145512787|NCT00833417|524738360|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
145512788|NCT00833417|524738361|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
145512789|NCT00833417|524738360|FG000|Overall Study|Disease Progression|18|||
145512790|NCT00833417|524738361|FG001|Overall Study|Disease Progression|17|||
145512791|NCT00833417|524738360|FG000|Overall Study|Reason Not Specified|0|||
145512792|NCT00833417|524738361|FG001|Overall Study|Reason Not Specified|1|||
145512793|NCT01625260|524738362|FG000|Overall Study|Adverse Event|3|||
145512794|NCT01625260|524738363|FG001|Overall Study|Adverse Event|0|||
145512795|NCT01625260|524738362|FG000|Overall Study|Study Terminated by Investigator|2|||
145512796|NCT01625260|524738363|FG001|Overall Study|Study Terminated by Investigator|0|||
145512797|NCT01625260|524738362|FG000|Overall Study|Disease Progression|2|||
145512798|NCT01625260|524738363|FG001|Overall Study|Disease Progression|0|||
145512799|NCT01625260|524738362|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
145402058|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
145402059|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
145512800|NCT01625260|524738363|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
145512801|NCT03899805|524738364|FG000|Overall Study|Physician Decision|3|||
145512802|NCT03899805|524738365|FG001|Overall Study|Physician Decision|0|||
145512803|NCT03899805|524738366|FG002|Overall Study|Physician Decision|2|||
145512804|NCT03899805|524738364|FG000|Overall Study|Withdrawal by Subject|1|||
145512805|NCT03899805|524738365|FG001|Overall Study|Withdrawal by Subject|0|||
145512806|NCT03899805|524738366|FG002|Overall Study|Withdrawal by Subject|2|||
145512807|NCT03899805|524738364|FG000|Overall Study|Progressive Disease|10|||
145512808|NCT03899805|524738365|FG001|Overall Study|Progressive Disease|18|||
145512809|NCT03899805|524738366|FG002|Overall Study|Progressive Disease|12|||
145512810|NCT03899805|524738364|FG000|Overall Study|Adverse Event|3|||
145512811|NCT03899805|524738365|FG001|Overall Study|Adverse Event|1|||
145512812|NCT03899805|524738366|FG002|Overall Study|Adverse Event|0|||
145512813|NCT03899805|524738364|FG000|Overall Study|Death|2|||
145512814|NCT03899805|524738365|FG001|Overall Study|Death|0|||
145512815|NCT03899805|524738366|FG002|Overall Study|Death|0|||
145512816|NCT03899805|524738364|FG000|Overall Study|Came off for surgery|0|||
145512817|NCT03899805|524738365|FG001|Overall Study|Came off for surgery|0|||
145512818|NCT03899805|524738366|FG002|Overall Study|Came off for surgery|1|||
145512819|NCT03317405|524738367|FG000|Overall Study|Withdrawal by Subject|1|||
145512820|NCT03317405|524738368|FG001|Overall Study|Withdrawal by Subject|0|||
145512821|NCT03317405|524738369|FG002|Overall Study|Withdrawal by Subject|0|||
145512822|NCT03317405|524738367|FG000|Overall Study|Physician Decision|0|||
145512823|NCT03317405|524738368|FG001|Overall Study|Physician Decision|0|||
145402060|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
145402061|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
145402062|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
145402063|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
145402064|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
145402065|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
145402066|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
145402067|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145402068|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145402069|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145402070|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
145402071|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
145402072|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145402073|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145402074|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145402075|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
145402076|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145512824|NCT03317405|524738369|FG002|Overall Study|Physician Decision|1|||
145512825|NCT03317405|524738367|FG000|Overall Study|Surgery Rescheduled|0|||
145512826|NCT03317405|524738368|FG001|Overall Study|Surgery Rescheduled|1|||
145512827|NCT03317405|524738369|FG002|Overall Study|Surgery Rescheduled|0|||
145512828|NCT04075734|524738372|FG000|Overall Study|Lost to Follow-up|1|||
145512829|NCT04075734|524738373|FG001|Overall Study|Lost to Follow-up|1|||
145512830|NCT04075734|524738374|FG002|Overall Study|Lost to Follow-up|0|||
145512831|NCT04075734|524738372|FG000|Overall Study|Withdrawal by Subject|3|||
145512832|NCT04075734|524738373|FG001|Overall Study|Withdrawal by Subject|0|||
145512833|NCT04075734|524738374|FG002|Overall Study|Withdrawal by Subject|0|||
145512834|NCT01137604|524738377|FG000|Overall Study|Adverse Event|3|||
145512835|NCT01137604|524738378|FG001|Overall Study|Adverse Event|6|||
145512836|NCT01137604|524738379|FG002|Overall Study|Adverse Event|9|||
145512837|NCT01137604|524738380|FG003|Overall Study|Adverse Event|9|||
145512838|NCT01137604|524738377|FG000|Overall Study|Participant Choice|0|||
145512839|NCT01137604|524738378|FG001|Overall Study|Participant Choice|2|||
145512840|NCT01137604|524738379|FG002|Overall Study|Participant Choice|2|||
145512841|NCT01137604|524738380|FG003|Overall Study|Participant Choice|0|||
145512842|NCT01137604|524738377|FG000|Overall Study|Withdrawal of consent|0|||
145512843|NCT01137604|524738378|FG001|Overall Study|Withdrawal of consent|0|||
145512844|NCT01137604|524738379|FG002|Overall Study|Withdrawal of consent|0|||
145512845|NCT01137604|524738380|FG003|Overall Study|Withdrawal of consent|2|||
145512846|NCT01137604|524738377|FG000|Overall Study|Clinical progression/deterioration|1|||
145512847|NCT01137604|524738378|FG001|Overall Study|Clinical progression/deterioration|2|||
145512848|NCT01137604|524738379|FG002|Overall Study|Clinical progression/deterioration|2|||
145512849|NCT01137604|524738380|FG003|Overall Study|Clinical progression/deterioration|0|||
145512850|NCT00591318|524738381|FG000|Overall Study|Lack of Efficacy|2|||
145512851|NCT00591318|524738382|FG001|Overall Study|Lack of Efficacy|0|||
145512852|NCT00591318|524738381|FG000|Overall Study|Adverse Event|2|||
145512853|NCT00591318|524738382|FG001|Overall Study|Adverse Event|0|||
145512854|NCT01776307|524738383|FG000|Overall Study|Not dosed|0|||
145512855|NCT01776307|524738384|FG001|Overall Study|Not dosed|0|||
145512856|NCT01776307|524738385|FG002|Overall Study|Not dosed|1|||
145512857|NCT01024309|524738391|FG000|Overall Study|Physician Decision|4|||
145512858|NCT01024309|524738392|FG001|Overall Study|Physician Decision|0|||
145512859|NCT01024309|524738391|FG000|Overall Study|Withdrawal by Subject|4|||
145512860|NCT01024309|524738392|FG001|Overall Study|Withdrawal by Subject|4|||
145512861|NCT02745145|524738395|FG000|Overall Study|Adverse Event|1|||
145512862|NCT02745145|524738396|FG001|Overall Study|Adverse Event|0|||
145512863|NCT02745145|524738397|FG002|Overall Study|Adverse Event|0|||
145512864|NCT02745145|524738395|FG000|Overall Study|Death|0|||
145512865|NCT02745145|524738396|FG001|Overall Study|Death|1|||
145512866|NCT02745145|524738397|FG002|Overall Study|Death|0|||
145512867|NCT02745145|524738395|FG000|Overall Study|Progressive disease|0|||
145512868|NCT02745145|524738396|FG001|Overall Study|Progressive disease|0|||
145512869|NCT02745145|524738397|FG002|Overall Study|Progressive disease|1|||
145512870|NCT02745145|524738395|FG000|Overall Study|Withdrew consent|1|||
145512871|NCT02745145|524738396|FG001|Overall Study|Withdrew consent|1|||
145512872|NCT02745145|524738397|FG002|Overall Study|Withdrew consent|1|||
145512873|NCT02745145|524738395|FG000|Overall Study|Study Termination|8|||
145512874|NCT02745145|524738396|FG001|Overall Study|Study Termination|3|||
145733055|NCT00312221|525540906|FG002|Open-label Run-in Period|Adverse Event|0|||
145512875|NCT02745145|524738397|FG002|Overall Study|Study Termination|7|||
145512876|NCT03083990|524738398|FG000|Overall Study|Adverse Event|1|||
145512877|NCT03083990|524738399|FG001|Overall Study|Adverse Event|0|||
145512878|NCT02424578|524738400|FG000|Overall Study|Withdrawal by Subject|0|||
145512879|NCT02424578|524738401|FG001|Overall Study|Withdrawal by Subject|1|||
145512880|NCT02640508|524738407|FG000|Overall Study|Death|19|||
145512881|NCT02640508|524738407|FG000|Overall Study|Withdrawal by Subject|8|||
145512882|NCT02640508|524738407|FG000|Overall Study|Physician Decision|1|||
145512883|NCT02640508|524738407|FG000|Overall Study|Lost to Follow-up|1|||
145512884|NCT00862082|524738408|FG000|Overall Study|Sponsor decision to terminate the study|5|||
145512885|NCT00862082|524738409|FG001|Overall Study|Sponsor decision to terminate the study|0|||
145512886|NCT00862082|524738408|FG000|Overall Study|Withdrawal by Subject|0|||
145512887|NCT00862082|524738409|FG001|Overall Study|Withdrawal by Subject|1|||
145512888|NCT05405257|524738410|FG000|Overall Study|Withdrawal by Subject|1|||
145512889|NCT00776919|524738411|FG000|Overall Study|Withdrawal by Subject|16|||
145512890|NCT00776919|524738412|FG001|Overall Study|Withdrawal by Subject|14|||
145512891|NCT00776919|524738413|FG002|Overall Study|Withdrawal by Subject|15|||
145512892|NCT00776919|524738414|FG003|Overall Study|Withdrawal by Subject|26|||
145512893|NCT00776919|524738411|FG000|Overall Study|Lost to Follow-up|8|||
145512894|NCT00776919|524738412|FG001|Overall Study|Lost to Follow-up|12|||
145512895|NCT00776919|524738413|FG002|Overall Study|Lost to Follow-up|11|||
145512896|NCT00776919|524738414|FG003|Overall Study|Lost to Follow-up|8|||
145512897|NCT00776919|524738411|FG000|Overall Study|Adverse Event|1|||
145512898|NCT00776919|524738412|FG001|Overall Study|Adverse Event|0|||
145512899|NCT00776919|524738413|FG002|Overall Study|Adverse Event|2|||
145512900|NCT00776919|524738414|FG003|Overall Study|Adverse Event|2|||
145512901|NCT00776919|524738411|FG000|Overall Study|Protocol Violation|1|||
145512902|NCT00776919|524738412|FG001|Overall Study|Protocol Violation|2|||
145512903|NCT00776919|524738413|FG002|Overall Study|Protocol Violation|0|||
145512904|NCT00776919|524738414|FG003|Overall Study|Protocol Violation|1|||
145512905|NCT00776919|524738411|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
145512906|NCT00776919|524738412|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
145512907|NCT00776919|524738413|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
145512908|NCT00776919|524738414|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
145512909|NCT03116152|524738415|FG000|Overall Study|Disease Progression|49|||
145512910|NCT03116152|524738416|FG001|Overall Study|Disease Progression|47|||
145512911|NCT03116152|524738415|FG000|Overall Study|Death|5|||
145512912|NCT03116152|524738416|FG001|Overall Study|Death|2|||
145512913|NCT03116152|524738415|FG000|Overall Study|Adverse Event|21|||
145512914|NCT03116152|524738416|FG001|Overall Study|Adverse Event|7|||
145512915|NCT03116152|524738415|FG000|Overall Study|Protocol Violation|2|||
145512916|NCT03116152|524738416|FG001|Overall Study|Protocol Violation|2|||
145512917|NCT03116152|524738415|FG000|Overall Study|Withdrawal by Subject|0|||
145512918|NCT03116152|524738416|FG001|Overall Study|Withdrawal by Subject|1|||
145512919|NCT03116152|524738415|FG000|Overall Study|Physician Decision|3|||
145512920|NCT03116152|524738416|FG001|Overall Study|Physician Decision|2|||
145512921|NCT03116152|524738415|FG000|Overall Study|other|11|||
145512922|NCT03116152|524738416|FG001|Overall Study|other|34|||
145512923|NCT00862641|524738418|FG000|Overall Study|Randomized, but drug not received|1|||
145512924|NCT00862641|524738419|FG001|Overall Study|Randomized, but drug not received|4|||
145512925|NCT00862641|524738420|FG002|Overall Study|Randomized, but drug not received|1|||
145512926|NCT00862641|524738421|FG003|Overall Study|Randomized, but drug not received|4|||
145512927|NCT03179605|524738422|FG000|Overall Study|Withdrawal by Subject|1|||
145512928|NCT00635999|524738423|FG000|Overall Study|Withdrawal by Subject|4|||
145512929|NCT00635999|524738424|FG001|Overall Study|Withdrawal by Subject|2|||
145512930|NCT00635999|524738425|FG002|Overall Study|Withdrawal by Subject|1|||
145512931|NCT00711477|524738426|FG000|Overall Study|Adverse Event|3|||
145512932|NCT00711477|524738427|FG001|Overall Study|Adverse Event|1|||
145512933|NCT00711477|524738426|FG000|Overall Study|Lost to Follow-up|0|||
145512934|NCT00711477|524738427|FG001|Overall Study|Lost to Follow-up|1|||
145512935|NCT00711477|524738426|FG000|Overall Study|Noncompliance|0|||
145512936|NCT00711477|524738427|FG001|Overall Study|Noncompliance|1|||
145512937|NCT01798849|524738428|FG000|Overall Study|Physician Decision|0|||
145512938|NCT01798849|524738429|FG001|Overall Study|Physician Decision|0|||
145512939|NCT01798849|524738430|FG002|Overall Study|Physician Decision|1|||
145512940|NCT02636361|524738431|FG000|Period 4|Physician Decision|0|||
145512941|NCT02636361|524738432|FG001|Period 4|Physician Decision|0|||
145512942|NCT02636361|524738433|FG002|Period 4|Physician Decision|0|||
145512943|NCT02636361|524738434|FG003|Period 4|Physician Decision|1|||
145512944|NCT02636361|524738435|FG004|Period 4|Physician Decision|0|||
145512945|NCT00228553|524738439|FG000|Overall Study|Adverse Event|112|||
145512946|NCT00228553|524738439|FG000|Overall Study|Lack of Efficacy|34|||
145512947|NCT00228553|524738439|FG000|Overall Study|Lost to Follow-up|67|||
145512948|NCT00228553|524738439|FG000|Overall Study|Physician Decision|48|||
145512949|NCT00228553|524738439|FG000|Overall Study|Protocol Violation|6|||
145512950|NCT00228553|524738439|FG000|Overall Study|Withdrawal by Subject|115|||
145512951|NCT00228553|524738439|FG000|Overall Study|Pregnancy|2|||
145512952|NCT00228553|524738439|FG000|Overall Study|Miscellaneous|46|||
145512953|NCT04556383|524738440|FG000|PCP|Lack of Efficacy|28|||
145512954|NCT04556383|524738441|FG001|PCP|Lack of Efficacy|23|||
145512955|NCT04556383|524738442|FG002|PCP|Lack of Efficacy|23|||
145512956|NCT04556383|524738443|FG003|PCP|Lack of Efficacy|0|||
145512957|NCT04556383|524738440|FG000|PCP|Study terminated by sponsor|15|||
145512958|NCT04556383|524738441|FG001|PCP|Study terminated by sponsor|13|||
145512959|NCT04556383|524738442|FG002|PCP|Study terminated by sponsor|16|||
145512960|NCT04556383|524738443|FG003|PCP|Study terminated by sponsor|0|||
145512961|NCT04556383|524738440|FG000|PCP|Withdrawal by Subject|8|||
145512962|NCT04556383|524738441|FG001|PCP|Withdrawal by Subject|6|||
145512963|NCT04556383|524738442|FG002|PCP|Withdrawal by Subject|6|||
145512964|NCT04556383|524738443|FG003|PCP|Withdrawal by Subject|0|||
145512965|NCT04556383|524738440|FG000|PCP|Adverse Event|1|||
145512966|NCT04556383|524738441|FG001|PCP|Adverse Event|7|||
145512967|NCT04556383|524738442|FG002|PCP|Adverse Event|7|||
145512968|NCT04556383|524738443|FG003|PCP|Adverse Event|0|||
145512969|NCT04556383|524738440|FG000|PCP|Other, Not Specified|1|||
145512970|NCT04556383|524738441|FG001|PCP|Other, Not Specified|2|||
145512971|NCT04556383|524738442|FG002|PCP|Other, Not Specified|1|||
145512972|NCT04556383|524738443|FG003|PCP|Other, Not Specified|0|||
145512973|NCT04556383|524738440|FG000|PCP|Protocol Violation|1|||
145512974|NCT04556383|524738441|FG001|PCP|Protocol Violation|0|||
145512975|NCT04556383|524738442|FG002|PCP|Protocol Violation|1|||
145512976|NCT04556383|524738443|FG003|PCP|Protocol Violation|0|||
145512977|NCT04556383|524738440|FG000|PCP|Lost to Follow-up|1|||
145512978|NCT04556383|524738441|FG001|PCP|Lost to Follow-up|0|||
145512979|NCT04556383|524738442|FG002|PCP|Lost to Follow-up|0|||
145512980|NCT04556383|524738443|FG003|PCP|Lost to Follow-up|0|||
145512981|NCT04556383|524738440|FG000|PCP|Physician Decision|0|||
145512982|NCT04556383|524738441|FG001|PCP|Physician Decision|1|||
145512983|NCT04556383|524738442|FG002|PCP|Physician Decision|0|||
145512984|NCT04556383|524738443|FG003|PCP|Physician Decision|0|||
145512985|NCT04556383|524738440|FG000|PCP|Site terminated by sponsor|0|||
145512986|NCT04556383|524738441|FG001|PCP|Site terminated by sponsor|1|||
145512987|NCT04556383|524738442|FG002|PCP|Site terminated by sponsor|0|||
145512988|NCT04556383|524738443|FG003|PCP|Site terminated by sponsor|0|||
145512989|NCT04556383|524738440|FG000|OLE|Study terminated by sponsor|0|||
145512990|NCT04556383|524738441|FG001|OLE|Study terminated by sponsor|0|||
145512991|NCT04556383|524738442|FG002|OLE|Study terminated by sponsor|0|||
145512992|NCT04556383|524738443|FG003|OLE|Study terminated by sponsor|68|||
145512993|NCT04556383|524738440|FG000|OLE|Withdrawal by Subject|0|||
145512994|NCT04556383|524738441|FG001|OLE|Withdrawal by Subject|0|||
145512995|NCT04556383|524738442|FG002|OLE|Withdrawal by Subject|0|||
145512996|NCT04556383|524738443|FG003|OLE|Withdrawal by Subject|10|||
145512997|NCT04556383|524738440|FG000|OLE|Lack of Efficacy|0|||
145512998|NCT04556383|524738441|FG001|OLE|Lack of Efficacy|0|||
145512999|NCT04556383|524738442|FG002|OLE|Lack of Efficacy|0|||
145513000|NCT04556383|524738443|FG003|OLE|Lack of Efficacy|7|||
145513001|NCT04556383|524738440|FG000|OLE|Adverse Event|0|||
145513002|NCT04556383|524738441|FG001|OLE|Adverse Event|0|||
145513003|NCT04556383|524738442|FG002|OLE|Adverse Event|0|||
145513004|NCT04556383|524738443|FG003|OLE|Adverse Event|2|||
145513005|NCT04556383|524738440|FG000|OLE|Other, Not Specified|0|||
145513006|NCT04556383|524738441|FG001|OLE|Other, Not Specified|0|||
145513007|NCT04556383|524738442|FG002|OLE|Other, Not Specified|0|||
145513008|NCT04556383|524738443|FG003|OLE|Other, Not Specified|2|||
145513009|NCT04556383|524738440|FG000|OLE|Death|0|||
145513010|NCT04556383|524738441|FG001|OLE|Death|0|||
145513011|NCT04556383|524738442|FG002|OLE|Death|0|||
145513012|NCT04556383|524738443|FG003|OLE|Death|1|||
145513013|NCT04556383|524738440|FG000|OLE|Lost to Follow-up|0|||
145513014|NCT04556383|524738441|FG001|OLE|Lost to Follow-up|0|||
145513015|NCT04556383|524738442|FG002|OLE|Lost to Follow-up|0|||
145513016|NCT04556383|524738443|FG003|OLE|Lost to Follow-up|1|||
145513017|NCT00612807|524738444|FG000|Overall Study|Withdrawal by Subject|2|||
145513018|NCT00612807|524738445|FG001|Overall Study|Withdrawal by Subject|0|||
145513019|NCT00744042|524738448|FG000|Overall Study|Withdrawal by Subject|1|||
145513020|NCT02970942|524738451|FG000|Overall Study|Death|0|||
145513021|NCT02970942|524738452|FG001|Overall Study|Death|1|||
145513022|NCT02970942|524738453|FG002|Overall Study|Death|0|||
145513023|NCT02970942|524738454|FG003|Overall Study|Death|0|||
145513024|NCT02970942|524738451|FG000|Overall Study|Lost to Follow-up|1|||
145513025|NCT02970942|524738452|FG001|Overall Study|Lost to Follow-up|0|||
145513026|NCT02970942|524738453|FG002|Overall Study|Lost to Follow-up|2|||
145513027|NCT02970942|524738454|FG003|Overall Study|Lost to Follow-up|1|||
145513028|NCT02970942|524738451|FG000|Overall Study|Withdrawal by Subject|3|||
145513029|NCT02970942|524738452|FG001|Overall Study|Withdrawal by Subject|5|||
145513030|NCT02970942|524738453|FG002|Overall Study|Withdrawal by Subject|3|||
145513031|NCT02970942|524738454|FG003|Overall Study|Withdrawal by Subject|2|||
145513032|NCT01065454|524738457|FG000|Treatment|Adverse Event|7|||
145513033|NCT01065454|524738458|FG001|Treatment|Adverse Event|4|||
145513034|NCT01065454|524738459|FG002|Treatment|Adverse Event|3|||
145513035|NCT01065454|524738460|FG003|Treatment|Adverse Event|6|||
145513036|NCT01065454|524738457|FG000|Treatment|Death|1|||
145513037|NCT01065454|524738458|FG001|Treatment|Death|0|||
145513038|NCT01065454|524738459|FG002|Treatment|Death|0|||
145513039|NCT01065454|524738460|FG003|Treatment|Death|0|||
145513040|NCT01065454|524738457|FG000|Treatment|Non-compliance|1|||
145513041|NCT01065454|524738458|FG001|Treatment|Non-compliance|0|||
145513042|NCT01065454|524738459|FG002|Treatment|Non-compliance|0|||
145513043|NCT01065454|524738460|FG003|Treatment|Non-compliance|1|||
145513044|NCT01065454|524738457|FG000|Treatment|Protocol Decision|0|||
145513045|NCT01065454|524738458|FG001|Treatment|Protocol Decision|0|||
145513046|NCT01065454|524738459|FG002|Treatment|Protocol Decision|3|||
145513047|NCT01065454|524738460|FG003|Treatment|Protocol Decision|2|||
145513048|NCT01065454|524738457|FG000|Treatment|Protocol Violation|1|||
145513049|NCT01065454|524738458|FG001|Treatment|Protocol Violation|0|||
145513050|NCT01065454|524738459|FG002|Treatment|Protocol Violation|1|||
145513051|NCT01065454|524738460|FG003|Treatment|Protocol Violation|0|||
145513052|NCT01065454|524738457|FG000|Treatment|Withdrawal by Subject|3|||
145513053|NCT01065454|524738458|FG001|Treatment|Withdrawal by Subject|1|||
145513054|NCT01065454|524738459|FG002|Treatment|Withdrawal by Subject|2|||
145513055|NCT01065454|524738460|FG003|Treatment|Withdrawal by Subject|3|||
145513056|NCT01065454|524738457|FG000|Follow up|Adverse Event|1|||
145513057|NCT01065454|524738458|FG001|Follow up|Adverse Event|0|||
145513058|NCT01065454|524738459|FG002|Follow up|Adverse Event|0|||
145513059|NCT01065454|524738460|FG003|Follow up|Adverse Event|1|||
145513060|NCT01065454|524738457|FG000|Follow up|Death|0|||
145513061|NCT01065454|524738458|FG001|Follow up|Death|1|||
145513062|NCT01065454|524738459|FG002|Follow up|Death|1|||
145513063|NCT01065454|524738460|FG003|Follow up|Death|0|||
145513064|NCT01065454|524738457|FG000|Follow up|Lost to Follow-up|0|||
145513065|NCT01065454|524738458|FG001|Follow up|Lost to Follow-up|0|||
145513066|NCT01065454|524738459|FG002|Follow up|Lost to Follow-up|0|||
145513067|NCT01065454|524738460|FG003|Follow up|Lost to Follow-up|1|||
145513068|NCT01065454|524738457|FG000|Follow up|Progressive disease|0|||
145513069|NCT01065454|524738458|FG001|Follow up|Progressive disease|0|||
145513070|NCT01065454|524738459|FG002|Follow up|Progressive disease|0|||
145513071|NCT01065454|524738460|FG003|Follow up|Progressive disease|1|||
145513072|NCT01065454|524738457|FG000|Follow up|Withdrawal by Subject|1|||
145513073|NCT01065454|524738458|FG001|Follow up|Withdrawal by Subject|1|||
145513074|NCT01065454|524738459|FG002|Follow up|Withdrawal by Subject|1|||
145513075|NCT01065454|524738460|FG003|Follow up|Withdrawal by Subject|0|||
145513076|NCT01065454|524738457|FG000|Follow up|study ongoing|37|||
145513077|NCT01065454|524738458|FG001|Follow up|study ongoing|22|||
145513078|NCT01065454|524738459|FG002|Follow up|study ongoing|15|||
145513079|NCT01065454|524738460|FG003|Follow up|study ongoing|41|||
145513080|NCT02537015|524738461|FG000|Overall Study|Adverse Event|3|||
145513081|NCT02537015|524738461|FG000|Overall Study|Withdrawal by Subject|2|||
145513082|NCT02537015|524738461|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145513083|NCT01097005|524738465|FG000|Overall Study|Case Report Form not collected|18|||
145513084|NCT01097005|524738465|FG000|Overall Study|Subjects cannot visit the hospital|1|||
145513085|NCT01097005|524738465|FG000|Overall Study|Poor medication compliance|1|||
145513086|NCT01097005|524738465|FG000|Overall Study|No examination data available|244|||
145513087|NCT01097005|524738465|FG000|Overall Study|Deviation from exclusion criteria|37|||
145513088|NCT01097005|524738465|FG000|Overall Study|Adverse Event|14|||
145513089|NCT01097005|524738465|FG000|Overall Study|Discontinuance by complication|50|||
145513090|NCT00588861|524739597|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
145513091|NCT00588861|524739598|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
145513092|NCT00588861|524739597|FG000|6 Months|Patients did not return for follow-up|98|||
145513093|NCT00588861|524739598|FG001|6 Months|Patients did not return for follow-up|73|||
145513094|NCT00588861|524739597|FG000|1 Year|Patients did not return for follow-up|89|||
145513095|NCT00588861|524739598|FG001|1 Year|Patients did not return for follow-up|82|||
145513096|NCT00588861|524739597|FG000|2 Years|Patients did not return for follow-up|92|||
145513097|NCT00588861|524739598|FG001|2 Years|Patients did not return for follow-up|87|||
145513098|NCT00588861|524739597|FG000|4 Years|Patients did not return for follow-up|91|||
145513099|NCT00588861|524739598|FG001|4 Years|Patients did not return for follow-up|103|||
145513100|NCT00588861|524739597|FG000|6 Years|Patients did not return for follow-up|104|||
145513101|NCT00588861|524739598|FG001|6 Years|Patients did not return for follow-up|109|||
145513102|NCT00588861|524739597|FG000|8 Years|Patients did not return for follow-up|105|||
145513103|NCT00588861|524739598|FG001|8 Years|Patients did not return for follow-up|114|||
145513104|NCT00588861|524739597|FG000|10 Years|Incomplete due to study termination|107|||
145513105|NCT00588861|524739598|FG001|10 Years|Incomplete due to study termination|114|||
145513106|NCT03254459|524739604|FG000|Overall Study|Adverse Event|7|||
145513107|NCT03254459|524739605|FG001|Overall Study|Adverse Event|20|||
145513108|NCT03254459|524739604|FG000|Overall Study|Withdrawal by Subject Consent|3|||
145513109|NCT03254459|524739605|FG001|Overall Study|Withdrawal by Subject Consent|1|||
145513110|NCT03254459|524739604|FG000|Overall Study|Lost to Follow-up|0|||
145513111|NCT03254459|524739605|FG001|Overall Study|Lost to Follow-up|1|||
145513112|NCT03254459|524739604|FG000|Overall Study|Miscellaneous|0|||
145513113|NCT03254459|524739605|FG001|Overall Study|Miscellaneous|1|||
145513114|NCT00617669|524739612|FG000|Overall Study|Withdrawal by Subject|71|||
145513115|NCT00617669|524739613|FG001|Overall Study|Withdrawal by Subject|77|||
145733056|NCT00312221|525540907|FG003|Open-label Run-in Period|Adverse Event|0|||
145733057|NCT00312221|525540904|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
145733058|NCT00312221|525540905|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
145733059|NCT00312221|525540906|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
145733060|NCT00312221|525540907|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
145733061|NCT00312221|525540904|FG000|Open-label Run-in Period|Administrative|42|||
145733062|NCT00312221|525540905|FG001|Open-label Run-in Period|Administrative|0|||
145733063|NCT00312221|525540906|FG002|Open-label Run-in Period|Administrative|0|||
145733064|NCT00312221|525540907|FG003|Open-label Run-in Period|Administrative|0|||
145733065|NCT00312221|525540904|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
145733066|NCT00312221|525540905|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
145733067|NCT00312221|525540906|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
145733068|NCT00312221|525540907|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
145733069|NCT00312221|525540904|FG000|Open-label Run-in Period|Did not qualify|5|||
145733070|NCT00312221|525540905|FG001|Open-label Run-in Period|Did not qualify|0|||
145733071|NCT00312221|525540906|FG002|Open-label Run-in Period|Did not qualify|0|||
145733072|NCT00312221|525540907|FG003|Open-label Run-in Period|Did not qualify|0|||
145733073|NCT00312221|525540904|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145733074|NCT00312221|525540905|FG001|Double-blind Phase|Withdrawal by Subject|6|||
145733075|NCT00312221|525540906|FG002|Double-blind Phase|Withdrawal by Subject|8|||
145733076|NCT00312221|525540907|FG003|Double-blind Phase|Withdrawal by Subject|7|||
145733077|NCT00312221|525540904|FG000|Double-blind Phase|Adverse Event|0|||
145733078|NCT00312221|525540905|FG001|Double-blind Phase|Adverse Event|10|||
145733079|NCT00312221|525540906|FG002|Double-blind Phase|Adverse Event|19|||
145733080|NCT00312221|525540907|FG003|Double-blind Phase|Adverse Event|18|||
145733081|NCT00312221|525540904|FG000|Double-blind Phase|Lost to Follow-up|0|||
145733082|NCT00312221|525540905|FG001|Double-blind Phase|Lost to Follow-up|0|||
145733083|NCT00312221|525540906|FG002|Double-blind Phase|Lost to Follow-up|2|||
145733084|NCT00312221|525540907|FG003|Double-blind Phase|Lost to Follow-up|2|||
145513116|NCT00617669|524739612|FG000|Overall Study|Lost to Follow-up|3|||
145513117|NCT00617669|524739613|FG001|Overall Study|Lost to Follow-up|2|||
145513118|NCT00617669|524739612|FG000|Overall Study|Adverse Event|87|||
145513119|NCT00617669|524739613|FG001|Overall Study|Adverse Event|76|||
145733085|NCT00312221|525540904|FG000|Double-blind Phase|Administrative|0|||
145733086|NCT00312221|525540905|FG001|Double-blind Phase|Administrative|26|||
145733087|NCT00312221|525540906|FG002|Double-blind Phase|Administrative|37|||
145733088|NCT00312221|525540907|FG003|Double-blind Phase|Administrative|33|||
145733089|NCT00312221|525540904|FG000|Double-blind Phase|Lack of Efficacy|0|||
145733090|NCT00312221|525540905|FG001|Double-blind Phase|Lack of Efficacy|17|||
145733091|NCT00312221|525540906|FG002|Double-blind Phase|Lack of Efficacy|6|||
145733092|NCT00312221|525540907|FG003|Double-blind Phase|Lack of Efficacy|10|||
145733093|NCT02060721|525540908|FG000|Overall Study|Lost to Follow-up|1|||
145733094|NCT02060721|525540908|FG000|Overall Study|Physician Decision|2|||
145513120|NCT00617669|524739612|FG000|Overall Study|Protocol Violation|2|||
145733095|NCT02060721|525540908|FG000|Overall Study|Death|14|||
145733096|NCT02060721|525540908|FG000|Overall Study|Withdrawal by Subject|2|||
145733097|NCT02060721|525540908|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
145733098|NCT00866723|525540909|FG000|Overall Study|Withdrawal by Subject|1|||
145733099|NCT00866723|525540909|FG000|Overall Study|Disease Progression|4|||
145513121|NCT00617669|524739613|FG001|Overall Study|Protocol Violation|3|||
145513122|NCT00617669|524739612|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
145733100|NCT04178967|525540910|FG000|Induction Period|Adverse Event|4|||
145733101|NCT04178967|525540911|FG001|Induction Period|Adverse Event|6|||
145733102|NCT04178967|525540912|FG002|Induction Period|Adverse Event|0|||
145733103|NCT04178967|525540913|FG003|Induction Period|Adverse Event|0|||
145733104|NCT04178967|525540914|FG004|Induction Period|Adverse Event|0|||
145733105|NCT04178967|525540915|FG005|Induction Period|Adverse Event|0|||
145733106|NCT04178967|525540916|FG006|Induction Period|Adverse Event|0|||
145733107|NCT04178967|525540917|FG007|Induction Period|Adverse Event|0|||
145733108|NCT04178967|525540918|FG008|Induction Period|Adverse Event|0|||
145733109|NCT04178967|525540919|FG009|Induction Period|Adverse Event|0|||
145733110|NCT04178967|525540920|FG010|Induction Period|Adverse Event|0|||
145733111|NCT04178967|525540910|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
145733112|NCT04178967|525540911|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
145733113|NCT04178967|525540912|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
145733114|NCT04178967|525540913|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
145733115|NCT04178967|525540914|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
145733116|NCT04178967|525540915|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
145733117|NCT04178967|525540916|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
145733118|NCT04178967|525540917|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
145733119|NCT04178967|525540918|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
145733120|NCT04178967|525540919|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
145733121|NCT04178967|525540920|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
145733122|NCT04178967|525540910|FG000|Induction Period|Lack of Efficacy|4|||
145733123|NCT04178967|525540911|FG001|Induction Period|Lack of Efficacy|1|||
145733124|NCT04178967|525540912|FG002|Induction Period|Lack of Efficacy|0|||
145733125|NCT04178967|525540913|FG003|Induction Period|Lack of Efficacy|0|||
145733126|NCT04178967|525540914|FG004|Induction Period|Lack of Efficacy|0|||
145733127|NCT04178967|525540915|FG005|Induction Period|Lack of Efficacy|0|||
145733128|NCT04178967|525540916|FG006|Induction Period|Lack of Efficacy|0|||
145733129|NCT04178967|525540917|FG007|Induction Period|Lack of Efficacy|0|||
145733130|NCT04178967|525540918|FG008|Induction Period|Lack of Efficacy|0|||
145733131|NCT04178967|525540919|FG009|Induction Period|Lack of Efficacy|0|||
145733132|NCT04178967|525540920|FG010|Induction Period|Lack of Efficacy|0|||
145733133|NCT04178967|525540910|FG000|Induction Period|Protocol Violation|0|||
145733134|NCT04178967|525540911|FG001|Induction Period|Protocol Violation|6|||
145733135|NCT04178967|525540912|FG002|Induction Period|Protocol Violation|0|||
145733136|NCT04178967|525540913|FG003|Induction Period|Protocol Violation|0|||
145733137|NCT04178967|525540914|FG004|Induction Period|Protocol Violation|0|||
145733138|NCT04178967|525540915|FG005|Induction Period|Protocol Violation|0|||
145733139|NCT04178967|525540916|FG006|Induction Period|Protocol Violation|0|||
145733140|NCT04178967|525540917|FG007|Induction Period|Protocol Violation|0|||
145733141|NCT04178967|525540918|FG008|Induction Period|Protocol Violation|0|||
145733142|NCT04178967|525540919|FG009|Induction Period|Protocol Violation|0|||
145733143|NCT04178967|525540920|FG010|Induction Period|Protocol Violation|0|||
145733144|NCT04178967|525540910|FG000|Induction Period|Withdrawal by Subject|6|||
145733145|NCT04178967|525540911|FG001|Induction Period|Withdrawal by Subject|4|||
145733146|NCT04178967|525540912|FG002|Induction Period|Withdrawal by Subject|0|||
145733147|NCT04178967|525540913|FG003|Induction Period|Withdrawal by Subject|0|||
145733148|NCT04178967|525540914|FG004|Induction Period|Withdrawal by Subject|0|||
145733149|NCT04178967|525540915|FG005|Induction Period|Withdrawal by Subject|0|||
145733150|NCT04178967|525540916|FG006|Induction Period|Withdrawal by Subject|0|||
145733151|NCT04178967|525540917|FG007|Induction Period|Withdrawal by Subject|0|||
145733152|NCT04178967|525540918|FG008|Induction Period|Withdrawal by Subject|0|||
145733153|NCT04178967|525540919|FG009|Induction Period|Withdrawal by Subject|0|||
145733154|NCT04178967|525540920|FG010|Induction Period|Withdrawal by Subject|0|||
145733155|NCT04178967|525540910|FG000|Induction Period|Lost to Follow-up|2|||
145733156|NCT04178967|525540911|FG001|Induction Period|Lost to Follow-up|0|||
145733157|NCT04178967|525540912|FG002|Induction Period|Lost to Follow-up|0|||
145733158|NCT04178967|525540913|FG003|Induction Period|Lost to Follow-up|0|||
145733159|NCT04178967|525540914|FG004|Induction Period|Lost to Follow-up|0|||
145733160|NCT04178967|525540915|FG005|Induction Period|Lost to Follow-up|0|||
145733161|NCT04178967|525540916|FG006|Induction Period|Lost to Follow-up|0|||
145733162|NCT04178967|525540917|FG007|Induction Period|Lost to Follow-up|0|||
145733163|NCT04178967|525540918|FG008|Induction Period|Lost to Follow-up|0|||
145513123|NCT00617669|524739613|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
145513124|NCT00617669|524739612|FG000|Overall Study|Patients randomized but not treated|2|||
145733164|NCT04178967|525540919|FG009|Induction Period|Lost to Follow-up|0|||
145513125|NCT00617669|524739613|FG001|Overall Study|Patients randomized but not treated|3|||
145733165|NCT04178967|525540920|FG010|Induction Period|Lost to Follow-up|0|||
145733166|NCT04178967|525540910|FG000|Induction Period|Participant Missed Study Visits|0|||
145733167|NCT04178967|525540911|FG001|Induction Period|Participant Missed Study Visits|1|||
145733168|NCT04178967|525540912|FG002|Induction Period|Participant Missed Study Visits|0|||
145733169|NCT04178967|525540913|FG003|Induction Period|Participant Missed Study Visits|0|||
145733170|NCT04178967|525540914|FG004|Induction Period|Participant Missed Study Visits|0|||
145733171|NCT04178967|525540915|FG005|Induction Period|Participant Missed Study Visits|0|||
145733172|NCT04178967|525540916|FG006|Induction Period|Participant Missed Study Visits|0|||
145513126|NCT03680742|524739614|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
145513127|NCT02894502|524739615|FG000|Baseline|Withdrawal by Subject|24|||
145513128|NCT02894502|524739616|FG001|Baseline|Withdrawal by Subject|31|||
145513129|NCT02894502|524739617|FG002|Baseline|Withdrawal by Subject|36|||
145513130|NCT02894502|524739615|FG000|Baseline|Death|3|||
145513131|NCT02894502|524739616|FG001|Baseline|Death|1|||
145513132|NCT02894502|524739617|FG002|Baseline|Death|9|||
145513133|NCT02894502|524739615|FG000|First Follow up|Withdrawal by Subject|32|||
145513134|NCT02894502|524739616|FG001|First Follow up|Withdrawal by Subject|29|||
145513135|NCT02894502|524739617|FG002|First Follow up|Withdrawal by Subject|37|||
145513136|NCT02894502|524739615|FG000|First Follow up|Death|2|||
145513137|NCT02894502|524739616|FG001|First Follow up|Death|2|||
145513138|NCT02894502|524739617|FG002|First Follow up|Death|3|||
145513139|NCT02894502|524739615|FG000|Second Follow up|Withdrawal by Subject|13|||
145513140|NCT02894502|524739616|FG001|Second Follow up|Withdrawal by Subject|15|||
145513141|NCT02894502|524739617|FG002|Second Follow up|Withdrawal by Subject|13|||
145513142|NCT02894502|524739615|FG000|Second Follow up|Death|2|||
145513143|NCT02894502|524739616|FG001|Second Follow up|Death|3|||
145513144|NCT02894502|524739617|FG002|Second Follow up|Death|1|||
145513145|NCT02894502|524739615|FG000|Third Follow up|Withdrawal by Subject|5|||
145513146|NCT02894502|524739616|FG001|Third Follow up|Withdrawal by Subject|6|||
145513147|NCT02894502|524739617|FG002|Third Follow up|Withdrawal by Subject|3|||
145513148|NCT02894502|524739615|FG000|Third Follow up|Death|1|||
145513149|NCT02894502|524739616|FG001|Third Follow up|Death|1|||
145513150|NCT02894502|524739617|FG002|Third Follow up|Death|0|||
145513151|NCT00615901|524739618|FG000|Overall Study|Withdrawal by Subject|2|||
145513152|NCT00615901|524739618|FG000|Overall Study|Adverse Event|7|||
145513153|NCT00796445|524739623|FG000|Overall Study|Protocol Violation|5|||
145513154|NCT00796445|524739624|FG001|Overall Study|Protocol Violation|3|||
145513155|NCT00796445|524739623|FG000|Overall Study|Adverse event, serious fatal|10|||
145513156|NCT00796445|524739624|FG001|Overall Study|Adverse event, serious fatal|5|||
145513157|NCT00796445|524739623|FG000|Overall Study|Adverse event, non-fatal|4|||
145513158|NCT00796445|524739624|FG001|Overall Study|Adverse event, non-fatal|0|||
145513159|NCT00796445|524739623|FG000|Overall Study|Disease progression/recurrence|537|||
145513160|NCT00796445|524739624|FG001|Overall Study|Disease progression/recurrence|268|||
145513161|NCT00796445|524739623|FG000|Overall Study|Other|10|||
145513162|NCT00796445|524739624|FG001|Overall Study|Other|7|||
145513163|NCT00796445|524739623|FG000|Overall Study|Withdrawal by Subject|18|||
145513164|NCT00796445|524739624|FG001|Overall Study|Withdrawal by Subject|9|||
145513165|NCT00796445|524739623|FG000|Overall Study|Invalid Informed Consent Form|1|||
145513166|NCT00796445|524739624|FG001|Overall Study|Invalid Informed Consent Form|0|||
145513167|NCT00388583|524739627|FG000|Overall Study|Protocol Violation|1|||
145513168|NCT00388583|524739628|FG001|Overall Study|Protocol Violation|0|||
145513169|NCT00388583|524739627|FG000|Overall Study|Withdrawal by Subject|3|||
145513170|NCT00388583|524739628|FG001|Overall Study|Withdrawal by Subject|3|||
145513171|NCT00388583|524739627|FG000|Overall Study|Serious Adverse Event|2|||
145513172|NCT00388583|524739628|FG001|Overall Study|Serious Adverse Event|0|||
145513173|NCT00388583|524739627|FG000|Overall Study|Did not receive vaccine|0|||
145513174|NCT00388583|524739628|FG001|Overall Study|Did not receive vaccine|1|||
145513175|NCT05194579|524739629|FG000|Overall Study|Lost to Follow-up|2|||
145513176|NCT05194579|524739630|FG001|Overall Study|Lost to Follow-up|3|||
145513177|NCT05194579|524739629|FG000|Overall Study|Withdrawal by Subject|3|||
145513178|NCT05194579|524739630|FG001|Overall Study|Withdrawal by Subject|4|||
145513179|NCT05194579|524739629|FG000|Overall Study|Refused further study procedures|0|||
145513180|NCT05194579|524739630|FG001|Overall Study|Refused further study procedures|1|||
145513181|NCT05194579|524739629|FG000|Overall Study|Protocol deviation|1|||
145513182|NCT05194579|524739630|FG001|Overall Study|Protocol deviation|0|||
145513183|NCT03595228|524739635|FG000|Overall Study|Death|2|||
145513184|NCT03595228|524739635|FG000|Overall Study|Lack of Efficacy|13|||
145513185|NCT03595228|524739635|FG000|Overall Study|Withdrawal by Subject|3|||
145513186|NCT03595228|524739635|FG000|Overall Study|Withdrawal by Sponsor|1|||
145513187|NCT03232333|524739636|FG000|Overall Study|Infection or Osteomyelitis|9|||
145513188|NCT03232333|524739636|FG000|Overall Study|Lost to Follow-up|4|||
145513189|NCT03232333|524739636|FG000|Overall Study|Withdrawal by Subject|2|||
145513190|NCT01087736|524739637|FG000|Overall Study|Lost to Follow-up|1|||
145513191|NCT01087736|524739638|FG001|Overall Study|Lost to Follow-up|0|||
145513192|NCT01087736|524739637|FG000|Overall Study|Death|0|||
145513193|NCT01087736|524739638|FG001|Overall Study|Death|1|||
145513194|NCT01087736|524739637|FG000|Overall Study|Withdrawal by Subject|0|||
145513195|NCT01087736|524739638|FG001|Overall Study|Withdrawal by Subject|1|||
145513196|NCT01253811|524739639|FG000|Overall Study|Withdrawal criteria|1|||
145513197|NCT00435045|524739641|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
145733173|NCT04178967|525540917|FG007|Induction Period|Participant Missed Study Visits|0|||
145733174|NCT04178967|525540918|FG008|Induction Period|Participant Missed Study Visits|0|||
145733175|NCT04178967|525540919|FG009|Induction Period|Participant Missed Study Visits|0|||
145733176|NCT04178967|525540920|FG010|Induction Period|Participant Missed Study Visits|0|||
145733177|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
145733178|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
145513198|NCT00435045|524739642|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
145513199|NCT00435045|524739641|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
145513200|NCT00435045|524739642|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
145513201|NCT00435045|524739641|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
145513202|NCT00435045|524739642|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
145513203|NCT00435045|524739641|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
145513204|NCT00435045|524739642|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
145513205|NCT00435045|524739641|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
145513206|NCT00435045|524739642|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
145513207|NCT00435045|524739641|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
145513208|NCT00435045|524739642|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
145513209|NCT00435045|524739641|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
145513210|NCT00435045|524739642|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
145513211|NCT00435045|524739641|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
145513212|NCT00435045|524739642|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
145513213|NCT00435045|524739641|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
145513214|NCT00435045|524739642|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
145513215|NCT00435045|524739641|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
145513216|NCT00435045|524739642|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
145513217|NCT00435045|524739641|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
145513218|NCT00435045|524739642|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
145513219|NCT00567255|524739643|FG000|Overall Study|Adverse Event|241|||
145513220|NCT00567255|524739644|FG001|Overall Study|Adverse Event|68|||
145513221|NCT00567255|524739643|FG000|Overall Study|Lost to Follow-up|77|||
145513222|NCT00567255|524739644|FG001|Overall Study|Lost to Follow-up|48|||
145513223|NCT00567255|524739643|FG000|Overall Study|Withdrawal by Subject|75|||
145513224|NCT00567255|524739644|FG001|Overall Study|Withdrawal by Subject|56|||
145513225|NCT00567255|524739643|FG000|Overall Study|Lack of Efficacy|19|||
145513226|NCT00567255|524739644|FG001|Overall Study|Lack of Efficacy|33|||
145513227|NCT00567255|524739643|FG000|Overall Study|Protocol Violation|20|||
145513228|NCT00567255|524739644|FG001|Overall Study|Protocol Violation|8|||
145513229|NCT00567255|524739643|FG000|Overall Study|Pregnancy|6|||
145513230|NCT00567255|524739644|FG001|Overall Study|Pregnancy|0|||
145513231|NCT00567255|524739643|FG000|Overall Study|Drug noncompliance,moved,other|25|||
145513232|NCT00567255|524739644|FG001|Overall Study|Drug noncompliance,moved,other|15|||
145513233|NCT01743001|524739647|FG000|Overall Study|Physician Decision|1|||
145513234|NCT01743001|524739648|FG001|Overall Study|Physician Decision|0|||
145513235|NCT01743001|524739647|FG000|Overall Study|Pregnancy|1|||
145513236|NCT01743001|524739648|FG001|Overall Study|Pregnancy|0|||
145513237|NCT01743001|524739647|FG000|Overall Study|Death|1|||
145513238|NCT01743001|524739648|FG001|Overall Study|Death|0|||
145513239|NCT03052426|524739651|FG000|Overall Study|Withdrawal by Subject|0|||
145513240|NCT03052426|524739652|FG001|Overall Study|Withdrawal by Subject|1|||
145513241|NCT03052426|524739653|FG002|Overall Study|Withdrawal by Subject|0|||
145513242|NCT03052426|524739651|FG000|Overall Study|Lost to Follow-up|2|||
145513243|NCT03052426|524739652|FG001|Overall Study|Lost to Follow-up|0|||
145513244|NCT03052426|524739653|FG002|Overall Study|Lost to Follow-up|1|||
145513245|NCT01565343|524739656|FG000|Overall Study|Administrative decision/technical issues|1|||
145513246|NCT01565343|524739657|FG001|Overall Study|Administrative decision/technical issues|0|||
145513247|NCT01565343|524739658|FG002|Overall Study|Administrative decision/technical issues|0|||
145513248|NCT01853839|524739664|FG000|Overall Study|Violated inclusion criteria|2|||
145513249|NCT01853839|524739664|FG000|Overall Study|Not meet ITT population definition|58|||
145513250|NCT01853839|524739664|FG000|Overall Study|End of treatment visit too early|33|||
145513251|NCT01853839|524739664|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
145513252|NCT01018810|524739665|FG000|Overall Study|Withdrawal by Subject|0|||
145513253|NCT01018810|524739666|FG001|Overall Study|Withdrawal by Subject|1|||
145513254|NCT01018810|524739667|FG002|Overall Study|Withdrawal by Subject|0|||
145513255|NCT01018810|524739668|FG003|Overall Study|Withdrawal by Subject|0|||
145513256|NCT01018810|524739669|FG004|Overall Study|Withdrawal by Subject|0|||
145513257|NCT01018810|524739665|FG000|Overall Study|Sponsor Decision|2|||
145513258|NCT01018810|524739666|FG001|Overall Study|Sponsor Decision|0|||
145513259|NCT01018810|524739667|FG002|Overall Study|Sponsor Decision|1|||
145513260|NCT01018810|524739668|FG003|Overall Study|Sponsor Decision|1|||
145513261|NCT01018810|524739669|FG004|Overall Study|Sponsor Decision|1|||
145513262|NCT03672097|524739670|FG000|Period 1|Withdrawal by Subject|2|||
145513263|NCT03672097|524739670|FG000|Period 1|Adverse Event|1|||
145513264|NCT03672097|524739670|FG000|Period 1|Did not receive treatment|1|||
145513265|NCT03672097|524739670|FG000|Period 2|Withdrawal by Subject|3|||
145513266|NCT03672097|524739670|FG000|Period 2|Other|1|||
145513267|NCT03087617|524739672|FG000|Overall Study|Lost to Follow-up|32|||
145513268|NCT03087617|524739673|FG001|Overall Study|Lost to Follow-up|30|||
145513269|NCT03087617|524739674|FG002|Overall Study|Lost to Follow-up|30|||
145513270|NCT03087617|524739675|FG003|Overall Study|Lost to Follow-up|39|||
145513271|NCT02410343|524739681|FG000|Core Period (24 Weeks)|Adverse Event|1|||
145513272|NCT02410343|524739682|FG001|Core Period (24 Weeks)|Adverse Event|0|||
145513273|NCT02410343|524739681|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
145513274|NCT02410343|524739682|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
145513275|NCT02410343|524739681|FG000|Extension Period (12 Months)|Adverse Event|1|||
145513276|NCT02410343|524739682|FG001|Extension Period (12 Months)|Adverse Event|0|||
145513277|NCT02410343|524739681|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
145513278|NCT02410343|524739682|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
145513279|NCT02036853|524739683|FG000|Overall Study|Adverse Event|0|||
145513280|NCT02036853|524739684|FG001|Overall Study|Adverse Event|2|||
145513281|NCT02036853|524739683|FG000|Overall Study|Lack of Efficacy|0|||
145513282|NCT02036853|524739684|FG001|Overall Study|Lack of Efficacy|2|||
145513283|NCT02036853|524739683|FG000|Overall Study|Physician Decision|0|||
145513284|NCT02036853|524739684|FG001|Overall Study|Physician Decision|1|||
145513285|NCT02036853|524739683|FG000|Overall Study|Withdrawal by Subject|0|||
145513286|NCT02036853|524739684|FG001|Overall Study|Withdrawal by Subject|1|||
145513287|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
145513288|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
145513289|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
145513290|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
145513291|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Death|3|||
145513292|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Death|0|||
145513293|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Death|0|||
145513294|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Death|0|||
145513295|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
145513296|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
145513297|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
145513298|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
145513299|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
145513300|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
145513301|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
145513302|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
145513303|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
145513304|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
145513305|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
145513306|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
145513307|NCT00884741|524739694|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
145513308|NCT00884741|524739695|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
145513309|NCT00884741|524739696|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
145513310|NCT00884741|524739697|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
145513311|NCT00884741|524739694|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
145513312|NCT00884741|524739695|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
145513313|NCT00884741|524739696|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
145513314|NCT00884741|524739697|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
145513315|NCT00884741|524739694|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
145513316|NCT00884741|524739695|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
145513317|NCT00884741|524739696|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
145513318|NCT00884741|524739697|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
145402077|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
145402078|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145402079|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145402080|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
145402081|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
145402082|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
145402083|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
145402084|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
145402085|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
145402086|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145402087|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
145402088|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145402089|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145513319|NCT00884741|524739694|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
145513320|NCT00884741|524739695|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
145513321|NCT00884741|524739696|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
145513322|NCT00884741|524739697|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
145513323|NCT00884741|524739694|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
145513324|NCT00884741|524739695|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
145513325|NCT00884741|524739696|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
145513326|NCT00884741|524739697|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
145513327|NCT00884741|524739694|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
145513328|NCT00884741|524739695|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
145513329|NCT00884741|524739696|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
145513330|NCT00884741|524739697|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
145513331|NCT00884741|524739694|FG000|Randomization|Protocol Violation|0|||
145513332|NCT00884741|524739695|FG001|Randomization|Protocol Violation|0|||
145513333|NCT00884741|524739696|FG002|Randomization|Protocol Violation|8|||
145513334|NCT00884741|524739697|FG003|Randomization|Protocol Violation|8|||
145513335|NCT00335764|524739698|FG000|Overall Study|wrong histology|1|||
145513336|NCT00335764|524739699|FG001|Overall Study|wrong histology|0|||
145513337|NCT00335764|524739700|FG002|Overall Study|wrong histology|0|||
145513338|NCT00335764|524739701|FG003|Overall Study|wrong histology|0|||
145513339|NCT00335764|524739702|FG004|Overall Study|wrong histology|1|||
145513340|NCT04303195|524739703|FG000|Overall Study|Adverse Event|1|||
145513341|NCT04303195|524739704|FG001|Overall Study|Adverse Event|3|||
145513342|NCT04303195|524739705|FG002|Overall Study|Adverse Event|7|||
145513343|NCT04303195|524739706|FG003|Overall Study|Adverse Event|0|||
145513344|NCT04303195|524739703|FG000|Overall Study|Lost to Follow-up|1|||
145513345|NCT04303195|524739704|FG001|Overall Study|Lost to Follow-up|0|||
145513346|NCT04303195|524739705|FG002|Overall Study|Lost to Follow-up|1|||
145513347|NCT04303195|524739706|FG003|Overall Study|Lost to Follow-up|4|||
145513348|NCT04303195|524739703|FG000|Overall Study|Withdrawal by Subject|3|||
145513349|NCT04303195|524739704|FG001|Overall Study|Withdrawal by Subject|1|||
145513350|NCT04303195|524739705|FG002|Overall Study|Withdrawal by Subject|1|||
145513351|NCT04303195|524739706|FG003|Overall Study|Withdrawal by Subject|1|||
145513352|NCT04303195|524739703|FG000|Overall Study|No study drug administered or protocol deviation|0|||
145513353|NCT04303195|524739704|FG001|Overall Study|No study drug administered or protocol deviation|2|||
145513354|NCT04303195|524739705|FG002|Overall Study|No study drug administered or protocol deviation|0|||
145513355|NCT04303195|524739706|FG003|Overall Study|No study drug administered or protocol deviation|2|||
145513356|NCT05688670|524739707|FG000|Overall Study|Change in surgery plan|1|||
145513357|NCT05688670|524739708|FG001|Overall Study|Change in surgery plan|4|||
145513358|NCT05688670|524739707|FG000|Overall Study|Inability to extubate|1|||
145513359|NCT05688670|524739708|FG001|Overall Study|Inability to extubate|2|||
145513360|NCT05688670|524739707|FG000|Overall Study|Day of surgery cancellation|0|||
145513361|NCT05688670|524739708|FG001|Overall Study|Day of surgery cancellation|1|||
145513362|NCT05688670|524739707|FG000|Overall Study|Reintubated on PCICU arrival|0|||
145513363|NCT05688670|524739708|FG001|Overall Study|Reintubated on PCICU arrival|1|||
145513364|NCT04627285|524739715|FG000|Overall Study|Adverse Event|0|||
145513365|NCT04627285|524739716|FG001|Overall Study|Adverse Event|2|||
145513366|NCT04627285|524739715|FG000|Overall Study|Lost to Follow-up|1|||
145513367|NCT04627285|524739716|FG001|Overall Study|Lost to Follow-up|0|||
145513368|NCT04627285|524739715|FG000|Overall Study|Withdrawal by Subject|1|||
145513369|NCT04627285|524739716|FG001|Overall Study|Withdrawal by Subject|1|||
145513370|NCT04627285|524739715|FG000|Overall Study|Sponsor decision|5|||
145513371|NCT04627285|524739716|FG001|Overall Study|Sponsor decision|0|||
145513372|NCT04627285|524739715|FG000|Overall Study|Participant left country; aunt informed the site|0|||
145513373|NCT04627285|524739716|FG001|Overall Study|Participant left country; aunt informed the site|1|||
145513374|NCT00635219|524741434|FG000|Overall Study|Adverse Event|12|||
145513375|NCT00635219|524741435|FG001|Overall Study|Adverse Event|10|||
145513376|NCT00635219|524741436|FG002|Overall Study|Adverse Event|18|||
145513377|NCT00635219|524741437|FG003|Overall Study|Adverse Event|15|||
145513378|NCT00635219|524741438|FG004|Overall Study|Adverse Event|19|||
145513379|NCT00635219|524741434|FG000|Overall Study|Lack of Efficacy|5|||
145513380|NCT00635219|524741435|FG001|Overall Study|Lack of Efficacy|6|||
145513381|NCT00635219|524741436|FG002|Overall Study|Lack of Efficacy|3|||
145733179|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
145733180|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
145513382|NCT00635219|524741437|FG003|Overall Study|Lack of Efficacy|4|||
145513383|NCT00635219|524741438|FG004|Overall Study|Lack of Efficacy|6|||
145733181|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
145513384|NCT00635219|524741434|FG000|Overall Study|Non-compliance With Study Product|0|||
145513385|NCT00635219|524741435|FG001|Overall Study|Non-compliance With Study Product|0|||
145513386|NCT00635219|524741436|FG002|Overall Study|Non-compliance With Study Product|0|||
145513387|NCT00635219|524741437|FG003|Overall Study|Non-compliance With Study Product|2|||
145513388|NCT00635219|524741438|FG004|Overall Study|Non-compliance With Study Product|1|||
145733182|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
145733183|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
145733184|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
145733185|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
145733186|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
145733187|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
145733188|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733189|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733190|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733191|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733192|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733193|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
145733194|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733195|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733196|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733197|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733198|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145733199|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733200|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733201|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733202|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
145733203|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733204|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733205|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733206|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733207|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733208|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733209|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145733210|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733211|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733212|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733213|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733214|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733215|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733216|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
145733217|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733218|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733219|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733220|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
145733221|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733222|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733223|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733224|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733225|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
145733226|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
145733227|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733228|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
145733229|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733230|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733231|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145733232|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
145402090|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
145402091|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
145402092|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145402093|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145402094|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145402095|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
145402096|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145402097|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
145513389|NCT00635219|524741434|FG000|Overall Study|Protocol Violation|0|||
145513390|NCT00635219|524741435|FG001|Overall Study|Protocol Violation|2|||
145513391|NCT00635219|524741436|FG002|Overall Study|Protocol Violation|3|||
145513392|NCT00635219|524741437|FG003|Overall Study|Protocol Violation|2|||
145513393|NCT00635219|524741438|FG004|Overall Study|Protocol Violation|4|||
145513394|NCT00635219|524741434|FG000|Overall Study|Withdrawal of Consent|8|||
145513395|NCT00635219|524741435|FG001|Overall Study|Withdrawal of Consent|6|||
145513396|NCT00635219|524741436|FG002|Overall Study|Withdrawal of Consent|8|||
145513397|NCT00635219|524741437|FG003|Overall Study|Withdrawal of Consent|11|||
145513398|NCT00635219|524741438|FG004|Overall Study|Withdrawal of Consent|8|||
145513399|NCT00635219|524741434|FG000|Overall Study|Lost to Follow-up|0|||
145513400|NCT00635219|524741435|FG001|Overall Study|Lost to Follow-up|0|||
145513401|NCT00635219|524741436|FG002|Overall Study|Lost to Follow-up|2|||
145513402|NCT00635219|524741437|FG003|Overall Study|Lost to Follow-up|0|||
145513403|NCT00635219|524741438|FG004|Overall Study|Lost to Follow-up|3|||
145513404|NCT00635219|524741434|FG000|Overall Study|Administrative or Other Reasons|0|||
145513405|NCT00635219|524741435|FG001|Overall Study|Administrative or Other Reasons|1|||
145513406|NCT00635219|524741436|FG002|Overall Study|Administrative or Other Reasons|1|||
145513407|NCT00635219|524741437|FG003|Overall Study|Administrative or Other Reasons|0|||
145513408|NCT00635219|524741438|FG004|Overall Study|Administrative or Other Reasons|1|||
145513409|NCT01639729|524741439|FG000|Overall Study|Withdrawal by Subject|1|||
145513410|NCT01639729|524741440|FG001|Overall Study|Withdrawal by Subject|0|||
145513411|NCT01639729|524741441|FG002|Overall Study|Withdrawal by Subject|1|||
145513412|NCT01639729|524741442|FG003|Overall Study|Withdrawal by Subject|1|||
145513413|NCT01639729|524741443|FG004|Overall Study|Withdrawal by Subject|0|||
145513414|NCT01639729|524741444|FG005|Overall Study|Withdrawal by Subject|0|||
145513415|NCT00759564|524741445|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
145513416|NCT00759564|524741446|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
145513417|NCT00759564|524741447|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
145513418|NCT00759564|524741448|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
145513419|NCT00759564|524741449|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
145513420|NCT04145219|524741450|FG000|Overall Study|Adverse Event|18|||
145513421|NCT04145219|524741451|FG001|Overall Study|Adverse Event|6|||
145513422|NCT04145219|524741450|FG000|Overall Study|Lost to Follow-up|2|||
145513423|NCT04145219|524741451|FG001|Overall Study|Lost to Follow-up|3|||
145513424|NCT04145219|524741450|FG000|Overall Study|Physician Decision|0|||
145513425|NCT04145219|524741451|FG001|Overall Study|Physician Decision|2|||
145513426|NCT04145219|524741450|FG000|Overall Study|Withdrawal by Subject|12|||
145513427|NCT04145219|524741451|FG001|Overall Study|Withdrawal by Subject|8|||
145513428|NCT04145219|524741450|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
145513429|NCT04145219|524741451|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
145513430|NCT01640314|524741452|FG000|Overall Study|Protocol Violation|0|||
145513431|NCT01640314|524741453|FG001|Overall Study|Protocol Violation|1|||
145513432|NCT01290796|524741454|FG000|Overall Study|Lost to Follow-up|21|||
145513433|NCT01290796|524741454|FG000|Overall Study|Withdrawal by Subject|4|||
145513434|NCT01290796|524741454|FG000|Overall Study|Physician Decision|2|||
145513435|NCT01290796|524741454|FG000|Overall Study|Secondary Surgical Intervention|2|||
145513436|NCT01290796|524741454|FG000|Overall Study|Withdrawal by Sponsor|1|||
145513437|NCT02709538|524741456|FG000|Overall Study|Adverse Event|13|||
145513438|NCT02709538|524741457|FG001|Overall Study|Adverse Event|2|||
145513439|NCT02709538|524741458|FG002|Overall Study|Adverse Event|3|||
145513440|NCT02709538|524741456|FG000|Overall Study|Lack of Efficacy|1|||
145513441|NCT02709538|524741457|FG001|Overall Study|Lack of Efficacy|0|||
145513442|NCT02709538|524741458|FG002|Overall Study|Lack of Efficacy|0|||
145513443|NCT02709538|524741456|FG000|Overall Study|Lost to Follow-up|24|||
145513444|NCT02709538|524741457|FG001|Overall Study|Lost to Follow-up|8|||
145513445|NCT02709538|524741458|FG002|Overall Study|Lost to Follow-up|4|||
145513446|NCT02709538|524741456|FG000|Overall Study|Physician Decision|1|||
145513447|NCT02709538|524741457|FG001|Overall Study|Physician Decision|0|||
145513448|NCT02709538|524741458|FG002|Overall Study|Physician Decision|0|||
145513449|NCT02709538|524741456|FG000|Overall Study|Withdrawal by Subject|40|||
145513450|NCT02709538|524741457|FG001|Overall Study|Withdrawal by Subject|7|||
145513451|NCT02709538|524741458|FG002|Overall Study|Withdrawal by Subject|4|||
145513452|NCT02709538|524741456|FG000|Overall Study|Non-compliance with study procedures|5|||
145513453|NCT02709538|524741457|FG001|Overall Study|Non-compliance with study procedures|0|||
145513454|NCT02709538|524741458|FG002|Overall Study|Non-compliance with study procedures|0|||
145513455|NCT02709538|524741456|FG000|Overall Study|Non-compliance with study drug|2|||
145513456|NCT02709538|524741457|FG001|Overall Study|Non-compliance with study drug|0|||
145513457|NCT02709538|524741458|FG002|Overall Study|Non-compliance with study drug|0|||
145513458|NCT02709538|524741456|FG000|Overall Study|Protocol deviation|10|||
145513459|NCT02709538|524741457|FG001|Overall Study|Protocol deviation|4|||
145513460|NCT02709538|524741458|FG002|Overall Study|Protocol deviation|4|||
145513461|NCT02709538|524741456|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
145513462|NCT02709538|524741457|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
145513463|NCT02709538|524741458|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
145513464|NCT02709538|524741456|FG000|Overall Study|Other|16|||
145513465|NCT02709538|524741457|FG001|Overall Study|Other|7|||
145513466|NCT02709538|524741458|FG002|Overall Study|Other|5|||
145513467|NCT00835211|524741459|FG000|First Intervention|Withdrawal by Subject|0|||
145513468|NCT00835211|524741460|FG001|First Intervention|Withdrawal by Subject|1|||
145513469|NCT00835211|524741459|FG000|Washout: 7 Days|Adverse Event|2|||
145513470|NCT00835211|524741460|FG001|Washout: 7 Days|Adverse Event|1|||
145513471|NCT00835211|524741459|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145513472|NCT00835211|524741460|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145513473|NCT02343549|524741461|FG000|Overall Study|Death|11|||
145513474|NCT02343549|524741461|FG000|Overall Study|Withdrawal by Subject|2|||
145513475|NCT02160041|524741463|FG000|Overall Study|Adverse Event|11|||
145513476|NCT02160041|524741463|FG000|Overall Study|Death|2|||
145513477|NCT02160041|524741463|FG000|Overall Study|disease progression|57|||
145513478|NCT02160041|524741463|FG000|Overall Study|Protocol Violation|1|||
145513479|NCT02160041|524741463|FG000|Overall Study|non-compliance with study|1|||
145513480|NCT02160041|524741463|FG000|Overall Study|Physician Decision|3|||
145513481|NCT02160041|524741463|FG000|Overall Study|Withdrawal by Subject|8|||
145513482|NCT02160041|524741463|FG000|Overall Study|study terminated by by sponsor|1|||
145513483|NCT01403948|524741464|FG000|Overall Study|Progressive disease|0|||
145733233|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
145733234|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
145733235|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
145513484|NCT01403948|524741465|FG001|Overall Study|Progressive disease|2|||
145513485|NCT01403948|524741466|FG002|Overall Study|Progressive disease|2|||
145513486|NCT01403948|524741467|FG003|Overall Study|Progressive disease|4|||
145513487|NCT01403948|524741468|FG004|Overall Study|Progressive disease|2|||
145513488|NCT01403948|524741469|FG005|Overall Study|Progressive disease|6|||
145513489|NCT01403948|524741470|FG006|Overall Study|Progressive disease|2|||
145513490|NCT01403948|524741471|FG007|Overall Study|Progressive disease|4|||
145513491|NCT01403948|524741472|FG008|Overall Study|Progressive disease|5|||
145513492|NCT01403948|524741473|FG009|Overall Study|Progressive disease|5|||
145513493|NCT01403948|524741464|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513494|NCT01403948|524741465|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513495|NCT01403948|524741466|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513496|NCT01403948|524741467|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513497|NCT01403948|524741468|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
145513498|NCT01403948|524741469|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513499|NCT01403948|524741470|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
145513500|NCT01403948|524741471|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513501|NCT01403948|524741472|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
145513502|NCT01403948|524741473|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
145513503|NCT01403948|524741464|FG000|Overall Study|Lost to Follow-up|0|||
145513504|NCT01403948|524741465|FG001|Overall Study|Lost to Follow-up|0|||
145513505|NCT01403948|524741466|FG002|Overall Study|Lost to Follow-up|0|||
145513506|NCT01403948|524741467|FG003|Overall Study|Lost to Follow-up|0|||
145513507|NCT01403948|524741468|FG004|Overall Study|Lost to Follow-up|0|||
145513508|NCT01403948|524741469|FG005|Overall Study|Lost to Follow-up|0|||
145513509|NCT01403948|524741470|FG006|Overall Study|Lost to Follow-up|0|||
145513510|NCT01403948|524741471|FG007|Overall Study|Lost to Follow-up|0|||
145513511|NCT01403948|524741472|FG008|Overall Study|Lost to Follow-up|0|||
145513512|NCT01403948|524741473|FG009|Overall Study|Lost to Follow-up|1|||
145513513|NCT01403948|524741464|FG000|Overall Study|Refused cont. medication|0|||
145513514|NCT01403948|524741465|FG001|Overall Study|Refused cont. medication|0|||
145513515|NCT01403948|524741466|FG002|Overall Study|Refused cont. medication|0|||
145513516|NCT01403948|524741467|FG003|Overall Study|Refused cont. medication|0|||
145513517|NCT01403948|524741468|FG004|Overall Study|Refused cont. medication|1|||
145733236|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
145513518|NCT01403948|524741469|FG005|Overall Study|Refused cont. medication|0|||
145513519|NCT01403948|524741470|FG006|Overall Study|Refused cont. medication|0|||
145513520|NCT01403948|524741471|FG007|Overall Study|Refused cont. medication|0|||
145513521|NCT01403948|524741472|FG008|Overall Study|Refused cont. medication|0|||
145733237|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
145733238|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
145733239|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
145733240|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
145733241|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
145733242|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
145733243|NCT04178967|525540910|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733244|NCT04178967|525540911|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733245|NCT04178967|525540912|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733246|NCT04178967|525540913|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
145733247|NCT04178967|525540914|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733248|NCT04178967|525540915|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
145733249|NCT04178967|525540916|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
145733250|NCT04178967|525540917|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
145733251|NCT04178967|525540918|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733252|NCT04178967|525540919|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733253|NCT04178967|525540920|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145733254|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733255|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
145513522|NCT01403948|524741473|FG009|Overall Study|Refused cont. medication|1|||
145733256|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733257|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
145513523|NCT01403948|524741464|FG000|Overall Study|other than above|1|||
145513524|NCT01403948|524741465|FG001|Overall Study|other than above|2|||
145513525|NCT01403948|524741466|FG002|Overall Study|other than above|1|||
145513526|NCT01403948|524741467|FG003|Overall Study|other than above|0|||
145513527|NCT01403948|524741468|FG004|Overall Study|other than above|1|||
145513528|NCT01403948|524741469|FG005|Overall Study|other than above|1|||
145513529|NCT01403948|524741470|FG006|Overall Study|other than above|2|||
145513530|NCT01403948|524741471|FG007|Overall Study|other than above|0|||
145513531|NCT01403948|524741472|FG008|Overall Study|other than above|0|||
145513532|NCT01403948|524741473|FG009|Overall Study|other than above|0|||
145513533|NCT04450381|524741474|FG000|Overall Study|Protocol Violation|4|||
145513534|NCT04450381|524741474|FG000|Overall Study|Wrong device setting|2|||
145513535|NCT01090323|524741475|FG000|Overall Study|Adverse Event|12|||
145513536|NCT01090323|524741476|FG001|Overall Study|Adverse Event|2|||
145513537|NCT01090323|524741475|FG000|Overall Study|Abnormal Lab Values|3|||
145513538|NCT01090323|524741476|FG001|Overall Study|Abnormal Lab Values|1|||
145513539|NCT01090323|524741475|FG000|Overall Study|Abnormal Test Procedure Results|2|||
145513540|NCT01090323|524741476|FG001|Overall Study|Abnormal Test Procedure Results|0|||
145513541|NCT01090323|524741475|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145513542|NCT01090323|524741476|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145513543|NCT01090323|524741475|FG000|Overall Study|Condition no longer requires drug|5|||
145513544|NCT01090323|524741476|FG001|Overall Study|Condition no longer requires drug|4|||
145513545|NCT01090323|524741475|FG000|Overall Study|Protocol Violation|2|||
145513546|NCT01090323|524741476|FG001|Overall Study|Protocol Violation|1|||
145513547|NCT01090323|524741475|FG000|Overall Study|Withdrew consent|33|||
145513548|NCT01090323|524741476|FG001|Overall Study|Withdrew consent|11|||
145513549|NCT01090323|524741475|FG000|Overall Study|Lost to Follow-up|11|||
145513550|NCT01090323|524741476|FG001|Overall Study|Lost to Follow-up|6|||
145513551|NCT01090323|524741475|FG000|Overall Study|Administrative problems|6|||
145513552|NCT01090323|524741476|FG001|Overall Study|Administrative problems|4|||
145513553|NCT01090323|524741475|FG000|Overall Study|Death|1|||
145513554|NCT01090323|524741476|FG001|Overall Study|Death|2|||
145513555|NCT01090323|524741475|FG000|Overall Study|Stopped end of core|7|||
145513556|NCT01090323|524741476|FG001|Overall Study|Stopped end of core|0|||
145513557|NCT01090323|524741475|FG000|Overall Study|Stopped end of extension 1#|3|||
145513558|NCT01090323|524741476|FG001|Overall Study|Stopped end of extension 1#|1|||
145513559|NCT05498701|524741477|FG000|Period 3|Adverse Event|1|||
145513560|NCT05498701|524741478|FG001|Period 3|Adverse Event|0|||
145513561|NCT01864005|524741479|FG000|Overall Study|Protocol Violation|0|||
145513562|NCT01864005|524741480|FG001|Overall Study|Protocol Violation|1|||
145513563|NCT01864005|524741479|FG000|Overall Study|Withdrawal by Subject|0|||
145513564|NCT01864005|524741480|FG001|Overall Study|Withdrawal by Subject|1|||
145513565|NCT01864005|524741479|FG000|Overall Study|Incorrect enrolment|1|||
145513566|NCT01864005|524741480|FG001|Overall Study|Incorrect enrolment|0|||
145513567|NCT01864005|524741479|FG000|Overall Study|Disease need|1|||
145513568|NCT01864005|524741480|FG001|Overall Study|Disease need|1|||
145733258|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733259|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733260|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733261|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
145513569|NCT01864005|524741479|FG000|Overall Study|Need GP IIb/IIIa|1|||
145513570|NCT01864005|524741480|FG001|Overall Study|Need GP IIb/IIIa|3|||
145733262|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
145733263|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
145733264|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
145733265|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145513571|NCT00763698|524741486|FG000|Overall Study|Unsuccessful Implant|5|||
145513572|NCT00763698|524741486|FG000|Overall Study|Death|4|||
145513573|NCT00763698|524741486|FG000|Overall Study|Withdrawal by Subject|1|||
145513574|NCT02184572|524741487|FG000|Overall Study|Lost to Follow-up|29|||
145513575|NCT02184572|524741488|FG001|Overall Study|Lost to Follow-up|21|||
145513576|NCT02184572|524741487|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
145513577|NCT02184572|524741488|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
145513578|NCT02184572|524741487|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
145733266|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733267|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733268|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733269|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733270|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733271|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733272|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145733273|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
145733274|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
145733275|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
145733276|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145513579|NCT02184572|524741488|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
145513580|NCT02184572|524741487|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
145513581|NCT02184572|524741488|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
145513582|NCT02184572|524741487|FG000|Overall Study|Traveling Outside The Country|1|||
145513583|NCT02184572|524741488|FG001|Overall Study|Traveling Outside The Country|0|||
145513584|NCT02184572|524741487|FG000|Overall Study|Withdrawal by Subject|14|||
145513585|NCT02184572|524741488|FG001|Overall Study|Withdrawal by Subject|9|||
145513586|NCT00006409|524741492|FG000|Baseline|Protocol Violation|48|||
145513587|NCT00006409|524741493|FG001|Baseline|Protocol Violation|70|||
145513588|NCT00006409|524741494|FG002|Baseline|Protocol Violation|0|||
145513589|NCT00006409|524741495|FG003|Baseline|Protocol Violation|0|||
145513590|NCT00006409|524741496|FG004|Baseline|Protocol Violation|0|||
145513591|NCT00006409|524741497|FG005|Baseline|Protocol Violation|0|||
145733277|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733278|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733279|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733280|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733281|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733282|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733283|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733284|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733285|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
145733286|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145733287|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733288|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733289|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733290|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733291|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733292|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733293|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733294|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145733295|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
145733296|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
145733297|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
145733298|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733299|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733300|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145513592|NCT00006409|524741492|FG000|Post-2 Year Intervention|Protocol Violation|0|||
145513593|NCT00006409|524741493|FG001|Post-2 Year Intervention|Protocol Violation|0|||
145513594|NCT00006409|524741494|FG002|Post-2 Year Intervention|Protocol Violation|251|||
145513595|NCT00006409|524741495|FG003|Post-2 Year Intervention|Protocol Violation|168|||
145733301|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733302|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145513596|NCT00006409|524741496|FG004|Post-2 Year Intervention|Protocol Violation|0|||
145513597|NCT00006409|524741497|FG005|Post-2 Year Intervention|Protocol Violation|0|||
145733303|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733304|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733305|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733306|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733307|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
145733308|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
145733309|NCT04178967|525540910|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733310|NCT04178967|525540911|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733311|NCT04178967|525540912|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733312|NCT04178967|525540913|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733313|NCT04178967|525540914|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733314|NCT04178967|525540915|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733315|NCT04178967|525540916|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733316|NCT04178967|525540917|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733317|NCT04178967|525540918|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733318|NCT04178967|525540919|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
145733319|NCT04178967|525540920|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
145733320|NCT01251120|525540922|FG000|Overall Study|Lack of Efficacy|0|||
145733321|NCT01251120|525540923|FG001|Overall Study|Lack of Efficacy|1|||
145733322|NCT01822522|525540924|FG000|Overall Study|Adverse Event|1|||
145733323|NCT01822522|525540925|FG001|Overall Study|Adverse Event|1|||
145733324|NCT01822522|525540926|FG002|Overall Study|Adverse Event|1|||
145733325|NCT01822522|525540927|FG003|Overall Study|Adverse Event|0|||
145733326|NCT01822522|525540928|FG004|Overall Study|Adverse Event|0|||
145733327|NCT01822522|525540929|FG005|Overall Study|Adverse Event|1|||
145733328|NCT01822522|525540924|FG000|Overall Study|Death|3|||
145733329|NCT01822522|525540925|FG001|Overall Study|Death|0|||
145733330|NCT01822522|525540926|FG002|Overall Study|Death|2|||
145513598|NCT00006409|524741492|FG000|Post-3 Year Intervention|Protocol Violation|0|||
145513599|NCT00006409|524741493|FG001|Post-3 Year Intervention|Protocol Violation|0|||
145513600|NCT00006409|524741494|FG002|Post-3 Year Intervention|Protocol Violation|0|||
145513601|NCT00006409|524741495|FG003|Post-3 Year Intervention|Protocol Violation|0|||
145513602|NCT00006409|524741496|FG004|Post-3 Year Intervention|Protocol Violation|62|||
145513603|NCT00006409|524741497|FG005|Post-3 Year Intervention|Protocol Violation|62|||
145513604|NCT00638183|524741498|FG000|Overall Study|Adverse Event|23|||
145513605|NCT00638183|524741498|FG000|Overall Study|Lack of Efficacy|14|||
145513606|NCT00638183|524741498|FG000|Overall Study|Physician Decision|9|||
145513607|NCT00638183|524741498|FG000|Overall Study|Lost to Follow-up|46|||
145513608|NCT00638183|524741498|FG000|Overall Study|Other reason not defined above|27|||
145513609|NCT02059291|524741499|FG000|Epoch 2|Lack of Efficacy|0|||
145513610|NCT02059291|524741500|FG001|Epoch 2|Lack of Efficacy|0|||
145513611|NCT02059291|524741501|FG002|Epoch 2|Lack of Efficacy|0|||
145513612|NCT02059291|524741502|FG003|Epoch 2|Lack of Efficacy|1|||
145513613|NCT02059291|524741503|FG004|Epoch 2|Lack of Efficacy|0|||
145513614|NCT02059291|524741504|FG005|Epoch 2|Lack of Efficacy|1|||
145513615|NCT02059291|524741505|FG006|Epoch 2|Lack of Efficacy|0|||
145513616|NCT02059291|524741506|FG007|Epoch 2|Lack of Efficacy|0|||
145513617|NCT02059291|524741507|FG008|Epoch 2|Lack of Efficacy|0|||
145513618|NCT02059291|524741508|FG009|Epoch 2|Lack of Efficacy|0|||
145513619|NCT02059291|524741509|FG010|Epoch 2|Lack of Efficacy|0|||
145513620|NCT02059291|524741510|FG011|Epoch 2|Lack of Efficacy|0|||
145513621|NCT02059291|524741511|FG012|Epoch 2|Lack of Efficacy|0|||
145513622|NCT02059291|524741512|FG013|Epoch 2|Lack of Efficacy|0|||
145513623|NCT02059291|524741513|FG014|Epoch 2|Lack of Efficacy|0|||
145513624|NCT02059291|524741514|FG015|Epoch 2|Lack of Efficacy|0|||
145513625|NCT02059291|524741515|FG016|Epoch 2|Lack of Efficacy|0|||
145513626|NCT02059291|524741516|FG017|Epoch 2|Lack of Efficacy|0|||
145513627|NCT02059291|524741517|FG018|Epoch 2|Lack of Efficacy|0|||
145513628|NCT02059291|524741518|FG019|Epoch 2|Lack of Efficacy|0|||
145513629|NCT02059291|524741519|FG020|Epoch 2|Lack of Efficacy|0|||
145513630|NCT02059291|524741520|FG021|Epoch 2|Lack of Efficacy|0|||
145513631|NCT02059291|524741521|FG022|Epoch 2|Lack of Efficacy|0|||
145513632|NCT02059291|524741522|FG023|Epoch 2|Lack of Efficacy|0|||
145513633|NCT02059291|524741523|FG024|Epoch 2|Lack of Efficacy|0|||
145513634|NCT02059291|524741499|FG000|Epoch 2|Adverse Event|0|||
145513635|NCT02059291|524741500|FG001|Epoch 2|Adverse Event|0|||
145513636|NCT02059291|524741501|FG002|Epoch 2|Adverse Event|1|||
145513637|NCT02059291|524741502|FG003|Epoch 2|Adverse Event|1|||
145513638|NCT02059291|524741503|FG004|Epoch 2|Adverse Event|0|||
145513639|NCT02059291|524741504|FG005|Epoch 2|Adverse Event|0|||
145513640|NCT02059291|524741505|FG006|Epoch 2|Adverse Event|0|||
145513641|NCT02059291|524741506|FG007|Epoch 2|Adverse Event|1|||
145513642|NCT02059291|524741507|FG008|Epoch 2|Adverse Event|1|||
145513643|NCT02059291|524741508|FG009|Epoch 2|Adverse Event|0|||
145513644|NCT02059291|524741509|FG010|Epoch 2|Adverse Event|0|||
145513645|NCT02059291|524741510|FG011|Epoch 2|Adverse Event|0|||
145513646|NCT02059291|524741511|FG012|Epoch 2|Adverse Event|0|||
145513647|NCT02059291|524741512|FG013|Epoch 2|Adverse Event|0|||
145513648|NCT02059291|524741513|FG014|Epoch 2|Adverse Event|0|||
145513649|NCT02059291|524741514|FG015|Epoch 2|Adverse Event|0|||
145513650|NCT02059291|524741515|FG016|Epoch 2|Adverse Event|0|||
145513651|NCT02059291|524741516|FG017|Epoch 2|Adverse Event|0|||
145513652|NCT02059291|524741517|FG018|Epoch 2|Adverse Event|0|||
145513653|NCT02059291|524741518|FG019|Epoch 2|Adverse Event|0|||
145513654|NCT02059291|524741519|FG020|Epoch 2|Adverse Event|0|||
145513655|NCT02059291|524741520|FG021|Epoch 2|Adverse Event|0|||
145513656|NCT02059291|524741521|FG022|Epoch 2|Adverse Event|0|||
145513657|NCT02059291|524741522|FG023|Epoch 2|Adverse Event|0|||
145513658|NCT02059291|524741523|FG024|Epoch 2|Adverse Event|0|||
145513659|NCT02059291|524741499|FG000|Epoch 2|Withdrawal by Subject|0|||
145513660|NCT02059291|524741500|FG001|Epoch 2|Withdrawal by Subject|1|||
145513661|NCT02059291|524741501|FG002|Epoch 2|Withdrawal by Subject|0|||
145513662|NCT02059291|524741502|FG003|Epoch 2|Withdrawal by Subject|0|||
145513663|NCT02059291|524741503|FG004|Epoch 2|Withdrawal by Subject|0|||
145513664|NCT02059291|524741504|FG005|Epoch 2|Withdrawal by Subject|1|||
145513665|NCT02059291|524741505|FG006|Epoch 2|Withdrawal by Subject|0|||
145513666|NCT02059291|524741506|FG007|Epoch 2|Withdrawal by Subject|0|||
145513667|NCT02059291|524741507|FG008|Epoch 2|Withdrawal by Subject|1|||
145513668|NCT02059291|524741508|FG009|Epoch 2|Withdrawal by Subject|0|||
145513669|NCT02059291|524741509|FG010|Epoch 2|Withdrawal by Subject|0|||
145513670|NCT02059291|524741510|FG011|Epoch 2|Withdrawal by Subject|0|||
145513671|NCT02059291|524741511|FG012|Epoch 2|Withdrawal by Subject|0|||
145513672|NCT02059291|524741512|FG013|Epoch 2|Withdrawal by Subject|0|||
145513673|NCT02059291|524741513|FG014|Epoch 2|Withdrawal by Subject|0|||
145513674|NCT02059291|524741514|FG015|Epoch 2|Withdrawal by Subject|0|||
145513675|NCT02059291|524741515|FG016|Epoch 2|Withdrawal by Subject|0|||
145513676|NCT02059291|524741516|FG017|Epoch 2|Withdrawal by Subject|0|||
145513677|NCT02059291|524741517|FG018|Epoch 2|Withdrawal by Subject|0|||
145513678|NCT02059291|524741518|FG019|Epoch 2|Withdrawal by Subject|0|||
145513679|NCT02059291|524741519|FG020|Epoch 2|Withdrawal by Subject|0|||
145513680|NCT02059291|524741520|FG021|Epoch 2|Withdrawal by Subject|0|||
145513681|NCT02059291|524741521|FG022|Epoch 2|Withdrawal by Subject|0|||
145513682|NCT02059291|524741522|FG023|Epoch 2|Withdrawal by Subject|0|||
145513683|NCT02059291|524741523|FG024|Epoch 2|Withdrawal by Subject|0|||
145513684|NCT02059291|524741499|FG000|Epoch 3|Physician Decision|0|||
145513685|NCT02059291|524741500|FG001|Epoch 3|Physician Decision|0|||
145513686|NCT02059291|524741501|FG002|Epoch 3|Physician Decision|0|||
145513687|NCT02059291|524741502|FG003|Epoch 3|Physician Decision|0|||
145513688|NCT02059291|524741503|FG004|Epoch 3|Physician Decision|0|||
145513689|NCT02059291|524741504|FG005|Epoch 3|Physician Decision|0|||
145513690|NCT02059291|524741505|FG006|Epoch 3|Physician Decision|0|||
145513691|NCT02059291|524741506|FG007|Epoch 3|Physician Decision|0|||
145513692|NCT02059291|524741507|FG008|Epoch 3|Physician Decision|0|||
145513693|NCT02059291|524741508|FG009|Epoch 3|Physician Decision|0|||
145513694|NCT02059291|524741509|FG010|Epoch 3|Physician Decision|0|||
145513695|NCT02059291|524741510|FG011|Epoch 3|Physician Decision|0|||
145513696|NCT02059291|524741511|FG012|Epoch 3|Physician Decision|0|||
145513697|NCT02059291|524741512|FG013|Epoch 3|Physician Decision|1|||
145513698|NCT02059291|524741513|FG014|Epoch 3|Physician Decision|0|||
145513699|NCT02059291|524741514|FG015|Epoch 3|Physician Decision|1|||
145513700|NCT02059291|524741515|FG016|Epoch 3|Physician Decision|0|||
145513701|NCT02059291|524741516|FG017|Epoch 3|Physician Decision|0|||
145513702|NCT02059291|524741517|FG018|Epoch 3|Physician Decision|0|||
145513703|NCT02059291|524741518|FG019|Epoch 3|Physician Decision|0|||
145513704|NCT02059291|524741519|FG020|Epoch 3|Physician Decision|0|||
145513705|NCT02059291|524741520|FG021|Epoch 3|Physician Decision|0|||
145513706|NCT02059291|524741521|FG022|Epoch 3|Physician Decision|0|||
145513707|NCT02059291|524741522|FG023|Epoch 3|Physician Decision|0|||
145513708|NCT02059291|524741523|FG024|Epoch 3|Physician Decision|0|||
145513709|NCT02059291|524741499|FG000|Epoch 3|Adverse Event|0|||
145513710|NCT02059291|524741500|FG001|Epoch 3|Adverse Event|0|||
145513711|NCT02059291|524741501|FG002|Epoch 3|Adverse Event|0|||
145513712|NCT02059291|524741502|FG003|Epoch 3|Adverse Event|0|||
145513713|NCT02059291|524741503|FG004|Epoch 3|Adverse Event|0|||
145513714|NCT02059291|524741504|FG005|Epoch 3|Adverse Event|0|||
145513715|NCT02059291|524741505|FG006|Epoch 3|Adverse Event|0|||
145513716|NCT02059291|524741506|FG007|Epoch 3|Adverse Event|0|||
145513717|NCT02059291|524741507|FG008|Epoch 3|Adverse Event|0|||
145513718|NCT02059291|524741508|FG009|Epoch 3|Adverse Event|0|||
145513719|NCT02059291|524741509|FG010|Epoch 3|Adverse Event|0|||
145513720|NCT02059291|524741510|FG011|Epoch 3|Adverse Event|0|||
145513721|NCT02059291|524741511|FG012|Epoch 3|Adverse Event|0|||
145513722|NCT02059291|524741512|FG013|Epoch 3|Adverse Event|0|||
145513723|NCT02059291|524741513|FG014|Epoch 3|Adverse Event|0|||
145513724|NCT02059291|524741514|FG015|Epoch 3|Adverse Event|1|||
145513725|NCT02059291|524741515|FG016|Epoch 3|Adverse Event|0|||
145513726|NCT02059291|524741516|FG017|Epoch 3|Adverse Event|0|||
145513727|NCT02059291|524741517|FG018|Epoch 3|Adverse Event|0|||
145513728|NCT02059291|524741518|FG019|Epoch 3|Adverse Event|0|||
145513729|NCT02059291|524741519|FG020|Epoch 3|Adverse Event|0|||
145513730|NCT02059291|524741520|FG021|Epoch 3|Adverse Event|0|||
145513731|NCT02059291|524741521|FG022|Epoch 3|Adverse Event|0|||
145733331|NCT01822522|525540927|FG003|Overall Study|Death|0|||
145733332|NCT01822522|525540928|FG004|Overall Study|Death|0|||
145733333|NCT01822522|525540929|FG005|Overall Study|Death|0|||
145733334|NCT01822522|525540924|FG000|Overall Study|Lost to Follow-up|0|||
145733335|NCT01822522|525540925|FG001|Overall Study|Lost to Follow-up|0|||
145733336|NCT01822522|525540926|FG002|Overall Study|Lost to Follow-up|1|||
145733337|NCT01822522|525540927|FG003|Overall Study|Lost to Follow-up|1|||
145733338|NCT01822522|525540928|FG004|Overall Study|Lost to Follow-up|0|||
145733339|NCT01822522|525540929|FG005|Overall Study|Lost to Follow-up|1|||
145733340|NCT01822522|525540924|FG000|Overall Study|Withdrawal by Subject|0|||
145733341|NCT01822522|525540925|FG001|Overall Study|Withdrawal by Subject|0|||
145733342|NCT01822522|525540926|FG002|Overall Study|Withdrawal by Subject|0|||
145733343|NCT01822522|525540927|FG003|Overall Study|Withdrawal by Subject|1|||
145733344|NCT01822522|525540928|FG004|Overall Study|Withdrawal by Subject|0|||
145733345|NCT01822522|525540929|FG005|Overall Study|Withdrawal by Subject|0|||
145733346|NCT01822522|525540924|FG000|Overall Study|Lack of Efficacy|0|||
145733347|NCT01822522|525540925|FG001|Overall Study|Lack of Efficacy|0|||
145733348|NCT01822522|525540926|FG002|Overall Study|Lack of Efficacy|0|||
145733349|NCT01822522|525540927|FG003|Overall Study|Lack of Efficacy|0|||
145733350|NCT01822522|525540928|FG004|Overall Study|Lack of Efficacy|0|||
145733351|NCT01822522|525540929|FG005|Overall Study|Lack of Efficacy|2|||
145733352|NCT01807923|525540930|FG000|Overall Study|Adverse Event|2|||
145733353|NCT01807923|525540931|FG001|Overall Study|Adverse Event|1|||
145733354|NCT01807923|525540932|FG002|Overall Study|Adverse Event|2|||
145733355|NCT01807923|525540930|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145733356|NCT01807923|525540931|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
145402098|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145733357|NCT01807923|525540932|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
145733358|NCT01807923|525540930|FG000|Overall Study|Physician Decision|0|||
145733359|NCT01807923|525540931|FG001|Overall Study|Physician Decision|0|||
145733360|NCT01807923|525540932|FG002|Overall Study|Physician Decision|1|||
145402099|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145402100|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
145402101|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
145402102|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145402103|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145402104|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145402105|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
145402106|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145402107|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
145402108|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145402109|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145402110|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
145402111|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
145402112|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145402113|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145402114|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145402115|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
145402116|NCT02717195|524328833|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
145402117|NCT02717195|524328834|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145402118|NCT02717195|524328835|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145402119|NCT02717195|524328836|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145402120|NCT02717195|524328837|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
145402121|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
145402122|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
145402123|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
145402124|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
145402125|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
145402126|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
145402127|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
145402128|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
145402129|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
145402130|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
145733361|NCT01807923|525540930|FG000|Overall Study|Not Eligible (Genotype)|0|||
145733362|NCT01807923|525540931|FG001|Overall Study|Not Eligible (Genotype)|0|||
145733363|NCT01807923|525540932|FG002|Overall Study|Not Eligible (Genotype)|1|||
145733364|NCT01807923|525540930|FG000|Overall Study|Randomized But Not Treated|3|||
145733365|NCT01807923|525540931|FG001|Overall Study|Randomized But Not Treated|2|||
145733366|NCT01807923|525540932|FG002|Overall Study|Randomized But Not Treated|5|||
145733367|NCT02558231|525540934|FG000|Overall Study|Death|4|||
145733368|NCT02558231|525540935|FG001|Overall Study|Death|12|||
145733369|NCT02558231|525540934|FG000|Overall Study|Lost to Follow-up|7|||
145733370|NCT02558231|525540935|FG001|Overall Study|Lost to Follow-up|4|||
145733371|NCT02558231|525540934|FG000|Overall Study|Withdrawal by Subject|7|||
145733372|NCT02558231|525540935|FG001|Overall Study|Withdrawal by Subject|4|||
145733373|NCT02558231|525540934|FG000|Overall Study|Physician Decision|7|||
145733374|NCT02558231|525540935|FG001|Overall Study|Physician Decision|5|||
145733375|NCT02558231|525540934|FG000|Overall Study|Sponsor Decision|0|||
145733376|NCT02558231|525540935|FG001|Overall Study|Sponsor Decision|1|||
145733377|NCT00995007|525540936|FG000|Overall Study|Withdrew consent|1|||
145733378|NCT00995007|525540937|FG001|Overall Study|Withdrew consent|0|||
145733379|NCT00995007|525540936|FG000|Overall Study|Refused further treatment|8|||
145733380|NCT00995007|525540937|FG001|Overall Study|Refused further treatment|2|||
145733381|NCT00995007|525540936|FG000|Overall Study|Toxicity|8|||
145733382|NCT00995007|525540937|FG001|Overall Study|Toxicity|0|||
145733383|NCT03933397|525540938|FG000|Overall Study|No emergency department visit|65|||
145733384|NCT03933397|525540939|FG001|Overall Study|No emergency department visit|71|||
145733385|NCT03933397|525540938|FG000|Overall Study|Missed emergency department visit|25|||
145733386|NCT03933397|525540939|FG001|Overall Study|Missed emergency department visit|30|||
145733387|NCT03933397|525540938|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
145733388|NCT03933397|525540939|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
145733389|NCT03933397|525540938|FG000|Overall Study|Withdrawal by Subject|1|||
145733390|NCT03933397|525540939|FG001|Overall Study|Withdrawal by Subject|0|||
145733391|NCT03933397|525540938|FG000|Overall Study|Physician Decision|1|||
145733392|NCT03933397|525540939|FG001|Overall Study|Physician Decision|1|||
145733393|NCT03933397|525540938|FG000|Overall Study|missing pain score|1|||
145733394|NCT03933397|525540939|FG001|Overall Study|missing pain score|1|||
145733395|NCT03933397|525540938|FG000|Overall Study|Confirmed COVID-19|1|||
145733396|NCT03933397|525540939|FG001|Overall Study|Confirmed COVID-19|2|||
145733397|NCT02066051|525540942|FG000|Overall Study|Subject developed active GVHD|1|||
145733398|NCT00685685|525540943|FG000|Washout Period of 7 Days|Adverse Event|2|||
145733399|NCT00685685|525540944|FG001|Washout Period of 7 Days|Adverse Event|0|||
145733400|NCT00685685|525540943|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145733401|NCT00685685|525540944|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145733402|NCT04029116|525540945|FG000|Overall Study|Adverse Event|0|||
145733403|NCT04029116|525540946|FG001|Overall Study|Adverse Event|2|||
145733404|NCT04029116|525540945|FG000|Overall Study|Lost to Follow-up|3|||
145733405|NCT04029116|525540946|FG001|Overall Study|Lost to Follow-up|5|||
145733406|NCT04029116|525540945|FG000|Overall Study|Physician Decision|2|||
145733407|NCT04029116|525540946|FG001|Overall Study|Physician Decision|0|||
145733408|NCT04029116|525540945|FG000|Overall Study|Pregnancy|1|||
145733409|NCT04029116|525540946|FG001|Overall Study|Pregnancy|2|||
145733410|NCT04029116|525540945|FG000|Overall Study|Withdrawal by Subject|4|||
145733411|NCT04029116|525540946|FG001|Overall Study|Withdrawal by Subject|6|||
145733412|NCT04029116|525540945|FG000|Overall Study|Other|2|||
145733413|NCT04029116|525540946|FG001|Overall Study|Other|1|||
145733414|NCT02469896|525540947|FG000|Overall Study|Withdrawal by Subject|2|||
145733415|NCT02469896|525540948|FG001|Overall Study|Withdrawal by Subject|0|||
145733416|NCT02401412|525540949|FG000|Overall Study|Lost to Follow-up|1|||
145402131|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
145733417|NCT02401412|525540950|FG001|Overall Study|Lost to Follow-up|0|||
145733418|NCT02401412|525540949|FG000|Overall Study|Discontinued Intervention|15|||
145733419|NCT02401412|525540950|FG001|Overall Study|Discontinued Intervention|21|||
145733420|NCT02401412|525540949|FG000|Overall Study|Withdrawal by Subject|4|||
145733421|NCT02401412|525540950|FG001|Overall Study|Withdrawal by Subject|4|||
145733422|NCT02401412|525540949|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
145733423|NCT02401412|525540950|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
145733424|NCT02401412|525540949|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
145733425|NCT02401412|525540950|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
145733426|NCT02014740|525540953|FG000|Overall Study|Lost to Follow-up|4|||
145402132|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
145402133|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
145733427|NCT02014740|525540954|FG001|Overall Study|Lost to Follow-up|4|||
145733428|NCT02014740|525540953|FG000|Overall Study|Withdrawal by Subject|2|||
145733429|NCT02014740|525540954|FG001|Overall Study|Withdrawal by Subject|1|||
145402134|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
145402135|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
145513732|NCT02059291|524741522|FG023|Epoch 3|Adverse Event|0|||
145513733|NCT02059291|524741523|FG024|Epoch 3|Adverse Event|0|||
145513734|NCT02059291|524741499|FG000|Epoch 3|Lack of Efficacy|0|||
145513735|NCT02059291|524741500|FG001|Epoch 3|Lack of Efficacy|0|||
145513736|NCT02059291|524741501|FG002|Epoch 3|Lack of Efficacy|0|||
145513737|NCT02059291|524741502|FG003|Epoch 3|Lack of Efficacy|0|||
145513738|NCT02059291|524741503|FG004|Epoch 3|Lack of Efficacy|0|||
145513739|NCT02059291|524741504|FG005|Epoch 3|Lack of Efficacy|0|||
145513740|NCT02059291|524741505|FG006|Epoch 3|Lack of Efficacy|0|||
145513741|NCT02059291|524741506|FG007|Epoch 3|Lack of Efficacy|0|||
145513742|NCT02059291|524741507|FG008|Epoch 3|Lack of Efficacy|0|||
145513743|NCT02059291|524741508|FG009|Epoch 3|Lack of Efficacy|0|||
145513744|NCT02059291|524741509|FG010|Epoch 3|Lack of Efficacy|0|||
145513745|NCT02059291|524741510|FG011|Epoch 3|Lack of Efficacy|0|||
145513746|NCT02059291|524741511|FG012|Epoch 3|Lack of Efficacy|0|||
145513747|NCT02059291|524741512|FG013|Epoch 3|Lack of Efficacy|0|||
145513748|NCT02059291|524741513|FG014|Epoch 3|Lack of Efficacy|0|||
145513749|NCT02059291|524741514|FG015|Epoch 3|Lack of Efficacy|3|||
145513750|NCT02059291|524741515|FG016|Epoch 3|Lack of Efficacy|0|||
145513751|NCT02059291|524741516|FG017|Epoch 3|Lack of Efficacy|0|||
145513752|NCT02059291|524741517|FG018|Epoch 3|Lack of Efficacy|0|||
145513753|NCT02059291|524741518|FG019|Epoch 3|Lack of Efficacy|0|||
145513754|NCT02059291|524741519|FG020|Epoch 3|Lack of Efficacy|0|||
145513755|NCT02059291|524741520|FG021|Epoch 3|Lack of Efficacy|0|||
145513756|NCT02059291|524741521|FG022|Epoch 3|Lack of Efficacy|0|||
145513757|NCT02059291|524741522|FG023|Epoch 3|Lack of Efficacy|0|||
145513758|NCT02059291|524741523|FG024|Epoch 3|Lack of Efficacy|0|||
145513759|NCT02059291|524741499|FG000|Epoch 3|Withdrawal by Subject|0|||
145513760|NCT02059291|524741500|FG001|Epoch 3|Withdrawal by Subject|0|||
145513761|NCT02059291|524741501|FG002|Epoch 3|Withdrawal by Subject|0|||
145513762|NCT02059291|524741502|FG003|Epoch 3|Withdrawal by Subject|0|||
145513763|NCT02059291|524741503|FG004|Epoch 3|Withdrawal by Subject|0|||
145513764|NCT02059291|524741504|FG005|Epoch 3|Withdrawal by Subject|0|||
145513765|NCT02059291|524741505|FG006|Epoch 3|Withdrawal by Subject|0|||
145513766|NCT02059291|524741506|FG007|Epoch 3|Withdrawal by Subject|0|||
145513767|NCT02059291|524741507|FG008|Epoch 3|Withdrawal by Subject|0|||
145513768|NCT02059291|524741508|FG009|Epoch 3|Withdrawal by Subject|0|||
145513769|NCT02059291|524741509|FG010|Epoch 3|Withdrawal by Subject|0|||
145513770|NCT02059291|524741510|FG011|Epoch 3|Withdrawal by Subject|0|||
145513771|NCT02059291|524741511|FG012|Epoch 3|Withdrawal by Subject|0|||
145513772|NCT02059291|524741512|FG013|Epoch 3|Withdrawal by Subject|0|||
145513773|NCT02059291|524741513|FG014|Epoch 3|Withdrawal by Subject|0|||
145513774|NCT02059291|524741514|FG015|Epoch 3|Withdrawal by Subject|1|||
145513775|NCT02059291|524741515|FG016|Epoch 3|Withdrawal by Subject|0|||
145513776|NCT02059291|524741516|FG017|Epoch 3|Withdrawal by Subject|0|||
145513777|NCT02059291|524741517|FG018|Epoch 3|Withdrawal by Subject|0|||
145513778|NCT02059291|524741518|FG019|Epoch 3|Withdrawal by Subject|0|||
145513779|NCT02059291|524741519|FG020|Epoch 3|Withdrawal by Subject|0|||
145733430|NCT02608879|525540955|FG000|Overall Study|Lost to Follow-up|1|||
145733431|NCT02608879|525540956|FG001|Overall Study|Lost to Follow-up|0|||
145733432|NCT02608879|525540957|FG002|Overall Study|Lost to Follow-up|0|||
145513780|NCT02059291|524741520|FG021|Epoch 3|Withdrawal by Subject|0|||
145513781|NCT02059291|524741521|FG022|Epoch 3|Withdrawal by Subject|0|||
145513782|NCT02059291|524741522|FG023|Epoch 3|Withdrawal by Subject|0|||
145513783|NCT02059291|524741523|FG024|Epoch 3|Withdrawal by Subject|0|||
145513784|NCT02059291|524741499|FG000|Epoch 4|Adverse Event|0|||
145513785|NCT02059291|524741500|FG001|Epoch 4|Adverse Event|0|||
145513786|NCT02059291|524741501|FG002|Epoch 4|Adverse Event|0|||
145513787|NCT02059291|524741502|FG003|Epoch 4|Adverse Event|0|||
145513788|NCT02059291|524741503|FG004|Epoch 4|Adverse Event|0|||
145513789|NCT02059291|524741504|FG005|Epoch 4|Adverse Event|0|||
145513790|NCT02059291|524741505|FG006|Epoch 4|Adverse Event|0|||
145513791|NCT02059291|524741506|FG007|Epoch 4|Adverse Event|0|||
145513792|NCT02059291|524741507|FG008|Epoch 4|Adverse Event|0|||
145513793|NCT02059291|524741508|FG009|Epoch 4|Adverse Event|0|||
145513794|NCT02059291|524741509|FG010|Epoch 4|Adverse Event|0|||
145733433|NCT02608879|525540955|FG000|Overall Study|Did not meet continuation criteria|0|||
145733434|NCT02608879|525540956|FG001|Overall Study|Did not meet continuation criteria|0|||
145513795|NCT02059291|524741510|FG011|Epoch 4|Adverse Event|0|||
145513796|NCT02059291|524741511|FG012|Epoch 4|Adverse Event|0|||
145513797|NCT02059291|524741512|FG013|Epoch 4|Adverse Event|0|||
145513798|NCT02059291|524741513|FG014|Epoch 4|Adverse Event|0|||
145513799|NCT02059291|524741514|FG015|Epoch 4|Adverse Event|0|||
145513800|NCT02059291|524741515|FG016|Epoch 4|Adverse Event|1|||
145513801|NCT02059291|524741516|FG017|Epoch 4|Adverse Event|0|||
145513802|NCT02059291|524741517|FG018|Epoch 4|Adverse Event|0|||
145513803|NCT02059291|524741518|FG019|Epoch 4|Adverse Event|0|||
145513804|NCT02059291|524741519|FG020|Epoch 4|Adverse Event|0|||
145513805|NCT02059291|524741520|FG021|Epoch 4|Adverse Event|0|||
145513806|NCT02059291|524741521|FG022|Epoch 4|Adverse Event|1|||
145513807|NCT02059291|524741522|FG023|Epoch 4|Adverse Event|0|||
145402136|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145402137|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145402138|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
145402139|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
145402140|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
145402141|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145402142|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145402143|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
145402144|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
145402145|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
145402146|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145402147|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145402148|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
145402149|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
145402150|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
145402151|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145402152|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145402153|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
145402154|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145402155|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
145402156|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
145402157|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
145402158|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
145402159|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
145402160|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
145402161|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145402162|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145402163|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
145402164|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
145402165|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
145402166|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145402167|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145402168|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145402169|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
145402170|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
145402171|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
145402172|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
145402173|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
145402174|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
145402175|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
145402176|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145402177|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145402178|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145402179|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
145402180|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
145402181|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145402182|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145402183|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
145402184|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145733435|NCT02608879|525540957|FG002|Overall Study|Did not meet continuation criteria|3|||
145733436|NCT06132425|525540958|FG000|Overall Study|Withdrawal by Subject|3|||
145733437|NCT06132425|525540959|FG001|Overall Study|Withdrawal by Subject|0|||
145733438|NCT06132425|525540958|FG000|Overall Study|Did not follow study instructions|0|||
145733439|NCT06132425|525540959|FG001|Overall Study|Did not follow study instructions|2|||
145733440|NCT06132425|525540958|FG000|Overall Study|Lost to Follow-up|3|||
145733441|NCT06132425|525540959|FG001|Overall Study|Lost to Follow-up|5|||
145733442|NCT02446600|525540960|FG000|Overall Study|Never treated|20|||
145733443|NCT02446600|525540961|FG001|Overall Study|Never treated|2|||
145733444|NCT02446600|525540962|FG002|Overall Study|Never treated|6|||
145733445|NCT02446600|525540963|FG003|Overall Study|Never treated|0|||
145733446|NCT02446600|525540960|FG000|Overall Study|Withdrawal by Subject|19|||
145733447|NCT02446600|525540961|FG001|Overall Study|Withdrawal by Subject|5|||
145733448|NCT02446600|525540962|FG002|Overall Study|Withdrawal by Subject|17|||
145733449|NCT02446600|525540963|FG003|Overall Study|Withdrawal by Subject|0|||
145733450|NCT02446600|525540960|FG000|Overall Study|Ineligible|1|||
145733451|NCT02446600|525540961|FG001|Overall Study|Ineligible|4|||
145733452|NCT02446600|525540962|FG002|Overall Study|Ineligible|4|||
145733453|NCT02446600|525540963|FG003|Overall Study|Ineligible|1|||
145733454|NCT02446600|525540960|FG000|Overall Study|Duplicate Enrollment|0|||
145733455|NCT02446600|525540961|FG001|Overall Study|Duplicate Enrollment|1|||
145733456|NCT02446600|525540962|FG002|Overall Study|Duplicate Enrollment|0|||
145733457|NCT02446600|525540963|FG003|Overall Study|Duplicate Enrollment|0|||
145733458|NCT04409353|525540964|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
145733459|NCT04409353|525540965|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
145733460|NCT04409353|525540966|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
145733461|NCT04409353|525540964|FG000|Overall Study|Lost to Follow-up|6|||
145733462|NCT04409353|525540965|FG001|Overall Study|Lost to Follow-up|8|||
145733463|NCT04409353|525540966|FG002|Overall Study|Lost to Follow-up|7|||
145733464|NCT04409353|525540964|FG000|Overall Study|Major surgery during participation window|4|||
145733465|NCT04409353|525540965|FG001|Overall Study|Major surgery during participation window|3|||
145733466|NCT04409353|525540966|FG002|Overall Study|Major surgery during participation window|3|||
145733467|NCT04409353|525540964|FG000|Overall Study|Life event occurred during participation window|3|||
145733468|NCT04409353|525540965|FG001|Overall Study|Life event occurred during participation window|2|||
145733469|NCT04409353|525540966|FG002|Overall Study|Life event occurred during participation window|4|||
145733470|NCT04409353|525540964|FG000|Overall Study|Lack of Efficacy|4|||
145733471|NCT04409353|525540965|FG001|Overall Study|Lack of Efficacy|1|||
145733472|NCT04409353|525540966|FG002|Overall Study|Lack of Efficacy|3|||
145733473|NCT04409353|525540964|FG000|Overall Study|Adverse Event|2|||
145733474|NCT04409353|525540965|FG001|Overall Study|Adverse Event|1|||
145733475|NCT04409353|525540966|FG002|Overall Study|Adverse Event|1|||
145733476|NCT04409353|525540964|FG000|Overall Study|Disease burden - unable to participate|0|||
145733477|NCT04409353|525540965|FG001|Overall Study|Disease burden - unable to participate|1|||
145733478|NCT04409353|525540966|FG002|Overall Study|Disease burden - unable to participate|1|||
145733479|NCT04409353|525540964|FG000|Overall Study|Intervention too complicated|1|||
145402185|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
145402186|NCT02717195|524328833|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145402187|NCT02717195|524328834|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145733480|NCT04409353|525540965|FG001|Overall Study|Intervention too complicated|0|||
145733481|NCT04409353|525540966|FG002|Overall Study|Intervention too complicated|1|||
145733482|NCT06308666|525540967|FG000|Overall Study|Withdrawal by Subject|1|||
145733483|NCT06308666|525540967|FG000|Overall Study|Protocol Violation|2|||
145733484|NCT02499770|525540970|FG000|Overall Study|Death|17|||
145402188|NCT02717195|524328835|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
145402189|NCT02717195|524328836|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
145402190|NCT02717195|524328837|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
145402191|NCT03092752|524328840|FG000|Overall Study|Aged <40 years|14209|||
145402192|NCT03092752|524328840|FG000|Overall Study|At least one claim with T2DM|61299|||
145402193|NCT03092752|524328840|FG000|Overall Study|Having no claim of study drugs|29282|||
145402194|NCT03092752|524328840|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
145402195|NCT03092752|524328840|FG000|Overall Study|<6 month history|245900|||
145402196|NCT03882918|524328841|FG000|Overall Study|Study terminated by sponsor|98|||
145402197|NCT03882918|524328841|FG000|Overall Study|Protocol Violation|1|||
145402198|NCT03882918|524328841|FG000|Overall Study|Other|9|||
145402199|NCT03882918|524328841|FG000|Overall Study|Lack of Efficacy|14|||
145402200|NCT03882918|524328841|FG000|Overall Study|Adverse Event|13|||
145402201|NCT03882918|524328841|FG000|Overall Study|Withdrawal by Subject|5|||
145402202|NCT06996301|524328842|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
145402203|NCT06996301|524328843|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
145402204|NCT06996301|524328842|FG000|Overall Study|Patients with discordant diagnostic results|107|||
145513808|NCT02059291|524741523|FG024|Epoch 4|Adverse Event|0|||
145513809|NCT02059291|524741499|FG000|Epoch 4|Pregnancy|0|||
145513810|NCT02059291|524741500|FG001|Epoch 4|Pregnancy|0|||
145513811|NCT02059291|524741501|FG002|Epoch 4|Pregnancy|0|||
145513812|NCT02059291|524741502|FG003|Epoch 4|Pregnancy|0|||
145513813|NCT02059291|524741503|FG004|Epoch 4|Pregnancy|0|||
145513814|NCT02059291|524741504|FG005|Epoch 4|Pregnancy|0|||
145513815|NCT02059291|524741505|FG006|Epoch 4|Pregnancy|0|||
145513816|NCT02059291|524741506|FG007|Epoch 4|Pregnancy|0|||
145513817|NCT02059291|524741507|FG008|Epoch 4|Pregnancy|0|||
145513818|NCT02059291|524741508|FG009|Epoch 4|Pregnancy|0|||
145513819|NCT02059291|524741509|FG010|Epoch 4|Pregnancy|0|||
145513820|NCT02059291|524741510|FG011|Epoch 4|Pregnancy|0|||
145513821|NCT02059291|524741511|FG012|Epoch 4|Pregnancy|0|||
145513822|NCT02059291|524741512|FG013|Epoch 4|Pregnancy|0|||
145513823|NCT02059291|524741513|FG014|Epoch 4|Pregnancy|0|||
145513824|NCT02059291|524741514|FG015|Epoch 4|Pregnancy|0|||
145513825|NCT02059291|524741515|FG016|Epoch 4|Pregnancy|1|||
145513826|NCT02059291|524741516|FG017|Epoch 4|Pregnancy|0|||
145513827|NCT02059291|524741517|FG018|Epoch 4|Pregnancy|0|||
145513828|NCT02059291|524741518|FG019|Epoch 4|Pregnancy|0|||
145513829|NCT02059291|524741519|FG020|Epoch 4|Pregnancy|0|||
145513830|NCT02059291|524741520|FG021|Epoch 4|Pregnancy|0|||
145513831|NCT02059291|524741521|FG022|Epoch 4|Pregnancy|0|||
145513832|NCT02059291|524741522|FG023|Epoch 4|Pregnancy|0|||
145513833|NCT02059291|524741523|FG024|Epoch 4|Pregnancy|0|||
145513834|NCT02059291|524741499|FG000|Epoch 4|Withdrawal by Subject|0|||
145513835|NCT02059291|524741500|FG001|Epoch 4|Withdrawal by Subject|0|||
145513836|NCT02059291|524741501|FG002|Epoch 4|Withdrawal by Subject|0|||
145513837|NCT02059291|524741502|FG003|Epoch 4|Withdrawal by Subject|0|||
145513838|NCT02059291|524741503|FG004|Epoch 4|Withdrawal by Subject|0|||
145513839|NCT02059291|524741504|FG005|Epoch 4|Withdrawal by Subject|0|||
145513840|NCT02059291|524741505|FG006|Epoch 4|Withdrawal by Subject|0|||
145513841|NCT02059291|524741506|FG007|Epoch 4|Withdrawal by Subject|0|||
145513842|NCT02059291|524741507|FG008|Epoch 4|Withdrawal by Subject|0|||
145513843|NCT02059291|524741508|FG009|Epoch 4|Withdrawal by Subject|0|||
145513844|NCT02059291|524741509|FG010|Epoch 4|Withdrawal by Subject|0|||
145513845|NCT02059291|524741510|FG011|Epoch 4|Withdrawal by Subject|0|||
145513846|NCT02059291|524741511|FG012|Epoch 4|Withdrawal by Subject|0|||
145513847|NCT02059291|524741512|FG013|Epoch 4|Withdrawal by Subject|0|||
145513848|NCT02059291|524741513|FG014|Epoch 4|Withdrawal by Subject|0|||
145513849|NCT02059291|524741514|FG015|Epoch 4|Withdrawal by Subject|0|||
145513850|NCT02059291|524741515|FG016|Epoch 4|Withdrawal by Subject|0|||
145513851|NCT02059291|524741516|FG017|Epoch 4|Withdrawal by Subject|0|||
145513852|NCT02059291|524741517|FG018|Epoch 4|Withdrawal by Subject|0|||
145513853|NCT02059291|524741518|FG019|Epoch 4|Withdrawal by Subject|0|||
145513854|NCT02059291|524741519|FG020|Epoch 4|Withdrawal by Subject|1|||
145733485|NCT02499770|525540971|FG001|Overall Study|Death|56|||
145733486|NCT02499770|525540970|FG000|Overall Study|Study completion|1|||
145733487|NCT02499770|525540971|FG001|Overall Study|Study completion|10|||
145733488|NCT02499770|525540970|FG000|Overall Study|Withdrawal by Subject|0|||
145733489|NCT02499770|525540971|FG001|Overall Study|Withdrawal by Subject|7|||
145733490|NCT02499770|525540970|FG000|Overall Study|Lost to Follow-up|0|||
145733491|NCT02499770|525540971|FG001|Overall Study|Lost to Follow-up|2|||
145733492|NCT02499770|525540970|FG000|Overall Study|Subject declined further treatment|1|||
145733493|NCT02499770|525540971|FG001|Overall Study|Subject declined further treatment|0|||
145733494|NCT02499770|525540970|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
145733495|NCT02499770|525540971|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
145733496|NCT02499770|525540970|FG000|Overall Study|Randomized but not enrolled|0|||
145733497|NCT02499770|525540971|FG001|Overall Study|Randomized but not enrolled|1|||
145513855|NCT02059291|524741520|FG021|Epoch 4|Withdrawal by Subject|0|||
145513856|NCT02059291|524741521|FG022|Epoch 4|Withdrawal by Subject|0|||
145513857|NCT02059291|524741522|FG023|Epoch 4|Withdrawal by Subject|0|||
145513858|NCT02059291|524741523|FG024|Epoch 4|Withdrawal by Subject|0|||
145513859|NCT02059291|524741499|FG000|Epoch 4|Lack of Efficacy|0|||
145513860|NCT02059291|524741500|FG001|Epoch 4|Lack of Efficacy|0|||
145513861|NCT02059291|524741501|FG002|Epoch 4|Lack of Efficacy|0|||
145733498|NCT00671554|525540978|FG000|Overall Study|Disease progression|3|||
145733499|NCT04376060|525540979|FG000|Overall Study|Physician Decision|1|||
145513862|NCT02059291|524741502|FG003|Epoch 4|Lack of Efficacy|0|||
145513863|NCT02059291|524741503|FG004|Epoch 4|Lack of Efficacy|0|||
145513864|NCT02059291|524741504|FG005|Epoch 4|Lack of Efficacy|0|||
145513865|NCT02059291|524741505|FG006|Epoch 4|Lack of Efficacy|0|||
145513866|NCT02059291|524741506|FG007|Epoch 4|Lack of Efficacy|0|||
145513867|NCT02059291|524741507|FG008|Epoch 4|Lack of Efficacy|0|||
145513868|NCT02059291|524741508|FG009|Epoch 4|Lack of Efficacy|0|||
145513869|NCT02059291|524741509|FG010|Epoch 4|Lack of Efficacy|0|||
145513870|NCT02059291|524741510|FG011|Epoch 4|Lack of Efficacy|0|||
145513871|NCT02059291|524741511|FG012|Epoch 4|Lack of Efficacy|0|||
145513872|NCT02059291|524741512|FG013|Epoch 4|Lack of Efficacy|0|||
145513873|NCT02059291|524741513|FG014|Epoch 4|Lack of Efficacy|0|||
145513874|NCT02059291|524741514|FG015|Epoch 4|Lack of Efficacy|0|||
145513875|NCT02059291|524741515|FG016|Epoch 4|Lack of Efficacy|0|||
145733500|NCT00977574|525540980|FG000|Overall Study|Never Treated|4|||
145733501|NCT00977574|525540981|FG001|Overall Study|Never Treated|2|||
145733502|NCT00977574|525540982|FG002|Overall Study|Never Treated|4|||
145733503|NCT07052682|525540983|FG000|Overall Study|Withdrawal by Subject|4|||
145733504|NCT04667247|525540984|FG000|Overall Study|Withdrawal by Subject|0|||
145733505|NCT04667247|525540985|FG001|Overall Study|Withdrawal by Subject|1|||
145733506|NCT05460273|525540986|FG000|Overall Study|Death|43|||
145733507|NCT05460273|525540987|FG001|Overall Study|Death|9|||
145733508|NCT05460273|525540986|FG000|Overall Study|Lost to Follow-up|7|||
145733509|NCT05460273|525540987|FG001|Overall Study|Lost to Follow-up|0|||
145733510|NCT05460273|525540986|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
145733511|NCT05460273|525540987|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
145733512|NCT04124614|525540988|FG000|Placebo Run-in Period|Not Randomized|34|||
145733513|NCT04124614|525540989|FG001|Placebo Run-in Period|Not Randomized|0|||
145733514|NCT04124614|525540990|FG002|Placebo Run-in Period|Not Randomized|0|||
145733515|NCT04124614|525540988|FG000|Double Blind Treatment Period|Adverse Event|0|||
145733516|NCT04124614|525540989|FG001|Double Blind Treatment Period|Adverse Event|7|||
145733517|NCT04124614|525540990|FG002|Double Blind Treatment Period|Adverse Event|22|||
145733518|NCT04124614|525540988|FG000|Double Blind Treatment Period|Death|0|||
145733519|NCT04124614|525540989|FG001|Double Blind Treatment Period|Death|0|||
145733520|NCT04124614|525540990|FG002|Double Blind Treatment Period|Death|1|||
145733521|NCT04124614|525540988|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
145513876|NCT02059291|524741516|FG017|Epoch 4|Lack of Efficacy|0|||
145513877|NCT02059291|524741517|FG018|Epoch 4|Lack of Efficacy|0|||
145513878|NCT02059291|524741518|FG019|Epoch 4|Lack of Efficacy|0|||
145513879|NCT02059291|524741519|FG020|Epoch 4|Lack of Efficacy|0|||
145513880|NCT02059291|524741520|FG021|Epoch 4|Lack of Efficacy|0|||
145513881|NCT02059291|524741521|FG022|Epoch 4|Lack of Efficacy|0|||
145513882|NCT02059291|524741522|FG023|Epoch 4|Lack of Efficacy|1|||
145513883|NCT02059291|524741523|FG024|Epoch 4|Lack of Efficacy|0|||
145513884|NCT01433289|524741524|FG000|Overall Study|Pregnancy|0|||
145513885|NCT01433289|524741525|FG001|Overall Study|Pregnancy|1|||
145513886|NCT01433289|524741526|FG002|Overall Study|Pregnancy|0|||
145513887|NCT01433289|524741527|FG003|Overall Study|Pregnancy|0|||
145513888|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
145513889|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
145733522|NCT04124614|525540989|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
145733523|NCT04124614|525540990|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
145733524|NCT04124614|525540988|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
145733525|NCT04124614|525540989|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
145733526|NCT04124614|525540990|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
145733527|NCT04124614|525540988|FG000|Double Blind Treatment Period|Physician Decision|0|||
145733528|NCT04124614|525540989|FG001|Double Blind Treatment Period|Physician Decision|0|||
145733529|NCT04124614|525540990|FG002|Double Blind Treatment Period|Physician Decision|3|||
145733530|NCT04124614|525540988|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
145733531|NCT04124614|525540989|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
145733532|NCT04124614|525540990|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
145733533|NCT04124614|525540988|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
145733534|NCT04124614|525540989|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
145733535|NCT04124614|525540990|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
145733536|NCT04124614|525540988|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
145733537|NCT04124614|525540989|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
145733538|NCT04124614|525540990|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
145733539|NCT05749952|525540991|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
145733540|NCT06950879|525540992|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
145513890|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Adverse Event|7|||
145513891|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Adverse Event|6|||
145513892|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
145513893|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
145513894|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Physician Decision|4|||
145513895|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Physician Decision|4|||
145733541|NCT00726622|525543253|FG000|Overall Study|Withdrawal by Subject|16|||
145733542|NCT00726622|525543254|FG001|Overall Study|Withdrawal by Subject|2|||
145733543|NCT00726622|525543253|FG000|Overall Study|Physician Decision|0|||
145733544|NCT00726622|525543254|FG001|Overall Study|Physician Decision|1|||
145733545|NCT00726622|525543253|FG000|Overall Study|Metastasis|2|||
145733546|NCT00726622|525543254|FG001|Overall Study|Metastasis|0|||
145733547|NCT01016964|525543261|FG000|Overall Study|Lost to Follow-up|3|||
145733548|NCT01016964|525543262|FG001|Overall Study|Lost to Follow-up|3|||
145733549|NCT00352885|525543263|FG000|Overall Study|Withdrawal by Subject|0|||
145513896|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
145513897|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
145513898|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
145733550|NCT00352885|525543264|FG001|Overall Study|Withdrawal by Subject|3|||
145733551|NCT00352885|525543263|FG000|Overall Study|Development of major depression|0|||
145733552|NCT00352885|525543264|FG001|Overall Study|Development of major depression|1|||
145513899|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
145733553|NCT00352885|525543263|FG000|Overall Study|Progression of metastatic melanoma|5|||
145733554|NCT00352885|525543264|FG001|Overall Study|Progression of metastatic melanoma|3|||
145733555|NCT00352885|525543263|FG000|Overall Study|Side effects of IL-2 administration|1|||
145733556|NCT00352885|525543264|FG001|Overall Study|Side effects of IL-2 administration|0|||
145733557|NCT03873493|525543265|FG000|Overall Study|Withdrawal by Subject|1|||
145733558|NCT03873493|525543265|FG000|Overall Study|Death|9|||
145733559|NCT03873493|525543265|FG000|Overall Study|Lost to Follow-up|1|||
145733560|NCT03873493|525543265|FG000|Overall Study|Study Terminated by Sponsor|1|||
145733561|NCT03873493|525543265|FG000|Overall Study|Other|2|||
145733562|NCT00440700|525543267|FG000|Overall Study|Withdrawal by Subject|8|||
145733563|NCT00440700|525543268|FG001|Overall Study|Withdrawal by Subject|8|||
145733564|NCT00440700|525543269|FG002|Overall Study|Withdrawal by Subject|4|||
145733565|NCT04906616|525543270|FG000|Overall Study|Divorce|3|||
145733566|NCT04906616|525543271|FG001|Overall Study|Divorce|2|||
145733567|NCT00385203|525543274|FG000|Overall Study|Adverse Event|5|||
145733568|NCT00385203|525543275|FG001|Overall Study|Adverse Event|4|||
145733569|NCT00385203|525543274|FG000|Overall Study|Death|1|||
145733570|NCT00385203|525543275|FG001|Overall Study|Death|0|||
145733571|NCT00385203|525543274|FG000|Overall Study|Condition under investigation worsened|18|||
145733572|NCT00385203|525543275|FG001|Overall Study|Condition under investigation worsened|3|||
145733573|NCT00385203|525543274|FG000|Overall Study|Incorrect enrollment|2|||
145733574|NCT00385203|525543275|FG001|Overall Study|Incorrect enrollment|0|||
145733575|NCT00698451|525543284|FG000|Overall Study|Adverse Event|22|||
145733576|NCT00698451|525543284|FG000|Overall Study|Physician Decision|2|||
145733577|NCT00698451|525543284|FG000|Overall Study|Protocol Violation|6|||
145733578|NCT00698451|525543284|FG000|Overall Study|Withdrawal by Subject|6|||
145733579|NCT00698451|525543284|FG000|Overall Study|Disease progression|3|||
145733580|NCT01187550|525543287|FG000|Overall Study|Protocol Violation|3|||
145733581|NCT01187550|525543288|FG001|Overall Study|Protocol Violation|1|||
145733582|NCT01187550|525543287|FG000|Overall Study|Other|3|||
145733583|NCT01187550|525543288|FG001|Overall Study|Other|0|||
145733584|NCT01187550|525543287|FG000|Overall Study|Randomized but not treated|8|||
145733585|NCT01187550|525543288|FG001|Overall Study|Randomized but not treated|0|||
145733586|NCT00733304|525543289|FG000|Overall Study|Adverse Event|3|||
145733587|NCT00733304|525543290|FG001|Overall Study|Adverse Event|0|||
145733588|NCT00733304|525543291|FG002|Overall Study|Adverse Event|0|||
145733589|NCT00733304|525543289|FG000|Overall Study|Lack of Efficacy|0|||
145733590|NCT00733304|525543290|FG001|Overall Study|Lack of Efficacy|0|||
145733591|NCT00733304|525543291|FG002|Overall Study|Lack of Efficacy|2|||
145733592|NCT00733304|525543289|FG000|Overall Study|Lost to Follow-up|0|||
145733593|NCT00733304|525543290|FG001|Overall Study|Lost to Follow-up|1|||
145733594|NCT00733304|525543291|FG002|Overall Study|Lost to Follow-up|0|||
145513900|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
145513901|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
145513902|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Non-compliance|1|||
145513903|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Non-compliance|0|||
145513904|NCT00470834|524741528|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
145513905|NCT00470834|524741529|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
145513906|NCT00470834|524741528|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
145513907|NCT00470834|524741529|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
145513908|NCT00470834|524741528|FG000|Extension Period (24 Months)|Adverse Event|3|||
145513909|NCT00470834|524741529|FG001|Extension Period (24 Months)|Adverse Event|4|||
145513910|NCT00470834|524741528|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
145733595|NCT00733304|525543289|FG000|Overall Study|Physician Decision|3|||
145733596|NCT00733304|525543290|FG001|Overall Study|Physician Decision|1|||
145733597|NCT00733304|525543291|FG002|Overall Study|Physician Decision|3|||
145733598|NCT00733304|525543289|FG000|Overall Study|Withdrawal by Subject|1|||
145733599|NCT00733304|525543290|FG001|Overall Study|Withdrawal by Subject|1|||
145733600|NCT00733304|525543291|FG002|Overall Study|Withdrawal by Subject|0|||
145733601|NCT02445755|525543301|FG000|Overall Study|Withdrawal by Subject|2|||
145733602|NCT02445755|525543301|FG000|Overall Study|Protocol Violation|6|||
145733603|NCT02445755|525543301|FG000|Overall Study|Screen Failure|5|||
145733604|NCT05352048|525543302|FG000|Overall Study|Lost to Follow-up|1|||
145733605|NCT05352048|525543302|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
145733606|NCT02308007|525543312|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
145733607|NCT02308007|525543313|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
145513911|NCT00470834|524741529|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
145513912|NCT00470834|524741528|FG000|Extension Period (24 Months)|Physician Decision|4|||
145513913|NCT00470834|524741529|FG001|Extension Period (24 Months)|Physician Decision|3|||
145513914|NCT00470834|524741528|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
145513915|NCT00470834|524741529|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
145513916|NCT00470834|524741528|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
145513917|NCT00470834|524741529|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
145513918|NCT00470834|524741528|FG000|Extension Period (24 Months)|Non-compliance|0|||
145513919|NCT00470834|524741529|FG001|Extension Period (24 Months)|Non-compliance|1|||
145513920|NCT00470834|524741528|FG000|Extension Period (24 Months)|Disease Progression|0|||
145513921|NCT00470834|524741529|FG001|Extension Period (24 Months)|Disease Progression|1|||
145513922|NCT01989208|524741535|FG000|200 mg (7 Days)|Protocol Violation|0|||
145513923|NCT01989208|524741536|FG001|200 mg (7 Days)|Protocol Violation|1|||
145513924|NCT04973436|524741537|FG000|Overall Study|Lost to Follow-up|3|||
145513925|NCT04973436|524741537|FG000|Overall Study|Withdrawal by Subject|1|||
145513926|NCT04973436|524741537|FG000|Overall Study|Death|2|||
145513927|NCT00080899|524741541|FG000|Overall Study|Adverse Event|1|||
145513928|NCT01276054|524741544|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
145513929|NCT01276054|524741545|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
145513930|NCT04343235|524741546|FG000|Overall Study|Lost to Follow-up|3|||
145513931|NCT04343235|524741547|FG001|Overall Study|Lost to Follow-up|2|||
145513932|NCT00787267|524741548|FG000|Overall Study|Screen failure/Ineligible|10|||
145513933|NCT00787267|524741548|FG000|Overall Study|No Reason Provided|1|||
145513934|NCT00787267|524741548|FG000|Overall Study|Withdrawal by Subject|1|||
145513935|NCT01763996|524741549|FG000|Treatment Period 2|Adverse Event|0|||
145513936|NCT01763996|524741550|FG001|Treatment Period 2|Adverse Event|1|||
145513937|NCT00865280|524741551|FG000|Overall Study|Withdrawal by Subject|4|||
145513938|NCT00865280|524741552|FG001|Overall Study|Withdrawal by Subject|1|||
145513939|NCT00865280|524741551|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
145513940|NCT00865280|524741552|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
145513941|NCT00865280|524741551|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
145513942|NCT00865280|524741552|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
145513943|NCT00865280|524741551|FG000|Overall Study|Exclusion Condition|1|||
145513944|NCT00865280|524741552|FG001|Overall Study|Exclusion Condition|0|||
145513945|NCT00865280|524741551|FG000|Overall Study|Adverse Event|0|||
145513946|NCT00865280|524741552|FG001|Overall Study|Adverse Event|1|||
145513947|NCT01788215|524741556|FG000|Overall Study|Withdrawal by Subject|0|||
145513948|NCT01788215|524741557|FG001|Overall Study|Withdrawal by Subject|1|||
145513949|NCT01788215|524741556|FG000|Overall Study|Lost to Follow-up|2|||
145513950|NCT01788215|524741557|FG001|Overall Study|Lost to Follow-up|0|||
145513951|NCT02365480|524741562|FG000|Overall Study|Withdrawal by Subject|2|||
145513952|NCT02365480|524741563|FG001|Overall Study|Withdrawal by Subject|0|||
145513953|NCT03091348|524741564|FG000|Overall Study|Lost to Follow-up|2|||
145513954|NCT03091348|524741565|FG001|Overall Study|Lost to Follow-up|1|||
145513955|NCT00706342|524741566|FG000|Overall Study|Adverse Event|3|||
145513956|NCT00706342|524741566|FG000|Overall Study|Not responding to treatment|2|||
145513957|NCT00706342|524741566|FG000|Overall Study|Withdrawn due to failure to respond|1|||
145513958|NCT00706342|524741566|FG000|Overall Study|Death|1|||
145513959|NCT00706342|524741566|FG000|Overall Study|Withdrew from the study on his own.|1|||
145513960|NCT00706342|524741566|FG000|Overall Study|Investigator discretion|2|||
145513961|NCT00706342|524741566|FG000|Overall Study|Non-responder Week 12|1|||
145513962|NCT00706342|524741566|FG000|Overall Study|Ongoing|6|||
145513963|NCT00706342|524741566|FG000|Overall Study|WIthdrawal of consent|1|||
145513964|NCT04534686|524741567|FG000|Baseline Measurement|Lost to Follow-up|4|||
145513965|NCT04534686|524741568|FG001|Baseline Measurement|Lost to Follow-up|6|||
145513966|NCT04534686|524741567|FG000|Baseline Measurement|Withdrawal by Subject|3|||
145513967|NCT04534686|524741568|FG001|Baseline Measurement|Withdrawal by Subject|1|||
145513968|NCT04534686|524741567|FG000|Intervention|Withdrawal by Subject|2|||
145513969|NCT04534686|524741568|FG001|Intervention|Withdrawal by Subject|2|||
145513970|NCT01419197|524741573|FG000|Overall Study|Death|247|||
145513971|NCT01419197|524741574|FG001|Overall Study|Death|122|||
145513972|NCT01419197|524741573|FG000|Overall Study|Physician Decision|4|||
145513973|NCT01419197|524741574|FG001|Overall Study|Physician Decision|4|||
145513974|NCT01419197|524741573|FG000|Overall Study|Non-compliance|3|||
145513975|NCT01419197|524741574|FG001|Overall Study|Non-compliance|1|||
145513976|NCT01419197|524741573|FG000|Overall Study|Withdrawal by Subject|33|||
145513977|NCT01419197|524741574|FG001|Overall Study|Withdrawal by Subject|32|||
145513978|NCT01419197|524741573|FG000|Overall Study|Study Completed by Sponsor|103|||
145513979|NCT01419197|524741574|FG001|Overall Study|Study Completed by Sponsor|34|||
145513980|NCT01419197|524741573|FG000|Overall Study|Reason Not Specified|0|||
145513981|NCT01419197|524741574|FG001|Overall Study|Reason Not Specified|1|||
145513982|NCT01419197|524741573|FG000|Overall Study|Lost to Follow-up|14|||
145513983|NCT01419197|524741574|FG001|Overall Study|Lost to Follow-up|4|||
145513984|NCT01781299|524741575|FG000|Overall Study|Withdrawal by Subject|0|||
145513985|NCT01781299|524741576|FG001|Overall Study|Withdrawal by Subject|1|||
145513986|NCT00146848|524741580|FG000|Pre-randomization|Death|19|||
145733608|NCT02308007|525543314|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
145733609|NCT02308007|525543312|FG000|Overall Study|Positive for STD at Baseline|7|||
145733610|NCT02308007|525543313|FG001|Overall Study|Positive for STD at Baseline|11|||
145733611|NCT02308007|525543314|FG002|Overall Study|Positive for STD at Baseline|7|||
145733612|NCT02308007|525543312|FG000|Overall Study|Lost to Follow-up|3|||
145733613|NCT02308007|525543313|FG001|Overall Study|Lost to Follow-up|0|||
145733614|NCT02308007|525543314|FG002|Overall Study|Lost to Follow-up|1|||
145733615|NCT00528567|525543320|FG000|Overall Study|Death|4|||
145733616|NCT00528567|525543321|FG001|Overall Study|Death|5|||
145733617|NCT00528567|525543320|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
145733618|NCT00528567|525543321|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
145733619|NCT00528567|525543320|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
145733620|NCT00528567|525543321|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
145733621|NCT00528567|525543320|FG000|Overall Study|Violation Criteria at Entry|3|||
145733622|NCT00528567|525543321|FG001|Overall Study|Violation Criteria at Entry|17|||
145733623|NCT00528567|525543320|FG000|Overall Study|Withdrew Consent|59|||
145733624|NCT00528567|525543321|FG001|Overall Study|Withdrew Consent|55|||
145733625|NCT00528567|525543320|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
145733626|NCT00528567|525543321|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
145733627|NCT00528567|525543320|FG000|Overall Study|Failure to Return|1|||
145513987|NCT00146848|524741581|FG001|Pre-randomization|Death|0|||
145513988|NCT00146848|524741582|FG002|Pre-randomization|Death|0|||
145513989|NCT00146848|524741580|FG000|Pre-randomization|Lost to Follow-up|70|||
145513990|NCT00146848|524741581|FG001|Pre-randomization|Lost to Follow-up|0|||
145513991|NCT00146848|524741582|FG002|Pre-randomization|Lost to Follow-up|0|||
145513992|NCT00146848|524741580|FG000|Pre-randomization|Physician Decision|8|||
145513993|NCT00146848|524741581|FG001|Pre-randomization|Physician Decision|0|||
145513994|NCT00146848|524741582|FG002|Pre-randomization|Physician Decision|0|||
145513995|NCT00146848|524741580|FG000|Pre-randomization|Protocol Violation|172|||
145513996|NCT00146848|524741581|FG001|Pre-randomization|Protocol Violation|0|||
145513997|NCT00146848|524741582|FG002|Pre-randomization|Protocol Violation|0|||
145513998|NCT00146848|524741580|FG000|Pre-randomization|Withdrawal by Subject|40|||
145513999|NCT00146848|524741581|FG001|Pre-randomization|Withdrawal by Subject|0|||
145514000|NCT00146848|524741582|FG002|Pre-randomization|Withdrawal by Subject|0|||
145514001|NCT00146848|524741580|FG000|Post-randomization|Lost to Follow-up|12|||
145514002|NCT00146848|524741581|FG001|Post-randomization|Lost to Follow-up|15|||
145514003|NCT00146848|524741582|FG002|Post-randomization|Lost to Follow-up|12|||
145514004|NCT00146848|524741580|FG000|Post-randomization|Withdrawn|26|||
145514005|NCT00146848|524741581|FG001|Post-randomization|Withdrawn|32|||
145514006|NCT00146848|524741582|FG002|Post-randomization|Withdrawn|27|||
145514007|NCT00743106|524741583|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
145514008|NCT00743106|524741584|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
145514009|NCT02720042|524741586|FG000|Overall Study|Death|3|||
145514010|NCT02720042|524741586|FG000|Overall Study|Lost to Follow-up|4|||
145514011|NCT02720042|524741586|FG000|Overall Study|Withdrawal by Subject|1|||
145733628|NCT00528567|525543321|FG001|Overall Study|Failure to Return|4|||
145733629|NCT00528567|525543320|FG000|Overall Study|Other Protocol Violation|5|||
145514012|NCT02720042|524741586|FG000|Overall Study|Physician Decision|3|||
145733630|NCT00528567|525543321|FG001|Overall Study|Other Protocol Violation|21|||
145514013|NCT02720042|524741586|FG000|Overall Study|Phasix Mesh explanted|1|||
145514014|NCT02720042|524741586|FG000|Overall Study|unable due to non-study-related illness|3|||
145514015|NCT00246740|524741589|FG000|Initial Enrollment|Death|1|||
145514016|NCT00246740|524741590|FG001|Initial Enrollment|Death|0|||
145514017|NCT00246740|524741589|FG000|Initial Enrollment|Additional surgery scheduled|0|||
145514018|NCT00246740|524741590|FG001|Initial Enrollment|Additional surgery scheduled|2|||
145514019|NCT00246740|524741589|FG000|Initial Enrollment|Surgery schedule change|4|||
145514020|NCT00246740|524741590|FG001|Initial Enrollment|Surgery schedule change|4|||
145514021|NCT00246740|524741589|FG000|Initial Enrollment|Other|1|||
145514022|NCT00246740|524741590|FG001|Initial Enrollment|Other|2|||
145514023|NCT00101452|524741593|FG000|Overall Study|Adverse Event|2|||
145514024|NCT00101452|524741594|FG001|Overall Study|Adverse Event|0|||
145514025|NCT00101452|524741595|FG002|Overall Study|Adverse Event|1|||
145514026|NCT00101452|524741593|FG000|Overall Study|Lost to Follow-up|13|||
145514027|NCT00101452|524741594|FG001|Overall Study|Lost to Follow-up|8|||
145514028|NCT00101452|524741595|FG002|Overall Study|Lost to Follow-up|14|||
145514029|NCT00101452|524741593|FG000|Overall Study|Withdrawal by Subject|10|||
145514030|NCT00101452|524741594|FG001|Overall Study|Withdrawal by Subject|14|||
145514031|NCT00101452|524741595|FG002|Overall Study|Withdrawal by Subject|9|||
145514032|NCT00101452|524741593|FG000|Overall Study|Baseline Fail|2|||
145514033|NCT00101452|524741594|FG001|Overall Study|Baseline Fail|1|||
145514034|NCT00101452|524741595|FG002|Overall Study|Baseline Fail|2|||
145514035|NCT00101452|524741593|FG000|Overall Study|Physician Decision|0|||
145514036|NCT00101452|524741594|FG001|Overall Study|Physician Decision|3|||
145514037|NCT00101452|524741595|FG002|Overall Study|Physician Decision|2|||
145514038|NCT00101452|524741593|FG000|Overall Study|Protocol Violation|2|||
145514039|NCT00101452|524741594|FG001|Overall Study|Protocol Violation|1|||
145514040|NCT00101452|524741595|FG002|Overall Study|Protocol Violation|3|||
145514041|NCT00101452|524741593|FG000|Overall Study|Other|15|||
145514042|NCT00101452|524741594|FG001|Overall Study|Other|16|||
145514043|NCT00101452|524741595|FG002|Overall Study|Other|12|||
145514044|NCT02969655|524741596|FG000|Overall Study|Withdrawal by Subject|3|||
145514045|NCT02969655|524741597|FG001|Overall Study|Withdrawal by Subject|2|||
145514046|NCT02969655|524741596|FG000|Overall Study|Physician Decision|4|||
145514047|NCT02969655|524741597|FG001|Overall Study|Physician Decision|3|||
145514048|NCT02969655|524741596|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
145514049|NCT02969655|524741597|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
145514050|NCT02969655|524741596|FG000|Overall Study|Adverse Event|10|||
145514051|NCT02969655|524741597|FG001|Overall Study|Adverse Event|8|||
145514052|NCT02466659|524741600|FG000|Overall Study|Lost to Follow-up|5|||
145514053|NCT02466659|524741601|FG001|Overall Study|Lost to Follow-up|2|||
145514054|NCT03753789|524741602|FG000|Overall Study|Withdrawal by Subject|2|||
145514055|NCT00145977|524741604|FG000|Overall Study|Lack of Efficacy|0|||
145514056|NCT00145977|524741605|FG001|Overall Study|Lack of Efficacy|4|||
145514057|NCT00145977|524741604|FG000|Overall Study|Lost to Follow-up|1|||
145514058|NCT00145977|524741605|FG001|Overall Study|Lost to Follow-up|0|||
145514059|NCT00145977|524741604|FG000|Overall Study|Withdrawal by Subject|1|||
145514060|NCT00145977|524741605|FG001|Overall Study|Withdrawal by Subject|0|||
145514061|NCT03060551|524741610|FG000|Overall Study|Withdrawal by Subject|1|||
145514062|NCT03060551|524741610|FG000|Overall Study|Adverse Event|1|||
145514063|NCT04629066|524741611|FG000|Overall Study|Lost to Follow-up|3|||
145514064|NCT04629066|524741612|FG001|Overall Study|Lost to Follow-up|2|||
145514065|NCT04359901|524741617|FG000|Overall Study|Withdrawal by Subject|0|||
145514066|NCT04359901|524741618|FG001|Overall Study|Withdrawal by Subject|1|||
145514067|NCT04359901|524741617|FG000|Overall Study|Death|6|||
145733631|NCT00528567|525543320|FG000|Overall Study|Administrative/Other|22|||
145733632|NCT00528567|525543321|FG001|Overall Study|Administrative/Other|75|||
145733633|NCT03085758|525543324|FG000|Overall Study|Death|26|||
145733634|NCT03085758|525543325|FG001|Overall Study|Death|24|||
145733635|NCT03085758|525543326|FG002|Overall Study|Death|53|||
145733636|NCT03085758|525543324|FG000|Overall Study|Lost to Follow-up|1|||
145733637|NCT03085758|525543325|FG001|Overall Study|Lost to Follow-up|1|||
145733638|NCT03085758|525543326|FG002|Overall Study|Lost to Follow-up|1|||
145514068|NCT04359901|524741618|FG001|Overall Study|Death|2|||
145514069|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
145514070|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
145514071|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
145514072|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
145514073|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Other|2|||
145514074|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
145514075|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
145514076|NCT02509026|524741622|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
145514077|NCT02509026|524741622|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
145514078|NCT02509026|524741622|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
145514079|NCT02509026|524741622|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
145514080|NCT02509026|524741622|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
145514081|NCT02509026|524741622|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
145514082|NCT00243841|524741626|FG000|Overall Study|Physician Decision|0|||
145514083|NCT00243841|524741627|FG001|Overall Study|Physician Decision|0|||
145514084|NCT00243841|524741628|FG002|Overall Study|Physician Decision|1|||
145514085|NCT00243841|524741629|FG003|Overall Study|Physician Decision|0|||
145733639|NCT03085758|525543324|FG000|Overall Study|Withdrawal by Subject|2|||
145733640|NCT03085758|525543325|FG001|Overall Study|Withdrawal by Subject|2|||
145733641|NCT03085758|525543326|FG002|Overall Study|Withdrawal by Subject|1|||
145733642|NCT03085758|525543324|FG000|Overall Study|Refusal to recall it up to day 90|0|||
145733643|NCT03085758|525543325|FG001|Overall Study|Refusal to recall it up to day 90|0|||
145733644|NCT03085758|525543326|FG002|Overall Study|Refusal to recall it up to day 90|1|||
145733645|NCT03085758|525543324|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
145733646|NCT03085758|525543325|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
145733647|NCT03085758|525543326|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
145733648|NCT00631189|525543329|FG000|Initial Phase|Protocol Violation|347|||
145733649|NCT00631189|525543330|FG001|Initial Phase|Protocol Violation|0|||
145733650|NCT00631189|525543331|FG002|Initial Phase|Protocol Violation|0|||
145733651|NCT00631189|525543332|FG003|Initial Phase|Protocol Violation|0|||
145733652|NCT00631189|525543329|FG000|Initial Phase|Withdrawal by Subject|4|||
145733653|NCT00631189|525543330|FG001|Initial Phase|Withdrawal by Subject|0|||
145733654|NCT00631189|525543331|FG002|Initial Phase|Withdrawal by Subject|0|||
145733655|NCT00631189|525543332|FG003|Initial Phase|Withdrawal by Subject|0|||
145733656|NCT00631189|525543329|FG000|Treatment Phase|Withdrawal by Subject|0|||
145733657|NCT00631189|525543330|FG001|Treatment Phase|Withdrawal by Subject|2|||
145733658|NCT00631189|525543331|FG002|Treatment Phase|Withdrawal by Subject|1|||
145733659|NCT00631189|525543332|FG003|Treatment Phase|Withdrawal by Subject|1|||
145733660|NCT00631189|525543329|FG000|Treatment Phase|Protocol Violation|0|||
145733661|NCT00631189|525543330|FG001|Treatment Phase|Protocol Violation|1|||
145733662|NCT00631189|525543331|FG002|Treatment Phase|Protocol Violation|6|||
145733663|NCT00631189|525543332|FG003|Treatment Phase|Protocol Violation|2|||
145733664|NCT00631189|525543329|FG000|Treatment Phase|Adverse Event|0|||
145733665|NCT00631189|525543330|FG001|Treatment Phase|Adverse Event|3|||
145733666|NCT00631189|525543331|FG002|Treatment Phase|Adverse Event|2|||
145733667|NCT00631189|525543332|FG003|Treatment Phase|Adverse Event|4|||
145733668|NCT00631189|525543329|FG000|Treatment Phase|Lost to Follow-up|0|||
145733669|NCT00631189|525543330|FG001|Treatment Phase|Lost to Follow-up|1|||
145733670|NCT00631189|525543331|FG002|Treatment Phase|Lost to Follow-up|0|||
145733671|NCT00631189|525543332|FG003|Treatment Phase|Lost to Follow-up|0|||
145733672|NCT00631189|525543329|FG000|Treatment Phase|Pregnancy|0|||
145733673|NCT00631189|525543330|FG001|Treatment Phase|Pregnancy|0|||
145733674|NCT00631189|525543331|FG002|Treatment Phase|Pregnancy|1|||
145733675|NCT00631189|525543332|FG003|Treatment Phase|Pregnancy|0|||
145733676|NCT00631189|525543329|FG000|Treatment Phase|patient did not take pravastatin|0|||
145733677|NCT00631189|525543330|FG001|Treatment Phase|patient did not take pravastatin|0|||
145514086|NCT00243841|524741630|FG004|Overall Study|Physician Decision|0|||
145514087|NCT00243841|524741631|FG005|Overall Study|Physician Decision|2|||
145514088|NCT01808092|524741632|FG000|Overall Study|Death|39|||
145514089|NCT01808092|524741633|FG001|Overall Study|Death|29|||
145514090|NCT01808092|524741632|FG000|Overall Study|Lost to Follow-up|3|||
145514091|NCT01808092|524741633|FG001|Overall Study|Lost to Follow-up|7|||
145514092|NCT01808092|524741632|FG000|Overall Study|Withdrawal by Subject|9|||
145514093|NCT01808092|524741633|FG001|Overall Study|Withdrawal by Subject|4|||
145514094|NCT01808092|524741632|FG000|Overall Study|Other Eligibility criteria|3|||
145514095|NCT01808092|524741633|FG001|Overall Study|Other Eligibility criteria|5|||
145514096|NCT03425253|524741638|FG000|Overall Study|Adverse Event|2|||
145514097|NCT03425253|524741638|FG000|Overall Study|Lost to Follow-up|3|||
145514098|NCT03425253|524741638|FG000|Overall Study|Withdrew Consent|6|||
145514099|NCT03425253|524741638|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
145514100|NCT01031836|524743360|FG000|Stage I|Adverse Event|1|||
145514101|NCT01031836|524743361|FG001|Stage I|Adverse Event|1|||
145514102|NCT01031836|524743362|FG002|Stage I|Adverse Event|0|||
145514103|NCT01031836|524743363|FG003|Stage I|Adverse Event|0|||
145514104|NCT01031836|524743364|FG004|Stage I|Adverse Event|0|||
145514105|NCT01031836|524743365|FG005|Stage I|Adverse Event|0|||
145606649|NCT01576718|525075119|FG002|Treatment Period|Withdrawal by Subject|1|||
145733678|NCT00631189|525543331|FG002|Treatment Phase|patient did not take pravastatin|1|||
145733679|NCT00631189|525543332|FG003|Treatment Phase|patient did not take pravastatin|0|||
145606650|NCT01576718|525075120|FG003|Treatment Period|Withdrawal by Subject|0|||
145402205|NCT06996301|524328843|FG001|Overall Study|Patients with discordant diagnostic results|90|||
145733680|NCT00974090|525543333|FG000|Period 1: Double Blind Period|Adverse Event|2|||
145733681|NCT00974090|525543334|FG001|Period 1: Double Blind Period|Adverse Event|1|||
145733682|NCT00974090|525543333|FG000|Period 1: Double Blind Period|Physician Decision|1|||
145402206|NCT06996301|524328842|FG000|Overall Study|Lost to Follow-up|31|||
145514106|NCT01031836|524743360|FG000|Stage I|Other|0|||
145514107|NCT01031836|524743361|FG001|Stage I|Other|1|||
145514108|NCT01031836|524743362|FG002|Stage I|Other|0|||
145514109|NCT01031836|524743363|FG003|Stage I|Other|0|||
145514110|NCT01031836|524743364|FG004|Stage I|Other|0|||
145514111|NCT01031836|524743365|FG005|Stage I|Other|1|||
145514112|NCT01031836|524743360|FG000|Stage II|Adverse Event|0|||
145514113|NCT01031836|524743361|FG001|Stage II|Adverse Event|0|||
145514114|NCT01031836|524743362|FG002|Stage II|Adverse Event|2|||
145514115|NCT01031836|524743363|FG003|Stage II|Adverse Event|2|||
145514116|NCT01031836|524743364|FG004|Stage II|Adverse Event|1|||
145514117|NCT01031836|524743365|FG005|Stage II|Adverse Event|1|||
145514118|NCT01031836|524743360|FG000|Stage II|Other|2|||
145514119|NCT01031836|524743361|FG001|Stage II|Other|0|||
145514120|NCT01031836|524743362|FG002|Stage II|Other|0|||
145514121|NCT01031836|524743363|FG003|Stage II|Other|1|||
145514122|NCT01031836|524743364|FG004|Stage II|Other|1|||
145514123|NCT01031836|524743365|FG005|Stage II|Other|0|||
145514124|NCT03180619|524743366|FG000|Overall Study|Withdrew Consent|5|||
145514125|NCT03180619|524743367|FG001|Overall Study|Withdrew Consent|0|||
145514126|NCT03180619|524743368|FG002|Overall Study|Withdrew Consent|2|||
145514127|NCT03180619|524743366|FG000|Overall Study|Death|2|||
145514128|NCT03180619|524743367|FG001|Overall Study|Death|1|||
145514129|NCT03180619|524743368|FG002|Overall Study|Death|2|||
145514130|NCT03180619|524743366|FG000|Overall Study|Adverse Event|2|||
145514131|NCT03180619|524743367|FG001|Overall Study|Adverse Event|0|||
145514132|NCT03180619|524743368|FG002|Overall Study|Adverse Event|1|||
145514133|NCT03180619|524743366|FG000|Overall Study|Investigator's discretion|2|||
145514134|NCT03180619|524743367|FG001|Overall Study|Investigator's discretion|0|||
145514135|NCT03180619|524743368|FG002|Overall Study|Investigator's discretion|1|||
145514136|NCT00729469|524743369|FG000|Overall Study|Adverse Event|14|||
145514137|NCT00729469|524743370|FG001|Overall Study|Adverse Event|25|||
145514138|NCT00729469|524743369|FG000|Overall Study|Lost to Follow-up|9|||
145514139|NCT00729469|524743370|FG001|Overall Study|Lost to Follow-up|9|||
145514140|NCT00729469|524743369|FG000|Overall Study|Protocol Violation|2|||
145514141|NCT00729469|524743370|FG001|Overall Study|Protocol Violation|1|||
145514142|NCT00729469|524743369|FG000|Overall Study|Withdrawal by Subject|19|||
145514143|NCT00729469|524743370|FG001|Overall Study|Withdrawal by Subject|8|||
145514144|NCT00729469|524743369|FG000|Overall Study|Other-Not mentioned|9|||
145514145|NCT00729469|524743370|FG001|Overall Study|Other-Not mentioned|4|||
145514146|NCT00561977|524743373|FG000|Overall Study|Withdrawal by Subject|0|||
145514147|NCT00561977|524743374|FG001|Overall Study|Withdrawal by Subject|2|||
145514148|NCT00561977|524743375|FG002|Overall Study|Withdrawal by Subject|1|||
145514149|NCT00561977|524743373|FG000|Overall Study|Pregnancy|0|||
145514150|NCT00561977|524743374|FG001|Overall Study|Pregnancy|1|||
145514151|NCT00561977|524743375|FG002|Overall Study|Pregnancy|1|||
145514152|NCT04975438|524743376|FG000|Overall Study|Lost to Follow-up|1|||
145514153|NCT04975438|524743377|FG001|Overall Study|Lost to Follow-up|0|||
145514154|NCT04975438|524743378|FG002|Overall Study|Lost to Follow-up|1|||
145514155|NCT04975438|524743379|FG003|Overall Study|Lost to Follow-up|0|||
145514156|NCT04975438|524743376|FG000|Overall Study|Withdrawal by Subject|1|||
145514157|NCT04975438|524743377|FG001|Overall Study|Withdrawal by Subject|0|||
145514158|NCT04975438|524743378|FG002|Overall Study|Withdrawal by Subject|0|||
145514159|NCT04975438|524743379|FG003|Overall Study|Withdrawal by Subject|0|||
145514160|NCT00977080|524743380|FG000|Overall Study|Adverse Event|2|||
145514161|NCT00977080|524743381|FG001|Overall Study|Adverse Event|7|||
145514162|NCT00977080|524743382|FG002|Overall Study|Adverse Event|7|||
145514163|NCT00977080|524743383|FG003|Overall Study|Adverse Event|7|||
145514164|NCT00977080|524743380|FG000|Overall Study|Withdrawal by Subject|1|||
145514165|NCT00977080|524743381|FG001|Overall Study|Withdrawal by Subject|5|||
145514166|NCT00977080|524743382|FG002|Overall Study|Withdrawal by Subject|1|||
145514167|NCT00977080|524743383|FG003|Overall Study|Withdrawal by Subject|5|||
145514168|NCT00977080|524743380|FG000|Overall Study|Protocol Violation|7|||
145514169|NCT00977080|524743381|FG001|Overall Study|Protocol Violation|3|||
145514170|NCT00977080|524743382|FG002|Overall Study|Protocol Violation|4|||
145514171|NCT00977080|524743383|FG003|Overall Study|Protocol Violation|3|||
145514172|NCT00977080|524743380|FG000|Overall Study|Noncompliance|0|||
145514173|NCT00977080|524743381|FG001|Overall Study|Noncompliance|2|||
145514174|NCT00977080|524743382|FG002|Overall Study|Noncompliance|1|||
145514175|NCT00977080|524743383|FG003|Overall Study|Noncompliance|0|||
145514176|NCT00977080|524743380|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
145514177|NCT00977080|524743381|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
145514178|NCT00977080|524743382|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
145514179|NCT00977080|524743383|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
145514180|NCT00977080|524743380|FG000|Overall Study|Required kidney transplantation|1|||
145514181|NCT00977080|524743381|FG001|Overall Study|Required kidney transplantation|3|||
145514182|NCT00977080|524743382|FG002|Overall Study|Required kidney transplantation|3|||
145514183|NCT00977080|524743383|FG003|Overall Study|Required kidney transplantation|1|||
145514184|NCT00977080|524743380|FG000|Overall Study|Travel for family reasons|1|||
145514185|NCT00977080|524743381|FG001|Overall Study|Travel for family reasons|0|||
145514186|NCT00977080|524743382|FG002|Overall Study|Travel for family reasons|0|||
145514187|NCT00977080|524743383|FG003|Overall Study|Travel for family reasons|0|||
145514188|NCT00566696|524743384|FG000|Overall Study|Met Exclusion Criteria|2|||
145514189|NCT00566696|524743384|FG000|Overall Study|Muromonab not available|1|||
145514190|NCT00566696|524743384|FG000|Overall Study|Health Status Change|1|||
145733683|NCT00974090|525543334|FG001|Period 1: Double Blind Period|Physician Decision|0|||
145733684|NCT00974090|525543333|FG000|Period 2: Open-label Period|Adverse Event|4|||
145733685|NCT00974090|525543334|FG001|Period 2: Open-label Period|Adverse Event|6|||
145733686|NCT00974090|525543333|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
145733687|NCT00974090|525543334|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
145733688|NCT00974090|525543333|FG000|Period 2: Open-label Period|Physician Decision|0|||
145733689|NCT00974090|525543334|FG001|Period 2: Open-label Period|Physician Decision|3|||
145733690|NCT00974090|525543333|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
145733691|NCT00974090|525543334|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
145733692|NCT03189862|525543335|FG000|Overall Study|Withdrawal by Subject|1|||
145733693|NCT03189862|525543336|FG001|Overall Study|Withdrawal by Subject|0|||
145733694|NCT03189862|525543335|FG000|Overall Study|Lost to Follow-up|54|||
145733695|NCT03189862|525543336|FG001|Overall Study|Lost to Follow-up|62|||
145733696|NCT01122576|525543337|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
145733697|NCT01122576|525543338|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
145733698|NCT01122576|525543339|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
145733699|NCT01122576|525543337|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
145733700|NCT01122576|525543338|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
145733701|NCT01122576|525543339|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
145733702|NCT01122576|525543337|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
145733703|NCT01122576|525543338|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
145733704|NCT01122576|525543339|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
145733705|NCT05696236|525543340|FG000|Overall Study|Lost to Follow-up|1|||
145733706|NCT05696236|525543341|FG001|Overall Study|Lost to Follow-up|0|||
145733707|NCT05696236|525543340|FG000|Overall Study|Later determined to not be eligible for participation|0|||
145733708|NCT05696236|525543341|FG001|Overall Study|Later determined to not be eligible for participation|1|||
145733709|NCT05696236|525543340|FG000|Overall Study|Withdrawal by Subject|2|||
145733710|NCT05696236|525543341|FG001|Overall Study|Withdrawal by Subject|2|||
145733711|NCT01829360|525543342|FG000|Overall Study|Protocol Violation|0|||
145733712|NCT01829360|525543343|FG001|Overall Study|Protocol Violation|0|||
145733713|NCT01829360|525543344|FG002|Overall Study|Protocol Violation|1|||
145733714|NCT01829360|525543345|FG003|Overall Study|Protocol Violation|0|||
145733715|NCT00578786|525543346|FG000|Overall Study|Adverse Event|27|||
145733716|NCT00578786|525543347|FG001|Overall Study|Adverse Event|37|||
145733717|NCT00578786|525543348|FG002|Overall Study|Adverse Event|17|||
145733718|NCT00578786|525543346|FG000|Overall Study|Lack of Efficacy|2|||
145733719|NCT00578786|525543347|FG001|Overall Study|Lack of Efficacy|5|||
145733720|NCT00578786|525543348|FG002|Overall Study|Lack of Efficacy|2|||
145733721|NCT00578786|525543346|FG000|Overall Study|Early Escape from Prior Study|2|||
145733722|NCT00578786|525543347|FG001|Overall Study|Early Escape from Prior Study|1|||
145733723|NCT00578786|525543348|FG002|Overall Study|Early Escape from Prior Study|2|||
145733724|NCT00578786|525543346|FG000|Overall Study|Withdrawal by Subject|7|||
145514191|NCT00566696|524743384|FG000|Overall Study|Physician Decision|1|||
145514192|NCT00566696|524743384|FG000|Overall Study|Non-Patient Donors|37|||
145514193|NCT00275340|524743392|FG000|Overall Study|Lost to Follow-up|2|||
145514194|NCT00275340|524743393|FG001|Overall Study|Lost to Follow-up|4|||
145514195|NCT02032238|524743395|FG000|Overall Study|Lost to Follow-up|2|||
145514196|NCT02032238|524743396|FG001|Overall Study|Lost to Follow-up|0|||
145514197|NCT00653939|524743397|FG000|Overall Study|Adverse Event|1|||
145514198|NCT00653939|524743398|FG001|Overall Study|Adverse Event|3|||
145514199|NCT00653939|524743397|FG000|Overall Study|Withdrawal by Subject|3|||
145514200|NCT00653939|524743398|FG001|Overall Study|Withdrawal by Subject|3|||
145514201|NCT00653939|524743397|FG000|Overall Study|Physician Decision|4|||
145514202|NCT00653939|524743398|FG001|Overall Study|Physician Decision|0|||
145514203|NCT00653939|524743397|FG000|Overall Study|Disease Progression|2|||
145514204|NCT00653939|524743398|FG001|Overall Study|Disease Progression|3|||
145514205|NCT00653939|524743397|FG000|Overall Study|Other|2|||
145514206|NCT00653939|524743398|FG001|Overall Study|Other|6|||
145514207|NCT00717236|524743399|FG000|Double-Blind Period|Adverse Event|33|||
145514208|NCT00717236|524743400|FG001|Double-Blind Period|Adverse Event|6|||
145514209|NCT00717236|524743399|FG000|Double-Blind Period|Lack of Efficacy|6|||
145514210|NCT00717236|524743400|FG001|Double-Blind Period|Lack of Efficacy|6|||
145514211|NCT00717236|524743399|FG000|Double-Blind Period|Lost to Follow-up|3|||
145514212|NCT00717236|524743400|FG001|Double-Blind Period|Lost to Follow-up|5|||
145514213|NCT00717236|524743399|FG000|Double-Blind Period|Withdrawal by Subject|10|||
145514214|NCT00717236|524743400|FG001|Double-Blind Period|Withdrawal by Subject|2|||
145514215|NCT00717236|524743399|FG000|Double-Blind Period|Loss of efficacy|3|||
145514216|NCT00717236|524743400|FG001|Double-Blind Period|Loss of efficacy|0|||
145514217|NCT00717236|524743399|FG000|Double-Blind Period|Other: Death|1|||
145514218|NCT00717236|524743400|FG001|Double-Blind Period|Other: Death|0|||
145514219|NCT00717236|524743399|FG000|Double-Blind Period|Other: Pregnancy|1|||
145514220|NCT00717236|524743400|FG001|Double-Blind Period|Other: Pregnancy|0|||
145514221|NCT00717236|524743399|FG000|Double-Blind Period|Other: Protocol Violation|2|||
145514222|NCT00717236|524743400|FG001|Double-Blind Period|Other: Protocol Violation|0|||
145514223|NCT00717236|524743399|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
145514224|NCT00717236|524743400|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
145514225|NCT00717236|524743399|FG000|Double-Blind Period|Other: Site withdrew|2|||
145514226|NCT00717236|524743400|FG001|Double-Blind Period|Other: Site withdrew|0|||
145514227|NCT00717236|524743399|FG000|Double-Blind Period|Other: Screening failure|1|||
145514228|NCT00717236|524743400|FG001|Double-Blind Period|Other: Screening failure|0|||
145514229|NCT00717236|524743399|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
145514230|NCT00717236|524743400|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
145514231|NCT00717236|524743399|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
145514232|NCT00717236|524743400|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
145514233|NCT00717236|524743399|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
145514234|NCT00717236|524743400|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
145514235|NCT00717236|524743399|FG000|Double-Blind Period|Other: History of cancer|1|||
145514236|NCT00717236|524743400|FG001|Double-Blind Period|Other: History of cancer|0|||
145514237|NCT00717236|524743399|FG000|Double-Blind Period|Other: Sponsor request|1|||
145514238|NCT00717236|524743400|FG001|Double-Blind Period|Other: Sponsor request|0|||
145514239|NCT00717236|524743399|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
145514240|NCT00717236|524743400|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
145514241|NCT00717236|524743399|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
145514242|NCT00717236|524743400|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
145514243|NCT00717236|524743399|FG000|Double-Blind Period|Other: Subject moved|1|||
145514244|NCT00717236|524743400|FG001|Double-Blind Period|Other: Subject moved|1|||
145514245|NCT00717236|524743399|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
145514246|NCT00717236|524743400|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
145514247|NCT00717236|524743399|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
145514248|NCT00717236|524743400|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
145514249|NCT00717236|524743399|FG000|Double-Blind Period|Other: Transportation problems|0|||
145514250|NCT00717236|524743400|FG001|Double-Blind Period|Other: Transportation problems|1|||
145514251|NCT00717236|524743399|FG000|Double-Blind Period|Other: Investigator Decision|0|||
145514252|NCT00717236|524743400|FG001|Double-Blind Period|Other: Investigator Decision|1|||
145514253|NCT00717236|524743399|FG000|Open-Label Period|Adverse Event|29|||
145514254|NCT00717236|524743400|FG001|Open-Label Period|Adverse Event|4|||
145514255|NCT00717236|524743399|FG000|Open-Label Period|Lack of Efficacy|30|||
145514256|NCT00717236|524743400|FG001|Open-Label Period|Lack of Efficacy|8|||
145514257|NCT00717236|524743399|FG000|Open-Label Period|Lost to Follow-up|28|||
145733725|NCT00578786|525543347|FG001|Overall Study|Withdrawal by Subject|8|||
145733726|NCT00578786|525543348|FG002|Overall Study|Withdrawal by Subject|5|||
145733727|NCT00578786|525543346|FG000|Overall Study|Protocol Violation|0|||
145733728|NCT00578786|525543347|FG001|Overall Study|Protocol Violation|3|||
145733729|NCT00578786|525543348|FG002|Overall Study|Protocol Violation|1|||
145733730|NCT00578786|525543346|FG000|Overall Study|Physician Decision|1|||
145733731|NCT00578786|525543347|FG001|Overall Study|Physician Decision|0|||
145733732|NCT00578786|525543348|FG002|Overall Study|Physician Decision|1|||
145733733|NCT00578786|525543346|FG000|Overall Study|Sponsor Decision|0|||
145733734|NCT00578786|525543347|FG001|Overall Study|Sponsor Decision|0|||
145733735|NCT00578786|525543348|FG002|Overall Study|Sponsor Decision|1|||
145733736|NCT00578786|525543346|FG000|Overall Study|Lost to Follow-up|0|||
145733737|NCT00578786|525543347|FG001|Overall Study|Lost to Follow-up|4|||
145514258|NCT00717236|524743400|FG001|Open-Label Period|Lost to Follow-up|4|||
145514259|NCT00717236|524743399|FG000|Open-Label Period|Withdrawal by Subject|20|||
145514260|NCT00717236|524743400|FG001|Open-Label Period|Withdrawal by Subject|2|||
145733738|NCT00578786|525543348|FG002|Overall Study|Lost to Follow-up|0|||
145733739|NCT00578786|525543346|FG000|Overall Study|Pregnancy|0|||
145733740|NCT00578786|525543347|FG001|Overall Study|Pregnancy|1|||
145733741|NCT00578786|525543348|FG002|Overall Study|Pregnancy|0|||
145733742|NCT00578786|525543346|FG000|Overall Study|Not Otherwise Specified|0|||
145733743|NCT00578786|525543347|FG001|Overall Study|Not Otherwise Specified|4|||
145733744|NCT00578786|525543348|FG002|Overall Study|Not Otherwise Specified|1|||
145733745|NCT00578786|525543346|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
145733746|NCT00578786|525543347|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
145733747|NCT00578786|525543348|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
145733748|NCT05105789|525543349|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
145733749|NCT01271803|525543353|FG000|Overall Study|Progressive disease|0|||
145733750|NCT01271803|525543354|FG001|Overall Study|Progressive disease|0|||
145733751|NCT01271803|525543355|FG002|Overall Study|Progressive disease|2|||
145733752|NCT01271803|525543353|FG000|Overall Study|Death|53|||
145733753|NCT01271803|525543354|FG001|Overall Study|Death|34|||
145733754|NCT01271803|525543355|FG002|Overall Study|Death|0|||
145733755|NCT01271803|525543353|FG000|Overall Study|Withdrawal by Subject|1|||
145733756|NCT01271803|525543354|FG001|Overall Study|Withdrawal by Subject|5|||
145733757|NCT01271803|525543355|FG002|Overall Study|Withdrawal by Subject|0|||
145733758|NCT01271803|525543353|FG000|Overall Study|Lost to Follow-up|1|||
145733759|NCT01271803|525543354|FG001|Overall Study|Lost to Follow-up|0|||
145733760|NCT01271803|525543355|FG002|Overall Study|Lost to Follow-up|0|||
145733761|NCT00728481|525543356|FG000|Overall Study|Withdrawal by Subject|0|||
145733762|NCT00728481|525543357|FG001|Overall Study|Withdrawal by Subject|1|||
145733763|NCT00728481|525543356|FG000|Overall Study|Adverse Event|0|||
145733764|NCT00728481|525543357|FG001|Overall Study|Adverse Event|1|||
145733765|NCT00728481|525543356|FG000|Overall Study|Study medication non-compliance|0|||
145733766|NCT00728481|525543357|FG001|Overall Study|Study medication non-compliance|2|||
145733767|NCT00728481|525543356|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
145733768|NCT00728481|525543357|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
145733769|NCT02545322|525543358|FG000|Overall Study|Withdrawal by Subject|3|||
145733770|NCT00041067|525543359|FG000|Overall Study|Adverse Event|20|||
145733771|NCT00041067|525543359|FG000|Overall Study|Progression|19|||
145733772|NCT00041067|525543359|FG000|Overall Study|Patient refusal|12|||
145514261|NCT00717236|524743399|FG000|Open-Label Period|Loss of Efficacy|6|||
145514262|NCT00717236|524743400|FG001|Open-Label Period|Loss of Efficacy|1|||
145514263|NCT00717236|524743399|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
145514264|NCT00717236|524743400|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
145514265|NCT00717236|524743399|FG000|Open-Label Period|Other: Lack of Compliance|1|||
145514266|NCT00717236|524743400|FG001|Open-Label Period|Other: Lack of Compliance|1|||
145514267|NCT00717236|524743399|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
145514268|NCT00717236|524743400|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
145514269|NCT00717236|524743399|FG000|Open-Label Period|Other: Moved|1|||
145514270|NCT00717236|524743400|FG001|Open-Label Period|Other: Moved|0|||
145514271|NCT00717236|524743399|FG000|Open-Label Period|Other: Investigator Decision|1|||
145514272|NCT00717236|524743400|FG001|Open-Label Period|Other: Investigator Decision|0|||
145514273|NCT00717236|524743399|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
145514274|NCT00717236|524743400|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
145514275|NCT00717236|524743399|FG000|Open-Label Period|Other: Sponsor Request|3|||
145514276|NCT00717236|524743400|FG001|Open-Label Period|Other: Sponsor Request|0|||
145514277|NCT00717236|524743399|FG000|Open-Label Period|Other: Cataract Surgery|1|||
145514278|NCT00717236|524743400|FG001|Open-Label Period|Other: Cataract Surgery|0|||
145514279|NCT00717236|524743399|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
145514280|NCT00717236|524743400|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
145514281|NCT00717236|524743399|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
145514282|NCT00717236|524743400|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
145514283|NCT00717236|524743399|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
145514284|NCT00717236|524743400|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
145514285|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
145514286|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
145514287|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
145514288|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
145514289|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
145514290|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
145514291|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
145514292|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
145514293|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
145514294|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
145514295|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
145514296|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
145514297|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
145514298|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
145514299|NCT00612105|524743401|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
145514300|NCT00612105|524743402|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
145514301|NCT00612105|524743401|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
145514302|NCT00612105|524743402|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
145514303|NCT00612105|524743401|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
145514304|NCT00612105|524743402|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
145514305|NCT00612105|524743401|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
145514306|NCT00612105|524743402|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
145514307|NCT00612105|524743401|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
145514308|NCT00612105|524743402|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
145514309|NCT01105767|524743403|FG000|Overall Study|Lost to Follow-up|1160|||
145514310|NCT01105767|524743404|FG001|Overall Study|Lost to Follow-up|1614|||
145514311|NCT01105767|524743405|FG002|Overall Study|Lost to Follow-up|1184|||
145514312|NCT00475982|524743406|FG000|Overall Study|surgery rescheduled|7|||
145514313|NCT00475982|524743407|FG001|Overall Study|surgery rescheduled|3|||
145514314|NCT00783198|524743413|FG000|Overall Study|Adverse Event|15|||
145514315|NCT00783198|524743414|FG001|Overall Study|Adverse Event|19|||
145514316|NCT00783198|524743415|FG002|Overall Study|Adverse Event|3|||
145514317|NCT00783198|524743413|FG000|Overall Study|Lost to Follow-up|11|||
145514318|NCT00783198|524743414|FG001|Overall Study|Lost to Follow-up|1|||
145514319|NCT00783198|524743415|FG002|Overall Study|Lost to Follow-up|7|||
145514320|NCT00783198|524743413|FG000|Overall Study|Withdrawal by Subject|22|||
145514321|NCT00783198|524743414|FG001|Overall Study|Withdrawal by Subject|14|||
145514322|NCT00783198|524743415|FG002|Overall Study|Withdrawal by Subject|20|||
145514323|NCT00783198|524743413|FG000|Overall Study|Noncompliance with protocol|7|||
145514324|NCT00783198|524743414|FG001|Overall Study|Noncompliance with protocol|7|||
145514325|NCT00783198|524743415|FG002|Overall Study|Noncompliance with protocol|10|||
145514326|NCT00783198|524743413|FG000|Overall Study|Did not meet protocol eligibility|0|||
145514327|NCT00783198|524743414|FG001|Overall Study|Did not meet protocol eligibility|1|||
145514328|NCT00783198|524743415|FG002|Overall Study|Did not meet protocol eligibility|0|||
145514329|NCT00783198|524743413|FG000|Overall Study|Administrative|2|||
145514330|NCT00783198|524743414|FG001|Overall Study|Administrative|1|||
145514331|NCT00783198|524743415|FG002|Overall Study|Administrative|2|||
145514332|NCT00119678|524743417|FG000|Double-blind Treatment Period|Death|1|||
145514333|NCT00119678|524743418|FG001|Double-blind Treatment Period|Death|0|||
145514334|NCT00119678|524743417|FG000|Double-blind Treatment Period|Adverse Event|7|||
145514335|NCT00119678|524743418|FG001|Double-blind Treatment Period|Adverse Event|1|||
145514336|NCT00119678|524743417|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
145514337|NCT00119678|524743418|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
145514338|NCT00119678|524743417|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
145514339|NCT00119678|524743418|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
145514340|NCT00119678|524743417|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
145514341|NCT00119678|524743418|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
145514342|NCT00119678|524743417|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
145514343|NCT00119678|524743418|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
145514344|NCT00119678|524743417|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
145514345|NCT00119678|524743418|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
145514346|NCT00119678|524743417|FG000|Double-blind Treatment Period|Pregnancy|0|||
145514347|NCT00119678|524743418|FG001|Double-blind Treatment Period|Pregnancy|2|||
145514348|NCT00119678|524743417|FG000|Double-blind Treatment Period|Not treated|1|||
145514349|NCT00119678|524743418|FG001|Double-blind Treatment Period|Not treated|2|||
145514350|NCT00119678|524743417|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
145514351|NCT00119678|524743418|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
145514352|NCT00119678|524743417|FG000|Open-label Treatment Period|Death|1|||
145514353|NCT00119678|524743418|FG001|Open-label Treatment Period|Death|0|||
145514354|NCT00119678|524743417|FG000|Open-label Treatment Period|Adverse Event|3|||
145514355|NCT00119678|524743418|FG001|Open-label Treatment Period|Adverse Event|0|||
145514356|NCT00119678|524743417|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
145514357|NCT00119678|524743418|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
145514358|NCT00119678|524743417|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
145514359|NCT00119678|524743418|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
145514360|NCT00119678|524743417|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
145514361|NCT00119678|524743418|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
145514362|NCT00119678|524743417|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
145514363|NCT00119678|524743418|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
145514364|NCT00119678|524743417|FG000|Open-label Treatment Period|Pregnancy|1|||
145514365|NCT00119678|524743418|FG001|Open-label Treatment Period|Pregnancy|0|||
145514366|NCT00119678|524743417|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
145514367|NCT00119678|524743418|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
145514368|NCT03704636|524743419|FG000|Overall Study|Inadequate Venous Flow|3|||
145514369|NCT01134705|524743422|FG000|Overall Study|Adverse Event|1|||
145514370|NCT01134705|524743423|FG001|Overall Study|Adverse Event|7|||
145514371|NCT01134705|524743422|FG000|Overall Study|Withdrawal by Subject|6|||
145514372|NCT01134705|524743423|FG001|Overall Study|Withdrawal by Subject|6|||
145514373|NCT01134705|524743422|FG000|Overall Study|Pregnancy|1|||
145514374|NCT01134705|524743423|FG001|Overall Study|Pregnancy|0|||
145514375|NCT01134705|524743422|FG000|Overall Study|Lost to Follow-up|5|||
145514376|NCT01134705|524743423|FG001|Overall Study|Lost to Follow-up|2|||
145514377|NCT01134705|524743422|FG000|Overall Study|Protocol Violation|1|||
145514378|NCT01134705|524743423|FG001|Overall Study|Protocol Violation|1|||
145514379|NCT01134705|524743422|FG000|Overall Study|Other|1|||
145514380|NCT01134705|524743423|FG001|Overall Study|Other|6|||
145514381|NCT00509145|524743424|FG000|Overall Study|Death|0|||
145402207|NCT06996301|524328843|FG001|Overall Study|Lost to Follow-up|56|||
145514382|NCT00509145|524743425|FG001|Overall Study|Death|2|||
145514383|NCT00509145|524743424|FG000|Overall Study|Adverse Event|42|||
145514384|NCT00509145|524743425|FG001|Overall Study|Adverse Event|28|||
145514385|NCT00509145|524743424|FG000|Overall Study|Withdrawal by Subject|32|||
145514386|NCT00509145|524743425|FG001|Overall Study|Withdrawal by Subject|38|||
145514387|NCT00509145|524743424|FG000|Overall Study|Physician Decision|11|||
145514388|NCT00509145|524743425|FG001|Overall Study|Physician Decision|14|||
145514389|NCT00509145|524743424|FG000|Overall Study|Protocol Violation|1|||
145514390|NCT00509145|524743425|FG001|Overall Study|Protocol Violation|6|||
145514391|NCT00509145|524743424|FG000|Overall Study|Pregnancy|3|||
145514392|NCT00509145|524743425|FG001|Overall Study|Pregnancy|8|||
145514393|NCT00509145|524743424|FG000|Overall Study|Lost to Follow-up|6|||
145514394|NCT00509145|524743425|FG001|Overall Study|Lost to Follow-up|5|||
145514395|NCT00509145|524743424|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
145514396|NCT00509145|524743425|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
145514397|NCT00509145|524743424|FG000|Overall Study|Other|6|||
145514398|NCT00509145|524743425|FG001|Overall Study|Other|6|||
145514399|NCT01994889|524743426|FG000|Overall Study|Adverse Event|5|||
145514400|NCT01994889|524743427|FG001|Overall Study|Adverse Event|12|||
145514401|NCT01994889|524743428|FG002|Overall Study|Adverse Event|11|||
145514402|NCT01994889|524743426|FG000|Overall Study|Cardiac Device Implantation|0|||
145514403|NCT01994889|524743427|FG001|Overall Study|Cardiac Device Implantation|2|||
145514404|NCT01994889|524743428|FG002|Overall Study|Cardiac Device Implantation|0|||
145514405|NCT01994889|524743426|FG000|Overall Study|Organ Transplantation|1|||
145514406|NCT01994889|524743427|FG001|Overall Study|Organ Transplantation|5|||
145514407|NCT01994889|524743428|FG002|Overall Study|Organ Transplantation|5|||
145514408|NCT01994889|524743426|FG000|Overall Study|No longer willing to participate|8|||
145514409|NCT01994889|524743427|FG001|Overall Study|No longer willing to participate|17|||
145514410|NCT01994889|524743428|FG002|Overall Study|No longer willing to participate|37|||
145514411|NCT01994889|524743426|FG000|Overall Study|Lost to Follow-up|0|||
145514412|NCT01994889|524743427|FG001|Overall Study|Lost to Follow-up|1|||
145514413|NCT01994889|524743428|FG002|Overall Study|Lost to Follow-up|0|||
145514414|NCT01994889|524743426|FG000|Overall Study|Protocol Violation|0|||
145514415|NCT01994889|524743427|FG001|Overall Study|Protocol Violation|1|||
145514416|NCT01994889|524743428|FG002|Overall Study|Protocol Violation|1|||
145514417|NCT01994889|524743426|FG000|Overall Study|Death|14|||
145514418|NCT01994889|524743427|FG001|Overall Study|Death|25|||
145514419|NCT01994889|524743428|FG002|Overall Study|Death|38|||
145514420|NCT01510769|524743429|FG000|Overall Study|Adverse Event|7|||
145733773|NCT00041067|525543359|FG000|Overall Study|Other reasons|23|||
145514421|NCT01510769|524743430|FG001|Overall Study|Adverse Event|6|||
145514422|NCT01510769|524743431|FG002|Overall Study|Adverse Event|4|||
145514423|NCT01510769|524743429|FG000|Overall Study|Gout Flare|0|||
145514424|NCT01510769|524743430|FG001|Overall Study|Gout Flare|3|||
145514425|NCT01510769|524743431|FG002|Overall Study|Gout Flare|1|||
145514426|NCT01510769|524743429|FG000|Overall Study|Protocol Violation|11|||
145514427|NCT01510769|524743430|FG001|Overall Study|Protocol Violation|10|||
145514428|NCT01510769|524743431|FG002|Overall Study|Protocol Violation|9|||
145514429|NCT01510769|524743429|FG000|Overall Study|Lost to Follow-up|5|||
145733774|NCT00041067|525543359|FG000|Overall Study|Ineligible|2|||
145733775|NCT00778622|525543360|FG000|Overall Study|Adverse Event|5|||
145733776|NCT00778622|525543361|FG001|Overall Study|Adverse Event|4|||
145733777|NCT00778622|525543362|FG002|Overall Study|Adverse Event|7|||
145733778|NCT00778622|525543360|FG000|Overall Study|Withdrawal by Subject|4|||
145733779|NCT00778622|525543361|FG001|Overall Study|Withdrawal by Subject|5|||
145733780|NCT00778622|525543362|FG002|Overall Study|Withdrawal by Subject|5|||
145733781|NCT00778622|525543360|FG000|Overall Study|Lost to Follow-up|3|||
145733782|NCT00778622|525543361|FG001|Overall Study|Lost to Follow-up|3|||
145733783|NCT00778622|525543362|FG002|Overall Study|Lost to Follow-up|2|||
145733784|NCT00778622|525543360|FG000|Overall Study|Protocol Violation|0|||
145733785|NCT00778622|525543361|FG001|Overall Study|Protocol Violation|3|||
145733786|NCT00778622|525543362|FG002|Overall Study|Protocol Violation|0|||
145733787|NCT00778622|525543360|FG000|Overall Study|Lack of Efficacy|2|||
145733788|NCT00778622|525543361|FG001|Overall Study|Lack of Efficacy|0|||
145733789|NCT00778622|525543362|FG002|Overall Study|Lack of Efficacy|0|||
145733790|NCT00778622|525543360|FG000|Overall Study|immigration|1|||
145733791|NCT00778622|525543361|FG001|Overall Study|immigration|0|||
145733792|NCT00778622|525543362|FG002|Overall Study|immigration|0|||
145733793|NCT00778622|525543360|FG000|Overall Study|Other|1|||
145514430|NCT01510769|524743430|FG001|Overall Study|Lost to Follow-up|1|||
145733794|NCT00778622|525543361|FG001|Overall Study|Other|0|||
145514431|NCT01510769|524743431|FG002|Overall Study|Lost to Follow-up|5|||
145514432|NCT01510769|524743429|FG000|Overall Study|Withdrawal by Subject|3|||
145514433|NCT01510769|524743430|FG001|Overall Study|Withdrawal by Subject|4|||
145514434|NCT01510769|524743431|FG002|Overall Study|Withdrawal by Subject|3|||
145514435|NCT01510769|524743429|FG000|Overall Study|Death|1|||
145514436|NCT01510769|524743430|FG001|Overall Study|Death|1|||
145514437|NCT01510769|524743431|FG002|Overall Study|Death|0|||
145514438|NCT02674204|524743432|FG000|Overall Study|Adverse Event|1|||
145514439|NCT02674204|524743433|FG001|Overall Study|Adverse Event|0|||
145514440|NCT00929643|524743434|FG000|Overall Study|Protocol Violation|2|||
145514441|NCT01536392|524743435|FG000|Overall Study|Adverse Event|2|||
145514442|NCT01536392|524743436|FG001|Overall Study|Adverse Event|2|||
145514443|NCT01536392|524743435|FG000|Overall Study|Physician Decision|2|||
145514444|NCT01536392|524743436|FG001|Overall Study|Physician Decision|3|||
145514445|NCT01536392|524743435|FG000|Overall Study|Withdrawal by Subject|3|||
145514446|NCT01536392|524743436|FG001|Overall Study|Withdrawal by Subject|6|||
145514447|NCT01536392|524743435|FG000|Overall Study|Non Compliance|3|||
145514448|NCT01536392|524743436|FG001|Overall Study|Non Compliance|4|||
145514449|NCT01536392|524743435|FG000|Overall Study|Completed therapy early|3|||
145514450|NCT01536392|524743436|FG001|Overall Study|Completed therapy early|0|||
145514451|NCT02874144|524743437|FG000|Overall Study|Lost to Follow-up|3|||
145514452|NCT02874144|524743438|FG001|Overall Study|Lost to Follow-up|5|||
145514453|NCT01578850|524743442|FG000|Period 1|Insufficient Clinical Response|1|||
145514454|NCT01578850|524743443|FG001|Period 1|Insufficient Clinical Response|0|||
145514455|NCT01578850|524743444|FG002|Period 1|Insufficient Clinical Response|0|||
145514456|NCT01578850|524743442|FG000|Period 1|Adverse Event|11|||
145514457|NCT01578850|524743443|FG001|Period 1|Adverse Event|0|||
145514458|NCT01578850|524743444|FG002|Period 1|Adverse Event|0|||
145514459|NCT01578850|524743442|FG000|Period 1|Death|1|||
145514460|NCT01578850|524743443|FG001|Period 1|Death|0|||
145514461|NCT01578850|524743444|FG002|Period 1|Death|0|||
145514462|NCT01578850|524743442|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
145514463|NCT01578850|524743443|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
145514464|NCT01578850|524743444|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
145514465|NCT01578850|524743442|FG000|Period 1|Withdrawal by Subject|9|||
145514466|NCT01578850|524743443|FG001|Period 1|Withdrawal by Subject|0|||
145514467|NCT01578850|524743444|FG002|Period 1|Withdrawal by Subject|0|||
145733795|NCT00778622|525543362|FG002|Overall Study|Other|1|||
145733796|NCT01968070|525543363|FG000|Period 1|Withdrawal by Subject|0|||
145733797|NCT01968070|525543364|FG001|Period 1|Withdrawal by Subject|1|||
145733798|NCT01968070|525543365|FG002|Period 1|Withdrawal by Subject|0|||
145733799|NCT01968070|525543366|FG003|Period 1|Withdrawal by Subject|0|||
145733800|NCT01968070|525543367|FG004|Period 1|Withdrawal by Subject|0|||
145733801|NCT01968070|525543368|FG005|Period 1|Withdrawal by Subject|0|||
145733802|NCT01968070|525543369|FG006|Period 1|Withdrawal by Subject|1|||
145733803|NCT01968070|525543370|FG007|Period 1|Withdrawal by Subject|0|||
145733804|NCT01968070|525543371|FG008|Period 1|Withdrawal by Subject|0|||
145514468|NCT01578850|524743442|FG000|Period 1|Study Terminated by Sponsor|3|||
145514469|NCT01578850|524743443|FG001|Period 1|Study Terminated by Sponsor|0|||
145514470|NCT01578850|524743444|FG002|Period 1|Study Terminated by Sponsor|0|||
145514471|NCT01578850|524743442|FG000|Period 2|Insufficient Clinical Response|0|||
145514472|NCT01578850|524743443|FG001|Period 2|Insufficient Clinical Response|1|||
145514473|NCT01578850|524743444|FG002|Period 2|Insufficient Clinical Response|0|||
145514474|NCT01578850|524743442|FG000|Period 2|Adverse Event|0|||
145514475|NCT01578850|524743443|FG001|Period 2|Adverse Event|3|||
145514476|NCT01578850|524743444|FG002|Period 2|Adverse Event|6|||
145514477|NCT01578850|524743442|FG000|Period 2|Lost to Follow-up|0|||
145514478|NCT01578850|524743443|FG001|Period 2|Lost to Follow-up|1|||
145733805|NCT01968070|525543372|FG009|Period 1|Withdrawal by Subject|0|||
145514479|NCT01578850|524743444|FG002|Period 2|Lost to Follow-up|2|||
145514480|NCT01578850|524743442|FG000|Period 2|Withdrawal by Subject|0|||
145514481|NCT01578850|524743443|FG001|Period 2|Withdrawal by Subject|2|||
145514482|NCT01578850|524743444|FG002|Period 2|Withdrawal by Subject|2|||
145514483|NCT01578850|524743442|FG000|Period 2|Study Terminated by Sponsor|0|||
145514484|NCT01578850|524743443|FG001|Period 2|Study Terminated by Sponsor|5|||
145514485|NCT01578850|524743444|FG002|Period 2|Study Terminated by Sponsor|4|||
145514486|NCT01578850|524743442|FG000|Period 2|Unspecified Reasons|0|||
145514487|NCT01578850|524743443|FG001|Period 2|Unspecified Reasons|1|||
145514488|NCT01578850|524743444|FG002|Period 2|Unspecified Reasons|0|||
145514489|NCT01711216|524743445|FG000|Overall Study|Adverse Event|4|||
145514490|NCT01711216|524743445|FG000|Overall Study|Pregnancy|56|||
145514491|NCT01711216|524743445|FG000|Overall Study|Withdrawal by Subject|6|||
145514492|NCT01711216|524743445|FG000|Overall Study|Lost to Follow-up|46|||
145514493|NCT01711216|524743445|FG000|Overall Study|variety of other minor reasons|83|||
145514494|NCT01711216|524743445|FG000|Overall Study|no reason specified|22|||
145514495|NCT02228980|524743446|FG000|Overall Study|Adverse Event|14|||
145514496|NCT02228980|524743447|FG001|Overall Study|Adverse Event|0|||
145514497|NCT02228980|524743448|FG002|Overall Study|Adverse Event|0|||
145514498|NCT02228980|524743449|FG003|Overall Study|Adverse Event|0|||
145514499|NCT02228980|524743446|FG000|Overall Study|Protocol Violation|7|||
145733806|NCT01968070|525543373|FG010|Period 1|Withdrawal by Subject|0|||
145733807|NCT01968070|525543374|FG011|Period 1|Withdrawal by Subject|0|||
145733808|NCT01968070|525543375|FG012|Period 1|Withdrawal by Subject|0|||
145733809|NCT01968070|525543376|FG013|Period 1|Withdrawal by Subject|0|||
145733810|NCT01968070|525543377|FG014|Period 1|Withdrawal by Subject|0|||
145733811|NCT01968070|525543378|FG015|Period 1|Withdrawal by Subject|1|||
145733812|NCT01968070|525543379|FG016|Period 1|Withdrawal by Subject|0|||
145514500|NCT02228980|524743447|FG001|Overall Study|Protocol Violation|0|||
145514501|NCT02228980|524743448|FG002|Overall Study|Protocol Violation|0|||
145514502|NCT02228980|524743449|FG003|Overall Study|Protocol Violation|0|||
145733813|NCT01968070|525543380|FG017|Period 1|Withdrawal by Subject|0|||
145514503|NCT02228980|524743446|FG000|Overall Study|Withdrawal by Subject|3|||
145514504|NCT02228980|524743447|FG001|Overall Study|Withdrawal by Subject|3|||
145733814|NCT01968070|525543363|FG000|Period 1|Protocol Violation|0|||
145733815|NCT01968070|525543364|FG001|Period 1|Protocol Violation|0|||
145733816|NCT01968070|525543365|FG002|Period 1|Protocol Violation|0|||
145733817|NCT01968070|525543366|FG003|Period 1|Protocol Violation|1|||
145733818|NCT01968070|525543367|FG004|Period 1|Protocol Violation|1|||
145514505|NCT02228980|524743448|FG002|Overall Study|Withdrawal by Subject|2|||
145514506|NCT02228980|524743449|FG003|Overall Study|Withdrawal by Subject|3|||
145514507|NCT02929498|524743450|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
145733819|NCT01968070|525543368|FG005|Period 1|Protocol Violation|0|||
145733820|NCT01968070|525543369|FG006|Period 1|Protocol Violation|0|||
145733821|NCT01968070|525543370|FG007|Period 1|Protocol Violation|0|||
145733822|NCT01968070|525543371|FG008|Period 1|Protocol Violation|0|||
145733823|NCT01968070|525543372|FG009|Period 1|Protocol Violation|0|||
145733824|NCT01968070|525543373|FG010|Period 1|Protocol Violation|0|||
145733825|NCT01968070|525543374|FG011|Period 1|Protocol Violation|0|||
145733826|NCT01968070|525543375|FG012|Period 1|Protocol Violation|0|||
145733827|NCT01968070|525543376|FG013|Period 1|Protocol Violation|0|||
145733828|NCT01968070|525543377|FG014|Period 1|Protocol Violation|0|||
145733829|NCT01968070|525543378|FG015|Period 1|Protocol Violation|0|||
145514508|NCT02929498|524743451|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
145733830|NCT01968070|525543379|FG016|Period 1|Protocol Violation|0|||
145733831|NCT01968070|525543380|FG017|Period 1|Protocol Violation|0|||
145733832|NCT01968070|525543363|FG000|Period 1|Lost to Follow-up|0|||
145733833|NCT01968070|525543364|FG001|Period 1|Lost to Follow-up|0|||
145733834|NCT01968070|525543365|FG002|Period 1|Lost to Follow-up|0|||
145733835|NCT01968070|525543366|FG003|Period 1|Lost to Follow-up|1|||
145514509|NCT02929498|524743452|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
145514510|NCT02929498|524743450|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
145514511|NCT02929498|524743451|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
145514512|NCT02929498|524743452|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
145514513|NCT00750152|524743455|FG000|Overall Study|Adverse Event|2|||
145514514|NCT00750152|524743456|FG001|Overall Study|Adverse Event|1|||
145514515|NCT00750152|524743455|FG000|Overall Study|Lost to Follow-up|8|||
145514516|NCT00750152|524743456|FG001|Overall Study|Lost to Follow-up|13|||
145733836|NCT01968070|525543367|FG004|Period 1|Lost to Follow-up|0|||
145733837|NCT01968070|525543368|FG005|Period 1|Lost to Follow-up|0|||
145733838|NCT01968070|525543369|FG006|Period 1|Lost to Follow-up|0|||
145514517|NCT00750152|524743455|FG000|Overall Study|Withdrawal by Subject|3|||
145514518|NCT00750152|524743456|FG001|Overall Study|Withdrawal by Subject|3|||
145514519|NCT00750152|524743455|FG000|Overall Study|Physician Decision|1|||
145514520|NCT00750152|524743456|FG001|Overall Study|Physician Decision|1|||
145514521|NCT00750152|524743455|FG000|Overall Study|Non-compliance|0|||
145514522|NCT00750152|524743456|FG001|Overall Study|Non-compliance|1|||
145514523|NCT00750152|524743455|FG000|Overall Study|Termination by sponsor|1|||
145514524|NCT00750152|524743456|FG001|Overall Study|Termination by sponsor|0|||
145514525|NCT00750152|524743455|FG000|Overall Study|Other|7|||
145514526|NCT00750152|524743456|FG001|Overall Study|Other|8|||
145514527|NCT00715910|524743457|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
145514528|NCT00715910|524743458|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
145514529|NCT00715910|524743459|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
145514530|NCT00715910|524743460|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
145514531|NCT00715910|524743461|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
145514532|NCT00715910|524743462|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
145514533|NCT00715910|524743457|FG000|Booster and ESFU Phase|Other|0|||
145514534|NCT00715910|524743458|FG001|Booster and ESFU Phase|Other|0|||
145514535|NCT00715910|524743459|FG002|Booster and ESFU Phase|Other|0|||
145514536|NCT00715910|524743460|FG003|Booster and ESFU Phase|Other|5|||
145514537|NCT00715910|524743461|FG004|Booster and ESFU Phase|Other|1|||
145514538|NCT00715910|524743462|FG005|Booster and ESFU Phase|Other|0|||
145514539|NCT01030666|524743463|FG000|Overall Study|Lost to Follow-up|3|||
145514540|NCT01030666|524743464|FG001|Overall Study|Lost to Follow-up|2|||
145514541|NCT04002908|524743467|FG000|Overall Study|Death|41|||
145514542|NCT04002908|524743468|FG001|Overall Study|Death|0|||
145514543|NCT04002908|524743469|FG002|Overall Study|Death|0|||
145514544|NCT04002908|524743470|FG003|Overall Study|Death|0|||
145514545|NCT04002908|524743467|FG000|Overall Study|Withdrawal by Subject|112|||
145514546|NCT04002908|524743468|FG001|Overall Study|Withdrawal by Subject|0|||
145514547|NCT04002908|524743469|FG002|Overall Study|Withdrawal by Subject|0|||
145514548|NCT04002908|524743470|FG003|Overall Study|Withdrawal by Subject|0|||
145514549|NCT04002908|524743467|FG000|Overall Study|Lost to Follow-up|72|||
145514550|NCT04002908|524743468|FG001|Overall Study|Lost to Follow-up|0|||
145514551|NCT04002908|524743469|FG002|Overall Study|Lost to Follow-up|0|||
145514552|NCT04002908|524743470|FG003|Overall Study|Lost to Follow-up|0|||
145514553|NCT04002908|524743467|FG000|Overall Study|Infant died, so mother withdrawn|34|||
145514554|NCT04002908|524743468|FG001|Overall Study|Infant died, so mother withdrawn|0|||
145514555|NCT04002908|524743469|FG002|Overall Study|Infant died, so mother withdrawn|0|||
145514556|NCT04002908|524743470|FG003|Overall Study|Infant died, so mother withdrawn|0|||
145514557|NCT03698591|524743471|FG000|Overall Study|Withdrawal by Subject|2|||
145514558|NCT03698591|524743472|FG001|Overall Study|Withdrawal by Subject|2|||
145514559|NCT03698591|524743471|FG000|Overall Study|Failed drug screen|1|||
145514560|NCT03698591|524743472|FG001|Overall Study|Failed drug screen|1|||
145514561|NCT03698591|524743471|FG000|Overall Study|Failed health screen|0|||
145514562|NCT03698591|524743472|FG001|Overall Study|Failed health screen|1|||
145514563|NCT03698591|524743471|FG000|Overall Study|Ineligible for financial compensation|1|||
145514564|NCT03698591|524743472|FG001|Overall Study|Ineligible for financial compensation|0|||
145514565|NCT03698591|524743471|FG000|Overall Study|Equipment Error|1|||
145514566|NCT03698591|524743472|FG001|Overall Study|Equipment Error|0|||
145514567|NCT03698591|524743471|FG000|Overall Study|Could not establish TMS dosage|0|||
145514568|NCT03698591|524743472|FG001|Overall Study|Could not establish TMS dosage|1|||
145514569|NCT05477108|524743476|FG000|Overall Study|Participants randomized, not treated|1|||
145514570|NCT05477108|524743477|FG001|Overall Study|Participants randomized, not treated|1|||
145514571|NCT05477108|524743478|FG002|Overall Study|Participants randomized, not treated|1|||
145514572|NCT05477108|524743476|FG000|Overall Study|Physician Decision|0|||
145514573|NCT05477108|524743477|FG001|Overall Study|Physician Decision|0|||
145514574|NCT05477108|524743478|FG002|Overall Study|Physician Decision|1|||
145514575|NCT05477108|524743476|FG000|Overall Study|withdrawn from study|0|||
145514576|NCT05477108|524743477|FG001|Overall Study|withdrawn from study|0|||
145514577|NCT05477108|524743478|FG002|Overall Study|withdrawn from study|1|||
145514578|NCT00334113|524743480|FG000|Overall Study|Lost to Follow-up|2|||
145514579|NCT00334113|524743481|FG001|Overall Study|Lost to Follow-up|2|||
145514580|NCT00334113|524743480|FG000|Overall Study|Withdrawal by Subject|0|||
145514581|NCT00334113|524743481|FG001|Overall Study|Withdrawal by Subject|1|||
145514582|NCT01165216|524743486|FG000|Overall Study|Adverse Event|6|||
145514583|NCT01165216|524743487|FG001|Overall Study|Adverse Event|3|||
145514584|NCT01165216|524743486|FG000|Overall Study|Withdrawal by Subject|1|||
145514585|NCT01165216|524743487|FG001|Overall Study|Withdrawal by Subject|1|||
145514586|NCT01165216|524743486|FG000|Overall Study|Disease progression|1|||
145514587|NCT01165216|524743487|FG001|Overall Study|Disease progression|3|||
145514588|NCT01379508|524743490|FG000|Treatment to Week 104|Adverse Event|2|||
145514589|NCT01379508|524743491|FG001|Treatment to Week 104|Adverse Event|0|||
145514590|NCT01379508|524743492|FG002|Treatment to Week 104|Adverse Event|5|||
145514591|NCT01379508|524743493|FG003|Treatment to Week 104|Adverse Event|0|||
145514592|NCT01379508|524743490|FG000|Treatment to Week 104|Abnormal lab value|1|||
145514593|NCT01379508|524743491|FG001|Treatment to Week 104|Abnormal lab value|0|||
145514594|NCT01379508|524743492|FG002|Treatment to Week 104|Abnormal lab value|0|||
145514595|NCT01379508|524743493|FG003|Treatment to Week 104|Abnormal lab value|0|||
145514596|NCT01379508|524743490|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
145514597|NCT01379508|524743491|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
145514598|NCT01379508|524743492|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
145514599|NCT01379508|524743493|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
145514600|NCT01379508|524743490|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
145514601|NCT01379508|524743491|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
145514602|NCT01379508|524743492|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
145514603|NCT01379508|524743493|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
145514604|NCT01379508|524743490|FG000|Treatment to Week 104|Lost to Follow-up|5|||
145514605|NCT01379508|524743491|FG001|Treatment to Week 104|Lost to Follow-up|0|||
145514606|NCT01379508|524743492|FG002|Treatment to Week 104|Lost to Follow-up|3|||
145514607|NCT01379508|524743493|FG003|Treatment to Week 104|Lost to Follow-up|0|||
145514608|NCT01379508|524743490|FG000|Treatment to Week 104|Administrative problems|3|||
145514609|NCT01379508|524743491|FG001|Treatment to Week 104|Administrative problems|1|||
145514610|NCT01379508|524743492|FG002|Treatment to Week 104|Administrative problems|0|||
145514611|NCT01379508|524743493|FG003|Treatment to Week 104|Administrative problems|0|||
145514612|NCT01379508|524743490|FG000|Treatment to Week 104|Protocol Violation|1|||
145514613|NCT01379508|524743491|FG001|Treatment to Week 104|Protocol Violation|1|||
145514614|NCT01379508|524743492|FG002|Treatment to Week 104|Protocol Violation|1|||
145514615|NCT01379508|524743493|FG003|Treatment to Week 104|Protocol Violation|0|||
145514616|NCT01379508|524743490|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
145514617|NCT01379508|524743491|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
145514618|NCT01379508|524743492|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
145514619|NCT01379508|524743493|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
145514620|NCT01379508|524743490|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
145514621|NCT01379508|524743491|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
145514622|NCT01379508|524743492|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
145514623|NCT01379508|524743493|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
145514624|NCT01379508|524743490|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
145514625|NCT01379508|524743491|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
145514626|NCT01379508|524743492|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
145514627|NCT01379508|524743493|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
145514628|NCT01379508|524743490|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
145514629|NCT01379508|524743491|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
145514630|NCT01379508|524743492|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
145514631|NCT01379508|524743493|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
145514632|NCT02626624|524743496|FG000|Overall Study|Adverse Event|1|||
145514633|NCT02626624|524743496|FG000|Overall Study|Lost to Follow-up|3|||
145514634|NCT02626624|524743496|FG000|Overall Study|Protocol Violation|4|||
145514635|NCT02626624|524743496|FG000|Overall Study|Death|2|||
145514636|NCT04614324|524743499|FG000|Overall Study|Lost to Follow-up|3|||
145514637|NCT04614324|524743499|FG000|Overall Study|Physician Decision|1|||
145514638|NCT04614324|524743499|FG000|Overall Study|Withdrawal by Subject|2|||
145514639|NCT04614324|524743499|FG000|Overall Study|Remaining in Follow up|123|||
145514640|NCT01948193|524745421|FG000|Overall Study|Serious event|2|||
145514641|NCT01948193|524745421|FG000|Overall Study|Lost to Follow-up|7|||
145514642|NCT00490529|524745422|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
145514643|NCT00490529|524745422|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
145514644|NCT00490529|524745422|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
145514645|NCT00490529|524745422|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
145514646|NCT00490529|524745422|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
145514647|NCT00490529|524745422|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
145514648|NCT01964755|524745426|FG000|Overall Study|Death|2|||
145514649|NCT01410357|524745427|FG000|Overall Study|Death|2|||
145514650|NCT01410357|524745428|FG001|Overall Study|Death|1|||
145514651|NCT01410357|524745427|FG000|Overall Study|Withdrawal by Subject|1|||
145514652|NCT01410357|524745428|FG001|Overall Study|Withdrawal by Subject|2|||
145514653|NCT01410357|524745427|FG000|Overall Study|Lost to Follow-up|23|||
145514654|NCT01410357|524745428|FG001|Overall Study|Lost to Follow-up|21|||
145514655|NCT03467152|524745433|FG000|Overall Study|Adverse Event|4|||
145514656|NCT03467152|524745434|FG001|Overall Study|Adverse Event|5|||
145514657|NCT03467152|524745435|FG002|Overall Study|Adverse Event|0|||
145514658|NCT03467152|524745433|FG000|Overall Study|Subject Choice|1|||
145514659|NCT03467152|524745434|FG001|Overall Study|Subject Choice|3|||
145514660|NCT03467152|524745435|FG002|Overall Study|Subject Choice|0|||
145514661|NCT03467152|524745433|FG000|Overall Study|Lost to Follow-up|1|||
145514662|NCT03467152|524745434|FG001|Overall Study|Lost to Follow-up|0|||
145514663|NCT03467152|524745435|FG002|Overall Study|Lost to Follow-up|0|||
145514664|NCT03467152|524745433|FG000|Overall Study|Withdrawal by Subject|4|||
145514665|NCT03467152|524745434|FG001|Overall Study|Withdrawal by Subject|2|||
145514666|NCT03467152|524745435|FG002|Overall Study|Withdrawal by Subject|0|||
145514667|NCT03467152|524745433|FG000|Overall Study|Others|3|||
145514668|NCT03467152|524745434|FG001|Overall Study|Others|0|||
145514669|NCT03467152|524745435|FG002|Overall Study|Others|0|||
145514670|NCT03467152|524745433|FG000|Overall Study|Not treated|3|||
145514671|NCT03467152|524745434|FG001|Overall Study|Not treated|1|||
145514672|NCT03467152|524745435|FG002|Overall Study|Not treated|6|||
145514673|NCT00945906|524745437|FG000|Overall Study|Withdrawal by Subject|1|||
145514674|NCT00945906|524745437|FG000|Overall Study|Did not want to return for last visit|2|||
145514675|NCT00945906|524745437|FG000|Overall Study|Unable to return for last visit|2|||
145514676|NCT00945906|524745437|FG000|Overall Study|Moved to another country|2|||
145514677|NCT03700684|524745438|FG000|Overall Study|COVID-19|0|||
145514678|NCT03700684|524745439|FG001|Overall Study|COVID-19|0|||
145514679|NCT03700684|524745440|FG002|Overall Study|COVID-19|2|||
145514680|NCT01120782|524745441|FG000|Overall Study|Test article shipping error|11|||
145514681|NCT04140227|524745442|FG000|Overall Study|Withdrawal by Subject|26|||
145514682|NCT04140227|524745442|FG000|Overall Study|Lost to Follow-up|8|||
145514683|NCT04140227|524745442|FG000|Overall Study|Adverse Event|8|||
145514684|NCT04140227|524745442|FG000|Overall Study|Death|1|||
145514685|NCT04140227|524745442|FG000|Overall Study|Other|3|||
145514686|NCT04140227|524745442|FG000|Overall Study|Protocol Violation|2|||
145514687|NCT00361634|524745453|FG000|Overall Study|Lost to Follow-up|1|||
145514688|NCT00361634|524745453|FG000|Overall Study|Withdrawal by Subject|1|||
145514689|NCT05315908|524745454|FG000|Overall Study|Lost to Follow-up|4477|||
145514690|NCT05315908|524745455|FG001|Overall Study|Lost to Follow-up|4606|||
145514691|NCT00294762|524745456|FG000|Overall Study|Did not receive study treatment|3|||
145514692|NCT00294762|524745457|FG001|Overall Study|Did not receive study treatment|3|||
145514693|NCT02937584|524745458|FG000|Period 1|Adverse Event|1|||
145514694|NCT02937584|524745459|FG001|Period 1|Adverse Event|2|||
145514695|NCT02937584|524745458|FG000|Washout|Adverse Event|0|||
145514696|NCT02937584|524745459|FG001|Washout|Adverse Event|1|||
145514697|NCT02238080|524745460|FG000|Overall Study|Death|13|||
145514698|NCT02238080|524745460|FG000|Overall Study|Treatment interrupted|6|||
145514699|NCT02238080|524745460|FG000|Overall Study|Withdrawal by Subject|2|||
145514700|NCT02238080|524745460|FG000|Overall Study|Other|4|||
145514701|NCT01738646|524745469|FG000|Overall Study|Still Receiving Treatment|2|||
145514702|NCT01598129|524745470|FG000|Overall Study|Disease progression|6|||
145514703|NCT01598129|524745470|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
145514704|NCT01598129|524745470|FG000|Overall Study|Withdrawal by Subject|1|||
145514705|NCT00505076|524745471|FG000|Overall Study|Adverse Event|1|||
145514706|NCT00505076|524745472|FG001|Overall Study|Adverse Event|0|||
145514707|NCT00505076|524745473|FG002|Overall Study|Adverse Event|1|||
145514708|NCT00505076|524745471|FG000|Overall Study|Protocol Violation|2|||
145514709|NCT00505076|524745472|FG001|Overall Study|Protocol Violation|1|||
145514710|NCT00505076|524745473|FG002|Overall Study|Protocol Violation|2|||
145514711|NCT00505076|524745471|FG000|Overall Study|Withdrawal by Subject|0|||
145514712|NCT00505076|524745472|FG001|Overall Study|Withdrawal by Subject|1|||
145514713|NCT00505076|524745473|FG002|Overall Study|Withdrawal by Subject|2|||
145514714|NCT04093024|524745476|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
145514715|NCT04093024|524745477|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
145514716|NCT04093024|524745476|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
145514717|NCT04093024|524745477|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
145514718|NCT04093024|524745476|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
145514719|NCT04093024|524745477|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
145514720|NCT04093024|524745476|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
145514721|NCT04093024|524745477|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
145514722|NCT00647270|524745482|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
145514723|NCT00647270|524745483|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
145514724|NCT00647270|524745484|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
145514725|NCT00647270|524745482|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
145514726|NCT00647270|524745483|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
145514727|NCT00647270|524745484|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
145514728|NCT00647270|524745482|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
145514729|NCT00647270|524745483|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
145514730|NCT00647270|524745484|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
145514731|NCT00647270|524745482|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
145514732|NCT00647270|524745483|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
145514733|NCT00647270|524745484|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
145514734|NCT00647270|524745482|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
145514735|NCT00647270|524745483|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
145514736|NCT00647270|524745484|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
145514737|NCT00647270|524745482|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
145514738|NCT00647270|524745483|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
145514739|NCT00647270|524745484|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
145733839|NCT01968070|525543370|FG007|Period 1|Lost to Follow-up|0|||
145514740|NCT00647270|524745482|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
145514741|NCT00647270|524745483|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
145514742|NCT00647270|524745484|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
145514743|NCT03615040|524745485|FG000|Overall Study|Withdrawal by Subject|2|||
145514744|NCT03615040|524745486|FG001|Overall Study|Withdrawal by Subject|1|||
145514745|NCT03615040|524745485|FG000|Overall Study|Physician Decision|2|||
145514746|NCT03615040|524745486|FG001|Overall Study|Physician Decision|2|||
145514747|NCT03615040|524745485|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
145514748|NCT03615040|524745486|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
145514749|NCT03615040|524745485|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
145514750|NCT03615040|524745486|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
145514751|NCT03615040|524745485|FG000|Overall Study|Death|0|||
145514752|NCT03615040|524745486|FG001|Overall Study|Death|2|||
145514753|NCT01541397|524745487|FG000|Overall Study|Study ended prior to data collection|4|||
145514754|NCT01541397|524745488|FG001|Overall Study|Study ended prior to data collection|2|||
145514755|NCT02267317|524745489|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
145514756|NCT02267317|524745490|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
145514757|NCT02267317|524745491|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
145514758|NCT02267317|524745492|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
145514759|NCT02267317|524745493|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
145514760|NCT02267317|524745494|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
145514761|NCT02267317|524745489|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
145514762|NCT02267317|524745490|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
145514763|NCT02267317|524745491|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
145514764|NCT02267317|524745492|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
145514765|NCT02267317|524745493|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
145514766|NCT02267317|524745494|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
145514767|NCT01128621|524745497|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
145514768|NCT01128621|524745498|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
145514769|NCT00233454|524745502|FG000|Overall Study|Death|6|||
145514770|NCT04224688|524745503|FG000|Overall Study|Withdrawal by Subject|1|||
145514771|NCT04224688|524745504|FG001|Overall Study|Withdrawal by Subject|3|||
145514772|NCT04224688|524745503|FG000|Overall Study|Lack of Efficacy|1|||
145514773|NCT04224688|524745504|FG001|Overall Study|Lack of Efficacy|1|||
145514774|NCT04224688|524745503|FG000|Overall Study|Adverse event, not fatal|0|||
145514775|NCT04224688|524745504|FG001|Overall Study|Adverse event, not fatal|2|||
145514776|NCT04224688|524745503|FG000|Overall Study|COVID-19|0|||
145514777|NCT04224688|524745504|FG001|Overall Study|COVID-19|1|||
145514778|NCT03726996|524745510|FG000|Overall Study|Parent's decision|2|||
145514779|NCT03726996|524745510|FG000|Overall Study|Study early termination|2|||
145514780|NCT03531632|524745511|FG000|Overall Study|Adverse Event|0|||
145514781|NCT03531632|524745512|FG001|Overall Study|Adverse Event|0|||
145514782|NCT03531632|524745513|FG002|Overall Study|Adverse Event|1|||
145514783|NCT03531632|524745511|FG000|Overall Study|Death|4|||
145514784|NCT03531632|524745512|FG001|Overall Study|Death|0|||
145514785|NCT03531632|524745513|FG002|Overall Study|Death|14|||
145514786|NCT03531632|524745511|FG000|Overall Study|Study Terminated|1|||
145514787|NCT03531632|524745512|FG001|Overall Study|Study Terminated|3|||
145514788|NCT03531632|524745513|FG002|Overall Study|Study Terminated|11|||
145514789|NCT02743611|524745514|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
145514790|NCT02743611|524745515|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
145514791|NCT02743611|524745516|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
145514792|NCT02743611|524745517|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
145514793|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
145514794|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
145514795|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
145514796|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
145514797|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
145514798|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
145514799|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145514800|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
145514801|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
145514802|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145514803|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145514804|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145514805|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
145514806|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
145514807|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
145514808|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
145402208|NCT06996301|524328842|FG000|Overall Study|Withdrawal by Subject|12|||
145402209|NCT06996301|524328843|FG001|Overall Study|Withdrawal by Subject|7|||
145514809|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
145514810|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
145514811|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
145514812|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
145514813|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
145514814|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
145514815|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
145402210|NCT00750269|524330677|FG000|Overall Study|Protocol Violation|0|||
145402211|NCT00750269|524330678|FG001|Overall Study|Protocol Violation|1|||
145402212|NCT00750269|524330679|FG002|Overall Study|Protocol Violation|1|||
145402213|NCT00750269|524330680|FG003|Overall Study|Protocol Violation|2|||
145402214|NCT00750269|524330681|FG004|Overall Study|Protocol Violation|4|||
145514816|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
145514817|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
145514818|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
145514819|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
145514820|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
145514821|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
145514822|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
145514823|NCT00600119|524745518|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
145514824|NCT00600119|524745519|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
145514825|NCT00600119|524745520|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
145514826|NCT00600119|524745521|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
145514827|NCT00600119|524745522|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
145514828|NCT00600119|524745523|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
145514829|NCT00600119|524745518|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
145514830|NCT00600119|524745519|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145514831|NCT00600119|524745520|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145514832|NCT00600119|524745521|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
145514833|NCT00600119|524745522|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
145514834|NCT00600119|524745523|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
145514835|NCT00600119|524745518|FG000|Double-blind Treatment Period|Other|0|||
145514836|NCT00600119|524745519|FG001|Double-blind Treatment Period|Other|0|||
145514837|NCT00600119|524745520|FG002|Double-blind Treatment Period|Other|0|||
145514838|NCT00600119|524745521|FG003|Double-blind Treatment Period|Other|0|||
145514839|NCT00600119|524745522|FG004|Double-blind Treatment Period|Other|2|||
145514840|NCT00600119|524745523|FG005|Double-blind Treatment Period|Other|1|||
145514841|NCT00600119|524745518|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
145514842|NCT00600119|524745519|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
145514843|NCT00600119|524745520|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
145514844|NCT00600119|524745521|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
145514845|NCT00600119|524745522|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
145514846|NCT00600119|524745523|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
145514847|NCT00600119|524745518|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
145514848|NCT00600119|524745519|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
145514849|NCT00600119|524745520|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
145514850|NCT00600119|524745521|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
145514851|NCT00600119|524745522|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
145514852|NCT00600119|524745523|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
145514853|NCT00600119|524745518|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
145514854|NCT00600119|524745519|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
145514855|NCT00600119|524745520|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
145514856|NCT00600119|524745521|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
145514857|NCT00600119|524745522|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
145514858|NCT00600119|524745523|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
145514859|NCT00600119|524745518|FG000|Double-blind Treatment Period|Physician Decision|2|||
145514860|NCT00600119|524745519|FG001|Double-blind Treatment Period|Physician Decision|0|||
145514861|NCT00600119|524745520|FG002|Double-blind Treatment Period|Physician Decision|0|||
145514862|NCT00600119|524745521|FG003|Double-blind Treatment Period|Physician Decision|0|||
145514863|NCT00600119|524745522|FG004|Double-blind Treatment Period|Physician Decision|0|||
145514864|NCT00600119|524745523|FG005|Double-blind Treatment Period|Physician Decision|0|||
145514865|NCT00600119|524745518|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145514866|NCT00600119|524745519|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
145514867|NCT00600119|524745520|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145514868|NCT00600119|524745521|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145514869|NCT00600119|524745522|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
145514870|NCT00600119|524745523|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
145514871|NCT00600119|524745518|FG000|Double-blind Treatment Period|Adverse Event|1|||
145514872|NCT00600119|524745519|FG001|Double-blind Treatment Period|Adverse Event|1|||
145514873|NCT00600119|524745520|FG002|Double-blind Treatment Period|Adverse Event|0|||
145514874|NCT00600119|524745521|FG003|Double-blind Treatment Period|Adverse Event|1|||
145514875|NCT00600119|524745522|FG004|Double-blind Treatment Period|Adverse Event|2|||
145514876|NCT00600119|524745523|FG005|Double-blind Treatment Period|Adverse Event|10|||
145514877|NCT00600119|524745518|FG000|Follow-up Period|Adverse Event|0|||
145514878|NCT00600119|524745519|FG001|Follow-up Period|Adverse Event|0|||
145514879|NCT00600119|524745520|FG002|Follow-up Period|Adverse Event|0|||
145514880|NCT00600119|524745521|FG003|Follow-up Period|Adverse Event|0|||
145514881|NCT00600119|524745522|FG004|Follow-up Period|Adverse Event|0|||
145514882|NCT00600119|524745523|FG005|Follow-up Period|Adverse Event|1|||
145514883|NCT00600119|524745518|FG000|Follow-up Period|Other|1|||
145514884|NCT00600119|524745519|FG001|Follow-up Period|Other|0|||
145514885|NCT00600119|524745520|FG002|Follow-up Period|Other|0|||
145514886|NCT00600119|524745521|FG003|Follow-up Period|Other|0|||
145514887|NCT00600119|524745522|FG004|Follow-up Period|Other|0|||
145514888|NCT00600119|524745523|FG005|Follow-up Period|Other|0|||
145514889|NCT01616693|524745524|FG000|Evaluated for Safety|Physician Decision|1|||
145514890|NCT01616693|524745525|FG001|Evaluated for Safety|Physician Decision|0|||
145514891|NCT01616693|524745526|FG002|Evaluated for Safety|Physician Decision|1|||
145514892|NCT01616693|524745527|FG003|Evaluated for Safety|Physician Decision|0|||
145514893|NCT01616693|524745524|FG000|Received Both Vaccines|Adverse Event|2|||
145514894|NCT01616693|524745525|FG001|Received Both Vaccines|Adverse Event|0|||
145514895|NCT01616693|524745526|FG002|Received Both Vaccines|Adverse Event|0|||
145514896|NCT01616693|524745527|FG003|Received Both Vaccines|Adverse Event|0|||
145514897|NCT01616693|524745524|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
145514898|NCT01616693|524745525|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
145514899|NCT01616693|524745526|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
145514900|NCT01616693|524745527|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
145514901|NCT01616693|524745524|FG000|Received Both Vaccines|Lost to Follow-up|4|||
145514902|NCT01616693|524745525|FG001|Received Both Vaccines|Lost to Follow-up|3|||
145514903|NCT01616693|524745526|FG002|Received Both Vaccines|Lost to Follow-up|4|||
145514904|NCT01616693|524745527|FG003|Received Both Vaccines|Lost to Follow-up|4|||
145514905|NCT01616693|524745524|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
145514906|NCT01616693|524745525|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
145514907|NCT01616693|524745526|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
145514908|NCT01616693|524745527|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
145514909|NCT01950013|524745528|FG000|Overall Study|Withdrawal by Subject|0|||
145514910|NCT01950013|524745529|FG001|Overall Study|Withdrawal by Subject|2|||
145514911|NCT01950013|524745530|FG002|Overall Study|Withdrawal by Subject|0|||
145514912|NCT00271505|524745534|FG000|Overall Study|Screen Failure|3|||
145514913|NCT00271505|524745534|FG000|Overall Study|Adverse Event|1|||
145514914|NCT00271505|524745534|FG000|Overall Study|Death|1|||
145514915|NCT00539188|524745535|FG000|Overall Study|Withdrawal by Subject|1|||
145514916|NCT00539188|524745536|FG001|Overall Study|Withdrawal by Subject|0|||
145514917|NCT00539188|524745535|FG000|Overall Study|Lost to Follow-up|2|||
145514918|NCT00539188|524745536|FG001|Overall Study|Lost to Follow-up|1|||
145514919|NCT04784442|524745537|FG000|Overall Study|Adverse Event|1|||
145514920|NCT04784442|524745538|FG001|Overall Study|Adverse Event|0|||
145514921|NCT04784442|524745539|FG002|Overall Study|Adverse Event|2|||
145514922|NCT04784442|524745540|FG003|Overall Study|Adverse Event|1|||
145514923|NCT04784442|524745537|FG000|Overall Study|Protocol Violation|1|||
145514924|NCT04784442|524745538|FG001|Overall Study|Protocol Violation|0|||
145514925|NCT04784442|524745539|FG002|Overall Study|Protocol Violation|0|||
145514926|NCT04784442|524745540|FG003|Overall Study|Protocol Violation|0|||
145514927|NCT04784442|524745537|FG000|Overall Study|Non-compliance with study drug|1|||
145514928|NCT04784442|524745538|FG001|Overall Study|Non-compliance with study drug|0|||
145514929|NCT04784442|524745539|FG002|Overall Study|Non-compliance with study drug|0|||
145514930|NCT04784442|524745540|FG003|Overall Study|Non-compliance with study drug|0|||
145514931|NCT00486811|524745543|FG000|Overall Study|Adverse Event|28|||
145514932|NCT00486811|524745544|FG001|Overall Study|Adverse Event|60|||
145514933|NCT00486811|524745545|FG002|Overall Study|Adverse Event|135|||
145514934|NCT00486811|524745543|FG000|Overall Study|Lack of Efficacy|34|||
145514935|NCT00486811|524745544|FG001|Overall Study|Lack of Efficacy|14|||
145514936|NCT00486811|524745545|FG002|Overall Study|Lack of Efficacy|7|||
145514937|NCT00486811|524745543|FG000|Overall Study|Lost to Follow-up|4|||
145514938|NCT00486811|524745544|FG001|Overall Study|Lost to Follow-up|6|||
145514939|NCT00486811|524745545|FG002|Overall Study|Lost to Follow-up|4|||
145514940|NCT00486811|524745543|FG000|Overall Study|Withdrawal by Subject|33|||
145514941|NCT00486811|524745544|FG001|Overall Study|Withdrawal by Subject|44|||
145514942|NCT00486811|524745545|FG002|Overall Study|Withdrawal by Subject|58|||
145514943|NCT00486811|524745543|FG000|Overall Study|Study drug non-compliant|5|||
145514944|NCT00486811|524745544|FG001|Overall Study|Study drug non-compliant|6|||
145514945|NCT00486811|524745545|FG002|Overall Study|Study drug non-compliant|3|||
145514946|NCT00486811|524745543|FG000|Overall Study|All other|18|||
145514947|NCT00486811|524745544|FG001|Overall Study|All other|11|||
145514948|NCT00486811|524745545|FG002|Overall Study|All other|7|||
145514949|NCT00852371|524745549|FG000|Overall Study|Lost to Follow-up|2|||
145514950|NCT00852371|524745550|FG001|Overall Study|Lost to Follow-up|3|||
145514951|NCT00852371|524745551|FG002|Overall Study|Lost to Follow-up|4|||
145514952|NCT00852371|524745552|FG003|Overall Study|Lost to Follow-up|2|||
145514953|NCT02756806|524745553|FG000|Overall Study|Study terminated early|5|||
145514954|NCT03158285|524745554|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
145514955|NCT03158285|524745555|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
145514956|NCT03158285|524745556|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
145514957|NCT03158285|524745554|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
145514958|NCT03158285|524745555|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
145514959|NCT03158285|524745556|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
145514960|NCT03158285|524745554|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
145514961|NCT03158285|524745555|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
145514962|NCT03158285|524745556|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
145514963|NCT03158285|524745554|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
145514964|NCT03158285|524745555|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
145514965|NCT03158285|524745556|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
145514966|NCT03158285|524745554|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
145514967|NCT03158285|524745555|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
145514968|NCT03158285|524745556|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
145514969|NCT03158285|524745554|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
145514970|NCT03158285|524745555|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
145514971|NCT03158285|524745556|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
145514972|NCT03158285|524745554|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
145514973|NCT03158285|524745555|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
145514974|NCT03158285|524745556|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
145514975|NCT03158285|524745554|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
145514976|NCT03158285|524745555|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
145514977|NCT03158285|524745556|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
145514978|NCT03158285|524745554|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
145514979|NCT03158285|524745555|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
145514980|NCT03158285|524745556|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
145514981|NCT03158285|524745554|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
145514982|NCT03158285|524745555|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
145514983|NCT03158285|524745556|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
145514984|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
145514985|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
145514986|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
145514987|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
145514988|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
145514989|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
145514990|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
145514991|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
145514992|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
145514993|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
145514994|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
145514995|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
145514996|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Death|1|||
145514997|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Death|0|||
145514998|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Death|0|||
145514999|NCT03158285|524745554|FG000|Active Treatment Period: Week 52-100|Other|4|||
145515000|NCT03158285|524745555|FG001|Active Treatment Period: Week 52-100|Other|1|||
145515001|NCT03158285|524745556|FG002|Active Treatment Period: Week 52-100|Other|0|||
145515002|NCT05141448|524745559|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145515003|NCT05141448|524745560|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
145515004|NCT05141448|524745561|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145515005|NCT05141448|524745562|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145515006|NCT05141448|524745563|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145515007|NCT05141448|524745564|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145515008|NCT05141448|524745559|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145515009|NCT05141448|524745560|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145515010|NCT05141448|524745561|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145515011|NCT05141448|524745562|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145515012|NCT05141448|524745563|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
145515013|NCT05141448|524745564|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145515014|NCT05141448|524745559|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145515015|NCT05141448|524745560|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
145515016|NCT05141448|524745561|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145515017|NCT05141448|524745562|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145515018|NCT05141448|524745563|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145515019|NCT05141448|524745564|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145515020|NCT05141448|524745559|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145515021|NCT05141448|524745560|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145515022|NCT05141448|524745561|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145515023|NCT05141448|524745562|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145515024|NCT05141448|524745563|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145515025|NCT05141448|524745564|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
145515026|NCT05141448|524745559|FG000|Period 2|COVID-19 Related|0|||
145515027|NCT05141448|524745560|FG001|Period 2|COVID-19 Related|0|||
145515028|NCT05141448|524745561|FG002|Period 2|COVID-19 Related|0|||
145515029|NCT05141448|524745562|FG003|Period 2|COVID-19 Related|1|||
145515030|NCT05141448|524745563|FG004|Period 2|COVID-19 Related|0|||
145515031|NCT05141448|524745564|FG005|Period 2|COVID-19 Related|1|||
145515032|NCT05141448|524745559|FG000|3|Covid-19 related|2|||
145515033|NCT05141448|524745560|FG001|3|Covid-19 related|0|||
145515034|NCT05141448|524745561|FG002|3|Covid-19 related|0|||
145515035|NCT05141448|524745562|FG003|3|Covid-19 related|0|||
145515036|NCT05141448|524745563|FG004|3|Covid-19 related|0|||
145515037|NCT05141448|524745564|FG005|3|Covid-19 related|1|||
145515038|NCT05141448|524745559|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
145515039|NCT05141448|524745560|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
145515040|NCT05141448|524745561|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
145515041|NCT05141448|524745562|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
145515042|NCT05141448|524745563|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
145515043|NCT05141448|524745564|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
145515044|NCT03865316|524746814|FG000|Overall Study|Procedure Cancelled|4|||
145515045|NCT03865316|524746814|FG000|Overall Study|Equipment failure|4|||
145515046|NCT03137069|524746820|FG000|Overall Study|Withdrawal by Subject|1|||
145515047|NCT03137069|524746821|FG001|Overall Study|Withdrawal by Subject|2|||
145515048|NCT03137069|524746822|FG002|Overall Study|Withdrawal by Subject|2|||
145515049|NCT03137069|524746823|FG003|Overall Study|Withdrawal by Subject|2|||
145515050|NCT03137069|524746824|FG004|Overall Study|Withdrawal by Subject|0|||
145515051|NCT03137069|524746825|FG005|Overall Study|Withdrawal by Subject|0|||
145515052|NCT03137069|524746820|FG000|Overall Study|Adverse Event|0|||
145515053|NCT03137069|524746821|FG001|Overall Study|Adverse Event|3|||
145515054|NCT03137069|524746822|FG002|Overall Study|Adverse Event|1|||
145515055|NCT03137069|524746823|FG003|Overall Study|Adverse Event|1|||
145515056|NCT03137069|524746824|FG004|Overall Study|Adverse Event|0|||
145515057|NCT03137069|524746825|FG005|Overall Study|Adverse Event|1|||
145515058|NCT03137069|524746820|FG000|Overall Study|Protocol Violation|0|||
145515059|NCT03137069|524746821|FG001|Overall Study|Protocol Violation|1|||
145515060|NCT03137069|524746822|FG002|Overall Study|Protocol Violation|0|||
145515061|NCT03137069|524746823|FG003|Overall Study|Protocol Violation|1|||
145515062|NCT03137069|524746824|FG004|Overall Study|Protocol Violation|1|||
145515063|NCT03137069|524746825|FG005|Overall Study|Protocol Violation|1|||
145515064|NCT03137069|524746820|FG000|Overall Study|Physician Decision|0|||
145515065|NCT03137069|524746821|FG001|Overall Study|Physician Decision|0|||
145515066|NCT03137069|524746822|FG002|Overall Study|Physician Decision|0|||
145515067|NCT03137069|524746823|FG003|Overall Study|Physician Decision|1|||
145515068|NCT03137069|524746824|FG004|Overall Study|Physician Decision|0|||
145515069|NCT03137069|524746825|FG005|Overall Study|Physician Decision|0|||
145515070|NCT03137069|524746820|FG000|Overall Study|Study Terminated by Sponsor|0|||
145515071|NCT03137069|524746821|FG001|Overall Study|Study Terminated by Sponsor|0|||
145515072|NCT03137069|524746822|FG002|Overall Study|Study Terminated by Sponsor|0|||
145515073|NCT03137069|524746823|FG003|Overall Study|Study Terminated by Sponsor|0|||
145515074|NCT03137069|524746824|FG004|Overall Study|Study Terminated by Sponsor|1|||
145515075|NCT03137069|524746825|FG005|Overall Study|Study Terminated by Sponsor|0|||
145515076|NCT03137069|524746820|FG000|Overall Study|Data Entry Error|0|||
145515077|NCT03137069|524746821|FG001|Overall Study|Data Entry Error|0|||
145515078|NCT03137069|524746822|FG002|Overall Study|Data Entry Error|0|||
145515079|NCT03137069|524746823|FG003|Overall Study|Data Entry Error|1|||
145515080|NCT03137069|524746824|FG004|Overall Study|Data Entry Error|0|||
145515081|NCT03137069|524746825|FG005|Overall Study|Data Entry Error|0|||
145515082|NCT00336856|524746826|FG000|Overall Study|Withdrawal by Subject|3|||
145515083|NCT00336856|524746826|FG000|Overall Study|Found ineligible at time of analysis|1|||
145515084|NCT02522624|524746828|FG000|Overall Study|Technical failure|1|||
145515085|NCT02522624|524746829|FG001|Overall Study|Technical failure|0|||
145515086|NCT01347580|524746837|FG000|Overall Study|Withdrawal by Subject|13|||
145515087|NCT01347580|524746838|FG001|Overall Study|Withdrawal by Subject|23|||
145515088|NCT01347580|524746837|FG000|Overall Study|Death|30|||
145515089|NCT01347580|524746838|FG001|Overall Study|Death|19|||
145515090|NCT01347580|524746837|FG000|Overall Study|Protocol Violation|10|||
145515091|NCT01347580|524746838|FG001|Overall Study|Protocol Violation|7|||
145515092|NCT01347580|524746837|FG000|Overall Study|Lost to Follow-up|3|||
145515093|NCT01347580|524746838|FG001|Overall Study|Lost to Follow-up|1|||
145515094|NCT01347580|524746837|FG000|Overall Study|Had other reason|9|||
145515095|NCT01347580|524746838|FG001|Overall Study|Had other reason|6|||
145515096|NCT00538785|524746840|FG000|Overall Study|Death|9|||
145515097|NCT00538785|524746841|FG001|Overall Study|Death|10|||
145515098|NCT00538785|524746840|FG000|Overall Study|Withdrawal of consent|9|||
145515099|NCT00538785|524746841|FG001|Overall Study|Withdrawal of consent|7|||
145515100|NCT00538785|524746840|FG000|Overall Study|Lost to Follow-up|1|||
145515101|NCT00538785|524746841|FG001|Overall Study|Lost to Follow-up|0|||
145515102|NCT04022733|524746842|FG000|Overall Study|conversion to open surgery|3|||
145515103|NCT04022733|524746843|FG001|Overall Study|conversion to open surgery|2|||
145515104|NCT04022733|524746842|FG000|Overall Study|bradycardia|0|||
145515105|NCT04022733|524746843|FG001|Overall Study|bradycardia|1|||
145515106|NCT04074161|524746851|FG000|Overall Study|Withdrawal by Subject|2|||
145515107|NCT04074161|524746852|FG001|Overall Study|Withdrawal by Subject|4|||
145515108|NCT04074161|524746853|FG002|Overall Study|Withdrawal by Subject|1|||
145515109|NCT04074161|524746851|FG000|Overall Study|Lost to Follow-up|4|||
145515110|NCT04074161|524746852|FG001|Overall Study|Lost to Follow-up|5|||
145515111|NCT04074161|524746853|FG002|Overall Study|Lost to Follow-up|3|||
145515112|NCT02208063|524746856|FG000|Overall Study|Death|3|||
145515113|NCT02208063|524746857|FG001|Overall Study|Death|5|||
145515114|NCT02208063|524746856|FG000|Overall Study|Not Specified in report|3|||
145515115|NCT02208063|524746857|FG001|Overall Study|Not Specified in report|4|||
145515116|NCT02208063|524746856|FG000|Overall Study|Withdrawal by Subject|5|||
145515117|NCT02208063|524746857|FG001|Overall Study|Withdrawal by Subject|2|||
145515118|NCT02208063|524746856|FG000|Overall Study|Lost to Follow-up|1|||
145515119|NCT02208063|524746857|FG001|Overall Study|Lost to Follow-up|0|||
145515120|NCT02122783|524746863|FG000|Overall Study|Adverse Event|0|||
145515121|NCT02122783|524746864|FG001|Overall Study|Adverse Event|1|||
145515122|NCT00329849|524746865|FG000|Overall Study|Withdrawal by Subject|6|||
145515123|NCT00329849|524746866|FG001|Overall Study|Withdrawal by Subject|4|||
145515124|NCT00322621|524746873|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
145515125|NCT00322621|524746874|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
145515126|NCT00322621|524746875|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
145515127|NCT00322621|524746873|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
145515128|NCT00322621|524746874|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
145515129|NCT00322621|524746875|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
145515130|NCT00322621|524746873|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
145515131|NCT00322621|524746874|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
145515132|NCT00322621|524746875|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
145515133|NCT00322621|524746873|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
145515134|NCT00322621|524746874|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
145515135|NCT00322621|524746875|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
145515136|NCT00322621|524746873|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
145515137|NCT00322621|524746874|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
145515138|NCT00322621|524746875|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
145515139|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
145515140|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
145515141|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
145515142|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
145515143|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
145515144|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
145515145|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
145515146|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
145515147|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
145515148|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
145515149|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
145515150|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
145515151|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
145515152|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
145515153|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
145515154|NCT00322621|524746873|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
145515155|NCT00322621|524746874|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
145515156|NCT00322621|524746875|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
145515157|NCT01038869|524746878|FG000|Overall Study|Withdrawal by Subject|1|||
145515158|NCT01038869|524746878|FG000|Overall Study|Lost to Follow-up|6|||
145515159|NCT02238067|524746879|FG000|Overall Study|Not completed survey at Month 6|45|||
145515160|NCT02213133|524746880|FG000|Overall Study|Participant discontinued study therapy|2|||
145515161|NCT02213133|524746881|FG001|Overall Study|Participant discontinued study therapy|0|||
145515162|NCT02213133|524746882|FG002|Overall Study|Participant discontinued study therapy|0|||
145515163|NCT02213133|524746880|FG000|Overall Study|Participant withdrew informed consent|2|||
145515164|NCT02213133|524746881|FG001|Overall Study|Participant withdrew informed consent|1|||
145515165|NCT02213133|524746882|FG002|Overall Study|Participant withdrew informed consent|2|||
145515166|NCT02213133|524746880|FG000|Overall Study|Disease progression|11|||
145515167|NCT02213133|524746881|FG001|Overall Study|Disease progression|2|||
145515168|NCT02213133|524746882|FG002|Overall Study|Disease progression|0|||
145515169|NCT02213133|524746880|FG000|Overall Study|Adverse Event (AE)|1|||
145515170|NCT02213133|524746881|FG001|Overall Study|Adverse Event (AE)|0|||
145515171|NCT02213133|524746882|FG002|Overall Study|Adverse Event (AE)|0|||
145515172|NCT02213133|524746880|FG000|Overall Study|Death|16|||
145515173|NCT02213133|524746881|FG001|Overall Study|Death|2|||
145515174|NCT02213133|524746882|FG002|Overall Study|Death|1|||
145515175|NCT02213133|524746880|FG000|Overall Study|Other|5|||
145515176|NCT02213133|524746881|FG001|Overall Study|Other|0|||
145515177|NCT02213133|524746882|FG002|Overall Study|Other|0|||
145515178|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
145515179|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145515180|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145515181|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
145515182|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
145515183|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
145515184|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
145515185|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
145515186|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
145515187|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
145402215|NCT00750269|524330677|FG000|Overall Study|Withdrawal by Subject|0|||
145515188|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
145515189|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
145515190|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
145515191|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
145515192|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
145515193|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
145515194|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
145515195|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
145515196|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
145515197|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
145515198|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
145515199|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
145515200|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
145515201|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
145515202|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
145515203|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145515204|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145515205|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145515206|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145515207|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145515208|NCT01328444|524746883|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145515209|NCT01328444|524746884|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
145515210|NCT01328444|524746885|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
145515211|NCT01328444|524746886|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
145515212|NCT01328444|524746887|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
145515213|NCT01328444|524746888|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145515214|NCT01328444|524746883|FG000|Washout Period (14 Days)|Adverse Event|1|||
145515215|NCT01328444|524746884|FG001|Washout Period (14 Days)|Adverse Event|1|||
145515216|NCT01328444|524746885|FG002|Washout Period (14 Days)|Adverse Event|0|||
145515217|NCT01328444|524746886|FG003|Washout Period (14 Days)|Adverse Event|1|||
145515218|NCT01328444|524746887|FG004|Washout Period (14 Days)|Adverse Event|1|||
145515219|NCT01328444|524746888|FG005|Washout Period (14 Days)|Adverse Event|2|||
145515220|NCT01328444|524746883|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
145515221|NCT01328444|524746884|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
145515222|NCT01328444|524746885|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
145515223|NCT01328444|524746886|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
145515224|NCT01328444|524746887|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
145515225|NCT01328444|524746888|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
145515226|NCT01328444|524746883|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
145515227|NCT01328444|524746884|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
145515228|NCT01328444|524746885|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
145515229|NCT01328444|524746886|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
145515230|NCT01328444|524746887|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
145515231|NCT01328444|524746888|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
145515232|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
145515233|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145515234|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145515235|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145515236|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145515237|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145733840|NCT01968070|525543371|FG008|Period 1|Lost to Follow-up|0|||
145733841|NCT01968070|525543372|FG009|Period 1|Lost to Follow-up|0|||
145515238|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
145515239|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145515240|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145515241|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
145515242|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
145515243|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
145515244|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
145515245|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
145515246|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
145515247|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
145515248|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
145515249|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
145515250|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
145515251|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
145515252|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
145515253|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
145515254|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
145515255|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
145515256|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145515257|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145515258|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
145515259|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
145515260|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
145515261|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
145515262|NCT01328444|524746883|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145515263|NCT01328444|524746884|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145515264|NCT01328444|524746885|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145515265|NCT01328444|524746886|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145515266|NCT01328444|524746887|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145515267|NCT01328444|524746888|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145515268|NCT02744040|524746891|FG000|Overall Study|Withdrawal by Subject|3|||
145515269|NCT02744040|524746892|FG001|Overall Study|Withdrawal by Subject|2|||
145515270|NCT02744040|524746893|FG002|Overall Study|Withdrawal by Subject|2|||
145515271|NCT02744040|524746891|FG000|Overall Study|Physician Decision|0|||
145515272|NCT02744040|524746892|FG001|Overall Study|Physician Decision|8|||
145515273|NCT02744040|524746893|FG002|Overall Study|Physician Decision|13|||
145515274|NCT02744040|524746891|FG000|Overall Study|Lost to Follow-up|3|||
145515275|NCT02744040|524746892|FG001|Overall Study|Lost to Follow-up|1|||
145515276|NCT02744040|524746893|FG002|Overall Study|Lost to Follow-up|7|||
145515277|NCT01642615|524746894|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
145733842|NCT01968070|525543373|FG010|Period 1|Lost to Follow-up|0|||
145515278|NCT01642615|524746895|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
145515279|NCT01642615|524746896|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
145515280|NCT01642615|524746894|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
145515281|NCT01642615|524746895|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
145515282|NCT01642615|524746896|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
145515283|NCT01642615|524746894|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
145515284|NCT01642615|524746895|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
145515285|NCT01642615|524746896|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
145515286|NCT01642615|524746894|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
145515287|NCT01642615|524746895|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
145515288|NCT01642615|524746896|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
145515289|NCT01642615|524746894|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
145515290|NCT01642615|524746895|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
145515291|NCT01642615|524746896|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
145515292|NCT01642615|524746894|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
145515293|NCT01642615|524746895|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
145515294|NCT01642615|524746896|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
145515295|NCT01642615|524746894|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
145515296|NCT01642615|524746895|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
145515297|NCT01642615|524746896|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
145515298|NCT01642615|524746894|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
145515299|NCT01642615|524746895|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
145515300|NCT01642615|524746896|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
145515301|NCT01642615|524746894|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
145515302|NCT01642615|524746895|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
145515303|NCT01642615|524746896|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
145515304|NCT00096356|524746897|FG000|Overall Study|Adverse Event|11|||
145515305|NCT00096356|524746898|FG001|Overall Study|Adverse Event|9|||
145515306|NCT00096356|524746897|FG000|Overall Study|Physician Decision|5|||
145515307|NCT00096356|524746898|FG001|Overall Study|Physician Decision|3|||
145515308|NCT00096356|524746897|FG000|Overall Study|Withdrawal by Subject|17|||
145515309|NCT00096356|524746898|FG001|Overall Study|Withdrawal by Subject|23|||
145515310|NCT00096356|524746897|FG000|Overall Study|Lack of Efficacy|1|||
145515311|NCT00096356|524746898|FG001|Overall Study|Lack of Efficacy|0|||
145515312|NCT00096356|524746897|FG000|Overall Study|multiple reasons|10|||
145515313|NCT00096356|524746898|FG001|Overall Study|multiple reasons|18|||
145515314|NCT01008423|524746899|FG000|Overall Study|Adverse Event|13|||
145515315|NCT01008423|524746900|FG001|Overall Study|Adverse Event|6|||
145515316|NCT01008423|524746899|FG000|Overall Study|Withdrawal by Subject|4|||
145515317|NCT01008423|524746900|FG001|Overall Study|Withdrawal by Subject|7|||
145515318|NCT01008423|524746899|FG000|Overall Study|Lost to Follow-up|0|||
145515319|NCT01008423|524746900|FG001|Overall Study|Lost to Follow-up|2|||
145515320|NCT01008423|524746899|FG000|Overall Study|Low Cortisol|0|||
145515321|NCT01008423|524746900|FG001|Overall Study|Low Cortisol|1|||
145515322|NCT01008423|524746899|FG000|Overall Study|Lack of Efficacy|0|||
145515323|NCT01008423|524746900|FG001|Overall Study|Lack of Efficacy|5|||
145515324|NCT01008423|524746899|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
145515325|NCT01008423|524746900|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
145515326|NCT01008423|524746899|FG000|Overall Study|Personal Conflict|1|||
145515327|NCT01008423|524746900|FG001|Overall Study|Personal Conflict|0|||
145515328|NCT01008423|524746899|FG000|Overall Study|Other|0|||
145515329|NCT01008423|524746900|FG001|Overall Study|Other|1|||
145515330|NCT00402740|524746906|FG000|Overall Study|Withdrawal by Subject|18|||
145515331|NCT00402740|524746906|FG000|Overall Study|Death|50|||
145515332|NCT00402740|524746906|FG000|Overall Study|Lost to Follow-up|6|||
145515333|NCT00402740|524746906|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
145515334|NCT00402740|524746906|FG000|Overall Study|Subject disposition unknown.|1|||
145515335|NCT01028300|524746907|FG000|Overall Study|Study Terminated|4|||
145515336|NCT00946153|524746913|FG000|Phase 2|Adverse Event|0|||
145515337|NCT00946153|524746914|FG001|Phase 2|Adverse Event|0|||
145515338|NCT00946153|524746915|FG002|Phase 2|Adverse Event|0|||
145515339|NCT00946153|524746916|FG003|Phase 2|Adverse Event|0|||
145515340|NCT00946153|524746917|FG004|Phase 2|Adverse Event|6|||
145515341|NCT00946153|524746913|FG000|Phase 2|Need more reduction of dose|0|||
145515342|NCT00946153|524746914|FG001|Phase 2|Need more reduction of dose|0|||
145515343|NCT00946153|524746915|FG002|Phase 2|Need more reduction of dose|0|||
145515344|NCT00946153|524746916|FG003|Phase 2|Need more reduction of dose|0|||
145515345|NCT00946153|524746917|FG004|Phase 2|Need more reduction of dose|2|||
145515346|NCT00946153|524746913|FG000|Phase 2|Physician Decision|0|||
145515347|NCT00946153|524746914|FG001|Phase 2|Physician Decision|0|||
145515348|NCT00946153|524746915|FG002|Phase 2|Physician Decision|0|||
145515349|NCT00946153|524746916|FG003|Phase 2|Physician Decision|0|||
145515350|NCT00946153|524746917|FG004|Phase 2|Physician Decision|1|||
145515351|NCT00946153|524746913|FG000|Phase 2|14 days washout for recovery due to AE|0|||
145515352|NCT00946153|524746914|FG001|Phase 2|14 days washout for recovery due to AE|0|||
145515353|NCT00946153|524746915|FG002|Phase 2|14 days washout for recovery due to AE|0|||
145515354|NCT00946153|524746916|FG003|Phase 2|14 days washout for recovery due to AE|0|||
145515355|NCT00946153|524746917|FG004|Phase 2|14 days washout for recovery due to AE|4|||
145515356|NCT01699867|524746918|FG000|Overall Study|Screening Failure|3|||
145515357|NCT00530504|524746933|FG000|Overall Study|Death|54|||
145515358|NCT00530504|524746933|FG000|Overall Study|Lost to Follow-up|26|||
145515359|NCT00530504|524746933|FG000|Overall Study|Withdrawal by Subject|39|||
145515360|NCT00530504|524746933|FG000|Overall Study|Exited study due to other reasons|33|||
145515361|NCT00006289|524746934|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
145515362|NCT00006289|524746935|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
145515363|NCT00006289|524746934|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
145515364|NCT00006289|524746935|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
145515365|NCT01675167|524746945|FG000|Open-label Titration Phase|Adverse Event|81|||
145515366|NCT01675167|524746946|FG001|Open-label Titration Phase|Adverse Event|0|||
145515367|NCT01675167|524746947|FG002|Open-label Titration Phase|Adverse Event|0|||
145515368|NCT01675167|524746945|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
145515369|NCT01675167|524746946|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
145515370|NCT01675167|524746947|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
145515371|NCT01675167|524746945|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
145515372|NCT01675167|524746946|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
145515373|NCT01675167|524746947|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
145515374|NCT01675167|524746945|FG000|Open-label Titration Phase|Protocol Violation|43|||
145515375|NCT01675167|524746946|FG001|Open-label Titration Phase|Protocol Violation|0|||
145515376|NCT01675167|524746947|FG002|Open-label Titration Phase|Protocol Violation|0|||
145515377|NCT01675167|524746945|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
145515378|NCT01675167|524746946|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
145515379|NCT01675167|524746947|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
145515380|NCT01675167|524746945|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
145515381|NCT01675167|524746946|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
145515382|NCT01675167|524746947|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
145515383|NCT01675167|524746945|FG000|Open-label Titration Phase|Other|55|||
145515384|NCT01675167|524746946|FG001|Open-label Titration Phase|Other|0|||
145515385|NCT01675167|524746947|FG002|Open-label Titration Phase|Other|0|||
145515386|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
145515387|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
145515388|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
145515389|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145515390|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
145515391|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
145515392|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145515393|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Adverse Event|5|||
145515394|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Adverse Event|13|||
145515395|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
145515396|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
145515397|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
145515398|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145515399|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
145515400|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
145515401|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
145515402|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
145515403|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
145515404|NCT01675167|524746945|FG000|Double-blind Treatment Phase|Other|0|||
145515405|NCT01675167|524746946|FG001|Double-blind Treatment Phase|Other|7|||
145515406|NCT01675167|524746947|FG002|Double-blind Treatment Phase|Other|5|||
145515407|NCT03255083|524746948|FG000|Overall Study|Clinical progression|1|||
145515408|NCT03255083|524746949|FG001|Overall Study|Clinical progression|0|||
145515409|NCT03255083|524746950|FG002|Overall Study|Clinical progression|0|||
145515410|NCT03255083|524746951|FG003|Overall Study|Clinical progression|0|||
145515411|NCT03255083|524746948|FG000|Overall Study|Adverse Event|0|||
145515412|NCT03255083|524746949|FG001|Overall Study|Adverse Event|1|||
145515413|NCT03255083|524746950|FG002|Overall Study|Adverse Event|0|||
145515414|NCT03255083|524746951|FG003|Overall Study|Adverse Event|0|||
145515415|NCT03255083|524746948|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
145515416|NCT03255083|524746949|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
145515417|NCT03255083|524746950|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
145515418|NCT03255083|524746951|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
145515419|NCT03255083|524746948|FG000|Overall Study|Withdrawal by Subject|1|||
145515420|NCT03255083|524746949|FG001|Overall Study|Withdrawal by Subject|1|||
145515421|NCT03255083|524746950|FG002|Overall Study|Withdrawal by Subject|1|||
145515422|NCT03255083|524746951|FG003|Overall Study|Withdrawal by Subject|0|||
145515423|NCT00363545|524746952|FG000|Overall Study|Serious Adverse Event|0|||
145515424|NCT00363545|524746953|FG001|Overall Study|Serious Adverse Event|1|||
145515425|NCT00363545|524746952|FG000|Overall Study|Withdrawal by Subject|12|||
145515426|NCT00363545|524746953|FG001|Overall Study|Withdrawal by Subject|15|||
145515427|NCT00363545|524746952|FG000|Overall Study|Migrated/moved from study area|3|||
145515428|NCT00363545|524746953|FG001|Overall Study|Migrated/moved from study area|6|||
145515429|NCT00363545|524746952|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
145515430|NCT00363545|524746953|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
145515431|NCT00363545|524746952|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
145515432|NCT00363545|524746953|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
145515433|NCT00363545|524746952|FG000|Overall Study|Others|1|||
145515434|NCT00363545|524746953|FG001|Overall Study|Others|0|||
145515435|NCT01457352|524746954|FG000|Period 1|Adverse Event|2|||
145515436|NCT01457352|524746955|FG001|Period 1|Adverse Event|0|||
145515437|NCT01457352|524746954|FG000|Period 1|Withdrawal by Subject|2|||
145515438|NCT01457352|524746955|FG001|Period 1|Withdrawal by Subject|0|||
145515439|NCT01457352|524746954|FG000|Period 1|Physician Decision|2|||
145515440|NCT01457352|524746955|FG001|Period 1|Physician Decision|0|||
145515441|NCT01457352|524746954|FG000|Period 1|MS related disease progression|1|||
145515442|NCT01457352|524746955|FG001|Period 1|MS related disease progression|0|||
145515443|NCT01457352|524746954|FG000|Period 1|Withdrawn|1|||
145515444|NCT01457352|524746955|FG001|Period 1|Withdrawn|0|||
145515445|NCT01457352|524746954|FG000|Period 1|withdrew per sponsor|1|||
145515446|NCT01457352|524746955|FG001|Period 1|withdrew per sponsor|0|||
145515447|NCT01457352|524746954|FG000|Period 1|Protocol Violation|4|||
145515448|NCT01457352|524746955|FG001|Period 1|Protocol Violation|0|||
145515449|NCT01457352|524746954|FG000|Period 1|Did not meet eligibility criteria|3|||
145515450|NCT01457352|524746955|FG001|Period 1|Did not meet eligibility criteria|0|||
145515451|NCT01457352|524746954|FG000|Period 2|Withdrawal by Subject|23|||
145515452|NCT01457352|524746955|FG001|Period 2|Withdrawal by Subject|0|||
145515453|NCT01457352|524746954|FG000|Period 2|Adverse Event|22|||
145515454|NCT01457352|524746955|FG001|Period 2|Adverse Event|0|||
145515455|NCT01457352|524746954|FG000|Period 2|no analysis|10|||
145515456|NCT01457352|524746955|FG001|Period 2|no analysis|0|||
145515457|NCT01457352|524746954|FG000|Period 2|Lack of Efficacy|8|||
145515458|NCT01457352|524746955|FG001|Period 2|Lack of Efficacy|0|||
145515459|NCT01457352|524746954|FG000|Period 2|Protocol Violation|4|||
145515460|NCT01457352|524746955|FG001|Period 2|Protocol Violation|0|||
145515461|NCT01457352|524746954|FG000|Period 2|Sponsor's withdrawal|7|||
145515462|NCT01457352|524746955|FG001|Period 2|Sponsor's withdrawal|0|||
145515463|NCT01457352|524746954|FG000|Period 2|Lost to Follow-up|1|||
145515464|NCT01457352|524746955|FG001|Period 2|Lost to Follow-up|0|||
145515465|NCT01457352|524746954|FG000|Period 2|dose change|1|||
145402216|NCT00750269|524330678|FG001|Overall Study|Withdrawal by Subject|0|||
145515466|NCT01457352|524746955|FG001|Period 2|dose change|0|||
145515467|NCT01457352|524746954|FG000|Period 2|Physician Decision|1|||
145515468|NCT01457352|524746955|FG001|Period 2|Physician Decision|0|||
145515469|NCT01457352|524746954|FG000|Period 2|Did not meet eligibility criteria|3|||
145515470|NCT01457352|524746955|FG001|Period 2|Did not meet eligibility criteria|0|||
145515471|NCT01457352|524746954|FG000|Period 3|Adverse Event|1|||
145515472|NCT01457352|524746955|FG001|Period 3|Adverse Event|1|||
145515473|NCT01457352|524746954|FG000|Period 3|Withdrawal by Subject|0|||
145515474|NCT01457352|524746955|FG001|Period 3|Withdrawal by Subject|2|||
145515475|NCT01457352|524746954|FG000|Period 3|incorrect treatment|0|||
145515476|NCT01457352|524746955|FG001|Period 3|incorrect treatment|1|||
145515477|NCT01457352|524746954|FG000|Period 3|Sponsor's withdrawal|0|||
145515478|NCT01457352|524746955|FG001|Period 3|Sponsor's withdrawal|1|||
145515479|NCT03952039|524746956|FG000|Overall Study|Adverse Event|22|||
145515480|NCT03952039|524746957|FG001|Overall Study|Adverse Event|8|||
145515481|NCT03952039|524746956|FG000|Overall Study|Withdrawal by Participant|17|||
145515482|NCT03952039|524746957|FG001|Overall Study|Withdrawal by Participant|12|||
145515483|NCT03952039|524746956|FG000|Overall Study|Death|13|||
145515484|NCT03952039|524746957|FG001|Overall Study|Death|6|||
145515485|NCT03952039|524746956|FG000|Overall Study|Lack of Efficacy|12|||
145515486|NCT03952039|524746957|FG001|Overall Study|Lack of Efficacy|2|||
145515487|NCT03952039|524746956|FG000|Overall Study|Physician Decision|9|||
145515488|NCT03952039|524746957|FG001|Overall Study|Physician Decision|3|||
145515489|NCT03952039|524746956|FG000|Overall Study|Progressive Disease|6|||
145515490|NCT03952039|524746957|FG001|Overall Study|Progressive Disease|4|||
145515491|NCT03952039|524746956|FG000|Overall Study|Other Reasons|12|||
145515492|NCT03952039|524746957|FG001|Overall Study|Other Reasons|4|||
145515493|NCT05009979|524746958|FG000|Overall Study|Withdrawal by Subject|1|||
145515494|NCT04174365|524746959|FG000|Overall Study|Lost to Follow-up|1|||
145515495|NCT04174365|524746960|FG001|Overall Study|Lost to Follow-up|2|||
145515496|NCT04174365|524746959|FG000|Overall Study|Adverse Event|2|||
145515497|NCT04174365|524746960|FG001|Overall Study|Adverse Event|1|||
145515498|NCT04174365|524746959|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
145515499|NCT04174365|524746960|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
145515500|NCT04174365|524746959|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
145515501|NCT04174365|524746960|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
145515502|NCT04174365|524746959|FG000|Overall Study|Protocol Deviation|1|||
145515503|NCT04174365|524746960|FG001|Overall Study|Protocol Deviation|0|||
145515504|NCT04174365|524746959|FG000|Overall Study|Lack of Efficacy|0|||
145515505|NCT04174365|524746960|FG001|Overall Study|Lack of Efficacy|2|||
145515506|NCT04174365|524746959|FG000|Overall Study|Disease Relapse|1|||
145515507|NCT04174365|524746960|FG001|Overall Study|Disease Relapse|0|||
145515508|NCT04174365|524746959|FG000|Overall Study|Reason Not Specified|0|||
145515509|NCT04174365|524746960|FG001|Overall Study|Reason Not Specified|1|||
145515510|NCT03472547|524746961|FG000|Overall Study|Withdrawal by Subject|30|||
145515511|NCT01325337|524748546|FG000|Overall Study|Adverse Event|0|||
145515512|NCT01325337|524748547|FG001|Overall Study|Adverse Event|2|||
145515513|NCT01325337|524748548|FG002|Overall Study|Adverse Event|2|||
145515514|NCT01325337|524748549|FG003|Overall Study|Adverse Event|1|||
145515515|NCT01325337|524748550|FG004|Overall Study|Adverse Event|2|||
145515516|NCT01325337|524748546|FG000|Overall Study|Lost to Follow-up|2|||
145515517|NCT01325337|524748547|FG001|Overall Study|Lost to Follow-up|2|||
145515518|NCT01325337|524748548|FG002|Overall Study|Lost to Follow-up|2|||
145515519|NCT01325337|524748549|FG003|Overall Study|Lost to Follow-up|1|||
145515520|NCT01325337|524748550|FG004|Overall Study|Lost to Follow-up|2|||
145515521|NCT01325337|524748546|FG000|Overall Study|Personal Reasons|2|||
145515522|NCT01325337|524748547|FG001|Overall Study|Personal Reasons|5|||
145515523|NCT01325337|524748548|FG002|Overall Study|Personal Reasons|4|||
145515524|NCT01325337|524748549|FG003|Overall Study|Personal Reasons|8|||
145515525|NCT01325337|524748550|FG004|Overall Study|Personal Reasons|3|||
145515526|NCT01325337|524748546|FG000|Overall Study|Withdrawal by Subject|1|||
145515527|NCT01325337|524748547|FG001|Overall Study|Withdrawal by Subject|0|||
145515528|NCT01325337|524748548|FG002|Overall Study|Withdrawal by Subject|1|||
145515529|NCT01325337|524748549|FG003|Overall Study|Withdrawal by Subject|0|||
145515530|NCT01325337|524748550|FG004|Overall Study|Withdrawal by Subject|1|||
145515531|NCT00843778|524748556|FG000|Overall Study|Adverse Event|15|||
145515532|NCT00843778|524748556|FG000|Overall Study|Lack of Efficacy|14|||
145515533|NCT00843778|524748556|FG000|Overall Study|Loss of efficacy|2|||
145515534|NCT00843778|524748556|FG000|Overall Study|Withdrawal by Subject|4|||
145515535|NCT00369629|524748557|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
145515536|NCT00369629|524748558|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
145515537|NCT00369629|524748559|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
145515538|NCT00369629|524748560|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
145515539|NCT00369629|524748557|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
145515540|NCT00369629|524748558|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
145515541|NCT00369629|524748559|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
145515542|NCT00369629|524748560|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
145515543|NCT00369629|524748557|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
145515544|NCT00369629|524748558|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
145515545|NCT00369629|524748559|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
145515546|NCT00369629|524748560|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
145515547|NCT00369629|524748557|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
145515548|NCT00369629|524748558|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
145515549|NCT00369629|524748559|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
145515550|NCT00369629|524748560|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
145515551|NCT00369629|524748557|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
145515552|NCT00369629|524748558|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
145515553|NCT00369629|524748559|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
145515554|NCT00369629|524748560|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
145515555|NCT00369629|524748557|FG000|Completed 4 More Cycles|Progressive disease|2|||
145515556|NCT00369629|524748558|FG001|Completed 4 More Cycles|Progressive disease|1|||
145515557|NCT00369629|524748559|FG002|Completed 4 More Cycles|Progressive disease|2|||
145515558|NCT00369629|524748560|FG003|Completed 4 More Cycles|Progressive disease|0|||
145515559|NCT00369629|524748557|FG000|Follow up for 1 Year|Death|2|||
145515560|NCT00369629|524748558|FG001|Follow up for 1 Year|Death|1|||
145515561|NCT00369629|524748559|FG002|Follow up for 1 Year|Death|1|||
145515562|NCT00369629|524748560|FG003|Follow up for 1 Year|Death|0|||
145515563|NCT00369629|524748557|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
145515564|NCT00369629|524748558|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
145515565|NCT00369629|524748559|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
145515566|NCT00369629|524748560|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
145515567|NCT00369629|524748557|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
145515568|NCT00369629|524748558|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
145515569|NCT00369629|524748559|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
145515570|NCT00369629|524748560|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
145515571|NCT02600871|524748561|FG000|Overall Study|Lost to Follow-up|13|||
145515572|NCT02600871|524748562|FG001|Overall Study|Lost to Follow-up|10|||
145515573|NCT03338959|524748563|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
145515574|NCT03338959|524748563|FG000|Overall Study|Physician Decision|1|||
145515575|NCT01604278|524748568|FG000|Overall Study|Lack of Efficacy|0|||
145515576|NCT01604278|524748569|FG001|Overall Study|Lack of Efficacy|1|||
145515577|NCT01604278|524748568|FG000|Overall Study|Lost to Follow-up|1|||
145515578|NCT01604278|524748569|FG001|Overall Study|Lost to Follow-up|0|||
145515579|NCT01604278|524748568|FG000|Overall Study|Administrative problems|2|||
145515580|NCT01604278|524748569|FG001|Overall Study|Administrative problems|1|||
145515581|NCT01604278|524748568|FG000|Overall Study|Withdrawal by Subject|3|||
145515582|NCT01604278|524748569|FG001|Overall Study|Withdrawal by Subject|3|||
145515583|NCT01604278|524748568|FG000|Overall Study|Adverse Event|3|||
145515584|NCT01604278|524748569|FG001|Overall Study|Adverse Event|5|||
145515585|NCT01604278|524748568|FG000|Overall Study|Protocol Deviation|5|||
145515586|NCT01604278|524748569|FG001|Overall Study|Protocol Deviation|3|||
145515587|NCT00409331|524748570|FG000|Overall Study|Physician Decision|1|||
145515588|NCT02184455|524748571|FG000|Overall Study|Lost to Follow-up|1|||
145515589|NCT00730028|524748576|FG000|Overall Study|Adverse Event|23|||
145515590|NCT00730028|524748577|FG001|Overall Study|Adverse Event|26|||
145515591|NCT00730028|524748578|FG002|Overall Study|Adverse Event|16|||
145515592|NCT00730028|524748579|FG003|Overall Study|Adverse Event|20|||
145515593|NCT00730028|524748580|FG004|Overall Study|Adverse Event|43|||
145515594|NCT00730028|524748576|FG000|Overall Study|Lost to Follow-up|13|||
145515595|NCT00730028|524748577|FG001|Overall Study|Lost to Follow-up|26|||
145515596|NCT00730028|524748578|FG002|Overall Study|Lost to Follow-up|22|||
145515597|NCT00730028|524748579|FG003|Overall Study|Lost to Follow-up|26|||
145515598|NCT00730028|524748580|FG004|Overall Study|Lost to Follow-up|25|||
145515599|NCT00730028|524748576|FG000|Overall Study|Protocol Violation|6|||
145515600|NCT00730028|524748577|FG001|Overall Study|Protocol Violation|1|||
145515601|NCT00730028|524748578|FG002|Overall Study|Protocol Violation|1|||
145515602|NCT00730028|524748579|FG003|Overall Study|Protocol Violation|2|||
145515603|NCT00730028|524748580|FG004|Overall Study|Protocol Violation|0|||
145515604|NCT00730028|524748576|FG000|Overall Study|Withdrawal by Subject|9|||
145515605|NCT00730028|524748577|FG001|Overall Study|Withdrawal by Subject|5|||
145515606|NCT00730028|524748578|FG002|Overall Study|Withdrawal by Subject|4|||
145515607|NCT00730028|524748579|FG003|Overall Study|Withdrawal by Subject|5|||
145515608|NCT00730028|524748580|FG004|Overall Study|Withdrawal by Subject|9|||
145515609|NCT00730028|524748576|FG000|Overall Study|Physician Decision|3|||
145515610|NCT00730028|524748577|FG001|Overall Study|Physician Decision|3|||
145515611|NCT00730028|524748578|FG002|Overall Study|Physician Decision|2|||
145515612|NCT00730028|524748579|FG003|Overall Study|Physician Decision|3|||
145515613|NCT00730028|524748580|FG004|Overall Study|Physician Decision|2|||
145515614|NCT00730028|524748576|FG000|Overall Study|Treatment Failure|5|||
145515615|NCT00730028|524748577|FG001|Overall Study|Treatment Failure|5|||
145515616|NCT00730028|524748578|FG002|Overall Study|Treatment Failure|0|||
145515617|NCT00730028|524748579|FG003|Overall Study|Treatment Failure|0|||
145515618|NCT00730028|524748580|FG004|Overall Study|Treatment Failure|1|||
145515619|NCT00730028|524748576|FG000|Overall Study|Randomization Error|1|||
145515620|NCT00730028|524748577|FG001|Overall Study|Randomization Error|0|||
145515621|NCT00730028|524748578|FG002|Overall Study|Randomization Error|0|||
145515622|NCT00730028|524748579|FG003|Overall Study|Randomization Error|0|||
145733843|NCT01968070|525543374|FG011|Period 1|Lost to Follow-up|0|||
145733844|NCT01968070|525543375|FG012|Period 1|Lost to Follow-up|0|||
145733845|NCT01968070|525543376|FG013|Period 1|Lost to Follow-up|0|||
145515623|NCT00730028|524748580|FG004|Overall Study|Randomization Error|2|||
145515624|NCT00874939|524748581|FG000|Overall Study|Study terminated|4|||
145515625|NCT02870933|524748582|FG000|Overall Study|Death|2|||
145515626|NCT02870933|524748583|FG001|Overall Study|Death|1|||
145515627|NCT02870933|524748582|FG000|Overall Study|Withdrawal by Subject|0|||
145515628|NCT02870933|524748583|FG001|Overall Study|Withdrawal by Subject|1|||
145515629|NCT01250496|524748586|FG000|Overall Study|Study terminated|124|||
145515630|NCT01250496|524748587|FG001|Overall Study|Study terminated|124|||
145515631|NCT00003590|524748588|FG000|Overall Study|Ineligible Patient|1|||
145515632|NCT00003590|524748588|FG000|Overall Study|Adverse Event|7|||
145515633|NCT00003590|524748588|FG000|Overall Study|Withdrawal by Subject|1|||
145733846|NCT01968070|525543377|FG014|Period 1|Lost to Follow-up|0|||
145515634|NCT00003590|524748588|FG000|Overall Study|Lack of Efficacy|11|||
145515635|NCT00003590|524748588|FG000|Overall Study|Death|1|||
145515636|NCT00003590|524748588|FG000|Overall Study|Physician Decision|1|||
145515637|NCT01425463|524748594|FG000|Overall Study|Adverse Event|5|||
145515638|NCT01425463|524748595|FG001|Overall Study|Adverse Event|7|||
145515639|NCT01425463|524748594|FG000|Overall Study|Lack of Efficacy|1|||
145515640|NCT01425463|524748595|FG001|Overall Study|Lack of Efficacy|1|||
145515641|NCT01425463|524748594|FG000|Overall Study|Protocol Violation|2|||
145515642|NCT01425463|524748595|FG001|Overall Study|Protocol Violation|2|||
145515643|NCT01425463|524748594|FG000|Overall Study|Lost to Follow-up|5|||
145515644|NCT01425463|524748595|FG001|Overall Study|Lost to Follow-up|2|||
145515645|NCT01425463|524748594|FG000|Overall Study|Withdrawal by Subject|7|||
145515646|NCT01425463|524748595|FG001|Overall Study|Withdrawal by Subject|5|||
145515647|NCT01425463|524748594|FG000|Overall Study|Unknown Reason|4|||
145515648|NCT01425463|524748595|FG001|Overall Study|Unknown Reason|7|||
145515649|NCT01332799|524748596|FG000|Overall Study|Insufficient funding|10|||
145515650|NCT01332799|524748597|FG001|Overall Study|Insufficient funding|10|||
145515651|NCT00668733|524748598|FG000|Overall Study|Lost to Follow-up|2|||
145515652|NCT00668733|524748599|FG001|Overall Study|Lost to Follow-up|3|||
145515653|NCT00668733|524748598|FG000|Overall Study|Withdrawal by Subject|0|||
145515654|NCT00668733|524748599|FG001|Overall Study|Withdrawal by Subject|4|||
145515655|NCT01909791|524748600|FG000|Overall Study|Death|9|||
145515656|NCT01909791|524748601|FG001|Overall Study|Death|8|||
145515657|NCT01909791|524748602|FG002|Overall Study|Death|4|||
145515658|NCT01909791|524748600|FG000|Overall Study|Withdrawal by Subject|5|||
145515659|NCT01909791|524748601|FG001|Overall Study|Withdrawal by Subject|9|||
145515660|NCT01909791|524748602|FG002|Overall Study|Withdrawal by Subject|13|||
145515661|NCT01909791|524748600|FG000|Overall Study|Lost to Follow-up|5|||
145515662|NCT01909791|524748601|FG001|Overall Study|Lost to Follow-up|11|||
145515663|NCT01909791|524748602|FG002|Overall Study|Lost to Follow-up|10|||
145515664|NCT01909791|524748600|FG000|Overall Study|Missed Visit|2|||
145515665|NCT01909791|524748601|FG001|Overall Study|Missed Visit|0|||
145515666|NCT01909791|524748602|FG002|Overall Study|Missed Visit|1|||
145515667|NCT02168387|524748605|FG000|Overall Study|Planned exubation|6|||
145515668|NCT02168387|524748606|FG001|Overall Study|Planned exubation|3|||
145515669|NCT02168387|524748605|FG000|Overall Study|Death|1|||
145515670|NCT02168387|524748606|FG001|Overall Study|Death|0|||
145515671|NCT01659554|524748607|FG000|Overall Study|Study Termination|4|||
145515672|NCT00640224|524748614|FG000|Overall Study|Lost to Follow-up|5|||
145515673|NCT00640224|524748615|FG001|Overall Study|Lost to Follow-up|2|||
145515674|NCT00640224|524748616|FG002|Overall Study|Lost to Follow-up|0|||
145515675|NCT00640224|524748617|FG003|Overall Study|Lost to Follow-up|0|||
145515676|NCT00640224|524748614|FG000|Overall Study|Withdrawal by Subject|1|||
145515677|NCT00640224|524748615|FG001|Overall Study|Withdrawal by Subject|0|||
145515678|NCT00640224|524748616|FG002|Overall Study|Withdrawal by Subject|0|||
145515679|NCT00640224|524748617|FG003|Overall Study|Withdrawal by Subject|0|||
145515680|NCT00640224|524748614|FG000|Overall Study|Headaches|0|||
145515681|NCT00640224|524748615|FG001|Overall Study|Headaches|1|||
145515682|NCT00640224|524748616|FG002|Overall Study|Headaches|0|||
145515683|NCT00640224|524748617|FG003|Overall Study|Headaches|0|||
145515684|NCT00422513|524748618|FG000|Overall Study|Lack of Efficacy|4|||
145515685|NCT00422513|524748619|FG001|Overall Study|Lack of Efficacy|5|||
145515686|NCT00422513|524748618|FG000|Overall Study|Protocol Violation|23|||
145515687|NCT00422513|524748619|FG001|Overall Study|Protocol Violation|7|||
145515688|NCT00422513|524748618|FG000|Overall Study|Refused Treatment|4|||
145515689|NCT00422513|524748619|FG001|Overall Study|Refused Treatment|2|||
145515690|NCT00422513|524748618|FG000|Overall Study|Withdrawal by Subject|2|||
145515691|NCT00422513|524748619|FG001|Overall Study|Withdrawal by Subject|1|||
145515692|NCT00422513|524748618|FG000|Overall Study|early termination of the study|67|||
145515693|NCT00422513|524748619|FG001|Overall Study|early termination of the study|80|||
145515694|NCT00422513|524748618|FG000|Overall Study|Adverse Event|4|||
145515695|NCT00422513|524748619|FG001|Overall Study|Adverse Event|4|||
145515696|NCT00422513|524748618|FG000|Overall Study|Death|3|||
145515697|NCT00422513|524748619|FG001|Overall Study|Death|7|||
145515698|NCT01445548|524748620|FG000|Overall Study|Adverse Event|1|||
145515699|NCT03642132|524748621|FG000|Chemotherapy Period|Adverse Event|1|||
145515700|NCT03642132|524748622|FG001|Chemotherapy Period|Adverse Event|1|||
145515701|NCT03642132|524748623|FG002|Chemotherapy Period|Adverse Event|0|||
145515702|NCT03642132|524748621|FG000|Chemotherapy Period|Physician's decision|4|||
145515703|NCT03642132|524748622|FG001|Chemotherapy Period|Physician's decision|1|||
145515704|NCT03642132|524748623|FG002|Chemotherapy Period|Physician's decision|0|||
145515705|NCT03642132|524748621|FG000|Chemotherapy Period|Progressive disease|0|||
145515706|NCT03642132|524748622|FG001|Chemotherapy Period|Progressive disease|0|||
145515707|NCT03642132|524748623|FG002|Chemotherapy Period|Progressive disease|1|||
145515708|NCT03642132|524748621|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
145515709|NCT03642132|524748622|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
145515710|NCT03642132|524748623|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
145515711|NCT03642132|524748621|FG000|Chemotherapy Period|Other|1|||
145515712|NCT03642132|524748622|FG001|Chemotherapy Period|Other|0|||
145515713|NCT03642132|524748623|FG002|Chemotherapy Period|Other|2|||
145515714|NCT03642132|524748621|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
145515715|NCT03642132|524748622|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
145515716|NCT03642132|524748623|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
145515717|NCT03642132|524748621|FG000|Maintenance Period|Adverse Event|1|||
145515718|NCT03642132|524748622|FG001|Maintenance Period|Adverse Event|2|||
145515719|NCT03642132|524748623|FG002|Maintenance Period|Adverse Event|0|||
145515720|NCT03642132|524748621|FG000|Maintenance Period|Non-compliance with study drug|0|||
145515721|NCT03642132|524748622|FG001|Maintenance Period|Non-compliance with study drug|0|||
145515722|NCT03642132|524748623|FG002|Maintenance Period|Non-compliance with study drug|1|||
145515723|NCT03642132|524748621|FG000|Maintenance Period|Physician's decision|2|||
145515724|NCT03642132|524748622|FG001|Maintenance Period|Physician's decision|2|||
145515725|NCT03642132|524748623|FG002|Maintenance Period|Physician's decision|2|||
145515726|NCT03642132|524748621|FG000|Maintenance Period|Progressive disease|9|||
145515727|NCT03642132|524748622|FG001|Maintenance Period|Progressive disease|3|||
145515728|NCT03642132|524748623|FG002|Maintenance Period|Progressive disease|6|||
145515729|NCT03642132|524748621|FG000|Maintenance Period|Other|0|||
145515730|NCT03642132|524748622|FG001|Maintenance Period|Other|0|||
145515731|NCT03642132|524748623|FG002|Maintenance Period|Other|3|||
145515732|NCT03642132|524748621|FG000|Maintenance Period|Withdrawal by Subject|1|||
145515733|NCT03642132|524748622|FG001|Maintenance Period|Withdrawal by Subject|1|||
145515734|NCT03642132|524748623|FG002|Maintenance Period|Withdrawal by Subject|2|||
145515735|NCT03642132|524748621|FG000|Follow-up Period|Other|0|||
145515736|NCT03642132|524748622|FG001|Follow-up Period|Other|0|||
145733847|NCT01968070|525543378|FG015|Period 1|Lost to Follow-up|0|||
145402217|NCT00750269|524330679|FG002|Overall Study|Withdrawal by Subject|2|||
145515737|NCT03642132|524748623|FG002|Follow-up Period|Other|1|||
145515738|NCT03642132|524748621|FG000|Follow-up Period|Withdrawal by Subject|1|||
145733848|NCT01968070|525543379|FG016|Period 1|Lost to Follow-up|0|||
145515739|NCT03642132|524748622|FG001|Follow-up Period|Withdrawal by Subject|2|||
145515740|NCT03642132|524748623|FG002|Follow-up Period|Withdrawal by Subject|0|||
145515741|NCT03642132|524748621|FG000|Follow-up Period|Study terminated by sponsor|1|||
145515742|NCT03642132|524748622|FG001|Follow-up Period|Study terminated by sponsor|0|||
145515743|NCT03642132|524748623|FG002|Follow-up Period|Study terminated by sponsor|1|||
145515744|NCT03642132|524748621|FG000|Follow-up Period|Lack of Efficacy|1|||
145515745|NCT03642132|524748622|FG001|Follow-up Period|Lack of Efficacy|0|||
145515746|NCT03642132|524748623|FG002|Follow-up Period|Lack of Efficacy|0|||
145515747|NCT03642132|524748621|FG000|Follow-up Period|Death|1|||
145515748|NCT03642132|524748622|FG001|Follow-up Period|Death|0|||
145515749|NCT03642132|524748623|FG002|Follow-up Period|Death|2|||
145515750|NCT03642132|524748621|FG000|Follow-up Period|Adverse Event|1|||
145515751|NCT03642132|524748622|FG001|Follow-up Period|Adverse Event|0|||
145733849|NCT01968070|525543380|FG017|Period 1|Lost to Follow-up|0|||
145515752|NCT03642132|524748623|FG002|Follow-up Period|Adverse Event|0|||
145515753|NCT02577887|524748625|FG000|Overall Study|Death|93|||
145515754|NCT02577887|524748625|FG000|Overall Study|Protocol Violation|125|||
145515755|NCT02577887|524748625|FG000|Overall Study|Withdrawal by Subject|80|||
145515756|NCT00913458|524748626|FG000|Phase 1|Non-Responder|54|||
145515757|NCT00913458|524748627|FG001|Phase 1|Non-Responder|0|||
145515758|NCT00913458|524748628|FG002|Phase 1|Non-Responder|0|||
145515759|NCT00913458|524748629|FG003|Phase 1|Non-Responder|0|||
145515760|NCT00913458|524748630|FG004|Phase 1|Non-Responder|0|||
145515761|NCT00913458|524748631|FG005|Phase 1|Non-Responder|0|||
145515762|NCT00913458|524748632|FG006|Phase 1|Non-Responder|0|||
145515763|NCT00913458|524748626|FG000|Phase 1|Subject Request|17|||
145515764|NCT00913458|524748627|FG001|Phase 1|Subject Request|0|||
145515765|NCT00913458|524748628|FG002|Phase 1|Subject Request|0|||
145515766|NCT00913458|524748629|FG003|Phase 1|Subject Request|0|||
145515767|NCT00913458|524748630|FG004|Phase 1|Subject Request|0|||
145515768|NCT00913458|524748631|FG005|Phase 1|Subject Request|0|||
145515769|NCT00913458|524748632|FG006|Phase 1|Subject Request|0|||
145515770|NCT00913458|524748626|FG000|Phase 1|Adverse Event|20|||
145515771|NCT00913458|524748627|FG001|Phase 1|Adverse Event|0|||
145515772|NCT00913458|524748628|FG002|Phase 1|Adverse Event|0|||
145515773|NCT00913458|524748629|FG003|Phase 1|Adverse Event|0|||
145515774|NCT00913458|524748630|FG004|Phase 1|Adverse Event|0|||
145515775|NCT00913458|524748631|FG005|Phase 1|Adverse Event|0|||
145515776|NCT00913458|524748632|FG006|Phase 1|Adverse Event|0|||
145515777|NCT00913458|524748626|FG000|Phase 1|Lost to Follow-up|2|||
145515778|NCT00913458|524748627|FG001|Phase 1|Lost to Follow-up|0|||
145515779|NCT00913458|524748628|FG002|Phase 1|Lost to Follow-up|0|||
145515780|NCT00913458|524748629|FG003|Phase 1|Lost to Follow-up|0|||
145515781|NCT00913458|524748630|FG004|Phase 1|Lost to Follow-up|0|||
145515782|NCT00913458|524748631|FG005|Phase 1|Lost to Follow-up|0|||
145515783|NCT00913458|524748632|FG006|Phase 1|Lost to Follow-up|0|||
145515784|NCT00913458|524748626|FG000|Phase 1|Protocol Violation|10|||
145515785|NCT00913458|524748627|FG001|Phase 1|Protocol Violation|0|||
145515786|NCT00913458|524748628|FG002|Phase 1|Protocol Violation|0|||
145515787|NCT00913458|524748629|FG003|Phase 1|Protocol Violation|0|||
145515788|NCT00913458|524748630|FG004|Phase 1|Protocol Violation|0|||
145515789|NCT00913458|524748631|FG005|Phase 1|Protocol Violation|0|||
145515790|NCT00913458|524748632|FG006|Phase 1|Protocol Violation|0|||
145515791|NCT00913458|524748626|FG000|Phase 1|Sponsor|2|||
145515792|NCT00913458|524748627|FG001|Phase 1|Sponsor|0|||
145515793|NCT00913458|524748628|FG002|Phase 1|Sponsor|0|||
145515794|NCT00913458|524748629|FG003|Phase 1|Sponsor|0|||
145515795|NCT00913458|524748630|FG004|Phase 1|Sponsor|0|||
145515796|NCT00913458|524748631|FG005|Phase 1|Sponsor|0|||
145515797|NCT00913458|524748632|FG006|Phase 1|Sponsor|0|||
145515798|NCT00913458|524748626|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
145515799|NCT00913458|524748627|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
145515800|NCT00913458|524748628|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
145515801|NCT00913458|524748629|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
145515802|NCT00913458|524748630|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
145515803|NCT00913458|524748631|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
145515804|NCT00913458|524748632|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
145515805|NCT00913458|524748626|FG000|Phase 2|Non-Responder|0|||
145515806|NCT00913458|524748627|FG001|Phase 2|Non-Responder|5|||
145515807|NCT00913458|524748628|FG002|Phase 2|Non-Responder|7|||
145515808|NCT00913458|524748629|FG003|Phase 2|Non-Responder|12|||
145515809|NCT00913458|524748630|FG004|Phase 2|Non-Responder|0|||
145515810|NCT00913458|524748631|FG005|Phase 2|Non-Responder|0|||
145515811|NCT00913458|524748632|FG006|Phase 2|Non-Responder|0|||
145515812|NCT00913458|524748626|FG000|Phase 2|Subject Request|0|||
145515813|NCT00913458|524748627|FG001|Phase 2|Subject Request|0|||
145515814|NCT00913458|524748628|FG002|Phase 2|Subject Request|1|||
145515815|NCT00913458|524748629|FG003|Phase 2|Subject Request|2|||
145515816|NCT00913458|524748630|FG004|Phase 2|Subject Request|0|||
145515817|NCT00913458|524748631|FG005|Phase 2|Subject Request|0|||
145515818|NCT00913458|524748632|FG006|Phase 2|Subject Request|0|||
145515819|NCT00913458|524748626|FG000|Phase 2|Adverse Event|0|||
145515820|NCT00913458|524748627|FG001|Phase 2|Adverse Event|3|||
145515821|NCT00913458|524748628|FG002|Phase 2|Adverse Event|0|||
145515822|NCT00913458|524748629|FG003|Phase 2|Adverse Event|1|||
145515823|NCT00913458|524748630|FG004|Phase 2|Adverse Event|0|||
145515824|NCT00913458|524748631|FG005|Phase 2|Adverse Event|0|||
145515825|NCT00913458|524748632|FG006|Phase 2|Adverse Event|0|||
145515826|NCT00913458|524748626|FG000|Phase 2|Lost to Follow-up|0|||
145515827|NCT00913458|524748627|FG001|Phase 2|Lost to Follow-up|0|||
145515828|NCT00913458|524748628|FG002|Phase 2|Lost to Follow-up|0|||
145515829|NCT00913458|524748629|FG003|Phase 2|Lost to Follow-up|1|||
145515830|NCT00913458|524748630|FG004|Phase 2|Lost to Follow-up|0|||
145515831|NCT00913458|524748631|FG005|Phase 2|Lost to Follow-up|0|||
145515832|NCT00913458|524748632|FG006|Phase 2|Lost to Follow-up|0|||
145515833|NCT00913458|524748626|FG000|Phase 2|Protocol Violation|0|||
145515834|NCT00913458|524748627|FG001|Phase 2|Protocol Violation|2|||
145515835|NCT00913458|524748628|FG002|Phase 2|Protocol Violation|0|||
145515836|NCT00913458|524748629|FG003|Phase 2|Protocol Violation|0|||
145515837|NCT00913458|524748630|FG004|Phase 2|Protocol Violation|0|||
145515838|NCT00913458|524748631|FG005|Phase 2|Protocol Violation|0|||
145515839|NCT00913458|524748632|FG006|Phase 2|Protocol Violation|0|||
145515840|NCT00913458|524748626|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
145515841|NCT00913458|524748627|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
145515842|NCT00913458|524748628|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
145515843|NCT00913458|524748629|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
145515844|NCT00913458|524748630|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
145515845|NCT00913458|524748631|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
145515846|NCT00913458|524748632|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
145515847|NCT00913458|524748626|FG000|Phase 3|Adverse Event|0|||
145515848|NCT00913458|524748627|FG001|Phase 3|Adverse Event|0|||
145515849|NCT00913458|524748628|FG002|Phase 3|Adverse Event|0|||
145515850|NCT00913458|524748629|FG003|Phase 3|Adverse Event|0|||
145515851|NCT00913458|524748630|FG004|Phase 3|Adverse Event|5|||
145515852|NCT00913458|524748631|FG005|Phase 3|Adverse Event|4|||
145515853|NCT00913458|524748632|FG006|Phase 3|Adverse Event|1|||
145515854|NCT00913458|524748626|FG000|Phase 3|Lost to Follow-up|0|||
145515855|NCT00913458|524748627|FG001|Phase 3|Lost to Follow-up|0|||
145515856|NCT00913458|524748628|FG002|Phase 3|Lost to Follow-up|0|||
145515857|NCT00913458|524748629|FG003|Phase 3|Lost to Follow-up|0|||
145515858|NCT00913458|524748630|FG004|Phase 3|Lost to Follow-up|2|||
145515859|NCT00913458|524748631|FG005|Phase 3|Lost to Follow-up|0|||
145515860|NCT00913458|524748632|FG006|Phase 3|Lost to Follow-up|0|||
145515861|NCT00913458|524748626|FG000|Phase 3|Non-Responder|0|||
145515862|NCT00913458|524748627|FG001|Phase 3|Non-Responder|0|||
145515863|NCT00913458|524748628|FG002|Phase 3|Non-Responder|0|||
145515864|NCT00913458|524748629|FG003|Phase 3|Non-Responder|0|||
145515865|NCT00913458|524748630|FG004|Phase 3|Non-Responder|0|||
145515866|NCT00913458|524748631|FG005|Phase 3|Non-Responder|1|||
145515867|NCT00913458|524748632|FG006|Phase 3|Non-Responder|3|||
145515868|NCT00913458|524748626|FG000|Phase 3|Withdrawal by Subject|0|||
145515869|NCT00913458|524748627|FG001|Phase 3|Withdrawal by Subject|0|||
145515870|NCT00913458|524748628|FG002|Phase 3|Withdrawal by Subject|0|||
145515871|NCT00913458|524748629|FG003|Phase 3|Withdrawal by Subject|0|||
145515872|NCT00913458|524748630|FG004|Phase 3|Withdrawal by Subject|1|||
145515873|NCT00913458|524748631|FG005|Phase 3|Withdrawal by Subject|2|||
145515874|NCT00913458|524748632|FG006|Phase 3|Withdrawal by Subject|0|||
145515875|NCT00913458|524748626|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
145515876|NCT00913458|524748627|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
145515877|NCT00913458|524748628|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
145515878|NCT00913458|524748629|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
145515879|NCT00913458|524748630|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
145515880|NCT00913458|524748631|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
145515881|NCT00913458|524748632|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
145515882|NCT02279407|524748633|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
145515883|NCT02279407|524748634|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
145515884|NCT02279407|524748635|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
145515885|NCT02279407|524748636|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
145515886|NCT02279407|524748633|FG000|Overall Study|Withdrawal by Subject|1|||
145515887|NCT02279407|524748634|FG001|Overall Study|Withdrawal by Subject|0|||
145515888|NCT02279407|524748635|FG002|Overall Study|Withdrawal by Subject|1|||
145515889|NCT02279407|524748636|FG003|Overall Study|Withdrawal by Subject|1|||
145515890|NCT02279407|524748633|FG000|Overall Study|Adverse Event|1|||
145515891|NCT02279407|524748634|FG001|Overall Study|Adverse Event|1|||
145515892|NCT02279407|524748635|FG002|Overall Study|Adverse Event|2|||
145515893|NCT02279407|524748636|FG003|Overall Study|Adverse Event|0|||
145515894|NCT02500056|524748637|FG000|Overall Study|Lost to Follow-up|3|||
145515895|NCT02500056|524748638|FG001|Overall Study|Lost to Follow-up|7|||
145515896|NCT02500056|524748637|FG000|Overall Study|Recurrence|1|||
145515897|NCT02500056|524748638|FG001|Overall Study|Recurrence|0|||
145515898|NCT02500056|524748637|FG000|Overall Study|Death|3|||
145515899|NCT02500056|524748638|FG001|Overall Study|Death|1|||
145515900|NCT03890666|524748639|FG000|Overall Study|Withdrawal by Subject|0|||
145515901|NCT03890666|524748640|FG001|Overall Study|Withdrawal by Subject|1|||
145515902|NCT03890666|524748639|FG000|Overall Study|Protocol deviation|1|||
145515903|NCT03890666|524748640|FG001|Overall Study|Protocol deviation|4|||
145515904|NCT03890666|524748639|FG000|Overall Study|Lost to Follow-up|2|||
145515905|NCT03890666|524748640|FG001|Overall Study|Lost to Follow-up|5|||
145515906|NCT03890666|524748639|FG000|Overall Study|Other than specified|1|||
145515907|NCT03890666|524748640|FG001|Overall Study|Other than specified|8|||
145515908|NCT01105065|524748642|FG000|Overall Study|Adverse Event|5|||
145515909|NCT01105065|524748642|FG000|Overall Study|Technical Problems|1|||
145733850|NCT01968070|525543363|FG000|Period 1|Adverse Event|0|||
145266703|NCT04668066|523825237|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266704|NCT04668066|523825238|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266705|NCT04668066|523825239|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266706|NCT04668066|523825240|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266707|NCT04668066|523825241|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266708|NCT04668066|523825242|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266709|NCT04668066|523825243|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266710|NCT04668066|523825244|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266711|NCT04668066|523825245|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266712|NCT04668066|523825246|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266713|NCT04668066|523825247|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266714|NCT04668066|523825248|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
145733851|NCT01968070|525543364|FG001|Period 1|Adverse Event|0|||
145733852|NCT01968070|525543365|FG002|Period 1|Adverse Event|0|||
145266715|NCT04668066|523825249|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
145266716|NCT04668066|523825250|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
145733853|NCT01968070|525543366|FG003|Period 1|Adverse Event|0|||
145733854|NCT01968070|525543367|FG004|Period 1|Adverse Event|0|||
145733855|NCT01968070|525543368|FG005|Period 1|Adverse Event|0|||
145733856|NCT01968070|525543369|FG006|Period 1|Adverse Event|1|||
145402218|NCT00750269|524330680|FG003|Overall Study|Withdrawal by Subject|2|||
145266717|NCT04668066|523825251|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
145733857|NCT01968070|525543370|FG007|Period 1|Adverse Event|0|||
145266718|NCT04668066|523825252|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
145266719|NCT04668066|523825253|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266720|NCT04668066|523825254|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266721|NCT04668066|523825255|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
145266722|NCT04668066|523825237|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145515910|NCT01155011|524748647|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
145733858|NCT01968070|525543371|FG008|Period 1|Adverse Event|0|||
145733859|NCT01968070|525543372|FG009|Period 1|Adverse Event|0|||
145733860|NCT01968070|525543373|FG010|Period 1|Adverse Event|0|||
145733861|NCT01968070|525543374|FG011|Period 1|Adverse Event|0|||
145733862|NCT01968070|525543375|FG012|Period 1|Adverse Event|0|||
145733863|NCT01968070|525543376|FG013|Period 1|Adverse Event|0|||
145733864|NCT01968070|525543377|FG014|Period 1|Adverse Event|0|||
145733865|NCT01968070|525543378|FG015|Period 1|Adverse Event|0|||
145733866|NCT01968070|525543379|FG016|Period 1|Adverse Event|0|||
145733867|NCT01968070|525543380|FG017|Period 1|Adverse Event|0|||
145733868|NCT01968070|525543363|FG000|Period 1|Physician Decision|0|||
145733869|NCT01968070|525543364|FG001|Period 1|Physician Decision|0|||
145733870|NCT01968070|525543365|FG002|Period 1|Physician Decision|0|||
145733871|NCT01968070|525543366|FG003|Period 1|Physician Decision|0|||
145733872|NCT01968070|525543367|FG004|Period 1|Physician Decision|0|||
145733873|NCT01968070|525543368|FG005|Period 1|Physician Decision|0|||
145733874|NCT01968070|525543369|FG006|Period 1|Physician Decision|0|||
145733875|NCT01968070|525543370|FG007|Period 1|Physician Decision|0|||
145733876|NCT01968070|525543371|FG008|Period 1|Physician Decision|0|||
145733877|NCT01968070|525543372|FG009|Period 1|Physician Decision|0|||
145733878|NCT01968070|525543373|FG010|Period 1|Physician Decision|0|||
145733879|NCT01968070|525543374|FG011|Period 1|Physician Decision|1|||
145733880|NCT01968070|525543375|FG012|Period 1|Physician Decision|0|||
145733881|NCT01968070|525543376|FG013|Period 1|Physician Decision|0|||
145733882|NCT01968070|525543377|FG014|Period 1|Physician Decision|0|||
145733883|NCT01968070|525543378|FG015|Period 1|Physician Decision|0|||
145733884|NCT01968070|525543379|FG016|Period 1|Physician Decision|0|||
145733885|NCT01968070|525543380|FG017|Period 1|Physician Decision|0|||
145733886|NCT01968070|525543363|FG000|Period 2|Withdrawal by Subject|0|||
145733887|NCT01968070|525543364|FG001|Period 2|Withdrawal by Subject|0|||
145733888|NCT01968070|525543365|FG002|Period 2|Withdrawal by Subject|0|||
145733889|NCT01968070|525543366|FG003|Period 2|Withdrawal by Subject|0|||
145733890|NCT01968070|525543367|FG004|Period 2|Withdrawal by Subject|1|||
145733891|NCT01968070|525543368|FG005|Period 2|Withdrawal by Subject|0|||
145733892|NCT01968070|525543369|FG006|Period 2|Withdrawal by Subject|0|||
145733893|NCT01968070|525543370|FG007|Period 2|Withdrawal by Subject|0|||
145733894|NCT01968070|525543371|FG008|Period 2|Withdrawal by Subject|0|||
145733895|NCT01968070|525543372|FG009|Period 2|Withdrawal by Subject|0|||
145733896|NCT01968070|525543373|FG010|Period 2|Withdrawal by Subject|0|||
145733897|NCT01968070|525543374|FG011|Period 2|Withdrawal by Subject|0|||
145733898|NCT01968070|525543375|FG012|Period 2|Withdrawal by Subject|0|||
145733899|NCT01968070|525543376|FG013|Period 2|Withdrawal by Subject|0|||
145733900|NCT01968070|525543377|FG014|Period 2|Withdrawal by Subject|0|||
145733901|NCT01968070|525543378|FG015|Period 2|Withdrawal by Subject|0|||
145733902|NCT01968070|525543379|FG016|Period 2|Withdrawal by Subject|0|||
145733903|NCT01968070|525543380|FG017|Period 2|Withdrawal by Subject|0|||
145733904|NCT00890929|525543383|FG000|Overall Study|Death before treatment|2|||
145733905|NCT00890929|525543383|FG000|Overall Study|Withdrawal by Subject|3|||
145733906|NCT00890929|525543383|FG000|Overall Study|Physician Decision|1|||
145733907|NCT00108069|525543384|FG000|Overall Study|Never rec'd study drug|0|||
145733908|NCT00108069|525543385|FG001|Overall Study|Never rec'd study drug|1|||
145733909|NCT00108069|525543384|FG000|Overall Study|Adverse Event|1|||
145733910|NCT00108069|525543385|FG001|Overall Study|Adverse Event|1|||
145733911|NCT00108069|525543384|FG000|Overall Study|Withdrawal by Subject|1|||
145733912|NCT00108069|525543385|FG001|Overall Study|Withdrawal by Subject|0|||
145733913|NCT00108069|525543384|FG000|Overall Study|Death|1|||
145733914|NCT00108069|525543385|FG001|Overall Study|Death|0|||
145266723|NCT04668066|523825238|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266724|NCT04668066|523825239|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266725|NCT04668066|523825240|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266726|NCT04668066|523825241|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266727|NCT04668066|523825242|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266728|NCT04668066|523825243|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266729|NCT04668066|523825244|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266730|NCT04668066|523825245|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266731|NCT04668066|523825246|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266732|NCT04668066|523825247|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266733|NCT04668066|523825248|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266734|NCT04668066|523825249|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266735|NCT04668066|523825250|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266736|NCT04668066|523825251|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266737|NCT04668066|523825252|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266738|NCT04668066|523825253|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266739|NCT04668066|523825254|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
145266740|NCT04668066|523825255|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
145266741|NCT04668066|523825237|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266742|NCT04668066|523825238|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266743|NCT04668066|523825239|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266744|NCT04668066|523825240|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266745|NCT04668066|523825241|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266746|NCT04668066|523825242|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266747|NCT04668066|523825243|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266748|NCT04668066|523825244|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266749|NCT04668066|523825245|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266750|NCT04668066|523825246|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266751|NCT04668066|523825247|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266752|NCT04668066|523825248|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266753|NCT04668066|523825249|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266754|NCT04668066|523825250|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266755|NCT04668066|523825251|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266756|NCT04668066|523825252|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266757|NCT04668066|523825253|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266758|NCT04668066|523825254|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
145266759|NCT04668066|523825255|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
145266760|NCT04668066|523825237|FG000|Part 2: Treatment Phase|Other|0|||
145266761|NCT04668066|523825238|FG001|Part 2: Treatment Phase|Other|0|||
145266762|NCT04668066|523825239|FG002|Part 2: Treatment Phase|Other|0|||
145266763|NCT04668066|523825240|FG003|Part 2: Treatment Phase|Other|0|||
145266764|NCT04668066|523825241|FG004|Part 2: Treatment Phase|Other|0|||
145266765|NCT04668066|523825242|FG005|Part 2: Treatment Phase|Other|0|||
145266766|NCT04668066|523825243|FG006|Part 2: Treatment Phase|Other|0|||
145266767|NCT04668066|523825244|FG007|Part 2: Treatment Phase|Other|0|||
145266768|NCT04668066|523825245|FG008|Part 2: Treatment Phase|Other|0|||
145266769|NCT04668066|523825246|FG009|Part 2: Treatment Phase|Other|0|||
145266770|NCT04668066|523825247|FG010|Part 2: Treatment Phase|Other|0|||
145266771|NCT04668066|523825248|FG011|Part 2: Treatment Phase|Other|0|||
145266772|NCT04668066|523825249|FG012|Part 2: Treatment Phase|Other|0|||
145266773|NCT04668066|523825250|FG013|Part 2: Treatment Phase|Other|0|||
145266774|NCT04668066|523825251|FG014|Part 2: Treatment Phase|Other|0|||
145266775|NCT04668066|523825252|FG015|Part 2: Treatment Phase|Other|0|||
145266776|NCT04668066|523825253|FG016|Part 2: Treatment Phase|Other|0|||
145266777|NCT04668066|523825254|FG017|Part 2: Treatment Phase|Other|0|||
145266778|NCT04668066|523825255|FG018|Part 2: Treatment Phase|Other|1|||
145266779|NCT04668066|523825237|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266780|NCT04668066|523825238|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266781|NCT04668066|523825239|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266782|NCT04668066|523825240|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266783|NCT04668066|523825241|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266784|NCT04668066|523825242|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266785|NCT04668066|523825243|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266786|NCT04668066|523825244|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266787|NCT04668066|523825245|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266788|NCT04668066|523825246|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266789|NCT04668066|523825247|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266790|NCT04668066|523825248|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266791|NCT04668066|523825249|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266792|NCT04668066|523825250|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266793|NCT04668066|523825251|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266794|NCT04668066|523825252|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266795|NCT04668066|523825253|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266796|NCT04668066|523825254|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
145266797|NCT04668066|523825255|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
145266798|NCT02369874|523825256|FG000|Overall Study|Lost to Follow-up|2|||
145266799|NCT02369874|523825257|FG001|Overall Study|Lost to Follow-up|2|||
145266800|NCT02369874|523825258|FG002|Overall Study|Lost to Follow-up|2|||
145266801|NCT02369874|523825256|FG000|Overall Study|Withdrawal by Subject|7|||
145266802|NCT02369874|523825257|FG001|Overall Study|Withdrawal by Subject|9|||
145266803|NCT02369874|523825258|FG002|Overall Study|Withdrawal by Subject|27|||
145266804|NCT02369874|523825256|FG000|Overall Study|Miscellaneous|1|||
145266805|NCT02369874|523825257|FG001|Overall Study|Miscellaneous|1|||
145266806|NCT02369874|523825258|FG002|Overall Study|Miscellaneous|0|||
145266807|NCT02369874|523825256|FG000|Overall Study|On Treatment/Off Study|34|||
145266808|NCT02369874|523825257|FG001|Overall Study|On Treatment/Off Study|45|||
145266809|NCT02369874|523825258|FG002|Overall Study|On Treatment/Off Study|32|||
145402219|NCT00750269|524330681|FG004|Overall Study|Withdrawal by Subject|2|||
145266810|NCT02331680|523825259|FG000|Overall Study|Adverse Event|3|||
145266811|NCT02331680|523825260|FG001|Overall Study|Adverse Event|0|||
145266812|NCT02331680|523825261|FG002|Overall Study|Adverse Event|2|||
145266813|NCT02331680|523825259|FG000|Overall Study|Physician Decision|1|||
145266814|NCT02331680|523825260|FG001|Overall Study|Physician Decision|1|||
145266815|NCT02331680|523825261|FG002|Overall Study|Physician Decision|2|||
145266816|NCT02331680|523825259|FG000|Overall Study|Withdrawal by Subject|0|||
145266817|NCT02331680|523825260|FG001|Overall Study|Withdrawal by Subject|1|||
145266818|NCT02331680|523825261|FG002|Overall Study|Withdrawal by Subject|2|||
145266819|NCT02331680|523825259|FG000|Overall Study|Met withdrawal criteria|2|||
145266820|NCT02331680|523825260|FG001|Overall Study|Met withdrawal criteria|2|||
145266821|NCT02331680|523825261|FG002|Overall Study|Met withdrawal criteria|5|||
145266822|NCT02331680|523825259|FG000|Overall Study|Non-compliance with study drug|0|||
145266823|NCT02331680|523825260|FG001|Overall Study|Non-compliance with study drug|0|||
145266824|NCT02331680|523825261|FG002|Overall Study|Non-compliance with study drug|1|||
145266825|NCT02331680|523825259|FG000|Overall Study|Protocol Violation|0|||
145266826|NCT02331680|523825260|FG001|Overall Study|Protocol Violation|0|||
145266827|NCT02331680|523825261|FG002|Overall Study|Protocol Violation|3|||
145266828|NCT00596466|523825262|FG000|Overall Study|Lack of Efficacy|5|||
145266829|NCT00596466|523825262|FG000|Overall Study|Adverse Event|4|||
145266830|NCT00596466|523825262|FG000|Overall Study|Withdrawal by Subject|2|||
145266831|NCT00596466|523825262|FG000|Overall Study|Protocol Violation|2|||
145266832|NCT00596466|523825262|FG000|Overall Study|Unpecified|2|||
145266833|NCT00596466|523825262|FG000|Overall Study|Enrolled, not treated|2|||
145266834|NCT00145795|523825263|FG000|Overall Study|Adverse Event|1|||
145266835|NCT00145795|523825264|FG001|Overall Study|Adverse Event|0|||
145266836|NCT01891669|523825265|FG000|Overall Study|Death|0|||
145266837|NCT01891669|523825266|FG001|Overall Study|Death|0|||
145266838|NCT01891669|523825267|FG002|Overall Study|Death|0|||
145266839|NCT01891669|523825268|FG003|Overall Study|Death|0|||
145266840|NCT01891669|523825269|FG004|Overall Study|Death|0|||
145266841|NCT01891669|523825270|FG005|Overall Study|Death|0|||
145266842|NCT01891669|523825271|FG006|Overall Study|Death|0|||
145266843|NCT01891669|523825272|FG007|Overall Study|Death|1|||
145266844|NCT01891669|523825273|FG008|Overall Study|Death|0|||
145266845|NCT01891669|523825274|FG009|Overall Study|Death|1|||
145266846|NCT01891669|523825265|FG000|Overall Study|Withdrawal by Subject|1|||
145266847|NCT01891669|523825266|FG001|Overall Study|Withdrawal by Subject|1|||
145266848|NCT01891669|523825267|FG002|Overall Study|Withdrawal by Subject|0|||
145266849|NCT01891669|523825268|FG003|Overall Study|Withdrawal by Subject|0|||
145266850|NCT01891669|523825269|FG004|Overall Study|Withdrawal by Subject|0|||
145266851|NCT01891669|523825270|FG005|Overall Study|Withdrawal by Subject|0|||
145266852|NCT01891669|523825271|FG006|Overall Study|Withdrawal by Subject|1|||
145266853|NCT01891669|523825272|FG007|Overall Study|Withdrawal by Subject|2|||
145266854|NCT01891669|523825273|FG008|Overall Study|Withdrawal by Subject|1|||
145266855|NCT01891669|523825274|FG009|Overall Study|Withdrawal by Subject|1|||
145266856|NCT01891669|523825265|FG000|Overall Study|Other|1|||
145266857|NCT01891669|523825266|FG001|Overall Study|Other|0|||
145266858|NCT01891669|523825267|FG002|Overall Study|Other|0|||
145266859|NCT01891669|523825268|FG003|Overall Study|Other|0|||
145266860|NCT01891669|523825269|FG004|Overall Study|Other|0|||
145266861|NCT01891669|523825270|FG005|Overall Study|Other|0|||
145266862|NCT01891669|523825271|FG006|Overall Study|Other|0|||
145266863|NCT01891669|523825272|FG007|Overall Study|Other|1|||
145266864|NCT01891669|523825273|FG008|Overall Study|Other|0|||
145266865|NCT01891669|523825274|FG009|Overall Study|Other|0|||
145266866|NCT01015118|523825275|FG000|Overall Study|Protocol Violation|5|||
145266867|NCT01015118|523825276|FG001|Overall Study|Protocol Violation|6|||
145266868|NCT01015118|523825275|FG000|Overall Study|Withdrawal by Subject|103|||
145266869|NCT01015118|523825276|FG001|Overall Study|Withdrawal by Subject|27|||
145266870|NCT01015118|523825275|FG000|Overall Study|Other Adverse Event (AE)|141|||
145266871|NCT01015118|523825276|FG001|Overall Study|Other Adverse Event (AE)|33|||
145266872|NCT01015118|523825275|FG000|Overall Study|Worsening or AE of underlying disease|5|||
145266873|NCT01015118|523825276|FG001|Overall Study|Worsening or AE of underlying disease|4|||
145266874|NCT01015118|523825275|FG000|Overall Study|Progressive disease|364|||
145733915|NCT00108069|525543384|FG000|Overall Study|Progessive disease|27|||
145733916|NCT00108069|525543385|FG001|Overall Study|Progessive disease|11|||
145266875|NCT01015118|523825276|FG001|Overall Study|Progressive disease|229|||
145266876|NCT01015118|523825275|FG000|Overall Study|Not treated|9|||
145266877|NCT01015118|523825276|FG001|Overall Study|Not treated|5|||
145266878|NCT01015118|523825275|FG000|Overall Study|Other than stated above|42|||
145266879|NCT01015118|523825276|FG001|Overall Study|Other than stated above|23|||
145266880|NCT03522506|523825277|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145266881|NCT03522506|523825278|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145266882|NCT03522506|523825279|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145266883|NCT03522506|523825280|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145266884|NCT03522506|523825277|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145733917|NCT01294150|525543388|FG000|Overall Study|Physician Decision|2|||
145733918|NCT01294150|525543389|FG001|Overall Study|Physician Decision|2|||
145733919|NCT03675776|525543390|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
145266885|NCT03522506|523825278|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145266886|NCT03522506|523825279|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145266887|NCT03522506|523825280|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
145266888|NCT03480243|523825281|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
145266889|NCT03480243|523825281|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
145266890|NCT02388906|523825290|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
145266891|NCT02388906|523825291|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145266892|NCT02388906|523825290|FG000|Treatment Period|Disease progression|121|||
145266893|NCT02388906|523825291|FG001|Treatment Period|Disease progression|100|||
145266894|NCT02388906|523825290|FG000|Treatment Period|Study drug toxicity|41|||
145266895|NCT02388906|523825291|FG001|Treatment Period|Study drug toxicity|208|||
145266896|NCT02388906|523825290|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
145266897|NCT02388906|523825291|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
145266898|NCT02388906|523825290|FG000|Treatment Period|Participant request to stop treatment|5|||
145266899|NCT02388906|523825291|FG001|Treatment Period|Participant request to stop treatment|9|||
145266900|NCT02388906|523825290|FG000|Treatment Period|Participant withdrew consent|2|||
145266901|NCT02388906|523825291|FG001|Treatment Period|Participant withdrew consent|3|||
145266902|NCT02388906|523825290|FG000|Treatment Period|Poor/non-compliance|0|||
145266903|NCT02388906|523825291|FG001|Treatment Period|Poor/non-compliance|1|||
145266904|NCT02388906|523825290|FG000|Treatment Period|Participant no longer meets study criteria|0|||
145266905|NCT02388906|523825291|FG001|Treatment Period|Participant no longer meets study criteria|1|||
145266906|NCT02388906|523825290|FG000|Treatment Period|Other reasons|3|||
145266907|NCT02388906|523825291|FG001|Treatment Period|Other reasons|3|||
145266908|NCT04365387|523825300|FG000|Overall Study|Adverse Event|4|||
145266909|NCT04365387|523825301|FG001|Overall Study|Adverse Event|2|||
145266910|NCT04365387|523825300|FG000|Overall Study|Participants request|14|||
145266911|NCT04365387|523825301|FG001|Overall Study|Participants request|14|||
145266912|NCT04365387|523825300|FG000|Overall Study|Lost to Follow-up|8|||
145266913|NCT04365387|523825301|FG001|Overall Study|Lost to Follow-up|5|||
145266914|NCT04365387|523825300|FG000|Overall Study|Protocol deviation|3|||
145266915|NCT04365387|523825301|FG001|Overall Study|Protocol deviation|4|||
145266916|NCT04365387|523825300|FG000|Overall Study|Participant compliance with visit schedule|1|||
145266917|NCT04365387|523825301|FG001|Overall Study|Participant compliance with visit schedule|0|||
145266918|NCT04365387|523825300|FG000|Overall Study|Participant incarcerated|1|||
145266919|NCT04365387|523825301|FG001|Overall Study|Participant incarcerated|0|||
145266920|NCT04365387|523825300|FG000|Overall Study|Participant moved out of town (relocated)|0|||
145266921|NCT04365387|523825301|FG001|Overall Study|Participant moved out of town (relocated)|1|||
145266922|NCT04365387|523825300|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
145266923|NCT04365387|523825301|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
145266924|NCT04365387|523825300|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
145266925|NCT04365387|523825301|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
145266926|NCT05770401|523825302|FG000|Overall Study|Lost to Follow-up|5|||
145266927|NCT05770401|523825303|FG001|Overall Study|Lost to Follow-up|4|||
145266928|NCT00402298|523825304|FG000|Overall Study|Withdrawal by Subject|1|||
145266929|NCT00402298|523825305|FG001|Overall Study|Withdrawal by Subject|0|||
145266930|NCT00480077|523825306|FG000|Overall Study|Death|19|||
145266931|NCT00480077|523825307|FG001|Overall Study|Death|15|||
145266932|NCT00480077|523825306|FG000|Overall Study|early exit|12|||
145266933|NCT00480077|523825307|FG001|Overall Study|early exit|11|||
145266934|NCT04784455|523825308|FG000|Overall Study|Death|4|||
145266935|NCT04298229|523825311|FG000|Overall Study|Physician Decision|1|||
145266936|NCT04298229|523825312|FG001|Overall Study|Physician Decision|1|||
145266937|NCT04298229|523825311|FG000|Overall Study|Withdrawal by Subject|1|||
145266938|NCT04298229|523825312|FG001|Overall Study|Withdrawal by Subject|1|||
145266939|NCT04298229|523825311|FG000|Overall Study|Did not receive IV loop diuretics|2|||
145266940|NCT04298229|523825312|FG001|Overall Study|Did not receive IV loop diuretics|0|||
145266941|NCT00262119|523825313|FG000|Overall Study|Lost to Follow-up|38|||
145266942|NCT00262119|523825314|FG001|Overall Study|Lost to Follow-up|51|||
145266943|NCT00262119|523825315|FG002|Overall Study|Lost to Follow-up|42|||
145266944|NCT00262119|523825313|FG000|Overall Study|Death|20|||
145266945|NCT00262119|523825314|FG001|Overall Study|Death|19|||
145266946|NCT00262119|523825315|FG002|Overall Study|Death|16|||
145266947|NCT00071006|523825316|FG000|Overall Study|Lack of Efficacy|7|||
145266948|NCT00071006|523825316|FG000|Overall Study|Adverse Event|1|||
145266949|NCT00071006|523825316|FG000|Overall Study|Withdrawal by Subject|1|||
145266950|NCT00071006|523825316|FG000|Overall Study|Other|3|||
145266951|NCT00859313|523825317|FG000|Overall Study|Lack of Efficacy|2|||
145266952|NCT00859313|523825317|FG000|Overall Study|Adverse Event|1|||
145266953|NCT00859313|523825317|FG000|Overall Study|staff error|1|||
145266954|NCT05261126|523825322|FG000|Overall Study|Death|0|||
145266955|NCT05261126|523825323|FG001|Overall Study|Death|0|||
145266956|NCT05261126|523825324|FG002|Overall Study|Death|1|||
145266957|NCT05261126|523825325|FG003|Overall Study|Death|0|||
145266958|NCT05261126|523825326|FG004|Overall Study|Death|0|||
145266959|NCT05261126|523825322|FG000|Overall Study|Lost to Follow-up|0|||
145266960|NCT05261126|523825323|FG001|Overall Study|Lost to Follow-up|0|||
145266961|NCT05261126|523825324|FG002|Overall Study|Lost to Follow-up|0|||
145266962|NCT05261126|523825325|FG003|Overall Study|Lost to Follow-up|0|||
145266963|NCT05261126|523825326|FG004|Overall Study|Lost to Follow-up|1|||
145266964|NCT05261126|523825322|FG000|Overall Study|Physician Decision|1|||
145266965|NCT05261126|523825323|FG001|Overall Study|Physician Decision|0|||
145266966|NCT05261126|523825324|FG002|Overall Study|Physician Decision|0|||
145266967|NCT05261126|523825325|FG003|Overall Study|Physician Decision|0|||
145266968|NCT05261126|523825326|FG004|Overall Study|Physician Decision|0|||
145266969|NCT05261126|523825322|FG000|Overall Study|Screen Failure|0|||
145266970|NCT05261126|523825323|FG001|Overall Study|Screen Failure|0|||
145266971|NCT05261126|523825324|FG002|Overall Study|Screen Failure|0|||
145266972|NCT05261126|523825325|FG003|Overall Study|Screen Failure|0|||
145266973|NCT05261126|523825326|FG004|Overall Study|Screen Failure|1|||
145266974|NCT05261126|523825322|FG000|Overall Study|Withdrawal by Subject|1|||
145266975|NCT05261126|523825323|FG001|Overall Study|Withdrawal by Subject|0|||
145266976|NCT05261126|523825324|FG002|Overall Study|Withdrawal by Subject|1|||
145266977|NCT05261126|523825325|FG003|Overall Study|Withdrawal by Subject|1|||
145266978|NCT05261126|523825326|FG004|Overall Study|Withdrawal by Subject|0|||
145266979|NCT05261126|523825322|FG000|Overall Study|Not Recorded|0|||
145266980|NCT05261126|523825323|FG001|Overall Study|Not Recorded|0|||
145266981|NCT05261126|523825324|FG002|Overall Study|Not Recorded|0|||
145266982|NCT05261126|523825325|FG003|Overall Study|Not Recorded|1|||
145266983|NCT05261126|523825326|FG004|Overall Study|Not Recorded|0|||
145266984|NCT05939388|523825327|FG000|Overall Study|Lost to Follow-up|1|||
145266985|NCT03901274|523825328|FG000|Overall Study|Lost to Follow-up|120|||
145266986|NCT03901274|523825329|FG001|Overall Study|Lost to Follow-up|124|||
145266987|NCT03901274|523825328|FG000|Overall Study|Withdrawal by Subject|0|||
145266988|NCT03901274|523825329|FG001|Overall Study|Withdrawal by Subject|6|||
145266989|NCT05570604|523825330|FG000|Overall Study|Lost to Follow-up|1|||
145266990|NCT05570604|523825331|FG001|Overall Study|Lost to Follow-up|5|||
145266991|NCT05570604|523825330|FG000|Overall Study|Illness|2|||
145266992|NCT05570604|523825331|FG001|Overall Study|Illness|2|||
145266993|NCT04527380|523825334|FG000|Overall Study|Lack of Efficacy|0|||
145266994|NCT04527380|523825335|FG001|Overall Study|Lack of Efficacy|1|||
145266995|NCT04527380|523825334|FG000|Overall Study|Withdrawal by Subject|1|||
145266996|NCT04527380|523825335|FG001|Overall Study|Withdrawal by Subject|0|||
145266997|NCT05643573|523825336|FG000|Overall Study|Adverse Event|117|||
145266998|NCT05643573|523825337|FG001|Overall Study|Adverse Event|90|||
145266999|NCT05643573|523825336|FG000|Overall Study|Death|53|||
145267000|NCT05643573|523825337|FG001|Overall Study|Death|57|||
145267001|NCT05643573|523825336|FG000|Overall Study|Lost to Follow-up|6|||
145267002|NCT05643573|523825337|FG001|Overall Study|Lost to Follow-up|3|||
145267003|NCT05643573|523825336|FG000|Overall Study|Other|18|||
145267004|NCT05643573|523825337|FG001|Overall Study|Other|15|||
145267005|NCT05643573|523825336|FG000|Overall Study|Outcome event|64|||
145267006|NCT05643573|523825337|FG001|Overall Study|Outcome event|36|||
145267007|NCT05643573|523825336|FG000|Overall Study|Physician Decision|33|||
145267008|NCT05643573|523825337|FG001|Overall Study|Physician Decision|19|||
145267009|NCT05643573|523825336|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
145267010|NCT05643573|523825337|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
145267011|NCT05643573|523825336|FG000|Overall Study|Site terminated by sponsor|10|||
145267012|NCT05643573|523825337|FG001|Overall Study|Site terminated by sponsor|10|||
145267013|NCT05643573|523825336|FG000|Overall Study|Study terminated by sponsor|1|||
145267014|NCT05643573|523825337|FG001|Overall Study|Study terminated by sponsor|0|||
145267015|NCT05643573|523825336|FG000|Overall Study|Withdrawal by Subject|178|||
145267016|NCT05643573|523825337|FG001|Overall Study|Withdrawal by Subject|130|||
145267017|NCT05182840|523825338|FG000|Run-in Period|Not treated|0|||
145267018|NCT05182840|523825339|FG001|Run-in Period|Not treated|1|||
145267019|NCT05182840|523825340|FG002|Run-in Period|Not treated|0|||
145267020|NCT05182840|523825341|FG003|Run-in Period|Not treated|0|||
145267021|NCT05182840|523825342|FG004|Run-in Period|Not treated|0|||
145267022|NCT05182840|523825343|FG005|Run-in Period|Not treated|0|||
145267023|NCT05182840|523825344|FG006|Run-in Period|Not treated|0|||
145267024|NCT05182840|523825345|FG007|Run-in Period|Not treated|0|||
145267025|NCT05182840|523825346|FG008|Run-in Period|Not treated|0|||
145267026|NCT05182840|523825347|FG009|Run-in Period|Not treated|0|||
145402220|NCT00750269|524330677|FG000|Overall Study|Physician Decision|0|||
145402221|NCT00750269|524330678|FG001|Overall Study|Physician Decision|0|||
145267027|NCT05182840|523825338|FG000|Run-in Period|Other reason but not sponsor termination|14|||
145267028|NCT05182840|523825339|FG001|Run-in Period|Other reason but not sponsor termination|18|||
145267029|NCT05182840|523825340|FG002|Run-in Period|Other reason but not sponsor termination|0|||
145267030|NCT05182840|523825341|FG003|Run-in Period|Other reason but not sponsor termination|0|||
145267031|NCT05182840|523825342|FG004|Run-in Period|Other reason but not sponsor termination|0|||
145267032|NCT05182840|523825343|FG005|Run-in Period|Other reason but not sponsor termination|0|||
145267033|NCT05182840|523825344|FG006|Run-in Period|Other reason but not sponsor termination|0|||
145267034|NCT05182840|523825345|FG007|Run-in Period|Other reason but not sponsor termination|0|||
145267035|NCT05182840|523825346|FG008|Run-in Period|Other reason but not sponsor termination|0|||
145267036|NCT05182840|523825347|FG009|Run-in Period|Other reason but not sponsor termination|0|||
145267037|NCT05182840|523825338|FG000|Run-in Period|No reason available|2|||
145267038|NCT05182840|523825339|FG001|Run-in Period|No reason available|2|||
145267039|NCT05182840|523825340|FG002|Run-in Period|No reason available|0|||
145267040|NCT05182840|523825341|FG003|Run-in Period|No reason available|0|||
145267041|NCT05182840|523825342|FG004|Run-in Period|No reason available|0|||
145267042|NCT05182840|523825343|FG005|Run-in Period|No reason available|0|||
145267043|NCT05182840|523825344|FG006|Run-in Period|No reason available|0|||
145267044|NCT05182840|523825345|FG007|Run-in Period|No reason available|0|||
145267045|NCT05182840|523825346|FG008|Run-in Period|No reason available|0|||
145267046|NCT05182840|523825347|FG009|Run-in Period|No reason available|0|||
145267047|NCT05182840|523825338|FG000|Run-in Period|Burden of study procedures|2|||
145267048|NCT05182840|523825339|FG001|Run-in Period|Burden of study procedures|2|||
145267049|NCT05182840|523825340|FG002|Run-in Period|Burden of study procedures|0|||
145267050|NCT05182840|523825341|FG003|Run-in Period|Burden of study procedures|0|||
145267051|NCT05182840|523825342|FG004|Run-in Period|Burden of study procedures|0|||
145267052|NCT05182840|523825343|FG005|Run-in Period|Burden of study procedures|0|||
145267053|NCT05182840|523825344|FG006|Run-in Period|Burden of study procedures|0|||
145267054|NCT05182840|523825345|FG007|Run-in Period|Burden of study procedures|0|||
145267055|NCT05182840|523825346|FG008|Run-in Period|Burden of study procedures|0|||
145267056|NCT05182840|523825347|FG009|Run-in Period|Burden of study procedures|0|||
145267057|NCT05182840|523825338|FG000|Run-in Period|Change of residence|1|||
145267058|NCT05182840|523825339|FG001|Run-in Period|Change of residence|0|||
145267059|NCT05182840|523825340|FG002|Run-in Period|Change of residence|0|||
145267060|NCT05182840|523825341|FG003|Run-in Period|Change of residence|0|||
145267061|NCT05182840|523825342|FG004|Run-in Period|Change of residence|0|||
145267062|NCT05182840|523825343|FG005|Run-in Period|Change of residence|0|||
145267063|NCT05182840|523825344|FG006|Run-in Period|Change of residence|0|||
145267064|NCT05182840|523825345|FG007|Run-in Period|Change of residence|0|||
145267065|NCT05182840|523825346|FG008|Run-in Period|Change of residence|0|||
145267066|NCT05182840|523825347|FG009|Run-in Period|Change of residence|0|||
145267067|NCT05182840|523825338|FG000|Run-in Period|Adverse Event|5|||
145267068|NCT05182840|523825339|FG001|Run-in Period|Adverse Event|5|||
145267069|NCT05182840|523825340|FG002|Run-in Period|Adverse Event|0|||
145267070|NCT05182840|523825341|FG003|Run-in Period|Adverse Event|0|||
145267071|NCT05182840|523825342|FG004|Run-in Period|Adverse Event|0|||
145267072|NCT05182840|523825343|FG005|Run-in Period|Adverse Event|0|||
145267073|NCT05182840|523825344|FG006|Run-in Period|Adverse Event|0|||
145267074|NCT05182840|523825345|FG007|Run-in Period|Adverse Event|0|||
145267075|NCT05182840|523825346|FG008|Run-in Period|Adverse Event|0|||
145267076|NCT05182840|523825347|FG009|Run-in Period|Adverse Event|0|||
145267077|NCT05182840|523825338|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
145515911|NCT01155011|524748648|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
145515912|NCT01155011|524748647|FG000|Baseline to 6 Months|investigator decision, moved|4|||
145515913|NCT01155011|524748648|FG001|Baseline to 6 Months|investigator decision, moved|5|||
145267078|NCT05182840|523825339|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
145267079|NCT05182840|523825340|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267080|NCT05182840|523825341|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267081|NCT05182840|523825342|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267082|NCT05182840|523825343|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145515914|NCT01155011|524748647|FG000|Baseline to 6 Months|Death|0|||
145267083|NCT05182840|523825344|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267084|NCT05182840|523825345|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267085|NCT05182840|523825346|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267086|NCT05182840|523825347|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
145267087|NCT05182840|523825338|FG000|Treatment Period|Reason missing|0|||
145267088|NCT05182840|523825339|FG001|Treatment Period|Reason missing|0|||
145267089|NCT05182840|523825340|FG002|Treatment Period|Reason missing|1|||
145267090|NCT05182840|523825341|FG003|Treatment Period|Reason missing|0|||
145267091|NCT05182840|523825342|FG004|Treatment Period|Reason missing|0|||
145267092|NCT05182840|523825343|FG005|Treatment Period|Reason missing|0|||
145267093|NCT05182840|523825344|FG006|Treatment Period|Reason missing|0|||
145267094|NCT05182840|523825345|FG007|Treatment Period|Reason missing|0|||
145267095|NCT05182840|523825346|FG008|Treatment Period|Reason missing|0|||
145267096|NCT05182840|523825347|FG009|Treatment Period|Reason missing|0|||
145267097|NCT05182840|523825338|FG000|Treatment Period|Other but not sponsor termination|0|||
145267098|NCT05182840|523825339|FG001|Treatment Period|Other but not sponsor termination|0|||
145267099|NCT05182840|523825340|FG002|Treatment Period|Other but not sponsor termination|8|||
145267100|NCT05182840|523825341|FG003|Treatment Period|Other but not sponsor termination|6|||
145267101|NCT05182840|523825342|FG004|Treatment Period|Other but not sponsor termination|6|||
145267102|NCT05182840|523825343|FG005|Treatment Period|Other but not sponsor termination|7|||
145267103|NCT05182840|523825344|FG006|Treatment Period|Other but not sponsor termination|5|||
145267104|NCT05182840|523825345|FG007|Treatment Period|Other but not sponsor termination|8|||
145267105|NCT05182840|523825346|FG008|Treatment Period|Other but not sponsor termination|7|||
145267106|NCT05182840|523825347|FG009|Treatment Period|Other but not sponsor termination|2|||
145267107|NCT05182840|523825338|FG000|Treatment Period|Protocol deviation|0|||
145267108|NCT05182840|523825339|FG001|Treatment Period|Protocol deviation|0|||
145267109|NCT05182840|523825340|FG002|Treatment Period|Protocol deviation|0|||
145267110|NCT05182840|523825341|FG003|Treatment Period|Protocol deviation|0|||
145267111|NCT05182840|523825342|FG004|Treatment Period|Protocol deviation|0|||
145267112|NCT05182840|523825343|FG005|Treatment Period|Protocol deviation|0|||
145267113|NCT05182840|523825344|FG006|Treatment Period|Protocol deviation|0|||
145267114|NCT05182840|523825345|FG007|Treatment Period|Protocol deviation|0|||
145267115|NCT05182840|523825346|FG008|Treatment Period|Protocol deviation|1|||
145267116|NCT05182840|523825347|FG009|Treatment Period|Protocol deviation|0|||
145267117|NCT05182840|523825338|FG000|Treatment Period|No reason available|0|||
145267118|NCT05182840|523825339|FG001|Treatment Period|No reason available|0|||
145267119|NCT05182840|523825340|FG002|Treatment Period|No reason available|0|||
145267120|NCT05182840|523825341|FG003|Treatment Period|No reason available|1|||
145267121|NCT05182840|523825342|FG004|Treatment Period|No reason available|0|||
145267122|NCT05182840|523825343|FG005|Treatment Period|No reason available|2|||
145267123|NCT05182840|523825344|FG006|Treatment Period|No reason available|0|||
145267124|NCT05182840|523825345|FG007|Treatment Period|No reason available|1|||
145267125|NCT05182840|523825346|FG008|Treatment Period|No reason available|0|||
145267126|NCT05182840|523825347|FG009|Treatment Period|No reason available|0|||
145267127|NCT05182840|523825338|FG000|Treatment Period|Burden of study procedures|0|||
145267128|NCT05182840|523825339|FG001|Treatment Period|Burden of study procedures|0|||
145267129|NCT05182840|523825340|FG002|Treatment Period|Burden of study procedures|0|||
145267130|NCT05182840|523825341|FG003|Treatment Period|Burden of study procedures|0|||
145267131|NCT05182840|523825342|FG004|Treatment Period|Burden of study procedures|1|||
145267132|NCT05182840|523825343|FG005|Treatment Period|Burden of study procedures|0|||
145267133|NCT05182840|523825344|FG006|Treatment Period|Burden of study procedures|0|||
145267134|NCT05182840|523825345|FG007|Treatment Period|Burden of study procedures|0|||
145267135|NCT05182840|523825346|FG008|Treatment Period|Burden of study procedures|0|||
145267136|NCT05182840|523825347|FG009|Treatment Period|Burden of study procedures|0|||
145267137|NCT05182840|523825338|FG000|Treatment Period|Change of residence|0|||
145267138|NCT05182840|523825339|FG001|Treatment Period|Change of residence|0|||
145267139|NCT05182840|523825340|FG002|Treatment Period|Change of residence|0|||
145267140|NCT05182840|523825341|FG003|Treatment Period|Change of residence|0|||
145267141|NCT05182840|523825342|FG004|Treatment Period|Change of residence|0|||
145267142|NCT05182840|523825343|FG005|Treatment Period|Change of residence|1|||
145267143|NCT05182840|523825344|FG006|Treatment Period|Change of residence|0|||
145267144|NCT05182840|523825345|FG007|Treatment Period|Change of residence|0|||
145267145|NCT05182840|523825346|FG008|Treatment Period|Change of residence|0|||
145267146|NCT05182840|523825347|FG009|Treatment Period|Change of residence|0|||
145267147|NCT05182840|523825338|FG000|Treatment Period|Adverse Event|0|||
145267148|NCT05182840|523825339|FG001|Treatment Period|Adverse Event|0|||
145267149|NCT05182840|523825340|FG002|Treatment Period|Adverse Event|4|||
145267150|NCT05182840|523825341|FG003|Treatment Period|Adverse Event|16|||
145267151|NCT05182840|523825342|FG004|Treatment Period|Adverse Event|12|||
145267152|NCT05182840|523825343|FG005|Treatment Period|Adverse Event|6|||
145267153|NCT05182840|523825344|FG006|Treatment Period|Adverse Event|4|||
145267154|NCT05182840|523825345|FG007|Treatment Period|Adverse Event|8|||
145267155|NCT05182840|523825346|FG008|Treatment Period|Adverse Event|16|||
145267156|NCT05182840|523825347|FG009|Treatment Period|Adverse Event|5|||
145267157|NCT05182840|523825338|FG000|Treatment Period|Not treated with study drug|0|||
145267158|NCT05182840|523825339|FG001|Treatment Period|Not treated with study drug|0|||
145267159|NCT05182840|523825340|FG002|Treatment Period|Not treated with study drug|0|||
145267160|NCT05182840|523825341|FG003|Treatment Period|Not treated with study drug|1|||
145267161|NCT05182840|523825342|FG004|Treatment Period|Not treated with study drug|0|||
145267162|NCT05182840|523825343|FG005|Treatment Period|Not treated with study drug|0|||
145267163|NCT05182840|523825344|FG006|Treatment Period|Not treated with study drug|1|||
145267164|NCT05182840|523825345|FG007|Treatment Period|Not treated with study drug|1|||
145267165|NCT05182840|523825346|FG008|Treatment Period|Not treated with study drug|0|||
145267166|NCT05182840|523825347|FG009|Treatment Period|Not treated with study drug|0|||
145267167|NCT03759340|523825349|FG000|Overall Study|Adverse Event|2|||
145267168|NCT03759340|523825349|FG000|Overall Study|Lost to Follow-up|1|||
145267169|NCT03759340|523825349|FG000|Overall Study|Withdrawal by Subject|15|||
145267170|NCT03759340|523825349|FG000|Overall Study|Study Terminated by Sponsor|38|||
145267171|NCT01396434|523825350|FG000|Overall Study|Lost to Follow-up|1|||
145267172|NCT01396434|523825351|FG001|Overall Study|Lost to Follow-up|0|||
145267173|NCT01396434|523825352|FG002|Overall Study|Lost to Follow-up|0|||
145267174|NCT01396434|523825350|FG000|Overall Study|Other|10|||
145267175|NCT01396434|523825351|FG001|Overall Study|Other|0|||
145267176|NCT01396434|523825352|FG002|Overall Study|Other|0|||
145267177|NCT00563706|523827308|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
145267178|NCT00563706|523827309|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
145267179|NCT00563706|523827310|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
145267180|NCT00563706|523827311|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
145267181|NCT00563706|523827312|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
145267182|NCT00563706|523827313|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
145267183|NCT00563706|523827314|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
145267184|NCT00563706|523827315|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
145267185|NCT00563706|523827316|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
145267186|NCT00563706|523827308|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
145267187|NCT00563706|523827309|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
145267188|NCT00563706|523827310|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
145267189|NCT00563706|523827311|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
145267190|NCT00563706|523827312|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
145267191|NCT00563706|523827313|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
145267192|NCT00563706|523827314|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
145267193|NCT00563706|523827315|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
145267194|NCT00563706|523827316|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
145267195|NCT00563706|523827308|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
145267196|NCT00563706|523827309|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
145267197|NCT00563706|523827310|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
145267198|NCT00563706|523827311|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
145267199|NCT00563706|523827312|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
145267200|NCT00563706|523827313|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
145267201|NCT00563706|523827314|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
145267202|NCT00563706|523827315|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
145267203|NCT00563706|523827316|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
145267204|NCT00563706|523827308|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
145267205|NCT00563706|523827309|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267206|NCT00563706|523827310|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267207|NCT00563706|523827311|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267208|NCT00563706|523827312|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267209|NCT00563706|523827313|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267210|NCT00563706|523827314|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267211|NCT00563706|523827315|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
145267212|NCT00563706|523827316|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
145267213|NCT00563706|523827308|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267214|NCT00563706|523827309|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267215|NCT00563706|523827310|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267216|NCT00563706|523827311|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267217|NCT00563706|523827312|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267218|NCT00563706|523827313|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267219|NCT00563706|523827314|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
145267220|NCT00563706|523827315|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
145267221|NCT00563706|523827316|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
145267222|NCT03280628|523827319|FG000|Overall Study|Lost to Follow-up|8|||
145267223|NCT03280628|523827320|FG001|Overall Study|Lost to Follow-up|6|||
145267224|NCT03280628|523827321|FG002|Overall Study|Lost to Follow-up|11|||
145267225|NCT01361308|523827324|FG000|Overall Study|Withdrawal by Subject|9|||
145267226|NCT01361308|523827325|FG001|Overall Study|Withdrawal by Subject|13|||
145267227|NCT01361308|523827324|FG000|Overall Study|Physician Decision|3|||
145267228|NCT01361308|523827325|FG001|Overall Study|Physician Decision|3|||
145267229|NCT01361308|523827324|FG000|Overall Study|Lack of Efficacy|2|||
145267230|NCT01361308|523827325|FG001|Overall Study|Lack of Efficacy|0|||
145267231|NCT01361308|523827324|FG000|Overall Study|Protocol Violation|1|||
145267232|NCT01361308|523827325|FG001|Overall Study|Protocol Violation|0|||
145267233|NCT01361308|523827324|FG000|Overall Study|Lost to Follow-up|5|||
145267234|NCT01361308|523827325|FG001|Overall Study|Lost to Follow-up|4|||
145267235|NCT01361308|523827324|FG000|Overall Study|Adverse Event|8|||
145267236|NCT01361308|523827325|FG001|Overall Study|Adverse Event|4|||
145267237|NCT01361308|523827324|FG000|Overall Study|Eligibility Criteria Not Met|2|||
145267238|NCT01361308|523827325|FG001|Overall Study|Eligibility Criteria Not Met|3|||
145733920|NCT03675776|525543391|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
145733921|NCT03675776|525543392|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
145733922|NCT03675776|525543390|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
145733923|NCT03675776|525543391|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
145733924|NCT03675776|525543392|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
145733925|NCT04513665|525543393|FG000|Overall Study|Adverse Event|2|||
145733926|NCT04513665|525543394|FG001|Overall Study|Adverse Event|0|||
145733927|NCT04513665|525543393|FG000|Overall Study|Lack of Efficacy|14|||
145733928|NCT04513665|525543394|FG001|Overall Study|Lack of Efficacy|0|||
145733929|NCT03684642|525543395|FG000|Overall Study|Adverse Event|6|||
145733930|NCT03684642|525543396|FG001|Overall Study|Adverse Event|15|||
145733931|NCT03684642|525543397|FG002|Overall Study|Adverse Event|11|||
145733932|NCT03684642|525543395|FG000|Overall Study|Withdrawal by Subject|35|||
145733933|NCT03684642|525543396|FG001|Overall Study|Withdrawal by Subject|53|||
145733934|NCT03684642|525543397|FG002|Overall Study|Withdrawal by Subject|23|||
145733935|NCT03684642|525543395|FG000|Overall Study|Lack of Efficacy|0|||
145733936|NCT03684642|525543396|FG001|Overall Study|Lack of Efficacy|0|||
145733937|NCT03684642|525543397|FG002|Overall Study|Lack of Efficacy|1|||
145733938|NCT03684642|525543395|FG000|Overall Study|Poor compliance to protocol|0|||
145733939|NCT03684642|525543396|FG001|Overall Study|Poor compliance to protocol|4|||
145267239|NCT01361308|523827324|FG000|Overall Study|Failed C-SSRS|5|||
145267240|NCT01361308|523827325|FG001|Overall Study|Failed C-SSRS|2|||
145267241|NCT01361308|523827324|FG000|Overall Study|Other|0|||
145267242|NCT01361308|523827325|FG001|Overall Study|Other|1|||
145267243|NCT03839693|523827330|FG000|Overall Study|Lost to Follow-up|0|||
145267244|NCT03839693|523827331|FG001|Overall Study|Lost to Follow-up|2|||
145267245|NCT03839693|523827332|FG002|Overall Study|Lost to Follow-up|2|||
145267246|NCT03839693|523827330|FG000|Overall Study|Withdrawal by Subject|1|||
145267247|NCT03839693|523827331|FG001|Overall Study|Withdrawal by Subject|0|||
145267248|NCT03839693|523827332|FG002|Overall Study|Withdrawal by Subject|2|||
145267249|NCT03839693|523827330|FG000|Overall Study|subject moved out of the area|1|||
145515915|NCT01155011|524748648|FG001|Baseline to 6 Months|Death|1|||
145267250|NCT03839693|523827331|FG001|Overall Study|subject moved out of the area|0|||
145267251|NCT03839693|523827332|FG002|Overall Study|subject moved out of the area|0|||
145267252|NCT00700115|523827341|FG000|Overall Study|Withdrawal by Subject|1|||
145515916|NCT01155011|524748647|FG000|6 to 12 Months|Withdrawal by Subject|8|||
145267253|NCT00700115|523827342|FG001|Overall Study|Withdrawal by Subject|0|||
145267254|NCT00700115|523827341|FG000|Overall Study|Lost to Follow-up|0|||
145267255|NCT00700115|523827342|FG001|Overall Study|Lost to Follow-up|1|||
145267256|NCT02503215|523827343|FG000|Overall Study|Unable to wear compression stockings|1|||
145267257|NCT02503215|523827343|FG000|Overall Study|Unable to use positive airway pressure|2|||
145267258|NCT02983305|523827344|FG000|Overall Study|incomplete data|2|||
145267259|NCT02983305|523827345|FG001|Overall Study|incomplete data|0|||
145267260|NCT00706901|523827346|FG000|Overall Study|Lost to Follow-up|2|||
145267261|NCT00706901|523827347|FG001|Overall Study|Lost to Follow-up|3|||
145267262|NCT00706901|523827348|FG002|Overall Study|Lost to Follow-up|2|||
145267263|NCT00706901|523827346|FG000|Overall Study|Withdrawal by Subject|4|||
145267264|NCT00706901|523827347|FG001|Overall Study|Withdrawal by Subject|2|||
145267265|NCT00706901|523827348|FG002|Overall Study|Withdrawal by Subject|5|||
145267266|NCT00706901|523827346|FG000|Overall Study|In Jail|1|||
145267267|NCT00706901|523827347|FG001|Overall Study|In Jail|0|||
145267268|NCT00706901|523827348|FG002|Overall Study|In Jail|1|||
145267269|NCT00706901|523827346|FG000|Overall Study|Death|1|||
145267270|NCT00706901|523827347|FG001|Overall Study|Death|0|||
145267271|NCT00706901|523827348|FG002|Overall Study|Death|0|||
145267272|NCT00822237|523827349|FG000|Dose 1 Vaccination|Not vaccinated|3|||
145267273|NCT00822237|523827350|FG001|Dose 1 Vaccination|Not vaccinated|0|||
145267274|NCT00822237|523827349|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
145267275|NCT00822237|523827350|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
145267276|NCT00822237|523827349|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
145267277|NCT00822237|523827350|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
145267278|NCT00822237|523827349|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
145267279|NCT00822237|523827350|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
145267280|NCT00822237|523827349|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
145267281|NCT00822237|523827350|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
145267282|NCT03433482|523827351|FG000|Overall Study|Lost to Follow-up|1|||
145267283|NCT03433482|523827352|FG001|Overall Study|Lost to Follow-up|0|||
145267284|NCT03433482|523827353|FG002|Overall Study|Lost to Follow-up|1|||
145267285|NCT03433482|523827354|FG003|Overall Study|Lost to Follow-up|1|||
145267286|NCT03433482|523827351|FG000|Overall Study|Withdrawal by Subject|0|||
145267287|NCT03433482|523827352|FG001|Overall Study|Withdrawal by Subject|0|||
145267288|NCT03433482|523827353|FG002|Overall Study|Withdrawal by Subject|1|||
145267289|NCT03433482|523827354|FG003|Overall Study|Withdrawal by Subject|0|||
145402222|NCT00750269|524330679|FG002|Overall Study|Physician Decision|0|||
145267290|NCT03433482|523827351|FG000|Overall Study|Unknown reason|0|||
145267291|NCT03433482|523827352|FG001|Overall Study|Unknown reason|0|||
145267292|NCT03433482|523827353|FG002|Overall Study|Unknown reason|2|||
145402223|NCT00750269|524330680|FG003|Overall Study|Physician Decision|0|||
145267293|NCT03433482|523827354|FG003|Overall Study|Unknown reason|0|||
145267294|NCT01519635|523827357|FG000|Overall Study|Withdrawal by Subject|0|||
145267295|NCT01519635|523827358|FG001|Overall Study|Withdrawal by Subject|1|||
145267296|NCT01519635|523827357|FG000|Overall Study|No possibility to put a catheter|1|||
145267297|NCT01519635|523827358|FG001|Overall Study|No possibility to put a catheter|2|||
145267298|NCT00968539|523827359|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
145267299|NCT00968539|523827360|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145267300|NCT00938392|523827361|FG000|Overall Study|Adverse Event|0|||
145267301|NCT00938392|523827362|FG001|Overall Study|Adverse Event|1|||
145267302|NCT00938392|523827361|FG000|Overall Study|Withdrawal by Subject|0|||
145267303|NCT00938392|523827362|FG001|Overall Study|Withdrawal by Subject|1|||
145267304|NCT00938392|523827361|FG000|Overall Study|Lost to Follow-up|2|||
145267305|NCT00938392|523827362|FG001|Overall Study|Lost to Follow-up|2|||
145267306|NCT04341727|523827365|FG000|Overall Study|Withdrawal by Subject|0|||
145267307|NCT04341727|523827366|FG001|Overall Study|Withdrawal by Subject|0|||
145267308|NCT04341727|523827367|FG002|Overall Study|Withdrawal by Subject|1|||
145267309|NCT04341727|523827368|FG003|Overall Study|Withdrawal by Subject|0|||
145267310|NCT04341727|523827365|FG000|Overall Study|Lost to Follow-up|0|||
145267311|NCT04341727|523827366|FG001|Overall Study|Lost to Follow-up|0|||
145267312|NCT04341727|523827367|FG002|Overall Study|Lost to Follow-up|0|||
145267313|NCT04341727|523827368|FG003|Overall Study|Lost to Follow-up|1|||
145733940|NCT03684642|525543397|FG002|Overall Study|Poor compliance to protocol|1|||
145267314|NCT05604521|523827369|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
145267315|NCT05604521|523827370|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
145267316|NCT05604521|523827369|FG000|Overall Study|Adverse Event|1|||
145733941|NCT03684642|525543395|FG000|Overall Study|Other than specified|62|||
145733942|NCT03684642|525543396|FG001|Overall Study|Other than specified|60|||
145733943|NCT03684642|525543397|FG002|Overall Study|Other than specified|67|||
145733944|NCT03684642|525543395|FG000|Overall Study|Randomized and not treated|0|||
145733945|NCT03684642|525543396|FG001|Overall Study|Randomized and not treated|0|||
145733946|NCT03684642|525543397|FG002|Overall Study|Randomized and not treated|1|||
145733947|NCT03684642|525543395|FG000|Overall Study|Missing completion status but alive at last contact|0|||
145733948|NCT03684642|525543396|FG001|Overall Study|Missing completion status but alive at last contact|1|||
145733949|NCT03684642|525543397|FG002|Overall Study|Missing completion status but alive at last contact|2|||
145733950|NCT02742766|525543401|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733951|NCT02742766|525543402|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733952|NCT02742766|525543403|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733953|NCT02742766|525543404|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733954|NCT02742766|525543405|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733955|NCT02742766|525543406|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733956|NCT02742766|525543407|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733957|NCT02742766|525543408|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733958|NCT02742766|525543409|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733959|NCT02742766|525543410|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733960|NCT02742766|525543411|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733961|NCT02742766|525543412|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733962|NCT02742766|525543413|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733963|NCT02742766|525543414|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
145733964|NCT02742766|525543415|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733965|NCT02742766|525543416|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733966|NCT02742766|525543417|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733967|NCT02742766|525543418|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733968|NCT02742766|525543419|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
145733969|NCT02742766|525543401|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733970|NCT02742766|525543402|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733971|NCT02742766|525543403|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733972|NCT02742766|525543404|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733973|NCT02742766|525543405|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733974|NCT02742766|525543406|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733975|NCT02742766|525543407|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733976|NCT02742766|525543408|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733977|NCT02742766|525543409|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733978|NCT02742766|525543410|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733979|NCT02742766|525543411|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733980|NCT02742766|525543412|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733981|NCT02742766|525543413|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
145267317|NCT05604521|523827370|FG001|Overall Study|Adverse Event|0|||
145267318|NCT01491737|523827371|FG000|Overall Study|Withdrawal by Subject|20|||
145267319|NCT01491737|523827372|FG001|Overall Study|Withdrawal by Subject|17|||
145733982|NCT02742766|525543414|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
145733983|NCT02742766|525543415|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733984|NCT02742766|525543416|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
145267320|NCT01491737|523827371|FG000|Overall Study|Lost to Follow-up|2|||
145267321|NCT01491737|523827372|FG001|Overall Study|Lost to Follow-up|10|||
145267322|NCT01491737|523827371|FG000|Overall Study|Death|63|||
145267323|NCT01491737|523827372|FG001|Overall Study|Death|57|||
145267324|NCT01491737|523827371|FG000|Overall Study|Study Termination by Sponsor|36|||
145267325|NCT01491737|523827372|FG001|Overall Study|Study Termination by Sponsor|36|||
145267326|NCT01491737|523827371|FG000|Overall Study|Reason Not Specified|8|||
145267327|NCT01491737|523827372|FG001|Overall Study|Reason Not Specified|9|||
145267328|NCT01817764|523827373|FG000|Overall Study|Adverse Event|7|||
145267329|NCT01817764|523827374|FG001|Overall Study|Adverse Event|10|||
145267330|NCT01817764|523827373|FG000|Overall Study|Lack of Efficacy|9|||
145267331|NCT01817764|523827374|FG001|Overall Study|Lack of Efficacy|7|||
145267332|NCT01817764|523827373|FG000|Overall Study|Protocol Violation|7|||
145267333|NCT01817764|523827374|FG001|Overall Study|Protocol Violation|5|||
145267334|NCT01817764|523827373|FG000|Overall Study|Lost to Follow-up|1|||
145267335|NCT01817764|523827374|FG001|Overall Study|Lost to Follow-up|4|||
145267336|NCT01817764|523827373|FG000|Overall Study|Withdrawal by Subject|10|||
145267337|NCT01817764|523827374|FG001|Overall Study|Withdrawal by Subject|12|||
145267338|NCT05993299|523827376|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
145267339|NCT05993299|523827376|FG000|Overall Study|Ongoing|4|||
145267340|NCT05644756|523827377|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
145267341|NCT05644756|523827377|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
145267342|NCT03110107|523827378|FG000|Treatment Period|Disease Progression|3|||
145267343|NCT03110107|523827379|FG001|Treatment Period|Disease Progression|9|||
145267344|NCT03110107|523827380|FG002|Treatment Period|Disease Progression|8|||
145267345|NCT03110107|523827381|FG003|Treatment Period|Disease Progression|11|||
145267346|NCT03110107|523827382|FG004|Treatment Period|Disease Progression|8|||
145267347|NCT03110107|523827383|FG005|Treatment Period|Disease Progression|4|||
145267348|NCT03110107|523827384|FG006|Treatment Period|Disease Progression|6|||
145267349|NCT03110107|523827385|FG007|Treatment Period|Disease Progression|7|||
145267350|NCT03110107|523827386|FG008|Treatment Period|Disease Progression|2|||
145267351|NCT03110107|523827387|FG009|Treatment Period|Disease Progression|10|||
145267352|NCT03110107|523827388|FG010|Treatment Period|Disease Progression|5|||
145267353|NCT03110107|523827389|FG011|Treatment Period|Disease Progression|2|||
145267354|NCT03110107|523827390|FG012|Treatment Period|Disease Progression|0|||
145267355|NCT03110107|523827391|FG013|Treatment Period|Disease Progression|5|||
145267356|NCT03110107|523827392|FG014|Treatment Period|Disease Progression|14|||
145267357|NCT03110107|523827393|FG015|Treatment Period|Disease Progression|14|||
145267358|NCT03110107|523827394|FG016|Treatment Period|Disease Progression|4|||
145267359|NCT03110107|523827395|FG017|Treatment Period|Disease Progression|3|||
145267360|NCT03110107|523827396|FG018|Treatment Period|Disease Progression|16|||
145267361|NCT03110107|523827397|FG019|Treatment Period|Disease Progression|14|||
145267362|NCT03110107|523827398|FG020|Treatment Period|Disease Progression|12|||
145267363|NCT03110107|523827399|FG021|Treatment Period|Disease Progression|16|||
145267364|NCT03110107|523827400|FG022|Treatment Period|Disease Progression|18|||
145267365|NCT03110107|523827401|FG023|Treatment Period|Disease Progression|13|||
145733985|NCT02742766|525543417|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
145267366|NCT03110107|523827402|FG024|Treatment Period|Disease Progression|16|||
145267367|NCT03110107|523827403|FG025|Treatment Period|Disease Progression|31|||
145267368|NCT03110107|523827378|FG000|Treatment Period|Study drug toxicity|1|||
145733986|NCT02742766|525543418|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733987|NCT02742766|525543419|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
145733988|NCT00999713|525543420|FG000|Overall Study|Physician Decision|2|||
145733989|NCT00999713|525543421|FG001|Overall Study|Physician Decision|0|||
145733990|NCT01840605|525543424|FG000|Overall Study|Adverse Event|0|||
145733991|NCT01840605|525543425|FG001|Overall Study|Adverse Event|1|||
145733992|NCT01840605|525543424|FG000|Overall Study|Physician Decision|2|||
145733993|NCT01840605|525543425|FG001|Overall Study|Physician Decision|1|||
145733994|NCT03739437|525543426|FG000|Overall Study|Lost to Follow-up|2|||
145733995|NCT03739437|525543427|FG001|Overall Study|Lost to Follow-up|5|||
145733996|NCT01351623|525543428|FG000|Overall Study|Protocol Violation|2|||
145733997|NCT01351623|525543428|FG000|Overall Study|Adverse Event|4|||
145733998|NCT01351623|525543428|FG000|Overall Study|Withdrawal by Subject|1|||
145733999|NCT01351623|525543428|FG000|Overall Study|Death|2|||
145734000|NCT04201821|525543432|FG000|Overall Study|Withdrawal by Subject|2|||
145734001|NCT01130974|525543433|FG000|Overall Study|Protocol Violation|10|||
145734002|NCT01130974|525543434|FG001|Overall Study|Protocol Violation|10|||
145734003|NCT01130974|525543433|FG000|Overall Study|Withdrawal by Subject|0|||
145734004|NCT01130974|525543434|FG001|Overall Study|Withdrawal by Subject|1|||
145734005|NCT01130974|525543433|FG000|Overall Study|Ineligibility criteria|5|||
145267369|NCT03110107|523827379|FG001|Treatment Period|Study drug toxicity|0|||
145267370|NCT03110107|523827380|FG002|Treatment Period|Study drug toxicity|1|||
145734006|NCT01130974|525543434|FG001|Overall Study|Ineligibility criteria|2|||
145734007|NCT01395316|525543435|FG000|Overall Study|Lost to Follow-up|2|||
145267371|NCT03110107|523827381|FG003|Treatment Period|Study drug toxicity|2|||
145267372|NCT03110107|523827382|FG004|Treatment Period|Study drug toxicity|0|||
145267373|NCT03110107|523827383|FG005|Treatment Period|Study drug toxicity|3|||
145267374|NCT03110107|523827384|FG006|Treatment Period|Study drug toxicity|1|||
145267375|NCT03110107|523827385|FG007|Treatment Period|Study drug toxicity|1|||
145267376|NCT03110107|523827386|FG008|Treatment Period|Study drug toxicity|3|||
145734008|NCT01395316|525543435|FG000|Overall Study|poor MRI quality|1|||
145734009|NCT03359590|525543439|FG000|First Intervention|Withdrawal by Subject|1|||
145734010|NCT03359590|525543440|FG001|First Intervention|Withdrawal by Subject|1|||
145267377|NCT03110107|523827387|FG009|Treatment Period|Study drug toxicity|2|||
145267378|NCT03110107|523827388|FG010|Treatment Period|Study drug toxicity|0|||
145267379|NCT03110107|523827389|FG011|Treatment Period|Study drug toxicity|2|||
145267380|NCT03110107|523827390|FG012|Treatment Period|Study drug toxicity|0|||
145267381|NCT03110107|523827391|FG013|Treatment Period|Study drug toxicity|0|||
145267382|NCT03110107|523827392|FG014|Treatment Period|Study drug toxicity|2|||
145267383|NCT03110107|523827393|FG015|Treatment Period|Study drug toxicity|3|||
145267384|NCT03110107|523827394|FG016|Treatment Period|Study drug toxicity|3|||
145267385|NCT03110107|523827395|FG017|Treatment Period|Study drug toxicity|3|||
145267386|NCT03110107|523827396|FG018|Treatment Period|Study drug toxicity|1|||
145267387|NCT03110107|523827397|FG019|Treatment Period|Study drug toxicity|2|||
145267388|NCT03110107|523827398|FG020|Treatment Period|Study drug toxicity|2|||
145267389|NCT03110107|523827399|FG021|Treatment Period|Study drug toxicity|0|||
145267390|NCT03110107|523827400|FG022|Treatment Period|Study drug toxicity|2|||
145267391|NCT03110107|523827401|FG023|Treatment Period|Study drug toxicity|6|||
145267392|NCT03110107|523827402|FG024|Treatment Period|Study drug toxicity|7|||
145267393|NCT03110107|523827403|FG025|Treatment Period|Study drug toxicity|6|||
145267394|NCT03110107|523827378|FG000|Treatment Period|Death|0|||
145267395|NCT03110107|523827379|FG001|Treatment Period|Death|0|||
145267396|NCT03110107|523827380|FG002|Treatment Period|Death|0|||
145267397|NCT03110107|523827381|FG003|Treatment Period|Death|0|||
145267398|NCT03110107|523827382|FG004|Treatment Period|Death|0|||
145267399|NCT03110107|523827383|FG005|Treatment Period|Death|0|||
145267400|NCT03110107|523827384|FG006|Treatment Period|Death|0|||
145267401|NCT03110107|523827385|FG007|Treatment Period|Death|0|||
145267402|NCT03110107|523827386|FG008|Treatment Period|Death|0|||
145267403|NCT03110107|523827387|FG009|Treatment Period|Death|0|||
145267404|NCT03110107|523827388|FG010|Treatment Period|Death|0|||
145267405|NCT03110107|523827389|FG011|Treatment Period|Death|0|||
145267406|NCT03110107|523827390|FG012|Treatment Period|Death|1|||
145267407|NCT03110107|523827391|FG013|Treatment Period|Death|0|||
145267408|NCT03110107|523827392|FG014|Treatment Period|Death|0|||
145267409|NCT03110107|523827393|FG015|Treatment Period|Death|0|||
145267410|NCT03110107|523827394|FG016|Treatment Period|Death|0|||
145267411|NCT03110107|523827395|FG017|Treatment Period|Death|0|||
145267412|NCT03110107|523827396|FG018|Treatment Period|Death|0|||
145267413|NCT03110107|523827397|FG019|Treatment Period|Death|0|||
145267414|NCT03110107|523827398|FG020|Treatment Period|Death|0|||
145267415|NCT03110107|523827399|FG021|Treatment Period|Death|0|||
145267416|NCT03110107|523827400|FG022|Treatment Period|Death|0|||
145267417|NCT03110107|523827401|FG023|Treatment Period|Death|0|||
145267418|NCT03110107|523827402|FG024|Treatment Period|Death|0|||
145267419|NCT03110107|523827403|FG025|Treatment Period|Death|0|||
145267420|NCT03110107|523827378|FG000|Treatment Period|Adverse Event|0|||
145267421|NCT03110107|523827379|FG001|Treatment Period|Adverse Event|0|||
145267422|NCT03110107|523827380|FG002|Treatment Period|Adverse Event|1|||
145267423|NCT03110107|523827381|FG003|Treatment Period|Adverse Event|0|||
145267424|NCT03110107|523827382|FG004|Treatment Period|Adverse Event|0|||
145267425|NCT03110107|523827383|FG005|Treatment Period|Adverse Event|2|||
145267426|NCT03110107|523827384|FG006|Treatment Period|Adverse Event|0|||
145267427|NCT03110107|523827385|FG007|Treatment Period|Adverse Event|2|||
145267428|NCT03110107|523827386|FG008|Treatment Period|Adverse Event|0|||
145267429|NCT03110107|523827387|FG009|Treatment Period|Adverse Event|1|||
145267430|NCT03110107|523827388|FG010|Treatment Period|Adverse Event|0|||
145267431|NCT03110107|523827389|FG011|Treatment Period|Adverse Event|0|||
145267432|NCT03110107|523827390|FG012|Treatment Period|Adverse Event|0|||
145267433|NCT03110107|523827391|FG013|Treatment Period|Adverse Event|0|||
145267434|NCT03110107|523827392|FG014|Treatment Period|Adverse Event|0|||
145267435|NCT03110107|523827393|FG015|Treatment Period|Adverse Event|2|||
145267436|NCT03110107|523827394|FG016|Treatment Period|Adverse Event|0|||
145267437|NCT03110107|523827395|FG017|Treatment Period|Adverse Event|1|||
145402224|NCT00750269|524330681|FG004|Overall Study|Physician Decision|2|||
145267438|NCT03110107|523827396|FG018|Treatment Period|Adverse Event|2|||
145267439|NCT03110107|523827397|FG019|Treatment Period|Adverse Event|1|||
145267440|NCT03110107|523827398|FG020|Treatment Period|Adverse Event|4|||
145267441|NCT03110107|523827399|FG021|Treatment Period|Adverse Event|2|||
145267442|NCT03110107|523827400|FG022|Treatment Period|Adverse Event|2|||
145267443|NCT03110107|523827401|FG023|Treatment Period|Adverse Event|2|||
145267444|NCT03110107|523827402|FG024|Treatment Period|Adverse Event|2|||
145267445|NCT03110107|523827403|FG025|Treatment Period|Adverse Event|4|||
145267446|NCT03110107|523827378|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
145515917|NCT01155011|524748648|FG001|6 to 12 Months|Withdrawal by Subject|5|||
145515918|NCT01155011|524748647|FG000|6 to 12 Months|Death|1|||
145515919|NCT01155011|524748648|FG001|6 to 12 Months|Death|5|||
145267447|NCT03110107|523827379|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
145267448|NCT03110107|523827380|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
145267449|NCT03110107|523827381|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
145402225|NCT00750269|524330677|FG000|Overall Study|Patient too large for positioning|0|||
145515920|NCT04620798|524748651|FG000|Overall Study|Lost to Follow-up|126|||
145402226|NCT00750269|524330678|FG001|Overall Study|Patient too large for positioning|0|||
145267450|NCT03110107|523827382|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
145267451|NCT03110107|523827383|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
145267452|NCT03110107|523827384|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
145267453|NCT03110107|523827385|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
145267454|NCT03110107|523827386|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
145267455|NCT03110107|523827387|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
145267456|NCT03110107|523827388|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
145267457|NCT03110107|523827389|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
145267458|NCT03110107|523827390|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
145267459|NCT03110107|523827391|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
145267460|NCT03110107|523827392|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
145267461|NCT03110107|523827393|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
145267462|NCT03110107|523827394|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
145267463|NCT03110107|523827395|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
145267464|NCT03110107|523827396|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
145267465|NCT03110107|523827397|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
145267466|NCT03110107|523827398|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
145402227|NCT00750269|524330679|FG002|Overall Study|Patient too large for positioning|1|||
145515921|NCT04620798|524748652|FG001|Overall Study|Lost to Follow-up|138|||
145515922|NCT01960907|524748653|FG000|Overall Study|Death|4|||
145515923|NCT01960907|524748654|FG001|Overall Study|Death|3|||
145515924|NCT01960907|524748653|FG000|Overall Study|Withdrawal by Subject|32|||
145515925|NCT01960907|524748654|FG001|Overall Study|Withdrawal by Subject|42|||
145515926|NCT03288142|524748662|FG000|Overall Study|Lost to Follow-up|22|||
145515927|NCT03288142|524748663|FG001|Overall Study|Lost to Follow-up|15|||
145515928|NCT01214395|524748666|FG000|Overall Study|All patients had infection|5|||
145515929|NCT02034409|524748667|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
145515930|NCT02034409|524748668|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
145515931|NCT02034409|524748667|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
145515932|NCT02034409|524748668|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
145515933|NCT02034409|524748667|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
145515934|NCT02034409|524748668|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
145515935|NCT02034409|524748667|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
145515936|NCT02034409|524748668|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
145267467|NCT03110107|523827399|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
145267468|NCT03110107|523827400|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
145515937|NCT02034409|524748667|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
145515938|NCT02034409|524748668|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
145515939|NCT02034409|524748667|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
145515940|NCT02034409|524748668|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
145515941|NCT00934843|524748669|FG000|Overall Study|Protocol Violation|0|||
145515942|NCT00934843|524748670|FG001|Overall Study|Protocol Violation|1|||
145515943|NCT00831493|524748673|FG000|Overall Study|Intractable nausea and vomiting|1|||
145515944|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
145515945|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
145515946|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
145515947|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
145515948|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
145267469|NCT03110107|523827401|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
145267470|NCT03110107|523827402|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
145267471|NCT03110107|523827403|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
145267472|NCT03110107|523827378|FG000|Treatment Period|Participant withdrew consent|0|||
145267473|NCT03110107|523827379|FG001|Treatment Period|Participant withdrew consent|0|||
145267474|NCT03110107|523827380|FG002|Treatment Period|Participant withdrew consent|1|||
145267475|NCT03110107|523827381|FG003|Treatment Period|Participant withdrew consent|0|||
145267476|NCT03110107|523827382|FG004|Treatment Period|Participant withdrew consent|4|||
145267477|NCT03110107|523827383|FG005|Treatment Period|Participant withdrew consent|3|||
145515949|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
145515950|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
145515951|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
145515952|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
145515953|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
145515954|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145515955|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
145515956|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145515957|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145515958|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145267478|NCT03110107|523827384|FG006|Treatment Period|Participant withdrew consent|0|||
145267479|NCT03110107|523827385|FG007|Treatment Period|Participant withdrew consent|0|||
145515959|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145515960|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145515961|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
145267480|NCT03110107|523827386|FG008|Treatment Period|Participant withdrew consent|0|||
145267481|NCT03110107|523827387|FG009|Treatment Period|Participant withdrew consent|1|||
145267482|NCT03110107|523827388|FG010|Treatment Period|Participant withdrew consent|0|||
145267483|NCT03110107|523827389|FG011|Treatment Period|Participant withdrew consent|0|||
145267484|NCT03110107|523827390|FG012|Treatment Period|Participant withdrew consent|0|||
145267485|NCT03110107|523827391|FG013|Treatment Period|Participant withdrew consent|0|||
145267486|NCT03110107|523827392|FG014|Treatment Period|Participant withdrew consent|0|||
145267487|NCT03110107|523827393|FG015|Treatment Period|Participant withdrew consent|0|||
145267488|NCT03110107|523827394|FG016|Treatment Period|Participant withdrew consent|0|||
145267489|NCT03110107|523827395|FG017|Treatment Period|Participant withdrew consent|0|||
145267490|NCT03110107|523827396|FG018|Treatment Period|Participant withdrew consent|0|||
145267491|NCT03110107|523827397|FG019|Treatment Period|Participant withdrew consent|1|||
145267492|NCT03110107|523827398|FG020|Treatment Period|Participant withdrew consent|0|||
145267493|NCT03110107|523827399|FG021|Treatment Period|Participant withdrew consent|2|||
145267494|NCT03110107|523827400|FG022|Treatment Period|Participant withdrew consent|0|||
145267495|NCT03110107|523827401|FG023|Treatment Period|Participant withdrew consent|0|||
145267496|NCT03110107|523827402|FG024|Treatment Period|Participant withdrew consent|0|||
145267497|NCT03110107|523827403|FG025|Treatment Period|Participant withdrew consent|2|||
145267498|NCT03110107|523827378|FG000|Treatment Period|Participants no longer meets study criteria|0|||
145267499|NCT03110107|523827379|FG001|Treatment Period|Participants no longer meets study criteria|0|||
145267500|NCT03110107|523827380|FG002|Treatment Period|Participants no longer meets study criteria|0|||
145267501|NCT03110107|523827381|FG003|Treatment Period|Participants no longer meets study criteria|0|||
145267502|NCT03110107|523827382|FG004|Treatment Period|Participants no longer meets study criteria|0|||
145267503|NCT03110107|523827383|FG005|Treatment Period|Participants no longer meets study criteria|0|||
145267504|NCT03110107|523827384|FG006|Treatment Period|Participants no longer meets study criteria|0|||
145267505|NCT03110107|523827385|FG007|Treatment Period|Participants no longer meets study criteria|0|||
145402228|NCT00750269|524330680|FG003|Overall Study|Patient too large for positioning|0|||
145267506|NCT03110107|523827386|FG008|Treatment Period|Participants no longer meets study criteria|0|||
145267507|NCT03110107|523827387|FG009|Treatment Period|Participants no longer meets study criteria|0|||
145267508|NCT03110107|523827388|FG010|Treatment Period|Participants no longer meets study criteria|0|||
145267509|NCT03110107|523827389|FG011|Treatment Period|Participants no longer meets study criteria|0|||
145267510|NCT03110107|523827390|FG012|Treatment Period|Participants no longer meets study criteria|0|||
145267511|NCT03110107|523827391|FG013|Treatment Period|Participants no longer meets study criteria|0|||
145267512|NCT03110107|523827392|FG014|Treatment Period|Participants no longer meets study criteria|0|||
145267513|NCT03110107|523827393|FG015|Treatment Period|Participants no longer meets study criteria|0|||
145267514|NCT03110107|523827394|FG016|Treatment Period|Participants no longer meets study criteria|0|||
145267515|NCT03110107|523827395|FG017|Treatment Period|Participants no longer meets study criteria|0|||
145267516|NCT03110107|523827396|FG018|Treatment Period|Participants no longer meets study criteria|0|||
145267517|NCT03110107|523827397|FG019|Treatment Period|Participants no longer meets study criteria|0|||
145267518|NCT03110107|523827398|FG020|Treatment Period|Participants no longer meets study criteria|0|||
145267519|NCT03110107|523827399|FG021|Treatment Period|Participants no longer meets study criteria|0|||
145267520|NCT03110107|523827400|FG022|Treatment Period|Participants no longer meets study criteria|0|||
145267521|NCT03110107|523827401|FG023|Treatment Period|Participants no longer meets study criteria|1|||
145267522|NCT03110107|523827402|FG024|Treatment Period|Participants no longer meets study criteria|0|||
145267523|NCT03110107|523827403|FG025|Treatment Period|Participants no longer meets study criteria|0|||
145267524|NCT03110107|523827378|FG000|Treatment Period|Other Reasons|0|||
145267525|NCT03110107|523827379|FG001|Treatment Period|Other Reasons|0|||
145267526|NCT03110107|523827380|FG002|Treatment Period|Other Reasons|1|||
145267527|NCT03110107|523827381|FG003|Treatment Period|Other Reasons|1|||
145267528|NCT03110107|523827382|FG004|Treatment Period|Other Reasons|0|||
145267529|NCT03110107|523827383|FG005|Treatment Period|Other Reasons|1|||
145267530|NCT03110107|523827384|FG006|Treatment Period|Other Reasons|0|||
145267531|NCT03110107|523827385|FG007|Treatment Period|Other Reasons|0|||
145267532|NCT03110107|523827386|FG008|Treatment Period|Other Reasons|0|||
145267533|NCT03110107|523827387|FG009|Treatment Period|Other Reasons|0|||
145267534|NCT03110107|523827388|FG010|Treatment Period|Other Reasons|0|||
145267535|NCT03110107|523827389|FG011|Treatment Period|Other Reasons|0|||
145267536|NCT03110107|523827390|FG012|Treatment Period|Other Reasons|0|||
145267537|NCT03110107|523827391|FG013|Treatment Period|Other Reasons|0|||
145267538|NCT03110107|523827392|FG014|Treatment Period|Other Reasons|0|||
145267539|NCT03110107|523827393|FG015|Treatment Period|Other Reasons|0|||
145267540|NCT03110107|523827394|FG016|Treatment Period|Other Reasons|0|||
145267541|NCT03110107|523827395|FG017|Treatment Period|Other Reasons|0|||
145267542|NCT03110107|523827396|FG018|Treatment Period|Other Reasons|0|||
145267543|NCT03110107|523827397|FG019|Treatment Period|Other Reasons|0|||
145267544|NCT03110107|523827398|FG020|Treatment Period|Other Reasons|0|||
145267545|NCT03110107|523827399|FG021|Treatment Period|Other Reasons|0|||
145267546|NCT03110107|523827400|FG022|Treatment Period|Other Reasons|0|||
145267547|NCT03110107|523827401|FG023|Treatment Period|Other Reasons|0|||
145267548|NCT03110107|523827402|FG024|Treatment Period|Other Reasons|1|||
145267549|NCT03110107|523827403|FG025|Treatment Period|Other Reasons|0|||
145515962|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
145267550|NCT03985982|523827404|FG000|Double-Blind Phase|Lost to Follow-up|4|||
145267551|NCT03985982|523827405|FG001|Double-Blind Phase|Lost to Follow-up|3|||
145267552|NCT03985982|523827406|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145267553|NCT03985982|523827404|FG000|Double-Blind Phase|Physician Decision|1|||
145267554|NCT03985982|523827405|FG001|Double-Blind Phase|Physician Decision|0|||
145267555|NCT03985982|523827406|FG002|Double-Blind Phase|Physician Decision|0|||
145267556|NCT03985982|523827404|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
145267557|NCT03985982|523827405|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
145267558|NCT03985982|523827406|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145267559|NCT03985982|523827404|FG000|Double-Blind Phase|COVID-19|1|||
145267560|NCT03985982|523827405|FG001|Double-Blind Phase|COVID-19|0|||
145267561|NCT03985982|523827406|FG002|Double-Blind Phase|COVID-19|0|||
145267562|NCT03985982|523827404|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
145292746|NCT06179108|523922227|FG001|Overall Study|Withdrawal by Subject|19|||
145267563|NCT03985982|523827405|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
145267564|NCT03985982|523827406|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
145267565|NCT03985982|523827404|FG000|Open-Label Phase|Lost to Follow-up|0|||
145267566|NCT03985982|523827405|FG001|Open-Label Phase|Lost to Follow-up|0|||
145267567|NCT03985982|523827406|FG002|Open-Label Phase|Lost to Follow-up|13|||
145267568|NCT03985982|523827404|FG000|Open-Label Phase|Physician Decision|0|||
145267569|NCT03985982|523827405|FG001|Open-Label Phase|Physician Decision|0|||
145267570|NCT03985982|523827406|FG002|Open-Label Phase|Physician Decision|2|||
145267571|NCT03985982|523827404|FG000|Open-Label Phase|Withdrawal by Subject|0|||
145267572|NCT03985982|523827405|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145267573|NCT03985982|523827406|FG002|Open-Label Phase|Withdrawal by Subject|11|||
145267574|NCT01283009|523827407|FG000|Overall Study|Death|83|||
145267575|NCT01283009|523827408|FG001|Overall Study|Death|78|||
145267576|NCT01283009|523827407|FG000|Overall Study|Study ended early|23|||
145267577|NCT01283009|523827408|FG001|Overall Study|Study ended early|26|||
145267578|NCT01283009|523827407|FG000|Overall Study|Withdrawal by Subject|10|||
145267579|NCT01283009|523827408|FG001|Overall Study|Withdrawal by Subject|8|||
145267580|NCT01283009|523827407|FG000|Overall Study|Physician Decision|1|||
145267581|NCT01283009|523827408|FG001|Overall Study|Physician Decision|1|||
145267582|NCT01283009|523827407|FG000|Overall Study|Lost to Follow-up|1|||
145267583|NCT01283009|523827408|FG001|Overall Study|Lost to Follow-up|0|||
145267584|NCT01283009|523827407|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
145267585|NCT01283009|523827408|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
145267586|NCT02743117|523827409|FG000|Overall Study|Lost to Follow-up|0|||
145267587|NCT02743117|523827410|FG001|Overall Study|Lost to Follow-up|1|||
145267588|NCT02743117|523827409|FG000|Overall Study|Other|1|||
145267589|NCT02743117|523827410|FG001|Overall Study|Other|0|||
145267590|NCT00585468|523827413|FG000|First Intervention|Withdrawal by Subject|1|||
145267591|NCT00585468|523827414|FG001|First Intervention|Withdrawal by Subject|1|||
145267592|NCT00762073|523827417|FG000|Overall Study|Lack of Efficacy|1|||
145267593|NCT00762073|523827418|FG001|Overall Study|Lack of Efficacy|1|||
145267594|NCT00762073|523827419|FG002|Overall Study|Lack of Efficacy|0|||
145267595|NCT00762073|523827420|FG003|Overall Study|Lack of Efficacy|0|||
145267596|NCT00762073|523827417|FG000|Overall Study|Adverse Event|1|||
145267597|NCT00762073|523827418|FG001|Overall Study|Adverse Event|0|||
145267598|NCT00762073|523827419|FG002|Overall Study|Adverse Event|1|||
145267599|NCT00762073|523827420|FG003|Overall Study|Adverse Event|1|||
145267600|NCT00762073|523827417|FG000|Overall Study|Significant Subject Noncompliance|0|||
145267601|NCT00762073|523827418|FG001|Overall Study|Significant Subject Noncompliance|1|||
145267602|NCT00762073|523827419|FG002|Overall Study|Significant Subject Noncompliance|0|||
145267603|NCT00762073|523827420|FG003|Overall Study|Significant Subject Noncompliance|1|||
145267604|NCT00762073|523827417|FG000|Overall Study|Withdrawal by Subject|1|||
145267605|NCT00762073|523827418|FG001|Overall Study|Withdrawal by Subject|2|||
145267606|NCT00762073|523827419|FG002|Overall Study|Withdrawal by Subject|1|||
145267607|NCT00762073|523827420|FG003|Overall Study|Withdrawal by Subject|1|||
145267608|NCT00762073|523827417|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
145267609|NCT00762073|523827418|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
145267610|NCT00762073|523827419|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
145267611|NCT00762073|523827420|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
145267612|NCT00938366|523827427|FG000|Overall Study|Withdrawal by Subject|1|||
145267613|NCT00938366|523827428|FG001|Overall Study|Withdrawal by Subject|0|||
145267614|NCT01215968|523827431|FG000|Overall Study|Adverse Event|0|||
145267615|NCT01215968|523827432|FG001|Overall Study|Adverse Event|2|||
145267616|NCT01215968|523827431|FG000|Overall Study|Protocol Violation|2|||
145267617|NCT01215968|523827432|FG001|Overall Study|Protocol Violation|4|||
145267618|NCT01215968|523827431|FG000|Overall Study|Not received study drug|0|||
145267619|NCT01215968|523827432|FG001|Overall Study|Not received study drug|1|||
145267620|NCT01958619|523827435|FG000|Overall Study|Protocol Violation|2|||
145267621|NCT01958619|523827436|FG001|Overall Study|Protocol Violation|0|||
145267622|NCT01958619|523827437|FG002|Overall Study|Protocol Violation|1|||
145267623|NCT01958619|523827438|FG003|Overall Study|Protocol Violation|0|||
145267624|NCT04794491|523827439|FG000|Overall Study|Adverse Event|1|||
145267625|NCT04794491|523827439|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
145267626|NCT04794491|523827439|FG000|Overall Study|Noncompliance With Study Intervention|1|||
145267627|NCT04794491|523827439|FG000|Overall Study|Withdrawal by Subject|2|||
145267628|NCT03795233|523827440|FG000|Overall Study|Withdrawal by Subject|2|||
145267629|NCT03795233|523827441|FG001|Overall Study|Withdrawal by Subject|1|||
145267630|NCT03795233|523827440|FG000|Overall Study|Lost to Follow-up|1|||
145267631|NCT03795233|523827441|FG001|Overall Study|Lost to Follow-up|0|||
145267632|NCT03795233|523827440|FG000|Overall Study|Death|1|||
145267633|NCT03795233|523827441|FG001|Overall Study|Death|0|||
145267634|NCT01054443|523827442|FG000|Overall Study|Withdrawal by Subject|0|||
145267635|NCT01054443|523827443|FG001|Overall Study|Withdrawal by Subject|0|||
145267636|NCT01054443|523827444|FG002|Overall Study|Withdrawal by Subject|0|||
145267637|NCT01054443|523827445|FG003|Overall Study|Withdrawal by Subject|1|||
145267638|NCT00985114|523827447|FG000|Overall Study|Adverse Event|1|||
145515963|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
145515964|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
145515965|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
145515966|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
145515967|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
145267639|NCT00985114|523827448|FG001|Overall Study|Adverse Event|0|||
145267640|NCT00985114|523827447|FG000|Overall Study|Withdrawal by Subject|0|||
145267641|NCT00985114|523827448|FG001|Overall Study|Withdrawal by Subject|2|||
145267642|NCT02950831|523827449|FG000|Overall Study|Lost to Follow-up|1|||
145267643|NCT02950831|523827449|FG000|Overall Study|Withdrawal by Subject|3|||
145267644|NCT02950831|523827449|FG000|Overall Study|stimulation trail failure|5|||
145267645|NCT01119118|523827450|FG000|Overall Study|Adverse Event|1|||
145267646|NCT02711306|523827456|FG000|Overall Study|Withdrawal by Subject|2|||
145267647|NCT02711306|523827457|FG001|Overall Study|Withdrawal by Subject|2|||
145267648|NCT03145207|523827462|FG000|Overall Study|volunteer started taking allergy shots|1|||
145267649|NCT03145207|523827462|FG000|Overall Study|baseline blood pressure high|1|||
145267650|NCT01676818|523827466|FG000|Overall Study|Physician Decision|1|||
145267651|NCT01676818|523827466|FG000|Overall Study|Withdrawal by Subject|1|||
145267652|NCT03213704|523827471|FG000|Overall Study|Physician Decision|3|||
145267653|NCT03213704|523827471|FG000|Overall Study|Protocol Violation|1|||
145267654|NCT03213704|523827471|FG000|Overall Study|Progressive disease|4|||
145267655|NCT04075656|523827472|FG000|Overall Study|Withdrawal by Subject|5|||
145267656|NCT04075656|523827473|FG001|Overall Study|Withdrawal by Subject|5|||
145267657|NCT01646268|523829242|FG000|Overall Study|Adverse Event|6|||
145267658|NCT01646268|523829243|FG001|Overall Study|Adverse Event|7|||
145267659|NCT01646268|523829242|FG000|Overall Study|Lack of Efficacy|1|||
145267660|NCT01646268|523829243|FG001|Overall Study|Lack of Efficacy|3|||
145267661|NCT01646268|523829242|FG000|Overall Study|Protocol Violation|0|||
145267662|NCT01646268|523829243|FG001|Overall Study|Protocol Violation|1|||
145267663|NCT01646268|523829242|FG000|Overall Study|Withdrawal by Subject|2|||
145267664|NCT01646268|523829243|FG001|Overall Study|Withdrawal by Subject|5|||
145267665|NCT01646268|523829242|FG000|Overall Study|Other|2|||
145267666|NCT01646268|523829243|FG001|Overall Study|Other|0|||
145267667|NCT02325414|523829244|FG000|Overall Study|Withdrawal by Subject|3|||
145267668|NCT02325414|523829245|FG001|Overall Study|Withdrawal by Subject|1|||
145267669|NCT02325414|523829244|FG000|Overall Study|Lost to Follow-up|5|||
145267670|NCT02325414|523829245|FG001|Overall Study|Lost to Follow-up|5|||
145267671|NCT00347776|523829246|FG000|1.5 Month Follow-up|Death|2|||
145267672|NCT00347776|523829247|FG001|1.5 Month Follow-up|Death|0|||
145267673|NCT00347776|523829248|FG002|1.5 Month Follow-up|Death|0|||
145267674|NCT00347776|523829246|FG000|1.5 Month Follow-up|reached the endpoint|12|||
145267675|NCT00347776|523829247|FG001|1.5 Month Follow-up|reached the endpoint|8|||
145267676|NCT00347776|523829248|FG002|1.5 Month Follow-up|reached the endpoint|12|||
145267677|NCT00347776|523829246|FG000|6 Month Follow-up|Death|2|||
145267678|NCT00347776|523829247|FG001|6 Month Follow-up|Death|1|||
145267679|NCT00347776|523829248|FG002|6 Month Follow-up|Death|3|||
145267680|NCT00347776|523829246|FG000|6 Month Follow-up|reached endpont|20|||
145267681|NCT00347776|523829247|FG001|6 Month Follow-up|reached endpont|12|||
145267682|NCT00347776|523829248|FG002|6 Month Follow-up|reached endpont|15|||
145267683|NCT00347776|523829246|FG000|12 Month Follow-up|Lost to Follow-up|7|||
145267684|NCT00347776|523829247|FG001|12 Month Follow-up|Lost to Follow-up|6|||
145267685|NCT00347776|523829248|FG002|12 Month Follow-up|Lost to Follow-up|6|||
145267686|NCT00347776|523829246|FG000|12 Month Follow-up|Death|3|||
145267687|NCT00347776|523829247|FG001|12 Month Follow-up|Death|4|||
145267688|NCT00347776|523829248|FG002|12 Month Follow-up|Death|4|||
145267689|NCT00347776|523829246|FG000|12 Month Follow-up|Reached endpoint|13|||
145267690|NCT00347776|523829247|FG001|12 Month Follow-up|Reached endpoint|6|||
145267691|NCT00347776|523829248|FG002|12 Month Follow-up|Reached endpoint|9|||
145267692|NCT00457249|523829249|FG000|Overall Study|Lost to Follow-up|3|||
145267693|NCT00457249|523829250|FG001|Overall Study|Lost to Follow-up|0|||
145267694|NCT00457249|523829249|FG000|Overall Study|Protocol Violation|4|||
145267695|NCT00457249|523829250|FG001|Overall Study|Protocol Violation|1|||
145267696|NCT00457249|523829249|FG000|Overall Study|Withdrawal by Subject|3|||
145267697|NCT00457249|523829250|FG001|Overall Study|Withdrawal by Subject|1|||
145267698|NCT00457249|523829249|FG000|Overall Study|Serious Adverse Events|2|||
145267699|NCT00457249|523829250|FG001|Overall Study|Serious Adverse Events|0|||
145267700|NCT00326118|523829251|FG000|Active Phase|Withdrawal by Subject|4|||
145267701|NCT00326118|523829252|FG001|Active Phase|Withdrawal by Subject|1|||
145267702|NCT02916056|523829253|FG000|Overall Study|Adverse Event|6|||
145267703|NCT02916056|523829253|FG000|Overall Study|Lost to Follow-up|1|||
145267704|NCT02916056|523829253|FG000|Overall Study|Other|12|||
145267705|NCT02916056|523829253|FG000|Overall Study|Protocol Violation|1|||
145267706|NCT02916056|523829253|FG000|Overall Study|Withdrawal by Subject|8|||
145267707|NCT02916056|523829253|FG000|Overall Study|Study Terminated by Sponsor|269|||
145267708|NCT00124709|523829254|FG000|Overall Study|Randomized but did not take medication|3|||
145267709|NCT00124709|523829255|FG001|Overall Study|Randomized but did not take medication|1|||
145267710|NCT00124709|523829254|FG000|Overall Study|Adverse Event|3|||
145267711|NCT00124709|523829255|FG001|Overall Study|Adverse Event|0|||
145267712|NCT00124709|523829254|FG000|Overall Study|Lack of Efficacy|5|||
145267713|NCT00124709|523829255|FG001|Overall Study|Lack of Efficacy|10|||
145267714|NCT00124709|523829254|FG000|Overall Study|Protocol Violation|3|||
145267715|NCT00124709|523829255|FG001|Overall Study|Protocol Violation|5|||
145267716|NCT00124709|523829254|FG000|Overall Study|Withdrawal by Subject|127|||
145267717|NCT00124709|523829255|FG001|Overall Study|Withdrawal by Subject|136|||
145267718|NCT00124709|523829254|FG000|Overall Study|Lost to Follow-up|114|||
145267719|NCT00124709|523829255|FG001|Overall Study|Lost to Follow-up|120|||
145267720|NCT00122954|523829256|FG000|Overall Study|Withdrawal by Subject|2|||
145267721|NCT00122954|523829257|FG001|Overall Study|Withdrawal by Subject|2|||
145267722|NCT00122954|523829256|FG000|Overall Study|Protocol Violation|0|||
145267723|NCT00122954|523829257|FG001|Overall Study|Protocol Violation|1|||
145267724|NCT05279807|523829267|FG000|Overall Study|Withdrawal by Subject|1|||
145267725|NCT05279807|523829268|FG001|Overall Study|Withdrawal by Subject|0|||
145267726|NCT05279807|523829267|FG000|Overall Study|Adverse Event|0|||
145267727|NCT05279807|523829268|FG001|Overall Study|Adverse Event|1|||
145267728|NCT05279807|523829267|FG000|Overall Study|Laboratory Abnormal Results|1|||
145267729|NCT05279807|523829268|FG001|Overall Study|Laboratory Abnormal Results|0|||
145267730|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
145267731|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
145267732|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
145267733|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145267734|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145267735|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145267736|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145267737|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145267738|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
145267739|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
145267740|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145267741|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145267742|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145267743|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145267744|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
145267745|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
145267746|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
145267747|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145267748|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145267749|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145267750|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145267751|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
145267752|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
145267753|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
145267754|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145267755|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145267756|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145267757|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145267758|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
145267759|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267760|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267761|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267762|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267763|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267764|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
145267765|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267766|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267767|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
145267768|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267769|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267770|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267771|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
145267772|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267773|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267774|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
145267775|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267776|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267777|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267778|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
145267779|NCT04242446|523829273|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145267780|NCT04242446|523829274|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
145267781|NCT04242446|523829275|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
145267782|NCT04242446|523829276|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145267783|NCT04242446|523829277|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145267784|NCT04242446|523829278|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145267785|NCT04242446|523829279|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145267786|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145267787|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145267788|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145267789|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
145267790|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
145267791|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
145267792|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
145267793|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145267794|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145267795|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145267796|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
145267797|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
145267798|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
145267799|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
145267800|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145267801|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145267802|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145267803|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
145267804|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
145267805|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
145267806|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
145267807|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145267808|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145267809|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145267810|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
145267811|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
145267812|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
145267813|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
145267814|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145267815|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145267816|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145267817|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
145267818|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
145267819|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
145267820|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
145267821|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267822|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267823|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267824|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
145267825|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267826|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267827|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
145267828|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267829|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267830|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267831|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267832|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
145267833|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267834|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
145267835|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145267836|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145267837|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145402229|NCT00750269|524330681|FG004|Overall Study|Patient too large for positioning|0|||
145402230|NCT00750269|524330677|FG000|Overall Study|Site error|0|||
145267838|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145267839|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
145267840|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145267841|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
145267842|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267843|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267844|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267845|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267846|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
145267847|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267848|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
145267849|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267850|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267851|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267852|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267853|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
145267854|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267855|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
145267856|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267857|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267858|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267859|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267860|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
145267861|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267862|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
145267863|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267864|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267865|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267866|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267867|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267868|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
145267869|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
145267870|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267871|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267872|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267873|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267874|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267875|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
145267876|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
145267877|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267878|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267879|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267880|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267881|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267882|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
145267883|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
145267884|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267885|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267886|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267887|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267888|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267889|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
145267890|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
145267891|NCT04242446|523829273|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145515968|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
145515969|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
145267892|NCT04242446|523829274|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145267893|NCT04242446|523829275|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145267894|NCT04242446|523829276|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145267895|NCT04242446|523829277|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145267896|NCT04242446|523829278|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
145267897|NCT04242446|523829279|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
145267898|NCT03587116|523829280|FG000|Overall Study|Lost to Follow-up|0|||
145267899|NCT03587116|523829281|FG001|Overall Study|Lost to Follow-up|1|||
145267900|NCT03587116|523829280|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
145267901|NCT03587116|523829281|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
145267902|NCT03587116|523829280|FG000|Overall Study|Withdrawal by Subject|4|||
145267903|NCT03587116|523829281|FG001|Overall Study|Withdrawal by Subject|0|||
145267904|NCT03526549|523829286|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
145267905|NCT03526549|523829287|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
145267906|NCT03526549|523829286|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
145267907|NCT03526549|523829287|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
145267908|NCT03526549|523829286|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
145267909|NCT03526549|523829287|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
145515970|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
145515971|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|Other|0|||
145515972|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|Other|0|||
145515973|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|Other|1|||
145515974|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|Other|1|||
145515975|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|Other|0|||
145515976|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|Other|0|||
145267910|NCT03526549|523829286|FG000|Open-label Phase|Adverse Event|4|||
145267911|NCT03526549|523829287|FG001|Open-label Phase|Adverse Event|0|||
145267912|NCT03526549|523829286|FG000|Open-label Phase|Withdrawal by Subject|54|||
145267913|NCT03526549|523829287|FG001|Open-label Phase|Withdrawal by Subject|0|||
145267914|NCT03526549|523829286|FG000|Open-label Phase|Lost to Follow-up|35|||
145515977|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|Other|0|||
145515978|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|Other|1|||
145515979|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|Other|0|||
145515980|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|Death|0|||
145515981|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|Death|0|||
145515982|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|Death|0|||
145515983|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|Death|0|||
145515984|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|Death|0|||
145515985|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|Death|1|||
145515986|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|Death|0|||
145515987|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|Death|0|||
145515988|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|Death|0|||
145515989|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145515990|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145515991|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145267915|NCT03526549|523829287|FG001|Open-label Phase|Lost to Follow-up|0|||
145267916|NCT03526549|523829286|FG000|Open-label Phase|Other than Specified|5|||
145267917|NCT03526549|523829287|FG001|Open-label Phase|Other than Specified|0|||
145267918|NCT05981365|523829288|FG000|Period 1|Adverse Event|1|||
145267919|NCT05981365|523829289|FG001|Period 1|Adverse Event|0|||
145267920|NCT03927989|523829291|FG000|Overall Study|Withdrawal by Subject|0|||
145267921|NCT03927989|523829292|FG001|Overall Study|Withdrawal by Subject|1|||
145267922|NCT02593175|523829293|FG000|Overall Study|Adverse Event|5|||
145267923|NCT02593175|523829293|FG000|Overall Study|Disease progression|4|||
145267924|NCT00478933|523829297|FG000|Overall Study|Protocol Violation|22|||
145267925|NCT00478933|523829297|FG000|Overall Study|Informed consent not verified|3|||
145267926|NCT00478933|523829297|FG000|Overall Study|Inadequate data available|53|||
145267927|NCT00643006|523829298|FG000|Overall Study|Lost to Follow-up|5|||
145267928|NCT00643006|523829299|FG001|Overall Study|Lost to Follow-up|4|||
145267929|NCT03586427|523829306|FG000|Overall Study|Lost to Follow-up|0|||
145267930|NCT03586427|523829307|FG001|Overall Study|Lost to Follow-up|3|||
145267931|NCT03586427|523829308|FG002|Overall Study|Lost to Follow-up|1|||
145267932|NCT03586427|523829309|FG003|Overall Study|Lost to Follow-up|3|||
145267933|NCT03586427|523829310|FG004|Overall Study|Lost to Follow-up|3|||
145267934|NCT03586427|523829306|FG000|Overall Study|Withdrawal by Subject|0|||
145267935|NCT03586427|523829307|FG001|Overall Study|Withdrawal by Subject|1|||
145267936|NCT03586427|523829308|FG002|Overall Study|Withdrawal by Subject|2|||
145267937|NCT03586427|523829309|FG003|Overall Study|Withdrawal by Subject|1|||
145267938|NCT03586427|523829310|FG004|Overall Study|Withdrawal by Subject|1|||
145267939|NCT03586427|523829306|FG000|Overall Study|Adverse Event|0|||
145267940|NCT03586427|523829307|FG001|Overall Study|Adverse Event|0|||
145267941|NCT03586427|523829308|FG002|Overall Study|Adverse Event|1|||
145267942|NCT03586427|523829309|FG003|Overall Study|Adverse Event|0|||
145267943|NCT03586427|523829310|FG004|Overall Study|Adverse Event|0|||
145267944|NCT03586427|523829306|FG000|Overall Study|Protocol Violation|0|||
145267945|NCT03586427|523829307|FG001|Overall Study|Protocol Violation|0|||
145267946|NCT03586427|523829308|FG002|Overall Study|Protocol Violation|1|||
145267947|NCT03586427|523829309|FG003|Overall Study|Protocol Violation|0|||
145267948|NCT03586427|523829310|FG004|Overall Study|Protocol Violation|1|||
145267949|NCT03586427|523829306|FG000|Overall Study|Noncompliance with study drug|0|||
145267950|NCT03586427|523829307|FG001|Overall Study|Noncompliance with study drug|0|||
145267951|NCT03586427|523829308|FG002|Overall Study|Noncompliance with study drug|1|||
145267952|NCT03586427|523829309|FG003|Overall Study|Noncompliance with study drug|0|||
145267953|NCT03586427|523829310|FG004|Overall Study|Noncompliance with study drug|0|||
145515992|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145515993|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145267954|NCT00593385|523829313|FG000|Overall Study|Death|14|||
145267955|NCT00593385|523829313|FG000|Overall Study|Lost to Follow-up|17|||
145267956|NCT00593385|523829313|FG000|Overall Study|Withdrawal by Subject|9|||
145267957|NCT01471197|523829314|FG000|Overall Study|Disease Progression|4|||
145267958|NCT01471197|523829315|FG001|Overall Study|Disease Progression|2|||
145267959|NCT01471197|523829314|FG000|Overall Study|Death|1|||
145267960|NCT01471197|523829315|FG001|Overall Study|Death|0|||
145267961|NCT01471197|523829314|FG000|Overall Study|Study Drug Toxicity|1|||
145267962|NCT01471197|523829315|FG001|Overall Study|Study Drug Toxicity|0|||
145267963|NCT00924313|523829318|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
145267964|NCT01453296|523829326|FG000|Treatment Period 1|Adverse Event|0|||
145267965|NCT01453296|523829327|FG001|Treatment Period 1|Adverse Event|1|||
145267966|NCT01453296|523829326|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
145267967|NCT01453296|523829327|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
145267968|NCT01453296|523829326|FG000|Treatment Period 2|Adverse Event|1|||
145267969|NCT01453296|523829327|FG001|Treatment Period 2|Adverse Event|0|||
145267970|NCT01453296|523829326|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145402231|NCT00750269|524330678|FG001|Overall Study|Site error|0|||
145402232|NCT00750269|524330679|FG002|Overall Study|Site error|0|||
145267971|NCT01453296|523829327|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145267972|NCT04983589|523829328|FG000|Overall Study|Withdrawal by Subject|0|||
145267973|NCT04983589|523829329|FG001|Overall Study|Withdrawal by Subject|3|||
145267974|NCT04983589|523829328|FG000|Overall Study|COVID-19 Infection|1|||
145267975|NCT04983589|523829329|FG001|Overall Study|COVID-19 Infection|0|||
145267976|NCT04983589|523829328|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
145267977|NCT04983589|523829329|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
145267978|NCT00978120|523829332|FG000|Overall Study|Death|0|||
145267979|NCT00978120|523829333|FG001|Overall Study|Death|0|||
145267980|NCT00978120|523829334|FG002|Overall Study|Death|0|||
145267981|NCT00978120|523829335|FG003|Overall Study|Death|1|||
145267982|NCT00978120|523829332|FG000|Overall Study|Lost to Follow-up|0|||
145267983|NCT00978120|523829333|FG001|Overall Study|Lost to Follow-up|0|||
145267984|NCT00978120|523829334|FG002|Overall Study|Lost to Follow-up|3|||
145267985|NCT00978120|523829335|FG003|Overall Study|Lost to Follow-up|0|||
145267986|NCT00978120|523829332|FG000|Overall Study|Withdrawal by Subject|2|||
145267987|NCT00978120|523829333|FG001|Overall Study|Withdrawal by Subject|0|||
145267988|NCT00978120|523829334|FG002|Overall Study|Withdrawal by Subject|0|||
145267989|NCT00978120|523829335|FG003|Overall Study|Withdrawal by Subject|0|||
145267990|NCT00978120|523829332|FG000|Overall Study|Moved out of state|0|||
145267991|NCT00978120|523829333|FG001|Overall Study|Moved out of state|0|||
145267992|NCT00978120|523829334|FG002|Overall Study|Moved out of state|0|||
145267993|NCT00978120|523829335|FG003|Overall Study|Moved out of state|1|||
145267994|NCT03155269|523829336|FG000|Overall Study|Withdrawal by Subject|4|||
145267995|NCT03155269|523829337|FG001|Overall Study|Withdrawal by Subject|5|||
145267996|NCT03155269|523829336|FG000|Overall Study|Lost to Follow-up|1|||
145267997|NCT03155269|523829337|FG001|Overall Study|Lost to Follow-up|2|||
145267998|NCT00455923|523829345|FG000|Overall Study|Pregnancy|0|||
145267999|NCT00455923|523829346|FG001|Overall Study|Pregnancy|2|||
145268000|NCT00455923|523829345|FG000|Overall Study|Other|3|||
145268001|NCT00455923|523829346|FG001|Overall Study|Other|1|||
145268002|NCT02686749|523829348|FG000|Overall Study|terminated for poor enrollment|2|||
145268003|NCT02686749|523829349|FG001|Overall Study|terminated for poor enrollment|2|||
145268004|NCT03707145|523829354|FG000|Overall Study|Lost to Follow-up|0|||
145268005|NCT03707145|523829355|FG001|Overall Study|Lost to Follow-up|1|||
145268006|NCT03707145|523829356|FG002|Overall Study|Lost to Follow-up|1|||
145268007|NCT03707145|523829357|FG003|Overall Study|Lost to Follow-up|0|||
145268008|NCT04882085|523829358|FG000|Overall Study|Death|6|||
145268009|NCT04882085|523829359|FG001|Overall Study|Death|9|||
145268010|NCT04882085|523829358|FG000|Overall Study|Withdrawal by Subject|0|||
145268011|NCT04882085|523829359|FG001|Overall Study|Withdrawal by Subject|3|||
145268012|NCT04882085|523829358|FG000|Overall Study|Randomized not treated|1|||
145268013|NCT04882085|523829359|FG001|Overall Study|Randomized not treated|0|||
145268014|NCT00145119|523829360|FG000|Overall Study|Death|45|||
145268015|NCT05403502|523829361|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
145268016|NCT05403502|523829361|FG000|Humalog Lead-In Period|Physician Decision|2|||
145268017|NCT05403502|523829361|FG000|Humalog Lead-In Period|Protocol Violation|1|||
145268018|NCT05403502|523829361|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
145268019|NCT05403502|523829361|FG000|Lyumjev Treatment Period|Physician Decision|2|||
145268020|NCT01003691|523829362|FG000|Overall Study|Adverse Event|0|||
145268021|NCT01003691|523829363|FG001|Overall Study|Adverse Event|0|||
145268022|NCT01003691|523829364|FG002|Overall Study|Adverse Event|0|||
145268023|NCT01003691|523829365|FG003|Overall Study|Adverse Event|1|||
145268024|NCT04814654|523829366|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
145268025|NCT04814654|523829367|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
145268026|NCT04814654|523829368|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
145268027|NCT02207413|523829371|FG000|Overall Study|Withdrawal by Subject|1|||
145268028|NCT02207413|523829372|FG001|Overall Study|Withdrawal by Subject|0|||
145268029|NCT02207413|523829373|FG002|Overall Study|Withdrawal by Subject|0|||
145268030|NCT02207413|523829374|FG003|Overall Study|Withdrawal by Subject|0|||
145268031|NCT02207413|523829375|FG004|Overall Study|Withdrawal by Subject|3|||
145515994|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
145268032|NCT02207413|523829376|FG005|Overall Study|Withdrawal by Subject|7|||
145268033|NCT02207413|523829371|FG000|Overall Study|Lost to Follow-up|0|||
145268034|NCT02207413|523829372|FG001|Overall Study|Lost to Follow-up|0|||
145268035|NCT02207413|523829373|FG002|Overall Study|Lost to Follow-up|0|||
145268036|NCT02207413|523829374|FG003|Overall Study|Lost to Follow-up|1|||
145268037|NCT02207413|523829375|FG004|Overall Study|Lost to Follow-up|1|||
145268038|NCT02207413|523829376|FG005|Overall Study|Lost to Follow-up|5|||
145268039|NCT02207413|523829371|FG000|Overall Study|Adverse Event|0|||
145268040|NCT02207413|523829372|FG001|Overall Study|Adverse Event|0|||
145268041|NCT02207413|523829373|FG002|Overall Study|Adverse Event|0|||
145268042|NCT02207413|523829374|FG003|Overall Study|Adverse Event|0|||
145268043|NCT02207413|523829375|FG004|Overall Study|Adverse Event|2|||
145268044|NCT02207413|523829376|FG005|Overall Study|Adverse Event|1|||
145515995|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
145268045|NCT02207413|523829371|FG000|Overall Study|Migrated/moved from study area|0|||
145268046|NCT02207413|523829372|FG001|Overall Study|Migrated/moved from study area|0|||
145268047|NCT02207413|523829373|FG002|Overall Study|Migrated/moved from study area|0|||
145268048|NCT02207413|523829374|FG003|Overall Study|Migrated/moved from study area|0|||
145268049|NCT02207413|523829375|FG004|Overall Study|Migrated/moved from study area|1|||
145268050|NCT02207413|523829376|FG005|Overall Study|Migrated/moved from study area|0|||
145268051|NCT01100073|523830816|FG000|Overall Study|Lack of Efficacy|4|||
145268052|NCT01100073|523830816|FG000|Overall Study|Insufficient Tolerability|21|||
145268053|NCT01100073|523830816|FG000|Overall Study|Withdrawal by Subject|13|||
145268054|NCT01100073|523830816|FG000|Overall Study|Lost to Follow-up|39|||
145268055|NCT01100073|523830816|FG000|Overall Study|Lack of effect + patient's wish|2|||
145268056|NCT01100073|523830816|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
145268057|NCT01100073|523830816|FG000|Overall Study|Other|8|||
145268058|NCT01100073|523830816|FG000|Overall Study|Missing|5|||
145268059|NCT00299546|523830817|FG000|Overall Study|Death|3|||
145268060|NCT00299546|523830818|FG001|Overall Study|Death|2|||
145268061|NCT00299546|523830819|FG002|Overall Study|Death|0|||
145268062|NCT00299546|523830817|FG000|Overall Study|Lost to Follow-up|2|||
145268063|NCT00299546|523830818|FG001|Overall Study|Lost to Follow-up|2|||
145268064|NCT00299546|523830819|FG002|Overall Study|Lost to Follow-up|5|||
145268065|NCT00299546|523830817|FG000|Overall Study|Adverse Event|37|||
145268066|NCT00299546|523830818|FG001|Overall Study|Adverse Event|22|||
145268067|NCT00299546|523830819|FG002|Overall Study|Adverse Event|27|||
145268068|NCT00299546|523830817|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
145268069|NCT00299546|523830818|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
145268070|NCT00299546|523830819|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
145268071|NCT00299546|523830817|FG000|Overall Study|Other|24|||
145268072|NCT00299546|523830818|FG001|Overall Study|Other|26|||
145268073|NCT00299546|523830819|FG002|Overall Study|Other|19|||
145268074|NCT00299546|523830817|FG000|Overall Study|Not treated|0|||
145268075|NCT00299546|523830818|FG001|Overall Study|Not treated|1|||
145268076|NCT00299546|523830819|FG002|Overall Study|Not treated|1|||
145268077|NCT01741259|523830820|FG000|Overall Study|Protocol Violation|6|||
145268078|NCT01741259|523830821|FG001|Overall Study|Protocol Violation|4|||
145268079|NCT01741259|523830820|FG000|Overall Study|Withdrawal by Subject|0|||
145268080|NCT01741259|523830821|FG001|Overall Study|Withdrawal by Subject|2|||
145268081|NCT02074982|523830822|FG000|Overall Study|Adverse Event|15|||
145268082|NCT02074982|523830823|FG001|Overall Study|Adverse Event|7|||
145268083|NCT02074982|523830822|FG000|Overall Study|Lack of Efficacy|6|||
145268084|NCT02074982|523830823|FG001|Overall Study|Lack of Efficacy|1|||
145268085|NCT02074982|523830822|FG000|Overall Study|Lost to Follow-up|9|||
145268086|NCT02074982|523830823|FG001|Overall Study|Lost to Follow-up|10|||
145268087|NCT02074982|523830822|FG000|Overall Study|Non-compliance with study treatment|0|||
145268088|NCT02074982|523830823|FG001|Overall Study|Non-compliance with study treatment|2|||
145268089|NCT02074982|523830822|FG000|Overall Study|Physician Decision|1|||
145268090|NCT02074982|523830823|FG001|Overall Study|Physician Decision|1|||
145268091|NCT02074982|523830822|FG000|Overall Study|Pregnancy|1|||
145268092|NCT02074982|523830823|FG001|Overall Study|Pregnancy|2|||
145268093|NCT02074982|523830822|FG000|Overall Study|Protocol deviation|4|||
145268094|NCT02074982|523830823|FG001|Overall Study|Protocol deviation|3|||
145268095|NCT02074982|523830822|FG000|Overall Study|Technical problems|0|||
145268096|NCT02074982|523830823|FG001|Overall Study|Technical problems|2|||
145268097|NCT02074982|523830822|FG000|Overall Study|Subject/guardian decision|15|||
145268098|NCT02074982|523830823|FG001|Overall Study|Subject/guardian decision|24|||
145268099|NCT02074982|523830822|FG000|Overall Study|Death|0|||
145268100|NCT02074982|523830823|FG001|Overall Study|Death|2|||
145268101|NCT00526162|523830826|FG000|Overall Study|Device not implanted|3|||
145268102|NCT03772574|523830832|FG000|Overall Study|Protocol Violation|2|||
145268103|NCT03772574|523830833|FG001|Overall Study|Protocol Violation|0|||
145268104|NCT03772574|523830834|FG002|Overall Study|Protocol Violation|0|||
145268105|NCT03772574|523830832|FG000|Overall Study|Discomfort|0|||
145268106|NCT03772574|523830833|FG001|Overall Study|Discomfort|5|||
145268107|NCT03772574|523830834|FG002|Overall Study|Discomfort|4|||
145268108|NCT03193996|523830837|FG000|Overall Study|Withdrawal by Subject|4|||
145268109|NCT03193996|523830837|FG000|Overall Study|Lost to Follow-up|4|||
145268110|NCT03193996|523830837|FG000|Overall Study|Physician Decision|2|||
145268111|NCT03193996|523830837|FG000|Overall Study|Pregnancy|1|||
145268112|NCT03193996|523830837|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
145268113|NCT03193996|523830837|FG000|Overall Study|Complicating disease|1|||
145268114|NCT05027958|523830838|FG000|Overall Study|Lost to Follow-up|1|||
145268115|NCT05027958|523830839|FG001|Overall Study|Lost to Follow-up|1|||
145268116|NCT05027958|523830838|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
145268117|NCT05027958|523830839|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
145268118|NCT05027958|523830838|FG000|Overall Study|Physician Decision|1|||
145268119|NCT05027958|523830839|FG001|Overall Study|Physician Decision|4|||
145268120|NCT05027958|523830838|FG000|Overall Study|Adverse Event|0|||
145268121|NCT05027958|523830839|FG001|Overall Study|Adverse Event|1|||
145268122|NCT00491322|523830841|FG000|Overall Study|Protocol Violation|1|||
145268123|NCT00491322|523830842|FG001|Overall Study|Protocol Violation|0|||
145268124|NCT00491322|523830841|FG000|Overall Study|Pregnancy|0|||
145268125|NCT00491322|523830842|FG001|Overall Study|Pregnancy|1|||
145268126|NCT01870921|523830855|FG000|Overall Study|Subject decision|80|||
145268127|NCT01870921|523830855|FG000|Overall Study|Severe non-compliance to protocol|7|||
145268128|NCT01870921|523830855|FG000|Overall Study|Subject Lost to Follow up|2|||
145268129|NCT01870921|523830855|FG000|Overall Study|Other|1|||
145268130|NCT03075826|523830856|FG000|Overall Study|Withdrawal by Subject|1|||
145268131|NCT03075826|523830856|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
145268132|NCT00650806|523830857|FG000|Overall Study|Adverse Event|0|||
145268133|NCT00650806|523830858|FG001|Overall Study|Adverse Event|5|||
145268134|NCT00650806|523830859|FG002|Overall Study|Adverse Event|3|||
145268135|NCT00650806|523830860|FG003|Overall Study|Adverse Event|4|||
145268136|NCT00650806|523830857|FG000|Overall Study|Lost to Follow-up|7|||
145268137|NCT00650806|523830858|FG001|Overall Study|Lost to Follow-up|6|||
145268138|NCT00650806|523830859|FG002|Overall Study|Lost to Follow-up|11|||
145268139|NCT00650806|523830860|FG003|Overall Study|Lost to Follow-up|10|||
145268140|NCT00650806|523830857|FG000|Overall Study|Protocol Violation|0|||
145268141|NCT00650806|523830858|FG001|Overall Study|Protocol Violation|0|||
145268142|NCT00650806|523830859|FG002|Overall Study|Protocol Violation|0|||
145268143|NCT00650806|523830860|FG003|Overall Study|Protocol Violation|1|||
145268144|NCT00650806|523830857|FG000|Overall Study|Pregnancy|0|||
145268145|NCT00650806|523830858|FG001|Overall Study|Pregnancy|0|||
145268146|NCT00650806|523830859|FG002|Overall Study|Pregnancy|0|||
145268147|NCT00650806|523830860|FG003|Overall Study|Pregnancy|1|||
145268148|NCT00650806|523830857|FG000|Overall Study|Withdrawal by Subject|7|||
145268149|NCT00650806|523830858|FG001|Overall Study|Withdrawal by Subject|5|||
145268150|NCT00650806|523830859|FG002|Overall Study|Withdrawal by Subject|8|||
145268151|NCT00650806|523830860|FG003|Overall Study|Withdrawal by Subject|6|||
145268152|NCT00650806|523830857|FG000|Overall Study|Noncompliance with study drug regimen|1|||
145268153|NCT00650806|523830858|FG001|Overall Study|Noncompliance with study drug regimen|1|||
145268154|NCT00650806|523830859|FG002|Overall Study|Noncompliance with study drug regimen|0|||
145268155|NCT00650806|523830860|FG003|Overall Study|Noncompliance with study drug regimen|0|||
145268156|NCT00650806|523830857|FG000|Overall Study|Study terminated by sponsor|2|||
145268157|NCT00650806|523830858|FG001|Overall Study|Study terminated by sponsor|3|||
145268158|NCT00650806|523830859|FG002|Overall Study|Study terminated by sponsor|5|||
145268159|NCT00650806|523830860|FG003|Overall Study|Study terminated by sponsor|4|||
145268160|NCT00650806|523830857|FG000|Overall Study|Other|1|||
145268161|NCT00650806|523830858|FG001|Overall Study|Other|1|||
145268162|NCT00650806|523830859|FG002|Overall Study|Other|2|||
145268163|NCT00650806|523830860|FG003|Overall Study|Other|0|||
145268164|NCT04221477|523830861|FG000|Overall Study|Adverse Event|1|||
145268165|NCT04221477|523830862|FG001|Overall Study|Adverse Event|1|||
145268166|NCT04221477|523830861|FG000|Overall Study|Death|5|||
145515996|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145515997|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
145515998|NCT00557856|524748676|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
145515999|NCT00557856|524748677|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516000|NCT00557856|524748678|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516001|NCT00557856|524748679|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516002|NCT00557856|524748680|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516003|NCT00557856|524748681|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516004|NCT00557856|524748682|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516005|NCT00557856|524748683|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516006|NCT00557856|524748684|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
145516007|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516008|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516009|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516010|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516011|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516012|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516013|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516014|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
145516015|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
145516016|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145268167|NCT04221477|523830862|FG001|Overall Study|Death|4|||
145268168|NCT04221477|523830861|FG000|Overall Study|Lack of Efficacy|1|||
145268169|NCT04221477|523830862|FG001|Overall Study|Lack of Efficacy|2|||
145268170|NCT04221477|523830861|FG000|Overall Study|Lost to Follow-up|1|||
145268171|NCT04221477|523830862|FG001|Overall Study|Lost to Follow-up|2|||
145268172|NCT04221477|523830861|FG000|Overall Study|Non-compliance with Study Drug|1|||
145268173|NCT04221477|523830862|FG001|Overall Study|Non-compliance with Study Drug|0|||
145268174|NCT04221477|523830861|FG000|Overall Study|Reason not Specified|0|||
145268175|NCT04221477|523830862|FG001|Overall Study|Reason not Specified|5|||
145268176|NCT04221477|523830861|FG000|Overall Study|Physician Decision|0|||
145268177|NCT04221477|523830862|FG001|Overall Study|Physician Decision|6|||
145268178|NCT04221477|523830861|FG000|Overall Study|Withdrawal by Subject|10|||
145268179|NCT04221477|523830862|FG001|Overall Study|Withdrawal by Subject|14|||
145268180|NCT04221477|523830861|FG000|Overall Study|Ongoing in the Study|116|||
145268181|NCT04221477|523830862|FG001|Overall Study|Ongoing in the Study|102|||
145268182|NCT02242942|523830863|FG000|Overall Study|Death|17|||
145268183|NCT02242942|523830864|FG001|Overall Study|Death|20|||
145268184|NCT02242942|523830865|FG002|Overall Study|Death|2|||
145268185|NCT02242942|523830863|FG000|Overall Study|Physician Decision|1|||
145268186|NCT02242942|523830864|FG001|Overall Study|Physician Decision|0|||
145268187|NCT02242942|523830865|FG002|Overall Study|Physician Decision|0|||
145268188|NCT02242942|523830863|FG000|Overall Study|Withdrawal by Subject|8|||
145268189|NCT02242942|523830864|FG001|Overall Study|Withdrawal by Subject|10|||
145268190|NCT02242942|523830865|FG002|Overall Study|Withdrawal by Subject|0|||
145268191|NCT02242942|523830863|FG000|Overall Study|On-going in Study|190|||
145268192|NCT02242942|523830864|FG001|Overall Study|On-going in Study|186|||
145268193|NCT02242942|523830865|FG002|Overall Study|On-going in Study|11|||
145268194|NCT05681715|523830874|FG000|Training Period (6-weeks)|Adverse Event|3|||
145268195|NCT05681715|523830875|FG001|Training Period (6-weeks)|Adverse Event|0|||
145268196|NCT05681715|523830876|FG002|Training Period (6-weeks)|Adverse Event|0|||
145268197|NCT05681715|523830874|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
145268198|NCT05681715|523830875|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
145268199|NCT05681715|523830876|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
145268200|NCT05681715|523830874|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
145268201|NCT05681715|523830875|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
145268202|NCT05681715|523830876|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
145268203|NCT05681715|523830874|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
145268204|NCT05681715|523830875|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
145268205|NCT05681715|523830876|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
145268206|NCT05681715|523830874|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
145268207|NCT05681715|523830875|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
145268208|NCT05681715|523830876|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
145268209|NCT05681715|523830874|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
145268210|NCT05681715|523830875|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
145268211|NCT05681715|523830876|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
145268212|NCT05681715|523830874|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
145268213|NCT05681715|523830875|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
145268214|NCT05681715|523830876|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
145268215|NCT05681715|523830874|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
145268216|NCT05681715|523830875|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
145268217|NCT05681715|523830876|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
145268218|NCT05455684|523830877|FG000|Overall Study|Withdrawal by Subject|7|||
145268219|NCT05455684|523830878|FG001|Overall Study|Withdrawal by Subject|4|||
145268220|NCT05455684|523830877|FG000|Overall Study|Lost to Follow-up|3|||
145268221|NCT05455684|523830878|FG001|Overall Study|Lost to Follow-up|3|||
145268222|NCT05455684|523830877|FG000|Overall Study|Adverse Event|2|||
145516017|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145268223|NCT05455684|523830878|FG001|Overall Study|Adverse Event|3|||
145268224|NCT05455684|523830877|FG000|Overall Study|Protocol Violation|1|||
145268225|NCT05455684|523830878|FG001|Overall Study|Protocol Violation|1|||
145268226|NCT05455684|523830877|FG000|Overall Study|Non-Compliant with study drug|0|||
145268227|NCT05455684|523830878|FG001|Overall Study|Non-Compliant with study drug|1|||
145268228|NCT05455684|523830877|FG000|Overall Study|Other|1|||
145268229|NCT05455684|523830878|FG001|Overall Study|Other|2|||
145268230|NCT05455684|523830877|FG000|Overall Study|Randomized but not treated|1|||
145268231|NCT05455684|523830878|FG001|Overall Study|Randomized but not treated|0|||
145268232|NCT05116241|523830879|FG000|Study|Withdrawal by Subject|5|||
145268233|NCT05116241|523830880|FG001|Study|Withdrawal by Subject|2|||
145268234|NCT05116241|523830881|FG002|Study|Withdrawal by Subject|1|||
145268235|NCT05116241|523830879|FG000|Study|Lost to Follow-up|0|||
145268236|NCT05116241|523830880|FG001|Study|Lost to Follow-up|2|||
145268237|NCT05116241|523830881|FG002|Study|Lost to Follow-up|2|||
145268238|NCT05204563|523830882|FG000|Overall Study|Other than Specified|2|||
145268239|NCT05204563|523830883|FG001|Overall Study|Other than Specified|1|||
145268240|NCT05204563|523830882|FG000|Overall Study|Death|18|||
145268241|NCT05204563|523830883|FG001|Overall Study|Death|4|||
145268242|NCT05204563|523830882|FG000|Overall Study|Lost to Follow-up|6|||
145268243|NCT05204563|523830883|FG001|Overall Study|Lost to Follow-up|3|||
145268244|NCT05204563|523830882|FG000|Overall Study|Withdrawal by Subject|12|||
145268245|NCT05204563|523830883|FG001|Overall Study|Withdrawal by Subject|3|||
145268246|NCT05204563|523830882|FG000|Overall Study|Enrolled, Not Treated|1|||
145268247|NCT05204563|523830883|FG001|Overall Study|Enrolled, Not Treated|0|||
145268248|NCT04755283|523830886|FG000|Overall Study|Withdrawal by Subject|14|||
145402233|NCT00750269|524330680|FG003|Overall Study|Site error|1|||
145734011|NCT03359590|525543439|FG000|First Intervention|Protocol Violation|0|||
145734012|NCT03359590|525543440|FG001|First Intervention|Protocol Violation|1|||
145734013|NCT05390580|525543444|FG000|Overall Study|Physician Decision|3|||
145734014|NCT05390580|525543445|FG001|Overall Study|Physician Decision|2|||
145734015|NCT04014361|525543446|FG000|Period 2|Physician Decision|0|||
145268249|NCT04755283|523830887|FG001|Overall Study|Withdrawal by Subject|3|||
145268250|NCT04755283|523830888|FG002|Overall Study|Withdrawal by Subject|6|||
145268251|NCT04755283|523830886|FG000|Overall Study|Lost to Follow-up|0|||
145268252|NCT04755283|523830887|FG001|Overall Study|Lost to Follow-up|0|||
145268253|NCT04755283|523830888|FG002|Overall Study|Lost to Follow-up|1|||
145268254|NCT04755283|523830886|FG000|Overall Study|Death|31|||
145268255|NCT04755283|523830887|FG001|Overall Study|Death|36|||
145268256|NCT04755283|523830888|FG002|Overall Study|Death|34|||
145268257|NCT02268214|523830889|FG000|Overall Study|Subject no longer meets study criteria|0|||
145268258|NCT02268214|523830890|FG001|Overall Study|Subject no longer meets study criteria|2|||
145268259|NCT02268214|523830891|FG002|Overall Study|Subject no longer meets study criteria|0|||
145268260|NCT02268214|523830889|FG000|Overall Study|Pregnancy|2|||
145268261|NCT02268214|523830890|FG001|Overall Study|Pregnancy|2|||
145268262|NCT02268214|523830891|FG002|Overall Study|Pregnancy|1|||
145268263|NCT02268214|523830889|FG000|Overall Study|Lost to Follow-up|3|||
145268264|NCT02268214|523830890|FG001|Overall Study|Lost to Follow-up|3|||
145268265|NCT02268214|523830891|FG002|Overall Study|Lost to Follow-up|4|||
145268266|NCT02268214|523830889|FG000|Overall Study|Lack of Efficacy|1|||
145268267|NCT02268214|523830890|FG001|Overall Study|Lack of Efficacy|0|||
145268268|NCT02268214|523830891|FG002|Overall Study|Lack of Efficacy|2|||
145268269|NCT02268214|523830889|FG000|Overall Study|Adverse Event|11|||
145268270|NCT02268214|523830890|FG001|Overall Study|Adverse Event|14|||
145268271|NCT02268214|523830891|FG002|Overall Study|Adverse Event|9|||
145268272|NCT02268214|523830889|FG000|Overall Study|Withdrawal by Subject|4|||
145268273|NCT02268214|523830890|FG001|Overall Study|Withdrawal by Subject|5|||
145268274|NCT02268214|523830891|FG002|Overall Study|Withdrawal by Subject|10|||
145268275|NCT02268214|523830889|FG000|Overall Study|Subject request to discontinue treatment|10|||
145268276|NCT02268214|523830890|FG001|Overall Study|Subject request to discontinue treatment|8|||
145268277|NCT02268214|523830891|FG002|Overall Study|Subject request to discontinue treatment|6|||
145268278|NCT02268214|523830889|FG000|Overall Study|Poor/non-compliance|2|||
145268279|NCT02268214|523830890|FG001|Overall Study|Poor/non-compliance|1|||
145268280|NCT02268214|523830891|FG002|Overall Study|Poor/non-compliance|2|||
145268281|NCT02268214|523830889|FG000|Overall Study|Other reasons|7|||
145268282|NCT02268214|523830890|FG001|Overall Study|Other reasons|3|||
145268283|NCT02268214|523830891|FG002|Overall Study|Other reasons|3|||
145268284|NCT02268214|523830889|FG000|Overall Study|Not entering long-term period|2|||
145268285|NCT02268214|523830890|FG001|Overall Study|Not entering long-term period|3|||
145268286|NCT02268214|523830891|FG002|Overall Study|Not entering long-term period|5|||
145268287|NCT04342390|523830892|FG000|Overall Study|Lost to Follow-up|3|||
145268288|NCT04342390|523830893|FG001|Overall Study|Lost to Follow-up|0|||
145268289|NCT02951130|523830897|FG000|Overall Study|Protocol Violation|1|||
145268290|NCT02951130|523830898|FG001|Overall Study|Protocol Violation|1|||
145268291|NCT04584294|523830899|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
145268292|NCT04584294|523830900|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
145268293|NCT04584294|523830899|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
145268294|NCT04584294|523830900|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
145268295|NCT04584294|523830899|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
145268296|NCT04584294|523830900|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
145268297|NCT04584294|523830899|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
145268298|NCT04584294|523830900|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
145268299|NCT04584294|523830899|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
145268300|NCT04584294|523830900|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
145268301|NCT04584294|523830899|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
145268302|NCT04584294|523830900|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
145268303|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
145268304|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
145268305|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
145268306|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145268307|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145268308|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145268309|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
145268310|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268311|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268312|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
145268313|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268314|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268315|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268316|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
145268317|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
145268318|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145402234|NCT00750269|524330681|FG004|Overall Study|Site error|0|||
145268319|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
145268320|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145268321|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145268322|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145268323|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
145268324|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
145268325|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145268326|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
145268327|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145268328|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145268329|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145268330|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
145268331|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
145268332|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
145268333|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
145268334|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145268335|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145268336|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145268337|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
145268338|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268339|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268340|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
145268341|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268342|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268343|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268344|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
145268345|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268346|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268347|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
145268348|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268349|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268350|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268351|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
145268352|NCT04242498|523830901|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145268353|NCT04242498|523830902|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
145268354|NCT04242498|523830903|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
145268355|NCT04242498|523830904|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145268356|NCT04242498|523830905|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145268357|NCT04242498|523830906|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145268358|NCT04242498|523830907|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
145268359|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145268360|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145268361|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145268362|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
145268363|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
145268364|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
145268365|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
145268366|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145268367|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145268368|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145268369|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
145268370|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
145268371|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
145268372|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
145268373|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145268374|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145268375|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145268376|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145268377|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
145268378|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
145516018|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145516019|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145268379|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
145268380|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145268381|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145268382|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
145268383|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
145268384|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
145268385|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
145268386|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
145268387|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145268388|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145268389|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
145268390|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
145268391|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
145268392|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
145268393|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
145402235|NCT00750269|524330677|FG000|Overall Study|SBRT plan could not be drawn|0|||
145516020|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145268394|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268395|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268396|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268397|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268398|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
145268399|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268400|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
145268401|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268402|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268403|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268404|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268405|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268406|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
145268407|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
145268408|NCT04242498|523830901|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
145268409|NCT04242498|523830902|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
145268410|NCT04242498|523830903|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
145268411|NCT04242498|523830904|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
145268412|NCT04242498|523830905|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
145268413|NCT04242498|523830906|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
145268414|NCT04242498|523830907|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
145268415|NCT01083121|523830908|FG000|Overall Study|Use of Humira outside the approved label|81|||
145268416|NCT03743571|523830909|FG000|Overall Study|Withdrawal by Subject|1|||
145268417|NCT03743571|523830910|FG001|Overall Study|Withdrawal by Subject|1|||
145268418|NCT03743571|523830909|FG000|Overall Study|Lost to Follow-up|1|||
145268419|NCT03743571|523830910|FG001|Overall Study|Lost to Follow-up|2|||
145268420|NCT04115488|523830911|FG000|Overall Study|Adverse Event|8|||
145268421|NCT04115488|523830912|FG001|Overall Study|Adverse Event|4|||
145268422|NCT04115488|523830911|FG000|Overall Study|Withdrawal by Subject|3|||
145268423|NCT04115488|523830912|FG001|Overall Study|Withdrawal by Subject|6|||
145268424|NCT04115488|523830911|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
145268425|NCT04115488|523830912|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
145734016|NCT04014361|525543447|FG001|Period 2|Physician Decision|0|||
145734017|NCT04014361|525543448|FG002|Period 2|Physician Decision|0|||
145734018|NCT04014361|525543449|FG003|Period 2|Physician Decision|1|||
145734019|NCT04014361|525543450|FG004|Period 2|Physician Decision|0|||
145734020|NCT04014361|525543451|FG005|Period 2|Physician Decision|0|||
145734021|NCT04014361|525543452|FG006|Period 2|Physician Decision|0|||
145734022|NCT04014361|525543453|FG007|Period 2|Physician Decision|0|||
145734023|NCT01130051|525543455|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
145734024|NCT01130051|525543456|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
145734025|NCT01130051|525543455|FG000|Washout Period of 14 Days|Protocol Violation|1|||
145734026|NCT01130051|525543456|FG001|Washout Period of 14 Days|Protocol Violation|1|||
145734027|NCT01298518|525543459|FG000|Overall Study|Withdrawal by Subject|0|||
145734028|NCT01298518|525543460|FG001|Overall Study|Withdrawal by Subject|0|||
145734029|NCT01298518|525543461|FG002|Overall Study|Withdrawal by Subject|1|||
145734030|NCT03610165|525543462|FG000|Overall Study|Device didn't work|0|||
145734031|NCT03610165|525543463|FG001|Overall Study|Device didn't work|1|||
145734032|NCT02129205|525543464|FG000|Overall Study|Withdrawal by Subject|0|||
145734033|NCT02129205|525543465|FG001|Overall Study|Withdrawal by Subject|0|||
145734034|NCT02129205|525543466|FG002|Overall Study|Withdrawal by Subject|0|||
145734035|NCT02129205|525543467|FG003|Overall Study|Withdrawal by Subject|0|||
145734036|NCT02129205|525543468|FG004|Overall Study|Withdrawal by Subject|1|||
145734037|NCT02129205|525543469|FG005|Overall Study|Withdrawal by Subject|1|||
145734038|NCT02129205|525543470|FG006|Overall Study|Withdrawal by Subject|1|||
145734039|NCT02129205|525543471|FG007|Overall Study|Withdrawal by Subject|0|||
145734040|NCT02129205|525543472|FG008|Overall Study|Withdrawal by Subject|1|||
145734041|NCT02129205|525543473|FG009|Overall Study|Withdrawal by Subject|0|||
145734042|NCT02129205|525543464|FG000|Overall Study|Other|1|||
145734043|NCT02129205|525543465|FG001|Overall Study|Other|0|||
145734044|NCT02129205|525543466|FG002|Overall Study|Other|0|||
145734045|NCT02129205|525543467|FG003|Overall Study|Other|0|||
145734046|NCT02129205|525543468|FG004|Overall Study|Other|2|||
145734047|NCT02129205|525543469|FG005|Overall Study|Other|3|||
145734048|NCT02129205|525543470|FG006|Overall Study|Other|3|||
145734049|NCT02129205|525543471|FG007|Overall Study|Other|2|||
145734050|NCT02129205|525543472|FG008|Overall Study|Other|1|||
145734051|NCT02129205|525543473|FG009|Overall Study|Other|0|||
145734052|NCT04313153|525544724|FG000|Overall Study|Adverse Event (includes Death)|14|||
145734053|NCT04313153|525544725|FG001|Overall Study|Adverse Event (includes Death)|19|||
145734054|NCT04313153|525544726|FG002|Overall Study|Adverse Event (includes Death)|10|||
145734055|NCT04313153|525544724|FG000|Overall Study|Physician Decision|4|||
145734056|NCT04313153|525544725|FG001|Overall Study|Physician Decision|2|||
145734057|NCT04313153|525544726|FG002|Overall Study|Physician Decision|1|||
145734058|NCT04313153|525544724|FG000|Overall Study|Withdrawal by Subject|7|||
145734059|NCT04313153|525544725|FG001|Overall Study|Withdrawal by Subject|6|||
145734060|NCT04313153|525544726|FG002|Overall Study|Withdrawal by Subject|2|||
145734061|NCT04313153|525544724|FG000|Overall Study|Lack of Efficacy|3|||
145734062|NCT04313153|525544725|FG001|Overall Study|Lack of Efficacy|3|||
145734063|NCT04313153|525544726|FG002|Overall Study|Lack of Efficacy|0|||
145734064|NCT04313153|525544724|FG000|Overall Study|Lost to Follow-up|1|||
145734065|NCT04313153|525544725|FG001|Overall Study|Lost to Follow-up|0|||
145734066|NCT04313153|525544726|FG002|Overall Study|Lost to Follow-up|2|||
145734067|NCT04313153|525544724|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
145734068|NCT04313153|525544725|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
145734069|NCT04313153|525544726|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
145734070|NCT04313153|525544724|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
145734071|NCT04313153|525544725|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
145734072|NCT04313153|525544726|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
145734073|NCT04313153|525544724|FG000|Overall Study|Change in Dialysis Modality|0|||
145734074|NCT04313153|525544725|FG001|Overall Study|Change in Dialysis Modality|1|||
145734075|NCT04313153|525544726|FG002|Overall Study|Change in Dialysis Modality|2|||
145734076|NCT04313153|525544724|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
145734077|NCT04313153|525544725|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
145734078|NCT04313153|525544726|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
145734079|NCT04313153|525544724|FG000|Overall Study|Other|5|||
145734080|NCT04313153|525544725|FG001|Overall Study|Other|3|||
145734081|NCT04313153|525544726|FG002|Overall Study|Other|2|||
145734082|NCT05586269|525544727|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
145734083|NCT05586269|525544728|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
145734084|NCT05586269|525544729|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
145734085|NCT05586269|525544730|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
145734086|NCT05586269|525544727|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
145734087|NCT05586269|525544728|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
145734088|NCT05586269|525544729|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
145734089|NCT05586269|525544730|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
145734090|NCT04752475|525544731|FG000|Overall Study|Withdrawal by Subject|1|||
145734091|NCT04752475|525544732|FG001|Overall Study|Withdrawal by Subject|1|||
145268426|NCT04115488|523830911|FG000|Overall Study|Patient 's location change|1|||
145268427|NCT04115488|523830912|FG001|Overall Study|Patient 's location change|0|||
145268428|NCT04115488|523830911|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
145268429|NCT04115488|523830912|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
145268430|NCT00885677|523830913|FG000|Overall Study|Death|40|||
145268431|NCT00885677|523830914|FG001|Overall Study|Death|34|||
145268432|NCT00885677|523830913|FG000|Overall Study|Lost to Follow-up|15|||
145268433|NCT00885677|523830914|FG001|Overall Study|Lost to Follow-up|13|||
145268434|NCT00885677|523830913|FG000|Overall Study|Protocol Violation|54|||
145268435|NCT00885677|523830914|FG001|Overall Study|Protocol Violation|54|||
145268436|NCT00885677|523830913|FG000|Overall Study|premature study closure|41|||
145268437|NCT00885677|523830914|FG001|Overall Study|premature study closure|44|||
145268438|NCT00885677|523830913|FG000|Overall Study|device/lead revision or replacement|7|||
145268439|NCT00885677|523830914|FG001|Overall Study|device/lead revision or replacement|6|||
145268440|NCT00885677|523830913|FG000|Overall Study|Heart transplantation|1|||
145268441|NCT00885677|523830914|FG001|Overall Study|Heart transplantation|0|||
145268442|NCT00885677|523830913|FG000|Overall Study|Inclusion/exclusion not met|25|||
145268443|NCT00885677|523830914|FG001|Overall Study|Inclusion/exclusion not met|27|||
145268444|NCT01233284|523830926|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
145268445|NCT01233284|523830927|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145268446|NCT01233284|523830928|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145268447|NCT01233284|523830929|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145268448|NCT01233284|523830930|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145268449|NCT01233284|523830926|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145268450|NCT01233284|523830927|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
145268451|NCT01233284|523830928|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145268452|NCT01233284|523830929|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145268453|NCT01233284|523830930|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
145268454|NCT01233284|523830926|FG000|Period 1 (4 Weeks)|Other|0|||
145268455|NCT01233284|523830927|FG001|Period 1 (4 Weeks)|Other|0|||
145268456|NCT01233284|523830928|FG002|Period 1 (4 Weeks)|Other|1|||
145268457|NCT01233284|523830929|FG003|Period 1 (4 Weeks)|Other|0|||
145268458|NCT01233284|523830930|FG004|Period 1 (4 Weeks)|Other|0|||
145268459|NCT01233284|523830926|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145268460|NCT01233284|523830927|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145268461|NCT01233284|523830928|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
145268462|NCT01233284|523830929|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145268463|NCT01233284|523830930|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145268464|NCT01233284|523830926|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145268465|NCT01233284|523830927|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145268466|NCT01233284|523830928|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
145268467|NCT01233284|523830929|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145268468|NCT01233284|523830930|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145268469|NCT01233284|523830926|FG000|Period 3 (4 Weeks)|Other|0|||
145268470|NCT01233284|523830927|FG001|Period 3 (4 Weeks)|Other|0|||
145268471|NCT01233284|523830928|FG002|Period 3 (4 Weeks)|Other|0|||
145268472|NCT01233284|523830929|FG003|Period 3 (4 Weeks)|Other|1|||
145268473|NCT01233284|523830930|FG004|Period 3 (4 Weeks)|Other|0|||
145268474|NCT01233284|523830926|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
145268475|NCT01233284|523830927|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
145268476|NCT01233284|523830928|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
145268477|NCT01233284|523830929|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
145268478|NCT01233284|523830930|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
145268479|NCT01233284|523830926|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
145268480|NCT01233284|523830927|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
145268481|NCT01233284|523830928|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
145268482|NCT01233284|523830929|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
145268483|NCT01233284|523830930|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
145268484|NCT02756182|523830932|FG000|Overall Study|StudyTechnical Difficulties|4|||
145268485|NCT00167414|523830934|FG000|Overall Study|Death|10|||
145268486|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
145268487|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
145268488|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
145268489|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
145268490|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
145268491|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
145268492|NCT00828009|523830941|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
145268493|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
145268494|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
145268495|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Death|1|||
145268496|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
145268497|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
145268498|NCT00828009|523830941|FG000|Step 2 - Maintenance Therapy|Other|1|||
145268499|NCT04478994|523832587|FG000|Overall Study|Withdrawal by Subject|1|||
145268500|NCT04478994|523832588|FG001|Overall Study|Withdrawal by Subject|1|||
145268501|NCT03099265|523832589|FG000|Overall Study|Adverse Event|1|||
145268502|NCT02094573|523832595|FG000|Overall Study|Adverse Event|4|||
145268503|NCT02094573|523832596|FG001|Overall Study|Adverse Event|14|||
145268504|NCT02094573|523832595|FG000|Overall Study|Clinical Progressive Disease|9|||
145268505|NCT02094573|523832596|FG001|Overall Study|Clinical Progressive Disease|13|||
145268506|NCT02094573|523832595|FG000|Overall Study|Death|11|||
145268507|NCT02094573|523832596|FG001|Overall Study|Death|3|||
145268508|NCT02094573|523832595|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
145268509|NCT02094573|523832596|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
145268510|NCT02094573|523832595|FG000|Overall Study|Non-compliance with Study Drug|1|||
145268511|NCT02094573|523832596|FG001|Overall Study|Non-compliance with Study Drug|1|||
145268512|NCT02094573|523832595|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
145268513|NCT02094573|523832596|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
145268514|NCT02094573|523832595|FG000|Overall Study|Physician Decision|4|||
145268515|NCT02094573|523832596|FG001|Overall Study|Physician Decision|4|||
145268516|NCT02094573|523832595|FG000|Overall Study|Site Terminated by Sponsor|10|||
145268517|NCT02094573|523832596|FG001|Overall Study|Site Terminated by Sponsor|17|||
145268518|NCT02094573|523832595|FG000|Overall Study|Withdrawal by Subject|6|||
145268519|NCT02094573|523832596|FG001|Overall Study|Withdrawal by Subject|8|||
145268520|NCT02094573|523832595|FG000|Overall Study|Randomized but not Treated|3|||
145268521|NCT02094573|523832596|FG001|Overall Study|Randomized but not Treated|0|||
145268522|NCT02411110|523832597|FG000|Treatment Period 1|Adverse Event|4|||
145268523|NCT02411110|523832598|FG001|Treatment Period 1|Adverse Event|2|||
145268524|NCT02411110|523832597|FG000|Treatment Period 1|Lost to Follow-up|1|||
145268525|NCT02411110|523832598|FG001|Treatment Period 1|Lost to Follow-up|0|||
145268526|NCT02411110|523832597|FG000|Treatment Period 1|Personal Reasons|2|||
145268527|NCT02411110|523832598|FG001|Treatment Period 1|Personal Reasons|5|||
145268528|NCT02411110|523832597|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
145268529|NCT02411110|523832598|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
145268530|NCT02411110|523832597|FG000|Treatment Period 2|Adverse Event|1|||
145268531|NCT02411110|523832598|FG001|Treatment Period 2|Adverse Event|0|||
145268532|NCT02411110|523832597|FG000|Treatment Period 2|Lost to Follow-up|0|||
145268533|NCT02411110|523832598|FG001|Treatment Period 2|Lost to Follow-up|2|||
145268534|NCT02411110|523832597|FG000|Treatment Period 2|Personal Reasons|0|||
145268535|NCT02411110|523832598|FG001|Treatment Period 2|Personal Reasons|2|||
145268536|NCT01353586|523832599|FG000|Overall Study|Procedure terminated prior to ablation|3|||
145268537|NCT01353586|523832600|FG001|Overall Study|Procedure terminated prior to ablation|0|||
145268538|NCT01353586|523832599|FG000|Overall Study|Never had insertion of study catheter|4|||
145268539|NCT01353586|523832600|FG001|Overall Study|Never had insertion of study catheter|1|||
145268540|NCT01353586|523832599|FG000|Overall Study|Neurological exam not done|0|||
145268541|NCT01353586|523832600|FG001|Overall Study|Neurological exam not done|1|||
145268542|NCT00807040|523832601|FG000|Overall Study|Death|24|||
145268543|NCT00807040|523832602|FG001|Overall Study|Death|29|||
145268544|NCT00807040|523832601|FG000|Overall Study|Withdrawal by Subject|8|||
145268545|NCT00807040|523832602|FG001|Overall Study|Withdrawal by Subject|6|||
145268546|NCT00807040|523832601|FG000|Overall Study|Lost to Follow-up|4|||
145268547|NCT00807040|523832602|FG001|Overall Study|Lost to Follow-up|6|||
145268548|NCT00890409|523832603|FG000|Overall Study|Lost to Follow-up|20|||
145268549|NCT00890409|523832604|FG001|Overall Study|Lost to Follow-up|21|||
145268550|NCT02353572|523832605|FG000|Overall Study|Withdrawal by Subject|1|||
145268551|NCT02353572|523832605|FG000|Overall Study|Study terminated|2|||
145268552|NCT02060188|523832607|FG000|Overall Study|Disease Progression|36|||
145268553|NCT02060188|523832608|FG001|Overall Study|Disease Progression|42|||
145268554|NCT02060188|523832609|FG002|Overall Study|Disease Progression|8|||
145268555|NCT02060188|523832610|FG003|Overall Study|Disease Progression|5|||
145268556|NCT02060188|523832611|FG004|Overall Study|Disease Progression|6|||
145268557|NCT02060188|523832612|FG005|Overall Study|Disease Progression|3|||
145268558|NCT02060188|523832613|FG006|Overall Study|Disease Progression|23|||
145268559|NCT02060188|523832614|FG007|Overall Study|Disease Progression|20|||
145268560|NCT02060188|523832615|FG008|Overall Study|Disease Progression|43|||
145268561|NCT02060188|523832607|FG000|Overall Study|Study Drug Toxicity|10|||
145268562|NCT02060188|523832608|FG001|Overall Study|Study Drug Toxicity|18|||
145402236|NCT00750269|524330678|FG001|Overall Study|SBRT plan could not be drawn|0|||
145268563|NCT02060188|523832609|FG002|Overall Study|Study Drug Toxicity|7|||
145268564|NCT02060188|523832610|FG003|Overall Study|Study Drug Toxicity|4|||
145268565|NCT02060188|523832611|FG004|Overall Study|Study Drug Toxicity|3|||
145268566|NCT02060188|523832612|FG005|Overall Study|Study Drug Toxicity|0|||
145268567|NCT02060188|523832613|FG006|Overall Study|Study Drug Toxicity|2|||
145268568|NCT02060188|523832614|FG007|Overall Study|Study Drug Toxicity|5|||
145268569|NCT02060188|523832615|FG008|Overall Study|Study Drug Toxicity|0|||
145268570|NCT02060188|523832607|FG000|Overall Study|Adverse event unrelated to study drug|2|||
145268571|NCT02060188|523832608|FG001|Overall Study|Adverse event unrelated to study drug|5|||
145268572|NCT02060188|523832609|FG002|Overall Study|Adverse event unrelated to study drug|6|||
145268573|NCT02060188|523832610|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145268574|NCT02060188|523832611|FG004|Overall Study|Adverse event unrelated to study drug|1|||
145268575|NCT02060188|523832612|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145268576|NCT02060188|523832613|FG006|Overall Study|Adverse event unrelated to study drug|4|||
145268577|NCT02060188|523832614|FG007|Overall Study|Adverse event unrelated to study drug|4|||
145268578|NCT02060188|523832615|FG008|Overall Study|Adverse event unrelated to study drug|1|||
145268579|NCT02060188|523832607|FG000|Overall Study|Participant request to discontinue study treatment|7|||
145268580|NCT02060188|523832608|FG001|Overall Study|Participant request to discontinue study treatment|7|||
145268581|NCT02060188|523832609|FG002|Overall Study|Participant request to discontinue study treatment|4|||
145268582|NCT02060188|523832610|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145268583|NCT02060188|523832611|FG004|Overall Study|Participant request to discontinue study treatment|0|||
145268584|NCT02060188|523832612|FG005|Overall Study|Participant request to discontinue study treatment|0|||
145268585|NCT02060188|523832613|FG006|Overall Study|Participant request to discontinue study treatment|1|||
145268586|NCT02060188|523832614|FG007|Overall Study|Participant request to discontinue study treatment|1|||
145268587|NCT02060188|523832615|FG008|Overall Study|Participant request to discontinue study treatment|0|||
145268588|NCT02060188|523832607|FG000|Overall Study|Participant withdrew consent|3|||
145268589|NCT02060188|523832608|FG001|Overall Study|Participant withdrew consent|0|||
145268590|NCT02060188|523832609|FG002|Overall Study|Participant withdrew consent|0|||
145268591|NCT02060188|523832610|FG003|Overall Study|Participant withdrew consent|0|||
145268592|NCT02060188|523832611|FG004|Overall Study|Participant withdrew consent|0|||
145268593|NCT02060188|523832612|FG005|Overall Study|Participant withdrew consent|0|||
145268594|NCT02060188|523832613|FG006|Overall Study|Participant withdrew consent|0|||
145268595|NCT02060188|523832614|FG007|Overall Study|Participant withdrew consent|0|||
145268596|NCT02060188|523832615|FG008|Overall Study|Participant withdrew consent|0|||
145268597|NCT02060188|523832607|FG000|Overall Study|Maximum clinical benefit|13|||
145268598|NCT02060188|523832608|FG001|Overall Study|Maximum clinical benefit|38|||
145268599|NCT02060188|523832609|FG002|Overall Study|Maximum clinical benefit|19|||
145268600|NCT02060188|523832610|FG003|Overall Study|Maximum clinical benefit|0|||
145268601|NCT02060188|523832611|FG004|Overall Study|Maximum clinical benefit|0|||
145268602|NCT02060188|523832612|FG005|Overall Study|Maximum clinical benefit|0|||
145268603|NCT02060188|523832613|FG006|Overall Study|Maximum clinical benefit|0|||
145268604|NCT02060188|523832614|FG007|Overall Study|Maximum clinical benefit|10|||
145268605|NCT02060188|523832615|FG008|Overall Study|Maximum clinical benefit|0|||
145268606|NCT02060188|523832607|FG000|Overall Study|Other reason|3|||
145268607|NCT02060188|523832608|FG001|Overall Study|Other reason|7|||
145268608|NCT02060188|523832609|FG002|Overall Study|Other reason|0|||
145268609|NCT02060188|523832610|FG003|Overall Study|Other reason|1|||
145268610|NCT02060188|523832611|FG004|Overall Study|Other reason|0|||
145268611|NCT02060188|523832612|FG005|Overall Study|Other reason|0|||
145268612|NCT02060188|523832613|FG006|Overall Study|Other reason|0|||
145268613|NCT02060188|523832614|FG007|Overall Study|Other reason|9|||
145268614|NCT02060188|523832615|FG008|Overall Study|Other reason|0|||
145268615|NCT02060188|523832607|FG000|Overall Study|Death|0|||
145268616|NCT02060188|523832608|FG001|Overall Study|Death|1|||
145268617|NCT02060188|523832609|FG002|Overall Study|Death|0|||
145268618|NCT02060188|523832610|FG003|Overall Study|Death|0|||
145268619|NCT02060188|523832611|FG004|Overall Study|Death|0|||
145268620|NCT02060188|523832612|FG005|Overall Study|Death|0|||
145268621|NCT02060188|523832613|FG006|Overall Study|Death|0|||
145268622|NCT02060188|523832614|FG007|Overall Study|Death|1|||
145268623|NCT02060188|523832615|FG008|Overall Study|Death|0|||
145268624|NCT02060188|523832607|FG000|Overall Study|Administrative reasons by sponsor|0|||
145268625|NCT02060188|523832608|FG001|Overall Study|Administrative reasons by sponsor|1|||
145268626|NCT02060188|523832609|FG002|Overall Study|Administrative reasons by sponsor|0|||
145268627|NCT02060188|523832610|FG003|Overall Study|Administrative reasons by sponsor|0|||
145268628|NCT02060188|523832611|FG004|Overall Study|Administrative reasons by sponsor|0|||
145268629|NCT02060188|523832612|FG005|Overall Study|Administrative reasons by sponsor|0|||
145268630|NCT02060188|523832613|FG006|Overall Study|Administrative reasons by sponsor|0|||
145268631|NCT02060188|523832614|FG007|Overall Study|Administrative reasons by sponsor|0|||
145268632|NCT02060188|523832615|FG008|Overall Study|Administrative reasons by sponsor|0|||
145268633|NCT02060188|523832607|FG000|Overall Study|Lost to Follow-up|0|||
145268634|NCT02060188|523832608|FG001|Overall Study|Lost to Follow-up|0|||
145268635|NCT02060188|523832609|FG002|Overall Study|Lost to Follow-up|1|||
145268636|NCT02060188|523832610|FG003|Overall Study|Lost to Follow-up|0|||
145268637|NCT02060188|523832611|FG004|Overall Study|Lost to Follow-up|0|||
145268638|NCT02060188|523832612|FG005|Overall Study|Lost to Follow-up|0|||
145268639|NCT02060188|523832613|FG006|Overall Study|Lost to Follow-up|0|||
145268640|NCT02060188|523832614|FG007|Overall Study|Lost to Follow-up|0|||
145268641|NCT02060188|523832615|FG008|Overall Study|Lost to Follow-up|0|||
145268642|NCT03426995|523832616|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268643|NCT03426995|523832617|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268644|NCT03426995|523832618|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
145268645|NCT03426995|523832619|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268646|NCT03426995|523832620|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268647|NCT03426995|523832621|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268648|NCT03426995|523832622|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268649|NCT03426995|523832623|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268650|NCT03426995|523832624|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268651|NCT03426995|523832625|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268652|NCT03426995|523832626|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268653|NCT03426995|523832627|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268654|NCT03426995|523832628|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268655|NCT03426995|523832629|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268656|NCT03426995|523832630|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268657|NCT03426995|523832631|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268658|NCT03426995|523832632|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268659|NCT03426995|523832633|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268660|NCT03426995|523832634|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
145268661|NCT03426995|523832616|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268662|NCT03426995|523832617|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268663|NCT03426995|523832618|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268664|NCT03426995|523832619|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268665|NCT03426995|523832620|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268666|NCT03426995|523832621|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
145268667|NCT03426995|523832622|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268668|NCT03426995|523832623|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268669|NCT03426995|523832624|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268670|NCT03426995|523832625|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268671|NCT03426995|523832626|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268672|NCT03426995|523832627|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268673|NCT03426995|523832628|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268674|NCT03426995|523832629|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268675|NCT03426995|523832630|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268676|NCT03426995|523832631|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268677|NCT03426995|523832632|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268678|NCT03426995|523832633|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268679|NCT03426995|523832634|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
145268680|NCT03426995|523832616|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268681|NCT03426995|523832617|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268682|NCT03426995|523832618|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268683|NCT03426995|523832619|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268684|NCT03426995|523832620|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
145268685|NCT03426995|523832621|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
145268686|NCT03426995|523832622|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268687|NCT03426995|523832623|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268688|NCT03426995|523832624|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268689|NCT03426995|523832625|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268690|NCT03426995|523832626|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268691|NCT03426995|523832627|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268692|NCT03426995|523832628|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268693|NCT03426995|523832629|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268694|NCT03426995|523832630|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268695|NCT03426995|523832631|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268696|NCT03426995|523832632|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268697|NCT03426995|523832633|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268698|NCT03426995|523832634|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
145268699|NCT03426995|523832616|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268700|NCT03426995|523832617|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268701|NCT03426995|523832618|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268702|NCT03426995|523832619|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268703|NCT03426995|523832620|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268704|NCT03426995|523832621|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268705|NCT03426995|523832622|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268706|NCT03426995|523832623|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268707|NCT03426995|523832624|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268708|NCT03426995|523832625|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268709|NCT03426995|523832626|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
145268710|NCT03426995|523832627|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268711|NCT03426995|523832628|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268712|NCT03426995|523832629|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268713|NCT03426995|523832630|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268714|NCT03426995|523832631|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268715|NCT03426995|523832632|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268716|NCT03426995|523832633|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268717|NCT03426995|523832634|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
145268718|NCT03426995|523832616|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268719|NCT03426995|523832617|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268720|NCT03426995|523832618|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268721|NCT03426995|523832619|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268722|NCT03426995|523832620|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145402237|NCT00750269|524330679|FG002|Overall Study|SBRT plan could not be drawn|0|||
145268723|NCT03426995|523832621|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268724|NCT03426995|523832622|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268725|NCT03426995|523832623|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
145268726|NCT03426995|523832624|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268727|NCT03426995|523832625|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268728|NCT03426995|523832626|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268729|NCT03426995|523832627|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268730|NCT03426995|523832628|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268731|NCT03426995|523832629|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268732|NCT03426995|523832630|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268733|NCT03426995|523832631|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268734|NCT03426995|523832632|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268735|NCT03426995|523832633|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268736|NCT03426995|523832634|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
145268737|NCT03426995|523832616|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268738|NCT03426995|523832617|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268739|NCT03426995|523832618|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268740|NCT03426995|523832619|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268741|NCT03426995|523832620|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145402238|NCT00750269|524330680|FG003|Overall Study|SBRT plan could not be drawn|0|||
145516021|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145516022|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145516023|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
145268742|NCT03426995|523832621|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268743|NCT03426995|523832622|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268744|NCT03426995|523832623|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268745|NCT03426995|523832624|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268746|NCT03426995|523832625|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268747|NCT03426995|523832626|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268748|NCT03426995|523832627|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268749|NCT03426995|523832628|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268750|NCT03426995|523832629|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268751|NCT03426995|523832630|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
145268752|NCT03426995|523832631|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
145268753|NCT03426995|523832632|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268754|NCT03426995|523832633|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268755|NCT03426995|523832634|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
145268756|NCT03426995|523832616|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268757|NCT03426995|523832617|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268758|NCT03426995|523832618|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268759|NCT03426995|523832619|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268760|NCT03426995|523832620|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268761|NCT03426995|523832621|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268762|NCT03426995|523832622|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268763|NCT03426995|523832623|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268764|NCT03426995|523832624|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268765|NCT03426995|523832625|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268766|NCT03426995|523832626|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268767|NCT03426995|523832627|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268768|NCT03426995|523832628|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268769|NCT03426995|523832629|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268770|NCT03426995|523832630|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
145268771|NCT03426995|523832631|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
145268772|NCT03426995|523832632|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268773|NCT03426995|523832633|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268774|NCT03426995|523832634|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
145268775|NCT02335411|523832635|FG000|Overall Study|Death|223|||
145268776|NCT02335411|523832636|FG001|Overall Study|Death|22|||
145268777|NCT02335411|523832637|FG002|Overall Study|Death|26|||
145268778|NCT02335411|523832635|FG000|Overall Study|Physician Decision|3|||
145268779|NCT02335411|523832636|FG001|Overall Study|Physician Decision|0|||
145268780|NCT02335411|523832637|FG002|Overall Study|Physician Decision|0|||
145268781|NCT02335411|523832635|FG000|Overall Study|Protocol Violation|1|||
145268782|NCT02335411|523832636|FG001|Overall Study|Protocol Violation|0|||
145268783|NCT02335411|523832637|FG002|Overall Study|Protocol Violation|0|||
145268784|NCT02335411|523832635|FG000|Overall Study|Withdrawal by Subject|11|||
145268785|NCT02335411|523832636|FG001|Overall Study|Withdrawal by Subject|0|||
145268786|NCT02335411|523832637|FG002|Overall Study|Withdrawal by Subject|3|||
145268787|NCT02335411|523832635|FG000|Overall Study|Sponsor Decision|12|||
145268788|NCT02335411|523832636|FG001|Overall Study|Sponsor Decision|3|||
145268789|NCT02335411|523832637|FG002|Overall Study|Sponsor Decision|2|||
145268790|NCT02335411|523832635|FG000|Overall Study|Adverse Event|9|||
145268791|NCT02335411|523832636|FG001|Overall Study|Adverse Event|0|||
145268792|NCT02335411|523832637|FG002|Overall Study|Adverse Event|0|||
145268793|NCT04150107|523832641|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
145402239|NCT00750269|524330681|FG004|Overall Study|SBRT plan could not be drawn|1|||
145516024|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
145516025|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
145516026|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
145516027|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
145516028|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
145516029|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
145516030|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
145516031|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
145516032|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
145516033|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
145516034|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|Other|0|||
145516035|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|Other|0|||
145516036|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|Other|0|||
145516037|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|Other|0|||
145516038|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|Other|0|||
145516039|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|Other|0|||
145516040|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|Other|0|||
145516041|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|Other|0|||
145516042|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|Other|1|||
145516043|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|Death|0|||
145516044|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|Death|0|||
145516045|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|Death|0|||
145516046|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|Death|0|||
145516047|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|Death|0|||
145516048|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|Death|0|||
145516049|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|Death|0|||
145516050|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|Death|0|||
145516051|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|Death|2|||
145516052|NCT00557856|524748676|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516053|NCT00557856|524748677|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516054|NCT00557856|524748678|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516055|NCT00557856|524748679|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516056|NCT00557856|524748680|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516057|NCT00557856|524748681|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516058|NCT00557856|524748682|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516059|NCT00557856|524748683|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
145516060|NCT00557856|524748684|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
145516061|NCT05092360|524748685|FG000|Overall Study|Withdrawal by Subject|21|||
145516062|NCT05092360|524748686|FG001|Overall Study|Withdrawal by Subject|4|||
145516063|NCT05092360|524748687|FG002|Overall Study|Withdrawal by Subject|9|||
145516064|NCT05092360|524748688|FG003|Overall Study|Withdrawal by Subject|26|||
145516065|NCT05092360|524748685|FG000|Overall Study|Death|97|||
145516066|NCT05092360|524748686|FG001|Overall Study|Death|14|||
145516067|NCT05092360|524748687|FG002|Overall Study|Death|31|||
145516068|NCT05092360|524748688|FG003|Overall Study|Death|101|||
145516069|NCT05092360|524748685|FG000|Overall Study|Lost to Follow-up|1|||
145516070|NCT05092360|524748686|FG001|Overall Study|Lost to Follow-up|2|||
145516071|NCT05092360|524748687|FG002|Overall Study|Lost to Follow-up|2|||
145516072|NCT05092360|524748688|FG003|Overall Study|Lost to Follow-up|2|||
145516073|NCT05092360|524748685|FG000|Overall Study|Study terminated by sponsor|65|||
145516074|NCT05092360|524748686|FG001|Overall Study|Study terminated by sponsor|7|||
145516075|NCT05092360|524748687|FG002|Overall Study|Study terminated by sponsor|13|||
145516076|NCT05092360|524748688|FG003|Overall Study|Study terminated by sponsor|61|||
145516077|NCT01525225|524748689|FG000|Enrollment|No longer met study criteria|1|||
145516078|NCT01525225|524748689|FG000|Enrollment|Other|1|||
145516079|NCT01236547|524750446|FG000|Overall Study|Protocol Violation|0|||
145516080|NCT01236547|524750447|FG001|Overall Study|Protocol Violation|1|||
145516081|NCT01236547|524750448|FG002|Overall Study|Protocol Violation|1|||
145516082|NCT01236547|524750449|FG003|Overall Study|Protocol Violation|6|||
145516083|NCT01236547|524750450|FG004|Overall Study|Protocol Violation|12|||
145516084|NCT03135119|524750451|FG000|Overall Study|Lost to Follow-up|2|||
145516085|NCT03135119|524750452|FG001|Overall Study|Lost to Follow-up|0|||
145516086|NCT03135119|524750451|FG000|Overall Study|Physician Decision|1|||
145516087|NCT03135119|524750452|FG001|Overall Study|Physician Decision|1|||
145516088|NCT03135119|524750451|FG000|Overall Study|COVID-19 Shutdown|2|||
145516089|NCT03135119|524750452|FG001|Overall Study|COVID-19 Shutdown|2|||
145516090|NCT01478048|524750453|FG000|Overall Study|Disease Progression|52|||
145516091|NCT01478048|524750454|FG001|Overall Study|Disease Progression|35|||
145516092|NCT01478048|524750453|FG000|Overall Study|study drug toxicity|11|||
145516093|NCT01478048|524750454|FG001|Overall Study|study drug toxicity|14|||
145516094|NCT01478048|524750453|FG000|Overall Study|Adverse Event|2|||
145516095|NCT01478048|524750454|FG001|Overall Study|Adverse Event|11|||
145516096|NCT01478048|524750453|FG000|Overall Study|subject request to discontinue treatment|3|||
145516097|NCT01478048|524750454|FG001|Overall Study|subject request to discontinue treatment|5|||
145516098|NCT01478048|524750453|FG000|Overall Study|Withdrawal by Subject|2|||
145516099|NCT01478048|524750454|FG001|Overall Study|Withdrawal by Subject|5|||
145516100|NCT01478048|524750453|FG000|Overall Study|non-specified|6|||
145516101|NCT01478048|524750454|FG001|Overall Study|non-specified|4|||
145516102|NCT01478048|524750453|FG000|Overall Study|poor/non-compliance|0|||
145268794|NCT04150107|523832642|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
145268795|NCT04150107|523832641|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
145516103|NCT01478048|524750454|FG001|Overall Study|poor/non-compliance|1|||
145516104|NCT01478048|524750453|FG000|Overall Study|no longer meets study criteria|1|||
145516105|NCT01478048|524750454|FG001|Overall Study|no longer meets study criteria|0|||
145516106|NCT01252667|524750459|FG000|Overall Study|Transplant aborted post-conditioning|0|||
145516107|NCT01252667|524750460|FG001|Overall Study|Transplant aborted post-conditioning|0|||
145516108|NCT01252667|524750461|FG002|Overall Study|Transplant aborted post-conditioning|0|||
145516109|NCT01252667|524750462|FG003|Overall Study|Transplant aborted post-conditioning|0|||
145516110|NCT01252667|524750463|FG004|Overall Study|Transplant aborted post-conditioning|0|||
145516111|NCT01252667|524750464|FG005|Overall Study|Transplant aborted post-conditioning|1|||
145516112|NCT03032380|524750465|FG000|Overall Study|Adverse Event|0|||
145516113|NCT03032380|524750466|FG001|Overall Study|Adverse Event|1|||
145516114|NCT03032380|524750465|FG000|Overall Study|Lack of Efficacy|1|||
145516115|NCT03032380|524750466|FG001|Overall Study|Lack of Efficacy|0|||
145516116|NCT03032380|524750465|FG000|Overall Study|Withdrawal by Subject|2|||
145516117|NCT03032380|524750466|FG001|Overall Study|Withdrawal by Subject|3|||
145516118|NCT03032380|524750465|FG000|Overall Study|Recovery|0|||
145516119|NCT03032380|524750466|FG001|Overall Study|Recovery|1|||
145516120|NCT03032380|524750465|FG000|Overall Study|Death|39|||
145516121|NCT03032380|524750466|FG001|Overall Study|Death|34|||
145516122|NCT03032380|524750465|FG000|Overall Study|Other - Miscellaneous|0|||
145516123|NCT03032380|524750466|FG001|Overall Study|Other - Miscellaneous|1|||
145516124|NCT04644315|524750467|FG000|Overall Study|Subject withdrawal of consent|1|||
145516125|NCT01836276|524750468|FG000|Overall Study|Lost to Follow-up|28|||
145516126|NCT01836276|524750469|FG001|Overall Study|Lost to Follow-up|51|||
145516127|NCT01561898|524750472|FG000|Overall Study|Withdrawal by Subject|0|||
145516128|NCT01561898|524750473|FG001|Overall Study|Withdrawal by Subject|8|||
145516129|NCT01561898|524750474|FG002|Overall Study|Withdrawal by Subject|12|||
145516130|NCT01561898|524750475|FG003|Overall Study|Withdrawal by Subject|5|||
145516131|NCT01561898|524750472|FG000|Overall Study|Lack of Efficacy|0|||
145516132|NCT01561898|524750473|FG001|Overall Study|Lack of Efficacy|8|||
145516133|NCT01561898|524750474|FG002|Overall Study|Lack of Efficacy|10|||
145516134|NCT01561898|524750475|FG003|Overall Study|Lack of Efficacy|5|||
145516135|NCT01561898|524750472|FG000|Overall Study|Worsening of complications|0|||
145516136|NCT01561898|524750473|FG001|Overall Study|Worsening of complications|1|||
145516137|NCT01561898|524750474|FG002|Overall Study|Worsening of complications|0|||
145516138|NCT01561898|524750475|FG003|Overall Study|Worsening of complications|0|||
145516139|NCT01561898|524750472|FG000|Overall Study|Lost to Follow-up|0|||
145516140|NCT01561898|524750473|FG001|Overall Study|Lost to Follow-up|0|||
145516141|NCT01561898|524750474|FG002|Overall Study|Lost to Follow-up|1|||
145516142|NCT01561898|524750475|FG003|Overall Study|Lost to Follow-up|0|||
145516143|NCT01561898|524750472|FG000|Overall Study|Adverse Event|1|||
145516144|NCT01561898|524750473|FG001|Overall Study|Adverse Event|19|||
145516145|NCT01561898|524750474|FG002|Overall Study|Adverse Event|14|||
145516146|NCT01561898|524750475|FG003|Overall Study|Adverse Event|9|||
145516147|NCT01561898|524750472|FG000|Overall Study|Physician Decision|1|||
145516148|NCT01561898|524750473|FG001|Overall Study|Physician Decision|5|||
145516149|NCT01561898|524750474|FG002|Overall Study|Physician Decision|7|||
145516150|NCT01561898|524750475|FG003|Overall Study|Physician Decision|1|||
145516151|NCT00331552|524750476|FG000|Period 3: Phase II|Neurological Symptoms|1|||
145516152|NCT00331552|524750477|FG001|Period 3: Phase II|Neurological Symptoms|0|||
145516153|NCT00331552|524750476|FG000|Period 3: Phase II|Severe Nausea|1|||
145516154|NCT00331552|524750477|FG001|Period 3: Phase II|Severe Nausea|0|||
145516155|NCT01883453|524750478|FG000|Overall Study|No episode of common cold|25|||
145516156|NCT01883453|524750479|FG001|Overall Study|No episode of common cold|23|||
145516157|NCT02366091|524750482|FG000|Overall Study|Withdrawal by Subject|3|||
145516158|NCT02366091|524750483|FG001|Overall Study|Withdrawal by Subject|7|||
145516159|NCT02366091|524750484|FG002|Overall Study|Withdrawal by Subject|3|||
145516160|NCT02366091|524750485|FG003|Overall Study|Withdrawal by Subject|1|||
145516161|NCT03595618|524750486|FG000|Overall Study|Adverse Event|16|||
145516162|NCT03595618|524750487|FG001|Overall Study|Adverse Event|17|||
145516163|NCT03595618|524750488|FG002|Overall Study|Adverse Event|20|||
145516164|NCT03595618|524750489|FG003|Overall Study|Adverse Event|8|||
145516165|NCT03595618|524750486|FG000|Overall Study|Withdrawal by Subject|12|||
145516166|NCT03595618|524750487|FG001|Overall Study|Withdrawal by Subject|14|||
145516167|NCT03595618|524750488|FG002|Overall Study|Withdrawal by Subject|14|||
145516168|NCT03595618|524750489|FG003|Overall Study|Withdrawal by Subject|10|||
145516169|NCT03595618|524750486|FG000|Overall Study|Lost to Follow-up|6|||
145516170|NCT03595618|524750487|FG001|Overall Study|Lost to Follow-up|4|||
145516171|NCT03595618|524750488|FG002|Overall Study|Lost to Follow-up|5|||
145516172|NCT03595618|524750489|FG003|Overall Study|Lost to Follow-up|6|||
145516173|NCT03595618|524750486|FG000|Overall Study|Protocol Violation|2|||
145516174|NCT03595618|524750487|FG001|Overall Study|Protocol Violation|0|||
145516175|NCT03595618|524750488|FG002|Overall Study|Protocol Violation|6|||
145516176|NCT03595618|524750489|FG003|Overall Study|Protocol Violation|2|||
145516177|NCT03595618|524750486|FG000|Overall Study|Physician Decision|0|||
145516178|NCT03595618|524750487|FG001|Overall Study|Physician Decision|0|||
145516179|NCT03595618|524750488|FG002|Overall Study|Physician Decision|1|||
145516180|NCT03595618|524750489|FG003|Overall Study|Physician Decision|2|||
145516181|NCT03595618|524750486|FG000|Overall Study|Miscellaneous|7|||
145516182|NCT03595618|524750487|FG001|Overall Study|Miscellaneous|5|||
145516183|NCT03595618|524750488|FG002|Overall Study|Miscellaneous|10|||
145516184|NCT03595618|524750489|FG003|Overall Study|Miscellaneous|6|||
145516185|NCT02338232|524750490|FG000|Overall Study|Screen Failure|3|||
145516186|NCT02338232|524750490|FG000|Overall Study|Withdrawal by Subject|6|||
145516187|NCT02338232|524750490|FG000|Overall Study|Adverse Event|2|||
145516188|NCT00864916|524750493|FG000|Overall Study|Lost to Follow-up|4|||
145516189|NCT00864916|524750494|FG001|Overall Study|Lost to Follow-up|4|||
145516190|NCT00864916|524750493|FG000|Overall Study|Protocol Violation|1|||
145516191|NCT00864916|524750494|FG001|Overall Study|Protocol Violation|0|||
145516192|NCT00864916|524750493|FG000|Overall Study|Withdrawal by Subject|1|||
145516193|NCT00864916|524750494|FG001|Overall Study|Withdrawal by Subject|0|||
145516194|NCT00422084|524750495|FG000|Overall Study|Adverse Event|21|||
145516195|NCT00422084|524750496|FG001|Overall Study|Adverse Event|7|||
145516196|NCT00422084|524750495|FG000|Overall Study|Withdrawal by Subject|12|||
145516197|NCT00422084|524750496|FG001|Overall Study|Withdrawal by Subject|9|||
145516198|NCT00422084|524750495|FG000|Overall Study|Lost to Follow-up|14|||
145516199|NCT00422084|524750496|FG001|Overall Study|Lost to Follow-up|9|||
145516200|NCT00422084|524750495|FG000|Overall Study|Protocol Violation|4|||
145516201|NCT00422084|524750496|FG001|Overall Study|Protocol Violation|1|||
145516202|NCT00422084|524750495|FG000|Overall Study|Lack of Efficacy|40|||
145516203|NCT00422084|524750496|FG001|Overall Study|Lack of Efficacy|42|||
145516204|NCT00422084|524750495|FG000|Overall Study|P. vivax infection|3|||
145516205|NCT00422084|524750496|FG001|Overall Study|P. vivax infection|6|||
145516206|NCT00422084|524750495|FG000|Overall Study|Cyesis|1|||
145516207|NCT00422084|524750496|FG001|Overall Study|Cyesis|0|||
145516208|NCT00422084|524750495|FG000|Overall Study|Withdrawn from study accidentally|1|||
145516209|NCT00422084|524750496|FG001|Overall Study|Withdrawn from study accidentally|0|||
145516210|NCT00422084|524750495|FG000|Overall Study|Non-compliance|1|||
145516211|NCT00422084|524750496|FG001|Overall Study|Non-compliance|0|||
145516212|NCT00422084|524750495|FG000|Overall Study|Re-location|0|||
145516213|NCT00422084|524750496|FG001|Overall Study|Re-location|1|||
145516214|NCT00422084|524750495|FG000|Overall Study|Not defined|1|||
145734092|NCT00523718|525544738|FG000|Overall Study|Withdrawal by Subject|1|||
145516215|NCT00422084|524750496|FG001|Overall Study|Not defined|1|||
145516216|NCT03774823|524750497|FG000|Overall Study|Withdrawal by Subject|1|||
145516217|NCT03774823|524750498|FG001|Overall Study|Withdrawal by Subject|1|||
145516218|NCT03996369|524750503|FG000|Overall Study|Protocol deviation|1|||
145516219|NCT03996369|524750504|FG001|Overall Study|Protocol deviation|1|||
145516220|NCT03996369|524750503|FG000|Overall Study|Physician Decision|4|||
145516221|NCT03996369|524750504|FG001|Overall Study|Physician Decision|2|||
145516222|NCT03996369|524750503|FG000|Overall Study|Participant decision|0|||
145516223|NCT03996369|524750504|FG001|Overall Study|Participant decision|1|||
145516224|NCT03996369|524750503|FG000|Overall Study|Lack of Efficacy|4|||
145516225|NCT03996369|524750504|FG001|Overall Study|Lack of Efficacy|0|||
145516226|NCT03996369|524750503|FG000|Overall Study|Adverse Event|9|||
145516227|NCT03996369|524750504|FG001|Overall Study|Adverse Event|0|||
145516228|NCT03996369|524750503|FG000|Overall Study|Withdrawal by Subject|6|||
145516229|NCT03996369|524750504|FG001|Overall Study|Withdrawal by Subject|8|||
145516230|NCT03996369|524750503|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
145516231|NCT03996369|524750504|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
145734093|NCT00523718|525544739|FG001|Overall Study|Withdrawal by Subject|0|||
145734094|NCT00523718|525544738|FG000|Overall Study|Protocol Violation|2|||
145734095|NCT00523718|525544739|FG001|Overall Study|Protocol Violation|0|||
145734096|NCT01310803|525544740|FG000|Overall Study|Subject terminated by Sponsor|1|||
145734097|NCT01310803|525544741|FG001|Overall Study|Subject terminated by Sponsor|0|||
145734098|NCT00332839|525544742|FG000|Core (Months 0 - 12)|Administrative problems|1|||
145734099|NCT00332839|525544743|FG001|Core (Months 0 - 12)|Administrative problems|1|||
145734100|NCT00332839|525544742|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
145734101|NCT00332839|525544743|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
145734102|NCT00332839|525544742|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
145734103|NCT00332839|525544743|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
145734104|NCT00332839|525544742|FG000|Core (Months 0 - 12)|Adverse Event|5|||
145734105|NCT00332839|525544743|FG001|Core (Months 0 - 12)|Adverse Event|15|||
145734106|NCT00332839|525544742|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
145734107|NCT00332839|525544743|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
145734108|NCT00332839|525544742|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
145734109|NCT00332839|525544743|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
145268796|NCT04150107|523832642|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
145268797|NCT04456998|523832646|FG000|Overall Study|Adverse Event|0|||
145268798|NCT04456998|523832647|FG001|Overall Study|Adverse Event|4|||
145268799|NCT04456998|523832646|FG000|Overall Study|Protocol Deviation|0|||
145268800|NCT04456998|523832647|FG001|Overall Study|Protocol Deviation|1|||
145268801|NCT04456998|523832646|FG000|Overall Study|Withdrawal by Subject|0|||
145268802|NCT04456998|523832647|FG001|Overall Study|Withdrawal by Subject|1|||
145268803|NCT04455620|523832651|FG000|Overall Study|Withdrawal by Subject|0|||
145268804|NCT04455620|523832652|FG001|Overall Study|Withdrawal by Subject|0|||
145268805|NCT04455620|523832653|FG002|Overall Study|Withdrawal by Subject|2|||
145268806|NCT04455620|523832654|FG003|Overall Study|Withdrawal by Subject|0|||
145268807|NCT04455620|523832655|FG004|Overall Study|Withdrawal by Subject|1|||
145268808|NCT04455620|523832651|FG000|Overall Study|Lost to Follow-up|0|||
145268809|NCT04455620|523832652|FG001|Overall Study|Lost to Follow-up|0|||
145268810|NCT04455620|523832653|FG002|Overall Study|Lost to Follow-up|1|||
145268811|NCT04455620|523832654|FG003|Overall Study|Lost to Follow-up|1|||
145268812|NCT04455620|523832655|FG004|Overall Study|Lost to Follow-up|0|||
145268813|NCT04455620|523832651|FG000|Overall Study|Death|1|||
145268814|NCT04455620|523832652|FG001|Overall Study|Death|6|||
145268815|NCT04455620|523832653|FG002|Overall Study|Death|20|||
145268816|NCT04455620|523832654|FG003|Overall Study|Death|1|||
145268817|NCT04455620|523832655|FG004|Overall Study|Death|7|||
145268818|NCT04455620|523832651|FG000|Overall Study|Study Termination|0|||
145268819|NCT04455620|523832652|FG001|Overall Study|Study Termination|2|||
145268820|NCT04455620|523832653|FG002|Overall Study|Study Termination|1|||
145268821|NCT04455620|523832654|FG003|Overall Study|Study Termination|0|||
145268822|NCT04455620|523832655|FG004|Overall Study|Study Termination|6|||
145268823|NCT05012943|523832656|FG000|Overall Study|Adverse Event|2|||
145268824|NCT05012943|523832657|FG001|Overall Study|Adverse Event|1|||
145268825|NCT05012943|523832658|FG002|Overall Study|Adverse Event|0|||
145268826|NCT05012943|523832656|FG000|Overall Study|Withdrawal by Subject|1052|||
145268827|NCT05012943|523832657|FG001|Overall Study|Withdrawal by Subject|1006|||
145268828|NCT05012943|523832658|FG002|Overall Study|Withdrawal by Subject|20|||
145268829|NCT05012943|523832656|FG000|Overall Study|Death|25|||
145268830|NCT05012943|523832657|FG001|Overall Study|Death|17|||
145268831|NCT05012943|523832658|FG002|Overall Study|Death|4|||
145268832|NCT05012943|523832656|FG000|Overall Study|Lost to Follow-up|11|||
145268833|NCT05012943|523832657|FG001|Overall Study|Lost to Follow-up|24|||
145268834|NCT05012943|523832658|FG002|Overall Study|Lost to Follow-up|3|||
145268835|NCT05012943|523832656|FG000|Overall Study|Physician Decision|1|||
145268836|NCT05012943|523832657|FG001|Overall Study|Physician Decision|1|||
145268837|NCT05012943|523832658|FG002|Overall Study|Physician Decision|0|||
145268838|NCT05012943|523832656|FG000|Overall Study|Other than Specified|2|||
145268839|NCT05012943|523832657|FG001|Overall Study|Other than Specified|1|||
145268840|NCT05012943|523832658|FG002|Overall Study|Other than Specified|0|||
145268841|NCT04228107|523832659|FG000|Overall Study|Protocol Violation|1|||
145516232|NCT03996369|524750503|FG000|Overall Study|Lost to Follow-up|0|||
145516233|NCT03996369|524750504|FG001|Overall Study|Lost to Follow-up|1|||
145734110|NCT00332839|525544742|FG000|Follow-up (Months 12 - 60)|Death|1|||
145734111|NCT00332839|525544743|FG001|Follow-up (Months 12 - 60)|Death|1|||
145734112|NCT01436071|525544744|FG000|Overall Study|Adverse Event|1|||
145734113|NCT01436071|525544745|FG001|Overall Study|Adverse Event|0|||
145268842|NCT04228107|523832660|FG001|Overall Study|Protocol Violation|0|||
145268843|NCT04228107|523832659|FG000|Overall Study|Withdrawal by Subject|6|||
145268844|NCT04228107|523832660|FG001|Overall Study|Withdrawal by Subject|0|||
145268845|NCT04228107|523832659|FG000|Overall Study|Lost to Follow-up|18|||
145268846|NCT04228107|523832660|FG001|Overall Study|Lost to Follow-up|0|||
145268847|NCT04228107|523832659|FG000|Overall Study|No controller use data|1|||
145268848|NCT04228107|523832660|FG001|Overall Study|No controller use data|0|||
145268849|NCT04228107|523832659|FG000|Overall Study|No medication data collected|1|||
145268850|NCT04228107|523832660|FG001|Overall Study|No medication data collected|0|||
145734114|NCT01436071|525544744|FG000|Overall Study|Lack of Efficacy|16|||
145734115|NCT01436071|525544745|FG001|Overall Study|Lack of Efficacy|7|||
145734116|NCT01436071|525544744|FG000|Overall Study|Protocol Violation|0|||
145606651|NCT01576718|525075121|FG004|Treatment Period|Withdrawal by Subject|2|||
145734117|NCT01436071|525544745|FG001|Overall Study|Protocol Violation|1|||
145606652|NCT01576718|525075122|FG005|Treatment Period|Withdrawal by Subject|4|||
145606653|NCT01576718|525075123|FG006|Treatment Period|Withdrawal by Subject|2|||
145606654|NCT01576718|525075117|FG000|Treatment Period|Physician Decision|0|||
145606655|NCT01576718|525075118|FG001|Treatment Period|Physician Decision|1|||
145606656|NCT01576718|525075119|FG002|Treatment Period|Physician Decision|1|||
145734118|NCT01436071|525544744|FG000|Overall Study|Lost to Follow-up|3|||
145734119|NCT01436071|525544745|FG001|Overall Study|Lost to Follow-up|1|||
145734120|NCT01436071|525544744|FG000|Overall Study|Physician Decision|1|||
145516234|NCT00653432|524750506|FG000|Overall Study|Adverse Event|4|||
145516235|NCT00653432|524750507|FG001|Overall Study|Adverse Event|1|||
145516236|NCT00653432|524750506|FG000|Overall Study|Withdrawal by Subject|4|||
145516237|NCT00653432|524750507|FG001|Overall Study|Withdrawal by Subject|5|||
145516238|NCT00653432|524750506|FG000|Overall Study|Lost to Follow-up|7|||
145516239|NCT00653432|524750507|FG001|Overall Study|Lost to Follow-up|6|||
145516240|NCT00653432|524750506|FG000|Overall Study|Use/Need of Con Therapy|2|||
145516241|NCT00653432|524750507|FG001|Overall Study|Use/Need of Con Therapy|1|||
145516242|NCT00653432|524750506|FG000|Overall Study|Other - Reason Not Provided|5|||
145516243|NCT00653432|524750507|FG001|Overall Study|Other - Reason Not Provided|3|||
145516244|NCT05277337|524750508|FG000|Overall Study|Lost to Follow-up|2|||
145516245|NCT05277337|524750509|FG001|Overall Study|Lost to Follow-up|0|||
145516246|NCT05277337|524750508|FG000|Overall Study|Withdrawal by Subject|1|||
145516247|NCT05277337|524750509|FG001|Overall Study|Withdrawal by Subject|0|||
145516248|NCT01782469|524750510|FG000|Overall Study|Lost to Follow-up|1|||
145516249|NCT00357760|524750513|FG000|Overall Study|Disease progression|44|||
145516250|NCT00357760|524750514|FG001|Overall Study|Disease progression|17|||
145516251|NCT00357760|524750513|FG000|Overall Study|Adverse Event|10|||
145516252|NCT00357760|524750514|FG001|Overall Study|Adverse Event|7|||
145516253|NCT00357760|524750513|FG000|Overall Study|Death|0|||
145516254|NCT00357760|524750514|FG001|Overall Study|Death|3|||
145516255|NCT00357760|524750513|FG000|Overall Study|Alternative therapy|1|||
145516256|NCT00357760|524750514|FG001|Overall Study|Alternative therapy|0|||
145516257|NCT00357760|524750513|FG000|Overall Study|Withdrawal by Subject|0|||
145516258|NCT00357760|524750514|FG001|Overall Study|Withdrawal by Subject|2|||
145516259|NCT00357760|524750513|FG000|Overall Study|Never started treatment|2|||
145516260|NCT00357760|524750514|FG001|Overall Study|Never started treatment|1|||
145516261|NCT00357760|524750513|FG000|Overall Study|Ineligible|0|||
145516262|NCT00357760|524750514|FG001|Overall Study|Ineligible|2|||
145516263|NCT00357760|524750513|FG000|Overall Study|Physician Decision|2|||
145516264|NCT00357760|524750514|FG001|Overall Study|Physician Decision|1|||
145516265|NCT00357760|524750513|FG000|Overall Study|Protocol Violation|0|||
145516266|NCT00357760|524750514|FG001|Overall Study|Protocol Violation|1|||
145516267|NCT00357760|524750513|FG000|Overall Study|To receive hospice care|0|||
145516268|NCT00357760|524750514|FG001|Overall Study|To receive hospice care|1|||
145516269|NCT02350764|524750515|FG000|Overall Study|Adverse Event|4|||
145516270|NCT02350764|524750515|FG000|Overall Study|Death|3|||
145516271|NCT02350764|524750515|FG000|Overall Study|Physician Decision|2|||
145516272|NCT02350764|524750515|FG000|Overall Study|Withdrawal by Subject|2|||
145606657|NCT01576718|525075120|FG003|Treatment Period|Physician Decision|1|||
145606658|NCT01576718|525075121|FG004|Treatment Period|Physician Decision|1|||
145606659|NCT01576718|525075122|FG005|Treatment Period|Physician Decision|0|||
145606660|NCT01576718|525075123|FG006|Treatment Period|Physician Decision|0|||
145606661|NCT01576718|525075117|FG000|Treatment Period|Protocol Violation|0|||
145606662|NCT01576718|525075118|FG001|Treatment Period|Protocol Violation|5|||
145268851|NCT00400985|523832661|FG000|Overall Study|Withdrawal by Subject|5|||
145606663|NCT01576718|525075119|FG002|Treatment Period|Protocol Violation|4|||
145606664|NCT01576718|525075120|FG003|Treatment Period|Protocol Violation|10|||
145606665|NCT01576718|525075121|FG004|Treatment Period|Protocol Violation|6|||
145606666|NCT01576718|525075122|FG005|Treatment Period|Protocol Violation|8|||
145402240|NCT00750269|524330677|FG000|Overall Study|Fiducials could not be placed|0|||
145516273|NCT01224782|524750519|FG000|Overall Study|Lost to Follow-up|177|||
145516274|NCT01224782|524750519|FG000|Overall Study|Withdrawal by Subject|16|||
145402241|NCT00750269|524330678|FG001|Overall Study|Fiducials could not be placed|0|||
145516275|NCT01224782|524750519|FG000|Overall Study|Death|14|||
145516276|NCT01224782|524750519|FG000|Overall Study|Improvement|13|||
145516277|NCT01224782|524750519|FG000|Overall Study|Adverse Event|12|||
145516278|NCT01224782|524750519|FG000|Overall Study|Adverse Reaction|11|||
145516279|NCT01224782|524750519|FG000|Overall Study|Noncompliance|10|||
145516280|NCT01224782|524750519|FG000|Overall Study|Other|4|||
145516281|NCT01224782|524750519|FG000|Overall Study|Start of Dialysis|3|||
145516282|NCT01224782|524750519|FG000|Overall Study|Change of Treatment|1|||
145516283|NCT01224782|524750519|FG000|Overall Study|Financial Reasons|1|||
145606667|NCT01576718|525075123|FG006|Treatment Period|Protocol Violation|12|||
145606668|NCT01576718|525075117|FG000|Treatment Period|Sponsor request|0|||
145268852|NCT00400985|523832661|FG000|Overall Study|system modification|8|||
145268853|NCT00400985|523832661|FG000|Overall Study|Death|30|||
145268854|NCT00400985|523832661|FG000|Overall Study|Lost to Follow-up|9|||
145268855|NCT00965562|523832662|FG000|Overall Study|Lost to Follow-up|1|||
145268856|NCT00965562|523832663|FG001|Overall Study|Lost to Follow-up|2|||
145268857|NCT00965562|523832664|FG002|Overall Study|Lost to Follow-up|3|||
145268858|NCT00965562|523832662|FG000|Overall Study|Withdrawal by Subject|2|||
145268859|NCT00965562|523832663|FG001|Overall Study|Withdrawal by Subject|2|||
145268860|NCT00965562|523832664|FG002|Overall Study|Withdrawal by Subject|0|||
145268861|NCT03792633|523832665|FG000|Overall Study|Alternative Treatment|17|||
145268862|NCT03792633|523832666|FG001|Overall Study|Alternative Treatment|19|||
145268863|NCT03792633|523832665|FG000|Overall Study|Death|2|||
145268864|NCT03792633|523832666|FG001|Overall Study|Death|0|||
145268865|NCT03792633|523832665|FG000|Overall Study|Disease progression|8|||
145268866|NCT03792633|523832666|FG001|Overall Study|Disease progression|9|||
145268867|NCT03792633|523832665|FG000|Overall Study|Lost to Follow-up|1|||
145268868|NCT03792633|523832666|FG001|Overall Study|Lost to Follow-up|1|||
145268869|NCT03792633|523832665|FG000|Overall Study|Screen fail|1|||
145268870|NCT03792633|523832666|FG001|Overall Study|Screen fail|0|||
145516284|NCT01224782|524750519|FG000|Overall Study|Deterioration|1|||
145516285|NCT01224782|524750519|FG000|Overall Study|Transplantation|1|||
145516286|NCT00441116|524750520|FG000|Overall Study|Adverse Event|1|||
145516287|NCT00441116|524750521|FG001|Overall Study|Adverse Event|1|||
145516288|NCT00441116|524750520|FG000|Overall Study|Withdrawal by Subject|1|||
145516289|NCT00441116|524750521|FG001|Overall Study|Withdrawal by Subject|0|||
145516290|NCT00441116|524750520|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
145516291|NCT00441116|524750521|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
145516292|NCT02925338|524750522|FG000|Overall Study|Death|0|||
145516293|NCT02925338|524750523|FG001|Overall Study|Death|2|||
145516294|NCT02925338|524750524|FG002|Overall Study|Death|1|||
145516295|NCT02925338|524750525|FG003|Overall Study|Death|0|||
145516296|NCT02925338|524750526|FG004|Overall Study|Death|0|||
145516297|NCT02925338|524750522|FG000|Overall Study|Lost to Follow-up|30|||
145516298|NCT02925338|524750523|FG001|Overall Study|Lost to Follow-up|10|||
145516299|NCT02925338|524750524|FG002|Overall Study|Lost to Follow-up|1|||
145516300|NCT02925338|524750525|FG003|Overall Study|Lost to Follow-up|16|||
145516301|NCT02925338|524750526|FG004|Overall Study|Lost to Follow-up|3|||
145516302|NCT02925338|524750522|FG000|Overall Study|Withdrawal by Subject|3|||
145516303|NCT02925338|524750523|FG001|Overall Study|Withdrawal by Subject|0|||
145268871|NCT03792633|523832665|FG000|Overall Study|Second malignancy|0|||
145268872|NCT03792633|523832666|FG001|Overall Study|Second malignancy|1|||
145268873|NCT05048875|523832668|FG000|Overall Study|Withdrawal by Subject|1|||
145268874|NCT05048875|523832669|FG001|Overall Study|Withdrawal by Subject|0|||
145268875|NCT05048875|523832670|FG002|Overall Study|Withdrawal by Subject|0|||
145268876|NCT05048875|523832671|FG003|Overall Study|Withdrawal by Subject|0|||
145268877|NCT05048875|523832672|FG004|Overall Study|Withdrawal by Subject|0|||
145268878|NCT05048875|523832673|FG005|Overall Study|Withdrawal by Subject|0|||
145268879|NCT05048875|523832674|FG006|Overall Study|Withdrawal by Subject|0|||
145268880|NCT05048875|523832675|FG007|Overall Study|Withdrawal by Subject|0|||
145268881|NCT05048875|523832668|FG000|Overall Study|Adverse Event|0|||
145268882|NCT05048875|523832669|FG001|Overall Study|Adverse Event|0|||
145268883|NCT05048875|523832670|FG002|Overall Study|Adverse Event|0|||
145268884|NCT05048875|523832671|FG003|Overall Study|Adverse Event|1|||
145268885|NCT05048875|523832672|FG004|Overall Study|Adverse Event|0|||
145268886|NCT05048875|523832673|FG005|Overall Study|Adverse Event|0|||
145268887|NCT05048875|523832674|FG006|Overall Study|Adverse Event|0|||
145268888|NCT05048875|523832675|FG007|Overall Study|Adverse Event|0|||
145268889|NCT02684162|523832684|FG000|Overall Study|Physician Decision|0|||
145268890|NCT02684162|523832685|FG001|Overall Study|Physician Decision|1|||
145268891|NCT02684162|523832686|FG002|Overall Study|Physician Decision|0|||
145516304|NCT02925338|524750524|FG002|Overall Study|Withdrawal by Subject|3|||
145268892|NCT05153629|523832688|FG000|Overall Study|Withdrawal by Subject|0|||
145268893|NCT05153629|523832689|FG001|Overall Study|Withdrawal by Subject|2|||
145268894|NCT04089566|523832694|FG000|Overall Study|Death|0|||
145268895|NCT04089566|523832695|FG001|Overall Study|Death|6|||
145268896|NCT04089566|523832696|FG002|Overall Study|Death|10|||
145516305|NCT02925338|524750525|FG003|Overall Study|Withdrawal by Subject|2|||
145516306|NCT02925338|524750526|FG004|Overall Study|Withdrawal by Subject|2|||
145516307|NCT02925338|524750522|FG000|Overall Study|Missing|38|||
145516308|NCT02925338|524750523|FG001|Overall Study|Missing|27|||
145268897|NCT04089566|523832697|FG003|Overall Study|Death|0|||
145268898|NCT04089566|523832698|FG004|Overall Study|Death|0|||
145516309|NCT02925338|524750524|FG002|Overall Study|Missing|0|||
145268899|NCT04089566|523832699|FG005|Overall Study|Death|0|||
145268900|NCT04089566|523832694|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
145268901|NCT04089566|523832695|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
145268902|NCT04089566|523832696|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
145268903|NCT04089566|523832697|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
145268904|NCT04089566|523832698|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
145516310|NCT02925338|524750525|FG003|Overall Study|Missing|3|||
145734121|NCT01436071|525544745|FG001|Overall Study|Physician Decision|0|||
145734122|NCT01436071|525544744|FG000|Overall Study|Withdrawal by Subject|2|||
145734123|NCT01436071|525544745|FG001|Overall Study|Withdrawal by Subject|2|||
145734124|NCT01436071|525544744|FG000|Overall Study|Did Not Receive Trial Medication|3|||
145734125|NCT01436071|525544745|FG001|Overall Study|Did Not Receive Trial Medication|3|||
145734126|NCT03047551|525544748|FG000|Overall Study|Did not receive TAS|1|||
145734127|NCT03047551|525544749|FG001|Overall Study|Did not receive TAS|0|||
145734128|NCT03047551|525544748|FG000|Overall Study|Physician Decision|1|||
145734129|NCT03047551|525544749|FG001|Overall Study|Physician Decision|0|||
145734130|NCT03047551|525544748|FG000|Overall Study|Withdrawal by Subject|0|||
145734131|NCT03047551|525544749|FG001|Overall Study|Withdrawal by Subject|1|||
145734132|NCT03047551|525544748|FG000|Overall Study|Probe malfunction|0|||
145734133|NCT03047551|525544749|FG001|Overall Study|Probe malfunction|1|||
145734134|NCT03047551|525544748|FG000|Overall Study|Ineligible|0|||
145734135|NCT03047551|525544749|FG001|Overall Study|Ineligible|1|||
145734136|NCT00594516|525544750|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
145734137|NCT00594516|525544751|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
145734138|NCT00594516|525544752|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
145734139|NCT00594516|525544750|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
145734140|NCT00594516|525544751|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
145734141|NCT00594516|525544752|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
145734142|NCT00594516|525544750|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
145734143|NCT00594516|525544751|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
145734144|NCT00594516|525544752|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
145734145|NCT00594516|525544750|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
145734146|NCT00594516|525544751|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
145734147|NCT00594516|525544752|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
145734148|NCT00594516|525544750|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
145734149|NCT00594516|525544751|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
145734150|NCT00594516|525544752|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
145734151|NCT00594516|525544750|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
145734152|NCT00594516|525544751|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
145734153|NCT00594516|525544752|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
145734154|NCT00594516|525544750|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
145734155|NCT00594516|525544751|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
145734156|NCT00594516|525544752|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
145734157|NCT00594516|525544750|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
145734158|NCT00594516|525544751|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
145734159|NCT00594516|525544752|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
145734160|NCT00594516|525544750|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
145734161|NCT00594516|525544751|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
145734162|NCT00594516|525544752|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
145734163|NCT02462928|525544753|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145606669|NCT01576718|525075118|FG001|Treatment Period|Sponsor request|1|||
145606670|NCT01576718|525075119|FG002|Treatment Period|Sponsor request|0|||
145402242|NCT00750269|524330679|FG002|Overall Study|Fiducials could not be placed|0|||
145516311|NCT02925338|524750526|FG004|Overall Study|Missing|2|||
145516312|NCT02925338|524750522|FG000|Overall Study|Participant's Decision|11|||
145516313|NCT02925338|524750523|FG001|Overall Study|Participant's Decision|7|||
145516314|NCT02925338|524750524|FG002|Overall Study|Participant's Decision|3|||
145516315|NCT02925338|524750525|FG003|Overall Study|Participant's Decision|8|||
145516316|NCT02925338|524750526|FG004|Overall Study|Participant's Decision|1|||
145516317|NCT02925338|524750522|FG000|Overall Study|Treatment Discontinuation|144|||
145516318|NCT02925338|524750523|FG001|Overall Study|Treatment Discontinuation|65|||
145516319|NCT02925338|524750524|FG002|Overall Study|Treatment Discontinuation|56|||
145516320|NCT02925338|524750525|FG003|Overall Study|Treatment Discontinuation|131|||
145516321|NCT02925338|524750526|FG004|Overall Study|Treatment Discontinuation|22|||
145516322|NCT00548184|524750527|FG000|Overall Study|Adverse Event|3|||
145516323|NCT00548184|524750527|FG000|Overall Study|took other drug|1|||
145516324|NCT00548184|524750527|FG000|Overall Study|Found Her2 negative|1|||
145516325|NCT02395172|524750528|FG000|Overall Study|Participants randomized but not treated|3|||
145734164|NCT02462928|525544754|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145516326|NCT02395172|524750529|FG001|Overall Study|Participants randomized but not treated|31|||
145516327|NCT00029146|524750532|FG000|Overall Study|Lost to Follow-up|2|||
145516328|NCT00029146|524750533|FG001|Overall Study|Lost to Follow-up|1|||
145606671|NCT01576718|525075120|FG003|Treatment Period|Sponsor request|0|||
145606672|NCT01576718|525075121|FG004|Treatment Period|Sponsor request|0|||
145734165|NCT02462928|525544755|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
145734166|NCT02462928|525544753|FG000|Overall Study|Adverse Event|47|||
145734167|NCT02462928|525544754|FG001|Overall Study|Adverse Event|51|||
145734168|NCT02462928|525544755|FG002|Overall Study|Adverse Event|25|||
145734169|NCT02462928|525544753|FG000|Overall Study|Lack of Efficacy|3|||
145734170|NCT02462928|525544754|FG001|Overall Study|Lack of Efficacy|8|||
145734171|NCT02462928|525544755|FG002|Overall Study|Lack of Efficacy|3|||
145734172|NCT02462928|525544753|FG000|Overall Study|Lost to Follow-up|4|||
145734173|NCT02462928|525544754|FG001|Overall Study|Lost to Follow-up|4|||
145734174|NCT02462928|525544755|FG002|Overall Study|Lost to Follow-up|1|||
145734175|NCT02462928|525544753|FG000|Overall Study|Withdrawal by Patient|31|||
145734176|NCT02462928|525544754|FG001|Overall Study|Withdrawal by Patient|21|||
145734177|NCT02462928|525544755|FG002|Overall Study|Withdrawal by Patient|21|||
145734178|NCT02462928|525544753|FG000|Overall Study|Protocol Violation|0|||
145734179|NCT02462928|525544754|FG001|Overall Study|Protocol Violation|1|||
145734180|NCT02462928|525544755|FG002|Overall Study|Protocol Violation|0|||
145734181|NCT02462928|525544753|FG000|Overall Study|Reason not Specified|4|||
145734182|NCT02462928|525544754|FG001|Overall Study|Reason not Specified|6|||
145734183|NCT02462928|525544755|FG002|Overall Study|Reason not Specified|5|||
145734184|NCT04641299|525544756|FG000|Overall Study|Adverse Event|0|||
145734185|NCT04641299|525544757|FG001|Overall Study|Adverse Event|0|||
145734186|NCT04641299|525544758|FG002|Overall Study|Adverse Event|2|||
145734187|NCT04641299|525544759|FG003|Overall Study|Adverse Event|0|||
145734188|NCT04641299|525544756|FG000|Overall Study|Lost to Follow-up|0|||
145734189|NCT04641299|525544757|FG001|Overall Study|Lost to Follow-up|1|||
145734190|NCT04641299|525544758|FG002|Overall Study|Lost to Follow-up|0|||
145734191|NCT04641299|525544759|FG003|Overall Study|Lost to Follow-up|0|||
145734192|NCT04641299|525544756|FG000|Overall Study|Withdrawal by Subject|1|||
145734193|NCT04641299|525544757|FG001|Overall Study|Withdrawal by Subject|0|||
145734194|NCT04641299|525544758|FG002|Overall Study|Withdrawal by Subject|0|||
145734195|NCT04641299|525544759|FG003|Overall Study|Withdrawal by Subject|0|||
145734196|NCT04641299|525544756|FG000|Overall Study|Reason not given|1|||
145734197|NCT04641299|525544757|FG001|Overall Study|Reason not given|0|||
145734198|NCT04641299|525544758|FG002|Overall Study|Reason not given|0|||
145734199|NCT04641299|525544759|FG003|Overall Study|Reason not given|0|||
145734200|NCT00702845|525544762|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
145734201|NCT00702845|525544763|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
145734202|NCT00702845|525544762|FG000|Overall Study|Too high ovarian response|5|||
145734203|NCT00702845|525544763|FG001|Overall Study|Too high ovarian response|1|||
145734204|NCT00702845|525544762|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
145734205|NCT00702845|525544763|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
145734206|NCT00702845|525544762|FG000|Overall Study|Insufficient ovarian response|1|||
145734207|NCT00702845|525544763|FG001|Overall Study|Insufficient ovarian response|0|||
145734208|NCT00702845|525544762|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
145516329|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
145516330|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
145516331|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
145516332|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
145516333|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
145516334|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
145516335|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
145516336|NCT00946985|524750534|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
145516337|NCT00946985|524750534|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
145516338|NCT01546623|524750535|FG000|Overall Study|Adverse Event|2|||
145516339|NCT01546623|524750536|FG001|Overall Study|Adverse Event|3|||
145516340|NCT01546623|524750535|FG000|Overall Study|Major Protocol Deviation|1|||
145516341|NCT01546623|524750536|FG001|Overall Study|Major Protocol Deviation|1|||
145516342|NCT01546623|524750535|FG000|Overall Study|High Prostate specific antigen|2|||
145516343|NCT01546623|524750536|FG001|Overall Study|High Prostate specific antigen|1|||
145516344|NCT01546623|524750535|FG000|Overall Study|Did Not Receive Study Drug|1|||
145516345|NCT01546623|524750536|FG001|Overall Study|Did Not Receive Study Drug|1|||
145516346|NCT01590758|524750537|FG000|Overall Study|Withdrawal by Subject|0|||
145516347|NCT01590758|524750538|FG001|Overall Study|Withdrawal by Subject|3|||
145516348|NCT01590758|524750537|FG000|Overall Study|Physician Decision|1|||
145516349|NCT01590758|524750538|FG001|Overall Study|Physician Decision|2|||
145516350|NCT01590758|524750537|FG000|Overall Study|Lost to Follow-up|4|||
145516351|NCT01590758|524750538|FG001|Overall Study|Lost to Follow-up|2|||
145516352|NCT04525885|524750539|FG000|Overall Study|Screen Failure|1|||
145516353|NCT04525885|524750540|FG001|Overall Study|Screen Failure|0|||
145516354|NCT04525885|524750541|FG002|Overall Study|Screen Failure|0|||
145516355|NCT04525885|524750539|FG000|Overall Study|Withdrawal by Subject|14|||
145516356|NCT04525885|524750540|FG001|Overall Study|Withdrawal by Subject|6|||
145734209|NCT00702845|525544763|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
145734210|NCT00702845|525544762|FG000|Overall Study|No or abnormal fertilization|4|||
145734211|NCT00702845|525544763|FG001|Overall Study|No or abnormal fertilization|2|||
145734212|NCT00702845|525544762|FG000|Overall Study|Patient's decision|2|||
145734213|NCT00702845|525544763|FG001|Overall Study|Patient's decision|1|||
145734214|NCT00702845|525544762|FG000|Overall Study|Not randomized|0|||
145734215|NCT00702845|525544763|FG001|Overall Study|Not randomized|1|||
145606673|NCT01576718|525075122|FG005|Treatment Period|Sponsor request|1|||
145606674|NCT01576718|525075123|FG006|Treatment Period|Sponsor request|0|||
145606675|NCT01576718|525075117|FG000|Treatment Period|Met stopping criteria|0|||
145606676|NCT01576718|525075118|FG001|Treatment Period|Met stopping criteria|16|||
145606677|NCT01576718|525075119|FG002|Treatment Period|Met stopping criteria|13|||
145606678|NCT01576718|525075120|FG003|Treatment Period|Met stopping criteria|19|||
145606679|NCT01576718|525075121|FG004|Treatment Period|Met stopping criteria|16|||
145606680|NCT01576718|525075122|FG005|Treatment Period|Met stopping criteria|33|||
145606681|NCT01576718|525075123|FG006|Treatment Period|Met stopping criteria|15|||
145606682|NCT01576718|525075117|FG000|Treatment Period|Lost to Follow-up|0|||
145606683|NCT01576718|525075118|FG001|Treatment Period|Lost to Follow-up|0|||
145606684|NCT01576718|525075119|FG002|Treatment Period|Lost to Follow-up|0|||
145606685|NCT01576718|525075120|FG003|Treatment Period|Lost to Follow-up|0|||
145606686|NCT01576718|525075121|FG004|Treatment Period|Lost to Follow-up|1|||
145606687|NCT01576718|525075122|FG005|Treatment Period|Lost to Follow-up|0|||
145606688|NCT01576718|525075123|FG006|Treatment Period|Lost to Follow-up|0|||
145606689|NCT01576718|525075117|FG000|Treatment Period|Noncompliance to study medication|0|||
145606690|NCT01576718|525075118|FG001|Treatment Period|Noncompliance to study medication|0|||
145606691|NCT01576718|525075119|FG002|Treatment Period|Noncompliance to study medication|0|||
145606692|NCT01576718|525075120|FG003|Treatment Period|Noncompliance to study medication|0|||
145606693|NCT01576718|525075121|FG004|Treatment Period|Noncompliance to study medication|0|||
145606694|NCT01576718|525075122|FG005|Treatment Period|Noncompliance to study medication|1|||
145516357|NCT04525885|524750541|FG002|Overall Study|Withdrawal by Subject|20|||
145516358|NCT04525885|524750539|FG000|Overall Study|Physician Decision|1|||
145516359|NCT04525885|524750540|FG001|Overall Study|Physician Decision|0|||
145516360|NCT04525885|524750541|FG002|Overall Study|Physician Decision|1|||
145516361|NCT02717832|524750542|FG000|Overall Study|Inability to place IV|3|||
145516362|NCT00978757|524750545|FG000|Overall Study|Physician Decision|1|||
145516363|NCT00978757|524750546|FG001|Overall Study|Physician Decision|3|||
145516364|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
145516365|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
145516366|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
145516367|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
145516368|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
145516369|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
145516370|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
145516371|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
145516372|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
145516373|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
145516374|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516375|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516376|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516377|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516378|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
145516379|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516380|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516381|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516382|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516383|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
145516384|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
145516385|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516386|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516387|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516388|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
145516389|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516390|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516391|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516392|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516393|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
145516394|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516395|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516396|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
145516397|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516398|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
145516399|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516400|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516401|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145606695|NCT01576718|525075123|FG006|Treatment Period|Noncompliance to study medication|1|||
145516402|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516403|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
145516404|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516405|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516406|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516407|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516408|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
145516409|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145734216|NCT00928564|525544767|FG000|Overall Study|Lost to Follow-up|6|||
145734217|NCT00928564|525544768|FG001|Overall Study|Lost to Follow-up|0|||
145734218|NCT02973425|525544770|FG000|Overall Study|Lost to Follow-up|49|||
145734219|NCT02973425|525544771|FG001|Overall Study|Lost to Follow-up|53|||
145734220|NCT01448213|525544776|FG000|Overall Study|Lost to Follow-up|12|||
145734221|NCT01448213|525544777|FG001|Overall Study|Lost to Follow-up|10|||
145734222|NCT01448213|525544776|FG000|Overall Study|Adverse Event|4|||
145734223|NCT01448213|525544777|FG001|Overall Study|Adverse Event|10|||
145516410|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145734224|NCT01448213|525544776|FG000|Overall Study|Protocol Violation|1|||
145734225|NCT01448213|525544777|FG001|Overall Study|Protocol Violation|2|||
145734226|NCT02012296|525544778|FG000|Overall Study|Lack of Efficacy|0|||
145734227|NCT02012296|525544779|FG001|Overall Study|Lack of Efficacy|0|||
145734228|NCT02012296|525544780|FG002|Overall Study|Lack of Efficacy|15|||
145734229|NCT02012296|525544778|FG000|Overall Study|Adverse Event|0|||
145734230|NCT02012296|525544779|FG001|Overall Study|Adverse Event|0|||
145734231|NCT02012296|525544780|FG002|Overall Study|Adverse Event|2|||
145734232|NCT02012296|525544778|FG000|Overall Study|Early study closure|0|||
145734233|NCT02012296|525544779|FG001|Overall Study|Early study closure|0|||
145734234|NCT02012296|525544780|FG002|Overall Study|Early study closure|5|||
145734235|NCT02012296|525544778|FG000|Overall Study|Protocol Violation|0|||
145734236|NCT02012296|525544779|FG001|Overall Study|Protocol Violation|1|||
145734237|NCT02012296|525544780|FG002|Overall Study|Protocol Violation|0|||
145734238|NCT03876171|525544781|FG000|Overall Study|Withdrawal by Subject|3|||
145734239|NCT03876171|525544782|FG001|Overall Study|Withdrawal by Subject|3|||
145734240|NCT03876171|525544781|FG000|Overall Study|Re-arrest|0|||
145734241|NCT03876171|525544782|FG001|Overall Study|Re-arrest|4|||
145734242|NCT01330914|525544783|FG000|Overall Study|Withdrawal by Subject|4|||
145734243|NCT01330914|525544783|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
145734244|NCT03503513|525544788|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
145734245|NCT03503513|525544788|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
145734246|NCT03503513|525544788|FG000|Overall Study|Physician Decision|3|||
145734247|NCT03503513|525544788|FG000|Overall Study|Withdrawal by Subject|2|||
145734248|NCT03503513|525544788|FG000|Overall Study|Lost to Follow-up|1|||
145734249|NCT02294682|525544791|FG000|Overall Study|Could not swallow pills|1|||
145734250|NCT02294682|525544792|FG001|Overall Study|Could not swallow pills|0|||
145734251|NCT01754857|525544793|FG000|Overall Study|Adverse Event|7|||
145734252|NCT01754857|525544793|FG000|Overall Study|Disease progression|3|||
145734253|NCT01754857|525544793|FG000|Overall Study|Physician Decision|2|||
145734254|NCT01754857|525544793|FG000|Overall Study|Withdrawal by Subject|3|||
145734255|NCT01754857|525544793|FG000|Overall Study|other complicating disease|1|||
145734256|NCT01754857|525544793|FG000|Overall Study|ineligible to continue onto maintenance|1|||
145734257|NCT01754857|525544793|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
145734258|NCT01754857|525544793|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
145734259|NCT00059839|525544796|FG000|Overall Study|Death|1|||
145734260|NCT00059839|525544797|FG001|Overall Study|Death|1|||
145734261|NCT00059839|525544796|FG000|Overall Study|Lack of Efficacy|6|||
145734262|NCT00059839|525544797|FG001|Overall Study|Lack of Efficacy|5|||
145734263|NCT00059839|525544796|FG000|Overall Study|Lost to Follow-up|2|||
145734264|NCT00059839|525544797|FG001|Overall Study|Lost to Follow-up|0|||
145734265|NCT00059839|525544796|FG000|Overall Study|Physician Decision|1|||
145734266|NCT00059839|525544797|FG001|Overall Study|Physician Decision|2|||
145734267|NCT00059839|525544796|FG000|Overall Study|Withdrawal by Subject|1|||
145734268|NCT00059839|525544797|FG001|Overall Study|Withdrawal by Subject|6|||
145734269|NCT00059839|525544796|FG000|Overall Study|Ineligible|1|||
145734270|NCT00059839|525544797|FG001|Overall Study|Ineligible|3|||
145734271|NCT03842163|525544798|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
145734272|NCT03842163|525544798|FG000|Overall Study|Scintigraphy was not performed|44|||
145516411|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516412|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145734273|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
145734274|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
145734275|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
145734276|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
145734277|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
145734278|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
145734279|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
145734280|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
145734281|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
145734282|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
145402243|NCT00750269|524330680|FG003|Overall Study|Fiducials could not be placed|0|||
145516413|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
145516414|NCT01185353|524750547|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
145516415|NCT01185353|524750548|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516416|NCT01185353|524750549|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516417|NCT01185353|524750550|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516418|NCT01185353|524750551|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
145516419|NCT01185353|524750552|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516420|NCT01185353|524750553|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516421|NCT01185353|524750554|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516422|NCT01185353|524750555|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516423|NCT01185353|524750556|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
145516424|NCT01185353|524750547|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516425|NCT01185353|524750548|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516426|NCT01185353|524750549|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
145516427|NCT01185353|524750550|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516428|NCT01185353|524750551|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516429|NCT01185353|524750552|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
145516430|NCT01185353|524750553|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516431|NCT01185353|524750554|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516432|NCT01185353|524750555|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516433|NCT01185353|524750556|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
145516434|NCT01185353|524750547|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516435|NCT01185353|524750548|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
145516436|NCT01185353|524750549|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516437|NCT01185353|524750550|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
145516438|NCT01185353|524750551|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516439|NCT01185353|524750552|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516440|NCT01185353|524750553|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516441|NCT01185353|524750554|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516442|NCT01185353|524750555|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516443|NCT01185353|524750556|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
145516444|NCT01185353|524750547|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516445|NCT01185353|524750548|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516446|NCT01185353|524750549|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516447|NCT01185353|524750550|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
145516448|NCT01185353|524750551|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516449|NCT01185353|524750552|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516450|NCT01185353|524750553|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
145516451|NCT01185353|524750554|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516452|NCT01185353|524750555|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516453|NCT01185353|524750556|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
145516454|NCT01185353|524750547|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516455|NCT01185353|524750548|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516456|NCT01185353|524750549|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
145516457|NCT01185353|524750550|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
145516458|NCT01185353|524750551|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516459|NCT01185353|524750552|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
145516460|NCT01185353|524750553|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
145516461|NCT01185353|524750554|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516462|NCT01185353|524750555|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516463|NCT01185353|524750556|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
145516464|NCT01185353|524750547|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516465|NCT01185353|524750548|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516466|NCT01185353|524750549|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516467|NCT01185353|524750550|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516468|NCT01185353|524750551|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145734283|NCT03829241|525544799|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
145734284|NCT03829241|525544800|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
145734285|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
145734286|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
145734287|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
145734288|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
145734289|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
145734290|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
145734291|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
145734292|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
145734293|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
145734294|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
145734295|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
145734296|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
145734297|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
145516469|NCT01185353|524750552|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516470|NCT01185353|524750553|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
145516471|NCT01185353|524750554|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516472|NCT01185353|524750555|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516473|NCT01185353|524750556|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
145516474|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516475|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516476|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516477|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516478|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516479|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516480|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
145516481|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
145516482|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
145516483|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
145516484|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516485|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516486|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516487|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516488|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516489|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145516490|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
145734298|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
145734299|NCT03829241|525544799|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
145734300|NCT03829241|525544800|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
145734301|NCT03083847|525544801|FG000|Main|Physician Decision|0|||
145734302|NCT03083847|525544802|FG001|Main|Physician Decision|0|||
145734303|NCT03083847|525544803|FG002|Main|Physician Decision|0|||
145734304|NCT03083847|525544804|FG003|Main|Physician Decision|0|||
145734305|NCT03083847|525544805|FG004|Main|Physician Decision|0|||
145734306|NCT03083847|525544806|FG005|Main|Physician Decision|1|||
145734307|NCT03083847|525544807|FG006|Main|Physician Decision|0|||
145734308|NCT03083847|525544808|FG007|Main|Physician Decision|0|||
145734309|NCT03083847|525544809|FG008|Main|Physician Decision|0|||
145734310|NCT03083847|525544810|FG009|Main|Physician Decision|0|||
145734311|NCT03083847|525544801|FG000|Main|Pregnancy|0|||
145734312|NCT03083847|525544802|FG001|Main|Pregnancy|0|||
145734313|NCT03083847|525544803|FG002|Main|Pregnancy|0|||
145734314|NCT03083847|525544804|FG003|Main|Pregnancy|0|||
145734315|NCT03083847|525544805|FG004|Main|Pregnancy|0|||
145734316|NCT03083847|525544806|FG005|Main|Pregnancy|0|||
145734317|NCT03083847|525544807|FG006|Main|Pregnancy|0|||
145606696|NCT01874145|525075124|FG000|Core Period|Non-compliance|1|||
145606697|NCT01874145|525075125|FG001|Core Period|Non-compliance|0|||
145606698|NCT01874145|525075124|FG000|Core Period|Protocol Violation|1|||
145606699|NCT01874145|525075125|FG001|Core Period|Protocol Violation|1|||
145606700|NCT01874145|525075124|FG000|Core Period|Physician Decision|1|||
145606701|NCT01874145|525075125|FG001|Core Period|Physician Decision|1|||
145734318|NCT03083847|525544808|FG007|Main|Pregnancy|1|||
145516491|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
145516492|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
145606702|NCT01874145|525075124|FG000|Core Period|Adverse Event|0|||
145606703|NCT01874145|525075125|FG001|Core Period|Adverse Event|1|||
145606704|NCT01874145|525075124|FG000|Core Period|Withdrawal by Subject|0|||
145734319|NCT03083847|525544809|FG008|Main|Pregnancy|0|||
145734320|NCT03083847|525544810|FG009|Main|Pregnancy|0|||
145734321|NCT03083847|525544801|FG000|Main|Adverse Event|0|||
145734322|NCT03083847|525544802|FG001|Main|Adverse Event|0|||
145734323|NCT03083847|525544803|FG002|Main|Adverse Event|0|||
145734324|NCT03083847|525544804|FG003|Main|Adverse Event|0|||
145516493|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
145516494|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516495|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516496|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516497|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516498|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516499|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516500|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
145516501|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
145516502|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
145516503|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
145516504|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516505|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516506|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516507|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516508|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516509|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516510|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516511|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516512|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
145516513|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
145516514|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Death|0|||
145516515|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Death|0|||
145516516|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Death|0|||
145516517|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Death|0|||
145516518|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Death|0|||
145516519|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Death|0|||
145516520|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Death|0|||
145516521|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Death|0|||
145516522|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Death|0|||
145516523|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Death|1|||
145516524|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516525|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516526|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516527|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516528|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516529|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516530|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516531|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516532|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
145516533|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
145516534|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516535|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516536|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516537|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516538|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516539|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516540|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516541|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516542|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
145516543|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
145516544|NCT01185353|524750547|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516545|NCT01185353|524750548|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516546|NCT01185353|524750549|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516547|NCT01185353|524750550|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516548|NCT01185353|524750551|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516549|NCT01185353|524750552|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516550|NCT01185353|524750553|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
145268905|NCT04089566|523832699|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
145516551|NCT01185353|524750554|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
145516552|NCT01185353|524750555|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
145516553|NCT01185353|524750556|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
145268906|NCT04089566|523832694|FG000|Overall Study|Reason not Specified|0|||
145268907|NCT04089566|523832695|FG001|Overall Study|Reason not Specified|4|||
145268908|NCT04089566|523832696|FG002|Overall Study|Reason not Specified|4|||
145516554|NCT01185353|524750547|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145516555|NCT01185353|524750548|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145734325|NCT03083847|525544805|FG004|Main|Adverse Event|0|||
145734326|NCT03083847|525544806|FG005|Main|Adverse Event|0|||
145516556|NCT01185353|524750549|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145734327|NCT03083847|525544807|FG006|Main|Adverse Event|0|||
145268909|NCT04089566|523832697|FG003|Overall Study|Reason not Specified|1|||
145268910|NCT04089566|523832698|FG004|Overall Study|Reason not Specified|0|||
145268911|NCT04089566|523832699|FG005|Overall Study|Reason not Specified|0|||
145268912|NCT01489865|523832705|FG000|Overall Study|Progression of Disease|4|||
145268913|NCT01489865|523832706|FG001|Overall Study|Progression of Disease|2|||
145516557|NCT01185353|524750550|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145268914|NCT01489865|523832707|FG002|Overall Study|Progression of Disease|2|||
145268915|NCT01489865|523832708|FG003|Overall Study|Progression of Disease|3|||
145268916|NCT01489865|523832709|FG004|Overall Study|Progression of Disease|1|||
145268917|NCT01489865|523832710|FG005|Overall Study|Progression of Disease|6|||
145268918|NCT01489865|523832711|FG006|Overall Study|Progression of Disease|3|||
145268919|NCT01489865|523832712|FG007|Overall Study|Progression of Disease|0|||
145268920|NCT01489865|523832713|FG008|Overall Study|Progression of Disease|23|||
145268921|NCT01489865|523832705|FG000|Overall Study|Adverse Event|2|||
145268922|NCT01489865|523832706|FG001|Overall Study|Adverse Event|0|||
145268923|NCT01489865|523832707|FG002|Overall Study|Adverse Event|0|||
145268924|NCT01489865|523832708|FG003|Overall Study|Adverse Event|0|||
145516558|NCT01185353|524750551|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145516559|NCT01185353|524750552|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145516560|NCT01185353|524750553|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145516561|NCT01185353|524750554|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
145516562|NCT01185353|524750555|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
145516563|NCT01185353|524750556|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
145516564|NCT01185353|524750547|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516565|NCT01185353|524750548|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516566|NCT01185353|524750549|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516567|NCT01185353|524750550|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516568|NCT01185353|524750551|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516569|NCT01185353|524750552|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516570|NCT01185353|524750553|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
145516571|NCT01185353|524750554|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
145516572|NCT01185353|524750555|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
145516573|NCT01185353|524750556|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
145516574|NCT01185353|524750547|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516575|NCT01185353|524750548|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516576|NCT01185353|524750549|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516577|NCT01185353|524750550|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516578|NCT01185353|524750551|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516579|NCT01185353|524750552|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516580|NCT01185353|524750553|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516581|NCT01185353|524750554|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
145516582|NCT01185353|524750555|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
145516583|NCT01185353|524750556|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
145516584|NCT02270944|524750560|FG000|Overall Study|Lost to Follow-up|9|||
145516585|NCT02270944|524750561|FG001|Overall Study|Lost to Follow-up|4|||
145516586|NCT02270944|524750560|FG000|Overall Study|Withdrawal by Subject|2|||
145516587|NCT02270944|524750561|FG001|Overall Study|Withdrawal by Subject|1|||
145516588|NCT01144299|524750562|FG000|Overall Study|Lost to Follow-up|1|||
145516589|NCT01144299|524750563|FG001|Overall Study|Lost to Follow-up|0|||
145516590|NCT01144299|524750562|FG000|Overall Study|Withdrawal by Subject|1|||
145516591|NCT01144299|524750563|FG001|Overall Study|Withdrawal by Subject|0|||
145516592|NCT02342418|524750566|FG000|Overall Study|Adverse Event|0|||
145516593|NCT02342418|524750567|FG001|Overall Study|Adverse Event|1|||
145516594|NCT04255394|524750568|FG000|Overall Study|Death|35|||
145516595|NCT04255394|524750569|FG001|Overall Study|Death|25|||
145516596|NCT04255394|524750568|FG000|Overall Study|Device removed|2|||
145516597|NCT04255394|524750569|FG001|Overall Study|Device removed|10|||
145516598|NCT04255394|524750568|FG000|Overall Study|Withdrawal by Subject|9|||
145516599|NCT04255394|524750569|FG001|Overall Study|Withdrawal by Subject|8|||
145516600|NCT04255394|524750568|FG000|Overall Study|Screen Failure/Not treated|12|||
145516601|NCT04255394|524750569|FG001|Overall Study|Screen Failure/Not treated|8|||
145516602|NCT04255394|524750568|FG000|Overall Study|Lost to Follow-up|123|||
145268925|NCT01489865|523832709|FG004|Overall Study|Adverse Event|1|||
145402244|NCT00750269|524330681|FG004|Overall Study|Fiducials could not be placed|1|||
145516603|NCT04255394|524750569|FG001|Overall Study|Lost to Follow-up|265|||
145516604|NCT04255394|524750568|FG000|Overall Study|Adverse Event|1|||
145734328|NCT03083847|525544808|FG007|Main|Adverse Event|2|||
145516605|NCT04255394|524750569|FG001|Overall Study|Adverse Event|3|||
145516606|NCT03612856|524750579|FG000|Pre-dose Period|Physician Decision|0|||
145516607|NCT03612856|524750580|FG001|Pre-dose Period|Physician Decision|1|||
145734329|NCT03083847|525544809|FG008|Main|Adverse Event|0|||
145734330|NCT03083847|525544810|FG009|Main|Adverse Event|0|||
145268926|NCT01489865|523832710|FG005|Overall Study|Adverse Event|0|||
145268927|NCT01489865|523832711|FG006|Overall Study|Adverse Event|2|||
145734331|NCT03083847|525544801|FG000|Main|Withdrawal by Subject|0|||
145734332|NCT03083847|525544802|FG001|Main|Withdrawal by Subject|0|||
145734333|NCT03083847|525544803|FG002|Main|Withdrawal by Subject|0|||
145734334|NCT03083847|525544804|FG003|Main|Withdrawal by Subject|0|||
145734335|NCT03083847|525544805|FG004|Main|Withdrawal by Subject|0|||
145734336|NCT03083847|525544806|FG005|Main|Withdrawal by Subject|0|||
145734337|NCT03083847|525544807|FG006|Main|Withdrawal by Subject|1|||
145734338|NCT03083847|525544808|FG007|Main|Withdrawal by Subject|1|||
145734339|NCT03083847|525544809|FG008|Main|Withdrawal by Subject|0|||
145734340|NCT03083847|525544810|FG009|Main|Withdrawal by Subject|0|||
145734341|NCT02224599|525544811|FG000|Overall Study|Physician Decision|1|||
145734342|NCT02224599|525544811|FG000|Overall Study|Progression of Disease|1|||
145734343|NCT00129623|525544812|FG000|Overall Study|Adverse Event|3|||
145734344|NCT00129623|525544813|FG001|Overall Study|Adverse Event|7|||
145734345|NCT00129623|525544812|FG000|Overall Study|Refused Treatment|5|||
145734346|NCT00129623|525544813|FG001|Overall Study|Refused Treatment|3|||
145734347|NCT00129623|525544812|FG000|Overall Study|Failure to Return|1|||
145734348|NCT00129623|525544813|FG001|Overall Study|Failure to Return|1|||
145734349|NCT00129623|525544812|FG000|Overall Study|Relocated job out of state|1|||
145734350|NCT00129623|525544813|FG001|Overall Study|Relocated job out of state|0|||
145734351|NCT00129623|525544812|FG000|Overall Study|Uncertainty to return|0|||
145734352|NCT00129623|525544813|FG001|Overall Study|Uncertainty to return|1|||
145734353|NCT00596934|525544814|FG000|Overall Study|Protocol Violation|1|||
145734354|NCT00596934|525544814|FG000|Overall Study|Withdrawal by Subject|1|||
145734355|NCT02315898|525544817|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
145734356|NCT02315898|525544818|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
145734357|NCT02315898|525544819|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
145734358|NCT02315898|525544820|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
145734359|NCT03239483|525544821|FG000|Overall Study|Lost to Follow-up|1|||
145734360|NCT03239483|525544822|FG001|Overall Study|Lost to Follow-up|0|||
145734361|NCT03239483|525544821|FG000|Overall Study|Withdrawal by Subject|1|||
145734362|NCT03239483|525544822|FG001|Overall Study|Withdrawal by Subject|0|||
145734363|NCT00056862|525544825|FG000|Overall Study|Protocol Violation|1|||
145734364|NCT00056862|525544826|FG001|Overall Study|Protocol Violation|0|||
145734365|NCT05395104|525544831|FG000|Overall Study|Met Liver Stopping Criteria|1|||
145734366|NCT05395104|525544831|FG000|Overall Study|Withdrawal by Subject|1|||
145734367|NCT00381563|525544832|FG000|Overall Study|Withdrawal by Subject|5|||
145734368|NCT00381563|525544833|FG001|Overall Study|Withdrawal by Subject|5|||
145734369|NCT00381563|525544832|FG000|Overall Study|Lost to Follow-up|2|||
145734370|NCT00381563|525544833|FG001|Overall Study|Lost to Follow-up|0|||
145734371|NCT00381563|525544832|FG000|Overall Study|Protocol Violation|0|||
145734372|NCT00381563|525544833|FG001|Overall Study|Protocol Violation|1|||
145734373|NCT03974334|525544834|FG000|Overall Study|Lost to Follow-up|1|||
145734374|NCT01109173|525544836|FG000|Overall Study|Adverse Event|15|||
145734375|NCT01109173|525544837|FG001|Overall Study|Adverse Event|17|||
145734376|NCT01109173|525544838|FG002|Overall Study|Adverse Event|9|||
145734377|NCT01109173|525544839|FG003|Overall Study|Adverse Event|6|||
145734378|NCT01109173|525544836|FG000|Overall Study|Lost to Follow-up|0|||
145734379|NCT01109173|525544837|FG001|Overall Study|Lost to Follow-up|1|||
145734380|NCT01109173|525544838|FG002|Overall Study|Lost to Follow-up|0|||
145734381|NCT01109173|525544839|FG003|Overall Study|Lost to Follow-up|0|||
145734382|NCT01109173|525544836|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
145734383|NCT01109173|525544837|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
145734384|NCT01109173|525544838|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
145734385|NCT01109173|525544839|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
145734386|NCT01109173|525544836|FG000|Overall Study|Noncompliance|0|||
145734387|NCT01109173|525544837|FG001|Overall Study|Noncompliance|1|||
145268928|NCT01489865|523832712|FG007|Overall Study|Adverse Event|0|||
145268929|NCT01489865|523832713|FG008|Overall Study|Adverse Event|5|||
145734388|NCT01109173|525544838|FG002|Overall Study|Noncompliance|0|||
145268930|NCT01489865|523832705|FG000|Overall Study|Death|0|||
145516608|NCT03612856|524750581|FG002|Pre-dose Period|Physician Decision|1|||
145516609|NCT03612856|524750579|FG000|Pre-dose Period|Withdrawal by Subject|0|||
145734389|NCT01109173|525544839|FG003|Overall Study|Noncompliance|0|||
145734390|NCT01109173|525544836|FG000|Overall Study|Treatment Failure|25|||
145734391|NCT01109173|525544837|FG001|Overall Study|Treatment Failure|32|||
145734392|NCT01109173|525544838|FG002|Overall Study|Treatment Failure|69|||
145734393|NCT01109173|525544839|FG003|Overall Study|Treatment Failure|64|||
145734394|NCT01109173|525544836|FG000|Overall Study|Protocol Violation|4|||
145734395|NCT01109173|525544837|FG001|Overall Study|Protocol Violation|5|||
145734396|NCT01109173|525544838|FG002|Overall Study|Protocol Violation|1|||
145734397|NCT01109173|525544839|FG003|Overall Study|Protocol Violation|2|||
145734398|NCT01109173|525544836|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
145734399|NCT01109173|525544837|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
145734400|NCT01109173|525544838|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
145268931|NCT01489865|523832706|FG001|Overall Study|Death|1|||
145734401|NCT01109173|525544839|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
145734402|NCT01109173|525544836|FG000|Overall Study|Not Specifiied|5|||
145734403|NCT01109173|525544837|FG001|Overall Study|Not Specifiied|4|||
145734404|NCT01109173|525544838|FG002|Overall Study|Not Specifiied|9|||
145734405|NCT01109173|525544839|FG003|Overall Study|Not Specifiied|14|||
145734406|NCT01132612|525544843|FG000|Overall Study|Death|0|||
145734407|NCT01132612|525544844|FG001|Overall Study|Death|0|||
145734408|NCT01132612|525544845|FG002|Overall Study|Death|1|||
145734409|NCT01132612|525544843|FG000|Overall Study|Protocol deviation|0|||
145734410|NCT01132612|525544844|FG001|Overall Study|Protocol deviation|0|||
145734411|NCT01132612|525544845|FG002|Overall Study|Protocol deviation|3|||
145734412|NCT01132612|525544843|FG000|Overall Study|Lost to Follow-up|2|||
145734413|NCT01132612|525544844|FG001|Overall Study|Lost to Follow-up|2|||
145734414|NCT01132612|525544845|FG002|Overall Study|Lost to Follow-up|7|||
145734415|NCT01132612|525544843|FG000|Overall Study|Adverse Event|5|||
145734416|NCT01132612|525544844|FG001|Overall Study|Adverse Event|2|||
145734417|NCT01132612|525544845|FG002|Overall Study|Adverse Event|15|||
145734418|NCT01132612|525544843|FG000|Overall Study|Withdrawal by Subject|5|||
145734419|NCT01132612|525544844|FG001|Overall Study|Withdrawal by Subject|8|||
145734420|NCT01132612|525544845|FG002|Overall Study|Withdrawal by Subject|19|||
145734421|NCT01132612|525544843|FG000|Overall Study|Administrative problems|5|||
145734422|NCT01132612|525544844|FG001|Overall Study|Administrative problems|1|||
145734423|NCT01132612|525544845|FG002|Overall Study|Administrative problems|52|||
145734424|NCT01132612|525544843|FG000|Overall Study|Lack of Efficacy|23|||
145734425|NCT01132612|525544844|FG001|Overall Study|Lack of Efficacy|22|||
145734426|NCT01132612|525544845|FG002|Overall Study|Lack of Efficacy|73|||
145734427|NCT02252536|525544846|FG000|Overall Study|Lost to Follow-up|5|||
145734428|NCT02252536|525544847|FG001|Overall Study|Lost to Follow-up|3|||
145734429|NCT04435782|525544855|FG000|Overall Study|Study terminated by sponsor|4|||
145734430|NCT03672461|525544856|FG000|Overall Study|COVID Related|4|||
145734431|NCT03672461|525544857|FG001|Overall Study|COVID Related|2|||
145734432|NCT03672461|525544856|FG000|Overall Study|Adverse Event|2|||
145734433|NCT03672461|525544857|FG001|Overall Study|Adverse Event|0|||
145734434|NCT03672461|525544856|FG000|Overall Study|Serious Adverse Event|0|||
145734435|NCT03672461|525544857|FG001|Overall Study|Serious Adverse Event|1|||
145734436|NCT03672461|525544856|FG000|Overall Study|Too Busy|3|||
145734437|NCT03672461|525544857|FG001|Overall Study|Too Busy|1|||
145734438|NCT03672461|525544856|FG000|Overall Study|Lost to Follow-up|1|||
145734439|NCT03672461|525544857|FG001|Overall Study|Lost to Follow-up|2|||
145734440|NCT03672461|525544856|FG000|Overall Study|Family|2|||
145734441|NCT03672461|525544857|FG001|Overall Study|Family|2|||
145734442|NCT03672461|525544856|FG000|Overall Study|No remote technology access|0|||
145734443|NCT03672461|525544857|FG001|Overall Study|No remote technology access|1|||
145734444|NCT03672461|525544856|FG000|Overall Study|Withdrawal by Subject|1|||
145734445|NCT03672461|525544857|FG001|Overall Study|Withdrawal by Subject|0|||
145734446|NCT03672461|525544856|FG000|Overall Study|Cannot tolerate intervention|1|||
145734447|NCT03672461|525544857|FG001|Overall Study|Cannot tolerate intervention|0|||
145734448|NCT03672461|525544856|FG000|Overall Study|Incomplete outcome data|6|||
145734449|NCT03672461|525544857|FG001|Overall Study|Incomplete outcome data|1|||
145734450|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
145734451|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
145734452|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
145734453|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
145734454|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
145734455|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
145402245|NCT00761319|524330685|FG000|Overall Study|Protocol Violation|21|||
145734456|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
145734457|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
145734458|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
145734459|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
145734460|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
145734461|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
145734462|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
145734463|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
145734464|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
145734465|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
145734466|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
145734467|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
145734468|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Early termination|0|||
145734469|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Early termination|0|||
145734470|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Early termination|34|||
145734471|NCT01493557|525546436|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
145734472|NCT01493557|525546437|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
145734473|NCT01493557|525546438|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
145734474|NCT01493557|525546436|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
145734475|NCT01493557|525546437|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
145734476|NCT01493557|525546438|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
145734477|NCT01493557|525546436|FG000|Randomized to Management Strategies|Other adverse event|8|||
145734478|NCT01493557|525546437|FG001|Randomized to Management Strategies|Other adverse event|5|||
145734479|NCT01493557|525546438|FG002|Randomized to Management Strategies|Other adverse event|0|||
145734480|NCT01493557|525546436|FG000|Randomized to Management Strategies|Protocol Violation|3|||
145734481|NCT01493557|525546437|FG001|Randomized to Management Strategies|Protocol Violation|0|||
145734482|NCT01493557|525546438|FG002|Randomized to Management Strategies|Protocol Violation|0|||
145734483|NCT01493557|525546436|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
145734484|NCT01493557|525546437|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
145734485|NCT01493557|525546438|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
145734486|NCT01493557|525546436|FG000|Randomized to Management Strategies|Other than stated above|1|||
145734487|NCT01493557|525546437|FG001|Randomized to Management Strategies|Other than stated above|3|||
145734488|NCT01493557|525546438|FG002|Randomized to Management Strategies|Other than stated above|0|||
145734489|NCT01493557|525546436|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
145734490|NCT01493557|525546437|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
145734491|NCT01493557|525546438|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
145734492|NCT01493557|525546436|FG000|Adding the Second Strategy|Other adverse event|1|||
145734493|NCT01493557|525546437|FG001|Adding the Second Strategy|Other adverse event|2|||
145734494|NCT01493557|525546438|FG002|Adding the Second Strategy|Other adverse event|0|||
145734495|NCT01493557|525546436|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
145734496|NCT01493557|525546437|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
145734497|NCT01493557|525546438|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
145734498|NCT03335163|525546445|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
145734499|NCT03335163|525546445|FG000|Overall Study|Withdrawal by Subject|18|||
145734500|NCT02020863|525546447|FG000|Overall Study|Discovery of Metastatic disease|4|||
145734501|NCT02020863|525546447|FG000|Overall Study|Team chose not to place an a line|1|||
145734502|NCT01920594|525546448|FG000|Overall Study|Adverse Event|4|||
145734503|NCT01920594|525546449|FG001|Overall Study|Adverse Event|2|||
145734504|NCT01920594|525546448|FG000|Overall Study|Lost to Follow-up|1|||
145734505|NCT01920594|525546449|FG001|Overall Study|Lost to Follow-up|0|||
145734506|NCT01920594|525546448|FG000|Overall Study|Recovery|2|||
145734507|NCT01920594|525546449|FG001|Overall Study|Recovery|0|||
145734508|NCT01920594|525546448|FG000|Overall Study|Investigator discretion|0|||
145734509|NCT01920594|525546449|FG001|Overall Study|Investigator discretion|1|||
145734510|NCT01170039|525546452|FG000|Overall Study|Withdrawal by Subject|5|||
145734511|NCT01170039|525546453|FG001|Overall Study|Withdrawal by Subject|3|||
145734512|NCT01170039|525546452|FG000|Overall Study|Lack of funding, drug not available|3|||
145734513|NCT01170039|525546453|FG001|Overall Study|Lack of funding, drug not available|3|||
145734514|NCT00908583|525546454|FG000|Phase 1|Withdrawal by Subject|1|||
145734515|NCT00908583|525546454|FG000|Phase 1|Adverse Event|4|||
145734516|NCT00908583|525546454|FG000|Phase 2|Physician Decision|1|||
145734517|NCT00908583|525546454|FG000|Phase 2|Adverse Event|1|||
145734518|NCT00908583|525546454|FG000|Phase 3|Adverse Event|2|||
145734519|NCT00908583|525546454|FG000|Phase 4|Adverse Event|1|||
145734520|NCT00908583|525546454|FG000|Phase 4|Physician Decision|1|||
145734521|NCT00908583|525546454|FG000|Phase 5|Adverse Event|3|||
145734522|NCT00993954|525546455|FG000|Overall Study|Protocol Violation|21|||
145734523|NCT00993954|525546456|FG001|Overall Study|Protocol Violation|2|||
145516610|NCT03612856|524750580|FG001|Pre-dose Period|Withdrawal by Subject|1|||
145516611|NCT03612856|524750581|FG002|Pre-dose Period|Withdrawal by Subject|0|||
145516612|NCT01576159|524750582|FG000|Overall Study|Withdrawal by Subject|0|||
145516613|NCT01576159|524750583|FG001|Overall Study|Withdrawal by Subject|1|||
145516614|NCT01576159|524750584|FG002|Overall Study|Withdrawal by Subject|0|||
145516615|NCT01576159|524750585|FG003|Overall Study|Withdrawal by Subject|0|||
145516616|NCT01576159|524750582|FG000|Overall Study|Physician Decision|0|||
145516617|NCT01576159|524750583|FG001|Overall Study|Physician Decision|0|||
145516618|NCT01576159|524750584|FG002|Overall Study|Physician Decision|1|||
145516619|NCT01576159|524750585|FG003|Overall Study|Physician Decision|0|||
145516620|NCT01576159|524750582|FG000|Overall Study|Lost to Follow-up|0|||
145516621|NCT01576159|524750583|FG001|Overall Study|Lost to Follow-up|0|||
145516622|NCT01576159|524750584|FG002|Overall Study|Lost to Follow-up|0|||
145516623|NCT01576159|524750585|FG003|Overall Study|Lost to Follow-up|1|||
145734524|NCT00860951|525546457|FG000|Overall Study|Withdrawal by Subject|2|||
145734525|NCT00860951|525546457|FG000|Overall Study|Lost to Follow-up|5|||
145734526|NCT00727649|525546458|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
145734527|NCT00727649|525546459|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
145734528|NCT00727649|525546458|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
145734529|NCT00727649|525546459|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
145734530|NCT00727649|525546458|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
145734531|NCT00727649|525546459|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
145734532|NCT00727649|525546458|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
145734533|NCT00727649|525546459|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
145734534|NCT00727649|525546458|FG000|Second Intervention (4-weeks)|Death|1|||
145734535|NCT00727649|525546459|FG001|Second Intervention (4-weeks)|Death|0|||
145734536|NCT00727649|525546458|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
145734537|NCT00727649|525546459|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
145734538|NCT00727649|525546458|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
145734539|NCT00727649|525546459|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
145734540|NCT02953639|525546462|FG000|Overall Study|Adverse Event|2|||
145734541|NCT02953639|525546463|FG001|Overall Study|Adverse Event|0|||
145734542|NCT02953639|525546464|FG002|Overall Study|Adverse Event|1|||
145734543|NCT02953639|525546462|FG000|Overall Study|Lost to Follow-up|8|||
145734544|NCT02953639|525546463|FG001|Overall Study|Lost to Follow-up|4|||
145734545|NCT02953639|525546464|FG002|Overall Study|Lost to Follow-up|3|||
145734546|NCT02953639|525546462|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145734547|NCT02953639|525546463|FG001|Overall Study|Non-Compliance With Study Drug|2|||
145734548|NCT02953639|525546464|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145734549|NCT02953639|525546462|FG000|Overall Study|Multiple Reasons|1|||
145734550|NCT02953639|525546463|FG001|Overall Study|Multiple Reasons|0|||
145734551|NCT02953639|525546464|FG002|Overall Study|Multiple Reasons|1|||
145734552|NCT02953639|525546462|FG000|Overall Study|Physician Decision|1|||
145734553|NCT02953639|525546463|FG001|Overall Study|Physician Decision|0|||
145734554|NCT02953639|525546464|FG002|Overall Study|Physician Decision|0|||
145734555|NCT02953639|525546462|FG000|Overall Study|Withdrawal by Subject|7|||
145734556|NCT02953639|525546463|FG001|Overall Study|Withdrawal by Subject|8|||
145734557|NCT02953639|525546464|FG002|Overall Study|Withdrawal by Subject|10|||
145734558|NCT02953639|525546462|FG000|Overall Study|Completed or Discontinued information is missing|1|||
145734559|NCT02953639|525546463|FG001|Overall Study|Completed or Discontinued information is missing|0|||
145734560|NCT02953639|525546464|FG002|Overall Study|Completed or Discontinued information is missing|0|||
145734561|NCT01830855|525546465|FG000|Overall Study|Other|7|||
145734562|NCT01830855|525546466|FG001|Overall Study|Other|1|||
145734563|NCT01830855|525546467|FG002|Overall Study|Other|4|||
145734564|NCT01830855|525546468|FG003|Overall Study|Other|4|||
145734565|NCT01830855|525546465|FG000|Overall Study|Medication error without associated AE|1|||
145734566|NCT01830855|525546466|FG001|Overall Study|Medication error without associated AE|0|||
145734567|NCT01830855|525546467|FG002|Overall Study|Medication error without associated AE|0|||
145734568|NCT01830855|525546468|FG003|Overall Study|Medication error without associated AE|1|||
145734569|NCT01830855|525546465|FG000|Overall Study|Pregnancy|3|||
145734570|NCT01830855|525546466|FG001|Overall Study|Pregnancy|1|||
145734571|NCT01830855|525546467|FG002|Overall Study|Pregnancy|2|||
145734572|NCT01830855|525546468|FG003|Overall Study|Pregnancy|1|||
145734573|NCT01830855|525546465|FG000|Overall Study|No longer meets eligibility criteria|11|||
145734574|NCT01830855|525546466|FG001|Overall Study|No longer meets eligibility criteria|2|||
145734575|NCT01830855|525546467|FG002|Overall Study|No longer meets eligibility criteria|3|||
145734576|NCT01830855|525546468|FG003|Overall Study|No longer meets eligibility criteria|5|||
145734577|NCT01830855|525546465|FG000|Overall Study|Adverse Event|11|||
145734578|NCT01830855|525546466|FG001|Overall Study|Adverse Event|5|||
145734579|NCT01830855|525546467|FG002|Overall Study|Adverse Event|6|||
145734580|NCT01830855|525546468|FG003|Overall Study|Adverse Event|3|||
145516624|NCT01576159|524750582|FG000|Overall Study|Protocol Violation|1|||
145516625|NCT01576159|524750583|FG001|Overall Study|Protocol Violation|0|||
145734581|NCT01830855|525546465|FG000|Overall Study|Protocol deviation|10|||
145734582|NCT01830855|525546466|FG001|Overall Study|Protocol deviation|5|||
145734583|NCT01830855|525546467|FG002|Overall Study|Protocol deviation|6|||
145734584|NCT01830855|525546468|FG003|Overall Study|Protocol deviation|6|||
145734585|NCT01830855|525546465|FG000|Overall Study|Withdrawal by Subject|33|||
145402246|NCT00761319|524330686|FG001|Overall Study|Protocol Violation|14|||
145516626|NCT01576159|524750584|FG002|Overall Study|Protocol Violation|0|||
145516627|NCT01576159|524750585|FG003|Overall Study|Protocol Violation|0|||
145516628|NCT01181986|524750586|FG000|Phase 1|Lost to Follow-up|0|||
145516629|NCT01181986|524750587|FG001|Phase 1|Lost to Follow-up|1|||
145516630|NCT01181986|524750588|FG002|Phase 1|Lost to Follow-up|1|||
145516631|NCT01181986|524750586|FG000|Phase 1|Adverse Event|0|||
145516632|NCT01181986|524750587|FG001|Phase 1|Adverse Event|0|||
145516633|NCT01181986|524750588|FG002|Phase 1|Adverse Event|1|||
145516634|NCT01181986|524750586|FG000|Phase 1|Protocol Violation|1|||
145516635|NCT01181986|524750587|FG001|Phase 1|Protocol Violation|0|||
145516636|NCT01181986|524750588|FG002|Phase 1|Protocol Violation|0|||
145734586|NCT01830855|525546466|FG001|Overall Study|Withdrawal by Subject|14|||
145734587|NCT01830855|525546467|FG002|Overall Study|Withdrawal by Subject|10|||
145734588|NCT01830855|525546468|FG003|Overall Study|Withdrawal by Subject|12|||
145734589|NCT01830855|525546465|FG000|Overall Study|No longer willing to participate|32|||
145734590|NCT01830855|525546466|FG001|Overall Study|No longer willing to participate|13|||
145734591|NCT01830855|525546467|FG002|Overall Study|No longer willing to participate|12|||
145734592|NCT01830855|525546468|FG003|Overall Study|No longer willing to participate|17|||
145734593|NCT01830855|525546465|FG000|Overall Study|Lost to Follow-up|47|||
145734594|NCT01830855|525546466|FG001|Overall Study|Lost to Follow-up|20|||
145734595|NCT01830855|525546467|FG002|Overall Study|Lost to Follow-up|23|||
145734596|NCT01830855|525546468|FG003|Overall Study|Lost to Follow-up|33|||
145734597|NCT01667081|525546469|FG000|Overall Study|Death|43|||
145734598|NCT01667081|525546470|FG001|Overall Study|Death|3|||
145734599|NCT01667081|525546469|FG000|Overall Study|Lost to Follow-up|99|||
145734600|NCT01667081|525546470|FG001|Overall Study|Lost to Follow-up|48|||
145734601|NCT01667081|525546469|FG000|Overall Study|Physician Decision|16|||
145734602|NCT01667081|525546470|FG001|Overall Study|Physician Decision|2|||
145734603|NCT01667081|525546469|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
145734604|NCT01667081|525546470|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
145734605|NCT01667081|525546469|FG000|Overall Study|Withdrawal by Subject|90|||
145734606|NCT01667081|525546470|FG001|Overall Study|Withdrawal by Subject|35|||
145734607|NCT03034460|525546471|FG000|Overall Study|Adverse Event|0|||
145734608|NCT03034460|525546472|FG001|Overall Study|Adverse Event|1|||
145734609|NCT03034460|525546471|FG000|Overall Study|Withdrawal by Subject|2|||
145734610|NCT03034460|525546472|FG001|Overall Study|Withdrawal by Subject|2|||
145734611|NCT03034460|525546471|FG000|Overall Study|Personal Reasons|1|||
145734612|NCT03034460|525546472|FG001|Overall Study|Personal Reasons|0|||
145734613|NCT00295633|525546475|FG000|Overall Study|Lack of Efficacy|19|||
145734614|NCT00295633|525546476|FG001|Overall Study|Lack of Efficacy|7|||
145734615|NCT00295633|525546477|FG002|Overall Study|Lack of Efficacy|16|||
145734616|NCT00295633|525546475|FG000|Overall Study|Withdrawal of consent by subject|16|||
145734617|NCT00295633|525546476|FG001|Overall Study|Withdrawal of consent by subject|16|||
145734618|NCT00295633|525546477|FG002|Overall Study|Withdrawal of consent by subject|26|||
145734619|NCT00295633|525546475|FG000|Overall Study|Adverse Event|9|||
145734620|NCT00295633|525546476|FG001|Overall Study|Adverse Event|17|||
145734621|NCT00295633|525546477|FG002|Overall Study|Adverse Event|9|||
145734622|NCT00295633|525546475|FG000|Overall Study|Lost to Follow-up|6|||
145734623|NCT00295633|525546476|FG001|Overall Study|Lost to Follow-up|11|||
145734624|NCT00295633|525546477|FG002|Overall Study|Lost to Follow-up|7|||
145734625|NCT00295633|525546475|FG000|Overall Study|Physician Decision|9|||
145734626|NCT00295633|525546476|FG001|Overall Study|Physician Decision|10|||
145734627|NCT00295633|525546477|FG002|Overall Study|Physician Decision|8|||
145734628|NCT00295633|525546475|FG000|Overall Study|Poor/Noncompliance|2|||
145734629|NCT00295633|525546476|FG001|Overall Study|Poor/Noncompliance|2|||
145734630|NCT00295633|525546477|FG002|Overall Study|Poor/Noncompliance|6|||
145734631|NCT00295633|525546475|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
145734632|NCT00295633|525546476|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
145734633|NCT00295633|525546477|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
145734634|NCT00295633|525546475|FG000|Overall Study|Death|1|||
145734635|NCT00295633|525546476|FG001|Overall Study|Death|1|||
145734636|NCT00295633|525546477|FG002|Overall Study|Death|0|||
145734637|NCT00295633|525546475|FG000|Overall Study|Administrative reason by sponsor|0|||
145734638|NCT00295633|525546476|FG001|Overall Study|Administrative reason by sponsor|0|||
145734639|NCT00295633|525546477|FG002|Overall Study|Administrative reason by sponsor|1|||
145734640|NCT01516970|525546478|FG000|Overall Study|Lost to Follow-up|7|||
145734641|NCT01516970|525546479|FG001|Overall Study|Lost to Follow-up|8|||
145734642|NCT01516970|525546478|FG000|Overall Study|Adverse Event|1|||
145734643|NCT01516970|525546479|FG001|Overall Study|Adverse Event|5|||
145734644|NCT01516970|525546478|FG000|Overall Study|Withdrawal by Subject|1|||
145734645|NCT01516970|525546479|FG001|Overall Study|Withdrawal by Subject|1|||
145734646|NCT01516970|525546478|FG000|Overall Study|Other|9|||
145734647|NCT01516970|525546479|FG001|Overall Study|Other|7|||
145734648|NCT00434421|525546480|FG000|Overall Study|Withdrawal by Subject|1|||
145734649|NCT00434421|525546480|FG000|Overall Study|Non-compliance with study treatment|1|||
145734650|NCT01205438|525546481|FG000|Overall Study|Adverse Event|19|||
145734651|NCT01205438|525546482|FG001|Overall Study|Adverse Event|17|||
145734652|NCT01205438|525546483|FG002|Overall Study|Adverse Event|24|||
145402247|NCT00761319|524330685|FG000|Overall Study|Adverse Event|11|||
145734653|NCT01205438|525546481|FG000|Overall Study|Death|1|||
145734654|NCT01205438|525546482|FG001|Overall Study|Death|1|||
145734655|NCT01205438|525546483|FG002|Overall Study|Death|3|||
145734656|NCT01205438|525546481|FG000|Overall Study|Entry Criteria Not Met|16|||
145734657|NCT01205438|525546482|FG001|Overall Study|Entry Criteria Not Met|15|||
145734658|NCT01205438|525546483|FG002|Overall Study|Entry Criteria Not Met|13|||
145734659|NCT01205438|525546481|FG000|Overall Study|Lack of Efficacy|14|||
145734660|NCT01205438|525546482|FG001|Overall Study|Lack of Efficacy|11|||
145734661|NCT01205438|525546483|FG002|Overall Study|Lack of Efficacy|14|||
145734662|NCT01205438|525546481|FG000|Overall Study|Lost to Follow-up|6|||
145734663|NCT01205438|525546482|FG001|Overall Study|Lost to Follow-up|7|||
145734664|NCT01205438|525546483|FG002|Overall Study|Lost to Follow-up|8|||
145734665|NCT01205438|525546481|FG000|Overall Study|Withdrawal by Subject|19|||
145734666|NCT01205438|525546482|FG001|Overall Study|Withdrawal by Subject|25|||
145734667|NCT01205438|525546483|FG002|Overall Study|Withdrawal by Subject|19|||
145734668|NCT01205438|525546481|FG000|Overall Study|Physician Decision|0|||
145734669|NCT01205438|525546482|FG001|Overall Study|Physician Decision|3|||
145734670|NCT01205438|525546483|FG002|Overall Study|Physician Decision|2|||
145734671|NCT01205438|525546481|FG000|Overall Study|Protocol Violation|2|||
145734672|NCT01205438|525546482|FG001|Overall Study|Protocol Violation|7|||
145734673|NCT01205438|525546483|FG002|Overall Study|Protocol Violation|4|||
145734674|NCT01205438|525546481|FG000|Overall Study|Sponsor Decision|0|||
145734675|NCT01205438|525546482|FG001|Overall Study|Sponsor Decision|1|||
145734676|NCT01205438|525546483|FG002|Overall Study|Sponsor Decision|1|||
145734677|NCT03823404|525546484|FG000|Overall Study|Lost to Follow-up|1|||
145734678|NCT03823404|525546485|FG001|Overall Study|Lost to Follow-up|2|||
145734679|NCT03823404|525546486|FG002|Overall Study|Lost to Follow-up|3|||
145734680|NCT03823404|525546484|FG000|Overall Study|Protocol Violation|2|||
145734681|NCT03823404|525546485|FG001|Overall Study|Protocol Violation|0|||
145734682|NCT03823404|525546486|FG002|Overall Study|Protocol Violation|2|||
145734683|NCT03823404|525546484|FG000|Overall Study|Adverse Event|35|||
145734684|NCT03823404|525546485|FG001|Overall Study|Adverse Event|38|||
145734685|NCT03823404|525546486|FG002|Overall Study|Adverse Event|8|||
145734686|NCT03823404|525546484|FG000|Overall Study|Withdrawal by Subject|38|||
145734687|NCT03823404|525546485|FG001|Overall Study|Withdrawal by Subject|40|||
145734688|NCT03823404|525546486|FG002|Overall Study|Withdrawal by Subject|35|||
145734689|NCT03823404|525546484|FG000|Overall Study|Death|4|||
145734690|NCT03823404|525546485|FG001|Overall Study|Death|0|||
145734691|NCT03823404|525546486|FG002|Overall Study|Death|0|||
145734692|NCT03823404|525546484|FG000|Overall Study|Other: Various reasons provided|5|||
145734693|NCT03823404|525546485|FG001|Overall Study|Other: Various reasons provided|5|||
145734694|NCT03823404|525546486|FG002|Overall Study|Other: Various reasons provided|6|||
145734695|NCT00892177|525546491|FG000|Phase II|Ineligible|0|||
145734696|NCT00892177|525546492|FG001|Phase II|Ineligible|0|||
145734697|NCT00892177|525546493|FG002|Phase II|Ineligible|0|||
145734698|NCT00892177|525546494|FG003|Phase II|Ineligible|0|||
145734699|NCT00892177|525546495|FG004|Phase II|Ineligible|1|||
145734700|NCT00892177|525546496|FG005|Phase II|Ineligible|1|||
145734701|NCT00892177|525546491|FG000|Phase II|Withdrawal by Subject|0|||
145734702|NCT00892177|525546492|FG001|Phase II|Withdrawal by Subject|0|||
145734703|NCT00892177|525546493|FG002|Phase II|Withdrawal by Subject|0|||
145734704|NCT00892177|525546494|FG003|Phase II|Withdrawal by Subject|0|||
145734705|NCT00892177|525546495|FG004|Phase II|Withdrawal by Subject|4|||
145734706|NCT00892177|525546496|FG005|Phase II|Withdrawal by Subject|1|||
145734707|NCT00404066|525546502|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
145734708|NCT00404066|525546502|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
145734709|NCT01399190|525546503|FG000|Overall Study|Not Eligible for Final Analysis|5|||
145734710|NCT01399190|525546503|FG000|Overall Study|Adverse Event|8|||
145734711|NCT01399190|525546503|FG000|Overall Study|Participant's Request|5|||
145734712|NCT01399190|525546503|FG000|Overall Study|Physician Decision|2|||
145734713|NCT01296035|525546504|FG000|Overall Study|Withdrawal by Subject|1|||
145734714|NCT00931944|525546509|FG000|Overall Study|Adverse Event|4|||
145734715|NCT00931944|525546509|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
145734716|NCT00931944|525546509|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
145734717|NCT00931944|525546509|FG000|Overall Study|Death|28|||
145734718|NCT00931944|525546509|FG000|Overall Study|Other|2|||
145734719|NCT00006392|525546515|FG000|Overall Study|Ineligible|11|||
145734720|NCT00006392|525546516|FG001|Overall Study|Ineligible|3|||
145734721|NCT00006392|525546517|FG002|Overall Study|Ineligible|5|||
145734722|NCT00006392|525546518|FG003|Overall Study|Ineligible|5|||
145734723|NCT00006392|525546515|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
145734724|NCT00006392|525546516|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
145734725|NCT00006392|525546517|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
145606705|NCT01874145|525075125|FG001|Core Period|Withdrawal by Subject|4|||
145606706|NCT01874145|525075124|FG000|Extension Period|Adverse Event|3|||
145606707|NCT01874145|525075125|FG001|Extension Period|Adverse Event|2|||
145606708|NCT01874145|525075124|FG000|Extension Period|Withdrawal by Subject|2|||
145734726|NCT00006392|525546518|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
145734727|NCT01186796|525546519|FG000|Overall Study|Adverse Event|3|||
145734728|NCT01186796|525546520|FG001|Overall Study|Adverse Event|0|||
145734729|NCT01186796|525546519|FG000|Overall Study|Withdrawal by Subject|1|||
145734730|NCT01186796|525546520|FG001|Overall Study|Withdrawal by Subject|1|||
145734731|NCT01186796|525546519|FG000|Overall Study|Protocol Violation|0|||
145734732|NCT01186796|525546520|FG001|Overall Study|Protocol Violation|1|||
145734733|NCT03838198|525546523|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
145734734|NCT03838198|525546524|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
145734735|NCT03838198|525546525|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
145734736|NCT03838198|525546526|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
145734737|NCT03838198|525546523|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
145734738|NCT03838198|525546524|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
145734739|NCT03838198|525546525|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
145734740|NCT03838198|525546526|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
145734741|NCT01287364|525546528|FG000|Overall Study|Adverse Event|0|||
145734742|NCT01287364|525546529|FG001|Overall Study|Adverse Event|3|||
145734743|NCT01287364|525546528|FG000|Overall Study|Protocol Violation|5|||
145734744|NCT01287364|525546529|FG001|Overall Study|Protocol Violation|5|||
145734745|NCT01287364|525546528|FG000|Overall Study|Other Reason|4|||
145734746|NCT01287364|525546529|FG001|Overall Study|Other Reason|2|||
145734747|NCT00770770|525546539|FG000|Overall Study|Lost to Follow-up|1|||
145734748|NCT00770770|525546540|FG001|Overall Study|Lost to Follow-up|0|||
145734749|NCT00770770|525546539|FG000|Overall Study|Withdrawal by Subject|1|||
145734750|NCT00770770|525546540|FG001|Overall Study|Withdrawal by Subject|0|||
145734751|NCT00770770|525546539|FG000|Overall Study|Death|0|||
145734752|NCT00770770|525546540|FG001|Overall Study|Death|1|||
145734753|NCT00770770|525546539|FG000|Overall Study|Study Terminated|8|||
145734754|NCT00770770|525546540|FG001|Overall Study|Study Terminated|0|||
145734755|NCT05372653|525546544|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
145734756|NCT05372653|525546545|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
145734757|NCT05372653|525546544|FG000|Overall Study|Adverse Event|0|||
145734758|NCT05372653|525546545|FG001|Overall Study|Adverse Event|1|||
145734759|NCT00117507|525546546|FG000|Overall Study|Adverse Event|4|||
145734760|NCT00117507|525546546|FG000|Overall Study|Abnormal laboratory values|3|||
145734761|NCT00117507|525546546|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145734762|NCT00117507|525546546|FG000|Overall Study|Patient withdrew consent|4|||
145734763|NCT00117507|525546546|FG000|Overall Study|Death|3|||
145734764|NCT00711529|525546547|FG000|Overall Study|Protocol Violation|2|||
145734765|NCT00711529|525546548|FG001|Overall Study|Protocol Violation|0|||
145734766|NCT00711529|525546547|FG000|Overall Study|Withdrawal by Subject|2|||
145734767|NCT00711529|525546548|FG001|Overall Study|Withdrawal by Subject|6|||
145734768|NCT03740997|525546551|FG000|Overall Study|Withdrawal by Subject|1|||
145734769|NCT03740997|525546552|FG001|Overall Study|Withdrawal by Subject|0|||
145734770|NCT03740997|525546551|FG000|Overall Study|Participant was unable to complete study procedures|1|||
145734771|NCT03740997|525546552|FG001|Overall Study|Participant was unable to complete study procedures|0|||
145734772|NCT01003990|525546553|FG000|Overall Study|Adverse Event|8|||
145734773|NCT01003990|525546554|FG001|Overall Study|Adverse Event|5|||
145734774|NCT01003990|525546555|FG002|Overall Study|Adverse Event|11|||
145734775|NCT01003990|525546553|FG000|Overall Study|Death|0|||
145734776|NCT01003990|525546554|FG001|Overall Study|Death|8|||
145734777|NCT01003990|525546555|FG002|Overall Study|Death|1|||
145734778|NCT01003990|525546553|FG000|Overall Study|Lack of Efficacy|10|||
145734779|NCT01003990|525546554|FG001|Overall Study|Lack of Efficacy|2|||
145734780|NCT01003990|525546555|FG002|Overall Study|Lack of Efficacy|3|||
145734781|NCT01003990|525546553|FG000|Overall Study|Lost to Follow-up|30|||
145734782|NCT01003990|525546554|FG001|Overall Study|Lost to Follow-up|12|||
145734783|NCT01003990|525546555|FG002|Overall Study|Lost to Follow-up|7|||
145734784|NCT01003990|525546553|FG000|Overall Study|Reasons Not Identified|14|||
145734785|NCT01003990|525546554|FG001|Overall Study|Reasons Not Identified|13|||
145734786|NCT01003990|525546555|FG002|Overall Study|Reasons Not Identified|8|||
145734787|NCT01003990|525546553|FG000|Overall Study|Poor/Non-compliance|4|||
145734788|NCT01003990|525546554|FG001|Overall Study|Poor/Non-compliance|3|||
145734789|NCT01003990|525546555|FG002|Overall Study|Poor/Non-compliance|2|||
145734790|NCT01003990|525546553|FG000|Overall Study|Pregnancy|10|||
145734791|NCT01003990|525546554|FG001|Overall Study|Pregnancy|2|||
145268932|NCT01489865|523832707|FG002|Overall Study|Death|0|||
145516637|NCT01181986|524750586|FG000|Phase 2|Adverse Event|0|||
145734792|NCT01003990|525546555|FG002|Overall Study|Pregnancy|4|||
145734793|NCT01003990|525546553|FG000|Overall Study|No Longer Met Study Criteria|4|||
145734794|NCT01003990|525546554|FG001|Overall Study|No Longer Met Study Criteria|1|||
145516638|NCT01181986|524750587|FG001|Phase 2|Adverse Event|3|||
145516639|NCT01181986|524750588|FG002|Phase 2|Adverse Event|0|||
145516640|NCT01181986|524750586|FG000|Phase 2|Medical condition|0|||
145516641|NCT01181986|524750587|FG001|Phase 2|Medical condition|1|||
145516642|NCT01181986|524750588|FG002|Phase 2|Medical condition|0|||
145516643|NCT01011309|524750589|FG000|Overall Study|Adverse Event|2|||
145516644|NCT01011309|524750590|FG001|Overall Study|Adverse Event|1|||
145516645|NCT01011309|524750591|FG002|Overall Study|Adverse Event|2|||
145516646|NCT01011309|524750589|FG000|Overall Study|Lack of Efficacy|0|||
145516647|NCT01011309|524750590|FG001|Overall Study|Lack of Efficacy|1|||
145516648|NCT01011309|524750591|FG002|Overall Study|Lack of Efficacy|0|||
145734795|NCT01003990|525546555|FG002|Overall Study|No Longer Met Study Criteria|0|||
145734796|NCT01003990|525546553|FG000|Overall Study|Subject Withdrew Consent|12|||
145734797|NCT01003990|525546554|FG001|Overall Study|Subject Withdrew Consent|5|||
145734798|NCT01003990|525546555|FG002|Overall Study|Subject Withdrew Consent|7|||
145734799|NCT01505010|525546558|FG000|Overall Study|Protocol Violation|0|||
145734800|NCT01505010|525546559|FG001|Overall Study|Protocol Violation|1|||
145734801|NCT01505010|525546558|FG000|Overall Study|Lost to Follow-up|0|||
145734802|NCT01505010|525546559|FG001|Overall Study|Lost to Follow-up|1|||
145734803|NCT03606980|525546566|FG000|Overall Study|Lost to Follow-up|3|||
145734804|NCT03606980|525546567|FG001|Overall Study|Lost to Follow-up|2|||
145734805|NCT03606980|525546568|FG002|Overall Study|Lost to Follow-up|3|||
145734806|NCT03606980|525546566|FG000|Overall Study|Withdrawal by Subject|1|||
145734807|NCT03606980|525546567|FG001|Overall Study|Withdrawal by Subject|0|||
145734808|NCT03606980|525546568|FG002|Overall Study|Withdrawal by Subject|4|||
145734809|NCT01102803|525546569|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
145734810|NCT01102803|525546570|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
145734811|NCT01102803|525546569|FG000|Post to Follow-Up|Lost to Follow-up|1|||
145734812|NCT01102803|525546570|FG001|Post to Follow-Up|Lost to Follow-up|3|||
145734813|NCT03427125|525546571|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
145734814|NCT03427125|525546572|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
145734815|NCT03427125|525546573|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
145734816|NCT02684279|525546574|FG000|Overall Study|Adverse Event|87|||
145734817|NCT02684279|525546574|FG000|Overall Study|Lack of Efficacy|4|||
145734818|NCT02684279|525546574|FG000|Overall Study|Lost to Follow-up|61|||
145734819|NCT02684279|525546574|FG000|Overall Study|Protocol Violation|6|||
145734820|NCT02684279|525546574|FG000|Overall Study|Pregnancy|8|||
145734821|NCT02684279|525546574|FG000|Overall Study|Withdrawal by Subject|92|||
145734822|NCT02684279|525546574|FG000|Overall Study|non-compliance with study drug|9|||
145734823|NCT02684279|525546574|FG000|Overall Study|non compliance with study visits|2|||
145734824|NCT02684279|525546574|FG000|Overall Study|subject to have surgery|1|||
145734825|NCT02684279|525546574|FG000|Overall Study|family emergency|1|||
145734826|NCT02684279|525546574|FG000|Overall Study|Site closures|7|||
145734827|NCT02684279|525546574|FG000|Overall Study|Physician Decision|1|||
145734828|NCT01798992|525548321|FG000|Overall Study|Administrative withdrawal|0|||
145734829|NCT01798992|525548322|FG001|Overall Study|Administrative withdrawal|1|||
145734830|NCT01798992|525548323|FG002|Overall Study|Administrative withdrawal|0|||
145734831|NCT01798992|525548324|FG003|Overall Study|Administrative withdrawal|1|||
145734832|NCT01798992|525548321|FG000|Overall Study|Lost to Follow-up|0|||
145734833|NCT01798992|525548322|FG001|Overall Study|Lost to Follow-up|1|||
145734834|NCT01798992|525548323|FG002|Overall Study|Lost to Follow-up|1|||
145734835|NCT01798992|525548324|FG003|Overall Study|Lost to Follow-up|0|||
145734836|NCT01798992|525548321|FG000|Overall Study|Insufficient biopsy tissue|0|||
145734837|NCT01798992|525548322|FG001|Overall Study|Insufficient biopsy tissue|0|||
145734838|NCT01798992|525548323|FG002|Overall Study|Insufficient biopsy tissue|1|||
145734839|NCT01798992|525548324|FG003|Overall Study|Insufficient biopsy tissue|0|||
145734840|NCT03631667|525548327|FG000|Overall Study|Withdrawal by Subject|3|||
145734841|NCT01087957|525548334|FG000|Overall Study|Death|2|||
145734842|NCT01087957|525548335|FG001|Overall Study|Death|2|||
145734843|NCT01087957|525548334|FG000|Overall Study|Lost to Follow-up|3|||
145734844|NCT01087957|525548335|FG001|Overall Study|Lost to Follow-up|4|||
145734845|NCT01087957|525548334|FG000|Overall Study|Protocol Violation|13|||
145606709|NCT01874145|525075125|FG001|Extension Period|Withdrawal by Subject|1|||
145606710|NCT01874145|525075124|FG000|Extension Period|Lost to Follow-up|1|||
145606711|NCT01874145|525075125|FG001|Extension Period|Lost to Follow-up|1|||
145606712|NCT04631705|525075126|FG000|Overall Study|Withdrawal by Subject|0|||
145606713|NCT04631705|525075127|FG001|Overall Study|Withdrawal by Subject|0|||
145606714|NCT04631705|525075128|FG002|Overall Study|Withdrawal by Subject|0|||
145606715|NCT04631705|525075129|FG003|Overall Study|Withdrawal by Subject|0|||
145606716|NCT04631705|525075130|FG004|Overall Study|Withdrawal by Subject|0|||
145606717|NCT04631705|525075131|FG005|Overall Study|Withdrawal by Subject|0|||
145606718|NCT04631705|525075132|FG006|Overall Study|Withdrawal by Subject|1|||
145606719|NCT04631705|525075133|FG007|Overall Study|Withdrawal by Subject|0|||
145606720|NCT04631705|525075134|FG008|Overall Study|Withdrawal by Subject|0|||
145606721|NCT02070484|525075136|FG000|Overall Study|Withdrawal by Subject|1|||
145606722|NCT02070484|525075137|FG001|Overall Study|Withdrawal by Subject|0|||
145606723|NCT02658630|525075138|FG000|Overall Study|Withdrawal by Subject|4|||
145606724|NCT02821819|525075139|FG000|Overall Study|Protocol Violation|1|||
145734846|NCT01087957|525548335|FG001|Overall Study|Protocol Violation|25|||
145606725|NCT01353222|525075145|FG000|Overall Study|Death|30|||
145606726|NCT01353222|525075146|FG001|Overall Study|Death|30|||
145606727|NCT01353222|525075145|FG000|Overall Study|Withdrawal by Subject|8|||
145606728|NCT01353222|525075146|FG001|Overall Study|Withdrawal by Subject|5|||
145734847|NCT01087957|525548334|FG000|Overall Study|Withdrawal by Subject|18|||
145734848|NCT01087957|525548335|FG001|Overall Study|Withdrawal by Subject|15|||
145734849|NCT01087957|525548334|FG000|Overall Study|Physician Decision|5|||
145734850|NCT01087957|525548335|FG001|Overall Study|Physician Decision|9|||
145734851|NCT01186939|525548336|FG000|Overall Study|Death|7|||
145734852|NCT01186939|525548336|FG000|Overall Study|Withdrawal by Subject|2|||
145734853|NCT01186939|525548336|FG000|Overall Study|No longer receiving clinical benefit|17|||
145734854|NCT01186939|525548336|FG000|Overall Study|Program closed|5|||
145734855|NCT01186939|525548336|FG000|Overall Study|Sponsor decision|4|||
145734856|NCT01186939|525548336|FG000|Overall Study|Started additional treatment|1|||
145734857|NCT01186939|525548336|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
145734858|NCT01186939|525548336|FG000|Overall Study|Myocardial infarction|1|||
145734859|NCT01186939|525548336|FG000|Overall Study|Bone marrow transplant|1|||
145734860|NCT01186939|525548336|FG000|Overall Study|Transformation to AML|1|||
145734861|NCT03945591|525548341|FG000|Overall Study|Participant not transplanted|1|||
145734862|NCT03945591|525548341|FG000|Overall Study|Change in treatment plan|3|||
145734863|NCT03945591|525548341|FG000|Overall Study|Adverse Event|1|||
145734864|NCT01118325|525548349|FG000|Overall Study|Adverse Event|1|||
145734865|NCT01118325|525548350|FG001|Overall Study|Adverse Event|0|||
145734866|NCT01118325|525548351|FG002|Overall Study|Adverse Event|1|||
145734867|NCT03678103|525548356|FG000|Overall Study|Withdrawn prior to completion|4|||
145734868|NCT01674712|525548357|FG000|Overall Study|Adverse Event|5|||
145734869|NCT01674712|525548358|FG001|Overall Study|Adverse Event|6|||
145734870|NCT01674712|525548359|FG002|Overall Study|Adverse Event|3|||
145734871|NCT01674712|525548360|FG003|Overall Study|Adverse Event|4|||
145734872|NCT01674712|525548361|FG004|Overall Study|Adverse Event|6|||
145734873|NCT01674712|525548357|FG000|Overall Study|Lost to Follow-up|1|||
145734874|NCT01674712|525548358|FG001|Overall Study|Lost to Follow-up|0|||
145734875|NCT01674712|525548359|FG002|Overall Study|Lost to Follow-up|0|||
145734876|NCT01674712|525548360|FG003|Overall Study|Lost to Follow-up|0|||
145734877|NCT01674712|525548361|FG004|Overall Study|Lost to Follow-up|0|||
145734878|NCT01674712|525548357|FG000|Overall Study|Protocol Violation|2|||
145734879|NCT01674712|525548358|FG001|Overall Study|Protocol Violation|0|||
145734880|NCT01674712|525548359|FG002|Overall Study|Protocol Violation|0|||
145734881|NCT01674712|525548360|FG003|Overall Study|Protocol Violation|0|||
145734882|NCT01674712|525548361|FG004|Overall Study|Protocol Violation|0|||
145734883|NCT01674712|525548357|FG000|Overall Study|Withdrawal by Subject|2|||
145734884|NCT01674712|525548358|FG001|Overall Study|Withdrawal by Subject|2|||
145734885|NCT01674712|525548359|FG002|Overall Study|Withdrawal by Subject|5|||
145734886|NCT01674712|525548360|FG003|Overall Study|Withdrawal by Subject|4|||
145734887|NCT01674712|525548361|FG004|Overall Study|Withdrawal by Subject|3|||
145734888|NCT01674712|525548357|FG000|Overall Study|Administrative|0|||
145734889|NCT01674712|525548358|FG001|Overall Study|Administrative|1|||
145734890|NCT01674712|525548359|FG002|Overall Study|Administrative|0|||
145734891|NCT01674712|525548360|FG003|Overall Study|Administrative|0|||
145734892|NCT01674712|525548361|FG004|Overall Study|Administrative|1|||
145734893|NCT01674712|525548357|FG000|Overall Study|Lack of Efficacy|0|||
145734894|NCT01674712|525548358|FG001|Overall Study|Lack of Efficacy|0|||
145734895|NCT01674712|525548359|FG002|Overall Study|Lack of Efficacy|1|||
145734896|NCT01674712|525548360|FG003|Overall Study|Lack of Efficacy|0|||
145734897|NCT01674712|525548361|FG004|Overall Study|Lack of Efficacy|1|||
145734898|NCT02092350|525548362|FG000|Overall Study|Adverse Event|0|||
145734899|NCT02092350|525548363|FG001|Overall Study|Adverse Event|3|||
145734900|NCT02092350|525548362|FG000|Overall Study|Death|2|||
145734901|NCT02092350|525548363|FG001|Overall Study|Death|5|||
145734902|NCT02092350|525548362|FG000|Overall Study|Lost to Follow-up|3|||
145734903|NCT02092350|525548363|FG001|Overall Study|Lost to Follow-up|1|||
145734904|NCT02092350|525548362|FG000|Overall Study|Protocol Violation|1|||
145734905|NCT02092350|525548363|FG001|Overall Study|Protocol Violation|0|||
145734906|NCT02092350|525548362|FG000|Overall Study|Physician Decision|1|||
145734907|NCT02092350|525548363|FG001|Overall Study|Physician Decision|1|||
145734908|NCT02092350|525548362|FG000|Overall Study|Screen Failure|1|||
145734909|NCT02092350|525548363|FG001|Overall Study|Screen Failure|0|||
145734910|NCT02092350|525548362|FG000|Overall Study|Withdrawal by Subject|2|||
145734911|NCT02092350|525548363|FG001|Overall Study|Withdrawal by Subject|2|||
145734912|NCT00800436|525548365|FG000|Overall Study|Withdrawal by Subject|0|||
145734913|NCT00800436|525548366|FG001|Overall Study|Withdrawal by Subject|0|||
145516649|NCT01011309|524750589|FG000|Overall Study|Protocol Violation|0|||
145516650|NCT01011309|524750590|FG001|Overall Study|Protocol Violation|1|||
145516651|NCT01011309|524750591|FG002|Overall Study|Protocol Violation|3|||
145516652|NCT01182844|524750601|FG000|Overall Study|Withdrawal by Subject|0|||
145734914|NCT00800436|525548367|FG002|Overall Study|Withdrawal by Subject|1|||
145734915|NCT00800436|525548368|FG003|Overall Study|Withdrawal by Subject|1|||
145734916|NCT00800436|525548369|FG004|Overall Study|Withdrawal by Subject|0|||
145734917|NCT00800436|525548370|FG005|Overall Study|Withdrawal by Subject|0|||
145734918|NCT00800436|525548371|FG006|Overall Study|Withdrawal by Subject|0|||
145734919|NCT01829425|525548381|FG000|Overall Study|Withdrawal by Subject|4|||
145516653|NCT01182844|524750602|FG001|Overall Study|Withdrawal by Subject|2|||
145516654|NCT01330017|524752319|FG000|Overall Study|Adverse Event|0|||
145734920|NCT01829425|525548382|FG001|Overall Study|Withdrawal by Subject|3|||
145734921|NCT01829425|525548381|FG000|Overall Study|Lost to Follow-up|2|||
145734922|NCT01829425|525548382|FG001|Overall Study|Lost to Follow-up|1|||
145734923|NCT05211739|525548383|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
145734924|NCT05211739|525548384|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
145734925|NCT05211739|525548383|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
145734926|NCT05211739|525548384|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
145734927|NCT05211739|525548383|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
145734928|NCT05211739|525548384|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
145734929|NCT05211739|525548383|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
145734930|NCT05211739|525548384|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
145734931|NCT03681951|525548385|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
145734932|NCT03681951|525548386|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145734933|NCT03681951|525548387|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145606729|NCT01353222|525075145|FG000|Overall Study|Study Terminated|31|||
145606730|NCT01353222|525075146|FG001|Overall Study|Study Terminated|37|||
145606731|NCT01353222|525075145|FG000|Overall Study|Site closed research department|1|||
145606732|NCT01353222|525075146|FG001|Overall Study|Site closed research department|0|||
145606733|NCT01654601|525075148|FG000|1st Administration|Withdrawal by Subject|2|||
145606734|NCT01654601|525075149|FG001|1st Administration|Withdrawal by Subject|0|||
145606735|NCT01654601|525075148|FG000|1st Administration|Protocol Violation|0|||
145606736|NCT01654601|525075149|FG001|1st Administration|Protocol Violation|2|||
145606737|NCT01654601|525075148|FG000|2nd Administration|Adverse Event|1|||
145606738|NCT01654601|525075149|FG001|2nd Administration|Adverse Event|0|||
145606739|NCT01654601|525075148|FG000|2nd Administration|Protocol Violation|0|||
145606740|NCT01654601|525075149|FG001|2nd Administration|Protocol Violation|1|||
145606741|NCT02636270|525075150|FG000|Overall Study|Adverse Event|1|||
145606742|NCT02636270|525075151|FG001|Overall Study|Adverse Event|0|||
145606743|NCT02636270|525075152|FG002|Overall Study|Adverse Event|0|||
145606744|NCT02636270|525075150|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
145606745|NCT02636270|525075151|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
145606746|NCT02636270|525075152|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
145606747|NCT01833143|525075153|FG000|Overall Study|Not Treated|1|||
145606748|NCT03021668|525075154|FG000|Overall Study|Physician Decision|0|||
145606749|NCT03021668|525075155|FG001|Overall Study|Physician Decision|1|||
145606750|NCT02217280|525075156|FG000|Overall Study|Withdrawal by Subject|2|||
145606751|NCT02217280|525075156|FG000|Overall Study|Post-consent sceen fail|2|||
145616838|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
145616839|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145616840|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
145616841|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145616842|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
145616843|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
145616844|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
145616845|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145616846|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
145616847|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
145616848|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
145616849|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145616850|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
145616851|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
145616852|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
145616853|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
145616854|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
145616855|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
145616856|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
145616857|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
145616858|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
145616859|NCT03230864|525111359|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
145616860|NCT03230864|525111360|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
145616861|NCT03230864|525111361|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
145616862|NCT03230864|525111362|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
145616863|NCT03230864|525111359|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
145616864|NCT03230864|525111360|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
145616865|NCT03230864|525111361|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
145734934|NCT03681951|525548388|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145616866|NCT03230864|525111362|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
145616867|NCT03230864|525111359|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145616868|NCT03230864|525111360|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145516655|NCT01330017|524752320|FG001|Overall Study|Adverse Event|1|||
145516656|NCT01330017|524752321|FG002|Overall Study|Adverse Event|1|||
145516657|NCT01330017|524752322|FG003|Overall Study|Adverse Event|4|||
145516658|NCT01330017|524752323|FG004|Overall Study|Adverse Event|0|||
145268933|NCT01489865|523832708|FG003|Overall Study|Death|0|||
145268934|NCT01489865|523832709|FG004|Overall Study|Death|1|||
145268935|NCT01489865|523832710|FG005|Overall Study|Death|0|||
145268936|NCT01489865|523832711|FG006|Overall Study|Death|0|||
145268937|NCT01489865|523832712|FG007|Overall Study|Death|0|||
145268938|NCT01489865|523832713|FG008|Overall Study|Death|2|||
145268939|NCT01489865|523832705|FG000|Overall Study|Withdrawal by Subject|0|||
145268940|NCT01489865|523832706|FG001|Overall Study|Withdrawal by Subject|0|||
145268941|NCT01489865|523832707|FG002|Overall Study|Withdrawal by Subject|0|||
145268942|NCT01489865|523832708|FG003|Overall Study|Withdrawal by Subject|0|||
145268943|NCT01489865|523832709|FG004|Overall Study|Withdrawal by Subject|0|||
145268944|NCT01489865|523832710|FG005|Overall Study|Withdrawal by Subject|1|||
145268945|NCT01489865|523832711|FG006|Overall Study|Withdrawal by Subject|1|||
145268946|NCT01489865|523832712|FG007|Overall Study|Withdrawal by Subject|0|||
145268947|NCT01489865|523832713|FG008|Overall Study|Withdrawal by Subject|2|||
145268948|NCT01489865|523832705|FG000|Overall Study|Shifted|0|||
145268949|NCT01489865|523832706|FG001|Overall Study|Shifted|0|||
145268950|NCT01489865|523832707|FG002|Overall Study|Shifted|1|||
145268951|NCT01489865|523832708|FG003|Overall Study|Shifted|0|||
145268952|NCT01489865|523832709|FG004|Overall Study|Shifted|0|||
145268953|NCT01489865|523832710|FG005|Overall Study|Shifted|0|||
145268954|NCT01489865|523832711|FG006|Overall Study|Shifted|0|||
145268955|NCT01489865|523832712|FG007|Overall Study|Shifted|0|||
145268956|NCT01489865|523832713|FG008|Overall Study|Shifted|0|||
145268957|NCT00972309|523832714|FG000|Overall Study|Switched to alternative treatment|0|||
145268958|NCT00972309|523832715|FG001|Overall Study|Switched to alternative treatment|2|||
145268959|NCT00972309|523832714|FG000|Overall Study|Refused further treatment|0|||
145268960|NCT00972309|523832715|FG001|Overall Study|Refused further treatment|1|||
145268961|NCT00972309|523832714|FG000|Overall Study|Late determination of ineligibility|0|||
145268962|NCT00972309|523832715|FG001|Overall Study|Late determination of ineligibility|1|||
145268963|NCT00972309|523832714|FG000|Overall Study|Second malignancy|1|||
145268964|NCT00972309|523832715|FG001|Overall Study|Second malignancy|1|||
145268965|NCT00972309|523832714|FG000|Overall Study|Visa issues|0|||
145268966|NCT00972309|523832715|FG001|Overall Study|Visa issues|1|||
145268967|NCT00972309|523832714|FG000|Overall Study|Secondary cancer (SCC)|0|||
145268968|NCT00972309|523832715|FG001|Overall Study|Secondary cancer (SCC)|1|||
145268969|NCT00972309|523832714|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
145516659|NCT01330017|524752319|FG000|Overall Study|Withdrawal by Subject|0|||
145516660|NCT01330017|524752320|FG001|Overall Study|Withdrawal by Subject|0|||
145516661|NCT01330017|524752321|FG002|Overall Study|Withdrawal by Subject|1|||
145268970|NCT00972309|523832715|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
145268971|NCT00972309|523832714|FG000|Overall Study|Lost to Follow-up|1|||
145268972|NCT00972309|523832715|FG001|Overall Study|Lost to Follow-up|1|||
145268973|NCT00972309|523832714|FG000|Overall Study|Disease progression on study|10|||
145268974|NCT00972309|523832715|FG001|Overall Study|Disease progression on study|4|||
145268975|NCT01058707|523832719|FG000|Overall Study|Disease Progression|15|||
145516662|NCT01330017|524752322|FG003|Overall Study|Withdrawal by Subject|0|||
145516663|NCT01330017|524752323|FG004|Overall Study|Withdrawal by Subject|1|||
145268976|NCT01058707|523832720|FG001|Overall Study|Disease Progression|20|||
145268977|NCT01058707|523832721|FG002|Overall Study|Disease Progression|20|||
145268978|NCT01058707|523832722|FG003|Overall Study|Disease Progression|15|||
145516664|NCT01330017|524752319|FG000|Overall Study|Lost to Follow-up|0|||
145516665|NCT01330017|524752320|FG001|Overall Study|Lost to Follow-up|0|||
145268979|NCT01058707|523832723|FG004|Overall Study|Disease Progression|23|||
145268980|NCT01058707|523832724|FG005|Overall Study|Disease Progression|10|||
145516666|NCT01330017|524752321|FG002|Overall Study|Lost to Follow-up|1|||
145516667|NCT01330017|524752322|FG003|Overall Study|Lost to Follow-up|0|||
145516668|NCT01330017|524752323|FG004|Overall Study|Lost to Follow-up|0|||
145516669|NCT01330017|524752319|FG000|Overall Study|Protocol Violation|0|||
145516670|NCT01330017|524752320|FG001|Overall Study|Protocol Violation|0|||
145516671|NCT01330017|524752321|FG002|Overall Study|Protocol Violation|0|||
145516672|NCT01330017|524752322|FG003|Overall Study|Protocol Violation|1|||
145516673|NCT01330017|524752323|FG004|Overall Study|Protocol Violation|0|||
145516674|NCT01330017|524752319|FG000|Overall Study|Unknown Reason|5|||
145516675|NCT01330017|524752320|FG001|Overall Study|Unknown Reason|3|||
145516676|NCT01330017|524752321|FG002|Overall Study|Unknown Reason|5|||
145516677|NCT01330017|524752322|FG003|Overall Study|Unknown Reason|7|||
145516678|NCT01330017|524752323|FG004|Overall Study|Unknown Reason|2|||
145516679|NCT01221272|524752325|FG000|Period 1|Adverse Event|2|||
145516680|NCT01221272|524752326|FG001|Period 1|Adverse Event|0|||
145516681|NCT01221272|524752325|FG000|Period 1|Consent Withdrawal|0|||
145516682|NCT01221272|524752326|FG001|Period 1|Consent Withdrawal|1|||
145516683|NCT01221272|524752325|FG000|Period 1|Significant Dosing Noncompliance|0|||
145516684|NCT01221272|524752326|FG001|Period 1|Significant Dosing Noncompliance|1|||
145516685|NCT01221272|524752325|FG000|Period 2|Adverse Event|0|||
145516686|NCT01221272|524752326|FG001|Period 2|Adverse Event|2|||
145516687|NCT02043899|524752330|FG000|Overall Study|Adverse Event|3|||
145516688|NCT02043899|524752330|FG000|Overall Study|Physician Decision|1|||
145516689|NCT02043899|524752330|FG000|Overall Study|Withdrawal by Subject|2|||
145516690|NCT02043899|524752330|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
145516691|NCT02043899|524752330|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
145516692|NCT02043899|524752330|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
145516693|NCT02043899|524752330|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
145516694|NCT02043899|524752330|FG000|Overall Study|Treatment delayed|1|||
145516695|NCT03254108|524752331|FG000|Overall Study|Adverse Event|0|||
145516696|NCT03254108|524752332|FG001|Overall Study|Adverse Event|2|||
145516697|NCT03254108|524752333|FG002|Overall Study|Adverse Event|0|||
145606752|NCT00957931|525076879|FG000|Overall Study|Death|4|||
145516698|NCT03254108|524752334|FG003|Overall Study|Adverse Event|1|||
145516699|NCT03254108|524752335|FG004|Overall Study|Adverse Event|1|||
145516700|NCT03254108|524752331|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
145516701|NCT03254108|524752332|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
145516702|NCT03254108|524752333|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
145606753|NCT00857805|525076880|FG000|Overall Study|Withdrawal by Subject|1|||
145606754|NCT00857805|525076881|FG001|Overall Study|Withdrawal by Subject|1|||
145606755|NCT01062763|525076882|FG000|Overall Study|Adverse Event|3|||
145606756|NCT01062763|525076883|FG001|Overall Study|Adverse Event|4|||
145606757|NCT02392611|525076889|FG000|Overall Study|Adverse Event|0|||
145606758|NCT02392611|525076890|FG001|Overall Study|Adverse Event|0|||
145606759|NCT02392611|525076891|FG002|Overall Study|Adverse Event|0|||
145606760|NCT02392611|525076892|FG003|Overall Study|Adverse Event|1|||
145606761|NCT02392611|525076893|FG004|Overall Study|Adverse Event|0|||
145606762|NCT02392611|525076894|FG005|Overall Study|Adverse Event|0|||
145606763|NCT02392611|525076895|FG006|Overall Study|Adverse Event|0|||
145606764|NCT02392611|525076896|FG007|Overall Study|Adverse Event|0|||
145734935|NCT03681951|525548389|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145734936|NCT03681951|525548390|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145734937|NCT03681951|525548391|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145734938|NCT03681951|525548392|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
145734939|NCT03681951|525548385|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
145734940|NCT03681951|525548386|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734941|NCT03681951|525548387|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734942|NCT03681951|525548388|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734943|NCT03681951|525548389|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734944|NCT03681951|525548390|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734945|NCT03681951|525548391|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145268981|NCT01058707|523832725|FG006|Overall Study|Disease Progression|12|||
145606765|NCT02392611|525076897|FG008|Overall Study|Adverse Event|0|||
145734946|NCT03681951|525548392|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
145734947|NCT03681951|525548385|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
145734948|NCT03681951|525548386|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734949|NCT03681951|525548387|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734950|NCT03681951|525548388|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734951|NCT03681951|525548389|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734952|NCT03681951|525548390|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734953|NCT03681951|525548391|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734954|NCT03681951|525548392|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
145734955|NCT02187809|525548393|FG000|Overall Study|The study was terminated|3|||
145734956|NCT01020448|525548394|FG000|Pre-assignment|Adverse Event|6|||
145734957|NCT01020448|525548394|FG000|Pre-assignment|Withdrawal by Subject|5|||
145734958|NCT01020448|525548394|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
145734959|NCT01020448|525548394|FG000|Treatment|Adverse Event|11|||
145734960|NCT01020448|525548394|FG000|Treatment|Consent Withdrawn|3|||
145734961|NCT01020448|525548394|FG000|Treatment|Disease Progression|2|||
145734962|NCT01020448|525548394|FG000|Treatment|Lack of Efficacy|8|||
145734963|NCT01020448|525548394|FG000|Treatment|Lost to Follow-up|2|||
145734964|NCT01006265|525548397|FG000|Overall Study|Lost to Follow-up|1|||
145734965|NCT01006265|525548398|FG001|Overall Study|Lost to Follow-up|0|||
145734966|NCT01006265|525548399|FG002|Overall Study|Lost to Follow-up|1|||
145734967|NCT01006265|525548400|FG003|Overall Study|Lost to Follow-up|0|||
145734968|NCT01006265|525548397|FG000|Overall Study|Withdrawal by Subject|4|||
145734969|NCT01006265|525548398|FG001|Overall Study|Withdrawal by Subject|7|||
145734970|NCT01006265|525548399|FG002|Overall Study|Withdrawal by Subject|5|||
145734971|NCT01006265|525548400|FG003|Overall Study|Withdrawal by Subject|5|||
145734972|NCT01006265|525548397|FG000|Overall Study|Administrative reason|1|||
145734973|NCT01006265|525548398|FG001|Overall Study|Administrative reason|2|||
145734974|NCT01006265|525548399|FG002|Overall Study|Administrative reason|3|||
145734975|NCT01006265|525548400|FG003|Overall Study|Administrative reason|0|||
145734976|NCT00698932|525548401|FG000|Overall Study|Adverse Event|0|||
145734977|NCT00698932|525548402|FG001|Overall Study|Adverse Event|2|||
145734978|NCT00698932|525548401|FG000|Overall Study|Incorrect enrollment|0|||
145734979|NCT00698932|525548402|FG001|Overall Study|Incorrect enrollment|2|||
145734980|NCT00698932|525548401|FG000|Overall Study|Study specific discontinuation criteria|3|||
145734981|NCT00698932|525548402|FG001|Overall Study|Study specific discontinuation criteria|4|||
145734982|NCT00698932|525548401|FG000|Overall Study|Withdrawal by Subject|11|||
145734983|NCT00698932|525548402|FG001|Overall Study|Withdrawal by Subject|23|||
145734984|NCT00698932|525548401|FG000|Overall Study|Lost to Follow-up|6|||
145734985|NCT00698932|525548402|FG001|Overall Study|Lost to Follow-up|1|||
145734986|NCT00698932|525548401|FG000|Overall Study|Severe non-compliance to protocol|1|||
145734987|NCT00698932|525548402|FG001|Overall Study|Severe non-compliance to protocol|2|||
145734988|NCT00698932|525548401|FG000|Overall Study|Safety reasons|0|||
145734989|NCT00698932|525548402|FG001|Overall Study|Safety reasons|2|||
145734990|NCT00698932|525548401|FG000|Overall Study|Death|1|||
145734991|NCT00698932|525548402|FG001|Overall Study|Death|0|||
145734992|NCT00757003|525548403|FG000|Overall Study|Death|33|||
145734993|NCT00757003|525548403|FG000|Overall Study|Lost to Follow-up|9|||
145734994|NCT00757003|525548403|FG000|Overall Study|Withdrawal by Subject|4|||
145734995|NCT00757003|525548403|FG000|Overall Study|Surgically explanted|2|||
145734996|NCT00757003|525548403|FG000|Overall Study|Not implanted|1|||
145734997|NCT00601705|525548404|FG000|Overall Study|Withdrawal by Subject|1|||
145734998|NCT02146599|525548408|FG000|Overall Study|Failed to meet inclusion criteria|5|||
145734999|NCT02101021|525548412|FG000|Overall Study|Death|4|||
145735000|NCT02101021|525548413|FG001|Overall Study|Death|3|||
145735001|NCT02101021|525548414|FG002|Overall Study|Death|6|||
145735002|NCT02101021|525548415|FG003|Overall Study|Death|0|||
145735003|NCT02101021|525548416|FG004|Overall Study|Death|3|||
145268982|NCT01058707|523832719|FG000|Overall Study|Adverse Event|11|||
145268983|NCT01058707|523832720|FG001|Overall Study|Adverse Event|4|||
145268984|NCT01058707|523832721|FG002|Overall Study|Adverse Event|7|||
145735004|NCT02101021|525548412|FG000|Overall Study|Withdrew Consent from study|1|||
145735005|NCT02101021|525548413|FG001|Overall Study|Withdrew Consent from study|1|||
145735006|NCT02101021|525548414|FG002|Overall Study|Withdrew Consent from study|0|||
145735007|NCT02101021|525548415|FG003|Overall Study|Withdrew Consent from study|2|||
145735008|NCT02101021|525548416|FG004|Overall Study|Withdrew Consent from study|0|||
145735009|NCT02101021|525548412|FG000|Overall Study|Lost to Follow-up|1|||
145735010|NCT02101021|525548413|FG001|Overall Study|Lost to Follow-up|0|||
145735011|NCT02101021|525548414|FG002|Overall Study|Lost to Follow-up|0|||
145735012|NCT02101021|525548415|FG003|Overall Study|Lost to Follow-up|0|||
145735013|NCT02101021|525548416|FG004|Overall Study|Lost to Follow-up|0|||
145735014|NCT02101021|525548412|FG000|Overall Study|Study Terminated by Sponsor|1|||
145735015|NCT02101021|525548413|FG001|Overall Study|Study Terminated by Sponsor|0|||
145735016|NCT02101021|525548414|FG002|Overall Study|Study Terminated by Sponsor|1|||
145735017|NCT02101021|525548415|FG003|Overall Study|Study Terminated by Sponsor|1|||
145735018|NCT02101021|525548416|FG004|Overall Study|Study Terminated by Sponsor|1|||
145735019|NCT00387764|525548417|FG000|Overall Study|Adverse Event|12|||
145735020|NCT00387764|525548417|FG000|Overall Study|Withdrawal by Subject|8|||
145735021|NCT00387764|525548417|FG000|Overall Study|Sponsor Terminated Study|1|||
145735022|NCT00387764|525548417|FG000|Overall Study|Physician Decision|1|||
145735023|NCT00387764|525548417|FG000|Overall Study|Other|2|||
145735024|NCT00387764|525548417|FG000|Overall Study|Death|7|||
145735025|NCT01326728|525548418|FG000|Overall Study|Death|13|||
145735026|NCT01326728|525548419|FG001|Overall Study|Death|0|||
145735027|NCT01326728|525548418|FG000|Overall Study|Early closure of study|34|||
145735028|NCT01326728|525548419|FG001|Overall Study|Early closure of study|9|||
145735029|NCT02966223|525548420|FG000|Overall Study|Physician Decision|3|||
145735030|NCT02966223|525548420|FG000|Overall Study|Withdrawal by Subject|11|||
145735031|NCT02966223|525548420|FG000|Overall Study|Lost to Follow-up|1|||
145735032|NCT01184053|525548421|FG000|Overall Study|progression while on treatment|3|||
145735033|NCT03785678|525548422|FG000|Overall Study|Death|44|||
145268985|NCT01058707|523832722|FG003|Overall Study|Adverse Event|6|||
145268986|NCT01058707|523832723|FG004|Overall Study|Adverse Event|7|||
145268987|NCT01058707|523832724|FG005|Overall Study|Adverse Event|3|||
145268988|NCT01058707|523832725|FG006|Overall Study|Adverse Event|1|||
145268989|NCT01058707|523832719|FG000|Overall Study|Subject Decision|5|||
145735034|NCT03785678|525548423|FG001|Overall Study|Death|42|||
145735035|NCT03785678|525548422|FG000|Overall Study|Lost to Follow-up|4|||
145735036|NCT03785678|525548423|FG001|Overall Study|Lost to Follow-up|2|||
145735037|NCT03785678|525548422|FG000|Overall Study|Physician Decision|0|||
145735038|NCT03785678|525548423|FG001|Overall Study|Physician Decision|2|||
145735039|NCT03785678|525548422|FG000|Overall Study|Withdrawal by Subject|5|||
145735040|NCT03785678|525548423|FG001|Overall Study|Withdrawal by Subject|3|||
145735041|NCT04399122|525548424|FG000|Overall Study|Lost to Follow-up|2|||
145735042|NCT04399122|525548425|FG001|Overall Study|Lost to Follow-up|0|||
145735043|NCT04399122|525548424|FG000|Overall Study|Withdrawal by Subject|1|||
145735044|NCT04399122|525548425|FG001|Overall Study|Withdrawal by Subject|0|||
145735045|NCT02536755|525548430|FG000|Overall Study|Adverse Event|4|||
145735046|NCT02301936|525548431|FG000|Overall Study|Lost to Follow-up|1|||
145735047|NCT02301936|525548432|FG001|Overall Study|Lost to Follow-up|0|||
145735048|NCT01174238|525548433|FG000|Overall Study|Lost to Follow-up|2|||
145735049|NCT02322229|525548435|FG000|Overall Study|Physician Decision|2|||
145735050|NCT03065023|525548436|FG000|Overall Study|Progressive Disease|0|||
145735051|NCT03065023|525548437|FG001|Overall Study|Progressive Disease|1|||
145735052|NCT03065023|525548438|FG002|Overall Study|Progressive Disease|0|||
145516703|NCT03254108|524752334|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
145516704|NCT03254108|524752335|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
145516705|NCT01771809|524752336|FG000|Overall Study|Adverse Event|4|||
145516706|NCT01771809|524752337|FG001|Overall Study|Adverse Event|12|||
145516707|NCT01771809|524752336|FG000|Overall Study|Protocol Violation|0|||
145516708|NCT01771809|524752337|FG001|Overall Study|Protocol Violation|1|||
145516709|NCT01771809|524752336|FG000|Overall Study|Withdrawal by Subject|34|||
145516710|NCT01771809|524752337|FG001|Overall Study|Withdrawal by Subject|42|||
145516711|NCT01771809|524752336|FG000|Overall Study|Lost to Follow-up|1|||
145516712|NCT01771809|524752337|FG001|Overall Study|Lost to Follow-up|3|||
145516713|NCT01771809|524752336|FG000|Overall Study|Other (Insufficient clinical response)|22|||
145516714|NCT01771809|524752337|FG001|Overall Study|Other (Insufficient clinical response)|20|||
145516715|NCT01771809|524752336|FG000|Overall Study|Death|1|||
145516716|NCT01771809|524752337|FG001|Overall Study|Death|0|||
145516717|NCT01771809|524752336|FG000|Overall Study|Other (other)|9|||
145516718|NCT01771809|524752337|FG001|Overall Study|Other (other)|5|||
145516719|NCT00362180|524752338|FG000|Treated Period|Withdrawal by Subject|1|||
145516720|NCT00362180|524752339|FG001|Treated Period|Withdrawal by Subject|0|||
145516721|NCT00362180|524752340|FG002|Treated Period|Withdrawal by Subject|0|||
145735053|NCT03065023|525548439|FG003|Overall Study|Progressive Disease|0|||
145735054|NCT03065023|525548440|FG004|Overall Study|Progressive Disease|0|||
145735055|NCT03065023|525548436|FG000|Overall Study|Death|2|||
145735056|NCT03065023|525548437|FG001|Overall Study|Death|0|||
145735057|NCT03065023|525548438|FG002|Overall Study|Death|1|||
145735058|NCT03065023|525548439|FG003|Overall Study|Death|1|||
145735059|NCT03065023|525548440|FG004|Overall Study|Death|0|||
145735060|NCT03065023|525548436|FG000|Overall Study|Lost to Follow-up|0|||
145735061|NCT03065023|525548437|FG001|Overall Study|Lost to Follow-up|1|||
145735062|NCT03065023|525548438|FG002|Overall Study|Lost to Follow-up|0|||
145735063|NCT03065023|525548439|FG003|Overall Study|Lost to Follow-up|0|||
145735064|NCT03065023|525548440|FG004|Overall Study|Lost to Follow-up|0|||
145735065|NCT03065023|525548436|FG000|Overall Study|Participant Decision|0|||
145735066|NCT03065023|525548437|FG001|Overall Study|Participant Decision|0|||
145735067|NCT03065023|525548438|FG002|Overall Study|Participant Decision|0|||
145735068|NCT03065023|525548439|FG003|Overall Study|Participant Decision|1|||
145735069|NCT03065023|525548440|FG004|Overall Study|Participant Decision|0|||
145735070|NCT03065023|525548436|FG000|Overall Study|Withdrawal by Subject|0|||
145735071|NCT03065023|525548437|FG001|Overall Study|Withdrawal by Subject|0|||
145735072|NCT03065023|525548438|FG002|Overall Study|Withdrawal by Subject|0|||
145735073|NCT03065023|525548439|FG003|Overall Study|Withdrawal by Subject|1|||
145735074|NCT03065023|525548440|FG004|Overall Study|Withdrawal by Subject|0|||
145735075|NCT00705432|525548441|FG000|Treatment Period|Adverse Event|45|||
145735076|NCT00705432|525548442|FG001|Treatment Period|Adverse Event|37|||
145735077|NCT00705432|525548443|FG002|Treatment Period|Adverse Event|51|||
145735078|NCT00705432|525548444|FG003|Treatment Period|Adverse Event|12|||
145735079|NCT00705432|525548445|FG004|Treatment Period|Adverse Event|8|||
145735080|NCT00705432|525548446|FG005|Treatment Period|Adverse Event|9|||
145516722|NCT00362180|524752341|FG003|Treated Period|Withdrawal by Subject|0|||
145735081|NCT00705432|525548441|FG000|Treatment Period|Treatment failure|92|||
145735082|NCT00705432|525548442|FG001|Treatment Period|Treatment failure|42|||
145735083|NCT00705432|525548443|FG002|Treatment Period|Treatment failure|33|||
145735084|NCT00705432|525548444|FG003|Treatment Period|Treatment failure|25|||
145735085|NCT00705432|525548445|FG004|Treatment Period|Treatment failure|13|||
145735086|NCT00705432|525548446|FG005|Treatment Period|Treatment failure|14|||
145516723|NCT00362180|524752342|FG004|Treated Period|Withdrawal by Subject|0|||
145516724|NCT00362180|524752343|FG005|Treated Period|Withdrawal by Subject|0|||
145735087|NCT00705432|525548441|FG000|Treatment Period|Non medical reason|26|||
145516725|NCT00362180|524752344|FG006|Treated Period|Withdrawal by Subject|0|||
145516726|NCT00362180|524752345|FG007|Treated Period|Withdrawal by Subject|0|||
145516727|NCT00362180|524752346|FG008|Treated Period|Withdrawal by Subject|0|||
145516728|NCT00362180|524752338|FG000|Treated Period|Adverse Event|0|||
145735088|NCT00705432|525548442|FG001|Treatment Period|Non medical reason|32|||
145735089|NCT00705432|525548443|FG002|Treatment Period|Non medical reason|37|||
145735090|NCT00705432|525548444|FG003|Treatment Period|Non medical reason|4|||
145735091|NCT00705432|525548445|FG004|Treatment Period|Non medical reason|7|||
145735092|NCT00705432|525548446|FG005|Treatment Period|Non medical reason|7|||
145735093|NCT00705432|525548441|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
145735094|NCT00705432|525548442|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
145735095|NCT00705432|525548443|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
145735096|NCT00705432|525548444|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
145735097|NCT00705432|525548445|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
145735098|NCT00705432|525548446|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
145735099|NCT00705432|525548441|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
145735100|NCT00705432|525548442|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
145735101|NCT00705432|525548443|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
145735102|NCT00705432|525548444|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
145735103|NCT00705432|525548445|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
145735104|NCT00705432|525548446|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
145735105|NCT00521053|525548447|FG000|Observation Phase|Disease Progression|55|||
145735106|NCT00521053|525548447|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
145735107|NCT00521053|525548447|FG000|Observation Phase|Death|2|||
145735108|NCT00521053|525548447|FG000|Observation Phase|Adverse Event|1|||
145735109|NCT00521053|525548447|FG000|Observation Phase|Other non-study melanoma treatment|1|||
145735110|NCT00521053|525548447|FG000|Observation Phase|Physician Decision|1|||
145735111|NCT00375219|525548448|FG000|Overall Study|Failure to achieve a response|16|||
145735112|NCT00375219|525548449|FG001|Overall Study|Failure to achieve a response|2|||
145735113|NCT00375219|525548450|FG002|Overall Study|Failure to achieve a response|0|||
145735114|NCT00375219|525548448|FG000|Overall Study|Adverse Event|8|||
145735115|NCT00375219|525548449|FG001|Overall Study|Adverse Event|2|||
145735116|NCT00375219|525548450|FG002|Overall Study|Adverse Event|1|||
145735117|NCT00375219|525548448|FG000|Overall Study|Protocol Violation|1|||
145735118|NCT00375219|525548449|FG001|Overall Study|Protocol Violation|0|||
145735119|NCT00375219|525548450|FG002|Overall Study|Protocol Violation|1|||
145735120|NCT00375219|525548448|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
145735121|NCT00375219|525548449|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
145735122|NCT00375219|525548450|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
145735123|NCT00375219|525548448|FG000|Overall Study|Lost to Follow-up|1|||
145735124|NCT00375219|525548449|FG001|Overall Study|Lost to Follow-up|1|||
145735125|NCT00375219|525548450|FG002|Overall Study|Lost to Follow-up|0|||
145735126|NCT00375219|525548448|FG000|Overall Study|Disease progression|18|||
145735127|NCT00375219|525548449|FG001|Overall Study|Disease progression|9|||
145735128|NCT00375219|525548450|FG002|Overall Study|Disease progression|12|||
145735129|NCT00375219|525548448|FG000|Overall Study|Death|4|||
145735130|NCT00375219|525548449|FG001|Overall Study|Death|3|||
145735131|NCT00375219|525548450|FG002|Overall Study|Death|7|||
145735132|NCT00375219|525548448|FG000|Overall Study|Hematologic resistance|1|||
145735133|NCT00375219|525548449|FG001|Overall Study|Hematologic resistance|0|||
145735134|NCT00375219|525548450|FG002|Overall Study|Hematologic resistance|0|||
145735135|NCT00375219|525548448|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
145735136|NCT00375219|525548449|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
145735137|NCT00375219|525548450|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
145735138|NCT00375219|525548448|FG000|Overall Study|Allograft|2|||
145735139|NCT00375219|525548449|FG001|Overall Study|Allograft|0|||
145735140|NCT00375219|525548450|FG002|Overall Study|Allograft|0|||
145735141|NCT00375219|525548448|FG000|Overall Study|Cord blood transplantation|1|||
145735142|NCT00375219|525548449|FG001|Overall Study|Cord blood transplantation|0|||
145735143|NCT00375219|525548450|FG002|Overall Study|Cord blood transplantation|0|||
145735144|NCT00375219|525548448|FG000|Overall Study|Withdrawal by Subject|1|||
145735145|NCT00375219|525548449|FG001|Overall Study|Withdrawal by Subject|0|||
145735146|NCT00375219|525548450|FG002|Overall Study|Withdrawal by Subject|0|||
145735147|NCT01667107|525548451|FG000|Overall Study|Adverse Event|4|||
145735148|NCT01667107|525548452|FG001|Overall Study|Adverse Event|3|||
145735149|NCT01667107|525548451|FG000|Overall Study|Tolerability issues|0|||
145735150|NCT01667107|525548452|FG001|Overall Study|Tolerability issues|2|||
145735151|NCT01667107|525548451|FG000|Overall Study|Protocol Violation|0|||
145735152|NCT01667107|525548452|FG001|Overall Study|Protocol Violation|1|||
145735153|NCT01667107|525548451|FG000|Overall Study|Lack of Efficacy|0|||
145735154|NCT01667107|525548452|FG001|Overall Study|Lack of Efficacy|1|||
145735155|NCT01162239|525548455|FG000|Treatment Phase|Withdrawal by Subject|1|||
145516729|NCT00362180|524752339|FG001|Treated Period|Adverse Event|0|||
145735156|NCT01162239|525548456|FG001|Treatment Phase|Withdrawal by Subject|3|||
145735157|NCT01162239|525548457|FG002|Treatment Phase|Withdrawal by Subject|2|||
145735158|NCT01162239|525548458|FG003|Treatment Phase|Withdrawal by Subject|3|||
145735159|NCT01162239|525548455|FG000|Treatment Phase|Death|0|||
145735160|NCT01162239|525548456|FG001|Treatment Phase|Death|0|||
145735161|NCT01162239|525548457|FG002|Treatment Phase|Death|0|||
145735162|NCT01162239|525548458|FG003|Treatment Phase|Death|1|||
145735163|NCT01162239|525548455|FG000|Treatment Phase|Lost to Follow-up|5|||
145735164|NCT01162239|525548456|FG001|Treatment Phase|Lost to Follow-up|4|||
145735165|NCT01162239|525548457|FG002|Treatment Phase|Lost to Follow-up|2|||
145735166|NCT01162239|525548458|FG003|Treatment Phase|Lost to Follow-up|1|||
145735167|NCT01162239|525548455|FG000|Extended Follow-up|Lost to Follow-up|8|||
145735168|NCT01162239|525548456|FG001|Extended Follow-up|Lost to Follow-up|13|||
145735169|NCT01162239|525548457|FG002|Extended Follow-up|Lost to Follow-up|8|||
145735170|NCT01162239|525548458|FG003|Extended Follow-up|Lost to Follow-up|6|||
145735171|NCT05975840|525548459|FG000|Overall Study|Other|1|||
145735172|NCT05975840|525548460|FG001|Overall Study|Other|0|||
145735173|NCT05975840|525548461|FG002|Overall Study|Other|0|||
145735174|NCT05975840|525548462|FG003|Overall Study|Other|0|||
145735175|NCT05975840|525548463|FG004|Overall Study|Other|1|||
145735176|NCT05975840|525548464|FG005|Overall Study|Other|0|||
145735177|NCT05975840|525548465|FG006|Overall Study|Other|0|||
145735178|NCT05975840|525548466|FG007|Overall Study|Other|0|||
145735179|NCT05975840|525548459|FG000|Overall Study|Lost to Follow-up|3|||
145735180|NCT05975840|525548460|FG001|Overall Study|Lost to Follow-up|6|||
145735181|NCT05975840|525548461|FG002|Overall Study|Lost to Follow-up|3|||
145735182|NCT05975840|525548462|FG003|Overall Study|Lost to Follow-up|1|||
145735183|NCT05975840|525548463|FG004|Overall Study|Lost to Follow-up|4|||
145735184|NCT05975840|525548464|FG005|Overall Study|Lost to Follow-up|1|||
145735185|NCT05975840|525548465|FG006|Overall Study|Lost to Follow-up|2|||
145735186|NCT05975840|525548466|FG007|Overall Study|Lost to Follow-up|4|||
145735187|NCT05975840|525548459|FG000|Overall Study|Migrated/moved from the study area|1|||
145735188|NCT05975840|525548460|FG001|Overall Study|Migrated/moved from the study area|0|||
145735189|NCT05975840|525548461|FG002|Overall Study|Migrated/moved from the study area|0|||
145735190|NCT05975840|525548462|FG003|Overall Study|Migrated/moved from the study area|0|||
145735191|NCT05975840|525548463|FG004|Overall Study|Migrated/moved from the study area|0|||
145735192|NCT05975840|525548464|FG005|Overall Study|Migrated/moved from the study area|0|||
145735193|NCT05975840|525548465|FG006|Overall Study|Migrated/moved from the study area|0|||
145606766|NCT02392611|525076889|FG000|Overall Study|Progressive disease|0|||
145606767|NCT02392611|525076890|FG001|Overall Study|Progressive disease|0|||
145606768|NCT02392611|525076891|FG002|Overall Study|Progressive disease|0|||
145606769|NCT02392611|525076892|FG003|Overall Study|Progressive disease|2|||
145606770|NCT02392611|525076893|FG004|Overall Study|Progressive disease|1|||
145606771|NCT02392611|525076894|FG005|Overall Study|Progressive disease|0|||
145606772|NCT02392611|525076895|FG006|Overall Study|Progressive disease|0|||
145606773|NCT02392611|525076896|FG007|Overall Study|Progressive disease|0|||
145606774|NCT02392611|525076897|FG008|Overall Study|Progressive disease|0|||
145606775|NCT02392611|525076889|FG000|Overall Study|Death|1|||
145606776|NCT02392611|525076890|FG001|Overall Study|Death|0|||
145606777|NCT02392611|525076891|FG002|Overall Study|Death|0|||
145606778|NCT02392611|525076892|FG003|Overall Study|Death|0|||
145606779|NCT02392611|525076893|FG004|Overall Study|Death|0|||
145606780|NCT02392611|525076894|FG005|Overall Study|Death|1|||
145606781|NCT02392611|525076895|FG006|Overall Study|Death|0|||
145606782|NCT02392611|525076896|FG007|Overall Study|Death|0|||
145606783|NCT02392611|525076897|FG008|Overall Study|Death|0|||
145606784|NCT02392611|525076889|FG000|Overall Study|Withdrawal by Subject|0|||
145606785|NCT02392611|525076890|FG001|Overall Study|Withdrawal by Subject|0|||
145606786|NCT02392611|525076891|FG002|Overall Study|Withdrawal by Subject|0|||
145606787|NCT02392611|525076892|FG003|Overall Study|Withdrawal by Subject|1|||
145606788|NCT02392611|525076893|FG004|Overall Study|Withdrawal by Subject|0|||
145606789|NCT02392611|525076894|FG005|Overall Study|Withdrawal by Subject|0|||
145606790|NCT02392611|525076895|FG006|Overall Study|Withdrawal by Subject|0|||
145606791|NCT02392611|525076896|FG007|Overall Study|Withdrawal by Subject|0|||
145606792|NCT02392611|525076897|FG008|Overall Study|Withdrawal by Subject|0|||
145606793|NCT02392611|525076889|FG000|Overall Study|Lost to Follow-up|0|||
145735194|NCT05975840|525548466|FG007|Overall Study|Migrated/moved from the study area|0|||
145735195|NCT05975840|525548459|FG000|Overall Study|Withdrawal by Subject|0|||
145606794|NCT02392611|525076890|FG001|Overall Study|Lost to Follow-up|0|||
145606795|NCT02392611|525076891|FG002|Overall Study|Lost to Follow-up|0|||
145606796|NCT02392611|525076892|FG003|Overall Study|Lost to Follow-up|0|||
145606797|NCT02392611|525076893|FG004|Overall Study|Lost to Follow-up|0|||
145735196|NCT05975840|525548460|FG001|Overall Study|Withdrawal by Subject|5|||
145735197|NCT05975840|525548461|FG002|Overall Study|Withdrawal by Subject|2|||
145735198|NCT05975840|525548462|FG003|Overall Study|Withdrawal by Subject|2|||
145268990|NCT01058707|523832720|FG001|Overall Study|Subject Decision|3|||
145268991|NCT01058707|523832721|FG002|Overall Study|Subject Decision|3|||
145268992|NCT01058707|523832722|FG003|Overall Study|Subject Decision|1|||
145606798|NCT02392611|525076894|FG005|Overall Study|Lost to Follow-up|0|||
145606799|NCT02392611|525076895|FG006|Overall Study|Lost to Follow-up|1|||
145606800|NCT02392611|525076896|FG007|Overall Study|Lost to Follow-up|0|||
145606801|NCT02392611|525076897|FG008|Overall Study|Lost to Follow-up|0|||
145606802|NCT02392611|525076889|FG000|Overall Study|Enrolled, not treated|0|||
145606803|NCT02392611|525076890|FG001|Overall Study|Enrolled, not treated|0|||
145606804|NCT02392611|525076891|FG002|Overall Study|Enrolled, not treated|0|||
145735199|NCT05975840|525548463|FG004|Overall Study|Withdrawal by Subject|0|||
145735200|NCT05975840|525548464|FG005|Overall Study|Withdrawal by Subject|2|||
145606805|NCT02392611|525076892|FG003|Overall Study|Enrolled, not treated|2|||
145606806|NCT02392611|525076893|FG004|Overall Study|Enrolled, not treated|0|||
145735201|NCT05975840|525548465|FG006|Overall Study|Withdrawal by Subject|2|||
145735202|NCT05975840|525548466|FG007|Overall Study|Withdrawal by Subject|1|||
145735203|NCT05975840|525548459|FG000|Overall Study|Protocol Violation|0|||
145735204|NCT05975840|525548460|FG001|Overall Study|Protocol Violation|1|||
145735205|NCT05975840|525548461|FG002|Overall Study|Protocol Violation|0|||
145735206|NCT05975840|525548462|FG003|Overall Study|Protocol Violation|0|||
145735207|NCT05975840|525548463|FG004|Overall Study|Protocol Violation|0|||
145735208|NCT05975840|525548464|FG005|Overall Study|Protocol Violation|0|||
145735209|NCT05975840|525548465|FG006|Overall Study|Protocol Violation|0|||
145735210|NCT05975840|525548466|FG007|Overall Study|Protocol Violation|0|||
145735211|NCT05975840|525548459|FG000|Overall Study|Adverse Event|0|||
145735212|NCT05975840|525548460|FG001|Overall Study|Adverse Event|0|||
145735213|NCT05975840|525548461|FG002|Overall Study|Adverse Event|0|||
145735214|NCT05975840|525548462|FG003|Overall Study|Adverse Event|1|||
145735215|NCT05975840|525548463|FG004|Overall Study|Adverse Event|0|||
145735216|NCT05975840|525548464|FG005|Overall Study|Adverse Event|0|||
145735217|NCT05975840|525548465|FG006|Overall Study|Adverse Event|0|||
145735218|NCT05975840|525548466|FG007|Overall Study|Adverse Event|0|||
145735219|NCT05975840|525548459|FG000|Overall Study|Death|0|||
145735220|NCT05975840|525548460|FG001|Overall Study|Death|1|||
145735221|NCT05975840|525548461|FG002|Overall Study|Death|0|||
145735222|NCT05975840|525548462|FG003|Overall Study|Death|0|||
145735223|NCT05975840|525548463|FG004|Overall Study|Death|0|||
145735224|NCT05975840|525548464|FG005|Overall Study|Death|0|||
145735225|NCT05975840|525548465|FG006|Overall Study|Death|0|||
145735226|NCT05975840|525548466|FG007|Overall Study|Death|1|||
145735227|NCT04448756|525548469|FG000|Overall Study|Adverse Event|0|||
145735228|NCT04448756|525548470|FG001|Overall Study|Adverse Event|1|||
145735229|NCT04448756|525548471|FG002|Overall Study|Adverse Event|0|||
145735230|NCT04448756|525548469|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
145735231|NCT04448756|525548470|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
145735232|NCT04448756|525548471|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
145735233|NCT04448756|525548469|FG000|Overall Study|Withdrawal by Subject|0|||
145735234|NCT04448756|525548470|FG001|Overall Study|Withdrawal by Subject|3|||
145735235|NCT04448756|525548471|FG002|Overall Study|Withdrawal by Subject|1|||
145735236|NCT04448756|525548469|FG000|Overall Study|Death|2|||
145735237|NCT04448756|525548470|FG001|Overall Study|Death|1|||
145735238|NCT04448756|525548471|FG002|Overall Study|Death|0|||
145735239|NCT02733185|525548472|FG000|Overall Study|Withdrawal by Subject|12|||
145735240|NCT02733185|525548473|FG001|Overall Study|Withdrawal by Subject|10|||
145735241|NCT02733185|525548474|FG002|Overall Study|Withdrawal by Subject|17|||
145735242|NCT02733185|525548475|FG003|Overall Study|Withdrawal by Subject|21|||
145735243|NCT02733185|525548472|FG000|Overall Study|Death|46|||
145735244|NCT02733185|525548473|FG001|Overall Study|Death|34|||
145735245|NCT02733185|525548474|FG002|Overall Study|Death|35|||
145735246|NCT02733185|525548475|FG003|Overall Study|Death|43|||
145735247|NCT02733185|525548472|FG000|Overall Study|Lost to Follow-up|17|||
145735248|NCT02733185|525548473|FG001|Overall Study|Lost to Follow-up|18|||
145735249|NCT02733185|525548474|FG002|Overall Study|Lost to Follow-up|16|||
145735250|NCT02733185|525548475|FG003|Overall Study|Lost to Follow-up|11|||
145735251|NCT04252287|525548476|FG000|Overall Study|Death|5|||
145735252|NCT04252287|525548477|FG001|Overall Study|Death|3|||
145735253|NCT04252287|525548476|FG000|Overall Study|Lost to Follow-up|4|||
145735254|NCT04252287|525548477|FG001|Overall Study|Lost to Follow-up|6|||
145402248|NCT00761319|524330686|FG001|Overall Study|Adverse Event|7|||
145516730|NCT00362180|524752340|FG002|Treated Period|Adverse Event|0|||
145516731|NCT00362180|524752341|FG003|Treated Period|Adverse Event|0|||
145516732|NCT00362180|524752342|FG004|Treated Period|Adverse Event|0|||
145516733|NCT00362180|524752343|FG005|Treated Period|Adverse Event|1|||
145516734|NCT00362180|524752344|FG006|Treated Period|Adverse Event|0|||
145516735|NCT00362180|524752345|FG007|Treated Period|Adverse Event|1|||
145516736|NCT00362180|524752346|FG008|Treated Period|Adverse Event|0|||
145516737|NCT01106092|524752347|FG000|Overall Study|Withdrawal by Subject|0|||
145516738|NCT01106092|524752348|FG001|Overall Study|Withdrawal by Subject|0|||
145516739|NCT01106092|524752349|FG002|Overall Study|Withdrawal by Subject|0|||
145516740|NCT01106092|524752350|FG003|Overall Study|Withdrawal by Subject|1|||
145516741|NCT02434471|524752355|FG000|Overall Study|Physician Decision|9|||
145516742|NCT04839562|524752360|FG000|Overall Study|Withdrawal by Subject|0|||
145516743|NCT04839562|524752361|FG001|Overall Study|Withdrawal by Subject|1|||
145516744|NCT04839562|524752360|FG000|Overall Study|Physician Decision|0|||
145735255|NCT04252287|525548476|FG000|Overall Study|Withdrawal by Subject|19|||
145735256|NCT04252287|525548477|FG001|Overall Study|Withdrawal by Subject|16|||
145735257|NCT04252287|525548476|FG000|Overall Study|Protocol Violation|3|||
145735258|NCT04252287|525548477|FG001|Overall Study|Protocol Violation|4|||
145735259|NCT01791803|525548479|FG000|Overall Study|Withdrawal by Subject|0|||
145735260|NCT01791803|525548480|FG001|Overall Study|Withdrawal by Subject|0|||
145735261|NCT01791803|525548481|FG002|Overall Study|Withdrawal by Subject|0|||
145735262|NCT01791803|525548482|FG003|Overall Study|Withdrawal by Subject|2|||
145735263|NCT01791803|525548479|FG000|Overall Study|Physician Decision|0|||
145735264|NCT01791803|525548480|FG001|Overall Study|Physician Decision|2|||
145735265|NCT01791803|525548481|FG002|Overall Study|Physician Decision|0|||
145735266|NCT01791803|525548482|FG003|Overall Study|Physician Decision|1|||
145735267|NCT01791803|525548479|FG000|Overall Study|Death|0|||
145735268|NCT01791803|525548480|FG001|Overall Study|Death|0|||
145516745|NCT04839562|524752361|FG001|Overall Study|Physician Decision|1|||
145516746|NCT00003472|524752367|FG000|Overall Study|Not evaluable|3|||
145516747|NCT01012219|524752368|FG000|Period 1|Withdrawal by Subject|1|||
145516748|NCT01012219|524752368|FG000|Period 2|Withdrawal by Subject|1|||
145516749|NCT01444092|524752373|FG000|Overall Study|Adverse Event|8|||
145516750|NCT01444092|524752373|FG000|Overall Study|Protocol Violation|1|||
145516751|NCT01444092|524752373|FG000|Overall Study|Withdrawal by Subject|1|||
145516752|NCT01444092|524752373|FG000|Overall Study|Other Eligibility criteria|7|||
145516753|NCT01328366|524752376|FG000|Overall Study|Death|1|||
145516754|NCT01328366|524752376|FG000|Overall Study|Withdrawal by Subject|2|||
145516755|NCT01328366|524752376|FG000|Overall Study|Lost to Follow-up|7|||
145516756|NCT00910624|524752377|FG000|Treatment Phase|Adverse Event|2|||
145516757|NCT00910624|524752378|FG001|Treatment Phase|Adverse Event|6|||
145516758|NCT00910624|524752379|FG002|Treatment Phase|Adverse Event|6|||
145516759|NCT00910624|524752380|FG003|Treatment Phase|Adverse Event|0|||
145516760|NCT00910624|524752377|FG000|Treatment Phase|Treatment Failure|23|||
145516761|NCT00910624|524752378|FG001|Treatment Phase|Treatment Failure|10|||
145516762|NCT00910624|524752379|FG002|Treatment Phase|Treatment Failure|0|||
145516763|NCT00910624|524752380|FG003|Treatment Phase|Treatment Failure|0|||
145516764|NCT00910624|524752377|FG000|Treatment Phase|Lost to Follow-up|0|||
145516765|NCT00910624|524752378|FG001|Treatment Phase|Lost to Follow-up|0|||
145516766|NCT00910624|524752379|FG002|Treatment Phase|Lost to Follow-up|1|||
145516767|NCT00910624|524752380|FG003|Treatment Phase|Lost to Follow-up|0|||
145516768|NCT00910624|524752377|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
145516769|NCT00910624|524752378|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
145516770|NCT00910624|524752379|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
145516771|NCT00910624|524752380|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
145516772|NCT00910624|524752377|FG000|Treatment Phase|Withdrawal by Subject|2|||
145516773|NCT00910624|524752378|FG001|Treatment Phase|Withdrawal by Subject|1|||
145516774|NCT00910624|524752379|FG002|Treatment Phase|Withdrawal by Subject|0|||
145516775|NCT00910624|524752380|FG003|Treatment Phase|Withdrawal by Subject|0|||
145606807|NCT02392611|525076894|FG005|Overall Study|Enrolled, not treated|0|||
145606808|NCT02392611|525076895|FG006|Overall Study|Enrolled, not treated|0|||
145606809|NCT02392611|525076896|FG007|Overall Study|Enrolled, not treated|0|||
145606810|NCT02392611|525076897|FG008|Overall Study|Enrolled, not treated|0|||
145606811|NCT00369681|525076899|FG000|Overall Study|Death|1|||
145606812|NCT02991482|525076901|FG000|Overall Study|Disease progression|56|||
145606813|NCT02991482|525076902|FG001|Overall Study|Disease progression|47|||
145606814|NCT02991482|525076901|FG000|Overall Study|Death|4|||
145606815|NCT02991482|525076902|FG001|Overall Study|Death|4|||
145606816|NCT02991482|525076901|FG000|Overall Study|Adverse Event|1|||
145606817|NCT02991482|525076902|FG001|Overall Study|Adverse Event|6|||
145606818|NCT02991482|525076901|FG000|Overall Study|Patient decision|1|||
145606819|NCT02991482|525076902|FG001|Overall Study|Patient decision|1|||
145606820|NCT02991482|525076901|FG000|Overall Study|Physician Decision|0|||
145606821|NCT02991482|525076902|FG001|Overall Study|Physician Decision|6|||
145606822|NCT02991482|525076901|FG000|Overall Study|Clinical deterioration|1|||
145606823|NCT02991482|525076902|FG001|Overall Study|Clinical deterioration|0|||
145606824|NCT02991482|525076901|FG000|Overall Study|Patient feeling too unwell|1|||
145606825|NCT02991482|525076902|FG001|Overall Study|Patient feeling too unwell|0|||
145606826|NCT02991482|525076901|FG000|Overall Study|Worsening of performance status|0|||
145606827|NCT02991482|525076902|FG001|Overall Study|Worsening of performance status|1|||
145606828|NCT02991482|525076901|FG000|Overall Study|Death prior to study drug initiation|1|||
145606829|NCT02991482|525076902|FG001|Overall Study|Death prior to study drug initiation|0|||
145606830|NCT02991482|525076901|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
145606831|NCT02991482|525076902|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
145606832|NCT01250119|525076905|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
145606833|NCT01250119|525076906|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
145606834|NCT01250119|525076905|FG000|Diagnostic Phase|Participants Not Tested|44|||
145606835|NCT01250119|525076906|FG001|Diagnostic Phase|Participants Not Tested|0|||
145606836|NCT01250119|525076905|FG000|Treatment Phase|Progressive Disease|0|||
145606837|NCT01250119|525076906|FG001|Treatment Phase|Progressive Disease|32|||
145606838|NCT01250119|525076905|FG000|Treatment Phase|Death|0|||
145606839|NCT01250119|525076906|FG001|Treatment Phase|Death|2|||
145606840|NCT01250119|525076905|FG000|Treatment Phase|Withdrawal by Subject|0|||
145606841|NCT01250119|525076906|FG001|Treatment Phase|Withdrawal by Subject|1|||
145606842|NCT01250119|525076905|FG000|Treatment Phase|Adverse Event|0|||
145606843|NCT01250119|525076906|FG001|Treatment Phase|Adverse Event|2|||
145268993|NCT01058707|523832723|FG004|Overall Study|Subject Decision|2|||
145606844|NCT01250119|525076905|FG000|Treatment Phase|Unknown reason|0|||
145606845|NCT01250119|525076906|FG001|Treatment Phase|Unknown reason|4|||
145606846|NCT02887989|525076910|FG000|Overall Study|Withdrawal by Subject|8|||
145268994|NCT01058707|523832724|FG005|Overall Study|Subject Decision|3|||
145268995|NCT01058707|523832725|FG006|Overall Study|Subject Decision|6|||
145268996|NCT01058707|523832719|FG000|Overall Study|Lost to Follow-up|0|||
145268997|NCT01058707|523832720|FG001|Overall Study|Lost to Follow-up|0|||
145268998|NCT01058707|523832721|FG002|Overall Study|Lost to Follow-up|1|||
145268999|NCT01058707|523832722|FG003|Overall Study|Lost to Follow-up|0|||
145269000|NCT01058707|523832723|FG004|Overall Study|Lost to Follow-up|0|||
145269001|NCT01058707|523832724|FG005|Overall Study|Lost to Follow-up|0|||
145516776|NCT00910624|524752377|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
145516777|NCT00910624|524752378|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
145516778|NCT00910624|524752379|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
145516779|NCT00910624|524752380|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
145516780|NCT00910624|524752377|FG000|Follow-Up Phase|Adverse Event|0|||
145516781|NCT00910624|524752378|FG001|Follow-Up Phase|Adverse Event|0|||
145516782|NCT00910624|524752379|FG002|Follow-Up Phase|Adverse Event|1|||
145516783|NCT00910624|524752380|FG003|Follow-Up Phase|Adverse Event|0|||
145735269|NCT01791803|525548481|FG002|Overall Study|Death|2|||
145735270|NCT01791803|525548482|FG003|Overall Study|Death|2|||
145735271|NCT04572854|525548483|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
145735272|NCT04572854|525548484|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
145735273|NCT04572854|525548485|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
145735274|NCT04572854|525548486|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
145735275|NCT04572854|525548483|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
145735276|NCT04572854|525548484|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
145735277|NCT04572854|525548485|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
145735278|NCT04572854|525548486|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
145735279|NCT00972777|525548487|FG000|Overall Study|Adverse Event|3|||
145735280|NCT00972777|525548488|FG001|Overall Study|Adverse Event|2|||
145735281|NCT00972777|525548487|FG000|Overall Study|Lost to Follow-up|0|||
145735282|NCT00972777|525548488|FG001|Overall Study|Lost to Follow-up|4|||
145735283|NCT00972777|525548487|FG000|Overall Study|Withdrawal by Subject|4|||
145735284|NCT00972777|525548488|FG001|Overall Study|Withdrawal by Subject|5|||
145735285|NCT00972777|525548487|FG000|Overall Study|Physician Decision|4|||
145735286|NCT00972777|525548488|FG001|Overall Study|Physician Decision|0|||
145735287|NCT00972777|525548487|FG000|Overall Study|Protocol Violation|0|||
145735288|NCT00972777|525548488|FG001|Overall Study|Protocol Violation|2|||
145735289|NCT00972777|525548487|FG000|Overall Study|Screening Failure|2|||
145735290|NCT00972777|525548488|FG001|Overall Study|Screening Failure|1|||
145735291|NCT00972777|525548487|FG000|Overall Study|Missed visit|1|||
145735292|NCT00972777|525548488|FG001|Overall Study|Missed visit|0|||
145735293|NCT01093326|525548489|FG000|Overall Study|Death|0|||
145735294|NCT01093326|525548490|FG001|Overall Study|Death|1|||
145735295|NCT01093326|525548491|FG002|Overall Study|Death|0|||
145735296|NCT01093326|525548489|FG000|Overall Study|Lack of Efficacy|7|||
145735297|NCT01093326|525548490|FG001|Overall Study|Lack of Efficacy|6|||
145735298|NCT01093326|525548491|FG002|Overall Study|Lack of Efficacy|3|||
145735299|NCT01093326|525548489|FG000|Overall Study|Lost to Follow-up|2|||
145735300|NCT01093326|525548490|FG001|Overall Study|Lost to Follow-up|5|||
145735301|NCT01093326|525548491|FG002|Overall Study|Lost to Follow-up|4|||
145735302|NCT01093326|525548489|FG000|Overall Study|Physician Decision|3|||
145735303|NCT01093326|525548490|FG001|Overall Study|Physician Decision|1|||
145735304|NCT01093326|525548491|FG002|Overall Study|Physician Decision|3|||
145735305|NCT01093326|525548489|FG000|Overall Study|Withdrawal by Subject|30|||
145735306|NCT01093326|525548490|FG001|Overall Study|Withdrawal by Subject|27|||
145735307|NCT01093326|525548491|FG002|Overall Study|Withdrawal by Subject|26|||
145735308|NCT01093326|525548489|FG000|Overall Study|Adverse Event|2|||
145735309|NCT01093326|525548490|FG001|Overall Study|Adverse Event|1|||
145735310|NCT01093326|525548491|FG002|Overall Study|Adverse Event|4|||
145735311|NCT01093326|525548489|FG000|Overall Study|Other|0|||
145735312|NCT01093326|525548490|FG001|Overall Study|Other|0|||
145735313|NCT01093326|525548491|FG002|Overall Study|Other|1|||
145735314|NCT04223791|525548492|FG000|Overall Study|Lost to Follow-up|0|||
145735315|NCT04223791|525548493|FG001|Overall Study|Lost to Follow-up|4|||
145735316|NCT04223791|525548492|FG000|Overall Study|Physician Decision|5|||
145735317|NCT04223791|525548493|FG001|Overall Study|Physician Decision|1|||
145735318|NCT04223791|525548492|FG000|Overall Study|Protocol Violation|1|||
145735319|NCT04223791|525548493|FG001|Overall Study|Protocol Violation|1|||
145735320|NCT04223791|525548492|FG000|Overall Study|Withdrawal by Subject|10|||
145735321|NCT04223791|525548493|FG001|Overall Study|Withdrawal by Subject|12|||
145269002|NCT01058707|523832725|FG006|Overall Study|Lost to Follow-up|0|||
145516784|NCT00910624|524752377|FG000|Follow-Up Phase|Lost to Follow-up|3|||
145735322|NCT04223791|525548492|FG000|Overall Study|Pregnancy|1|||
145735323|NCT04223791|525548493|FG001|Overall Study|Pregnancy|1|||
145735324|NCT04223791|525548492|FG000|Overall Study|Ongoing in Study|305|||
145735325|NCT04223791|525548493|FG001|Overall Study|Ongoing in Study|302|||
145735326|NCT02246582|525550161|FG000|Overall Study|Withdrawal by Subject|3|||
145269003|NCT01058707|523832719|FG000|Overall Study|Reason Not Specified|0|||
145269004|NCT01058707|523832720|FG001|Overall Study|Reason Not Specified|3|||
145735327|NCT02246582|525550162|FG001|Overall Study|Withdrawal by Subject|4|||
145735328|NCT02060383|525550166|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
145735329|NCT02060383|525550167|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
145735330|NCT02060383|525550168|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
145735331|NCT02060383|525550169|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
145735332|NCT02060383|525550170|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
145735333|NCT02060383|525550166|FG000|Core Phase|Adverse Event|2|||
145735334|NCT02060383|525550167|FG001|Core Phase|Adverse Event|0|||
145735335|NCT02060383|525550168|FG002|Core Phase|Adverse Event|0|||
145735336|NCT02060383|525550169|FG003|Core Phase|Adverse Event|2|||
145735337|NCT02060383|525550170|FG004|Core Phase|Adverse Event|6|||
145735338|NCT02060383|525550166|FG000|Core Phase|Administrative problems|0|||
145735339|NCT02060383|525550167|FG001|Core Phase|Administrative problems|1|||
145735340|NCT02060383|525550168|FG002|Core Phase|Administrative problems|0|||
145735341|NCT02060383|525550169|FG003|Core Phase|Administrative problems|0|||
145735342|NCT02060383|525550170|FG004|Core Phase|Administrative problems|0|||
145735343|NCT02060383|525550166|FG000|Core Phase|Protocol Violation|0|||
145735344|NCT02060383|525550167|FG001|Core Phase|Protocol Violation|0|||
145735345|NCT02060383|525550168|FG002|Core Phase|Protocol Violation|0|||
145735346|NCT02060383|525550169|FG003|Core Phase|Protocol Violation|1|||
145735347|NCT02060383|525550170|FG004|Core Phase|Protocol Violation|0|||
145735348|NCT02060383|525550166|FG000|Core Phase|Withdrawal by Subject|0|||
145735349|NCT02060383|525550167|FG001|Core Phase|Withdrawal by Subject|0|||
145735350|NCT02060383|525550168|FG002|Core Phase|Withdrawal by Subject|0|||
145735351|NCT02060383|525550169|FG003|Core Phase|Withdrawal by Subject|4|||
145735352|NCT02060383|525550170|FG004|Core Phase|Withdrawal by Subject|2|||
145735353|NCT02060383|525550166|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
145735354|NCT02060383|525550167|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
145735355|NCT02060383|525550168|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
145735356|NCT02060383|525550169|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
145735357|NCT02060383|525550170|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
145735358|NCT02060383|525550166|FG000|Extension Phase|Adverse Event|1|||
145735359|NCT02060383|525550167|FG001|Extension Phase|Adverse Event|1|||
145735360|NCT02060383|525550168|FG002|Extension Phase|Adverse Event|2|||
145735361|NCT02060383|525550169|FG003|Extension Phase|Adverse Event|0|||
145735362|NCT02060383|525550170|FG004|Extension Phase|Adverse Event|1|||
145735363|NCT02060383|525550166|FG000|Extension Phase|Withdrawal by Subject|0|||
145735364|NCT02060383|525550167|FG001|Extension Phase|Withdrawal by Subject|1|||
145735365|NCT02060383|525550168|FG002|Extension Phase|Withdrawal by Subject|0|||
145606847|NCT02887989|525076911|FG001|Overall Study|Withdrawal by Subject|11|||
145606848|NCT02887989|525076910|FG000|Overall Study|Death|1|||
145606849|NCT02887989|525076911|FG001|Overall Study|Death|0|||
145606850|NCT02045433|525076917|FG000|Overall Study|Withdrawal by Subject|1|||
145606851|NCT01559454|525076918|FG000|Overall Study|Lost to Follow-up|3|||
145606852|NCT01559454|525076919|FG001|Overall Study|Lost to Follow-up|2|||
145606853|NCT01559454|525076918|FG000|Overall Study|Withdrawal by Subject|0|||
145606854|NCT01559454|525076919|FG001|Overall Study|Withdrawal by Subject|1|||
145606855|NCT01559454|525076918|FG000|Overall Study|Physician Decision|0|||
145606856|NCT01559454|525076919|FG001|Overall Study|Physician Decision|1|||
145606857|NCT01559454|525076918|FG000|Overall Study|Protocol Violation|0|||
145606858|NCT01559454|525076919|FG001|Overall Study|Protocol Violation|1|||
145606859|NCT01559454|525076918|FG000|Overall Study|Lack of Efficacy|0|||
145606860|NCT01559454|525076919|FG001|Overall Study|Lack of Efficacy|1|||
145606861|NCT02207725|525076920|FG000|Overall Study|Did Not Receive Treatment|0|||
145606862|NCT02207725|525076921|FG001|Overall Study|Did Not Receive Treatment|1|||
145606863|NCT02207725|525076922|FG002|Overall Study|Did Not Receive Treatment|1|||
145606864|NCT02207725|525076923|FG003|Overall Study|Did Not Receive Treatment|1|||
145606865|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
145606866|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
145606867|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Adverse Event|2|||
145606868|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Adverse Event|5|||
145606869|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
145606870|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
145606871|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
145606872|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
145606873|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Randomized by error|0|||
145606874|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Randomized by error|5|||
145606875|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
145606876|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
145606877|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
145606878|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
145606879|NCT02948959|525076925|FG000|52 Weeks Treatment Period|Change of residence location|0|||
145606880|NCT02948959|525076926|FG001|52 Weeks Treatment Period|Change of residence location|1|||
145735366|NCT02060383|525550169|FG003|Extension Phase|Withdrawal by Subject|0|||
145606881|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
145735367|NCT02060383|525550170|FG004|Extension Phase|Withdrawal by Subject|2|||
145735368|NCT02060383|525550166|FG000|Extension Phase|Administrative problems|1|||
145735369|NCT02060383|525550167|FG001|Extension Phase|Administrative problems|0|||
145735370|NCT02060383|525550168|FG002|Extension Phase|Administrative problems|0|||
145735371|NCT02060383|525550169|FG003|Extension Phase|Administrative problems|0|||
145735372|NCT02060383|525550170|FG004|Extension Phase|Administrative problems|0|||
145735373|NCT02060383|525550166|FG000|Extension Phase|Death|0|||
145735374|NCT02060383|525550167|FG001|Extension Phase|Death|0|||
145735375|NCT02060383|525550168|FG002|Extension Phase|Death|1|||
145735376|NCT02060383|525550169|FG003|Extension Phase|Death|0|||
145735377|NCT02060383|525550170|FG004|Extension Phase|Death|1|||
145735378|NCT02060383|525550166|FG000|Extension Phase|Protocol Violation|0|||
145735379|NCT02060383|525550167|FG001|Extension Phase|Protocol Violation|0|||
145735380|NCT02060383|525550168|FG002|Extension Phase|Protocol Violation|0|||
145735381|NCT02060383|525550169|FG003|Extension Phase|Protocol Violation|0|||
145735382|NCT02060383|525550170|FG004|Extension Phase|Protocol Violation|1|||
145735383|NCT03441334|525550171|FG000|Overall Study|Withdrawal by Subject|1|||
145735384|NCT03441334|525550172|FG001|Overall Study|Withdrawal by Subject|0|||
145735385|NCT00395863|525550179|FG000|Overall Study|Patients did not complete both exams|2|||
145735386|NCT00395863|525550180|FG001|Overall Study|Patients did not complete both exams|3|||
145735387|NCT02592551|525550181|FG000|Overall Study|Not evaluable|1|||
145735388|NCT02592551|525550182|FG001|Overall Study|Not evaluable|3|||
145735389|NCT02592551|525550183|FG002|Overall Study|Not evaluable|0|||
145735390|NCT01876251|525550186|FG000|Overall Study|Clinical progression|1|||
145735391|NCT01876251|525550187|FG001|Overall Study|Clinical progression|0|||
145735392|NCT01876251|525550188|FG002|Overall Study|Clinical progression|0|||
145735393|NCT01876251|525550186|FG000|Overall Study|Death|2|||
145735394|NCT01876251|525550187|FG001|Overall Study|Death|0|||
145735395|NCT01876251|525550188|FG002|Overall Study|Death|1|||
145735396|NCT01876251|525550186|FG000|Overall Study|Participant started new treatment|1|||
145735397|NCT01876251|525550187|FG001|Overall Study|Participant started new treatment|0|||
145735398|NCT01876251|525550188|FG002|Overall Study|Participant started new treatment|1|||
145735399|NCT01876251|525550186|FG000|Overall Study|Participant refused further follow-up|0|||
145735400|NCT01876251|525550187|FG001|Overall Study|Participant refused further follow-up|0|||
145735401|NCT01876251|525550188|FG002|Overall Study|Participant refused further follow-up|1|||
145735402|NCT01876251|525550186|FG000|Overall Study|Study terminated|1|||
145735403|NCT01876251|525550187|FG001|Overall Study|Study terminated|0|||
145735404|NCT01876251|525550188|FG002|Overall Study|Study terminated|0|||
145735405|NCT01876251|525550186|FG000|Overall Study|Objective progression or relapse|10|||
145735406|NCT01876251|525550187|FG001|Overall Study|Objective progression or relapse|3|||
145735407|NCT01876251|525550188|FG002|Overall Study|Objective progression or relapse|8|||
145735408|NCT02460497|525550193|FG000|Overall Study|Participant Requested Withdrawal|4|||
145735409|NCT02460497|525550193|FG000|Overall Study|Non-Compliance|1|||
145735410|NCT02460497|525550193|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
145735411|NCT02460497|525550193|FG000|Overall Study|Lost to Follow-up|2|||
145606882|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
145606883|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
145606884|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
145606885|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
145606886|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
145606887|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
145606888|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
145606889|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
145606890|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
145606891|NCT02948959|525076925|FG000|12 Weeks Follow-up Period|Study site closure|1|||
145606892|NCT02948959|525076926|FG001|12 Weeks Follow-up Period|Study site closure|0|||
145606893|NCT00597714|525076927|FG000|Overall Study|Death|56|||
145606894|NCT00597714|525076928|FG001|Overall Study|Death|46|||
145606895|NCT00597714|525076929|FG002|Overall Study|Death|0|||
145606896|NCT00597714|525076927|FG000|Overall Study|Recipient death|0|||
145606897|NCT00597714|525076928|FG001|Overall Study|Recipient death|0|||
145735412|NCT02460497|525550193|FG000|Overall Study|Investigator Decision|1|||
145402249|NCT00761319|524330685|FG000|Overall Study|Withdrawal by Subject|8|||
145402250|NCT00761319|524330686|FG001|Overall Study|Withdrawal by Subject|7|||
145606898|NCT00597714|525076929|FG002|Overall Study|Recipient death|10|||
145606899|NCT01350141|525076930|FG000|Overall Study|Lost to Follow-up|1|||
145606900|NCT01350141|525076931|FG001|Overall Study|Lost to Follow-up|0|||
145606901|NCT01350141|525076932|FG002|Overall Study|Lost to Follow-up|1|||
145606902|NCT01350141|525076930|FG000|Overall Study|Withdrawal by Subject|1|||
145606903|NCT01350141|525076931|FG001|Overall Study|Withdrawal by Subject|0|||
145735413|NCT01650285|525550198|FG000|Overall Study|Adverse Event|1|||
145735414|NCT00659529|525550199|FG000|Overall Study|Withdrawal by Subject|4|||
145735415|NCT00659529|525550199|FG000|Overall Study|Protocol Violation|3|||
145735416|NCT00659529|525550199|FG000|Overall Study|Screen failure|9|||
145735417|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
145606904|NCT01350141|525076932|FG002|Overall Study|Withdrawal by Subject|0|||
145606905|NCT01350141|525076930|FG000|Overall Study|Randomized but not treated|1|||
145606906|NCT01350141|525076931|FG001|Overall Study|Randomized but not treated|0|||
145606907|NCT01350141|525076932|FG002|Overall Study|Randomized but not treated|0|||
145606908|NCT00810082|525076933|FG000|Overall Study|Lost to Follow-up|0|||
145606909|NCT00810082|525076934|FG001|Overall Study|Lost to Follow-up|4|||
145606910|NCT01588990|525076935|FG000|Phase A|Withdrawal by Subject|5|||
145606911|NCT01588990|525076935|FG000|Phase A|Physician Decision|11|||
145606912|NCT01588990|525076935|FG000|Phase A|Other|14|||
145606913|NCT01588990|525076935|FG000|Phase A|Lost to Follow-up|1|||
145606914|NCT01588990|525076935|FG000|Phase A|Death|5|||
145606915|NCT01588990|525076935|FG000|Phase A|Adverse Event|28|||
145606916|NCT01588990|525076935|FG000|Phase A|Still on therapy at end of study|6|||
145606917|NCT01588990|525076935|FG000|Phase B|Adverse Event|2|||
145606918|NCT01588990|525076935|FG000|Phase B|Still on therapy at end of study|5|||
145606919|NCT01588990|525076935|FG000|Phase B|Withdrawal by Subject|3|||
145606920|NCT01588990|525076935|FG000|Phase B|Physician Decision|4|||
145606921|NCT01588990|525076935|FG000|Phase B|Other|2|||
145606922|NCT02367716|525076936|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
145606923|NCT02341456|525076937|FG000|Overall Study|Disease progression|2|||
145606924|NCT02341456|525076938|FG001|Overall Study|Disease progression|3|||
145606925|NCT02341456|525076939|FG002|Overall Study|Disease progression|1|||
145606926|NCT02341456|525076937|FG000|Overall Study|Death|1|||
145606927|NCT02341456|525076938|FG001|Overall Study|Death|1|||
145606928|NCT02341456|525076939|FG002|Overall Study|Death|1|||
145606929|NCT02341456|525076937|FG000|Overall Study|Withdrawal by Subject|0|||
145606930|NCT02341456|525076938|FG001|Overall Study|Withdrawal by Subject|1|||
145606931|NCT02341456|525076939|FG002|Overall Study|Withdrawal by Subject|1|||
145606932|NCT02341456|525076937|FG000|Overall Study|Moved to local access programme.|0|||
145606933|NCT02341456|525076938|FG001|Overall Study|Moved to local access programme.|1|||
145606934|NCT02341456|525076939|FG002|Overall Study|Moved to local access programme.|1|||
145606935|NCT02341456|525076937|FG000|Overall Study|Physician Decision|1|||
145606936|NCT02341456|525076938|FG001|Overall Study|Physician Decision|0|||
145606937|NCT02341456|525076939|FG002|Overall Study|Physician Decision|0|||
145606938|NCT02508532|525076942|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606939|NCT02508532|525076943|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606940|NCT02508532|525076944|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606941|NCT02508532|525076945|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606942|NCT02508532|525076946|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606943|NCT02508532|525076947|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606944|NCT02508532|525076948|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
145606945|NCT02508532|525076949|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606946|NCT02508532|525076950|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
145606947|NCT02508532|525076942|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606948|NCT02508532|525076943|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606949|NCT02508532|525076944|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606950|NCT02508532|525076945|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606951|NCT02508532|525076946|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606952|NCT02508532|525076947|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606953|NCT02508532|525076948|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606954|NCT02508532|525076949|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
145606955|NCT02508532|525076950|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
145606956|NCT02508532|525076942|FG000|Part 2 - Treatment|Disease Progression|0|||
145606957|NCT02508532|525076943|FG001|Part 2 - Treatment|Disease Progression|0|||
145606958|NCT02508532|525076944|FG002|Part 2 - Treatment|Disease Progression|0|||
145606959|NCT02508532|525076945|FG003|Part 2 - Treatment|Disease Progression|0|||
145606960|NCT02508532|525076946|FG004|Part 2 - Treatment|Disease Progression|0|||
145606961|NCT02508532|525076947|FG005|Part 2 - Treatment|Disease Progression|0|||
145606962|NCT02508532|525076948|FG006|Part 2 - Treatment|Disease Progression|0|||
145606963|NCT02508532|525076949|FG007|Part 2 - Treatment|Disease Progression|0|||
145606964|NCT02508532|525076950|FG008|Part 2 - Treatment|Disease Progression|118|||
145606965|NCT02508532|525076942|FG000|Part 2 - Treatment|Adverse Event|0|||
145606966|NCT02508532|525076943|FG001|Part 2 - Treatment|Adverse Event|0|||
145735418|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
145735419|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
145735420|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
145735421|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
145735422|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
145735423|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
145735424|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
145735425|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
145735426|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
145735427|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
145735428|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
145735429|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
145516785|NCT00910624|524752378|FG001|Follow-Up Phase|Lost to Follow-up|1|||
145516786|NCT00910624|524752379|FG002|Follow-Up Phase|Lost to Follow-up|2|||
145516787|NCT00910624|524752380|FG003|Follow-Up Phase|Lost to Follow-up|0|||
145516788|NCT00910624|524752377|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
145516789|NCT00910624|524752378|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
145516790|NCT00910624|524752379|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
145516791|NCT00910624|524752380|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
145516792|NCT00910624|524752377|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
145516793|NCT00910624|524752378|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
145516794|NCT00910624|524752379|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
145516795|NCT00910624|524752380|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
145516796|NCT00910624|524752377|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
145516797|NCT00910624|524752378|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
145516798|NCT00910624|524752379|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
145516799|NCT00910624|524752380|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
145516800|NCT00910624|524752377|FG000|Follow-Up Phase|Administrative|0|||
145516801|NCT00910624|524752378|FG001|Follow-Up Phase|Administrative|1|||
145516802|NCT00910624|524752379|FG002|Follow-Up Phase|Administrative|1|||
145516803|NCT00910624|524752380|FG003|Follow-Up Phase|Administrative|0|||
145516804|NCT01122264|524752381|FG000|Overall Study|Adverse Event|6|||
145516805|NCT01122264|524752382|FG001|Overall Study|Adverse Event|5|||
145516806|NCT01122264|524752383|FG002|Overall Study|Adverse Event|7|||
145516807|NCT01122264|524752381|FG000|Overall Study|Death|1|||
145516808|NCT01122264|524752382|FG001|Overall Study|Death|0|||
145516809|NCT01122264|524752383|FG002|Overall Study|Death|0|||
145516810|NCT01122264|524752381|FG000|Overall Study|Lost to Follow-up|5|||
145516811|NCT01122264|524752382|FG001|Overall Study|Lost to Follow-up|9|||
145516812|NCT01122264|524752383|FG002|Overall Study|Lost to Follow-up|13|||
145516813|NCT01122264|524752381|FG000|Overall Study|Entry Criteria Not Met|1|||
145516814|NCT01122264|524752382|FG001|Overall Study|Entry Criteria Not Met|0|||
145516815|NCT01122264|524752383|FG002|Overall Study|Entry Criteria Not Met|0|||
145516816|NCT01122264|524752381|FG000|Overall Study|Protocol Violation|7|||
145516817|NCT01122264|524752382|FG001|Overall Study|Protocol Violation|7|||
145516818|NCT01122264|524752383|FG002|Overall Study|Protocol Violation|9|||
145516819|NCT01122264|524752381|FG000|Overall Study|Withdrawal by Subject|6|||
145516820|NCT01122264|524752382|FG001|Overall Study|Withdrawal by Subject|6|||
145516821|NCT01122264|524752383|FG002|Overall Study|Withdrawal by Subject|16|||
145516822|NCT01122264|524752381|FG000|Overall Study|Physician Decision|3|||
145516823|NCT01122264|524752382|FG001|Overall Study|Physician Decision|1|||
145516824|NCT01122264|524752383|FG002|Overall Study|Physician Decision|1|||
145516825|NCT01122264|524752381|FG000|Overall Study|Lack of Efficacy|3|||
145516826|NCT01122264|524752382|FG001|Overall Study|Lack of Efficacy|1|||
145516827|NCT01122264|524752383|FG002|Overall Study|Lack of Efficacy|1|||
145516828|NCT03005873|524752384|FG000|Overall Study|Prohibited medication use post radnomization|1|||
145516829|NCT03005873|524752385|FG001|Overall Study|Prohibited medication use post radnomization|1|||
145516830|NCT03005873|524752386|FG002|Overall Study|Prohibited medication use post radnomization|1|||
145516831|NCT03005873|524752384|FG000|Overall Study|Withdrew consent|0|||
145516832|NCT03005873|524752385|FG001|Overall Study|Withdrew consent|1|||
145516833|NCT03005873|524752386|FG002|Overall Study|Withdrew consent|2|||
145516834|NCT03005873|524752384|FG000|Overall Study|Lost to Follow-up|0|||
145516835|NCT03005873|524752385|FG001|Overall Study|Lost to Follow-up|1|||
145516836|NCT03005873|524752386|FG002|Overall Study|Lost to Follow-up|0|||
145516837|NCT03005873|524752384|FG000|Overall Study|Ineligible post randomization|0|||
145516838|NCT03005873|524752385|FG001|Overall Study|Ineligible post randomization|0|||
145516839|NCT03005873|524752386|FG002|Overall Study|Ineligible post randomization|1|||
145516840|NCT04585009|524752395|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
145735430|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
145516841|NCT04585009|524752396|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516842|NCT04585009|524752397|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516843|NCT04585009|524752398|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516844|NCT04585009|524752399|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145735431|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
145735432|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
145735433|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
145735434|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
145735435|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
145735436|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
145735437|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
145735438|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
145735439|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
145735440|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
145735441|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
145735442|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
145735443|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
145735444|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
145735445|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
145735446|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
145735447|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
145735448|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
145735449|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
145735450|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
145735451|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
145735452|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
145735453|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
145735454|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
145735455|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
145735456|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
145735457|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
145735458|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
145735459|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
145735460|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
145735461|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
145735462|NCT03627767|525550203|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
145735463|NCT03627767|525550204|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
145735464|NCT03627767|525550205|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
145735465|NCT03627767|525550206|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
145735466|NCT03627767|525550207|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
145735467|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
145735468|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
145735469|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
145735470|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
145735471|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
145735472|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145735473|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145735474|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
145735475|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
145735476|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145735477|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
145735478|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
145735479|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
145735480|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
145735481|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
145735482|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
145735483|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
145735484|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
145735485|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
145735486|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
145735487|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
145735488|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
145402251|NCT00761319|524330685|FG000|Overall Study|Noncompliance|4|||
145516845|NCT04585009|524752400|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145606967|NCT02508532|525076944|FG002|Part 2 - Treatment|Adverse Event|0|||
145735489|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
145735490|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
145735491|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
145735492|NCT03627767|525550203|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
145735493|NCT03627767|525550204|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
145735494|NCT03627767|525550205|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
145735495|NCT03627767|525550206|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
145735496|NCT03627767|525550207|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
145735497|NCT03627767|525550203|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
145735498|NCT03627767|525550204|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
145735499|NCT03627767|525550205|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
145735500|NCT03627767|525550206|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
145735501|NCT03627767|525550207|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
145735502|NCT03627767|525550203|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
145735503|NCT03627767|525550204|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
145735504|NCT03627767|525550205|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
145606968|NCT02508532|525076945|FG003|Part 2 - Treatment|Adverse Event|0|||
145606969|NCT02508532|525076946|FG004|Part 2 - Treatment|Adverse Event|0|||
145606970|NCT02508532|525076947|FG005|Part 2 - Treatment|Adverse Event|0|||
145606971|NCT02508532|525076948|FG006|Part 2 - Treatment|Adverse Event|0|||
145606972|NCT02508532|525076949|FG007|Part 2 - Treatment|Adverse Event|0|||
145606973|NCT02508532|525076950|FG008|Part 2 - Treatment|Adverse Event|49|||
145606974|NCT02508532|525076942|FG000|Part 2 - Treatment|Physician Decision|0|||
145606975|NCT02508532|525076943|FG001|Part 2 - Treatment|Physician Decision|0|||
145606976|NCT02508532|525076944|FG002|Part 2 - Treatment|Physician Decision|0|||
145606977|NCT02508532|525076945|FG003|Part 2 - Treatment|Physician Decision|0|||
145606978|NCT02508532|525076946|FG004|Part 2 - Treatment|Physician Decision|0|||
145606979|NCT02508532|525076947|FG005|Part 2 - Treatment|Physician Decision|0|||
145606980|NCT02508532|525076948|FG006|Part 2 - Treatment|Physician Decision|0|||
145606981|NCT02508532|525076949|FG007|Part 2 - Treatment|Physician Decision|0|||
145606982|NCT02508532|525076950|FG008|Part 2 - Treatment|Physician Decision|12|||
145606983|NCT02508532|525076942|FG000|Part 2 - Treatment|Administrative|0|||
145606984|NCT02508532|525076943|FG001|Part 2 - Treatment|Administrative|0|||
145606985|NCT02508532|525076944|FG002|Part 2 - Treatment|Administrative|0|||
145606986|NCT02508532|525076945|FG003|Part 2 - Treatment|Administrative|0|||
145606987|NCT02508532|525076946|FG004|Part 2 - Treatment|Administrative|0|||
145606988|NCT02508532|525076947|FG005|Part 2 - Treatment|Administrative|0|||
145606989|NCT02508532|525076948|FG006|Part 2 - Treatment|Administrative|0|||
145606990|NCT02508532|525076949|FG007|Part 2 - Treatment|Administrative|0|||
145606991|NCT02508532|525076950|FG008|Part 2 - Treatment|Administrative|3|||
145606992|NCT02508532|525076942|FG000|Part 2 - Treatment|Sponsor Decision|0|||
145606993|NCT02508532|525076943|FG001|Part 2 - Treatment|Sponsor Decision|0|||
145606994|NCT02508532|525076944|FG002|Part 2 - Treatment|Sponsor Decision|0|||
145606995|NCT02508532|525076945|FG003|Part 2 - Treatment|Sponsor Decision|0|||
145606996|NCT02508532|525076946|FG004|Part 2 - Treatment|Sponsor Decision|0|||
145606997|NCT02508532|525076947|FG005|Part 2 - Treatment|Sponsor Decision|0|||
145606998|NCT02508532|525076948|FG006|Part 2 - Treatment|Sponsor Decision|0|||
145606999|NCT02508532|525076949|FG007|Part 2 - Treatment|Sponsor Decision|0|||
145607000|NCT02508532|525076950|FG008|Part 2 - Treatment|Sponsor Decision|28|||
145607001|NCT02508532|525076942|FG000|Part 2 - Treatment|Death|0|||
145607002|NCT02508532|525076943|FG001|Part 2 - Treatment|Death|0|||
145607003|NCT02508532|525076944|FG002|Part 2 - Treatment|Death|0|||
145607004|NCT02508532|525076945|FG003|Part 2 - Treatment|Death|0|||
145607005|NCT02508532|525076946|FG004|Part 2 - Treatment|Death|0|||
145607006|NCT02508532|525076947|FG005|Part 2 - Treatment|Death|0|||
145607007|NCT02508532|525076948|FG006|Part 2 - Treatment|Death|0|||
145607008|NCT02508532|525076949|FG007|Part 2 - Treatment|Death|0|||
145607009|NCT02508532|525076950|FG008|Part 2 - Treatment|Death|1|||
145607010|NCT02508532|525076942|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
145607011|NCT02508532|525076943|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
145607012|NCT02508532|525076944|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
145607013|NCT02508532|525076945|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
145607014|NCT02508532|525076946|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
145516846|NCT04585009|524752401|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145402252|NCT00761319|524330686|FG001|Overall Study|Noncompliance|3|||
145402253|NCT00761319|524330685|FG000|Overall Study|Lost to Follow-up|1|||
145402254|NCT00761319|524330686|FG001|Overall Study|Lost to Follow-up|1|||
145516847|NCT04585009|524752402|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516848|NCT04585009|524752403|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516849|NCT04585009|524752404|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145516850|NCT04585009|524752405|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145735505|NCT03627767|525550206|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
145735506|NCT03627767|525550207|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
145735507|NCT03627767|525550203|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
145735508|NCT03627767|525550204|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
145735509|NCT03627767|525550205|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
145735510|NCT03627767|525550206|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
145735511|NCT03627767|525550207|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
145735512|NCT03627767|525550203|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
145735513|NCT03627767|525550204|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
145735514|NCT03627767|525550205|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
145735515|NCT03627767|525550206|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
145735516|NCT03627767|525550207|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
145735517|NCT00907257|525550210|FG000|Overall Study|Adverse Event|0|||
145735518|NCT00907257|525550211|FG001|Overall Study|Adverse Event|4|||
145735519|NCT00907257|525550210|FG000|Overall Study|Protocol Violation|1|||
145735520|NCT00907257|525550211|FG001|Overall Study|Protocol Violation|2|||
145735521|NCT00907257|525550210|FG000|Overall Study|Lost to Follow-up|3|||
145735522|NCT00907257|525550211|FG001|Overall Study|Lost to Follow-up|3|||
145735523|NCT00907257|525550210|FG000|Overall Study|Withdrawal by Subject|1|||
145735524|NCT00907257|525550211|FG001|Overall Study|Withdrawal by Subject|2|||
145735525|NCT00907257|525550210|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
145735526|NCT00907257|525550211|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
145735527|NCT00907257|525550210|FG000|Overall Study|Moved|1|||
145735528|NCT00907257|525550211|FG001|Overall Study|Moved|0|||
145735529|NCT00907257|525550210|FG000|Overall Study|Personal Reasons|6|||
145735530|NCT00907257|525550211|FG001|Overall Study|Personal Reasons|1|||
145735531|NCT04163900|525550212|FG000|Overall Study|Radiological disease progression|112|||
145735532|NCT04163900|525550213|FG001|Overall Study|Radiological disease progression|127|||
145735533|NCT04163900|525550212|FG000|Overall Study|Study closure|98|||
145735534|NCT04163900|525550213|FG001|Overall Study|Study closure|133|||
145735535|NCT04163900|525550212|FG000|Overall Study|Adverse Event|78|||
145735536|NCT04163900|525550213|FG001|Overall Study|Adverse Event|32|||
145735537|NCT04163900|525550212|FG000|Overall Study|Withdrawal by Subject|37|||
145735538|NCT04163900|525550213|FG001|Overall Study|Withdrawal by Subject|34|||
145735539|NCT04163900|525550212|FG000|Overall Study|Death|29|||
145735540|NCT04163900|525550213|FG001|Overall Study|Death|16|||
145735541|NCT04163900|525550212|FG000|Overall Study|Physician Decision|17|||
145735542|NCT04163900|525550213|FG001|Overall Study|Physician Decision|25|||
145735543|NCT04163900|525550212|FG000|Overall Study|Clinical disease progression|14|||
145735544|NCT04163900|525550213|FG001|Overall Study|Clinical disease progression|13|||
145735545|NCT04163900|525550212|FG000|Overall Study|Protocol Violation|3|||
145735546|NCT04163900|525550213|FG001|Overall Study|Protocol Violation|4|||
145735547|NCT04163900|525550212|FG000|Overall Study|Lost to Follow-up|0|||
145735548|NCT04163900|525550213|FG001|Overall Study|Lost to Follow-up|1|||
145735549|NCT00283049|525550214|FG000|Overall Study|Adverse Event|6|||
145735550|NCT00283049|525550215|FG001|Overall Study|Adverse Event|1|||
145735551|NCT00283049|525550216|FG002|Overall Study|Adverse Event|4|||
145735552|NCT00283049|525550214|FG000|Overall Study|Protocol Violation|3|||
145735553|NCT00283049|525550215|FG001|Overall Study|Protocol Violation|0|||
145735554|NCT00283049|525550216|FG002|Overall Study|Protocol Violation|3|||
145735555|NCT00283049|525550214|FG000|Overall Study|Death|1|||
145735556|NCT00283049|525550215|FG001|Overall Study|Death|1|||
145735557|NCT00283049|525550216|FG002|Overall Study|Death|1|||
145735558|NCT00283049|525550214|FG000|Overall Study|Lack of Efficacy|0|||
145735559|NCT00283049|525550215|FG001|Overall Study|Lack of Efficacy|1|||
145735560|NCT00283049|525550216|FG002|Overall Study|Lack of Efficacy|1|||
145735561|NCT00283049|525550214|FG000|Overall Study|Lost to Follow-up|4|||
145735562|NCT00283049|525550215|FG001|Overall Study|Lost to Follow-up|2|||
145735563|NCT00283049|525550216|FG002|Overall Study|Lost to Follow-up|5|||
145735564|NCT00283049|525550214|FG000|Overall Study|Withdrawal by Subject|26|||
145735565|NCT00283049|525550215|FG001|Overall Study|Withdrawal by Subject|24|||
145735566|NCT00283049|525550216|FG002|Overall Study|Withdrawal by Subject|19|||
145735567|NCT00283049|525550214|FG000|Overall Study|Discontinuation of Study|18|||
145735568|NCT00283049|525550215|FG001|Overall Study|Discontinuation of Study|16|||
145607015|NCT02508532|525076947|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
145607016|NCT02508532|525076948|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
145607017|NCT02508532|525076949|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
145735569|NCT00283049|525550216|FG002|Overall Study|Discontinuation of Study|20|||
145735570|NCT00283049|525550214|FG000|Overall Study|No longer requires study treatment|0|||
145735571|NCT00283049|525550215|FG001|Overall Study|No longer requires study treatment|0|||
145735572|NCT00283049|525550216|FG002|Overall Study|No longer requires study treatment|1|||
145735573|NCT01873417|525550217|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
145735574|NCT01873417|525550217|FG000|Overall Study|Adverse Event|24|||
145735575|NCT01873417|525550217|FG000|Overall Study|Lost to Follow-up|2|||
145735576|NCT01873417|525550217|FG000|Overall Study|Withdrawal by Subject|2|||
145735577|NCT01873417|525550217|FG000|Overall Study|Physician Decision|3|||
145735578|NCT00785044|525550218|FG000|Overall Study|Dosed at non-participating sites|152|||
145735579|NCT00785044|525550218|FG000|Overall Study|Death|77|||
145735580|NCT00785044|525550218|FG000|Overall Study|Lost to Follow-up|266|||
145735581|NCT00785044|525550218|FG000|Overall Study|Withdrawal by Subject|1|||
145735582|NCT01628107|525550219|FG000|Overall Study|Withdrawal by Subject|17|||
145735583|NCT01628107|525550219|FG000|Overall Study|Lost to Follow-up|4|||
145735584|NCT01628107|525550219|FG000|Overall Study|Adverse Event|33|||
145735585|NCT01628107|525550219|FG000|Overall Study|Physician Decision|2|||
145735586|NCT01628107|525550219|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
145735587|NCT01628107|525550219|FG000|Overall Study|Non-compliant with Study Procedures|10|||
145735588|NCT01628107|525550219|FG000|Overall Study|Not Treated|8|||
145735589|NCT01628107|525550219|FG000|Overall Study|Sponsor Decision|11|||
145735590|NCT01628107|525550219|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
145735591|NCT01628107|525550219|FG000|Overall Study|Relocated|8|||
145735592|NCT01628107|525550219|FG000|Overall Study|Kidney Transplant|9|||
145735593|NCT01628107|525550219|FG000|Overall Study|Use of Standard of Care|9|||
145735594|NCT01086410|525550220|FG000|Overall Study|Adverse Event|1|||
145735595|NCT01086410|525550221|FG001|Overall Study|Adverse Event|0|||
145735596|NCT01086410|525550222|FG002|Overall Study|Adverse Event|0|||
145735597|NCT01086410|525550223|FG003|Overall Study|Adverse Event|2|||
145735598|NCT01086410|525550220|FG000|Overall Study|Lack of Efficacy|1|||
145735599|NCT01086410|525550221|FG001|Overall Study|Lack of Efficacy|1|||
145735600|NCT01086410|525550222|FG002|Overall Study|Lack of Efficacy|0|||
145735601|NCT01086410|525550223|FG003|Overall Study|Lack of Efficacy|0|||
145735602|NCT01086410|525550220|FG000|Overall Study|Protocol Violation|1|||
145735603|NCT01086410|525550221|FG001|Overall Study|Protocol Violation|1|||
145735604|NCT01086410|525550222|FG002|Overall Study|Protocol Violation|0|||
145735605|NCT01086410|525550223|FG003|Overall Study|Protocol Violation|0|||
145735606|NCT01086410|525550220|FG000|Overall Study|Lost to Follow-up|0|||
145735607|NCT01086410|525550221|FG001|Overall Study|Lost to Follow-up|0|||
145735608|NCT01086410|525550222|FG002|Overall Study|Lost to Follow-up|1|||
145735609|NCT01086410|525550223|FG003|Overall Study|Lost to Follow-up|0|||
145735610|NCT04196803|525550224|FG000|Overall Study|Withdrawal by Subject|1|||
145735611|NCT04196803|525550225|FG001|Overall Study|Withdrawal by Subject|3|||
145735612|NCT04196803|525550224|FG000|Overall Study|Adverse Event|4|||
145735613|NCT04196803|525550225|FG001|Overall Study|Adverse Event|2|||
145735614|NCT04196803|525550224|FG000|Overall Study|Lost to Follow-up|0|||
145735615|NCT04196803|525550225|FG001|Overall Study|Lost to Follow-up|1|||
145735616|NCT01022996|525550226|FG000|Overall Study|Adverse Event|14|||
145735617|NCT01022996|525550226|FG000|Overall Study|Withdrawal by Subject|3|||
145735618|NCT01022996|525550226|FG000|Overall Study|Lost to Follow-up|1|||
145735619|NCT01022996|525550226|FG000|Overall Study|Administrative problems|6|||
145735620|NCT01022996|525550226|FG000|Overall Study|Disease Progression|32|||
145735621|NCT01022996|525550226|FG000|Overall Study|Protocol Violation|1|||
145735622|NCT00930722|525550227|FG000|Overall Study|Lost to Follow-up|16|||
145735623|NCT00930722|525550227|FG000|Overall Study|No longer willing to participate|9|||
145735624|NCT00930722|525550227|FG000|Overall Study|Study terminated by sponsor|2|||
145735625|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Adverse Event|2|||
145735626|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Adverse Event|2|||
145735627|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Adverse Event|4|||
145735628|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Adverse Event|0|||
145735629|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Adverse Event|0|||
145735630|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Progressive disease|0|||
145735631|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Progressive disease|0|||
145735632|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Progressive disease|1|||
145735633|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Progressive disease|0|||
145735634|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Progressive disease|0|||
145735635|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
145735636|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
145735637|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
145735638|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
145735639|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
145735640|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
145735641|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
145735642|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
145735643|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
145735644|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
145735645|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
145735646|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
145516851|NCT04585009|524752406|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
145735647|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
145735648|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
145735649|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
145735650|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
145735651|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
145735652|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
145516852|NCT04585009|524752395|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
145516853|NCT04585009|524752396|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516854|NCT04585009|524752397|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516855|NCT04585009|524752398|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145735653|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
145735654|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
145735655|NCT03523728|525550228|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
145735656|NCT03523728|525550229|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
145735657|NCT03523728|525550230|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
145735658|NCT03523728|525550231|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
145735659|NCT03523728|525550232|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
145735660|NCT03523728|525550228|FG000|Stage 2 (24 Months)|Adverse Event|0|||
145735661|NCT03523728|525550229|FG001|Stage 2 (24 Months)|Adverse Event|0|||
145735662|NCT03523728|525550230|FG002|Stage 2 (24 Months)|Adverse Event|0|||
145735663|NCT03523728|525550231|FG003|Stage 2 (24 Months)|Adverse Event|1|||
145735664|NCT03523728|525550232|FG004|Stage 2 (24 Months)|Adverse Event|2|||
145735665|NCT03523728|525550228|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
145735666|NCT03523728|525550229|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
145735667|NCT03523728|525550230|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
145735668|NCT03523728|525550231|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
145735669|NCT03523728|525550232|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
145735670|NCT03523728|525550228|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
145735671|NCT03523728|525550229|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
145735672|NCT03523728|525550230|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
145735673|NCT03523728|525550231|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
145735674|NCT03523728|525550232|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
145735675|NCT03523728|525550228|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
145735676|NCT03523728|525550229|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
145735677|NCT03523728|525550230|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
145735678|NCT03523728|525550231|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
145735679|NCT03523728|525550232|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
145735680|NCT03523728|525550228|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
145735681|NCT03523728|525550229|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
145735682|NCT03523728|525550230|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
145735683|NCT03523728|525550231|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
145735684|NCT03523728|525550232|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
145735685|NCT00621751|525550233|FG000|Overall Study|Adverse Event|0|||
145735686|NCT00621751|525550234|FG001|Overall Study|Adverse Event|1|||
145735687|NCT00419120|525550236|FG000|Long Term Follow up Period|study ongoing|10|||
145735688|NCT01950247|525550237|FG000|Overall Study|Withdrawal by Subject|28|||
145735689|NCT01950247|525550238|FG001|Overall Study|Withdrawal by Subject|13|||
145735690|NCT01950247|525550237|FG000|Overall Study|Lost to Follow-up|18|||
145735691|NCT01950247|525550238|FG001|Overall Study|Lost to Follow-up|16|||
145735692|NCT01950247|525550237|FG000|Overall Study|Physician Decision|3|||
145735693|NCT01950247|525550238|FG001|Overall Study|Physician Decision|4|||
145735694|NCT01950247|525550237|FG000|Overall Study|Adverse Event|3|||
145735695|NCT01950247|525550238|FG001|Overall Study|Adverse Event|2|||
145735696|NCT01950247|525550237|FG000|Overall Study|Death|1|||
145735697|NCT01950247|525550238|FG001|Overall Study|Death|1|||
145735698|NCT01950247|525550237|FG000|Overall Study|Not Defined|4|||
145735699|NCT01950247|525550238|FG001|Overall Study|Not Defined|10|||
145735700|NCT01069120|525550239|FG000|Overall Study|Study prematurely terminated|27|||
145735701|NCT00763971|525550240|FG000|Overall Study|Adverse Event|5|||
145735702|NCT00763971|525550241|FG001|Overall Study|Adverse Event|2|||
145735703|NCT00763971|525550242|FG002|Overall Study|Adverse Event|4|||
145735704|NCT00763971|525550240|FG000|Overall Study|Protocol Violation|3|||
145735705|NCT00763971|525550241|FG001|Overall Study|Protocol Violation|3|||
145735706|NCT00763971|525550242|FG002|Overall Study|Protocol Violation|2|||
145402255|NCT00761319|524330685|FG000|Overall Study|Nonspecified|2|||
145516856|NCT04585009|524752399|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516857|NCT04585009|524752400|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516858|NCT04585009|524752401|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516859|NCT04585009|524752402|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516860|NCT04585009|524752403|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516861|NCT04585009|524752404|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516862|NCT04585009|524752405|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516863|NCT04585009|524752406|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
145516864|NCT04585009|524752395|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516865|NCT04585009|524752396|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145735707|NCT00763971|525550240|FG000|Overall Study|Withdrawal by Subject|4|||
145735708|NCT00763971|525550241|FG001|Overall Study|Withdrawal by Subject|5|||
145735709|NCT00763971|525550242|FG002|Overall Study|Withdrawal by Subject|5|||
145735710|NCT00763971|525550240|FG000|Overall Study|Lost to Follow-up|0|||
145735711|NCT00763971|525550241|FG001|Overall Study|Lost to Follow-up|1|||
145735712|NCT00763971|525550242|FG002|Overall Study|Lost to Follow-up|0|||
145735713|NCT00763971|525550240|FG000|Overall Study|Lack of Efficacy|11|||
145735714|NCT00763971|525550241|FG001|Overall Study|Lack of Efficacy|22|||
145735715|NCT00763971|525550242|FG002|Overall Study|Lack of Efficacy|54|||
145735716|NCT00763971|525550240|FG000|Overall Study|Unable to swallow capsule|2|||
145735717|NCT00763971|525550241|FG001|Overall Study|Unable to swallow capsule|1|||
145735718|NCT00763971|525550242|FG002|Overall Study|Unable to swallow capsule|1|||
145735719|NCT00763971|525550240|FG000|Overall Study|Personal reason|3|||
145735720|NCT00763971|525550241|FG001|Overall Study|Personal reason|0|||
145735721|NCT00763971|525550242|FG002|Overall Study|Personal reason|0|||
145735722|NCT00763971|525550240|FG000|Overall Study|Exclusion criteria met|1|||
145735723|NCT00763971|525550241|FG001|Overall Study|Exclusion criteria met|0|||
145735724|NCT00763971|525550242|FG002|Overall Study|Exclusion criteria met|0|||
145735725|NCT00763971|525550240|FG000|Overall Study|Sponsor decision|1|||
145735726|NCT00763971|525550241|FG001|Overall Study|Sponsor decision|0|||
145735727|NCT00763971|525550242|FG002|Overall Study|Sponsor decision|0|||
145735728|NCT00763971|525550240|FG000|Overall Study|Due to holiday season|2|||
145735729|NCT00763971|525550241|FG001|Overall Study|Due to holiday season|0|||
145735730|NCT00763971|525550242|FG002|Overall Study|Due to holiday season|1|||
145735731|NCT00763971|525550240|FG000|Overall Study|Randomization error|0|||
145735732|NCT00763971|525550241|FG001|Overall Study|Randomization error|0|||
145735733|NCT00763971|525550242|FG002|Overall Study|Randomization error|1|||
145735734|NCT00763971|525550240|FG000|Overall Study|Medical monitor decision|0|||
145735735|NCT00763971|525550241|FG001|Overall Study|Medical monitor decision|0|||
145735736|NCT00763971|525550242|FG002|Overall Study|Medical monitor decision|1|||
145735737|NCT00763971|525550240|FG000|Overall Study|Moved to another country|0|||
145735738|NCT00763971|525550241|FG001|Overall Study|Moved to another country|1|||
145735739|NCT00763971|525550242|FG002|Overall Study|Moved to another country|0|||
145735740|NCT00763971|525550240|FG000|Overall Study|Subject wanted dose reduction|0|||
145735741|NCT00763971|525550241|FG001|Overall Study|Subject wanted dose reduction|1|||
145735742|NCT00763971|525550242|FG002|Overall Study|Subject wanted dose reduction|0|||
145735743|NCT00763971|525550240|FG000|Overall Study|Lack of availability|0|||
145735744|NCT00763971|525550241|FG001|Overall Study|Lack of availability|1|||
145735745|NCT00763971|525550242|FG002|Overall Study|Lack of availability|0|||
145735746|NCT00763971|525550240|FG000|Overall Study|Performed final visit on phone|0|||
145735747|NCT00763971|525550241|FG001|Overall Study|Performed final visit on phone|1|||
145735748|NCT00763971|525550242|FG002|Overall Study|Performed final visit on phone|0|||
145735749|NCT00763971|525550240|FG000|Overall Study|Participation in 489-326 required|1|||
145735750|NCT00763971|525550241|FG001|Overall Study|Participation in 489-326 required|0|||
145735751|NCT00763971|525550242|FG002|Overall Study|Participation in 489-326 required|0|||
145735752|NCT00710879|525550243|FG000|Overall Study|Lost to Follow-up|2|||
145735753|NCT00710879|525550244|FG001|Overall Study|Lost to Follow-up|1|||
145735754|NCT00710879|525550243|FG000|Overall Study|Protocol Violation|0|||
145735755|NCT00710879|525550244|FG001|Overall Study|Protocol Violation|3|||
145735756|NCT03383289|525550248|FG000|Overall Study|Death|83|||
145735757|NCT03383289|525550249|FG001|Overall Study|Death|78|||
145735758|NCT03383289|525550248|FG000|Overall Study|discharge from facility|84|||
145735759|NCT03383289|525550249|FG001|Overall Study|discharge from facility|84|||
145735760|NCT03383289|525550248|FG000|Overall Study|Withdrawal by Subject|4|||
145735761|NCT03383289|525550249|FG001|Overall Study|Withdrawal by Subject|1|||
145735762|NCT00884325|525550250|FG000|Overall Study|Lost to Follow-up|1|||
145735763|NCT00884325|525550251|FG001|Overall Study|Lost to Follow-up|2|||
145735764|NCT00884325|525550250|FG000|Overall Study|Lack of Efficacy|0|||
145735765|NCT00884325|525550251|FG001|Overall Study|Lack of Efficacy|1|||
145735766|NCT00884325|525550250|FG000|Overall Study|Withdrawal by Subject|1|||
145735767|NCT00884325|525550251|FG001|Overall Study|Withdrawal by Subject|1|||
145735768|NCT00884325|525550250|FG000|Overall Study|Not provided|1|||
145735769|NCT00884325|525550251|FG001|Overall Study|Not provided|0|||
145735770|NCT00832117|525550252|FG000|Overall Study|Death|1|||
145735771|NCT00832117|525550252|FG000|Overall Study|Disease Progression|11|||
145735772|NCT04439071|525550253|FG000|Overall Study|Lost to Follow-up|0|||
145735773|NCT04439071|525550254|FG001|Overall Study|Lost to Follow-up|3|||
145735774|NCT04439071|525550253|FG000|Overall Study|Withdrawal by Subject|3|||
145735775|NCT04439071|525550254|FG001|Overall Study|Withdrawal by Subject|8|||
145735776|NCT04439071|525550253|FG000|Overall Study|Death|6|||
145735777|NCT04439071|525550254|FG001|Overall Study|Death|4|||
145735778|NCT04439071|525550253|FG000|Overall Study|Other than specified|3|||
145735779|NCT04439071|525550254|FG001|Overall Study|Other than specified|3|||
145735780|NCT04439071|525550253|FG000|Overall Study|Randomized but not treated|2|||
145735781|NCT04439071|525550254|FG001|Overall Study|Randomized but not treated|0|||
145735782|NCT02606461|525550263|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
145735783|NCT02606461|525550264|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
145735784|NCT02606461|525550265|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
145735785|NCT02606461|525550266|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
145735786|NCT02606461|525550267|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
145735787|NCT02606461|525550268|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
145735788|NCT00024167|525550269|FG000|Overall Study|Death|53|||
145735789|NCT00024167|525550270|FG001|Overall Study|Death|47|||
145735790|NCT00307333|525550284|FG000|Overall Study|Lost to Follow-up|11|||
145735791|NCT00307333|525550285|FG001|Overall Study|Lost to Follow-up|3|||
145516866|NCT04585009|524752397|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516867|NCT04585009|524752398|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516868|NCT04585009|524752399|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516869|NCT04585009|524752400|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516870|NCT04585009|524752401|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516871|NCT04585009|524752402|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
145516872|NCT04585009|524752403|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516873|NCT04585009|524752404|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516874|NCT04585009|524752405|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516875|NCT04585009|524752406|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
145516876|NCT04585009|524752395|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145607018|NCT02508532|525076950|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
145607019|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
145607020|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607021|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607022|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607023|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607024|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607025|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
145607026|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
145607027|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
145607028|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
145607029|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607030|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
145607031|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607032|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607033|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607034|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607035|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
145607036|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
145607037|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Death|0|||
145607038|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Death|4|||
145607039|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Death|2|||
145607040|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Death|4|||
145607041|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Death|3|||
145607042|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Death|0|||
145607043|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Death|0|||
145607044|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Death|1|||
145607045|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Death|111|||
145607046|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
145607047|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
145607048|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
145607049|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
145607050|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
145607051|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
145607052|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
145607053|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
145607054|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
145607055|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607056|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607057|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607058|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607059|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607060|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607061|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607062|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
145607063|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
145607064|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607065|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607066|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
145607067|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607068|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
145607069|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607070|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607071|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
145607072|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
145607073|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607074|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607075|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607076|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607077|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607078|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607079|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607080|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
145607081|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
145607082|NCT02508532|525076942|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
145607083|NCT02508532|525076943|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
145607084|NCT02508532|525076944|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
145607085|NCT02508532|525076945|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
145607086|NCT02508532|525076946|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
145607087|NCT02508532|525076947|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
145607088|NCT02508532|525076948|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
145607089|NCT02508532|525076949|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
145607090|NCT02508532|525076950|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
145607091|NCT04359771|525076951|FG000|Overall Study|Lack of Efficacy|2|||
145607092|NCT04359771|525076952|FG001|Overall Study|Lack of Efficacy|2|||
145607093|NCT01216163|525076953|FG000|Overall Study|Withdrawal by Subject|1|||
145607094|NCT01216163|525076954|FG001|Overall Study|Withdrawal by Subject|1|||
145607095|NCT01216163|525076955|FG002|Overall Study|Withdrawal by Subject|0|||
145607096|NCT02237508|525076957|FG000|Overall Study|Withdrawal by Subject|0|||
145607097|NCT02237508|525076958|FG001|Overall Study|Withdrawal by Subject|2|||
145607098|NCT02237508|525076959|FG002|Overall Study|Withdrawal by Subject|0|||
145607099|NCT02237508|525076960|FG003|Overall Study|Withdrawal by Subject|1|||
145607100|NCT02237508|525076961|FG004|Overall Study|Withdrawal by Subject|0|||
145607101|NCT02237508|525076962|FG005|Overall Study|Withdrawal by Subject|1|||
145607102|NCT02237508|525076963|FG006|Overall Study|Withdrawal by Subject|1|||
145607103|NCT02237508|525076964|FG007|Overall Study|Withdrawal by Subject|0|||
145607104|NCT02237508|525076965|FG008|Overall Study|Withdrawal by Subject|1|||
145607105|NCT02237508|525076966|FG009|Overall Study|Withdrawal by Subject|0|||
145607106|NCT02237508|525076957|FG000|Overall Study|Physician Decision|0|||
145607107|NCT02237508|525076958|FG001|Overall Study|Physician Decision|1|||
145607108|NCT02237508|525076959|FG002|Overall Study|Physician Decision|0|||
145607109|NCT02237508|525076960|FG003|Overall Study|Physician Decision|0|||
145607110|NCT02237508|525076961|FG004|Overall Study|Physician Decision|0|||
145607111|NCT02237508|525076962|FG005|Overall Study|Physician Decision|0|||
145607112|NCT02237508|525076963|FG006|Overall Study|Physician Decision|0|||
145607113|NCT02237508|525076964|FG007|Overall Study|Physician Decision|0|||
145607114|NCT02237508|525076965|FG008|Overall Study|Physician Decision|0|||
145607115|NCT02237508|525076966|FG009|Overall Study|Physician Decision|0|||
145607116|NCT02237508|525076957|FG000|Overall Study|Protocol Violation|0|||
145607117|NCT02237508|525076958|FG001|Overall Study|Protocol Violation|0|||
145607118|NCT02237508|525076959|FG002|Overall Study|Protocol Violation|1|||
145607119|NCT02237508|525076960|FG003|Overall Study|Protocol Violation|0|||
145607120|NCT02237508|525076961|FG004|Overall Study|Protocol Violation|0|||
145607121|NCT02237508|525076962|FG005|Overall Study|Protocol Violation|0|||
145402256|NCT00761319|524330686|FG001|Overall Study|Nonspecified|2|||
145735792|NCT01245387|525550286|FG000|Overall Study|Lost to Follow-up|106|||
145735793|NCT01245387|525550286|FG000|Overall Study|Lack of Efficacy|195|||
145735794|NCT01245387|525550286|FG000|Overall Study|Adverse Event|9|||
145735795|NCT01245387|525550286|FG000|Overall Study|Death|3|||
145735796|NCT01245387|525550286|FG000|Overall Study|Other|131|||
145735797|NCT01245387|525550286|FG000|Overall Study|Missing discontinuation status|369|||
145735798|NCT04246801|525550287|FG000|Overall Study|Adverse Event|1|||
145735799|NCT04246801|525550288|FG001|Overall Study|Adverse Event|1|||
145735800|NCT04246801|525550287|FG000|Overall Study|Protocol Violation|1|||
145735801|NCT04246801|525550288|FG001|Overall Study|Protocol Violation|1|||
145735802|NCT04246801|525550287|FG000|Overall Study|Lack of Efficacy|0|||
145735803|NCT04246801|525550288|FG001|Overall Study|Lack of Efficacy|2|||
145735804|NCT04246801|525550287|FG000|Overall Study|Lost to Follow-up|1|||
145735805|NCT04246801|525550288|FG001|Overall Study|Lost to Follow-up|1|||
145735806|NCT04246801|525550287|FG000|Overall Study|Withdrawal by Subject|2|||
145735807|NCT04246801|525550288|FG001|Overall Study|Withdrawal by Subject|1|||
145735808|NCT01368042|525550289|FG000|Overall Study|Death|14|||
145735809|NCT01368042|525550289|FG000|Overall Study|Protocol Violation|11|||
145735810|NCT01368042|525550289|FG000|Overall Study|Lost to Follow-up|4|||
145735811|NCT01368042|525550289|FG000|Overall Study|Transplanted|1|||
145735812|NCT01621542|525550290|FG000|Overall Study|Adverse Event|0|||
145735813|NCT01621542|525550291|FG001|Overall Study|Adverse Event|0|||
145735814|NCT01621542|525550292|FG002|Overall Study|Adverse Event|1|||
145735815|NCT01621542|525550293|FG003|Overall Study|Adverse Event|3|||
145735816|NCT01621542|525550294|FG004|Overall Study|Adverse Event|0|||
145735817|NCT01621542|525550295|FG005|Overall Study|Adverse Event|0|||
145735818|NCT01621542|525550290|FG000|Overall Study|Death|0|||
145735819|NCT01621542|525550291|FG001|Overall Study|Death|1|||
145735820|NCT01621542|525550292|FG002|Overall Study|Death|0|||
145735821|NCT01621542|525550293|FG003|Overall Study|Death|0|||
145735822|NCT01621542|525550294|FG004|Overall Study|Death|0|||
145735823|NCT01621542|525550295|FG005|Overall Study|Death|0|||
145735824|NCT01621542|525550290|FG000|Overall Study|Physician Decision|1|||
145735825|NCT01621542|525550291|FG001|Overall Study|Physician Decision|0|||
145735826|NCT01621542|525550292|FG002|Overall Study|Physician Decision|1|||
145735827|NCT01621542|525550293|FG003|Overall Study|Physician Decision|13|||
145735828|NCT01621542|525550294|FG004|Overall Study|Physician Decision|3|||
145735829|NCT01621542|525550295|FG005|Overall Study|Physician Decision|1|||
145735830|NCT01621542|525550290|FG000|Overall Study|Withdrawal by Subject|2|||
145735831|NCT01621542|525550291|FG001|Overall Study|Withdrawal by Subject|0|||
145735832|NCT01621542|525550292|FG002|Overall Study|Withdrawal by Subject|1|||
145735833|NCT01621542|525550293|FG003|Overall Study|Withdrawal by Subject|3|||
145735834|NCT01621542|525550294|FG004|Overall Study|Withdrawal by Subject|3|||
145735835|NCT01621542|525550295|FG005|Overall Study|Withdrawal by Subject|3|||
145735836|NCT01621542|525550290|FG000|Overall Study|progression/treatment failure|2|||
145735837|NCT01621542|525550291|FG001|Overall Study|progression/treatment failure|4|||
145735838|NCT01621542|525550292|FG002|Overall Study|progression/treatment failure|3|||
145735839|NCT01621542|525550293|FG003|Overall Study|progression/treatment failure|7|||
145735840|NCT01621542|525550294|FG004|Overall Study|progression/treatment failure|3|||
145735841|NCT01621542|525550295|FG005|Overall Study|progression/treatment failure|5|||
145735842|NCT01621542|525550290|FG000|Overall Study|Protocol Violation|0|||
145735843|NCT01621542|525550291|FG001|Overall Study|Protocol Violation|0|||
145735844|NCT01621542|525550292|FG002|Overall Study|Protocol Violation|0|||
145735845|NCT01621542|525550293|FG003|Overall Study|Protocol Violation|1|||
145735846|NCT01621542|525550294|FG004|Overall Study|Protocol Violation|0|||
145735847|NCT01621542|525550295|FG005|Overall Study|Protocol Violation|0|||
145735848|NCT01621542|525550290|FG000|Overall Study|study stopped by sponsor|0|||
145402257|NCT00761319|524330685|FG000|Overall Study|Missing|1|||
145607122|NCT02237508|525076963|FG006|Overall Study|Protocol Violation|0|||
145607123|NCT02237508|525076964|FG007|Overall Study|Protocol Violation|0|||
145607124|NCT02237508|525076965|FG008|Overall Study|Protocol Violation|0|||
145607125|NCT02237508|525076966|FG009|Overall Study|Protocol Violation|0|||
145607126|NCT04000594|525076967|FG000|Overall Study|Withdrawal by Subject|1|||
145735849|NCT01621542|525550291|FG001|Overall Study|study stopped by sponsor|0|||
145735850|NCT01621542|525550292|FG002|Overall Study|study stopped by sponsor|0|||
145735851|NCT01621542|525550293|FG003|Overall Study|study stopped by sponsor|1|||
145735852|NCT01621542|525550294|FG004|Overall Study|study stopped by sponsor|0|||
145735853|NCT01621542|525550295|FG005|Overall Study|study stopped by sponsor|0|||
145735854|NCT02632721|525550297|FG000|Overall Study|Adverse Event|0|||
145735855|NCT02632721|525550298|FG001|Overall Study|Adverse Event|0|||
145735856|NCT02632721|525550299|FG002|Overall Study|Adverse Event|2|||
145735857|NCT02632721|525550300|FG003|Overall Study|Adverse Event|5|||
145735858|NCT02632721|525550301|FG004|Overall Study|Adverse Event|3|||
145735859|NCT02632721|525550297|FG000|Overall Study|Dose limiting toxicity|0|||
145735860|NCT02632721|525550298|FG001|Overall Study|Dose limiting toxicity|0|||
145735861|NCT02632721|525550299|FG002|Overall Study|Dose limiting toxicity|0|||
145735862|NCT02632721|525550300|FG003|Overall Study|Dose limiting toxicity|1|||
145735863|NCT02632721|525550301|FG004|Overall Study|Dose limiting toxicity|0|||
145735864|NCT02632721|525550297|FG000|Overall Study|Progressive disease|3|||
145735865|NCT02632721|525550298|FG001|Overall Study|Progressive disease|0|||
145735866|NCT02632721|525550299|FG002|Overall Study|Progressive disease|4|||
145735867|NCT02632721|525550300|FG003|Overall Study|Progressive disease|6|||
145735868|NCT02632721|525550301|FG004|Overall Study|Progressive disease|5|||
145735869|NCT02632721|525550297|FG000|Overall Study|Refused to continue taking trial medication|0|||
145735870|NCT02632721|525550298|FG001|Overall Study|Refused to continue taking trial medication|1|||
145735871|NCT02632721|525550299|FG002|Overall Study|Refused to continue taking trial medication|1|||
145735872|NCT02632721|525550300|FG003|Overall Study|Refused to continue taking trial medication|1|||
145735873|NCT02632721|525550301|FG004|Overall Study|Refused to continue taking trial medication|2|||
145735874|NCT02632721|525550297|FG000|Overall Study|Inadequate clinical condition|0|||
145735875|NCT02632721|525550298|FG001|Overall Study|Inadequate clinical condition|0|||
145735876|NCT02632721|525550299|FG002|Overall Study|Inadequate clinical condition|0|||
145735877|NCT02632721|525550300|FG003|Overall Study|Inadequate clinical condition|0|||
145735878|NCT02632721|525550301|FG004|Overall Study|Inadequate clinical condition|1|||
145735879|NCT02632721|525550297|FG000|Overall Study|No meet eligibility|0|||
145735880|NCT02632721|525550298|FG001|Overall Study|No meet eligibility|0|||
145735881|NCT02632721|525550299|FG002|Overall Study|No meet eligibility|0|||
145735882|NCT02632721|525550300|FG003|Overall Study|No meet eligibility|0|||
145735883|NCT02632721|525550301|FG004|Overall Study|No meet eligibility|1|||
145735884|NCT02632721|525550297|FG000|Overall Study|Allergic reaction|0|||
145735885|NCT02632721|525550298|FG001|Overall Study|Allergic reaction|0|||
145735886|NCT02632721|525550299|FG002|Overall Study|Allergic reaction|0|||
145735887|NCT02632721|525550300|FG003|Overall Study|Allergic reaction|1|||
145735888|NCT02632721|525550301|FG004|Overall Study|Allergic reaction|0|||
145735889|NCT02632721|525550297|FG000|Overall Study|Receiving Decitabine locally|0|||
145735890|NCT02632721|525550298|FG001|Overall Study|Receiving Decitabine locally|0|||
145735891|NCT02632721|525550299|FG002|Overall Study|Receiving Decitabine locally|1|||
145735892|NCT02632721|525550300|FG003|Overall Study|Receiving Decitabine locally|0|||
145735893|NCT02632721|525550301|FG004|Overall Study|Receiving Decitabine locally|0|||
145735894|NCT02632721|525550297|FG000|Overall Study|No benefit from study treatment|1|||
145735895|NCT02632721|525550298|FG001|Overall Study|No benefit from study treatment|1|||
145735896|NCT02632721|525550299|FG002|Overall Study|No benefit from study treatment|0|||
145735897|NCT02632721|525550300|FG003|Overall Study|No benefit from study treatment|0|||
145735898|NCT02632721|525550301|FG004|Overall Study|No benefit from study treatment|1|||
145735899|NCT02632721|525550297|FG000|Overall Study|Patient wish for other treatment|0|||
145735900|NCT02632721|525550298|FG001|Overall Study|Patient wish for other treatment|1|||
145735901|NCT02632721|525550299|FG002|Overall Study|Patient wish for other treatment|0|||
145735902|NCT02632721|525550300|FG003|Overall Study|Patient wish for other treatment|0|||
145735903|NCT02632721|525550301|FG004|Overall Study|Patient wish for other treatment|0|||
145735904|NCT02632721|525550297|FG000|Overall Study|Relapsed Pneumonia|0|||
145735905|NCT02632721|525550298|FG001|Overall Study|Relapsed Pneumonia|0|||
145735906|NCT02632721|525550299|FG002|Overall Study|Relapsed Pneumonia|0|||
145735907|NCT02632721|525550300|FG003|Overall Study|Relapsed Pneumonia|0|||
145735908|NCT02632721|525550301|FG004|Overall Study|Relapsed Pneumonia|1|||
145735909|NCT02632721|525550297|FG000|Overall Study|Therapy refractory AML|0|||
145735910|NCT02632721|525550298|FG001|Overall Study|Therapy refractory AML|0|||
145735911|NCT02632721|525550299|FG002|Overall Study|Therapy refractory AML|0|||
145735912|NCT02632721|525550300|FG003|Overall Study|Therapy refractory AML|0|||
145735913|NCT02632721|525550301|FG004|Overall Study|Therapy refractory AML|1|||
145735914|NCT02632721|525550297|FG000|Overall Study|Increase of white blood cell count|0|||
145735915|NCT02632721|525550298|FG001|Overall Study|Increase of white blood cell count|0|||
145735916|NCT02632721|525550299|FG002|Overall Study|Increase of white blood cell count|0|||
145735917|NCT02632721|525550300|FG003|Overall Study|Increase of white blood cell count|0|||
145735918|NCT02632721|525550301|FG004|Overall Study|Increase of white blood cell count|1|||
145735919|NCT02632721|525550297|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
145735920|NCT02632721|525550298|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
145735921|NCT02632721|525550299|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
145735922|NCT02632721|525550300|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
145735923|NCT02632721|525550301|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
145735924|NCT00544648|525550307|FG000|Overall Study|Withdrawal by Subject|1|||
145735925|NCT00544648|525550308|FG001|Overall Study|Withdrawal by Subject|0|||
145735926|NCT00544648|525550307|FG000|Overall Study|Adverse Event|1|||
145735927|NCT00544648|525550308|FG001|Overall Study|Adverse Event|1|||
145735928|NCT00544648|525550307|FG000|Overall Study|progression of disease|1|||
145735929|NCT00544648|525550308|FG001|Overall Study|progression of disease|0|||
145735930|NCT01572675|525550309|FG000|Overall Study|End of prescribed treatment|140|||
145402258|NCT00761319|524330686|FG001|Overall Study|Missing|0|||
145735931|NCT01572675|525550310|FG001|Overall Study|End of prescribed treatment|118|||
145735932|NCT01572675|525550309|FG000|Overall Study|Recovery|16|||
145735933|NCT01572675|525550310|FG001|Overall Study|Recovery|23|||
145735934|NCT01572675|525550309|FG000|Overall Study|Lack of Efficacy|31|||
145735935|NCT01572675|525550310|FG001|Overall Study|Lack of Efficacy|31|||
145402259|NCT01125930|524330687|FG000|Overall Study|Adverse Event|0|||
145735936|NCT01572675|525550309|FG000|Overall Study|Intolerance|6|||
145735937|NCT01572675|525550310|FG001|Overall Study|Intolerance|5|||
145735938|NCT01572675|525550309|FG000|Overall Study|Improved symptoms|8|||
145735939|NCT01572675|525550310|FG001|Overall Study|Improved symptoms|2|||
145735940|NCT01572675|525550309|FG000|Overall Study|Surgical intervention|3|||
145735941|NCT01572675|525550310|FG001|Overall Study|Surgical intervention|6|||
145735942|NCT01572675|525550309|FG000|Overall Study|Withdrawal by Subject|5|||
145735943|NCT01572675|525550310|FG001|Overall Study|Withdrawal by Subject|1|||
145735944|NCT01572675|525550309|FG000|Overall Study|Physician Decision|2|||
145735945|NCT01572675|525550310|FG001|Overall Study|Physician Decision|2|||
145735946|NCT01572675|525550309|FG000|Overall Study|Death unrelated to coxibs|1|||
145735947|NCT01572675|525550310|FG001|Overall Study|Death unrelated to coxibs|1|||
145735948|NCT01572675|525550309|FG000|Overall Study|Other disease detected|1|||
145735949|NCT01572675|525550310|FG001|Overall Study|Other disease detected|1|||
145735950|NCT01572675|525550309|FG000|Overall Study|Unknown reason|1|||
145735951|NCT01572675|525550310|FG001|Overall Study|Unknown reason|1|||
145735952|NCT01572675|525550309|FG000|Overall Study|Rheumatologist new evaluation|0|||
145735953|NCT01572675|525550310|FG001|Overall Study|Rheumatologist new evaluation|1|||
145735954|NCT01572675|525550309|FG000|Overall Study|Missing data|1|||
145735955|NCT01572675|525550310|FG001|Overall Study|Missing data|4|||
145735956|NCT01572675|525550309|FG000|Overall Study|Lost to Follow-up|22|||
145735957|NCT01572675|525550310|FG001|Overall Study|Lost to Follow-up|27|||
145735958|NCT03346057|525550311|FG000|Overall Study|Death|1|||
145735959|NCT03346057|525550312|FG001|Overall Study|Death|2|||
145735960|NCT03346057|525550313|FG002|Overall Study|Death|0|||
145735961|NCT03346057|525550314|FG003|Overall Study|Death|0|||
145735962|NCT03346057|525550311|FG000|Overall Study|Lost to Follow-up|0|||
145735963|NCT03346057|525550312|FG001|Overall Study|Lost to Follow-up|2|||
145735964|NCT03346057|525550313|FG002|Overall Study|Lost to Follow-up|1|||
145735965|NCT03346057|525550314|FG003|Overall Study|Lost to Follow-up|0|||
145735966|NCT03346057|525550311|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
145735967|NCT03346057|525550312|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
145735968|NCT03346057|525550313|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
145735969|NCT03346057|525550314|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
145735970|NCT03346057|525550311|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
145735971|NCT03346057|525550312|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
145735972|NCT03346057|525550313|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
145735973|NCT03346057|525550314|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
145735974|NCT03346057|525550311|FG000|Overall Study|Physician Decision|3|||
145735975|NCT03346057|525550312|FG001|Overall Study|Physician Decision|2|||
145735976|NCT03346057|525550313|FG002|Overall Study|Physician Decision|0|||
145735977|NCT03346057|525550314|FG003|Overall Study|Physician Decision|2|||
145735978|NCT03346057|525550311|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
145735979|NCT03346057|525550312|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
145735980|NCT03346057|525550313|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
145735981|NCT03346057|525550314|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
145735982|NCT03346057|525550311|FG000|Overall Study|Withdrawal by Subject|1|||
145735983|NCT03346057|525550312|FG001|Overall Study|Withdrawal by Subject|0|||
145735984|NCT03346057|525550313|FG002|Overall Study|Withdrawal by Subject|0|||
145735985|NCT03346057|525550314|FG003|Overall Study|Withdrawal by Subject|0|||
145735986|NCT02921269|525550315|FG000|Overall Study|Did not complete DLT period|1|||
145735987|NCT02281357|525550316|FG000|Overall Study|Adverse Event|2|||
145735988|NCT02281357|525550317|FG001|Overall Study|Adverse Event|1|||
145735989|NCT02281357|525550316|FG000|Overall Study|Lost to Follow-up|1|||
145735990|NCT02281357|525550317|FG001|Overall Study|Lost to Follow-up|0|||
145402260|NCT01125930|524330688|FG001|Overall Study|Adverse Event|1|||
145607127|NCT04000594|525076968|FG001|Overall Study|Withdrawal by Subject|0|||
145607128|NCT04000594|525076969|FG002|Overall Study|Withdrawal by Subject|0|||
145607129|NCT01905046|525076970|FG000|Months 13-24|Withdrawal by Subject|10|||
145607130|NCT01905046|525076971|FG001|Months 13-24|Withdrawal by Subject|10|||
145607131|NCT01905046|525076970|FG000|Months 13-24|Adverse Event|3|||
145735991|NCT02281357|525550316|FG000|Overall Study|Withdrawal by Subject|4|||
145735992|NCT02281357|525550317|FG001|Overall Study|Withdrawal by Subject|3|||
145735993|NCT00228566|525550318|FG000|Overall Study|Adverse Event|31|||
145735994|NCT00228566|525550318|FG000|Overall Study|Lack of Efficacy|14|||
145735995|NCT00228566|525550318|FG000|Overall Study|Lost to Follow-up|16|||
145735996|NCT00228566|525550318|FG000|Overall Study|Physician Decision|5|||
145735997|NCT00228566|525550318|FG000|Overall Study|Withdrawal by Subject|4|||
145735998|NCT00228566|525550318|FG000|Overall Study|Miscellaneous|1|||
145735999|NCT02877927|525550321|FG000|Overall Study|Adverse Event|1|||
145736000|NCT02877927|525550322|FG001|Overall Study|Adverse Event|0|||
145736001|NCT02877927|525550321|FG000|Overall Study|Lost to Follow-up|37|||
145736002|NCT02877927|525550322|FG001|Overall Study|Lost to Follow-up|38|||
145736003|NCT02877927|525550321|FG000|Overall Study|Withdrawal by Subject|11|||
145736004|NCT02877927|525550322|FG001|Overall Study|Withdrawal by Subject|12|||
145736005|NCT02877927|525550321|FG000|Overall Study|Physician Decision|0|||
145736006|NCT02877927|525550322|FG001|Overall Study|Physician Decision|1|||
145736007|NCT02877927|525550321|FG000|Overall Study|Missed EOT/PTE Visit|5|||
145736008|NCT02877927|525550322|FG001|Overall Study|Missed EOT/PTE Visit|6|||
145736009|NCT00601250|525550323|FG000|Overall Study|Adverse Event|3|||
145736010|NCT00601250|525550324|FG001|Overall Study|Adverse Event|9|||
145736011|NCT00601250|525550323|FG000|Overall Study|Protocol Violation|3|||
145736012|NCT00601250|525550324|FG001|Overall Study|Protocol Violation|2|||
145736013|NCT00601250|525550323|FG000|Overall Study|Lost to Follow-up|2|||
145736014|NCT00601250|525550324|FG001|Overall Study|Lost to Follow-up|6|||
145736015|NCT00601250|525550323|FG000|Overall Study|Withdrawal by Subject|4|||
145736016|NCT00601250|525550324|FG001|Overall Study|Withdrawal by Subject|13|||
145736017|NCT00601250|525550323|FG000|Overall Study|Other incl. lack of efficacy|2|||
145736018|NCT00601250|525550324|FG001|Overall Study|Other incl. lack of efficacy|9|||
145736019|NCT01810016|525550325|FG000|Overall Study|Progressive disease|1|||
145736020|NCT01810016|525550326|FG001|Overall Study|Progressive disease|1|||
145736021|NCT01810016|525550327|FG002|Overall Study|Progressive disease|0|||
145736022|NCT01810016|525550325|FG000|Overall Study|Death|0|||
145736023|NCT01810016|525550326|FG001|Overall Study|Death|0|||
145736024|NCT01810016|525550327|FG002|Overall Study|Death|1|||
145736025|NCT02229539|525551775|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
145736026|NCT02229539|525551776|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
145736027|NCT02229539|525551777|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
145736028|NCT02229539|525551775|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
145736029|NCT02229539|525551776|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
145736030|NCT02229539|525551777|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
145736031|NCT02229539|525551775|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
145736032|NCT02229539|525551776|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
145736033|NCT02229539|525551777|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
145736034|NCT02229539|525551775|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
145736035|NCT02229539|525551776|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
145736036|NCT02229539|525551777|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
145736037|NCT02229539|525551775|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
145736038|NCT02229539|525551776|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
145736039|NCT02229539|525551777|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
145736040|NCT02229539|525551775|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
145736041|NCT02229539|525551776|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
145736042|NCT02229539|525551777|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
145736043|NCT05162027|525551780|FG000|Overall Study|Adverse Event|1|||
145736044|NCT05162027|525551781|FG001|Overall Study|Adverse Event|0|||
145736045|NCT02553265|525551782|FG000|Enrollment|Death|0|||
145736046|NCT02553265|525551783|FG001|Enrollment|Death|0|||
145736047|NCT02553265|525551784|FG002|Enrollment|Death|1|||
145736048|NCT02553265|525551782|FG000|First Intervention (28 Days)|Adverse Event|1|||
145736049|NCT02553265|525551783|FG001|First Intervention (28 Days)|Adverse Event|0|||
145736050|NCT02553265|525551784|FG002|First Intervention (28 Days)|Adverse Event|0|||
145736051|NCT02553265|525551782|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
145736052|NCT02553265|525551783|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
145736053|NCT02553265|525551784|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
145736054|NCT02553265|525551782|FG000|Second Intervention (28 Days)|Adverse Event|1|||
145736055|NCT02553265|525551783|FG001|Second Intervention (28 Days)|Adverse Event|0|||
145736056|NCT02553265|525551784|FG002|Second Intervention (28 Days)|Adverse Event|0|||
145736057|NCT02553265|525551782|FG000|Third Intervention (28 Days)|Adverse Event|1|||
145736058|NCT02553265|525551783|FG001|Third Intervention (28 Days)|Adverse Event|0|||
145736059|NCT02553265|525551784|FG002|Third Intervention (28 Days)|Adverse Event|0|||
145736060|NCT02553265|525551782|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
145607132|NCT01905046|525076971|FG001|Months 13-24|Adverse Event|2|||
145607133|NCT01905046|525076970|FG000|Months 13-24|Protocol Violation|3|||
145607134|NCT01905046|525076971|FG001|Months 13-24|Protocol Violation|3|||
145607135|NCT01905046|525076970|FG000|Months 13-24|Physician Decision|1|||
145607136|NCT01905046|525076971|FG001|Months 13-24|Physician Decision|0|||
145607137|NCT01368900|525076976|FG000|Overall Study|Lost to Follow-up|7|||
145607138|NCT02277743|525076984|FG000|Overall Study|Protocol Violation|1|||
145607139|NCT02277743|525076985|FG001|Overall Study|Protocol Violation|1|||
145736061|NCT02553265|525551783|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
145736062|NCT02553265|525551784|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
145736063|NCT01809132|525551788|FG000|Overall Study|Withdrawal by Subject|0|||
145736064|NCT01809132|525551789|FG001|Overall Study|Withdrawal by Subject|0|||
145736065|NCT01809132|525551790|FG002|Overall Study|Withdrawal by Subject|1|||
145736066|NCT03583450|525551791|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
145736067|NCT03583450|525551792|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
145736068|NCT01446016|525551793|FG000|Overall Study|Lost to Follow-up|3|||
145736069|NCT01446016|525551793|FG000|Overall Study|Withdrawal by Subject|1|||
145736070|NCT01446016|525551793|FG000|Overall Study|Toxicity|3|||
145607140|NCT02277743|525076986|FG002|Overall Study|Protocol Violation|1|||
145736071|NCT00698204|525551796|FG000|Overall Study|Withdrawal by Subject|1|||
145736072|NCT00698204|525551797|FG001|Overall Study|Withdrawal by Subject|0|||
145736073|NCT01179672|525551798|FG000|Overall Study|Adverse Event|17|||
145736074|NCT01179672|525551799|FG001|Overall Study|Adverse Event|8|||
145736075|NCT01179672|525551798|FG000|Overall Study|Withdrawal by Subject|10|||
145736076|NCT01179672|525551799|FG001|Overall Study|Withdrawal by Subject|12|||
145736077|NCT01179672|525551798|FG000|Overall Study|Entry Criteria Not Met|0|||
145736078|NCT01179672|525551799|FG001|Overall Study|Entry Criteria Not Met|2|||
145736079|NCT01179672|525551798|FG000|Overall Study|Lost to Follow-up|0|||
145736080|NCT01179672|525551799|FG001|Overall Study|Lost to Follow-up|1|||
145736081|NCT01179672|525551798|FG000|Overall Study|Protocol Violation|2|||
145736082|NCT01179672|525551799|FG001|Overall Study|Protocol Violation|2|||
145736083|NCT01179672|525551798|FG000|Overall Study|Physician Decision|1|||
145736084|NCT01179672|525551799|FG001|Overall Study|Physician Decision|1|||
145736085|NCT01949155|525551801|FG000|Overall Study|Lost to Follow-up|1|||
145736086|NCT01949155|525551802|FG001|Overall Study|Lost to Follow-up|0|||
145736087|NCT01949155|525551801|FG000|Overall Study|Protocol Violation|1|||
145736088|NCT01949155|525551802|FG001|Overall Study|Protocol Violation|0|||
145736089|NCT00314249|525551803|FG000|Overall Study|Adverse Event|73|||
145736090|NCT00314249|525551804|FG001|Overall Study|Adverse Event|94|||
145736091|NCT00314249|525551803|FG000|Overall Study|Lack of Efficacy|33|||
145736092|NCT00314249|525551804|FG001|Overall Study|Lack of Efficacy|24|||
145736093|NCT00314249|525551803|FG000|Overall Study|Withdrawal by Subject|21|||
145736094|NCT00314249|525551804|FG001|Overall Study|Withdrawal by Subject|28|||
145736095|NCT00314249|525551803|FG000|Overall Study|Lost to Follow-up|15|||
145736096|NCT00314249|525551804|FG001|Overall Study|Lost to Follow-up|9|||
145736097|NCT00314249|525551803|FG000|Overall Study|Physician Decision|1|||
145736098|NCT00314249|525551804|FG001|Overall Study|Physician Decision|1|||
145736099|NCT00314249|525551803|FG000|Overall Study|Withdrawn for other reasons|4|||
145736100|NCT00314249|525551804|FG001|Overall Study|Withdrawn for other reasons|1|||
145736101|NCT00314249|525551803|FG000|Overall Study|Non-Compliant|5|||
145736102|NCT00314249|525551804|FG001|Overall Study|Non-Compliant|6|||
145736103|NCT00210184|525551805|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
145736104|NCT02316340|525551806|FG000|First Progression|Clinical progression|2|||
145736105|NCT02316340|525551807|FG001|First Progression|Clinical progression|1|||
145736106|NCT02316340|525551806|FG000|First Progression|Withdrawal by Subject|1|||
145736107|NCT02316340|525551807|FG001|First Progression|Withdrawal by Subject|0|||
145736108|NCT01835015|525551808|FG000|Overall Study|Adverse Event|0|||
145736109|NCT01835015|525551809|FG001|Overall Study|Adverse Event|0|||
145736110|NCT01835015|525551810|FG002|Overall Study|Adverse Event|1|||
145736111|NCT01835015|525551811|FG003|Overall Study|Adverse Event|0|||
145736112|NCT01835015|525551812|FG004|Overall Study|Adverse Event|0|||
145736113|NCT03334409|525551815|FG000|Overall Study|Did not meet inclusion criteria|1|||
145736114|NCT03334409|525551816|FG001|Overall Study|Did not meet inclusion criteria|0|||
145736115|NCT00975715|525551817|FG000|Titration Period|Adverse Event|6|||
145736116|NCT00975715|525551818|FG001|Titration Period|Adverse Event|0|||
145736117|NCT00975715|525551817|FG000|Titration Period|Protocol Violation|1|||
145736118|NCT00975715|525551818|FG001|Titration Period|Protocol Violation|0|||
145736119|NCT00975715|525551817|FG000|Maintenance Period|Adverse Event|2|||
145736120|NCT00975715|525551818|FG001|Maintenance Period|Adverse Event|1|||
145736121|NCT01241552|525551819|FG000|Overall Study|Lack of Efficacy|1|||
145736122|NCT01241552|525551820|FG001|Overall Study|Lack of Efficacy|0|||
145736123|NCT01241552|525551821|FG002|Overall Study|Lack of Efficacy|0|||
145736124|NCT01241552|525551822|FG003|Overall Study|Lack of Efficacy|0|||
145736125|NCT01241552|525551819|FG000|Overall Study|Death|26|||
145607141|NCT02277743|525076984|FG000|Overall Study|Adverse Event|10|||
145736126|NCT01241552|525551820|FG001|Overall Study|Death|30|||
145607142|NCT02277743|525076985|FG001|Overall Study|Adverse Event|6|||
145736127|NCT01241552|525551821|FG002|Overall Study|Death|20|||
145736128|NCT01241552|525551822|FG003|Overall Study|Death|25|||
145736129|NCT01241552|525551819|FG000|Overall Study|Adverse Event|1|||
145736130|NCT01241552|525551820|FG001|Overall Study|Adverse Event|1|||
145736131|NCT01241552|525551821|FG002|Overall Study|Adverse Event|0|||
145736132|NCT01241552|525551822|FG003|Overall Study|Adverse Event|0|||
145736133|NCT01241552|525551819|FG000|Overall Study|Technical Problems|2|||
145736134|NCT01241552|525551820|FG001|Overall Study|Technical Problems|0|||
145736135|NCT01241552|525551821|FG002|Overall Study|Technical Problems|2|||
145736136|NCT01241552|525551822|FG003|Overall Study|Technical Problems|2|||
145736137|NCT01241552|525551819|FG000|Overall Study|Progressive Disease|0|||
145736138|NCT01241552|525551820|FG001|Overall Study|Progressive Disease|0|||
145736139|NCT01241552|525551821|FG002|Overall Study|Progressive Disease|1|||
145736140|NCT01241552|525551822|FG003|Overall Study|Progressive Disease|2|||
145736141|NCT01241552|525551819|FG000|Overall Study|Protocol Violation|0|||
145736142|NCT01241552|525551820|FG001|Overall Study|Protocol Violation|2|||
145736143|NCT01241552|525551821|FG002|Overall Study|Protocol Violation|6|||
145736144|NCT01241552|525551822|FG003|Overall Study|Protocol Violation|1|||
145736145|NCT01241552|525551819|FG000|Overall Study|Withdrawal by Subject|7|||
145736146|NCT01241552|525551820|FG001|Overall Study|Withdrawal by Subject|15|||
145736147|NCT01241552|525551821|FG002|Overall Study|Withdrawal by Subject|14|||
145736148|NCT01241552|525551822|FG003|Overall Study|Withdrawal by Subject|15|||
145736149|NCT01241552|525551819|FG000|Overall Study|Physician Decision|2|||
145736150|NCT01241552|525551820|FG001|Overall Study|Physician Decision|4|||
145736151|NCT01241552|525551821|FG002|Overall Study|Physician Decision|2|||
145736152|NCT01241552|525551822|FG003|Overall Study|Physician Decision|3|||
145736153|NCT01241552|525551819|FG000|Overall Study|Lost to Follow-up|2|||
145736154|NCT01241552|525551820|FG001|Overall Study|Lost to Follow-up|11|||
145736155|NCT01241552|525551821|FG002|Overall Study|Lost to Follow-up|15|||
145736156|NCT01241552|525551822|FG003|Overall Study|Lost to Follow-up|16|||
145736157|NCT04004429|525551825|FG000|Overall Study|Protocol Violation|1|||
145736158|NCT04004429|525551826|FG001|Overall Study|Protocol Violation|0|||
145736159|NCT04004429|525551827|FG002|Overall Study|Protocol Violation|0|||
145736160|NCT04004429|525551825|FG000|Overall Study|Physician Decision|0|||
145736161|NCT04004429|525551826|FG001|Overall Study|Physician Decision|1|||
145736162|NCT04004429|525551827|FG002|Overall Study|Physician Decision|1|||
145736163|NCT04004429|525551825|FG000|Overall Study|Withdrawal by Subject|1|||
145736164|NCT04004429|525551826|FG001|Overall Study|Withdrawal by Subject|1|||
145736165|NCT04004429|525551827|FG002|Overall Study|Withdrawal by Subject|1|||
145736166|NCT00239226|525551832|FG000|Overall Study|permAF during stabilization period|0|||
145736167|NCT00239226|525551833|FG001|Overall Study|permAF during stabilization period|0|||
145736168|NCT00239226|525551834|FG002|Overall Study|permAF during stabilization period|0|||
145736169|NCT00239226|525551835|FG003|Overall Study|permAF during stabilization period|3|||
145736170|NCT00239226|525551832|FG000|Overall Study|Lost to Follow-up|1|||
145736171|NCT00239226|525551833|FG001|Overall Study|Lost to Follow-up|0|||
145736172|NCT00239226|525551834|FG002|Overall Study|Lost to Follow-up|1|||
145736173|NCT00239226|525551835|FG003|Overall Study|Lost to Follow-up|0|||
145736174|NCT00646906|525551836|FG000|Crossover Period 1|Withdrawal by Subject|1|||
145736175|NCT00646906|525551837|FG001|Crossover Period 1|Withdrawal by Subject|0|||
145736176|NCT00646906|525551838|FG002|Crossover Period 1|Withdrawal by Subject|0|||
145736177|NCT00646906|525551839|FG003|Crossover Period 1|Withdrawal by Subject|0|||
145736178|NCT00646906|525551840|FG004|Crossover Period 1|Withdrawal by Subject|0|||
145736179|NCT00646906|525551841|FG005|Crossover Period 1|Withdrawal by Subject|1|||
145736180|NCT00646906|525551842|FG006|Crossover Period 1|Withdrawal by Subject|0|||
145736181|NCT00646906|525551836|FG000|Crossover Period 2|Withdrawal by Subject|0|||
145736182|NCT00646906|525551837|FG001|Crossover Period 2|Withdrawal by Subject|1|||
145736183|NCT00646906|525551838|FG002|Crossover Period 2|Withdrawal by Subject|2|||
145736184|NCT00646906|525551839|FG003|Crossover Period 2|Withdrawal by Subject|1|||
145736185|NCT00646906|525551840|FG004|Crossover Period 2|Withdrawal by Subject|0|||
145736186|NCT00646906|525551841|FG005|Crossover Period 2|Withdrawal by Subject|0|||
145736187|NCT00646906|525551842|FG006|Crossover Period 2|Withdrawal by Subject|0|||
145736188|NCT00646906|525551836|FG000|Crossover Period 2|Physician Decision|0|||
145736189|NCT00646906|525551837|FG001|Crossover Period 2|Physician Decision|0|||
145736190|NCT00646906|525551838|FG002|Crossover Period 2|Physician Decision|0|||
145736191|NCT00646906|525551839|FG003|Crossover Period 2|Physician Decision|0|||
145736192|NCT00646906|525551840|FG004|Crossover Period 2|Physician Decision|0|||
145736193|NCT00646906|525551841|FG005|Crossover Period 2|Physician Decision|0|||
145736194|NCT00646906|525551842|FG006|Crossover Period 2|Physician Decision|1|||
145736195|NCT02448225|525551844|FG000|Overall Study|Withdrawal by Subject|1|||
145736196|NCT02448225|525551844|FG000|Overall Study|Did not get FSPG scan|18|||
145516877|NCT04585009|524752396|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516878|NCT04585009|524752397|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516879|NCT04585009|524752398|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145736197|NCT02448225|525551844|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
145736198|NCT00851682|525551845|FG000|Overall Study|screen failure|5|||
145736199|NCT00851682|525551846|FG001|Overall Study|screen failure|0|||
145736200|NCT04060563|525551847|FG000|Overall Study|Lost to Follow-up|1|||
145736201|NCT04060563|525551848|FG001|Overall Study|Lost to Follow-up|1|||
145736202|NCT04060563|525551847|FG000|Overall Study|Physician Decision|0|||
145736203|NCT04060563|525551848|FG001|Overall Study|Physician Decision|1|||
145736204|NCT01379573|525551854|FG000|Overall Study|Lost to Follow-up|1|||
145736205|NCT01379573|525551854|FG000|Overall Study|Screen Failure|10|||
145736206|NCT00962390|525551856|FG000|Overall Study|Adverse Event|0|||
145736207|NCT00962390|525551857|FG001|Overall Study|Adverse Event|0|||
145736208|NCT00962390|525551858|FG002|Overall Study|Adverse Event|3|||
145736209|NCT00962390|525551859|FG003|Overall Study|Adverse Event|1|||
145736210|NCT00962390|525551856|FG000|Overall Study|Lost to Follow-up|2|||
145736211|NCT00962390|525551857|FG001|Overall Study|Lost to Follow-up|2|||
145736212|NCT00962390|525551858|FG002|Overall Study|Lost to Follow-up|0|||
145736213|NCT00962390|525551859|FG003|Overall Study|Lost to Follow-up|0|||
145736214|NCT00962390|525551856|FG000|Overall Study|Protocol Violation|1|||
145736215|NCT00962390|525551857|FG001|Overall Study|Protocol Violation|0|||
145736216|NCT00962390|525551858|FG002|Overall Study|Protocol Violation|0|||
145736217|NCT00962390|525551859|FG003|Overall Study|Protocol Violation|0|||
145736218|NCT00962390|525551856|FG000|Overall Study|Withdrawal by Subject|1|||
145736219|NCT00962390|525551857|FG001|Overall Study|Withdrawal by Subject|1|||
145736220|NCT00962390|525551858|FG002|Overall Study|Withdrawal by Subject|1|||
145736221|NCT00962390|525551859|FG003|Overall Study|Withdrawal by Subject|0|||
145736222|NCT02613884|525551860|FG000|Overall Study|Death|1|||
145736223|NCT02613884|525551860|FG000|Overall Study|Lost to Follow-up|1|||
145736224|NCT04422990|525551861|FG000|Overall Study|Withdrawal by Subject|0|||
145736225|NCT04422990|525551862|FG001|Overall Study|Withdrawal by Subject|1|||
145736226|NCT04422990|525551861|FG000|Overall Study|Travel|3|||
145736227|NCT04422990|525551862|FG001|Overall Study|Travel|0|||
145736228|NCT02844920|525551865|FG000|Overall Study|Lost to Follow-up|2|||
145736229|NCT01910116|525551866|FG000|Overall Study|Adverse Event|0|||
145736230|NCT01910116|525551867|FG001|Overall Study|Adverse Event|3|||
145736231|NCT01910116|525551866|FG000|Overall Study|Lack of Efficacy|3|||
145736232|NCT01910116|525551867|FG001|Overall Study|Lack of Efficacy|4|||
145736233|NCT01910116|525551866|FG000|Overall Study|Lost to Follow-up|1|||
145736234|NCT01910116|525551867|FG001|Overall Study|Lost to Follow-up|0|||
145736235|NCT01910116|525551866|FG000|Overall Study|Protocol Violation|1|||
145736236|NCT01910116|525551867|FG001|Overall Study|Protocol Violation|2|||
145736237|NCT01910116|525551866|FG000|Overall Study|Withdrawal by Subject|8|||
145736238|NCT01910116|525551867|FG001|Overall Study|Withdrawal by Subject|3|||
145736239|NCT01910116|525551866|FG000|Overall Study|uncertain allocation|1|||
145736240|NCT01910116|525551867|FG001|Overall Study|uncertain allocation|3|||
145736241|NCT01910116|525551866|FG000|Overall Study|incomplete data|0|||
145736242|NCT01910116|525551867|FG001|Overall Study|incomplete data|1|||
145736243|NCT01849497|525551868|FG000|Overall Study|Withdrawal by Subject|1|||
145736244|NCT01849497|525551869|FG001|Overall Study|Withdrawal by Subject|2|||
145736245|NCT01849497|525551868|FG000|Overall Study|Sponsor Decision|0|||
145736246|NCT01849497|525551869|FG001|Overall Study|Sponsor Decision|1|||
145516880|NCT04585009|524752399|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
145516881|NCT04585009|524752400|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516882|NCT04585009|524752401|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516883|NCT04585009|524752402|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516884|NCT04585009|524752403|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516885|NCT04585009|524752404|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145607143|NCT02277743|525076986|FG002|Overall Study|Adverse Event|6|||
145736247|NCT01849497|525551868|FG000|Overall Study|Lost to Follow-up|0|||
145736248|NCT01849497|525551869|FG001|Overall Study|Lost to Follow-up|1|||
145736249|NCT00911625|525551870|FG000|Overall Study|Lost to Follow-up|7|||
145736250|NCT00911625|525551871|FG001|Overall Study|Lost to Follow-up|0|||
145736251|NCT02729740|525551874|FG000|Overall Study|Early Termination|130|||
145736252|NCT02729740|525551874|FG000|Overall Study|Other|1|||
145736253|NCT03061175|525551875|FG000|Baseline|Participant was deemed ineligible|1|||
145736254|NCT03061175|525551876|FG001|Baseline|Participant was deemed ineligible|0|||
145736255|NCT03061175|525551875|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
145736256|NCT03061175|525551876|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
145736257|NCT03061175|525551875|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
145736258|NCT03061175|525551876|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
145736259|NCT03061175|525551875|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
145736260|NCT03061175|525551876|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
145736261|NCT03044249|525551877|FG000|Overall Study|Adverse Event|4|||
145736262|NCT03044249|525551878|FG001|Overall Study|Adverse Event|9|||
145736263|NCT03044249|525551877|FG000|Overall Study|Lost to Follow-up|1|||
145736264|NCT03044249|525551878|FG001|Overall Study|Lost to Follow-up|0|||
145736265|NCT03044249|525551877|FG000|Overall Study|Non-compliance with Study Drug|1|||
145736266|NCT03044249|525551878|FG001|Overall Study|Non-compliance with Study Drug|0|||
145736267|NCT03044249|525551877|FG000|Overall Study|Study Terminated by Sponsor|2|||
145736268|NCT03044249|525551878|FG001|Overall Study|Study Terminated by Sponsor|0|||
145736269|NCT03044249|525551877|FG000|Overall Study|Withdrawal by Subject|2|||
145736270|NCT03044249|525551878|FG001|Overall Study|Withdrawal by Subject|5|||
145736271|NCT00760669|525551879|FG000|Overall Study|Not assessed for overall improvement|18|||
145736272|NCT00760669|525551879|FG000|Overall Study|Participants missing efficacy assessment|6|||
145736273|NCT00760669|525551879|FG000|Overall Study|Participants with overlapping cases|1|||
145736274|NCT00760669|525551879|FG000|Overall Study|Took drug before entering in contract|5|||
145736275|NCT02663271|525551880|FG000|Overall Study|Withdrawal by Subject|5|||
145736276|NCT02663271|525551880|FG000|Overall Study|Lack of Efficacy|1|||
145736277|NCT04166383|525551881|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
145736278|NCT04166383|525551881|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
145736279|NCT04166383|525551881|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
145736280|NCT03044886|525551883|FG000|Overall Study|Lost to Follow-up|15|||
145736281|NCT03044886|525551884|FG001|Overall Study|Lost to Follow-up|10|||
145736282|NCT03044886|525551885|FG002|Overall Study|Lost to Follow-up|12|||
145736283|NCT00504153|525551895|FG000|Overall Study|Withdrawal by Subject|1|||
145736284|NCT00504153|525551895|FG000|Overall Study|Adverse Event|4|||
145736285|NCT00504153|525551895|FG000|Overall Study|Death|1|||
145736286|NCT04029961|525551896|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
145736287|NCT04029961|525551897|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
145736288|NCT04029961|525551896|FG000|Overall Study|Change in Treatment Course|0|||
145736289|NCT04029961|525551897|FG001|Overall Study|Change in Treatment Course|1|||
145736290|NCT01624259|525551898|FG000|Overall Study|Adverse Event|18|||
145736291|NCT01624259|525551899|FG001|Overall Study|Adverse Event|18|||
145736292|NCT01624259|525551898|FG000|Overall Study|Protocol Violation|1|||
145736293|NCT01624259|525551899|FG001|Overall Study|Protocol Violation|2|||
145736294|NCT01624259|525551898|FG000|Overall Study|Withdrawal by Subject|5|||
145736295|NCT01624259|525551899|FG001|Overall Study|Withdrawal by Subject|7|||
145736296|NCT01624259|525551898|FG000|Overall Study|Physician Decision|1|||
145736297|NCT01624259|525551899|FG001|Overall Study|Physician Decision|1|||
145736298|NCT01624259|525551898|FG000|Overall Study|Lost to Follow-up|2|||
145736299|NCT01624259|525551899|FG001|Overall Study|Lost to Follow-up|3|||
145736300|NCT01624259|525551898|FG000|Overall Study|Abnormal laboratory measure|3|||
145736301|NCT01624259|525551899|FG001|Overall Study|Abnormal laboratory measure|0|||
145736302|NCT01479829|525551905|FG000|Overall Study|Withdrawal by Subject|8|||
145736303|NCT01479829|525551906|FG001|Overall Study|Withdrawal by Subject|10|||
145736304|NCT00088907|525553324|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
145736305|NCT00088907|525553325|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
145736306|NCT00088907|525553324|FG000|Randomized Study (Step 1)|Adverse Event|14|||
145736307|NCT00088907|525553325|FG001|Randomized Study (Step 1)|Adverse Event|19|||
145736308|NCT00088907|525553324|FG000|Randomized Study (Step 1)|Death|11|||
145736309|NCT00088907|525553325|FG001|Randomized Study (Step 1)|Death|12|||
145736310|NCT00088907|525553324|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
145736311|NCT00088907|525553325|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
145402261|NCT01125930|524330687|FG000|Overall Study|Withdrawal by Subject|1|||
145402262|NCT01125930|524330688|FG001|Overall Study|Withdrawal by Subject|6|||
145736312|NCT00088907|525553324|FG000|Randomized Study (Step 1)|complicating disease|3|||
145736313|NCT00088907|525553325|FG001|Randomized Study (Step 1)|complicating disease|1|||
145736314|NCT00088907|525553324|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
145736315|NCT00088907|525553325|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
145736316|NCT00088907|525553324|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
145736317|NCT00088907|525553325|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
145736318|NCT00088907|525553324|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
145736319|NCT00088907|525553325|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
145736320|NCT00088907|525553324|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
145736321|NCT00088907|525553325|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
145736322|NCT00088907|525553324|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
145736323|NCT00088907|525553325|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
145736324|NCT00088907|525553324|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
145736325|NCT00088907|525553325|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
145736326|NCT03426787|525553326|FG000|Overall Study|Withdrawal by Subject|6|||
145736327|NCT03426787|525553326|FG000|Overall Study|Lost to Follow-up|7|||
145736328|NCT03426787|525553326|FG000|Overall Study|Unrelated to intervention death|1|||
145736329|NCT00880555|525553328|FG000|Overall Study|Physician Decision|0|||
145736330|NCT00880555|525553329|FG001|Overall Study|Physician Decision|8|||
145736331|NCT00880555|525553330|FG002|Overall Study|Physician Decision|0|||
145736332|NCT00880555|525553331|FG003|Overall Study|Physician Decision|2|||
145736333|NCT00880555|525553332|FG004|Overall Study|Physician Decision|1|||
145736334|NCT00880555|525553333|FG005|Overall Study|Physician Decision|0|||
145736335|NCT00880555|525553328|FG000|Overall Study|Withdrawal by Subject|1|||
145402263|NCT01125930|524330687|FG000|Overall Study|Protocol Violation|0|||
145516886|NCT04585009|524752405|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145736336|NCT00880555|525553329|FG001|Overall Study|Withdrawal by Subject|1|||
145736337|NCT00880555|525553330|FG002|Overall Study|Withdrawal by Subject|0|||
145736338|NCT00880555|525553331|FG003|Overall Study|Withdrawal by Subject|0|||
145516887|NCT04585009|524752406|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
145516888|NCT04585009|524752395|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145736339|NCT00880555|525553332|FG004|Overall Study|Withdrawal by Subject|0|||
145736340|NCT00880555|525553333|FG005|Overall Study|Withdrawal by Subject|0|||
145736341|NCT00880555|525553328|FG000|Overall Study|Lack of resources (hired rater)|9|||
145736342|NCT00880555|525553329|FG001|Overall Study|Lack of resources (hired rater)|7|||
145736343|NCT00880555|525553330|FG002|Overall Study|Lack of resources (hired rater)|5|||
145736344|NCT00880555|525553331|FG003|Overall Study|Lack of resources (hired rater)|0|||
145736345|NCT00880555|525553332|FG004|Overall Study|Lack of resources (hired rater)|0|||
145736346|NCT00880555|525553333|FG005|Overall Study|Lack of resources (hired rater)|0|||
145736347|NCT00880555|525553328|FG000|Overall Study|Death|0|||
145736348|NCT00880555|525553329|FG001|Overall Study|Death|0|||
145736349|NCT00880555|525553330|FG002|Overall Study|Death|0|||
145736350|NCT00880555|525553331|FG003|Overall Study|Death|0|||
145736351|NCT00880555|525553332|FG004|Overall Study|Death|0|||
145736352|NCT00880555|525553333|FG005|Overall Study|Death|1|||
145736353|NCT00880555|525553328|FG000|Overall Study|Lost to Follow-up|0|||
145736354|NCT00880555|525553329|FG001|Overall Study|Lost to Follow-up|1|||
145736355|NCT00880555|525553330|FG002|Overall Study|Lost to Follow-up|0|||
145736356|NCT00880555|525553331|FG003|Overall Study|Lost to Follow-up|0|||
145736357|NCT00880555|525553332|FG004|Overall Study|Lost to Follow-up|0|||
145736358|NCT00880555|525553333|FG005|Overall Study|Lost to Follow-up|0|||
145736359|NCT02230254|525553334|FG000|Overall Study|Lost to Follow-up|3|||
145736360|NCT02023242|525553335|FG000|Overall Study|Lost to Follow-up|3|||
145736361|NCT02023242|525553336|FG001|Overall Study|Lost to Follow-up|1|||
145736362|NCT02023242|525553335|FG000|Overall Study|Death|0|||
145736363|NCT02023242|525553336|FG001|Overall Study|Death|1|||
145736364|NCT04854434|525553342|FG000|Overall Study|Death|1|||
145736365|NCT04854434|525553343|FG001|Overall Study|Death|3|||
145736366|NCT04854434|525553344|FG002|Overall Study|Death|4|||
145736367|NCT04854434|525553342|FG000|Overall Study|Study Terminated by Sponsor|2|||
145736368|NCT04854434|525553343|FG001|Overall Study|Study Terminated by Sponsor|0|||
145736369|NCT04854434|525553344|FG002|Overall Study|Study Terminated by Sponsor|0|||
145736370|NCT04854434|525553342|FG000|Overall Study|Other|1|||
145736371|NCT04854434|525553343|FG001|Overall Study|Other|1|||
145736372|NCT04854434|525553344|FG002|Overall Study|Other|0|||
145736373|NCT03349775|525553345|FG000|Overall Study|Side Effects|1|||
145736374|NCT03349775|525553346|FG001|Overall Study|Side Effects|2|||
145736375|NCT03349775|525553345|FG000|Overall Study|Withdrawal by Subject|1|||
145736376|NCT03349775|525553346|FG001|Overall Study|Withdrawal by Subject|1|||
145736377|NCT03349775|525553345|FG000|Overall Study|No primary outcome measurements|0|||
145736378|NCT03349775|525553346|FG001|Overall Study|No primary outcome measurements|1|||
145736379|NCT02667275|525553347|FG000|Overall Study|Protocol Violation|11|||
145736380|NCT02667275|525553348|FG001|Overall Study|Protocol Violation|7|||
145736381|NCT02667275|525553347|FG000|Overall Study|Lost to Follow-up|0|||
145736382|NCT02667275|525553348|FG001|Overall Study|Lost to Follow-up|2|||
145736383|NCT02667275|525553347|FG000|Overall Study|Withdrawal by Subject|0|||
145402264|NCT01125930|524330688|FG001|Overall Study|Protocol Violation|1|||
145402265|NCT01125930|524330687|FG000|Overall Study|Lost to Follow-up|0|||
145402266|NCT01125930|524330688|FG001|Overall Study|Lost to Follow-up|2|||
145736384|NCT02667275|525553348|FG001|Overall Study|Withdrawal by Subject|5|||
145736385|NCT02667275|525553347|FG000|Overall Study|Discontinued early without completing|0|||
145736386|NCT02667275|525553348|FG001|Overall Study|Discontinued early without completing|1|||
145736387|NCT01756040|525553349|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
145736388|NCT01756040|525553349|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
145736389|NCT01756040|525553349|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
145736390|NCT01274715|525553350|FG000|Overall Study|Lost to Follow-up|1|||
145736391|NCT01274715|525553350|FG000|Overall Study|After consent, met exclusion criteria.|1|||
145736392|NCT01274715|525553350|FG000|Overall Study|After consent, met exclusion criteria.|1|||
145736393|NCT01274715|525553350|FG000|Overall Study|After consent, met exclusion criteria.|1|||
145736394|NCT04479436|525553351|FG000|Overall Study|Progressive disease|26|||
145736395|NCT04479436|525553352|FG001|Overall Study|Progressive disease|1|||
145736396|NCT04479436|525553351|FG000|Overall Study|Adverse Event|6|||
145736397|NCT04479436|525553352|FG001|Overall Study|Adverse Event|0|||
145736398|NCT04479436|525553351|FG000|Overall Study|Withdrawal by Subject|5|||
145736399|NCT04479436|525553352|FG001|Overall Study|Withdrawal by Subject|0|||
145736400|NCT04479436|525553351|FG000|Overall Study|Clinical progression|1|||
145736401|NCT04479436|525553352|FG001|Overall Study|Clinical progression|0|||
145736402|NCT04479436|525553351|FG000|Overall Study|Physician Decision|1|||
145736403|NCT04479436|525553352|FG001|Overall Study|Physician Decision|0|||
145736404|NCT02357134|525553353|FG000|Overall Study|Lost to Follow-up|1|||
145736405|NCT02357134|525553354|FG001|Overall Study|Lost to Follow-up|0|||
145736406|NCT02357134|525553355|FG002|Overall Study|Lost to Follow-up|0|||
145736407|NCT02357134|525553356|FG003|Overall Study|Lost to Follow-up|0|||
145736408|NCT00467779|525553357|FG000|Stage 1|Adverse Event|1|||
145736409|NCT00467779|525553358|FG001|Stage 1|Adverse Event|0|||
145736410|NCT00467779|525553359|FG002|Stage 1|Adverse Event|0|||
145736411|NCT00467779|525553360|FG003|Stage 1|Adverse Event|0|||
145736412|NCT00467779|525553361|FG004|Stage 1|Adverse Event|0|||
145736413|NCT00467779|525553362|FG005|Stage 1|Adverse Event|1|||
145736414|NCT00467779|525553363|FG006|Stage 1|Adverse Event|2|||
145736415|NCT00467779|525553364|FG007|Stage 1|Adverse Event|1|||
145736416|NCT00467779|525553365|FG008|Stage 1|Adverse Event|0|||
145736417|NCT00467779|525553366|FG009|Stage 1|Adverse Event|0|||
145736418|NCT00467779|525553367|FG010|Stage 1|Adverse Event|0|||
145736419|NCT00467779|525553368|FG011|Stage 1|Adverse Event|0|||
145736420|NCT00467779|525553369|FG012|Stage 1|Adverse Event|0|||
145736421|NCT00467779|525553370|FG013|Stage 1|Adverse Event|0|||
145736422|NCT00467779|525553371|FG014|Stage 1|Adverse Event|0|||
145736423|NCT00467779|525553357|FG000|Stage 1|Disease Progression|2|||
145736424|NCT00467779|525553358|FG001|Stage 1|Disease Progression|2|||
145736425|NCT00467779|525553359|FG002|Stage 1|Disease Progression|2|||
145736426|NCT00467779|525553360|FG003|Stage 1|Disease Progression|3|||
145736427|NCT00467779|525553361|FG004|Stage 1|Disease Progression|2|||
145736428|NCT00467779|525553362|FG005|Stage 1|Disease Progression|2|||
145736429|NCT00467779|525553363|FG006|Stage 1|Disease Progression|4|||
145736430|NCT00467779|525553364|FG007|Stage 1|Disease Progression|5|||
145736431|NCT00467779|525553365|FG008|Stage 1|Disease Progression|0|||
145736432|NCT00467779|525553366|FG009|Stage 1|Disease Progression|0|||
145516889|NCT04585009|524752396|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516890|NCT04585009|524752397|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516891|NCT04585009|524752398|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516892|NCT04585009|524752399|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516893|NCT04585009|524752400|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516894|NCT04585009|524752401|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516895|NCT04585009|524752402|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516896|NCT04585009|524752403|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516897|NCT04585009|524752404|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
145516898|NCT04585009|524752405|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516899|NCT04585009|524752406|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
145516900|NCT04585009|524752395|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516901|NCT04585009|524752396|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516902|NCT04585009|524752397|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145736433|NCT00467779|525553367|FG010|Stage 1|Disease Progression|0|||
145736434|NCT00467779|525553368|FG011|Stage 1|Disease Progression|0|||
145736435|NCT00467779|525553369|FG012|Stage 1|Disease Progression|0|||
145736436|NCT00467779|525553370|FG013|Stage 1|Disease Progression|0|||
145736437|NCT00467779|525553371|FG014|Stage 1|Disease Progression|0|||
145736438|NCT00467779|525553357|FG000|Stage 1|Unspecified Reason|1|||
145736439|NCT00467779|525553358|FG001|Stage 1|Unspecified Reason|0|||
145736440|NCT00467779|525553359|FG002|Stage 1|Unspecified Reason|1|||
145736441|NCT00467779|525553360|FG003|Stage 1|Unspecified Reason|0|||
145736442|NCT00467779|525553361|FG004|Stage 1|Unspecified Reason|1|||
145516903|NCT04585009|524752398|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516904|NCT04585009|524752399|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145736443|NCT00467779|525553362|FG005|Stage 1|Unspecified Reason|2|||
145736444|NCT00467779|525553363|FG006|Stage 1|Unspecified Reason|0|||
145516905|NCT04585009|524752400|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516906|NCT04585009|524752401|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516907|NCT04585009|524752402|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516908|NCT04585009|524752403|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516909|NCT04585009|524752404|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145269005|NCT01058707|523832721|FG002|Overall Study|Reason Not Specified|2|||
145269006|NCT01058707|523832722|FG003|Overall Study|Reason Not Specified|0|||
145269007|NCT01058707|523832723|FG004|Overall Study|Reason Not Specified|7|||
145269008|NCT01058707|523832724|FG005|Overall Study|Reason Not Specified|1|||
145269009|NCT01058707|523832725|FG006|Overall Study|Reason Not Specified|7|||
145269010|NCT01593761|523832727|FG000|Overall Study|Lost to Follow-up|1|||
145269011|NCT01593761|523832727|FG000|Overall Study|culture negative for MRSA at baseline|5|||
145269012|NCT01593761|523832727|FG000|Overall Study|positive for hepatitis C virus|1|||
145269013|NCT01593761|523832727|FG000|Overall Study|secondary cellulitis|1|||
145269014|NCT00795886|523832729|FG000|Overall Study|Death|10|||
145269015|NCT04880850|523832733|FG000|Overall Study|Death|2|||
145269016|NCT04880850|523832734|FG001|Overall Study|Death|1|||
145269017|NCT04880850|523832733|FG000|Overall Study|Lost to Follow-up|3|||
145269018|NCT04880850|523832734|FG001|Overall Study|Lost to Follow-up|6|||
145269019|NCT04880850|523832733|FG000|Overall Study|Physician Decision|2|||
145269020|NCT04880850|523832734|FG001|Overall Study|Physician Decision|1|||
145269021|NCT04880850|523832733|FG000|Overall Study|Withdrawal by Subject|9|||
145269022|NCT04880850|523832734|FG001|Overall Study|Withdrawal by Subject|10|||
145269023|NCT03417102|523832735|FG000|Overall Study|Adverse Event|0|||
145269024|NCT03417102|523832736|FG001|Overall Study|Adverse Event|1|||
145269025|NCT03417102|523832735|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
145269026|NCT03417102|523832736|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
145269027|NCT03417102|523832735|FG000|Overall Study|Other|0|||
145269028|NCT03417102|523832736|FG001|Overall Study|Other|1|||
145269029|NCT03188991|523832738|FG000|Overall Study|Withdrawal by Subject|0|||
145269030|NCT03188991|523832739|FG001|Overall Study|Withdrawal by Subject|0|||
145269031|NCT03188991|523832740|FG002|Overall Study|Withdrawal by Subject|0|||
145269032|NCT03188991|523832741|FG003|Overall Study|Withdrawal by Subject|1|||
145269033|NCT01656850|523833815|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
145269034|NCT01656850|523833816|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
145269035|NCT02674568|523833817|FG000|Overall Study|Withdrawal by Subject|5|||
145269036|NCT02674568|523833817|FG000|Overall Study|Death|303|||
145269037|NCT02674568|523833817|FG000|Overall Study|Physician Decision|2|||
145269038|NCT02674568|523833817|FG000|Overall Study|Lost to Follow-up|9|||
145269039|NCT02674568|523833817|FG000|Overall Study|Other, Not Specified|20|||
145269040|NCT00396318|523833818|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
145269041|NCT01118949|523833819|FG000|Overall Study|Adverse Event|5|||
145269042|NCT01118949|523833819|FG000|Overall Study|Withdrawal by Subject|4|||
145269043|NCT03255226|523833825|FG000|Overall Study|Adverse Event|2|||
145269044|NCT03255226|523833825|FG000|Overall Study|Physician Decision|3|||
145269045|NCT03255226|523833825|FG000|Overall Study|Withdrawal by Subject|1|||
145269046|NCT03255226|523833825|FG000|Overall Study|Serum or blood sodium increased|4|||
145269047|NCT03255226|523833825|FG000|Overall Study|Serum or blood potassium increased|4|||
145269048|NCT00602927|523833826|FG000|Period 1: 13 Days|Protocol Violation|2|||
145269049|NCT00602927|523833827|FG001|Period 1: 13 Days|Protocol Violation|4|||
145269050|NCT00602927|523833826|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
145269051|NCT00602927|523833827|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
145269052|NCT00602927|523833826|FG000|Period 1: 13 Days|Time|1|||
145269053|NCT00602927|523833827|FG001|Period 1: 13 Days|Time|0|||
145269054|NCT00602927|523833826|FG000|Period 1: 13 Days|Claustrophobia|0|||
145269055|NCT00602927|523833827|FG001|Period 1: 13 Days|Claustrophobia|1|||
145269056|NCT00602927|523833826|FG000|Period 2: 14 Days|Protocol Violation|0|||
145269057|NCT00602927|523833827|FG001|Period 2: 14 Days|Protocol Violation|2|||
145269058|NCT00602927|523833826|FG000|Period 3: 13 Days|Protocol Violation|0|||
145269059|NCT00602927|523833827|FG001|Period 3: 13 Days|Protocol Violation|1|||
145269060|NCT00602927|523833826|FG000|Period 3: 13 Days|MRI data quality|2|||
145269061|NCT00602927|523833827|FG001|Period 3: 13 Days|MRI data quality|2|||
145269062|NCT00685763|523833834|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
145269063|NCT00685763|523833834|FG000|Overall Study|Protocol Violation|1|||
145269064|NCT02525627|523833835|FG000|Overall Study|Revision|1|||
145269065|NCT02525627|523833836|FG001|Overall Study|Revision|1|||
145269066|NCT02525627|523833835|FG000|Overall Study|Withdrawal by Subject|1|||
145269067|NCT02525627|523833836|FG001|Overall Study|Withdrawal by Subject|2|||
145269068|NCT02525627|523833835|FG000|Overall Study|Death|1|||
145269069|NCT02525627|523833836|FG001|Overall Study|Death|0|||
145269070|NCT02525627|523833835|FG000|Overall Study|Site terminated|11|||
145269071|NCT02525627|523833836|FG001|Overall Study|Site terminated|10|||
145269072|NCT02875340|523833838|FG000|Overall Study|Death|2|||
145269073|NCT02875340|523833838|FG000|Overall Study|Withdrawal by Subject|2|||
145269074|NCT02875340|523833838|FG000|Overall Study|Physician Decision|3|||
145269075|NCT02875340|523833838|FG000|Overall Study|Adverse Event|1|||
145269076|NCT01160770|523833839|FG000|Overall Study|Adverse Event|10|||
145269077|NCT01160770|523833839|FG000|Overall Study|Protocol Violation|2|||
145269078|NCT01160770|523833839|FG000|Overall Study|Subject/parent/caregiver request|33|||
145269079|NCT01160770|523833839|FG000|Overall Study|Physician Decision|1|||
145269080|NCT01160770|523833839|FG000|Overall Study|Lost to Follow-up|7|||
145269081|NCT01160770|523833839|FG000|Overall Study|Study termination or sponsor request|1|||
145607144|NCT02277743|525076984|FG000|Overall Study|Lack of Efficacy|11|||
145607145|NCT02277743|525076985|FG001|Overall Study|Lack of Efficacy|4|||
145607146|NCT02277743|525076986|FG002|Overall Study|Lack of Efficacy|3|||
145607147|NCT02277743|525076984|FG000|Overall Study|Other than specified above|18|||
145607148|NCT02277743|525076985|FG001|Overall Study|Other than specified above|5|||
145607149|NCT02277743|525076986|FG002|Overall Study|Other than specified above|16|||
145607150|NCT01224158|525076987|FG000|Overall Study|Withdrawal by Subject|1|||
145607151|NCT01224158|525076988|FG001|Overall Study|Withdrawal by Subject|0|||
145607152|NCT03976466|525076991|FG000|Overall Study|Lost to Follow-up|1|||
145607153|NCT03976466|525076992|FG001|Overall Study|Lost to Follow-up|3|||
145607154|NCT02055157|525076993|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
145607155|NCT02055157|525076994|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
145607156|NCT02055157|525076995|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
145607157|NCT02055157|525076996|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
145607158|NCT02055157|525076993|FG000|Initial 6 Months|Adverse Event|0|||
145607159|NCT02055157|525076994|FG001|Initial 6 Months|Adverse Event|0|||
145607160|NCT02055157|525076995|FG002|Initial 6 Months|Adverse Event|0|||
145607161|NCT02055157|525076996|FG003|Initial 6 Months|Adverse Event|1|||
145607162|NCT02055157|525076993|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
145607163|NCT02055157|525076994|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
145607164|NCT02055157|525076995|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
145607165|NCT02055157|525076996|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
145607166|NCT02055157|525076993|FG000|18-month Extension|Investigator decision|0|||
145607167|NCT02055157|525076994|FG001|18-month Extension|Investigator decision|1|||
145607168|NCT02055157|525076995|FG002|18-month Extension|Investigator decision|0|||
145269082|NCT01160770|523833839|FG000|Overall Study|Death|9|||
145269083|NCT01160770|523833839|FG000|Overall Study|Lack of Efficacy|15|||
145269084|NCT01160770|523833839|FG000|Overall Study|Other Reasons|1|||
145269085|NCT04930536|523833840|FG000|Overall Study|Adverse Event|1|||
145269086|NCT04930536|523833841|FG001|Overall Study|Adverse Event|0|||
145269087|NCT04930536|523833840|FG000|Overall Study|Disease Progression|2|||
145269088|NCT04930536|523833841|FG001|Overall Study|Disease Progression|0|||
145269089|NCT04930536|523833840|FG000|Overall Study|Patient Decision|4|||
145269090|NCT04930536|523833841|FG001|Overall Study|Patient Decision|2|||
145269091|NCT04930536|523833840|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
145269092|NCT04930536|523833841|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
145269093|NCT01432600|523833842|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
145269094|NCT01432600|523833843|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
145269095|NCT01432600|523833844|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
145269096|NCT00348348|523833848|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
145269097|NCT00348348|523833849|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
145269098|NCT00348348|523833848|FG000|Overall Study|Lack of Efficacy|1|||
145269099|NCT00348348|523833849|FG001|Overall Study|Lack of Efficacy|1|||
145269100|NCT00348348|523833848|FG000|Overall Study|Lost to Follow-up|8|||
145269101|NCT00348348|523833849|FG001|Overall Study|Lost to Follow-up|10|||
145269102|NCT00348348|523833848|FG000|Overall Study|Withdrawal by Subject|4|||
145269103|NCT00348348|523833849|FG001|Overall Study|Withdrawal by Subject|1|||
145269104|NCT00348348|523833848|FG000|Overall Study|Other|7|||
145269105|NCT00348348|523833849|FG001|Overall Study|Other|4|||
145269106|NCT00348348|523833848|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
145269107|NCT00348348|523833849|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
145269108|NCT00348348|523833848|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
145269109|NCT00348348|523833849|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
145269110|NCT00348348|523833848|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
145269111|NCT00348348|523833849|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
145269112|NCT00348348|523833848|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
145269113|NCT00348348|523833849|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
145269114|NCT00348348|523833848|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
145269115|NCT00348348|523833849|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
145269116|NCT00348348|523833848|FG000|Overall Study|Adverse event probably related to study|1|||
145269117|NCT00348348|523833849|FG001|Overall Study|Adverse event probably related to study|0|||
145269118|NCT01605370|523833852|FG000|Overall Study|Adverse Event|1|||
145269119|NCT01605370|523833853|FG001|Overall Study|Adverse Event|0|||
145269120|NCT05102162|523833857|FG000|Overall Study|Withdrawal by Subject|3|||
145269121|NCT05102162|523833858|FG001|Overall Study|Withdrawal by Subject|0|||
145269122|NCT05102162|523833857|FG000|Overall Study|Baseline cultures negative|4|||
145269123|NCT05102162|523833858|FG001|Overall Study|Baseline cultures negative|2|||
145269124|NCT05102162|523833857|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
145269125|NCT05102162|523833858|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
145269126|NCT05102162|523833857|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
145269127|NCT05102162|523833858|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
145269128|NCT01165424|523833859|FG000|Overall Study|Clinical adverse experiences|1|||
145269129|NCT01165424|523833859|FG000|Overall Study|Laboratory adverse experiences|1|||
145269130|NCT01165424|523833859|FG000|Overall Study|Did not meet entry criteria|1|||
145269131|NCT01165424|523833859|FG000|Overall Study|Participant moved (relocated)|1|||
145269132|NCT02181673|523833860|FG000|Up to Week 24|Adverse Event|2|||
145269133|NCT02181673|523833861|FG001|Up to Week 24|Adverse Event|0|||
145269134|NCT02181673|523833862|FG002|Up to Week 24|Adverse Event|3|||
145269135|NCT02181673|523833860|FG000|Up to Week 24|Death|1|||
145269136|NCT02181673|523833861|FG001|Up to Week 24|Death|0|||
145269137|NCT02181673|523833862|FG002|Up to Week 24|Death|0|||
145269138|NCT02181673|523833860|FG000|Up to Week 24|Lack of Efficacy|1|||
145269139|NCT02181673|523833861|FG001|Up to Week 24|Lack of Efficacy|0|||
145269140|NCT02181673|523833862|FG002|Up to Week 24|Lack of Efficacy|0|||
145269141|NCT02181673|523833860|FG000|Up to Week 24|Lost to Follow-up|1|||
145269142|NCT02181673|523833861|FG001|Up to Week 24|Lost to Follow-up|0|||
145269143|NCT02181673|523833862|FG002|Up to Week 24|Lost to Follow-up|0|||
145269144|NCT02181673|523833860|FG000|Up to Week 24|Physician Decision|0|||
145269145|NCT02181673|523833861|FG001|Up to Week 24|Physician Decision|0|||
145269146|NCT02181673|523833862|FG002|Up to Week 24|Physician Decision|3|||
145269147|NCT02181673|523833860|FG000|Up to Week 24|Withdrawal by Subject|10|||
145269148|NCT02181673|523833861|FG001|Up to Week 24|Withdrawal by Subject|0|||
145269149|NCT02181673|523833862|FG002|Up to Week 24|Withdrawal by Subject|1|||
145269150|NCT02181673|523833860|FG000|Up to Week 24|Other|2|||
145269151|NCT02181673|523833861|FG001|Up to Week 24|Other|0|||
145269152|NCT02181673|523833862|FG002|Up to Week 24|Other|3|||
145269153|NCT02181673|523833860|FG000|Up to Week 24|Randomized not Treated|0|||
145269154|NCT02181673|523833861|FG001|Up to Week 24|Randomized not Treated|0|||
145269155|NCT02181673|523833862|FG002|Up to Week 24|Randomized not Treated|1|||
145269156|NCT02181673|523833860|FG000|Week 24-Week 60|Adverse Event|0|||
145269157|NCT02181673|523833861|FG001|Week 24-Week 60|Adverse Event|4|||
145269158|NCT02181673|523833862|FG002|Week 24-Week 60|Adverse Event|10|||
145269159|NCT02181673|523833860|FG000|Week 24-Week 60|Other|0|||
145269160|NCT02181673|523833861|FG001|Week 24-Week 60|Other|2|||
145269161|NCT02181673|523833862|FG002|Week 24-Week 60|Other|1|||
145269162|NCT02181673|523833860|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
145269163|NCT02181673|523833861|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
145269164|NCT02181673|523833862|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
145269165|NCT02181673|523833860|FG000|Week 24-Week 60|Pregnancy|0|||
145269166|NCT02181673|523833861|FG001|Week 24-Week 60|Pregnancy|0|||
145607169|NCT02055157|525076996|FG003|18-month Extension|Investigator decision|0|||
145607170|NCT02055157|525076993|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
145607171|NCT02055157|525076994|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
145607172|NCT02055157|525076995|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
145607173|NCT02055157|525076996|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
145607174|NCT00733499|525076999|FG000|Pre-operative|Protocol Violation|0|||
145607175|NCT00733499|525077000|FG001|Pre-operative|Protocol Violation|1|||
145607176|NCT00733499|525076999|FG000|3 Months Follow-up|Death|1|||
145607177|NCT00733499|525077000|FG001|3 Months Follow-up|Death|2|||
145607178|NCT00733499|525076999|FG000|6 Months Follow-up|Death|0|||
145607179|NCT00733499|525077000|FG001|6 Months Follow-up|Death|2|||
145607180|NCT00733499|525076999|FG000|6 Months Follow-up|Adverse Event|0|||
145607181|NCT00733499|525077000|FG001|6 Months Follow-up|Adverse Event|1|||
145607182|NCT00733499|525076999|FG000|12 Months Follow-up|Death|2|||
145269167|NCT02181673|523833862|FG002|Week 24-Week 60|Pregnancy|1|||
145269168|NCT02181673|523833860|FG000|Week 24-Week 60|Lack of Efficacy|0|||
145269169|NCT02181673|523833861|FG001|Week 24-Week 60|Lack of Efficacy|0|||
145269170|NCT02181673|523833862|FG002|Week 24-Week 60|Lack of Efficacy|1|||
145269171|NCT02181673|523833860|FG000|Week 24-Week 60|Lost to Follow-up|0|||
145269172|NCT02181673|523833861|FG001|Week 24-Week 60|Lost to Follow-up|0|||
145269173|NCT02181673|523833862|FG002|Week 24-Week 60|Lost to Follow-up|1|||
145269174|NCT02181673|523833860|FG000|Week 24-Week 60|Physician Decision|0|||
145269175|NCT02181673|523833861|FG001|Week 24-Week 60|Physician Decision|0|||
145269176|NCT02181673|523833862|FG002|Week 24-Week 60|Physician Decision|1|||
145269177|NCT00433771|523833863|FG000|Overall Study|screen fail|14|||
145269178|NCT00433771|523833863|FG000|Overall Study|Treated and later found to be ineligible|2|||
145269179|NCT00433771|523833863|FG000|Overall Study|Death|2|||
145269180|NCT00433771|523833863|FG000|Overall Study|Failure to deploy stent|1|||
145269181|NCT02871921|523833866|FG000|Overall Study|Withdrawal by Subject|34|||
145269182|NCT02871921|523833867|FG001|Overall Study|Withdrawal by Subject|27|||
145607183|NCT00733499|525077000|FG001|12 Months Follow-up|Death|1|||
145607184|NCT00733499|525076999|FG000|24 Months Follow-up|Death|0|||
145607185|NCT00733499|525077000|FG001|24 Months Follow-up|Death|1|||
145607186|NCT00733499|525076999|FG000|5 Year Followup|Adverse Event|2|||
145607187|NCT00733499|525077000|FG001|5 Year Followup|Adverse Event|2|||
145607188|NCT00733499|525076999|FG000|5 Year Followup|Non device related AE|0|||
145607189|NCT00733499|525077000|FG001|5 Year Followup|Non device related AE|1|||
145607190|NCT00733499|525076999|FG000|5 Year Followup|Revision of Study Implant|0|||
145607191|NCT00733499|525077000|FG001|5 Year Followup|Revision of Study Implant|1|||
145607192|NCT00733499|525076999|FG000|5 Year Followup|Lost to Follow-up|2|||
145607193|NCT00733499|525077000|FG001|5 Year Followup|Lost to Follow-up|0|||
145607194|NCT00733499|525076999|FG000|5 Year Followup|Death|13|||
145607195|NCT00733499|525077000|FG001|5 Year Followup|Death|19|||
145607196|NCT00733499|525076999|FG000|5 Year Followup|missing, unable to locate|0|||
145607197|NCT00733499|525077000|FG001|5 Year Followup|missing, unable to locate|1|||
145607198|NCT00733499|525076999|FG000|5 Year Followup|Withdrawal by Subject|4|||
145607199|NCT00733499|525077000|FG001|5 Year Followup|Withdrawal by Subject|1|||
145607200|NCT00733499|525076999|FG000|10 Year Followup|Death|9|||
145607201|NCT00733499|525077000|FG001|10 Year Followup|Death|7|||
145607202|NCT00733499|525076999|FG000|10 Year Followup|Adverse Event|3|||
145607203|NCT00733499|525077000|FG001|10 Year Followup|Adverse Event|3|||
145607204|NCT00733499|525076999|FG000|10 Year Followup|Lost to Follow-up|3|||
145607205|NCT00733499|525077000|FG001|10 Year Followup|Lost to Follow-up|2|||
145269183|NCT02871921|523833868|FG002|Overall Study|Withdrawal by Subject|27|||
145607206|NCT00733499|525076999|FG000|10 Year Followup|Withdrawal by Subject|5|||
145607207|NCT00733499|525077000|FG001|10 Year Followup|Withdrawal by Subject|5|||
145607208|NCT00733499|525076999|FG000|10 Year Followup|missing, unable to locate|0|||
145607209|NCT00733499|525077000|FG001|10 Year Followup|missing, unable to locate|2|||
145607210|NCT02739347|525077001|FG000|Overall Study|Adverse Event|3|||
145607211|NCT02739347|525077002|FG001|Overall Study|Adverse Event|0|||
145607212|NCT02739347|525077001|FG000|Overall Study|Protocol Violation|0|||
145607213|NCT02739347|525077002|FG001|Overall Study|Protocol Violation|1|||
145607214|NCT02739347|525077001|FG000|Overall Study|Lost to Follow-up|0|||
145607215|NCT02739347|525077002|FG001|Overall Study|Lost to Follow-up|2|||
145607216|NCT01931735|525077003|FG000|Randomized Phase|Lost to Follow-up|2|||
145607217|NCT01931735|525077004|FG001|Randomized Phase|Lost to Follow-up|2|||
145607218|NCT01931735|525077005|FG002|Randomized Phase|Lost to Follow-up|5|||
145607219|NCT01931735|525077006|FG003|Randomized Phase|Lost to Follow-up|0|||
145607220|NCT01931735|525077003|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
145607221|NCT01931735|525077004|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
145607222|NCT01931735|525077005|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
145607223|NCT01931735|525077006|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
145607224|NCT01931735|525077003|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
145607225|NCT01931735|525077004|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
145607226|NCT01931735|525077005|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
145269184|NCT02871921|523833869|FG003|Overall Study|Withdrawal by Subject|30|||
145607227|NCT01931735|525077006|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
145607228|NCT01395823|525077007|FG000|Overall Study|Death|4|||
145607229|NCT01395823|525077008|FG001|Overall Study|Death|4|||
145607230|NCT01395823|525077007|FG000|Overall Study|Physician Decision|3|||
145607231|NCT01395823|525077008|FG001|Overall Study|Physician Decision|1|||
145607232|NCT01395823|525077007|FG000|Overall Study|Lost to Follow-up|1|||
145607233|NCT01395823|525077008|FG001|Overall Study|Lost to Follow-up|0|||
145607234|NCT01395823|525077007|FG000|Overall Study|Transplant|1|||
145269185|NCT00320801|523833870|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
145607235|NCT01395823|525077008|FG001|Overall Study|Transplant|0|||
145607236|NCT01395823|525077007|FG000|Overall Study|GI symptoms|1|||
145269186|NCT00320801|523833871|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
145607237|NCT01395823|525077008|FG001|Overall Study|GI symptoms|0|||
145607238|NCT01395823|525077007|FG000|Overall Study|Withdrawal by Subject|5|||
145607239|NCT01395823|525077008|FG001|Overall Study|Withdrawal by Subject|4|||
145607240|NCT02719990|525077009|FG000|Overall Study|Physician Decision|2|||
145607241|NCT02719990|525077009|FG000|Overall Study|Withdrawal by Subject|2|||
145607242|NCT02719990|525077009|FG000|Overall Study|Study Terminated By Sponsor|32|||
145607243|NCT00717314|525077011|FG000|Overall Study|Adverse Event|3|||
145607244|NCT00717314|525077012|FG001|Overall Study|Adverse Event|2|||
145607245|NCT00717314|525077011|FG000|Overall Study|Protocol Violation|1|||
145607246|NCT00717314|525077012|FG001|Overall Study|Protocol Violation|0|||
145607247|NCT00717314|525077011|FG000|Overall Study|Lost to Follow-up|1|||
145607248|NCT00717314|525077012|FG001|Overall Study|Lost to Follow-up|5|||
145607249|NCT00717314|525077011|FG000|Overall Study|Withdrawal by Subject|1|||
145607250|NCT00717314|525077012|FG001|Overall Study|Withdrawal by Subject|3|||
145607251|NCT05076149|525077013|FG000|Overall Study|Adverse Event|3|||
145607252|NCT05076149|525077014|FG001|Overall Study|Adverse Event|9|||
145607253|NCT05076149|525077013|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145607254|NCT05076149|525077014|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
145607255|NCT05076149|525077013|FG000|Overall Study|Lost to Follow-up|0|||
145607256|NCT05076149|525077014|FG001|Overall Study|Lost to Follow-up|1|||
145607257|NCT05076149|525077013|FG000|Overall Study|Commercial drug is available for participant|0|||
145607258|NCT05076149|525077014|FG001|Overall Study|Commercial drug is available for participant|1|||
145607259|NCT05076149|525077013|FG000|Overall Study|Other non compliance|1|||
145607260|NCT05076149|525077014|FG001|Overall Study|Other non compliance|1|||
145607261|NCT05076149|525077013|FG000|Overall Study|Physician Decision|0|||
145607262|NCT05076149|525077014|FG001|Overall Study|Physician Decision|1|||
145607263|NCT05076149|525077013|FG000|Overall Study|Other|5|||
145607264|NCT05076149|525077014|FG001|Overall Study|Other|4|||
145607265|NCT05096208|525077015|FG000|Overall Study|Lost to Follow-up|3|||
145607266|NCT05096208|525077016|FG001|Overall Study|Lost to Follow-up|5|||
145607267|NCT05096208|525077017|FG002|Overall Study|Lost to Follow-up|5|||
145607268|NCT05096208|525077018|FG003|Overall Study|Lost to Follow-up|2|||
145607269|NCT05096208|525077015|FG000|Overall Study|Withdrawal by Subject|0|||
145607270|NCT05096208|525077016|FG001|Overall Study|Withdrawal by Subject|1|||
145607271|NCT05096208|525077017|FG002|Overall Study|Withdrawal by Subject|2|||
145607272|NCT05096208|525077018|FG003|Overall Study|Withdrawal by Subject|3|||
145607273|NCT05096208|525077015|FG000|Overall Study|No longer met eligibility criteria|1|||
145607274|NCT05096208|525077016|FG001|Overall Study|No longer met eligibility criteria|0|||
145607275|NCT05096208|525077017|FG002|Overall Study|No longer met eligibility criteria|0|||
145607276|NCT05096208|525077018|FG003|Overall Study|No longer met eligibility criteria|0|||
145607277|NCT05096208|525077015|FG000|Overall Study|Other|0|||
145607278|NCT05096208|525077016|FG001|Overall Study|Other|0|||
145607279|NCT05096208|525077017|FG002|Overall Study|Other|1|||
145607280|NCT05096208|525077018|FG003|Overall Study|Other|0|||
145607281|NCT00782496|525077019|FG000|Overall Study|Lost to Follow-up|14|||
145607282|NCT00782496|525077020|FG001|Overall Study|Lost to Follow-up|15|||
145607283|NCT01919970|525077024|FG000|Overall Study|Withdrawal by Subject|3|||
145607284|NCT01919970|525077025|FG001|Overall Study|Withdrawal by Subject|0|||
145607285|NCT04043962|525077026|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
145607286|NCT04043962|525077026|FG000|Post-Treatment|Withdrawal by Subject|5|||
145607287|NCT04043962|525077026|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
145607288|NCT00990340|525077028|FG000|First 14-day Treatment|Not Compliant|2|||
145607289|NCT00990340|525077029|FG001|First 14-day Treatment|Not Compliant|1|||
145607290|NCT00990340|525077028|FG000|First 14-day Treatment|Lost to Follow-up|2|||
145607291|NCT00990340|525077029|FG001|First 14-day Treatment|Lost to Follow-up|1|||
145607292|NCT00990340|525077028|FG000|First 14-day Treatment|Protocol Violation|2|||
145607293|NCT00990340|525077029|FG001|First 14-day Treatment|Protocol Violation|2|||
145607294|NCT04615182|525077030|FG000|Overall Study|Re-transplanted|2|||
145607295|NCT04615182|525077030|FG000|Overall Study|Protocol Violation|6|||
145607296|NCT04615182|525077030|FG000|Overall Study|Death|6|||
145607297|NCT04615182|525077030|FG000|Overall Study|Death and protocol violation|1|||
145607298|NCT02130284|525077034|FG000|Overall Study|Withdrawal by Subject|3|||
145607299|NCT02130284|525077034|FG000|Overall Study|Subject Withdrew Consent|1|||
145607300|NCT02130284|525077034|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
145607301|NCT02130284|525077034|FG000|Overall Study|Subject was screened as backup for study|3|||
145607302|NCT02130284|525077034|FG000|Overall Study|Screen Failure|1|||
145607303|NCT01119898|525077037|FG000|Overall Study|Adverse Event|4|||
145607304|NCT01119898|525077038|FG001|Overall Study|Adverse Event|5|||
145607305|NCT01119898|525077037|FG000|Overall Study|Withdrawal by Subject|1|||
145607306|NCT01119898|525077038|FG001|Overall Study|Withdrawal by Subject|4|||
145607307|NCT01119898|525077037|FG000|Overall Study|Lack of Efficacy|0|||
145607308|NCT01119898|525077038|FG001|Overall Study|Lack of Efficacy|2|||
145516910|NCT04585009|524752405|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
145516911|NCT04585009|524752406|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
145516912|NCT00097981|524752407|FG000|Overall Study|Adverse Event|31|||
145516913|NCT00097981|524752408|FG001|Overall Study|Adverse Event|44|||
145516914|NCT00097981|524752407|FG000|Overall Study|Withdrawal by Subject|10|||
145516915|NCT00097981|524752408|FG001|Overall Study|Withdrawal by Subject|8|||
145516916|NCT00097981|524752407|FG000|Overall Study|Protocol Violation|1|||
145516917|NCT00097981|524752408|FG001|Overall Study|Protocol Violation|1|||
145516918|NCT00097981|524752407|FG000|Overall Study|Death|2|||
145516919|NCT00097981|524752408|FG001|Overall Study|Death|4|||
145516920|NCT00097981|524752407|FG000|Overall Study|Physician Decision|7|||
145516921|NCT00097981|524752408|FG001|Overall Study|Physician Decision|1|||
145516922|NCT00097981|524752407|FG000|Overall Study|Disease Progression|8|||
145516923|NCT00097981|524752408|FG001|Overall Study|Disease Progression|2|||
145516924|NCT00097981|524752407|FG000|Overall Study|Transplant planned|28|||
145516925|NCT00097981|524752408|FG001|Overall Study|Transplant planned|27|||
145516926|NCT00097981|524752407|FG000|Overall Study|Other|19|||
145516927|NCT00097981|524752408|FG001|Overall Study|Other|13|||
145607309|NCT01119898|525077037|FG000|Overall Study|Protocol Violation|1|||
145607310|NCT01119898|525077038|FG001|Overall Study|Protocol Violation|1|||
145607311|NCT01119898|525077037|FG000|Overall Study|Medical procedure|1|||
145607312|NCT01119898|525077038|FG001|Overall Study|Medical procedure|0|||
145607313|NCT01119898|525077037|FG000|Overall Study|Randomized in error did not participate|1|||
145607314|NCT01119898|525077038|FG001|Overall Study|Randomized in error did not participate|0|||
145607315|NCT00116844|525077039|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
145607316|NCT00116844|525077040|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
145607317|NCT00116844|525077039|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
145607318|NCT00116844|525077040|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
145607319|NCT00116844|525077039|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
145607320|NCT00116844|525077040|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
145607321|NCT00116844|525077039|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
145607322|NCT00116844|525077040|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
145607323|NCT00116844|525077039|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
145607324|NCT00116844|525077040|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
145607325|NCT00116844|525077039|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
145607326|NCT00116844|525077040|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
145607327|NCT00116844|525077039|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
145607328|NCT00116844|525077040|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
145607329|NCT00116844|525077039|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
145607330|NCT00116844|525077040|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
145607331|NCT00116844|525077039|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
145607332|NCT00116844|525077040|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
145607333|NCT03995784|525077041|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
145607334|NCT01786330|525077045|FG000|Overall Study|Withdrawal by Subject|0|||
145607335|NCT01786330|525077046|FG001|Overall Study|Withdrawal by Subject|1|||
145607336|NCT01786330|525077045|FG000|Overall Study|Lost to Follow-up|0|||
145607337|NCT01786330|525077046|FG001|Overall Study|Lost to Follow-up|1|||
145607338|NCT01786330|525077045|FG000|Overall Study|Excluded intraoperatively|0|||
145607339|NCT01786330|525077046|FG001|Overall Study|Excluded intraoperatively|1|||
145607340|NCT01786330|525077045|FG000|Overall Study|Protocol Violation|1|||
145607341|NCT01786330|525077046|FG001|Overall Study|Protocol Violation|0|||
145607342|NCT02172625|525077047|FG000|Overall Study|Adverse Event|0|||
145607343|NCT02172625|525077048|FG001|Overall Study|Adverse Event|1|||
145607344|NCT02172625|525077047|FG000|Overall Study|Pregnancy|0|||
145607345|NCT02172625|525077048|FG001|Overall Study|Pregnancy|1|||
145607346|NCT02172625|525077047|FG000|Overall Study|car accident|0|||
145607347|NCT02172625|525077048|FG001|Overall Study|car accident|1|||
145607348|NCT01816763|525079143|FG000|Overall Study|The main reason for an incomplete survey|4|||
145607349|NCT01816763|525079144|FG001|Overall Study|The main reason for an incomplete survey|15|||
145607350|NCT01816763|525079145|FG002|Overall Study|The main reason for an incomplete survey|11|||
145607351|NCT00429494|525079146|FG000|Overall Study|Withdrawal by Subject|9|||
145607352|NCT00429494|525079146|FG000|Overall Study|Death|6|||
145607353|NCT00976703|525079147|FG000|Overall Study|Physician Decision|1|||
145607354|NCT00976703|525079148|FG001|Overall Study|Physician Decision|1|||
145607355|NCT00976703|525079147|FG000|Overall Study|ineligible for study|2|||
145607356|NCT00976703|525079148|FG001|Overall Study|ineligible for study|2|||
145607357|NCT01900054|525079152|FG000|Overall Study|Physician Decision|1|||
145607358|NCT01900054|525079152|FG000|Overall Study|Withdrawal by Subject|1|||
145607359|NCT01186328|525079153|FG000|Overall Study|Death|1|||
145607360|NCT01186328|525079154|FG001|Overall Study|Death|0|||
145516928|NCT01713933|524752409|FG000|Overall Study|Lost to Follow-up|2|||
145516929|NCT01713933|524752409|FG000|Overall Study|Withdrawal by Subject|3|||
145516930|NCT01713933|524752409|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
145516931|NCT00412373|524752412|FG000|Overall Study|Adverse Event|8|||
145269187|NCT00320801|523833872|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
145269188|NCT00320801|523833873|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
145269189|NCT00320801|523833870|FG000|Open-label Run-in Period|Adverse Event|33|||
145269190|NCT00320801|523833871|FG001|Open-label Run-in Period|Adverse Event|0|||
145269191|NCT00320801|523833872|FG002|Open-label Run-in Period|Adverse Event|0|||
145269192|NCT00320801|523833873|FG003|Open-label Run-in Period|Adverse Event|0|||
145269193|NCT00320801|523833870|FG000|Open-label Run-in Period|Administrative|10|||
145269194|NCT00320801|523833871|FG001|Open-label Run-in Period|Administrative|0|||
145269195|NCT00320801|523833872|FG002|Open-label Run-in Period|Administrative|0|||
145269196|NCT00320801|523833873|FG003|Open-label Run-in Period|Administrative|0|||
145269197|NCT00320801|523833870|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
145269198|NCT00320801|523833871|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
145269199|NCT00320801|523833872|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
145269200|NCT00320801|523833873|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
145269201|NCT00320801|523833870|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
145269202|NCT00320801|523833871|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
145269203|NCT00320801|523833872|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
145269204|NCT00320801|523833873|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
145269205|NCT00320801|523833870|FG000|Open-label Run-in Period|Did not qualify|1|||
145269206|NCT00320801|523833871|FG001|Open-label Run-in Period|Did not qualify|0|||
145269207|NCT00320801|523833872|FG002|Open-label Run-in Period|Did not qualify|0|||
145269208|NCT00320801|523833873|FG003|Open-label Run-in Period|Did not qualify|0|||
145269209|NCT00320801|523833870|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145269210|NCT00320801|523833871|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145269211|NCT00320801|523833872|FG002|Double-blind Phase|Withdrawal by Subject|1|||
145269212|NCT00320801|523833873|FG003|Double-blind Phase|Withdrawal by Subject|0|||
145269213|NCT00320801|523833870|FG000|Double-blind Phase|Adverse Event|0|||
145269214|NCT00320801|523833871|FG001|Double-blind Phase|Adverse Event|2|||
145269215|NCT00320801|523833872|FG002|Double-blind Phase|Adverse Event|8|||
145269216|NCT00320801|523833873|FG003|Double-blind Phase|Adverse Event|0|||
145269217|NCT00320801|523833870|FG000|Double-blind Phase|Administrative|0|||
145269218|NCT00320801|523833871|FG001|Double-blind Phase|Administrative|0|||
145269219|NCT00320801|523833872|FG002|Double-blind Phase|Administrative|4|||
145269220|NCT00320801|523833873|FG003|Double-blind Phase|Administrative|0|||
145269221|NCT00320801|523833870|FG000|Double-blind Phase|Lack of Efficacy|0|||
145269222|NCT00320801|523833871|FG001|Double-blind Phase|Lack of Efficacy|9|||
145269223|NCT00320801|523833872|FG002|Double-blind Phase|Lack of Efficacy|1|||
145269224|NCT00320801|523833873|FG003|Double-blind Phase|Lack of Efficacy|0|||
145269225|NCT00320801|523833870|FG000|Extension Phase|Withdrawal by Subject|0|||
145269226|NCT00320801|523833871|FG001|Extension Phase|Withdrawal by Subject|0|||
145269227|NCT00320801|523833872|FG002|Extension Phase|Withdrawal by Subject|0|||
145269228|NCT00320801|523833873|FG003|Extension Phase|Withdrawal by Subject|6|||
145269229|NCT00320801|523833870|FG000|Extension Phase|Adverse Event|0|||
145269230|NCT00320801|523833871|FG001|Extension Phase|Adverse Event|0|||
145269231|NCT00320801|523833872|FG002|Extension Phase|Adverse Event|0|||
145269232|NCT00320801|523833873|FG003|Extension Phase|Adverse Event|8|||
145269233|NCT00320801|523833870|FG000|Extension Phase|Administrative|0|||
145269234|NCT00320801|523833871|FG001|Extension Phase|Administrative|0|||
145269235|NCT00320801|523833872|FG002|Extension Phase|Administrative|0|||
145269236|NCT00320801|523833873|FG003|Extension Phase|Administrative|29|||
145269237|NCT00320801|523833870|FG000|Extension Phase|Lack of Efficacy|0|||
145269238|NCT00320801|523833871|FG001|Extension Phase|Lack of Efficacy|0|||
145269239|NCT00320801|523833872|FG002|Extension Phase|Lack of Efficacy|0|||
145269240|NCT00320801|523833873|FG003|Extension Phase|Lack of Efficacy|2|||
145269241|NCT00320801|523833870|FG000|Extension Phase|Lost to Follow-up|0|||
145269242|NCT00320801|523833871|FG001|Extension Phase|Lost to Follow-up|0|||
145269243|NCT00320801|523833872|FG002|Extension Phase|Lost to Follow-up|0|||
145269244|NCT00320801|523833873|FG003|Extension Phase|Lost to Follow-up|3|||
145269245|NCT04764669|523833876|FG000|Overall Study|Adverse Event|1|||
145269246|NCT04764669|523833877|FG001|Overall Study|Adverse Event|0|||
145269247|NCT04764669|523833878|FG002|Overall Study|Adverse Event|1|||
145402267|NCT01715831|524330691|FG000|Overall Study|Adverse Event|1|||
145269248|NCT04764669|523833879|FG003|Overall Study|Adverse Event|0|||
145269249|NCT04764669|523833876|FG000|Overall Study|Subject Choice|0|||
145269250|NCT04764669|523833877|FG001|Overall Study|Subject Choice|0|||
145269251|NCT04764669|523833878|FG002|Overall Study|Subject Choice|1|||
145269252|NCT04764669|523833879|FG003|Overall Study|Subject Choice|0|||
145269253|NCT04764669|523833876|FG000|Overall Study|Withdrawal by Subject|2|||
145269254|NCT04764669|523833877|FG001|Overall Study|Withdrawal by Subject|0|||
145402268|NCT03261401|524330692|FG000|Overall Study|Withdrawal by Subject|0|||
145269255|NCT04764669|523833878|FG002|Overall Study|Withdrawal by Subject|0|||
145269256|NCT04764669|523833879|FG003|Overall Study|Withdrawal by Subject|0|||
145269257|NCT00625846|523833880|FG000|Overall Study|Withdrawal by Subject|2|||
145269258|NCT00625846|523833881|FG001|Overall Study|Withdrawal by Subject|0|||
145269259|NCT00625846|523833882|FG002|Overall Study|Withdrawal by Subject|1|||
145402269|NCT03261401|524330693|FG001|Overall Study|Withdrawal by Subject|0|||
145516932|NCT00412373|524752413|FG001|Overall Study|Adverse Event|13|||
145736445|NCT00467779|525553364|FG007|Stage 1|Unspecified Reason|0|||
145736446|NCT00467779|525553365|FG008|Stage 1|Unspecified Reason|0|||
145736447|NCT00467779|525553366|FG009|Stage 1|Unspecified Reason|0|||
145516933|NCT00412373|524752412|FG000|Overall Study|Lack of Efficacy|16|||
145516934|NCT00412373|524752413|FG001|Overall Study|Lack of Efficacy|22|||
145516935|NCT00412373|524752412|FG000|Overall Study|Lost to Follow-up|7|||
145516936|NCT00412373|524752413|FG001|Overall Study|Lost to Follow-up|13|||
145516937|NCT00412373|524752412|FG000|Overall Study|Withdrawal by Subject|8|||
145516938|NCT00412373|524752413|FG001|Overall Study|Withdrawal by Subject|27|||
145516939|NCT00412373|524752412|FG000|Overall Study|Other|2|||
145516940|NCT00412373|524752413|FG001|Overall Study|Other|2|||
145516941|NCT01009840|524752416|FG000|Overall Study|Lost to Follow-up|1|||
145516942|NCT01009840|524752416|FG000|Overall Study|Adverse Event|4|||
145516943|NCT01009840|524752416|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
145516944|NCT01009840|524752416|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
145516945|NCT01009840|524752416|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
145516946|NCT01104376|524752419|FG000|Overall Study|Withdrawal by Subject|15|||
145516947|NCT01104376|524752419|FG000|Overall Study|Consented but excluded after labs|13|||
145516948|NCT00797966|524752422|FG000|Phase A|Lost to Follow-up|0|||
145516949|NCT00797966|524752423|FG001|Phase A|Lost to Follow-up|0|||
145516950|NCT00797966|524752424|FG002|Phase A|Lost to Follow-up|0|||
145516951|NCT00797966|524752425|FG003|Phase A|Lost to Follow-up|0|||
145516952|NCT00797966|524752426|FG004|Phase A|Lost to Follow-up|33|||
145516953|NCT00797966|524752427|FG005|Phase A|Lost to Follow-up|0|||
145516954|NCT00797966|524752422|FG000|Phase A|Adverse Event|0|||
145516955|NCT00797966|524752423|FG001|Phase A|Adverse Event|0|||
145516956|NCT00797966|524752424|FG002|Phase A|Adverse Event|0|||
145516957|NCT00797966|524752425|FG003|Phase A|Adverse Event|0|||
145516958|NCT00797966|524752426|FG004|Phase A|Adverse Event|46|||
145516959|NCT00797966|524752427|FG005|Phase A|Adverse Event|0|||
145516960|NCT00797966|524752422|FG000|Phase A|Met withdrawal criteria|0|||
145516961|NCT00797966|524752423|FG001|Phase A|Met withdrawal criteria|0|||
145516962|NCT00797966|524752424|FG002|Phase A|Met withdrawal criteria|0|||
145516963|NCT00797966|524752425|FG003|Phase A|Met withdrawal criteria|0|||
145516964|NCT00797966|524752426|FG004|Phase A|Met withdrawal criteria|4|||
145516965|NCT00797966|524752427|FG005|Phase A|Met withdrawal criteria|0|||
145516966|NCT00797966|524752422|FG000|Phase A|Physician Decision|0|||
145516967|NCT00797966|524752423|FG001|Phase A|Physician Decision|0|||
145516968|NCT00797966|524752424|FG002|Phase A|Physician Decision|0|||
145516969|NCT00797966|524752425|FG003|Phase A|Physician Decision|0|||
145516970|NCT00797966|524752426|FG004|Phase A|Physician Decision|13|||
145516971|NCT00797966|524752427|FG005|Phase A|Physician Decision|0|||
145516972|NCT00797966|524752422|FG000|Phase A|Withdrawal by Subject|0|||
145516973|NCT00797966|524752423|FG001|Phase A|Withdrawal by Subject|0|||
145516974|NCT00797966|524752424|FG002|Phase A|Withdrawal by Subject|0|||
145516975|NCT00797966|524752425|FG003|Phase A|Withdrawal by Subject|0|||
145516976|NCT00797966|524752426|FG004|Phase A|Withdrawal by Subject|33|||
145516977|NCT00797966|524752427|FG005|Phase A|Withdrawal by Subject|0|||
145516978|NCT00797966|524752422|FG000|Phase A|Protocol deviation|0|||
145516979|NCT00797966|524752423|FG001|Phase A|Protocol deviation|0|||
145516980|NCT00797966|524752424|FG002|Phase A|Protocol deviation|0|||
145516981|NCT00797966|524752425|FG003|Phase A|Protocol deviation|0|||
145516982|NCT00797966|524752426|FG004|Phase A|Protocol deviation|56|||
145516983|NCT00797966|524752427|FG005|Phase A|Protocol deviation|0|||
145516984|NCT00797966|524752422|FG000|Phase B|Lost to Follow-up|0|||
145516985|NCT00797966|524752423|FG001|Phase B|Lost to Follow-up|1|||
145516986|NCT00797966|524752424|FG002|Phase B|Lost to Follow-up|3|||
145516987|NCT00797966|524752425|FG003|Phase B|Lost to Follow-up|0|||
145516988|NCT00797966|524752426|FG004|Phase B|Lost to Follow-up|0|||
145516989|NCT00797966|524752427|FG005|Phase B|Lost to Follow-up|0|||
145516990|NCT00797966|524752422|FG000|Phase B|Adverse Event|2|||
145516991|NCT00797966|524752423|FG001|Phase B|Adverse Event|1|||
145516992|NCT00797966|524752424|FG002|Phase B|Adverse Event|3|||
145516993|NCT00797966|524752425|FG003|Phase B|Adverse Event|1|||
145516994|NCT00797966|524752426|FG004|Phase B|Adverse Event|0|||
145516995|NCT00797966|524752427|FG005|Phase B|Adverse Event|0|||
145516996|NCT00797966|524752422|FG000|Phase B|Met Withdrawal Criteria|3|||
145516997|NCT00797966|524752423|FG001|Phase B|Met Withdrawal Criteria|3|||
145516998|NCT00797966|524752424|FG002|Phase B|Met Withdrawal Criteria|6|||
145516999|NCT00797966|524752425|FG003|Phase B|Met Withdrawal Criteria|1|||
145517000|NCT00797966|524752426|FG004|Phase B|Met Withdrawal Criteria|0|||
145517001|NCT00797966|524752427|FG005|Phase B|Met Withdrawal Criteria|0|||
145517002|NCT00797966|524752422|FG000|Phase B|Physician Decision|1|||
145517003|NCT00797966|524752423|FG001|Phase B|Physician Decision|0|||
145517004|NCT00797966|524752424|FG002|Phase B|Physician Decision|3|||
145517005|NCT00797966|524752425|FG003|Phase B|Physician Decision|1|||
145517006|NCT00797966|524752426|FG004|Phase B|Physician Decision|0|||
145517007|NCT00797966|524752427|FG005|Phase B|Physician Decision|0|||
145517008|NCT00797966|524752422|FG000|Phase B|Withdrawal by Subject|1|||
145269260|NCT00625846|523833883|FG003|Overall Study|Withdrawal by Subject|2|||
145269261|NCT04411641|523833885|FG000|DB Period|Other|7|||
145269262|NCT04411641|523833886|FG001|DB Period|Other|27|||
145269263|NCT04411641|523833887|FG002|DB Period|Other|0|||
145269264|NCT04411641|523833888|FG003|DB Period|Other|0|||
145269265|NCT04411641|523833885|FG000|DB Period|Withdrawal by Subject|67|||
145269266|NCT04411641|523833886|FG001|DB Period|Withdrawal by Subject|122|||
145269267|NCT04411641|523833887|FG002|DB Period|Withdrawal by Subject|0|||
145269268|NCT04411641|523833888|FG003|DB Period|Withdrawal by Subject|0|||
145269269|NCT04411641|523833885|FG000|DB Period|Progressive disease|76|||
145269270|NCT04411641|523833886|FG001|DB Period|Progressive disease|116|||
145517009|NCT00797966|524752423|FG001|Phase B|Withdrawal by Subject|4|||
145517010|NCT00797966|524752424|FG002|Phase B|Withdrawal by Subject|3|||
145517011|NCT00797966|524752425|FG003|Phase B|Withdrawal by Subject|3|||
145517012|NCT00797966|524752426|FG004|Phase B|Withdrawal by Subject|0|||
145517013|NCT00797966|524752427|FG005|Phase B|Withdrawal by Subject|0|||
145517014|NCT00797966|524752422|FG000|Phase B|Protocol Deviation|4|||
145269271|NCT04411641|523833887|FG002|DB Period|Progressive disease|0|||
145269272|NCT04411641|523833888|FG003|DB Period|Progressive disease|0|||
145269273|NCT04411641|523833885|FG000|DB Period|Poor compliance to protocol|1|||
145269274|NCT04411641|523833886|FG001|DB Period|Poor compliance to protocol|5|||
145269275|NCT04411641|523833887|FG002|DB Period|Poor compliance to protocol|0|||
145269276|NCT04411641|523833888|FG003|DB Period|Poor compliance to protocol|0|||
145269277|NCT04411641|523833885|FG000|DB Period|Lack of Efficacy|19|||
145269278|NCT04411641|523833886|FG001|DB Period|Lack of Efficacy|19|||
145269279|NCT04411641|523833887|FG002|DB Period|Lack of Efficacy|0|||
145269280|NCT04411641|523833888|FG003|DB Period|Lack of Efficacy|0|||
145269281|NCT04411641|523833885|FG000|DB Period|Adverse Event|13|||
145269282|NCT04411641|523833886|FG001|DB Period|Adverse Event|29|||
145269283|NCT04411641|523833887|FG002|DB Period|Adverse Event|0|||
145269284|NCT04411641|523833888|FG003|DB Period|Adverse Event|0|||
145269285|NCT04411641|523833885|FG000|DB Period|Randomized and not treated|2|||
145269286|NCT04411641|523833886|FG001|DB Period|Randomized and not treated|2|||
145269287|NCT04411641|523833887|FG002|DB Period|Randomized and not treated|0|||
145269288|NCT04411641|523833888|FG003|DB Period|Randomized and not treated|0|||
145269289|NCT04411641|523833885|FG000|OL|Withdrawal by Subject|0|||
145269290|NCT04411641|523833886|FG001|OL|Withdrawal by Subject|0|||
145269291|NCT04411641|523833887|FG002|OL|Withdrawal by Subject|6|||
145269292|NCT04411641|523833888|FG003|OL|Withdrawal by Subject|17|||
145269293|NCT04411641|523833885|FG000|OL|Progressive disease|0|||
145269294|NCT04411641|523833886|FG001|OL|Progressive disease|0|||
145269295|NCT04411641|523833887|FG002|OL|Progressive disease|1|||
145269296|NCT04411641|523833888|FG003|OL|Progressive disease|2|||
145269297|NCT04411641|523833885|FG000|OL|Poor compliance to protocol|0|||
145269298|NCT04411641|523833886|FG001|OL|Poor compliance to protocol|0|||
145269299|NCT04411641|523833887|FG002|OL|Poor compliance to protocol|1|||
145269300|NCT04411641|523833888|FG003|OL|Poor compliance to protocol|0|||
145269301|NCT04411641|523833885|FG000|OL|Adverse Event|0|||
145269302|NCT04411641|523833886|FG001|OL|Adverse Event|0|||
145269303|NCT04411641|523833887|FG002|OL|Adverse Event|1|||
145269304|NCT04411641|523833888|FG003|OL|Adverse Event|0|||
145269305|NCT04411641|523833885|FG000|OL|Other|0|||
145269306|NCT04411641|523833886|FG001|OL|Other|0|||
145269307|NCT04411641|523833887|FG002|OL|Other|0|||
145269308|NCT04411641|523833888|FG003|OL|Other|6|||
145269309|NCT04410978|523833900|FG000|Overall Study|Poor compliance to protocol|2|||
145269310|NCT04410978|523833901|FG001|Overall Study|Poor compliance to protocol|4|||
145269311|NCT04410978|523833900|FG000|Overall Study|Withdrawal by Subject|64|||
145269312|NCT04410978|523833901|FG001|Overall Study|Withdrawal by Subject|66|||
145269313|NCT04410978|523833900|FG000|Overall Study|Other|6|||
145269314|NCT04410978|523833901|FG001|Overall Study|Other|7|||
145269315|NCT04410978|523833900|FG000|Overall Study|Missing study status|1|||
145269316|NCT04410978|523833901|FG001|Overall Study|Missing study status|0|||
145269317|NCT05554471|523833904|FG000|Overall Study|Physician Decision|2|||
145517015|NCT00797966|524752423|FG001|Phase B|Protocol Deviation|8|||
145517016|NCT00797966|524752424|FG002|Phase B|Protocol Deviation|2|||
145517017|NCT00797966|524752425|FG003|Phase B|Protocol Deviation|6|||
145269318|NCT05554471|523833905|FG001|Overall Study|Physician Decision|1|||
145269319|NCT05554471|523833904|FG000|Overall Study|Lost to Follow-up|2|||
145269320|NCT05554471|523833905|FG001|Overall Study|Lost to Follow-up|1|||
145269321|NCT05554471|523833904|FG000|Overall Study|Death|0|||
145269322|NCT05554471|523833905|FG001|Overall Study|Death|1|||
145269323|NCT01875731|523833907|FG000|Overall Study|Fail to obtain lab sample|1|||
145269324|NCT01875731|523833908|FG001|Overall Study|Fail to obtain lab sample|0|||
145517018|NCT00797966|524752426|FG004|Phase B|Protocol Deviation|0|||
145269325|NCT02576951|523833909|FG000|Overall Study|Lost to Follow-up|0|||
145269326|NCT02576951|523833910|FG001|Overall Study|Lost to Follow-up|0|||
145269327|NCT02576951|523833911|FG002|Overall Study|Lost to Follow-up|2|||
145269328|NCT02576951|523833912|FG003|Overall Study|Lost to Follow-up|2|||
145269329|NCT02576951|523833909|FG000|Overall Study|Withdrawal by Subject|1|||
145269330|NCT02576951|523833910|FG001|Overall Study|Withdrawal by Subject|0|||
145517019|NCT00797966|524752427|FG005|Phase B|Protocol Deviation|0|||
145517020|NCT00797966|524752422|FG000|Phase B|Lack of Efficacy|0|||
145269331|NCT02576951|523833911|FG002|Overall Study|Withdrawal by Subject|0|||
145269332|NCT02576951|523833912|FG003|Overall Study|Withdrawal by Subject|2|||
145269333|NCT02576951|523833909|FG000|Overall Study|Protocol Violation|0|||
145269334|NCT02576951|523833910|FG001|Overall Study|Protocol Violation|0|||
145269335|NCT02576951|523833911|FG002|Overall Study|Protocol Violation|0|||
145269336|NCT02576951|523833912|FG003|Overall Study|Protocol Violation|1|||
145269337|NCT02062385|523833915|FG000|Overall Study|Adverse Event|19|||
145269338|NCT02062385|523833916|FG001|Overall Study|Adverse Event|13|||
145269339|NCT02062385|523833917|FG002|Overall Study|Adverse Event|1|||
145269340|NCT02062385|523833918|FG003|Overall Study|Adverse Event|0|||
145269341|NCT02062385|523833915|FG000|Overall Study|Protocol Violation|1|||
145269342|NCT02062385|523833916|FG001|Overall Study|Protocol Violation|0|||
145269343|NCT02062385|523833917|FG002|Overall Study|Protocol Violation|0|||
145269344|NCT02062385|523833918|FG003|Overall Study|Protocol Violation|0|||
145269345|NCT02062385|523833915|FG000|Overall Study|Incomplete EPI by database lock|2|||
145269346|NCT02062385|523833916|FG001|Overall Study|Incomplete EPI by database lock|0|||
145269347|NCT02062385|523833917|FG002|Overall Study|Incomplete EPI by database lock|0|||
145269348|NCT02062385|523833918|FG003|Overall Study|Incomplete EPI by database lock|0|||
145269349|NCT02062385|523833915|FG000|Overall Study|Moved|10|||
145269350|NCT02062385|523833916|FG001|Overall Study|Moved|11|||
145269351|NCT02062385|523833917|FG002|Overall Study|Moved|1|||
145269352|NCT02062385|523833918|FG003|Overall Study|Moved|0|||
145269353|NCT02062385|523833915|FG000|Overall Study|Withdrawn by parent/guardian|46|||
145269354|NCT02062385|523833916|FG001|Overall Study|Withdrawn by parent/guardian|41|||
145269355|NCT02062385|523833917|FG002|Overall Study|Withdrawn by parent/guardian|9|||
145269356|NCT02062385|523833918|FG003|Overall Study|Withdrawn by parent/guardian|8|||
145269357|NCT02062385|523833915|FG000|Overall Study|Death|0|||
145269358|NCT02062385|523833916|FG001|Overall Study|Death|0|||
145269359|NCT02062385|523833917|FG002|Overall Study|Death|0|||
145269360|NCT02062385|523833918|FG003|Overall Study|Death|1|||
145269361|NCT02062385|523833915|FG000|Overall Study|Lost to Follow-up|0|||
145269362|NCT02062385|523833916|FG001|Overall Study|Lost to Follow-up|0|||
145269363|NCT02062385|523833917|FG002|Overall Study|Lost to Follow-up|1|||
145269364|NCT02062385|523833918|FG003|Overall Study|Lost to Follow-up|0|||
145269365|NCT00157820|523833923|FG000|Randomized|Physician Decision|4|||
145269366|NCT00157820|523833924|FG001|Randomized|Physician Decision|2|||
145269367|NCT00157820|523833925|FG002|Randomized|Physician Decision|3|||
145269368|NCT00157820|523833923|FG000|Randomized|Withdrawal by Subject|1|||
145269369|NCT00157820|523833924|FG001|Randomized|Withdrawal by Subject|2|||
145269370|NCT00157820|523833925|FG002|Randomized|Withdrawal by Subject|3|||
145269371|NCT00157820|523833923|FG000|Randomized|Protocol Violation|2|||
145269372|NCT00157820|523833924|FG001|Randomized|Protocol Violation|1|||
145269373|NCT00157820|523833925|FG002|Randomized|Protocol Violation|2|||
145269374|NCT00157820|523833923|FG000|1st 8 Month|Death|7|||
145269375|NCT00157820|523833924|FG001|1st 8 Month|Death|8|||
145269376|NCT00157820|523833925|FG002|1st 8 Month|Death|3|||
145269377|NCT00157820|523833923|FG000|1st 8 Month|Lost to Follow-up|1|||
145269378|NCT00157820|523833924|FG001|1st 8 Month|Lost to Follow-up|2|||
145269379|NCT00157820|523833925|FG002|1st 8 Month|Lost to Follow-up|1|||
145269380|NCT00157820|523833923|FG000|1st 8 Month|Premature cross-over|0|||
145269381|NCT00157820|523833924|FG001|1st 8 Month|Premature cross-over|2|||
145269382|NCT00157820|523833925|FG002|1st 8 Month|Premature cross-over|2|||
145269383|NCT00157820|523833923|FG000|2nd 8 Months|Death|3|||
145269384|NCT00157820|523833924|FG001|2nd 8 Months|Death|1|||
145269385|NCT00157820|523833925|FG002|2nd 8 Months|Death|3|||
145269386|NCT00157820|523833923|FG000|2nd 8 Months|Lost to Follow-up|1|||
145269387|NCT00157820|523833924|FG001|2nd 8 Months|Lost to Follow-up|5|||
145269388|NCT00157820|523833925|FG002|2nd 8 Months|Lost to Follow-up|2|||
145269389|NCT00157820|523833923|FG000|2nd 8 Months|Premature cross-over|1|||
145269390|NCT00157820|523833924|FG001|2nd 8 Months|Premature cross-over|7|||
145269391|NCT00157820|523833925|FG002|2nd 8 Months|Premature cross-over|9|||
145269392|NCT00223990|523833926|FG000|Overall Study|Moved from area|2|||
145269393|NCT00223990|523833927|FG001|Overall Study|Moved from area|1|||
145269394|NCT00223990|523833926|FG000|Overall Study|Withdrawal by Subject|4|||
145269395|NCT00223990|523833927|FG001|Overall Study|Withdrawal by Subject|8|||
145517021|NCT00797966|524752423|FG001|Phase B|Lack of Efficacy|1|||
145269396|NCT00223990|523833926|FG000|Overall Study|Lost to Follow-up|1|||
145269397|NCT00223990|523833927|FG001|Overall Study|Lost to Follow-up|0|||
145269398|NCT01319994|523835332|FG000|Overall Study|Protocol Violation|7|||
145269399|NCT01319994|523835333|FG001|Overall Study|Protocol Violation|6|||
145517022|NCT00797966|524752424|FG002|Phase B|Lack of Efficacy|1|||
145269400|NCT01340794|523835334|FG000|Overall Study|Withdrawal by Subject|0|||
145269401|NCT01340794|523835335|FG001|Overall Study|Withdrawal by Subject|1|||
145269402|NCT00698009|523835340|FG000|Overall Study|Withdrawal by Subject|1|||
145269403|NCT00798707|523835348|FG000|Overall Study|Adverse Event|6|||
145269404|NCT00798707|523835349|FG001|Overall Study|Adverse Event|8|||
145517023|NCT00797966|524752425|FG003|Phase B|Lack of Efficacy|4|||
145269405|NCT00798707|523835350|FG002|Overall Study|Adverse Event|8|||
145269406|NCT00798707|523835348|FG000|Overall Study|Failed to return|2|||
145269407|NCT00798707|523835349|FG001|Overall Study|Failed to return|2|||
145269408|NCT00798707|523835350|FG002|Overall Study|Failed to return|0|||
145607361|NCT01186328|525079155|FG002|Overall Study|Death|0|||
145607362|NCT03075501|525079156|FG000|Overall Study|Scheduling difficulties|15|||
145607363|NCT03075501|525079157|FG001|Overall Study|Scheduling difficulties|9|||
145607364|NCT02762981|525079158|FG000|Overall Study|Adverse Event|2|||
145607365|NCT02762981|525079159|FG001|Overall Study|Adverse Event|3|||
145607366|NCT02762981|525079160|FG002|Overall Study|Adverse Event|1|||
145607367|NCT02762981|525079161|FG003|Overall Study|Adverse Event|1|||
145607368|NCT02762981|525079162|FG004|Overall Study|Adverse Event|3|||
145607369|NCT02762981|525079158|FG000|Overall Study|Physician Decision|0|||
145607370|NCT02762981|525079159|FG001|Overall Study|Physician Decision|1|||
145607371|NCT02762981|525079160|FG002|Overall Study|Physician Decision|0|||
145607372|NCT02762981|525079161|FG003|Overall Study|Physician Decision|0|||
145607373|NCT02762981|525079162|FG004|Overall Study|Physician Decision|1|||
145607374|NCT02762981|525079158|FG000|Overall Study|Disease progression|11|||
145607375|NCT02762981|525079159|FG001|Overall Study|Disease progression|23|||
145607376|NCT02762981|525079160|FG002|Overall Study|Disease progression|4|||
145607377|NCT02762981|525079161|FG003|Overall Study|Disease progression|10|||
145607378|NCT02762981|525079162|FG004|Overall Study|Disease progression|1|||
145607379|NCT02762981|525079158|FG000|Overall Study|Enrolled not treated|1|||
145607380|NCT02762981|525079159|FG001|Overall Study|Enrolled not treated|5|||
145607381|NCT02762981|525079160|FG002|Overall Study|Enrolled not treated|0|||
145607382|NCT02762981|525079161|FG003|Overall Study|Enrolled not treated|2|||
145607383|NCT02762981|525079162|FG004|Overall Study|Enrolled not treated|0|||
145607384|NCT02762981|525079158|FG000|Overall Study|Other|2|||
145607385|NCT02762981|525079159|FG001|Overall Study|Other|3|||
145607386|NCT02762981|525079160|FG002|Overall Study|Other|1|||
145607387|NCT02762981|525079161|FG003|Overall Study|Other|0|||
145607388|NCT02762981|525079162|FG004|Overall Study|Other|0|||
145607389|NCT02762981|525079158|FG000|Overall Study|Missing|1|||
145607390|NCT02762981|525079159|FG001|Overall Study|Missing|0|||
145607391|NCT02762981|525079160|FG002|Overall Study|Missing|0|||
145607392|NCT02762981|525079161|FG003|Overall Study|Missing|0|||
145607393|NCT02762981|525079162|FG004|Overall Study|Missing|0|||
145607394|NCT02762981|525079158|FG000|Overall Study|Withdrawal by Subject|0|||
145607395|NCT02762981|525079159|FG001|Overall Study|Withdrawal by Subject|5|||
145607396|NCT02762981|525079160|FG002|Overall Study|Withdrawal by Subject|1|||
145607397|NCT02762981|525079161|FG003|Overall Study|Withdrawal by Subject|3|||
145607398|NCT02762981|525079162|FG004|Overall Study|Withdrawal by Subject|0|||
145607399|NCT05648357|525079165|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
145607400|NCT00255346|525079166|FG000|Overall Study|Adverse Event|1|||
145607401|NCT00255346|525079167|FG001|Overall Study|Adverse Event|0|||
145607402|NCT00255346|525079168|FG002|Overall Study|Adverse Event|0|||
145607403|NCT00255346|525079169|FG003|Overall Study|Adverse Event|0|||
145607404|NCT00255346|525079170|FG004|Overall Study|Adverse Event|0|||
145607405|NCT00674323|525079171|FG000|Overall Study|Adverse Event|0|||
145607406|NCT00674323|525079172|FG001|Overall Study|Adverse Event|1|||
145607407|NCT00674323|525079173|FG002|Overall Study|Adverse Event|0|||
145607408|NCT00674323|525079171|FG000|Overall Study|Protocol Violation|1|||
145607409|NCT00674323|525079172|FG001|Overall Study|Protocol Violation|0|||
145607410|NCT00674323|525079173|FG002|Overall Study|Protocol Violation|0|||
145607411|NCT00409786|525079174|FG000|Overall Study|Withdrawal by Subject|3|||
145607412|NCT00301080|525079175|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
145607413|NCT00301080|525079176|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
145607414|NCT00301080|525079177|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
145607415|NCT00301080|525079178|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
145607416|NCT00301080|525079179|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
145607417|NCT03502616|525079180|FG000|Up to Week 16|Withdrawal by Subject|1|||
145607418|NCT03502616|525079181|FG001|Up to Week 16|Withdrawal by Subject|2|||
145607419|NCT03502616|525079180|FG000|Up to Week 16|Lost to Follow-up|0|||
145607420|NCT03502616|525079181|FG001|Up to Week 16|Lost to Follow-up|1|||
145607421|NCT03502616|525079180|FG000|Up to Week 16|Randomized, but not treated|1|||
145607422|NCT03502616|525079181|FG001|Up to Week 16|Randomized, but not treated|0|||
145607423|NCT03502616|525079180|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
145607424|NCT03502616|525079181|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
145607425|NCT03502616|525079180|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
145607426|NCT03502616|525079181|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
145607427|NCT02917265|525079183|FG000|Overall Study|Physician Decision|1|||
145607428|NCT02917265|525079184|FG001|Overall Study|Physician Decision|0|||
145607429|NCT02917265|525079183|FG000|Overall Study|Withdrawal by Subject|1|||
145607430|NCT02917265|525079184|FG001|Overall Study|Withdrawal by Subject|0|||
145607431|NCT05672680|525079185|FG000|Overall Study|Patient Did Not Complete the Form|5|||
145517024|NCT00797966|524752426|FG004|Phase B|Lack of Efficacy|0|||
145736448|NCT00467779|525553367|FG010|Stage 1|Unspecified Reason|0|||
145517025|NCT00797966|524752427|FG005|Phase B|Lack of Efficacy|0|||
145517026|NCT00797966|524752422|FG000|Phase A+|Lost to Follow-up|0|||
145517027|NCT00797966|524752423|FG001|Phase A+|Lost to Follow-up|0|||
145517028|NCT00797966|524752424|FG002|Phase A+|Lost to Follow-up|0|||
145517029|NCT00797966|524752425|FG003|Phase A+|Lost to Follow-up|0|||
145517030|NCT00797966|524752426|FG004|Phase A+|Lost to Follow-up|0|||
145517031|NCT00797966|524752427|FG005|Phase A+|Lost to Follow-up|9|||
145517032|NCT00797966|524752422|FG000|Phase A+|Met withdrawal criteria|0|||
145517033|NCT00797966|524752423|FG001|Phase A+|Met withdrawal criteria|0|||
145517034|NCT00797966|524752424|FG002|Phase A+|Met withdrawal criteria|0|||
145517035|NCT00797966|524752425|FG003|Phase A+|Met withdrawal criteria|0|||
145517036|NCT00797966|524752426|FG004|Phase A+|Met withdrawal criteria|0|||
145517037|NCT00797966|524752427|FG005|Phase A+|Met withdrawal criteria|5|||
145517038|NCT00797966|524752422|FG000|Phase A+|Withdrawal by Subject|0|||
145517039|NCT00797966|524752423|FG001|Phase A+|Withdrawal by Subject|0|||
145517040|NCT00797966|524752424|FG002|Phase A+|Withdrawal by Subject|0|||
145517041|NCT00797966|524752425|FG003|Phase A+|Withdrawal by Subject|0|||
145517042|NCT00797966|524752426|FG004|Phase A+|Withdrawal by Subject|0|||
145736449|NCT00467779|525553368|FG011|Stage 1|Unspecified Reason|0|||
145736450|NCT00467779|525553369|FG012|Stage 1|Unspecified Reason|0|||
145736451|NCT00467779|525553370|FG013|Stage 1|Unspecified Reason|0|||
145736452|NCT00467779|525553371|FG014|Stage 1|Unspecified Reason|0|||
145736453|NCT00467779|525553357|FG000|Stage 1|Physician Decision|0|||
145736454|NCT00467779|525553358|FG001|Stage 1|Physician Decision|1|||
145736455|NCT00467779|525553359|FG002|Stage 1|Physician Decision|0|||
145736456|NCT00467779|525553360|FG003|Stage 1|Physician Decision|0|||
145736457|NCT00467779|525553361|FG004|Stage 1|Physician Decision|0|||
145736458|NCT00467779|525553362|FG005|Stage 1|Physician Decision|0|||
145736459|NCT00467779|525553363|FG006|Stage 1|Physician Decision|0|||
145736460|NCT00467779|525553364|FG007|Stage 1|Physician Decision|0|||
145736461|NCT00467779|525553365|FG008|Stage 1|Physician Decision|0|||
145736462|NCT00467779|525553366|FG009|Stage 1|Physician Decision|0|||
145736463|NCT00467779|525553367|FG010|Stage 1|Physician Decision|0|||
145736464|NCT00467779|525553368|FG011|Stage 1|Physician Decision|0|||
145736465|NCT00467779|525553369|FG012|Stage 1|Physician Decision|0|||
145736466|NCT00467779|525553370|FG013|Stage 1|Physician Decision|0|||
145736467|NCT00467779|525553371|FG014|Stage 1|Physician Decision|0|||
145736468|NCT00467779|525553357|FG000|Stage 1|Withdrawal by Subject|0|||
145736469|NCT00467779|525553358|FG001|Stage 1|Withdrawal by Subject|0|||
145736470|NCT00467779|525553359|FG002|Stage 1|Withdrawal by Subject|0|||
145736471|NCT00467779|525553360|FG003|Stage 1|Withdrawal by Subject|0|||
145736472|NCT00467779|525553361|FG004|Stage 1|Withdrawal by Subject|0|||
145736473|NCT00467779|525553362|FG005|Stage 1|Withdrawal by Subject|0|||
145736474|NCT00467779|525553363|FG006|Stage 1|Withdrawal by Subject|1|||
145736475|NCT00467779|525553364|FG007|Stage 1|Withdrawal by Subject|1|||
145736476|NCT00467779|525553365|FG008|Stage 1|Withdrawal by Subject|0|||
145736477|NCT00467779|525553366|FG009|Stage 1|Withdrawal by Subject|0|||
145736478|NCT00467779|525553367|FG010|Stage 1|Withdrawal by Subject|0|||
145736479|NCT00467779|525553368|FG011|Stage 1|Withdrawal by Subject|0|||
145736480|NCT00467779|525553369|FG012|Stage 1|Withdrawal by Subject|0|||
145736481|NCT00467779|525553370|FG013|Stage 1|Withdrawal by Subject|0|||
145736482|NCT00467779|525553371|FG014|Stage 1|Withdrawal by Subject|0|||
145736483|NCT00467779|525553357|FG000|Stage 1A|Adverse Event|0|||
145736484|NCT00467779|525553358|FG001|Stage 1A|Adverse Event|0|||
145736485|NCT00467779|525553359|FG002|Stage 1A|Adverse Event|0|||
145736486|NCT00467779|525553360|FG003|Stage 1A|Adverse Event|0|||
145736487|NCT00467779|525553361|FG004|Stage 1A|Adverse Event|0|||
145607432|NCT05672680|525079186|FG001|Overall Study|Patient Did Not Complete the Form|4|||
145607433|NCT05672680|525079185|FG000|Overall Study|Procedure Aborted|1|||
145517043|NCT00797966|524752427|FG005|Phase A+|Withdrawal by Subject|6|||
145517044|NCT00797966|524752422|FG000|Phase A+|Adverse Event|0|||
145517045|NCT00797966|524752423|FG001|Phase A+|Adverse Event|0|||
145517046|NCT00797966|524752424|FG002|Phase A+|Adverse Event|0|||
145517047|NCT00797966|524752425|FG003|Phase A+|Adverse Event|0|||
145736488|NCT00467779|525553362|FG005|Stage 1A|Adverse Event|0|||
145736489|NCT00467779|525553363|FG006|Stage 1A|Adverse Event|0|||
145736490|NCT00467779|525553364|FG007|Stage 1A|Adverse Event|0|||
145736491|NCT00467779|525553365|FG008|Stage 1A|Adverse Event|0|||
145736492|NCT00467779|525553366|FG009|Stage 1A|Adverse Event|0|||
145736493|NCT00467779|525553367|FG010|Stage 1A|Adverse Event|0|||
145517048|NCT00797966|524752426|FG004|Phase A+|Adverse Event|0|||
145736494|NCT00467779|525553368|FG011|Stage 1A|Adverse Event|0|||
145517049|NCT00797966|524752427|FG005|Phase A+|Adverse Event|4|||
145517050|NCT00797966|524752422|FG000|Phase A+|Protocol deviation|0|||
145517051|NCT00797966|524752423|FG001|Phase A+|Protocol deviation|0|||
145517052|NCT00797966|524752424|FG002|Phase A+|Protocol deviation|0|||
145736495|NCT00467779|525553369|FG012|Stage 1A|Adverse Event|1|||
145736496|NCT00467779|525553370|FG013|Stage 1A|Adverse Event|0|||
145736497|NCT00467779|525553371|FG014|Stage 1A|Adverse Event|0|||
145736498|NCT00467779|525553357|FG000|Stage 1A|Death|0|||
145736499|NCT00467779|525553358|FG001|Stage 1A|Death|0|||
145517053|NCT00797966|524752425|FG003|Phase A+|Protocol deviation|0|||
145736500|NCT00467779|525553359|FG002|Stage 1A|Death|0|||
145736501|NCT00467779|525553360|FG003|Stage 1A|Death|0|||
145736502|NCT00467779|525553361|FG004|Stage 1A|Death|0|||
145736503|NCT00467779|525553362|FG005|Stage 1A|Death|0|||
145736504|NCT00467779|525553363|FG006|Stage 1A|Death|0|||
145736505|NCT00467779|525553364|FG007|Stage 1A|Death|0|||
145736506|NCT00467779|525553365|FG008|Stage 1A|Death|0|||
145736507|NCT00467779|525553366|FG009|Stage 1A|Death|0|||
145517054|NCT00797966|524752426|FG004|Phase A+|Protocol deviation|0|||
145517055|NCT00797966|524752427|FG005|Phase A+|Protocol deviation|4|||
145517056|NCT01002820|524752433|FG000|Overall Study|Adverse Event|1|||
145517057|NCT01002820|524752433|FG000|Overall Study|Withdrawal by Subject|2|||
145517058|NCT01002820|524752433|FG000|Overall Study|Lack of Efficacy|1|||
145517059|NCT01673347|524752434|FG000|Overall Study|failure of allograft|7|||
145517060|NCT00895011|524752440|FG000|Overall Study|Withdrawal by Subject|14|||
145517061|NCT00895011|524752441|FG001|Overall Study|Withdrawal by Subject|7|||
145517062|NCT00895011|524752442|FG002|Overall Study|Withdrawal by Subject|2|||
145517063|NCT00895011|524752440|FG000|Overall Study|Lost to Follow-up|5|||
145517064|NCT00895011|524752441|FG001|Overall Study|Lost to Follow-up|4|||
145517065|NCT00895011|524752442|FG002|Overall Study|Lost to Follow-up|1|||
145517066|NCT00895011|524752440|FG000|Overall Study|Protocol Violation|3|||
145517067|NCT00895011|524752441|FG001|Overall Study|Protocol Violation|1|||
145517068|NCT00895011|524752442|FG002|Overall Study|Protocol Violation|3|||
145517069|NCT00895011|524752440|FG000|Overall Study|Adverse Event|1|||
145517070|NCT00895011|524752441|FG001|Overall Study|Adverse Event|2|||
145517071|NCT00895011|524752442|FG002|Overall Study|Adverse Event|2|||
145517072|NCT00895011|524752440|FG000|Overall Study|schedule conflict|1|||
145517073|NCT00895011|524752441|FG001|Overall Study|schedule conflict|0|||
145517074|NCT00895011|524752442|FG002|Overall Study|schedule conflict|0|||
145517075|NCT02661178|524752450|FG000|Part 1|Protocol Violation|1|||
145517076|NCT02661178|524752451|FG001|Part 1|Protocol Violation|0|||
145517077|NCT02661178|524752452|FG002|Part 1|Protocol Violation|0|||
145517078|NCT02661178|524752453|FG003|Part 1|Protocol Violation|0|||
145517079|NCT02661178|524752454|FG004|Part 1|Protocol Violation|0|||
145517080|NCT02661178|524752455|FG005|Part 1|Protocol Violation|0|||
145517081|NCT02661178|524752456|FG006|Part 1|Protocol Violation|0|||
145517082|NCT02661178|524752457|FG007|Part 1|Protocol Violation|0|||
145517083|NCT02661178|524752458|FG008|Part 1|Protocol Violation|0|||
145517084|NCT02661178|524752459|FG009|Part 1|Protocol Violation|0|||
145517085|NCT02661178|524752460|FG010|Part 1|Protocol Violation|0|||
145517086|NCT02661178|524752461|FG011|Part 1|Protocol Violation|0|||
145517087|NCT02661178|524752462|FG012|Part 1|Protocol Violation|0|||
145517088|NCT02661178|524752463|FG013|Part 1|Protocol Violation|0|||
145517089|NCT02661178|524752464|FG014|Part 1|Protocol Violation|0|||
145517090|NCT03859973|524752465|FG000|Overall Study|Other reason than listed|3|||
145517091|NCT03859973|524752466|FG001|Overall Study|Other reason than listed|2|||
145517092|NCT03859973|524752465|FG000|Overall Study|COVID-19 related, not due to AE|3|||
145517093|NCT03859973|524752466|FG001|Overall Study|COVID-19 related, not due to AE|4|||
145517094|NCT03859973|524752465|FG000|Overall Study|Withdrawal by Subject|8|||
145517095|NCT03859973|524752466|FG001|Overall Study|Withdrawal by Subject|9|||
145517096|NCT03859973|524752465|FG000|Overall Study|Lost to Follow-up|2|||
145517097|NCT03859973|524752466|FG001|Overall Study|Lost to Follow-up|3|||
145517098|NCT03859973|524752465|FG000|Overall Study|Protocol Violation|1|||
145517099|NCT03859973|524752466|FG001|Overall Study|Protocol Violation|3|||
145517100|NCT03859973|524752465|FG000|Overall Study|Adverse Event|3|||
145517101|NCT03859973|524752466|FG001|Overall Study|Adverse Event|5|||
145517102|NCT02855541|524752467|FG000|Overall Study|Change in health status|2|||
145517103|NCT02855541|524752467|FG000|Overall Study|Withdrawal by Subject|2|||
145517104|NCT01242813|524752468|FG000|Overall Study|Lost to Follow-up|2|||
145517105|NCT03337490|524752475|FG000|Overall Study|Withdrawal by Subject|1|||
145517106|NCT03337490|524752476|FG001|Overall Study|Withdrawal by Subject|0|||
145736508|NCT00467779|525553367|FG010|Stage 1A|Death|0|||
145736509|NCT00467779|525553368|FG011|Stage 1A|Death|1|||
145736510|NCT00467779|525553369|FG012|Stage 1A|Death|1|||
145607434|NCT05672680|525079186|FG001|Overall Study|Procedure Aborted|0|||
145607435|NCT00116272|525079187|FG000|Overall Study|Lost to Follow-up|11|||
145607436|NCT00116272|525079188|FG001|Overall Study|Lost to Follow-up|6|||
145607437|NCT03188120|525079189|FG000|Overall Study|Adverse Event|4|||
145607438|NCT03188120|525079189|FG000|Overall Study|Insufficient Effectiveness|8|||
145607439|NCT03188120|525079189|FG000|Overall Study|Improved|12|||
145607440|NCT03188120|525079189|FG000|Overall Study|Lost to Follow-up|7|||
145607441|NCT03188120|525079189|FG000|Overall Study|Other than specified|3|||
145607442|NCT03188120|525079189|FG000|Overall Study|No visit after the first visit|13|||
145607443|NCT00576732|525079190|FG000|DOUBLE BLIND|Adverse Event|0|||
145607444|NCT00576732|525079191|FG001|DOUBLE BLIND|Adverse Event|0|||
145607445|NCT00576732|525079192|FG002|DOUBLE BLIND|Adverse Event|1|||
145607446|NCT00576732|525079193|FG003|DOUBLE BLIND|Adverse Event|0|||
145607447|NCT00576732|525079194|FG004|DOUBLE BLIND|Adverse Event|0|||
145607448|NCT00576732|525079195|FG005|DOUBLE BLIND|Adverse Event|0|||
145607449|NCT00576732|525079190|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
145607450|NCT00576732|525079191|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
145607451|NCT00576732|525079192|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
145607452|NCT00576732|525079193|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
145607453|NCT00576732|525079194|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
145607454|NCT00576732|525079195|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
145607455|NCT00576732|525079190|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
145607456|NCT00576732|525079191|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
145607457|NCT00576732|525079192|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
145517107|NCT03337490|524752477|FG002|Overall Study|Withdrawal by Subject|0|||
145517108|NCT03337490|524752475|FG000|Overall Study|Lack of Efficacy|10|||
145517109|NCT03337490|524752476|FG001|Overall Study|Lack of Efficacy|12|||
145517110|NCT03337490|524752477|FG002|Overall Study|Lack of Efficacy|35|||
145517111|NCT03337490|524752475|FG000|Overall Study|Physician Decision|0|||
145517112|NCT03337490|524752476|FG001|Overall Study|Physician Decision|1|||
145517113|NCT03337490|524752477|FG002|Overall Study|Physician Decision|0|||
145517114|NCT03337490|524752475|FG000|Overall Study|Lost to Follow-up|0|||
145517115|NCT03337490|524752476|FG001|Overall Study|Lost to Follow-up|1|||
145517116|NCT03337490|524752477|FG002|Overall Study|Lost to Follow-up|0|||
145517117|NCT04493892|524752478|FG000|Overall Study|Withdrawal by Subject|15|||
145517118|NCT03560518|524752479|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
145517119|NCT03560518|524752480|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
145517120|NCT03560518|524752481|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
145517121|NCT03560518|524752479|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
145517122|NCT03560518|524752480|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
145517123|NCT03560518|524752481|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
145517124|NCT03560518|524752479|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145517125|NCT03560518|524752480|FG001|Double Blind Treatment Period|Protocol Violation|2|||
145517126|NCT03560518|524752481|FG002|Double Blind Treatment Period|Protocol Violation|0|||
145517127|NCT03560518|524752479|FG000|Double Blind Treatment Period|Pregnancy|0|||
145517128|NCT03560518|524752480|FG001|Double Blind Treatment Period|Pregnancy|2|||
145517129|NCT03560518|524752481|FG002|Double Blind Treatment Period|Pregnancy|0|||
145517130|NCT03560518|524752479|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
145517131|NCT03560518|524752480|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
145517132|NCT03560518|524752481|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
145517133|NCT03560518|524752479|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
145517134|NCT03560518|524752480|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
145607458|NCT00576732|525079193|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
145607459|NCT00576732|525079194|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
145607460|NCT00576732|525079195|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
145607461|NCT00576732|525079190|FG000|DOUBLE BLIND|OTHER|0|||
145607462|NCT00576732|525079191|FG001|DOUBLE BLIND|OTHER|2|||
145607463|NCT00576732|525079192|FG002|DOUBLE BLIND|OTHER|1|||
145607464|NCT00576732|525079193|FG003|DOUBLE BLIND|OTHER|0|||
145607465|NCT00576732|525079194|FG004|DOUBLE BLIND|OTHER|0|||
145607466|NCT00576732|525079195|FG005|DOUBLE BLIND|OTHER|0|||
145607467|NCT00576732|525079190|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
145607468|NCT00576732|525079191|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
145607469|NCT00576732|525079192|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
145607470|NCT00576732|525079193|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
145607471|NCT00576732|525079194|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
145607472|NCT00576732|525079195|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
145607473|NCT00576732|525079190|FG000|DOUBLE BLIND|Protocol Violation|1|||
145607474|NCT00576732|525079191|FG001|DOUBLE BLIND|Protocol Violation|0|||
145607475|NCT00576732|525079192|FG002|DOUBLE BLIND|Protocol Violation|0|||
145607476|NCT00576732|525079193|FG003|DOUBLE BLIND|Protocol Violation|0|||
145607477|NCT00576732|525079194|FG004|DOUBLE BLIND|Protocol Violation|0|||
145607478|NCT00576732|525079195|FG005|DOUBLE BLIND|Protocol Violation|0|||
145607479|NCT00576732|525079190|FG000|OPEN LABEL|Adverse Event|0|||
145607480|NCT00576732|525079191|FG001|OPEN LABEL|Adverse Event|0|||
145607481|NCT00576732|525079192|FG002|OPEN LABEL|Adverse Event|0|||
145607482|NCT00576732|525079193|FG003|OPEN LABEL|Adverse Event|4|||
145607483|NCT00576732|525079194|FG004|OPEN LABEL|Adverse Event|0|||
145607484|NCT00576732|525079195|FG005|OPEN LABEL|Adverse Event|1|||
145607485|NCT00576732|525079190|FG000|OPEN LABEL|Lost to Follow-up|0|||
145607486|NCT00576732|525079191|FG001|OPEN LABEL|Lost to Follow-up|0|||
145607487|NCT00576732|525079192|FG002|OPEN LABEL|Lost to Follow-up|0|||
145607488|NCT00576732|525079193|FG003|OPEN LABEL|Lost to Follow-up|2|||
145607489|NCT00576732|525079194|FG004|OPEN LABEL|Lost to Follow-up|1|||
145607490|NCT00576732|525079195|FG005|OPEN LABEL|Lost to Follow-up|1|||
145607491|NCT00576732|525079190|FG000|OPEN LABEL|Withdrawal by Subject|0|||
145607492|NCT00576732|525079191|FG001|OPEN LABEL|Withdrawal by Subject|0|||
145607493|NCT00576732|525079192|FG002|OPEN LABEL|Withdrawal by Subject|0|||
145607494|NCT00576732|525079193|FG003|OPEN LABEL|Withdrawal by Subject|1|||
145607495|NCT00576732|525079194|FG004|OPEN LABEL|Withdrawal by Subject|0|||
145607496|NCT00576732|525079195|FG005|OPEN LABEL|Withdrawal by Subject|1|||
145607497|NCT00576732|525079190|FG000|OPEN LABEL|OTHER|0|||
145607498|NCT00576732|525079191|FG001|OPEN LABEL|OTHER|0|||
145607499|NCT00576732|525079192|FG002|OPEN LABEL|OTHER|0|||
145607500|NCT00576732|525079193|FG003|OPEN LABEL|OTHER|0|||
145607501|NCT00576732|525079194|FG004|OPEN LABEL|OTHER|0|||
145607502|NCT00576732|525079195|FG005|OPEN LABEL|OTHER|2|||
145607503|NCT00576732|525079190|FG000|OPEN LABEL|Lack of Efficacy|0|||
145607504|NCT00576732|525079191|FG001|OPEN LABEL|Lack of Efficacy|0|||
145607505|NCT00576732|525079192|FG002|OPEN LABEL|Lack of Efficacy|0|||
145607506|NCT00576732|525079193|FG003|OPEN LABEL|Lack of Efficacy|2|||
145607507|NCT00576732|525079194|FG004|OPEN LABEL|Lack of Efficacy|2|||
145607508|NCT00576732|525079195|FG005|OPEN LABEL|Lack of Efficacy|3|||
145607509|NCT00576732|525079190|FG000|OPEN LABEL|Protocol Violation|0|||
145607510|NCT00576732|525079191|FG001|OPEN LABEL|Protocol Violation|0|||
145607511|NCT00576732|525079192|FG002|OPEN LABEL|Protocol Violation|0|||
145607512|NCT00576732|525079193|FG003|OPEN LABEL|Protocol Violation|2|||
145607513|NCT00576732|525079194|FG004|OPEN LABEL|Protocol Violation|1|||
145607514|NCT00576732|525079195|FG005|OPEN LABEL|Protocol Violation|0|||
145607515|NCT01235403|525079197|FG000|Overall Study|Adverse Event|14|||
145607516|NCT01235403|525079197|FG000|Overall Study|Lost to Follow-up|2|||
145607517|NCT01235403|525079197|FG000|Overall Study|Withdrawal by Subject|4|||
145607518|NCT01235403|525079197|FG000|Overall Study|Lack of Efficacy|2|||
145607519|NCT01235403|525079197|FG000|Overall Study|Other reasons for premature termination|4|||
145607520|NCT02978443|525079198|FG000|Overall Study|Withdrawal by Subject|1|||
145607521|NCT02978443|525079198|FG000|Overall Study|Adverse Event|3|||
145607522|NCT02978443|525079198|FG000|Overall Study|Disease Progression on study|6|||
145607523|NCT02978443|525079198|FG000|Overall Study|Death|1|||
145607524|NCT02978443|525079198|FG000|Overall Study|Physician Decision|1|||
145607525|NCT02978443|525079198|FG000|Overall Study|Switch to alternative therapy|1|||
145607526|NCT02978443|525079198|FG000|Overall Study|Refused further treatment|1|||
145269409|NCT00798707|523835348|FG000|Overall Study|Investigator|0|||
145402270|NCT03261401|524330694|FG002|Overall Study|Withdrawal by Subject|0|||
145402271|NCT03261401|524330695|FG003|Overall Study|Withdrawal by Subject|0|||
145607527|NCT02296190|525079199|FG000|Overall Study|Lost to Follow-up|0|||
145607528|NCT02296190|525079200|FG001|Overall Study|Lost to Follow-up|0|||
145607529|NCT02296190|525079201|FG002|Overall Study|Lost to Follow-up|0|||
145607530|NCT02296190|525079202|FG003|Overall Study|Lost to Follow-up|0|||
145607531|NCT02296190|525079203|FG004|Overall Study|Lost to Follow-up|1|||
145607532|NCT02296190|525079204|FG005|Overall Study|Lost to Follow-up|0|||
145607533|NCT02296190|525079199|FG000|Overall Study|Failure to induce PSVT|6|||
145607534|NCT02296190|525079200|FG001|Overall Study|Failure to induce PSVT|10|||
145607535|NCT02296190|525079201|FG002|Overall Study|Failure to induce PSVT|5|||
145607536|NCT02296190|525079202|FG003|Overall Study|Failure to induce PSVT|13|||
145607537|NCT02296190|525079203|FG004|Overall Study|Failure to induce PSVT|8|||
145607538|NCT02296190|525079204|FG005|Overall Study|Failure to induce PSVT|0|||
145607539|NCT02296190|525079199|FG000|Overall Study|Physician Decision|1|||
145607540|NCT02296190|525079200|FG001|Overall Study|Physician Decision|1|||
145607541|NCT02296190|525079201|FG002|Overall Study|Physician Decision|0|||
145607542|NCT02296190|525079202|FG003|Overall Study|Physician Decision|1|||
145607543|NCT02296190|525079203|FG004|Overall Study|Physician Decision|2|||
145607544|NCT02296190|525079204|FG005|Overall Study|Physician Decision|0|||
145607545|NCT02296190|525079199|FG000|Overall Study|Withdrawal by Subject|0|||
145607546|NCT02296190|525079200|FG001|Overall Study|Withdrawal by Subject|1|||
145517135|NCT03560518|524752481|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
145517136|NCT03560518|524752479|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
145517137|NCT03560518|524752480|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
145517138|NCT03560518|524752481|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
145517139|NCT03560518|524752479|FG000|Double Blind Treatment Period|Adverse Event|0|||
145517140|NCT03560518|524752480|FG001|Double Blind Treatment Period|Adverse Event|3|||
145517141|NCT03560518|524752481|FG002|Double Blind Treatment Period|Adverse Event|1|||
145517142|NCT01689532|524752482|FG000|Overall Study|Adverse Event|9|||
145517143|NCT01689532|524752483|FG001|Overall Study|Adverse Event|5|||
145517144|NCT01689532|524752482|FG000|Overall Study|Lack of Efficacy|2|||
145517145|NCT01689532|524752483|FG001|Overall Study|Lack of Efficacy|2|||
145517146|NCT01689532|524752482|FG000|Overall Study|Withdrawal by Subject|1|||
145517147|NCT01689532|524752483|FG001|Overall Study|Withdrawal by Subject|2|||
145517148|NCT01689532|524752482|FG000|Overall Study|Physician Decision|2|||
145517149|NCT01689532|524752483|FG001|Overall Study|Physician Decision|0|||
145517150|NCT01363349|524752484|FG000|Overall Study|Adverse Event|6|||
145517151|NCT01363349|524752485|FG001|Overall Study|Adverse Event|7|||
145517152|NCT01363349|524752484|FG000|Overall Study|Lack of Efficacy|3|||
145517153|NCT01363349|524752485|FG001|Overall Study|Lack of Efficacy|10|||
145517154|NCT01363349|524752484|FG000|Overall Study|Non compliance/Protocol deviations|2|||
145517155|NCT01363349|524752485|FG001|Overall Study|Non compliance/Protocol deviations|2|||
145517156|NCT01363349|524752484|FG000|Overall Study|Withdrawal by Subject|14|||
145517157|NCT01363349|524752485|FG001|Overall Study|Withdrawal by Subject|6|||
145517158|NCT01363349|524752484|FG000|Overall Study|Lost to Follow-up|5|||
145517159|NCT01363349|524752485|FG001|Overall Study|Lost to Follow-up|6|||
145517160|NCT01363349|524752484|FG000|Overall Study|Not reported|36|||
145517161|NCT01363349|524752485|FG001|Overall Study|Not reported|37|||
145517162|NCT01363349|524752484|FG000|Overall Study|missing|1|||
145517163|NCT01363349|524752485|FG001|Overall Study|missing|2|||
145517164|NCT01958489|524752486|FG000|Period 2|Adverse Event|0|||
145517165|NCT01958489|524752487|FG001|Period 2|Adverse Event|1|||
145517166|NCT00917644|524752488|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
145517167|NCT00917644|524752489|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
145517168|NCT00917644|524752488|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
145517169|NCT00917644|524752489|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
145517170|NCT00917644|524752488|FG000|Period 2: Second Intervention|family emergency|1|||
145269410|NCT00798707|523835349|FG001|Overall Study|Investigator|1|||
145269411|NCT00798707|523835350|FG002|Overall Study|Investigator|2|||
145736511|NCT00467779|525553370|FG013|Stage 1A|Death|0|||
145736512|NCT00467779|525553371|FG014|Stage 1A|Death|0|||
145736513|NCT00467779|525553357|FG000|Stage 1A|Disease Progression|0|||
145736514|NCT00467779|525553358|FG001|Stage 1A|Disease Progression|0|||
145736515|NCT00467779|525553359|FG002|Stage 1A|Disease Progression|0|||
145736516|NCT00467779|525553360|FG003|Stage 1A|Disease Progression|0|||
145736517|NCT00467779|525553361|FG004|Stage 1A|Disease Progression|0|||
145736518|NCT00467779|525553362|FG005|Stage 1A|Disease Progression|0|||
145736519|NCT00467779|525553363|FG006|Stage 1A|Disease Progression|0|||
145736520|NCT00467779|525553364|FG007|Stage 1A|Disease Progression|0|||
145736521|NCT00467779|525553365|FG008|Stage 1A|Disease Progression|0|||
145736522|NCT00467779|525553366|FG009|Stage 1A|Disease Progression|2|||
145736523|NCT00467779|525553367|FG010|Stage 1A|Disease Progression|2|||
145736524|NCT00467779|525553368|FG011|Stage 1A|Disease Progression|5|||
145736525|NCT00467779|525553369|FG012|Stage 1A|Disease Progression|2|||
145736526|NCT00467779|525553370|FG013|Stage 1A|Disease Progression|0|||
145736527|NCT00467779|525553371|FG014|Stage 1A|Disease Progression|0|||
145736528|NCT00467779|525553357|FG000|Stage 1A|Physician Decision|0|||
145736529|NCT00467779|525553358|FG001|Stage 1A|Physician Decision|0|||
145736530|NCT00467779|525553359|FG002|Stage 1A|Physician Decision|0|||
145736531|NCT00467779|525553360|FG003|Stage 1A|Physician Decision|0|||
145736532|NCT00467779|525553361|FG004|Stage 1A|Physician Decision|0|||
145736533|NCT00467779|525553362|FG005|Stage 1A|Physician Decision|0|||
145736534|NCT00467779|525553363|FG006|Stage 1A|Physician Decision|0|||
145736535|NCT00467779|525553364|FG007|Stage 1A|Physician Decision|0|||
145736536|NCT00467779|525553365|FG008|Stage 1A|Physician Decision|0|||
145736537|NCT00467779|525553366|FG009|Stage 1A|Physician Decision|1|||
145736538|NCT00467779|525553367|FG010|Stage 1A|Physician Decision|0|||
145736539|NCT00467779|525553368|FG011|Stage 1A|Physician Decision|0|||
145736540|NCT00467779|525553369|FG012|Stage 1A|Physician Decision|0|||
145736541|NCT00467779|525553370|FG013|Stage 1A|Physician Decision|0|||
145736542|NCT00467779|525553371|FG014|Stage 1A|Physician Decision|0|||
145736543|NCT00467779|525553357|FG000|Stage 1A|Withdrawal by Subject|0|||
145736544|NCT00467779|525553358|FG001|Stage 1A|Withdrawal by Subject|0|||
145736545|NCT00467779|525553359|FG002|Stage 1A|Withdrawal by Subject|0|||
145736546|NCT00467779|525553360|FG003|Stage 1A|Withdrawal by Subject|0|||
145736547|NCT00467779|525553361|FG004|Stage 1A|Withdrawal by Subject|0|||
145736548|NCT00467779|525553362|FG005|Stage 1A|Withdrawal by Subject|0|||
145736549|NCT00467779|525553363|FG006|Stage 1A|Withdrawal by Subject|0|||
145736550|NCT00467779|525553364|FG007|Stage 1A|Withdrawal by Subject|0|||
145736551|NCT00467779|525553365|FG008|Stage 1A|Withdrawal by Subject|0|||
145736552|NCT00467779|525553366|FG009|Stage 1A|Withdrawal by Subject|0|||
145736553|NCT00467779|525553367|FG010|Stage 1A|Withdrawal by Subject|1|||
145736554|NCT00467779|525553368|FG011|Stage 1A|Withdrawal by Subject|1|||
145736555|NCT00467779|525553369|FG012|Stage 1A|Withdrawal by Subject|1|||
145736556|NCT00467779|525553370|FG013|Stage 1A|Withdrawal by Subject|0|||
145736557|NCT00467779|525553371|FG014|Stage 1A|Withdrawal by Subject|0|||
145736558|NCT00467779|525553357|FG000|Stage 1A|Unspecified Reason|0|||
145736559|NCT00467779|525553358|FG001|Stage 1A|Unspecified Reason|0|||
145736560|NCT00467779|525553359|FG002|Stage 1A|Unspecified Reason|0|||
145736561|NCT00467779|525553360|FG003|Stage 1A|Unspecified Reason|0|||
145736562|NCT00467779|525553361|FG004|Stage 1A|Unspecified Reason|0|||
145736563|NCT00467779|525553362|FG005|Stage 1A|Unspecified Reason|0|||
145736564|NCT00467779|525553363|FG006|Stage 1A|Unspecified Reason|0|||
145736565|NCT00467779|525553364|FG007|Stage 1A|Unspecified Reason|0|||
145736566|NCT00467779|525553365|FG008|Stage 1A|Unspecified Reason|0|||
145736567|NCT00467779|525553366|FG009|Stage 1A|Unspecified Reason|0|||
145736568|NCT00467779|525553367|FG010|Stage 1A|Unspecified Reason|0|||
145736569|NCT00467779|525553368|FG011|Stage 1A|Unspecified Reason|1|||
145736570|NCT00467779|525553369|FG012|Stage 1A|Unspecified Reason|1|||
145736571|NCT00467779|525553370|FG013|Stage 1A|Unspecified Reason|0|||
145736572|NCT00467779|525553371|FG014|Stage 1A|Unspecified Reason|0|||
145736573|NCT00467779|525553357|FG000|Stage 2|Adverse Event|0|||
145736574|NCT00467779|525553358|FG001|Stage 2|Adverse Event|0|||
145736575|NCT00467779|525553359|FG002|Stage 2|Adverse Event|0|||
145736576|NCT00467779|525553360|FG003|Stage 2|Adverse Event|0|||
145736577|NCT00467779|525553361|FG004|Stage 2|Adverse Event|0|||
145736578|NCT00467779|525553362|FG005|Stage 2|Adverse Event|0|||
145736579|NCT00467779|525553363|FG006|Stage 2|Adverse Event|0|||
145736580|NCT00467779|525553364|FG007|Stage 2|Adverse Event|0|||
145736581|NCT00467779|525553365|FG008|Stage 2|Adverse Event|1|||
145736582|NCT00467779|525553366|FG009|Stage 2|Adverse Event|0|||
145736583|NCT00467779|525553367|FG010|Stage 2|Adverse Event|0|||
145736584|NCT00467779|525553368|FG011|Stage 2|Adverse Event|0|||
145736585|NCT00467779|525553369|FG012|Stage 2|Adverse Event|0|||
145736586|NCT00467779|525553370|FG013|Stage 2|Adverse Event|0|||
145736587|NCT00467779|525553371|FG014|Stage 2|Adverse Event|0|||
145736588|NCT00467779|525553357|FG000|Stage 2|Death|0|||
145736589|NCT00467779|525553358|FG001|Stage 2|Death|0|||
145736590|NCT00467779|525553359|FG002|Stage 2|Death|0|||
145736591|NCT00467779|525553360|FG003|Stage 2|Death|0|||
145736592|NCT00467779|525553361|FG004|Stage 2|Death|0|||
145736593|NCT00467779|525553362|FG005|Stage 2|Death|0|||
145736594|NCT00467779|525553363|FG006|Stage 2|Death|0|||
145736595|NCT00467779|525553364|FG007|Stage 2|Death|0|||
145736596|NCT00467779|525553365|FG008|Stage 2|Death|1|||
145736597|NCT00467779|525553366|FG009|Stage 2|Death|0|||
145736598|NCT00467779|525553367|FG010|Stage 2|Death|0|||
145736599|NCT00467779|525553368|FG011|Stage 2|Death|0|||
145736600|NCT00467779|525553369|FG012|Stage 2|Death|0|||
145736601|NCT00467779|525553370|FG013|Stage 2|Death|0|||
145736602|NCT00467779|525553371|FG014|Stage 2|Death|0|||
145736603|NCT00467779|525553357|FG000|Stage 2|Disease Progression|0|||
145736604|NCT00467779|525553358|FG001|Stage 2|Disease Progression|0|||
145736605|NCT00467779|525553359|FG002|Stage 2|Disease Progression|0|||
145736606|NCT00467779|525553360|FG003|Stage 2|Disease Progression|0|||
145736607|NCT00467779|525553361|FG004|Stage 2|Disease Progression|0|||
145736608|NCT00467779|525553362|FG005|Stage 2|Disease Progression|0|||
145736609|NCT00467779|525553363|FG006|Stage 2|Disease Progression|0|||
145736610|NCT00467779|525553364|FG007|Stage 2|Disease Progression|0|||
145736611|NCT00467779|525553365|FG008|Stage 2|Disease Progression|16|||
145736612|NCT00467779|525553366|FG009|Stage 2|Disease Progression|0|||
145736613|NCT00467779|525553367|FG010|Stage 2|Disease Progression|0|||
145736614|NCT00467779|525553368|FG011|Stage 2|Disease Progression|0|||
145736615|NCT00467779|525553369|FG012|Stage 2|Disease Progression|0|||
145736616|NCT00467779|525553370|FG013|Stage 2|Disease Progression|0|||
145736617|NCT00467779|525553371|FG014|Stage 2|Disease Progression|0|||
145736618|NCT00467779|525553357|FG000|Stage 2|Unspecified Reason|0|||
145736619|NCT00467779|525553358|FG001|Stage 2|Unspecified Reason|0|||
145736620|NCT00467779|525553359|FG002|Stage 2|Unspecified Reason|0|||
145736621|NCT00467779|525553360|FG003|Stage 2|Unspecified Reason|0|||
145736622|NCT00467779|525553361|FG004|Stage 2|Unspecified Reason|0|||
145736623|NCT00467779|525553362|FG005|Stage 2|Unspecified Reason|0|||
145736624|NCT00467779|525553363|FG006|Stage 2|Unspecified Reason|0|||
145736625|NCT00467779|525553364|FG007|Stage 2|Unspecified Reason|0|||
145736626|NCT00467779|525553365|FG008|Stage 2|Unspecified Reason|3|||
145736627|NCT00467779|525553366|FG009|Stage 2|Unspecified Reason|0|||
145736628|NCT00467779|525553367|FG010|Stage 2|Unspecified Reason|0|||
145736629|NCT00467779|525553368|FG011|Stage 2|Unspecified Reason|0|||
145736630|NCT00467779|525553369|FG012|Stage 2|Unspecified Reason|0|||
145736631|NCT00467779|525553370|FG013|Stage 2|Unspecified Reason|0|||
145736632|NCT00467779|525553371|FG014|Stage 2|Unspecified Reason|0|||
145736633|NCT00467779|525553357|FG000|Stage 2A|Adverse Event|0|||
145736634|NCT00467779|525553358|FG001|Stage 2A|Adverse Event|0|||
145736635|NCT00467779|525553359|FG002|Stage 2A|Adverse Event|0|||
145736636|NCT00467779|525553360|FG003|Stage 2A|Adverse Event|0|||
145736637|NCT00467779|525553361|FG004|Stage 2A|Adverse Event|0|||
145736638|NCT00467779|525553362|FG005|Stage 2A|Adverse Event|0|||
145736639|NCT00467779|525553363|FG006|Stage 2A|Adverse Event|0|||
145736640|NCT00467779|525553364|FG007|Stage 2A|Adverse Event|0|||
145736641|NCT00467779|525553365|FG008|Stage 2A|Adverse Event|0|||
145736642|NCT00467779|525553366|FG009|Stage 2A|Adverse Event|0|||
145736643|NCT00467779|525553367|FG010|Stage 2A|Adverse Event|0|||
145736644|NCT00467779|525553368|FG011|Stage 2A|Adverse Event|0|||
145736645|NCT00467779|525553369|FG012|Stage 2A|Adverse Event|0|||
145736646|NCT00467779|525553370|FG013|Stage 2A|Adverse Event|2|||
145736647|NCT00467779|525553371|FG014|Stage 2A|Adverse Event|0|||
145736648|NCT00467779|525553357|FG000|Stage 2A|Death|0|||
145736649|NCT00467779|525553358|FG001|Stage 2A|Death|0|||
145736650|NCT00467779|525553359|FG002|Stage 2A|Death|0|||
145736651|NCT00467779|525553360|FG003|Stage 2A|Death|0|||
145736652|NCT00467779|525553361|FG004|Stage 2A|Death|0|||
145736653|NCT00467779|525553362|FG005|Stage 2A|Death|0|||
145736654|NCT00467779|525553363|FG006|Stage 2A|Death|0|||
145736655|NCT00467779|525553364|FG007|Stage 2A|Death|0|||
145736656|NCT00467779|525553365|FG008|Stage 2A|Death|0|||
145736657|NCT00467779|525553366|FG009|Stage 2A|Death|0|||
145736658|NCT00467779|525553367|FG010|Stage 2A|Death|0|||
145736659|NCT00467779|525553368|FG011|Stage 2A|Death|0|||
145736660|NCT00467779|525553369|FG012|Stage 2A|Death|0|||
145736661|NCT00467779|525553370|FG013|Stage 2A|Death|1|||
145736662|NCT00467779|525553371|FG014|Stage 2A|Death|0|||
145736663|NCT00467779|525553357|FG000|Stage 2A|Disease Progression|0|||
145736664|NCT00467779|525553358|FG001|Stage 2A|Disease Progression|0|||
145736665|NCT00467779|525553359|FG002|Stage 2A|Disease Progression|0|||
145736666|NCT00467779|525553360|FG003|Stage 2A|Disease Progression|0|||
145736667|NCT00467779|525553361|FG004|Stage 2A|Disease Progression|0|||
145736668|NCT00467779|525553362|FG005|Stage 2A|Disease Progression|0|||
145736669|NCT00467779|525553363|FG006|Stage 2A|Disease Progression|0|||
145736670|NCT00467779|525553364|FG007|Stage 2A|Disease Progression|0|||
145736671|NCT00467779|525553365|FG008|Stage 2A|Disease Progression|0|||
145736672|NCT00467779|525553366|FG009|Stage 2A|Disease Progression|0|||
145736673|NCT00467779|525553367|FG010|Stage 2A|Disease Progression|0|||
145736674|NCT00467779|525553368|FG011|Stage 2A|Disease Progression|0|||
145736675|NCT00467779|525553369|FG012|Stage 2A|Disease Progression|0|||
145736676|NCT00467779|525553370|FG013|Stage 2A|Disease Progression|10|||
145736677|NCT00467779|525553371|FG014|Stage 2A|Disease Progression|0|||
145736678|NCT00467779|525553357|FG000|Stage 2A|Unspecified Reason|0|||
145736679|NCT00467779|525553358|FG001|Stage 2A|Unspecified Reason|0|||
145736680|NCT00467779|525553359|FG002|Stage 2A|Unspecified Reason|0|||
145736681|NCT00467779|525553360|FG003|Stage 2A|Unspecified Reason|0|||
145736682|NCT00467779|525553361|FG004|Stage 2A|Unspecified Reason|0|||
145736683|NCT00467779|525553362|FG005|Stage 2A|Unspecified Reason|0|||
145736684|NCT00467779|525553363|FG006|Stage 2A|Unspecified Reason|0|||
145736685|NCT00467779|525553364|FG007|Stage 2A|Unspecified Reason|0|||
145736686|NCT00467779|525553365|FG008|Stage 2A|Unspecified Reason|0|||
145736687|NCT00467779|525553366|FG009|Stage 2A|Unspecified Reason|0|||
145736688|NCT00467779|525553367|FG010|Stage 2A|Unspecified Reason|0|||
145736689|NCT00467779|525553368|FG011|Stage 2A|Unspecified Reason|0|||
145736690|NCT00467779|525553369|FG012|Stage 2A|Unspecified Reason|0|||
145736691|NCT00467779|525553370|FG013|Stage 2A|Unspecified Reason|7|||
145736692|NCT00467779|525553371|FG014|Stage 2A|Unspecified Reason|0|||
145736693|NCT00467779|525553357|FG000|Stage 2A|Withdrawal by Subject|0|||
145736694|NCT00467779|525553358|FG001|Stage 2A|Withdrawal by Subject|0|||
145736695|NCT00467779|525553359|FG002|Stage 2A|Withdrawal by Subject|0|||
145736696|NCT00467779|525553360|FG003|Stage 2A|Withdrawal by Subject|0|||
145736697|NCT00467779|525553361|FG004|Stage 2A|Withdrawal by Subject|0|||
145736698|NCT00467779|525553362|FG005|Stage 2A|Withdrawal by Subject|0|||
145736699|NCT00467779|525553363|FG006|Stage 2A|Withdrawal by Subject|0|||
145736700|NCT00467779|525553364|FG007|Stage 2A|Withdrawal by Subject|0|||
145736701|NCT00467779|525553365|FG008|Stage 2A|Withdrawal by Subject|0|||
145517171|NCT00917644|524752489|FG001|Period 2: Second Intervention|family emergency|0|||
145517172|NCT00958438|524752492|FG000|Overall Study|Protocol Violation|3|||
145517173|NCT00958438|524752493|FG001|Overall Study|Protocol Violation|2|||
145517174|NCT00958438|524752494|FG002|Overall Study|Protocol Violation|2|||
145736702|NCT00467779|525553366|FG009|Stage 2A|Withdrawal by Subject|0|||
145736703|NCT00467779|525553367|FG010|Stage 2A|Withdrawal by Subject|0|||
145736704|NCT00467779|525553368|FG011|Stage 2A|Withdrawal by Subject|0|||
145736705|NCT00467779|525553369|FG012|Stage 2A|Withdrawal by Subject|0|||
145736706|NCT00467779|525553370|FG013|Stage 2A|Withdrawal by Subject|1|||
145517175|NCT00958438|524752492|FG000|Overall Study|Withdrawal by Subject|4|||
145736707|NCT00467779|525553371|FG014|Stage 2A|Withdrawal by Subject|0|||
145736708|NCT00467779|525553357|FG000|Stage 3|Adverse Event|0|||
145736709|NCT00467779|525553358|FG001|Stage 3|Adverse Event|0|||
145736710|NCT00467779|525553359|FG002|Stage 3|Adverse Event|0|||
145736711|NCT00467779|525553360|FG003|Stage 3|Adverse Event|0|||
145736712|NCT00467779|525553361|FG004|Stage 3|Adverse Event|0|||
145736713|NCT00467779|525553362|FG005|Stage 3|Adverse Event|0|||
145736714|NCT00467779|525553363|FG006|Stage 3|Adverse Event|0|||
145736715|NCT00467779|525553364|FG007|Stage 3|Adverse Event|0|||
145736716|NCT00467779|525553365|FG008|Stage 3|Adverse Event|0|||
145736717|NCT00467779|525553366|FG009|Stage 3|Adverse Event|0|||
145736718|NCT00467779|525553367|FG010|Stage 3|Adverse Event|0|||
145736719|NCT00467779|525553368|FG011|Stage 3|Adverse Event|0|||
145736720|NCT00467779|525553369|FG012|Stage 3|Adverse Event|0|||
145736721|NCT00467779|525553370|FG013|Stage 3|Adverse Event|0|||
145736722|NCT00467779|525553371|FG014|Stage 3|Adverse Event|2|||
145736723|NCT00467779|525553357|FG000|Stage 3|Death|0|||
145736724|NCT00467779|525553358|FG001|Stage 3|Death|0|||
145736725|NCT00467779|525553359|FG002|Stage 3|Death|0|||
145736726|NCT00467779|525553360|FG003|Stage 3|Death|0|||
145736727|NCT00467779|525553361|FG004|Stage 3|Death|0|||
145736728|NCT00467779|525553362|FG005|Stage 3|Death|0|||
145736729|NCT00467779|525553363|FG006|Stage 3|Death|0|||
145736730|NCT00467779|525553364|FG007|Stage 3|Death|0|||
145736731|NCT00467779|525553365|FG008|Stage 3|Death|0|||
145736732|NCT00467779|525553366|FG009|Stage 3|Death|0|||
145736733|NCT00467779|525553367|FG010|Stage 3|Death|0|||
145736734|NCT00467779|525553368|FG011|Stage 3|Death|0|||
145736735|NCT00467779|525553369|FG012|Stage 3|Death|0|||
145736736|NCT00467779|525553370|FG013|Stage 3|Death|0|||
145736737|NCT00467779|525553371|FG014|Stage 3|Death|1|||
145736738|NCT00467779|525553357|FG000|Stage 3|Disease Progression|0|||
145736739|NCT00467779|525553358|FG001|Stage 3|Disease Progression|0|||
145736740|NCT00467779|525553359|FG002|Stage 3|Disease Progression|0|||
145736741|NCT00467779|525553360|FG003|Stage 3|Disease Progression|0|||
145736742|NCT00467779|525553361|FG004|Stage 3|Disease Progression|0|||
145736743|NCT00467779|525553362|FG005|Stage 3|Disease Progression|0|||
145736744|NCT00467779|525553363|FG006|Stage 3|Disease Progression|0|||
145736745|NCT00467779|525553364|FG007|Stage 3|Disease Progression|0|||
145736746|NCT00467779|525553365|FG008|Stage 3|Disease Progression|0|||
145736747|NCT00467779|525553366|FG009|Stage 3|Disease Progression|0|||
145736748|NCT00467779|525553367|FG010|Stage 3|Disease Progression|0|||
145736749|NCT00467779|525553368|FG011|Stage 3|Disease Progression|0|||
145736750|NCT00467779|525553369|FG012|Stage 3|Disease Progression|0|||
145736751|NCT00467779|525553370|FG013|Stage 3|Disease Progression|0|||
145736752|NCT00467779|525553371|FG014|Stage 3|Disease Progression|9|||
145736753|NCT00467779|525553357|FG000|Stage 3|Unspecified Reason|0|||
145736754|NCT00467779|525553358|FG001|Stage 3|Unspecified Reason|0|||
145736755|NCT00467779|525553359|FG002|Stage 3|Unspecified Reason|0|||
145736756|NCT00467779|525553360|FG003|Stage 3|Unspecified Reason|0|||
145736757|NCT00467779|525553361|FG004|Stage 3|Unspecified Reason|0|||
145736758|NCT00467779|525553362|FG005|Stage 3|Unspecified Reason|0|||
145736759|NCT00467779|525553363|FG006|Stage 3|Unspecified Reason|0|||
145736760|NCT00467779|525553364|FG007|Stage 3|Unspecified Reason|0|||
145736761|NCT00467779|525553365|FG008|Stage 3|Unspecified Reason|0|||
145736762|NCT00467779|525553366|FG009|Stage 3|Unspecified Reason|0|||
145736763|NCT00467779|525553367|FG010|Stage 3|Unspecified Reason|0|||
145736764|NCT00467779|525553368|FG011|Stage 3|Unspecified Reason|0|||
145736765|NCT00467779|525553369|FG012|Stage 3|Unspecified Reason|0|||
145736766|NCT00467779|525553370|FG013|Stage 3|Unspecified Reason|0|||
145736767|NCT00467779|525553371|FG014|Stage 3|Unspecified Reason|5|||
145736768|NCT01509079|525553372|FG000|Overall Study|Lack of Efficacy|0|||
145736769|NCT01509079|525553373|FG001|Overall Study|Lack of Efficacy|2|||
145736770|NCT01509079|525553372|FG000|Overall Study|started an excluded medication|0|||
145736771|NCT01509079|525553373|FG001|Overall Study|started an excluded medication|1|||
145736772|NCT05111041|525553374|FG000|Overall Study|Lost to Follow-up|6|||
145736773|NCT05111041|525553375|FG001|Overall Study|Lost to Follow-up|7|||
145736774|NCT05111041|525553374|FG000|Overall Study|Withdrawal by Subject|1|||
145736775|NCT05111041|525553375|FG001|Overall Study|Withdrawal by Subject|0|||
145736776|NCT00791258|525553376|FG000|Overall Study|Adverse Event|87|||
145736777|NCT00791258|525553376|FG000|Overall Study|Lost to Follow-up|18|||
145736778|NCT00791258|525553376|FG000|Overall Study|Protocol Violation|109|||
145517176|NCT00958438|524752493|FG001|Overall Study|Withdrawal by Subject|2|||
145736779|NCT00791258|525553376|FG000|Overall Study|Withdrawal by Subject|40|||
145517177|NCT00958438|524752494|FG002|Overall Study|Withdrawal by Subject|1|||
145736780|NCT00791258|525553376|FG000|Overall Study|Did not take medication for >3 days|1|||
145736781|NCT00791258|525553376|FG000|Overall Study|subject left area|2|||
145736782|NCT00791258|525553376|FG000|Overall Study|non-compliance|3|||
145736783|NCT00791258|525553376|FG000|Overall Study|Subject incarcerated|1|||
145736784|NCT00791258|525553376|FG000|Overall Study|Subject required restricted medication|1|||
145736785|NCT00791258|525553376|FG000|Overall Study|Lack of Efficacy|1|||
145736786|NCT00041080|525553377|FG000|Overall Study|Adverse Event|21|||
145736787|NCT00041080|525553378|FG001|Overall Study|Adverse Event|1|||
145736788|NCT00041080|525553377|FG000|Overall Study|Withdrawal by Subject|6|||
145736789|NCT00041080|525553378|FG001|Overall Study|Withdrawal by Subject|6|||
145736790|NCT00041080|525553377|FG000|Overall Study|Concommitant Illness/Other|1|||
145736791|NCT00041080|525553378|FG001|Overall Study|Concommitant Illness/Other|2|||
145736792|NCT00041080|525553377|FG000|Overall Study|Did not start therapy|1|||
145736793|NCT00041080|525553378|FG001|Overall Study|Did not start therapy|1|||
145736794|NCT00041080|525553377|FG000|Overall Study|Ineligible|1|||
145736795|NCT00041080|525553378|FG001|Overall Study|Ineligible|0|||
145736796|NCT00436618|525553379|FG000|Overall Study|Withdrawal by Subject|5|||
145736797|NCT00436618|525553380|FG001|Overall Study|Withdrawal by Subject|8|||
145736798|NCT00436618|525553381|FG002|Overall Study|Withdrawal by Subject|11|||
145736799|NCT00436618|525553379|FG000|Overall Study|Adverse Event|8|||
145736800|NCT00436618|525553380|FG001|Overall Study|Adverse Event|8|||
145736801|NCT00436618|525553381|FG002|Overall Study|Adverse Event|9|||
145736802|NCT00436618|525553379|FG000|Overall Study|Alternate Treatment|3|||
145736803|NCT00436618|525553380|FG001|Overall Study|Alternate Treatment|4|||
145736804|NCT00436618|525553381|FG002|Overall Study|Alternate Treatment|12|||
145736805|NCT00436618|525553379|FG000|Overall Study|Other Medical Problems|3|||
145736806|NCT00436618|525553380|FG001|Overall Study|Other Medical Problems|1|||
145736807|NCT00436618|525553381|FG002|Overall Study|Other Medical Problems|7|||
145736808|NCT00436618|525553379|FG000|Overall Study|Death|4|||
145736809|NCT00436618|525553380|FG001|Overall Study|Death|2|||
145736810|NCT00436618|525553381|FG002|Overall Study|Death|3|||
145736811|NCT00436618|525553379|FG000|Overall Study|New Primary or Other Reasons|6|||
145736812|NCT00436618|525553380|FG001|Overall Study|New Primary or Other Reasons|2|||
145736813|NCT00436618|525553381|FG002|Overall Study|New Primary or Other Reasons|12|||
145736814|NCT00436618|525553379|FG000|Overall Study|Still on treatment|1|||
145736815|NCT00436618|525553380|FG001|Overall Study|Still on treatment|2|||
145736816|NCT00436618|525553381|FG002|Overall Study|Still on treatment|7|||
145736817|NCT04667377|525553382|FG000|Dose Escalation Period|Other not specified below|3|||
145736818|NCT04667377|525553383|FG001|Dose Escalation Period|Other not specified below|3|||
145736819|NCT04667377|525553384|FG002|Dose Escalation Period|Other not specified below|2|||
145736820|NCT04667377|525553385|FG003|Dose Escalation Period|Other not specified below|1|||
145736821|NCT04667377|525553386|FG004|Dose Escalation Period|Other not specified below|3|||
145736822|NCT04667377|525553382|FG000|Dose Escalation Period|Protocol Violation|2|||
145736823|NCT04667377|525553383|FG001|Dose Escalation Period|Protocol Violation|2|||
145736824|NCT04667377|525553384|FG002|Dose Escalation Period|Protocol Violation|0|||
145736825|NCT04667377|525553385|FG003|Dose Escalation Period|Protocol Violation|2|||
145736826|NCT04667377|525553386|FG004|Dose Escalation Period|Protocol Violation|1|||
145736827|NCT04667377|525553382|FG000|Dose Escalation Period|Burden of study procedures|2|||
145736828|NCT04667377|525553383|FG001|Dose Escalation Period|Burden of study procedures|1|||
145736829|NCT04667377|525553384|FG002|Dose Escalation Period|Burden of study procedures|1|||
145736830|NCT04667377|525553385|FG003|Dose Escalation Period|Burden of study procedures|1|||
145736831|NCT04667377|525553386|FG004|Dose Escalation Period|Burden of study procedures|5|||
145736832|NCT04667377|525553382|FG000|Dose Escalation Period|Change of residence|0|||
145736833|NCT04667377|525553383|FG001|Dose Escalation Period|Change of residence|0|||
145736834|NCT04667377|525553384|FG002|Dose Escalation Period|Change of residence|1|||
145736835|NCT04667377|525553385|FG003|Dose Escalation Period|Change of residence|0|||
145736836|NCT04667377|525553386|FG004|Dose Escalation Period|Change of residence|0|||
145736837|NCT04667377|525553382|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
145736838|NCT04667377|525553383|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
145736839|NCT04667377|525553384|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
145736840|NCT04667377|525553385|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
145736841|NCT04667377|525553386|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
145736842|NCT04667377|525553382|FG000|Dose Escalation Period|Adverse Event|9|||
145736843|NCT04667377|525553383|FG001|Dose Escalation Period|Adverse Event|10|||
145736844|NCT04667377|525553384|FG002|Dose Escalation Period|Adverse Event|12|||
145736845|NCT04667377|525553385|FG003|Dose Escalation Period|Adverse Event|17|||
145736846|NCT04667377|525553386|FG004|Dose Escalation Period|Adverse Event|3|||
145736847|NCT04667377|525553382|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
145736848|NCT04667377|525553383|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
145736849|NCT04667377|525553384|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
145736850|NCT04667377|525553385|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
145736851|NCT04667377|525553386|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
145736852|NCT04667377|525553382|FG000|Dose Escalation Period|Not treated|1|||
145736853|NCT04667377|525553383|FG001|Dose Escalation Period|Not treated|0|||
145736854|NCT04667377|525553384|FG002|Dose Escalation Period|Not treated|0|||
145736855|NCT04667377|525553385|FG003|Dose Escalation Period|Not treated|0|||
145736856|NCT04667377|525553386|FG004|Dose Escalation Period|Not treated|0|||
145736857|NCT04667377|525553382|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
145736858|NCT04667377|525553383|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
145736859|NCT04667377|525553384|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
145736860|NCT04667377|525553385|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
145736861|NCT04667377|525553386|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
145736862|NCT04667377|525553382|FG000|Dose Escalation Period|Lost to Follow-up|0|||
145736863|NCT04667377|525553383|FG001|Dose Escalation Period|Lost to Follow-up|1|||
145736864|NCT04667377|525553384|FG002|Dose Escalation Period|Lost to Follow-up|0|||
145736865|NCT04667377|525553385|FG003|Dose Escalation Period|Lost to Follow-up|0|||
145736866|NCT04667377|525553386|FG004|Dose Escalation Period|Lost to Follow-up|0|||
145736867|NCT04667377|525553382|FG000|Maintenance Period|Perceived lack of efficacy|0|||
145736868|NCT04667377|525553383|FG001|Maintenance Period|Perceived lack of efficacy|2|||
145736869|NCT04667377|525553384|FG002|Maintenance Period|Perceived lack of efficacy|1|||
145736870|NCT04667377|525553385|FG003|Maintenance Period|Perceived lack of efficacy|0|||
145736871|NCT04667377|525553386|FG004|Maintenance Period|Perceived lack of efficacy|1|||
145736872|NCT04667377|525553382|FG000|Maintenance Period|Adverse Event|2|||
145736873|NCT04667377|525553383|FG001|Maintenance Period|Adverse Event|8|||
145736874|NCT04667377|525553384|FG002|Maintenance Period|Adverse Event|5|||
145736875|NCT04667377|525553385|FG003|Maintenance Period|Adverse Event|4|||
145736876|NCT04667377|525553386|FG004|Maintenance Period|Adverse Event|1|||
145736877|NCT04667377|525553382|FG000|Maintenance Period|Adverse event: COVID infection|0|||
145736878|NCT04667377|525553383|FG001|Maintenance Period|Adverse event: COVID infection|1|||
145736879|NCT04667377|525553384|FG002|Maintenance Period|Adverse event: COVID infection|0|||
145736880|NCT04667377|525553385|FG003|Maintenance Period|Adverse event: COVID infection|0|||
145736881|NCT04667377|525553386|FG004|Maintenance Period|Adverse event: COVID infection|0|||
145736882|NCT04667377|525553382|FG000|Maintenance Period|COVID-related|0|||
145736883|NCT04667377|525553383|FG001|Maintenance Period|COVID-related|0|||
145736884|NCT04667377|525553384|FG002|Maintenance Period|COVID-related|1|||
145736885|NCT04667377|525553385|FG003|Maintenance Period|COVID-related|1|||
145736886|NCT04667377|525553386|FG004|Maintenance Period|COVID-related|0|||
145736887|NCT04667377|525553382|FG000|Maintenance Period|Protocol Violation|1|||
145736888|NCT04667377|525553383|FG001|Maintenance Period|Protocol Violation|0|||
145736889|NCT04667377|525553384|FG002|Maintenance Period|Protocol Violation|0|||
145736890|NCT04667377|525553385|FG003|Maintenance Period|Protocol Violation|0|||
145736891|NCT04667377|525553386|FG004|Maintenance Period|Protocol Violation|1|||
145736892|NCT04667377|525553382|FG000|Maintenance Period|Burden of study procedures|1|||
145736893|NCT04667377|525553383|FG001|Maintenance Period|Burden of study procedures|2|||
145736894|NCT04667377|525553384|FG002|Maintenance Period|Burden of study procedures|0|||
145736895|NCT04667377|525553385|FG003|Maintenance Period|Burden of study procedures|1|||
145736896|NCT04667377|525553386|FG004|Maintenance Period|Burden of study procedures|0|||
145736897|NCT04667377|525553382|FG000|Maintenance Period|Change of residence|0|||
145736898|NCT04667377|525553383|FG001|Maintenance Period|Change of residence|1|||
145736899|NCT04667377|525553384|FG002|Maintenance Period|Change of residence|0|||
145736900|NCT04667377|525553385|FG003|Maintenance Period|Change of residence|0|||
145736901|NCT04667377|525553386|FG004|Maintenance Period|Change of residence|1|||
145736902|NCT04667377|525553382|FG000|Maintenance Period|Missing|1|||
145736903|NCT04667377|525553383|FG001|Maintenance Period|Missing|0|||
145736904|NCT04667377|525553384|FG002|Maintenance Period|Missing|0|||
145736905|NCT04667377|525553385|FG003|Maintenance Period|Missing|0|||
145736906|NCT04667377|525553386|FG004|Maintenance Period|Missing|0|||
145736907|NCT04667377|525553382|FG000|Maintenance Period|Other than listed above|2|||
145736908|NCT04667377|525553383|FG001|Maintenance Period|Other than listed above|0|||
145736909|NCT04667377|525553384|FG002|Maintenance Period|Other than listed above|3|||
145736910|NCT04667377|525553385|FG003|Maintenance Period|Other than listed above|2|||
145736911|NCT04667377|525553386|FG004|Maintenance Period|Other than listed above|6|||
145736912|NCT04667377|525553382|FG000|Maintenance Period|Withdrawal by Subject|0|||
145736913|NCT04667377|525553383|FG001|Maintenance Period|Withdrawal by Subject|1|||
145736914|NCT04667377|525553384|FG002|Maintenance Period|Withdrawal by Subject|0|||
145736915|NCT04667377|525553385|FG003|Maintenance Period|Withdrawal by Subject|0|||
145736916|NCT04667377|525553386|FG004|Maintenance Period|Withdrawal by Subject|0|||
145736917|NCT04667377|525553382|FG000|Maintenance Period|Lost to Follow-up|1|||
145736918|NCT04667377|525553383|FG001|Maintenance Period|Lost to Follow-up|0|||
145736919|NCT04667377|525553384|FG002|Maintenance Period|Lost to Follow-up|1|||
145736920|NCT04667377|525553385|FG003|Maintenance Period|Lost to Follow-up|0|||
145736921|NCT04667377|525553386|FG004|Maintenance Period|Lost to Follow-up|1|||
145736922|NCT01011439|525553387|FG000|Overall Study|Death|37|||
145736923|NCT01011439|525553387|FG000|Overall Study|Lost to Follow-up|4|||
145736924|NCT01011439|525553387|FG000|Overall Study|Withdrawal by Subject|1|||
145736925|NCT01011439|525553387|FG000|Overall Study|Sponsor's decision|15|||
145736926|NCT05418673|525553388|FG000|Overall Study|Study Terminated by Sponsor|2|||
145736927|NCT05418673|525553389|FG001|Overall Study|Study Terminated by Sponsor|4|||
145736928|NCT05418673|525553388|FG000|Overall Study|Lost to Follow-up|1|||
145736929|NCT05418673|525553389|FG001|Overall Study|Lost to Follow-up|0|||
145736930|NCT01986920|525553390|FG000|A- 101 25%|Withdrawal by Subject|1|||
145736931|NCT01986920|525553391|FG001|A- 101 25%|Withdrawal by Subject|0|||
145736932|NCT01986920|525553392|FG002|A- 101 25%|Withdrawal by Subject|0|||
145736933|NCT01986920|525553393|FG003|A- 101 25%|Withdrawal by Subject|0|||
145736934|NCT01986920|525553390|FG000|A-101 32.5%|Withdrawal by Subject|0|||
145736935|NCT01986920|525553391|FG001|A-101 32.5%|Withdrawal by Subject|1|||
145736936|NCT01986920|525553392|FG002|A-101 32.5%|Withdrawal by Subject|0|||
145736937|NCT01986920|525553393|FG003|A-101 32.5%|Withdrawal by Subject|0|||
145736938|NCT01986920|525553390|FG000|A-101 40%|Withdrawal by Subject|0|||
145736939|NCT01986920|525553391|FG001|A-101 40%|Withdrawal by Subject|0|||
145736940|NCT01986920|525553392|FG002|A-101 40%|Withdrawal by Subject|1|||
145736941|NCT01986920|525553393|FG003|A-101 40%|Withdrawal by Subject|0|||
145736942|NCT01986920|525553390|FG000|Placebo|Withdrawal by Subject|0|||
145736943|NCT01986920|525553391|FG001|Placebo|Withdrawal by Subject|0|||
145736944|NCT01986920|525553392|FG002|Placebo|Withdrawal by Subject|0|||
145736945|NCT01986920|525553393|FG003|Placebo|Withdrawal by Subject|1|||
145736946|NCT00874770|525553394|FG000|Overall Study|Lack of Efficacy|2|||
145736947|NCT00874770|525553395|FG001|Overall Study|Lack of Efficacy|0|||
145736948|NCT00874770|525553396|FG002|Overall Study|Lack of Efficacy|0|||
145736949|NCT00874770|525553397|FG003|Overall Study|Lack of Efficacy|2|||
145736950|NCT00874770|525553394|FG000|Overall Study|Adverse Event|1|||
145736951|NCT00874770|525553395|FG001|Overall Study|Adverse Event|1|||
145736952|NCT00874770|525553396|FG002|Overall Study|Adverse Event|4|||
145736953|NCT00874770|525553397|FG003|Overall Study|Adverse Event|2|||
145736954|NCT00874770|525553394|FG000|Overall Study|Lost to Follow-up|1|||
145736955|NCT00874770|525553395|FG001|Overall Study|Lost to Follow-up|0|||
145736956|NCT00874770|525553396|FG002|Overall Study|Lost to Follow-up|0|||
145736957|NCT00874770|525553397|FG003|Overall Study|Lost to Follow-up|1|||
145736958|NCT00874770|525553394|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
145736959|NCT00874770|525553395|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
145736960|NCT00874770|525553396|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
145736961|NCT00874770|525553397|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
145736962|NCT05215262|525553398|FG000|Overall Study|Lost to Follow-up|12|||
145736963|NCT05215262|525553399|FG001|Overall Study|Lost to Follow-up|0|||
145736964|NCT00718549|525553402|FG000|Induction Phase|Disease Progression|1|||
145736965|NCT00718549|525553403|FG001|Induction Phase|Disease Progression|0|||
145736966|NCT00718549|525553404|FG002|Induction Phase|Disease Progression|0|||
145736967|NCT00718549|525553402|FG000|Induction Phase|Eligibility Criteria Violation|2|||
145736968|NCT00718549|525553403|FG001|Induction Phase|Eligibility Criteria Violation|0|||
145736969|NCT00718549|525553404|FG002|Induction Phase|Eligibility Criteria Violation|0|||
145736970|NCT00718549|525553402|FG000|Induction Phase|Early Termination - No Additional Info|59|||
145736971|NCT00718549|525553403|FG001|Induction Phase|Early Termination - No Additional Info|0|||
145736972|NCT00718549|525553404|FG002|Induction Phase|Early Termination - No Additional Info|0|||
145736973|NCT00718549|525553402|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
145736974|NCT00718549|525553403|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
145736975|NCT00718549|525553404|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
145736976|NCT00718549|525553402|FG000|Maintenance/ Observation Phase|Death|0|||
145736977|NCT00718549|525553403|FG001|Maintenance/ Observation Phase|Death|1|||
145736978|NCT00718549|525553404|FG002|Maintenance/ Observation Phase|Death|2|||
145736979|NCT00718549|525553402|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
145736980|NCT00718549|525553403|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
145736981|NCT00718549|525553404|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
145736982|NCT00718549|525553402|FG000|Maintenance/ Observation Phase|Progression|0|||
145736983|NCT00718549|525553403|FG001|Maintenance/ Observation Phase|Progression|5|||
145736984|NCT00718549|525553404|FG002|Maintenance/ Observation Phase|Progression|14|||
145736985|NCT00718549|525553402|FG000|Maintenance/ Observation Phase|Relapse|0|||
145736986|NCT00718549|525553403|FG001|Maintenance/ Observation Phase|Relapse|3|||
145736987|NCT00718549|525553404|FG002|Maintenance/ Observation Phase|Relapse|2|||
145736988|NCT01353508|525553405|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
145736989|NCT01353508|525553406|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
145736990|NCT01353508|525553407|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
145736991|NCT01353508|525553408|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
145736992|NCT01353508|525553405|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
145736993|NCT01353508|525553406|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
145736994|NCT01353508|525553407|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
145736995|NCT01353508|525553408|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
145736996|NCT01576172|525553409|FG000|Overall Study|Ineligible|2|||
145736997|NCT01576172|525553410|FG001|Overall Study|Ineligible|1|||
145736998|NCT01576172|525553409|FG000|Overall Study|Withdrawal by Subject|2|||
145736999|NCT01576172|525553410|FG001|Overall Study|Withdrawal by Subject|0|||
145737000|NCT01576172|525553409|FG000|Overall Study|Insurance issue|1|||
145737001|NCT01576172|525553410|FG001|Overall Study|Insurance issue|0|||
145737002|NCT00433914|525553411|FG000|Overall Study|Withdrawal by Subject|0|||
145737003|NCT00433914|525553412|FG001|Overall Study|Withdrawal by Subject|2|||
145737004|NCT00433914|525553411|FG000|Overall Study|Lost to Follow-up|0|||
145737005|NCT00433914|525553412|FG001|Overall Study|Lost to Follow-up|1|||
145737006|NCT02486653|525553415|FG000|Overall Study|Withdrawal by Subject|1|||
145737007|NCT02486653|525553416|FG001|Overall Study|Withdrawal by Subject|3|||
145737008|NCT02486653|525553415|FG000|Overall Study|Protocol Violation|1|||
145737009|NCT02486653|525553416|FG001|Overall Study|Protocol Violation|0|||
145737010|NCT02486653|525553415|FG000|Overall Study|surgery cancelled|4|||
145737011|NCT02486653|525553416|FG001|Overall Study|surgery cancelled|1|||
145737012|NCT00766090|525553417|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737013|NCT00766090|525553418|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737014|NCT00766090|525553419|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737015|NCT00766090|525553420|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737016|NCT00766090|525553421|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737017|NCT00766090|525553422|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737018|NCT00766090|525553423|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737019|NCT00766090|525553424|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737020|NCT00766090|525553425|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
145737021|NCT00766090|525553426|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737022|NCT00766090|525553427|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737023|NCT00766090|525553428|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145737024|NCT00766090|525553417|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
145737025|NCT00766090|525553418|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737026|NCT00766090|525553419|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737027|NCT00766090|525553420|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737028|NCT00766090|525553421|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737029|NCT00766090|525553422|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737030|NCT00766090|525553423|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737031|NCT00766090|525553424|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737032|NCT00766090|525553425|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737033|NCT00766090|525553426|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737034|NCT00766090|525553427|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737035|NCT00766090|525553428|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
145737036|NCT00766090|525553417|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145737037|NCT00766090|525553418|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737038|NCT00766090|525553419|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737039|NCT00766090|525553420|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145737040|NCT00766090|525553421|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737041|NCT00766090|525553422|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737042|NCT00766090|525553423|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737043|NCT00766090|525553424|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737044|NCT00766090|525553425|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737045|NCT00766090|525553426|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737046|NCT00766090|525553427|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737047|NCT00766090|525553428|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145737048|NCT00766090|525553417|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737049|NCT00766090|525553418|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737050|NCT00766090|525553419|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
145737051|NCT00766090|525553420|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737052|NCT00766090|525553421|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737053|NCT00766090|525553422|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737054|NCT00766090|525553423|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737055|NCT00766090|525553424|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737056|NCT00766090|525553425|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737057|NCT00766090|525553426|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737058|NCT00766090|525553427|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737059|NCT00766090|525553428|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
145737060|NCT00766090|525553417|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737061|NCT00766090|525553418|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737062|NCT00766090|525553419|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737063|NCT00766090|525553420|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737064|NCT00766090|525553421|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
145737065|NCT00766090|525553422|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737066|NCT00766090|525553423|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737067|NCT00766090|525553424|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737068|NCT00766090|525553425|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737069|NCT00766090|525553426|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737070|NCT00766090|525553427|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737071|NCT00766090|525553428|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145737072|NCT00766090|525553417|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737073|NCT00766090|525553418|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737074|NCT00766090|525553419|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
145737075|NCT00766090|525553420|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737076|NCT00766090|525553421|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737077|NCT00766090|525553422|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737078|NCT00766090|525553423|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737079|NCT00766090|525553424|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737080|NCT00766090|525553425|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737081|NCT00766090|525553426|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737082|NCT00766090|525553427|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145517178|NCT00958438|524752492|FG000|Overall Study|Adverse Event|0|||
145737083|NCT00766090|525553428|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
145737084|NCT00766090|525553417|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
145737085|NCT00766090|525553418|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
145737086|NCT00766090|525553419|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
145737087|NCT00766090|525553420|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
145737088|NCT00766090|525553421|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
145737089|NCT00766090|525553422|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
145737090|NCT00766090|525553423|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
145737091|NCT00766090|525553424|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
145737092|NCT00766090|525553425|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
145737093|NCT00766090|525553426|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
145737094|NCT00766090|525553427|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
145737095|NCT00766090|525553428|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
145737096|NCT00766090|525553417|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737097|NCT00766090|525553418|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737098|NCT00766090|525553419|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737099|NCT00766090|525553420|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737100|NCT00766090|525553421|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737101|NCT00766090|525553422|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
145737102|NCT00766090|525553423|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737103|NCT00766090|525553424|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737104|NCT00766090|525553425|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737105|NCT00766090|525553426|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737106|NCT00766090|525553427|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737107|NCT00766090|525553428|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
145737108|NCT00766090|525553417|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737109|NCT00766090|525553418|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
145737110|NCT00766090|525553419|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737111|NCT00766090|525553420|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
145737112|NCT00766090|525553421|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737113|NCT00766090|525553422|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737114|NCT00766090|525553423|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737115|NCT00766090|525553424|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737116|NCT00766090|525553425|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737117|NCT00766090|525553426|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737118|NCT00766090|525553427|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
145737119|NCT00766090|525553428|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
145737120|NCT00766090|525553417|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737121|NCT00766090|525553418|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737122|NCT00766090|525553419|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737123|NCT00766090|525553420|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737124|NCT00766090|525553421|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
145737125|NCT00766090|525553422|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737126|NCT00766090|525553423|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737127|NCT00766090|525553424|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737128|NCT00766090|525553425|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737129|NCT00766090|525553426|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737130|NCT00766090|525553427|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737131|NCT00766090|525553428|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
145737132|NCT00131469|525553435|FG000|Overall Study|Withdrawal by Subject|3|||
145737133|NCT00131469|525553436|FG001|Overall Study|Withdrawal by Subject|4|||
145737134|NCT00131469|525553435|FG000|Overall Study|Protocol Violation|3|||
145737135|NCT00131469|525553436|FG001|Overall Study|Protocol Violation|1|||
145737136|NCT00131469|525553435|FG000|Overall Study|Death|0|||
145737137|NCT00131469|525553436|FG001|Overall Study|Death|1|||
145737138|NCT00131469|525553435|FG000|Overall Study|Lost to Follow-up|0|||
145737139|NCT00131469|525553436|FG001|Overall Study|Lost to Follow-up|1|||
145737140|NCT00131469|525553435|FG000|Overall Study|scan not analyzable|3|||
145737141|NCT00131469|525553436|FG001|Overall Study|scan not analyzable|6|||
145517179|NCT00958438|524752493|FG001|Overall Study|Adverse Event|3|||
145737142|NCT02871778|525553437|FG000|Part A: Treatment Period 1|Adverse Event|1|||
145737143|NCT02871778|525553438|FG001|Part A: Treatment Period 1|Adverse Event|1|||
145737144|NCT02871778|525553439|FG002|Part A: Treatment Period 1|Adverse Event|1|||
145737145|NCT02871778|525553440|FG003|Part A: Treatment Period 1|Adverse Event|0|||
145737146|NCT02871778|525553441|FG004|Part A: Treatment Period 1|Adverse Event|0|||
145737147|NCT02871778|525553442|FG005|Part A: Treatment Period 1|Adverse Event|0|||
145737148|NCT02871778|525553443|FG006|Part A: Treatment Period 1|Adverse Event|0|||
145737149|NCT02871778|525553444|FG007|Part A: Treatment Period 1|Adverse Event|0|||
145737150|NCT02871778|525553437|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
145737151|NCT02871778|525553438|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
145737152|NCT02871778|525553439|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
145269412|NCT00798707|523835348|FG000|Overall Study|Lack of Efficacy|2|||
145737153|NCT02871778|525553440|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
145737154|NCT02871778|525553441|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
145737155|NCT02871778|525553442|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
145737156|NCT02871778|525553443|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
145737157|NCT02871778|525553444|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
145737158|NCT02871778|525553437|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737159|NCT02871778|525553438|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737160|NCT02871778|525553439|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
145737161|NCT02871778|525553440|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737162|NCT02871778|525553441|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737163|NCT02871778|525553442|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737164|NCT02871778|525553443|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737165|NCT02871778|525553444|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
145737166|NCT02871778|525553437|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737167|NCT02871778|525553438|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737168|NCT02871778|525553439|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
145737169|NCT02871778|525553440|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737170|NCT02871778|525553441|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737171|NCT02871778|525553442|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737172|NCT02871778|525553443|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737173|NCT02871778|525553444|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
145737174|NCT02871778|525553437|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737175|NCT02871778|525553438|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
145737176|NCT02871778|525553439|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737177|NCT02871778|525553440|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737178|NCT02871778|525553441|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737179|NCT02871778|525553442|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737180|NCT02871778|525553443|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737181|NCT02871778|525553444|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
145737182|NCT02871778|525553437|FG000|Part A: Treatment Period 2|Adverse Event|2|||
145737183|NCT02871778|525553438|FG001|Part A: Treatment Period 2|Adverse Event|2|||
145737184|NCT02871778|525553439|FG002|Part A: Treatment Period 2|Adverse Event|0|||
145737185|NCT02871778|525553440|FG003|Part A: Treatment Period 2|Adverse Event|0|||
145737186|NCT02871778|525553441|FG004|Part A: Treatment Period 2|Adverse Event|0|||
145737187|NCT02871778|525553442|FG005|Part A: Treatment Period 2|Adverse Event|0|||
145737188|NCT02871778|525553443|FG006|Part A: Treatment Period 2|Adverse Event|0|||
145737189|NCT02871778|525553444|FG007|Part A: Treatment Period 2|Adverse Event|0|||
145737190|NCT02871778|525553437|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737191|NCT02871778|525553438|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737192|NCT02871778|525553439|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737193|NCT02871778|525553440|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
145737194|NCT02871778|525553441|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737195|NCT02871778|525553442|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737196|NCT02871778|525553443|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737197|NCT02871778|525553444|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
145737198|NCT02871778|525553437|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
145737199|NCT02871778|525553438|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737200|NCT02871778|525553439|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
145737201|NCT02871778|525553440|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737202|NCT02871778|525553441|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737203|NCT02871778|525553442|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737204|NCT02871778|525553443|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737205|NCT02871778|525553444|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
145737206|NCT02871778|525553437|FG000|Part B: Treatment Period 3|Adverse Event|0|||
145737207|NCT02871778|525553438|FG001|Part B: Treatment Period 3|Adverse Event|0|||
145737208|NCT02871778|525553439|FG002|Part B: Treatment Period 3|Adverse Event|0|||
145737209|NCT02871778|525553440|FG003|Part B: Treatment Period 3|Adverse Event|0|||
145737210|NCT02871778|525553441|FG004|Part B: Treatment Period 3|Adverse Event|1|||
145737211|NCT02871778|525553442|FG005|Part B: Treatment Period 3|Adverse Event|1|||
145737212|NCT02871778|525553443|FG006|Part B: Treatment Period 3|Adverse Event|1|||
145737213|NCT02871778|525553444|FG007|Part B: Treatment Period 3|Adverse Event|0|||
145737214|NCT01230554|525553445|FG000|Overall Study|Lost to Follow-up|2|||
145737215|NCT01230554|525553445|FG000|Overall Study|Inability to maintain visit schedule|1|||
145737216|NCT02653300|525553446|FG000|Overall Study|Withdrawal by Subject|2|||
145737217|NCT01289821|525553447|FG000|Treatment Period|Withdrawal by Subject|1|||
145737218|NCT01289821|525553447|FG000|Treatment Period|Physician Decision|3|||
145737219|NCT01289821|525553447|FG000|Treatment Period|Adverse Event|4|||
145737220|NCT01289821|525553447|FG000|Treatment Period|Radiological Progression|43|||
145737221|NCT01289821|525553447|FG000|Treatment Period|Clinical Progression|2|||
145737222|NCT01289821|525553447|FG000|Treatment Period|Therapeutic procedure required|1|||
145737223|NCT01289821|525553447|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
145737224|NCT01289821|525553447|FG000|Safety Follow-up Period|Protocol Violation|3|||
145737225|NCT01289821|525553447|FG000|Safety Follow-up Period|Unspecified reason|1|||
145737226|NCT01289821|525553447|FG000|Survival Follow-up Period|Protocol Violation|1|||
145737227|NCT01289821|525553447|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
145737228|NCT01289821|525553447|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
145737229|NCT00732251|525553471|FG000|Overall Study|Lost to Follow-up|3|||
145737230|NCT00732251|525553471|FG000|Overall Study|Withdrawal by Subject|3|||
145737231|NCT00732251|525553471|FG000|Overall Study|Early Term due to Site Closure|1|||
145737232|NCT00805025|525553472|FG000|Overall Study|Screened but not enrolled/treated|42|||
145737233|NCT00805025|525553472|FG000|Overall Study|Adverse Event|4|||
145737234|NCT00805025|525553472|FG000|Overall Study|Withdrawal by Subject|2|||
145737235|NCT00805025|525553472|FG000|Overall Study|Physician Decision|1|||
145737236|NCT03007979|525553476|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
145737237|NCT00232141|525553477|FG000|Overall Study|Adverse Event|9|||
145737238|NCT00232141|525553478|FG001|Overall Study|Adverse Event|4|||
145737239|NCT00232141|525553477|FG000|Overall Study|Lack of Efficacy|0|||
145737240|NCT00232141|525553478|FG001|Overall Study|Lack of Efficacy|3|||
145737241|NCT00232141|525553477|FG000|Overall Study|Lost to Follow-up|9|||
145737242|NCT00232141|525553478|FG001|Overall Study|Lost to Follow-up|6|||
145737243|NCT00232141|525553477|FG000|Overall Study|Other|8|||
145737244|NCT00232141|525553478|FG001|Overall Study|Other|10|||
145737245|NCT00232141|525553477|FG000|Overall Study|Withdrawal by Subject|5|||
145737246|NCT00232141|525553478|FG001|Overall Study|Withdrawal by Subject|3|||
145737247|NCT02273726|525553479|FG000|Overall Study|Death|70|||
145737248|NCT02273726|525553480|FG001|Overall Study|Death|62|||
145737249|NCT02273726|525553479|FG000|Overall Study|Withdrawal by Subject|41|||
145737250|NCT02273726|525553480|FG001|Overall Study|Withdrawal by Subject|29|||
145737251|NCT02273726|525553479|FG000|Overall Study|Kidney transplant|31|||
145737252|NCT02273726|525553480|FG001|Overall Study|Kidney transplant|39|||
145737253|NCT02273726|525553479|FG000|Overall Study|Physician Decision|30|||
145737254|NCT02273726|525553480|FG001|Overall Study|Physician Decision|15|||
145737255|NCT02273726|525553479|FG000|Overall Study|Adverse Event|27|||
145737256|NCT02273726|525553480|FG001|Overall Study|Adverse Event|9|||
145737257|NCT02273726|525553479|FG000|Overall Study|Lost to Follow-up|6|||
145737258|NCT02273726|525553480|FG001|Overall Study|Lost to Follow-up|3|||
145737259|NCT02273726|525553479|FG000|Overall Study|Lack of Efficacy|6|||
145737260|NCT02273726|525553480|FG001|Overall Study|Lack of Efficacy|1|||
145737261|NCT02273726|525553479|FG000|Overall Study|Protocol Violation|4|||
145737262|NCT02273726|525553480|FG001|Overall Study|Protocol Violation|0|||
145737263|NCT02273726|525553479|FG000|Overall Study|Other than specified|28|||
145737264|NCT02273726|525553480|FG001|Overall Study|Other than specified|30|||
145737265|NCT04263896|525553482|FG000|Overall Study|Withdrawal by Subject|2|||
145737266|NCT04263896|525553483|FG001|Overall Study|Withdrawal by Subject|4|||
145737267|NCT04263896|525553482|FG000|Overall Study|converted to open procedure|0|||
145737268|NCT04263896|525553483|FG001|Overall Study|converted to open procedure|1|||
145737269|NCT04263896|525553482|FG000|Overall Study|Lost to Follow-up|9|||
145737270|NCT04263896|525553483|FG001|Overall Study|Lost to Follow-up|11|||
145737271|NCT04263896|525553482|FG000|Overall Study|surveys lost in mail|5|||
145737272|NCT04263896|525553483|FG001|Overall Study|surveys lost in mail|3|||
145737273|NCT04263896|525553482|FG000|Overall Study|excluded from analysis|1|||
145737274|NCT04263896|525553483|FG001|Overall Study|excluded from analysis|0|||
145737275|NCT04376827|525553487|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
145737276|NCT04376827|525553488|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
145737277|NCT04376827|525553487|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
145737278|NCT04376827|525553488|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
145737279|NCT04376827|525553487|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
145737280|NCT04376827|525553488|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
145269413|NCT00798707|523835349|FG001|Overall Study|Lack of Efficacy|2|||
145269414|NCT00798707|523835350|FG002|Overall Study|Lack of Efficacy|1|||
145737281|NCT04376827|525553487|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
145737282|NCT04376827|525553488|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
145737283|NCT04376827|525553487|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
145737284|NCT04376827|525553488|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
145737285|NCT04050670|525555208|FG000|Period 3|Physician Decision|0|||
145737286|NCT04050670|525555209|FG001|Period 3|Physician Decision|1|||
145737287|NCT04050670|525555210|FG002|Period 3|Physician Decision|0|||
145737288|NCT00761306|525555211|FG000|Overall Study|Adverse Event|5|||
145737289|NCT00761306|525555211|FG000|Overall Study|Lack of Efficacy|4|||
145737290|NCT00761306|525555211|FG000|Overall Study|Protocol Violation|2|||
145737291|NCT00761306|525555211|FG000|Overall Study|Withdrawal of Consent|3|||
145517180|NCT00958438|524752494|FG002|Overall Study|Adverse Event|0|||
145517181|NCT00958438|524752492|FG000|Overall Study|Physician Decision|1|||
145737292|NCT00761306|525555211|FG000|Overall Study|Lost to Follow-up|1|||
145737293|NCT00761306|525555211|FG000|Overall Study|Administrative or Other Reasons|5|||
145737294|NCT00268437|525555212|FG000|Overall Study|Ineligible|1|||
145737295|NCT02615470|525555213|FG000|Overall Study|Lost to Follow-up|21|||
145737296|NCT02615470|525555214|FG001|Overall Study|Lost to Follow-up|32|||
145737297|NCT03713034|525555215|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
145737298|NCT03713034|525555216|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
145737299|NCT02982239|525555219|FG000|Overall Study|Lost to Follow-up|3|||
145737300|NCT02982239|525555220|FG001|Overall Study|Lost to Follow-up|2|||
145737301|NCT02982590|525555226|FG000|Overall Study|Lost to Follow-up|0|||
145737302|NCT02982590|525555227|FG001|Overall Study|Lost to Follow-up|1|||
145737303|NCT02982590|525555226|FG000|Overall Study|Death|4|||
145737304|NCT02982590|525555227|FG001|Overall Study|Death|0|||
145737305|NCT01168973|525555229|FG000|Overall Study|Progressive Disease|341|||
145737306|NCT01168973|525555230|FG001|Overall Study|Progressive Disease|429|||
145737307|NCT01168973|525555229|FG000|Overall Study|Adverse Event|94|||
145737308|NCT01168973|525555230|FG001|Overall Study|Adverse Event|55|||
145737309|NCT01168973|525555229|FG000|Overall Study|Withdrawal by Subject|90|||
145737310|NCT01168973|525555230|FG001|Overall Study|Withdrawal by Subject|53|||
145737311|NCT01168973|525555229|FG000|Overall Study|Death|42|||
145737312|NCT01168973|525555230|FG001|Overall Study|Death|45|||
145737313|NCT01168973|525555229|FG000|Overall Study|Physician Decision|37|||
145737314|NCT01168973|525555230|FG001|Overall Study|Physician Decision|19|||
145737315|NCT01168973|525555229|FG000|Overall Study|Sponsor Decision|2|||
145737316|NCT01168973|525555230|FG001|Overall Study|Sponsor Decision|1|||
145737317|NCT01168973|525555229|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
145737318|NCT01168973|525555230|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
145737319|NCT02767323|525555231|FG000|Overall Study|Withdrawal by Subject|17|||
145737320|NCT02767323|525555232|FG001|Overall Study|Withdrawal by Subject|5|||
145737321|NCT02767323|525555233|FG002|Overall Study|Withdrawal by Subject|13|||
145517182|NCT00958438|524752493|FG001|Overall Study|Physician Decision|0|||
145737322|NCT02767323|525555234|FG003|Overall Study|Withdrawal by Subject|0|||
145517183|NCT00958438|524752494|FG002|Overall Study|Physician Decision|1|||
145737323|NCT02767323|525555231|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
145737324|NCT02767323|525555232|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
145737325|NCT02767323|525555233|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
145737326|NCT02767323|525555234|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
145737327|NCT02713542|525555238|FG000|Overall Study|Use of prohibited medication|14|||
145737328|NCT02713542|525555239|FG001|Overall Study|Use of prohibited medication|5|||
145737329|NCT02713542|525555238|FG000|Overall Study|Withdrawal by Subject|4|||
145737330|NCT02713542|525555239|FG001|Overall Study|Withdrawal by Subject|1|||
145737331|NCT01301456|525555240|FG000|Stage 1|Withdrawal by Subject|0|||
145737332|NCT01301456|525555241|FG001|Stage 1|Withdrawal by Subject|0|||
145737333|NCT01301456|525555242|FG002|Stage 1|Withdrawal by Subject|1|||
145737334|NCT01301456|525555243|FG003|Stage 1|Withdrawal by Subject|0|||
145737335|NCT01301456|525555244|FG004|Stage 1|Withdrawal by Subject|1|||
145737336|NCT01301456|525555245|FG005|Stage 1|Withdrawal by Subject|0|||
145737337|NCT01301456|525555246|FG006|Stage 1|Withdrawal by Subject|0|||
145737338|NCT01301456|525555247|FG007|Stage 1|Withdrawal by Subject|0|||
145737339|NCT01301456|525555248|FG008|Stage 1|Withdrawal by Subject|0|||
145737340|NCT01301456|525555249|FG009|Stage 1|Withdrawal by Subject|0|||
145737341|NCT01301456|525555250|FG010|Stage 1|Withdrawal by Subject|0|||
145737342|NCT01301456|525555251|FG011|Stage 1|Withdrawal by Subject|0|||
145737343|NCT01301456|525555240|FG000|Stage 1|Randomized but not treated|0|||
145737344|NCT01301456|525555241|FG001|Stage 1|Randomized but not treated|0|||
145737345|NCT01301456|525555242|FG002|Stage 1|Randomized but not treated|0|||
145737346|NCT01301456|525555243|FG003|Stage 1|Randomized but not treated|0|||
145737347|NCT01301456|525555244|FG004|Stage 1|Randomized but not treated|0|||
145737348|NCT01301456|525555245|FG005|Stage 1|Randomized but not treated|0|||
145737349|NCT01301456|525555246|FG006|Stage 1|Randomized but not treated|1|||
145737350|NCT01301456|525555247|FG007|Stage 1|Randomized but not treated|0|||
145737351|NCT01301456|525555248|FG008|Stage 1|Randomized but not treated|0|||
145737352|NCT01301456|525555249|FG009|Stage 1|Randomized but not treated|0|||
145737353|NCT01301456|525555250|FG010|Stage 1|Randomized but not treated|0|||
145737354|NCT01301456|525555251|FG011|Stage 1|Randomized but not treated|0|||
145737355|NCT01301456|525555240|FG000|Stage 2|Adverse Event|0|||
145737356|NCT01301456|525555241|FG001|Stage 2|Adverse Event|0|||
145737357|NCT01301456|525555242|FG002|Stage 2|Adverse Event|0|||
145737358|NCT01301456|525555243|FG003|Stage 2|Adverse Event|0|||
145737359|NCT01301456|525555244|FG004|Stage 2|Adverse Event|0|||
145737360|NCT01301456|525555245|FG005|Stage 2|Adverse Event|0|||
145737361|NCT01301456|525555246|FG006|Stage 2|Adverse Event|0|||
145737362|NCT01301456|525555247|FG007|Stage 2|Adverse Event|0|||
145517184|NCT00958438|524752492|FG000|Overall Study|Other than specified above|2|||
145517185|NCT00958438|524752493|FG001|Overall Study|Other than specified above|3|||
145517186|NCT00958438|524752494|FG002|Overall Study|Other than specified above|2|||
145517187|NCT02788279|524752495|FG000|Overall Study|Death|62|||
145517188|NCT02788279|524752496|FG001|Overall Study|Death|136|||
145517189|NCT02788279|524752497|FG002|Overall Study|Death|72|||
145737363|NCT01301456|525555248|FG008|Stage 2|Adverse Event|0|||
145737364|NCT01301456|525555249|FG009|Stage 2|Adverse Event|0|||
145737365|NCT01301456|525555250|FG010|Stage 2|Adverse Event|1|||
145269415|NCT00798707|523835348|FG000|Overall Study|Lost to Follow-up|5|||
145517190|NCT02788279|524752495|FG000|Overall Study|Withdrawal by Subject|10|||
145737366|NCT01301456|525555251|FG011|Stage 2|Adverse Event|0|||
145737367|NCT05097716|525555254|FG000|Period 1|Adverse Event|1|||
145737368|NCT05097716|525555254|FG000|Period 1|Close contact with highly-transmissible infection|1|||
145737369|NCT00616434|525555255|FG000|Overall Study|Adverse Event|5|||
145737370|NCT00616434|525555256|FG001|Overall Study|Adverse Event|2|||
145737371|NCT00616434|525555255|FG000|Overall Study|Physician Decision|0|||
145737372|NCT00616434|525555256|FG001|Overall Study|Physician Decision|4|||
145737373|NCT00616434|525555255|FG000|Overall Study|Withdrawal by Subject|1|||
145737374|NCT00616434|525555256|FG001|Overall Study|Withdrawal by Subject|1|||
145737375|NCT00616434|525555255|FG000|Overall Study|Protocol deviation|0|||
145737376|NCT00616434|525555256|FG001|Overall Study|Protocol deviation|1|||
145737377|NCT00359021|525555259|FG000|Overall Study|Adverse Event|26|||
145737378|NCT00359021|525555260|FG001|Overall Study|Adverse Event|8|||
145737379|NCT00359021|525555259|FG000|Overall Study|Subject Non-Compliant|1|||
145737380|NCT00359021|525555260|FG001|Overall Study|Subject Non-Compliant|2|||
145737381|NCT00359021|525555259|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
145737382|NCT00359021|525555260|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
145737383|NCT00359021|525555259|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
145737384|NCT00359021|525555260|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
145737385|NCT00359021|525555259|FG000|Overall Study|Withdrawal by Subject|2|||
145737386|NCT00359021|525555260|FG001|Overall Study|Withdrawal by Subject|9|||
145737387|NCT00359021|525555259|FG000|Overall Study|Lost to Follow-up|1|||
145737388|NCT00359021|525555260|FG001|Overall Study|Lost to Follow-up|0|||
145517191|NCT02788279|524752496|FG001|Overall Study|Withdrawal by Subject|15|||
145517192|NCT02788279|524752497|FG002|Overall Study|Withdrawal by Subject|5|||
145517193|NCT02788279|524752495|FG000|Overall Study|Lost to Follow-up|0|||
145517194|NCT02788279|524752496|FG001|Overall Study|Lost to Follow-up|3|||
145517195|NCT02788279|524752497|FG002|Overall Study|Lost to Follow-up|2|||
145517196|NCT02788279|524752495|FG000|Overall Study|Sponsor decision|18|||
145517197|NCT02788279|524752496|FG001|Overall Study|Sponsor decision|29|||
145737389|NCT00359021|525555259|FG000|Overall Study|Other|4|||
145737390|NCT00359021|525555260|FG001|Overall Study|Other|1|||
145737391|NCT00359021|525555259|FG000|Overall Study|Pregnancy|1|||
145737392|NCT00359021|525555260|FG001|Overall Study|Pregnancy|0|||
145737393|NCT02066311|525555261|FG000|Overall Study|Adverse Event|4|||
145737394|NCT02066311|525555261|FG000|Overall Study|Withdrawal by Subject|1|||
145737395|NCT01338415|525555262|FG000|Core + Extension|Adverse Event|8|||
145737396|NCT01338415|525555263|FG001|Core + Extension|Adverse Event|6|||
145737397|NCT01338415|525555264|FG002|Core + Extension|Adverse Event|0|||
145737398|NCT01338415|525555262|FG000|Core + Extension|Withdrawal by Subject|1|||
145737399|NCT01338415|525555263|FG001|Core + Extension|Withdrawal by Subject|1|||
145737400|NCT01338415|525555264|FG002|Core + Extension|Withdrawal by Subject|0|||
145737401|NCT01338415|525555262|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
145737402|NCT01338415|525555263|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
145737403|NCT01338415|525555264|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
145737404|NCT01338415|525555262|FG000|Core + Extension|Other (administrative reason)|1|||
145737405|NCT01338415|525555263|FG001|Core + Extension|Other (administrative reason)|0|||
145737406|NCT01338415|525555264|FG002|Core + Extension|Other (administrative reason)|0|||
145737407|NCT01338415|525555262|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
145737408|NCT01338415|525555263|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
145737409|NCT01338415|525555264|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
145737410|NCT01338415|525555262|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
145737411|NCT01338415|525555263|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
145737412|NCT01338415|525555264|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
145737413|NCT01338415|525555262|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
145737414|NCT01338415|525555263|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
145737415|NCT01338415|525555264|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
145737416|NCT01338415|525555262|FG000|Exceptional Use Treatment Period|Death|0|||
145737417|NCT01338415|525555263|FG001|Exceptional Use Treatment Period|Death|0|||
145737418|NCT01338415|525555264|FG002|Exceptional Use Treatment Period|Death|1|||
145737419|NCT00233363|525555270|FG000|Overall Study|Adverse Event|1|||
145737420|NCT00233363|525555271|FG001|Overall Study|Adverse Event|2|||
145737421|NCT00233363|525555270|FG000|Overall Study|Lack of Efficacy|0|||
145737422|NCT00233363|525555271|FG001|Overall Study|Lack of Efficacy|2|||
145737423|NCT00233363|525555270|FG000|Overall Study|Withdrawal by Subject|1|||
145737424|NCT00233363|525555271|FG001|Overall Study|Withdrawal by Subject|1|||
145737425|NCT00233363|525555270|FG000|Overall Study|Aggravation of complication|1|||
145737426|NCT00233363|525555271|FG001|Overall Study|Aggravation of complication|0|||
145737427|NCT01526551|525555272|FG000|Overall Study|Lack of returned parental consent form|424|||
145737428|NCT04880447|525555273|FG000|Overall Study|No vaccination information|1|||
145737429|NCT04880447|525555273|FG000|Overall Study|No adverse event information (missing information)|1|||
145737430|NCT04880447|525555273|FG000|Overall Study|Disease not covered in this study|35|||
145737431|NCT03024970|525555280|FG000|First Intervention|Adverse Event|1|||
145737432|NCT03024970|525555281|FG001|First Intervention|Adverse Event|0|||
145737433|NCT03024970|525555280|FG000|Second Intervention|Lost to Follow-up|1|||
145737434|NCT03024970|525555281|FG001|Second Intervention|Lost to Follow-up|0|||
145737435|NCT01106027|525555282|FG000|Overall Study|Lost graft early, discontinued|1|||
145737436|NCT01390272|525555295|FG000|Overall Study|Death|3|||
145737437|NCT01390272|525555296|FG001|Overall Study|Death|2|||
145737438|NCT01390272|525555295|FG000|Overall Study|Withdrawal by Subject|9|||
145737439|NCT01390272|525555296|FG001|Overall Study|Withdrawal by Subject|5|||
145737440|NCT01390272|525555295|FG000|Overall Study|Patient moved, no longer eligible|5|||
145737441|NCT01390272|525555296|FG001|Overall Study|Patient moved, no longer eligible|8|||
145737442|NCT01177384|525555297|FG000|Overall Study|Adverse Event|6|||
145737443|NCT01177384|525555298|FG001|Overall Study|Adverse Event|4|||
145737444|NCT01177384|525555297|FG000|Overall Study|Lack of Efficacy|0|||
145737445|NCT01177384|525555298|FG001|Overall Study|Lack of Efficacy|1|||
145737446|NCT01177384|525555297|FG000|Overall Study|Lost to Follow-up|3|||
145737447|NCT01177384|525555298|FG001|Overall Study|Lost to Follow-up|4|||
145737448|NCT01177384|525555297|FG000|Overall Study|Physician Decision|0|||
145737449|NCT01177384|525555298|FG001|Overall Study|Physician Decision|3|||
145737450|NCT01177384|525555297|FG000|Overall Study|Protocol Violation|0|||
145737451|NCT01177384|525555298|FG001|Overall Study|Protocol Violation|2|||
145737452|NCT01177384|525555297|FG000|Overall Study|Withdrawal by Subject|5|||
145737453|NCT01177384|525555298|FG001|Overall Study|Withdrawal by Subject|12|||
145737454|NCT00175877|525555327|FG000|Overall Study|Adverse Event|136|||
145737455|NCT00175877|525555327|FG000|Overall Study|Withdrawal by Subject|141|||
145737456|NCT00175877|525555327|FG000|Overall Study|Lost to Follow-up|9|||
145737457|NCT00175877|525555327|FG000|Overall Study|Lack of Efficacy|26|||
145737458|NCT00175877|525555327|FG000|Overall Study|Protocol Violation|15|||
145737459|NCT00175877|525555327|FG000|Overall Study|Other Reason|20|||
145737460|NCT00175877|525555327|FG000|Overall Study|AE & Other|1|||
145737461|NCT00175877|525555327|FG000|Overall Study|Withdrawal by subject & Other|1|||
145737462|NCT00955279|525555330|FG000|Overall Study|Other|0|||
145737463|NCT00955279|525555331|FG001|Overall Study|Other|0|||
145737464|NCT00955279|525555332|FG002|Overall Study|Other|3|||
145737465|NCT00955279|525555330|FG000|Overall Study|Death|1|||
145737466|NCT00955279|525555331|FG001|Overall Study|Death|1|||
145737467|NCT00955279|525555332|FG002|Overall Study|Death|1|||
145737468|NCT00955279|525555330|FG000|Overall Study|Lost to Follow-up|0|||
145737469|NCT00955279|525555331|FG001|Overall Study|Lost to Follow-up|3|||
145737470|NCT00955279|525555332|FG002|Overall Study|Lost to Follow-up|1|||
145737471|NCT00955279|525555330|FG000|Overall Study|Withdrawal by Subject|2|||
145737472|NCT00955279|525555331|FG001|Overall Study|Withdrawal by Subject|0|||
145737473|NCT00955279|525555332|FG002|Overall Study|Withdrawal by Subject|3|||
145737474|NCT01235793|525555333|FG000|Overall Study|Death|6|||
145737475|NCT01159912|525555334|FG000|Overall Study|Adverse Event|2|||
145737476|NCT01159912|525555335|FG001|Overall Study|Adverse Event|2|||
145402272|NCT03261401|524330696|FG004|Overall Study|Withdrawal by Subject|0|||
145402273|NCT03261401|524330697|FG005|Overall Study|Withdrawal by Subject|1|||
145517198|NCT02788279|524752497|FG002|Overall Study|Sponsor decision|11|||
145737477|NCT01159912|525555336|FG002|Overall Study|Adverse Event|3|||
145737478|NCT01159912|525555334|FG000|Overall Study|Lack of Efficacy|23|||
145737479|NCT01159912|525555335|FG001|Overall Study|Lack of Efficacy|15|||
145737480|NCT01159912|525555336|FG002|Overall Study|Lack of Efficacy|14|||
145737481|NCT01159912|525555334|FG000|Overall Study|Protocol Violation|1|||
145737482|NCT01159912|525555335|FG001|Overall Study|Protocol Violation|2|||
145737483|NCT01159912|525555336|FG002|Overall Study|Protocol Violation|3|||
145737484|NCT01159912|525555334|FG000|Overall Study|Lost to Follow-up|4|||
145737485|NCT01159912|525555335|FG001|Overall Study|Lost to Follow-up|0|||
145737486|NCT01159912|525555336|FG002|Overall Study|Lost to Follow-up|0|||
145737487|NCT01159912|525555334|FG000|Overall Study|Physician Decision|0|||
145737488|NCT01159912|525555335|FG001|Overall Study|Physician Decision|0|||
145737489|NCT01159912|525555336|FG002|Overall Study|Physician Decision|3|||
145737490|NCT01159912|525555334|FG000|Overall Study|Withdrawal by Subject|10|||
145737491|NCT01159912|525555335|FG001|Overall Study|Withdrawal by Subject|3|||
145737492|NCT01159912|525555336|FG002|Overall Study|Withdrawal by Subject|3|||
145737493|NCT02456662|525555339|FG000|Overall Study|Lost to Follow-up|2|||
145737494|NCT02456662|525555340|FG001|Overall Study|Lost to Follow-up|1|||
145737495|NCT02374021|525555343|FG000|Overall Study|Adverse Event|1|||
145737496|NCT02374021|525555344|FG001|Overall Study|Adverse Event|0|||
145737497|NCT02374021|525555343|FG000|Overall Study|Lost to Follow-up|3|||
145737498|NCT02374021|525555344|FG001|Overall Study|Lost to Follow-up|2|||
145737499|NCT02374021|525555343|FG000|Overall Study|Physician Decision|0|||
145737500|NCT02374021|525555344|FG001|Overall Study|Physician Decision|3|||
145737501|NCT02374021|525555343|FG000|Overall Study|Withdrawal by Subject|6|||
145737502|NCT02374021|525555344|FG001|Overall Study|Withdrawal by Subject|5|||
145737503|NCT02374021|525555343|FG000|Overall Study|Poor Adherence|0|||
145737504|NCT02374021|525555344|FG001|Overall Study|Poor Adherence|1|||
145737505|NCT02374021|525555343|FG000|Overall Study|Scan protocol not followed|0|||
145737506|NCT02374021|525555344|FG001|Overall Study|Scan protocol not followed|1|||
145737507|NCT02374021|525555343|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
145737508|NCT02374021|525555344|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
145737509|NCT04411628|525555346|FG000|Overall Study|Withdrawal by Subject|1|||
145517199|NCT01579812|524752498|FG000|Overall Study|Ineligible after treatment start|40|||
145737510|NCT04411628|525555347|FG001|Overall Study|Withdrawal by Subject|1|||
145737511|NCT04411628|525555348|FG002|Overall Study|Withdrawal by Subject|2|||
145737512|NCT04411628|525555349|FG003|Overall Study|Withdrawal by Subject|0|||
145737513|NCT04411628|525555346|FG000|Overall Study|Lost to Follow-up|0|||
145737514|NCT04411628|525555347|FG001|Overall Study|Lost to Follow-up|1|||
145737515|NCT04411628|525555348|FG002|Overall Study|Lost to Follow-up|0|||
145737516|NCT04411628|525555349|FG003|Overall Study|Lost to Follow-up|0|||
145737517|NCT03828292|525555350|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
145737518|NCT03828292|525555351|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
145737519|NCT03828292|525555352|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
145737520|NCT03828292|525555353|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
145737521|NCT03828292|525555354|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
145737522|NCT03828292|525555355|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
145737523|NCT03828292|525555350|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
145737524|NCT03828292|525555351|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
145737525|NCT03828292|525555352|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
145737526|NCT03828292|525555353|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
145737527|NCT03828292|525555354|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
145737528|NCT03828292|525555355|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
145737529|NCT03828292|525555350|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
145737530|NCT03828292|525555351|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
145737531|NCT03828292|525555352|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
145737532|NCT03828292|525555353|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
145737533|NCT03828292|525555354|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
145737534|NCT03828292|525555355|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
145737535|NCT03828292|525555350|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
145737536|NCT03828292|525555351|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
145737537|NCT03828292|525555352|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
145737538|NCT03828292|525555353|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
145737539|NCT03828292|525555354|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
145737540|NCT03828292|525555355|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
145737541|NCT03828292|525555350|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
145737542|NCT03828292|525555351|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
145737543|NCT03828292|525555352|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
145737544|NCT03828292|525555353|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
145737545|NCT03828292|525555354|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
145737546|NCT03828292|525555355|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
145737547|NCT01444456|525555356|FG000|Overall Study|Withdrawal by Subject|21|||
145737548|NCT01444456|525555356|FG000|Overall Study|Physician Decision|9|||
145737549|NCT01444456|525555356|FG000|Overall Study|Lost to Follow-up|37|||
145737550|NCT01444456|525555356|FG000|Overall Study|Death|73|||
145737551|NCT01444456|525555356|FG000|Overall Study|Ineligibility determined|23|||
145737552|NCT01444456|525555356|FG000|Overall Study|Other|18|||
145737553|NCT01444456|525555356|FG000|Overall Study|Not treated|104|||
145737554|NCT00682448|525557000|FG000|Overall Study|Adverse Event|1|||
145737555|NCT00682448|525557001|FG001|Overall Study|Adverse Event|2|||
145737556|NCT00682448|525557000|FG000|Overall Study|Lack of Efficacy|1|||
145737557|NCT00682448|525557001|FG001|Overall Study|Lack of Efficacy|0|||
145737558|NCT00682448|525557000|FG000|Overall Study|Lost to Follow-up|1|||
145737559|NCT00682448|525557001|FG001|Overall Study|Lost to Follow-up|3|||
145737560|NCT00682448|525557000|FG000|Overall Study|Pregnancy|0|||
145737561|NCT00682448|525557001|FG001|Overall Study|Pregnancy|1|||
145737562|NCT00682448|525557000|FG000|Overall Study|Withdrawal by Subject|2|||
145737563|NCT00682448|525557001|FG001|Overall Study|Withdrawal by Subject|0|||
145737564|NCT00525044|525557004|FG000|Overall Study|Lost to Follow-up|0|||
145402274|NCT03261401|524330698|FG006|Overall Study|Withdrawal by Subject|0|||
145402275|NCT03261401|524330699|FG007|Overall Study|Withdrawal by Subject|0|||
145737565|NCT00525044|525557005|FG001|Overall Study|Lost to Follow-up|1|||
145737566|NCT02142738|525557006|FG000|Overall Study|Adverse Event|13|||
145737567|NCT02142738|525557007|FG001|Overall Study|Adverse Event|9|||
145737568|NCT02142738|525557006|FG000|Overall Study|Death|92|||
145737569|NCT02142738|525557007|FG001|Overall Study|Death|112|||
145737570|NCT02142738|525557006|FG000|Overall Study|Lost to Follow-up|0|||
145737571|NCT02142738|525557007|FG001|Overall Study|Lost to Follow-up|3|||
145737572|NCT02142738|525557006|FG000|Overall Study|Withdrawal by Subject|6|||
145737573|NCT02142738|525557007|FG001|Overall Study|Withdrawal by Subject|7|||
145737574|NCT02142738|525557006|FG000|Overall Study|Follow up ended by sponsor|43|||
145737575|NCT02142738|525557007|FG001|Overall Study|Follow up ended by sponsor|20|||
145737576|NCT03688880|525557008|FG000|Overall Study|Withdrawal by Subject|0|||
145737577|NCT03688880|525557009|FG001|Overall Study|Withdrawal by Subject|2|||
145737578|NCT03688880|525557008|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
145737579|NCT03688880|525557009|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
145402276|NCT03261401|524330700|FG008|Overall Study|Withdrawal by Subject|0|||
145737580|NCT03688880|525557008|FG000|Overall Study|Lost to Follow-up|4|||
145737581|NCT03688880|525557009|FG001|Overall Study|Lost to Follow-up|7|||
145737582|NCT03688880|525557008|FG000|Overall Study|Adverse Event|0|||
145737583|NCT03688880|525557009|FG001|Overall Study|Adverse Event|2|||
145737584|NCT03688880|525557008|FG000|Overall Study|Device deficiencies|0|||
145737585|NCT03688880|525557009|FG001|Overall Study|Device deficiencies|2|||
145737586|NCT03688880|525557008|FG000|Overall Study|Other|10|||
145737587|NCT03688880|525557009|FG001|Overall Study|Other|16|||
145737588|NCT01704287|525557010|FG000|Initial Treatment Period|Death|139|||
145737589|NCT01704287|525557011|FG001|Initial Treatment Period|Death|129|||
145737590|NCT01704287|525557012|FG002|Initial Treatment Period|Death|71|||
145737591|NCT01704287|525557013|FG003|Initial Treatment Period|Death|0|||
145737592|NCT01704287|525557014|FG004|Initial Treatment Period|Death|0|||
145737593|NCT01704287|525557010|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
145737594|NCT01704287|525557011|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
145737595|NCT01704287|525557012|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
145737596|NCT01704287|525557013|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
145737597|NCT01704287|525557014|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
145737598|NCT01704287|525557010|FG000|Initial Treatment Period|Lost to Follow-up|5|||
145737599|NCT01704287|525557011|FG001|Initial Treatment Period|Lost to Follow-up|3|||
145737600|NCT01704287|525557012|FG002|Initial Treatment Period|Lost to Follow-up|0|||
145737601|NCT01704287|525557013|FG003|Initial Treatment Period|Lost to Follow-up|0|||
145737602|NCT01704287|525557014|FG004|Initial Treatment Period|Lost to Follow-up|0|||
145737603|NCT01704287|525557010|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
145737604|NCT01704287|525557011|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
145737605|NCT01704287|525557012|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
145737606|NCT01704287|525557013|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
145737607|NCT01704287|525557014|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
145737608|NCT01704287|525557010|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
145737609|NCT01704287|525557011|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
145737610|NCT01704287|525557012|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
145737611|NCT01704287|525557013|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
145737612|NCT01704287|525557014|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
145737613|NCT01704287|525557010|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
145737614|NCT01704287|525557011|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
145737615|NCT01704287|525557012|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
145737616|NCT01704287|525557013|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
145737617|NCT01704287|525557014|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
145737618|NCT01704287|525557010|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
145737619|NCT01704287|525557011|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
145737620|NCT01704287|525557012|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
145737621|NCT01704287|525557013|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
145737622|NCT01704287|525557014|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
145737623|NCT04024228|525557016|FG000|Overall Study|Adverse Event|1|||
145737624|NCT04024228|525557017|FG001|Overall Study|Adverse Event|0|||
145737625|NCT04024228|525557016|FG000|Overall Study|Protocol Deviation|0|||
145737626|NCT04024228|525557017|FG001|Overall Study|Protocol Deviation|2|||
145737627|NCT04024228|525557016|FG000|Overall Study|Withdrawal by Subject|3|||
145737628|NCT04024228|525557017|FG001|Overall Study|Withdrawal by Subject|4|||
145737629|NCT00709111|525557043|FG000|Overall Study|Withdrawal by Subject|1|||
145737630|NCT00709111|525557043|FG000|Overall Study|Unable to attend clinic visits|1|||
145737631|NCT01383096|525557048|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
145737632|NCT01383096|525557049|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
145737633|NCT01383096|525557050|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
145737634|NCT01383096|525557048|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
145737635|NCT01383096|525557049|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
145737636|NCT01383096|525557050|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
145737637|NCT01383096|525557048|FG000|Third Intervention (8 Days)|Elevated AST|0|||
145737638|NCT01383096|525557049|FG001|Third Intervention (8 Days)|Elevated AST|1|||
145737639|NCT01383096|525557050|FG002|Third Intervention (8 Days)|Elevated AST|0|||
145737640|NCT01383096|525557048|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
145737641|NCT01383096|525557049|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
145737642|NCT01383096|525557050|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
145402277|NCT03261401|524330701|FG009|Overall Study|Withdrawal by Subject|0|||
145737643|NCT01383096|525557048|FG000|Third Intervention (8 Days)|Adverse Event|1|||
145737644|NCT01383096|525557049|FG001|Third Intervention (8 Days)|Adverse Event|0|||
145737645|NCT01383096|525557050|FG002|Third Intervention (8 Days)|Adverse Event|0|||
145737646|NCT01383096|525557048|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
145737647|NCT01383096|525557049|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
145737648|NCT01383096|525557050|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
145737649|NCT01383096|525557048|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
145737650|NCT01383096|525557049|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
145737651|NCT01383096|525557050|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
145737652|NCT01383096|525557048|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
145737653|NCT01383096|525557049|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
145737654|NCT01383096|525557050|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
145737655|NCT01383096|525557048|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
145737656|NCT01383096|525557049|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
145737657|NCT01383096|525557050|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
145737658|NCT01383096|525557048|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
145737659|NCT01383096|525557049|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
145737660|NCT01383096|525557050|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
145737661|NCT01383096|525557048|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
145737662|NCT01383096|525557049|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
145737663|NCT01383096|525557050|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
145737664|NCT01994382|525557053|FG000|Overall Study|Informed consent withdrawn|0|||
145737665|NCT01994382|525557054|FG001|Overall Study|Informed consent withdrawn|0|||
145737666|NCT01994382|525557055|FG002|Overall Study|Informed consent withdrawn|0|||
145737667|NCT01994382|525557056|FG003|Overall Study|Informed consent withdrawn|0|||
145737668|NCT01994382|525557057|FG004|Overall Study|Informed consent withdrawn|0|||
145737669|NCT01994382|525557058|FG005|Overall Study|Informed consent withdrawn|0|||
145737670|NCT01994382|525557059|FG006|Overall Study|Informed consent withdrawn|1|||
145737671|NCT01994382|525557060|FG007|Overall Study|Informed consent withdrawn|0|||
145737672|NCT01994382|525557061|FG008|Overall Study|Informed consent withdrawn|0|||
145737673|NCT01994382|525557062|FG009|Overall Study|Informed consent withdrawn|0|||
145737674|NCT01994382|525557063|FG010|Overall Study|Informed consent withdrawn|0|||
145737675|NCT01994382|525557064|FG011|Overall Study|Informed consent withdrawn|0|||
145737676|NCT01994382|525557065|FG012|Overall Study|Informed consent withdrawn|0|||
145737677|NCT01994382|525557066|FG013|Overall Study|Informed consent withdrawn|0|||
145737678|NCT01994382|525557067|FG014|Overall Study|Informed consent withdrawn|0|||
145737679|NCT01994382|525557068|FG015|Overall Study|Informed consent withdrawn|0|||
145737680|NCT01994382|525557069|FG016|Overall Study|Informed consent withdrawn|0|||
145737681|NCT01994382|525557053|FG000|Overall Study|Progressive disease|3|||
145737682|NCT01994382|525557054|FG001|Overall Study|Progressive disease|4|||
145737683|NCT01994382|525557055|FG002|Overall Study|Progressive disease|4|||
145737684|NCT01994382|525557056|FG003|Overall Study|Progressive disease|3|||
145737685|NCT01994382|525557057|FG004|Overall Study|Progressive disease|2|||
145737686|NCT01994382|525557058|FG005|Overall Study|Progressive disease|3|||
145737687|NCT01994382|525557059|FG006|Overall Study|Progressive disease|3|||
145737688|NCT01994382|525557060|FG007|Overall Study|Progressive disease|6|||
145737689|NCT01994382|525557061|FG008|Overall Study|Progressive disease|2|||
145737690|NCT01994382|525557062|FG009|Overall Study|Progressive disease|2|||
145737691|NCT01994382|525557063|FG010|Overall Study|Progressive disease|13|||
145737692|NCT01994382|525557064|FG011|Overall Study|Progressive disease|8|||
145737693|NCT01994382|525557065|FG012|Overall Study|Progressive disease|7|||
145737694|NCT01994382|525557066|FG013|Overall Study|Progressive disease|3|||
145737695|NCT01994382|525557067|FG014|Overall Study|Progressive disease|6|||
145737696|NCT01994382|525557068|FG015|Overall Study|Progressive disease|44|||
145737697|NCT01994382|525557069|FG016|Overall Study|Progressive disease|28|||
145737698|NCT01994382|525557053|FG000|Overall Study|Physician Decision|0|||
145737699|NCT01994382|525557054|FG001|Overall Study|Physician Decision|1|||
145737700|NCT01994382|525557055|FG002|Overall Study|Physician Decision|0|||
145737701|NCT01994382|525557056|FG003|Overall Study|Physician Decision|0|||
145737702|NCT01994382|525557057|FG004|Overall Study|Physician Decision|0|||
145737703|NCT01994382|525557058|FG005|Overall Study|Physician Decision|0|||
145737704|NCT01994382|525557059|FG006|Overall Study|Physician Decision|0|||
145737705|NCT01994382|525557060|FG007|Overall Study|Physician Decision|0|||
145737706|NCT01994382|525557061|FG008|Overall Study|Physician Decision|0|||
145737707|NCT01994382|525557062|FG009|Overall Study|Physician Decision|0|||
145737708|NCT01994382|525557063|FG010|Overall Study|Physician Decision|3|||
145737709|NCT01994382|525557064|FG011|Overall Study|Physician Decision|1|||
145737710|NCT01994382|525557065|FG012|Overall Study|Physician Decision|1|||
145402278|NCT03261401|524330702|FG010|Overall Study|Withdrawal by Subject|0|||
145402279|NCT03261401|524330703|FG011|Overall Study|Withdrawal by Subject|0|||
145402280|NCT03261401|524330704|FG012|Overall Study|Withdrawal by Subject|0|||
145517200|NCT01579812|524752498|FG000|Overall Study|Patient choice|3|||
145737711|NCT01994382|525557066|FG013|Overall Study|Physician Decision|0|||
145737712|NCT01994382|525557067|FG014|Overall Study|Physician Decision|1|||
145737713|NCT01994382|525557068|FG015|Overall Study|Physician Decision|4|||
145737714|NCT01994382|525557069|FG016|Overall Study|Physician Decision|2|||
145737715|NCT01994382|525557053|FG000|Overall Study|Death|0|||
145737716|NCT01994382|525557054|FG001|Overall Study|Death|0|||
145737717|NCT01994382|525557055|FG002|Overall Study|Death|0|||
145517201|NCT01579812|524752498|FG000|Overall Study|Noncompliance|3|||
145737718|NCT01994382|525557056|FG003|Overall Study|Death|0|||
145737719|NCT01994382|525557057|FG004|Overall Study|Death|1|||
145737720|NCT01994382|525557058|FG005|Overall Study|Death|0|||
145737721|NCT01994382|525557059|FG006|Overall Study|Death|0|||
145737722|NCT01994382|525557060|FG007|Overall Study|Death|0|||
145737723|NCT01994382|525557061|FG008|Overall Study|Death|1|||
145737724|NCT01994382|525557062|FG009|Overall Study|Death|1|||
145737725|NCT01994382|525557063|FG010|Overall Study|Death|0|||
145737726|NCT01994382|525557064|FG011|Overall Study|Death|0|||
145737727|NCT01994382|525557065|FG012|Overall Study|Death|0|||
145737728|NCT01994382|525557066|FG013|Overall Study|Death|0|||
145737729|NCT01994382|525557067|FG014|Overall Study|Death|0|||
145737730|NCT01994382|525557068|FG015|Overall Study|Death|1|||
145737731|NCT01994382|525557069|FG016|Overall Study|Death|0|||
145737732|NCT01994382|525557053|FG000|Overall Study|Adverse Event|0|||
145737733|NCT01994382|525557054|FG001|Overall Study|Adverse Event|1|||
145737734|NCT01994382|525557055|FG002|Overall Study|Adverse Event|2|||
145737735|NCT01994382|525557056|FG003|Overall Study|Adverse Event|0|||
145737736|NCT01994382|525557057|FG004|Overall Study|Adverse Event|0|||
145737737|NCT01994382|525557058|FG005|Overall Study|Adverse Event|0|||
145737738|NCT01994382|525557059|FG006|Overall Study|Adverse Event|0|||
145737739|NCT01994382|525557060|FG007|Overall Study|Adverse Event|0|||
145737740|NCT01994382|525557061|FG008|Overall Study|Adverse Event|0|||
145737741|NCT01994382|525557062|FG009|Overall Study|Adverse Event|0|||
145737742|NCT01994382|525557063|FG010|Overall Study|Adverse Event|15|||
145737743|NCT01994382|525557064|FG011|Overall Study|Adverse Event|2|||
145737744|NCT01994382|525557065|FG012|Overall Study|Adverse Event|7|||
145737745|NCT01994382|525557066|FG013|Overall Study|Adverse Event|3|||
145737746|NCT01994382|525557067|FG014|Overall Study|Adverse Event|17|||
145737747|NCT01994382|525557068|FG015|Overall Study|Adverse Event|6|||
145737748|NCT01994382|525557069|FG016|Overall Study|Adverse Event|3|||
145737749|NCT01994382|525557053|FG000|Overall Study|Other than specified|0|||
145737750|NCT01994382|525557054|FG001|Overall Study|Other than specified|0|||
145737751|NCT01994382|525557055|FG002|Overall Study|Other than specified|0|||
145737752|NCT01994382|525557056|FG003|Overall Study|Other than specified|0|||
145737753|NCT01994382|525557057|FG004|Overall Study|Other than specified|0|||
145737754|NCT01994382|525557058|FG005|Overall Study|Other than specified|0|||
145737755|NCT01994382|525557059|FG006|Overall Study|Other than specified|0|||
145737756|NCT01994382|525557060|FG007|Overall Study|Other than specified|0|||
145737757|NCT01994382|525557061|FG008|Overall Study|Other than specified|0|||
145737758|NCT01994382|525557062|FG009|Overall Study|Other than specified|0|||
145737759|NCT01994382|525557063|FG010|Overall Study|Other than specified|2|||
145737760|NCT01994382|525557064|FG011|Overall Study|Other than specified|0|||
145737761|NCT01994382|525557065|FG012|Overall Study|Other than specified|2|||
145737762|NCT01994382|525557066|FG013|Overall Study|Other than specified|0|||
145737763|NCT01994382|525557067|FG014|Overall Study|Other than specified|0|||
145737764|NCT01994382|525557068|FG015|Overall Study|Other than specified|4|||
145737765|NCT01994382|525557069|FG016|Overall Study|Other than specified|4|||
145737766|NCT01994382|525557053|FG000|Overall Study|Withdrawal by Subject|0|||
145737767|NCT01994382|525557054|FG001|Overall Study|Withdrawal by Subject|0|||
145737768|NCT01994382|525557055|FG002|Overall Study|Withdrawal by Subject|0|||
145737769|NCT01994382|525557056|FG003|Overall Study|Withdrawal by Subject|0|||
145737770|NCT01994382|525557057|FG004|Overall Study|Withdrawal by Subject|0|||
145737771|NCT01994382|525557058|FG005|Overall Study|Withdrawal by Subject|0|||
145737772|NCT01994382|525557059|FG006|Overall Study|Withdrawal by Subject|0|||
145737773|NCT01994382|525557060|FG007|Overall Study|Withdrawal by Subject|0|||
145737774|NCT01994382|525557061|FG008|Overall Study|Withdrawal by Subject|0|||
145737775|NCT01994382|525557062|FG009|Overall Study|Withdrawal by Subject|0|||
145737776|NCT01994382|525557063|FG010|Overall Study|Withdrawal by Subject|6|||
145737777|NCT01994382|525557064|FG011|Overall Study|Withdrawal by Subject|0|||
145737778|NCT01994382|525557065|FG012|Overall Study|Withdrawal by Subject|2|||
145737779|NCT01994382|525557066|FG013|Overall Study|Withdrawal by Subject|0|||
145737780|NCT01994382|525557067|FG014|Overall Study|Withdrawal by Subject|4|||
145737781|NCT01994382|525557068|FG015|Overall Study|Withdrawal by Subject|3|||
145737782|NCT01994382|525557069|FG016|Overall Study|Withdrawal by Subject|0|||
145737783|NCT01994382|525557053|FG000|Overall Study|Lost to Follow-up|0|||
145737784|NCT01994382|525557054|FG001|Overall Study|Lost to Follow-up|0|||
145737785|NCT01994382|525557055|FG002|Overall Study|Lost to Follow-up|0|||
145737786|NCT01994382|525557056|FG003|Overall Study|Lost to Follow-up|0|||
145737787|NCT01994382|525557057|FG004|Overall Study|Lost to Follow-up|0|||
145737788|NCT01994382|525557058|FG005|Overall Study|Lost to Follow-up|0|||
145737789|NCT01994382|525557059|FG006|Overall Study|Lost to Follow-up|0|||
145737790|NCT01994382|525557060|FG007|Overall Study|Lost to Follow-up|0|||
145737791|NCT01994382|525557061|FG008|Overall Study|Lost to Follow-up|0|||
145737792|NCT01994382|525557062|FG009|Overall Study|Lost to Follow-up|0|||
145737793|NCT01994382|525557063|FG010|Overall Study|Lost to Follow-up|1|||
145737794|NCT01994382|525557064|FG011|Overall Study|Lost to Follow-up|0|||
145737795|NCT01994382|525557065|FG012|Overall Study|Lost to Follow-up|0|||
145737796|NCT01994382|525557066|FG013|Overall Study|Lost to Follow-up|0|||
145737797|NCT01994382|525557067|FG014|Overall Study|Lost to Follow-up|0|||
145737798|NCT01994382|525557068|FG015|Overall Study|Lost to Follow-up|0|||
145737799|NCT01994382|525557069|FG016|Overall Study|Lost to Follow-up|0|||
145737800|NCT01994382|525557053|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737801|NCT01994382|525557054|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737802|NCT01994382|525557055|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737803|NCT01994382|525557056|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737804|NCT01994382|525557057|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737805|NCT01994382|525557058|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737806|NCT01994382|525557059|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737807|NCT01994382|525557060|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737808|NCT01994382|525557061|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737809|NCT01994382|525557062|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737810|NCT01994382|525557063|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
145737811|NCT01994382|525557064|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737812|NCT01994382|525557065|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
145737813|NCT01994382|525557066|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737814|NCT01994382|525557067|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
145737815|NCT01994382|525557068|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
145737816|NCT01994382|525557069|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
145737817|NCT01994382|525557053|FG000|Overall Study|Protocol violation/noncompliance|0|||
145737818|NCT01994382|525557054|FG001|Overall Study|Protocol violation/noncompliance|0|||
145737819|NCT01994382|525557055|FG002|Overall Study|Protocol violation/noncompliance|0|||
145737820|NCT01994382|525557056|FG003|Overall Study|Protocol violation/noncompliance|0|||
145737821|NCT01994382|525557057|FG004|Overall Study|Protocol violation/noncompliance|0|||
145737822|NCT01994382|525557058|FG005|Overall Study|Protocol violation/noncompliance|0|||
145737823|NCT01994382|525557059|FG006|Overall Study|Protocol violation/noncompliance|0|||
145737824|NCT01994382|525557060|FG007|Overall Study|Protocol violation/noncompliance|0|||
145737825|NCT01994382|525557061|FG008|Overall Study|Protocol violation/noncompliance|0|||
145737826|NCT01994382|525557062|FG009|Overall Study|Protocol violation/noncompliance|0|||
145737827|NCT01994382|525557063|FG010|Overall Study|Protocol violation/noncompliance|0|||
145737828|NCT01994382|525557064|FG011|Overall Study|Protocol violation/noncompliance|1|||
145737829|NCT01994382|525557065|FG012|Overall Study|Protocol violation/noncompliance|0|||
145737830|NCT01994382|525557066|FG013|Overall Study|Protocol violation/noncompliance|0|||
145737831|NCT01994382|525557067|FG014|Overall Study|Protocol violation/noncompliance|0|||
145737832|NCT01994382|525557068|FG015|Overall Study|Protocol violation/noncompliance|0|||
145737833|NCT01994382|525557069|FG016|Overall Study|Protocol violation/noncompliance|2|||
145737834|NCT01994382|525557053|FG000|Overall Study|Rolled over to Phase 2a|0|||
145737835|NCT01994382|525557054|FG001|Overall Study|Rolled over to Phase 2a|0|||
145737836|NCT01994382|525557055|FG002|Overall Study|Rolled over to Phase 2a|1|||
145737837|NCT01994382|525557056|FG003|Overall Study|Rolled over to Phase 2a|0|||
145737838|NCT01994382|525557057|FG004|Overall Study|Rolled over to Phase 2a|0|||
145737839|NCT01994382|525557058|FG005|Overall Study|Rolled over to Phase 2a|0|||
145737840|NCT01994382|525557059|FG006|Overall Study|Rolled over to Phase 2a|0|||
145737841|NCT01994382|525557060|FG007|Overall Study|Rolled over to Phase 2a|0|||
145737842|NCT01994382|525557061|FG008|Overall Study|Rolled over to Phase 2a|0|||
145737843|NCT01994382|525557062|FG009|Overall Study|Rolled over to Phase 2a|2|||
145737844|NCT01994382|525557063|FG010|Overall Study|Rolled over to Phase 2a|0|||
145737845|NCT01994382|525557064|FG011|Overall Study|Rolled over to Phase 2a|0|||
145737846|NCT01994382|525557065|FG012|Overall Study|Rolled over to Phase 2a|0|||
145737847|NCT01994382|525557066|FG013|Overall Study|Rolled over to Phase 2a|0|||
145737848|NCT01994382|525557067|FG014|Overall Study|Rolled over to Phase 2a|0|||
145737849|NCT01994382|525557068|FG015|Overall Study|Rolled over to Phase 2a|0|||
145737850|NCT01994382|525557069|FG016|Overall Study|Rolled over to Phase 2a|0|||
145737851|NCT02428855|525557070|FG000|Overall Study|Withdrawal by Subject|2|||
145737852|NCT04353596|525557071|FG000|Overall Study|Protocol Violation|4|||
145737853|NCT04353596|525557072|FG001|Overall Study|Protocol Violation|4|||
145737854|NCT04353596|525557071|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
145737855|NCT04353596|525557072|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
145737856|NCT03023059|525557073|FG000|Overall Study|Withdrawal by Subject|5|||
145737857|NCT03781323|525557074|FG000|Overall Study|Withdrawal by Subject|1|||
145737858|NCT01303965|525557075|FG000|Overall Study|Adverse Event|1|||
145737859|NCT01303965|525557076|FG001|Overall Study|Adverse Event|1|||
145737860|NCT01303965|525557075|FG000|Overall Study|Death|0|||
145737861|NCT01303965|525557076|FG001|Overall Study|Death|3|||
145517202|NCT01579812|524752498|FG000|Overall Study|Withdrawal by Subject|6|||
145737862|NCT01303965|525557075|FG000|Overall Study|Withdrawal by Subject|1|||
145737863|NCT01303965|525557076|FG001|Overall Study|Withdrawal by Subject|0|||
145737864|NCT01303965|525557075|FG000|Overall Study|Disease Progression|1|||
145737865|NCT01303965|525557076|FG001|Overall Study|Disease Progression|6|||
145737866|NCT04534491|525557078|FG000|Overall Study|Not completed end-of-study interview|24|||
145737867|NCT04534491|525557078|FG000|Overall Study|Non-users|70|||
145737868|NCT04534491|525557078|FG000|Overall Study|Non-verifiable users|58|||
145737869|NCT02678416|525557083|FG000|Part 1|Withdrawal by Subject|1|||
145737870|NCT02678416|525557083|FG000|Part 2|Adverse Event|2|||
145737871|NCT02678416|525557083|FG000|Part 2|Withdrawal by Subject|1|||
145737872|NCT01848353|525557084|FG000|Phase 1|Withdrawal by Subject|3|||
145737873|NCT01848353|525557085|FG001|Phase 1|Withdrawal by Subject|1|||
145737874|NCT01848353|525557086|FG002|Phase 1|Withdrawal by Subject|0|||
145737875|NCT01848353|525557087|FG003|Phase 1|Withdrawal by Subject|0|||
145737876|NCT01848353|525557084|FG000|Phase 2|Withdrawal by Subject|3|||
145737877|NCT01848353|525557085|FG001|Phase 2|Withdrawal by Subject|2|||
145737878|NCT01848353|525557086|FG002|Phase 2|Withdrawal by Subject|0|||
145737879|NCT01848353|525557087|FG003|Phase 2|Withdrawal by Subject|0|||
145737880|NCT01848353|525557084|FG000|Phase 3|Withdrawal by Subject|1|||
145737881|NCT01848353|525557085|FG001|Phase 3|Withdrawal by Subject|1|||
145737882|NCT01848353|525557086|FG002|Phase 3|Withdrawal by Subject|0|||
145737883|NCT01848353|525557087|FG003|Phase 3|Withdrawal by Subject|0|||
145737884|NCT00935272|525557088|FG000|Overall Study|Lost to Follow-up|10|||
145737885|NCT00935272|525557089|FG001|Overall Study|Lost to Follow-up|3|||
145737886|NCT00935272|525557088|FG000|Overall Study|Withdrawal by Subject|8|||
145737887|NCT00935272|525557089|FG001|Overall Study|Withdrawal by Subject|2|||
145737888|NCT00935272|525557088|FG000|Overall Study|Physician Decision|1|||
145737889|NCT00935272|525557089|FG001|Overall Study|Physician Decision|0|||
145737890|NCT00935272|525557088|FG000|Overall Study|Protocol Violation|0|||
145737891|NCT00935272|525557089|FG001|Overall Study|Protocol Violation|1|||
145737892|NCT01478360|525557092|FG000|Overall Study|Lost to Follow-up|1|||
145737893|NCT01478360|525557093|FG001|Overall Study|Lost to Follow-up|0|||
145737894|NCT01478360|525557092|FG000|Overall Study|Adverse Event|0|||
145737895|NCT01478360|525557093|FG001|Overall Study|Adverse Event|1|||
145737896|NCT01478360|525557092|FG000|Overall Study|Administrative problems|1|||
145737897|NCT01478360|525557093|FG001|Overall Study|Administrative problems|2|||
145737898|NCT02289352|525557094|FG000|Overall Study|Withdrawal by Subject|1|||
145737899|NCT02289352|525557095|FG001|Overall Study|Withdrawal by Subject|1|||
145737900|NCT02289352|525557096|FG002|Overall Study|Withdrawal by Subject|0|||
145737901|NCT00590044|525557102|FG000|Overall Study|Withdrawal by Subject|2|||
145737902|NCT00590044|525557103|FG001|Overall Study|Withdrawal by Subject|2|||
145737903|NCT00590044|525557102|FG000|Overall Study|wrong insulin arm assigned|1|||
145737904|NCT00590044|525557103|FG001|Overall Study|wrong insulin arm assigned|0|||
145737905|NCT00590044|525557102|FG000|Overall Study|Protocol Violation|1|||
145737906|NCT00590044|525557103|FG001|Overall Study|Protocol Violation|0|||
145737907|NCT01514136|525557107|FG000|Test Period 1; Test A|Protocol Violation|1|||
145737908|NCT01514136|525557108|FG001|Test Period 1; Test A|Protocol Violation|0|||
145737909|NCT01514136|525557109|FG002|Test Period 1; Test A|Protocol Violation|0|||
145737910|NCT01514136|525557110|FG003|Test Period 1; Test A|Protocol Violation|0|||
145737911|NCT01514136|525557111|FG004|Test Period 1; Test A|Protocol Violation|0|||
145737912|NCT01514136|525557112|FG005|Test Period 1; Test A|Protocol Violation|0|||
145737913|NCT01514136|525557113|FG006|Test Period 1; Test A|Protocol Violation|0|||
145737914|NCT01514136|525557114|FG007|Test Period 1; Test A|Protocol Violation|0|||
145737915|NCT01514136|525557107|FG000|Test Period 1; Test A|Break from study holiday|2|||
145737916|NCT01514136|525557108|FG001|Test Period 1; Test A|Break from study holiday|0|||
145737917|NCT01514136|525557109|FG002|Test Period 1; Test A|Break from study holiday|0|||
145737918|NCT01514136|525557110|FG003|Test Period 1; Test A|Break from study holiday|0|||
145737919|NCT01514136|525557111|FG004|Test Period 1; Test A|Break from study holiday|0|||
145737920|NCT01514136|525557112|FG005|Test Period 1; Test A|Break from study holiday|0|||
145737921|NCT01514136|525557113|FG006|Test Period 1; Test A|Break from study holiday|0|||
145737922|NCT01514136|525557114|FG007|Test Period 1; Test A|Break from study holiday|0|||
145737923|NCT01514136|525557107|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
145737924|NCT01514136|525557108|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
145737925|NCT01514136|525557109|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
145737926|NCT01514136|525557110|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
145737927|NCT01514136|525557111|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
145737928|NCT01514136|525557112|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
145737929|NCT01514136|525557113|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
145517203|NCT04987944|524752500|FG000|Overall Study|Adverse Event|0|||
145517204|NCT04987944|524752501|FG001|Overall Study|Adverse Event|1|||
145517205|NCT04987944|524752500|FG000|Overall Study|Withdrawal by Subject|0|||
145517206|NCT04987944|524752501|FG001|Overall Study|Withdrawal by Subject|1|||
145737930|NCT01514136|525557114|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
145737931|NCT01514136|525557107|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737932|NCT01514136|525557108|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737933|NCT01514136|525557109|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737934|NCT01514136|525557110|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
145737935|NCT01514136|525557111|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737936|NCT01514136|525557112|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737937|NCT01514136|525557113|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737938|NCT01514136|525557114|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
145737939|NCT01514136|525557107|FG000|Test Period 2; Test A*|Adverse Event|0|||
145737940|NCT01514136|525557108|FG001|Test Period 2; Test A*|Adverse Event|0|||
145558207|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
145737941|NCT01514136|525557109|FG002|Test Period 2; Test A*|Adverse Event|0|||
145737942|NCT01514136|525557110|FG003|Test Period 2; Test A*|Adverse Event|0|||
145737943|NCT01514136|525557111|FG004|Test Period 2; Test A*|Adverse Event|1|||
145737944|NCT01514136|525557112|FG005|Test Period 2; Test A*|Adverse Event|0|||
145737945|NCT01514136|525557113|FG006|Test Period 2; Test A*|Adverse Event|0|||
145737946|NCT01514136|525557114|FG007|Test Period 2; Test A*|Adverse Event|0|||
145737947|NCT01514136|525557107|FG000|Test Period 2; Test A*|Holiday|0|||
145737948|NCT01514136|525557108|FG001|Test Period 2; Test A*|Holiday|0|||
145737949|NCT01514136|525557109|FG002|Test Period 2; Test A*|Holiday|0|||
145737950|NCT01514136|525557110|FG003|Test Period 2; Test A*|Holiday|0|||
145737951|NCT01514136|525557111|FG004|Test Period 2; Test A*|Holiday|1|||
145737952|NCT01514136|525557112|FG005|Test Period 2; Test A*|Holiday|0|||
145737953|NCT01514136|525557113|FG006|Test Period 2; Test A*|Holiday|0|||
145737954|NCT01514136|525557114|FG007|Test Period 2; Test A*|Holiday|0|||
145737955|NCT01514136|525557107|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737956|NCT01514136|525557108|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737957|NCT01514136|525557109|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737958|NCT01514136|525557110|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737959|NCT01514136|525557111|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737960|NCT01514136|525557112|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
145737961|NCT01514136|525557113|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737962|NCT01514136|525557114|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
145737963|NCT01514136|525557107|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737964|NCT01514136|525557108|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737965|NCT01514136|525557109|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737966|NCT01514136|525557110|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737967|NCT01514136|525557111|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737968|NCT01514136|525557112|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737969|NCT01514136|525557113|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
145737970|NCT01514136|525557114|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
145737971|NCT01514136|525557107|FG000|Test Period 2; Test C*|holiday|0|||
145737972|NCT01514136|525557108|FG001|Test Period 2; Test C*|holiday|0|||
145737973|NCT01514136|525557109|FG002|Test Period 2; Test C*|holiday|0|||
145737974|NCT01514136|525557110|FG003|Test Period 2; Test C*|holiday|0|||
145737975|NCT01514136|525557111|FG004|Test Period 2; Test C*|holiday|0|||
145737976|NCT01514136|525557112|FG005|Test Period 2; Test C*|holiday|0|||
145737977|NCT01514136|525557113|FG006|Test Period 2; Test C*|holiday|1|||
145737978|NCT01514136|525557114|FG007|Test Period 2; Test C*|holiday|0|||
145737979|NCT01514136|525557107|FG000|Test Period 2; Test C*|Protocol Violation|0|||
145737980|NCT01514136|525557108|FG001|Test Period 2; Test C*|Protocol Violation|0|||
145737981|NCT01514136|525557109|FG002|Test Period 2; Test C*|Protocol Violation|0|||
145737982|NCT01514136|525557110|FG003|Test Period 2; Test C*|Protocol Violation|0|||
145737983|NCT01514136|525557111|FG004|Test Period 2; Test C*|Protocol Violation|0|||
145737984|NCT01514136|525557112|FG005|Test Period 2; Test C*|Protocol Violation|0|||
145737985|NCT01514136|525557113|FG006|Test Period 2; Test C*|Protocol Violation|1|||
145737986|NCT01514136|525557114|FG007|Test Period 2; Test C*|Protocol Violation|0|||
145737987|NCT01010633|525557115|FG000|Overall Study|Adverse Event|1|||
145737988|NCT01010633|525557116|FG001|Overall Study|Adverse Event|1|||
145737989|NCT01010633|525557115|FG000|Overall Study|Protocol Violation|1|||
145737990|NCT01010633|525557116|FG001|Overall Study|Protocol Violation|2|||
145737991|NCT01010633|525557115|FG000|Overall Study|Withdrawal by Subject|2|||
145737992|NCT01010633|525557116|FG001|Overall Study|Withdrawal by Subject|1|||
145737993|NCT01010633|525557115|FG000|Overall Study|Investigator decision|0|||
145737994|NCT01010633|525557116|FG001|Overall Study|Investigator decision|1|||
145737995|NCT02941926|525557118|FG000|Core Phase|Progressive disease|1109|||
145737996|NCT02941926|525557118|FG000|Core Phase|Adverse Event|504|||
145737997|NCT02941926|525557118|FG000|Core Phase|Subject/guardian decision|127|||
145737998|NCT02941926|525557118|FG000|Core Phase|Physician Decision|112|||
145737999|NCT02941926|525557118|FG000|Core Phase|Death|46|||
145738000|NCT02941926|525557118|FG000|Core Phase|Protocol deviation|34|||
145738001|NCT02941926|525557118|FG000|Core Phase|Lost to Follow-up|8|||
145738002|NCT02941926|525557118|FG000|Core Phase|Technical problems|5|||
145738003|NCT02941926|525557118|FG000|Extension Phase|Physician Decision|155|||
145738004|NCT02941926|525557118|FG000|Extension Phase|Progressive disease|115|||
145738005|NCT02941926|525557118|FG000|Extension Phase|Adverse Event|13|||
145738006|NCT02941926|525557118|FG000|Extension Phase|Subject/Guardian decision|12|||
145738007|NCT02941926|525557118|FG000|Extension Phase|Death|6|||
145738008|NCT00888381|525557119|FG000|Overall Study|Lost to Follow-up|0|||
145738009|NCT00888381|525557120|FG001|Overall Study|Lost to Follow-up|1|||
145738010|NCT00097773|525557121|FG000|Overall Study|Lost to Follow-up|2|||
145738011|NCT00097773|525557122|FG001|Overall Study|Lost to Follow-up|2|||
145738012|NCT00097773|525557123|FG002|Overall Study|Lost to Follow-up|0|||
145738013|NCT00097773|525557124|FG003|Overall Study|Lost to Follow-up|1|||
145738014|NCT00097773|525557121|FG000|Overall Study|Physician Decision|2|||
145738015|NCT00097773|525557122|FG001|Overall Study|Physician Decision|2|||
145738016|NCT00097773|525557123|FG002|Overall Study|Physician Decision|3|||
145738017|NCT00097773|525557124|FG003|Overall Study|Physician Decision|1|||
145738018|NCT00097773|525557121|FG000|Overall Study|Withdrawal by Subject|3|||
145738019|NCT00097773|525557122|FG001|Overall Study|Withdrawal by Subject|3|||
145738020|NCT00097773|525557123|FG002|Overall Study|Withdrawal by Subject|3|||
145738021|NCT00097773|525557124|FG003|Overall Study|Withdrawal by Subject|1|||
145738022|NCT00097773|525557121|FG000|Overall Study|Adverse Event|0|||
145738023|NCT00097773|525557122|FG001|Overall Study|Adverse Event|1|||
145738024|NCT00097773|525557123|FG002|Overall Study|Adverse Event|0|||
145738025|NCT00097773|525557124|FG003|Overall Study|Adverse Event|0|||
145738026|NCT00097773|525557121|FG000|Overall Study|Other|1|||
145738027|NCT00097773|525557122|FG001|Overall Study|Other|0|||
145738028|NCT00097773|525557123|FG002|Overall Study|Other|2|||
145738029|NCT00097773|525557124|FG003|Overall Study|Other|0|||
145738030|NCT04305275|525557125|FG000|Overall Study|Adverse Event|4|||
145738031|NCT04305275|525557126|FG001|Overall Study|Adverse Event|0|||
145738032|NCT04305275|525557125|FG000|Overall Study|Lost to Follow-up|1|||
145738033|NCT04305275|525557126|FG001|Overall Study|Lost to Follow-up|1|||
145738034|NCT04305275|525557125|FG000|Overall Study|Withdrawal by Participant|8|||
145738035|NCT04305275|525557126|FG001|Overall Study|Withdrawal by Participant|1|||
145738036|NCT02243865|525557129|FG000|Overall Study|Protocol Violation|1|||
145738037|NCT02243865|525557130|FG001|Overall Study|Protocol Violation|3|||
145738038|NCT02243865|525557129|FG000|Overall Study|Lost to Follow-up|1|||
145738039|NCT02243865|525557130|FG001|Overall Study|Lost to Follow-up|1|||
145738040|NCT02243865|525557129|FG000|Overall Study|Withdrawal by Subject|1|||
145402281|NCT03261401|524330692|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
145402282|NCT03261401|524330693|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
145402283|NCT03261401|524330694|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
145402284|NCT03261401|524330695|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
145738041|NCT02243865|525557130|FG001|Overall Study|Withdrawal by Subject|0|||
145738042|NCT02243865|525557129|FG000|Overall Study|Adverse Event|1|||
145738043|NCT02243865|525557130|FG001|Overall Study|Adverse Event|1|||
145738044|NCT02003014|525557141|FG000|Overall Study|Case report forms uncollected|9|||
145738045|NCT02003014|525557141|FG000|Overall Study|Treatment started after contract period|1|||
145738046|NCT02003014|525557141|FG000|Overall Study|Patient did not visit the study site|5|||
145738047|NCT02003014|525557141|FG000|Overall Study|Investigator's transfer|4|||
145738048|NCT01660451|525557142|FG000|Overall Study|Protocol Violation|0|||
145738049|NCT01660451|525557143|FG001|Overall Study|Protocol Violation|1|||
145738050|NCT01660451|525557144|FG002|Overall Study|Protocol Violation|1|||
145738051|NCT01660451|525557142|FG000|Overall Study|AE not associated with clinical disease progression|13|||
145738052|NCT01660451|525557143|FG001|Overall Study|AE not associated with clinical disease progression|10|||
145517207|NCT04136444|524752507|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
145517208|NCT04136444|524752508|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
145517209|NCT02946931|524752513|FG000|Overall Study|Did not require collection of CRFs|588|||
145517210|NCT02946931|524752513|FG000|Overall Study|Other than listed|37|||
145517211|NCT02946931|524752513|FG000|Overall Study|Discharge from hospital|118|||
145517212|NCT02946931|524752513|FG000|Overall Study|Adverse Event|81|||
145517213|NCT02946931|524752513|FG000|Overall Study|CRFs not valid|1|||
145517214|NCT02946931|524752513|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
145517215|NCT03241368|524752514|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
145517216|NCT03241368|524752514|FG000|Overall Study|Lost to Follow-up|1|||
145517217|NCT03241368|524752514|FG000|Overall Study|Physician Decision|6|||
145517218|NCT03241368|524752514|FG000|Overall Study|Withdrawal by Subject|6|||
145517219|NCT03241368|524752514|FG000|Overall Study|Protocol Violation|1|||
145517220|NCT00065429|524752517|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145269416|NCT00798707|523835349|FG001|Overall Study|Lost to Follow-up|6|||
145738053|NCT01660451|525557144|FG002|Overall Study|AE not associated with clinical disease progression|40|||
145738054|NCT01660451|525557142|FG000|Overall Study|AE associated with clinical disease progression|1|||
145738055|NCT01660451|525557143|FG001|Overall Study|AE associated with clinical disease progression|3|||
145738056|NCT01660451|525557144|FG002|Overall Study|AE associated with clinical disease progression|11|||
145738057|NCT01660451|525557142|FG000|Overall Study|Sponsor Decision|0|||
145738058|NCT01660451|525557143|FG001|Overall Study|Sponsor Decision|0|||
145738059|NCT01660451|525557144|FG002|Overall Study|Sponsor Decision|1|||
145738060|NCT01660451|525557142|FG000|Overall Study|Protocol Deviation|0|||
145738061|NCT01660451|525557143|FG001|Overall Study|Protocol Deviation|0|||
145738062|NCT01660451|525557144|FG002|Overall Study|Protocol Deviation|1|||
145738063|NCT01660451|525557142|FG000|Overall Study|Physician Decision|1|||
145738064|NCT01660451|525557143|FG001|Overall Study|Physician Decision|2|||
145738065|NCT01660451|525557144|FG002|Overall Study|Physician Decision|5|||
145738066|NCT01660451|525557142|FG000|Overall Study|Withdrawal by Subject|1|||
145738067|NCT01660451|525557143|FG001|Overall Study|Withdrawal by Subject|1|||
145738068|NCT01660451|525557144|FG002|Overall Study|Withdrawal by Subject|20|||
145738069|NCT01660451|525557142|FG000|Overall Study|Trial closure.|0|||
145738070|NCT01660451|525557143|FG001|Overall Study|Trial closure.|0|||
145738071|NCT01660451|525557144|FG002|Overall Study|Trial closure.|1|||
145738072|NCT01660451|525557142|FG000|Overall Study|Switching to other therapy|0|||
145738073|NCT01660451|525557143|FG001|Overall Study|Switching to other therapy|1|||
145738074|NCT01660451|525557144|FG002|Overall Study|Switching to other therapy|1|||
145738075|NCT01660451|525557142|FG000|Overall Study|Progressive disease - clinical progression|4|||
145738076|NCT01660451|525557143|FG001|Overall Study|Progressive disease - clinical progression|10|||
145738077|NCT01660451|525557144|FG002|Overall Study|Progressive disease - clinical progression|9|||
145738078|NCT01660451|525557142|FG000|Overall Study|Progressive disease - radiological progression|12|||
145738079|NCT01660451|525557143|FG001|Overall Study|Progressive disease - radiological progression|23|||
145738080|NCT01660451|525557144|FG002|Overall Study|Progressive disease - radiological progression|50|||
145738081|NCT01660451|525557142|FG000|Overall Study|Death|1|||
145738082|NCT01660451|525557143|FG001|Overall Study|Death|0|||
145738083|NCT01660451|525557144|FG002|Overall Study|Death|1|||
145738084|NCT01660451|525557142|FG000|Overall Study|Other|0|||
145738085|NCT01660451|525557143|FG001|Overall Study|Other|0|||
145738086|NCT01660451|525557144|FG002|Overall Study|Other|1|||
145738087|NCT05093322|525557145|FG000|Overall Study|Death|6|||
145738088|NCT05093322|525557146|FG001|Overall Study|Death|2|||
145738089|NCT05093322|525557145|FG000|Overall Study|Other|4|||
145738090|NCT05093322|525557146|FG001|Overall Study|Other|1|||
145738091|NCT00074581|525557148|FG000|Overall Study|Death|15|||
145738092|NCT00074581|525557149|FG001|Overall Study|Death|16|||
145738093|NCT00074581|525557148|FG000|Overall Study|Withdrawal by Subject|50|||
145738094|NCT00074581|525557149|FG001|Overall Study|Withdrawal by Subject|49|||
145738095|NCT00074581|525557148|FG000|Overall Study|Unable to adhere to visit schedule|13|||
145738096|NCT00074581|525557149|FG001|Overall Study|Unable to adhere to visit schedule|14|||
145738097|NCT00074581|525557148|FG000|Overall Study|Relocated|14|||
145738098|NCT00074581|525557149|FG001|Overall Study|Relocated|9|||
145738099|NCT00074581|525557148|FG000|Overall Study|Were withdrawn by investigator|5|||
145738100|NCT00074581|525557149|FG001|Overall Study|Were withdrawn by investigator|2|||
145738101|NCT00074581|525557148|FG000|Overall Study|Lost to Follow-up|16|||
145738102|NCT00074581|525557149|FG001|Overall Study|Lost to Follow-up|11|||
145738103|NCT00074581|525557148|FG000|Overall Study|Ended relationship w. index participant|117|||
145738104|NCT00074581|525557149|FG001|Overall Study|Ended relationship w. index participant|106|||
145738105|NCT00074581|525557148|FG000|Overall Study|Other|14|||
145738106|NCT00074581|525557149|FG001|Overall Study|Other|19|||
145738107|NCT05293743|525557157|FG000|Overall Study|Withdrawal by Subject|1|||
145738108|NCT05293743|525557158|FG001|Overall Study|Withdrawal by Subject|0|||
145738109|NCT02064920|525557159|FG000|Overall Study|Adverse Event|0|||
145738110|NCT02064920|525557160|FG001|Overall Study|Adverse Event|4|||
145517221|NCT00065429|524752518|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145517222|NCT00065429|524752519|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145738111|NCT02064920|525557159|FG000|Overall Study|Physician Decision|0|||
145738112|NCT02064920|525557160|FG001|Overall Study|Physician Decision|1|||
145738113|NCT02064920|525557159|FG000|Overall Study|Technical Problems|0|||
145738114|NCT02064920|525557160|FG001|Overall Study|Technical Problems|1|||
145738115|NCT02064920|525557159|FG000|Overall Study|Withdrawal by Subject|1|||
145738116|NCT02064920|525557160|FG001|Overall Study|Withdrawal by Subject|3|||
145738117|NCT00916279|525557161|FG000|Overall Study|Death|2|||
145738118|NCT00916279|525557161|FG000|Overall Study|Lost to Follow-up|2|||
145517223|NCT00065429|524752520|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145517224|NCT00065429|524752521|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145517225|NCT00065429|524752522|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
145517226|NCT00065429|524752523|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
145517227|NCT00065429|524752517|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145517228|NCT00065429|524752518|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145738119|NCT00257166|525558871|FG000|Overall Study|Adverse Event|18|||
145738120|NCT00257166|525558872|FG001|Overall Study|Adverse Event|13|||
145738121|NCT00257166|525558871|FG000|Overall Study|Laboratory abnormality|1|||
145738122|NCT00257166|525558872|FG001|Overall Study|Laboratory abnormality|0|||
145738123|NCT00257166|525558871|FG000|Overall Study|Lost to Follow-up|8|||
145738124|NCT00257166|525558872|FG001|Overall Study|Lost to Follow-up|1|||
145738125|NCT00257166|525558871|FG000|Overall Study|Withdrawal by Subject|9|||
145738126|NCT00257166|525558872|FG001|Overall Study|Withdrawal by Subject|2|||
145738127|NCT00257166|525558871|FG000|Overall Study|Other|16|||
145738128|NCT00257166|525558872|FG001|Overall Study|Other|21|||
145738129|NCT00257166|525558871|FG000|Overall Study|Randomized, but not treated|1|||
145738130|NCT00257166|525558872|FG001|Overall Study|Randomized, but not treated|0|||
145738131|NCT01641237|525558882|FG000|Period II|Withdrawal by Subject|1|||
145738132|NCT01641237|525558883|FG001|Period II|Withdrawal by Subject|0|||
145738133|NCT01641237|525558884|FG002|Period II|Withdrawal by Subject|0|||
145738134|NCT01641237|525558885|FG003|Period II|Withdrawal by Subject|0|||
145738135|NCT01641237|525558882|FG000|Period III|Lost to Follow-up|1|||
145738136|NCT01641237|525558883|FG001|Period III|Lost to Follow-up|0|||
145738137|NCT01641237|525558884|FG002|Period III|Lost to Follow-up|0|||
145738138|NCT01641237|525558885|FG003|Period III|Lost to Follow-up|0|||
145738139|NCT02716675|525558886|FG000|Overall Study|Death|2|||
145517229|NCT00065429|524752519|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
145738140|NCT02716675|525558887|FG001|Overall Study|Death|3|||
145738141|NCT02716675|525558888|FG002|Overall Study|Death|0|||
145738142|NCT02716675|525558886|FG000|Overall Study|Physician Decision|2|||
145738143|NCT02716675|525558887|FG001|Overall Study|Physician Decision|1|||
145738144|NCT02716675|525558888|FG002|Overall Study|Physician Decision|1|||
145738145|NCT02716675|525558886|FG000|Overall Study|Lost to Follow-up|100|||
145738146|NCT02716675|525558887|FG001|Overall Study|Lost to Follow-up|87|||
145738147|NCT02716675|525558888|FG002|Overall Study|Lost to Follow-up|99|||
145738148|NCT02716675|525558886|FG000|Overall Study|Withdrawal by Subject|22|||
145738149|NCT02716675|525558887|FG001|Overall Study|Withdrawal by Subject|25|||
145738150|NCT02716675|525558888|FG002|Overall Study|Withdrawal by Subject|20|||
145738151|NCT02716675|525558886|FG000|Overall Study|Protocol Violation|0|||
145738152|NCT02716675|525558887|FG001|Overall Study|Protocol Violation|3|||
145738153|NCT02716675|525558888|FG002|Overall Study|Protocol Violation|1|||
145738154|NCT02716675|525558886|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
145738155|NCT02716675|525558887|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
145738156|NCT02716675|525558888|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
145738157|NCT02716675|525558886|FG000|Overall Study|Other|38|||
145738158|NCT02716675|525558887|FG001|Overall Study|Other|47|||
145738159|NCT02716675|525558888|FG002|Overall Study|Other|48|||
145738160|NCT00290290|525558889|FG000|Overall Study|Death|3|||
145738161|NCT00290290|525558890|FG001|Overall Study|Death|4|||
145738162|NCT00290290|525558889|FG000|Overall Study|Withdrawal by Subject|2|||
145738163|NCT00290290|525558890|FG001|Overall Study|Withdrawal by Subject|2|||
145738164|NCT00290290|525558889|FG000|Overall Study|Underwent clean surgical procedure|13|||
145738165|NCT00290290|525558890|FG001|Overall Study|Underwent clean surgical procedure|12|||
145738166|NCT00915772|525558893|FG000|Overall Study|Adverse Event|12|||
145738167|NCT00915772|525558894|FG001|Overall Study|Adverse Event|13|||
145738168|NCT00915772|525558895|FG002|Overall Study|Adverse Event|11|||
145738169|NCT00915772|525558893|FG000|Overall Study|Protocol Violation|4|||
145738170|NCT00915772|525558894|FG001|Overall Study|Protocol Violation|1|||
145738171|NCT00915772|525558895|FG002|Overall Study|Protocol Violation|2|||
145738172|NCT00915772|525558893|FG000|Overall Study|Lost to Follow-up|1|||
145738173|NCT00915772|525558894|FG001|Overall Study|Lost to Follow-up|2|||
145738174|NCT00915772|525558895|FG002|Overall Study|Lost to Follow-up|2|||
145738175|NCT00915772|525558893|FG000|Overall Study|Lack of Efficacy|9|||
145738176|NCT00915772|525558894|FG001|Overall Study|Lack of Efficacy|15|||
145738177|NCT00915772|525558895|FG002|Overall Study|Lack of Efficacy|3|||
145738178|NCT00915772|525558893|FG000|Overall Study|Refused to continue trial medication|6|||
145738179|NCT00915772|525558894|FG001|Overall Study|Refused to continue trial medication|8|||
145738180|NCT00915772|525558895|FG002|Overall Study|Refused to continue trial medication|4|||
145738181|NCT00915772|525558893|FG000|Overall Study|Any other reason|4|||
145738182|NCT00915772|525558894|FG001|Overall Study|Any other reason|7|||
145738183|NCT00915772|525558895|FG002|Overall Study|Any other reason|7|||
145738184|NCT01211535|525558896|FG000|Overall Study|Adverse Event|0|||
145738185|NCT01211535|525558897|FG001|Overall Study|Adverse Event|1|||
145738186|NCT00549939|525558903|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
145738187|NCT00549939|525558904|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
145738188|NCT00549939|525558905|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
145738189|NCT00549939|525558903|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
145738190|NCT00549939|525558904|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
145738191|NCT00549939|525558905|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
145738192|NCT00549939|525558903|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
145738193|NCT00549939|525558904|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
145738194|NCT00549939|525558905|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
145738195|NCT00549939|525558903|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
145738196|NCT00549939|525558904|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
145738197|NCT00549939|525558905|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
145738198|NCT00549939|525558903|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
145738199|NCT00549939|525558904|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
145738200|NCT00549939|525558905|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
145738201|NCT00549939|525558903|FG000|40-week Open Label Treatment Period|Other|0|||
145738202|NCT00549939|525558904|FG001|40-week Open Label Treatment Period|Other|1|||
145738203|NCT00549939|525558905|FG002|40-week Open Label Treatment Period|Other|4|||
145738204|NCT03593850|525558906|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
145738205|NCT03593850|525558907|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
145738206|NCT00058552|525558912|FG000|Overall Study|Died prior to receiving treatment|4|||
145738207|NCT00058552|525558913|FG001|Overall Study|Died prior to receiving treatment|2|||
145738208|NCT00058552|525558912|FG000|Overall Study|Disease progression|52|||
145738209|NCT00058552|525558913|FG001|Overall Study|Disease progression|44|||
145738210|NCT00058552|525558912|FG000|Overall Study|Adverse Event|4|||
145738211|NCT00058552|525558913|FG001|Overall Study|Adverse Event|2|||
145738212|NCT00058552|525558912|FG000|Overall Study|Withdrawal by Subject|3|||
145738213|NCT00058552|525558913|FG001|Overall Study|Withdrawal by Subject|5|||
145738214|NCT00058552|525558912|FG000|Overall Study|Physician Decision|2|||
145738215|NCT00058552|525558913|FG001|Overall Study|Physician Decision|5|||
145738216|NCT00058552|525558912|FG000|Overall Study|Clinical disease progression|0|||
145738217|NCT00058552|525558913|FG001|Overall Study|Clinical disease progression|4|||
145738218|NCT03861936|525558914|FG000|Overall Study|Withdrawal by Subject|4|||
145738219|NCT03861936|525558915|FG001|Overall Study|Withdrawal by Subject|1|||
145738220|NCT03861936|525558916|FG002|Overall Study|Withdrawal by Subject|3|||
145738221|NCT03861936|525558914|FG000|Overall Study|Lost to Follow-up|5|||
145738222|NCT03861936|525558915|FG001|Overall Study|Lost to Follow-up|3|||
145738223|NCT03861936|525558916|FG002|Overall Study|Lost to Follow-up|3|||
145738224|NCT03861936|525558914|FG000|Overall Study|Physician Decision|0|||
145738225|NCT03861936|525558915|FG001|Overall Study|Physician Decision|1|||
145738226|NCT03861936|525558916|FG002|Overall Study|Physician Decision|0|||
145738227|NCT03861936|525558914|FG000|Overall Study|Protocol Deviation|0|||
145738228|NCT03861936|525558915|FG001|Overall Study|Protocol Deviation|0|||
145738229|NCT03861936|525558916|FG002|Overall Study|Protocol Deviation|1|||
145738230|NCT03861936|525558914|FG000|Overall Study|Reason not Specified|5|||
145738231|NCT03861936|525558915|FG001|Overall Study|Reason not Specified|5|||
145738232|NCT03861936|525558916|FG002|Overall Study|Reason not Specified|3|||
145738233|NCT02319668|525558919|FG000|Overall Study|Other (Not specified)|0|||
145738234|NCT02319668|525558920|FG001|Overall Study|Other (Not specified)|2|||
145738235|NCT01372150|525558925|FG000|Overall Study|Lack of Efficacy|3|||
145738236|NCT01372150|525558926|FG001|Overall Study|Lack of Efficacy|0|||
145738237|NCT01372150|525558927|FG002|Overall Study|Lack of Efficacy|1|||
145738238|NCT01372150|525558925|FG000|Overall Study|Lost to Follow-up|4|||
145738239|NCT01372150|525558926|FG001|Overall Study|Lost to Follow-up|5|||
145738240|NCT01372150|525558927|FG002|Overall Study|Lost to Follow-up|6|||
145738241|NCT01372150|525558925|FG000|Overall Study|Protocol Violation|1|||
145738242|NCT01372150|525558926|FG001|Overall Study|Protocol Violation|0|||
145738243|NCT01372150|525558927|FG002|Overall Study|Protocol Violation|3|||
145738244|NCT01372150|525558925|FG000|Overall Study|Withdrawal by Subject|2|||
145738245|NCT01372150|525558926|FG001|Overall Study|Withdrawal by Subject|7|||
145738246|NCT01372150|525558927|FG002|Overall Study|Withdrawal by Subject|2|||
145738247|NCT01372150|525558925|FG000|Overall Study|Other|1|||
145738248|NCT01372150|525558926|FG001|Overall Study|Other|0|||
145738249|NCT01372150|525558927|FG002|Overall Study|Other|2|||
145738250|NCT01372150|525558925|FG000|Overall Study|Adverse Event|2|||
145738251|NCT01372150|525558926|FG001|Overall Study|Adverse Event|1|||
145738252|NCT01372150|525558927|FG002|Overall Study|Adverse Event|2|||
145738253|NCT01372150|525558925|FG000|Overall Study|Randomized but not treated|0|||
145738254|NCT01372150|525558926|FG001|Overall Study|Randomized but not treated|1|||
145738255|NCT01372150|525558927|FG002|Overall Study|Randomized but not treated|0|||
145738256|NCT03198520|525558928|FG000|Overall Study|Physician Decision|2|||
145738257|NCT03198520|525558928|FG000|Overall Study|Protocol Violation|2|||
145738258|NCT03198520|525558928|FG000|Overall Study|Withdrawal by Subject|1|||
145738259|NCT03198520|525558928|FG000|Overall Study|Study Ended|1|||
145738260|NCT01670539|525558929|FG000|Overall Study|Death|3|||
145738261|NCT01670539|525558930|FG001|Overall Study|Death|5|||
145738262|NCT01670539|525558929|FG000|Overall Study|Withdrawal by Subject|3|||
145738263|NCT01670539|525558930|FG001|Overall Study|Withdrawal by Subject|0|||
145738264|NCT01236573|525558931|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738265|NCT01236573|525558932|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738266|NCT01236573|525558933|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738267|NCT01236573|525558934|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738268|NCT01236573|525558935|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738269|NCT01236573|525558936|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738270|NCT01236573|525558937|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
145738271|NCT01236573|525558938|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738272|NCT01236573|525558939|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
145738273|NCT01236573|525558940|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
145738274|NCT01236573|525558941|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
145738275|NCT01236573|525558931|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738276|NCT01236573|525558932|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738277|NCT01236573|525558933|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738278|NCT01236573|525558934|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738279|NCT01236573|525558935|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738280|NCT01236573|525558936|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738281|NCT01236573|525558937|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738282|NCT01236573|525558938|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738283|NCT01236573|525558939|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
145738284|NCT01236573|525558940|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738285|NCT01236573|525558941|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
145738286|NCT01236573|525558931|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738287|NCT01236573|525558932|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738288|NCT01236573|525558933|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738289|NCT01236573|525558934|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738290|NCT01236573|525558935|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738291|NCT01236573|525558936|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738292|NCT01236573|525558937|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738293|NCT01236573|525558938|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738294|NCT01236573|525558939|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738295|NCT01236573|525558940|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
145738296|NCT01236573|525558941|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
145738297|NCT00823823|525558944|FG000|Overall Study|Lost to Follow-up|3|||
145738298|NCT00823823|525558945|FG001|Overall Study|Lost to Follow-up|1|||
145738299|NCT00823823|525558944|FG000|Overall Study|Protocol Violation|5|||
145738300|NCT00823823|525558945|FG001|Overall Study|Protocol Violation|5|||
145738301|NCT00536809|525558946|FG000|Phase II|Adverse Event|1|||
145738302|NCT00536809|525558946|FG000|Phase II|Referred for surgical resection|1|||
145738303|NCT00113074|525558965|FG000|Overall Study|Lost to Follow-up|10|||
145738304|NCT00113074|525558966|FG001|Overall Study|Lost to Follow-up|10|||
145738305|NCT00113074|525558967|FG002|Overall Study|Lost to Follow-up|14|||
145738306|NCT02170779|525558970|FG000|Overall Study|Withdrawal by Subject|1|||
145738307|NCT02170779|525558971|FG001|Overall Study|Withdrawal by Subject|0|||
145738308|NCT02170779|525558970|FG000|Overall Study|Lost to Follow-up|0|||
145738309|NCT02170779|525558971|FG001|Overall Study|Lost to Follow-up|1|||
145738310|NCT00369785|525558972|FG000|Overall Study|Physician Decision|3|||
145738311|NCT00369785|525558973|FG001|Overall Study|Physician Decision|2|||
145738312|NCT00369785|525558972|FG000|Overall Study|Death|1|||
145738313|NCT00369785|525558973|FG001|Overall Study|Death|2|||
145738314|NCT00369785|525558972|FG000|Overall Study|Withdrawal by Subject|7|||
145738315|NCT00369785|525558973|FG001|Overall Study|Withdrawal by Subject|6|||
145738316|NCT00369785|525558972|FG000|Overall Study|Toxicity|6|||
145738317|NCT00369785|525558973|FG001|Overall Study|Toxicity|4|||
145738318|NCT00369785|525558972|FG000|Overall Study|Never started|0|||
145738319|NCT00369785|525558973|FG001|Overall Study|Never started|2|||
145738320|NCT00369785|525558972|FG000|Overall Study|Progression|4|||
145738321|NCT00369785|525558973|FG001|Overall Study|Progression|4|||
145738322|NCT00369785|525558972|FG000|Overall Study|Multiple reasons|6|||
145738323|NCT00369785|525558973|FG001|Overall Study|Multiple reasons|5|||
145738324|NCT00800683|525558974|FG000|Overall Study|Adverse Event|11|||
145738325|NCT00800683|525558975|FG001|Overall Study|Adverse Event|8|||
145738326|NCT00800683|525558974|FG000|Overall Study|Lost to Follow-up|3|||
145738327|NCT00800683|525558975|FG001|Overall Study|Lost to Follow-up|1|||
145738328|NCT00800683|525558974|FG000|Overall Study|Withdrawal by Subject|1|||
145738329|NCT00800683|525558975|FG001|Overall Study|Withdrawal by Subject|7|||
145738330|NCT00800683|525558974|FG000|Overall Study|Lack of Efficacy|1|||
145738331|NCT00800683|525558975|FG001|Overall Study|Lack of Efficacy|1|||
145738332|NCT00800683|525558974|FG000|Overall Study|Other|1|||
145738333|NCT00800683|525558975|FG001|Overall Study|Other|2|||
145738334|NCT00356889|525558977|FG000|Overall Study|Protocol Violation|2|||
145738335|NCT00356889|525558977|FG000|Overall Study|Adverse Event|1|||
145738336|NCT03492554|525558982|FG000|Overall Study|Protocol Violation|0|||
145738337|NCT03492554|525558983|FG001|Overall Study|Protocol Violation|14|||
145738338|NCT00736034|525558986|FG000|Overall Study|Adverse Event|2|||
145738339|NCT03716050|525558990|FG000|Overall Study|Lost to Follow-up|0|||
145738340|NCT03716050|525558991|FG001|Overall Study|Lost to Follow-up|0|||
145738341|NCT03716050|525558992|FG002|Overall Study|Lost to Follow-up|1|||
145738342|NCT03716050|525558993|FG003|Overall Study|Lost to Follow-up|0|||
145738343|NCT03716050|525558994|FG004|Overall Study|Lost to Follow-up|0|||
145738344|NCT03716050|525558995|FG005|Overall Study|Lost to Follow-up|0|||
145738345|NCT03716050|525558996|FG006|Overall Study|Lost to Follow-up|0|||
145738346|NCT03716050|525558997|FG007|Overall Study|Lost to Follow-up|0|||
145738347|NCT03716050|525558990|FG000|Overall Study|Physician Decision|0|||
145738348|NCT03716050|525558991|FG001|Overall Study|Physician Decision|0|||
145738349|NCT03716050|525558992|FG002|Overall Study|Physician Decision|0|||
145738350|NCT03716050|525558993|FG003|Overall Study|Physician Decision|1|||
145738351|NCT03716050|525558994|FG004|Overall Study|Physician Decision|0|||
145738352|NCT03716050|525558995|FG005|Overall Study|Physician Decision|0|||
145738353|NCT03716050|525558996|FG006|Overall Study|Physician Decision|0|||
145738354|NCT03716050|525558997|FG007|Overall Study|Physician Decision|0|||
145738355|NCT03716050|525558990|FG000|Overall Study|Protocol Violation|0|||
145738356|NCT03716050|525558991|FG001|Overall Study|Protocol Violation|0|||
145738357|NCT03716050|525558992|FG002|Overall Study|Protocol Violation|0|||
145738358|NCT03716050|525558993|FG003|Overall Study|Protocol Violation|1|||
145738359|NCT03716050|525558994|FG004|Overall Study|Protocol Violation|0|||
145738360|NCT03716050|525558995|FG005|Overall Study|Protocol Violation|0|||
145738361|NCT03716050|525558996|FG006|Overall Study|Protocol Violation|0|||
145738362|NCT03716050|525558997|FG007|Overall Study|Protocol Violation|2|||
145738363|NCT03123250|525558998|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
145738364|NCT04340557|525558999|FG000|Overall Study|Transferred to ICU and/or death|1|||
145738365|NCT04340557|525559000|FG001|Overall Study|Transferred to ICU and/or death|2|||
145738366|NCT01221727|525559001|FG000|Overall Study|Physician Decision|2|||
145738367|NCT01221727|525559002|FG001|Overall Study|Physician Decision|0|||
145738368|NCT01221727|525559001|FG000|Overall Study|Withdrawal by Subject|1|||
145738369|NCT01221727|525559002|FG001|Overall Study|Withdrawal by Subject|1|||
145738370|NCT00529451|525559003|FG000|Overall Study|Subject withdrew consent|16|||
145738371|NCT00529451|525559004|FG001|Overall Study|Subject withdrew consent|21|||
145738372|NCT00529451|525559005|FG002|Overall Study|Subject withdrew consent|13|||
145738373|NCT00529451|525559006|FG003|Overall Study|Subject withdrew consent|12|||
145738374|NCT00529451|525559003|FG000|Overall Study|Adverse Event|9|||
145738375|NCT00529451|525559004|FG001|Overall Study|Adverse Event|16|||
145738376|NCT00529451|525559005|FG002|Overall Study|Adverse Event|14|||
145738377|NCT00529451|525559006|FG003|Overall Study|Adverse Event|8|||
145738378|NCT00529451|525559003|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
145738379|NCT00529451|525559004|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
145738380|NCT00529451|525559005|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
145738381|NCT00529451|525559006|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
145738382|NCT00529451|525559003|FG000|Overall Study|Lost to Follow-up|4|||
145738383|NCT00529451|525559004|FG001|Overall Study|Lost to Follow-up|7|||
145738384|NCT00529451|525559005|FG002|Overall Study|Lost to Follow-up|4|||
145738385|NCT00529451|525559006|FG003|Overall Study|Lost to Follow-up|4|||
145738386|NCT00529451|525559003|FG000|Overall Study|Protocol deviation|1|||
145738387|NCT00529451|525559004|FG001|Overall Study|Protocol deviation|1|||
145738388|NCT00529451|525559005|FG002|Overall Study|Protocol deviation|4|||
145738389|NCT00529451|525559006|FG003|Overall Study|Protocol deviation|1|||
145738390|NCT00529451|525559003|FG000|Overall Study|Administrative problems|1|||
145738391|NCT00529451|525559004|FG001|Overall Study|Administrative problems|1|||
145738392|NCT00529451|525559005|FG002|Overall Study|Administrative problems|0|||
145738393|NCT00529451|525559006|FG003|Overall Study|Administrative problems|2|||
145738394|NCT00773136|525559007|FG000|Overall Study|Physician Decision|2|||
145738395|NCT02463071|525559010|FG000|Overall Study|Adverse Event|3|||
145738396|NCT02463071|525559011|FG001|Overall Study|Adverse Event|5|||
145738397|NCT02463071|525559012|FG002|Overall Study|Adverse Event|1|||
145738398|NCT02463071|525559010|FG000|Overall Study|Death|1|||
145738399|NCT02463071|525559011|FG001|Overall Study|Death|0|||
145738400|NCT02463071|525559012|FG002|Overall Study|Death|0|||
145738401|NCT02463071|525559010|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
145738402|NCT02463071|525559011|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145738403|NCT02463071|525559012|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145738404|NCT02463071|525559010|FG000|Overall Study|Reason not specified|7|||
145738405|NCT02463071|525559011|FG001|Overall Study|Reason not specified|9|||
145738406|NCT02463071|525559012|FG002|Overall Study|Reason not specified|4|||
145738407|NCT02463071|525559010|FG000|Overall Study|Protocol Violation|0|||
145402285|NCT03261401|524330696|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
145738408|NCT02463071|525559011|FG001|Overall Study|Protocol Violation|2|||
145738409|NCT02463071|525559012|FG002|Overall Study|Protocol Violation|0|||
145738410|NCT02463071|525559010|FG000|Overall Study|Lost to Follow-up|0|||
145738411|NCT02463071|525559011|FG001|Overall Study|Lost to Follow-up|0|||
145738412|NCT02463071|525559012|FG002|Overall Study|Lost to Follow-up|1|||
145738413|NCT01009034|525559013|FG000|Overall Study|Lost to Follow-up|2|||
145738414|NCT01009034|525559013|FG000|Overall Study|Withdrawal by Subject|2|||
145738415|NCT01494350|525559014|FG000|Overall Study|Worsening of lesion|1|||
145738416|NCT00199836|525559016|FG000|Overall Study|Progressive Disease|5|||
145738417|NCT00199836|525559016|FG000|Overall Study|Death|1|||
145738418|NCT03098836|525559022|FG000|Overall Study|Adverse Event|1|||
145738419|NCT03098836|525559023|FG001|Overall Study|Adverse Event|3|||
145738420|NCT03098836|525559022|FG000|Overall Study|Lack of Efficacy|30|||
145738421|NCT03098836|525559023|FG001|Overall Study|Lack of Efficacy|15|||
145738422|NCT03098836|525559022|FG000|Overall Study|Physician Decision|2|||
145738423|NCT03098836|525559023|FG001|Overall Study|Physician Decision|1|||
145738424|NCT03098836|525559022|FG000|Overall Study|Withdrawal by Subject|3|||
145738425|NCT03098836|525559023|FG001|Overall Study|Withdrawal by Subject|2|||
145738426|NCT03986866|525559024|FG000|Overall Study|Withdrawal by Subject|0|||
145738427|NCT03986866|525559025|FG001|Overall Study|Withdrawal by Subject|3|||
145738428|NCT03986866|525559024|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
145738429|NCT03986866|525559025|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
145738430|NCT00898443|525559026|FG000|Overall Study|Withdrawal by Subject|1|||
145738431|NCT00898443|525559027|FG001|Overall Study|Withdrawal by Subject|0|||
145738432|NCT00617604|525559029|FG000|Overall Study|Death|2|||
145738433|NCT00617604|525559030|FG001|Overall Study|Death|1|||
145738434|NCT00617604|525559029|FG000|Overall Study|Lost to Follow-up|1|||
145738435|NCT00617604|525559030|FG001|Overall Study|Lost to Follow-up|0|||
145738436|NCT00617604|525559029|FG000|Overall Study|Miscellaneous Reasons|8|||
145738437|NCT00617604|525559030|FG001|Overall Study|Miscellaneous Reasons|10|||
145738438|NCT00617604|525559029|FG000|Overall Study|Withdrawal by Subject|4|||
145738439|NCT00617604|525559030|FG001|Overall Study|Withdrawal by Subject|6|||
145738440|NCT00617604|525559029|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
145738441|NCT00617604|525559030|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
145738442|NCT03250832|525559031|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
145738443|NCT03250832|525559032|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
145738444|NCT03250832|525559033|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
145738445|NCT03250832|525559034|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
145738446|NCT03250832|525559035|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
145738447|NCT03250832|525559036|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
145738448|NCT03250832|525559037|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
145738449|NCT03250832|525559038|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
145738450|NCT03250832|525559039|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
145738451|NCT03250832|525559040|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
145738452|NCT03250832|525559041|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
145738453|NCT03250832|525559042|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
145738454|NCT03250832|525559031|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
145738455|NCT03250832|525559032|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
145738456|NCT03250832|525559033|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
145738457|NCT03250832|525559034|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
145738458|NCT03250832|525559035|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
145738459|NCT03250832|525559036|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
145738460|NCT03250832|525559037|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
145738461|NCT03250832|525559038|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
145738462|NCT03250832|525559039|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
145738463|NCT03250832|525559040|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
145738464|NCT03250832|525559041|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
145738465|NCT03250832|525559042|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
145738466|NCT03250832|525559031|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738467|NCT03250832|525559032|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738468|NCT03250832|525559033|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
145738469|NCT03250832|525559034|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738470|NCT03250832|525559035|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738471|NCT03250832|525559036|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738472|NCT03250832|525559037|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738473|NCT03250832|525559038|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738474|NCT03250832|525559039|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738475|NCT03250832|525559040|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738476|NCT03250832|525559041|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145517230|NCT00065429|524752520|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145738477|NCT03250832|525559042|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
145738478|NCT03250832|525559031|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738479|NCT03250832|525559032|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738480|NCT03250832|525559033|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738481|NCT03250832|525559034|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738482|NCT03250832|525559035|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
145517231|NCT00065429|524752521|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145738483|NCT03250832|525559036|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738484|NCT03250832|525559037|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738485|NCT03250832|525559038|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
145738486|NCT03250832|525559039|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738487|NCT03250832|525559040|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738488|NCT03250832|525559041|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738489|NCT03250832|525559042|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
145738490|NCT03250832|525559031|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738491|NCT03250832|525559032|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738492|NCT03250832|525559033|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738493|NCT03250832|525559034|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738494|NCT03250832|525559035|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738495|NCT03250832|525559036|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738496|NCT03250832|525559037|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738497|NCT03250832|525559038|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
145738498|NCT03250832|525559039|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738499|NCT03250832|525559040|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738500|NCT03250832|525559041|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738501|NCT03250832|525559042|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
145738502|NCT03250832|525559031|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738503|NCT03250832|525559032|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145517232|NCT00065429|524752522|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145517233|NCT00065429|524752523|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
145517234|NCT00065429|524752517|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
145517235|NCT00065429|524752518|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517236|NCT00065429|524752519|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517237|NCT00065429|524752520|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517238|NCT00065429|524752521|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517239|NCT00065429|524752522|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517240|NCT00065429|524752523|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
145517241|NCT00065429|524752517|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
145517242|NCT00065429|524752518|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
145738504|NCT03250832|525559033|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738505|NCT03250832|525559034|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738506|NCT03250832|525559035|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738507|NCT03250832|525559036|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738508|NCT03250832|525559037|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738509|NCT03250832|525559038|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
145738510|NCT03250832|525559039|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738511|NCT03250832|525559040|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738512|NCT03250832|525559041|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738513|NCT03250832|525559042|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
145738514|NCT03250832|525559031|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145517243|NCT00065429|524752519|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
145517244|NCT00065429|524752520|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
145517245|NCT00065429|524752521|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
145517246|NCT00065429|524752522|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
145517247|NCT00065429|524752523|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
145517248|NCT00065429|524752517|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
145517249|NCT00065429|524752518|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
145517250|NCT00065429|524752519|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
145517251|NCT00065429|524752520|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
145517252|NCT00065429|524752521|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
145517253|NCT00065429|524752522|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
145517254|NCT00065429|524752523|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
145517255|NCT00065429|524752517|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145517256|NCT00065429|524752518|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145517257|NCT00065429|524752519|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145517258|NCT00065429|524752520|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145738515|NCT03250832|525559032|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738516|NCT03250832|525559033|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145517259|NCT00065429|524752521|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
145517260|NCT00065429|524752522|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145517261|NCT00065429|524752523|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
145517262|NCT00065429|524752517|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145738517|NCT03250832|525559034|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738518|NCT03250832|525559035|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738519|NCT03250832|525559036|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738520|NCT03250832|525559037|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738521|NCT03250832|525559038|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
145738522|NCT03250832|525559039|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738523|NCT03250832|525559040|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738524|NCT03250832|525559041|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738525|NCT03250832|525559042|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
145738526|NCT03250832|525559031|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738527|NCT03250832|525559032|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738528|NCT03250832|525559033|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738529|NCT03250832|525559034|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738530|NCT03250832|525559035|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738531|NCT03250832|525559036|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738532|NCT03250832|525559037|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738533|NCT03250832|525559038|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
145738534|NCT03250832|525559039|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738535|NCT03250832|525559040|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738536|NCT03250832|525559041|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738537|NCT03250832|525559042|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
145738538|NCT03250832|525559031|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738539|NCT03250832|525559032|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738540|NCT03250832|525559033|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738541|NCT03250832|525559034|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738542|NCT03250832|525559035|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738543|NCT03250832|525559036|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738544|NCT03250832|525559037|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738545|NCT03250832|525559038|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738546|NCT03250832|525559039|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
145738547|NCT03250832|525559040|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
145738548|NCT03250832|525559041|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738549|NCT03250832|525559042|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
145738550|NCT03250832|525559031|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738551|NCT03250832|525559032|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738552|NCT03250832|525559033|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738553|NCT03250832|525559034|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738554|NCT03250832|525559035|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738555|NCT03250832|525559036|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738556|NCT03250832|525559037|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738557|NCT03250832|525559038|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738558|NCT03250832|525559039|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
145738559|NCT03250832|525559040|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
145738560|NCT03250832|525559041|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738561|NCT03250832|525559042|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
145738562|NCT03250832|525559031|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738563|NCT03250832|525559032|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738564|NCT03250832|525559033|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738565|NCT03250832|525559034|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738566|NCT03250832|525559035|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738567|NCT03250832|525559036|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738568|NCT03250832|525559037|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738569|NCT03250832|525559038|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738570|NCT03250832|525559039|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
145738571|NCT03250832|525559040|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
145738572|NCT03250832|525559041|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738573|NCT03250832|525559042|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
145738574|NCT03250832|525559031|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738575|NCT03250832|525559032|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738576|NCT03250832|525559033|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738577|NCT03250832|525559034|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738578|NCT03250832|525559035|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738579|NCT03250832|525559036|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738580|NCT03250832|525559037|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738581|NCT03250832|525559038|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738582|NCT03250832|525559039|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738583|NCT03250832|525559040|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738584|NCT03250832|525559041|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
145738585|NCT03250832|525559042|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
145738586|NCT02303704|525559043|FG000|Overall Study|Protocol Violation|5|||
145738587|NCT02303704|525559044|FG001|Overall Study|Protocol Violation|9|||
145738588|NCT01034540|525559047|FG000|Overall Study|Adverse Event|0|||
145738589|NCT01034540|525559048|FG001|Overall Study|Adverse Event|1|||
145738590|NCT00932425|525559049|FG000|Overall Study|Lost to Follow-up|0|||
145738591|NCT00932425|525559050|FG001|Overall Study|Lost to Follow-up|1|||
145738592|NCT00932425|525559049|FG000|Overall Study|Withdrawal by Subject|0|||
145738593|NCT00932425|525559050|FG001|Overall Study|Withdrawal by Subject|1|||
145738594|NCT00310804|525559051|FG000|Overall Study|Lost to Follow-up|2|||
145738595|NCT00310804|525559052|FG001|Overall Study|Lost to Follow-up|0|||
145738596|NCT00310804|525559051|FG000|Overall Study|Withdrawal by Subject|3|||
145738597|NCT00310804|525559052|FG001|Overall Study|Withdrawal by Subject|0|||
145738598|NCT02109562|525559053|FG000|Overall Study|Insufficient clinical response|2|||
145738599|NCT02109562|525559054|FG001|Overall Study|Insufficient clinical response|0|||
145738600|NCT02109562|525559055|FG002|Overall Study|Insufficient clinical response|4|||
145738601|NCT02109562|525559053|FG000|Overall Study|Adverse Event|0|||
145738602|NCT02109562|525559054|FG001|Overall Study|Adverse Event|2|||
145738603|NCT02109562|525559055|FG002|Overall Study|Adverse Event|3|||
145738604|NCT02109562|525559053|FG000|Overall Study|Lost to Follow-up|1|||
145738605|NCT02109562|525559054|FG001|Overall Study|Lost to Follow-up|0|||
145738606|NCT02109562|525559055|FG002|Overall Study|Lost to Follow-up|1|||
145738607|NCT02109562|525559053|FG000|Overall Study|Protocol Violation|0|||
145738608|NCT02109562|525559054|FG001|Overall Study|Protocol Violation|3|||
145738609|NCT02109562|525559055|FG002|Overall Study|Protocol Violation|1|||
145738610|NCT02109562|525559053|FG000|Overall Study|Withdrawal by Subject|20|||
145738611|NCT02109562|525559054|FG001|Overall Study|Withdrawal by Subject|25|||
145738612|NCT02109562|525559055|FG002|Overall Study|Withdrawal by Subject|21|||
145738613|NCT02109562|525559053|FG000|Overall Study|Physician Decision|3|||
145738614|NCT02109562|525559054|FG001|Overall Study|Physician Decision|4|||
145738615|NCT02109562|525559055|FG002|Overall Study|Physician Decision|5|||
145738616|NCT00688155|525559056|FG000|Overall Study|Withdrawal by Subject|2|||
145738617|NCT00688155|525559057|FG001|Overall Study|Withdrawal by Subject|2|||
145738618|NCT00688155|525559058|FG002|Overall Study|Withdrawal by Subject|1|||
145738619|NCT00688155|525559059|FG003|Overall Study|Withdrawal by Subject|1|||
145738620|NCT03734016|525559060|FG000|Overall Study|Sponsor Ended Study|225|||
145738621|NCT03734016|525559061|FG001|Overall Study|Sponsor Ended Study|200|||
145738622|NCT03734016|525559060|FG000|Overall Study|Death|69|||
145738623|NCT03734016|525559061|FG001|Overall Study|Death|83|||
145738624|NCT03734016|525559060|FG000|Overall Study|Withdrawal by Subject|21|||
145738625|NCT03734016|525559061|FG001|Overall Study|Withdrawal by Subject|27|||
145738626|NCT03734016|525559060|FG000|Overall Study|Physician Decision|1|||
145738627|NCT03734016|525559061|FG001|Overall Study|Physician Decision|12|||
145738628|NCT03734016|525559060|FG000|Overall Study|Lost to Follow-up|6|||
145738629|NCT03734016|525559061|FG001|Overall Study|Lost to Follow-up|2|||
145738630|NCT03734016|525559060|FG000|Overall Study|Miscellaneous|5|||
145738631|NCT03734016|525559061|FG001|Overall Study|Miscellaneous|1|||
145738632|NCT01428661|525559064|FG000|Double-Masked Phase|Protocol Violation|9|||
145738633|NCT01428661|525559065|FG001|Double-Masked Phase|Protocol Violation|4|||
145738634|NCT01428661|525559066|FG002|Double-Masked Phase|Protocol Violation|0|||
145738635|NCT01428661|525559064|FG000|Double-Masked Phase|Adverse Event|13|||
145738636|NCT01428661|525559065|FG001|Double-Masked Phase|Adverse Event|4|||
145738637|NCT01428661|525559066|FG002|Double-Masked Phase|Adverse Event|0|||
145738638|NCT01428661|525559064|FG000|Double-Masked Phase|Lost to Follow-up|14|||
145738639|NCT01428661|525559065|FG001|Double-Masked Phase|Lost to Follow-up|14|||
145738640|NCT01428661|525559066|FG002|Double-Masked Phase|Lost to Follow-up|0|||
145738641|NCT01428661|525559064|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
145738642|NCT01428661|525559065|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
145738643|NCT01428661|525559066|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
145738644|NCT01428661|525559064|FG000|Double-Masked Phase|Lack of Efficacy|2|||
145738645|NCT01428661|525559065|FG001|Double-Masked Phase|Lack of Efficacy|1|||
145738646|NCT01428661|525559066|FG002|Double-Masked Phase|Lack of Efficacy|0|||
145738647|NCT01428661|525559064|FG000|Double-Masked Phase|*Various|1|||
145738648|NCT01428661|525559065|FG001|Double-Masked Phase|*Various|6|||
145738649|NCT01428661|525559066|FG002|Double-Masked Phase|*Various|0|||
145738650|NCT01428661|525559064|FG000|Open Label Extension|Protocol Violation|0|||
145738651|NCT01428661|525559065|FG001|Open Label Extension|Protocol Violation|0|||
145738652|NCT01428661|525559066|FG002|Open Label Extension|Protocol Violation|9|||
145738653|NCT01428661|525559064|FG000|Open Label Extension|Adverse Event|0|||
145738654|NCT01428661|525559065|FG001|Open Label Extension|Adverse Event|0|||
145738655|NCT01428661|525559066|FG002|Open Label Extension|Adverse Event|15|||
145738656|NCT01428661|525559064|FG000|Open Label Extension|Lost to Follow-up|0|||
145738657|NCT01428661|525559065|FG001|Open Label Extension|Lost to Follow-up|0|||
145738658|NCT01428661|525559066|FG002|Open Label Extension|Lost to Follow-up|38|||
145738659|NCT01428661|525559064|FG000|Open Label Extension|Withdrawal by Subject|0|||
145738660|NCT01428661|525559065|FG001|Open Label Extension|Withdrawal by Subject|0|||
145738661|NCT01428661|525559066|FG002|Open Label Extension|Withdrawal by Subject|49|||
145738662|NCT01428661|525559064|FG000|Open Label Extension|Lack of Efficacy|0|||
145738663|NCT01428661|525559065|FG001|Open Label Extension|Lack of Efficacy|0|||
145738664|NCT01428661|525559066|FG002|Open Label Extension|Lack of Efficacy|24|||
145738665|NCT01428661|525559064|FG000|Open Label Extension|**Various|0|||
145738666|NCT01428661|525559065|FG001|Open Label Extension|**Various|0|||
145738667|NCT01428661|525559066|FG002|Open Label Extension|**Various|185|||
145738668|NCT00382720|525560383|FG000|Overall Study|Adverse Event|21|||
145738669|NCT00382720|525560384|FG001|Overall Study|Adverse Event|23|||
145738670|NCT00382720|525560385|FG002|Overall Study|Adverse Event|15|||
145738671|NCT00382720|525560383|FG000|Overall Study|Protocol Violation|2|||
145738672|NCT00382720|525560384|FG001|Overall Study|Protocol Violation|5|||
145738673|NCT00382720|525560385|FG002|Overall Study|Protocol Violation|1|||
145517263|NCT00065429|524752518|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145517264|NCT00065429|524752519|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145517265|NCT00065429|524752520|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145517266|NCT00065429|524752521|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
145517267|NCT00065429|524752522|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145517268|NCT00065429|524752523|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
145517269|NCT00832624|524752527|FG000|Overall Study|Study Terminated|10|||
145738674|NCT00382720|525560383|FG000|Overall Study|Death|0|||
145738675|NCT00382720|525560384|FG001|Overall Study|Death|1|||
145738676|NCT00382720|525560385|FG002|Overall Study|Death|2|||
145738677|NCT00382720|525560383|FG000|Overall Study|Progressive disease|37|||
145738678|NCT00382720|525560384|FG001|Overall Study|Progressive disease|28|||
145738679|NCT00382720|525560385|FG002|Overall Study|Progressive disease|38|||
145738680|NCT00382720|525560383|FG000|Overall Study|Withdrew consent|1|||
145738681|NCT00382720|525560384|FG001|Overall Study|Withdrew consent|1|||
145738682|NCT00382720|525560385|FG002|Overall Study|Withdrew consent|2|||
145738683|NCT00382720|525560383|FG000|Overall Study|Withdrawal by Subject|11|||
145738684|NCT00382720|525560384|FG001|Overall Study|Withdrawal by Subject|20|||
145738685|NCT00382720|525560385|FG002|Overall Study|Withdrawal by Subject|12|||
145738686|NCT00382720|525560383|FG000|Overall Study|Surgery|1|||
145738687|NCT00382720|525560384|FG001|Overall Study|Surgery|1|||
145738688|NCT00382720|525560385|FG002|Overall Study|Surgery|4|||
145738689|NCT00382720|525560383|FG000|Overall Study|Patient did not receive study medication|1|||
145738690|NCT00382720|525560384|FG001|Overall Study|Patient did not receive study medication|1|||
145738691|NCT00382720|525560385|FG002|Overall Study|Patient did not receive study medication|4|||
145738692|NCT00382720|525560383|FG000|Overall Study|Clinically progressive disease|0|||
145738693|NCT00382720|525560384|FG001|Overall Study|Clinically progressive disease|1|||
145738694|NCT00382720|525560385|FG002|Overall Study|Clinically progressive disease|0|||
145738695|NCT00382720|525560383|FG000|Overall Study|Good prognosis|0|||
145738696|NCT00382720|525560384|FG001|Overall Study|Good prognosis|1|||
145738697|NCT00382720|525560385|FG002|Overall Study|Good prognosis|0|||
145738698|NCT00382720|525560383|FG000|Overall Study|Investigator/Clinical decision|5|||
145738699|NCT00382720|525560384|FG001|Overall Study|Investigator/Clinical decision|6|||
145738700|NCT00382720|525560385|FG002|Overall Study|Investigator/Clinical decision|6|||
145738701|NCT00382720|525560383|FG000|Overall Study|Discontinued at end of study|0|||
145738702|NCT00382720|525560384|FG001|Overall Study|Discontinued at end of study|1|||
145738703|NCT00382720|525560385|FG002|Overall Study|Discontinued at end of study|2|||
145738704|NCT02737852|525560388|FG000|Overall Study|Withdrawal by Subject|2|||
145738705|NCT01183143|525560389|FG000|Overall Study|Protocol Violation|115|||
145738706|NCT01183143|525560389|FG000|Overall Study|Withdrawal by Subject|19|||
145738707|NCT01183143|525560389|FG000|Overall Study|Subject Questionnaires not returned|5|||
145738708|NCT01183143|525560389|FG000|Overall Study|Subjects enrolled, but not treated|11|||
145738709|NCT04042740|525560391|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
145738710|NCT04042740|525560391|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
145738711|NCT01717287|525560392|FG000|Overall Study|Lost to Follow-up|0|||
145738712|NCT01717287|525560393|FG001|Overall Study|Lost to Follow-up|2|||
145738713|NCT01717287|525560392|FG000|Overall Study|Protocol Violation|0|||
145738714|NCT01717287|525560393|FG001|Overall Study|Protocol Violation|1|||
145738715|NCT04490395|525560394|FG000|Overall Study|Lost to Follow-up|0|||
145738716|NCT04490395|525560395|FG001|Overall Study|Lost to Follow-up|1|||
145738717|NCT00388505|525560397|FG000|Overall Study|Adverse Event or Death|43|||
145738718|NCT00388505|525560398|FG001|Overall Study|Adverse Event or Death|17|||
145738719|NCT00388505|525560397|FG000|Overall Study|Withdrawal by Subject|24|||
145738720|NCT00388505|525560398|FG001|Overall Study|Withdrawal by Subject|9|||
145738721|NCT00388505|525560397|FG000|Overall Study|Lost to Follow-up|5|||
145738722|NCT00388505|525560398|FG001|Overall Study|Lost to Follow-up|3|||
145738723|NCT00388505|525560397|FG000|Overall Study|Inappropriate Enrollment|0|||
145517270|NCT01350544|524754237|FG000|Overall Study|Administrative Withdrawal|0|||
145517271|NCT01350544|524754238|FG001|Overall Study|Administrative Withdrawal|1|||
145517272|NCT01350544|524754237|FG000|Overall Study|Death|1|||
145517273|NCT01350544|524754238|FG001|Overall Study|Death|2|||
145517274|NCT01350544|524754237|FG000|Overall Study|Moved out of LA County|2|||
145517275|NCT01350544|524754238|FG001|Overall Study|Moved out of LA County|2|||
145517276|NCT01350544|524754237|FG000|Overall Study|Medical Issues|1|||
145517277|NCT01350544|524754238|FG001|Overall Study|Medical Issues|1|||
145517278|NCT01350544|524754237|FG000|Overall Study|Withdrawal by Subject|0|||
145517279|NCT01350544|524754238|FG001|Overall Study|Withdrawal by Subject|1|||
145517280|NCT01350544|524754237|FG000|Overall Study|Incarceration|1|||
145517281|NCT01350544|524754238|FG001|Overall Study|Incarceration|0|||
145517282|NCT01350544|524754237|FG000|Overall Study|Lost to Follow-up|18|||
145517283|NCT01350544|524754238|FG001|Overall Study|Lost to Follow-up|15|||
145517284|NCT01133990|524754245|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
145517285|NCT01133990|524754246|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145517286|NCT01133990|524754247|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145517287|NCT01133990|524754248|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145517288|NCT01133990|524754249|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145517289|NCT01133990|524754250|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145517290|NCT01133990|524754245|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
145517291|NCT01133990|524754246|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
145517292|NCT01133990|524754247|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
145517293|NCT01133990|524754248|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
145517294|NCT01133990|524754249|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
145517295|NCT01133990|524754250|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
145517296|NCT01133990|524754245|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
145517297|NCT01133990|524754246|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145517298|NCT01133990|524754247|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145517299|NCT01133990|524754248|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145517300|NCT01133990|524754249|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145517301|NCT01133990|524754250|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145517302|NCT01133990|524754245|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
145517303|NCT01133990|524754246|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
145738724|NCT00388505|525560398|FG001|Overall Study|Inappropriate Enrollment|1|||
145738725|NCT00388505|525560397|FG000|Overall Study|Administrative Reason|1|||
145738726|NCT00388505|525560398|FG001|Overall Study|Administrative Reason|0|||
145738727|NCT00388505|525560397|FG000|Overall Study|Protocol Violation|6|||
145738728|NCT00388505|525560398|FG001|Overall Study|Protocol Violation|5|||
145738729|NCT00388505|525560397|FG000|Overall Study|Unable to classify|4|||
145738730|NCT00388505|525560398|FG001|Overall Study|Unable to classify|3|||
145738731|NCT02163187|525560403|FG000|Overall Study|Device removed|1|||
145517304|NCT01133990|524754247|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
145517305|NCT01133990|524754248|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
145517306|NCT01133990|524754249|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
145517307|NCT01133990|524754250|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
145738732|NCT02163187|525560404|FG001|Overall Study|Device removed|0|||
145738733|NCT02163187|525560403|FG000|Overall Study|Progressive disease|1|||
145738734|NCT02163187|525560404|FG001|Overall Study|Progressive disease|0|||
145738735|NCT02369848|525560405|FG000|Overall Study|Death|1|||
145738736|NCT02369848|525560405|FG000|Overall Study|Withdrawal by Subject|2|||
145738737|NCT02369848|525560405|FG000|Overall Study|Lost to Follow-up|1|||
145517308|NCT02282345|524754252|FG000|Overall Study|Progression|0|||
145517309|NCT02282345|524754253|FG001|Overall Study|Progression|1|||
145517310|NCT02683746|524754254|FG000|Overall Study|Adverse Event|3|||
145517311|NCT02683746|524754255|FG001|Overall Study|Adverse Event|2|||
145517312|NCT02683746|524754254|FG000|Overall Study|Lost to Follow-up|5|||
145738738|NCT03281668|525560406|FG000|Overall Study|Physician Decision|1|||
145738739|NCT03281668|525560406|FG000|Overall Study|scheduling conflict, family circumstance|2|||
145738740|NCT03281668|525560406|FG000|Overall Study|Withdrawal by Subject|4|||
145738741|NCT03281668|525560406|FG000|Overall Study|Lost to Follow-up|1|||
145738742|NCT02573870|525560407|FG000|Overall Study|Adverse Event|0|||
145738743|NCT02573870|525560408|FG001|Overall Study|Adverse Event|2|||
145738744|NCT02573870|525560407|FG000|Overall Study|Lack of Efficacy|0|||
145738745|NCT02573870|525560408|FG001|Overall Study|Lack of Efficacy|1|||
145738746|NCT02573870|525560407|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
145738747|NCT02573870|525560408|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
145738748|NCT02573870|525560407|FG000|Overall Study|Lost to Follow-up|0|||
145738749|NCT02573870|525560408|FG001|Overall Study|Lost to Follow-up|1|||
145738750|NCT02573870|525560407|FG000|Overall Study|Other: Fail to Meet Visit|0|||
145738751|NCT02573870|525560408|FG001|Overall Study|Other: Fail to Meet Visit|2|||
145738752|NCT03785925|525560409|FG000|Overall Study|Withdrawal by Subject|15|||
145738753|NCT03785925|525560409|FG000|Overall Study|Lost to Follow-up|1|||
145738754|NCT00957528|525560411|FG000|Overall Study|Protocol Violation|0|||
145738755|NCT00957528|525560412|FG001|Overall Study|Protocol Violation|1|||
145738756|NCT00957528|525560413|FG002|Overall Study|Protocol Violation|0|||
145738757|NCT00957528|525560411|FG000|Overall Study|Withdrawal by Subject|0|||
145738758|NCT00957528|525560412|FG001|Overall Study|Withdrawal by Subject|0|||
145738759|NCT00957528|525560413|FG002|Overall Study|Withdrawal by Subject|1|||
145738760|NCT00762892|525560414|FG000|Overall Study|Lost to Follow-up|2|||
145738761|NCT00762892|525560415|FG001|Overall Study|Lost to Follow-up|5|||
145738762|NCT00762892|525560414|FG000|Overall Study|Withdrawal by Subject|0|||
145738763|NCT00762892|525560415|FG001|Overall Study|Withdrawal by Subject|1|||
145738764|NCT00762892|525560414|FG000|Overall Study|Death|1|||
145738765|NCT00762892|525560415|FG001|Overall Study|Death|0|||
145738766|NCT00762892|525560414|FG000|Overall Study|Pregnancy|1|||
145738767|NCT00762892|525560415|FG001|Overall Study|Pregnancy|0|||
145738768|NCT00762892|525560414|FG000|Overall Study|Incarceration|1|||
145738769|NCT00762892|525560415|FG001|Overall Study|Incarceration|0|||
145738770|NCT01848288|525560417|FG000|Overall Study|Death|1|||
145738771|NCT01848288|525560417|FG000|Overall Study|Protocol Violation|1|||
145738772|NCT01848288|525560417|FG000|Overall Study|Withdrawal by Subject|1|||
145738773|NCT01841749|525560419|FG000|Overall Study|Protocol Violation|1|||
145738774|NCT02285920|525560420|FG000|Overall Study|Kidney transplantation|2|||
145738775|NCT02285920|525560421|FG001|Overall Study|Kidney transplantation|2|||
145738776|NCT02285920|525560422|FG002|Overall Study|Kidney transplantation|2|||
145738777|NCT02285920|525560423|FG003|Overall Study|Kidney transplantation|0|||
145738778|NCT02285920|525560420|FG000|Overall Study|Change to peritoneal dialysis|0|||
145738779|NCT02285920|525560421|FG001|Overall Study|Change to peritoneal dialysis|0|||
145738780|NCT02285920|525560422|FG002|Overall Study|Change to peritoneal dialysis|1|||
145738781|NCT02285920|525560423|FG003|Overall Study|Change to peritoneal dialysis|0|||
145738782|NCT02285920|525560420|FG000|Overall Study|Transfer to non-participating unit|0|||
145738783|NCT02285920|525560421|FG001|Overall Study|Transfer to non-participating unit|1|||
145738784|NCT02285920|525560422|FG002|Overall Study|Transfer to non-participating unit|0|||
145738785|NCT02285920|525560423|FG003|Overall Study|Transfer to non-participating unit|0|||
145738786|NCT02285920|525560420|FG000|Overall Study|Dialysis discontinuation|0|||
145738787|NCT02285920|525560421|FG001|Overall Study|Dialysis discontinuation|1|||
145738788|NCT02285920|525560422|FG002|Overall Study|Dialysis discontinuation|0|||
145738789|NCT02285920|525560423|FG003|Overall Study|Dialysis discontinuation|0|||
145738790|NCT02285920|525560420|FG000|Overall Study|Death|2|||
145738791|NCT02285920|525560421|FG001|Overall Study|Death|0|||
145738792|NCT02285920|525560422|FG002|Overall Study|Death|2|||
145738793|NCT02285920|525560423|FG003|Overall Study|Death|1|||
145738794|NCT00677820|525560424|FG000|Overall Study|Lost to Follow-up|1|||
145738795|NCT00677820|525560425|FG001|Overall Study|Lost to Follow-up|0|||
145738796|NCT01480284|525560431|FG000|Overall Study|Withdrawal by Subject|2|||
145738797|NCT01480284|525560432|FG001|Overall Study|Withdrawal by Subject|0|||
145738798|NCT01480284|525560431|FG000|Overall Study|Adverse Event|1|||
145738799|NCT01480284|525560432|FG001|Overall Study|Adverse Event|0|||
145738800|NCT01480284|525560431|FG000|Overall Study|Study closed/terminated|3|||
145738801|NCT01480284|525560432|FG001|Overall Study|Study closed/terminated|0|||
145738802|NCT01480284|525560431|FG000|Overall Study|Lost to Follow-up|1|||
145738803|NCT01480284|525560432|FG001|Overall Study|Lost to Follow-up|0|||
145738804|NCT01480284|525560431|FG000|Overall Study|Physician Decision|1|||
145738805|NCT01480284|525560432|FG001|Overall Study|Physician Decision|0|||
145738806|NCT03374995|525560437|FG000|Overall Study|Withdrawal by Subject|0|||
145738807|NCT03374995|525560438|FG001|Overall Study|Withdrawal by Subject|1|||
145738808|NCT00003895|525560443|FG000|Overall Study|Adverse Event|4|||
145738809|NCT00003895|525560444|FG001|Overall Study|Adverse Event|0|||
145738810|NCT00003895|525560443|FG000|Overall Study|Lack of Efficacy|1|||
145738811|NCT00003895|525560444|FG001|Overall Study|Lack of Efficacy|1|||
145738812|NCT00003895|525560443|FG000|Overall Study|Patient Vacation|2|||
145738813|NCT00003895|525560444|FG001|Overall Study|Patient Vacation|0|||
145738814|NCT00003895|525560443|FG000|Overall Study|Withdrawal by Subject|0|||
145738815|NCT00003895|525560444|FG001|Overall Study|Withdrawal by Subject|3|||
145738816|NCT01735279|525560447|FG000|Overall Study|Lost to Follow-up|11|||
145738817|NCT01735279|525560448|FG001|Overall Study|Lost to Follow-up|8|||
145738818|NCT01380730|525560449|FG000|Overall Study|Death|0|||
145738819|NCT01380730|525560450|FG001|Overall Study|Death|0|||
145738820|NCT01380730|525560451|FG002|Overall Study|Death|0|||
145738821|NCT01380730|525560452|FG003|Overall Study|Death|0|||
145738822|NCT01380730|525560453|FG004|Overall Study|Death|1|||
145738823|NCT01380730|525560454|FG005|Overall Study|Death|0|||
145738824|NCT01380730|525560455|FG006|Overall Study|Death|0|||
145738825|NCT01380730|525560456|FG007|Overall Study|Death|0|||
145738826|NCT02490475|525560457|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
145738827|NCT02490475|525560458|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
145738828|NCT02490475|525560459|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
145738829|NCT02490475|525560460|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
145738830|NCT02490475|525560457|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
145738831|NCT02490475|525560458|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
145738832|NCT02490475|525560459|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
145738833|NCT02490475|525560460|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
145738834|NCT02490475|525560457|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
145738835|NCT02490475|525560458|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
145738836|NCT02490475|525560459|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
145738837|NCT02490475|525560460|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
145738838|NCT02490475|525560457|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
145738839|NCT02490475|525560458|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
145738840|NCT02490475|525560459|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
145738841|NCT02490475|525560460|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
145738842|NCT02490475|525560457|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
145738843|NCT02490475|525560458|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
145738844|NCT02490475|525560459|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
145738845|NCT02490475|525560460|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
145738846|NCT02490475|525560457|FG000|Period 2: Extension Phase|Refused Treatment|0|||
145738847|NCT02490475|525560458|FG001|Period 2: Extension Phase|Refused Treatment|0|||
145738848|NCT02490475|525560459|FG002|Period 2: Extension Phase|Refused Treatment|0|||
145738849|NCT02490475|525560460|FG003|Period 2: Extension Phase|Refused Treatment|1|||
145738850|NCT02490475|525560457|FG000|Period 2: Extension Phase|Adverse Event|0|||
145738851|NCT02490475|525560458|FG001|Period 2: Extension Phase|Adverse Event|0|||
145738852|NCT02490475|525560459|FG002|Period 2: Extension Phase|Adverse Event|1|||
145738853|NCT02490475|525560460|FG003|Period 2: Extension Phase|Adverse Event|0|||
145738854|NCT01195090|525560465|FG000|Overall Study|Adverse Event|1|||
145738855|NCT01195090|525560466|FG001|Overall Study|Adverse Event|2|||
145738856|NCT01195090|525560465|FG000|Overall Study|Lost to Follow-up|2|||
145738857|NCT01195090|525560466|FG001|Overall Study|Lost to Follow-up|2|||
145738858|NCT01195090|525560465|FG000|Overall Study|Protocol Violation|3|||
145738859|NCT01195090|525560466|FG001|Overall Study|Protocol Violation|4|||
145738860|NCT04912245|525560467|FG000|Overall Study|Withdrawal by Subject|21|||
145738861|NCT04912245|525560468|FG001|Overall Study|Withdrawal by Subject|4|||
145738862|NCT04912245|525560467|FG000|Overall Study|Lost to Follow-up|5|||
145738863|NCT04912245|525560468|FG001|Overall Study|Lost to Follow-up|11|||
145738864|NCT01205230|525560469|FG000|Overall Study|Adverse Event|4|||
145738865|NCT01205230|525560470|FG001|Overall Study|Adverse Event|0|||
145738866|NCT01205230|525560469|FG000|Overall Study|Physician Decision|1|||
145402286|NCT03261401|524330697|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
145738867|NCT01205230|525560470|FG001|Overall Study|Physician Decision|0|||
145738868|NCT00922480|525560471|FG000|Main Study|Protocol Violation|3|||
145402287|NCT03261401|524330698|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
145738869|NCT00922480|525560472|FG001|Main Study|Protocol Violation|6|||
145738870|NCT00922480|525560471|FG000|Main Study|Adverse Event|6|||
145738871|NCT00922480|525560472|FG001|Main Study|Adverse Event|7|||
145738872|NCT00922480|525560471|FG000|Main Study|Lack of Efficacy|3|||
145738873|NCT00922480|525560472|FG001|Main Study|Lack of Efficacy|0|||
145738874|NCT00922480|525560471|FG000|Main Study|Withdrawal by Subject|20|||
145738875|NCT00922480|525560472|FG001|Main Study|Withdrawal by Subject|15|||
145738876|NCT00922480|525560471|FG000|Main Study|Lost to Follow-up|5|||
145738877|NCT00922480|525560472|FG001|Main Study|Lost to Follow-up|0|||
145738878|NCT00922480|525560471|FG000|Main Study|Physician Decision|0|||
145738879|NCT00922480|525560472|FG001|Main Study|Physician Decision|1|||
145738880|NCT00922480|525560471|FG000|Extension Study|Protocol Violation|3|||
145738881|NCT00922480|525560472|FG001|Extension Study|Protocol Violation|0|||
145738882|NCT00922480|525560471|FG000|Extension Study|Adverse Event|1|||
145738883|NCT00922480|525560472|FG001|Extension Study|Adverse Event|1|||
145738884|NCT00922480|525560471|FG000|Extension Study|Withdrawal by Subject|1|||
145738885|NCT00922480|525560472|FG001|Extension Study|Withdrawal by Subject|1|||
145738886|NCT00922480|525560471|FG000|Extension Study|Others|0|||
145738887|NCT00922480|525560472|FG001|Extension Study|Others|1|||
145738888|NCT04784897|525560473|FG000|Overall Study|Death|4|||
145738889|NCT04784897|525560474|FG001|Overall Study|Death|2|||
145738890|NCT04784897|525560475|FG002|Overall Study|Death|1|||
145738891|NCT04784897|525560473|FG000|Overall Study|Withdrawal by Subject|0|||
145738892|NCT04784897|525560474|FG001|Overall Study|Withdrawal by Subject|0|||
145738893|NCT04784897|525560475|FG002|Overall Study|Withdrawal by Subject|1|||
145738894|NCT02665052|525560476|FG000|Overall Study|Lost to Follow-up|1|||
145738895|NCT02665052|525560477|FG001|Overall Study|Lost to Follow-up|0|||
145738896|NCT02665052|525560478|FG002|Overall Study|Lost to Follow-up|0|||
145738897|NCT02665052|525560479|FG003|Overall Study|Lost to Follow-up|0|||
145738898|NCT02665052|525560476|FG000|Overall Study|Withdrawal by Subject|1|||
145738899|NCT02665052|525560477|FG001|Overall Study|Withdrawal by Subject|1|||
145738900|NCT02665052|525560478|FG002|Overall Study|Withdrawal by Subject|0|||
145738901|NCT02665052|525560479|FG003|Overall Study|Withdrawal by Subject|5|||
145738902|NCT02665052|525560476|FG000|Overall Study|Adverse Event|1|||
145738903|NCT02665052|525560477|FG001|Overall Study|Adverse Event|1|||
145738904|NCT02665052|525560478|FG002|Overall Study|Adverse Event|0|||
145738905|NCT02665052|525560479|FG003|Overall Study|Adverse Event|0|||
145738906|NCT02234284|525560480|FG000|Overall Study|Death|4|||
145738907|NCT02234284|525560481|FG001|Overall Study|Death|2|||
145738908|NCT02234284|525560480|FG000|Overall Study|Withdrawal by Subject|1|||
145738909|NCT02234284|525560481|FG001|Overall Study|Withdrawal by Subject|0|||
145738910|NCT02234284|525560480|FG000|Overall Study|Lost to Follow-up|20|||
145738911|NCT02234284|525560481|FG001|Overall Study|Lost to Follow-up|7|||
145738912|NCT04754802|525560483|FG000|Overall Study|Lost to Follow-up|0|||
145738913|NCT04754802|525560484|FG001|Overall Study|Lost to Follow-up|2|||
145738914|NCT04754802|525560483|FG000|Overall Study|Withdrawal by Subject|2|||
145738915|NCT04754802|525560484|FG001|Overall Study|Withdrawal by Subject|0|||
145738916|NCT04569032|525560485|FG000|Overall Study|Death|10|||
145738917|NCT04569032|525560486|FG001|Overall Study|Death|13|||
145738918|NCT04569032|525560485|FG000|Overall Study|Withdrawal by Subject|2|||
145738919|NCT04569032|525560486|FG001|Overall Study|Withdrawal by Subject|0|||
145738920|NCT04569032|525560485|FG000|Overall Study|Lost to Follow-up|0|||
145738921|NCT04569032|525560486|FG001|Overall Study|Lost to Follow-up|1|||
145738922|NCT04569032|525560485|FG000|Overall Study|In long term follow up|22|||
145738923|NCT04569032|525560486|FG001|Overall Study|In long term follow up|34|||
145738924|NCT00873366|525560487|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
145738925|NCT00873366|525560487|FG000|Overall Study|Off tamoxifen due to side effects|2|||
145738926|NCT00873366|525560487|FG000|Overall Study|Refused to continue DM-BT testing|3|||
145738927|NCT01970488|525560488|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
145738928|NCT01970488|525560489|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
145738929|NCT01970488|525560490|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
145738930|NCT01970488|525560491|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
145738931|NCT01970488|525560492|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
145738932|NCT01970488|525560488|FG000|Part 1: Through Week 16|Protocol Violation|1|||
145738933|NCT01970488|525560489|FG001|Part 1: Through Week 16|Protocol Violation|2|||
145738934|NCT01970488|525560490|FG002|Part 1: Through Week 16|Protocol Violation|0|||
145738935|NCT01970488|525560491|FG003|Part 1: Through Week 16|Protocol Violation|0|||
145738936|NCT01970488|525560492|FG004|Part 1: Through Week 16|Protocol Violation|0|||
145738937|NCT01970488|525560488|FG000|Part 1: Through Week 16|Adverse Event|6|||
145738938|NCT01970488|525560489|FG001|Part 1: Through Week 16|Adverse Event|5|||
145738939|NCT01970488|525560490|FG002|Part 1: Through Week 16|Adverse Event|0|||
145738940|NCT01970488|525560491|FG003|Part 1: Through Week 16|Adverse Event|0|||
145738941|NCT01970488|525560492|FG004|Part 1: Through Week 16|Adverse Event|0|||
145738942|NCT01970488|525560488|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
145738943|NCT01970488|525560489|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
145738944|NCT01970488|525560490|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
145738945|NCT01970488|525560491|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
145738946|NCT01970488|525560492|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
145738947|NCT01970488|525560488|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
145738948|NCT01970488|525560489|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
145738949|NCT01970488|525560490|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
145738950|NCT01970488|525560491|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
145738951|NCT01970488|525560492|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
145738952|NCT01970488|525560488|FG000|Part 2: Post Week 16|Physician Decision|0|||
145738953|NCT01970488|525560489|FG001|Part 2: Post Week 16|Physician Decision|0|||
145738954|NCT01970488|525560490|FG002|Part 2: Post Week 16|Physician Decision|0|||
145738955|NCT01970488|525560491|FG003|Part 2: Post Week 16|Physician Decision|0|||
145738956|NCT01970488|525560492|FG004|Part 2: Post Week 16|Physician Decision|1|||
145738957|NCT01970488|525560488|FG000|Part 2: Post Week 16|Non-compliance|0|||
145738958|NCT01970488|525560489|FG001|Part 2: Post Week 16|Non-compliance|0|||
145738959|NCT01970488|525560490|FG002|Part 2: Post Week 16|Non-compliance|1|||
145738960|NCT01970488|525560491|FG003|Part 2: Post Week 16|Non-compliance|0|||
145738961|NCT01970488|525560492|FG004|Part 2: Post Week 16|Non-compliance|0|||
145738962|NCT01970488|525560488|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
145738963|NCT01970488|525560489|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
145738964|NCT01970488|525560490|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
145738965|NCT01970488|525560491|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
145738966|NCT01970488|525560492|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
145738967|NCT01970488|525560488|FG000|Part 2: Post Week 16|Adverse Event|0|||
145738968|NCT01970488|525560489|FG001|Part 2: Post Week 16|Adverse Event|0|||
145738969|NCT01970488|525560490|FG002|Part 2: Post Week 16|Adverse Event|5|||
145738970|NCT01970488|525560491|FG003|Part 2: Post Week 16|Adverse Event|1|||
145738971|NCT01970488|525560492|FG004|Part 2: Post Week 16|Adverse Event|1|||
145738972|NCT01970488|525560488|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
145738973|NCT01970488|525560489|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
145738974|NCT01970488|525560490|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
145738975|NCT01970488|525560491|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
145738976|NCT01970488|525560492|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
145738977|NCT01970488|525560488|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
145738978|NCT01970488|525560489|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
145738979|NCT01970488|525560490|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
145738980|NCT01970488|525560491|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
145738981|NCT01970488|525560492|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
145738982|NCT01490814|525560498|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
145738983|NCT01490814|525560499|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
145738984|NCT01490814|525560498|FG000|Overall Study|Physician Decision|1|||
145738985|NCT01490814|525560499|FG001|Overall Study|Physician Decision|0|||
145738986|NCT01490814|525560498|FG000|Overall Study|Withdrawal by Subject|0|||
145738987|NCT01490814|525560499|FG001|Overall Study|Withdrawal by Subject|5|||
145738988|NCT01537198|525560500|FG000|Overall Study|RSV infection|2|||
145738989|NCT01537198|525560500|FG000|Overall Study|Adverse Event|4|||
145738990|NCT01537198|525560500|FG000|Overall Study|No Further Visits to the Clinic|37|||
145738991|NCT01537198|525560500|FG000|Overall Study|Other|111|||
145738992|NCT00496730|525560501|FG000|Overall Study|Lost to Follow-up|4|||
145738993|NCT00496730|525560502|FG001|Overall Study|Lost to Follow-up|3|||
145738994|NCT00496730|525560501|FG000|Overall Study|Withdrawal by Subject|2|||
145738995|NCT00496730|525560502|FG001|Overall Study|Withdrawal by Subject|2|||
145738996|NCT01721876|525560510|FG000|Overall Study|Not treated|1|||
145738997|NCT01721876|525560511|FG001|Overall Study|Not treated|4|||
145738998|NCT01721876|525560510|FG000|Overall Study|Disease progression / relapse|123|||
145738999|NCT01721876|525560511|FG001|Overall Study|Disease progression / relapse|156|||
145739000|NCT01721876|525560510|FG000|Overall Study|Death|6|||
145739001|NCT01721876|525560511|FG001|Overall Study|Death|13|||
145739002|NCT01721876|525560510|FG000|Overall Study|Adverse Event|41|||
145739003|NCT01721876|525560511|FG001|Overall Study|Adverse Event|165|||
145402288|NCT03261401|524330699|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
145739004|NCT01721876|525560510|FG000|Overall Study|Protocol Violation|2|||
145739005|NCT01721876|525560511|FG001|Overall Study|Protocol Violation|1|||
145739006|NCT01721876|525560510|FG000|Overall Study|Withdrawal by Subject|15|||
145739007|NCT01721876|525560511|FG001|Overall Study|Withdrawal by Subject|38|||
145739008|NCT01721876|525560510|FG000|Overall Study|Reason not listed|34|||
145739009|NCT01721876|525560511|FG001|Overall Study|Reason not listed|63|||
145739010|NCT01721876|525560510|FG000|Overall Study|Sponsor terminated trial|0|||
145739011|NCT01721876|525560511|FG001|Overall Study|Sponsor terminated trial|4|||
145739012|NCT01979835|525560516|FG000|Primary Outcome SA Measurment|failed insertion|18|||
145739013|NCT01979835|525560516|FG000|Follow-up|Lost to Follow-up|32|||
145739014|NCT04096274|525562323|FG000|Phase I|Lost to Follow-up|5|||
145739015|NCT04096274|525562324|FG001|Phase I|Lost to Follow-up|5|||
145739016|NCT04096274|525562323|FG000|Phase II|Lost to Follow-up|11|||
145739017|NCT04096274|525562324|FG001|Phase II|Lost to Follow-up|11|||
145739018|NCT05092919|525562325|FG000|Overall Study|Lost to Follow-up|7|||
145739019|NCT05092919|525562325|FG000|Overall Study|Withdrawal by Subject|2|||
145517313|NCT02683746|524754255|FG001|Overall Study|Lost to Follow-up|6|||
145517314|NCT02683746|524754254|FG000|Overall Study|Withdrawal by Subject|6|||
145517315|NCT02683746|524754255|FG001|Overall Study|Withdrawal by Subject|5|||
145517316|NCT02683746|524754254|FG000|Overall Study|Physician Decision|2|||
145739020|NCT01942148|525562327|FG000|Overall Study|Adverse Event|4|||
145739021|NCT01942148|525562327|FG000|Overall Study|Lack of Efficacy|2|||
145739022|NCT01942148|525562327|FG000|Overall Study|Physician Decision|11|||
145739023|NCT01942148|525562327|FG000|Overall Study|Protocol Violation|1|||
145739024|NCT01942148|525562327|FG000|Overall Study|Withdrawal by Subject|8|||
145739025|NCT01942148|525562327|FG000|Overall Study|Use of the prohibition medicine|1|||
145739026|NCT02248259|525562328|FG000|Treatment Period 1|Adverse Event|0|||
145739027|NCT02248259|525562329|FG001|Treatment Period 1|Adverse Event|0|||
145739028|NCT02248259|525562330|FG002|Treatment Period 1|Adverse Event|1|||
145739029|NCT02248259|525562331|FG003|Treatment Period 1|Adverse Event|0|||
145739030|NCT00096785|525562336|FG000|Overall Study|Lost to Follow-up|1|||
145739031|NCT00096785|525562337|FG001|Overall Study|Lost to Follow-up|0|||
145739032|NCT00096785|525562336|FG000|Overall Study|Withdrawal by Subject|0|||
145739033|NCT00096785|525562337|FG001|Overall Study|Withdrawal by Subject|1|||
145739034|NCT00096785|525562336|FG000|Overall Study|Relocated|1|||
145739035|NCT00096785|525562337|FG001|Overall Study|Relocated|0|||
145739036|NCT00257725|525562338|FG000|Overall Study|Adverse Event|3|||
145739037|NCT01858532|525562339|FG000|Overall Study|Adverse Event|58|||
145517317|NCT02683746|524754255|FG001|Overall Study|Physician Decision|1|||
145517318|NCT04905498|524754266|FG000|Overall Study|Lost to Follow-up|0|||
145517319|NCT04905498|524754267|FG001|Overall Study|Lost to Follow-up|2|||
145517320|NCT04905498|524754266|FG000|Overall Study|COVID lockdown|1|||
145517321|NCT04905498|524754267|FG001|Overall Study|COVID lockdown|0|||
145517322|NCT00869778|524754268|FG000|Overall Study|Adverse Event|2|||
145517323|NCT00869778|524754269|FG001|Overall Study|Adverse Event|0|||
145517324|NCT00869778|524754270|FG002|Overall Study|Adverse Event|0|||
145517325|NCT00869778|524754268|FG000|Overall Study|Withdrawal by Subject|3|||
145517326|NCT00869778|524754269|FG001|Overall Study|Withdrawal by Subject|4|||
145517327|NCT00869778|524754270|FG002|Overall Study|Withdrawal by Subject|5|||
145517328|NCT00869778|524754268|FG000|Overall Study|Pregnancy|1|||
145517329|NCT00869778|524754269|FG001|Overall Study|Pregnancy|0|||
145517330|NCT00869778|524754270|FG002|Overall Study|Pregnancy|0|||
145517331|NCT00869778|524754268|FG000|Overall Study|Protocol Violation|5|||
145517332|NCT00869778|524754269|FG001|Overall Study|Protocol Violation|3|||
145517333|NCT00869778|524754270|FG002|Overall Study|Protocol Violation|5|||
145517334|NCT00869778|524754268|FG000|Overall Study|Unblinding|1|||
145517335|NCT00869778|524754269|FG001|Overall Study|Unblinding|0|||
145517336|NCT00869778|524754270|FG002|Overall Study|Unblinding|0|||
145517337|NCT03339297|524754271|FG000|Overall Study|Relapse of Hematologic Disease|1|||
145517338|NCT03339297|524754272|FG001|Overall Study|Relapse of Hematologic Disease|0|||
145517339|NCT03339297|524754271|FG000|Overall Study|Death|10|||
145517340|NCT03339297|524754272|FG001|Overall Study|Death|7|||
145739038|NCT01858532|525562340|FG001|Overall Study|Adverse Event|50|||
145739039|NCT01858532|525562341|FG002|Overall Study|Adverse Event|23|||
145739040|NCT01858532|525562342|FG003|Overall Study|Adverse Event|28|||
145739041|NCT01858532|525562339|FG000|Overall Study|Withdrew consent|71|||
145517341|NCT03339297|524754271|FG000|Overall Study|Hepatic Candidosis|1|||
145517342|NCT03339297|524754272|FG001|Overall Study|Hepatic Candidosis|0|||
145517343|NCT03339297|524754271|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
145517344|NCT03339297|524754272|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
145517345|NCT03339297|524754271|FG000|Overall Study|Consent Withdrawn by Participant|3|||
145517346|NCT03339297|524754272|FG001|Overall Study|Consent Withdrawn by Participant|3|||
145517347|NCT03339297|524754271|FG000|Overall Study|Disease Relapse|2|||
145517348|NCT03339297|524754272|FG001|Overall Study|Disease Relapse|0|||
145739042|NCT01858532|525562340|FG001|Overall Study|Withdrew consent|93|||
145739043|NCT01858532|525562341|FG002|Overall Study|Withdrew consent|46|||
145739044|NCT01858532|525562342|FG003|Overall Study|Withdrew consent|27|||
145739045|NCT01858532|525562339|FG000|Overall Study|Lost to Follow-up|17|||
145739046|NCT01858532|525562340|FG001|Overall Study|Lost to Follow-up|26|||
145739047|NCT01858532|525562341|FG002|Overall Study|Lost to Follow-up|11|||
145739048|NCT01858532|525562342|FG003|Overall Study|Lost to Follow-up|14|||
145739049|NCT01858532|525562339|FG000|Overall Study|Deterioration of medical status|3|||
145739050|NCT01858532|525562340|FG001|Overall Study|Deterioration of medical status|4|||
145739051|NCT01858532|525562341|FG002|Overall Study|Deterioration of medical status|3|||
145739052|NCT01858532|525562342|FG003|Overall Study|Deterioration of medical status|7|||
145739053|NCT01858532|525562339|FG000|Overall Study|Investigator request|3|||
145739054|NCT01858532|525562340|FG001|Overall Study|Investigator request|4|||
145739055|NCT01858532|525562341|FG002|Overall Study|Investigator request|2|||
145739056|NCT01858532|525562342|FG003|Overall Study|Investigator request|6|||
145739057|NCT01858532|525562339|FG000|Overall Study|Other, not specified|29|||
145739058|NCT01858532|525562340|FG001|Overall Study|Other, not specified|15|||
145739059|NCT01858532|525562341|FG002|Overall Study|Other, not specified|13|||
145739060|NCT01858532|525562342|FG003|Overall Study|Other, not specified|11|||
145739061|NCT00514514|525562343|FG000|Pre-phase|Death|10|||
145739062|NCT00514514|525562344|FG001|Pre-phase|Death|0|||
145739063|NCT00514514|525562345|FG002|Pre-phase|Death|0|||
145739064|NCT00514514|525562343|FG000|Pre-phase|administrative problems|2|||
145739065|NCT00514514|525562344|FG001|Pre-phase|administrative problems|0|||
145739066|NCT00514514|525562345|FG002|Pre-phase|administrative problems|0|||
145739067|NCT00514514|525562343|FG000|Pre-phase|Protocol Violation|6|||
145739068|NCT00514514|525562344|FG001|Pre-phase|Protocol Violation|0|||
145739069|NCT00514514|525562345|FG002|Pre-phase|Protocol Violation|0|||
145739070|NCT00514514|525562343|FG000|Pre-phase|condition no longer requires study drug|7|||
145739071|NCT00514514|525562344|FG001|Pre-phase|condition no longer requires study drug|0|||
145739072|NCT00514514|525562345|FG002|Pre-phase|condition no longer requires study drug|0|||
145739073|NCT00514514|525562343|FG000|Pre-phase|abnormal test procedure results|15|||
145739074|NCT00514514|525562344|FG001|Pre-phase|abnormal test procedure results|0|||
145739075|NCT00514514|525562345|FG002|Pre-phase|abnormal test procedure results|0|||
145739076|NCT00514514|525562343|FG000|Pre-phase|Lost to Follow-up|2|||
145739077|NCT00514514|525562344|FG001|Pre-phase|Lost to Follow-up|0|||
145739078|NCT00514514|525562345|FG002|Pre-phase|Lost to Follow-up|0|||
145739079|NCT00514514|525562343|FG000|Pre-phase|abnormal lab values|23|||
145739080|NCT00514514|525562344|FG001|Pre-phase|abnormal lab values|0|||
145739081|NCT00514514|525562345|FG002|Pre-phase|abnormal lab values|0|||
145739082|NCT00514514|525562343|FG000|Pre-phase|Lack of Efficacy|35|||
145739083|NCT00514514|525562344|FG001|Pre-phase|Lack of Efficacy|0|||
145739084|NCT00514514|525562345|FG002|Pre-phase|Lack of Efficacy|0|||
145739085|NCT00514514|525562343|FG000|Pre-phase|Adverse Event|137|||
145739086|NCT00514514|525562344|FG001|Pre-phase|Adverse Event|0|||
145739087|NCT00514514|525562345|FG002|Pre-phase|Adverse Event|0|||
145739088|NCT00514514|525562343|FG000|Pre-phase|Withdrawal by Subject|66|||
145739089|NCT00514514|525562344|FG001|Pre-phase|Withdrawal by Subject|0|||
145739090|NCT00514514|525562345|FG002|Pre-phase|Withdrawal by Subject|0|||
145739091|NCT00514514|525562343|FG000|Randomized - 9 Month|Death|3|||
145739092|NCT00514514|525562344|FG001|Randomized - 9 Month|Death|2|||
145739093|NCT00514514|525562345|FG002|Randomized - 9 Month|Death|2|||
145739094|NCT00514514|525562343|FG000|Randomized - 9 Month|Administrative problems|1|||
145739095|NCT00514514|525562344|FG001|Randomized - 9 Month|Administrative problems|1|||
145739096|NCT00514514|525562345|FG002|Randomized - 9 Month|Administrative problems|2|||
145739097|NCT00514514|525562343|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
145739098|NCT00514514|525562344|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
145739099|NCT00514514|525562345|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
145739100|NCT00514514|525562343|FG000|Randomized - 9 Month|Protocol Violation|1|||
145739101|NCT00514514|525562344|FG001|Randomized - 9 Month|Protocol Violation|1|||
145739102|NCT00514514|525562345|FG002|Randomized - 9 Month|Protocol Violation|0|||
145739103|NCT00514514|525562343|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
145739104|NCT00514514|525562344|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
145739105|NCT00514514|525562345|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
145739106|NCT00514514|525562343|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
145739107|NCT00514514|525562344|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
145739108|NCT00514514|525562345|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
145739109|NCT00514514|525562343|FG000|Randomized - 9 Month|Adverse Event|25|||
145739110|NCT00514514|525562344|FG001|Randomized - 9 Month|Adverse Event|44|||
145739111|NCT00514514|525562345|FG002|Randomized - 9 Month|Adverse Event|27|||
145402289|NCT03261401|524330700|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
145739112|NCT00514514|525562343|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
145739113|NCT00514514|525562344|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
145739114|NCT00514514|525562345|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
145739115|NCT00514514|525562343|FG000|Extension - 4 Years|Lost to Follow-up|12|||
145739116|NCT00514514|525562344|FG001|Extension - 4 Years|Lost to Follow-up|10|||
145739117|NCT00514514|525562345|FG002|Extension - 4 Years|Lost to Follow-up|9|||
145739118|NCT00514514|525562343|FG000|Extension - 4 Years|Administrative problems|3|||
145739119|NCT00514514|525562344|FG001|Extension - 4 Years|Administrative problems|1|||
145739120|NCT00514514|525562345|FG002|Extension - 4 Years|Administrative problems|1|||
145739121|NCT00514514|525562343|FG000|Extension - 4 Years|Death|8|||
145739122|NCT00514514|525562344|FG001|Extension - 4 Years|Death|3|||
145739123|NCT00514514|525562345|FG002|Extension - 4 Years|Death|6|||
145739124|NCT00514514|525562343|FG000|Extension - 4 Years|Adverse Event|9|||
145739125|NCT00514514|525562344|FG001|Extension - 4 Years|Adverse Event|6|||
145739126|NCT00514514|525562345|FG002|Extension - 4 Years|Adverse Event|3|||
145739127|NCT01101438|525562348|FG000|Overall Study|Withdrawal by Subject|8|||
145739128|NCT01101438|525562349|FG001|Overall Study|Withdrawal by Subject|9|||
145739129|NCT00066742|525562350|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
145739130|NCT00066742|525562350|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
145739131|NCT00066742|525562350|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
145739132|NCT00066742|525562350|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
145739133|NCT00066742|525562350|FG000|Induction Chemoradiotherapy|Ineligible|3|||
145739134|NCT00066742|525562350|FG000|Consolidation Chemotherapy|not protocol specified|1|||
145739135|NCT00066742|525562350|FG000|Consolidation Chemotherapy|Ineligible|2|||
145739136|NCT01231659|525562351|FG000|Overall Study|Adverse Event|9|||
145739137|NCT01231659|525562351|FG000|Overall Study|Disease Progression|48|||
145739138|NCT01231659|525562351|FG000|Overall Study|Death|2|||
145739139|NCT01231659|525562351|FG000|Overall Study|Patient refused to complete study visit|1|||
145739140|NCT01231659|525562351|FG000|Overall Study|Other protocol defined criteria|12|||
145739141|NCT03680911|525562352|FG000|At Home Treatment|Study Termination|3|||
145739142|NCT03680911|525562353|FG001|At Home Treatment|Study Termination|0|||
145739143|NCT03680911|525562352|FG000|At Home Treatment|Lost to Follow-up|0|||
145739144|NCT03680911|525562353|FG001|At Home Treatment|Lost to Follow-up|1|||
145739145|NCT03680911|525562352|FG000|At Home Treatment|Withdrawal by Subject|0|||
145739146|NCT03680911|525562353|FG001|At Home Treatment|Withdrawal by Subject|2|||
145739147|NCT03680911|525562352|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
145739148|NCT03680911|525562353|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
145739149|NCT03962738|525562354|FG000|Overall Study|Protocol Deviation|3|||
145739150|NCT03962738|525562355|FG001|Overall Study|Protocol Deviation|0|||
145739151|NCT03962738|525562356|FG002|Overall Study|Protocol Deviation|1|||
145739152|NCT03962738|525562357|FG003|Overall Study|Protocol Deviation|1|||
145739153|NCT03962738|525562354|FG000|Overall Study|Withdrawal by Subject|4|||
145739154|NCT03962738|525562355|FG001|Overall Study|Withdrawal by Subject|0|||
145739155|NCT03962738|525562356|FG002|Overall Study|Withdrawal by Subject|0|||
145739156|NCT03962738|525562357|FG003|Overall Study|Withdrawal by Subject|0|||
145739157|NCT03962738|525562354|FG000|Overall Study|Lost to Follow-up|0|||
145739158|NCT03962738|525562355|FG001|Overall Study|Lost to Follow-up|0|||
145739159|NCT03962738|525562356|FG002|Overall Study|Lost to Follow-up|1|||
145739160|NCT03962738|525562357|FG003|Overall Study|Lost to Follow-up|0|||
145739161|NCT00574288|525562358|FG000|Overall Study|Adverse Event|2|||
145739162|NCT00574288|525562359|FG001|Overall Study|Adverse Event|0|||
145739163|NCT00574288|525562360|FG002|Overall Study|Adverse Event|0|||
145739164|NCT00574288|525562361|FG003|Overall Study|Adverse Event|0|||
145739165|NCT00574288|525562362|FG004|Overall Study|Adverse Event|1|||
145739166|NCT00574288|525562363|FG005|Overall Study|Adverse Event|0|||
145739167|NCT00574288|525562364|FG006|Overall Study|Adverse Event|0|||
145739168|NCT00574288|525562358|FG000|Overall Study|Death|0|||
145739169|NCT00574288|525562359|FG001|Overall Study|Death|0|||
145739170|NCT00574288|525562360|FG002|Overall Study|Death|0|||
145739171|NCT00574288|525562361|FG003|Overall Study|Death|0|||
145739172|NCT00574288|525562362|FG004|Overall Study|Death|0|||
145739173|NCT00574288|525562363|FG005|Overall Study|Death|25|||
145739174|NCT00574288|525562364|FG006|Overall Study|Death|21|||
145739175|NCT00574288|525562358|FG000|Overall Study|Lost to Follow-up|0|||
145739176|NCT00574288|525562359|FG001|Overall Study|Lost to Follow-up|0|||
145739177|NCT00574288|525562360|FG002|Overall Study|Lost to Follow-up|0|||
145739178|NCT00574288|525562361|FG003|Overall Study|Lost to Follow-up|0|||
145739179|NCT00574288|525562362|FG004|Overall Study|Lost to Follow-up|0|||
145739180|NCT00574288|525562363|FG005|Overall Study|Lost to Follow-up|1|||
145739181|NCT00574288|525562364|FG006|Overall Study|Lost to Follow-up|2|||
145739182|NCT00574288|525562358|FG000|Overall Study|Study Terminated By Sponsor|0|||
145739183|NCT00574288|525562359|FG001|Overall Study|Study Terminated By Sponsor|0|||
145739184|NCT00574288|525562360|FG002|Overall Study|Study Terminated By Sponsor|0|||
145739185|NCT00574288|525562361|FG003|Overall Study|Study Terminated By Sponsor|0|||
145739186|NCT00574288|525562362|FG004|Overall Study|Study Terminated By Sponsor|0|||
145739187|NCT00574288|525562363|FG005|Overall Study|Study Terminated By Sponsor|0|||
145739188|NCT00574288|525562364|FG006|Overall Study|Study Terminated By Sponsor|5|||
145739189|NCT00574288|525562358|FG000|Overall Study|Progressive Disease|17|||
145739190|NCT00574288|525562359|FG001|Overall Study|Progressive Disease|2|||
145739191|NCT00574288|525562360|FG002|Overall Study|Progressive Disease|3|||
145739192|NCT00574288|525562361|FG003|Overall Study|Progressive Disease|2|||
145739193|NCT00574288|525562362|FG004|Overall Study|Progressive Disease|1|||
145739194|NCT00574288|525562363|FG005|Overall Study|Progressive Disease|0|||
145739195|NCT00574288|525562364|FG006|Overall Study|Progressive Disease|0|||
145739196|NCT00574288|525562358|FG000|Overall Study|Other|1|||
145739197|NCT00574288|525562359|FG001|Overall Study|Other|1|||
145739198|NCT00574288|525562360|FG002|Overall Study|Other|0|||
145739199|NCT00574288|525562361|FG003|Overall Study|Other|0|||
145739200|NCT00574288|525562362|FG004|Overall Study|Other|0|||
145739201|NCT00574288|525562363|FG005|Overall Study|Other|0|||
145739202|NCT00574288|525562364|FG006|Overall Study|Other|0|||
145739203|NCT02247960|525562378|FG000|Patient Consent and Randomization|Physician Decision|2|||
145739204|NCT02247960|525562379|FG001|Patient Consent and Randomization|Physician Decision|2|||
145739205|NCT02247960|525562378|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
145739206|NCT02247960|525562379|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
145739207|NCT02247960|525562378|FG000|Catheter Removed|Lost to Follow-up|7|||
145739208|NCT02247960|525562379|FG001|Catheter Removed|Lost to Follow-up|10|||
145739209|NCT00702325|525562380|FG000|Overall Study|Adverse Event|1|||
145739210|NCT00702325|525562381|FG001|Overall Study|Adverse Event|0|||
145739211|NCT00702325|525562380|FG000|Overall Study|Withdrawal by Subject|7|||
145739212|NCT00702325|525562381|FG001|Overall Study|Withdrawal by Subject|7|||
145739213|NCT00702325|525562380|FG000|Overall Study|Lost to Follow-up|3|||
145739214|NCT00702325|525562381|FG001|Overall Study|Lost to Follow-up|4|||
145739215|NCT00702325|525562380|FG000|Overall Study|Incorrect enrollment|5|||
145739216|NCT00702325|525562381|FG001|Overall Study|Incorrect enrollment|7|||
145739217|NCT00702325|525562380|FG000|Overall Study|Developed study discontinuation criteria|18|||
145739218|NCT00702325|525562381|FG001|Overall Study|Developed study discontinuation criteria|28|||
145739219|NCT00702325|525562380|FG000|Overall Study|Severe noncompliance to protocol|3|||
145739220|NCT00702325|525562381|FG001|Overall Study|Severe noncompliance to protocol|3|||
145739221|NCT00702325|525562380|FG000|Overall Study|Termination due to lab results|1|||
145739222|NCT00702325|525562381|FG001|Overall Study|Termination due to lab results|0|||
145739223|NCT00702325|525562380|FG000|Overall Study|Didn't follow study medication dosage|0|||
145739224|NCT00702325|525562381|FG001|Overall Study|Didn't follow study medication dosage|2|||
145739225|NCT00702325|525562380|FG000|Overall Study|Withdrew consent|0|||
145739226|NCT00702325|525562381|FG001|Overall Study|Withdrew consent|1|||
145739227|NCT00702325|525562380|FG000|Overall Study|Incorrectly Discontinued|0|||
145739228|NCT00702325|525562381|FG001|Overall Study|Incorrectly Discontinued|1|||
145739229|NCT04556136|525562385|FG000|Overall Study|Lost to Follow-up|6|||
145739230|NCT04556136|525562386|FG001|Overall Study|Lost to Follow-up|6|||
145739231|NCT04556136|525562385|FG000|Overall Study|Physician Decision|2|||
145739232|NCT04556136|525562386|FG001|Overall Study|Physician Decision|1|||
145739233|NCT04556136|525562385|FG000|Overall Study|Withdrawal by Subject|2|||
145739234|NCT04556136|525562386|FG001|Overall Study|Withdrawal by Subject|1|||
145739235|NCT01022502|525562389|FG000|Overall Study|Adverse Event|1|||
145739236|NCT01022502|525562389|FG000|Overall Study|employment related reasons|1|||
145739237|NCT01022502|525562389|FG000|Overall Study|Withdrawal by Subject|1|||
145739238|NCT02361944|525562390|FG000|Overall Study|surgery cancellation|0|||
145739239|NCT02361944|525562391|FG001|Overall Study|surgery cancellation|1|||
145739240|NCT02566577|525562392|FG000|Overall Study|Withdrawal by Subject|1|||
145739241|NCT02566577|525562393|FG001|Overall Study|Withdrawal by Subject|1|||
145739242|NCT02566577|525562392|FG000|Overall Study|Equipment failure|1|||
145739243|NCT02566577|525562393|FG001|Overall Study|Equipment failure|1|||
145739244|NCT02566577|525562392|FG000|Overall Study|Physical limitation|1|||
145739245|NCT02566577|525562393|FG001|Overall Study|Physical limitation|0|||
145739246|NCT00073528|525562404|FG000|Overall Study|Death|488|||
145739247|NCT00073528|525562405|FG001|Overall Study|Death|473|||
145739248|NCT00073528|525562404|FG000|Overall Study|Lost to Follow-up|52|||
145739249|NCT00073528|525562405|FG001|Overall Study|Lost to Follow-up|45|||
145739250|NCT00073528|525562404|FG000|Overall Study|Withdrawal by Subject|50|||
145739251|NCT00073528|525562405|FG001|Overall Study|Withdrawal by Subject|45|||
145739252|NCT00073528|525562404|FG000|Overall Study|Study terminated by Sponsor|10|||
145739253|NCT00073528|525562405|FG001|Overall Study|Study terminated by Sponsor|29|||
145739254|NCT00073528|525562404|FG000|Overall Study|Other|18|||
145739255|NCT00073528|525562405|FG001|Overall Study|Other|19|||
145739256|NCT00073528|525562404|FG000|Overall Study|Other|9|||
145739257|NCT00073528|525562405|FG001|Overall Study|Other|12|||
145739258|NCT00073528|525562404|FG000|Overall Study|Protocol Violation|3|||
145739259|NCT00073528|525562405|FG001|Overall Study|Protocol Violation|5|||
145739260|NCT03086057|525562406|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
145739261|NCT03086057|525562407|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
145739262|NCT03086057|525562408|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
145739263|NCT03086057|525562409|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
145739264|NCT03086057|525562406|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
145739265|NCT03086057|525562407|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
145739266|NCT03086057|525562408|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
145739267|NCT03086057|525562409|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
145739268|NCT03086057|525562406|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
145739269|NCT03086057|525562407|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
145739270|NCT03086057|525562408|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
145739271|NCT03086057|525562409|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
145739272|NCT03086057|525562406|FG000|Stage 1: PrEP Uptake|Death|1|||
145739273|NCT03086057|525562407|FG001|Stage 1: PrEP Uptake|Death|0|||
145739274|NCT03086057|525562408|FG002|Stage 1: PrEP Uptake|Death|0|||
145739275|NCT03086057|525562409|FG003|Stage 1: PrEP Uptake|Death|0|||
145739276|NCT03086057|525562406|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
145739277|NCT03086057|525562407|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
145739278|NCT03086057|525562408|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
145739279|NCT03086057|525562409|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
145739280|NCT03086057|525562406|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
145739281|NCT03086057|525562407|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
145739282|NCT03086057|525562408|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
145739283|NCT03086057|525562409|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
145739284|NCT03086057|525562406|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
145739285|NCT03086057|525562407|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
145739286|NCT03086057|525562408|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
145739287|NCT03086057|525562409|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
145739288|NCT00003702|525562412|FG000|Overall Study|Ineligible cell types|2|||
145739289|NCT00003702|525562413|FG001|Overall Study|Ineligible cell types|2|||
145739290|NCT00003702|525562412|FG000|Overall Study|Did not meet criteria for persistence|8|||
145739291|NCT00003702|525562413|FG001|Overall Study|Did not meet criteria for persistence|5|||
145739292|NCT00003702|525562412|FG000|Overall Study|WHO score > 6|2|||
145739293|NCT00003702|525562413|FG001|Overall Study|WHO score > 6|1|||
145739294|NCT00003702|525562412|FG000|Overall Study|Inadequate documentation of disease|1|||
145739295|NCT00003702|525562413|FG001|Overall Study|Inadequate documentation of disease|3|||
145739296|NCT01786603|525562414|FG000|Overall Study|Death|5|||
145739297|NCT01786603|525562415|FG001|Overall Study|Death|1|||
145739298|NCT01786603|525562414|FG000|Overall Study|Adverse Event|6|||
145739299|NCT01786603|525562415|FG001|Overall Study|Adverse Event|2|||
145739300|NCT01786603|525562414|FG000|Overall Study|Physician decision to withdraw|6|||
145739301|NCT01786603|525562415|FG001|Overall Study|Physician decision to withdraw|7|||
145739302|NCT01786603|525562414|FG000|Overall Study|Lost to Follow-up|1|||
145739303|NCT01786603|525562415|FG001|Overall Study|Lost to Follow-up|2|||
145739304|NCT01226459|525562416|FG000|Overall Study|Adverse Event|2|||
145739305|NCT01226459|525562417|FG001|Overall Study|Adverse Event|8|||
145739306|NCT01226459|525562416|FG000|Overall Study|Protocol Violation|4|||
145739307|NCT01226459|525562417|FG001|Overall Study|Protocol Violation|3|||
145739308|NCT01226459|525562416|FG000|Overall Study|Withdrawal by Subject|10|||
145739309|NCT01226459|525562417|FG001|Overall Study|Withdrawal by Subject|13|||
145739310|NCT01226459|525562416|FG000|Overall Study|Lost to Follow-up|4|||
145739311|NCT01226459|525562417|FG001|Overall Study|Lost to Follow-up|8|||
145739312|NCT01226459|525562416|FG000|Overall Study|Pregnancy|1|||
145739313|NCT01226459|525562417|FG001|Overall Study|Pregnancy|0|||
145739314|NCT00474708|525562418|FG000|Overall Study|Lack of Efficacy|11|||
145739315|NCT00474708|525562419|FG001|Overall Study|Lack of Efficacy|5|||
145739316|NCT00474708|525562418|FG000|Overall Study|Suicide ideation/behavior|0|||
145739317|NCT00474708|525562419|FG001|Overall Study|Suicide ideation/behavior|1|||
145739318|NCT00474708|525562418|FG000|Overall Study|Withdrawal by Subject|7|||
145739319|NCT00474708|525562419|FG001|Overall Study|Withdrawal by Subject|0|||
145739320|NCT00474708|525562418|FG000|Overall Study|Lack of compliance|12|||
145739321|NCT00474708|525562419|FG001|Overall Study|Lack of compliance|4|||
145739322|NCT00474708|525562418|FG000|Overall Study|Lost to Follow-up|18|||
145739323|NCT00474708|525562419|FG001|Overall Study|Lost to Follow-up|9|||
145739324|NCT00474708|525562418|FG000|Overall Study|Physician Decision|9|||
145739325|NCT00474708|525562419|FG001|Overall Study|Physician Decision|6|||
145739326|NCT03700320|525562420|FG000|Overall Study|Adverse Event|5|||
145739327|NCT03700320|525562421|FG001|Overall Study|Adverse Event|31|||
145739328|NCT03700320|525562420|FG000|Overall Study|Lack of Efficacy|2|||
145739329|NCT03700320|525562421|FG001|Overall Study|Lack of Efficacy|5|||
145739330|NCT03700320|525562420|FG000|Overall Study|Withdrawal by Subject|29|||
145739331|NCT03700320|525562421|FG001|Overall Study|Withdrawal by Subject|75|||
145739332|NCT03700320|525562420|FG000|Overall Study|Lost to Follow-up|16|||
145739333|NCT03700320|525562421|FG001|Overall Study|Lost to Follow-up|23|||
145739334|NCT03700320|525562420|FG000|Overall Study|Pregnancy|2|||
145739335|NCT03700320|525562421|FG001|Overall Study|Pregnancy|4|||
145739336|NCT03700320|525562420|FG000|Overall Study|Protocol Deviation|7|||
145739337|NCT03700320|525562421|FG001|Overall Study|Protocol Deviation|31|||
145739338|NCT03700320|525562420|FG000|Overall Study|Non-compliance with Study Drug|1|||
145739339|NCT03700320|525562421|FG001|Overall Study|Non-compliance with Study Drug|3|||
145739340|NCT03700320|525562420|FG000|Overall Study|Reason not Specified|0|||
145739341|NCT03700320|525562421|FG001|Overall Study|Reason not Specified|1|||
145739342|NCT01092143|525562424|FG000|Overall Study|Adverse Event|10|||
145739343|NCT01092143|525562425|FG001|Overall Study|Adverse Event|5|||
145739344|NCT01092143|525562426|FG002|Overall Study|Adverse Event|1|||
145739345|NCT01092143|525562427|FG003|Overall Study|Adverse Event|4|||
145739346|NCT01092143|525562428|FG004|Overall Study|Adverse Event|3|||
145739347|NCT01092143|525562424|FG000|Overall Study|Lost to Follow-up|1|||
145739348|NCT01092143|525562425|FG001|Overall Study|Lost to Follow-up|0|||
145739349|NCT01092143|525562426|FG002|Overall Study|Lost to Follow-up|1|||
145739350|NCT01092143|525562427|FG003|Overall Study|Lost to Follow-up|0|||
145739351|NCT01092143|525562428|FG004|Overall Study|Lost to Follow-up|0|||
145739352|NCT01092143|525562424|FG000|Overall Study|Consent withdrawn|2|||
145739353|NCT01092143|525562425|FG001|Overall Study|Consent withdrawn|1|||
145739354|NCT01092143|525562426|FG002|Overall Study|Consent withdrawn|0|||
145739355|NCT01092143|525562427|FG003|Overall Study|Consent withdrawn|1|||
145739356|NCT01092143|525562428|FG004|Overall Study|Consent withdrawn|3|||
145739357|NCT01092143|525562424|FG000|Overall Study|Not treated|0|||
145739358|NCT01092143|525562425|FG001|Overall Study|Not treated|0|||
145739359|NCT01092143|525562426|FG002|Overall Study|Not treated|1|||
145739360|NCT01092143|525562427|FG003|Overall Study|Not treated|0|||
145739361|NCT01092143|525562428|FG004|Overall Study|Not treated|0|||
145739362|NCT01092143|525562424|FG000|Overall Study|did not reversibility criteria|0|||
145739363|NCT01092143|525562425|FG001|Overall Study|did not reversibility criteria|0|||
145739364|NCT01092143|525562426|FG002|Overall Study|did not reversibility criteria|1|||
145739365|NCT01092143|525562427|FG003|Overall Study|did not reversibility criteria|0|||
145739366|NCT01092143|525562428|FG004|Overall Study|did not reversibility criteria|0|||
145739367|NCT01092143|525562424|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
145739368|NCT01092143|525562425|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
145739369|NCT01092143|525562426|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
145739370|NCT01092143|525562427|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
145739371|NCT01092143|525562428|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
145739372|NCT01092143|525562424|FG000|Overall Study|Ineligible patient|1|||
145739373|NCT01092143|525562425|FG001|Overall Study|Ineligible patient|0|||
145739374|NCT01092143|525562426|FG002|Overall Study|Ineligible patient|0|||
145739375|NCT01092143|525562427|FG003|Overall Study|Ineligible patient|0|||
145739376|NCT01092143|525562428|FG004|Overall Study|Ineligible patient|0|||
145739377|NCT01092143|525562424|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
145739378|NCT01092143|525562425|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
145739379|NCT01092143|525562426|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
145739380|NCT01092143|525562427|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
145739381|NCT01092143|525562428|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
145739382|NCT01092143|525562424|FG000|Overall Study|Patient travel|0|||
145739383|NCT01092143|525562425|FG001|Overall Study|Patient travel|0|||
145739384|NCT01092143|525562426|FG002|Overall Study|Patient travel|0|||
145739385|NCT01092143|525562427|FG003|Overall Study|Patient travel|0|||
145739386|NCT01092143|525562428|FG004|Overall Study|Patient travel|1|||
145739387|NCT01092143|525562424|FG000|Overall Study|Non compliance with study medication|0|||
145739388|NCT01092143|525562425|FG001|Overall Study|Non compliance with study medication|0|||
145739389|NCT01092143|525562426|FG002|Overall Study|Non compliance with study medication|0|||
145739390|NCT01092143|525562427|FG003|Overall Study|Non compliance with study medication|0|||
145739391|NCT01092143|525562428|FG004|Overall Study|Non compliance with study medication|1|||
145739392|NCT01092143|525562424|FG000|Overall Study|Randomized by mistake|0|||
145739393|NCT01092143|525562425|FG001|Overall Study|Randomized by mistake|0|||
145739394|NCT01092143|525562426|FG002|Overall Study|Randomized by mistake|0|||
145739395|NCT01092143|525562427|FG003|Overall Study|Randomized by mistake|1|||
145739396|NCT01092143|525562428|FG004|Overall Study|Randomized by mistake|0|||
145739397|NCT01092143|525562424|FG000|Overall Study|Pregnancy|0|||
145739398|NCT01092143|525562425|FG001|Overall Study|Pregnancy|0|||
145739399|NCT01092143|525562426|FG002|Overall Study|Pregnancy|0|||
145739400|NCT01092143|525562427|FG003|Overall Study|Pregnancy|1|||
145739401|NCT01092143|525562428|FG004|Overall Study|Pregnancy|0|||
145739402|NCT00117598|525562434|FG000|Prior to Treatment Cross Over|Death|40|||
145739403|NCT00117598|525562435|FG001|Prior to Treatment Cross Over|Death|41|||
145739404|NCT00117598|525562436|FG002|Prior to Treatment Cross Over|Death|37|||
145739405|NCT00117598|525562437|FG003|Prior to Treatment Cross Over|Death|0|||
145739406|NCT00117598|525562438|FG004|Prior to Treatment Cross Over|Death|0|||
145739407|NCT00117598|525562434|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
145739408|NCT00117598|525562435|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
145739409|NCT00117598|525562436|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
145739410|NCT00117598|525562437|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
145739411|NCT00117598|525562438|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
145739412|NCT00117598|525562434|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
145739413|NCT00117598|525562435|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
145739414|NCT00117598|525562436|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
145739415|NCT00117598|525562437|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
145739416|NCT00117598|525562438|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
145739417|NCT00117598|525562434|FG000|Prior to Treatment Cross Over|Other|15|||
145739418|NCT00117598|525562435|FG001|Prior to Treatment Cross Over|Other|9|||
145517349|NCT03339297|524754271|FG000|Overall Study|Physician Decision|1|||
145517350|NCT03339297|524754272|FG001|Overall Study|Physician Decision|1|||
145517351|NCT03339297|524754271|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
145517352|NCT03339297|524754272|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
145517353|NCT03339297|524754271|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
145517354|NCT03339297|524754272|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
145517355|NCT03339297|524754271|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
145517356|NCT03339297|524754272|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
145517357|NCT03339297|524754271|FG000|Overall Study|Adverse Event, Non-fatal|1|||
145517358|NCT03339297|524754272|FG001|Overall Study|Adverse Event, Non-fatal|0|||
145517359|NCT03339297|524754271|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
145517360|NCT03339297|524754272|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
145517361|NCT03339297|524754271|FG000|Overall Study|Patient Was Not Eligible|1|||
145517362|NCT03339297|524754272|FG001|Overall Study|Patient Was Not Eligible|0|||
145517363|NCT03316911|524754282|FG000|Overall Study|Lost to Follow-up|33|||
145517364|NCT03316911|524754283|FG001|Overall Study|Lost to Follow-up|29|||
145517365|NCT01119937|524754284|FG000|Overall Study|Adverse Event|11|||
145517366|NCT01119937|524754285|FG001|Overall Study|Adverse Event|5|||
145517367|NCT01119937|524754284|FG000|Overall Study|Protocol deviation|3|||
145517368|NCT01119937|524754285|FG001|Overall Study|Protocol deviation|1|||
145517369|NCT01119937|524754284|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145517370|NCT01119937|524754285|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145517371|NCT01119937|524754284|FG000|Overall Study|Withdrawal by Subject|2|||
145517372|NCT01119937|524754285|FG001|Overall Study|Withdrawal by Subject|1|||
145517373|NCT01270802|524754286|FG000|Overall Study|Withdrawal by Subject|1|||
145517374|NCT01270802|524754287|FG001|Overall Study|Withdrawal by Subject|0|||
145517375|NCT01270802|524754286|FG000|Overall Study|Adverse Event|1|||
145517376|NCT01270802|524754287|FG001|Overall Study|Adverse Event|0|||
145517377|NCT01270802|524754286|FG000|Overall Study|Lost to Follow-up|0|||
145517378|NCT01270802|524754287|FG001|Overall Study|Lost to Follow-up|1|||
145517379|NCT04740905|524754288|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
145739419|NCT00117598|525562436|FG002|Prior to Treatment Cross Over|Other|9|||
145517380|NCT04740905|524754289|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
145517381|NCT04740905|524754288|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
145517382|NCT04740905|524754289|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
145517383|NCT04740905|524754288|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
145517384|NCT04740905|524754289|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
145739420|NCT00117598|525562437|FG003|Prior to Treatment Cross Over|Other|0|||
145739421|NCT00117598|525562438|FG004|Prior to Treatment Cross Over|Other|0|||
145739422|NCT00117598|525562434|FG000|After Treament Cross Over|Death|0|||
145739423|NCT00117598|525562435|FG001|After Treament Cross Over|Death|0|||
145739424|NCT00117598|525562436|FG002|After Treament Cross Over|Death|0|||
145739425|NCT00117598|525562437|FG003|After Treament Cross Over|Death|1|||
145739426|NCT00117598|525562438|FG004|After Treament Cross Over|Death|2|||
145739427|NCT00117598|525562434|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
145739428|NCT00117598|525562435|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
145739429|NCT00117598|525562436|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
145739430|NCT00117598|525562437|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
145739431|NCT00117598|525562438|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
145739432|NCT00117598|525562434|FG000|After Treament Cross Over|Other|0|||
145739433|NCT00117598|525562435|FG001|After Treament Cross Over|Other|0|||
145739434|NCT00117598|525562436|FG002|After Treament Cross Over|Other|0|||
145739435|NCT00117598|525562437|FG003|After Treament Cross Over|Other|1|||
145739436|NCT00117598|525562438|FG004|After Treament Cross Over|Other|2|||
145739437|NCT01770912|525562441|FG000|Overall Study|Lost to Follow-up|2|||
145739438|NCT01770912|525562442|FG001|Overall Study|Lost to Follow-up|0|||
145739439|NCT00430482|525562446|FG000|Completed Treatment|Insufficient Treatment|7|||
145517385|NCT04740905|524754288|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
145517386|NCT04740905|524754289|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
145517387|NCT04740905|524754288|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
145517388|NCT04740905|524754289|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
145517389|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
145517390|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
145517391|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
145517392|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
145517393|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
145517394|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
145517395|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
145517396|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
145517397|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
145517398|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
145517399|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
145517400|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
145517401|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
145517402|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
145517403|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
145517404|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
145517405|NCT04740905|524754288|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
145517406|NCT04740905|524754289|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
145517407|NCT01566214|524754290|FG000|Overall Study|Lost to Follow-up|3|||
145517408|NCT01566214|524754291|FG001|Overall Study|Lost to Follow-up|0|||
145517409|NCT03051620|524754292|FG000|Overall Study|Lost to Follow-up|6|||
145517410|NCT03051620|524754292|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
145517411|NCT01073462|524754296|FG000|Overall Study|Death|14|||
145517412|NCT01073462|524754296|FG000|Overall Study|Kidney transplant|10|||
145517413|NCT01073462|524754296|FG000|Overall Study|Low parathyroid hormone levels|8|||
145517414|NCT01073462|524754296|FG000|Overall Study|Serious adverse event|2|||
145517415|NCT01073462|524754296|FG000|Overall Study|Lost to Follow-up|7|||
145517416|NCT03554486|524754297|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
145517417|NCT03554486|524754298|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
145517418|NCT03554486|524754299|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
145517419|NCT03554486|524754297|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
145517420|NCT03554486|524754298|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
145517421|NCT03554486|524754299|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
145517422|NCT03554486|524754297|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145517423|NCT03554486|524754298|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
145739440|NCT00430482|525562447|FG001|Completed Treatment|Insufficient Treatment|11|||
145739441|NCT00545402|525562448|FG000|Overall Study|Discontinuation of treatment|17|||
145739442|NCT00545402|525562449|FG001|Overall Study|Discontinuation of treatment|9|||
145739443|NCT00545402|525562448|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
145739444|NCT00545402|525562449|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
145739445|NCT00545402|525562448|FG000|Overall Study|Death|5|||
145517424|NCT03554486|524754299|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
145517425|NCT02509117|524754303|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145739446|NCT00545402|525562449|FG001|Overall Study|Death|7|||
145739447|NCT00545402|525562448|FG000|Overall Study|Graft loss|2|||
145739448|NCT00545402|525562449|FG001|Overall Study|Graft loss|4|||
145739449|NCT00545402|525562448|FG000|Overall Study|Withdrawal by Subject|0|||
145739450|NCT00545402|525562449|FG001|Overall Study|Withdrawal by Subject|1|||
145739451|NCT00545402|525562448|FG000|Overall Study|Protocol Violation|1|||
145739452|NCT00545402|525562449|FG001|Overall Study|Protocol Violation|0|||
145739453|NCT00545402|525562448|FG000|Overall Study|Reason not specified|1|||
145739454|NCT00545402|525562449|FG001|Overall Study|Reason not specified|1|||
145739455|NCT00555477|525562450|FG000|Overall Study|Adverse Event|0|||
145739456|NCT00555477|525562451|FG001|Overall Study|Adverse Event|9|||
145739457|NCT00555477|525562450|FG000|Overall Study|Withdrawal by Subject|1|||
145739458|NCT00555477|525562451|FG001|Overall Study|Withdrawal by Subject|2|||
145739459|NCT00555477|525562450|FG000|Overall Study|Physician Decision|1|||
145739460|NCT00555477|525562451|FG001|Overall Study|Physician Decision|2|||
145739461|NCT00397033|525562452|FG000|Overall Study|Adverse Event|7|||
145739462|NCT00397033|525562453|FG001|Overall Study|Adverse Event|10|||
145739463|NCT00397033|525562454|FG002|Overall Study|Adverse Event|4|||
145739464|NCT00397033|525562452|FG000|Overall Study|Lack of Efficacy|22|||
145739465|NCT00397033|525562453|FG001|Overall Study|Lack of Efficacy|12|||
145739466|NCT00397033|525562454|FG002|Overall Study|Lack of Efficacy|9|||
145739467|NCT00397033|525562452|FG000|Overall Study|Lost to Follow-up|3|||
145739468|NCT00397033|525562453|FG001|Overall Study|Lost to Follow-up|3|||
145739469|NCT00397033|525562454|FG002|Overall Study|Lost to Follow-up|3|||
145517426|NCT02509117|524754304|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
145517427|NCT02509117|524754305|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517428|NCT02509117|524754306|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517429|NCT02509117|524754307|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517430|NCT02509117|524754308|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517431|NCT02509117|524754309|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517432|NCT02509117|524754310|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517433|NCT02509117|524754311|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517434|NCT02509117|524754312|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
145517435|NCT02509117|524754303|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517436|NCT02509117|524754304|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517437|NCT02509117|524754305|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517438|NCT02509117|524754306|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517439|NCT02509117|524754307|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517440|NCT02509117|524754308|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517441|NCT02509117|524754309|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517442|NCT02509117|524754310|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517443|NCT02509117|524754311|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
145517444|NCT02509117|524754312|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
145517445|NCT02509117|524754303|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145739470|NCT00397033|525562452|FG000|Overall Study|Withdrawal by Subject|12|||
145739471|NCT00397033|525562453|FG001|Overall Study|Withdrawal by Subject|7|||
145739472|NCT00397033|525562454|FG002|Overall Study|Withdrawal by Subject|5|||
145739473|NCT00397033|525562452|FG000|Overall Study|Other|0|||
145739474|NCT00397033|525562453|FG001|Overall Study|Other|5|||
145739475|NCT00397033|525562454|FG002|Overall Study|Other|2|||
145402290|NCT03261401|524330701|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
145739476|NCT03519867|525562455|FG000|Overall Study|Adverse Event|1|||
145739477|NCT03519867|525562456|FG001|Overall Study|Adverse Event|1|||
145739478|NCT03519867|525562457|FG002|Overall Study|Adverse Event|0|||
145739479|NCT03519867|525562458|FG003|Overall Study|Adverse Event|0|||
145739480|NCT03519867|525562459|FG004|Overall Study|Adverse Event|0|||
145739481|NCT03519867|525562460|FG005|Overall Study|Adverse Event|0|||
145739482|NCT03519867|525562461|FG006|Overall Study|Adverse Event|0|||
145739483|NCT03519867|525562462|FG007|Overall Study|Adverse Event|0|||
145739484|NCT03519867|525562463|FG008|Overall Study|Adverse Event|0|||
145739485|NCT03519867|525562464|FG009|Overall Study|Adverse Event|0|||
145739486|NCT03519867|525562455|FG000|Overall Study|Protocol Violation|0|||
145739487|NCT03519867|525562456|FG001|Overall Study|Protocol Violation|0|||
145739488|NCT03519867|525562457|FG002|Overall Study|Protocol Violation|0|||
145739489|NCT03519867|525562458|FG003|Overall Study|Protocol Violation|0|||
145739490|NCT03519867|525562459|FG004|Overall Study|Protocol Violation|0|||
145517446|NCT02509117|524754304|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517447|NCT02509117|524754305|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517448|NCT02509117|524754306|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517449|NCT02509117|524754307|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517450|NCT02509117|524754308|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517451|NCT02509117|524754309|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517452|NCT02509117|524754310|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517453|NCT02509117|524754311|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
145517454|NCT02509117|524754312|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
145517455|NCT00636363|524754313|FG000|Overall Study|Conjunctivitis|0|||
145517456|NCT00636363|524754314|FG001|Overall Study|Conjunctivitis|0|||
145517457|NCT00636363|524754315|FG002|Overall Study|Conjunctivitis|1|||
145517458|NCT00636363|524754313|FG000|Overall Study|Adverse Event|0|||
145517459|NCT00636363|524754314|FG001|Overall Study|Adverse Event|0|||
145517460|NCT00636363|524754315|FG002|Overall Study|Adverse Event|1|||
145517461|NCT00636363|524754313|FG000|Overall Study|Positive slit lamp finding|0|||
145517462|NCT00636363|524754314|FG001|Overall Study|Positive slit lamp finding|2|||
145517463|NCT00636363|524754315|FG002|Overall Study|Positive slit lamp finding|1|||
145517464|NCT00636363|524754313|FG000|Overall Study|Study related symptoms/complaints|8|||
145517465|NCT00636363|524754314|FG001|Overall Study|Study related symptoms/complaints|7|||
145517466|NCT00636363|524754315|FG002|Overall Study|Study related symptoms/complaints|4|||
145517467|NCT00636363|524754313|FG000|Overall Study|Met ineligibility criteria|0|||
145517468|NCT00636363|524754314|FG001|Overall Study|Met ineligibility criteria|0|||
145517469|NCT00636363|524754315|FG002|Overall Study|Met ineligibility criteria|3|||
145517470|NCT00636363|524754313|FG000|Overall Study|Missed > 1 visit|0|||
145517471|NCT00636363|524754314|FG001|Overall Study|Missed > 1 visit|1|||
145517472|NCT00636363|524754315|FG002|Overall Study|Missed > 1 visit|3|||
145517473|NCT00636363|524754313|FG000|Overall Study|Lack of motivation|1|||
145517474|NCT00636363|524754314|FG001|Overall Study|Lack of motivation|0|||
145517475|NCT00636363|524754315|FG002|Overall Study|Lack of motivation|1|||
145517476|NCT00636363|524754313|FG000|Overall Study|Protocol Violation|0|||
145517477|NCT00636363|524754314|FG001|Overall Study|Protocol Violation|3|||
145517478|NCT00636363|524754315|FG002|Overall Study|Protocol Violation|0|||
145517479|NCT00636363|524754313|FG000|Overall Study|Lost to Follow-up|3|||
145517480|NCT00636363|524754314|FG001|Overall Study|Lost to Follow-up|4|||
145517481|NCT00636363|524754315|FG002|Overall Study|Lost to Follow-up|2|||
145517482|NCT00636363|524754313|FG000|Overall Study|Withdrawal by Subject|1|||
145517483|NCT00636363|524754314|FG001|Overall Study|Withdrawal by Subject|3|||
145517484|NCT00636363|524754315|FG002|Overall Study|Withdrawal by Subject|2|||
145517485|NCT00280748|524754319|FG000|Overall Study|Decline in performance|3|||
145517486|NCT00280748|524754319|FG000|Overall Study|Extra-cranial disease progression|1|||
145517487|NCT01765218|524754320|FG000|Overall Study|Protocol Violation|1|||
145517488|NCT01765218|524754321|FG001|Overall Study|Protocol Violation|2|||
145517489|NCT00313781|524754322|FG000|Before Crossover|Death|22|||
145517490|NCT00313781|524754323|FG001|Before Crossover|Death|8|||
145517491|NCT00313781|524754324|FG002|Before Crossover|Death|0|||
145739491|NCT03519867|525562460|FG005|Overall Study|Protocol Violation|1|||
145517492|NCT00313781|524754322|FG000|Before Crossover|Lost to Follow-up|0|||
145517493|NCT00313781|524754323|FG001|Before Crossover|Lost to Follow-up|3|||
145517494|NCT00313781|524754324|FG002|Before Crossover|Lost to Follow-up|0|||
145517495|NCT00313781|524754322|FG000|Before Crossover|Withdrawal by Subject|3|||
145517496|NCT00313781|524754323|FG001|Before Crossover|Withdrawal by Subject|1|||
145517497|NCT00313781|524754324|FG002|Before Crossover|Withdrawal by Subject|0|||
145739492|NCT03519867|525562461|FG006|Overall Study|Protocol Violation|0|||
145739493|NCT03519867|525562462|FG007|Overall Study|Protocol Violation|0|||
145739494|NCT03519867|525562463|FG008|Overall Study|Protocol Violation|0|||
145739495|NCT03519867|525562464|FG009|Overall Study|Protocol Violation|0|||
145517498|NCT00313781|524754322|FG000|Before Crossover|Other|45|||
145517499|NCT00313781|524754323|FG001|Before Crossover|Other|30|||
145517500|NCT00313781|524754324|FG002|Before Crossover|Other|0|||
145739496|NCT03519867|525562455|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739497|NCT03519867|525562456|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739498|NCT03519867|525562457|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739499|NCT03519867|525562458|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739500|NCT03519867|525562459|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739501|NCT03519867|525562460|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739502|NCT03519867|525562461|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
145739503|NCT03519867|525562462|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739504|NCT03519867|525562463|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739505|NCT03519867|525562464|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
145739506|NCT03519867|525562455|FG000|Overall Study|Admin. of other reversal agent|1|||
145739507|NCT03519867|525562456|FG001|Overall Study|Admin. of other reversal agent|1|||
145739508|NCT03519867|525562457|FG002|Overall Study|Admin. of other reversal agent|0|||
145739509|NCT03519867|525562458|FG003|Overall Study|Admin. of other reversal agent|0|||
145739510|NCT03519867|525562459|FG004|Overall Study|Admin. of other reversal agent|0|||
145739511|NCT03519867|525562460|FG005|Overall Study|Admin. of other reversal agent|1|||
145739512|NCT03519867|525562461|FG006|Overall Study|Admin. of other reversal agent|0|||
145739513|NCT03519867|525562462|FG007|Overall Study|Admin. of other reversal agent|0|||
145739514|NCT03519867|525562463|FG008|Overall Study|Admin. of other reversal agent|0|||
145739515|NCT03519867|525562464|FG009|Overall Study|Admin. of other reversal agent|0|||
145739516|NCT03519867|525562455|FG000|Overall Study|Reason not provided|1|||
145739517|NCT03519867|525562456|FG001|Overall Study|Reason not provided|1|||
145739518|NCT03519867|525562457|FG002|Overall Study|Reason not provided|1|||
145739519|NCT03519867|525562458|FG003|Overall Study|Reason not provided|1|||
145739520|NCT03519867|525562459|FG004|Overall Study|Reason not provided|0|||
145739521|NCT03519867|525562460|FG005|Overall Study|Reason not provided|1|||
145739522|NCT03519867|525562461|FG006|Overall Study|Reason not provided|0|||
145739523|NCT03519867|525562462|FG007|Overall Study|Reason not provided|1|||
145739524|NCT03519867|525562463|FG008|Overall Study|Reason not provided|1|||
145739525|NCT03519867|525562464|FG009|Overall Study|Reason not provided|0|||
145739526|NCT01721057|525562465|FG000|Treatment Period|Withdrawal by Subject|11|||
145739527|NCT01721057|525562466|FG001|Treatment Period|Withdrawal by Subject|5|||
145739528|NCT01721057|525562467|FG002|Treatment Period|Withdrawal by Subject|8|||
145739529|NCT01721057|525562468|FG003|Treatment Period|Withdrawal by Subject|0|||
145739530|NCT01721057|525562469|FG004|Treatment Period|Withdrawal by Subject|0|||
145517501|NCT00313781|524754322|FG000|Before Crossover|Crossover|0|||
145517502|NCT00313781|524754323|FG001|Before Crossover|Crossover|37|||
145517503|NCT00313781|524754324|FG002|Before Crossover|Crossover|0|||
145517504|NCT00313781|524754322|FG000|Before Crossover|Randomized, not treated|5|||
145517505|NCT00313781|524754323|FG001|Before Crossover|Randomized, not treated|0|||
145517506|NCT00313781|524754324|FG002|Before Crossover|Randomized, not treated|0|||
145517507|NCT00313781|524754322|FG000|After Crossover|Death|0|||
145517508|NCT00313781|524754323|FG001|After Crossover|Death|0|||
145517509|NCT00313781|524754324|FG002|After Crossover|Death|6|||
145517510|NCT00313781|524754322|FG000|After Crossover|Withdrawal by Subject|0|||
145517511|NCT00313781|524754323|FG001|After Crossover|Withdrawal by Subject|0|||
145517512|NCT00313781|524754324|FG002|After Crossover|Withdrawal by Subject|3|||
145517513|NCT00313781|524754322|FG000|After Crossover|Other|0|||
145517514|NCT00313781|524754323|FG001|After Crossover|Other|0|||
145517515|NCT00313781|524754324|FG002|After Crossover|Other|18|||
145517516|NCT03567343|524754326|FG000|Overall Study|Lost to Follow-up|2|||
145517517|NCT03567343|524754327|FG001|Overall Study|Lost to Follow-up|1|||
145517518|NCT03567343|524754326|FG000|Overall Study|No longer eligible|2|||
145517519|NCT03567343|524754327|FG001|Overall Study|No longer eligible|1|||
145739531|NCT01721057|525562470|FG005|Treatment Period|Withdrawal by Subject|0|||
145739532|NCT01721057|525562471|FG006|Treatment Period|Withdrawal by Subject|0|||
145739533|NCT01721057|525562465|FG000|Treatment Period|Adverse Event|7|||
145739534|NCT01721057|525562466|FG001|Treatment Period|Adverse Event|10|||
145739535|NCT01721057|525562467|FG002|Treatment Period|Adverse Event|12|||
145739536|NCT01721057|525562468|FG003|Treatment Period|Adverse Event|0|||
145739537|NCT01721057|525562469|FG004|Treatment Period|Adverse Event|0|||
145739538|NCT01721057|525562470|FG005|Treatment Period|Adverse Event|0|||
145739539|NCT01721057|525562471|FG006|Treatment Period|Adverse Event|0|||
145517520|NCT03567343|524754326|FG000|Overall Study|Adverse Event|1|||
145517521|NCT03567343|524754327|FG001|Overall Study|Adverse Event|0|||
145517522|NCT03567343|524754326|FG000|Overall Study|Protocol Violation|1|||
145517523|NCT03567343|524754327|FG001|Overall Study|Protocol Violation|1|||
145517524|NCT01433250|524754328|FG000|Overall Study|Protocol Violation|0|||
145517525|NCT01433250|524754329|FG001|Overall Study|Protocol Violation|1|||
145739540|NCT01721057|525562465|FG000|Treatment Period|Lack of Efficacy|7|||
145739541|NCT01721057|525562466|FG001|Treatment Period|Lack of Efficacy|3|||
145739542|NCT01721057|525562467|FG002|Treatment Period|Lack of Efficacy|0|||
145739543|NCT01721057|525562468|FG003|Treatment Period|Lack of Efficacy|0|||
145739544|NCT01721057|525562469|FG004|Treatment Period|Lack of Efficacy|0|||
145739545|NCT01721057|525562470|FG005|Treatment Period|Lack of Efficacy|0|||
145739546|NCT01721057|525562471|FG006|Treatment Period|Lack of Efficacy|0|||
145739547|NCT01721057|525562465|FG000|Treatment Period|Lost to Follow-up|1|||
145739548|NCT01721057|525562466|FG001|Treatment Period|Lost to Follow-up|0|||
145739549|NCT01721057|525562467|FG002|Treatment Period|Lost to Follow-up|0|||
145739550|NCT01721057|525562468|FG003|Treatment Period|Lost to Follow-up|0|||
145739551|NCT01721057|525562469|FG004|Treatment Period|Lost to Follow-up|0|||
145739552|NCT01721057|525562470|FG005|Treatment Period|Lost to Follow-up|0|||
145739553|NCT01721057|525562471|FG006|Treatment Period|Lost to Follow-up|0|||
145739554|NCT01721057|525562465|FG000|Treatment Period|Physician Decision|0|||
145739555|NCT01721057|525562466|FG001|Treatment Period|Physician Decision|1|||
145739556|NCT01721057|525562467|FG002|Treatment Period|Physician Decision|3|||
145739557|NCT01721057|525562468|FG003|Treatment Period|Physician Decision|0|||
145739558|NCT01721057|525562469|FG004|Treatment Period|Physician Decision|0|||
145739559|NCT01721057|525562470|FG005|Treatment Period|Physician Decision|0|||
145739560|NCT01721057|525562471|FG006|Treatment Period|Physician Decision|0|||
145739561|NCT01721057|525562465|FG000|Treatment Period|Death|2|||
145739562|NCT01721057|525562466|FG001|Treatment Period|Death|0|||
145739563|NCT01721057|525562467|FG002|Treatment Period|Death|0|||
145739564|NCT01721057|525562468|FG003|Treatment Period|Death|0|||
145739565|NCT01721057|525562469|FG004|Treatment Period|Death|0|||
145739566|NCT01721057|525562470|FG005|Treatment Period|Death|0|||
145739567|NCT01721057|525562471|FG006|Treatment Period|Death|0|||
145739568|NCT01721057|525562465|FG000|Rescue Period|Adverse Event|0|||
145739569|NCT01721057|525562466|FG001|Rescue Period|Adverse Event|0|||
145739570|NCT01721057|525562467|FG002|Rescue Period|Adverse Event|0|||
145739571|NCT01721057|525562468|FG003|Rescue Period|Adverse Event|1|||
145739572|NCT01721057|525562469|FG004|Rescue Period|Adverse Event|0|||
145739573|NCT01721057|525562470|FG005|Rescue Period|Adverse Event|0|||
145739574|NCT01721057|525562471|FG006|Rescue Period|Adverse Event|0|||
145739575|NCT01721057|525562465|FG000|Rescue Period|Lack of Efficacy|0|||
145739576|NCT01721057|525562466|FG001|Rescue Period|Lack of Efficacy|0|||
145739577|NCT01721057|525562467|FG002|Rescue Period|Lack of Efficacy|0|||
145739578|NCT01721057|525562468|FG003|Rescue Period|Lack of Efficacy|2|||
145739579|NCT01721057|525562469|FG004|Rescue Period|Lack of Efficacy|0|||
145739580|NCT01721057|525562470|FG005|Rescue Period|Lack of Efficacy|0|||
145739581|NCT01721057|525562471|FG006|Rescue Period|Lack of Efficacy|0|||
145739582|NCT01202279|525562474|FG000|Overall Study|Adverse Event|8|||
145739583|NCT01202279|525562475|FG001|Overall Study|Adverse Event|6|||
145739584|NCT01202279|525562474|FG000|Overall Study|Withdrawal by Subject|13|||
145739585|NCT01202279|525562475|FG001|Overall Study|Withdrawal by Subject|10|||
145739586|NCT01202279|525562474|FG000|Overall Study|Physician Decision|0|||
145739587|NCT01202279|525562475|FG001|Overall Study|Physician Decision|1|||
145739588|NCT01202279|525562474|FG000|Overall Study|Lost to Follow-up|10|||
145739589|NCT01202279|525562475|FG001|Overall Study|Lost to Follow-up|7|||
145739590|NCT01202279|525562474|FG000|Overall Study|Protocol Violation|1|||
145739591|NCT01202279|525562475|FG001|Overall Study|Protocol Violation|1|||
145739592|NCT01202279|525562474|FG000|Overall Study|study compliance|5|||
145739593|NCT01202279|525562475|FG001|Overall Study|study compliance|2|||
145739594|NCT03805750|525562476|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
145739595|NCT03805750|525562477|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
145739596|NCT01984164|525562478|FG000|Overall Study|Withdrawal by Subject|4|||
145739597|NCT01984164|525562479|FG001|Overall Study|Withdrawal by Subject|3|||
145739598|NCT01984164|525562478|FG000|Overall Study|Adverse Event|5|||
145739599|NCT01984164|525562479|FG001|Overall Study|Adverse Event|19|||
145739600|NCT01984164|525562478|FG000|Overall Study|Lost to Follow-up|1|||
145739601|NCT01984164|525562479|FG001|Overall Study|Lost to Follow-up|3|||
145739602|NCT02811549|525562480|FG000|Overall Study|Lost to Follow-up|1|||
145739603|NCT02811549|525562480|FG000|Overall Study|Withdrawal by Subject|3|||
145739604|NCT02811549|525562480|FG000|Overall Study|Subject screen failed|4|||
145739605|NCT02811549|525562480|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
145739606|NCT03472924|525562481|FG000|Overall Study|Adverse Event|1|||
145739607|NCT03472924|525562482|FG001|Overall Study|Adverse Event|0|||
145739608|NCT02546765|525562486|FG000|Overall Study|Withdrawal by Subject|0|||
145739609|NCT02546765|525562487|FG001|Overall Study|Withdrawal by Subject|1|||
145739610|NCT02546765|525562488|FG002|Overall Study|Withdrawal by Subject|0|||
145739611|NCT02546765|525562489|FG003|Overall Study|Withdrawal by Subject|0|||
145739612|NCT00475722|525562490|FG000|Overall Study|Withdrawal by Subject|12|||
145739613|NCT00475722|525562491|FG001|Overall Study|Withdrawal by Subject|12|||
145739614|NCT00475722|525562490|FG000|Overall Study|Protocol Violation|3|||
145739615|NCT00475722|525562491|FG001|Overall Study|Protocol Violation|0|||
145739616|NCT01889238|525562493|FG000|Overall Study|Death|1|||
145739617|NCT01889238|525562493|FG000|Overall Study|Withdrawal by Subject|1|||
145739618|NCT01889238|525562493|FG000|Overall Study|Adverse Event|6|||
145739619|NCT01889238|525562493|FG000|Overall Study|Disease Progression|104|||
145739620|NCT01889238|525562493|FG000|Overall Study|Other|6|||
145739621|NCT04136184|525562494|FG000|Overall Study|Lost to Follow-up|0|||
145739622|NCT04136184|525562495|FG001|Overall Study|Lost to Follow-up|3|||
145739623|NCT04136184|525562494|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
145739624|NCT04136184|525562495|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
145739625|NCT03318978|525562499|FG000|Overall Study|Withdrawal by Subject|1|||
145739626|NCT02844816|525562500|FG000|Overall Study|No protocol treatment received|5|||
145739627|NCT02844816|525562501|FG001|Overall Study|No protocol treatment received|1|||
145739628|NCT02844816|525562500|FG000|Overall Study|Ineligible|22|||
145739629|NCT02844816|525562501|FG001|Overall Study|Ineligible|15|||
145739630|NCT02844816|525562500|FG000|Overall Study|Participant refusal|5|||
145739631|NCT02844816|525562501|FG001|Overall Study|Participant refusal|5|||
145739632|NCT02844816|525562500|FG000|Overall Study|Adverse Event|5|||
145739633|NCT02844816|525562501|FG001|Overall Study|Adverse Event|4|||
145739634|NCT02844816|525562500|FG000|Overall Study|Death|0|||
145739635|NCT02844816|525562501|FG001|Overall Study|Death|1|||
145739636|NCT02844816|525562500|FG000|Overall Study|Disease progression/recurrence|50|||
145739637|NCT02844816|525562501|FG001|Overall Study|Disease progression/recurrence|24|||
145739638|NCT02844816|525562500|FG000|Overall Study|Physician Decision|1|||
145739639|NCT02844816|525562501|FG001|Overall Study|Physician Decision|1|||
145739640|NCT01200238|525562505|FG000|Overall Study|Adverse Event|2|||
145739641|NCT01200238|525562506|FG001|Overall Study|Adverse Event|1|||
145739642|NCT01200238|525562505|FG000|Overall Study|Progressive Disease|5|||
145739643|NCT01200238|525562506|FG001|Overall Study|Progressive Disease|8|||
145739644|NCT01200238|525562505|FG000|Overall Study|Withdrawal by Subject|0|||
145739645|NCT01200238|525562506|FG001|Overall Study|Withdrawal by Subject|1|||
145739646|NCT02717754|525562507|FG000|Overall Study|Incorrect Infusion Duration|0|||
145739647|NCT02717754|525562508|FG001|Overall Study|Incorrect Infusion Duration|0|||
145739648|NCT02717754|525562509|FG002|Overall Study|Incorrect Infusion Duration|0|||
145739649|NCT02717754|525562510|FG003|Overall Study|Incorrect Infusion Duration|10|||
145739650|NCT02717754|525562511|FG004|Overall Study|Incorrect Infusion Duration|20|||
145739651|NCT02717754|525562512|FG005|Overall Study|Incorrect Infusion Duration|20|||
145739652|NCT00482703|525562513|FG000|Overall Study|Poor compliance|1|||
145739653|NCT00482703|525562514|FG001|Overall Study|Poor compliance|0|||
145739654|NCT00667823|525562516|FG000|Overall Study|Lost to Follow-up|5|||
145739655|NCT00667823|525562516|FG000|Overall Study|Adverse Event|7|||
145739656|NCT00667823|525562516|FG000|Overall Study|Death|182|||
145739657|NCT00667823|525562516|FG000|Overall Study|Withdrawal by Subject|12|||
145739658|NCT00667823|525562516|FG000|Overall Study|Other|8|||
145739659|NCT00667823|525562516|FG000|Overall Study|Missing (completion page missing)|2|||
145739660|NCT02592018|525562517|FG000|Overall Study|Adverse Event|1|||
145739661|NCT02592018|525562517|FG000|Overall Study|Lost to Follow-up|1|||
145739662|NCT03697720|525563905|FG000|Overall Study|Lost to Follow-up|7|||
145739663|NCT05050318|525563908|FG000|Overall Study|Protocol Deviation|1|||
145739664|NCT05050318|525563909|FG001|Overall Study|Protocol Deviation|0|||
145739665|NCT05050318|525563910|FG002|Overall Study|Protocol Deviation|0|||
145739666|NCT00766038|525563916|FG000|Overall Study|Lost to Follow-up|15|||
145739667|NCT00766038|525563917|FG001|Overall Study|Lost to Follow-up|14|||
145739668|NCT04183790|525563918|FG000|Overall Study|Participants did not rollover to Part B|12|||
145739669|NCT04183790|525563919|FG001|Overall Study|Participants did not rollover to Part B|0|||
145739670|NCT04183790|525563918|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
145739671|NCT04183790|525563919|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
145739672|NCT04183790|525563918|FG000|Overall Study|Commercial drug is available for participant|6|||
145739673|NCT04183790|525563919|FG001|Overall Study|Commercial drug is available for participant|0|||
145739674|NCT04183790|525563918|FG000|Overall Study|Adverse Event|1|||
145402291|NCT03261401|524330702|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
145402292|NCT03261401|524330703|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
145402293|NCT03261401|524330704|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
145402294|NCT01516216|524330707|FG000|Overall Study|Adverse Event|2|||
145402295|NCT01516216|524330708|FG001|Overall Study|Adverse Event|4|||
145517526|NCT01433250|524754328|FG000|Overall Study|Withdrawal by Subject|3|||
145517527|NCT01433250|524754329|FG001|Overall Study|Withdrawal by Subject|2|||
145517528|NCT03148691|524754330|FG000|Overall Study|Protocol Violation|1|||
145517529|NCT03148691|524754331|FG001|Overall Study|Protocol Violation|2|||
145517530|NCT03148691|524754332|FG002|Overall Study|Protocol Violation|7|||
145517531|NCT03148691|524754330|FG000|Overall Study|Lost to Follow-up|0|||
145517532|NCT03148691|524754331|FG001|Overall Study|Lost to Follow-up|0|||
145517533|NCT03148691|524754332|FG002|Overall Study|Lost to Follow-up|1|||
145517534|NCT03148691|524754330|FG000|Overall Study|Other|1|||
145517535|NCT03148691|524754331|FG001|Overall Study|Other|0|||
145517536|NCT03148691|524754332|FG002|Overall Study|Other|0|||
145517537|NCT03148691|524754330|FG000|Overall Study|Withdrawal by Subject|1|||
145517538|NCT03148691|524754331|FG001|Overall Study|Withdrawal by Subject|0|||
145517539|NCT03148691|524754332|FG002|Overall Study|Withdrawal by Subject|0|||
145517540|NCT04345367|524754333|FG000|Overall Study|Other|3|||
145517541|NCT04345367|524754334|FG001|Overall Study|Other|4|||
145517542|NCT04345367|524754333|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
145517543|NCT04345367|524754334|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
145517544|NCT04345367|524754333|FG000|Overall Study|Withdrawal by Subject|11|||
145517545|NCT04345367|524754334|FG001|Overall Study|Withdrawal by Subject|11|||
145517546|NCT04345367|524754333|FG000|Overall Study|Protocol Violation|4|||
145517547|NCT04345367|524754334|FG001|Overall Study|Protocol Violation|3|||
145517548|NCT04345367|524754333|FG000|Overall Study|Lost to Follow-up|2|||
145517549|NCT04345367|524754334|FG001|Overall Study|Lost to Follow-up|4|||
145517550|NCT04345367|524754333|FG000|Overall Study|Lack of Efficacy|2|||
145517551|NCT04345367|524754334|FG001|Overall Study|Lack of Efficacy|0|||
145517552|NCT04345367|524754333|FG000|Overall Study|Death|2|||
145517553|NCT04345367|524754334|FG001|Overall Study|Death|0|||
145517554|NCT04345367|524754333|FG000|Overall Study|Adverse Event|10|||
145517555|NCT04345367|524754334|FG001|Overall Study|Adverse Event|9|||
145517556|NCT02576145|524754340|FG000|Overall Study|Adverse Event|1|||
145517557|NCT02576145|524754341|FG001|Overall Study|Adverse Event|0|||
145517558|NCT02576145|524754340|FG000|Overall Study|Withdrawal by Subject|1|||
145517559|NCT02576145|524754341|FG001|Overall Study|Withdrawal by Subject|0|||
145517560|NCT02576145|524754340|FG000|Overall Study|Acute rejection|1|||
145517561|NCT02576145|524754341|FG001|Overall Study|Acute rejection|0|||
145517562|NCT02576145|524754340|FG000|Overall Study|Tetanus Titers Decreased|0|||
145517563|NCT02576145|524754341|FG001|Overall Study|Tetanus Titers Decreased|1|||
145517564|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
145517565|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
145517566|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
145517567|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
145517568|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
145517569|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
145402296|NCT01516216|524330707|FG000|Overall Study|Disease Progression|38|||
145402297|NCT01516216|524330708|FG001|Overall Study|Disease Progression|34|||
145402298|NCT01516216|524330707|FG000|Overall Study|Withdrawal by Subject|9|||
145402299|NCT01516216|524330708|FG001|Overall Study|Withdrawal by Subject|11|||
145402300|NCT01516216|524330707|FG000|Overall Study|Potentially Curative Resection|6|||
145402301|NCT01516216|524330708|FG001|Overall Study|Potentially Curative Resection|12|||
145517570|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
145517571|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
145517572|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
145517573|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
145517574|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
145517575|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
145517576|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
145517577|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
145517578|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
145517579|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
145517580|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
145517581|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
145517582|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
145517583|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
145517584|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
145517585|NCT01227824|524754342|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
145402302|NCT01516216|524330707|FG000|Overall Study|Nonadherence|2|||
145517586|NCT01227824|524754343|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
145517587|NCT01227824|524754344|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
145517588|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
145517589|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
145517590|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
145517591|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
145517592|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
145517593|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
145517594|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
145517595|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
145517596|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
145517597|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
145739675|NCT04183790|525563919|FG001|Overall Study|Adverse Event|0|||
145739676|NCT04183790|525563918|FG000|Overall Study|Not enrolled in 107 study|0|||
145739677|NCT04183790|525563919|FG001|Overall Study|Not enrolled in 107 study|2|||
145739678|NCT01251653|525563920|FG000|Overall Study|Progressive Disease|1|||
145739679|NCT01251653|525563921|FG001|Overall Study|Progressive Disease|7|||
145739680|NCT01251653|525563922|FG002|Overall Study|Progressive Disease|16|||
145739681|NCT01251653|525563923|FG003|Overall Study|Progressive Disease|4|||
145739682|NCT01251653|525563924|FG004|Overall Study|Progressive Disease|0|||
145739683|NCT01251653|525563925|FG005|Overall Study|Progressive Disease|17|||
145739684|NCT01251653|525563926|FG006|Overall Study|Progressive Disease|14|||
145739685|NCT01251653|525563927|FG007|Overall Study|Progressive Disease|7|||
145739686|NCT01251653|525563928|FG008|Overall Study|Progressive Disease|5|||
145739687|NCT01251653|525563920|FG000|Overall Study|Dose-limiting toxicity|0|||
145739688|NCT01251653|525563921|FG001|Overall Study|Dose-limiting toxicity|1|||
145739689|NCT01251653|525563922|FG002|Overall Study|Dose-limiting toxicity|1|||
145739690|NCT01251653|525563923|FG003|Overall Study|Dose-limiting toxicity|1|||
145739691|NCT01251653|525563924|FG004|Overall Study|Dose-limiting toxicity|0|||
145739692|NCT01251653|525563925|FG005|Overall Study|Dose-limiting toxicity|0|||
145739693|NCT01251653|525563926|FG006|Overall Study|Dose-limiting toxicity|2|||
145739694|NCT01251653|525563927|FG007|Overall Study|Dose-limiting toxicity|0|||
145739695|NCT01251653|525563928|FG008|Overall Study|Dose-limiting toxicity|0|||
145739696|NCT01251653|525563920|FG000|Overall Study|Adverse Event|1|||
145739697|NCT01251653|525563921|FG001|Overall Study|Adverse Event|0|||
145739698|NCT01251653|525563922|FG002|Overall Study|Adverse Event|2|||
145739699|NCT01251653|525563923|FG003|Overall Study|Adverse Event|1|||
145739700|NCT01251653|525563924|FG004|Overall Study|Adverse Event|1|||
145739701|NCT01251653|525563925|FG005|Overall Study|Adverse Event|0|||
145739702|NCT01251653|525563926|FG006|Overall Study|Adverse Event|2|||
145739703|NCT01251653|525563927|FG007|Overall Study|Adverse Event|2|||
145739704|NCT01251653|525563928|FG008|Overall Study|Adverse Event|1|||
145739705|NCT01251653|525563920|FG000|Overall Study|Withdrawal by Subject|1|||
145739706|NCT01251653|525563921|FG001|Overall Study|Withdrawal by Subject|0|||
145739707|NCT01251653|525563922|FG002|Overall Study|Withdrawal by Subject|1|||
145739708|NCT01251653|525563923|FG003|Overall Study|Withdrawal by Subject|0|||
145739709|NCT01251653|525563924|FG004|Overall Study|Withdrawal by Subject|1|||
145739710|NCT01251653|525563925|FG005|Overall Study|Withdrawal by Subject|1|||
145739711|NCT01251653|525563926|FG006|Overall Study|Withdrawal by Subject|0|||
145739712|NCT01251653|525563927|FG007|Overall Study|Withdrawal by Subject|1|||
145739713|NCT01251653|525563928|FG008|Overall Study|Withdrawal by Subject|0|||
145739714|NCT01251653|525563920|FG000|Overall Study|Other reason not mentioned above|0|||
145739715|NCT01251653|525563921|FG001|Overall Study|Other reason not mentioned above|0|||
145739716|NCT01251653|525563922|FG002|Overall Study|Other reason not mentioned above|0|||
145739717|NCT01251653|525563923|FG003|Overall Study|Other reason not mentioned above|0|||
145739718|NCT01251653|525563924|FG004|Overall Study|Other reason not mentioned above|0|||
145739719|NCT01251653|525563925|FG005|Overall Study|Other reason not mentioned above|0|||
145739720|NCT01251653|525563926|FG006|Overall Study|Other reason not mentioned above|0|||
145739721|NCT01251653|525563927|FG007|Overall Study|Other reason not mentioned above|2|||
145739722|NCT01251653|525563928|FG008|Overall Study|Other reason not mentioned above|0|||
145739723|NCT02232802|525563929|FG000|Period 1|Sponsor request|1|||
145739724|NCT02232802|525563930|FG001|Period 1|Sponsor request|0|||
145517598|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
145517599|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
145517600|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
145739725|NCT02232802|525563929|FG000|Period 1|Adverse Event|1|||
145739726|NCT02232802|525563930|FG001|Period 1|Adverse Event|1|||
145739727|NCT00938717|525563934|FG000|Overall Study|Adverse Event|10|||
145739728|NCT00938717|525563935|FG001|Overall Study|Adverse Event|41|||
145739729|NCT00938717|525563934|FG000|Overall Study|Protocol Violation|11|||
145739730|NCT00938717|525563935|FG001|Overall Study|Protocol Violation|8|||
145739731|NCT00938717|525563934|FG000|Overall Study|Withdrawal by Subject|26|||
145402303|NCT01516216|524330708|FG001|Overall Study|Nonadherence|3|||
145402304|NCT01516216|524330707|FG000|Overall Study|Physician Decision|6|||
145402305|NCT01516216|524330708|FG001|Overall Study|Physician Decision|3|||
145402306|NCT01516216|524330707|FG000|Overall Study|Prolonged Treatment Delay|5|||
145402307|NCT01516216|524330708|FG001|Overall Study|Prolonged Treatment Delay|1|||
145402308|NCT01516216|524330707|FG000|Overall Study|Intercurrent Illness|1|||
145402309|NCT01516216|524330708|FG001|Overall Study|Intercurrent Illness|0|||
145402310|NCT01516216|524330707|FG000|Overall Study|Death|1|||
145517601|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
145739732|NCT00938717|525563935|FG001|Overall Study|Withdrawal by Subject|24|||
145739733|NCT00938717|525563934|FG000|Overall Study|Lost to Follow-up|13|||
145739734|NCT00938717|525563935|FG001|Overall Study|Lost to Follow-up|18|||
145739735|NCT00938717|525563934|FG000|Overall Study|Lack of Efficacy|33|||
145739736|NCT00938717|525563935|FG001|Overall Study|Lack of Efficacy|15|||
145739737|NCT00938717|525563934|FG000|Overall Study|Other reason|5|||
145739738|NCT00938717|525563935|FG001|Overall Study|Other reason|2|||
145739739|NCT03197493|525563936|FG000|Overall Study|Withdrawal by Subject|5|||
145739740|NCT02807480|525563939|FG000|Overall Study|Withdrawal by Subject|14|||
145739741|NCT02807480|525563940|FG001|Overall Study|Withdrawal by Subject|10|||
145739742|NCT02053168|525563942|FG000|Overall Study|Withdrawal by Subject|1|||
145517602|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
145517603|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
145517604|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
145517605|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
145517606|NCT01227824|524754342|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
145517607|NCT01227824|524754343|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
145517608|NCT01227824|524754344|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
145517609|NCT00781885|524754345|FG000|Overall Study|Physician Decision|1|||
145517610|NCT01755026|524754346|FG000|Overall Study|Adverse Event|1|||
145517611|NCT01755026|524754347|FG001|Overall Study|Adverse Event|0|||
145517612|NCT01755026|524754346|FG000|Overall Study|Withdrawal by Subject|1|||
145517613|NCT01755026|524754347|FG001|Overall Study|Withdrawal by Subject|1|||
145517614|NCT01700387|524754350|FG000|Overall Study|Withdrawal by Subject|1|||
145517615|NCT01700387|524754351|FG001|Overall Study|Withdrawal by Subject|2|||
145517616|NCT01700387|524754350|FG000|Overall Study|Adverse Event|1|||
145517617|NCT01700387|524754351|FG001|Overall Study|Adverse Event|1|||
145517618|NCT01700387|524754350|FG000|Overall Study|Lost to Follow-up|2|||
145517619|NCT01700387|524754351|FG001|Overall Study|Lost to Follow-up|1|||
145517620|NCT02730793|524754359|FG000|Overall Study|Physician Decision|0|||
145517621|NCT02730793|524754360|FG001|Overall Study|Physician Decision|1|||
145517622|NCT02730793|524754359|FG000|Overall Study|Withdrawal by Subject|0|||
145517623|NCT02730793|524754360|FG001|Overall Study|Withdrawal by Subject|1|||
145739743|NCT02053168|525563942|FG000|Overall Study|Physician Decision|1|||
145739744|NCT02053168|525563942|FG000|Overall Study|Lost to Follow-up|1|||
145517624|NCT02365233|524754361|FG000|Overall Study|IRB withheld the data|1|||
145517625|NCT02365233|524754362|FG001|Overall Study|IRB withheld the data|2|||
145517626|NCT02365233|524754363|FG002|Overall Study|IRB withheld the data|2|||
145739745|NCT00636675|525563946|FG000|Overall Study|Lost to Follow-up|121|||
145739746|NCT00636675|525563947|FG001|Overall Study|Lost to Follow-up|31|||
145739747|NCT00636675|525563946|FG000|Overall Study|Withdrawal by Subject|19|||
145402311|NCT01516216|524330708|FG001|Overall Study|Death|1|||
145402312|NCT03098979|524330709|FG000|Overall Study|Adverse Event|1|||
145402313|NCT03098979|524330710|FG001|Overall Study|Adverse Event|0|||
145739748|NCT00636675|525563947|FG001|Overall Study|Withdrawal by Subject|10|||
145739749|NCT02081534|525563953|FG000|Overall Study|Adverse Event|5|||
145739750|NCT02081534|525563954|FG001|Overall Study|Adverse Event|4|||
145739751|NCT02081534|525563955|FG002|Overall Study|Adverse Event|3|||
145739752|NCT02081534|525563956|FG003|Overall Study|Adverse Event|10|||
145739753|NCT02081534|525563957|FG004|Overall Study|Adverse Event|2|||
145739754|NCT02081534|525563958|FG005|Overall Study|Adverse Event|8|||
145739755|NCT02081534|525563959|FG006|Overall Study|Adverse Event|2|||
145739756|NCT02081534|525563953|FG000|Overall Study|Withdrawal by Subject|0|||
145739757|NCT02081534|525563954|FG001|Overall Study|Withdrawal by Subject|1|||
145739758|NCT02081534|525563955|FG002|Overall Study|Withdrawal by Subject|1|||
145739759|NCT02081534|525563956|FG003|Overall Study|Withdrawal by Subject|1|||
145739760|NCT02081534|525563957|FG004|Overall Study|Withdrawal by Subject|1|||
145739761|NCT02081534|525563958|FG005|Overall Study|Withdrawal by Subject|0|||
145739762|NCT02081534|525563959|FG006|Overall Study|Withdrawal by Subject|1|||
145739763|NCT02081534|525563953|FG000|Overall Study|Protocol Violation|0|||
145739764|NCT02081534|525563954|FG001|Overall Study|Protocol Violation|3|||
145739765|NCT02081534|525563955|FG002|Overall Study|Protocol Violation|0|||
145739766|NCT02081534|525563956|FG003|Overall Study|Protocol Violation|0|||
145739767|NCT02081534|525563957|FG004|Overall Study|Protocol Violation|0|||
145739768|NCT02081534|525563958|FG005|Overall Study|Protocol Violation|0|||
145739769|NCT02081534|525563959|FG006|Overall Study|Protocol Violation|1|||
145739770|NCT02081534|525563953|FG000|Overall Study|Lost to Follow-up|0|||
145739771|NCT02081534|525563954|FG001|Overall Study|Lost to Follow-up|0|||
145739772|NCT02081534|525563955|FG002|Overall Study|Lost to Follow-up|0|||
145739773|NCT02081534|525563956|FG003|Overall Study|Lost to Follow-up|2|||
145739774|NCT02081534|525563957|FG004|Overall Study|Lost to Follow-up|1|||
145739775|NCT02081534|525563958|FG005|Overall Study|Lost to Follow-up|1|||
145739776|NCT02081534|525563959|FG006|Overall Study|Lost to Follow-up|0|||
145739777|NCT02234479|525563960|FG000|Overall Study|Withdrawal by Subject|1|||
145739778|NCT02234479|525563961|FG001|Overall Study|Withdrawal by Subject|3|||
145739779|NCT01007032|525563963|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
145739780|NCT01007032|525563964|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
145739781|NCT01007032|525563965|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
145739782|NCT01007032|525563966|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
145739783|NCT01007032|525563963|FG000|Overall Study|Withdrawal by Subject|0|||
145739784|NCT01007032|525563964|FG001|Overall Study|Withdrawal by Subject|0|||
145739785|NCT01007032|525563965|FG002|Overall Study|Withdrawal by Subject|0|||
145739786|NCT01007032|525563966|FG003|Overall Study|Withdrawal by Subject|1|||
145739787|NCT03677596|525563971|FG000|Overall Study|Adverse Event|0|||
145739788|NCT03677596|525563972|FG001|Overall Study|Adverse Event|1|||
145739789|NCT03677596|525563971|FG000|Overall Study|Death|10|||
145739790|NCT03677596|525563972|FG001|Overall Study|Death|6|||
145739791|NCT03677596|525563971|FG000|Overall Study|Lost to Follow-up|0|||
145739792|NCT03677596|525563972|FG001|Overall Study|Lost to Follow-up|1|||
145517627|NCT00995566|524754364|FG000|Overall Study|Adverse Event|2|||
145739793|NCT03677596|525563971|FG000|Overall Study|Progressive Disease|8|||
145739794|NCT03677596|525563972|FG001|Overall Study|Progressive Disease|8|||
145739795|NCT03677596|525563971|FG000|Overall Study|Withdrawal by Subject|3|||
145739796|NCT03677596|525563972|FG001|Overall Study|Withdrawal by Subject|0|||
145739797|NCT03677596|525563971|FG000|Overall Study|Disease Relapse|2|||
145739798|NCT03677596|525563972|FG001|Overall Study|Disease Relapse|2|||
145739799|NCT03677596|525563971|FG000|Overall Study|Other|0|||
145739800|NCT03677596|525563972|FG001|Overall Study|Other|1|||
145739801|NCT03794583|525563973|FG000|Overall Study|Death|8|||
145739802|NCT03794583|525563973|FG000|Overall Study|Study Terminated by Sponsor|24|||
145739803|NCT03794583|525563973|FG000|Overall Study|Withdrawal by Subject|9|||
145739804|NCT00806195|525563974|FG000|Overall Study|Death|6|||
145739805|NCT00806195|525563975|FG001|Overall Study|Death|0|||
145739806|NCT00806195|525563976|FG002|Overall Study|Death|1|||
145739807|NCT00806195|525563977|FG003|Overall Study|Death|0|||
145739808|NCT00806195|525563974|FG000|Overall Study|Adverse Event|25|||
145739809|NCT00806195|525563975|FG001|Overall Study|Adverse Event|5|||
145739810|NCT00806195|525563976|FG002|Overall Study|Adverse Event|11|||
145739811|NCT00806195|525563977|FG003|Overall Study|Adverse Event|2|||
145739812|NCT00806195|525563974|FG000|Overall Study|Withdrawal by Subject|119|||
145739813|NCT00806195|525563975|FG001|Overall Study|Withdrawal by Subject|31|||
145739814|NCT00806195|525563976|FG002|Overall Study|Withdrawal by Subject|76|||
145739815|NCT00806195|525563977|FG003|Overall Study|Withdrawal by Subject|35|||
145739816|NCT00806195|525563974|FG000|Overall Study|Lost to Follow-up|217|||
145739817|NCT00806195|525563975|FG001|Overall Study|Lost to Follow-up|66|||
145739818|NCT00806195|525563976|FG002|Overall Study|Lost to Follow-up|90|||
145739819|NCT00806195|525563977|FG003|Overall Study|Lost to Follow-up|34|||
145739820|NCT00806195|525563974|FG000|Overall Study|Inappropriate Enrollment|0|||
145739821|NCT00806195|525563975|FG001|Overall Study|Inappropriate Enrollment|1|||
145739822|NCT00806195|525563976|FG002|Overall Study|Inappropriate Enrollment|0|||
145739823|NCT00806195|525563977|FG003|Overall Study|Inappropriate Enrollment|0|||
145739824|NCT00806195|525563974|FG000|Overall Study|Administrative Reason|113|||
145739825|NCT00806195|525563975|FG001|Overall Study|Administrative Reason|35|||
145739826|NCT00806195|525563976|FG002|Overall Study|Administrative Reason|66|||
145739827|NCT00806195|525563977|FG003|Overall Study|Administrative Reason|26|||
145739828|NCT00806195|525563974|FG000|Overall Study|Protocol Violation|34|||
145739829|NCT00806195|525563975|FG001|Overall Study|Protocol Violation|24|||
145739830|NCT00806195|525563976|FG002|Overall Study|Protocol Violation|26|||
145739831|NCT00806195|525563977|FG003|Overall Study|Protocol Violation|9|||
145739832|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
145739833|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
145739834|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
145739835|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
145739836|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
145739837|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
145739838|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
145739839|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
145739840|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
145739841|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
145739842|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
145739843|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
145739844|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
145739845|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
145739846|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
145739847|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
145739848|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
145739849|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
145739850|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
145739851|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
145739852|NCT02752035|525563983|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
145739853|NCT02752035|525563984|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
145739854|NCT02752035|525563985|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
145739855|NCT02752035|525563986|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
145739856|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
145739857|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
145739858|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
145739859|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
145739860|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
145739861|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
145739862|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
145739863|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
145739864|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
145739865|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
145739866|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
145739867|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
145739868|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
145739869|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
145739870|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
145739871|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
145739872|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
145739873|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
145739874|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
145739875|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
145739876|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Death|0|||
145739877|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Death|25|||
145739878|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Death|13|||
145739879|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Death|4|||
145739880|NCT02752035|525563983|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
145739881|NCT02752035|525563984|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
145739882|NCT02752035|525563985|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
145739883|NCT02752035|525563986|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
145739884|NCT02752035|525563983|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
145739885|NCT02752035|525563984|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
145739886|NCT02752035|525563985|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
145739887|NCT02752035|525563986|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
145739888|NCT02752035|525563983|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
145739889|NCT02752035|525563984|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
145739890|NCT02752035|525563985|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
145739891|NCT02752035|525563986|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
145739892|NCT02752035|525563983|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
145739893|NCT02752035|525563984|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
145739894|NCT02752035|525563985|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
145517628|NCT00995566|524754364|FG000|Overall Study|Early study termination|52|||
145517629|NCT03678870|524754365|FG000|Overall Study|prescribed non- protocol medications|10|||
145517630|NCT03678870|524754366|FG001|Overall Study|prescribed non- protocol medications|6|||
145517631|NCT03678870|524754365|FG000|Overall Study|Lost to Follow-up|3|||
145517632|NCT03678870|524754366|FG001|Overall Study|Lost to Follow-up|2|||
145517633|NCT01454778|524754367|FG000|Overall Study|Lost to Follow-up|2|||
145517634|NCT01454778|524754367|FG000|Overall Study|Death|1|||
145517635|NCT00348881|524754368|FG000|Overall Study|Lost to Follow-up|12|||
145517636|NCT00348881|524754369|FG001|Overall Study|Lost to Follow-up|6|||
145517637|NCT00348881|524754368|FG000|Overall Study|Withdrawal by Subject|3|||
145517638|NCT00348881|524754369|FG001|Overall Study|Withdrawal by Subject|4|||
145517639|NCT00348881|524754368|FG000|Overall Study|Adverse Event|2|||
145517640|NCT00348881|524754369|FG001|Overall Study|Adverse Event|0|||
145517641|NCT00348881|524754368|FG000|Overall Study|Serious Adverse Event|0|||
145517642|NCT00348881|524754369|FG001|Overall Study|Serious Adverse Event|2|||
145517643|NCT01981551|524754376|FG000|Overall Study|Refused further treatment|8|||
145739895|NCT02752035|525563986|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
145739896|NCT02752035|525563983|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
145739897|NCT02752035|525563984|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
145739898|NCT02752035|525563985|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
145739899|NCT02752035|525563986|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
145739900|NCT01519934|525563991|FG000|Overall Study|Lost to Follow-up|3|||
145739901|NCT01161043|525563994|FG000|Overall Study|Withdrawal by Subject|3|||
145739902|NCT02164929|525563997|FG000|Overall Study|Converted to open procedure|1|||
145739903|NCT02164929|525563998|FG001|Overall Study|Converted to open procedure|0|||
145739904|NCT02164929|525563999|FG002|Overall Study|Converted to open procedure|0|||
145739905|NCT02164929|525564000|FG003|Overall Study|Converted to open procedure|2|||
145739906|NCT02164929|525563997|FG000|Overall Study|Failed regional block|0|||
145739907|NCT02164929|525563998|FG001|Overall Study|Failed regional block|0|||
145739908|NCT02164929|525563999|FG002|Overall Study|Failed regional block|1|||
145739909|NCT02164929|525564000|FG003|Overall Study|Failed regional block|0|||
145739910|NCT02161575|525564004|FG000|Overall Study|Protocol Violation|8|||
145739911|NCT02161575|525564004|FG000|Overall Study|Lack of Efficacy|1|||
145739912|NCT02161575|525564004|FG000|Overall Study|Adverse Event|2|||
145739913|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
145739914|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
145517644|NCT01981551|524754376|FG000|Overall Study|Adverse Event|1|||
145739915|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
145739916|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
145739917|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
145739918|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
145739919|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
145517645|NCT02880956|524754377|FG000|Overall Study|Adverse Event|3|||
145517646|NCT02880956|524754378|FG001|Overall Study|Adverse Event|6|||
145517647|NCT02880956|524754379|FG002|Overall Study|Adverse Event|5|||
145517648|NCT02880956|524754380|FG003|Overall Study|Adverse Event|4|||
145517649|NCT02880956|524754377|FG000|Overall Study|Withdrawal by Subject|9|||
145517650|NCT02880956|524754378|FG001|Overall Study|Withdrawal by Subject|4|||
145517651|NCT02880956|524754379|FG002|Overall Study|Withdrawal by Subject|6|||
145517652|NCT02880956|524754380|FG003|Overall Study|Withdrawal by Subject|11|||
145739920|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
145739921|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
145739922|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
145739923|NCT01299376|525564014|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
145739924|NCT01299376|525564015|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
145739925|NCT01299376|525564014|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
145739926|NCT01299376|525564015|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
145739927|NCT01299376|525564014|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
145739928|NCT01299376|525564015|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
145739929|NCT01299376|525564014|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
145739930|NCT01299376|525564015|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
145739931|NCT01299376|525564014|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
145739932|NCT01299376|525564015|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
145739933|NCT01299376|525564014|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
145739934|NCT01299376|525564015|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
145739935|NCT02790138|525564018|FG000|Overall Study|Adverse Event|5|||
145739936|NCT02790138|525564019|FG001|Overall Study|Adverse Event|2|||
145739937|NCT02790138|525564018|FG000|Overall Study|Significant Protocol Deviation|0|||
145739938|NCT02790138|525564019|FG001|Overall Study|Significant Protocol Deviation|1|||
145517653|NCT02880956|524754377|FG000|Overall Study|Lost to Follow-up|0|||
145517654|NCT02880956|524754378|FG001|Overall Study|Lost to Follow-up|1|||
145517655|NCT02880956|524754379|FG002|Overall Study|Lost to Follow-up|0|||
145517656|NCT02880956|524754380|FG003|Overall Study|Lost to Follow-up|0|||
145517657|NCT02880956|524754377|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
145517658|NCT02880956|524754378|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
145517659|NCT02880956|524754379|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
145517660|NCT02880956|524754380|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
145517661|NCT02880956|524754377|FG000|Overall Study|Other, Not Specified|4|||
145517662|NCT02880956|524754378|FG001|Overall Study|Other, Not Specified|2|||
145517663|NCT02880956|524754379|FG002|Overall Study|Other, Not Specified|0|||
145517664|NCT02880956|524754380|FG003|Overall Study|Other, Not Specified|3|||
145517665|NCT00576420|524756593|FG000|Overall Study|Death|0|||
145517666|NCT00576420|524756594|FG001|Overall Study|Death|0|||
145517667|NCT00576420|524756595|FG002|Overall Study|Death|1|||
145517668|NCT01340872|524756597|FG000|Double-blind Phase|Adverse Event|6|||
145517669|NCT01340872|524756598|FG001|Double-blind Phase|Adverse Event|4|||
145517670|NCT01340872|524756599|FG002|Double-blind Phase|Adverse Event|0|||
145517671|NCT01340872|524756600|FG003|Double-blind Phase|Adverse Event|0|||
145517672|NCT01340872|524756597|FG000|Double-blind Phase|Withdrawal by Subject|3|||
145517673|NCT01340872|524756598|FG001|Double-blind Phase|Withdrawal by Subject|5|||
145517674|NCT01340872|524756599|FG002|Double-blind Phase|Withdrawal by Subject|0|||
145517675|NCT01340872|524756600|FG003|Double-blind Phase|Withdrawal by Subject|0|||
145517676|NCT01340872|524756597|FG000|Double-blind Phase|Lost to Follow-up|0|||
145517677|NCT01340872|524756598|FG001|Double-blind Phase|Lost to Follow-up|1|||
145517678|NCT01340872|524756599|FG002|Double-blind Phase|Lost to Follow-up|0|||
145517679|NCT01340872|524756600|FG003|Double-blind Phase|Lost to Follow-up|0|||
145517680|NCT01340872|524756597|FG000|Double-blind Phase|Protocol Violation|0|||
145517681|NCT01340872|524756598|FG001|Double-blind Phase|Protocol Violation|1|||
145517682|NCT01340872|524756599|FG002|Double-blind Phase|Protocol Violation|0|||
145517683|NCT01340872|524756600|FG003|Double-blind Phase|Protocol Violation|0|||
145517684|NCT01340872|524756597|FG000|Open-label Phase|Physician Decision|0|||
145517685|NCT01340872|524756598|FG001|Open-label Phase|Physician Decision|0|||
145517686|NCT01340872|524756599|FG002|Open-label Phase|Physician Decision|2|||
145739939|NCT02790138|525564018|FG000|Overall Study|Lost to Follow-up|1|||
145739940|NCT02790138|525564019|FG001|Overall Study|Lost to Follow-up|0|||
145517687|NCT01340872|524756600|FG003|Open-label Phase|Physician Decision|1|||
145517688|NCT01340872|524756597|FG000|Open-label Phase|Pregnancy|0|||
145517689|NCT01340872|524756598|FG001|Open-label Phase|Pregnancy|0|||
145517690|NCT01340872|524756599|FG002|Open-label Phase|Pregnancy|1|||
145517691|NCT01340872|524756600|FG003|Open-label Phase|Pregnancy|0|||
145517692|NCT01340872|524756597|FG000|Open-label Phase|Adverse Event|0|||
145517693|NCT01340872|524756598|FG001|Open-label Phase|Adverse Event|0|||
145517694|NCT01340872|524756599|FG002|Open-label Phase|Adverse Event|8|||
145739941|NCT02790138|525564018|FG000|Overall Study|Voluntary Withdrawal|8|||
145739942|NCT02790138|525564019|FG001|Overall Study|Voluntary Withdrawal|9|||
145517695|NCT01340872|524756600|FG003|Open-label Phase|Adverse Event|4|||
145517696|NCT01340872|524756597|FG000|Open-label Phase|Withdrawal by Subject|0|||
145517697|NCT01340872|524756598|FG001|Open-label Phase|Withdrawal by Subject|0|||
145517698|NCT01340872|524756599|FG002|Open-label Phase|Withdrawal by Subject|1|||
145517699|NCT01340872|524756600|FG003|Open-label Phase|Withdrawal by Subject|6|||
145517700|NCT01340872|524756597|FG000|Open-label Phase|Worsening of IBD|0|||
145517701|NCT01340872|524756598|FG001|Open-label Phase|Worsening of IBD|0|||
145517702|NCT01340872|524756599|FG002|Open-label Phase|Worsening of IBD|1|||
145517703|NCT01340872|524756600|FG003|Open-label Phase|Worsening of IBD|0|||
145517704|NCT02656680|524756603|FG000|Overall Study|Lost to Follow-up|0|||
145517705|NCT02656680|524756604|FG001|Overall Study|Lost to Follow-up|1|||
145517706|NCT02656680|524756605|FG002|Overall Study|Lost to Follow-up|7|||
145517707|NCT01246466|524756608|FG000|Overall Study|Death|1|||
145517708|NCT01246466|524756608|FG000|Overall Study|Withdrawal by Subject|1|||
145517709|NCT00877773|524756609|FG000|Overall Study|Disease Progression|44|||
145739943|NCT02790138|525564018|FG000|Overall Study|Lack of Efficacy|6|||
145739944|NCT02790138|525564019|FG001|Overall Study|Lack of Efficacy|7|||
145739945|NCT02790138|525564018|FG000|Overall Study|Reason not Specified|1|||
145739946|NCT02790138|525564019|FG001|Overall Study|Reason not Specified|0|||
145739947|NCT03199040|525564020|FG000|Overall Study|Lack of Efficacy|2|||
145739948|NCT03199040|525564021|FG001|Overall Study|Lack of Efficacy|0|||
145739949|NCT03199040|525564020|FG000|Overall Study|Withdrawal by Subject|2|||
145739950|NCT03199040|525564021|FG001|Overall Study|Withdrawal by Subject|0|||
145739951|NCT03199040|525564020|FG000|Overall Study|Adverse Event|0|||
145739952|NCT03199040|525564021|FG001|Overall Study|Adverse Event|1|||
145739953|NCT03199040|525564020|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
145739954|NCT03199040|525564021|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
145739955|NCT03654976|525564022|FG000|Overall Study|Withdrawal by Subject|12|||
145739956|NCT03654976|525564023|FG001|Overall Study|Withdrawal by Subject|11|||
145739957|NCT03654976|525564022|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
145739958|NCT03654976|525564023|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
145739959|NCT03654976|525564022|FG000|Overall Study|Adverse Event|5|||
145739960|NCT03654976|525564023|FG001|Overall Study|Adverse Event|0|||
145739961|NCT03654976|525564022|FG000|Overall Study|Lost to Follow-up|2|||
145739962|NCT03654976|525564023|FG001|Overall Study|Lost to Follow-up|0|||
145739963|NCT03654976|525564022|FG000|Overall Study|Lack of Efficacy|0|||
145739964|NCT03654976|525564023|FG001|Overall Study|Lack of Efficacy|1|||
145739965|NCT02054325|525564024|FG000|Overall Study|Lost to Follow-up|8|||
145739966|NCT02054325|525564025|FG001|Overall Study|Lost to Follow-up|5|||
145739967|NCT01708291|525564026|FG000|Overall Study|fighting|2|||
145739968|NCT01708291|525564027|FG001|Overall Study|fighting|1|||
145739969|NCT01536951|525564028|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739970|NCT01536951|525564029|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739971|NCT01536951|525564030|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
145739972|NCT01536951|525564031|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739973|NCT01536951|525564032|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739974|NCT01536951|525564033|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739975|NCT01536951|525564034|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739976|NCT01536951|525564035|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739977|NCT01536951|525564036|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
145739978|NCT01536951|525564028|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
145739979|NCT01536951|525564029|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
145739980|NCT01536951|525564030|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
145739981|NCT01536951|525564031|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
145739982|NCT01536951|525564032|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
145739983|NCT01536951|525564033|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
145739984|NCT01536951|525564034|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
145739985|NCT01536951|525564035|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
145739986|NCT01536951|525564036|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
145739987|NCT01252810|525564041|FG000|Overall Study|Withdrawal by Subject|4|||
145739988|NCT01252810|525564042|FG001|Overall Study|Withdrawal by Subject|1|||
145739989|NCT01252810|525564041|FG000|Overall Study|Lost to Follow-up|0|||
145739990|NCT01252810|525564042|FG001|Overall Study|Lost to Follow-up|1|||
145739991|NCT01252810|525564041|FG000|Overall Study|Physician Decision|2|||
145739992|NCT01252810|525564042|FG001|Overall Study|Physician Decision|1|||
145739993|NCT01252810|525564041|FG000|Overall Study|Various reasons|8|||
145739994|NCT01252810|525564042|FG001|Overall Study|Various reasons|0|||
145739995|NCT00698997|525564043|FG000|Overall Study|Lost to Follow-up|3|||
145739996|NCT00698997|525564044|FG001|Overall Study|Lost to Follow-up|0|||
145739997|NCT00698997|525564043|FG000|Overall Study|Withdrawal by Subject|7|||
145739998|NCT00698997|525564044|FG001|Overall Study|Withdrawal by Subject|27|||
145739999|NCT00493220|525564045|FG000|Third Intervention|Withdrawal by Subject|1|||
145740000|NCT00493220|525564046|FG001|Third Intervention|Withdrawal by Subject|0|||
145740001|NCT00493220|525564047|FG002|Third Intervention|Withdrawal by Subject|0|||
145740002|NCT00493220|525564048|FG003|Third Intervention|Withdrawal by Subject|0|||
145740003|NCT00493220|525564049|FG004|Third Intervention|Withdrawal by Subject|0|||
145740004|NCT00493220|525564050|FG005|Third Intervention|Withdrawal by Subject|0|||
145740005|NCT06156215|525564055|FG000|Overall Study|Withdrawal by Subject|2|||
145740006|NCT06156215|525564056|FG001|Overall Study|Withdrawal by Subject|4|||
145517710|NCT02882152|524756610|FG000|Overall Study|Lost to Follow-up|1|||
145517711|NCT02882152|524756611|FG001|Overall Study|Lost to Follow-up|0|||
145740007|NCT06156215|525564057|FG002|Overall Study|Withdrawal by Subject|4|||
145740008|NCT06156215|525564058|FG003|Overall Study|Withdrawal by Subject|0|||
145740009|NCT06156215|525564059|FG004|Overall Study|Withdrawal by Subject|2|||
145740010|NCT06156215|525564060|FG005|Overall Study|Withdrawal by Subject|2|||
145740011|NCT06156215|525564055|FG000|Overall Study|Left ED without completing study|9|||
145740012|NCT06156215|525564056|FG001|Overall Study|Left ED without completing study|3|||
145740013|NCT06156215|525564057|FG002|Overall Study|Left ED without completing study|9|||
145740014|NCT06156215|525564058|FG003|Overall Study|Left ED without completing study|0|||
145740015|NCT06156215|525564059|FG004|Overall Study|Left ED without completing study|8|||
145740016|NCT06156215|525564060|FG005|Overall Study|Left ED without completing study|16|||
145740017|NCT06156215|525564055|FG000|Overall Study|Physician Decision|1|||
145740018|NCT06156215|525564056|FG001|Overall Study|Physician Decision|0|||
145740019|NCT06156215|525564057|FG002|Overall Study|Physician Decision|0|||
145740020|NCT06156215|525564058|FG003|Overall Study|Physician Decision|0|||
145740021|NCT06156215|525564059|FG004|Overall Study|Physician Decision|0|||
145740022|NCT06156215|525564060|FG005|Overall Study|Physician Decision|0|||
145740023|NCT06156215|525564055|FG000|Overall Study|Became or found ineligible|2|||
145740024|NCT06156215|525564056|FG001|Overall Study|Became or found ineligible|0|||
145740025|NCT06156215|525564057|FG002|Overall Study|Became or found ineligible|2|||
145740026|NCT06156215|525564058|FG003|Overall Study|Became or found ineligible|0|||
145740027|NCT06156215|525564059|FG004|Overall Study|Became or found ineligible|1|||
145740028|NCT06156215|525564060|FG005|Overall Study|Became or found ineligible|2|||
145740029|NCT03496012|525565609|FG000|Overall Study|Withdrawal by Subject|2|||
145740030|NCT03496012|525565610|FG001|Overall Study|Withdrawal by Subject|0|||
145740031|NCT03496012|525565611|FG002|Overall Study|Withdrawal by Subject|2|||
145740032|NCT03496012|525565609|FG000|Overall Study|Adverse Event|0|||
145740033|NCT03496012|525565610|FG001|Overall Study|Adverse Event|0|||
145740034|NCT03496012|525565611|FG002|Overall Study|Adverse Event|1|||
145740035|NCT03496012|525565609|FG000|Overall Study|Reason Not Specified|2|||
145740036|NCT03496012|525565610|FG001|Overall Study|Reason Not Specified|0|||
145740037|NCT03496012|525565611|FG002|Overall Study|Reason Not Specified|1|||
145740038|NCT00574145|525565612|FG000|Overall Study|Withdrawal by Subject|2|||
145740039|NCT00574145|525565613|FG001|Overall Study|Withdrawal by Subject|1|||
145740040|NCT03227471|525565614|FG000|Overall Study|Withdrawal by Subject|0|||
145740041|NCT03227471|525565615|FG001|Overall Study|Withdrawal by Subject|0|||
145740042|NCT03227471|525565616|FG002|Overall Study|Withdrawal by Subject|0|||
145740043|NCT03227471|525565617|FG003|Overall Study|Withdrawal by Subject|0|||
145740044|NCT03227471|525565618|FG004|Overall Study|Withdrawal by Subject|1|||
145740045|NCT03227471|525565619|FG005|Overall Study|Withdrawal by Subject|0|||
145740046|NCT03227471|525565620|FG006|Overall Study|Withdrawal by Subject|0|||
145740047|NCT03227471|525565621|FG007|Overall Study|Withdrawal by Subject|0|||
145740048|NCT03227471|525565622|FG008|Overall Study|Withdrawal by Subject|0|||
145740049|NCT03227471|525565623|FG009|Overall Study|Withdrawal by Subject|0|||
145740050|NCT03227471|525565624|FG010|Overall Study|Withdrawal by Subject|0|||
145740051|NCT03227471|525565625|FG011|Overall Study|Withdrawal by Subject|0|||
145740052|NCT03227471|525565626|FG012|Overall Study|Withdrawal by Subject|1|||
145740053|NCT03227471|525565627|FG013|Overall Study|Withdrawal by Subject|0|||
145740054|NCT03227471|525565628|FG014|Overall Study|Withdrawal by Subject|0|||
145740055|NCT03227471|525565614|FG000|Overall Study|Randomized, Never Dosed|0|||
145740056|NCT03227471|525565615|FG001|Overall Study|Randomized, Never Dosed|0|||
145740057|NCT03227471|525565616|FG002|Overall Study|Randomized, Never Dosed|0|||
145740058|NCT03227471|525565617|FG003|Overall Study|Randomized, Never Dosed|0|||
145740059|NCT03227471|525565618|FG004|Overall Study|Randomized, Never Dosed|0|||
145740060|NCT03227471|525565619|FG005|Overall Study|Randomized, Never Dosed|0|||
145740061|NCT03227471|525565620|FG006|Overall Study|Randomized, Never Dosed|0|||
145740062|NCT03227471|525565621|FG007|Overall Study|Randomized, Never Dosed|0|||
145740063|NCT03227471|525565622|FG008|Overall Study|Randomized, Never Dosed|0|||
145740064|NCT03227471|525565623|FG009|Overall Study|Randomized, Never Dosed|0|||
145517712|NCT01430754|524756612|FG000|Run-In Phase|Circadian Period Ineligible|24|||
145740065|NCT03227471|525565624|FG010|Overall Study|Randomized, Never Dosed|0|||
145740066|NCT03227471|525565625|FG011|Overall Study|Randomized, Never Dosed|0|||
145740067|NCT03227471|525565626|FG012|Overall Study|Randomized, Never Dosed|0|||
145740068|NCT03227471|525565627|FG013|Overall Study|Randomized, Never Dosed|0|||
145740069|NCT03227471|525565628|FG014|Overall Study|Randomized, Never Dosed|1|||
145740070|NCT02322125|525565629|FG000|Overall Study|Withdrawal by Subject|2|||
145740071|NCT00449670|525565635|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
145740072|NCT00449670|525565636|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
145740073|NCT00449670|525565635|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
145740074|NCT00449670|525565636|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
145740075|NCT00449670|525565635|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
145740076|NCT00449670|525565636|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
145740077|NCT00449670|525565635|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
145740078|NCT00449670|525565636|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
145740079|NCT00449670|525565635|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
145740080|NCT00449670|525565636|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
145740081|NCT00449670|525565635|FG000|Booster Phase (Study no.109873)|Other|0|||
145740082|NCT00449670|525565636|FG001|Booster Phase (Study no.109873)|Other|2|||
145740083|NCT01524198|525565638|FG000|Overall Study|Protocol Violation|8|||
145740084|NCT01524198|525565639|FG001|Overall Study|Protocol Violation|6|||
145740085|NCT01524198|525565638|FG000|Overall Study|Withdrawal by Subject|15|||
145740086|NCT01524198|525565639|FG001|Overall Study|Withdrawal by Subject|10|||
145740087|NCT00885703|525565641|FG000|Overall Study|Death|9|||
145740088|NCT00885703|525565642|FG001|Overall Study|Death|7|||
145740089|NCT00885703|525565643|FG002|Overall Study|Death|8|||
145740090|NCT00885703|525565644|FG003|Overall Study|Death|7|||
145740091|NCT00885703|525565645|FG004|Overall Study|Death|7|||
145740092|NCT00885703|525565646|FG005|Overall Study|Death|8|||
145740093|NCT00885703|525565647|FG006|Overall Study|Death|4|||
145740094|NCT00885703|525565641|FG000|Overall Study|Lost to Follow-up|0|||
145740095|NCT00885703|525565642|FG001|Overall Study|Lost to Follow-up|0|||
145740096|NCT00885703|525565643|FG002|Overall Study|Lost to Follow-up|1|||
145740097|NCT00885703|525565644|FG003|Overall Study|Lost to Follow-up|0|||
145740098|NCT00885703|525565645|FG004|Overall Study|Lost to Follow-up|0|||
145740099|NCT00885703|525565646|FG005|Overall Study|Lost to Follow-up|1|||
145740100|NCT00885703|525565647|FG006|Overall Study|Lost to Follow-up|0|||
145740101|NCT00885703|525565641|FG000|Overall Study|Withdrawal by Subject|0|||
145740102|NCT00885703|525565642|FG001|Overall Study|Withdrawal by Subject|0|||
145740103|NCT00885703|525565643|FG002|Overall Study|Withdrawal by Subject|0|||
145740104|NCT00885703|525565644|FG003|Overall Study|Withdrawal by Subject|1|||
145740105|NCT00885703|525565645|FG004|Overall Study|Withdrawal by Subject|3|||
145740106|NCT00885703|525565646|FG005|Overall Study|Withdrawal by Subject|1|||
145740107|NCT00885703|525565647|FG006|Overall Study|Withdrawal by Subject|1|||
145740108|NCT00885703|525565641|FG000|Overall Study|Ineligible (no CM)|1|||
145740109|NCT00885703|525565642|FG001|Overall Study|Ineligible (no CM)|3|||
145740110|NCT00885703|525565643|FG002|Overall Study|Ineligible (no CM)|2|||
145740111|NCT00885703|525565644|FG003|Overall Study|Ineligible (no CM)|1|||
145740112|NCT00885703|525565645|FG004|Overall Study|Ineligible (no CM)|2|||
145740113|NCT00885703|525565646|FG005|Overall Study|Ineligible (no CM)|3|||
145740114|NCT00885703|525565647|FG006|Overall Study|Ineligible (no CM)|1|||
145740115|NCT01490450|525565648|FG000|Period 1|Lack of Efficacy|2|||
145740116|NCT01490450|525565649|FG001|Period 1|Lack of Efficacy|0|||
145740117|NCT01490450|525565650|FG002|Period 1|Lack of Efficacy|3|||
145740118|NCT01490450|525565651|FG003|Period 1|Lack of Efficacy|0|||
145740119|NCT01490450|525565648|FG000|Period 1|Adverse Event|0|||
145740120|NCT01490450|525565649|FG001|Period 1|Adverse Event|0|||
145740121|NCT01490450|525565650|FG002|Period 1|Adverse Event|0|||
145740122|NCT01490450|525565651|FG003|Period 1|Adverse Event|5|||
145740123|NCT01490450|525565648|FG000|Period 1|Request to discontinue treatment|1|||
145740124|NCT01490450|525565649|FG001|Period 1|Request to discontinue treatment|0|||
145740125|NCT01490450|525565650|FG002|Period 1|Request to discontinue treatment|0|||
145740126|NCT01490450|525565651|FG003|Period 1|Request to discontinue treatment|0|||
145740127|NCT01490450|525565648|FG000|Period 1|Withdrawal by Subject|0|||
145740128|NCT01490450|525565649|FG001|Period 1|Withdrawal by Subject|0|||
145740129|NCT01490450|525565650|FG002|Period 1|Withdrawal by Subject|0|||
145740130|NCT01490450|525565651|FG003|Period 1|Withdrawal by Subject|3|||
145740131|NCT01490450|525565648|FG000|Period 1|No longer met study criteria|0|||
145740132|NCT01490450|525565649|FG001|Period 1|No longer met study criteria|1|||
145740133|NCT01490450|525565650|FG002|Period 1|No longer met study criteria|1|||
145740134|NCT01490450|525565651|FG003|Period 1|No longer met study criteria|0|||
145740135|NCT01490450|525565648|FG000|Period 2|Lack of Efficacy|0|||
145740136|NCT01490450|525565649|FG001|Period 2|Lack of Efficacy|0|||
145740137|NCT01490450|525565650|FG002|Period 2|Lack of Efficacy|0|||
145740138|NCT01490450|525565651|FG003|Period 2|Lack of Efficacy|1|||
145740139|NCT01490450|525565648|FG000|Period 2|Adverse Event|1|||
145740140|NCT01490450|525565649|FG001|Period 2|Adverse Event|1|||
145740141|NCT01490450|525565650|FG002|Period 2|Adverse Event|0|||
145740142|NCT01490450|525565651|FG003|Period 2|Adverse Event|1|||
145740143|NCT01490450|525565648|FG000|Period 2|Withdrawal by Subject|1|||
145740144|NCT01490450|525565649|FG001|Period 2|Withdrawal by Subject|0|||
145740145|NCT01490450|525565650|FG002|Period 2|Withdrawal by Subject|0|||
145740146|NCT01490450|525565651|FG003|Period 2|Withdrawal by Subject|0|||
145740147|NCT01490450|525565648|FG000|Period 2|Lost to Follow-up|0|||
145740148|NCT01490450|525565649|FG001|Period 2|Lost to Follow-up|0|||
145740149|NCT01490450|525565650|FG002|Period 2|Lost to Follow-up|0|||
145740150|NCT01490450|525565651|FG003|Period 2|Lost to Follow-up|2|||
145740151|NCT01462435|525565652|FG000|Overall Study|Lack of Efficacy|1|||
145740152|NCT01462435|525565653|FG001|Overall Study|Lack of Efficacy|0|||
145740153|NCT01462435|525565654|FG002|Overall Study|Lack of Efficacy|0|||
145740154|NCT01462435|525565655|FG003|Overall Study|Lack of Efficacy|3|||
145740155|NCT01462435|525565652|FG000|Overall Study|Physician Decision|0|||
145740156|NCT01462435|525565653|FG001|Overall Study|Physician Decision|0|||
145740157|NCT01462435|525565654|FG002|Overall Study|Physician Decision|1|||
145740158|NCT01462435|525565655|FG003|Overall Study|Physician Decision|0|||
145740159|NCT01462435|525565652|FG000|Overall Study|Withdrawal by Subject|0|||
145740160|NCT01462435|525565653|FG001|Overall Study|Withdrawal by Subject|0|||
145740161|NCT01462435|525565654|FG002|Overall Study|Withdrawal by Subject|0|||
145740162|NCT01462435|525565655|FG003|Overall Study|Withdrawal by Subject|1|||
145740163|NCT01462435|525565652|FG000|Overall Study|Lost to Follow-up|0|||
145740164|NCT01462435|525565653|FG001|Overall Study|Lost to Follow-up|0|||
145740165|NCT01462435|525565654|FG002|Overall Study|Lost to Follow-up|0|||
145740166|NCT01462435|525565655|FG003|Overall Study|Lost to Follow-up|1|||
145740167|NCT01543152|525565662|FG000|Overall Study|Withdrawal by Subject|0|||
145740168|NCT01543152|525565663|FG001|Overall Study|Withdrawal by Subject|2|||
145740169|NCT01543152|525565664|FG002|Overall Study|Withdrawal by Subject|0|||
145740170|NCT01543152|525565665|FG003|Overall Study|Withdrawal by Subject|0|||
145740171|NCT01543152|525565666|FG004|Overall Study|Withdrawal by Subject|0|||
145740172|NCT02687542|525565667|FG000|Overall Study|Medication error without associated AEs|0|||
145740173|NCT02687542|525565668|FG001|Overall Study|Medication error without associated AEs|0|||
145740174|NCT02687542|525565669|FG002|Overall Study|Medication error without associated AEs|0|||
145740175|NCT02687542|525565670|FG003|Overall Study|Medication error without associated AEs|0|||
145740176|NCT02687542|525565671|FG004|Overall Study|Medication error without associated AEs|1|||
145740177|NCT02687542|525565667|FG000|Overall Study|Lost to Follow-up|0|||
145740178|NCT02687542|525565668|FG001|Overall Study|Lost to Follow-up|0|||
145740179|NCT02687542|525565669|FG002|Overall Study|Lost to Follow-up|0|||
145740180|NCT02687542|525565670|FG003|Overall Study|Lost to Follow-up|0|||
145740181|NCT02687542|525565671|FG004|Overall Study|Lost to Follow-up|1|||
145740182|NCT02687542|525565667|FG000|Overall Study|Protocol Violation|0|||
145740183|NCT02687542|525565668|FG001|Overall Study|Protocol Violation|1|||
145740184|NCT02687542|525565669|FG002|Overall Study|Protocol Violation|0|||
145740185|NCT02687542|525565670|FG003|Overall Study|Protocol Violation|0|||
145740186|NCT02687542|525565671|FG004|Overall Study|Protocol Violation|0|||
145740187|NCT02687542|525565667|FG000|Overall Study|Other|5|||
145740188|NCT02687542|525565668|FG001|Overall Study|Other|9|||
145740189|NCT02687542|525565669|FG002|Overall Study|Other|10|||
145740190|NCT02687542|525565670|FG003|Overall Study|Other|6|||
145740191|NCT02687542|525565671|FG004|Overall Study|Other|5|||
145740192|NCT02687542|525565667|FG000|Overall Study|Adverse Event|3|||
145740193|NCT02687542|525565668|FG001|Overall Study|Adverse Event|1|||
145740194|NCT02687542|525565669|FG002|Overall Study|Adverse Event|3|||
145740195|NCT02687542|525565670|FG003|Overall Study|Adverse Event|2|||
145740196|NCT02687542|525565671|FG004|Overall Study|Adverse Event|9|||
145740197|NCT02687542|525565667|FG000|Overall Study|Withdrawal by Subject|0|||
145740198|NCT02687542|525565668|FG001|Overall Study|Withdrawal by Subject|1|||
145740199|NCT02687542|525565669|FG002|Overall Study|Withdrawal by Subject|1|||
145740200|NCT02687542|525565670|FG003|Overall Study|Withdrawal by Subject|2|||
145740201|NCT02687542|525565671|FG004|Overall Study|Withdrawal by Subject|4|||
145740202|NCT01838616|525565672|FG000|Titration Period|Adverse Event|18|||
145740203|NCT01838616|525565673|FG001|Titration Period|Adverse Event|48|||
145740204|NCT01838616|525565672|FG000|Titration Period|Lack of Efficacy|5|||
145740205|NCT01838616|525565673|FG001|Titration Period|Lack of Efficacy|12|||
145740206|NCT01838616|525565672|FG000|Titration Period|Withdrawal by Subject|5|||
145740207|NCT01838616|525565673|FG001|Titration Period|Withdrawal by Subject|5|||
145740208|NCT01838616|525565672|FG000|Titration Period|Technical problems|1|||
145740209|NCT01838616|525565673|FG001|Titration Period|Technical problems|0|||
145740210|NCT01838616|525565672|FG000|Titration Period|Other|1|||
145740211|NCT01838616|525565673|FG001|Titration Period|Other|0|||
145740212|NCT01838616|525565672|FG000|Titration Period|Protocol Violation|0|||
145740213|NCT01838616|525565673|FG001|Titration Period|Protocol Violation|1|||
145740214|NCT01838616|525565672|FG000|Continuation Period|Lack of Efficacy|3|||
145740215|NCT01838616|525565673|FG001|Continuation Period|Lack of Efficacy|5|||
145740216|NCT01838616|525565672|FG000|Continuation Period|Adverse Event|8|||
145740217|NCT01838616|525565673|FG001|Continuation Period|Adverse Event|4|||
145740218|NCT01838616|525565672|FG000|Continuation Period|Protocol Violation|2|||
145740219|NCT01838616|525565673|FG001|Continuation Period|Protocol Violation|0|||
145740220|NCT01838616|525565672|FG000|Continuation Period|Lost to Follow-up|1|||
145740221|NCT01838616|525565673|FG001|Continuation Period|Lost to Follow-up|0|||
145740222|NCT01838616|525565672|FG000|Continuation Period|Withdrawal by Subject|0|||
145740223|NCT01838616|525565673|FG001|Continuation Period|Withdrawal by Subject|4|||
145740224|NCT01838616|525565672|FG000|Continuation Period|Technical problems|0|||
145740225|NCT01838616|525565673|FG001|Continuation Period|Technical problems|1|||
145740226|NCT01838616|525565672|FG000|Pick-up Arm|Lack of Efficacy|4|||
145740227|NCT01838616|525565673|FG001|Pick-up Arm|Lack of Efficacy|0|||
145740228|NCT01838616|525565672|FG000|Pick-up Arm|Adverse Event|9|||
145740229|NCT01838616|525565673|FG001|Pick-up Arm|Adverse Event|0|||
145740230|NCT01838616|525565672|FG000|Pick-up Arm|Withdrawal by Subject|1|||
145740231|NCT01838616|525565673|FG001|Pick-up Arm|Withdrawal by Subject|0|||
145740232|NCT01838616|525565672|FG000|Pick-up Arm|Technical problems|1|||
145740233|NCT01838616|525565673|FG001|Pick-up Arm|Technical problems|0|||
145740234|NCT00176605|525565674|FG000|Overall Study|Withdrawal by Subject|2|||
145740235|NCT02318667|525565675|FG000|Overall Study|Adverse Event|1|||
145740236|NCT02318667|525565675|FG000|Overall Study|Lack of Efficacy|6|||
145740237|NCT02318667|525565675|FG000|Overall Study|Protocol Violation|2|||
145740238|NCT01033734|525565676|FG000|Overall Study|Withdrawal by Subject|1|||
145740239|NCT00139776|525565685|FG000|Period I|Did not enter Period II|575|||
145740240|NCT00139776|525565686|FG001|Period I|Did not enter Period II|0|||
145740241|NCT00139776|525565687|FG002|Period I|Did not enter Period II|0|||
145740242|NCT00139776|525565688|FG003|Period I|Did not enter Period II|0|||
145740243|NCT00139776|525565685|FG000|Period II|Not Randomized into Period III|0|||
145740244|NCT00139776|525565686|FG001|Period II|Not Randomized into Period III|322|||
145740245|NCT00139776|525565687|FG002|Period II|Not Randomized into Period III|0|||
145740246|NCT00139776|525565688|FG003|Period II|Not Randomized into Period III|0|||
145740247|NCT00139776|525565685|FG000|Period III|Adverse Event|0|||
145740248|NCT00139776|525565686|FG001|Period III|Adverse Event|0|||
145740249|NCT00139776|525565687|FG002|Period III|Adverse Event|22|||
145740250|NCT00139776|525565688|FG003|Period III|Adverse Event|23|||
145740251|NCT00139776|525565685|FG000|Period III|Other|0|||
145740252|NCT00139776|525565686|FG001|Period III|Other|0|||
145740253|NCT00139776|525565687|FG002|Period III|Other|23|||
145740254|NCT00139776|525565688|FG003|Period III|Other|34|||
145740255|NCT00139776|525565685|FG000|Period III|Lack of Efficacy|0|||
145740256|NCT00139776|525565686|FG001|Period III|Lack of Efficacy|0|||
145740257|NCT00139776|525565687|FG002|Period III|Lack of Efficacy|10|||
145740258|NCT00139776|525565688|FG003|Period III|Lack of Efficacy|24|||
145740259|NCT00139776|525565685|FG000|Period III|Lost to Follow-up|0|||
145740260|NCT00139776|525565686|FG001|Period III|Lost to Follow-up|0|||
145740261|NCT00139776|525565687|FG002|Period III|Lost to Follow-up|5|||
145740262|NCT00139776|525565688|FG003|Period III|Lost to Follow-up|4|||
145740263|NCT00139776|525565685|FG000|Period III|Withdrawal by Subject|0|||
145740264|NCT00139776|525565686|FG001|Period III|Withdrawal by Subject|0|||
145740265|NCT00139776|525565687|FG002|Period III|Withdrawal by Subject|16|||
145740266|NCT00139776|525565688|FG003|Period III|Withdrawal by Subject|21|||
145740267|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
145740268|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
145740269|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
145740270|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
145740271|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
145740272|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
145740273|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
145740274|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
145740275|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
145740276|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
145517713|NCT01430754|524756613|FG001|Run-In Phase|Circadian Period Ineligible|0|||
145517714|NCT01430754|524756612|FG000|Run-In Phase|Protocol Violation|6|||
145517715|NCT01430754|524756613|FG001|Run-In Phase|Protocol Violation|0|||
145517716|NCT01430754|524756612|FG000|Run-In Phase|Adverse Event|2|||
145517717|NCT01430754|524756613|FG001|Run-In Phase|Adverse Event|0|||
145517718|NCT01430754|524756612|FG000|Run-In Phase|Other|2|||
145740277|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
145517719|NCT01430754|524756613|FG001|Run-In Phase|Other|0|||
145740278|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
145740279|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
145740280|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
145740281|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
145740282|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
145740283|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
145740284|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
145740285|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
145740286|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
145740287|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
145740288|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
145740289|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
145740290|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
145740291|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
145517720|NCT01430754|524756612|FG000|Run-In Phase|Withdrawal by Subject|2|||
145517721|NCT01430754|524756613|FG001|Run-In Phase|Withdrawal by Subject|0|||
145517722|NCT01430754|524756612|FG000|Run-In Phase|Lost to Follow-up|1|||
145517723|NCT01430754|524756613|FG001|Run-In Phase|Lost to Follow-up|0|||
145517724|NCT01369329|524756616|FG000|Overall Study|Withdrawal by Subject|8|||
145517725|NCT01369329|524756617|FG001|Overall Study|Withdrawal by Subject|6|||
145517726|NCT01369329|524756618|FG002|Overall Study|Withdrawal by Subject|10|||
145517727|NCT01369329|524756616|FG000|Overall Study|Lost to Follow-up|2|||
145517728|NCT01369329|524756617|FG001|Overall Study|Lost to Follow-up|2|||
145517729|NCT01369329|524756618|FG002|Overall Study|Lost to Follow-up|2|||
145517730|NCT01369329|524756616|FG000|Overall Study|Other|2|||
145517731|NCT01369329|524756617|FG001|Overall Study|Other|3|||
145517732|NCT01369329|524756618|FG002|Overall Study|Other|2|||
145517733|NCT00701662|524756619|FG000|Overall Study|Lack of Efficacy|1|||
145517734|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
145517735|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Adverse Event|9|||
145517736|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Death|4|||
145517737|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
145517738|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
145740292|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
145740293|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
145740294|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
145740295|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
145740296|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
145740297|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740298|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
145740299|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
145740300|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
145740301|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740302|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
145740303|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
145740304|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
145740305|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
145740306|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
145740307|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
145740308|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
145740309|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
145740310|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
145740311|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
145740312|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
145740313|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
145740314|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
145740315|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
145740316|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
145740317|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
145740318|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
145740319|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
145740320|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
145740321|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
145740322|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
145740323|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
145740324|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
145740325|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
145740326|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
145740327|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
145740328|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
145740329|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
145740330|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
145740331|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
145740332|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
145740333|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
145740334|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
145740335|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
145740336|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
145740337|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
145740338|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
145740339|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
145740340|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
145740341|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
145740342|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
145740343|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
145740344|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
145740345|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
145740346|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
145740347|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
145740348|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
145740349|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
145740350|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
145740351|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
145740352|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
145740353|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
145740354|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
145740355|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
145740356|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
145740357|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
145740358|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
145740359|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
145740360|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
145740361|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
145740362|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
145740363|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
145740364|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
145740365|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
145740366|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
145740367|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
145740368|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
145740369|NCT00111800|525565693|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
145740370|NCT00111800|525565694|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
145740371|NCT00111800|525565695|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
145740372|NCT00111800|525565696|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
145740373|NCT00111800|525565697|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
145740374|NCT00111800|525565698|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
145740375|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
145740376|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
145740377|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
145740378|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
145740379|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
145740380|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
145740381|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
145740382|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
145740383|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
145740384|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
145740385|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
145740386|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
145740387|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
145740388|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
145740389|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
145740390|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
145740391|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
145740392|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
145740393|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
145740394|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
145740395|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
145740396|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
145740397|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
145740398|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
145740399|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740400|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740401|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
145740402|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740403|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740404|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
145740405|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
145740406|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
145740407|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
145740408|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
145740409|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
145740410|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
145740411|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
145517739|NCT00159822|524756620|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
145517740|NCT00159822|524756620|FG000|Post-treatment Follow-up Period|Death|1|||
145517741|NCT00159822|524756620|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
145517742|NCT00159822|524756620|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
145517743|NCT00275821|524756621|FG000|Overall Study|Adverse Event|4|||
145517744|NCT00275821|524756622|FG001|Overall Study|Adverse Event|12|||
145740412|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
145740413|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
145517745|NCT00275821|524756623|FG002|Overall Study|Adverse Event|5|||
145740414|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
145740415|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
145740416|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
145740417|NCT00111800|525565693|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
145740418|NCT00111800|525565694|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
145740419|NCT00111800|525565695|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
145740420|NCT00111800|525565696|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
145740421|NCT00111800|525565697|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
145740422|NCT00111800|525565698|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
145740423|NCT00914927|525565700|FG000|Overall Study|Adverse Event|0|||
145740424|NCT00914927|525565701|FG001|Overall Study|Adverse Event|0|||
145740425|NCT00914927|525565702|FG002|Overall Study|Adverse Event|0|||
145740426|NCT00914927|525565703|FG003|Overall Study|Adverse Event|0|||
145740427|NCT00914927|525565704|FG004|Overall Study|Adverse Event|1|||
145740428|NCT00914927|525565705|FG005|Overall Study|Adverse Event|0|||
145740429|NCT00914927|525565706|FG006|Overall Study|Adverse Event|0|||
145740430|NCT00914927|525565700|FG000|Overall Study|Withdrawal by Subject|0|||
145740431|NCT00914927|525565701|FG001|Overall Study|Withdrawal by Subject|1|||
145740432|NCT00914927|525565702|FG002|Overall Study|Withdrawal by Subject|0|||
145740433|NCT00914927|525565703|FG003|Overall Study|Withdrawal by Subject|1|||
145740434|NCT00914927|525565704|FG004|Overall Study|Withdrawal by Subject|0|||
145740435|NCT00914927|525565705|FG005|Overall Study|Withdrawal by Subject|0|||
145740436|NCT00914927|525565706|FG006|Overall Study|Withdrawal by Subject|0|||
145740437|NCT00914927|525565700|FG000|Overall Study|Lost to Follow-up|0|||
145740438|NCT00914927|525565701|FG001|Overall Study|Lost to Follow-up|0|||
145740439|NCT00914927|525565702|FG002|Overall Study|Lost to Follow-up|0|||
145740440|NCT00914927|525565703|FG003|Overall Study|Lost to Follow-up|1|||
145740441|NCT00914927|525565704|FG004|Overall Study|Lost to Follow-up|0|||
145740442|NCT00914927|525565705|FG005|Overall Study|Lost to Follow-up|0|||
145740443|NCT00914927|525565706|FG006|Overall Study|Lost to Follow-up|0|||
145740444|NCT00914927|525565700|FG000|Overall Study|Administrative/Other|2|||
145740445|NCT00914927|525565701|FG001|Overall Study|Administrative/Other|1|||
145740446|NCT00914927|525565702|FG002|Overall Study|Administrative/Other|0|||
145740447|NCT00914927|525565703|FG003|Overall Study|Administrative/Other|0|||
145740448|NCT00914927|525565704|FG004|Overall Study|Administrative/Other|1|||
145740449|NCT00914927|525565705|FG005|Overall Study|Administrative/Other|0|||
145740450|NCT00914927|525565706|FG006|Overall Study|Administrative/Other|0|||
145740451|NCT00971178|525565712|FG000|Overall Study|Lost to Follow-up|2|||
145740452|NCT00971178|525565713|FG001|Overall Study|Lost to Follow-up|2|||
145740453|NCT00971178|525565714|FG002|Overall Study|Lost to Follow-up|2|||
145740454|NCT00365456|525565715|FG000|Trial Period I (12 Months)|Adverse Event|84|||
145740455|NCT00365456|525565716|FG001|Trial Period I (12 Months)|Adverse Event|0|||
145740456|NCT00365456|525565715|FG000|Trial Period I (12 Months)|Non-compliance|3|||
145740457|NCT00365456|525565716|FG001|Trial Period I (12 Months)|Non-compliance|0|||
145740458|NCT00365456|525565715|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
145740459|NCT00365456|525565716|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
145740460|NCT00365456|525565715|FG000|Trial Period I (12 Months)|Other|11|||
145740461|NCT00365456|525565716|FG001|Trial Period I (12 Months)|Other|0|||
145740462|NCT00365456|525565715|FG000|Trial Period II (12 Months)|Adverse Event|0|||
145740463|NCT00365456|525565716|FG001|Trial Period II (12 Months)|Adverse Event|6|||
145740464|NCT00365456|525565715|FG000|Trial Period II (12 Months)|Non-compliance|0|||
145740465|NCT00365456|525565716|FG001|Trial Period II (12 Months)|Non-compliance|2|||
145740466|NCT00365456|525565715|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
145740467|NCT00365456|525565716|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
145740468|NCT00365456|525565715|FG000|Trial Period II (12 Months)|Other|0|||
145740469|NCT00365456|525565716|FG001|Trial Period II (12 Months)|Other|1|||
145740470|NCT00365456|525565715|FG000|Trial Period III (12 Months)|Adverse Event|13|||
145740471|NCT00365456|525565716|FG001|Trial Period III (12 Months)|Adverse Event|3|||
145517746|NCT00275821|524756621|FG000|Overall Study|Administrative problems|3|||
145517747|NCT00275821|524756622|FG001|Overall Study|Administrative problems|4|||
145740472|NCT00365456|525565715|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
145740473|NCT00365456|525565716|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
145740474|NCT00365456|525565715|FG000|Trial Period III (12 Months)|Other|1|||
145740475|NCT00365456|525565716|FG001|Trial Period III (12 Months)|Other|1|||
145740476|NCT00701090|525565720|FG000|Overall Study|Adverse Event|11|||
145740477|NCT00701090|525565721|FG001|Overall Study|Adverse Event|2|||
145740478|NCT00701090|525565720|FG000|Overall Study|Death|0|||
145740479|NCT00701090|525565721|FG001|Overall Study|Death|1|||
145740480|NCT00701090|525565720|FG000|Overall Study|Lack of Efficacy|5|||
145740481|NCT00701090|525565721|FG001|Overall Study|Lack of Efficacy|4|||
145740482|NCT00701090|525565720|FG000|Overall Study|Lost to Follow-up|9|||
145740483|NCT00701090|525565721|FG001|Overall Study|Lost to Follow-up|9|||
145740484|NCT00701090|525565720|FG000|Overall Study|Physician Decision|3|||
145740485|NCT00701090|525565721|FG001|Overall Study|Physician Decision|4|||
145740486|NCT00701090|525565720|FG000|Overall Study|Protocol Violation|2|||
145740487|NCT00701090|525565721|FG001|Overall Study|Protocol Violation|3|||
145740488|NCT00701090|525565720|FG000|Overall Study|Withdrawal by Subject|11|||
145740489|NCT00701090|525565721|FG001|Overall Study|Withdrawal by Subject|16|||
145740490|NCT00701090|525565720|FG000|Overall Study|Other|7|||
145740491|NCT00701090|525565721|FG001|Overall Study|Other|12|||
145740492|NCT05525689|525565722|FG000|Overall Study|Lost to Follow-up|1|||
145740493|NCT05525689|525565723|FG001|Overall Study|Lost to Follow-up|0|||
145740494|NCT00509067|525565729|FG000|Overall Study|Lost to Follow-up|1|||
145740495|NCT00509067|525565730|FG001|Overall Study|Lost to Follow-up|1|||
145740496|NCT00509067|525565729|FG000|Overall Study|Adverse Event|3|||
145740497|NCT00509067|525565730|FG001|Overall Study|Adverse Event|1|||
145740498|NCT00509067|525565729|FG000|Overall Study|Protocol Violation|0|||
145740499|NCT00509067|525565730|FG001|Overall Study|Protocol Violation|3|||
145740500|NCT01854645|525565736|FG000|Overall Study|Protocol-Specified Criteria|13|||
145740501|NCT01854645|525565737|FG001|Overall Study|Protocol-Specified Criteria|10|||
145740502|NCT01854645|525565738|FG002|Overall Study|Protocol-Specified Criteria|8|||
145740503|NCT01854645|525565739|FG003|Overall Study|Protocol-Specified Criteria|5|||
145740504|NCT01854645|525565740|FG004|Overall Study|Protocol-Specified Criteria|7|||
145740505|NCT01854645|525565736|FG000|Overall Study|Administrative Reasons / Missing|0|||
145740506|NCT01854645|525565737|FG001|Overall Study|Administrative Reasons / Missing|0|||
145740507|NCT01854645|525565738|FG002|Overall Study|Administrative Reasons / Missing|0|||
145740508|NCT01854645|525565739|FG003|Overall Study|Administrative Reasons / Missing|1|||
145740509|NCT01854645|525565740|FG004|Overall Study|Administrative Reasons / Missing|1|||
145740510|NCT01854645|525565736|FG000|Overall Study|Protocol Violation|3|||
145740511|NCT01854645|525565737|FG001|Overall Study|Protocol Violation|0|||
145740512|NCT01854645|525565738|FG002|Overall Study|Protocol Violation|5|||
145740513|NCT01854645|525565739|FG003|Overall Study|Protocol Violation|4|||
145740514|NCT01854645|525565740|FG004|Overall Study|Protocol Violation|1|||
145740515|NCT01854645|525565736|FG000|Overall Study|Lost to Follow-up|10|||
145740516|NCT01854645|525565737|FG001|Overall Study|Lost to Follow-up|7|||
145740517|NCT01854645|525565738|FG002|Overall Study|Lost to Follow-up|8|||
145740518|NCT01854645|525565739|FG003|Overall Study|Lost to Follow-up|5|||
145740519|NCT01854645|525565740|FG004|Overall Study|Lost to Follow-up|0|||
145740520|NCT01854645|525565736|FG000|Overall Study|Physician Decision|1|||
145740521|NCT01854645|525565737|FG001|Overall Study|Physician Decision|5|||
145740522|NCT01854645|525565738|FG002|Overall Study|Physician Decision|3|||
145740523|NCT01854645|525565739|FG003|Overall Study|Physician Decision|3|||
145740524|NCT01854645|525565740|FG004|Overall Study|Physician Decision|7|||
145740525|NCT01854645|525565736|FG000|Overall Study|Withdrawal by Subject|31|||
145740526|NCT01854645|525565737|FG001|Overall Study|Withdrawal by Subject|41|||
145740527|NCT01854645|525565738|FG002|Overall Study|Withdrawal by Subject|30|||
145740528|NCT01854645|525565739|FG003|Overall Study|Withdrawal by Subject|21|||
145740529|NCT01854645|525565740|FG004|Overall Study|Withdrawal by Subject|24|||
145740530|NCT01854645|525565736|FG000|Overall Study|Lack of Efficacy|7|||
145740531|NCT01854645|525565737|FG001|Overall Study|Lack of Efficacy|12|||
145740532|NCT01854645|525565738|FG002|Overall Study|Lack of Efficacy|9|||
145740533|NCT01854645|525565739|FG003|Overall Study|Lack of Efficacy|3|||
145740534|NCT01854645|525565740|FG004|Overall Study|Lack of Efficacy|9|||
145740535|NCT01854645|525565736|FG000|Overall Study|Adverse Event|33|||
145740536|NCT01854645|525565737|FG001|Overall Study|Adverse Event|31|||
145740537|NCT01854645|525565738|FG002|Overall Study|Adverse Event|19|||
145740538|NCT01854645|525565739|FG003|Overall Study|Adverse Event|20|||
145740539|NCT01854645|525565740|FG004|Overall Study|Adverse Event|11|||
145740540|NCT01817751|525565743|FG000|Overall Study|Physician Decision|1|||
145740541|NCT00382018|525565744|FG000|Overall Study|Progression|0|||
145740542|NCT00382018|525565745|FG001|Overall Study|Progression|136|||
145740543|NCT00382018|525565746|FG002|Overall Study|Progression|51|||
145740544|NCT00382018|525565747|FG003|Overall Study|Progression|43|||
145740545|NCT00382018|525565744|FG000|Overall Study|Death|0|||
145740546|NCT00382018|525565745|FG001|Overall Study|Death|9|||
145517748|NCT00275821|524756623|FG002|Overall Study|Administrative problems|4|||
145517749|NCT00275821|524756621|FG000|Overall Study|Withdrawal by Subject|0|||
145517750|NCT00275821|524756622|FG001|Overall Study|Withdrawal by Subject|2|||
145517751|NCT00275821|524756623|FG002|Overall Study|Withdrawal by Subject|1|||
145517752|NCT00275821|524756621|FG000|Overall Study|Lost to Follow-up|0|||
145517753|NCT00275821|524756622|FG001|Overall Study|Lost to Follow-up|1|||
145517754|NCT00275821|524756623|FG002|Overall Study|Lost to Follow-up|1|||
145517755|NCT00275821|524756621|FG000|Overall Study|Death|0|||
145517756|NCT00275821|524756622|FG001|Overall Study|Death|2|||
145517757|NCT00275821|524756623|FG002|Overall Study|Death|1|||
145517758|NCT00275821|524756621|FG000|Overall Study|Lack of Efficacy|2|||
145517759|NCT00275821|524756622|FG001|Overall Study|Lack of Efficacy|1|||
145517760|NCT00275821|524756623|FG002|Overall Study|Lack of Efficacy|0|||
145517761|NCT00275821|524756621|FG000|Overall Study|Protocol Violation|5|||
145517762|NCT00275821|524756622|FG001|Overall Study|Protocol Violation|1|||
145517763|NCT00275821|524756623|FG002|Overall Study|Protocol Violation|0|||
145517764|NCT01185301|524756624|FG000|Overall Study|Adverse Event|3|||
145517765|NCT01185301|524756625|FG001|Overall Study|Adverse Event|0|||
145517766|NCT01185301|524756626|FG002|Overall Study|Adverse Event|2|||
145517767|NCT01185301|524756627|FG003|Overall Study|Adverse Event|3|||
145517768|NCT01185301|524756624|FG000|Overall Study|Withdrawal by Subject|7|||
145517769|NCT01185301|524756625|FG001|Overall Study|Withdrawal by Subject|5|||
145517770|NCT01185301|524756626|FG002|Overall Study|Withdrawal by Subject|2|||
145517771|NCT01185301|524756627|FG003|Overall Study|Withdrawal by Subject|3|||
145517772|NCT01185301|524756624|FG000|Overall Study|Lost to Follow-up|2|||
145517773|NCT01185301|524756625|FG001|Overall Study|Lost to Follow-up|0|||
145517774|NCT01185301|524756626|FG002|Overall Study|Lost to Follow-up|0|||
145517775|NCT01185301|524756627|FG003|Overall Study|Lost to Follow-up|1|||
145517776|NCT01185301|524756624|FG000|Overall Study|Other Reason|3|||
145517777|NCT01185301|524756625|FG001|Overall Study|Other Reason|2|||
145517778|NCT01185301|524756626|FG002|Overall Study|Other Reason|2|||
145517779|NCT01185301|524756627|FG003|Overall Study|Other Reason|2|||
145517780|NCT02095132|524756628|FG000|Overall Study|Adverse Event|0|||
145740547|NCT00382018|525565746|FG002|Overall Study|Death|7|||
145740548|NCT00382018|525565747|FG003|Overall Study|Death|11|||
145740549|NCT00382018|525565744|FG000|Overall Study|Withdrawal by Subject|0|||
145740550|NCT00382018|525565745|FG001|Overall Study|Withdrawal by Subject|4|||
145740551|NCT00382018|525565746|FG002|Overall Study|Withdrawal by Subject|3|||
145740552|NCT00382018|525565747|FG003|Overall Study|Withdrawal by Subject|4|||
145740553|NCT00382018|525565744|FG000|Overall Study|Other, not protocol specified|0|||
145740554|NCT00382018|525565745|FG001|Overall Study|Other, not protocol specified|16|||
145740555|NCT00382018|525565746|FG002|Overall Study|Other, not protocol specified|3|||
145740556|NCT00382018|525565747|FG003|Overall Study|Other, not protocol specified|1|||
145517781|NCT02095132|524756629|FG001|Overall Study|Adverse Event|0|||
145517782|NCT02095132|524756630|FG002|Overall Study|Adverse Event|0|||
145517783|NCT02095132|524756631|FG003|Overall Study|Adverse Event|0|||
145517784|NCT02095132|524756632|FG004|Overall Study|Adverse Event|1|||
145517785|NCT02095132|524756633|FG005|Overall Study|Adverse Event|0|||
145517786|NCT02095132|524756634|FG006|Overall Study|Adverse Event|1|||
145740557|NCT01846624|525565748|FG000|Overall Study|Died during induction, no midostaurin|1|||
145402314|NCT03098979|524330711|FG002|Overall Study|Adverse Event|1|||
145517787|NCT02095132|524756635|FG007|Overall Study|Adverse Event|0|||
145740558|NCT00427349|525565752|FG000|Overall Study|Lack of Efficacy|23|||
145740559|NCT00427349|525565752|FG000|Overall Study|Adverse Event|14|||
145740560|NCT00427349|525565752|FG000|Overall Study|Death|1|||
145517788|NCT02095132|524756636|FG008|Overall Study|Adverse Event|0|||
145517789|NCT02095132|524756628|FG000|Overall Study|Death|0|||
145517790|NCT02095132|524756629|FG001|Overall Study|Death|0|||
145517791|NCT02095132|524756630|FG002|Overall Study|Death|0|||
145517792|NCT02095132|524756631|FG003|Overall Study|Death|0|||
145517793|NCT02095132|524756632|FG004|Overall Study|Death|0|||
145740561|NCT00427349|525565752|FG000|Overall Study|Withdrawal by Subject|3|||
145740562|NCT00427349|525565752|FG000|Overall Study|Alternative therapy|1|||
145740563|NCT00427349|525565752|FG000|Overall Study|Other|2|||
145740564|NCT00427349|525565752|FG000|Overall Study|Ineligible|1|||
145740565|NCT00427349|525565752|FG000|Overall Study|Never started therapy|1|||
145740566|NCT05082376|525565753|FG000|Overall Study|Lost to Follow-up|2|||
145740567|NCT02625233|525565754|FG000|Overall Study|Adverse Event|2|||
145740568|NCT02625233|525565755|FG001|Overall Study|Adverse Event|0|||
145740569|NCT04425720|525565761|FG000|Overall Study|Withdrawal by Subject|0|||
145740570|NCT04425720|525565762|FG001|Overall Study|Withdrawal by Subject|20|||
145740571|NCT00445224|525565763|FG000|Specific Exercises|Withdrawal by Subject|3|||
145740572|NCT00445224|525565764|FG001|Specific Exercises|Withdrawal by Subject|3|||
145740573|NCT00445224|525565763|FG000|Specific Exercises|Withdrawal by Subject|1|||
145740574|NCT00445224|525565764|FG001|Specific Exercises|Withdrawal by Subject|0|||
145740575|NCT03184077|525565769|FG000|Overall Study|Lost to Follow-up|21|||
145740576|NCT03184077|525565770|FG001|Overall Study|Lost to Follow-up|21|||
145740577|NCT00262522|525565773|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
145740578|NCT00262522|525565774|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
145740579|NCT00262522|525565775|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
145740580|NCT00262522|525565776|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
145740581|NCT00262522|525565773|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
145740582|NCT00262522|525565774|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
145740583|NCT00262522|525565775|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
145740584|NCT00262522|525565776|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
145740585|NCT00262522|525565773|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
145740586|NCT00262522|525565774|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
145740587|NCT00262522|525565775|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
145740588|NCT00262522|525565776|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
145740589|NCT00262522|525565773|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
145740590|NCT00262522|525565774|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
145740591|NCT00262522|525565775|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
145740592|NCT00262522|525565776|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
145740593|NCT00262522|525565773|FG000|Study Start Through 8 Weeks|Death|1|||
145740594|NCT00262522|525565774|FG001|Study Start Through 8 Weeks|Death|0|||
145517794|NCT02095132|524756633|FG005|Overall Study|Death|0|||
145740595|NCT00262522|525565775|FG002|Study Start Through 8 Weeks|Death|0|||
145740596|NCT00262522|525565776|FG003|Study Start Through 8 Weeks|Death|0|||
145517795|NCT02095132|524756634|FG006|Overall Study|Death|1|||
145740597|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
145740598|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
145740599|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
145740600|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
145740601|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
145740602|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
145740603|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
145740604|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
145740605|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
145740606|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
145740607|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
145740608|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
145740609|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
145740610|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
145740611|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
145740612|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
145740613|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Death|2|||
145740614|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Death|0|||
145740615|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Death|1|||
145740616|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Death|0|||
145740617|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
145740618|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
145740619|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
145740620|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
145740621|NCT00262522|525565773|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
145740622|NCT00262522|525565774|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
145740623|NCT00262522|525565775|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
145740624|NCT00262522|525565776|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
145740625|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
145517796|NCT02095132|524756635|FG007|Overall Study|Death|0|||
145517797|NCT02095132|524756636|FG008|Overall Study|Death|0|||
145740626|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
145740627|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
145740628|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
145740629|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
145740630|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
145740631|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
145740632|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
145740633|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
145740634|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
145740635|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
145740636|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
145740637|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
145740638|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
145740639|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
145740640|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
145740641|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Death|2|||
145740642|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Death|0|||
145740643|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Death|2|||
145740644|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Death|0|||
145740645|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
145740646|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
145740647|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
145740648|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
145740649|NCT00262522|525565773|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
145740650|NCT00262522|525565774|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
145740651|NCT00262522|525565775|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
145740652|NCT00262522|525565776|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
145740653|NCT00404820|525567308|FG000|Overall Study|Adverse Event|4|||
145740654|NCT00404820|525567309|FG001|Overall Study|Adverse Event|16|||
145740655|NCT00404820|525567308|FG000|Overall Study|Withdrawal by Subject|5|||
145740656|NCT00404820|525567309|FG001|Overall Study|Withdrawal by Subject|3|||
145740657|NCT00404820|525567308|FG000|Overall Study|Lost to Follow-up|7|||
145740658|NCT00404820|525567309|FG001|Overall Study|Lost to Follow-up|3|||
145740659|NCT00404820|525567308|FG000|Overall Study|Administrative problems|2|||
145740660|NCT00404820|525567309|FG001|Overall Study|Administrative problems|0|||
145740661|NCT00404820|525567308|FG000|Overall Study|Death|1|||
145740662|NCT00404820|525567309|FG001|Overall Study|Death|0|||
145740663|NCT00404820|525567308|FG000|Overall Study|Other|0|||
145740664|NCT00404820|525567309|FG001|Overall Study|Other|2|||
145740665|NCT01321710|525567311|FG000|Overall Study|Lost to Follow-up|4|||
145740666|NCT01321710|525567312|FG001|Overall Study|Lost to Follow-up|5|||
145740667|NCT01321710|525567313|FG002|Overall Study|Lost to Follow-up|0|||
145517798|NCT02095132|524756628|FG000|Overall Study|Lack of Efficacy|3|||
145517799|NCT02095132|524756629|FG001|Overall Study|Lack of Efficacy|5|||
145740668|NCT01566773|525567315|FG000|Overall Study|Protocol specified criteria|4|||
145740669|NCT01566773|525567315|FG000|Overall Study|Protocol Violation|4|||
145740670|NCT01566773|525567315|FG000|Overall Study|Withdrawal by Subject|9|||
145740671|NCT01566773|525567315|FG000|Overall Study|Administrative reason|1|||
145740672|NCT01566773|525567315|FG000|Overall Study|Adverse Event|10|||
145740673|NCT01566773|525567315|FG000|Overall Study|Physician Decision|2|||
145740674|NCT00833053|525567316|FG000|Overall Study|Adverse Event|4|||
145740675|NCT00833053|525567317|FG001|Overall Study|Adverse Event|0|||
145740676|NCT00833053|525567316|FG000|Overall Study|Treatment Failure|3|||
145740677|NCT00833053|525567317|FG001|Overall Study|Treatment Failure|1|||
145740678|NCT00833053|525567316|FG000|Overall Study|Withdrawal by Subject|0|||
145740679|NCT00833053|525567317|FG001|Overall Study|Withdrawal by Subject|1|||
145740680|NCT00833053|525567316|FG000|Overall Study|Protocol Violation|2|||
145740681|NCT00833053|525567317|FG001|Overall Study|Protocol Violation|1|||
145740682|NCT02187471|525567318|FG000|Overall Study|Protocol Violation|4|||
145740683|NCT02187471|525567319|FG001|Overall Study|Protocol Violation|5|||
145740684|NCT02187471|525567320|FG002|Overall Study|Protocol Violation|4|||
145740685|NCT02187471|525567321|FG003|Overall Study|Protocol Violation|4|||
145740686|NCT02187471|525567318|FG000|Overall Study|Missing|0|||
145740687|NCT02187471|525567319|FG001|Overall Study|Missing|0|||
145740688|NCT02187471|525567320|FG002|Overall Study|Missing|0|||
145740689|NCT02187471|525567321|FG003|Overall Study|Missing|1|||
145740690|NCT02187471|525567318|FG000|Overall Study|Lack of Efficacy|18|||
145740691|NCT02187471|525567319|FG001|Overall Study|Lack of Efficacy|9|||
145740692|NCT02187471|525567320|FG002|Overall Study|Lack of Efficacy|13|||
145740693|NCT02187471|525567321|FG003|Overall Study|Lack of Efficacy|11|||
145740694|NCT02187471|525567318|FG000|Overall Study|Adverse Event|24|||
145740695|NCT02187471|525567319|FG001|Overall Study|Adverse Event|34|||
145517800|NCT02095132|524756630|FG002|Overall Study|Lack of Efficacy|2|||
145517801|NCT02095132|524756631|FG003|Overall Study|Lack of Efficacy|8|||
145517802|NCT02095132|524756632|FG004|Overall Study|Lack of Efficacy|3|||
145517803|NCT02095132|524756633|FG005|Overall Study|Lack of Efficacy|6|||
145517804|NCT02095132|524756634|FG006|Overall Study|Lack of Efficacy|10|||
145517805|NCT02095132|524756635|FG007|Overall Study|Lack of Efficacy|9|||
145517806|NCT02095132|524756636|FG008|Overall Study|Lack of Efficacy|8|||
145517807|NCT02095132|524756628|FG000|Overall Study|Physician Decision|1|||
145517808|NCT02095132|524756629|FG001|Overall Study|Physician Decision|0|||
145517809|NCT02095132|524756630|FG002|Overall Study|Physician Decision|0|||
145517810|NCT02095132|524756631|FG003|Overall Study|Physician Decision|0|||
145517811|NCT02095132|524756632|FG004|Overall Study|Physician Decision|0|||
145517812|NCT02095132|524756633|FG005|Overall Study|Physician Decision|0|||
145517813|NCT02095132|524756634|FG006|Overall Study|Physician Decision|1|||
145517814|NCT02095132|524756635|FG007|Overall Study|Physician Decision|0|||
145517815|NCT02095132|524756636|FG008|Overall Study|Physician Decision|2|||
145517816|NCT02095132|524756628|FG000|Overall Study|Withdrawal by Subject|0|||
145517817|NCT02095132|524756629|FG001|Overall Study|Withdrawal by Subject|0|||
145517818|NCT02095132|524756630|FG002|Overall Study|Withdrawal by Subject|2|||
145517819|NCT02095132|524756631|FG003|Overall Study|Withdrawal by Subject|2|||
145517820|NCT02095132|524756632|FG004|Overall Study|Withdrawal by Subject|3|||
145740696|NCT02187471|525567320|FG002|Overall Study|Adverse Event|44|||
145740697|NCT02187471|525567321|FG003|Overall Study|Adverse Event|36|||
145740698|NCT02187471|525567318|FG000|Overall Study|Withdrawal by Subject|23|||
145517821|NCT02095132|524756633|FG005|Overall Study|Withdrawal by Subject|0|||
145517822|NCT02095132|524756634|FG006|Overall Study|Withdrawal by Subject|5|||
145517823|NCT02095132|524756635|FG007|Overall Study|Withdrawal by Subject|0|||
145517824|NCT02095132|524756636|FG008|Overall Study|Withdrawal by Subject|0|||
145517825|NCT00409175|524756637|FG000|Overall Study|Adverse Event|4|||
145517826|NCT00409175|524756638|FG001|Overall Study|Adverse Event|3|||
145517827|NCT00409175|524756637|FG000|Overall Study|Withdrawal by Subject|1|||
145517828|NCT00409175|524756638|FG001|Overall Study|Withdrawal by Subject|2|||
145740699|NCT02187471|525567319|FG001|Overall Study|Withdrawal by Subject|29|||
145740700|NCT02187471|525567320|FG002|Overall Study|Withdrawal by Subject|22|||
145740701|NCT02187471|525567321|FG003|Overall Study|Withdrawal by Subject|24|||
145740702|NCT02187471|525567318|FG000|Overall Study|Other|7|||
145740703|NCT02187471|525567319|FG001|Overall Study|Other|5|||
145740704|NCT02187471|525567320|FG002|Overall Study|Other|3|||
145740705|NCT02187471|525567321|FG003|Overall Study|Other|4|||
145740706|NCT02236520|525567322|FG000|Overall Study|Physician Decision|0|||
145740707|NCT02236520|525567323|FG001|Overall Study|Physician Decision|5|||
145740708|NCT02236520|525567324|FG002|Overall Study|Physician Decision|0|||
145740709|NCT02236520|525567325|FG003|Overall Study|Physician Decision|0|||
145517829|NCT00409175|524756637|FG000|Overall Study|Negative genotype|0|||
145517830|NCT00409175|524756638|FG001|Overall Study|Negative genotype|1|||
145517831|NCT00409175|524756637|FG000|Overall Study|Liver transplantation|13|||
145517832|NCT00409175|524756638|FG001|Overall Study|Liver transplantation|13|||
145517833|NCT02108262|524756641|FG000|Overall Study|Non-compliance|0|||
145517834|NCT02108262|524756642|FG001|Overall Study|Non-compliance|2|||
145740710|NCT02236520|525567322|FG000|Overall Study|Withdrawal by Subject|1|||
145740711|NCT02236520|525567323|FG001|Overall Study|Withdrawal by Subject|0|||
145740712|NCT02236520|525567324|FG002|Overall Study|Withdrawal by Subject|0|||
145740713|NCT02236520|525567325|FG003|Overall Study|Withdrawal by Subject|1|||
145740714|NCT02236520|525567322|FG000|Overall Study|Pregnancy|1|||
145740715|NCT02236520|525567323|FG001|Overall Study|Pregnancy|0|||
145740716|NCT02236520|525567324|FG002|Overall Study|Pregnancy|0|||
145740717|NCT02236520|525567325|FG003|Overall Study|Pregnancy|0|||
145740718|NCT01785160|525567326|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
145740719|NCT01785160|525567326|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
145740720|NCT00003535|525567327|FG000|Overall Study|Not evaluable|5|||
145740721|NCT02289742|525567332|FG000|First Wear Period|Adverse event prior to treatment|0|||
145740722|NCT02289742|525567333|FG001|First Wear Period|Adverse event prior to treatment|1|||
145740723|NCT02289742|525567334|FG002|First Wear Period|Adverse event prior to treatment|0|||
145740724|NCT02289742|525567335|FG003|First Wear Period|Adverse event prior to treatment|0|||
145740725|NCT02289742|525567332|FG000|First Wear Period|Adverse Event|0|||
145740726|NCT02289742|525567333|FG001|First Wear Period|Adverse Event|0|||
145740727|NCT02289742|525567334|FG002|First Wear Period|Adverse Event|1|||
145740728|NCT02289742|525567335|FG003|First Wear Period|Adverse Event|0|||
145740729|NCT02289742|525567332|FG000|First Wear Period|Other prior to treatment|0|||
145740730|NCT02289742|525567333|FG001|First Wear Period|Other prior to treatment|0|||
145740731|NCT02289742|525567334|FG002|First Wear Period|Other prior to treatment|0|||
145740732|NCT02289742|525567335|FG003|First Wear Period|Other prior to treatment|1|||
145740733|NCT02289742|525567332|FG000|Third Wear Period|Adverse Event|0|||
145517835|NCT02108262|524756643|FG002|Overall Study|Non-compliance|1|||
145517836|NCT02108262|524756644|FG003|Overall Study|Non-compliance|1|||
145517837|NCT02108262|524756641|FG000|Overall Study|Randomized by error/screen failure|0|||
145517838|NCT02108262|524756642|FG001|Overall Study|Randomized by error/screen failure|0|||
145517839|NCT02108262|524756643|FG002|Overall Study|Randomized by error/screen failure|1|||
145517840|NCT02108262|524756644|FG003|Overall Study|Randomized by error/screen failure|0|||
145517841|NCT02108262|524756641|FG000|Overall Study|Distance to center|0|||
145517842|NCT02108262|524756642|FG001|Overall Study|Distance to center|1|||
145517843|NCT02108262|524756643|FG002|Overall Study|Distance to center|1|||
145517844|NCT02108262|524756644|FG003|Overall Study|Distance to center|0|||
145517845|NCT02108262|524756641|FG000|Overall Study|Adverse Event|0|||
145517846|NCT02108262|524756642|FG001|Overall Study|Adverse Event|11|||
145517847|NCT02108262|524756643|FG002|Overall Study|Adverse Event|6|||
145517848|NCT02108262|524756644|FG003|Overall Study|Adverse Event|12|||
145517849|NCT02108262|524756641|FG000|Overall Study|Death|0|||
145517850|NCT02108262|524756642|FG001|Overall Study|Death|2|||
145517851|NCT02108262|524756643|FG002|Overall Study|Death|2|||
145517852|NCT02108262|524756644|FG003|Overall Study|Death|1|||
145517853|NCT02108262|524756641|FG000|Overall Study|Lost to Follow-up|0|||
145517854|NCT02108262|524756642|FG001|Overall Study|Lost to Follow-up|0|||
145517855|NCT02108262|524756643|FG002|Overall Study|Lost to Follow-up|1|||
145517856|NCT02108262|524756644|FG003|Overall Study|Lost to Follow-up|0|||
145517857|NCT02108262|524756641|FG000|Overall Study|Physician Decision|0|||
145517858|NCT02108262|524756642|FG001|Overall Study|Physician Decision|0|||
145517859|NCT02108262|524756643|FG002|Overall Study|Physician Decision|2|||
145517860|NCT02108262|524756644|FG003|Overall Study|Physician Decision|0|||
145517861|NCT02108262|524756641|FG000|Overall Study|Withdrawal by Subject|0|||
145517862|NCT02108262|524756642|FG001|Overall Study|Withdrawal by Subject|7|||
145517863|NCT02108262|524756643|FG002|Overall Study|Withdrawal by Subject|3|||
145517864|NCT02108262|524756644|FG003|Overall Study|Withdrawal by Subject|4|||
145517865|NCT02108262|524756641|FG000|Overall Study|Due to key hepatic values|0|||
145517866|NCT02108262|524756642|FG001|Overall Study|Due to key hepatic values|1|||
145517867|NCT02108262|524756643|FG002|Overall Study|Due to key hepatic values|0|||
145517868|NCT02108262|524756644|FG003|Overall Study|Due to key hepatic values|0|||
145517869|NCT02108262|524756641|FG000|Overall Study|Unable to contact patient|0|||
145517870|NCT02108262|524756642|FG001|Overall Study|Unable to contact patient|3|||
145517871|NCT02108262|524756643|FG002|Overall Study|Unable to contact patient|1|||
145740734|NCT02289742|525567333|FG001|Third Wear Period|Adverse Event|1|||
145740735|NCT02289742|525567334|FG002|Third Wear Period|Adverse Event|0|||
145517872|NCT02108262|524756644|FG003|Overall Study|Unable to contact patient|2|||
145517873|NCT02108262|524756641|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
145740736|NCT02289742|525567335|FG003|Third Wear Period|Adverse Event|0|||
145517874|NCT02108262|524756642|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
145517875|NCT02108262|524756643|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
145517876|NCT02108262|524756644|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
145517877|NCT02108262|524756641|FG000|Overall Study|Patient did not want another infusion|0|||
145517878|NCT02108262|524756642|FG001|Overall Study|Patient did not want another infusion|3|||
145517879|NCT02108262|524756643|FG002|Overall Study|Patient did not want another infusion|3|||
145517880|NCT02108262|524756644|FG003|Overall Study|Patient did not want another infusion|2|||
145517881|NCT02108262|524756641|FG000|Overall Study|Vacation|0|||
145517882|NCT02108262|524756642|FG001|Overall Study|Vacation|1|||
145517883|NCT02108262|524756643|FG002|Overall Study|Vacation|0|||
145517884|NCT02108262|524756644|FG003|Overall Study|Vacation|0|||
145517885|NCT02108262|524756641|FG000|Overall Study|Patient decision|0|||
145517886|NCT02108262|524756642|FG001|Overall Study|Patient decision|7|||
145517887|NCT02108262|524756643|FG002|Overall Study|Patient decision|9|||
145517888|NCT02108262|524756644|FG003|Overall Study|Patient decision|14|||
145517889|NCT02108262|524756641|FG000|Overall Study|Missed IV due to pharmacy error|0|||
145517890|NCT02108262|524756642|FG001|Overall Study|Missed IV due to pharmacy error|0|||
145517891|NCT02108262|524756643|FG002|Overall Study|Missed IV due to pharmacy error|1|||
145517892|NCT02108262|524756644|FG003|Overall Study|Missed IV due to pharmacy error|0|||
145517893|NCT02412488|524756662|FG000|Overall Study|Lost to Follow-up|10|||
145517894|NCT02412488|524756662|FG000|Overall Study|Withdrawal by Subject|5|||
145517895|NCT02412488|524756662|FG000|Overall Study|Physician Decision|1|||
145517896|NCT02412488|524756662|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
145517897|NCT02412488|524756662|FG000|Overall Study|Reveal LINQ explant|1|||
145517898|NCT01989468|524756663|FG000|Overall Study|Adverse Event|10|||
145517899|NCT01989468|524756664|FG001|Overall Study|Adverse Event|15|||
145517900|NCT01989468|524756665|FG002|Overall Study|Adverse Event|4|||
145517901|NCT01989468|524756666|FG003|Overall Study|Adverse Event|5|||
145517902|NCT01989468|524756667|FG004|Overall Study|Adverse Event|4|||
145517903|NCT01989468|524756663|FG000|Overall Study|Lack of Efficacy|11|||
145517904|NCT01989468|524756664|FG001|Overall Study|Lack of Efficacy|11|||
145517905|NCT01989468|524756665|FG002|Overall Study|Lack of Efficacy|7|||
145517906|NCT01989468|524756666|FG003|Overall Study|Lack of Efficacy|4|||
145517907|NCT01989468|524756667|FG004|Overall Study|Lack of Efficacy|2|||
145517908|NCT01989468|524756663|FG000|Overall Study|Lost to Follow-up|5|||
145517909|NCT01989468|524756664|FG001|Overall Study|Lost to Follow-up|2|||
145517910|NCT01989468|524756665|FG002|Overall Study|Lost to Follow-up|0|||
145517911|NCT01989468|524756666|FG003|Overall Study|Lost to Follow-up|1|||
145517912|NCT01989468|524756667|FG004|Overall Study|Lost to Follow-up|1|||
145517913|NCT01989468|524756663|FG000|Overall Study|Physician Decision|4|||
145517914|NCT01989468|524756664|FG001|Overall Study|Physician Decision|1|||
145517915|NCT01989468|524756665|FG002|Overall Study|Physician Decision|0|||
145517916|NCT01989468|524756666|FG003|Overall Study|Physician Decision|1|||
145517917|NCT01989468|524756667|FG004|Overall Study|Physician Decision|0|||
145517918|NCT01989468|524756663|FG000|Overall Study|Pregnancy|0|||
145517919|NCT01989468|524756664|FG001|Overall Study|Pregnancy|1|||
145517920|NCT01989468|524756665|FG002|Overall Study|Pregnancy|0|||
145517921|NCT01989468|524756666|FG003|Overall Study|Pregnancy|0|||
145517922|NCT01989468|524756667|FG004|Overall Study|Pregnancy|0|||
145517923|NCT01989468|524756663|FG000|Overall Study|Technical Problems|3|||
145517924|NCT01989468|524756664|FG001|Overall Study|Technical Problems|1|||
145517925|NCT01989468|524756665|FG002|Overall Study|Technical Problems|3|||
145517926|NCT01989468|524756666|FG003|Overall Study|Technical Problems|1|||
145517927|NCT01989468|524756667|FG004|Overall Study|Technical Problems|0|||
145517928|NCT01989468|524756663|FG000|Overall Study|Subject Guardian Decision|11|||
145517929|NCT01989468|524756664|FG001|Overall Study|Subject Guardian Decision|6|||
145517930|NCT01989468|524756665|FG002|Overall Study|Subject Guardian Decision|4|||
145517931|NCT01989468|524756666|FG003|Overall Study|Subject Guardian Decision|4|||
145517932|NCT01989468|524756667|FG004|Overall Study|Subject Guardian Decision|1|||
145517933|NCT01989468|524756663|FG000|Overall Study|Death|3|||
145517934|NCT01989468|524756664|FG001|Overall Study|Death|0|||
145517935|NCT01989468|524756665|FG002|Overall Study|Death|1|||
145517936|NCT01989468|524756666|FG003|Overall Study|Death|0|||
145517937|NCT01989468|524756667|FG004|Overall Study|Death|0|||
145517938|NCT00674154|524756669|FG000|Overall Study|Withdrawal by Subject|3|||
145517939|NCT00674154|524756670|FG001|Overall Study|Withdrawal by Subject|1|||
145517940|NCT00674154|524756669|FG000|Overall Study|Did not want parathyroidectomy|0|||
145517941|NCT00674154|524756670|FG001|Overall Study|Did not want parathyroidectomy|2|||
145517942|NCT00816023|524756671|FG000|Overall Study|Lost to Follow-up|1|||
145517943|NCT00816023|524756672|FG001|Overall Study|Lost to Follow-up|1|||
145517944|NCT00816023|524756673|FG002|Overall Study|Lost to Follow-up|0|||
145517945|NCT00816023|524756674|FG003|Overall Study|Lost to Follow-up|0|||
145517946|NCT00816023|524756671|FG000|Overall Study|Withdrawal by Subject|1|||
145517947|NCT00816023|524756672|FG001|Overall Study|Withdrawal by Subject|0|||
145517948|NCT00816023|524756673|FG002|Overall Study|Withdrawal by Subject|0|||
145517949|NCT00816023|524756674|FG003|Overall Study|Withdrawal by Subject|0|||
145517950|NCT00816023|524756671|FG000|Overall Study|Physician Decision|0|||
145517951|NCT00816023|524756672|FG001|Overall Study|Physician Decision|0|||
145517952|NCT00816023|524756673|FG002|Overall Study|Physician Decision|1|||
145517953|NCT00816023|524756674|FG003|Overall Study|Physician Decision|0|||
145517954|NCT00816023|524756671|FG000|Overall Study|assessments complete prior to window|1|||
145517955|NCT00816023|524756672|FG001|Overall Study|assessments complete prior to window|1|||
145517956|NCT00816023|524756673|FG002|Overall Study|assessments complete prior to window|2|||
145517957|NCT00816023|524756674|FG003|Overall Study|assessments complete prior to window|1|||
145517958|NCT00816023|524756671|FG000|Overall Study|Randomized Not Treated|6|||
145740737|NCT02289742|525567332|FG000|Third Wear Period|Reason not given|0|||
145740738|NCT02289742|525567333|FG001|Third Wear Period|Reason not given|0|||
145740739|NCT02289742|525567334|FG002|Third Wear Period|Reason not given|0|||
145740740|NCT02289742|525567335|FG003|Third Wear Period|Reason not given|1|||
145740741|NCT02865018|525567336|FG000|Overall Study|Withdrawal by Subject|1|||
145740742|NCT00424749|525567339|FG000|Overall Study|Withdrawal by Subject|1|||
145740743|NCT00714285|525567340|FG000|Overall Study|Lost to Follow-up|0|||
145740744|NCT00714285|525567341|FG001|Overall Study|Lost to Follow-up|2|||
145740745|NCT00714285|525567342|FG002|Overall Study|Lost to Follow-up|0|||
145740746|NCT00714285|525567343|FG003|Overall Study|Lost to Follow-up|1|||
145740747|NCT00714285|525567340|FG000|Overall Study|Migrated/moved from study area|0|||
145740748|NCT00714285|525567341|FG001|Overall Study|Migrated/moved from study area|1|||
145740749|NCT00714285|525567342|FG002|Overall Study|Migrated/moved from study area|0|||
145740750|NCT00714285|525567343|FG003|Overall Study|Migrated/moved from study area|0|||
145740751|NCT01131676|525567344|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
145740752|NCT01131676|525567345|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
145740753|NCT01131676|525567346|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
145740754|NCT01131676|525567344|FG000|Discontinuation From Treatment|Not treated|4|||
145740755|NCT01131676|525567345|FG001|Discontinuation From Treatment|Not treated|2|||
145740756|NCT01131676|525567346|FG002|Discontinuation From Treatment|Not treated|2|||
145740757|NCT01131676|525567344|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
145740758|NCT01131676|525567345|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
145740759|NCT01131676|525567346|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
145740760|NCT01131676|525567344|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
145740761|NCT01131676|525567345|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
145740762|NCT01131676|525567346|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
145740763|NCT01131676|525567344|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
145740764|NCT01131676|525567345|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
145740765|NCT01131676|525567346|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
145740766|NCT01131676|525567344|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
145517959|NCT00816023|524756672|FG001|Overall Study|Randomized Not Treated|4|||
145740767|NCT01131676|525567345|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
145740768|NCT01131676|525567346|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
145740769|NCT01131676|525567344|FG000|Discontinuation From Treatment|Other than those specified|162|||
145740770|NCT01131676|525567345|FG001|Discontinuation From Treatment|Other than those specified|142|||
145740771|NCT01131676|525567346|FG002|Discontinuation From Treatment|Other than those specified|125|||
145740772|NCT01131676|525567344|FG000|Discontinuation From Treatment|Adverse Event|303|||
145740773|NCT01131676|525567345|FG001|Discontinuation From Treatment|Adverse Event|267|||
145740774|NCT01131676|525567346|FG002|Discontinuation From Treatment|Adverse Event|273|||
145517960|NCT00816023|524756673|FG002|Overall Study|Randomized Not Treated|6|||
145740775|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
145740776|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
145740777|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
145740778|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
145740779|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
145740780|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
145740781|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
145740782|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
145740783|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
145740784|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
145740785|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
145740786|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
145740787|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
145740788|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
145740789|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
145740790|NCT01131676|525567344|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
145740791|NCT01131676|525567345|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
145740792|NCT01131676|525567346|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
145740793|NCT04109222|525567347|FG000|Overall Study|Adverse Event|1|||
145740794|NCT04109222|525567348|FG001|Overall Study|Adverse Event|0|||
145740795|NCT04109222|525567349|FG002|Overall Study|Adverse Event|0|||
145740796|NCT02577406|525567350|FG000|Randomized Period|Death|1|||
145740797|NCT02577406|525567351|FG001|Randomized Period|Death|0|||
145740798|NCT02577406|525567350|FG000|Randomized Period|Other reasons|0|||
145740799|NCT02577406|525567351|FG001|Randomized Period|Other reasons|20|||
145740800|NCT02577406|525567350|FG000|Treatment Period|Death|38|||
145740801|NCT02577406|525567351|FG001|Treatment Period|Death|23|||
145740802|NCT02577406|525567350|FG000|Treatment Period|Adverse Event|17|||
145740803|NCT02577406|525567351|FG001|Treatment Period|Adverse Event|12|||
145740804|NCT02577406|525567350|FG000|Treatment Period|Progressive Disease|53|||
145740805|NCT02577406|525567351|FG001|Treatment Period|Progressive Disease|37|||
145740806|NCT02577406|525567350|FG000|Treatment Period|Withdrawal by Subject|10|||
145740807|NCT02577406|525567351|FG001|Treatment Period|Withdrawal by Subject|24|||
145740808|NCT02577406|525567350|FG000|Treatment Period|Lost to Follow-up|0|||
145740809|NCT02577406|525567351|FG001|Treatment Period|Lost to Follow-up|1|||
145740810|NCT02577406|525567350|FG000|Treatment Period|Transition to commercially available treatment|1|||
145740811|NCT02577406|525567351|FG001|Treatment Period|Transition to commercially available treatment|1|||
145740812|NCT02577406|525567350|FG000|Treatment Period|Physician Decision|1|||
145740813|NCT02577406|525567351|FG001|Treatment Period|Physician Decision|0|||
145740814|NCT02577406|525567350|FG000|Treatment Period|Disease Relapse|28|||
145740815|NCT02577406|525567351|FG001|Treatment Period|Disease Relapse|1|||
145740816|NCT02577406|525567350|FG000|Treatment Period|Protocol Violation|0|||
145740817|NCT02577406|525567351|FG001|Treatment Period|Protocol Violation|1|||
145740818|NCT02577406|525567350|FG000|Treatment Period|Other Reasons|3|||
145740819|NCT02577406|525567351|FG001|Treatment Period|Other Reasons|39|||
145740820|NCT02577406|525567350|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
145740821|NCT02577406|525567351|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
145740822|NCT02138617|525567352|FG000|Overall Study|Death|1|||
145740823|NCT02138617|525567353|FG001|Overall Study|Death|2|||
145740824|NCT02138617|525567354|FG002|Overall Study|Death|2|||
145740825|NCT02138617|525567352|FG000|Overall Study|Adverse Event|8|||
145740826|NCT02138617|525567353|FG001|Overall Study|Adverse Event|5|||
145740827|NCT02138617|525567354|FG002|Overall Study|Adverse Event|2|||
145740828|NCT02138617|525567352|FG000|Overall Study|Disease Progression|20|||
145740829|NCT02138617|525567353|FG001|Overall Study|Disease Progression|13|||
145740830|NCT02138617|525567354|FG002|Overall Study|Disease Progression|4|||
145740831|NCT02138617|525567352|FG000|Overall Study|Withdrawal by Subject|7|||
145740832|NCT02138617|525567353|FG001|Overall Study|Withdrawal by Subject|10|||
145740833|NCT02138617|525567354|FG002|Overall Study|Withdrawal by Subject|2|||
145740834|NCT02138617|525567352|FG000|Overall Study|other complicating disease|0|||
145740835|NCT02138617|525567353|FG001|Overall Study|other complicating disease|2|||
145740836|NCT02138617|525567354|FG002|Overall Study|other complicating disease|0|||
145740837|NCT02138617|525567352|FG000|Overall Study|Protocol Violation|1|||
145740838|NCT02138617|525567353|FG001|Overall Study|Protocol Violation|0|||
145740839|NCT02138617|525567354|FG002|Overall Study|Protocol Violation|0|||
145740840|NCT02138617|525567352|FG000|Overall Study|Physician Decision|7|||
145740841|NCT02138617|525567353|FG001|Overall Study|Physician Decision|6|||
145740842|NCT02138617|525567354|FG002|Overall Study|Physician Decision|0|||
145740843|NCT02138617|525567352|FG000|Overall Study|financial reason|0|||
145740844|NCT02138617|525567353|FG001|Overall Study|financial reason|1|||
145740845|NCT02138617|525567354|FG002|Overall Study|financial reason|0|||
145740846|NCT02138617|525567352|FG000|Overall Study|other therapy|3|||
145740847|NCT02138617|525567353|FG001|Overall Study|other therapy|4|||
145740848|NCT02138617|525567354|FG002|Overall Study|other therapy|0|||
145740849|NCT01961349|525567355|FG000|Overall Study|Withdrawal by Subject|1|||
145740850|NCT01961349|525567356|FG001|Overall Study|Withdrawal by Subject|4|||
145740851|NCT01961349|525567357|FG002|Overall Study|Withdrawal by Subject|0|||
145740852|NCT01961349|525567355|FG000|Overall Study|Adverse Event|0|||
145740853|NCT01961349|525567356|FG001|Overall Study|Adverse Event|0|||
145740854|NCT01961349|525567357|FG002|Overall Study|Adverse Event|1|||
145740855|NCT01961349|525567355|FG000|Overall Study|registration error, personal reason etc|2|||
145740856|NCT01961349|525567356|FG001|Overall Study|registration error, personal reason etc|2|||
145740857|NCT01961349|525567357|FG002|Overall Study|registration error, personal reason etc|1|||
145740858|NCT00596947|525567358|FG000|Overall Study|study halted due to low enrollment|5|||
145740859|NCT00596947|525567359|FG001|Overall Study|study halted due to low enrollment|3|||
145740860|NCT00596947|525567358|FG000|Overall Study|Lost to Follow-up|1|||
145740861|NCT00596947|525567359|FG001|Overall Study|Lost to Follow-up|0|||
145740862|NCT00829179|525567360|FG000|Overall Study|Withdrawal by Subject|1|||
145740863|NCT03000179|525567361|FG000|Overall Study|Lost to Follow-up|2|||
145740864|NCT02343159|525567362|FG000|Overall Study|Early Study Termination|16|||
145740865|NCT02343159|525567363|FG001|Overall Study|Early Study Termination|19|||
145740866|NCT02343159|525567364|FG002|Overall Study|Early Study Termination|23|||
145740867|NCT02343159|525567362|FG000|Overall Study|Physician Decision|2|||
145740868|NCT02343159|525567363|FG001|Overall Study|Physician Decision|0|||
145740869|NCT02343159|525567364|FG002|Overall Study|Physician Decision|1|||
145740870|NCT02343159|525567362|FG000|Overall Study|Withdrawal by Subject|3|||
145740871|NCT02343159|525567363|FG001|Overall Study|Withdrawal by Subject|0|||
145740872|NCT02343159|525567364|FG002|Overall Study|Withdrawal by Subject|2|||
145740873|NCT02343159|525567362|FG000|Overall Study|Lost to Follow-up|0|||
145740874|NCT02343159|525567363|FG001|Overall Study|Lost to Follow-up|2|||
145740875|NCT02343159|525567364|FG002|Overall Study|Lost to Follow-up|2|||
145740876|NCT02343159|525567362|FG000|Overall Study|Adverse Event|4|||
145740877|NCT02343159|525567363|FG001|Overall Study|Adverse Event|4|||
145740878|NCT02343159|525567364|FG002|Overall Study|Adverse Event|2|||
145740879|NCT02343159|525567362|FG000|Overall Study|Sponsor Decision|0|||
145740880|NCT02343159|525567363|FG001|Overall Study|Sponsor Decision|1|||
145740881|NCT02343159|525567364|FG002|Overall Study|Sponsor Decision|0|||
145740882|NCT02343159|525567362|FG000|Overall Study|Enrollment Error|1|||
145740883|NCT02343159|525567363|FG001|Overall Study|Enrollment Error|0|||
145740884|NCT02343159|525567364|FG002|Overall Study|Enrollment Error|0|||
145740885|NCT00545064|525567367|FG000|Overall Study|Lost to Follow-up|3|||
145740886|NCT00545064|525567367|FG000|Overall Study|Withdrawal by Subject|2|||
145740887|NCT00545064|525567367|FG000|Overall Study|did not complete course of treatment|1|||
145740888|NCT00545064|525567367|FG000|Overall Study|cancel all appointments, no rebooking|1|||
145740889|NCT00545064|525567367|FG000|Overall Study|inclement weather|1|||
145740890|NCT04688775|525567370|FG000|Placebo-controlled Period|Randomized, not treated|1|||
145740891|NCT04688775|525567371|FG001|Placebo-controlled Period|Randomized, not treated|1|||
145740892|NCT04688775|525567372|FG002|Placebo-controlled Period|Randomized, not treated|0|||
145740893|NCT04688775|525567373|FG003|Placebo-controlled Period|Randomized, not treated|0|||
145740894|NCT04688775|525567370|FG000|Placebo-controlled Period|Adverse Event|2|||
145740895|NCT04688775|525567371|FG001|Placebo-controlled Period|Adverse Event|0|||
145740896|NCT04688775|525567372|FG002|Placebo-controlled Period|Adverse Event|0|||
145740897|NCT04688775|525567373|FG003|Placebo-controlled Period|Adverse Event|0|||
145740898|NCT04688775|525567370|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
145740899|NCT04688775|525567371|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
145740900|NCT04688775|525567372|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
145740901|NCT04688775|525567373|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
145740902|NCT04688775|525567370|FG000|Placebo-controlled Period|Protocol Violation|0|||
145740903|NCT04688775|525567371|FG001|Placebo-controlled Period|Protocol Violation|1|||
145740904|NCT04688775|525567372|FG002|Placebo-controlled Period|Protocol Violation|0|||
145740905|NCT04688775|525567373|FG003|Placebo-controlled Period|Protocol Violation|0|||
145740906|NCT04688775|525567370|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
145740907|NCT04688775|525567371|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
145740908|NCT04688775|525567372|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
145740909|NCT04688775|525567373|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
145740910|NCT04688775|525567370|FG000|Placebo-controlled Period|Other reasons|0|||
145740911|NCT04688775|525567371|FG001|Placebo-controlled Period|Other reasons|1|||
145740912|NCT04688775|525567372|FG002|Placebo-controlled Period|Other reasons|0|||
145740913|NCT04688775|525567373|FG003|Placebo-controlled Period|Other reasons|0|||
145740914|NCT04688775|525567370|FG000|Delayed Start Period|Adverse Event|0|||
145740915|NCT04688775|525567371|FG001|Delayed Start Period|Adverse Event|0|||
145740916|NCT04688775|525567372|FG002|Delayed Start Period|Adverse Event|1|||
145517961|NCT00816023|524756674|FG003|Overall Study|Randomized Not Treated|11|||
145517962|NCT04449029|524756675|FG000|Overall Study|Adverse Event|0|||
145517963|NCT04449029|524756676|FG001|Overall Study|Adverse Event|1|||
145740917|NCT04688775|525567373|FG003|Delayed Start Period|Adverse Event|0|||
145740918|NCT04688775|525567370|FG000|Delayed Start Period|Lack of Efficacy|0|||
145740919|NCT04688775|525567371|FG001|Delayed Start Period|Lack of Efficacy|0|||
145740920|NCT04688775|525567372|FG002|Delayed Start Period|Lack of Efficacy|0|||
145740921|NCT04688775|525567373|FG003|Delayed Start Period|Lack of Efficacy|3|||
145740922|NCT04688775|525567370|FG000|Delayed Start Period|Withdrawal by Subject|0|||
145740923|NCT04688775|525567371|FG001|Delayed Start Period|Withdrawal by Subject|0|||
145740924|NCT04688775|525567372|FG002|Delayed Start Period|Withdrawal by Subject|2|||
145740925|NCT04688775|525567373|FG003|Delayed Start Period|Withdrawal by Subject|4|||
145740926|NCT04688775|525567370|FG000|Delayed Start Period|Lost to Follow-up|0|||
145740927|NCT04688775|525567371|FG001|Delayed Start Period|Lost to Follow-up|0|||
145740928|NCT04688775|525567372|FG002|Delayed Start Period|Lost to Follow-up|2|||
145740929|NCT04688775|525567373|FG003|Delayed Start Period|Lost to Follow-up|1|||
145740930|NCT04688775|525567370|FG000|Delayed Start Period|other reasons|0|||
145740931|NCT04688775|525567371|FG001|Delayed Start Period|other reasons|0|||
145740932|NCT04688775|525567372|FG002|Delayed Start Period|other reasons|1|||
145740933|NCT04688775|525567373|FG003|Delayed Start Period|other reasons|0|||
145740934|NCT01843972|525567374|FG000|Overall Study|Withdrawal by Subject|0|||
145740935|NCT01843972|525567375|FG001|Overall Study|Withdrawal by Subject|0|||
145740936|NCT01843972|525567376|FG002|Overall Study|Withdrawal by Subject|0|||
145740937|NCT01843972|525567377|FG003|Overall Study|Withdrawal by Subject|0|||
145740938|NCT01843972|525567378|FG004|Overall Study|Withdrawal by Subject|1|||
145740939|NCT01843972|525567379|FG005|Overall Study|Withdrawal by Subject|0|||
145740940|NCT01843972|525567380|FG006|Overall Study|Withdrawal by Subject|0|||
145740941|NCT01843972|525567381|FG007|Overall Study|Withdrawal by Subject|0|||
145740942|NCT01843972|525567382|FG008|Overall Study|Withdrawal by Subject|0|||
145740943|NCT01843972|525567383|FG009|Overall Study|Withdrawal by Subject|0|||
145740944|NCT04702737|525567386|FG000|Overall Study|Decision by Sponsor|1|||
145740945|NCT04702737|525567386|FG000|Overall Study|Withdrawal of Consent from Study|3|||
145740946|NCT04702737|525567386|FG000|Overall Study|Lost to Follow-up|1|||
145740947|NCT04702737|525567386|FG000|Overall Study|Death|35|||
145740948|NCT01177683|525567387|FG000|Study Treatment|Disease Progressions during treatment|2|||
145740949|NCT01177683|525567388|FG001|Study Treatment|Disease Progressions during treatment|0|||
145740950|NCT01177683|525567389|FG002|Study Treatment|Disease Progressions during treatment|3|||
145740951|NCT01177683|525567387|FG000|Study Treatment|Adverse Event|0|||
145740952|NCT01177683|525567388|FG001|Study Treatment|Adverse Event|1|||
145740953|NCT01177683|525567389|FG002|Study Treatment|Adverse Event|12|||
145740954|NCT01177683|525567387|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
145740955|NCT01177683|525567388|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
145740956|NCT01177683|525567389|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
145740957|NCT01177683|525567387|FG000|Study Treatment|Alternative therapy|0|||
145740958|NCT01177683|525567388|FG001|Study Treatment|Alternative therapy|0|||
145740959|NCT01177683|525567389|FG002|Study Treatment|Alternative therapy|4|||
145740960|NCT01177683|525567387|FG000|Study Treatment|Physician Decision|1|||
145740961|NCT01177683|525567388|FG001|Study Treatment|Physician Decision|0|||
145740962|NCT01177683|525567389|FG002|Study Treatment|Physician Decision|1|||
145740963|NCT01177683|525567387|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
145740964|NCT01177683|525567388|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
145740965|NCT01177683|525567389|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
145740966|NCT01177683|525567387|FG000|Study Treatment|Symptomatic Deterioration|0|||
145740967|NCT01177683|525567388|FG001|Study Treatment|Symptomatic Deterioration|0|||
145740968|NCT01177683|525567389|FG002|Study Treatment|Symptomatic Deterioration|1|||
145740969|NCT01177683|525567387|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
145740970|NCT01177683|525567388|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
145740971|NCT01177683|525567389|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
145740972|NCT01177683|525567387|FG000|Follow up|Patient lost to follow up|0|||
145740973|NCT01177683|525567388|FG001|Follow up|Patient lost to follow up|0|||
145517964|NCT04449029|524756677|FG002|Overall Study|Adverse Event|1|||
145740974|NCT01177683|525567389|FG002|Follow up|Patient lost to follow up|2|||
145740975|NCT01177683|525567387|FG000|Follow up|Death|2|||
145740976|NCT01177683|525567388|FG001|Follow up|Death|1|||
145740977|NCT01177683|525567389|FG002|Follow up|Death|7|||
145740978|NCT01177683|525567387|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
145740979|NCT01177683|525567388|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
145740980|NCT01177683|525567389|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
145740981|NCT01977820|525567392|FG000|Overall Study|Sponsor terminated the study|1|||
145740982|NCT01977820|525567393|FG001|Overall Study|Sponsor terminated the study|1|||
145740983|NCT02568475|525567397|FG000|Overall Study|Lost to Follow-up|40|||
145740984|NCT02568475|525567398|FG001|Overall Study|Lost to Follow-up|39|||
145517965|NCT04449029|524756678|FG003|Overall Study|Adverse Event|0|||
145740985|NCT02568475|525567397|FG000|Overall Study|Withdrawal by Subject|2|||
145740986|NCT02568475|525567398|FG001|Overall Study|Withdrawal by Subject|0|||
145740987|NCT02568475|525567397|FG000|Overall Study|Discharged home|4|||
145740988|NCT02568475|525567398|FG001|Overall Study|Discharged home|4|||
145740989|NCT02568475|525567397|FG000|Overall Study|Short-term: Discharge location unknown|4|||
145740990|NCT02568475|525567398|FG001|Overall Study|Short-term: Discharge location unknown|0|||
145740991|NCT02568475|525567397|FG000|Overall Study|Transferred to another facility|1|||
145740992|NCT02568475|525567398|FG001|Overall Study|Transferred to another facility|0|||
145740993|NCT00290186|525567403|FG000|Overall Study|Adverse Event|1|||
145740994|NCT00290186|525567404|FG001|Overall Study|Adverse Event|1|||
145740995|NCT00290186|525567403|FG000|Overall Study|Lost to Follow-up|3|||
145740996|NCT00290186|525567404|FG001|Overall Study|Lost to Follow-up|2|||
145740997|NCT00290186|525567403|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
145740998|NCT00290186|525567404|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
145740999|NCT00290186|525567403|FG000|Overall Study|Withdrawal by Subject|0|||
145741000|NCT00290186|525567404|FG001|Overall Study|Withdrawal by Subject|1|||
145741001|NCT03159091|525567405|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
145741002|NCT03159091|525567406|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
145741003|NCT03159091|525567405|FG000|Overall Study|Patient has taken no dose of study drug|0|||
145741004|NCT03159091|525567406|FG001|Overall Study|Patient has taken no dose of study drug|1|||
145741005|NCT02044133|525567407|FG000|Overall Study|Lost to Follow-up|1|||
145741006|NCT02044133|525567408|FG001|Overall Study|Lost to Follow-up|1|||
145741007|NCT02044133|525567407|FG000|Overall Study|Death|1|||
145741008|NCT02044133|525567408|FG001|Overall Study|Death|0|||
145741009|NCT02044133|525567407|FG000|Overall Study|Release|3|||
145741010|NCT02044133|525567408|FG001|Overall Study|Release|4|||
145741011|NCT02044133|525567407|FG000|Overall Study|Transfer|1|||
145741012|NCT02044133|525567408|FG001|Overall Study|Transfer|0|||
145741013|NCT02044133|525567407|FG000|Overall Study|refusal of blood sampling|0|||
145741014|NCT02044133|525567408|FG001|Overall Study|refusal of blood sampling|1|||
145741015|NCT04085523|525567409|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
145741016|NCT04085523|525567410|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
145741017|NCT04085523|525567411|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
145741018|NCT04085523|525567412|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
145741019|NCT04085523|525567413|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
145741020|NCT04085523|525567414|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
145741021|NCT04722042|525567415|FG000|Overall Study|Withdrawal by Subject|2|||
145741022|NCT04722042|525567416|FG001|Overall Study|Withdrawal by Subject|1|||
145741023|NCT04722042|525567417|FG002|Overall Study|Withdrawal by Subject|0|||
145741024|NCT04490018|525567425|FG000|Overall Study|Protocol Violation|0|||
145741025|NCT04490018|525567426|FG001|Overall Study|Protocol Violation|2|||
145741026|NCT04490018|525567427|FG002|Overall Study|Protocol Violation|1|||
145741027|NCT04490018|525567425|FG000|Overall Study|Lost to Follow-up|2|||
145741028|NCT04490018|525567426|FG001|Overall Study|Lost to Follow-up|2|||
145741029|NCT04490018|525567427|FG002|Overall Study|Lost to Follow-up|0|||
145741030|NCT04490018|525567425|FG000|Overall Study|Withdrawal by Subject|2|||
145741031|NCT04490018|525567426|FG001|Overall Study|Withdrawal by Subject|1|||
145741032|NCT04490018|525567427|FG002|Overall Study|Withdrawal by Subject|0|||
145741033|NCT04490018|525567425|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145741034|NCT04490018|525567426|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145741035|NCT04490018|525567427|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145517966|NCT04449029|524756679|FG004|Overall Study|Adverse Event|1|||
145517967|NCT04449029|524756680|FG005|Overall Study|Adverse Event|0|||
145741036|NCT00943579|525567430|FG000|Overall Study|Adverse Event|4|||
145741037|NCT00943579|525567431|FG001|Overall Study|Adverse Event|3|||
145517968|NCT04449029|524756681|FG006|Overall Study|Adverse Event|1|||
145517969|NCT04449029|524756682|FG007|Overall Study|Adverse Event|0|||
145741038|NCT00943579|525567430|FG000|Overall Study|Lack of Efficacy|2|||
145741039|NCT00943579|525567431|FG001|Overall Study|Lack of Efficacy|2|||
145741040|NCT02710136|525567432|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
145741041|NCT02710136|525567433|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
145741042|NCT00418665|525567434|FG000|Treatment Period|Ineligibility determined|1|||
145741043|NCT00418665|525567435|FG001|Treatment Period|Ineligibility determined|1|||
145741044|NCT00418665|525567436|FG002|Treatment Period|Ineligibility determined|0|||
145741045|NCT00418665|525567434|FG000|Treatment Period|Adverse Event|2|||
145741046|NCT00418665|525567435|FG001|Treatment Period|Adverse Event|2|||
145741047|NCT00418665|525567436|FG002|Treatment Period|Adverse Event|0|||
145741048|NCT00418665|525567434|FG000|Treatment Period|Withdrawal by Subject|0|||
145741049|NCT00418665|525567435|FG001|Treatment Period|Withdrawal by Subject|3|||
145741050|NCT00418665|525567436|FG002|Treatment Period|Withdrawal by Subject|1|||
145741051|NCT00418665|525567434|FG000|Treatment Period|Requirement for alternative therapy|1|||
145741052|NCT00418665|525567435|FG001|Treatment Period|Requirement for alternative therapy|0|||
145741053|NCT00418665|525567436|FG002|Treatment Period|Requirement for alternative therapy|0|||
145741054|NCT00418665|525567434|FG000|Treatment Period|Physician Decision|1|||
145741055|NCT00418665|525567435|FG001|Treatment Period|Physician Decision|0|||
145741056|NCT00418665|525567436|FG002|Treatment Period|Physician Decision|3|||
145741057|NCT00418665|525567434|FG000|Treatment Extension|Adverse Event|1|||
145741058|NCT00418665|525567435|FG001|Treatment Extension|Adverse Event|0|||
145741059|NCT00418665|525567436|FG002|Treatment Extension|Adverse Event|0|||
145741060|NCT00418665|525567434|FG000|Treatment Extension|Withdrawal by Subject|1|||
145741061|NCT00418665|525567435|FG001|Treatment Extension|Withdrawal by Subject|0|||
145741062|NCT00418665|525567436|FG002|Treatment Extension|Withdrawal by Subject|0|||
145741063|NCT00418665|525567434|FG000|Treatment Extension|Requirement for alternative therapy|2|||
145741064|NCT00418665|525567435|FG001|Treatment Extension|Requirement for alternative therapy|2|||
145741065|NCT00418665|525567436|FG002|Treatment Extension|Requirement for alternative therapy|0|||
145741066|NCT00418665|525567434|FG000|Treatment Extension|Physician Decision|2|||
145741067|NCT00418665|525567435|FG001|Treatment Extension|Physician Decision|2|||
145741068|NCT00418665|525567436|FG002|Treatment Extension|Physician Decision|1|||
145741069|NCT00418665|525567434|FG000|Treatment Extension|Death|0|||
145741070|NCT00418665|525567435|FG001|Treatment Extension|Death|0|||
145741071|NCT00418665|525567436|FG002|Treatment Extension|Death|1|||
145741072|NCT01133379|525567437|FG000|Overall Study|Withdrawal by Subject|0|||
145741073|NCT01133379|525567438|FG001|Overall Study|Withdrawal by Subject|1|||
145741074|NCT01133379|525567439|FG002|Overall Study|Withdrawal by Subject|1|||
145517970|NCT04449029|524756675|FG000|Overall Study|Lost to Follow-up|0|||
145517971|NCT04449029|524756676|FG001|Overall Study|Lost to Follow-up|1|||
145741075|NCT01133379|525567437|FG000|Overall Study|Lost to Follow-up|1|||
145517972|NCT04449029|524756677|FG002|Overall Study|Lost to Follow-up|0|||
145517973|NCT04449029|524756678|FG003|Overall Study|Lost to Follow-up|0|||
145517974|NCT04449029|524756679|FG004|Overall Study|Lost to Follow-up|0|||
145517975|NCT04449029|524756680|FG005|Overall Study|Lost to Follow-up|0|||
145517976|NCT04449029|524756681|FG006|Overall Study|Lost to Follow-up|0|||
145517977|NCT04449029|524756682|FG007|Overall Study|Lost to Follow-up|0|||
145517978|NCT04449029|524756675|FG000|Overall Study|Protocol Violation|0|||
145517979|NCT04449029|524756676|FG001|Overall Study|Protocol Violation|1|||
145517980|NCT04449029|524756677|FG002|Overall Study|Protocol Violation|0|||
145517981|NCT04449029|524756678|FG003|Overall Study|Protocol Violation|0|||
145517982|NCT04449029|524756679|FG004|Overall Study|Protocol Violation|0|||
145517983|NCT04449029|524756680|FG005|Overall Study|Protocol Violation|0|||
145517984|NCT04449029|524756681|FG006|Overall Study|Protocol Violation|0|||
145517985|NCT04449029|524756682|FG007|Overall Study|Protocol Violation|0|||
145517986|NCT04449029|524756675|FG000|Overall Study|Physician Decision|0|||
145517987|NCT04449029|524756676|FG001|Overall Study|Physician Decision|0|||
145517988|NCT04449029|524756677|FG002|Overall Study|Physician Decision|0|||
145517989|NCT04449029|524756678|FG003|Overall Study|Physician Decision|0|||
145517990|NCT04449029|524756679|FG004|Overall Study|Physician Decision|0|||
145517991|NCT04449029|524756680|FG005|Overall Study|Physician Decision|1|||
145517992|NCT04449029|524756681|FG006|Overall Study|Physician Decision|0|||
145741076|NCT01133379|525567438|FG001|Overall Study|Lost to Follow-up|1|||
145517993|NCT04449029|524756682|FG007|Overall Study|Physician Decision|0|||
145741077|NCT01133379|525567439|FG002|Overall Study|Lost to Follow-up|1|||
145741078|NCT02269787|525567441|FG000|Overall Study|Lost to Follow-up|20|||
145517994|NCT04449029|524756675|FG000|Overall Study|Withdrawal by Subject|3|||
145517995|NCT04449029|524756676|FG001|Overall Study|Withdrawal by Subject|0|||
145517996|NCT04449029|524756677|FG002|Overall Study|Withdrawal by Subject|1|||
145741079|NCT02269787|525567442|FG001|Overall Study|Lost to Follow-up|6|||
145741080|NCT02269787|525567441|FG000|Overall Study|Death|2|||
145741081|NCT02269787|525567442|FG001|Overall Study|Death|3|||
145517997|NCT04449029|524756678|FG003|Overall Study|Withdrawal by Subject|1|||
145741082|NCT02269787|525567441|FG000|Overall Study|Incapacitated|0|||
145741083|NCT02269787|525567442|FG001|Overall Study|Incapacitated|1|||
145741084|NCT00798135|525567443|FG000|Overall Study|Disease progression, relapse|11|||
145741085|NCT00798135|525567443|FG000|Overall Study|Disease progression, refractory|1|||
145741086|NCT00798135|525567443|FG000|Overall Study|Physician Decision|1|||
145741087|NCT00687440|525567444|FG000|Overall Study|Adverse Event|3|||
145741088|NCT00687440|525567444|FG000|Overall Study|Lost to Follow-up|3|||
145741089|NCT00687440|525567444|FG000|Overall Study|Lack of Efficacy|2|||
145741090|NCT00687440|525567444|FG000|Overall Study|Death|2|||
145741091|NCT00687440|525567444|FG000|Overall Study|Other|1|||
145741092|NCT00687440|525567444|FG000|Overall Study|Missing|1|||
145741093|NCT02228720|525567445|FG000|Open Label - Day 30|Lost to Follow-up|1|||
145741094|NCT03977974|525567454|FG000|Period 2|Adverse Event|0|||
145741095|NCT03977974|525567455|FG001|Period 2|Adverse Event|0|||
145741096|NCT03977974|525567456|FG002|Period 2|Adverse Event|0|||
145741097|NCT03977974|525567457|FG003|Period 2|Adverse Event|0|||
145741098|NCT03977974|525567458|FG004|Period 2|Adverse Event|1|||
145741099|NCT03977974|525567459|FG005|Period 2|Adverse Event|0|||
145741100|NCT03977974|525567460|FG006|Period 2|Adverse Event|0|||
145741101|NCT03977974|525567461|FG007|Period 2|Adverse Event|0|||
145741102|NCT03977974|525567462|FG008|Period 2|Adverse Event|0|||
145741103|NCT03977974|525567463|FG009|Period 2|Adverse Event|0|||
145741104|NCT03977974|525567464|FG010|Period 2|Adverse Event|0|||
145741105|NCT03977974|525567465|FG011|Period 2|Adverse Event|0|||
145741106|NCT03977974|525567466|FG012|Period 2|Adverse Event|0|||
145741107|NCT04360551|525568659|FG000|Overall Study|Withdrawal by Subject|1|||
145741108|NCT04360551|525568660|FG001|Overall Study|Withdrawal by Subject|0|||
145741109|NCT00736255|525568661|FG000|Overall Study|Adverse Event|1|||
145741110|NCT00736255|525568662|FG001|Overall Study|Adverse Event|0|||
145741111|NCT00736255|525568661|FG000|Overall Study|Physician Decision|1|||
145741112|NCT00736255|525568662|FG001|Overall Study|Physician Decision|0|||
145741113|NCT00736255|525568661|FG000|Overall Study|Non-compliance|1|||
145741114|NCT00736255|525568662|FG001|Overall Study|Non-compliance|1|||
145741115|NCT02833974|525568676|FG000|Overall Study|Lost to Follow-up|1|||
145741116|NCT02833974|525568677|FG001|Overall Study|Lost to Follow-up|0|||
145741117|NCT02833974|525568676|FG000|Overall Study|Adverse Event|0|||
145741118|NCT02833974|525568677|FG001|Overall Study|Adverse Event|3|||
145741119|NCT01502709|525568682|FG000|Overall Study|Lost to Follow-up|4|||
145741120|NCT01502709|525568683|FG001|Overall Study|Lost to Follow-up|0|||
145741121|NCT00307151|525568684|FG000|Overall Study|Death|4|||
145741122|NCT00307151|525568685|FG001|Overall Study|Death|3|||
145741123|NCT00307151|525568686|FG002|Overall Study|Death|10|||
145741124|NCT00307151|525568687|FG003|Overall Study|Death|3|||
145741125|NCT00307151|525568684|FG000|Overall Study|Severe debilitation, unable to continue|1|||
145741126|NCT00307151|525568685|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145741127|NCT00307151|525568686|FG002|Overall Study|Severe debilitation, unable to continue|0|||
145741128|NCT00307151|525568687|FG003|Overall Study|Severe debilitation, unable to continue|0|||
145741129|NCT00307151|525568684|FG000|Overall Study|Subject unable to get to clinic|1|||
145741130|NCT00307151|525568685|FG001|Overall Study|Subject unable to get to clinic|0|||
145741131|NCT00307151|525568686|FG002|Overall Study|Subject unable to get to clinic|6|||
145741132|NCT00307151|525568687|FG003|Overall Study|Subject unable to get to clinic|2|||
145741133|NCT00307151|525568684|FG000|Overall Study|Withdrew consent|0|||
145741134|NCT00307151|525568685|FG001|Overall Study|Withdrew consent|1|||
145741135|NCT00307151|525568686|FG002|Overall Study|Withdrew consent|1|||
145741136|NCT00307151|525568687|FG003|Overall Study|Withdrew consent|3|||
145741137|NCT00307151|525568684|FG000|Overall Study|Not willing to adhere to study reqs|2|||
145741138|NCT00307151|525568685|FG001|Overall Study|Not willing to adhere to study reqs|0|||
145741139|NCT00307151|525568686|FG002|Overall Study|Not willing to adhere to study reqs|2|||
145741140|NCT00307151|525568687|FG003|Overall Study|Not willing to adhere to study reqs|2|||
145741141|NCT00307151|525568684|FG000|Overall Study|Clinic unable to contact subject|3|||
145741142|NCT00307151|525568685|FG001|Overall Study|Clinic unable to contact subject|3|||
145741143|NCT00307151|525568686|FG002|Overall Study|Clinic unable to contact subject|1|||
145402315|NCT03098979|524330712|FG003|Overall Study|Adverse Event|4|||
145741144|NCT00307151|525568687|FG003|Overall Study|Clinic unable to contact subject|1|||
145741145|NCT02966509|525568691|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
145741146|NCT02966509|525568692|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
145741147|NCT02966509|525568691|FG000|Baseline Satisfaction Survey|Death|0|||
145741148|NCT02966509|525568692|FG001|Baseline Satisfaction Survey|Death|1|||
145741149|NCT02966509|525568691|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
145741150|NCT02966509|525568692|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
145741151|NCT02966509|525568691|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
145741152|NCT02966509|525568692|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
145741153|NCT02966509|525568691|FG000|6 Month Satisfaction Decision Survey|Death|22|||
145741154|NCT02966509|525568692|FG001|6 Month Satisfaction Decision Survey|Death|25|||
145741155|NCT02966509|525568691|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
145741156|NCT02966509|525568692|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
145741157|NCT02966509|525568691|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
145741158|NCT02966509|525568692|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
145741159|NCT02966509|525568691|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
145741160|NCT02966509|525568692|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
145741161|NCT02966509|525568691|FG000|6 Month Satisfaction Survey|Death|36|||
145741162|NCT02966509|525568692|FG001|6 Month Satisfaction Survey|Death|33|||
145741163|NCT02966509|525568691|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
145741164|NCT02966509|525568692|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
145741165|NCT02966509|525568691|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
145741166|NCT02966509|525568692|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
145741167|NCT02966509|525568691|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
145741168|NCT02966509|525568692|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
145741169|NCT02966509|525568691|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
145741170|NCT02966509|525568692|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
145741171|NCT02966509|525568691|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
145741172|NCT02966509|525568692|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
145741173|NCT01365039|525568694|FG000|Overall Study|Study related symptoms and complaints|1|||
145741174|NCT01365039|525568695|FG001|Overall Study|Study related symptoms and complaints|0|||
145741175|NCT03807349|525568696|FG000|Overall Study|Early Study Termination|9|||
145741176|NCT00294060|525568697|FG000|Overall Study|Death|225|||
145741177|NCT00294060|525568697|FG000|Overall Study|Other|59|||
145741178|NCT00294060|525568697|FG000|Overall Study|Lost to Follow-up|55|||
145741179|NCT00294060|525568697|FG000|Overall Study|Withdrawal by Subject|11|||
145741180|NCT00294060|525568697|FG000|Overall Study|Physician Decision|797|||
145741181|NCT00294060|525568697|FG000|Overall Study|Medical condition|3|||
145741182|NCT00294060|525568697|FG000|Overall Study|Device explanted/not replaced|23|||
145741183|NCT01360554|525568698|FG000|Overall Study|Death|359|||
145741184|NCT01360554|525568699|FG001|Overall Study|Death|371|||
145517998|NCT04449029|524756679|FG004|Overall Study|Withdrawal by Subject|5|||
145517999|NCT04449029|524756680|FG005|Overall Study|Withdrawal by Subject|1|||
145518000|NCT04449029|524756681|FG006|Overall Study|Withdrawal by Subject|4|||
145518001|NCT04449029|524756682|FG007|Overall Study|Withdrawal by Subject|0|||
145518002|NCT02025556|524756688|FG000|Overall Study|Adverse Event|0|||
145741185|NCT01360554|525568698|FG000|Overall Study|Lost to Follow-up|4|||
145741186|NCT01360554|525568699|FG001|Overall Study|Lost to Follow-up|4|||
145741187|NCT01360554|525568698|FG000|Overall Study|Withdrawal by Subject|23|||
145741188|NCT01360554|525568699|FG001|Overall Study|Withdrawal by Subject|24|||
145741189|NCT01360554|525568698|FG000|Overall Study|Study terminated by sponsor|49|||
145741190|NCT01360554|525568699|FG001|Overall Study|Study terminated by sponsor|37|||
145741191|NCT01360554|525568698|FG000|Overall Study|Other, not specified|1|||
145402316|NCT03098979|524330713|FG004|Overall Study|Adverse Event|6|||
145402317|NCT03098979|524330714|FG005|Overall Study|Adverse Event|1|||
145741192|NCT01360554|525568699|FG001|Overall Study|Other, not specified|0|||
145741193|NCT01360554|525568698|FG000|Overall Study|Randomized but not treated.|3|||
145741194|NCT01360554|525568699|FG001|Overall Study|Randomized but not treated.|3|||
145741195|NCT00187096|525568700|FG000|Overall Study|unacceptable toxicity|0|||
145741196|NCT00187096|525568701|FG001|Overall Study|unacceptable toxicity|0|||
145741197|NCT00187096|525568702|FG002|Overall Study|unacceptable toxicity|1|||
145741198|NCT03668600|525568709|FG000|Overall Study|Study Terminated by the Sponsor|157|||
145741199|NCT03668600|525568709|FG000|Overall Study|Protocol Violation|1|||
145741200|NCT03668600|525568709|FG000|Overall Study|Pregnancy|1|||
145518003|NCT02025556|524756689|FG001|Overall Study|Adverse Event|4|||
145741201|NCT03668600|525568709|FG000|Overall Study|Lost to Follow-up|7|||
145741202|NCT03668600|525568709|FG000|Overall Study|Withdrawal by Subject|56|||
145741203|NCT03668600|525568709|FG000|Overall Study|Lack of Efficacy|7|||
145741204|NCT03668600|525568709|FG000|Overall Study|Adverse Event|1|||
145741205|NCT01263483|525568711|FG000|Overall Study|Adverse Event|4|||
145741206|NCT01263483|525568712|FG001|Overall Study|Adverse Event|0|||
145741207|NCT01263483|525568713|FG002|Overall Study|Adverse Event|3|||
145518004|NCT02025556|524756690|FG002|Overall Study|Adverse Event|2|||
145741208|NCT01263483|525568711|FG000|Overall Study|Withdrawal by Subject|1|||
145741209|NCT01263483|525568712|FG001|Overall Study|Withdrawal by Subject|0|||
145518005|NCT02025556|524756688|FG000|Overall Study|Lack of Efficacy|2|||
145518006|NCT02025556|524756689|FG001|Overall Study|Lack of Efficacy|1|||
145402318|NCT03098979|524330709|FG000|Overall Study|Withdrawal by Subject|2|||
145741210|NCT01263483|525568713|FG002|Overall Study|Withdrawal by Subject|0|||
145518007|NCT02025556|524756690|FG002|Overall Study|Lack of Efficacy|0|||
145518008|NCT02025556|524756688|FG000|Overall Study|Protocol Violation|2|||
145518009|NCT02025556|524756689|FG001|Overall Study|Protocol Violation|1|||
145518010|NCT02025556|524756690|FG002|Overall Study|Protocol Violation|0|||
145518011|NCT02025556|524756688|FG000|Overall Study|Withdrawal by Subject|0|||
145518012|NCT02025556|524756689|FG001|Overall Study|Withdrawal by Subject|3|||
145518013|NCT02025556|524756690|FG002|Overall Study|Withdrawal by Subject|6|||
145518014|NCT02025556|524756688|FG000|Overall Study|Lost to Follow-up|2|||
145518015|NCT02025556|524756689|FG001|Overall Study|Lost to Follow-up|4|||
145518016|NCT02025556|524756690|FG002|Overall Study|Lost to Follow-up|0|||
145518017|NCT02025556|524756688|FG000|Overall Study|Reason not reported|0|||
145518018|NCT02025556|524756689|FG001|Overall Study|Reason not reported|0|||
145518019|NCT02025556|524756690|FG002|Overall Study|Reason not reported|1|||
145518020|NCT02486627|524756692|FG000|Overall Study|Death|1|||
145518021|NCT02486627|524756693|FG001|Overall Study|Death|0|||
145518022|NCT02486627|524756692|FG000|Overall Study|Other Unspecified|0|||
145518023|NCT02486627|524756693|FG001|Overall Study|Other Unspecified|2|||
145518024|NCT02486627|524756692|FG000|Overall Study|Consent Withdrawn by Participant|4|||
145518025|NCT02486627|524756693|FG001|Overall Study|Consent Withdrawn by Participant|3|||
145518026|NCT02486627|524756692|FG000|Overall Study|Significant Participant Noncompliance|1|||
145518027|NCT02486627|524756693|FG001|Overall Study|Significant Participant Noncompliance|1|||
145518028|NCT02486627|524756692|FG000|Overall Study|Lost to Follow-up|1|||
145518029|NCT02486627|524756693|FG001|Overall Study|Lost to Follow-up|3|||
145518030|NCT00796991|524756703|FG000|Overall Study|Adverse Event|0|||
145518031|NCT00796991|524756704|FG001|Overall Study|Adverse Event|0|||
145518032|NCT00796991|524756705|FG002|Overall Study|Adverse Event|1|||
145518033|NCT00796991|524756703|FG000|Overall Study|Death|2|||
145518034|NCT00796991|524756704|FG001|Overall Study|Death|0|||
145518035|NCT00796991|524756705|FG002|Overall Study|Death|0|||
145518036|NCT00796991|524756703|FG000|Overall Study|Disease Progression|10|||
145518037|NCT00796991|524756704|FG001|Overall Study|Disease Progression|9|||
145518038|NCT00796991|524756705|FG002|Overall Study|Disease Progression|7|||
145518039|NCT00796991|524756703|FG000|Overall Study|Study Drug Toxicity|3|||
145518040|NCT00796991|524756704|FG001|Overall Study|Study Drug Toxicity|3|||
145518041|NCT00796991|524756705|FG002|Overall Study|Study Drug Toxicity|5|||
145518042|NCT00796991|524756703|FG000|Overall Study|Withdrawal by Subject|0|||
145518043|NCT00796991|524756704|FG001|Overall Study|Withdrawal by Subject|0|||
145518044|NCT00796991|524756705|FG002|Overall Study|Withdrawal by Subject|1|||
145518045|NCT00171834|524756706|FG000|Overall Study|Adverse Event|2|||
145518046|NCT00171834|524756707|FG001|Overall Study|Adverse Event|1|||
145518047|NCT00171834|524756708|FG002|Overall Study|Adverse Event|3|||
145518048|NCT00171834|524756709|FG003|Overall Study|Adverse Event|2|||
145518049|NCT00171834|524756710|FG004|Overall Study|Adverse Event|2|||
145518050|NCT00171834|524756711|FG005|Overall Study|Adverse Event|15|||
145518051|NCT00171834|524756712|FG006|Overall Study|Adverse Event|1|||
145518052|NCT00171834|524756706|FG000|Overall Study|Withdrawal by Subject|0|||
145518053|NCT00171834|524756707|FG001|Overall Study|Withdrawal by Subject|2|||
145518054|NCT00171834|524756708|FG002|Overall Study|Withdrawal by Subject|0|||
145518055|NCT00171834|524756709|FG003|Overall Study|Withdrawal by Subject|1|||
145518056|NCT00171834|524756710|FG004|Overall Study|Withdrawal by Subject|1|||
145518057|NCT00171834|524756711|FG005|Overall Study|Withdrawal by Subject|1|||
145741211|NCT01263483|525568711|FG000|Overall Study|Lack of Efficacy|2|||
145741212|NCT01263483|525568712|FG001|Overall Study|Lack of Efficacy|0|||
145741213|NCT01263483|525568713|FG002|Overall Study|Lack of Efficacy|0|||
145741214|NCT01263483|525568711|FG000|Overall Study|Protocol Violation|0|||
145741215|NCT01263483|525568712|FG001|Overall Study|Protocol Violation|1|||
145741216|NCT01263483|525568713|FG002|Overall Study|Protocol Violation|1|||
145741217|NCT01263483|525568711|FG000|Overall Study|Participant Unavailability|0|||
145741218|NCT01263483|525568712|FG001|Overall Study|Participant Unavailability|1|||
145741219|NCT01263483|525568713|FG002|Overall Study|Participant Unavailability|1|||
145741220|NCT00326209|525568714|FG000|Overall Study|Adverse Event|28|||
145741221|NCT00326209|525568714|FG000|Overall Study|Withdrawal by Subject|22|||
145741222|NCT00326209|525568714|FG000|Overall Study|Lack of Efficacy|31|||
145741223|NCT00326209|525568714|FG000|Overall Study|Lost to Follow-up|18|||
145741224|NCT00326209|525568714|FG000|Overall Study|Participant non-compliant|6|||
145741225|NCT00326209|525568714|FG000|Overall Study|Sponsor closed study|173|||
145269417|NCT00798707|523835350|FG002|Overall Study|Lost to Follow-up|6|||
145269418|NCT00798707|523835348|FG000|Overall Study|Other|0|||
145402319|NCT03098979|524330710|FG001|Overall Study|Withdrawal by Subject|1|||
145518058|NCT00171834|524756712|FG006|Overall Study|Withdrawal by Subject|0|||
145518059|NCT00171834|524756706|FG000|Overall Study|Death from study indication|0|||
145518060|NCT00171834|524756707|FG001|Overall Study|Death from study indication|1|||
145518061|NCT00171834|524756708|FG002|Overall Study|Death from study indication|0|||
145518062|NCT00171834|524756709|FG003|Overall Study|Death from study indication|0|||
145518063|NCT00171834|524756710|FG004|Overall Study|Death from study indication|1|||
145518064|NCT00171834|524756711|FG005|Overall Study|Death from study indication|0|||
145518065|NCT00171834|524756712|FG006|Overall Study|Death from study indication|0|||
145518066|NCT00171834|524756706|FG000|Overall Study|Disease Progression|4|||
145741226|NCT00326209|525568714|FG000|Overall Study|Prohibited medication use|1|||
145741227|NCT00326209|525568714|FG000|Overall Study|Violation of entry criteria|1|||
145741228|NCT00326209|525568714|FG000|Overall Study|Withdrawn in error|1|||
145741229|NCT00326209|525568714|FG000|Overall Study|Pregnancy|1|||
145741230|NCT01111851|525568717|FG000|Overall Study|All planned PET scans were not obtained.|2|||
145741231|NCT01111851|525568718|FG001|Overall Study|All planned PET scans were not obtained.|0|||
145741232|NCT05500274|525568719|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
145741233|NCT05500274|525568720|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
145741234|NCT05500274|525568719|FG000|Overall Study|Lost to Follow-up|76|||
145741235|NCT05500274|525568720|FG001|Overall Study|Lost to Follow-up|51|||
145741236|NCT05807464|525568723|FG000|Overall Study|Adverse Event|1|||
145741237|NCT04451161|525568724|FG000|Overall Study|Lost to Follow-up|28|||
145741238|NCT04451161|525568725|FG001|Overall Study|Lost to Follow-up|37|||
145741239|NCT04451161|525568726|FG002|Overall Study|Lost to Follow-up|22|||
145741240|NCT04451161|525568727|FG003|Overall Study|Lost to Follow-up|13|||
145741241|NCT04451161|525568728|FG004|Overall Study|Lost to Follow-up|11|||
145741242|NCT04451161|525568729|FG005|Overall Study|Lost to Follow-up|14|||
145741243|NCT04451161|525568724|FG000|Overall Study|Withdrawal by Subject|3|||
145741244|NCT04451161|525568725|FG001|Overall Study|Withdrawal by Subject|0|||
145741245|NCT04451161|525568726|FG002|Overall Study|Withdrawal by Subject|0|||
145741246|NCT04451161|525568727|FG003|Overall Study|Withdrawal by Subject|0|||
145741247|NCT04451161|525568728|FG004|Overall Study|Withdrawal by Subject|2|||
145741248|NCT04451161|525568729|FG005|Overall Study|Withdrawal by Subject|4|||
145741249|NCT03596866|525568731|FG000|Overall Study|Site terminated by Sponsor|64|||
145741250|NCT03596866|525568732|FG001|Overall Study|Site terminated by Sponsor|65|||
145741251|NCT03596866|525568731|FG000|Overall Study|Death|37|||
145741252|NCT03596866|525568732|FG001|Overall Study|Death|24|||
145741253|NCT03596866|525568731|FG000|Overall Study|Withdrawal by Subject|4|||
145741254|NCT03596866|525568732|FG001|Overall Study|Withdrawal by Subject|6|||
145741255|NCT03596866|525568731|FG000|Overall Study|Missing|0|||
145741256|NCT03596866|525568732|FG001|Overall Study|Missing|6|||
145741257|NCT03596866|525568731|FG000|Overall Study|Lost to Follow-up|2|||
145741258|NCT03596866|525568732|FG001|Overall Study|Lost to Follow-up|3|||
145741259|NCT03596866|525568731|FG000|Overall Study|Protocol Violation|1|||
145741260|NCT03596866|525568732|FG001|Overall Study|Protocol Violation|0|||
145741261|NCT03596866|525568731|FG000|Overall Study|Reason Not Specified|14|||
145741262|NCT03596866|525568732|FG001|Overall Study|Reason Not Specified|13|||
145741263|NCT01075412|525568736|FG000|Overall Study|Withdrawal by Subject|0|||
145741264|NCT01075412|525568737|FG001|Overall Study|Withdrawal by Subject|1|||
145741265|NCT01378858|525568740|FG000|Overall Study|Withdrawal by Subject|4|||
145741266|NCT01378858|525568741|FG001|Overall Study|Withdrawal by Subject|4|||
145741267|NCT02664272|525568742|FG000|Overall Study|Fluoroscopic images not made available|2|||
145741268|NCT03073980|525568743|FG000|Overall Study|Lost to Follow-up|10|||
145741269|NCT03073980|525568744|FG001|Overall Study|Lost to Follow-up|2|||
145741270|NCT03073980|525568745|FG002|Overall Study|Lost to Follow-up|9|||
145741271|NCT03073980|525568743|FG000|Overall Study|No post-procedure data|0|||
145741272|NCT03073980|525568744|FG001|Overall Study|No post-procedure data|0|||
145741273|NCT03073980|525568745|FG002|Overall Study|No post-procedure data|2|||
145741274|NCT01358760|525568746|FG000|Overall Study|Adverse Event|3|||
145741275|NCT01358760|525568747|FG001|Overall Study|Adverse Event|4|||
145741276|NCT01358760|525568748|FG002|Overall Study|Adverse Event|3|||
145741277|NCT01358760|525568746|FG000|Overall Study|Lost to Follow-up|1|||
145741278|NCT01358760|525568747|FG001|Overall Study|Lost to Follow-up|1|||
145741279|NCT01358760|525568748|FG002|Overall Study|Lost to Follow-up|3|||
145741280|NCT01358760|525568746|FG000|Overall Study|Withdrawal by Subject|5|||
145741281|NCT01358760|525568747|FG001|Overall Study|Withdrawal by Subject|3|||
145741282|NCT01358760|525568748|FG002|Overall Study|Withdrawal by Subject|2|||
145741283|NCT01358760|525568746|FG000|Overall Study|Physician Decision|1|||
145741284|NCT01358760|525568747|FG001|Overall Study|Physician Decision|0|||
145741285|NCT01358760|525568748|FG002|Overall Study|Physician Decision|1|||
145741286|NCT01358760|525568746|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
145741287|NCT01358760|525568747|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
145518067|NCT00171834|524756707|FG001|Overall Study|Disease Progression|8|||
145518068|NCT00171834|524756708|FG002|Overall Study|Disease Progression|8|||
145518069|NCT00171834|524756709|FG003|Overall Study|Disease Progression|9|||
145518070|NCT00171834|524756710|FG004|Overall Study|Disease Progression|2|||
145518071|NCT00171834|524756711|FG005|Overall Study|Disease Progression|18|||
145518072|NCT00171834|524756712|FG006|Overall Study|Disease Progression|3|||
145518073|NCT00171834|524756706|FG000|Overall Study|Treatment Duration Completed|0|||
145518074|NCT00171834|524756707|FG001|Overall Study|Treatment Duration Completed|0|||
145518075|NCT00171834|524756708|FG002|Overall Study|Treatment Duration Completed|1|||
145518076|NCT00171834|524756709|FG003|Overall Study|Treatment Duration Completed|0|||
145518077|NCT00171834|524756710|FG004|Overall Study|Treatment Duration Completed|2|||
145518078|NCT00171834|524756711|FG005|Overall Study|Treatment Duration Completed|1|||
145518079|NCT00171834|524756712|FG006|Overall Study|Treatment Duration Completed|0|||
145518080|NCT02431260|524756713|FG000|Overall Study|Subject Decision|0|||
145518081|NCT02431260|524756714|FG001|Overall Study|Subject Decision|1|||
145518082|NCT02431260|524756715|FG002|Overall Study|Subject Decision|1|||
145518083|NCT02431260|524756716|FG003|Overall Study|Subject Decision|0|||
145518084|NCT02431260|524756717|FG004|Overall Study|Subject Decision|0|||
145518085|NCT02431260|524756718|FG005|Overall Study|Subject Decision|0|||
145518086|NCT02431260|524756719|FG006|Overall Study|Subject Decision|0|||
145518087|NCT02431260|524756720|FG007|Overall Study|Subject Decision|0|||
145518088|NCT02431260|524756721|FG008|Overall Study|Subject Decision|1|||
145518089|NCT02431260|524756722|FG009|Overall Study|Subject Decision|1|||
145518090|NCT02431260|524756723|FG010|Overall Study|Subject Decision|0|||
145518091|NCT02431260|524756724|FG011|Overall Study|Subject Decision|1|||
145518092|NCT02431260|524756725|FG012|Overall Study|Subject Decision|0|||
145518093|NCT02431260|524756726|FG013|Overall Study|Subject Decision|0|||
145518094|NCT02431260|524756713|FG000|Overall Study|Death|4|||
145518095|NCT02431260|524756714|FG001|Overall Study|Death|4|||
145518096|NCT02431260|524756715|FG002|Overall Study|Death|3|||
145518097|NCT02431260|524756716|FG003|Overall Study|Death|4|||
145518098|NCT02431260|524756717|FG004|Overall Study|Death|2|||
145518099|NCT02431260|524756718|FG005|Overall Study|Death|2|||
145518100|NCT02431260|524756719|FG006|Overall Study|Death|3|||
145518101|NCT02431260|524756720|FG007|Overall Study|Death|1|||
145518102|NCT02431260|524756721|FG008|Overall Study|Death|6|||
145518103|NCT02431260|524756722|FG009|Overall Study|Death|6|||
145518104|NCT02431260|524756723|FG010|Overall Study|Death|3|||
145518105|NCT02431260|524756724|FG011|Overall Study|Death|2|||
145518106|NCT02431260|524756725|FG012|Overall Study|Death|5|||
145518107|NCT02431260|524756726|FG013|Overall Study|Death|1|||
145518108|NCT02431260|524756713|FG000|Overall Study|Lost to Follow-up|0|||
145518109|NCT02431260|524756714|FG001|Overall Study|Lost to Follow-up|0|||
145518110|NCT02431260|524756715|FG002|Overall Study|Lost to Follow-up|0|||
145518111|NCT02431260|524756716|FG003|Overall Study|Lost to Follow-up|0|||
145518112|NCT02431260|524756717|FG004|Overall Study|Lost to Follow-up|0|||
145518113|NCT02431260|524756718|FG005|Overall Study|Lost to Follow-up|1|||
145518114|NCT02431260|524756719|FG006|Overall Study|Lost to Follow-up|0|||
145518115|NCT02431260|524756720|FG007|Overall Study|Lost to Follow-up|0|||
145518116|NCT02431260|524756721|FG008|Overall Study|Lost to Follow-up|0|||
145518117|NCT02431260|524756722|FG009|Overall Study|Lost to Follow-up|0|||
145518118|NCT02431260|524756723|FG010|Overall Study|Lost to Follow-up|0|||
145518119|NCT02431260|524756724|FG011|Overall Study|Lost to Follow-up|0|||
145518120|NCT02431260|524756725|FG012|Overall Study|Lost to Follow-up|0|||
145518121|NCT02431260|524756726|FG013|Overall Study|Lost to Follow-up|0|||
145518122|NCT02431260|524756713|FG000|Overall Study|Study Terminated by the Sponsor|0|||
145518123|NCT02431260|524756714|FG001|Overall Study|Study Terminated by the Sponsor|0|||
145518124|NCT02431260|524756715|FG002|Overall Study|Study Terminated by the Sponsor|2|||
145518125|NCT02431260|524756716|FG003|Overall Study|Study Terminated by the Sponsor|1|||
145518126|NCT02431260|524756717|FG004|Overall Study|Study Terminated by the Sponsor|1|||
145518127|NCT02431260|524756718|FG005|Overall Study|Study Terminated by the Sponsor|0|||
145518128|NCT02431260|524756719|FG006|Overall Study|Study Terminated by the Sponsor|1|||
145518129|NCT02431260|524756720|FG007|Overall Study|Study Terminated by the Sponsor|2|||
145518130|NCT02431260|524756721|FG008|Overall Study|Study Terminated by the Sponsor|1|||
145518131|NCT02431260|524756722|FG009|Overall Study|Study Terminated by the Sponsor|1|||
145518132|NCT02431260|524756723|FG010|Overall Study|Study Terminated by the Sponsor|1|||
145518133|NCT02431260|524756724|FG011|Overall Study|Study Terminated by the Sponsor|0|||
145518134|NCT02431260|524756725|FG012|Overall Study|Study Terminated by the Sponsor|4|||
145518135|NCT02431260|524756726|FG013|Overall Study|Study Terminated by the Sponsor|0|||
145741288|NCT01358760|525568748|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
145741289|NCT01506960|525568749|FG000|Overall Study|Did not meet angiographic criteria|47|||
145741290|NCT00789880|525568752|FG000|Overall Study|Adverse Event|0|||
145741291|NCT00789880|525568753|FG001|Overall Study|Adverse Event|0|||
145741292|NCT00789880|525568754|FG002|Overall Study|Adverse Event|0|||
145741293|NCT00789880|525568755|FG003|Overall Study|Adverse Event|0|||
145741294|NCT00789880|525568756|FG004|Overall Study|Adverse Event|1|||
145741295|NCT00789880|525568757|FG005|Overall Study|Adverse Event|0|||
145741296|NCT00789880|525568752|FG000|Overall Study|Protocol Violation|0|||
145741297|NCT00789880|525568753|FG001|Overall Study|Protocol Violation|1|||
145741298|NCT00789880|525568754|FG002|Overall Study|Protocol Violation|0|||
145741299|NCT00789880|525568755|FG003|Overall Study|Protocol Violation|1|||
145741300|NCT00789880|525568756|FG004|Overall Study|Protocol Violation|0|||
145741301|NCT00789880|525568757|FG005|Overall Study|Protocol Violation|0|||
145741302|NCT00789880|525568752|FG000|Overall Study|Withdrawal by Subject|1|||
145741303|NCT00789880|525568753|FG001|Overall Study|Withdrawal by Subject|0|||
145741304|NCT00789880|525568754|FG002|Overall Study|Withdrawal by Subject|0|||
145741305|NCT00789880|525568755|FG003|Overall Study|Withdrawal by Subject|0|||
145741306|NCT00789880|525568756|FG004|Overall Study|Withdrawal by Subject|2|||
145741307|NCT00789880|525568757|FG005|Overall Study|Withdrawal by Subject|0|||
145741308|NCT00609986|525568758|FG000|Overall Study|Did not receive transplant or treatment|8|||
145741309|NCT00609986|525568759|FG001|Overall Study|Did not receive transplant or treatment|3|||
145741310|NCT04814823|525568761|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
145741311|NCT05318937|525568766|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145741312|NCT05318937|525568767|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145741313|NCT05318937|525568766|FG000|Overall Study|Lost to Follow-up|0|||
145741314|NCT05318937|525568767|FG001|Overall Study|Lost to Follow-up|1|||
145741315|NCT05318937|525568766|FG000|Overall Study|Withdrawal by Subject|0|||
145741316|NCT05318937|525568767|FG001|Overall Study|Withdrawal by Subject|2|||
145741317|NCT05318937|525568766|FG000|Overall Study|Protocol Violation|0|||
145741318|NCT05318937|525568767|FG001|Overall Study|Protocol Violation|1|||
145741319|NCT01877915|525568768|FG000|Overall Study|Lost to Follow-up|10|||
145741320|NCT01877915|525568769|FG001|Overall Study|Lost to Follow-up|9|||
145741321|NCT01877915|525568768|FG000|Overall Study|Withdrawal by Subject|42|||
145741322|NCT01877915|525568769|FG001|Overall Study|Withdrawal by Subject|55|||
145741323|NCT01877915|525568768|FG000|Overall Study|Other|2|||
145741324|NCT01877915|525568769|FG001|Overall Study|Other|4|||
145741325|NCT00591214|525568772|FG000|Overall Study|Physician Decision|7|||
145741326|NCT00591214|525568772|FG000|Overall Study|Withdrawal by Subject|1|||
145741327|NCT04857996|525568775|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
145741328|NCT04857996|525568776|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
145741329|NCT04857996|525568775|FG000|Overall Study|Lost to Follow-up|1|||
145741330|NCT04857996|525568776|FG001|Overall Study|Lost to Follow-up|3|||
145741331|NCT04857996|525568775|FG000|Overall Study|Site Closure|1|||
145741332|NCT04857996|525568776|FG001|Overall Study|Site Closure|0|||
145741333|NCT04857996|525568775|FG000|Overall Study|Withdrawal by Subject|1|||
145741334|NCT04857996|525568776|FG001|Overall Study|Withdrawal by Subject|0|||
145741335|NCT01129921|525568777|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
145741336|NCT01129921|525568778|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
145741337|NCT01129921|525568777|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
145741338|NCT01129921|525568778|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
145741339|NCT01129921|525568777|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
145741340|NCT01129921|525568778|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
145741341|NCT01129921|525568777|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
145741342|NCT01129921|525568778|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
145741343|NCT00282295|525568779|FG000|Overall Study|Adverse Event|0|||
145741344|NCT00282295|525568780|FG001|Overall Study|Adverse Event|1|||
145741345|NCT00282295|525568781|FG002|Overall Study|Adverse Event|0|||
145741346|NCT00282295|525568779|FG000|Overall Study|Serious Adverse Events|0|||
145741347|NCT00282295|525568780|FG001|Overall Study|Serious Adverse Events|0|||
145741348|NCT00282295|525568781|FG002|Overall Study|Serious Adverse Events|1|||
145741349|NCT00282295|525568779|FG000|Overall Study|Protocol Violation|0|||
145741350|NCT00282295|525568780|FG001|Overall Study|Protocol Violation|2|||
145741351|NCT00282295|525568781|FG002|Overall Study|Protocol Violation|1|||
145741352|NCT00282295|525568779|FG000|Overall Study|Withdrawal by Subject|2|||
145741353|NCT00282295|525568780|FG001|Overall Study|Withdrawal by Subject|6|||
145741354|NCT00282295|525568781|FG002|Overall Study|Withdrawal by Subject|4|||
145741355|NCT00282295|525568779|FG000|Overall Study|Lost to Follow-up|1|||
145741356|NCT00282295|525568780|FG001|Overall Study|Lost to Follow-up|7|||
145741357|NCT00282295|525568781|FG002|Overall Study|Lost to Follow-up|2|||
145741358|NCT00282295|525568779|FG000|Overall Study|Other|0|||
145741359|NCT00282295|525568780|FG001|Overall Study|Other|1|||
145741360|NCT00282295|525568781|FG002|Overall Study|Other|0|||
145741361|NCT01401842|525568784|FG000|Overall Study|Withdrawal by Subject|3|||
145741362|NCT01401842|525568785|FG001|Overall Study|Withdrawal by Subject|2|||
145741363|NCT01401842|525568784|FG000|Overall Study|academic reason|4|||
145741364|NCT01401842|525568785|FG001|Overall Study|academic reason|1|||
145741365|NCT01401842|525568784|FG000|Overall Study|changed companies|20|||
145741366|NCT01401842|525568785|FG001|Overall Study|changed companies|34|||
145741367|NCT01401842|525568784|FG000|Overall Study|discharged from US Army|3|||
145741368|NCT01401842|525568785|FG001|Overall Study|discharged from US Army|4|||
145741369|NCT01401842|525568784|FG000|Overall Study|invalid follow-up strength data|1|||
145741370|NCT01401842|525568785|FG001|Overall Study|invalid follow-up strength data|4|||
145741371|NCT01401842|525568784|FG000|Overall Study|on profile|9|||
145741372|NCT01401842|525568785|FG001|Overall Study|on profile|5|||
145741373|NCT01401842|525568784|FG000|Overall Study|other/unknown|28|||
145741374|NCT01401842|525568785|FG001|Overall Study|other/unknown|17|||
145741375|NCT03337542|525568786|FG000|Overall Study|Withdrew Consent|17|||
145741376|NCT03337542|525568786|FG000|Overall Study|Allergic Adverse Event|1|||
145741377|NCT03337542|525568786|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
145741378|NCT03337542|525568786|FG000|Overall Study|Lost to Follow-up|1|||
145741379|NCT03337542|525568786|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
145741380|NCT00583024|525568795|FG000|Overall Study|Lost to Follow-up|4|||
145741381|NCT00847145|525570125|FG000|Overall Study|AE or Death|0|||
145741382|NCT00847145|525570126|FG001|Overall Study|AE or Death|1|||
145741383|NCT00847145|525570127|FG002|Overall Study|AE or Death|1|||
145269419|NCT00798707|523835349|FG001|Overall Study|Other|1|||
145741384|NCT00847145|525570128|FG003|Overall Study|AE or Death|0|||
145741385|NCT00847145|525570129|FG004|Overall Study|AE or Death|0|||
145741386|NCT00847145|525570130|FG005|Overall Study|AE or Death|0|||
145741387|NCT00847145|525570131|FG006|Overall Study|AE or Death|0|||
145741388|NCT00847145|525570132|FG007|Overall Study|AE or Death|0|||
145741389|NCT00847145|525570125|FG000|Overall Study|Withdrawal by Subject|3|||
145741390|NCT00847145|525570126|FG001|Overall Study|Withdrawal by Subject|4|||
145741391|NCT00847145|525570127|FG002|Overall Study|Withdrawal by Subject|6|||
145741392|NCT00847145|525570128|FG003|Overall Study|Withdrawal by Subject|1|||
145741393|NCT00847145|525570129|FG004|Overall Study|Withdrawal by Subject|0|||
145741394|NCT00847145|525570130|FG005|Overall Study|Withdrawal by Subject|0|||
145741395|NCT00847145|525570131|FG006|Overall Study|Withdrawal by Subject|1|||
145741396|NCT00847145|525570132|FG007|Overall Study|Withdrawal by Subject|1|||
145741397|NCT00847145|525570125|FG000|Overall Study|Lost to Follow-up|3|||
145741398|NCT00847145|525570126|FG001|Overall Study|Lost to Follow-up|1|||
145741399|NCT00847145|525570127|FG002|Overall Study|Lost to Follow-up|1|||
145741400|NCT00847145|525570128|FG003|Overall Study|Lost to Follow-up|0|||
145741401|NCT00847145|525570129|FG004|Overall Study|Lost to Follow-up|4|||
145741402|NCT00847145|525570130|FG005|Overall Study|Lost to Follow-up|4|||
145741403|NCT00847145|525570131|FG006|Overall Study|Lost to Follow-up|8|||
145741404|NCT00847145|525570132|FG007|Overall Study|Lost to Follow-up|2|||
145741405|NCT00847145|525570125|FG000|Overall Study|Inappropriate enrollment|0|||
145741406|NCT00847145|525570126|FG001|Overall Study|Inappropriate enrollment|0|||
145741407|NCT00847145|525570127|FG002|Overall Study|Inappropriate enrollment|0|||
145741408|NCT00847145|525570128|FG003|Overall Study|Inappropriate enrollment|0|||
145741409|NCT00847145|525570129|FG004|Overall Study|Inappropriate enrollment|1|||
145741410|NCT00847145|525570130|FG005|Overall Study|Inappropriate enrollment|0|||
145741411|NCT00847145|525570131|FG006|Overall Study|Inappropriate enrollment|0|||
145741412|NCT00847145|525570132|FG007|Overall Study|Inappropriate enrollment|0|||
145741413|NCT00847145|525570125|FG000|Overall Study|Protocol Violation|0|||
145741414|NCT00847145|525570126|FG001|Overall Study|Protocol Violation|0|||
145741415|NCT00847145|525570127|FG002|Overall Study|Protocol Violation|3|||
145741416|NCT00847145|525570128|FG003|Overall Study|Protocol Violation|0|||
145741417|NCT00847145|525570129|FG004|Overall Study|Protocol Violation|1|||
145741418|NCT00847145|525570130|FG005|Overall Study|Protocol Violation|0|||
145741419|NCT00847145|525570131|FG006|Overall Study|Protocol Violation|0|||
145741420|NCT00847145|525570132|FG007|Overall Study|Protocol Violation|1|||
145741421|NCT04419610|525570133|FG000|Overall Study|Withdrawal by Subject|3|||
145741422|NCT04419610|525570134|FG001|Overall Study|Withdrawal by Subject|1|||
145269420|NCT00798707|523835350|FG002|Overall Study|Other|0|||
145269421|NCT00798707|523835348|FG000|Overall Study|Protocol Violation|4|||
145269422|NCT00798707|523835349|FG001|Overall Study|Protocol Violation|0|||
145269423|NCT00798707|523835350|FG002|Overall Study|Protocol Violation|2|||
145269424|NCT00798707|523835348|FG000|Overall Study|Withdrawal by Subject|3|||
145269425|NCT00798707|523835349|FG001|Overall Study|Withdrawal by Subject|8|||
145269426|NCT00798707|523835350|FG002|Overall Study|Withdrawal by Subject|2|||
145269427|NCT00798707|523835348|FG000|Overall Study|Randomized not treated|4|||
145269428|NCT00798707|523835349|FG001|Overall Study|Randomized not treated|5|||
145269429|NCT00798707|523835350|FG002|Overall Study|Randomized not treated|1|||
145269430|NCT01473589|523835353|FG000|Overall Study|Adverse Event|1|||
145269431|NCT01473589|523835354|FG001|Overall Study|Adverse Event|1|||
145269432|NCT01473589|523835353|FG000|Overall Study|Death|2|||
145269433|NCT01473589|523835354|FG001|Overall Study|Death|0|||
145269434|NCT01473589|523835353|FG000|Overall Study|Lost to Follow-up|2|||
145269435|NCT01473589|523835354|FG001|Overall Study|Lost to Follow-up|2|||
145269436|NCT01473589|523835353|FG000|Overall Study|Protocol Violation|1|||
145269437|NCT01473589|523835354|FG001|Overall Study|Protocol Violation|0|||
145269438|NCT01473589|523835353|FG000|Overall Study|Withdrawal by Subject|5|||
145269439|NCT01473589|523835354|FG001|Overall Study|Withdrawal by Subject|11|||
145518136|NCT02431260|524756713|FG000|Overall Study|Physician Decision|0|||
145518137|NCT02431260|524756714|FG001|Overall Study|Physician Decision|0|||
145269440|NCT01473589|523835353|FG000|Overall Study|Physician Decision|0|||
145269441|NCT01473589|523835354|FG001|Overall Study|Physician Decision|1|||
145269442|NCT01473589|523835353|FG000|Overall Study|Entry criteria not met|0|||
145269443|NCT01473589|523835354|FG001|Overall Study|Entry criteria not met|1|||
145269444|NCT03457727|523835355|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
145269445|NCT03457727|523835356|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
145741423|NCT04419610|525570133|FG000|Overall Study|Adverse Event|1|||
145741424|NCT04419610|525570134|FG001|Overall Study|Adverse Event|0|||
145741425|NCT04419610|525570133|FG000|Overall Study|discharged early|1|||
145741426|NCT04419610|525570134|FG001|Overall Study|discharged early|1|||
145741427|NCT01439282|525570135|FG000|Overall Study|Adverse Event|5|||
145741428|NCT01439282|525570136|FG001|Overall Study|Adverse Event|0|||
145269446|NCT03457727|523835357|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
145269447|NCT03457727|523835358|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
145518138|NCT02431260|524756715|FG002|Overall Study|Physician Decision|0|||
145741429|NCT01439282|525570135|FG000|Overall Study|Withdrawal by Subject|2|||
145741430|NCT01439282|525570136|FG001|Overall Study|Withdrawal by Subject|0|||
145741431|NCT01439282|525570135|FG000|Overall Study|Other|1|||
145741432|NCT01439282|525570136|FG001|Overall Study|Other|1|||
145741433|NCT00346073|525570140|FG000|Overall Study|Serious Adverse Event|2|||
145741434|NCT00346073|525570141|FG001|Overall Study|Serious Adverse Event|0|||
145741435|NCT00346073|525570140|FG000|Overall Study|Lost to Follow-up|39|||
145741436|NCT00346073|525570141|FG001|Overall Study|Lost to Follow-up|24|||
145741437|NCT00980200|525570143|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
145741438|NCT00980200|525570144|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
145741439|NCT00980200|525570145|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
145741440|NCT00980200|525570146|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
145741441|NCT00980200|525570147|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
145741442|NCT00980200|525570143|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
145741443|NCT00980200|525570144|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
145741444|NCT00980200|525570145|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
145741445|NCT00980200|525570146|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
145741446|NCT00980200|525570147|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
145741447|NCT04179734|525570151|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
145741448|NCT04179734|525570152|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
145741449|NCT04179734|525570151|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
145741450|NCT04179734|525570152|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
145741451|NCT00937937|525570153|FG000|Overall Study|Adverse Event|6|||
145741452|NCT00937937|525570153|FG000|Overall Study|Withdrawal by Subject|2|||
145741453|NCT00937937|525570153|FG000|Overall Study|Progression/relapse|61|||
145741454|NCT00937937|525570153|FG000|Overall Study|Death|1|||
145741455|NCT00937937|525570153|FG000|Overall Study|Other|2|||
145741456|NCT00054704|525570154|FG000|Overall Study|Lack of Efficacy|2|||
145741457|NCT00054704|525570155|FG001|Overall Study|Lack of Efficacy|3|||
145741458|NCT00054704|525570154|FG000|Overall Study|Adverse Event|3|||
145741459|NCT00054704|525570155|FG001|Overall Study|Adverse Event|1|||
145741460|NCT00054704|525570154|FG000|Overall Study|Lost to Follow-up|0|||
145741461|NCT00054704|525570155|FG001|Overall Study|Lost to Follow-up|1|||
145741462|NCT00362414|525570156|FG000|Overall Study|Death|2|||
145741463|NCT00362414|525570156|FG000|Overall Study|Adverse Event|1|||
145741464|NCT01761292|525570159|FG000|Part 1|Adverse Event|1|||
145741465|NCT01761292|525570159|FG000|Part 1|not receiving treatment in Part 1|1|||
145741466|NCT01761292|525570159|FG000|Extension 1|Withdrawal by Subject|1|||
145741467|NCT02181816|525570160|FG000|Overall Study|Case Report Forms Uncollected|38|||
145741468|NCT02181816|525570160|FG000|Overall Study|Protocol Deviation|21|||
145741469|NCT00253643|525570163|FG000|Overall Study|Withdrawal by Subject|0|||
145741470|NCT00253643|525570164|FG001|Overall Study|Withdrawal by Subject|0|||
145741471|NCT00253643|525570165|FG002|Overall Study|Withdrawal by Subject|1|||
145741472|NCT00253643|525570166|FG003|Overall Study|Withdrawal by Subject|1|||
145741473|NCT00253643|525570163|FG000|Overall Study|Non-Compliance|0|||
145741474|NCT00253643|525570164|FG001|Overall Study|Non-Compliance|0|||
145741475|NCT00253643|525570165|FG002|Overall Study|Non-Compliance|0|||
145741476|NCT00253643|525570166|FG003|Overall Study|Non-Compliance|2|||
145741477|NCT01368536|525570167|FG000|Overall Study|Adverse Event|5|||
145741478|NCT01368536|525570168|FG001|Overall Study|Adverse Event|6|||
145741479|NCT01368536|525570169|FG002|Overall Study|Adverse Event|8|||
145741480|NCT01368536|525570167|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145741481|NCT01368536|525570168|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145741482|NCT01368536|525570169|FG002|Overall Study|Abnormal laboratory value(s)|2|||
145518139|NCT02431260|524756716|FG003|Overall Study|Physician Decision|0|||
145518140|NCT02431260|524756717|FG004|Overall Study|Physician Decision|0|||
145518141|NCT02431260|524756718|FG005|Overall Study|Physician Decision|1|||
145518142|NCT02431260|524756719|FG006|Overall Study|Physician Decision|0|||
145518143|NCT02431260|524756720|FG007|Overall Study|Physician Decision|0|||
145518144|NCT02431260|524756721|FG008|Overall Study|Physician Decision|0|||
145518145|NCT02431260|524756722|FG009|Overall Study|Physician Decision|0|||
145518146|NCT02431260|524756723|FG010|Overall Study|Physician Decision|0|||
145518147|NCT02431260|524756724|FG011|Overall Study|Physician Decision|0|||
145518148|NCT02431260|524756725|FG012|Overall Study|Physician Decision|0|||
145518149|NCT02431260|524756726|FG013|Overall Study|Physician Decision|0|||
145518150|NCT02431260|524756713|FG000|Overall Study|Other Unspecified|0|||
145518151|NCT02431260|524756714|FG001|Overall Study|Other Unspecified|0|||
145518152|NCT02431260|524756715|FG002|Overall Study|Other Unspecified|0|||
145518153|NCT02431260|524756716|FG003|Overall Study|Other Unspecified|0|||
145518154|NCT02431260|524756717|FG004|Overall Study|Other Unspecified|0|||
145518155|NCT02431260|524756718|FG005|Overall Study|Other Unspecified|0|||
145741483|NCT01368536|525570167|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145741484|NCT01368536|525570168|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145741485|NCT01368536|525570169|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145741486|NCT01368536|525570167|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
145741487|NCT01368536|525570168|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145518156|NCT02431260|524756719|FG006|Overall Study|Other Unspecified|0|||
145741488|NCT01368536|525570169|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145741489|NCT01368536|525570167|FG000|Overall Study|No longer required study medication|0|||
145741490|NCT01368536|525570168|FG001|Overall Study|No longer required study medication|0|||
145741491|NCT01368536|525570169|FG002|Overall Study|No longer required study medication|1|||
145741492|NCT01368536|525570167|FG000|Overall Study|Withdrawal by Subject|2|||
145741493|NCT01368536|525570168|FG001|Overall Study|Withdrawal by Subject|5|||
145741494|NCT01368536|525570169|FG002|Overall Study|Withdrawal by Subject|4|||
145741495|NCT01368536|525570167|FG000|Overall Study|Lost to Follow-up|3|||
145741496|NCT01368536|525570168|FG001|Overall Study|Lost to Follow-up|3|||
145741497|NCT01368536|525570169|FG002|Overall Study|Lost to Follow-up|5|||
145741498|NCT01368536|525570167|FG000|Overall Study|Administrative problems|34|||
145741499|NCT01368536|525570168|FG001|Overall Study|Administrative problems|39|||
145741500|NCT01368536|525570169|FG002|Overall Study|Administrative problems|35|||
145741501|NCT01368536|525570167|FG000|Overall Study|Protocol deviation|0|||
145741502|NCT01368536|525570168|FG001|Overall Study|Protocol deviation|3|||
145741503|NCT01368536|525570169|FG002|Overall Study|Protocol deviation|1|||
145741504|NCT00383084|525570170|FG000|Overall Study|Withdrawal by Subject|12|||
145741505|NCT00383084|525570171|FG001|Overall Study|Withdrawal by Subject|10|||
145741506|NCT02113436|525570172|FG000|Period 1: 8 Weeks|Adverse Event|1|||
145741507|NCT02113436|525570173|FG001|Period 1: 8 Weeks|Adverse Event|0|||
145741508|NCT02113436|525570174|FG002|Period 1: 8 Weeks|Adverse Event|0|||
145741509|NCT02113436|525570175|FG003|Period 1: 8 Weeks|Adverse Event|0|||
145741510|NCT02113436|525570172|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
145741511|NCT02113436|525570173|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
145741512|NCT02113436|525570174|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
145741513|NCT02113436|525570175|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
145741514|NCT02113436|525570172|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
145741515|NCT02113436|525570173|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
145741516|NCT02113436|525570174|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
145741517|NCT02113436|525570175|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
145741518|NCT02113436|525570172|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
145741519|NCT02113436|525570173|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
145741520|NCT02113436|525570174|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
145741521|NCT02113436|525570175|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
145518157|NCT02431260|524756720|FG007|Overall Study|Other Unspecified|0|||
145741522|NCT02113436|525570172|FG000|Period 2: 16 Weeks|Adverse Event|0|||
145741523|NCT02113436|525570173|FG001|Period 2: 16 Weeks|Adverse Event|0|||
145741524|NCT02113436|525570174|FG002|Period 2: 16 Weeks|Adverse Event|4|||
145741525|NCT02113436|525570175|FG003|Period 2: 16 Weeks|Adverse Event|5|||
145741526|NCT02113436|525570172|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
145741527|NCT02113436|525570173|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
145741528|NCT02113436|525570174|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
145741529|NCT02113436|525570175|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
145518158|NCT02431260|524756721|FG008|Overall Study|Other Unspecified|0|||
145518159|NCT02431260|524756722|FG009|Overall Study|Other Unspecified|0|||
145518160|NCT02431260|524756723|FG010|Overall Study|Other Unspecified|0|||
145741530|NCT02113436|525570172|FG000|Period 2: 16 Weeks|Physician Decision|0|||
145741531|NCT02113436|525570173|FG001|Period 2: 16 Weeks|Physician Decision|0|||
145741532|NCT02113436|525570174|FG002|Period 2: 16 Weeks|Physician Decision|2|||
145741533|NCT02113436|525570175|FG003|Period 2: 16 Weeks|Physician Decision|0|||
145741534|NCT02113436|525570172|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
145741535|NCT02113436|525570173|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
145741536|NCT02113436|525570174|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
145741537|NCT02113436|525570175|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
145741538|NCT01648790|525570176|FG000|Treatment 3|Withdrawal by Subject|0|||
145741539|NCT01648790|525570177|FG001|Treatment 3|Withdrawal by Subject|0|||
145518161|NCT02431260|524756724|FG011|Overall Study|Other Unspecified|1|||
145518162|NCT02431260|524756725|FG012|Overall Study|Other Unspecified|1|||
145518163|NCT02431260|524756726|FG013|Overall Study|Other Unspecified|0|||
145518164|NCT00439738|524756728|FG000|Overall Study|Withdrawal by Subject|16|||
145518165|NCT00439738|524756729|FG001|Overall Study|Withdrawal by Subject|13|||
145518166|NCT00439738|524756728|FG000|Overall Study|Adverse Event|6|||
145518167|NCT00439738|524756729|FG001|Overall Study|Adverse Event|4|||
145518168|NCT00439738|524756728|FG000|Overall Study|Lost to Follow-up|5|||
145518169|NCT00439738|524756729|FG001|Overall Study|Lost to Follow-up|6|||
145518170|NCT00439738|524756728|FG000|Overall Study|Protocol Violation|6|||
145518171|NCT00439738|524756729|FG001|Overall Study|Protocol Violation|3|||
145518172|NCT00439738|524756728|FG000|Overall Study|Lack of Efficacy|2|||
145518173|NCT00439738|524756729|FG001|Overall Study|Lack of Efficacy|2|||
145518174|NCT00439738|524756728|FG000|Overall Study|Abnormal Lab Values|1|||
145741540|NCT01648790|525570178|FG002|Treatment 3|Withdrawal by Subject|0|||
145741541|NCT01648790|525570179|FG003|Treatment 3|Withdrawal by Subject|1|||
145269448|NCT00929201|523835359|FG000|Period 1|Withdrawal by Subject|0|||
145269449|NCT00929201|523835360|FG001|Period 1|Withdrawal by Subject|1|||
145518175|NCT00439738|524756729|FG001|Overall Study|Abnormal Lab Values|0|||
145518176|NCT00392379|524756730|FG000|Overall Study|Withdrawal by Subject|17|||
145518177|NCT00392379|524756731|FG001|Overall Study|Withdrawal by Subject|28|||
145741542|NCT01648790|525570180|FG004|Treatment 3|Withdrawal by Subject|0|||
145741543|NCT02159729|525570181|FG000|Overall Study|Adverse Event|0|||
145741544|NCT02159729|525570182|FG001|Overall Study|Adverse Event|1|||
145741545|NCT02159729|525570181|FG000|Overall Study|Subject's Request|13|||
145741546|NCT02159729|525570182|FG001|Overall Study|Subject's Request|10|||
145741547|NCT02159729|525570181|FG000|Overall Study|Lost to Follow-up|24|||
145741548|NCT02159729|525570182|FG001|Overall Study|Lost to Follow-up|9|||
145741549|NCT02159729|525570181|FG000|Overall Study|Non compliance|2|||
145741550|NCT02159729|525570182|FG001|Overall Study|Non compliance|0|||
145741551|NCT02159729|525570181|FG000|Overall Study|Other Unspecified|3|||
145741552|NCT02159729|525570182|FG001|Overall Study|Other Unspecified|1|||
145741553|NCT02636582|525570183|FG000|Overall Study|Surgical Pathology|1|||
145741554|NCT02636582|525570184|FG001|Overall Study|Surgical Pathology|0|||
145741555|NCT01555151|525570185|FG000|Overall Study|Withdrawal by Subject|6|||
145741556|NCT01555151|525570186|FG001|Overall Study|Withdrawal by Subject|2|||
145741557|NCT01555151|525570187|FG002|Overall Study|Withdrawal by Subject|0|||
145741558|NCT01555151|525570188|FG003|Overall Study|Withdrawal by Subject|2|||
145741559|NCT01555151|525570185|FG000|Overall Study|Administrative|3|||
145741560|NCT01555151|525570186|FG001|Overall Study|Administrative|1|||
145741561|NCT01555151|525570187|FG002|Overall Study|Administrative|2|||
145741562|NCT01555151|525570188|FG003|Overall Study|Administrative|0|||
145741563|NCT01555151|525570185|FG000|Overall Study|Protocol Violation|3|||
145741564|NCT01555151|525570186|FG001|Overall Study|Protocol Violation|3|||
145741565|NCT01555151|525570187|FG002|Overall Study|Protocol Violation|3|||
145741566|NCT01555151|525570188|FG003|Overall Study|Protocol Violation|5|||
145741567|NCT01555151|525570185|FG000|Overall Study|Adverse Event|1|||
145741568|NCT01555151|525570186|FG001|Overall Study|Adverse Event|2|||
145741569|NCT01555151|525570187|FG002|Overall Study|Adverse Event|1|||
145741570|NCT01555151|525570188|FG003|Overall Study|Adverse Event|2|||
145741571|NCT01555151|525570185|FG000|Overall Study|Lost to Follow-up|0|||
145741572|NCT01555151|525570186|FG001|Overall Study|Lost to Follow-up|0|||
145741573|NCT01555151|525570187|FG002|Overall Study|Lost to Follow-up|0|||
145741574|NCT01555151|525570188|FG003|Overall Study|Lost to Follow-up|1|||
145741575|NCT01816061|525570189|FG000|Overall Study|Lost to Follow-up|13|||
145741576|NCT01816061|525570190|FG001|Overall Study|Lost to Follow-up|24|||
145741577|NCT01671111|525570192|FG000|Overall Study|Adverse Event|2|||
145741578|NCT01671111|525570192|FG000|Overall Study|Lack of Efficacy|1|||
145741579|NCT01671111|525570192|FG000|Overall Study|Withdrawal by Subject|2|||
145741580|NCT01671111|525570192|FG000|Overall Study|Physician Decision|1|||
145741581|NCT01671111|525570192|FG000|Overall Study|Other|24|||
145741582|NCT02114268|525570195|FG000|Overall Study|Lost to Follow-up|4|||
145741583|NCT02114268|525570196|FG001|Overall Study|Lost to Follow-up|1|||
145741584|NCT02114268|525570197|FG002|Overall Study|Lost to Follow-up|1|||
145741585|NCT02114268|525570198|FG003|Overall Study|Lost to Follow-up|0|||
145741586|NCT02114268|525570199|FG004|Overall Study|Lost to Follow-up|0|||
145741587|NCT02114268|525570200|FG005|Overall Study|Lost to Follow-up|2|||
145741588|NCT02114268|525570195|FG000|Overall Study|Withdrawal by Subject|1|||
145741589|NCT02114268|525570196|FG001|Overall Study|Withdrawal by Subject|0|||
145741590|NCT02114268|525570197|FG002|Overall Study|Withdrawal by Subject|0|||
145741591|NCT02114268|525570198|FG003|Overall Study|Withdrawal by Subject|0|||
145741592|NCT02114268|525570199|FG004|Overall Study|Withdrawal by Subject|0|||
145741593|NCT02114268|525570200|FG005|Overall Study|Withdrawal by Subject|1|||
145741594|NCT02114268|525570195|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
145741595|NCT02114268|525570196|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
145741596|NCT02114268|525570197|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
145741597|NCT02114268|525570198|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
145741598|NCT02114268|525570199|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
145741599|NCT02114268|525570200|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
145741600|NCT00865904|525570203|FG000|Overall Study|Randomized but not Treated|2|||
145741601|NCT00865904|525570204|FG001|Overall Study|Randomized but not Treated|0|||
145741602|NCT00865904|525570205|FG002|Overall Study|Randomized but not Treated|0|||
145741603|NCT00865904|525570206|FG003|Overall Study|Randomized but not Treated|1|||
145741604|NCT00865904|525570207|FG004|Overall Study|Randomized but not Treated|1|||
145741605|NCT01431274|525570208|FG000|Overall Study|Adverse Event|51|||
145741606|NCT01431274|525570209|FG001|Overall Study|Adverse Event|37|||
145741607|NCT01431274|525570210|FG002|Overall Study|Adverse Event|43|||
145741608|NCT01431274|525570211|FG003|Overall Study|Adverse Event|30|||
145741609|NCT01431274|525570212|FG004|Overall Study|Adverse Event|37|||
145741610|NCT01431274|525570208|FG000|Overall Study|Consent withdrawn not due to AE|29|||
145741611|NCT01431274|525570209|FG001|Overall Study|Consent withdrawn not due to AE|20|||
145741612|NCT01431274|525570210|FG002|Overall Study|Consent withdrawn not due to AE|17|||
145741613|NCT01431274|525570211|FG003|Overall Study|Consent withdrawn not due to AE|20|||
145741614|NCT01431274|525570212|FG004|Overall Study|Consent withdrawn not due to AE|11|||
145741615|NCT01431274|525570208|FG000|Overall Study|Non compliant with protocol|5|||
145741616|NCT01431274|525570209|FG001|Overall Study|Non compliant with protocol|8|||
145741617|NCT01431274|525570210|FG002|Overall Study|Non compliant with protocol|4|||
145741618|NCT01431274|525570211|FG003|Overall Study|Non compliant with protocol|4|||
145741619|NCT01431274|525570212|FG004|Overall Study|Non compliant with protocol|4|||
145741620|NCT01431274|525570208|FG000|Overall Study|Lost to Follow-up|6|||
145741621|NCT01431274|525570209|FG001|Overall Study|Lost to Follow-up|7|||
145741622|NCT01431274|525570210|FG002|Overall Study|Lost to Follow-up|1|||
145741623|NCT01431274|525570211|FG003|Overall Study|Lost to Follow-up|4|||
145741624|NCT01431274|525570212|FG004|Overall Study|Lost to Follow-up|0|||
145741625|NCT01431274|525570208|FG000|Overall Study|Other reason not stated above|6|||
145741626|NCT01431274|525570209|FG001|Overall Study|Other reason not stated above|5|||
145741627|NCT01431274|525570210|FG002|Overall Study|Other reason not stated above|7|||
145741628|NCT01431274|525570211|FG003|Overall Study|Other reason not stated above|2|||
145741629|NCT01431274|525570212|FG004|Overall Study|Other reason not stated above|4|||
145741630|NCT00133991|525570215|FG000|Overall Study|Death|4|||
145741631|NCT00450723|525570217|FG000|Overall Study|Physician Decision|5|||
145741632|NCT02047253|525570220|FG000|Overall Study|Lost to Follow-up|8|||
145741633|NCT03574753|525570221|FG000|Overall Study|Adverse Event|3|||
145741634|NCT03574753|525570221|FG000|Overall Study|Progression/relapse|19|||
145741635|NCT03574753|525570221|FG000|Overall Study|Death|1|||
145741636|NCT05678257|525570226|FG000|Overall Study|Withdrawal by Subject|2|||
145741637|NCT05678257|525570227|FG001|Overall Study|Withdrawal by Subject|0|||
145741638|NCT05678257|525570228|FG002|Overall Study|Withdrawal by Subject|5|||
145741639|NCT05678257|525570226|FG000|Overall Study|Physician Decision|1|||
145741640|NCT05678257|525570227|FG001|Overall Study|Physician Decision|0|||
145741641|NCT05678257|525570228|FG002|Overall Study|Physician Decision|1|||
145518178|NCT00392379|524756730|FG000|Overall Study|Lost to Follow-up|4|||
145518179|NCT00392379|524756731|FG001|Overall Study|Lost to Follow-up|9|||
145518180|NCT00392379|524756730|FG000|Overall Study|Adverse Event|1|||
145741642|NCT05678257|525570226|FG000|Overall Study|Adverse Event|1|||
145741643|NCT05678257|525570227|FG001|Overall Study|Adverse Event|3|||
145741644|NCT05678257|525570228|FG002|Overall Study|Adverse Event|1|||
145741645|NCT05678257|525570226|FG000|Overall Study|Progressive disease|11|||
145741646|NCT05678257|525570227|FG001|Overall Study|Progressive disease|18|||
145741647|NCT05678257|525570228|FG002|Overall Study|Progressive disease|7|||
145741648|NCT05678257|525570226|FG000|Overall Study|No longer clinically benefitting|2|||
145741649|NCT05678257|525570227|FG001|Overall Study|No longer clinically benefitting|1|||
145741650|NCT05678257|525570228|FG002|Overall Study|No longer clinically benefitting|0|||
145741651|NCT05678257|525570226|FG000|Overall Study|Sponsor decision|5|||
145741652|NCT05678257|525570227|FG001|Overall Study|Sponsor decision|9|||
145741653|NCT05678257|525570228|FG002|Overall Study|Sponsor decision|8|||
145741654|NCT05678257|525570226|FG000|Overall Study|Protocol Violation|0|||
145741655|NCT05678257|525570227|FG001|Overall Study|Protocol Violation|0|||
145741656|NCT05678257|525570228|FG002|Overall Study|Protocol Violation|1|||
145741657|NCT05678257|525570226|FG000|Overall Study|Patient non-compliance|0|||
145741658|NCT05678257|525570227|FG001|Overall Study|Patient non-compliance|0|||
145741659|NCT05678257|525570228|FG002|Overall Study|Patient non-compliance|3|||
145741660|NCT02046096|525570229|FG000|Overall Study|Death|28|||
145741661|NCT02046096|525570230|FG001|Overall Study|Death|45|||
145741662|NCT02046096|525570229|FG000|Overall Study|Lost to Follow-up|9|||
145741663|NCT02046096|525570230|FG001|Overall Study|Lost to Follow-up|20|||
145741664|NCT02046096|525570229|FG000|Overall Study|Withdrawal by Subject|5|||
145741665|NCT02046096|525570230|FG001|Overall Study|Withdrawal by Subject|17|||
145741666|NCT02046096|525570229|FG000|Overall Study|Other endpoint|2|||
145741667|NCT02046096|525570230|FG001|Overall Study|Other endpoint|19|||
145741668|NCT03520959|525570231|FG000|Overall Study|Study terminated by Sponsor|0|||
145741669|NCT03520959|525570232|FG001|Overall Study|Study terminated by Sponsor|1|||
145741670|NCT01449461|525570233|FG000|Overall Study|Adverse Event|0|||
145741671|NCT01449461|525570234|FG001|Overall Study|Adverse Event|3|||
145741672|NCT01449461|525570235|FG002|Overall Study|Adverse Event|2|||
145741673|NCT01449461|525570236|FG003|Overall Study|Adverse Event|3|||
145741674|NCT01449461|525570237|FG004|Overall Study|Adverse Event|4|||
145741675|NCT01449461|525570238|FG005|Overall Study|Adverse Event|4|||
145741676|NCT01449461|525570233|FG000|Overall Study|Death|0|||
145741677|NCT01449461|525570234|FG001|Overall Study|Death|2|||
145269450|NCT00464308|523835364|FG000|Overall Study|Adverse Event|22|||
145741678|NCT01449461|525570235|FG002|Overall Study|Death|0|||
145741679|NCT01449461|525570236|FG003|Overall Study|Death|0|||
145741680|NCT01449461|525570237|FG004|Overall Study|Death|7|||
145741681|NCT01449461|525570238|FG005|Overall Study|Death|1|||
145741682|NCT01449461|525570233|FG000|Overall Study|Physician Decision|0|||
145741683|NCT01449461|525570234|FG001|Overall Study|Physician Decision|1|||
145741684|NCT01449461|525570235|FG002|Overall Study|Physician Decision|0|||
145741685|NCT01449461|525570236|FG003|Overall Study|Physician Decision|4|||
145741686|NCT01449461|525570237|FG004|Overall Study|Physician Decision|1|||
145741687|NCT01449461|525570238|FG005|Overall Study|Physician Decision|0|||
145741688|NCT01449461|525570233|FG000|Overall Study|Documented Progressive Disease|4|||
145741689|NCT01449461|525570234|FG001|Overall Study|Documented Progressive Disease|7|||
145741690|NCT01449461|525570235|FG002|Overall Study|Documented Progressive Disease|14|||
145741691|NCT01449461|525570236|FG003|Overall Study|Documented Progressive Disease|15|||
145741692|NCT01449461|525570237|FG004|Overall Study|Documented Progressive Disease|24|||
145741693|NCT01449461|525570238|FG005|Overall Study|Documented Progressive Disease|5|||
145741694|NCT01449461|525570233|FG000|Overall Study|Clinical Progressive Disease|2|||
145741695|NCT01449461|525570234|FG001|Overall Study|Clinical Progressive Disease|2|||
145741696|NCT01449461|525570235|FG002|Overall Study|Clinical Progressive Disease|0|||
145741697|NCT01449461|525570236|FG003|Overall Study|Clinical Progressive Disease|3|||
145741698|NCT01449461|525570237|FG004|Overall Study|Clinical Progressive Disease|4|||
145741699|NCT01449461|525570238|FG005|Overall Study|Clinical Progressive Disease|2|||
145741700|NCT01449461|525570233|FG000|Overall Study|Protocol Violation|0|||
145741701|NCT01449461|525570234|FG001|Overall Study|Protocol Violation|0|||
145741702|NCT01449461|525570235|FG002|Overall Study|Protocol Violation|0|||
145741703|NCT01449461|525570236|FG003|Overall Study|Protocol Violation|1|||
145741704|NCT01449461|525570237|FG004|Overall Study|Protocol Violation|0|||
145741705|NCT01449461|525570238|FG005|Overall Study|Protocol Violation|0|||
145741706|NCT01449461|525570233|FG000|Overall Study|Site Terminated by Sponsor|0|||
145741707|NCT01449461|525570234|FG001|Overall Study|Site Terminated by Sponsor|1|||
145741708|NCT01449461|525570235|FG002|Overall Study|Site Terminated by Sponsor|2|||
145741709|NCT01449461|525570236|FG003|Overall Study|Site Terminated by Sponsor|3|||
145741710|NCT01449461|525570237|FG004|Overall Study|Site Terminated by Sponsor|4|||
145741711|NCT01449461|525570238|FG005|Overall Study|Site Terminated by Sponsor|1|||
145741712|NCT01449461|525570233|FG000|Overall Study|Withdrawal by Subject|0|||
145741713|NCT01449461|525570234|FG001|Overall Study|Withdrawal by Subject|1|||
145741714|NCT01449461|525570235|FG002|Overall Study|Withdrawal by Subject|0|||
145741715|NCT01449461|525570236|FG003|Overall Study|Withdrawal by Subject|0|||
145741716|NCT01449461|525570237|FG004|Overall Study|Withdrawal by Subject|2|||
145402320|NCT03098979|524330711|FG002|Overall Study|Withdrawal by Subject|1|||
145402321|NCT03098979|524330712|FG003|Overall Study|Withdrawal by Subject|1|||
145402322|NCT03098979|524330713|FG004|Overall Study|Withdrawal by Subject|2|||
145402323|NCT03098979|524330714|FG005|Overall Study|Withdrawal by Subject|1|||
145402324|NCT03098979|524330709|FG000|Overall Study|Death|1|||
145402325|NCT03098979|524330710|FG001|Overall Study|Death|0|||
145402326|NCT03098979|524330711|FG002|Overall Study|Death|2|||
145402327|NCT03098979|524330712|FG003|Overall Study|Death|0|||
145402328|NCT03098979|524330713|FG004|Overall Study|Death|1|||
145402329|NCT03098979|524330714|FG005|Overall Study|Death|0|||
145402330|NCT03098979|524330709|FG000|Overall Study|Physician Decision|2|||
145402331|NCT03098979|524330710|FG001|Overall Study|Physician Decision|1|||
145402332|NCT03098979|524330711|FG002|Overall Study|Physician Decision|0|||
145518181|NCT00392379|524756731|FG001|Overall Study|Adverse Event|1|||
145518182|NCT01978938|524756732|FG000|Overall Study|Lost to Follow-up|12|||
145518183|NCT01978938|524756733|FG001|Overall Study|Lost to Follow-up|6|||
145518184|NCT01978938|524756732|FG000|Overall Study|Withdrawal by Subject|8|||
145518185|NCT01978938|524756733|FG001|Overall Study|Withdrawal by Subject|4|||
145518186|NCT01978938|524756732|FG000|Overall Study|Adverse Event, non-fatal|2|||
145518187|NCT01978938|524756733|FG001|Overall Study|Adverse Event, non-fatal|1|||
145518188|NCT01978938|524756732|FG000|Overall Study|Participant noncompliance|1|||
145518189|NCT01978938|524756733|FG001|Overall Study|Participant noncompliance|1|||
145518190|NCT01978938|524756732|FG000|Overall Study|Did not meet inclusion criteria|0|||
145518191|NCT01978938|524756733|FG001|Overall Study|Did not meet inclusion criteria|1|||
145518192|NCT01978938|524756732|FG000|Overall Study|Previously scheduled procedure|0|||
145518193|NCT01978938|524756733|FG001|Overall Study|Previously scheduled procedure|1|||
145518194|NCT01806662|524756737|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
145518195|NCT01806662|524756738|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
145518196|NCT01806662|524756737|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
145518197|NCT01806662|524756738|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
145518198|NCT01806662|524756737|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
145518199|NCT01806662|524756738|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
145518200|NCT01806662|524756737|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
145518201|NCT01806662|524756738|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
145518202|NCT00043550|524756741|FG000|Overall Study|Withdrawal by Subject|22|||
145518203|NCT00043550|524756742|FG001|Overall Study|Withdrawal by Subject|12|||
145518204|NCT00043550|524756743|FG002|Overall Study|Withdrawal by Subject|20|||
145518205|NCT00710762|524756748|FG000|Overall Study|Progressive disease|27|||
145518206|NCT00710762|524756749|FG001|Overall Study|Progressive disease|30|||
145518207|NCT00710762|524756748|FG000|Overall Study|Adverse Event other disease worsening|2|||
145518208|NCT00710762|524756749|FG001|Overall Study|Adverse Event other disease worsening|1|||
145518209|NCT00710762|524756748|FG000|Overall Study|Other Adverse Event|7|||
145518210|NCT00710762|524756749|FG001|Overall Study|Other Adverse Event|7|||
145518211|NCT00710762|524756748|FG000|Overall Study|Lost to Follow-up|1|||
145518212|NCT00710762|524756749|FG001|Overall Study|Lost to Follow-up|0|||
145518213|NCT00710762|524756748|FG000|Overall Study|Reason other than listed above|2|||
145518214|NCT00710762|524756749|FG001|Overall Study|Reason other than listed above|2|||
145518215|NCT01375075|524756750|FG000|Overall Study|Adverse Event|0|||
145518216|NCT01375075|524756751|FG001|Overall Study|Adverse Event|0|||
145518217|NCT01375075|524756752|FG002|Overall Study|Adverse Event|3|||
145518218|NCT01375075|524756753|FG003|Overall Study|Adverse Event|1|||
145518219|NCT01375075|524756754|FG004|Overall Study|Adverse Event|0|||
145518220|NCT01375075|524756755|FG005|Overall Study|Adverse Event|1|||
145518221|NCT01375075|524756750|FG000|Overall Study|Entry Criterion Not Met|1|||
145518222|NCT01375075|524756751|FG001|Overall Study|Entry Criterion Not Met|0|||
145518223|NCT01375075|524756752|FG002|Overall Study|Entry Criterion Not Met|0|||
145518224|NCT01375075|524756753|FG003|Overall Study|Entry Criterion Not Met|0|||
145518225|NCT01375075|524756754|FG004|Overall Study|Entry Criterion Not Met|0|||
145518226|NCT01375075|524756755|FG005|Overall Study|Entry Criterion Not Met|1|||
145518227|NCT01375075|524756750|FG000|Overall Study|Withdrawal by Subject|0|||
145518228|NCT01375075|524756751|FG001|Overall Study|Withdrawal by Subject|1|||
145518229|NCT01375075|524756752|FG002|Overall Study|Withdrawal by Subject|0|||
145518230|NCT01375075|524756753|FG003|Overall Study|Withdrawal by Subject|0|||
145518231|NCT01375075|524756754|FG004|Overall Study|Withdrawal by Subject|0|||
145518232|NCT01375075|524756755|FG005|Overall Study|Withdrawal by Subject|1|||
145518233|NCT03104816|524756757|FG000|Overall Study|Lack of Efficacy|0|||
145518234|NCT03104816|524756758|FG001|Overall Study|Lack of Efficacy|2|||
145518235|NCT03104816|524756759|FG002|Overall Study|Lack of Efficacy|0|||
145518236|NCT03104816|524756757|FG000|Overall Study|Protocol Violation|2|||
145518237|NCT03104816|524756758|FG001|Overall Study|Protocol Violation|0|||
145518238|NCT03104816|524756759|FG002|Overall Study|Protocol Violation|2|||
145518239|NCT00807573|524756760|FG000|Overall Study|Withdrawal by Subject|1|||
145518240|NCT00807573|524756760|FG000|Overall Study|Adverse Event|1|||
145402333|NCT03098979|524330712|FG003|Overall Study|Physician Decision|0|||
145402334|NCT03098979|524330713|FG004|Overall Study|Physician Decision|0|||
145402335|NCT03098979|524330714|FG005|Overall Study|Physician Decision|0|||
145741717|NCT01449461|525570238|FG005|Overall Study|Withdrawal by Subject|1|||
145741718|NCT01449461|525570233|FG000|Overall Study|Reason not Specified|0|||
145741719|NCT01449461|525570234|FG001|Overall Study|Reason not Specified|1|||
145741720|NCT01449461|525570235|FG002|Overall Study|Reason not Specified|0|||
145741721|NCT01449461|525570236|FG003|Overall Study|Reason not Specified|3|||
145741722|NCT01449461|525570237|FG004|Overall Study|Reason not Specified|2|||
145741723|NCT01449461|525570238|FG005|Overall Study|Reason not Specified|1|||
145741724|NCT05314517|525570240|FG000|Double-blind Period|Adverse Event|4|||
145741725|NCT05314517|525570241|FG001|Double-blind Period|Adverse Event|0|||
145741726|NCT05314517|525570242|FG002|Double-blind Period|Adverse Event|0|||
145741727|NCT05314517|525570243|FG003|Double-blind Period|Adverse Event|0|||
145741728|NCT05314517|525570240|FG000|Double-blind Period|Noncompliance|0|||
145741729|NCT05314517|525570241|FG001|Double-blind Period|Noncompliance|1|||
145741730|NCT05314517|525570242|FG002|Double-blind Period|Noncompliance|0|||
145741731|NCT05314517|525570243|FG003|Double-blind Period|Noncompliance|0|||
145741732|NCT05314517|525570240|FG000|Double-blind Period|Randomized, not treated|1|||
145741733|NCT05314517|525570241|FG001|Double-blind Period|Randomized, not treated|0|||
145741734|NCT05314517|525570242|FG002|Double-blind Period|Randomized, not treated|0|||
145741735|NCT05314517|525570243|FG003|Double-blind Period|Randomized, not treated|0|||
145741736|NCT05314517|525570240|FG000|Open-label Extension|Adverse Event|0|||
145741737|NCT05314517|525570241|FG001|Open-label Extension|Adverse Event|0|||
145741738|NCT05314517|525570242|FG002|Open-label Extension|Adverse Event|1|||
145741739|NCT05314517|525570243|FG003|Open-label Extension|Adverse Event|2|||
145741740|NCT05314517|525570240|FG000|Open-label Extension|Investigator decision|0|||
145741741|NCT05314517|525570241|FG001|Open-label Extension|Investigator decision|0|||
145741742|NCT05314517|525570242|FG002|Open-label Extension|Investigator decision|1|||
145741743|NCT05314517|525570243|FG003|Open-label Extension|Investigator decision|0|||
145741744|NCT05314517|525570240|FG000|Open-label Extension|Lost to Follow-up|0|||
145741745|NCT05314517|525570241|FG001|Open-label Extension|Lost to Follow-up|0|||
145741746|NCT05314517|525570242|FG002|Open-label Extension|Lost to Follow-up|0|||
145741747|NCT05314517|525570243|FG003|Open-label Extension|Lost to Follow-up|1|||
145741748|NCT05314517|525570240|FG000|Open-label Extension|Withdrawal by Subject|0|||
145741749|NCT05314517|525570241|FG001|Open-label Extension|Withdrawal by Subject|0|||
145741750|NCT05314517|525570242|FG002|Open-label Extension|Withdrawal by Subject|1|||
145741751|NCT05314517|525570243|FG003|Open-label Extension|Withdrawal by Subject|2|||
145741752|NCT05314517|525570240|FG000|Open-label Extension|Use of prohibited medication|0|||
145741753|NCT05314517|525570241|FG001|Open-label Extension|Use of prohibited medication|0|||
145741754|NCT05314517|525570242|FG002|Open-label Extension|Use of prohibited medication|1|||
145741755|NCT05314517|525570243|FG003|Open-label Extension|Use of prohibited medication|0|||
145741756|NCT05314517|525570240|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
145741757|NCT05314517|525570241|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
145741758|NCT05314517|525570242|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
145741759|NCT05314517|525570243|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
145741760|NCT04969276|525570244|FG000|Overall Study|Protocol Deviation|0|||
145741761|NCT04969276|525570245|FG001|Overall Study|Protocol Deviation|1|||
145741762|NCT04969276|525570246|FG002|Overall Study|Protocol Deviation|0|||
145741763|NCT04969276|525570244|FG000|Overall Study|Withdrawal by Subject|1|||
145741764|NCT04969276|525570245|FG001|Overall Study|Withdrawal by Subject|10|||
145741765|NCT04969276|525570246|FG002|Overall Study|Withdrawal by Subject|0|||
145741766|NCT04969276|525570244|FG000|Overall Study|Lost to Follow-up|0|||
145741767|NCT04969276|525570245|FG001|Overall Study|Lost to Follow-up|1|||
145741768|NCT04969276|525570246|FG002|Overall Study|Lost to Follow-up|0|||
145741769|NCT05248295|525570250|FG000|Overall Study|found ineligible|4|||
145741770|NCT05248295|525570251|FG001|Overall Study|found ineligible|1|||
145741771|NCT05248295|525570250|FG000|Overall Study|Withdrawal by Subject|0|||
145741772|NCT05248295|525570251|FG001|Overall Study|Withdrawal by Subject|1|||
145741773|NCT05248295|525570250|FG000|Overall Study|Data loss: audio recording error|1|||
145741774|NCT05248295|525570251|FG001|Overall Study|Data loss: audio recording error|1|||
145741775|NCT04655144|525570252|FG000|Overall Study|Consumed THC|1|||
145741776|NCT04655144|525570253|FG001|Overall Study|Consumed THC|0|||
145741777|NCT04655144|525570252|FG000|Overall Study|Unilateral embolization|0|||
145741778|NCT04655144|525570253|FG001|Overall Study|Unilateral embolization|1|||
145741779|NCT01484977|525570256|FG000|Overall Study|Adverse Event|8|||
145741780|NCT01484977|525570256|FG000|Overall Study|Lack of Efficacy|4|||
145741781|NCT01484977|525570256|FG000|Overall Study|Protocol Violation|6|||
145741782|NCT01484977|525570256|FG000|Overall Study|Lost to Follow-up|1|||
145741783|NCT01484977|525570256|FG000|Overall Study|Withdrawal by Subject|4|||
145741784|NCT01484977|525570256|FG000|Overall Study|Subject Protocol Non-compliant|1|||
145741785|NCT01484977|525570256|FG000|Overall Study|Moving Overseas|1|||
145741786|NCT01484977|525570256|FG000|Overall Study|Low White Blood Cell Count|1|||
145741787|NCT01484977|525570256|FG000|Overall Study|Lack of Compliance|1|||
145741788|NCT01392677|525570257|FG000|Overall Study|Adverse Event|3|||
145741789|NCT01392677|525570258|FG001|Overall Study|Adverse Event|1|||
145741790|NCT01392677|525570257|FG000|Overall Study|Withdrawal by Subject|0|||
145741791|NCT01392677|525570258|FG001|Overall Study|Withdrawal by Subject|2|||
145518241|NCT01227629|524756767|FG000|Overall Study|Adverse Event|2|||
145518242|NCT01227629|524756768|FG001|Overall Study|Adverse Event|2|||
145518243|NCT01227629|524756769|FG002|Overall Study|Adverse Event|1|||
145518244|NCT01227629|524756770|FG003|Overall Study|Adverse Event|6|||
145518245|NCT01227629|524756771|FG004|Overall Study|Adverse Event|1|||
145741792|NCT01392677|525570257|FG000|Overall Study|Incorrect enrollment|2|||
145741793|NCT01392677|525570258|FG001|Overall Study|Incorrect enrollment|3|||
145741794|NCT01392677|525570257|FG000|Overall Study|Other reason|3|||
145741795|NCT01392677|525570258|FG001|Overall Study|Other reason|2|||
145741796|NCT00121108|525570261|FG000|Overall Study|Lost to Follow-up|10|||
145741797|NCT00121108|525570262|FG001|Overall Study|Lost to Follow-up|22|||
145741798|NCT00121108|525570261|FG000|Overall Study|Withdrawal by Subject|106|||
145741799|NCT00121108|525570262|FG001|Overall Study|Withdrawal by Subject|195|||
145741800|NCT00121108|525570261|FG000|Overall Study|Death|5|||
145741801|NCT00121108|525570262|FG001|Overall Study|Death|8|||
145741802|NCT01380379|525570265|FG000|Overall Study|Pregnancy|1|||
145741803|NCT01357577|525570268|FG000|Overall Study|Lost to Follow-up|20|||
145741804|NCT01357577|525570269|FG001|Overall Study|Lost to Follow-up|16|||
145741805|NCT01357577|525570268|FG000|Overall Study|Withdrawal by Subject|16|||
145741806|NCT01357577|525570269|FG001|Overall Study|Withdrawal by Subject|8|||
145741807|NCT01357577|525570268|FG000|Overall Study|look at data in database?|1|||
145741808|NCT01357577|525570269|FG001|Overall Study|look at data in database?|2|||
145741809|NCT03080883|525570270|FG000|Overall Study|Withdrawal by Subject|11|||
145741810|NCT03080883|525570271|FG001|Overall Study|Withdrawal by Subject|15|||
145741811|NCT03080883|525570270|FG000|Overall Study|Adverse Event|22|||
145741812|NCT03080883|525570271|FG001|Overall Study|Adverse Event|22|||
145741813|NCT03080883|525570270|FG000|Overall Study|Alternative Therapy|0|||
145741814|NCT03080883|525570271|FG001|Overall Study|Alternative Therapy|3|||
145741815|NCT03080883|525570270|FG000|Overall Study|Other Complicating Disease|9|||
145741816|NCT03080883|525570271|FG001|Overall Study|Other Complicating Disease|5|||
145518246|NCT01227629|524756772|FG005|Overall Study|Adverse Event|1|||
145741817|NCT03080883|525570270|FG000|Overall Study|Death|21|||
145741818|NCT03080883|525570271|FG001|Overall Study|Death|16|||
145741819|NCT03080883|525570270|FG000|Overall Study|Physician Decision|2|||
145741820|NCT03080883|525570271|FG001|Overall Study|Physician Decision|2|||
145269451|NCT00464308|523835365|FG001|Overall Study|Adverse Event|27|||
145269452|NCT00464308|523835366|FG002|Overall Study|Adverse Event|16|||
145269453|NCT00464308|523835364|FG000|Overall Study|Lost to Follow-up|29|||
145269454|NCT00464308|523835365|FG001|Overall Study|Lost to Follow-up|19|||
145269455|NCT00464308|523835366|FG002|Overall Study|Lost to Follow-up|20|||
145269456|NCT00464308|523835364|FG000|Overall Study|Patient discontinued and other reasons|17|||
145269457|NCT00464308|523835365|FG001|Overall Study|Patient discontinued and other reasons|17|||
145269458|NCT00464308|523835366|FG002|Overall Study|Patient discontinued and other reasons|23|||
145269459|NCT00464308|523835364|FG000|Overall Study|Physician Decision|1|||
145269460|NCT00464308|523835365|FG001|Overall Study|Physician Decision|0|||
145269461|NCT00464308|523835366|FG002|Overall Study|Physician Decision|0|||
145269462|NCT03722849|523835373|FG000|Overall Study|Withdrawal by Subject|1|||
145269463|NCT03722849|523835374|FG001|Overall Study|Withdrawal by Subject|1|||
145269464|NCT03533608|523835375|FG000|Overall Study|Withdrawal by Subject|3|||
145269465|NCT03533608|523835375|FG000|Overall Study|Physician Decision|2|||
145269466|NCT03286426|523835376|FG000|Overall Study|Physician Decision|3|||
145269467|NCT03514121|523835379|FG000|Overall Study|Withdrawal by Subject|0|||
145269468|NCT03514121|523835380|FG001|Overall Study|Withdrawal by Subject|0|||
145269469|NCT03514121|523835381|FG002|Overall Study|Withdrawal by Subject|0|||
145269470|NCT03514121|523835382|FG003|Overall Study|Withdrawal by Subject|0|||
145269471|NCT03514121|523835383|FG004|Overall Study|Withdrawal by Subject|1|||
145269472|NCT03514121|523835384|FG005|Overall Study|Withdrawal by Subject|2|||
145269473|NCT03514121|523835385|FG006|Overall Study|Withdrawal by Subject|1|||
145269474|NCT03514121|523835386|FG007|Overall Study|Withdrawal by Subject|1|||
145269475|NCT03514121|523835387|FG008|Overall Study|Withdrawal by Subject|7|||
145269476|NCT03514121|523835388|FG009|Overall Study|Withdrawal by Subject|2|||
145269477|NCT03514121|523835379|FG000|Overall Study|Death|0|||
145269478|NCT03514121|523835380|FG001|Overall Study|Death|0|||
145269479|NCT03514121|523835381|FG002|Overall Study|Death|0|||
145269480|NCT03514121|523835382|FG003|Overall Study|Death|0|||
145269481|NCT03514121|523835383|FG004|Overall Study|Death|0|||
145269482|NCT03514121|523835384|FG005|Overall Study|Death|3|||
145269483|NCT03514121|523835385|FG006|Overall Study|Death|2|||
145269484|NCT03514121|523835386|FG007|Overall Study|Death|1|||
145269485|NCT03514121|523835387|FG008|Overall Study|Death|26|||
145269486|NCT03514121|523835388|FG009|Overall Study|Death|3|||
145269487|NCT03514121|523835379|FG000|Overall Study|Lost to Follow-up|0|||
145269488|NCT03514121|523835380|FG001|Overall Study|Lost to Follow-up|0|||
145269489|NCT03514121|523835381|FG002|Overall Study|Lost to Follow-up|1|||
145269490|NCT03514121|523835382|FG003|Overall Study|Lost to Follow-up|0|||
145269491|NCT03514121|523835383|FG004|Overall Study|Lost to Follow-up|0|||
145269492|NCT03514121|523835384|FG005|Overall Study|Lost to Follow-up|0|||
145269493|NCT03514121|523835385|FG006|Overall Study|Lost to Follow-up|0|||
145269494|NCT03514121|523835386|FG007|Overall Study|Lost to Follow-up|0|||
145269495|NCT03514121|523835387|FG008|Overall Study|Lost to Follow-up|1|||
145269496|NCT03514121|523835388|FG009|Overall Study|Lost to Follow-up|0|||
145269497|NCT03514121|523835379|FG000|Overall Study|Adverse Event|0|||
145269498|NCT03514121|523835380|FG001|Overall Study|Adverse Event|0|||
145269499|NCT03514121|523835381|FG002|Overall Study|Adverse Event|0|||
145269500|NCT03514121|523835382|FG003|Overall Study|Adverse Event|0|||
145269501|NCT03514121|523835383|FG004|Overall Study|Adverse Event|0|||
145269502|NCT03514121|523835384|FG005|Overall Study|Adverse Event|0|||
145269503|NCT03514121|523835385|FG006|Overall Study|Adverse Event|1|||
145269504|NCT03514121|523835386|FG007|Overall Study|Adverse Event|0|||
145269505|NCT03514121|523835387|FG008|Overall Study|Adverse Event|0|||
145269506|NCT03514121|523835388|FG009|Overall Study|Adverse Event|0|||
145269507|NCT03514121|523835379|FG000|Overall Study|Other|0|||
145269508|NCT03514121|523835380|FG001|Overall Study|Other|1|||
145269509|NCT03514121|523835381|FG002|Overall Study|Other|1|||
145269510|NCT03514121|523835382|FG003|Overall Study|Other|0|||
145269511|NCT03514121|523835383|FG004|Overall Study|Other|1|||
145269512|NCT03514121|523835384|FG005|Overall Study|Other|2|||
145269513|NCT03514121|523835385|FG006|Overall Study|Other|3|||
145269514|NCT03514121|523835386|FG007|Overall Study|Other|2|||
145269515|NCT03514121|523835387|FG008|Overall Study|Other|7|||
145269516|NCT03514121|523835388|FG009|Overall Study|Other|3|||
145269517|NCT03514121|523835379|FG000|Overall Study|Study termination by Sponsor|0|||
145269518|NCT03514121|523835380|FG001|Overall Study|Study termination by Sponsor|0|||
145269519|NCT03514121|523835381|FG002|Overall Study|Study termination by Sponsor|0|||
145269520|NCT03514121|523835382|FG003|Overall Study|Study termination by Sponsor|0|||
145269521|NCT03514121|523835383|FG004|Overall Study|Study termination by Sponsor|0|||
145741821|NCT03080883|525570270|FG000|Overall Study|Disease Progression|2|||
145269522|NCT03514121|523835384|FG005|Overall Study|Study termination by Sponsor|0|||
145269523|NCT03514121|523835385|FG006|Overall Study|Study termination by Sponsor|0|||
145269524|NCT03514121|523835386|FG007|Overall Study|Study termination by Sponsor|0|||
145269525|NCT03514121|523835387|FG008|Overall Study|Study termination by Sponsor|11|||
145269526|NCT03514121|523835388|FG009|Overall Study|Study termination by Sponsor|3|||
145269527|NCT03514121|523835379|FG000|Overall Study|Investigator decision|0|||
145269528|NCT03514121|523835380|FG001|Overall Study|Investigator decision|0|||
145269529|NCT03514121|523835381|FG002|Overall Study|Investigator decision|0|||
145741822|NCT03080883|525570271|FG001|Overall Study|Disease Progression|8|||
145741823|NCT03080883|525570270|FG000|Overall Study|Lost to Follow-up|1|||
145741824|NCT03080883|525570271|FG001|Overall Study|Lost to Follow-up|1|||
145269530|NCT03514121|523835382|FG003|Overall Study|Investigator decision|0|||
145269531|NCT03514121|523835383|FG004|Overall Study|Investigator decision|0|||
145269532|NCT03514121|523835384|FG005|Overall Study|Investigator decision|0|||
145269533|NCT03514121|523835385|FG006|Overall Study|Investigator decision|0|||
145269534|NCT03514121|523835386|FG007|Overall Study|Investigator decision|0|||
145269535|NCT03514121|523835387|FG008|Overall Study|Investigator decision|1|||
145269536|NCT03514121|523835388|FG009|Overall Study|Investigator decision|0|||
145269537|NCT05553600|523835389|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
145269538|NCT05553600|523835390|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
145269539|NCT05553600|523835391|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
145269540|NCT05553600|523835392|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
145269541|NCT05553600|523835389|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
145269542|NCT05553600|523835390|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
145269543|NCT05553600|523835391|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
145269544|NCT05553600|523835392|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
145269545|NCT05553600|523835389|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
145269546|NCT05553600|523835390|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
145269547|NCT05553600|523835391|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
145269548|NCT05553600|523835392|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
145269549|NCT05553600|523835389|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
145518247|NCT01227629|524756773|FG006|Overall Study|Adverse Event|6|||
145518248|NCT01227629|524756774|FG007|Overall Study|Adverse Event|6|||
145518249|NCT01227629|524756775|FG008|Overall Study|Adverse Event|4|||
145518250|NCT01227629|524756776|FG009|Overall Study|Adverse Event|0|||
145518251|NCT01227629|524756767|FG000|Overall Study|Protocol Violation|0|||
145269550|NCT05553600|523835390|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
145269551|NCT05553600|523835391|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
145269552|NCT05553600|523835392|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
145269553|NCT05553600|523835389|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
145269554|NCT05553600|523835390|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
145269555|NCT05553600|523835391|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
145269556|NCT05553600|523835392|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
145269557|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
145269558|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
145269559|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
145269560|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
145269561|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
145269562|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
145269563|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
145269564|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
145269565|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
145269566|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
145269567|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
145269568|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
145269569|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
145269570|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
145269571|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
145269572|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
145269573|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
145269574|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
145269575|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
145269576|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
145269577|NCT05553600|523835389|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
145269578|NCT05553600|523835390|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
145269579|NCT05553600|523835391|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
145269580|NCT05553600|523835392|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
145518252|NCT01227629|524756768|FG001|Overall Study|Protocol Violation|0|||
145518253|NCT01227629|524756769|FG002|Overall Study|Protocol Violation|0|||
145518254|NCT01227629|524756770|FG003|Overall Study|Protocol Violation|1|||
145518255|NCT01227629|524756771|FG004|Overall Study|Protocol Violation|0|||
145518256|NCT01227629|524756772|FG005|Overall Study|Protocol Violation|0|||
145518257|NCT01227629|524756773|FG006|Overall Study|Protocol Violation|0|||
145741825|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
145741826|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
145741827|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
145741828|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
145741829|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
145741830|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
145741831|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Death|2|||
145741832|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Death|0|||
145741833|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
145741834|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
145741835|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
145741836|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
145741837|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
145741838|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145741839|NCT02603120|525571579|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
145741840|NCT02603120|525571580|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
145741841|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
145741842|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
145741843|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
145741844|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
145741845|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
145741846|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
145741847|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
145741848|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
145741849|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
145741850|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
145741851|NCT02603120|525571579|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
145741852|NCT02603120|525571580|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
145741853|NCT01469182|525571583|FG000|Overall Study|Adverse Event|21|||
145741854|NCT01469182|525571584|FG001|Overall Study|Adverse Event|3|||
145741855|NCT01469182|525571583|FG000|Overall Study|Lost to Follow-up|3|||
145741856|NCT01469182|525571584|FG001|Overall Study|Lost to Follow-up|0|||
145741857|NCT01469182|525571583|FG000|Overall Study|Withdrawal by Subject|4|||
145741858|NCT01469182|525571584|FG001|Overall Study|Withdrawal by Subject|1|||
145741859|NCT01469182|525571583|FG000|Overall Study|Protocol Violation|4|||
145741860|NCT01469182|525571584|FG001|Overall Study|Protocol Violation|2|||
145741861|NCT01469182|525571583|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
145741862|NCT01469182|525571584|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
145741863|NCT01227187|525571585|FG000|Overall Study|Physician Decision|0|||
145741864|NCT01227187|525571586|FG001|Overall Study|Physician Decision|0|||
145741865|NCT01227187|525571587|FG002|Overall Study|Physician Decision|0|||
145741866|NCT01227187|525571588|FG003|Overall Study|Physician Decision|1|||
145741867|NCT00840086|525571589|FG000|Overall Study|Adverse Event|1|||
145741868|NCT00840086|525571589|FG000|Overall Study|Protocol Violation|2|||
145741869|NCT00840086|525571589|FG000|Overall Study|Lost to Follow-up|1|||
145741870|NCT03332498|525571590|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
145741871|NCT03332498|525571591|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
145741872|NCT03332498|525571592|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
145741873|NCT02830880|525571593|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
145741874|NCT02830880|525571593|FG000|Overall Study|Death|1|||
145741875|NCT02830880|525571593|FG000|Overall Study|Physician Decision|1|||
145741876|NCT01911442|525571600|FG000|Overall Study|Adverse Event|2|||
145741877|NCT01911442|525571601|FG001|Overall Study|Adverse Event|2|||
145741878|NCT01911442|525571602|FG002|Overall Study|Adverse Event|4|||
145518258|NCT01227629|524756774|FG007|Overall Study|Protocol Violation|0|||
145518259|NCT01227629|524756775|FG008|Overall Study|Protocol Violation|0|||
145518260|NCT01227629|524756776|FG009|Overall Study|Protocol Violation|0|||
145518261|NCT01227629|524756767|FG000|Overall Study|Lost to Follow-up|0|||
145518262|NCT01227629|524756768|FG001|Overall Study|Lost to Follow-up|0|||
145518263|NCT01227629|524756769|FG002|Overall Study|Lost to Follow-up|0|||
145518264|NCT01227629|524756770|FG003|Overall Study|Lost to Follow-up|0|||
145518265|NCT01227629|524756771|FG004|Overall Study|Lost to Follow-up|1|||
145518266|NCT01227629|524756772|FG005|Overall Study|Lost to Follow-up|0|||
145518267|NCT01227629|524756773|FG006|Overall Study|Lost to Follow-up|0|||
145518268|NCT01227629|524756774|FG007|Overall Study|Lost to Follow-up|0|||
145518269|NCT01227629|524756775|FG008|Overall Study|Lost to Follow-up|0|||
145518270|NCT01227629|524756776|FG009|Overall Study|Lost to Follow-up|0|||
145518271|NCT01227629|524756767|FG000|Overall Study|Withdrawal by Subject|0|||
145518272|NCT01227629|524756768|FG001|Overall Study|Withdrawal by Subject|0|||
145518273|NCT01227629|524756769|FG002|Overall Study|Withdrawal by Subject|0|||
145518274|NCT01227629|524756770|FG003|Overall Study|Withdrawal by Subject|0|||
145741879|NCT01911442|525571600|FG000|Overall Study|Lack of Efficacy|1|||
145518275|NCT01227629|524756771|FG004|Overall Study|Withdrawal by Subject|0|||
145518276|NCT01227629|524756772|FG005|Overall Study|Withdrawal by Subject|0|||
145741880|NCT01911442|525571601|FG001|Overall Study|Lack of Efficacy|1|||
145741881|NCT01911442|525571602|FG002|Overall Study|Lack of Efficacy|1|||
145741882|NCT01911442|525571600|FG000|Overall Study|Lost to Follow-up|2|||
145741883|NCT01911442|525571601|FG001|Overall Study|Lost to Follow-up|0|||
145741884|NCT01911442|525571602|FG002|Overall Study|Lost to Follow-up|1|||
145741885|NCT01911442|525571600|FG000|Overall Study|Withdrawal by Subject|1|||
145741886|NCT01911442|525571601|FG001|Overall Study|Withdrawal by Subject|0|||
145741887|NCT01911442|525571602|FG002|Overall Study|Withdrawal by Subject|6|||
145741888|NCT01911442|525571600|FG000|Overall Study|Mother's Work Schedule|0|||
145741889|NCT01911442|525571601|FG001|Overall Study|Mother's Work Schedule|1|||
145741890|NCT01911442|525571602|FG002|Overall Study|Mother's Work Schedule|0|||
145741891|NCT01549275|525571603|FG000|Overall Study|Lost to Follow-up|1|||
145741892|NCT01549275|525571604|FG001|Overall Study|Lost to Follow-up|0|||
145741893|NCT01278745|525571605|FG000|Overall Study|Death|2|||
145741894|NCT01278745|525571606|FG001|Overall Study|Death|5|||
145741895|NCT01278745|525571607|FG002|Overall Study|Death|7|||
145741896|NCT01278745|525571608|FG003|Overall Study|Death|0|||
145741897|NCT01278745|525571605|FG000|Overall Study|Physician Decision|1|||
145741898|NCT01278745|525571606|FG001|Overall Study|Physician Decision|0|||
145741899|NCT01278745|525571607|FG002|Overall Study|Physician Decision|0|||
145741900|NCT01278745|525571608|FG003|Overall Study|Physician Decision|9|||
145741901|NCT01278745|525571605|FG000|Overall Study|Withdrawal by Subject|1|||
145741902|NCT01278745|525571606|FG001|Overall Study|Withdrawal by Subject|1|||
145741903|NCT01278745|525571607|FG002|Overall Study|Withdrawal by Subject|5|||
145741904|NCT01278745|525571608|FG003|Overall Study|Withdrawal by Subject|1|||
145741905|NCT01278745|525571605|FG000|Overall Study|Sponsor Decision|1|||
145741906|NCT01278745|525571606|FG001|Overall Study|Sponsor Decision|0|||
145741907|NCT01278745|525571607|FG002|Overall Study|Sponsor Decision|62|||
145741908|NCT01278745|525571608|FG003|Overall Study|Sponsor Decision|6|||
145741909|NCT01278745|525571605|FG000|Overall Study|Ineligible|0|||
145741910|NCT01278745|525571606|FG001|Overall Study|Ineligible|0|||
145741911|NCT01278745|525571607|FG002|Overall Study|Ineligible|42|||
145741912|NCT01278745|525571608|FG003|Overall Study|Ineligible|61|||
145741913|NCT01278745|525571605|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
145741914|NCT01278745|525571606|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
145741915|NCT01278745|525571607|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
145741916|NCT01278745|525571608|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
145741917|NCT01148537|525571609|FG000|Overall Study|Withdrawal by Subject|1|||
145741918|NCT01148537|525571610|FG001|Overall Study|Withdrawal by Subject|0|||
145741919|NCT01148537|525571611|FG002|Overall Study|Withdrawal by Subject|2|||
145741920|NCT01148537|525571609|FG000|Overall Study|Adverse Event|2|||
145741921|NCT01148537|525571610|FG001|Overall Study|Adverse Event|0|||
145741922|NCT01148537|525571611|FG002|Overall Study|Adverse Event|1|||
145741923|NCT02953340|525571612|FG000|Overall Study|Death|0|||
145741924|NCT02953340|525571613|FG001|Overall Study|Death|1|||
145741925|NCT02953340|525571612|FG000|Overall Study|Investigator Decision|3|||
145741926|NCT02953340|525571613|FG001|Overall Study|Investigator Decision|3|||
145741927|NCT02953340|525571612|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
145741928|NCT02953340|525571613|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
145741929|NCT02953340|525571612|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
145741930|NCT02953340|525571613|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
145741931|NCT02953340|525571612|FG000|Overall Study|Withdrawal by Subject|9|||
145741932|NCT02953340|525571613|FG001|Overall Study|Withdrawal by Subject|9|||
145741933|NCT02953340|525571612|FG000|Overall Study|Sponsor decision|0|||
145741934|NCT02953340|525571613|FG001|Overall Study|Sponsor decision|2|||
145741935|NCT02953340|525571612|FG000|Overall Study|Lost to Follow-up|3|||
145741936|NCT02953340|525571613|FG001|Overall Study|Lost to Follow-up|2|||
145741937|NCT02953340|525571612|FG000|Overall Study|Reason not specified|2|||
145741938|NCT02953340|525571613|FG001|Overall Study|Reason not specified|2|||
145741939|NCT00454857|525571614|FG000|Overall Study|Withdrawal by Subject|15|||
145741940|NCT00454857|525571614|FG000|Overall Study|Lost to Follow-up|16|||
145741941|NCT00454857|525571614|FG000|Overall Study|Noncompliance|6|||
145741942|NCT00454857|525571614|FG000|Overall Study|Death|5|||
145741943|NCT00454857|525571614|FG000|Overall Study|Other|11|||
145741944|NCT00454857|525571614|FG000|Overall Study|Reason unknown|1|||
145741945|NCT00632099|525571615|FG000|Overall Study|Lost to Follow-up|3|||
145741946|NCT00632099|525571616|FG001|Overall Study|Lost to Follow-up|3|||
145741947|NCT04712110|525571621|FG000|Overall Study|Lost to Follow-up|0|||
145741948|NCT04712110|525571622|FG001|Overall Study|Lost to Follow-up|1|||
145741949|NCT04712110|525571621|FG000|Overall Study|Withdrawal by Subject|0|||
145741950|NCT04712110|525571622|FG001|Overall Study|Withdrawal by Subject|4|||
145741951|NCT04712110|525571621|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
145741952|NCT04712110|525571622|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
145741953|NCT01197521|525571623|FG000|Overall Study|Not reported|24|||
145741954|NCT01197521|525571624|FG001|Overall Study|Not reported|25|||
145741955|NCT01197521|525571625|FG002|Overall Study|Not reported|21|||
145518277|NCT01227629|524756773|FG006|Overall Study|Withdrawal by Subject|2|||
145518278|NCT01227629|524756774|FG007|Overall Study|Withdrawal by Subject|0|||
145518279|NCT01227629|524756775|FG008|Overall Study|Withdrawal by Subject|0|||
145518280|NCT01227629|524756776|FG009|Overall Study|Withdrawal by Subject|1|||
145518281|NCT01227629|524756767|FG000|Overall Study|Other|0|||
145518282|NCT01227629|524756768|FG001|Overall Study|Other|0|||
145518283|NCT01227629|524756769|FG002|Overall Study|Other|0|||
145518284|NCT01227629|524756770|FG003|Overall Study|Other|1|||
145518285|NCT01227629|524756771|FG004|Overall Study|Other|0|||
145518286|NCT01227629|524756772|FG005|Overall Study|Other|0|||
145518287|NCT01227629|524756773|FG006|Overall Study|Other|0|||
145518288|NCT01227629|524756774|FG007|Overall Study|Other|0|||
145518289|NCT01227629|524756775|FG008|Overall Study|Other|2|||
145518290|NCT01227629|524756776|FG009|Overall Study|Other|1|||
145518291|NCT03976648|524756778|FG000|Overall Study|Adverse Event|0|||
145518292|NCT03976648|524756779|FG001|Overall Study|Adverse Event|2|||
145518293|NCT03976648|524756778|FG000|Overall Study|Study terminated by sponsor|21|||
145518294|NCT03976648|524756779|FG001|Overall Study|Study terminated by sponsor|8|||
145518295|NCT01155167|524756780|FG000|Overall Study|Insufficient ultrasound data|2|||
145518296|NCT01155167|524756781|FG001|Overall Study|Insufficient ultrasound data|0|||
145518297|NCT01155167|524756780|FG000|Overall Study|Access site changed to femoral artery|1|||
145518298|NCT01155167|524756781|FG001|Overall Study|Access site changed to femoral artery|0|||
145518299|NCT00881868|524756782|FG000|Overall Study|Adverse Event|0|||
145518300|NCT00881868|524756783|FG001|Overall Study|Adverse Event|1|||
145518301|NCT00881868|524756782|FG000|Overall Study|Lost to Follow-up|2|||
145518302|NCT00881868|524756783|FG001|Overall Study|Lost to Follow-up|1|||
145518303|NCT00881868|524756782|FG000|Overall Study|Physician Decision|4|||
145518304|NCT00881868|524756783|FG001|Overall Study|Physician Decision|0|||
145518305|NCT00881868|524756782|FG000|Overall Study|Protocol Violation|2|||
145518306|NCT00881868|524756783|FG001|Overall Study|Protocol Violation|0|||
145518307|NCT00960570|524756784|FG000|21 Day Washout Period|Adverse Event|1|||
145518308|NCT00960570|524756784|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
145518309|NCT00960570|524756784|FG000|1 Day Period Between Dosing|Adverse Event|2|||
145518310|NCT00960570|524756784|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
145518311|NCT01451437|524756785|FG000|Overall Study|Adverse Event|0|||
145518312|NCT01451437|524756786|FG001|Overall Study|Adverse Event|0|||
145518313|NCT01451437|524756787|FG002|Overall Study|Adverse Event|0|||
145518314|NCT01451437|524756788|FG003|Overall Study|Adverse Event|0|||
145518315|NCT01451437|524756789|FG004|Overall Study|Adverse Event|0|||
145518316|NCT01451437|524756790|FG005|Overall Study|Adverse Event|1|||
145518317|NCT01451437|524756791|FG006|Overall Study|Adverse Event|1|||
145518318|NCT01451437|524756792|FG007|Overall Study|Adverse Event|2|||
145518319|NCT01451437|524756793|FG008|Overall Study|Adverse Event|1|||
145518320|NCT01451437|524756785|FG000|Overall Study|Physician Decision|1|||
145518321|NCT01451437|524756786|FG001|Overall Study|Physician Decision|1|||
145518322|NCT01451437|524756787|FG002|Overall Study|Physician Decision|2|||
145518323|NCT01451437|524756788|FG003|Overall Study|Physician Decision|0|||
145518324|NCT01451437|524756789|FG004|Overall Study|Physician Decision|0|||
145518325|NCT01451437|524756790|FG005|Overall Study|Physician Decision|0|||
145518326|NCT01451437|524756791|FG006|Overall Study|Physician Decision|0|||
145518327|NCT01451437|524756792|FG007|Overall Study|Physician Decision|0|||
145518328|NCT01451437|524756793|FG008|Overall Study|Physician Decision|0|||
145518329|NCT01451437|524756785|FG000|Overall Study|Disease Progression|0|||
145518330|NCT01451437|524756786|FG001|Overall Study|Disease Progression|0|||
145741956|NCT01197521|525571623|FG000|Overall Study|Enrolment in long term extension|42|||
145741957|NCT01197521|525571624|FG001|Overall Study|Enrolment in long term extension|36|||
145741958|NCT01197521|525571625|FG002|Overall Study|Enrolment in long term extension|87|||
145741959|NCT01197521|525571623|FG000|Overall Study|Severe non-compliance to protocol|1|||
145741960|NCT01197521|525571624|FG001|Overall Study|Severe non-compliance to protocol|3|||
145741961|NCT01197521|525571625|FG002|Overall Study|Severe non-compliance to protocol|3|||
145741962|NCT01197521|525571623|FG000|Overall Study|Lack of therapeutic response|2|||
145741963|NCT01197521|525571624|FG001|Overall Study|Lack of therapeutic response|3|||
145741964|NCT01197521|525571625|FG002|Overall Study|Lack of therapeutic response|4|||
145741965|NCT01197521|525571623|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
145741966|NCT01197521|525571624|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
145741967|NCT01197521|525571625|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
145741968|NCT01197521|525571623|FG000|Overall Study|Lost to Follow-up|3|||
145741969|NCT01197521|525571624|FG001|Overall Study|Lost to Follow-up|2|||
145741970|NCT01197521|525571625|FG002|Overall Study|Lost to Follow-up|2|||
145741971|NCT01197521|525571623|FG000|Overall Study|Adverse Event|25|||
145741972|NCT01197521|525571624|FG001|Overall Study|Adverse Event|28|||
145741973|NCT01197521|525571625|FG002|Overall Study|Adverse Event|24|||
145741974|NCT04707157|525571633|FG000|Overall Study|Adverse Event|12|||
145741975|NCT04707157|525571634|FG001|Overall Study|Adverse Event|3|||
145741976|NCT04707157|525571633|FG000|Overall Study|Lost to Follow-up|2|||
145741977|NCT04707157|525571634|FG001|Overall Study|Lost to Follow-up|0|||
145741978|NCT04707157|525571633|FG000|Overall Study|Sponsor's decision|1|||
145741979|NCT04707157|525571634|FG001|Overall Study|Sponsor's decision|0|||
145741980|NCT04707157|525571633|FG000|Overall Study|Physician Decision|8|||
145741981|NCT04707157|525571634|FG001|Overall Study|Physician Decision|5|||
145741982|NCT04707157|525571633|FG000|Overall Study|Protocol Deviation|1|||
145741983|NCT04707157|525571634|FG001|Overall Study|Protocol Deviation|0|||
145741984|NCT04707157|525571633|FG000|Overall Study|Withdrawal by Subject|1|||
145741985|NCT04707157|525571634|FG001|Overall Study|Withdrawal by Subject|1|||
145741986|NCT03625687|525571642|FG000|Overall Study|Death|1|||
145741987|NCT04206605|525571645|FG000|Overall Study|Adverse Event|0|||
145741988|NCT04206605|525571646|FG001|Overall Study|Adverse Event|1|||
145741989|NCT04206605|525571645|FG000|Overall Study|Withdrawal by Subject|1|||
145741990|NCT04206605|525571646|FG001|Overall Study|Withdrawal by Subject|0|||
145741991|NCT05879107|525571647|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
145741992|NCT05879107|525571648|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
145741993|NCT05879107|525571647|FG000|Overall Study|Migrated / moved from the study area|1|||
145741994|NCT05879107|525571648|FG001|Overall Study|Migrated / moved from the study area|1|||
145741995|NCT05879107|525571647|FG000|Overall Study|Lost to Follow-up|8|||
145741996|NCT05879107|525571648|FG001|Overall Study|Lost to Follow-up|13|||
145741997|NCT05879107|525571647|FG000|Overall Study|Death|0|||
145741998|NCT05879107|525571648|FG001|Overall Study|Death|2|||
145741999|NCT05879107|525571647|FG000|Overall Study|Other|0|||
145742000|NCT05879107|525571648|FG001|Overall Study|Other|3|||
145742001|NCT00827606|525571649|FG000|Overall Study|Protocol Violation|4|||
145742002|NCT00827606|525571650|FG001|Overall Study|Protocol Violation|3|||
145742003|NCT00827606|525571649|FG000|Overall Study|Lost to Follow-up|3|||
145742004|NCT00827606|525571650|FG001|Overall Study|Lost to Follow-up|1|||
145742005|NCT00827606|525571649|FG000|Overall Study|Withdrawal by Subject|7|||
145742006|NCT00827606|525571650|FG001|Overall Study|Withdrawal by Subject|6|||
145742007|NCT00827606|525571649|FG000|Overall Study|Pregnancy|0|||
145742008|NCT00827606|525571650|FG001|Overall Study|Pregnancy|1|||
145742009|NCT00827606|525571649|FG000|Overall Study|Other|5|||
145742010|NCT00827606|525571650|FG001|Overall Study|Other|13|||
145742011|NCT00827606|525571649|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
145742012|NCT00827606|525571650|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
145742013|NCT00827606|525571649|FG000|Overall Study|Adverse Event|4|||
145742014|NCT00827606|525571650|FG001|Overall Study|Adverse Event|2|||
145742015|NCT00589420|525571653|FG000|Overall Study|screen failure|1|||
145742016|NCT00243386|525571654|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
145742017|NCT00243386|525571655|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
145742018|NCT00243386|525571656|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
145742019|NCT00243386|525571654|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
145742020|NCT00243386|525571655|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
145742021|NCT00243386|525571656|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
145742022|NCT00243386|525571654|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
145742023|NCT00243386|525571655|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
145742024|NCT00243386|525571656|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
145742025|NCT00243386|525571654|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
145742026|NCT00243386|525571655|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
145742027|NCT00243386|525571656|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
145742028|NCT00243386|525571654|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
145742029|NCT00243386|525571655|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
145742030|NCT00243386|525571656|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
145742031|NCT00243386|525571654|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
145742032|NCT00243386|525571655|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
145742033|NCT00243386|525571656|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
145742034|NCT00243386|525571654|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
145742035|NCT00243386|525571655|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
145742036|NCT00243386|525571656|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
145742037|NCT00243386|525571654|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
145742038|NCT00243386|525571655|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
145742039|NCT00243386|525571656|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
145742040|NCT04037748|525571657|FG000|Treatment Period 1|Withdrawal by Subject|3|||
145742041|NCT04037748|525571658|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145742042|NCT04037748|525571657|FG000|Treatment Period 1|Adverse Event|1|||
145742043|NCT04037748|525571658|FG001|Treatment Period 1|Adverse Event|1|||
145742044|NCT04037748|525571657|FG000|Treatment Period 1|Protocol Violation|4|||
145742045|NCT04037748|525571658|FG001|Treatment Period 1|Protocol Violation|5|||
145742046|NCT04037748|525571657|FG000|Treatment Period 2|Adverse Event|0|||
145742047|NCT04037748|525571658|FG001|Treatment Period 2|Adverse Event|1|||
145742048|NCT04037748|525571657|FG000|Treatment Period 2|Protocol Violation|2|||
145742049|NCT04037748|525571658|FG001|Treatment Period 2|Protocol Violation|0|||
145742050|NCT04995055|525571662|FG000|Period 1|COVID-19 Related|1|||
145742051|NCT04995055|525571663|FG001|Period 1|COVID-19 Related|0|||
145742052|NCT04995055|525571662|FG000|Period 1|Withdrawal by Subject|0|||
145742053|NCT04995055|525571663|FG001|Period 1|Withdrawal by Subject|1|||
145742054|NCT04995055|525571662|FG000|Period 1|Subject discontinued due to timing|4|||
145742055|NCT04995055|525571663|FG001|Period 1|Subject discontinued due to timing|4|||
145742056|NCT04695392|525571667|FG000|Overall Study|Withdrawn by parent/guardian|0|||
145742057|NCT04695392|525571668|FG001|Overall Study|Withdrawn by parent/guardian|1|||
145742058|NCT04695392|525571667|FG000|Overall Study|Withdrawn by physician|0|||
145742059|NCT04695392|525571668|FG001|Overall Study|Withdrawn by physician|1|||
145742060|NCT03710486|525571669|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
145742061|NCT03710486|525571670|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
145742062|NCT03710486|525571669|FG000|Overall Study|Missing|0|||
145742063|NCT03710486|525571670|FG001|Overall Study|Missing|2|||
145742064|NCT01987960|525571671|FG000|Period 1|Adverse Event|24|||
145742065|NCT01987960|525571672|FG001|Period 1|Adverse Event|0|||
145742066|NCT01987960|525571673|FG002|Period 1|Adverse Event|0|||
145742067|NCT01987960|525571674|FG003|Period 1|Adverse Event|0|||
145742068|NCT01987960|525571671|FG000|Period 1|Lack of Efficacy|4|||
145518331|NCT01451437|524756787|FG002|Overall Study|Disease Progression|1|||
145742069|NCT01987960|525571672|FG001|Period 1|Lack of Efficacy|0|||
145742070|NCT01987960|525571673|FG002|Period 1|Lack of Efficacy|0|||
145402336|NCT03098979|524330709|FG000|Overall Study|Non-compliance|0|||
145742071|NCT01987960|525571674|FG003|Period 1|Lack of Efficacy|0|||
145742072|NCT01987960|525571671|FG000|Period 1|Non-compliance with IMP|6|||
145742073|NCT01987960|525571672|FG001|Period 1|Non-compliance with IMP|0|||
145742074|NCT01987960|525571673|FG002|Period 1|Non-compliance with IMP|0|||
145742075|NCT01987960|525571674|FG003|Period 1|Non-compliance with IMP|0|||
145742076|NCT01987960|525571671|FG000|Period 1|Protocol Violation|12|||
145742077|NCT01987960|525571672|FG001|Period 1|Protocol Violation|0|||
145742078|NCT01987960|525571673|FG002|Period 1|Protocol Violation|0|||
145742079|NCT01987960|525571674|FG003|Period 1|Protocol Violation|0|||
145742080|NCT01987960|525571671|FG000|Period 1|Withdrawal by Subject|21|||
145742081|NCT01987960|525571672|FG001|Period 1|Withdrawal by Subject|0|||
145742082|NCT01987960|525571673|FG002|Period 1|Withdrawal by Subject|0|||
145742083|NCT01987960|525571674|FG003|Period 1|Withdrawal by Subject|0|||
145742084|NCT01987960|525571671|FG000|Period 1|Lost to Follow-up|40|||
145742085|NCT01987960|525571672|FG001|Period 1|Lost to Follow-up|0|||
145742086|NCT01987960|525571673|FG002|Period 1|Lost to Follow-up|0|||
145742087|NCT01987960|525571674|FG003|Period 1|Lost to Follow-up|0|||
145742088|NCT01987960|525571671|FG000|Period 1|administrative or other reason|75|||
145742089|NCT01987960|525571672|FG001|Period 1|administrative or other reason|0|||
145742090|NCT01987960|525571673|FG002|Period 1|administrative or other reason|0|||
145742091|NCT01987960|525571674|FG003|Period 1|administrative or other reason|0|||
145742092|NCT01987960|525571671|FG000|Period 1|Withdrawal of consent before treatment|4|||
145742093|NCT01987960|525571672|FG001|Period 1|Withdrawal of consent before treatment|0|||
145742094|NCT01987960|525571673|FG002|Period 1|Withdrawal of consent before treatment|0|||
145742095|NCT01987960|525571674|FG003|Period 1|Withdrawal of consent before treatment|0|||
145742096|NCT01987960|525571671|FG000|Period 2|Adverse Event|0|||
145742097|NCT01987960|525571672|FG001|Period 2|Adverse Event|0|||
145742098|NCT01987960|525571673|FG002|Period 2|Adverse Event|1|||
145742099|NCT01987960|525571674|FG003|Period 2|Adverse Event|0|||
145742100|NCT01987960|525571671|FG000|Period 2|Withdrawal by Subject|0|||
145742101|NCT01987960|525571672|FG001|Period 2|Withdrawal by Subject|0|||
145742102|NCT01987960|525571673|FG002|Period 2|Withdrawal by Subject|1|||
145742103|NCT01987960|525571674|FG003|Period 2|Withdrawal by Subject|0|||
145742104|NCT01987960|525571671|FG000|Period 2|Administrative or other reason|0|||
145742105|NCT01987960|525571672|FG001|Period 2|Administrative or other reason|5|||
145742106|NCT01987960|525571673|FG002|Period 2|Administrative or other reason|7|||
145742107|NCT01987960|525571674|FG003|Period 2|Administrative or other reason|0|||
145742108|NCT01987960|525571671|FG000|Period 3|Adverse Event|0|||
145742109|NCT01987960|525571672|FG001|Period 3|Adverse Event|0|||
145742110|NCT01987960|525571673|FG002|Period 3|Adverse Event|0|||
145742111|NCT01987960|525571674|FG003|Period 3|Adverse Event|7|||
145742112|NCT01987960|525571671|FG000|Period 3|Non-compliance with IMP|0|||
145742113|NCT01987960|525571672|FG001|Period 3|Non-compliance with IMP|0|||
145742114|NCT01987960|525571673|FG002|Period 3|Non-compliance with IMP|0|||
145742115|NCT01987960|525571674|FG003|Period 3|Non-compliance with IMP|1|||
145269581|NCT05553600|523835389|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
145742116|NCT01987960|525571671|FG000|Period 3|Protocol Violation|0|||
145742117|NCT01987960|525571672|FG001|Period 3|Protocol Violation|0|||
145742118|NCT01987960|525571673|FG002|Period 3|Protocol Violation|0|||
145742119|NCT01987960|525571674|FG003|Period 3|Protocol Violation|6|||
145742120|NCT01987960|525571671|FG000|Period 3|Withdrawal by Subject|0|||
145742121|NCT01987960|525571672|FG001|Period 3|Withdrawal by Subject|0|||
145742122|NCT01987960|525571673|FG002|Period 3|Withdrawal by Subject|0|||
145742123|NCT01987960|525571674|FG003|Period 3|Withdrawal by Subject|9|||
145742124|NCT01987960|525571671|FG000|Period 3|Lost to Follow-up|0|||
145742125|NCT01987960|525571672|FG001|Period 3|Lost to Follow-up|0|||
145742126|NCT01987960|525571673|FG002|Period 3|Lost to Follow-up|0|||
145742127|NCT01987960|525571674|FG003|Period 3|Lost to Follow-up|5|||
145742128|NCT01987960|525571671|FG000|Period 3|Administrative or other reason|0|||
145742129|NCT01987960|525571672|FG001|Period 3|Administrative or other reason|0|||
145742130|NCT01987960|525571673|FG002|Period 3|Administrative or other reason|0|||
145742131|NCT01987960|525571674|FG003|Period 3|Administrative or other reason|43|||
145742132|NCT01279850|525571679|FG000|Overall Study|Protocol Violation|50|||
145742133|NCT01279850|525571679|FG000|Overall Study|No Drug Administration Information|7|||
145742134|NCT01279850|525571679|FG000|Overall Study|No Visit After Treatment|34|||
145742135|NCT01131520|525571680|FG000|Overall Study|Computer problem|1|||
145742136|NCT01131520|525571681|FG001|Overall Study|Computer problem|0|||
145742137|NCT01131520|525571680|FG000|Overall Study|Counselor not available|0|||
145742138|NCT01131520|525571681|FG001|Overall Study|Counselor not available|3|||
145742139|NCT01131520|525571680|FG000|Overall Study|Subject changed history after enrollment|0|||
145742140|NCT01131520|525571681|FG001|Overall Study|Subject changed history after enrollment|1|||
145742141|NCT01436084|525571684|FG000|Overall Study|Disease Progression|2|||
145742142|NCT01436084|525571684|FG000|Overall Study|Withdrawal by Subject|1|||
145742143|NCT01436084|525571684|FG000|Overall Study|Early Closure of Study|1|||
145742144|NCT01744665|525571685|FG000|Monitoring Phase|Adverse Event|4|||
145742145|NCT01744665|525571685|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
145742146|NCT01744665|525571685|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
145742147|NCT01744665|525571685|FG000|Monitoring Phase|Withdrawal by Subject|5|||
145742148|NCT01744665|525571685|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
145742149|NCT01744665|525571685|FG000|Consolidation Phase|Adverse Event|2|||
145742150|NCT01744665|525571685|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
145742151|NCT01744665|525571685|FG000|Consolidation Phase|Withdrawal by Subject|4|||
145742152|NCT01744665|525571685|FG000|Consolidation Phase|Administrative problems|9|||
145742153|NCT01744665|525571685|FG000|Re-initiation Phase|Administrative problems|10|||
145742154|NCT01744665|525571685|FG000|Re-initiation Phase|Adverse Event|1|||
145742155|NCT01744665|525571685|FG000|Re-initiation Phase|No longer required treatment|1|||
145742156|NCT01744665|525571685|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
145742157|NCT00807742|525571686|FG000|Overall Study|Death|9|||
145742158|NCT00807742|525571687|FG001|Overall Study|Death|2|||
145742159|NCT00807742|525571686|FG000|Overall Study|Withdrawal by Subject|2|||
145742160|NCT00807742|525571687|FG001|Overall Study|Withdrawal by Subject|1|||
145742161|NCT00807742|525571686|FG000|Overall Study|Lost to Follow-up|35|||
145742162|NCT00807742|525571687|FG001|Overall Study|Lost to Follow-up|51|||
145742163|NCT05419128|525571688|FG000|Overall Study|Withdrawal by Subject|1|||
145742164|NCT05419128|525571689|FG001|Overall Study|Withdrawal by Subject|1|||
145742165|NCT05419128|525571690|FG002|Overall Study|Withdrawal by Subject|0|||
145742166|NCT05419128|525571691|FG003|Overall Study|Withdrawal by Subject|1|||
145742167|NCT05419128|525571692|FG004|Overall Study|Withdrawal by Subject|1|||
145742168|NCT05419128|525571693|FG005|Overall Study|Withdrawal by Subject|0|||
145742169|NCT05419128|525571688|FG000|Overall Study|Lost to Follow-up|0|||
145742170|NCT05419128|525571689|FG001|Overall Study|Lost to Follow-up|0|||
145742171|NCT05419128|525571690|FG002|Overall Study|Lost to Follow-up|1|||
145742172|NCT05419128|525571691|FG003|Overall Study|Lost to Follow-up|0|||
145742173|NCT05419128|525571692|FG004|Overall Study|Lost to Follow-up|0|||
145742174|NCT05419128|525571693|FG005|Overall Study|Lost to Follow-up|1|||
145742175|NCT03834519|525571694|FG000|Overall Study|Lost to Follow-up|2|||
145742176|NCT03834519|525571695|FG001|Overall Study|Lost to Follow-up|1|||
145742177|NCT03834519|525571694|FG000|Overall Study|Withdrawal by Subject|5|||
145742178|NCT03834519|525571695|FG001|Overall Study|Withdrawal by Subject|8|||
145742179|NCT03834519|525571694|FG000|Overall Study|Death|368|||
145742180|NCT03834519|525571695|FG001|Overall Study|Death|174|||
145742181|NCT03834519|525571694|FG000|Overall Study|Physician Decision|5|||
145742182|NCT03834519|525571695|FG001|Overall Study|Physician Decision|1|||
145742183|NCT03834519|525571694|FG000|Overall Study|Sponsor decision|149|||
145742184|NCT03834519|525571695|FG001|Overall Study|Sponsor decision|80|||
145742185|NCT00853749|525571696|FG000|Overall Study|Lost to Follow-up|0|||
145742186|NCT00853749|525571697|FG001|Overall Study|Lost to Follow-up|1|||
145742187|NCT01538628|525571700|FG000|Overall Study|Withdrawal by Subject|1|||
145742188|NCT01538628|525571701|FG001|Overall Study|Withdrawal by Subject|1|||
145742189|NCT01538628|525571700|FG000|Overall Study|Lost to Follow-up|0|||
145742190|NCT01538628|525571701|FG001|Overall Study|Lost to Follow-up|1|||
145742191|NCT01617460|525573555|FG000|Overall Study|Adverse Event|10|||
145742192|NCT01617460|525573555|FG000|Overall Study|Physician Decision|16|||
145742193|NCT01617460|525573555|FG000|Overall Study|Protocol Violation|5|||
145742194|NCT01617460|525573555|FG000|Overall Study|Withdrawal by Subject|9|||
145742195|NCT03703882|525573556|FG000|Overall Study|Adverse Event|1|||
145742196|NCT03703882|525573557|FG001|Overall Study|Adverse Event|0|||
145742197|NCT03703882|525573556|FG000|Overall Study|Lost to Follow-up|0|||
145742198|NCT03703882|525573557|FG001|Overall Study|Lost to Follow-up|2|||
145742199|NCT03703882|525573556|FG000|Overall Study|Non-compliance with study drug|0|||
145742200|NCT03703882|525573557|FG001|Overall Study|Non-compliance with study drug|1|||
145742201|NCT03703882|525573556|FG000|Overall Study|Physician Decision|0|||
145742202|NCT03703882|525573557|FG001|Overall Study|Physician Decision|1|||
145742203|NCT03703882|525573556|FG000|Overall Study|Progressive disease|1|||
145742204|NCT03703882|525573557|FG001|Overall Study|Progressive disease|0|||
145742205|NCT03703882|525573556|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145742206|NCT03703882|525573557|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145742207|NCT03703882|525573556|FG000|Overall Study|Starting another treatment|0|||
145742208|NCT03703882|525573557|FG001|Overall Study|Starting another treatment|1|||
145742209|NCT03703882|525573556|FG000|Overall Study|noncompliance with study procedures|0|||
145742210|NCT03703882|525573557|FG001|Overall Study|noncompliance with study procedures|1|||
145742211|NCT00457015|525573561|FG000|Overall Study|Left study site against medical advice|0|||
145742212|NCT00457015|525573562|FG001|Overall Study|Left study site against medical advice|1|||
145742213|NCT00075023|525573563|FG000|Pilot Study|Physician Decision|1|||
145742214|NCT00075023|525573564|FG001|Pilot Study|Physician Decision|2|||
145742215|NCT00075023|525573563|FG000|Pilot Study|Withdrawal by Subject|1|||
145742216|NCT00075023|525573564|FG001|Pilot Study|Withdrawal by Subject|0|||
145742217|NCT03670953|525573565|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
145742218|NCT03670953|525573566|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
145742219|NCT03670953|525573567|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
145742220|NCT03670953|525573568|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
145742221|NCT03670953|525573565|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
145742222|NCT03670953|525573566|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
145742223|NCT03670953|525573567|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
145742224|NCT03670953|525573568|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
145742225|NCT03670953|525573565|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
145742226|NCT03670953|525573566|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
145742227|NCT03670953|525573567|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
145742228|NCT03670953|525573568|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
145518332|NCT01451437|524756788|FG003|Overall Study|Disease Progression|1|||
145518333|NCT01451437|524756789|FG004|Overall Study|Disease Progression|3|||
145742229|NCT03670953|525573565|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
145742230|NCT03670953|525573566|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
145518334|NCT01451437|524756790|FG005|Overall Study|Disease Progression|2|||
145518335|NCT01451437|524756791|FG006|Overall Study|Disease Progression|3|||
145518336|NCT01451437|524756792|FG007|Overall Study|Disease Progression|1|||
145742231|NCT03670953|525573567|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
145742232|NCT03670953|525573568|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
145518337|NCT01451437|524756793|FG008|Overall Study|Disease Progression|3|||
145742233|NCT03670953|525573565|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
145742234|NCT03670953|525573566|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
145742235|NCT03670953|525573567|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
145742236|NCT03670953|525573568|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
145518338|NCT01451437|524756785|FG000|Overall Study|Protocol Violation|0|||
145518339|NCT01451437|524756786|FG001|Overall Study|Protocol Violation|0|||
145518340|NCT01451437|524756787|FG002|Overall Study|Protocol Violation|0|||
145742237|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
145742238|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
145742239|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
145742240|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
145742241|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
145742242|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
145742243|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
145742244|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
145742245|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
145742246|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
145742247|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
145742248|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
145742249|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
145742250|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
145742251|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
145742252|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
145742253|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
145742254|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
145742255|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
145742256|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
145742257|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
145742258|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
145742259|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
145742260|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
145742261|NCT03670953|525573565|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
145742262|NCT03670953|525573566|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
145742263|NCT03670953|525573567|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
145742264|NCT03670953|525573568|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
145742265|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
145742266|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
145742267|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
145742268|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
145742269|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
145742270|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
145742271|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
145742272|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
145742273|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
145742274|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
145742275|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
145742276|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
145742277|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
145742278|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
145742279|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
145742280|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
145742281|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
145742282|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
145269582|NCT05553600|523835390|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
145518341|NCT01451437|524756788|FG003|Overall Study|Protocol Violation|0|||
145518342|NCT01451437|524756789|FG004|Overall Study|Protocol Violation|0|||
145518343|NCT01451437|524756790|FG005|Overall Study|Protocol Violation|0|||
145518344|NCT01451437|524756791|FG006|Overall Study|Protocol Violation|1|||
145518345|NCT01451437|524756792|FG007|Overall Study|Protocol Violation|0|||
145518346|NCT01451437|524756793|FG008|Overall Study|Protocol Violation|0|||
145518347|NCT01451437|524756785|FG000|Overall Study|Withdrawal by Subject|0|||
145518348|NCT01451437|524756786|FG001|Overall Study|Withdrawal by Subject|0|||
145518349|NCT01451437|524756787|FG002|Overall Study|Withdrawal by Subject|0|||
145518350|NCT01451437|524756788|FG003|Overall Study|Withdrawal by Subject|0|||
145518351|NCT01451437|524756789|FG004|Overall Study|Withdrawal by Subject|1|||
145518352|NCT01451437|524756790|FG005|Overall Study|Withdrawal by Subject|0|||
145518353|NCT01451437|524756791|FG006|Overall Study|Withdrawal by Subject|1|||
145518354|NCT01451437|524756792|FG007|Overall Study|Withdrawal by Subject|0|||
145518355|NCT01451437|524756793|FG008|Overall Study|Withdrawal by Subject|0|||
145518356|NCT02081859|524756796|FG000|Overall Study|No fertilization|2|||
145518357|NCT02081859|524756797|FG001|Overall Study|No fertilization|2|||
145518358|NCT02081859|524756796|FG000|Overall Study|No sperm|1|||
145518359|NCT02081859|524756797|FG001|Overall Study|No sperm|0|||
145518360|NCT02081859|524756796|FG000|Overall Study|Unanticipated freeze all cycle|2|||
145518361|NCT02081859|524756797|FG001|Overall Study|Unanticipated freeze all cycle|6|||
145518362|NCT02081859|524756796|FG000|Overall Study|< 4 embryos|27|||
145742283|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
145742284|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
145742285|NCT03670953|525573565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
145742286|NCT03670953|525573566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
145742287|NCT03670953|525573567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
145742288|NCT03670953|525573568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
145518363|NCT02081859|524756797|FG001|Overall Study|< 4 embryos|23|||
145518364|NCT02081859|524756796|FG000|Overall Study|Other reasons|2|||
145518365|NCT02081859|524756797|FG001|Overall Study|Other reasons|0|||
145518366|NCT00603590|524758914|FG000|Overall Study|Did not attend study clinic|39|||
145518367|NCT00603590|524758915|FG001|Overall Study|Did not attend study clinic|30|||
145518368|NCT00603590|524758914|FG000|Overall Study|Refused blood test|5|||
145518369|NCT00603590|524758915|FG001|Overall Study|Refused blood test|1|||
145742289|NCT02982954|525573571|FG000|Overall Study|Death|55|||
145742290|NCT02982954|525573572|FG001|Overall Study|Death|29|||
145742291|NCT02982954|525573573|FG002|Overall Study|Death|15|||
145742292|NCT02982954|525573574|FG003|Overall Study|Death|20|||
145742293|NCT02982954|525573571|FG000|Overall Study|Lost to Follow-up|2|||
145742294|NCT02982954|525573572|FG001|Overall Study|Lost to Follow-up|1|||
145742295|NCT02982954|525573573|FG002|Overall Study|Lost to Follow-up|0|||
145742296|NCT02982954|525573574|FG003|Overall Study|Lost to Follow-up|0|||
145742297|NCT02982954|525573571|FG000|Overall Study|Participant withdrew consent|7|||
145742298|NCT02982954|525573572|FG001|Overall Study|Participant withdrew consent|5|||
145742299|NCT02982954|525573573|FG002|Overall Study|Participant withdrew consent|1|||
145742300|NCT02982954|525573574|FG003|Overall Study|Participant withdrew consent|1|||
145742301|NCT02982954|525573571|FG000|Overall Study|Other reasons|42|||
145742302|NCT02982954|525573572|FG001|Overall Study|Other reasons|17|||
145742303|NCT02982954|525573573|FG002|Overall Study|Other reasons|12|||
145742304|NCT02982954|525573574|FG003|Overall Study|Other reasons|3|||
145742305|NCT02982954|525573571|FG000|Overall Study|Premature site closure|0|||
145742306|NCT02982954|525573572|FG001|Overall Study|Premature site closure|0|||
145742307|NCT02982954|525573573|FG002|Overall Study|Premature site closure|0|||
145742308|NCT02982954|525573574|FG003|Overall Study|Premature site closure|1|||
145742309|NCT00516048|525573575|FG000|Overall Study|Death|0|||
145742310|NCT00516048|525573576|FG001|Overall Study|Death|0|||
145742311|NCT00516048|525573577|FG002|Overall Study|Death|1|||
145742312|NCT00516048|525573575|FG000|Overall Study|Subject Decision|0|||
145742313|NCT00516048|525573576|FG001|Overall Study|Subject Decision|2|||
145742314|NCT00516048|525573577|FG002|Overall Study|Subject Decision|0|||
145742315|NCT02263079|525573578|FG000|Overall Study|Physician Decision|1|||
145742316|NCT02263079|525573579|FG001|Overall Study|Physician Decision|0|||
145742317|NCT02263079|525573580|FG002|Overall Study|Physician Decision|0|||
145742318|NCT02263079|525573578|FG000|Overall Study|Withdrawal by Subject|2|||
145742319|NCT02263079|525573579|FG001|Overall Study|Withdrawal by Subject|8|||
145742320|NCT02263079|525573580|FG002|Overall Study|Withdrawal by Subject|0|||
145742321|NCT02554019|525573582|FG000|Overall Study|Withdrawal by Subject|1|||
145742322|NCT02554019|525573583|FG001|Overall Study|Withdrawal by Subject|0|||
145742323|NCT02554019|525573584|FG002|Overall Study|Withdrawal by Subject|2|||
145742324|NCT02554019|525573582|FG000|Overall Study|Adverse Event|1|||
145742325|NCT02554019|525573583|FG001|Overall Study|Adverse Event|0|||
145742326|NCT02554019|525573584|FG002|Overall Study|Adverse Event|0|||
145742327|NCT02463409|525573585|FG000|Overall Study|Withdrawal by Subject|1|||
145518370|NCT00603590|524758914|FG000|Overall Study|Patient discontinued study drug|22|||
145518371|NCT00603590|524758915|FG001|Overall Study|Patient discontinued study drug|15|||
145518372|NCT00603590|524758914|FG000|Overall Study|Adverse Event|2|||
145742328|NCT02463409|525573585|FG000|Overall Study|Screen failure|1|||
145742329|NCT00916357|525573586|FG000|Period 1|Withdrawal by Subject|1|||
145742330|NCT00916357|525573587|FG001|Period 1|Withdrawal by Subject|0|||
145742331|NCT00916357|525573588|FG002|Period 1|Withdrawal by Subject|0|||
145742332|NCT00916357|525573589|FG003|Period 1|Withdrawal by Subject|0|||
145742333|NCT00916357|525573590|FG004|Period 1|Withdrawal by Subject|0|||
145742334|NCT00916357|525573591|FG005|Period 1|Withdrawal by Subject|0|||
145742335|NCT00916357|525573586|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
145742336|NCT00916357|525573587|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
145742337|NCT00916357|525573588|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
145742338|NCT00916357|525573589|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
145742339|NCT00916357|525573590|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
145742340|NCT00916357|525573591|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
145742341|NCT03577730|525573592|FG000|Overall Study|Physician Decision|3|||
145742342|NCT03577730|525573593|FG001|Overall Study|Physician Decision|1|||
145742343|NCT03577730|525573592|FG000|Overall Study|Did not receive allocated intervention|1|||
145742344|NCT03577730|525573593|FG001|Overall Study|Did not receive allocated intervention|0|||
145742345|NCT02634151|525573595|FG000|Overall Study|Withdrawal by Subject|1|||
145742346|NCT02634151|525573596|FG001|Overall Study|Withdrawal by Subject|0|||
145742347|NCT02634151|525573595|FG000|Overall Study|Non-Compliance|0|||
145742348|NCT02634151|525573596|FG001|Overall Study|Non-Compliance|1|||
145742349|NCT02634151|525573595|FG000|Overall Study|Other|0|||
145742350|NCT02634151|525573596|FG001|Overall Study|Other|1|||
145742351|NCT02347098|525573597|FG000|Overall Study|Death|1|||
145742352|NCT02347098|525573598|FG001|Overall Study|Death|0|||
145742353|NCT02347098|525573597|FG000|Overall Study|Withdrawal by Subject|1|||
145742354|NCT02347098|525573598|FG001|Overall Study|Withdrawal by Subject|0|||
145742355|NCT02347098|525573597|FG000|Overall Study|Lost to Follow-up|2|||
145742356|NCT02347098|525573598|FG001|Overall Study|Lost to Follow-up|2|||
145742357|NCT02347098|525573597|FG000|Overall Study|Refuse Follow-up Visit|1|||
145742358|NCT02347098|525573598|FG001|Overall Study|Refuse Follow-up Visit|5|||
145742359|NCT02347098|525573597|FG000|Overall Study|no visit due to illness|2|||
145742360|NCT02347098|525573598|FG001|Overall Study|no visit due to illness|1|||
145742361|NCT01444742|525573599|FG000|Overall Study|Death|1|||
145742362|NCT02187172|525573600|FG000|Overall Study|Lost to Follow-up|1|||
145742363|NCT02187172|525573601|FG001|Overall Study|Lost to Follow-up|2|||
145742364|NCT02187172|525573600|FG000|Overall Study|Lack of Efficacy|1|||
145742365|NCT02187172|525573601|FG001|Overall Study|Lack of Efficacy|2|||
145742366|NCT02187172|525573600|FG000|Overall Study|Adverse Event|0|||
145742367|NCT02187172|525573601|FG001|Overall Study|Adverse Event|1|||
145742368|NCT02187172|525573600|FG000|Overall Study|Physician Decision|1|||
145742369|NCT02187172|525573601|FG001|Overall Study|Physician Decision|1|||
145742370|NCT02349048|525573602|FG000|Overall Study|Withdrawal by Subject|4|||
145742371|NCT02349048|525573603|FG001|Overall Study|Withdrawal by Subject|0|||
145742372|NCT02349048|525573602|FG000|Overall Study|Lost to Follow-up|1|||
145742373|NCT02349048|525573603|FG001|Overall Study|Lost to Follow-up|0|||
145742374|NCT00122681|525573613|FG000|Overall Study|Adverse Event|20|||
145742375|NCT00122681|525573614|FG001|Overall Study|Adverse Event|16|||
145742376|NCT00122681|525573613|FG000|Overall Study|Lost to Follow-up|1080|||
145742377|NCT00122681|525573614|FG001|Overall Study|Lost to Follow-up|1097|||
145742378|NCT00122681|525573613|FG000|Overall Study|Protocol Violation|7|||
145742379|NCT00122681|525573614|FG001|Overall Study|Protocol Violation|10|||
145742380|NCT00122681|525573613|FG000|Overall Study|Withdrawal by Subject|257|||
145742381|NCT00122681|525573614|FG001|Overall Study|Withdrawal by Subject|251|||
145742382|NCT00122681|525573613|FG000|Overall Study|Personal reasons|150|||
145742383|NCT00122681|525573614|FG001|Overall Study|Personal reasons|147|||
145742384|NCT03179891|525573622|FG000|First Intervention|Withdrawal by Subject|1|||
145742385|NCT03179891|525573623|FG001|First Intervention|Withdrawal by Subject|1|||
145742386|NCT03179891|525573622|FG000|First Intervention|Unspecified reason|1|||
145742387|NCT03179891|525573623|FG001|First Intervention|Unspecified reason|0|||
145742388|NCT03179891|525573622|FG000|First Intervention|Protocol Violation|0|||
145742389|NCT03179891|525573623|FG001|First Intervention|Protocol Violation|1|||
145742390|NCT02969187|525573624|FG000|Overall Study|Physician Decision|12|||
145742391|NCT02969187|525573625|FG001|Overall Study|Physician Decision|13|||
145742392|NCT01486927|525573626|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
145742393|NCT01486927|525573626|FG000|Overall Study|Physician Decision|1|||
145742394|NCT01486927|525573626|FG000|Overall Study|50 Exposure days not reached|2|||
145742395|NCT01486927|525573626|FG000|Overall Study|Withdrawal by Subject|8|||
145742396|NCT01486927|525573626|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
145742397|NCT00573430|525573632|FG000|Overall Study|Incorrect enrollment of randomization|0|||
145742398|NCT00573430|525573633|FG001|Overall Study|Incorrect enrollment of randomization|4|||
145742399|NCT00573430|525573634|FG002|Overall Study|Incorrect enrollment of randomization|3|||
145742400|NCT00573430|525573632|FG000|Overall Study|Adverse Event|0|||
145742401|NCT00573430|525573633|FG001|Overall Study|Adverse Event|0|||
145742402|NCT00573430|525573634|FG002|Overall Study|Adverse Event|2|||
145742403|NCT00573430|525573632|FG000|Overall Study|Withdrawal by Subject|1|||
145742404|NCT00573430|525573633|FG001|Overall Study|Withdrawal by Subject|0|||
145742405|NCT00573430|525573634|FG002|Overall Study|Withdrawal by Subject|1|||
145742406|NCT00573430|525573632|FG000|Overall Study|Protocol Violation|0|||
145742407|NCT00573430|525573633|FG001|Overall Study|Protocol Violation|1|||
145742408|NCT00573430|525573634|FG002|Overall Study|Protocol Violation|1|||
145742409|NCT00573430|525573632|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145742410|NCT00573430|525573633|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145742411|NCT00573430|525573634|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
145742412|NCT03719690|525573635|FG000|Overall Study|Withdrawal by Subject|5|||
145742413|NCT03719690|525573636|FG001|Overall Study|Withdrawal by Subject|10|||
145742414|NCT03719690|525573635|FG000|Overall Study|Death|40|||
145742415|NCT03719690|525573636|FG001|Overall Study|Death|149|||
145742416|NCT03719690|525573635|FG000|Overall Study|Miscellaneous|12|||
145742417|NCT03719690|525573636|FG001|Overall Study|Miscellaneous|56|||
145742418|NCT03719690|525573635|FG000|Overall Study|Lost to Follow-up|2|||
145742419|NCT03719690|525573636|FG001|Overall Study|Lost to Follow-up|18|||
145742420|NCT03719690|525573635|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
145742421|NCT03719690|525573636|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
145742422|NCT01471015|525573637|FG000|Overall Study|Death|0|||
145742423|NCT01471015|525573638|FG001|Overall Study|Death|1|||
145742424|NCT01471015|525573639|FG002|Overall Study|Death|1|||
145742425|NCT01843842|525573645|FG000|Overall Study|Do not meet inclusion criteria|1|||
145742426|NCT01843842|525573646|FG001|Overall Study|Do not meet inclusion criteria|1|||
145742427|NCT01376778|525573647|FG000|Overall Study|Lost to Follow-up|3|||
145742428|NCT01376778|525573648|FG001|Overall Study|Lost to Follow-up|2|||
145742429|NCT03462576|525573660|FG000|Overall Study|Protocol Violation|5|||
145742430|NCT03462576|525573661|FG001|Overall Study|Protocol Violation|11|||
145742431|NCT03462576|525573662|FG002|Overall Study|Protocol Violation|7|||
145742432|NCT03462576|525573660|FG000|Overall Study|Device Malfunction|0|||
145742433|NCT03462576|525573661|FG001|Overall Study|Device Malfunction|0|||
145742434|NCT03462576|525573662|FG002|Overall Study|Device Malfunction|1|||
145742435|NCT00271596|525573663|FG000|Overall Study|Protocol Violation|1|||
145742436|NCT00271596|525573664|FG001|Overall Study|Protocol Violation|0|||
145742437|NCT00271596|525573663|FG000|Overall Study|Withdrawal by Subject|0|||
145742438|NCT00271596|525573664|FG001|Overall Study|Withdrawal by Subject|1|||
145742439|NCT00942175|525573665|FG000|Overall Study|Adverse Event|2|||
145742440|NCT00942175|525573666|FG001|Overall Study|Adverse Event|1|||
145742441|NCT00942175|525573667|FG002|Overall Study|Adverse Event|0|||
145742442|NCT00942175|525573668|FG003|Overall Study|Adverse Event|0|||
145742443|NCT00942175|525573665|FG000|Overall Study|Protocol Violation|0|||
145742444|NCT00942175|525573666|FG001|Overall Study|Protocol Violation|1|||
145742445|NCT00942175|525573667|FG002|Overall Study|Protocol Violation|2|||
145742446|NCT00942175|525573668|FG003|Overall Study|Protocol Violation|0|||
145742447|NCT00942175|525573665|FG000|Overall Study|Pregnancy|0|||
145742448|NCT00942175|525573666|FG001|Overall Study|Pregnancy|0|||
145742449|NCT00942175|525573667|FG002|Overall Study|Pregnancy|0|||
145742450|NCT00942175|525573668|FG003|Overall Study|Pregnancy|1|||
145742451|NCT00942175|525573665|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
145742452|NCT00942175|525573666|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
145742453|NCT00942175|525573667|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
145742454|NCT00942175|525573668|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
145742455|NCT00942175|525573665|FG000|Overall Study|Low Platelet Count|0|||
145742456|NCT00942175|525573666|FG001|Overall Study|Low Platelet Count|2|||
145742457|NCT00942175|525573667|FG002|Overall Study|Low Platelet Count|0|||
145742458|NCT00942175|525573668|FG003|Overall Study|Low Platelet Count|0|||
145742459|NCT01066585|525573669|FG000|Overall Study|Protocol Violation|1|||
145742460|NCT01066585|525573670|FG001|Overall Study|Protocol Violation|0|||
145742461|NCT01066585|525573669|FG000|Overall Study|Withdrawal by Subject|0|||
145742462|NCT01066585|525573670|FG001|Overall Study|Withdrawal by Subject|3|||
145742463|NCT00884273|525573673|FG000|Overall Study|Adverse Event|0|||
145742464|NCT00884273|525573674|FG001|Overall Study|Adverse Event|2|||
145742465|NCT00884273|525573673|FG000|Overall Study|Protocol Violation|1|||
145742466|NCT00884273|525573674|FG001|Overall Study|Protocol Violation|3|||
145742467|NCT00884273|525573673|FG000|Overall Study|Practical reasons|1|||
145742468|NCT00884273|525573674|FG001|Overall Study|Practical reasons|0|||
145742469|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
145742470|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
145742471|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
145742472|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
145742473|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
145742474|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
145742475|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145742476|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145742477|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
145742478|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
145742479|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
145742480|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
145742481|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
145742482|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
145742483|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
145742484|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
145742485|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
145742486|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
145742487|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
145742488|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
145518373|NCT00603590|524758915|FG001|Overall Study|Adverse Event|0|||
145518374|NCT00603590|524758914|FG000|Overall Study|Lost to Follow-up|8|||
145742489|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
145742490|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
145742491|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
145742492|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
145518375|NCT00603590|524758915|FG001|Overall Study|Lost to Follow-up|4|||
145518376|NCT00603590|524758914|FG000|Overall Study|Cardiovascular event|0|||
145518377|NCT00603590|524758915|FG001|Overall Study|Cardiovascular event|1|||
145269583|NCT05553600|523835391|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
145269584|NCT05553600|523835392|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
145269585|NCT04633434|523835393|FG000|Overall Study|Lost to Follow-up|32|||
145269586|NCT04633434|523835394|FG001|Overall Study|Lost to Follow-up|32|||
145269587|NCT00848965|523835399|FG000|Overall Study|Adverse Event|1|||
145269588|NCT00848965|523835399|FG000|Overall Study|Withdrawal by Subject|1|||
145269589|NCT01976104|523835404|FG000|Overall Study|Adverse Event|0|||
145269590|NCT01976104|523835405|FG001|Overall Study|Adverse Event|0|||
145518378|NCT05338671|524758916|FG000|Overall Study|Lost to Follow-up|2|||
145518379|NCT05338671|524758917|FG001|Overall Study|Lost to Follow-up|2|||
145269591|NCT01976104|523835406|FG002|Overall Study|Adverse Event|1|||
145269592|NCT01976104|523835407|FG003|Overall Study|Adverse Event|0|||
145269593|NCT01976104|523835404|FG000|Overall Study|Lost to Follow-up|3|||
145269594|NCT01976104|523835405|FG001|Overall Study|Lost to Follow-up|0|||
145269595|NCT01976104|523835406|FG002|Overall Study|Lost to Follow-up|1|||
145269596|NCT01976104|523835407|FG003|Overall Study|Lost to Follow-up|1|||
145269597|NCT01976104|523835404|FG000|Overall Study|Subject Choice|0|||
145269598|NCT01976104|523835405|FG001|Overall Study|Subject Choice|1|||
145269599|NCT01976104|523835406|FG002|Overall Study|Subject Choice|0|||
145269600|NCT01976104|523835407|FG003|Overall Study|Subject Choice|1|||
145269601|NCT01976104|523835404|FG000|Overall Study|Withdrawal by Subject|3|||
145269602|NCT01976104|523835405|FG001|Overall Study|Withdrawal by Subject|0|||
145269603|NCT01976104|523835406|FG002|Overall Study|Withdrawal by Subject|0|||
145269604|NCT01976104|523835407|FG003|Overall Study|Withdrawal by Subject|1|||
145269605|NCT01976104|523835404|FG000|Overall Study|Other|0|||
145269606|NCT01976104|523835405|FG001|Overall Study|Other|1|||
145269607|NCT01976104|523835406|FG002|Overall Study|Other|0|||
145269608|NCT01976104|523835407|FG003|Overall Study|Other|0|||
145269609|NCT01353209|523835408|FG000|Overall Study|Adverse Event|1|||
145269610|NCT01353209|523835409|FG001|Overall Study|Adverse Event|1|||
145269611|NCT00337727|523835414|FG000|Overall Study|Adverse Event|5|||
145269612|NCT00337727|523835415|FG001|Overall Study|Adverse Event|3|||
145269613|NCT00337727|523835414|FG000|Overall Study|Lost to Follow-up|5|||
145269614|NCT00337727|523835415|FG001|Overall Study|Lost to Follow-up|4|||
145269615|NCT00337727|523835414|FG000|Overall Study|Physician Decision|1|||
145269616|NCT00337727|523835415|FG001|Overall Study|Physician Decision|0|||
145269617|NCT00337727|523835414|FG000|Overall Study|Protocol Violation|4|||
145269618|NCT00337727|523835415|FG001|Overall Study|Protocol Violation|0|||
145269619|NCT00337727|523835414|FG000|Overall Study|Withdrawal by Subject|3|||
145269620|NCT00337727|523835415|FG001|Overall Study|Withdrawal by Subject|5|||
145269621|NCT00943826|523835416|FG000|Concurrent Phase|Adverse Event|50|||
145269622|NCT00943826|523835417|FG001|Concurrent Phase|Adverse Event|27|||
145269623|NCT00943826|523835416|FG000|Concurrent Phase|Withdrew consent|3|||
145269624|NCT00943826|523835417|FG001|Concurrent Phase|Withdrew consent|7|||
145269625|NCT00943826|523835416|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
145269626|NCT00943826|523835417|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
145269627|NCT00943826|523835416|FG000|Concurrent Phase|Administrative reasons|2|||
145269628|NCT00943826|523835417|FG001|Concurrent Phase|Administrative reasons|1|||
145269629|NCT00943826|523835416|FG000|Concurrent Phase|Protocol Violation|1|||
145269630|NCT00943826|523835417|FG001|Concurrent Phase|Protocol Violation|0|||
145269631|NCT00943826|523835416|FG000|Maintenance Phase|Adverse Event|31|||
145269632|NCT00943826|523835417|FG001|Maintenance Phase|Adverse Event|30|||
145269633|NCT00943826|523835416|FG000|Maintenance Phase|Withdrew consent|2|||
145269634|NCT00943826|523835417|FG001|Maintenance Phase|Withdrew consent|4|||
145269635|NCT00943826|523835416|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
145269636|NCT00943826|523835417|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
145269637|NCT00943826|523835416|FG000|Maintenance Phase|Administrative reasons|4|||
145269638|NCT00943826|523835417|FG001|Maintenance Phase|Administrative reasons|1|||
145269639|NCT00943826|523835416|FG000|Maintenance Phase|Failure to return|0|||
145269640|NCT00943826|523835417|FG001|Maintenance Phase|Failure to return|1|||
145269641|NCT00943826|523835416|FG000|Monotherapy Phase|Adverse Event|42|||
145269642|NCT00943826|523835417|FG001|Monotherapy Phase|Adverse Event|5|||
145269643|NCT00943826|523835416|FG000|Monotherapy Phase|Administrative reasons|11|||
145269644|NCT00943826|523835417|FG001|Monotherapy Phase|Administrative reasons|5|||
145518380|NCT05338671|524758916|FG000|Overall Study|Root canal completed in a single visit|1|||
145269645|NCT00943826|523835416|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
145269646|NCT00943826|523835417|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
145269647|NCT00943826|523835416|FG000|Monotherapy Phase|Withdrew Consent|2|||
145269648|NCT00943826|523835417|FG001|Monotherapy Phase|Withdrew Consent|3|||
145269649|NCT00943826|523835416|FG000|Monotherapy Phase|Failure to return|2|||
145269650|NCT00943826|523835417|FG001|Monotherapy Phase|Failure to return|1|||
145269651|NCT00943826|523835416|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
145269652|NCT00943826|523835417|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
145269653|NCT00943826|523835416|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
145269654|NCT00943826|523835417|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
145269655|NCT00943826|523835416|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
145742493|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Death|2|||
145742494|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Death|1|||
145742495|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Death|0|||
145742496|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Death|0|||
145742497|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
145742498|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
145742499|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145742500|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145742501|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
145742502|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
145742503|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
145742504|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
145742505|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
145742506|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
145742507|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
145742508|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
145742509|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
145742510|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
145742511|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
145742512|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
145742513|NCT01940471|525573675|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
145742514|NCT01940471|525573676|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
145742515|NCT01940471|525573677|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
145742516|NCT01940471|525573678|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
145742517|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
145742518|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
145742519|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
145742520|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
145742521|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145742522|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145742523|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
145742524|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
145742525|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
145742526|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
145742527|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
145742528|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
145742529|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
145742530|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
145742531|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
145742532|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
145742533|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
145742534|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
145742535|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
145742536|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
145742537|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
145742538|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
145742539|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
145742540|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
145742541|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145742542|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145742543|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
145742544|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145742545|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
145742546|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
145742547|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
145742548|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
145742549|NCT01940471|525573675|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145742550|NCT01940471|525573676|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145742551|NCT01940471|525573677|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
145742552|NCT01940471|525573678|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145742553|NCT00258674|525573679|FG000|Overall Study|Death|32|||
145742554|NCT00258674|525573680|FG001|Overall Study|Death|53|||
145742555|NCT00258674|525573681|FG002|Overall Study|Death|34|||
145742556|NCT03715153|525573682|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
145742557|NCT03715153|525573683|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
145742558|NCT03715153|525573682|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
145742559|NCT03715153|525573683|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
145742560|NCT03715153|525573682|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
145742561|NCT03715153|525573683|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
145742562|NCT03715153|525573682|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
145742563|NCT03715153|525573683|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
145518381|NCT05338671|524758917|FG001|Overall Study|Root canal completed in a single visit|0|||
145742564|NCT03715153|525573682|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
145742565|NCT03715153|525573683|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
145742566|NCT03715153|525573682|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
145742567|NCT03715153|525573683|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
145742568|NCT02973087|525573686|FG000|Overall Study|Withdrawal by Subject|2|||
145742569|NCT02973087|525573687|FG001|Overall Study|Withdrawal by Subject|1|||
145742570|NCT02973087|525573686|FG000|Overall Study|Adverse Event|1|||
145742571|NCT02973087|525573687|FG001|Overall Study|Adverse Event|0|||
145742572|NCT02973087|525573686|FG000|Overall Study|other|1|||
145742573|NCT02973087|525573687|FG001|Overall Study|other|1|||
145742574|NCT02090413|525573698|FG000|Overall Study|Adverse Event|11|||
145742575|NCT02090413|525573699|FG001|Overall Study|Adverse Event|15|||
145742576|NCT02090413|525573700|FG002|Overall Study|Adverse Event|20|||
145742577|NCT02090413|525573698|FG000|Overall Study|Flushing event|2|||
145742578|NCT02090413|525573699|FG001|Overall Study|Flushing event|0|||
145742579|NCT02090413|525573700|FG002|Overall Study|Flushing event|1|||
145742580|NCT02090413|525573698|FG000|Overall Study|Withdrawal by Subject|2|||
145742581|NCT02090413|525573699|FG001|Overall Study|Withdrawal by Subject|2|||
145742582|NCT02090413|525573700|FG002|Overall Study|Withdrawal by Subject|2|||
145742583|NCT02090413|525573698|FG000|Overall Study|Investigator Decision|1|||
145742584|NCT02090413|525573699|FG001|Overall Study|Investigator Decision|1|||
145742585|NCT02090413|525573700|FG002|Overall Study|Investigator Decision|0|||
145742586|NCT02090413|525573698|FG000|Overall Study|Other|2|||
145742587|NCT02090413|525573699|FG001|Overall Study|Other|1|||
145742588|NCT02090413|525573700|FG002|Overall Study|Other|0|||
145742589|NCT02090413|525573698|FG000|Overall Study|Lost to Follow-up|1|||
145742590|NCT02090413|525573699|FG001|Overall Study|Lost to Follow-up|1|||
145742591|NCT02090413|525573700|FG002|Overall Study|Lost to Follow-up|0|||
145742592|NCT03996876|525573701|FG000|Overall Study|Incomplete Data|2|||
145742593|NCT03996876|525573702|FG001|Overall Study|Incomplete Data|4|||
145742594|NCT02535715|525575208|FG000|Overall Study|Withdrawal by Subject|0|||
145742595|NCT02535715|525575209|FG001|Overall Study|Withdrawal by Subject|0|||
145742596|NCT02535715|525575210|FG002|Overall Study|Withdrawal by Subject|1|||
145742597|NCT00909181|525575211|FG000|Overall Study|Lost to Follow-up|39|||
145518382|NCT03085914|524758920|FG000|Overall Study|Death|6|||
145742598|NCT00909181|525575212|FG001|Overall Study|Lost to Follow-up|18|||
145742599|NCT00909181|525575213|FG002|Overall Study|Lost to Follow-up|33|||
145742600|NCT04353284|525575214|FG000|Overall Study|Adverse Event|1|||
145742601|NCT04353284|525575215|FG001|Overall Study|Adverse Event|1|||
145742602|NCT04353284|525575214|FG000|Overall Study|Lost to Follow-up|1|||
145742603|NCT04353284|525575215|FG001|Overall Study|Lost to Follow-up|0|||
145742604|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
145742605|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
145742606|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
145742607|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
145742608|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
145742609|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
145742610|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
145742611|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
145742612|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
145742613|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
145742614|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
145742615|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
145742616|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
145742617|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
145402337|NCT03098979|524330710|FG001|Overall Study|Non-compliance|0|||
145402338|NCT03098979|524330711|FG002|Overall Study|Non-compliance|0|||
145518383|NCT03085914|524758921|FG001|Overall Study|Death|6|||
145518384|NCT03085914|524758922|FG002|Overall Study|Death|4|||
145518385|NCT03085914|524758923|FG003|Overall Study|Death|1|||
145742618|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
145742619|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
145742620|NCT00094770|525575217|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
145742621|NCT00094770|525575218|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
145742622|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
145742623|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
145742624|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
145742625|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
145742626|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
145742627|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
145742628|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
145742629|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
145742630|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
145742631|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
145742632|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
145742633|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
145742634|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
145742635|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
145742636|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
145742637|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
145742638|NCT00094770|525575217|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
145742639|NCT00094770|525575218|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
145742640|NCT01040351|525575221|FG000|Overall Study|poor ovarian response|1|||
145742641|NCT01040351|525575222|FG001|Overall Study|poor ovarian response|2|||
145742642|NCT04773106|525575223|FG000|Overall Study|Withdrawal by Subject|3|||
145518386|NCT03085914|524758924|FG004|Overall Study|Death|5|||
145518387|NCT03085914|524758925|FG005|Overall Study|Death|2|||
145518388|NCT03085914|524758926|FG006|Overall Study|Death|2|||
145742643|NCT04773106|525575223|FG000|Overall Study|Death|1|||
145742644|NCT02819635|525575224|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
145742645|NCT02819635|525575225|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
145269656|NCT00943826|523835417|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
145269657|NCT00943826|523835416|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
145269658|NCT00943826|523835417|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
145269659|NCT00326625|523835418|FG000|Overall Study|Adverse Event|20|||
145269660|NCT00326625|523835419|FG001|Overall Study|Adverse Event|9|||
145269661|NCT00326625|523835418|FG000|Overall Study|Withdrawal by Subject|15|||
145269662|NCT00326625|523835419|FG001|Overall Study|Withdrawal by Subject|12|||
145269663|NCT00326625|523835418|FG000|Overall Study|Death|18|||
145269664|NCT00326625|523835419|FG001|Overall Study|Death|16|||
145269665|NCT00326625|523835418|FG000|Overall Study|Lost to Follow-up|1|||
145269666|NCT00326625|523835419|FG001|Overall Study|Lost to Follow-up|0|||
145269667|NCT00326625|523835418|FG000|Overall Study|prescheduled medical intervention|0|||
145269668|NCT00326625|523835419|FG001|Overall Study|prescheduled medical intervention|1|||
145269669|NCT06067191|523835421|FG000|Overall Study|Withdrawal by Subject|0|||
145269670|NCT06067191|523835422|FG001|Overall Study|Withdrawal by Subject|1|||
145269671|NCT01833897|523835433|FG000|Overall Study|Lack of Efficacy|1|||
145269672|NCT02860039|523835434|FG000|Overall Study|Death|4|||
145269673|NCT02860039|523835435|FG001|Overall Study|Death|0|||
145269674|NCT02860039|523835434|FG000|Overall Study|Lost to Follow-up|2|||
145269675|NCT02860039|523835435|FG001|Overall Study|Lost to Follow-up|2|||
145742646|NCT02819635|525575226|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
145742647|NCT02819635|525575227|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
145742648|NCT02819635|525575228|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
145742649|NCT02819635|525575229|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
145742650|NCT02819635|525575230|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
145742651|NCT02819635|525575231|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
145742652|NCT02819635|525575232|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
145742653|NCT02819635|525575233|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
145742654|NCT02819635|525575234|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
145742655|NCT02819635|525575235|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
145742656|NCT02819635|525575224|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145269676|NCT02860039|523835434|FG000|Overall Study|Protocol Violation|3|||
145269677|NCT02860039|523835435|FG001|Overall Study|Protocol Violation|1|||
145269678|NCT02860039|523835434|FG000|Overall Study|Withdrawal by Subject|1|||
145269679|NCT02860039|523835435|FG001|Overall Study|Withdrawal by Subject|0|||
145269680|NCT02860039|523835434|FG000|Overall Study|Not otherwise eligible|1|||
145269681|NCT02860039|523835435|FG001|Overall Study|Not otherwise eligible|1|||
145269682|NCT00669110|523835436|FG000|Overall Study|Adverse Event|4|||
145269683|NCT00669110|523835437|FG001|Overall Study|Adverse Event|3|||
145269684|NCT00669110|523835436|FG000|Overall Study|Caregiver request|3|||
145269685|NCT00669110|523835437|FG001|Overall Study|Caregiver request|2|||
145269686|NCT00669110|523835436|FG000|Overall Study|Physician Decision|0|||
145269687|NCT00669110|523835437|FG001|Overall Study|Physician Decision|1|||
145269688|NCT00669110|523835436|FG000|Overall Study|Lost to Follow-up|1|||
145269689|NCT00669110|523835437|FG001|Overall Study|Lost to Follow-up|0|||
145269690|NCT00669110|523835436|FG000|Overall Study|Protocol Violation|0|||
145269691|NCT00669110|523835437|FG001|Overall Study|Protocol Violation|5|||
145269692|NCT00669110|523835436|FG000|Overall Study|Withdrawal by Subject|0|||
145269693|NCT00669110|523835437|FG001|Overall Study|Withdrawal by Subject|2|||
145269694|NCT01244516|523835438|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
145269695|NCT01244516|523835439|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
145742657|NCT02819635|525575225|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145269696|NCT01244516|523835440|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
145269697|NCT01244516|523835438|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
145269698|NCT01244516|523835439|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
145402339|NCT03098979|524330712|FG003|Overall Study|Non-compliance|0|||
145269699|NCT01244516|523835440|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
145269700|NCT01244516|523835438|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
145269701|NCT01244516|523835439|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
145269702|NCT01244516|523835440|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
145269703|NCT01244516|523835438|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
145269704|NCT01244516|523835439|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
145269705|NCT01244516|523835440|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
145269706|NCT01244516|523835438|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
145269707|NCT01244516|523835439|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
145269708|NCT01244516|523835440|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
145269709|NCT01244516|523835438|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
145269710|NCT01244516|523835439|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
145269711|NCT01244516|523835440|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
145269712|NCT01244516|523835438|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
145269713|NCT01244516|523835439|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
145269714|NCT01244516|523835440|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
145269715|NCT00077766|523835446|FG000|Overall Study|Adverse Event|1|||
145742658|NCT02819635|525575226|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145742659|NCT02819635|525575227|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145742660|NCT02819635|525575228|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
145742661|NCT02819635|525575229|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
145742662|NCT02819635|525575230|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
145742663|NCT02819635|525575231|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145742664|NCT02819635|525575232|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145742665|NCT02819635|525575233|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145742666|NCT02819635|525575234|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145269716|NCT00077766|523835447|FG001|Overall Study|Adverse Event|1|||
145269717|NCT00077766|523835446|FG000|Overall Study|Withdrawal by Subject|4|||
145269718|NCT00077766|523835447|FG001|Overall Study|Withdrawal by Subject|3|||
145269719|NCT00077766|523835446|FG000|Overall Study|Death|12|||
145269720|NCT00077766|523835447|FG001|Overall Study|Death|10|||
145269721|NCT00077766|523835446|FG000|Overall Study|Lost to Follow-up|2|||
145269722|NCT00077766|523835447|FG001|Overall Study|Lost to Follow-up|0|||
145269723|NCT00077766|523835446|FG000|Overall Study|Protocol Violation|1|||
145269724|NCT00077766|523835447|FG001|Overall Study|Protocol Violation|0|||
145269725|NCT00077766|523835446|FG000|Overall Study|Kidney Transplantation|9|||
145269726|NCT00077766|523835447|FG001|Overall Study|Kidney Transplantation|5|||
145269727|NCT00077766|523835446|FG000|Overall Study|Transplantation|5|||
145269728|NCT00077766|523835447|FG001|Overall Study|Transplantation|1|||
145269729|NCT00077766|523835446|FG000|Overall Study|Investigators Discretion|1|||
145269730|NCT00077766|523835447|FG001|Overall Study|Investigators Discretion|0|||
145269731|NCT00077766|523835446|FG000|Overall Study|Participant's decision|1|||
145269732|NCT00077766|523835447|FG001|Overall Study|Participant's decision|0|||
145269733|NCT00077766|523835446|FG000|Overall Study|Dialysis Discontinued|1|||
145269734|NCT00077766|523835447|FG001|Overall Study|Dialysis Discontinued|0|||
145269735|NCT00077766|523835446|FG000|Overall Study|Dialysis|0|||
145269736|NCT00077766|523835447|FG001|Overall Study|Dialysis|1|||
145269737|NCT00077766|523835446|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
145269738|NCT00077766|523835447|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
145269739|NCT00077766|523835446|FG000|Overall Study|Started Nocturnal Dialysis|0|||
145269740|NCT00077766|523835447|FG001|Overall Study|Started Nocturnal Dialysis|1|||
145269741|NCT00077766|523835446|FG000|Overall Study|Stop Dialysis|0|||
145269742|NCT00077766|523835447|FG001|Overall Study|Stop Dialysis|1|||
145269743|NCT00077766|523835446|FG000|Overall Study|Participants Vacation|2|||
145269744|NCT00077766|523835447|FG001|Overall Study|Participants Vacation|1|||
145269745|NCT02255422|523835449|FG000|Overall Study|Withdrawal by Subject|0|||
145269746|NCT02255422|523835450|FG001|Overall Study|Withdrawal by Subject|0|||
145269747|NCT02255422|523835451|FG002|Overall Study|Withdrawal by Subject|0|||
145742667|NCT02819635|525575235|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
145269748|NCT02255422|523835452|FG003|Overall Study|Withdrawal by Subject|0|||
145269749|NCT02255422|523835453|FG004|Overall Study|Withdrawal by Subject|0|||
145269750|NCT02255422|523835454|FG005|Overall Study|Withdrawal by Subject|0|||
145269751|NCT02255422|523835455|FG006|Overall Study|Withdrawal by Subject|2|||
145269752|NCT02255422|523835449|FG000|Overall Study|Lost to Follow-up|0|||
145402340|NCT03098979|524330713|FG004|Overall Study|Non-compliance|0|||
145402341|NCT03098979|524330714|FG005|Overall Study|Non-compliance|1|||
145742668|NCT02819635|525575224|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742669|NCT02819635|525575225|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742670|NCT02819635|525575226|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145518389|NCT03085914|524758920|FG000|Overall Study|Withdrawal by Subject|1|||
145518390|NCT03085914|524758921|FG001|Overall Study|Withdrawal by Subject|1|||
145518391|NCT03085914|524758922|FG002|Overall Study|Withdrawal by Subject|2|||
145518392|NCT03085914|524758923|FG003|Overall Study|Withdrawal by Subject|2|||
145518393|NCT03085914|524758924|FG004|Overall Study|Withdrawal by Subject|2|||
145518394|NCT03085914|524758925|FG005|Overall Study|Withdrawal by Subject|0|||
145518395|NCT03085914|524758926|FG006|Overall Study|Withdrawal by Subject|1|||
145518396|NCT03085914|524758920|FG000|Overall Study|Lost to Follow-up|0|||
145518397|NCT03085914|524758921|FG001|Overall Study|Lost to Follow-up|0|||
145518398|NCT03085914|524758922|FG002|Overall Study|Lost to Follow-up|1|||
145518399|NCT03085914|524758923|FG003|Overall Study|Lost to Follow-up|0|||
145518400|NCT03085914|524758924|FG004|Overall Study|Lost to Follow-up|0|||
145518401|NCT03085914|524758925|FG005|Overall Study|Lost to Follow-up|1|||
145518402|NCT03085914|524758926|FG006|Overall Study|Lost to Follow-up|1|||
145518403|NCT03085914|524758920|FG000|Overall Study|Reason was not specified,|2|||
145518404|NCT03085914|524758921|FG001|Overall Study|Reason was not specified,|2|||
145518405|NCT03085914|524758922|FG002|Overall Study|Reason was not specified,|2|||
145518406|NCT03085914|524758923|FG003|Overall Study|Reason was not specified,|3|||
145518407|NCT03085914|524758924|FG004|Overall Study|Reason was not specified,|3|||
145518408|NCT03085914|524758925|FG005|Overall Study|Reason was not specified,|3|||
145518409|NCT03085914|524758926|FG006|Overall Study|Reason was not specified,|6|||
145518410|NCT03085914|524758920|FG000|Overall Study|Progressive Disease|0|||
145518411|NCT03085914|524758921|FG001|Overall Study|Progressive Disease|0|||
145518412|NCT03085914|524758922|FG002|Overall Study|Progressive Disease|2|||
145518413|NCT03085914|524758923|FG003|Overall Study|Progressive Disease|2|||
145518414|NCT03085914|524758924|FG004|Overall Study|Progressive Disease|1|||
145518415|NCT03085914|524758925|FG005|Overall Study|Progressive Disease|1|||
145518416|NCT03085914|524758926|FG006|Overall Study|Progressive Disease|1|||
145518417|NCT03085914|524758920|FG000|Overall Study|Study Terminated by the Sponsor|0|||
145518418|NCT03085914|524758921|FG001|Overall Study|Study Terminated by the Sponsor|0|||
145518419|NCT03085914|524758922|FG002|Overall Study|Study Terminated by the Sponsor|0|||
145518420|NCT03085914|524758923|FG003|Overall Study|Study Terminated by the Sponsor|1|||
145518421|NCT03085914|524758924|FG004|Overall Study|Study Terminated by the Sponsor|2|||
145518422|NCT03085914|524758925|FG005|Overall Study|Study Terminated by the Sponsor|1|||
145518423|NCT03085914|524758926|FG006|Overall Study|Study Terminated by the Sponsor|0|||
145518424|NCT01215916|524758927|FG000|Overall Study|Progressive Disease|0|||
145518425|NCT01215916|524758928|FG001|Overall Study|Progressive Disease|2|||
145518426|NCT01215916|524758929|FG002|Overall Study|Progressive Disease|1|||
145518427|NCT01215916|524758930|FG003|Overall Study|Progressive Disease|2|||
145518428|NCT01215916|524758931|FG004|Overall Study|Progressive Disease|5|||
145518429|NCT01215916|524758932|FG005|Overall Study|Progressive Disease|4|||
145518430|NCT01215916|524758933|FG006|Overall Study|Progressive Disease|5|||
145518431|NCT01215916|524758934|FG007|Overall Study|Progressive Disease|3|||
145742671|NCT02819635|525575227|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742672|NCT02819635|525575228|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742673|NCT02819635|525575229|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
145742674|NCT02819635|525575230|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
145742675|NCT02819635|525575231|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742676|NCT02819635|525575232|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742677|NCT02819635|525575233|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742678|NCT02819635|525575234|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742679|NCT02819635|525575235|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
145742680|NCT02819635|525575224|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742681|NCT02819635|525575225|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742682|NCT02819635|525575226|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742683|NCT02819635|525575227|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145402342|NCT03098979|524330709|FG000|Overall Study|Protocol Violation|0|||
145402343|NCT03098979|524330710|FG001|Overall Study|Protocol Violation|0|||
145269753|NCT02255422|523835450|FG001|Overall Study|Lost to Follow-up|0|||
145402344|NCT03098979|524330711|FG002|Overall Study|Protocol Violation|0|||
145269754|NCT02255422|523835451|FG002|Overall Study|Lost to Follow-up|1|||
145269755|NCT02255422|523835452|FG003|Overall Study|Lost to Follow-up|0|||
145269756|NCT02255422|523835453|FG004|Overall Study|Lost to Follow-up|0|||
145269757|NCT02255422|523835454|FG005|Overall Study|Lost to Follow-up|0|||
145269758|NCT02255422|523835455|FG006|Overall Study|Lost to Follow-up|0|||
145269759|NCT00352664|523835456|FG000|Overall Study|Withdrawal by Subject|7|||
145269760|NCT00352664|523835457|FG001|Overall Study|Withdrawal by Subject|0|||
145269761|NCT00242567|523837766|FG000|Overall Study|Adverse Event|70|||
145269762|NCT00242567|523837767|FG001|Overall Study|Adverse Event|43|||
145269763|NCT00242567|523837766|FG000|Overall Study|Disease Progression|17|||
145269764|NCT00242567|523837767|FG001|Overall Study|Disease Progression|22|||
145269765|NCT00242567|523837766|FG000|Overall Study|Symptomatic deterioration|9|||
145269766|NCT00242567|523837767|FG001|Overall Study|Symptomatic deterioration|3|||
145269767|NCT00242567|523837766|FG000|Overall Study|Lack of Efficacy|2|||
145269768|NCT00242567|523837767|FG001|Overall Study|Lack of Efficacy|2|||
145269769|NCT00242567|523837766|FG000|Overall Study|Lost to Follow-up|9|||
145269770|NCT00242567|523837767|FG001|Overall Study|Lost to Follow-up|19|||
145269771|NCT00242567|523837766|FG000|Overall Study|Withdrawal by Subject|33|||
145269772|NCT00242567|523837767|FG001|Overall Study|Withdrawal by Subject|28|||
145269773|NCT00242567|523837766|FG000|Overall Study|Protocol Violation|12|||
145269774|NCT00242567|523837767|FG001|Overall Study|Protocol Violation|12|||
145269775|NCT00242567|523837766|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
145269776|NCT00242567|523837767|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
145269777|NCT00242567|523837766|FG000|Overall Study|Other|14|||
145269778|NCT00242567|523837767|FG001|Overall Study|Other|9|||
145269779|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
145269780|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
145269781|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
145269782|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
145269783|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
145269784|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
145269785|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
145269786|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
145269787|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
145269788|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
145269789|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
145269790|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
145269791|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
145269792|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
145269793|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
145269794|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
145269795|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
145269796|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
145269797|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
145269798|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
145518432|NCT01215916|524758935|FG008|Overall Study|Progressive Disease|1|||
145518433|NCT01215916|524758927|FG000|Overall Study|Adverse Event|1|||
145518434|NCT01215916|524758928|FG001|Overall Study|Adverse Event|1|||
145518435|NCT01215916|524758929|FG002|Overall Study|Adverse Event|0|||
145518436|NCT01215916|524758930|FG003|Overall Study|Adverse Event|1|||
145518437|NCT01215916|524758931|FG004|Overall Study|Adverse Event|0|||
145518438|NCT01215916|524758932|FG005|Overall Study|Adverse Event|0|||
145518439|NCT01215916|524758933|FG006|Overall Study|Adverse Event|3|||
145518440|NCT01215916|524758934|FG007|Overall Study|Adverse Event|0|||
145518441|NCT01215916|524758935|FG008|Overall Study|Adverse Event|0|||
145518442|NCT01215916|524758927|FG000|Overall Study|Withdrawal by Subject|0|||
145518443|NCT01215916|524758928|FG001|Overall Study|Withdrawal by Subject|1|||
145518444|NCT01215916|524758929|FG002|Overall Study|Withdrawal by Subject|1|||
145518445|NCT01215916|524758930|FG003|Overall Study|Withdrawal by Subject|2|||
145518446|NCT01215916|524758931|FG004|Overall Study|Withdrawal by Subject|0|||
145742684|NCT02819635|525575228|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145518447|NCT01215916|524758932|FG005|Overall Study|Withdrawal by Subject|0|||
145518448|NCT01215916|524758933|FG006|Overall Study|Withdrawal by Subject|1|||
145742685|NCT02819635|525575229|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145269799|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
145269800|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
145269801|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
145269802|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
145269803|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
145269804|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
145269805|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
145269806|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
145518449|NCT01215916|524758934|FG007|Overall Study|Withdrawal by Subject|0|||
145742686|NCT02819635|525575230|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
145742687|NCT02819635|525575231|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742688|NCT02819635|525575232|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742689|NCT02819635|525575233|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742690|NCT02819635|525575234|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145742691|NCT02819635|525575235|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
145269807|NCT01299272|523837768|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
145269808|NCT01299272|523837769|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
145518450|NCT01215916|524758935|FG008|Overall Study|Withdrawal by Subject|0|||
145518451|NCT01215916|524758927|FG000|Overall Study|Death|0|||
145518452|NCT01215916|524758928|FG001|Overall Study|Death|1|||
145742692|NCT02819635|525575224|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
145742693|NCT02819635|525575225|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
145742694|NCT02819635|525575226|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
145742695|NCT02819635|525575227|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
145742696|NCT02819635|525575228|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
145742697|NCT02819635|525575229|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
145742698|NCT02819635|525575230|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
145742699|NCT02819635|525575231|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
145742700|NCT02819635|525575232|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
145742701|NCT02819635|525575233|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
145742702|NCT02819635|525575234|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
145742703|NCT02819635|525575235|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
145742704|NCT02819635|525575224|FG000|Substudy 2, Part 2|Adverse Event|0|||
145742705|NCT02819635|525575225|FG001|Substudy 2, Part 2|Adverse Event|0|||
145742706|NCT02819635|525575226|FG002|Substudy 2, Part 2|Adverse Event|0|||
145742707|NCT02819635|525575227|FG003|Substudy 2, Part 2|Adverse Event|0|||
145742708|NCT02819635|525575228|FG004|Substudy 2, Part 2|Adverse Event|0|||
145742709|NCT02819635|525575229|FG005|Substudy 2, Part 2|Adverse Event|4|||
145742710|NCT02819635|525575230|FG006|Substudy 2, Part 2|Adverse Event|0|||
145742711|NCT02819635|525575231|FG007|Substudy 2, Part 2|Adverse Event|0|||
145742712|NCT02819635|525575232|FG008|Substudy 2, Part 2|Adverse Event|0|||
145742713|NCT02819635|525575233|FG009|Substudy 2, Part 2|Adverse Event|0|||
145742714|NCT02819635|525575234|FG010|Substudy 2, Part 2|Adverse Event|0|||
145742715|NCT02819635|525575235|FG011|Substudy 2, Part 2|Adverse Event|0|||
145742716|NCT02819635|525575224|FG000|Substudy 2, Part 2|Withdrew consent|0|||
145742717|NCT02819635|525575225|FG001|Substudy 2, Part 2|Withdrew consent|0|||
145269809|NCT01299272|523837770|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
145742718|NCT02819635|525575226|FG002|Substudy 2, Part 2|Withdrew consent|0|||
145402345|NCT03098979|524330712|FG003|Overall Study|Protocol Violation|0|||
145742719|NCT02819635|525575227|FG003|Substudy 2, Part 2|Withdrew consent|0|||
145742720|NCT02819635|525575228|FG004|Substudy 2, Part 2|Withdrew consent|0|||
145742721|NCT02819635|525575229|FG005|Substudy 2, Part 2|Withdrew consent|3|||
145518453|NCT01215916|524758929|FG002|Overall Study|Death|0|||
145518454|NCT01215916|524758930|FG003|Overall Study|Death|0|||
145518455|NCT01215916|524758931|FG004|Overall Study|Death|1|||
145518456|NCT01215916|524758932|FG005|Overall Study|Death|0|||
145518457|NCT01215916|524758933|FG006|Overall Study|Death|0|||
145518458|NCT01215916|524758934|FG007|Overall Study|Death|0|||
145742722|NCT02819635|525575230|FG006|Substudy 2, Part 2|Withdrew consent|1|||
145742723|NCT02819635|525575231|FG007|Substudy 2, Part 2|Withdrew consent|0|||
145742724|NCT02819635|525575232|FG008|Substudy 2, Part 2|Withdrew consent|0|||
145518459|NCT01215916|524758935|FG008|Overall Study|Death|1|||
145742725|NCT02819635|525575233|FG009|Substudy 2, Part 2|Withdrew consent|0|||
145742726|NCT02819635|525575234|FG010|Substudy 2, Part 2|Withdrew consent|0|||
145742727|NCT02819635|525575235|FG011|Substudy 2, Part 2|Withdrew consent|0|||
145742728|NCT02819635|525575224|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
145742729|NCT02819635|525575225|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
145742730|NCT02819635|525575226|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
145742731|NCT02819635|525575227|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
145742732|NCT02819635|525575228|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
145742733|NCT02819635|525575229|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
145742734|NCT02819635|525575230|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
145742735|NCT02819635|525575231|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
145742736|NCT02819635|525575232|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
145742737|NCT02819635|525575233|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
145742738|NCT02819635|525575234|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
145742739|NCT02819635|525575235|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
145742740|NCT02819635|525575224|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742741|NCT02819635|525575225|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742742|NCT02819635|525575226|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742743|NCT02819635|525575227|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742744|NCT02819635|525575228|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742745|NCT02819635|525575229|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742746|NCT02819635|525575230|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
145742747|NCT02819635|525575231|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742748|NCT02819635|525575232|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742749|NCT02819635|525575233|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742750|NCT02819635|525575234|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742751|NCT02819635|525575235|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
145742752|NCT02819635|525575224|FG000|Substudy 2, Part 2|Other, not specified|0|||
145742753|NCT02819635|525575225|FG001|Substudy 2, Part 2|Other, not specified|0|||
145742754|NCT02819635|525575226|FG002|Substudy 2, Part 2|Other, not specified|0|||
145742755|NCT02819635|525575227|FG003|Substudy 2, Part 2|Other, not specified|0|||
145742756|NCT02819635|525575228|FG004|Substudy 2, Part 2|Other, not specified|0|||
145742757|NCT02819635|525575229|FG005|Substudy 2, Part 2|Other, not specified|4|||
145742758|NCT02819635|525575230|FG006|Substudy 2, Part 2|Other, not specified|8|||
145742759|NCT02819635|525575231|FG007|Substudy 2, Part 2|Other, not specified|0|||
145742760|NCT02819635|525575232|FG008|Substudy 2, Part 2|Other, not specified|0|||
145742761|NCT02819635|525575233|FG009|Substudy 2, Part 2|Other, not specified|0|||
145742762|NCT02819635|525575234|FG010|Substudy 2, Part 2|Other, not specified|0|||
145742763|NCT02819635|525575235|FG011|Substudy 2, Part 2|Other, not specified|0|||
145742764|NCT02819635|525575224|FG000|Substudy 3|Adverse Event|0|||
145742765|NCT02819635|525575225|FG001|Substudy 3|Adverse Event|0|||
145742766|NCT02819635|525575226|FG002|Substudy 3|Adverse Event|0|||
145742767|NCT02819635|525575227|FG003|Substudy 3|Adverse Event|0|||
145742768|NCT02819635|525575228|FG004|Substudy 3|Adverse Event|0|||
145742769|NCT02819635|525575229|FG005|Substudy 3|Adverse Event|0|||
145742770|NCT02819635|525575230|FG006|Substudy 3|Adverse Event|0|||
145742771|NCT02819635|525575231|FG007|Substudy 3|Adverse Event|0|||
145742772|NCT02819635|525575232|FG008|Substudy 3|Adverse Event|32|||
145742773|NCT02819635|525575233|FG009|Substudy 3|Adverse Event|3|||
145742774|NCT02819635|525575234|FG010|Substudy 3|Adverse Event|12|||
145742775|NCT02819635|525575235|FG011|Substudy 3|Adverse Event|18|||
145742776|NCT02819635|525575224|FG000|Substudy 3|Withdrew consent|0|||
145742777|NCT02819635|525575225|FG001|Substudy 3|Withdrew consent|0|||
145742778|NCT02819635|525575226|FG002|Substudy 3|Withdrew consent|0|||
145742779|NCT02819635|525575227|FG003|Substudy 3|Withdrew consent|0|||
145742780|NCT02819635|525575228|FG004|Substudy 3|Withdrew consent|0|||
145742781|NCT02819635|525575229|FG005|Substudy 3|Withdrew consent|0|||
145742782|NCT02819635|525575230|FG006|Substudy 3|Withdrew consent|0|||
145518460|NCT01215916|524758927|FG000|Overall Study|Physician Decision|0|||
145742783|NCT02819635|525575231|FG007|Substudy 3|Withdrew consent|0|||
145742784|NCT02819635|525575232|FG008|Substudy 3|Withdrew consent|11|||
145742785|NCT02819635|525575233|FG009|Substudy 3|Withdrew consent|1|||
145742786|NCT02819635|525575234|FG010|Substudy 3|Withdrew consent|4|||
145742787|NCT02819635|525575235|FG011|Substudy 3|Withdrew consent|9|||
145742788|NCT02819635|525575224|FG000|Substudy 3|Lost to Follow-up|0|||
145742789|NCT02819635|525575225|FG001|Substudy 3|Lost to Follow-up|0|||
145742790|NCT02819635|525575226|FG002|Substudy 3|Lost to Follow-up|0|||
145269810|NCT01299272|523837771|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
145269811|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
145269812|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
145269813|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
145269814|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
145269815|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
145269816|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
145269817|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
145269818|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
145269819|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
145269820|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
145269821|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
145269822|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
145269823|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
145269824|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
145269825|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
145269826|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
145269827|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
145269828|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
145269829|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
145269830|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
145269831|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
145269832|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
145269833|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
145269834|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
145269835|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
145269836|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
145269837|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
145269838|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
145269839|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
145269840|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
145269841|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
145269842|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
145269843|NCT01299272|523837768|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
145269844|NCT01299272|523837769|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
145269845|NCT01299272|523837770|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
145269846|NCT01299272|523837771|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
145269847|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
145269848|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
145269849|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
145269850|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
145269851|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
145269852|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
145269853|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
145269854|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
145742791|NCT02819635|525575227|FG003|Substudy 3|Lost to Follow-up|0|||
145742792|NCT02819635|525575228|FG004|Substudy 3|Lost to Follow-up|0|||
145742793|NCT02819635|525575229|FG005|Substudy 3|Lost to Follow-up|0|||
145742794|NCT02819635|525575230|FG006|Substudy 3|Lost to Follow-up|0|||
145742795|NCT02819635|525575231|FG007|Substudy 3|Lost to Follow-up|0|||
145742796|NCT02819635|525575232|FG008|Substudy 3|Lost to Follow-up|1|||
145742797|NCT02819635|525575233|FG009|Substudy 3|Lost to Follow-up|0|||
145269855|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
145269856|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
145269857|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
145269858|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
145269859|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
145269860|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
145269861|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
145402346|NCT03098979|524330713|FG004|Overall Study|Protocol Violation|0|||
145742798|NCT02819635|525575234|FG010|Substudy 3|Lost to Follow-up|1|||
145742799|NCT02819635|525575235|FG011|Substudy 3|Lost to Follow-up|1|||
145742800|NCT02819635|525575224|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742801|NCT02819635|525575225|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742802|NCT02819635|525575226|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742803|NCT02819635|525575227|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742804|NCT02819635|525575228|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742805|NCT02819635|525575229|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742806|NCT02819635|525575230|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742807|NCT02819635|525575231|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742808|NCT02819635|525575232|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742809|NCT02819635|525575233|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742810|NCT02819635|525575234|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
145742811|NCT02819635|525575235|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
145742812|NCT02819635|525575224|FG000|Substudy 3|Other, not specified|0|||
145742813|NCT02819635|525575225|FG001|Substudy 3|Other, not specified|0|||
145742814|NCT02819635|525575226|FG002|Substudy 3|Other, not specified|0|||
145742815|NCT02819635|525575227|FG003|Substudy 3|Other, not specified|0|||
145742816|NCT02819635|525575228|FG004|Substudy 3|Other, not specified|0|||
145742817|NCT02819635|525575229|FG005|Substudy 3|Other, not specified|0|||
145742818|NCT02819635|525575230|FG006|Substudy 3|Other, not specified|0|||
145742819|NCT02819635|525575231|FG007|Substudy 3|Other, not specified|0|||
145269862|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
145269863|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
145269864|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
145269865|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
145269866|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
145402347|NCT03098979|524330714|FG005|Overall Study|Protocol Violation|1|||
145742820|NCT02819635|525575232|FG008|Substudy 3|Other, not specified|202|||
145742821|NCT02819635|525575233|FG009|Substudy 3|Other, not specified|5|||
145742822|NCT02819635|525575234|FG010|Substudy 3|Other, not specified|89|||
145269867|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
145269868|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
145269869|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
145269870|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
145269871|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
145269872|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
145269873|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
145269874|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
145269875|NCT01299272|523837768|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
145269876|NCT01299272|523837769|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
145269877|NCT01299272|523837770|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
145269878|NCT01299272|523837771|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
145269879|NCT01721200|523837772|FG000|Overall Study|Lost to Follow-up|3|||
145269880|NCT01721200|523837773|FG001|Overall Study|Lost to Follow-up|5|||
145269881|NCT01513759|523837774|FG000|Overall Study|Protocol Violation|4|||
145269882|NCT01513759|523837774|FG000|Overall Study|Death during catheter placement|1|||
145269883|NCT03606109|523837775|FG000|Overall Study|Lost to Follow-up|2|||
145269884|NCT03606109|523837776|FG001|Overall Study|Lost to Follow-up|1|||
145269885|NCT00630994|523837777|FG000|Overall Study|Adverse Event|1|||
145269886|NCT00630994|523837777|FG000|Overall Study|Disease Progression|1|||
145269887|NCT00630994|523837777|FG000|Overall Study|Lack of Efficacy|1|||
145269888|NCT00630994|523837777|FG000|Overall Study|Other|1|||
145269889|NCT03669640|523837778|FG000|Overall Study|Study Terminated by Sponsor|0|||
145269890|NCT03669640|523837779|FG001|Overall Study|Study Terminated by Sponsor|0|||
145269891|NCT03669640|523837780|FG002|Overall Study|Study Terminated by Sponsor|0|||
145269892|NCT03669640|523837781|FG003|Overall Study|Study Terminated by Sponsor|0|||
145269893|NCT03669640|523837782|FG004|Overall Study|Study Terminated by Sponsor|1|||
145269894|NCT03669640|523837783|FG005|Overall Study|Study Terminated by Sponsor|0|||
145269895|NCT03669640|523837778|FG000|Overall Study|Lost to Follow-up|0|||
145269896|NCT03669640|523837779|FG001|Overall Study|Lost to Follow-up|0|||
145269897|NCT03669640|523837780|FG002|Overall Study|Lost to Follow-up|2|||
145269898|NCT03669640|523837781|FG003|Overall Study|Lost to Follow-up|0|||
145269899|NCT03669640|523837782|FG004|Overall Study|Lost to Follow-up|0|||
145269900|NCT03669640|523837783|FG005|Overall Study|Lost to Follow-up|0|||
145269901|NCT03669640|523837778|FG000|Overall Study|Death|0|||
145269902|NCT03669640|523837779|FG001|Overall Study|Death|0|||
145269903|NCT03669640|523837780|FG002|Overall Study|Death|1|||
145269904|NCT03669640|523837781|FG003|Overall Study|Death|0|||
145269905|NCT03669640|523837782|FG004|Overall Study|Death|0|||
145269906|NCT03669640|523837783|FG005|Overall Study|Death|0|||
145269907|NCT03669640|523837778|FG000|Overall Study|Withdrawal by Subject|1|||
145269908|NCT03669640|523837779|FG001|Overall Study|Withdrawal by Subject|2|||
145269909|NCT03669640|523837780|FG002|Overall Study|Withdrawal by Subject|1|||
145269910|NCT03669640|523837781|FG003|Overall Study|Withdrawal by Subject|0|||
145269911|NCT03669640|523837782|FG004|Overall Study|Withdrawal by Subject|1|||
145269912|NCT03669640|523837783|FG005|Overall Study|Withdrawal by Subject|3|||
145269913|NCT03669640|523837778|FG000|Overall Study|Protocol Violation|1|||
145269914|NCT03669640|523837779|FG001|Overall Study|Protocol Violation|0|||
145269915|NCT03669640|523837780|FG002|Overall Study|Protocol Violation|0|||
145269916|NCT03669640|523837781|FG003|Overall Study|Protocol Violation|0|||
145269917|NCT03669640|523837782|FG004|Overall Study|Protocol Violation|0|||
145269918|NCT03669640|523837783|FG005|Overall Study|Protocol Violation|0|||
145269919|NCT03669640|523837778|FG000|Overall Study|Physician Decision|0|||
145269920|NCT03669640|523837779|FG001|Overall Study|Physician Decision|2|||
145269921|NCT03669640|523837780|FG002|Overall Study|Physician Decision|0|||
145269922|NCT03669640|523837781|FG003|Overall Study|Physician Decision|0|||
145269923|NCT03669640|523837782|FG004|Overall Study|Physician Decision|0|||
145269924|NCT03669640|523837783|FG005|Overall Study|Physician Decision|0|||
145269925|NCT03669640|523837778|FG000|Overall Study|Disease Relapse|1|||
145269926|NCT03669640|523837779|FG001|Overall Study|Disease Relapse|0|||
145269927|NCT03669640|523837780|FG002|Overall Study|Disease Relapse|0|||
145269928|NCT03669640|523837781|FG003|Overall Study|Disease Relapse|0|||
145269929|NCT03669640|523837782|FG004|Overall Study|Disease Relapse|0|||
145269930|NCT03669640|523837783|FG005|Overall Study|Disease Relapse|0|||
145269931|NCT03669640|523837778|FG000|Overall Study|Adverse Event|2|||
145269932|NCT03669640|523837779|FG001|Overall Study|Adverse Event|1|||
145269933|NCT03669640|523837780|FG002|Overall Study|Adverse Event|0|||
145269934|NCT03669640|523837781|FG003|Overall Study|Adverse Event|0|||
145269935|NCT03669640|523837782|FG004|Overall Study|Adverse Event|1|||
145269936|NCT03669640|523837783|FG005|Overall Study|Adverse Event|0|||
145269937|NCT00366678|523837784|FG000|Infant Series|Withdrawal by Subject|8|||
145269938|NCT00366678|523837785|FG001|Infant Series|Withdrawal by Subject|6|||
145269939|NCT00366678|523837786|FG002|Infant Series|Withdrawal by Subject|0|||
145269940|NCT00366678|523837784|FG000|Infant Series|Protocol Violation|4|||
145269941|NCT00366678|523837785|FG001|Infant Series|Protocol Violation|3|||
145269942|NCT00366678|523837786|FG002|Infant Series|Protocol Violation|0|||
145269943|NCT00366678|523837784|FG000|Infant Series|Failed to return|1|||
145269944|NCT00366678|523837785|FG001|Infant Series|Failed to return|1|||
145269945|NCT00366678|523837786|FG002|Infant Series|Failed to return|0|||
145269946|NCT00366678|523837784|FG000|Infant Series|Adverse Event|1|||
145269947|NCT00366678|523837785|FG001|Infant Series|Adverse Event|0|||
145269948|NCT00366678|523837786|FG002|Infant Series|Adverse Event|0|||
145269949|NCT00366678|523837784|FG000|After Infant|Withdrawal by Subject|8|||
145269950|NCT00366678|523837785|FG001|After Infant|Withdrawal by Subject|4|||
145269951|NCT00366678|523837786|FG002|After Infant|Withdrawal by Subject|0|||
145269952|NCT00366678|523837784|FG000|After Infant|Lost to Follow-up|2|||
145269953|NCT00366678|523837785|FG001|After Infant|Lost to Follow-up|1|||
145269954|NCT00366678|523837786|FG002|After Infant|Lost to Follow-up|0|||
145269955|NCT00366678|523837784|FG000|After Infant|Failed to return|5|||
145269956|NCT00366678|523837785|FG001|After Infant|Failed to return|5|||
145269957|NCT00366678|523837786|FG002|After Infant|Failed to return|0|||
145269958|NCT00366678|523837784|FG000|After Infant|Adverse Event|1|||
145269959|NCT00366678|523837785|FG001|After Infant|Adverse Event|0|||
145269960|NCT00366678|523837786|FG002|After Infant|Adverse Event|0|||
145269961|NCT00366678|523837784|FG000|After Infant|Protocol Violation|1|||
145269962|NCT00366678|523837785|FG001|After Infant|Protocol Violation|0|||
145269963|NCT00366678|523837786|FG002|After Infant|Protocol Violation|0|||
145269964|NCT00366678|523837784|FG000|Toddler Dose|Protocol Violation|2|||
145269965|NCT00366678|523837785|FG001|Toddler Dose|Protocol Violation|1|||
145269966|NCT00366678|523837786|FG002|Toddler Dose|Protocol Violation|0|||
145269967|NCT00366678|523837784|FG000|Toddler Dose|Failed to return|1|||
145269968|NCT00366678|523837785|FG001|Toddler Dose|Failed to return|0|||
145269969|NCT00366678|523837786|FG002|Toddler Dose|Failed to return|0|||
145269970|NCT00366678|523837784|FG000|Toddler Dose|Withdrawal by Subject|1|||
145269971|NCT00366678|523837785|FG001|Toddler Dose|Withdrawal by Subject|0|||
145269972|NCT00366678|523837786|FG002|Toddler Dose|Withdrawal by Subject|0|||
145742823|NCT02819635|525575235|FG011|Substudy 3|Other, not specified|39|||
145742824|NCT00530894|525575237|FG000|Overall Study|Death|84|||
145742825|NCT00530894|525575238|FG001|Overall Study|Death|89|||
145742826|NCT00530894|525575239|FG002|Overall Study|Death|55|||
145269973|NCT00366678|523837784|FG000|Toddler Dose|protocol deviation|1|||
145269974|NCT00366678|523837785|FG001|Toddler Dose|protocol deviation|0|||
145269975|NCT00366678|523837786|FG002|Toddler Dose|protocol deviation|0|||
145269976|NCT04292171|523837787|FG000|Overall Study|Pharmacy error|2|||
145269977|NCT04292171|523837788|FG001|Overall Study|Pharmacy error|0|||
145518461|NCT01215916|524758928|FG001|Overall Study|Physician Decision|0|||
145518462|NCT01215916|524758929|FG002|Overall Study|Physician Decision|1|||
145518463|NCT01215916|524758930|FG003|Overall Study|Physician Decision|1|||
145518464|NCT01215916|524758931|FG004|Overall Study|Physician Decision|0|||
145518465|NCT01215916|524758932|FG005|Overall Study|Physician Decision|0|||
145518466|NCT01215916|524758933|FG006|Overall Study|Physician Decision|0|||
145518467|NCT01215916|524758934|FG007|Overall Study|Physician Decision|0|||
145518468|NCT01215916|524758935|FG008|Overall Study|Physician Decision|0|||
145518469|NCT02353143|524758936|FG000|Overall Study|Withdrawal by Subject|1|||
145518470|NCT02353143|524758937|FG001|Overall Study|Withdrawal by Subject|0|||
145518471|NCT02353143|524758938|FG002|Overall Study|Withdrawal by Subject|0|||
145518472|NCT02353143|524758939|FG003|Overall Study|Withdrawal by Subject|0|||
145518473|NCT02353143|524758940|FG004|Overall Study|Withdrawal by Subject|1|||
145518474|NCT02353143|524758941|FG005|Overall Study|Withdrawal by Subject|0|||
145518475|NCT02353143|524758942|FG006|Overall Study|Withdrawal by Subject|0|||
145518476|NCT02353143|524758943|FG007|Overall Study|Withdrawal by Subject|1|||
145518477|NCT02353143|524758944|FG008|Overall Study|Withdrawal by Subject|1|||
145518478|NCT02353143|524758936|FG000|Overall Study|Lack of Efficacy|2|||
145742827|NCT00530894|525575240|FG003|Overall Study|Death|89|||
145742828|NCT00530894|525575237|FG000|Overall Study|Lost to Follow-up|1|||
145742829|NCT00530894|525575238|FG001|Overall Study|Lost to Follow-up|3|||
145742830|NCT00530894|525575239|FG002|Overall Study|Lost to Follow-up|0|||
145742831|NCT00530894|525575240|FG003|Overall Study|Lost to Follow-up|0|||
145742832|NCT00530894|525575237|FG000|Overall Study|Withdrawal by Subject|1|||
145742833|NCT00530894|525575238|FG001|Overall Study|Withdrawal by Subject|23|||
145269978|NCT04292171|523837787|FG000|Overall Study|Delivered prior to procedure|0|||
145269979|NCT04292171|523837788|FG001|Overall Study|Delivered prior to procedure|1|||
145269980|NCT00826176|523837795|FG000|Overall Study|Lost to Follow-up|1|||
145269981|NCT00826176|523837796|FG001|Overall Study|Lost to Follow-up|0|||
145269982|NCT00826176|523837795|FG000|Overall Study|Subject Withdrew Consent|3|||
145269983|NCT00826176|523837796|FG001|Overall Study|Subject Withdrew Consent|0|||
145269984|NCT00826176|523837795|FG000|Overall Study|Administrative|9|||
145269985|NCT00826176|523837796|FG001|Overall Study|Administrative|0|||
145269986|NCT03079869|523837798|FG000|Overall Study|Adverse Event|6|||
145518479|NCT02353143|524758937|FG001|Overall Study|Lack of Efficacy|1|||
145518480|NCT02353143|524758938|FG002|Overall Study|Lack of Efficacy|2|||
145742834|NCT00530894|525575239|FG002|Overall Study|Withdrawal by Subject|0|||
145742835|NCT00530894|525575240|FG003|Overall Study|Withdrawal by Subject|5|||
145269987|NCT03079869|523837799|FG001|Overall Study|Adverse Event|8|||
145518481|NCT02353143|524758939|FG003|Overall Study|Lack of Efficacy|4|||
145742836|NCT00530894|525575237|FG000|Overall Study|Alive and censored prior to 1 year|2|||
145269988|NCT03079869|523837798|FG000|Overall Study|Withdrawal by Subject|4|||
145269989|NCT03079869|523837799|FG001|Overall Study|Withdrawal by Subject|1|||
145269990|NCT03079869|523837798|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
145269991|NCT03079869|523837799|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
145269992|NCT00388674|523837801|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
145269993|NCT00388674|523837802|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
145269994|NCT00388674|523837801|FG000|Initial Treatment|Adverse Event|22|||
145269995|NCT00388674|523837802|FG001|Initial Treatment|Adverse Event|87|||
145269996|NCT00388674|523837801|FG000|Initial Treatment|Death|215|||
145269997|NCT00388674|523837802|FG001|Initial Treatment|Death|216|||
145269998|NCT00388674|523837801|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
145269999|NCT00388674|523837802|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
145270000|NCT00388674|523837801|FG000|Initial Treatment|HCC|12|||
145270001|NCT00388674|523837802|FG001|Initial Treatment|HCC|20|||
145270002|NCT00388674|523837801|FG000|Initial Treatment|Lost to Follow-up|526|||
145270003|NCT00388674|523837802|FG001|Initial Treatment|Lost to Follow-up|624|||
145270004|NCT00388674|523837801|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
145270005|NCT00388674|523837802|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
145270006|NCT00388674|523837801|FG000|Initial Treatment|Never Treated with Study Medication|1|||
145270007|NCT00388674|523837802|FG001|Initial Treatment|Never Treated with Study Medication|7|||
145270008|NCT00388674|523837801|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
145270009|NCT00388674|523837802|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
145270010|NCT00388674|523837801|FG000|Initial Treatment|Not Defined|125|||
145270011|NCT00388674|523837802|FG001|Initial Treatment|Not Defined|172|||
145270012|NCT00388674|523837801|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
145270013|NCT00388674|523837802|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
145270014|NCT00388674|523837801|FG000|Initial Treatment|Pregnancy|26|||
145270015|NCT00388674|523837802|FG001|Initial Treatment|Pregnancy|16|||
145270016|NCT00388674|523837801|FG000|Initial Treatment|Study Drug Toxicity|5|||
145270017|NCT00388674|523837802|FG001|Initial Treatment|Study Drug Toxicity|92|||
145270018|NCT00388674|523837801|FG000|Initial Treatment|Participant Request|501|||
145270019|NCT00388674|523837802|FG001|Initial Treatment|Participant Request|673|||
145270020|NCT00388674|523837801|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
145270021|NCT00388674|523837802|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
145270022|NCT00388674|523837801|FG000|Initial Treatment|Not Reported|10|||
145270023|NCT00388674|523837802|FG001|Initial Treatment|Not Reported|12|||
145270024|NCT00388674|523837801|FG000|End of Study|Administrative Reason By Sponsor|299|||
145270025|NCT00388674|523837802|FG001|End of Study|Administrative Reason By Sponsor|253|||
145270026|NCT00388674|523837801|FG000|End of Study|Death|239|||
145270027|NCT00388674|523837802|FG001|End of Study|Death|262|||
145270028|NCT00388674|523837801|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
145270029|NCT00388674|523837802|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
145270030|NCT00388674|523837801|FG000|End of Study|HCC|8|||
145270031|NCT00388674|523837802|FG001|End of Study|HCC|7|||
145270032|NCT00388674|523837801|FG000|End of Study|Lost to Follow-up|587|||
145270033|NCT00388674|523837802|FG001|End of Study|Lost to Follow-up|715|||
145270034|NCT00388674|523837801|FG000|End of Study|Malignancy (Non-HCC)|1|||
145270035|NCT00388674|523837802|FG001|End of Study|Malignancy (Non-HCC)|1|||
145270036|NCT00388674|523837801|FG000|End of Study|Non-Study Related Comorbidities|3|||
145270037|NCT00388674|523837802|FG001|End of Study|Non-Study Related Comorbidities|4|||
145270038|NCT00388674|523837801|FG000|End of Study|Not Defined|135|||
145270039|NCT00388674|523837802|FG001|End of Study|Not Defined|214|||
145270040|NCT00388674|523837801|FG000|End of Study|Participant Withdrew Consent|437|||
145270041|NCT00388674|523837802|FG001|End of Study|Participant Withdrew Consent|673|||
145270042|NCT00388674|523837801|FG000|End of Study|No Off-Treatment Status Data|22|||
145270043|NCT00388674|523837802|FG001|End of Study|No Off-Treatment Status Data|30|||
145270044|NCT00388674|523837801|FG000|End of Study|Not Reported|0|||
145270045|NCT00388674|523837802|FG001|End of Study|Not Reported|1|||
145518482|NCT02353143|524758940|FG004|Overall Study|Lack of Efficacy|13|||
145518483|NCT02353143|524758941|FG005|Overall Study|Lack of Efficacy|2|||
145518484|NCT02353143|524758942|FG006|Overall Study|Lack of Efficacy|2|||
145518485|NCT02353143|524758943|FG007|Overall Study|Lack of Efficacy|2|||
145518486|NCT02353143|524758944|FG008|Overall Study|Lack of Efficacy|1|||
145270046|NCT00297882|523837806|FG000|Day 14|Lack of Efficacy|12|||
145270047|NCT00297882|523837807|FG001|Day 14|Lack of Efficacy|49|||
145270048|NCT00297882|523837806|FG000|Day 28|Lost to Follow-up|13|||
145270049|NCT00297882|523837807|FG001|Day 28|Lost to Follow-up|23|||
145270050|NCT00297882|523837806|FG000|Day 28|Lack of Efficacy|3|||
145270051|NCT00297882|523837807|FG001|Day 28|Lack of Efficacy|0|||
145270052|NCT04484805|523837808|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
145270053|NCT04484805|523837809|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
145270054|NCT04484805|523837808|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
145270055|NCT04484805|523837809|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
145518487|NCT02353143|524758936|FG000|Overall Study|reason not specified|1|||
145518488|NCT02353143|524758937|FG001|Overall Study|reason not specified|2|||
145518489|NCT02353143|524758938|FG002|Overall Study|reason not specified|0|||
145518490|NCT02353143|524758939|FG003|Overall Study|reason not specified|0|||
145518491|NCT02353143|524758940|FG004|Overall Study|reason not specified|6|||
145518492|NCT02353143|524758941|FG005|Overall Study|reason not specified|1|||
145518493|NCT02353143|524758942|FG006|Overall Study|reason not specified|0|||
145518494|NCT02353143|524758943|FG007|Overall Study|reason not specified|3|||
145518495|NCT02353143|524758944|FG008|Overall Study|reason not specified|1|||
145518496|NCT02353143|524758936|FG000|Overall Study|Physician Decision|0|||
145518497|NCT02353143|524758937|FG001|Overall Study|Physician Decision|4|||
145518498|NCT02353143|524758938|FG002|Overall Study|Physician Decision|2|||
145518499|NCT02353143|524758939|FG003|Overall Study|Physician Decision|3|||
145518500|NCT02353143|524758940|FG004|Overall Study|Physician Decision|4|||
145518501|NCT02353143|524758941|FG005|Overall Study|Physician Decision|0|||
145518502|NCT02353143|524758942|FG006|Overall Study|Physician Decision|1|||
145518503|NCT02353143|524758943|FG007|Overall Study|Physician Decision|2|||
145518504|NCT02353143|524758944|FG008|Overall Study|Physician Decision|0|||
145518505|NCT02353143|524758936|FG000|Overall Study|Adverse Event|0|||
145518506|NCT02353143|524758937|FG001|Overall Study|Adverse Event|0|||
145518507|NCT02353143|524758938|FG002|Overall Study|Adverse Event|1|||
145518508|NCT02353143|524758939|FG003|Overall Study|Adverse Event|0|||
145518509|NCT02353143|524758940|FG004|Overall Study|Adverse Event|1|||
145518510|NCT02353143|524758941|FG005|Overall Study|Adverse Event|1|||
145518511|NCT02353143|524758942|FG006|Overall Study|Adverse Event|0|||
145518512|NCT02353143|524758943|FG007|Overall Study|Adverse Event|0|||
145518513|NCT02353143|524758944|FG008|Overall Study|Adverse Event|0|||
145518514|NCT02353143|524758936|FG000|Overall Study|patient receiving other treatment for AML|0|||
145518515|NCT02353143|524758937|FG001|Overall Study|patient receiving other treatment for AML|0|||
145518516|NCT02353143|524758938|FG002|Overall Study|patient receiving other treatment for AML|1|||
145518517|NCT02353143|524758939|FG003|Overall Study|patient receiving other treatment for AML|0|||
145518518|NCT02353143|524758940|FG004|Overall Study|patient receiving other treatment for AML|0|||
145518519|NCT02353143|524758941|FG005|Overall Study|patient receiving other treatment for AML|0|||
145518520|NCT02353143|524758942|FG006|Overall Study|patient receiving other treatment for AML|0|||
145518521|NCT02353143|524758943|FG007|Overall Study|patient receiving other treatment for AML|0|||
145518522|NCT02353143|524758944|FG008|Overall Study|patient receiving other treatment for AML|0|||
145518523|NCT02353143|524758936|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
145518524|NCT02353143|524758937|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
145518525|NCT02353143|524758938|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
145518526|NCT02353143|524758939|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
145518527|NCT02353143|524758940|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
145518528|NCT02353143|524758941|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
145518529|NCT02353143|524758942|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
145518530|NCT02353143|524758943|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
145518531|NCT02353143|524758944|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
145518532|NCT01029405|524758945|FG000|Overall Study|Withdrawal by Subject|0|||
145518533|NCT01029405|524758946|FG001|Overall Study|Withdrawal by Subject|1|||
145742837|NCT00530894|525575238|FG001|Overall Study|Alive and censored prior to 1 year|0|||
145742838|NCT00530894|525575239|FG002|Overall Study|Alive and censored prior to 1 year|0|||
145742839|NCT00530894|525575240|FG003|Overall Study|Alive and censored prior to 1 year|0|||
145742840|NCT01349465|525575241|FG000|Overall Study|Adverse Event|1|||
145742841|NCT01349465|525575242|FG001|Overall Study|Adverse Event|0|||
145742842|NCT01349465|525575241|FG000|Overall Study|Death|3|||
145742843|NCT01349465|525575242|FG001|Overall Study|Death|0|||
145742844|NCT01349465|525575241|FG000|Overall Study|Lost to Follow-up|10|||
145742845|NCT01349465|525575242|FG001|Overall Study|Lost to Follow-up|1|||
145742846|NCT01349465|525575241|FG000|Overall Study|Withdrawal by Subject|4|||
145742847|NCT01349465|525575242|FG001|Overall Study|Withdrawal by Subject|2|||
145742848|NCT01349465|525575241|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
145742849|NCT01349465|525575242|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
145742850|NCT00928889|525575248|FG000|Overall Study|Lost to Follow-up|3|||
145742851|NCT00928889|525575249|FG001|Overall Study|Lost to Follow-up|1|||
145742852|NCT00928889|525575248|FG000|Overall Study|Protocol Violation|0|||
145742853|NCT00928889|525575249|FG001|Overall Study|Protocol Violation|1|||
145742854|NCT00928889|525575248|FG000|Overall Study|Adverse Event|1|||
145742855|NCT00928889|525575249|FG001|Overall Study|Adverse Event|0|||
145742856|NCT00928889|525575248|FG000|Overall Study|Other|1|||
145742857|NCT00928889|525575249|FG001|Overall Study|Other|0|||
145742858|NCT01923285|525575250|FG000|Overall Study|Withdrawal by Subject|7|||
145742859|NCT01923285|525575251|FG001|Overall Study|Withdrawal by Subject|6|||
145742860|NCT03374189|525575252|FG000|Overall Study|Lost to Follow-up|1|||
145742861|NCT03374189|525575253|FG001|Overall Study|Lost to Follow-up|0|||
145742862|NCT02375724|525575254|FG000|Overall Study|Lack of Efficacy|1|||
145742863|NCT02375724|525575255|FG001|Overall Study|Lack of Efficacy|1|||
145742864|NCT02375724|525575254|FG000|Overall Study|Withdrawal by Subject|1|||
145742865|NCT02375724|525575255|FG001|Overall Study|Withdrawal by Subject|1|||
145742866|NCT02375724|525575254|FG000|Overall Study|Lost to Follow-up|1|||
145742867|NCT02375724|525575255|FG001|Overall Study|Lost to Follow-up|0|||
145742868|NCT02375724|525575254|FG000|Overall Study|Protocol Violation|1|||
145742869|NCT02375724|525575255|FG001|Overall Study|Protocol Violation|0|||
145742870|NCT02375724|525575254|FG000|Overall Study|Adverse Event|2|||
145742871|NCT02375724|525575255|FG001|Overall Study|Adverse Event|4|||
145742872|NCT01517893|525575258|FG000|Overall Study|Withdrawal by Subject|3|||
145742873|NCT01517893|525575259|FG001|Overall Study|Withdrawal by Subject|0|||
145742874|NCT02285777|525575260|FG000|Overall Study|Withdrawal by Subject|1|||
145742875|NCT02285777|525575261|FG001|Overall Study|Withdrawal by Subject|1|||
145742876|NCT02285777|525575260|FG000|Overall Study|Lost to Follow-up|4|||
145742877|NCT02285777|525575261|FG001|Overall Study|Lost to Follow-up|2|||
145742878|NCT03962101|525575262|FG000|Overall Study|Adverse Event|1|||
145742879|NCT03962101|525575262|FG000|Overall Study|Physician Decision|2|||
145742880|NCT03962101|525575262|FG000|Overall Study|Not related to medical events|1|||
145742881|NCT03699007|525575263|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
145742882|NCT03699007|525575264|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
145742883|NCT03699007|525575263|FG000|6-month Follow Up|Lost to Follow-up|2|||
145742884|NCT03699007|525575264|FG001|6-month Follow Up|Lost to Follow-up|3|||
145742885|NCT01543828|525575267|FG000|Treatment 2|Lost to Follow-up|1|||
145742886|NCT01543828|525575268|FG001|Treatment 2|Lost to Follow-up|0|||
145742887|NCT01069172|525575271|FG000|Overall Study|Withdrawal by Subject|1|||
145518534|NCT01029405|524758947|FG002|Overall Study|Withdrawal by Subject|2|||
145518535|NCT01029405|524758948|FG003|Overall Study|Withdrawal by Subject|0|||
145518536|NCT01029405|524758945|FG000|Overall Study|Protocol Violation|0|||
145518537|NCT01029405|524758946|FG001|Overall Study|Protocol Violation|0|||
145518538|NCT01029405|524758947|FG002|Overall Study|Protocol Violation|0|||
145518539|NCT01029405|524758948|FG003|Overall Study|Protocol Violation|1|||
145518540|NCT01029405|524758945|FG000|Overall Study|Adverse Event|0|||
145518541|NCT01029405|524758946|FG001|Overall Study|Adverse Event|0|||
145518542|NCT01029405|524758947|FG002|Overall Study|Adverse Event|1|||
145518543|NCT01029405|524758948|FG003|Overall Study|Adverse Event|1|||
145518544|NCT01029405|524758945|FG000|Overall Study|Lost to Follow-up|2|||
145518545|NCT01029405|524758946|FG001|Overall Study|Lost to Follow-up|1|||
145742888|NCT01069172|525575272|FG001|Overall Study|Withdrawal by Subject|0|||
145742889|NCT00711425|525575274|FG000|Overall Study|Protocol Violation|1|||
145742890|NCT00711425|525575274|FG000|Overall Study|Death|2|||
145742891|NCT00711425|525575274|FG000|Overall Study|Lost to Follow-up|1|||
145742892|NCT03901079|525575277|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
145742893|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
145742894|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
145742895|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Death|0|||
145742896|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Death|1|||
145518546|NCT01029405|524758947|FG002|Overall Study|Lost to Follow-up|1|||
145518547|NCT01029405|524758948|FG003|Overall Study|Lost to Follow-up|2|||
145518548|NCT01029405|524758945|FG000|Overall Study|Other|0|||
145518549|NCT01029405|524758946|FG001|Overall Study|Other|1|||
145518550|NCT01029405|524758947|FG002|Overall Study|Other|0|||
145518551|NCT01029405|524758948|FG003|Overall Study|Other|1|||
145518552|NCT00393510|524758949|FG000|Overall Study|Physician Decision|3|||
145518553|NCT00393510|524758950|FG001|Overall Study|Physician Decision|9|||
145518554|NCT01534182|524758952|FG000|Overall Study|Administrative problems|1|||
145518555|NCT01534182|524758953|FG001|Overall Study|Administrative problems|0|||
145518556|NCT01534182|524758952|FG000|Overall Study|Withdrawal by Subject|4|||
145518557|NCT01534182|524758953|FG001|Overall Study|Withdrawal by Subject|7|||
145518558|NCT01534182|524758952|FG000|Overall Study|Adverse Event|7|||
145518559|NCT01534182|524758953|FG001|Overall Study|Adverse Event|3|||
145518560|NCT03077087|524758954|FG000|Overall Study|Physician Decision|2|||
145518561|NCT00770146|524758955|FG000|Treatment Period|Withdrawal by Subject|6|||
145518562|NCT00770146|524758956|FG001|Treatment Period|Withdrawal by Subject|13|||
145742897|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
145742898|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
145742899|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
145518563|NCT00770146|524758955|FG000|Treatment Period|Adverse Event|2|||
145518564|NCT00770146|524758956|FG001|Treatment Period|Adverse Event|26|||
145518565|NCT00770146|524758955|FG000|Treatment Period|Other|1|||
145742900|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
145742901|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
145742902|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
145518566|NCT00770146|524758956|FG001|Treatment Period|Other|5|||
145518567|NCT00770146|524758955|FG000|Treatment Period|Protocol non-compliance|0|||
145518568|NCT00770146|524758956|FG001|Treatment Period|Protocol non-compliance|1|||
145518569|NCT00770146|524758955|FG000|Follow-up Period|Withdrawal by Subject|7|||
145518570|NCT00770146|524758956|FG001|Follow-up Period|Withdrawal by Subject|13|||
145742903|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
145518571|NCT00770146|524758955|FG000|Follow-up Period|Adverse Event|0|||
145518572|NCT00770146|524758956|FG001|Follow-up Period|Adverse Event|2|||
145518573|NCT00770146|524758955|FG000|Follow-up Period|Other|4|||
145518574|NCT00770146|524758956|FG001|Follow-up Period|Other|5|||
145518575|NCT03222492|524758959|FG000|Overall Study|Withdrawal by Subject|0|||
145518576|NCT03222492|524758960|FG001|Overall Study|Withdrawal by Subject|0|||
145518577|NCT03222492|524758961|FG002|Overall Study|Withdrawal by Subject|1|||
145518578|NCT03222492|524758962|FG003|Overall Study|Withdrawal by Subject|0|||
145518579|NCT03222492|524758959|FG000|Overall Study|COVID-19 related|0|||
145518580|NCT03222492|524758960|FG001|Overall Study|COVID-19 related|0|||
145518581|NCT03222492|524758961|FG002|Overall Study|COVID-19 related|1|||
145518582|NCT03222492|524758962|FG003|Overall Study|COVID-19 related|0|||
145518583|NCT01525901|524758963|FG000|Period 2: 12 Weeks|Adverse Event|0|||
145518584|NCT01525901|524758964|FG001|Period 2: 12 Weeks|Adverse Event|1|||
145518585|NCT01525901|524758965|FG002|Period 2: 12 Weeks|Adverse Event|0|||
145518586|NCT01525901|524758966|FG003|Period 2: 12 Weeks|Adverse Event|0|||
145518587|NCT05027971|524758969|FG000|Overall Study|Physician Decision|7|||
145518588|NCT05027971|524758970|FG001|Overall Study|Physician Decision|3|||
145518589|NCT05027971|524758969|FG000|Overall Study|Lost to Follow-up|1|||
145518590|NCT05027971|524758970|FG001|Overall Study|Lost to Follow-up|1|||
145518591|NCT05027971|524758969|FG000|Overall Study|Withdrawal by Subject|0|||
145518592|NCT05027971|524758970|FG001|Overall Study|Withdrawal by Subject|2|||
145518593|NCT05027971|524758969|FG000|Overall Study|Non-study fiber used.|0|||
145742904|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
145518594|NCT05027971|524758970|FG001|Overall Study|Non-study fiber used.|1|||
145518595|NCT05027971|524758969|FG000|Overall Study|Protocol Violation|0|||
145518596|NCT05027971|524758970|FG001|Overall Study|Protocol Violation|2|||
145518597|NCT02112045|524758971|FG000|Overall Study|Withdrawal by Subject|1|||
145518598|NCT02112045|524758972|FG001|Overall Study|Withdrawal by Subject|0|||
145518599|NCT00627445|524758973|FG000|Overall Study|Adverse Event|3|||
145518600|NCT00627445|524758974|FG001|Overall Study|Adverse Event|3|||
145518601|NCT00627445|524758973|FG000|Overall Study|Lack of Efficacy|0|||
145518602|NCT00627445|524758974|FG001|Overall Study|Lack of Efficacy|1|||
145518603|NCT00627445|524758973|FG000|Overall Study|Other|6|||
145518604|NCT00627445|524758974|FG001|Overall Study|Other|8|||
145518605|NCT01238588|524758980|FG000|Overall Study|Withdrawal by Subject|1|||
145518606|NCT01238588|524758980|FG000|Overall Study|Physician Decision|2|||
145742905|NCT00843518|525575278|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
145742906|NCT00843518|525575279|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
145742907|NCT04607148|525575282|FG000|Overall Study|Withdrawal by Subject|0|||
145742908|NCT04607148|525575283|FG001|Overall Study|Withdrawal by Subject|4|||
145742909|NCT04607148|525575284|FG002|Overall Study|Withdrawal by Subject|2|||
145742910|NCT04607148|525575285|FG003|Overall Study|Withdrawal by Subject|8|||
145742911|NCT04607148|525575282|FG000|Overall Study|Study Terminated by Sponsor|14|||
145742912|NCT04607148|525575283|FG001|Overall Study|Study Terminated by Sponsor|59|||
145742913|NCT04607148|525575284|FG002|Overall Study|Study Terminated by Sponsor|9|||
145742914|NCT04607148|525575285|FG003|Overall Study|Study Terminated by Sponsor|39|||
145742915|NCT04607148|525575282|FG000|Overall Study|Sponsor Decision|0|||
145742916|NCT04607148|525575283|FG001|Overall Study|Sponsor Decision|0|||
145742917|NCT04607148|525575284|FG002|Overall Study|Sponsor Decision|1|||
145742918|NCT04607148|525575285|FG003|Overall Study|Sponsor Decision|0|||
145742919|NCT04607148|525575282|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145742920|NCT04607148|525575283|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145742921|NCT04607148|525575284|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145742922|NCT04607148|525575285|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145742923|NCT04607148|525575282|FG000|Overall Study|Lost to Follow-up|0|||
145742924|NCT04607148|525575283|FG001|Overall Study|Lost to Follow-up|2|||
145742925|NCT04607148|525575284|FG002|Overall Study|Lost to Follow-up|0|||
145742926|NCT04607148|525575285|FG003|Overall Study|Lost to Follow-up|0|||
145742927|NCT04607148|525575282|FG000|Overall Study|Death|0|||
145742928|NCT04607148|525575283|FG001|Overall Study|Death|3|||
145742929|NCT04607148|525575284|FG002|Overall Study|Death|0|||
145742930|NCT04607148|525575285|FG003|Overall Study|Death|1|||
145742931|NCT04607148|525575282|FG000|Overall Study|Adverse Event|0|||
145742932|NCT04607148|525575283|FG001|Overall Study|Adverse Event|1|||
145742933|NCT04607148|525575284|FG002|Overall Study|Adverse Event|0|||
145742934|NCT04607148|525575285|FG003|Overall Study|Adverse Event|0|||
145742935|NCT04251910|525575288|FG000|Overall Study|Covid 19 lockdown|0|||
145742936|NCT04251910|525575289|FG001|Overall Study|Covid 19 lockdown|5|||
145742937|NCT04251910|525575290|FG002|Overall Study|Covid 19 lockdown|0|||
145742938|NCT04251910|525575291|FG003|Overall Study|Covid 19 lockdown|4|||
145742939|NCT04251910|525575292|FG004|Overall Study|Covid 19 lockdown|0|||
145742940|NCT04251910|525575293|FG005|Overall Study|Covid 19 lockdown|0|||
145742941|NCT04251910|525575288|FG000|Overall Study|Assisted living facility was closed|0|||
145742942|NCT04251910|525575289|FG001|Overall Study|Assisted living facility was closed|0|||
145742943|NCT04251910|525575290|FG002|Overall Study|Assisted living facility was closed|0|||
145742944|NCT04251910|525575291|FG003|Overall Study|Assisted living facility was closed|0|||
145742945|NCT04251910|525575292|FG004|Overall Study|Assisted living facility was closed|1|||
145742946|NCT04251910|525575293|FG005|Overall Study|Assisted living facility was closed|0|||
145742947|NCT00804570|525575294|FG000|Overall Study|Adverse Event|14|||
145742948|NCT00804570|525575295|FG001|Overall Study|Adverse Event|7|||
145742949|NCT00804570|525575294|FG000|Overall Study|Lack of Efficacy|0|||
145742950|NCT00804570|525575295|FG001|Overall Study|Lack of Efficacy|1|||
145742951|NCT00804570|525575294|FG000|Overall Study|Lost to Follow-up|18|||
145742952|NCT00804570|525575295|FG001|Overall Study|Lost to Follow-up|21|||
145742953|NCT00804570|525575294|FG000|Overall Study|Entry criteria not met|5|||
145270056|NCT02118896|523837810|FG000|Overall Study|Death|4|||
145270057|NCT02118896|523837811|FG001|Overall Study|Death|0|||
145270058|NCT02118896|523837812|FG002|Overall Study|Death|4|||
145270059|NCT02118896|523837813|FG003|Overall Study|Death|6|||
145518607|NCT00247611|524758981|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
145518608|NCT00247611|524758982|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
145518609|NCT00247611|524758981|FG000|Baselined|Completed baseline only|9|||
145742954|NCT00804570|525575295|FG001|Overall Study|Entry criteria not met|5|||
145742955|NCT00804570|525575294|FG000|Overall Study|Protocol Violation|12|||
145742956|NCT00804570|525575295|FG001|Overall Study|Protocol Violation|16|||
145742957|NCT00804570|525575294|FG000|Overall Study|Physician Decision|1|||
145742958|NCT00804570|525575295|FG001|Overall Study|Physician Decision|2|||
145742959|NCT00804570|525575294|FG000|Overall Study|Sponsor decision|1|||
145742960|NCT00804570|525575295|FG001|Overall Study|Sponsor decision|4|||
145742961|NCT00804570|525575294|FG000|Overall Study|Withdrawal by Subject|21|||
145742962|NCT00804570|525575295|FG001|Overall Study|Withdrawal by Subject|38|||
145742963|NCT00290342|525575296|FG000|Overall Study|Other|0|||
145270060|NCT02118896|523837814|FG004|Overall Study|Death|3|||
145518610|NCT00247611|524758982|FG001|Baselined|Completed baseline only|8|||
145518611|NCT05395091|524758983|FG000|Baseline to Month 12|Adverse Event|7|||
145742964|NCT00290342|525575297|FG001|Overall Study|Other|1|||
145742965|NCT00290342|525575296|FG000|Overall Study|Withdrawal by Subject|6|||
145742966|NCT00290342|525575297|FG001|Overall Study|Withdrawal by Subject|4|||
145742967|NCT00290342|525575296|FG000|Overall Study|Lost to Follow-up|1|||
145742968|NCT00290342|525575297|FG001|Overall Study|Lost to Follow-up|0|||
145742969|NCT00916149|525575298|FG000|Overall Study|Lost to Follow-up|3|||
145742970|NCT00916149|525575299|FG001|Overall Study|Lost to Follow-up|2|||
145742971|NCT00916149|525575300|FG002|Overall Study|Lost to Follow-up|0|||
145742972|NCT00916149|525575298|FG000|Overall Study|Unable to place scalp EEG leads|1|||
145742973|NCT00916149|525575299|FG001|Overall Study|Unable to place scalp EEG leads|0|||
145742974|NCT00916149|525575300|FG002|Overall Study|Unable to place scalp EEG leads|0|||
145742975|NCT01056510|525575303|FG000|Overall Study|Dropout Before Start of Treatment|1|||
145742976|NCT01056510|525575304|FG001|Overall Study|Dropout Before Start of Treatment|1|||
145742977|NCT01056510|525575303|FG000|Overall Study|Withdrawal by Subject|4|||
145742978|NCT01056510|525575304|FG001|Overall Study|Withdrawal by Subject|2|||
145742979|NCT01056510|525575303|FG000|Overall Study|Death|29|||
145742980|NCT01056510|525575304|FG001|Overall Study|Death|34|||
145742981|NCT01056510|525575303|FG000|Overall Study|Noncompliance|1|||
145742982|NCT01056510|525575304|FG001|Overall Study|Noncompliance|3|||
145742983|NCT01056510|525575303|FG000|Overall Study|Physician Decision|4|||
145742984|NCT01056510|525575304|FG001|Overall Study|Physician Decision|5|||
145742985|NCT01056510|525575303|FG000|Overall Study|Lost to Follow-up|5|||
145742986|NCT01056510|525575304|FG001|Overall Study|Lost to Follow-up|6|||
145742987|NCT01056510|525575303|FG000|Overall Study|Other|10|||
145742988|NCT01056510|525575304|FG001|Overall Study|Other|12|||
145742989|NCT01056510|525575303|FG000|Overall Study|Missing|0|||
145742990|NCT01056510|525575304|FG001|Overall Study|Missing|1|||
145742991|NCT00912028|525575307|FG000|Overall Study|Lost to Follow-up|2|||
145742992|NCT00912028|525575308|FG001|Overall Study|Lost to Follow-up|3|||
145742993|NCT00912028|525575309|FG002|Overall Study|Lost to Follow-up|0|||
145742994|NCT00912028|525575310|FG003|Overall Study|Lost to Follow-up|1|||
145742995|NCT00912028|525575311|FG004|Overall Study|Lost to Follow-up|3|||
145742996|NCT00912028|525575307|FG000|Overall Study|Withdrawal by Subject|3|||
145742997|NCT00912028|525575308|FG001|Overall Study|Withdrawal by Subject|0|||
145742998|NCT00912028|525575309|FG002|Overall Study|Withdrawal by Subject|0|||
145742999|NCT00912028|525575310|FG003|Overall Study|Withdrawal by Subject|0|||
145743000|NCT00912028|525575311|FG004|Overall Study|Withdrawal by Subject|0|||
145743001|NCT03002155|525575312|FG000|Overall Study|Lost to Follow-up|1|||
145743002|NCT03002155|525575313|FG001|Overall Study|Lost to Follow-up|2|||
145743003|NCT03002155|525575312|FG000|Overall Study|Withdrawal by Subject|1|||
145743004|NCT03002155|525575313|FG001|Overall Study|Withdrawal by Subject|0|||
145743005|NCT03002155|525575312|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
145743006|NCT03002155|525575313|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
145743007|NCT03451084|525575316|FG000|Overall Study|Withdrawal by Subject|2|||
145743008|NCT03451084|525575317|FG001|Overall Study|Withdrawal by Subject|1|||
145743009|NCT03451084|525575318|FG002|Overall Study|Withdrawal by Subject|2|||
145743010|NCT03451084|525575319|FG003|Overall Study|Withdrawal by Subject|1|||
145743011|NCT03451084|525575316|FG000|Overall Study|Disease recurrence|0|||
145743012|NCT03451084|525575317|FG001|Overall Study|Disease recurrence|2|||
145743013|NCT03451084|525575318|FG002|Overall Study|Disease recurrence|0|||
145743014|NCT03451084|525575319|FG003|Overall Study|Disease recurrence|0|||
145743015|NCT03451084|525575316|FG000|Overall Study|Lack of Efficacy|0|||
145743016|NCT03451084|525575317|FG001|Overall Study|Lack of Efficacy|3|||
145743017|NCT03451084|525575318|FG002|Overall Study|Lack of Efficacy|0|||
145743018|NCT03451084|525575319|FG003|Overall Study|Lack of Efficacy|1|||
145743019|NCT03451084|525575316|FG000|Overall Study|Death|1|||
145743020|NCT03451084|525575317|FG001|Overall Study|Death|0|||
145518612|NCT05395091|524758984|FG001|Baseline to Month 12|Adverse Event|2|||
145518613|NCT05395091|524758985|FG002|Baseline to Month 12|Adverse Event|0|||
145518614|NCT05395091|524758983|FG000|Baseline to Month 12|Death|3|||
145518615|NCT05395091|524758984|FG001|Baseline to Month 12|Death|1|||
145518616|NCT05395091|524758985|FG002|Baseline to Month 12|Death|0|||
145518617|NCT05395091|524758983|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
145518618|NCT05395091|524758984|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
145743021|NCT03451084|525575318|FG002|Overall Study|Death|2|||
145743022|NCT03451084|525575319|FG003|Overall Study|Death|0|||
145743023|NCT03451084|525575316|FG000|Overall Study|Physician Decision|0|||
145743024|NCT03451084|525575317|FG001|Overall Study|Physician Decision|0|||
145743025|NCT03451084|525575318|FG002|Overall Study|Physician Decision|2|||
145743026|NCT03451084|525575319|FG003|Overall Study|Physician Decision|2|||
145743027|NCT03451084|525575316|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
145743028|NCT03451084|525575317|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
145743029|NCT03451084|525575318|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
145743030|NCT03451084|525575319|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
145518619|NCT05395091|524758985|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
145743031|NCT03418129|525575320|FG000|Overall Study|Lost to Follow-up|11|||
145743032|NCT03418129|525575321|FG001|Overall Study|Lost to Follow-up|20|||
145743033|NCT03418129|525575322|FG002|Overall Study|Lost to Follow-up|15|||
145743034|NCT03418129|525575320|FG000|Overall Study|Withdrawal by Subject|3|||
145743035|NCT03418129|525575321|FG001|Overall Study|Withdrawal by Subject|6|||
145743036|NCT03418129|525575322|FG002|Overall Study|Withdrawal by Subject|4|||
145743037|NCT01617070|525575327|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
145743038|NCT05289570|525575333|FG000|Overall Study|Physician Decision|1|||
145743039|NCT04544475|525575335|FG000|Overall Study|Withdrawal by Subject|1|||
145743040|NCT04544475|525575336|FG001|Overall Study|Withdrawal by Subject|3|||
145743041|NCT00808236|525575337|FG000|Overall Study|Was not resuscitated|50|||
145743042|NCT00808236|525575338|FG001|Overall Study|Was not resuscitated|56|||
145743043|NCT00808236|525575337|FG000|Overall Study|Pre-defined exclusion|13|||
145743044|NCT00808236|525575338|FG001|Overall Study|Pre-defined exclusion|3|||
145743045|NCT00808236|525575337|FG000|Overall Study|Lost to Follow-up|1|||
145743046|NCT00808236|525575338|FG001|Overall Study|Lost to Follow-up|1|||
145743047|NCT00808236|525575337|FG000|Overall Study|Physician Decision|0|||
145743048|NCT00808236|525575338|FG001|Overall Study|Physician Decision|1|||
145743049|NCT00808236|525575337|FG000|Overall Study|Death|18|||
145743050|NCT00808236|525575338|FG001|Overall Study|Death|30|||
145743051|NCT01147744|525575339|FG000|Overall Study|Protocol Violation|1|||
145743052|NCT01147744|525575340|FG001|Overall Study|Protocol Violation|0|||
145743053|NCT01147744|525575341|FG002|Overall Study|Protocol Violation|1|||
145743054|NCT01147744|525575342|FG003|Overall Study|Protocol Violation|0|||
145743055|NCT01147744|525575343|FG004|Overall Study|Protocol Violation|1|||
145743056|NCT01147744|525575344|FG005|Overall Study|Protocol Violation|3|||
145743057|NCT01147744|525575345|FG006|Overall Study|Protocol Violation|1|||
145743058|NCT01147744|525575339|FG000|Overall Study|Physician Decision|0|||
145743059|NCT01147744|525575340|FG001|Overall Study|Physician Decision|1|||
145743060|NCT01147744|525575341|FG002|Overall Study|Physician Decision|1|||
145743061|NCT01147744|525575342|FG003|Overall Study|Physician Decision|0|||
145743062|NCT01147744|525575343|FG004|Overall Study|Physician Decision|0|||
145743063|NCT01147744|525575344|FG005|Overall Study|Physician Decision|0|||
145743064|NCT01147744|525575345|FG006|Overall Study|Physician Decision|1|||
145743065|NCT01147744|525575339|FG000|Overall Study|Lack of Efficacy|11|||
145743066|NCT01147744|525575340|FG001|Overall Study|Lack of Efficacy|11|||
145743067|NCT01147744|525575341|FG002|Overall Study|Lack of Efficacy|9|||
145743068|NCT01147744|525575342|FG003|Overall Study|Lack of Efficacy|11|||
145743069|NCT01147744|525575343|FG004|Overall Study|Lack of Efficacy|13|||
145743070|NCT01147744|525575344|FG005|Overall Study|Lack of Efficacy|8|||
145743071|NCT01147744|525575345|FG006|Overall Study|Lack of Efficacy|7|||
145743072|NCT01147744|525575339|FG000|Overall Study|Adverse Event|1|||
145743073|NCT01147744|525575340|FG001|Overall Study|Adverse Event|2|||
145743074|NCT01147744|525575341|FG002|Overall Study|Adverse Event|3|||
145743075|NCT01147744|525575342|FG003|Overall Study|Adverse Event|0|||
145743076|NCT01147744|525575343|FG004|Overall Study|Adverse Event|2|||
145743077|NCT01147744|525575344|FG005|Overall Study|Adverse Event|1|||
145743078|NCT01147744|525575345|FG006|Overall Study|Adverse Event|2|||
145743079|NCT01147744|525575339|FG000|Overall Study|Withdrawal by Subject|8|||
145743080|NCT01147744|525575340|FG001|Overall Study|Withdrawal by Subject|4|||
145743081|NCT01147744|525575341|FG002|Overall Study|Withdrawal by Subject|2|||
145743082|NCT01147744|525575342|FG003|Overall Study|Withdrawal by Subject|2|||
145743083|NCT01147744|525575343|FG004|Overall Study|Withdrawal by Subject|2|||
145743084|NCT01147744|525575344|FG005|Overall Study|Withdrawal by Subject|5|||
145743085|NCT01147744|525575345|FG006|Overall Study|Withdrawal by Subject|2|||
145743086|NCT01147744|525575339|FG000|Overall Study|Lost to Follow-up|0|||
145743087|NCT01147744|525575340|FG001|Overall Study|Lost to Follow-up|1|||
145743088|NCT01147744|525575341|FG002|Overall Study|Lost to Follow-up|0|||
145743089|NCT01147744|525575342|FG003|Overall Study|Lost to Follow-up|0|||
145743090|NCT01147744|525575343|FG004|Overall Study|Lost to Follow-up|0|||
145743091|NCT01147744|525575344|FG005|Overall Study|Lost to Follow-up|0|||
145743092|NCT01147744|525575345|FG006|Overall Study|Lost to Follow-up|0|||
145743093|NCT01147744|525575339|FG000|Overall Study|Sponsor decision to amend protocol|7|||
145518620|NCT05395091|524758983|FG000|Baseline to Month 12|Protocol Violation|2|||
145518621|NCT05395091|524758984|FG001|Baseline to Month 12|Protocol Violation|3|||
145743094|NCT01147744|525575340|FG001|Overall Study|Sponsor decision to amend protocol|4|||
145743095|NCT01147744|525575341|FG002|Overall Study|Sponsor decision to amend protocol|2|||
145743096|NCT01147744|525575342|FG003|Overall Study|Sponsor decision to amend protocol|5|||
145743097|NCT01147744|525575343|FG004|Overall Study|Sponsor decision to amend protocol|7|||
145743098|NCT01147744|525575344|FG005|Overall Study|Sponsor decision to amend protocol|2|||
145402348|NCT03736967|524330715|FG000|Overall Study|Withdrawal by Subject|26|||
145518622|NCT05395091|524758985|FG002|Baseline to Month 12|Protocol Violation|0|||
145743099|NCT01147744|525575345|FG006|Overall Study|Sponsor decision to amend protocol|6|||
145743100|NCT01147744|525575339|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145743101|NCT01147744|525575340|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145743102|NCT01147744|525575341|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145743103|NCT01147744|525575342|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145743104|NCT01147744|525575343|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145743105|NCT01147744|525575344|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145743106|NCT01147744|525575345|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145743107|NCT01342484|525575347|FG000|Overall Study|Other Reasons|1|||
145743108|NCT01342484|525575348|FG001|Overall Study|Other Reasons|0|||
145743109|NCT01342484|525575349|FG002|Overall Study|Other Reasons|0|||
145743110|NCT01342484|525575347|FG000|Overall Study|Protocol Violation|0|||
145743111|NCT01342484|525575348|FG001|Overall Study|Protocol Violation|0|||
145743112|NCT01342484|525575349|FG002|Overall Study|Protocol Violation|1|||
145743113|NCT01342484|525575347|FG000|Overall Study|Withdrawal by Subject|1|||
145743114|NCT01342484|525575348|FG001|Overall Study|Withdrawal by Subject|0|||
145743115|NCT01342484|525575349|FG002|Overall Study|Withdrawal by Subject|0|||
145743116|NCT05003622|525575351|FG000|Overall Study|Progressive disease|2|||
145743117|NCT05003622|525575351|FG000|Overall Study|Withdrawal by Subject|1|||
145743118|NCT01045798|525575355|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
145743119|NCT01045798|525575356|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
145743120|NCT01045798|525575355|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
145743121|NCT01045798|525575356|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
145743122|NCT01045798|525575355|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
145743123|NCT01045798|525575356|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
145743124|NCT01045798|525575355|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
145743125|NCT01045798|525575356|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
145743126|NCT04066491|525575357|FG000|Overall Study|Randomized, not treated|0|||
145743127|NCT04066491|525575358|FG001|Overall Study|Randomized, not treated|0|||
145743128|NCT04066491|525575359|FG002|Overall Study|Randomized, not treated|2|||
145743129|NCT04506086|525575360|FG000|Overall Study|Withdrawal by Subject|2|||
145743130|NCT02321930|525575368|FG000|Overall Study|Lost to Follow-up|1|||
145743131|NCT01293968|525575369|FG000|Overall Study|non-cooperation|3|||
145743132|NCT01293968|525575370|FG001|Overall Study|non-cooperation|3|||
145743133|NCT00597753|525575372|FG000|Overall Study|Adverse Event|6|||
145743134|NCT00597753|525575373|FG001|Overall Study|Adverse Event|2|||
145743135|NCT00597753|525575372|FG000|Overall Study|Death|55|||
145743136|NCT00597753|525575373|FG001|Overall Study|Death|29|||
145743137|NCT00597753|525575372|FG000|Overall Study|Lack of Efficacy|2|||
145743138|NCT00597753|525575373|FG001|Overall Study|Lack of Efficacy|0|||
145743139|NCT00597753|525575372|FG000|Overall Study|Lost to Follow-up|10|||
145743140|NCT00597753|525575373|FG001|Overall Study|Lost to Follow-up|3|||
145743141|NCT00597753|525575372|FG000|Overall Study|Physician Decision|5|||
145743142|NCT00597753|525575373|FG001|Overall Study|Physician Decision|1|||
145743143|NCT00597753|525575372|FG000|Overall Study|Pregnancy|1|||
145743144|NCT00597753|525575373|FG001|Overall Study|Pregnancy|0|||
145743145|NCT00597753|525575372|FG000|Overall Study|Withdrawal by Subject|35|||
145743146|NCT00597753|525575373|FG001|Overall Study|Withdrawal by Subject|12|||
145743147|NCT00597753|525575372|FG000|Overall Study|Discontinued Dialysis|0|||
145743148|NCT00597753|525575373|FG001|Overall Study|Discontinued Dialysis|1|||
145743149|NCT00597753|525575372|FG000|Overall Study|Never dosed|2|||
145743150|NCT00597753|525575373|FG001|Overall Study|Never dosed|0|||
145743151|NCT00597753|525575372|FG000|Overall Study|Noncompliance|2|||
145743152|NCT00597753|525575373|FG001|Overall Study|Noncompliance|1|||
145743153|NCT00597753|525575372|FG000|Overall Study|Relocation|17|||
145743154|NCT00597753|525575373|FG001|Overall Study|Relocation|6|||
145743155|NCT00597753|525575372|FG000|Overall Study|Renal transplant|10|||
145743156|NCT00597753|525575373|FG001|Overall Study|Renal transplant|3|||
145743157|NCT00597753|525575372|FG000|Overall Study|Site closed by sponsor|19|||
145743158|NCT00597753|525575373|FG001|Overall Study|Site closed by sponsor|7|||
145743159|NCT00597753|525575372|FG000|Overall Study|Site elected to close|2|||
145743160|NCT00597753|525575373|FG001|Overall Study|Site elected to close|4|||
145743161|NCT00388973|525577204|FG000|Overall Study|Adverse Event|16|||
145743162|NCT00388973|525577205|FG001|Overall Study|Adverse Event|6|||
145743163|NCT00388973|525577204|FG000|Overall Study|Lack of Efficacy|1|||
145743164|NCT00388973|525577205|FG001|Overall Study|Lack of Efficacy|12|||
145743165|NCT00388973|525577204|FG000|Overall Study|Protocol Violation|3|||
145743166|NCT00388973|525577205|FG001|Overall Study|Protocol Violation|0|||
145743167|NCT00388973|525577204|FG000|Overall Study|Withdrawal by Subject|14|||
145743168|NCT00388973|525577205|FG001|Overall Study|Withdrawal by Subject|17|||
145743169|NCT00388973|525577204|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
145743170|NCT00388973|525577205|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
145743171|NCT00388973|525577204|FG000|Overall Study|Did not complete 61 days of treatment|5|||
145743172|NCT00388973|525577205|FG001|Overall Study|Did not complete 61 days of treatment|4|||
145743173|NCT00388973|525577204|FG000|Overall Study|Left region|0|||
145743174|NCT00388973|525577205|FG001|Overall Study|Left region|1|||
145743175|NCT00388973|525577204|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
145743176|NCT00388973|525577205|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
145743177|NCT01652885|525577218|FG000|Overall Study|Adverse Event|1|||
145743178|NCT00075400|525577219|FG000|Overall Study|Ineligible: wrong primary|1|||
145743179|NCT00075400|525577219|FG000|Overall Study|Never treated|2|||
145743180|NCT03723707|525577221|FG000|Overall Study|Death|32|||
145743181|NCT03723707|525577222|FG001|Overall Study|Death|32|||
145743182|NCT03723707|525577221|FG000|Overall Study|Admitted to long term care|12|||
145743183|NCT03723707|525577222|FG001|Overall Study|Admitted to long term care|12|||
145743184|NCT03723707|525577221|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
145743185|NCT03723707|525577222|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
145743186|NCT03723707|525577221|FG000|Overall Study|Lost to Follow-up|40|||
145743187|NCT03723707|525577222|FG001|Overall Study|Lost to Follow-up|22|||
145743188|NCT03723707|525577221|FG000|Overall Study|Discontinued after study closure|24|||
145743189|NCT03723707|525577222|FG001|Overall Study|Discontinued after study closure|12|||
145743190|NCT04342871|525577223|FG000|Overall Study|Death|4|||
145743191|NCT04342871|525577223|FG000|Overall Study|Clinical deterioration/illness progression|2|||
145743192|NCT04342871|525577223|FG000|Overall Study|Did not complete baseline assessments|5|||
145743193|NCT04342871|525577223|FG000|Overall Study|Lost to Follow-up|13|||
145743194|NCT00666458|525577224|FG000|Overall Study|Adverse Event|8|||
145743195|NCT00666458|525577225|FG001|Overall Study|Adverse Event|7|||
145743196|NCT00666458|525577224|FG000|Overall Study|Withdrawal by Subject|5|||
145743197|NCT00666458|525577225|FG001|Overall Study|Withdrawal by Subject|4|||
145743198|NCT00666458|525577224|FG000|Overall Study|Lost to Follow-up|0|||
145743199|NCT00666458|525577225|FG001|Overall Study|Lost to Follow-up|3|||
145743200|NCT00666458|525577224|FG000|Overall Study|Administrative reason by sponsor|1|||
145743201|NCT00666458|525577225|FG001|Overall Study|Administrative reason by sponsor|1|||
145743202|NCT00666458|525577224|FG000|Overall Study|Incorrect enrollment|7|||
145743203|NCT00666458|525577225|FG001|Overall Study|Incorrect enrollment|1|||
145743204|NCT00666458|525577224|FG000|Overall Study|Study specific discontinuation criteria|14|||
145743205|NCT00666458|525577225|FG001|Overall Study|Study specific discontinuation criteria|7|||
145743206|NCT00666458|525577224|FG000|Overall Study|Severe non-compliance to the protocol|1|||
145743207|NCT00666458|525577225|FG001|Overall Study|Severe non-compliance to the protocol|1|||
145743208|NCT00666458|525577224|FG000|Overall Study|Safety reasons|1|||
145743209|NCT00666458|525577225|FG001|Overall Study|Safety reasons|0|||
145743210|NCT00666458|525577224|FG000|Overall Study|Medical history of anemia|1|||
145743211|NCT00666458|525577225|FG001|Overall Study|Medical history of anemia|0|||
145743212|NCT02222207|525577226|FG000|Overall Study|Death|1|||
145743213|NCT02222207|525577226|FG000|Overall Study|Other reasons|2|||
145743214|NCT02222207|525577226|FG000|Overall Study|Adverse Event|1|||
145743215|NCT04682405|525577228|FG000|Overall Study|Adverse Event|0|||
145743216|NCT04682405|525577229|FG001|Overall Study|Adverse Event|1|||
145743217|NCT01429584|525577230|FG000|Overall Study|Withdrawal by Subject|1|||
145743218|NCT01429584|525577231|FG001|Overall Study|Withdrawal by Subject|0|||
145743219|NCT01429584|525577230|FG000|Overall Study|Protocol Violation|0|||
145743220|NCT01429584|525577231|FG001|Overall Study|Protocol Violation|1|||
145743221|NCT00747643|525577235|FG000|Overall Study|Withdrawal by Subject|36|||
145743222|NCT00747643|525577236|FG001|Overall Study|Withdrawal by Subject|27|||
145743223|NCT00750698|525577237|FG000|Overall Study|Withdrawal by Subject|1|||
145743224|NCT00750698|525577238|FG001|Overall Study|Withdrawal by Subject|0|||
145743225|NCT00750698|525577237|FG000|Overall Study|Progressive disease|5|||
145743226|NCT00750698|525577238|FG001|Overall Study|Progressive disease|2|||
145743227|NCT03557281|525577239|FG000|Overall Study|Investigator discretion|0|||
145270061|NCT02118896|523837815|FG005|Overall Study|Death|1|||
145270062|NCT02118896|523837816|FG006|Overall Study|Death|0|||
145270063|NCT02118896|523837817|FG007|Overall Study|Death|0|||
145270064|NCT02118896|523837818|FG008|Overall Study|Death|0|||
145743228|NCT03557281|525577240|FG001|Overall Study|Investigator discretion|0|||
145743229|NCT03557281|525577241|FG002|Overall Study|Investigator discretion|1|||
145743230|NCT03557281|525577242|FG003|Overall Study|Investigator discretion|0|||
145743231|NCT03557281|525577243|FG004|Overall Study|Investigator discretion|0|||
145743232|NCT03557281|525577239|FG000|Overall Study|Withdrawal by Subject|0|||
145743233|NCT03557281|525577240|FG001|Overall Study|Withdrawal by Subject|1|||
145743234|NCT03557281|525577241|FG002|Overall Study|Withdrawal by Subject|1|||
145743235|NCT03557281|525577242|FG003|Overall Study|Withdrawal by Subject|1|||
145743236|NCT03557281|525577243|FG004|Overall Study|Withdrawal by Subject|2|||
145743237|NCT03557281|525577239|FG000|Overall Study|Randomized, but did not receive treatment|0|||
145743238|NCT03557281|525577240|FG001|Overall Study|Randomized, but did not receive treatment|0|||
145743239|NCT03557281|525577241|FG002|Overall Study|Randomized, but did not receive treatment|0|||
145743240|NCT03557281|525577242|FG003|Overall Study|Randomized, but did not receive treatment|0|||
145743241|NCT03557281|525577243|FG004|Overall Study|Randomized, but did not receive treatment|1|||
145270065|NCT02118896|523837819|FG009|Overall Study|Death|0|||
145270066|NCT02118896|523837810|FG000|Overall Study|Adverse Event|5|||
145270067|NCT02118896|523837811|FG001|Overall Study|Adverse Event|4|||
145743242|NCT00402649|525577244|FG000|Overall Study|Lost to Follow-up|1|||
145270068|NCT02118896|523837812|FG002|Overall Study|Adverse Event|4|||
145270069|NCT02118896|523837813|FG003|Overall Study|Adverse Event|5|||
145270070|NCT02118896|523837814|FG004|Overall Study|Adverse Event|5|||
145270071|NCT02118896|523837815|FG005|Overall Study|Adverse Event|9|||
145270072|NCT02118896|523837816|FG006|Overall Study|Adverse Event|1|||
145270073|NCT02118896|523837817|FG007|Overall Study|Adverse Event|1|||
145743243|NCT00402649|525577244|FG000|Overall Study|Withdrawal by Subject|1|||
145743244|NCT01199042|525577245|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
145743245|NCT01199042|525577245|FG000|At Home (3 Months)|Lost to Follow-up|1|||
145743246|NCT01999465|525577246|FG000|Overall Study|Lost to Follow-up|0|||
145743247|NCT01999465|525577247|FG001|Overall Study|Lost to Follow-up|2|||
145743248|NCT01999465|525577246|FG000|Overall Study|Protocol Violation|0|||
145743249|NCT01999465|525577247|FG001|Overall Study|Protocol Violation|1|||
145743250|NCT00390546|525577257|FG000|Overall Study|Renal impairment|1|||
145743251|NCT00390546|525577258|FG001|Overall Study|Renal impairment|0|||
145743252|NCT00390546|525577257|FG000|Overall Study|Physician Decision|5|||
145743253|NCT00390546|525577258|FG001|Overall Study|Physician Decision|5|||
145743254|NCT01308008|525577259|FG000|4 Weeks|Illness, disinterest, time|9|||
145743255|NCT01308008|525577260|FG001|4 Weeks|Illness, disinterest, time|2|||
145743256|NCT01417195|525577261|FG000|Overall Study|Stimulation failure|1|||
145743257|NCT01417195|525577262|FG001|Overall Study|Stimulation failure|0|||
145743258|NCT01417195|525577261|FG000|Overall Study|No embryos for transfer|0|||
145743259|NCT01417195|525577262|FG001|Overall Study|No embryos for transfer|1|||
145743260|NCT01417195|525577261|FG000|Overall Study|No transfer due to risk of OHSS|1|||
145743261|NCT01417195|525577262|FG001|Overall Study|No transfer due to risk of OHSS|0|||
145743262|NCT01417195|525577261|FG000|Overall Study|No transfer due to elevated progesterone|1|||
145743263|NCT01417195|525577262|FG001|Overall Study|No transfer due to elevated progesterone|0|||
145743264|NCT03357731|525577263|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
145743265|NCT03357731|525577264|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
145743266|NCT03357731|525577265|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
145743267|NCT03357731|525577266|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
145743268|NCT03357731|525577267|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
145743269|NCT03357731|525577268|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
145743270|NCT03357731|525577263|FG000|Overall Study|Acute bradycardia and hypotension|0|||
145743271|NCT03357731|525577264|FG001|Overall Study|Acute bradycardia and hypotension|0|||
145743272|NCT03357731|525577265|FG002|Overall Study|Acute bradycardia and hypotension|0|||
145743273|NCT03357731|525577266|FG003|Overall Study|Acute bradycardia and hypotension|1|||
145743274|NCT03357731|525577267|FG004|Overall Study|Acute bradycardia and hypotension|0|||
145743275|NCT03357731|525577268|FG005|Overall Study|Acute bradycardia and hypotension|0|||
145743276|NCT03357731|525577263|FG000|Overall Study|Adverse Event|0|||
145743277|NCT03357731|525577264|FG001|Overall Study|Adverse Event|0|||
145743278|NCT03357731|525577265|FG002|Overall Study|Adverse Event|0|||
145743279|NCT03357731|525577266|FG003|Overall Study|Adverse Event|0|||
145743280|NCT03357731|525577267|FG004|Overall Study|Adverse Event|0|||
145743281|NCT03357731|525577268|FG005|Overall Study|Adverse Event|1|||
145743282|NCT03357731|525577263|FG000|Overall Study|Hypotension|0|||
145743283|NCT03357731|525577264|FG001|Overall Study|Hypotension|0|||
145743284|NCT03357731|525577265|FG002|Overall Study|Hypotension|1|||
145743285|NCT03357731|525577266|FG003|Overall Study|Hypotension|1|||
145743286|NCT03357731|525577267|FG004|Overall Study|Hypotension|0|||
145743287|NCT03357731|525577268|FG005|Overall Study|Hypotension|0|||
145743288|NCT03357731|525577263|FG000|Overall Study|Lost to Follow-up|0|||
145743289|NCT03357731|525577264|FG001|Overall Study|Lost to Follow-up|0|||
145743290|NCT03357731|525577265|FG002|Overall Study|Lost to Follow-up|0|||
145743291|NCT03357731|525577266|FG003|Overall Study|Lost to Follow-up|1|||
145743292|NCT03357731|525577267|FG004|Overall Study|Lost to Follow-up|0|||
145270074|NCT02118896|523837818|FG008|Overall Study|Adverse Event|4|||
145270075|NCT02118896|523837819|FG009|Overall Study|Adverse Event|0|||
145270076|NCT02118896|523837810|FG000|Overall Study|Consent withdrawn|2|||
145270077|NCT02118896|523837811|FG001|Overall Study|Consent withdrawn|0|||
145270078|NCT02118896|523837812|FG002|Overall Study|Consent withdrawn|3|||
145270079|NCT02118896|523837813|FG003|Overall Study|Consent withdrawn|4|||
145270080|NCT02118896|523837814|FG004|Overall Study|Consent withdrawn|1|||
145270081|NCT02118896|523837815|FG005|Overall Study|Consent withdrawn|4|||
145270082|NCT02118896|523837816|FG006|Overall Study|Consent withdrawn|0|||
145270083|NCT02118896|523837817|FG007|Overall Study|Consent withdrawn|0|||
145270084|NCT02118896|523837818|FG008|Overall Study|Consent withdrawn|0|||
145743293|NCT03357731|525577268|FG005|Overall Study|Lost to Follow-up|0|||
145743294|NCT01773109|525577269|FG000|Overall Study|Symptomatic Progression|2|||
145743295|NCT01773109|525577269|FG000|Overall Study|Death|1|||
145743296|NCT01239342|525577270|FG000|Overall Study|Adverse Event|1|||
145743297|NCT01239342|525577271|FG001|Overall Study|Adverse Event|0|||
145743298|NCT01239342|525577270|FG000|Overall Study|Withdrawal by Subject|1|||
145743299|NCT01239342|525577271|FG001|Overall Study|Withdrawal by Subject|5|||
145743300|NCT01239342|525577270|FG000|Overall Study|Reason Unknown|1|||
145743301|NCT01239342|525577271|FG001|Overall Study|Reason Unknown|1|||
145743302|NCT02325219|525577274|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
145743303|NCT02325219|525577275|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
145743304|NCT02325219|525577276|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
145743305|NCT02325219|525577277|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
145270085|NCT02118896|523837819|FG009|Overall Study|Consent withdrawn|0|||
145270086|NCT02118896|523837810|FG000|Overall Study|Non-compliance|2|||
145743306|NCT02325219|525577278|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
145518623|NCT05395091|524758983|FG000|Baseline to Month 12|Physician Decision|1|||
145518624|NCT05395091|524758984|FG001|Baseline to Month 12|Physician Decision|0|||
145518625|NCT05395091|524758985|FG002|Baseline to Month 12|Physician Decision|0|||
145518626|NCT05395091|524758983|FG000|Month 12 to Month 18|Death|1|||
145518627|NCT05395091|524758984|FG001|Month 12 to Month 18|Death|0|||
145518628|NCT05395091|524758985|FG002|Month 12 to Month 18|Death|0|||
145518629|NCT05395091|524758983|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
145518630|NCT05395091|524758984|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
145518631|NCT05395091|524758985|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
145518632|NCT05395091|524758983|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
145518633|NCT05395091|524758984|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
145518634|NCT05395091|524758985|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
145518635|NCT05395091|524758983|FG000|Month 12 to Month 18|Other reasons|0|||
145518636|NCT05395091|524758984|FG001|Month 12 to Month 18|Other reasons|0|||
145518637|NCT05395091|524758985|FG002|Month 12 to Month 18|Other reasons|1|||
145518638|NCT01509053|524758987|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
145518639|NCT01509053|524758987|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
145518640|NCT01509053|524758987|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
145518641|NCT01509053|524758987|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
145518642|NCT01509053|524758987|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
145518643|NCT01509053|524758987|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
145518644|NCT01915303|524758990|FG000|Core Phase|Adverse Event|7|||
145518645|NCT01915303|524758990|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
145518646|NCT01915303|524758990|FG000|Core Phase|Death|2|||
145518647|NCT01915303|524758990|FG000|Core Phase|Protocol Violation|2|||
145518648|NCT01915303|524758990|FG000|Core Phase|Abnormal lab value|1|||
145518649|NCT01915303|524758990|FG000|Core Phase|Withdrawal by Subject|1|||
145518650|NCT01915303|524758990|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
145518651|NCT01915303|524758990|FG000|Extension Phase|Withdrawal by Subject|4|||
145518652|NCT01915303|524758990|FG000|Extension Phase|Adverse Event|3|||
145518653|NCT01915303|524758990|FG000|Extension Phase|Death|1|||
145518654|NCT01915303|524758990|FG000|Extension Phase|Protocol Violation|1|||
145518655|NCT00834080|524758992|FG000|Overall Study|Adverse Event|7|||
145518656|NCT00834080|524758992|FG000|Overall Study|Lost to Follow-up|7|||
145518657|NCT00834080|524758992|FG000|Overall Study|Withdrawal by Subject|5|||
145518658|NCT00834080|524758992|FG000|Overall Study|Other - Pregnancy|1|||
145518659|NCT00834080|524758992|FG000|Overall Study|Other - False positive tests of the UDS|1|||
145518660|NCT00834080|524758992|FG000|Overall Study|Physician Decision|1|||
145518661|NCT00834080|524758992|FG000|Overall Study|Subject Relocated|1|||
145518662|NCT00796523|524758996|FG000|Overall Study|Lost to Follow-up|9|||
145518663|NCT00796523|524758997|FG001|Overall Study|Lost to Follow-up|7|||
145518664|NCT00321646|524758998|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
145518665|NCT00321646|524758998|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
145518666|NCT00321646|524758998|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
145518667|NCT02694757|524759000|FG000|Overall Study|Lack of Efficacy|3|||
145518668|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
145518669|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
145518670|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
145518671|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
145518672|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
145518673|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
145518674|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
145518675|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
145518676|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
145518677|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
145518678|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
145518679|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
145518680|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
145518681|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
145518682|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
145518683|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
145518684|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
145518685|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
145518686|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
145518687|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
145518688|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
145518689|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
145518690|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
145518691|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
145518692|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
145518693|NCT00095147|524759001|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
145518694|NCT00095147|524759002|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
145743307|NCT02325219|525577274|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
145743308|NCT02325219|525577275|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
145743309|NCT02325219|525577276|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145743310|NCT02325219|525577277|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145743311|NCT02325219|525577278|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145743312|NCT02325219|525577274|FG000|Controlled Period (Week 0 - 16)|Other|0|||
145743313|NCT02325219|525577275|FG001|Controlled Period (Week 0 - 16)|Other|0|||
145743314|NCT02325219|525577276|FG002|Controlled Period (Week 0 - 16)|Other|1|||
145743315|NCT02325219|525577277|FG003|Controlled Period (Week 0 - 16)|Other|0|||
145743316|NCT02325219|525577278|FG004|Controlled Period (Week 0 - 16)|Other|0|||
145743317|NCT02325219|525577274|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
145743318|NCT02325219|525577275|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
145743319|NCT02325219|525577276|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
145743320|NCT02325219|525577277|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
145743321|NCT02325219|525577278|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
145743322|NCT02325219|525577274|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
145743323|NCT02325219|525577275|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
145743324|NCT02325219|525577276|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
145743325|NCT02325219|525577277|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
145743326|NCT02325219|525577278|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
145743327|NCT02325219|525577274|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145743328|NCT02325219|525577275|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
145743329|NCT02325219|525577276|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145743330|NCT02325219|525577277|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145743331|NCT02325219|525577278|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145743332|NCT04036708|525577279|FG000|Overall Study|Lost to Follow-up|14|||
145743333|NCT04036708|525577280|FG001|Overall Study|Lost to Follow-up|4|||
145743334|NCT04036708|525577281|FG002|Overall Study|Lost to Follow-up|14|||
145743335|NCT04036708|525577282|FG003|Overall Study|Lost to Follow-up|4|||
145743336|NCT02918864|525577283|FG000|Overall Study|Withdrawal by Subject|1|||
145743337|NCT02918864|525577284|FG001|Overall Study|Withdrawal by Subject|1|||
145743338|NCT02918864|525577283|FG000|Overall Study|Lost to Follow-up|3|||
145743339|NCT02918864|525577284|FG001|Overall Study|Lost to Follow-up|2|||
145743340|NCT04766021|525577285|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
145743341|NCT04766021|525577285|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
145743342|NCT02257372|525577292|FG000|Overall Study|Adverse Event|3|||
145743343|NCT02257372|525577293|FG001|Overall Study|Adverse Event|7|||
145743344|NCT02257372|525577292|FG000|Overall Study|Lack of Efficacy|2|||
145743345|NCT02257372|525577293|FG001|Overall Study|Lack of Efficacy|1|||
145743346|NCT02257372|525577292|FG000|Overall Study|Protocol Violation|1|||
145743347|NCT02257372|525577293|FG001|Overall Study|Protocol Violation|1|||
145743348|NCT02257372|525577292|FG000|Overall Study|Lost to Follow-up|0|||
145743349|NCT02257372|525577293|FG001|Overall Study|Lost to Follow-up|1|||
145743350|NCT02257372|525577292|FG000|Overall Study|Withdrew consent|1|||
145743351|NCT02257372|525577293|FG001|Overall Study|Withdrew consent|0|||
145743352|NCT01849874|525577295|FG000|Overall Study|Death|89|||
145743353|NCT01849874|525577296|FG001|Overall Study|Death|42|||
145743354|NCT01849874|525577295|FG000|Overall Study|Withdrawal by Subject|17|||
145743355|NCT01849874|525577296|FG001|Overall Study|Withdrawal by Subject|16|||
145743356|NCT01849874|525577295|FG000|Overall Study|Lost to Follow-up|3|||
145743357|NCT01849874|525577296|FG001|Overall Study|Lost to Follow-up|2|||
145743358|NCT01849874|525577295|FG000|Overall Study|Study Termination By Sponsor|93|||
145743359|NCT01849874|525577296|FG001|Overall Study|Study Termination By Sponsor|48|||
145743360|NCT01849874|525577295|FG000|Overall Study|Completed as per protocol amendment 6|3|||
145743361|NCT01849874|525577296|FG001|Overall Study|Completed as per protocol amendment 6|0|||
145743362|NCT01849874|525577295|FG000|Overall Study|Physician Decision|7|||
145743363|NCT01849874|525577296|FG001|Overall Study|Physician Decision|1|||
145743364|NCT01849874|525577295|FG000|Overall Study|Other|16|||
145743365|NCT01849874|525577296|FG001|Overall Study|Other|4|||
145743366|NCT02104583|525577297|FG000|Overall Study|New ICD or CRT-D implanted|2|||
145743367|NCT02104583|525577298|FG001|Overall Study|New ICD or CRT-D implanted|0|||
145743368|NCT02104583|525577299|FG002|Overall Study|New ICD or CRT-D implanted|1|||
145743369|NCT02104583|525577300|FG003|Overall Study|New ICD or CRT-D implanted|0|||
145743370|NCT02104583|525577301|FG004|Overall Study|New ICD or CRT-D implanted|0|||
145743371|NCT02104583|525577297|FG000|Overall Study|Death|2|||
145743372|NCT02104583|525577298|FG001|Overall Study|Death|1|||
145743373|NCT02104583|525577299|FG002|Overall Study|Death|3|||
145743374|NCT02104583|525577300|FG003|Overall Study|Death|3|||
145743375|NCT02104583|525577301|FG004|Overall Study|Death|5|||
145743376|NCT02104583|525577297|FG000|Overall Study|Subject required cardiac ablation|6|||
145743377|NCT02104583|525577298|FG001|Overall Study|Subject required cardiac ablation|4|||
145743378|NCT02104583|525577299|FG002|Overall Study|Subject required cardiac ablation|4|||
145743379|NCT02104583|525577300|FG003|Overall Study|Subject required cardiac ablation|5|||
145743380|NCT02104583|525577301|FG004|Overall Study|Subject required cardiac ablation|4|||
145743381|NCT02104583|525577297|FG000|Overall Study|Subject required prohibited medication|0|||
145743382|NCT02104583|525577298|FG001|Overall Study|Subject required prohibited medication|1|||
145743383|NCT02104583|525577299|FG002|Overall Study|Subject required prohibited medication|1|||
145743384|NCT02104583|525577300|FG003|Overall Study|Subject required prohibited medication|0|||
145743385|NCT02104583|525577301|FG004|Overall Study|Subject required prohibited medication|1|||
145743386|NCT02104583|525577297|FG000|Overall Study|Withdrew Consent|3|||
145743387|NCT02104583|525577298|FG001|Overall Study|Withdrew Consent|2|||
145743388|NCT02104583|525577299|FG002|Overall Study|Withdrew Consent|0|||
145743389|NCT02104583|525577300|FG003|Overall Study|Withdrew Consent|2|||
145743390|NCT02104583|525577301|FG004|Overall Study|Withdrew Consent|1|||
145743391|NCT02104583|525577297|FG000|Overall Study|Investigator's Discretion|1|||
145743392|NCT02104583|525577298|FG001|Overall Study|Investigator's Discretion|0|||
145743393|NCT02104583|525577299|FG002|Overall Study|Investigator's Discretion|0|||
145743394|NCT02104583|525577300|FG003|Overall Study|Investigator's Discretion|0|||
145743395|NCT02104583|525577301|FG004|Overall Study|Investigator's Discretion|0|||
145743396|NCT02104583|525577297|FG000|Overall Study|Protocol Violation|0|||
145743397|NCT02104583|525577298|FG001|Overall Study|Protocol Violation|0|||
145743398|NCT02104583|525577299|FG002|Overall Study|Protocol Violation|1|||
145743399|NCT02104583|525577300|FG003|Overall Study|Protocol Violation|0|||
145743400|NCT02104583|525577301|FG004|Overall Study|Protocol Violation|0|||
145743401|NCT02104583|525577297|FG000|Overall Study|Adverse Event|3|||
145743402|NCT02104583|525577298|FG001|Overall Study|Adverse Event|3|||
145743403|NCT02104583|525577299|FG002|Overall Study|Adverse Event|6|||
145743404|NCT02104583|525577300|FG003|Overall Study|Adverse Event|6|||
145743405|NCT02104583|525577301|FG004|Overall Study|Adverse Event|1|||
145743406|NCT02104583|525577297|FG000|Overall Study|Lost to Follow-up|1|||
145743407|NCT02104583|525577298|FG001|Overall Study|Lost to Follow-up|0|||
145743408|NCT02104583|525577299|FG002|Overall Study|Lost to Follow-up|0|||
145743409|NCT02104583|525577300|FG003|Overall Study|Lost to Follow-up|0|||
145743410|NCT02104583|525577301|FG004|Overall Study|Lost to Follow-up|0|||
145743411|NCT02104583|525577297|FG000|Overall Study|Randomized but Never Treated|0|||
145743412|NCT02104583|525577298|FG001|Overall Study|Randomized but Never Treated|0|||
145743413|NCT02104583|525577299|FG002|Overall Study|Randomized but Never Treated|0|||
145743414|NCT02104583|525577300|FG003|Overall Study|Randomized but Never Treated|1|||
145743415|NCT02104583|525577301|FG004|Overall Study|Randomized but Never Treated|0|||
145743416|NCT04640272|525577303|FG000|Overall Study|Subject moved out of area|1|||
145743417|NCT04329702|525577311|FG000|Overall Study|illness|3|||
145743418|NCT04329702|525577312|FG001|Overall Study|illness|4|||
145743419|NCT04329702|525577313|FG002|Overall Study|illness|0|||
145743420|NCT04329702|525577311|FG000|Overall Study|Lost to Follow-up|0|||
145743421|NCT04329702|525577312|FG001|Overall Study|Lost to Follow-up|0|||
145743422|NCT04329702|525577313|FG002|Overall Study|Lost to Follow-up|2|||
145743423|NCT04329702|525577311|FG000|Overall Study|Death|0|||
145743424|NCT04329702|525577312|FG001|Overall Study|Death|2|||
145743425|NCT04329702|525577313|FG002|Overall Study|Death|0|||
145743426|NCT00766532|525577314|FG000|Overall Study|Protocol Violation|2|||
145743427|NCT01438489|525577315|FG000|Overall Study|Lost to Follow-up|4|||
145518695|NCT00095147|524759003|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
145518696|NCT00095147|524759004|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
145518697|NCT00095147|524759005|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
145402349|NCT03736967|524330716|FG001|Overall Study|Withdrawal by Subject|25|||
145518698|NCT00095147|524759001|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
145518699|NCT00095147|524759002|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
145743428|NCT01438489|525577316|FG001|Overall Study|Lost to Follow-up|2|||
145743429|NCT01438489|525577317|FG002|Overall Study|Lost to Follow-up|2|||
145743430|NCT01438489|525577315|FG000|Overall Study|Withdrawal by Subject|11|||
145743431|NCT01438489|525577316|FG001|Overall Study|Withdrawal by Subject|3|||
145743432|NCT01438489|525577317|FG002|Overall Study|Withdrawal by Subject|8|||
145743433|NCT01438489|525577315|FG000|Overall Study|Death|0|||
145743434|NCT01438489|525577316|FG001|Overall Study|Death|0|||
145743435|NCT01438489|525577317|FG002|Overall Study|Death|1|||
145743436|NCT01438489|525577315|FG000|Overall Study|Sponsor decision|4|||
145743437|NCT01438489|525577316|FG001|Overall Study|Sponsor decision|1|||
145402350|NCT03736967|524330717|FG002|Overall Study|Withdrawal by Subject|23|||
145743438|NCT01438489|525577317|FG002|Overall Study|Sponsor decision|4|||
145743439|NCT01438489|525577315|FG000|Overall Study|Subject choice/Subject moved|2|||
145743440|NCT01438489|525577316|FG001|Overall Study|Subject choice/Subject moved|1|||
145743441|NCT01438489|525577317|FG002|Overall Study|Subject choice/Subject moved|1|||
145743442|NCT01438489|525577315|FG000|Overall Study|Investigator decision|0|||
145743443|NCT01438489|525577316|FG001|Overall Study|Investigator decision|1|||
145743444|NCT01438489|525577317|FG002|Overall Study|Investigator decision|0|||
145743445|NCT01438489|525577315|FG000|Overall Study|AE/SAEs|2|||
145743446|NCT01438489|525577316|FG001|Overall Study|AE/SAEs|1|||
145743447|NCT01438489|525577317|FG002|Overall Study|AE/SAEs|1|||
145743448|NCT01438489|525577315|FG000|Overall Study|Received prohibited medication|1|||
145743449|NCT01438489|525577316|FG001|Overall Study|Received prohibited medication|0|||
145743450|NCT01438489|525577317|FG002|Overall Study|Received prohibited medication|0|||
145743451|NCT01438489|525577315|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
145743452|NCT01438489|525577316|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
145743453|NCT01438489|525577317|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
145743454|NCT01438489|525577315|FG000|Overall Study|Inadequate venous access|0|||
145743455|NCT01438489|525577316|FG001|Overall Study|Inadequate venous access|2|||
145743456|NCT01438489|525577317|FG002|Overall Study|Inadequate venous access|0|||
145743457|NCT01476475|525577319|FG000|Overall Study|Adverse Event|6|||
145743458|NCT01476475|525577320|FG001|Overall Study|Adverse Event|0|||
145743459|NCT01476475|525577319|FG000|Overall Study|Poor compliance to protocol|1|||
145743460|NCT01476475|525577320|FG001|Overall Study|Poor compliance to protocol|1|||
145743461|NCT01476475|525577319|FG000|Overall Study|Other reasons|4|||
145743462|NCT01476475|525577320|FG001|Overall Study|Other reasons|2|||
145743463|NCT03370120|525577321|FG000|Overall Study|Adverse event, non-fatal|24|||
145743464|NCT03370120|525577321|FG000|Overall Study|Withdrawal by Subject|6|||
145743465|NCT03370120|525577321|FG000|Overall Study|Lost to Follow-up|1|||
145743466|NCT03370120|525577321|FG000|Overall Study|Lack of Efficacy|37|||
145743467|NCT03370120|525577321|FG000|Overall Study|Per sponsor's instructions|1|||
145743468|NCT03370120|525577321|FG000|Overall Study|Study was terminated by parent company UCB|2|||
145743469|NCT03370120|525577321|FG000|Overall Study|The study was ended by the promoter|3|||
145743470|NCT03370120|525577321|FG000|Overall Study|Discontinuation of drug development|3|||
145743471|NCT03370120|525577321|FG000|Overall Study|End of project|2|||
145743472|NCT03370120|525577321|FG000|Overall Study|Premature study closure|2|||
145743473|NCT03370120|525577321|FG000|Overall Study|Premature program termination|1|||
145743474|NCT03370120|525577321|FG000|Overall Study|Premature study termination|7|||
145743475|NCT03370120|525577321|FG000|Overall Study|Trial terminated by sponsor|2|||
145743476|NCT03370120|525577321|FG000|Overall Study|Trial discontinued by sponsor|2|||
145743477|NCT03370120|525577321|FG000|Overall Study|Study ended|15|||
145743478|NCT03370120|525577321|FG000|Overall Study|Clinical trial has been cancelled|1|||
145743479|NCT03370120|525577321|FG000|Overall Study|End of study per sponsor decision|2|||
145743480|NCT03370120|525577321|FG000|Overall Study|Promoter's decision|2|||
145743481|NCT03370120|525577321|FG000|Overall Study|The trial has been suspended|3|||
145743482|NCT03370120|525577321|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
145743483|NCT03370120|525577321|FG000|Overall Study|Early termination by order of sponsor|2|||
145743484|NCT03370120|525577321|FG000|Overall Study|Discontinuation of the study|5|||
145743485|NCT03370120|525577321|FG000|Overall Study|End of clinical trial discontinuation|1|||
145743486|NCT03370120|525577321|FG000|Overall Study|Because the clinical trial ended halfway|4|||
145743487|NCT03370120|525577321|FG000|Overall Study|Development discontinued|5|||
145743488|NCT03370120|525577321|FG000|Overall Study|Padsenovil program closed|3|||
145743489|NCT03370120|525577321|FG000|Overall Study|End of project|2|||
145743490|NCT03370120|525577321|FG000|Overall Study|Termination of project|1|||
145743491|NCT03370120|525577321|FG000|Overall Study|The study was interrupted by sponsor|4|||
145743492|NCT03370120|525577321|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
145743493|NCT03370120|525577321|FG000|Overall Study|End of sponsor decision|1|||
145743494|NCT03370120|525577321|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
145743495|NCT03370120|525577321|FG000|Overall Study|Early termination of studies|5|||
145518700|NCT00095147|524759003|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
145518701|NCT00095147|524759004|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
145743496|NCT03370120|525577321|FG000|Overall Study|This study is ended early|1|||
145743497|NCT03370120|525577321|FG000|Overall Study|End of padsevonil program|2|||
145743498|NCT03370120|525577321|FG000|Overall Study|Decision of sponsor|6|||
145518702|NCT00095147|524759005|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
145743499|NCT03370120|525577321|FG000|Overall Study|Asked by the sponsor|3|||
145743500|NCT03370120|525577321|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
145743501|NCT03370120|525577321|FG000|Overall Study|PI decision poor compliance from participant|1|||
145743502|NCT03370120|525577321|FG000|Overall Study|Promoter ended the study|3|||
145518703|NCT00095147|524759001|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
145518704|NCT00095147|524759002|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
145518705|NCT00095147|524759003|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
145518706|NCT00095147|524759004|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
145518707|NCT00095147|524759005|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
145518708|NCT00095147|524759001|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
145518709|NCT00095147|524759002|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
145518710|NCT00095147|524759003|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
145518711|NCT00095147|524759004|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
145518712|NCT00095147|524759005|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
145518713|NCT00095147|524759001|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
145518714|NCT00095147|524759002|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
145518715|NCT00095147|524759003|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
145518716|NCT00095147|524759004|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
145518717|NCT00095147|524759005|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
145743503|NCT03370120|525577321|FG000|Overall Study|Premature study close by sponsor's decision|4|||
145518718|NCT00095147|524759001|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
145518719|NCT00095147|524759002|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
145518720|NCT00095147|524759003|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
145518721|NCT00095147|524759004|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
145518722|NCT00095147|524759005|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
145518723|NCT00095147|524759001|FG000|Long-term Extension Period|Death|0|||
145518724|NCT00095147|524759002|FG001|Long-term Extension Period|Death|0|||
145518725|NCT00095147|524759003|FG002|Long-term Extension Period|Death|0|||
145518726|NCT00095147|524759004|FG003|Long-term Extension Period|Death|0|||
145518727|NCT00095147|524759005|FG004|Long-term Extension Period|Death|3|||
145518728|NCT00095147|524759001|FG000|Long-term Extension Period|Adverse Event|0|||
145518729|NCT00095147|524759002|FG001|Long-term Extension Period|Adverse Event|0|||
145518730|NCT00095147|524759003|FG002|Long-term Extension Period|Adverse Event|0|||
145518731|NCT00095147|524759004|FG003|Long-term Extension Period|Adverse Event|0|||
145518732|NCT00095147|524759005|FG004|Long-term Extension Period|Adverse Event|11|||
145518733|NCT00095147|524759001|FG000|Long-term Extension Period|Lack of Efficacy|0|||
145518734|NCT00095147|524759002|FG001|Long-term Extension Period|Lack of Efficacy|0|||
145518735|NCT00095147|524759003|FG002|Long-term Extension Period|Lack of Efficacy|0|||
145518736|NCT00095147|524759004|FG003|Long-term Extension Period|Lack of Efficacy|0|||
145518737|NCT00095147|524759005|FG004|Long-term Extension Period|Lack of Efficacy|9|||
145518738|NCT00095147|524759001|FG000|Long-term Extension Period|Lost to Follow-up|0|||
145518739|NCT00095147|524759002|FG001|Long-term Extension Period|Lost to Follow-up|0|||
145518740|NCT00095147|524759003|FG002|Long-term Extension Period|Lost to Follow-up|0|||
145518741|NCT00095147|524759004|FG003|Long-term Extension Period|Lost to Follow-up|0|||
145518742|NCT00095147|524759005|FG004|Long-term Extension Period|Lost to Follow-up|6|||
145518743|NCT00095147|524759001|FG000|Long-term Extension Period|Withdrawal of consent|0|||
145518744|NCT00095147|524759002|FG001|Long-term Extension Period|Withdrawal of consent|0|||
145518745|NCT00095147|524759003|FG002|Long-term Extension Period|Withdrawal of consent|0|||
145518746|NCT00095147|524759004|FG003|Long-term Extension Period|Withdrawal of consent|0|||
145518747|NCT00095147|524759005|FG004|Long-term Extension Period|Withdrawal of consent|12|||
145518748|NCT00095147|524759001|FG000|Long-term Extension Period|Pregnancy|0|||
145518749|NCT00095147|524759002|FG001|Long-term Extension Period|Pregnancy|0|||
145518750|NCT00095147|524759003|FG002|Long-term Extension Period|Pregnancy|0|||
145518751|NCT00095147|524759004|FG003|Long-term Extension Period|Pregnancy|0|||
145518752|NCT00095147|524759005|FG004|Long-term Extension Period|Pregnancy|1|||
145518753|NCT00095147|524759001|FG000|Long-term Extension Period|No longer meets study criteria|0|||
145518754|NCT00095147|524759002|FG001|Long-term Extension Period|No longer meets study criteria|0|||
145518755|NCT00095147|524759003|FG002|Long-term Extension Period|No longer meets study criteria|0|||
145518756|NCT00095147|524759004|FG003|Long-term Extension Period|No longer meets study criteria|0|||
145743504|NCT03370120|525577321|FG000|Overall Study|Study terminated by sponsor|33|||
145743505|NCT03370120|525577321|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
145518757|NCT00095147|524759005|FG004|Long-term Extension Period|No longer meets study criteria|1|||
145518758|NCT00095147|524759001|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
145518759|NCT00095147|524759002|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
145518760|NCT00095147|524759003|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
145518761|NCT00095147|524759004|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
145518762|NCT00095147|524759005|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
145518763|NCT00095147|524759001|FG000|Long-term Extension Period|Leaving country|0|||
145518764|NCT00095147|524759002|FG001|Long-term Extension Period|Leaving country|0|||
145518765|NCT00095147|524759003|FG002|Long-term Extension Period|Leaving country|0|||
145518766|NCT00095147|524759004|FG003|Long-term Extension Period|Leaving country|0|||
145518767|NCT00095147|524759005|FG004|Long-term Extension Period|Leaving country|1|||
145518768|NCT02650921|524759006|FG000|Overall Study|Withdrawal by Subject|4|||
145518769|NCT02650921|524759006|FG000|Overall Study|Lost to Follow-up|2|||
145518770|NCT02650921|524759006|FG000|Overall Study|Adverse Event|1|||
145518771|NCT02650921|524759006|FG000|Overall Study|Due to Medical Condition|1|||
145518772|NCT02395302|524759007|FG000|Overall Study|Screen Failure|3|||
145518773|NCT02395302|524759007|FG000|Overall Study|Run In Failure|7|||
145518774|NCT02395302|524759007|FG000|Overall Study|Withdrawal by Subject|2|||
145518775|NCT02395302|524759007|FG000|Overall Study|Physician Decision|2|||
145518776|NCT00783302|524759008|FG000|Overall Study|Lost to Follow-up|17|||
145518777|NCT00783302|524759008|FG000|Overall Study|Technical Problems|11|||
145518778|NCT00783302|524759008|FG000|Overall Study|Protocol Violation|3|||
145518779|NCT00783302|524759008|FG000|Overall Study|Physician Decision|1|||
145518780|NCT00783302|524759008|FG000|Overall Study|Withdrawal by Subject|3|||
145518781|NCT00160667|524759009|FG000|Overall Study|Adverse Event|3|||
145518782|NCT00160667|524759010|FG001|Overall Study|Adverse Event|1|||
145518783|NCT00160667|524759011|FG002|Overall Study|Adverse Event|4|||
145518784|NCT00160667|524759009|FG000|Overall Study|Withdrawal by Subject|2|||
145518785|NCT00160667|524759010|FG001|Overall Study|Withdrawal by Subject|0|||
145518786|NCT00160667|524759011|FG002|Overall Study|Withdrawal by Subject|1|||
145518787|NCT00160667|524759009|FG000|Overall Study|Lack of Efficacy|0|||
145518788|NCT00160667|524759010|FG001|Overall Study|Lack of Efficacy|1|||
145518789|NCT00160667|524759011|FG002|Overall Study|Lack of Efficacy|0|||
145518790|NCT00160667|524759009|FG000|Overall Study|Protocol Violation|0|||
145518791|NCT00160667|524759010|FG001|Overall Study|Protocol Violation|1|||
145518792|NCT00160667|524759011|FG002|Overall Study|Protocol Violation|0|||
145518793|NCT00160667|524759009|FG000|Overall Study|Patient decision|0|||
145518794|NCT00160667|524759010|FG001|Overall Study|Patient decision|0|||
145518795|NCT00160667|524759011|FG002|Overall Study|Patient decision|1|||
145518796|NCT01917656|524759015|FG000|Overall Study|Adverse Event|11|||
145518797|NCT01917656|524759016|FG001|Overall Study|Adverse Event|0|||
145518798|NCT01917656|524759015|FG000|Overall Study|Withdrawal criteria|8|||
145518799|NCT01917656|524759016|FG001|Overall Study|Withdrawal criteria|14|||
145518800|NCT01917656|524759015|FG000|Overall Study|Unclassified|0|||
145518801|NCT01917656|524759016|FG001|Overall Study|Unclassified|3|||
145518802|NCT01917656|524759015|FG000|Overall Study|Withdrawal by Subject|4|||
145518803|NCT01917656|524759016|FG001|Overall Study|Withdrawal by Subject|3|||
145518804|NCT01917656|524759015|FG000|Overall Study|Lost to Follow-up|3|||
145518805|NCT01917656|524759016|FG001|Overall Study|Lost to Follow-up|4|||
145518806|NCT02285062|524759017|FG000|Pre-Treatment Period|Protocol Violation|0|||
145518807|NCT02285062|524759018|FG001|Pre-Treatment Period|Protocol Violation|2|||
145518808|NCT02285062|524759017|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
145518809|NCT02285062|524759018|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145518810|NCT02015221|524759019|FG000|Overall Study|Withdrawal by Subject|8|||
145518811|NCT02015221|524759020|FG001|Overall Study|Withdrawal by Subject|6|||
145518812|NCT02015221|524759019|FG000|Overall Study|Lost to Follow-up|1|||
145518813|NCT02015221|524759020|FG001|Overall Study|Lost to Follow-up|0|||
145518814|NCT01306929|524759021|FG000|Overall Study|Withdrawal by Subject|23|||
145518815|NCT01306929|524759021|FG000|Overall Study|Adverse Event|21|||
145518816|NCT01306929|524759021|FG000|Overall Study|Physician Decision|13|||
145518817|NCT01306929|524759021|FG000|Overall Study|Death|8|||
145518818|NCT01306929|524759021|FG000|Overall Study|Withdrawal by parent/guardian|5|||
145518819|NCT01306929|524759021|FG000|Overall Study|Protocol Violation|3|||
145518820|NCT01306929|524759021|FG000|Overall Study|Non-compliance with study drug|2|||
145518821|NCT01306929|524759021|FG000|Overall Study|Lost to Follow-up|2|||
145518822|NCT01306929|524759021|FG000|Overall Study|Various|17|||
145518823|NCT03709576|524759027|FG000|Overall Study|progression prior to enrollment|1|||
145518824|NCT03041129|524759031|FG000|Overall Study|Withdrawal by Subject|2|||
145518825|NCT03041129|524759032|FG001|Overall Study|Withdrawal by Subject|0|||
145518826|NCT03041129|524759033|FG002|Overall Study|Withdrawal by Subject|0|||
145518827|NCT03041129|524759034|FG003|Overall Study|Withdrawal by Subject|0|||
145518828|NCT00510653|524759037|FG000|Overall Study|Withdrawal by Subject|8|||
145518829|NCT00510653|524759037|FG000|Overall Study|Monetary|3|||
145518830|NCT00890045|524759038|FG000|Overall Study|Death|0|||
145518831|NCT00890045|524759039|FG001|Overall Study|Death|1|||
145518832|NCT00890045|524759038|FG000|Overall Study|Did not receive HeRO Graft|0|||
145518833|NCT00890045|524759039|FG001|Overall Study|Did not receive HeRO Graft|2|||
145518834|NCT00890045|524759038|FG000|Overall Study|Lost to Follow-up|5|||
145518835|NCT00890045|524759039|FG001|Overall Study|Lost to Follow-up|7|||
145518836|NCT00436501|524759042|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
145518837|NCT00436501|524759043|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
145518838|NCT00436501|524759042|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
145518839|NCT00436501|524759043|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
145518840|NCT00495040|524759044|FG000|Overall Study|Withdrawal by Subject|3|||
145518841|NCT00621621|524759047|FG000|Overall Study|Subjects were exited at EP study|30|||
145518842|NCT00621621|524759048|FG001|Overall Study|Subjects were exited at EP study|0|||
145518843|NCT00906971|524759052|FG000|Overall Study|Withdrawal by Subject|8|||
145518844|NCT00906971|524759053|FG001|Overall Study|Withdrawal by Subject|2|||
145518845|NCT00906971|524759052|FG000|Overall Study|Lost to Follow-up|0|||
145518846|NCT00906971|524759053|FG001|Overall Study|Lost to Follow-up|1|||
145518847|NCT00545129|524759054|FG000|Overall Study|Lack of Efficacy|2|||
145518848|NCT00545129|524759055|FG001|Overall Study|Lack of Efficacy|5|||
145518849|NCT00545129|524759054|FG000|Overall Study|Death|2|||
145518850|NCT00545129|524759055|FG001|Overall Study|Death|1|||
145518851|NCT00545129|524759054|FG000|Overall Study|Adverse Event|1|||
145518852|NCT00545129|524759055|FG001|Overall Study|Adverse Event|1|||
145518853|NCT00545129|524759054|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
145518854|NCT00545129|524759055|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
145518855|NCT00545129|524759054|FG000|Overall Study|Other|3|||
145518856|NCT00545129|524759055|FG001|Overall Study|Other|3|||
145518857|NCT00821509|524759056|FG000|Overall Study|Withdrawal by Subject|12|||
145518858|NCT00821509|524759057|FG001|Overall Study|Withdrawal by Subject|11|||
145518859|NCT00821509|524759058|FG002|Overall Study|Withdrawal by Subject|34|||
145518860|NCT01894568|524759059|FG000|Overall Study|Adverse Event|2|||
145518861|NCT01894568|524759060|FG001|Overall Study|Adverse Event|3|||
145518862|NCT01894568|524759059|FG000|Overall Study|Protocol required discontinuation|2|||
145518863|NCT01894568|524759060|FG001|Overall Study|Protocol required discontinuation|1|||
145518864|NCT01894568|524759059|FG000|Overall Study|Withdrawal by Subject|5|||
145518865|NCT01894568|524759060|FG001|Overall Study|Withdrawal by Subject|5|||
145518866|NCT01894568|524759059|FG000|Overall Study|Physician Decision|1|||
145518867|NCT01894568|524759060|FG001|Overall Study|Physician Decision|0|||
145518868|NCT01894568|524759059|FG000|Overall Study|Lost to Follow-up|0|||
145518869|NCT01894568|524759060|FG001|Overall Study|Lost to Follow-up|1|||
145518870|NCT01551420|524759061|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
145518871|NCT01551420|524759062|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
145518872|NCT01551420|524759061|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
145518873|NCT01551420|524759062|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
145518874|NCT01551420|524759061|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
145518875|NCT01551420|524759062|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
145518876|NCT01551420|524759061|FG000|Screened for Part B Eligibility|Declined participation|8|||
145518877|NCT01551420|524759062|FG001|Screened for Part B Eligibility|Declined participation|1|||
145518878|NCT01551420|524759061|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
145518879|NCT01551420|524759062|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
145518880|NCT01551420|524759061|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
145518881|NCT01551420|524759062|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
145518882|NCT01551420|524759061|FG000|Home Use (Part B)|Withdrawal by staff|0|||
145518883|NCT01551420|524759062|FG001|Home Use (Part B)|Withdrawal by staff|1|||
145518884|NCT00169442|524759063|FG000|Overall Study|Withdrawal by Subject|0|||
145518885|NCT00169442|524759064|FG001|Overall Study|Withdrawal by Subject|0|||
145518886|NCT00169442|524759065|FG002|Overall Study|Withdrawal by Subject|1|||
145518887|NCT00169442|524759066|FG003|Overall Study|Withdrawal by Subject|0|||
145518888|NCT00169442|524759067|FG004|Overall Study|Withdrawal by Subject|0|||
145518889|NCT00169442|524759068|FG005|Overall Study|Withdrawal by Subject|0|||
145518890|NCT00169442|524759063|FG000|Overall Study|Migrated/moved from study area|0|||
145518891|NCT00169442|524759064|FG001|Overall Study|Migrated/moved from study area|0|||
145518892|NCT00169442|524759065|FG002|Overall Study|Migrated/moved from study area|0|||
145743506|NCT03370120|525577321|FG000|Overall Study|Sponsor decision to terminate study|63|||
145743507|NCT03370120|525577321|FG000|Overall Study|Program closure|3|||
145743508|NCT03370120|525577321|FG000|Overall Study|Study ended prematurely|1|||
145518893|NCT00169442|524759066|FG003|Overall Study|Migrated/moved from study area|0|||
145518894|NCT00169442|524759067|FG004|Overall Study|Migrated/moved from study area|0|||
145518895|NCT00169442|524759068|FG005|Overall Study|Migrated/moved from study area|2|||
145518896|NCT00169442|524759063|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145518897|NCT00169442|524759064|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145518898|NCT00169442|524759065|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145518899|NCT00169442|524759066|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145518900|NCT00169442|524759067|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
145518901|NCT00169442|524759068|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
145518902|NCT00169442|524759063|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
145518903|NCT00169442|524759064|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
145518904|NCT00169442|524759065|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
145518905|NCT00169442|524759066|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
145518906|NCT00169442|524759067|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
145518907|NCT00169442|524759068|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
145518908|NCT01426789|524759069|FG000|Part 1|Protocol deviation|0|||
145518909|NCT01426789|524759070|FG001|Part 1|Protocol deviation|1|||
145518910|NCT01426789|524759071|FG002|Part 1|Protocol deviation|0|||
145518911|NCT01426789|524759072|FG003|Part 1|Protocol deviation|0|||
145518912|NCT01426789|524759073|FG004|Part 1|Protocol deviation|0|||
145518913|NCT01426789|524759074|FG005|Part 1|Protocol deviation|0|||
145518914|NCT01426789|524759069|FG000|Part 1|Lost to Follow-up|1|||
145518915|NCT01426789|524759070|FG001|Part 1|Lost to Follow-up|2|||
145518916|NCT01426789|524759071|FG002|Part 1|Lost to Follow-up|0|||
145518917|NCT01426789|524759072|FG003|Part 1|Lost to Follow-up|0|||
145518918|NCT01426789|524759073|FG004|Part 1|Lost to Follow-up|0|||
145518919|NCT01426789|524759074|FG005|Part 1|Lost to Follow-up|0|||
145518920|NCT01426789|524759069|FG000|Part 1|Lack of Efficacy|2|||
145518921|NCT01426789|524759070|FG001|Part 1|Lack of Efficacy|1|||
145518922|NCT01426789|524759071|FG002|Part 1|Lack of Efficacy|0|||
145518923|NCT01426789|524759072|FG003|Part 1|Lack of Efficacy|0|||
145518924|NCT01426789|524759073|FG004|Part 1|Lack of Efficacy|0|||
145518925|NCT01426789|524759074|FG005|Part 1|Lack of Efficacy|0|||
145518926|NCT01426789|524759069|FG000|Part 1|Adverse Event|3|||
145518927|NCT01426789|524759070|FG001|Part 1|Adverse Event|0|||
145518928|NCT01426789|524759071|FG002|Part 1|Adverse Event|0|||
145518929|NCT01426789|524759072|FG003|Part 1|Adverse Event|0|||
145518930|NCT01426789|524759073|FG004|Part 1|Adverse Event|0|||
145518931|NCT01426789|524759074|FG005|Part 1|Adverse Event|0|||
145518932|NCT01426789|524759069|FG000|Part 2|Protocol deviation|0|||
145518933|NCT01426789|524759070|FG001|Part 2|Protocol deviation|0|||
145518934|NCT01426789|524759071|FG002|Part 2|Protocol deviation|1|||
145518935|NCT01426789|524759072|FG003|Part 2|Protocol deviation|0|||
145518936|NCT01426789|524759073|FG004|Part 2|Protocol deviation|0|||
145518937|NCT01426789|524759074|FG005|Part 2|Protocol deviation|0|||
145518938|NCT01426789|524759069|FG000|Part 2|Death|0|||
145518939|NCT01426789|524759070|FG001|Part 2|Death|0|||
145518940|NCT01426789|524759071|FG002|Part 2|Death|1|||
145518941|NCT01426789|524759072|FG003|Part 2|Death|0|||
145518942|NCT01426789|524759073|FG004|Part 2|Death|1|||
145518943|NCT01426789|524759074|FG005|Part 2|Death|0|||
145518944|NCT01426789|524759069|FG000|Part 2|Administrative problems|0|||
145402351|NCT03736967|524330718|FG003|Overall Study|Withdrawal by Subject|26|||
145402352|NCT03736967|524330715|FG000|Overall Study|Lost to Follow-up|3|||
145402353|NCT03736967|524330716|FG001|Overall Study|Lost to Follow-up|2|||
145402354|NCT03736967|524330717|FG002|Overall Study|Lost to Follow-up|1|||
145402355|NCT03736967|524330718|FG003|Overall Study|Lost to Follow-up|1|||
145518945|NCT01426789|524759070|FG001|Part 2|Administrative problems|0|||
145743509|NCT03370120|525577321|FG000|Overall Study|Study stopped by sponsor|2|||
145402356|NCT03736967|524330715|FG000|Overall Study|Physician Decision|1|||
145402357|NCT03736967|524330716|FG001|Overall Study|Physician Decision|0|||
145402358|NCT03736967|524330717|FG002|Overall Study|Physician Decision|0|||
145518946|NCT01426789|524759071|FG002|Part 2|Administrative problems|2|||
145518947|NCT01426789|524759072|FG003|Part 2|Administrative problems|0|||
145518948|NCT01426789|524759073|FG004|Part 2|Administrative problems|1|||
145518949|NCT01426789|524759074|FG005|Part 2|Administrative problems|0|||
145518950|NCT01426789|524759069|FG000|Part 2|Lost to Follow-up|0|||
145518951|NCT01426789|524759070|FG001|Part 2|Lost to Follow-up|0|||
145518952|NCT01426789|524759071|FG002|Part 2|Lost to Follow-up|4|||
145518953|NCT01426789|524759072|FG003|Part 2|Lost to Follow-up|0|||
145518954|NCT01426789|524759073|FG004|Part 2|Lost to Follow-up|1|||
145518955|NCT01426789|524759074|FG005|Part 2|Lost to Follow-up|0|||
145518956|NCT01426789|524759069|FG000|Part 2|Withdrawal by Subject|0|||
145518957|NCT01426789|524759070|FG001|Part 2|Withdrawal by Subject|0|||
145518958|NCT01426789|524759071|FG002|Part 2|Withdrawal by Subject|0|||
145518959|NCT01426789|524759072|FG003|Part 2|Withdrawal by Subject|1|||
145518960|NCT01426789|524759073|FG004|Part 2|Withdrawal by Subject|2|||
145743510|NCT03370120|525577321|FG000|Overall Study|Program termination|55|||
145402359|NCT03736967|524330718|FG003|Overall Study|Physician Decision|1|||
145402360|NCT03736967|524330715|FG000|Overall Study|Adverse Event|0|||
145402361|NCT03736967|524330716|FG001|Overall Study|Adverse Event|1|||
145402362|NCT03736967|524330717|FG002|Overall Study|Adverse Event|0|||
145402363|NCT03736967|524330718|FG003|Overall Study|Adverse Event|1|||
145402364|NCT03736967|524330715|FG000|Overall Study|Death|0|||
145402365|NCT03736967|524330716|FG001|Overall Study|Death|0|||
145402366|NCT03736967|524330717|FG002|Overall Study|Death|0|||
145402367|NCT03736967|524330718|FG003|Overall Study|Death|1|||
145402368|NCT03736967|524330715|FG000|Overall Study|Randomized but never treated|1|||
145402369|NCT03736967|524330716|FG001|Overall Study|Randomized but never treated|0|||
145402370|NCT03736967|524330717|FG002|Overall Study|Randomized but never treated|0|||
145402371|NCT03736967|524330718|FG003|Overall Study|Randomized but never treated|0|||
145402372|NCT02419807|524330719|FG000|Overall Study|Withdrawal by Subject|4|||
145402373|NCT02419807|524330719|FG000|Overall Study|Physician Decision|1|||
145402374|NCT02419807|524330719|FG000|Overall Study|Protocol Violation|5|||
145402375|NCT03587636|524330720|FG000|Overall Study|Lost to Follow-up|2|||
145402376|NCT03587636|524330721|FG001|Overall Study|Lost to Follow-up|5|||
145402377|NCT01006629|524330722|FG000|Overall Study|Adverse Event|1|||
145402378|NCT01006629|524330722|FG000|Overall Study|Parent refused to continue participation|1|||
145402379|NCT01006629|524330722|FG000|Overall Study|Parent unable to perform site visit|4|||
145402380|NCT00316004|524330723|FG000|Overall Study|Subject was not given study fluid.|14|||
145402381|NCT00316004|524330724|FG001|Overall Study|Subject was not given study fluid.|14|||
145402382|NCT00316004|524330725|FG002|Overall Study|Subject was not given study fluid.|21|||
145402383|NCT01065818|524330726|FG000|Overall Study|Withdrawal by Subject|1|||
145402384|NCT01065818|524330726|FG000|Overall Study|Not a candidate for surgery|1|||
145402385|NCT04459338|524330729|FG000|Overall Study|Loss of IV during study|1|||
145402386|NCT04459338|524330730|FG001|Overall Study|Loss of IV during study|0|||
145402387|NCT02665117|524330731|FG000|Overall Study|Physician Decision|1|||
145402388|NCT02665117|524330732|FG001|Overall Study|Physician Decision|0|||
145402389|NCT00784875|524330733|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
145402390|NCT00784875|524330734|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
145402391|NCT00784875|524330735|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
145402392|NCT00784875|524330736|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
145402393|NCT00784875|524330733|FG000|Period A - Baseline|Adverse Event|0|||
145402394|NCT00784875|524330734|FG001|Period A - Baseline|Adverse Event|0|||
145402395|NCT00784875|524330735|FG002|Period A - Baseline|Adverse Event|0|||
145402396|NCT00784875|524330736|FG003|Period A - Baseline|Adverse Event|8|||
145402397|NCT00784875|524330733|FG000|Period A - Baseline|Protocol Violation|0|||
145402398|NCT00784875|524330734|FG001|Period A - Baseline|Protocol Violation|0|||
145402399|NCT00784875|524330735|FG002|Period A - Baseline|Protocol Violation|0|||
145402400|NCT00784875|524330736|FG003|Period A - Baseline|Protocol Violation|25|||
145402401|NCT00784875|524330733|FG000|Period A - Baseline|Withdrawal by Subject|0|||
145402402|NCT00784875|524330734|FG001|Period A - Baseline|Withdrawal by Subject|0|||
145402403|NCT00784875|524330735|FG002|Period A - Baseline|Withdrawal by Subject|0|||
145402404|NCT00784875|524330736|FG003|Period A - Baseline|Withdrawal by Subject|27|||
145402405|NCT00784875|524330733|FG000|Period A - Baseline|Physician Decision|0|||
145402406|NCT00784875|524330734|FG001|Period A - Baseline|Physician Decision|0|||
145402407|NCT00784875|524330735|FG002|Period A - Baseline|Physician Decision|0|||
145402408|NCT00784875|524330736|FG003|Period A - Baseline|Physician Decision|2|||
145402409|NCT00784875|524330733|FG000|Period A - Baseline|Sponsor Decision|0|||
145402410|NCT00784875|524330734|FG001|Period A - Baseline|Sponsor Decision|0|||
145402411|NCT00784875|524330735|FG002|Period A - Baseline|Sponsor Decision|0|||
145402412|NCT00784875|524330736|FG003|Period A - Baseline|Sponsor Decision|113|||
145402413|NCT00784875|524330733|FG000|Period A - Baseline|Lost to Follow-up|0|||
145402414|NCT00784875|524330734|FG001|Period A - Baseline|Lost to Follow-up|0|||
145402415|NCT00784875|524330735|FG002|Period A - Baseline|Lost to Follow-up|0|||
145402416|NCT00784875|524330736|FG003|Period A - Baseline|Lost to Follow-up|2|||
145518961|NCT01426789|524759074|FG005|Part 2|Withdrawal by Subject|0|||
145518962|NCT01426789|524759069|FG000|Part 2|Lack of Efficacy|0|||
145518963|NCT01426789|524759070|FG001|Part 2|Lack of Efficacy|0|||
145402417|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
145402418|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
145402419|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
145402420|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
145402421|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
145402422|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
145402423|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
145402424|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
145402425|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
145402426|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
145402427|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
145518964|NCT01426789|524759071|FG002|Part 2|Lack of Efficacy|5|||
145518965|NCT01426789|524759072|FG003|Part 2|Lack of Efficacy|0|||
145518966|NCT01426789|524759073|FG004|Part 2|Lack of Efficacy|2|||
145518967|NCT01426789|524759074|FG005|Part 2|Lack of Efficacy|0|||
145518968|NCT01426789|524759069|FG000|Part 2|Adverse Event|0|||
145518969|NCT01426789|524759070|FG001|Part 2|Adverse Event|0|||
145518970|NCT01426789|524759071|FG002|Part 2|Adverse Event|2|||
145518971|NCT01426789|524759072|FG003|Part 2|Adverse Event|0|||
145518972|NCT01426789|524759073|FG004|Part 2|Adverse Event|1|||
145518973|NCT01426789|524759074|FG005|Part 2|Adverse Event|0|||
145518974|NCT04054947|524759075|FG000|Overall Study|Withdrawal by Subject|1|||
145518975|NCT04054947|524759076|FG001|Overall Study|Withdrawal by Subject|0|||
145518976|NCT04054947|524759075|FG000|Overall Study|Lost to Follow-up|2|||
145518977|NCT04054947|524759076|FG001|Overall Study|Lost to Follow-up|5|||
145518978|NCT04463069|524759079|FG000|Overall Study|Withdrawal by Subject|2|||
145518979|NCT04463069|524759080|FG001|Overall Study|Withdrawal by Subject|10|||
145518980|NCT04463069|524759079|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
145518981|NCT04463069|524759080|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
145518982|NCT00311584|524759081|FG000|Overall Study|Death|1|||
145518983|NCT00311584|524759082|FG001|Overall Study|Death|0|||
145518984|NCT00311584|524759081|FG000|Overall Study|Lack of Efficacy|12|||
145518985|NCT00311584|524759082|FG001|Overall Study|Lack of Efficacy|15|||
145518986|NCT00311584|524759081|FG000|Overall Study|Physician Decision|4|||
145518987|NCT00311584|524759082|FG001|Overall Study|Physician Decision|5|||
145518988|NCT00311584|524759081|FG000|Overall Study|Withdrawal by Subject|1|||
145518989|NCT00311584|524759082|FG001|Overall Study|Withdrawal by Subject|1|||
145518990|NCT00311584|524759081|FG000|Overall Study|ineligible|2|||
145518991|NCT00311584|524759082|FG001|Overall Study|ineligible|2|||
145518992|NCT03720652|524759083|FG000|Overall Study|Withdrawal by Subject|2|||
145518993|NCT03720652|524759084|FG001|Overall Study|Withdrawal by Subject|7|||
145518994|NCT03720652|524759083|FG000|Overall Study|Lost to Follow-up|0|||
145518995|NCT03720652|524759084|FG001|Overall Study|Lost to Follow-up|4|||
145518996|NCT03073733|524759085|FG000|Overall Study|Lost to Follow-up|1|||
145518997|NCT03073733|524759086|FG001|Overall Study|Lost to Follow-up|0|||
145518998|NCT03073733|524759087|FG002|Overall Study|Lost to Follow-up|0|||
145518999|NCT03073733|524759085|FG000|Overall Study|Physician Decision|0|||
145519000|NCT03073733|524759086|FG001|Overall Study|Physician Decision|1|||
145519001|NCT03073733|524759087|FG002|Overall Study|Physician Decision|0|||
145519002|NCT03073733|524759085|FG000|Overall Study|Withdrawal by Subject|0|||
145519003|NCT03073733|524759086|FG001|Overall Study|Withdrawal by Subject|0|||
145519004|NCT03073733|524759087|FG002|Overall Study|Withdrawal by Subject|1|||
145519005|NCT00835731|524759088|FG000|Overall Study|Withdrawal by Subject|1|||
145519006|NCT00835731|524759089|FG001|Overall Study|Withdrawal by Subject|0|||
145519007|NCT00835731|524759088|FG000|Overall Study|Physician Decision|1|||
145519008|NCT00835731|524759089|FG001|Overall Study|Physician Decision|1|||
145519009|NCT03658876|524760880|FG000|Overall Study|Protocol Violation|3|||
145519010|NCT03658876|524760881|FG001|Overall Study|Protocol Violation|2|||
145519011|NCT03658876|524760880|FG000|Overall Study|Withdrawal by Subject|2|||
145519012|NCT03658876|524760881|FG001|Overall Study|Withdrawal by Subject|0|||
145519013|NCT03658876|524760880|FG000|Overall Study|Death|0|||
145519014|NCT03658876|524760881|FG001|Overall Study|Death|1|||
145519015|NCT03658876|524760880|FG000|Overall Study|Intercurrent illness|6|||
145519016|NCT03658876|524760881|FG001|Overall Study|Intercurrent illness|4|||
145519017|NCT03658876|524760880|FG000|Overall Study|Transplantation/other operation|1|||
145519018|NCT03658876|524760881|FG001|Overall Study|Transplantation/other operation|5|||
145519019|NCT02616146|524760882|FG000|Overall Study|Adverse Event|64|||
145519020|NCT02616146|524760883|FG001|Overall Study|Adverse Event|24|||
145519021|NCT02616146|524760882|FG000|Overall Study|Lost to Follow-up|23|||
145519022|NCT02616146|524760883|FG001|Overall Study|Lost to Follow-up|13|||
145519023|NCT02616146|524760882|FG000|Overall Study|Non-compliance with study protocol|2|||
145519024|NCT02616146|524760883|FG001|Overall Study|Non-compliance with study protocol|0|||
145519025|NCT02616146|524760882|FG000|Overall Study|Non-compliance with study drug|4|||
145519026|NCT02616146|524760883|FG001|Overall Study|Non-compliance with study drug|2|||
145519027|NCT02616146|524760882|FG000|Overall Study|Pregnancy|2|||
145519028|NCT02616146|524760883|FG001|Overall Study|Pregnancy|2|||
145519029|NCT02616146|524760882|FG000|Overall Study|Pregnancy wish|3|||
145519030|NCT02616146|524760883|FG001|Overall Study|Pregnancy wish|0|||
145519031|NCT02616146|524760882|FG000|Overall Study|Protocol Violation|6|||
145519032|NCT02616146|524760883|FG001|Overall Study|Protocol Violation|3|||
145519033|NCT02616146|524760882|FG000|Overall Study|Study terminated by sponsor|1372|||
145519034|NCT02616146|524760883|FG001|Overall Study|Study terminated by sponsor|432|||
145519035|NCT02616146|524760882|FG000|Overall Study|Participant moved|4|||
145519036|NCT02616146|524760883|FG001|Overall Study|Participant moved|3|||
145519037|NCT02616146|524760882|FG000|Overall Study|Withdrawal by Subject|30|||
145519038|NCT02616146|524760883|FG001|Overall Study|Withdrawal by Subject|24|||
145519039|NCT02616146|524760882|FG000|Overall Study|Physician Decision|2|||
145519040|NCT02616146|524760883|FG001|Overall Study|Physician Decision|1|||
145519041|NCT03039621|524760884|FG000|Overall Study|Violation of inclusion criteria|3|||
145519042|NCT03039621|524760885|FG001|Overall Study|Violation of inclusion criteria|2|||
145519043|NCT03039621|524760884|FG000|Overall Study|Non-compliance with protocol requirement|4|||
145519044|NCT03039621|524760885|FG001|Overall Study|Non-compliance with protocol requirement|5|||
145519045|NCT03039621|524760884|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
145519046|NCT03039621|524760885|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
145519047|NCT03039621|524760884|FG000|Overall Study|Violation of non-inclusion criteria|1|||
145519048|NCT03039621|524760885|FG001|Overall Study|Violation of non-inclusion criteria|2|||
145519049|NCT01258998|524760888|FG000|Overall Study|Ineligible|1|||
145519050|NCT01143389|524760889|FG000|Overall Study|Lost to Follow-up|26|||
145519051|NCT01143389|524760890|FG001|Overall Study|Lost to Follow-up|25|||
145519052|NCT04966910|524760891|FG000|Baseline|Participant did not complete measure|0|||
145519053|NCT04966910|524760892|FG001|Baseline|Participant did not complete measure|0|||
145519054|NCT04966910|524760893|FG002|Baseline|Participant did not complete measure|1|||
145519055|NCT04966910|524760894|FG003|Baseline|Participant did not complete measure|0|||
145519056|NCT04966910|524760891|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
145519057|NCT04966910|524760892|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
145519058|NCT04966910|524760893|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
145519059|NCT04966910|524760894|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
145519060|NCT04966910|524760891|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
145519061|NCT04966910|524760892|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
145519062|NCT04966910|524760893|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
145519063|NCT04966910|524760894|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
145519064|NCT04966910|524760891|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
145519065|NCT04966910|524760892|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
145519066|NCT04966910|524760893|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
145519067|NCT04966910|524760894|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
145519068|NCT00002931|524760898|FG000|Overall Study|rapidly progressing disease during|2|||
145519069|NCT02276027|524760899|FG000|Overall Study|Death|1|||
145519070|NCT02276027|524760900|FG001|Overall Study|Death|0|||
145519071|NCT02276027|524760901|FG002|Overall Study|Death|0|||
145519072|NCT02276027|524760902|FG003|Overall Study|Death|2|||
145519073|NCT02276027|524760899|FG000|Overall Study|Physician Decision|0|||
145519074|NCT02276027|524760900|FG001|Overall Study|Physician Decision|0|||
145519075|NCT02276027|524760901|FG002|Overall Study|Physician Decision|0|||
145519076|NCT02276027|524760902|FG003|Overall Study|Physician Decision|1|||
145519077|NCT02276027|524760899|FG000|Overall Study|Progressive disease|1|||
145519078|NCT02276027|524760900|FG001|Overall Study|Progressive disease|13|||
145519079|NCT02276027|524760901|FG002|Overall Study|Progressive disease|12|||
145519080|NCT02276027|524760902|FG003|Overall Study|Progressive disease|14|||
145519081|NCT02276027|524760899|FG000|Overall Study|Subject/guardian decision|0|||
145519082|NCT02276027|524760900|FG001|Overall Study|Subject/guardian decision|1|||
145519083|NCT02276027|524760901|FG002|Overall Study|Subject/guardian decision|0|||
145519084|NCT02276027|524760902|FG003|Overall Study|Subject/guardian decision|3|||
145519085|NCT02276027|524760899|FG000|Overall Study|Adverse Event|0|||
145519086|NCT02276027|524760900|FG001|Overall Study|Adverse Event|2|||
145519087|NCT02276027|524760901|FG002|Overall Study|Adverse Event|8|||
145519088|NCT02276027|524760902|FG003|Overall Study|Adverse Event|2|||
145519089|NCT03224598|524760903|FG000|Overall Study|Lost to Follow-up|0|||
145743511|NCT03370120|525577321|FG000|Overall Study|Sponsor decision|62|||
145743512|NCT03370120|525577321|FG000|Overall Study|Sponsor study closure|10|||
145519090|NCT03224598|524760904|FG001|Overall Study|Lost to Follow-up|2|||
145519091|NCT03224598|524760905|FG002|Overall Study|Lost to Follow-up|0|||
145519092|NCT03224598|524760903|FG000|Overall Study|Other|0|||
145519093|NCT03224598|524760904|FG001|Overall Study|Other|1|||
145519094|NCT03224598|524760905|FG002|Overall Study|Other|0|||
145519095|NCT02446171|524760915|FG000|Overall Study|Withdrawal by Subject|0|||
145519096|NCT02446171|524760916|FG001|Overall Study|Withdrawal by Subject|0|||
145519097|NCT02446171|524760917|FG002|Overall Study|Withdrawal by Subject|2|||
145519098|NCT02446171|524760918|FG003|Overall Study|Withdrawal by Subject|0|||
145519099|NCT01142089|524760919|FG000|Overall Study|Physician Decision|1|||
145743513|NCT01309659|525577322|FG000|Overall Study|Protocol Violation|0|||
145519100|NCT01142089|524760920|FG001|Overall Study|Physician Decision|0|||
145519101|NCT01142089|524760919|FG000|Overall Study|Withdrawal by Subject|1|||
145519102|NCT01142089|524760920|FG001|Overall Study|Withdrawal by Subject|2|||
145519103|NCT01142089|524760919|FG000|Overall Study|Use of prohibited medications|0|||
145519104|NCT01142089|524760920|FG001|Overall Study|Use of prohibited medications|1|||
145519105|NCT01142089|524760919|FG000|Overall Study|Noncompliance with study procedures|2|||
145519106|NCT01142089|524760920|FG001|Overall Study|Noncompliance with study procedures|1|||
145519107|NCT01142089|524760919|FG000|Overall Study|Patient required rescue medication|8|||
145519108|NCT01142089|524760920|FG001|Overall Study|Patient required rescue medication|17|||
145519109|NCT02907892|524760925|FG000|Overall Study|Lost to Follow-up|27|||
145519110|NCT02907892|524760926|FG001|Overall Study|Lost to Follow-up|40|||
145519111|NCT01974765|524760927|FG000|Overall Study|Withdrawal by Subject|1|||
145519112|NCT01974765|524760927|FG000|Overall Study|Death|1|||
145519113|NCT01974765|524760927|FG000|Overall Study|Adverse Event|2|||
145519114|NCT03328182|524760930|FG000|Overall Study|Withdrawal by Subject|1|||
145519115|NCT03328182|524760930|FG000|Overall Study|Protocol Violation|2|||
145519116|NCT03328182|524760930|FG000|Overall Study|No Product Evaluated|1|||
145519117|NCT04531462|524760931|FG000|Overall Study|Withdrawal by Subject|3|||
145519118|NCT04531462|524760932|FG001|Overall Study|Withdrawal by Subject|1|||
145519119|NCT04531462|524760931|FG000|Overall Study|Adverse Event|3|||
145519120|NCT04531462|524760932|FG001|Overall Study|Adverse Event|3|||
145519121|NCT00504582|524760933|FG000|Overall Study|Lost to Follow-up|1|||
145519122|NCT00504582|524760934|FG001|Overall Study|Lost to Follow-up|0|||
145519123|NCT00504582|524760935|FG002|Overall Study|Lost to Follow-up|0|||
145519124|NCT00348933|524760938|FG000|Overall Study|Withdrawal by Subject|10|||
145519125|NCT00348933|524760938|FG000|Overall Study|Lost to Follow-up|6|||
145519126|NCT00348933|524760938|FG000|Overall Study|Protocol Violation|2|||
145519127|NCT00348933|524760938|FG000|Overall Study|Adverse Event|7|||
145519128|NCT01489111|524760939|FG000|Overall Study|Withdrawal criterion|1|||
145519129|NCT01757691|524760944|FG000|Overall Study|Administrative problems|2|||
145519130|NCT01757691|524760945|FG001|Overall Study|Administrative problems|0|||
145519131|NCT00464490|524760948|FG000|Overall Study|Physician Decision|11|||
145519132|NCT00464490|524760949|FG001|Overall Study|Physician Decision|11|||
145519133|NCT03188042|524760950|FG000|Overall Study|Withdrawal by Subject|1|||
145519134|NCT03188042|524760951|FG001|Overall Study|Withdrawal by Subject|1|||
145519135|NCT03860935|524760952|FG000|Overall Study|Withdrawal of Consent|15|||
145519136|NCT03860935|524760953|FG001|Overall Study|Withdrawal of Consent|6|||
145519137|NCT03860935|524760952|FG000|Overall Study|Death|75|||
145519138|NCT03860935|524760953|FG001|Overall Study|Death|51|||
145519139|NCT04575597|524760954|FG000|Overall Study|Death|0|||
145519140|NCT04575597|524760955|FG001|Overall Study|Death|0|||
145519141|NCT04575597|524760956|FG002|Overall Study|Death|0|||
145519142|NCT04575597|524760957|FG003|Overall Study|Death|1|||
145519143|NCT04575597|524760958|FG004|Overall Study|Death|3|||
145519144|NCT04575597|524760959|FG005|Overall Study|Death|14|||
145519145|NCT04575597|524760954|FG000|Overall Study|Lost to Follow-up|2|||
145519146|NCT04575597|524760955|FG001|Overall Study|Lost to Follow-up|1|||
145519147|NCT04575597|524760956|FG002|Overall Study|Lost to Follow-up|1|||
145519148|NCT04575597|524760957|FG003|Overall Study|Lost to Follow-up|2|||
145519149|NCT04575597|524760958|FG004|Overall Study|Lost to Follow-up|10|||
145519150|NCT04575597|524760959|FG005|Overall Study|Lost to Follow-up|8|||
145519151|NCT04575597|524760954|FG000|Overall Study|Withdrawal by Subject|2|||
145519152|NCT04575597|524760955|FG001|Overall Study|Withdrawal by Subject|2|||
145519153|NCT04575597|524760956|FG002|Overall Study|Withdrawal by Subject|4|||
145519154|NCT04575597|524760957|FG003|Overall Study|Withdrawal by Subject|2|||
145519155|NCT04575597|524760958|FG004|Overall Study|Withdrawal by Subject|25|||
145519156|NCT04575597|524760959|FG005|Overall Study|Withdrawal by Subject|28|||
145519157|NCT04575597|524760954|FG000|Overall Study|Not Recorded|0|||
145519158|NCT04575597|524760955|FG001|Overall Study|Not Recorded|0|||
145519159|NCT04575597|524760956|FG002|Overall Study|Not Recorded|0|||
145743514|NCT01309659|525577323|FG001|Overall Study|Protocol Violation|1|||
145743515|NCT03972969|525577327|FG000|3-month Follow-up|Death|1|||
145270087|NCT02118896|523837811|FG001|Overall Study|Non-compliance|1|||
145519160|NCT04575597|524760957|FG003|Overall Study|Not Recorded|0|||
145519161|NCT04575597|524760958|FG004|Overall Study|Not Recorded|0|||
145519162|NCT04575597|524760959|FG005|Overall Study|Not Recorded|2|||
145519163|NCT04575597|524760954|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145519164|NCT04575597|524760955|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145519165|NCT04575597|524760956|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145519166|NCT04575597|524760957|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145519167|NCT04575597|524760958|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
145519168|NCT04575597|524760959|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145519169|NCT01268579|524760960|FG000|Overall Study|Adverse Event|1|||
145519170|NCT01268579|524760960|FG000|Overall Study|Withdrawal by Subject|2|||
145519171|NCT02480712|524760961|FG000|Overall Study|Enrolled but Never Treated|1|||
145519172|NCT02480712|524760961|FG000|Overall Study|Lost to Follow-up|5|||
145743516|NCT03972969|525577328|FG001|3-month Follow-up|Death|1|||
145519173|NCT02480712|524760961|FG000|Overall Study|Withdrew Consent|3|||
145519174|NCT02480712|524760961|FG000|Overall Study|Death|1|||
145519175|NCT02480712|524760961|FG000|Overall Study|Lack of Efficacy|1|||
145519176|NCT01284491|524760965|FG000|Overall Study|Study termination|13|||
145519177|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
145519178|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
145519179|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
145519180|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
145519181|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
145519182|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
145519183|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
145519184|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
145519185|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
145519186|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
145519187|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
145519188|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
145519189|NCT01087788|524760966|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
145519190|NCT01087788|524760967|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
145519191|NCT01087788|524760968|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
145519192|NCT01087788|524760966|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
145519193|NCT01087788|524760967|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
145519194|NCT01087788|524760968|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
145519195|NCT01087788|524760966|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
145519196|NCT01087788|524760967|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
145519197|NCT01087788|524760968|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
145519198|NCT01087788|524760966|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
145519199|NCT01087788|524760967|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
145519200|NCT01087788|524760968|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
145519201|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
145519202|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
145743517|NCT03972969|525577329|FG002|3-month Follow-up|Death|0|||
145743518|NCT03972969|525577327|FG000|6-month Follow-up|Death|1|||
145743519|NCT03972969|525577328|FG001|6-month Follow-up|Death|1|||
145743520|NCT03972969|525577329|FG002|6-month Follow-up|Death|1|||
145743521|NCT03972969|525577327|FG000|6-month Follow-up|Lost to Follow-up|2|||
145743522|NCT03972969|525577328|FG001|6-month Follow-up|Lost to Follow-up|2|||
145743523|NCT03972969|525577329|FG002|6-month Follow-up|Lost to Follow-up|2|||
145402428|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
145402429|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145402430|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
145402431|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145519203|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
145519204|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
145519205|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
145519206|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
145519207|NCT01087788|524760966|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
145519208|NCT01087788|524760967|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
145519209|NCT01087788|524760968|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
145519210|NCT01087788|524760966|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
145519211|NCT01087788|524760967|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
145519212|NCT01087788|524760968|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
145519213|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
145519214|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
145519215|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
145519216|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
145519217|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
145519218|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
145519219|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
145519220|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
145519221|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
145519222|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
145519223|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
145519224|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
145519225|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
145519226|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
145519227|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
145743524|NCT01399788|525577333|FG000|First Intervention Period|Adverse Event|1|||
145743525|NCT01399788|525577334|FG001|First Intervention Period|Adverse Event|0|||
145270088|NCT02118896|523837812|FG002|Overall Study|Non-compliance|1|||
145270089|NCT02118896|523837813|FG003|Overall Study|Non-compliance|5|||
145270090|NCT02118896|523837814|FG004|Overall Study|Non-compliance|0|||
145270091|NCT02118896|523837815|FG005|Overall Study|Non-compliance|1|||
145270092|NCT02118896|523837816|FG006|Overall Study|Non-compliance|0|||
145270093|NCT02118896|523837817|FG007|Overall Study|Non-compliance|1|||
145270094|NCT02118896|523837818|FG008|Overall Study|Non-compliance|0|||
145270095|NCT02118896|523837819|FG009|Overall Study|Non-compliance|0|||
145270096|NCT02118896|523837810|FG000|Overall Study|Pregnancy|1|||
145270097|NCT02118896|523837811|FG001|Overall Study|Pregnancy|1|||
145270098|NCT02118896|523837812|FG002|Overall Study|Pregnancy|0|||
145270099|NCT02118896|523837813|FG003|Overall Study|Pregnancy|0|||
145270100|NCT02118896|523837814|FG004|Overall Study|Pregnancy|1|||
145270101|NCT02118896|523837815|FG005|Overall Study|Pregnancy|3|||
145270102|NCT02118896|523837816|FG006|Overall Study|Pregnancy|1|||
145270103|NCT02118896|523837817|FG007|Overall Study|Pregnancy|0|||
145270104|NCT02118896|523837818|FG008|Overall Study|Pregnancy|0|||
145270105|NCT02118896|523837819|FG009|Overall Study|Pregnancy|0|||
145270106|NCT02118896|523837810|FG000|Overall Study|Lost to Follow-up|1|||
145270107|NCT02118896|523837811|FG001|Overall Study|Lost to Follow-up|2|||
145270108|NCT02118896|523837812|FG002|Overall Study|Lost to Follow-up|1|||
145270109|NCT02118896|523837813|FG003|Overall Study|Lost to Follow-up|0|||
145270110|NCT02118896|523837814|FG004|Overall Study|Lost to Follow-up|2|||
145270111|NCT02118896|523837815|FG005|Overall Study|Lost to Follow-up|1|||
145270112|NCT02118896|523837816|FG006|Overall Study|Lost to Follow-up|0|||
145270113|NCT02118896|523837817|FG007|Overall Study|Lost to Follow-up|0|||
145270114|NCT02118896|523837818|FG008|Overall Study|Lost to Follow-up|0|||
145270115|NCT02118896|523837819|FG009|Overall Study|Lost to Follow-up|0|||
145270116|NCT02118896|523837810|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
145270117|NCT02118896|523837811|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
145270118|NCT02118896|523837812|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
145270119|NCT02118896|523837813|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
145270120|NCT02118896|523837814|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
145270121|NCT02118896|523837815|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
145270122|NCT02118896|523837816|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
145270123|NCT02118896|523837817|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
145270124|NCT02118896|523837818|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
145270125|NCT02118896|523837819|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
145519228|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
145743526|NCT02285998|525577335|FG000|Overall Study|Adverse Event|9|||
145743527|NCT02285998|525577336|FG001|Overall Study|Adverse Event|8|||
145743528|NCT02285998|525577335|FG000|Overall Study|Physician Decision|1|||
145270126|NCT02118896|523837810|FG000|Overall Study|Prohibited medication|0|||
145270127|NCT02118896|523837811|FG001|Overall Study|Prohibited medication|0|||
145270128|NCT02118896|523837812|FG002|Overall Study|Prohibited medication|0|||
145270129|NCT02118896|523837813|FG003|Overall Study|Prohibited medication|0|||
145270130|NCT02118896|523837814|FG004|Overall Study|Prohibited medication|1|||
145519229|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
145519230|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
145519231|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
145519232|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
145519233|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
145519234|NCT01087788|524760966|FG000|24-weeks Dose-blind Period|Patient moved|0|||
145519235|NCT01087788|524760967|FG001|24-weeks Dose-blind Period|Patient moved|0|||
145519236|NCT01087788|524760968|FG002|24-weeks Dose-blind Period|Patient moved|1|||
145519237|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
145519238|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
145519239|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
145519240|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
145519241|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
145519242|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
145519243|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
145519244|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
145519245|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
145519246|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
145519247|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
145519248|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
145519249|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
145743529|NCT02285998|525577336|FG001|Overall Study|Physician Decision|2|||
145743530|NCT02285998|525577335|FG000|Overall Study|Lost to Follow-up|176|||
145270131|NCT02118896|523837815|FG005|Overall Study|Prohibited medication|3|||
145270132|NCT02118896|523837816|FG006|Overall Study|Prohibited medication|0|||
145270133|NCT02118896|523837817|FG007|Overall Study|Prohibited medication|0|||
145270134|NCT02118896|523837818|FG008|Overall Study|Prohibited medication|0|||
145270135|NCT02118896|523837819|FG009|Overall Study|Prohibited medication|0|||
145270136|NCT02118896|523837810|FG000|Overall Study|Miscellaneous|1|||
145519250|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
145519251|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
145519252|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
145519253|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
145519254|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
145519255|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
145519256|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
145519257|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
145519258|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
145519259|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
145519260|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
145519261|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
145519262|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
145519263|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
145519264|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
145519265|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
145519266|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
145519267|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
145519268|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
145519269|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
145519270|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
145519271|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
145519272|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
145519273|NCT01087788|524760966|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
145519274|NCT01087788|524760967|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
145519275|NCT01087788|524760968|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
145519276|NCT04604132|524760969|FG000|Overall Study|Adverse Event|2|||
145519277|NCT04604132|524760970|FG001|Overall Study|Adverse Event|0|||
145519278|NCT04604132|524760971|FG002|Overall Study|Adverse Event|0|||
145519279|NCT04604132|524760972|FG003|Overall Study|Adverse Event|1|||
145519280|NCT04604132|524760973|FG004|Overall Study|Adverse Event|2|||
145519281|NCT04604132|524760969|FG000|Overall Study|Study terminated by sponsor|0|||
145519282|NCT04604132|524760970|FG001|Overall Study|Study terminated by sponsor|0|||
145519283|NCT04604132|524760971|FG002|Overall Study|Study terminated by sponsor|0|||
145519284|NCT04604132|524760972|FG003|Overall Study|Study terminated by sponsor|0|||
145519285|NCT04604132|524760973|FG004|Overall Study|Study terminated by sponsor|1|||
145519286|NCT04604132|524760969|FG000|Overall Study|Progressive disease: Clinical progression|0|||
145519287|NCT04604132|524760970|FG001|Overall Study|Progressive disease: Clinical progression|0|||
145519288|NCT04604132|524760971|FG002|Overall Study|Progressive disease: Clinical progression|1|||
145519289|NCT04604132|524760972|FG003|Overall Study|Progressive disease: Clinical progression|0|||
145519290|NCT04604132|524760973|FG004|Overall Study|Progressive disease: Clinical progression|0|||
145519291|NCT04604132|524760969|FG000|Overall Study|Progressive disease: Radiological progression|8|||
145519292|NCT04604132|524760970|FG001|Overall Study|Progressive disease: Radiological progression|7|||
145519293|NCT04604132|524760971|FG002|Overall Study|Progressive disease: Radiological progression|10|||
145519294|NCT04604132|524760972|FG003|Overall Study|Progressive disease: Radiological progression|4|||
145519295|NCT04604132|524760973|FG004|Overall Study|Progressive disease: Radiological progression|3|||
145519296|NCT04604132|524760969|FG000|Overall Study|Death|3|||
145519297|NCT04604132|524760970|FG001|Overall Study|Death|1|||
145519298|NCT04604132|524760971|FG002|Overall Study|Death|2|||
145270137|NCT02118896|523837811|FG001|Overall Study|Miscellaneous|2|||
145270138|NCT02118896|523837812|FG002|Overall Study|Miscellaneous|0|||
145270139|NCT02118896|523837813|FG003|Overall Study|Miscellaneous|2|||
145270140|NCT02118896|523837814|FG004|Overall Study|Miscellaneous|0|||
145270141|NCT02118896|523837815|FG005|Overall Study|Miscellaneous|4|||
145270142|NCT02118896|523837816|FG006|Overall Study|Miscellaneous|0|||
145270143|NCT02118896|523837817|FG007|Overall Study|Miscellaneous|0|||
145270144|NCT02118896|523837818|FG008|Overall Study|Miscellaneous|0|||
145402432|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
145402433|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
145519299|NCT04604132|524760972|FG003|Overall Study|Death|1|||
145519300|NCT04604132|524760973|FG004|Overall Study|Death|0|||
145519301|NCT00952380|524760974|FG000|Overall Study|Other|0|||
145519302|NCT00952380|524760975|FG001|Overall Study|Other|0|||
145519303|NCT00952380|524760976|FG002|Overall Study|Other|0|||
145519304|NCT00952380|524760977|FG003|Overall Study|Other|0|||
145519305|NCT00952380|524760978|FG004|Overall Study|Other|1|||
145519306|NCT00952380|524760974|FG000|Overall Study|Withdrawal by Subject|0|||
145402434|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
145519307|NCT00952380|524760975|FG001|Overall Study|Withdrawal by Subject|0|||
145519308|NCT00952380|524760976|FG002|Overall Study|Withdrawal by Subject|1|||
145519309|NCT00952380|524760977|FG003|Overall Study|Withdrawal by Subject|0|||
145270145|NCT02118896|523837819|FG009|Overall Study|Miscellaneous|0|||
145519310|NCT00952380|524760978|FG004|Overall Study|Withdrawal by Subject|2|||
145519311|NCT00952380|524760974|FG000|Overall Study|Adverse Event|0|||
145519312|NCT00952380|524760975|FG001|Overall Study|Adverse Event|1|||
145519313|NCT00952380|524760976|FG002|Overall Study|Adverse Event|0|||
145519314|NCT00952380|524760977|FG003|Overall Study|Adverse Event|0|||
145519315|NCT00952380|524760978|FG004|Overall Study|Adverse Event|3|||
145519316|NCT00952380|524760974|FG000|Overall Study|Physician Decision|0|||
145519317|NCT00952380|524760975|FG001|Overall Study|Physician Decision|0|||
145519318|NCT00952380|524760976|FG002|Overall Study|Physician Decision|1|||
145519319|NCT00952380|524760977|FG003|Overall Study|Physician Decision|2|||
145519320|NCT00952380|524760978|FG004|Overall Study|Physician Decision|0|||
145519321|NCT00952380|524760974|FG000|Overall Study|Non-compliant to protocol|0|||
145519322|NCT00952380|524760975|FG001|Overall Study|Non-compliant to protocol|0|||
145519323|NCT00952380|524760976|FG002|Overall Study|Non-compliant to protocol|0|||
145519324|NCT00952380|524760977|FG003|Overall Study|Non-compliant to protocol|1|||
145519325|NCT00952380|524760978|FG004|Overall Study|Non-compliant to protocol|0|||
145519326|NCT00534313|524760982|FG000|Short-term Period|Adverse Event|1|||
145519327|NCT00534313|524760983|FG001|Short-term Period|Adverse Event|2|||
145519328|NCT00534313|524760984|FG002|Short-term Period|Adverse Event|1|||
145519329|NCT00534313|524760985|FG003|Short-term Period|Adverse Event|3|||
145519330|NCT00534313|524760982|FG000|Short-term Period|Lack of Efficacy|3|||
145519331|NCT00534313|524760983|FG001|Short-term Period|Lack of Efficacy|4|||
145519332|NCT00534313|524760984|FG002|Short-term Period|Lack of Efficacy|0|||
145519333|NCT00534313|524760985|FG003|Short-term Period|Lack of Efficacy|3|||
145519334|NCT00534313|524760982|FG000|Short-term Period|Participant not meeting study criteria|0|||
145743531|NCT02285998|525577336|FG001|Overall Study|Lost to Follow-up|172|||
145743532|NCT02285998|525577335|FG000|Overall Study|Withdrawal by Subject|53|||
145743533|NCT02285998|525577336|FG001|Overall Study|Withdrawal by Subject|61|||
145743534|NCT02285998|525577335|FG000|Overall Study|Other Reasons|7|||
145402435|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
145402436|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
145402437|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
145402438|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
145402439|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
145402440|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
145519335|NCT00534313|524760983|FG001|Short-term Period|Participant not meeting study criteria|0|||
145519336|NCT00534313|524760984|FG002|Short-term Period|Participant not meeting study criteria|0|||
145743535|NCT02285998|525577336|FG001|Overall Study|Other Reasons|10|||
145402441|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
145402442|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
145519337|NCT00534313|524760985|FG003|Short-term Period|Participant not meeting study criteria|1|||
145519338|NCT00534313|524760982|FG000|Short-term Period|Participant withdrew consent|2|||
145743536|NCT00841568|525577337|FG000|Overall Study|Adverse Event|1|||
145519339|NCT00534313|524760983|FG001|Short-term Period|Participant withdrew consent|0|||
145519340|NCT00534313|524760984|FG002|Short-term Period|Participant withdrew consent|0|||
145519341|NCT00534313|524760985|FG003|Short-term Period|Participant withdrew consent|2|||
145519342|NCT00534313|524760982|FG000|Short-term Period|Pregnancy|0|||
145519343|NCT00534313|524760983|FG001|Short-term Period|Pregnancy|0|||
145519344|NCT00534313|524760984|FG002|Short-term Period|Pregnancy|1|||
145519345|NCT00534313|524760985|FG003|Short-term Period|Pregnancy|0|||
145519346|NCT00534313|524760982|FG000|Long-term Period|Adverse Event|2|||
145519347|NCT00534313|524760983|FG001|Long-term Period|Adverse Event|1|||
145519348|NCT00534313|524760984|FG002|Long-term Period|Adverse Event|0|||
145519349|NCT00534313|524760985|FG003|Long-term Period|Adverse Event|1|||
145519350|NCT00534313|524760982|FG000|Long-term Period|Lack of Efficacy|14|||
145519351|NCT00534313|524760983|FG001|Long-term Period|Lack of Efficacy|10|||
145519352|NCT00534313|524760984|FG002|Long-term Period|Lack of Efficacy|14|||
145519353|NCT00534313|524760985|FG003|Long-term Period|Lack of Efficacy|12|||
145519354|NCT00534313|524760982|FG000|Long-term Period|Lost to Follow-up|1|||
145519355|NCT00534313|524760983|FG001|Long-term Period|Lost to Follow-up|2|||
145519356|NCT00534313|524760984|FG002|Long-term Period|Lost to Follow-up|0|||
145519357|NCT00534313|524760985|FG003|Long-term Period|Lost to Follow-up|0|||
145519358|NCT00534313|524760982|FG000|Long-term Period|Withdrawal by Subject|2|||
145519359|NCT00534313|524760983|FG001|Long-term Period|Withdrawal by Subject|2|||
145519360|NCT00534313|524760984|FG002|Long-term Period|Withdrawal by Subject|0|||
145519361|NCT00534313|524760985|FG003|Long-term Period|Withdrawal by Subject|0|||
145519362|NCT00534313|524760982|FG000|Long-term Period|No longer meets study criteria|0|||
145519363|NCT00534313|524760983|FG001|Long-term Period|No longer meets study criteria|1|||
145519364|NCT00534313|524760984|FG002|Long-term Period|No longer meets study criteria|0|||
145519365|NCT00534313|524760985|FG003|Long-term Period|No longer meets study criteria|0|||
145519366|NCT00534313|524760982|FG000|Long-term Period|Poor compliance/noncompliance|0|||
145519367|NCT00534313|524760983|FG001|Long-term Period|Poor compliance/noncompliance|1|||
145519368|NCT00534313|524760984|FG002|Long-term Period|Poor compliance/noncompliance|1|||
145519369|NCT00534313|524760985|FG003|Long-term Period|Poor compliance/noncompliance|0|||
145519370|NCT00534313|524760982|FG000|Long-term Period|Administrative reason by sponsor|17|||
145519371|NCT00534313|524760983|FG001|Long-term Period|Administrative reason by sponsor|15|||
145519372|NCT00534313|524760984|FG002|Long-term Period|Administrative reason by sponsor|26|||
145519373|NCT00534313|524760985|FG003|Long-term Period|Administrative reason by sponsor|18|||
145519374|NCT00534313|524760982|FG000|Long-term Period|Other|1|||
145519375|NCT00534313|524760983|FG001|Long-term Period|Other|2|||
145519376|NCT00534313|524760984|FG002|Long-term Period|Other|2|||
145519377|NCT00534313|524760985|FG003|Long-term Period|Other|2|||
145519378|NCT00927940|524760986|FG000|Overall Study|Death|1|||
145270146|NCT04242264|523837820|FG000|Overall Study|Lost to Follow-up|2|||
145270147|NCT04242264|523837821|FG001|Overall Study|Lost to Follow-up|2|||
145270148|NCT04242264|523837822|FG002|Overall Study|Lost to Follow-up|1|||
145270149|NCT04242264|523837823|FG003|Overall Study|Lost to Follow-up|1|||
145519379|NCT03007888|524760987|FG000|First Intervention (14 Days)|Adverse Event|1|||
145519380|NCT03007888|524760988|FG001|First Intervention (14 Days)|Adverse Event|0|||
145519381|NCT00827931|524760990|FG000|Overall Study|Death|3|||
145519382|NCT00827931|524760991|FG001|Overall Study|Death|5|||
145270150|NCT04242264|523837820|FG000|Overall Study|Withdrawal by Subject|1|||
145270151|NCT04242264|523837821|FG001|Overall Study|Withdrawal by Subject|0|||
145270152|NCT04242264|523837822|FG002|Overall Study|Withdrawal by Subject|0|||
145270153|NCT04242264|523837823|FG003|Overall Study|Withdrawal by Subject|0|||
145270154|NCT02116309|523837825|FG000|Overall Study|Lost to Follow-up|0|||
145270155|NCT02116309|523837826|FG001|Overall Study|Lost to Follow-up|1|||
145270156|NCT03292731|523837827|FG000|Overall Study|Protocol Violation|4|||
145270157|NCT03292731|523837828|FG001|Overall Study|Protocol Violation|11|||
145270158|NCT03292731|523837829|FG002|Overall Study|Protocol Violation|1|||
145270159|NCT00471237|523837830|FG000|Overall Study|Adverse Event|6|||
145270160|NCT00471237|523837831|FG001|Overall Study|Adverse Event|5|||
145519383|NCT00827931|524760990|FG000|Overall Study|Adverse Event|1|||
145519384|NCT00827931|524760991|FG001|Overall Study|Adverse Event|0|||
145519385|NCT00827931|524760990|FG000|Overall Study|Lost to Follow-up|1|||
145519386|NCT00827931|524760991|FG001|Overall Study|Lost to Follow-up|0|||
145519387|NCT00827931|524760990|FG000|Overall Study|Withdrawal by Subject|0|||
145519388|NCT00827931|524760991|FG001|Overall Study|Withdrawal by Subject|1|||
145519389|NCT00827931|524760990|FG000|Overall Study|Other|1|||
145519390|NCT00827931|524760991|FG001|Overall Study|Other|0|||
145519391|NCT01870076|524760992|FG000|Overall Study|Withdrawal by Subject|1|||
145270161|NCT00471237|523837832|FG002|Overall Study|Adverse Event|4|||
145270162|NCT00471237|523837833|FG003|Overall Study|Adverse Event|8|||
145519392|NCT01870076|524760993|FG001|Overall Study|Withdrawal by Subject|0|||
145519393|NCT01870076|524760994|FG002|Overall Study|Withdrawal by Subject|1|||
145519394|NCT01870076|524760995|FG003|Overall Study|Withdrawal by Subject|0|||
145270163|NCT00471237|523837834|FG004|Overall Study|Adverse Event|7|||
145270164|NCT00471237|523837835|FG005|Overall Study|Adverse Event|5|||
145270165|NCT00471237|523837836|FG006|Overall Study|Adverse Event|0|||
145270166|NCT00471237|523837830|FG000|Overall Study|Lost to Follow-up|1|||
145519395|NCT00492063|524760996|FG000|Overall Study|Death|0|||
145519396|NCT00492063|524760997|FG001|Overall Study|Death|0|||
145519397|NCT00492063|524760998|FG002|Overall Study|Death|1|||
145519398|NCT00492063|524760999|FG003|Overall Study|Death|2|||
145519399|NCT00492063|524760996|FG000|Overall Study|Withdrawal by Subject|4|||
145519400|NCT00492063|524760997|FG001|Overall Study|Withdrawal by Subject|3|||
145519401|NCT00492063|524760998|FG002|Overall Study|Withdrawal by Subject|5|||
145519402|NCT00492063|524760999|FG003|Overall Study|Withdrawal by Subject|4|||
145519403|NCT00492063|524760996|FG000|Overall Study|Lost to Follow-up|6|||
145519404|NCT00492063|524760997|FG001|Overall Study|Lost to Follow-up|11|||
145519405|NCT00492063|524760998|FG002|Overall Study|Lost to Follow-up|5|||
145519406|NCT00492063|524760999|FG003|Overall Study|Lost to Follow-up|3|||
145519407|NCT00492063|524760996|FG000|Overall Study|Protocol Violation|0|||
145519408|NCT00492063|524760997|FG001|Overall Study|Protocol Violation|0|||
145519409|NCT00492063|524760998|FG002|Overall Study|Protocol Violation|0|||
145519410|NCT00492063|524760999|FG003|Overall Study|Protocol Violation|1|||
145519411|NCT00483756|524761002|FG000|Overall Study|Death|2|||
145519412|NCT00483756|524761003|FG001|Overall Study|Death|0|||
145519413|NCT00483756|524761004|FG002|Overall Study|Death|1|||
145519414|NCT00483756|524761002|FG000|Overall Study|Adverse Event|19|||
145519415|NCT00483756|524761003|FG001|Overall Study|Adverse Event|38|||
145519416|NCT00483756|524761004|FG002|Overall Study|Adverse Event|40|||
145519417|NCT00483756|524761002|FG000|Overall Study|Lack of Efficacy|1|||
145519418|NCT00483756|524761003|FG001|Overall Study|Lack of Efficacy|0|||
145519419|NCT00483756|524761004|FG002|Overall Study|Lack of Efficacy|0|||
145519420|NCT00483756|524761002|FG000|Overall Study|Lost to Follow-up|3|||
145519421|NCT00483756|524761003|FG001|Overall Study|Lost to Follow-up|1|||
145519422|NCT00483756|524761004|FG002|Overall Study|Lost to Follow-up|0|||
145519423|NCT00483756|524761002|FG000|Overall Study|Withdrawal by Subject|5|||
145519424|NCT00483756|524761003|FG001|Overall Study|Withdrawal by Subject|3|||
145519425|NCT00483756|524761004|FG002|Overall Study|Withdrawal by Subject|4|||
145519426|NCT00483756|524761002|FG000|Overall Study|Other|2|||
145519427|NCT00483756|524761003|FG001|Overall Study|Other|4|||
145519428|NCT00483756|524761004|FG002|Overall Study|Other|3|||
145519429|NCT00483756|524761002|FG000|Overall Study|Randomized, Not Treated|1|||
145519430|NCT00483756|524761003|FG001|Overall Study|Randomized, Not Treated|4|||
145519431|NCT00483756|524761004|FG002|Overall Study|Randomized, Not Treated|4|||
145519432|NCT01947855|524761005|FG000|Overall Study|Withdrawal by Subject|1|||
145519433|NCT01947855|524761006|FG001|Overall Study|Withdrawal by Subject|0|||
145519434|NCT01947855|524761007|FG002|Overall Study|Withdrawal by Subject|0|||
145519435|NCT02282293|524761011|FG000|Overall Study|Lost to Follow-up|2|||
145519436|NCT02282293|524761012|FG001|Overall Study|Lost to Follow-up|2|||
145519437|NCT02282293|524761011|FG000|Overall Study|Unable to comply with study procedures|1|||
145519438|NCT02282293|524761012|FG001|Overall Study|Unable to comply with study procedures|0|||
145519439|NCT02282293|524761011|FG000|Overall Study|Moved out of study area|0|||
145270167|NCT00471237|523837831|FG001|Overall Study|Lost to Follow-up|1|||
145270168|NCT00471237|523837832|FG002|Overall Study|Lost to Follow-up|0|||
145270169|NCT00471237|523837833|FG003|Overall Study|Lost to Follow-up|2|||
145519440|NCT02282293|524761012|FG001|Overall Study|Moved out of study area|1|||
145519441|NCT00608569|524761013|FG000|Overall Study|Death|4|||
145519442|NCT00608569|524761014|FG001|Overall Study|Death|3|||
145519443|NCT00608569|524761013|FG000|Overall Study|Lost to Follow-up|4|||
145519444|NCT00608569|524761014|FG001|Overall Study|Lost to Follow-up|5|||
145519445|NCT00608569|524761013|FG000|Overall Study|Withdrawal by Subject|1|||
145519446|NCT00608569|524761014|FG001|Overall Study|Withdrawal by Subject|0|||
145519447|NCT00608569|524761013|FG000|Overall Study|Adverse Event|1|||
145519448|NCT00608569|524761014|FG001|Overall Study|Adverse Event|0|||
145519449|NCT00608569|524761013|FG000|Overall Study|Unable to adhere with study requirements|0|||
145519450|NCT00608569|524761014|FG001|Overall Study|Unable to adhere with study requirements|1|||
145519451|NCT03011892|524761015|FG000|Double Blind (DB) Period|Adverse Event|0|||
145270170|NCT00471237|523837834|FG004|Overall Study|Lost to Follow-up|3|||
145519452|NCT03011892|524761016|FG001|Double Blind (DB) Period|Adverse Event|1|||
145519453|NCT03011892|524761017|FG002|Double Blind (DB) Period|Adverse Event|1|||
145519454|NCT03011892|524761018|FG003|Double Blind (DB) Period|Adverse Event|0|||
145519455|NCT03011892|524761019|FG004|Double Blind (DB) Period|Adverse Event|0|||
145519456|NCT03011892|524761020|FG005|Double Blind (DB) Period|Adverse Event|0|||
145519457|NCT03011892|524761021|FG006|Double Blind (DB) Period|Adverse Event|0|||
145270171|NCT00471237|523837835|FG005|Overall Study|Lost to Follow-up|0|||
145270172|NCT00471237|523837836|FG006|Overall Study|Lost to Follow-up|0|||
145270173|NCT00471237|523837830|FG000|Overall Study|Protocol Violation|3|||
145270174|NCT00471237|523837831|FG001|Overall Study|Protocol Violation|6|||
145270175|NCT00471237|523837832|FG002|Overall Study|Protocol Violation|3|||
145270176|NCT00471237|523837833|FG003|Overall Study|Protocol Violation|2|||
145270177|NCT00471237|523837834|FG004|Overall Study|Protocol Violation|2|||
145270178|NCT00471237|523837835|FG005|Overall Study|Protocol Violation|4|||
145270179|NCT00471237|523837836|FG006|Overall Study|Protocol Violation|1|||
145270180|NCT00471237|523837830|FG000|Overall Study|Withdrawal by Subject|8|||
145270181|NCT00471237|523837831|FG001|Overall Study|Withdrawal by Subject|6|||
145270182|NCT00471237|523837832|FG002|Overall Study|Withdrawal by Subject|5|||
145270183|NCT00471237|523837833|FG003|Overall Study|Withdrawal by Subject|8|||
145270184|NCT00471237|523837834|FG004|Overall Study|Withdrawal by Subject|7|||
145270185|NCT00471237|523837835|FG005|Overall Study|Withdrawal by Subject|4|||
145270186|NCT00471237|523837836|FG006|Overall Study|Withdrawal by Subject|2|||
145270187|NCT00471237|523837830|FG000|Overall Study|Sponsor terminated study|20|||
145270188|NCT00471237|523837831|FG001|Overall Study|Sponsor terminated study|23|||
145270189|NCT00471237|523837832|FG002|Overall Study|Sponsor terminated study|19|||
145270190|NCT00471237|523837833|FG003|Overall Study|Sponsor terminated study|22|||
145270191|NCT00471237|523837834|FG004|Overall Study|Sponsor terminated study|18|||
145270192|NCT00471237|523837835|FG005|Overall Study|Sponsor terminated study|24|||
145270193|NCT00471237|523837836|FG006|Overall Study|Sponsor terminated study|0|||
145270194|NCT00471237|523837830|FG000|Overall Study|Non-compliance|0|||
145270195|NCT00471237|523837831|FG001|Overall Study|Non-compliance|1|||
145270196|NCT00471237|523837832|FG002|Overall Study|Non-compliance|0|||
145270197|NCT00471237|523837833|FG003|Overall Study|Non-compliance|1|||
145270198|NCT00471237|523837834|FG004|Overall Study|Non-compliance|0|||
145519458|NCT03011892|524761022|FG007|Double Blind (DB) Period|Adverse Event|0|||
145519459|NCT03011892|524761023|FG008|Double Blind (DB) Period|Adverse Event|0|||
145270199|NCT00471237|523837835|FG005|Overall Study|Non-compliance|0|||
145270200|NCT00471237|523837836|FG006|Overall Study|Non-compliance|0|||
145270201|NCT00471237|523837830|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
145270202|NCT00471237|523837831|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
145270203|NCT00471237|523837832|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
145270204|NCT00471237|523837833|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
145270205|NCT00471237|523837834|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
145270206|NCT00471237|523837835|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
145270207|NCT00471237|523837836|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
145270208|NCT00471237|523837830|FG000|Overall Study|Early stopping due to non-efficacy|1|||
145270209|NCT00471237|523837831|FG001|Overall Study|Early stopping due to non-efficacy|0|||
145270210|NCT00471237|523837832|FG002|Overall Study|Early stopping due to non-efficacy|0|||
145270211|NCT00471237|523837833|FG003|Overall Study|Early stopping due to non-efficacy|0|||
145270212|NCT00471237|523837834|FG004|Overall Study|Early stopping due to non-efficacy|1|||
145519460|NCT03011892|524761024|FG009|Double Blind (DB) Period|Adverse Event|0|||
145519461|NCT03011892|524761025|FG010|Double Blind (DB) Period|Adverse Event|0|||
145519462|NCT03011892|524761026|FG011|Double Blind (DB) Period|Adverse Event|0|||
145519463|NCT03011892|524761015|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
145519464|NCT03011892|524761016|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
145519465|NCT03011892|524761017|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
145519466|NCT03011892|524761018|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
145519467|NCT03011892|524761019|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
145519468|NCT03011892|524761020|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
145519469|NCT03011892|524761021|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
145519470|NCT03011892|524761022|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
145519471|NCT03011892|524761023|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
145270213|NCT00471237|523837835|FG005|Overall Study|Early stopping due to non-efficacy|0|||
145270214|NCT00471237|523837836|FG006|Overall Study|Early stopping due to non-efficacy|0|||
145270215|NCT00471237|523837830|FG000|Overall Study|Participant planned to travel to abraod|1|||
145270216|NCT00471237|523837831|FG001|Overall Study|Participant planned to travel to abraod|0|||
145270217|NCT00471237|523837832|FG002|Overall Study|Participant planned to travel to abraod|0|||
145270218|NCT00471237|523837833|FG003|Overall Study|Participant planned to travel to abraod|0|||
145270219|NCT00471237|523837834|FG004|Overall Study|Participant planned to travel to abraod|0|||
145270220|NCT00471237|523837835|FG005|Overall Study|Participant planned to travel to abraod|1|||
145270221|NCT00471237|523837836|FG006|Overall Study|Participant planned to travel to abraod|0|||
145270222|NCT00471237|523837830|FG000|Overall Study|High parathyroid hormone|0|||
145519472|NCT03011892|524761024|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
145519473|NCT03011892|524761025|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
145519474|NCT03011892|524761026|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
145519475|NCT03011892|524761015|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
145519476|NCT03011892|524761016|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
145519477|NCT03011892|524761017|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
145519478|NCT03011892|524761018|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
145743537|NCT00841568|525577337|FG000|Overall Study|Death|1|||
145519479|NCT03011892|524761019|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
145519480|NCT03011892|524761020|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
145519481|NCT03011892|524761021|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
145519482|NCT03011892|524761022|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
145519483|NCT03011892|524761023|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
145519484|NCT03011892|524761024|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
145519485|NCT03011892|524761025|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
145519486|NCT03011892|524761026|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
145519487|NCT03011892|524761015|FG000|Double Blind (DB) Period|Other|1|||
145519488|NCT03011892|524761016|FG001|Double Blind (DB) Period|Other|1|||
145519489|NCT03011892|524761017|FG002|Double Blind (DB) Period|Other|1|||
145519490|NCT03011892|524761018|FG003|Double Blind (DB) Period|Other|0|||
145519491|NCT03011892|524761019|FG004|Double Blind (DB) Period|Other|1|||
145519492|NCT03011892|524761020|FG005|Double Blind (DB) Period|Other|0|||
145519493|NCT03011892|524761021|FG006|Double Blind (DB) Period|Other|0|||
145519494|NCT03011892|524761022|FG007|Double Blind (DB) Period|Other|0|||
145519495|NCT03011892|524761023|FG008|Double Blind (DB) Period|Other|0|||
145519496|NCT03011892|524761024|FG009|Double Blind (DB) Period|Other|0|||
145519497|NCT03011892|524761025|FG010|Double Blind (DB) Period|Other|0|||
145519498|NCT03011892|524761026|FG011|Double Blind (DB) Period|Other|0|||
145519499|NCT03011892|524761015|FG000|Double Blind (DB) Period|Physician Decision|1|||
145519500|NCT03011892|524761016|FG001|Double Blind (DB) Period|Physician Decision|0|||
145519501|NCT03011892|524761017|FG002|Double Blind (DB) Period|Physician Decision|1|||
145519502|NCT03011892|524761018|FG003|Double Blind (DB) Period|Physician Decision|0|||
145519503|NCT03011892|524761019|FG004|Double Blind (DB) Period|Physician Decision|0|||
145519504|NCT03011892|524761020|FG005|Double Blind (DB) Period|Physician Decision|0|||
145519505|NCT03011892|524761021|FG006|Double Blind (DB) Period|Physician Decision|0|||
145519506|NCT03011892|524761022|FG007|Double Blind (DB) Period|Physician Decision|0|||
145519507|NCT03011892|524761023|FG008|Double Blind (DB) Period|Physician Decision|0|||
145519508|NCT03011892|524761024|FG009|Double Blind (DB) Period|Physician Decision|0|||
145519509|NCT03011892|524761025|FG010|Double Blind (DB) Period|Physician Decision|0|||
145519510|NCT03011892|524761026|FG011|Double Blind (DB) Period|Physician Decision|0|||
145519511|NCT03011892|524761015|FG000|Double Blind (DB) Period|Pregnancy|0|||
145519512|NCT03011892|524761016|FG001|Double Blind (DB) Period|Pregnancy|0|||
145519513|NCT03011892|524761017|FG002|Double Blind (DB) Period|Pregnancy|0|||
145519514|NCT03011892|524761018|FG003|Double Blind (DB) Period|Pregnancy|0|||
145519515|NCT03011892|524761019|FG004|Double Blind (DB) Period|Pregnancy|1|||
145519516|NCT03011892|524761020|FG005|Double Blind (DB) Period|Pregnancy|0|||
145519517|NCT03011892|524761021|FG006|Double Blind (DB) Period|Pregnancy|0|||
145519518|NCT03011892|524761022|FG007|Double Blind (DB) Period|Pregnancy|0|||
145519519|NCT03011892|524761023|FG008|Double Blind (DB) Period|Pregnancy|0|||
145519520|NCT03011892|524761024|FG009|Double Blind (DB) Period|Pregnancy|0|||
145519521|NCT03011892|524761025|FG010|Double Blind (DB) Period|Pregnancy|0|||
145519522|NCT03011892|524761026|FG011|Double Blind (DB) Period|Pregnancy|0|||
145519523|NCT03011892|524761015|FG000|Double Blind (DB) Period|Protocol Violation|1|||
145519524|NCT03011892|524761016|FG001|Double Blind (DB) Period|Protocol Violation|0|||
145519525|NCT03011892|524761017|FG002|Double Blind (DB) Period|Protocol Violation|0|||
145270223|NCT00471237|523837831|FG001|Overall Study|High parathyroid hormone|0|||
145519526|NCT03011892|524761018|FG003|Double Blind (DB) Period|Protocol Violation|0|||
145519527|NCT03011892|524761019|FG004|Double Blind (DB) Period|Protocol Violation|0|||
145519528|NCT03011892|524761020|FG005|Double Blind (DB) Period|Protocol Violation|0|||
145519529|NCT03011892|524761021|FG006|Double Blind (DB) Period|Protocol Violation|0|||
145519530|NCT03011892|524761022|FG007|Double Blind (DB) Period|Protocol Violation|0|||
145519531|NCT03011892|524761023|FG008|Double Blind (DB) Period|Protocol Violation|0|||
145519532|NCT03011892|524761024|FG009|Double Blind (DB) Period|Protocol Violation|0|||
145519533|NCT03011892|524761025|FG010|Double Blind (DB) Period|Protocol Violation|0|||
145519534|NCT03011892|524761026|FG011|Double Blind (DB) Period|Protocol Violation|0|||
145519535|NCT03011892|524761015|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
145519536|NCT03011892|524761016|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
145519537|NCT03011892|524761017|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
145519538|NCT03011892|524761018|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
145519539|NCT03011892|524761019|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
145519540|NCT03011892|524761020|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
145519541|NCT03011892|524761021|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519542|NCT03011892|524761022|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519543|NCT03011892|524761023|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519544|NCT03011892|524761024|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519545|NCT03011892|524761025|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519546|NCT03011892|524761026|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
145519547|NCT03011892|524761015|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
145519548|NCT03011892|524761016|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
145519549|NCT03011892|524761017|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
145519550|NCT03011892|524761018|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
145519551|NCT03011892|524761019|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
145519552|NCT03011892|524761020|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
145519553|NCT03011892|524761021|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
145519554|NCT03011892|524761022|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
145519555|NCT03011892|524761023|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
145519556|NCT03011892|524761024|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
145519557|NCT03011892|524761025|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
145519558|NCT03011892|524761026|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
145519559|NCT03011892|524761015|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
145519560|NCT03011892|524761016|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
145519561|NCT03011892|524761017|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
145519562|NCT03011892|524761018|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
145519563|NCT03011892|524761019|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
145519564|NCT03011892|524761020|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
145519565|NCT03011892|524761021|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
145519566|NCT03011892|524761022|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
145519567|NCT03011892|524761023|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
145519568|NCT03011892|524761024|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
145519569|NCT03011892|524761025|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
145519570|NCT03011892|524761026|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
145519571|NCT03011892|524761015|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
145519572|NCT03011892|524761016|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
145519573|NCT03011892|524761017|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
145519574|NCT03011892|524761018|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
145519575|NCT03011892|524761019|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
145519576|NCT03011892|524761020|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
145519577|NCT03011892|524761021|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
145519578|NCT03011892|524761022|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
145519579|NCT03011892|524761023|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
145519580|NCT03011892|524761024|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
145519581|NCT03011892|524761025|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
145519582|NCT03011892|524761026|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
145519583|NCT03011892|524761015|FG000|Open Label (OL) Period|Reason not specified|0|||
145519584|NCT03011892|524761016|FG001|Open Label (OL) Period|Reason not specified|0|||
145519585|NCT03011892|524761017|FG002|Open Label (OL) Period|Reason not specified|0|||
145519586|NCT03011892|524761018|FG003|Open Label (OL) Period|Reason not specified|0|||
145519587|NCT03011892|524761019|FG004|Open Label (OL) Period|Reason not specified|0|||
145519588|NCT03011892|524761020|FG005|Open Label (OL) Period|Reason not specified|0|||
145519589|NCT03011892|524761021|FG006|Open Label (OL) Period|Reason not specified|0|||
145519590|NCT03011892|524761022|FG007|Open Label (OL) Period|Reason not specified|1|||
145519591|NCT03011892|524761023|FG008|Open Label (OL) Period|Reason not specified|0|||
145519592|NCT03011892|524761024|FG009|Open Label (OL) Period|Reason not specified|0|||
145519593|NCT03011892|524761025|FG010|Open Label (OL) Period|Reason not specified|0|||
145519594|NCT03011892|524761026|FG011|Open Label (OL) Period|Reason not specified|0|||
145519595|NCT02312687|524761039|FG000|Overall Study|Other, Not Specified|1|||
145519596|NCT00384111|524761040|FG000|Overall Study|Disease Progression|3|||
145519597|NCT00384111|524761040|FG000|Overall Study|Adverse Event|1|||
145519598|NCT00384111|524761040|FG000|Overall Study|Investigator Decision|3|||
145519599|NCT00384111|524761040|FG000|Overall Study|Study Terminated by the Sponsor|19|||
145519600|NCT03645434|524761046|FG000|Period 1|Adverse Event|0|||
145519601|NCT03645434|524761047|FG001|Period 1|Adverse Event|0|||
145519602|NCT03645434|524761048|FG002|Period 1|Adverse Event|0|||
145519603|NCT03645434|524761049|FG003|Period 1|Adverse Event|1|||
145519604|NCT03645434|524761050|FG004|Period 1|Adverse Event|0|||
145519605|NCT03645434|524761051|FG005|Period 1|Adverse Event|0|||
145519606|NCT03645434|524761046|FG000|Period 1|COPD exacerbation|0|||
145519607|NCT03645434|524761047|FG001|Period 1|COPD exacerbation|0|||
145519608|NCT03645434|524761048|FG002|Period 1|COPD exacerbation|0|||
145519609|NCT03645434|524761049|FG003|Period 1|COPD exacerbation|0|||
145519610|NCT03645434|524761050|FG004|Period 1|COPD exacerbation|1|||
145519611|NCT03645434|524761051|FG005|Period 1|COPD exacerbation|0|||
145519612|NCT00167778|524761052|FG000|Overall Study|Withdrawal by Subject|1|||
145519613|NCT02654717|524761053|FG000|Overall Study|Adverse Event|2|||
145519614|NCT02654717|524761054|FG001|Overall Study|Adverse Event|2|||
145519615|NCT02654717|524761053|FG000|Overall Study|Protocol Violation|1|||
145519616|NCT02654717|524761054|FG001|Overall Study|Protocol Violation|2|||
145519617|NCT02654717|524761053|FG000|Overall Study|Withdrawal by Subject|0|||
145519618|NCT02654717|524761054|FG001|Overall Study|Withdrawal by Subject|1|||
145519619|NCT02654717|524761053|FG000|Overall Study|Non-permitted medication|3|||
145519620|NCT02654717|524761054|FG001|Overall Study|Non-permitted medication|0|||
145519621|NCT02055365|524762150|FG000|Overall Study|Prematurely Withdrawn|1|||
145519622|NCT00336583|524762152|FG000|Overall Study|Lost to Follow-up|1|||
145519623|NCT00336583|524762152|FG000|Overall Study|Death|1|||
145519624|NCT01264081|524762153|FG000|Participants Screened|Screening failures|30|||
145519625|NCT01264081|524762153|FG000|Started Treatment|Withdrawal by Subject|1|||
145270224|NCT00471237|523837832|FG002|Overall Study|High parathyroid hormone|1|||
145270225|NCT00471237|523837833|FG003|Overall Study|High parathyroid hormone|0|||
145270226|NCT00471237|523837834|FG004|Overall Study|High parathyroid hormone|0|||
145270227|NCT00471237|523837835|FG005|Overall Study|High parathyroid hormone|0|||
145270228|NCT00471237|523837836|FG006|Overall Study|High parathyroid hormone|0|||
145270229|NCT00471237|523837830|FG000|Overall Study|Participant lost medication|0|||
145270230|NCT00471237|523837831|FG001|Overall Study|Participant lost medication|0|||
145270231|NCT00471237|523837832|FG002|Overall Study|Participant lost medication|0|||
145270232|NCT00471237|523837833|FG003|Overall Study|Participant lost medication|0|||
145270233|NCT00471237|523837834|FG004|Overall Study|Participant lost medication|1|||
145270234|NCT00471237|523837835|FG005|Overall Study|Participant lost medication|0|||
145270235|NCT00471237|523837836|FG006|Overall Study|Participant lost medication|0|||
145270236|NCT00471237|523837830|FG000|Overall Study|Administration of prohibited medicine|0|||
145270237|NCT00471237|523837831|FG001|Overall Study|Administration of prohibited medicine|0|||
145270238|NCT00471237|523837832|FG002|Overall Study|Administration of prohibited medicine|0|||
145270239|NCT00471237|523837833|FG003|Overall Study|Administration of prohibited medicine|0|||
145270240|NCT00471237|523837834|FG004|Overall Study|Administration of prohibited medicine|1|||
145270241|NCT00471237|523837835|FG005|Overall Study|Administration of prohibited medicine|0|||
145270242|NCT00471237|523837836|FG006|Overall Study|Administration of prohibited medicine|0|||
145270243|NCT00471237|523837830|FG000|Overall Study|Participant shifted residence|0|||
145270244|NCT00471237|523837831|FG001|Overall Study|Participant shifted residence|0|||
145270245|NCT00471237|523837832|FG002|Overall Study|Participant shifted residence|0|||
145270246|NCT00471237|523837833|FG003|Overall Study|Participant shifted residence|0|||
145270247|NCT00471237|523837834|FG004|Overall Study|Participant shifted residence|1|||
145270248|NCT00471237|523837835|FG005|Overall Study|Participant shifted residence|0|||
145270249|NCT00471237|523837836|FG006|Overall Study|Participant shifted residence|0|||
145270250|NCT00471237|523837830|FG000|Overall Study|Participant's decision|0|||
145270251|NCT00471237|523837831|FG001|Overall Study|Participant's decision|0|||
145270252|NCT00471237|523837832|FG002|Overall Study|Participant's decision|0|||
145270253|NCT00471237|523837833|FG003|Overall Study|Participant's decision|0|||
145270254|NCT00471237|523837834|FG004|Overall Study|Participant's decision|0|||
145270255|NCT00471237|523837835|FG005|Overall Study|Participant's decision|1|||
145270256|NCT00471237|523837836|FG006|Overall Study|Participant's decision|0|||
145270257|NCT03710824|523837837|FG000|Overall Study|Withdrawal by Subject|1|||
145270258|NCT03710824|523837837|FG000|Overall Study|Lost to Follow-up|3|||
145270259|NCT03710824|523837837|FG000|Overall Study|Adverse Event|25|||
145270260|NCT03710824|523837837|FG000|Overall Study|Treatment discontinuation|2|||
145270261|NCT02329834|523837838|FG000|Overall Study|Physician Decision|1|||
145270262|NCT02329834|523837839|FG001|Overall Study|Physician Decision|0|||
145270263|NCT01317199|523837840|FG000|Dose-escalation Phase 1|Physician Decision|5|||
145270264|NCT01317199|523837841|FG001|Dose-escalation Phase 1|Physician Decision|0|||
145270265|NCT01317199|523837842|FG002|Dose-escalation Phase 1|Physician Decision|0|||
145270266|NCT01317199|523837843|FG003|Dose-escalation Phase 1|Physician Decision|0|||
145270267|NCT01317199|523837840|FG000|Dose-escalation Phase 1|Disease progression|1|||
145270268|NCT01317199|523837841|FG001|Dose-escalation Phase 1|Disease progression|0|||
145270269|NCT01317199|523837842|FG002|Dose-escalation Phase 1|Disease progression|0|||
145270270|NCT01317199|523837843|FG003|Dose-escalation Phase 1|Disease progression|0|||
145270271|NCT01317199|523837840|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
145270272|NCT01317199|523837841|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
145270273|NCT01317199|523837842|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
145270274|NCT01317199|523837843|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
145270275|NCT01317199|523837840|FG000|Randomized Phase 2|Disease progression|0|||
145270276|NCT01317199|523837841|FG001|Randomized Phase 2|Disease progression|3|||
145270277|NCT01317199|523837842|FG002|Randomized Phase 2|Disease progression|7|||
145270278|NCT01317199|523837843|FG003|Randomized Phase 2|Disease progression|5|||
145270279|NCT01317199|523837840|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
145270280|NCT01317199|523837841|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
145270281|NCT01317199|523837842|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
145270282|NCT01317199|523837843|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
145270283|NCT01317199|523837840|FG000|Randomized Phase 2|Adverse Event|0|||
145270284|NCT01317199|523837841|FG001|Randomized Phase 2|Adverse Event|0|||
145270285|NCT01317199|523837842|FG002|Randomized Phase 2|Adverse Event|0|||
145270286|NCT01317199|523837843|FG003|Randomized Phase 2|Adverse Event|1|||
145270287|NCT01317199|523837840|FG000|Randomized Phase 2|Comorbidities|0|||
145270288|NCT01317199|523837841|FG001|Randomized Phase 2|Comorbidities|2|||
145270289|NCT01317199|523837842|FG002|Randomized Phase 2|Comorbidities|2|||
145270290|NCT01317199|523837843|FG003|Randomized Phase 2|Comorbidities|2|||
145270291|NCT01317199|523837840|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
145270292|NCT01317199|523837841|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
145270293|NCT01317199|523837842|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
145270294|NCT01317199|523837843|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
145270295|NCT01317199|523837840|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
145270296|NCT01317199|523837841|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
145519626|NCT01264081|524762153|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
145519627|NCT02716896|524762154|FG000|Overall Study|Physician Decision|0|||
145519628|NCT02716896|524762155|FG001|Overall Study|Physician Decision|1|||
145519629|NCT01727700|524762156|FG000|Overall Study|Adverse Event|0|||
145519630|NCT01727700|524762157|FG001|Overall Study|Adverse Event|7|||
145519631|NCT01727700|524762158|FG002|Overall Study|Adverse Event|1|||
145519632|NCT01727700|524762156|FG000|Overall Study|Particpant withdrew consent|0|||
145519633|NCT01727700|524762157|FG001|Overall Study|Particpant withdrew consent|3|||
145519634|NCT01727700|524762158|FG002|Overall Study|Particpant withdrew consent|1|||
145519635|NCT01727700|524762156|FG000|Overall Study|Protocol Violation|2|||
145519636|NCT01727700|524762157|FG001|Overall Study|Protocol Violation|0|||
145519637|NCT01727700|524762158|FG002|Overall Study|Protocol Violation|0|||
145519638|NCT02054481|524762161|FG000|Overall Study|Adverse Event|1|||
145519639|NCT02054481|524762162|FG001|Overall Study|Adverse Event|1|||
145519640|NCT02054481|524762163|FG002|Overall Study|Adverse Event|0|||
145519641|NCT02054481|524762164|FG003|Overall Study|Adverse Event|1|||
145519642|NCT02054481|524762161|FG000|Overall Study|Lost to Follow-up|1|||
145519643|NCT02054481|524762162|FG001|Overall Study|Lost to Follow-up|0|||
145519644|NCT02054481|524762163|FG002|Overall Study|Lost to Follow-up|0|||
145519645|NCT02054481|524762164|FG003|Overall Study|Lost to Follow-up|0|||
145519646|NCT02054481|524762161|FG000|Overall Study|Other reason|2|||
145519647|NCT02054481|524762162|FG001|Overall Study|Other reason|1|||
145519648|NCT02054481|524762163|FG002|Overall Study|Other reason|2|||
145519649|NCT02054481|524762164|FG003|Overall Study|Other reason|0|||
145519650|NCT02320903|524762165|FG000|Overall Study|Withdrawal by Subject|0|||
145519651|NCT02320903|524762166|FG001|Overall Study|Withdrawal by Subject|9|||
145519652|NCT02320903|524762167|FG002|Overall Study|Withdrawal by Subject|9|||
145519653|NCT02320903|524762165|FG000|Overall Study|Exited therapy; no longer eligible|8|||
145519654|NCT02320903|524762166|FG001|Overall Study|Exited therapy; no longer eligible|2|||
145519655|NCT02320903|524762167|FG002|Overall Study|Exited therapy; no longer eligible|2|||
145519656|NCT02320903|524762165|FG000|Overall Study|Lost to Follow-up|0|||
145519657|NCT02320903|524762166|FG001|Overall Study|Lost to Follow-up|5|||
145519658|NCT02320903|524762167|FG002|Overall Study|Lost to Follow-up|5|||
145519659|NCT00883688|524762168|FG000|Overall Study|Ineligible|2|||
145519660|NCT03086967|524762175|FG000|Overall Study|Screen Failure|2|||
145270297|NCT01317199|523837842|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
145270298|NCT01317199|523837843|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
145270299|NCT01317199|523837840|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
145270300|NCT01317199|523837841|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
145270301|NCT01317199|523837842|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
145270302|NCT01317199|523837843|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
145270303|NCT01317199|523837840|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
145270304|NCT01317199|523837841|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
145270305|NCT01317199|523837842|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
145270306|NCT01317199|523837843|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
145270307|NCT01301625|523837849|FG000|Overall Study|Death|5|||
145270308|NCT01301625|523837849|FG000|Overall Study|Not Due|21|||
145270309|NCT01301625|523837849|FG000|Overall Study|Expected|8|||
145270310|NCT01301625|523837849|FG000|Overall Study|Lost to Follow-up|1|||
145270311|NCT03237325|523837852|FG000|Overall Study|Lost to Follow-up|3|||
145270312|NCT03237325|523837853|FG001|Overall Study|Lost to Follow-up|5|||
145270313|NCT03237325|523837852|FG000|Overall Study|Physician Decision|2|||
145270314|NCT03237325|523837853|FG001|Overall Study|Physician Decision|4|||
145270315|NCT03237325|523837852|FG000|Overall Study|Withdrawal by Subject|9|||
145270316|NCT03237325|523837853|FG001|Overall Study|Withdrawal by Subject|12|||
145270317|NCT03237325|523837852|FG000|Overall Study|Noncompliance with Study Procedures|1|||
145270318|NCT03237325|523837853|FG001|Overall Study|Noncompliance with Study Procedures|1|||
145270319|NCT03237325|523837852|FG000|Overall Study|Termination by Sponsor|0|||
145402443|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
145519661|NCT03086967|524762176|FG001|Overall Study|Screen Failure|2|||
145519662|NCT01475071|524762183|FG000|Overall Study|Physician Decision|1|||
145519663|NCT01475071|524762183|FG000|Overall Study|Withdrawal by Subject|6|||
145519664|NCT01475071|524762183|FG000|Overall Study|Lost to Follow-up|1|||
145519665|NCT04461600|524762185|FG000|Overall Study|Death|6|||
145519666|NCT04461600|524762186|FG001|Overall Study|Death|5|||
145519667|NCT04461600|524762185|FG000|Overall Study|Withdrawal by Subject|0|||
145519668|NCT04461600|524762186|FG001|Overall Study|Withdrawal by Subject|1|||
145519669|NCT02278471|524762190|FG000|Overall Study|Lost to Follow-up|6|||
145519670|NCT02278471|524762191|FG001|Overall Study|Lost to Follow-up|15|||
145519671|NCT02278471|524762190|FG000|Overall Study|Death|2|||
145519672|NCT02278471|524762191|FG001|Overall Study|Death|2|||
145519673|NCT02278471|524762190|FG000|Overall Study|Withdrawal by Subject|0|||
145519674|NCT02278471|524762191|FG001|Overall Study|Withdrawal by Subject|3|||
145519675|NCT00640835|524762192|FG000|Overall Study|Adverse Event|5|||
145743538|NCT00841568|525577337|FG000|Overall Study|Withdrawal by Subject|2|||
145270320|NCT03237325|523837853|FG001|Overall Study|Termination by Sponsor|1|||
145519676|NCT00640835|524762193|FG001|Overall Study|Adverse Event|3|||
145519677|NCT00640835|524762192|FG000|Overall Study|Withdrawal by Subject|12|||
145519678|NCT00640835|524762193|FG001|Overall Study|Withdrawal by Subject|14|||
145519679|NCT00640835|524762192|FG000|Overall Study|Physician Decision|10|||
145519680|NCT00640835|524762193|FG001|Overall Study|Physician Decision|14|||
145519681|NCT00640835|524762192|FG000|Overall Study|Sponsor's Decision|11|||
145519682|NCT00640835|524762193|FG001|Overall Study|Sponsor's Decision|7|||
145519683|NCT00640835|524762192|FG000|Overall Study|Protocol Violation|2|||
145519684|NCT00640835|524762193|FG001|Overall Study|Protocol Violation|2|||
145519685|NCT00640835|524762192|FG000|Overall Study|Lost to Follow-up|17|||
145519686|NCT00640835|524762193|FG001|Overall Study|Lost to Follow-up|13|||
145519687|NCT00640835|524762192|FG000|Overall Study|Other Reason|19|||
145519688|NCT00640835|524762193|FG001|Overall Study|Other Reason|4|||
145519689|NCT01437995|524762194|FG000|Overall Study|Lost to Follow-up|11|||
145519690|NCT01437995|524762195|FG001|Overall Study|Lost to Follow-up|18|||
145519691|NCT01437995|524762196|FG002|Overall Study|Lost to Follow-up|20|||
145519692|NCT03874429|524762197|FG000|Overall Study|Adverse Event|2|||
145519693|NCT03874429|524762198|FG001|Overall Study|Adverse Event|2|||
145519694|NCT03874429|524762197|FG000|Overall Study|Lack of Efficacy|0|||
145519695|NCT03874429|524762198|FG001|Overall Study|Lack of Efficacy|1|||
145519696|NCT03874429|524762197|FG000|Overall Study|Covid-19 pandemic|4|||
145519697|NCT03874429|524762198|FG001|Overall Study|Covid-19 pandemic|2|||
145519698|NCT00775203|524762199|FG000|Overall Study|Adverse Event|25|||
145519699|NCT00775203|524762200|FG001|Overall Study|Adverse Event|6|||
145519700|NCT00775203|524762199|FG000|Overall Study|Lack of Efficacy|8|||
145519701|NCT00775203|524762200|FG001|Overall Study|Lack of Efficacy|9|||
145519702|NCT00775203|524762199|FG000|Overall Study|Withdrawal by Subject|11|||
145519703|NCT00775203|524762200|FG001|Overall Study|Withdrawal by Subject|9|||
145519704|NCT00775203|524762199|FG000|Overall Study|Lost to Follow-up|11|||
145519705|NCT00775203|524762200|FG001|Overall Study|Lost to Follow-up|15|||
145519706|NCT00775203|524762199|FG000|Overall Study|Administrative reason|2|||
145519707|NCT00775203|524762200|FG001|Overall Study|Administrative reason|0|||
145519708|NCT00775203|524762199|FG000|Overall Study|Noncompliance|4|||
145519709|NCT00775203|524762200|FG001|Overall Study|Noncompliance|2|||
145519710|NCT00775203|524762199|FG000|Overall Study|Protocol Violation|0|||
145519711|NCT00775203|524762200|FG001|Overall Study|Protocol Violation|1|||
145519712|NCT00775203|524762199|FG000|Overall Study|Entered other study|1|||
145519713|NCT00775203|524762200|FG001|Overall Study|Entered other study|0|||
145519714|NCT00775203|524762199|FG000|Overall Study|Physician Decision|0|||
145519715|NCT00775203|524762200|FG001|Overall Study|Physician Decision|1|||
145519716|NCT00704522|524762201|FG000|Overall Study|Lack of Efficacy|65|||
145519717|NCT00704522|524762202|FG001|Overall Study|Lack of Efficacy|17|||
145519718|NCT00704522|524762201|FG000|Overall Study|Failure to appear again at hospital|56|||
145519719|NCT00704522|524762202|FG001|Overall Study|Failure to appear again at hospital|10|||
145519720|NCT00704522|524762201|FG000|Overall Study|Withdrawal by Subject|17|||
145519721|NCT00704522|524762202|FG001|Overall Study|Withdrawal by Subject|8|||
145519722|NCT00704522|524762201|FG000|Overall Study|Adverse Event|9|||
145519723|NCT00704522|524762202|FG001|Overall Study|Adverse Event|1|||
145519724|NCT00704522|524762201|FG000|Overall Study|Undefined causes|9|||
145519725|NCT00704522|524762202|FG001|Overall Study|Undefined causes|7|||
145519726|NCT00704522|524762201|FG000|Overall Study|No information on therapy end|27|||
145519727|NCT00704522|524762202|FG001|Overall Study|No information on therapy end|2|||
145519728|NCT04896229|524762204|FG000|Overall Study|Lost to Follow-up|113|||
145519729|NCT04896229|524762205|FG001|Overall Study|Lost to Follow-up|113|||
145519730|NCT04418661|524762206|FG000|Overall Study|Adverse Event|0|||
145519731|NCT04418661|524762207|FG001|Overall Study|Adverse Event|1|||
145519732|NCT04418661|524762208|FG002|Overall Study|Adverse Event|5|||
145519733|NCT04418661|524762209|FG003|Overall Study|Adverse Event|3|||
145519734|NCT04418661|524762210|FG004|Overall Study|Adverse Event|0|||
145519735|NCT04418661|524762211|FG005|Overall Study|Adverse Event|2|||
145519736|NCT04418661|524762206|FG000|Overall Study|Progressive disease|4|||
145519737|NCT04418661|524762207|FG001|Overall Study|Progressive disease|11|||
145519738|NCT04418661|524762208|FG002|Overall Study|Progressive disease|6|||
145519739|NCT04418661|524762209|FG003|Overall Study|Progressive disease|11|||
145519740|NCT04418661|524762210|FG004|Overall Study|Progressive disease|1|||
145519741|NCT04418661|524762211|FG005|Overall Study|Progressive disease|12|||
145519742|NCT04418661|524762206|FG000|Overall Study|Withdrawal by Subject|0|||
145519743|NCT04418661|524762207|FG001|Overall Study|Withdrawal by Subject|1|||
145519744|NCT04418661|524762208|FG002|Overall Study|Withdrawal by Subject|0|||
145519745|NCT04418661|524762209|FG003|Overall Study|Withdrawal by Subject|1|||
145519746|NCT04418661|524762210|FG004|Overall Study|Withdrawal by Subject|0|||
145519747|NCT04418661|524762211|FG005|Overall Study|Withdrawal by Subject|0|||
145519748|NCT04418661|524762206|FG000|Overall Study|Other|0|||
145519749|NCT04418661|524762207|FG001|Overall Study|Other|0|||
145519750|NCT04418661|524762208|FG002|Overall Study|Other|1|||
145519751|NCT04418661|524762209|FG003|Overall Study|Other|3|||
145519752|NCT04418661|524762210|FG004|Overall Study|Other|0|||
145519753|NCT04418661|524762211|FG005|Overall Study|Other|1|||
145519754|NCT00329901|524762214|FG000|Overall Study|Withdrawal by Subject|4|||
145519755|NCT00329901|524762215|FG001|Overall Study|Withdrawal by Subject|3|||
145519756|NCT00329901|524762216|FG002|Overall Study|Withdrawal by Subject|2|||
145519757|NCT00329901|524762214|FG000|Overall Study|Lost to Follow-up|2|||
145519758|NCT00329901|524762215|FG001|Overall Study|Lost to Follow-up|0|||
145519759|NCT00329901|524762216|FG002|Overall Study|Lost to Follow-up|1|||
145519760|NCT00329901|524762214|FG000|Overall Study|Protocol Violation|1|||
145519761|NCT00329901|524762215|FG001|Overall Study|Protocol Violation|0|||
145519762|NCT00329901|524762216|FG002|Overall Study|Protocol Violation|1|||
145519763|NCT00329901|524762214|FG000|Overall Study|Unable to classify|2|||
145519764|NCT00329901|524762215|FG001|Overall Study|Unable to classify|2|||
145519765|NCT00329901|524762216|FG002|Overall Study|Unable to classify|0|||
145519766|NCT00992589|524762217|FG000|Open-Label Phase|Adverse Event|4|||
145519767|NCT00992589|524762218|FG001|Open-Label Phase|Adverse Event|0|||
145519768|NCT00992589|524762219|FG002|Open-Label Phase|Adverse Event|0|||
145519769|NCT00992589|524762220|FG003|Open-Label Phase|Adverse Event|0|||
145519770|NCT00992589|524762217|FG000|Open-Label Phase|Withdrawal by Subject|20|||
145519771|NCT00992589|524762218|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145519772|NCT00992589|524762219|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145519773|NCT00992589|524762220|FG003|Open-Label Phase|Withdrawal by Subject|0|||
145519774|NCT00992589|524762217|FG000|Open-Label Phase|Lost to Follow-up|1|||
145519775|NCT00992589|524762218|FG001|Open-Label Phase|Lost to Follow-up|0|||
145519776|NCT00992589|524762219|FG002|Open-Label Phase|Lost to Follow-up|0|||
145519777|NCT00992589|524762220|FG003|Open-Label Phase|Lost to Follow-up|0|||
145519778|NCT00992589|524762217|FG000|Open-Label Phase|Protocol Violation|3|||
145519779|NCT00992589|524762218|FG001|Open-Label Phase|Protocol Violation|0|||
145519780|NCT00992589|524762219|FG002|Open-Label Phase|Protocol Violation|0|||
145519781|NCT00992589|524762220|FG003|Open-Label Phase|Protocol Violation|0|||
145519782|NCT00992589|524762217|FG000|Open-Label Phase|Physician Decision|4|||
145519783|NCT00992589|524762218|FG001|Open-Label Phase|Physician Decision|0|||
145519784|NCT00992589|524762219|FG002|Open-Label Phase|Physician Decision|0|||
145519785|NCT00992589|524762220|FG003|Open-Label Phase|Physician Decision|0|||
145519786|NCT00992589|524762217|FG000|Open-Label Phase|Other|45|||
145519787|NCT00992589|524762218|FG001|Open-Label Phase|Other|0|||
145519788|NCT00992589|524762219|FG002|Open-Label Phase|Other|0|||
145519789|NCT00992589|524762220|FG003|Open-Label Phase|Other|0|||
145519790|NCT00992589|524762217|FG000|Double-Blind Phase|Adverse Event|0|||
145519791|NCT00992589|524762218|FG001|Double-Blind Phase|Adverse Event|6|||
145519792|NCT00992589|524762219|FG002|Double-Blind Phase|Adverse Event|2|||
145519793|NCT00992589|524762220|FG003|Double-Blind Phase|Adverse Event|3|||
145519794|NCT00992589|524762217|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145519795|NCT00992589|524762218|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
145519796|NCT00992589|524762219|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
145519797|NCT00992589|524762220|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
145519798|NCT00992589|524762217|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145519799|NCT00992589|524762218|FG001|Double-Blind Phase|Lost to Follow-up|0|||
145519800|NCT00992589|524762219|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145519801|NCT00992589|524762220|FG003|Double-Blind Phase|Lost to Follow-up|2|||
145519802|NCT00992589|524762217|FG000|Double-Blind Phase|Other|0|||
145519803|NCT00992589|524762218|FG001|Double-Blind Phase|Other|1|||
145519804|NCT00992589|524762219|FG002|Double-Blind Phase|Other|6|||
145519805|NCT00992589|524762220|FG003|Double-Blind Phase|Other|3|||
145519806|NCT00045942|524762221|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
145519807|NCT00045942|524762222|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519808|NCT00045942|524762223|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519809|NCT00045942|524762224|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519810|NCT00045942|524762225|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519811|NCT00045942|524762226|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519812|NCT00045942|524762227|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519813|NCT00045942|524762228|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519814|NCT00045942|524762229|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
145519815|NCT00045942|524762221|FG000|PKC412A2104 (Core)|Adverse Event|5|||
145519816|NCT00045942|524762222|FG001|PKC412A2104 (Core)|Adverse Event|0|||
145519817|NCT00045942|524762223|FG002|PKC412A2104 (Core)|Adverse Event|0|||
145519818|NCT00045942|524762224|FG003|PKC412A2104 (Core)|Adverse Event|0|||
145519819|NCT00045942|524762225|FG004|PKC412A2104 (Core)|Adverse Event|0|||
145519820|NCT00045942|524762226|FG005|PKC412A2104 (Core)|Adverse Event|0|||
145519821|NCT00045942|524762227|FG006|PKC412A2104 (Core)|Adverse Event|0|||
145519822|NCT00045942|524762228|FG007|PKC412A2104 (Core)|Adverse Event|0|||
145519823|NCT00045942|524762229|FG008|PKC412A2104 (Core)|Adverse Event|0|||
145519824|NCT00045942|524762221|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
145519825|NCT00045942|524762222|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519826|NCT00045942|524762223|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519827|NCT00045942|524762224|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519828|NCT00045942|524762225|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519829|NCT00045942|524762226|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519830|NCT00045942|524762227|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519831|NCT00045942|524762228|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519832|NCT00045942|524762229|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
145519833|NCT00045942|524762221|FG000|PKC412A2104 (Core)|Death|1|||
145519834|NCT00045942|524762222|FG001|PKC412A2104 (Core)|Death|0|||
145519835|NCT00045942|524762223|FG002|PKC412A2104 (Core)|Death|0|||
145519836|NCT00045942|524762224|FG003|PKC412A2104 (Core)|Death|0|||
145519837|NCT00045942|524762225|FG004|PKC412A2104 (Core)|Death|0|||
145519838|NCT00045942|524762226|FG005|PKC412A2104 (Core)|Death|0|||
145519839|NCT00045942|524762227|FG006|PKC412A2104 (Core)|Death|0|||
145519840|NCT00045942|524762228|FG007|PKC412A2104 (Core)|Death|0|||
145519841|NCT00045942|524762229|FG008|PKC412A2104 (Core)|Death|0|||
145519842|NCT00045942|524762221|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
145519843|NCT00045942|524762222|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
145519844|NCT00045942|524762223|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
145519845|NCT00045942|524762224|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
145519846|NCT00045942|524762225|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
145519847|NCT00045942|524762226|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
145519848|NCT00045942|524762227|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
145519849|NCT00045942|524762228|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
145519850|NCT00045942|524762229|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
145519851|NCT00045942|524762221|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
145519852|NCT00045942|524762222|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
145519853|NCT00045942|524762223|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
145519854|NCT00045942|524762224|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
145519855|NCT00045942|524762225|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
145519856|NCT00045942|524762226|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
145519857|NCT00045942|524762227|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
145519858|NCT00045942|524762228|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
145519859|NCT00045942|524762229|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
145519860|NCT00045942|524762221|FG000|PKC412A2104E1|Lack of Efficacy|0|||
145519861|NCT00045942|524762222|FG001|PKC412A2104E1|Lack of Efficacy|11|||
145519862|NCT00045942|524762223|FG002|PKC412A2104E1|Lack of Efficacy|11|||
145519863|NCT00045942|524762224|FG003|PKC412A2104E1|Lack of Efficacy|23|||
145519864|NCT00045942|524762225|FG004|PKC412A2104E1|Lack of Efficacy|17|||
145519865|NCT00045942|524762226|FG005|PKC412A2104E1|Lack of Efficacy|0|||
145519866|NCT00045942|524762227|FG006|PKC412A2104E1|Lack of Efficacy|0|||
145519867|NCT00045942|524762228|FG007|PKC412A2104E1|Lack of Efficacy|0|||
145519868|NCT00045942|524762229|FG008|PKC412A2104E1|Lack of Efficacy|0|||
145519869|NCT00045942|524762221|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
145519870|NCT00045942|524762222|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
145519871|NCT00045942|524762223|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
145519872|NCT00045942|524762224|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
145519873|NCT00045942|524762225|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
145519874|NCT00045942|524762226|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
145519875|NCT00045942|524762227|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
145519876|NCT00045942|524762228|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
145519877|NCT00045942|524762229|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
145519878|NCT00045942|524762221|FG000|PKC412A2104E1|Adverse Event|0|||
145519879|NCT00045942|524762222|FG001|PKC412A2104E1|Adverse Event|1|||
145519880|NCT00045942|524762223|FG002|PKC412A2104E1|Adverse Event|1|||
145519881|NCT00045942|524762224|FG003|PKC412A2104E1|Adverse Event|3|||
145519882|NCT00045942|524762225|FG004|PKC412A2104E1|Adverse Event|6|||
145519883|NCT00045942|524762226|FG005|PKC412A2104E1|Adverse Event|0|||
145519884|NCT00045942|524762227|FG006|PKC412A2104E1|Adverse Event|0|||
145519885|NCT00045942|524762228|FG007|PKC412A2104E1|Adverse Event|0|||
145519886|NCT00045942|524762229|FG008|PKC412A2104E1|Adverse Event|0|||
145519887|NCT00045942|524762221|FG000|PKC412A2104E1|Death|0|||
145519888|NCT00045942|524762222|FG001|PKC412A2104E1|Death|4|||
145519889|NCT00045942|524762223|FG002|PKC412A2104E1|Death|1|||
145519890|NCT00045942|524762224|FG003|PKC412A2104E1|Death|1|||
145519891|NCT00045942|524762225|FG004|PKC412A2104E1|Death|1|||
145519892|NCT00045942|524762226|FG005|PKC412A2104E1|Death|0|||
145743539|NCT00841568|525577337|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
145743540|NCT00545298|525577338|FG000|Overall Study|Issues with Standard of Care|2|||
145743541|NCT00545298|525577339|FG001|Overall Study|Issues with Standard of Care|0|||
145519893|NCT00045942|524762227|FG006|PKC412A2104E1|Death|0|||
145519894|NCT00045942|524762228|FG007|PKC412A2104E1|Death|0|||
145519895|NCT00045942|524762229|FG008|PKC412A2104E1|Death|0|||
145519896|NCT00045942|524762221|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519897|NCT00045942|524762222|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519898|NCT00045942|524762223|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
145519899|NCT00045942|524762224|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
145519900|NCT00045942|524762225|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519901|NCT00045942|524762226|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519902|NCT00045942|524762227|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519903|NCT00045942|524762228|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519904|NCT00045942|524762229|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
145519905|NCT00045942|524762221|FG000|PKC412A2104E2|Lost to Follow-up|0|||
145519906|NCT00045942|524762222|FG001|PKC412A2104E2|Lost to Follow-up|0|||
145519907|NCT00045942|524762223|FG002|PKC412A2104E2|Lost to Follow-up|0|||
145519908|NCT00045942|524762224|FG003|PKC412A2104E2|Lost to Follow-up|0|||
145519909|NCT00045942|524762225|FG004|PKC412A2104E2|Lost to Follow-up|0|||
145519910|NCT00045942|524762226|FG005|PKC412A2104E2|Lost to Follow-up|0|||
145519911|NCT00045942|524762227|FG006|PKC412A2104E2|Lost to Follow-up|0|||
145519912|NCT00045942|524762228|FG007|PKC412A2104E2|Lost to Follow-up|3|||
145519913|NCT00045942|524762229|FG008|PKC412A2104E2|Lost to Follow-up|0|||
145270321|NCT03237325|523837852|FG000|Overall Study|Reason other than described|0|||
145270322|NCT03237325|523837853|FG001|Overall Study|Reason other than described|2|||
145270323|NCT02684370|523837855|FG000|Part A|Adverse Event|2|||
145270324|NCT02684370|523837856|FG001|Part A|Adverse Event|0|||
145270325|NCT02684370|523837857|FG002|Part A|Adverse Event|1|||
145270326|NCT02684370|523837858|FG003|Part A|Adverse Event|0|||
145519914|NCT00045942|524762221|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
145519915|NCT00045942|524762222|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
145519916|NCT00045942|524762223|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
145519917|NCT00045942|524762224|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
145519918|NCT00045942|524762225|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
145519919|NCT00045942|524762226|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
145519920|NCT00045942|524762227|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
145519921|NCT00045942|524762228|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
145519922|NCT00045942|524762229|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
145519923|NCT00045942|524762221|FG000|PKC412A2104E2|Lack of Efficacy|0|||
145519924|NCT00045942|524762222|FG001|PKC412A2104E2|Lack of Efficacy|0|||
145519925|NCT00045942|524762223|FG002|PKC412A2104E2|Lack of Efficacy|0|||
145519926|NCT00045942|524762224|FG003|PKC412A2104E2|Lack of Efficacy|0|||
145519927|NCT00045942|524762225|FG004|PKC412A2104E2|Lack of Efficacy|0|||
145519928|NCT00045942|524762226|FG005|PKC412A2104E2|Lack of Efficacy|3|||
145519929|NCT00045942|524762227|FG006|PKC412A2104E2|Lack of Efficacy|2|||
145519930|NCT00045942|524762228|FG007|PKC412A2104E2|Lack of Efficacy|2|||
145519931|NCT00045942|524762229|FG008|PKC412A2104E2|Lack of Efficacy|6|||
145519932|NCT00045942|524762221|FG000|PKC412A2104E2|Adverse Event|0|||
145519933|NCT00045942|524762222|FG001|PKC412A2104E2|Adverse Event|0|||
145519934|NCT00045942|524762223|FG002|PKC412A2104E2|Adverse Event|0|||
145270327|NCT02684370|523837859|FG004|Part A|Adverse Event|0|||
145270328|NCT02684370|523837860|FG005|Part A|Adverse Event|0|||
145270329|NCT02684370|523837855|FG000|Part A|Lost to Follow-up|1|||
145270330|NCT02684370|523837856|FG001|Part A|Lost to Follow-up|1|||
145270331|NCT02684370|523837857|FG002|Part A|Lost to Follow-up|0|||
145270332|NCT02684370|523837858|FG003|Part A|Lost to Follow-up|0|||
145270333|NCT02684370|523837859|FG004|Part A|Lost to Follow-up|0|||
145270334|NCT02684370|523837860|FG005|Part A|Lost to Follow-up|0|||
145270335|NCT02684370|523837855|FG000|Part A|Subject Withdrawal|1|||
145270336|NCT02684370|523837856|FG001|Part A|Subject Withdrawal|0|||
145270337|NCT02684370|523837857|FG002|Part A|Subject Withdrawal|3|||
145270338|NCT02684370|523837858|FG003|Part A|Subject Withdrawal|0|||
145270339|NCT02684370|523837859|FG004|Part A|Subject Withdrawal|0|||
145270340|NCT02684370|523837860|FG005|Part A|Subject Withdrawal|0|||
145270341|NCT02684370|523837855|FG000|Part A|Other|0|||
145270342|NCT02684370|523837856|FG001|Part A|Other|0|||
145270343|NCT02684370|523837857|FG002|Part A|Other|1|||
145270344|NCT02684370|523837858|FG003|Part A|Other|0|||
145270345|NCT02684370|523837859|FG004|Part A|Other|0|||
145270346|NCT02684370|523837860|FG005|Part A|Other|0|||
145270347|NCT02684370|523837855|FG000|Part B|Adverse Event|0|||
145270348|NCT02684370|523837856|FG001|Part B|Adverse Event|0|||
145270349|NCT02684370|523837857|FG002|Part B|Adverse Event|0|||
145519935|NCT00045942|524762224|FG003|PKC412A2104E2|Adverse Event|0|||
145519936|NCT00045942|524762225|FG004|PKC412A2104E2|Adverse Event|0|||
145519937|NCT00045942|524762226|FG005|PKC412A2104E2|Adverse Event|4|||
145519938|NCT00045942|524762227|FG006|PKC412A2104E2|Adverse Event|3|||
145270350|NCT02684370|523837858|FG003|Part B|Adverse Event|0|||
145270351|NCT02684370|523837859|FG004|Part B|Adverse Event|2|||
145270352|NCT02684370|523837860|FG005|Part B|Adverse Event|1|||
145270353|NCT02684370|523837855|FG000|Part B|Lost to Follow-up|0|||
145270354|NCT02684370|523837856|FG001|Part B|Lost to Follow-up|0|||
145270355|NCT02684370|523837857|FG002|Part B|Lost to Follow-up|0|||
145270356|NCT02684370|523837858|FG003|Part B|Lost to Follow-up|1|||
145270357|NCT02684370|523837859|FG004|Part B|Lost to Follow-up|2|||
145270358|NCT02684370|523837860|FG005|Part B|Lost to Follow-up|5|||
145519939|NCT00045942|524762228|FG007|PKC412A2104E2|Adverse Event|1|||
145519940|NCT00045942|524762229|FG008|PKC412A2104E2|Adverse Event|0|||
145519941|NCT00045942|524762221|FG000|PKC412A2104E2|Death|0|||
145519942|NCT00045942|524762222|FG001|PKC412A2104E2|Death|0|||
145519943|NCT00045942|524762223|FG002|PKC412A2104E2|Death|0|||
145519944|NCT00045942|524762224|FG003|PKC412A2104E2|Death|0|||
145519945|NCT00045942|524762225|FG004|PKC412A2104E2|Death|0|||
145519946|NCT00045942|524762226|FG005|PKC412A2104E2|Death|1|||
145270359|NCT02684370|523837855|FG000|Part B|Subject Withdrawal|0|||
145270360|NCT02684370|523837856|FG001|Part B|Subject Withdrawal|0|||
145270361|NCT02684370|523837857|FG002|Part B|Subject Withdrawal|0|||
145270362|NCT02684370|523837858|FG003|Part B|Subject Withdrawal|1|||
145270363|NCT02684370|523837859|FG004|Part B|Subject Withdrawal|1|||
145270364|NCT02684370|523837860|FG005|Part B|Subject Withdrawal|2|||
145270365|NCT04139642|523837866|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
145743542|NCT00545298|525577340|FG002|Overall Study|Issues with Standard of Care|1|||
145270366|NCT04139642|523837867|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
145270367|NCT00138658|523837872|FG000|Overall Study|Adverse Event|23|||
145270368|NCT00138658|523837872|FG000|Overall Study|Death|1|||
145270369|NCT00138658|523837872|FG000|Overall Study|Disease Progression|21|||
145270370|NCT00138658|523837872|FG000|Overall Study|Physician Decision|11|||
145270371|NCT00138658|523837872|FG000|Overall Study|Withdrawal by Subject|5|||
145270372|NCT03733301|523837873|FG000|Overall Study|Screen Fail|1|||
145270373|NCT03733301|523837874|FG001|Overall Study|Screen Fail|0|||
145270374|NCT03733301|523837875|FG002|Overall Study|Screen Fail|0|||
145270375|NCT03733301|523837873|FG000|Overall Study|Non-compliance|1|||
145270376|NCT03733301|523837874|FG001|Overall Study|Non-compliance|0|||
145270377|NCT03733301|523837875|FG002|Overall Study|Non-compliance|0|||
145270378|NCT03733301|523837873|FG000|Overall Study|Lack of Efficacy|2|||
145270379|NCT03733301|523837874|FG001|Overall Study|Lack of Efficacy|3|||
145270380|NCT03733301|523837875|FG002|Overall Study|Lack of Efficacy|0|||
145270381|NCT03733301|523837873|FG000|Overall Study|Adverse Event|0|||
145270382|NCT03733301|523837874|FG001|Overall Study|Adverse Event|1|||
145270383|NCT03733301|523837875|FG002|Overall Study|Adverse Event|3|||
145270384|NCT03733301|523837873|FG000|Overall Study|Withdrawal by Subject|3|||
145270385|NCT03733301|523837874|FG001|Overall Study|Withdrawal by Subject|5|||
145270386|NCT03733301|523837875|FG002|Overall Study|Withdrawal by Subject|1|||
145270387|NCT02050373|523837876|FG000|Overall Study|Adverse Event|4|||
145270388|NCT02050373|523837877|FG001|Overall Study|Adverse Event|7|||
145270389|NCT02050373|523837876|FG000|Overall Study|Death|3|||
145270390|NCT02050373|523837877|FG001|Overall Study|Death|3|||
145270391|NCT01102972|523837881|FG000|Overall Study|Adverse Event|8|||
145270392|NCT01102972|523837882|FG001|Overall Study|Adverse Event|2|||
145270393|NCT01102972|523837881|FG000|Overall Study|Lack of Efficacy|2|||
145270394|NCT01102972|523837882|FG001|Overall Study|Lack of Efficacy|1|||
145270395|NCT01102972|523837881|FG000|Overall Study|Protocol Violation|1|||
145270396|NCT01102972|523837882|FG001|Overall Study|Protocol Violation|0|||
145270397|NCT01102972|523837881|FG000|Overall Study|Lost to Follow-up|10|||
145270398|NCT01102972|523837882|FG001|Overall Study|Lost to Follow-up|5|||
145270399|NCT01102972|523837881|FG000|Overall Study|Investigator Discretion|2|||
145270400|NCT01102972|523837882|FG001|Overall Study|Investigator Discretion|0|||
145270401|NCT01102972|523837881|FG000|Overall Study|Withdrawal by Subject|6|||
145270402|NCT01102972|523837882|FG001|Overall Study|Withdrawal by Subject|6|||
145270403|NCT01856257|523837883|FG000|Overall Study|Death|2|||
145519947|NCT00045942|524762227|FG006|PKC412A2104E2|Death|2|||
145519948|NCT00045942|524762228|FG007|PKC412A2104E2|Death|0|||
145519949|NCT00045942|524762229|FG008|PKC412A2104E2|Death|0|||
145519950|NCT01101308|524762230|FG000|Period 1|Adverse Event|2|||
145519951|NCT01101308|524762231|FG001|Period 1|Adverse Event|1|||
145519952|NCT01101308|524762230|FG000|Period 1|Positive for cotinine|1|||
145743543|NCT00978029|525577341|FG000|Overall Study|Adverse Event|1|||
145743544|NCT00978029|525577342|FG001|Overall Study|Adverse Event|2|||
145270404|NCT01856257|523837884|FG001|Overall Study|Death|0|||
145270405|NCT01856257|523837885|FG002|Overall Study|Death|0|||
145270406|NCT01856257|523837886|FG003|Overall Study|Death|0|||
145270407|NCT01856257|523837883|FG000|Overall Study|Physician Decision|0|||
145270408|NCT01856257|523837884|FG001|Overall Study|Physician Decision|0|||
145270409|NCT01856257|523837885|FG002|Overall Study|Physician Decision|0|||
145270410|NCT01856257|523837886|FG003|Overall Study|Physician Decision|1|||
145270411|NCT01856257|523837883|FG000|Overall Study|Withdrawal by Subject|1|||
145270412|NCT01856257|523837884|FG001|Overall Study|Withdrawal by Subject|1|||
145270413|NCT01856257|523837885|FG002|Overall Study|Withdrawal by Subject|0|||
145519953|NCT01101308|524762231|FG001|Period 1|Positive for cotinine|0|||
145519954|NCT02984943|524762232|FG000|Overall Study|Withdrawal by Subject|3|||
145519955|NCT02984943|524762232|FG000|Overall Study|Physician Decision|1|||
145519956|NCT00711516|524762237|FG000|Overall Study|Adverse Event|1|||
145743545|NCT00978029|525577343|FG002|Overall Study|Adverse Event|5|||
145270414|NCT01856257|523837886|FG003|Overall Study|Withdrawal by Subject|0|||
145270415|NCT01856257|523837883|FG000|Overall Study|Donor complication|0|||
145270416|NCT01856257|523837884|FG001|Overall Study|Donor complication|0|||
145270417|NCT01856257|523837885|FG002|Overall Study|Donor complication|0|||
145270418|NCT01856257|523837886|FG003|Overall Study|Donor complication|1|||
145270419|NCT03664024|523837890|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
145270420|NCT03664024|523837890|FG000|Overall Study|Lost to Follow-up|2|||
145270421|NCT03664024|523837890|FG000|Overall Study|Withdrawal by Subject|2|||
145270422|NCT03664024|523837890|FG000|Overall Study|Death|80|||
145270423|NCT01157065|523837891|FG000|Overall Study|Death|0|||
145270424|NCT01157065|523837892|FG001|Overall Study|Death|1|||
145270425|NCT05275673|523837895|FG000|Overall Study|Study Termination by Sponsor|2|||
145270426|NCT05275673|523837896|FG001|Overall Study|Study Termination by Sponsor|3|||
145519957|NCT00711516|524762238|FG001|Overall Study|Adverse Event|1|||
145270427|NCT05275673|523837895|FG000|Overall Study|Death|1|||
145270428|NCT05275673|523837896|FG001|Overall Study|Death|0|||
145519958|NCT00711516|524762237|FG000|Overall Study|Withdrawal by Subject|0|||
145743546|NCT00978029|525577341|FG000|Overall Study|Withdrawal by Subject|0|||
145519959|NCT00711516|524762238|FG001|Overall Study|Withdrawal by Subject|1|||
145519960|NCT00711516|524762237|FG000|Overall Study|Protocol Violation|0|||
145519961|NCT00711516|524762238|FG001|Overall Study|Protocol Violation|1|||
145519962|NCT01895361|524762242|FG000|Overall Study|Adverse Event|1|||
145519963|NCT01895361|524762243|FG001|Overall Study|Adverse Event|1|||
145519964|NCT01895361|524762244|FG002|Overall Study|Adverse Event|3|||
145519965|NCT01895361|524762242|FG000|Overall Study|Death|2|||
145519966|NCT01895361|524762243|FG001|Overall Study|Death|1|||
145519967|NCT01895361|524762244|FG002|Overall Study|Death|2|||
145519968|NCT01895361|524762242|FG000|Overall Study|Lost to Follow-up|4|||
145519969|NCT01895361|524762243|FG001|Overall Study|Lost to Follow-up|4|||
145519970|NCT01895361|524762244|FG002|Overall Study|Lost to Follow-up|6|||
145519971|NCT01895361|524762242|FG000|Overall Study|Non-compliance with study|1|||
145519972|NCT01895361|524762243|FG001|Overall Study|Non-compliance with study|3|||
145743547|NCT00978029|525577342|FG001|Overall Study|Withdrawal by Subject|0|||
145743548|NCT00978029|525577343|FG002|Overall Study|Withdrawal by Subject|1|||
145743549|NCT00978029|525577341|FG000|Overall Study|Protocol Violation|0|||
145743550|NCT00978029|525577342|FG001|Overall Study|Protocol Violation|1|||
145519973|NCT01895361|524762244|FG002|Overall Study|Non-compliance with study|1|||
145519974|NCT01895361|524762242|FG000|Overall Study|Physician Decision|2|||
145519975|NCT01895361|524762243|FG001|Overall Study|Physician Decision|2|||
145519976|NCT01895361|524762244|FG002|Overall Study|Physician Decision|2|||
145519977|NCT01895361|524762242|FG000|Overall Study|Withdrawal by Subject|7|||
145519978|NCT01895361|524762243|FG001|Overall Study|Withdrawal by Subject|6|||
145519979|NCT01895361|524762244|FG002|Overall Study|Withdrawal by Subject|6|||
145519980|NCT01895361|524762242|FG000|Overall Study|Lack of Efficacy|0|||
145519981|NCT01895361|524762243|FG001|Overall Study|Lack of Efficacy|1|||
145519982|NCT01895361|524762244|FG002|Overall Study|Lack of Efficacy|0|||
145519983|NCT01895361|524762242|FG000|Overall Study|Reasons different from categories above|7|||
145519984|NCT01895361|524762243|FG001|Overall Study|Reasons different from categories above|3|||
145519985|NCT01895361|524762244|FG002|Overall Study|Reasons different from categories above|4|||
145519986|NCT01209832|524762248|FG000|Period 1|Sponsor Decision and was not dosed|1|||
145519987|NCT01209832|524762248|FG000|Period 2|Sponsor Decision|1|||
145519988|NCT02692651|524762249|FG000|Study Treatment|Death|7|||
145519989|NCT02692651|524762250|FG001|Study Treatment|Death|3|||
145519990|NCT02692651|524762249|FG000|Study Treatment|comfort care|1|||
145519991|NCT02692651|524762250|FG001|Study Treatment|comfort care|1|||
145519992|NCT02692651|524762249|FG000|Study Treatment|Protocol violation per treating team preference|8|||
145519993|NCT02692651|524762250|FG001|Study Treatment|Protocol violation per treating team preference|6|||
145519994|NCT02692651|524762249|FG000|Post Study Treatment Follow-up|Death|4|||
145519995|NCT02692651|524762250|FG001|Post Study Treatment Follow-up|Death|4|||
145519996|NCT01860846|524762251|FG000|Overall Study|Lost to Follow-up|33|||
145519997|NCT00466687|524762252|FG000|Overall Study|Adverse Event|1|||
145519998|NCT00466687|524762252|FG000|Overall Study|Other complicating illness|3|||
145519999|NCT00466687|524762252|FG000|Overall Study|Withdrawal by Subject|1|||
145520000|NCT00466687|524762252|FG000|Overall Study|Disease progression|29|||
145520001|NCT01159431|524762259|FG000|Overall Study|Adverse Event|1|||
145520002|NCT01159431|524762260|FG001|Overall Study|Adverse Event|2|||
145520003|NCT01159431|524762259|FG000|Overall Study|non-compliance|1|||
145520004|NCT01159431|524762260|FG001|Overall Study|non-compliance|1|||
145520005|NCT01159431|524762259|FG000|Overall Study|Lack of Efficacy|0|||
145520006|NCT01159431|524762260|FG001|Overall Study|Lack of Efficacy|3|||
145520007|NCT00534599|524762262|FG000|Overall Study|Adverse Event|25|||
145520008|NCT00534599|524762263|FG001|Overall Study|Adverse Event|4|||
145520009|NCT00534599|524762262|FG000|Overall Study|Incorrect enrollment|2|||
145520010|NCT00534599|524762263|FG001|Overall Study|Incorrect enrollment|1|||
145520011|NCT00534599|524762262|FG000|Overall Study|Mis-randomization|2|||
145520012|NCT00534599|524762263|FG001|Overall Study|Mis-randomization|2|||
145520013|NCT00534599|524762262|FG000|Overall Study|Developed study-specific d/c criteria|5|||
145520014|NCT00534599|524762263|FG001|Overall Study|Developed study-specific d/c criteria|0|||
145520015|NCT00534599|524762262|FG000|Overall Study|Lack of Efficacy|0|||
145520016|NCT00534599|524762263|FG001|Overall Study|Lack of Efficacy|1|||
145743551|NCT00978029|525577343|FG002|Overall Study|Protocol Violation|0|||
145520017|NCT00534599|524762262|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
145520018|NCT00534599|524762263|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
145520019|NCT00534599|524762262|FG000|Overall Study|Protocol Violation|1|||
145520020|NCT00534599|524762263|FG001|Overall Study|Protocol Violation|3|||
145520021|NCT00534599|524762262|FG000|Overall Study|Lost to Follow-up|11|||
145520022|NCT00534599|524762263|FG001|Overall Study|Lost to Follow-up|14|||
145520023|NCT00534599|524762262|FG000|Overall Study|Withdrawal by Subject|4|||
145520024|NCT00534599|524762263|FG001|Overall Study|Withdrawal by Subject|6|||
145520025|NCT00534599|524762262|FG000|Overall Study|Other|7|||
145520026|NCT00534599|524762263|FG001|Overall Study|Other|0|||
145520027|NCT00773383|524764089|FG000|Overall Study|Adverse Event|4|||
145520028|NCT00773383|524764089|FG000|Overall Study|Death|1|||
145520029|NCT00773383|524764089|FG000|Overall Study|Progression of Disease|23|||
145520030|NCT00773383|524764089|FG000|Overall Study|Other|2|||
145743552|NCT01793142|525577344|FG000|Overall Study|Randomized not treated|7|||
145520031|NCT00773383|524764089|FG000|Overall Study|No study dose received|1|||
145520032|NCT03384693|524764090|FG000|Overall Study|Adverse Event|3|||
145520033|NCT01095094|524764093|FG000|Overall Study|Withdrawal by Subject|1|||
145520034|NCT01095094|524764093|FG000|Overall Study|Death|1|||
145520035|NCT01095094|524764093|FG000|Overall Study|Physician Decision|1|||
145520036|NCT03699475|524764095|FG000|Overall Study|Death|1|||
145520037|NCT00137839|524764096|FG000|Overall Study|Adverse Event|7|||
145520038|NCT00137839|524764096|FG000|Overall Study|Physician Decision|7|||
145520039|NCT00137839|524764096|FG000|Overall Study|Death|8|||
145520040|NCT00137839|524764096|FG000|Overall Study|Disease Progression|60|||
145520041|NCT00137839|524764096|FG000|Overall Study|Not Start Treatment|1|||
145520042|NCT00137839|524764096|FG000|Overall Study|Prolonged Treatment Delay|1|||
145520043|NCT00528970|524764097|FG000|Overall Study|Adverse Event|6|||
145520044|NCT00528970|524764098|FG001|Overall Study|Adverse Event|8|||
145520045|NCT00528970|524764099|FG002|Overall Study|Adverse Event|5|||
145520046|NCT00528970|524764097|FG000|Overall Study|Lost to Follow-up|0|||
145520047|NCT00528970|524764098|FG001|Overall Study|Lost to Follow-up|0|||
145520048|NCT00528970|524764099|FG002|Overall Study|Lost to Follow-up|1|||
145520049|NCT00528970|524764097|FG000|Overall Study|Other than specified|2|||
145520050|NCT00528970|524764098|FG001|Overall Study|Other than specified|3|||
145520051|NCT00528970|524764099|FG002|Overall Study|Other than specified|3|||
145520052|NCT00528970|524764097|FG000|Overall Study|Protocol Violation|2|||
145520053|NCT00528970|524764098|FG001|Overall Study|Protocol Violation|1|||
145520054|NCT00528970|524764099|FG002|Overall Study|Protocol Violation|4|||
145520055|NCT00528970|524764097|FG000|Overall Study|Lack of Efficacy|0|||
145520056|NCT00528970|524764098|FG001|Overall Study|Lack of Efficacy|0|||
145520057|NCT00528970|524764099|FG002|Overall Study|Lack of Efficacy|1|||
145520058|NCT00528970|524764097|FG000|Overall Study|Withdrawal by Subject|4|||
145520059|NCT00528970|524764098|FG001|Overall Study|Withdrawal by Subject|3|||
145520060|NCT00528970|524764099|FG002|Overall Study|Withdrawal by Subject|5|||
145520061|NCT00528970|524764097|FG000|Overall Study|Randomized but not treated|0|||
145520062|NCT00528970|524764098|FG001|Overall Study|Randomized but not treated|0|||
145520063|NCT00528970|524764099|FG002|Overall Study|Randomized but not treated|1|||
145520064|NCT01122394|524764107|FG000|Overall Study|Withdrawal by Subject|1|||
145520065|NCT01122394|524764108|FG001|Overall Study|Withdrawal by Subject|1|||
145520066|NCT01122394|524764107|FG000|Overall Study|Lost to Follow-up|2|||
145520067|NCT01122394|524764108|FG001|Overall Study|Lost to Follow-up|2|||
145520068|NCT01122394|524764107|FG000|Overall Study|Adverse Event|0|||
145520069|NCT01122394|524764108|FG001|Overall Study|Adverse Event|1|||
145520070|NCT03739242|524764109|FG000|Overall Study|Withdrawal by Subject|1|||
145520071|NCT03739242|524764110|FG001|Overall Study|Withdrawal by Subject|1|||
145520072|NCT03739242|524764109|FG000|Overall Study|Protocol Violation|0|||
145520073|NCT03739242|524764110|FG001|Overall Study|Protocol Violation|1|||
145520074|NCT02446743|524764111|FG000|Overall Study|Withdrawal by Subject|1|||
145520075|NCT02446743|524764112|FG001|Overall Study|Withdrawal by Subject|1|||
145520076|NCT02446743|524764111|FG000|Overall Study|Lost to Follow-up|1|||
145520077|NCT02446743|524764112|FG001|Overall Study|Lost to Follow-up|0|||
145520078|NCT02446743|524764111|FG000|Overall Study|Adverse Event|1|||
145520079|NCT02446743|524764112|FG001|Overall Study|Adverse Event|1|||
145520080|NCT02446743|524764111|FG000|Overall Study|Other|2|||
145520081|NCT02446743|524764112|FG001|Overall Study|Other|3|||
145520082|NCT00039871|524764113|FG000|Overall Study|Adverse Event|165|||
145520083|NCT00039871|524764113|FG000|Overall Study|Lost to Follow-up|18|||
145520084|NCT00039871|524764113|FG000|Overall Study|Protocol Violation|24|||
145520085|NCT00039871|524764113|FG000|Overall Study|Withdrawal by Subject|97|||
145520086|NCT00039871|524764113|FG000|Overall Study|Did not meet eligibility criteria|11|||
145520087|NCT00039871|524764113|FG000|Overall Study|Administrative|1|||
145520088|NCT00039871|524764113|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
145520089|NCT00039871|524764113|FG000|Overall Study|Never entered follow-up|7|||
145520090|NCT03361176|524764114|FG000|Overall Study|Lost to Follow-up|1|||
145520091|NCT03361176|524764115|FG001|Overall Study|Lost to Follow-up|2|||
145520092|NCT03361176|524764114|FG000|Overall Study|Adverse Event|0|||
145520093|NCT03361176|524764115|FG001|Overall Study|Adverse Event|2|||
145520094|NCT03361176|524764114|FG000|Overall Study|Withdrawal by Subject|0|||
145520095|NCT03361176|524764115|FG001|Overall Study|Withdrawal by Subject|1|||
145520096|NCT02478398|524764116|FG000|Overall Study|Adverse Event|20|||
145520097|NCT02478398|524764117|FG001|Overall Study|Adverse Event|5|||
145520098|NCT02478398|524764116|FG000|Overall Study|Lost to Follow-up|5|||
145520099|NCT02478398|524764117|FG001|Overall Study|Lost to Follow-up|4|||
145520100|NCT02478398|524764116|FG000|Overall Study|Non-Compliance With Study Drug|5|||
145520101|NCT02478398|524764117|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145520102|NCT02478398|524764116|FG000|Overall Study|Protocol Violation|3|||
145520103|NCT02478398|524764117|FG001|Overall Study|Protocol Violation|1|||
145520104|NCT02478398|524764116|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
145520105|NCT02478398|524764117|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
145520106|NCT02478398|524764116|FG000|Overall Study|Withdrawal By Participant|10|||
145520107|NCT02478398|524764117|FG001|Overall Study|Withdrawal By Participant|4|||
145520108|NCT02230527|524764118|FG000|Overall Study|Withdrawal by Subject|1|||
145743553|NCT01840579|525577347|FG000|Overall Study|Status not recorded|0|||
145520109|NCT02230527|524764119|FG001|Overall Study|Withdrawal by Subject|1|||
145520110|NCT02230527|524764118|FG000|Overall Study|Death|1|||
145520111|NCT02230527|524764119|FG001|Overall Study|Death|0|||
145520112|NCT02230527|524764118|FG000|Overall Study|Lost to Follow-up|2|||
145520113|NCT02230527|524764119|FG001|Overall Study|Lost to Follow-up|1|||
145520114|NCT02230527|524764118|FG000|Overall Study|Other|1|||
145520115|NCT02230527|524764119|FG001|Overall Study|Other|0|||
145520116|NCT01752036|524764120|FG000|Overall Study|Death|2|||
145520117|NCT01011478|524764121|FG000|Overall Study|No follow up data|12|||
145520118|NCT01011478|524764122|FG001|Overall Study|No follow up data|7|||
145520119|NCT04618770|524764123|FG000|Overall Study|Censored from Analysis|12|||
145520120|NCT04618770|524764123|FG000|Overall Study|Early Termination|25|||
145520121|NCT04456673|524764124|FG000|Overall Study|Adverse Event|7|||
145520122|NCT04456673|524764125|FG001|Overall Study|Adverse Event|14|||
145520123|NCT04456673|524764124|FG000|Overall Study|Poor compliance to protocol|1|||
145520124|NCT04456673|524764125|FG001|Overall Study|Poor compliance to protocol|0|||
145520125|NCT04456673|524764124|FG000|Overall Study|Withdrawal by Subject|31|||
145520126|NCT04456673|524764125|FG001|Overall Study|Withdrawal by Subject|23|||
145520127|NCT04456673|524764124|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
145520128|NCT04456673|524764125|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
145520129|NCT04391049|524764126|FG000|Overall Study|Protocol Violation|1|||
145520130|NCT04395001|524764127|FG000|Overall Study|Lost to Follow-up|8|||
145520131|NCT04395001|524764128|FG001|Overall Study|Lost to Follow-up|9|||
145520132|NCT04395001|524764129|FG002|Overall Study|Lost to Follow-up|5|||
145520133|NCT04395001|524764127|FG000|Overall Study|Withdrawal by Subject|3|||
145520134|NCT04395001|524764128|FG001|Overall Study|Withdrawal by Subject|1|||
145520135|NCT04395001|524764129|FG002|Overall Study|Withdrawal by Subject|3|||
145520136|NCT04395001|524764127|FG000|Overall Study|missed appointment|7|||
145520137|NCT04395001|524764128|FG001|Overall Study|missed appointment|4|||
145520138|NCT04395001|524764129|FG002|Overall Study|missed appointment|1|||
145520139|NCT00635024|524764130|FG000|Overall Study|Adverse Event|1|||
145520140|NCT02142387|524764132|FG000|Overall Study|<19 years old|49|||
145520141|NCT02142387|524764133|FG001|Overall Study|<19 years old|326|||
145402444|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
145520142|NCT02142387|524764132|FG000|Overall Study|non-cardiac etiology|504|||
145520143|NCT02142387|524764133|FG001|Overall Study|non-cardiac etiology|3431|||
145520144|NCT02142387|524764132|FG000|Overall Study|CPR not performed|74|||
145520145|NCT02142387|524764133|FG001|Overall Study|CPR not performed|473|||
145520146|NCT02142387|524764132|FG000|Overall Study|witnessed by paramedic|139|||
145520147|NCT02142387|524764133|FG001|Overall Study|witnessed by paramedic|917|||
145520148|NCT02142387|524764132|FG000|Overall Study|incomplete data|1|||
145520149|NCT02142387|524764133|FG001|Overall Study|incomplete data|9|||
145520150|NCT02142387|524764132|FG000|Overall Study|occurred not at home|298|||
145520151|NCT02142387|524764133|FG001|Overall Study|occurred not at home|2474|||
145743554|NCT01840579|525577348|FG001|Overall Study|Status not recorded|0|||
145743555|NCT01840579|525577349|FG002|Overall Study|Status not recorded|2|||
145520152|NCT05463198|524764140|FG000|Overall Study|Withdrawal by Subject|19|||
145520153|NCT05463198|524764140|FG000|Overall Study|Procedure Notes Missing|18|||
145520154|NCT02239120|524764143|FG000|Overall Study|Death|56|||
145520155|NCT02239120|524764144|FG001|Overall Study|Death|58|||
145520156|NCT02239120|524764143|FG000|Overall Study|Lost to Follow-up|19|||
145520157|NCT02239120|524764144|FG001|Overall Study|Lost to Follow-up|14|||
145520158|NCT00046891|524764145|FG000|Overall Study|Cancels|5|||
145520159|NCT00046891|524764146|FG001|Overall Study|Cancels|9|||
145520160|NCT00046891|524764145|FG000|Overall Study|Ineligible|1|||
145520161|NCT00046891|524764146|FG001|Overall Study|Ineligible|1|||
145520162|NCT00046891|524764145|FG000|Overall Study|Withdrawal by Subject|18|||
145520163|NCT00046891|524764146|FG001|Overall Study|Withdrawal by Subject|15|||
145520164|NCT00046891|524764145|FG000|Overall Study|Adverse Event|5|||
145520165|NCT00046891|524764146|FG001|Overall Study|Adverse Event|5|||
145520166|NCT00420641|524764149|FG000|Overall Study|Adverse Event|3|||
145520167|NCT00420641|524764150|FG001|Overall Study|Adverse Event|25|||
145520168|NCT00420641|524764151|FG002|Overall Study|Adverse Event|10|||
145520169|NCT00420641|524764149|FG000|Overall Study|Lost to Follow-up|2|||
145520170|NCT00420641|524764150|FG001|Overall Study|Lost to Follow-up|4|||
145520171|NCT00420641|524764151|FG002|Overall Study|Lost to Follow-up|2|||
145520172|NCT00420641|524764149|FG000|Overall Study|Protocol Violation|8|||
145520173|NCT00420641|524764150|FG001|Overall Study|Protocol Violation|8|||
145520174|NCT00420641|524764151|FG002|Overall Study|Protocol Violation|7|||
145520175|NCT00420641|524764149|FG000|Overall Study|Withdrawal by Subject|15|||
145520176|NCT00420641|524764150|FG001|Overall Study|Withdrawal by Subject|21|||
145520177|NCT00420641|524764151|FG002|Overall Study|Withdrawal by Subject|14|||
145520178|NCT00420641|524764149|FG000|Overall Study|Lack of Efficacy|6|||
145520179|NCT00420641|524764150|FG001|Overall Study|Lack of Efficacy|5|||
145520180|NCT00420641|524764151|FG002|Overall Study|Lack of Efficacy|4|||
145520181|NCT00420641|524764149|FG000|Overall Study|Non-compliance|7|||
145520182|NCT00420641|524764150|FG001|Overall Study|Non-compliance|5|||
145520183|NCT00420641|524764151|FG002|Overall Study|Non-compliance|4|||
145520184|NCT00420641|524764149|FG000|Overall Study|Other|4|||
145520185|NCT00420641|524764150|FG001|Overall Study|Other|4|||
145520186|NCT00420641|524764151|FG002|Overall Study|Other|3|||
145520187|NCT03459690|524764153|FG000|Overall Study|Lost to Follow-up|0|||
145520188|NCT03459690|524764154|FG001|Overall Study|Lost to Follow-up|1|||
145520189|NCT03459690|524764153|FG000|Overall Study|Withdrawal by Subject|1|||
145520190|NCT03459690|524764154|FG001|Overall Study|Withdrawal by Subject|1|||
145520191|NCT02586506|524764160|FG000|Overall Study|Protocol Violation|6|||
145520192|NCT02586506|524764160|FG000|Overall Study|Lost to Follow-up|1|||
145520193|NCT02586506|524764160|FG000|Overall Study|Other Reason|2|||
145520194|NCT02536404|524764168|FG000|Overall Study|Adverse Event|5|||
145520195|NCT02536404|524764169|FG001|Overall Study|Adverse Event|0|||
145520196|NCT02536404|524764168|FG000|Overall Study|Withdrawal by Subject|4|||
145520197|NCT02536404|524764169|FG001|Overall Study|Withdrawal by Subject|1|||
145520198|NCT02536404|524764168|FG000|Overall Study|Physician Decision|10|||
145520199|NCT02536404|524764169|FG001|Overall Study|Physician Decision|0|||
145520200|NCT02536404|524764168|FG000|Overall Study|Sponsor decision|1|||
145520201|NCT02536404|524764169|FG001|Overall Study|Sponsor decision|0|||
145520202|NCT02158364|524764170|FG000|Overall Study|Case report forms uncollected|10|||
145520203|NCT02158364|524764170|FG000|Overall Study|Protocol Deviation|50|||
145520204|NCT04381988|524764173|FG000|Overall Study|The study was terminated|4|||
145520205|NCT04381988|524764174|FG001|Overall Study|The study was terminated|0|||
145520206|NCT01944839|524764175|FG000|Overall Study|Physician Decision|2|||
145520207|NCT01944839|524764176|FG001|Overall Study|Physician Decision|2|||
145520208|NCT01944839|524764175|FG000|Overall Study|Protocol Violation|0|||
145520209|NCT01944839|524764176|FG001|Overall Study|Protocol Violation|1|||
145520210|NCT01944839|524764175|FG000|Overall Study|Adverse Event|10|||
145520211|NCT01944839|524764176|FG001|Overall Study|Adverse Event|5|||
145520212|NCT01944839|524764175|FG000|Overall Study|Withdrawal by Subject|9|||
145743556|NCT01840579|525577350|FG003|Overall Study|Status not recorded|3|||
145520213|NCT01944839|524764176|FG001|Overall Study|Withdrawal by Subject|17|||
145520214|NCT01944839|524764175|FG000|Overall Study|Lost to Follow-up|1|||
145520215|NCT01944839|524764176|FG001|Overall Study|Lost to Follow-up|0|||
145520216|NCT01944839|524764175|FG000|Overall Study|Subject non-compliance|0|||
145520217|NCT01944839|524764176|FG001|Overall Study|Subject non-compliance|3|||
145520218|NCT00609362|524764177|FG000|Overall Study|Withdrawal by Subject|2|||
145520219|NCT00609362|524764178|FG001|Overall Study|Withdrawal by Subject|1|||
145520220|NCT00609362|524764177|FG000|Overall Study|Adverse Event|1|||
145520221|NCT00609362|524764178|FG001|Overall Study|Adverse Event|0|||
145743557|NCT01840579|525577351|FG004|Overall Study|Status not recorded|4|||
145270429|NCT05275673|523837895|FG000|Overall Study|Withdrawal by Subject|1|||
145270430|NCT05275673|523837896|FG001|Overall Study|Withdrawal by Subject|0|||
145270431|NCT02325739|523837897|FG000|Phase I Part|Adverse Event|1|||
145270432|NCT02325739|523837898|FG001|Phase I Part|Adverse Event|0|||
145270433|NCT02325739|523837899|FG002|Phase I Part|Adverse Event|1|||
145270434|NCT02325739|523837900|FG003|Phase I Part|Adverse Event|2|||
145270435|NCT02325739|523837901|FG004|Phase I Part|Adverse Event|3|||
145270436|NCT02325739|523837902|FG005|Phase I Part|Adverse Event|1|||
145270437|NCT02325739|523837903|FG006|Phase I Part|Adverse Event|0|||
145270438|NCT02325739|523837904|FG007|Phase I Part|Adverse Event|2|||
145270439|NCT02325739|523837905|FG008|Phase I Part|Adverse Event|0|||
145270440|NCT02325739|523837906|FG009|Phase I Part|Adverse Event|0|||
145520222|NCT05093790|524764179|FG000|Overall Study|Failure to meet continuation criteria|0|||
145520223|NCT05093790|524764180|FG001|Overall Study|Failure to meet continuation criteria|0|||
145520224|NCT05093790|524764181|FG002|Overall Study|Failure to meet continuation criteria|1|||
145520225|NCT05093790|524764182|FG003|Overall Study|Failure to meet continuation criteria|0|||
145520226|NCT05093790|524764179|FG000|Overall Study|Adverse Event|1|||
145520227|NCT05093790|524764180|FG001|Overall Study|Adverse Event|0|||
145520228|NCT05093790|524764181|FG002|Overall Study|Adverse Event|0|||
145520229|NCT05093790|524764182|FG003|Overall Study|Adverse Event|0|||
145520230|NCT01587898|524764183|FG000|Overall Study|Adverse Event|1|||
145520231|NCT01587898|524764184|FG001|Overall Study|Adverse Event|1|||
145520232|NCT01587898|524764185|FG002|Overall Study|Adverse Event|0|||
145520233|NCT01587898|524764186|FG003|Overall Study|Adverse Event|0|||
145520234|NCT01587898|524764183|FG000|Overall Study|Protocol Violation|0|||
145520235|NCT01587898|524764184|FG001|Overall Study|Protocol Violation|2|||
145520236|NCT01587898|524764185|FG002|Overall Study|Protocol Violation|1|||
145520237|NCT01587898|524764186|FG003|Overall Study|Protocol Violation|1|||
145520238|NCT01587898|524764183|FG000|Overall Study|Lost to Follow-up|0|||
145520239|NCT01587898|524764184|FG001|Overall Study|Lost to Follow-up|0|||
145520240|NCT01587898|524764185|FG002|Overall Study|Lost to Follow-up|0|||
145520241|NCT01587898|524764186|FG003|Overall Study|Lost to Follow-up|1|||
145520242|NCT01587898|524764183|FG000|Overall Study|Withdrawal by Subject|2|||
145520243|NCT01587898|524764184|FG001|Overall Study|Withdrawal by Subject|1|||
145520244|NCT01587898|524764185|FG002|Overall Study|Withdrawal by Subject|0|||
145520245|NCT01587898|524764186|FG003|Overall Study|Withdrawal by Subject|0|||
145520246|NCT01587898|524764183|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
145520247|NCT01587898|524764184|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
145520248|NCT01587898|524764185|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
145520249|NCT01587898|524764186|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
145520250|NCT00502203|524764187|FG000|Overall Study|Inevaluable|1|||
145520251|NCT01903252|524764190|FG000|Double-Blind Induction|Adverse Event|20|||
145520252|NCT01903252|524764191|FG001|Double-Blind Induction|Adverse Event|18|||
145520253|NCT01903252|524764192|FG002|Double-Blind Induction|Adverse Event|0|||
145520254|NCT01903252|524764193|FG003|Double-Blind Induction|Adverse Event|0|||
145520255|NCT01903252|524764194|FG004|Double-Blind Induction|Adverse Event|0|||
145520256|NCT01903252|524764195|FG005|Double-Blind Induction|Adverse Event|0|||
145520257|NCT01903252|524764190|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
145520258|NCT01903252|524764191|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
145520259|NCT01903252|524764192|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
145520260|NCT01903252|524764193|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
145520261|NCT01903252|524764194|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
145520262|NCT01903252|524764195|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
145520263|NCT01903252|524764190|FG000|Double-Blind Induction|Physician Decision|2|||
145520264|NCT01903252|524764191|FG001|Double-Blind Induction|Physician Decision|3|||
145520265|NCT01903252|524764192|FG002|Double-Blind Induction|Physician Decision|0|||
145520266|NCT01903252|524764193|FG003|Double-Blind Induction|Physician Decision|0|||
145743558|NCT01840579|525577352|FG005|Overall Study|Status not recorded|3|||
145743559|NCT01840579|525577353|FG006|Overall Study|Status not recorded|0|||
145743560|NCT01840579|525577354|FG007|Overall Study|Status not recorded|3|||
145270441|NCT02325739|523837907|FG010|Phase I Part|Adverse Event|0|||
145402445|NCT00784875|524330733|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145520267|NCT01903252|524764194|FG004|Double-Blind Induction|Physician Decision|0|||
145520268|NCT01903252|524764195|FG005|Double-Blind Induction|Physician Decision|0|||
145520269|NCT01903252|524764190|FG000|Double-Blind Induction|non-compliance,|7|||
145520270|NCT01903252|524764191|FG001|Double-Blind Induction|non-compliance,|7|||
145520271|NCT01903252|524764192|FG002|Double-Blind Induction|non-compliance,|0|||
145520272|NCT01903252|524764193|FG003|Double-Blind Induction|non-compliance,|0|||
145520273|NCT01903252|524764194|FG004|Double-Blind Induction|non-compliance,|0|||
145520274|NCT01903252|524764195|FG005|Double-Blind Induction|non-compliance,|0|||
145743561|NCT01840579|525577355|FG008|Overall Study|Status not recorded|3|||
145743562|NCT01840579|525577356|FG009|Overall Study|Status not recorded|3|||
145270442|NCT02325739|523837897|FG000|Phase I Part|Progressive disease|9|||
145270443|NCT02325739|523837898|FG001|Phase I Part|Progressive disease|6|||
145270444|NCT02325739|523837899|FG002|Phase I Part|Progressive disease|3|||
145270445|NCT02325739|523837900|FG003|Phase I Part|Progressive disease|23|||
145270446|NCT02325739|523837901|FG004|Phase I Part|Progressive disease|14|||
145520275|NCT01903252|524764190|FG000|Extended Induction, Open-Label|Adverse Event|0|||
145520276|NCT01903252|524764191|FG001|Extended Induction, Open-Label|Adverse Event|0|||
145520277|NCT01903252|524764192|FG002|Extended Induction, Open-Label|Adverse Event|17|||
145520278|NCT01903252|524764193|FG003|Extended Induction, Open-Label|Adverse Event|0|||
145520279|NCT01903252|524764194|FG004|Extended Induction, Open-Label|Adverse Event|0|||
145520280|NCT01903252|524764195|FG005|Extended Induction, Open-Label|Adverse Event|0|||
145520281|NCT01903252|524764190|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
145520282|NCT01903252|524764191|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
145520283|NCT01903252|524764192|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
145743563|NCT01840579|525577347|FG000|Overall Study|Progressive disease|3|||
145743564|NCT01840579|525577348|FG001|Overall Study|Progressive disease|5|||
145743565|NCT01840579|525577349|FG002|Overall Study|Progressive disease|0|||
145743566|NCT01840579|525577350|FG003|Overall Study|Progressive disease|0|||
145743567|NCT01840579|525577351|FG004|Overall Study|Progressive disease|0|||
145743568|NCT01840579|525577352|FG005|Overall Study|Progressive disease|0|||
145743569|NCT01840579|525577353|FG006|Overall Study|Progressive disease|0|||
145743570|NCT01840579|525577354|FG007|Overall Study|Progressive disease|0|||
145520284|NCT01903252|524764193|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
145520285|NCT01903252|524764194|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
145520286|NCT01903252|524764195|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
145520287|NCT01903252|524764190|FG000|Extended Induction, Open-Label|Physician Decision|0|||
145520288|NCT01903252|524764191|FG001|Extended Induction, Open-Label|Physician Decision|0|||
145520289|NCT01903252|524764192|FG002|Extended Induction, Open-Label|Physician Decision|1|||
145520290|NCT01903252|524764193|FG003|Extended Induction, Open-Label|Physician Decision|0|||
145520291|NCT01903252|524764194|FG004|Extended Induction, Open-Label|Physician Decision|0|||
145520292|NCT01903252|524764195|FG005|Extended Induction, Open-Label|Physician Decision|0|||
145520293|NCT01903252|524764190|FG000|Maintenance, Open-Label|Adverse Event|0|||
145520294|NCT01903252|524764191|FG001|Maintenance, Open-Label|Adverse Event|0|||
145520295|NCT01903252|524764192|FG002|Maintenance, Open-Label|Adverse Event|0|||
145520296|NCT01903252|524764193|FG003|Maintenance, Open-Label|Adverse Event|3|||
145520297|NCT01903252|524764194|FG004|Maintenance, Open-Label|Adverse Event|9|||
145520298|NCT01903252|524764195|FG005|Maintenance, Open-Label|Adverse Event|14|||
145520299|NCT01903252|524764190|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
145520300|NCT01903252|524764191|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
145520301|NCT01903252|524764192|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
145520302|NCT01903252|524764193|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
145520303|NCT01903252|524764194|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
145520304|NCT01903252|524764195|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
145520305|NCT01903252|524764190|FG000|Maintenance, Open-Label|Other|0|||
145520306|NCT01903252|524764191|FG001|Maintenance, Open-Label|Other|0|||
145520307|NCT01903252|524764192|FG002|Maintenance, Open-Label|Other|0|||
145520308|NCT01903252|524764193|FG003|Maintenance, Open-Label|Other|2|||
145520309|NCT01903252|524764194|FG004|Maintenance, Open-Label|Other|6|||
145520310|NCT01903252|524764195|FG005|Maintenance, Open-Label|Other|2|||
145520311|NCT01239732|524764196|FG000|Overall Study|Termination of study per protocol|667|||
145520312|NCT01239732|524764196|FG000|Overall Study|Death|226|||
145520313|NCT01239732|524764196|FG000|Overall Study|Withdrawal by Subject|87|||
145520314|NCT01239732|524764196|FG000|Overall Study|Adverse Event|6|||
145520315|NCT01239732|524764196|FG000|Overall Study|Protocol Violation|3|||
145520316|NCT01239732|524764196|FG000|Overall Study|Participant non compliance|5|||
145520317|NCT01239732|524764196|FG000|Overall Study|Study termination by sponsor|2|||
145520318|NCT01239732|524764196|FG000|Overall Study|Investigator's decision|4|||
145520319|NCT01239732|524764196|FG000|Overall Study|Treatment failure|2|||
145520320|NCT01239732|524764196|FG000|Overall Study|Other|19|||
145520321|NCT01381562|524764197|FG000|Overall Study|Adverse Event|0|||
145520322|NCT01381562|524764198|FG001|Overall Study|Adverse Event|1|||
145520323|NCT01381562|524764199|FG002|Overall Study|Adverse Event|0|||
145520324|NCT02660138|524764200|FG000|Overall Study|Adverse Event|0|||
145520325|NCT02660138|524764201|FG001|Overall Study|Adverse Event|3|||
145520326|NCT02660138|524764202|FG002|Overall Study|Adverse Event|2|||
145520327|NCT02660138|524764200|FG000|Overall Study|Lack of Efficacy|1|||
145743571|NCT01840579|525577355|FG008|Overall Study|Progressive disease|0|||
145743572|NCT01840579|525577356|FG009|Overall Study|Progressive disease|0|||
145520328|NCT02660138|524764201|FG001|Overall Study|Lack of Efficacy|2|||
145520329|NCT02660138|524764202|FG002|Overall Study|Lack of Efficacy|1|||
145520330|NCT02660138|524764200|FG000|Overall Study|Withdrawal by Subject|7|||
145743573|NCT01840579|525577347|FG000|Overall Study|Ongoing in study|0|||
145743574|NCT01840579|525577348|FG001|Overall Study|Ongoing in study|1|||
145520331|NCT02660138|524764201|FG001|Overall Study|Withdrawal by Subject|6|||
145520332|NCT02660138|524764202|FG002|Overall Study|Withdrawal by Subject|6|||
145743575|NCT01840579|525577349|FG002|Overall Study|Ongoing in study|0|||
145520333|NCT02660138|524764200|FG000|Overall Study|Lost to Follow-up|4|||
145520334|NCT02660138|524764201|FG001|Overall Study|Lost to Follow-up|4|||
145520335|NCT02660138|524764202|FG002|Overall Study|Lost to Follow-up|1|||
145743576|NCT01840579|525577350|FG003|Overall Study|Ongoing in study|0|||
145270447|NCT02325739|523837902|FG005|Phase I Part|Progressive disease|6|||
145270448|NCT02325739|523837903|FG006|Phase I Part|Progressive disease|6|||
145270449|NCT02325739|523837904|FG007|Phase I Part|Progressive disease|3|||
145270450|NCT02325739|523837905|FG008|Phase I Part|Progressive disease|0|||
145270451|NCT02325739|523837906|FG009|Phase I Part|Progressive disease|0|||
145270452|NCT02325739|523837907|FG010|Phase I Part|Progressive disease|0|||
145270453|NCT02325739|523837897|FG000|Phase I Part|Subject/guardian decision|1|||
145270454|NCT02325739|523837898|FG001|Phase I Part|Subject/guardian decision|0|||
145270455|NCT02325739|523837899|FG002|Phase I Part|Subject/guardian decision|1|||
145270456|NCT02325739|523837900|FG003|Phase I Part|Subject/guardian decision|1|||
145270457|NCT02325739|523837901|FG004|Phase I Part|Subject/guardian decision|0|||
145270458|NCT02325739|523837902|FG005|Phase I Part|Subject/guardian decision|0|||
145270459|NCT02325739|523837903|FG006|Phase I Part|Subject/guardian decision|0|||
145520336|NCT02660138|524764200|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
145520337|NCT02660138|524764201|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
145520338|NCT02660138|524764202|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
145520339|NCT02660138|524764200|FG000|Overall Study|Other|1|||
145520340|NCT02660138|524764201|FG001|Overall Study|Other|1|||
145520341|NCT02660138|524764202|FG002|Overall Study|Other|0|||
145270460|NCT02325739|523837904|FG007|Phase I Part|Subject/guardian decision|1|||
145270461|NCT02325739|523837905|FG008|Phase I Part|Subject/guardian decision|0|||
145270462|NCT02325739|523837906|FG009|Phase I Part|Subject/guardian decision|0|||
145270463|NCT02325739|523837907|FG010|Phase I Part|Subject/guardian decision|0|||
145270464|NCT02325739|523837897|FG000|Phase I Part|Death|0|||
145270465|NCT02325739|523837898|FG001|Phase I Part|Death|0|||
145270466|NCT02325739|523837899|FG002|Phase I Part|Death|0|||
145270467|NCT02325739|523837900|FG003|Phase I Part|Death|0|||
145270468|NCT02325739|523837901|FG004|Phase I Part|Death|2|||
145270469|NCT02325739|523837902|FG005|Phase I Part|Death|0|||
145270470|NCT02325739|523837903|FG006|Phase I Part|Death|0|||
145270471|NCT02325739|523837904|FG007|Phase I Part|Death|0|||
145270472|NCT02325739|523837905|FG008|Phase I Part|Death|0|||
145270473|NCT02325739|523837906|FG009|Phase I Part|Death|0|||
145270474|NCT02325739|523837907|FG010|Phase I Part|Death|0|||
145270475|NCT02325739|523837897|FG000|Phase II Part|Adverse Event|0|||
145270476|NCT02325739|523837898|FG001|Phase II Part|Adverse Event|0|||
145270477|NCT02325739|523837899|FG002|Phase II Part|Adverse Event|0|||
145270478|NCT02325739|523837900|FG003|Phase II Part|Adverse Event|0|||
145270479|NCT02325739|523837901|FG004|Phase II Part|Adverse Event|0|||
145270480|NCT02325739|523837902|FG005|Phase II Part|Adverse Event|0|||
145270481|NCT02325739|523837903|FG006|Phase II Part|Adverse Event|0|||
145270482|NCT02325739|523837904|FG007|Phase II Part|Adverse Event|0|||
145270483|NCT02325739|523837905|FG008|Phase II Part|Adverse Event|4|||
145270484|NCT02325739|523837906|FG009|Phase II Part|Adverse Event|5|||
145270485|NCT02325739|523837907|FG010|Phase II Part|Adverse Event|1|||
145270486|NCT02325739|523837897|FG000|Phase II Part|Physician Decision|0|||
145270487|NCT02325739|523837898|FG001|Phase II Part|Physician Decision|0|||
145270488|NCT02325739|523837899|FG002|Phase II Part|Physician Decision|0|||
145270489|NCT02325739|523837900|FG003|Phase II Part|Physician Decision|0|||
145270490|NCT02325739|523837901|FG004|Phase II Part|Physician Decision|0|||
145270491|NCT02325739|523837902|FG005|Phase II Part|Physician Decision|0|||
145270492|NCT02325739|523837903|FG006|Phase II Part|Physician Decision|0|||
145270493|NCT02325739|523837904|FG007|Phase II Part|Physician Decision|0|||
145270494|NCT02325739|523837905|FG008|Phase II Part|Physician Decision|0|||
145270495|NCT02325739|523837906|FG009|Phase II Part|Physician Decision|1|||
145270496|NCT02325739|523837907|FG010|Phase II Part|Physician Decision|0|||
145270497|NCT02325739|523837897|FG000|Phase II Part|Progressive disease|0|||
145270498|NCT02325739|523837898|FG001|Phase II Part|Progressive disease|0|||
145270499|NCT02325739|523837899|FG002|Phase II Part|Progressive disease|0|||
145270500|NCT02325739|523837900|FG003|Phase II Part|Progressive disease|0|||
145402446|NCT00784875|524330734|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145520342|NCT02660138|524764200|FG000|Overall Study|Not treated|0|||
145520343|NCT02660138|524764201|FG001|Overall Study|Not treated|1|||
145520344|NCT02660138|524764202|FG002|Overall Study|Not treated|0|||
145520345|NCT00308581|524764207|FG000|Induction Phase|Adverse Event|0|||
145520346|NCT00308581|524764208|FG001|Induction Phase|Adverse Event|0|||
145270501|NCT02325739|523837901|FG004|Phase II Part|Progressive disease|0|||
145270502|NCT02325739|523837902|FG005|Phase II Part|Progressive disease|0|||
145270503|NCT02325739|523837903|FG006|Phase II Part|Progressive disease|0|||
145270504|NCT02325739|523837904|FG007|Phase II Part|Progressive disease|0|||
145270505|NCT02325739|523837905|FG008|Phase II Part|Progressive disease|22|||
145270506|NCT02325739|523837906|FG009|Phase II Part|Progressive disease|29|||
145270507|NCT02325739|523837907|FG010|Phase II Part|Progressive disease|18|||
145270508|NCT02325739|523837897|FG000|Phase II Part|Subject/guardian decision|0|||
145270509|NCT02325739|523837898|FG001|Phase II Part|Subject/guardian decision|0|||
145270510|NCT02325739|523837899|FG002|Phase II Part|Subject/guardian decision|0|||
145270511|NCT02325739|523837900|FG003|Phase II Part|Subject/guardian decision|0|||
145270512|NCT02325739|523837901|FG004|Phase II Part|Subject/guardian decision|0|||
145270513|NCT02325739|523837902|FG005|Phase II Part|Subject/guardian decision|0|||
145270514|NCT02325739|523837903|FG006|Phase II Part|Subject/guardian decision|0|||
145520347|NCT00308581|524764209|FG002|Induction Phase|Adverse Event|37|||
145520348|NCT00308581|524764207|FG000|Induction Phase|Lack of Efficacy|0|||
145520349|NCT00308581|524764208|FG001|Induction Phase|Lack of Efficacy|0|||
145520350|NCT00308581|524764209|FG002|Induction Phase|Lack of Efficacy|121|||
145520351|NCT00308581|524764207|FG000|Induction Phase|Withdrawal by Subject|0|||
145520352|NCT00308581|524764208|FG001|Induction Phase|Withdrawal by Subject|0|||
145520353|NCT00308581|524764209|FG002|Induction Phase|Withdrawal by Subject|5|||
145520354|NCT00308581|524764207|FG000|Induction Phase|Unknown reason|0|||
145520355|NCT00308581|524764208|FG001|Induction Phase|Unknown reason|0|||
145520356|NCT00308581|524764209|FG002|Induction Phase|Unknown reason|3|||
145520357|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Adverse Event|10|||
145520358|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Adverse Event|17|||
145520359|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Adverse Event|0|||
145520360|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
145520361|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
145520362|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
145520363|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
145520364|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
145520365|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
145520366|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
145520367|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
145520368|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
145520369|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
145520370|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
145520371|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
145520372|NCT00308581|524764207|FG000|Randomized Maintenance Phase|Unknown reason|3|||
145520373|NCT00308581|524764208|FG001|Randomized Maintenance Phase|Unknown reason|0|||
145520374|NCT00308581|524764209|FG002|Randomized Maintenance Phase|Unknown reason|0|||
145520375|NCT00899353|524764210|FG000|Overall Study|Adverse Event|2|||
145520376|NCT00899353|524764210|FG000|Overall Study|Lost to Follow-up|1|||
145520377|NCT00899353|524764210|FG000|Overall Study|Withdrawal by Subject|2|||
145520378|NCT01892384|524764221|FG000|Overall Study|Withdrawal by Subject|1|||
145520379|NCT01892384|524764222|FG001|Overall Study|Withdrawal by Subject|1|||
145520380|NCT01892384|524764223|FG002|Overall Study|Withdrawal by Subject|0|||
145520381|NCT01892384|524764224|FG003|Overall Study|Withdrawal by Subject|0|||
145520382|NCT00592774|524764225|FG000|Overall Study|Adverse Event|5|||
145520383|NCT00592774|524764226|FG001|Overall Study|Adverse Event|19|||
145520384|NCT00592774|524764227|FG002|Overall Study|Adverse Event|2|||
145520385|NCT00592774|524764228|FG003|Overall Study|Adverse Event|14|||
145520386|NCT00592774|524764229|FG004|Overall Study|Adverse Event|8|||
145520387|NCT00592774|524764225|FG000|Overall Study|Protocol Violation|0|||
145520388|NCT00592774|524764226|FG001|Overall Study|Protocol Violation|1|||
145520389|NCT00592774|524764227|FG002|Overall Study|Protocol Violation|0|||
145520390|NCT00592774|524764228|FG003|Overall Study|Protocol Violation|0|||
145520391|NCT00592774|524764229|FG004|Overall Study|Protocol Violation|1|||
145520392|NCT00592774|524764225|FG000|Overall Study|Withdrawal by Subject|3|||
145520393|NCT00592774|524764226|FG001|Overall Study|Withdrawal by Subject|7|||
145520394|NCT00592774|524764227|FG002|Overall Study|Withdrawal by Subject|0|||
145520395|NCT00592774|524764228|FG003|Overall Study|Withdrawal by Subject|0|||
145520396|NCT00592774|524764229|FG004|Overall Study|Withdrawal by Subject|0|||
145520397|NCT00592774|524764225|FG000|Overall Study|Lack of Efficacy|3|||
145520398|NCT00592774|524764226|FG001|Overall Study|Lack of Efficacy|3|||
145520399|NCT00592774|524764227|FG002|Overall Study|Lack of Efficacy|0|||
145520400|NCT00592774|524764228|FG003|Overall Study|Lack of Efficacy|0|||
145520401|NCT00592774|524764229|FG004|Overall Study|Lack of Efficacy|2|||
145520402|NCT00592774|524764225|FG000|Overall Study|Physician Decision|0|||
145520403|NCT00592774|524764226|FG001|Overall Study|Physician Decision|1|||
145520404|NCT00592774|524764227|FG002|Overall Study|Physician Decision|1|||
145520405|NCT00592774|524764228|FG003|Overall Study|Physician Decision|0|||
145520406|NCT00592774|524764229|FG004|Overall Study|Physician Decision|1|||
145520407|NCT00592774|524764225|FG000|Overall Study|Other|0|||
145520408|NCT00592774|524764226|FG001|Overall Study|Other|1|||
145520409|NCT00592774|524764227|FG002|Overall Study|Other|1|||
145520410|NCT00592774|524764228|FG003|Overall Study|Other|0|||
145520411|NCT00592774|524764229|FG004|Overall Study|Other|2|||
145520412|NCT01924429|524764233|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
145520413|NCT01924429|524764234|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
145520414|NCT01514370|524764238|FG000|Overall Study|Protocol Violation|2|||
145520415|NCT01514370|524764239|FG001|Overall Study|Protocol Violation|3|||
145520416|NCT01514370|524764238|FG000|Overall Study|Lost to Follow-up|0|||
145520417|NCT01514370|524764239|FG001|Overall Study|Lost to Follow-up|2|||
145520418|NCT01514370|524764238|FG000|Overall Study|Withdrawal by Subject|2|||
145520419|NCT01514370|524764239|FG001|Overall Study|Withdrawal by Subject|1|||
145520420|NCT01514370|524764238|FG000|Overall Study|Adverse Event|1|||
145520421|NCT01514370|524764239|FG001|Overall Study|Adverse Event|3|||
145520422|NCT01514370|524764238|FG000|Overall Study|Other|6|||
145270515|NCT02325739|523837904|FG007|Phase II Part|Subject/guardian decision|0|||
145520423|NCT01514370|524764239|FG001|Overall Study|Other|7|||
145520424|NCT00604214|524764242|FG000|Baseline to Day 28|Death|223|||
145520425|NCT00604214|524764243|FG001|Baseline to Day 28|Death|202|||
145520426|NCT00604214|524764242|FG000|Baseline to Day 28|Lost to Follow-up|2|||
145520427|NCT00604214|524764243|FG001|Baseline to Day 28|Lost to Follow-up|4|||
145520428|NCT00604214|524764242|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
145520429|NCT00604214|524764243|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
145520430|NCT00604214|524764242|FG000|Day 29 to Day 90|Death|64|||
145520431|NCT00604214|524764243|FG001|Day 29 to Day 90|Death|67|||
145520432|NCT00604214|524764242|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
145520433|NCT00604214|524764243|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
145520434|NCT00604214|524764242|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
145520435|NCT00604214|524764243|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
145520436|NCT00604214|524764242|FG000|Day 91 to Day 180|Death|19|||
145520437|NCT00604214|524764243|FG001|Day 91 to Day 180|Death|23|||
145520438|NCT00604214|524764242|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
145520439|NCT00604214|524764243|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
145520440|NCT00604214|524764242|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
145520441|NCT00604214|524764243|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
145520442|NCT03603509|524766189|FG000|Overall Study|Lost to Follow-up|3|||
145520443|NCT03603509|524766190|FG001|Overall Study|Lost to Follow-up|4|||
145520444|NCT01527357|524766192|FG000|Overall Study|Death|8|||
145520445|NCT01527357|524766193|FG001|Overall Study|Death|2|||
145520446|NCT01527357|524766192|FG000|Overall Study|Lost to Follow-up|6|||
145520447|NCT01527357|524766193|FG001|Overall Study|Lost to Follow-up|4|||
145520448|NCT01527357|524766192|FG000|Overall Study|Withdrew Consent|1|||
145520449|NCT01527357|524766193|FG001|Overall Study|Withdrew Consent|1|||
145520450|NCT01527357|524766192|FG000|Overall Study|Non-compliance|0|||
145520451|NCT01527357|524766193|FG001|Overall Study|Non-compliance|1|||
145520452|NCT01527357|524766192|FG000|Overall Study|No Day 29 Visit|0|||
145520453|NCT01527357|524766193|FG001|Overall Study|No Day 29 Visit|1|||
145520454|NCT01527357|524766192|FG000|Overall Study|Did Not Receive Treatment|2|||
145520455|NCT01527357|524766193|FG001|Overall Study|Did Not Receive Treatment|0|||
145520456|NCT00910247|524766194|FG000|Overall Study|Adverse Event|15|||
145520457|NCT00910247|524766194|FG000|Overall Study|Death|2|||
145520458|NCT00910247|524766194|FG000|Overall Study|Lost to Follow-up|10|||
145520459|NCT00910247|524766194|FG000|Overall Study|Physician Decision|3|||
145520460|NCT00910247|524766194|FG000|Overall Study|Protocol Violation|10|||
145520461|NCT00910247|524766194|FG000|Overall Study|Withdrawal by Subject|25|||
145520462|NCT00910247|524766194|FG000|Overall Study|Not collected|4|||
145520463|NCT02519855|524766196|FG000|Overall Study|Adverse Event|0|||
145520464|NCT02519855|524766197|FG001|Overall Study|Adverse Event|1|||
145520465|NCT02519855|524766196|FG000|Overall Study|Lost to Follow-up|3|||
145520466|NCT02519855|524766197|FG001|Overall Study|Lost to Follow-up|3|||
145520467|NCT00003830|524766213|FG000|Overall Study|No follow up data|3|||
145520468|NCT00003830|524766214|FG001|Overall Study|No follow up data|0|||
145520469|NCT00003830|524766213|FG000|Overall Study|Sentinel node positive patients|829|||
145520470|NCT00003830|524766214|FG001|Overall Study|Sentinel node positive patients|793|||
145520471|NCT03811093|524766215|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
145520472|NCT03811093|524766216|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
145520473|NCT03811093|524766215|FG000|Overall Study|Unable to measure body fat percentage|2|||
145520474|NCT03811093|524766216|FG001|Overall Study|Unable to measure body fat percentage|0|||
145520475|NCT05347147|524766218|FG000|Overall Study|Lost to Follow-up|0|||
145520476|NCT05347147|524766219|FG001|Overall Study|Lost to Follow-up|1|||
145520477|NCT05347147|524766218|FG000|Overall Study|Sponsor request|3|||
145520478|NCT05347147|524766219|FG001|Overall Study|Sponsor request|3|||
145520479|NCT05347147|524766218|FG000|Overall Study|Study termination|2|||
145520480|NCT05347147|524766219|FG001|Overall Study|Study termination|1|||
145520481|NCT03565367|524766220|FG000|Overall Study|No scan due to technical issues|4|||
145520482|NCT03565367|524766221|FG001|Overall Study|No scan due to technical issues|0|||
145520483|NCT00923364|524766226|FG000|Overall Study|Death|3|||
145520484|NCT00923364|524766227|FG001|Overall Study|Death|0|||
145520485|NCT00923364|524766226|FG000|Overall Study|Did not go to transplant|1|||
145520486|NCT00923364|524766227|FG001|Overall Study|Did not go to transplant|0|||
145520487|NCT01397825|524766228|FG000|Overall Study|Progressive Disease|10|||
145520488|NCT01397825|524766229|FG001|Overall Study|Progressive Disease|3|||
145520489|NCT01397825|524766230|FG002|Overall Study|Progressive Disease|11|||
145520490|NCT01397825|524766231|FG003|Overall Study|Progressive Disease|1|||
145520491|NCT01397825|524766232|FG004|Overall Study|Progressive Disease|0|||
145520492|NCT01397825|524766228|FG000|Overall Study|Symptomatic Deterioration|2|||
145520493|NCT01397825|524766229|FG001|Overall Study|Symptomatic Deterioration|0|||
145520494|NCT01397825|524766230|FG002|Overall Study|Symptomatic Deterioration|4|||
145520495|NCT01397825|524766231|FG003|Overall Study|Symptomatic Deterioration|0|||
145520496|NCT01397825|524766232|FG004|Overall Study|Symptomatic Deterioration|0|||
145520497|NCT01397825|524766228|FG000|Overall Study|Adverse Event|0|||
145520498|NCT01397825|524766229|FG001|Overall Study|Adverse Event|1|||
145520499|NCT01397825|524766230|FG002|Overall Study|Adverse Event|5|||
145520500|NCT01397825|524766231|FG003|Overall Study|Adverse Event|1|||
145520501|NCT01397825|524766232|FG004|Overall Study|Adverse Event|0|||
145520502|NCT01397825|524766228|FG000|Overall Study|Withdrawal by Subject|1|||
145520503|NCT01397825|524766229|FG001|Overall Study|Withdrawal by Subject|0|||
145520504|NCT01397825|524766230|FG002|Overall Study|Withdrawal by Subject|5|||
145520505|NCT01397825|524766231|FG003|Overall Study|Withdrawal by Subject|1|||
145520506|NCT01397825|524766232|FG004|Overall Study|Withdrawal by Subject|0|||
145520507|NCT01931670|524766234|FG000|Treatment Period|Exclusionary Medication Received|1|||
145520508|NCT01931670|524766235|FG001|Treatment Period|Exclusionary Medication Received|1|||
145520509|NCT01931670|524766236|FG002|Treatment Period|Exclusionary Medication Received|1|||
145520510|NCT01931670|524766234|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
145520511|NCT01931670|524766235|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
145520512|NCT01931670|524766236|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
145520513|NCT01931670|524766234|FG000|Treatment Period|Subject Noncompliant|4|||
145520514|NCT01931670|524766235|FG001|Treatment Period|Subject Noncompliant|9|||
145520515|NCT01931670|524766236|FG002|Treatment Period|Subject Noncompliant|5|||
145520516|NCT01931670|524766234|FG000|Treatment Period|Adverse Event|19|||
145520517|NCT01931670|524766235|FG001|Treatment Period|Adverse Event|8|||
145520518|NCT01931670|524766236|FG002|Treatment Period|Adverse Event|21|||
145520519|NCT01931670|524766234|FG000|Treatment Period|Lack of Efficacy|11|||
145520520|NCT01931670|524766235|FG001|Treatment Period|Lack of Efficacy|2|||
145520521|NCT01931670|524766236|FG002|Treatment Period|Lack of Efficacy|2|||
145520522|NCT01931670|524766234|FG000|Treatment Period|Pregnancy|7|||
145520523|NCT01931670|524766235|FG001|Treatment Period|Pregnancy|2|||
145520524|NCT01931670|524766236|FG002|Treatment Period|Pregnancy|0|||
145520525|NCT01931670|524766234|FG000|Treatment Period|Other|8|||
145520526|NCT01931670|524766235|FG001|Treatment Period|Other|7|||
145520527|NCT01931670|524766236|FG002|Treatment Period|Other|2|||
145520528|NCT01931670|524766234|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
145520529|NCT01931670|524766235|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
145520530|NCT01931670|524766236|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
145520531|NCT01931670|524766234|FG000|Treatment Period|Lost to Follow-up|19|||
145520532|NCT01931670|524766235|FG001|Treatment Period|Lost to Follow-up|5|||
145520533|NCT01931670|524766236|FG002|Treatment Period|Lost to Follow-up|7|||
145520534|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
145520535|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
145520536|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
145520537|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
145520538|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
145520539|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
145520540|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
145520541|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
145520542|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
145520543|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
145520544|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
145520545|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
145520546|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
145520547|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
145520548|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
145520549|NCT01931670|524766234|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
145520550|NCT01931670|524766235|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
145520551|NCT01931670|524766236|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
145520552|NCT04352127|524766238|FG000|Overall Study|Unable to obtain readings|4|||
145520553|NCT04352127|524766239|FG001|Overall Study|Unable to obtain readings|1|||
145520554|NCT03023046|524766243|FG000|Overall Study|Withdrawal by Subject|1|||
145520555|NCT01205581|524766244|FG000|Overall Study|Withdrawal by Subject|1|||
145520556|NCT01205581|524766245|FG001|Overall Study|Withdrawal by Subject|0|||
145520557|NCT01205581|524766246|FG002|Overall Study|Withdrawal by Subject|0|||
145520558|NCT01205581|524766247|FG003|Overall Study|Withdrawal by Subject|0|||
145520559|NCT01205581|524766248|FG004|Overall Study|Withdrawal by Subject|0|||
145520560|NCT01205581|524766249|FG005|Overall Study|Withdrawal by Subject|0|||
145520561|NCT01236118|524766250|FG000|Overall Study|Adverse Event|2|||
145520562|NCT01236118|524766251|FG001|Overall Study|Adverse Event|0|||
145520563|NCT01236118|524766252|FG002|Overall Study|Adverse Event|2|||
145520564|NCT01236118|524766250|FG000|Overall Study|Physician Decision|0|||
145520565|NCT01236118|524766251|FG001|Overall Study|Physician Decision|1|||
145520566|NCT01236118|524766252|FG002|Overall Study|Physician Decision|0|||
145520567|NCT01236118|524766250|FG000|Overall Study|Withdrawal by Subject|0|||
145520568|NCT01236118|524766251|FG001|Overall Study|Withdrawal by Subject|0|||
145520569|NCT01236118|524766252|FG002|Overall Study|Withdrawal by Subject|1|||
145520570|NCT04535167|524766253|FG000|Treatment|Adverse Event|0|||
145520571|NCT04535167|524766254|FG001|Treatment|Adverse Event|0|||
145520572|NCT04535167|524766255|FG002|Treatment|Adverse Event|0|||
145520573|NCT04535167|524766256|FG003|Treatment|Adverse Event|0|||
145520574|NCT04535167|524766257|FG004|Treatment|Adverse Event|0|||
145520575|NCT04535167|524766258|FG005|Treatment|Adverse Event|0|||
145520576|NCT04535167|524766259|FG006|Treatment|Adverse Event|1|||
145520577|NCT04535167|524766253|FG000|Follow-Up|Death|0|||
145520578|NCT04535167|524766254|FG001|Follow-Up|Death|0|||
145520579|NCT04535167|524766255|FG002|Follow-Up|Death|0|||
145520580|NCT04535167|524766256|FG003|Follow-Up|Death|0|||
145520581|NCT04535167|524766257|FG004|Follow-Up|Death|0|||
145520582|NCT04535167|524766258|FG005|Follow-Up|Death|0|||
145520583|NCT04535167|524766259|FG006|Follow-Up|Death|1|||
145520584|NCT04535167|524766253|FG000|Follow-Up|Lost to Follow-up|0|||
145520585|NCT04535167|524766254|FG001|Follow-Up|Lost to Follow-up|0|||
145520586|NCT04535167|524766255|FG002|Follow-Up|Lost to Follow-up|0|||
145520587|NCT04535167|524766256|FG003|Follow-Up|Lost to Follow-up|1|||
145520588|NCT04535167|524766257|FG004|Follow-Up|Lost to Follow-up|0|||
145520589|NCT04535167|524766258|FG005|Follow-Up|Lost to Follow-up|0|||
145520590|NCT04535167|524766259|FG006|Follow-Up|Lost to Follow-up|0|||
145520591|NCT00075270|524766260|FG000|Overall Study|Withdrawal by Subject|28|||
145520592|NCT00075270|524766261|FG001|Overall Study|Withdrawal by Subject|21|||
145520593|NCT00075270|524766260|FG000|Overall Study|Lost to Follow-up|25|||
145520594|NCT00075270|524766261|FG001|Overall Study|Lost to Follow-up|28|||
145520595|NCT00075270|524766260|FG000|Overall Study|Protocol Violation|0|||
145520596|NCT00075270|524766261|FG001|Overall Study|Protocol Violation|2|||
145520597|NCT00075270|524766260|FG000|Overall Study|Death|198|||
145520598|NCT00075270|524766261|FG001|Overall Study|Death|215|||
145520599|NCT00075270|524766260|FG000|Overall Study|Other/Unknown|9|||
145520600|NCT00075270|524766261|FG001|Overall Study|Other/Unknown|5|||
145520601|NCT00075270|524766260|FG000|Overall Study|Missing|26|||
145520602|NCT00075270|524766261|FG001|Overall Study|Missing|13|||
145520603|NCT00713310|524766262|FG000|Overall Study|Adverse Event|5|||
145520604|NCT00713310|524766263|FG001|Overall Study|Adverse Event|2|||
145520605|NCT00713310|524766262|FG000|Overall Study|Lack of Efficacy|0|||
145520606|NCT00713310|524766263|FG001|Overall Study|Lack of Efficacy|2|||
145520607|NCT00713310|524766262|FG000|Overall Study|Withdrawal by Subject|0|||
145520608|NCT00713310|524766263|FG001|Overall Study|Withdrawal by Subject|2|||
145520609|NCT05028361|524766264|FG000|Overall Study|Withdrawal by Subject|1|||
145520610|NCT05028361|524766265|FG001|Overall Study|Withdrawal by Subject|0|||
145520611|NCT01993836|524766266|FG000|Overall Study|Surgery Cancelled|3|||
145520612|NCT01993836|524766267|FG001|Overall Study|Surgery Cancelled|0|||
145520613|NCT01993836|524766268|FG002|Overall Study|Surgery Cancelled|0|||
145520614|NCT01993836|524766266|FG000|Overall Study|Physician Decision|2|||
145520615|NCT01993836|524766267|FG001|Overall Study|Physician Decision|1|||
145520616|NCT01993836|524766268|FG002|Overall Study|Physician Decision|0|||
145520617|NCT01993836|524766266|FG000|Overall Study|Death|0|||
145520618|NCT01993836|524766267|FG001|Overall Study|Death|2|||
145520619|NCT01993836|524766268|FG002|Overall Study|Death|0|||
145520620|NCT01993836|524766266|FG000|Overall Study|Withdrawal by Subject|12|||
145520621|NCT01993836|524766267|FG001|Overall Study|Withdrawal by Subject|10|||
145520622|NCT01993836|524766268|FG002|Overall Study|Withdrawal by Subject|5|||
145520623|NCT00779259|524766269|FG000|Quinine Alone|Adverse Event|2|||
145520624|NCT03490981|524766270|FG000|Overall Study|Lost to Follow-up|1|||
145520625|NCT03490981|524766271|FG001|Overall Study|Lost to Follow-up|2|||
145520626|NCT01107379|524766275|FG000|Overall Study|Withdrawal by Subject|18|||
145520627|NCT01107379|524766275|FG000|Overall Study|Lost to Follow-up|3|||
145520628|NCT04559529|524766276|FG000|First Intervention (1 Day)|Adverse Event|0|||
145520629|NCT04559529|524766277|FG001|First Intervention (1 Day)|Adverse Event|0|||
145520630|NCT04559529|524766278|FG002|First Intervention (1 Day)|Adverse Event|0|||
145520631|NCT04559529|524766279|FG003|First Intervention (1 Day)|Adverse Event|1|||
145520632|NCT04559529|524766276|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
145520633|NCT04559529|524766277|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
145520634|NCT04559529|524766278|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
145520635|NCT04559529|524766279|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
145520636|NCT04559529|524766276|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
145520637|NCT04559529|524766277|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
145520638|NCT04559529|524766278|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
145520639|NCT04559529|524766279|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
145520640|NCT00924170|524766280|FG000|Overall Study|Refused further treatment|0|||
145520641|NCT00924170|524766281|FG001|Overall Study|Refused further treatment|1|||
145520642|NCT00924170|524766280|FG000|Overall Study|Physician Decision|0|||
145520643|NCT00924170|524766281|FG001|Overall Study|Physician Decision|1|||
145520644|NCT00924170|524766280|FG000|Overall Study|Progressive disease|3|||
145520645|NCT00924170|524766281|FG001|Overall Study|Progressive disease|6|||
145520646|NCT00924170|524766280|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
145520647|NCT00924170|524766281|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
145520648|NCT00924170|524766280|FG000|Overall Study|Death|1|||
145520649|NCT00924170|524766281|FG001|Overall Study|Death|0|||
145520650|NCT04098224|524766284|FG000|Overall Study|Adverse Event|1|||
145520651|NCT04098224|524766285|FG001|Overall Study|Adverse Event|0|||
145520652|NCT04098224|524766284|FG000|Overall Study|Physician Decision|1|||
145520653|NCT04098224|524766285|FG001|Overall Study|Physician Decision|0|||
145520654|NCT04098224|524766284|FG000|Overall Study|Patient not required enteral feeding|1|||
145520655|NCT04098224|524766285|FG001|Overall Study|Patient not required enteral feeding|0|||
145520656|NCT04098224|524766284|FG000|Overall Study|Patient failure nasogastric tube|1|||
145520657|NCT04098224|524766285|FG001|Overall Study|Patient failure nasogastric tube|0|||
145520658|NCT04098224|524766284|FG000|Overall Study|Patient early extubation|1|||
145520659|NCT04098224|524766285|FG001|Overall Study|Patient early extubation|3|||
145520660|NCT01203852|524766286|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
145520661|NCT01203852|524766286|FG000|Washout 2 Weeks|Physician Decision|46|||
145520662|NCT01878149|524766289|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
145520663|NCT01878149|524766290|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
145520664|NCT04672252|524766293|FG000|Overall Study|Protocol Violation|1|||
145520665|NCT04672252|524766294|FG001|Overall Study|Protocol Violation|0|||
145520666|NCT01738477|524766301|FG000|Overall Study|Lost to Follow-up|1|||
145520667|NCT01738477|524766302|FG001|Overall Study|Lost to Follow-up|4|||
145520668|NCT01302834|524766305|FG000|Overall Study|Protocol Violation|17|||
145520669|NCT01302834|524766306|FG001|Overall Study|Protocol Violation|23|||
145520670|NCT01302834|524766305|FG000|Overall Study|HIV positive|1|||
145520671|NCT01302834|524766306|FG001|Overall Study|HIV positive|3|||
145520672|NCT00899392|524766307|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
145520673|NCT00899392|524766308|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
145520674|NCT02437110|524766309|FG000|Screening|Lost to Follow-up|3|||
145520675|NCT02437110|524766309|FG000|Screening|Physician Decision|1|||
145520676|NCT02437110|524766309|FG000|ART|Adverse Event|3|||
145520677|NCT02437110|524766309|FG000|ART|Protocol Violation|3|||
145520678|NCT02437110|524766309|FG000|ART|Withdrawal by Subject|4|||
145520679|NCT02437110|524766309|FG000|ART|Lost to follow-up prior to start of intervention|1|||
145520680|NCT02437110|524766309|FG000|ART|Physician decision prior to start of intervention|2|||
145520681|NCT02437110|524766309|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
145520682|NCT02437110|524766309|FG000|Post-ART|Lost to Follow-up|3|||
145520683|NCT02437110|524766309|FG000|Post-ART|Protocol Violation|4|||
145520684|NCT02437110|524766309|FG000|Post-ART|Withdrawal by Subject|3|||
145520685|NCT03735238|524766310|FG000|Overall Study|Did not want to participate in research|3|||
145520686|NCT03735238|524766310|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
145520687|NCT01431638|524766311|FG000|Overall Study|Adverse Event|1|||
145520688|NCT01431638|524766312|FG001|Overall Study|Adverse Event|3|||
145520689|NCT01431638|524766313|FG002|Overall Study|Adverse Event|1|||
145520690|NCT01431638|524766311|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145520691|NCT01431638|524766312|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145520692|NCT01431638|524766313|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
145520693|NCT01431638|524766311|FG000|Overall Study|Participants condition no longer requires study drug|0|||
145520694|NCT01431638|524766312|FG001|Overall Study|Participants condition no longer requires study drug|1|||
145520695|NCT01431638|524766313|FG002|Overall Study|Participants condition no longer requires study drug|0|||
145520696|NCT01431638|524766311|FG000|Overall Study|Participant withdrew consent|14|||
145520697|NCT01431638|524766312|FG001|Overall Study|Participant withdrew consent|5|||
145520698|NCT01431638|524766313|FG002|Overall Study|Participant withdrew consent|8|||
145520699|NCT01431638|524766311|FG000|Overall Study|Lost to Follow-up|7|||
145520700|NCT01431638|524766312|FG001|Overall Study|Lost to Follow-up|9|||
145520701|NCT01431638|524766313|FG002|Overall Study|Lost to Follow-up|7|||
145520702|NCT01431638|524766311|FG000|Overall Study|Administrative problems|1|||
145520703|NCT01431638|524766312|FG001|Overall Study|Administrative problems|4|||
145520704|NCT01431638|524766313|FG002|Overall Study|Administrative problems|6|||
145520705|NCT01431638|524766311|FG000|Overall Study|Death|1|||
145520706|NCT01431638|524766312|FG001|Overall Study|Death|0|||
145520707|NCT01431638|524766313|FG002|Overall Study|Death|0|||
145520708|NCT01431638|524766311|FG000|Overall Study|Protocol deviation|1|||
145520709|NCT01431638|524766312|FG001|Overall Study|Protocol deviation|1|||
145520710|NCT01431638|524766313|FG002|Overall Study|Protocol deviation|4|||
145520711|NCT01431638|524766311|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
145520712|NCT01431638|524766312|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
145520713|NCT01431638|524766313|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
145520714|NCT01261780|524766314|FG000|Overall Study|Withdrawal by Subject|1|||
145520715|NCT01261780|524766315|FG001|Overall Study|Withdrawal by Subject|0|||
145520716|NCT01261780|524766314|FG000|Overall Study|Event not related to subject|1|||
145520717|NCT01261780|524766315|FG001|Overall Study|Event not related to subject|2|||
145520718|NCT03400956|524766317|FG000|Treatment Period 1|Adverse Event|0|||
145520719|NCT03400956|524766318|FG001|Treatment Period 1|Adverse Event|1|||
145520720|NCT03400956|524766319|FG002|Treatment Period 1|Adverse Event|0|||
145520721|NCT03400956|524766317|FG000|Treatment Period 1|Lost to Follow-up|0|||
145520722|NCT03400956|524766318|FG001|Treatment Period 1|Lost to Follow-up|0|||
145520723|NCT03400956|524766319|FG002|Treatment Period 1|Lost to Follow-up|1|||
145520724|NCT03400956|524766317|FG000|Treatment Period 1|Protocol Violation|0|||
145520725|NCT03400956|524766318|FG001|Treatment Period 1|Protocol Violation|2|||
145520726|NCT03400956|524766319|FG002|Treatment Period 1|Protocol Violation|0|||
145520727|NCT03400956|524766317|FG000|Treatment Period 1|Study terminated by sponsor|3|||
145520728|NCT03400956|524766318|FG001|Treatment Period 1|Study terminated by sponsor|1|||
145520729|NCT03400956|524766319|FG002|Treatment Period 1|Study terminated by sponsor|1|||
145520730|NCT03400956|524766317|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145520731|NCT03400956|524766318|FG001|Treatment Period 1|Withdrawal by Subject|2|||
145520732|NCT03400956|524766319|FG002|Treatment Period 1|Withdrawal by Subject|4|||
145520733|NCT03400956|524766317|FG000|Treatment Period 1|Other|1|||
145520734|NCT03400956|524766318|FG001|Treatment Period 1|Other|2|||
145520735|NCT03400956|524766319|FG002|Treatment Period 1|Other|3|||
145520736|NCT03400956|524766317|FG000|Post-treatment Period 1|Adverse Event|0|||
145520737|NCT03400956|524766318|FG001|Post-treatment Period 1|Adverse Event|0|||
145520738|NCT03400956|524766319|FG002|Post-treatment Period 1|Adverse Event|1|||
145520739|NCT03400956|524766317|FG000|Post-treatment Period 1|Physician Decision|2|||
145520740|NCT03400956|524766318|FG001|Post-treatment Period 1|Physician Decision|3|||
145520741|NCT03400956|524766319|FG002|Post-treatment Period 1|Physician Decision|0|||
145520742|NCT03400956|524766317|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
145520743|NCT03400956|524766318|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
145520744|NCT03400956|524766319|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
145520745|NCT03400956|524766317|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
145520746|NCT03400956|524766318|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
145520747|NCT03400956|524766319|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
145520748|NCT03400956|524766317|FG000|Post-treatment Period 1|Other|4|||
145520749|NCT03400956|524766318|FG001|Post-treatment Period 1|Other|3|||
145520750|NCT03400956|524766319|FG002|Post-treatment Period 1|Other|4|||
145520751|NCT03400956|524766317|FG000|Treatment Period 2|Adverse Event|2|||
145520752|NCT03400956|524766318|FG001|Treatment Period 2|Adverse Event|1|||
145520753|NCT03400956|524766319|FG002|Treatment Period 2|Adverse Event|1|||
145520754|NCT03400956|524766317|FG000|Treatment Period 2|Lost to Follow-up|1|||
145520755|NCT03400956|524766318|FG001|Treatment Period 2|Lost to Follow-up|1|||
145520756|NCT03400956|524766319|FG002|Treatment Period 2|Lost to Follow-up|0|||
145520757|NCT03400956|524766317|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145520758|NCT03400956|524766318|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145520759|NCT03400956|524766319|FG002|Treatment Period 2|Withdrawal by Subject|3|||
145520760|NCT03400956|524766317|FG000|Treatment Period 2|Other|1|||
145520761|NCT03400956|524766318|FG001|Treatment Period 2|Other|1|||
145520762|NCT03400956|524766319|FG002|Treatment Period 2|Other|0|||
145520763|NCT03400956|524766317|FG000|Follow-up Period|Withdrawal by Subject|0|||
145520764|NCT03400956|524766318|FG001|Follow-up Period|Withdrawal by Subject|0|||
145520765|NCT03400956|524766319|FG002|Follow-up Period|Withdrawal by Subject|1|||
145520766|NCT03400956|524766317|FG000|Follow-up Period|Other|0|||
145520767|NCT03400956|524766318|FG001|Follow-up Period|Other|0|||
145520768|NCT03400956|524766319|FG002|Follow-up Period|Other|1|||
145520769|NCT02048241|524766320|FG000|Overall Study|Withdrawal by Subject|0|||
145520770|NCT02048241|524766321|FG001|Overall Study|Withdrawal by Subject|1|||
145520771|NCT03044574|524766324|FG000|Overall Study|Lost to Follow-up|37|||
145520772|NCT03044574|524766325|FG001|Overall Study|Lost to Follow-up|45|||
145520773|NCT03985878|524766339|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
145520774|NCT03985878|524766339|FG000|Overall Study|Study Terminated by Sponsor|12|||
145520775|NCT03985878|524766339|FG000|Overall Study|Withdrawal by Subject|1|||
145520776|NCT01606878|524766340|FG000|Overall Study|Adverse Event|1|||
145520777|NCT01606878|524766341|FG001|Overall Study|Adverse Event|1|||
145520778|NCT01606878|524766342|FG002|Overall Study|Adverse Event|0|||
145520779|NCT01606878|524766343|FG003|Overall Study|Adverse Event|0|||
145520780|NCT01606878|524766344|FG004|Overall Study|Adverse Event|0|||
145520781|NCT01606878|524766345|FG005|Overall Study|Adverse Event|0|||
145520782|NCT01606878|524766346|FG006|Overall Study|Adverse Event|1|||
145520783|NCT01606878|524766347|FG007|Overall Study|Adverse Event|0|||
145520784|NCT01606878|524766348|FG008|Overall Study|Adverse Event|1|||
145520785|NCT01606878|524766349|FG009|Overall Study|Adverse Event|3|||
145520786|NCT01606878|524766350|FG010|Overall Study|Adverse Event|0|||
145520787|NCT01606878|524766340|FG000|Overall Study|Lack of Efficacy|1|||
145520788|NCT01606878|524766341|FG001|Overall Study|Lack of Efficacy|1|||
145520789|NCT01606878|524766342|FG002|Overall Study|Lack of Efficacy|1|||
145270516|NCT02325739|523837905|FG008|Phase II Part|Subject/guardian decision|4|||
145270517|NCT02325739|523837906|FG009|Phase II Part|Subject/guardian decision|1|||
145270518|NCT02325739|523837907|FG010|Phase II Part|Subject/guardian decision|1|||
145270519|NCT00227591|523837908|FG000|Overall Study|Withdrawal by Subject|1|||
145270520|NCT01886105|523837909|FG000|Overall Study|Lack of Efficacy|3|||
145402447|NCT00784875|524330735|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
145402448|NCT00784875|524330736|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
145402449|NCT00784875|524330733|FG000|Period C|Adverse Event|1|||
145402450|NCT00784875|524330734|FG001|Period C|Adverse Event|0|||
145402451|NCT00784875|524330735|FG002|Period C|Adverse Event|4|||
145520790|NCT01606878|524766343|FG003|Overall Study|Lack of Efficacy|2|||
145520791|NCT01606878|524766344|FG004|Overall Study|Lack of Efficacy|1|||
145520792|NCT01606878|524766345|FG005|Overall Study|Lack of Efficacy|2|||
145520793|NCT01606878|524766346|FG006|Overall Study|Lack of Efficacy|1|||
145520794|NCT01606878|524766347|FG007|Overall Study|Lack of Efficacy|2|||
145520795|NCT01606878|524766348|FG008|Overall Study|Lack of Efficacy|2|||
145520796|NCT01606878|524766349|FG009|Overall Study|Lack of Efficacy|0|||
145520797|NCT01606878|524766350|FG010|Overall Study|Lack of Efficacy|1|||
145520798|NCT01606878|524766340|FG000|Overall Study|Physician Decision|1|||
145520799|NCT01606878|524766341|FG001|Overall Study|Physician Decision|0|||
145520800|NCT01606878|524766342|FG002|Overall Study|Physician Decision|2|||
145520801|NCT01606878|524766343|FG003|Overall Study|Physician Decision|1|||
145520802|NCT01606878|524766344|FG004|Overall Study|Physician Decision|1|||
145520803|NCT01606878|524766345|FG005|Overall Study|Physician Decision|1|||
145520804|NCT01606878|524766346|FG006|Overall Study|Physician Decision|2|||
145520805|NCT01606878|524766347|FG007|Overall Study|Physician Decision|0|||
145520806|NCT01606878|524766348|FG008|Overall Study|Physician Decision|1|||
145520807|NCT01606878|524766349|FG009|Overall Study|Physician Decision|0|||
145520808|NCT01606878|524766350|FG010|Overall Study|Physician Decision|0|||
145520809|NCT01606878|524766340|FG000|Overall Study|Withdrawal by Subject|3|||
145520810|NCT01606878|524766341|FG001|Overall Study|Withdrawal by Subject|2|||
145520811|NCT01606878|524766342|FG002|Overall Study|Withdrawal by Subject|2|||
145520812|NCT01606878|524766343|FG003|Overall Study|Withdrawal by Subject|0|||
145520813|NCT01606878|524766344|FG004|Overall Study|Withdrawal by Subject|1|||
145520814|NCT01606878|524766345|FG005|Overall Study|Withdrawal by Subject|1|||
145520815|NCT01606878|524766346|FG006|Overall Study|Withdrawal by Subject|2|||
145520816|NCT01606878|524766347|FG007|Overall Study|Withdrawal by Subject|1|||
145520817|NCT01606878|524766348|FG008|Overall Study|Withdrawal by Subject|2|||
145520818|NCT01606878|524766349|FG009|Overall Study|Withdrawal by Subject|0|||
145520819|NCT01606878|524766350|FG010|Overall Study|Withdrawal by Subject|2|||
145520820|NCT00129311|524766353|FG000|Overall Study|Withdrawal by Subject|12|||
145520821|NCT00129311|524766354|FG001|Overall Study|Withdrawal by Subject|19|||
145520822|NCT00853970|524766364|FG000|Overall Study|Withdrawal by Subject|2|||
145520823|NCT00853970|524766365|FG001|Overall Study|Withdrawal by Subject|1|||
145520824|NCT00853970|524766364|FG000|Overall Study|Cancelled surgery|4|||
145520825|NCT00853970|524766365|FG001|Overall Study|Cancelled surgery|2|||
145520826|NCT04085367|524767823|FG000|Overall Study|Adverse Event|1|||
145520827|NCT04085367|524767824|FG001|Overall Study|Adverse Event|1|||
145520828|NCT04085367|524767823|FG000|Overall Study|Withdrawal by Subject|13|||
145520829|NCT04085367|524767824|FG001|Overall Study|Withdrawal by Subject|4|||
145520830|NCT04085367|524767823|FG000|Overall Study|Lost to Follow-up|3|||
145520831|NCT04085367|524767824|FG001|Overall Study|Lost to Follow-up|1|||
145520832|NCT04085367|524767823|FG000|Overall Study|Other unspecified|2|||
145520833|NCT04085367|524767824|FG001|Overall Study|Other unspecified|1|||
145520834|NCT04085367|524767823|FG000|Overall Study|Status Unknown|1|||
145520835|NCT04085367|524767824|FG001|Overall Study|Status Unknown|1|||
145520836|NCT00130442|524767827|FG000|Overall Study|Withdrawal by Subject|0|||
145520837|NCT00130442|524767828|FG001|Overall Study|Withdrawal by Subject|1|||
145520838|NCT00130442|524767827|FG000|Overall Study|did not meet criteria|1|||
145520839|NCT00130442|524767828|FG001|Overall Study|did not meet criteria|1|||
145520840|NCT00814333|524767829|FG000|Enrollment|Lost to Follow-up|1|||
145520841|NCT00814333|524767830|FG001|Enrollment|Lost to Follow-up|0|||
145520842|NCT02233946|524767831|FG000|Baseline|Withdrawal by Subject|2|||
145520843|NCT02233946|524767832|FG001|Baseline|Withdrawal by Subject|0|||
145520844|NCT02233946|524767831|FG000|3-months Follow-up|Lost to Follow-up|53|||
145520845|NCT02233946|524767832|FG001|3-months Follow-up|Lost to Follow-up|29|||
145520846|NCT02233946|524767831|FG000|6-months Follow-up|Lost to Follow-up|21|||
145520847|NCT02233946|524767832|FG001|6-months Follow-up|Lost to Follow-up|2|||
145520848|NCT02233946|524767831|FG000|9-month Follow-up|Lost to Follow-up|20|||
145520849|NCT02233946|524767832|FG001|9-month Follow-up|Lost to Follow-up|11|||
145520850|NCT02233946|524767831|FG000|12-month Follow-up|Lost to Follow-up|28|||
145520851|NCT02233946|524767832|FG001|12-month Follow-up|Lost to Follow-up|11|||
145520852|NCT01879579|524767835|FG000|Overall Study|Phone incompatible with texting platform|3|||
145520853|NCT01879579|524767836|FG001|Overall Study|Phone incompatible with texting platform|0|||
145520854|NCT01879579|524767835|FG000|Overall Study|Did not enroll in texting platform|1|||
145520855|NCT01879579|524767836|FG001|Overall Study|Did not enroll in texting platform|0|||
145743577|NCT01840579|525577351|FG004|Overall Study|Ongoing in study|0|||
145402452|NCT00784875|524330736|FG003|Period C|Adverse Event|2|||
145520856|NCT01879579|524767835|FG000|Overall Study|Did not initiate insulin treatment|1|||
145520857|NCT01879579|524767836|FG001|Overall Study|Did not initiate insulin treatment|0|||
145520858|NCT01879579|524767835|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
145520859|NCT01879579|524767836|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
145520860|NCT01879579|524767835|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
145520861|NCT01879579|524767836|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
145520862|NCT02927067|524767837|FG000|Overall Study|Withdrawn Consent|20|||
145520863|NCT02927067|524767838|FG001|Overall Study|Withdrawn Consent|12|||
145520864|NCT02927067|524767837|FG000|Overall Study|Death|18|||
145520865|NCT02927067|524767838|FG001|Overall Study|Death|31|||
145520866|NCT02927067|524767837|FG000|Overall Study|Adverse Event|13|||
145520867|NCT02927067|524767838|FG001|Overall Study|Adverse Event|10|||
145520868|NCT02927067|524767837|FG000|Overall Study|Noncompliance|5|||
145520869|NCT02927067|524767838|FG001|Overall Study|Noncompliance|2|||
145520870|NCT02927067|524767837|FG000|Overall Study|Reason not Specified|4|||
145520871|NCT02927067|524767838|FG001|Overall Study|Reason not Specified|6|||
145520872|NCT02292784|524767841|FG000|Overall Study|Lost to Follow-up|1|||
145520873|NCT02292784|524767842|FG001|Overall Study|Lost to Follow-up|17|||
145520874|NCT02292784|524767843|FG002|Overall Study|Lost to Follow-up|18|||
145520875|NCT02292784|524767841|FG000|Overall Study|Withdrawal by Subject|0|||
145520876|NCT02292784|524767842|FG001|Overall Study|Withdrawal by Subject|3|||
145520877|NCT02292784|524767843|FG002|Overall Study|Withdrawal by Subject|3|||
145520878|NCT00134784|524767844|FG000|Overall Study|Withdrawal by Subject|2|||
145520879|NCT00134784|524767845|FG001|Overall Study|Withdrawal by Subject|2|||
145520880|NCT00134784|524767846|FG002|Overall Study|Withdrawal by Subject|2|||
145520881|NCT00134784|524767847|FG003|Overall Study|Withdrawal by Subject|1|||
145520882|NCT02919969|524767848|FG000|Overall Study|Lack of Efficacy|22|||
145520883|NCT02919969|524767848|FG000|Overall Study|Death|4|||
145520884|NCT02919969|524767848|FG000|Overall Study|Physician Decision|3|||
145520885|NCT02919969|524767848|FG000|Overall Study|Withdrawal by Subject|2|||
145520886|NCT03621475|524767849|FG000|Overall Study|No longer required restraints at initiation|0|||
145520887|NCT03621475|524767850|FG001|Overall Study|No longer required restraints at initiation|1|||
145520888|NCT01842633|524767851|FG000|Overall Study|Screen Failure|1|||
145520889|NCT01842633|524767852|FG001|Overall Study|Screen Failure|0|||
145520890|NCT01842633|524767853|FG002|Overall Study|Screen Failure|0|||
145520891|NCT01842633|524767851|FG000|Overall Study|Adverse Event|1|||
145520892|NCT01842633|524767852|FG001|Overall Study|Adverse Event|1|||
145520893|NCT01842633|524767853|FG002|Overall Study|Adverse Event|0|||
145520894|NCT01842633|524767851|FG000|Overall Study|Withdrawal by Subject|0|||
145520895|NCT01842633|524767852|FG001|Overall Study|Withdrawal by Subject|1|||
145520896|NCT01842633|524767853|FG002|Overall Study|Withdrawal by Subject|0|||
145520897|NCT01842633|524767851|FG000|Overall Study|Technical issues|1|||
145520898|NCT01842633|524767852|FG001|Overall Study|Technical issues|0|||
145520899|NCT01842633|524767853|FG002|Overall Study|Technical issues|0|||
145520900|NCT00706849|524767859|FG000|Treatment Period|Adverse Event|0|||
145520901|NCT00706849|524767860|FG001|Treatment Period|Adverse Event|9|||
145520902|NCT00706849|524767859|FG000|Treatment Period|Other|0|||
145520903|NCT00706849|524767860|FG001|Treatment Period|Other|1|||
145520904|NCT00706849|524767859|FG000|Follow-up Period|Withdrawal by Subject|0|||
145520905|NCT00706849|524767860|FG001|Follow-up Period|Withdrawal by Subject|2|||
145520906|NCT00706849|524767859|FG000|Follow-up Period|Protocol non-compliance|0|||
145520907|NCT00706849|524767860|FG001|Follow-up Period|Protocol non-compliance|1|||
145520908|NCT02616601|524767861|FG000|Overall Study|Withdrawal by Subject|4|||
145520909|NCT02616601|524767862|FG001|Overall Study|Withdrawal by Subject|4|||
145520910|NCT02616601|524767863|FG002|Overall Study|Withdrawal by Subject|3|||
145520911|NCT02616601|524767861|FG000|Overall Study|Adverse Event|2|||
145520912|NCT02616601|524767862|FG001|Overall Study|Adverse Event|0|||
145520913|NCT02616601|524767863|FG002|Overall Study|Adverse Event|2|||
145520914|NCT02616601|524767861|FG000|Overall Study|Death|1|||
145520915|NCT02616601|524767862|FG001|Overall Study|Death|0|||
145520916|NCT02616601|524767863|FG002|Overall Study|Death|0|||
145520917|NCT02616601|524767861|FG000|Overall Study|Lost to Follow-up|1|||
145520918|NCT02616601|524767862|FG001|Overall Study|Lost to Follow-up|0|||
145520919|NCT02616601|524767863|FG002|Overall Study|Lost to Follow-up|1|||
145520920|NCT02616601|524767861|FG000|Overall Study|Non-Compliance with Test Article|1|||
145520921|NCT02616601|524767862|FG001|Overall Study|Non-Compliance with Test Article|0|||
145520922|NCT02616601|524767863|FG002|Overall Study|Non-Compliance with Test Article|1|||
145520923|NCT03718299|524767864|FG000|Overall Study|Adverse Event|1|||
145520924|NCT03718299|524767864|FG000|Overall Study|Withdrawal by Subject|6|||
145520925|NCT03718299|524767864|FG000|Overall Study|Physician Decision|2|||
145520926|NCT03718299|524767864|FG000|Overall Study|Lost to Follow-up|1|||
145520927|NCT04389970|524767865|FG000|Overall Study|Lost to Follow-up|1|||
145520928|NCT01343823|524767866|FG000|Overall Study|Study Terminated|1|||
145520929|NCT01343823|524767867|FG001|Overall Study|Study Terminated|0|||
145520930|NCT01343823|524767868|FG002|Overall Study|Study Terminated|0|||
145520931|NCT01343823|524767869|FG003|Overall Study|Study Terminated|1|||
145520932|NCT01343823|524767866|FG000|Overall Study|Withdrawal by Subject|1|||
145520933|NCT01343823|524767867|FG001|Overall Study|Withdrawal by Subject|0|||
145520934|NCT01343823|524767868|FG002|Overall Study|Withdrawal by Subject|0|||
145520935|NCT01343823|524767869|FG003|Overall Study|Withdrawal by Subject|0|||
145520936|NCT00976508|524767872|FG000|Overall Study|Death|7|||
145520937|NCT00976508|524767873|FG001|Overall Study|Death|1|||
145520938|NCT00976508|524767872|FG000|Overall Study|Lost to Follow-up|1|||
145520939|NCT00976508|524767873|FG001|Overall Study|Lost to Follow-up|0|||
145520940|NCT00976508|524767872|FG000|Overall Study|Withdrawal by Subject|1|||
145520941|NCT00976508|524767873|FG001|Overall Study|Withdrawal by Subject|0|||
145520942|NCT00976508|524767872|FG000|Overall Study|Disease Progression|4|||
145520943|NCT00976508|524767873|FG001|Overall Study|Disease Progression|4|||
145520944|NCT00976508|524767872|FG000|Overall Study|Subject Enrolled in Hospice|1|||
145520945|NCT00976508|524767873|FG001|Overall Study|Subject Enrolled in Hospice|0|||
145520946|NCT00976508|524767872|FG000|Overall Study|Terminated by the Sponsor|0|||
145520947|NCT00976508|524767873|FG001|Overall Study|Terminated by the Sponsor|1|||
145520948|NCT01992159|524767874|FG000|Overall Study|Withdrawal by Subject|4|||
145520949|NCT01992159|524767875|FG001|Overall Study|Withdrawal by Subject|7|||
145520950|NCT01992159|524767876|FG002|Overall Study|Withdrawal by Subject|0|||
145520951|NCT01992159|524767877|FG003|Overall Study|Withdrawal by Subject|3|||
145520952|NCT01992159|524767874|FG000|Overall Study|Adverse Event|0|||
145520953|NCT01992159|524767875|FG001|Overall Study|Adverse Event|1|||
145520954|NCT01992159|524767876|FG002|Overall Study|Adverse Event|0|||
145520955|NCT01992159|524767877|FG003|Overall Study|Adverse Event|1|||
145520956|NCT01992159|524767874|FG000|Overall Study|Death|0|||
145520957|NCT01992159|524767875|FG001|Overall Study|Death|0|||
145520958|NCT01992159|524767876|FG002|Overall Study|Death|1|||
145520959|NCT01992159|524767877|FG003|Overall Study|Death|0|||
145520960|NCT02160002|524767878|FG000|Overall Study|Withdrawal by Subject|2|||
145520961|NCT02160002|524767879|FG001|Overall Study|Withdrawal by Subject|1|||
145520962|NCT05508074|524767886|FG000|Overall Study|Death|2|||
145520963|NCT05508074|524767887|FG001|Overall Study|Death|5|||
145520964|NCT05508074|524767886|FG000|Overall Study|Withdrawal by Subject|1|||
145520965|NCT05508074|524767887|FG001|Overall Study|Withdrawal by Subject|2|||
145520966|NCT05508074|524767886|FG000|Overall Study|Adverse Event|0|||
145520967|NCT05508074|524767887|FG001|Overall Study|Adverse Event|1|||
145520968|NCT05508074|524767886|FG000|Overall Study|Physician Decision|0|||
145520969|NCT05508074|524767887|FG001|Overall Study|Physician Decision|1|||
145520970|NCT05508074|524767886|FG000|Overall Study|wrongly randomized|0|||
145520971|NCT05508074|524767887|FG001|Overall Study|wrongly randomized|1|||
145520972|NCT05508074|524767886|FG000|Overall Study|non-compliance|0|||
145520973|NCT05508074|524767887|FG001|Overall Study|non-compliance|1|||
145520974|NCT00686634|524767893|FG000|Overall Study|Protocol Violation|6|||
145520975|NCT02047318|524767896|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
145520976|NCT02047318|524767896|FG000|Core Study Period|Adverse Event|1|||
145520977|NCT02047318|524767896|FG000|Core Study Period|Withdrawal by caregiver|3|||
145520978|NCT02047318|524767896|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
145520979|NCT02296138|524767897|FG000|Overall Study|Adverse Event|348|||
145520980|NCT02296138|524767898|FG001|Overall Study|Adverse Event|259|||
145520981|NCT02296138|524767897|FG000|Overall Study|Lack of Efficacy|59|||
145520982|NCT02296138|524767898|FG001|Overall Study|Lack of Efficacy|37|||
145520983|NCT02296138|524767897|FG000|Overall Study|Protocol Violation|35|||
145520984|NCT02296138|524767898|FG001|Overall Study|Protocol Violation|36|||
145520985|NCT02296138|524767897|FG000|Overall Study|Lost to Follow-up|9|||
145520986|NCT02296138|524767898|FG001|Overall Study|Lost to Follow-up|12|||
145520987|NCT02296138|524767897|FG000|Overall Study|Withdrawal by Subject|184|||
145520988|NCT02296138|524767898|FG001|Overall Study|Withdrawal by Subject|131|||
145520989|NCT02296138|524767897|FG000|Overall Study|Not Treated|1|||
145520990|NCT02296138|524767898|FG001|Overall Study|Not Treated|1|||
145520991|NCT02296138|524767897|FG000|Overall Study|Patients with data irregularities|10|||
145520992|NCT02296138|524767898|FG001|Overall Study|Patients with data irregularities|11|||
145520993|NCT02296138|524767897|FG000|Overall Study|Other than specified|15|||
145520994|NCT02296138|524767898|FG001|Overall Study|Other than specified|13|||
145520995|NCT01653132|524767899|FG000|First Intervention|Protocol Violation|1|||
145520996|NCT01653132|524767900|FG001|First Intervention|Protocol Violation|0|||
145520997|NCT02677324|524767901|FG000|Overall Study|Disease Progression|6|||
145520998|NCT02677324|524767901|FG000|Overall Study|Inability to Swallow pills|1|||
145520999|NCT02677324|524767901|FG000|Overall Study|Non-compliance|1|||
145521000|NCT02677324|524767901|FG000|Overall Study|Lack of Efficacy|1|||
145521001|NCT02677324|524767901|FG000|Overall Study|Medical insurance coverage|1|||
145521002|NCT02677324|524767901|FG000|Overall Study|Adverse Event|1|||
145521003|NCT02677324|524767901|FG000|Overall Study|IgM Myeloma diagnosis|1|||
145521004|NCT00761150|524767904|FG000|Open-label Period|Adverse Event|36|||
145521005|NCT00761150|524767905|FG001|Open-label Period|Adverse Event|0|||
145521006|NCT00761150|524767906|FG002|Open-label Period|Adverse Event|0|||
145521007|NCT00761150|524767904|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
145521008|NCT00761150|524767905|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
145521009|NCT00761150|524767906|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
145521010|NCT00761150|524767904|FG000|Open-label Period|Lost to Follow-up|7|||
145521011|NCT00761150|524767905|FG001|Open-label Period|Lost to Follow-up|0|||
145521012|NCT00761150|524767906|FG002|Open-label Period|Lost to Follow-up|0|||
145521013|NCT00761150|524767904|FG000|Open-label Period|Lack of Efficacy|4|||
145521014|NCT00761150|524767905|FG001|Open-label Period|Lack of Efficacy|0|||
145521015|NCT00761150|524767906|FG002|Open-label Period|Lack of Efficacy|0|||
145521016|NCT00761150|524767904|FG000|Open-label Period|Withdrawal by Subject|5|||
145743578|NCT01840579|525577352|FG005|Overall Study|Ongoing in study|0|||
145743579|NCT01840579|525577353|FG006|Overall Study|Ongoing in study|0|||
145521017|NCT00761150|524767905|FG001|Open-label Period|Withdrawal by Subject|0|||
145521018|NCT00761150|524767906|FG002|Open-label Period|Withdrawal by Subject|0|||
145521019|NCT00761150|524767904|FG000|Open-label Period|Noncompliance|2|||
145521020|NCT00761150|524767905|FG001|Open-label Period|Noncompliance|0|||
145521021|NCT00761150|524767906|FG002|Open-label Period|Noncompliance|0|||
145521022|NCT00761150|524767904|FG000|Open-label Period|Other|5|||
145521023|NCT00761150|524767905|FG001|Open-label Period|Other|0|||
145521024|NCT00761150|524767906|FG002|Open-label Period|Other|0|||
145521025|NCT00761150|524767904|FG000|Double-blind Period|Lack of Efficacy|0|||
145521026|NCT00761150|524767905|FG001|Double-blind Period|Lack of Efficacy|2|||
145521027|NCT00761150|524767906|FG002|Double-blind Period|Lack of Efficacy|19|||
145521028|NCT00761150|524767904|FG000|Double-blind Period|Adverse Event|0|||
145521029|NCT00761150|524767905|FG001|Double-blind Period|Adverse Event|3|||
145521030|NCT00761150|524767906|FG002|Double-blind Period|Adverse Event|3|||
145521031|NCT00761150|524767904|FG000|Double-blind Period|Withdrawal by Subject|0|||
145521032|NCT00761150|524767905|FG001|Double-blind Period|Withdrawal by Subject|3|||
145521033|NCT00761150|524767906|FG002|Double-blind Period|Withdrawal by Subject|2|||
145521034|NCT00761150|524767904|FG000|Double-blind Period|Lost to Follow-up|0|||
145521035|NCT00761150|524767905|FG001|Double-blind Period|Lost to Follow-up|2|||
145521036|NCT00761150|524767906|FG002|Double-blind Period|Lost to Follow-up|1|||
145521037|NCT00761150|524767904|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
145521038|NCT00761150|524767905|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
145521039|NCT00761150|524767906|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
145521040|NCT00761150|524767904|FG000|Double-blind Period|Noncompliance|0|||
145521041|NCT00761150|524767905|FG001|Double-blind Period|Noncompliance|1|||
145521042|NCT00761150|524767906|FG002|Double-blind Period|Noncompliance|0|||
145521043|NCT00761150|524767904|FG000|Double-blind Period|Other|0|||
145521044|NCT00761150|524767905|FG001|Double-blind Period|Other|3|||
145521045|NCT00761150|524767906|FG002|Double-blind Period|Other|3|||
145521046|NCT03312751|524767907|FG000|Overall Study|Death|7|||
145521047|NCT03312751|524767908|FG001|Overall Study|Death|9|||
145521048|NCT03312751|524767907|FG000|Overall Study|Study discontinuation due to other reason|0|||
145521049|NCT03312751|524767908|FG001|Overall Study|Study discontinuation due to other reason|1|||
145521050|NCT00282464|524767909|FG000|Overall Study|Adverse Event|26|||
145521051|NCT00282464|524767910|FG001|Overall Study|Adverse Event|20|||
145521052|NCT00282464|524767909|FG000|Overall Study|Lack of Efficacy|8|||
145521053|NCT00282464|524767910|FG001|Overall Study|Lack of Efficacy|8|||
145521054|NCT00282464|524767909|FG000|Overall Study|Lost to Follow-up|10|||
145521055|NCT00282464|524767910|FG001|Overall Study|Lost to Follow-up|10|||
145521056|NCT00282464|524767909|FG000|Overall Study|Withdrawal by Subject|24|||
145521057|NCT00282464|524767910|FG001|Overall Study|Withdrawal by Subject|10|||
145521058|NCT00282464|524767909|FG000|Overall Study|laboratory abnormality|1|||
145521059|NCT00282464|524767910|FG001|Overall Study|laboratory abnormality|2|||
145521060|NCT00282464|524767909|FG000|Overall Study|Protocol Violation|0|||
145521061|NCT00282464|524767910|FG001|Overall Study|Protocol Violation|7|||
145521062|NCT00282464|524767909|FG000|Overall Study|Patient moved|1|||
145521063|NCT00282464|524767910|FG001|Overall Study|Patient moved|0|||
145521064|NCT00282464|524767909|FG000|Overall Study|patient non-compliant|3|||
145521065|NCT00282464|524767910|FG001|Overall Study|patient non-compliant|0|||
145521066|NCT00282464|524767909|FG000|Overall Study|patient no show|0|||
145521067|NCT00282464|524767910|FG001|Overall Study|patient no show|1|||
145521068|NCT00282464|524767909|FG000|Overall Study|patient incarcerated|0|||
145743580|NCT01840579|525577354|FG007|Overall Study|Ongoing in study|0|||
145743581|NCT01840579|525577355|FG008|Overall Study|Ongoing in study|0|||
145521069|NCT00282464|524767910|FG001|Overall Study|patient incarcerated|1|||
145521070|NCT00282464|524767909|FG000|Overall Study|family crisis|0|||
145521071|NCT00282464|524767910|FG001|Overall Study|family crisis|1|||
145521072|NCT00282464|524767909|FG000|Overall Study|dispensed wrong kit|0|||
145521073|NCT00282464|524767910|FG001|Overall Study|dispensed wrong kit|1|||
145521074|NCT00282464|524767909|FG000|Overall Study|dropped due to missed visits|0|||
145521075|NCT00282464|524767910|FG001|Overall Study|dropped due to missed visits|1|||
145521076|NCT00475423|524767911|FG000|Overall Study|Protocol Violation|5|||
145521077|NCT00475423|524767911|FG000|Overall Study|Adverse Event|4|||
145521078|NCT00475423|524767911|FG000|Overall Study|Withdrawal by Subject|6|||
145521079|NCT00475423|524767911|FG000|Overall Study|Lack of Efficacy|8|||
145521080|NCT00475423|524767911|FG000|Overall Study|Death|1|||
145521081|NCT00475423|524767911|FG000|Overall Study|Reason not specified|1|||
145521082|NCT00475423|524767911|FG000|Overall Study|Lost to Follow-up|7|||
145521083|NCT01214174|524767912|FG000|Overall Study|Withdrawal by Subject|0|||
145521084|NCT01214174|524767913|FG001|Overall Study|Withdrawal by Subject|0|||
145743582|NCT01840579|525577356|FG009|Overall Study|Ongoing in study|0|||
145521085|NCT01214174|524767914|FG002|Overall Study|Withdrawal by Subject|1|||
145521086|NCT02496676|524767919|FG000|Phase 1 - Period 1|Adverse Event|0|||
145521087|NCT02496676|524767920|FG001|Phase 1 - Period 1|Adverse Event|1|||
145521088|NCT02496676|524767919|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
145521089|NCT02496676|524767920|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
145521090|NCT02514473|524767924|FG000|Overall Study|Adverse Event|0|||
145521091|NCT02514473|524767925|FG001|Overall Study|Adverse Event|2|||
145521092|NCT02514473|524767924|FG000|Overall Study|Withdrawal by Subject|2|||
145521093|NCT02514473|524767925|FG001|Overall Study|Withdrawal by Subject|1|||
145521094|NCT02514473|524767924|FG000|Overall Study|Lost to Follow-up|0|||
145521095|NCT02514473|524767925|FG001|Overall Study|Lost to Follow-up|1|||
145521096|NCT02514473|524767924|FG000|Overall Study|Other|1|||
145521097|NCT02514473|524767925|FG001|Overall Study|Other|1|||
145521098|NCT00548405|524767926|FG000|Overall Study|Adverse Event|6|||
145521099|NCT00548405|524767927|FG001|Overall Study|Adverse Event|2|||
145521100|NCT00548405|524767928|FG002|Overall Study|Adverse Event|0|||
145743583|NCT01840579|525577347|FG000|Overall Study|Death|0|||
145743584|NCT01840579|525577348|FG001|Overall Study|Death|0|||
145743585|NCT01840579|525577349|FG002|Overall Study|Death|0|||
145521101|NCT00548405|524767926|FG000|Overall Study|Lack of Efficacy|6|||
145521102|NCT00548405|524767927|FG001|Overall Study|Lack of Efficacy|0|||
145521103|NCT00548405|524767928|FG002|Overall Study|Lack of Efficacy|0|||
145521104|NCT00548405|524767926|FG000|Overall Study|Physician Decision|3|||
145521105|NCT00548405|524767927|FG001|Overall Study|Physician Decision|4|||
145521106|NCT00548405|524767928|FG002|Overall Study|Physician Decision|1|||
145521107|NCT00548405|524767926|FG000|Overall Study|Pregnancy|1|||
145521108|NCT00548405|524767927|FG001|Overall Study|Pregnancy|0|||
145521109|NCT00548405|524767928|FG002|Overall Study|Pregnancy|0|||
145521110|NCT00548405|524767926|FG000|Overall Study|Protocol Violation|1|||
145521111|NCT00548405|524767927|FG001|Overall Study|Protocol Violation|0|||
145521112|NCT00548405|524767928|FG002|Overall Study|Protocol Violation|0|||
145521113|NCT00548405|524767926|FG000|Overall Study|Withdrawal by Subject|36|||
145521114|NCT00548405|524767927|FG001|Overall Study|Withdrawal by Subject|12|||
145521115|NCT00548405|524767928|FG002|Overall Study|Withdrawal by Subject|5|||
145521116|NCT00548405|524767926|FG000|Overall Study|Lost to Follow-up|1|||
145521117|NCT00548405|524767927|FG001|Overall Study|Lost to Follow-up|1|||
145521118|NCT00548405|524767928|FG002|Overall Study|Lost to Follow-up|2|||
145521119|NCT00548405|524767926|FG000|Overall Study|Death|0|||
145521120|NCT00548405|524767927|FG001|Overall Study|Death|1|||
145521121|NCT00548405|524767928|FG002|Overall Study|Death|1|||
145521122|NCT00548405|524767926|FG000|Overall Study|Sponsor decision|1|||
145521123|NCT00548405|524767927|FG001|Overall Study|Sponsor decision|0|||
145521124|NCT00548405|524767928|FG002|Overall Study|Sponsor decision|0|||
145521125|NCT00548405|524767926|FG000|Overall Study|Randomized but not treated|1|||
145521126|NCT00548405|524767927|FG001|Overall Study|Randomized but not treated|0|||
145521127|NCT00548405|524767928|FG002|Overall Study|Randomized but not treated|0|||
145521128|NCT01624870|524767929|FG000|Overall Study|Death|19|||
145521129|NCT01624870|524767929|FG000|Overall Study|Withdrawal by Subject|1|||
145521130|NCT01624870|524767929|FG000|Overall Study|CoreValve not implanted|6|||
145521131|NCT01624870|524767929|FG000|Overall Study|Lost to follow up|1|||
145521132|NCT02582684|524767934|FG000|Overall Study|Unable to contact subject/parent|4|||
145521133|NCT02582684|524767934|FG000|Overall Study|Subject not able to get to clinic|10|||
145521134|NCT02582684|524767934|FG000|Overall Study|Subject withdrew consent|1|||
145521135|NCT02582684|524767934|FG000|Overall Study|Found to be ineligible after enrollment|2|||
145521136|NCT04658940|524767940|FG000|Overall Study|Withdrawal by Subject|1|||
145521137|NCT01700439|524767941|FG000|Overall Study|Lost to Follow-up|47|||
145521138|NCT01700439|524767941|FG000|Overall Study|Withdrawal by Subject|183|||
145521139|NCT01700439|524767941|FG000|Overall Study|Death|186|||
145521140|NCT01829243|524767942|FG000|First Intervention|Screen Failure|4|||
145521141|NCT01829243|524767943|FG001|First Intervention|Screen Failure|2|||
145521142|NCT00053898|524767946|FG000|Overall Study|No follow-up data from any source|9|||
145521143|NCT00053898|524767947|FG001|Overall Study|No follow-up data from any source|12|||
145521144|NCT00053898|524767946|FG000|Overall Study|Follow-up from telephone contact only|5|||
145521145|NCT00053898|524767947|FG001|Overall Study|Follow-up from telephone contact only|1|||
145521146|NCT00266877|524767948|FG000|Overall Study|Death|1|||
145521147|NCT00266877|524767949|FG001|Overall Study|Death|1|||
145521148|NCT00266877|524767950|FG002|Overall Study|Death|1|||
145521149|NCT00266877|524767948|FG000|Overall Study|Adverse Event|6|||
145521150|NCT00266877|524767949|FG001|Overall Study|Adverse Event|4|||
145521151|NCT00266877|524767950|FG002|Overall Study|Adverse Event|1|||
145521152|NCT00266877|524767948|FG000|Overall Study|Physician Decision|2|||
145521153|NCT00266877|524767949|FG001|Overall Study|Physician Decision|1|||
145521154|NCT00266877|524767950|FG002|Overall Study|Physician Decision|1|||
145521155|NCT00266877|524767948|FG000|Overall Study|Withdrawal by Subject|3|||
145521156|NCT00266877|524767949|FG001|Overall Study|Withdrawal by Subject|1|||
145521157|NCT00266877|524767950|FG002|Overall Study|Withdrawal by Subject|1|||
145521158|NCT00266877|524767948|FG000|Overall Study|Disease Progression|72|||
145521159|NCT00266877|524767949|FG001|Overall Study|Disease Progression|37|||
145521160|NCT00266877|524767950|FG002|Overall Study|Disease Progression|23|||
145521161|NCT00266877|524767948|FG000|Overall Study|Symptomatic Deterioration|6|||
145521162|NCT00266877|524767949|FG001|Overall Study|Symptomatic Deterioration|3|||
145521163|NCT00266877|524767950|FG002|Overall Study|Symptomatic Deterioration|1|||
145521164|NCT00266877|524767948|FG000|Overall Study|Hospitalization|1|||
145521165|NCT00266877|524767949|FG001|Overall Study|Hospitalization|0|||
145521166|NCT00266877|524767950|FG002|Overall Study|Hospitalization|0|||
145521167|NCT00266877|524767948|FG000|Overall Study|Concomitant Radiotherapy|0|||
145521168|NCT00266877|524767949|FG001|Overall Study|Concomitant Radiotherapy|1|||
145521169|NCT00266877|524767950|FG002|Overall Study|Concomitant Radiotherapy|0|||
145521170|NCT01077375|524767951|FG000|Overall Study|Adverse Event|2|||
145521171|NCT01077375|524767952|FG001|Overall Study|Adverse Event|15|||
145521172|NCT01077375|524767951|FG000|Overall Study|Lack of Efficacy|6|||
145521173|NCT01077375|524767952|FG001|Overall Study|Lack of Efficacy|8|||
145521174|NCT01077375|524767951|FG000|Overall Study|Withdrawal by Subject|0|||
145521175|NCT01077375|524767952|FG001|Overall Study|Withdrawal by Subject|6|||
145521176|NCT01077375|524767951|FG000|Overall Study|Lost to Follow-up|2|||
145521177|NCT01077375|524767952|FG001|Overall Study|Lost to Follow-up|5|||
145521178|NCT01077375|524767951|FG000|Overall Study|Other Reason|0|||
145521179|NCT01077375|524767952|FG001|Overall Study|Other Reason|1|||
145521180|NCT03353740|524767956|FG000|Overall Study|Images for these participants not viable|52|||
145521181|NCT02232880|524767957|FG000|Overall Study|study stopped prior to randomization|1|||
145521182|NCT02093351|524768937|FG000|Part A|Adverse Event|0|||
145521183|NCT02093351|524768938|FG001|Part A|Adverse Event|1|||
145521184|NCT02093351|524768939|FG002|Part A|Adverse Event|1|||
145521185|NCT02093351|524768940|FG003|Part A|Adverse Event|0|||
145521186|NCT02093351|524768937|FG000|Part A|Condition under investigation worsened|2|||
145521187|NCT02093351|524768938|FG001|Part A|Condition under investigation worsened|0|||
145521188|NCT02093351|524768939|FG002|Part A|Condition under investigation worsened|2|||
145521189|NCT02093351|524768940|FG003|Part A|Condition under investigation worsened|0|||
145521190|NCT02093351|524768937|FG000|Part A|Death|0|||
145521191|NCT02093351|524768938|FG001|Part A|Death|1|||
145521192|NCT02093351|524768939|FG002|Part A|Death|0|||
145521193|NCT02093351|524768940|FG003|Part A|Death|0|||
145521194|NCT02093351|524768937|FG000|Part B|Patient decision|0|||
145521195|NCT02093351|524768938|FG001|Part B|Patient decision|0|||
145521196|NCT02093351|524768939|FG002|Part B|Patient decision|0|||
145521197|NCT02093351|524768940|FG003|Part B|Patient decision|3|||
145521198|NCT02093351|524768937|FG000|Part B|Disease progression|0|||
145521199|NCT02093351|524768938|FG001|Part B|Disease progression|0|||
145521200|NCT02093351|524768939|FG002|Part B|Disease progression|0|||
145521201|NCT02093351|524768940|FG003|Part B|Disease progression|4|||
145521202|NCT02093351|524768937|FG000|Part B|Complete response|0|||
145521203|NCT02093351|524768938|FG001|Part B|Complete response|0|||
145521204|NCT02093351|524768939|FG002|Part B|Complete response|0|||
145521205|NCT02093351|524768940|FG003|Part B|Complete response|1|||
145521206|NCT02093351|524768937|FG000|Part B|Adverse event + disease progression|0|||
145521207|NCT02093351|524768938|FG001|Part B|Adverse event + disease progression|0|||
145521208|NCT02093351|524768939|FG002|Part B|Adverse event + disease progression|0|||
145521209|NCT02093351|524768940|FG003|Part B|Adverse event + disease progression|1|||
145521210|NCT02093351|524768937|FG000|Part B|Lack of therapeutic response|0|||
145521211|NCT02093351|524768938|FG001|Part B|Lack of therapeutic response|0|||
145521212|NCT02093351|524768939|FG002|Part B|Lack of therapeutic response|0|||
145521213|NCT02093351|524768940|FG003|Part B|Lack of therapeutic response|12|||
145521214|NCT02093351|524768937|FG000|Part B|Condition under investigation worsened|0|||
145521215|NCT02093351|524768938|FG001|Part B|Condition under investigation worsened|0|||
145521216|NCT02093351|524768939|FG002|Part B|Condition under investigation worsened|0|||
145521217|NCT02093351|524768940|FG003|Part B|Condition under investigation worsened|39|||
145521218|NCT02093351|524768937|FG000|Part B|Adverse Event|0|||
145521219|NCT02093351|524768938|FG001|Part B|Adverse Event|0|||
145521220|NCT02093351|524768939|FG002|Part B|Adverse Event|0|||
145521221|NCT02093351|524768940|FG003|Part B|Adverse Event|2|||
145521222|NCT02093351|524768937|FG000|Part B|Death|0|||
145521223|NCT02093351|524768938|FG001|Part B|Death|0|||
145521224|NCT02093351|524768939|FG002|Part B|Death|0|||
145521225|NCT02093351|524768940|FG003|Part B|Death|1|||
145521226|NCT01099709|524768941|FG000|Period 1|Withdrawal by Subject|0|||
145521227|NCT01099709|524768942|FG001|Period 1|Withdrawal by Subject|1|||
145521228|NCT01099709|524768941|FG000|Period 1|Positive cotinine test|0|||
145521229|NCT01099709|524768942|FG001|Period 1|Positive cotinine test|1|||
145521230|NCT01099709|524768941|FG000|Period 1|Adverse Event|1|||
145521231|NCT01099709|524768942|FG001|Period 1|Adverse Event|0|||
145521232|NCT01611454|524768943|FG000|Overall Study|Lack of Efficacy|18|||
145521233|NCT01611454|524768944|FG001|Overall Study|Lack of Efficacy|10|||
145521234|NCT00920907|524768945|FG000|Induction Period|Adverse Event|0|||
145521235|NCT00920907|524768946|FG001|Induction Period|Adverse Event|2|||
145521236|NCT00920907|524768945|FG000|Induction Period|Death|1|||
145521237|NCT00920907|524768946|FG001|Induction Period|Death|1|||
145521238|NCT00920907|524768945|FG000|Induction Period|Disease Progression|12|||
145521239|NCT00920907|524768946|FG001|Induction Period|Disease Progression|11|||
145521240|NCT00920907|524768945|FG000|Induction Period|Study Drug Toxicity|8|||
145521241|NCT00920907|524768946|FG001|Induction Period|Study Drug Toxicity|6|||
145743586|NCT01840579|525577350|FG003|Overall Study|Death|0|||
145402453|NCT00784875|524330733|FG000|Period C|Protocol Violation|0|||
145402454|NCT00784875|524330734|FG001|Period C|Protocol Violation|0|||
145402455|NCT00784875|524330735|FG002|Period C|Protocol Violation|1|||
145521242|NCT00920907|524768945|FG000|Induction Period|No longer meets study criteria|0|||
145521243|NCT00920907|524768946|FG001|Induction Period|No longer meets study criteria|1|||
145521244|NCT00920907|524768945|FG000|Induction Period|Withdrawal by Subject|1|||
145521245|NCT00920907|524768946|FG001|Induction Period|Withdrawal by Subject|1|||
145521246|NCT00920907|524768945|FG000|Maintenance Period|Disease Progression|3|||
145521247|NCT00920907|524768946|FG001|Maintenance Period|Disease Progression|7|||
145521248|NCT00920907|524768945|FG000|Maintenance Period|Administrative (study closure)|7|||
145521249|NCT00920907|524768946|FG001|Maintenance Period|Administrative (study closure)|2|||
145521250|NCT00920907|524768945|FG000|Maintenance Period|Study Drug Toxicity|0|||
145521251|NCT00920907|524768946|FG001|Maintenance Period|Study Drug Toxicity|2|||
145521252|NCT00920907|524768945|FG000|Maintenance Period|Death|1|||
145521253|NCT00920907|524768946|FG001|Maintenance Period|Death|1|||
145521254|NCT00920907|524768945|FG000|Maintenance Period|Withdrawal by Subject|1|||
145521255|NCT00920907|524768946|FG001|Maintenance Period|Withdrawal by Subject|0|||
145521256|NCT00920907|524768945|FG000|Maintenance Period|Adverse Event|0|||
145521257|NCT00920907|524768946|FG001|Maintenance Period|Adverse Event|1|||
145521258|NCT01275339|524768947|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
145521259|NCT01275339|524768948|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
145521260|NCT01275339|524768949|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
145521261|NCT01275339|524768950|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
145521262|NCT01275339|524768947|FG000|Overall Study|Withdrawal by Subject|0|||
145521263|NCT01275339|524768948|FG001|Overall Study|Withdrawal by Subject|0|||
145521264|NCT01275339|524768949|FG002|Overall Study|Withdrawal by Subject|1|||
145521265|NCT01275339|524768950|FG003|Overall Study|Withdrawal by Subject|0|||
145521266|NCT04656275|524768951|FG000|Overall Study|Study terminated by sponsor|2|||
145521267|NCT04656275|524768952|FG001|Overall Study|Study terminated by sponsor|4|||
145521268|NCT00934648|524768956|FG000|Overall Study|Failure to return|8|||
145521269|NCT00934648|524768956|FG000|Overall Study|Withdrawal by Subject|1|||
145521270|NCT00290407|524768957|FG000|Overall Study|Physician Decision|2|||
145521271|NCT01925989|524768968|FG000|Period 1|Sponsor Decision|1|||
145521272|NCT01925989|524768969|FG001|Period 1|Sponsor Decision|1|||
145521273|NCT01925989|524768970|FG002|Period 1|Sponsor Decision|0|||
145521274|NCT01925989|524768968|FG000|Period 1|Withdrawal by Subject|0|||
145521275|NCT01925989|524768969|FG001|Period 1|Withdrawal by Subject|1|||
145521276|NCT01925989|524768970|FG002|Period 1|Withdrawal by Subject|0|||
145521277|NCT00868517|524768971|FG000|Overall Study|Withdrawal by Subject|3|||
145521278|NCT00868517|524768972|FG001|Overall Study|Withdrawal by Subject|3|||
145521279|NCT00868517|524768973|FG002|Overall Study|Withdrawal by Subject|2|||
145521280|NCT00868517|524768971|FG000|Overall Study|Protocol Violation|1|||
145521281|NCT00868517|524768972|FG001|Overall Study|Protocol Violation|1|||
145521282|NCT00868517|524768973|FG002|Overall Study|Protocol Violation|0|||
145521283|NCT05442775|524768974|FG000|Overall Study|Trial terminated|61|||
145521284|NCT05442775|524768974|FG000|Overall Study|Lack of Efficacy|4|||
145521285|NCT05442775|524768974|FG000|Overall Study|Withdrawal by Subject|4|||
145521286|NCT05442775|524768974|FG000|Overall Study|Death|1|||
145521287|NCT05442775|524768974|FG000|Overall Study|Participant removed at Sponsor request|1|||
145521288|NCT02963831|524768976|FG000|Overall Study|Progressive Disease|3|||
145521289|NCT02963831|524768977|FG001|Overall Study|Progressive Disease|3|||
145521290|NCT02963831|524768978|FG002|Overall Study|Progressive Disease|16|||
145521291|NCT02963831|524768979|FG003|Overall Study|Progressive Disease|27|||
145521292|NCT02963831|524768976|FG000|Overall Study|Withdrawal by Subject|1|||
145521293|NCT02963831|524768977|FG001|Overall Study|Withdrawal by Subject|0|||
145521294|NCT02963831|524768978|FG002|Overall Study|Withdrawal by Subject|2|||
145270521|NCT02057549|523837911|FG000|Overall Study|Lost to Follow-up|1|||
145521295|NCT02963831|524768979|FG003|Overall Study|Withdrawal by Subject|4|||
145521296|NCT02963831|524768976|FG000|Overall Study|Adverse Event|0|||
145521297|NCT02963831|524768977|FG001|Overall Study|Adverse Event|1|||
145521298|NCT02963831|524768978|FG002|Overall Study|Adverse Event|1|||
145521299|NCT02963831|524768979|FG003|Overall Study|Adverse Event|2|||
145521300|NCT02963831|524768976|FG000|Overall Study|Death|0|||
145521301|NCT02963831|524768977|FG001|Overall Study|Death|0|||
145521302|NCT02963831|524768978|FG002|Overall Study|Death|0|||
145521303|NCT02963831|524768979|FG003|Overall Study|Death|2|||
145521304|NCT01966432|524768980|FG000|Overall Study|Lost to Follow-up|3|||
145521305|NCT01966432|524768981|FG001|Overall Study|Lost to Follow-up|2|||
145521306|NCT01966432|524768982|FG002|Overall Study|Lost to Follow-up|5|||
145521307|NCT01966432|524768980|FG000|Overall Study|Withdrawal by Subject|1|||
145521308|NCT01966432|524768981|FG001|Overall Study|Withdrawal by Subject|3|||
145521309|NCT01966432|524768982|FG002|Overall Study|Withdrawal by Subject|0|||
145521310|NCT01966432|524768980|FG000|Overall Study|Subject Incarcerated|0|||
145521311|NCT01966432|524768981|FG001|Overall Study|Subject Incarcerated|0|||
145521312|NCT01966432|524768982|FG002|Overall Study|Subject Incarcerated|1|||
145521313|NCT01966432|524768980|FG000|Overall Study|SBIRT program ended|1|||
145521314|NCT01966432|524768981|FG001|Overall Study|SBIRT program ended|8|||
145521315|NCT01966432|524768982|FG002|Overall Study|SBIRT program ended|20|||
145521316|NCT02815280|524768989|FG000|Double-Blind Phase|Adverse Event|1|||
145521317|NCT02815280|524768990|FG001|Double-Blind Phase|Adverse Event|1|||
145521318|NCT02815280|524768989|FG000|Double-Blind Phase|Lost to Follow-up|10|||
145521319|NCT02815280|524768990|FG001|Double-Blind Phase|Lost to Follow-up|9|||
145521320|NCT02815280|524768989|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
145521321|NCT02815280|524768990|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
145521322|NCT02815280|524768989|FG000|Double-Blind Phase|Protocol Violation|2|||
145521323|NCT02815280|524768990|FG001|Double-Blind Phase|Protocol Violation|2|||
145521324|NCT02815280|524768989|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
145521325|NCT02815280|524768990|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
145521326|NCT02815280|524768989|FG000|Open-Label Phase|Adverse Event|2|||
145521327|NCT02815280|524768990|FG001|Open-Label Phase|Adverse Event|3|||
145521328|NCT02815280|524768989|FG000|Open-Label Phase|Lost to Follow-up|18|||
145521329|NCT02815280|524768990|FG001|Open-Label Phase|Lost to Follow-up|9|||
145521330|NCT02815280|524768989|FG000|Open-Label Phase|Withdrawal by Subject|33|||
145521331|NCT02815280|524768990|FG001|Open-Label Phase|Withdrawal by Subject|18|||
145521332|NCT02815280|524768989|FG000|Open-Label Phase|Protocol Violation|3|||
145521333|NCT02815280|524768990|FG001|Open-Label Phase|Protocol Violation|0|||
145521334|NCT02815280|524768989|FG000|Open-Label Phase|Administrative|26|||
145521335|NCT02815280|524768990|FG001|Open-Label Phase|Administrative|12|||
145521336|NCT02815280|524768989|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
145521337|NCT02815280|524768990|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
145521338|NCT02106923|524769002|FG000|Overall Study|Protocol Violation|0|||
145521339|NCT02106923|524769003|FG001|Overall Study|Protocol Violation|0|||
145521340|NCT02106923|524769004|FG002|Overall Study|Protocol Violation|0|||
145521341|NCT02106923|524769005|FG003|Overall Study|Protocol Violation|0|||
145521342|NCT02106923|524769006|FG004|Overall Study|Protocol Violation|0|||
145521343|NCT02106923|524769007|FG005|Overall Study|Protocol Violation|1|||
145521344|NCT03485495|524769008|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
145521345|NCT03485495|524769009|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
145521346|NCT03915860|524769011|FG000|Overall Study|Adverse Event|3|||
145521347|NCT03915860|524769011|FG000|Overall Study|Withdrawal by Subject|6|||
145521348|NCT03915860|524769011|FG000|Overall Study|Lost to Follow-up|2|||
145521349|NCT03915860|524769011|FG000|Overall Study|Other than specified|3|||
145521350|NCT01009281|524769012|FG000|Overall Study|Administrative problems|7|||
145521351|NCT03901456|524769014|FG000|Overall Study|Withdrawal by Subject|0|||
145521352|NCT03901456|524769015|FG001|Overall Study|Withdrawal by Subject|0|||
145521353|NCT03901456|524769016|FG002|Overall Study|Withdrawal by Subject|1|||
145521354|NCT03901456|524769014|FG000|Overall Study|Lost to Follow-up|0|||
145521355|NCT03901456|524769015|FG001|Overall Study|Lost to Follow-up|1|||
145521356|NCT03901456|524769016|FG002|Overall Study|Lost to Follow-up|0|||
145521357|NCT02217527|524769019|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
145521358|NCT02217527|524769020|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
145521359|NCT02217527|524769019|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
145521360|NCT02217527|524769020|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
145521361|NCT03836001|524769021|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
145521362|NCT03836001|524769022|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
145521363|NCT03836001|524769023|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
145521364|NCT03836001|524769021|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
145521365|NCT03836001|524769022|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
145521366|NCT03836001|524769023|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
145521367|NCT03836001|524769021|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
145521368|NCT03836001|524769022|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
145521369|NCT03836001|524769023|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
145521370|NCT03836001|524769021|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
145521371|NCT03836001|524769022|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
145521372|NCT03836001|524769023|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
145521373|NCT01642732|524769024|FG000|Overall Study|Withdrawal by Subject|1|||
145521374|NCT03562767|524769027|FG000|Overall Study|Physician Decision|2|||
145521375|NCT03562767|524769028|FG001|Overall Study|Physician Decision|0|||
145521376|NCT03562767|524769029|FG002|Overall Study|Physician Decision|0|||
145521377|NCT03562767|524769027|FG000|Overall Study|Logistic Reason|1|||
145521378|NCT03562767|524769028|FG001|Overall Study|Logistic Reason|3|||
145521379|NCT03562767|524769029|FG002|Overall Study|Logistic Reason|0|||
145521380|NCT00402233|524769032|FG000|Overall Study|Adverse Event|1|||
145521381|NCT00402233|524769033|FG001|Overall Study|Adverse Event|7|||
145521382|NCT00402233|524769034|FG002|Overall Study|Adverse Event|9|||
145521383|NCT00402233|524769035|FG003|Overall Study|Adverse Event|9|||
145521384|NCT00402233|524769032|FG000|Overall Study|Protocol Violation|0|||
145521385|NCT00402233|524769033|FG001|Overall Study|Protocol Violation|1|||
145521386|NCT00402233|524769034|FG002|Overall Study|Protocol Violation|0|||
145521387|NCT00402233|524769035|FG003|Overall Study|Protocol Violation|0|||
145521388|NCT00402233|524769032|FG000|Overall Study|Withdrawal by Subject|2|||
145521389|NCT00402233|524769033|FG001|Overall Study|Withdrawal by Subject|1|||
145521390|NCT00402233|524769034|FG002|Overall Study|Withdrawal by Subject|2|||
145521391|NCT00402233|524769035|FG003|Overall Study|Withdrawal by Subject|2|||
145521392|NCT00402233|524769032|FG000|Overall Study|Worsening of disease under study|2|||
145521393|NCT00402233|524769033|FG001|Overall Study|Worsening of disease under study|0|||
145521394|NCT00402233|524769034|FG002|Overall Study|Worsening of disease under study|0|||
145521395|NCT00402233|524769035|FG003|Overall Study|Worsening of disease under study|0|||
145521396|NCT00402233|524769032|FG000|Overall Study|Worsening of other pre-existing disease|0|||
145521397|NCT00402233|524769033|FG001|Overall Study|Worsening of other pre-existing disease|1|||
145521398|NCT00402233|524769034|FG002|Overall Study|Worsening of other pre-existing disease|0|||
145521399|NCT00402233|524769035|FG003|Overall Study|Worsening of other pre-existing disease|0|||
145521400|NCT00938886|524769036|FG000|Overall Study|Death|0|||
145521401|NCT00938886|524769037|FG001|Overall Study|Death|1|||
145521402|NCT00938886|524769036|FG000|Overall Study|Withdrawal by Subject|4|||
145521403|NCT00938886|524769037|FG001|Overall Study|Withdrawal by Subject|7|||
145521404|NCT00938886|524769036|FG000|Overall Study|Lost to Follow-up|3|||
145521405|NCT00938886|524769037|FG001|Overall Study|Lost to Follow-up|2|||
145521406|NCT03579602|524769038|FG000|Overall Study|Subject unable to receive study drug|0|||
145521407|NCT03579602|524769039|FG001|Overall Study|Subject unable to receive study drug|2|||
145521408|NCT03579602|524769038|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
145521409|NCT03579602|524769039|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
145521410|NCT02518464|524769041|FG000|Overall Study|Adverse Event|2|||
145521411|NCT01120067|524769044|FG000|Overall Study|Lost to Follow-up|3|||
145521412|NCT01120067|524769045|FG001|Overall Study|Lost to Follow-up|1|||
145521413|NCT01120067|524769044|FG000|Overall Study|fail to engage >3 sessions|2|||
145521414|NCT01120067|524769045|FG001|Overall Study|fail to engage >3 sessions|0|||
145521415|NCT03021564|524769053|FG000|Overall Study|Death|84|||
145521416|NCT03021564|524769054|FG001|Overall Study|Death|466|||
145521417|NCT03021564|524769053|FG000|Overall Study|Lost to Follow-up|0|||
145521418|NCT03021564|524769054|FG001|Overall Study|Lost to Follow-up|2|||
145521419|NCT02889562|524769055|FG000|Overall Study|Physician Decision|0|||
145521420|NCT02889562|524769056|FG001|Overall Study|Physician Decision|1|||
145521421|NCT02889562|524769055|FG000|Overall Study|Withdrawal by Subject|0|||
145521422|NCT02889562|524769056|FG001|Overall Study|Withdrawal by Subject|1|||
145521423|NCT01470989|524769059|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
145521424|NCT01470989|524769060|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
145521425|NCT01470989|524769059|FG000|Overall Study|Adverse Event|2|||
145521426|NCT01470989|524769060|FG001|Overall Study|Adverse Event|5|||
145521427|NCT01470989|524769059|FG000|Overall Study|Abnormal laboratory value|1|||
145521428|NCT01470989|524769060|FG001|Overall Study|Abnormal laboratory value|1|||
145521429|NCT01470989|524769059|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145521430|NCT01470989|524769060|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
145521431|NCT01470989|524769059|FG000|Overall Study|Withdrawal by Subject|19|||
145521432|NCT01470989|524769060|FG001|Overall Study|Withdrawal by Subject|17|||
145521433|NCT01470989|524769059|FG000|Overall Study|Lost to Follow-up|18|||
145521434|NCT01470989|524769060|FG001|Overall Study|Lost to Follow-up|13|||
145521435|NCT01470989|524769059|FG000|Overall Study|Administrative problems|2|||
145521436|NCT01470989|524769060|FG001|Overall Study|Administrative problems|4|||
145521437|NCT01470989|524769059|FG000|Overall Study|Death|2|||
145521438|NCT01470989|524769060|FG001|Overall Study|Death|2|||
145521439|NCT01470989|524769059|FG000|Overall Study|Protocol deviation|1|||
145521440|NCT01470989|524769060|FG001|Overall Study|Protocol deviation|2|||
145521441|NCT00969280|524769061|FG000|Overall Study|Protocol Violation|2|||
145521442|NCT00969280|524769062|FG001|Overall Study|Protocol Violation|1|||
145521443|NCT00969280|524769061|FG000|Overall Study|Withdrawal by Subject|0|||
145521444|NCT00969280|524769062|FG001|Overall Study|Withdrawal by Subject|1|||
145521445|NCT00969280|524769061|FG000|Overall Study|infection of influenza A(H1N1)|0|||
145521446|NCT00969280|524769062|FG001|Overall Study|infection of influenza A(H1N1)|1|||
145521447|NCT00821327|524769063|FG000|Overall Study|Adverse Event|13|||
145521448|NCT00821327|524769063|FG000|Overall Study|Patient Request|1|||
145521449|NCT00821327|524769063|FG000|Overall Study|Investigator Request|2|||
145521450|NCT00821327|524769063|FG000|Overall Study|Sponsor Request|1|||
145521451|NCT00821327|524769063|FG000|Overall Study|Disease Progression|13|||
145521452|NCT00821327|524769063|FG000|Overall Study|Other/Unknown|5|||
145521453|NCT02119676|524769064|FG000|Overall Study|Adverse Event|9|||
145521454|NCT02119676|524769065|FG001|Overall Study|Adverse Event|17|||
145521455|NCT02119676|524769066|FG002|Overall Study|Adverse Event|10|||
145521456|NCT02119676|524769067|FG003|Overall Study|Adverse Event|10|||
145521457|NCT02119676|524769064|FG000|Overall Study|Disease progression|53|||
145521458|NCT02119676|524769065|FG001|Overall Study|Disease progression|55|||
145521459|NCT02119676|524769066|FG002|Overall Study|Disease progression|68|||
145521460|NCT02119676|524769067|FG003|Overall Study|Disease progression|73|||
145521461|NCT02119676|524769064|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
145521462|NCT02119676|524769065|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
145521463|NCT02119676|524769066|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
145521464|NCT02119676|524769067|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
145521465|NCT02119676|524769064|FG000|Overall Study|Physician Decision|4|||
145521466|NCT02119676|524769065|FG001|Overall Study|Physician Decision|2|||
145521467|NCT02119676|524769066|FG002|Overall Study|Physician Decision|3|||
145521468|NCT02119676|524769067|FG003|Overall Study|Physician Decision|2|||
145521469|NCT02119676|524769064|FG000|Overall Study|Death|9|||
145521470|NCT02119676|524769065|FG001|Overall Study|Death|3|||
145521471|NCT02119676|524769066|FG002|Overall Study|Death|2|||
145521472|NCT02119676|524769067|FG003|Overall Study|Death|1|||
145521473|NCT02119676|524769064|FG000|Overall Study|Noncompliance|0|||
145521474|NCT02119676|524769065|FG001|Overall Study|Noncompliance|1|||
145521475|NCT02119676|524769066|FG002|Overall Study|Noncompliance|0|||
145521476|NCT02119676|524769067|FG003|Overall Study|Noncompliance|0|||
145521477|NCT02119676|524769064|FG000|Overall Study|Lost to Follow-up|0|||
145521478|NCT02119676|524769065|FG001|Overall Study|Lost to Follow-up|0|||
145521479|NCT02119676|524769066|FG002|Overall Study|Lost to Follow-up|1|||
145521480|NCT02119676|524769067|FG003|Overall Study|Lost to Follow-up|0|||
145521481|NCT02119676|524769064|FG000|Overall Study|Protocol deviation|0|||
145521482|NCT02119676|524769065|FG001|Overall Study|Protocol deviation|0|||
145521483|NCT02119676|524769066|FG002|Overall Study|Protocol deviation|1|||
145521484|NCT02119676|524769067|FG003|Overall Study|Protocol deviation|0|||
145521485|NCT02119676|524769064|FG000|Overall Study|Other, unspecified|2|||
145521486|NCT02119676|524769065|FG001|Overall Study|Other, unspecified|1|||
145521487|NCT02119676|524769066|FG002|Overall Study|Other, unspecified|3|||
145521488|NCT02119676|524769067|FG003|Overall Study|Other, unspecified|4|||
145521489|NCT02119676|524769064|FG000|Overall Study|Did not receive study med|2|||
145521490|NCT02119676|524769065|FG001|Overall Study|Did not receive study med|2|||
145521491|NCT02119676|524769066|FG002|Overall Study|Did not receive study med|4|||
145521492|NCT02119676|524769067|FG003|Overall Study|Did not receive study med|5|||
145521493|NCT00217464|524769068|FG000|Overall Study|Progression|15|||
145521494|NCT00217464|524769068|FG000|Overall Study|Other|2|||
145521495|NCT01089361|524769069|FG000|Overall Study|Death|1|||
145521496|NCT01089361|524769070|FG001|Overall Study|Death|0|||
145521497|NCT00278915|524769073|FG000|Overall Study|Disease progression|1|||
145521498|NCT01007253|524769074|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
145521499|NCT01007253|524769075|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
145521500|NCT01007253|524769076|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
145521501|NCT01007253|524769077|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
145558208|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
145558209|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558210|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558211|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558212|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558213|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558214|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
145558215|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
145558216|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
145558217|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
145558218|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
145743587|NCT01840579|525577351|FG004|Overall Study|Death|0|||
145558219|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
145558220|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
145558221|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
145558222|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
145558223|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558224|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558225|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558226|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558227|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558228|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
145558229|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
145558230|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
145743588|NCT01840579|525577352|FG005|Overall Study|Death|1|||
145270522|NCT02057549|523837912|FG001|Overall Study|Lost to Follow-up|0|||
145270523|NCT02057549|523837911|FG000|Overall Study|Physician Decision|1|||
145270524|NCT02057549|523837912|FG001|Overall Study|Physician Decision|0|||
145270525|NCT02057549|523837911|FG000|Overall Study|Withdrawal by Subject|1|||
145270526|NCT02057549|523837912|FG001|Overall Study|Withdrawal by Subject|0|||
145270527|NCT03843775|523837915|FG000|Overall Study|Adverse Event|1|||
145270528|NCT03843775|523837916|FG001|Overall Study|Adverse Event|1|||
145270529|NCT03843775|523837915|FG000|Overall Study|Lack of Efficacy|2|||
145270530|NCT03843775|523837916|FG001|Overall Study|Lack of Efficacy|6|||
145270531|NCT03843775|523837915|FG000|Overall Study|Withdrawal by Subject|0|||
145270532|NCT03843775|523837916|FG001|Overall Study|Withdrawal by Subject|1|||
145270533|NCT00530621|523837920|FG000|Overall Study|Adverse Event|11|||
145270534|NCT00530621|523837921|FG001|Overall Study|Adverse Event|8|||
145270535|NCT00530621|523837920|FG000|Overall Study|Physician Decision|2|||
145270536|NCT00530621|523837921|FG001|Overall Study|Physician Decision|4|||
145270537|NCT00530621|523837920|FG000|Overall Study|Progressive Disease (PD)|47|||
145270538|NCT00530621|523837921|FG001|Overall Study|Progressive Disease (PD)|40|||
145270539|NCT00530621|523837920|FG000|Overall Study|Sponsor Decision|12|||
145270540|NCT00530621|523837921|FG001|Overall Study|Sponsor Decision|15|||
145270541|NCT00530621|523837920|FG000|Overall Study|Subject Decision|4|||
145270542|NCT00530621|523837921|FG001|Overall Study|Subject Decision|7|||
145521502|NCT00622739|524770598|FG000|Overall Study|Physician Decision|1|||
145521503|NCT00622739|524770599|FG001|Overall Study|Physician Decision|0|||
145521504|NCT00622739|524770598|FG000|Overall Study|Adverse Event|1|||
145521505|NCT00622739|524770599|FG001|Overall Study|Adverse Event|2|||
145521506|NCT00622739|524770598|FG000|Overall Study|Lack of Efficacy|0|||
145521507|NCT00622739|524770599|FG001|Overall Study|Lack of Efficacy|2|||
145521508|NCT00622739|524770598|FG000|Overall Study|Withdrawal by Subject|0|||
145521509|NCT00622739|524770599|FG001|Overall Study|Withdrawal by Subject|1|||
145521510|NCT00622739|524770598|FG000|Overall Study|Lost to Follow-up|0|||
145521511|NCT00622739|524770599|FG001|Overall Study|Lost to Follow-up|1|||
145521512|NCT03123185|524770607|FG000|Overall Study|Withdrawal by Subject|0|||
145521513|NCT03123185|524770608|FG001|Overall Study|Withdrawal by Subject|0|||
145521514|NCT03123185|524770609|FG002|Overall Study|Withdrawal by Subject|0|||
145521515|NCT03123185|524770610|FG003|Overall Study|Withdrawal by Subject|0|||
145521516|NCT03123185|524770611|FG004|Overall Study|Withdrawal by Subject|0|||
145521517|NCT03123185|524770612|FG005|Overall Study|Withdrawal by Subject|0|||
145521518|NCT03123185|524770613|FG006|Overall Study|Withdrawal by Subject|0|||
145521519|NCT03123185|524770614|FG007|Overall Study|Withdrawal by Subject|0|||
145521520|NCT03123185|524770615|FG008|Overall Study|Withdrawal by Subject|0|||
145521521|NCT03123185|524770616|FG009|Overall Study|Withdrawal by Subject|0|||
145521522|NCT03123185|524770617|FG010|Overall Study|Withdrawal by Subject|0|||
145521523|NCT03123185|524770618|FG011|Overall Study|Withdrawal by Subject|0|||
145521524|NCT03123185|524770619|FG012|Overall Study|Withdrawal by Subject|1|||
145521525|NCT03123185|524770620|FG013|Overall Study|Withdrawal by Subject|0|||
145521526|NCT00718081|524770621|FG000|Overall Study|Adverse Event|0|||
145521527|NCT00718081|524770622|FG001|Overall Study|Adverse Event|1|||
145521528|NCT00718081|524770623|FG002|Overall Study|Adverse Event|0|||
145521529|NCT00718081|524770621|FG000|Overall Study|Lack of Efficacy|7|||
145521530|NCT00718081|524770622|FG001|Overall Study|Lack of Efficacy|3|||
145521531|NCT00718081|524770623|FG002|Overall Study|Lack of Efficacy|21|||
145521532|NCT00815516|524770624|FG000|Overall Study|Death|3|||
145521533|NCT00815516|524770625|FG001|Overall Study|Death|1|||
145521534|NCT00815516|524770624|FG000|Overall Study|Physician Decision|1|||
145521535|NCT00815516|524770625|FG001|Overall Study|Physician Decision|0|||
145521536|NCT03468543|524770639|FG000|Overall Study|Protocol stopping rules met|3|||
145521537|NCT00470158|524770640|FG000|Overall Study|Death|0|||
145521538|NCT00470158|524770641|FG001|Overall Study|Death|0|||
145521539|NCT00470158|524770642|FG002|Overall Study|Death|0|||
145521540|NCT00470158|524770643|FG003|Overall Study|Death|0|||
145270543|NCT00530621|523837920|FG000|Overall Study|Death|3|||
145270544|NCT00530621|523837921|FG001|Overall Study|Death|6|||
145270545|NCT00530621|523837920|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
145521541|NCT00470158|524770644|FG004|Overall Study|Death|2|||
145521542|NCT00470158|524770640|FG000|Overall Study|Lost to Follow-up|7|||
145521543|NCT00470158|524770641|FG001|Overall Study|Lost to Follow-up|8|||
145521544|NCT00470158|524770642|FG002|Overall Study|Lost to Follow-up|8|||
145270546|NCT00530621|523837921|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
145270547|NCT04611152|523837924|FG000|Overall Study|Adverse Event|9|||
145270548|NCT04611152|523837925|FG001|Overall Study|Adverse Event|8|||
145402456|NCT00784875|524330736|FG003|Period C|Protocol Violation|2|||
145521545|NCT00470158|524770643|FG003|Overall Study|Lost to Follow-up|5|||
145521546|NCT00470158|524770644|FG004|Overall Study|Lost to Follow-up|4|||
145521547|NCT00470158|524770640|FG000|Overall Study|Protocol Violation|1|||
145521548|NCT00470158|524770641|FG001|Overall Study|Protocol Violation|0|||
145521549|NCT00470158|524770642|FG002|Overall Study|Protocol Violation|0|||
145521550|NCT00470158|524770643|FG003|Overall Study|Protocol Violation|0|||
145521551|NCT00470158|524770644|FG004|Overall Study|Protocol Violation|0|||
145521552|NCT00880685|524770645|FG000|Memantine 10mg|Lost to Follow-up|2|||
145521553|NCT00880685|524770645|FG000|Memantine 20mg|Withdrawal by Subject|1|||
145521554|NCT01249118|524770646|FG000|First Washout Period|Physician Decision|0|||
145521555|NCT01249118|524770647|FG001|First Washout Period|Physician Decision|1|||
145521556|NCT01249118|524770648|FG002|First Washout Period|Physician Decision|0|||
145521557|NCT04179890|524770649|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
145521558|NCT04179890|524770650|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
145521559|NCT04179890|524770649|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
145521560|NCT04179890|524770650|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
145521561|NCT04179890|524770649|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
145521562|NCT04179890|524770650|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
145521563|NCT04179890|524770649|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
145521564|NCT04179890|524770650|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
145521565|NCT04179890|524770649|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
145521566|NCT04179890|524770650|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
145521567|NCT04179890|524770649|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
145521568|NCT04179890|524770650|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
145521569|NCT04179890|524770649|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
145521570|NCT04179890|524770650|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
145521571|NCT04179890|524770649|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
145521572|NCT04179890|524770650|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
145521573|NCT04179890|524770649|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
145521574|NCT04179890|524770650|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
145521575|NCT00978432|524770652|FG000|Overall Study|Withdrawal by Subject|0|||
145521576|NCT00978432|524770653|FG001|Overall Study|Withdrawal by Subject|0|||
145521577|NCT00978432|524770654|FG002|Overall Study|Withdrawal by Subject|1|||
145521578|NCT00978432|524770652|FG000|Overall Study|Lack of Efficacy|1|||
145521579|NCT00978432|524770653|FG001|Overall Study|Lack of Efficacy|1|||
145521580|NCT00978432|524770654|FG002|Overall Study|Lack of Efficacy|3|||
145521581|NCT00978432|524770652|FG000|Overall Study|Adverse Event|2|||
145521582|NCT00978432|524770653|FG001|Overall Study|Adverse Event|0|||
145521583|NCT00978432|524770654|FG002|Overall Study|Adverse Event|1|||
145521584|NCT02579928|524770655|FG000|Overall Study|Withdrawal by Subject|1|||
145521585|NCT02579928|524770656|FG001|Overall Study|Withdrawal by Subject|0|||
145521586|NCT02311582|524770661|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
145521587|NCT02311582|524770662|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
145521588|NCT02311582|524770663|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
145521589|NCT02311582|524770664|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
145521590|NCT02311582|524770665|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
145521591|NCT03404960|524770667|FG000|Overall Study|Adverse Event|0|||
145521592|NCT03404960|524770668|FG001|Overall Study|Adverse Event|2|||
145521593|NCT03404960|524770667|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
145521594|NCT03404960|524770668|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
145521595|NCT03404960|524770667|FG000|Overall Study|Bowel obstruction|0|||
145521596|NCT03404960|524770668|FG001|Overall Study|Bowel obstruction|1|||
145521597|NCT03404960|524770667|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
145521598|NCT03404960|524770668|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
145521599|NCT03422627|524770671|FG000|Overall Study|Protocol-specified Criteria|1|||
145521600|NCT03422627|524770672|FG001|Overall Study|Protocol-specified Criteria|1|||
145521601|NCT03422627|524770673|FG002|Overall Study|Protocol-specified Criteria|0|||
145521602|NCT03422627|524770674|FG003|Overall Study|Protocol-specified Criteria|0|||
145521603|NCT03422627|524770675|FG004|Overall Study|Protocol-specified Criteria|2|||
145521604|NCT03422627|524770671|FG000|Overall Study|Requirement for Alternative Therapy|1|||
145521605|NCT03422627|524770672|FG001|Overall Study|Requirement for Alternative Therapy|1|||
145521606|NCT03422627|524770673|FG002|Overall Study|Requirement for Alternative Therapy|2|||
145521607|NCT03422627|524770674|FG003|Overall Study|Requirement for Alternative Therapy|0|||
145521608|NCT03422627|524770675|FG004|Overall Study|Requirement for Alternative Therapy|0|||
145521609|NCT03422627|524770671|FG000|Overall Study|Disease Progression|1|||
145521610|NCT03422627|524770672|FG001|Overall Study|Disease Progression|0|||
145521611|NCT03422627|524770673|FG002|Overall Study|Disease Progression|1|||
145521612|NCT03422627|524770674|FG003|Overall Study|Disease Progression|2|||
145521613|NCT03422627|524770675|FG004|Overall Study|Disease Progression|0|||
145521614|NCT03422627|524770671|FG000|Overall Study|Adverse Event|2|||
145521615|NCT03422627|524770672|FG001|Overall Study|Adverse Event|1|||
145521616|NCT03422627|524770673|FG002|Overall Study|Adverse Event|0|||
145521617|NCT03422627|524770674|FG003|Overall Study|Adverse Event|0|||
145521618|NCT03422627|524770675|FG004|Overall Study|Adverse Event|2|||
145743589|NCT01840579|525577353|FG006|Overall Study|Death|0|||
145270549|NCT04611152|523837924|FG000|Overall Study|Non-compliance with study schedule|1|||
145270550|NCT04611152|523837925|FG001|Overall Study|Non-compliance with study schedule|3|||
145270551|NCT04611152|523837924|FG000|Overall Study|Withdrawal by Subject|5|||
145270552|NCT04611152|523837925|FG001|Overall Study|Withdrawal by Subject|6|||
145270553|NCT04611152|523837924|FG000|Overall Study|Lost to Follow-up|11|||
145270554|NCT04611152|523837925|FG001|Overall Study|Lost to Follow-up|2|||
145270555|NCT00605839|523837931|FG000|Overall Study|Protocol Violation|1|||
145270556|NCT00605839|523837932|FG001|Overall Study|Protocol Violation|0|||
145270557|NCT00605839|523837933|FG002|Overall Study|Protocol Violation|0|||
145270558|NCT03917654|523837934|FG000|Year 1|Withdrawal by Subject|1|||
145270559|NCT03917654|523837935|FG001|Year 1|Withdrawal by Subject|0|||
145270560|NCT03917654|523837936|FG002|Year 1|Withdrawal by Subject|0|||
145270561|NCT03917654|523837937|FG003|Year 1|Withdrawal by Subject|0|||
145270562|NCT03917654|523837938|FG004|Year 1|Withdrawal by Subject|0|||
145270563|NCT03917654|523837939|FG005|Year 1|Withdrawal by Subject|1|||
145270564|NCT03917654|523837940|FG006|Year 1|Withdrawal by Subject|6|||
145270565|NCT03917654|523837941|FG007|Year 1|Withdrawal by Subject|2|||
145270566|NCT03917654|523837942|FG008|Year 1|Withdrawal by Subject|5|||
145270567|NCT03917654|523837943|FG009|Year 1|Withdrawal by Subject|3|||
145270568|NCT03917654|523837944|FG010|Year 1|Withdrawal by Subject|1|||
145270569|NCT03917654|523837945|FG011|Year 1|Withdrawal by Subject|0|||
145270570|NCT03917654|523837934|FG000|Year 1|Travel|0|||
145270571|NCT03917654|523837935|FG001|Year 1|Travel|1|||
145270572|NCT03917654|523837936|FG002|Year 1|Travel|1|||
145270573|NCT03917654|523837937|FG003|Year 1|Travel|0|||
145270574|NCT03917654|523837938|FG004|Year 1|Travel|4|||
145270575|NCT03917654|523837939|FG005|Year 1|Travel|4|||
145270576|NCT03917654|523837940|FG006|Year 1|Travel|10|||
145270577|NCT03917654|523837941|FG007|Year 1|Travel|8|||
145270578|NCT03917654|523837942|FG008|Year 1|Travel|2|||
145270579|NCT03917654|523837943|FG009|Year 1|Travel|5|||
145270580|NCT03917654|523837944|FG010|Year 1|Travel|3|||
145270581|NCT03917654|523837945|FG011|Year 1|Travel|3|||
145270582|NCT03917654|523837934|FG000|Year 1|Subject moved away from site|0|||
145270583|NCT03917654|523837935|FG001|Year 1|Subject moved away from site|1|||
145270584|NCT03917654|523837936|FG002|Year 1|Subject moved away from site|0|||
145270585|NCT03917654|523837937|FG003|Year 1|Subject moved away from site|0|||
145270586|NCT03917654|523837938|FG004|Year 1|Subject moved away from site|0|||
145270587|NCT03917654|523837939|FG005|Year 1|Subject moved away from site|0|||
145270588|NCT03917654|523837940|FG006|Year 1|Subject moved away from site|1|||
145270589|NCT03917654|523837941|FG007|Year 1|Subject moved away from site|2|||
145270590|NCT03917654|523837942|FG008|Year 1|Subject moved away from site|1|||
145270591|NCT03917654|523837943|FG009|Year 1|Subject moved away from site|0|||
145270592|NCT03917654|523837944|FG010|Year 1|Subject moved away from site|0|||
145270593|NCT03917654|523837945|FG011|Year 1|Subject moved away from site|3|||
145270594|NCT03917654|523837934|FG000|Year 1|Spouse/Family member request|0|||
145270595|NCT03917654|523837935|FG001|Year 1|Spouse/Family member request|0|||
145270596|NCT03917654|523837936|FG002|Year 1|Spouse/Family member request|1|||
145270597|NCT03917654|523837937|FG003|Year 1|Spouse/Family member request|0|||
145270598|NCT03917654|523837938|FG004|Year 1|Spouse/Family member request|1|||
145270599|NCT03917654|523837939|FG005|Year 1|Spouse/Family member request|0|||
145521619|NCT03422627|524770671|FG000|Overall Study|Ineligibility Determined|0|||
145521620|NCT03422627|524770672|FG001|Overall Study|Ineligibility Determined|1|||
145521621|NCT03422627|524770673|FG002|Overall Study|Ineligibility Determined|0|||
145521622|NCT03422627|524770674|FG003|Overall Study|Ineligibility Determined|0|||
145521623|NCT03422627|524770675|FG004|Overall Study|Ineligibility Determined|0|||
145521624|NCT03422627|524770671|FG000|Overall Study|Death|0|||
145521625|NCT03422627|524770672|FG001|Overall Study|Death|1|||
145270600|NCT03917654|523837940|FG006|Year 1|Spouse/Family member request|0|||
145270601|NCT03917654|523837941|FG007|Year 1|Spouse/Family member request|2|||
145270602|NCT03917654|523837942|FG008|Year 1|Spouse/Family member request|0|||
145270603|NCT03917654|523837943|FG009|Year 1|Spouse/Family member request|0|||
145270604|NCT03917654|523837944|FG010|Year 1|Spouse/Family member request|0|||
145270605|NCT03917654|523837945|FG011|Year 1|Spouse/Family member request|1|||
145270606|NCT03917654|523837934|FG000|Year 1|Death|0|||
145270607|NCT03917654|523837935|FG001|Year 1|Death|0|||
145270608|NCT03917654|523837936|FG002|Year 1|Death|0|||
145270609|NCT03917654|523837937|FG003|Year 1|Death|0|||
145270610|NCT03917654|523837938|FG004|Year 1|Death|0|||
145270611|NCT03917654|523837939|FG005|Year 1|Death|0|||
145270612|NCT03917654|523837940|FG006|Year 1|Death|0|||
145270613|NCT03917654|523837941|FG007|Year 1|Death|0|||
145270614|NCT03917654|523837942|FG008|Year 1|Death|1|||
145270615|NCT03917654|523837943|FG009|Year 1|Death|1|||
145270616|NCT03917654|523837944|FG010|Year 1|Death|0|||
145270617|NCT03917654|523837945|FG011|Year 1|Death|0|||
145270618|NCT03917654|523837934|FG000|Year 1|Lost to Follow-up|0|||
145270619|NCT03917654|523837935|FG001|Year 1|Lost to Follow-up|0|||
145521626|NCT03422627|524770673|FG002|Overall Study|Death|1|||
145270620|NCT03917654|523837936|FG002|Year 1|Lost to Follow-up|0|||
145270621|NCT03917654|523837937|FG003|Year 1|Lost to Follow-up|0|||
145270622|NCT03917654|523837938|FG004|Year 1|Lost to Follow-up|0|||
145270623|NCT03917654|523837939|FG005|Year 1|Lost to Follow-up|0|||
145521627|NCT03422627|524770674|FG003|Overall Study|Death|0|||
145521628|NCT03422627|524770675|FG004|Overall Study|Death|0|||
145521629|NCT03422627|524770671|FG000|Overall Study|Withdrawal by Subject|0|||
145521630|NCT03422627|524770672|FG001|Overall Study|Withdrawal by Subject|0|||
145521631|NCT03422627|524770673|FG002|Overall Study|Withdrawal by Subject|0|||
145521632|NCT03422627|524770674|FG003|Overall Study|Withdrawal by Subject|1|||
145521633|NCT03422627|524770675|FG004|Overall Study|Withdrawal by Subject|0|||
145521634|NCT02455557|524770676|FG000|Overall Study|Withdrawal by Subject|2|||
145521635|NCT02195687|524770677|FG000|Overall Study|Personal Reasons|1|||
145521636|NCT02195687|524770678|FG001|Overall Study|Personal Reasons|1|||
145521637|NCT02195687|524770677|FG000|Overall Study|Lost to Follow-up|4|||
145521638|NCT02195687|524770678|FG001|Overall Study|Lost to Follow-up|1|||
145521639|NCT04369924|524770681|FG000|Overall Study|Lost to Follow-up|302|||
145521640|NCT04369924|524770682|FG001|Overall Study|Lost to Follow-up|339|||
145521641|NCT03828370|524770683|FG000|3 Month Follow-up|Lost to Follow-up|4|||
145521642|NCT03828370|524770684|FG001|3 Month Follow-up|Lost to Follow-up|12|||
145521643|NCT03828370|524770683|FG000|9 Month Follow up|Lost to Follow-up|12|||
145521644|NCT03828370|524770684|FG001|9 Month Follow up|Lost to Follow-up|20|||
145521645|NCT01933789|524770685|FG000|Overall Study|Death|0|||
145521646|NCT01933789|524770686|FG001|Overall Study|Death|0|||
145521647|NCT01933789|524770687|FG002|Overall Study|Death|0|||
145521648|NCT01933789|524770688|FG003|Overall Study|Death|0|||
145521649|NCT01933789|524770689|FG004|Overall Study|Death|21|||
145521650|NCT01933789|524770690|FG005|Overall Study|Death|32|||
145521651|NCT01933789|524770691|FG006|Overall Study|Death|0|||
145521652|NCT01933789|524770692|FG007|Overall Study|Death|0|||
145521653|NCT01933789|524770693|FG008|Overall Study|Death|0|||
145521654|NCT01933789|524770685|FG000|Overall Study|Lost to Follow-up|0|||
145521655|NCT01933789|524770686|FG001|Overall Study|Lost to Follow-up|0|||
145521656|NCT01933789|524770687|FG002|Overall Study|Lost to Follow-up|0|||
145521657|NCT01933789|524770688|FG003|Overall Study|Lost to Follow-up|1|||
145521658|NCT01933789|524770689|FG004|Overall Study|Lost to Follow-up|8|||
145521659|NCT01933789|524770690|FG005|Overall Study|Lost to Follow-up|9|||
145521660|NCT01933789|524770691|FG006|Overall Study|Lost to Follow-up|1|||
145521661|NCT01933789|524770692|FG007|Overall Study|Lost to Follow-up|4|||
145521662|NCT01933789|524770693|FG008|Overall Study|Lost to Follow-up|0|||
145521663|NCT01933789|524770685|FG000|Overall Study|Withdrawal by Subject|2|||
145521664|NCT01933789|524770686|FG001|Overall Study|Withdrawal by Subject|1|||
145521665|NCT01933789|524770687|FG002|Overall Study|Withdrawal by Subject|0|||
145521666|NCT01933789|524770688|FG003|Overall Study|Withdrawal by Subject|0|||
145521667|NCT01933789|524770689|FG004|Overall Study|Withdrawal by Subject|17|||
145521668|NCT01933789|524770690|FG005|Overall Study|Withdrawal by Subject|16|||
145521669|NCT01933789|524770691|FG006|Overall Study|Withdrawal by Subject|1|||
145521670|NCT01933789|524770692|FG007|Overall Study|Withdrawal by Subject|4|||
145521671|NCT01933789|524770693|FG008|Overall Study|Withdrawal by Subject|0|||
145521672|NCT01933789|524770685|FG000|Overall Study|Became Ineligible|4|||
145521673|NCT01933789|524770686|FG001|Overall Study|Became Ineligible|0|||
145521674|NCT01933789|524770687|FG002|Overall Study|Became Ineligible|0|||
145521675|NCT01933789|524770688|FG003|Overall Study|Became Ineligible|0|||
145521676|NCT01933789|524770689|FG004|Overall Study|Became Ineligible|13|||
145521677|NCT01933789|524770690|FG005|Overall Study|Became Ineligible|10|||
145521678|NCT01933789|524770691|FG006|Overall Study|Became Ineligible|13|||
145521679|NCT01933789|524770692|FG007|Overall Study|Became Ineligible|6|||
145521680|NCT01933789|524770693|FG008|Overall Study|Became Ineligible|0|||
145521681|NCT01323920|524770694|FG000|Overall Study|Death|5|||
145521682|NCT01323920|524770694|FG000|Overall Study|Withdrawal by Subject|1|||
145521683|NCT00814801|524770695|FG000|Overall Study|Adverse Event|15|||
145521684|NCT00814801|524770696|FG001|Overall Study|Adverse Event|16|||
145521685|NCT00814801|524770697|FG002|Overall Study|Adverse Event|19|||
145521686|NCT00814801|524770695|FG000|Overall Study|Withdrawal by Subject|9|||
145521687|NCT00814801|524770696|FG001|Overall Study|Withdrawal by Subject|11|||
145521688|NCT00814801|524770697|FG002|Overall Study|Withdrawal by Subject|14|||
145521689|NCT00814801|524770695|FG000|Overall Study|Inappropriate as a subject|1|||
145521690|NCT00814801|524770696|FG001|Overall Study|Inappropriate as a subject|1|||
145521691|NCT00814801|524770697|FG002|Overall Study|Inappropriate as a subject|1|||
145521692|NCT00814801|524770695|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
145521693|NCT00814801|524770696|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
145521694|NCT00814801|524770697|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
145521695|NCT00814801|524770695|FG000|Overall Study|Missing or change of caregiver|6|||
145521696|NCT00814801|524770696|FG001|Overall Study|Missing or change of caregiver|2|||
145521697|NCT00814801|524770697|FG002|Overall Study|Missing or change of caregiver|4|||
145521698|NCT00814801|524770695|FG000|Overall Study|Non-compliance|0|||
145521699|NCT00814801|524770696|FG001|Overall Study|Non-compliance|1|||
145521700|NCT00814801|524770697|FG002|Overall Study|Non-compliance|1|||
145521701|NCT00814801|524770695|FG000|Overall Study|Other|2|||
145521702|NCT00814801|524770696|FG001|Overall Study|Other|6|||
145521703|NCT00814801|524770697|FG002|Overall Study|Other|4|||
145270624|NCT03917654|523837940|FG006|Year 1|Lost to Follow-up|2|||
145521704|NCT02486718|524770698|FG000|Enrollment Phase|Death|19|||
145521705|NCT02486718|524770699|FG001|Enrollment Phase|Death|0|||
145743590|NCT01840579|525577354|FG007|Overall Study|Death|0|||
145743591|NCT01840579|525577355|FG008|Overall Study|Death|0|||
145521706|NCT02486718|524770700|FG002|Enrollment Phase|Death|0|||
145521707|NCT02486718|524770698|FG000|Enrollment Phase|Symptomatic deterioration|1|||
145521708|NCT02486718|524770699|FG001|Enrollment Phase|Symptomatic deterioration|0|||
145521709|NCT02486718|524770700|FG002|Enrollment Phase|Symptomatic deterioration|0|||
145521710|NCT02486718|524770698|FG000|Enrollment Phase|Withdrawal by Subject|86|||
145521711|NCT02486718|524770699|FG001|Enrollment Phase|Withdrawal by Subject|0|||
145521712|NCT02486718|524770700|FG002|Enrollment Phase|Withdrawal by Subject|0|||
145521713|NCT02486718|524770698|FG000|Enrollment Phase|Protocol Violation|18|||
145521714|NCT02486718|524770699|FG001|Enrollment Phase|Protocol Violation|0|||
145521715|NCT02486718|524770700|FG002|Enrollment Phase|Protocol Violation|0|||
145521716|NCT02486718|524770698|FG000|Enrollment Phase|Physician Decision|18|||
145521717|NCT02486718|524770699|FG001|Enrollment Phase|Physician Decision|0|||
145521718|NCT02486718|524770700|FG002|Enrollment Phase|Physician Decision|0|||
145521719|NCT02486718|524770698|FG000|Enrollment Phase|Reason not provided|41|||
145521720|NCT02486718|524770699|FG001|Enrollment Phase|Reason not provided|0|||
145521721|NCT02486718|524770700|FG002|Enrollment Phase|Reason not provided|0|||
145521722|NCT02486718|524770698|FG000|Enrollment Phase|Disease relapse|54|||
145521723|NCT02486718|524770699|FG001|Enrollment Phase|Disease relapse|0|||
145521724|NCT02486718|524770700|FG002|Enrollment Phase|Disease relapse|0|||
145521725|NCT02486718|524770698|FG000|Enrollment Phase|Lost to Follow-up|4|||
145521726|NCT02486718|524770699|FG001|Enrollment Phase|Lost to Follow-up|0|||
145521727|NCT02486718|524770700|FG002|Enrollment Phase|Lost to Follow-up|0|||
145521728|NCT02486718|524770698|FG000|Enrollment Phase|Adverse Event|34|||
145521729|NCT02486718|524770699|FG001|Enrollment Phase|Adverse Event|0|||
145521730|NCT02486718|524770700|FG002|Enrollment Phase|Adverse Event|0|||
145521731|NCT02486718|524770698|FG000|Randomized Phase|Withdrawal by Subject|0|||
145521732|NCT02486718|524770699|FG001|Randomized Phase|Withdrawal by Subject|44|||
145521733|NCT02486718|524770700|FG002|Randomized Phase|Withdrawal by Subject|47|||
145521734|NCT02486718|524770698|FG000|Randomized Phase|Protocol Violation|0|||
145521735|NCT02486718|524770699|FG001|Randomized Phase|Protocol Violation|2|||
145521736|NCT02486718|524770700|FG002|Randomized Phase|Protocol Violation|0|||
145521737|NCT02486718|524770698|FG000|Randomized Phase|Physician Decision|0|||
145521738|NCT02486718|524770699|FG001|Randomized Phase|Physician Decision|0|||
145521739|NCT02486718|524770700|FG002|Randomized Phase|Physician Decision|3|||
145521740|NCT02486718|524770698|FG000|Randomized Phase|Lost to Follow-up|0|||
145521741|NCT02486718|524770699|FG001|Randomized Phase|Lost to Follow-up|5|||
145521742|NCT02486718|524770700|FG002|Randomized Phase|Lost to Follow-up|11|||
145521743|NCT02486718|524770698|FG000|Randomized Phase|Disease Relapse|0|||
145521744|NCT02486718|524770699|FG001|Randomized Phase|Disease Relapse|1|||
145521745|NCT02486718|524770700|FG002|Randomized Phase|Disease Relapse|0|||
145521746|NCT02486718|524770698|FG000|Randomized Phase|Death|0|||
145521747|NCT02486718|524770699|FG001|Randomized Phase|Death|154|||
145521748|NCT02486718|524770700|FG002|Randomized Phase|Death|155|||
145521749|NCT02486718|524770698|FG000|Randomized Phase|Ongoing|0|||
145521750|NCT02486718|524770699|FG001|Randomized Phase|Ongoing|301|||
145521751|NCT02486718|524770700|FG002|Randomized Phase|Ongoing|282|||
145521752|NCT02520089|524770701|FG000|Overall Study|Lost to Follow-up|3|||
145521753|NCT02520089|524770702|FG001|Overall Study|Lost to Follow-up|4|||
145521754|NCT02216812|524770705|FG000|Overall Study|Lost to Follow-up|10|||
145521755|NCT02216812|524770706|FG001|Overall Study|Lost to Follow-up|5|||
145521756|NCT00527488|524770711|FG000|Overall Study|Withdrawn prior to dosing|0|||
145521757|NCT00527488|524770712|FG001|Overall Study|Withdrawn prior to dosing|1|||
145521758|NCT00527488|524770713|FG002|Overall Study|Withdrawn prior to dosing|1|||
145521759|NCT00527488|524770714|FG003|Overall Study|Withdrawn prior to dosing|0|||
145521760|NCT02545543|524770715|FG000|Overall Study|Lost to Follow-up|67|||
145521761|NCT02545543|524770716|FG001|Overall Study|Lost to Follow-up|25|||
145521762|NCT02545543|524770715|FG000|Overall Study|Physician Decision|3|||
145521763|NCT02545543|524770716|FG001|Overall Study|Physician Decision|0|||
145521764|NCT02545543|524770715|FG000|Overall Study|Withdrawal by Subject|9|||
145521765|NCT02545543|524770716|FG001|Overall Study|Withdrawal by Subject|8|||
145521766|NCT02545543|524770715|FG000|Overall Study|Noncomplaince|1|||
145521767|NCT02545543|524770716|FG001|Overall Study|Noncomplaince|0|||
145521768|NCT02545543|524770715|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
145521769|NCT02545543|524770716|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
145521770|NCT02829944|524770720|FG000|Overall Study|Physician Decision|0|||
145521771|NCT02829944|524770721|FG001|Overall Study|Physician Decision|1|||
145521772|NCT02829944|524770720|FG000|Overall Study|Screen Failure|2|||
145521773|NCT02829944|524770721|FG001|Overall Study|Screen Failure|2|||
145521774|NCT02829944|524770720|FG000|Overall Study|Inadequate Neuraxial Block|1|||
145521775|NCT02829944|524770721|FG001|Overall Study|Inadequate Neuraxial Block|1|||
145521776|NCT02829944|524770720|FG000|Overall Study|Withdrawal by Subject|2|||
145743592|NCT01840579|525577356|FG009|Overall Study|Death|0|||
145521777|NCT02829944|524770721|FG001|Overall Study|Withdrawal by Subject|1|||
145521778|NCT02829944|524770720|FG000|Overall Study|Catheter Displacement|1|||
145743593|NCT01840579|525577347|FG000|Overall Study|Adverse Event|0|||
145743594|NCT01840579|525577348|FG001|Overall Study|Adverse Event|1|||
145743595|NCT01840579|525577349|FG002|Overall Study|Adverse Event|0|||
145743596|NCT01840579|525577350|FG003|Overall Study|Adverse Event|0|||
145743597|NCT01840579|525577351|FG004|Overall Study|Adverse Event|0|||
145743598|NCT01840579|525577352|FG005|Overall Study|Adverse Event|0|||
145743599|NCT01840579|525577353|FG006|Overall Study|Adverse Event|0|||
145743600|NCT01840579|525577354|FG007|Overall Study|Adverse Event|0|||
145743601|NCT01840579|525577355|FG008|Overall Study|Adverse Event|0|||
145743602|NCT01840579|525577356|FG009|Overall Study|Adverse Event|0|||
145743603|NCT01840579|525577347|FG000|Overall Study|Follow-up ended by Sponsor|0|||
145743604|NCT01840579|525577348|FG001|Overall Study|Follow-up ended by Sponsor|0|||
145743605|NCT01840579|525577349|FG002|Overall Study|Follow-up ended by Sponsor|0|||
145743606|NCT01840579|525577350|FG003|Overall Study|Follow-up ended by Sponsor|0|||
145743607|NCT01840579|525577351|FG004|Overall Study|Follow-up ended by Sponsor|0|||
145743608|NCT01840579|525577352|FG005|Overall Study|Follow-up ended by Sponsor|0|||
145743609|NCT01840579|525577353|FG006|Overall Study|Follow-up ended by Sponsor|2|||
145743610|NCT01840579|525577354|FG007|Overall Study|Follow-up ended by Sponsor|0|||
145743611|NCT01840579|525577355|FG008|Overall Study|Follow-up ended by Sponsor|0|||
145743612|NCT01840579|525577356|FG009|Overall Study|Follow-up ended by Sponsor|0|||
145743613|NCT03302975|525577358|FG000|Overall Study|Lost to Follow-up|4|||
145743614|NCT05885737|525577359|FG000|DB Period|Adverse Event|4|||
145743615|NCT05885737|525577360|FG001|DB Period|Adverse Event|4|||
145743616|NCT05885737|525577359|FG000|DB Period|Lost to Follow-up|0|||
145743617|NCT05885737|525577360|FG001|DB Period|Lost to Follow-up|1|||
145743618|NCT05885737|525577359|FG000|DB Period|Physician Decision|2|||
145521779|NCT02829944|524770721|FG001|Overall Study|Catheter Displacement|0|||
145521780|NCT02829944|524770720|FG000|Overall Study|Catheter broke|0|||
145521781|NCT02829944|524770721|FG001|Overall Study|Catheter broke|1|||
145521782|NCT02829944|524770720|FG000|Overall Study|Staff unavailable|0|||
145521783|NCT02829944|524770721|FG001|Overall Study|Staff unavailable|1|||
145743619|NCT05885737|525577360|FG001|DB Period|Physician Decision|0|||
145743620|NCT05885737|525577359|FG000|DB Period|Withdrawal by Subject|12|||
145743621|NCT05885737|525577360|FG001|DB Period|Withdrawal by Subject|6|||
145743622|NCT05885737|525577359|FG000|DB Period|Other: Unspecified|2|||
145743623|NCT05885737|525577360|FG001|DB Period|Other: Unspecified|2|||
145743624|NCT05885737|525577359|FG000|OLE Period|Adverse Event|3|||
145743625|NCT05885737|525577360|FG001|OLE Period|Adverse Event|2|||
145743626|NCT05885737|525577359|FG000|OLE Period|Physician Decision|1|||
145743627|NCT05885737|525577360|FG001|OLE Period|Physician Decision|0|||
145743628|NCT05885737|525577359|FG000|OLE Period|Withdrawal by Subject|5|||
145743629|NCT05885737|525577360|FG001|OLE Period|Withdrawal by Subject|5|||
145521784|NCT04675151|524770722|FG000|Overall Study|Protocol Violation|1|||
145521785|NCT04675151|524770723|FG001|Overall Study|Protocol Violation|0|||
145521786|NCT04675151|524770724|FG002|Overall Study|Protocol Violation|0|||
145521787|NCT04675151|524770725|FG003|Overall Study|Protocol Violation|1|||
145521788|NCT04035486|524770726|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
145521789|NCT04035486|524770727|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
145521790|NCT04035486|524770728|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
145521791|NCT04035486|524770729|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
145521792|NCT04035486|524770726|FG000|Overall Study|Death|6|||
145521793|NCT04035486|524770727|FG001|Overall Study|Death|3|||
145521794|NCT04035486|524770728|FG002|Overall Study|Death|70|||
145521795|NCT04035486|524770729|FG003|Overall Study|Death|77|||
145521796|NCT04035486|524770726|FG000|Overall Study|Screen Failure|0|||
145521797|NCT04035486|524770727|FG001|Overall Study|Screen Failure|0|||
145521798|NCT04035486|524770728|FG002|Overall Study|Screen Failure|1|||
145521799|NCT04035486|524770729|FG003|Overall Study|Screen Failure|1|||
145521800|NCT04035486|524770726|FG000|Overall Study|Withdrawal by Subject|1|||
145521801|NCT04035486|524770727|FG001|Overall Study|Withdrawal by Subject|1|||
145521802|NCT04035486|524770728|FG002|Overall Study|Withdrawal by Subject|11|||
145521803|NCT04035486|524770729|FG003|Overall Study|Withdrawal by Subject|9|||
145743630|NCT05885737|525577359|FG000|OLE Period|Other: Unspecified|2|||
145743631|NCT05885737|525577360|FG001|OLE Period|Other: Unspecified|1|||
145743632|NCT00751400|525578684|FG000|Overall Study|Lost to Follow-up|10|||
145743633|NCT01372384|525578688|FG000|Overall Study|Progression of disease|3|||
145743634|NCT00441974|525578692|FG000|Overall Study|Adverse Event|6|||
145402457|NCT00784875|524330733|FG000|Period C|Lack of Efficacy|0|||
145521804|NCT01730937|524770730|FG000|Overall Study|Protocol Violation|5|||
145521805|NCT01730937|524770731|FG001|Overall Study|Protocol Violation|11|||
145521806|NCT03947684|524770732|FG000|Overall Study|Lost to Follow-up|13|||
145521807|NCT03947684|524770733|FG001|Overall Study|Lost to Follow-up|5|||
145521808|NCT03947684|524770734|FG002|Overall Study|Lost to Follow-up|1|||
145743635|NCT00441974|525578692|FG000|Overall Study|Consent Withdrawn|35|||
145743636|NCT00441974|525578692|FG000|Overall Study|Lost to Follow-up|80|||
145743637|NCT00441974|525578692|FG000|Overall Study|Protocol Violation|7|||
145743638|NCT00661531|525578695|FG000|Overall Study|Withdrawal by Subject|3|||
145743639|NCT03134599|525578696|FG000|Week 1|Lost to Follow-up|0|||
145743640|NCT03134599|525578697|FG001|Week 1|Lost to Follow-up|0|||
145743641|NCT03134599|525578698|FG002|Week 1|Lost to Follow-up|0|||
145743642|NCT03134599|525578699|FG003|Week 1|Lost to Follow-up|0|||
145743643|NCT03134599|525578700|FG004|Week 1|Lost to Follow-up|1|||
145743644|NCT03134599|525578701|FG005|Week 1|Lost to Follow-up|0|||
145743645|NCT03134599|525578696|FG000|Week 2|Lost to Follow-up|1|||
145743646|NCT03134599|525578697|FG001|Week 2|Lost to Follow-up|0|||
145743647|NCT03134599|525578698|FG002|Week 2|Lost to Follow-up|0|||
145743648|NCT03134599|525578699|FG003|Week 2|Lost to Follow-up|1|||
145743649|NCT03134599|525578700|FG004|Week 2|Lost to Follow-up|1|||
145743650|NCT03134599|525578701|FG005|Week 2|Lost to Follow-up|0|||
145743651|NCT03134599|525578696|FG000|Week 3|Lost to Follow-up|0|||
145743652|NCT03134599|525578697|FG001|Week 3|Lost to Follow-up|0|||
145743653|NCT03134599|525578698|FG002|Week 3|Lost to Follow-up|0|||
145743654|NCT03134599|525578699|FG003|Week 3|Lost to Follow-up|1|||
145743655|NCT03134599|525578700|FG004|Week 3|Lost to Follow-up|0|||
145743656|NCT03134599|525578701|FG005|Week 3|Lost to Follow-up|1|||
145743657|NCT01265615|525578702|FG000|Overall Study|Protocol Violation|2|||
145743658|NCT01265615|525578703|FG001|Overall Study|Protocol Violation|2|||
145743659|NCT01265615|525578704|FG002|Overall Study|Protocol Violation|4|||
145743660|NCT01265615|525578705|FG003|Overall Study|Protocol Violation|3|||
145743661|NCT02576444|525578712|FG000|Overall Study|Death|1|||
145743662|NCT02576444|525578713|FG001|Overall Study|Death|1|||
145743663|NCT02576444|525578714|FG002|Overall Study|Death|0|||
145743664|NCT02576444|525578715|FG003|Overall Study|Death|0|||
145743665|NCT02576444|525578712|FG000|Overall Study|Withdrawal by Subject|0|||
145743666|NCT02576444|525578713|FG001|Overall Study|Withdrawal by Subject|0|||
145743667|NCT02576444|525578714|FG002|Overall Study|Withdrawal by Subject|2|||
145743668|NCT02576444|525578715|FG003|Overall Study|Withdrawal by Subject|0|||
145743669|NCT02576444|525578712|FG000|Overall Study|Adverse Event|0|||
145743670|NCT02576444|525578713|FG001|Overall Study|Adverse Event|0|||
145743671|NCT02576444|525578714|FG002|Overall Study|Adverse Event|1|||
145743672|NCT02576444|525578715|FG003|Overall Study|Adverse Event|0|||
145743673|NCT02576444|525578712|FG000|Overall Study|Physician Decision|0|||
145743674|NCT02576444|525578713|FG001|Overall Study|Physician Decision|0|||
145743675|NCT02576444|525578714|FG002|Overall Study|Physician Decision|1|||
145743676|NCT02576444|525578715|FG003|Overall Study|Physician Decision|0|||
145521809|NCT03947684|524770732|FG000|Overall Study|Withdrawal by Subject|11|||
145743677|NCT04206020|525578718|FG000|Overall Study|Adverse Event|1|||
145743678|NCT04206020|525578719|FG001|Overall Study|Adverse Event|4|||
145743679|NCT04206020|525578718|FG000|Overall Study|Protocol Violation|2|||
145521810|NCT03947684|524770733|FG001|Overall Study|Withdrawal by Subject|4|||
145521811|NCT03947684|524770734|FG002|Overall Study|Withdrawal by Subject|0|||
145521812|NCT03947684|524770732|FG000|Overall Study|Physician Decision|1|||
145521813|NCT03947684|524770733|FG001|Overall Study|Physician Decision|0|||
145521814|NCT03947684|524770734|FG002|Overall Study|Physician Decision|0|||
145521815|NCT03947684|524770732|FG000|Overall Study|Lack of adherence to study protocol|2|||
145521816|NCT03947684|524770733|FG001|Overall Study|Lack of adherence to study protocol|0|||
145521817|NCT03947684|524770734|FG002|Overall Study|Lack of adherence to study protocol|0|||
145521818|NCT03875235|524770735|FG000|Overall Study|Ongoing study treatment|63|||
145521819|NCT03875235|524770736|FG001|Overall Study|Ongoing study treatment|20|||
145521820|NCT03875235|524770735|FG000|Overall Study|Off treatment|77|||
145521821|NCT03875235|524770736|FG001|Overall Study|Off treatment|91|||
145521822|NCT03875235|524770735|FG000|Overall Study|Withdrawal by Subject|3|||
145521823|NCT03875235|524770736|FG001|Overall Study|Withdrawal by Subject|10|||
145521824|NCT03875235|524770735|FG000|Overall Study|Death|198|||
145521825|NCT03875235|524770736|FG001|Overall Study|Death|223|||
145521826|NCT01395784|524770746|FG000|Overall Study|Lost to Follow-up|7|||
145521827|NCT01395784|524770746|FG000|Overall Study|Withdrawal by Subject|3|||
145521828|NCT01395784|524770746|FG000|Overall Study|Physician Decision|5|||
145521829|NCT05772702|524770747|FG000|Overall Study|Adverse Event|1|||
145521830|NCT04268823|524770748|FG000|Overall Study|Adverse Event|1|||
145521831|NCT04268823|524770749|FG001|Overall Study|Adverse Event|0|||
145743680|NCT04206020|525578719|FG001|Overall Study|Protocol Violation|0|||
145743681|NCT04206020|525578718|FG000|Overall Study|Withdrawal by Subject|2|||
145521832|NCT04268823|524770748|FG000|Overall Study|Participant Decision|1|||
145521833|NCT04268823|524770749|FG001|Overall Study|Participant Decision|0|||
145521834|NCT04300751|524772283|FG000|Overall Study|Withdrawal by Subject|1|||
145521835|NCT04972630|524772286|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
145743682|NCT04206020|525578719|FG001|Overall Study|Withdrawal by Subject|0|||
145743683|NCT04206020|525578718|FG000|Overall Study|Lost to Follow-up|2|||
145743684|NCT04206020|525578719|FG001|Overall Study|Lost to Follow-up|0|||
145743685|NCT04206020|525578718|FG000|Overall Study|Pregnancy|0|||
145743686|NCT04206020|525578719|FG001|Overall Study|Pregnancy|1|||
145743687|NCT04206020|525578718|FG000|Overall Study|Unable to attend visits|1|||
145743688|NCT04206020|525578719|FG001|Overall Study|Unable to attend visits|2|||
145743689|NCT02700412|525578720|FG000|Overall Study|Adverse Event|6|||
145743690|NCT02700412|525578720|FG000|Overall Study|Death|1|||
145743691|NCT02700412|525578720|FG000|Overall Study|Lack of Efficacy|19|||
145743692|NCT02700412|525578720|FG000|Overall Study|Protocol Violation|5|||
145743693|NCT02700412|525578720|FG000|Overall Study|Withdrawal by Subject|2|||
145743694|NCT04962022|525578724|FG000|Period 1|Withdrawal by Subject|1|||
145743695|NCT04962022|525578725|FG001|Period 1|Withdrawal by Subject|0|||
145743696|NCT04416555|525578726|FG000|Overall Study|Withdrawal by Subject|0|||
145743697|NCT04416555|525578727|FG001|Overall Study|Withdrawal by Subject|3|||
145743698|NCT00530270|525578728|FG000|Overall Study|Protocol Violation|1|||
145743699|NCT00530270|525578729|FG001|Overall Study|Protocol Violation|0|||
145743700|NCT01356407|525578738|FG000|Overall Study|Lost to Follow-up|2|||
145743701|NCT01356407|525578739|FG001|Overall Study|Lost to Follow-up|0|||
145743702|NCT01356407|525578738|FG000|Overall Study|Patient Withdrew Consent|2|||
145743703|NCT01356407|525578739|FG001|Overall Study|Patient Withdrew Consent|1|||
145743704|NCT01356407|525578738|FG000|Overall Study|Could not afford IMP administration|0|||
145743705|NCT01356407|525578739|FG001|Overall Study|Could not afford IMP administration|1|||
145743706|NCT01356407|525578738|FG000|Overall Study|Not complete Endoscopy|2|||
145743707|NCT01356407|525578739|FG001|Overall Study|Not complete Endoscopy|2|||
145743708|NCT02018822|525578740|FG000|Overall Study|filling replaced by crown|0|||
145743709|NCT02018822|525578741|FG001|Overall Study|filling replaced by crown|1|||
145743710|NCT02018822|525578742|FG002|Overall Study|filling replaced by crown|0|||
145743711|NCT02018822|525578740|FG000|Overall Study|Physician Decision|0|||
145743712|NCT02018822|525578741|FG001|Overall Study|Physician Decision|1|||
145743713|NCT02018822|525578742|FG002|Overall Study|Physician Decision|1|||
145521836|NCT04972630|524772287|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
145521837|NCT04972630|524772288|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
145521838|NCT00246571|524772289|FG000|Overall Study|Adverse Event|7|||
145521839|NCT00246571|524772290|FG001|Overall Study|Adverse Event|0|||
145521840|NCT00246571|524772289|FG000|Overall Study|Protocol Violation|0|||
145521841|NCT00246571|524772290|FG001|Overall Study|Protocol Violation|1|||
145521842|NCT00246571|524772289|FG000|Overall Study|Withdrawal by Subject|2|||
145521843|NCT00246571|524772290|FG001|Overall Study|Withdrawal by Subject|3|||
145521844|NCT00246571|524772289|FG000|Overall Study|Lack of Efficacy|84|||
145521845|NCT00246571|524772290|FG001|Overall Study|Lack of Efficacy|21|||
145521846|NCT00246571|524772289|FG000|Overall Study|Death|17|||
145521847|NCT00246571|524772290|FG001|Overall Study|Death|3|||
145521848|NCT00246571|524772289|FG000|Overall Study|Sponsor|0|||
145743714|NCT02018822|525578740|FG000|Overall Study|Lost to Follow-up|6|||
145743715|NCT02018822|525578741|FG001|Overall Study|Lost to Follow-up|6|||
145743716|NCT02018822|525578742|FG002|Overall Study|Lost to Follow-up|5|||
145743717|NCT03201458|525578743|FG000|Overall Study|No longer eligible|2|||
145743718|NCT03201458|525578744|FG001|Overall Study|No longer eligible|5|||
145743719|NCT03201458|525578743|FG000|Overall Study|Health event before starting|1|||
145743720|NCT03201458|525578744|FG001|Overall Study|Health event before starting|0|||
145743721|NCT03201458|525578743|FG000|Overall Study|Physician Decision|1|||
145743722|NCT03201458|525578744|FG001|Overall Study|Physician Decision|0|||
145743723|NCT00715026|525578745|FG000|Overall Study|Withdrawal by Subject|5|||
145521849|NCT00246571|524772290|FG001|Overall Study|Sponsor|1|||
145521850|NCT00246571|524772289|FG000|Overall Study|Did not meet entrance criteria|2|||
145743724|NCT00715026|525578745|FG000|Overall Study|Lost to Follow-up|3|||
145743725|NCT00715026|525578745|FG000|Overall Study|Protocol Violation|1|||
145743726|NCT00715026|525578745|FG000|Overall Study|Surgery done on non-study consented hip|1|||
145743727|NCT00750737|525578746|FG000|Overall Study|Withdrawal by Subject|3|||
145743728|NCT00750737|525578747|FG001|Overall Study|Withdrawal by Subject|3|||
145743729|NCT02614859|525578748|FG000|Overall Study|Physician Decision|0|||
145743730|NCT02614859|525578749|FG001|Overall Study|Physician Decision|1|||
145743731|NCT02919436|525578751|FG000|Overall Study|Did not undergo surgery|16|||
145743732|NCT02919436|525578752|FG001|Overall Study|Did not undergo surgery|20|||
145743733|NCT02919436|525578751|FG000|Overall Study|Enrolled before trial registration|44|||
145743734|NCT02919436|525578752|FG001|Overall Study|Enrolled before trial registration|33|||
145743735|NCT01389752|525578753|FG000|Study Period 1|Sponsor decision|0|||
145743736|NCT01389752|525578754|FG001|Study Period 1|Sponsor decision|2|||
145743737|NCT01389752|525578753|FG000|Study Period 2|Sponsor decision|1|||
145743738|NCT01389752|525578754|FG001|Study Period 2|Sponsor decision|0|||
145743739|NCT03259074|525578755|FG000|Overall Study|Adverse Event|9|||
145743740|NCT03259074|525578756|FG001|Overall Study|Adverse Event|12|||
145743741|NCT03259074|525578757|FG002|Overall Study|Adverse Event|8|||
145743742|NCT03259074|525578755|FG000|Overall Study|Death|1|||
145743743|NCT03259074|525578756|FG001|Overall Study|Death|1|||
145743744|NCT03259074|525578757|FG002|Overall Study|Death|3|||
145743745|NCT03259074|525578755|FG000|Overall Study|Lost to Follow-up|2|||
145743746|NCT03259074|525578756|FG001|Overall Study|Lost to Follow-up|4|||
145743747|NCT03259074|525578757|FG002|Overall Study|Lost to Follow-up|3|||
145743748|NCT03259074|525578755|FG000|Overall Study|New Therapy For Study Indication|1|||
145743749|NCT03259074|525578756|FG001|Overall Study|New Therapy For Study Indication|2|||
145743750|NCT03259074|525578757|FG002|Overall Study|New Therapy For Study Indication|2|||
145743751|NCT03259074|525578755|FG000|Overall Study|Physician Decision|4|||
145743752|NCT03259074|525578756|FG001|Overall Study|Physician Decision|12|||
145743753|NCT03259074|525578757|FG002|Overall Study|Physician Decision|10|||
145743754|NCT03259074|525578755|FG000|Overall Study|Pregnancy|1|||
145743755|NCT03259074|525578756|FG001|Overall Study|Pregnancy|1|||
145743756|NCT03259074|525578757|FG002|Overall Study|Pregnancy|0|||
145743757|NCT03259074|525578755|FG000|Overall Study|Progressive Disease|1|||
145743758|NCT03259074|525578756|FG001|Overall Study|Progressive Disease|0|||
145743759|NCT03259074|525578757|FG002|Overall Study|Progressive Disease|0|||
145743760|NCT03259074|525578755|FG000|Overall Study|Protocol Deviation|1|||
145743761|NCT03259074|525578756|FG001|Overall Study|Protocol Deviation|1|||
145743762|NCT03259074|525578757|FG002|Overall Study|Protocol Deviation|3|||
145521851|NCT00246571|524772290|FG001|Overall Study|Did not meet entrance criteria|1|||
145521852|NCT00246571|524772289|FG000|Overall Study|Laboratory abnormalities|1|||
145521853|NCT00246571|524772290|FG001|Overall Study|Laboratory abnormalities|0|||
145521854|NCT00246571|524772289|FG000|Overall Study|Crossover participants|0|||
145521855|NCT00246571|524772290|FG001|Overall Study|Crossover participants|74|||
145521856|NCT05247398|524772294|FG000|Overall Study|Withdrawal by Subject|1|||
145521857|NCT04251156|524772295|FG000|Overall Study|Lost to Follow-up|1|||
145521858|NCT04251156|524772296|FG001|Overall Study|Lost to Follow-up|1|||
145521859|NCT04251156|524772295|FG000|Overall Study|Withdrawal by Subject|4|||
145521860|NCT04251156|524772296|FG001|Overall Study|Withdrawal by Subject|4|||
145521861|NCT04214288|524772297|FG000|Overall Study|Ongoing in the study|41|||
145521862|NCT04214288|524772298|FG001|Overall Study|Ongoing in the study|51|||
145521863|NCT04214288|524772299|FG002|Overall Study|Ongoing in the study|12|||
145521864|NCT04214288|524772300|FG003|Overall Study|Ongoing in the study|39|||
145521865|NCT04214288|524772297|FG000|Overall Study|Adverse Event|1|||
145521866|NCT04214288|524772298|FG001|Overall Study|Adverse Event|0|||
145521867|NCT04214288|524772299|FG002|Overall Study|Adverse Event|0|||
145521868|NCT04214288|524772300|FG003|Overall Study|Adverse Event|0|||
145521869|NCT04214288|524772297|FG000|Overall Study|Death|22|||
145521870|NCT04214288|524772298|FG001|Overall Study|Death|13|||
145521871|NCT04214288|524772299|FG002|Overall Study|Death|7|||
145521872|NCT04214288|524772300|FG003|Overall Study|Death|19|||
145521873|NCT04214288|524772297|FG000|Overall Study|Lost to Follow-up|1|||
145521874|NCT04214288|524772298|FG001|Overall Study|Lost to Follow-up|2|||
145521875|NCT04214288|524772299|FG002|Overall Study|Lost to Follow-up|1|||
145521876|NCT04214288|524772300|FG003|Overall Study|Lost to Follow-up|0|||
145521877|NCT04214288|524772297|FG000|Overall Study|Other|1|||
145743763|NCT03259074|525578755|FG000|Overall Study|Subject/Guardian Decision|13|||
145743764|NCT03259074|525578756|FG001|Overall Study|Subject/Guardian Decision|16|||
145743765|NCT03259074|525578757|FG002|Overall Study|Subject/Guardian Decision|14|||
145521878|NCT04214288|524772298|FG001|Overall Study|Other|2|||
145521879|NCT04214288|524772299|FG002|Overall Study|Other|0|||
145521880|NCT04214288|524772300|FG003|Overall Study|Other|6|||
145521881|NCT04214288|524772297|FG000|Overall Study|Protocol Violation|0|||
145743766|NCT00053417|525578768|FG000|Overall Study|Adverse Event|1|||
145743767|NCT00053417|525578769|FG001|Overall Study|Adverse Event|0|||
145743768|NCT00053417|525578770|FG002|Overall Study|Adverse Event|1|||
145743769|NCT00053417|525578771|FG003|Overall Study|Adverse Event|5|||
145743770|NCT00053417|525578768|FG000|Overall Study|Non-Compliance|0|||
145743771|NCT00053417|525578769|FG001|Overall Study|Non-Compliance|0|||
145521882|NCT04214288|524772298|FG001|Overall Study|Protocol Violation|1|||
145521883|NCT04214288|524772299|FG002|Overall Study|Protocol Violation|0|||
145743772|NCT00053417|525578770|FG002|Overall Study|Non-Compliance|0|||
145743773|NCT00053417|525578771|FG003|Overall Study|Non-Compliance|1|||
145521884|NCT04214288|524772300|FG003|Overall Study|Protocol Violation|0|||
145521885|NCT04214288|524772297|FG000|Overall Study|Withdrawal by Subject|8|||
145521886|NCT04214288|524772298|FG001|Overall Study|Withdrawal by Subject|4|||
145521887|NCT04214288|524772299|FG002|Overall Study|Withdrawal by Subject|0|||
145521888|NCT04214288|524772300|FG003|Overall Study|Withdrawal by Subject|9|||
145521889|NCT00807027|524772301|FG000|Overall Study|Withdrawal by Subject|13|||
145521890|NCT00807027|524772302|FG001|Overall Study|Withdrawal by Subject|14|||
145521891|NCT00807027|524772301|FG000|Overall Study|Protocol Violation|1|||
145521892|NCT00807027|524772302|FG001|Overall Study|Protocol Violation|1|||
145521893|NCT00807027|524772301|FG000|Overall Study|Adverse Event|2|||
145521894|NCT00807027|524772302|FG001|Overall Study|Adverse Event|2|||
145521895|NCT03997383|524772303|FG000|Double-blind Treatment Period|Adverse Event|4|||
145521896|NCT03997383|524772304|FG001|Double-blind Treatment Period|Adverse Event|3|||
145521897|NCT03997383|524772303|FG000|Double-blind Treatment Period|Death|4|||
145521898|NCT03997383|524772304|FG001|Double-blind Treatment Period|Death|4|||
145521899|NCT03997383|524772303|FG000|Double-blind Treatment Period|Physician Decision|2|||
145521900|NCT03997383|524772304|FG001|Double-blind Treatment Period|Physician Decision|0|||
145521901|NCT03997383|524772303|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
145521902|NCT03997383|524772304|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
145521903|NCT03997383|524772303|FG000|Open-label Extension Period|Ongoing|148|||
145521904|NCT03997383|524772304|FG001|Open-label Extension Period|Ongoing|151|||
145521905|NCT03997383|524772303|FG000|Open-label Extension Period|Adverse Event|4|||
145521906|NCT03997383|524772304|FG001|Open-label Extension Period|Adverse Event|1|||
145521907|NCT03997383|524772303|FG000|Open-label Extension Period|Death|8|||
145521908|NCT03997383|524772304|FG001|Open-label Extension Period|Death|9|||
145521909|NCT03997383|524772303|FG000|Open-label Extension Period|Physician Decision|1|||
145521910|NCT03997383|524772304|FG001|Open-label Extension Period|Physician Decision|1|||
145521911|NCT03997383|524772303|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
145521912|NCT03997383|524772304|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
145521913|NCT03997383|524772303|FG000|Open-label Extension Period|Reason Not Specified|2|||
145521914|NCT03997383|524772304|FG001|Open-label Extension Period|Reason Not Specified|0|||
145521915|NCT04798781|524772305|FG000|Overall Study|Withdrawal by Subject|1|||
145521916|NCT05954143|524772306|FG000|Overall Study|Progressive Disease|1|||
145521917|NCT05954143|524772307|FG001|Overall Study|Progressive Disease|0|||
145521918|NCT05954143|524772306|FG000|Overall Study|Physician Decision|1|||
145521919|NCT05954143|524772307|FG001|Overall Study|Physician Decision|0|||
145521920|NCT05954143|524772306|FG000|Overall Study|Study Terminated by Sponsor|2|||
145521921|NCT05954143|524772307|FG001|Overall Study|Study Terminated by Sponsor|4|||
145521922|NCT05954143|524772306|FG000|Overall Study|Death|1|||
145521923|NCT05954143|524772307|FG001|Overall Study|Death|0|||
145521924|NCT05954143|524772306|FG000|Overall Study|Withdrawal by Subject|0|||
145521925|NCT05954143|524772307|FG001|Overall Study|Withdrawal by Subject|1|||
145521926|NCT05954143|524772306|FG000|Overall Study|Other|1|||
145521927|NCT05954143|524772307|FG001|Overall Study|Other|0|||
145521928|NCT01129024|524772308|FG000|Overall Study|Physician Decision|5|||
145521929|NCT01129024|524772308|FG000|Overall Study|Study Terminated by Sponsor|8|||
145521930|NCT01129024|524772308|FG000|Overall Study|Withdrawal by Subject|2|||
145521931|NCT01129024|524772308|FG000|Overall Study|Lack of Efficacy|3|||
145521932|NCT01129024|524772308|FG000|Overall Study|Needed a Platelet Transfusion|1|||
145521933|NCT02361580|524772309|FG000|Overall Study|Lost to Follow-up|6|||
145521934|NCT02361580|524772310|FG001|Overall Study|Lost to Follow-up|3|||
145521935|NCT00924781|524772311|FG000|Overall Study|Study terminated by sponsor|12|||
145521936|NCT00924781|524772312|FG001|Overall Study|Study terminated by sponsor|10|||
145521937|NCT00708201|524772313|FG000|Overall Study|Adverse Event|4|||
145521938|NCT00708201|524772314|FG001|Overall Study|Adverse Event|4|||
145521939|NCT00708201|524772313|FG000|Overall Study|Withdrawal by Subject|1|||
145521940|NCT00708201|524772314|FG001|Overall Study|Withdrawal by Subject|1|||
145521941|NCT00708201|524772313|FG000|Overall Study|Lost to Follow-up|2|||
145521942|NCT00708201|524772314|FG001|Overall Study|Lost to Follow-up|0|||
145521943|NCT00708201|524772313|FG000|Overall Study|Protocol Violation|0|||
145521944|NCT00708201|524772314|FG001|Overall Study|Protocol Violation|1|||
145521945|NCT00761748|524772315|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
145521946|NCT00761748|524772316|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
145521947|NCT00761748|524772315|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
145521948|NCT00761748|524772316|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
145521949|NCT01857310|524772317|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
145521950|NCT01857310|524772318|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
145521951|NCT02554279|524772319|FG000|Overall Study|Adverse Event|2|||
145521952|NCT02554279|524772320|FG001|Overall Study|Adverse Event|5|||
145521953|NCT02554279|524772319|FG000|Overall Study|Lost to Follow-up|3|||
145743774|NCT00053417|525578768|FG000|Overall Study|Withdrawal by Subject|0|||
145743775|NCT00053417|525578769|FG001|Overall Study|Withdrawal by Subject|1|||
145743776|NCT00053417|525578770|FG002|Overall Study|Withdrawal by Subject|0|||
145743777|NCT00053417|525578771|FG003|Overall Study|Withdrawal by Subject|0|||
145743778|NCT00053417|525578768|FG000|Overall Study|Lost to Follow-up|1|||
145743779|NCT00053417|525578769|FG001|Overall Study|Lost to Follow-up|1|||
145743780|NCT00053417|525578770|FG002|Overall Study|Lost to Follow-up|0|||
145743781|NCT00053417|525578771|FG003|Overall Study|Lost to Follow-up|0|||
145743782|NCT00705783|525578772|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
145743783|NCT00705783|525578773|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
145743784|NCT00705783|525578774|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
145743785|NCT00705783|525578772|FG000|Conversion Phase|Lost to Follow-up|13|||
145743786|NCT00705783|525578773|FG001|Conversion Phase|Lost to Follow-up|0|||
145743787|NCT00705783|525578774|FG002|Conversion Phase|Lost to Follow-up|0|||
145521954|NCT02554279|524772320|FG001|Overall Study|Lost to Follow-up|2|||
145521955|NCT02554279|524772319|FG000|Overall Study|Withdrawal by Subject|6|||
145521956|NCT02554279|524772320|FG001|Overall Study|Withdrawal by Subject|4|||
145521957|NCT02554279|524772319|FG000|Overall Study|Protocol Violation|2|||
145521958|NCT02554279|524772320|FG001|Overall Study|Protocol Violation|1|||
145521959|NCT02554279|524772319|FG000|Overall Study|Other reason|19|||
145521960|NCT02554279|524772320|FG001|Overall Study|Other reason|6|||
145521961|NCT00812487|524772321|FG000|Overall Study|Lost to Follow-up|2|||
145521962|NCT00812487|524772322|FG001|Overall Study|Lost to Follow-up|0|||
145521963|NCT00812487|524772321|FG000|Overall Study|Withdrawal by Subject|3|||
145521964|NCT00812487|524772322|FG001|Overall Study|Withdrawal by Subject|2|||
145521965|NCT00812487|524772321|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
145521966|NCT00812487|524772322|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
145521967|NCT00812487|524772321|FG000|Overall Study|Protocol Violation|0|||
145521968|NCT00812487|524772322|FG001|Overall Study|Protocol Violation|1|||
145521969|NCT00998764|524772323|FG000|Overall Study|Lack of Efficacy|3|||
145521970|NCT00998764|524772324|FG001|Overall Study|Lack of Efficacy|6|||
145521971|NCT00998764|524772323|FG000|Overall Study|Adverse Event|17|||
145521972|NCT00998764|524772324|FG001|Overall Study|Adverse Event|12|||
145521973|NCT00998764|524772323|FG000|Overall Study|Withdrawal by Subject|19|||
145521974|NCT00998764|524772324|FG001|Overall Study|Withdrawal by Subject|25|||
145521975|NCT00998764|524772323|FG000|Overall Study|Physician Decision|3|||
145521976|NCT00998764|524772324|FG001|Overall Study|Physician Decision|3|||
145521977|NCT00998764|524772323|FG000|Overall Study|Death|3|||
145521978|NCT00998764|524772324|FG001|Overall Study|Death|1|||
145521979|NCT00998764|524772323|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
145521980|NCT00998764|524772324|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
145521981|NCT00998764|524772323|FG000|Overall Study|Protocol Violation|0|||
145521982|NCT00998764|524772324|FG001|Overall Study|Protocol Violation|1|||
145521983|NCT00998764|524772323|FG000|Overall Study|Failed to Return|1|||
145521984|NCT00998764|524772324|FG001|Overall Study|Failed to Return|1|||
145521985|NCT00998764|524772323|FG000|Overall Study|Lost to Follow-up|1|||
145521986|NCT00998764|524772324|FG001|Overall Study|Lost to Follow-up|1|||
145521987|NCT00998764|524772323|FG000|Overall Study|Loss of Caregiver|0|||
145521988|NCT00998764|524772324|FG001|Overall Study|Loss of Caregiver|3|||
145521989|NCT00998764|524772323|FG000|Overall Study|Other|4|||
145521990|NCT00998764|524772324|FG001|Overall Study|Other|4|||
145521991|NCT00998764|524772323|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
145521992|NCT00998764|524772324|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
145521993|NCT04761627|524772327|FG000|Run-in Period|Death|1|||
145521994|NCT04761627|524772328|FG001|Run-in Period|Death|0|||
145521995|NCT04761627|524772329|FG002|Run-in Period|Death|0|||
145521996|NCT04761627|524772327|FG000|Run-in Period|Required alternative therapy|2|||
145521997|NCT04761627|524772328|FG001|Run-in Period|Required alternative therapy|0|||
145521998|NCT04761627|524772329|FG002|Run-in Period|Required alternative therapy|0|||
145521999|NCT04761627|524772327|FG000|Run-in Period|Lost to Follow-up|2|||
145522000|NCT04761627|524772328|FG001|Run-in Period|Lost to Follow-up|0|||
145522001|NCT04761627|524772329|FG002|Run-in Period|Lost to Follow-up|0|||
145522002|NCT04761627|524772327|FG000|Run-in Period|Protocol Violation|3|||
145743788|NCT00705783|525578772|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
145743789|NCT00705783|525578773|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
145743790|NCT00705783|525578774|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
145743791|NCT00705783|525578772|FG000|Conversion Phase|Withdrawn by Investigator|4|||
145743792|NCT00705783|525578773|FG001|Conversion Phase|Withdrawn by Investigator|0|||
145743793|NCT00705783|525578774|FG002|Conversion Phase|Withdrawn by Investigator|0|||
145522003|NCT04761627|524772328|FG001|Run-in Period|Protocol Violation|0|||
145522004|NCT04761627|524772329|FG002|Run-in Period|Protocol Violation|0|||
145522005|NCT04761627|524772327|FG000|Run-in Period|Abnormal liver function|1|||
145522006|NCT04761627|524772328|FG001|Run-in Period|Abnormal liver function|0|||
145522007|NCT04761627|524772329|FG002|Run-in Period|Abnormal liver function|0|||
145522008|NCT04761627|524772327|FG000|Run-in Period|Adverse Event|6|||
145522009|NCT04761627|524772328|FG001|Run-in Period|Adverse Event|0|||
145522010|NCT04761627|524772329|FG002|Run-in Period|Adverse Event|0|||
145270625|NCT03917654|523837941|FG007|Year 1|Lost to Follow-up|0|||
145743794|NCT00705783|525578772|FG000|Conversion Phase|Withdrew Consent|24|||
145743795|NCT00705783|525578773|FG001|Conversion Phase|Withdrew Consent|0|||
145743796|NCT00705783|525578774|FG002|Conversion Phase|Withdrew Consent|0|||
145743797|NCT00705783|525578772|FG000|Conversion Phase|Protocol Deviation|2|||
145743798|NCT00705783|525578773|FG001|Conversion Phase|Protocol Deviation|0|||
145743799|NCT00705783|525578774|FG002|Conversion Phase|Protocol Deviation|0|||
145743800|NCT00705783|525578772|FG000|Conversion Phase|Adverse Event|11|||
145743801|NCT00705783|525578773|FG001|Conversion Phase|Adverse Event|0|||
145743802|NCT00705783|525578774|FG002|Conversion Phase|Adverse Event|0|||
145743803|NCT00705783|525578772|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
145743804|NCT00705783|525578773|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
145743805|NCT00705783|525578774|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
145743806|NCT00705783|525578772|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
145743807|NCT00705783|525578773|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
145743808|NCT00705783|525578774|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
145743809|NCT00705783|525578772|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
145743810|NCT00705783|525578773|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
145743811|NCT00705783|525578774|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
145743812|NCT00705783|525578772|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
145743813|NCT00705783|525578773|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
145743814|NCT00705783|525578774|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
145743815|NCT00705783|525578772|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
145743816|NCT00705783|525578773|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
145743817|NCT00705783|525578774|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
145743818|NCT00705783|525578772|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
145743819|NCT00705783|525578773|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
145743820|NCT00705783|525578774|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
145743821|NCT00705783|525578772|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
145743822|NCT00705783|525578773|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
145743823|NCT00705783|525578774|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
145743824|NCT00705783|525578772|FG000|Oral Stabilization Phase|Adverse Event|14|||
145743825|NCT00705783|525578773|FG001|Oral Stabilization Phase|Adverse Event|0|||
145743826|NCT00705783|525578774|FG002|Oral Stabilization Phase|Adverse Event|0|||
145270626|NCT03917654|523837942|FG008|Year 1|Lost to Follow-up|0|||
145270627|NCT03917654|523837943|FG009|Year 1|Lost to Follow-up|0|||
145270628|NCT03917654|523837944|FG010|Year 1|Lost to Follow-up|0|||
145270629|NCT03917654|523837945|FG011|Year 1|Lost to Follow-up|0|||
145270630|NCT03917654|523837934|FG000|Year 1|Missed visits|0|||
145270631|NCT03917654|523837935|FG001|Year 1|Missed visits|0|||
145270632|NCT03917654|523837936|FG002|Year 1|Missed visits|0|||
145270633|NCT03917654|523837937|FG003|Year 1|Missed visits|0|||
145270634|NCT03917654|523837938|FG004|Year 1|Missed visits|0|||
145270635|NCT03917654|523837939|FG005|Year 1|Missed visits|0|||
145270636|NCT03917654|523837940|FG006|Year 1|Missed visits|0|||
145270637|NCT03917654|523837941|FG007|Year 1|Missed visits|0|||
145270638|NCT03917654|523837942|FG008|Year 1|Missed visits|0|||
145270639|NCT03917654|523837943|FG009|Year 1|Missed visits|0|||
145270640|NCT03917654|523837944|FG010|Year 1|Missed visits|1|||
145270641|NCT03917654|523837945|FG011|Year 1|Missed visits|1|||
145270642|NCT03917654|523837934|FG000|Year 1|Pregnancy|0|||
145270643|NCT03917654|523837935|FG001|Year 1|Pregnancy|0|||
145270644|NCT03917654|523837936|FG002|Year 1|Pregnancy|0|||
145270645|NCT03917654|523837937|FG003|Year 1|Pregnancy|0|||
145270646|NCT03917654|523837938|FG004|Year 1|Pregnancy|0|||
145270647|NCT03917654|523837939|FG005|Year 1|Pregnancy|0|||
145270648|NCT03917654|523837940|FG006|Year 1|Pregnancy|0|||
145270649|NCT03917654|523837941|FG007|Year 1|Pregnancy|1|||
145270650|NCT03917654|523837942|FG008|Year 1|Pregnancy|0|||
145270651|NCT03917654|523837943|FG009|Year 1|Pregnancy|1|||
145270652|NCT03917654|523837944|FG010|Year 1|Pregnancy|0|||
145270653|NCT03917654|523837945|FG011|Year 1|Pregnancy|0|||
145743827|NCT00705783|525578772|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
145743828|NCT00705783|525578773|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145743829|NCT00705783|525578774|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145743830|NCT00705783|525578772|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
145270654|NCT03917654|523837934|FG000|Year 2|Travel|1|||
145270655|NCT03917654|523837935|FG001|Year 2|Travel|0|||
145270656|NCT03917654|523837936|FG002|Year 2|Travel|0|||
145270657|NCT03917654|523837937|FG003|Year 2|Travel|0|||
145270658|NCT03917654|523837938|FG004|Year 2|Travel|1|||
145270659|NCT03917654|523837939|FG005|Year 2|Travel|1|||
145270660|NCT03917654|523837940|FG006|Year 2|Travel|2|||
145743831|NCT00705783|525578773|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145270661|NCT03917654|523837941|FG007|Year 2|Travel|1|||
145270662|NCT03917654|523837942|FG008|Year 2|Travel|0|||
145270663|NCT03917654|523837943|FG009|Year 2|Travel|1|||
145270664|NCT03917654|523837944|FG010|Year 2|Travel|0|||
145270665|NCT03917654|523837945|FG011|Year 2|Travel|1|||
145270666|NCT03917654|523837934|FG000|Year 2|Married|1|||
145270667|NCT03917654|523837935|FG001|Year 2|Married|0|||
145270668|NCT03917654|523837936|FG002|Year 2|Married|0|||
145743832|NCT00705783|525578774|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145743833|NCT00705783|525578772|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
145743834|NCT00705783|525578773|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
145743835|NCT00705783|525578774|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
145522011|NCT04761627|524772327|FG000|Run-in Period|Withdrawal by Subject|7|||
145743836|NCT00705783|525578772|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
145743837|NCT00705783|525578773|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
145743838|NCT00705783|525578774|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
145743839|NCT00705783|525578772|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
145743840|NCT00705783|525578773|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
145743841|NCT00705783|525578774|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
145743842|NCT00705783|525578772|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
145743843|NCT00705783|525578773|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
145743844|NCT00705783|525578774|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
145743845|NCT00705783|525578772|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
145743846|NCT00705783|525578773|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
145743847|NCT00705783|525578774|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
145743848|NCT00705783|525578772|FG000|Depot Stabilization Phase|Adverse Event|17|||
145743849|NCT00705783|525578773|FG001|Depot Stabilization Phase|Adverse Event|0|||
145743850|NCT00705783|525578774|FG002|Depot Stabilization Phase|Adverse Event|0|||
145743851|NCT00705783|525578772|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
145743852|NCT00705783|525578773|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145743853|NCT00705783|525578774|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145743854|NCT00705783|525578772|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
145743855|NCT00705783|525578773|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145743856|NCT00705783|525578774|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145743857|NCT00705783|525578772|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
145743858|NCT00705783|525578773|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
145743859|NCT00705783|525578774|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
145743860|NCT00705783|525578772|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
145743861|NCT00705783|525578773|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
145743862|NCT00705783|525578774|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
145743863|NCT00705783|525578772|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
145522012|NCT04761627|524772328|FG001|Run-in Period|Withdrawal by Subject|0|||
145522013|NCT04761627|524772329|FG002|Run-in Period|Withdrawal by Subject|0|||
145522014|NCT04761627|524772327|FG000|Run-in Period|Did not meet PASI 50|15|||
145522015|NCT04761627|524772328|FG001|Run-in Period|Did not meet PASI 50|0|||
145522016|NCT04761627|524772329|FG002|Run-in Period|Did not meet PASI 50|0|||
145522017|NCT04761627|524772327|FG000|Run-in Period|Study site closure|2|||
145522018|NCT04761627|524772328|FG001|Run-in Period|Study site closure|0|||
145522019|NCT04761627|524772329|FG002|Run-in Period|Study site closure|0|||
145522020|NCT04761627|524772327|FG000|Run-in Period|Pregnancy|2|||
145522021|NCT04761627|524772328|FG001|Run-in Period|Pregnancy|0|||
145522022|NCT04761627|524772329|FG002|Run-in Period|Pregnancy|0|||
145522023|NCT04761627|524772327|FG000|Post-randomization Period|Military service|0|||
145522024|NCT04761627|524772328|FG001|Post-randomization Period|Military service|1|||
145522025|NCT04761627|524772329|FG002|Post-randomization Period|Military service|0|||
145522026|NCT04761627|524772327|FG000|Post-randomization Period|Adverse Event|0|||
145522027|NCT04761627|524772328|FG001|Post-randomization Period|Adverse Event|4|||
145522028|NCT04761627|524772329|FG002|Post-randomization Period|Adverse Event|2|||
145522029|NCT04761627|524772327|FG000|Post-randomization Period|Lost to Follow-up|0|||
145522030|NCT04761627|524772328|FG001|Post-randomization Period|Lost to Follow-up|6|||
145522031|NCT04761627|524772329|FG002|Post-randomization Period|Lost to Follow-up|6|||
145522032|NCT04761627|524772327|FG000|Post-randomization Period|Withdrawal by Subject|0|||
145522033|NCT04761627|524772328|FG001|Post-randomization Period|Withdrawal by Subject|7|||
145522034|NCT04761627|524772329|FG002|Post-randomization Period|Withdrawal by Subject|6|||
145522035|NCT04761627|524772327|FG000|Post-randomization Period|Pregnancy|0|||
145522036|NCT04761627|524772328|FG001|Post-randomization Period|Pregnancy|0|||
145522037|NCT04761627|524772329|FG002|Post-randomization Period|Pregnancy|1|||
145522038|NCT04761627|524772327|FG000|Post-randomization Period|Study site closure|0|||
145522039|NCT04761627|524772328|FG001|Post-randomization Period|Study site closure|0|||
145402458|NCT00784875|524330734|FG001|Period C|Lack of Efficacy|0|||
145522040|NCT04761627|524772329|FG002|Post-randomization Period|Study site closure|1|||
145522041|NCT04761627|524772327|FG000|Post-randomization Period|Family planning|0|||
145522042|NCT04761627|524772328|FG001|Post-randomization Period|Family planning|1|||
145522043|NCT04761627|524772329|FG002|Post-randomization Period|Family planning|0|||
145522044|NCT01117792|524772330|FG000|Overall Study|Death|1|||
145522045|NCT01117792|524772330|FG000|Overall Study|Adverse Event|3|||
145402459|NCT00784875|524330735|FG002|Period C|Lack of Efficacy|1|||
145522046|NCT00723203|524772331|FG000|Overall Study|Withdrawal by Subject|3|||
145270669|NCT03917654|523837937|FG003|Year 2|Married|0|||
145270670|NCT03917654|523837938|FG004|Year 2|Married|0|||
145270671|NCT03917654|523837939|FG005|Year 2|Married|0|||
145270672|NCT03917654|523837940|FG006|Year 2|Married|1|||
145270673|NCT03917654|523837941|FG007|Year 2|Married|1|||
145270674|NCT03917654|523837942|FG008|Year 2|Married|0|||
145270675|NCT03917654|523837943|FG009|Year 2|Married|0|||
145270676|NCT03917654|523837944|FG010|Year 2|Married|0|||
145270677|NCT03917654|523837945|FG011|Year 2|Married|0|||
145270678|NCT03917654|523837934|FG000|Year 2|Subject moved away from site|1|||
145270679|NCT03917654|523837935|FG001|Year 2|Subject moved away from site|0|||
145270680|NCT03917654|523837936|FG002|Year 2|Subject moved away from site|0|||
145270681|NCT03917654|523837937|FG003|Year 2|Subject moved away from site|0|||
145270682|NCT03917654|523837938|FG004|Year 2|Subject moved away from site|1|||
145270683|NCT03917654|523837939|FG005|Year 2|Subject moved away from site|0|||
145522047|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
145522048|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
145522049|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
145522050|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
145522051|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
145522052|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
145522053|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
145522054|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
145522055|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
145522056|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
145522057|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
145522058|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
145522059|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
145522060|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
145522061|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
145522062|NCT00274924|524772334|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
145522063|NCT00274924|524772335|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
145522064|NCT00274924|524772336|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
145522065|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
145522066|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
145522067|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
145522068|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
145522069|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
145522070|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
145522071|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
145522072|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
145522073|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
145522074|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
145522075|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
145522076|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
145522077|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
145522078|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
145522079|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
145522080|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
145522081|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
145522082|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
145522083|NCT00274924|524772334|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
145522084|NCT00274924|524772335|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
145522085|NCT00274924|524772336|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
145522086|NCT01055496|524772337|FG000|Overall Study|Withdrawal by Subject|2|||
145522087|NCT01055496|524772338|FG001|Overall Study|Withdrawal by Subject|4|||
145522088|NCT01055496|524772337|FG000|Overall Study|Death|13|||
145522089|NCT01055496|524772338|FG001|Overall Study|Death|23|||
145522090|NCT01055496|524772337|FG000|Overall Study|Lost to Follow-up|0|||
145522091|NCT01055496|524772338|FG001|Overall Study|Lost to Follow-up|2|||
145522092|NCT01055496|524772337|FG000|Overall Study|Other - Unspecified|0|||
145522093|NCT01055496|524772338|FG001|Overall Study|Other - Unspecified|1|||
145522094|NCT01046825|524772339|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
145522095|NCT01046825|524772340|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
145522096|NCT01046825|524772341|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
145522097|NCT01046825|524772342|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
145522098|NCT01046825|524772343|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
145270684|NCT03917654|523837940|FG006|Year 2|Subject moved away from site|2|||
145270685|NCT03917654|523837941|FG007|Year 2|Subject moved away from site|3|||
145270686|NCT03917654|523837942|FG008|Year 2|Subject moved away from site|0|||
145270687|NCT03917654|523837943|FG009|Year 2|Subject moved away from site|2|||
145270688|NCT03917654|523837944|FG010|Year 2|Subject moved away from site|0|||
145743864|NCT00705783|525578773|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
145743865|NCT00705783|525578774|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
145743866|NCT00705783|525578772|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
145743867|NCT00705783|525578773|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
145743868|NCT00705783|525578774|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
145743869|NCT00705783|525578772|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
145743870|NCT00705783|525578773|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
145743871|NCT00705783|525578774|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
145743872|NCT00705783|525578772|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
145743873|NCT00705783|525578773|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
145743874|NCT00705783|525578774|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
145743875|NCT00705783|525578772|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
145743876|NCT00705783|525578773|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
145522099|NCT01046825|524772339|FG000|Overall Study|Physician Decision|0|||
145743877|NCT00705783|525578774|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
145743878|NCT00705783|525578772|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
145743879|NCT00705783|525578773|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
145743880|NCT00705783|525578774|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
145743881|NCT00705783|525578772|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
145522100|NCT01046825|524772340|FG001|Overall Study|Physician Decision|1|||
145522101|NCT01046825|524772341|FG002|Overall Study|Physician Decision|2|||
145522102|NCT01046825|524772342|FG003|Overall Study|Physician Decision|0|||
145522103|NCT01046825|524772343|FG004|Overall Study|Physician Decision|0|||
145522104|NCT01046825|524772339|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
145522105|NCT01046825|524772340|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
145522106|NCT01046825|524772341|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
145522107|NCT01046825|524772342|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
145522108|NCT01046825|524772343|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
145522109|NCT01046825|524772339|FG000|Overall Study|Found to be ineligible|0|||
145522110|NCT01046825|524772340|FG001|Overall Study|Found to be ineligible|1|||
145522111|NCT01046825|524772341|FG002|Overall Study|Found to be ineligible|0|||
145522112|NCT01046825|524772342|FG003|Overall Study|Found to be ineligible|0|||
145522113|NCT01046825|524772343|FG004|Overall Study|Found to be ineligible|0|||
145522114|NCT01046825|524772339|FG000|Overall Study|Death|0|||
145522115|NCT01046825|524772340|FG001|Overall Study|Death|0|||
145522116|NCT01046825|524772341|FG002|Overall Study|Death|0|||
145522117|NCT01046825|524772342|FG003|Overall Study|Death|1|||
145522118|NCT01046825|524772343|FG004|Overall Study|Death|0|||
145743882|NCT00705783|525578773|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
145743883|NCT00705783|525578774|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
145743884|NCT02184195|525578775|FG000|Overall Study|Patient decision|5|||
145743885|NCT02184195|525578776|FG001|Overall Study|Patient decision|2|||
145743886|NCT02184195|525578775|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145522119|NCT01046825|524772339|FG000|Overall Study|Did not submit biology samples|0|||
145743887|NCT02184195|525578776|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145743888|NCT02184195|525578775|FG000|Overall Study|Death|67|||
145743889|NCT02184195|525578776|FG001|Overall Study|Death|44|||
145743890|NCT02184195|525578775|FG000|Overall Study|Lost to Follow-up|1|||
145743891|NCT02184195|525578776|FG001|Overall Study|Lost to Follow-up|5|||
145743892|NCT02184195|525578775|FG000|Overall Study|Other|0|||
145743893|NCT02184195|525578776|FG001|Overall Study|Other|3|||
145743894|NCT02830776|525578777|FG000|Overall Study|Lost to Follow-up|1|||
145743895|NCT01820364|525578778|FG000|Part I: LGX818|Death|1|||
145743896|NCT01820364|525578779|FG001|Part I: LGX818|Death|0|||
145743897|NCT01820364|525578778|FG000|Part I: LGX818|Administrative Problems|3|||
145743898|NCT01820364|525578779|FG001|Part I: LGX818|Administrative Problems|0|||
145743899|NCT01820364|525578778|FG000|Part I: LGX818|Adverse Event|6|||
145743900|NCT01820364|525578779|FG001|Part I: LGX818|Adverse Event|0|||
145743901|NCT01820364|525578778|FG000|Part I: LGX818|Disease Progression|4|||
145743902|NCT01820364|525578779|FG001|Part I: LGX818|Disease Progression|0|||
145743903|NCT01820364|525578778|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
145743904|NCT01820364|525578779|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
145743905|NCT01087775|525578783|FG000|Overall Study|failed inclusion criteria|2|||
145743906|NCT01553188|525578786|FG000|Overall Study|Patient choice|1|||
145743907|NCT01553188|525578787|FG001|Overall Study|Patient choice|0|||
145743908|NCT01553188|525578788|FG002|Overall Study|Patient choice|0|||
145743909|NCT01553188|525578789|FG003|Overall Study|Patient choice|0|||
145743910|NCT01553188|525578786|FG000|Overall Study|Intercurrent illness and adverse event|0|||
145743911|NCT01553188|525578787|FG001|Overall Study|Intercurrent illness and adverse event|1|||
145743912|NCT01553188|525578788|FG002|Overall Study|Intercurrent illness and adverse event|2|||
145743913|NCT01553188|525578789|FG003|Overall Study|Intercurrent illness and adverse event|0|||
145743914|NCT04744207|525578791|FG000|Treatment|Withdrawal by Subject|2|||
145743915|NCT04744207|525578792|FG001|Treatment|Withdrawal by Subject|0|||
145743916|NCT04744207|525578791|FG000|Treatment|Adverse Event|1|||
145743917|NCT04744207|525578792|FG001|Treatment|Adverse Event|2|||
145743918|NCT00777101|525578800|FG000|Overall Study|Death|48|||
145743919|NCT00777101|525578801|FG001|Overall Study|Death|43|||
145743920|NCT00777101|525578800|FG000|Overall Study|Withdrawal by Subject|11|||
145743921|NCT00777101|525578801|FG001|Overall Study|Withdrawal by Subject|6|||
145743922|NCT00777101|525578800|FG000|Overall Study|Lost to Follow-up|2|||
145743923|NCT00777101|525578801|FG001|Overall Study|Lost to Follow-up|1|||
145743924|NCT00777101|525578800|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
145743925|NCT00777101|525578801|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145743926|NCT00777101|525578800|FG000|Overall Study|Failed to Return|0|||
145743927|NCT00777101|525578801|FG001|Overall Study|Failed to Return|1|||
145743928|NCT00961220|525578802|FG000|Overall Study|Adverse Event|3|||
145743929|NCT00961220|525578802|FG000|Overall Study|Lack of Efficacy|1|||
145270689|NCT03917654|523837945|FG011|Year 2|Subject moved away from site|1|||
145270690|NCT03917654|523837934|FG000|Year 2|Year 2 Screening failure|0|||
145270691|NCT03917654|523837935|FG001|Year 2|Year 2 Screening failure|1|||
145270692|NCT03917654|523837936|FG002|Year 2|Year 2 Screening failure|0|||
145270693|NCT03917654|523837937|FG003|Year 2|Year 2 Screening failure|0|||
145402460|NCT00784875|524330736|FG003|Period C|Lack of Efficacy|0|||
145522120|NCT01046825|524772340|FG001|Overall Study|Did not submit biology samples|0|||
145522121|NCT01046825|524772341|FG002|Overall Study|Did not submit biology samples|0|||
145522122|NCT01046825|524772342|FG003|Overall Study|Did not submit biology samples|0|||
145522123|NCT01046825|524772343|FG004|Overall Study|Did not submit biology samples|13|||
145522124|NCT06390839|524772345|FG000|Overall Study|Ineligible|2|||
145522125|NCT06390839|524772345|FG000|Overall Study|Never start protocol therapy|3|||
145522126|NCT06390839|524772345|FG000|Overall Study|Adverse Event|1|||
145743930|NCT00961220|525578802|FG000|Overall Study|No IV access for O6BG|1|||
145743931|NCT00961220|525578802|FG000|Overall Study|O6BG no longer supplied|1|||
145743932|NCT00961220|525578802|FG000|Overall Study|Complete Response prior to 12 courses|1|||
145743933|NCT05376215|525578803|FG000|Overall Study|Withdrawal by Subject|2|||
145743934|NCT05376215|525578804|FG001|Overall Study|Withdrawal by Subject|1|||
145743935|NCT05376215|525578803|FG000|Overall Study|Lost to Follow-up|0|||
145743936|NCT05376215|525578804|FG001|Overall Study|Lost to Follow-up|1|||
145743937|NCT01301950|525578812|FG000|Overall Study|Surgery was cancelled by patient|0|||
145743938|NCT01301950|525578813|FG001|Overall Study|Surgery was cancelled by patient|1|||
145743939|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
145743940|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
145743941|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
145270694|NCT03917654|523837938|FG004|Year 2|Year 2 Screening failure|2|||
145402461|NCT00784875|524330733|FG000|Period C|Withdrawal by Subject|1|||
145522127|NCT06390839|524772345|FG000|Overall Study|Alternative therapy|2|||
145522128|NCT06390839|524772345|FG000|Overall Study|Death|3|||
145522129|NCT06390839|524772345|FG000|Overall Study|Disease progression|28|||
145743942|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
145743943|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
145743944|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
145743945|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
145743946|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
145402462|NCT00784875|524330734|FG001|Period C|Withdrawal by Subject|1|||
145522130|NCT06390839|524772345|FG000|Overall Study|Withdrawal by Subject|2|||
145522131|NCT06390839|524772345|FG000|Overall Study|Complicating disease|1|||
145522132|NCT06390839|524772345|FG000|Overall Study|Noncompliance|1|||
145522133|NCT02720094|524772351|FG000|Overall Study|Ongoing|2210|||
145522134|NCT02720094|524772352|FG001|Overall Study|Ongoing|2203|||
145522135|NCT02720094|524772351|FG000|Overall Study|Scheduled exit visit/end of study|2|||
145522136|NCT02720094|524772352|FG001|Overall Study|Scheduled exit visit/end of study|1|||
145522137|NCT02720094|524772351|FG000|Overall Study|Death|4|||
145522138|NCT02720094|524772352|FG001|Overall Study|Death|7|||
145522139|NCT02720094|524772351|FG000|Overall Study|Withdrawal by Subject|55|||
145522140|NCT02720094|524772352|FG001|Overall Study|Withdrawal by Subject|56|||
145522141|NCT02720094|524772351|FG000|Overall Study|Lost to Follow-up|2|||
145522142|NCT02720094|524772352|FG001|Overall Study|Lost to Follow-up|7|||
145522143|NCT02720094|524772351|FG000|Overall Study|Physician Decision|1|||
145522144|NCT02720094|524772352|FG001|Overall Study|Physician Decision|3|||
145522145|NCT02720094|524772351|FG000|Overall Study|Inappropriate enrollment|1|||
145522146|NCT02720094|524772352|FG001|Overall Study|Inappropriate enrollment|3|||
145522147|NCT02720094|524772351|FG000|Overall Study|Relocation|1|||
145522148|NCT02720094|524772352|FG001|Overall Study|Relocation|1|||
145522149|NCT00732940|524772359|FG000|Overall Study|Withdrawal by Subject|1|||
145522150|NCT00732940|524772360|FG001|Overall Study|Withdrawal by Subject|2|||
145522151|NCT00732940|524772359|FG000|Overall Study|Adverse Event|0|||
145522152|NCT00732940|524772360|FG001|Overall Study|Adverse Event|1|||
145522153|NCT00732940|524772359|FG000|Overall Study|Lost to Follow-up|1|||
145522154|NCT00732940|524772360|FG001|Overall Study|Lost to Follow-up|0|||
145522155|NCT01150474|524772364|FG000|Overall Study|Withdrawal by Subject|5|||
145522156|NCT01150474|524772365|FG001|Overall Study|Withdrawal by Subject|2|||
145522157|NCT01150474|524772364|FG000|Overall Study|Cancer found|1|||
145522158|NCT01150474|524772365|FG001|Overall Study|Cancer found|0|||
145522159|NCT01150474|524772364|FG000|Overall Study|Multiple Studies|0|||
145522160|NCT01150474|524772365|FG001|Overall Study|Multiple Studies|1|||
145522161|NCT01150474|524772364|FG000|Overall Study|Rectotomy|1|||
145522162|NCT01150474|524772365|FG001|Overall Study|Rectotomy|0|||
145522163|NCT01150474|524772364|FG000|Overall Study|Drug did not arrive in time|1|||
145522164|NCT01150474|524772365|FG001|Overall Study|Drug did not arrive in time|0|||
145522165|NCT01150474|524772364|FG000|Overall Study|Drug not administered|1|||
145522166|NCT01150474|524772365|FG001|Overall Study|Drug not administered|0|||
145522167|NCT01150474|524772364|FG000|Overall Study|Surgery Changed|1|||
145522168|NCT01150474|524772365|FG001|Overall Study|Surgery Changed|0|||
145522169|NCT00459979|524772366|FG000|Overall Study|Withdrawal by Subject|1|||
145522170|NCT00459979|524772366|FG000|Overall Study|Protocol Violation|1|||
145522171|NCT00219544|524772367|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
145522172|NCT00219544|524772368|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
145522173|NCT00219544|524772367|FG000|Single Blind Treatment Period|Adverse Event|9|||
145522174|NCT00219544|524772368|FG001|Single Blind Treatment Period|Adverse Event|0|||
145522175|NCT00219544|524772367|FG000|Single Blind Treatment Period|Protocol Violation|4|||
145522176|NCT00219544|524772368|FG001|Single Blind Treatment Period|Protocol Violation|0|||
145522177|NCT00219544|524772367|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
145522178|NCT00219544|524772368|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
145522179|NCT00219544|524772367|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
145522180|NCT00219544|524772368|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
145522181|NCT00219544|524772367|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
145522182|NCT00219544|524772368|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
145522183|NCT00989573|524772369|FG000|Overall Study|Adverse Event|8|||
145522184|NCT00989573|524772370|FG001|Overall Study|Adverse Event|12|||
145270695|NCT03917654|523837939|FG005|Year 2|Year 2 Screening failure|0|||
145522185|NCT00989573|524772371|FG002|Overall Study|Adverse Event|4|||
145522186|NCT00989573|524772369|FG000|Overall Study|Physician Decision|0|||
145522187|NCT00989573|524772370|FG001|Overall Study|Physician Decision|2|||
145522188|NCT00989573|524772371|FG002|Overall Study|Physician Decision|0|||
145522189|NCT00989573|524772369|FG000|Overall Study|Protocol Violation|1|||
145522190|NCT00989573|524772370|FG001|Overall Study|Protocol Violation|1|||
145522191|NCT00989573|524772371|FG002|Overall Study|Protocol Violation|1|||
145522192|NCT00989573|524772369|FG000|Overall Study|Withdrawal by Subject|4|||
145743947|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
145743948|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
145743949|NCT04041284|525578816|FG000|DB Phase (12 Weeks)|Other than specified|1|||
145743950|NCT04041284|525578817|FG001|DB Phase (12 Weeks)|Other than specified|0|||
145743951|NCT04041284|525578816|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
145743952|NCT04041284|525578817|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
145743953|NCT04041284|525578816|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
145743954|NCT04041284|525578817|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
145743955|NCT04041284|525578816|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
145743956|NCT04041284|525578817|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
145743957|NCT04041284|525578816|FG000|OL Phase (12 Weeks)|Other than specified|6|||
145743958|NCT04041284|525578817|FG001|OL Phase (12 Weeks)|Other than specified|2|||
145743959|NCT00825162|525578818|FG000|Overall Study|Withdrawal by Subject|11|||
145743960|NCT00825162|525578819|FG001|Overall Study|Withdrawal by Subject|13|||
145743961|NCT00825162|525578820|FG002|Overall Study|Withdrawal by Subject|3|||
145743962|NCT00825162|525578818|FG000|Overall Study|Lost to Follow-up|9|||
145743963|NCT00825162|525578819|FG001|Overall Study|Lost to Follow-up|6|||
145743964|NCT00825162|525578820|FG002|Overall Study|Lost to Follow-up|3|||
145743965|NCT00825162|525578818|FG000|Overall Study|Physician Decision|2|||
145743966|NCT00825162|525578819|FG001|Overall Study|Physician Decision|0|||
145743967|NCT00825162|525578820|FG002|Overall Study|Physician Decision|0|||
145743968|NCT00825162|525578818|FG000|Overall Study|Move away from the study area|1|||
145743969|NCT00825162|525578819|FG001|Overall Study|Move away from the study area|0|||
145743970|NCT00825162|525578820|FG002|Overall Study|Move away from the study area|0|||
145743971|NCT00825162|525578818|FG000|Overall Study|Unable to attend the study visit|5|||
145743972|NCT00825162|525578819|FG001|Overall Study|Unable to attend the study visit|2|||
145743973|NCT00825162|525578820|FG002|Overall Study|Unable to attend the study visit|0|||
145743974|NCT00964743|525578821|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
145743975|NCT00939783|525578826|FG000|Overall Study|Death|6|||
145743976|NCT00939783|525578826|FG000|Overall Study|Adverse Event|39|||
145743977|NCT00939783|525578826|FG000|Overall Study|Study Terminated by Sponsor|498|||
145743978|NCT00939783|525578826|FG000|Overall Study|Withdrawal by Subject|78|||
145743979|NCT00939783|525578826|FG000|Overall Study|Other|16|||
145743980|NCT00939783|525578826|FG000|Overall Study|Lost to Follow-up|8|||
145743981|NCT00939783|525578826|FG000|Overall Study|Protocol Violation|3|||
145743982|NCT00939783|525578826|FG000|Overall Study|Enrolled but not treated|1|||
145743983|NCT01549002|525578827|FG000|Overall Study|Excessive pain|0|||
145743984|NCT01549002|525578828|FG001|Overall Study|Excessive pain|2|||
145743985|NCT01549002|525578827|FG000|Overall Study|Moderate sedation required|0|||
145743986|NCT01549002|525578828|FG001|Overall Study|Moderate sedation required|2|||
145743987|NCT01924182|525578829|FG000|Overall Study|Withdrawal by Subject|1|||
145743988|NCT01924182|525578830|FG001|Overall Study|Withdrawal by Subject|0|||
145743989|NCT00432042|525578833|FG000|Overall Study|Protocol Violation|2|||
145743990|NCT00432042|525578834|FG001|Overall Study|Protocol Violation|0|||
145743991|NCT00432042|525578835|FG002|Overall Study|Protocol Violation|0|||
145743992|NCT00432042|525578833|FG000|Overall Study|Withdrawal by Subject|0|||
145743993|NCT00432042|525578834|FG001|Overall Study|Withdrawal by Subject|0|||
145743994|NCT00432042|525578835|FG002|Overall Study|Withdrawal by Subject|2|||
145743995|NCT00432042|525578833|FG000|Overall Study|Lost to Follow-up|5|||
145743996|NCT00432042|525578834|FG001|Overall Study|Lost to Follow-up|1|||
145743997|NCT00432042|525578835|FG002|Overall Study|Lost to Follow-up|0|||
145743998|NCT00492752|525578836|FG000|Double Blind Treatment|Death|13|||
145743999|NCT00492752|525578837|FG001|Double Blind Treatment|Death|0|||
145744000|NCT00492752|525578838|FG002|Double Blind Treatment|Death|2|||
145744001|NCT00492752|525578839|FG003|Double Blind Treatment|Death|0|||
145744002|NCT00492752|525578836|FG000|Double Blind Treatment|Adverse Event|1|||
145744003|NCT00492752|525578837|FG001|Double Blind Treatment|Adverse Event|0|||
145744004|NCT00492752|525578838|FG002|Double Blind Treatment|Adverse Event|0|||
145744005|NCT00492752|525578839|FG003|Double Blind Treatment|Adverse Event|0|||
145744006|NCT00492752|525578836|FG000|Double Blind Treatment|Protocol Violation|0|||
145744007|NCT00492752|525578837|FG001|Double Blind Treatment|Protocol Violation|0|||
145744008|NCT00492752|525578838|FG002|Double Blind Treatment|Protocol Violation|1|||
145744009|NCT00492752|525578839|FG003|Double Blind Treatment|Protocol Violation|0|||
145270696|NCT03917654|523837940|FG006|Year 2|Year 2 Screening failure|4|||
145744010|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
145744011|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
145744012|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
145744013|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
145744014|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
145744015|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
145744016|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
145744017|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
145744018|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
145744019|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
145744020|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
145522193|NCT00989573|524772370|FG001|Overall Study|Withdrawal by Subject|7|||
145522194|NCT00989573|524772371|FG002|Overall Study|Withdrawal by Subject|3|||
145522195|NCT05214573|524772374|FG000|Overall Study|Physician Decision|5924|||
145522196|NCT05214573|524772375|FG001|Overall Study|Physician Decision|0|||
145522197|NCT01163032|524772378|FG000|Randomization Phase|Withdrawal by Subject|2|||
145522198|NCT01163032|524772379|FG001|Randomization Phase|Withdrawal by Subject|3|||
145522199|NCT01163032|524772380|FG002|Randomization Phase|Withdrawal by Subject|0|||
145522200|NCT01163032|524772378|FG000|Randomization Phase|Adverse Event|3|||
145522201|NCT01163032|524772379|FG001|Randomization Phase|Adverse Event|3|||
145522202|NCT01163032|524772380|FG002|Randomization Phase|Adverse Event|0|||
145522203|NCT01163032|524772378|FG000|Randomization Phase|Protocol Violation|0|||
145522204|NCT01163032|524772379|FG001|Randomization Phase|Protocol Violation|1|||
145522205|NCT01163032|524772380|FG002|Randomization Phase|Protocol Violation|0|||
145522206|NCT01163032|524772378|FG000|Randomization Phase|Various*|5|||
145522207|NCT01163032|524772379|FG001|Randomization Phase|Various*|4|||
145522208|NCT01163032|524772380|FG002|Randomization Phase|Various*|0|||
145522209|NCT01163032|524772378|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
145522210|NCT01163032|524772379|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
145522211|NCT01163032|524772380|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
145522212|NCT01163032|524772378|FG000|Open Label Extension Phase|Adverse Event|0|||
145522213|NCT01163032|524772379|FG001|Open Label Extension Phase|Adverse Event|0|||
145522214|NCT01163032|524772380|FG002|Open Label Extension Phase|Adverse Event|3|||
145522215|NCT01163032|524772378|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
145522216|NCT01163032|524772379|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
145522217|NCT01163032|524772380|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
145522218|NCT01163032|524772378|FG000|Open Label Extension Phase|Protocol Violation|0|||
145522219|NCT01163032|524772379|FG001|Open Label Extension Phase|Protocol Violation|0|||
145522220|NCT01163032|524772380|FG002|Open Label Extension Phase|Protocol Violation|1|||
145522221|NCT01163032|524772378|FG000|Open Label Extension Phase|Study Termination|0|||
145522222|NCT01163032|524772379|FG001|Open Label Extension Phase|Study Termination|0|||
145522223|NCT01163032|524772380|FG002|Open Label Extension Phase|Study Termination|7|||
145522224|NCT01163032|524772378|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
145522225|NCT01163032|524772379|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
145522226|NCT01163032|524772380|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
145522227|NCT01037088|524772383|FG000|Overall Study|Withdrawal by Subject|3|||
145522228|NCT01958827|524772384|FG000|Overall Study|Adverse Event|3|||
145522229|NCT01958827|524772384|FG000|Overall Study|Lack of Efficacy|6|||
145522230|NCT01958827|524772384|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
145522231|NCT03036800|524772385|FG000|Overall Study|Protocol Violation|1|||
145522232|NCT03036800|524772386|FG001|Overall Study|Protocol Violation|0|||
145522233|NCT03036800|524772385|FG000|Overall Study|Non-compliance|1|||
145522234|NCT03036800|524772386|FG001|Overall Study|Non-compliance|0|||
145522235|NCT03036800|524772385|FG000|Overall Study|Lost to Follow-up|1|||
145522236|NCT03036800|524772386|FG001|Overall Study|Lost to Follow-up|0|||
145522237|NCT03036800|524772385|FG000|Overall Study|Death|1|||
145522238|NCT03036800|524772386|FG001|Overall Study|Death|0|||
145522239|NCT03036800|524772385|FG000|Overall Study|Tolerance|5|||
145522240|NCT03036800|524772386|FG001|Overall Study|Tolerance|0|||
145522241|NCT03036800|524772385|FG000|Overall Study|Unknown/no reason given|50|||
145522242|NCT03036800|524772386|FG001|Overall Study|Unknown/no reason given|39|||
145522243|NCT01077154|524772391|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
145522244|NCT01077154|524772392|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
145522245|NCT01077154|524772391|FG000|Overall Study|Withdrawal by Subject|369|||
145522246|NCT01077154|524772392|FG001|Overall Study|Withdrawal by Subject|385|||
145522247|NCT01077154|524772391|FG000|Overall Study|Death|215|||
145522248|NCT01077154|524772392|FG001|Overall Study|Death|214|||
145522249|NCT01077154|524772391|FG000|Overall Study|Lost to Follow-up|43|||
145522250|NCT01077154|524772392|FG001|Overall Study|Lost to Follow-up|35|||
145522251|NCT01077154|524772391|FG000|Overall Study|Noncompliance|22|||
145522252|NCT01077154|524772392|FG001|Overall Study|Noncompliance|20|||
145522253|NCT01077154|524772391|FG000|Overall Study|Disease Progression|18|||
145522254|NCT01077154|524772392|FG001|Overall Study|Disease Progression|20|||
145522255|NCT01077154|524772391|FG000|Overall Study|Ineligibility Determined|10|||
145522256|NCT01077154|524772392|FG001|Overall Study|Ineligibility Determined|14|||
145522257|NCT01077154|524772391|FG000|Overall Study|Other|14|||
145522258|NCT01077154|524772392|FG001|Overall Study|Other|11|||
145522259|NCT01077154|524772391|FG000|Overall Study|Adverse Event|9|||
145744021|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
145522260|NCT01077154|524772392|FG001|Overall Study|Adverse Event|9|||
145522261|NCT01077154|524772391|FG000|Overall Study|Administrative Decision|1|||
145522262|NCT01077154|524772392|FG001|Overall Study|Administrative Decision|6|||
145522263|NCT01077154|524772391|FG000|Overall Study|Protocol Deviation|1|||
145522264|NCT01077154|524772392|FG001|Overall Study|Protocol Deviation|0|||
145522265|NCT02207946|524772393|FG000|Overall Study|Lost to Follow-up|1|||
145522266|NCT02207946|524772394|FG001|Overall Study|Lost to Follow-up|0|||
145522267|NCT02207946|524772393|FG000|Overall Study|Adverse Event|0|||
145744022|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
145744023|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
145744024|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
145744025|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
145744026|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
145744027|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
145744028|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
145744029|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
145744030|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
145744031|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
145744032|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
145744033|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
145744034|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
145744035|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
145744036|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
145744037|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
145744038|NCT00492752|525578836|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
145744039|NCT00492752|525578837|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
145744040|NCT00492752|525578838|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
145744041|NCT00492752|525578839|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
145744042|NCT01357655|525578840|FG000|Overall Study|Administrative Reason by Sponsor|45|||
145744043|NCT01357655|525578841|FG001|Overall Study|Administrative Reason by Sponsor|0|||
145744044|NCT01357655|525578840|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145744045|NCT01357655|525578841|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145744046|NCT01357655|525578840|FG000|Overall Study|Disease Progression|1|||
145744047|NCT01357655|525578841|FG001|Overall Study|Disease Progression|0|||
145744048|NCT01357655|525578840|FG000|Overall Study|Lost to Follow-up|2|||
145744049|NCT01357655|525578841|FG001|Overall Study|Lost to Follow-up|0|||
145744050|NCT01357655|525578840|FG000|Overall Study|Maximum Clinical Benefit|2|||
145744051|NCT01357655|525578841|FG001|Overall Study|Maximum Clinical Benefit|0|||
145744052|NCT01357655|525578840|FG000|Overall Study|Reason Unspecified|1|||
145744053|NCT01357655|525578841|FG001|Overall Study|Reason Unspecified|0|||
145744054|NCT01357655|525578840|FG000|Overall Study|Study Drug Toxicity|11|||
145744055|NCT01357655|525578841|FG001|Overall Study|Study Drug Toxicity|0|||
145744056|NCT01357655|525578840|FG000|Overall Study|Subject Withdrew Consent|1|||
145744057|NCT01357655|525578841|FG001|Overall Study|Subject Withdrew Consent|0|||
145744058|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
145744059|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
145744060|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
145744061|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
145744062|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
145744063|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
145744064|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
145744065|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
145744066|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
145744067|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
145744068|NCT00219284|525578842|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
145744069|NCT00219284|525578843|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
145744070|NCT00219284|525578842|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
145744071|NCT00219284|525578843|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
145744072|NCT00219284|525578842|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
145744073|NCT00219284|525578843|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
145744074|NCT00219284|525578842|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
145744075|NCT00219284|525578843|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
145744076|NCT03803059|525578844|FG000|Overall Study|Protocol Violation|2|||
145744077|NCT03803059|525578844|FG000|Overall Study|Lost to Follow-up|1|||
145744078|NCT00880399|525580037|FG000|Overall Study|Adverse Event|4|||
145744079|NCT00880399|525580038|FG001|Overall Study|Adverse Event|6|||
145744080|NCT00880399|525580039|FG002|Overall Study|Adverse Event|5|||
145522268|NCT02207946|524772394|FG001|Overall Study|Adverse Event|1|||
145522269|NCT01006603|524772402|FG000|Overall Study|Withdrawal by Subject|17|||
145522270|NCT01006603|524772403|FG001|Overall Study|Withdrawal by Subject|19|||
145270697|NCT03917654|523837941|FG007|Year 2|Year 2 Screening failure|3|||
145270698|NCT03917654|523837942|FG008|Year 2|Year 2 Screening failure|10|||
145522271|NCT01006603|524772402|FG000|Overall Study|Lost to Follow-up|0|||
145522272|NCT01006603|524772403|FG001|Overall Study|Lost to Follow-up|1|||
145522273|NCT01006603|524772402|FG000|Overall Study|Safety reason|1|||
145744081|NCT00880399|525580037|FG000|Overall Study|Lack of Efficacy|1|||
145522274|NCT01006603|524772403|FG001|Overall Study|Safety reason|1|||
145744082|NCT00880399|525580038|FG001|Overall Study|Lack of Efficacy|4|||
145744083|NCT00880399|525580039|FG002|Overall Study|Lack of Efficacy|2|||
145744084|NCT00880399|525580037|FG000|Overall Study|Protocol Violation|4|||
145744085|NCT00880399|525580038|FG001|Overall Study|Protocol Violation|4|||
145744086|NCT00880399|525580039|FG002|Overall Study|Protocol Violation|6|||
145744087|NCT00880399|525580037|FG000|Overall Study|Study closed/terminated|3|||
145744088|NCT00880399|525580038|FG001|Overall Study|Study closed/terminated|7|||
145744089|NCT00880399|525580039|FG002|Overall Study|Study closed/terminated|4|||
145744090|NCT00880399|525580037|FG000|Overall Study|Lost to Follow-up|8|||
145744091|NCT00880399|525580038|FG001|Overall Study|Lost to Follow-up|5|||
145744092|NCT00880399|525580039|FG002|Overall Study|Lost to Follow-up|3|||
145744093|NCT00880399|525580037|FG000|Overall Study|Physician Decision|5|||
145744094|NCT00880399|525580038|FG001|Overall Study|Physician Decision|0|||
145744095|NCT00880399|525580039|FG002|Overall Study|Physician Decision|3|||
145744096|NCT00880399|525580037|FG000|Overall Study|Withdrawal by Subject|6|||
145744097|NCT00880399|525580038|FG001|Overall Study|Withdrawal by Subject|3|||
145744098|NCT00880399|525580039|FG002|Overall Study|Withdrawal by Subject|3|||
145744099|NCT03709654|525580040|FG000|Overall Study|Lost to Follow-up|1|||
145744100|NCT03709654|525580041|FG001|Overall Study|Lost to Follow-up|1|||
145744101|NCT03709654|525580040|FG000|Overall Study|Withdrawal by Subject|1|||
145744102|NCT03709654|525580041|FG001|Overall Study|Withdrawal by Subject|1|||
145744103|NCT03709654|525580040|FG000|Overall Study|Adverse Event|1|||
145744104|NCT03709654|525580041|FG001|Overall Study|Adverse Event|0|||
145744105|NCT01902966|525580042|FG000|Overall Study|Death|1|||
145744106|NCT01902966|525580042|FG000|Overall Study|Physician Decision|1|||
145402463|NCT00784875|524330735|FG002|Period C|Withdrawal by Subject|2|||
145522275|NCT01006603|524772402|FG000|Overall Study|Protocol Violation|1|||
145522276|NCT01006603|524772403|FG001|Overall Study|Protocol Violation|3|||
145522277|NCT01006603|524772402|FG000|Overall Study|Incorrect enrolment|0|||
145522278|NCT01006603|524772403|FG001|Overall Study|Incorrect enrolment|2|||
145522279|NCT01006603|524772402|FG000|Overall Study|Adverse Event|15|||
145522280|NCT01006603|524772403|FG001|Overall Study|Adverse Event|7|||
145522281|NCT01006603|524772402|FG000|Overall Study|Death|1|||
145522282|NCT01006603|524772403|FG001|Overall Study|Death|1|||
145522283|NCT01006603|524772402|FG000|Overall Study|Study specific discontinuation criteria|33|||
145522284|NCT01006603|524772403|FG001|Overall Study|Study specific discontinuation criteria|34|||
145522285|NCT01006603|524772402|FG000|Overall Study|Other|3|||
145522286|NCT01006603|524772403|FG001|Overall Study|Other|7|||
145522287|NCT00884377|524772841|FG000|Overall Study|Withdrawal by Subject|1|||
145522288|NCT00884377|524772842|FG001|Overall Study|Withdrawal by Subject|0|||
145522289|NCT00884377|524772841|FG000|Overall Study|Could not confirm diagnosis|1|||
145522290|NCT00884377|524772842|FG001|Overall Study|Could not confirm diagnosis|0|||
145522291|NCT00884377|524772841|FG000|Overall Study|Physician Decision|0|||
145522292|NCT00884377|524772842|FG001|Overall Study|Physician Decision|1|||
145522293|NCT02316548|524772843|FG000|Overall Study|Protocol Violation|0|||
145522294|NCT02316548|524772844|FG001|Overall Study|Protocol Violation|1|||
145522295|NCT05171816|524772847|FG000|Overall Study|Death|18|||
145522296|NCT05171816|524772848|FG001|Overall Study|Death|16|||
145522297|NCT02937571|524772849|FG000|Overall Study|Adverse Event|0|||
145522298|NCT02937571|524772850|FG001|Overall Study|Adverse Event|0|||
145522299|NCT02937571|524772851|FG002|Overall Study|Adverse Event|4|||
145522300|NCT02937571|524772849|FG000|Overall Study|Withdrawal by Subject|0|||
145522301|NCT02937571|524772850|FG001|Overall Study|Withdrawal by Subject|0|||
145522302|NCT02937571|524772851|FG002|Overall Study|Withdrawal by Subject|3|||
145744107|NCT01902966|525580042|FG000|Overall Study|Withdrawal by Subject|1|||
145744108|NCT01230307|525580043|FG000|Overall Study|LVAD Placement|0|||
145744109|NCT01230307|525580044|FG001|Overall Study|LVAD Placement|2|||
145744110|NCT01230242|525580048|FG000|Overall Study|Physician Decision|2|||
145744111|NCT01230242|525580048|FG000|Overall Study|Withdrawal by Subject|1|||
145522303|NCT05867342|524772852|FG000|Overall Study|Investigator Decision|3|||
145522304|NCT05867342|524772853|FG001|Overall Study|Investigator Decision|3|||
145522305|NCT00584740|524772855|FG000|Overall Study|Adverse Event|1|||
145522306|NCT00584740|524772856|FG001|Overall Study|Adverse Event|1|||
145522307|NCT00584740|524772855|FG000|Overall Study|Lack of Efficacy|8|||
145522308|NCT00584740|524772856|FG001|Overall Study|Lack of Efficacy|2|||
145522309|NCT00584740|524772855|FG000|Overall Study|Withdrawal by Subject|3|||
145522310|NCT00584740|524772856|FG001|Overall Study|Withdrawal by Subject|2|||
145744112|NCT02256540|525580049|FG000|Overall Study|Withdrawal by Subject|0|||
145744113|NCT02256540|525580050|FG001|Overall Study|Withdrawal by Subject|1|||
145744114|NCT02256540|525580051|FG002|Overall Study|Withdrawal by Subject|1|||
145744115|NCT02256540|525580049|FG000|Overall Study|Back pain preventing exercise|0|||
145744116|NCT02256540|525580050|FG001|Overall Study|Back pain preventing exercise|0|||
145522311|NCT00584740|524772855|FG000|Overall Study|Lost to Follow-up|0|||
145522312|NCT00584740|524772856|FG001|Overall Study|Lost to Follow-up|1|||
145744117|NCT02256540|525580051|FG002|Overall Study|Back pain preventing exercise|1|||
145744118|NCT03923426|525580052|FG000|Overall Study|Other|19|||
145744119|NCT03923426|525580052|FG000|Overall Study|Lost to Follow-up|16|||
145744120|NCT03923426|525580052|FG000|Overall Study|Death|107|||
145744121|NCT03923426|525580052|FG000|Overall Study|Incomplete response to question|13|||
145744122|NCT01918007|525580053|FG000|Overall Study|Baseline oximetry not acceptable|11|||
145744123|NCT01918007|525580054|FG001|Overall Study|Baseline oximetry not acceptable|7|||
145744124|NCT01918007|525580053|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
145744125|NCT01918007|525580054|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
145744126|NCT01918007|525580053|FG000|Overall Study|Lost to Follow-up|4|||
145744127|NCT01918007|525580054|FG001|Overall Study|Lost to Follow-up|7|||
145744128|NCT02037295|525580056|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
145744129|NCT02037295|525580057|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
145270699|NCT03917654|523837943|FG009|Year 2|Year 2 Screening failure|2|||
145522313|NCT01673282|524772857|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
145522314|NCT01673282|524772858|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
145522315|NCT01673282|524772857|FG000|Overall Study|Lack of Efficacy|9|||
145522316|NCT01673282|524772858|FG001|Overall Study|Lack of Efficacy|2|||
145522317|NCT01673282|524772857|FG000|Overall Study|Lost to Follow-up|11|||
145522318|NCT01673282|524772858|FG001|Overall Study|Lost to Follow-up|10|||
145522319|NCT01673282|524772857|FG000|Overall Study|Withdrawal by Subject|3|||
145522320|NCT01673282|524772858|FG001|Overall Study|Withdrawal by Subject|3|||
145522321|NCT01673282|524772857|FG000|Overall Study|Other|1|||
145522322|NCT01673282|524772858|FG001|Overall Study|Other|6|||
145522323|NCT02915874|524772859|FG000|Overall Study|Lost to Follow-up|5|||
145522324|NCT02915874|524772860|FG001|Overall Study|Lost to Follow-up|4|||
145522325|NCT02915874|524772859|FG000|Overall Study|Withdrawal by Subject|1|||
145522326|NCT02915874|524772860|FG001|Overall Study|Withdrawal by Subject|1|||
145522327|NCT02915874|524772859|FG000|Overall Study|Started New Anxiety Medication|0|||
145522328|NCT02915874|524772860|FG001|Overall Study|Started New Anxiety Medication|1|||
145522329|NCT05318183|524772862|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
145522330|NCT05318183|524772863|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
145522331|NCT05318183|524772862|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
145522332|NCT05318183|524772863|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145522333|NCT05318183|524772862|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
145522334|NCT05318183|524772863|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
145522335|NCT05318183|524772862|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145522336|NCT05318183|524772863|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
145522337|NCT06400251|524772864|FG000|Overall Study|Never Start Protocol Therapy|1|||
145522338|NCT06400251|524772864|FG000|Overall Study|Ineligible|2|||
145522339|NCT06400251|524772864|FG000|Overall Study|Mutation Status Not Confirmed|3|||
145522340|NCT06400251|524772864|FG000|Overall Study|Disease Progression|25|||
145522341|NCT06400251|524772864|FG000|Overall Study|Adverse Event|1|||
145522342|NCT06400251|524772864|FG000|Overall Study|Complicating Disease|1|||
145522343|NCT06400251|524772864|FG000|Overall Study|Physician Decision|2|||
145522344|NCT04391569|524772865|FG000|Overall Study|Death|15|||
145522345|NCT04391569|524772866|FG001|Overall Study|Death|10|||
145522346|NCT04391569|524772865|FG000|Overall Study|Withdrawal by Subject|1|||
145522347|NCT04391569|524772866|FG001|Overall Study|Withdrawal by Subject|0|||
145522348|NCT04391569|524772865|FG000|Overall Study|Lost to Follow-up|3|||
145522349|NCT04391569|524772866|FG001|Overall Study|Lost to Follow-up|2|||
145522350|NCT04391569|524772865|FG000|Overall Study|Lack of Efficacy|0|||
145522351|NCT04391569|524772866|FG001|Overall Study|Lack of Efficacy|1|||
145522352|NCT04391569|524772865|FG000|Overall Study|Participant discharged to hospice facility|0|||
145522353|NCT04391569|524772866|FG001|Overall Study|Participant discharged to hospice facility|1|||
145522354|NCT04391569|524772865|FG000|Overall Study|Participant family decision|1|||
145522355|NCT04391569|524772866|FG001|Overall Study|Participant family decision|0|||
145522356|NCT04391569|524772865|FG000|Overall Study|Participant discharged prematurely|1|||
145522357|NCT04391569|524772866|FG001|Overall Study|Participant discharged prematurely|0|||
145522358|NCT03025035|524772867|FG000|Overall Study|Death|2|||
145522359|NCT03025035|524772867|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
145522360|NCT03764033|524772869|FG000|Treatment Phase|Withdrawal by Subject|8|||
145522361|NCT03764033|524772870|FG001|Treatment Phase|Withdrawal by Subject|3|||
145522362|NCT03764033|524772869|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
145744130|NCT02037295|525580058|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
145744131|NCT02037295|525580059|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
145522363|NCT03764033|524772870|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
145522364|NCT03764033|524772869|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
145522365|NCT03764033|524772870|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
145522366|NCT05856760|524772871|FG000|Overall Study|Adverse Event|2|||
145522367|NCT05856760|524772871|FG000|Overall Study|Physician Decision|1|||
145522368|NCT05856760|524772871|FG000|Overall Study|Protocol Violation|1|||
145522369|NCT05856760|524772871|FG000|Overall Study|Withdrawal by Subject|3|||
145744132|NCT01140451|525580060|FG000|Overall Study|Withdrawal by Subject|26|||
145744133|NCT01140451|525580061|FG001|Overall Study|Withdrawal by Subject|33|||
145744134|NCT01140451|525580060|FG000|Overall Study|Adverse Event|2|||
145744135|NCT01140451|525580061|FG001|Overall Study|Adverse Event|6|||
145744136|NCT01140451|525580060|FG000|Overall Study|Physician Decision|5|||
145744137|NCT01140451|525580061|FG001|Overall Study|Physician Decision|3|||
145744138|NCT01140451|525580060|FG000|Overall Study|Lost to Follow-up|2|||
145744139|NCT01140451|525580061|FG001|Overall Study|Lost to Follow-up|0|||
145744140|NCT01140451|525580060|FG000|Overall Study|Participants Planning Pregnancy|3|||
145744141|NCT01140451|525580061|FG001|Overall Study|Participants Planning Pregnancy|0|||
145744142|NCT02004262|525580063|FG000|Overall Study|Death|67|||
145744143|NCT02004262|525580064|FG001|Overall Study|Death|64|||
145744144|NCT02004262|525580065|FG002|Overall Study|Death|66|||
145744145|NCT02004262|525580066|FG003|Overall Study|Death|28|||
145744146|NCT02004262|525580067|FG004|Overall Study|Death|29|||
145744147|NCT02004262|525580068|FG005|Overall Study|Death|22|||
145744148|NCT02004262|525580063|FG000|Overall Study|Withdrawal by Subject|1|||
145744149|NCT02004262|525580064|FG001|Overall Study|Withdrawal by Subject|0|||
145744150|NCT02004262|525580065|FG002|Overall Study|Withdrawal by Subject|4|||
145744151|NCT02004262|525580066|FG003|Overall Study|Withdrawal by Subject|0|||
145744152|NCT02004262|525580067|FG004|Overall Study|Withdrawal by Subject|1|||
145744153|NCT02004262|525580068|FG005|Overall Study|Withdrawal by Subject|3|||
145744154|NCT02004262|525580063|FG000|Overall Study|Lost to Follow-up|1|||
145744155|NCT02004262|525580064|FG001|Overall Study|Lost to Follow-up|1|||
145744156|NCT02004262|525580065|FG002|Overall Study|Lost to Follow-up|0|||
145744157|NCT02004262|525580066|FG003|Overall Study|Lost to Follow-up|0|||
145744158|NCT02004262|525580067|FG004|Overall Study|Lost to Follow-up|0|||
145744159|NCT02004262|525580068|FG005|Overall Study|Lost to Follow-up|0|||
145744160|NCT02004262|525580063|FG000|Overall Study|Study Terminated by Sponsor|4|||
145744161|NCT02004262|525580064|FG001|Overall Study|Study Terminated by Sponsor|3|||
145744162|NCT02004262|525580065|FG002|Overall Study|Study Terminated by Sponsor|2|||
145744163|NCT02004262|525580066|FG003|Overall Study|Study Terminated by Sponsor|1|||
145744164|NCT02004262|525580067|FG004|Overall Study|Study Terminated by Sponsor|1|||
145744165|NCT02004262|525580068|FG005|Overall Study|Study Terminated by Sponsor|5|||
145744166|NCT00552175|525580071|FG000|Overall Study|Lack of Efficacy|2|||
145744167|NCT00552175|525580072|FG001|Overall Study|Lack of Efficacy|0|||
145744168|NCT00552175|525580073|FG002|Overall Study|Lack of Efficacy|1|||
145744169|NCT00552175|525580071|FG000|Overall Study|Adverse Event|9|||
145744170|NCT00552175|525580072|FG001|Overall Study|Adverse Event|9|||
145744171|NCT00552175|525580073|FG002|Overall Study|Adverse Event|10|||
145744172|NCT00552175|525580071|FG000|Overall Study|Withdrawal by Subject|2|||
145744173|NCT00552175|525580072|FG001|Overall Study|Withdrawal by Subject|2|||
145744174|NCT00552175|525580073|FG002|Overall Study|Withdrawal by Subject|1|||
145744175|NCT00552175|525580071|FG000|Overall Study|Lost to Follow-up|0|||
145744176|NCT00552175|525580072|FG001|Overall Study|Lost to Follow-up|0|||
145270700|NCT03917654|523837944|FG010|Year 2|Year 2 Screening failure|1|||
145270701|NCT03917654|523837945|FG011|Year 2|Year 2 Screening failure|1|||
145270702|NCT03917654|523837934|FG000|Year 2|Death|0|||
145270703|NCT03917654|523837935|FG001|Year 2|Death|0|||
145270704|NCT03917654|523837936|FG002|Year 2|Death|0|||
145270705|NCT03917654|523837937|FG003|Year 2|Death|0|||
145270706|NCT03917654|523837938|FG004|Year 2|Death|0|||
145270707|NCT03917654|523837939|FG005|Year 2|Death|1|||
145270708|NCT03917654|523837940|FG006|Year 2|Death|0|||
145270709|NCT03917654|523837941|FG007|Year 2|Death|0|||
145270710|NCT03917654|523837942|FG008|Year 2|Death|1|||
145402464|NCT00784875|524330736|FG003|Period C|Withdrawal by Subject|0|||
145522370|NCT01892722|524772875|FG000|Overall Study|Protocol deviation|0|||
145522371|NCT01892722|524772876|FG001|Overall Study|Protocol deviation|1|||
145522372|NCT01892722|524772875|FG000|Overall Study|Administrative problems|0|||
145522373|NCT01892722|524772876|FG001|Overall Study|Administrative problems|1|||
145270711|NCT03917654|523837943|FG009|Year 2|Death|1|||
145522374|NCT01892722|524772875|FG000|Overall Study|Patient/guardian decision|0|||
145522375|NCT01892722|524772876|FG001|Overall Study|Patient/guardian decision|2|||
145522376|NCT01892722|524772875|FG000|Overall Study|Physician Decision|1|||
145270712|NCT03917654|523837944|FG010|Year 2|Death|0|||
145522377|NCT01892722|524772876|FG001|Overall Study|Physician Decision|2|||
145522378|NCT01892722|524772875|FG000|Overall Study|Adverse Event|3|||
145744177|NCT00552175|525580073|FG002|Overall Study|Lost to Follow-up|1|||
145744178|NCT00552175|525580071|FG000|Overall Study|Entry Criteria Not Met|1|||
145744179|NCT00552175|525580072|FG001|Overall Study|Entry Criteria Not Met|1|||
145744180|NCT00552175|525580073|FG002|Overall Study|Entry Criteria Not Met|0|||
145270713|NCT03917654|523837945|FG011|Year 2|Death|0|||
145744181|NCT00552175|525580071|FG000|Overall Study|Reason Not Specified|3|||
145744182|NCT00552175|525580072|FG001|Overall Study|Reason Not Specified|1|||
145270714|NCT03917654|523837934|FG000|Year 2|Withdrawal by Subject|0|||
145270715|NCT03917654|523837935|FG001|Year 2|Withdrawal by Subject|0|||
145744183|NCT00552175|525580073|FG002|Overall Study|Reason Not Specified|1|||
145744184|NCT01500278|525580074|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
145744185|NCT01500278|525580075|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
145744186|NCT01500278|525580074|FG000|Week 0 - Week 12|Protocol Violation|10|||
145522379|NCT01892722|524772876|FG001|Overall Study|Adverse Event|2|||
145522380|NCT01892722|524772875|FG000|Overall Study|Lack of Efficacy|0|||
145522381|NCT01892722|524772876|FG001|Overall Study|Lack of Efficacy|7|||
145522382|NCT01892722|524772875|FG000|Overall Study|Withdrawal by Subject|3|||
145522383|NCT01892722|524772876|FG001|Overall Study|Withdrawal by Subject|5|||
145522384|NCT05568888|524772877|FG000|Overall Study|Physician Decision|1|||
145522385|NCT05568888|524772878|FG001|Overall Study|Physician Decision|0|||
145522386|NCT05568888|524772877|FG000|Overall Study|Protocol Deviation|2|||
145522387|NCT05568888|524772878|FG001|Overall Study|Protocol Deviation|1|||
145522388|NCT05568888|524772877|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
145522389|NCT05568888|524772878|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
145522390|NCT05568888|524772877|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
145522391|NCT05568888|524772878|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
145522392|NCT05568888|524772877|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
145522393|NCT05568888|524772878|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
145522394|NCT02477696|524772881|FG000|Overall Study|Death|89|||
145522395|NCT02477696|524772882|FG001|Overall Study|Death|106|||
145522396|NCT02477696|524772881|FG000|Overall Study|Lost to Follow-up|7|||
145522397|NCT02477696|524772882|FG001|Overall Study|Lost to Follow-up|5|||
145522398|NCT02477696|524772881|FG000|Overall Study|Withdrawal by Subject|37|||
145522399|NCT02477696|524772882|FG001|Overall Study|Withdrawal by Subject|34|||
145522400|NCT02477696|524772881|FG000|Overall Study|Physician Decision|7|||
145522401|NCT02477696|524772882|FG001|Overall Study|Physician Decision|9|||
145522402|NCT02477696|524772881|FG000|Overall Study|Study terminated by sponsor|103|||
145522403|NCT02477696|524772882|FG001|Overall Study|Study terminated by sponsor|99|||
145522404|NCT02477696|524772881|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
145522405|NCT02477696|524772882|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
145522406|NCT02477696|524772881|FG000|Overall Study|Missing/Unknown|2|||
145522407|NCT02477696|524772882|FG001|Overall Study|Missing/Unknown|0|||
145522408|NCT03675321|524773246|FG000|Overall Study|Lack of Efficacy|2|||
145522409|NCT03675321|524773247|FG001|Overall Study|Lack of Efficacy|2|||
145522410|NCT03675321|524773246|FG000|Overall Study|Withdrawal by Subject|1|||
145522411|NCT03675321|524773247|FG001|Overall Study|Withdrawal by Subject|3|||
145522412|NCT01589770|524773267|FG000|Overall Study|EGFR <60ml/min|6|||
145522413|NCT01589770|524773268|FG001|Overall Study|EGFR <60ml/min|4|||
145522414|NCT01589770|524773267|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
145522415|NCT01589770|524773268|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
145522416|NCT02751931|524773271|FG000|Overall Study|Adverse Event|3|||
145522417|NCT02751931|524773272|FG001|Overall Study|Adverse Event|0|||
145522418|NCT02751931|524773271|FG000|Overall Study|Other: Miscelleneous|10|||
145522419|NCT02751931|524773272|FG001|Overall Study|Other: Miscelleneous|8|||
145522420|NCT01602666|524773278|FG000|Induction Chemotherapy|Death|2|||
145522421|NCT01602666|524773279|FG001|Induction Chemotherapy|Death|1|||
145522422|NCT01602666|524773278|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
145522423|NCT01602666|524773279|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
145522424|NCT01602666|524773278|FG000|Induction Chemotherapy|Physician Decision|12|||
145522425|NCT01602666|524773279|FG001|Induction Chemotherapy|Physician Decision|5|||
145522426|NCT01602666|524773278|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
145522427|NCT01602666|524773279|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
145522428|NCT01602666|524773278|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
145522429|NCT01602666|524773279|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
145522430|NCT01602666|524773278|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
145522431|NCT01602666|524773279|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
145522432|NCT01602666|524773278|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
145522433|NCT01602666|524773279|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
145522434|NCT01602666|524773278|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
145522435|NCT01602666|524773279|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
145522436|NCT01602666|524773278|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
145522437|NCT01602666|524773279|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
145522438|NCT01602666|524773278|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
145522439|NCT01602666|524773279|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
145522440|NCT01602666|524773278|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
145522441|NCT01602666|524773279|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
145522442|NCT01163318|524773280|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
145522443|NCT01163318|524773280|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
145522444|NCT01163318|524773280|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
145270716|NCT03917654|523837936|FG002|Year 2|Withdrawal by Subject|0|||
145522445|NCT01163318|524773280|FG000|Overall Study|Participants Without Case Report Form|7|||
145522446|NCT01163318|524773280|FG000|Overall Study|Multiple Reasons Per Participant|224|||
145522447|NCT04153149|524773286|FG000|Double Blind Period|Death|63|||
145522448|NCT04153149|524773287|FG001|Double Blind Period|Death|49|||
145270717|NCT03917654|523837937|FG003|Year 2|Withdrawal by Subject|0|||
145522449|NCT04153149|524773288|FG002|Double Blind Period|Death|0|||
145522450|NCT04153149|524773289|FG003|Double Blind Period|Death|0|||
145522451|NCT04153149|524773286|FG000|Double Blind Period|Withdrawal by Subject|16|||
145744187|NCT01500278|525580075|FG001|Week 0 - Week 12|Protocol Violation|16|||
145744188|NCT01500278|525580074|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
145744189|NCT01500278|525580075|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
145744190|NCT01500278|525580074|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
145744191|NCT01500278|525580075|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
145744192|NCT01500278|525580074|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
145744193|NCT01500278|525580075|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
145744194|NCT01500278|525580074|FG000|Week 0 - Week 12|Patient decision|1|||
145744195|NCT01500278|525580075|FG001|Week 0 - Week 12|Patient decision|0|||
145744196|NCT01500278|525580074|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
145744197|NCT01500278|525580075|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
145744198|NCT01500278|525580074|FG000|Week 0 - Week 12|Investigator decision|1|||
145744199|NCT01500278|525580075|FG001|Week 0 - Week 12|Investigator decision|0|||
145744200|NCT01500278|525580074|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
145744201|NCT01500278|525580075|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
145744202|NCT01500278|525580074|FG000|Week 0 - Week 12|Sponsor decision|1|||
145744203|NCT01500278|525580075|FG001|Week 0 - Week 12|Sponsor decision|0|||
145744204|NCT01500278|525580074|FG000|Week 0 - Week 12|Personal reason|0|||
145744205|NCT01500278|525580075|FG001|Week 0 - Week 12|Personal reason|1|||
145744206|NCT01500278|525580074|FG000|Week 0 - Week 12|Other serious disease|0|||
145744207|NCT01500278|525580075|FG001|Week 0 - Week 12|Other serious disease|1|||
145744208|NCT01500278|525580074|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
145744209|NCT01500278|525580075|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
145744210|NCT01500278|525580074|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
145744211|NCT01500278|525580075|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
145744212|NCT01500278|525580074|FG000|Week 13 - Week 104|Protocol Violation|6|||
145744213|NCT01500278|525580075|FG001|Week 13 - Week 104|Protocol Violation|6|||
145744214|NCT01500278|525580074|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
145744215|NCT01500278|525580075|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
145744216|NCT01500278|525580074|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
145744217|NCT01500278|525580075|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
145744218|NCT01500278|525580074|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
145744219|NCT01500278|525580075|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
145744220|NCT01500278|525580074|FG000|Week 13 - Week 104|Non/bad compliance|7|||
145744221|NCT01500278|525580075|FG001|Week 13 - Week 104|Non/bad compliance|5|||
145744222|NCT01500278|525580074|FG000|Week 13 - Week 104|Recurrent infections|1|||
145744223|NCT01500278|525580075|FG001|Week 13 - Week 104|Recurrent infections|0|||
145744224|NCT01500278|525580074|FG000|Week 13 - Week 104|False positive test|1|||
145744225|NCT01500278|525580075|FG001|Week 13 - Week 104|False positive test|2|||
145744226|NCT01500278|525580074|FG000|Week 13 - Week 104|Sponsor request|4|||
145744227|NCT01500278|525580075|FG001|Week 13 - Week 104|Sponsor request|0|||
145744228|NCT01500278|525580074|FG000|Week 13 - Week 104|Withdrawn in error|1|||
145744229|NCT01500278|525580075|FG001|Week 13 - Week 104|Withdrawn in error|0|||
145744230|NCT01500278|525580074|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
145744231|NCT01500278|525580075|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
145744232|NCT01500278|525580074|FG000|Week 13 - Week 104|Protocol deviation|1|||
145744233|NCT01500278|525580075|FG001|Week 13 - Week 104|Protocol deviation|0|||
145744234|NCT01500278|525580074|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
145744235|NCT01500278|525580075|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
145744236|NCT01500278|525580074|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
145744237|NCT01500278|525580075|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
145744238|NCT01500278|525580074|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
145744239|NCT01500278|525580075|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
145744240|NCT01500278|525580074|FG000|Week 13 - Week 104|Relocation|0|||
145744241|NCT01500278|525580075|FG001|Week 13 - Week 104|Relocation|1|||
145744242|NCT01500278|525580074|FG000|Week 13 - Week 104|Sponsor decision|0|||
145744243|NCT01500278|525580075|FG001|Week 13 - Week 104|Sponsor decision|2|||
145744244|NCT01500278|525580074|FG000|Week 13 - Week 104|Medical monitor decision|0|||
145522452|NCT04153149|524773287|FG001|Double Blind Period|Withdrawal by Subject|11|||
145744245|NCT01500278|525580075|FG001|Week 13 - Week 104|Medical monitor decision|2|||
145522453|NCT04153149|524773288|FG002|Double Blind Period|Withdrawal by Subject|0|||
145744246|NCT01500278|525580074|FG000|Week 13 - Week 104|Personal reason|0|||
145744247|NCT01500278|525580075|FG001|Week 13 - Week 104|Personal reason|1|||
145744248|NCT01500278|525580074|FG000|Week 13 - Week 104|Not completed|0|||
145744249|NCT01500278|525580075|FG001|Week 13 - Week 104|Not completed|1|||
145744250|NCT01500278|525580074|FG000|Week 13 - Week 104|Death|2|||
145744251|NCT01500278|525580075|FG001|Week 13 - Week 104|Death|4|||
145744252|NCT01500278|525580074|FG000|Week 13 - Week 104|Adverse Event|54|||
145744253|NCT01500278|525580075|FG001|Week 13 - Week 104|Adverse Event|54|||
145744254|NCT00283595|525580076|FG000|Overall Study|Withdrawal by Subject|1|||
145744255|NCT00283595|525580077|FG001|Overall Study|Withdrawal by Subject|2|||
145744256|NCT04718974|525580078|FG000|Overall Study|Death|0|||
145744257|NCT04718974|525580079|FG001|Overall Study|Death|2|||
145744258|NCT04718974|525580078|FG000|Overall Study|Lost to Follow-up|10|||
145744259|NCT04718974|525580079|FG001|Overall Study|Lost to Follow-up|20|||
145744260|NCT04718974|525580078|FG000|Overall Study|Transferred out|2|||
145744261|NCT04718974|525580079|FG001|Overall Study|Transferred out|4|||
145744262|NCT01709435|525580080|FG000|Overall Study|Adverse Event|1|||
145744263|NCT01709435|525580081|FG001|Overall Study|Adverse Event|1|||
145744264|NCT01709435|525580082|FG002|Overall Study|Adverse Event|1|||
145744265|NCT01709435|525580083|FG003|Overall Study|Adverse Event|0|||
145744266|NCT01709435|525580084|FG004|Overall Study|Adverse Event|0|||
145744267|NCT01709435|525580085|FG005|Overall Study|Adverse Event|1|||
145744268|NCT01709435|525580080|FG000|Overall Study|Lack of Efficacy|5|||
145744269|NCT01709435|525580081|FG001|Overall Study|Lack of Efficacy|7|||
145744270|NCT01709435|525580082|FG002|Overall Study|Lack of Efficacy|2|||
145744271|NCT01709435|525580083|FG003|Overall Study|Lack of Efficacy|2|||
145744272|NCT01709435|525580084|FG004|Overall Study|Lack of Efficacy|6|||
145744273|NCT01709435|525580085|FG005|Overall Study|Lack of Efficacy|3|||
145744274|NCT01709435|525580080|FG000|Overall Study|Physician Decision|0|||
145744275|NCT01709435|525580081|FG001|Overall Study|Physician Decision|1|||
145744276|NCT01709435|525580082|FG002|Overall Study|Physician Decision|0|||
145744277|NCT01709435|525580083|FG003|Overall Study|Physician Decision|1|||
145744278|NCT01709435|525580084|FG004|Overall Study|Physician Decision|2|||
145744279|NCT01709435|525580085|FG005|Overall Study|Physician Decision|0|||
145744280|NCT01709435|525580080|FG000|Overall Study|Withdrawal by Subject|0|||
145744281|NCT01709435|525580081|FG001|Overall Study|Withdrawal by Subject|0|||
145744282|NCT01709435|525580082|FG002|Overall Study|Withdrawal by Subject|3|||
145744283|NCT01709435|525580083|FG003|Overall Study|Withdrawal by Subject|0|||
145744284|NCT01709435|525580084|FG004|Overall Study|Withdrawal by Subject|2|||
145744285|NCT01709435|525580085|FG005|Overall Study|Withdrawal by Subject|2|||
145744286|NCT02409290|525580086|FG000|Overall Study|Protocol Violation|3|||
145744287|NCT02409290|525580087|FG001|Overall Study|Protocol Violation|6|||
145744288|NCT02409290|525580088|FG002|Overall Study|Protocol Violation|9|||
145744289|NCT02409290|525580089|FG003|Overall Study|Protocol Violation|4|||
145744290|NCT02409290|525580086|FG000|Overall Study|No positive culture/no baseline sample|3|||
145744291|NCT02409290|525580087|FG001|Overall Study|No positive culture/no baseline sample|9|||
145744292|NCT02409290|525580088|FG002|Overall Study|No positive culture/no baseline sample|6|||
145744293|NCT02409290|525580089|FG003|Overall Study|No positive culture/no baseline sample|5|||
145744294|NCT02409290|525580086|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
145744295|NCT02409290|525580087|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
145744296|NCT02409290|525580088|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
145744297|NCT02409290|525580089|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
145744298|NCT03029143|525580095|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
145744299|NCT03029143|525580096|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
145744300|NCT03029143|525580097|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
145744301|NCT03029143|525580095|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
145270718|NCT03917654|523837938|FG004|Year 2|Withdrawal by Subject|0|||
145522454|NCT04153149|524773289|FG003|Double Blind Period|Withdrawal by Subject|0|||
145522455|NCT04153149|524773286|FG000|Double Blind Period|Adverse Event|6|||
145522456|NCT04153149|524773287|FG001|Double Blind Period|Adverse Event|2|||
145522457|NCT04153149|524773288|FG002|Double Blind Period|Adverse Event|0|||
145522458|NCT04153149|524773289|FG003|Double Blind Period|Adverse Event|0|||
145522459|NCT04153149|524773286|FG000|Double Blind Period|Lost to Follow-up|2|||
145522460|NCT04153149|524773287|FG001|Double Blind Period|Lost to Follow-up|1|||
145522461|NCT04153149|524773288|FG002|Double Blind Period|Lost to Follow-up|0|||
145522462|NCT04153149|524773289|FG003|Double Blind Period|Lost to Follow-up|0|||
145744302|NCT03029143|525580096|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
145744303|NCT03029143|525580097|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
145744304|NCT03029143|525580095|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
145744305|NCT03029143|525580096|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
145744306|NCT03029143|525580097|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
145270719|NCT03917654|523837939|FG005|Year 2|Withdrawal by Subject|0|||
145744307|NCT03029143|525580095|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
145270720|NCT03917654|523837940|FG006|Year 2|Withdrawal by Subject|3|||
145270721|NCT03917654|523837941|FG007|Year 2|Withdrawal by Subject|0|||
145744308|NCT03029143|525580096|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
145744309|NCT03029143|525580097|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
145744310|NCT03029143|525580095|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
145744311|NCT03029143|525580096|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
145744312|NCT03029143|525580097|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
145744313|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
145744314|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
145744315|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
145744316|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
145744317|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
145744318|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
145744319|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145744320|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145744321|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
145744322|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
145744323|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
145744324|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
145744325|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145744326|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
145744327|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
145744328|NCT03029143|525580095|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
145744329|NCT03029143|525580096|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
145744330|NCT03029143|525580097|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
145744331|NCT00974675|525580098|FG000|Overall Study|Adverse Event|2|||
145744332|NCT00974675|525580099|FG001|Overall Study|Adverse Event|1|||
145744333|NCT00974675|525580100|FG002|Overall Study|Adverse Event|1|||
145744334|NCT00974675|525580101|FG003|Overall Study|Adverse Event|1|||
145744335|NCT00974675|525580098|FG000|Overall Study|Physician Decision|0|||
145744336|NCT00974675|525580099|FG001|Overall Study|Physician Decision|0|||
145522463|NCT04153149|524773286|FG000|Double Blind Period|Withdrawal by guardian|0|||
145522464|NCT04153149|524773287|FG001|Double Blind Period|Withdrawal by guardian|2|||
145522465|NCT04153149|524773288|FG002|Double Blind Period|Withdrawal by guardian|0|||
145522466|NCT04153149|524773289|FG003|Double Blind Period|Withdrawal by guardian|0|||
145522467|NCT04153149|524773286|FG000|Double Blind Period|Reason Not Specified|5|||
145522468|NCT04153149|524773287|FG001|Double Blind Period|Reason Not Specified|4|||
145522469|NCT04153149|524773288|FG002|Double Blind Period|Reason Not Specified|0|||
145522470|NCT04153149|524773289|FG003|Double Blind Period|Reason Not Specified|0|||
145522471|NCT04153149|524773286|FG000|Double Blind Period|Physician Decision|2|||
145522472|NCT04153149|524773287|FG001|Double Blind Period|Physician Decision|0|||
145522473|NCT04153149|524773288|FG002|Double Blind Period|Physician Decision|0|||
145522474|NCT04153149|524773289|FG003|Double Blind Period|Physician Decision|0|||
145522475|NCT04153149|524773286|FG000|Open Label Extension Period|Death|0|||
145522476|NCT04153149|524773287|FG001|Open Label Extension Period|Death|0|||
145522477|NCT04153149|524773288|FG002|Open Label Extension Period|Death|7|||
145522478|NCT04153149|524773289|FG003|Open Label Extension Period|Death|3|||
145522479|NCT04153149|524773286|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
145522480|NCT04153149|524773287|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
145522481|NCT04153149|524773288|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
145522482|NCT04153149|524773289|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
145522483|NCT04153149|524773286|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
145522484|NCT04153149|524773287|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
145522485|NCT04153149|524773288|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
145522486|NCT04153149|524773289|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
145522487|NCT04153149|524773286|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
145744337|NCT00974675|525580100|FG002|Overall Study|Physician Decision|1|||
145744338|NCT00974675|525580101|FG003|Overall Study|Physician Decision|0|||
145744339|NCT00974675|525580098|FG000|Overall Study|Participant on holiday; unable to attend|0|||
145522488|NCT04153149|524773287|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
145522489|NCT04153149|524773288|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
145522490|NCT04153149|524773289|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
145522491|NCT02003365|524774428|FG000|Overall Study|Lost to Follow-up|0|||
145522492|NCT02003365|524774429|FG001|Overall Study|Lost to Follow-up|0|||
145522493|NCT02003365|524774430|FG002|Overall Study|Lost to Follow-up|1|||
145522494|NCT00625742|524774431|FG000|Overall Study|Disease Progression|2|||
145522495|NCT00625742|524774431|FG000|Overall Study|Withdrawal by Subject|1|||
145522496|NCT00625742|524774431|FG000|Overall Study|Adverse Event|4|||
145522497|NCT00625742|524774431|FG000|Overall Study|Lost to Follow-up|4|||
145522498|NCT00625742|524774431|FG000|Overall Study|Ineligible|1|||
145522499|NCT00371761|524774432|FG000|Overall Study|Adverse Event|1|||
145522500|NCT00371761|524774433|FG001|Overall Study|Adverse Event|1|||
145522501|NCT00371761|524774432|FG000|Overall Study|Withdrawal by Subject|1|||
145522502|NCT00371761|524774433|FG001|Overall Study|Withdrawal by Subject|3|||
145744340|NCT00974675|525580099|FG001|Overall Study|Participant on holiday; unable to attend|0|||
145744341|NCT00974675|525580100|FG002|Overall Study|Participant on holiday; unable to attend|0|||
145744342|NCT00974675|525580101|FG003|Overall Study|Participant on holiday; unable to attend|1|||
145744343|NCT02121262|525580102|FG000|Overall Study|Adverse Event|6|||
145744344|NCT02121262|525580103|FG001|Overall Study|Adverse Event|3|||
145744345|NCT02121262|525580102|FG000|Overall Study|Lack of Efficacy|3|||
145744346|NCT02121262|525580103|FG001|Overall Study|Lack of Efficacy|0|||
145744347|NCT02121262|525580102|FG000|Overall Study|Personal Reasons|19|||
145744348|NCT02121262|525580103|FG001|Overall Study|Personal Reasons|5|||
145744349|NCT02121262|525580102|FG000|Overall Study|Protocol Violation|1|||
145744350|NCT02121262|525580103|FG001|Overall Study|Protocol Violation|1|||
145744351|NCT02121262|525580102|FG000|Overall Study|Participant Dropped-out|0|||
145744352|NCT02121262|525580103|FG001|Overall Study|Participant Dropped-out|1|||
145744353|NCT02121262|525580102|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
145744354|NCT02121262|525580103|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
145744355|NCT02121262|525580102|FG000|Overall Study|Consent Withdrawn|1|||
145744356|NCT02121262|525580103|FG001|Overall Study|Consent Withdrawn|0|||
145744357|NCT02230384|525580105|FG000|Phase 1|Lost to Follow-up|1|||
145744358|NCT02230384|525580106|FG001|Phase 1|Lost to Follow-up|0|||
145744359|NCT02230384|525580105|FG000|Phase 1|Physician Decision|0|||
145744360|NCT02230384|525580106|FG001|Phase 1|Physician Decision|1|||
145744361|NCT02230384|525580105|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
145744362|NCT02230384|525580106|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
145744363|NCT02230384|525580105|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
145744364|NCT02230384|525580106|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
145744365|NCT02230384|525580105|FG000|Phase 2 - Switch|Adverse Event|2|||
145744366|NCT02230384|525580106|FG001|Phase 2 - Switch|Adverse Event|0|||
145744367|NCT00282334|525580107|FG000|Overall Study|Withdrawal by Subject|8|||
145744368|NCT00282334|525580108|FG001|Overall Study|Withdrawal by Subject|5|||
145744369|NCT00781911|525580116|FG000|Overall Study|Adverse Event|4|||
145744370|NCT00781911|525580117|FG001|Overall Study|Adverse Event|4|||
145744371|NCT00781911|525580116|FG000|Overall Study|Withdrawal by Subject|1|||
145744372|NCT00781911|525580117|FG001|Overall Study|Withdrawal by Subject|2|||
145744373|NCT00781911|525580116|FG000|Overall Study|Physician Decision|0|||
145744374|NCT00781911|525580117|FG001|Overall Study|Physician Decision|2|||
145744375|NCT00781911|525580116|FG000|Overall Study|Sponsor Decision|1|||
145744376|NCT00781911|525580117|FG001|Overall Study|Sponsor Decision|0|||
145744377|NCT03317795|525580122|FG000|Overall Study|IUD Expulsion|1|||
145744378|NCT03317795|525580123|FG001|Overall Study|IUD Expulsion|0|||
145744379|NCT03317795|525580122|FG000|Overall Study|Lost to Follow-up|1|||
145744380|NCT03317795|525580123|FG001|Overall Study|Lost to Follow-up|3|||
145744381|NCT03317795|525580122|FG000|Overall Study|Treatment change|0|||
145744382|NCT03317795|525580123|FG001|Overall Study|Treatment change|3|||
145744383|NCT03317795|525580122|FG000|Overall Study|Intolerance of medication|0|||
145744384|NCT03317795|525580123|FG001|Overall Study|Intolerance of medication|1|||
145744385|NCT00501007|525580126|FG000|Overall Study|Inclusion criteria not met.|29|||
145744386|NCT00501007|525580127|FG001|Overall Study|Inclusion criteria not met.|25|||
145744387|NCT00135668|525580128|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
145744388|NCT00135668|525580129|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
145744389|NCT00135668|525580130|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
145744390|NCT00135668|525580131|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
145744391|NCT01892163|525580136|FG000|Overall Study|Death|1|||
145744392|NCT01892163|525580137|FG001|Overall Study|Death|1|||
145744393|NCT01892163|525580136|FG000|Overall Study|Lost to Follow-up|1|||
145744394|NCT01892163|525580137|FG001|Overall Study|Lost to Follow-up|0|||
145744395|NCT02577146|525580138|FG000|Overall Study|Lost to Follow-up|8|||
145744396|NCT02577146|525580138|FG000|Overall Study|Physician Decision|3|||
145744397|NCT02577146|525580138|FG000|Overall Study|Screen Failure|17|||
145744398|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
145744399|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
145744400|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
145744401|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
145744402|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
145744403|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
145744404|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
145270722|NCT03917654|523837942|FG008|Year 2|Withdrawal by Subject|2|||
145744405|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
145744406|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to death|4|||
145744407|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to death|3|||
145744408|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
145744409|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
145744410|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
145744411|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
145744412|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
145744413|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
145744414|NCT02258451|525580143|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
145744415|NCT02258451|525580144|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
145744416|NCT02258451|525580143|FG000|Overall Study|Other reason|1|||
145744417|NCT02258451|525580144|FG001|Overall Study|Other reason|1|||
145744418|NCT02258451|525580143|FG000|Overall Study|Never treated|2|||
145744419|NCT02258451|525580144|FG001|Overall Study|Never treated|3|||
145744420|NCT03021499|525580145|FG000|Overall Study|Adverse Event|1|||
145744421|NCT03021499|525580146|FG001|Overall Study|Adverse Event|0|||
145744422|NCT03021499|525580145|FG000|Overall Study|Death|1|||
145744423|NCT03021499|525580146|FG001|Overall Study|Death|5|||
145744424|NCT03021499|525580145|FG000|Overall Study|Lack of Efficacy|0|||
145744425|NCT03021499|525580146|FG001|Overall Study|Lack of Efficacy|1|||
145744426|NCT03021499|525580145|FG000|Overall Study|Lost to Follow-up|1|||
145744427|NCT03021499|525580146|FG001|Overall Study|Lost to Follow-up|3|||
145744428|NCT03021499|525580145|FG000|Overall Study|Physician Decision|2|||
145744429|NCT03021499|525580146|FG001|Overall Study|Physician Decision|3|||
145744430|NCT03021499|525580145|FG000|Overall Study|Pregnancy|1|||
145744431|NCT03021499|525580146|FG001|Overall Study|Pregnancy|0|||
145744432|NCT03021499|525580145|FG000|Overall Study|Withdrawal by Subject|7|||
145744433|NCT03021499|525580146|FG001|Overall Study|Withdrawal by Subject|14|||
145744434|NCT03021499|525580145|FG000|Overall Study|Prohibited medication required|1|||
145744435|NCT03021499|525580146|FG001|Overall Study|Prohibited medication required|0|||
145744436|NCT03021499|525580145|FG000|Overall Study|Protocol non-compliance|1|||
145744437|NCT03021499|525580146|FG001|Overall Study|Protocol non-compliance|1|||
145744438|NCT03021499|525580145|FG000|Overall Study|None of the above|0|||
145744439|NCT03021499|525580146|FG001|Overall Study|None of the above|4|||
145744440|NCT03021499|525580145|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
145744441|NCT03021499|525580146|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
145744442|NCT01210690|525580147|FG000|Overall Study|Adverse Event|7|||
145744443|NCT01210690|525580147|FG000|Overall Study|Lack of Efficacy|12|||
145744444|NCT01210690|525580147|FG000|Overall Study|Lost to Follow-up|3|||
145744445|NCT01210690|525580147|FG000|Overall Study|Disease Remission|1|||
145744446|NCT01210690|525580147|FG000|Overall Study|Withdrawal by Subject|1|||
145744447|NCT01210690|525580147|FG000|Overall Study|Patient refused to swallow|1|||
145744448|NCT01210690|525580147|FG000|Overall Study|Patient could not take glucose|1|||
145744449|NCT00470054|525580148|FG000|Overall Study|Ineligible|1|||
145744450|NCT00820950|525580149|FG000|Overall Study|Scheduling Conflict|0|||
145744451|NCT00820950|525580150|FG001|Overall Study|Scheduling Conflict|0|||
145744452|NCT00820950|525580151|FG002|Overall Study|Scheduling Conflict|0|||
145744453|NCT00820950|525580152|FG003|Overall Study|Scheduling Conflict|0|||
145744454|NCT00820950|525580153|FG004|Overall Study|Scheduling Conflict|0|||
145744455|NCT00820950|525580154|FG005|Overall Study|Scheduling Conflict|0|||
145744456|NCT00820950|525580155|FG006|Overall Study|Scheduling Conflict|1|||
145744457|NCT00820950|525580156|FG007|Overall Study|Scheduling Conflict|1|||
145744458|NCT00820950|525580157|FG008|Overall Study|Scheduling Conflict|0|||
145744459|NCT00820950|525580158|FG009|Overall Study|Scheduling Conflict|0|||
145744460|NCT00820950|525580149|FG000|Overall Study|Protocol Violation|1|||
145744461|NCT00820950|525580150|FG001|Overall Study|Protocol Violation|1|||
145744462|NCT00820950|525580151|FG002|Overall Study|Protocol Violation|0|||
145744463|NCT00820950|525580152|FG003|Overall Study|Protocol Violation|0|||
145744464|NCT00820950|525580153|FG004|Overall Study|Protocol Violation|0|||
145522503|NCT00371761|524774432|FG000|Overall Study|Investigator Judgment|2|||
145522504|NCT00371761|524774433|FG001|Overall Study|Investigator Judgment|3|||
145522505|NCT00371761|524774432|FG000|Overall Study|Study termination|4|||
145522506|NCT00371761|524774433|FG001|Overall Study|Study termination|3|||
145522507|NCT05040971|524774435|FG000|Overall Study|Withdrawal by Subject|0|||
145744465|NCT00820950|525580154|FG005|Overall Study|Protocol Violation|0|||
145744466|NCT00820950|525580155|FG006|Overall Study|Protocol Violation|0|||
145744467|NCT00820950|525580156|FG007|Overall Study|Protocol Violation|0|||
145744468|NCT00820950|525580157|FG008|Overall Study|Protocol Violation|0|||
145744469|NCT00820950|525580158|FG009|Overall Study|Protocol Violation|0|||
145744470|NCT00528021|525580161|FG000|Overall Study|Lack of Efficacy|17|||
145744471|NCT00528021|525580162|FG001|Overall Study|Lack of Efficacy|13|||
145744472|NCT00528021|525580163|FG002|Overall Study|Lack of Efficacy|7|||
145744473|NCT00528021|525580164|FG003|Overall Study|Lack of Efficacy|9|||
145744474|NCT05264740|525580165|FG000|Baseline|Withdrawal by Subject|0|||
145744475|NCT05264740|525580166|FG001|Baseline|Withdrawal by Subject|1|||
145744476|NCT05264740|525580165|FG000|Follow Up 1|Lost to Follow-up|1|||
145744477|NCT05264740|525580166|FG001|Follow Up 1|Lost to Follow-up|1|||
145744478|NCT05264740|525580165|FG000|Follow Up 1|Withdrawal by Subject|0|||
145744479|NCT05264740|525580166|FG001|Follow Up 1|Withdrawal by Subject|1|||
145744480|NCT05264740|525580165|FG000|Follow Up 2|Lost to Follow-up|1|||
145744481|NCT05264740|525580166|FG001|Follow Up 2|Lost to Follow-up|4|||
145744482|NCT05264740|525580165|FG000|Follow Up 3|Lost to Follow-up|7|||
145744483|NCT05264740|525580166|FG001|Follow Up 3|Lost to Follow-up|4|||
145744484|NCT00733954|525580168|FG000|Overall Study|Lost to Follow-up|5|||
145744485|NCT00733954|525580169|FG001|Overall Study|Lost to Follow-up|2|||
145744486|NCT00733954|525580168|FG000|Overall Study|Protocol Violation|1|||
145744487|NCT00733954|525580169|FG001|Overall Study|Protocol Violation|0|||
145744488|NCT00733954|525580168|FG000|Overall Study|Withdrawal by Subject|2|||
145744489|NCT00733954|525580169|FG001|Overall Study|Withdrawal by Subject|0|||
145744490|NCT02663453|525580170|FG000|Overall Study|Death|4|||
145744491|NCT02663453|525580171|FG001|Overall Study|Death|4|||
145744492|NCT02663453|525580170|FG000|Overall Study|Withdrawal by Subject|1|||
145744493|NCT02663453|525580171|FG001|Overall Study|Withdrawal by Subject|0|||
145744494|NCT01146873|525581578|FG000|Overall Study|Transfer out|0|||
145744495|NCT01146873|525581579|FG001|Overall Study|Transfer out|6|||
145744496|NCT01967628|525581580|FG000|Overall Study|Withdrawal by Subject|2|||
145744497|NCT01967628|525581581|FG001|Overall Study|Withdrawal by Subject|0|||
145744498|NCT01967628|525581580|FG000|Overall Study|Unable to complete bronchoscopy|4|||
145744499|NCT01967628|525581581|FG001|Overall Study|Unable to complete bronchoscopy|6|||
145744500|NCT01967628|525581580|FG000|Overall Study|Lost to Follow-up|1|||
145744501|NCT01967628|525581581|FG001|Overall Study|Lost to Follow-up|0|||
145744502|NCT01967628|525581580|FG000|Overall Study|Low protein concentration in sample|20|||
145744503|NCT01967628|525581581|FG001|Overall Study|Low protein concentration in sample|25|||
145744504|NCT00838331|525581582|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
145744505|NCT03200366|525581585|FG000|Patient Navigation Intervention Given|Death|0|||
145744506|NCT03200366|525581586|FG001|Patient Navigation Intervention Given|Death|2|||
145744507|NCT03200366|525581587|FG002|Patient Navigation Intervention Given|Death|0|||
145744508|NCT03200366|525581585|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
145744509|NCT03200366|525581586|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
145744510|NCT03200366|525581587|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
145744511|NCT03200366|525581585|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
145744512|NCT03200366|525581586|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
145744513|NCT03200366|525581587|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
145744514|NCT03200366|525581585|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
145744515|NCT03200366|525581586|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
145744516|NCT03200366|525581587|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
145744517|NCT03200366|525581585|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
145744518|NCT03200366|525581586|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
145744519|NCT03200366|525581587|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
145744520|NCT03200366|525581585|FG000|6 Month Post-Baseline Interview|Death|1|||
145744521|NCT03200366|525581586|FG001|6 Month Post-Baseline Interview|Death|1|||
145744522|NCT03200366|525581587|FG002|6 Month Post-Baseline Interview|Death|1|||
145744523|NCT03200366|525581585|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
145744524|NCT03200366|525581586|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
145744525|NCT03200366|525581587|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
145744526|NCT03200366|525581585|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
145744527|NCT03200366|525581586|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
145270723|NCT03917654|523837943|FG009|Year 2|Withdrawal by Subject|5|||
145270724|NCT03917654|523837944|FG010|Year 2|Withdrawal by Subject|0|||
145270725|NCT03917654|523837945|FG011|Year 2|Withdrawal by Subject|0|||
145270726|NCT03917654|523837934|FG000|Year 2|Spouse/family member request|0|||
145270727|NCT03917654|523837935|FG001|Year 2|Spouse/family member request|0|||
145270728|NCT03917654|523837936|FG002|Year 2|Spouse/family member request|0|||
145270729|NCT03917654|523837937|FG003|Year 2|Spouse/family member request|0|||
145270730|NCT03917654|523837938|FG004|Year 2|Spouse/family member request|0|||
145270731|NCT03917654|523837939|FG005|Year 2|Spouse/family member request|0|||
145270732|NCT03917654|523837940|FG006|Year 2|Spouse/family member request|1|||
145270733|NCT03917654|523837941|FG007|Year 2|Spouse/family member request|0|||
145402465|NCT00784875|524330733|FG000|Period C|Physician Decision|0|||
145522508|NCT05040971|524774436|FG001|Overall Study|Withdrawal by Subject|2|||
145744528|NCT03200366|525581587|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
145744529|NCT03200366|525581585|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
145744530|NCT03200366|525581586|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
145270734|NCT03917654|523837942|FG008|Year 2|Spouse/family member request|0|||
145402466|NCT00784875|524330734|FG001|Period C|Physician Decision|0|||
145744531|NCT03200366|525581587|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
145744532|NCT03200366|525581585|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
145744533|NCT03200366|525581586|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
145744534|NCT03200366|525581587|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
145744535|NCT03200366|525581585|FG000|9 Month Post-Baseline Interview|Death|1|||
145744536|NCT03200366|525581586|FG001|9 Month Post-Baseline Interview|Death|1|||
145744537|NCT03200366|525581587|FG002|9 Month Post-Baseline Interview|Death|1|||
145744538|NCT03200366|525581585|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
145744539|NCT03200366|525581586|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
145744540|NCT03200366|525581587|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
145744541|NCT03200366|525581585|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
145744542|NCT03200366|525581586|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
145744543|NCT03200366|525581587|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
145744544|NCT03200366|525581585|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
145744545|NCT03200366|525581586|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
145744546|NCT03200366|525581587|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
145744547|NCT04677959|525581588|FG000|Overall Study|Adverse Event|1|||
145744548|NCT04677959|525581589|FG001|Overall Study|Adverse Event|9|||
145744549|NCT04677959|525581588|FG000|Overall Study|Withdrawal by Subject|2|||
145744550|NCT04677959|525581589|FG001|Overall Study|Withdrawal by Subject|15|||
145744551|NCT04677959|525581588|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145744552|NCT04677959|525581589|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145744553|NCT04677959|525581588|FG000|Overall Study|Non-compliance with study drug|0|||
145744554|NCT04677959|525581589|FG001|Overall Study|Non-compliance with study drug|2|||
145744555|NCT04677959|525581588|FG000|Overall Study|Protocol deviation|0|||
145744556|NCT04677959|525581589|FG001|Overall Study|Protocol deviation|11|||
145744557|NCT04677959|525581588|FG000|Overall Study|Lost to Follow-up|9|||
145744558|NCT04677959|525581589|FG001|Overall Study|Lost to Follow-up|13|||
145744559|NCT04677959|525581588|FG000|Overall Study|Other than specified|0|||
145744560|NCT04677959|525581589|FG001|Overall Study|Other than specified|8|||
145744561|NCT01074190|525581590|FG000|Overall Study|Emergency Cesarean Delivery|1|||
145744562|NCT01074190|525581591|FG001|Overall Study|Emergency Cesarean Delivery|2|||
145744563|NCT01074190|525581592|FG002|Overall Study|Emergency Cesarean Delivery|1|||
145744564|NCT01074190|525581590|FG000|Overall Study|Protocol Violation|2|||
145744565|NCT01074190|525581591|FG001|Overall Study|Protocol Violation|1|||
145744566|NCT01074190|525581592|FG002|Overall Study|Protocol Violation|0|||
145744567|NCT01074190|525581590|FG000|Overall Study|Delivered in under 90 minutes|0|||
145744568|NCT01074190|525581591|FG001|Overall Study|Delivered in under 90 minutes|2|||
145744569|NCT01074190|525581592|FG002|Overall Study|Delivered in under 90 minutes|1|||
145744570|NCT01074190|525581590|FG000|Overall Study|Subject withdrew consent|1|||
145744571|NCT01074190|525581591|FG001|Overall Study|Subject withdrew consent|1|||
145744572|NCT01074190|525581592|FG002|Overall Study|Subject withdrew consent|1|||
145744573|NCT00732303|525581593|FG000|Overall Study|Study Terminated|2|||
145744574|NCT00264875|525581600|FG000|Overall Study|Adverse Event|6|||
145744575|NCT00264875|525581600|FG000|Overall Study|Lost to Follow-up|6|||
145744576|NCT00264875|525581600|FG000|Overall Study|Protocol Violation|11|||
145744577|NCT00264875|525581600|FG000|Overall Study|Withdrawal by Subject|7|||
145744578|NCT01394627|525581604|FG000|First Intervention (1 Day)|poor intravenous access|0|||
145744579|NCT01394627|525581605|FG001|First Intervention (1 Day)|poor intravenous access|1|||
145744580|NCT01394627|525581604|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
145744581|NCT01394627|525581605|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
145744582|NCT03223428|525581606|FG000|Overall Study|No longer taking Xermelo|27|||
145744583|NCT03223428|525581606|FG000|Overall Study|Declined Consent|1|||
145744584|NCT03223428|525581606|FG000|Overall Study|Non-responders|56|||
145744585|NCT03223428|525581606|FG000|Overall Study|Withdrawal by Subject|14|||
145744586|NCT03917823|525581608|FG000|Overall Study|Lost to Follow-up|1|||
145744587|NCT03917823|525581609|FG001|Overall Study|Lost to Follow-up|1|||
145744588|NCT03917823|525581608|FG000|Overall Study|Withdrawal by Subject|0|||
145744589|NCT03917823|525581609|FG001|Overall Study|Withdrawal by Subject|1|||
145744590|NCT02424253|525581612|FG000|Overall Study|Other, unspecified|1|||
145744591|NCT02424253|525581613|FG001|Overall Study|Other, unspecified|0|||
145744592|NCT02424253|525581612|FG000|Overall Study|Compliance problems|1|||
145744593|NCT02424253|525581613|FG001|Overall Study|Compliance problems|0|||
145744594|NCT02424253|525581612|FG000|Overall Study|Physician Decision|2|||
145744595|NCT02424253|525581613|FG001|Overall Study|Physician Decision|0|||
145744596|NCT02424253|525581612|FG000|Overall Study|Lack of Efficacy|0|||
145744597|NCT02424253|525581613|FG001|Overall Study|Lack of Efficacy|7|||
145744598|NCT02424253|525581612|FG000|Overall Study|Adverse Event|2|||
145744599|NCT02424253|525581613|FG001|Overall Study|Adverse Event|0|||
145744600|NCT02424253|525581612|FG000|Overall Study|Consent withdrawn by subject|4|||
145744601|NCT02424253|525581613|FG001|Overall Study|Consent withdrawn by subject|1|||
145744602|NCT02424253|525581612|FG000|Overall Study|Lost to Follow-up|1|||
145744603|NCT02424253|525581613|FG001|Overall Study|Lost to Follow-up|1|||
145744604|NCT02290873|525581616|FG000|Overall Study|Withdrawal by Subject|0|||
145744605|NCT02290873|525581617|FG001|Overall Study|Withdrawal by Subject|1|||
145744606|NCT02290873|525581618|FG002|Overall Study|Withdrawal by Subject|1|||
145744607|NCT02290873|525581616|FG000|Overall Study|Nellcor device error|1|||
145744608|NCT02290873|525581617|FG001|Overall Study|Nellcor device error|0|||
145744609|NCT02290873|525581618|FG002|Overall Study|Nellcor device error|0|||
145744610|NCT02290873|525581616|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
145744611|NCT02290873|525581617|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
145744612|NCT02290873|525581618|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
145744613|NCT02290873|525581616|FG000|Overall Study|Protocol Violation|0|||
145744614|NCT02290873|525581617|FG001|Overall Study|Protocol Violation|0|||
145744615|NCT02290873|525581618|FG002|Overall Study|Protocol Violation|1|||
145744616|NCT01378104|525581621|FG000|Overall Study|Adverse Event|8|||
145744617|NCT01378104|525581622|FG001|Overall Study|Adverse Event|8|||
145744618|NCT01378104|525581621|FG000|Overall Study|Lack of Efficacy|7|||
145744619|NCT01378104|525581622|FG001|Overall Study|Lack of Efficacy|5|||
145744620|NCT01378104|525581621|FG000|Overall Study|Withdrawal by Subject|12|||
145744621|NCT01378104|525581622|FG001|Overall Study|Withdrawal by Subject|13|||
145744622|NCT02700997|525581623|FG000|Overall Study|Did not undergo CT imaging|1|||
145744623|NCT02700997|525581623|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
145744624|NCT00455013|525581627|FG000|Short Term Period|Adverse Event|2|||
145744625|NCT00455013|525581628|FG001|Short Term Period|Adverse Event|5|||
145744626|NCT00455013|525581629|FG002|Short Term Period|Adverse Event|0|||
145744627|NCT00455013|525581627|FG000|Short Term Period|Withdrawal by Subject|0|||
145744628|NCT00455013|525581628|FG001|Short Term Period|Withdrawal by Subject|0|||
145744629|NCT00455013|525581629|FG002|Short Term Period|Withdrawal by Subject|1|||
145744630|NCT00455013|525581627|FG000|Short Term Period|Lack of Efficacy|4|||
145744631|NCT00455013|525581628|FG001|Short Term Period|Lack of Efficacy|0|||
145744632|NCT00455013|525581629|FG002|Short Term Period|Lack of Efficacy|0|||
145744633|NCT00455013|525581627|FG000|Short Term Period|Other|0|||
145744634|NCT00455013|525581628|FG001|Short Term Period|Other|0|||
145744635|NCT00455013|525581629|FG002|Short Term Period|Other|1|||
145744636|NCT00455013|525581627|FG000|Long Term Extension (LTE)|Adverse Event|0|||
145744637|NCT00455013|525581628|FG001|Long Term Extension (LTE)|Adverse Event|1|||
145744638|NCT00455013|525581629|FG002|Long Term Extension (LTE)|Adverse Event|1|||
145744639|NCT00455013|525581627|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
145744640|NCT00455013|525581628|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
145744641|NCT00455013|525581629|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
145744642|NCT00455013|525581627|FG000|Long Term Extension (LTE)|Death|1|||
145744643|NCT00455013|525581628|FG001|Long Term Extension (LTE)|Death|1|||
145744644|NCT00455013|525581629|FG002|Long Term Extension (LTE)|Death|0|||
145744645|NCT00455013|525581627|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
145744646|NCT00455013|525581628|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
145744647|NCT00455013|525581629|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
145744648|NCT00455013|525581627|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
145744649|NCT00455013|525581628|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
145744650|NCT00455013|525581629|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
145744651|NCT00455013|525581627|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
145744652|NCT00455013|525581628|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
145744653|NCT00455013|525581629|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
145744654|NCT00455013|525581627|FG000|Long Term Extension (LTE)|non-specified|0|||
145744655|NCT00455013|525581628|FG001|Long Term Extension (LTE)|non-specified|0|||
145744656|NCT00455013|525581629|FG002|Long Term Extension (LTE)|non-specified|1|||
145744657|NCT01445951|525581630|FG000|Overall Study|Adverse Event|16|||
145522509|NCT05040971|524774435|FG000|Overall Study|Lost to Follow-up|8|||
145522510|NCT05040971|524774436|FG001|Overall Study|Lost to Follow-up|3|||
145522511|NCT05040971|524774435|FG000|Overall Study|Death|2|||
145522512|NCT05040971|524774436|FG001|Overall Study|Death|0|||
145522513|NCT02241889|524774442|FG000|Overall Study|device issues|0|||
145522514|NCT02241889|524774443|FG001|Overall Study|device issues|0|||
145522515|NCT02241889|524774444|FG002|Overall Study|device issues|1|||
145744658|NCT01445951|525581631|FG001|Overall Study|Adverse Event|9|||
145744659|NCT01445951|525581632|FG002|Overall Study|Adverse Event|0|||
145744660|NCT01445951|525581630|FG000|Overall Study|Protocol Violation|2|||
145744661|NCT01445951|525581631|FG001|Overall Study|Protocol Violation|2|||
145744662|NCT01445951|525581632|FG002|Overall Study|Protocol Violation|2|||
145744663|NCT01445951|525581630|FG000|Overall Study|Withdrawal by Subject|21|||
145744664|NCT01445951|525581631|FG001|Overall Study|Withdrawal by Subject|16|||
145744665|NCT01445951|525581632|FG002|Overall Study|Withdrawal by Subject|8|||
145744666|NCT01445951|525581630|FG000|Overall Study|Physician Decision|3|||
145744667|NCT01445951|525581631|FG001|Overall Study|Physician Decision|1|||
145744668|NCT01445951|525581632|FG002|Overall Study|Physician Decision|0|||
145744669|NCT01445951|525581630|FG000|Overall Study|Lost to Follow-up|1|||
145744670|NCT01445951|525581631|FG001|Overall Study|Lost to Follow-up|2|||
145522516|NCT02241889|524774445|FG003|Overall Study|device issues|0|||
145522517|NCT02241889|524774446|FG004|Overall Study|device issues|0|||
145522518|NCT02241889|524774447|FG005|Overall Study|device issues|0|||
145744671|NCT01445951|525581632|FG002|Overall Study|Lost to Follow-up|4|||
145744672|NCT01445951|525581630|FG000|Overall Study|Pregnancy|0|||
145744673|NCT01445951|525581631|FG001|Overall Study|Pregnancy|1|||
145744674|NCT01445951|525581632|FG002|Overall Study|Pregnancy|4|||
145744675|NCT01445951|525581630|FG000|Overall Study|Death|0|||
145744676|NCT01445951|525581631|FG001|Overall Study|Death|0|||
145744677|NCT01445951|525581632|FG002|Overall Study|Death|1|||
145744678|NCT01445951|525581630|FG000|Overall Study|Non-compliance with study drug|1|||
145744679|NCT01445951|525581631|FG001|Overall Study|Non-compliance with study drug|2|||
145744680|NCT01445951|525581632|FG002|Overall Study|Non-compliance with study drug|0|||
145744681|NCT01445951|525581630|FG000|Overall Study|Non-compliance with protocol|0|||
145744682|NCT01445951|525581631|FG001|Overall Study|Non-compliance with protocol|1|||
145744683|NCT01445951|525581632|FG002|Overall Study|Non-compliance with protocol|0|||
145744684|NCT01445951|525581630|FG000|Overall Study|Sponsor decision - subject travel|0|||
145744685|NCT01445951|525581631|FG001|Overall Study|Sponsor decision - subject travel|1|||
145744686|NCT01445951|525581632|FG002|Overall Study|Sponsor decision - subject travel|0|||
145744687|NCT01445951|525581630|FG000|Overall Study|Cough|0|||
145744688|NCT01445951|525581631|FG001|Overall Study|Cough|1|||
145744689|NCT01445951|525581632|FG002|Overall Study|Cough|0|||
145744690|NCT00078325|525581635|FG000|Overall Study|Adverse Event|15|||
145744691|NCT00078325|525581636|FG001|Overall Study|Adverse Event|10|||
145744692|NCT00078325|525581637|FG002|Overall Study|Adverse Event|5|||
145744693|NCT00078325|525581635|FG000|Overall Study|Protocol Violation|2|||
145744694|NCT00078325|525581636|FG001|Overall Study|Protocol Violation|2|||
145744695|NCT00078325|525581637|FG002|Overall Study|Protocol Violation|0|||
145744696|NCT00078325|525581635|FG000|Overall Study|Withdrawal by Subject|1|||
145744697|NCT00078325|525581636|FG001|Overall Study|Withdrawal by Subject|5|||
145744698|NCT00078325|525581637|FG002|Overall Study|Withdrawal by Subject|3|||
145744699|NCT00078325|525581635|FG000|Overall Study|Lost to Follow-up|0|||
145744700|NCT00078325|525581636|FG001|Overall Study|Lost to Follow-up|1|||
145744701|NCT00078325|525581637|FG002|Overall Study|Lost to Follow-up|1|||
145744702|NCT00078325|525581635|FG000|Overall Study|Physician Decision|2|||
145744703|NCT00078325|525581636|FG001|Overall Study|Physician Decision|0|||
145744704|NCT00078325|525581637|FG002|Overall Study|Physician Decision|1|||
145744705|NCT00078325|525581635|FG000|Overall Study|Miscellaneous|1|||
145744706|NCT00078325|525581636|FG001|Overall Study|Miscellaneous|1|||
145744707|NCT00078325|525581637|FG002|Overall Study|Miscellaneous|1|||
145744708|NCT01519765|525581638|FG000|Overall Study|Adverse Event|0|||
145744709|NCT01519765|525581639|FG001|Overall Study|Adverse Event|1|||
145744710|NCT01519765|525581638|FG000|Overall Study|Lack of Efficacy|2|||
145744711|NCT01519765|525581639|FG001|Overall Study|Lack of Efficacy|0|||
145744712|NCT01519765|525581638|FG000|Overall Study|Protocol Violation|1|||
145744713|NCT01519765|525581639|FG001|Overall Study|Protocol Violation|0|||
145744714|NCT01519765|525581638|FG000|Overall Study|Withdrawal by Subject|0|||
145744715|NCT01519765|525581639|FG001|Overall Study|Withdrawal by Subject|1|||
145744716|NCT02739620|525581640|FG000|Overall Study|Lost to Follow-up|3|||
145744717|NCT02739620|525581641|FG001|Overall Study|Lost to Follow-up|1|||
145744718|NCT02739620|525581640|FG000|Overall Study|Adverse Event|0|||
145744719|NCT02739620|525581641|FG001|Overall Study|Adverse Event|1|||
145744720|NCT04126083|525581642|FG000|Overall Study|Withdrawal by Subject|1|||
145522519|NCT02241889|524774442|FG000|Overall Study|Withdrawal by Subject|0|||
145522520|NCT02241889|524774443|FG001|Overall Study|Withdrawal by Subject|0|||
145522521|NCT02241889|524774444|FG002|Overall Study|Withdrawal by Subject|0|||
145522522|NCT02241889|524774445|FG003|Overall Study|Withdrawal by Subject|0|||
145522523|NCT02241889|524774446|FG004|Overall Study|Withdrawal by Subject|0|||
145522524|NCT02241889|524774447|FG005|Overall Study|Withdrawal by Subject|1|||
145744721|NCT02354222|525581643|FG000|Overall Study|Adverse Event|0|||
145744722|NCT02354222|525581644|FG001|Overall Study|Adverse Event|3|||
145744723|NCT02354222|525581643|FG000|Overall Study|Physician Decision|1|||
145744724|NCT02354222|525581644|FG001|Overall Study|Physician Decision|1|||
145744725|NCT02354222|525581643|FG000|Overall Study|Pregnancy|1|||
145744726|NCT02354222|525581644|FG001|Overall Study|Pregnancy|0|||
145744727|NCT02354222|525581643|FG000|Overall Study|Withdrawal by Subject|2|||
145744728|NCT02354222|525581644|FG001|Overall Study|Withdrawal by Subject|3|||
145744729|NCT02354222|525581643|FG000|Overall Study|Conflict with the stopping criteria|0|||
145744730|NCT02354222|525581644|FG001|Overall Study|Conflict with the stopping criteria|4|||
145744731|NCT00786565|525581648|FG000|Enrollment Prior to Surgery|Site Closed|3|||
145522525|NCT00773838|524774448|FG000|Overall Study|Adverse Event|29|||
145744732|NCT00786565|525581648|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
145744733|NCT00786565|525581648|FG000|Post Surgery|Abnormal macular pucker|1|||
145744734|NCT00786565|525581648|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
145744735|NCT00578136|525581649|FG000|Overall Study|Not given intervention|1|||
145744736|NCT00578136|525581650|FG001|Overall Study|Not given intervention|1|||
145744737|NCT00754793|525581654|FG000|Overall Study|voluntary withdrawn from study|0|||
145744738|NCT00754793|525581655|FG001|Overall Study|voluntary withdrawn from study|1|||
145522526|NCT00773838|524774448|FG000|Overall Study|Lost to Follow-up|1|||
145744739|NCT00932360|525581657|FG000|Washout (One Week)|Withdrawal by Subject|0|||
145744740|NCT00932360|525581658|FG001|Washout (One Week)|Withdrawal by Subject|0|||
145744741|NCT00932360|525581659|FG002|Washout (One Week)|Withdrawal by Subject|0|||
145744742|NCT00932360|525581660|FG003|Washout (One Week)|Withdrawal by Subject|0|||
145744743|NCT00932360|525581661|FG004|Washout (One Week)|Withdrawal by Subject|2|||
145744744|NCT00932360|525581662|FG005|Washout (One Week)|Withdrawal by Subject|0|||
145744745|NCT02536313|525581663|FG000|Overall Study|Lack of Efficacy|0|||
145522527|NCT00773838|524774448|FG000|Overall Study|Physician Decision|8|||
145522528|NCT00773838|524774448|FG000|Overall Study|Progressive Disease|82|||
145522529|NCT00773838|524774448|FG000|Overall Study|Protocol Violation|2|||
145522530|NCT00773838|524774448|FG000|Overall Study|Withdrawal by Subject|21|||
145522531|NCT01853618|524774451|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
145522532|NCT01853618|524774452|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
145522533|NCT01853618|524774453|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
145522534|NCT01853618|524774454|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
145522535|NCT01853618|524774455|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
145522536|NCT01853618|524774451|FG000|Overall Study|Progressive disease|1|||
145522537|NCT01853618|524774452|FG001|Overall Study|Progressive disease|1|||
145744746|NCT02536313|525581664|FG001|Overall Study|Lack of Efficacy|1|||
145744747|NCT02437864|525581670|FG000|Overall Study|Protocol Violation|4|||
145744748|NCT02437864|525581671|FG001|Overall Study|Protocol Violation|0|||
145744749|NCT00645593|525581673|FG000|Overall Study|Later found to be ineligible|1|||
145744750|NCT00645593|525581674|FG001|Overall Study|Later found to be ineligible|0|||
145744751|NCT01585272|525581675|FG000|Overall Study|Adverse Event|22|||
145744752|NCT01585272|525581675|FG000|Overall Study|Protocol Violation|7|||
145744753|NCT01585272|525581675|FG000|Overall Study|Withdrawal by Subject|10|||
145744754|NCT00993265|525581680|FG000|Overall Study|Adverse Event|1|||
145744755|NCT00993265|525581681|FG001|Overall Study|Adverse Event|0|||
145744756|NCT00993265|525581680|FG000|Overall Study|Changed dose of concomitant drug|2|||
145744757|NCT00993265|525581681|FG001|Overall Study|Changed dose of concomitant drug|0|||
145744758|NCT00993265|525581680|FG000|Overall Study|Non-compliant with study medication|1|||
145744759|NCT00993265|525581681|FG001|Overall Study|Non-compliant with study medication|0|||
145744760|NCT03765138|525581682|FG000|Overall Study|Lost to Follow-up|1|||
145744761|NCT00361270|525581683|FG000|Overall Study|Death|0|||
145744762|NCT00361270|525581684|FG001|Overall Study|Death|0|||
145744763|NCT00361270|525581685|FG002|Overall Study|Death|0|||
145744764|NCT00361270|525581686|FG003|Overall Study|Death|2|||
145744765|NCT00361270|525581683|FG000|Overall Study|Lost to Follow-up|4|||
145744766|NCT00361270|525581684|FG001|Overall Study|Lost to Follow-up|1|||
145744767|NCT00361270|525581685|FG002|Overall Study|Lost to Follow-up|0|||
145744768|NCT00361270|525581686|FG003|Overall Study|Lost to Follow-up|0|||
145744769|NCT00361270|525581683|FG000|Overall Study|Physician Decision|0|||
145744770|NCT00361270|525581684|FG001|Overall Study|Physician Decision|0|||
145744771|NCT00361270|525581685|FG002|Overall Study|Physician Decision|1|||
145744772|NCT00361270|525581686|FG003|Overall Study|Physician Decision|0|||
145744773|NCT00361270|525581683|FG000|Overall Study|Protocol Violation|9|||
145744774|NCT00361270|525581684|FG001|Overall Study|Protocol Violation|4|||
145744775|NCT00361270|525581685|FG002|Overall Study|Protocol Violation|5|||
145744776|NCT00361270|525581686|FG003|Overall Study|Protocol Violation|4|||
145744777|NCT00361270|525581683|FG000|Overall Study|Withdrawal by Subject|6|||
145744778|NCT00361270|525581684|FG001|Overall Study|Withdrawal by Subject|6|||
145744779|NCT00361270|525581685|FG002|Overall Study|Withdrawal by Subject|3|||
145744780|NCT00361270|525581686|FG003|Overall Study|Withdrawal by Subject|7|||
145744781|NCT00361270|525581683|FG000|Overall Study|Afraid of Hypnosis|1|||
145744782|NCT00361270|525581684|FG001|Overall Study|Afraid of Hypnosis|2|||
145744783|NCT00361270|525581685|FG002|Overall Study|Afraid of Hypnosis|0|||
145744784|NCT00361270|525581686|FG003|Overall Study|Afraid of Hypnosis|0|||
145744785|NCT00361270|525581683|FG000|Overall Study|Problems with Transportation|4|||
145744786|NCT00361270|525581684|FG001|Overall Study|Problems with Transportation|0|||
145522538|NCT01853618|524774453|FG002|Overall Study|Progressive disease|1|||
145522539|NCT01853618|524774454|FG003|Overall Study|Progressive disease|1|||
145744787|NCT00361270|525581685|FG002|Overall Study|Problems with Transportation|0|||
145744788|NCT00361270|525581686|FG003|Overall Study|Problems with Transportation|0|||
145522540|NCT01853618|524774455|FG004|Overall Study|Progressive disease|2|||
145744789|NCT00361270|525581683|FG000|Overall Study|Adverse Event|0|||
145744790|NCT00361270|525581684|FG001|Overall Study|Adverse Event|1|||
145744791|NCT00361270|525581685|FG002|Overall Study|Adverse Event|1|||
145744792|NCT00361270|525581686|FG003|Overall Study|Adverse Event|0|||
145744793|NCT03116698|525581688|FG000|Overall Study|Adverse Event|1|||
145744794|NCT03116698|525581689|FG001|Overall Study|Adverse Event|1|||
145744795|NCT03116698|525581690|FG002|Overall Study|Adverse Event|1|||
145744796|NCT03116698|525581691|FG003|Overall Study|Adverse Event|0|||
145744797|NCT03116698|525581688|FG000|Overall Study|Withdrawal by Subject|1|||
145744798|NCT03116698|525581689|FG001|Overall Study|Withdrawal by Subject|4|||
145744799|NCT03116698|525581690|FG002|Overall Study|Withdrawal by Subject|5|||
145744800|NCT03116698|525581691|FG003|Overall Study|Withdrawal by Subject|2|||
145744801|NCT03116698|525581688|FG000|Overall Study|Lost to Follow-up|2|||
145744802|NCT03116698|525581689|FG001|Overall Study|Lost to Follow-up|0|||
145744803|NCT03116698|525581690|FG002|Overall Study|Lost to Follow-up|0|||
145744804|NCT03116698|525581691|FG003|Overall Study|Lost to Follow-up|0|||
145744805|NCT03116698|525581688|FG000|Overall Study|Physician Decision|1|||
145744806|NCT03116698|525581689|FG001|Overall Study|Physician Decision|1|||
145744807|NCT03116698|525581690|FG002|Overall Study|Physician Decision|0|||
145744808|NCT03116698|525581691|FG003|Overall Study|Physician Decision|0|||
145744809|NCT03116698|525581688|FG000|Overall Study|Protocol Violation|1|||
145744810|NCT03116698|525581689|FG001|Overall Study|Protocol Violation|0|||
145744811|NCT03116698|525581690|FG002|Overall Study|Protocol Violation|0|||
145744812|NCT03116698|525581691|FG003|Overall Study|Protocol Violation|0|||
145744813|NCT03116698|525581688|FG000|Overall Study|Death|0|||
145744814|NCT03116698|525581689|FG001|Overall Study|Death|0|||
145744815|NCT03116698|525581690|FG002|Overall Study|Death|2|||
145744816|NCT03116698|525581691|FG003|Overall Study|Death|0|||
145744817|NCT03099187|525581694|FG000|Double-blind Treatment|Adverse Event|19|||
145744818|NCT03099187|525581695|FG001|Double-blind Treatment|Adverse Event|1|||
145744819|NCT03099187|525581696|FG002|Double-blind Treatment|Adverse Event|0|||
145744820|NCT03099187|525581697|FG003|Double-blind Treatment|Adverse Event|0|||
145744821|NCT03099187|525581694|FG000|Double-blind Treatment|Death|1|||
145744822|NCT03099187|525581695|FG001|Double-blind Treatment|Death|3|||
145744823|NCT03099187|525581696|FG002|Double-blind Treatment|Death|0|||
145744824|NCT03099187|525581697|FG003|Double-blind Treatment|Death|0|||
145744825|NCT03099187|525581694|FG000|Double-blind Treatment|Lack of Efficacy|1|||
145744826|NCT03099187|525581695|FG001|Double-blind Treatment|Lack of Efficacy|0|||
145744827|NCT03099187|525581696|FG002|Double-blind Treatment|Lack of Efficacy|0|||
145744828|NCT03099187|525581697|FG003|Double-blind Treatment|Lack of Efficacy|0|||
145744829|NCT03099187|525581694|FG000|Double-blind Treatment|Physician Decision|2|||
145744830|NCT03099187|525581695|FG001|Double-blind Treatment|Physician Decision|1|||
145744831|NCT03099187|525581696|FG002|Double-blind Treatment|Physician Decision|0|||
145744832|NCT03099187|525581697|FG003|Double-blind Treatment|Physician Decision|0|||
145744833|NCT03099187|525581694|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
145744834|NCT03099187|525581695|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
145744835|NCT03099187|525581696|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
145744836|NCT03099187|525581697|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
145744837|NCT03099187|525581694|FG000|Double-blind Treatment|Lung transplantation|0|||
145744838|NCT03099187|525581695|FG001|Double-blind Treatment|Lung transplantation|1|||
145744839|NCT03099187|525581696|FG002|Double-blind Treatment|Lung transplantation|0|||
145744840|NCT03099187|525581697|FG003|Double-blind Treatment|Lung transplantation|0|||
145744841|NCT03099187|525581694|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
145744842|NCT03099187|525581695|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
145744843|NCT03099187|525581696|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
145744844|NCT03099187|525581697|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
145744845|NCT03099187|525581694|FG000|Double-blind Treatment|Disease progression|0|||
145744846|NCT03099187|525581695|FG001|Double-blind Treatment|Disease progression|1|||
145744847|NCT03099187|525581696|FG002|Double-blind Treatment|Disease progression|0|||
145744848|NCT03099187|525581697|FG003|Double-blind Treatment|Disease progression|0|||
145744849|NCT03099187|525581694|FG000|Double-blind Treatment|Randomization error|0|||
145744850|NCT03099187|525581695|FG001|Double-blind Treatment|Randomization error|2|||
145744851|NCT03099187|525581696|FG002|Double-blind Treatment|Randomization error|0|||
145744852|NCT03099187|525581697|FG003|Double-blind Treatment|Randomization error|0|||
145744853|NCT03099187|525581694|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
145522541|NCT01853618|524774451|FG000|Overall Study|Physician Decision|0|||
145522542|NCT01853618|524774452|FG001|Overall Study|Physician Decision|1|||
145522543|NCT01853618|524774453|FG002|Overall Study|Physician Decision|1|||
145522544|NCT01853618|524774454|FG003|Overall Study|Physician Decision|0|||
145522545|NCT01853618|524774455|FG004|Overall Study|Physician Decision|0|||
145522546|NCT01853618|524774451|FG000|Overall Study|Refused further treatment|0|||
145744854|NCT03099187|525581695|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
145744855|NCT03099187|525581696|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
145744856|NCT03099187|525581697|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
145744857|NCT03099187|525581694|FG000|12-month Safety Follow-up|Adverse Event|0|||
145744858|NCT03099187|525581695|FG001|12-month Safety Follow-up|Adverse Event|0|||
145744859|NCT03099187|525581696|FG002|12-month Safety Follow-up|Adverse Event|5|||
145744860|NCT03099187|525581697|FG003|12-month Safety Follow-up|Adverse Event|12|||
145744861|NCT03099187|525581694|FG000|12-month Safety Follow-up|Death|0|||
145522547|NCT01853618|524774452|FG001|Overall Study|Refused further treatment|0|||
145522548|NCT01853618|524774453|FG002|Overall Study|Refused further treatment|0|||
145522549|NCT01853618|524774454|FG003|Overall Study|Refused further treatment|0|||
145744862|NCT03099187|525581695|FG001|12-month Safety Follow-up|Death|0|||
145744863|NCT03099187|525581696|FG002|12-month Safety Follow-up|Death|7|||
145522550|NCT01853618|524774455|FG004|Overall Study|Refused further treatment|1|||
145744864|NCT03099187|525581697|FG003|12-month Safety Follow-up|Death|9|||
145744865|NCT03099187|525581694|FG000|12-month Safety Follow-up|Lung transplantation|0|||
145744866|NCT03099187|525581695|FG001|12-month Safety Follow-up|Lung transplantation|0|||
145744867|NCT03099187|525581696|FG002|12-month Safety Follow-up|Lung transplantation|2|||
145744868|NCT03099187|525581697|FG003|12-month Safety Follow-up|Lung transplantation|1|||
145744869|NCT03099187|525581694|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
145744870|NCT03099187|525581695|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
145744871|NCT03099187|525581696|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
145744872|NCT03099187|525581697|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
145744873|NCT03099187|525581694|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
145744874|NCT03099187|525581695|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
145744875|NCT03099187|525581696|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
145744876|NCT03099187|525581697|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
145744877|NCT03099187|525581694|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
145744878|NCT03099187|525581695|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
145744879|NCT03099187|525581696|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
145744880|NCT03099187|525581697|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
145744881|NCT03099187|525581694|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
145744882|NCT03099187|525581695|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
145744883|NCT03099187|525581696|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
145744884|NCT03099187|525581697|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
145744885|NCT00517751|525581698|FG000|Overall Study|Death|3|||
145744886|NCT00517751|525581698|FG000|Overall Study|Withdrawal by Subject|37|||
145744887|NCT00517751|525581698|FG000|Overall Study|Lost to Follow-up|4|||
145744888|NCT00517751|525581698|FG000|Overall Study|patient not over due|6|||
145744889|NCT00517751|525581698|FG000|Overall Study|Patient not due for visit|76|||
145744890|NCT00517751|525581698|FG000|Overall Study|Missing|3|||
145744891|NCT00495820|525581699|FG000|Overall Study|Adverse Event|1|||
145744892|NCT00495820|525581700|FG001|Overall Study|Adverse Event|1|||
145744893|NCT04050982|525581706|FG000|Overall Study|Did not meet eligibility criteria|0|||
145744894|NCT04050982|525581707|FG001|Overall Study|Did not meet eligibility criteria|1|||
145744895|NCT04050982|525581708|FG002|Overall Study|Did not meet eligibility criteria|0|||
145744896|NCT04050982|525581706|FG000|Overall Study|Withdrawal by Subject|1|||
145744897|NCT04050982|525581707|FG001|Overall Study|Withdrawal by Subject|0|||
145744898|NCT04050982|525581708|FG002|Overall Study|Withdrawal by Subject|0|||
145744899|NCT04050982|525581706|FG000|Overall Study|Unable to enroll on platform|1|||
145744900|NCT04050982|525581707|FG001|Overall Study|Unable to enroll on platform|0|||
145744901|NCT04050982|525581708|FG002|Overall Study|Unable to enroll on platform|0|||
145744902|NCT01246583|525581709|FG000|Overall Study|Lost to Follow-up|0|||
145744903|NCT01246583|525581710|FG001|Overall Study|Lost to Follow-up|0|||
145744904|NCT01246583|525581711|FG002|Overall Study|Lost to Follow-up|0|||
145744905|NCT01246583|525581712|FG003|Overall Study|Lost to Follow-up|1|||
145744906|NCT01246583|525581709|FG000|Overall Study|Protocol Violation|0|||
145744907|NCT01246583|525581710|FG001|Overall Study|Protocol Violation|0|||
145744908|NCT01246583|525581711|FG002|Overall Study|Protocol Violation|1|||
145744909|NCT01246583|525581712|FG003|Overall Study|Protocol Violation|0|||
145744910|NCT01246583|525581709|FG000|Overall Study|Withdrawal by Subject|1|||
145744911|NCT01246583|525581710|FG001|Overall Study|Withdrawal by Subject|0|||
145744912|NCT01246583|525581711|FG002|Overall Study|Withdrawal by Subject|0|||
145744913|NCT01246583|525581712|FG003|Overall Study|Withdrawal by Subject|0|||
145744914|NCT02116777|525581713|FG000|Overall Study|Adverse Event|0|||
145744915|NCT02116777|525581714|FG001|Overall Study|Adverse Event|0|||
145744916|NCT02116777|525581715|FG002|Overall Study|Adverse Event|0|||
145744917|NCT02116777|525581716|FG003|Overall Study|Adverse Event|0|||
145744918|NCT02116777|525581717|FG004|Overall Study|Adverse Event|2|||
145744919|NCT02116777|525581718|FG005|Overall Study|Adverse Event|2|||
145744920|NCT02116777|525581719|FG006|Overall Study|Adverse Event|0|||
145744921|NCT02116777|525581713|FG000|Overall Study|Death|0|||
145744922|NCT02116777|525581714|FG001|Overall Study|Death|0|||
145744923|NCT02116777|525581715|FG002|Overall Study|Death|0|||
145744924|NCT02116777|525581716|FG003|Overall Study|Death|1|||
145744925|NCT02116777|525581717|FG004|Overall Study|Death|0|||
145744926|NCT02116777|525581718|FG005|Overall Study|Death|0|||
145270735|NCT03917654|523837943|FG009|Year 2|Spouse/family member request|0|||
145270736|NCT03917654|523837944|FG010|Year 2|Spouse/family member request|0|||
145744927|NCT02116777|525581719|FG006|Overall Study|Death|0|||
145744928|NCT02116777|525581713|FG000|Overall Study|Lack of Efficacy|3|||
145744929|NCT02116777|525581714|FG001|Overall Study|Lack of Efficacy|3|||
145744930|NCT02116777|525581715|FG002|Overall Study|Lack of Efficacy|3|||
145744931|NCT02116777|525581716|FG003|Overall Study|Lack of Efficacy|8|||
145744932|NCT02116777|525581717|FG004|Overall Study|Lack of Efficacy|4|||
145744933|NCT02116777|525581718|FG005|Overall Study|Lack of Efficacy|1|||
145744934|NCT02116777|525581719|FG006|Overall Study|Lack of Efficacy|9|||
145744935|NCT02116777|525581713|FG000|Overall Study|Physician Decision|0|||
145744936|NCT02116777|525581714|FG001|Overall Study|Physician Decision|0|||
145744937|NCT02116777|525581715|FG002|Overall Study|Physician Decision|0|||
145744938|NCT02116777|525581716|FG003|Overall Study|Physician Decision|2|||
145744939|NCT02116777|525581717|FG004|Overall Study|Physician Decision|0|||
145744940|NCT02116777|525581718|FG005|Overall Study|Physician Decision|0|||
145744941|NCT02116777|525581719|FG006|Overall Study|Physician Decision|0|||
145744942|NCT02116777|525581713|FG000|Overall Study|Protocol Violation|0|||
145744943|NCT02116777|525581714|FG001|Overall Study|Protocol Violation|0|||
145744944|NCT02116777|525581715|FG002|Overall Study|Protocol Violation|0|||
145744945|NCT02116777|525581716|FG003|Overall Study|Protocol Violation|1|||
145744946|NCT02116777|525581717|FG004|Overall Study|Protocol Violation|0|||
145744947|NCT02116777|525581718|FG005|Overall Study|Protocol Violation|0|||
145744948|NCT02116777|525581719|FG006|Overall Study|Protocol Violation|0|||
145744949|NCT02116777|525581713|FG000|Overall Study|Withdrawal by Subject|0|||
145744950|NCT02116777|525581714|FG001|Overall Study|Withdrawal by Subject|0|||
145744951|NCT02116777|525581715|FG002|Overall Study|Withdrawal by Subject|0|||
145744952|NCT02116777|525581716|FG003|Overall Study|Withdrawal by Subject|1|||
145744953|NCT02116777|525581717|FG004|Overall Study|Withdrawal by Subject|0|||
145744954|NCT02116777|525581718|FG005|Overall Study|Withdrawal by Subject|0|||
145744955|NCT02116777|525581719|FG006|Overall Study|Withdrawal by Subject|0|||
145744956|NCT01423851|525581721|FG000|Whole Study|Disease progression|2|||
145744957|NCT01423851|525581722|FG001|Whole Study|Disease progression|1|||
145744958|NCT01423851|525581723|FG002|Whole Study|Disease progression|1|||
145744959|NCT01423851|525581724|FG003|Whole Study|Disease progression|4|||
145744960|NCT01423851|525581725|FG004|Whole Study|Disease progression|1|||
145744961|NCT01423851|525581726|FG005|Whole Study|Disease progression|3|||
145744962|NCT01423851|525581727|FG006|Whole Study|Disease progression|1|||
145744963|NCT01423851|525581728|FG007|Whole Study|Disease progression|4|||
145744964|NCT01423851|525581729|FG008|Whole Study|Disease progression|0|||
145744965|NCT01423851|525581730|FG009|Whole Study|Disease progression|2|||
145744966|NCT01423851|525581731|FG010|Whole Study|Disease progression|10|||
145744967|NCT01423851|525581721|FG000|Whole Study|Physician Decision|0|||
145744968|NCT01423851|525581722|FG001|Whole Study|Physician Decision|1|||
145744969|NCT01423851|525581723|FG002|Whole Study|Physician Decision|2|||
145744970|NCT01423851|525581724|FG003|Whole Study|Physician Decision|0|||
145744971|NCT01423851|525581725|FG004|Whole Study|Physician Decision|2|||
145744972|NCT01423851|525581726|FG005|Whole Study|Physician Decision|0|||
145744973|NCT01423851|525581727|FG006|Whole Study|Physician Decision|2|||
145744974|NCT01423851|525581728|FG007|Whole Study|Physician Decision|1|||
145270737|NCT03917654|523837945|FG011|Year 2|Spouse/family member request|0|||
145522551|NCT01658813|524774456|FG000|Overall Study|Disease progression|3|||
145522552|NCT02283177|524774457|FG000|Overall Study|Withdrawal by Subject|1|||
145522553|NCT02283177|524774458|FG001|Overall Study|Withdrawal by Subject|1|||
145522554|NCT01101191|524774463|FG000|Period 1|Withdrawal by Subject|1|||
145522555|NCT01101191|524774464|FG001|Period 1|Withdrawal by Subject|0|||
145522556|NCT01101191|524774463|FG000|Period 1|Adverse Event|1|||
145522557|NCT01101191|524774464|FG001|Period 1|Adverse Event|2|||
145522558|NCT02009384|524774465|FG000|Overall Study|Death|2|||
145522559|NCT00722371|524774466|FG000|Overall Study|Adverse Event|6|||
145522560|NCT00722371|524774467|FG001|Overall Study|Adverse Event|13|||
145522561|NCT00722371|524774468|FG002|Overall Study|Adverse Event|9|||
145522562|NCT00722371|524774469|FG003|Overall Study|Adverse Event|10|||
145522563|NCT00722371|524774470|FG004|Overall Study|Adverse Event|6|||
145522564|NCT00722371|524774471|FG005|Overall Study|Adverse Event|8|||
145522565|NCT00722371|524774472|FG006|Overall Study|Adverse Event|4|||
145522566|NCT00722371|524774466|FG000|Overall Study|Contraindication|0|||
145522567|NCT00722371|524774467|FG001|Overall Study|Contraindication|0|||
145522568|NCT00722371|524774468|FG002|Overall Study|Contraindication|1|||
145522569|NCT00722371|524774469|FG003|Overall Study|Contraindication|0|||
145522570|NCT00722371|524774470|FG004|Overall Study|Contraindication|0|||
145522571|NCT00722371|524774471|FG005|Overall Study|Contraindication|0|||
145522572|NCT00722371|524774472|FG006|Overall Study|Contraindication|0|||
145522573|NCT00722371|524774466|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
145744975|NCT01423851|525581729|FG008|Whole Study|Physician Decision|3|||
145744976|NCT01423851|525581730|FG009|Whole Study|Physician Decision|4|||
145744977|NCT01423851|525581731|FG010|Whole Study|Physician Decision|12|||
145744978|NCT01423851|525581721|FG000|Whole Study|Withdrawal by Subject|1|||
145744979|NCT01423851|525581722|FG001|Whole Study|Withdrawal by Subject|1|||
145744980|NCT01423851|525581723|FG002|Whole Study|Withdrawal by Subject|0|||
145744981|NCT01423851|525581724|FG003|Whole Study|Withdrawal by Subject|0|||
145744982|NCT01423851|525581725|FG004|Whole Study|Withdrawal by Subject|0|||
145744983|NCT01423851|525581726|FG005|Whole Study|Withdrawal by Subject|0|||
145744984|NCT01423851|525581727|FG006|Whole Study|Withdrawal by Subject|0|||
145744985|NCT01423851|525581728|FG007|Whole Study|Withdrawal by Subject|0|||
145744986|NCT01423851|525581729|FG008|Whole Study|Withdrawal by Subject|2|||
145744987|NCT01423851|525581730|FG009|Whole Study|Withdrawal by Subject|0|||
145744988|NCT01423851|525581731|FG010|Whole Study|Withdrawal by Subject|4|||
145744989|NCT01423851|525581721|FG000|Whole Study|Adverse Event|0|||
145744990|NCT01423851|525581722|FG001|Whole Study|Adverse Event|0|||
145744991|NCT01423851|525581723|FG002|Whole Study|Adverse Event|0|||
145744992|NCT01423851|525581724|FG003|Whole Study|Adverse Event|2|||
145744993|NCT01423851|525581725|FG004|Whole Study|Adverse Event|0|||
145744994|NCT01423851|525581726|FG005|Whole Study|Adverse Event|0|||
145744995|NCT01423851|525581727|FG006|Whole Study|Adverse Event|0|||
145744996|NCT01423851|525581728|FG007|Whole Study|Adverse Event|3|||
145744997|NCT01423851|525581729|FG008|Whole Study|Adverse Event|3|||
145744998|NCT01423851|525581730|FG009|Whole Study|Adverse Event|2|||
145744999|NCT01423851|525581731|FG010|Whole Study|Adverse Event|3|||
145745000|NCT03416153|525581735|FG000|Overall Study|Physician Decision|1|||
145745001|NCT03416153|525581736|FG001|Overall Study|Physician Decision|1|||
145745002|NCT03416153|525581735|FG000|Overall Study|Withdrawal by Subject|1|||
145745003|NCT03416153|525581736|FG001|Overall Study|Withdrawal by Subject|0|||
145745004|NCT00609791|525583102|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
145745005|NCT04218201|525583103|FG000|Overall Study|Death|0|||
145745006|NCT04218201|525583104|FG001|Overall Study|Death|0|||
145745007|NCT04218201|525583105|FG002|Overall Study|Death|2|||
145745008|NCT04218201|525583106|FG003|Overall Study|Death|0|||
145270738|NCT03917654|523837934|FG000|Year 2|Lost to Follow-up|0|||
145270739|NCT03917654|523837935|FG001|Year 2|Lost to Follow-up|0|||
145270740|NCT03917654|523837936|FG002|Year 2|Lost to Follow-up|0|||
145270741|NCT03917654|523837937|FG003|Year 2|Lost to Follow-up|0|||
145270742|NCT03917654|523837938|FG004|Year 2|Lost to Follow-up|0|||
145270743|NCT03917654|523837939|FG005|Year 2|Lost to Follow-up|0|||
145270744|NCT03917654|523837940|FG006|Year 2|Lost to Follow-up|1|||
145270745|NCT03917654|523837941|FG007|Year 2|Lost to Follow-up|0|||
145270746|NCT03917654|523837942|FG008|Year 2|Lost to Follow-up|1|||
145270747|NCT03917654|523837943|FG009|Year 2|Lost to Follow-up|0|||
145270748|NCT03917654|523837944|FG010|Year 2|Lost to Follow-up|0|||
145270749|NCT03917654|523837945|FG011|Year 2|Lost to Follow-up|1|||
145270750|NCT03917654|523837934|FG000|Year 2|Adverse Event|0|||
145270751|NCT03917654|523837935|FG001|Year 2|Adverse Event|0|||
145270752|NCT03917654|523837936|FG002|Year 2|Adverse Event|0|||
145270753|NCT03917654|523837937|FG003|Year 2|Adverse Event|0|||
145270754|NCT03917654|523837938|FG004|Year 2|Adverse Event|0|||
145270755|NCT03917654|523837939|FG005|Year 2|Adverse Event|0|||
145270756|NCT03917654|523837940|FG006|Year 2|Adverse Event|0|||
145270757|NCT03917654|523837941|FG007|Year 2|Adverse Event|0|||
145270758|NCT03917654|523837942|FG008|Year 2|Adverse Event|0|||
145270759|NCT03917654|523837943|FG009|Year 2|Adverse Event|1|||
145270760|NCT03917654|523837944|FG010|Year 2|Adverse Event|0|||
145270761|NCT03917654|523837945|FG011|Year 2|Adverse Event|0|||
145270762|NCT00602667|523837946|FG000|Overall Study|Still on Therapy|0|||
145270763|NCT00602667|523837947|FG001|Overall Study|Still on Therapy|2|||
145270764|NCT00602667|523837948|FG002|Overall Study|Still on Therapy|2|||
145270765|NCT00602667|523837946|FG000|Overall Study|Death|0|||
145270766|NCT00602667|523837947|FG001|Overall Study|Death|1|||
145270767|NCT00602667|523837948|FG002|Overall Study|Death|1|||
145270768|NCT00602667|523837946|FG000|Overall Study|Family request|3|||
145270769|NCT00602667|523837947|FG001|Overall Study|Family request|25|||
145745009|NCT04218201|525583103|FG000|Overall Study|Unable to contact participant|4|||
145745010|NCT04218201|525583104|FG001|Overall Study|Unable to contact participant|0|||
145745011|NCT04218201|525583105|FG002|Overall Study|Unable to contact participant|3|||
145745012|NCT04218201|525583106|FG003|Overall Study|Unable to contact participant|0|||
145745013|NCT04218201|525583103|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
145745014|NCT04218201|525583104|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
145745015|NCT04218201|525583105|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
145270770|NCT00602667|523837948|FG002|Overall Study|Family request|6|||
145270771|NCT00602667|523837946|FG000|Overall Study|Excessive toxicity|1|||
145270772|NCT00602667|523837947|FG001|Overall Study|Excessive toxicity|1|||
145270773|NCT00602667|523837948|FG002|Overall Study|Excessive toxicity|0|||
145270774|NCT00602667|523837946|FG000|Overall Study|Second malignancy|0|||
145745016|NCT04218201|525583106|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
145270775|NCT00602667|523837947|FG001|Overall Study|Second malignancy|1|||
145270776|NCT00602667|523837948|FG002|Overall Study|Second malignancy|0|||
145270777|NCT00602667|523837946|FG000|Overall Study|Physician Decision|2|||
145270778|NCT00602667|523837947|FG001|Overall Study|Physician Decision|3|||
145270779|NCT00602667|523837948|FG002|Overall Study|Physician Decision|8|||
145270780|NCT00602667|523837946|FG000|Overall Study|Progressive disease|13|||
145270781|NCT00602667|523837947|FG001|Overall Study|Progressive disease|48|||
145270782|NCT00602667|523837948|FG002|Overall Study|Progressive disease|45|||
145270783|NCT00602667|523837946|FG000|Overall Study|Progressive disease prior to therapy|0|||
145270784|NCT00602667|523837947|FG001|Overall Study|Progressive disease prior to therapy|0|||
145745017|NCT04218201|525583103|FG000|Overall Study|Withdrawal by Subject|2|||
145745018|NCT04218201|525583104|FG001|Overall Study|Withdrawal by Subject|0|||
145745019|NCT04218201|525583105|FG002|Overall Study|Withdrawal by Subject|0|||
145745020|NCT04218201|525583106|FG003|Overall Study|Withdrawal by Subject|0|||
145745021|NCT04218201|525583103|FG000|Overall Study|PCP plans to leave practice|0|||
145745022|NCT04218201|525583104|FG001|Overall Study|PCP plans to leave practice|8|||
145745023|NCT04218201|525583105|FG002|Overall Study|PCP plans to leave practice|0|||
145745024|NCT04218201|525583106|FG003|Overall Study|PCP plans to leave practice|5|||
145745025|NCT04218201|525583103|FG000|Overall Study|Reduced panel|0|||
145745026|NCT04218201|525583104|FG001|Overall Study|Reduced panel|0|||
145745027|NCT04218201|525583105|FG002|Overall Study|Reduced panel|0|||
145745028|NCT04218201|525583106|FG003|Overall Study|Reduced panel|1|||
145745029|NCT04218201|525583103|FG000|Overall Study|No longer interested in participating|0|||
145745030|NCT04218201|525583104|FG001|Overall Study|No longer interested in participating|1|||
145745031|NCT04218201|525583105|FG002|Overall Study|No longer interested in participating|0|||
145745032|NCT04218201|525583106|FG003|Overall Study|No longer interested in participating|0|||
145745033|NCT04649255|525583107|FG000|Overall Study|Death|9|||
145745034|NCT04649255|525583107|FG000|Overall Study|Withdrawal by Subject|1|||
145745035|NCT02484911|525583108|FG000|Overall Study|Withdrawal by Subject|2|||
145745036|NCT02484911|525583109|FG001|Overall Study|Withdrawal by Subject|1|||
145745037|NCT02484911|525583108|FG000|Overall Study|Protocol Violation|2|||
145745038|NCT02484911|525583109|FG001|Overall Study|Protocol Violation|1|||
145745039|NCT00490568|525583115|FG000|Overall Study|Adverse Event|116|||
145522574|NCT00722371|524774467|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
145522575|NCT00722371|524774468|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
145522576|NCT00722371|524774469|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
145522577|NCT00722371|524774470|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
145522578|NCT00722371|524774471|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
145522579|NCT00722371|524774472|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
145522580|NCT00722371|524774466|FG000|Overall Study|Excluded medication|0|||
145522581|NCT00722371|524774467|FG001|Overall Study|Excluded medication|1|||
145522582|NCT00722371|524774468|FG002|Overall Study|Excluded medication|1|||
145522583|NCT00722371|524774469|FG003|Overall Study|Excluded medication|0|||
145522584|NCT00722371|524774470|FG004|Overall Study|Excluded medication|0|||
145522585|NCT00722371|524774471|FG005|Overall Study|Excluded medication|0|||
145522586|NCT00722371|524774472|FG006|Overall Study|Excluded medication|1|||
145522587|NCT00722371|524774466|FG000|Overall Study|Hyperglycemia|2|||
145522588|NCT00722371|524774467|FG001|Overall Study|Hyperglycemia|6|||
145522589|NCT00722371|524774468|FG002|Overall Study|Hyperglycemia|4|||
145522590|NCT00722371|524774469|FG003|Overall Study|Hyperglycemia|2|||
145522591|NCT00722371|524774470|FG004|Overall Study|Hyperglycemia|5|||
145522592|NCT00722371|524774471|FG005|Overall Study|Hyperglycemia|1|||
145522593|NCT00722371|524774472|FG006|Overall Study|Hyperglycemia|1|||
145522594|NCT00722371|524774466|FG000|Overall Study|Hypoglycemia|1|||
145522595|NCT00722371|524774467|FG001|Overall Study|Hypoglycemia|0|||
145522596|NCT00722371|524774468|FG002|Overall Study|Hypoglycemia|0|||
145522597|NCT00722371|524774469|FG003|Overall Study|Hypoglycemia|0|||
145522598|NCT00722371|524774470|FG004|Overall Study|Hypoglycemia|0|||
145522599|NCT00722371|524774471|FG005|Overall Study|Hypoglycemia|0|||
145522600|NCT00722371|524774472|FG006|Overall Study|Hypoglycemia|0|||
145522601|NCT00722371|524774466|FG000|Overall Study|Lack of Efficacy|4|||
145522602|NCT00722371|524774467|FG001|Overall Study|Lack of Efficacy|6|||
145522603|NCT00722371|524774468|FG002|Overall Study|Lack of Efficacy|6|||
145522604|NCT00722371|524774469|FG003|Overall Study|Lack of Efficacy|6|||
145522605|NCT00722371|524774470|FG004|Overall Study|Lack of Efficacy|2|||
145522606|NCT00722371|524774471|FG005|Overall Study|Lack of Efficacy|3|||
145522607|NCT00722371|524774472|FG006|Overall Study|Lack of Efficacy|0|||
145522608|NCT00722371|524774466|FG000|Overall Study|Lost to Follow-up|11|||
145522609|NCT00722371|524774467|FG001|Overall Study|Lost to Follow-up|14|||
145522610|NCT00722371|524774468|FG002|Overall Study|Lost to Follow-up|21|||
145522611|NCT00722371|524774469|FG003|Overall Study|Lost to Follow-up|13|||
145522612|NCT00722371|524774470|FG004|Overall Study|Lost to Follow-up|8|||
145522613|NCT00722371|524774471|FG005|Overall Study|Lost to Follow-up|16|||
145522614|NCT00722371|524774472|FG006|Overall Study|Lost to Follow-up|13|||
145522615|NCT00722371|524774466|FG000|Overall Study|Physician Decision|5|||
145522616|NCT00722371|524774467|FG001|Overall Study|Physician Decision|2|||
145745040|NCT00490568|525583115|FG000|Overall Study|Lost to Follow-up|13|||
145745041|NCT00490568|525583115|FG000|Overall Study|Protocol Violation|45|||
145745042|NCT00490568|525583115|FG000|Overall Study|Withdrawal by Subject|135|||
145745043|NCT00490568|525583115|FG000|Overall Study|Still in the study at termination|974|||
145522617|NCT00722371|524774468|FG002|Overall Study|Physician Decision|2|||
145745044|NCT00490568|525583115|FG000|Overall Study|Other|1|||
145402467|NCT00784875|524330735|FG002|Period C|Physician Decision|1|||
145522618|NCT00722371|524774469|FG003|Overall Study|Physician Decision|5|||
145522619|NCT00722371|524774470|FG004|Overall Study|Physician Decision|2|||
145522620|NCT00722371|524774471|FG005|Overall Study|Physician Decision|3|||
145522621|NCT00722371|524774472|FG006|Overall Study|Physician Decision|4|||
145522622|NCT00722371|524774466|FG000|Overall Study|Pregnancy|1|||
145522623|NCT00722371|524774467|FG001|Overall Study|Pregnancy|1|||
145522624|NCT00722371|524774468|FG002|Overall Study|Pregnancy|0|||
145522625|NCT00722371|524774469|FG003|Overall Study|Pregnancy|0|||
145522626|NCT00722371|524774470|FG004|Overall Study|Pregnancy|0|||
145522627|NCT00722371|524774471|FG005|Overall Study|Pregnancy|1|||
145522628|NCT00722371|524774472|FG006|Overall Study|Pregnancy|0|||
145522629|NCT00722371|524774466|FG000|Overall Study|Protocol Violation|6|||
145522630|NCT00722371|524774467|FG001|Overall Study|Protocol Violation|1|||
145522631|NCT00722371|524774468|FG002|Overall Study|Protocol Violation|0|||
145522632|NCT00722371|524774469|FG003|Overall Study|Protocol Violation|1|||
145522633|NCT00722371|524774470|FG004|Overall Study|Protocol Violation|4|||
145522634|NCT00722371|524774471|FG005|Overall Study|Protocol Violation|2|||
145522635|NCT00722371|524774472|FG006|Overall Study|Protocol Violation|1|||
145522636|NCT00722371|524774466|FG000|Overall Study|Withdrawal by Subject|18|||
145522637|NCT00722371|524774467|FG001|Overall Study|Withdrawal by Subject|27|||
145522638|NCT00722371|524774468|FG002|Overall Study|Withdrawal by Subject|19|||
145522639|NCT00722371|524774469|FG003|Overall Study|Withdrawal by Subject|23|||
145522640|NCT00722371|524774470|FG004|Overall Study|Withdrawal by Subject|19|||
145522641|NCT00722371|524774471|FG005|Overall Study|Withdrawal by Subject|18|||
145522642|NCT00722371|524774472|FG006|Overall Study|Withdrawal by Subject|26|||
145522643|NCT01092832|524774473|FG000|Overall Study|Other|1|||
145522644|NCT01092832|524774474|FG001|Overall Study|Other|0|||
145522645|NCT02674854|524774475|FG000|Overall Study|Adverse Event|17|||
145522646|NCT02674854|524774476|FG001|Overall Study|Adverse Event|15|||
145522647|NCT02674854|524774477|FG002|Overall Study|Adverse Event|5|||
145522648|NCT02674854|524774475|FG000|Overall Study|Withdrawal by Subject|1|||
145522649|NCT02674854|524774476|FG001|Overall Study|Withdrawal by Subject|5|||
145522650|NCT02674854|524774477|FG002|Overall Study|Withdrawal by Subject|4|||
145522651|NCT02674854|524774475|FG000|Overall Study|No-compliant subject|1|||
145522652|NCT02674854|524774476|FG001|Overall Study|No-compliant subject|0|||
145522653|NCT02674854|524774477|FG002|Overall Study|No-compliant subject|1|||
145522654|NCT02674854|524774475|FG000|Overall Study|Lost to Follow-up|1|||
145522655|NCT02674854|524774476|FG001|Overall Study|Lost to Follow-up|0|||
145522656|NCT02674854|524774477|FG002|Overall Study|Lost to Follow-up|2|||
145522657|NCT02674854|524774475|FG000|Overall Study|Lack of Efficacy|0|||
145522658|NCT02674854|524774476|FG001|Overall Study|Lack of Efficacy|3|||
145522659|NCT02674854|524774477|FG002|Overall Study|Lack of Efficacy|0|||
145522660|NCT02674854|524774475|FG000|Overall Study|Disallowed Concurrent Medication|2|||
145522661|NCT02674854|524774476|FG001|Overall Study|Disallowed Concurrent Medication|2|||
145522662|NCT02674854|524774477|FG002|Overall Study|Disallowed Concurrent Medication|0|||
145522663|NCT02674854|524774475|FG000|Overall Study|Protocol Violation|1|||
145522664|NCT02674854|524774476|FG001|Overall Study|Protocol Violation|1|||
145522665|NCT02674854|524774477|FG002|Overall Study|Protocol Violation|2|||
145522666|NCT02674854|524774475|FG000|Overall Study|Death|0|||
145522667|NCT02674854|524774476|FG001|Overall Study|Death|1|||
145522668|NCT02674854|524774477|FG002|Overall Study|Death|0|||
145522669|NCT02674854|524774475|FG000|Overall Study|Subject missed V6.2|1|||
145522670|NCT02674854|524774476|FG001|Overall Study|Subject missed V6.2|0|||
145522671|NCT02674854|524774477|FG002|Overall Study|Subject missed V6.2|0|||
145522672|NCT02635646|524774479|FG000|Overall Study|Lost to Follow-up|24|||
145522673|NCT02635646|524774480|FG001|Overall Study|Lost to Follow-up|25|||
145522674|NCT02635646|524774479|FG000|Overall Study|Pregnancy|1|||
145522675|NCT02635646|524774480|FG001|Overall Study|Pregnancy|1|||
145522676|NCT00913692|524774481|FG000|Screening (4 Months)|Physician Decision|3|||
145522677|NCT00913692|524774481|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
145522678|NCT00913692|524774481|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
145522679|NCT03761797|524774482|FG000|Overall Study|Changing hospital|11|||
145522680|NCT03761797|524774482|FG000|Overall Study|Improvement/remission|6|||
145522681|NCT03761797|524774482|FG000|Overall Study|Withdrawal by Subject|19|||
145522682|NCT03761797|524774482|FG000|Overall Study|Lost to Follow-up|33|||
145522683|NCT03761797|524774482|FG000|Overall Study|Adverse Event|37|||
145522684|NCT03761797|524774482|FG000|Overall Study|Case report form (CRF) not collected|5|||
145522685|NCT03761797|524774482|FG000|Overall Study|No patient visit after entry|13|||
145522686|NCT03761797|524774482|FG000|Overall Study|Switch to other diabetes medication|10|||
145402468|NCT00784875|524330736|FG003|Period C|Physician Decision|1|||
145522687|NCT03761797|524774482|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
145522688|NCT03761797|524774482|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
145522689|NCT03761797|524774482|FG000|Overall Study|Insufficient effectives|2|||
145522690|NCT03761797|524774482|FG000|Overall Study|Excessive alcohol intake|1|||
145522691|NCT00879879|524774489|FG000|Overall Study|Death|1|||
145522692|NCT00879879|524774489|FG000|Overall Study|Withdrawal by Subject|1|||
145522693|NCT00879879|524774489|FG000|Overall Study|Physician Decision|1|||
145522694|NCT00400153|524774494|FG000|Overall Study|AE due to study disease worsening|14|||
145522695|NCT00400153|524774495|FG001|Overall Study|AE due to study disease worsening|19|||
145522696|NCT00400153|524774496|FG002|Overall Study|AE due to study disease worsening|20|||
145522697|NCT00400153|524774494|FG000|Overall Study|AE due to other disease worsening|2|||
145522698|NCT00400153|524774495|FG001|Overall Study|AE due to other disease worsening|1|||
145522699|NCT00400153|524774496|FG002|Overall Study|AE due to other disease worsening|0|||
145522700|NCT00400153|524774494|FG000|Overall Study|AE due to other condition|3|||
145522701|NCT00400153|524774495|FG001|Overall Study|AE due to other condition|14|||
145522702|NCT00400153|524774496|FG002|Overall Study|AE due to other condition|15|||
145522703|NCT00400153|524774494|FG000|Overall Study|Protocol Violation|7|||
145522704|NCT00400153|524774495|FG001|Overall Study|Protocol Violation|4|||
145522705|NCT00400153|524774496|FG002|Overall Study|Protocol Violation|9|||
145522706|NCT00400153|524774494|FG000|Overall Study|Lost to Follow-up|2|||
145522707|NCT00400153|524774495|FG001|Overall Study|Lost to Follow-up|1|||
145522708|NCT00400153|524774496|FG002|Overall Study|Lost to Follow-up|4|||
145522709|NCT00400153|524774494|FG000|Overall Study|Withdrawal by Subject|12|||
145522710|NCT00400153|524774495|FG001|Overall Study|Withdrawal by Subject|11|||
145522711|NCT00400153|524774496|FG002|Overall Study|Withdrawal by Subject|10|||
145522712|NCT00400153|524774494|FG000|Overall Study|Other reasons - not mentioned above|8|||
145522713|NCT00400153|524774495|FG001|Overall Study|Other reasons - not mentioned above|5|||
145522714|NCT00400153|524774496|FG002|Overall Study|Other reasons - not mentioned above|3|||
145522715|NCT00327470|524774499|FG000|Overall Study|Randomized, but not treated|0|||
145522716|NCT00327470|524774500|FG001|Overall Study|Randomized, but not treated|2|||
145522717|NCT00327470|524774499|FG000|Overall Study|Adverse Event|9|||
145522718|NCT00327470|524774500|FG001|Overall Study|Adverse Event|14|||
145522719|NCT00327470|524774499|FG000|Overall Study|Lack of Efficacy|7|||
145522720|NCT00327470|524774500|FG001|Overall Study|Lack of Efficacy|19|||
145522721|NCT00327470|524774499|FG000|Overall Study|Other|5|||
145522722|NCT00327470|524774500|FG001|Overall Study|Other|9|||
145522723|NCT00327470|524774499|FG000|Overall Study|Lost to Follow-up|1|||
145522724|NCT00327470|524774500|FG001|Overall Study|Lost to Follow-up|3|||
145522725|NCT00327470|524774499|FG000|Overall Study|Withdrawal by Subject|6|||
145522726|NCT00327470|524774500|FG001|Overall Study|Withdrawal by Subject|12|||
145522727|NCT00327470|524774499|FG000|Overall Study|Death|1|||
145522728|NCT00327470|524774500|FG001|Overall Study|Death|4|||
145522729|NCT04231981|524774501|FG000|Overall Study|Adverse Event|1|||
145522730|NCT04231981|524774501|FG000|Overall Study|Death|16|||
145522731|NCT04231981|524774501|FG000|Overall Study|Lost to Follow-up|1|||
145522732|NCT02197234|524774502|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
145522733|NCT02197234|524774502|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
145522734|NCT02197234|524774502|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
145522735|NCT02197234|524774502|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
145522736|NCT02197234|524774502|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
145522737|NCT02197234|524774502|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
145522738|NCT03370276|524774511|FG000|Overall Study|Death|0|||
145522739|NCT03370276|524774512|FG001|Overall Study|Death|2|||
145522740|NCT03370276|524774513|FG002|Overall Study|Death|5|||
145522741|NCT04030026|524774514|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
145522742|NCT04030026|524774515|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
145522743|NCT04030026|524774514|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
145522744|NCT04030026|524774515|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
145522745|NCT04030026|524774514|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
145522746|NCT04030026|524774515|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
145522747|NCT04030026|524774514|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
145522748|NCT04030026|524774515|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
145522749|NCT04030026|524774514|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
145522750|NCT04030026|524774515|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
145522751|NCT04030026|524774514|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
145522752|NCT04030026|524774515|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
145522753|NCT04030026|524774514|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
145522754|NCT04030026|524774515|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
145522755|NCT00811642|524774516|FG000|Overall Study|Adverse Event|3|||
145522756|NCT00811642|524774516|FG000|Overall Study|Protocol Violation|1|||
145745045|NCT00490568|525583115|FG000|Overall Study|Exclusion criteria met|1|||
145522757|NCT00811642|524774516|FG000|Overall Study|Death|2|||
145522758|NCT00811642|524774516|FG000|Overall Study|Withdrawal by Subject|7|||
145522759|NCT00811642|524774516|FG000|Overall Study|Cumulative use of antifungal agent|2|||
145522760|NCT02361346|524774517|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522761|NCT02361346|524774518|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
145745046|NCT00490568|525583115|FG000|Overall Study|Caregiver related|20|||
145402469|NCT00784875|524330733|FG000|Period C|Sponsor Decision|5|||
145522762|NCT02361346|524774519|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522763|NCT02361346|524774520|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
145522764|NCT02361346|524774521|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522765|NCT02361346|524774522|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522766|NCT02361346|524774523|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522767|NCT02361346|524774524|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522768|NCT02361346|524774525|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
145522769|NCT02361346|524774517|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522770|NCT02361346|524774518|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522771|NCT02361346|524774519|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522772|NCT02361346|524774520|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522773|NCT02361346|524774521|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
145522774|NCT02361346|524774522|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522775|NCT02361346|524774523|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522776|NCT02361346|524774524|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522777|NCT02361346|524774525|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
145522778|NCT02361346|524774517|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
145522779|NCT02361346|524774518|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
145522780|NCT02361346|524774519|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
145522781|NCT02361346|524774520|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
145522782|NCT02361346|524774521|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
145522783|NCT02361346|524774522|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
145522784|NCT02361346|524774523|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
145522785|NCT02361346|524774524|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
145522786|NCT02361346|524774525|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
145522787|NCT02361346|524774517|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522788|NCT02361346|524774518|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522789|NCT02361346|524774519|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522790|NCT02361346|524774520|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522791|NCT02361346|524774521|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522792|NCT02361346|524774522|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522793|NCT02361346|524774523|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522794|NCT02361346|524774524|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
145522795|NCT02361346|524774525|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
145522796|NCT02361346|524774517|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522797|NCT02361346|524774518|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522798|NCT02361346|524774519|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522799|NCT02361346|524774520|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522800|NCT02361346|524774521|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522801|NCT02361346|524774522|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522802|NCT02361346|524774523|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522803|NCT02361346|524774524|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
145522804|NCT02361346|524774525|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
145522805|NCT02361346|524774517|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145745047|NCT00490568|525583115|FG000|Overall Study|Abnormal ECG|25|||
145745048|NCT00490568|525583115|FG000|Overall Study|Participant refused follow-up|9|||
145745049|NCT00490568|525583115|FG000|Overall Study|Legal representative withdrew consent|1|||
145745050|NCT00490568|525583115|FG000|Overall Study|Disease progression|4|||
145745051|NCT00490568|525583115|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
145745052|NCT00490568|525583115|FG000|Overall Study|Investigator decision|3|||
145745053|NCT00490568|525583115|FG000|Overall Study|Non-Compliance|7|||
145745054|NCT00490568|525583115|FG000|Overall Study|Efficacy related|3|||
145745055|NCT00490568|525583115|FG000|Overall Study|Participant died|1|||
145745056|NCT00490568|525583115|FG000|Overall Study|Participant withdrawal due to surgery|1|||
145745057|NCT00105443|525583118|FG000|Double-Blind Treatment|Adverse Event|1|||
145745058|NCT00105443|525583119|FG001|Double-Blind Treatment|Adverse Event|0|||
145745059|NCT00105443|525583120|FG002|Double-Blind Treatment|Adverse Event|0|||
145745060|NCT00105443|525583121|FG003|Double-Blind Treatment|Adverse Event|0|||
145745061|NCT00105443|525583118|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
145745062|NCT00105443|525583119|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
145745063|NCT00105443|525583120|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
145745064|NCT00105443|525583121|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
145745065|NCT00105443|525583118|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
145745066|NCT00105443|525583119|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
145745067|NCT00105443|525583120|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
145745068|NCT00105443|525583121|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
145745069|NCT00105443|525583118|FG000|Double-Blind Treatment|Physician Decision|1|||
145745070|NCT00105443|525583119|FG001|Double-Blind Treatment|Physician Decision|0|||
145745071|NCT00105443|525583120|FG002|Double-Blind Treatment|Physician Decision|2|||
145745072|NCT00105443|525583121|FG003|Double-Blind Treatment|Physician Decision|0|||
145745073|NCT00105443|525583118|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
145745074|NCT00105443|525583119|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
145745075|NCT00105443|525583120|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
145745076|NCT00105443|525583121|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
145745077|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
145745078|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
145745079|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
145745080|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
145745081|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
145745082|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
145745083|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
145745084|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
145745085|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
145745086|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
145745087|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
145745088|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
145745089|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
145745090|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
145745091|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
145745092|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
145745093|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
145745094|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
145745095|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
145745096|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
145745097|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
145745098|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
145745099|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
145745100|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
145745101|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
145745102|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
145745103|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
145745104|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
145745105|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
145745106|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
145745107|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
145745108|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
145745109|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
145745110|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
145745111|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
145745112|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
145745113|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
145745114|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
145745115|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
145745116|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
145745117|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
145745118|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
145745119|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
145745120|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
145745121|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
145745122|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
145745123|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
145745124|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
145745125|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
145745126|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
145745127|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
145745128|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
145745129|NCT00105443|525583118|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
145745130|NCT00105443|525583119|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
145745131|NCT00105443|525583120|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
145745132|NCT00105443|525583121|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
145745133|NCT01157078|525583122|FG000|Overall Study|Withdrawal by Subject|12|||
145745134|NCT01157078|525583123|FG001|Overall Study|Withdrawal by Subject|14|||
145745135|NCT01157078|525583122|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145745136|NCT01157078|525583123|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145745137|NCT01157078|525583122|FG000|Overall Study|Adverse Event|6|||
145745138|NCT01157078|525583123|FG001|Overall Study|Adverse Event|6|||
145745139|NCT01157078|525583122|FG000|Overall Study|Severe non-compliance to protocol|2|||
145745140|NCT01157078|525583123|FG001|Overall Study|Severe non-compliance to protocol|4|||
145745141|NCT01157078|525583122|FG000|Overall Study|Condition under investigation worsened|0|||
145745142|NCT01157078|525583123|FG001|Overall Study|Condition under investigation worsened|1|||
145745143|NCT01157078|525583122|FG000|Overall Study|Lack of Efficacy|2|||
145745144|NCT01157078|525583123|FG001|Overall Study|Lack of Efficacy|0|||
145745145|NCT01157078|525583122|FG000|Overall Study|Study-specific withdrawal criteria|2|||
145745146|NCT01157078|525583123|FG001|Overall Study|Study-specific withdrawal criteria|2|||
145745147|NCT01157078|525583122|FG000|Overall Study|Lost to Follow-up|7|||
145522806|NCT02361346|524774518|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522807|NCT02361346|524774519|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522808|NCT02361346|524774520|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522809|NCT02361346|524774521|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145745148|NCT01157078|525583123|FG001|Overall Study|Lost to Follow-up|5|||
145745149|NCT01157078|525583122|FG000|Overall Study|Other|2|||
145745150|NCT01157078|525583123|FG001|Overall Study|Other|4|||
145745151|NCT01324232|525583131|FG000|Overall Study|Protocol Violation|0|||
145745152|NCT01324232|525583132|FG001|Overall Study|Protocol Violation|0|||
145745153|NCT01324232|525583133|FG002|Overall Study|Protocol Violation|0|||
145745154|NCT01324232|525583134|FG003|Overall Study|Protocol Violation|2|||
145745155|NCT01324232|525583131|FG000|Overall Study|Missing|0|||
145745156|NCT01324232|525583132|FG001|Overall Study|Missing|0|||
145745157|NCT01324232|525583133|FG002|Overall Study|Missing|1|||
145745158|NCT01324232|525583134|FG003|Overall Study|Missing|0|||
145745159|NCT01324232|525583131|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
145745160|NCT01324232|525583132|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
145745161|NCT01324232|525583133|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
145745162|NCT01324232|525583134|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
145745163|NCT01324232|525583131|FG000|Overall Study|Lack of Efficacy|2|||
145745164|NCT01324232|525583132|FG001|Overall Study|Lack of Efficacy|1|||
145745165|NCT01324232|525583133|FG002|Overall Study|Lack of Efficacy|2|||
145745166|NCT01324232|525583134|FG003|Overall Study|Lack of Efficacy|2|||
145745167|NCT01324232|525583131|FG000|Overall Study|Participant Refused Medication|0|||
145745168|NCT01324232|525583132|FG001|Overall Study|Participant Refused Medication|1|||
145745169|NCT01324232|525583133|FG002|Overall Study|Participant Refused Medication|0|||
145745170|NCT01324232|525583134|FG003|Overall Study|Participant Refused Medication|0|||
145745171|NCT01324232|525583131|FG000|Overall Study|Intercurrent illness|0|||
145745172|NCT01324232|525583132|FG001|Overall Study|Intercurrent illness|0|||
145745173|NCT01324232|525583133|FG002|Overall Study|Intercurrent illness|0|||
145745174|NCT01324232|525583134|FG003|Overall Study|Intercurrent illness|1|||
145745175|NCT01324232|525583131|FG000|Overall Study|Adverse Event|2|||
145745176|NCT01324232|525583132|FG001|Overall Study|Adverse Event|5|||
145745177|NCT01324232|525583133|FG002|Overall Study|Adverse Event|6|||
145745178|NCT01324232|525583134|FG003|Overall Study|Adverse Event|6|||
145745179|NCT01324232|525583131|FG000|Overall Study|Withdrawal by Subject|0|||
145745180|NCT01324232|525583132|FG001|Overall Study|Withdrawal by Subject|3|||
145745181|NCT01324232|525583133|FG002|Overall Study|Withdrawal by Subject|4|||
145745182|NCT01324232|525583134|FG003|Overall Study|Withdrawal by Subject|0|||
145745183|NCT01324232|525583131|FG000|Overall Study|Lost to Follow-up|1|||
145745184|NCT01324232|525583132|FG001|Overall Study|Lost to Follow-up|0|||
145745185|NCT01324232|525583133|FG002|Overall Study|Lost to Follow-up|0|||
145745186|NCT01324232|525583134|FG003|Overall Study|Lost to Follow-up|0|||
145745187|NCT05440539|525583135|FG000|Overall Study|Lost to Follow-up|4|||
145745188|NCT05440539|525583136|FG001|Overall Study|Lost to Follow-up|4|||
145745189|NCT05440539|525583135|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
145745190|NCT05440539|525583136|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
145745191|NCT00393887|525583137|FG000|Overall Study|Physician Decision|5|||
145745192|NCT00393887|525583138|FG001|Overall Study|Physician Decision|0|||
145745193|NCT00393887|525583137|FG000|Overall Study|Lost to Follow-up|11|||
145745194|NCT00393887|525583138|FG001|Overall Study|Lost to Follow-up|9|||
145745195|NCT02055820|525583141|FG000|Phase I: Dose-Finding|Death|1|||
145745196|NCT02055820|525583142|FG001|Phase I: Dose-Finding|Death|0|||
145745197|NCT02055820|525583143|FG002|Phase I: Dose-Finding|Death|1|||
145745198|NCT02055820|525583144|FG003|Phase I: Dose-Finding|Death|2|||
145745199|NCT02055820|525583145|FG004|Phase I: Dose-Finding|Death|0|||
145745200|NCT02055820|525583146|FG005|Phase I: Dose-Finding|Death|1|||
145745201|NCT02055820|525583147|FG006|Phase I: Dose-Finding|Death|1|||
145745202|NCT02055820|525583148|FG007|Phase I: Dose-Finding|Death|0|||
145745203|NCT02055820|525583149|FG008|Phase I: Dose-Finding|Death|0|||
145745204|NCT02055820|525583150|FG009|Phase I: Dose-Finding|Death|0|||
145522810|NCT02361346|524774522|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522811|NCT02361346|524774523|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522812|NCT02361346|524774524|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
145522813|NCT02361346|524774525|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
145522814|NCT03587727|524774527|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
145522815|NCT03587727|524774527|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
145522816|NCT04102189|524774528|FG000|Overall Study|Withdrawal by Subject|1|||
145522817|NCT04102189|524774529|FG001|Overall Study|Withdrawal by Subject|2|||
145522818|NCT04102189|524774528|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145522819|NCT04102189|524774529|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145522820|NCT04102189|524774528|FG000|Overall Study|Lost to Follow-up|1|||
145522821|NCT04102189|524774529|FG001|Overall Study|Lost to Follow-up|0|||
145522822|NCT00562627|524775900|FG000|Overall Study|Protocol Violation|1|||
145522823|NCT00562627|524775901|FG001|Overall Study|Protocol Violation|1|||
145522824|NCT00562627|524775902|FG002|Overall Study|Protocol Violation|1|||
145522825|NCT04393298|524775903|FG000|Overall Study|Adverse Event|0|||
145522826|NCT04393298|524775904|FG001|Overall Study|Adverse Event|0|||
145522827|NCT04393298|524775905|FG002|Overall Study|Adverse Event|0|||
145522828|NCT04393298|524775906|FG003|Overall Study|Adverse Event|0|||
145522829|NCT04393298|524775907|FG004|Overall Study|Adverse Event|1|||
145522830|NCT04393298|524775908|FG005|Overall Study|Adverse Event|0|||
145522831|NCT04393298|524775909|FG006|Overall Study|Adverse Event|0|||
145522832|NCT04393298|524775910|FG007|Overall Study|Adverse Event|0|||
145522833|NCT04393298|524775911|FG008|Overall Study|Adverse Event|2|||
145522834|NCT04393298|524775912|FG009|Overall Study|Adverse Event|0|||
145522835|NCT04393298|524775913|FG010|Overall Study|Adverse Event|0|||
145522836|NCT04393298|524775914|FG011|Overall Study|Adverse Event|0|||
145522837|NCT04393298|524775915|FG012|Overall Study|Adverse Event|1|||
145522838|NCT04393298|524775916|FG013|Overall Study|Adverse Event|1|||
145522839|NCT04393298|524775917|FG014|Overall Study|Adverse Event|0|||
145522840|NCT04393298|524775903|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522841|NCT04393298|524775904|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522842|NCT04393298|524775905|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
145522843|NCT04393298|524775906|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522844|NCT04393298|524775907|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522845|NCT04393298|524775908|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522846|NCT04393298|524775909|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522847|NCT04393298|524775910|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522848|NCT04393298|524775911|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522849|NCT04393298|524775912|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522850|NCT04393298|524775913|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522851|NCT04393298|524775914|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522852|NCT04393298|524775915|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522853|NCT04393298|524775916|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
145522854|NCT04393298|524775917|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
145522855|NCT04393298|524775903|FG000|Overall Study|Lack of Efficacy|0|||
145522856|NCT04393298|524775904|FG001|Overall Study|Lack of Efficacy|0|||
145522857|NCT04393298|524775905|FG002|Overall Study|Lack of Efficacy|0|||
145522858|NCT04393298|524775906|FG003|Overall Study|Lack of Efficacy|0|||
145522859|NCT04393298|524775907|FG004|Overall Study|Lack of Efficacy|0|||
145522860|NCT04393298|524775908|FG005|Overall Study|Lack of Efficacy|0|||
145522861|NCT04393298|524775909|FG006|Overall Study|Lack of Efficacy|0|||
145522862|NCT04393298|524775910|FG007|Overall Study|Lack of Efficacy|0|||
145522863|NCT04393298|524775911|FG008|Overall Study|Lack of Efficacy|0|||
145522864|NCT04393298|524775912|FG009|Overall Study|Lack of Efficacy|0|||
145522865|NCT04393298|524775913|FG010|Overall Study|Lack of Efficacy|0|||
145522866|NCT04393298|524775914|FG011|Overall Study|Lack of Efficacy|0|||
145522867|NCT04393298|524775915|FG012|Overall Study|Lack of Efficacy|0|||
145522868|NCT04393298|524775916|FG013|Overall Study|Lack of Efficacy|0|||
145522869|NCT04393298|524775917|FG014|Overall Study|Lack of Efficacy|1|||
145522870|NCT04393298|524775903|FG000|Overall Study|Progression|1|||
145522871|NCT04393298|524775904|FG001|Overall Study|Progression|0|||
145522872|NCT04393298|524775905|FG002|Overall Study|Progression|0|||
145522873|NCT04393298|524775906|FG003|Overall Study|Progression|0|||
145522874|NCT04393298|524775907|FG004|Overall Study|Progression|0|||
145522875|NCT04393298|524775908|FG005|Overall Study|Progression|0|||
145522876|NCT04393298|524775909|FG006|Overall Study|Progression|0|||
145522877|NCT04393298|524775910|FG007|Overall Study|Progression|0|||
145522878|NCT04393298|524775911|FG008|Overall Study|Progression|0|||
145522879|NCT04393298|524775912|FG009|Overall Study|Progression|0|||
145522880|NCT04393298|524775913|FG010|Overall Study|Progression|1|||
145745205|NCT02055820|525583141|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145522881|NCT04393298|524775914|FG011|Overall Study|Progression|1|||
145522882|NCT04393298|524775915|FG012|Overall Study|Progression|0|||
145522883|NCT04393298|524775916|FG013|Overall Study|Progression|0|||
145745206|NCT02055820|525583142|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745207|NCT02055820|525583143|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745208|NCT02055820|525583144|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745209|NCT02055820|525583145|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745210|NCT02055820|525583146|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
145745211|NCT02055820|525583147|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745212|NCT02055820|525583148|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745213|NCT02055820|525583149|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745214|NCT02055820|525583150|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
145745215|NCT02055820|525583141|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745216|NCT02055820|525583142|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745217|NCT02055820|525583143|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745218|NCT02055820|525583144|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
145745219|NCT02055820|525583145|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745220|NCT02055820|525583146|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745221|NCT02055820|525583147|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
145745222|NCT02055820|525583148|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745223|NCT02055820|525583149|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745224|NCT02055820|525583150|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
145745225|NCT02055820|525583141|FG000|Phase II: Expansion|Death|0|||
145745226|NCT02055820|525583142|FG001|Phase II: Expansion|Death|0|||
145745227|NCT02055820|525583143|FG002|Phase II: Expansion|Death|0|||
145745228|NCT02055820|525583144|FG003|Phase II: Expansion|Death|0|||
145745229|NCT02055820|525583145|FG004|Phase II: Expansion|Death|33|||
145745230|NCT02055820|525583146|FG005|Phase II: Expansion|Death|0|||
145745231|NCT02055820|525583147|FG006|Phase II: Expansion|Death|0|||
145745232|NCT02055820|525583148|FG007|Phase II: Expansion|Death|0|||
145745233|NCT02055820|525583149|FG008|Phase II: Expansion|Death|0|||
145745234|NCT02055820|525583150|FG009|Phase II: Expansion|Death|0|||
145745235|NCT02055820|525583141|FG000|Phase II: Expansion|Lost to Follow-up|0|||
145745236|NCT02055820|525583142|FG001|Phase II: Expansion|Lost to Follow-up|0|||
145745237|NCT02055820|525583143|FG002|Phase II: Expansion|Lost to Follow-up|0|||
145745238|NCT02055820|525583144|FG003|Phase II: Expansion|Lost to Follow-up|0|||
145745239|NCT02055820|525583145|FG004|Phase II: Expansion|Lost to Follow-up|4|||
145745240|NCT02055820|525583146|FG005|Phase II: Expansion|Lost to Follow-up|0|||
145745241|NCT02055820|525583147|FG006|Phase II: Expansion|Lost to Follow-up|0|||
145745242|NCT02055820|525583148|FG007|Phase II: Expansion|Lost to Follow-up|0|||
145745243|NCT02055820|525583149|FG008|Phase II: Expansion|Lost to Follow-up|0|||
145745244|NCT02055820|525583150|FG009|Phase II: Expansion|Lost to Follow-up|0|||
145745245|NCT02055820|525583141|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
145270785|NCT00602667|523837948|FG002|Overall Study|Progressive disease prior to therapy|1|||
145745246|NCT02055820|525583142|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
145745247|NCT02055820|525583143|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
145745248|NCT02055820|525583144|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
145745249|NCT02055820|525583145|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
145745250|NCT02055820|525583146|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
145745251|NCT02055820|525583147|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
145745252|NCT02055820|525583148|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
145745253|NCT02055820|525583149|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
145745254|NCT02055820|525583150|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
145745255|NCT00930761|525583153|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
145745256|NCT00930761|525583154|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
145745257|NCT00930761|525583153|FG000|Overall Study|less than 3 music therapy sessions|0|||
145745258|NCT00930761|525583154|FG001|Overall Study|less than 3 music therapy sessions|3|||
145270786|NCT03179462|523837954|FG000|Overall Study|screening failure|1|||
145270787|NCT03179462|523837955|FG001|Overall Study|screening failure|2|||
145270788|NCT03179462|523837956|FG002|Overall Study|screening failure|0|||
145270789|NCT04636437|523837957|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
145270790|NCT04636437|523837958|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
145745259|NCT00631020|525583155|FG000|Overall Study|Lost to Follow-up|7|||
145745260|NCT00631020|525583155|FG000|Overall Study|Incarcerated|1|||
145745261|NCT03548935|525583157|FG000|Overall Study|Withdrawal by Subject|26|||
145745262|NCT03548935|525583158|FG001|Overall Study|Withdrawal by Subject|17|||
145745263|NCT03548935|525583157|FG000|Overall Study|Lost to Follow-up|39|||
145745264|NCT03548935|525583158|FG001|Overall Study|Lost to Follow-up|28|||
145745265|NCT03548935|525583157|FG000|Overall Study|Death|1|||
145270791|NCT04636437|523837959|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
145270792|NCT04636437|523837957|FG000|Overall Study|Started weight loss drug/program|2|||
145522884|NCT04393298|524775917|FG014|Overall Study|Progression|0|||
145522885|NCT04393298|524775903|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
145745266|NCT03548935|525583158|FG001|Overall Study|Death|1|||
145745267|NCT03571646|525583159|FG000|Overall Study|Adverse Event|1|||
145745268|NCT03571646|525583160|FG001|Overall Study|Adverse Event|0|||
145745269|NCT03571646|525583159|FG000|Overall Study|Withdrawal by Subject|1|||
145522886|NCT04393298|524775904|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
145745270|NCT03571646|525583160|FG001|Overall Study|Withdrawal by Subject|1|||
145745271|NCT01970995|525583161|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
145745272|NCT01970995|525583162|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
145745273|NCT01970995|525583163|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
145745274|NCT01970995|525583161|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
145745275|NCT01970995|525583162|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
145745276|NCT01970995|525583163|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
145745277|NCT01157364|525583166|FG000|Overall Study|Other Reasons|1|||
145745278|NCT01157364|525583167|FG001|Overall Study|Other Reasons|1|||
145270793|NCT04636437|523837958|FG001|Overall Study|Started weight loss drug/program|1|||
145270794|NCT04636437|523837959|FG002|Overall Study|Started weight loss drug/program|1|||
145270795|NCT04636437|523837957|FG000|Overall Study|Lost to Follow-up|3|||
145270796|NCT04636437|523837958|FG001|Overall Study|Lost to Follow-up|1|||
145270797|NCT04636437|523837959|FG002|Overall Study|Lost to Follow-up|4|||
145270798|NCT04636437|523837957|FG000|Overall Study|Participant or physician decision|3|||
145270799|NCT04636437|523837958|FG001|Overall Study|Participant or physician decision|1|||
145270800|NCT04636437|523837959|FG002|Overall Study|Participant or physician decision|1|||
145270801|NCT00816166|523837963|FG000|Overall Study|Lost to Follow-up|6|||
145270802|NCT00816166|523837964|FG001|Overall Study|Lost to Follow-up|10|||
145270803|NCT00816166|523837963|FG000|Overall Study|Death|4|||
145270804|NCT00816166|523837964|FG001|Overall Study|Death|2|||
145270805|NCT02851069|523837965|FG000|Overall Study|Failure to Return|3|||
145270806|NCT02851069|523837965|FG000|Overall Study|Other|3|||
145270807|NCT02146365|523837966|FG000|Overall Study|Lost to Follow-up|2|||
145270808|NCT02146365|523837967|FG001|Overall Study|Lost to Follow-up|1|||
145270809|NCT02146365|523837968|FG002|Overall Study|Lost to Follow-up|3|||
145270810|NCT02146365|523837969|FG003|Overall Study|Lost to Follow-up|3|||
145270811|NCT02146365|523837970|FG004|Overall Study|Lost to Follow-up|1|||
145270812|NCT02146365|523837971|FG005|Overall Study|Lost to Follow-up|1|||
145270813|NCT02146365|523837972|FG006|Overall Study|Lost to Follow-up|0|||
145270814|NCT02146365|523837973|FG007|Overall Study|Lost to Follow-up|1|||
145270815|NCT02146365|523837966|FG000|Overall Study|Withdrawal by Subject|1|||
145270816|NCT02146365|523837967|FG001|Overall Study|Withdrawal by Subject|2|||
145270817|NCT02146365|523837968|FG002|Overall Study|Withdrawal by Subject|1|||
145270818|NCT02146365|523837969|FG003|Overall Study|Withdrawal by Subject|5|||
145270819|NCT02146365|523837970|FG004|Overall Study|Withdrawal by Subject|1|||
145270820|NCT02146365|523837971|FG005|Overall Study|Withdrawal by Subject|0|||
145270821|NCT02146365|523837972|FG006|Overall Study|Withdrawal by Subject|0|||
145270822|NCT02146365|523837973|FG007|Overall Study|Withdrawal by Subject|0|||
145270823|NCT02146365|523837966|FG000|Overall Study|Unable to Comply with Protocol|0|||
145270824|NCT02146365|523837967|FG001|Overall Study|Unable to Comply with Protocol|1|||
145270825|NCT02146365|523837968|FG002|Overall Study|Unable to Comply with Protocol|1|||
145270826|NCT02146365|523837969|FG003|Overall Study|Unable to Comply with Protocol|0|||
145270827|NCT02146365|523837970|FG004|Overall Study|Unable to Comply with Protocol|0|||
145270828|NCT02146365|523837971|FG005|Overall Study|Unable to Comply with Protocol|0|||
145270829|NCT02146365|523837972|FG006|Overall Study|Unable to Comply with Protocol|0|||
145270830|NCT02146365|523837973|FG007|Overall Study|Unable to Comply with Protocol|0|||
145270831|NCT02146365|523837966|FG000|Overall Study|Other|1|||
145270832|NCT02146365|523837967|FG001|Overall Study|Other|0|||
145745279|NCT01157364|525583168|FG002|Overall Study|Other Reasons|2|||
145745280|NCT01157364|525583169|FG003|Overall Study|Other Reasons|1|||
145402470|NCT00784875|524330734|FG001|Period C|Sponsor Decision|5|||
145270833|NCT02146365|523837968|FG002|Overall Study|Other|2|||
145270834|NCT02146365|523837969|FG003|Overall Study|Other|1|||
145270835|NCT02146365|523837970|FG004|Overall Study|Other|0|||
145270836|NCT02146365|523837971|FG005|Overall Study|Other|0|||
145270837|NCT02146365|523837972|FG006|Overall Study|Other|0|||
145270838|NCT02146365|523837973|FG007|Overall Study|Other|0|||
145270839|NCT03505606|523839526|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
145402471|NCT00784875|524330735|FG002|Period C|Sponsor Decision|4|||
145745281|NCT01157364|525583170|FG004|Overall Study|Other Reasons|0|||
145745282|NCT01157364|525583171|FG005|Overall Study|Other Reasons|0|||
145745283|NCT01157364|525583166|FG000|Overall Study|Personal Reasons|0|||
145745284|NCT01157364|525583167|FG001|Overall Study|Personal Reasons|2|||
145745285|NCT01157364|525583168|FG002|Overall Study|Personal Reasons|0|||
145745286|NCT01157364|525583169|FG003|Overall Study|Personal Reasons|0|||
145745287|NCT01157364|525583170|FG004|Overall Study|Personal Reasons|1|||
145745288|NCT01157364|525583171|FG005|Overall Study|Personal Reasons|1|||
145745289|NCT01157364|525583166|FG000|Overall Study|Lost to Follow-up|1|||
145745290|NCT01157364|525583167|FG001|Overall Study|Lost to Follow-up|0|||
145745291|NCT01157364|525583168|FG002|Overall Study|Lost to Follow-up|1|||
145745292|NCT01157364|525583169|FG003|Overall Study|Lost to Follow-up|0|||
145745293|NCT01157364|525583170|FG004|Overall Study|Lost to Follow-up|0|||
145745294|NCT01157364|525583171|FG005|Overall Study|Lost to Follow-up|0|||
145745295|NCT01157364|525583166|FG000|Overall Study|Lack of Efficacy|0|||
145745296|NCT01157364|525583167|FG001|Overall Study|Lack of Efficacy|0|||
145745297|NCT01157364|525583168|FG002|Overall Study|Lack of Efficacy|0|||
145745298|NCT01157364|525583169|FG003|Overall Study|Lack of Efficacy|1|||
145745299|NCT01157364|525583170|FG004|Overall Study|Lack of Efficacy|0|||
145745300|NCT01157364|525583171|FG005|Overall Study|Lack of Efficacy|0|||
145745301|NCT01157364|525583166|FG000|Overall Study|Adverse Event|0|||
145745302|NCT01157364|525583167|FG001|Overall Study|Adverse Event|1|||
145745303|NCT01157364|525583168|FG002|Overall Study|Adverse Event|1|||
145745304|NCT01157364|525583169|FG003|Overall Study|Adverse Event|0|||
145745305|NCT01157364|525583170|FG004|Overall Study|Adverse Event|1|||
145745306|NCT01157364|525583171|FG005|Overall Study|Adverse Event|0|||
145745307|NCT01263639|525583172|FG000|Overall Study|Lost to Follow-up|66|||
145745308|NCT01263639|525583173|FG001|Overall Study|Lost to Follow-up|70|||
145745309|NCT01263639|525583172|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
145745310|NCT01263639|525583173|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
145745311|NCT01780662|525583174|FG000|Overall Study|Adverse Event|1|||
145745312|NCT01780662|525583175|FG001|Overall Study|Adverse Event|0|||
145745313|NCT01780662|525583176|FG002|Overall Study|Adverse Event|2|||
145745314|NCT01780662|525583174|FG000|Overall Study|Physician Decision|0|||
145745315|NCT01780662|525583175|FG001|Overall Study|Physician Decision|5|||
145745316|NCT01780662|525583176|FG002|Overall Study|Physician Decision|7|||
145745317|NCT01780662|525583174|FG000|Overall Study|Protocol Violation|0|||
145745318|NCT01780662|525583175|FG001|Overall Study|Protocol Violation|1|||
145745319|NCT01780662|525583176|FG002|Overall Study|Protocol Violation|0|||
145745320|NCT01780662|525583174|FG000|Overall Study|Ineligible|0|||
145745321|NCT01780662|525583175|FG001|Overall Study|Ineligible|0|||
145745322|NCT01780662|525583176|FG002|Overall Study|Ineligible|1|||
145745323|NCT00586495|525583179|FG000|Treatment Period|Adverse Event|11|||
145745324|NCT00586495|525583179|FG000|Treatment Period|Death|1|||
145745325|NCT00586495|525583179|FG000|Treatment Period|Protocol Violation|1|||
145745326|NCT00586495|525583179|FG000|Treatment Period|Withdrawal by Subject|1|||
145745327|NCT00586495|525583179|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
145745328|NCT00586495|525583179|FG000|Treatment Period|Switch to commercial drug|10|||
145745329|NCT00586495|525583179|FG000|Follow-up|Death|40|||
145745330|NCT00586495|525583179|FG000|Follow-up|Lost to Follow-up|1|||
145745331|NCT00586495|525583179|FG000|Follow-up|Withdrawal by Subject|4|||
145745332|NCT00586495|525583179|FG000|Follow-up|Protocol driven decision point|37|||
145745333|NCT00586495|525583179|FG000|Follow-up|Switch to commercial drug|10|||
145745334|NCT03882970|525583187|FG000|Overall Study|Adverse Event|5|||
145745335|NCT03882970|525583188|FG001|Overall Study|Adverse Event|7|||
145745336|NCT03882970|525583189|FG002|Overall Study|Adverse Event|3|||
145745337|NCT03882970|525583190|FG003|Overall Study|Adverse Event|1|||
145745338|NCT03882970|525583187|FG000|Overall Study|Death|1|||
145745339|NCT03882970|525583188|FG001|Overall Study|Death|2|||
145745340|NCT03882970|525583189|FG002|Overall Study|Death|1|||
145745341|NCT03882970|525583190|FG003|Overall Study|Death|1|||
145745342|NCT03882970|525583187|FG000|Overall Study|Lost to Follow-up|8|||
145745343|NCT03882970|525583188|FG001|Overall Study|Lost to Follow-up|9|||
145745344|NCT03882970|525583189|FG002|Overall Study|Lost to Follow-up|5|||
145745345|NCT03882970|525583190|FG003|Overall Study|Lost to Follow-up|5|||
145745346|NCT03882970|525583187|FG000|Overall Study|Physician Decision|0|||
145745347|NCT03882970|525583188|FG001|Overall Study|Physician Decision|2|||
145745348|NCT03882970|525583189|FG002|Overall Study|Physician Decision|2|||
145745349|NCT03882970|525583190|FG003|Overall Study|Physician Decision|2|||
145745350|NCT03882970|525583187|FG000|Overall Study|Protocol Violation|2|||
145745351|NCT03882970|525583188|FG001|Overall Study|Protocol Violation|0|||
145745352|NCT03882970|525583189|FG002|Overall Study|Protocol Violation|0|||
145745353|NCT03882970|525583190|FG003|Overall Study|Protocol Violation|0|||
145745354|NCT03882970|525583187|FG000|Overall Study|Withdrawal by Subject|8|||
145745355|NCT03882970|525583188|FG001|Overall Study|Withdrawal by Subject|17|||
145745356|NCT03882970|525583189|FG002|Overall Study|Withdrawal by Subject|7|||
145745357|NCT03882970|525583190|FG003|Overall Study|Withdrawal by Subject|22|||
145745358|NCT03882970|525583187|FG000|Overall Study|Personal Reason|2|||
145745359|NCT03882970|525583188|FG001|Overall Study|Personal Reason|3|||
145745360|NCT03882970|525583189|FG002|Overall Study|Personal Reason|1|||
145745361|NCT03882970|525583190|FG003|Overall Study|Personal Reason|3|||
145745362|NCT02025907|525583205|FG000|Overall Study|Lack of Efficacy|1|||
145745363|NCT02025907|525583206|FG001|Overall Study|Lack of Efficacy|0|||
145745364|NCT02025907|525583205|FG000|Overall Study|Withdrawal by Subject|15|||
145745365|NCT02025907|525583206|FG001|Overall Study|Withdrawal by Subject|8|||
145745366|NCT02025907|525583205|FG000|Overall Study|Protocol Violation|2|||
145745367|NCT02025907|525583206|FG001|Overall Study|Protocol Violation|0|||
145745368|NCT02025907|525583205|FG000|Overall Study|Physician Decision|2|||
145745369|NCT02025907|525583206|FG001|Overall Study|Physician Decision|0|||
145745370|NCT02025907|525583205|FG000|Overall Study|Lost to Follow-up|2|||
145745371|NCT02025907|525583206|FG001|Overall Study|Lost to Follow-up|2|||
145745372|NCT02025907|525583205|FG000|Overall Study|Adverse Event|3|||
145745373|NCT02025907|525583206|FG001|Overall Study|Adverse Event|1|||
145745374|NCT02025907|525583205|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
145745375|NCT02025907|525583206|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
145745376|NCT02411539|525583210|FG000|Overall Study|Lost to Follow-up|2|||
145745377|NCT02411539|525583211|FG001|Overall Study|Lost to Follow-up|0|||
145745378|NCT02411539|525583210|FG000|Overall Study|Confounding medical condition|0|||
145745379|NCT02411539|525583211|FG001|Overall Study|Confounding medical condition|1|||
145745380|NCT03631732|525583219|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
145745381|NCT03631732|525583220|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
145745382|NCT03631732|525583219|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
145745383|NCT03631732|525583220|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
145745384|NCT03631732|525583219|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
145745385|NCT03631732|525583220|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
145745386|NCT03631732|525583219|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
145745387|NCT03631732|525583220|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
145745388|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
145745389|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
145745390|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
145745391|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
145745392|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
145745393|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
145745394|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
145745395|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
145745396|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
145745397|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
145745398|NCT03631732|525583219|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
145745399|NCT03631732|525583220|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
145745400|NCT00886600|525583221|FG000|Double-blind Monotherapy|Adverse Event|1|||
145745401|NCT00886600|525583222|FG001|Double-blind Monotherapy|Adverse Event|1|||
145745402|NCT00886600|525583223|FG002|Double-blind Monotherapy|Adverse Event|1|||
145745403|NCT00886600|525583224|FG003|Double-blind Monotherapy|Adverse Event|1|||
145745404|NCT00886600|525583221|FG000|Double-blind Monotherapy|Protocol Violation|0|||
145745405|NCT00886600|525583222|FG001|Double-blind Monotherapy|Protocol Violation|0|||
145745406|NCT00886600|525583223|FG002|Double-blind Monotherapy|Protocol Violation|0|||
145745407|NCT00886600|525583224|FG003|Double-blind Monotherapy|Protocol Violation|1|||
145745408|NCT00886600|525583221|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
145745409|NCT00886600|525583222|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
145745410|NCT00886600|525583223|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
145522887|NCT04393298|524775905|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522888|NCT04393298|524775906|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522889|NCT04393298|524775907|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522890|NCT04393298|524775908|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522891|NCT04393298|524775909|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522892|NCT04393298|524775910|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522893|NCT04393298|524775911|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522894|NCT04393298|524775912|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522895|NCT04393298|524775913|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522896|NCT04393298|524775914|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522897|NCT04393298|524775915|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
145745411|NCT00886600|525583224|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
145745412|NCT00886600|525583221|FG000|Combination Therapy Period|Adverse Event|0|||
145745413|NCT00886600|525583222|FG001|Combination Therapy Period|Adverse Event|0|||
145522898|NCT04393298|524775916|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
145745414|NCT00886600|525583223|FG002|Combination Therapy Period|Adverse Event|1|||
145745415|NCT00886600|525583224|FG003|Combination Therapy Period|Adverse Event|0|||
145745416|NCT00886600|525583221|FG000|Combination Therapy Period|Protocol Violation|0|||
145745417|NCT00886600|525583222|FG001|Combination Therapy Period|Protocol Violation|0|||
145745418|NCT00886600|525583223|FG002|Combination Therapy Period|Protocol Violation|1|||
145745419|NCT00886600|525583224|FG003|Combination Therapy Period|Protocol Violation|0|||
145745420|NCT01251367|525583225|FG000|Overall Study|Protocol Violation|1|||
145745421|NCT01251367|525583225|FG000|Overall Study|Lack of Efficacy|2|||
145745422|NCT01251367|525583225|FG000|Overall Study|Adverse Event|19|||
145745423|NCT01251367|525583225|FG000|Overall Study|Withdrawal by Subject|36|||
145745424|NCT01251367|525583225|FG000|Overall Study|Lost to Follow-up|5|||
145745425|NCT01251367|525583225|FG000|Overall Study|Subject Required Alternative Treatment|7|||
145745426|NCT01251367|525583225|FG000|Overall Study|No Study Drug Available|1|||
145745427|NCT01251367|525583225|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
145745428|NCT01251367|525583225|FG000|Overall Study|End of Study Visit Performed in Error|1|||
145745429|NCT02016820|525583228|FG000|Overall Study|Lost to Follow-up|2|||
145745430|NCT02016820|525583229|FG001|Overall Study|Lost to Follow-up|4|||
145745431|NCT00473343|525583230|FG000|Overall Study|Adverse Event|9|||
145745432|NCT00473343|525583230|FG000|Overall Study|Lost to Follow-up|8|||
145745433|NCT00473343|525583230|FG000|Overall Study|Treatment failure|27|||
145745434|NCT00473343|525583230|FG000|Overall Study|Withdrew consent|3|||
145745435|NCT00473343|525583230|FG000|Overall Study|Other un-specified reason|3|||
145745436|NCT02370615|525583231|FG000|Overall Study|Adverse Event|1|||
145745437|NCT02370615|525583232|FG001|Overall Study|Adverse Event|0|||
145745438|NCT03610724|525583233|FG000|Overall Study|Death|17|||
145745439|NCT03610724|525583233|FG000|Overall Study|Lost to Follow-up|1|||
145745440|NCT03610724|525583233|FG000|Overall Study|Physician Decision|1|||
145745441|NCT03610724|525583233|FG000|Overall Study|Died prior to infusion|1|||
145745442|NCT01473563|525583234|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
145745443|NCT00788372|525583235|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
145745444|NCT00788372|525583235|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
145745445|NCT00788372|525583235|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
145745446|NCT00788372|525583235|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
145522899|NCT04393298|524775917|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
145522900|NCT04393298|524775903|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522901|NCT04393298|524775904|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
145522902|NCT04393298|524775905|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522903|NCT04393298|524775906|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522904|NCT04393298|524775907|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522905|NCT04393298|524775908|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522906|NCT04393298|524775909|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522907|NCT04393298|524775910|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522908|NCT04393298|524775911|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522909|NCT04393298|524775912|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522910|NCT04393298|524775913|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522911|NCT04393298|524775914|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522912|NCT04393298|524775915|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522913|NCT04393298|524775916|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522914|NCT04393298|524775917|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
145522915|NCT04393298|524775903|FG000|Overall Study|Clinical Progression|0|||
145522916|NCT04393298|524775904|FG001|Overall Study|Clinical Progression|2|||
145522917|NCT04393298|524775905|FG002|Overall Study|Clinical Progression|0|||
145522918|NCT04393298|524775906|FG003|Overall Study|Clinical Progression|0|||
145522919|NCT04393298|524775907|FG004|Overall Study|Clinical Progression|0|||
145522920|NCT04393298|524775908|FG005|Overall Study|Clinical Progression|0|||
145522921|NCT04393298|524775909|FG006|Overall Study|Clinical Progression|0|||
145522922|NCT04393298|524775910|FG007|Overall Study|Clinical Progression|0|||
145522923|NCT04393298|524775911|FG008|Overall Study|Clinical Progression|0|||
145522924|NCT04393298|524775912|FG009|Overall Study|Clinical Progression|0|||
145522925|NCT04393298|524775913|FG010|Overall Study|Clinical Progression|0|||
145522926|NCT04393298|524775914|FG011|Overall Study|Clinical Progression|0|||
145522927|NCT04393298|524775915|FG012|Overall Study|Clinical Progression|0|||
145745447|NCT00788372|525583235|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
145745448|NCT00788372|525583235|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
145745449|NCT00788372|525583235|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
145745450|NCT01439555|525583240|FG000|Overall Study|Protocol Violation|1|||
145745451|NCT02581202|525583248|FG000|Overall Study|Lack of Efficacy|2|||
145745452|NCT02581202|525583248|FG000|Overall Study|Withdrawal by Subject|4|||
145522928|NCT04393298|524775916|FG013|Overall Study|Clinical Progression|0|||
145522929|NCT04393298|524775917|FG014|Overall Study|Clinical Progression|0|||
145745453|NCT02581202|525583248|FG000|Overall Study|Lost to Follow-up|5|||
145745454|NCT02581202|525583248|FG000|Overall Study|Pregnancy|3|||
145745455|NCT04129528|525584735|FG000|Overall Study|Adverse Event|1|||
145745456|NCT04129528|525584736|FG001|Overall Study|Adverse Event|0|||
145745457|NCT04129528|525584735|FG000|Overall Study|Physician Decision|1|||
145745458|NCT04129528|525584736|FG001|Overall Study|Physician Decision|1|||
145745459|NCT04129528|525584735|FG000|Overall Study|Withdrawal by Subject|1|||
145745460|NCT04129528|525584736|FG001|Overall Study|Withdrawal by Subject|1|||
145745461|NCT01395394|525584740|FG000|Baseline Study Visit|Protocol Violation|1|||
145745462|NCT01395394|525584741|FG001|Baseline Study Visit|Protocol Violation|0|||
145745463|NCT01395394|525584742|FG002|Baseline Study Visit|Protocol Violation|0|||
145745464|NCT05121480|525584743|FG000|Overall Study|Lack of Efficacy|2|||
145745465|NCT05121480|525584744|FG001|Overall Study|Lack of Efficacy|2|||
145745466|NCT05121480|525584745|FG002|Overall Study|Lack of Efficacy|1|||
145745467|NCT05121480|525584746|FG003|Overall Study|Lack of Efficacy|4|||
145745468|NCT05121480|525584747|FG004|Overall Study|Lack of Efficacy|0|||
145745469|NCT05121480|525584748|FG005|Overall Study|Lack of Efficacy|1|||
145745470|NCT05121480|525584749|FG006|Overall Study|Lack of Efficacy|0|||
145745471|NCT05121480|525584750|FG007|Overall Study|Lack of Efficacy|2|||
145745472|NCT05121480|525584743|FG000|Overall Study|Treatment Failure|0|||
145745473|NCT05121480|525584744|FG001|Overall Study|Treatment Failure|2|||
145745474|NCT05121480|525584745|FG002|Overall Study|Treatment Failure|0|||
145745475|NCT05121480|525584746|FG003|Overall Study|Treatment Failure|1|||
145745476|NCT05121480|525584747|FG004|Overall Study|Treatment Failure|0|||
145745477|NCT05121480|525584748|FG005|Overall Study|Treatment Failure|0|||
145745478|NCT05121480|525584749|FG006|Overall Study|Treatment Failure|0|||
145745479|NCT05121480|525584750|FG007|Overall Study|Treatment Failure|0|||
145745480|NCT05121480|525584743|FG000|Overall Study|Adverse Event|0|||
145745481|NCT05121480|525584744|FG001|Overall Study|Adverse Event|1|||
145745482|NCT05121480|525584745|FG002|Overall Study|Adverse Event|0|||
145522930|NCT04393298|524775903|FG000|Overall Study|Disease Progression|0|||
145522931|NCT04393298|524775904|FG001|Overall Study|Disease Progression|1|||
145745483|NCT05121480|525584746|FG003|Overall Study|Adverse Event|5|||
145522932|NCT04393298|524775905|FG002|Overall Study|Disease Progression|0|||
145745484|NCT05121480|525584747|FG004|Overall Study|Adverse Event|3|||
145745485|NCT05121480|525584748|FG005|Overall Study|Adverse Event|2|||
145745486|NCT05121480|525584749|FG006|Overall Study|Adverse Event|0|||
145745487|NCT05121480|525584750|FG007|Overall Study|Adverse Event|4|||
145745488|NCT05121480|525584743|FG000|Overall Study|Withdrawal by Subject|4|||
145745489|NCT05121480|525584744|FG001|Overall Study|Withdrawal by Subject|9|||
145745490|NCT05121480|525584745|FG002|Overall Study|Withdrawal by Subject|1|||
145745491|NCT05121480|525584746|FG003|Overall Study|Withdrawal by Subject|8|||
145522933|NCT04393298|524775906|FG003|Overall Study|Disease Progression|0|||
145522934|NCT04393298|524775907|FG004|Overall Study|Disease Progression|0|||
145522935|NCT04393298|524775908|FG005|Overall Study|Disease Progression|3|||
145522936|NCT04393298|524775909|FG006|Overall Study|Disease Progression|2|||
145522937|NCT04393298|524775910|FG007|Overall Study|Disease Progression|1|||
145522938|NCT04393298|524775911|FG008|Overall Study|Disease Progression|2|||
145522939|NCT04393298|524775912|FG009|Overall Study|Disease Progression|1|||
145522940|NCT04393298|524775913|FG010|Overall Study|Disease Progression|0|||
145522941|NCT04393298|524775914|FG011|Overall Study|Disease Progression|3|||
145522942|NCT04393298|524775915|FG012|Overall Study|Disease Progression|0|||
145745492|NCT05121480|525584747|FG004|Overall Study|Withdrawal by Subject|0|||
145745493|NCT05121480|525584748|FG005|Overall Study|Withdrawal by Subject|9|||
145745494|NCT05121480|525584749|FG006|Overall Study|Withdrawal by Subject|0|||
145745495|NCT05121480|525584750|FG007|Overall Study|Withdrawal by Subject|4|||
145745496|NCT05121480|525584743|FG000|Overall Study|Non-compliance with the protocol|0|||
145745497|NCT05121480|525584744|FG001|Overall Study|Non-compliance with the protocol|0|||
145745498|NCT05121480|525584745|FG002|Overall Study|Non-compliance with the protocol|0|||
145745499|NCT05121480|525584746|FG003|Overall Study|Non-compliance with the protocol|0|||
145745500|NCT05121480|525584747|FG004|Overall Study|Non-compliance with the protocol|1|||
145745501|NCT05121480|525584748|FG005|Overall Study|Non-compliance with the protocol|6|||
145745502|NCT05121480|525584749|FG006|Overall Study|Non-compliance with the protocol|0|||
145745503|NCT05121480|525584750|FG007|Overall Study|Non-compliance with the protocol|1|||
145745504|NCT05121480|525584743|FG000|Overall Study|Lost to Follow-up|0|||
145745505|NCT05121480|525584744|FG001|Overall Study|Lost to Follow-up|4|||
145522943|NCT04393298|524775916|FG013|Overall Study|Disease Progression|0|||
145522944|NCT04393298|524775917|FG014|Overall Study|Disease Progression|1|||
145522945|NCT04393298|524775903|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522946|NCT04393298|524775904|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145745506|NCT05121480|525584745|FG002|Overall Study|Lost to Follow-up|1|||
145745507|NCT05121480|525584746|FG003|Overall Study|Lost to Follow-up|3|||
145522947|NCT04393298|524775905|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
145522948|NCT04393298|524775906|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522949|NCT04393298|524775907|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145745508|NCT05121480|525584747|FG004|Overall Study|Lost to Follow-up|1|||
145745509|NCT05121480|525584748|FG005|Overall Study|Lost to Follow-up|1|||
145745510|NCT05121480|525584749|FG006|Overall Study|Lost to Follow-up|1|||
145745511|NCT05121480|525584750|FG007|Overall Study|Lost to Follow-up|4|||
145745512|NCT05121480|525584743|FG000|Overall Study|Physician Decision|0|||
145745513|NCT05121480|525584744|FG001|Overall Study|Physician Decision|0|||
145745514|NCT05121480|525584745|FG002|Overall Study|Physician Decision|0|||
145745515|NCT05121480|525584746|FG003|Overall Study|Physician Decision|0|||
145745516|NCT05121480|525584747|FG004|Overall Study|Physician Decision|0|||
145745517|NCT05121480|525584748|FG005|Overall Study|Physician Decision|1|||
145745518|NCT05121480|525584749|FG006|Overall Study|Physician Decision|0|||
145745519|NCT05121480|525584750|FG007|Overall Study|Physician Decision|1|||
145745520|NCT05121480|525584743|FG000|Overall Study|Other Reason|0|||
145745521|NCT05121480|525584744|FG001|Overall Study|Other Reason|0|||
145745522|NCT05121480|525584745|FG002|Overall Study|Other Reason|0|||
145745523|NCT05121480|525584746|FG003|Overall Study|Other Reason|0|||
145745524|NCT05121480|525584747|FG004|Overall Study|Other Reason|0|||
145745525|NCT05121480|525584748|FG005|Overall Study|Other Reason|1|||
145745526|NCT05121480|525584749|FG006|Overall Study|Other Reason|1|||
145745527|NCT05121480|525584750|FG007|Overall Study|Other Reason|1|||
145745528|NCT00772954|525584751|FG000|Overall Study|Adverse Event|0|||
145745529|NCT00772954|525584752|FG001|Overall Study|Adverse Event|0|||
145745530|NCT00772954|525584753|FG002|Overall Study|Adverse Event|1|||
145522950|NCT04393298|524775908|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522951|NCT04393298|524775909|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145745531|NCT00789529|525584759|FG000|Overall Study|Withdrawal by Subject|0|||
145745532|NCT00789529|525584760|FG001|Overall Study|Withdrawal by Subject|1|||
145745533|NCT00789529|525584759|FG000|Overall Study|Other Reason|1|||
145745534|NCT00789529|525584760|FG001|Overall Study|Other Reason|0|||
145745535|NCT01135498|525584761|FG000|Overall Study|Adverse Event|20|||
145745536|NCT01135498|525584761|FG000|Overall Study|Progressive disease|38|||
145745537|NCT01135498|525584761|FG000|Overall Study|Investigator judgement|25|||
145745538|NCT01135498|525584761|FG000|Overall Study|Withdrawal by Subject|4|||
145745539|NCT01135498|525584761|FG000|Overall Study|Death|1|||
145745540|NCT01135498|525584761|FG000|Overall Study|Ongoing at time of analysis|2|||
145745541|NCT00129766|525584762|FG000|Overall Study|Death|3|||
145745542|NCT00129766|525584763|FG001|Overall Study|Death|8|||
145745543|NCT00129766|525584762|FG000|Overall Study|Withdrawal of consent|31|||
145745544|NCT00129766|525584763|FG001|Overall Study|Withdrawal of consent|30|||
145745545|NCT00129766|525584762|FG000|Overall Study|Lost to Follow-up|26|||
145745546|NCT00129766|525584763|FG001|Overall Study|Lost to Follow-up|21|||
145745547|NCT01081912|525584766|FG000|Conversion/Titration|Adverse Event|47|||
145745548|NCT01081912|525584767|FG001|Conversion/Titration|Adverse Event|0|||
145745549|NCT01081912|525584768|FG002|Conversion/Titration|Adverse Event|0|||
145745550|NCT01081912|525584766|FG000|Conversion/Titration|Lack of Efficacy|17|||
145745551|NCT01081912|525584767|FG001|Conversion/Titration|Lack of Efficacy|0|||
145745552|NCT01081912|525584768|FG002|Conversion/Titration|Lack of Efficacy|0|||
145745553|NCT01081912|525584766|FG000|Conversion/Titration|Lost to Follow-up|5|||
145522952|NCT04393298|524775910|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522953|NCT04393298|524775911|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522954|NCT04393298|524775912|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522955|NCT04393298|524775913|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522956|NCT04393298|524775914|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522957|NCT04393298|524775915|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522958|NCT04393298|524775916|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522959|NCT04393298|524775917|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
145522960|NCT04393298|524775903|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522961|NCT04393298|524775904|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522962|NCT04393298|524775905|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
145522963|NCT04393298|524775906|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522964|NCT04393298|524775907|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522965|NCT04393298|524775908|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522966|NCT04393298|524775909|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522967|NCT04393298|524775910|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522968|NCT04393298|524775911|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522969|NCT04393298|524775912|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
145745554|NCT01081912|525584767|FG001|Conversion/Titration|Lost to Follow-up|0|||
145745555|NCT01081912|525584768|FG002|Conversion/Titration|Lost to Follow-up|0|||
145745556|NCT01081912|525584766|FG000|Conversion/Titration|Physician Decision|2|||
145745557|NCT01081912|525584767|FG001|Conversion/Titration|Physician Decision|0|||
145745558|NCT01081912|525584768|FG002|Conversion/Titration|Physician Decision|0|||
145745559|NCT01081912|525584766|FG000|Conversion/Titration|Protocol Violation|67|||
145402472|NCT00784875|524330736|FG003|Period C|Sponsor Decision|2|||
145745560|NCT01081912|525584767|FG001|Conversion/Titration|Protocol Violation|0|||
145745561|NCT01081912|525584768|FG002|Conversion/Titration|Protocol Violation|0|||
145745562|NCT01081912|525584766|FG000|Conversion/Titration|Withdrawal by Subject|23|||
145745563|NCT01081912|525584767|FG001|Conversion/Titration|Withdrawal by Subject|0|||
145745564|NCT01081912|525584768|FG002|Conversion/Titration|Withdrawal by Subject|0|||
145745565|NCT01081912|525584766|FG000|Conversion/Titration|Non-Compliance|47|||
145745566|NCT01081912|525584767|FG001|Conversion/Titration|Non-Compliance|0|||
145745567|NCT01081912|525584768|FG002|Conversion/Titration|Non-Compliance|0|||
145745568|NCT01081912|525584766|FG000|Maintenance Treatment|Adverse Event|0|||
145745569|NCT01081912|525584767|FG001|Maintenance Treatment|Adverse Event|2|||
145745570|NCT01081912|525584768|FG002|Maintenance Treatment|Adverse Event|12|||
145745571|NCT01081912|525584766|FG000|Maintenance Treatment|Lack of Efficacy|0|||
145745572|NCT01081912|525584767|FG001|Maintenance Treatment|Lack of Efficacy|14|||
145745573|NCT01081912|525584768|FG002|Maintenance Treatment|Lack of Efficacy|64|||
145745574|NCT01081912|525584766|FG000|Maintenance Treatment|Lost to Follow-up|0|||
145745575|NCT01081912|525584767|FG001|Maintenance Treatment|Lost to Follow-up|1|||
145745576|NCT01081912|525584768|FG002|Maintenance Treatment|Lost to Follow-up|0|||
145745577|NCT01081912|525584766|FG000|Maintenance Treatment|Physician Decision|0|||
145745578|NCT01081912|525584767|FG001|Maintenance Treatment|Physician Decision|0|||
145745579|NCT01081912|525584768|FG002|Maintenance Treatment|Physician Decision|1|||
145745580|NCT01081912|525584766|FG000|Maintenance Treatment|Protocol Violation|0|||
145745581|NCT01081912|525584767|FG001|Maintenance Treatment|Protocol Violation|1|||
145745582|NCT01081912|525584768|FG002|Maintenance Treatment|Protocol Violation|2|||
145745583|NCT01081912|525584766|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
145745584|NCT01081912|525584767|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
145745585|NCT01081912|525584768|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
145745586|NCT01081912|525584766|FG000|Maintenance Treatment|Non-Compliance|0|||
145745587|NCT01081912|525584767|FG001|Maintenance Treatment|Non-Compliance|4|||
145745588|NCT01081912|525584768|FG002|Maintenance Treatment|Non-Compliance|7|||
145745589|NCT01081912|525584766|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
145745590|NCT01081912|525584767|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
145745591|NCT01081912|525584768|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
145745592|NCT02699892|525584772|FG000|Overall Study|Other|36|||
145745593|NCT02770547|525584773|FG000|Overall Study|Patient non-compliant|1|||
145745594|NCT02770547|525584774|FG001|Overall Study|Patient non-compliant|0|||
145745595|NCT02770547|525584773|FG000|Overall Study|Adverse Event|0|||
145745596|NCT02770547|525584774|FG001|Overall Study|Adverse Event|1|||
145745597|NCT00847912|525584775|FG000|Overall Study|Protocol Violation|6|||
145745598|NCT00847912|525584776|FG001|Overall Study|Protocol Violation|7|||
145745599|NCT00847912|525584775|FG000|Overall Study|Withdrawal by Subject|3|||
145745600|NCT00847912|525584776|FG001|Overall Study|Withdrawal by Subject|6|||
145745601|NCT01732796|525584778|FG000|Overall Study|Adverse Event|16|||
145745602|NCT01732796|525584779|FG001|Overall Study|Adverse Event|16|||
145745603|NCT01732796|525584780|FG002|Overall Study|Adverse Event|4|||
145745604|NCT01732796|525584778|FG000|Overall Study|Lack of Efficacy|21|||
145745605|NCT01732796|525584779|FG001|Overall Study|Lack of Efficacy|18|||
145745606|NCT01732796|525584780|FG002|Overall Study|Lack of Efficacy|5|||
145745607|NCT01732796|525584778|FG000|Overall Study|Lost to Follow-up|2|||
145745608|NCT01732796|525584779|FG001|Overall Study|Lost to Follow-up|0|||
145745609|NCT01732796|525584780|FG002|Overall Study|Lost to Follow-up|0|||
145745610|NCT01732796|525584778|FG000|Overall Study|Withdrawal by Subject|6|||
145745611|NCT01732796|525584779|FG001|Overall Study|Withdrawal by Subject|8|||
145745612|NCT01732796|525584780|FG002|Overall Study|Withdrawal by Subject|2|||
145745613|NCT01732796|525584778|FG000|Overall Study|Other reason not defined above|1|||
145745614|NCT01732796|525584779|FG001|Overall Study|Other reason not defined above|0|||
145745615|NCT01732796|525584780|FG002|Overall Study|Other reason not defined above|2|||
145745616|NCT01379274|525584783|FG000|Overall Study|funding withdrawn|1|||
145745617|NCT01650636|525584784|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
145745618|NCT01650636|525584785|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
145745619|NCT01650636|525584784|FG000|Washout up to 5 Months|Physician Decision|2|||
145745620|NCT01650636|525584785|FG001|Washout up to 5 Months|Physician Decision|2|||
145745621|NCT01650636|525584784|FG000|Washout up to 5 Months|Death|1|||
145522970|NCT04393298|524775913|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522971|NCT04393298|524775914|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522972|NCT04393298|524775915|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522973|NCT04393298|524775916|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522974|NCT04393298|524775917|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
145522975|NCT04393298|524775903|FG000|Overall Study|Progressive Disease (PD)|0|||
145745622|NCT01650636|525584785|FG001|Washout up to 5 Months|Death|0|||
145745623|NCT01650636|525584784|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
145745624|NCT01650636|525584785|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
145745625|NCT01650636|525584784|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
145745626|NCT01650636|525584785|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
145745627|NCT01650636|525584784|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
145745628|NCT01650636|525584785|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
145745629|NCT03287219|525584787|FG000|Overall Study|Protocol Violation|0|||
145745630|NCT03287219|525584788|FG001|Overall Study|Protocol Violation|2|||
145745631|NCT01576549|525584795|FG000|Overall Study|Sponsor Decision|2|||
145745632|NCT04081363|525584796|FG000|Overall Study|Withdrawal by Subject|1|||
145745633|NCT04081363|525584797|FG001|Overall Study|Withdrawal by Subject|0|||
145745634|NCT00708500|525584798|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
145745635|NCT00708500|525584799|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
145745636|NCT00708500|525584800|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
145745637|NCT00708500|525584798|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
145745638|NCT00708500|525584799|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
145745639|NCT00708500|525584800|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
145745640|NCT00708500|525584798|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
145745641|NCT00708500|525584799|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
145745642|NCT00708500|525584800|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
145745643|NCT00708500|525584798|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
145745644|NCT00708500|525584799|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
145745645|NCT00708500|525584800|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
145745646|NCT00708500|525584798|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
145745647|NCT00708500|525584799|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
145745648|NCT00708500|525584800|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
145745649|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
145745650|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
145745651|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
145745652|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
145745653|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
145745654|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
145745655|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
145745656|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
145745657|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
145745658|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
145745659|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
145745660|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
145745661|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
145745662|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
145745663|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
145745664|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
145745665|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
145745666|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
145745667|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
145745668|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
145745669|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
145745670|NCT00708500|525584798|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
145745671|NCT00708500|525584799|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
145745672|NCT00708500|525584800|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
145745673|NCT00708500|525584798|FG000|FOLLOWUP|Adverse Event|0|||
145745674|NCT00708500|525584799|FG001|FOLLOWUP|Adverse Event|1|||
145745675|NCT00708500|525584800|FG002|FOLLOWUP|Adverse Event|0|||
145745676|NCT00708500|525584798|FG000|FOLLOWUP|Lost to Follow-up|1|||
145745677|NCT00708500|525584799|FG001|FOLLOWUP|Lost to Follow-up|6|||
145745678|NCT00708500|525584800|FG002|FOLLOWUP|Lost to Follow-up|4|||
145745679|NCT00708500|525584798|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
145745680|NCT00708500|525584799|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
145745681|NCT00708500|525584800|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
145745682|NCT00708500|525584798|FG000|FOLLOWUP|Subject withdrew consent|31|||
145745683|NCT00708500|525584799|FG001|FOLLOWUP|Subject withdrew consent|4|||
145745684|NCT00708500|525584800|FG002|FOLLOWUP|Subject withdrew consent|5|||
145745685|NCT00708500|525584798|FG000|FOLLOWUP|Non-compliance with protocol|5|||
145745686|NCT00708500|525584799|FG001|FOLLOWUP|Non-compliance with protocol|0|||
145745687|NCT00708500|525584800|FG002|FOLLOWUP|Non-compliance with protocol|1|||
145745688|NCT03975920|525584803|FG000|Overall Study|Lost to Follow-up|1|||
145745689|NCT03975920|525584804|FG001|Overall Study|Lost to Follow-up|2|||
145745690|NCT03975920|525584803|FG000|Overall Study|Protocol Violation|1|||
145745691|NCT03975920|525584804|FG001|Overall Study|Protocol Violation|1|||
145745692|NCT03975920|525584803|FG000|Overall Study|Did not complete survey|2|||
145745693|NCT03975920|525584804|FG001|Overall Study|Did not complete survey|1|||
145745694|NCT02182687|525584808|FG000|Overall Study|Withdrawal by Subject|4|||
145522976|NCT04393298|524775904|FG001|Overall Study|Progressive Disease (PD)|0|||
145522977|NCT04393298|524775905|FG002|Overall Study|Progressive Disease (PD)|0|||
145522978|NCT04393298|524775906|FG003|Overall Study|Progressive Disease (PD)|3|||
145522979|NCT04393298|524775907|FG004|Overall Study|Progressive Disease (PD)|0|||
145402473|NCT00784875|524330733|FG000|Period D|Adverse Event|0|||
145522980|NCT04393298|524775908|FG005|Overall Study|Progressive Disease (PD)|0|||
145522981|NCT04393298|524775909|FG006|Overall Study|Progressive Disease (PD)|0|||
145522982|NCT04393298|524775910|FG007|Overall Study|Progressive Disease (PD)|0|||
145522983|NCT04393298|524775911|FG008|Overall Study|Progressive Disease (PD)|0|||
145522984|NCT04393298|524775912|FG009|Overall Study|Progressive Disease (PD)|0|||
145522985|NCT04393298|524775913|FG010|Overall Study|Progressive Disease (PD)|0|||
145522986|NCT04393298|524775914|FG011|Overall Study|Progressive Disease (PD)|0|||
145522987|NCT04393298|524775915|FG012|Overall Study|Progressive Disease (PD)|0|||
145522988|NCT04393298|524775916|FG013|Overall Study|Progressive Disease (PD)|0|||
145522989|NCT04393298|524775917|FG014|Overall Study|Progressive Disease (PD)|0|||
145522990|NCT04393298|524775903|FG000|Overall Study|Started a New Cancer Treatment|0|||
145522991|NCT04393298|524775904|FG001|Overall Study|Started a New Cancer Treatment|0|||
145522992|NCT04393298|524775905|FG002|Overall Study|Started a New Cancer Treatment|0|||
145522993|NCT04393298|524775906|FG003|Overall Study|Started a New Cancer Treatment|0|||
145522994|NCT04393298|524775907|FG004|Overall Study|Started a New Cancer Treatment|1|||
145522995|NCT04393298|524775908|FG005|Overall Study|Started a New Cancer Treatment|0|||
145522996|NCT04393298|524775909|FG006|Overall Study|Started a New Cancer Treatment|0|||
145522997|NCT04393298|524775910|FG007|Overall Study|Started a New Cancer Treatment|0|||
145522998|NCT04393298|524775911|FG008|Overall Study|Started a New Cancer Treatment|0|||
145522999|NCT04393298|524775912|FG009|Overall Study|Started a New Cancer Treatment|0|||
145523000|NCT04393298|524775913|FG010|Overall Study|Started a New Cancer Treatment|0|||
145523001|NCT04393298|524775914|FG011|Overall Study|Started a New Cancer Treatment|0|||
145523002|NCT04393298|524775915|FG012|Overall Study|Started a New Cancer Treatment|0|||
145523003|NCT04393298|524775916|FG013|Overall Study|Started a New Cancer Treatment|0|||
145523004|NCT04393298|524775917|FG014|Overall Study|Started a New Cancer Treatment|0|||
145523005|NCT04393298|524775903|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523006|NCT04393298|524775904|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523007|NCT04393298|524775905|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523008|NCT04393298|524775906|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523009|NCT04393298|524775907|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
145523010|NCT04393298|524775908|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523011|NCT04393298|524775909|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523012|NCT04393298|524775910|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523013|NCT04393298|524775911|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523014|NCT04393298|524775912|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523015|NCT04393298|524775913|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523016|NCT04393298|524775914|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523017|NCT04393298|524775915|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523018|NCT04393298|524775916|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523019|NCT04393298|524775917|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
145523020|NCT04393298|524775903|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523021|NCT04393298|524775904|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523022|NCT04393298|524775905|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523023|NCT04393298|524775906|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523024|NCT04393298|524775907|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523025|NCT04393298|524775908|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
145523026|NCT04393298|524775909|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523027|NCT04393298|524775910|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523028|NCT04393298|524775911|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523029|NCT04393298|524775912|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523030|NCT04393298|524775913|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523031|NCT04393298|524775914|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523032|NCT04393298|524775915|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523033|NCT04393298|524775916|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523034|NCT04393298|524775917|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
145523035|NCT04393298|524775903|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523036|NCT04393298|524775904|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523037|NCT04393298|524775905|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145745695|NCT02182687|525584809|FG001|Overall Study|Withdrawal by Subject|0|||
145745696|NCT02182687|525584808|FG000|Overall Study|Adverse Event|1|||
145745697|NCT02182687|525584809|FG001|Overall Study|Adverse Event|0|||
145745698|NCT02182687|525584808|FG000|Overall Study|Lost to Follow-up|0|||
145745699|NCT02182687|525584809|FG001|Overall Study|Lost to Follow-up|1|||
145745700|NCT02716987|525584811|FG000|Overall Study|Ligand synthesis failure|0|||
145745701|NCT02716987|525584812|FG001|Overall Study|Ligand synthesis failure|0|||
145745702|NCT02716987|525584813|FG002|Overall Study|Ligand synthesis failure|1|||
145745703|NCT02716987|525584814|FG003|Overall Study|Ligand synthesis failure|0|||
145745704|NCT02716987|525584815|FG004|Overall Study|Ligand synthesis failure|0|||
145745705|NCT02716987|525584816|FG005|Overall Study|Ligand synthesis failure|0|||
145745706|NCT02716987|525584811|FG000|Overall Study|Withdrawal by Subject|0|||
145745707|NCT02716987|525584812|FG001|Overall Study|Withdrawal by Subject|0|||
145745708|NCT02716987|525584813|FG002|Overall Study|Withdrawal by Subject|0|||
145745709|NCT02716987|525584814|FG003|Overall Study|Withdrawal by Subject|0|||
145745710|NCT02716987|525584815|FG004|Overall Study|Withdrawal by Subject|1|||
145745711|NCT02716987|525584816|FG005|Overall Study|Withdrawal by Subject|1|||
145745712|NCT02829138|525584817|FG000|Overall Study|Withdrawal by Subject|1|||
145745713|NCT02829138|525584818|FG001|Overall Study|Withdrawal by Subject|0|||
145745714|NCT01765920|525584823|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
145745715|NCT01765920|525584824|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
145745716|NCT01765920|525584823|FG000|Overall Study|Patient code disclosure|0|||
145745717|NCT01765920|525584824|FG001|Overall Study|Patient code disclosure|1|||
145745718|NCT01081249|525584825|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
145745719|NCT01081249|525584826|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
145745720|NCT01439204|525584829|FG000|Overall Study|Withdrawal by Subject|0|||
145745721|NCT01439204|525584830|FG001|Overall Study|Withdrawal by Subject|1|||
145745722|NCT01439204|525584829|FG000|Overall Study|Lost to Follow-up|0|||
145745723|NCT01439204|525584830|FG001|Overall Study|Lost to Follow-up|2|||
145745724|NCT01439204|525584829|FG000|Overall Study|No longer meets study criteria|1|||
145745725|NCT01439204|525584830|FG001|Overall Study|No longer meets study criteria|0|||
145745726|NCT01439204|525584829|FG000|Overall Study|poor/non-compliance|3|||
145745727|NCT01439204|525584830|FG001|Overall Study|poor/non-compliance|0|||
145745728|NCT02255409|525584831|FG000|Overall Study|Administrative Reason|3|||
145745729|NCT02255409|525584832|FG001|Overall Study|Administrative Reason|7|||
145745730|NCT02255409|525584831|FG000|Overall Study|Withdrawal by Subject|1|||
145745731|NCT02255409|525584832|FG001|Overall Study|Withdrawal by Subject|5|||
145745732|NCT02255409|525584831|FG000|Overall Study|Lost to Follow-up|10|||
145745733|NCT02255409|525584832|FG001|Overall Study|Lost to Follow-up|19|||
145745734|NCT03775421|525584833|FG000|Overall Study|Lost to Follow-up|2|||
145745735|NCT03775421|525584833|FG000|Overall Study|Withdrawal by Subject|10|||
145745736|NCT03775421|525584833|FG000|Overall Study|Physician Decision|3|||
145745737|NCT03775421|525584833|FG000|Overall Study|Death|1|||
145745738|NCT03775421|525584833|FG000|Overall Study|Study Terminated by Sponsor|94|||
145745739|NCT02287623|525584839|FG000|Overall Study|Protocol Violation|0|||
145745740|NCT02287623|525584840|FG001|Overall Study|Protocol Violation|1|||
145745741|NCT00506883|525584843|FG000|Overall Study|Lost to Follow-up|1|||
145745742|NCT00506883|525584844|FG001|Overall Study|Lost to Follow-up|1|||
145745743|NCT00506883|525584845|FG002|Overall Study|Lost to Follow-up|1|||
145745744|NCT00506883|525584843|FG000|Overall Study|Withdrawal by Subject|1|||
145745745|NCT00506883|525584844|FG001|Overall Study|Withdrawal by Subject|0|||
145745746|NCT00506883|525584845|FG002|Overall Study|Withdrawal by Subject|1|||
145745747|NCT00506883|525584843|FG000|Overall Study|Lack of Efficacy|0|||
145745748|NCT00506883|525584844|FG001|Overall Study|Lack of Efficacy|1|||
145745749|NCT00506883|525584845|FG002|Overall Study|Lack of Efficacy|1|||
145745750|NCT00506883|525584843|FG000|Overall Study|Other|5|||
145270840|NCT03505606|523839527|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
145270841|NCT03505606|523839528|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
145270842|NCT03505606|523839526|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
145270843|NCT03505606|523839527|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
145270844|NCT03505606|523839528|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
145402474|NCT00784875|524330734|FG001|Period D|Adverse Event|2|||
145523038|NCT04393298|524775906|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523039|NCT04393298|524775907|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145745751|NCT00506883|525584844|FG001|Overall Study|Other|1|||
145745752|NCT00506883|525584845|FG002|Overall Study|Other|1|||
145745753|NCT02943564|525584846|FG000|Overall Study|Miscellaneous Reasons|0|||
145745754|NCT02943564|525584847|FG001|Overall Study|Miscellaneous Reasons|0|||
145745755|NCT02943564|525584848|FG002|Overall Study|Miscellaneous Reasons|3|||
145402475|NCT00784875|524330735|FG002|Period D|Adverse Event|2|||
145402476|NCT00784875|524330736|FG003|Period D|Adverse Event|0|||
145745756|NCT02943564|525584846|FG000|Overall Study|Site terminated by sponsor|0|||
145745757|NCT02943564|525584847|FG001|Overall Study|Site terminated by sponsor|1|||
145745758|NCT02943564|525584848|FG002|Overall Study|Site terminated by sponsor|0|||
145745759|NCT02943564|525584846|FG000|Overall Study|Non-compliance with study drug|0|||
145745760|NCT02943564|525584847|FG001|Overall Study|Non-compliance with study drug|1|||
145745761|NCT02943564|525584848|FG002|Overall Study|Non-compliance with study drug|0|||
145745762|NCT02943564|525584846|FG000|Overall Study|Pregnancy|0|||
145745763|NCT02943564|525584847|FG001|Overall Study|Pregnancy|1|||
145745764|NCT02943564|525584848|FG002|Overall Study|Pregnancy|1|||
145745765|NCT02943564|525584846|FG000|Overall Study|Protocol Violation|2|||
145745766|NCT02943564|525584847|FG001|Overall Study|Protocol Violation|2|||
145745767|NCT02943564|525584848|FG002|Overall Study|Protocol Violation|2|||
145745768|NCT02943564|525584846|FG000|Overall Study|Lost to Follow-up|1|||
145745769|NCT02943564|525584847|FG001|Overall Study|Lost to Follow-up|0|||
145745770|NCT02943564|525584848|FG002|Overall Study|Lost to Follow-up|0|||
145745771|NCT02943564|525584846|FG000|Overall Study|Withdrawal by Subject|6|||
145745772|NCT02943564|525584847|FG001|Overall Study|Withdrawal by Subject|5|||
145745773|NCT02943564|525584848|FG002|Overall Study|Withdrawal by Subject|2|||
145745774|NCT02943564|525584846|FG000|Overall Study|Adverse Event|1|||
145745775|NCT02943564|525584847|FG001|Overall Study|Adverse Event|2|||
145745776|NCT02943564|525584848|FG002|Overall Study|Adverse Event|1|||
145745777|NCT02943564|525584846|FG000|Overall Study|Lack of Efficacy|0|||
145745778|NCT02943564|525584847|FG001|Overall Study|Lack of Efficacy|1|||
145745779|NCT02943564|525584848|FG002|Overall Study|Lack of Efficacy|0|||
145745780|NCT00917150|525584851|FG000|Overall Study|Adverse Event|12|||
145745781|NCT00917150|525584852|FG001|Overall Study|Adverse Event|7|||
145745782|NCT00917150|525584853|FG002|Overall Study|Adverse Event|12|||
145745783|NCT00917150|525584854|FG003|Overall Study|Adverse Event|11|||
145745784|NCT00917150|525584851|FG000|Overall Study|Death|1|||
145745785|NCT00917150|525584852|FG001|Overall Study|Death|4|||
145745786|NCT00917150|525584853|FG002|Overall Study|Death|3|||
145402477|NCT00784875|524330733|FG000|Period D|Protocol Violation|1|||
145745787|NCT00917150|525584854|FG003|Overall Study|Death|2|||
145745788|NCT00917150|525584851|FG000|Overall Study|Lost to Follow-up|1|||
145745789|NCT00917150|525584852|FG001|Overall Study|Lost to Follow-up|0|||
145745790|NCT00917150|525584853|FG002|Overall Study|Lost to Follow-up|4|||
145745791|NCT00917150|525584854|FG003|Overall Study|Lost to Follow-up|2|||
145745792|NCT00917150|525584851|FG000|Overall Study|Physician Decision|0|||
145745793|NCT00917150|525584852|FG001|Overall Study|Physician Decision|2|||
145745794|NCT00917150|525584853|FG002|Overall Study|Physician Decision|0|||
145745795|NCT00917150|525584854|FG003|Overall Study|Physician Decision|1|||
145745796|NCT00917150|525584851|FG000|Overall Study|Protocol Violation|5|||
145745797|NCT00917150|525584852|FG001|Overall Study|Protocol Violation|5|||
145745798|NCT00917150|525584853|FG002|Overall Study|Protocol Violation|3|||
145745799|NCT00917150|525584854|FG003|Overall Study|Protocol Violation|5|||
145745800|NCT00917150|525584851|FG000|Overall Study|Withdrawal by Subject|15|||
145745801|NCT00917150|525584852|FG001|Overall Study|Withdrawal by Subject|16|||
145745802|NCT00917150|525584853|FG002|Overall Study|Withdrawal by Subject|18|||
145745803|NCT00917150|525584854|FG003|Overall Study|Withdrawal by Subject|11|||
145745804|NCT00917150|525584851|FG000|Overall Study|Other than specified|3|||
145745805|NCT00917150|525584852|FG001|Overall Study|Other than specified|3|||
145745806|NCT00917150|525584853|FG002|Overall Study|Other than specified|2|||
145745807|NCT00917150|525584854|FG003|Overall Study|Other than specified|2|||
145745808|NCT03891264|525584855|FG000|Overall Study|Adverse Event|1|||
145745809|NCT03891264|525584855|FG000|Overall Study|Withdrawal by Subject|2|||
145745810|NCT03891264|525584855|FG000|Overall Study|Physician Decision|2|||
145745811|NCT04143009|525584856|FG000|Pilot Trial|Lost to Follow-up|0|||
145745812|NCT04143009|525584857|FG001|Pilot Trial|Lost to Follow-up|1|||
145745813|NCT04143009|525584858|FG002|Pilot Trial|Lost to Follow-up|1|||
145745814|NCT01505634|525584859|FG000|Overall Study|Withdrawal by Subject|2|||
145745815|NCT01505634|525584860|FG001|Overall Study|Withdrawal by Subject|5|||
145745816|NCT01505634|525584861|FG002|Overall Study|Withdrawal by Subject|1|||
145745817|NCT01505634|525584859|FG000|Overall Study|Physician Decision|1|||
145745818|NCT01505634|525584860|FG001|Overall Study|Physician Decision|1|||
145745819|NCT01505634|525584861|FG002|Overall Study|Physician Decision|0|||
145745820|NCT01505634|525584859|FG000|Overall Study|Adverse Event|1|||
145745821|NCT01505634|525584860|FG001|Overall Study|Adverse Event|0|||
145745822|NCT01505634|525584861|FG002|Overall Study|Adverse Event|0|||
145745823|NCT01505634|525584859|FG000|Overall Study|Insufficient supply of drug at site|1|||
145745824|NCT01505634|525584860|FG001|Overall Study|Insufficient supply of drug at site|0|||
145745825|NCT01505634|525584861|FG002|Overall Study|Insufficient supply of drug at site|0|||
145745826|NCT01505634|525584859|FG000|Overall Study|Protocol Violation|2|||
145745827|NCT01505634|525584860|FG001|Overall Study|Protocol Violation|0|||
145745828|NCT01505634|525584861|FG002|Overall Study|Protocol Violation|0|||
145745829|NCT01505634|525584859|FG000|Overall Study|Lost to Follow-up|1|||
145745830|NCT01505634|525584860|FG001|Overall Study|Lost to Follow-up|4|||
145745831|NCT01505634|525584861|FG002|Overall Study|Lost to Follow-up|4|||
145745832|NCT01505634|525584859|FG000|Overall Study|Death|1|||
145745833|NCT01505634|525584860|FG001|Overall Study|Death|0|||
145745834|NCT01505634|525584861|FG002|Overall Study|Death|0|||
145745835|NCT01505634|525584859|FG000|Overall Study|In a conflict zone|0|||
145745836|NCT01505634|525584860|FG001|Overall Study|In a conflict zone|0|||
145745837|NCT01505634|525584861|FG002|Overall Study|In a conflict zone|1|||
145745838|NCT04013529|525584866|FG000|Overall Study|Withdrawal by Subject|1|||
145745839|NCT04013529|525584867|FG001|Overall Study|Withdrawal by Subject|1|||
145745840|NCT04869345|525584870|FG000|Overall Study|Lost to Follow-up|8|||
145745841|NCT04869345|525584871|FG001|Overall Study|Lost to Follow-up|3|||
145745842|NCT05054114|525584880|FG000|Overall Study|Protocol Violation|13|||
145745843|NCT05054114|525584881|FG001|Overall Study|Protocol Violation|1|||
145745844|NCT05054114|525584880|FG000|Overall Study|Pregnancy|0|||
145745845|NCT05054114|525584881|FG001|Overall Study|Pregnancy|1|||
145745846|NCT01806779|525584882|FG000|Overall Study|Physician Decision|2|||
145523040|NCT04393298|524775908|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
145523041|NCT04393298|524775909|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523042|NCT04393298|524775910|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523043|NCT04393298|524775911|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523044|NCT04393298|524775912|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523045|NCT04393298|524775913|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523046|NCT04393298|524775914|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523047|NCT04393298|524775915|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523048|NCT04393298|524775916|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
145523049|NCT04393298|524775917|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
145523050|NCT04393298|524775903|FG000|Overall Study|Death|0|||
145523051|NCT04393298|524775904|FG001|Overall Study|Death|0|||
145745847|NCT01806779|525584883|FG001|Overall Study|Physician Decision|0|||
145745848|NCT01806779|525584884|FG002|Overall Study|Physician Decision|1|||
145745849|NCT01806779|525584882|FG000|Overall Study|Lack of Efficacy|1|||
145745850|NCT01806779|525584883|FG001|Overall Study|Lack of Efficacy|1|||
145745851|NCT01806779|525584884|FG002|Overall Study|Lack of Efficacy|0|||
145745852|NCT01806779|525584882|FG000|Overall Study|Lost to Follow-up|19|||
145745853|NCT01806779|525584883|FG001|Overall Study|Lost to Follow-up|20|||
145745854|NCT01806779|525584884|FG002|Overall Study|Lost to Follow-up|0|||
145745855|NCT01806779|525584882|FG000|Overall Study|Withdrawal by Subject|20|||
145745856|NCT01806779|525584883|FG001|Overall Study|Withdrawal by Subject|23|||
145745857|NCT01806779|525584884|FG002|Overall Study|Withdrawal by Subject|22|||
145745858|NCT02595450|525584885|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
145745859|NCT02595450|525584885|FG000|Overall Study|Enrolled, but not treated|8|||
145745860|NCT01934556|525584889|FG000|Overall Study|Withdrawal by Subject|0|||
145745861|NCT01934556|525584890|FG001|Overall Study|Withdrawal by Subject|1|||
145745862|NCT01934556|525584891|FG002|Overall Study|Withdrawal by Subject|1|||
145745863|NCT01934556|525584889|FG000|Overall Study|Lost to Follow-up|4|||
145745864|NCT01934556|525584890|FG001|Overall Study|Lost to Follow-up|10|||
145745865|NCT01934556|525584891|FG002|Overall Study|Lost to Follow-up|7|||
145745866|NCT01934556|525584889|FG000|Overall Study|Death|1|||
145745867|NCT01934556|525584890|FG001|Overall Study|Death|5|||
145745868|NCT01934556|525584891|FG002|Overall Study|Death|2|||
145745869|NCT00102960|525584894|FG000|Overall Study|Death|23|||
145745870|NCT00102960|525584895|FG001|Overall Study|Death|11|||
145745871|NCT00102960|525584896|FG002|Overall Study|Death|11|||
145745872|NCT00102960|525584894|FG000|Overall Study|Lost to Follow-up|6|||
145745873|NCT00102960|525584895|FG001|Overall Study|Lost to Follow-up|12|||
145745874|NCT00102960|525584896|FG002|Overall Study|Lost to Follow-up|16|||
145745875|NCT00102960|525584894|FG000|Overall Study|Withdrawal by Subject|1|||
145745876|NCT00102960|525584895|FG001|Overall Study|Withdrawal by Subject|0|||
145745877|NCT00102960|525584896|FG002|Overall Study|Withdrawal by Subject|1|||
145745878|NCT01908101|525586161|FG000|Overall Study|Physician Decision|1|||
145745879|NCT01908101|525586161|FG000|Overall Study|Withdrawal by Subject|1|||
145745880|NCT01908101|525586161|FG000|Overall Study|Incorrect Diagnosis|2|||
145745881|NCT01908101|525586161|FG000|Overall Study|Incorrect Starting Dose|1|||
145745882|NCT01908101|525586161|FG000|Overall Study|Did not complete the first cycle|4|||
145745883|NCT02356562|525586165|FG000|Overall Study|Withdrawal by Subject|0|||
145745884|NCT02356562|525586166|FG001|Overall Study|Withdrawal by Subject|1|||
145745885|NCT02356562|525586165|FG000|Overall Study|Re-entered treatment in a previous study|1|||
145745886|NCT02356562|525586166|FG001|Overall Study|Re-entered treatment in a previous study|0|||
145745887|NCT02356562|525586165|FG000|Overall Study|site closure|1|||
145745888|NCT02356562|525586166|FG001|Overall Study|site closure|0|||
145745889|NCT00150592|525586167|FG000|Overall Study|Adverse Event|4|||
145745890|NCT00150592|525586168|FG001|Overall Study|Adverse Event|1|||
145745891|NCT00150592|525586167|FG000|Overall Study|Protocol Violation|1|||
145745892|NCT00150592|525586168|FG001|Overall Study|Protocol Violation|0|||
145745893|NCT00150592|525586167|FG000|Overall Study|Withdrawal by Subject|1|||
145745894|NCT00150592|525586168|FG001|Overall Study|Withdrawal by Subject|2|||
145745895|NCT00150592|525586167|FG000|Overall Study|Non-compliance|1|||
145745896|NCT00150592|525586168|FG001|Overall Study|Non-compliance|0|||
145745897|NCT00412750|525586169|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145745898|NCT00412750|525586170|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145745899|NCT00412750|525586171|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145745900|NCT00412750|525586169|FG000|Overall Study|Administrative problems|21|||
145745901|NCT00412750|525586170|FG001|Overall Study|Administrative problems|17|||
145745902|NCT00412750|525586171|FG002|Overall Study|Administrative problems|14|||
145745903|NCT00412750|525586169|FG000|Overall Study|Adverse Event|8|||
145745904|NCT00412750|525586170|FG001|Overall Study|Adverse Event|3|||
145745905|NCT00412750|525586171|FG002|Overall Study|Adverse Event|3|||
145745906|NCT00412750|525586169|FG000|Overall Study|Lost to Follow-up|1|||
145745907|NCT00412750|525586170|FG001|Overall Study|Lost to Follow-up|0|||
145745908|NCT00412750|525586171|FG002|Overall Study|Lost to Follow-up|1|||
145745909|NCT00412750|525586169|FG000|Overall Study|Withdrawal by Subject|0|||
145745910|NCT00412750|525586170|FG001|Overall Study|Withdrawal by Subject|1|||
145745911|NCT00412750|525586171|FG002|Overall Study|Withdrawal by Subject|2|||
145745912|NCT00412750|525586169|FG000|Overall Study|Lack of Efficacy|0|||
145745913|NCT00412750|525586170|FG001|Overall Study|Lack of Efficacy|0|||
145745914|NCT00412750|525586171|FG002|Overall Study|Lack of Efficacy|3|||
145745915|NCT00874120|525586179|FG000|First Intervention|Adverse Event|0|||
145523052|NCT04393298|524775905|FG002|Overall Study|Death|0|||
145523053|NCT04393298|524775906|FG003|Overall Study|Death|0|||
145523054|NCT04393298|524775907|FG004|Overall Study|Death|0|||
145523055|NCT04393298|524775908|FG005|Overall Study|Death|1|||
145745916|NCT00874120|525586180|FG001|First Intervention|Adverse Event|1|||
145745917|NCT00874120|525586179|FG000|First Intervention|Withdrawal by Subject|2|||
145745918|NCT00874120|525586180|FG001|First Intervention|Withdrawal by Subject|0|||
145745919|NCT00874120|525586179|FG000|First Intervention|Lost to Follow-up|0|||
145745920|NCT00874120|525586180|FG001|First Intervention|Lost to Follow-up|1|||
145745921|NCT00874120|525586179|FG000|First Intervention|Protocol Violation|3|||
145745922|NCT00874120|525586180|FG001|First Intervention|Protocol Violation|0|||
145745923|NCT00874120|525586179|FG000|First Intervention|positive drug test|1|||
145745924|NCT00874120|525586180|FG001|First Intervention|positive drug test|0|||
145745925|NCT00874120|525586179|FG000|Second Intervention|Withdrawal by Subject|1|||
145745926|NCT00874120|525586180|FG001|Second Intervention|Withdrawal by Subject|0|||
145745927|NCT00874120|525586179|FG000|Second Intervention|Protocol Violation|1|||
145745928|NCT00874120|525586180|FG001|Second Intervention|Protocol Violation|0|||
145270845|NCT03505606|523839526|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
145523056|NCT04393298|524775909|FG006|Overall Study|Death|1|||
145523057|NCT04393298|524775910|FG007|Overall Study|Death|0|||
145745929|NCT01823679|525586181|FG000|Overall Study|Death|1|||
145745930|NCT02135692|525586189|FG000|Overall Study|Adverse Event|3|||
145745931|NCT02135692|525586189|FG000|Overall Study|Lack of Efficacy|2|||
145745932|NCT02135692|525586189|FG000|Overall Study|Protocol Violation|2|||
145745933|NCT02135692|525586189|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
145745934|NCT02135692|525586189|FG000|Overall Study|Product commercially available|159|||
145745935|NCT02135692|525586189|FG000|Overall Study|Study closed/terminated|153|||
145745936|NCT02135692|525586189|FG000|Overall Study|Lost to Follow-up|4|||
145745937|NCT02135692|525586189|FG000|Overall Study|Withdrawal by Subject|15|||
145745938|NCT01611974|525586192|FG000|Overall Study|Death|10|||
145745939|NCT01611974|525586193|FG001|Overall Study|Death|12|||
145745940|NCT01611974|525586194|FG002|Overall Study|Death|10|||
145745941|NCT01611974|525586192|FG000|Overall Study|Lost to Follow-up|0|||
145745942|NCT01611974|525586193|FG001|Overall Study|Lost to Follow-up|1|||
145745943|NCT01611974|525586194|FG002|Overall Study|Lost to Follow-up|0|||
145745944|NCT01611974|525586192|FG000|Overall Study|Physician Decision|5|||
145745945|NCT01611974|525586193|FG001|Overall Study|Physician Decision|1|||
145745946|NCT01611974|525586194|FG002|Overall Study|Physician Decision|2|||
145745947|NCT01611974|525586192|FG000|Overall Study|Withdrawal by Subject|0|||
145745948|NCT01611974|525586193|FG001|Overall Study|Withdrawal by Subject|1|||
145745949|NCT01611974|525586194|FG002|Overall Study|Withdrawal by Subject|4|||
145745950|NCT01097746|525586195|FG000|Overall Study|Adverse Event|4|||
145745951|NCT01097746|525586195|FG000|Overall Study|taken off study before any treatment given|1|||
145745952|NCT00522431|525586196|FG000|Overall Study|Adverse Event|5|||
145745953|NCT00522431|525586196|FG000|Overall Study|Protocol Violation|2|||
145745954|NCT00522431|525586196|FG000|Overall Study|Withdrawal by Subject|2|||
145745955|NCT00522431|525586196|FG000|Overall Study|Subject non-compliance|1|||
145745956|NCT00522431|525586196|FG000|Overall Study|Other/unknown|1|||
145745957|NCT02495844|525586197|FG000|Overall Study|Lack of Efficacy|1|||
145745958|NCT02495844|525586198|FG001|Overall Study|Lack of Efficacy|2|||
145745959|NCT02495844|525586197|FG000|Overall Study|AE, non-fatal|0|||
145745960|NCT02495844|525586198|FG001|Overall Study|AE, non-fatal|1|||
145745961|NCT02495844|525586197|FG000|Overall Study|Hepatitis Positivity|0|||
145745962|NCT02495844|525586198|FG001|Overall Study|Hepatitis Positivity|1|||
145745963|NCT03927105|525586199|FG000|Overall Study|Death|1|||
145745964|NCT03927105|525586199|FG000|Overall Study|In observation for potential re-treatment|2|||
145745965|NCT03927105|525586199|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
145745966|NCT02145741|525586201|FG000|Overall Study|Progressive disease|3|||
145745967|NCT02145741|525586202|FG001|Overall Study|Progressive disease|6|||
145745968|NCT02145741|525586203|FG002|Overall Study|Progressive disease|6|||
145745969|NCT02145741|525586201|FG000|Overall Study|quality issue with the administered drug|3|||
145745970|NCT02145741|525586202|FG001|Overall Study|quality issue with the administered drug|0|||
145745971|NCT02145741|525586203|FG002|Overall Study|quality issue with the administered drug|0|||
145745972|NCT05634577|525586204|FG000|Overall Study|Lost to Follow-up|1|||
145745973|NCT05634577|525586204|FG000|Overall Study|Withdrawal by Subject|1|||
145745974|NCT02311153|525586206|FG000|Overall Study|Lost to Follow-up|5|||
145745975|NCT02311153|525586207|FG001|Overall Study|Lost to Follow-up|7|||
145745976|NCT00405067|525586212|FG000|Overall Study|Adverse Event|4|||
145745977|NCT00405067|525586213|FG001|Overall Study|Adverse Event|9|||
145745978|NCT00405067|525586214|FG002|Overall Study|Adverse Event|4|||
145745979|NCT00405067|525586212|FG000|Overall Study|Lost to Follow-up|0|||
145745980|NCT00405067|525586213|FG001|Overall Study|Lost to Follow-up|0|||
145745981|NCT00405067|525586214|FG002|Overall Study|Lost to Follow-up|1|||
145745982|NCT01560780|525586215|FG000|Overall Study|Death|2|||
145745983|NCT01560780|525586216|FG001|Overall Study|Death|1|||
145745984|NCT01560780|525586215|FG000|Overall Study|Patient Preference|11|||
145745985|NCT01560780|525586216|FG001|Overall Study|Patient Preference|11|||
145745986|NCT01577186|525586217|FG000|Overall Study|Adverse Event|23|||
145745987|NCT01577186|525586217|FG000|Overall Study|Death|1|||
145745988|NCT01577186|525586217|FG000|Overall Study|Lost to Follow-up|28|||
145745989|NCT01577186|525586217|FG000|Overall Study|Withdrawal by Subject|35|||
145745990|NCT01577186|525586217|FG000|Overall Study|Insufficient Response|18|||
145745991|NCT01577186|525586217|FG000|Overall Study|Ineligible to Continue|15|||
145745992|NCT01577186|525586217|FG000|Overall Study|Non-Compliant|8|||
145523058|NCT04393298|524775911|FG008|Overall Study|Death|1|||
145523059|NCT04393298|524775912|FG009|Overall Study|Death|1|||
145745993|NCT01577186|525586217|FG000|Overall Study|Other|2|||
145745994|NCT00957008|525586218|FG000|Overall Study|Withdrawal by Subject|13|||
145745995|NCT00957008|525586219|FG001|Overall Study|Withdrawal by Subject|10|||
145745996|NCT00957008|525586220|FG002|Overall Study|Withdrawal by Subject|12|||
145745997|NCT00957008|525586221|FG003|Overall Study|Withdrawal by Subject|16|||
145745998|NCT00957008|525586218|FG000|Overall Study|Lost to Follow-up|3|||
145745999|NCT00957008|525586219|FG001|Overall Study|Lost to Follow-up|1|||
145523060|NCT04393298|524775913|FG010|Overall Study|Death|0|||
145746000|NCT00957008|525586220|FG002|Overall Study|Lost to Follow-up|3|||
145746001|NCT00957008|525586221|FG003|Overall Study|Lost to Follow-up|4|||
145746002|NCT00957008|525586218|FG000|Overall Study|Physician Decision|1|||
145746003|NCT00957008|525586219|FG001|Overall Study|Physician Decision|0|||
145746004|NCT00957008|525586220|FG002|Overall Study|Physician Decision|1|||
145746005|NCT00957008|525586221|FG003|Overall Study|Physician Decision|1|||
145746006|NCT00957008|525586218|FG000|Overall Study|Relocated; Family conflict|4|||
145746007|NCT00957008|525586219|FG001|Overall Study|Relocated; Family conflict|1|||
145746008|NCT00957008|525586220|FG002|Overall Study|Relocated; Family conflict|1|||
145746009|NCT00957008|525586221|FG003|Overall Study|Relocated; Family conflict|3|||
145746010|NCT00811135|525586222|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
145746011|NCT00811135|525586222|FG000|Overall Study|Death|3|||
145746012|NCT00811135|525586222|FG000|Overall Study|Protocol Violation|2|||
145746013|NCT00811135|525586222|FG000|Overall Study|Violation of Selection Criteria|1|||
145746014|NCT00811135|525586222|FG000|Overall Study|Refused Treatment|1|||
145746015|NCT00811135|525586222|FG000|Overall Study|Withdrawal by Subject|3|||
145746016|NCT00811135|525586222|FG000|Overall Study|Administrative/Other Unspecified|11|||
145746017|NCT00811135|525586222|FG000|Overall Study|Ongoing|59|||
145746018|NCT01118351|525586223|FG000|Overall Study|Adverse Event|3|||
145746019|NCT01118351|525586223|FG000|Overall Study|Withdrawal by Subject|1|||
145746020|NCT02797808|525586227|FG000|Overall Study|Withdrawal by Subject|1|||
145746021|NCT02797808|525586228|FG001|Overall Study|Withdrawal by Subject|1|||
145746022|NCT02797808|525586227|FG000|Overall Study|Physician Decision|6|||
145746023|NCT02797808|525586228|FG001|Overall Study|Physician Decision|2|||
145746024|NCT02192827|525586229|FG000|Overall Study|Lost to Follow-up|25|||
145746025|NCT02192827|525586230|FG001|Overall Study|Lost to Follow-up|27|||
145746026|NCT02192827|525586229|FG000|Overall Study|Given additional steroids with admission|13|||
145746027|NCT02192827|525586230|FG001|Overall Study|Given additional steroids with admission|11|||
145746028|NCT00845728|525586231|FG000|Overall Study|Abnormal laboratory value (s)|2|||
145746029|NCT00845728|525586232|FG001|Overall Study|Abnormal laboratory value (s)|2|||
145746030|NCT00845728|525586231|FG000|Overall Study|Patient's inability to use the device|4|||
145270846|NCT03505606|523839527|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
145270847|NCT03505606|523839528|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
145270848|NCT03505606|523839526|FG000|Overall Study|Poor compliance with refractive correction|0|||
145270849|NCT03505606|523839527|FG001|Overall Study|Poor compliance with refractive correction|0|||
145270850|NCT03505606|523839528|FG002|Overall Study|Poor compliance with refractive correction|1|||
145270851|NCT03505606|523839526|FG000|Overall Study|Insufficient anisometropia|0|||
145270852|NCT03505606|523839527|FG001|Overall Study|Insufficient anisometropia|0|||
145270853|NCT03505606|523839528|FG002|Overall Study|Insufficient anisometropia|2|||
145270854|NCT03505606|523839526|FG000|Overall Study|Ectopia Lentis|0|||
145270855|NCT03505606|523839527|FG001|Overall Study|Ectopia Lentis|0|||
145270856|NCT03505606|523839528|FG002|Overall Study|Ectopia Lentis|1|||
145270857|NCT03505606|523839526|FG000|Overall Study|alternation of amblyopic eye|0|||
145270858|NCT03505606|523839527|FG001|Overall Study|alternation of amblyopic eye|1|||
145270859|NCT03505606|523839528|FG002|Overall Study|alternation of amblyopic eye|0|||
145270860|NCT02087865|523839530|FG000|Overall Study|Withdrawal by Subject|6|||
145270861|NCT02087865|523839531|FG001|Overall Study|Withdrawal by Subject|0|||
145270862|NCT02087865|523839532|FG002|Overall Study|Withdrawal by Subject|1|||
145270863|NCT02087865|523839530|FG000|Overall Study|Lost to Follow-up|0|||
145270864|NCT02087865|523839531|FG001|Overall Study|Lost to Follow-up|0|||
145270865|NCT02087865|523839532|FG002|Overall Study|Lost to Follow-up|1|||
145270866|NCT02087865|523839530|FG000|Overall Study|Drug Non-compliance|0|||
145270867|NCT02087865|523839531|FG001|Overall Study|Drug Non-compliance|2|||
145270868|NCT02087865|523839532|FG002|Overall Study|Drug Non-compliance|0|||
145270869|NCT02087865|523839530|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
145270870|NCT02087865|523839531|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
145270871|NCT02087865|523839532|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
145270872|NCT01392469|523839535|FG000|Overall Study|Adverse Event|2|||
145270873|NCT01392469|523839535|FG000|Overall Study|Withdrawal by Subject|1|||
145270874|NCT01392469|523839535|FG000|Overall Study|Protocol Violation|1|||
145270875|NCT01808508|523839537|FG000|Overall Study|Lost to Follow-up|1|||
145523061|NCT04393298|524775914|FG011|Overall Study|Death|1|||
145746031|NCT00845728|525586232|FG001|Overall Study|Patient's inability to use the device|6|||
145270876|NCT01808508|523839538|FG001|Overall Study|Lost to Follow-up|0|||
145270877|NCT01808508|523839539|FG002|Overall Study|Lost to Follow-up|0|||
145270878|NCT01017731|523839540|FG000|Overall Study|Lost to Follow-up|2|||
145270879|NCT01017731|523839540|FG000|Overall Study|Withdrawal by Subject|3|||
145270880|NCT01017731|523839540|FG000|Overall Study|Physician Decision|2|||
145270881|NCT01017731|523839540|FG000|Overall Study|Adverse Event|1|||
145523062|NCT04393298|524775915|FG012|Overall Study|Death|1|||
145523063|NCT04393298|524775916|FG013|Overall Study|Death|0|||
145746032|NCT00845728|525586231|FG000|Overall Study|Abnormal test procedure result (s)|7|||
145523064|NCT04393298|524775917|FG014|Overall Study|Death|1|||
145746033|NCT00845728|525586232|FG001|Overall Study|Abnormal test procedure result (s)|2|||
145270882|NCT01035229|523839541|FG000|Overall Study|Adverse Event|61|||
145270883|NCT01035229|523839542|FG001|Overall Study|Adverse Event|14|||
145270884|NCT01035229|523839541|FG000|Overall Study|Withdrawal by Subject|20|||
145270885|NCT01035229|523839542|FG001|Overall Study|Withdrawal by Subject|7|||
145523065|NCT04393298|524775903|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523066|NCT04393298|524775904|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523067|NCT04393298|524775905|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523068|NCT04393298|524775906|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523069|NCT04393298|524775907|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523070|NCT04393298|524775908|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
145523071|NCT04393298|524775909|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523072|NCT04393298|524775910|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523073|NCT04393298|524775911|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523074|NCT04393298|524775912|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523075|NCT04393298|524775913|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523076|NCT04393298|524775914|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523077|NCT04393298|524775915|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523078|NCT04393298|524775916|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523079|NCT04393298|524775917|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
145523080|NCT04393298|524775903|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
145523081|NCT04393298|524775904|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
145523082|NCT04393298|524775905|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
145523083|NCT04393298|524775906|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
145523084|NCT04393298|524775907|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
145523085|NCT04393298|524775908|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
145523086|NCT04393298|524775909|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
145523087|NCT04393298|524775910|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
145523088|NCT04393298|524775911|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
145523089|NCT04393298|524775912|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
145523090|NCT04393298|524775913|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
145523091|NCT04393298|524775914|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
145523092|NCT04393298|524775915|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
145523093|NCT04393298|524775916|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
145523094|NCT04393298|524775917|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
145523095|NCT04393298|524775903|FG000|Overall Study|Patient Passed Away|0|||
145523096|NCT04393298|524775904|FG001|Overall Study|Patient Passed Away|0|||
145523097|NCT04393298|524775905|FG002|Overall Study|Patient Passed Away|0|||
145523098|NCT04393298|524775906|FG003|Overall Study|Patient Passed Away|0|||
145523099|NCT04393298|524775907|FG004|Overall Study|Patient Passed Away|0|||
145523100|NCT04393298|524775908|FG005|Overall Study|Patient Passed Away|0|||
145523101|NCT04393298|524775909|FG006|Overall Study|Patient Passed Away|0|||
145523102|NCT04393298|524775910|FG007|Overall Study|Patient Passed Away|1|||
145523103|NCT04393298|524775911|FG008|Overall Study|Patient Passed Away|0|||
145523104|NCT04393298|524775912|FG009|Overall Study|Patient Passed Away|0|||
145523105|NCT04393298|524775913|FG010|Overall Study|Patient Passed Away|0|||
145523106|NCT04393298|524775914|FG011|Overall Study|Patient Passed Away|0|||
145523107|NCT04393298|524775915|FG012|Overall Study|Patient Passed Away|0|||
145523108|NCT04393298|524775916|FG013|Overall Study|Patient Passed Away|0|||
145523109|NCT04393298|524775917|FG014|Overall Study|Patient Passed Away|0|||
145523110|NCT04393298|524775903|FG000|Overall Study|Patient Deceased|0|||
145523111|NCT04393298|524775904|FG001|Overall Study|Patient Deceased|0|||
145523112|NCT04393298|524775905|FG002|Overall Study|Patient Deceased|0|||
145523113|NCT04393298|524775906|FG003|Overall Study|Patient Deceased|0|||
145523114|NCT04393298|524775907|FG004|Overall Study|Patient Deceased|0|||
145523115|NCT04393298|524775908|FG005|Overall Study|Patient Deceased|0|||
145523116|NCT04393298|524775909|FG006|Overall Study|Patient Deceased|0|||
145523117|NCT04393298|524775910|FG007|Overall Study|Patient Deceased|1|||
145523118|NCT04393298|524775911|FG008|Overall Study|Patient Deceased|0|||
145746034|NCT00845728|525586231|FG000|Overall Study|Lost to Follow-up|22|||
145746035|NCT00845728|525586232|FG001|Overall Study|Lost to Follow-up|13|||
145523119|NCT04393298|524775912|FG009|Overall Study|Patient Deceased|0|||
145523120|NCT04393298|524775913|FG010|Overall Study|Patient Deceased|0|||
145523121|NCT04393298|524775914|FG011|Overall Study|Patient Deceased|0|||
145523122|NCT04393298|524775915|FG012|Overall Study|Patient Deceased|0|||
145523123|NCT04393298|524775916|FG013|Overall Study|Patient Deceased|0|||
145523124|NCT04393298|524775917|FG014|Overall Study|Patient Deceased|0|||
145523125|NCT04393298|524775903|FG000|Overall Study|Patient Discharged to Hospice|0|||
145523126|NCT04393298|524775904|FG001|Overall Study|Patient Discharged to Hospice|0|||
145523127|NCT04393298|524775905|FG002|Overall Study|Patient Discharged to Hospice|0|||
145523128|NCT04393298|524775906|FG003|Overall Study|Patient Discharged to Hospice|0|||
145523129|NCT04393298|524775907|FG004|Overall Study|Patient Discharged to Hospice|0|||
145523130|NCT04393298|524775908|FG005|Overall Study|Patient Discharged to Hospice|0|||
145523131|NCT04393298|524775909|FG006|Overall Study|Patient Discharged to Hospice|0|||
145523132|NCT04393298|524775910|FG007|Overall Study|Patient Discharged to Hospice|0|||
145523133|NCT04393298|524775911|FG008|Overall Study|Patient Discharged to Hospice|1|||
145523134|NCT04393298|524775912|FG009|Overall Study|Patient Discharged to Hospice|0|||
145523135|NCT04393298|524775913|FG010|Overall Study|Patient Discharged to Hospice|0|||
145746036|NCT00845728|525586231|FG000|Overall Study|Death|24|||
145746037|NCT00845728|525586232|FG001|Overall Study|Death|26|||
145746038|NCT00845728|525586231|FG000|Overall Study|Administrative Problems|34|||
145746039|NCT00845728|525586232|FG001|Overall Study|Administrative Problems|26|||
145746040|NCT00845728|525586231|FG000|Overall Study|Protocol Violation|36|||
145746041|NCT00845728|525586232|FG001|Overall Study|Protocol Violation|24|||
145746042|NCT00845728|525586231|FG000|Overall Study|Lack of Efficacy|51|||
145746043|NCT00845728|525586232|FG001|Overall Study|Lack of Efficacy|39|||
145746044|NCT00845728|525586231|FG000|Overall Study|Adverse Event|101|||
145746045|NCT00845728|525586232|FG001|Overall Study|Adverse Event|96|||
145746046|NCT00845728|525586231|FG000|Overall Study|Withdrawal by Subject|105|||
145746047|NCT00845728|525586232|FG001|Overall Study|Withdrawal by Subject|108|||
145746048|NCT01227044|525586238|FG000|Overall Study|Lost to Follow-up|5|||
145746049|NCT01227044|525586239|FG001|Overall Study|Lost to Follow-up|7|||
145746050|NCT01227044|525586238|FG000|Overall Study|Discontinued Intervention|1|||
145746051|NCT01227044|525586239|FG001|Overall Study|Discontinued Intervention|2|||
145746052|NCT00205855|525586250|FG000|Overall Study|Only received temporary implants|16|||
145746053|NCT00205855|525586250|FG000|Overall Study|Withdrawal by Subject|5|||
145746054|NCT01073267|525586251|FG000|Overall Study|Disease Progression|3|||
145746055|NCT01624662|525586255|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
145746056|NCT01624662|525586256|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
145746057|NCT01624662|525586257|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
145746058|NCT01624662|525586258|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
145746059|NCT01624662|525586255|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
145746060|NCT01624662|525586256|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
145746061|NCT01624662|525586257|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
145746062|NCT01624662|525586258|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
145746063|NCT01624662|525586255|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
145746064|NCT01624662|525586256|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
145746065|NCT01624662|525586257|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
145746066|NCT01624662|525586258|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
145746067|NCT01624662|525586255|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
145746068|NCT01624662|525586256|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
145746069|NCT01624662|525586257|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
145746070|NCT01624662|525586258|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
145746071|NCT01624662|525586255|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
145746072|NCT01624662|525586256|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
145746073|NCT01624662|525586257|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
145746074|NCT01624662|525586258|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
145746075|NCT01624662|525586255|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145746076|NCT01624662|525586256|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
145746077|NCT01624662|525586257|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145746078|NCT01624662|525586258|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145746079|NCT01624662|525586255|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
145746080|NCT01624662|525586256|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
145746081|NCT01624662|525586257|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
145746082|NCT01624662|525586258|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
145746083|NCT01714687|525586259|FG000|Overall Study|Withdrawal by Subject|1|||
145746084|NCT01714687|525586260|FG001|Overall Study|Withdrawal by Subject|0|||
145746085|NCT01714687|525586259|FG000|Overall Study|Lost to Follow-up|2|||
145746086|NCT01714687|525586260|FG001|Overall Study|Lost to Follow-up|4|||
145746087|NCT01883635|525586261|FG000|Overall Study|Withdrawal by Subject|4|||
145746088|NCT01883635|525586262|FG001|Overall Study|Withdrawal by Subject|0|||
145746089|NCT01464307|525586266|FG000|Main Period|Death|0|||
145746090|NCT01464307|525586267|FG001|Main Period|Death|1|||
145746091|NCT01464307|525586266|FG000|Main Period|Adverse Event|6|||
145402478|NCT00784875|524330734|FG001|Period D|Protocol Violation|0|||
145523136|NCT04393298|524775914|FG011|Overall Study|Patient Discharged to Hospice|0|||
145523137|NCT04393298|524775915|FG012|Overall Study|Patient Discharged to Hospice|0|||
145523138|NCT04393298|524775916|FG013|Overall Study|Patient Discharged to Hospice|0|||
145523139|NCT04393298|524775917|FG014|Overall Study|Patient Discharged to Hospice|0|||
145523140|NCT04393298|524775903|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523141|NCT04393298|524775904|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145746092|NCT01464307|525586267|FG001|Main Period|Adverse Event|1|||
145746093|NCT01464307|525586266|FG000|Main Period|Lack of Efficacy|2|||
145746094|NCT01464307|525586267|FG001|Main Period|Lack of Efficacy|0|||
145746095|NCT01464307|525586266|FG000|Main Period|Withdrawal by Subject|5|||
145746096|NCT01464307|525586267|FG001|Main Period|Withdrawal by Subject|2|||
145746097|NCT01464307|525586266|FG000|Main Period|Predefined discontinuation criteria|2|||
145746098|NCT01464307|525586267|FG001|Main Period|Predefined discontinuation criteria|1|||
145746099|NCT01464307|525586266|FG000|Open-Label Extension Period|Adverse Event|15|||
145746100|NCT01464307|525586267|FG001|Open-Label Extension Period|Adverse Event|0|||
145746101|NCT01464307|525586266|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
145746102|NCT01464307|525586267|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
145746103|NCT01464307|525586266|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
145746104|NCT01464307|525586267|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
145746105|NCT01464307|525586266|FG000|Open-Label Extension Period|Death|1|||
145746106|NCT01464307|525586267|FG001|Open-Label Extension Period|Death|0|||
145746107|NCT01464307|525586266|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
145746108|NCT01464307|525586267|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
145746109|NCT01464307|525586266|FG000|Open-Label Extension Period|Non-compliance|9|||
145746110|NCT01464307|525586267|FG001|Open-Label Extension Period|Non-compliance|0|||
145746111|NCT01464307|525586266|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
145746112|NCT01464307|525586267|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
145746113|NCT02457637|525586270|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
145746114|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Death|3|||
145746115|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Death|0|||
145746116|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Adverse Event|12|||
145746117|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Adverse Event|6|||
145746118|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
145746119|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
145746120|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
145746121|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
145746122|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
145746123|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
145746124|NCT00159861|525586272|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
145746125|NCT00159861|525586273|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
145746126|NCT00159861|525586272|FG000|Extension Study - up to 3 Years|Death|24|||
145746127|NCT00159861|525586273|FG001|Extension Study - up to 3 Years|Death|28|||
145746128|NCT00159861|525586272|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
145746129|NCT00159861|525586273|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
145746130|NCT00159861|525586272|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
145746131|NCT00159861|525586273|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
145746132|NCT00159861|525586272|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
145746133|NCT00159861|525586273|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
145746134|NCT00159861|525586272|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
145746135|NCT00159861|525586273|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
145746136|NCT01553136|525586275|FG000|Overall Study|Adverse Event|3|||
145746137|NCT01553136|525586276|FG001|Overall Study|Adverse Event|2|||
145746138|NCT01553136|525586275|FG000|Overall Study|Withdrawal by Subject|2|||
145746139|NCT01553136|525586276|FG001|Overall Study|Withdrawal by Subject|3|||
145746140|NCT01553136|525586275|FG000|Overall Study|Lost to Follow-up|4|||
145746141|NCT01553136|525586276|FG001|Overall Study|Lost to Follow-up|10|||
145746142|NCT01553136|525586275|FG000|Overall Study|Physician Decision|2|||
145746143|NCT01553136|525586276|FG001|Overall Study|Physician Decision|3|||
145746144|NCT01553136|525586275|FG000|Overall Study|Scheduling Difficulties|5|||
145746145|NCT01553136|525586276|FG001|Overall Study|Scheduling Difficulties|4|||
145746146|NCT03349099|525586279|FG000|Overall Study|Physician Decision|3|||
145746147|NCT03349099|525586280|FG001|Overall Study|Physician Decision|4|||
145746148|NCT03349099|525586279|FG000|Overall Study|Stone migrated from the kidney|1|||
145746149|NCT03349099|525586280|FG001|Overall Study|Stone migrated from the kidney|0|||
145746150|NCT00278993|525586281|FG000|Overall Study|Adverse Event|24|||
145746151|NCT00278993|525586281|FG000|Overall Study|Withdrawal by Subject|5|||
145746152|NCT00278993|525586281|FG000|Overall Study|Progressive Disease|65|||
145746153|NCT00278993|525586281|FG000|Overall Study|Physician Decision|9|||
145270886|NCT01035229|523839541|FG000|Overall Study|Lost to Follow-up|1|||
145270887|NCT01035229|523839542|FG001|Overall Study|Lost to Follow-up|0|||
145270888|NCT01035229|523839541|FG000|Overall Study|Administrative problems|1|||
145523142|NCT04393298|524775905|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523143|NCT04393298|524775906|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523144|NCT04393298|524775907|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145270889|NCT01035229|523839542|FG001|Overall Study|Administrative problems|1|||
145270890|NCT01035229|523839541|FG000|Overall Study|Death|13|||
145270891|NCT01035229|523839542|FG001|Overall Study|Death|5|||
145746154|NCT00278993|525586281|FG000|Overall Study|Not Otherwise Specified|4|||
145746155|NCT03077685|525586285|FG000|Overall Study|Lost to Follow-up|0|||
145746156|NCT03077685|525586286|FG001|Overall Study|Lost to Follow-up|0|||
145746157|NCT03077685|525586287|FG002|Overall Study|Lost to Follow-up|0|||
145746158|NCT03077685|525586288|FG003|Overall Study|Lost to Follow-up|0|||
145746159|NCT03077685|525586289|FG004|Overall Study|Lost to Follow-up|1|||
145746160|NCT03077685|525586285|FG000|Overall Study|Death|0|||
145270892|NCT01035229|523839541|FG000|Overall Study|New cancer therapy|2|||
145746161|NCT03077685|525586286|FG001|Overall Study|Death|0|||
145746162|NCT03077685|525586287|FG002|Overall Study|Death|1|||
145746163|NCT03077685|525586288|FG003|Overall Study|Death|1|||
145746164|NCT03077685|525586289|FG004|Overall Study|Death|3|||
145746165|NCT03077685|525586285|FG000|Overall Study|Withdrawal by Subject|0|||
145746166|NCT03077685|525586286|FG001|Overall Study|Withdrawal by Subject|0|||
145746167|NCT03077685|525586287|FG002|Overall Study|Withdrawal by Subject|0|||
145746168|NCT03077685|525586288|FG003|Overall Study|Withdrawal by Subject|2|||
145746169|NCT03077685|525586289|FG004|Overall Study|Withdrawal by Subject|1|||
145746170|NCT03077685|525586285|FG000|Overall Study|Physician Decision|0|||
145746171|NCT03077685|525586286|FG001|Overall Study|Physician Decision|0|||
145746172|NCT03077685|525586287|FG002|Overall Study|Physician Decision|1|||
145746173|NCT03077685|525586288|FG003|Overall Study|Physician Decision|0|||
145746174|NCT03077685|525586289|FG004|Overall Study|Physician Decision|3|||
145746175|NCT03077685|525586285|FG000|Overall Study|Disease Progression|1|||
145746176|NCT03077685|525586286|FG001|Overall Study|Disease Progression|0|||
145746177|NCT03077685|525586287|FG002|Overall Study|Disease Progression|0|||
145746178|NCT03077685|525586288|FG003|Overall Study|Disease Progression|2|||
145746179|NCT03077685|525586289|FG004|Overall Study|Disease Progression|1|||
145746180|NCT03077685|525586285|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
145746181|NCT03077685|525586286|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
145746182|NCT03077685|525586287|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
145746183|NCT03077685|525586288|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
145746184|NCT03077685|525586289|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
145523145|NCT04393298|524775908|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523146|NCT04393298|524775909|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523147|NCT04393298|524775910|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523148|NCT04393298|524775911|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523149|NCT04393298|524775912|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
145523150|NCT04393298|524775913|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145746185|NCT03077685|525586285|FG000|Overall Study|Subject entered hospice care|0|||
145746186|NCT03077685|525586286|FG001|Overall Study|Subject entered hospice care|0|||
145746187|NCT03077685|525586287|FG002|Overall Study|Subject entered hospice care|0|||
145746188|NCT03077685|525586288|FG003|Overall Study|Subject entered hospice care|0|||
145746189|NCT03077685|525586289|FG004|Overall Study|Subject entered hospice care|1|||
145746190|NCT01979536|525586290|FG000|Overall Study|Physician Decision|2|||
145746191|NCT01979536|525586291|FG001|Overall Study|Physician Decision|3|||
145746192|NCT01979536|525586290|FG000|Overall Study|Withdrawal by Subject|0|||
145746193|NCT01979536|525586291|FG001|Overall Study|Withdrawal by Subject|1|||
145746194|NCT01979536|525586290|FG000|Overall Study|Refusal|0|||
145746195|NCT01979536|525586291|FG001|Overall Study|Refusal|1|||
145746196|NCT01979536|525586290|FG000|Overall Study|Relapse|0|||
145746197|NCT01979536|525586291|FG001|Overall Study|Relapse|1|||
145746198|NCT01979536|525586290|FG000|Overall Study|Study terminated by Sponsor|0|||
145746199|NCT01979536|525586291|FG001|Overall Study|Study terminated by Sponsor|1|||
145746200|NCT01979536|525586290|FG000|Overall Study|Did not start treatment|0|||
145746201|NCT01979536|525586291|FG001|Overall Study|Did not start treatment|1|||
145746202|NCT04194528|525586293|FG000|Overall Study|Adverse Event|1|||
145746203|NCT04294901|525586302|FG000|Overall Study|Death|86|||
145746204|NCT04294901|525586303|FG001|Overall Study|Death|110|||
145746205|NCT04294901|525586302|FG000|Overall Study|Provider did not have historical control patients|581|||
145746206|NCT04294901|525586303|FG001|Overall Study|Provider did not have historical control patients|0|||
145746207|NCT04294901|525586302|FG000|Overall Study|Provider did not have intervention patients|0|||
145746208|NCT04294901|525586303|FG001|Overall Study|Provider did not have intervention patients|98|||
145523151|NCT04393298|524775914|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523152|NCT04393298|524775915|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523153|NCT04393298|524775916|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145746209|NCT05038020|525586305|FG000|Overall Study|Early Termination|3|||
145746210|NCT05038020|525586306|FG001|Overall Study|Early Termination|0|||
145746211|NCT01192022|525588923|FG000|Overall Study|Withdrawal of Consent|3|||
145746212|NCT01192022|525588924|FG001|Overall Study|Withdrawal of Consent|1|||
145746213|NCT01192022|525588925|FG002|Overall Study|Withdrawal of Consent|0|||
145523154|NCT04393298|524775917|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
145523155|NCT04393298|524775903|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
145746214|NCT01192022|525588926|FG003|Overall Study|Withdrawal of Consent|0|||
145746215|NCT01192022|525588927|FG004|Overall Study|Withdrawal of Consent|0|||
145746216|NCT01192022|525588923|FG000|Overall Study|Lost to Follow-up|4|||
145746217|NCT01192022|525588924|FG001|Overall Study|Lost to Follow-up|2|||
145523156|NCT04393298|524775904|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
145746218|NCT01192022|525588925|FG002|Overall Study|Lost to Follow-up|1|||
145746219|NCT01192022|525588926|FG003|Overall Study|Lost to Follow-up|1|||
145746220|NCT01192022|525588927|FG004|Overall Study|Lost to Follow-up|0|||
145746221|NCT01192022|525588923|FG000|Overall Study|Adverse Event|1|||
145746222|NCT01192022|525588924|FG001|Overall Study|Adverse Event|0|||
145746223|NCT01192022|525588925|FG002|Overall Study|Adverse Event|0|||
145746224|NCT01192022|525588926|FG003|Overall Study|Adverse Event|0|||
145746225|NCT01192022|525588927|FG004|Overall Study|Adverse Event|0|||
145746226|NCT01192022|525588923|FG000|Overall Study|Fatal Adverse Event|4|||
145746227|NCT01192022|525588924|FG001|Overall Study|Fatal Adverse Event|6|||
145746228|NCT01192022|525588925|FG002|Overall Study|Fatal Adverse Event|0|||
145746229|NCT01192022|525588926|FG003|Overall Study|Fatal Adverse Event|0|||
145746230|NCT01192022|525588927|FG004|Overall Study|Fatal Adverse Event|1|||
145746231|NCT01192022|525588923|FG000|Overall Study|Physician withdrew-patient hardship|1|||
145746232|NCT01192022|525588924|FG001|Overall Study|Physician withdrew-patient hardship|0|||
145746233|NCT01192022|525588925|FG002|Overall Study|Physician withdrew-patient hardship|0|||
145746234|NCT01192022|525588926|FG003|Overall Study|Physician withdrew-patient hardship|0|||
145746235|NCT01192022|525588927|FG004|Overall Study|Physician withdrew-patient hardship|0|||
145746236|NCT01192022|525588923|FG000|Overall Study|Patient too sick from chemotherapy|0|||
145746237|NCT01192022|525588924|FG001|Overall Study|Patient too sick from chemotherapy|1|||
145746238|NCT01192022|525588925|FG002|Overall Study|Patient too sick from chemotherapy|0|||
145746239|NCT01192022|525588926|FG003|Overall Study|Patient too sick from chemotherapy|0|||
145746240|NCT01192022|525588927|FG004|Overall Study|Patient too sick from chemotherapy|0|||
145746241|NCT01192022|525588923|FG000|Overall Study|Patient needed surgery|0|||
145746242|NCT01192022|525588924|FG001|Overall Study|Patient needed surgery|1|||
145746243|NCT01192022|525588925|FG002|Overall Study|Patient needed surgery|0|||
145746244|NCT01192022|525588926|FG003|Overall Study|Patient needed surgery|0|||
145746245|NCT01192022|525588927|FG004|Overall Study|Patient needed surgery|0|||
145746246|NCT01192022|525588923|FG000|Overall Study|Parents did not allow all follow up|0|||
145746247|NCT01192022|525588924|FG001|Overall Study|Parents did not allow all follow up|0|||
145746248|NCT01192022|525588925|FG002|Overall Study|Parents did not allow all follow up|0|||
145746249|NCT01192022|525588926|FG003|Overall Study|Parents did not allow all follow up|1|||
145746250|NCT01192022|525588927|FG004|Overall Study|Parents did not allow all follow up|0|||
145746251|NCT01351389|525588928|FG000|Overall Study|Withdrawal by Subject|7|||
145746252|NCT01351389|525588929|FG001|Overall Study|Withdrawal by Subject|0|||
145746253|NCT01351389|525588928|FG000|Overall Study|did not complete intervention|23|||
145746254|NCT01351389|525588929|FG001|Overall Study|did not complete intervention|15|||
145746255|NCT04839978|525588930|FG000|Overall Study|Lost to Follow-up|135|||
145746256|NCT04839978|525588931|FG001|Overall Study|Lost to Follow-up|147|||
145746257|NCT00623480|525588932|FG000|Overall Study|Lost to Follow-up|0|||
145746258|NCT00623480|525588933|FG001|Overall Study|Lost to Follow-up|1|||
145746259|NCT00623480|525588932|FG000|Overall Study|Withdrawal by Subject|2|||
145746260|NCT00623480|525588933|FG001|Overall Study|Withdrawal by Subject|4|||
145746261|NCT00623480|525588932|FG000|Overall Study|Lack of Efficacy|1|||
145746262|NCT00623480|525588933|FG001|Overall Study|Lack of Efficacy|0|||
145746263|NCT00623480|525588932|FG000|Overall Study|Non-compliant with study medication|4|||
145746264|NCT00623480|525588933|FG001|Overall Study|Non-compliant with study medication|0|||
145746265|NCT00623480|525588932|FG000|Overall Study|Protocol Violation|0|||
145746266|NCT00623480|525588933|FG001|Overall Study|Protocol Violation|1|||
145746267|NCT00623480|525588932|FG000|Overall Study|Site closed by sponsor|0|||
145746268|NCT00623480|525588933|FG001|Overall Study|Site closed by sponsor|1|||
145746269|NCT03551509|525588934|FG000|Overall Study|Lost to Follow-up|0|||
145746270|NCT03551509|525588935|FG001|Overall Study|Lost to Follow-up|1|||
145746271|NCT03551509|525588936|FG002|Overall Study|Lost to Follow-up|0|||
145746272|NCT02631200|525588937|FG000|First Period|Death|1|||
145746273|NCT02631200|525588938|FG001|First Period|Death|2|||
145746274|NCT02631200|525588937|FG000|First Period|Patient ill-health|2|||
145746275|NCT02631200|525588938|FG001|First Period|Patient ill-health|4|||
145523157|NCT04393298|524775905|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
145523158|NCT04393298|524775906|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
145523159|NCT04393298|524775907|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
145523160|NCT04393298|524775908|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
145523161|NCT04393298|524775909|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
145523162|NCT04393298|524775910|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
145523163|NCT04393298|524775911|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
145523164|NCT04393298|524775912|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
145746276|NCT02631200|525588937|FG000|First Period|Withdrawal by Subject|4|||
145746277|NCT02631200|525588938|FG001|First Period|Withdrawal by Subject|1|||
145746278|NCT02631200|525588937|FG000|Deferred Period|Death|0|||
145746279|NCT02631200|525588938|FG001|Deferred Period|Death|1|||
145402479|NCT00784875|524330735|FG002|Period D|Protocol Violation|0|||
145523165|NCT04393298|524775913|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
145746280|NCT02631200|525588937|FG000|Deferred Period|Received kidney transplant|0|||
145746281|NCT02631200|525588938|FG001|Deferred Period|Received kidney transplant|1|||
145746282|NCT02631200|525588937|FG000|Deferred Period|Withdrawal by Subject|0|||
145746283|NCT02631200|525588938|FG001|Deferred Period|Withdrawal by Subject|2|||
145746284|NCT02631200|525588937|FG000|Deferred Period|Lost to Follow-up|0|||
145746285|NCT02631200|525588938|FG001|Deferred Period|Lost to Follow-up|1|||
145746286|NCT01877187|525588939|FG000|Overall Study|Death|2|||
145746287|NCT01877187|525588939|FG000|Overall Study|Withdrawal by Subject|4|||
145746288|NCT01877187|525588939|FG000|Overall Study|Lost to Follow-up|3|||
145746289|NCT01877187|525588939|FG000|Overall Study|Declining clinical status|11|||
145746290|NCT01877187|525588939|FG000|Overall Study|Liver transplant|2|||
145746291|NCT00769002|525588941|FG000|Overall Study|Study was not completed, no data|9|||
145746292|NCT00769002|525588942|FG001|Overall Study|Study was not completed, no data|9|||
145746293|NCT04091087|525588944|FG000|Overall Study|Not treated|1|||
145746294|NCT04091087|525588945|FG001|Overall Study|Not treated|0|||
145746295|NCT04091087|525588944|FG000|Overall Study|Adverse Event|4|||
145746296|NCT04091087|525588945|FG001|Overall Study|Adverse Event|4|||
145746297|NCT04091087|525588944|FG000|Overall Study|Protocol Violation|0|||
145746298|NCT04091087|525588945|FG001|Overall Study|Protocol Violation|1|||
145746299|NCT04091087|525588944|FG000|Overall Study|Withdrawal by Subject|5|||
145746300|NCT04091087|525588945|FG001|Overall Study|Withdrawal by Subject|2|||
145746301|NCT04677712|525588946|FG000|Overall Study|Lost to Follow-up|0|||
145746302|NCT04677712|525588947|FG001|Overall Study|Lost to Follow-up|1|||
145746303|NCT04677712|525588948|FG002|Overall Study|Lost to Follow-up|0|||
145746304|NCT04677712|525588949|FG003|Overall Study|Lost to Follow-up|0|||
145746305|NCT04677712|525588950|FG004|Overall Study|Lost to Follow-up|0|||
145746306|NCT04677712|525588951|FG005|Overall Study|Lost to Follow-up|0|||
145746307|NCT00711100|525588952|FG000|Overall Study|Lack of Efficacy|5|||
145746308|NCT00711100|525588952|FG000|Overall Study|Withdrawal by Subject|8|||
145746309|NCT00783094|525588953|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
145746310|NCT00783094|525588954|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
145746311|NCT00783094|525588955|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
145746312|NCT00783094|525588953|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
145746313|NCT00783094|525588954|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
145746314|NCT00783094|525588955|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
145746315|NCT00783094|525588953|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
145746316|NCT00783094|525588954|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
145746317|NCT00783094|525588955|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
145746318|NCT00783094|525588953|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
145746319|NCT00783094|525588954|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
145746320|NCT00783094|525588955|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
145746321|NCT00783094|525588953|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
145746322|NCT00783094|525588954|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
145746323|NCT00783094|525588955|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
145523166|NCT04393298|524775914|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
145523167|NCT04393298|524775915|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
145523168|NCT04393298|524775916|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
145523169|NCT04393298|524775917|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
145523170|NCT02987660|524775918|FG000|Overall Study|Study terminated by sponsor|10|||
145523171|NCT02987660|524775919|FG001|Overall Study|Study terminated by sponsor|10|||
145523172|NCT05007717|524775920|FG000|Overall Study|Death|3|||
145523173|NCT05007717|524775921|FG001|Overall Study|Death|2|||
145523174|NCT03553836|524775922|FG000|Overall Study|Ongoing in Study|460|||
145523175|NCT03553836|524775923|FG001|Overall Study|Ongoing in Study|459|||
145402480|NCT00784875|524330736|FG003|Period D|Protocol Violation|0|||
145523176|NCT03553836|524775922|FG000|Overall Study|Withdrawal by Subject|9|||
145523177|NCT03553836|524775923|FG001|Overall Study|Withdrawal by Subject|10|||
145523178|NCT03553836|524775922|FG000|Overall Study|Lost to Follow-up|1|||
145523179|NCT03553836|524775923|FG001|Overall Study|Lost to Follow-up|3|||
145523180|NCT03553836|524775922|FG000|Overall Study|Death|17|||
145523181|NCT03553836|524775923|FG001|Overall Study|Death|17|||
145523182|NCT04062123|524775924|FG000|Overall Study|Withdrawal by Subject|0|||
145523183|NCT04062123|524775925|FG001|Overall Study|Withdrawal by Subject|1|||
145523184|NCT04062123|524775926|FG002|Overall Study|Withdrawal by Subject|0|||
145523185|NCT01479985|524775930|FG000|Overall Study|Tablet malfunction, no data saved|1|||
145523186|NCT01479985|524775931|FG001|Overall Study|Tablet malfunction, no data saved|1|||
145523187|NCT01479985|524775930|FG000|Overall Study|No decisional conflict scale responses|0|||
145523188|NCT01479985|524775931|FG001|Overall Study|No decisional conflict scale responses|2|||
145746324|NCT00783094|525588953|FG000|Open-Label Extension Period|Adverse Event|12|||
145746325|NCT00783094|525588954|FG001|Open-Label Extension Period|Adverse Event|7|||
145746326|NCT00783094|525588955|FG002|Open-Label Extension Period|Adverse Event|16|||
145746327|NCT00783094|525588953|FG000|Open-Label Extension Period|Death|0|||
145402481|NCT00784875|524330733|FG000|Period D|Withdrawal by Subject|2|||
145523189|NCT01479985|524775930|FG000|Overall Study|No post-visit survey|5|||
145523190|NCT01479985|524775931|FG001|Overall Study|No post-visit survey|3|||
145746328|NCT00783094|525588954|FG001|Open-Label Extension Period|Death|0|||
145746329|NCT00783094|525588955|FG002|Open-Label Extension Period|Death|1|||
145746330|NCT00783094|525588953|FG000|Open-Label Extension Period|Protocol Violation|4|||
145746331|NCT00783094|525588954|FG001|Open-Label Extension Period|Protocol Violation|5|||
145746332|NCT00783094|525588955|FG002|Open-Label Extension Period|Protocol Violation|7|||
145746333|NCT00783094|525588953|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
145746334|NCT00783094|525588954|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
145746335|NCT00783094|525588955|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
145746336|NCT00783094|525588953|FG000|Open-Label Extension Period|Physician Decision|4|||
145746337|NCT00783094|525588954|FG001|Open-Label Extension Period|Physician Decision|2|||
145746338|NCT00783094|525588955|FG002|Open-Label Extension Period|Physician Decision|3|||
145746339|NCT00783094|525588953|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
145746340|NCT00783094|525588954|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
145746341|NCT00783094|525588955|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
145746342|NCT02513329|525588956|FG000|Overall Study|Lost to Follow-up|5|||
145746343|NCT02513329|525588957|FG001|Overall Study|Lost to Follow-up|2|||
145746344|NCT01294670|525588958|FG000|Overall Study|Not treated|1|||
145746345|NCT01294670|525588959|FG001|Overall Study|Not treated|0|||
145746346|NCT01294670|525588960|FG002|Overall Study|Not treated|0|||
145746347|NCT01294670|525588961|FG003|Overall Study|Not treated|0|||
145746348|NCT01294670|525588962|FG004|Overall Study|Not treated|0|||
145746349|NCT03808077|525588963|FG000|Overall Study|Physician Decision|2|||
145746350|NCT03808077|525588964|FG001|Overall Study|Physician Decision|3|||
145746351|NCT03808077|525588963|FG000|Overall Study|Withdrawal by Subject|1|||
145746352|NCT03808077|525588964|FG001|Overall Study|Withdrawal by Subject|0|||
145746353|NCT03808077|525588963|FG000|Overall Study|Equipment Issues|2|||
145746354|NCT03808077|525588964|FG001|Overall Study|Equipment Issues|1|||
145746355|NCT04152161|525588965|FG000|Overall Study|Death|0|||
145746356|NCT04152161|525588966|FG001|Overall Study|Death|1|||
145746357|NCT04152161|525588965|FG000|Overall Study|Physician Decision|0|||
145746358|NCT04152161|525588966|FG001|Overall Study|Physician Decision|1|||
145746359|NCT04152161|525588965|FG000|Overall Study|Lost to Follow-up|9|||
145746360|NCT04152161|525588966|FG001|Overall Study|Lost to Follow-up|3|||
145746361|NCT04152161|525588965|FG000|Overall Study|Protocol Violation|1|||
145746362|NCT04152161|525588966|FG001|Overall Study|Protocol Violation|0|||
145746363|NCT04152161|525588965|FG000|Overall Study|Withdrawal by Subject|29|||
145746364|NCT04152161|525588966|FG001|Overall Study|Withdrawal by Subject|28|||
145746365|NCT04152161|525588965|FG000|Overall Study|Sponsor termination of study|750|||
145746366|NCT04152161|525588966|FG001|Overall Study|Sponsor termination of study|755|||
145746367|NCT04152161|525588965|FG000|Overall Study|Other|20|||
145746368|NCT04152161|525588966|FG001|Overall Study|Other|18|||
145746369|NCT00001379|525588967|FG000|Initial Treatment|Disease progression|21|||
145746370|NCT00001379|525588968|FG001|Initial Treatment|Disease progression|3|||
145746371|NCT00001379|525588969|FG002|Initial Treatment|Disease progression|0|||
145746372|NCT00001379|525588970|FG003|Initial Treatment|Disease progression|0|||
145746373|NCT00001379|525588967|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
145746374|NCT00001379|525588968|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
145746375|NCT00001379|525588969|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
145746376|NCT00001379|525588970|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
145746377|NCT00001379|525588967|FG000|Initial Treatment|Received alternative treatment|2|||
145746378|NCT00001379|525588968|FG001|Initial Treatment|Received alternative treatment|1|||
145746379|NCT00001379|525588969|FG002|Initial Treatment|Received alternative treatment|0|||
145746380|NCT00001379|525588970|FG003|Initial Treatment|Received alternative treatment|0|||
145746381|NCT00001379|525588967|FG000|Initial Treatment|Refused further treatment|2|||
145523191|NCT01653782|524775932|FG000|Overall Study|Withdrawal by Subject|9|||
145523192|NCT01653782|524775933|FG001|Overall Study|Withdrawal by Subject|15|||
145746382|NCT00001379|525588968|FG001|Initial Treatment|Refused further treatment|0|||
145746383|NCT00001379|525588969|FG002|Initial Treatment|Refused further treatment|0|||
145523193|NCT01653782|524775934|FG002|Overall Study|Withdrawal by Subject|4|||
145523194|NCT01653782|524775932|FG000|Overall Study|Lost to Follow-up|7|||
145746384|NCT00001379|525588970|FG003|Initial Treatment|Refused further treatment|0|||
145746385|NCT00001379|525588967|FG000|Initial Treatment|Did not receive protocol treatment|0|||
145746386|NCT00001379|525588968|FG001|Initial Treatment|Did not receive protocol treatment|0|||
145746387|NCT00001379|525588969|FG002|Initial Treatment|Did not receive protocol treatment|5|||
145746388|NCT00001379|525588970|FG003|Initial Treatment|Did not receive protocol treatment|0|||
145746389|NCT00001379|525588967|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
145746390|NCT00001379|525588968|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
145746391|NCT00001379|525588969|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
145746392|NCT00001379|525588970|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
145746393|NCT00001379|525588967|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
145746394|NCT00001379|525588968|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
145746395|NCT00001379|525588969|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
145746396|NCT00001379|525588970|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
145746397|NCT00001379|525588967|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
145746398|NCT00001379|525588968|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
145746399|NCT00001379|525588969|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
145746400|NCT00001379|525588970|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
145746401|NCT00001379|525588967|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
145746402|NCT00001379|525588968|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
145746403|NCT00001379|525588969|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
145746404|NCT00001379|525588970|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
145746405|NCT00001379|525588967|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
145746406|NCT00001379|525588968|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
145746407|NCT00001379|525588969|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
145746408|NCT00001379|525588970|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
145746409|NCT03703102|525588974|FG000|Overall Study|Adverse Event|4|||
145746410|NCT03703102|525588975|FG001|Overall Study|Adverse Event|3|||
145746411|NCT03703102|525588976|FG002|Overall Study|Adverse Event|7|||
145746412|NCT03703102|525588977|FG003|Overall Study|Adverse Event|3|||
145746413|NCT03703102|525588978|FG004|Overall Study|Adverse Event|13|||
145746414|NCT03703102|525588974|FG000|Overall Study|Lack of Efficacy|4|||
145746415|NCT03703102|525588975|FG001|Overall Study|Lack of Efficacy|0|||
145746416|NCT03703102|525588976|FG002|Overall Study|Lack of Efficacy|1|||
145746417|NCT03703102|525588977|FG003|Overall Study|Lack of Efficacy|4|||
145746418|NCT03703102|525588978|FG004|Overall Study|Lack of Efficacy|1|||
145746419|NCT03703102|525588974|FG000|Overall Study|Lost to Follow-up|0|||
145746420|NCT03703102|525588975|FG001|Overall Study|Lost to Follow-up|0|||
145746421|NCT03703102|525588976|FG002|Overall Study|Lost to Follow-up|1|||
145746422|NCT03703102|525588977|FG003|Overall Study|Lost to Follow-up|2|||
145746423|NCT03703102|525588978|FG004|Overall Study|Lost to Follow-up|2|||
145746424|NCT03703102|525588974|FG000|Overall Study|Physician Decision|2|||
145746425|NCT03703102|525588975|FG001|Overall Study|Physician Decision|2|||
145746426|NCT03703102|525588976|FG002|Overall Study|Physician Decision|2|||
145746427|NCT03703102|525588977|FG003|Overall Study|Physician Decision|2|||
145746428|NCT03703102|525588978|FG004|Overall Study|Physician Decision|4|||
145746429|NCT03703102|525588974|FG000|Overall Study|Withdrawal by Subject|7|||
145746430|NCT03703102|525588975|FG001|Overall Study|Withdrawal by Subject|5|||
145746431|NCT03703102|525588976|FG002|Overall Study|Withdrawal by Subject|5|||
145523195|NCT01653782|524775933|FG001|Overall Study|Lost to Follow-up|3|||
145523196|NCT01653782|524775934|FG002|Overall Study|Lost to Follow-up|2|||
145523197|NCT01850602|524775940|FG000|Overall Study|Adverse Event|7|||
145523198|NCT01850602|524775941|FG001|Overall Study|Adverse Event|10|||
145523199|NCT01850602|524775940|FG000|Overall Study|Physician Decision|2|||
145523200|NCT01850602|524775941|FG001|Overall Study|Physician Decision|1|||
145523201|NCT01850602|524775940|FG000|Overall Study|Withdrawal by Subject|2|||
145523202|NCT01850602|524775941|FG001|Overall Study|Withdrawal by Subject|4|||
145523203|NCT01850602|524775940|FG000|Overall Study|Decrease in serum calcium|2|||
145523204|NCT01850602|524775941|FG001|Overall Study|Decrease in serum calcium|3|||
145523205|NCT01850602|524775940|FG000|Overall Study|Increase in serum ferritin|1|||
145523206|NCT01850602|524775941|FG001|Overall Study|Increase in serum ferritin|0|||
145523207|NCT01155479|524775942|FG000|Part I|Adverse Event|13|||
145523208|NCT01155479|524775943|FG001|Part I|Adverse Event|8|||
145523209|NCT01155479|524775944|FG002|Part I|Adverse Event|18|||
145523210|NCT01155479|524775945|FG003|Part I|Adverse Event|7|||
145523211|NCT01155479|524775946|FG004|Part I|Adverse Event|6|||
145523212|NCT01155479|524775942|FG000|Part I|Administrative|2|||
145523213|NCT01155479|524775943|FG001|Part I|Administrative|2|||
145523214|NCT01155479|524775944|FG002|Part I|Administrative|2|||
145523215|NCT01155479|524775945|FG003|Part I|Administrative|0|||
145523216|NCT01155479|524775946|FG004|Part I|Administrative|0|||
145523217|NCT01155479|524775942|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
145523218|NCT01155479|524775943|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
145746432|NCT03703102|525588977|FG003|Overall Study|Withdrawal by Subject|5|||
145523219|NCT01155479|524775944|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
145746433|NCT03703102|525588978|FG004|Overall Study|Withdrawal by Subject|9|||
145746434|NCT03703102|525588974|FG000|Overall Study|Ineligibility|0|||
145746435|NCT03703102|525588975|FG001|Overall Study|Ineligibility|0|||
145746436|NCT03703102|525588976|FG002|Overall Study|Ineligibility|1|||
145746437|NCT03703102|525588977|FG003|Overall Study|Ineligibility|0|||
145746438|NCT03703102|525588978|FG004|Overall Study|Ineligibility|0|||
145746439|NCT03703102|525588974|FG000|Overall Study|Protocol Deviation|4|||
145523220|NCT01155479|524775945|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
145523221|NCT01155479|524775946|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
145523222|NCT01155479|524775942|FG000|Part I|Withdrawal by Subject|11|||
145523223|NCT01155479|524775943|FG001|Part I|Withdrawal by Subject|13|||
145523224|NCT01155479|524775944|FG002|Part I|Withdrawal by Subject|8|||
145523225|NCT01155479|524775945|FG003|Part I|Withdrawal by Subject|8|||
145523226|NCT01155479|524775946|FG004|Part I|Withdrawal by Subject|9|||
145523227|NCT01155479|524775942|FG000|Part I|Lost to Follow-up|0|||
145746440|NCT03703102|525588975|FG001|Overall Study|Protocol Deviation|4|||
145746441|NCT03703102|525588976|FG002|Overall Study|Protocol Deviation|3|||
145746442|NCT03703102|525588977|FG003|Overall Study|Protocol Deviation|0|||
145746443|NCT03703102|525588978|FG004|Overall Study|Protocol Deviation|0|||
145746444|NCT03703102|525588974|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145746445|NCT03703102|525588975|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145746446|NCT03703102|525588976|FG002|Overall Study|Non-Compliance with Study Drug|2|||
145746447|NCT03703102|525588977|FG003|Overall Study|Non-Compliance with Study Drug|1|||
145746448|NCT03703102|525588978|FG004|Overall Study|Non-Compliance with Study Drug|4|||
145746449|NCT00876187|525588979|FG000|Overall Study|Adverse Event|14|||
145746450|NCT00876187|525588980|FG001|Overall Study|Adverse Event|12|||
145746451|NCT00876187|525588981|FG002|Overall Study|Adverse Event|19|||
145746452|NCT00876187|525588982|FG003|Overall Study|Adverse Event|29|||
145746453|NCT00876187|525588983|FG004|Overall Study|Adverse Event|10|||
145746454|NCT00876187|525588979|FG000|Overall Study|Lack of Efficacy|59|||
145746455|NCT00876187|525588980|FG001|Overall Study|Lack of Efficacy|34|||
145746456|NCT00876187|525588981|FG002|Overall Study|Lack of Efficacy|45|||
145746457|NCT00876187|525588982|FG003|Overall Study|Lack of Efficacy|34|||
145746458|NCT00876187|525588983|FG004|Overall Study|Lack of Efficacy|59|||
145746459|NCT00876187|525588979|FG000|Overall Study|Lost to Follow-up|9|||
145746460|NCT00876187|525588980|FG001|Overall Study|Lost to Follow-up|10|||
145746461|NCT00876187|525588981|FG002|Overall Study|Lost to Follow-up|8|||
145746462|NCT00876187|525588982|FG003|Overall Study|Lost to Follow-up|8|||
145746463|NCT00876187|525588983|FG004|Overall Study|Lost to Follow-up|11|||
145746464|NCT00876187|525588979|FG000|Overall Study|Protocol Violation|6|||
145746465|NCT00876187|525588980|FG001|Overall Study|Protocol Violation|7|||
145402482|NCT00784875|524330734|FG001|Period D|Withdrawal by Subject|0|||
145523228|NCT01155479|524775943|FG001|Part I|Lost to Follow-up|0|||
145746466|NCT00876187|525588981|FG002|Overall Study|Protocol Violation|7|||
145746467|NCT00876187|525588982|FG003|Overall Study|Protocol Violation|6|||
145746468|NCT00876187|525588983|FG004|Overall Study|Protocol Violation|3|||
145746469|NCT00876187|525588979|FG000|Overall Study|Withdrawal by Subject|16|||
145746470|NCT00876187|525588980|FG001|Overall Study|Withdrawal by Subject|26|||
145746471|NCT00876187|525588981|FG002|Overall Study|Withdrawal by Subject|32|||
145746472|NCT00876187|525588982|FG003|Overall Study|Withdrawal by Subject|38|||
145270893|NCT01035229|523839542|FG001|Overall Study|New cancer therapy|0|||
145270894|NCT01035229|523839541|FG000|Overall Study|Protocol Violation|0|||
145270895|NCT01035229|523839542|FG001|Overall Study|Protocol Violation|2|||
145270896|NCT01035229|523839541|FG000|Overall Study|Sponsor's decision to end study|3|||
145270897|NCT01035229|523839542|FG001|Overall Study|Sponsor's decision to end study|3|||
145270898|NCT01035229|523839541|FG000|Overall Study|Disease Progression|261|||
145270899|NCT01035229|523839542|FG001|Overall Study|Disease Progression|152|||
145270900|NCT00648739|523839544|FG000|Overall Study|Adverse Event|1|||
145270901|NCT00648739|523839545|FG001|Overall Study|Adverse Event|0|||
145270902|NCT00648739|523839546|FG002|Overall Study|Adverse Event|1|||
145270903|NCT00648739|523839547|FG003|Overall Study|Adverse Event|2|||
145270904|NCT00648739|523839548|FG004|Overall Study|Adverse Event|1|||
145270905|NCT00648739|523839549|FG005|Overall Study|Adverse Event|0|||
145270906|NCT00648739|523839550|FG006|Overall Study|Adverse Event|0|||
145270907|NCT00648739|523839544|FG000|Overall Study|Withdrawal by Subject|1|||
145270908|NCT00648739|523839545|FG001|Overall Study|Withdrawal by Subject|0|||
145270909|NCT00648739|523839546|FG002|Overall Study|Withdrawal by Subject|1|||
145270910|NCT00648739|523839547|FG003|Overall Study|Withdrawal by Subject|0|||
145746473|NCT00876187|525588983|FG004|Overall Study|Withdrawal by Subject|37|||
145746474|NCT00876187|525588979|FG000|Overall Study|Entered extension study|101|||
145746475|NCT00876187|525588980|FG001|Overall Study|Entered extension study|120|||
145746476|NCT00876187|525588981|FG002|Overall Study|Entered extension study|156|||
145746477|NCT00876187|525588982|FG003|Overall Study|Entered extension study|151|||
145746478|NCT00876187|525588983|FG004|Overall Study|Entered extension study|144|||
145746479|NCT00876187|525588979|FG000|Overall Study|Randomized but not treated|3|||
145746480|NCT00876187|525588980|FG001|Overall Study|Randomized but not treated|1|||
145746481|NCT00876187|525588981|FG002|Overall Study|Randomized but not treated|3|||
145746482|NCT00876187|525588982|FG003|Overall Study|Randomized but not treated|2|||
145746483|NCT00876187|525588983|FG004|Overall Study|Randomized but not treated|3|||
145746484|NCT00876187|525588979|FG000|Overall Study|Other|2|||
145746485|NCT00876187|525588980|FG001|Overall Study|Other|5|||
145746486|NCT00876187|525588981|FG002|Overall Study|Other|9|||
145746487|NCT00876187|525588982|FG003|Overall Study|Other|7|||
145746488|NCT00876187|525588983|FG004|Overall Study|Other|4|||
145746489|NCT00794677|525588986|FG000|First Intervention|Withdrawal by Subject|2|||
145270911|NCT00648739|523839548|FG004|Overall Study|Withdrawal by Subject|0|||
145270912|NCT00648739|523839549|FG005|Overall Study|Withdrawal by Subject|2|||
145270913|NCT00648739|523839550|FG006|Overall Study|Withdrawal by Subject|0|||
145270914|NCT00648739|523839544|FG000|Overall Study|Lack of Efficacy|0|||
145270915|NCT00648739|523839545|FG001|Overall Study|Lack of Efficacy|0|||
145270916|NCT00648739|523839546|FG002|Overall Study|Lack of Efficacy|0|||
145270917|NCT00648739|523839547|FG003|Overall Study|Lack of Efficacy|0|||
145270918|NCT00648739|523839548|FG004|Overall Study|Lack of Efficacy|1|||
145270919|NCT00648739|523839549|FG005|Overall Study|Lack of Efficacy|2|||
145270920|NCT00648739|523839550|FG006|Overall Study|Lack of Efficacy|0|||
145270921|NCT00648739|523839544|FG000|Overall Study|Investigator Considered it Advisable|0|||
145270922|NCT00648739|523839545|FG001|Overall Study|Investigator Considered it Advisable|0|||
145270923|NCT00648739|523839546|FG002|Overall Study|Investigator Considered it Advisable|0|||
145270924|NCT00648739|523839547|FG003|Overall Study|Investigator Considered it Advisable|0|||
145270925|NCT00648739|523839548|FG004|Overall Study|Investigator Considered it Advisable|0|||
145270926|NCT00648739|523839549|FG005|Overall Study|Investigator Considered it Advisable|1|||
145270927|NCT00648739|523839550|FG006|Overall Study|Investigator Considered it Advisable|1|||
145270928|NCT00648739|523839544|FG000|Overall Study|Death|0|||
145270929|NCT00648739|523839545|FG001|Overall Study|Death|1|||
145270930|NCT00648739|523839546|FG002|Overall Study|Death|0|||
145270931|NCT00648739|523839547|FG003|Overall Study|Death|0|||
145270932|NCT00648739|523839548|FG004|Overall Study|Death|0|||
145270933|NCT00648739|523839549|FG005|Overall Study|Death|0|||
145270934|NCT00648739|523839550|FG006|Overall Study|Death|0|||
145523229|NCT01155479|524775944|FG002|Part I|Lost to Follow-up|1|||
145523230|NCT01155479|524775945|FG003|Part I|Lost to Follow-up|1|||
145270935|NCT00648739|523839544|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
145270936|NCT00648739|523839545|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
145523231|NCT01155479|524775946|FG004|Part I|Lost to Follow-up|0|||
145270937|NCT00648739|523839546|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
145523232|NCT01155479|524775942|FG000|Part I|Treatment Failure|3|||
145523233|NCT01155479|524775943|FG001|Part I|Treatment Failure|0|||
145746490|NCT00794677|525588987|FG001|First Intervention|Withdrawal by Subject|0|||
145746491|NCT02863809|525588988|FG000|Overall Study|Adverse Event|8|||
145746492|NCT02863809|525588989|FG001|Overall Study|Adverse Event|8|||
145270938|NCT00648739|523839547|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
145270939|NCT00648739|523839548|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
145523234|NCT01155479|524775944|FG002|Part I|Treatment Failure|3|||
145746493|NCT02863809|525588988|FG000|Overall Study|Withdrawal by Subject|0|||
145746494|NCT02863809|525588989|FG001|Overall Study|Withdrawal by Subject|1|||
145746495|NCT02863809|525588988|FG000|Overall Study|Lost to Follow-up|1|||
145402483|NCT00784875|524330735|FG002|Period D|Withdrawal by Subject|2|||
145746496|NCT02863809|525588989|FG001|Overall Study|Lost to Follow-up|1|||
145746497|NCT02863809|525588988|FG000|Overall Study|Death|1|||
145746498|NCT02863809|525588989|FG001|Overall Study|Death|0|||
145746499|NCT00607386|525588990|FG000|Overall Study|Physician Decision|1|||
145746500|NCT01422915|525588993|FG000|Overall Study|Adverse Event|1|||
145746501|NCT01265797|525588994|FG000|Run-in Month|Withdrawal by Subject|0|||
145746502|NCT01265797|525588995|FG001|Run-in Month|Withdrawal by Subject|4|||
145746503|NCT01265797|525588994|FG000|Run-in Month|1st seizure during run-in month|0|||
145746504|NCT01265797|525588995|FG001|Run-in Month|1st seizure during run-in month|1|||
145746505|NCT01265797|525588994|FG000|Blinded Month|Lack of Efficacy|5|||
145746506|NCT01265797|525588995|FG001|Blinded Month|Lack of Efficacy|0|||
145746507|NCT01265797|525588994|FG000|Blinded Month|Lost to Follow-up|1|||
145746508|NCT01265797|525588995|FG001|Blinded Month|Lost to Follow-up|0|||
145746509|NCT01265797|525588994|FG000|Blinded Month|Protocol Violation|2|||
145746510|NCT01265797|525588995|FG001|Blinded Month|Protocol Violation|1|||
145746511|NCT01265797|525588994|FG000|Blinded Month|Adverse Event|2|||
145746512|NCT01265797|525588995|FG001|Blinded Month|Adverse Event|0|||
145746513|NCT01265797|525588994|FG000|Blinded Month|Diary data incomplete|0|||
145746514|NCT01265797|525588995|FG001|Blinded Month|Diary data incomplete|1|||
145746515|NCT01265797|525588994|FG000|Open Label Month|Lost to Follow-up|0|||
145746516|NCT01265797|525588995|FG001|Open Label Month|Lost to Follow-up|1|||
145746517|NCT02980224|525588996|FG000|Overall Study|Adverse Event|4|||
145746518|NCT02980224|525588997|FG001|Overall Study|Adverse Event|1|||
145746519|NCT02980224|525588996|FG000|Overall Study|Withdrawal by Subject|0|||
145746520|NCT02980224|525588997|FG001|Overall Study|Withdrawal by Subject|2|||
145746521|NCT00879645|525588998|FG000|Overall Study|Adverse Event|1|||
145746522|NCT00879645|525588999|FG001|Overall Study|Adverse Event|0|||
145746523|NCT00879645|525589000|FG002|Overall Study|Adverse Event|0|||
145746524|NCT00879645|525589001|FG003|Overall Study|Adverse Event|0|||
145746525|NCT04288154|525589002|FG000|Overall Study|Withdrawal by Subject|9|||
145746526|NCT04288154|525589003|FG001|Overall Study|Withdrawal by Subject|9|||
145746527|NCT00996944|525589004|FG000|Double-blind Treatment Period|Adverse Event|2|||
145746528|NCT00996944|525589005|FG001|Double-blind Treatment Period|Adverse Event|1|||
145746529|NCT00996944|525589004|FG000|Double-blind Treatment Period|Protocol Violation|1|||
145746530|NCT00996944|525589005|FG001|Double-blind Treatment Period|Protocol Violation|0|||
145746531|NCT00996944|525589004|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
145746532|NCT00996944|525589005|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
145746533|NCT00996944|525589004|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145746534|NCT00996944|525589005|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145746535|NCT00996944|525589004|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
145746536|NCT00996944|525589005|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
145746537|NCT00769184|525589006|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
145746538|NCT00769184|525589007|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
145746539|NCT00769184|525589006|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
145746540|NCT00769184|525589007|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
145746541|NCT00769184|525589006|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
145746542|NCT00769184|525589007|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
145746543|NCT00385255|525589008|FG000|Overall Study|Serious Adverse Event|1|||
145746544|NCT00385255|525589009|FG001|Overall Study|Serious Adverse Event|2|||
145746545|NCT00385255|525589008|FG000|Overall Study|Protocol Violation|0|||
145746546|NCT00385255|525589009|FG001|Overall Study|Protocol Violation|4|||
145746547|NCT00385255|525589008|FG000|Overall Study|Withdrawal by Subject|0|||
145746548|NCT00385255|525589009|FG001|Overall Study|Withdrawal by Subject|8|||
145746549|NCT00385255|525589008|FG000|Overall Study|Migrated/moved from study area|0|||
145746550|NCT00385255|525589009|FG001|Overall Study|Migrated/moved from study area|1|||
145746551|NCT00385255|525589008|FG000|Overall Study|Lost to Follow-up|20|||
145746552|NCT00385255|525589009|FG001|Overall Study|Lost to Follow-up|58|||
145746553|NCT00583362|525589010|FG000|Overall Study|Adverse Event|44|||
145746554|NCT00583362|525589010|FG000|Overall Study|Lack of Efficacy|22|||
145523235|NCT01155479|524775945|FG003|Part I|Treatment Failure|1|||
145523236|NCT01155479|524775946|FG004|Part I|Treatment Failure|2|||
145523237|NCT01155479|524775942|FG000|Part I|Did Not Receive Treatment|4|||
145746555|NCT00583362|525589010|FG000|Overall Study|Lost to Follow-up|4|||
145746556|NCT00583362|525589010|FG000|Overall Study|Non-compliance with study drug|28|||
145746557|NCT00583362|525589010|FG000|Overall Study|Pregnancy|7|||
145746558|NCT00583362|525589010|FG000|Overall Study|Miscommunication of visit window|5|||
145746559|NCT00583362|525589010|FG000|Overall Study|Current site closed|7|||
145746560|NCT00583362|525589010|FG000|Overall Study|Subject not dosed in LBSL99|1|||
145746561|NCT00583362|525589010|FG000|Overall Study|Subject moved out of the country/state|2|||
145746562|NCT00583362|525589010|FG000|Overall Study|Missed visits due to staff changes|1|||
145746563|NCT00583362|525589010|FG000|Overall Study|Misunderstanding of protocol|1|||
145746564|NCT00583362|525589010|FG000|Overall Study|Behavioral problems and non-compliance|1|||
145746565|NCT00583362|525589010|FG000|Overall Study|Sponsor request due to missed doses|1|||
145746566|NCT00583362|525589010|FG000|Overall Study|Physician Decision|19|||
145746567|NCT00583362|525589010|FG000|Overall Study|Protocol Violation|2|||
145746568|NCT00583362|525589010|FG000|Overall Study|Withdrawal by Subject|57|||
145523238|NCT01155479|524775943|FG001|Part I|Did Not Receive Treatment|2|||
145523239|NCT01155479|524775944|FG002|Part I|Did Not Receive Treatment|2|||
145523240|NCT01155479|524775945|FG003|Part I|Did Not Receive Treatment|6|||
145523241|NCT01155479|524775946|FG004|Part I|Did Not Receive Treatment|1|||
145523242|NCT01155479|524775942|FG000|Part I|Non-Compliance with Protocol|2|||
145523243|NCT01155479|524775943|FG001|Part I|Non-Compliance with Protocol|1|||
145523244|NCT01155479|524775944|FG002|Part I|Non-Compliance with Protocol|3|||
145523245|NCT01155479|524775945|FG003|Part I|Non-Compliance with Protocol|3|||
145523246|NCT01155479|524775946|FG004|Part I|Non-Compliance with Protocol|2|||
145523247|NCT01155479|524775942|FG000|Part II|Adverse Event|7|||
145523248|NCT01155479|524775943|FG001|Part II|Adverse Event|6|||
145523249|NCT01155479|524775944|FG002|Part II|Adverse Event|8|||
145523250|NCT01155479|524775945|FG003|Part II|Adverse Event|3|||
145523251|NCT01155479|524775946|FG004|Part II|Adverse Event|4|||
145523252|NCT01155479|524775942|FG000|Part II|Administrative|43|||
145523253|NCT01155479|524775943|FG001|Part II|Administrative|49|||
145523254|NCT01155479|524775944|FG002|Part II|Administrative|36|||
145523255|NCT01155479|524775945|FG003|Part II|Administrative|38|||
145523256|NCT01155479|524775946|FG004|Part II|Administrative|46|||
145523257|NCT01155479|524775942|FG000|Part II|Withdrawal by Subject|8|||
145523258|NCT01155479|524775943|FG001|Part II|Withdrawal by Subject|4|||
145523259|NCT01155479|524775944|FG002|Part II|Withdrawal by Subject|12|||
145523260|NCT01155479|524775945|FG003|Part II|Withdrawal by Subject|7|||
145523261|NCT01155479|524775946|FG004|Part II|Withdrawal by Subject|3|||
145523262|NCT01155479|524775942|FG000|Part II|Lost to Follow-up|1|||
145523263|NCT01155479|524775943|FG001|Part II|Lost to Follow-up|0|||
145523264|NCT01155479|524775944|FG002|Part II|Lost to Follow-up|0|||
145523265|NCT01155479|524775945|FG003|Part II|Lost to Follow-up|0|||
145523266|NCT01155479|524775946|FG004|Part II|Lost to Follow-up|1|||
145523267|NCT01155479|524775942|FG000|Part II|Treatment Failure|0|||
145523268|NCT01155479|524775943|FG001|Part II|Treatment Failure|1|||
145523269|NCT01155479|524775944|FG002|Part II|Treatment Failure|2|||
145523270|NCT01155479|524775945|FG003|Part II|Treatment Failure|0|||
145523271|NCT01155479|524775946|FG004|Part II|Treatment Failure|1|||
145523272|NCT01155479|524775942|FG000|Part II|Non-Compliance with Protocol|0|||
145523273|NCT01155479|524775943|FG001|Part II|Non-Compliance with Protocol|1|||
145523274|NCT01155479|524775944|FG002|Part II|Non-Compliance with Protocol|0|||
145523275|NCT01155479|524775945|FG003|Part II|Non-Compliance with Protocol|2|||
145523276|NCT01155479|524775946|FG004|Part II|Non-Compliance with Protocol|0|||
145523277|NCT02360605|524775947|FG000|Overall Study|Withdrawal by Subject|4|||
145523278|NCT02360605|524775948|FG001|Overall Study|Withdrawal by Subject|9|||
145523279|NCT02360605|524775947|FG000|Overall Study|Lost to Follow-up|7|||
145523280|NCT02360605|524775948|FG001|Overall Study|Lost to Follow-up|8|||
145523281|NCT02360605|524775947|FG000|Overall Study|Death|0|||
145523282|NCT02360605|524775948|FG001|Overall Study|Death|1|||
145523283|NCT01634178|524775954|FG000|Treatment Period 1|Adverse Event|0|||
145523284|NCT01634178|524775955|FG001|Treatment Period 1|Adverse Event|1|||
145523285|NCT01634178|524775954|FG000|Treatment Period 2|Adverse Event|1|||
145523286|NCT01634178|524775955|FG001|Treatment Period 2|Adverse Event|0|||
145523287|NCT01721577|524775958|FG000|Overall Study|Lack of Efficacy|1|||
145523288|NCT01721577|524775959|FG001|Overall Study|Lack of Efficacy|0|||
145523289|NCT01721577|524775958|FG000|Overall Study|Death|1|||
145523290|NCT01721577|524775959|FG001|Overall Study|Death|0|||
145523291|NCT01721577|524775958|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
145523292|NCT01721577|524775959|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
145523293|NCT01721577|524775958|FG000|Overall Study|Adverse Event|0|||
145523294|NCT01721577|524775959|FG001|Overall Study|Adverse Event|2|||
145523295|NCT02497976|524775960|FG000|Overall Study|Withdrawal by Subject|2|||
145523296|NCT02497976|524775961|FG001|Overall Study|Withdrawal by Subject|0|||
145523297|NCT02497976|524775960|FG000|Overall Study|Moved out of area|0|||
145523298|NCT02497976|524775961|FG001|Overall Study|Moved out of area|1|||
145523299|NCT01282203|524775962|FG000|Overall Study|Adverse Event|1|||
145523300|NCT00058539|524775965|FG000|Overall Study|Disease progression|24|||
145523301|NCT00058539|524775965|FG000|Overall Study|Adverse Event|3|||
145523302|NCT00058539|524775965|FG000|Overall Study|Withdrawal by Subject|5|||
145523303|NCT00058539|524775965|FG000|Overall Study|Physician Decision|9|||
145523304|NCT00058539|524775965|FG000|Overall Study|Death|1|||
145523305|NCT00740051|524775966|FG000|Overall Study|Lack of Efficacy|2|||
145523306|NCT00740051|524775967|FG001|Overall Study|Lack of Efficacy|5|||
145523307|NCT00740051|524775966|FG000|Overall Study|Adverse Event|1|||
145523308|NCT00740051|524775967|FG001|Overall Study|Adverse Event|4|||
145523309|NCT00740051|524775966|FG000|Overall Study|Protocol Violation|2|||
145523310|NCT00740051|524775967|FG001|Overall Study|Protocol Violation|6|||
145746569|NCT04247061|525589011|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
145746570|NCT04247061|525589011|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
145746571|NCT04247061|525589011|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
145746572|NCT01136655|525589016|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
145746573|NCT01136655|525589016|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
145746574|NCT01136655|525589016|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
145746575|NCT01136655|525589016|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
145746576|NCT02873936|525589019|FG000|Overall Study|Withdrew Consent|4|||
145746577|NCT02873936|525589020|FG001|Overall Study|Withdrew Consent|11|||
145746578|NCT02873936|525589021|FG002|Overall Study|Withdrew Consent|20|||
145746579|NCT02873936|525589019|FG000|Overall Study|Investigator's Discretion|3|||
145746580|NCT02873936|525589020|FG001|Overall Study|Investigator's Discretion|5|||
145746581|NCT02873936|525589021|FG002|Overall Study|Investigator's Discretion|4|||
145746582|NCT02873936|525589019|FG000|Overall Study|Adverse Event|3|||
145746583|NCT02873936|525589020|FG001|Overall Study|Adverse Event|5|||
145746584|NCT02873936|525589021|FG002|Overall Study|Adverse Event|3|||
145746585|NCT02873936|525589019|FG000|Overall Study|Protocol Violation|0|||
145746586|NCT02873936|525589020|FG001|Overall Study|Protocol Violation|1|||
145746587|NCT02873936|525589021|FG002|Overall Study|Protocol Violation|3|||
145746588|NCT02873936|525589019|FG000|Overall Study|Lost to Follow-up|1|||
145746589|NCT02873936|525589020|FG001|Overall Study|Lost to Follow-up|1|||
145746590|NCT02873936|525589021|FG002|Overall Study|Lost to Follow-up|1|||
145746591|NCT02873936|525589019|FG000|Overall Study|Non-compliance With Study Drug|1|||
145746592|NCT02873936|525589020|FG001|Overall Study|Non-compliance With Study Drug|0|||
145746593|NCT02873936|525589021|FG002|Overall Study|Non-compliance With Study Drug|1|||
145746594|NCT02873936|525589019|FG000|Overall Study|Randomized but not Dosed|1|||
145746595|NCT02873936|525589020|FG001|Overall Study|Randomized but not Dosed|0|||
145746596|NCT02873936|525589021|FG002|Overall Study|Randomized but not Dosed|0|||
145746597|NCT05513625|525589022|FG000|Overall Study|Withdrawal by Subject|1|||
145746598|NCT01015768|525589023|FG000|Overall Study|Some subject data unuseable|4|||
145746599|NCT01015768|525589024|FG001|Overall Study|Some subject data unuseable|4|||
145746600|NCT01225731|525589026|FG000|Part 1|Did not meet eligibility criteria|1|||
145746601|NCT01225731|525589027|FG001|Part 1|Did not meet eligibility criteria|0|||
145746602|NCT01225731|525589028|FG002|Part 1|Did not meet eligibility criteria|0|||
145746603|NCT01225731|525589029|FG003|Part 1|Did not meet eligibility criteria|0|||
145746604|NCT01225731|525589030|FG004|Part 1|Did not meet eligibility criteria|1|||
145746605|NCT01225731|525589031|FG005|Part 1|Did not meet eligibility criteria|0|||
145746606|NCT01225731|525589032|FG006|Part 1|Did not meet eligibility criteria|0|||
145746607|NCT01225731|525589033|FG007|Part 1|Did not meet eligibility criteria|0|||
145746608|NCT01225731|525589034|FG008|Part 1|Did not meet eligibility criteria|0|||
145746609|NCT01225731|525589035|FG009|Part 1|Did not meet eligibility criteria|0|||
145746610|NCT01225731|525589036|FG010|Part 1|Did not meet eligibility criteria|0|||
145746611|NCT01225731|525589037|FG011|Part 1|Did not meet eligibility criteria|0|||
145746612|NCT01225731|525589038|FG012|Part 1|Did not meet eligibility criteria|0|||
145746613|NCT01225731|525589026|FG000|Part 1|Adverse Event|1|||
145746614|NCT01225731|525589027|FG001|Part 1|Adverse Event|2|||
145746615|NCT01225731|525589028|FG002|Part 1|Adverse Event|1|||
145746616|NCT01225731|525589029|FG003|Part 1|Adverse Event|1|||
145746617|NCT01225731|525589030|FG004|Part 1|Adverse Event|1|||
145746618|NCT01225731|525589031|FG005|Part 1|Adverse Event|0|||
145746619|NCT01225731|525589032|FG006|Part 1|Adverse Event|0|||
145746620|NCT01225731|525589033|FG007|Part 1|Adverse Event|0|||
145746621|NCT01225731|525589034|FG008|Part 1|Adverse Event|0|||
145746622|NCT01225731|525589035|FG009|Part 1|Adverse Event|0|||
145746623|NCT01225731|525589036|FG010|Part 1|Adverse Event|0|||
145746624|NCT01225731|525589037|FG011|Part 1|Adverse Event|0|||
145746625|NCT01225731|525589038|FG012|Part 1|Adverse Event|0|||
145746626|NCT01225731|525589026|FG000|Part 1|Withdrawal by Subject|0|||
145746627|NCT01225731|525589027|FG001|Part 1|Withdrawal by Subject|3|||
145746628|NCT01225731|525589028|FG002|Part 1|Withdrawal by Subject|0|||
145746629|NCT01225731|525589029|FG003|Part 1|Withdrawal by Subject|0|||
145402484|NCT00784875|524330736|FG003|Period D|Withdrawal by Subject|0|||
145746630|NCT01225731|525589030|FG004|Part 1|Withdrawal by Subject|4|||
145746631|NCT01225731|525589031|FG005|Part 1|Withdrawal by Subject|0|||
145746632|NCT01225731|525589032|FG006|Part 1|Withdrawal by Subject|0|||
145746633|NCT01225731|525589033|FG007|Part 1|Withdrawal by Subject|0|||
145746634|NCT01225731|525589034|FG008|Part 1|Withdrawal by Subject|0|||
145746635|NCT01225731|525589035|FG009|Part 1|Withdrawal by Subject|0|||
145746636|NCT01225731|525589036|FG010|Part 1|Withdrawal by Subject|0|||
145746637|NCT01225731|525589037|FG011|Part 1|Withdrawal by Subject|0|||
145746638|NCT01225731|525589038|FG012|Part 1|Withdrawal by Subject|0|||
145746639|NCT01225731|525589026|FG000|Part 1|Protocol Violation|0|||
145746640|NCT01225731|525589027|FG001|Part 1|Protocol Violation|0|||
145746641|NCT01225731|525589028|FG002|Part 1|Protocol Violation|0|||
145746642|NCT01225731|525589029|FG003|Part 1|Protocol Violation|1|||
145746643|NCT01225731|525589030|FG004|Part 1|Protocol Violation|0|||
145746644|NCT01225731|525589031|FG005|Part 1|Protocol Violation|0|||
145746645|NCT01225731|525589032|FG006|Part 1|Protocol Violation|0|||
145746646|NCT01225731|525589033|FG007|Part 1|Protocol Violation|0|||
145746647|NCT01225731|525589034|FG008|Part 1|Protocol Violation|0|||
145746648|NCT01225731|525589035|FG009|Part 1|Protocol Violation|0|||
145746649|NCT01225731|525589036|FG010|Part 1|Protocol Violation|0|||
145746650|NCT01225731|525589037|FG011|Part 1|Protocol Violation|0|||
145746651|NCT01225731|525589038|FG012|Part 1|Protocol Violation|0|||
145746652|NCT01225731|525589026|FG000|Part 2|Protocol Violation|0|||
145746653|NCT01225731|525589027|FG001|Part 2|Protocol Violation|0|||
145746654|NCT01225731|525589028|FG002|Part 2|Protocol Violation|0|||
145746655|NCT01225731|525589029|FG003|Part 2|Protocol Violation|0|||
145746656|NCT01225731|525589030|FG004|Part 2|Protocol Violation|0|||
145746657|NCT01225731|525589031|FG005|Part 2|Protocol Violation|1|||
145746658|NCT01225731|525589032|FG006|Part 2|Protocol Violation|0|||
145746659|NCT01225731|525589033|FG007|Part 2|Protocol Violation|0|||
145746660|NCT01225731|525589034|FG008|Part 2|Protocol Violation|1|||
145746661|NCT01225731|525589035|FG009|Part 2|Protocol Violation|0|||
145746662|NCT01225731|525589036|FG010|Part 2|Protocol Violation|0|||
145746663|NCT01225731|525589037|FG011|Part 2|Protocol Violation|0|||
145746664|NCT01225731|525589038|FG012|Part 2|Protocol Violation|0|||
145746665|NCT01225731|525589026|FG000|Part 2|Adverse Event|0|||
145746666|NCT01225731|525589027|FG001|Part 2|Adverse Event|0|||
145746667|NCT01225731|525589028|FG002|Part 2|Adverse Event|0|||
145746668|NCT01225731|525589029|FG003|Part 2|Adverse Event|0|||
145746669|NCT01225731|525589030|FG004|Part 2|Adverse Event|0|||
145523311|NCT00740051|524775966|FG000|Overall Study|Lost to Follow-up|3|||
145523312|NCT00740051|524775967|FG001|Overall Study|Lost to Follow-up|8|||
145746670|NCT01225731|525589031|FG005|Part 2|Adverse Event|0|||
145746671|NCT01225731|525589032|FG006|Part 2|Adverse Event|4|||
145746672|NCT01225731|525589033|FG007|Part 2|Adverse Event|4|||
145746673|NCT01225731|525589034|FG008|Part 2|Adverse Event|2|||
145746674|NCT01225731|525589035|FG009|Part 2|Adverse Event|0|||
145746675|NCT01225731|525589036|FG010|Part 2|Adverse Event|0|||
145746676|NCT01225731|525589037|FG011|Part 2|Adverse Event|0|||
145746677|NCT01225731|525589038|FG012|Part 2|Adverse Event|0|||
145746678|NCT01225731|525589026|FG000|Part 2|Lack of Efficacy|0|||
145746679|NCT01225731|525589027|FG001|Part 2|Lack of Efficacy|0|||
145746680|NCT01225731|525589028|FG002|Part 2|Lack of Efficacy|0|||
145746681|NCT01225731|525589029|FG003|Part 2|Lack of Efficacy|0|||
145746682|NCT01225731|525589030|FG004|Part 2|Lack of Efficacy|0|||
145746683|NCT01225731|525589031|FG005|Part 2|Lack of Efficacy|1|||
145746684|NCT01225731|525589032|FG006|Part 2|Lack of Efficacy|0|||
145746685|NCT01225731|525589033|FG007|Part 2|Lack of Efficacy|12|||
145746686|NCT01225731|525589034|FG008|Part 2|Lack of Efficacy|3|||
145746687|NCT01225731|525589035|FG009|Part 2|Lack of Efficacy|0|||
145746688|NCT01225731|525589036|FG010|Part 2|Lack of Efficacy|0|||
145746689|NCT01225731|525589037|FG011|Part 2|Lack of Efficacy|0|||
145746690|NCT01225731|525589038|FG012|Part 2|Lack of Efficacy|0|||
145746691|NCT01225731|525589026|FG000|Part 2|Pregnancy|0|||
145746692|NCT01225731|525589027|FG001|Part 2|Pregnancy|0|||
145746693|NCT01225731|525589028|FG002|Part 2|Pregnancy|0|||
145746694|NCT01225731|525589029|FG003|Part 2|Pregnancy|0|||
145746695|NCT01225731|525589030|FG004|Part 2|Pregnancy|0|||
145746696|NCT01225731|525589031|FG005|Part 2|Pregnancy|0|||
145746697|NCT01225731|525589032|FG006|Part 2|Pregnancy|1|||
145746698|NCT01225731|525589033|FG007|Part 2|Pregnancy|0|||
145746699|NCT01225731|525589034|FG008|Part 2|Pregnancy|1|||
145746700|NCT01225731|525589035|FG009|Part 2|Pregnancy|0|||
145746701|NCT01225731|525589036|FG010|Part 2|Pregnancy|0|||
145746702|NCT01225731|525589037|FG011|Part 2|Pregnancy|0|||
145746703|NCT01225731|525589038|FG012|Part 2|Pregnancy|0|||
145746704|NCT01225731|525589026|FG000|Part 2|Lost to Follow-up|0|||
145523313|NCT00740051|524775966|FG000|Overall Study|Withdrawal by Subject|6|||
145746705|NCT01225731|525589027|FG001|Part 2|Lost to Follow-up|0|||
145746706|NCT01225731|525589028|FG002|Part 2|Lost to Follow-up|0|||
145523314|NCT00740051|524775967|FG001|Overall Study|Withdrawal by Subject|8|||
145523315|NCT00740051|524775966|FG000|Overall Study|Other reason (not specified)|4|||
145523316|NCT00740051|524775967|FG001|Overall Study|Other reason (not specified)|1|||
145746707|NCT01225731|525589029|FG003|Part 2|Lost to Follow-up|0|||
145746708|NCT01225731|525589030|FG004|Part 2|Lost to Follow-up|0|||
145746709|NCT01225731|525589031|FG005|Part 2|Lost to Follow-up|0|||
145746710|NCT01225731|525589032|FG006|Part 2|Lost to Follow-up|0|||
145746711|NCT01225731|525589033|FG007|Part 2|Lost to Follow-up|3|||
145746712|NCT01225731|525589034|FG008|Part 2|Lost to Follow-up|1|||
145746713|NCT01225731|525589035|FG009|Part 2|Lost to Follow-up|0|||
145746714|NCT01225731|525589036|FG010|Part 2|Lost to Follow-up|0|||
145523317|NCT01903525|524775970|FG000|Overall Study|Lost to Follow-up|5|||
145523318|NCT01903525|524775971|FG001|Overall Study|Lost to Follow-up|9|||
145746715|NCT01225731|525589037|FG011|Part 2|Lost to Follow-up|0|||
145746716|NCT01225731|525589038|FG012|Part 2|Lost to Follow-up|0|||
145746717|NCT01225731|525589026|FG000|Part 2|Physician Decision|0|||
145746718|NCT01225731|525589027|FG001|Part 2|Physician Decision|0|||
145746719|NCT01225731|525589028|FG002|Part 2|Physician Decision|0|||
145746720|NCT01225731|525589029|FG003|Part 2|Physician Decision|0|||
145746721|NCT01225731|525589030|FG004|Part 2|Physician Decision|0|||
145746722|NCT01225731|525589031|FG005|Part 2|Physician Decision|0|||
145746723|NCT01225731|525589032|FG006|Part 2|Physician Decision|0|||
145746724|NCT01225731|525589033|FG007|Part 2|Physician Decision|2|||
145746725|NCT01225731|525589034|FG008|Part 2|Physician Decision|2|||
145746726|NCT01225731|525589035|FG009|Part 2|Physician Decision|0|||
145746727|NCT01225731|525589036|FG010|Part 2|Physician Decision|0|||
145746728|NCT01225731|525589037|FG011|Part 2|Physician Decision|0|||
145746729|NCT01225731|525589038|FG012|Part 2|Physician Decision|0|||
145746730|NCT01225731|525589026|FG000|Part 2|Withdrawal by Subject|0|||
145746731|NCT01225731|525589027|FG001|Part 2|Withdrawal by Subject|0|||
145746732|NCT01225731|525589028|FG002|Part 2|Withdrawal by Subject|0|||
145746733|NCT01225731|525589029|FG003|Part 2|Withdrawal by Subject|0|||
145746734|NCT01225731|525589030|FG004|Part 2|Withdrawal by Subject|0|||
145746735|NCT01225731|525589031|FG005|Part 2|Withdrawal by Subject|1|||
145746736|NCT01225731|525589032|FG006|Part 2|Withdrawal by Subject|3|||
145746737|NCT01225731|525589033|FG007|Part 2|Withdrawal by Subject|4|||
145746738|NCT01225731|525589034|FG008|Part 2|Withdrawal by Subject|1|||
145746739|NCT01225731|525589035|FG009|Part 2|Withdrawal by Subject|0|||
145746740|NCT01225731|525589036|FG010|Part 2|Withdrawal by Subject|0|||
145746741|NCT01225731|525589037|FG011|Part 2|Withdrawal by Subject|0|||
145746742|NCT01225731|525589038|FG012|Part 2|Withdrawal by Subject|0|||
145746743|NCT01225731|525589026|FG000|Part 3|Adverse Event|0|||
145746744|NCT01225731|525589027|FG001|Part 3|Adverse Event|0|||
145746745|NCT01225731|525589028|FG002|Part 3|Adverse Event|0|||
145746746|NCT01225731|525589029|FG003|Part 3|Adverse Event|0|||
145746747|NCT01225731|525589030|FG004|Part 3|Adverse Event|0|||
145746748|NCT01225731|525589031|FG005|Part 3|Adverse Event|0|||
145746749|NCT01225731|525589032|FG006|Part 3|Adverse Event|0|||
145746750|NCT01225731|525589033|FG007|Part 3|Adverse Event|0|||
145746751|NCT01225731|525589034|FG008|Part 3|Adverse Event|0|||
145746752|NCT01225731|525589035|FG009|Part 3|Adverse Event|0|||
145746753|NCT01225731|525589036|FG010|Part 3|Adverse Event|1|||
145746754|NCT01225731|525589037|FG011|Part 3|Adverse Event|1|||
145746755|NCT01225731|525589038|FG012|Part 3|Adverse Event|0|||
145746756|NCT01225731|525589026|FG000|Part 3|Lost to Follow-up|0|||
145746757|NCT01225731|525589027|FG001|Part 3|Lost to Follow-up|0|||
145746758|NCT01225731|525589028|FG002|Part 3|Lost to Follow-up|0|||
145746759|NCT01225731|525589029|FG003|Part 3|Lost to Follow-up|0|||
145746760|NCT01225731|525589030|FG004|Part 3|Lost to Follow-up|0|||
145746761|NCT01225731|525589031|FG005|Part 3|Lost to Follow-up|0|||
145746762|NCT01225731|525589032|FG006|Part 3|Lost to Follow-up|0|||
145746763|NCT01225731|525589033|FG007|Part 3|Lost to Follow-up|0|||
145746764|NCT01225731|525589034|FG008|Part 3|Lost to Follow-up|0|||
145746765|NCT01225731|525589035|FG009|Part 3|Lost to Follow-up|0|||
145746766|NCT01225731|525589036|FG010|Part 3|Lost to Follow-up|1|||
145746767|NCT01225731|525589037|FG011|Part 3|Lost to Follow-up|2|||
145746768|NCT01225731|525589038|FG012|Part 3|Lost to Follow-up|1|||
145746769|NCT01225731|525589026|FG000|Part 3|Physician Decision|0|||
145746770|NCT01225731|525589027|FG001|Part 3|Physician Decision|0|||
145746771|NCT01225731|525589028|FG002|Part 3|Physician Decision|0|||
145746772|NCT01225731|525589029|FG003|Part 3|Physician Decision|0|||
145746773|NCT01225731|525589030|FG004|Part 3|Physician Decision|0|||
145746774|NCT01225731|525589031|FG005|Part 3|Physician Decision|0|||
145746775|NCT01225731|525589032|FG006|Part 3|Physician Decision|0|||
145746776|NCT01225731|525589033|FG007|Part 3|Physician Decision|0|||
145746777|NCT01225731|525589034|FG008|Part 3|Physician Decision|0|||
145270940|NCT00648739|523839549|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
145523319|NCT01903525|524775970|FG000|Overall Study|Adverse Event|0|||
145523320|NCT01903525|524775971|FG001|Overall Study|Adverse Event|1|||
145523321|NCT03977454|524775972|FG000|Overall Study|immediate postoperative revision|2|||
145523322|NCT03977454|524775973|FG001|Overall Study|immediate postoperative revision|2|||
145523323|NCT00930982|524775974|FG000|Overall Study|Adverse Event|19|||
145523324|NCT00930982|524775975|FG001|Overall Study|Adverse Event|23|||
145523325|NCT00930982|524775974|FG000|Overall Study|Protocol Violation|1|||
145523326|NCT00930982|524775975|FG001|Overall Study|Protocol Violation|5|||
145523327|NCT00930982|524775974|FG000|Overall Study|Withdrawal by Subject|1|||
145523328|NCT00930982|524775975|FG001|Overall Study|Withdrawal by Subject|1|||
145746778|NCT01225731|525589035|FG009|Part 3|Physician Decision|0|||
145746779|NCT01225731|525589036|FG010|Part 3|Physician Decision|0|||
145746780|NCT01225731|525589037|FG011|Part 3|Physician Decision|1|||
145746781|NCT01225731|525589038|FG012|Part 3|Physician Decision|2|||
145746782|NCT01225731|525589026|FG000|Part 3|Withdrawal by Subject|0|||
145746783|NCT01225731|525589027|FG001|Part 3|Withdrawal by Subject|0|||
145746784|NCT01225731|525589028|FG002|Part 3|Withdrawal by Subject|0|||
145746785|NCT01225731|525589029|FG003|Part 3|Withdrawal by Subject|0|||
145746786|NCT01225731|525589030|FG004|Part 3|Withdrawal by Subject|0|||
145746787|NCT01225731|525589031|FG005|Part 3|Withdrawal by Subject|0|||
145746788|NCT01225731|525589032|FG006|Part 3|Withdrawal by Subject|0|||
145746789|NCT01225731|525589033|FG007|Part 3|Withdrawal by Subject|0|||
145746790|NCT01225731|525589034|FG008|Part 3|Withdrawal by Subject|0|||
145746791|NCT01225731|525589035|FG009|Part 3|Withdrawal by Subject|0|||
145746792|NCT01225731|525589036|FG010|Part 3|Withdrawal by Subject|4|||
145746793|NCT01225731|525589037|FG011|Part 3|Withdrawal by Subject|6|||
145746794|NCT01225731|525589038|FG012|Part 3|Withdrawal by Subject|4|||
145746795|NCT00577642|525589039|FG000|Overall Study|Clinical Disease Progression|1|||
145746796|NCT02039375|525589044|FG000|Overall Study|Lost to Follow-up|2|||
145746797|NCT04770389|525589045|FG000|Overall Study|Adverse Event|1|||
145270941|NCT00648739|523839550|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
145270942|NCT00648739|523839544|FG000|Overall Study|Follow-up Visits Not Completed|0|||
145270943|NCT00648739|523839545|FG001|Overall Study|Follow-up Visits Not Completed|1|||
145270944|NCT00648739|523839546|FG002|Overall Study|Follow-up Visits Not Completed|0|||
145270945|NCT00648739|523839547|FG003|Overall Study|Follow-up Visits Not Completed|0|||
145270946|NCT00648739|523839548|FG004|Overall Study|Follow-up Visits Not Completed|0|||
145270947|NCT00648739|523839549|FG005|Overall Study|Follow-up Visits Not Completed|0|||
145270948|NCT00648739|523839550|FG006|Overall Study|Follow-up Visits Not Completed|0|||
145270949|NCT00564486|523839557|FG000|Overall Study|Adverse Event|0|||
145270950|NCT00564486|523839558|FG001|Overall Study|Adverse Event|1|||
145270951|NCT00564486|523839559|FG002|Overall Study|Adverse Event|0|||
145270952|NCT00564486|523839560|FG003|Overall Study|Adverse Event|0|||
145270953|NCT00564486|523839557|FG000|Overall Study|Withdrawal by Subject|4|||
145270954|NCT00564486|523839558|FG001|Overall Study|Withdrawal by Subject|0|||
145270955|NCT00564486|523839559|FG002|Overall Study|Withdrawal by Subject|0|||
145270956|NCT00564486|523839560|FG003|Overall Study|Withdrawal by Subject|5|||
145270957|NCT00564486|523839557|FG000|Overall Study|Subject refused to have blood drawn|0|||
145270958|NCT00564486|523839558|FG001|Overall Study|Subject refused to have blood drawn|0|||
145270959|NCT00564486|523839559|FG002|Overall Study|Subject refused to have blood drawn|1|||
145270960|NCT00564486|523839560|FG003|Overall Study|Subject refused to have blood drawn|0|||
145270961|NCT00564486|523839557|FG000|Overall Study|Lost to Follow-up|3|||
145270962|NCT00564486|523839558|FG001|Overall Study|Lost to Follow-up|0|||
145270963|NCT00564486|523839559|FG002|Overall Study|Lost to Follow-up|2|||
145270964|NCT00564486|523839560|FG003|Overall Study|Lost to Follow-up|2|||
145270965|NCT03387423|523839561|FG000|Overall Study|Lost to Follow-up|16|||
145270966|NCT03387423|523839562|FG001|Overall Study|Lost to Follow-up|12|||
145270967|NCT03387423|523839563|FG002|Overall Study|Lost to Follow-up|1|||
145270968|NCT03387423|523839564|FG003|Overall Study|Lost to Follow-up|0|||
145270969|NCT03387423|523839561|FG000|Overall Study|Other|0|||
145270970|NCT03387423|523839562|FG001|Overall Study|Other|3|||
145270971|NCT03387423|523839563|FG002|Overall Study|Other|0|||
145270972|NCT03387423|523839564|FG003|Overall Study|Other|0|||
145270973|NCT03387423|523839561|FG000|Overall Study|Administrative Reason|166|||
145270974|NCT03387423|523839562|FG001|Overall Study|Administrative Reason|89|||
145270975|NCT03387423|523839563|FG002|Overall Study|Administrative Reason|17|||
145270976|NCT03387423|523839564|FG003|Overall Study|Administrative Reason|19|||
145270977|NCT03387423|523839561|FG000|Overall Study|Revocation Consent|76|||
145270978|NCT03387423|523839562|FG001|Overall Study|Revocation Consent|32|||
145270979|NCT03387423|523839563|FG002|Overall Study|Revocation Consent|3|||
145270980|NCT03387423|523839564|FG003|Overall Study|Revocation Consent|5|||
145270981|NCT03862807|523839569|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
145270982|NCT04362761|523839570|FG000|Part A (48 Weeks)|Adverse Event|2|||
145270983|NCT04362761|523839570|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
145270984|NCT04362761|523839570|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
145270985|NCT04362761|523839570|FG000|Part A (48 Weeks)|Other|5|||
145270986|NCT04362761|523839570|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
145270987|NCT04362761|523839570|FG000|Part B (86 Weeks)|Other|4|||
145270988|NCT03286400|523839573|FG000|Overall Study|Death|10|||
145270989|NCT03286400|523839573|FG000|Overall Study|Lost to Follow-up|10|||
145270990|NCT03286400|523839573|FG000|Overall Study|Physician Decision|1|||
145270991|NCT03286400|523839573|FG000|Overall Study|Scheduling difficulty|4|||
145270992|NCT03576131|523839576|FG000|Overall Study|Investigator decision|0|||
145270993|NCT03576131|523839577|FG001|Overall Study|Investigator decision|0|||
145270994|NCT03576131|523839578|FG002|Overall Study|Investigator decision|0|||
145270995|NCT03576131|523839579|FG003|Overall Study|Investigator decision|1|||
145270996|NCT03576131|523839580|FG004|Overall Study|Investigator decision|0|||
145270997|NCT03576131|523839581|FG005|Overall Study|Investigator decision|1|||
145270998|NCT03576131|523839582|FG006|Overall Study|Investigator decision|0|||
145270999|NCT03576131|523839583|FG007|Overall Study|Investigator decision|0|||
145271000|NCT03576131|523839576|FG000|Overall Study|Withdrawal by Subject|1|||
145271001|NCT03576131|523839577|FG001|Overall Study|Withdrawal by Subject|1|||
145271002|NCT03576131|523839578|FG002|Overall Study|Withdrawal by Subject|0|||
145271003|NCT03576131|523839579|FG003|Overall Study|Withdrawal by Subject|1|||
145271004|NCT03576131|523839580|FG004|Overall Study|Withdrawal by Subject|2|||
145271005|NCT03576131|523839581|FG005|Overall Study|Withdrawal by Subject|3|||
145271006|NCT03576131|523839582|FG006|Overall Study|Withdrawal by Subject|1|||
145271007|NCT03576131|523839583|FG007|Overall Study|Withdrawal by Subject|0|||
145271008|NCT03576131|523839576|FG000|Overall Study|Death|3|||
145271009|NCT03576131|523839577|FG001|Overall Study|Death|3|||
145271010|NCT03576131|523839578|FG002|Overall Study|Death|1|||
145271011|NCT03576131|523839579|FG003|Overall Study|Death|5|||
145271012|NCT03576131|523839580|FG004|Overall Study|Death|4|||
145271013|NCT03576131|523839581|FG005|Overall Study|Death|1|||
145271014|NCT03576131|523839582|FG006|Overall Study|Death|0|||
145271015|NCT03576131|523839583|FG007|Overall Study|Death|1|||
145271016|NCT03576131|523839576|FG000|Overall Study|New anti-cancer treatment|5|||
145271017|NCT03576131|523839577|FG001|Overall Study|New anti-cancer treatment|1|||
145746798|NCT04770389|525589046|FG001|Overall Study|Adverse Event|2|||
145746799|NCT04770389|525589047|FG002|Overall Study|Adverse Event|0|||
145746800|NCT04770389|525589048|FG003|Overall Study|Adverse Event|1|||
145746801|NCT04770389|525589045|FG000|Overall Study|Withdrawal by Subject|0|||
145746802|NCT04770389|525589046|FG001|Overall Study|Withdrawal by Subject|2|||
145746803|NCT04770389|525589047|FG002|Overall Study|Withdrawal by Subject|1|||
145746804|NCT04770389|525589048|FG003|Overall Study|Withdrawal by Subject|0|||
145746805|NCT04770389|525589045|FG000|Overall Study|Failed attempt to draw blood|1|||
145746806|NCT04770389|525589046|FG001|Overall Study|Failed attempt to draw blood|0|||
145746807|NCT04770389|525589047|FG002|Overall Study|Failed attempt to draw blood|0|||
145746808|NCT04770389|525589048|FG003|Overall Study|Failed attempt to draw blood|0|||
145746809|NCT04770389|525589045|FG000|Overall Study|Left the country|0|||
145746810|NCT04770389|525589046|FG001|Overall Study|Left the country|0|||
145746811|NCT04770389|525589047|FG002|Overall Study|Left the country|1|||
145746812|NCT04770389|525589048|FG003|Overall Study|Left the country|2|||
145746813|NCT04770389|525589045|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
145746814|NCT04770389|525589046|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
145746815|NCT04770389|525589047|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
145746816|NCT04770389|525589048|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
145746817|NCT04770389|525589045|FG000|Overall Study|Lost to Follow-up|0|||
145746818|NCT04770389|525589046|FG001|Overall Study|Lost to Follow-up|0|||
145746819|NCT04770389|525589047|FG002|Overall Study|Lost to Follow-up|0|||
145746820|NCT04770389|525589048|FG003|Overall Study|Lost to Follow-up|1|||
145746821|NCT04770389|525589045|FG000|Overall Study|Moved away from study site|0|||
145746822|NCT04770389|525589046|FG001|Overall Study|Moved away from study site|1|||
145746823|NCT04770389|525589047|FG002|Overall Study|Moved away from study site|0|||
145746824|NCT04770389|525589048|FG003|Overall Study|Moved away from study site|0|||
145746825|NCT00542269|525589060|FG000|Overall Study|Adverse Event|10|||
145746826|NCT00542269|525589061|FG001|Overall Study|Adverse Event|4|||
145746827|NCT00542269|525589062|FG002|Overall Study|Adverse Event|5|||
145746828|NCT00542269|525589060|FG000|Overall Study|Protocol Violation|1|||
145746829|NCT00542269|525589061|FG001|Overall Study|Protocol Violation|1|||
145746830|NCT00542269|525589062|FG002|Overall Study|Protocol Violation|0|||
145746831|NCT00542269|525589060|FG000|Overall Study|Withdrawal by Subject|1|||
145746832|NCT00542269|525589061|FG001|Overall Study|Withdrawal by Subject|0|||
145746833|NCT00542269|525589062|FG002|Overall Study|Withdrawal by Subject|0|||
145746834|NCT00542269|525589060|FG000|Overall Study|Administrative problems|1|||
145746835|NCT00542269|525589061|FG001|Overall Study|Administrative problems|1|||
145746836|NCT00542269|525589062|FG002|Overall Study|Administrative problems|1|||
145746837|NCT03873714|525589063|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
145746838|NCT00794157|525589064|FG000|Overall Study|Adverse Event|4|||
145746839|NCT00794157|525589065|FG001|Overall Study|Adverse Event|1|||
145746840|NCT00794157|525589066|FG002|Overall Study|Adverse Event|8|||
145746841|NCT00794157|525589064|FG000|Overall Study|Subject withdrew consent|2|||
145746842|NCT00794157|525589065|FG001|Overall Study|Subject withdrew consent|0|||
145746843|NCT00794157|525589066|FG002|Overall Study|Subject withdrew consent|3|||
145746844|NCT00794157|525589064|FG000|Overall Study|Lost to Follow-up|2|||
145746845|NCT00794157|525589065|FG001|Overall Study|Lost to Follow-up|0|||
145746846|NCT00794157|525589066|FG002|Overall Study|Lost to Follow-up|1|||
145746847|NCT00794157|525589064|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145746848|NCT00794157|525589065|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145746849|NCT00794157|525589066|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145746850|NCT00794157|525589064|FG000|Overall Study|Administrative problems|1|||
145746851|NCT00794157|525589065|FG001|Overall Study|Administrative problems|7|||
145746852|NCT00794157|525589066|FG002|Overall Study|Administrative problems|4|||
145746853|NCT00794157|525589064|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145746854|NCT00794157|525589065|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145746855|NCT00794157|525589066|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145746856|NCT00794157|525589064|FG000|Overall Study|Protocol deviation|0|||
145746857|NCT00794157|525589065|FG001|Overall Study|Protocol deviation|1|||
145746858|NCT00794157|525589066|FG002|Overall Study|Protocol deviation|1|||
145746859|NCT01970501|525589067|FG000|Overall Study|Discontinuation of study by sponsor|16|||
145746860|NCT01970501|525589068|FG001|Overall Study|Discontinuation of study by sponsor|14|||
145746861|NCT01970501|525589067|FG000|Overall Study|Withdrawal by Subject|6|||
145746862|NCT01970501|525589068|FG001|Overall Study|Withdrawal by Subject|7|||
145746863|NCT01970501|525589067|FG000|Overall Study|Adverse Event|2|||
145746864|NCT01970501|525589068|FG001|Overall Study|Adverse Event|4|||
145746865|NCT01970501|525589067|FG000|Overall Study|Death|1|||
145746866|NCT01970501|525589068|FG001|Overall Study|Death|3|||
145746867|NCT01970501|525589067|FG000|Overall Study|Physician Decision|2|||
145746868|NCT01970501|525589068|FG001|Overall Study|Physician Decision|0|||
145523329|NCT00991952|524775976|FG000|Overall Study|Adverse Event|0|||
145523330|NCT00991952|524775977|FG001|Overall Study|Adverse Event|1|||
145523331|NCT02483533|524775980|FG000|Overall Study|Lack of Efficacy|50|||
145746869|NCT01692275|525589069|FG000|Overall Study|Lost to Follow-up|57|||
145746870|NCT01692275|525589070|FG001|Overall Study|Lost to Follow-up|48|||
145746871|NCT01692275|525589069|FG000|Overall Study|Withdrawal by Subject|9|||
145523332|NCT02483533|524775981|FG001|Overall Study|Lack of Efficacy|50|||
145523333|NCT04365257|524775982|FG000|Overall Study|Physician Decision|1|||
145523334|NCT04365257|524775983|FG001|Overall Study|Physician Decision|0|||
145523335|NCT04365257|524775982|FG000|Overall Study|Patient Noncompliance|1|||
145523336|NCT04365257|524775983|FG001|Overall Study|Patient Noncompliance|0|||
145523337|NCT04365257|524775982|FG000|Overall Study|Withdrawal by Subject|0|||
145523338|NCT04365257|524775983|FG001|Overall Study|Withdrawal by Subject|1|||
145523339|NCT01609478|524775986|FG000|Overall Study|Adverse Event|3|||
145523340|NCT01609478|524775987|FG001|Overall Study|Adverse Event|1|||
145523341|NCT01609478|524775988|FG002|Overall Study|Adverse Event|5|||
145523342|NCT01609478|524775986|FG000|Overall Study|Protocol Deviation|0|||
145523343|NCT01609478|524775987|FG001|Overall Study|Protocol Deviation|1|||
145523344|NCT01609478|524775988|FG002|Overall Study|Protocol Deviation|1|||
145523345|NCT01609478|524775986|FG000|Overall Study|Non-Compliance with study treatment|1|||
145523346|NCT01609478|524775987|FG001|Overall Study|Non-Compliance with study treatment|0|||
145523347|NCT01609478|524775988|FG002|Overall Study|Non-Compliance with study treatment|0|||
145523348|NCT01609478|524775986|FG000|Overall Study|Physician Decision|1|||
145523349|NCT01609478|524775987|FG001|Overall Study|Physician Decision|0|||
145523350|NCT01609478|524775988|FG002|Overall Study|Physician Decision|1|||
145523351|NCT01609478|524775986|FG000|Overall Study|Withdrawal by Subject|2|||
145523352|NCT01609478|524775987|FG001|Overall Study|Withdrawal by Subject|0|||
145523353|NCT01609478|524775988|FG002|Overall Study|Withdrawal by Subject|2|||
145523354|NCT00509262|524775993|FG000|Overall Study|Adverse Event|16|||
145523355|NCT00509262|524775994|FG001|Overall Study|Adverse Event|18|||
145523356|NCT00509262|524775993|FG000|Overall Study|Other|2|||
145523357|NCT00509262|524775994|FG001|Overall Study|Other|2|||
145523358|NCT00509262|524775993|FG000|Overall Study|Lack of Efficacy|1|||
145523359|NCT00509262|524775994|FG001|Overall Study|Lack of Efficacy|0|||
145523360|NCT00509262|524775993|FG000|Overall Study|Lost to Follow-up|1|||
145523361|NCT00509262|524775994|FG001|Overall Study|Lost to Follow-up|6|||
145523362|NCT00509262|524775993|FG000|Overall Study|Physician Decision|1|||
145523363|NCT00509262|524775994|FG001|Overall Study|Physician Decision|3|||
145523364|NCT00509262|524775993|FG000|Overall Study|Protocol Violation|2|||
145523365|NCT00509262|524775994|FG001|Overall Study|Protocol Violation|2|||
145523366|NCT00509262|524775993|FG000|Overall Study|Withdrawal by Subject|24|||
145523367|NCT00509262|524775994|FG001|Overall Study|Withdrawal by Subject|11|||
145523368|NCT02398227|524775995|FG000|Overall Study|Lost to Follow-up|21|||
145523369|NCT02398227|524775996|FG001|Overall Study|Lost to Follow-up|12|||
145523370|NCT02398227|524775995|FG000|Overall Study|Withdrawal by Subject|5|||
145523371|NCT02398227|524775996|FG001|Overall Study|Withdrawal by Subject|6|||
145523372|NCT02398227|524775995|FG000|Overall Study|Removed from treatment and dropped out|1|||
145523373|NCT02398227|524775996|FG001|Overall Study|Removed from treatment and dropped out|0|||
145523374|NCT01715129|524775997|FG000|Overall Study|Adverse Event, fatal|1|||
145523375|NCT01715129|524775997|FG000|Overall Study|Lack of Efficacy|3|||
145523376|NCT01715129|524775997|FG000|Overall Study|Protocol Violation|1|||
145523377|NCT01715129|524775997|FG000|Overall Study|Consent Withdrawn|2|||
145523378|NCT01715129|524775997|FG000|Overall Study|Lost to Follow-up|1|||
145523379|NCT01715129|524775997|FG000|Overall Study|Other|1|||
145523380|NCT01146860|524775998|FG000|Overall Study|Withdrawal by Subject|0|||
145523381|NCT01146860|524775999|FG001|Overall Study|Withdrawal by Subject|1|||
145523382|NCT00645788|524776000|FG000|Overall Study|Did not receive study drug|1|||
145523383|NCT00645788|524776001|FG001|Overall Study|Did not receive study drug|1|||
145523384|NCT00645788|524776002|FG002|Overall Study|Did not receive study drug|0|||
145523385|NCT00645788|524776003|FG003|Overall Study|Did not receive study drug|0|||
145523386|NCT00645788|524776000|FG000|Overall Study|Adverse Event|4|||
145523387|NCT00645788|524776001|FG001|Overall Study|Adverse Event|9|||
145746872|NCT01692275|525589070|FG001|Overall Study|Withdrawal by Subject|11|||
145746873|NCT00708123|525589073|FG000|Period 1|Protocol Violation|0|||
145746874|NCT00708123|525589074|FG001|Period 1|Protocol Violation|1|||
145523388|NCT00645788|524776002|FG002|Overall Study|Adverse Event|5|||
145523389|NCT00645788|524776003|FG003|Overall Study|Adverse Event|3|||
145746875|NCT00708123|525589075|FG002|Period 1|Protocol Violation|0|||
145746876|NCT00708123|525589076|FG003|Period 1|Protocol Violation|1|||
145523390|NCT00645788|524776000|FG000|Overall Study|Lost to Follow-up|1|||
145523391|NCT00645788|524776001|FG001|Overall Study|Lost to Follow-up|0|||
145523392|NCT00645788|524776002|FG002|Overall Study|Lost to Follow-up|0|||
145523393|NCT00645788|524776003|FG003|Overall Study|Lost to Follow-up|0|||
145523394|NCT00645788|524776000|FG000|Overall Study|Protocol Violation|1|||
145523395|NCT00645788|524776001|FG001|Overall Study|Protocol Violation|0|||
145523396|NCT00645788|524776002|FG002|Overall Study|Protocol Violation|2|||
145523397|NCT00645788|524776003|FG003|Overall Study|Protocol Violation|0|||
145523398|NCT00645788|524776000|FG000|Overall Study|Withdrawal by Subject|0|||
145746877|NCT00708123|525589077|FG004|Period 1|Protocol Violation|0|||
145746878|NCT00708123|525589073|FG000|Period 1|Adverse Event|0|||
145746879|NCT00708123|525589074|FG001|Period 1|Adverse Event|0|||
145746880|NCT00708123|525589075|FG002|Period 1|Adverse Event|1|||
145746881|NCT00708123|525589076|FG003|Period 1|Adverse Event|0|||
145746882|NCT00708123|525589077|FG004|Period 1|Adverse Event|0|||
145746883|NCT00708123|525589073|FG000|Period 2|Protocol Violation|0|||
145746884|NCT00708123|525589074|FG001|Period 2|Protocol Violation|0|||
145746885|NCT00708123|525589075|FG002|Period 2|Protocol Violation|0|||
145746886|NCT00708123|525589076|FG003|Period 2|Protocol Violation|1|||
145746887|NCT00708123|525589077|FG004|Period 2|Protocol Violation|0|||
145746888|NCT00708123|525589073|FG000|Period 2|Other Reason|1|||
145746889|NCT00708123|525589074|FG001|Period 2|Other Reason|0|||
145746890|NCT00708123|525589075|FG002|Period 2|Other Reason|0|||
145746891|NCT00708123|525589076|FG003|Period 2|Other Reason|0|||
145746892|NCT00708123|525589077|FG004|Period 2|Other Reason|0|||
145746893|NCT00708123|525589073|FG000|Period 3|Lost to Follow-up|0|||
145746894|NCT00708123|525589074|FG001|Period 3|Lost to Follow-up|0|||
145746895|NCT00708123|525589075|FG002|Period 3|Lost to Follow-up|1|||
145746896|NCT00708123|525589076|FG003|Period 3|Lost to Follow-up|1|||
145746897|NCT00708123|525589077|FG004|Period 3|Lost to Follow-up|0|||
145746898|NCT00708123|525589073|FG000|Period 4|Protocol Violation|0|||
145746899|NCT00708123|525589074|FG001|Period 4|Protocol Violation|1|||
145746900|NCT00708123|525589075|FG002|Period 4|Protocol Violation|0|||
145746901|NCT00708123|525589076|FG003|Period 4|Protocol Violation|0|||
145746902|NCT00708123|525589077|FG004|Period 4|Protocol Violation|0|||
145746903|NCT00845650|525589078|FG000|Overall Study|Withdrawal by Subject|0|||
145746904|NCT00845650|525589079|FG001|Overall Study|Withdrawal by Subject|0|||
145746905|NCT00845650|525589080|FG002|Overall Study|Withdrawal by Subject|0|||
145746906|NCT00845650|525589081|FG003|Overall Study|Withdrawal by Subject|0|||
145746907|NCT00845650|525589082|FG004|Overall Study|Withdrawal by Subject|2|||
145746908|NCT00845650|525589083|FG005|Overall Study|Withdrawal by Subject|0|||
145746909|NCT00845650|525589078|FG000|Overall Study|Lost to Follow-up|0|||
145746910|NCT00845650|525589079|FG001|Overall Study|Lost to Follow-up|0|||
145746911|NCT00845650|525589080|FG002|Overall Study|Lost to Follow-up|3|||
145746912|NCT00845650|525589081|FG003|Overall Study|Lost to Follow-up|1|||
145746913|NCT00845650|525589082|FG004|Overall Study|Lost to Follow-up|0|||
145746914|NCT00845650|525589083|FG005|Overall Study|Lost to Follow-up|1|||
145746915|NCT00845650|525589078|FG000|Overall Study|Sponsor hold on dosing|0|||
145746916|NCT00845650|525589079|FG001|Overall Study|Sponsor hold on dosing|0|||
145746917|NCT00845650|525589080|FG002|Overall Study|Sponsor hold on dosing|0|||
145746918|NCT00845650|525589081|FG003|Overall Study|Sponsor hold on dosing|0|||
145746919|NCT00845650|525589082|FG004|Overall Study|Sponsor hold on dosing|1|||
145523399|NCT00645788|524776001|FG001|Overall Study|Withdrawal by Subject|1|||
145523400|NCT00645788|524776002|FG002|Overall Study|Withdrawal by Subject|0|||
145523401|NCT00645788|524776003|FG003|Overall Study|Withdrawal by Subject|2|||
145523402|NCT00645788|524776000|FG000|Overall Study|Pulmonary exacerbation|13|||
145523403|NCT00645788|524776001|FG001|Overall Study|Pulmonary exacerbation|16|||
145523404|NCT00645788|524776002|FG002|Overall Study|Pulmonary exacerbation|11|||
145523405|NCT00645788|524776003|FG003|Overall Study|Pulmonary exacerbation|9|||
145523406|NCT03149848|524776004|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
145523407|NCT03149848|524776004|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
145523408|NCT04738318|524776007|FG000|Overall Study|Protocol Violation|1|||
145523409|NCT04738318|524776008|FG001|Overall Study|Protocol Violation|0|||
145523410|NCT01226121|524776009|FG000|Overall Study|Lost to Follow-up|2|||
145523411|NCT01226121|524776010|FG001|Overall Study|Lost to Follow-up|0|||
145523412|NCT01226121|524776011|FG002|Overall Study|Lost to Follow-up|1|||
145523413|NCT00378079|524776012|FG000|Overall Study|Lost to Follow-up|6|||
145523414|NCT00378079|524776013|FG001|Overall Study|Lost to Follow-up|1|||
145523415|NCT00378079|524776014|FG002|Overall Study|Lost to Follow-up|0|||
145523416|NCT02581943|524776015|FG000|Overall Study|Death|5|||
145523417|NCT02581943|524776016|FG001|Overall Study|Death|2|||
145746920|NCT00845650|525589083|FG005|Overall Study|Sponsor hold on dosing|1|||
145746921|NCT00845650|525589078|FG000|Overall Study|Unable to access IV line|1|||
145746922|NCT00845650|525589079|FG001|Overall Study|Unable to access IV line|0|||
145746923|NCT00845650|525589080|FG002|Overall Study|Unable to access IV line|0|||
145746924|NCT00845650|525589081|FG003|Overall Study|Unable to access IV line|0|||
145746925|NCT00845650|525589082|FG004|Overall Study|Unable to access IV line|0|||
145746926|NCT00845650|525589083|FG005|Overall Study|Unable to access IV line|0|||
145746927|NCT00814892|525589084|FG000|Overall Study|Disease Progression|1|||
145746928|NCT00814892|525589084|FG000|Overall Study|Study Termination|1|||
145746929|NCT04486950|525589087|FG000|Overall Study|Lost to Follow-up|0|||
145746930|NCT04486950|525589088|FG001|Overall Study|Lost to Follow-up|0|||
145746931|NCT04486950|525589089|FG002|Overall Study|Lost to Follow-up|0|||
145523418|NCT02581943|524776015|FG000|Overall Study|Disease Progression|12|||
145523419|NCT02581943|524776016|FG001|Overall Study|Disease Progression|15|||
145523420|NCT02581943|524776015|FG000|Overall Study|Withdrawal by Subject|1|||
145746932|NCT04486950|525589090|FG003|Overall Study|Lost to Follow-up|0|||
145746933|NCT04486950|525589091|FG004|Overall Study|Lost to Follow-up|0|||
145746934|NCT04486950|525589092|FG005|Overall Study|Lost to Follow-up|1|||
145523421|NCT02581943|524776016|FG001|Overall Study|Withdrawal by Subject|2|||
145523422|NCT01233687|524776017|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
145523423|NCT01233687|524776017|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
145523424|NCT01233687|524776017|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
145523425|NCT02290431|524776018|FG000|Overall Study|Adverse Event|20|||
145523426|NCT02290431|524776018|FG000|Overall Study|Progressive disease|4|||
145523427|NCT02290431|524776018|FG000|Overall Study|Study terminated by Sponsor|1|||
145523428|NCT02290431|524776018|FG000|Overall Study|Physician Decision|2|||
145523429|NCT02274038|524776023|FG000|Overall Study|Death|1|||
145523430|NCT03783702|524776024|FG000|Overall Study|Lost to Follow-up|6|||
145523431|NCT03783702|524776025|FG001|Overall Study|Lost to Follow-up|8|||
145523432|NCT03783702|524776024|FG000|Overall Study|Protocol Violation|1|||
145523433|NCT03783702|524776025|FG001|Overall Study|Protocol Violation|3|||
145523434|NCT04473482|524776026|FG000|Overall Study|Death|0|||
145523435|NCT04473482|524776027|FG001|Overall Study|Death|3|||
145523436|NCT04473482|524776026|FG000|Overall Study|Lost to Follow-up|9|||
145523437|NCT04473482|524776027|FG001|Overall Study|Lost to Follow-up|7|||
145523438|NCT04473482|524776026|FG000|Overall Study|Withdrawal by Subject|2|||
145523439|NCT04473482|524776027|FG001|Overall Study|Withdrawal by Subject|1|||
145523440|NCT00745615|524776034|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
145523441|NCT00745615|524776035|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
145523442|NCT00745615|524776036|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
145523443|NCT00745615|524776037|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
145523444|NCT00745615|524776038|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
145523445|NCT00745615|524776039|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
145523446|NCT00745615|524776034|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
145523447|NCT00745615|524776035|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
145523448|NCT00745615|524776036|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
145523449|NCT00745615|524776037|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
145523450|NCT00745615|524776038|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
145523451|NCT00745615|524776039|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
145523452|NCT00745615|524776034|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
145523453|NCT00745615|524776035|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
145523454|NCT00745615|524776036|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
145523455|NCT00745615|524776037|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
145523456|NCT00745615|524776038|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
145523457|NCT00745615|524776039|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
145523458|NCT00745615|524776034|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145523459|NCT00745615|524776035|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
145523460|NCT00745615|524776036|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145523461|NCT00745615|524776037|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145523462|NCT00745615|524776038|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145523463|NCT00745615|524776039|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
145523464|NCT00745615|524776034|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
145523465|NCT00745615|524776035|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
145523466|NCT00745615|524776036|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
145523467|NCT00745615|524776037|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
145523468|NCT00745615|524776038|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
145523469|NCT00745615|524776039|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
145523470|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
145523471|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
145523472|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
145523473|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
145523474|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
145523475|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
145523476|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
145523477|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
145523478|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
145523479|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
145523480|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
145523481|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
145523482|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
145523483|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
145523484|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
145523485|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
145523486|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
145523487|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
145523488|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
145523489|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
145523490|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
145746935|NCT04486950|525589093|FG006|Overall Study|Lost to Follow-up|0|||
145746936|NCT00401375|525589094|FG000|Overall Study|Protocol Violation|2|||
145746937|NCT00401375|525589095|FG001|Overall Study|Protocol Violation|2|||
145746938|NCT00401375|525589096|FG002|Overall Study|Protocol Violation|1|||
145746939|NCT00401375|525589094|FG000|Overall Study|Adverse Event|6|||
145746940|NCT00401375|525589095|FG001|Overall Study|Adverse Event|11|||
145746941|NCT00401375|525589096|FG002|Overall Study|Adverse Event|10|||
145746942|NCT00401375|525589094|FG000|Overall Study|Withdrawal by Subject|9|||
145746943|NCT00401375|525589095|FG001|Overall Study|Withdrawal by Subject|7|||
145746944|NCT00401375|525589096|FG002|Overall Study|Withdrawal by Subject|7|||
145746945|NCT00401375|525589094|FG000|Overall Study|Lost to Follow-up|0|||
145746946|NCT00401375|525589095|FG001|Overall Study|Lost to Follow-up|1|||
145746947|NCT00401375|525589096|FG002|Overall Study|Lost to Follow-up|1|||
145746948|NCT00401375|525589094|FG000|Overall Study|Other than specified|2|||
145746949|NCT00401375|525589095|FG001|Overall Study|Other than specified|1|||
145746950|NCT00401375|525589096|FG002|Overall Study|Other than specified|3|||
145746951|NCT00401375|525589094|FG000|Overall Study|Randomized but not treated|3|||
145746952|NCT00401375|525589095|FG001|Overall Study|Randomized but not treated|3|||
145746953|NCT00401375|525589096|FG002|Overall Study|Randomized but not treated|3|||
145746954|NCT00950664|525589097|FG000|First Intervention|Lost to Follow-up|1|||
145746955|NCT00950664|525589098|FG001|First Intervention|Lost to Follow-up|3|||
145746956|NCT00950664|525589097|FG000|First Intervention|Withdrawal by Subject|2|||
145746957|NCT00950664|525589098|FG001|First Intervention|Withdrawal by Subject|2|||
145746958|NCT00677014|525589099|FG000|Overall Study|Lost to Follow-up|20|||
145746959|NCT00677014|525589100|FG001|Overall Study|Lost to Follow-up|12|||
145746960|NCT00677014|525589101|FG002|Overall Study|Lost to Follow-up|24|||
145523491|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
145523492|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
145523493|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
145523494|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
145523495|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
145523496|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
145523497|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
145523498|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
145523499|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
145523500|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
145523501|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
145523502|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
145523503|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
145523504|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
145523505|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
145523506|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
145523507|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
145523508|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
145523509|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
145523510|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
145523511|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
145523512|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
145523513|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
145523514|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
145523515|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
145523516|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
145523517|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
145523518|NCT00745615|524776034|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
145523519|NCT00745615|524776035|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
145523520|NCT00745615|524776036|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
145523521|NCT00745615|524776037|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
145523522|NCT00745615|524776038|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
145746961|NCT00677014|525589099|FG000|Overall Study|Death|6|||
145746962|NCT00677014|525589100|FG001|Overall Study|Death|15|||
145746963|NCT00677014|525589101|FG002|Overall Study|Death|7|||
145746964|NCT00677014|525589099|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
145746965|NCT00677014|525589100|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
145746966|NCT00677014|525589101|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
145746967|NCT02821715|525589102|FG000|Overall Study|Protocol Violation|1|||
145746968|NCT02821715|525589103|FG001|Overall Study|Protocol Violation|0|||
145746969|NCT02821715|525589104|FG002|Overall Study|Protocol Violation|0|||
145271018|NCT03576131|523839578|FG002|Overall Study|New anti-cancer treatment|2|||
145271019|NCT03576131|523839579|FG003|Overall Study|New anti-cancer treatment|3|||
145271020|NCT03576131|523839580|FG004|Overall Study|New anti-cancer treatment|0|||
145271021|NCT03576131|523839581|FG005|Overall Study|New anti-cancer treatment|0|||
145271022|NCT03576131|523839582|FG006|Overall Study|New anti-cancer treatment|0|||
145271023|NCT03576131|523839583|FG007|Overall Study|New anti-cancer treatment|0|||
145271024|NCT03576131|523839576|FG000|Overall Study|Unspecified reason|0|||
145271025|NCT03576131|523839577|FG001|Overall Study|Unspecified reason|0|||
145271026|NCT03576131|523839578|FG002|Overall Study|Unspecified reason|1|||
145271027|NCT03576131|523839579|FG003|Overall Study|Unspecified reason|1|||
145271028|NCT03576131|523839580|FG004|Overall Study|Unspecified reason|1|||
145271029|NCT03576131|523839581|FG005|Overall Study|Unspecified reason|1|||
145271030|NCT03576131|523839582|FG006|Overall Study|Unspecified reason|0|||
145271031|NCT03576131|523839583|FG007|Overall Study|Unspecified reason|0|||
145271032|NCT03576131|523839576|FG000|Overall Study|Subject non-compliance|0|||
145271033|NCT03576131|523839577|FG001|Overall Study|Subject non-compliance|0|||
145271034|NCT03576131|523839578|FG002|Overall Study|Subject non-compliance|0|||
145271035|NCT03576131|523839579|FG003|Overall Study|Subject non-compliance|0|||
145271036|NCT03576131|523839580|FG004|Overall Study|Subject non-compliance|0|||
145271037|NCT03576131|523839581|FG005|Overall Study|Subject non-compliance|1|||
145271038|NCT03576131|523839582|FG006|Overall Study|Subject non-compliance|0|||
145271039|NCT03576131|523839583|FG007|Overall Study|Subject non-compliance|0|||
145271040|NCT00996632|523839588|FG000|Overall Study|Physician Decision|0|||
145271041|NCT00996632|523839589|FG001|Overall Study|Physician Decision|0|||
145271042|NCT00578448|523839600|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
145271043|NCT00578448|523839600|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
145271044|NCT00578448|523839600|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
145271045|NCT00578448|523839600|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
145271046|NCT04221373|523839601|FG000|Overall Study|Physician Decision|4|||
145271047|NCT04221373|523839602|FG001|Overall Study|Physician Decision|0|||
145271048|NCT00627094|523839603|FG000|Overall Study|Adverse Event|8|||
145271049|NCT00627094|523839604|FG001|Overall Study|Adverse Event|7|||
145271050|NCT00627094|523839603|FG000|Overall Study|Lost to Follow-up|1|||
145271051|NCT00627094|523839604|FG001|Overall Study|Lost to Follow-up|0|||
145271052|NCT00627094|523839603|FG000|Overall Study|Withdrawal by Subject|1|||
145271053|NCT00627094|523839604|FG001|Overall Study|Withdrawal by Subject|1|||
145271054|NCT00627094|523839603|FG000|Overall Study|ulcer healed|1|||
145271055|NCT00627094|523839604|FG001|Overall Study|ulcer healed|7|||
145271056|NCT00627094|523839603|FG000|Overall Study|Other reason|1|||
145271057|NCT00627094|523839604|FG001|Overall Study|Other reason|0|||
145271058|NCT00539006|523839610|FG000|Pre-treatment|Other|0|||
145271059|NCT00539006|523839611|FG001|Pre-treatment|Other|1|||
145271060|NCT00539006|523839612|FG002|Pre-treatment|Other|0|||
145271061|NCT00539006|523839613|FG003|Pre-treatment|Other|0|||
145271062|NCT00539006|523839610|FG000|Treatment Period 1|Lost to Follow-up|0|||
145271063|NCT00539006|523839611|FG001|Treatment Period 1|Lost to Follow-up|0|||
145271064|NCT00539006|523839612|FG002|Treatment Period 1|Lost to Follow-up|1|||
145271065|NCT00539006|523839613|FG003|Treatment Period 1|Lost to Follow-up|0|||
145271066|NCT00539006|523839610|FG000|Treatment Period 1|Protocol Violation|0|||
145271067|NCT00539006|523839611|FG001|Treatment Period 1|Protocol Violation|0|||
145271068|NCT00539006|523839612|FG002|Treatment Period 1|Protocol Violation|1|||
145271069|NCT00539006|523839613|FG003|Treatment Period 1|Protocol Violation|0|||
145523523|NCT00745615|524776039|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
145523524|NCT00570232|524776040|FG000|Overall Study|Adverse Event|10|||
145523525|NCT00570232|524776040|FG000|Overall Study|discontinued due to medical condition|3|||
145523526|NCT00570232|524776040|FG000|Overall Study|discontinued due to recurrence|8|||
145523527|NCT00570232|524776040|FG000|Overall Study|discontinued due to noncompliance|2|||
145523528|NCT01076075|524776041|FG000|Overall Study|Adverse Event|3|||
145271070|NCT00539006|523839610|FG000|Treatment Period 1|Lack of Efficacy|0|||
145271071|NCT00539006|523839611|FG001|Treatment Period 1|Lack of Efficacy|0|||
145271072|NCT00539006|523839612|FG002|Treatment Period 1|Lack of Efficacy|0|||
145271073|NCT00539006|523839613|FG003|Treatment Period 1|Lack of Efficacy|1|||
145271074|NCT00539006|523839610|FG000|Washout|Adverse Event|2|||
145271075|NCT00539006|523839611|FG001|Washout|Adverse Event|1|||
145271076|NCT00539006|523839612|FG002|Washout|Adverse Event|0|||
145271077|NCT00539006|523839613|FG003|Washout|Adverse Event|0|||
145523529|NCT01076075|524776042|FG001|Overall Study|Adverse Event|9|||
145271078|NCT00539006|523839610|FG000|Washout|Protocol Violation|1|||
145271079|NCT00539006|523839611|FG001|Washout|Protocol Violation|1|||
145271080|NCT00539006|523839612|FG002|Washout|Protocol Violation|0|||
145271081|NCT00539006|523839613|FG003|Washout|Protocol Violation|0|||
145271082|NCT00539006|523839610|FG000|Washout|Withdrawal by Subject|0|||
145271083|NCT00539006|523839611|FG001|Washout|Withdrawal by Subject|2|||
145271084|NCT00539006|523839612|FG002|Washout|Withdrawal by Subject|0|||
145271085|NCT00539006|523839613|FG003|Washout|Withdrawal by Subject|0|||
145271086|NCT00539006|523839610|FG000|Washout|Failed to meet continuation criteria|16|||
145271087|NCT00539006|523839611|FG001|Washout|Failed to meet continuation criteria|5|||
145523530|NCT01076075|524776041|FG000|Overall Study|Lack of Efficacy|5|||
145523531|NCT01076075|524776042|FG001|Overall Study|Lack of Efficacy|4|||
145523532|NCT01076075|524776041|FG000|Overall Study|Lost to Follow-up|6|||
145523533|NCT01076075|524776042|FG001|Overall Study|Lost to Follow-up|5|||
145523534|NCT01076075|524776041|FG000|Overall Study|other|19|||
145523535|NCT01076075|524776042|FG001|Overall Study|other|9|||
145523536|NCT01076075|524776041|FG000|Overall Study|Protocol Violation|0|||
145523537|NCT01076075|524776042|FG001|Overall Study|Protocol Violation|1|||
145523538|NCT01076075|524776041|FG000|Overall Study|Withdrawal by Subject|8|||
145523539|NCT01076075|524776042|FG001|Overall Study|Withdrawal by Subject|19|||
145746970|NCT02821715|525589105|FG003|Overall Study|Protocol Violation|0|||
145746971|NCT02821715|525589106|FG004|Overall Study|Protocol Violation|0|||
145746972|NCT02821715|525589107|FG005|Overall Study|Protocol Violation|0|||
145746973|NCT00640328|525589108|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
145746974|NCT00640328|525589109|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
145746975|NCT00640328|525589110|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
145746976|NCT00640328|525589111|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
145746977|NCT00640328|525589112|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
145746978|NCT00640328|525589113|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
145746979|NCT00640328|525589108|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
145746980|NCT00640328|525589109|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
145746981|NCT00640328|525589110|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
145746982|NCT00640328|525589111|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
145523540|NCT01445886|524776048|FG000|Overall Study|Lost to Follow-up|2|||
145523541|NCT01445886|524776048|FG000|Overall Study|Protocol Violation|3|||
145523542|NCT00586664|524776049|FG000|Overall Study|Withdrawal by Subject|3|||
145523543|NCT00586664|524776050|FG001|Overall Study|Withdrawal by Subject|7|||
145523544|NCT00586664|524776051|FG002|Overall Study|Withdrawal by Subject|1|||
145523545|NCT00586664|524776049|FG000|Overall Study|Exclusion criteria met|2|||
145523546|NCT00586664|524776050|FG001|Overall Study|Exclusion criteria met|0|||
145523547|NCT00586664|524776051|FG002|Overall Study|Exclusion criteria met|0|||
145523548|NCT03473548|524776055|FG000|Overall Study|Did not attempt HST testing|3|||
145523549|NCT03473548|524776056|FG001|Overall Study|Did not attempt HST testing|0|||
145523550|NCT01585584|524776059|FG000|Overall Study|Lack of Efficacy|1|||
145523551|NCT01585584|524776059|FG000|Overall Study|Withdrawal by Subject|1|||
145523552|NCT01585584|524776059|FG000|Overall Study|Physician Decision|2|||
145523553|NCT01986933|524776060|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
145523554|NCT01986933|524776061|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
145523555|NCT01986933|524776062|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
145523556|NCT01986933|524776063|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
145523557|NCT01986933|524776064|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
145523558|NCT01986933|524776060|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
145523559|NCT01986933|524776061|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
145523560|NCT01986933|524776062|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
145523561|NCT01986933|524776063|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
145523562|NCT01986933|524776064|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
145523563|NCT01986933|524776060|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
145523564|NCT01986933|524776061|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
145523565|NCT01986933|524776062|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
145523566|NCT01986933|524776063|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
145523567|NCT01986933|524776064|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
145523568|NCT01986933|524776060|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
145523569|NCT01986933|524776061|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
145523570|NCT01986933|524776062|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
145523571|NCT01986933|524776063|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
145523572|NCT01986933|524776064|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
145523573|NCT01986933|524776060|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
145523574|NCT01986933|524776061|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
145523575|NCT01986933|524776062|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
145523576|NCT01986933|524776063|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
145523577|NCT01986933|524776064|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
145523578|NCT01986933|524776060|FG000|Active-to-active (Part B)|Adverse Event|0|||
145523579|NCT01986933|524776061|FG001|Active-to-active (Part B)|Adverse Event|2|||
145523580|NCT01986933|524776062|FG002|Active-to-active (Part B)|Adverse Event|0|||
145523581|NCT01986933|524776063|FG003|Active-to-active (Part B)|Adverse Event|1|||
145523582|NCT01986933|524776064|FG004|Active-to-active (Part B)|Adverse Event|3|||
145523583|NCT01986933|524776060|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
145523584|NCT01986933|524776061|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
145523585|NCT01986933|524776062|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
145523586|NCT01986933|524776063|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
145523587|NCT01986933|524776064|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
145523588|NCT01986933|524776060|FG000|Active-to-active (Part B)|Pregnancy|0|||
145523589|NCT01986933|524776061|FG001|Active-to-active (Part B)|Pregnancy|0|||
145523590|NCT01986933|524776062|FG002|Active-to-active (Part B)|Pregnancy|0|||
145523591|NCT01986933|524776063|FG003|Active-to-active (Part B)|Pregnancy|0|||
145523592|NCT01986933|524776064|FG004|Active-to-active (Part B)|Pregnancy|1|||
145523593|NCT01986933|524776060|FG000|Active-to-active (Part B)|Physician Decision|0|||
145523594|NCT01986933|524776061|FG001|Active-to-active (Part B)|Physician Decision|0|||
145523595|NCT01986933|524776062|FG002|Active-to-active (Part B)|Physician Decision|1|||
145523596|NCT01986933|524776063|FG003|Active-to-active (Part B)|Physician Decision|1|||
145523597|NCT01986933|524776064|FG004|Active-to-active (Part B)|Physician Decision|0|||
145523598|NCT01986933|524776060|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
145523599|NCT01986933|524776061|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
145523600|NCT01986933|524776062|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
145523601|NCT01986933|524776063|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
145523602|NCT01986933|524776064|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
145523603|NCT01986933|524776060|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
145523604|NCT01986933|524776061|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
145523605|NCT01986933|524776062|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
145402485|NCT00784875|524330733|FG000|Period D|Physician Decision|0|||
145523606|NCT01986933|524776063|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
145523607|NCT01986933|524776064|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
145523608|NCT01986933|524776060|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
145523609|NCT01986933|524776061|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
145523610|NCT01986933|524776062|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
145523611|NCT01986933|524776063|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
145523612|NCT01986933|524776064|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
145523613|NCT01986933|524776060|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
145523614|NCT01986933|524776061|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
145523615|NCT01986933|524776062|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
145523616|NCT01986933|524776063|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
145523617|NCT01986933|524776064|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
145523618|NCT01986933|524776060|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
145523619|NCT01986933|524776061|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
145523620|NCT01986933|524776062|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
145523621|NCT01986933|524776063|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
145523622|NCT01986933|524776064|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
145523623|NCT01986933|524776060|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
145523624|NCT01986933|524776061|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
145523625|NCT01986933|524776062|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
145523626|NCT01986933|524776063|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
145523627|NCT01986933|524776064|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
145523628|NCT01986933|524776060|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
145523629|NCT01986933|524776061|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
145523630|NCT01986933|524776062|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
145523631|NCT01986933|524776063|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
145523632|NCT01986933|524776064|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
145523633|NCT01986933|524776060|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
145523634|NCT01986933|524776061|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
145523635|NCT01986933|524776062|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
145523636|NCT01986933|524776063|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
145523637|NCT01986933|524776064|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
145523638|NCT00686998|524776065|FG000|Overall Study|Adverse Event|3|||
145523639|NCT00686998|524776066|FG001|Overall Study|Adverse Event|2|||
145523640|NCT00686998|524776067|FG002|Overall Study|Adverse Event|1|||
145523641|NCT00686998|524776065|FG000|Overall Study|Withdrawal by Subject|2|||
145523642|NCT00686998|524776066|FG001|Overall Study|Withdrawal by Subject|1|||
145523643|NCT00686998|524776067|FG002|Overall Study|Withdrawal by Subject|2|||
145523644|NCT00686998|524776065|FG000|Overall Study|Lack of Efficacy|7|||
145523645|NCT00686998|524776066|FG001|Overall Study|Lack of Efficacy|5|||
145523646|NCT00686998|524776067|FG002|Overall Study|Lack of Efficacy|0|||
145523647|NCT00686998|524776065|FG000|Overall Study|Other|0|||
145523648|NCT00686998|524776066|FG001|Overall Study|Other|0|||
145523649|NCT00686998|524776067|FG002|Overall Study|Other|1|||
145523650|NCT00686998|524776065|FG000|Overall Study|Safety Reasons|1|||
145523651|NCT00686998|524776066|FG001|Overall Study|Safety Reasons|0|||
145523652|NCT00686998|524776067|FG002|Overall Study|Safety Reasons|0|||
145523653|NCT05985980|524776068|FG000|Overall Study|Withdrawal by Subject|1|||
145523654|NCT05985980|524776068|FG000|Overall Study|Withdrawal by Subject|1|||
145523655|NCT05985980|524776068|FG000|Overall Study|Withdrawal by Subject|1|||
145523656|NCT05985980|524776068|FG000|Overall Study|Withdrawal by Subject|1|||
145523657|NCT03576274|524776070|FG000|Overall Study|Lost to Follow-up|3|||
145523658|NCT03576274|524776071|FG001|Overall Study|Lost to Follow-up|2|||
145523659|NCT03576274|524776072|FG002|Overall Study|Lost to Follow-up|3|||
145523660|NCT03576274|524776073|FG003|Overall Study|Lost to Follow-up|1|||
145523661|NCT03576274|524776074|FG004|Overall Study|Lost to Follow-up|3|||
145523662|NCT03576274|524776070|FG000|Overall Study|Withdrawal by Subject|5|||
145523663|NCT03576274|524776071|FG001|Overall Study|Withdrawal by Subject|3|||
145523664|NCT03576274|524776072|FG002|Overall Study|Withdrawal by Subject|2|||
145523665|NCT03576274|524776073|FG003|Overall Study|Withdrawal by Subject|8|||
145523666|NCT03576274|524776074|FG004|Overall Study|Withdrawal by Subject|6|||
145523667|NCT04854642|524777955|FG000|Overall Study|Adverse Event|1|||
145523668|NCT04854642|524777956|FG001|Overall Study|Adverse Event|2|||
145523669|NCT04854642|524777955|FG000|Overall Study|Withdrawal by Subject|0|||
145746983|NCT00640328|525589112|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
145746984|NCT00640328|525589113|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
145746985|NCT00640328|525589108|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
145746986|NCT00640328|525589109|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
145746987|NCT00640328|525589110|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
145746988|NCT00640328|525589111|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
145746989|NCT00640328|525589112|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
145746990|NCT00640328|525589113|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
145746991|NCT00640328|525589108|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
145746992|NCT00640328|525589109|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
145746993|NCT00640328|525589110|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
145746994|NCT00640328|525589111|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
145746995|NCT00640328|525589112|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
145746996|NCT00640328|525589113|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
145746997|NCT02374099|525589116|FG000|Overall Study|Adverse Event|1|||
145746998|NCT02374099|525589117|FG001|Overall Study|Adverse Event|0|||
145746999|NCT02374099|525589116|FG000|Overall Study|Progressive Disease|35|||
145747000|NCT02374099|525589117|FG001|Overall Study|Progressive Disease|40|||
145747001|NCT02374099|525589116|FG000|Overall Study|Withdrawal by Subject|5|||
145747002|NCT02374099|525589117|FG001|Overall Study|Withdrawal by Subject|1|||
145747003|NCT02374099|525589116|FG000|Overall Study|Miscellaneous|2|||
145747004|NCT02374099|525589117|FG001|Overall Study|Miscellaneous|3|||
145747005|NCT02374099|525589116|FG000|Overall Study|Randomized, but not treated|2|||
145747006|NCT02374099|525589117|FG001|Overall Study|Randomized, but not treated|1|||
145747007|NCT02374099|525589116|FG000|Overall Study|Study Terminated by Sponsor|3|||
145747008|NCT02374099|525589117|FG001|Overall Study|Study Terminated by Sponsor|4|||
145747009|NCT01033825|525589118|FG000|Overall Study|Withdrawal by Subject|2|||
145747010|NCT01033825|525589119|FG001|Overall Study|Withdrawal by Subject|3|||
145747011|NCT01033825|525589120|FG002|Overall Study|Withdrawal by Subject|2|||
145747012|NCT01033825|525589121|FG003|Overall Study|Withdrawal by Subject|1|||
145747013|NCT01033825|525589122|FG004|Overall Study|Withdrawal by Subject|1|||
145747014|NCT01033825|525589123|FG005|Overall Study|Withdrawal by Subject|0|||
145747015|NCT01033825|525589124|FG006|Overall Study|Withdrawal by Subject|0|||
145747016|NCT01033825|525589118|FG000|Overall Study|Adverse Event|0|||
145747017|NCT01033825|525589119|FG001|Overall Study|Adverse Event|0|||
145747018|NCT01033825|525589120|FG002|Overall Study|Adverse Event|0|||
145747019|NCT01033825|525589121|FG003|Overall Study|Adverse Event|1|||
145747020|NCT01033825|525589122|FG004|Overall Study|Adverse Event|0|||
145747021|NCT01033825|525589123|FG005|Overall Study|Adverse Event|0|||
145747022|NCT01033825|525589124|FG006|Overall Study|Adverse Event|0|||
145747023|NCT01033825|525589118|FG000|Overall Study|Protocol Violation|1|||
145747024|NCT01033825|525589119|FG001|Overall Study|Protocol Violation|0|||
145747025|NCT01033825|525589120|FG002|Overall Study|Protocol Violation|0|||
145747026|NCT01033825|525589121|FG003|Overall Study|Protocol Violation|0|||
145747027|NCT01033825|525589122|FG004|Overall Study|Protocol Violation|0|||
145747028|NCT01033825|525589123|FG005|Overall Study|Protocol Violation|0|||
145747029|NCT01033825|525589124|FG006|Overall Study|Protocol Violation|0|||
145747030|NCT01033825|525589118|FG000|Overall Study|Other|0|||
145747031|NCT01033825|525589119|FG001|Overall Study|Other|0|||
145747032|NCT01033825|525589120|FG002|Overall Study|Other|0|||
145747033|NCT01033825|525589121|FG003|Overall Study|Other|0|||
145747034|NCT01033825|525589122|FG004|Overall Study|Other|1|||
145747035|NCT01033825|525589123|FG005|Overall Study|Other|0|||
145747036|NCT01033825|525589124|FG006|Overall Study|Other|0|||
145747037|NCT04294719|525589125|FG000|Overall Study|Withdrawal by Subject|1|||
145747038|NCT00081159|525589127|FG000|Overall Study|Withdrawal by Subject|0|||
145747039|NCT00081159|525589128|FG001|Overall Study|Withdrawal by Subject|3|||
145747040|NCT00081159|525589127|FG000|Overall Study|Myelosuppression prior to treatment|0|||
145747041|NCT00081159|525589128|FG001|Overall Study|Myelosuppression prior to treatment|1|||
145747042|NCT00081159|525589127|FG000|Overall Study|Lost to Follow-up|2|||
145747043|NCT00081159|525589128|FG001|Overall Study|Lost to Follow-up|1|||
145747044|NCT03693625|525589129|FG000|Overall Study|Adverse Event|2|||
145747045|NCT03693625|525589130|FG001|Overall Study|Adverse Event|0|||
145747046|NCT03693625|525589129|FG000|Overall Study|Study Terminated By Sponsor|20|||
145747047|NCT03693625|525589130|FG001|Overall Study|Study Terminated By Sponsor|7|||
145747048|NCT03693625|525589129|FG000|Overall Study|Withdrawal by Subject|1|||
145747049|NCT03693625|525589130|FG001|Overall Study|Withdrawal by Subject|1|||
145747050|NCT01187953|525589132|FG000|Overall Study|Death|11|||
145747051|NCT01187953|525589133|FG001|Overall Study|Death|13|||
145747052|NCT01187953|525589132|FG000|Overall Study|Adverse Event|1|||
145747053|NCT01187953|525589133|FG001|Overall Study|Adverse Event|2|||
145747054|NCT01187953|525589132|FG000|Overall Study|Lost to Follow-up|0|||
145747055|NCT01187953|525589133|FG001|Overall Study|Lost to Follow-up|3|||
145747056|NCT01187953|525589132|FG000|Overall Study|Withdrawal by Subject|3|||
145747057|NCT01187953|525589133|FG001|Overall Study|Withdrawal by Subject|3|||
145747058|NCT00761514|525589136|FG000|Overall Study|Adverse Event|1|||
145747059|NCT00761514|525589136|FG000|Overall Study|Withdrawal by Subject|2|||
145747060|NCT00761514|525589136|FG000|Overall Study|Lost to Follow-up|1|||
145747061|NCT00761514|525589136|FG000|Overall Study|Health insurance didn't cover study drug|1|||
145747062|NCT00761514|525589136|FG000|Overall Study|Problem complying with study visit|1|||
145747063|NCT00761514|525589136|FG000|Overall Study|Unable to pay for medications|1|||
145747064|NCT03885089|525589137|FG000|Overall Study|No informed consent for publication of study results|2|||
145747065|NCT03921424|525589138|FG000|Overall Study|Lost to Follow-up|0|||
145747066|NCT03921424|525589139|FG001|Overall Study|Lost to Follow-up|1|||
145747067|NCT03921424|525589138|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145747068|NCT03921424|525589139|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
145747069|NCT03770260|525590721|FG000|Overall Study|Disease progression|0|||
145747070|NCT03770260|525590722|FG001|Overall Study|Disease progression|1|||
145747071|NCT03770260|525590723|FG002|Overall Study|Disease progression|0|||
145747072|NCT03770260|525590724|FG003|Overall Study|Disease progression|0|||
145747073|NCT03451773|525590726|FG000|Overall Study|Death on study|1|||
145747074|NCT03451773|525590727|FG001|Overall Study|Death on study|5|||
145747075|NCT03451773|525590726|FG000|Overall Study|Death during follow-up period|0|||
145747076|NCT03451773|525590727|FG001|Overall Study|Death during follow-up period|1|||
145747077|NCT01964352|525590728|FG000|Overall Study|Adverse Event|13|||
145747078|NCT01964352|525590729|FG001|Overall Study|Adverse Event|3|||
145747079|NCT01964352|525590730|FG002|Overall Study|Adverse Event|4|||
145747080|NCT01964352|525590731|FG003|Overall Study|Adverse Event|3|||
145747081|NCT01964352|525590728|FG000|Overall Study|Lack of Efficacy|6|||
145747082|NCT01964352|525590729|FG001|Overall Study|Lack of Efficacy|0|||
145747083|NCT01964352|525590730|FG002|Overall Study|Lack of Efficacy|0|||
145747084|NCT01964352|525590731|FG003|Overall Study|Lack of Efficacy|0|||
145747085|NCT01964352|525590728|FG000|Overall Study|Protocol Violation|2|||
145747086|NCT01964352|525590729|FG001|Overall Study|Protocol Violation|4|||
145747087|NCT01964352|525590730|FG002|Overall Study|Protocol Violation|0|||
145747088|NCT01964352|525590731|FG003|Overall Study|Protocol Violation|2|||
145747089|NCT01964352|525590728|FG000|Overall Study|Lost to Follow-up|1|||
145747090|NCT01964352|525590729|FG001|Overall Study|Lost to Follow-up|0|||
145747091|NCT01964352|525590730|FG002|Overall Study|Lost to Follow-up|0|||
145747092|NCT01964352|525590731|FG003|Overall Study|Lost to Follow-up|1|||
145747093|NCT01964352|525590728|FG000|Overall Study|Withdrawal by Subject|4|||
145747094|NCT01964352|525590729|FG001|Overall Study|Withdrawal by Subject|2|||
145747095|NCT01964352|525590730|FG002|Overall Study|Withdrawal by Subject|1|||
145747096|NCT01964352|525590731|FG003|Overall Study|Withdrawal by Subject|0|||
145747097|NCT01964352|525590728|FG000|Overall Study|Other than stated above|0|||
145747098|NCT01964352|525590729|FG001|Overall Study|Other than stated above|2|||
145747099|NCT01964352|525590730|FG002|Overall Study|Other than stated above|1|||
145747100|NCT01964352|525590731|FG003|Overall Study|Other than stated above|2|||
145747101|NCT03468855|525590732|FG000|Overall Study|Adverse Event|2|||
145747102|NCT03468855|525590732|FG000|Overall Study|Lost to Follow-up|5|||
145747103|NCT03468855|525590732|FG000|Overall Study|Withdrawal by Subject|3|||
145747104|NCT03468855|525590732|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
145747105|NCT01394939|525590733|FG000|Overall Study|Adverse Event|1|||
145747106|NCT01394939|525590734|FG001|Overall Study|Adverse Event|3|||
145747107|NCT01394939|525590735|FG002|Overall Study|Adverse Event|0|||
145747108|NCT01394939|525590736|FG003|Overall Study|Adverse Event|2|||
145747109|NCT01394939|525590733|FG000|Overall Study|Death|0|||
145747110|NCT01394939|525590734|FG001|Overall Study|Death|2|||
145747111|NCT01394939|525590735|FG002|Overall Study|Death|0|||
145747112|NCT01394939|525590736|FG003|Overall Study|Death|0|||
145747113|NCT01394939|525590733|FG000|Overall Study|Physician Decision|0|||
145747114|NCT01394939|525590734|FG001|Overall Study|Physician Decision|1|||
145747115|NCT01394939|525590735|FG002|Overall Study|Physician Decision|0|||
145747116|NCT01394939|525590736|FG003|Overall Study|Physician Decision|0|||
145747117|NCT01394939|525590733|FG000|Overall Study|Withdrawal by Subject|0|||
145747118|NCT01394939|525590734|FG001|Overall Study|Withdrawal by Subject|2|||
145747119|NCT01394939|525590735|FG002|Overall Study|Withdrawal by Subject|0|||
145747120|NCT01394939|525590736|FG003|Overall Study|Withdrawal by Subject|2|||
145747121|NCT01394939|525590733|FG000|Overall Study|Others|0|||
145747122|NCT01394939|525590734|FG001|Overall Study|Others|2|||
145747123|NCT01394939|525590735|FG002|Overall Study|Others|0|||
145747124|NCT01394939|525590736|FG003|Overall Study|Others|3|||
145747125|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
145747126|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
145747127|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
145747128|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
145747129|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
145747130|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
145747131|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
145747132|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
145747133|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
145747134|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
145747135|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
145747136|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
145747137|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
145747138|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
145747139|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
145747140|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
145747141|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
145747142|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
145747143|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
145747144|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
145747145|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
145747146|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
145747147|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
145747148|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
145747149|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
145747150|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
145747151|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
145747152|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
145747153|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
145747154|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
145747155|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
145747156|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
145747157|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
145747158|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
145747159|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
145747160|NCT02831673|525590737|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
145747161|NCT02831673|525590738|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
145747162|NCT02831673|525590739|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
145747163|NCT02831673|525590740|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
145747164|NCT02831673|525590741|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
145747165|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145747166|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145747167|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
145747168|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
145747169|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145747170|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145747171|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145747172|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
145523670|NCT04854642|524777956|FG001|Overall Study|Withdrawal by Subject|1|||
145523671|NCT03387150|524777961|FG000|Overall Study|Withdrawal by Subject|3|||
145523672|NCT03387150|524777962|FG001|Overall Study|Withdrawal by Subject|0|||
145523673|NCT03387150|524777963|FG002|Overall Study|Withdrawal by Subject|3|||
145523674|NCT03387150|524777964|FG003|Overall Study|Withdrawal by Subject|4|||
145523675|NCT03387150|524777965|FG004|Overall Study|Withdrawal by Subject|1|||
145271088|NCT00539006|523839612|FG002|Washout|Failed to meet continuation criteria|14|||
145402486|NCT00784875|524330734|FG001|Period D|Physician Decision|1|||
145523676|NCT03387150|524777966|FG005|Overall Study|Withdrawal by Subject|2|||
145747173|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
145747174|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145747175|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145747176|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145747177|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145747178|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
145747179|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145747180|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
145747181|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
145747182|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
145747183|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
145747184|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
145747185|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145747186|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145747187|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
145747188|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
145747189|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145747190|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145747191|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145747192|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
145747193|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
145747194|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145747195|NCT02831673|525590737|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145747196|NCT02831673|525590738|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145747197|NCT02831673|525590739|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
145747198|NCT02831673|525590740|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
145747199|NCT02831673|525590741|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145747200|NCT02831673|525590737|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
145747201|NCT02831673|525590738|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
145747202|NCT02831673|525590739|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
145747203|NCT02831673|525590740|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
145747204|NCT02831673|525590741|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
145747205|NCT02831673|525590737|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145747206|NCT02831673|525590738|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145747207|NCT02831673|525590739|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145747208|NCT02831673|525590740|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145747209|NCT02831673|525590741|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
145747210|NCT02831673|525590737|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145747211|NCT02831673|525590738|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145747212|NCT02831673|525590739|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145747213|NCT02831673|525590740|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145747214|NCT02831673|525590741|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
145747215|NCT02831673|525590737|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145747216|NCT02831673|525590738|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145747217|NCT02831673|525590739|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145747218|NCT02831673|525590740|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145747219|NCT02831673|525590741|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
145523677|NCT03387150|524777967|FG006|Overall Study|Withdrawal by Subject|0|||
145523678|NCT03387150|524777961|FG000|Overall Study|Lost to Follow-up|3|||
145523679|NCT03387150|524777962|FG001|Overall Study|Lost to Follow-up|2|||
145523680|NCT03387150|524777963|FG002|Overall Study|Lost to Follow-up|2|||
145523681|NCT03387150|524777964|FG003|Overall Study|Lost to Follow-up|3|||
145523682|NCT03387150|524777965|FG004|Overall Study|Lost to Follow-up|3|||
145523683|NCT03387150|524777966|FG005|Overall Study|Lost to Follow-up|3|||
145523684|NCT03387150|524777967|FG006|Overall Study|Lost to Follow-up|0|||
145523685|NCT03387150|524777961|FG000|Overall Study|Participant unable to adhere to visit|0|||
145523686|NCT03387150|524777962|FG001|Overall Study|Participant unable to adhere to visit|1|||
145747220|NCT02831673|525590737|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145747221|NCT02831673|525590738|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145747222|NCT02831673|525590739|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145523687|NCT03387150|524777963|FG002|Overall Study|Participant unable to adhere to visit|0|||
145523688|NCT03387150|524777964|FG003|Overall Study|Participant unable to adhere to visit|0|||
145523689|NCT03387150|524777965|FG004|Overall Study|Participant unable to adhere to visit|2|||
145523690|NCT03387150|524777966|FG005|Overall Study|Participant unable to adhere to visit|2|||
145747223|NCT02831673|525590740|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145747224|NCT02831673|525590741|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
145747225|NCT00477165|525590742|FG000|Overall Study|Adverse Event|7|||
145747226|NCT00477165|525590743|FG001|Overall Study|Adverse Event|2|||
145747227|NCT01623271|525590750|FG000|Overall Study|Withdrawal by Subject|2|||
145747228|NCT00879229|525590757|FG000|Overall Study|Study terminated by Sponsor|13|||
145747229|NCT00879229|525590758|FG001|Overall Study|Study terminated by Sponsor|12|||
145747230|NCT00879229|525590757|FG000|Overall Study|Death|4|||
145747231|NCT00879229|525590758|FG001|Overall Study|Death|2|||
145747232|NCT00879229|525590757|FG000|Overall Study|Adverse Event|2|||
145747233|NCT00879229|525590758|FG001|Overall Study|Adverse Event|0|||
145747234|NCT00879229|525590757|FG000|Overall Study|Withdrawal by Subject|1|||
145747235|NCT00879229|525590758|FG001|Overall Study|Withdrawal by Subject|0|||
145747236|NCT00879229|525590757|FG000|Overall Study|Clinical status did not improve|1|||
145747237|NCT00879229|525590758|FG001|Overall Study|Clinical status did not improve|0|||
145747238|NCT00879229|525590757|FG000|Overall Study|Other|1|||
145747239|NCT00879229|525590758|FG001|Overall Study|Other|0|||
145747240|NCT00513409|525590762|FG000|Overall Study|Adverse Event|0|||
145747241|NCT00513409|525590763|FG001|Overall Study|Adverse Event|1|||
145747242|NCT00513409|525590762|FG000|Overall Study|Withdrawal by Subject|0|||
145747243|NCT00513409|525590763|FG001|Overall Study|Withdrawal by Subject|2|||
145747244|NCT00513409|525590762|FG000|Overall Study|Lost to Follow-up|0|||
145747245|NCT00513409|525590763|FG001|Overall Study|Lost to Follow-up|1|||
145747246|NCT00513409|525590762|FG000|Overall Study|Physician Decision|1|||
145747247|NCT00513409|525590763|FG001|Overall Study|Physician Decision|0|||
145747248|NCT00513409|525590762|FG000|Overall Study|Visit 3 not done|1|||
145747249|NCT00513409|525590763|FG001|Overall Study|Visit 3 not done|2|||
145747250|NCT01049035|525590764|FG000|Overall Study|Serious adverse event|0|||
145747251|NCT01049035|525590765|FG001|Overall Study|Serious adverse event|1|||
145747252|NCT01049035|525590766|FG002|Overall Study|Serious adverse event|1|||
145747253|NCT01049035|525590767|FG003|Overall Study|Serious adverse event|2|||
145747254|NCT01049035|525590768|FG004|Overall Study|Serious adverse event|0|||
145747255|NCT01049035|525590769|FG005|Overall Study|Serious adverse event|0|||
145747256|NCT01049035|525590770|FG006|Overall Study|Serious adverse event|0|||
145747257|NCT01049035|525590764|FG000|Overall Study|Other adverse event (AE)|0|||
145747258|NCT01049035|525590765|FG001|Overall Study|Other adverse event (AE)|0|||
145747259|NCT01049035|525590766|FG002|Overall Study|Other adverse event (AE)|0|||
145747260|NCT01049035|525590767|FG003|Overall Study|Other adverse event (AE)|1|||
145747261|NCT01049035|525590768|FG004|Overall Study|Other adverse event (AE)|0|||
145747262|NCT01049035|525590769|FG005|Overall Study|Other adverse event (AE)|0|||
145747263|NCT01049035|525590770|FG006|Overall Study|Other adverse event (AE)|0|||
145747264|NCT01049035|525590764|FG000|Overall Study|Non-compliance with the protocol|12|||
145747265|NCT01049035|525590765|FG001|Overall Study|Non-compliance with the protocol|6|||
145747266|NCT01049035|525590766|FG002|Overall Study|Non-compliance with the protocol|14|||
145747267|NCT01049035|525590767|FG003|Overall Study|Non-compliance with the protocol|5|||
145747268|NCT01049035|525590768|FG004|Overall Study|Non-compliance with the protocol|3|||
145747269|NCT01049035|525590769|FG005|Overall Study|Non-compliance with the protocol|4|||
145747270|NCT01049035|525590770|FG006|Overall Study|Non-compliance with the protocol|10|||
145747271|NCT01049035|525590764|FG000|Overall Study|Lost to Follow-up|5|||
145747272|NCT01049035|525590765|FG001|Overall Study|Lost to Follow-up|4|||
145747273|NCT01049035|525590766|FG002|Overall Study|Lost to Follow-up|4|||
145747274|NCT01049035|525590767|FG003|Overall Study|Lost to Follow-up|1|||
145747275|NCT01049035|525590768|FG004|Overall Study|Lost to Follow-up|0|||
145747276|NCT01049035|525590769|FG005|Overall Study|Lost to Follow-up|3|||
145747277|NCT01049035|525590770|FG006|Overall Study|Lost to Follow-up|3|||
145747278|NCT01049035|525590764|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
145747279|NCT01049035|525590765|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
145747280|NCT01049035|525590766|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
145523691|NCT03387150|524777967|FG006|Overall Study|Participant unable to adhere to visit|0|||
145523692|NCT04078178|524777968|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
145523693|NCT04078178|524777969|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
145523694|NCT04078178|524777968|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
145523695|NCT04078178|524777969|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
145523696|NCT04078178|524777968|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
145747281|NCT01049035|525590767|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
145747282|NCT01049035|525590768|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
145747283|NCT01049035|525590769|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
145747284|NCT01049035|525590770|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
145747285|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
145523697|NCT04078178|524777969|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
145523698|NCT04078178|524777968|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
145747286|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
145747287|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
145747288|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
145747289|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
145747290|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
145747291|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
145747292|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
145747293|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
145747294|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
145747295|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
145747296|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
145747297|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
145747298|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
145747299|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
145747300|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
145747301|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
145747302|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
145747303|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
145747304|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
145747305|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
145747306|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
145747307|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
145747308|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
145747309|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
145747310|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
145747311|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
145747312|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
145747313|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
145747314|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
145747315|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
145747316|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
145747317|NCT03605680|525590776|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
145747318|NCT03605680|525590777|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
145747319|NCT03605680|525590778|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
145747320|NCT03605680|525590779|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
145747321|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
145747322|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
145747323|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
145747324|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
145747325|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
145747326|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
145747327|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
145747328|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
145747329|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145747330|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145747331|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145747332|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
145747333|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
145747334|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145747335|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
145747336|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145747337|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
145747338|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
145747339|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
145747340|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
145747341|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
145747342|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
145747343|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
145747344|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
145747345|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
145747346|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
145747347|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
145747348|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
145747349|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
145747350|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
145747351|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
145747352|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
145747353|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
145747354|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
145747355|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
145747356|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
145747357|NCT03605680|525590776|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
145747358|NCT03605680|525590777|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
145747359|NCT03605680|525590778|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
145747360|NCT03605680|525590779|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
145747361|NCT03189446|525590780|FG000|Overall Study|Adverse Event|2|||
145747362|NCT03189446|525590780|FG000|Overall Study|Withdrawal by Subject|2|||
145747363|NCT03189446|525590780|FG000|Overall Study|Physician Decision|1|||
145271089|NCT00539006|523839613|FG003|Washout|Failed to meet continuation criteria|6|||
145523699|NCT04078178|524777969|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
145523700|NCT04078178|524777968|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
145523701|NCT04078178|524777969|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
145523702|NCT04006119|524777970|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
145523703|NCT04006119|524777970|FG000|End of Treatment Veledimex|Adverse Event|2|||
145523704|NCT04006119|524777970|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
145523705|NCT04006119|524777970|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
145523706|NCT04006119|524777970|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
145523707|NCT04006119|524777970|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
145523708|NCT04617795|524777971|FG000|Main Study|Lost to Follow-up|1|||
145523709|NCT04617795|524777972|FG001|Main Study|Lost to Follow-up|0|||
145523710|NCT00472459|524777973|FG000|Overall Study|Adverse Event|13|||
145523711|NCT00472459|524777974|FG001|Overall Study|Adverse Event|13|||
145523712|NCT00472459|524777973|FG000|Overall Study|Withdrawal by Subject|5|||
145523713|NCT00472459|524777974|FG001|Overall Study|Withdrawal by Subject|5|||
145523714|NCT00472459|524777973|FG000|Overall Study|Protocol Violation|3|||
145523715|NCT00472459|524777974|FG001|Overall Study|Protocol Violation|3|||
145523716|NCT00472459|524777973|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
145523717|NCT00472459|524777974|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
145523718|NCT00472459|524777973|FG000|Overall Study|Lost to Follow-up|1|||
145523719|NCT00472459|524777974|FG001|Overall Study|Lost to Follow-up|1|||
145523720|NCT04850313|524777975|FG000|Overall Study|Withdrawal by Subject|0|||
145523721|NCT04850313|524777976|FG001|Overall Study|Withdrawal by Subject|1|||
145523722|NCT03269552|524777977|FG000|Overall Study|Adverse Event|2|||
145523723|NCT02186301|524777978|FG000|Overall Study|Progressive Disease|7|||
145523724|NCT02186301|524777979|FG001|Overall Study|Progressive Disease|22|||
145523725|NCT02186301|524777980|FG002|Overall Study|Progressive Disease|27|||
145523726|NCT02186301|524777978|FG000|Overall Study|Adverse Event|5|||
145523727|NCT02186301|524777979|FG001|Overall Study|Adverse Event|5|||
145523728|NCT02186301|524777980|FG002|Overall Study|Adverse Event|5|||
145523729|NCT02186301|524777978|FG000|Overall Study|Death|1|||
145523730|NCT02186301|524777979|FG001|Overall Study|Death|0|||
145523731|NCT02186301|524777980|FG002|Overall Study|Death|0|||
145523732|NCT02186301|524777978|FG000|Overall Study|Withdrawal by Subject|5|||
145523733|NCT02186301|524777979|FG001|Overall Study|Withdrawal by Subject|1|||
145523734|NCT02186301|524777980|FG002|Overall Study|Withdrawal by Subject|3|||
145523735|NCT02186301|524777978|FG000|Overall Study|Physician Decision|1|||
145747364|NCT00647556|525590781|FG000|Overall Study|Adverse Event|0|||
145747365|NCT00647556|525590782|FG001|Overall Study|Adverse Event|1|||
145747366|NCT00647556|525590781|FG000|Overall Study|Lost to Follow-up|1|||
145747367|NCT00647556|525590782|FG001|Overall Study|Lost to Follow-up|0|||
145747368|NCT00647556|525590781|FG000|Overall Study|Protocol Violation|0|||
145747369|NCT00647556|525590782|FG001|Overall Study|Protocol Violation|1|||
145747370|NCT00647556|525590781|FG000|Overall Study|Withdrawal by Subject|1|||
145747371|NCT00647556|525590782|FG001|Overall Study|Withdrawal by Subject|0|||
145747372|NCT00647556|525590781|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
145747373|NCT00647556|525590782|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
145747374|NCT05594173|525590783|FG000|Overall Study|Adverse Event|1|||
145747375|NCT05594173|525590783|FG000|Overall Study|COVID-19 Pandemic|2|||
145747376|NCT03865706|525590784|FG000|Overall Study|Death|0|||
145747377|NCT03865706|525590785|FG001|Overall Study|Death|3|||
145747378|NCT03865706|525590786|FG002|Overall Study|Death|1|||
145747379|NCT02646982|525590787|FG000|Overall Study|Adverse Event|1|||
145747380|NCT02646982|525590788|FG001|Overall Study|Adverse Event|1|||
145747381|NCT02646982|525590787|FG000|Overall Study|Withdrawal by Subject|2|||
145747382|NCT02646982|525590788|FG001|Overall Study|Withdrawal by Subject|1|||
145747383|NCT02095535|525590789|FG000|Recruitment|Protocol Violation|2|||
145747384|NCT00713700|525590790|FG000|Overall Study|Lost to Follow-up|3|||
145747385|NCT00713700|525590790|FG000|Overall Study|Withdrawal by Subject|1|||
145747386|NCT00781456|525590791|FG000|Overall Study|Adverse Event|3|||
145747387|NCT00781456|525590792|FG001|Overall Study|Adverse Event|3|||
145747388|NCT00781456|525590791|FG000|Overall Study|Withdrawal by Subject|3|||
145747389|NCT00781456|525590792|FG001|Overall Study|Withdrawal by Subject|5|||
145747390|NCT00781456|525590791|FG000|Overall Study|Protocol Violation|4|||
145747391|NCT00781456|525590792|FG001|Overall Study|Protocol Violation|1|||
145747392|NCT00781456|525590791|FG000|Overall Study|Noncompliance With Protocol|1|||
145747393|NCT00781456|525590792|FG001|Overall Study|Noncompliance With Protocol|1|||
145747394|NCT00781456|525590791|FG000|Overall Study|Lost to Follow-up|10|||
145747395|NCT00781456|525590792|FG001|Overall Study|Lost to Follow-up|5|||
145747396|NCT00781456|525590791|FG000|Overall Study|Other Reason, Unknown|0|||
145747397|NCT00781456|525590792|FG001|Overall Study|Other Reason, Unknown|1|||
145747398|NCT01594853|525590793|FG000|Overall Study|Withdrawal by Subject|1|||
145747399|NCT01594853|525590794|FG001|Overall Study|Withdrawal by Subject|1|||
145747400|NCT01594853|525590793|FG000|Overall Study|Lost to Follow-up|1|||
145747401|NCT01594853|525590794|FG001|Overall Study|Lost to Follow-up|1|||
145747402|NCT01594853|525590793|FG000|Overall Study|noncompliance with exercise|0|||
145747403|NCT01594853|525590794|FG001|Overall Study|noncompliance with exercise|1|||
145747404|NCT03776175|525590798|FG000|Treatment Period (42 Days)|Adverse Event|0|||
145747405|NCT03776175|525590799|FG001|Treatment Period (42 Days)|Adverse Event|1|||
145747406|NCT03776175|525590800|FG002|Treatment Period (42 Days)|Adverse Event|1|||
145747407|NCT03776175|525590801|FG003|Treatment Period (42 Days)|Adverse Event|0|||
145747408|NCT03776175|525590798|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
145747409|NCT03776175|525590799|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
145747410|NCT03776175|525590800|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
145747411|NCT03776175|525590801|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
145747412|NCT03776175|525590798|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
145747413|NCT03776175|525590799|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
145747414|NCT03776175|525590800|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
145747415|NCT03776175|525590801|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
145747416|NCT03776175|525590798|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
145747417|NCT03776175|525590799|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
145747418|NCT03776175|525590800|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
145747419|NCT03776175|525590801|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
145747420|NCT03776175|525590798|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
145747421|NCT03776175|525590799|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
145747422|NCT03776175|525590800|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
145747423|NCT03776175|525590801|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
145747424|NCT03776175|525590798|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
145747425|NCT03776175|525590799|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
145747426|NCT03776175|525590800|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
145747427|NCT03776175|525590801|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
145747428|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
145747429|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
145747430|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
145747431|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
145747432|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
145747433|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
145747434|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
145747435|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
145747436|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
145747437|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
145747438|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
145747439|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
145747440|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
145747441|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
145747442|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
145747443|NCT00960661|525590802|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
145747444|NCT00960661|525590803|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
145747445|NCT00960661|525590804|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
145747446|NCT00960661|525590802|FG000|Interventional Phase|Adverse Event|0|||
145747447|NCT00960661|525590803|FG001|Interventional Phase|Adverse Event|17|||
145747448|NCT00960661|525590804|FG002|Interventional Phase|Adverse Event|8|||
145747449|NCT00960661|525590802|FG000|Interventional Phase|Death|0|||
145747450|NCT00960661|525590803|FG001|Interventional Phase|Death|1|||
145747451|NCT00960661|525590804|FG002|Interventional Phase|Death|0|||
145747452|NCT00960661|525590802|FG000|Interventional Phase|Lost to Follow-up|0|||
145747453|NCT00960661|525590803|FG001|Interventional Phase|Lost to Follow-up|0|||
145747454|NCT00960661|525590804|FG002|Interventional Phase|Lost to Follow-up|2|||
145747455|NCT00960661|525590802|FG000|Interventional Phase|entry criteria not met|0|||
145747456|NCT00960661|525590803|FG001|Interventional Phase|entry criteria not met|3|||
145747457|NCT00960661|525590804|FG002|Interventional Phase|entry criteria not met|0|||
145747458|NCT00960661|525590802|FG000|Interventional Phase|Protocol Violation|0|||
145747459|NCT00960661|525590803|FG001|Interventional Phase|Protocol Violation|7|||
145747460|NCT00960661|525590804|FG002|Interventional Phase|Protocol Violation|2|||
145747461|NCT00960661|525590802|FG000|Interventional Phase|Withdrawal by Subject|0|||
145747462|NCT00960661|525590803|FG001|Interventional Phase|Withdrawal by Subject|18|||
145747463|NCT00960661|525590804|FG002|Interventional Phase|Withdrawal by Subject|29|||
145747464|NCT00960661|525590802|FG000|Interventional Phase|Physician Decision|0|||
145747465|NCT00960661|525590803|FG001|Interventional Phase|Physician Decision|3|||
145747466|NCT00960661|525590804|FG002|Interventional Phase|Physician Decision|5|||
145747467|NCT00960661|525590802|FG000|Interventional Phase|sponsor decision|0|||
145747468|NCT00960661|525590803|FG001|Interventional Phase|sponsor decision|1|||
145747469|NCT00960661|525590804|FG002|Interventional Phase|sponsor decision|0|||
145747470|NCT00960661|525590802|FG000|Interventional Phase|Lack of Efficacy|0|||
145747471|NCT00960661|525590803|FG001|Interventional Phase|Lack of Efficacy|2|||
145747472|NCT00960661|525590804|FG002|Interventional Phase|Lack of Efficacy|0|||
145747473|NCT03273166|525590806|FG000|Overall Study|Withdrawn prior to Completion|31|||
145747474|NCT02083380|525590810|FG000|Overall Study|Lack of Efficacy|68|||
145747475|NCT02083380|525590811|FG001|Overall Study|Lack of Efficacy|79|||
145747476|NCT02083380|525590812|FG002|Overall Study|Lack of Efficacy|64|||
145747477|NCT02083380|525590810|FG000|Overall Study|Withdrawal by Subject|9|||
145747478|NCT02083380|525590811|FG001|Overall Study|Withdrawal by Subject|3|||
145747479|NCT02083380|525590812|FG002|Overall Study|Withdrawal by Subject|7|||
145747480|NCT02083380|525590810|FG000|Overall Study|Physician Decision|1|||
145747481|NCT02083380|525590811|FG001|Overall Study|Physician Decision|6|||
145747482|NCT02083380|525590812|FG002|Overall Study|Physician Decision|3|||
145747483|NCT02083380|525590810|FG000|Overall Study|Adverse Event|0|||
145747484|NCT02083380|525590811|FG001|Overall Study|Adverse Event|0|||
145747485|NCT02083380|525590812|FG002|Overall Study|Adverse Event|1|||
145747486|NCT02083380|525590810|FG000|Overall Study|Lost to Follow-up|5|||
145747487|NCT02083380|525590811|FG001|Overall Study|Lost to Follow-up|3|||
145747488|NCT02083380|525590812|FG002|Overall Study|Lost to Follow-up|3|||
145747489|NCT02083380|525590810|FG000|Overall Study|Other|8|||
145747490|NCT02083380|525590811|FG001|Overall Study|Other|4|||
145747491|NCT02083380|525590812|FG002|Overall Study|Other|6|||
145747492|NCT02412787|525590813|FG000|Overall Study|Withdrawal by Subject|9|||
145747493|NCT02412787|525590813|FG000|Overall Study|Participation Terminated by Investigator|1|||
145747494|NCT02412787|525590813|FG000|Overall Study|Site Terminated by Sponsor|21|||
145747495|NCT02412787|525590813|FG000|Overall Study|Technical Problems|1|||
145747496|NCT02412787|525590813|FG000|Overall Study|Reason Not Specified|1|||
145747497|NCT03246958|525590814|FG000|Overall Study|Withdrawal by Subject|0|||
145747498|NCT03246958|525590815|FG001|Overall Study|Withdrawal by Subject|1|||
145747499|NCT03246958|525590816|FG002|Overall Study|Withdrawal by Subject|0|||
145747500|NCT03246958|525590817|FG003|Overall Study|Withdrawal by Subject|0|||
145747501|NCT03246958|525590818|FG004|Overall Study|Withdrawal by Subject|0|||
145747502|NCT03246958|525590819|FG005|Overall Study|Withdrawal by Subject|1|||
145747503|NCT03246958|525590820|FG006|Overall Study|Withdrawal by Subject|0|||
145747504|NCT03246958|525590814|FG000|Overall Study|Progression|13|||
145747505|NCT03246958|525590815|FG001|Overall Study|Progression|9|||
145747506|NCT03246958|525590816|FG002|Overall Study|Progression|3|||
145747507|NCT03246958|525590817|FG003|Overall Study|Progression|2|||
145747508|NCT03246958|525590818|FG004|Overall Study|Progression|1|||
145747509|NCT03246958|525590819|FG005|Overall Study|Progression|2|||
145747510|NCT03246958|525590820|FG006|Overall Study|Progression|1|||
145747511|NCT03246958|525590814|FG000|Overall Study|Adverse Event|2|||
145747512|NCT03246958|525590815|FG001|Overall Study|Adverse Event|2|||
145747513|NCT03246958|525590816|FG002|Overall Study|Adverse Event|0|||
145747514|NCT03246958|525590817|FG003|Overall Study|Adverse Event|1|||
145747515|NCT03246958|525590818|FG004|Overall Study|Adverse Event|1|||
145747516|NCT03246958|525590819|FG005|Overall Study|Adverse Event|0|||
145747517|NCT03246958|525590820|FG006|Overall Study|Adverse Event|2|||
145747518|NCT03246958|525590814|FG000|Overall Study|Death|0|||
145747519|NCT03246958|525590815|FG001|Overall Study|Death|1|||
145747520|NCT03246958|525590816|FG002|Overall Study|Death|0|||
145747521|NCT03246958|525590817|FG003|Overall Study|Death|0|||
145747522|NCT03246958|525590818|FG004|Overall Study|Death|0|||
145747523|NCT03246958|525590819|FG005|Overall Study|Death|0|||
145747524|NCT03246958|525590820|FG006|Overall Study|Death|0|||
145523736|NCT02186301|524777979|FG001|Overall Study|Physician Decision|0|||
145747525|NCT03246958|525590814|FG000|Overall Study|Physician Decision|0|||
145747526|NCT03246958|525590815|FG001|Overall Study|Physician Decision|0|||
145747527|NCT03246958|525590816|FG002|Overall Study|Physician Decision|0|||
145747528|NCT03246958|525590817|FG003|Overall Study|Physician Decision|1|||
145747529|NCT03246958|525590818|FG004|Overall Study|Physician Decision|0|||
145747530|NCT03246958|525590819|FG005|Overall Study|Physician Decision|0|||
145747531|NCT03246958|525590820|FG006|Overall Study|Physician Decision|0|||
145747532|NCT03246958|525590814|FG000|Overall Study|Never start treatment|1|||
145747533|NCT03246958|525590815|FG001|Overall Study|Never start treatment|0|||
145747534|NCT03246958|525590816|FG002|Overall Study|Never start treatment|0|||
145747535|NCT03246958|525590817|FG003|Overall Study|Never start treatment|0|||
145747536|NCT03246958|525590818|FG004|Overall Study|Never start treatment|0|||
145747537|NCT03246958|525590819|FG005|Overall Study|Never start treatment|0|||
145747538|NCT03246958|525590820|FG006|Overall Study|Never start treatment|0|||
145747539|NCT03246958|525590814|FG000|Overall Study|Over enrollment|0|||
145747540|NCT03246958|525590815|FG001|Overall Study|Over enrollment|2|||
145747541|NCT03246958|525590816|FG002|Overall Study|Over enrollment|0|||
145747542|NCT03246958|525590817|FG003|Overall Study|Over enrollment|0|||
145747543|NCT03246958|525590818|FG004|Overall Study|Over enrollment|0|||
145747544|NCT03246958|525590819|FG005|Overall Study|Over enrollment|0|||
145747545|NCT03246958|525590820|FG006|Overall Study|Over enrollment|0|||
145747546|NCT03363321|525590823|FG000|Overall Study|Withdrawal by Subject|0|||
145747547|NCT03363321|525590824|FG001|Overall Study|Withdrawal by Subject|1|||
145747548|NCT03363321|525590825|FG002|Overall Study|Withdrawal by Subject|0|||
145747549|NCT03363321|525590826|FG003|Overall Study|Withdrawal by Subject|1|||
145747550|NCT03363321|525590827|FG004|Overall Study|Withdrawal by Subject|0|||
145747551|NCT01032915|525590828|FG000|Overall Study|Adverse Event|2|||
145747552|NCT01032915|525590829|FG001|Overall Study|Adverse Event|2|||
145747553|NCT01032915|525590830|FG002|Overall Study|Adverse Event|1|||
145747554|NCT01032915|525590831|FG003|Overall Study|Adverse Event|1|||
145747555|NCT01032915|525590828|FG000|Overall Study|Abnormal test procedure result|0|||
145747556|NCT01032915|525590829|FG001|Overall Study|Abnormal test procedure result|0|||
145747557|NCT01032915|525590830|FG002|Overall Study|Abnormal test procedure result|1|||
145747558|NCT01032915|525590831|FG003|Overall Study|Abnormal test procedure result|0|||
145747559|NCT01032915|525590828|FG000|Overall Study|Withdrawal by Subject|0|||
145747560|NCT01032915|525590829|FG001|Overall Study|Withdrawal by Subject|3|||
145747561|NCT01032915|525590830|FG002|Overall Study|Withdrawal by Subject|1|||
145747562|NCT01032915|525590831|FG003|Overall Study|Withdrawal by Subject|1|||
145747563|NCT01032915|525590828|FG000|Overall Study|Administrative reasons|5|||
145747564|NCT01032915|525590829|FG001|Overall Study|Administrative reasons|6|||
145747565|NCT01032915|525590830|FG002|Overall Study|Administrative reasons|4|||
145747566|NCT01032915|525590831|FG003|Overall Study|Administrative reasons|4|||
145747567|NCT01032915|525590828|FG000|Overall Study|Protocol Violation|1|||
145747568|NCT01032915|525590829|FG001|Overall Study|Protocol Violation|0|||
145747569|NCT01032915|525590830|FG002|Overall Study|Protocol Violation|0|||
145747570|NCT01032915|525590831|FG003|Overall Study|Protocol Violation|1|||
145747571|NCT02915523|525590832|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
145747572|NCT02915523|525590833|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
145747573|NCT02915523|525590834|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
145747574|NCT02915523|525590835|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
145747575|NCT02915523|525590832|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
145747576|NCT02915523|525590833|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
145747577|NCT02915523|525590834|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
145747578|NCT02915523|525590835|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
145523737|NCT02186301|524777980|FG002|Overall Study|Physician Decision|1|||
145523738|NCT02186301|524777978|FG000|Overall Study|Study Terminated by Sponsor|1|||
145523739|NCT02186301|524777979|FG001|Overall Study|Study Terminated by Sponsor|0|||
145523740|NCT02186301|524777980|FG002|Overall Study|Study Terminated by Sponsor|11|||
145523741|NCT02186301|524777978|FG000|Overall Study|Protocol Deviation|0|||
145523742|NCT02186301|524777979|FG001|Overall Study|Protocol Deviation|2|||
145523743|NCT02186301|524777980|FG002|Overall Study|Protocol Deviation|0|||
145747579|NCT02915523|525590832|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
145523744|NCT02186301|524777978|FG000|Overall Study|Missing|0|||
145747580|NCT02915523|525590833|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
145747581|NCT02915523|525590834|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
145747582|NCT02915523|525590835|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
145747583|NCT02915523|525590832|FG000|Expansion Phase (Phase 2)|Death|0|||
145747584|NCT02915523|525590833|FG001|Expansion Phase (Phase 2)|Death|0|||
145523745|NCT02186301|524777979|FG001|Overall Study|Missing|0|||
145523746|NCT02186301|524777980|FG002|Overall Study|Missing|2|||
145523747|NCT02186301|524777978|FG000|Overall Study|Other|0|||
145523748|NCT02186301|524777979|FG001|Overall Study|Other|0|||
145523749|NCT02186301|524777980|FG002|Overall Study|Other|1|||
145523750|NCT03560739|524777982|FG000|Overall Study|Adverse Event|0|||
145523751|NCT03560739|524777983|FG001|Overall Study|Adverse Event|1|||
145523752|NCT03560739|524777984|FG002|Overall Study|Adverse Event|0|||
145523753|NCT03560739|524777985|FG003|Overall Study|Adverse Event|0|||
145523754|NCT01741012|524777989|FG000|Overall Study|Lost to Follow-up|1|||
145523755|NCT01741012|524777989|FG000|Overall Study|Withdrawal by Subject|2|||
145523756|NCT00997438|524777990|FG000|Overall Study|Blood draw difficulty|2|||
145523757|NCT00997438|524777991|FG001|Overall Study|Blood draw difficulty|0|||
145523758|NCT00997438|524777992|FG002|Overall Study|Blood draw difficulty|1|||
145523759|NCT00997438|524777990|FG000|Overall Study|Withdrawal by Subject|1|||
145523760|NCT00997438|524777991|FG001|Overall Study|Withdrawal by Subject|1|||
145523761|NCT00997438|524777992|FG002|Overall Study|Withdrawal by Subject|0|||
145523762|NCT00997438|524777990|FG000|Overall Study|Exclusion criteria at visit 1|2|||
145523763|NCT00997438|524777991|FG001|Overall Study|Exclusion criteria at visit 1|2|||
145523764|NCT00997438|524777992|FG002|Overall Study|Exclusion criteria at visit 1|3|||
145523765|NCT00095238|524777993|FG000|Overall Study|Lack of Efficacy|9|||
145523766|NCT00095238|524777994|FG001|Overall Study|Lack of Efficacy|9|||
145523767|NCT00095238|524777993|FG000|Overall Study|Adverse Event|331|||
145402487|NCT00784875|524330735|FG002|Period D|Physician Decision|0|||
145402488|NCT00784875|524330736|FG003|Period D|Physician Decision|0|||
145402489|NCT00784875|524330733|FG000|Period D|Sponsor Decision|1|||
145402490|NCT00784875|524330734|FG001|Period D|Sponsor Decision|1|||
145402491|NCT00784875|524330735|FG002|Period D|Sponsor Decision|1|||
145523768|NCT00095238|524777994|FG001|Overall Study|Adverse Event|287|||
145523769|NCT00095238|524777993|FG000|Overall Study|Subject Withdrew Consent|208|||
145523770|NCT00095238|524777994|FG001|Overall Study|Subject Withdrew Consent|223|||
145523771|NCT00095238|524777993|FG000|Overall Study|Death|154|||
145523772|NCT00095238|524777994|FG001|Overall Study|Death|170|||
145523773|NCT00095238|524777993|FG000|Overall Study|Lost to Follow-up|19|||
145523774|NCT00095238|524777994|FG001|Overall Study|Lost to Follow-up|24|||
145523775|NCT00095238|524777993|FG000|Overall Study|Noncompliance|44|||
145523776|NCT00095238|524777994|FG001|Overall Study|Noncompliance|45|||
145523777|NCT00095238|524777993|FG000|Overall Study|No longer met study criteria|4|||
145523778|NCT00095238|524777994|FG001|Overall Study|No longer met study criteria|5|||
145523779|NCT00095238|524777993|FG000|Overall Study|Study terminated by sponsor|0|||
145523780|NCT00095238|524777994|FG001|Overall Study|Study terminated by sponsor|1|||
145523781|NCT00095238|524777993|FG000|Overall Study|Missing|1|||
145523782|NCT00095238|524777994|FG001|Overall Study|Missing|0|||
145523783|NCT00095238|524777993|FG000|Overall Study|Other Reasons|87|||
145523784|NCT00095238|524777994|FG001|Overall Study|Other Reasons|88|||
145523785|NCT03505671|524777995|FG000|Overall Study|Withdrawal by Subject|2|||
145523786|NCT03505671|524777996|FG001|Overall Study|Withdrawal by Subject|1|||
145523787|NCT03505671|524777995|FG000|Overall Study|Lost to Follow-up|1|||
145523788|NCT03505671|524777996|FG001|Overall Study|Lost to Follow-up|0|||
145523789|NCT02038829|524777999|FG000|Washout Period 1|Death|0|||
145523790|NCT02038829|524778000|FG001|Washout Period 1|Death|0|||
145523791|NCT02038829|524778001|FG002|Washout Period 1|Death|0|||
145523792|NCT02038829|524778002|FG003|Washout Period 1|Death|0|||
145523793|NCT02038829|524778003|FG004|Washout Period 1|Death|1|||
145523794|NCT02038829|524778004|FG005|Washout Period 1|Death|0|||
145523795|NCT02038829|524778005|FG006|Washout Period 1|Death|0|||
145523796|NCT02038829|524778006|FG007|Washout Period 1|Death|0|||
145747585|NCT02915523|525590834|FG002|Expansion Phase (Phase 2)|Death|26|||
145747586|NCT02915523|525590835|FG003|Expansion Phase (Phase 2)|Death|53|||
145747587|NCT02915523|525590832|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
145402492|NCT00784875|524330736|FG003|Period D|Sponsor Decision|0|||
145402493|NCT00784875|524330733|FG000|Period D|Lost to Follow-up|1|||
145523797|NCT02038829|524778007|FG008|Washout Period 1|Death|0|||
145523798|NCT02038829|524778008|FG009|Washout Period 1|Death|0|||
145523799|NCT02038829|524778009|FG010|Washout Period 1|Death|0|||
145523800|NCT02038829|524778010|FG011|Washout Period 1|Death|0|||
145523801|NCT02038829|524777999|FG000|Treatment Period 2|Adverse Event|0|||
145523802|NCT02038829|524778000|FG001|Treatment Period 2|Adverse Event|0|||
145747588|NCT02915523|525590833|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
145523803|NCT02038829|524778001|FG002|Treatment Period 2|Adverse Event|0|||
145523804|NCT02038829|524778002|FG003|Treatment Period 2|Adverse Event|0|||
145523805|NCT02038829|524778003|FG004|Treatment Period 2|Adverse Event|0|||
145523806|NCT02038829|524778004|FG005|Treatment Period 2|Adverse Event|0|||
145523807|NCT02038829|524778005|FG006|Treatment Period 2|Adverse Event|0|||
145523808|NCT02038829|524778006|FG007|Treatment Period 2|Adverse Event|0|||
145523809|NCT02038829|524778007|FG008|Treatment Period 2|Adverse Event|0|||
145523810|NCT02038829|524778008|FG009|Treatment Period 2|Adverse Event|0|||
145523811|NCT02038829|524778009|FG010|Treatment Period 2|Adverse Event|1|||
145523812|NCT02038829|524778010|FG011|Treatment Period 2|Adverse Event|0|||
145523813|NCT02038829|524777999|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145523814|NCT02038829|524778000|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145523815|NCT02038829|524778001|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145523816|NCT02038829|524778002|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145523817|NCT02038829|524778003|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145523818|NCT02038829|524778004|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145523819|NCT02038829|524778005|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145523820|NCT02038829|524778006|FG007|Treatment Period 2|Withdrawal by Subject|0|||
145523821|NCT02038829|524778007|FG008|Treatment Period 2|Withdrawal by Subject|0|||
145523822|NCT02038829|524778008|FG009|Treatment Period 2|Withdrawal by Subject|0|||
145523823|NCT02038829|524778009|FG010|Treatment Period 2|Withdrawal by Subject|0|||
145523824|NCT02038829|524778010|FG011|Treatment Period 2|Withdrawal by Subject|0|||
145523825|NCT02038829|524777999|FG000|Washout Period 2|Adverse Event|0|||
145523826|NCT02038829|524778000|FG001|Washout Period 2|Adverse Event|0|||
145402494|NCT00784875|524330734|FG001|Period D|Lost to Follow-up|0|||
145402495|NCT00784875|524330735|FG002|Period D|Lost to Follow-up|1|||
145402496|NCT00784875|524330736|FG003|Period D|Lost to Follow-up|1|||
145402497|NCT00941928|524330743|FG000|Overall Study|Withdrawal by Subject|1|||
145402498|NCT00941928|524330743|FG000|Overall Study|Disease Progression|1|||
145402499|NCT02300610|524330744|FG000|Overall Study|Withdrawal by Subject|1|||
145402500|NCT02300610|524330745|FG001|Overall Study|Withdrawal by Subject|0|||
145402501|NCT02300610|524330746|FG002|Overall Study|Withdrawal by Subject|1|||
145402502|NCT01829347|524330747|FG000|VTI-210|Death|5|||
145402503|NCT01829347|524330748|FG001|VTI-210|Death|3|||
145402504|NCT01829347|524330747|FG000|VTI-210|Withdrawal by Subject|1|||
145402505|NCT01829347|524330748|FG001|VTI-210|Withdrawal by Subject|0|||
145402506|NCT01829347|524330747|FG000|VTI-210E|Death|2|||
145402507|NCT01829347|524330748|FG001|VTI-210E|Death|1|||
145402508|NCT01829347|524330747|FG000|VTI-210E|Study terminated prematurely|1|||
145402509|NCT01829347|524330748|FG001|VTI-210E|Study terminated prematurely|5|||
145402510|NCT00856180|524330752|FG000|Overall Study|Adverse Event|4|||
145402511|NCT00856180|524330752|FG000|Overall Study|Progressive Disease|16|||
145402512|NCT00929669|524330753|FG000|Overall Study|elevated glucose levels|1|||
145402513|NCT02714153|524330754|FG000|Overall Study|Death|1|||
145402514|NCT01901185|524330755|FG000|Overall Study|Withdrawal by Subject|2|||
145402515|NCT00296335|524330757|FG000|Overall Study|Recurrence|3|||
145402516|NCT00296335|524330758|FG001|Overall Study|Recurrence|51|||
145402517|NCT00296335|524330757|FG000|Overall Study|Adverse Event|17|||
145402518|NCT00296335|524330758|FG001|Overall Study|Adverse Event|27|||
145402519|NCT00296335|524330757|FG000|Overall Study|Lost to Follow-up|7|||
145402520|NCT00296335|524330758|FG001|Overall Study|Lost to Follow-up|33|||
145402521|NCT00296335|524330757|FG000|Overall Study|Physician Decision|3|||
145402522|NCT00296335|524330758|FG001|Overall Study|Physician Decision|11|||
145402523|NCT01670292|524330759|FG000|Overall Study|Lost to Follow-up|14|||
145402524|NCT04494646|524330762|FG000|Overall Study|Adverse Event|0|||
145402525|NCT04494646|524330763|FG001|Overall Study|Adverse Event|1|||
145402526|NCT04494646|524330762|FG000|Overall Study|Withdrawal by Subject|0|||
145402527|NCT04494646|524330763|FG001|Overall Study|Withdrawal by Subject|1|||
145402528|NCT01192815|524330774|FG000|Overall Study|Withdrawal by Subject|1|||
145402529|NCT01192815|524330774|FG000|Overall Study|Lack of Efficacy|1|||
145402530|NCT03054428|524330777|FG000|Overall Study|Physician Decision|0|||
145402531|NCT03054428|524330778|FG001|Overall Study|Physician Decision|1|||
145402532|NCT03054428|524330779|FG002|Overall Study|Physician Decision|1|||
145402533|NCT03054428|524330777|FG000|Overall Study|Lack of Efficacy|3|||
145523827|NCT02038829|524778001|FG002|Washout Period 2|Adverse Event|0|||
145523828|NCT02038829|524778002|FG003|Washout Period 2|Adverse Event|0|||
145523829|NCT02038829|524778003|FG004|Washout Period 2|Adverse Event|0|||
145523830|NCT02038829|524778004|FG005|Washout Period 2|Adverse Event|0|||
145523831|NCT02038829|524778005|FG006|Washout Period 2|Adverse Event|0|||
145402534|NCT03054428|524330778|FG001|Overall Study|Lack of Efficacy|1|||
145402535|NCT03054428|524330779|FG002|Overall Study|Lack of Efficacy|0|||
145523832|NCT02038829|524778006|FG007|Washout Period 2|Adverse Event|0|||
145523833|NCT02038829|524778007|FG008|Washout Period 2|Adverse Event|1|||
145523834|NCT02038829|524778008|FG009|Washout Period 2|Adverse Event|0|||
145402536|NCT03054428|524330777|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
145523835|NCT02038829|524778009|FG010|Washout Period 2|Adverse Event|0|||
145523836|NCT02038829|524778010|FG011|Washout Period 2|Adverse Event|0|||
145523837|NCT02038829|524777999|FG000|Washout Period 2|Withdrawal by Subject|0|||
145402537|NCT03054428|524330778|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
145747589|NCT02915523|525590834|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
145747590|NCT02915523|525590835|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
145747591|NCT02915523|525590832|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
145747592|NCT02915523|525590833|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
145747593|NCT02915523|525590834|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
145747594|NCT02915523|525590835|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
145747595|NCT02915523|525590832|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
145747596|NCT02915523|525590833|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
145747597|NCT02915523|525590834|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
145747598|NCT02915523|525590835|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
145747599|NCT00763815|525590840|FG000|Overall Study|Adverse Event|14|||
145747600|NCT00763815|525590841|FG001|Overall Study|Adverse Event|29|||
145747601|NCT00763815|525590840|FG000|Overall Study|Lack of Efficacy|10|||
145747602|NCT00763815|525590841|FG001|Overall Study|Lack of Efficacy|11|||
145747603|NCT00763815|525590840|FG000|Overall Study|Poor Compliance to Protocol|6|||
145747604|NCT00763815|525590841|FG001|Overall Study|Poor Compliance to Protocol|6|||
145747605|NCT00763815|525590840|FG000|Overall Study|Lost to Follow-up|2|||
145747606|NCT00763815|525590841|FG001|Overall Study|Lost to Follow-up|4|||
145747607|NCT00763815|525590840|FG000|Overall Study|Early Termination|1|||
145747608|NCT00763815|525590841|FG001|Overall Study|Early Termination|0|||
145747609|NCT00763815|525590840|FG000|Overall Study|Familial and Personal Reasons|9|||
145747610|NCT00763815|525590841|FG001|Overall Study|Familial and Personal Reasons|16|||
145747611|NCT00763815|525590840|FG000|Overall Study|Physician Decision|1|||
145747612|NCT00763815|525590841|FG001|Overall Study|Physician Decision|0|||
145747613|NCT00763815|525590840|FG000|Overall Study|Withdrawal by Subject|7|||
145402538|NCT03054428|524330779|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
145402539|NCT03054428|524330777|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
145747614|NCT00763815|525590841|FG001|Overall Study|Withdrawal by Subject|12|||
145747615|NCT00763815|525590840|FG000|Overall Study|Protocol Violation|2|||
145747616|NCT00763815|525590841|FG001|Overall Study|Protocol Violation|5|||
145747617|NCT00763815|525590840|FG000|Overall Study|Sponsor's Decision|0|||
145747618|NCT00763815|525590841|FG001|Overall Study|Sponsor's Decision|1|||
145747619|NCT00414453|525590842|FG000|Overall Study|Abnormal lab work|16|||
145747620|NCT01780831|525590843|FG000|Overall Study|Withdrawal by Subject|0|||
145747621|NCT01780831|525590844|FG001|Overall Study|Withdrawal by Subject|0|||
145747622|NCT01780831|525590845|FG002|Overall Study|Withdrawal by Subject|4|||
145747623|NCT01780831|525590846|FG003|Overall Study|Withdrawal by Subject|0|||
145747624|NCT01780831|525590843|FG000|Overall Study|Lost to Follow-up|0|||
145747625|NCT01780831|525590844|FG001|Overall Study|Lost to Follow-up|0|||
145747626|NCT01780831|525590845|FG002|Overall Study|Lost to Follow-up|0|||
145747627|NCT01780831|525590846|FG003|Overall Study|Lost to Follow-up|1|||
145747628|NCT00183274|525590847|FG000|Phase 1: Open-Label|Adverse Event|31|||
145747629|NCT00183274|525590848|FG001|Phase 1: Open-Label|Adverse Event|0|||
145747630|NCT00183274|525590849|FG002|Phase 1: Open-Label|Adverse Event|0|||
145747631|NCT00183274|525590850|FG003|Phase 1: Open-Label|Adverse Event|0|||
145747632|NCT00183274|525590851|FG004|Phase 1: Open-Label|Adverse Event|0|||
145747633|NCT00183274|525590852|FG005|Phase 1: Open-Label|Adverse Event|0|||
145747634|NCT00183274|525590847|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
145747635|NCT00183274|525590848|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
145747636|NCT00183274|525590849|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
145747637|NCT00183274|525590850|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
145747638|NCT00183274|525590851|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
145747639|NCT00183274|525590852|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
145747640|NCT00183274|525590847|FG000|Phase 1: Open-Label|Protocol Violation|11|||
145747641|NCT00183274|525590848|FG001|Phase 1: Open-Label|Protocol Violation|0|||
145747642|NCT00183274|525590849|FG002|Phase 1: Open-Label|Protocol Violation|0|||
145747643|NCT00183274|525590850|FG003|Phase 1: Open-Label|Protocol Violation|0|||
145747644|NCT00183274|525590851|FG004|Phase 1: Open-Label|Protocol Violation|0|||
145747645|NCT00183274|525590852|FG005|Phase 1: Open-Label|Protocol Violation|0|||
145747646|NCT00183274|525590847|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
145402540|NCT03054428|524330778|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
145402541|NCT03054428|524330779|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
145402542|NCT03054428|524330777|FG000|Overall Study|Transitioned to OLE study|76|||
145402543|NCT03054428|524330778|FG001|Overall Study|Transitioned to OLE study|76|||
145523838|NCT02038829|524778000|FG001|Washout Period 2|Withdrawal by Subject|0|||
145523839|NCT02038829|524778001|FG002|Washout Period 2|Withdrawal by Subject|0|||
145747647|NCT00183274|525590848|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
145747648|NCT00183274|525590849|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
145747649|NCT00183274|525590850|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
145747650|NCT00183274|525590851|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
145747651|NCT00183274|525590852|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
145747652|NCT00183274|525590847|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
145747653|NCT00183274|525590848|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
145747654|NCT00183274|525590849|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
145402544|NCT03054428|524330779|FG002|Overall Study|Transitioned to OLE study|73|||
145402545|NCT03054428|524330777|FG000|Overall Study|Withdrawal by Subject|3|||
145402546|NCT03054428|524330778|FG001|Overall Study|Withdrawal by Subject|2|||
145402547|NCT03054428|524330779|FG002|Overall Study|Withdrawal by Subject|3|||
145402548|NCT03054428|524330777|FG000|Overall Study|Lost to Follow-up|0|||
145402549|NCT03054428|524330778|FG001|Overall Study|Lost to Follow-up|0|||
145402550|NCT03054428|524330779|FG002|Overall Study|Lost to Follow-up|1|||
145402551|NCT01499810|524330780|FG000|Overall Study|Lost to Follow-up|10|||
145402552|NCT01499810|524330780|FG000|Overall Study|Protocol Violation|1|||
145402553|NCT01499810|524330780|FG000|Overall Study|Withdrawal by Subject|1|||
145402554|NCT04030598|524330781|FG000|Overall Study|Voluntary Withdrawal|0|||
145402555|NCT04030598|524330782|FG001|Overall Study|Voluntary Withdrawal|1|||
145402556|NCT04030598|524330783|FG002|Overall Study|Voluntary Withdrawal|0|||
145402557|NCT05117060|524330786|FG000|Overall Study|Adverse Event|3|||
145402558|NCT05117060|524330787|FG001|Overall Study|Adverse Event|5|||
145402559|NCT05117060|524330788|FG002|Overall Study|Adverse Event|6|||
145402560|NCT05117060|524330789|FG003|Overall Study|Adverse Event|1|||
145402561|NCT05117060|524330786|FG000|Overall Study|Lost to Follow-up|0|||
145402562|NCT05117060|524330787|FG001|Overall Study|Lost to Follow-up|0|||
145402563|NCT05117060|524330788|FG002|Overall Study|Lost to Follow-up|0|||
145402564|NCT05117060|524330789|FG003|Overall Study|Lost to Follow-up|1|||
145402565|NCT05117060|524330786|FG000|Overall Study|Lack of Efficacy|4|||
145402566|NCT05117060|524330787|FG001|Overall Study|Lack of Efficacy|5|||
145402567|NCT05117060|524330788|FG002|Overall Study|Lack of Efficacy|2|||
145402568|NCT05117060|524330789|FG003|Overall Study|Lack of Efficacy|6|||
145402569|NCT05117060|524330786|FG000|Overall Study|Withdrawal by Subject|8|||
145402570|NCT05117060|524330787|FG001|Overall Study|Withdrawal by Subject|5|||
145402571|NCT05117060|524330788|FG002|Overall Study|Withdrawal by Subject|5|||
145402572|NCT05117060|524330789|FG003|Overall Study|Withdrawal by Subject|6|||
145402573|NCT05117060|524330786|FG000|Overall Study|Other|2|||
145402574|NCT05117060|524330787|FG001|Overall Study|Other|1|||
145402575|NCT05117060|524330788|FG002|Overall Study|Other|3|||
145402576|NCT05117060|524330789|FG003|Overall Study|Other|1|||
145402577|NCT03141359|524330790|FG000|Overall Study|Death|32|||
145402578|NCT03141359|524330790|FG000|Overall Study|Still On Study (in follow up)|29|||
145402579|NCT05079321|524330791|FG000|Overall Study|Withdrawal by Subject|2|||
145402580|NCT05079321|524330792|FG001|Overall Study|Withdrawal by Subject|2|||
145402581|NCT05079321|524330791|FG000|Overall Study|Lost to Follow-up|0|||
145402582|NCT05079321|524330792|FG001|Overall Study|Lost to Follow-up|1|||
145402583|NCT01884597|524330793|FG000|Overall Study|Adverse Event|0|||
145402584|NCT01884597|524330794|FG001|Overall Study|Adverse Event|0|||
145402585|NCT01884597|524330795|FG002|Overall Study|Adverse Event|1|||
145402586|NCT01884597|524330793|FG000|Overall Study|Lack of Efficacy|1|||
145402587|NCT01884597|524330794|FG001|Overall Study|Lack of Efficacy|0|||
145402588|NCT01884597|524330795|FG002|Overall Study|Lack of Efficacy|0|||
145402589|NCT01884597|524330793|FG000|Overall Study|Death|0|||
145402590|NCT01884597|524330794|FG001|Overall Study|Death|1|||
145402591|NCT01884597|524330795|FG002|Overall Study|Death|0|||
145402592|NCT02097823|524330796|FG000|Overall Study|Withdrawal by Subject|1|||
145402593|NCT02097823|524330797|FG001|Overall Study|Withdrawal by Subject|1|||
145402594|NCT01081626|524330798|FG000|Overall Study|Dosing error|1|||
145747655|NCT00183274|525590850|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
145747656|NCT00183274|525590851|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
145747657|NCT00183274|525590852|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
145747658|NCT00183274|525590847|FG000|Phase 1: Open-Label|Other|9|||
145747659|NCT00183274|525590848|FG001|Phase 1: Open-Label|Other|0|||
145747660|NCT00183274|525590849|FG002|Phase 1: Open-Label|Other|0|||
145747661|NCT00183274|525590850|FG003|Phase 1: Open-Label|Other|0|||
145747662|NCT00183274|525590851|FG004|Phase 1: Open-Label|Other|0|||
145747663|NCT00183274|525590852|FG005|Phase 1: Open-Label|Other|0|||
145747664|NCT00183274|525590847|FG000|Phase 2: Double-Blind|Relapsed|0|||
145747665|NCT00183274|525590848|FG001|Phase 2: Double-Blind|Relapsed|8|||
145402595|NCT01081626|524330799|FG001|Overall Study|Dosing error|1|||
145402596|NCT01081626|524330798|FG000|Overall Study|Missing Estradiol|25|||
145402597|NCT01081626|524330799|FG001|Overall Study|Missing Estradiol|28|||
145402598|NCT01081626|524330798|FG000|Overall Study|Low antral follicle count|1|||
145402599|NCT01081626|524330799|FG001|Overall Study|Low antral follicle count|0|||
145402600|NCT01081626|524330798|FG000|Overall Study|Overstimulation|0|||
145402601|NCT01081626|524330799|FG001|Overall Study|Overstimulation|1|||
145402602|NCT01081626|524330798|FG000|Overall Study|Lost to Follow-up|0|||
145402603|NCT01081626|524330799|FG001|Overall Study|Lost to Follow-up|1|||
145402604|NCT01081626|524330798|FG000|Overall Study|Other|33|||
145402605|NCT01081626|524330799|FG001|Overall Study|Other|30|||
145402606|NCT01419535|524330801|FG000|Overall Study|could not maintain iv line|1|||
145747666|NCT00183274|525590849|FG002|Phase 2: Double-Blind|Relapsed|29|||
145747667|NCT00183274|525590850|FG003|Phase 2: Double-Blind|Relapsed|0|||
145402607|NCT01419535|524330802|FG001|Overall Study|could not maintain iv line|1|||
145402608|NCT01419535|524330801|FG000|Overall Study|Withdrawal by Subject|0|||
145402609|NCT01419535|524330802|FG001|Overall Study|Withdrawal by Subject|1|||
145747668|NCT00183274|525590851|FG004|Phase 2: Double-Blind|Relapsed|0|||
145747669|NCT00183274|525590852|FG005|Phase 2: Double-Blind|Relapsed|0|||
145747670|NCT00183274|525590847|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
145747671|NCT00183274|525590848|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
145747672|NCT00183274|525590849|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
145747673|NCT00183274|525590850|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
145747674|NCT00183274|525590851|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
145747675|NCT00183274|525590852|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
145747676|NCT00183274|525590847|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
145747677|NCT00183274|525590848|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
145747678|NCT00183274|525590849|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
145747679|NCT00183274|525590850|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
145747680|NCT00183274|525590851|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
145747681|NCT00183274|525590852|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
145747682|NCT00183274|525590847|FG000|Phase 3: Double-Blind|Relapsed|0|||
145747683|NCT00183274|525590848|FG001|Phase 3: Double-Blind|Relapsed|0|||
145747684|NCT00183274|525590849|FG002|Phase 3: Double-Blind|Relapsed|0|||
145747685|NCT00183274|525590850|FG003|Phase 3: Double-Blind|Relapsed|1|||
145747686|NCT00183274|525590851|FG004|Phase 3: Double-Blind|Relapsed|11|||
145747687|NCT00183274|525590852|FG005|Phase 3: Double-Blind|Relapsed|2|||
145747688|NCT00618410|525590863|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
145747689|NCT00618410|525590864|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
145747690|NCT00513500|525590874|FG000|Overall Study|Lost to Follow-up|35|||
145747691|NCT00513500|525590875|FG001|Overall Study|Lost to Follow-up|39|||
145747692|NCT00513500|525590874|FG000|Overall Study|Death|2|||
145747693|NCT00513500|525590875|FG001|Overall Study|Death|1|||
145747694|NCT00513500|525590874|FG000|Overall Study|Hospitalized|4|||
145747695|NCT00513500|525590875|FG001|Overall Study|Hospitalized|14|||
145747696|NCT00749996|525590876|FG000|Overall Study|Lost to Follow-up|7|||
145747697|NCT00749996|525590877|FG001|Overall Study|Lost to Follow-up|4|||
145747698|NCT00749996|525590876|FG000|Overall Study|Withdrawal by Subject|5|||
145747699|NCT00749996|525590877|FG001|Overall Study|Withdrawal by Subject|4|||
145747700|NCT00749996|525590876|FG000|Overall Study|Protocol Violation|2|||
145747701|NCT00749996|525590877|FG001|Overall Study|Protocol Violation|3|||
145747702|NCT00749996|525590876|FG000|Overall Study|Physician Decision|2|||
145747703|NCT00749996|525590877|FG001|Overall Study|Physician Decision|0|||
145747704|NCT00749996|525590876|FG000|Overall Study|Pregnancy|0|||
145747705|NCT00749996|525590877|FG001|Overall Study|Pregnancy|2|||
145747706|NCT00749996|525590876|FG000|Overall Study|Adverse Event|1|||
145747707|NCT00749996|525590877|FG001|Overall Study|Adverse Event|0|||
145747708|NCT00749996|525590876|FG000|Overall Study|Death|1|||
145747709|NCT00749996|525590877|FG001|Overall Study|Death|0|||
145747710|NCT00631371|525592471|FG000|Overall Study|Lost to Follow-up|24|||
145747711|NCT00631371|525592472|FG001|Overall Study|Lost to Follow-up|19|||
145271090|NCT00539006|523839610|FG000|Washout|Other|1|||
145271091|NCT00539006|523839611|FG001|Washout|Other|1|||
145747712|NCT00631371|525592471|FG000|Overall Study|Other reason|5|||
145747713|NCT00631371|525592472|FG001|Overall Study|Other reason|12|||
145747714|NCT00631371|525592471|FG000|Overall Study|subject request|38|||
145747715|NCT00631371|525592472|FG001|Overall Study|subject request|45|||
145747716|NCT00631371|525592471|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
145747717|NCT00631371|525592472|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
145747718|NCT00631371|525592471|FG000|Overall Study|Death|263|||
145747719|NCT00631371|525592472|FG001|Overall Study|Death|239|||
145747720|NCT00812214|525592475|FG000|Overall Study|Lost to Follow-up|3|||
145271092|NCT00539006|523839612|FG002|Washout|Other|2|||
145747721|NCT00812214|525592476|FG001|Overall Study|Lost to Follow-up|1|||
145747722|NCT01659320|525592477|FG000|Overall Study|Withdrawal by Subject|2|||
145747723|NCT01659320|525592477|FG000|Overall Study|Physician Decision|1|||
145747724|NCT01514682|525592478|FG000|Overall Study|Withdrawal by Subject|2|||
145747725|NCT01514682|525592479|FG001|Overall Study|Withdrawal by Subject|3|||
145747726|NCT01514682|525592478|FG000|Overall Study|Physician Decision|4|||
145747727|NCT01514682|525592479|FG001|Overall Study|Physician Decision|3|||
145747728|NCT00590590|525592480|FG000|Overall Study|Lack of Efficacy|1|||
145747729|NCT00590590|525592481|FG001|Overall Study|Lack of Efficacy|2|||
145747730|NCT00590590|525592482|FG002|Overall Study|Lack of Efficacy|0|||
145747731|NCT00590590|525592480|FG000|Overall Study|Adverse Event|1|||
145747732|NCT00590590|525592481|FG001|Overall Study|Adverse Event|0|||
145747733|NCT00590590|525592482|FG002|Overall Study|Adverse Event|0|||
145747734|NCT00590590|525592480|FG000|Overall Study|Protocol Violation|0|||
145747735|NCT00590590|525592481|FG001|Overall Study|Protocol Violation|0|||
145747736|NCT00590590|525592482|FG002|Overall Study|Protocol Violation|2|||
145747737|NCT00590590|525592480|FG000|Overall Study|Lost to Follow-up|4|||
145747738|NCT00590590|525592481|FG001|Overall Study|Lost to Follow-up|1|||
145747739|NCT00590590|525592482|FG002|Overall Study|Lost to Follow-up|2|||
145747740|NCT00590590|525592480|FG000|Overall Study|Withdrawal by Subject|0|||
145747741|NCT00590590|525592481|FG001|Overall Study|Withdrawal by Subject|1|||
145747742|NCT00590590|525592482|FG002|Overall Study|Withdrawal by Subject|1|||
145747743|NCT00590590|525592480|FG000|Overall Study|Did not complete due to study closure|1|||
145747744|NCT00590590|525592481|FG001|Overall Study|Did not complete due to study closure|1|||
145747745|NCT00590590|525592482|FG002|Overall Study|Did not complete due to study closure|1|||
145747746|NCT00590590|525592480|FG000|Overall Study|Did not complete study|0|||
145747747|NCT00590590|525592481|FG001|Overall Study|Did not complete study|1|||
145747748|NCT00590590|525592482|FG002|Overall Study|Did not complete study|0|||
145747749|NCT00132132|525592483|FG000|Overall Study|Lost to Follow-up|7|||
145747750|NCT00132132|525592484|FG001|Overall Study|Lost to Follow-up|2|||
145747751|NCT01870401|525592485|FG000|Overall Study|Death|48|||
145747752|NCT01870401|525592486|FG001|Overall Study|Death|24|||
145747753|NCT01870401|525592485|FG000|Overall Study|Withdrawal by Subject|39|||
145747754|NCT01870401|525592486|FG001|Overall Study|Withdrawal by Subject|26|||
145747755|NCT01870401|525592485|FG000|Overall Study|Lost to Follow-up|19|||
145747756|NCT01870401|525592486|FG001|Overall Study|Lost to Follow-up|14|||
145747757|NCT01870401|525592485|FG000|Overall Study|Other|9|||
145747758|NCT01870401|525592486|FG001|Overall Study|Other|7|||
145747759|NCT01870401|525592485|FG000|Overall Study|On-going in the Study|35|||
145747760|NCT01870401|525592486|FG001|Overall Study|On-going in the Study|25|||
145747761|NCT00915681|525592491|FG000|Overall Study|Screening failures|46|||
145747762|NCT03221751|525592492|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
145747763|NCT03221751|525592493|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
145747764|NCT00535132|525592496|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
145747765|NCT00535132|525592497|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
145747766|NCT00535132|525592496|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
145747767|NCT00535132|525592497|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
145747768|NCT00267748|525592501|FG000|Non-randomized Period|Progressive disease|10|||
145747769|NCT00267748|525592502|FG001|Non-randomized Period|Progressive disease|0|||
145747770|NCT00267748|525592503|FG002|Non-randomized Period|Progressive disease|0|||
145402610|NCT05965752|524330805|FG000|Overall Study|Adverse Event|0|||
145747771|NCT00267748|525592501|FG000|Non-randomized Period|Adverse Event|8|||
145747772|NCT00267748|525592502|FG001|Non-randomized Period|Adverse Event|0|||
145747773|NCT00267748|525592503|FG002|Non-randomized Period|Adverse Event|0|||
145747774|NCT00267748|525592501|FG000|Non-randomized Period|Death|1|||
145747775|NCT00267748|525592502|FG001|Non-randomized Period|Death|0|||
145747776|NCT00267748|525592503|FG002|Non-randomized Period|Death|0|||
145747777|NCT00267748|525592501|FG000|Non-randomized Period|Participant not willing to participate|1|||
145747778|NCT00267748|525592502|FG001|Non-randomized Period|Participant not willing to participate|0|||
145747779|NCT00267748|525592503|FG002|Non-randomized Period|Participant not willing to participate|0|||
145747780|NCT00267748|525592501|FG000|Non-randomized Period|Other|3|||
145747781|NCT00267748|525592502|FG001|Non-randomized Period|Other|0|||
145747782|NCT00267748|525592503|FG002|Non-randomized Period|Other|0|||
145747783|NCT00267748|525592501|FG000|Randomized Period|Death|0|||
145747784|NCT00267748|525592502|FG001|Randomized Period|Death|2|||
145747785|NCT00267748|525592503|FG002|Randomized Period|Death|3|||
145747786|NCT00267748|525592501|FG000|Randomized Period|Adverse Event|0|||
145747787|NCT00267748|525592502|FG001|Randomized Period|Adverse Event|23|||
145747788|NCT00267748|525592503|FG002|Randomized Period|Adverse Event|25|||
145747789|NCT00267748|525592501|FG000|Randomized Period|Global deterioration of health status|0|||
145747790|NCT00267748|525592502|FG001|Randomized Period|Global deterioration of health status|6|||
145747791|NCT00267748|525592503|FG002|Randomized Period|Global deterioration of health status|7|||
145747792|NCT00267748|525592501|FG000|Randomized Period|Lost to Follow-up|0|||
145747793|NCT00267748|525592502|FG001|Randomized Period|Lost to Follow-up|1|||
145747794|NCT00267748|525592503|FG002|Randomized Period|Lost to Follow-up|0|||
145747795|NCT00267748|525592501|FG000|Randomized Period|Objective progression or relapse|0|||
145747796|NCT00267748|525592502|FG001|Randomized Period|Objective progression or relapse|77|||
145747797|NCT00267748|525592503|FG002|Randomized Period|Objective progression or relapse|86|||
145747798|NCT00267748|525592501|FG000|Randomized Period|Withdrawal by Subject|0|||
145747799|NCT00267748|525592502|FG001|Randomized Period|Withdrawal by Subject|9|||
145747800|NCT00267748|525592503|FG002|Randomized Period|Withdrawal by Subject|2|||
145747801|NCT00267748|525592501|FG000|Randomized Period|Other|0|||
145747802|NCT00267748|525592502|FG001|Randomized Period|Other|9|||
145747803|NCT00267748|525592503|FG002|Randomized Period|Other|6|||
145747804|NCT00267748|525592501|FG000|Randomized Period|randomized but not treated|0|||
145747805|NCT00267748|525592502|FG001|Randomized Period|randomized but not treated|0|||
145747806|NCT00267748|525592503|FG002|Randomized Period|randomized but not treated|3|||
145747807|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
145747808|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
145747809|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
145747810|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
145747811|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
145747812|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
145747813|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
145747814|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
145747815|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
145747816|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
145747817|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
145747818|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
145747819|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
145747820|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
145747821|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
145747822|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
145747823|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
145747824|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
145747825|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
145747826|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
145747827|NCT02706873|525592504|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
145747828|NCT02706873|525592505|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
145747829|NCT02706873|525592506|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
145747830|NCT02706873|525592507|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
145747831|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
145747832|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
145747833|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
145747834|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
145747835|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
145747836|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
145747837|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
145747838|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
145747839|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
145747840|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
145747841|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
145747842|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
145747843|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
145747844|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
145747845|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
145747846|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
145747847|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
145747848|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
145747849|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
145747850|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
145747851|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
145747852|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
145747853|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
145747854|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
145747855|NCT02706873|525592504|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
145747856|NCT02706873|525592505|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
145747857|NCT02706873|525592506|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
145747858|NCT02706873|525592507|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
145747859|NCT05098041|525592508|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
145747860|NCT00464334|525592513|FG000|Overall Study|Adverse Event|0|||
145747861|NCT00464334|525592514|FG001|Overall Study|Adverse Event|0|||
145747862|NCT00464334|525592515|FG002|Overall Study|Adverse Event|0|||
145747863|NCT00464334|525592516|FG003|Overall Study|Adverse Event|1|||
145747864|NCT00464334|525592517|FG004|Overall Study|Adverse Event|1|||
145747865|NCT00464334|525592518|FG005|Overall Study|Adverse Event|1|||
145747866|NCT00464334|525592519|FG006|Overall Study|Adverse Event|0|||
145747867|NCT00464334|525592520|FG007|Overall Study|Adverse Event|0|||
145747868|NCT00464334|525592521|FG008|Overall Study|Adverse Event|2|||
145747869|NCT00464334|525592522|FG009|Overall Study|Adverse Event|1|||
145747870|NCT00464334|525592523|FG010|Overall Study|Adverse Event|2|||
145747871|NCT00464334|525592513|FG000|Overall Study|Lack of Efficacy|0|||
145747872|NCT00464334|525592514|FG001|Overall Study|Lack of Efficacy|1|||
145747873|NCT00464334|525592515|FG002|Overall Study|Lack of Efficacy|0|||
145747874|NCT00464334|525592516|FG003|Overall Study|Lack of Efficacy|0|||
145747875|NCT00464334|525592517|FG004|Overall Study|Lack of Efficacy|0|||
145747876|NCT00464334|525592518|FG005|Overall Study|Lack of Efficacy|0|||
145747877|NCT00464334|525592519|FG006|Overall Study|Lack of Efficacy|0|||
145747878|NCT00464334|525592520|FG007|Overall Study|Lack of Efficacy|0|||
145747879|NCT00464334|525592521|FG008|Overall Study|Lack of Efficacy|0|||
145747880|NCT00464334|525592522|FG009|Overall Study|Lack of Efficacy|0|||
145747881|NCT00464334|525592523|FG010|Overall Study|Lack of Efficacy|0|||
145747882|NCT00464334|525592513|FG000|Overall Study|Lost to Follow-up|0|||
145747883|NCT00464334|525592514|FG001|Overall Study|Lost to Follow-up|0|||
145747884|NCT00464334|525592515|FG002|Overall Study|Lost to Follow-up|1|||
145747885|NCT00464334|525592516|FG003|Overall Study|Lost to Follow-up|0|||
145747886|NCT00464334|525592517|FG004|Overall Study|Lost to Follow-up|1|||
145747887|NCT00464334|525592518|FG005|Overall Study|Lost to Follow-up|0|||
145747888|NCT00464334|525592519|FG006|Overall Study|Lost to Follow-up|1|||
145747889|NCT00464334|525592520|FG007|Overall Study|Lost to Follow-up|0|||
145747890|NCT00464334|525592521|FG008|Overall Study|Lost to Follow-up|0|||
145747891|NCT00464334|525592522|FG009|Overall Study|Lost to Follow-up|0|||
145747892|NCT00464334|525592523|FG010|Overall Study|Lost to Follow-up|2|||
145747893|NCT00464334|525592513|FG000|Overall Study|Progressive Disease|0|||
145747894|NCT00464334|525592514|FG001|Overall Study|Progressive Disease|0|||
145747895|NCT00464334|525592515|FG002|Overall Study|Progressive Disease|0|||
145747896|NCT00464334|525592516|FG003|Overall Study|Progressive Disease|0|||
145747897|NCT00464334|525592517|FG004|Overall Study|Progressive Disease|0|||
145747898|NCT00464334|525592518|FG005|Overall Study|Progressive Disease|1|||
145747899|NCT00464334|525592519|FG006|Overall Study|Progressive Disease|0|||
145747900|NCT00464334|525592520|FG007|Overall Study|Progressive Disease|0|||
145747901|NCT00464334|525592521|FG008|Overall Study|Progressive Disease|1|||
145747902|NCT00464334|525592522|FG009|Overall Study|Progressive Disease|0|||
145747903|NCT00464334|525592523|FG010|Overall Study|Progressive Disease|0|||
145747904|NCT00464334|525592513|FG000|Overall Study|Study Terminated by Sponsor|0|||
145747905|NCT00464334|525592514|FG001|Overall Study|Study Terminated by Sponsor|0|||
145747906|NCT00464334|525592515|FG002|Overall Study|Study Terminated by Sponsor|0|||
145747907|NCT00464334|525592516|FG003|Overall Study|Study Terminated by Sponsor|1|||
145747908|NCT00464334|525592517|FG004|Overall Study|Study Terminated by Sponsor|0|||
145747909|NCT00464334|525592518|FG005|Overall Study|Study Terminated by Sponsor|0|||
145747910|NCT00464334|525592519|FG006|Overall Study|Study Terminated by Sponsor|0|||
145747911|NCT00464334|525592520|FG007|Overall Study|Study Terminated by Sponsor|0|||
145747912|NCT00464334|525592521|FG008|Overall Study|Study Terminated by Sponsor|0|||
145747913|NCT00464334|525592522|FG009|Overall Study|Study Terminated by Sponsor|0|||
145747914|NCT00464334|525592523|FG010|Overall Study|Study Terminated by Sponsor|0|||
145747915|NCT00464334|525592513|FG000|Overall Study|Withdrawal by Subject|1|||
145747916|NCT00464334|525592514|FG001|Overall Study|Withdrawal by Subject|7|||
145747917|NCT00464334|525592515|FG002|Overall Study|Withdrawal by Subject|4|||
145747918|NCT00464334|525592516|FG003|Overall Study|Withdrawal by Subject|2|||
145747919|NCT00464334|525592517|FG004|Overall Study|Withdrawal by Subject|2|||
145747920|NCT00464334|525592518|FG005|Overall Study|Withdrawal by Subject|2|||
145747921|NCT00464334|525592519|FG006|Overall Study|Withdrawal by Subject|2|||
145747922|NCT00464334|525592520|FG007|Overall Study|Withdrawal by Subject|1|||
145747923|NCT00464334|525592521|FG008|Overall Study|Withdrawal by Subject|3|||
145747924|NCT00464334|525592522|FG009|Overall Study|Withdrawal by Subject|0|||
145747925|NCT00464334|525592523|FG010|Overall Study|Withdrawal by Subject|0|||
145747926|NCT03948178|525592526|FG000|Overall Study|Protocol Violation|1|||
145747927|NCT03948178|525592526|FG000|Overall Study|Lost to Follow-up|2|||
145747928|NCT03948178|525592526|FG000|Overall Study|Withdrawal by Subject|2|||
145747929|NCT03948178|525592526|FG000|Overall Study|Reason not known|2|||
145747930|NCT03948178|525592526|FG000|Overall Study|Personal reason|14|||
145747931|NCT03948178|525592526|FG000|Overall Study|Disease progression|30|||
145747932|NCT03948178|525592526|FG000|Overall Study|Adverse Event|12|||
145747933|NCT03948178|525592526|FG000|Overall Study|Sponsor terminated study|164|||
145747934|NCT01297270|525592527|FG000|Overall Study|Adverse Event|19|||
145747935|NCT01297270|525592528|FG001|Overall Study|Adverse Event|32|||
145747936|NCT01297270|525592529|FG002|Overall Study|Adverse Event|5|||
145747937|NCT01297270|525592527|FG000|Overall Study|Lack of Efficacy|15|||
145747938|NCT01297270|525592528|FG001|Overall Study|Lack of Efficacy|17|||
145747939|NCT01297270|525592529|FG002|Overall Study|Lack of Efficacy|15|||
145747940|NCT01297270|525592527|FG000|Overall Study|Lost to Follow-up|1|||
145747941|NCT01297270|525592528|FG001|Overall Study|Lost to Follow-up|2|||
145747942|NCT01297270|525592529|FG002|Overall Study|Lost to Follow-up|1|||
145747943|NCT01297270|525592527|FG000|Overall Study|Protocol Violation|0|||
145747944|NCT01297270|525592528|FG001|Overall Study|Protocol Violation|2|||
145747945|NCT01297270|525592529|FG002|Overall Study|Protocol Violation|0|||
145747946|NCT01297270|525592527|FG000|Overall Study|Withdrawal by Subject|7|||
145747947|NCT01297270|525592528|FG001|Overall Study|Withdrawal by Subject|15|||
145747948|NCT01297270|525592529|FG002|Overall Study|Withdrawal by Subject|7|||
145747949|NCT01297270|525592527|FG000|Overall Study|Other reason not defined above|3|||
145747950|NCT01297270|525592528|FG001|Overall Study|Other reason not defined above|3|||
145747951|NCT01297270|525592529|FG002|Overall Study|Other reason not defined above|1|||
145747952|NCT01297270|525592527|FG000|Overall Study|Not treated|0|||
145747953|NCT01297270|525592528|FG001|Overall Study|Not treated|1|||
145747954|NCT01297270|525592529|FG002|Overall Study|Not treated|0|||
145747955|NCT00382993|525592530|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
145747956|NCT00382993|525592531|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
145747957|NCT00382993|525592530|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
145747958|NCT00382993|525592531|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
145747959|NCT00382993|525592530|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
145747960|NCT00382993|525592531|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
145747961|NCT00382993|525592530|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
145747962|NCT00382993|525592531|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
145747963|NCT00382993|525592530|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
145747964|NCT00382993|525592531|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
145747965|NCT00382993|525592530|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
145747966|NCT00382993|525592531|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
145747967|NCT00382993|525592530|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
145747968|NCT00382993|525592531|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
145747969|NCT00382993|525592530|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
145747970|NCT00382993|525592531|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
145747971|NCT00382993|525592530|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
145747972|NCT00382993|525592531|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
145747973|NCT00382993|525592530|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
145747974|NCT00382993|525592531|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
145747975|NCT01965262|525592538|FG000|Second Intervention (7 Days)|Discontinued|0|||
145747976|NCT01965262|525592539|FG001|Second Intervention (7 Days)|Discontinued|1|||
145747977|NCT01965262|525592538|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
145747978|NCT01965262|525592539|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
145747979|NCT01965262|525592538|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
145747980|NCT01965262|525592539|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
145747981|NCT00906087|525592545|FG000|Initial Washout|Withdrawal by Subject|1|||
145747982|NCT00906087|525592545|FG000|Initial Washout|Physician Decision|1|||
145747983|NCT04839380|525592554|FG000|Overall Study|Withdrawal by Subject|2|||
145747984|NCT04839380|525592554|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
145747985|NCT01347554|525592555|FG000|Overall Study|Lack of Efficacy|7|||
145747986|NCT01347554|525592556|FG001|Overall Study|Lack of Efficacy|11|||
145747987|NCT00004259|525592559|FG000|Overall Study|Protocol Violation|1|||
145747988|NCT00004259|525592560|FG001|Overall Study|Protocol Violation|2|||
145747989|NCT00004259|525592561|FG002|Overall Study|Protocol Violation|0|||
145747990|NCT00004259|525592562|FG003|Overall Study|Protocol Violation|0|||
145747991|NCT00004259|525592559|FG000|Overall Study|Withdrawal by Subject|0|||
145747992|NCT00004259|525592560|FG001|Overall Study|Withdrawal by Subject|2|||
145747993|NCT00004259|525592561|FG002|Overall Study|Withdrawal by Subject|0|||
145747994|NCT00004259|525592562|FG003|Overall Study|Withdrawal by Subject|0|||
145747995|NCT01902290|525592567|FG000|Overall Study|Withdrawal by Subject|19|||
145747996|NCT01902290|525592568|FG001|Overall Study|Withdrawal by Subject|27|||
145747997|NCT01902290|525592567|FG000|Overall Study|Lost to Follow-up|2|||
145747998|NCT01902290|525592568|FG001|Overall Study|Lost to Follow-up|2|||
145747999|NCT01902290|525592567|FG000|Overall Study|Death|1|||
145748000|NCT01902290|525592568|FG001|Overall Study|Death|0|||
145748001|NCT01902290|525592567|FG000|Overall Study|Sponsor Decision|26|||
145748002|NCT01902290|525592568|FG001|Overall Study|Sponsor Decision|24|||
145748003|NCT00517829|525592569|FG000|Overall Study|Adverse Event|22|||
145748004|NCT00517829|525592570|FG001|Overall Study|Adverse Event|34|||
145748005|NCT00517829|525592569|FG000|Overall Study|Disease Progression|39|||
145748006|NCT00517829|525592570|FG001|Overall Study|Disease Progression|32|||
145748007|NCT00517829|525592569|FG000|Overall Study|Patient Request|6|||
145748008|NCT00517829|525592570|FG001|Overall Study|Patient Request|5|||
145748009|NCT00517829|525592569|FG000|Overall Study|Investigator Request|5|||
145748010|NCT00517829|525592570|FG001|Overall Study|Investigator Request|3|||
145748011|NCT00517829|525592569|FG000|Overall Study|Other|3|||
145748012|NCT00517829|525592570|FG001|Overall Study|Other|1|||
145748013|NCT00109707|525592575|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
145748014|NCT00109707|525592576|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
145748015|NCT00109707|525592577|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
145748016|NCT00109707|525592575|FG000|Overall Study|Abnormal laboratory values|1|||
145748017|NCT00109707|525592576|FG001|Overall Study|Abnormal laboratory values|0|||
145748018|NCT00109707|525592577|FG002|Overall Study|Abnormal laboratory values|0|||
145748019|NCT00109707|525592575|FG000|Overall Study|Administrative problems|2|||
145748020|NCT00109707|525592576|FG001|Overall Study|Administrative problems|0|||
145748021|NCT00109707|525592577|FG002|Overall Study|Administrative problems|1|||
145748022|NCT00109707|525592575|FG000|Overall Study|Adverse Event|10|||
145748023|NCT00109707|525592576|FG001|Overall Study|Adverse Event|2|||
145748024|NCT00109707|525592577|FG002|Overall Study|Adverse Event|3|||
145748025|NCT00109707|525592575|FG000|Overall Study|Death|4|||
145748026|NCT00109707|525592576|FG001|Overall Study|Death|0|||
145748027|NCT00109707|525592577|FG002|Overall Study|Death|0|||
145748028|NCT00109707|525592575|FG000|Overall Study|Disease progression|12|||
145748029|NCT00109707|525592576|FG001|Overall Study|Disease progression|4|||
145748030|NCT00109707|525592577|FG002|Overall Study|Disease progression|3|||
145748031|NCT00109707|525592575|FG000|Overall Study|Lost to Follow-up|3|||
145748032|NCT00109707|525592576|FG001|Overall Study|Lost to Follow-up|0|||
145748033|NCT00109707|525592577|FG002|Overall Study|Lost to Follow-up|0|||
145748034|NCT00109707|525592575|FG000|Overall Study|Protocol Violation|1|||
145748035|NCT00109707|525592576|FG001|Overall Study|Protocol Violation|0|||
145748036|NCT00109707|525592577|FG002|Overall Study|Protocol Violation|0|||
145748037|NCT00109707|525592575|FG000|Overall Study|Patient withdrew consent|6|||
145748038|NCT00109707|525592576|FG001|Overall Study|Patient withdrew consent|1|||
145748039|NCT00109707|525592577|FG002|Overall Study|Patient withdrew consent|0|||
145748040|NCT02443883|525592582|FG000|Overall Study|Adverse Event|0|||
145748041|NCT02443883|525592583|FG001|Overall Study|Adverse Event|1|||
145748042|NCT02443883|525592584|FG002|Overall Study|Adverse Event|0|||
145748043|NCT02443883|525592585|FG003|Overall Study|Adverse Event|0|||
145748044|NCT02443883|525592582|FG000|Overall Study|Lost to Follow-up|3|||
145748045|NCT02443883|525592583|FG001|Overall Study|Lost to Follow-up|2|||
145748046|NCT02443883|525592584|FG002|Overall Study|Lost to Follow-up|1|||
145748047|NCT02443883|525592585|FG003|Overall Study|Lost to Follow-up|0|||
145748048|NCT02443883|525592582|FG000|Overall Study|Physician Decision|1|||
145748049|NCT02443883|525592583|FG001|Overall Study|Physician Decision|1|||
145748050|NCT02443883|525592584|FG002|Overall Study|Physician Decision|0|||
145748051|NCT02443883|525592585|FG003|Overall Study|Physician Decision|3|||
145748052|NCT02443883|525592582|FG000|Overall Study|Withdrawal by Subject|1|||
145748053|NCT02443883|525592583|FG001|Overall Study|Withdrawal by Subject|0|||
145748054|NCT02443883|525592584|FG002|Overall Study|Withdrawal by Subject|0|||
145271093|NCT00539006|523839613|FG003|Washout|Other|3|||
145748055|NCT02443883|525592585|FG003|Overall Study|Withdrawal by Subject|2|||
145748056|NCT02443883|525592582|FG000|Overall Study|Randomized, but never treated|1|||
145748057|NCT02443883|525592583|FG001|Overall Study|Randomized, but never treated|0|||
145748058|NCT02443883|525592584|FG002|Overall Study|Randomized, but never treated|0|||
145748059|NCT02443883|525592585|FG003|Overall Study|Randomized, but never treated|0|||
145748060|NCT02199080|525592586|FG000|Overall Study|Protocol Violation|12|||
145748061|NCT02250274|525592587|FG000|Overall Study|Insufficient blood draw amount|7|||
145748062|NCT02250274|525592588|FG001|Overall Study|Insufficient blood draw amount|6|||
145748063|NCT00446511|525592591|FG000|Overall Study|Adverse Event|7|||
145748064|NCT00446511|525592592|FG001|Overall Study|Adverse Event|2|||
145748065|NCT00446511|525592593|FG002|Overall Study|Adverse Event|3|||
145748066|NCT00446511|525592594|FG003|Overall Study|Adverse Event|1|||
145748067|NCT00446511|525592591|FG000|Overall Study|Protocol Violation|0|||
145748068|NCT00446511|525592592|FG001|Overall Study|Protocol Violation|0|||
145748069|NCT00446511|525592593|FG002|Overall Study|Protocol Violation|0|||
145748070|NCT00446511|525592594|FG003|Overall Study|Protocol Violation|1|||
145748071|NCT00446511|525592591|FG000|Overall Study|Withdrawal by Subject|0|||
145748072|NCT00446511|525592592|FG001|Overall Study|Withdrawal by Subject|0|||
145748073|NCT00446511|525592593|FG002|Overall Study|Withdrawal by Subject|0|||
145748074|NCT00446511|525592594|FG003|Overall Study|Withdrawal by Subject|3|||
145748075|NCT00446511|525592591|FG000|Overall Study|Administrative Problems|3|||
145748076|NCT00446511|525592592|FG001|Overall Study|Administrative Problems|0|||
145748077|NCT00446511|525592593|FG002|Overall Study|Administrative Problems|4|||
145748078|NCT00446511|525592594|FG003|Overall Study|Administrative Problems|1|||
145748079|NCT00835237|525592597|FG000|Overall Study|Lost to Follow-up|4|||
145748080|NCT00835237|525592598|FG001|Overall Study|Lost to Follow-up|0|||
145748081|NCT00835237|525592597|FG000|Overall Study|Withdrawal by Subject|2|||
145748082|NCT00835237|525592598|FG001|Overall Study|Withdrawal by Subject|0|||
145748083|NCT01265550|525592601|FG000|Pre Randomization|Withdrawal by Subject|0|||
145748084|NCT01265550|525592602|FG001|Pre Randomization|Withdrawal by Subject|0|||
145748085|NCT01265550|525592603|FG002|Pre Randomization|Withdrawal by Subject|0|||
145748086|NCT01265550|525592604|FG003|Pre Randomization|Withdrawal by Subject|70|||
145748087|NCT01265550|525592601|FG000|Pre Randomization|Technical Exclusions|0|||
145748088|NCT01265550|525592602|FG001|Pre Randomization|Technical Exclusions|0|||
145748089|NCT01265550|525592603|FG002|Pre Randomization|Technical Exclusions|0|||
145748090|NCT01265550|525592604|FG003|Pre Randomization|Technical Exclusions|54|||
145748091|NCT01265550|525592601|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
145748092|NCT01265550|525592602|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
145748093|NCT01265550|525592603|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
145748094|NCT01265550|525592604|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
145748095|NCT01265550|525592601|FG000|Pre Randomization|Non-GERD organic disorders|0|||
145748096|NCT01265550|525592602|FG001|Pre Randomization|Non-GERD organic disorders|0|||
145748097|NCT01265550|525592603|FG002|Pre Randomization|Non-GERD organic disorders|0|||
145748098|NCT01265550|525592604|FG003|Pre Randomization|Non-GERD organic disorders|23|||
145748099|NCT01265550|525592601|FG000|Pre Randomization|Functional heartburn|0|||
145748100|NCT01265550|525592602|FG001|Pre Randomization|Functional heartburn|0|||
145748101|NCT01265550|525592603|FG002|Pre Randomization|Functional heartburn|0|||
145748102|NCT01265550|525592604|FG003|Pre Randomization|Functional heartburn|99|||
145748103|NCT01627860|525592605|FG000|Overall Study|Adverse Event|9|||
145748104|NCT01627860|525592606|FG001|Overall Study|Adverse Event|4|||
145748105|NCT01627860|525592605|FG000|Overall Study|Withdrawal by Subject|2|||
145748106|NCT01627860|525592606|FG001|Overall Study|Withdrawal by Subject|1|||
145748107|NCT01627860|525592605|FG000|Overall Study|Seizure frequency doubled|0|||
145748108|NCT01627860|525592606|FG001|Overall Study|Seizure frequency doubled|1|||
145748109|NCT01627860|525592605|FG000|Overall Study|Protocol Violation|1|||
145748110|NCT01627860|525592606|FG001|Overall Study|Protocol Violation|0|||
145748111|NCT01326546|525592607|FG000|Overall Study|Lost to Follow-up|8|||
145748112|NCT01326546|525592608|FG001|Overall Study|Lost to Follow-up|7|||
145748113|NCT01326546|525592607|FG000|Overall Study|Protocol Violation|3|||
145748114|NCT01326546|525592608|FG001|Overall Study|Protocol Violation|4|||
145748115|NCT01326546|525592607|FG000|Overall Study|Pregnancy|0|||
145748116|NCT01326546|525592608|FG001|Overall Study|Pregnancy|1|||
145748117|NCT01326546|525592607|FG000|Overall Study|Adverse Event|1|||
145748118|NCT01326546|525592608|FG001|Overall Study|Adverse Event|0|||
145748119|NCT01326546|525592607|FG000|Overall Study|Withdrawal by Subject|5|||
145748120|NCT01326546|525592608|FG001|Overall Study|Withdrawal by Subject|1|||
145748121|NCT03152019|525592609|FG000|Overall Study|Adverse Event|0|||
145748122|NCT03152019|525592610|FG001|Overall Study|Adverse Event|1|||
145748123|NCT00923130|525592615|FG000|Overall Study|Stopped treatment due to progression|17|||
145748124|NCT00923130|525592615|FG000|Overall Study|Death|1|||
145748125|NCT00923130|525592615|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
145748126|NCT00923130|525592615|FG000|Overall Study|Switched to alternative treatment|2|||
145748127|NCT00923130|525592615|FG000|Overall Study|Refused further treatment|2|||
145748128|NCT00894556|525592616|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
145748129|NCT00894556|525592617|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
145748130|NCT00894556|525592618|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
145748131|NCT00894556|525592619|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
145748132|NCT00894556|525592616|FG000|Treatment Phase|Lost to Follow-up|2|||
145748133|NCT00894556|525592617|FG001|Treatment Phase|Lost to Follow-up|3|||
145748134|NCT00894556|525592618|FG002|Treatment Phase|Lost to Follow-up|1|||
145748135|NCT00894556|525592619|FG003|Treatment Phase|Lost to Follow-up|0|||
145748136|NCT00894556|525592616|FG000|Treatment Phase|Lack of Qualifying Event|2|||
145748137|NCT00894556|525592617|FG001|Treatment Phase|Lack of Qualifying Event|1|||
145748138|NCT00894556|525592618|FG002|Treatment Phase|Lack of Qualifying Event|0|||
145748139|NCT00894556|525592619|FG003|Treatment Phase|Lack of Qualifying Event|0|||
145748140|NCT01014689|525592622|FG000|Overall Study|Lack of Efficacy|0|||
145748141|NCT01014689|525592623|FG001|Overall Study|Lack of Efficacy|1|||
145748142|NCT01014689|525592622|FG000|Overall Study|Adverse Event|3|||
145748143|NCT01014689|525592623|FG001|Overall Study|Adverse Event|0|||
145748144|NCT01014689|525592622|FG000|Overall Study|Withdrawal by Subject|5|||
145748145|NCT01014689|525592623|FG001|Overall Study|Withdrawal by Subject|4|||
145748146|NCT01014689|525592622|FG000|Overall Study|Protocol Violation|1|||
145748147|NCT01014689|525592623|FG001|Overall Study|Protocol Violation|1|||
145748148|NCT01014689|525592622|FG000|Overall Study|Lost to Follow-up|3|||
145748149|NCT01014689|525592623|FG001|Overall Study|Lost to Follow-up|7|||
145748150|NCT01014689|525592622|FG000|Overall Study|Pregnancy|1|||
145748151|NCT01014689|525592623|FG001|Overall Study|Pregnancy|0|||
145748152|NCT00333359|525592626|FG000|Overall Study|Adverse Event|29|||
145748153|NCT00333359|525592627|FG001|Overall Study|Adverse Event|35|||
145748154|NCT00333359|525592626|FG000|Overall Study|Withdrawal by Subject|19|||
145748155|NCT00333359|525592627|FG001|Overall Study|Withdrawal by Subject|37|||
145748156|NCT00333359|525592626|FG000|Overall Study|Physician Decision|2|||
145748157|NCT00333359|525592627|FG001|Overall Study|Physician Decision|2|||
145748158|NCT00333359|525592626|FG000|Overall Study|Protocol Non-compliance|2|||
145748159|NCT00333359|525592627|FG001|Overall Study|Protocol Non-compliance|8|||
145748160|NCT00333359|525592626|FG000|Overall Study|Lost to Follow-up|15|||
145748161|NCT00333359|525592627|FG001|Overall Study|Lost to Follow-up|25|||
145748162|NCT00333359|525592626|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
145748163|NCT00333359|525592627|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
145748164|NCT00333359|525592626|FG000|Overall Study|Treatment Failure|3|||
145748165|NCT00333359|525592627|FG001|Overall Study|Treatment Failure|8|||
145748166|NCT00333359|525592626|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
145748167|NCT00333359|525592627|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
145748168|NCT00805480|525592630|FG000|Overall Study|Withdrawal by Subject|13|||
145748169|NCT00805480|525592631|FG001|Overall Study|Withdrawal by Subject|5|||
145748170|NCT00805480|525592632|FG002|Overall Study|Withdrawal by Subject|11|||
145748171|NCT00805480|525592633|FG003|Overall Study|Withdrawal by Subject|5|||
145748172|NCT00805480|525592630|FG000|Overall Study|Lost to Follow-up|1|||
145748173|NCT00805480|525592631|FG001|Overall Study|Lost to Follow-up|2|||
145748174|NCT00805480|525592632|FG002|Overall Study|Lost to Follow-up|0|||
145748175|NCT00805480|525592633|FG003|Overall Study|Lost to Follow-up|0|||
145748176|NCT00805480|525592630|FG000|Overall Study|Adverse Event|0|||
145748177|NCT00805480|525592631|FG001|Overall Study|Adverse Event|0|||
145748178|NCT00805480|525592632|FG002|Overall Study|Adverse Event|1|||
145748179|NCT00805480|525592633|FG003|Overall Study|Adverse Event|0|||
145748180|NCT01534533|525592634|FG000|Overall Study|Lost to Follow-up|3|||
145748181|NCT01534533|525592635|FG001|Overall Study|Lost to Follow-up|0|||
145748182|NCT01534533|525592636|FG002|Overall Study|Lost to Follow-up|4|||
145748183|NCT01534533|525592637|FG003|Overall Study|Lost to Follow-up|3|||
145748184|NCT01534533|525592634|FG000|Overall Study|Withdrawal by Subject|5|||
145748185|NCT01534533|525592635|FG001|Overall Study|Withdrawal by Subject|3|||
145748186|NCT01534533|525592636|FG002|Overall Study|Withdrawal by Subject|4|||
145748187|NCT01534533|525592637|FG003|Overall Study|Withdrawal by Subject|1|||
145748188|NCT04311502|525593943|FG000|Overall Study|Death|1|||
145748189|NCT04311502|525593944|FG001|Overall Study|Death|1|||
145748190|NCT04311502|525593945|FG002|Overall Study|Death|1|||
145748191|NCT04311502|525593943|FG000|Overall Study|Lost to Follow-up|2|||
145748192|NCT04311502|525593944|FG001|Overall Study|Lost to Follow-up|3|||
145748193|NCT04311502|525593945|FG002|Overall Study|Lost to Follow-up|0|||
145748194|NCT04311502|525593943|FG000|Overall Study|Participant is in prison|1|||
145748195|NCT04311502|525593944|FG001|Overall Study|Participant is in prison|0|||
145748196|NCT04311502|525593945|FG002|Overall Study|Participant is in prison|0|||
145748197|NCT04311502|525593943|FG000|Overall Study|Participant moved out of country|1|||
145748198|NCT04311502|525593944|FG001|Overall Study|Participant moved out of country|0|||
145748199|NCT04311502|525593945|FG002|Overall Study|Participant moved out of country|0|||
145402611|NCT05965752|524330806|FG001|Overall Study|Adverse Event|1|||
145402612|NCT05965752|524330807|FG002|Overall Study|Adverse Event|0|||
145402613|NCT05965752|524330808|FG003|Overall Study|Adverse Event|1|||
145402614|NCT05965752|524330809|FG004|Overall Study|Adverse Event|3|||
145748200|NCT04311502|525593943|FG000|Overall Study|Withdrawal by Subject|2|||
145748201|NCT04311502|525593944|FG001|Overall Study|Withdrawal by Subject|0|||
145748202|NCT04311502|525593945|FG002|Overall Study|Withdrawal by Subject|0|||
145748203|NCT04311502|525593943|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
145748204|NCT04311502|525593944|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
145402615|NCT05965752|524330805|FG000|Overall Study|Lost to Follow-up|2|||
145748205|NCT04311502|525593945|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
145748206|NCT03040999|525593946|FG000|Overall Study|Lost to Follow-up|2|||
145748207|NCT03040999|525593947|FG001|Overall Study|Lost to Follow-up|2|||
145748208|NCT03040999|525593946|FG000|Overall Study|Withdrawal by Subject|12|||
145748209|NCT03040999|525593947|FG001|Overall Study|Withdrawal by Subject|13|||
145402616|NCT05965752|524330806|FG001|Overall Study|Lost to Follow-up|0|||
145748210|NCT03040999|525593946|FG000|Overall Study|Death|155|||
145748211|NCT03040999|525593947|FG001|Overall Study|Death|171|||
145748212|NCT03040999|525593946|FG000|Overall Study|Physician Decision|0|||
145748213|NCT03040999|525593947|FG001|Overall Study|Physician Decision|3|||
145748214|NCT01979523|525593948|FG000|Overall Study|Withdrawal by Subject|1|||
145748215|NCT01979523|525593949|FG001|Overall Study|Withdrawal by Subject|0|||
145748216|NCT01137773|525593950|FG000|Overall Study|Death|3|||
145748217|NCT01137773|525593951|FG001|Overall Study|Death|3|||
145748218|NCT01137773|525593950|FG000|Overall Study|Lost to Follow-up|6|||
145748219|NCT01137773|525593951|FG001|Overall Study|Lost to Follow-up|0|||
145748220|NCT03548051|525593952|FG000|Overall Study|Death|1|||
145748221|NCT03548051|525593953|FG001|Overall Study|Death|1|||
145748222|NCT03548051|525593952|FG000|Overall Study|Withdrawal by Subject|1|||
145748223|NCT03548051|525593953|FG001|Overall Study|Withdrawal by Subject|0|||
145748224|NCT00817531|525593955|FG000|Overall Study|Adverse Event|1|||
145748225|NCT00817531|525593955|FG000|Overall Study|Lack of Efficacy|1|||
145748226|NCT02239939|525593956|FG000|Overall Study|Adverse Event|1|||
145748227|NCT02239939|525593957|FG001|Overall Study|Adverse Event|0|||
145748228|NCT02239939|525593956|FG000|Overall Study|Withdrawal by Subject|1|||
145748229|NCT02239939|525593957|FG001|Overall Study|Withdrawal by Subject|1|||
145748230|NCT02239939|525593956|FG000|Overall Study|Lost to Follow-up|0|||
145748231|NCT02239939|525593957|FG001|Overall Study|Lost to Follow-up|1|||
145748232|NCT03325673|525593959|FG000|Overall Study|Adverse Event|4|||
145748233|NCT03325673|525593960|FG001|Overall Study|Adverse Event|0|||
145748234|NCT02590588|525593963|FG000|Overall Study|Adverse Event|1|||
145748235|NCT02559687|525593971|FG000|Overall Study|Death|112|||
145748236|NCT02559687|525593971|FG000|Overall Study|Sponsor Decision|5|||
145748237|NCT02559687|525593971|FG000|Overall Study|Withdrawal by Subject|4|||
145748238|NCT05630937|525593972|FG000|Overall Study|Study terminated by sponsor|1|||
145748239|NCT05630937|525593973|FG001|Overall Study|Study terminated by sponsor|1|||
145748240|NCT05630937|525593974|FG002|Overall Study|Study terminated by sponsor|8|||
145748241|NCT05630937|525593975|FG003|Overall Study|Study terminated by sponsor|0|||
145748242|NCT05630937|525593972|FG000|Overall Study|Lost to Follow-up|0|||
145748243|NCT05630937|525593973|FG001|Overall Study|Lost to Follow-up|0|||
145748244|NCT05630937|525593974|FG002|Overall Study|Lost to Follow-up|1|||
145748245|NCT05630937|525593975|FG003|Overall Study|Lost to Follow-up|0|||
145748246|NCT05630937|525593972|FG000|Overall Study|Enrolled but not treated|0|||
145748247|NCT05630937|525593973|FG001|Overall Study|Enrolled but not treated|0|||
145748248|NCT05630937|525593974|FG002|Overall Study|Enrolled but not treated|0|||
145748249|NCT05630937|525593975|FG003|Overall Study|Enrolled but not treated|1|||
145748250|NCT03245450|525593978|FG000|Overall Study|Radiological disease progression|3|||
145748251|NCT03245450|525593979|FG001|Overall Study|Radiological disease progression|3|||
145748252|NCT03245450|525593980|FG002|Overall Study|Radiological disease progression|2|||
145748253|NCT03245450|525593981|FG003|Overall Study|Radiological disease progression|2|||
145748254|NCT03245450|525593982|FG004|Overall Study|Radiological disease progression|7|||
145748255|NCT03245450|525593983|FG005|Overall Study|Radiological disease progression|6|||
145748256|NCT03245450|525593984|FG006|Overall Study|Radiological disease progression|6|||
145748257|NCT03245450|525593978|FG000|Overall Study|Clinical disease progression|0|||
145748258|NCT03245450|525593979|FG001|Overall Study|Clinical disease progression|0|||
145748259|NCT03245450|525593980|FG002|Overall Study|Clinical disease progression|1|||
145748260|NCT03245450|525593981|FG003|Overall Study|Clinical disease progression|0|||
145748261|NCT03245450|525593982|FG004|Overall Study|Clinical disease progression|0|||
145748262|NCT03245450|525593983|FG005|Overall Study|Clinical disease progression|2|||
145748263|NCT03245450|525593984|FG006|Overall Study|Clinical disease progression|0|||
145748264|NCT03245450|525593978|FG000|Overall Study|Other|0|||
145748265|NCT03245450|525593979|FG001|Overall Study|Other|0|||
145748266|NCT03245450|525593980|FG002|Overall Study|Other|0|||
145748267|NCT03245450|525593981|FG003|Overall Study|Other|1|||
145748268|NCT03245450|525593982|FG004|Overall Study|Other|1|||
145748269|NCT03245450|525593983|FG005|Overall Study|Other|1|||
145748270|NCT03245450|525593984|FG006|Overall Study|Other|1|||
145748271|NCT03245450|525593978|FG000|Overall Study|Withdrawal by Subject|0|||
145748272|NCT03245450|525593979|FG001|Overall Study|Withdrawal by Subject|1|||
145523840|NCT02038829|524778002|FG003|Washout Period 2|Withdrawal by Subject|0|||
145748273|NCT03245450|525593980|FG002|Overall Study|Withdrawal by Subject|0|||
145748274|NCT03245450|525593981|FG003|Overall Study|Withdrawal by Subject|0|||
145748275|NCT03245450|525593982|FG004|Overall Study|Withdrawal by Subject|0|||
145748276|NCT03245450|525593983|FG005|Overall Study|Withdrawal by Subject|0|||
145748277|NCT03245450|525593984|FG006|Overall Study|Withdrawal by Subject|0|||
145748278|NCT03245450|525593978|FG000|Overall Study|Adverse Event|0|||
145748279|NCT03245450|525593979|FG001|Overall Study|Adverse Event|0|||
145748280|NCT03245450|525593980|FG002|Overall Study|Adverse Event|0|||
145748281|NCT03245450|525593981|FG003|Overall Study|Adverse Event|0|||
145748282|NCT03245450|525593982|FG004|Overall Study|Adverse Event|1|||
145748283|NCT03245450|525593983|FG005|Overall Study|Adverse Event|0|||
145748284|NCT03245450|525593984|FG006|Overall Study|Adverse Event|2|||
145748285|NCT01784861|525593987|FG000|Overall Study|Adverse Event|0|||
145748286|NCT01784861|525593988|FG001|Overall Study|Adverse Event|0|||
145748287|NCT01784861|525593989|FG002|Overall Study|Adverse Event|1|||
145748288|NCT01784861|525593990|FG003|Overall Study|Adverse Event|2|||
145748289|NCT01784861|525593991|FG004|Overall Study|Adverse Event|1|||
145748290|NCT01784861|525593992|FG005|Overall Study|Adverse Event|0|||
145748291|NCT01784861|525593987|FG000|Overall Study|Withdrawal by Subject|0|||
145748292|NCT01784861|525593988|FG001|Overall Study|Withdrawal by Subject|0|||
145748293|NCT01784861|525593989|FG002|Overall Study|Withdrawal by Subject|0|||
145748294|NCT01784861|525593990|FG003|Overall Study|Withdrawal by Subject|1|||
145748295|NCT01784861|525593991|FG004|Overall Study|Withdrawal by Subject|0|||
145748296|NCT01784861|525593992|FG005|Overall Study|Withdrawal by Subject|0|||
145748297|NCT01784861|525593987|FG000|Overall Study|Physician Decision|0|||
145748298|NCT01784861|525593988|FG001|Overall Study|Physician Decision|0|||
145748299|NCT01784861|525593989|FG002|Overall Study|Physician Decision|0|||
145748300|NCT01784861|525593990|FG003|Overall Study|Physician Decision|2|||
145748301|NCT01784861|525593991|FG004|Overall Study|Physician Decision|0|||
145748302|NCT01784861|525593992|FG005|Overall Study|Physician Decision|1|||
145748303|NCT00401752|525593993|FG000|Overall Study|Adverse Event|2|||
145748304|NCT00401752|525593994|FG001|Overall Study|Adverse Event|5|||
145748305|NCT00401752|525593993|FG000|Overall Study|Withdrawal by Subject|2|||
145748306|NCT00401752|525593994|FG001|Overall Study|Withdrawal by Subject|6|||
145748307|NCT00401752|525593993|FG000|Overall Study|Lost to Follow-up|1|||
145748308|NCT00401752|525593994|FG001|Overall Study|Lost to Follow-up|4|||
145748309|NCT00401752|525593993|FG000|Overall Study|Development of any exclusion criteria|4|||
145748310|NCT00401752|525593994|FG001|Overall Study|Development of any exclusion criteria|2|||
145748311|NCT00401752|525593993|FG000|Overall Study|Physician Decision|1|||
145748312|NCT00401752|525593994|FG001|Overall Study|Physician Decision|1|||
145748313|NCT02432235|525593995|FG000|Overall Study|Death|1|||
145748314|NCT02432235|525593996|FG001|Overall Study|Death|1|||
145748315|NCT02432235|525593997|FG002|Overall Study|Death|2|||
145748316|NCT02432235|525593998|FG003|Overall Study|Death|2|||
145748317|NCT02432235|525593999|FG004|Overall Study|Death|1|||
145748318|NCT02432235|525594000|FG005|Overall Study|Death|3|||
145748319|NCT02432235|525594001|FG006|Overall Study|Death|11|||
145748320|NCT02432235|525594002|FG007|Overall Study|Death|15|||
145748321|NCT02432235|525594003|FG008|Overall Study|Death|15|||
145748322|NCT02432235|525594004|FG009|Overall Study|Death|3|||
145748323|NCT02432235|525594005|FG010|Overall Study|Death|1|||
145748324|NCT02432235|525594006|FG011|Overall Study|Death|0|||
145748325|NCT02432235|525593995|FG000|Overall Study|Withdrawal by Subject|0|||
145748326|NCT02432235|525593996|FG001|Overall Study|Withdrawal by Subject|1|||
145748327|NCT02432235|525593997|FG002|Overall Study|Withdrawal by Subject|0|||
145748328|NCT02432235|525593998|FG003|Overall Study|Withdrawal by Subject|0|||
145748329|NCT02432235|525593999|FG004|Overall Study|Withdrawal by Subject|0|||
145748330|NCT02432235|525594000|FG005|Overall Study|Withdrawal by Subject|2|||
145748331|NCT02432235|525594001|FG006|Overall Study|Withdrawal by Subject|5|||
145748332|NCT02432235|525594002|FG007|Overall Study|Withdrawal by Subject|3|||
145748333|NCT02432235|525594003|FG008|Overall Study|Withdrawal by Subject|1|||
145748334|NCT02432235|525594004|FG009|Overall Study|Withdrawal by Subject|0|||
145748335|NCT02432235|525594005|FG010|Overall Study|Withdrawal by Subject|0|||
145748336|NCT02432235|525594006|FG011|Overall Study|Withdrawal by Subject|0|||
145748337|NCT02432235|525593995|FG000|Overall Study|Lost to Follow-up|0|||
145748338|NCT02432235|525593996|FG001|Overall Study|Lost to Follow-up|0|||
145748339|NCT02432235|525593997|FG002|Overall Study|Lost to Follow-up|0|||
145748340|NCT02432235|525593998|FG003|Overall Study|Lost to Follow-up|0|||
145748341|NCT02432235|525593999|FG004|Overall Study|Lost to Follow-up|0|||
145748342|NCT02432235|525594000|FG005|Overall Study|Lost to Follow-up|1|||
145748343|NCT02432235|525594001|FG006|Overall Study|Lost to Follow-up|0|||
145748344|NCT02432235|525594002|FG007|Overall Study|Lost to Follow-up|0|||
145748345|NCT02432235|525594003|FG008|Overall Study|Lost to Follow-up|1|||
145748346|NCT02432235|525594004|FG009|Overall Study|Lost to Follow-up|0|||
145748347|NCT02432235|525594005|FG010|Overall Study|Lost to Follow-up|0|||
145748348|NCT02432235|525594006|FG011|Overall Study|Lost to Follow-up|0|||
145748349|NCT02432235|525593995|FG000|Overall Study|Miscellaneous|0|||
145748350|NCT02432235|525593996|FG001|Overall Study|Miscellaneous|0|||
145748351|NCT02432235|525593997|FG002|Overall Study|Miscellaneous|0|||
145748352|NCT02432235|525593998|FG003|Overall Study|Miscellaneous|0|||
145748353|NCT02432235|525593999|FG004|Overall Study|Miscellaneous|1|||
145748354|NCT02432235|525594000|FG005|Overall Study|Miscellaneous|6|||
145748355|NCT02432235|525594001|FG006|Overall Study|Miscellaneous|2|||
145748356|NCT02432235|525594002|FG007|Overall Study|Miscellaneous|2|||
145748357|NCT02432235|525594003|FG008|Overall Study|Miscellaneous|4|||
145748358|NCT02432235|525594004|FG009|Overall Study|Miscellaneous|0|||
145748359|NCT02432235|525594005|FG010|Overall Study|Miscellaneous|0|||
145748360|NCT02432235|525594006|FG011|Overall Study|Miscellaneous|1|||
145748361|NCT01895322|525594007|FG000|Overall Study|Adverse Event|1|||
145748362|NCT01895322|525594007|FG000|Overall Study|Withdrawal by Subject|2|||
145748363|NCT01895322|525594007|FG000|Overall Study|Protocol Violation|10|||
145748364|NCT00143312|525594008|FG000|Overall Study|Death|11|||
145748365|NCT00143312|525594008|FG000|Overall Study|Adverse Event|2|||
145748366|NCT00143312|525594008|FG000|Overall Study|Lost to Follow-up|1|||
145748367|NCT00143312|525594008|FG000|Overall Study|Other|1|||
145748368|NCT00143312|525594008|FG000|Overall Study|Withdrawal by Subject|1|||
145748369|NCT01029366|525594009|FG000|Overall Study|Withdrawal by Subject|1|||
145748370|NCT01029366|525594010|FG001|Overall Study|Withdrawal by Subject|0|||
145748371|NCT01029366|525594009|FG000|Overall Study|Death|1|||
145748372|NCT01029366|525594010|FG001|Overall Study|Death|1|||
145748373|NCT01029366|525594009|FG000|Overall Study|disease progression|2|||
145748374|NCT01029366|525594010|FG001|Overall Study|disease progression|0|||
145748375|NCT01029366|525594009|FG000|Overall Study|manufacturing failure|0|||
145748376|NCT01029366|525594010|FG001|Overall Study|manufacturing failure|1|||
145748377|NCT01046877|525594012|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
145748378|NCT01046877|525594012|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
145748379|NCT01834274|525594013|FG000|Overall Study|Study Termination|41|||
145748380|NCT01834274|525594014|FG001|Overall Study|Study Termination|38|||
145748381|NCT01834274|525594013|FG000|Overall Study|Withdrawal by Subject|1|||
145748382|NCT01834274|525594014|FG001|Overall Study|Withdrawal by Subject|1|||
145748383|NCT01834274|525594013|FG000|Overall Study|Lost to Follow-up|3|||
145748384|NCT01834274|525594014|FG001|Overall Study|Lost to Follow-up|1|||
145748385|NCT01834274|525594013|FG000|Overall Study|Other|2|||
145748386|NCT01834274|525594014|FG001|Overall Study|Other|1|||
145748387|NCT01827670|525594015|FG000|Overall Study|Withdrawal of Consent|3|||
145748388|NCT01827670|525594016|FG001|Overall Study|Withdrawal of Consent|2|||
145748389|NCT01827670|525594015|FG000|Overall Study|Lost to Follow-up|0|||
145748390|NCT01827670|525594016|FG001|Overall Study|Lost to Follow-up|1|||
145748391|NCT03681119|525594021|FG000|Overall Study|No specific reason|4|||
145748392|NCT03681119|525594022|FG001|Overall Study|No specific reason|0|||
145748393|NCT03681119|525594021|FG000|Overall Study|Sickness|2|||
145748394|NCT03681119|525594022|FG001|Overall Study|Sickness|0|||
145748395|NCT02970292|525594023|FG000|Overall Study|Physician Decision|1|||
145748396|NCT02970292|525594024|FG001|Overall Study|Physician Decision|1|||
145748397|NCT02970292|525594023|FG000|Overall Study|Withdrawal by Subject|11|||
145748398|NCT02970292|525594024|FG001|Overall Study|Withdrawal by Subject|5|||
145748399|NCT02970292|525594023|FG000|Overall Study|Noncompliance with study drug|2|||
145748400|NCT02970292|525594024|FG001|Overall Study|Noncompliance with study drug|2|||
145748401|NCT02970292|525594023|FG000|Overall Study|Adverse Event|5|||
145748402|NCT02970292|525594024|FG001|Overall Study|Adverse Event|0|||
145748403|NCT02970292|525594023|FG000|Overall Study|Lack of Efficacy|1|||
145748404|NCT02970292|525594024|FG001|Overall Study|Lack of Efficacy|0|||
145748405|NCT02970292|525594023|FG000|Overall Study|Lost to Follow-up|1|||
145748406|NCT02970292|525594024|FG001|Overall Study|Lost to Follow-up|0|||
145748407|NCT02970292|525594023|FG000|Overall Study|Protocol Violation|2|||
145748408|NCT02970292|525594024|FG001|Overall Study|Protocol Violation|0|||
145748409|NCT02970292|525594023|FG000|Overall Study|Other|1|||
145748410|NCT02970292|525594024|FG001|Overall Study|Other|0|||
145748411|NCT02813694|525594025|FG000|Overall Study|Physician Decision|0|||
145748412|NCT02813694|525594026|FG001|Overall Study|Physician Decision|1|||
145748413|NCT02813694|525594025|FG000|Overall Study|Withdrawal by Subject|10|||
145748414|NCT02813694|525594026|FG001|Overall Study|Withdrawal by Subject|9|||
145748415|NCT02813694|525594025|FG000|Overall Study|Lost to Follow-up|1|||
145748416|NCT02813694|525594026|FG001|Overall Study|Lost to Follow-up|1|||
145748417|NCT02813694|525594025|FG000|Overall Study|Death|3|||
145748418|NCT02813694|525594026|FG001|Overall Study|Death|3|||
145748419|NCT02813694|525594025|FG000|Overall Study|Randomized- did not receive study drug|2|||
145748420|NCT02813694|525594026|FG001|Overall Study|Randomized- did not receive study drug|0|||
145748421|NCT02813694|525594025|FG000|Overall Study|Patient hospitalized|1|||
145748422|NCT02813694|525594026|FG001|Overall Study|Patient hospitalized|0|||
145748423|NCT02941627|525594037|FG000|Overall Study|Death|1|||
145748424|NCT02941627|525594037|FG000|Overall Study|Surgical failure|1|||
145748425|NCT02941627|525594037|FG000|Overall Study|cholesteatoma prevented implantation|1|||
145748426|NCT00606320|525594038|FG000|Overall Study|Adverse Event|3|||
145748427|NCT00606320|525594038|FG000|Overall Study|Lack of Efficacy|5|||
145748428|NCT00606320|525594038|FG000|Overall Study|Physician Decision|7|||
145748429|NCT00606320|525594038|FG000|Overall Study|Protocol Violation|8|||
145748430|NCT00606320|525594038|FG000|Overall Study|Withdrawal by Subject|10|||
145748431|NCT00606320|525594038|FG000|Overall Study|Progression to depressive phase|4|||
145748432|NCT00563186|525594039|FG000|Overall Study|LOS<48 hours|97|||
145748433|NCT00563186|525594040|FG001|Overall Study|LOS<48 hours|74|||
145748434|NCT00563186|525594039|FG000|Overall Study|Incomplete data|1|||
145402617|NCT05965752|524330807|FG002|Overall Study|Lost to Follow-up|1|||
145402618|NCT05965752|524330808|FG003|Overall Study|Lost to Follow-up|1|||
145402619|NCT05965752|524330809|FG004|Overall Study|Lost to Follow-up|1|||
145402620|NCT05965752|524330805|FG000|Overall Study|Withdrawal by Subject|2|||
145402621|NCT05965752|524330806|FG001|Overall Study|Withdrawal by Subject|2|||
145402622|NCT05965752|524330807|FG002|Overall Study|Withdrawal by Subject|1|||
145402623|NCT05965752|524330808|FG003|Overall Study|Withdrawal by Subject|5|||
145402624|NCT05965752|524330809|FG004|Overall Study|Withdrawal by Subject|0|||
145402625|NCT05965752|524330805|FG000|Overall Study|Disease Relapse|1|||
145402626|NCT05965752|524330806|FG001|Overall Study|Disease Relapse|0|||
145402627|NCT05965752|524330807|FG002|Overall Study|Disease Relapse|1|||
145402628|NCT05965752|524330808|FG003|Overall Study|Disease Relapse|0|||
145402629|NCT05965752|524330809|FG004|Overall Study|Disease Relapse|0|||
145402630|NCT05965752|524330805|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145402631|NCT05965752|524330806|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
145402632|NCT05965752|524330807|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145748435|NCT00563186|525594040|FG001|Overall Study|Incomplete data|1|||
145748436|NCT01152021|525594041|FG000|Overall Study|Adverse Event|4|||
145402633|NCT05965752|524330808|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
145402634|NCT05965752|524330809|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
145402635|NCT05965752|524330805|FG000|Overall Study|Unable to Return for Study Visits|0|||
145402636|NCT05965752|524330806|FG001|Overall Study|Unable to Return for Study Visits|1|||
145402637|NCT05965752|524330807|FG002|Overall Study|Unable to Return for Study Visits|0|||
145523841|NCT02038829|524778003|FG004|Washout Period 2|Withdrawal by Subject|0|||
145523842|NCT02038829|524778004|FG005|Washout Period 2|Withdrawal by Subject|1|||
145523843|NCT02038829|524778005|FG006|Washout Period 2|Withdrawal by Subject|0|||
145523844|NCT02038829|524778006|FG007|Washout Period 2|Withdrawal by Subject|0|||
145523845|NCT02038829|524778007|FG008|Washout Period 2|Withdrawal by Subject|0|||
145748437|NCT01152021|525594042|FG001|Overall Study|Adverse Event|4|||
145748438|NCT01152021|525594041|FG000|Overall Study|Study drug had expired|1|||
145748439|NCT01152021|525594042|FG001|Overall Study|Study drug had expired|0|||
145748440|NCT01152021|525594041|FG000|Overall Study|Physician Decision|1|||
145748441|NCT01152021|525594042|FG001|Overall Study|Physician Decision|1|||
145748442|NCT01152021|525594041|FG000|Overall Study|No access to study drug in Pharmacy|0|||
145523846|NCT02038829|524778008|FG009|Washout Period 2|Withdrawal by Subject|0|||
145523847|NCT02038829|524778009|FG010|Washout Period 2|Withdrawal by Subject|0|||
145748443|NCT01152021|525594042|FG001|Overall Study|No access to study drug in Pharmacy|1|||
145748444|NCT02595723|525594043|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
145748445|NCT02595723|525594044|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
145748446|NCT02595723|525594045|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
145748447|NCT02595723|525594043|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
145748448|NCT02595723|525594044|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
145523848|NCT02038829|524778010|FG011|Washout Period 2|Withdrawal by Subject|0|||
145748449|NCT02595723|525594045|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
145748450|NCT01087905|525594046|FG000|Overall Study|Lost to Follow-up|24|||
145523849|NCT02038829|524777999|FG000|Treatment Period 4|Adverse Event|0|||
145523850|NCT02038829|524778000|FG001|Treatment Period 4|Adverse Event|1|||
145523851|NCT02038829|524778001|FG002|Treatment Period 4|Adverse Event|0|||
145748451|NCT01087905|525594047|FG001|Overall Study|Lost to Follow-up|28|||
145748452|NCT01087905|525594048|FG002|Overall Study|Lost to Follow-up|18|||
145748453|NCT01087905|525594049|FG003|Overall Study|Lost to Follow-up|31|||
145748454|NCT01087905|525594050|FG004|Overall Study|Lost to Follow-up|27|||
145748455|NCT01087905|525594051|FG005|Overall Study|Lost to Follow-up|25|||
145748456|NCT01087905|525594052|FG006|Overall Study|Lost to Follow-up|20|||
145748457|NCT01087905|525594053|FG007|Overall Study|Lost to Follow-up|24|||
145748458|NCT01087905|525594046|FG000|Overall Study|Withdrawal by Subject|5|||
145523852|NCT02038829|524778002|FG003|Treatment Period 4|Adverse Event|0|||
145523853|NCT02038829|524778003|FG004|Treatment Period 4|Adverse Event|0|||
145523854|NCT02038829|524778004|FG005|Treatment Period 4|Adverse Event|0|||
145748459|NCT01087905|525594047|FG001|Overall Study|Withdrawal by Subject|4|||
145748460|NCT01087905|525594048|FG002|Overall Study|Withdrawal by Subject|4|||
145748461|NCT01087905|525594049|FG003|Overall Study|Withdrawal by Subject|5|||
145748462|NCT01087905|525594050|FG004|Overall Study|Withdrawal by Subject|4|||
145402638|NCT05965752|524330808|FG003|Overall Study|Unable to Return for Study Visits|3|||
145402639|NCT05965752|524330809|FG004|Overall Study|Unable to Return for Study Visits|1|||
145402640|NCT05965752|524330805|FG000|Overall Study|Early Termination|0|||
145523855|NCT02038829|524778005|FG006|Treatment Period 4|Adverse Event|0|||
145523856|NCT02038829|524778006|FG007|Treatment Period 4|Adverse Event|0|||
145748463|NCT01087905|525594051|FG005|Overall Study|Withdrawal by Subject|3|||
145748464|NCT01087905|525594052|FG006|Overall Study|Withdrawal by Subject|3|||
145748465|NCT01087905|525594053|FG007|Overall Study|Withdrawal by Subject|5|||
145748466|NCT03436862|525594056|FG000|Overall Study|Adverse Event|4|||
145748467|NCT03436862|525594056|FG000|Overall Study|Progressive Disease|2|||
145748468|NCT02937818|525594057|FG000|Overall Study|Participants decision|2|||
145748469|NCT02937818|525594058|FG001|Overall Study|Participants decision|1|||
145748470|NCT02937818|525594059|FG002|Overall Study|Participants decision|1|||
145748471|NCT02937818|525594060|FG003|Overall Study|Participants decision|1|||
145748472|NCT02937818|525594057|FG000|Overall Study|Adverse Event|2|||
145748473|NCT02937818|525594058|FG001|Overall Study|Adverse Event|4|||
145748474|NCT02937818|525594059|FG002|Overall Study|Adverse Event|1|||
145748475|NCT02937818|525594060|FG003|Overall Study|Adverse Event|1|||
145748476|NCT02937818|525594057|FG000|Overall Study|Disease progression|17|||
145748477|NCT02937818|525594058|FG001|Overall Study|Disease progression|15|||
145748478|NCT02937818|525594059|FG002|Overall Study|Disease progression|7|||
145748479|NCT02937818|525594060|FG003|Overall Study|Disease progression|19|||
145748480|NCT02937818|525594057|FG000|Overall Study|Condition under investigation worsened|0|||
145748481|NCT02937818|525594058|FG001|Overall Study|Condition under investigation worsened|0|||
145748482|NCT02937818|525594059|FG002|Overall Study|Condition under investigation worsened|1|||
145748483|NCT02937818|525594060|FG003|Overall Study|Condition under investigation worsened|0|||
145748484|NCT01929408|525594063|FG000|Overall Study|received HCT as initial treatment|8|||
145748485|NCT00689871|525594067|FG000|Overall Study|Lost to Follow-up|123|||
145748486|NCT00689871|525594068|FG001|Overall Study|Lost to Follow-up|13|||
145748487|NCT00689871|525594069|FG002|Overall Study|Lost to Follow-up|37|||
145748488|NCT00689871|525594070|FG003|Overall Study|Lost to Follow-up|1|||
145748489|NCT00689871|525594067|FG000|Overall Study|Explanted of All Study Devices|36|||
145748490|NCT00689871|525594068|FG001|Overall Study|Explanted of All Study Devices|25|||
145748491|NCT00689871|525594069|FG002|Overall Study|Explanted of All Study Devices|29|||
145748492|NCT00689871|525594070|FG003|Overall Study|Explanted of All Study Devices|3|||
145748493|NCT00689871|525594067|FG000|Overall Study|Withdrawal by Subject|13|||
145748494|NCT00689871|525594068|FG001|Overall Study|Withdrawal by Subject|3|||
145748495|NCT00689871|525594069|FG002|Overall Study|Withdrawal by Subject|4|||
145748496|NCT00689871|525594070|FG003|Overall Study|Withdrawal by Subject|1|||
145748497|NCT00689871|525594067|FG000|Overall Study|Death|1|||
145748498|NCT00689871|525594068|FG001|Overall Study|Death|10|||
145748499|NCT00689871|525594069|FG002|Overall Study|Death|2|||
145748500|NCT00689871|525594070|FG003|Overall Study|Death|2|||
145748501|NCT00689871|525594067|FG000|Overall Study|Physician Decision|2|||
145748502|NCT00689871|525594068|FG001|Overall Study|Physician Decision|1|||
145748503|NCT00689871|525594069|FG002|Overall Study|Physician Decision|1|||
145748504|NCT00689871|525594070|FG003|Overall Study|Physician Decision|0|||
145748505|NCT02054897|525594071|FG000|Overall Study|Withdrawal by Subject|2|||
145748506|NCT02054897|525594072|FG001|Overall Study|Withdrawal by Subject|0|||
145748507|NCT02054897|525594073|FG002|Overall Study|Withdrawal by Subject|2|||
145748508|NCT02054897|525594071|FG000|Overall Study|Missing follow-up information|3|||
145748509|NCT02054897|525594072|FG001|Overall Study|Missing follow-up information|5|||
145748510|NCT02054897|525594073|FG002|Overall Study|Missing follow-up information|3|||
145748511|NCT02054897|525594071|FG000|Overall Study|Lost to Follow-up|4|||
145748512|NCT02054897|525594072|FG001|Overall Study|Lost to Follow-up|2|||
145748513|NCT02054897|525594073|FG002|Overall Study|Lost to Follow-up|7|||
145748514|NCT02054897|525594071|FG000|Overall Study|Randomized but not exposed|1|||
145748515|NCT02054897|525594072|FG001|Overall Study|Randomized but not exposed|0|||
145748516|NCT02054897|525594073|FG002|Overall Study|Randomized but not exposed|0|||
145748517|NCT00254501|525594074|FG000|Overall Study|Lost to Follow-up|1|||
145748518|NCT00254501|525594075|FG001|Overall Study|Lost to Follow-up|1|||
145748519|NCT01119248|525594076|FG000|Overall Study|Physician Decision|5|||
145748520|NCT00550680|525594077|FG000|Overall Study|Administrative Reasons|1|||
145748521|NCT00550680|525594077|FG000|Overall Study|Adverse Event|5|||
145748522|NCT00550680|525594077|FG000|Overall Study|Death|3|||
145748523|NCT00550680|525594077|FG000|Overall Study|Early Improvement|1|||
145748524|NCT00550680|525594077|FG000|Overall Study|Lost to Follow-up|3|||
145748525|NCT00550680|525594077|FG000|Overall Study|Lack of Efficacy|1|||
145748526|NCT00550680|525594077|FG000|Overall Study|Other|10|||
145748527|NCT00550680|525594077|FG000|Overall Study|Protocol Violation|7|||
145748528|NCT00550680|525594077|FG000|Overall Study|Refused Treatment|19|||
145748529|NCT00550680|525594077|FG000|Overall Study|Screen Failure|6|||
145748530|NCT01967550|525594078|FG000|Overall Study|Withdrawal by Subject|1|||
145748531|NCT01967550|525594079|FG001|Overall Study|Withdrawal by Subject|0|||
145748532|NCT01967550|525594078|FG000|Overall Study|Adverse Event|2|||
145748533|NCT01967550|525594079|FG001|Overall Study|Adverse Event|0|||
145748534|NCT01967550|525594078|FG000|Overall Study|Protocol Violation|2|||
145748535|NCT01967550|525594079|FG001|Overall Study|Protocol Violation|1|||
145748536|NCT01967550|525594078|FG000|Overall Study|Non Compliance|0|||
145748537|NCT01967550|525594079|FG001|Overall Study|Non Compliance|1|||
145748538|NCT00250835|525594082|FG000|Overall Study|Withdrawal by Subject|1|||
145748539|NCT01100437|525594084|FG000|Titration/Stabilization|Adverse Event|0|||
145748540|NCT01100437|525594085|FG001|Titration/Stabilization|Adverse Event|0|||
145748541|NCT01100437|525594086|FG002|Titration/Stabilization|Adverse Event|4|||
145748542|NCT01100437|525594084|FG000|Titration/Stabilization|Non-compliance|0|||
145748543|NCT01100437|525594085|FG001|Titration/Stabilization|Non-compliance|0|||
145748544|NCT01100437|525594086|FG002|Titration/Stabilization|Non-compliance|1|||
145748545|NCT01100437|525594084|FG000|Titration/Stabilization|Sponsor canceled study|0|||
145748546|NCT01100437|525594085|FG001|Titration/Stabilization|Sponsor canceled study|0|||
145748547|NCT01100437|525594086|FG002|Titration/Stabilization|Sponsor canceled study|1|||
145748548|NCT01100437|525594084|FG000|Maintenance|Withdrawal by Subject|0|||
145748549|NCT01100437|525594085|FG001|Maintenance|Withdrawal by Subject|0|||
145748550|NCT01100437|525594086|FG002|Maintenance|Withdrawal by Subject|1|||
145748551|NCT01100437|525594084|FG000|Maintenance|Sponsor termination of study|0|||
145748552|NCT01100437|525594085|FG001|Maintenance|Sponsor termination of study|0|||
145748553|NCT01100437|525594086|FG002|Maintenance|Sponsor termination of study|1|||
145523857|NCT02038829|524778007|FG008|Treatment Period 4|Adverse Event|0|||
145748554|NCT04099251|525595903|FG000|Pre-Treatment|Other reasons|1|||
145748555|NCT04099251|525595904|FG001|Pre-Treatment|Other reasons|0|||
145748556|NCT04099251|525595903|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
145748557|NCT04099251|525595904|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
145748558|NCT04099251|525595903|FG000|Blinded Treatment Phase|Other reasons|16|||
145748559|NCT04099251|525595904|FG001|Blinded Treatment Phase|Other reasons|7|||
145748560|NCT04099251|525595903|FG000|Blinded Treatment Phase|Disease recurrence|26|||
145748561|NCT04099251|525595904|FG001|Blinded Treatment Phase|Disease recurrence|41|||
145748562|NCT04099251|525595903|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
145748563|NCT04099251|525595904|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
145748564|NCT04099251|525595903|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
145748565|NCT04099251|525595904|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
145748566|NCT04099251|525595903|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
145748567|NCT04099251|525595904|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
145748568|NCT04099251|525595903|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
145748569|NCT04099251|525595904|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
145748570|NCT04099251|525595903|FG000|Blinded Treatment Phase|Death|6|||
145748571|NCT04099251|525595904|FG001|Blinded Treatment Phase|Death|2|||
145748572|NCT04099251|525595903|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
145748573|NCT04099251|525595904|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
145748574|NCT04099251|525595903|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
145748575|NCT04099251|525595904|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
145748576|NCT04099251|525595903|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
145748577|NCT04099251|525595904|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
145748578|NCT04099251|525595903|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
145748579|NCT04099251|525595904|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
145748580|NCT04099251|525595903|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
145748581|NCT04099251|525595904|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
145748582|NCT04099251|525595903|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
145748583|NCT04099251|525595904|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
145748584|NCT04099251|525595903|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
145748585|NCT04099251|525595904|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
145748586|NCT04099251|525595903|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
145748587|NCT04099251|525595904|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
145748588|NCT04099251|525595903|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
145748589|NCT04099251|525595904|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
145748590|NCT05032157|525595905|FG000|Overall Study|Adverse Event|12|||
145748591|NCT05032157|525595906|FG001|Overall Study|Adverse Event|7|||
145748592|NCT05032157|525595905|FG000|Overall Study|Pregnancy|0|||
145748593|NCT05032157|525595906|FG001|Overall Study|Pregnancy|2|||
145748594|NCT05032157|525595905|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145748595|NCT05032157|525595906|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
145748596|NCT05032157|525595905|FG000|Overall Study|Protocol Deviation|8|||
145748597|NCT05032157|525595906|FG001|Overall Study|Protocol Deviation|4|||
145748598|NCT05032157|525595905|FG000|Overall Study|Lost to Follow-up|1|||
145748599|NCT05032157|525595906|FG001|Overall Study|Lost to Follow-up|3|||
145748600|NCT05032157|525595905|FG000|Overall Study|Physician Decision|7|||
145748601|NCT05032157|525595906|FG001|Overall Study|Physician Decision|2|||
145748602|NCT05032157|525595905|FG000|Overall Study|Patient Decision|38|||
145402641|NCT05965752|524330806|FG001|Overall Study|Early Termination|0|||
145748603|NCT05032157|525595906|FG001|Overall Study|Patient Decision|19|||
145748604|NCT02068547|525595907|FG000|Overall Study|Lost to Follow-up|3|||
145748605|NCT02068547|525595908|FG001|Overall Study|Lost to Follow-up|3|||
145748606|NCT02068547|525595907|FG000|Overall Study|Physician Decision|1|||
145748607|NCT02068547|525595908|FG001|Overall Study|Physician Decision|0|||
145748608|NCT03657043|525595909|FG000|Overall Study|Withdrawal by Subject|1|||
145748609|NCT03657043|525595910|FG001|Overall Study|Withdrawal by Subject|1|||
145748610|NCT03657043|525595911|FG002|Overall Study|Withdrawal by Subject|0|||
145748611|NCT03657043|525595912|FG003|Overall Study|Withdrawal by Subject|0|||
145748612|NCT03657043|525595913|FG004|Overall Study|Withdrawal by Subject|4|||
145748613|NCT03657043|525595909|FG000|Overall Study|Study closure by Sponsor|0|||
145748614|NCT03657043|525595910|FG001|Overall Study|Study closure by Sponsor|2|||
145748615|NCT03657043|525595911|FG002|Overall Study|Study closure by Sponsor|0|||
145748616|NCT03657043|525595912|FG003|Overall Study|Study closure by Sponsor|0|||
145748617|NCT03657043|525595913|FG004|Overall Study|Study closure by Sponsor|17|||
145748618|NCT03657043|525595909|FG000|Overall Study|Lost to Follow-up|0|||
145748619|NCT03657043|525595910|FG001|Overall Study|Lost to Follow-up|0|||
145748620|NCT03657043|525595911|FG002|Overall Study|Lost to Follow-up|0|||
145748621|NCT03657043|525595912|FG003|Overall Study|Lost to Follow-up|0|||
145748622|NCT03657043|525595913|FG004|Overall Study|Lost to Follow-up|4|||
145748623|NCT03657043|525595909|FG000|Overall Study|Death|6|||
145748624|NCT03657043|525595910|FG001|Overall Study|Death|5|||
145748625|NCT03657043|525595911|FG002|Overall Study|Death|0|||
145748626|NCT03657043|525595912|FG003|Overall Study|Death|0|||
145748627|NCT03657043|525595913|FG004|Overall Study|Death|53|||
145748628|NCT03657043|525595909|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
145748629|NCT03657043|525595910|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
145748630|NCT03657043|525595911|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
145748631|NCT03657043|525595912|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
145748632|NCT03657043|525595913|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
145748633|NCT03657043|525595909|FG000|Overall Study|Adverse Event|0|||
145748634|NCT03657043|525595910|FG001|Overall Study|Adverse Event|0|||
145748635|NCT03657043|525595911|FG002|Overall Study|Adverse Event|0|||
145748636|NCT03657043|525595912|FG003|Overall Study|Adverse Event|0|||
145748637|NCT03657043|525595913|FG004|Overall Study|Adverse Event|2|||
145748638|NCT03657043|525595909|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
145748639|NCT03657043|525595910|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
145748640|NCT03657043|525595911|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
145748641|NCT03657043|525595912|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
145748642|NCT03657043|525595913|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
145748643|NCT03657043|525595909|FG000|Overall Study|Withdrawal - declined follow-up|0|||
145748644|NCT03657043|525595910|FG001|Overall Study|Withdrawal - declined follow-up|0|||
145748645|NCT03657043|525595911|FG002|Overall Study|Withdrawal - declined follow-up|0|||
145748646|NCT03657043|525595912|FG003|Overall Study|Withdrawal - declined follow-up|0|||
145748647|NCT03657043|525595913|FG004|Overall Study|Withdrawal - declined follow-up|1|||
145748648|NCT03047980|525595914|FG000|Overall Study|Adverse Event|1|||
145748649|NCT02627495|525595917|FG000|Overall Study|Withdrawal by Subject|4|||
145748650|NCT00880893|525595918|FG000|Overall Study|Protocol Violation|13|||
145748651|NCT00880893|525595919|FG001|Overall Study|Protocol Violation|1|||
145748652|NCT00880893|525595918|FG000|Overall Study|Withdrawal by Subject|15|||
145748653|NCT00880893|525595919|FG001|Overall Study|Withdrawal by Subject|11|||
145748654|NCT00880893|525595918|FG000|Overall Study|Lost to Follow-up|76|||
145748655|NCT00880893|525595919|FG001|Overall Study|Lost to Follow-up|33|||
145748656|NCT00880893|525595918|FG000|Overall Study|Serious adverse event|3|||
145748657|NCT00880893|525595919|FG001|Overall Study|Serious adverse event|0|||
145748658|NCT01995071|525595920|FG000|Overall Study|Adverse Event|0|||
145748659|NCT01995071|525595921|FG001|Overall Study|Adverse Event|0|||
145748660|NCT01995071|525595922|FG002|Overall Study|Adverse Event|0|||
145748661|NCT01995071|525595923|FG003|Overall Study|Adverse Event|0|||
145748662|NCT01995071|525595924|FG004|Overall Study|Adverse Event|0|||
145748663|NCT01995071|525595925|FG005|Overall Study|Adverse Event|0|||
145748664|NCT01995071|525595926|FG006|Overall Study|Adverse Event|1|||
145748665|NCT01995071|525595927|FG007|Overall Study|Adverse Event|0|||
145748666|NCT01995071|525595928|FG008|Overall Study|Adverse Event|0|||
145748667|NCT01995071|525595929|FG009|Overall Study|Adverse Event|0|||
145748668|NCT01995071|525595930|FG010|Overall Study|Adverse Event|0|||
145748669|NCT01995071|525595931|FG011|Overall Study|Adverse Event|0|||
145748670|NCT01995071|525595920|FG000|Overall Study|Moved|0|||
145748671|NCT01995071|525595921|FG001|Overall Study|Moved|0|||
145748672|NCT01995071|525595922|FG002|Overall Study|Moved|1|||
145748673|NCT01995071|525595923|FG003|Overall Study|Moved|0|||
145748674|NCT01995071|525595924|FG004|Overall Study|Moved|1|||
145748675|NCT01995071|525595925|FG005|Overall Study|Moved|0|||
145748676|NCT01995071|525595926|FG006|Overall Study|Moved|0|||
145748677|NCT01995071|525595927|FG007|Overall Study|Moved|0|||
145748678|NCT01995071|525595928|FG008|Overall Study|Moved|0|||
145748679|NCT01995071|525595929|FG009|Overall Study|Moved|0|||
145748680|NCT01995071|525595930|FG010|Overall Study|Moved|1|||
145748681|NCT01995071|525595931|FG011|Overall Study|Moved|0|||
145748682|NCT01995071|525595920|FG000|Overall Study|Lost to Follow-up|1|||
145748683|NCT01995071|525595921|FG001|Overall Study|Lost to Follow-up|0|||
145748684|NCT01995071|525595922|FG002|Overall Study|Lost to Follow-up|0|||
145748685|NCT01995071|525595923|FG003|Overall Study|Lost to Follow-up|0|||
145748686|NCT01995071|525595924|FG004|Overall Study|Lost to Follow-up|0|||
145748687|NCT01995071|525595925|FG005|Overall Study|Lost to Follow-up|0|||
145748688|NCT01995071|525595926|FG006|Overall Study|Lost to Follow-up|0|||
145748689|NCT01995071|525595927|FG007|Overall Study|Lost to Follow-up|1|||
145748690|NCT01995071|525595928|FG008|Overall Study|Lost to Follow-up|1|||
145748691|NCT01995071|525595929|FG009|Overall Study|Lost to Follow-up|0|||
145748692|NCT01995071|525595930|FG010|Overall Study|Lost to Follow-up|0|||
145748693|NCT01995071|525595931|FG011|Overall Study|Lost to Follow-up|0|||
145748694|NCT01995071|525595920|FG000|Overall Study|Incarcerated|0|||
145748695|NCT01995071|525595921|FG001|Overall Study|Incarcerated|0|||
145748696|NCT01995071|525595922|FG002|Overall Study|Incarcerated|0|||
145748697|NCT01995071|525595923|FG003|Overall Study|Incarcerated|0|||
145748698|NCT01995071|525595924|FG004|Overall Study|Incarcerated|0|||
145748699|NCT01995071|525595925|FG005|Overall Study|Incarcerated|0|||
145748700|NCT01995071|525595926|FG006|Overall Study|Incarcerated|0|||
145748701|NCT01995071|525595927|FG007|Overall Study|Incarcerated|1|||
145748702|NCT01995071|525595928|FG008|Overall Study|Incarcerated|0|||
145748703|NCT01995071|525595929|FG009|Overall Study|Incarcerated|0|||
145748704|NCT01995071|525595930|FG010|Overall Study|Incarcerated|0|||
145748705|NCT01995071|525595931|FG011|Overall Study|Incarcerated|0|||
145748706|NCT02404103|525595932|FG000|Overall Study|Adverse Event|1|||
145748707|NCT02404103|525595933|FG001|Overall Study|Adverse Event|0|||
145748708|NCT02404103|525595932|FG000|Overall Study|Lost to Follow-up|3|||
145748709|NCT02404103|525595933|FG001|Overall Study|Lost to Follow-up|3|||
145748710|NCT01783678|525595934|FG000|Overall Study|Randomized but Not Treated|0|||
145748711|NCT01783678|525595935|FG001|Overall Study|Randomized but Not Treated|0|||
145748712|NCT01783678|525595936|FG002|Overall Study|Randomized but Not Treated|0|||
145748713|NCT01783678|525595937|FG003|Overall Study|Randomized but Not Treated|1|||
145748714|NCT01783678|525595938|FG004|Overall Study|Randomized but Not Treated|0|||
145748715|NCT01783678|525595939|FG005|Overall Study|Randomized but Not Treated|0|||
145748716|NCT01783678|525595934|FG000|Overall Study|Lack of Efficacy|1|||
145748717|NCT01783678|525595935|FG001|Overall Study|Lack of Efficacy|13|||
145748718|NCT01783678|525595936|FG002|Overall Study|Lack of Efficacy|1|||
145748719|NCT01783678|525595937|FG003|Overall Study|Lack of Efficacy|3|||
145748720|NCT01783678|525595938|FG004|Overall Study|Lack of Efficacy|6|||
145748721|NCT01783678|525595939|FG005|Overall Study|Lack of Efficacy|5|||
145748722|NCT01783678|525595934|FG000|Overall Study|Lost to Follow-up|0|||
145748723|NCT01783678|525595935|FG001|Overall Study|Lost to Follow-up|4|||
145748724|NCT01783678|525595936|FG002|Overall Study|Lost to Follow-up|0|||
145748725|NCT01783678|525595937|FG003|Overall Study|Lost to Follow-up|2|||
145748726|NCT01783678|525595938|FG004|Overall Study|Lost to Follow-up|1|||
145748727|NCT01783678|525595939|FG005|Overall Study|Lost to Follow-up|0|||
145748728|NCT01783678|525595934|FG000|Overall Study|Withdrew Consent|1|||
145748729|NCT01783678|525595935|FG001|Overall Study|Withdrew Consent|1|||
145748730|NCT01783678|525595936|FG002|Overall Study|Withdrew Consent|0|||
145523858|NCT02038829|524778008|FG009|Treatment Period 4|Adverse Event|0|||
145748731|NCT01783678|525595937|FG003|Overall Study|Withdrew Consent|2|||
145748732|NCT01783678|525595938|FG004|Overall Study|Withdrew Consent|0|||
145748733|NCT01783678|525595939|FG005|Overall Study|Withdrew Consent|0|||
145748734|NCT00112905|525595940|FG000|Overall Study|Adverse Event|4|||
145748735|NCT00112905|525595940|FG000|Overall Study|Death|1|||
145748736|NCT00112905|525595940|FG000|Overall Study|Ineligibility|5|||
145748737|NCT00112905|525595940|FG000|Overall Study|Alternative treatment|1|||
145748738|NCT00112905|525595940|FG000|Overall Study|performance status was deteiorating|1|||
145748739|NCT02600507|525595941|FG000|Overall Study|Adverse Event|3|||
145748740|NCT02600507|525595942|FG001|Overall Study|Adverse Event|15|||
145748741|NCT02600507|525595943|FG002|Overall Study|Adverse Event|5|||
145748742|NCT02600507|525595941|FG000|Overall Study|Lack of Efficacy|3|||
145748743|NCT02600507|525595942|FG001|Overall Study|Lack of Efficacy|8|||
145748744|NCT02600507|525595943|FG002|Overall Study|Lack of Efficacy|5|||
145748745|NCT02600507|525595941|FG000|Overall Study|Lost to Follow-up|3|||
145748746|NCT02600507|525595942|FG001|Overall Study|Lost to Follow-up|5|||
145748747|NCT02600507|525595943|FG002|Overall Study|Lost to Follow-up|2|||
145748748|NCT02600507|525595941|FG000|Overall Study|Protocol Violation|12|||
145748749|NCT02600507|525595942|FG001|Overall Study|Protocol Violation|4|||
145748750|NCT02600507|525595943|FG002|Overall Study|Protocol Violation|4|||
145748751|NCT02600507|525595941|FG000|Overall Study|Physician Decision|1|||
145748752|NCT02600507|525595942|FG001|Overall Study|Physician Decision|0|||
145748753|NCT02600507|525595943|FG002|Overall Study|Physician Decision|1|||
145748754|NCT02600507|525595941|FG000|Overall Study|Withdrawal by Subject|7|||
145748755|NCT02600507|525595942|FG001|Overall Study|Withdrawal by Subject|11|||
145748756|NCT02600507|525595943|FG002|Overall Study|Withdrawal by Subject|7|||
145748757|NCT02600507|525595941|FG000|Overall Study|Other|0|||
145748758|NCT02600507|525595942|FG001|Overall Study|Other|1|||
145748759|NCT02600507|525595943|FG002|Overall Study|Other|1|||
145748760|NCT04541004|525595948|FG000|Overall Study|Adverse Event|2|||
145748761|NCT00605085|525595949|FG000|Overall Study|Withdrawal by Subject|8|||
145748762|NCT00605085|525595950|FG001|Overall Study|Withdrawal by Subject|5|||
145748763|NCT00605085|525595949|FG000|Overall Study|Adverse Event|9|||
145748764|NCT00605085|525595950|FG001|Overall Study|Adverse Event|5|||
145748765|NCT00605085|525595949|FG000|Overall Study|Pregnancy|2|||
145748766|NCT00605085|525595950|FG001|Overall Study|Pregnancy|0|||
145748767|NCT00605085|525595949|FG000|Overall Study|Protocol Violation|3|||
145748768|NCT00605085|525595950|FG001|Overall Study|Protocol Violation|2|||
145748769|NCT00605085|525595949|FG000|Overall Study|Lost to Follow-up|10|||
145748770|NCT00605085|525595950|FG001|Overall Study|Lost to Follow-up|5|||
145748771|NCT00605085|525595949|FG000|Overall Study|administrative reasons|18|||
145748772|NCT00605085|525595950|FG001|Overall Study|administrative reasons|8|||
145748773|NCT00621504|525595951|FG000|Overall Study|Adverse Event|1|||
145748774|NCT00621504|525595952|FG001|Overall Study|Adverse Event|3|||
145748775|NCT00621504|525595951|FG000|Overall Study|At the request of sponsor/investigator|1|||
145748776|NCT00621504|525595952|FG001|Overall Study|At the request of sponsor/investigator|0|||
145748777|NCT00621504|525595951|FG000|Overall Study|Withdrew consent|9|||
145748778|NCT00621504|525595952|FG001|Overall Study|Withdrew consent|6|||
145748779|NCT00621504|525595951|FG000|Overall Study|Lost to Follow-up|8|||
145748780|NCT00621504|525595952|FG001|Overall Study|Lost to Follow-up|10|||
145748781|NCT00621504|525595951|FG000|Overall Study|Other|1|||
145748782|NCT00621504|525595952|FG001|Overall Study|Other|0|||
145748783|NCT00621504|525595951|FG000|Overall Study|Death|6|||
145748784|NCT00621504|525595952|FG001|Overall Study|Death|6|||
145748785|NCT03311711|525595957|FG000|Overall Study|Death|1|||
145748786|NCT03311711|525595958|FG001|Overall Study|Death|0|||
145748787|NCT03311711|525595959|FG002|Overall Study|Death|0|||
145748788|NCT03311711|525595960|FG003|Overall Study|Death|0|||
145748789|NCT03311711|525595961|FG004|Overall Study|Death|0|||
145748790|NCT03311711|525595962|FG005|Overall Study|Death|0|||
145748791|NCT03311711|525595963|FG006|Overall Study|Death|1|||
145748792|NCT03311711|525595964|FG007|Overall Study|Death|0|||
145748793|NCT03311711|525595965|FG008|Overall Study|Death|1|||
145748794|NCT03311711|525595966|FG009|Overall Study|Death|0|||
145748795|NCT03311711|525595957|FG000|Overall Study|Death of dyad partner|0|||
145748796|NCT03311711|525595958|FG001|Overall Study|Death of dyad partner|1|||
145748797|NCT03311711|525595959|FG002|Overall Study|Death of dyad partner|0|||
145748798|NCT03311711|525595960|FG003|Overall Study|Death of dyad partner|0|||
145748799|NCT03311711|525595961|FG004|Overall Study|Death of dyad partner|0|||
145748800|NCT03311711|525595962|FG005|Overall Study|Death of dyad partner|0|||
145748801|NCT03311711|525595963|FG006|Overall Study|Death of dyad partner|0|||
145748802|NCT03311711|525595964|FG007|Overall Study|Death of dyad partner|1|||
145748803|NCT03311711|525595965|FG008|Overall Study|Death of dyad partner|0|||
145748804|NCT03311711|525595966|FG009|Overall Study|Death of dyad partner|1|||
145748805|NCT03311711|525595957|FG000|Overall Study|Lost to Follow-up|2|||
145748806|NCT03311711|525595958|FG001|Overall Study|Lost to Follow-up|2|||
145748807|NCT03311711|525595959|FG002|Overall Study|Lost to Follow-up|0|||
145748808|NCT03311711|525595960|FG003|Overall Study|Lost to Follow-up|0|||
145748809|NCT03311711|525595961|FG004|Overall Study|Lost to Follow-up|0|||
145748810|NCT03311711|525595962|FG005|Overall Study|Lost to Follow-up|0|||
145748811|NCT03311711|525595963|FG006|Overall Study|Lost to Follow-up|1|||
145748812|NCT03311711|525595964|FG007|Overall Study|Lost to Follow-up|1|||
145748813|NCT03311711|525595965|FG008|Overall Study|Lost to Follow-up|0|||
145748814|NCT03311711|525595966|FG009|Overall Study|Lost to Follow-up|0|||
145748815|NCT03311711|525595957|FG000|Overall Study|Withdrawal by Subject|1|||
145748816|NCT03311711|525595958|FG001|Overall Study|Withdrawal by Subject|1|||
145748817|NCT03311711|525595959|FG002|Overall Study|Withdrawal by Subject|0|||
145748818|NCT03311711|525595960|FG003|Overall Study|Withdrawal by Subject|0|||
145748819|NCT03311711|525595961|FG004|Overall Study|Withdrawal by Subject|0|||
145748820|NCT03311711|525595962|FG005|Overall Study|Withdrawal by Subject|0|||
145748821|NCT03311711|525595963|FG006|Overall Study|Withdrawal by Subject|3|||
145748822|NCT03311711|525595964|FG007|Overall Study|Withdrawal by Subject|3|||
145748823|NCT03311711|525595965|FG008|Overall Study|Withdrawal by Subject|0|||
145748824|NCT03311711|525595966|FG009|Overall Study|Withdrawal by Subject|0|||
145748825|NCT01982292|525595967|FG000|Overall Study|Adverse Event|2|||
145748826|NCT01982292|525595968|FG001|Overall Study|Adverse Event|0|||
145748827|NCT01982292|525595967|FG000|Overall Study|Death|1|||
145748828|NCT01982292|525595968|FG001|Overall Study|Death|0|||
145748829|NCT01982292|525595967|FG000|Overall Study|Lost to Follow-up|2|||
145748830|NCT01982292|525595968|FG001|Overall Study|Lost to Follow-up|0|||
145748831|NCT01982292|525595967|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
145748832|NCT01982292|525595968|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
145748833|NCT01982292|525595967|FG000|Overall Study|Protocol Deviation|1|||
145748834|NCT01982292|525595968|FG001|Overall Study|Protocol Deviation|0|||
145748835|NCT01982292|525595967|FG000|Overall Study|Patient/Guardian Decision|3|||
145523859|NCT02038829|524778009|FG010|Treatment Period 4|Adverse Event|0|||
145748836|NCT01982292|525595968|FG001|Overall Study|Patient/Guardian Decision|1|||
145748837|NCT01982292|525595967|FG000|Overall Study|Technical Problems|2|||
145748838|NCT01982292|525595968|FG001|Overall Study|Technical Problems|0|||
145748839|NCT01339559|525595976|FG000|Overall Study|Adverse Event|92|||
145748840|NCT01339559|525595976|FG000|Overall Study|Death|5|||
145748841|NCT01339559|525595976|FG000|Overall Study|Lack of Efficacy|164|||
145748842|NCT01339559|525595976|FG000|Overall Study|Lost to Follow-up|22|||
145748843|NCT01339559|525595976|FG000|Overall Study|Subject choice|89|||
145748844|NCT01339559|525595976|FG000|Overall Study|Protocol Violation|15|||
145748845|NCT01339559|525595976|FG000|Overall Study|Study closure at site|1|||
145748846|NCT01339559|525595976|FG000|Overall Study|Incarcerated|2|||
145748847|NCT01339559|525595976|FG000|Overall Study|Epilepsy surgery|1|||
145748848|NCT01339559|525595976|FG000|Overall Study|Pregnancy planned|2|||
145748849|NCT01339559|525595976|FG000|Overall Study|Left the country|1|||
145748850|NCT01339559|525595976|FG000|Overall Study|Investigator decision|2|||
145748851|NCT01339559|525595976|FG000|Overall Study|Patient didn't wish to continue|1|||
145523860|NCT02038829|524778010|FG011|Treatment Period 4|Adverse Event|0|||
145523861|NCT02038829|524777999|FG000|Washout Period 4|Adverse Event|0|||
145523862|NCT02038829|524778000|FG001|Washout Period 4|Adverse Event|0|||
145523863|NCT02038829|524778001|FG002|Washout Period 4|Adverse Event|0|||
145523864|NCT02038829|524778002|FG003|Washout Period 4|Adverse Event|0|||
145523865|NCT02038829|524778003|FG004|Washout Period 4|Adverse Event|0|||
145523866|NCT02038829|524778004|FG005|Washout Period 4|Adverse Event|0|||
145523867|NCT02038829|524778005|FG006|Washout Period 4|Adverse Event|1|||
145523868|NCT02038829|524778006|FG007|Washout Period 4|Adverse Event|0|||
145523869|NCT02038829|524778007|FG008|Washout Period 4|Adverse Event|0|||
145523870|NCT02038829|524778008|FG009|Washout Period 4|Adverse Event|0|||
145523871|NCT02038829|524778009|FG010|Washout Period 4|Adverse Event|0|||
145523872|NCT02038829|524778010|FG011|Washout Period 4|Adverse Event|0|||
145523873|NCT02038829|524777999|FG000|Treatment Period 6|Adverse Event|0|||
145523874|NCT02038829|524778000|FG001|Treatment Period 6|Adverse Event|0|||
145523875|NCT02038829|524778001|FG002|Treatment Period 6|Adverse Event|1|||
145523876|NCT02038829|524778002|FG003|Treatment Period 6|Adverse Event|0|||
145523877|NCT02038829|524778003|FG004|Treatment Period 6|Adverse Event|0|||
145523878|NCT02038829|524778004|FG005|Treatment Period 6|Adverse Event|0|||
145523879|NCT02038829|524778005|FG006|Treatment Period 6|Adverse Event|0|||
145523880|NCT02038829|524778006|FG007|Treatment Period 6|Adverse Event|0|||
145523881|NCT02038829|524778007|FG008|Treatment Period 6|Adverse Event|0|||
145523882|NCT02038829|524778008|FG009|Treatment Period 6|Adverse Event|0|||
145523883|NCT02038829|524778009|FG010|Treatment Period 6|Adverse Event|0|||
145523884|NCT02038829|524778010|FG011|Treatment Period 6|Adverse Event|0|||
145523885|NCT03754972|524778013|FG000|Overall Study|Protocol Violation|25|||
145523886|NCT03410823|524778014|FG000|Overall Study|Death|1|||
145523887|NCT03410823|524778014|FG000|Overall Study|Withdrawal by Subject|2|||
145523888|NCT03410823|524778014|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
145523889|NCT06460493|524778021|FG000|Overall Study|Withdrawal by Subject|2|||
145523890|NCT05128929|524778022|FG000|Overall Study|Adverse Event|0|||
145523891|NCT05128929|524778023|FG001|Overall Study|Adverse Event|1|||
145523892|NCT04626310|524778034|FG000|Overall Study|4-miss from treatment|6|||
145523893|NCT04626310|524778035|FG001|Overall Study|4-miss from treatment|5|||
145523894|NCT04626310|524778036|FG002|Overall Study|4-miss from treatment|5|||
145523895|NCT04626310|524778034|FG000|Overall Study|Withdrawal by Subject|1|||
145523896|NCT04626310|524778035|FG001|Overall Study|Withdrawal by Subject|0|||
145523897|NCT04626310|524778036|FG002|Overall Study|Withdrawal by Subject|3|||
145523898|NCT02278341|524778037|FG000|Overall Study|Randomized but never received study drug|1|||
145523899|NCT02278341|524778038|FG001|Overall Study|Randomized but never received study drug|1|||
145523900|NCT02278341|524778037|FG000|Overall Study|Adverse Event|3|||
145523901|NCT02278341|524778038|FG001|Overall Study|Adverse Event|0|||
145523902|NCT02278341|524778037|FG000|Overall Study|Death|68|||
145523903|NCT02278341|524778038|FG001|Overall Study|Death|56|||
145523904|NCT02278341|524778037|FG000|Overall Study|Withdrawal by Subject|30|||
145523905|NCT02278341|524778038|FG001|Overall Study|Withdrawal by Subject|19|||
145523906|NCT02278341|524778037|FG000|Overall Study|Lost to Follow-up|0|||
145523907|NCT02278341|524778038|FG001|Overall Study|Lost to Follow-up|1|||
145523908|NCT02278341|524778037|FG000|Overall Study|Physician Decision|1|||
145523909|NCT02278341|524778038|FG001|Overall Study|Physician Decision|1|||
145523910|NCT02278341|524778037|FG000|Overall Study|Miscellaneous|15|||
145523911|NCT02278341|524778038|FG001|Overall Study|Miscellaneous|14|||
145523912|NCT04902326|524778039|FG000|Overall Study|Withdrawal by Subject|1|||
145523913|NCT04902326|524778040|FG001|Overall Study|Withdrawal by Subject|3|||
145523914|NCT04902326|524778041|FG002|Overall Study|Withdrawal by Subject|0|||
145523915|NCT04902326|524778042|FG003|Overall Study|Withdrawal by Subject|1|||
145523916|NCT04902326|524778039|FG000|Overall Study|Lost to Follow-up|14|||
145523917|NCT04902326|524778040|FG001|Overall Study|Lost to Follow-up|14|||
145523918|NCT04902326|524778041|FG002|Overall Study|Lost to Follow-up|14|||
145523919|NCT04902326|524778042|FG003|Overall Study|Lost to Follow-up|6|||
145523920|NCT02604017|524778044|FG000|Overall Study|Withdrew Consent|0|||
145523921|NCT02604017|524778045|FG001|Overall Study|Withdrew Consent|2|||
145523922|NCT02604017|524778044|FG000|Overall Study|Lost to Follow-up|5|||
145523923|NCT02604017|524778045|FG001|Overall Study|Lost to Follow-up|6|||
145523924|NCT02604017|524778044|FG000|Overall Study|Other|1|||
145523925|NCT02604017|524778045|FG001|Overall Study|Other|0|||
145523926|NCT01041495|524778046|FG000|Overall Study|Withdrawal by Subject|2|||
145523927|NCT01041495|524778047|FG001|Overall Study|Withdrawal by Subject|5|||
145523928|NCT01041495|524778046|FG000|Overall Study|Adverse Event|2|||
145523929|NCT01041495|524778047|FG001|Overall Study|Adverse Event|1|||
145523930|NCT01041495|524778046|FG000|Overall Study|Lost to Follow-up|0|||
145523931|NCT01041495|524778047|FG001|Overall Study|Lost to Follow-up|1|||
145523932|NCT01117051|524778048|FG000|Overall Study|Withdrawal by Subject|5|||
145523933|NCT01117051|524778049|FG001|Overall Study|Withdrawal by Subject|3|||
145523934|NCT01117051|524778048|FG000|Overall Study|Adverse Event|4|||
145523935|NCT01117051|524778049|FG001|Overall Study|Adverse Event|3|||
145523936|NCT01117051|524778048|FG000|Overall Study|Lost to Follow-up|0|||
145523937|NCT01117051|524778049|FG001|Overall Study|Lost to Follow-up|1|||
145523938|NCT01117051|524778048|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
145748852|NCT01339559|525595976|FG000|Overall Study|PI decision|1|||
145748853|NCT00971945|525595977|FG000|Overall Study|Progressive Disease|3|||
145748854|NCT00971945|525595977|FG000|Overall Study|Change in treatment policy|1|||
145748855|NCT00971945|525595977|FG000|Overall Study|Other reasons|2|||
145748856|NCT03354663|525595978|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
145748857|NCT03354663|525595978|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
145748858|NCT03354663|525595978|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
145748859|NCT03354663|525595978|FG000|Completed 30-day Visit|Missed Visit|1|||
145748860|NCT01661140|525595979|FG000|Open-Label Period|Adverse Event|44|||
145748861|NCT01661140|525595980|FG001|Open-Label Period|Adverse Event|0|||
145748862|NCT01661140|525595981|FG002|Open-Label Period|Adverse Event|0|||
145748863|NCT01661140|525595979|FG000|Open-Label Period|Protocol Violation|3|||
145748864|NCT01661140|525595980|FG001|Open-Label Period|Protocol Violation|0|||
145748865|NCT01661140|525595981|FG002|Open-Label Period|Protocol Violation|0|||
145748866|NCT01661140|525595979|FG000|Open-Label Period|Withdrawal by Subject|5|||
145748867|NCT01661140|525595980|FG001|Open-Label Period|Withdrawal by Subject|0|||
145748868|NCT01661140|525595981|FG002|Open-Label Period|Withdrawal by Subject|0|||
145748869|NCT01661140|525595979|FG000|Open-Label Period|Investigator Decision|3|||
145748870|NCT01661140|525595980|FG001|Open-Label Period|Investigator Decision|0|||
145748871|NCT01661140|525595981|FG002|Open-Label Period|Investigator Decision|0|||
145748872|NCT01661140|525595979|FG000|Open-Label Period|Death|1|||
145748873|NCT01661140|525595980|FG001|Open-Label Period|Death|0|||
145748874|NCT01661140|525595981|FG002|Open-Label Period|Death|0|||
145748875|NCT01661140|525595979|FG000|Open-Label Period|Administrative/Other|1|||
145748876|NCT01661140|525595980|FG001|Open-Label Period|Administrative/Other|0|||
145748877|NCT01661140|525595981|FG002|Open-Label Period|Administrative/Other|0|||
145748878|NCT01661140|525595979|FG000|Open-Label Period|Sponsor termination|16|||
145748879|NCT01661140|525595980|FG001|Open-Label Period|Sponsor termination|0|||
145748880|NCT01661140|525595981|FG002|Open-Label Period|Sponsor termination|0|||
145748881|NCT01661140|525595979|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
145748882|NCT01661140|525595980|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
145748883|NCT01661140|525595981|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
145748884|NCT01661140|525595979|FG000|Open-Label Period|Lost to Follow-up|2|||
145748885|NCT01661140|525595980|FG001|Open-Label Period|Lost to Follow-up|0|||
145748886|NCT01661140|525595981|FG002|Open-Label Period|Lost to Follow-up|0|||
145748887|NCT01661140|525595979|FG000|Double-Blind Period|Refused Treatment|0|||
145748888|NCT01661140|525595980|FG001|Double-Blind Period|Refused Treatment|0|||
145748889|NCT01661140|525595981|FG002|Double-Blind Period|Refused Treatment|1|||
145748890|NCT01661140|525595979|FG000|Double-Blind Period|Adverse Event|0|||
145748891|NCT01661140|525595980|FG001|Double-Blind Period|Adverse Event|16|||
145748892|NCT01661140|525595981|FG002|Double-Blind Period|Adverse Event|18|||
145748893|NCT01661140|525595979|FG000|Double-Blind Period|Protocol Violation|0|||
145748894|NCT01661140|525595980|FG001|Double-Blind Period|Protocol Violation|2|||
145748895|NCT01661140|525595981|FG002|Double-Blind Period|Protocol Violation|3|||
145748896|NCT01661140|525595979|FG000|Double-Blind Period|Withdrawal by Subject|0|||
145748897|NCT01661140|525595980|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145748898|NCT01661140|525595981|FG002|Double-Blind Period|Withdrawal by Subject|3|||
145748899|NCT01661140|525595979|FG000|Double-Blind Period|Investigator's Decision|0|||
145748900|NCT01661140|525595980|FG001|Double-Blind Period|Investigator's Decision|1|||
145748901|NCT01661140|525595981|FG002|Double-Blind Period|Investigator's Decision|2|||
145748902|NCT01661140|525595979|FG000|Double-Blind Period|Sponsor Termination|0|||
145748903|NCT01661140|525595980|FG001|Double-Blind Period|Sponsor Termination|14|||
145748904|NCT01661140|525595981|FG002|Double-Blind Period|Sponsor Termination|17|||
145748905|NCT01661140|525595979|FG000|Double-Blind Period|Administrative/Other|0|||
145748906|NCT01661140|525595980|FG001|Double-Blind Period|Administrative/Other|7|||
145523939|NCT01117051|524778049|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
145523940|NCT01117051|524778048|FG000|Overall Study|Sponsor's decision|3|||
145523941|NCT01117051|524778049|FG001|Overall Study|Sponsor's decision|1|||
145748907|NCT01661140|525595981|FG002|Double-Blind Period|Administrative/Other|6|||
145748908|NCT01496885|525595983|FG000|Overall Study|Lost to Follow-up|13|||
145748909|NCT01496885|525595983|FG000|Overall Study|Withdrawal by Subject|7|||
145748910|NCT01496885|525595983|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
145748911|NCT01496885|525595983|FG000|Overall Study|Death|1|||
145748912|NCT02669017|525595985|FG000|Overall Study|Death|1|||
145748913|NCT02669017|525595986|FG001|Overall Study|Death|2|||
145748914|NCT02669017|525595987|FG002|Overall Study|Death|2|||
145748915|NCT02669017|525595988|FG003|Overall Study|Death|3|||
145748916|NCT02669017|525595989|FG004|Overall Study|Death|8|||
145748917|NCT02669017|525595990|FG005|Overall Study|Death|18|||
145748918|NCT02669017|525595991|FG006|Overall Study|Death|10|||
145748919|NCT02669017|525595992|FG007|Overall Study|Death|47|||
145748920|NCT02669017|525595993|FG008|Overall Study|Death|20|||
145748921|NCT02669017|525595985|FG000|Overall Study|Withdrawal by Subject|0|||
145748922|NCT02669017|525595986|FG001|Overall Study|Withdrawal by Subject|0|||
145748923|NCT02669017|525595987|FG002|Overall Study|Withdrawal by Subject|0|||
145748924|NCT02669017|525595988|FG003|Overall Study|Withdrawal by Subject|1|||
145748925|NCT02669017|525595989|FG004|Overall Study|Withdrawal by Subject|2|||
145748926|NCT02669017|525595990|FG005|Overall Study|Withdrawal by Subject|0|||
145748927|NCT02669017|525595991|FG006|Overall Study|Withdrawal by Subject|0|||
145748928|NCT02669017|525595992|FG007|Overall Study|Withdrawal by Subject|2|||
145748929|NCT02669017|525595993|FG008|Overall Study|Withdrawal by Subject|2|||
145748930|NCT02669017|525595985|FG000|Overall Study|Lost to Follow-up|0|||
145748931|NCT02669017|525595986|FG001|Overall Study|Lost to Follow-up|0|||
145748932|NCT02669017|525595987|FG002|Overall Study|Lost to Follow-up|0|||
145748933|NCT02669017|525595988|FG003|Overall Study|Lost to Follow-up|0|||
145748934|NCT02669017|525595989|FG004|Overall Study|Lost to Follow-up|0|||
145748935|NCT02669017|525595990|FG005|Overall Study|Lost to Follow-up|0|||
145748936|NCT02669017|525595991|FG006|Overall Study|Lost to Follow-up|0|||
145748937|NCT02669017|525595992|FG007|Overall Study|Lost to Follow-up|0|||
145748938|NCT02669017|525595993|FG008|Overall Study|Lost to Follow-up|1|||
145748939|NCT02669017|525595985|FG000|Overall Study|Miscellaneous|0|||
145748940|NCT02669017|525595986|FG001|Overall Study|Miscellaneous|0|||
145748941|NCT02669017|525595987|FG002|Overall Study|Miscellaneous|0|||
145748942|NCT02669017|525595988|FG003|Overall Study|Miscellaneous|0|||
145748943|NCT02669017|525595989|FG004|Overall Study|Miscellaneous|2|||
145748944|NCT02669017|525595990|FG005|Overall Study|Miscellaneous|1|||
145748945|NCT02669017|525595991|FG006|Overall Study|Miscellaneous|1|||
145748946|NCT02669017|525595992|FG007|Overall Study|Miscellaneous|13|||
145748947|NCT02669017|525595993|FG008|Overall Study|Miscellaneous|2|||
145748948|NCT01289015|525595994|FG000|Overall Study|Protocol Violation|12|||
145748949|NCT01289015|525595995|FG001|Overall Study|Protocol Violation|9|||
145748950|NCT01289015|525595994|FG000|Overall Study|Adverse Event|3|||
145748951|NCT01289015|525595995|FG001|Overall Study|Adverse Event|0|||
145748952|NCT01289015|525595994|FG000|Overall Study|Lost to Follow-up|33|||
145748953|NCT01289015|525595995|FG001|Overall Study|Lost to Follow-up|17|||
145748954|NCT01289015|525595994|FG000|Overall Study|Withdrawal by Subject|17|||
145748955|NCT01289015|525595995|FG001|Overall Study|Withdrawal by Subject|8|||
145748956|NCT01289015|525595994|FG000|Overall Study|Disease progression|1|||
145748957|NCT01289015|525595995|FG001|Overall Study|Disease progression|0|||
145748958|NCT01289015|525595994|FG000|Overall Study|Negative baseline culture and others|33|||
145748959|NCT01289015|525595995|FG001|Overall Study|Negative baseline culture and others|20|||
145748960|NCT03509350|525595999|FG000|Overall Study|Withdrawal by Subject|0|||
145748961|NCT03509350|525596000|FG001|Overall Study|Withdrawal by Subject|2|||
145748962|NCT04951037|525596005|FG000|Overall Study|Lost to Follow-up|16|||
145748963|NCT04951037|525596005|FG000|Overall Study|Withdrawal by Subject|5|||
145748964|NCT04951037|525596005|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
145748965|NCT02429414|525596007|FG000|Overall Study|Physician Decision|0|||
145748966|NCT02429414|525596008|FG001|Overall Study|Physician Decision|1|||
145748967|NCT01604265|525596012|FG000|Overall Study|Adverse Event|1|||
145748968|NCT01604265|525596013|FG001|Overall Study|Adverse Event|0|||
145748969|NCT01604265|525596012|FG000|Overall Study|Withdrawal by Subject|1|||
145748970|NCT01604265|525596013|FG001|Overall Study|Withdrawal by Subject|0|||
145748971|NCT00440947|525596016|FG000|36-Week Induction Phase|Adverse Event|16|||
145748972|NCT00440947|525596017|FG001|36-Week Induction Phase|Adverse Event|0|||
145748973|NCT00440947|525596018|FG002|36-Week Induction Phase|Adverse Event|0|||
145523942|NCT01117051|524778048|FG000|Overall Study|Surgical procedure|0|||
145748974|NCT00440947|525596019|FG003|36-Week Induction Phase|Adverse Event|0|||
145748975|NCT00440947|525596020|FG004|36-Week Induction Phase|Adverse Event|0|||
145748976|NCT00440947|525596016|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
145748977|NCT00440947|525596017|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
145748978|NCT00440947|525596018|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
145748979|NCT00440947|525596019|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
145748980|NCT00440947|525596020|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
145748981|NCT00440947|525596016|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
145748982|NCT00440947|525596017|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
145271094|NCT00539006|523839610|FG000|Treatment Period 2|Protocol Violation|1|||
145271095|NCT00539006|523839611|FG001|Treatment Period 2|Protocol Violation|0|||
145271096|NCT00539006|523839612|FG002|Treatment Period 2|Protocol Violation|0|||
145271097|NCT00539006|523839613|FG003|Treatment Period 2|Protocol Violation|0|||
145271098|NCT00539006|523839610|FG000|Treatment Period 2|Other|0|||
145271099|NCT00539006|523839611|FG001|Treatment Period 2|Other|1|||
145271100|NCT00539006|523839612|FG002|Treatment Period 2|Other|0|||
145271101|NCT00539006|523839613|FG003|Treatment Period 2|Other|0|||
145271102|NCT01965431|523839616|FG000|Overall Study|Adverse Event|0|||
145271103|NCT01965431|523839617|FG001|Overall Study|Adverse Event|1|||
145271104|NCT01965431|523839618|FG002|Overall Study|Adverse Event|0|||
145271105|NCT01965431|523839619|FG003|Overall Study|Adverse Event|0|||
145271106|NCT01965431|523839620|FG004|Overall Study|Adverse Event|0|||
145402642|NCT05965752|524330807|FG002|Overall Study|Early Termination|1|||
145523943|NCT01117051|524778049|FG001|Overall Study|Surgical procedure|1|||
145523944|NCT01117051|524778048|FG000|Overall Study|Randomized by mistake|0|||
145523945|NCT01117051|524778049|FG001|Overall Study|Randomized by mistake|1|||
145523946|NCT01117051|524778048|FG000|Overall Study|Convenience issue|1|||
145523947|NCT01117051|524778049|FG001|Overall Study|Convenience issue|0|||
145523948|NCT03780400|524778050|FG000|Overall Study|Lost to Follow-up|5|||
145523949|NCT03780400|524778050|FG000|Overall Study|Withdrawal by Subject|2|||
145523950|NCT00367770|524778051|FG000|Overall Study|Adverse Event|1|||
145523951|NCT00367770|524778051|FG000|Overall Study|Withdrawal by Subject|1|||
145523952|NCT00287079|524778054|FG000|Overall Study|Qualifying relapse|12|||
145523953|NCT00287079|524778055|FG001|Overall Study|Qualifying relapse|1|||
145523954|NCT00287079|524778054|FG000|Overall Study|Non-qualifying relapse|1|||
145523955|NCT00287079|524778055|FG001|Overall Study|Non-qualifying relapse|0|||
145523956|NCT00287079|524778054|FG000|Overall Study|Adverse Event|5|||
145523957|NCT00287079|524778055|FG001|Overall Study|Adverse Event|0|||
145523958|NCT00287079|524778054|FG000|Overall Study|Protocol Violation|1|||
145523959|NCT00287079|524778055|FG001|Overall Study|Protocol Violation|0|||
145523960|NCT00287079|524778054|FG000|Overall Study|Other|3|||
145523961|NCT00287079|524778055|FG001|Overall Study|Other|0|||
145523962|NCT00470184|524778056|FG000|Overall Study|Not Treated(became ineligible)|4|||
145523963|NCT00470184|524778056|FG000|Overall Study|Not treated (other)|1|||
145523964|NCT00470184|524778056|FG000|Overall Study|disease Progression|4|||
145523965|NCT00470184|524778056|FG000|Overall Study|Adverse Event|3|||
145523966|NCT00470184|524778056|FG000|Overall Study|Withdrawal by Subject|4|||
145523967|NCT00470184|524778056|FG000|Overall Study|other|5|||
145523968|NCT00470184|524778056|FG000|Overall Study|recurrence|1|||
145523969|NCT03282565|524778059|FG000|Overall Study|COVID-19 Research Shutdown|0|||
145523970|NCT03282565|524778060|FG001|Overall Study|COVID-19 Research Shutdown|2|||
145523971|NCT03282565|524778061|FG002|Overall Study|COVID-19 Research Shutdown|2|||
145523972|NCT02011893|524778062|FG000|Enrollment to Randomization|Adverse Event|2|||
145523973|NCT02011893|524778063|FG001|Enrollment to Randomization|Adverse Event|0|||
145523974|NCT02011893|524778064|FG002|Enrollment to Randomization|Adverse Event|0|||
145523975|NCT02011893|524778062|FG000|Enrollment to Randomization|Physician Decision|10|||
145523976|NCT02011893|524778063|FG001|Enrollment to Randomization|Physician Decision|0|||
145523977|NCT02011893|524778064|FG002|Enrollment to Randomization|Physician Decision|0|||
145523978|NCT02011893|524778062|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
145523979|NCT02011893|524778063|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
145523980|NCT02011893|524778064|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
145523981|NCT02011893|524778062|FG000|Enrollment to Randomization|Screening Failure|29|||
145523982|NCT02011893|524778063|FG001|Enrollment to Randomization|Screening Failure|0|||
145523983|NCT02011893|524778064|FG002|Enrollment to Randomization|Screening Failure|0|||
145523984|NCT02011893|524778062|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
145523985|NCT02011893|524778063|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
145523986|NCT02011893|524778064|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
145523987|NCT02011893|524778062|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
145523988|NCT02011893|524778063|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
145523989|NCT02011893|524778064|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
145523990|NCT02011893|524778062|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
145523991|NCT02011893|524778063|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
145271107|NCT01965431|523839621|FG005|Overall Study|Adverse Event|0|||
145271108|NCT01965431|523839616|FG000|Overall Study|Other than stated above|6|||
145271109|NCT01965431|523839617|FG001|Overall Study|Other than stated above|5|||
145402643|NCT05965752|524330808|FG003|Overall Study|Early Termination|0|||
145523992|NCT02011893|524778064|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
145523993|NCT02011893|524778062|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
145523994|NCT02011893|524778063|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
145523995|NCT02011893|524778064|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
145523996|NCT02011893|524778062|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
145523997|NCT02011893|524778063|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
145523998|NCT02011893|524778064|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
145523999|NCT00518973|524778065|FG000|Overall Study|Withdrawal by Subject|3|||
145748983|NCT00440947|525596018|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
145748984|NCT00440947|525596019|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
145748985|NCT00440947|525596020|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
145748986|NCT00440947|525596016|FG000|36-Week Induction Phase|Non-compliance|10|||
145748987|NCT00440947|525596017|FG001|36-Week Induction Phase|Non-compliance|0|||
145748988|NCT00440947|525596018|FG002|36-Week Induction Phase|Non-compliance|0|||
145748989|NCT00440947|525596019|FG003|36-Week Induction Phase|Non-compliance|0|||
145748990|NCT00440947|525596020|FG004|36-Week Induction Phase|Non-compliance|0|||
145748991|NCT00440947|525596016|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
145748992|NCT00440947|525596017|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
145748993|NCT00440947|525596018|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
145748994|NCT00440947|525596019|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
145748995|NCT00440947|525596020|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
145748996|NCT00440947|525596016|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
145748997|NCT00440947|525596017|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
145748998|NCT00440947|525596018|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
145748999|NCT00440947|525596019|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
145749000|NCT00440947|525596020|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
145749001|NCT00440947|525596016|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
145749002|NCT00440947|525596017|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
145749003|NCT00440947|525596018|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
145749004|NCT00440947|525596019|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
145749005|NCT00440947|525596020|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
145749006|NCT00440947|525596016|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
145749007|NCT00440947|525596017|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
145749008|NCT00440947|525596018|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
145749009|NCT00440947|525596019|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
145749010|NCT00440947|525596020|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
145749011|NCT00440947|525596016|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
145749012|NCT00440947|525596017|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
145749013|NCT00440947|525596018|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
145749014|NCT00440947|525596019|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
145749015|NCT00440947|525596020|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
145749016|NCT00440947|525596016|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
145749017|NCT00440947|525596017|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
145749018|NCT00440947|525596018|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
145749019|NCT00440947|525596019|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
145749020|NCT00440947|525596020|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
145749021|NCT00440947|525596016|FG000|36-Week Induction Phase|Incarceration|3|||
145749022|NCT00440947|525596017|FG001|36-Week Induction Phase|Incarceration|0|||
145749023|NCT00440947|525596018|FG002|36-Week Induction Phase|Incarceration|0|||
145749024|NCT00440947|525596019|FG003|36-Week Induction Phase|Incarceration|0|||
145749025|NCT00440947|525596020|FG004|36-Week Induction Phase|Incarceration|0|||
145749026|NCT00440947|525596016|FG000|36-Week Induction Phase|Pregnancy|1|||
145749027|NCT00440947|525596017|FG001|36-Week Induction Phase|Pregnancy|0|||
145749028|NCT00440947|525596018|FG002|36-Week Induction Phase|Pregnancy|0|||
145749029|NCT00440947|525596019|FG003|36-Week Induction Phase|Pregnancy|0|||
145749030|NCT00440947|525596020|FG004|36-Week Induction Phase|Pregnancy|0|||
145749031|NCT00440947|525596016|FG000|48-Week Randomization Phase|Adverse Event|0|||
145749032|NCT00440947|525596017|FG001|48-Week Randomization Phase|Adverse Event|2|||
145749033|NCT00440947|525596018|FG002|48-Week Randomization Phase|Adverse Event|5|||
145749034|NCT00440947|525596019|FG003|48-Week Randomization Phase|Adverse Event|0|||
145749035|NCT00440947|525596020|FG004|48-Week Randomization Phase|Adverse Event|0|||
145749036|NCT00440947|525596016|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
145749037|NCT00440947|525596017|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
145749038|NCT00440947|525596018|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
145749039|NCT00440947|525596019|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
145749040|NCT00440947|525596020|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
145749041|NCT00440947|525596016|FG000|48-Week Randomization Phase|Non-compliance|0|||
145749042|NCT00440947|525596017|FG001|48-Week Randomization Phase|Non-compliance|3|||
145749043|NCT00440947|525596018|FG002|48-Week Randomization Phase|Non-compliance|4|||
145749044|NCT00440947|525596019|FG003|48-Week Randomization Phase|Non-compliance|0|||
145749045|NCT00440947|525596020|FG004|48-Week Randomization Phase|Non-compliance|0|||
145749046|NCT00440947|525596016|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
145749047|NCT00440947|525596017|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
145749048|NCT00440947|525596018|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
145749049|NCT00440947|525596019|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
145749050|NCT00440947|525596020|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
145749051|NCT00440947|525596016|FG000|48-Week Randomization Phase|Protocol Violation|0|||
145749052|NCT00440947|525596017|FG001|48-Week Randomization Phase|Protocol Violation|0|||
145749053|NCT00440947|525596018|FG002|48-Week Randomization Phase|Protocol Violation|1|||
145749054|NCT00440947|525596019|FG003|48-Week Randomization Phase|Protocol Violation|0|||
145749055|NCT00440947|525596020|FG004|48-Week Randomization Phase|Protocol Violation|0|||
145749056|NCT00440947|525596016|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
145749057|NCT00440947|525596017|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
145749058|NCT00440947|525596018|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
145749059|NCT00440947|525596019|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
145749060|NCT00440947|525596020|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
145749061|NCT00440947|525596016|FG000|48-Week Randomization Phase|Pregnancy|0|||
145749062|NCT00440947|525596017|FG001|48-Week Randomization Phase|Pregnancy|0|||
145749063|NCT00440947|525596018|FG002|48-Week Randomization Phase|Pregnancy|1|||
145749064|NCT00440947|525596019|FG003|48-Week Randomization Phase|Pregnancy|0|||
145749065|NCT00440947|525596020|FG004|48-Week Randomization Phase|Pregnancy|0|||
145749066|NCT00440947|525596016|FG000|48-Week Randomization Phase|Incarceration|0|||
145749067|NCT00440947|525596017|FG001|48-Week Randomization Phase|Incarceration|3|||
145749068|NCT00440947|525596018|FG002|48-Week Randomization Phase|Incarceration|0|||
145749069|NCT00440947|525596019|FG003|48-Week Randomization Phase|Incarceration|0|||
145749070|NCT00440947|525596020|FG004|48-Week Randomization Phase|Incarceration|0|||
145749071|NCT00440947|525596016|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
145749072|NCT00440947|525596017|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
145749073|NCT00440947|525596018|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
145749074|NCT00440947|525596019|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
145749075|NCT00440947|525596020|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
145749076|NCT00440947|525596016|FG000|48-Week Randomization Phase|Physician Decision|0|||
145749077|NCT00440947|525596017|FG001|48-Week Randomization Phase|Physician Decision|2|||
145749078|NCT00440947|525596018|FG002|48-Week Randomization Phase|Physician Decision|0|||
145749079|NCT00440947|525596019|FG003|48-Week Randomization Phase|Physician Decision|0|||
145749080|NCT00440947|525596020|FG004|48-Week Randomization Phase|Physician Decision|0|||
145749081|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
145749082|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
145749083|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
145749084|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
145749085|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
145271110|NCT01965431|523839618|FG002|Overall Study|Other than stated above|6|||
145271111|NCT01965431|523839619|FG003|Overall Study|Other than stated above|6|||
145271112|NCT01965431|523839620|FG004|Overall Study|Other than stated above|6|||
145271113|NCT01965431|523839621|FG005|Overall Study|Other than stated above|6|||
145271114|NCT00577031|523839622|FG000|Overall Study|Adverse Event|52|||
145402644|NCT05965752|524330809|FG004|Overall Study|Early Termination|0|||
145749086|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
145749087|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
145749088|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
145749089|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
145749090|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
145749091|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
145749092|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
145749093|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
145749094|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
145749095|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
145749096|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
145749097|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
145749098|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
145749099|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
145749100|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
145749101|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
145749102|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
145749103|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
145749104|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
145749105|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
145749106|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
145749107|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
145749108|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
145749109|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
145749110|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
145749111|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
145749112|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
145749113|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
145749114|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
145749115|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
145749116|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
145749117|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
145749118|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
145749119|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
145749120|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
145749121|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
145749122|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
145749123|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
145749124|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
145749125|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
145749126|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
145749127|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
145749128|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
145749129|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
145749130|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
145524000|NCT00518973|524778066|FG001|Overall Study|Withdrawal by Subject|2|||
145524001|NCT03452527|524778067|FG000|Overall Study|Withdrawal by Subject|1|||
145524002|NCT03452527|524778068|FG001|Overall Study|Withdrawal by Subject|1|||
145524003|NCT03452527|524778067|FG000|Overall Study|Study Terminated|2|||
145524004|NCT03452527|524778068|FG001|Overall Study|Study Terminated|3|||
145524005|NCT00582816|524778069|FG000|Overall Study|Engraftment Failure|3|||
145524006|NCT02129777|524778072|FG000|Double-Blind Period|Adverse Event|0|||
145524007|NCT02129777|524778073|FG001|Double-Blind Period|Adverse Event|0|||
145524008|NCT02129777|524778074|FG002|Double-Blind Period|Adverse Event|0|||
145524009|NCT02129777|524778075|FG003|Double-Blind Period|Adverse Event|0|||
145524010|NCT02129777|524778076|FG004|Double-Blind Period|Adverse Event|1|||
145749131|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
145749132|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
145749133|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
145749134|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
145749135|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
145749136|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Other|0|||
145749137|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Other|0|||
145749138|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Other|0|||
145749139|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Other|1|||
145749140|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Other|0|||
145749141|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
145749142|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
145749143|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
145749144|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
145524011|NCT02129777|524778077|FG005|Double-Blind Period|Adverse Event|0|||
145524012|NCT02129777|524778078|FG006|Double-Blind Period|Adverse Event|0|||
145524013|NCT02129777|524778072|FG000|Double-Blind Period|Lost to Follow-up|1|||
145749145|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
145749146|NCT00440947|525596016|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
145749147|NCT00440947|525596017|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
145749148|NCT00440947|525596018|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
145749149|NCT00440947|525596019|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
145749150|NCT00440947|525596020|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
145749151|NCT02898259|525596021|FG000|Overall Study|Adverse Event|0|||
145749152|NCT02898259|525596022|FG001|Overall Study|Adverse Event|0|||
145749153|NCT02898259|525596023|FG002|Overall Study|Adverse Event|1|||
145749154|NCT02898259|525596024|FG003|Overall Study|Adverse Event|0|||
145749155|NCT02898259|525596025|FG004|Overall Study|Adverse Event|0|||
145749156|NCT02898259|525596021|FG000|Overall Study|Lack of Efficacy|1|||
145749157|NCT02898259|525596022|FG001|Overall Study|Lack of Efficacy|1|||
145749158|NCT02898259|525596023|FG002|Overall Study|Lack of Efficacy|3|||
145749159|NCT02898259|525596024|FG003|Overall Study|Lack of Efficacy|0|||
145749160|NCT02898259|525596025|FG004|Overall Study|Lack of Efficacy|0|||
145749161|NCT02898259|525596021|FG000|Overall Study|Lost to Follow-up|0|||
145749162|NCT02898259|525596022|FG001|Overall Study|Lost to Follow-up|0|||
145749163|NCT02898259|525596023|FG002|Overall Study|Lost to Follow-up|1|||
145749164|NCT02898259|525596024|FG003|Overall Study|Lost to Follow-up|0|||
145749165|NCT02898259|525596025|FG004|Overall Study|Lost to Follow-up|0|||
145749166|NCT02898259|525596021|FG000|Overall Study|Transformation before study began|0|||
145749167|NCT02898259|525596022|FG001|Overall Study|Transformation before study began|0|||
145749168|NCT02898259|525596023|FG002|Overall Study|Transformation before study began|0|||
145749169|NCT02898259|525596024|FG003|Overall Study|Transformation before study began|1|||
145749170|NCT02898259|525596025|FG004|Overall Study|Transformation before study began|0|||
145749171|NCT03016325|525596032|FG000|Treatment Period|Participant withdrew consent|0|||
145749172|NCT03016325|525596033|FG001|Treatment Period|Participant withdrew consent|1|||
145749173|NCT03016325|525596034|FG002|Treatment Period|Participant withdrew consent|0|||
145749174|NCT03016325|525596035|FG003|Treatment Period|Participant withdrew consent|0|||
145749175|NCT03016325|525596036|FG004|Treatment Period|Participant withdrew consent|0|||
145749176|NCT03016325|525596037|FG005|Treatment Period|Participant withdrew consent|0|||
145749177|NCT03016325|525596038|FG006|Treatment Period|Participant withdrew consent|0|||
145749178|NCT03016325|525596039|FG007|Treatment Period|Participant withdrew consent|0|||
145749179|NCT03016325|525596032|FG000|Treatment Period|Death|0|||
145749180|NCT03016325|525596033|FG001|Treatment Period|Death|0|||
145749181|NCT03016325|525596034|FG002|Treatment Period|Death|0|||
145749182|NCT03016325|525596035|FG003|Treatment Period|Death|0|||
145749183|NCT03016325|525596036|FG004|Treatment Period|Death|2|||
145749184|NCT03016325|525596037|FG005|Treatment Period|Death|0|||
145749185|NCT03016325|525596038|FG006|Treatment Period|Death|0|||
145749186|NCT03016325|525596039|FG007|Treatment Period|Death|0|||
145749187|NCT03016325|525596032|FG000|Treatment Period|Participant refuses assessments|0|||
145749188|NCT03016325|525596033|FG001|Treatment Period|Participant refuses assessments|0|||
145749189|NCT03016325|525596034|FG002|Treatment Period|Participant refuses assessments|1|||
145749190|NCT03016325|525596035|FG003|Treatment Period|Participant refuses assessments|0|||
145749191|NCT03016325|525596036|FG004|Treatment Period|Participant refuses assessments|0|||
145749192|NCT03016325|525596037|FG005|Treatment Period|Participant refuses assessments|0|||
145749193|NCT03016325|525596038|FG006|Treatment Period|Participant refuses assessments|0|||
145749194|NCT03016325|525596039|FG007|Treatment Period|Participant refuses assessments|0|||
145749195|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Death|2|||
145749196|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Death|0|||
145749197|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Death|5|||
145749198|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Death|6|||
145271115|NCT00577031|523839622|FG000|Overall Study|Progression of disease|93|||
145271116|NCT00577031|523839622|FG000|Overall Study|Protocol Violation|5|||
145271117|NCT00577031|523839622|FG000|Overall Study|Participant withdrew consent|13|||
145271118|NCT00577031|523839622|FG000|Overall Study|Participant non-compliance|5|||
145271119|NCT00577031|523839622|FG000|Overall Study|Need for surgery|17|||
145271120|NCT00577031|523839622|FG000|Overall Study|Medical decision|14|||
145749199|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Death|3|||
145271121|NCT00577031|523839622|FG000|Overall Study|Death|6|||
145271122|NCT04635631|523839623|FG000|Overall Study|Adverse Event|1|||
145749200|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Death|0|||
145749201|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Death|0|||
145749202|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Death|0|||
145749203|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
145749204|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
145749205|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
145749206|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
145749207|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
145749208|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
145749209|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
145749210|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
145749211|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
145749212|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
145749213|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
145749214|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
145749215|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
145749216|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
145749217|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
145749218|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
145749219|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
145749220|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
145749221|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
145749222|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
145749223|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
145749224|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
145749225|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
145749226|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
145749227|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749228|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749229|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749230|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749231|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
145749232|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749233|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
145749234|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
145749235|NCT03016325|525596032|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749236|NCT03016325|525596033|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749237|NCT03016325|525596034|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
145749238|NCT03016325|525596035|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749239|NCT03016325|525596036|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749240|NCT03016325|525596037|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749241|NCT03016325|525596038|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749242|NCT03016325|525596039|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
145749243|NCT03016325|525596032|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749244|NCT03016325|525596033|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
145749245|NCT03016325|525596034|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749246|NCT03016325|525596035|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749247|NCT03016325|525596036|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749248|NCT03016325|525596037|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749249|NCT03016325|525596038|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749250|NCT03016325|525596039|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
145749251|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Death|3|||
145749252|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Death|3|||
145749253|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Death|11|||
145749254|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Death|12|||
145524014|NCT02129777|524778073|FG001|Double-Blind Period|Lost to Follow-up|1|||
145524015|NCT02129777|524778074|FG002|Double-Blind Period|Lost to Follow-up|1|||
145524016|NCT02129777|524778075|FG003|Double-Blind Period|Lost to Follow-up|2|||
145524017|NCT02129777|524778076|FG004|Double-Blind Period|Lost to Follow-up|0|||
145524018|NCT02129777|524778077|FG005|Double-Blind Period|Lost to Follow-up|0|||
145524019|NCT02129777|524778078|FG006|Double-Blind Period|Lost to Follow-up|0|||
145524020|NCT02129777|524778072|FG000|Double-Blind Period|Withdrawal by Subject|2|||
145524021|NCT02129777|524778073|FG001|Double-Blind Period|Withdrawal by Subject|4|||
145524022|NCT02129777|524778074|FG002|Double-Blind Period|Withdrawal by Subject|3|||
145524023|NCT02129777|524778075|FG003|Double-Blind Period|Withdrawal by Subject|2|||
145524024|NCT02129777|524778076|FG004|Double-Blind Period|Withdrawal by Subject|3|||
145749255|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Death|9|||
145524025|NCT02129777|524778077|FG005|Double-Blind Period|Withdrawal by Subject|0|||
145749256|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Death|0|||
145402645|NCT05965752|524330805|FG000|Overall Study|Reported Unwanted Symptoms|0|||
145402646|NCT05965752|524330806|FG001|Overall Study|Reported Unwanted Symptoms|0|||
145402647|NCT05965752|524330807|FG002|Overall Study|Reported Unwanted Symptoms|0|||
145271123|NCT04635631|523839623|FG000|Overall Study|Progressive disease|13|||
145402648|NCT05965752|524330808|FG003|Overall Study|Reported Unwanted Symptoms|0|||
145524026|NCT02129777|524778078|FG006|Double-Blind Period|Withdrawal by Subject|0|||
145524027|NCT02129777|524778072|FG000|Double-Blind Period|Pregnancy|0|||
145524028|NCT02129777|524778073|FG001|Double-Blind Period|Pregnancy|0|||
145524029|NCT02129777|524778074|FG002|Double-Blind Period|Pregnancy|0|||
145524030|NCT02129777|524778075|FG003|Double-Blind Period|Pregnancy|0|||
145524031|NCT02129777|524778076|FG004|Double-Blind Period|Pregnancy|1|||
145524032|NCT02129777|524778077|FG005|Double-Blind Period|Pregnancy|0|||
145524033|NCT02129777|524778078|FG006|Double-Blind Period|Pregnancy|0|||
145524034|NCT02129777|524778072|FG000|Double-Blind Period|Lack of Efficacy|3|||
145524035|NCT02129777|524778073|FG001|Double-Blind Period|Lack of Efficacy|1|||
145524036|NCT02129777|524778074|FG002|Double-Blind Period|Lack of Efficacy|0|||
145524037|NCT02129777|524778075|FG003|Double-Blind Period|Lack of Efficacy|3|||
145524038|NCT02129777|524778076|FG004|Double-Blind Period|Lack of Efficacy|2|||
145524039|NCT02129777|524778077|FG005|Double-Blind Period|Lack of Efficacy|0|||
145524040|NCT02129777|524778078|FG006|Double-Blind Period|Lack of Efficacy|0|||
145524041|NCT02129777|524778072|FG000|Double-Blind Period|Other|1|||
145524042|NCT02129777|524778073|FG001|Double-Blind Period|Other|2|||
145749257|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Death|0|||
145749258|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Death|1|||
145749259|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
145749260|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145749261|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145749262|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145524043|NCT02129777|524778074|FG002|Double-Blind Period|Other|0|||
145524044|NCT02129777|524778075|FG003|Double-Blind Period|Other|0|||
145524045|NCT02129777|524778076|FG004|Double-Blind Period|Other|0|||
145524046|NCT02129777|524778077|FG005|Double-Blind Period|Other|0|||
145524047|NCT02129777|524778078|FG006|Double-Blind Period|Other|0|||
145524048|NCT02129777|524778072|FG000|Open-Label Period|Lack of Efficacy|0|||
145524049|NCT02129777|524778073|FG001|Open-Label Period|Lack of Efficacy|0|||
145524050|NCT02129777|524778074|FG002|Open-Label Period|Lack of Efficacy|0|||
145524051|NCT02129777|524778075|FG003|Open-Label Period|Lack of Efficacy|0|||
145749263|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145749264|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145524052|NCT02129777|524778076|FG004|Open-Label Period|Lack of Efficacy|0|||
145524053|NCT02129777|524778077|FG005|Open-Label Period|Lack of Efficacy|0|||
145524054|NCT02129777|524778078|FG006|Open-Label Period|Lack of Efficacy|5|||
145524055|NCT02129777|524778072|FG000|Open-Label Period|Lost to Follow-up|0|||
145524056|NCT02129777|524778073|FG001|Open-Label Period|Lost to Follow-up|0|||
145524057|NCT02129777|524778074|FG002|Open-Label Period|Lost to Follow-up|0|||
145524058|NCT02129777|524778075|FG003|Open-Label Period|Lost to Follow-up|0|||
145524059|NCT02129777|524778076|FG004|Open-Label Period|Lost to Follow-up|0|||
145524060|NCT02129777|524778077|FG005|Open-Label Period|Lost to Follow-up|1|||
145524061|NCT02129777|524778078|FG006|Open-Label Period|Lost to Follow-up|1|||
145524062|NCT02129777|524778072|FG000|Open-Label Period|Withdrawal by Subject|0|||
145524063|NCT02129777|524778073|FG001|Open-Label Period|Withdrawal by Subject|0|||
145524064|NCT02129777|524778074|FG002|Open-Label Period|Withdrawal by Subject|0|||
145524065|NCT02129777|524778075|FG003|Open-Label Period|Withdrawal by Subject|0|||
145524066|NCT02129777|524778076|FG004|Open-Label Period|Withdrawal by Subject|0|||
145524067|NCT02129777|524778077|FG005|Open-Label Period|Withdrawal by Subject|1|||
145524068|NCT02129777|524778078|FG006|Open-Label Period|Withdrawal by Subject|3|||
145524069|NCT02129777|524778072|FG000|Open-Label Period|Study Termination|0|||
145524070|NCT02129777|524778073|FG001|Open-Label Period|Study Termination|0|||
145524071|NCT02129777|524778074|FG002|Open-Label Period|Study Termination|0|||
145524072|NCT02129777|524778075|FG003|Open-Label Period|Study Termination|0|||
145749265|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145524073|NCT02129777|524778076|FG004|Open-Label Period|Study Termination|0|||
145524074|NCT02129777|524778077|FG005|Open-Label Period|Study Termination|10|||
145524075|NCT02129777|524778078|FG006|Open-Label Period|Study Termination|39|||
145524076|NCT01565499|524778080|FG000|Overall Study|Physician Decision|1|||
145524077|NCT01565499|524778080|FG000|Overall Study|Adverse Event|5|||
145524078|NCT01565499|524778080|FG000|Overall Study|Withdrawal by Subject|2|||
145524079|NCT01923168|524778087|FG000|Overall Study|Protocol Violation|1|||
145524080|NCT01923168|524778088|FG001|Overall Study|Protocol Violation|1|||
145524081|NCT01923168|524778089|FG002|Overall Study|Protocol Violation|0|||
145524082|NCT01923168|524778087|FG000|Overall Study|Subject/guardian decision|14|||
145524083|NCT01923168|524778088|FG001|Overall Study|Subject/guardian decision|14|||
145524084|NCT01923168|524778089|FG002|Overall Study|Subject/guardian decision|4|||
145524085|NCT01923168|524778087|FG000|Overall Study|Adverse Event|12|||
145524086|NCT01923168|524778088|FG001|Overall Study|Adverse Event|12|||
145524087|NCT01923168|524778089|FG002|Overall Study|Adverse Event|0|||
145524088|NCT01923168|524778087|FG000|Overall Study|Physician Decision|6|||
145524089|NCT01923168|524778088|FG001|Overall Study|Physician Decision|9|||
145524090|NCT01923168|524778089|FG002|Overall Study|Physician Decision|5|||
145524091|NCT01923168|524778087|FG000|Overall Study|Progressive disease|4|||
145524092|NCT01923168|524778088|FG001|Overall Study|Progressive disease|3|||
145524093|NCT01923168|524778089|FG002|Overall Study|Progressive disease|7|||
145524094|NCT01923168|524778087|FG000|Overall Study|Death|0|||
145524095|NCT01923168|524778088|FG001|Overall Study|Death|0|||
145524096|NCT01923168|524778089|FG002|Overall Study|Death|1|||
145524097|NCT03116347|524778090|FG000|Overall Study|Withdrawal by Subject|1|||
145524098|NCT03116347|524778091|FG001|Overall Study|Withdrawal by Subject|2|||
145524099|NCT01255787|524778092|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
145524100|NCT01255787|524778093|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
145524101|NCT01255787|524778094|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
145524102|NCT01255787|524778095|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
145524103|NCT01255787|524778092|FG000|Overall Study|Major Protocol Deviation|1|||
145524104|NCT01255787|524778093|FG001|Overall Study|Major Protocol Deviation|1|||
145524105|NCT01255787|524778094|FG002|Overall Study|Major Protocol Deviation|0|||
145524106|NCT01255787|524778095|FG003|Overall Study|Major Protocol Deviation|4|||
145524107|NCT01255787|524778092|FG000|Overall Study|Lost to Follow-up|1|||
145524108|NCT01255787|524778093|FG001|Overall Study|Lost to Follow-up|2|||
145749266|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
145749267|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
145271124|NCT04635631|523839623|FG000|Overall Study|Withdrawal by Subject|1|||
145271125|NCT01067339|523839626|FG000|Overall Study|Withdrawal by Subject|6|||
145271126|NCT01067339|523839627|FG001|Overall Study|Withdrawal by Subject|5|||
145271127|NCT00769132|523839628|FG000|Period 1|Adverse Event|1|||
145271128|NCT00769132|523839629|FG001|Period 1|Adverse Event|0|||
145271129|NCT00769132|523839630|FG002|Period 1|Adverse Event|0|||
145271130|NCT00769132|523839631|FG003|Period 1|Adverse Event|1|||
145271131|NCT00769132|523839628|FG000|Period 2|Withdrawal by Subject|0|||
145271132|NCT00769132|523839629|FG001|Period 2|Withdrawal by Subject|0|||
145271133|NCT00769132|523839630|FG002|Period 2|Withdrawal by Subject|0|||
145271134|NCT00769132|523839631|FG003|Period 2|Withdrawal by Subject|1|||
145749268|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
145749269|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
145749270|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
145749271|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
145271135|NCT00769132|523839628|FG000|Period 3|Withdrawal by Subject|1|||
145749272|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
145524109|NCT01255787|524778094|FG002|Overall Study|Lost to Follow-up|4|||
145524110|NCT01255787|524778095|FG003|Overall Study|Lost to Follow-up|2|||
145524111|NCT01255787|524778092|FG000|Overall Study|Withdrawal of Consent|3|||
145524112|NCT01255787|524778093|FG001|Overall Study|Withdrawal of Consent|9|||
145524113|NCT01255787|524778094|FG002|Overall Study|Withdrawal of Consent|3|||
145524114|NCT01255787|524778095|FG003|Overall Study|Withdrawal of Consent|4|||
145524115|NCT01255787|524778092|FG000|Overall Study|Pregnancy|0|||
145271136|NCT00769132|523839629|FG001|Period 3|Withdrawal by Subject|0|||
145271137|NCT00769132|523839630|FG002|Period 3|Withdrawal by Subject|0|||
145749273|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
145749274|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
145749275|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749276|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749277|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749278|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749279|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
145749280|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749281|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749282|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
145749283|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749284|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749285|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749286|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749287|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
145749288|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749289|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749290|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
145749291|NCT03016325|525596032|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749292|NCT03016325|525596033|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749293|NCT03016325|525596034|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749294|NCT03016325|525596035|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
145749295|NCT03016325|525596036|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749296|NCT03016325|525596037|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749297|NCT03016325|525596038|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145524116|NCT01255787|524778093|FG001|Overall Study|Pregnancy|0|||
145271138|NCT00769132|523839631|FG003|Period 3|Withdrawal by Subject|0|||
145524117|NCT01255787|524778094|FG002|Overall Study|Pregnancy|0|||
145749298|NCT03016325|525596039|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
145749299|NCT03016325|525596032|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145524118|NCT01255787|524778095|FG003|Overall Study|Pregnancy|1|||
145524119|NCT01255787|524778092|FG000|Overall Study|Lack of Efficacy|2|||
145524120|NCT01255787|524778093|FG001|Overall Study|Lack of Efficacy|2|||
145524121|NCT01255787|524778094|FG002|Overall Study|Lack of Efficacy|2|||
145524122|NCT01255787|524778095|FG003|Overall Study|Lack of Efficacy|2|||
145524123|NCT01255787|524778092|FG000|Overall Study|Noncompliance with Study Drug|3|||
145524124|NCT01255787|524778093|FG001|Overall Study|Noncompliance with Study Drug|1|||
145524125|NCT01255787|524778094|FG002|Overall Study|Noncompliance with Study Drug|0|||
145271139|NCT00769132|523839628|FG000|Period 4|Withdrawal by Subject|0|||
145271140|NCT00769132|523839629|FG001|Period 4|Withdrawal by Subject|1|||
145524126|NCT01255787|524778095|FG003|Overall Study|Noncompliance with Study Drug|0|||
145524127|NCT03882008|524778096|FG000|Overall Study|Withdrawal by Subject|1|||
145524128|NCT03882008|524778096|FG000|Overall Study|Lost to Follow-up|1|||
145524129|NCT00768469|524778098|FG000|Overall Study|Adverse Event|0|||
145524130|NCT00768469|524778099|FG001|Overall Study|Adverse Event|2|||
145524131|NCT00768469|524778098|FG000|Overall Study|Disease Progression|3|||
145524132|NCT00768469|524778099|FG001|Overall Study|Disease Progression|4|||
145524133|NCT00768469|524778098|FG000|Overall Study|Withdrawal by Subject|0|||
145524134|NCT00768469|524778099|FG001|Overall Study|Withdrawal by Subject|1|||
145524135|NCT04966741|524778100|FG000|Overall Study|Lost to Follow-up|1|||
145749300|NCT03016325|525596033|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
145749301|NCT03016325|525596034|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749302|NCT03016325|525596035|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749303|NCT03016325|525596036|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749304|NCT03016325|525596037|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749305|NCT03016325|525596038|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749306|NCT03016325|525596039|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
145749307|NCT03016325|525596032|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
145749308|NCT03016325|525596033|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
145749309|NCT03016325|525596034|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
145271141|NCT00769132|523839630|FG002|Period 4|Withdrawal by Subject|0|||
145271142|NCT00769132|523839631|FG003|Period 4|Withdrawal by Subject|0|||
145271143|NCT02230332|523839632|FG000|Overall Study|Adverse Event|2|||
145271144|NCT02230332|523839633|FG001|Overall Study|Adverse Event|1|||
145271145|NCT02230332|523839632|FG000|Overall Study|Lost to Follow-up|1|||
145271146|NCT02230332|523839633|FG001|Overall Study|Lost to Follow-up|0|||
145524136|NCT04966741|524778101|FG001|Overall Study|Lost to Follow-up|0|||
145524137|NCT02953509|524778102|FG000|Overall Study|Death|1|||
145524138|NCT02953509|524778103|FG001|Overall Study|Death|3|||
145524139|NCT02953509|524778104|FG002|Overall Study|Death|3|||
145524140|NCT02953509|524778105|FG003|Overall Study|Death|4|||
145524141|NCT02953509|524778106|FG004|Overall Study|Death|12|||
145524142|NCT02953509|524778107|FG005|Overall Study|Death|3|||
145524143|NCT02953509|524778108|FG006|Overall Study|Death|25|||
145524144|NCT02953509|524778109|FG007|Overall Study|Death|10|||
145524145|NCT02953509|524778110|FG008|Overall Study|Death|21|||
145524146|NCT02953509|524778111|FG009|Overall Study|Death|20|||
145524147|NCT02953509|524778102|FG000|Overall Study|Reason Not Specified|0|||
145524148|NCT02953509|524778103|FG001|Overall Study|Reason Not Specified|2|||
145524149|NCT02953509|524778104|FG002|Overall Study|Reason Not Specified|8|||
145524150|NCT02953509|524778105|FG003|Overall Study|Reason Not Specified|2|||
145524151|NCT02953509|524778106|FG004|Overall Study|Reason Not Specified|11|||
145524152|NCT02953509|524778107|FG005|Overall Study|Reason Not Specified|4|||
145524153|NCT02953509|524778108|FG006|Overall Study|Reason Not Specified|12|||
145524154|NCT02953509|524778109|FG007|Overall Study|Reason Not Specified|2|||
145271147|NCT02230332|523839632|FG000|Overall Study|Protocol Violation|1|||
145271148|NCT02230332|523839633|FG001|Overall Study|Protocol Violation|0|||
145271149|NCT00877799|523839635|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
145271150|NCT00877799|523839636|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
145524155|NCT02953509|524778110|FG008|Overall Study|Reason Not Specified|7|||
145749310|NCT03016325|525596035|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
145749311|NCT03016325|525596036|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
145271151|NCT00877799|523839637|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
145271152|NCT00877799|523839638|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
145271153|NCT00877799|523839639|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
145271154|NCT00877799|523839635|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
145271155|NCT00877799|523839636|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
145524156|NCT02953509|524778111|FG009|Overall Study|Reason Not Specified|2|||
145524157|NCT02953509|524778102|FG000|Overall Study|Consent Withdrawn|1|||
145524158|NCT02953509|524778103|FG001|Overall Study|Consent Withdrawn|1|||
145524159|NCT02953509|524778104|FG002|Overall Study|Consent Withdrawn|2|||
145524160|NCT02953509|524778105|FG003|Overall Study|Consent Withdrawn|1|||
145524161|NCT02953509|524778106|FG004|Overall Study|Consent Withdrawn|3|||
145524162|NCT02953509|524778107|FG005|Overall Study|Consent Withdrawn|0|||
145749312|NCT03016325|525596037|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
145749313|NCT03016325|525596038|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
145749314|NCT03016325|525596039|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
145749315|NCT01618214|525596043|FG000|Overall Study|Adverse Event|3|||
145749316|NCT01618214|525596044|FG001|Overall Study|Adverse Event|1|||
145749317|NCT01618214|525596043|FG000|Overall Study|Lack of Efficacy|1|||
145749318|NCT01618214|525596044|FG001|Overall Study|Lack of Efficacy|1|||
145749319|NCT01618214|525596043|FG000|Overall Study|Protocol Violation|1|||
145749320|NCT01618214|525596044|FG001|Overall Study|Protocol Violation|4|||
145749321|NCT01618214|525596043|FG000|Overall Study|Withdrawal Criteria|1|||
145749322|NCT01618214|525596044|FG001|Overall Study|Withdrawal Criteria|2|||
145749323|NCT01618214|525596043|FG000|Overall Study|Unclassified|4|||
145749324|NCT01618214|525596044|FG001|Overall Study|Unclassified|5|||
145749325|NCT00606086|525596045|FG000|Overall Study|Adverse Event|1|||
145749326|NCT00606086|525596046|FG001|Overall Study|Adverse Event|1|||
145749327|NCT00606086|525596045|FG000|Overall Study|Lost to Follow-up|4|||
145749328|NCT00606086|525596046|FG001|Overall Study|Lost to Follow-up|8|||
145749329|NCT00606086|525596045|FG000|Overall Study|Protocol Violation|1|||
145749330|NCT00606086|525596046|FG001|Overall Study|Protocol Violation|0|||
145524163|NCT02953509|524778108|FG006|Overall Study|Consent Withdrawn|4|||
145524164|NCT02953509|524778109|FG007|Overall Study|Consent Withdrawn|1|||
145524165|NCT02953509|524778110|FG008|Overall Study|Consent Withdrawn|1|||
145524166|NCT02953509|524778111|FG009|Overall Study|Consent Withdrawn|4|||
145524167|NCT02953509|524778102|FG000|Overall Study|Lost to Follow-up|0|||
145749331|NCT00606086|525596045|FG000|Overall Study|Withdrawal by Subject|5|||
145749332|NCT00606086|525596046|FG001|Overall Study|Withdrawal by Subject|3|||
145749333|NCT00606086|525596045|FG000|Overall Study|Non-compliance|0|||
145749334|NCT00606086|525596046|FG001|Overall Study|Non-compliance|1|||
145749335|NCT00606086|525596045|FG000|Overall Study|Randomized, not treated|1|||
145749336|NCT00606086|525596046|FG001|Overall Study|Randomized, not treated|2|||
145749337|NCT00391222|525596049|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
145524168|NCT02953509|524778103|FG001|Overall Study|Lost to Follow-up|0|||
145524169|NCT02953509|524778104|FG002|Overall Study|Lost to Follow-up|0|||
145524170|NCT02953509|524778105|FG003|Overall Study|Lost to Follow-up|0|||
145749338|NCT00391222|525596050|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
145749339|NCT00391222|525596051|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
145749340|NCT00391222|525596052|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
145749341|NCT00391222|525596049|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
145749342|NCT00391222|525596050|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
145749343|NCT00391222|525596051|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
145749344|NCT00391222|525596052|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
145749345|NCT00391222|525596049|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
145524171|NCT02953509|524778106|FG004|Overall Study|Lost to Follow-up|0|||
145524172|NCT02953509|524778107|FG005|Overall Study|Lost to Follow-up|0|||
145524173|NCT02953509|524778108|FG006|Overall Study|Lost to Follow-up|1|||
145524174|NCT02953509|524778109|FG007|Overall Study|Lost to Follow-up|1|||
145524175|NCT02953509|524778110|FG008|Overall Study|Lost to Follow-up|1|||
145524176|NCT02953509|524778111|FG009|Overall Study|Lost to Follow-up|1|||
145524177|NCT02953509|524778102|FG000|Overall Study|Study terminated by sponsor|1|||
145524178|NCT02953509|524778103|FG001|Overall Study|Study terminated by sponsor|0|||
145524179|NCT02953509|524778104|FG002|Overall Study|Study terminated by sponsor|0|||
145749346|NCT00391222|525596050|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
145749347|NCT00391222|525596051|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
145749348|NCT00391222|525596052|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
145749349|NCT00391222|525596049|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
145271156|NCT00877799|523839637|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
145271157|NCT00877799|523839638|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
145271158|NCT00877799|523839639|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
145271159|NCT00877799|523839635|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
145271160|NCT00877799|523839636|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
145271161|NCT00877799|523839637|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
145271162|NCT00877799|523839638|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
145271163|NCT00877799|523839639|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
145271164|NCT00877799|523839635|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
145271165|NCT00877799|523839636|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
145271166|NCT00877799|523839637|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
145271167|NCT00877799|523839638|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
145271168|NCT00877799|523839639|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
145524180|NCT02953509|524778105|FG003|Overall Study|Study terminated by sponsor|0|||
145524181|NCT02953509|524778106|FG004|Overall Study|Study terminated by sponsor|0|||
145524182|NCT02953509|524778107|FG005|Overall Study|Study terminated by sponsor|0|||
145524183|NCT02953509|524778108|FG006|Overall Study|Study terminated by sponsor|1|||
145749350|NCT00391222|525596050|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
145524184|NCT02953509|524778109|FG007|Overall Study|Study terminated by sponsor|0|||
145524185|NCT02953509|524778110|FG008|Overall Study|Study terminated by sponsor|1|||
145524186|NCT02953509|524778111|FG009|Overall Study|Study terminated by sponsor|1|||
145524187|NCT00484185|524778114|FG000|Overall Study|Lost to Follow-up|44|||
145524188|NCT00484185|524778114|FG000|Overall Study|Other|20|||
145524189|NCT00484185|524778114|FG000|Overall Study|Randomized but not treated|5|||
145524190|NCT00484185|524778114|FG000|Overall Study|Death|2|||
145524191|NCT00725842|524778117|FG000|Overall Study|Lost to Follow-up|19|||
145524192|NCT00725842|524778117|FG000|Overall Study|Death|1|||
145524193|NCT00725842|524778117|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
145524194|NCT00725842|524778117|FG000|Overall Study|Consent date prior to study start date|5|||
145524195|NCT00725842|524778117|FG000|Overall Study|Inclusion criterion not met|1|||
145524196|NCT00725842|524778117|FG000|Overall Study|No Visit 1 data|1|||
145524197|NCT02793622|524778121|FG000|Overall Study|Lost to Follow-up|31|||
145524198|NCT02793622|524778122|FG001|Overall Study|Lost to Follow-up|19|||
145524199|NCT02793622|524778121|FG000|Overall Study|Withdrawal by Subject|21|||
145524200|NCT02793622|524778122|FG001|Overall Study|Withdrawal by Subject|17|||
145524201|NCT02793622|524778121|FG000|Overall Study|Adverse Event|0|||
145524202|NCT02793622|524778122|FG001|Overall Study|Adverse Event|1|||
145524203|NCT02793622|524778121|FG000|Overall Study|Protocol Violation|1|||
145524204|NCT02793622|524778122|FG001|Overall Study|Protocol Violation|5|||
145524205|NCT02068768|524778123|FG000|Overall Study|Lost to Follow-up|5|||
145524206|NCT02068768|524778123|FG000|Overall Study|Early Termination by Sponsor|2|||
145524207|NCT01423604|524778124|FG000|Safety Run-In|Adverse Event|3|||
145524208|NCT01423604|524778125|FG001|Safety Run-In|Adverse Event|0|||
145524209|NCT01423604|524778124|FG000|Safety Run-In|Death|1|||
145524210|NCT01423604|524778125|FG001|Safety Run-In|Death|0|||
145524211|NCT01423604|524778124|FG000|Safety Run-In|Physician Decision|1|||
145524212|NCT01423604|524778125|FG001|Safety Run-In|Physician Decision|0|||
145524213|NCT01423604|524778124|FG000|Safety Run-In|Disease progression|3|||
145524214|NCT01423604|524778125|FG001|Safety Run-In|Disease progression|0|||
145524215|NCT01423604|524778124|FG000|Safety Run-In|Patient decision|1|||
145524216|NCT01423604|524778125|FG001|Safety Run-In|Patient decision|0|||
145524217|NCT01423604|524778124|FG000|Randomized|Adverse Event|4|||
145524218|NCT01423604|524778125|FG001|Randomized|Adverse Event|10|||
145524219|NCT01423604|524778124|FG000|Randomized|Death|1|||
145524220|NCT01423604|524778125|FG001|Randomized|Death|0|||
145524221|NCT01423604|524778124|FG000|Randomized|Physician Decision|16|||
145524222|NCT01423604|524778125|FG001|Randomized|Physician Decision|13|||
145524223|NCT01423604|524778124|FG000|Randomized|Other - unspecified|37|||
145524224|NCT01423604|524778125|FG001|Randomized|Other - unspecified|31|||
145524225|NCT01423604|524778124|FG000|Randomized|Patient decision|5|||
145524226|NCT01423604|524778125|FG001|Randomized|Patient decision|9|||
145749351|NCT00391222|525596051|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
145749352|NCT00391222|525596052|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
145749353|NCT00391222|525596049|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
145749354|NCT00391222|525596050|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
145749355|NCT00391222|525596051|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
145749356|NCT00391222|525596052|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
145749357|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
145749358|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
145749359|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
145749360|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
145749361|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
145749362|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
145749363|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
145749364|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
145749365|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
145749366|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
145749367|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
145749368|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
145524227|NCT01683019|524779353|FG000|Overall Study|Withdrawal by Subject|2|||
145749369|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
145749370|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
145749371|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
145524228|NCT01683019|524779354|FG001|Overall Study|Withdrawal by Subject|1|||
145524229|NCT01683019|524779355|FG002|Overall Study|Withdrawal by Subject|4|||
145524230|NCT04050371|524779361|FG000|Overall Study|Withdrawal by Subject|1|||
145524231|NCT04050371|524779362|FG001|Overall Study|Withdrawal by Subject|0|||
145524232|NCT01107418|524779363|FG000|Overall Study|Disease Progression|45|||
145524233|NCT01107418|524779363|FG000|Overall Study|Adverse Event|3|||
145524234|NCT01107418|524779363|FG000|Overall Study|Withdrawal by Subject|1|||
145524235|NCT01107418|524779363|FG000|Overall Study|Study Closing|1|||
145524236|NCT01107418|524779363|FG000|Overall Study|Started Other Therapy|1|||
145524237|NCT01107418|524779363|FG000|Overall Study|Entered Extension Study|1|||
145524238|NCT00597701|524779364|FG000|Overall Study|Withdrawal by Subject|5|||
145749372|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
145524239|NCT00597701|524779365|FG001|Overall Study|Withdrawal by Subject|5|||
145524240|NCT00597701|524779364|FG000|Overall Study|Death|0|||
145524241|NCT00597701|524779365|FG001|Overall Study|Death|1|||
145524242|NCT00597701|524779364|FG000|Overall Study|Physician Decision|2|||
145524243|NCT00597701|524779365|FG001|Overall Study|Physician Decision|0|||
145524244|NCT00597701|524779364|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
145524245|NCT00597701|524779365|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
145524246|NCT01155219|524779369|FG000|Overall Study|Adverse Event|3|||
145524247|NCT01155219|524779370|FG001|Overall Study|Adverse Event|1|||
145524248|NCT01155219|524779369|FG000|Overall Study|non-medical reason|1|||
145524249|NCT01155219|524779370|FG001|Overall Study|non-medical reason|2|||
145524250|NCT01394718|524779371|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
145524251|NCT01394718|524779372|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
145524252|NCT01547780|524779373|FG000|Baseline PET Scan|Physician Decision|1|||
145524253|NCT01547780|524779374|FG001|Baseline PET Scan|Physician Decision|0|||
145524254|NCT01547780|524779375|FG002|Baseline PET Scan|Physician Decision|1|||
145524255|NCT01547780|524779376|FG003|Baseline PET Scan|Physician Decision|0|||
145524256|NCT01547780|524779373|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
145524257|NCT01547780|524779374|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
145524258|NCT01547780|524779375|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
145524259|NCT01547780|524779376|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
145524260|NCT01362595|524779380|FG000|Overall Study|Screen failure|10|||
145524261|NCT01362595|524779380|FG000|Overall Study|Withdrawal by Subject|2|||
145524262|NCT00959374|524779381|FG000|Overall Study|Withdrawal by Subject|2|||
145749373|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
145749374|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
145749375|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
145749376|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
145749377|NCT00391222|525596049|FG000|Period III (Double-Blind Treatment)|Other|6|||
145749378|NCT00391222|525596050|FG001|Period III (Double-Blind Treatment)|Other|1|||
145749379|NCT00391222|525596051|FG002|Period III (Double-Blind Treatment)|Other|6|||
145749380|NCT00391222|525596052|FG003|Period III (Double-Blind Treatment)|Other|0|||
145749381|NCT00960843|525596057|FG000|Overall Study|Lost to Follow-up|2|||
145749382|NCT00960843|525596058|FG001|Overall Study|Lost to Follow-up|0|||
145524263|NCT00959374|524779381|FG000|Overall Study|Lost to Follow-up|14|||
145524264|NCT00959374|524779381|FG000|Overall Study|Death|1|||
145524265|NCT00959374|524779381|FG000|Overall Study|Protocol Violation|1|||
145524266|NCT00959374|524779381|FG000|Overall Study|Implant Removed/Not Replaced|4|||
145524267|NCT00959374|524779381|FG000|Overall Study|Physician Decision|1|||
145524268|NCT02448680|524779382|FG000|Overall Study|Physician Decision|1|||
145524269|NCT02448680|524779383|FG001|Overall Study|Physician Decision|1|||
145749383|NCT00960843|525596057|FG000|Overall Study|Protocol Violation|0|||
145749384|NCT00960843|525596058|FG001|Overall Study|Protocol Violation|4|||
145749385|NCT00960843|525596057|FG000|Overall Study|Repeated needle dislodgment|0|||
145749386|NCT00960843|525596058|FG001|Overall Study|Repeated needle dislodgment|1|||
145749387|NCT00652366|525596059|FG000|Overall Study|Adverse Event|8|||
145271169|NCT00877799|523839635|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
145271170|NCT00877799|523839636|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
145271171|NCT00877799|523839637|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
145271172|NCT00877799|523839638|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
145271173|NCT00877799|523839639|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
145271174|NCT00557830|523839640|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
145524270|NCT02448680|524779382|FG000|Overall Study|Withdrawal by Subject|0|||
145524271|NCT02448680|524779383|FG001|Overall Study|Withdrawal by Subject|2|||
145524272|NCT01736657|524779384|FG000|Overall Study|insufficient vascular access|1|||
145524273|NCT00749580|524779393|FG000|Overall Study|Lost to Follow-up|4|||
145524274|NCT00749580|524779394|FG001|Overall Study|Lost to Follow-up|8|||
145524275|NCT00749580|524779393|FG000|Overall Study|Adverse Event|0|||
145524276|NCT00749580|524779394|FG001|Overall Study|Adverse Event|1|||
145524277|NCT03707184|524779397|FG000|Overall Study|Withdrawal by Subject|2|||
145524278|NCT04704154|524779398|FG000|Overall Study|Adverse Event|3|||
145524279|NCT04704154|524779399|FG001|Overall Study|Adverse Event|2|||
145524280|NCT04704154|524779400|FG002|Overall Study|Adverse Event|4|||
145749388|NCT00652366|525596060|FG001|Overall Study|Adverse Event|4|||
145749389|NCT00652366|525596061|FG002|Overall Study|Adverse Event|7|||
145524281|NCT04704154|524779401|FG003|Overall Study|Adverse Event|2|||
145524282|NCT04704154|524779402|FG004|Overall Study|Adverse Event|3|||
145524283|NCT04704154|524779403|FG005|Overall Study|Adverse Event|0|||
145524284|NCT04704154|524779398|FG000|Overall Study|Death|3|||
145524285|NCT04704154|524779399|FG001|Overall Study|Death|0|||
145524286|NCT04704154|524779400|FG002|Overall Study|Death|0|||
145524287|NCT04704154|524779401|FG003|Overall Study|Death|0|||
145524288|NCT04704154|524779402|FG004|Overall Study|Death|3|||
145524289|NCT04704154|524779403|FG005|Overall Study|Death|0|||
145524290|NCT04704154|524779398|FG000|Overall Study|Physician Decision|1|||
145524291|NCT04704154|524779399|FG001|Overall Study|Physician Decision|0|||
145524292|NCT04704154|524779400|FG002|Overall Study|Physician Decision|1|||
145524293|NCT04704154|524779401|FG003|Overall Study|Physician Decision|0|||
145524294|NCT04704154|524779402|FG004|Overall Study|Physician Decision|2|||
145524295|NCT04704154|524779403|FG005|Overall Study|Physician Decision|0|||
145524296|NCT04704154|524779398|FG000|Overall Study|Participant Decision|1|||
145524297|NCT04704154|524779399|FG001|Overall Study|Participant Decision|1|||
145524298|NCT04704154|524779400|FG002|Overall Study|Participant Decision|0|||
145524299|NCT04704154|524779401|FG003|Overall Study|Participant Decision|0|||
145524300|NCT04704154|524779402|FG004|Overall Study|Participant Decision|0|||
145524301|NCT04704154|524779403|FG005|Overall Study|Participant Decision|0|||
145524302|NCT04704154|524779398|FG000|Overall Study|Progressive Disease|19|||
145524303|NCT04704154|524779399|FG001|Overall Study|Progressive Disease|17|||
145524304|NCT04704154|524779400|FG002|Overall Study|Progressive Disease|20|||
145524305|NCT04704154|524779401|FG003|Overall Study|Progressive Disease|18|||
145524306|NCT04704154|524779402|FG004|Overall Study|Progressive Disease|36|||
145524307|NCT04704154|524779403|FG005|Overall Study|Progressive Disease|30|||
145524308|NCT04704154|524779398|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
145524309|NCT04704154|524779399|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
145524310|NCT04704154|524779400|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
145524311|NCT04704154|524779401|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
145524312|NCT04704154|524779402|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
145524313|NCT04704154|524779403|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
145524314|NCT04704154|524779398|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
145524315|NCT04704154|524779399|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
145524316|NCT04704154|524779400|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
145524317|NCT04704154|524779401|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
145524318|NCT04704154|524779402|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
145524319|NCT04704154|524779403|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
145524320|NCT04950608|524779404|FG000|Overall Study|Withdrawal by Subject|2|||
145524321|NCT04950608|524779404|FG000|Overall Study|Physician Decision|3|||
145524322|NCT03220438|524779405|FG000|Overall Study|Lost to Follow-up|0|||
145524323|NCT03220438|524779406|FG001|Overall Study|Lost to Follow-up|0|||
145524324|NCT03220438|524779407|FG002|Overall Study|Lost to Follow-up|1|||
145524325|NCT03220438|524779408|FG003|Overall Study|Lost to Follow-up|0|||
145524326|NCT04565236|524779409|FG000|Overall Study|Patient/Guardian Decision|0|||
145524327|NCT04565236|524779410|FG001|Overall Study|Patient/Guardian Decision|0|||
145524328|NCT04565236|524779411|FG002|Overall Study|Patient/Guardian Decision|1|||
145524329|NCT04565236|524779412|FG003|Overall Study|Patient/Guardian Decision|0|||
145524330|NCT00740246|524779416|FG000|Overall Study|Received Blood Transfusion|0|||
145524331|NCT00740246|524779417|FG001|Overall Study|Received Blood Transfusion|1|||
145524332|NCT00740246|524779416|FG000|Overall Study|Adverse Event|1|||
145524333|NCT00740246|524779417|FG001|Overall Study|Adverse Event|2|||
145524334|NCT00740246|524779416|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
145524335|NCT00740246|524779417|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
145524336|NCT00740246|524779416|FG000|Overall Study|Lost to Follow-up|2|||
145524337|NCT00740246|524779417|FG001|Overall Study|Lost to Follow-up|2|||
145524338|NCT00740246|524779416|FG000|Overall Study|Withdrawal by Subject|4|||
145524339|NCT00740246|524779417|FG001|Overall Study|Withdrawal by Subject|3|||
145524340|NCT00740246|524779416|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
145524341|NCT00740246|524779417|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
145524342|NCT00740246|524779416|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
145524343|NCT00740246|524779417|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
145524344|NCT00740246|524779416|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
145524345|NCT00740246|524779417|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
145524346|NCT00740246|524779416|FG000|Overall Study|Unable To Comply With Study Visits|2|||
145524347|NCT00740246|524779417|FG001|Overall Study|Unable To Comply With Study Visits|0|||
145524348|NCT00740246|524779416|FG000|Overall Study|Unable to Access Vein|0|||
145524349|NCT00740246|524779417|FG001|Overall Study|Unable to Access Vein|2|||
145524350|NCT00740246|524779416|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
145524351|NCT00740246|524779417|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
145524352|NCT03584373|524779418|FG000|Overall Study|Lost to Follow-up|7|||
145524353|NCT03584373|524779419|FG001|Overall Study|Lost to Follow-up|8|||
145524354|NCT01487577|524779420|FG000|Overall Study|Became ineligible after signing consent|1|||
145524355|NCT01315236|524779421|FG000|Double-blind Phase|Death|1|||
145524356|NCT01315236|524779422|FG001|Double-blind Phase|Death|0|||
145524357|NCT01315236|524779421|FG000|Double-blind Phase|Adverse Event|1|||
145524358|NCT01315236|524779422|FG001|Double-blind Phase|Adverse Event|0|||
145524359|NCT01315236|524779421|FG000|Double-blind Phase|Withdrawal of Consent|1|||
145524360|NCT01315236|524779422|FG001|Double-blind Phase|Withdrawal of Consent|0|||
145524361|NCT01315236|524779421|FG000|Double-blind Phase|Lost to Follow-up|1|||
145524362|NCT01315236|524779422|FG001|Double-blind Phase|Lost to Follow-up|0|||
145524363|NCT01315236|524779421|FG000|Open-label Phase|Death|1|||
145524364|NCT01315236|524779422|FG001|Open-label Phase|Death|0|||
145524365|NCT01315236|524779421|FG000|Open-label Phase|Adverse Event|0|||
145524366|NCT01315236|524779422|FG001|Open-label Phase|Adverse Event|1|||
145524367|NCT01315236|524779421|FG000|Open-label Phase|Other|0|||
145524368|NCT01315236|524779422|FG001|Open-label Phase|Other|1|||
145524369|NCT01315236|524779421|FG000|12-Month Follow-up Period|Death|0|||
145524370|NCT01315236|524779422|FG001|12-Month Follow-up Period|Death|1|||
145524371|NCT01315236|524779421|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
145524372|NCT01315236|524779422|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
145524373|NCT01001299|524779424|FG000|Overall Study|Insufficient Therapeutic Response|20|||
145524374|NCT01001299|524779424|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
145524375|NCT01001299|524779424|FG000|Overall Study|Death|1|||
145524376|NCT01001299|524779424|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
145524377|NCT01001299|524779424|FG000|Overall Study|Withdrew Consent|1|||
145524378|NCT00476047|524779425|FG000|Overall Study|Lost to Follow-up|1|||
145524379|NCT01056380|524779426|FG000|Overall Study|Lost to Follow-up|2|||
145524380|NCT01056380|524779427|FG001|Overall Study|Lost to Follow-up|3|||
145524381|NCT03170232|524779428|FG000|Overall Study|Adverse Event|0|||
145524382|NCT03170232|524779429|FG001|Overall Study|Adverse Event|1|||
145524383|NCT03170232|524779428|FG000|Overall Study|Protocol Violation|0|||
145524384|NCT03170232|524779429|FG001|Overall Study|Protocol Violation|1|||
145524385|NCT03170232|524779428|FG000|Overall Study|Lack of Efficacy|0|||
145524386|NCT03170232|524779429|FG001|Overall Study|Lack of Efficacy|1|||
145524387|NCT03170232|524779428|FG000|Overall Study|Study closed/terminated|26|||
145524388|NCT03170232|524779429|FG001|Overall Study|Study closed/terminated|23|||
145524389|NCT03170232|524779428|FG000|Overall Study|Lost to Follow-up|1|||
145524390|NCT03170232|524779429|FG001|Overall Study|Lost to Follow-up|0|||
145524391|NCT03170232|524779428|FG000|Overall Study|Withdrawal by Subject|0|||
145524392|NCT03170232|524779429|FG001|Overall Study|Withdrawal by Subject|1|||
145524393|NCT01582854|524779432|FG000|Overall Study|Death|8|||
145524394|NCT01582854|524779433|FG001|Overall Study|Death|5|||
145524395|NCT01582854|524779432|FG000|Overall Study|Adverse Event|2|||
145524396|NCT01582854|524779433|FG001|Overall Study|Adverse Event|3|||
145524397|NCT01582854|524779432|FG000|Overall Study|Withdrawal by Participant|8|||
145524398|NCT01582854|524779433|FG001|Overall Study|Withdrawal by Participant|11|||
145524399|NCT01582854|524779432|FG000|Overall Study|Lost to Follow-up|1|||
145524400|NCT01582854|524779433|FG001|Overall Study|Lost to Follow-up|2|||
145524401|NCT01582854|524779432|FG000|Overall Study|Physician Decision|0|||
145524402|NCT01582854|524779433|FG001|Overall Study|Physician Decision|1|||
145524403|NCT01582854|524779432|FG000|Overall Study|Recurrent Stroke|13|||
145524404|NCT01582854|524779433|FG001|Overall Study|Recurrent Stroke|8|||
145524405|NCT01582854|524779432|FG000|Overall Study|Disallowed Concomitant Medication|3|||
145524406|NCT01582854|524779433|FG001|Overall Study|Disallowed Concomitant Medication|2|||
145524407|NCT01582854|524779432|FG000|Overall Study|Carotid or Neurosurgery|0|||
145524408|NCT01582854|524779433|FG001|Overall Study|Carotid or Neurosurgery|1|||
145524409|NCT01582854|524779432|FG000|Overall Study|General Anaesthesia|0|||
145524410|NCT01582854|524779433|FG001|Overall Study|General Anaesthesia|1|||
145524411|NCT01582854|524779432|FG000|Overall Study|Other Miscellaneous Reason|1|||
145524412|NCT01582854|524779433|FG001|Overall Study|Other Miscellaneous Reason|0|||
145524413|NCT04068896|524779434|FG000|Overall Study|Adverse Event|2|||
145524414|NCT04068896|524779435|FG001|Overall Study|Adverse Event|0|||
145524415|NCT04068896|524779436|FG002|Overall Study|Adverse Event|1|||
145524416|NCT04068896|524779437|FG003|Overall Study|Adverse Event|0|||
145524417|NCT04068896|524779438|FG004|Overall Study|Adverse Event|0|||
145524418|NCT04068896|524779439|FG005|Overall Study|Adverse Event|0|||
145524419|NCT04068896|524779434|FG000|Overall Study|Death|3|||
145271175|NCT00557830|523839641|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
145271176|NCT00557830|523839642|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
145524420|NCT04068896|524779435|FG001|Overall Study|Death|1|||
145524421|NCT04068896|524779436|FG002|Overall Study|Death|3|||
145524422|NCT04068896|524779437|FG003|Overall Study|Death|19|||
145524423|NCT04068896|524779438|FG004|Overall Study|Death|17|||
145524424|NCT04068896|524779439|FG005|Overall Study|Death|0|||
145524425|NCT04068896|524779434|FG000|Overall Study|Physician Decision|0|||
145524426|NCT04068896|524779435|FG001|Overall Study|Physician Decision|0|||
145524427|NCT04068896|524779436|FG002|Overall Study|Physician Decision|0|||
145524428|NCT04068896|524779437|FG003|Overall Study|Physician Decision|1|||
145524429|NCT04068896|524779438|FG004|Overall Study|Physician Decision|0|||
145524430|NCT04068896|524779439|FG005|Overall Study|Physician Decision|0|||
145524431|NCT04068896|524779434|FG000|Overall Study|progressive disease|3|||
145524432|NCT04068896|524779435|FG001|Overall Study|progressive disease|5|||
145524433|NCT04068896|524779436|FG002|Overall Study|progressive disease|3|||
145524434|NCT04068896|524779437|FG003|Overall Study|progressive disease|2|||
145524435|NCT04068896|524779438|FG004|Overall Study|progressive disease|1|||
145524436|NCT04068896|524779439|FG005|Overall Study|progressive disease|2|||
145524437|NCT04068896|524779434|FG000|Overall Study|Study terminated by sponsor|0|||
145524438|NCT04068896|524779435|FG001|Overall Study|Study terminated by sponsor|0|||
145524439|NCT04068896|524779436|FG002|Overall Study|Study terminated by sponsor|1|||
145524440|NCT04068896|524779437|FG003|Overall Study|Study terminated by sponsor|2|||
145524441|NCT04068896|524779438|FG004|Overall Study|Study terminated by sponsor|1|||
145524442|NCT04068896|524779439|FG005|Overall Study|Study terminated by sponsor|4|||
145524443|NCT04068896|524779434|FG000|Overall Study|Protocol Violation|0|||
145524444|NCT04068896|524779435|FG001|Overall Study|Protocol Violation|0|||
145524445|NCT04068896|524779436|FG002|Overall Study|Protocol Violation|0|||
145524446|NCT04068896|524779437|FG003|Overall Study|Protocol Violation|1|||
145524447|NCT04068896|524779438|FG004|Overall Study|Protocol Violation|0|||
145524448|NCT04068896|524779439|FG005|Overall Study|Protocol Violation|0|||
145524449|NCT04068896|524779434|FG000|Overall Study|Withdrawal by Subject|0|||
145524450|NCT04068896|524779435|FG001|Overall Study|Withdrawal by Subject|3|||
145524451|NCT04068896|524779436|FG002|Overall Study|Withdrawal by Subject|0|||
145524452|NCT04068896|524779437|FG003|Overall Study|Withdrawal by Subject|2|||
145524453|NCT04068896|524779438|FG004|Overall Study|Withdrawal by Subject|1|||
145524454|NCT04068896|524779439|FG005|Overall Study|Withdrawal by Subject|0|||
145524455|NCT04068896|524779434|FG000|Overall Study|Symptomatic deterioration|2|||
145524456|NCT04068896|524779435|FG001|Overall Study|Symptomatic deterioration|0|||
145524457|NCT04068896|524779436|FG002|Overall Study|Symptomatic deterioration|0|||
145524458|NCT04068896|524779437|FG003|Overall Study|Symptomatic deterioration|0|||
145524459|NCT04068896|524779438|FG004|Overall Study|Symptomatic deterioration|0|||
145524460|NCT04068896|524779439|FG005|Overall Study|Symptomatic deterioration|0|||
145524461|NCT00459056|524779440|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
145524462|NCT00459056|524779441|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
145524463|NCT02522871|524779442|FG000|Overall Study|Protocol Violation|1|||
145524464|NCT02522871|524779443|FG001|Overall Study|Protocol Violation|4|||
145524465|NCT02522871|524779442|FG000|Overall Study|Treated without randomization|1|||
145524466|NCT02522871|524779443|FG001|Overall Study|Treated without randomization|0|||
145524467|NCT02522871|524779442|FG000|Overall Study|Death|9|||
145524468|NCT02522871|524779443|FG001|Overall Study|Death|9|||
145524469|NCT02522871|524779442|FG000|Overall Study|Died in operating room prior to transplant|0|||
145524470|NCT02522871|524779443|FG001|Overall Study|Died in operating room prior to transplant|1|||
145524471|NCT01222403|524779444|FG000|Overall Study|Inappropriate enrollment|0|||
145524472|NCT01222403|524779445|FG001|Overall Study|Inappropriate enrollment|2|||
145524473|NCT01075191|524779447|FG000|Overall Study|Death|1|||
145524474|NCT01075191|524779447|FG000|Overall Study|Intensification|3|||
145524475|NCT01075191|524779447|FG000|Overall Study|Co-morbidities|1|||
145524476|NCT01075191|524779447|FG000|Overall Study|Adverse Event|4|||
145524477|NCT01075191|524779447|FG000|Overall Study|Noncompliance|3|||
145524478|NCT01075191|524779447|FG000|Overall Study|Therapy Break|3|||
145524479|NCT01075191|524779447|FG000|Overall Study|Patient's Wish|2|||
145524480|NCT01075191|524779447|FG000|Overall Study|Unknown Reasons|1|||
145524481|NCT00718237|524779452|FG000|Overall Study|Adverse Event|1|||
145524482|NCT00718237|524779453|FG001|Overall Study|Adverse Event|3|||
145524483|NCT00718237|524779452|FG000|Overall Study|Lost to Follow-up|2|||
145524484|NCT00718237|524779453|FG001|Overall Study|Lost to Follow-up|2|||
145524485|NCT00718237|524779452|FG000|Overall Study|Physician Decision|1|||
145524486|NCT00718237|524779453|FG001|Overall Study|Physician Decision|0|||
145524487|NCT00718237|524779452|FG000|Overall Study|Withdrawal by Subject|9|||
145524488|NCT00718237|524779453|FG001|Overall Study|Withdrawal by Subject|10|||
145524489|NCT01262352|524779454|FG000|Period 1|Illness after randomization|1|||
145524490|NCT01262352|524779455|FG001|Period 1|Illness after randomization|0|||
145524491|NCT01262352|524779454|FG000|Washout|Adverse Event|1|||
145524492|NCT01262352|524779455|FG001|Washout|Adverse Event|1|||
145524493|NCT01262352|524779454|FG000|Washout|Extended Washout|0|||
145524494|NCT01262352|524779455|FG001|Washout|Extended Washout|1|||
145524495|NCT01401959|524779456|FG000|Enrolled|Withdrawal by Subject|1|||
145524496|NCT01401959|524779457|FG001|Enrolled|Withdrawal by Subject|0|||
145524497|NCT01401959|524779458|FG002|Enrolled|Withdrawal by Subject|0|||
145524498|NCT01401959|524779456|FG000|Treated|Disease Progression|2|||
145524499|NCT01401959|524779457|FG001|Treated|Disease Progression|2|||
145524500|NCT01401959|524779458|FG002|Treated|Disease Progression|1|||
145524501|NCT01401959|524779456|FG000|Treated|Adverse Event|4|||
145524502|NCT01401959|524779457|FG001|Treated|Adverse Event|3|||
145524503|NCT01401959|524779458|FG002|Treated|Adverse Event|2|||
145524504|NCT01401959|524779456|FG000|Treated|Withdrawal by Subject|1|||
145524505|NCT01401959|524779457|FG001|Treated|Withdrawal by Subject|2|||
145524506|NCT01401959|524779458|FG002|Treated|Withdrawal by Subject|2|||
145524507|NCT01401959|524779456|FG000|Treated|Protocol Violation|0|||
145524508|NCT01401959|524779457|FG001|Treated|Protocol Violation|1|||
145524509|NCT01401959|524779458|FG002|Treated|Protocol Violation|0|||
145524510|NCT00251004|524779459|FG000|Overall Study|Withdrawal by Subject|23|||
145524511|NCT00251004|524779460|FG001|Overall Study|Withdrawal by Subject|16|||
145524512|NCT00251004|524779461|FG002|Overall Study|Withdrawal by Subject|14|||
145524513|NCT00251004|524779459|FG000|Overall Study|Death|9|||
145524514|NCT00251004|524779460|FG001|Overall Study|Death|10|||
145524515|NCT00251004|524779461|FG002|Overall Study|Death|8|||
145524516|NCT00251004|524779459|FG000|Overall Study|Lost to Follow-up|1|||
145524517|NCT00251004|524779460|FG001|Overall Study|Lost to Follow-up|2|||
145524518|NCT00251004|524779461|FG002|Overall Study|Lost to Follow-up|1|||
145524519|NCT00251004|524779459|FG000|Overall Study|Graft Loss|12|||
145524520|NCT00251004|524779460|FG001|Overall Study|Graft Loss|13|||
145524521|NCT00251004|524779461|FG002|Overall Study|Graft Loss|8|||
145524522|NCT01244490|524779466|FG000|Overall Study|Lack of Efficacy|14|||
145524523|NCT01244490|524779467|FG001|Overall Study|Lack of Efficacy|5|||
145524524|NCT01244490|524779468|FG002|Overall Study|Lack of Efficacy|5|||
145524525|NCT01244490|524779466|FG000|Overall Study|Withdrawal by Subject|4|||
145524526|NCT01244490|524779467|FG001|Overall Study|Withdrawal by Subject|4|||
145524527|NCT01244490|524779468|FG002|Overall Study|Withdrawal by Subject|9|||
145524528|NCT01244490|524779466|FG000|Overall Study|Adverse Event|1|||
145524529|NCT01244490|524779467|FG001|Overall Study|Adverse Event|9|||
145524530|NCT01244490|524779468|FG002|Overall Study|Adverse Event|5|||
145524531|NCT01244490|524779466|FG000|Overall Study|Lost to Follow-up|0|||
145524532|NCT01244490|524779467|FG001|Overall Study|Lost to Follow-up|6|||
145524533|NCT01244490|524779468|FG002|Overall Study|Lost to Follow-up|3|||
145524534|NCT01244490|524779466|FG000|Overall Study|Other|0|||
145524535|NCT01244490|524779467|FG001|Overall Study|Other|0|||
145524536|NCT01244490|524779468|FG002|Overall Study|Other|1|||
145524537|NCT00393042|524779469|FG000|First Intervention|Withdrawal by Subject|1|||
145524538|NCT00393042|524779470|FG001|First Intervention|Withdrawal by Subject|2|||
145524539|NCT00393042|524779469|FG000|First Intervention|Lost to Follow-up|3|||
145524540|NCT00393042|524779470|FG001|First Intervention|Lost to Follow-up|3|||
145524541|NCT00393042|524779469|FG000|First Intervention|Protocol Violation|1|||
145524542|NCT00393042|524779470|FG001|First Intervention|Protocol Violation|0|||
145524543|NCT00393042|524779469|FG000|First Intervention|Adverse Event|0|||
145524544|NCT00393042|524779470|FG001|First Intervention|Adverse Event|1|||
145524545|NCT00393042|524779469|FG000|Second Intervetion|Adverse Event|0|||
145524546|NCT00393042|524779470|FG001|Second Intervetion|Adverse Event|3|||
145524547|NCT00393042|524779469|FG000|Second Intervetion|Withdrawal by Subject|0|||
145524548|NCT00393042|524779470|FG001|Second Intervetion|Withdrawal by Subject|2|||
145524549|NCT00393042|524779469|FG000|Second Intervetion|Lack of Efficacy|1|||
145524550|NCT00393042|524779470|FG001|Second Intervetion|Lack of Efficacy|0|||
145524551|NCT00393042|524779469|FG000|Second Intervetion|Lost to Follow-up|0|||
145524552|NCT00393042|524779470|FG001|Second Intervetion|Lost to Follow-up|2|||
145524553|NCT00393042|524779469|FG000|Second Intervetion|Protocol Violation|1|||
145524554|NCT00393042|524779470|FG001|Second Intervetion|Protocol Violation|1|||
145524555|NCT03324581|524779475|FG000|Overall Study|Adverse Event|18|||
145524556|NCT03324581|524779476|FG001|Overall Study|Adverse Event|11|||
145524557|NCT03324581|524779477|FG002|Overall Study|Adverse Event|7|||
145524558|NCT03324581|524779475|FG000|Overall Study|Lack of Efficacy|0|||
145524559|NCT03324581|524779476|FG001|Overall Study|Lack of Efficacy|1|||
145524560|NCT03324581|524779477|FG002|Overall Study|Lack of Efficacy|0|||
145524561|NCT03324581|524779475|FG000|Overall Study|Lost to Follow-up|5|||
145524562|NCT03324581|524779476|FG001|Overall Study|Lost to Follow-up|3|||
145524563|NCT03324581|524779477|FG002|Overall Study|Lost to Follow-up|6|||
145524564|NCT03324581|524779475|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
145524565|NCT03324581|524779476|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
145524566|NCT03324581|524779477|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
145524567|NCT03324581|524779475|FG000|Overall Study|Physician Decision|0|||
145524568|NCT03324581|524779476|FG001|Overall Study|Physician Decision|1|||
145524569|NCT03324581|524779477|FG002|Overall Study|Physician Decision|2|||
145524570|NCT03324581|524779475|FG000|Overall Study|Protocol Deviation|8|||
145524571|NCT03324581|524779476|FG001|Overall Study|Protocol Deviation|9|||
145524572|NCT03324581|524779477|FG002|Overall Study|Protocol Deviation|4|||
145524573|NCT03324581|524779475|FG000|Overall Study|Withdrawal by Subject|6|||
145524574|NCT03324581|524779476|FG001|Overall Study|Withdrawal by Subject|8|||
145524575|NCT03324581|524779477|FG002|Overall Study|Withdrawal by Subject|6|||
145524576|NCT03324581|524779475|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
145524577|NCT03324581|524779476|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
145524578|NCT03324581|524779477|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
145524579|NCT00321893|524779479|FG000|Overall Study|Non-Compliance/Refusal|16|||
145524580|NCT00321893|524779480|FG001|Overall Study|Non-Compliance/Refusal|10|||
145524581|NCT00321893|524779479|FG000|Overall Study|Lost to Follow-up|2|||
145524582|NCT00321893|524779480|FG001|Overall Study|Lost to Follow-up|1|||
145524583|NCT00321893|524779479|FG000|Overall Study|Adverse Event|6|||
145524584|NCT00321893|524779480|FG001|Overall Study|Adverse Event|3|||
145524585|NCT03455764|524779481|FG000|Overall Study|Adverse Event|1|||
145524586|NCT03455764|524779482|FG001|Overall Study|Adverse Event|0|||
145524587|NCT03455764|524779483|FG002|Overall Study|Adverse Event|0|||
145524588|NCT03455764|524779484|FG003|Overall Study|Adverse Event|0|||
145524589|NCT03455764|524779485|FG004|Overall Study|Adverse Event|0|||
145524590|NCT03455764|524779481|FG000|Overall Study|Disease Progression|4|||
145524591|NCT03455764|524779482|FG001|Overall Study|Disease Progression|0|||
145524592|NCT03455764|524779483|FG002|Overall Study|Disease Progression|0|||
145524593|NCT03455764|524779484|FG003|Overall Study|Disease Progression|0|||
145524594|NCT03455764|524779485|FG004|Overall Study|Disease Progression|0|||
145524595|NCT03455764|524779481|FG000|Overall Study|On Treatment|1|||
145524596|NCT03455764|524779482|FG001|Overall Study|On Treatment|0|||
145524597|NCT03455764|524779483|FG002|Overall Study|On Treatment|0|||
145524598|NCT03455764|524779484|FG003|Overall Study|On Treatment|0|||
145524599|NCT03455764|524779485|FG004|Overall Study|On Treatment|0|||
145524600|NCT00727532|524779486|FG000|Overall Study|Adverse Event|1|||
145524601|NCT00727532|524779486|FG000|Overall Study|Withdrawal by Subject|1|||
145524602|NCT00829933|524779487|FG000|Overall Study|Adverse Event|2|||
145524603|NCT00829933|524779488|FG001|Overall Study|Adverse Event|3|||
145524604|NCT00829933|524779489|FG002|Overall Study|Adverse Event|2|||
145524605|NCT00829933|524779490|FG003|Overall Study|Adverse Event|1|||
145524606|NCT00829933|524779487|FG000|Overall Study|Death|0|||
145524607|NCT00829933|524779488|FG001|Overall Study|Death|0|||
145524608|NCT00829933|524779489|FG002|Overall Study|Death|1|||
145524609|NCT00829933|524779490|FG003|Overall Study|Death|1|||
145524610|NCT00829933|524779487|FG000|Overall Study|Lack of Efficacy|0|||
145524611|NCT00829933|524779488|FG001|Overall Study|Lack of Efficacy|1|||
145524612|NCT00829933|524779489|FG002|Overall Study|Lack of Efficacy|0|||
145524613|NCT00829933|524779490|FG003|Overall Study|Lack of Efficacy|0|||
145524614|NCT00829933|524779487|FG000|Overall Study|Physician Decision|5|||
145524615|NCT00829933|524779488|FG001|Overall Study|Physician Decision|7|||
145524616|NCT00829933|524779489|FG002|Overall Study|Physician Decision|8|||
145524617|NCT00829933|524779490|FG003|Overall Study|Physician Decision|1|||
145524618|NCT00829933|524779487|FG000|Overall Study|Pregnancy|0|||
145524619|NCT00829933|524779488|FG001|Overall Study|Pregnancy|0|||
145524620|NCT00829933|524779489|FG002|Overall Study|Pregnancy|0|||
145524621|NCT00829933|524779490|FG003|Overall Study|Pregnancy|2|||
145524622|NCT00829933|524779487|FG000|Overall Study|Protocol Violation|2|||
145524623|NCT00829933|524779488|FG001|Overall Study|Protocol Violation|1|||
145524624|NCT00829933|524779489|FG002|Overall Study|Protocol Violation|0|||
145524625|NCT00829933|524779490|FG003|Overall Study|Protocol Violation|0|||
145524626|NCT00829933|524779487|FG000|Overall Study|withdrew before treatment started|5|||
145524627|NCT00829933|524779488|FG001|Overall Study|withdrew before treatment started|1|||
145524628|NCT00829933|524779489|FG002|Overall Study|withdrew before treatment started|2|||
145524629|NCT00829933|524779490|FG003|Overall Study|withdrew before treatment started|9|||
145524630|NCT00523367|524779491|FG000|Overall Study|19 screen failures|19|||
145524631|NCT00523367|524779491|FG000|Overall Study|4 Withdrawn by PI|4|||
145524632|NCT00543855|524781146|FG000|Overall Study|Adverse Event|3|||
145524633|NCT00543855|524781147|FG001|Overall Study|Adverse Event|1|||
145524634|NCT00543855|524781148|FG002|Overall Study|Adverse Event|3|||
145524635|NCT00543855|524781149|FG003|Overall Study|Adverse Event|4|||
145524636|NCT00543855|524781146|FG000|Overall Study|Lost to Follow-up|0|||
145524637|NCT00543855|524781147|FG001|Overall Study|Lost to Follow-up|0|||
145524638|NCT00543855|524781148|FG002|Overall Study|Lost to Follow-up|1|||
145524639|NCT00543855|524781149|FG003|Overall Study|Lost to Follow-up|0|||
145524640|NCT00543855|524781146|FG000|Overall Study|Withdrawal by Subject|0|||
145524641|NCT00543855|524781147|FG001|Overall Study|Withdrawal by Subject|1|||
145524642|NCT00543855|524781148|FG002|Overall Study|Withdrawal by Subject|2|||
145524643|NCT00543855|524781149|FG003|Overall Study|Withdrawal by Subject|0|||
145524644|NCT00543855|524781146|FG000|Overall Study|Protocol Violation|1|||
145524645|NCT00543855|524781147|FG001|Overall Study|Protocol Violation|0|||
145524646|NCT00543855|524781148|FG002|Overall Study|Protocol Violation|0|||
145524647|NCT00543855|524781149|FG003|Overall Study|Protocol Violation|0|||
145524648|NCT04285580|524781150|FG000|Overall Study|Protocol Violation|0|||
145524649|NCT04285580|524781151|FG001|Overall Study|Protocol Violation|1|||
145524650|NCT02582255|524781152|FG000|Overall Study|Protocol Violation|0|||
145524651|NCT02582255|524781153|FG001|Overall Study|Protocol Violation|3|||
145524652|NCT01709578|524781155|FG000|Overall Study|Rescued and entered in long term safety|63|||
145524653|NCT01709578|524781156|FG001|Overall Study|Rescued and entered in long term safety|25|||
145524654|NCT01709578|524781157|FG002|Overall Study|Rescued and entered in long term safety|26|||
145524655|NCT01709578|524781155|FG000|Overall Study|Adverse Event|9|||
145524656|NCT01709578|524781156|FG001|Overall Study|Adverse Event|18|||
145524657|NCT01709578|524781157|FG002|Overall Study|Adverse Event|17|||
145524658|NCT01709578|524781155|FG000|Overall Study|Lack of Efficacy|5|||
145524659|NCT01709578|524781156|FG001|Overall Study|Lack of Efficacy|4|||
145524660|NCT01709578|524781157|FG002|Overall Study|Lack of Efficacy|2|||
145524661|NCT01709578|524781155|FG000|Overall Study|Poor compliance to protocol|1|||
145524662|NCT01709578|524781156|FG001|Overall Study|Poor compliance to protocol|2|||
145524663|NCT01709578|524781157|FG002|Overall Study|Poor compliance to protocol|1|||
145524664|NCT01709578|524781155|FG000|Overall Study|Other, not related to safety or efficacy|2|||
145524665|NCT01709578|524781156|FG001|Overall Study|Other, not related to safety or efficacy|7|||
145524666|NCT01709578|524781157|FG002|Overall Study|Other, not related to safety or efficacy|5|||
145524667|NCT01314911|524781159|FG000|Overall Study|Lost to Follow-up|3|||
145524668|NCT01314911|524781160|FG001|Overall Study|Lost to Follow-up|2|||
145524669|NCT01314911|524781159|FG000|Overall Study|Withdrawal by Subject|1|||
145524670|NCT01314911|524781160|FG001|Overall Study|Withdrawal by Subject|3|||
145524671|NCT01314911|524781159|FG000|Overall Study|Received Non-randomized Study Drug|0|||
145524672|NCT01314911|524781160|FG001|Overall Study|Received Non-randomized Study Drug|1|||
145524673|NCT01314911|524781159|FG000|Overall Study|Never Started Treatment|1|||
145524674|NCT01314911|524781160|FG001|Overall Study|Never Started Treatment|0|||
145524675|NCT03150485|524781161|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
145524676|NCT03150485|524781162|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
145524677|NCT03150485|524781163|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
145524678|NCT03150485|524781164|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
145524679|NCT03150485|524781165|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
145524680|NCT03150485|524781166|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
145524681|NCT05828095|524781168|FG000|Overall Study|Lost to Follow-up|1|||
145524682|NCT05828095|524781169|FG001|Overall Study|Lost to Follow-up|0|||
145749390|NCT00652366|525596062|FG003|Overall Study|Adverse Event|17|||
145749391|NCT00652366|525596063|FG004|Overall Study|Adverse Event|13|||
145524683|NCT05828095|524781168|FG000|Overall Study|Reactogenicity symptom|0|||
145524684|NCT05828095|524781169|FG001|Overall Study|Reactogenicity symptom|1|||
145524685|NCT00096954|524781175|FG000|Overall Study|Adverse Event|3|||
145524686|NCT00096954|524781176|FG001|Overall Study|Adverse Event|1|||
145524687|NCT00096954|524781175|FG000|Overall Study|Withdrawal by Subject|9|||
145524688|NCT00096954|524781176|FG001|Overall Study|Withdrawal by Subject|8|||
145524689|NCT00096954|524781175|FG000|Overall Study|Physician Decision|1|||
145524690|NCT00096954|524781176|FG001|Overall Study|Physician Decision|1|||
145749392|NCT00652366|525596059|FG000|Overall Study|Death|5|||
145749393|NCT00652366|525596060|FG001|Overall Study|Death|4|||
145749394|NCT00652366|525596061|FG002|Overall Study|Death|1|||
145524691|NCT00096954|524781175|FG000|Overall Study|Sponsors Decision|1|||
145749395|NCT00652366|525596062|FG003|Overall Study|Death|8|||
145524692|NCT00096954|524781176|FG001|Overall Study|Sponsors Decision|1|||
145524693|NCT00096954|524781175|FG000|Overall Study|Pregnancy|1|||
145524694|NCT00096954|524781176|FG001|Overall Study|Pregnancy|1|||
145524695|NCT00096954|524781175|FG000|Overall Study|Initiation of immunotherapy|1|||
145524696|NCT00096954|524781176|FG001|Overall Study|Initiation of immunotherapy|0|||
145524697|NCT00096954|524781175|FG000|Overall Study|Non-compliance|0|||
145524698|NCT00096954|524781176|FG001|Overall Study|Non-compliance|3|||
145524699|NCT00096954|524781175|FG000|Overall Study|Lost to Follow-up|8|||
145524700|NCT00096954|524781176|FG001|Overall Study|Lost to Follow-up|5|||
145524701|NCT03442764|524781177|FG000|Overall Study|Adverse Event|1|||
145524702|NCT03442764|524781178|FG001|Overall Study|Adverse Event|0|||
145524703|NCT03442764|524781179|FG002|Overall Study|Adverse Event|0|||
145524704|NCT04478123|524781180|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
145524705|NCT04478123|524781180|FG000|Overall Study|NE|1|||
145524706|NCT02395016|524781181|FG000|Overall Study|Adverse Event|4|||
145524707|NCT02395016|524781182|FG001|Overall Study|Adverse Event|3|||
145524708|NCT02395016|524781181|FG000|Overall Study|Withdrawal by Subject|9|||
145524709|NCT02395016|524781182|FG001|Overall Study|Withdrawal by Subject|6|||
145749396|NCT00652366|525596063|FG004|Overall Study|Death|5|||
145749397|NCT00652366|525596059|FG000|Overall Study|Lack of Efficacy|84|||
145749398|NCT00652366|525596060|FG001|Overall Study|Lack of Efficacy|58|||
145749399|NCT00652366|525596061|FG002|Overall Study|Lack of Efficacy|53|||
145749400|NCT00652366|525596062|FG003|Overall Study|Lack of Efficacy|133|||
145749401|NCT00652366|525596063|FG004|Overall Study|Lack of Efficacy|13|||
145749402|NCT00652366|525596059|FG000|Overall Study|Violation of Selection Criteria|0|||
145749403|NCT00652366|525596060|FG001|Overall Study|Violation of Selection Criteria|0|||
145749404|NCT00652366|525596061|FG002|Overall Study|Violation of Selection Criteria|1|||
145749405|NCT00652366|525596062|FG003|Overall Study|Violation of Selection Criteria|0|||
145749406|NCT00652366|525596063|FG004|Overall Study|Violation of Selection Criteria|0|||
145749407|NCT00652366|525596059|FG000|Overall Study|Protocol Violation|1|||
145749408|NCT00652366|525596060|FG001|Overall Study|Protocol Violation|0|||
145749409|NCT00652366|525596061|FG002|Overall Study|Protocol Violation|0|||
145749410|NCT00652366|525596062|FG003|Overall Study|Protocol Violation|0|||
145749411|NCT00652366|525596063|FG004|Overall Study|Protocol Violation|0|||
145749412|NCT00652366|525596059|FG000|Overall Study|Refused treatment|3|||
145524710|NCT02395016|524781181|FG000|Overall Study|Protocol Violation|2|||
145524711|NCT02395016|524781182|FG001|Overall Study|Protocol Violation|3|||
145524712|NCT04444895|524781183|FG000|Overall Study|Adverse Event|2|||
145524713|NCT04444895|524781183|FG000|Overall Study|Lost to Follow-up|2|||
145524714|NCT04444895|524781183|FG000|Overall Study|Withdrawal by Subject|5|||
145524715|NCT00814879|524781184|FG000|By Week 24|Cancer Diagnosis|1|||
145524716|NCT00814879|524781185|FG001|By Week 24|Cancer Diagnosis|0|||
145524717|NCT00814879|524781184|FG000|By Week 24|Incarceration|0|||
145524718|NCT00814879|524781185|FG001|By Week 24|Incarceration|1|||
145524719|NCT00814879|524781184|FG000|By Week 48|Lost to Follow-up|2|||
145524720|NCT00814879|524781185|FG001|By Week 48|Lost to Follow-up|2|||
145524721|NCT00814879|524781184|FG000|By Week 48|Death|0|||
145524722|NCT00814879|524781185|FG001|By Week 48|Death|1|||
145524723|NCT01461057|524781186|FG000|Overall Study|Death|10|||
145524724|NCT01461057|524781187|FG001|Overall Study|Death|9|||
145524725|NCT01461057|524781186|FG000|Overall Study|Withdrawal by Subject|2|||
145524726|NCT01461057|524781187|FG001|Overall Study|Withdrawal by Subject|3|||
145524727|NCT01461057|524781186|FG000|Overall Study|Physician Decision|0|||
145524728|NCT01461057|524781187|FG001|Overall Study|Physician Decision|2|||
145524729|NCT01461057|524781186|FG000|Overall Study|Adverse Event|0|||
145524730|NCT01461057|524781187|FG001|Overall Study|Adverse Event|1|||
145524731|NCT01461057|524781186|FG000|Overall Study|Progression of Disease|1|||
145524732|NCT01461057|524781187|FG001|Overall Study|Progression of Disease|0|||
145524733|NCT01461057|524781186|FG000|Overall Study|Study Terminated by Sponsor|2|||
145524734|NCT01461057|524781187|FG001|Overall Study|Study Terminated by Sponsor|0|||
145524735|NCT03034200|524781188|FG000|Overall Study|Disease progression|8|||
145524736|NCT03034200|524781189|FG001|Overall Study|Disease progression|10|||
145749413|NCT00652366|525596060|FG001|Overall Study|Refused treatment|7|||
145524737|NCT03034200|524781190|FG002|Overall Study|Disease progression|4|||
145524738|NCT03034200|524781188|FG000|Overall Study|Physician Decision|2|||
145749414|NCT00652366|525596061|FG002|Overall Study|Refused treatment|6|||
145524739|NCT03034200|524781189|FG001|Overall Study|Physician Decision|0|||
145524740|NCT03034200|524781190|FG002|Overall Study|Physician Decision|3|||
145524741|NCT03034200|524781188|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
145524742|NCT03034200|524781189|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
145749415|NCT00652366|525596062|FG003|Overall Study|Refused treatment|17|||
145749416|NCT00652366|525596063|FG004|Overall Study|Refused treatment|5|||
145749417|NCT00652366|525596059|FG000|Overall Study|Other|5|||
145524743|NCT03034200|524781190|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
145524744|NCT03034200|524781188|FG000|Overall Study|Adjuvant Therapy|0|||
145524745|NCT03034200|524781189|FG001|Overall Study|Adjuvant Therapy|0|||
145524746|NCT03034200|524781190|FG002|Overall Study|Adjuvant Therapy|1|||
145749418|NCT00652366|525596060|FG001|Overall Study|Other|2|||
145524747|NCT01288976|524781191|FG000|Overall Study|Withdrawal by Subject|58|||
145524748|NCT01288976|524781192|FG001|Overall Study|Withdrawal by Subject|12|||
145524749|NCT01288976|524781193|FG002|Overall Study|Withdrawal by Subject|9|||
145524750|NCT01288976|524781191|FG000|Overall Study|Death|98|||
145524751|NCT01288976|524781192|FG001|Overall Study|Death|6|||
145524752|NCT01288976|524781193|FG002|Overall Study|Death|4|||
145524753|NCT01288976|524781191|FG000|Overall Study|Data unavailable|22|||
145524754|NCT01288976|524781192|FG001|Overall Study|Data unavailable|9|||
145524755|NCT01288976|524781193|FG002|Overall Study|Data unavailable|7|||
145524756|NCT05523323|524781200|FG000|Overall Study|Death|26|||
145524757|NCT05523323|524781201|FG001|Overall Study|Death|21|||
145524758|NCT05523323|524781200|FG000|Overall Study|Ongoing participants|35|||
145524759|NCT05523323|524781201|FG001|Overall Study|Ongoing participants|30|||
145524760|NCT00642473|524781202|FG000|Overall Study|Withdrawal by Subject|0|||
145524761|NCT00642473|524781203|FG001|Overall Study|Withdrawal by Subject|5|||
145524762|NCT00642473|524781202|FG000|Overall Study|Progression or death|2|||
145524763|NCT00642473|524781203|FG001|Overall Study|Progression or death|4|||
145524764|NCT00642473|524781202|FG000|Overall Study|Other|2|||
145524765|NCT00642473|524781203|FG001|Overall Study|Other|2|||
145524766|NCT01347307|524781204|FG000|Overall Study|Death|0|||
145524767|NCT01347307|524781205|FG001|Overall Study|Death|4|||
145524768|NCT01347307|524781204|FG000|Overall Study|Physician Decision|0|||
145524769|NCT01347307|524781205|FG001|Overall Study|Physician Decision|1|||
145524770|NCT04533880|524781208|FG000|Overall Study|Lost to Follow-up|0|||
145524771|NCT04533880|524781209|FG001|Overall Study|Lost to Follow-up|1|||
145524772|NCT04533880|524781210|FG002|Overall Study|Lost to Follow-up|1|||
145524773|NCT02284178|524781213|FG000|Overall Study|Met exclusion criteria|49|||
145524774|NCT02284178|524781214|FG001|Overall Study|Met exclusion criteria|54|||
145524775|NCT01483690|524781217|FG000|Overall Study|Adverse Event|1|||
145524776|NCT01483690|524781218|FG001|Overall Study|Adverse Event|2|||
145524777|NCT01483690|524781217|FG000|Overall Study|clinical deterioration|1|||
145524778|NCT01483690|524781218|FG001|Overall Study|clinical deterioration|0|||
145524779|NCT01483690|524781217|FG000|Overall Study|Physician Decision|0|||
145524780|NCT01483690|524781218|FG001|Overall Study|Physician Decision|2|||
145524781|NCT01483690|524781217|FG000|Overall Study|exclusionary procedure|0|||
145524782|NCT01483690|524781218|FG001|Overall Study|exclusionary procedure|1|||
145524783|NCT00958789|524781222|FG000|Overall Study|Death|5|||
145524784|NCT00958789|524781222|FG000|Overall Study|Lost to Follow-up|14|||
145524785|NCT00958789|524781222|FG000|Overall Study|Withdrawal by Subject|17|||
145524786|NCT00958789|524781222|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
145524787|NCT00958789|524781222|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
145524788|NCT00958789|524781222|FG000|Overall Study|Subject terminated|2|||
145524789|NCT00958789|524781222|FG000|Overall Study|Revision|7|||
145524790|NCT00478881|524781223|FG000|Overall Study|Adverse Event|31|||
145524791|NCT00478881|524781224|FG001|Overall Study|Adverse Event|12|||
145524792|NCT00478881|524781223|FG000|Overall Study|Lack of Efficacy|0|||
145524793|NCT00478881|524781224|FG001|Overall Study|Lack of Efficacy|3|||
145524794|NCT00478881|524781223|FG000|Overall Study|Lost to Follow-up|0|||
145524795|NCT00478881|524781224|FG001|Overall Study|Lost to Follow-up|1|||
145524796|NCT00478881|524781223|FG000|Overall Study|Protocol Violation|2|||
145524797|NCT00478881|524781224|FG001|Overall Study|Protocol Violation|2|||
145524798|NCT00478881|524781223|FG000|Overall Study|Withdrawal by Subject|6|||
145524799|NCT00478881|524781224|FG001|Overall Study|Withdrawal by Subject|2|||
145524800|NCT00478881|524781223|FG000|Overall Study|Non-Compliance with Study Medication|0|||
145524801|NCT00478881|524781224|FG001|Overall Study|Non-Compliance with Study Medication|2|||
145524802|NCT01083173|524781225|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
145524803|NCT01083173|524781226|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
145524804|NCT01083173|524781225|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
145524805|NCT01083173|524781226|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
145524806|NCT01083173|524781225|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
145524807|NCT01083173|524781226|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
145524808|NCT01083173|524781225|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
145524809|NCT01083173|524781226|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
145524810|NCT01083173|524781225|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
145524811|NCT01083173|524781226|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
145524812|NCT01083173|524781225|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
145524813|NCT01083173|524781226|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
145524814|NCT01083173|524781225|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
145524815|NCT01083173|524781226|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
145524816|NCT01083173|524781225|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
145524817|NCT01083173|524781226|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
145524818|NCT01083173|524781225|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
145524819|NCT01083173|524781226|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
145524820|NCT01083173|524781225|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
145524821|NCT01083173|524781226|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
145524822|NCT01083173|524781225|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
145524823|NCT01083173|524781226|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
145524824|NCT00662532|524781230|FG000|Overall Study|Adverse Event|0|||
145524825|NCT00662532|524781231|FG001|Overall Study|Adverse Event|1|||
145524826|NCT00662532|524781230|FG000|Overall Study|Lost to Follow-up|0|||
145524827|NCT00662532|524781231|FG001|Overall Study|Lost to Follow-up|1|||
145524828|NCT00442468|524781232|FG000|Overall Study|Adverse Event|4|||
145524829|NCT00442468|524781232|FG000|Overall Study|Withdrawal by Subject|91|||
145524830|NCT00442468|524781232|FG000|Overall Study|Did not complete all study procedures|88|||
145524831|NCT00589784|524781233|FG000|Overall Study|Withdrawal by Subject|0|||
145524832|NCT00589784|524781234|FG001|Overall Study|Withdrawal by Subject|6|||
145524833|NCT00589784|524781233|FG000|Overall Study|Patient inevaluable|1|||
145524834|NCT00589784|524781234|FG001|Overall Study|Patient inevaluable|0|||
145524835|NCT00589784|524781233|FG000|Overall Study|Adverse Event|0|||
145524836|NCT00589784|524781234|FG001|Overall Study|Adverse Event|4|||
145524837|NCT03823378|524781237|FG000|Overall Study|Adverse Event|2|||
145524838|NCT03823378|524781238|FG001|Overall Study|Adverse Event|2|||
145524839|NCT03823378|524781239|FG002|Overall Study|Adverse Event|0|||
145524840|NCT03823378|524781240|FG003|Overall Study|Adverse Event|0|||
145524841|NCT03823378|524781241|FG004|Overall Study|Adverse Event|0|||
145524842|NCT03823378|524781242|FG005|Overall Study|Adverse Event|0|||
145524843|NCT03823378|524781237|FG000|Overall Study|Lost to Follow-up|0|||
145749419|NCT00652366|525596061|FG002|Overall Study|Other|3|||
145749420|NCT00652366|525596062|FG003|Overall Study|Other|4|||
145749421|NCT00652366|525596063|FG004|Overall Study|Other|0|||
145749422|NCT00889265|525596064|FG000|Overall Study|Adverse Event|1|||
145749423|NCT00889265|525596064|FG000|Overall Study|Lost to Follow-up|5|||
145749424|NCT00889265|525596064|FG000|Overall Study|Protocol Violation|1|||
145749425|NCT03028870|525596065|FG000|Overall Study|Adverse Event|7|||
145749426|NCT03028870|525596066|FG001|Overall Study|Adverse Event|4|||
145749427|NCT03028870|525596067|FG002|Overall Study|Adverse Event|3|||
145749428|NCT03028870|525596068|FG003|Overall Study|Adverse Event|3|||
145749429|NCT03028870|525596065|FG000|Overall Study|Withdrawal by Subject|1|||
145749430|NCT03028870|525596066|FG001|Overall Study|Withdrawal by Subject|1|||
145749431|NCT03028870|525596067|FG002|Overall Study|Withdrawal by Subject|1|||
145749432|NCT03028870|525596068|FG003|Overall Study|Withdrawal by Subject|2|||
145749433|NCT03028870|525596065|FG000|Overall Study|Lost to Follow-up|1|||
145749434|NCT03028870|525596066|FG001|Overall Study|Lost to Follow-up|0|||
145749435|NCT03028870|525596067|FG002|Overall Study|Lost to Follow-up|0|||
145749436|NCT03028870|525596068|FG003|Overall Study|Lost to Follow-up|0|||
145749437|NCT03028870|525596065|FG000|Overall Study|Lack of Efficacy|3|||
145749438|NCT03028870|525596066|FG001|Overall Study|Lack of Efficacy|0|||
145749439|NCT03028870|525596067|FG002|Overall Study|Lack of Efficacy|0|||
145749440|NCT03028870|525596068|FG003|Overall Study|Lack of Efficacy|0|||
145749441|NCT03028870|525596065|FG000|Overall Study|Administrative|5|||
145749442|NCT03028870|525596066|FG001|Overall Study|Administrative|5|||
145749443|NCT03028870|525596067|FG002|Overall Study|Administrative|12|||
145749444|NCT03028870|525596068|FG003|Overall Study|Administrative|4|||
145749445|NCT02069899|525596073|FG000|Overall Study|Adverse Event|6|||
145749446|NCT02069899|525596074|FG001|Overall Study|Adverse Event|0|||
145749447|NCT02069899|525596075|FG002|Overall Study|Adverse Event|1|||
145524844|NCT03823378|524781238|FG001|Overall Study|Lost to Follow-up|1|||
145524845|NCT03823378|524781239|FG002|Overall Study|Lost to Follow-up|0|||
145524846|NCT03823378|524781240|FG003|Overall Study|Lost to Follow-up|0|||
145524847|NCT03823378|524781241|FG004|Overall Study|Lost to Follow-up|1|||
145524848|NCT03823378|524781242|FG005|Overall Study|Lost to Follow-up|0|||
145524849|NCT03823378|524781237|FG000|Overall Study|Withdrawal by Subject|0|||
145524850|NCT03823378|524781238|FG001|Overall Study|Withdrawal by Subject|1|||
145749448|NCT02069899|525596073|FG000|Overall Study|Withdrawal by Participant|2|||
145749449|NCT02069899|525596074|FG001|Overall Study|Withdrawal by Participant|0|||
145524851|NCT03823378|524781239|FG002|Overall Study|Withdrawal by Subject|4|||
145524852|NCT03823378|524781240|FG003|Overall Study|Withdrawal by Subject|2|||
145524853|NCT03823378|524781241|FG004|Overall Study|Withdrawal by Subject|0|||
145524854|NCT03823378|524781242|FG005|Overall Study|Withdrawal by Subject|1|||
145524855|NCT03823378|524781237|FG000|Overall Study|Other, not specified|19|||
145749450|NCT02069899|525596075|FG002|Overall Study|Withdrawal by Participant|0|||
145749451|NCT02069899|525596073|FG000|Overall Study|Lost to Follow-up|1|||
145749452|NCT02069899|525596074|FG001|Overall Study|Lost to Follow-up|0|||
145749453|NCT02069899|525596075|FG002|Overall Study|Lost to Follow-up|1|||
145749454|NCT02069899|525596073|FG000|Overall Study|Other|4|||
145524856|NCT03823378|524781238|FG001|Overall Study|Other, not specified|12|||
145524857|NCT03823378|524781239|FG002|Overall Study|Other, not specified|6|||
145524858|NCT03823378|524781240|FG003|Overall Study|Other, not specified|8|||
145524859|NCT03823378|524781241|FG004|Overall Study|Other, not specified|17|||
145524860|NCT03823378|524781242|FG005|Overall Study|Other, not specified|7|||
145524861|NCT03190369|524781243|FG000|Overall Study|Poor compliance to protocol|0|||
145524862|NCT03190369|524781244|FG001|Overall Study|Poor compliance to protocol|1|||
145524863|NCT03190369|524781243|FG000|Overall Study|Withdraw before treatment|1|||
145524864|NCT03190369|524781244|FG001|Overall Study|Withdraw before treatment|5|||
145524865|NCT03190369|524781243|FG000|Overall Study|Randomized but not treated|0|||
145524866|NCT03190369|524781244|FG001|Overall Study|Randomized but not treated|2|||
145524867|NCT01606254|524781245|FG000|Overall Study|Withdrawal by Subject|1|||
145524868|NCT01606254|524781246|FG001|Overall Study|Withdrawal by Subject|3|||
145524869|NCT01606254|524781247|FG002|Overall Study|Withdrawal by Subject|0|||
145524870|NCT01606254|524781248|FG003|Overall Study|Withdrawal by Subject|2|||
145524871|NCT01606254|524781245|FG000|Overall Study|Adverse Event|1|||
145524872|NCT01606254|524781246|FG001|Overall Study|Adverse Event|1|||
145524873|NCT01606254|524781247|FG002|Overall Study|Adverse Event|0|||
145524874|NCT01606254|524781248|FG003|Overall Study|Adverse Event|1|||
145524875|NCT04543409|524781249|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145524876|NCT04543409|524781250|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145524877|NCT04543409|524781249|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
145524878|NCT04543409|524781250|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
145524879|NCT04543409|524781249|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
145524880|NCT04543409|524781250|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
145524881|NCT04543409|524781249|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
145524882|NCT04543409|524781250|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
145524883|NCT04543409|524781249|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
145524884|NCT04543409|524781250|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
145524885|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
145524886|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
145524887|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
145524888|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
145524889|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
145524890|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
145524891|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
145524892|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
145524893|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
145524894|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
145524895|NCT04543409|524781249|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
145524896|NCT04543409|524781250|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
145524897|NCT01289782|524781251|FG000|Overall Study|Lost to Follow-up|14|||
145524898|NCT01289782|524781252|FG001|Overall Study|Lost to Follow-up|7|||
145524899|NCT01289782|524781251|FG000|Overall Study|Protocol Violation|1|||
145524900|NCT01289782|524781252|FG001|Overall Study|Protocol Violation|1|||
145524901|NCT01289782|524781251|FG000|Overall Study|Withdrawal by Subject|8|||
145524902|NCT01289782|524781252|FG001|Overall Study|Withdrawal by Subject|2|||
145524903|NCT01289782|524781251|FG000|Overall Study|Sponsor's Decision|1|||
145524904|NCT01289782|524781252|FG001|Overall Study|Sponsor's Decision|0|||
145524905|NCT01289782|524781251|FG000|Overall Study|Reason not specified|1|||
145524906|NCT01289782|524781252|FG001|Overall Study|Reason not specified|2|||
145524907|NCT02131532|524781253|FG000|Overall Study|Withdrawal by Subject|1|||
145524908|NCT02131532|524781253|FG000|Overall Study|Physician Decision|1|||
145524909|NCT02131532|524781253|FG000|Overall Study|Other health conditions|2|||
145524910|NCT02093026|524781254|FG000|Overall Study|Adverse Event|26|||
145524911|NCT02093026|524781254|FG000|Overall Study|Death|10|||
145524912|NCT02093026|524781254|FG000|Overall Study|Other|157|||
145524913|NCT02195011|524781269|FG000|Overall Study|Adverse Event|4|||
145271177|NCT00557830|523839640|FG000|Screening Treatment Phase|Adverse Event|2|||
145271178|NCT00557830|523839641|FG001|Screening Treatment Phase|Adverse Event|0|||
145524914|NCT02195011|524781270|FG001|Overall Study|Adverse Event|0|||
145524915|NCT02195011|524781269|FG000|Overall Study|Progressive Disease|18|||
145524916|NCT02195011|524781270|FG001|Overall Study|Progressive Disease|1|||
145524917|NCT02195011|524781269|FG000|Overall Study|Withdrawal by Subject|3|||
145524918|NCT02195011|524781270|FG001|Overall Study|Withdrawal by Subject|0|||
145524919|NCT00174291|524781271|FG000|Overall Study|Lost to Follow-up|1|||
145524920|NCT00174291|524781272|FG001|Overall Study|Lost to Follow-up|1|||
145524921|NCT00174291|524781271|FG000|Overall Study|Protocol Violation|0|||
145524922|NCT00174291|524781272|FG001|Overall Study|Protocol Violation|2|||
145524923|NCT00174291|524781271|FG000|Overall Study|Study terminated by sponsor|1|||
145524924|NCT00174291|524781272|FG001|Overall Study|Study terminated by sponsor|0|||
145524925|NCT00174291|524781271|FG000|Overall Study|Withdrawal by Subject|3|||
145749455|NCT02069899|525596074|FG001|Overall Study|Other|0|||
145749456|NCT02069899|525596075|FG002|Overall Study|Other|0|||
145749457|NCT02069899|525596073|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
145524926|NCT00174291|524781272|FG001|Overall Study|Withdrawal by Subject|3|||
145524927|NCT00450112|524781273|FG000|Overall Study|Other Treatment Required|5|||
145749458|NCT02069899|525596074|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
145749459|NCT02069899|525596075|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
145749460|NCT02069899|525596073|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
145524928|NCT00450112|524781274|FG001|Overall Study|Other Treatment Required|1|||
145524929|NCT00450112|524781273|FG000|Overall Study|Withdrawal by Subject|4|||
145524930|NCT00450112|524781274|FG001|Overall Study|Withdrawal by Subject|1|||
145524931|NCT00450112|524781273|FG000|Overall Study|Lost to Follow-up|2|||
145524932|NCT00450112|524781274|FG001|Overall Study|Lost to Follow-up|1|||
145524933|NCT00450112|524781273|FG000|Overall Study|Others|2|||
145524934|NCT00450112|524781274|FG001|Overall Study|Others|3|||
145524935|NCT00555425|524781275|FG000|Overall Study|Missed Medication > 1 wk|34|||
145524936|NCT00555425|524781276|FG001|Overall Study|Missed Medication > 1 wk|15|||
145524937|NCT00555425|524781275|FG000|Overall Study|Missed 3 physician management visits|1|||
145524938|NCT00555425|524781276|FG001|Overall Study|Missed 3 physician management visits|0|||
145524939|NCT00555425|524781275|FG000|Overall Study|Met criteria for protective transfer|16|||
145524940|NCT00555425|524781276|FG001|Overall Study|Met criteria for protective transfer|3|||
145524941|NCT00555425|524781275|FG000|Overall Study|Became pregnant and transferred care|0|||
145524942|NCT00555425|524781276|FG001|Overall Study|Became pregnant and transferred care|1|||
145524943|NCT01185834|524781277|FG000|Overall Study|Lost to Follow-up|2|||
145524944|NCT01185834|524781277|FG000|Overall Study|Discomfort|4|||
145524945|NCT01185834|524781277|FG000|Overall Study|Biomicroscopy|4|||
145524946|NCT01185834|524781277|FG000|Overall Study|Time/Job Conflict|2|||
145524947|NCT01185834|524781277|FG000|Overall Study|Early exit - Site error|2|||
145524948|NCT03189381|524781278|FG000|Overall Study|Death|1|||
145524949|NCT03189381|524781279|FG001|Overall Study|Death|0|||
145524950|NCT01975831|524781280|FG000|Overall Study|Adverse Event|1|||
145524951|NCT01975831|524781281|FG001|Overall Study|Adverse Event|2|||
145524952|NCT01975831|524781282|FG002|Overall Study|Adverse Event|2|||
145524953|NCT01975831|524781283|FG003|Overall Study|Adverse Event|0|||
145524954|NCT01975831|524781284|FG004|Overall Study|Adverse Event|1|||
145524955|NCT01975831|524781285|FG005|Overall Study|Adverse Event|1|||
145524956|NCT01975831|524781286|FG006|Overall Study|Adverse Event|3|||
145524957|NCT01975831|524781287|FG007|Overall Study|Adverse Event|4|||
145524958|NCT01975831|524781288|FG008|Overall Study|Adverse Event|1|||
145524959|NCT01975831|524781280|FG000|Overall Study|Death|1|||
145524960|NCT01975831|524781281|FG001|Overall Study|Death|1|||
145524961|NCT01975831|524781282|FG002|Overall Study|Death|0|||
145524962|NCT01975831|524781283|FG003|Overall Study|Death|0|||
145524963|NCT01975831|524781284|FG004|Overall Study|Death|1|||
145524964|NCT01975831|524781285|FG005|Overall Study|Death|0|||
145524965|NCT01975831|524781286|FG006|Overall Study|Death|1|||
145749461|NCT02069899|525596074|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
145749462|NCT02069899|525596075|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
145749463|NCT00531752|525596078|FG000|First Double-blind Intervention Period|Adverse Event|2|||
145749464|NCT00531752|525596079|FG001|First Double-blind Intervention Period|Adverse Event|0|||
145749465|NCT00531752|525596080|FG002|First Double-blind Intervention Period|Adverse Event|1|||
145749466|NCT00531752|525596081|FG003|First Double-blind Intervention Period|Adverse Event|1|||
145749467|NCT00531752|525596078|FG000|First Double-blind Intervention Period|Other|1|||
145524966|NCT01975831|524781287|FG007|Overall Study|Death|0|||
145524967|NCT01975831|524781288|FG008|Overall Study|Death|0|||
145749468|NCT00531752|525596079|FG001|First Double-blind Intervention Period|Other|4|||
145749469|NCT00531752|525596080|FG002|First Double-blind Intervention Period|Other|4|||
145749470|NCT00531752|525596081|FG003|First Double-blind Intervention Period|Other|0|||
145749471|NCT00531752|525596078|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
145749472|NCT00531752|525596079|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
145749473|NCT00531752|525596080|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
145749474|NCT00531752|525596081|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
145524968|NCT01975831|524781280|FG000|Overall Study|Progressive Disease|1|||
145524969|NCT01975831|524781281|FG001|Overall Study|Progressive Disease|3|||
145524970|NCT01975831|524781282|FG002|Overall Study|Progressive Disease|2|||
145524971|NCT01975831|524781283|FG003|Overall Study|Progressive Disease|4|||
145524972|NCT01975831|524781284|FG004|Overall Study|Progressive Disease|13|||
145524973|NCT01975831|524781285|FG005|Overall Study|Progressive Disease|9|||
145524974|NCT01975831|524781286|FG006|Overall Study|Progressive Disease|10|||
145524975|NCT01975831|524781287|FG007|Overall Study|Progressive Disease|8|||
145524976|NCT01975831|524781288|FG008|Overall Study|Progressive Disease|10|||
145524977|NCT01975831|524781280|FG000|Overall Study|Withdrawal by Subject|0|||
145524978|NCT01975831|524781281|FG001|Overall Study|Withdrawal by Subject|3|||
145524979|NCT01975831|524781282|FG002|Overall Study|Withdrawal by Subject|0|||
145524980|NCT01975831|524781283|FG003|Overall Study|Withdrawal by Subject|0|||
145524981|NCT01975831|524781284|FG004|Overall Study|Withdrawal by Subject|3|||
145524982|NCT01975831|524781285|FG005|Overall Study|Withdrawal by Subject|1|||
145524983|NCT01975831|524781286|FG006|Overall Study|Withdrawal by Subject|1|||
145524984|NCT01975831|524781287|FG007|Overall Study|Withdrawal by Subject|0|||
145524985|NCT01975831|524781288|FG008|Overall Study|Withdrawal by Subject|0|||
145524986|NCT01975831|524781280|FG000|Overall Study|Physician Decision|0|||
145524987|NCT01975831|524781281|FG001|Overall Study|Physician Decision|0|||
145524988|NCT01975831|524781282|FG002|Overall Study|Physician Decision|0|||
145524989|NCT01975831|524781283|FG003|Overall Study|Physician Decision|0|||
145524990|NCT01975831|524781284|FG004|Overall Study|Physician Decision|0|||
145524991|NCT01975831|524781285|FG005|Overall Study|Physician Decision|1|||
145524992|NCT01975831|524781286|FG006|Overall Study|Physician Decision|0|||
145524993|NCT01975831|524781287|FG007|Overall Study|Physician Decision|1|||
145524994|NCT01975831|524781288|FG008|Overall Study|Physician Decision|0|||
145524995|NCT01975831|524781280|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
145524996|NCT01975831|524781281|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
145524997|NCT01975831|524781282|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
145524998|NCT01975831|524781283|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
145524999|NCT01975831|524781284|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
145525000|NCT01975831|524781285|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
145525001|NCT01975831|524781286|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
145525002|NCT01975831|524781287|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
145525003|NCT01975831|524781288|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
145525004|NCT01975831|524781280|FG000|Overall Study|Entered Hospice|0|||
145525005|NCT01975831|524781281|FG001|Overall Study|Entered Hospice|0|||
145525006|NCT01975831|524781282|FG002|Overall Study|Entered Hospice|0|||
145525007|NCT01975831|524781283|FG003|Overall Study|Entered Hospice|0|||
145749475|NCT00531752|525596078|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
145749476|NCT00531752|525596079|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
145749477|NCT00531752|525596080|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
145749478|NCT00531752|525596081|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
145749479|NCT00531752|525596078|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
145749480|NCT00531752|525596079|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
145749481|NCT00531752|525596080|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
145749482|NCT00531752|525596081|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
145749483|NCT00531752|525596078|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
145749484|NCT00531752|525596079|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
145749485|NCT00531752|525596080|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
145749486|NCT00531752|525596081|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
145749487|NCT00531752|525596078|FG000|Second Double-blind Intervention Period|Other|1|||
145749488|NCT00531752|525596079|FG001|Second Double-blind Intervention Period|Other|1|||
145749489|NCT00531752|525596080|FG002|Second Double-blind Intervention Period|Other|0|||
145749490|NCT00531752|525596081|FG003|Second Double-blind Intervention Period|Other|0|||
145749491|NCT00531752|525596078|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
145749492|NCT00531752|525596079|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
145749493|NCT00531752|525596080|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
145749494|NCT00531752|525596081|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
145749495|NCT00531752|525596078|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
145749496|NCT00531752|525596079|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
145749497|NCT00531752|525596080|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
145749498|NCT00531752|525596081|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
145749499|NCT00490451|525596082|FG000|Overall Study|Adverse Event|3|||
145749500|NCT00490451|525596083|FG001|Overall Study|Adverse Event|3|||
145749501|NCT00490451|525596082|FG000|Overall Study|Death|3|||
145749502|NCT00490451|525596083|FG001|Overall Study|Death|1|||
145525008|NCT01975831|524781284|FG004|Overall Study|Entered Hospice|0|||
145525009|NCT01975831|524781285|FG005|Overall Study|Entered Hospice|1|||
145525010|NCT01975831|524781286|FG006|Overall Study|Entered Hospice|0|||
145525011|NCT01975831|524781287|FG007|Overall Study|Entered Hospice|0|||
145402649|NCT05965752|524330809|FG004|Overall Study|Reported Unwanted Symptoms|1|||
145525012|NCT01975831|524781288|FG008|Overall Study|Entered Hospice|0|||
145525013|NCT01975831|524781280|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
145525014|NCT01975831|524781281|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
145402650|NCT05965752|524330805|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145525015|NCT01975831|524781282|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
145525016|NCT01975831|524781283|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
145525017|NCT01975831|524781284|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
145749503|NCT00490451|525596082|FG000|Overall Study|Withdrawal by Subject|2|||
145749504|NCT00490451|525596083|FG001|Overall Study|Withdrawal by Subject|0|||
145749505|NCT00490451|525596082|FG000|Overall Study|Investigator Decision|1|||
145749506|NCT00490451|525596083|FG001|Overall Study|Investigator Decision|0|||
145749507|NCT00490451|525596082|FG000|Overall Study|Protocol Violation|1|||
145749508|NCT00490451|525596083|FG001|Overall Study|Protocol Violation|0|||
145749509|NCT00490451|525596082|FG000|Overall Study|Progressive Disease|53|||
145749510|NCT00490451|525596083|FG001|Overall Study|Progressive Disease|34|||
145749511|NCT01181011|525596084|FG000|Overall Study|Adverse Event|2|||
145749512|NCT01181011|525596084|FG000|Overall Study|Lost to Follow-up|1|||
145749513|NCT04703075|525596085|FG000|Overall Study|Adverse Event|11|||
145271179|NCT00557830|523839642|FG002|Screening Treatment Phase|Adverse Event|0|||
145271180|NCT00557830|523839640|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
145271181|NCT00557830|523839641|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
145271182|NCT00557830|523839642|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
145525018|NCT01975831|524781285|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
145525019|NCT01975831|524781286|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
145525020|NCT01975831|524781287|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
145525021|NCT01975831|524781288|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
145525022|NCT02694718|524781289|FG000|Overall Study|Death|1|||
145525023|NCT02694718|524781289|FG000|Overall Study|Withdrawal by Subject|1|||
145525024|NCT02925793|524781290|FG000|Overall Study|Adverse Event|3|||
145525025|NCT02925793|524781291|FG001|Overall Study|Adverse Event|3|||
145525026|NCT02925793|524781292|FG002|Overall Study|Adverse Event|6|||
145525027|NCT02925793|524781290|FG000|Overall Study|Withdrawal by Subject|16|||
145525028|NCT02925793|524781291|FG001|Overall Study|Withdrawal by Subject|15|||
145525029|NCT02925793|524781292|FG002|Overall Study|Withdrawal by Subject|13|||
145525030|NCT02925793|524781290|FG000|Overall Study|Investigator Discretion|0|||
145271183|NCT00538473|523839646|FG000|Overall Study|Adverse Event|1|||
145402651|NCT05965752|524330806|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145525031|NCT02925793|524781291|FG001|Overall Study|Investigator Discretion|1|||
145525032|NCT02925793|524781292|FG002|Overall Study|Investigator Discretion|1|||
145525033|NCT02925793|524781290|FG000|Overall Study|Lost to Follow-up|2|||
145525034|NCT02925793|524781291|FG001|Overall Study|Lost to Follow-up|3|||
145525035|NCT02925793|524781292|FG002|Overall Study|Lost to Follow-up|1|||
145525036|NCT02925793|524781290|FG000|Overall Study|Lack of Efficacy|2|||
145525037|NCT02925793|524781291|FG001|Overall Study|Lack of Efficacy|6|||
145525038|NCT02925793|524781292|FG002|Overall Study|Lack of Efficacy|4|||
145525039|NCT02925793|524781290|FG000|Overall Study|Other:|2|||
145525040|NCT02925793|524781291|FG001|Overall Study|Other:|1|||
145525041|NCT02925793|524781292|FG002|Overall Study|Other:|3|||
145525042|NCT03523000|524781294|FG000|Overall Study|Withdrawal by Subject|3|||
145525043|NCT03523000|524781295|FG001|Overall Study|Withdrawal by Subject|0|||
145525044|NCT03523000|524781294|FG000|Overall Study|Unsuccessful trial|2|||
145525045|NCT03523000|524781295|FG001|Overall Study|Unsuccessful trial|0|||
145271184|NCT00538473|523839647|FG001|Overall Study|Adverse Event|0|||
145271185|NCT01803464|523839648|FG000|Overall Study|Incomplete data|0|||
145271186|NCT01803464|523839649|FG001|Overall Study|Incomplete data|0|||
145525046|NCT00495131|524781296|FG000|Overall Study|Adverse Event|6|||
145525047|NCT00495131|524781297|FG001|Overall Study|Adverse Event|2|||
145525048|NCT00495131|524781296|FG000|Overall Study|Lack of Efficacy|0|||
145525049|NCT00495131|524781297|FG001|Overall Study|Lack of Efficacy|2|||
145525050|NCT00495131|524781296|FG000|Overall Study|Lost to Follow-up|0|||
145525051|NCT00495131|524781297|FG001|Overall Study|Lost to Follow-up|2|||
145525052|NCT00495131|524781296|FG000|Overall Study|Withdrawal by Subject|1|||
145749514|NCT04703075|525596086|FG001|Overall Study|Adverse Event|7|||
145525053|NCT00495131|524781297|FG001|Overall Study|Withdrawal by Subject|0|||
145525054|NCT00076024|524783116|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
145525055|NCT00076024|524783117|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
145525056|NCT00076024|524783118|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
145525057|NCT00076024|524783119|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
145525058|NCT00076024|524783116|FG000|Phase 1, Lead-in|Adverse Event|1|||
145525059|NCT00076024|524783117|FG001|Phase 1, Lead-in|Adverse Event|0|||
145525060|NCT00076024|524783118|FG002|Phase 1, Lead-in|Adverse Event|0|||
145525061|NCT00076024|524783119|FG003|Phase 1, Lead-in|Adverse Event|0|||
145525062|NCT00076024|524783116|FG000|Phase 1, Lead-in|Clinical progression|1|||
145525063|NCT00076024|524783117|FG001|Phase 1, Lead-in|Clinical progression|0|||
145525064|NCT00076024|524783118|FG002|Phase 1, Lead-in|Clinical progression|0|||
145525065|NCT00076024|524783119|FG003|Phase 1, Lead-in|Clinical progression|0|||
145525066|NCT00076024|524783116|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
145525067|NCT00076024|524783117|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
145525068|NCT00076024|524783118|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
145525069|NCT00076024|524783119|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
145525070|NCT00076024|524783116|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
145525071|NCT00076024|524783117|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
145525072|NCT00076024|524783118|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
145525073|NCT00076024|524783119|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
145525074|NCT00076024|524783116|FG000|Phase 2, Double-blind|Adverse Event|0|||
145525075|NCT00076024|524783117|FG001|Phase 2, Double-blind|Adverse Event|25|||
145525076|NCT00076024|524783118|FG002|Phase 2, Double-blind|Adverse Event|6|||
145525077|NCT00076024|524783119|FG003|Phase 2, Double-blind|Adverse Event|0|||
145525078|NCT00076024|524783116|FG000|Phase 2, Double-blind|Un-specified|0|||
145525079|NCT00076024|524783117|FG001|Phase 2, Double-blind|Un-specified|14|||
145525080|NCT00076024|524783118|FG002|Phase 2, Double-blind|Un-specified|6|||
145525081|NCT00076024|524783119|FG003|Phase 2, Double-blind|Un-specified|0|||
145525082|NCT00076024|524783116|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
145525083|NCT00076024|524783117|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
145525084|NCT00076024|524783118|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
145525085|NCT00076024|524783119|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
145525086|NCT00076024|524783116|FG000|Phase 2, Open-label|Adverse Event|0|||
145525087|NCT00076024|524783117|FG001|Phase 2, Open-label|Adverse Event|0|||
145525088|NCT00076024|524783118|FG002|Phase 2, Open-label|Adverse Event|0|||
145525089|NCT00076024|524783119|FG003|Phase 2, Open-label|Adverse Event|2|||
145525090|NCT00076024|524783116|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
145525091|NCT00076024|524783117|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
145525092|NCT00076024|524783118|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
145525093|NCT00076024|524783119|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
145525094|NCT00076024|524783116|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
145525095|NCT00076024|524783117|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
145525096|NCT00076024|524783118|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
145525097|NCT00076024|524783119|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
145525098|NCT00076024|524783116|FG000|Phase 2, Open-label|Other|0|||
145525099|NCT00076024|524783117|FG001|Phase 2, Open-label|Other|0|||
145525100|NCT00076024|524783118|FG002|Phase 2, Open-label|Other|0|||
145525101|NCT00076024|524783119|FG003|Phase 2, Open-label|Other|2|||
145525102|NCT00301821|524783126|FG000|Overall Study|Ineligible|25|||
145525103|NCT00301821|524783126|FG000|Overall Study|Cancel|1|||
145525104|NCT02294773|524783127|FG000|Overall Study|Withdrawal by Subject|0|||
145525105|NCT02294773|524783128|FG001|Overall Study|Withdrawal by Subject|2|||
145525106|NCT03052764|524783129|FG000|Double-Blind Treatment Period|Adverse Event|2|||
145525107|NCT03052764|524783130|FG001|Double-Blind Treatment Period|Adverse Event|0|||
145525108|NCT03052764|524783129|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
145525109|NCT03052764|524783130|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
145525110|NCT03052764|524783129|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
145525111|NCT03052764|524783130|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
145525112|NCT03052764|524783129|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
145525113|NCT03052764|524783130|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145525114|NCT03052764|524783129|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
145525115|NCT03052764|524783130|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
145525116|NCT03206073|524783131|FG000|Overall Study|Participant Noncompliance|0|||
145525117|NCT03206073|524783132|FG001|Overall Study|Participant Noncompliance|1|||
145525118|NCT03206073|524783133|FG002|Overall Study|Participant Noncompliance|0|||
145525119|NCT03206073|524783134|FG003|Overall Study|Participant Noncompliance|0|||
145525120|NCT03206073|524783131|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
145525121|NCT03206073|524783132|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
145525122|NCT03206073|524783133|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
145525123|NCT03206073|524783134|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
145525124|NCT03206073|524783131|FG000|Overall Study|Death|0|||
145525125|NCT03206073|524783132|FG001|Overall Study|Death|0|||
145525126|NCT03206073|524783133|FG002|Overall Study|Death|1|||
145525127|NCT03206073|524783134|FG003|Overall Study|Death|0|||
145525128|NCT03206073|524783131|FG000|Overall Study|Taken off active treatment|0|||
145525129|NCT03206073|524783132|FG001|Overall Study|Taken off active treatment|0|||
145525130|NCT03206073|524783133|FG002|Overall Study|Taken off active treatment|3|||
145525131|NCT03206073|524783134|FG003|Overall Study|Taken off active treatment|0|||
145525132|NCT03332771|524783135|FG000|Overall Study|Adverse Event|6|||
145525133|NCT03332771|524783136|FG001|Overall Study|Adverse Event|4|||
145525134|NCT03332771|524783137|FG002|Overall Study|Adverse Event|1|||
145525135|NCT03332771|524783138|FG003|Overall Study|Adverse Event|3|||
145525136|NCT03332771|524783135|FG000|Overall Study|Poor Compliance to Protocol|0|||
145525137|NCT03332771|524783136|FG001|Overall Study|Poor Compliance to Protocol|1|||
145525138|NCT03332771|524783137|FG002|Overall Study|Poor Compliance to Protocol|0|||
145525139|NCT03332771|524783138|FG003|Overall Study|Poor Compliance to Protocol|1|||
145525140|NCT03332771|524783135|FG000|Overall Study|Lost to Follow-up|2|||
145525141|NCT03332771|524783136|FG001|Overall Study|Lost to Follow-up|2|||
145525142|NCT03332771|524783137|FG002|Overall Study|Lost to Follow-up|1|||
145525143|NCT03332771|524783138|FG003|Overall Study|Lost to Follow-up|2|||
145525144|NCT03332771|524783135|FG000|Overall Study|At the Participant's own request|20|||
145525145|NCT03332771|524783136|FG001|Overall Study|At the Participant's own request|26|||
145525146|NCT03332771|524783137|FG002|Overall Study|At the Participant's own request|14|||
145525147|NCT03332771|524783138|FG003|Overall Study|At the Participant's own request|23|||
145525148|NCT03332771|524783135|FG000|Overall Study|Reason Not Specified|6|||
145525149|NCT03332771|524783136|FG001|Overall Study|Reason Not Specified|18|||
145525150|NCT03332771|524783137|FG002|Overall Study|Reason Not Specified|16|||
145525151|NCT03332771|524783138|FG003|Overall Study|Reason Not Specified|19|||
145525152|NCT00719264|524783140|FG000|Overall Study|Adverse Event|41|||
145525153|NCT00719264|524783141|FG001|Overall Study|Adverse Event|49|||
145525154|NCT00719264|524783140|FG000|Overall Study|Death|13|||
145525155|NCT00719264|524783141|FG001|Overall Study|Death|10|||
145525156|NCT00719264|524783140|FG000|Overall Study|Administrative Problems|6|||
145525157|NCT00719264|524783141|FG001|Overall Study|Administrative Problems|4|||
145525158|NCT00719264|524783140|FG000|Overall Study|Lost to Follow-up|1|||
145525159|NCT00719264|524783141|FG001|Overall Study|Lost to Follow-up|1|||
145525160|NCT00719264|524783140|FG000|Overall Study|Withdrawal by Subject|12|||
145525161|NCT00719264|524783141|FG001|Overall Study|Withdrawal by Subject|7|||
145525162|NCT00719264|524783140|FG000|Overall Study|Protocol Deviation|1|||
145525163|NCT00719264|524783141|FG001|Overall Study|Protocol Deviation|3|||
145525164|NCT00719264|524783140|FG000|Overall Study|New Cancer Therapy|4|||
145525165|NCT00719264|524783141|FG001|Overall Study|New Cancer Therapy|2|||
145525166|NCT00719264|524783140|FG000|Overall Study|Disease Progression|104|||
145525167|NCT00719264|524783141|FG001|Overall Study|Disease Progression|107|||
145525168|NCT00588952|524783142|FG000|Overall Study|Adverse Event|0|||
145525169|NCT00588952|524783143|FG001|Overall Study|Adverse Event|2|||
145525170|NCT00588952|524783142|FG000|Overall Study|Withdrawal by Subject|3|||
145525171|NCT00588952|524783143|FG001|Overall Study|Withdrawal by Subject|5|||
145525172|NCT01277042|524783144|FG000|Overall Study|Adverse Event|4|||
145525173|NCT01277042|524783145|FG001|Overall Study|Adverse Event|3|||
145525174|NCT01277042|524783144|FG000|Overall Study|Lost to Follow-up|2|||
145525175|NCT01277042|524783145|FG001|Overall Study|Lost to Follow-up|2|||
145525176|NCT01277042|524783144|FG000|Overall Study|Withdrawal by Subject|2|||
145525177|NCT01277042|524783145|FG001|Overall Study|Withdrawal by Subject|0|||
145525178|NCT02469038|524783146|FG000|Overall Study|Physician Decision|4|||
145525179|NCT02469038|524783147|FG001|Overall Study|Physician Decision|5|||
145525180|NCT03435640|524783148|FG000|Overall Study|Withdrawal by Subject|0|||
145525181|NCT03435640|524783149|FG001|Overall Study|Withdrawal by Subject|1|||
145525182|NCT03435640|524783150|FG002|Overall Study|Withdrawal by Subject|0|||
145525183|NCT03435640|524783151|FG003|Overall Study|Withdrawal by Subject|2|||
145525184|NCT03435640|524783152|FG004|Overall Study|Withdrawal by Subject|0|||
145525185|NCT03435640|524783153|FG005|Overall Study|Withdrawal by Subject|0|||
145525186|NCT03435640|524783154|FG006|Overall Study|Withdrawal by Subject|3|||
145525187|NCT03435640|524783155|FG007|Overall Study|Withdrawal by Subject|0|||
145525188|NCT03435640|524783156|FG008|Overall Study|Withdrawal by Subject|0|||
145525189|NCT03435640|524783157|FG009|Overall Study|Withdrawal by Subject|2|||
145525190|NCT03435640|524783158|FG010|Overall Study|Withdrawal by Subject|3|||
145525191|NCT03435640|524783148|FG000|Overall Study|Lost to Follow-up|0|||
145525192|NCT03435640|524783149|FG001|Overall Study|Lost to Follow-up|0|||
145525193|NCT03435640|524783150|FG002|Overall Study|Lost to Follow-up|1|||
145525194|NCT03435640|524783151|FG003|Overall Study|Lost to Follow-up|0|||
145525195|NCT03435640|524783152|FG004|Overall Study|Lost to Follow-up|0|||
145525196|NCT03435640|524783153|FG005|Overall Study|Lost to Follow-up|0|||
145525197|NCT03435640|524783154|FG006|Overall Study|Lost to Follow-up|0|||
145525198|NCT03435640|524783155|FG007|Overall Study|Lost to Follow-up|0|||
145525199|NCT03435640|524783156|FG008|Overall Study|Lost to Follow-up|0|||
145525200|NCT03435640|524783157|FG009|Overall Study|Lost to Follow-up|0|||
145525201|NCT03435640|524783158|FG010|Overall Study|Lost to Follow-up|0|||
145525202|NCT00636987|524783159|FG000|Overall Study|Death|44|||
145525203|NCT00636987|524783159|FG000|Overall Study|Explanted|13|||
145525204|NCT00636987|524783159|FG000|Overall Study|Lost to Follow-up|63|||
145525205|NCT00636987|524783159|FG000|Overall Study|5 year visit window not complete|69|||
145525206|NCT01251146|524783160|FG000|Overall Study|Lost to Follow-up|3|||
145525207|NCT01251146|524783161|FG001|Overall Study|Lost to Follow-up|10|||
145525208|NCT01739400|524783162|FG000|Overall Study|Physician Decision|3|||
145525209|NCT01739400|524783163|FG001|Overall Study|Physician Decision|0|||
145525210|NCT01739400|524783162|FG000|Overall Study|Lost to Follow-up|2|||
145525211|NCT01739400|524783163|FG001|Overall Study|Lost to Follow-up|0|||
145525212|NCT01739400|524783162|FG000|Overall Study|Death|5|||
145525213|NCT01739400|524783163|FG001|Overall Study|Death|2|||
145525214|NCT01739400|524783162|FG000|Overall Study|Withdrawal by Subject|7|||
145525215|NCT01739400|524783163|FG001|Overall Study|Withdrawal by Subject|7|||
145525216|NCT03350984|524783164|FG000|Overall Study|Death|1|||
145525217|NCT03350984|524783165|FG001|Overall Study|Death|0|||
145525218|NCT03350984|524783164|FG000|Overall Study|Lost to Follow-up|5|||
145525219|NCT03350984|524783165|FG001|Overall Study|Lost to Follow-up|6|||
145525220|NCT03350984|524783164|FG000|Overall Study|Protocol Violation|1|||
145525221|NCT03350984|524783165|FG001|Overall Study|Protocol Violation|2|||
145525222|NCT03350984|524783164|FG000|Overall Study|Physician Decision|1|||
145525223|NCT03350984|524783165|FG001|Overall Study|Physician Decision|0|||
145525224|NCT00920829|524783166|FG000|Allocation|No post randomization data|3|||
145525225|NCT00920829|524783167|FG001|Allocation|No post randomization data|1|||
145525226|NCT00920829|524783168|FG002|Allocation|No post randomization data|0|||
145525227|NCT00920829|524783169|FG003|Allocation|No post randomization data|2|||
145525228|NCT00920829|524783166|FG000|Available for Analysis|Withdrawal by Subject|6|||
145525229|NCT00920829|524783167|FG001|Available for Analysis|Withdrawal by Subject|6|||
145525230|NCT00920829|524783168|FG002|Available for Analysis|Withdrawal by Subject|6|||
145525231|NCT00920829|524783169|FG003|Available for Analysis|Withdrawal by Subject|10|||
145525232|NCT00920829|524783166|FG000|Available for Analysis|Required Medical Treatment|0|||
145525233|NCT00920829|524783167|FG001|Available for Analysis|Required Medical Treatment|1|||
145525234|NCT00920829|524783168|FG002|Available for Analysis|Required Medical Treatment|2|||
145525235|NCT00920829|524783169|FG003|Available for Analysis|Required Medical Treatment|0|||
145525236|NCT00920829|524783166|FG000|Available for Analysis|Adverse Event|1|||
145525237|NCT00920829|524783167|FG001|Available for Analysis|Adverse Event|2|||
145525238|NCT00920829|524783168|FG002|Available for Analysis|Adverse Event|1|||
145525239|NCT00920829|524783169|FG003|Available for Analysis|Adverse Event|0|||
145525240|NCT00920829|524783166|FG000|Available for Analysis|Death|1|||
145525241|NCT00920829|524783167|FG001|Available for Analysis|Death|0|||
145525242|NCT00920829|524783168|FG002|Available for Analysis|Death|0|||
145525243|NCT00920829|524783169|FG003|Available for Analysis|Death|0|||
145525244|NCT00920829|524783166|FG000|Available for Analysis|Protocol Violation|0|||
145525245|NCT00920829|524783167|FG001|Available for Analysis|Protocol Violation|0|||
145525246|NCT00920829|524783168|FG002|Available for Analysis|Protocol Violation|1|||
145525247|NCT00920829|524783169|FG003|Available for Analysis|Protocol Violation|0|||
145525248|NCT00920829|524783166|FG000|Available for Analysis|Required more treatment|0|||
145525249|NCT00920829|524783167|FG001|Available for Analysis|Required more treatment|2|||
145525250|NCT00920829|524783168|FG002|Available for Analysis|Required more treatment|0|||
145525251|NCT00920829|524783169|FG003|Available for Analysis|Required more treatment|1|||
145525252|NCT04123665|524783170|FG000|Overall Study|Withdrawal by Subject|7|||
145525253|NCT04123665|524783171|FG001|Overall Study|Withdrawal by Subject|0|||
145525254|NCT04123665|524783170|FG000|Overall Study|Lost to Follow-up|1|||
145525255|NCT04123665|524783171|FG001|Overall Study|Lost to Follow-up|0|||
145525256|NCT01711879|524783176|FG000|Overall Study|Death|1|||
145525257|NCT01711879|524783177|FG001|Overall Study|Death|0|||
145525258|NCT02239224|524783185|FG000|Overall Study|Administrative|0|||
145525259|NCT02239224|524783186|FG001|Overall Study|Administrative|0|||
145525260|NCT02239224|524783187|FG002|Overall Study|Administrative|3|||
145749515|NCT04703075|525596085|FG000|Overall Study|Lost to Follow-up|6|||
145525261|NCT02239224|524783188|FG003|Overall Study|Administrative|1|||
145749516|NCT04703075|525596086|FG001|Overall Study|Lost to Follow-up|12|||
145749517|NCT04703075|525596085|FG000|Overall Study|Physician Decision|3|||
145525262|NCT01466179|524783190|FG000|Overall Study|Ongoing in core study|2|||
145525263|NCT01466179|524783190|FG000|Overall Study|Physician Decision|46|||
145525264|NCT01466179|524783190|FG000|Overall Study|Progressive disease|43|||
145525265|NCT01466179|524783190|FG000|Overall Study|Adverse Event|32|||
145525266|NCT01466179|524783190|FG000|Overall Study|Disease relapse|23|||
145525267|NCT01466179|524783190|FG000|Overall Study|Lack of Efficacy|14|||
145525268|NCT01466179|524783190|FG000|Overall Study|Death|7|||
145525269|NCT01466179|524783190|FG000|Overall Study|Withdrawal by Subject|7|||
145525270|NCT01466179|524783190|FG000|Overall Study|Protocol Violation|2|||
145525271|NCT01466179|524783190|FG000|Overall Study|Other|3|||
145525272|NCT00737464|524783191|FG000|Overall Study|Adverse Event|1|||
145525273|NCT00737464|524783191|FG000|Overall Study|Death|6|||
145749518|NCT04703075|525596086|FG001|Overall Study|Physician Decision|0|||
145525274|NCT00737464|524783191|FG000|Overall Study|Other - Failure to Return|1|||
145525275|NCT00737464|524783191|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
145525276|NCT00737464|524783191|FG000|Overall Study|Other reasons|4|||
145525277|NCT04177355|524783200|FG000|Overall Study|Lost to Follow-up|0|||
145525278|NCT04177355|524783201|FG001|Overall Study|Lost to Follow-up|2|||
145525279|NCT04177355|524783202|FG002|Overall Study|Lost to Follow-up|0|||
145525280|NCT04177355|524783203|FG003|Overall Study|Lost to Follow-up|1|||
145525281|NCT04177355|524783204|FG004|Overall Study|Lost to Follow-up|2|||
145525282|NCT04177355|524783205|FG005|Overall Study|Lost to Follow-up|0|||
145271187|NCT01803464|523839650|FG002|Overall Study|Incomplete data|4|||
145271188|NCT01803464|523839651|FG003|Overall Study|Incomplete data|0|||
145402652|NCT05965752|524330807|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145525283|NCT04177355|524783206|FG006|Overall Study|Lost to Follow-up|1|||
145525284|NCT04177355|524783207|FG007|Overall Study|Lost to Follow-up|0|||
145525285|NCT04177355|524783208|FG008|Overall Study|Lost to Follow-up|0|||
145525286|NCT04177355|524783209|FG009|Overall Study|Lost to Follow-up|0|||
145525287|NCT04177355|524783210|FG010|Overall Study|Lost to Follow-up|0|||
145525288|NCT04177355|524783200|FG000|Overall Study|Withdrawal by Subject|0|||
145525289|NCT04177355|524783201|FG001|Overall Study|Withdrawal by Subject|0|||
145525290|NCT04177355|524783202|FG002|Overall Study|Withdrawal by Subject|0|||
145525291|NCT04177355|524783203|FG003|Overall Study|Withdrawal by Subject|1|||
145525292|NCT04177355|524783204|FG004|Overall Study|Withdrawal by Subject|1|||
145525293|NCT04177355|524783205|FG005|Overall Study|Withdrawal by Subject|0|||
145525294|NCT04177355|524783206|FG006|Overall Study|Withdrawal by Subject|0|||
145525295|NCT04177355|524783207|FG007|Overall Study|Withdrawal by Subject|0|||
145525296|NCT04177355|524783208|FG008|Overall Study|Withdrawal by Subject|1|||
145525297|NCT04177355|524783209|FG009|Overall Study|Withdrawal by Subject|0|||
145525298|NCT04177355|524783210|FG010|Overall Study|Withdrawal by Subject|0|||
145525299|NCT03139604|524783212|FG000|Overall Study|Other|7|||
145525300|NCT03139604|524783213|FG001|Overall Study|Other|3|||
145525301|NCT03139604|524783212|FG000|Overall Study|Withdrawal by Subject|16|||
145525302|NCT03139604|524783213|FG001|Overall Study|Withdrawal by Subject|17|||
145525303|NCT03139604|524783212|FG000|Overall Study|Physician Decision|1|||
145525304|NCT03139604|524783213|FG001|Overall Study|Physician Decision|2|||
145525305|NCT03139604|524783212|FG000|Overall Study|Lost to Follow-up|3|||
145525306|NCT03139604|524783213|FG001|Overall Study|Lost to Follow-up|1|||
145525307|NCT03139604|524783212|FG000|Overall Study|Death|65|||
145525308|NCT03139604|524783213|FG001|Overall Study|Death|67|||
145525309|NCT03139604|524783212|FG000|Overall Study|Study Terminated by Sponsor|122|||
145525310|NCT03139604|524783213|FG001|Overall Study|Study Terminated by Sponsor|127|||
145525311|NCT03139604|524783212|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
145525312|NCT03139604|524783213|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
145525313|NCT00366340|524783215|FG000|Infant Series|Protocol Violation|3|||
145525314|NCT00366340|524783216|FG001|Infant Series|Protocol Violation|4|||
145525315|NCT00366340|524783215|FG000|Infant Series|Withdrawal by Subject|3|||
145525316|NCT00366340|524783216|FG001|Infant Series|Withdrawal by Subject|3|||
145525317|NCT00366340|524783215|FG000|Infant Series|Adverse Event|0|||
145525318|NCT00366340|524783216|FG001|Infant Series|Adverse Event|2|||
145525319|NCT00366340|524783215|FG000|Infant Series|Lost to Follow-up|1|||
145271189|NCT01803464|523839648|FG000|Overall Study|Withdrawal by Subject|1|||
145525320|NCT00366340|524783216|FG001|Infant Series|Lost to Follow-up|1|||
145525321|NCT00366340|524783215|FG000|Infant Series|Failure to return|1|||
145525322|NCT00366340|524783216|FG001|Infant Series|Failure to return|0|||
145525323|NCT00366340|524783215|FG000|After the Infant Series|Parent/legal guardian request|1|||
145525324|NCT00366340|524783216|FG001|After the Infant Series|Parent/legal guardian request|1|||
145525325|NCT00366340|524783215|FG000|After the Infant Series|Failed to return|0|||
145525326|NCT00366340|524783216|FG001|After the Infant Series|Failed to return|1|||
145271190|NCT01803464|523839649|FG001|Overall Study|Withdrawal by Subject|0|||
145525327|NCT00366340|524783215|FG000|After the Infant Series|Protocol Violation|2|||
145525328|NCT00366340|524783216|FG001|After the Infant Series|Protocol Violation|2|||
145525329|NCT00366340|524783215|FG000|After the Infant Series|Adverse Event|0|||
145525330|NCT00366340|524783216|FG001|After the Infant Series|Adverse Event|1|||
145525331|NCT00366340|524783215|FG000|After the Infant Series|Lost to Follow-up|0|||
145525332|NCT00366340|524783216|FG001|After the Infant Series|Lost to Follow-up|1|||
145525333|NCT00366340|524783215|FG000|Toddler Dose|Failed to return|1|||
145525334|NCT00366340|524783216|FG001|Toddler Dose|Failed to return|0|||
145525335|NCT00366340|524783215|FG000|Toddler Dose|Parent/legal guardian request|0|||
145525336|NCT00366340|524783216|FG001|Toddler Dose|Parent/legal guardian request|1|||
145525337|NCT03101267|524783224|FG000|Primary Study Period|Withdrawal by Subject|1|||
145525338|NCT03101267|524783225|FG001|Primary Study Period|Withdrawal by Subject|2|||
145525339|NCT03101267|524783226|FG002|Primary Study Period|Withdrawal by Subject|3|||
145525340|NCT03101267|524783224|FG000|Primary Study Period|Miscellaneous|2|||
145525341|NCT03101267|524783225|FG001|Primary Study Period|Miscellaneous|0|||
145525342|NCT03101267|524783226|FG002|Primary Study Period|Miscellaneous|0|||
145525343|NCT00107952|524783227|FG000|Overall Study|Death|75|||
145525344|NCT00107952|524783228|FG001|Overall Study|Death|61|||
145525345|NCT00107952|524783227|FG000|Overall Study|Lost to Follow-up|0|||
145525346|NCT00107952|524783228|FG001|Overall Study|Lost to Follow-up|3|||
145525347|NCT00107952|524783227|FG000|Overall Study|Withdrawal by Subject|9|||
145525348|NCT00107952|524783228|FG001|Overall Study|Withdrawal by Subject|6|||
145525349|NCT00107952|524783227|FG000|Overall Study|Other|2|||
145525350|NCT00107952|524783228|FG001|Overall Study|Other|5|||
145525351|NCT00107952|524783227|FG000|Overall Study|Never received study treatment|9|||
145525352|NCT00107952|524783228|FG001|Overall Study|Never received study treatment|6|||
145525353|NCT02045303|524783236|FG000|Overall Study|Protocol Violation|2|||
145525354|NCT02045303|524783237|FG001|Overall Study|Protocol Violation|1|||
145525355|NCT02045303|524783238|FG002|Overall Study|Protocol Violation|0|||
145525356|NCT02045303|524783236|FG000|Overall Study|Withdrawal by Subject|0|||
145525357|NCT02045303|524783237|FG001|Overall Study|Withdrawal by Subject|2|||
145525358|NCT02045303|524783238|FG002|Overall Study|Withdrawal by Subject|0|||
145525359|NCT01856023|524783239|FG000|Overall Study|Death|1|||
145525360|NCT01856023|524783240|FG001|Overall Study|Death|2|||
145525361|NCT01856023|524783239|FG000|Overall Study|Adverse Event|2|||
145525362|NCT01856023|524783240|FG001|Overall Study|Adverse Event|1|||
145525363|NCT01856023|524783239|FG000|Overall Study|Lack of Efficacy|5|||
145525364|NCT01856023|524783240|FG001|Overall Study|Lack of Efficacy|5|||
145525365|NCT01856023|524783239|FG000|Overall Study|non compliance, study closure|1|||
145525366|NCT01856023|524783240|FG001|Overall Study|non compliance, study closure|3|||
145525367|NCT01856023|524783239|FG000|Overall Study|Withdrawal by Subject|1|||
145525368|NCT01856023|524783240|FG001|Overall Study|Withdrawal by Subject|1|||
145525369|NCT00424255|524783241|FG000|Overall Study|Death|115|||
145525370|NCT00424255|524783242|FG001|Overall Study|Death|111|||
145525371|NCT00424255|524783241|FG000|Overall Study|Lost to Follow-up|26|||
145525372|NCT00424255|524783242|FG001|Overall Study|Lost to Follow-up|20|||
145525373|NCT00424255|524783241|FG000|Overall Study|Protocol Violation|0|||
145525374|NCT00424255|524783242|FG001|Overall Study|Protocol Violation|1|||
145525375|NCT00424255|524783241|FG000|Overall Study|Withdrawal by Subject|34|||
145525376|NCT00424255|524783242|FG001|Overall Study|Withdrawal by Subject|38|||
145525377|NCT00424255|524783241|FG000|Overall Study|Physician Decision|3|||
145525378|NCT00424255|524783242|FG001|Overall Study|Physician Decision|7|||
145525379|NCT00424255|524783241|FG000|Overall Study|Cognitive Disturbance|1|||
145525380|NCT00424255|524783242|FG001|Overall Study|Cognitive Disturbance|0|||
145525381|NCT00424255|524783241|FG000|Overall Study|Non-compliance by Participants|1|||
145525382|NCT00424255|524783242|FG001|Overall Study|Non-compliance by Participants|0|||
145525383|NCT00424255|524783241|FG000|Overall Study|Fatigue|1|||
145525384|NCT00424255|524783242|FG001|Overall Study|Fatigue|0|||
145525385|NCT00424255|524783241|FG000|Overall Study|Disease Progression|0|||
145525386|NCT00424255|524783242|FG001|Overall Study|Disease Progression|2|||
145525387|NCT00424255|524783241|FG000|Overall Study|Sponsor Terminated Study|161|||
145525388|NCT00424255|524783242|FG001|Overall Study|Sponsor Terminated Study|167|||
145525389|NCT00256282|524783243|FG000|Overall Study|Disease progression, relapse during acti|12|||
145525390|NCT00256282|524783243|FG000|Overall Study|Adverse Event|3|||
145525391|NCT00256282|524783243|FG000|Overall Study|Physician Decision|1|||
145525392|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
145525393|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
145525394|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Other|2|||
145525395|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Other|2|||
145525396|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Personal reasons|2|||
145525397|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Personal reasons|2|||
145525398|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
145525399|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
145525400|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
145525401|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
145525402|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
145525403|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
145525404|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
145525405|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
145525406|NCT00667446|524783244|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
145525407|NCT00667446|524783245|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
145525408|NCT00667446|524783244|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
145525409|NCT00667446|524783245|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
145525410|NCT03945175|524783247|FG000|Overall Study|Did not meet inclusion criteria|31|||
145525411|NCT03945175|524783247|FG000|Overall Study|Withdrew consent|2|||
145525412|NCT03945175|524783247|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
145525413|NCT03945175|524783247|FG000|Overall Study|Early termination during Mydayis treatment|1|||
145525414|NCT00769483|524783255|FG000|Overall Study|Withdrawal by Subject|0|||
145525415|NCT00769483|524783256|FG001|Overall Study|Withdrawal by Subject|1|||
145525416|NCT00769483|524783257|FG002|Overall Study|Withdrawal by Subject|0|||
145525417|NCT00769483|524783258|FG003|Overall Study|Withdrawal by Subject|0|||
145525418|NCT00769483|524783259|FG004|Overall Study|Withdrawal by Subject|1|||
145525419|NCT00769483|524783260|FG005|Overall Study|Withdrawal by Subject|0|||
145525420|NCT01306877|524783261|FG000|Overall Study|Lost to Follow-up|3|||
145525421|NCT01306877|524783262|FG001|Overall Study|Lost to Follow-up|3|||
145525422|NCT01306877|524783261|FG000|Overall Study|Physician Decision|0|||
145525423|NCT01306877|524783262|FG001|Overall Study|Physician Decision|1|||
145525424|NCT00006389|524783263|FG000|Overall Study|Adverse Event|1|||
145525425|NCT01307020|524783265|FG000|Overall Study|Lost to Follow-up|0|||
145525426|NCT01307020|524783266|FG001|Overall Study|Lost to Follow-up|0|||
145525427|NCT01307020|524783267|FG002|Overall Study|Lost to Follow-up|1|||
145525428|NCT01307020|524783268|FG003|Overall Study|Lost to Follow-up|1|||
145525429|NCT01307020|524783269|FG004|Overall Study|Lost to Follow-up|0|||
145525430|NCT01307020|524783270|FG005|Overall Study|Lost to Follow-up|0|||
145525431|NCT01307020|524783271|FG006|Overall Study|Lost to Follow-up|1|||
145525432|NCT01307020|524783272|FG007|Overall Study|Lost to Follow-up|0|||
145525433|NCT01307020|524783273|FG008|Overall Study|Lost to Follow-up|0|||
145525434|NCT01307020|524783274|FG009|Overall Study|Lost to Follow-up|0|||
145525435|NCT01307020|524783265|FG000|Overall Study|Electronic data capture failure|0|||
145525436|NCT01307020|524783266|FG001|Overall Study|Electronic data capture failure|1|||
145525437|NCT01307020|524783267|FG002|Overall Study|Electronic data capture failure|0|||
145525438|NCT01307020|524783268|FG003|Overall Study|Electronic data capture failure|0|||
145525439|NCT01307020|524783269|FG004|Overall Study|Electronic data capture failure|0|||
145525440|NCT01307020|524783270|FG005|Overall Study|Electronic data capture failure|0|||
145525441|NCT01307020|524783271|FG006|Overall Study|Electronic data capture failure|0|||
145525442|NCT01307020|524783272|FG007|Overall Study|Electronic data capture failure|0|||
145525443|NCT01307020|524783273|FG008|Overall Study|Electronic data capture failure|0|||
145525444|NCT01307020|524783274|FG009|Overall Study|Electronic data capture failure|0|||
145749519|NCT04703075|525596085|FG000|Overall Study|Moved|0|||
145525445|NCT02380690|524783275|FG000|Overall Study|Lost to Follow-up|14|||
145525446|NCT02380690|524783276|FG001|Overall Study|Lost to Follow-up|4|||
145525447|NCT02380690|524783275|FG000|Overall Study|Withdrawal by Subject|20|||
145525448|NCT02380690|524783276|FG001|Overall Study|Withdrawal by Subject|8|||
145525449|NCT00266864|524783277|FG000|Overall Study|Lost to Follow-up|4|||
145525450|NCT00266864|524783278|FG001|Overall Study|Lost to Follow-up|1|||
145525451|NCT00266864|524783277|FG000|Overall Study|Withdrawal by Subject|1|||
145525452|NCT00266864|524783278|FG001|Overall Study|Withdrawal by Subject|1|||
145525453|NCT03687970|524783286|FG000|Overall Study|visit scheduling conflicts|2|||
145525454|NCT03687970|524783287|FG001|Overall Study|visit scheduling conflicts|0|||
145525455|NCT03119701|524783288|FG000|6-day Dosing|Death|4|||
145525456|NCT03119701|524783289|FG001|6-day Dosing|Death|1|||
145525457|NCT03119701|524783288|FG000|6-day Dosing|Adverse Event|3|||
145749520|NCT04703075|525596086|FG001|Overall Study|Moved|2|||
145749521|NCT04703075|525596085|FG000|Overall Study|Index INH Resistant|0|||
145749522|NCT04703075|525596086|FG001|Overall Study|Index INH Resistant|1|||
145749523|NCT04703075|525596085|FG000|Overall Study|Lack of Efficacy|6|||
145749524|NCT04703075|525596086|FG001|Overall Study|Lack of Efficacy|18|||
145525458|NCT03119701|524783289|FG001|6-day Dosing|Adverse Event|0|||
145525459|NCT03119701|524783288|FG000|6-day Dosing|Physician Decision|0|||
145749525|NCT01035905|525596093|FG000|Overall Study|Lack of Efficacy|1|||
145749526|NCT01035905|525596094|FG001|Overall Study|Lack of Efficacy|1|||
145749527|NCT04942925|525596095|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
145749528|NCT04942925|525596096|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
145525460|NCT03119701|524783289|FG001|6-day Dosing|Physician Decision|1|||
145749529|NCT04942925|525596095|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
145749530|NCT04942925|525596096|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
145525461|NCT03119701|524783288|FG000|6-day Dosing|Withdrawal by Subject|0|||
145525462|NCT03119701|524783289|FG001|6-day Dosing|Withdrawal by Subject|1|||
145525463|NCT03119701|524783288|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
145525464|NCT03119701|524783289|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
145525465|NCT01909453|524783299|FG000|Overall Study|Ongoing|118|||
145525466|NCT01909453|524783300|FG001|Overall Study|Ongoing|103|||
145525467|NCT01909453|524783301|FG002|Overall Study|Ongoing|83|||
145749531|NCT02164981|525597468|FG000|Started|Withdrawal by Subject|2|||
145749532|NCT02164981|525597469|FG001|Started|Withdrawal by Subject|1|||
145525468|NCT01909453|524783302|FG003|Overall Study|Ongoing|164|||
145525469|NCT01909453|524783303|FG004|Overall Study|Ongoing|50|||
145525470|NCT01909453|524783299|FG000|Overall Study|Death|69|||
145525471|NCT01909453|524783300|FG001|Overall Study|Death|74|||
145525472|NCT01909453|524783301|FG002|Overall Study|Death|88|||
145525473|NCT01909453|524783302|FG003|Overall Study|Death|86|||
145525474|NCT01909453|524783303|FG004|Overall Study|Death|29|||
145525475|NCT01909453|524783299|FG000|Overall Study|Lost to Follow-up|3|||
145525476|NCT01909453|524783300|FG001|Overall Study|Lost to Follow-up|4|||
145525477|NCT01909453|524783301|FG002|Overall Study|Lost to Follow-up|4|||
145525478|NCT01909453|524783302|FG003|Overall Study|Lost to Follow-up|3|||
145525479|NCT01909453|524783303|FG004|Overall Study|Lost to Follow-up|3|||
145525480|NCT01909453|524783299|FG000|Overall Study|Withdrawal by Subject|2|||
145525481|NCT01909453|524783300|FG001|Overall Study|Withdrawal by Subject|13|||
145525482|NCT01909453|524783301|FG002|Overall Study|Withdrawal by Subject|16|||
145525483|NCT01909453|524783302|FG003|Overall Study|Withdrawal by Subject|5|||
145525484|NCT01909453|524783303|FG004|Overall Study|Withdrawal by Subject|4|||
145525485|NCT03607422|524785085|FG000|Overall Study|Adverse Event|7|||
145525486|NCT03607422|524785086|FG001|Overall Study|Adverse Event|3|||
145525487|NCT03607422|524785087|FG002|Overall Study|Adverse Event|2|||
145525488|NCT03607422|524785088|FG003|Overall Study|Adverse Event|0|||
145525489|NCT03607422|524785089|FG004|Overall Study|Adverse Event|2|||
145525490|NCT03607422|524785090|FG005|Overall Study|Adverse Event|0|||
145525491|NCT03607422|524785085|FG000|Overall Study|Withdrawal by Subject|11|||
145525492|NCT03607422|524785086|FG001|Overall Study|Withdrawal by Subject|3|||
145525493|NCT03607422|524785087|FG002|Overall Study|Withdrawal by Subject|6|||
145525494|NCT03607422|524785088|FG003|Overall Study|Withdrawal by Subject|2|||
145525495|NCT03607422|524785089|FG004|Overall Study|Withdrawal by Subject|0|||
145525496|NCT03607422|524785090|FG005|Overall Study|Withdrawal by Subject|0|||
145525497|NCT03607422|524785085|FG000|Overall Study|Lost to Follow-up|0|||
145525498|NCT03607422|524785086|FG001|Overall Study|Lost to Follow-up|0|||
145525499|NCT03607422|524785087|FG002|Overall Study|Lost to Follow-up|1|||
145525500|NCT03607422|524785088|FG003|Overall Study|Lost to Follow-up|0|||
145525501|NCT03607422|524785089|FG004|Overall Study|Lost to Follow-up|0|||
145525502|NCT03607422|524785090|FG005|Overall Study|Lost to Follow-up|0|||
145525503|NCT03607422|524785085|FG000|Overall Study|Other|12|||
145525504|NCT03607422|524785086|FG001|Overall Study|Other|4|||
145525505|NCT03607422|524785087|FG002|Overall Study|Other|1|||
145525506|NCT03607422|524785088|FG003|Overall Study|Other|2|||
145525507|NCT03607422|524785089|FG004|Overall Study|Other|0|||
145525508|NCT03607422|524785090|FG005|Overall Study|Other|2|||
145525509|NCT03607422|524785085|FG000|Overall Study|Ongoing at Time of Analysis|8|||
145525510|NCT03607422|524785086|FG001|Overall Study|Ongoing at Time of Analysis|0|||
145525511|NCT03607422|524785087|FG002|Overall Study|Ongoing at Time of Analysis|2|||
145525512|NCT03607422|524785088|FG003|Overall Study|Ongoing at Time of Analysis|1|||
145525513|NCT03607422|524785089|FG004|Overall Study|Ongoing at Time of Analysis|1|||
145525514|NCT03607422|524785090|FG005|Overall Study|Ongoing at Time of Analysis|1|||
145525515|NCT00053365|524785091|FG000|Overall Study|Incorrect cell type|1|||
145525516|NCT00053365|524785091|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
145525517|NCT00053365|524785091|FG000|Overall Study|Never treated|4|||
145525518|NCT03183778|524785094|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
145525519|NCT00721123|524785095|FG000|Overall Study|Adverse Event|96|||
145525520|NCT00721123|524785095|FG000|Overall Study|Death|10|||
145525521|NCT00721123|524785095|FG000|Overall Study|Insufficient Therapeutic Response|21|||
145525522|NCT00721123|524785095|FG000|Overall Study|Protocol Violation|1|||
145525523|NCT00721123|524785095|FG000|Overall Study|Refused Treatment|41|||
145525524|NCT00721123|524785095|FG000|Overall Study|Failure to Return|9|||
145525525|NCT00721123|524785095|FG000|Overall Study|Withdrawal by Subject|5|||
145525526|NCT03228420|524785101|FG000|Overall Study|Lost to Follow-up|5|||
145525527|NCT03228420|524785102|FG001|Overall Study|Lost to Follow-up|3|||
145525528|NCT03228420|524785101|FG000|Overall Study|Withdrawal by Subject|10|||
145525529|NCT03228420|524785102|FG001|Overall Study|Withdrawal by Subject|0|||
145525530|NCT03228420|524785101|FG000|Overall Study|Adverse Event|5|||
145525531|NCT03228420|524785102|FG001|Overall Study|Adverse Event|2|||
145525532|NCT03954041|524785105|FG000|Overall Study|Lost to Follow-up|3|||
145525533|NCT03954041|524785106|FG001|Overall Study|Lost to Follow-up|3|||
145525534|NCT03954041|524785107|FG002|Overall Study|Lost to Follow-up|6|||
145525535|NCT03954041|524785105|FG000|Overall Study|Death|4|||
145525536|NCT03954041|524785106|FG001|Overall Study|Death|0|||
145525537|NCT03954041|524785107|FG002|Overall Study|Death|1|||
145525538|NCT03954041|524785105|FG000|Overall Study|Death by neurologic criteria|0|||
145525539|NCT03954041|524785106|FG001|Overall Study|Death by neurologic criteria|0|||
145525540|NCT03954041|524785107|FG002|Overall Study|Death by neurologic criteria|1|||
145525541|NCT03954041|524785105|FG000|Overall Study|Reason not specified|7|||
145525542|NCT03954041|524785106|FG001|Overall Study|Reason not specified|4|||
145525543|NCT03954041|524785107|FG002|Overall Study|Reason not specified|2|||
145525544|NCT03954041|524785105|FG000|Overall Study|Withdrew prior to dosing|4|||
145525545|NCT03954041|524785106|FG001|Overall Study|Withdrew prior to dosing|2|||
145525546|NCT03954041|524785107|FG002|Overall Study|Withdrew prior to dosing|0|||
145525547|NCT03981822|524785108|FG000|Overall Study|Lost to Follow-up|0|||
145525548|NCT03981822|524785109|FG001|Overall Study|Lost to Follow-up|1|||
145525549|NCT03981822|524785110|FG002|Overall Study|Lost to Follow-up|1|||
145525550|NCT03981822|524785111|FG003|Overall Study|Lost to Follow-up|0|||
145749533|NCT02164981|525597470|FG002|Started|Withdrawal by Subject|0|||
145749534|NCT02164981|525597468|FG000|Started|Protocol Violation|2|||
145749535|NCT02164981|525597469|FG001|Started|Protocol Violation|0|||
145749536|NCT02164981|525597470|FG002|Started|Protocol Violation|0|||
145749537|NCT02164981|525597468|FG000|Started|Adverse Event|1|||
145749538|NCT02164981|525597469|FG001|Started|Adverse Event|2|||
145749539|NCT02164981|525597470|FG002|Started|Adverse Event|0|||
145749540|NCT02164981|525597468|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
145749541|NCT02164981|525597469|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
145749542|NCT02164981|525597470|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
145749543|NCT02164981|525597468|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
145749544|NCT02164981|525597469|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
145749545|NCT02164981|525597470|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
145749546|NCT02164981|525597468|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
145749547|NCT02164981|525597469|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
145749548|NCT02164981|525597470|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
145749549|NCT01736579|525597471|FG000|Overall Study|Termination of Study by Sponsor|2|||
145749550|NCT01736579|525597472|FG001|Overall Study|Termination of Study by Sponsor|2|||
145749551|NCT02543528|525597480|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
145749552|NCT02543528|525597481|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
145749553|NCT02543528|525597482|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
145749554|NCT02543528|525597483|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
145749555|NCT02543528|525597484|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
145749556|NCT02543528|525597480|FG000|Adaptation Period|Lens Handling Difficultes|0|||
145525551|NCT03981822|524785112|FG004|Overall Study|Lost to Follow-up|6|||
145525552|NCT03981822|524785113|FG005|Overall Study|Lost to Follow-up|4|||
145525553|NCT03981822|524785114|FG006|Overall Study|Lost to Follow-up|4|||
145525554|NCT03981822|524785115|FG007|Overall Study|Lost to Follow-up|2|||
145525555|NCT03981822|524785108|FG000|Overall Study|Withdrawal by Subject|0|||
145525556|NCT03981822|524785109|FG001|Overall Study|Withdrawal by Subject|1|||
145525557|NCT03981822|524785110|FG002|Overall Study|Withdrawal by Subject|0|||
145525558|NCT03981822|524785111|FG003|Overall Study|Withdrawal by Subject|0|||
145525559|NCT03981822|524785112|FG004|Overall Study|Withdrawal by Subject|0|||
145525560|NCT03981822|524785113|FG005|Overall Study|Withdrawal by Subject|1|||
145525561|NCT03981822|524785114|FG006|Overall Study|Withdrawal by Subject|0|||
145525562|NCT03981822|524785115|FG007|Overall Study|Withdrawal by Subject|2|||
145525563|NCT03981822|524785108|FG000|Overall Study|COVID-19 Related|0|||
145525564|NCT03981822|524785109|FG001|Overall Study|COVID-19 Related|0|||
145525565|NCT03981822|524785110|FG002|Overall Study|COVID-19 Related|0|||
145525566|NCT03981822|524785111|FG003|Overall Study|COVID-19 Related|0|||
145525567|NCT03981822|524785112|FG004|Overall Study|COVID-19 Related|2|||
145525568|NCT03981822|524785113|FG005|Overall Study|COVID-19 Related|1|||
145525569|NCT03981822|524785114|FG006|Overall Study|COVID-19 Related|2|||
145525570|NCT03981822|524785115|FG007|Overall Study|COVID-19 Related|1|||
145525571|NCT02742246|524785116|FG000|Overall Study|Never initiated treatment|5|||
145525572|NCT02742246|524785117|FG001|Overall Study|Never initiated treatment|3|||
145525573|NCT02742246|524785118|FG002|Overall Study|Never initiated treatment|1|||
145749557|NCT02543528|525597481|FG001|Adaptation Period|Lens Handling Difficultes|0|||
145749558|NCT02543528|525597482|FG002|Adaptation Period|Lens Handling Difficultes|0|||
145749559|NCT02543528|525597483|FG003|Adaptation Period|Lens Handling Difficultes|0|||
145749560|NCT02543528|525597484|FG004|Adaptation Period|Lens Handling Difficultes|8|||
145749561|NCT02543528|525597480|FG000|Adaptation Period|Lost to Follow-up|0|||
145525574|NCT02742246|524785116|FG000|Overall Study|dropped out during treatment|7|||
145525575|NCT02742246|524785117|FG001|Overall Study|dropped out during treatment|13|||
145525576|NCT02742246|524785118|FG002|Overall Study|dropped out during treatment|10|||
145525577|NCT02742246|524785116|FG000|Overall Study|Death|1|||
145525578|NCT02742246|524785117|FG001|Overall Study|Death|0|||
145525579|NCT02742246|524785118|FG002|Overall Study|Death|0|||
145525580|NCT03489551|524785119|FG000|Overall Study|Withdrawal by Subject|2|||
145525581|NCT00054717|524785120|FG000|Overall Study|Randomized but not treated|2|||
145525582|NCT00054717|524785121|FG001|Overall Study|Randomized but not treated|8|||
145749562|NCT02543528|525597481|FG001|Adaptation Period|Lost to Follow-up|0|||
145749563|NCT02543528|525597482|FG002|Adaptation Period|Lost to Follow-up|0|||
145749564|NCT02543528|525597483|FG003|Adaptation Period|Lost to Follow-up|0|||
145749565|NCT02543528|525597484|FG004|Adaptation Period|Lost to Follow-up|14|||
145749566|NCT02543528|525597480|FG000|Adaptation Period|Adverse Event|0|||
145749567|NCT02543528|525597481|FG001|Adaptation Period|Adverse Event|0|||
145749568|NCT02543528|525597482|FG002|Adaptation Period|Adverse Event|0|||
145749569|NCT02543528|525597483|FG003|Adaptation Period|Adverse Event|0|||
145749570|NCT02543528|525597484|FG004|Adaptation Period|Adverse Event|2|||
145749571|NCT02543528|525597480|FG000|Extended Wear Period|Adverse Event|17|||
145749572|NCT02543528|525597481|FG001|Extended Wear Period|Adverse Event|11|||
145749573|NCT02543528|525597482|FG002|Extended Wear Period|Adverse Event|16|||
145749574|NCT02543528|525597483|FG003|Extended Wear Period|Adverse Event|3|||
145749575|NCT02543528|525597484|FG004|Extended Wear Period|Adverse Event|0|||
145749576|NCT02543528|525597480|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
145749577|NCT02543528|525597481|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
145749578|NCT02543528|525597482|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
145749579|NCT02543528|525597483|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
145749580|NCT02543528|525597484|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
145749581|NCT02543528|525597480|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
145749582|NCT02543528|525597481|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
145749583|NCT02543528|525597482|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
145749584|NCT02543528|525597483|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
145749585|NCT02543528|525597484|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
145749586|NCT02543528|525597480|FG000|Extended Wear Period|Lost to Follow-up|0|||
145749587|NCT02543528|525597481|FG001|Extended Wear Period|Lost to Follow-up|1|||
145749588|NCT02543528|525597482|FG002|Extended Wear Period|Lost to Follow-up|2|||
145749589|NCT02543528|525597483|FG003|Extended Wear Period|Lost to Follow-up|1|||
145749590|NCT02543528|525597484|FG004|Extended Wear Period|Lost to Follow-up|0|||
145749591|NCT02543528|525597480|FG000|Extended Wear Period|Withdrawal by Subject|10|||
145749592|NCT02543528|525597481|FG001|Extended Wear Period|Withdrawal by Subject|9|||
145749593|NCT02543528|525597482|FG002|Extended Wear Period|Withdrawal by Subject|4|||
145749594|NCT02543528|525597483|FG003|Extended Wear Period|Withdrawal by Subject|5|||
145749595|NCT02543528|525597484|FG004|Extended Wear Period|Withdrawal by Subject|0|||
145749596|NCT01408147|525597485|FG000|Overall Study|Withdrawal by Subject|0|||
145749597|NCT01408147|525597486|FG001|Overall Study|Withdrawal by Subject|1|||
145749598|NCT01042600|525597487|FG000|Overall Study|Ineligible|1|||
145749599|NCT01042600|525597488|FG001|Overall Study|Ineligible|0|||
145749600|NCT05048719|525597489|FG000|Overall Study|Withdrawal by Subject|2|||
145749601|NCT05048719|525597490|FG001|Overall Study|Withdrawal by Subject|1|||
145749602|NCT05048719|525597491|FG002|Overall Study|Withdrawal by Subject|3|||
145749603|NCT05048719|525597492|FG003|Overall Study|Withdrawal by Subject|1|||
145749604|NCT05048719|525597493|FG004|Overall Study|Withdrawal by Subject|0|||
145749605|NCT05048719|525597494|FG005|Overall Study|Withdrawal by Subject|2|||
145749606|NCT05048719|525597495|FG006|Overall Study|Withdrawal by Subject|1|||
145749607|NCT05048719|525597496|FG007|Overall Study|Withdrawal by Subject|1|||
145749608|NCT05048719|525597497|FG008|Overall Study|Withdrawal by Subject|0|||
145271191|NCT01803464|523839650|FG002|Overall Study|Withdrawal by Subject|0|||
145271192|NCT01803464|523839651|FG003|Overall Study|Withdrawal by Subject|0|||
145271193|NCT01360021|523839657|FG000|Overall Study|Eligibility criteria + other|2|||
145271194|NCT01360021|523839658|FG001|Overall Study|Eligibility criteria + other|1|||
145271195|NCT01360021|523839659|FG002|Overall Study|Eligibility criteria + other|1|||
145271196|NCT01360021|523839657|FG000|Overall Study|Protocol Violation|0|||
145271197|NCT01360021|523839658|FG001|Overall Study|Protocol Violation|0|||
145525583|NCT00054717|524785120|FG000|Overall Study|Adverse Event|70|||
145525584|NCT00054717|524785121|FG001|Overall Study|Adverse Event|22|||
145525585|NCT00054717|524785120|FG000|Overall Study|Protocol Violation|18|||
145271198|NCT01360021|523839659|FG002|Overall Study|Protocol Violation|1|||
145271199|NCT01360021|523839657|FG000|Overall Study|Withdrawal by Subject|4|||
145271200|NCT01360021|523839658|FG001|Overall Study|Withdrawal by Subject|0|||
145525586|NCT00054717|524785121|FG001|Overall Study|Protocol Violation|19|||
145525587|NCT00054717|524785120|FG000|Overall Study|Lost to Follow-up|23|||
145749609|NCT05048719|525597489|FG000|Overall Study|Death|1|||
145749610|NCT05048719|525597490|FG001|Overall Study|Death|0|||
145749611|NCT05048719|525597491|FG002|Overall Study|Death|0|||
145749612|NCT05048719|525597492|FG003|Overall Study|Death|0|||
145749613|NCT05048719|525597493|FG004|Overall Study|Death|0|||
145749614|NCT05048719|525597494|FG005|Overall Study|Death|0|||
145525588|NCT00054717|524785121|FG001|Overall Study|Lost to Follow-up|13|||
145749615|NCT05048719|525597495|FG006|Overall Study|Death|0|||
145749616|NCT05048719|525597496|FG007|Overall Study|Death|0|||
145749617|NCT05048719|525597497|FG008|Overall Study|Death|0|||
145749618|NCT05048719|525597489|FG000|Overall Study|Adverse Event|0|||
145749619|NCT05048719|525597490|FG001|Overall Study|Adverse Event|1|||
145749620|NCT05048719|525597491|FG002|Overall Study|Adverse Event|2|||
145749621|NCT05048719|525597492|FG003|Overall Study|Adverse Event|0|||
145749622|NCT05048719|525597493|FG004|Overall Study|Adverse Event|1|||
145749623|NCT05048719|525597494|FG005|Overall Study|Adverse Event|0|||
145749624|NCT05048719|525597495|FG006|Overall Study|Adverse Event|0|||
145749625|NCT05048719|525597496|FG007|Overall Study|Adverse Event|0|||
145749626|NCT05048719|525597497|FG008|Overall Study|Adverse Event|0|||
145749627|NCT05048719|525597489|FG000|Overall Study|Lost to Follow-up|0|||
145749628|NCT05048719|525597490|FG001|Overall Study|Lost to Follow-up|0|||
145749629|NCT05048719|525597491|FG002|Overall Study|Lost to Follow-up|1|||
145749630|NCT05048719|525597492|FG003|Overall Study|Lost to Follow-up|3|||
145749631|NCT05048719|525597493|FG004|Overall Study|Lost to Follow-up|1|||
145749632|NCT05048719|525597494|FG005|Overall Study|Lost to Follow-up|1|||
145749633|NCT05048719|525597495|FG006|Overall Study|Lost to Follow-up|1|||
145749634|NCT05048719|525597496|FG007|Overall Study|Lost to Follow-up|1|||
145749635|NCT05048719|525597497|FG008|Overall Study|Lost to Follow-up|0|||
145749636|NCT05048719|525597489|FG000|Overall Study|Physician Decision|0|||
145749637|NCT05048719|525597490|FG001|Overall Study|Physician Decision|0|||
145749638|NCT05048719|525597491|FG002|Overall Study|Physician Decision|0|||
145749639|NCT05048719|525597492|FG003|Overall Study|Physician Decision|0|||
145749640|NCT05048719|525597493|FG004|Overall Study|Physician Decision|0|||
145749641|NCT05048719|525597494|FG005|Overall Study|Physician Decision|0|||
145749642|NCT05048719|525597495|FG006|Overall Study|Physician Decision|0|||
145749643|NCT05048719|525597496|FG007|Overall Study|Physician Decision|1|||
145525589|NCT00054717|524785120|FG000|Overall Study|Withdrawal by Subject|32|||
145525590|NCT00054717|524785121|FG001|Overall Study|Withdrawal by Subject|20|||
145525591|NCT00054717|524785120|FG000|Overall Study|Other reason not defined above|117|||
145525592|NCT00054717|524785121|FG001|Overall Study|Other reason not defined above|217|||
145525593|NCT00206076|524785124|FG000|Overall Study|Physician Decision|2|||
145525594|NCT00206076|524785125|FG001|Overall Study|Physician Decision|0|||
145525595|NCT00206076|524785124|FG000|Overall Study|Withdrawal by Subject|1|||
145525596|NCT00206076|524785125|FG001|Overall Study|Withdrawal by Subject|1|||
145525597|NCT01142128|524785127|FG000|Overall Study|Physician Decision|1|||
145525598|NCT01142128|524785127|FG000|Overall Study|Lost to Follow-up|1|||
145525599|NCT01142128|524785127|FG000|Overall Study|Withdrawal by Subject|2|||
145525600|NCT03355664|524785128|FG000|Overall Study|Adverse Event|1|||
145525601|NCT03355664|524785129|FG001|Overall Study|Adverse Event|2|||
145525602|NCT03355664|524785128|FG000|Overall Study|Lost to Follow-up|11|||
145525603|NCT03355664|524785129|FG001|Overall Study|Lost to Follow-up|7|||
145525604|NCT03355664|524785128|FG000|Overall Study|Protocol Violation|1|||
145525605|NCT03355664|524785129|FG001|Overall Study|Protocol Violation|2|||
145525606|NCT03355664|524785128|FG000|Overall Study|Withdrawal by Subject|2|||
145525607|NCT03355664|524785129|FG001|Overall Study|Withdrawal by Subject|1|||
145525608|NCT04163718|524785135|FG000|Overall Study|Study terminated|12|||
145525609|NCT03418571|524785136|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
145525610|NCT03418571|524785137|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
145525611|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
145525612|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
145525613|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
145525614|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
145525615|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
145525616|NCT00586326|524785138|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
145525617|NCT00586326|524785138|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
145525618|NCT00586326|524785138|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
145525619|NCT00586326|524785138|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
145749644|NCT05048719|525597497|FG008|Overall Study|Physician Decision|1|||
145749645|NCT05048719|525597489|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
145749646|NCT05048719|525597490|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749647|NCT05048719|525597491|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749648|NCT05048719|525597492|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749649|NCT05048719|525597493|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749650|NCT05048719|525597494|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749651|NCT05048719|525597495|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749652|NCT05048719|525597496|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749653|NCT05048719|525597497|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
145749654|NCT05048719|525597489|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749655|NCT05048719|525597490|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
145749656|NCT05048719|525597491|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749657|NCT05048719|525597492|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749658|NCT05048719|525597493|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749659|NCT05048719|525597494|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749660|NCT05048719|525597495|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749661|NCT05048719|525597496|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749662|NCT05048719|525597497|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
145749663|NCT05048719|525597489|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749664|NCT05048719|525597490|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
145749665|NCT05048719|525597491|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749666|NCT05048719|525597492|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749667|NCT05048719|525597493|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749668|NCT05048719|525597494|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749669|NCT05048719|525597495|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749670|NCT05048719|525597496|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749671|NCT05048719|525597497|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
145749672|NCT05048719|525597489|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749673|NCT05048719|525597490|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749674|NCT05048719|525597491|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749675|NCT05048719|525597492|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
145749676|NCT05048719|525597493|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749677|NCT05048719|525597494|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749678|NCT05048719|525597495|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749679|NCT05048719|525597496|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749680|NCT05048719|525597497|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
145749681|NCT05048719|525597489|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749682|NCT05048719|525597490|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749683|NCT05048719|525597491|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749684|NCT05048719|525597492|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749685|NCT05048719|525597493|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749686|NCT05048719|525597494|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
145749687|NCT05048719|525597495|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749688|NCT05048719|525597496|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749689|NCT05048719|525597497|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
145749690|NCT03257267|525597498|FG000|Overall Study|Adverse Event|17|||
145749691|NCT03257267|525597499|FG001|Overall Study|Adverse Event|7|||
145749692|NCT03257267|525597498|FG000|Overall Study|Death|96|||
145749693|NCT03257267|525597499|FG001|Overall Study|Death|98|||
145749694|NCT03257267|525597498|FG000|Overall Study|Lost to Follow-up|2|||
145749695|NCT03257267|525597499|FG001|Overall Study|Lost to Follow-up|2|||
145749696|NCT03257267|525597498|FG000|Overall Study|Non-compliance with Study Drug|0|||
145749697|NCT03257267|525597499|FG001|Overall Study|Non-compliance with Study Drug|2|||
145749698|NCT03257267|525597498|FG000|Overall Study|Participant Decision|35|||
145749699|NCT03257267|525597499|FG001|Overall Study|Participant Decision|43|||
145749700|NCT03257267|525597498|FG000|Overall Study|Sponsor Decision|1|||
145749701|NCT03257267|525597499|FG001|Overall Study|Sponsor Decision|0|||
145749702|NCT03257267|525597498|FG000|Overall Study|Physician Decision|1|||
145749703|NCT03257267|525597499|FG001|Overall Study|Physician Decision|3|||
145749704|NCT03257267|525597498|FG000|Overall Study|Disease Progression|109|||
145749705|NCT03257267|525597499|FG001|Overall Study|Disease Progression|121|||
145749706|NCT03257267|525597498|FG000|Overall Study|Withdrawal by Subject|8|||
145749707|NCT03257267|525597499|FG001|Overall Study|Withdrawal by Subject|26|||
145271201|NCT01360021|523839659|FG002|Overall Study|Withdrawal by Subject|2|||
145749708|NCT03257267|525597498|FG000|Overall Study|Other|0|||
145749709|NCT03257267|525597499|FG001|Overall Study|Other|2|||
145749710|NCT02229552|525597500|FG000|Baseline|Withdrawal by Subject|6|||
145749711|NCT02229552|525597500|FG000|1-year Follow up|Withdrawal by Subject|7|||
145749712|NCT02229552|525597500|FG000|1-year Follow up|Lost to Follow-up|18|||
145749713|NCT02229552|525597500|FG000|2-Year Follow up|Withdrawal by Subject|9|||
145749714|NCT02229552|525597500|FG000|2-Year Follow up|Lost to Follow-up|17|||
145749715|NCT01485627|525597501|FG000|Overall Study|Patient withdrew|6|||
145749716|NCT01485627|525597502|FG001|Overall Study|Patient withdrew|5|||
145749717|NCT01485627|525597501|FG000|Overall Study|Patient died|3|||
145749718|NCT01485627|525597502|FG001|Overall Study|Patient died|1|||
145749719|NCT01485627|525597501|FG000|Overall Study|Patient lost to followup|0|||
145749720|NCT01485627|525597502|FG001|Overall Study|Patient lost to followup|1|||
145749721|NCT01485627|525597501|FG000|Overall Study|Caregiver withdrew|3|||
145749722|NCT01485627|525597502|FG001|Overall Study|Caregiver withdrew|3|||
145749723|NCT01485627|525597501|FG000|Overall Study|Caregiver lost to follow up|11|||
145749724|NCT01485627|525597502|FG001|Overall Study|Caregiver lost to follow up|12|||
145749725|NCT01485627|525597501|FG000|Overall Study|Caregiver died|1|||
145749726|NCT01485627|525597502|FG001|Overall Study|Caregiver died|0|||
145749727|NCT01485627|525597501|FG000|Overall Study|caregiver was not bereaved|42|||
145749728|NCT01485627|525597502|FG001|Overall Study|caregiver was not bereaved|35|||
145749729|NCT01709149|525597506|FG000|Open-label Lead-in Phase|Adverse Event|109|||
145749730|NCT01709149|525597507|FG001|Open-label Lead-in Phase|Adverse Event|0|||
145749731|NCT01709149|525597508|FG002|Open-label Lead-in Phase|Adverse Event|0|||
145749732|NCT01709149|525597506|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
145749733|NCT01709149|525597507|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
145749734|NCT01709149|525597508|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
145749735|NCT01709149|525597506|FG000|Open-label Lead-in Phase|Death|1|||
145749736|NCT01709149|525597507|FG001|Open-label Lead-in Phase|Death|0|||
145749737|NCT01709149|525597508|FG002|Open-label Lead-in Phase|Death|0|||
145749738|NCT01709149|525597506|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
145749739|NCT01709149|525597507|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
145749740|NCT01709149|525597508|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
145749741|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
145749742|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
145749743|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
145749744|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145749745|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
145749746|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
145749747|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145749748|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
145749749|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
145749750|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
145749751|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
145749752|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
145749753|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
145749754|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
145749755|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
145749756|NCT01709149|525597506|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145749757|NCT01709149|525597507|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
145749758|NCT01709149|525597508|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145749759|NCT01425203|525597509|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
145749760|NCT01425203|525597510|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
145749761|NCT01425203|525597511|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
145749762|NCT01425203|525597509|FG000|Treatment Phase|Failure at futility timepoint|8|||
145749763|NCT01425203|525597510|FG001|Treatment Phase|Failure at futility timepoint|27|||
145749764|NCT01425203|525597511|FG002|Treatment Phase|Failure at futility timepoint|0|||
145525620|NCT00586326|524785138|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
145525621|NCT00586326|524785138|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
145525622|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
145749765|NCT01425203|525597509|FG000|Treatment Phase|Other virologic failure criteria|5|||
145749766|NCT01425203|525597510|FG001|Treatment Phase|Other virologic failure criteria|3|||
145749767|NCT01425203|525597511|FG002|Treatment Phase|Other virologic failure criteria|0|||
145271202|NCT01360021|523839657|FG000|Overall Study|Adverse Event|2|||
145749768|NCT01425203|525597509|FG000|Treatment Phase|Unidentified reasons|11|||
145749769|NCT01425203|525597510|FG001|Treatment Phase|Unidentified reasons|5|||
145749770|NCT01425203|525597511|FG002|Treatment Phase|Unidentified reasons|0|||
145749771|NCT01425203|525597509|FG000|Treatment Phase|Did not receive treatment|0|||
145749772|NCT01425203|525597510|FG001|Treatment Phase|Did not receive treatment|1|||
145749773|NCT01425203|525597511|FG002|Treatment Phase|Did not receive treatment|0|||
145749774|NCT01425203|525597509|FG000|Crossover Phase|Failure at futility timepoint|0|||
145749775|NCT01425203|525597510|FG001|Crossover Phase|Failure at futility timepoint|0|||
145749776|NCT01425203|525597511|FG002|Crossover Phase|Failure at futility timepoint|3|||
145749777|NCT01425203|525597509|FG000|Crossover Phase|Other virologic failure criteria|0|||
145749778|NCT01425203|525597510|FG001|Crossover Phase|Other virologic failure criteria|0|||
145749779|NCT01425203|525597511|FG002|Crossover Phase|Other virologic failure criteria|3|||
145749780|NCT03031301|525597512|FG000|Overall Study|Protocol Violation|4|||
145749781|NCT03031301|525597513|FG001|Overall Study|Protocol Violation|8|||
145749782|NCT03031301|525597512|FG000|Overall Study|Withdrawal by Subject|7|||
145749783|NCT03031301|525597513|FG001|Overall Study|Withdrawal by Subject|4|||
145749784|NCT03031301|525597512|FG000|Overall Study|Lost to Follow-up|4|||
145749785|NCT03031301|525597513|FG001|Overall Study|Lost to Follow-up|12|||
145749786|NCT03031301|525597512|FG000|Overall Study|Noncompliance|1|||
145749787|NCT03031301|525597513|FG001|Overall Study|Noncompliance|3|||
145749788|NCT03031301|525597512|FG000|Overall Study|Technical issue|1|||
145749789|NCT03031301|525597513|FG001|Overall Study|Technical issue|1|||
145749790|NCT03031301|525597512|FG000|Overall Study|Adverse Event|1|||
145749791|NCT03031301|525597513|FG001|Overall Study|Adverse Event|0|||
145749792|NCT02599961|525597515|FG000|Overall Study|Withdrawal by Subject|1|||
145749793|NCT02599961|525597515|FG000|Overall Study|Subject Non-Compliance|2|||
145749794|NCT02599961|525597515|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
145749795|NCT02599961|525597515|FG000|Overall Study|Other, Not Specified|3|||
145749796|NCT02228590|525597524|FG000|Overall Study|Withdrawal by Subject|1|||
145749797|NCT02111993|525597525|FG000|Overall Study|Physician Decision|5|||
145749798|NCT02111993|525597526|FG001|Overall Study|Physician Decision|4|||
145749799|NCT01097863|525597527|FG000|Overall Study|Discomfort|1|||
145749800|NCT01097863|525597528|FG001|Overall Study|Discomfort|0|||
145749801|NCT01097863|525597529|FG002|Overall Study|Discomfort|1|||
145749802|NCT01097863|525597527|FG000|Overall Study|Did not return for final visit|0|||
145749803|NCT01097863|525597528|FG001|Overall Study|Did not return for final visit|0|||
145749804|NCT01097863|525597529|FG002|Overall Study|Did not return for final visit|1|||
145749805|NCT00796315|525597530|FG000|Overall Study|Protocol Violation|0|||
145749806|NCT00796315|525597531|FG001|Overall Study|Protocol Violation|1|||
145749807|NCT00796315|525597532|FG002|Overall Study|Protocol Violation|0|||
145749808|NCT01400451|525597539|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
145749809|NCT01400451|525597540|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
145749810|NCT01400451|525597541|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
145749811|NCT01400451|525597539|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
145749812|NCT01400451|525597540|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
145749813|NCT01400451|525597541|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
145749814|NCT01400451|525597539|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
145749815|NCT01400451|525597540|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
145271203|NCT01360021|523839658|FG001|Overall Study|Adverse Event|3|||
145271204|NCT01360021|523839659|FG002|Overall Study|Adverse Event|3|||
145271205|NCT00127192|523839660|FG000|Overall Study|Adverse Event|0|||
145271206|NCT00127192|523839661|FG001|Overall Study|Adverse Event|1|||
145749816|NCT01400451|525597541|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
145271207|NCT00127192|523839662|FG002|Overall Study|Adverse Event|1|||
145271208|NCT00127192|523839663|FG003|Overall Study|Adverse Event|1|||
145271209|NCT00127192|523839664|FG004|Overall Study|Adverse Event|0|||
145271210|NCT00127192|523839660|FG000|Overall Study|Lack of Efficacy|2|||
145271211|NCT00127192|523839661|FG001|Overall Study|Lack of Efficacy|0|||
145271212|NCT00127192|523839662|FG002|Overall Study|Lack of Efficacy|0|||
145271213|NCT00127192|523839663|FG003|Overall Study|Lack of Efficacy|0|||
145271214|NCT00127192|523839664|FG004|Overall Study|Lack of Efficacy|2|||
145271215|NCT00127192|523839660|FG000|Overall Study|Withdrawal by Subject|0|||
145271216|NCT00127192|523839661|FG001|Overall Study|Withdrawal by Subject|0|||
145749817|NCT01400451|525597539|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
145271217|NCT00127192|523839662|FG002|Overall Study|Withdrawal by Subject|1|||
145749818|NCT01400451|525597540|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
145271218|NCT00127192|523839663|FG003|Overall Study|Withdrawal by Subject|0|||
145271219|NCT00127192|523839664|FG004|Overall Study|Withdrawal by Subject|3|||
145749819|NCT01400451|525597541|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
145749820|NCT01400451|525597539|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
145749821|NCT01400451|525597540|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
145749822|NCT01400451|525597541|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
145749823|NCT02788747|525597545|FG000|Overall Study|Adverse Event|1|||
145749824|NCT02788747|525597546|FG001|Overall Study|Adverse Event|0|||
145749825|NCT02788747|525597547|FG002|Overall Study|Adverse Event|0|||
145749826|NCT00879697|525597548|FG000|Overall Study|Physician Decision|2|||
145749827|NCT00879697|525597549|FG001|Overall Study|Physician Decision|2|||
145749828|NCT02500121|525597550|FG000|Overall Study|Lost to Follow-up|0|||
145749829|NCT02500121|525597551|FG001|Overall Study|Lost to Follow-up|1|||
145749830|NCT02500121|525597550|FG000|Overall Study|Withdrawal by Subject|1|||
145749831|NCT02500121|525597551|FG001|Overall Study|Withdrawal by Subject|1|||
145749832|NCT02500121|525597550|FG000|Overall Study|Death|26|||
145749833|NCT02500121|525597551|FG001|Overall Study|Death|24|||
145749834|NCT01836783|525597553|FG000|Overall Study|Withdrawal by Subject|0|||
145749835|NCT01836783|525597554|FG001|Overall Study|Withdrawal by Subject|2|||
145749836|NCT01273883|525597556|FG000|First Intervention|Adverse Event|2|||
145749837|NCT01273883|525597557|FG001|First Intervention|Adverse Event|1|||
145749838|NCT01273883|525597556|FG000|Second Intervention|Lost to Follow-up|1|||
145749839|NCT01273883|525597557|FG001|Second Intervention|Lost to Follow-up|1|||
145749840|NCT01273883|525597556|FG000|Second Intervention|Lack of Efficacy|1|||
145749841|NCT01273883|525597557|FG001|Second Intervention|Lack of Efficacy|0|||
145749842|NCT04489888|525597563|FG000|Overall Study|Death|75|||
145749843|NCT04489888|525597563|FG000|Overall Study|Sponsor Decision|26|||
145749844|NCT02043548|525597566|FG000|Overall Study|Lack of Efficacy|1|||
145749845|NCT02043548|525597567|FG001|Overall Study|Lack of Efficacy|0|||
145749846|NCT02043548|525597566|FG000|Overall Study|Adverse Event|0|||
145749847|NCT02043548|525597567|FG001|Overall Study|Adverse Event|1|||
145749848|NCT01430455|525597577|FG000|Overall Study|Withdrawal by Subject|1|||
145749849|NCT01430455|525597577|FG000|Overall Study|Switched to follow-up phase|1|||
145749850|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
145749851|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
145749852|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
145749853|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
145749854|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
145749855|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
145749856|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145749857|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145749858|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145749859|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145749860|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
145749861|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
145749862|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
145749863|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
145749864|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
145749865|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
145749866|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
145749867|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
145749868|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145749869|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145749870|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
145749871|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
145749872|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
145749873|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
145749874|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
145749875|NCT03829657|525597578|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
145749876|NCT03829657|525597579|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
145749877|NCT03829657|525597580|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
145749878|NCT03829657|525597581|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
145749879|NCT03829657|525597582|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
145749880|NCT03829657|525597578|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
145749881|NCT03829657|525597579|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
145271220|NCT00127192|523839660|FG000|Overall Study|Adverse event in pre-treatment period|1|||
145271221|NCT00127192|523839661|FG001|Overall Study|Adverse event in pre-treatment period|0|||
145271222|NCT00127192|523839662|FG002|Overall Study|Adverse event in pre-treatment period|0|||
145271223|NCT00127192|523839663|FG003|Overall Study|Adverse event in pre-treatment period|0|||
145271224|NCT00127192|523839664|FG004|Overall Study|Adverse event in pre-treatment period|0|||
145271225|NCT00203892|523839665|FG000|Overall Study|Physician Decision|1|||
145749882|NCT03829657|525597580|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
145749883|NCT03829657|525597581|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
145749884|NCT03829657|525597582|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
145749885|NCT03829657|525597578|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
145271226|NCT00203892|523839666|FG001|Overall Study|Physician Decision|2|||
145271227|NCT00203892|523839667|FG002|Overall Study|Physician Decision|0|||
145271228|NCT00203892|523839665|FG000|Overall Study|Death|1|||
145271229|NCT00203892|523839666|FG001|Overall Study|Death|0|||
145271230|NCT00203892|523839667|FG002|Overall Study|Death|0|||
145271231|NCT00806416|523839670|FG000|Period 1 - Part I|Adverse Event|0|||
145271232|NCT00806416|523839671|FG001|Period 1 - Part I|Adverse Event|1|||
145271233|NCT00806416|523839672|FG002|Period 1 - Part I|Adverse Event|0|||
145271234|NCT00806416|523839673|FG003|Period 1 - Part I|Adverse Event|0|||
145271235|NCT00806416|523839670|FG000|Period 1 - Part I|Lost to Follow-up|0|||
145271236|NCT00806416|523839671|FG001|Period 1 - Part I|Lost to Follow-up|2|||
145271237|NCT00806416|523839672|FG002|Period 1 - Part I|Lost to Follow-up|0|||
145271238|NCT00806416|523839673|FG003|Period 1 - Part I|Lost to Follow-up|0|||
145271239|NCT00806416|523839670|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
145271240|NCT00806416|523839671|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
145271241|NCT00806416|523839672|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
145271242|NCT00806416|523839673|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
145749886|NCT03829657|525597579|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
145271243|NCT00806416|523839670|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
145271244|NCT00806416|523839671|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
145271245|NCT00806416|523839672|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
145271246|NCT00806416|523839673|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
145271247|NCT04935931|523839678|FG000|Overall Study|Withdrawal by Subject|1|||
145271248|NCT02596009|523839681|FG000|Overall Study|Administrative problems|0|||
145271249|NCT02596009|523839682|FG001|Overall Study|Administrative problems|1|||
145271250|NCT02596009|523839683|FG002|Overall Study|Administrative problems|0|||
145271251|NCT02596009|523839684|FG003|Overall Study|Administrative problems|0|||
145271252|NCT02596009|523839685|FG004|Overall Study|Administrative problems|0|||
145271253|NCT02596009|523839686|FG005|Overall Study|Administrative problems|0|||
145271254|NCT01821391|523839687|FG000|Overall Study|Adverse Event|1|||
145271255|NCT01821391|523839688|FG001|Overall Study|Adverse Event|0|||
145271256|NCT01843660|523839689|FG000|Overall Study|Other|30|||
145271257|NCT01977482|523839690|FG000|Overall Study|Adverse Event|0|||
145271258|NCT01977482|523839691|FG001|Overall Study|Adverse Event|1|||
145271259|NCT01977482|523839692|FG002|Overall Study|Adverse Event|1|||
145271260|NCT01977482|523839693|FG003|Overall Study|Adverse Event|0|||
145271261|NCT01977482|523839694|FG004|Overall Study|Adverse Event|2|||
145271262|NCT01977482|523839695|FG005|Overall Study|Adverse Event|0|||
145525623|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
145749887|NCT03829657|525597580|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
145749888|NCT03829657|525597581|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
145749889|NCT03829657|525597582|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
145749890|NCT03829657|525597578|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
145749891|NCT03829657|525597579|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
145749892|NCT03829657|525597580|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
145749893|NCT03829657|525597581|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
145749894|NCT03829657|525597582|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
145749895|NCT03829657|525597578|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
145749896|NCT03829657|525597579|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
145749897|NCT03829657|525597580|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
145749898|NCT03829657|525597581|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
145749899|NCT03829657|525597582|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
145749900|NCT04418076|525597584|FG000|Overall Study|Death|1|||
145749901|NCT04418076|525597585|FG001|Overall Study|Death|0|||
145749902|NCT04418076|525597586|FG002|Overall Study|Death|0|||
145749903|NCT04418076|525597587|FG003|Overall Study|Death|0|||
145749904|NCT04418076|525597584|FG000|Overall Study|Lost to Follow-up|2|||
145749905|NCT04418076|525597585|FG001|Overall Study|Lost to Follow-up|5|||
145749906|NCT04418076|525597586|FG002|Overall Study|Lost to Follow-up|1|||
145749907|NCT04418076|525597587|FG003|Overall Study|Lost to Follow-up|2|||
145749908|NCT04418076|525597584|FG000|Overall Study|Withdrawal by Subject|1|||
145749909|NCT04418076|525597585|FG001|Overall Study|Withdrawal by Subject|0|||
145749910|NCT04418076|525597586|FG002|Overall Study|Withdrawal by Subject|1|||
145271263|NCT01977482|523839690|FG000|Overall Study|Lost to Follow-up|1|||
145271264|NCT01977482|523839691|FG001|Overall Study|Lost to Follow-up|0|||
145525624|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
145525625|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
145525626|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
145271265|NCT01977482|523839692|FG002|Overall Study|Lost to Follow-up|0|||
145271266|NCT01977482|523839693|FG003|Overall Study|Lost to Follow-up|0|||
145271267|NCT01977482|523839694|FG004|Overall Study|Lost to Follow-up|0|||
145271268|NCT01977482|523839695|FG005|Overall Study|Lost to Follow-up|0|||
145271269|NCT01977482|523839690|FG000|Overall Study|Physician Decision|0|||
145271270|NCT01977482|523839691|FG001|Overall Study|Physician Decision|1|||
145271271|NCT01977482|523839692|FG002|Overall Study|Physician Decision|0|||
145749911|NCT04418076|525597587|FG003|Overall Study|Withdrawal by Subject|1|||
145749912|NCT04418076|525597584|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
145749913|NCT04418076|525597585|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
145749914|NCT04418076|525597586|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
145749915|NCT04418076|525597587|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
145749916|NCT01425008|525597588|FG000|Dose Escalation Phase|Progressive Disease|2|||
145749917|NCT01425008|525597589|FG001|Dose Escalation Phase|Progressive Disease|3|||
145749918|NCT01425008|525597590|FG002|Dose Escalation Phase|Progressive Disease|2|||
145749919|NCT01425008|525597591|FG003|Dose Escalation Phase|Progressive Disease|3|||
145749920|NCT01425008|525597592|FG004|Dose Escalation Phase|Progressive Disease|5|||
145749921|NCT01425008|525597593|FG005|Dose Escalation Phase|Progressive Disease|4|||
145749922|NCT01425008|525597594|FG006|Dose Escalation Phase|Progressive Disease|0|||
145749923|NCT01425008|525597595|FG007|Dose Escalation Phase|Progressive Disease|2|||
145749924|NCT01425008|525597596|FG008|Dose Escalation Phase|Progressive Disease|6|||
145749925|NCT01425008|525597597|FG009|Dose Escalation Phase|Progressive Disease|2|||
145749926|NCT01425008|525597598|FG010|Dose Escalation Phase|Progressive Disease|0|||
145749927|NCT01425008|525597599|FG011|Dose Escalation Phase|Progressive Disease|0|||
145749928|NCT01425008|525597600|FG012|Dose Escalation Phase|Progressive Disease|0|||
145749929|NCT01425008|525597601|FG013|Dose Escalation Phase|Progressive Disease|0|||
145749930|NCT01425008|525597602|FG014|Dose Escalation Phase|Progressive Disease|0|||
145749931|NCT01425008|525597603|FG015|Dose Escalation Phase|Progressive Disease|0|||
145749932|NCT01425008|525597604|FG016|Dose Escalation Phase|Progressive Disease|0|||
145749933|NCT01425008|525597605|FG017|Dose Escalation Phase|Progressive Disease|0|||
145749934|NCT01425008|525597606|FG018|Dose Escalation Phase|Progressive Disease|0|||
145749935|NCT01425008|525597588|FG000|Dose Escalation Phase|Adverse Event|2|||
145749936|NCT01425008|525597589|FG001|Dose Escalation Phase|Adverse Event|0|||
145749937|NCT01425008|525597590|FG002|Dose Escalation Phase|Adverse Event|0|||
145749938|NCT01425008|525597591|FG003|Dose Escalation Phase|Adverse Event|0|||
145749939|NCT01425008|525597592|FG004|Dose Escalation Phase|Adverse Event|0|||
145749940|NCT01425008|525597593|FG005|Dose Escalation Phase|Adverse Event|2|||
145749941|NCT01425008|525597594|FG006|Dose Escalation Phase|Adverse Event|0|||
145749942|NCT01425008|525597595|FG007|Dose Escalation Phase|Adverse Event|0|||
145749943|NCT01425008|525597596|FG008|Dose Escalation Phase|Adverse Event|2|||
145749944|NCT01425008|525597597|FG009|Dose Escalation Phase|Adverse Event|0|||
145749945|NCT01425008|525597598|FG010|Dose Escalation Phase|Adverse Event|0|||
145749946|NCT01425008|525597599|FG011|Dose Escalation Phase|Adverse Event|0|||
145749947|NCT01425008|525597600|FG012|Dose Escalation Phase|Adverse Event|0|||
145749948|NCT01425008|525597601|FG013|Dose Escalation Phase|Adverse Event|0|||
145271272|NCT01977482|523839693|FG003|Overall Study|Physician Decision|0|||
145271273|NCT01977482|523839694|FG004|Overall Study|Physician Decision|0|||
145271274|NCT01977482|523839695|FG005|Overall Study|Physician Decision|0|||
145749949|NCT01425008|525597602|FG014|Dose Escalation Phase|Adverse Event|0|||
145749950|NCT01425008|525597603|FG015|Dose Escalation Phase|Adverse Event|0|||
145749951|NCT01425008|525597604|FG016|Dose Escalation Phase|Adverse Event|0|||
145749952|NCT01425008|525597605|FG017|Dose Escalation Phase|Adverse Event|0|||
145749953|NCT01425008|525597606|FG018|Dose Escalation Phase|Adverse Event|0|||
145749954|NCT01425008|525597588|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749955|NCT01425008|525597589|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145525627|NCT00586326|524785138|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
145525628|NCT03595774|524785139|FG000|Overall Study|Adverse Event|1|||
145525629|NCT03595774|524785140|FG001|Overall Study|Adverse Event|0|||
145525630|NCT03595774|524785141|FG002|Overall Study|Adverse Event|1|||
145525631|NCT03595774|524785142|FG003|Overall Study|Adverse Event|0|||
145525632|NCT03595774|524785139|FG000|Overall Study|screen failure|0|||
145525633|NCT03595774|524785140|FG001|Overall Study|screen failure|1|||
145525634|NCT03595774|524785141|FG002|Overall Study|screen failure|0|||
145525635|NCT03595774|524785142|FG003|Overall Study|screen failure|1|||
145525636|NCT03519386|524785143|FG000|Overall Study|Withdrawal by Subject|4|||
145525637|NCT03519386|524785144|FG001|Overall Study|Withdrawal by Subject|1|||
145525638|NCT03519386|524785145|FG002|Overall Study|Withdrawal by Subject|2|||
145525639|NCT03519386|524785143|FG000|Overall Study|Physician Decision|1|||
145525640|NCT03519386|524785144|FG001|Overall Study|Physician Decision|1|||
145525641|NCT03519386|524785145|FG002|Overall Study|Physician Decision|1|||
145525642|NCT03519386|524785143|FG000|Overall Study|Lost to Follow-up|0|||
145525643|NCT03519386|524785144|FG001|Overall Study|Lost to Follow-up|1|||
145525644|NCT03519386|524785145|FG002|Overall Study|Lost to Follow-up|1|||
145525645|NCT03519386|524785143|FG000|Overall Study|Death|1|||
145525646|NCT03519386|524785144|FG001|Overall Study|Death|0|||
145525647|NCT03519386|524785145|FG002|Overall Study|Death|4|||
145525648|NCT03519386|524785143|FG000|Overall Study|Adverse Event|2|||
145525649|NCT03519386|524785144|FG001|Overall Study|Adverse Event|1|||
145525650|NCT03519386|524785145|FG002|Overall Study|Adverse Event|2|||
145525651|NCT03519386|524785143|FG000|Overall Study|Explanted|2|||
145525652|NCT03519386|524785144|FG001|Overall Study|Explanted|1|||
145525653|NCT03519386|524785145|FG002|Overall Study|Explanted|0|||
145525654|NCT03519386|524785143|FG000|Overall Study|Ongoing in study|190|||
145525655|NCT03519386|524785144|FG001|Overall Study|Ongoing in study|192|||
145525656|NCT03519386|524785145|FG002|Overall Study|Ongoing in study|183|||
145525657|NCT01642407|524785146|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
145525658|NCT01642407|524785146|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
145525659|NCT01642407|524785146|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
145525660|NCT03063203|524785147|FG000|Overall Study|Chose alternative therapy|3|||
145525661|NCT03063203|524785147|FG000|Overall Study|Death|2|||
145525662|NCT03063203|524785147|FG000|Overall Study|Disease progression|4|||
145525663|NCT03063203|524785147|FG000|Overall Study|Physician Decision|5|||
145525664|NCT00829283|524785148|FG000|Overall Study|Lost to Follow-up|7|||
145525665|NCT00829283|524785149|FG001|Overall Study|Lost to Follow-up|25|||
145525666|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
145525667|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
145525668|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
145525669|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
145525670|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
145525671|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
145525672|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
145525673|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
145525674|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
145525675|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
145525676|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
145525677|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
145525678|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
145525679|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
145525680|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
145525681|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
145525682|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
145525683|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
145525684|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
145525685|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
145525686|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
145525687|NCT02431247|524785150|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
145525688|NCT02431247|524785151|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
145525689|NCT02431247|524785152|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
145525690|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
145525691|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
145525692|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
145525693|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
145749956|NCT01425008|525597590|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749957|NCT01425008|525597591|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749958|NCT01425008|525597592|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
145749959|NCT01425008|525597593|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749960|NCT01425008|525597594|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
145749961|NCT01425008|525597595|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
145749962|NCT01425008|525597596|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
145749963|NCT01425008|525597597|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749964|NCT01425008|525597598|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749965|NCT01425008|525597599|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749966|NCT01425008|525597600|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749967|NCT01425008|525597601|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749968|NCT01425008|525597602|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749969|NCT01425008|525597603|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749970|NCT01425008|525597604|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749971|NCT01425008|525597605|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749972|NCT01425008|525597606|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145749973|NCT01425008|525597588|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145749974|NCT01425008|525597589|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
145749975|NCT01425008|525597590|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
145749976|NCT01425008|525597591|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145749977|NCT01425008|525597592|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
145749978|NCT01425008|525597593|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
145749979|NCT01425008|525597594|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
145749980|NCT01425008|525597595|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
145749981|NCT01425008|525597596|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
145749982|NCT01425008|525597597|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
145749983|NCT01425008|525597598|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
145749984|NCT01425008|525597599|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
145749985|NCT01425008|525597600|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
145749986|NCT01425008|525597601|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
145749987|NCT01425008|525597602|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
145749988|NCT01425008|525597603|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
145749989|NCT01425008|525597604|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
145749990|NCT01425008|525597605|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
145749991|NCT01425008|525597606|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
145749992|NCT01425008|525597588|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749993|NCT01425008|525597589|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749994|NCT01425008|525597590|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
145749995|NCT01425008|525597591|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749996|NCT01425008|525597592|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749997|NCT01425008|525597593|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749998|NCT01425008|525597594|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
145749999|NCT01425008|525597595|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750000|NCT01425008|525597596|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
145750001|NCT01425008|525597597|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
145750002|NCT01425008|525597598|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750003|NCT01425008|525597599|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750004|NCT01425008|525597600|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750005|NCT01425008|525597601|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750006|NCT01425008|525597602|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750007|NCT01425008|525597603|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750008|NCT01425008|525597604|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750009|NCT01425008|525597605|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750010|NCT01425008|525597606|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
145750011|NCT01425008|525597588|FG000|Dose Escalation Phase|Other|0|||
145750012|NCT01425008|525597589|FG001|Dose Escalation Phase|Other|0|||
145750013|NCT01425008|525597590|FG002|Dose Escalation Phase|Other|0|||
145750014|NCT01425008|525597591|FG003|Dose Escalation Phase|Other|0|||
145750015|NCT01425008|525597592|FG004|Dose Escalation Phase|Other|0|||
145750016|NCT01425008|525597593|FG005|Dose Escalation Phase|Other|0|||
145525694|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
145750017|NCT01425008|525597594|FG006|Dose Escalation Phase|Other|0|||
145750018|NCT01425008|525597595|FG007|Dose Escalation Phase|Other|0|||
145750019|NCT01425008|525597596|FG008|Dose Escalation Phase|Other|1|||
145525695|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
145525696|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
145525697|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
145525698|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
145525699|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
145525700|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
145525701|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
145525702|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
145525703|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
145525704|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
145525705|NCT02431247|524785150|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
145525706|NCT02431247|524785151|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
145525707|NCT02431247|524785152|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
145525708|NCT00322153|524785153|FG000|Overall Study|Adverse Event|21|||
145525709|NCT00322153|524785154|FG001|Overall Study|Adverse Event|34|||
145525710|NCT00322153|524785153|FG000|Overall Study|Protocol Violation|6|||
145525711|NCT00322153|524785154|FG001|Overall Study|Protocol Violation|14|||
145525712|NCT00322153|524785153|FG000|Overall Study|Withdrawal by Subject|18|||
145525713|NCT00322153|524785154|FG001|Overall Study|Withdrawal by Subject|10|||
145525714|NCT00322153|524785153|FG000|Overall Study|Lack of Efficacy|8|||
145525715|NCT00322153|524785154|FG001|Overall Study|Lack of Efficacy|3|||
145525716|NCT00322153|524785153|FG000|Overall Study|Lost to Follow-up|5|||
145525717|NCT00322153|524785154|FG001|Overall Study|Lost to Follow-up|4|||
145525718|NCT00322153|524785153|FG000|Overall Study|Withdrawn for other reasons|5|||
145525719|NCT00322153|524785154|FG001|Overall Study|Withdrawn for other reasons|4|||
145525720|NCT02414139|524785157|FG000|Treatment Period|Adverse Event|11|||
145525721|NCT02414139|524785158|FG001|Treatment Period|Adverse Event|6|||
145525722|NCT02414139|524785159|FG002|Treatment Period|Adverse Event|8|||
145525723|NCT02414139|524785160|FG003|Treatment Period|Adverse Event|5|||
145525724|NCT02414139|524785161|FG004|Treatment Period|Adverse Event|14|||
145525725|NCT02414139|524785162|FG005|Treatment Period|Adverse Event|3|||
145525726|NCT02414139|524785163|FG006|Treatment Period|Adverse Event|6|||
145525727|NCT02414139|524785164|FG007|Treatment Period|Adverse Event|1|||
145525728|NCT02414139|524785165|FG008|Treatment Period|Adverse Event|6|||
145525729|NCT02414139|524785166|FG009|Treatment Period|Adverse Event|8|||
145525730|NCT02414139|524785157|FG000|Treatment Period|Death|0|||
145525731|NCT02414139|524785158|FG001|Treatment Period|Death|0|||
145525732|NCT02414139|524785159|FG002|Treatment Period|Death|1|||
145525733|NCT02414139|524785160|FG003|Treatment Period|Death|1|||
145525734|NCT02414139|524785161|FG004|Treatment Period|Death|0|||
145525735|NCT02414139|524785162|FG005|Treatment Period|Death|0|||
145525736|NCT02414139|524785163|FG006|Treatment Period|Death|0|||
145525737|NCT02414139|524785164|FG007|Treatment Period|Death|0|||
145525738|NCT02414139|524785165|FG008|Treatment Period|Death|0|||
145525739|NCT02414139|524785166|FG009|Treatment Period|Death|1|||
145525740|NCT02414139|524785157|FG000|Treatment Period|Physician Decision|5|||
145525741|NCT02414139|524785158|FG001|Treatment Period|Physician Decision|4|||
145525742|NCT02414139|524785159|FG002|Treatment Period|Physician Decision|6|||
145525743|NCT02414139|524785160|FG003|Treatment Period|Physician Decision|1|||
145525744|NCT02414139|524785161|FG004|Treatment Period|Physician Decision|4|||
145525745|NCT02414139|524785162|FG005|Treatment Period|Physician Decision|0|||
145525746|NCT02414139|524785163|FG006|Treatment Period|Physician Decision|2|||
145525747|NCT02414139|524785164|FG007|Treatment Period|Physician Decision|0|||
145525748|NCT02414139|524785165|FG008|Treatment Period|Physician Decision|1|||
145525749|NCT02414139|524785166|FG009|Treatment Period|Physician Decision|4|||
145525750|NCT02414139|524785157|FG000|Treatment Period|Progressive disease|48|||
145525751|NCT02414139|524785158|FG001|Treatment Period|Progressive disease|31|||
145750020|NCT01425008|525597597|FG009|Dose Escalation Phase|Other|0|||
145271275|NCT01977482|523839690|FG000|Overall Study|Protocol Violation|0|||
145525752|NCT02414139|524785159|FG002|Treatment Period|Progressive disease|37|||
145525753|NCT02414139|524785160|FG003|Treatment Period|Progressive disease|21|||
145525754|NCT02414139|524785161|FG004|Treatment Period|Progressive disease|43|||
145525755|NCT02414139|524785162|FG005|Treatment Period|Progressive disease|12|||
145525756|NCT02414139|524785163|FG006|Treatment Period|Progressive disease|16|||
145525757|NCT02414139|524785164|FG007|Treatment Period|Progressive disease|2|||
145271276|NCT01977482|523839691|FG001|Overall Study|Protocol Violation|0|||
145525758|NCT02414139|524785165|FG008|Treatment Period|Progressive disease|20|||
145525759|NCT02414139|524785166|FG009|Treatment Period|Progressive disease|14|||
145525760|NCT02414139|524785157|FG000|Treatment Period|Protocol deviation|0|||
145525761|NCT02414139|524785158|FG001|Treatment Period|Protocol deviation|0|||
145525762|NCT02414139|524785159|FG002|Treatment Period|Protocol deviation|1|||
145525763|NCT02414139|524785160|FG003|Treatment Period|Protocol deviation|0|||
145525764|NCT02414139|524785161|FG004|Treatment Period|Protocol deviation|0|||
145525765|NCT02414139|524785162|FG005|Treatment Period|Protocol deviation|0|||
145750021|NCT01425008|525597598|FG010|Dose Escalation Phase|Other|0|||
145750022|NCT01425008|525597599|FG011|Dose Escalation Phase|Other|0|||
145750023|NCT01425008|525597600|FG012|Dose Escalation Phase|Other|0|||
145750024|NCT01425008|525597601|FG013|Dose Escalation Phase|Other|0|||
145750025|NCT01425008|525597602|FG014|Dose Escalation Phase|Other|0|||
145750026|NCT01425008|525597603|FG015|Dose Escalation Phase|Other|0|||
145750027|NCT01425008|525597604|FG016|Dose Escalation Phase|Other|0|||
145750028|NCT01425008|525597605|FG017|Dose Escalation Phase|Other|0|||
145750029|NCT01425008|525597606|FG018|Dose Escalation Phase|Other|0|||
145750030|NCT01425008|525597588|FG000|Dose Expansion Phase|Progressive Disease|0|||
145750031|NCT01425008|525597589|FG001|Dose Expansion Phase|Progressive Disease|0|||
145750032|NCT01425008|525597590|FG002|Dose Expansion Phase|Progressive Disease|0|||
145750033|NCT01425008|525597591|FG003|Dose Expansion Phase|Progressive Disease|0|||
145750034|NCT01425008|525597592|FG004|Dose Expansion Phase|Progressive Disease|0|||
145750035|NCT01425008|525597593|FG005|Dose Expansion Phase|Progressive Disease|0|||
145750036|NCT01425008|525597594|FG006|Dose Expansion Phase|Progressive Disease|0|||
145750037|NCT01425008|525597595|FG007|Dose Expansion Phase|Progressive Disease|0|||
145750038|NCT01425008|525597596|FG008|Dose Expansion Phase|Progressive Disease|0|||
145750039|NCT01425008|525597597|FG009|Dose Expansion Phase|Progressive Disease|0|||
145750040|NCT01425008|525597598|FG010|Dose Expansion Phase|Progressive Disease|10|||
145750041|NCT01425008|525597599|FG011|Dose Expansion Phase|Progressive Disease|4|||
145750042|NCT01425008|525597600|FG012|Dose Expansion Phase|Progressive Disease|12|||
145750043|NCT01425008|525597601|FG013|Dose Expansion Phase|Progressive Disease|1|||
145750044|NCT01425008|525597602|FG014|Dose Expansion Phase|Progressive Disease|5|||
145750045|NCT01425008|525597603|FG015|Dose Expansion Phase|Progressive Disease|8|||
145750046|NCT01425008|525597604|FG016|Dose Expansion Phase|Progressive Disease|9|||
145750047|NCT01425008|525597605|FG017|Dose Expansion Phase|Progressive Disease|2|||
145750048|NCT01425008|525597606|FG018|Dose Expansion Phase|Progressive Disease|10|||
145750049|NCT01425008|525597588|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
145750050|NCT01425008|525597589|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
145750051|NCT01425008|525597590|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
145750052|NCT01425008|525597591|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
145750053|NCT01425008|525597592|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
145750054|NCT01425008|525597593|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
145750055|NCT01425008|525597594|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
145750056|NCT01425008|525597595|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
145750057|NCT01425008|525597596|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
145750058|NCT01425008|525597597|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
145750059|NCT01425008|525597598|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
145750060|NCT01425008|525597599|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
145750061|NCT01425008|525597600|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
145750062|NCT01425008|525597601|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
145750063|NCT01425008|525597602|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
145750064|NCT01425008|525597603|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
145750065|NCT01425008|525597604|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
145750066|NCT01425008|525597605|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
145750067|NCT01425008|525597606|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
145750068|NCT01425008|525597588|FG000|Dose Expansion Phase|Other|0|||
145750069|NCT01425008|525597589|FG001|Dose Expansion Phase|Other|0|||
145750070|NCT01425008|525597590|FG002|Dose Expansion Phase|Other|0|||
145750071|NCT01425008|525597591|FG003|Dose Expansion Phase|Other|0|||
145750072|NCT01425008|525597592|FG004|Dose Expansion Phase|Other|0|||
145750073|NCT01425008|525597593|FG005|Dose Expansion Phase|Other|0|||
145750074|NCT01425008|525597594|FG006|Dose Expansion Phase|Other|0|||
145750075|NCT01425008|525597595|FG007|Dose Expansion Phase|Other|0|||
145750076|NCT01425008|525597596|FG008|Dose Expansion Phase|Other|0|||
145750077|NCT01425008|525597597|FG009|Dose Expansion Phase|Other|0|||
145750078|NCT01425008|525597598|FG010|Dose Expansion Phase|Other|0|||
145750079|NCT01425008|525597599|FG011|Dose Expansion Phase|Other|0|||
145750080|NCT01425008|525597600|FG012|Dose Expansion Phase|Other|1|||
145750081|NCT01425008|525597601|FG013|Dose Expansion Phase|Other|0|||
145750082|NCT01425008|525597602|FG014|Dose Expansion Phase|Other|0|||
145750083|NCT01425008|525597603|FG015|Dose Expansion Phase|Other|0|||
145750084|NCT01425008|525597604|FG016|Dose Expansion Phase|Other|2|||
145750085|NCT01425008|525597605|FG017|Dose Expansion Phase|Other|0|||
145750086|NCT01425008|525597606|FG018|Dose Expansion Phase|Other|4|||
145750087|NCT01425008|525597588|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750088|NCT01425008|525597589|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750089|NCT01425008|525597590|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750090|NCT01425008|525597591|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750091|NCT01425008|525597592|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750092|NCT01425008|525597593|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750093|NCT01425008|525597594|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750094|NCT01425008|525597595|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750095|NCT01425008|525597596|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
145525766|NCT02414139|524785163|FG006|Treatment Period|Protocol deviation|0|||
145750096|NCT01425008|525597597|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750097|NCT01425008|525597598|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
145750098|NCT01425008|525597599|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
145750099|NCT01425008|525597600|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750100|NCT01425008|525597601|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750101|NCT01425008|525597602|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750102|NCT01425008|525597603|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
145750103|NCT01425008|525597604|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
145750104|NCT01425008|525597605|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
145750105|NCT01425008|525597606|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
145750106|NCT01425008|525597588|FG000|Dose Expansion Phase|Adverse Event|0|||
145750107|NCT01425008|525597589|FG001|Dose Expansion Phase|Adverse Event|0|||
145750108|NCT01425008|525597590|FG002|Dose Expansion Phase|Adverse Event|0|||
145750109|NCT01425008|525597591|FG003|Dose Expansion Phase|Adverse Event|0|||
145750110|NCT01425008|525597592|FG004|Dose Expansion Phase|Adverse Event|0|||
145750111|NCT01425008|525597593|FG005|Dose Expansion Phase|Adverse Event|0|||
145750112|NCT01425008|525597594|FG006|Dose Expansion Phase|Adverse Event|0|||
145750113|NCT01425008|525597595|FG007|Dose Expansion Phase|Adverse Event|0|||
145750114|NCT01425008|525597596|FG008|Dose Expansion Phase|Adverse Event|0|||
145750115|NCT01425008|525597597|FG009|Dose Expansion Phase|Adverse Event|0|||
145750116|NCT01425008|525597598|FG010|Dose Expansion Phase|Adverse Event|2|||
145750117|NCT01425008|525597599|FG011|Dose Expansion Phase|Adverse Event|3|||
145750118|NCT01425008|525597600|FG012|Dose Expansion Phase|Adverse Event|3|||
145750119|NCT01425008|525597601|FG013|Dose Expansion Phase|Adverse Event|0|||
145750120|NCT01425008|525597602|FG014|Dose Expansion Phase|Adverse Event|1|||
145750121|NCT01425008|525597603|FG015|Dose Expansion Phase|Adverse Event|1|||
145750122|NCT01425008|525597604|FG016|Dose Expansion Phase|Adverse Event|5|||
145750123|NCT01425008|525597605|FG017|Dose Expansion Phase|Adverse Event|0|||
145750124|NCT01425008|525597606|FG018|Dose Expansion Phase|Adverse Event|3|||
145750125|NCT01425008|525597588|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
145271277|NCT01977482|523839692|FG002|Overall Study|Protocol Violation|1|||
145271278|NCT01977482|523839693|FG003|Overall Study|Protocol Violation|0|||
145525767|NCT02414139|524785164|FG007|Treatment Period|Protocol deviation|0|||
145525768|NCT02414139|524785165|FG008|Treatment Period|Protocol deviation|0|||
145525769|NCT02414139|524785166|FG009|Treatment Period|Protocol deviation|0|||
145525770|NCT02414139|524785157|FG000|Treatment Period|Subject/Guardian decision|5|||
145525771|NCT02414139|524785158|FG001|Treatment Period|Subject/Guardian decision|1|||
145525772|NCT02414139|524785159|FG002|Treatment Period|Subject/Guardian decision|1|||
145525773|NCT02414139|524785160|FG003|Treatment Period|Subject/Guardian decision|2|||
145525774|NCT02414139|524785161|FG004|Treatment Period|Subject/Guardian decision|5|||
145525775|NCT02414139|524785162|FG005|Treatment Period|Subject/Guardian decision|0|||
145525776|NCT02414139|524785163|FG006|Treatment Period|Subject/Guardian decision|2|||
145525777|NCT02414139|524785164|FG007|Treatment Period|Subject/Guardian decision|0|||
145525778|NCT02414139|524785165|FG008|Treatment Period|Subject/Guardian decision|1|||
145271279|NCT01977482|523839694|FG004|Overall Study|Protocol Violation|0|||
145271280|NCT01977482|523839695|FG005|Overall Study|Protocol Violation|0|||
145271281|NCT01977482|523839690|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
145525779|NCT02414139|524785166|FG009|Treatment Period|Subject/Guardian decision|1|||
145525780|NCT02414139|524785157|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145525781|NCT02414139|524785158|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145750126|NCT01425008|525597589|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
145750127|NCT01425008|525597590|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
145750128|NCT01425008|525597591|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
145750129|NCT01425008|525597592|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
145750130|NCT01425008|525597593|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
145750131|NCT01425008|525597594|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
145525782|NCT02414139|524785159|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145525783|NCT02414139|524785160|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145525784|NCT02414139|524785161|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
145750132|NCT01425008|525597595|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
145750133|NCT01425008|525597596|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
145750134|NCT01425008|525597597|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
145750135|NCT01425008|525597598|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
145750136|NCT01425008|525597599|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
145750137|NCT01425008|525597600|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
145750138|NCT01425008|525597601|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
145750139|NCT01425008|525597602|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
145750140|NCT01425008|525597603|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
145750141|NCT01425008|525597604|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
145750142|NCT01425008|525597605|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
145750143|NCT01425008|525597606|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
145750144|NCT01425008|525597588|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750145|NCT01425008|525597589|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750146|NCT01425008|525597590|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750147|NCT01425008|525597591|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750148|NCT01425008|525597592|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750149|NCT01425008|525597593|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750150|NCT01425008|525597594|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750151|NCT01425008|525597595|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750152|NCT01425008|525597596|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750153|NCT01425008|525597597|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750154|NCT01425008|525597598|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750155|NCT01425008|525597599|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750156|NCT01425008|525597600|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750157|NCT01425008|525597601|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750158|NCT01425008|525597602|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750159|NCT01425008|525597603|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750160|NCT01425008|525597604|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750161|NCT01425008|525597605|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145750162|NCT01425008|525597606|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
145750163|NCT00264238|525597607|FG000|Overall Study|Protocol Violation|1|||
145750164|NCT00562588|525597610|FG000|Overall Study|Adverse Event|40|||
145750165|NCT00562588|525597611|FG001|Overall Study|Adverse Event|58|||
145750166|NCT00562588|525597610|FG000|Overall Study|Protocol Violation|30|||
145525785|NCT02414139|524785162|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145525786|NCT02414139|524785163|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
145750167|NCT00562588|525597611|FG001|Overall Study|Protocol Violation|26|||
145750168|NCT00562588|525597610|FG000|Overall Study|Lost to Follow-up|12|||
145750169|NCT00562588|525597611|FG001|Overall Study|Lost to Follow-up|4|||
145750170|NCT00562588|525597610|FG000|Overall Study|Withdrawal by Subject|10|||
145750171|NCT00562588|525597611|FG001|Overall Study|Withdrawal by Subject|9|||
145750172|NCT00562588|525597610|FG000|Overall Study|Other|0|||
145750173|NCT00562588|525597611|FG001|Overall Study|Other|2|||
145750174|NCT01452152|525597612|FG000|Overall Study|Study termination by sponsor|5|||
145750175|NCT01452152|525597613|FG001|Overall Study|Study termination by sponsor|0|||
145750176|NCT01452152|525597614|FG002|Overall Study|Study termination by sponsor|4|||
145750177|NCT02867995|525597617|FG000|Overall Study|Withdrawal by Subject|0|||
145750178|NCT02867995|525597618|FG001|Overall Study|Withdrawal by Subject|1|||
145750179|NCT02867995|525597617|FG000|Overall Study|Lost to Follow-up|0|||
145750180|NCT02867995|525597618|FG001|Overall Study|Lost to Follow-up|2|||
145750181|NCT03315871|525597619|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
145750182|NCT03315871|525597620|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
145750183|NCT03315871|525597621|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
145750184|NCT03315871|525597619|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
145750185|NCT03315871|525597620|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
145750186|NCT03315871|525597621|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
145750187|NCT03315871|525597619|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
145750188|NCT03315871|525597620|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
145750189|NCT03315871|525597621|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
145750190|NCT03315871|525597619|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
145750191|NCT03315871|525597620|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
145750192|NCT03315871|525597621|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
145750193|NCT03315871|525597619|FG000|PROSTVAC + CV301|Progressive disease|0|||
145750194|NCT03315871|525597620|FG001|PROSTVAC + CV301|Progressive disease|0|||
145750195|NCT03315871|525597621|FG002|PROSTVAC + CV301|Progressive disease|1|||
145750196|NCT03315871|525597619|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
145750197|NCT03315871|525597620|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
145750198|NCT03315871|525597621|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
145750199|NCT03368170|525599188|FG000|Overall Study|Adverse Event|2|||
145750200|NCT03368170|525599189|FG001|Overall Study|Adverse Event|1|||
145750201|NCT01761266|525599197|FG000|Overall Study|Death|415|||
145750202|NCT01761266|525599198|FG001|Overall Study|Death|402|||
145750203|NCT01761266|525599197|FG000|Overall Study|Lost to Follow-up|8|||
145750204|NCT01761266|525599198|FG001|Overall Study|Lost to Follow-up|12|||
145750205|NCT01761266|525599197|FG000|Overall Study|Withdrawal by Subject|14|||
145750206|NCT01761266|525599198|FG001|Overall Study|Withdrawal by Subject|10|||
145750207|NCT01761266|525599197|FG000|Overall Study|Sponsor Decision|41|||
145750208|NCT01761266|525599198|FG001|Overall Study|Sponsor Decision|52|||
145750209|NCT03445000|525599201|FG000|Overall Study|Disease progression|8|||
145750210|NCT03445000|525599201|FG000|Overall Study|Adverse Event|3|||
145750211|NCT03445000|525599201|FG000|Overall Study|Death|2|||
145750212|NCT03445000|525599201|FG000|Overall Study|Physician Decision|1|||
145750213|NCT00706134|525599202|FG000|Overall Study|Adverse Event|8|||
145750214|NCT00706134|525599203|FG001|Overall Study|Adverse Event|7|||
145750215|NCT00706134|525599204|FG002|Overall Study|Adverse Event|2|||
145750216|NCT00706134|525599205|FG003|Overall Study|Adverse Event|3|||
145750217|NCT00706134|525599202|FG000|Overall Study|Lost to Follow-up|0|||
145750218|NCT00706134|525599203|FG001|Overall Study|Lost to Follow-up|1|||
145750219|NCT00706134|525599204|FG002|Overall Study|Lost to Follow-up|0|||
145750220|NCT00706134|525599205|FG003|Overall Study|Lost to Follow-up|0|||
145402653|NCT05965752|524330808|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
145750221|NCT00706134|525599202|FG000|Overall Study|Protocol Violation|0|||
145750222|NCT00706134|525599203|FG001|Overall Study|Protocol Violation|6|||
145750223|NCT00706134|525599204|FG002|Overall Study|Protocol Violation|0|||
145750224|NCT00706134|525599205|FG003|Overall Study|Protocol Violation|3|||
145750225|NCT00706134|525599202|FG000|Overall Study|Withdrawal by Subject|1|||
145750226|NCT00706134|525599203|FG001|Overall Study|Withdrawal by Subject|2|||
145750227|NCT00706134|525599204|FG002|Overall Study|Withdrawal by Subject|1|||
145750228|NCT00706134|525599205|FG003|Overall Study|Withdrawal by Subject|0|||
145750229|NCT00706134|525599202|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
145750230|NCT00706134|525599203|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145750231|NCT00706134|525599204|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
145750232|NCT00706134|525599205|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
145750233|NCT00706134|525599202|FG000|Overall Study|Did not meet study criteria|2|||
145750234|NCT00706134|525599203|FG001|Overall Study|Did not meet study criteria|0|||
145750235|NCT00706134|525599204|FG002|Overall Study|Did not meet study criteria|0|||
145750236|NCT00706134|525599205|FG003|Overall Study|Did not meet study criteria|0|||
145750237|NCT00746252|525599208|FG000|Overall Study|weight gain >7.5 %|1|||
145750238|NCT00746252|525599209|FG001|Overall Study|weight gain >7.5 %|2|||
145750239|NCT01391000|525599210|FG000|Overall Study|Lost to Follow-up|2|||
145750240|NCT01391000|525599211|FG001|Overall Study|Lost to Follow-up|0|||
145750241|NCT00082888|525599212|FG000|Overall Study|Ineligible|1|||
145750242|NCT00082888|525599213|FG001|Overall Study|Ineligible|0|||
145750243|NCT00082888|525599214|FG002|Overall Study|Ineligible|0|||
145750244|NCT02684981|525599217|FG000|Overall Study|Permanently discontinued the treatment|157|||
145750245|NCT02684981|525599218|FG001|Overall Study|Permanently discontinued the treatment|161|||
145750246|NCT02684981|525599219|FG002|Overall Study|Permanently discontinued the treatment|110|||
145750247|NCT02684981|525599217|FG000|Overall Study|Other|83|||
145750248|NCT02684981|525599218|FG001|Overall Study|Other|49|||
145750249|NCT02684981|525599219|FG002|Overall Study|Other|17|||
145750250|NCT00820898|525599222|FG000|Overall Study|Inelgible - wrong primary site|1|||
145750251|NCT02921971|525599225|FG000|Overall Study|Adverse Event|1|||
145750252|NCT02921971|525599226|FG001|Overall Study|Adverse Event|2|||
145750253|NCT02921971|525599225|FG000|Overall Study|Lack of Efficacy|3|||
145750254|NCT02921971|525599226|FG001|Overall Study|Lack of Efficacy|1|||
145750255|NCT02921971|525599225|FG000|Overall Study|Other than specified above|2|||
145750256|NCT02921971|525599226|FG001|Overall Study|Other than specified above|1|||
145750257|NCT00452699|525599227|FG000|Overall Study|Adverse Event|10|||
145750258|NCT00452699|525599228|FG001|Overall Study|Adverse Event|3|||
145750259|NCT00452699|525599227|FG000|Overall Study|Lack of Efficacy|6|||
145750260|NCT00452699|525599228|FG001|Overall Study|Lack of Efficacy|4|||
145750261|NCT00452699|525599227|FG000|Overall Study|Lost to Follow-up|6|||
145750262|NCT00452699|525599228|FG001|Overall Study|Lost to Follow-up|9|||
145750263|NCT00452699|525599227|FG000|Overall Study|Protocol Violation|21|||
145750264|NCT00452699|525599228|FG001|Overall Study|Protocol Violation|25|||
145750265|NCT00452699|525599227|FG000|Overall Study|Withdrawal by Subject|26|||
145750266|NCT00452699|525599228|FG001|Overall Study|Withdrawal by Subject|25|||
145750267|NCT00452699|525599227|FG000|Overall Study|Other|12|||
145750268|NCT00452699|525599228|FG001|Overall Study|Other|7|||
145750269|NCT00272038|525599231|FG000|Overall Study|withdrew before they received 2 cycles|7|||
145750270|NCT00356278|525599234|FG000|Overall Study|Withdrawal by Subject|25|||
145750271|NCT00356278|525599235|FG001|Overall Study|Withdrawal by Subject|15|||
145750272|NCT00356278|525599236|FG002|Overall Study|Withdrawal by Subject|19|||
145750273|NCT00527605|525599239|FG000|Overall Study|Adverse Event|3|||
145750274|NCT00527605|525599240|FG001|Overall Study|Adverse Event|0|||
145750275|NCT00527605|525599239|FG000|Overall Study|Withdrawal by Subject|3|||
145750276|NCT00527605|525599240|FG001|Overall Study|Withdrawal by Subject|7|||
145750277|NCT00527605|525599239|FG000|Overall Study|Lost to Follow-up|6|||
145750278|NCT00527605|525599240|FG001|Overall Study|Lost to Follow-up|2|||
145750279|NCT00527605|525599239|FG000|Overall Study|Protocol Violation|1|||
145750280|NCT00527605|525599240|FG001|Overall Study|Protocol Violation|2|||
145750281|NCT03468309|525599241|FG000|Overall Study|Lost to Follow-up|4|||
145750282|NCT03468309|525599241|FG000|Overall Study|Withdrawal by Subject|2|||
145750283|NCT00179309|525599244|FG000|Treatment|Toxicity|2|||
145750284|NCT00179309|525599245|FG001|Treatment|Toxicity|3|||
145750285|NCT00179309|525599244|FG000|Treatment|Withdrawal by Subject|1|||
145750286|NCT00179309|525599245|FG001|Treatment|Withdrawal by Subject|2|||
145402654|NCT05965752|524330809|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
145525787|NCT02414139|524785164|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
145525788|NCT02414139|524785165|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
145525789|NCT02414139|524785166|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
145750287|NCT00179309|525599244|FG000|Treatment|Allergy|1|||
145750288|NCT00179309|525599245|FG001|Treatment|Allergy|0|||
145750289|NCT00488982|525599246|FG000|Course 1|Physician Decision|0|||
145750290|NCT00488982|525599247|FG001|Course 1|Physician Decision|2|||
145750291|NCT00488982|525599248|FG002|Course 1|Physician Decision|4|||
145750292|NCT00488982|525599246|FG000|Course 1|Withdrawal by Subject|0|||
145750293|NCT00488982|525599247|FG001|Course 1|Withdrawal by Subject|8|||
145750294|NCT00488982|525599248|FG002|Course 1|Withdrawal by Subject|2|||
145750295|NCT00488982|525599246|FG000|Course 1|nonprotocol therapy|0|||
145750296|NCT00488982|525599247|FG001|Course 1|nonprotocol therapy|2|||
145750297|NCT00488982|525599248|FG002|Course 1|nonprotocol therapy|2|||
145750298|NCT00488982|525599246|FG000|Course 1|Adverse Event|0|||
145750299|NCT00488982|525599247|FG001|Course 1|Adverse Event|0|||
145750300|NCT00488982|525599248|FG002|Course 1|Adverse Event|6|||
145750301|NCT01777152|525599252|FG000|Overall Study|Withdrawal by Subject|22|||
145750302|NCT01777152|525599253|FG001|Overall Study|Withdrawal by Subject|16|||
145750303|NCT01777152|525599252|FG000|Overall Study|Lost to Follow-up|3|||
145750304|NCT01777152|525599253|FG001|Overall Study|Lost to Follow-up|5|||
145750305|NCT01777152|525599252|FG000|Overall Study|Death|68|||
145750306|NCT01777152|525599253|FG001|Overall Study|Death|89|||
145750307|NCT01777152|525599252|FG000|Overall Study|Not eligible, no study drug received|1|||
145525790|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
145525791|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525792|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525793|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525794|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
145525795|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525796|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525797|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525798|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525799|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145525800|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Death|0|||
145525801|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Death|1|||
145525802|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Death|0|||
145525803|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Death|0|||
145525804|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Death|1|||
145525805|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Death|0|||
145525806|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Death|0|||
145525807|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Death|0|||
145525808|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Death|0|||
145525809|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Death|1|||
145525810|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
145525811|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525812|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525813|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525814|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525815|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525816|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525817|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145750308|NCT01777152|525599253|FG001|Overall Study|Not eligible, no study drug received|0|||
145750309|NCT01777152|525599252|FG000|Overall Study|Change of diagnosis|1|||
145750310|NCT01777152|525599253|FG001|Overall Study|Change of diagnosis|0|||
145750311|NCT03548558|525599254|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
145750312|NCT03548558|525599255|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
145525818|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525819|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145525820|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
145525821|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145525822|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
145525823|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145525824|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
145525825|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145525826|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145525827|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145525828|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145525829|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145525830|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
145525831|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
145525832|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
145525833|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
145525834|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
145525835|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
145525836|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
145525837|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
145525838|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
145525839|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
145525840|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525841|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
145525842|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525843|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525844|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525845|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145750313|NCT03548558|525599256|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
145525846|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525847|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145750314|NCT03548558|525599257|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
145525848|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
145525849|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
145525850|NCT02414139|524785157|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
145525851|NCT02414139|524785158|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145525852|NCT02414139|524785159|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
145525853|NCT02414139|524785160|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
145525854|NCT02414139|524785161|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
145525855|NCT02414139|524785162|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
145525856|NCT02414139|524785163|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
145525857|NCT02414139|524785164|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
145525858|NCT02414139|524785165|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
145525859|NCT02414139|524785166|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145525860|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
145525861|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
145525862|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
145525863|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
145525864|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
145525865|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
145525866|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
145525867|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
145525868|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
145525869|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
145525870|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
145525871|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
145525872|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
145525873|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
145525874|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
145525875|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
145525876|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
145525877|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
145525878|NCT00591578|524785167|FG000|Double-Blind Treatment Phase|Other|4|||
145525879|NCT00591578|524785168|FG001|Double-Blind Treatment Phase|Other|9|||
145525880|NCT00591578|524785169|FG002|Double-Blind Treatment Phase|Other|4|||
145525881|NCT00591578|524785167|FG000|Open-Label Extension Phase|Adverse Event|3|||
145525882|NCT00591578|524785168|FG001|Open-Label Extension Phase|Adverse Event|5|||
145525883|NCT00591578|524785169|FG002|Open-Label Extension Phase|Adverse Event|0|||
145525884|NCT00591578|524785167|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
145525885|NCT00591578|524785168|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
145525886|NCT00591578|524785169|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145525887|NCT00591578|524785167|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
145525888|NCT00591578|524785168|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
145525889|NCT00591578|524785169|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
145525890|NCT00591578|524785167|FG000|Open-Label Extension Phase|Other|1|||
145525891|NCT00591578|524785168|FG001|Open-Label Extension Phase|Other|0|||
145525892|NCT00591578|524785169|FG002|Open-Label Extension Phase|Other|0|||
145525893|NCT02632838|524785170|FG000|Overall Study|Withdrawal by Subject|3|||
145525894|NCT02632838|524785171|FG001|Overall Study|Withdrawal by Subject|0|||
145525895|NCT02632838|524785170|FG000|Overall Study|Lost to Follow-up|0|||
145525896|NCT02632838|524785171|FG001|Overall Study|Lost to Follow-up|2|||
145525897|NCT03631355|524785172|FG000|Overall Study|Lost to Follow-up|1|||
145525898|NCT03631355|524785173|FG001|Overall Study|Lost to Follow-up|2|||
145525899|NCT02810340|524785174|FG000|Overall Study|Withdrawal by Subject|1|||
145525900|NCT02810340|524785175|FG001|Overall Study|Withdrawal by Subject|0|||
145525901|NCT02810340|524785176|FG002|Overall Study|Withdrawal by Subject|0|||
145525902|NCT02810340|524785174|FG000|Overall Study|Incarceration|0|||
145525903|NCT02810340|524785175|FG001|Overall Study|Incarceration|1|||
145525904|NCT02810340|524785176|FG002|Overall Study|Incarceration|0|||
145525905|NCT02810340|524785174|FG000|Overall Study|Lost to Follow-up|0|||
145525906|NCT02810340|524785175|FG001|Overall Study|Lost to Follow-up|0|||
145525907|NCT02810340|524785176|FG002|Overall Study|Lost to Follow-up|1|||
145525908|NCT00870233|524785179|FG000|Overall Study|Withdrawal by Subject|18|||
145525909|NCT00870233|524785179|FG000|Overall Study|Did not undergo laparotomy|3|||
145525910|NCT00870233|524785179|FG000|Overall Study|Incompatible internet browser|2|||
145525911|NCT00870233|524785179|FG000|Overall Study|Death|1|||
145525912|NCT00999921|524785189|FG000|Overall Study|Lost to Follow-up|10|||
145525913|NCT00999921|524785190|FG001|Overall Study|Lost to Follow-up|19|||
145525914|NCT00772070|524785200|FG000|Overall Study|Lost to Follow-up|0|||
145525915|NCT00772070|524785201|FG001|Overall Study|Lost to Follow-up|8|||
145525916|NCT00772070|524785200|FG000|Overall Study|Withdrawal by Subject|0|||
145525917|NCT00772070|524785201|FG001|Overall Study|Withdrawal by Subject|2|||
145525918|NCT00772070|524785200|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
145525919|NCT00772070|524785201|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
145750315|NCT03548558|525599258|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
145750316|NCT03548558|525599259|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
145750317|NCT03548558|525599260|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
145750318|NCT03548558|525599254|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
145750319|NCT03548558|525599255|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
145750320|NCT03548558|525599256|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
145750321|NCT03548558|525599257|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
145750322|NCT03548558|525599258|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
145750323|NCT03548558|525599259|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
145750324|NCT03548558|525599260|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
145750325|NCT03548558|525599254|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
145750326|NCT03548558|525599255|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
145750327|NCT03548558|525599256|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
145750328|NCT03548558|525599257|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
145750329|NCT03548558|525599258|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
145750330|NCT03548558|525599259|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
145750331|NCT03548558|525599260|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
145750332|NCT03548558|525599254|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
145750333|NCT03548558|525599255|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
145750334|NCT03548558|525599256|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
145750335|NCT03548558|525599257|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
145750336|NCT03548558|525599258|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
145750337|NCT03548558|525599259|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
145750338|NCT03548558|525599260|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
145750339|NCT03548558|525599254|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
145750340|NCT03548558|525599255|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
145750341|NCT03548558|525599256|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
145750342|NCT03548558|525599257|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
145750343|NCT03548558|525599258|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
145750344|NCT03548558|525599259|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
145750345|NCT03548558|525599260|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
145750346|NCT03548558|525599254|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
145750347|NCT03548558|525599255|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
145750348|NCT03548558|525599256|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
145750349|NCT03548558|525599257|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
145750350|NCT03548558|525599258|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
145750351|NCT03548558|525599259|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
145750352|NCT03548558|525599260|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
145750353|NCT01098071|525599283|FG000|Overall Study|Surgery (adenoidectomy)|2|||
145750354|NCT01098071|525599283|FG000|Overall Study|Lost to Follow-up|13|||
145750355|NCT01903837|525599285|FG000|Part A|Withdrawal by Subject|4|||
145750356|NCT01903837|525599286|FG001|Part A|Withdrawal by Subject|9|||
145750357|NCT01903837|525599287|FG002|Part A|Withdrawal by Subject|8|||
145750358|NCT01903837|525599288|FG003|Part A|Withdrawal by Subject|5|||
145750359|NCT01903837|525599285|FG000|Part A|Adverse Event|3|||
145750360|NCT01903837|525599286|FG001|Part A|Adverse Event|6|||
145750361|NCT01903837|525599287|FG002|Part A|Adverse Event|9|||
145750362|NCT01903837|525599288|FG003|Part A|Adverse Event|6|||
145750363|NCT01903837|525599285|FG000|Part A|Lost to Follow-up|9|||
145750364|NCT01903837|525599286|FG001|Part A|Lost to Follow-up|7|||
145750365|NCT01903837|525599287|FG002|Part A|Lost to Follow-up|7|||
145750366|NCT01903837|525599288|FG003|Part A|Lost to Follow-up|2|||
145750367|NCT01903837|525599285|FG000|Part A|Non-compliance with study drug|1|||
145750368|NCT01903837|525599286|FG001|Part A|Non-compliance with study drug|4|||
145750369|NCT01903837|525599287|FG002|Part A|Non-compliance with study drug|4|||
145525920|NCT01309308|524785202|FG000|Overall Study|Lost to Follow-up|6|||
145525921|NCT01309308|524785203|FG001|Overall Study|Lost to Follow-up|4|||
145750370|NCT01903837|525599288|FG003|Part A|Non-compliance with study drug|0|||
145750371|NCT01903837|525599285|FG000|Part A|Physician Decision|1|||
145750372|NCT01903837|525599286|FG001|Part A|Physician Decision|1|||
145750373|NCT01903837|525599287|FG002|Part A|Physician Decision|0|||
145750374|NCT01903837|525599288|FG003|Part A|Physician Decision|0|||
145750375|NCT01903837|525599285|FG000|Part A|Protocol Violation|1|||
145525922|NCT01962922|524785204|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
145525923|NCT01962922|524785205|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
145525924|NCT01962922|524785204|FG000|PK Portion Day 7|non-compliance|1|||
145525925|NCT01962922|524785205|FG001|PK Portion Day 7|non-compliance|0|||
145525926|NCT01962922|524785204|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
145750376|NCT01903837|525599286|FG001|Part A|Protocol Violation|1|||
145750377|NCT01903837|525599287|FG002|Part A|Protocol Violation|0|||
145750378|NCT01903837|525599288|FG003|Part A|Protocol Violation|0|||
145750379|NCT01903837|525599285|FG000|Part B|Lost to Follow-up|0|||
145750380|NCT01903837|525599286|FG001|Part B|Lost to Follow-up|3|||
145750381|NCT01903837|525599287|FG002|Part B|Lost to Follow-up|3|||
145750382|NCT01903837|525599288|FG003|Part B|Lost to Follow-up|4|||
145750383|NCT01903837|525599285|FG000|Part B|Withdrawal by Subject|1|||
145750384|NCT01903837|525599286|FG001|Part B|Withdrawal by Subject|2|||
145750385|NCT01903837|525599287|FG002|Part B|Withdrawal by Subject|0|||
145750386|NCT01903837|525599288|FG003|Part B|Withdrawal by Subject|3|||
145750387|NCT01903837|525599285|FG000|Part B|Adverse Event|3|||
145750388|NCT01903837|525599286|FG001|Part B|Adverse Event|0|||
145750389|NCT01903837|525599287|FG002|Part B|Adverse Event|2|||
145750390|NCT01903837|525599288|FG003|Part B|Adverse Event|0|||
145750391|NCT01903837|525599285|FG000|Part B|Non-compliance with study drug|2|||
145750392|NCT01903837|525599286|FG001|Part B|Non-compliance with study drug|0|||
145750393|NCT01903837|525599287|FG002|Part B|Non-compliance with study drug|0|||
145750394|NCT01903837|525599288|FG003|Part B|Non-compliance with study drug|1|||
145750395|NCT01903837|525599285|FG000|Part B|Incarceration|2|||
145750396|NCT01903837|525599286|FG001|Part B|Incarceration|0|||
145750397|NCT01903837|525599287|FG002|Part B|Incarceration|0|||
145750398|NCT01903837|525599288|FG003|Part B|Incarceration|1|||
145750399|NCT01903837|525599285|FG000|Part B|Physician Decision|1|||
145750400|NCT01903837|525599286|FG001|Part B|Physician Decision|0|||
145750401|NCT01903837|525599287|FG002|Part B|Physician Decision|0|||
145750402|NCT01903837|525599288|FG003|Part B|Physician Decision|2|||
145750403|NCT01903837|525599285|FG000|Part B|Lack of Efficacy|0|||
145750404|NCT01903837|525599286|FG001|Part B|Lack of Efficacy|1|||
145750405|NCT01903837|525599287|FG002|Part B|Lack of Efficacy|0|||
145750406|NCT01903837|525599288|FG003|Part B|Lack of Efficacy|0|||
145750407|NCT00705939|525599289|FG000|Overall Study|Protocol Violation|0|||
145750408|NCT00705939|525599290|FG001|Overall Study|Protocol Violation|0|||
145750409|NCT00705939|525599291|FG002|Overall Study|Protocol Violation|1|||
145750410|NCT00705939|525599289|FG000|Overall Study|Withdrawal by Subject|0|||
145750411|NCT00705939|525599290|FG001|Overall Study|Withdrawal by Subject|1|||
145750412|NCT00705939|525599291|FG002|Overall Study|Withdrawal by Subject|3|||
145750413|NCT00705939|525599289|FG000|Overall Study|Physician Decision|0|||
145750414|NCT00705939|525599290|FG001|Overall Study|Physician Decision|1|||
145750415|NCT00705939|525599291|FG002|Overall Study|Physician Decision|0|||
145750416|NCT00797732|525599292|FG000|Overall Study|Withdrawal by Subject|3|||
145750417|NCT00797732|525599293|FG001|Overall Study|Withdrawal by Subject|3|||
145750418|NCT00797732|525599294|FG002|Overall Study|Withdrawal by Subject|0|||
145750419|NCT00797732|525599292|FG000|Overall Study|Lost to Follow-up|1|||
145750420|NCT00797732|525599293|FG001|Overall Study|Lost to Follow-up|0|||
145750421|NCT00797732|525599294|FG002|Overall Study|Lost to Follow-up|0|||
145750422|NCT00797732|525599292|FG000|Overall Study|Death|1|||
145750423|NCT00797732|525599293|FG001|Overall Study|Death|0|||
145750424|NCT00797732|525599294|FG002|Overall Study|Death|0|||
145750425|NCT00797732|525599292|FG000|Overall Study|Not meet inclusion criteria|0|||
145750426|NCT00797732|525599293|FG001|Overall Study|Not meet inclusion criteria|0|||
145750427|NCT00797732|525599294|FG002|Overall Study|Not meet inclusion criteria|7|||
145750428|NCT00797732|525599292|FG000|Overall Study|Excluded due to time constraints|0|||
145750429|NCT00797732|525599293|FG001|Overall Study|Excluded due to time constraints|0|||
145750430|NCT00797732|525599294|FG002|Overall Study|Excluded due to time constraints|24|||
145750431|NCT00797732|525599292|FG000|Overall Study|Refused to Participate|0|||
145750432|NCT00797732|525599293|FG001|Overall Study|Refused to Participate|0|||
145750433|NCT00797732|525599294|FG002|Overall Study|Refused to Participate|123|||
145750434|NCT02275338|525599295|FG000|Overall Study|Adverse Event|15|||
145750435|NCT02275338|525599295|FG000|Overall Study|Lack of Efficacy|3|||
145750436|NCT02275338|525599295|FG000|Overall Study|Withdrawal by Subject|4|||
145750437|NCT02275338|525599295|FG000|Overall Study|Disease progression (death)|1|||
145750438|NCT02275338|525599295|FG000|Overall Study|Ineligible to start Phase 2|4|||
145750439|NCT02275338|525599295|FG000|Overall Study|Reason not specified|5|||
145750440|NCT02275338|525599295|FG000|Overall Study|Does not meet entry criteria|1|||
145750441|NCT01857869|525599300|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
145750442|NCT01857869|525599301|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
145525927|NCT01962922|524785205|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
145750443|NCT01857869|525599302|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
145750444|NCT01857869|525599303|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
145750445|NCT01857869|525599304|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
145750446|NCT01857869|525599305|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
145750447|NCT01857869|525599306|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
145750448|NCT01857869|525599307|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
145750449|NCT01857869|525599308|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
145750450|NCT01857869|525599309|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
145750451|NCT01857869|525599300|FG000|Primary/Challenge Phase|Pregnancy|1|||
145750452|NCT01857869|525599301|FG001|Primary/Challenge Phase|Pregnancy|0|||
145750453|NCT01857869|525599302|FG002|Primary/Challenge Phase|Pregnancy|0|||
145750454|NCT01857869|525599303|FG003|Primary/Challenge Phase|Pregnancy|0|||
145750455|NCT01857869|525599304|FG004|Primary/Challenge Phase|Pregnancy|0|||
145750456|NCT01857869|525599305|FG005|Primary/Challenge Phase|Pregnancy|0|||
145750457|NCT01857869|525599306|FG006|Primary/Challenge Phase|Pregnancy|0|||
145750458|NCT01857869|525599307|FG007|Primary/Challenge Phase|Pregnancy|0|||
145750459|NCT01857869|525599308|FG008|Primary/Challenge Phase|Pregnancy|0|||
145750460|NCT01857869|525599309|FG009|Primary/Challenge Phase|Pregnancy|0|||
145750461|NCT01857869|525599300|FG000|Primary/Challenge Phase|Protocol Violation|1|||
145750462|NCT01857869|525599301|FG001|Primary/Challenge Phase|Protocol Violation|0|||
145750463|NCT01857869|525599302|FG002|Primary/Challenge Phase|Protocol Violation|0|||
145750464|NCT01857869|525599303|FG003|Primary/Challenge Phase|Protocol Violation|0|||
145750465|NCT01857869|525599304|FG004|Primary/Challenge Phase|Protocol Violation|0|||
145750466|NCT01857869|525599305|FG005|Primary/Challenge Phase|Protocol Violation|0|||
145750467|NCT01857869|525599306|FG006|Primary/Challenge Phase|Protocol Violation|0|||
145750468|NCT01857869|525599307|FG007|Primary/Challenge Phase|Protocol Violation|0|||
145750469|NCT01857869|525599308|FG008|Primary/Challenge Phase|Protocol Violation|0|||
145750470|NCT01857869|525599309|FG009|Primary/Challenge Phase|Protocol Violation|0|||
145750471|NCT01857869|525599300|FG000|Primary/Challenge Phase|Other|1|||
145750472|NCT01857869|525599301|FG001|Primary/Challenge Phase|Other|1|||
145750473|NCT01857869|525599302|FG002|Primary/Challenge Phase|Other|0|||
145750474|NCT01857869|525599303|FG003|Primary/Challenge Phase|Other|0|||
145750475|NCT01857869|525599304|FG004|Primary/Challenge Phase|Other|0|||
145750476|NCT01857869|525599305|FG005|Primary/Challenge Phase|Other|0|||
145750477|NCT01857869|525599306|FG006|Primary/Challenge Phase|Other|0|||
145750478|NCT01857869|525599307|FG007|Primary/Challenge Phase|Other|0|||
145750479|NCT01857869|525599308|FG008|Primary/Challenge Phase|Other|0|||
145750480|NCT01857869|525599309|FG009|Primary/Challenge Phase|Other|0|||
145750481|NCT01857869|525599300|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750482|NCT01857869|525599301|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750483|NCT01857869|525599302|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750484|NCT01857869|525599303|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
145750485|NCT01857869|525599304|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750486|NCT01857869|525599305|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750487|NCT01857869|525599306|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750488|NCT01857869|525599307|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750489|NCT01857869|525599308|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750490|NCT01857869|525599309|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
145750491|NCT01857869|525599300|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750492|NCT01857869|525599301|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750493|NCT01857869|525599302|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750494|NCT01857869|525599303|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
145750495|NCT01857869|525599304|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750496|NCT01857869|525599305|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750497|NCT01857869|525599306|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750498|NCT01857869|525599307|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750499|NCT01857869|525599308|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750500|NCT01857869|525599309|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
145750501|NCT04607733|525599313|FG000|Overall Study|Lost to Follow-up|1|||
145750502|NCT04607733|525599314|FG001|Overall Study|Lost to Follow-up|0|||
145750503|NCT04607733|525599315|FG002|Overall Study|Lost to Follow-up|0|||
145750504|NCT04607733|525599316|FG003|Overall Study|Lost to Follow-up|1|||
145750505|NCT04607733|525599317|FG004|Overall Study|Lost to Follow-up|1|||
145750506|NCT04607733|525599318|FG005|Overall Study|Lost to Follow-up|0|||
145750507|NCT04607733|525599313|FG000|Overall Study|Withdrawal by Subject|0|||
145750508|NCT04607733|525599314|FG001|Overall Study|Withdrawal by Subject|0|||
145750509|NCT04607733|525599315|FG002|Overall Study|Withdrawal by Subject|0|||
145750510|NCT04607733|525599316|FG003|Overall Study|Withdrawal by Subject|0|||
145750511|NCT04607733|525599317|FG004|Overall Study|Withdrawal by Subject|1|||
145750512|NCT04607733|525599318|FG005|Overall Study|Withdrawal by Subject|0|||
145525928|NCT01962922|524785204|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
145525929|NCT01962922|524785205|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
145525930|NCT00596362|524785211|FG000|Overall Study|Progressive Disease|1|||
145525931|NCT00817479|524785212|FG000|Overall Study|Physician Decision|1|||
145525932|NCT00817479|524785213|FG001|Overall Study|Physician Decision|1|||
145525933|NCT02793128|524785217|FG000|Overall Study|Death|4|||
145750513|NCT01665807|525599319|FG000|Overall Study|Withdrawal by Subject|2|||
145750514|NCT01665807|525599320|FG001|Overall Study|Withdrawal by Subject|0|||
145750515|NCT01665807|525599321|FG002|Overall Study|Withdrawal by Subject|1|||
145750516|NCT03603496|525599323|FG000|Overall Study|Death|19|||
145750517|NCT03603496|525599324|FG001|Overall Study|Death|24|||
145750518|NCT03603496|525599323|FG000|Overall Study|Lost to Follow-up|141|||
145750519|NCT03603496|525599324|FG001|Overall Study|Lost to Follow-up|141|||
145750520|NCT03603496|525599323|FG000|Overall Study|Withdrawal by Subject|26|||
145750521|NCT03603496|525599324|FG001|Overall Study|Withdrawal by Subject|20|||
145750522|NCT03594227|525599325|FG000|Overall Study|Adverse Event|2|||
145750523|NCT03594227|525599326|FG001|Overall Study|Adverse Event|1|||
145525934|NCT02793128|524785217|FG000|Overall Study|Withdrawal by Subject|2|||
145750524|NCT03594227|525599327|FG002|Overall Study|Adverse Event|0|||
145750525|NCT03594227|525599328|FG003|Overall Study|Adverse Event|2|||
145750526|NCT03594227|525599325|FG000|Overall Study|Lost to Follow-up|1|||
145750527|NCT03594227|525599326|FG001|Overall Study|Lost to Follow-up|1|||
145750528|NCT03594227|525599327|FG002|Overall Study|Lost to Follow-up|1|||
145750529|NCT03594227|525599328|FG003|Overall Study|Lost to Follow-up|0|||
145750530|NCT03594227|525599325|FG000|Overall Study|Withdrawal by Subject|1|||
145750531|NCT03594227|525599326|FG001|Overall Study|Withdrawal by Subject|1|||
145750532|NCT03594227|525599327|FG002|Overall Study|Withdrawal by Subject|1|||
145750533|NCT03594227|525599328|FG003|Overall Study|Withdrawal by Subject|1|||
145750534|NCT03594227|525599325|FG000|Overall Study|Pregnancy|0|||
145750535|NCT03594227|525599326|FG001|Overall Study|Pregnancy|1|||
145750536|NCT03594227|525599327|FG002|Overall Study|Pregnancy|0|||
145750537|NCT03594227|525599328|FG003|Overall Study|Pregnancy|0|||
145750538|NCT03594227|525599325|FG000|Overall Study|Sponsor Decision|0|||
145750539|NCT03594227|525599326|FG001|Overall Study|Sponsor Decision|0|||
145750540|NCT03594227|525599327|FG002|Overall Study|Sponsor Decision|0|||
145750541|NCT03594227|525599328|FG003|Overall Study|Sponsor Decision|1|||
145750542|NCT03594227|525599325|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
145750543|NCT03594227|525599326|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
145750544|NCT03594227|525599327|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
145750545|NCT03594227|525599328|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
145750546|NCT00790907|525599329|FG000|Overall Study|Adverse Event|9|||
145750547|NCT00790907|525599330|FG001|Overall Study|Adverse Event|7|||
145750548|NCT00790907|525599331|FG002|Overall Study|Adverse Event|6|||
145750549|NCT00790907|525599329|FG000|Overall Study|Physician Decision|304|||
145750550|NCT00790907|525599330|FG001|Overall Study|Physician Decision|271|||
145750551|NCT00790907|525599331|FG002|Overall Study|Physician Decision|255|||
145750552|NCT00790907|525599329|FG000|Overall Study|Withdrawal by Subject|1|||
145750553|NCT00790907|525599330|FG001|Overall Study|Withdrawal by Subject|7|||
145750554|NCT00790907|525599331|FG002|Overall Study|Withdrawal by Subject|5|||
145750555|NCT00790907|525599329|FG000|Overall Study|Bleeding Event|11|||
145750556|NCT00790907|525599330|FG001|Overall Study|Bleeding Event|16|||
145750557|NCT00790907|525599331|FG002|Overall Study|Bleeding Event|21|||
145750558|NCT00790907|525599329|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
145750559|NCT00790907|525599330|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
145750560|NCT00790907|525599331|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
145750561|NCT00790907|525599329|FG000|Overall Study|Qualifying Condition Not Present|29|||
145750562|NCT00790907|525599330|FG001|Overall Study|Qualifying Condition Not Present|14|||
145750563|NCT00790907|525599331|FG002|Overall Study|Qualifying Condition Not Present|16|||
145750564|NCT00790907|525599329|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
145750565|NCT00790907|525599330|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
145750566|NCT00790907|525599331|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
145750567|NCT00790907|525599329|FG000|Overall Study|Did Not Receive Study Drug|10|||
145750568|NCT00790907|525599330|FG001|Overall Study|Did Not Receive Study Drug|0|||
145750569|NCT00790907|525599331|FG002|Overall Study|Did Not Receive Study Drug|0|||
145750570|NCT01888640|525599332|FG000|Overall Study|Lost to Follow-up|1|||
145750571|NCT01888640|525599333|FG001|Overall Study|Lost to Follow-up|2|||
145750572|NCT01888640|525599334|FG002|Overall Study|Lost to Follow-up|0|||
145750573|NCT01888640|525599332|FG000|Overall Study|Withdrawal by Subject|15|||
145750574|NCT01888640|525599333|FG001|Overall Study|Withdrawal by Subject|11|||
145750575|NCT01888640|525599334|FG002|Overall Study|Withdrawal by Subject|4|||
145750576|NCT01888640|525599332|FG000|Overall Study|Minimum dose not met|10|||
145750577|NCT01888640|525599333|FG001|Overall Study|Minimum dose not met|16|||
145750578|NCT01888640|525599334|FG002|Overall Study|Minimum dose not met|0|||
145750579|NCT01888640|525599332|FG000|Overall Study|Given wrong unit (placebo)|1|||
145750580|NCT01888640|525599333|FG001|Overall Study|Given wrong unit (placebo)|0|||
145750581|NCT01888640|525599334|FG002|Overall Study|Given wrong unit (placebo)|0|||
145271282|NCT01977482|523839691|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
145271283|NCT01977482|523839692|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
145402655|NCT01274351|524330811|FG000|Overall Study|Lost to Follow-up|1|||
145402656|NCT01274351|524330811|FG000|Overall Study|patient not compliant with the protocol|1|||
145525935|NCT02793128|524785217|FG000|Overall Study|Physician Decision|1|||
145525936|NCT02793128|524785217|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
145750582|NCT01888640|525599332|FG000|Overall Study|Excluded for prior TENS|0|||
145750583|NCT01888640|525599333|FG001|Overall Study|Excluded for prior TENS|1|||
145750584|NCT01888640|525599334|FG002|Overall Study|Excluded for prior TENS|0|||
145750585|NCT01888640|525599332|FG000|Overall Study|Researcher Termination of Participant|0|||
145750586|NCT01888640|525599333|FG001|Overall Study|Researcher Termination of Participant|1|||
145750587|NCT01888640|525599334|FG002|Overall Study|Researcher Termination of Participant|1|||
145750588|NCT00774345|525599335|FG000|Pre-treatment|Other reasons|2|||
145750589|NCT00774345|525599336|FG001|Pre-treatment|Other reasons|0|||
145750590|NCT00774345|525599335|FG000|Treatment|Adverse Event|61|||
145750591|NCT00774345|525599336|FG001|Treatment|Adverse Event|15|||
145750592|NCT00774345|525599335|FG000|Treatment|Progressive Disease without histologic transformation|51|||
145750593|NCT00774345|525599336|FG001|Treatment|Progressive Disease without histologic transformation|111|||
145750594|NCT00774345|525599335|FG000|Treatment|Progressive Disease with histologic transformation|4|||
145750595|NCT00774345|525599336|FG001|Treatment|Progressive Disease with histologic transformation|2|||
145525937|NCT02793128|524785217|FG000|Overall Study|Patient elected nephroureterectomy|1|||
145525938|NCT00282347|524785220|FG000|Treatment Period|Death|2|||
145750596|NCT00774345|525599335|FG000|Treatment|Withdrawal by Subject|5|||
145750597|NCT00774345|525599336|FG001|Treatment|Withdrawal by Subject|2|||
145525939|NCT00282347|524785221|FG001|Treatment Period|Death|0|||
145525940|NCT00282347|524785220|FG000|Treatment Period|Lost to Follow-up|2|||
145525941|NCT00282347|524785221|FG001|Treatment Period|Lost to Follow-up|5|||
145525942|NCT00282347|524785220|FG000|Treatment Period|Withdrawal by Subject|1|||
145525943|NCT00282347|524785221|FG001|Treatment Period|Withdrawal by Subject|3|||
145525944|NCT00282347|524785220|FG000|Treatment Period|Physician Decision|0|||
145525945|NCT00282347|524785221|FG001|Treatment Period|Physician Decision|1|||
145525946|NCT00282347|524785220|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
145525947|NCT00282347|524785221|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
145525948|NCT00282347|524785220|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
145525949|NCT00282347|524785221|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
145525950|NCT00282347|524785220|FG000|Safety Follow-up Period|Physician Decision|1|||
145525951|NCT00282347|524785221|FG001|Safety Follow-up Period|Physician Decision|1|||
145525952|NCT00282347|524785220|FG000|Safety Follow-up Period|Protocol Deviation|0|||
145525953|NCT00282347|524785221|FG001|Safety Follow-up Period|Protocol Deviation|2|||
145525954|NCT00282347|524785220|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
145525955|NCT00282347|524785221|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
145525956|NCT00282347|524785220|FG000|B Cell Follow-up Period|Physician Decision|1|||
145525957|NCT00282347|524785221|FG001|B Cell Follow-up Period|Physician Decision|0|||
145525958|NCT00282347|524785220|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
145525959|NCT00282347|524785221|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
145525960|NCT02125604|524785222|FG000|Overall Study|Other|4|||
145750598|NCT00774345|525599335|FG000|Treatment|Lost to Follow-up|1|||
145750599|NCT00774345|525599336|FG001|Treatment|Lost to Follow-up|1|||
145750600|NCT00774345|525599335|FG000|Treatment|Death|4|||
145750601|NCT00774345|525599336|FG001|Treatment|Death|0|||
145750602|NCT00774345|525599335|FG000|Treatment|Other Reasons|32|||
145525961|NCT02125604|524785222|FG000|Overall Study|Investigator Decision|1|||
145525962|NCT02125604|524785222|FG000|Overall Study|Lost to Follow-up|2|||
145750603|NCT00774345|525599336|FG001|Treatment|Other Reasons|26|||
145750604|NCT00075504|525599337|FG000|Overall Study|Withdrawal by Subject|9|||
145525963|NCT02125604|524785222|FG000|Overall Study|Consent Withdrawn|4|||
145525964|NCT02125604|524785222|FG000|Overall Study|Adverse Event|20|||
145525965|NCT04340063|524785223|FG000|Overall Study|Withdrawal by Subject|1|||
145525966|NCT04340063|524785224|FG001|Overall Study|Withdrawal by Subject|2|||
145525967|NCT04340063|524785223|FG000|Overall Study|Lost to Follow-up|3|||
145750605|NCT00075504|525599338|FG001|Overall Study|Withdrawal by Subject|7|||
145750606|NCT02109484|525599339|FG000|Overall Study|Lost to Follow-up|0|||
145750607|NCT02109484|525599340|FG001|Overall Study|Lost to Follow-up|0|||
145750608|NCT02109484|525599341|FG002|Overall Study|Lost to Follow-up|0|||
145750609|NCT02109484|525599342|FG003|Overall Study|Lost to Follow-up|1|||
145750610|NCT02109484|525599343|FG004|Overall Study|Lost to Follow-up|1|||
145750611|NCT02109484|525599344|FG005|Overall Study|Lost to Follow-up|0|||
145750612|NCT02109484|525599345|FG006|Overall Study|Lost to Follow-up|1|||
145750613|NCT02109484|525599346|FG007|Overall Study|Lost to Follow-up|0|||
145750614|NCT02109484|525599339|FG000|Overall Study|Withdrawal by Subject|0|||
145750615|NCT02109484|525599340|FG001|Overall Study|Withdrawal by Subject|0|||
145750616|NCT02109484|525599341|FG002|Overall Study|Withdrawal by Subject|0|||
145750617|NCT02109484|525599342|FG003|Overall Study|Withdrawal by Subject|0|||
145750618|NCT02109484|525599343|FG004|Overall Study|Withdrawal by Subject|1|||
145750619|NCT02109484|525599344|FG005|Overall Study|Withdrawal by Subject|1|||
145750620|NCT02109484|525599345|FG006|Overall Study|Withdrawal by Subject|1|||
145750621|NCT02109484|525599346|FG007|Overall Study|Withdrawal by Subject|0|||
145525968|NCT04340063|524785224|FG001|Overall Study|Lost to Follow-up|1|||
145525969|NCT04340063|524785223|FG000|Overall Study|Protocol Violation|0|||
145750622|NCT02109484|525599339|FG000|Overall Study|Physician Decision|0|||
145525970|NCT04340063|524785224|FG001|Overall Study|Protocol Violation|1|||
145525971|NCT00356122|524785225|FG000|TREATMENT|Lack of Efficacy|26|||
145525972|NCT00356122|524785225|FG000|TREATMENT|Adverse Event|10|||
145525973|NCT00356122|524785225|FG000|TREATMENT|Subject's request|4|||
145525974|NCT00356122|524785225|FG000|TREATMENT|Other|4|||
145525975|NCT00356122|524785225|FG000|TREATMENT|Did not receive study medication|1|||
145525976|NCT00356122|524785225|FG000|FOLLOW-UP|Death|37|||
145525977|NCT00356122|524785225|FG000|FOLLOW-UP|Lost to Follow-up|2|||
145525978|NCT00356122|524785225|FG000|FOLLOW-UP|Other|2|||
145525979|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
145750623|NCT02109484|525599340|FG001|Overall Study|Physician Decision|0|||
145750624|NCT02109484|525599341|FG002|Overall Study|Physician Decision|0|||
145750625|NCT02109484|525599342|FG003|Overall Study|Physician Decision|0|||
145750626|NCT02109484|525599343|FG004|Overall Study|Physician Decision|2|||
145750627|NCT02109484|525599344|FG005|Overall Study|Physician Decision|0|||
145750628|NCT02109484|525599345|FG006|Overall Study|Physician Decision|0|||
145750629|NCT02109484|525599346|FG007|Overall Study|Physician Decision|0|||
145750630|NCT02109484|525599339|FG000|Overall Study|Death|0|||
145750631|NCT02109484|525599340|FG001|Overall Study|Death|0|||
145750632|NCT02109484|525599341|FG002|Overall Study|Death|0|||
145750633|NCT02109484|525599342|FG003|Overall Study|Death|0|||
145750634|NCT02109484|525599343|FG004|Overall Study|Death|0|||
145525980|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
145525981|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
145525982|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
145525983|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
145525984|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
145525985|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
145525986|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
145750635|NCT02109484|525599344|FG005|Overall Study|Death|0|||
145750636|NCT02109484|525599345|FG006|Overall Study|Death|0|||
145750637|NCT02109484|525599346|FG007|Overall Study|Death|2|||
145750638|NCT02109484|525599339|FG000|Overall Study|Moved away from study area|0|||
145750639|NCT02109484|525599340|FG001|Overall Study|Moved away from study area|0|||
145750640|NCT02109484|525599341|FG002|Overall Study|Moved away from study area|0|||
145750641|NCT02109484|525599342|FG003|Overall Study|Moved away from study area|0|||
145750642|NCT02109484|525599343|FG004|Overall Study|Moved away from study area|0|||
145750643|NCT02109484|525599344|FG005|Overall Study|Moved away from study area|0|||
145750644|NCT02109484|525599345|FG006|Overall Study|Moved away from study area|1|||
145750645|NCT02109484|525599346|FG007|Overall Study|Moved away from study area|1|||
145750646|NCT03861559|525599352|FG000|Overall Study|Adverse Event|0|||
145750647|NCT03861559|525599353|FG001|Overall Study|Adverse Event|2|||
145750648|NCT03861559|525599352|FG000|Overall Study|Treatment failure|0|||
145750649|NCT03861559|525599353|FG001|Overall Study|Treatment failure|2|||
145750650|NCT03861559|525599352|FG000|Overall Study|Noncompliance|1|||
145750651|NCT03861559|525599353|FG001|Overall Study|Noncompliance|1|||
145525987|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
145525988|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
145525989|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
145525990|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
145525991|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
145525992|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
145750652|NCT03861559|525599352|FG000|Overall Study|Did not meet eligibility requirements|1|||
145750653|NCT03861559|525599353|FG001|Overall Study|Did not meet eligibility requirements|0|||
145750654|NCT01437397|525599357|FG000|Overall Study|Lost to Follow-up|9|||
145750655|NCT01437397|525599358|FG001|Overall Study|Lost to Follow-up|4|||
145750656|NCT01437397|525599359|FG002|Overall Study|Lost to Follow-up|2|||
145525993|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
145525994|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
145525995|NCT00491556|524785226|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
145750657|NCT01437397|525599360|FG003|Overall Study|Lost to Follow-up|4|||
145750658|NCT01437397|525599361|FG004|Overall Study|Lost to Follow-up|5|||
145750659|NCT01437397|525599357|FG000|Overall Study|Withdrawal by Subject|11|||
145525996|NCT00491556|524785227|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
145525997|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
145525998|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
145525999|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
145750660|NCT01437397|525599358|FG001|Overall Study|Withdrawal by Subject|12|||
145750661|NCT01437397|525599359|FG002|Overall Study|Withdrawal by Subject|24|||
145750662|NCT01437397|525599360|FG003|Overall Study|Withdrawal by Subject|11|||
145750663|NCT01437397|525599361|FG004|Overall Study|Withdrawal by Subject|22|||
145750664|NCT01437397|525599357|FG000|Overall Study|Protocol Violation|10|||
145750665|NCT01437397|525599358|FG001|Overall Study|Protocol Violation|12|||
145750666|NCT01437397|525599359|FG002|Overall Study|Protocol Violation|13|||
145750667|NCT01437397|525599360|FG003|Overall Study|Protocol Violation|21|||
145750668|NCT01437397|525599361|FG004|Overall Study|Protocol Violation|19|||
145750669|NCT01437397|525599357|FG000|Overall Study|Lack of Efficacy|5|||
145750670|NCT01437397|525599358|FG001|Overall Study|Lack of Efficacy|4|||
145750671|NCT01437397|525599359|FG002|Overall Study|Lack of Efficacy|8|||
145750672|NCT01437397|525599360|FG003|Overall Study|Lack of Efficacy|10|||
145750673|NCT01437397|525599361|FG004|Overall Study|Lack of Efficacy|20|||
145750674|NCT01437397|525599357|FG000|Overall Study|Adverse Event|21|||
145750675|NCT01437397|525599358|FG001|Overall Study|Adverse Event|22|||
145750676|NCT01437397|525599359|FG002|Overall Study|Adverse Event|16|||
145750677|NCT01437397|525599360|FG003|Overall Study|Adverse Event|14|||
145750678|NCT01437397|525599361|FG004|Overall Study|Adverse Event|21|||
145750679|NCT01437397|525599357|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
145750680|NCT01437397|525599358|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
145750681|NCT01437397|525599359|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
145750682|NCT01437397|525599360|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
145750683|NCT01437397|525599361|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
145750684|NCT00903175|525599362|FG000|Period 1 - First Line|Adverse Event|36|||
145750685|NCT00903175|525599363|FG001|Period 1 - First Line|Adverse Event|50|||
145750686|NCT00903175|525599362|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
145750687|NCT00903175|525599363|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
145750688|NCT00903175|525599362|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
145750689|NCT00903175|525599363|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
145750690|NCT00903175|525599362|FG000|Period 1 - First Line|Protocol Violation|3|||
145750691|NCT00903175|525599363|FG001|Period 1 - First Line|Protocol Violation|3|||
145750692|NCT00903175|525599362|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
145750693|NCT00903175|525599363|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
145750694|NCT00903175|525599362|FG000|Period 1 - First Line|Administrative problems|12|||
145750695|NCT00903175|525599363|FG001|Period 1 - First Line|Administrative problems|13|||
145750696|NCT00903175|525599362|FG000|Period 1 - First Line|Death|17|||
145750697|NCT00903175|525599363|FG001|Period 1 - First Line|Death|10|||
145750698|NCT00903175|525599362|FG000|Period 2 - Second Line|Missing|1|||
145750699|NCT00903175|525599363|FG001|Period 2 - Second Line|Missing|0|||
145750700|NCT00903175|525599362|FG000|Period 2 - Second Line|Adverse Event|16|||
145750701|NCT00903175|525599363|FG001|Period 2 - Second Line|Adverse Event|20|||
145750702|NCT00903175|525599362|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
145750703|NCT00903175|525599363|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
145750704|NCT00903175|525599362|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
145750705|NCT00903175|525599363|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
145750706|NCT00903175|525599362|FG000|Period 2 - Second Line|Administrative problems|19|||
145526000|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
145526001|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
145526002|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
145526003|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
145526004|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
145526005|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
145526006|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
145526007|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
145750707|NCT00903175|525599363|FG001|Period 2 - Second Line|Administrative problems|9|||
145750708|NCT00903175|525599362|FG000|Period 2 - Second Line|Death|5|||
145750709|NCT00903175|525599363|FG001|Period 2 - Second Line|Death|2|||
145750710|NCT03074474|525599366|FG000|Overall Study|Lost to Follow-up|10|||
145750711|NCT03074474|525599366|FG000|Overall Study|Withdrawal by Subject|10|||
145750712|NCT03074474|525599366|FG000|Overall Study|Death|4|||
145750713|NCT03074474|525599366|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
145750714|NCT02124564|525599372|FG000|Treatment Period|Adverse Event|2|||
145750715|NCT02124564|525599372|FG000|Treatment Period|Lack of Efficacy|3|||
145750716|NCT02124564|525599372|FG000|Treatment Period|Withdrawal by Subject|2|||
145750717|NCT00328627|525602195|FG000|Overall Study|Hyperglycemic Rescue|41|||
145750718|NCT00328627|525602196|FG001|Overall Study|Hyperglycemic Rescue|18|||
145750719|NCT00328627|525602197|FG002|Overall Study|Hyperglycemic Rescue|16|||
145750720|NCT00328627|525602198|FG003|Overall Study|Hyperglycemic Rescue|13|||
145750721|NCT00328627|525602199|FG004|Overall Study|Hyperglycemic Rescue|6|||
145750722|NCT00328627|525602200|FG005|Overall Study|Hyperglycemic Rescue|5|||
145750723|NCT00328627|525602201|FG006|Overall Study|Hyperglycemic Rescue|19|||
145750724|NCT00328627|525602202|FG007|Overall Study|Hyperglycemic Rescue|6|||
145750725|NCT00328627|525602203|FG008|Overall Study|Hyperglycemic Rescue|6|||
145526008|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
145526009|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
145526010|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
145526011|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
145750726|NCT00328627|525602204|FG009|Overall Study|Hyperglycemic Rescue|11|||
145750727|NCT00328627|525602205|FG010|Overall Study|Hyperglycemic Rescue|3|||
145750728|NCT00328627|525602206|FG011|Overall Study|Hyperglycemic Rescue|2|||
145750729|NCT00328627|525602195|FG000|Overall Study|Adverse Event|3|||
145750730|NCT00328627|525602196|FG001|Overall Study|Adverse Event|1|||
145750731|NCT00328627|525602197|FG002|Overall Study|Adverse Event|2|||
145750732|NCT00328627|525602198|FG003|Overall Study|Adverse Event|3|||
145750733|NCT00328627|525602199|FG004|Overall Study|Adverse Event|1|||
145750734|NCT00328627|525602200|FG005|Overall Study|Adverse Event|2|||
145750735|NCT00328627|525602201|FG006|Overall Study|Adverse Event|1|||
145750736|NCT00328627|525602202|FG007|Overall Study|Adverse Event|2|||
145750737|NCT00328627|525602203|FG008|Overall Study|Adverse Event|0|||
145750738|NCT00328627|525602204|FG009|Overall Study|Adverse Event|7|||
145750739|NCT00328627|525602205|FG010|Overall Study|Adverse Event|5|||
145750740|NCT00328627|525602206|FG011|Overall Study|Adverse Event|4|||
145750741|NCT00328627|525602195|FG000|Overall Study|Protocol Violation|2|||
145750742|NCT00328627|525602196|FG001|Overall Study|Protocol Violation|2|||
145750743|NCT00328627|525602197|FG002|Overall Study|Protocol Violation|2|||
145750744|NCT00328627|525602198|FG003|Overall Study|Protocol Violation|8|||
145750745|NCT00328627|525602199|FG004|Overall Study|Protocol Violation|5|||
145750746|NCT00328627|525602200|FG005|Overall Study|Protocol Violation|5|||
145750747|NCT00328627|525602201|FG006|Overall Study|Protocol Violation|6|||
145750748|NCT00328627|525602202|FG007|Overall Study|Protocol Violation|2|||
145750749|NCT00328627|525602203|FG008|Overall Study|Protocol Violation|1|||
145750750|NCT00328627|525602204|FG009|Overall Study|Protocol Violation|4|||
145750751|NCT00328627|525602205|FG010|Overall Study|Protocol Violation|6|||
145750752|NCT00328627|525602206|FG011|Overall Study|Protocol Violation|2|||
145750753|NCT00328627|525602195|FG000|Overall Study|Lost to Follow-up|4|||
145750754|NCT00328627|525602196|FG001|Overall Study|Lost to Follow-up|2|||
145750755|NCT00328627|525602197|FG002|Overall Study|Lost to Follow-up|2|||
145750756|NCT00328627|525602198|FG003|Overall Study|Lost to Follow-up|4|||
145750757|NCT00328627|525602199|FG004|Overall Study|Lost to Follow-up|0|||
145750758|NCT00328627|525602200|FG005|Overall Study|Lost to Follow-up|2|||
145750759|NCT00328627|525602201|FG006|Overall Study|Lost to Follow-up|3|||
145750760|NCT00328627|525602202|FG007|Overall Study|Lost to Follow-up|0|||
145750761|NCT00328627|525602203|FG008|Overall Study|Lost to Follow-up|3|||
145750762|NCT00328627|525602204|FG009|Overall Study|Lost to Follow-up|2|||
145750763|NCT00328627|525602205|FG010|Overall Study|Lost to Follow-up|0|||
145750764|NCT00328627|525602206|FG011|Overall Study|Lost to Follow-up|1|||
145750765|NCT00328627|525602195|FG000|Overall Study|Withdrawal by Subject|5|||
145750766|NCT00328627|525602196|FG001|Overall Study|Withdrawal by Subject|4|||
145750767|NCT00328627|525602197|FG002|Overall Study|Withdrawal by Subject|5|||
145750768|NCT00328627|525602198|FG003|Overall Study|Withdrawal by Subject|6|||
145750769|NCT00328627|525602199|FG004|Overall Study|Withdrawal by Subject|2|||
145750770|NCT00328627|525602200|FG005|Overall Study|Withdrawal by Subject|5|||
145750771|NCT00328627|525602201|FG006|Overall Study|Withdrawal by Subject|4|||
145750772|NCT00328627|525602202|FG007|Overall Study|Withdrawal by Subject|4|||
145750773|NCT00328627|525602203|FG008|Overall Study|Withdrawal by Subject|4|||
145750774|NCT00328627|525602204|FG009|Overall Study|Withdrawal by Subject|5|||
145750775|NCT00328627|525602205|FG010|Overall Study|Withdrawal by Subject|2|||
145750776|NCT00328627|525602206|FG011|Overall Study|Withdrawal by Subject|7|||
145526012|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
145526013|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
145526014|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
145526015|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
145526016|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
145750777|NCT00328627|525602195|FG000|Overall Study|Pregnancy|0|||
145750778|NCT00328627|525602196|FG001|Overall Study|Pregnancy|1|||
145750779|NCT00328627|525602197|FG002|Overall Study|Pregnancy|0|||
145750780|NCT00328627|525602198|FG003|Overall Study|Pregnancy|0|||
145750781|NCT00328627|525602199|FG004|Overall Study|Pregnancy|0|||
145750782|NCT00328627|525602200|FG005|Overall Study|Pregnancy|0|||
145750783|NCT00328627|525602201|FG006|Overall Study|Pregnancy|0|||
145750784|NCT00328627|525602202|FG007|Overall Study|Pregnancy|0|||
145750785|NCT00328627|525602203|FG008|Overall Study|Pregnancy|0|||
145750786|NCT00328627|525602204|FG009|Overall Study|Pregnancy|0|||
145750787|NCT00328627|525602205|FG010|Overall Study|Pregnancy|0|||
145750788|NCT00328627|525602206|FG011|Overall Study|Pregnancy|0|||
145750789|NCT00328627|525602195|FG000|Overall Study|Physician Decision|4|||
145750790|NCT00328627|525602196|FG001|Overall Study|Physician Decision|3|||
145750791|NCT00328627|525602197|FG002|Overall Study|Physician Decision|1|||
145750792|NCT00328627|525602198|FG003|Overall Study|Physician Decision|2|||
145750793|NCT00328627|525602199|FG004|Overall Study|Physician Decision|1|||
145750794|NCT00328627|525602200|FG005|Overall Study|Physician Decision|1|||
145750795|NCT00328627|525602201|FG006|Overall Study|Physician Decision|1|||
145750796|NCT00328627|525602202|FG007|Overall Study|Physician Decision|0|||
145750797|NCT00328627|525602203|FG008|Overall Study|Physician Decision|3|||
145750798|NCT00328627|525602204|FG009|Overall Study|Physician Decision|2|||
145750799|NCT00328627|525602205|FG010|Overall Study|Physician Decision|1|||
145750800|NCT00328627|525602206|FG011|Overall Study|Physician Decision|0|||
145750801|NCT00328627|525602195|FG000|Overall Study|Other|0|||
145750802|NCT00328627|525602196|FG001|Overall Study|Other|0|||
145750803|NCT00328627|525602197|FG002|Overall Study|Other|0|||
145750804|NCT00328627|525602198|FG003|Overall Study|Other|1|||
145750805|NCT00328627|525602199|FG004|Overall Study|Other|0|||
145750806|NCT00328627|525602200|FG005|Overall Study|Other|0|||
145750807|NCT00328627|525602201|FG006|Overall Study|Other|1|||
145750808|NCT00328627|525602202|FG007|Overall Study|Other|0|||
145750809|NCT00328627|525602203|FG008|Overall Study|Other|0|||
145750810|NCT00328627|525602204|FG009|Overall Study|Other|1|||
145750811|NCT00328627|525602205|FG010|Overall Study|Other|1|||
145750812|NCT00328627|525602206|FG011|Overall Study|Other|0|||
145750813|NCT03409744|525602207|FG000|Overall Study|Death|2|||
145750814|NCT03409744|525602207|FG000|Overall Study|Physician Decision|5|||
145750815|NCT03409744|525602207|FG000|Overall Study|Pregnancy|1|||
145750816|NCT03409744|525602207|FG000|Overall Study|Lost to Follow-up|1|||
145750817|NCT03409744|525602207|FG000|Overall Study|Protocol Violation|1|||
145750818|NCT00264004|525602209|FG000|Overall Study|Adverse Event|2|||
145750819|NCT00264004|525602210|FG001|Overall Study|Adverse Event|3|||
145750820|NCT00264004|525602211|FG002|Overall Study|Adverse Event|6|||
145750821|NCT00264004|525602212|FG003|Overall Study|Adverse Event|4|||
145750822|NCT00264004|525602209|FG000|Overall Study|Withdrawal by Subject|0|||
145750823|NCT00264004|525602210|FG001|Overall Study|Withdrawal by Subject|1|||
145750824|NCT00264004|525602211|FG002|Overall Study|Withdrawal by Subject|2|||
145750825|NCT00264004|525602212|FG003|Overall Study|Withdrawal by Subject|2|||
145750826|NCT00264004|525602209|FG000|Overall Study|Other|2|||
145750827|NCT00264004|525602210|FG001|Overall Study|Other|2|||
145750828|NCT00264004|525602211|FG002|Overall Study|Other|0|||
145750829|NCT00264004|525602212|FG003|Overall Study|Other|3|||
145750830|NCT00264004|525602209|FG000|Overall Study|Development study specific disc. crit.|1|||
145750831|NCT00264004|525602210|FG001|Overall Study|Development study specific disc. crit.|0|||
145750832|NCT00264004|525602211|FG002|Overall Study|Development study specific disc. crit.|1|||
145750833|NCT00264004|525602212|FG003|Overall Study|Development study specific disc. crit.|0|||
145750834|NCT00264004|525602209|FG000|Overall Study|Cond. under inv. worsened|9|||
145750835|NCT00264004|525602210|FG001|Overall Study|Cond. under inv. worsened|5|||
145750836|NCT00264004|525602211|FG002|Overall Study|Cond. under inv. worsened|3|||
145750837|NCT00264004|525602212|FG003|Overall Study|Cond. under inv. worsened|4|||
145750838|NCT00264004|525602209|FG000|Overall Study|Not treated|3|||
145750839|NCT00264004|525602210|FG001|Overall Study|Not treated|0|||
145750840|NCT00264004|525602211|FG002|Overall Study|Not treated|2|||
145750841|NCT00264004|525602212|FG003|Overall Study|Not treated|2|||
145750842|NCT04986202|525602215|FG000|Overall Study|Death|10|||
145750843|NCT04986202|525602216|FG001|Overall Study|Death|3|||
145750844|NCT04986202|525602217|FG002|Overall Study|Death|10|||
145750845|NCT04986202|525602215|FG000|Overall Study|Physician Decision|3|||
145750846|NCT04986202|525602216|FG001|Overall Study|Physician Decision|1|||
145750847|NCT04986202|525602217|FG002|Overall Study|Physician Decision|2|||
145750848|NCT04986202|525602215|FG000|Overall Study|Withdrawal by Subject|4|||
145750849|NCT04986202|525602216|FG001|Overall Study|Withdrawal by Subject|2|||
145750850|NCT04986202|525602217|FG002|Overall Study|Withdrawal by Subject|4|||
145750851|NCT02118792|525602218|FG000|Overall Study|Withdrawal by Subject|6|||
145750852|NCT02118792|525602219|FG001|Overall Study|Withdrawal by Subject|3|||
145750853|NCT02118792|525602218|FG000|Overall Study|Lost to Follow-up|4|||
145750854|NCT02118792|525602219|FG001|Overall Study|Lost to Follow-up|4|||
145750855|NCT02118792|525602218|FG000|Overall Study|Adverse Event|5|||
145750856|NCT02118792|525602219|FG001|Overall Study|Adverse Event|4|||
145750857|NCT02118792|525602218|FG000|Overall Study|Withdrawal by parent/guardian|14|||
145750858|NCT02118792|525602219|FG001|Overall Study|Withdrawal by parent/guardian|20|||
145750859|NCT02118792|525602218|FG000|Overall Study|Other|1|||
145750860|NCT02118792|525602219|FG001|Overall Study|Other|6|||
145750861|NCT02118792|525602218|FG000|Overall Study|Randomised but not treated|1|||
145750862|NCT02118792|525602219|FG001|Overall Study|Randomised but not treated|0|||
145750863|NCT05131204|525602220|FG000|Overall Study|Sponsor request|2|||
145750864|NCT05131204|525602221|FG001|Overall Study|Sponsor request|1|||
145750865|NCT04735653|525602222|FG000|Overall Study|Lost to Follow-up|17|||
145750866|NCT04735653|525602223|FG001|Overall Study|Lost to Follow-up|7|||
145750867|NCT04735653|525602222|FG000|Overall Study|Withdrawal by Subject|8|||
145750868|NCT04735653|525602223|FG001|Overall Study|Withdrawal by Subject|2|||
145750869|NCT04735653|525602222|FG000|Overall Study|Death|0|||
145750870|NCT04735653|525602223|FG001|Overall Study|Death|2|||
145750871|NCT04735653|525602222|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
145750872|NCT04735653|525602223|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
145750873|NCT05980299|525602228|FG000|Overall Study|Death|28|||
145750874|NCT05980299|525602229|FG001|Overall Study|Death|0|||
145750875|NCT05980299|525602228|FG000|Overall Study|Discharged from Nursing Home|9|||
145750876|NCT05980299|525602229|FG001|Overall Study|Discharged from Nursing Home|0|||
145750877|NCT05980299|525602228|FG000|Overall Study|Lost to Follow-up|0|||
145750878|NCT05980299|525602229|FG001|Overall Study|Lost to Follow-up|10|||
145750879|NCT00290433|525602232|FG000|Overall Study|Disease Progression|13|||
145750880|NCT00290433|525602232|FG000|Overall Study|Adverse Event|14|||
145750881|NCT00290433|525602232|FG000|Overall Study|Withdrawal by Subject|1|||
145750882|NCT00290433|525602232|FG000|Overall Study|Non-Compliance|1|||
145750883|NCT00290433|525602232|FG000|Overall Study|Congestive Heart Failure|1|||
145750884|NCT00290433|525602232|FG000|Overall Study|Transplant in CR|5|||
145750885|NCT00290433|525602232|FG000|Overall Study|Unrelated Infection/Death|1|||
145750886|NCT00252057|525602233|FG000|Overall Study|Withdrawal by Subject|2|||
145750887|NCT00252057|525602234|FG001|Overall Study|Withdrawal by Subject|5|||
145750888|NCT00252057|525602233|FG000|Overall Study|Death|1|||
145750889|NCT00252057|525602234|FG001|Overall Study|Death|2|||
145750890|NCT00252057|525602233|FG000|Overall Study|Participant previously enrolled|0|||
145750891|NCT00252057|525602234|FG001|Overall Study|Participant previously enrolled|1|||
145750892|NCT02264990|525602235|FG000|Overall Study|Death|255|||
145750893|NCT02264990|525602236|FG001|Overall Study|Death|250|||
145750894|NCT02264990|525602235|FG000|Overall Study|Withdrawal by Subject|4|||
145750895|NCT02264990|525602236|FG001|Overall Study|Withdrawal by Subject|5|||
145750896|NCT02264990|525602235|FG000|Overall Study|Lost to Follow-up|1|||
145750897|NCT02264990|525602236|FG001|Overall Study|Lost to Follow-up|3|||
145750898|NCT02264990|525602235|FG000|Overall Study|Other|0|||
145750899|NCT02264990|525602236|FG001|Overall Study|Other|1|||
145750900|NCT01662895|525602239|FG000|Overall Study|Lost to Follow-up|0|||
145750901|NCT01662895|525602240|FG001|Overall Study|Lost to Follow-up|1|||
145750902|NCT05048342|525602241|FG000|Overall Study|Adverse Event|1|||
145750903|NCT05048342|525602241|FG000|Overall Study|Subject decision|2|||
145750904|NCT01441063|525602242|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
145750905|NCT01441063|525602242|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
145750906|NCT03504397|525602253|FG000|Overall Study|Progressive Disease|151|||
145750907|NCT03504397|525602254|FG001|Overall Study|Progressive Disease|199|||
145750908|NCT03504397|525602253|FG000|Overall Study|Withdrawal by Subject|29|||
145750909|NCT03504397|525602254|FG001|Overall Study|Withdrawal by Subject|17|||
145750910|NCT03504397|525602253|FG000|Overall Study|Lost to Follow-up|1|||
145750911|NCT03504397|525602254|FG001|Overall Study|Lost to Follow-up|0|||
145750912|NCT03504397|525602253|FG000|Overall Study|Death|14|||
145750913|NCT03504397|525602254|FG001|Overall Study|Death|16|||
145750914|NCT03504397|525602253|FG000|Overall Study|Adverse Event|40|||
145750915|NCT03504397|525602254|FG001|Overall Study|Adverse Event|14|||
145750916|NCT03504397|525602253|FG000|Overall Study|miscellaneous|17|||
145750917|NCT03504397|525602254|FG001|Overall Study|miscellaneous|15|||
145750918|NCT03504397|525602253|FG000|Overall Study|Protocol deviation|1|||
145750919|NCT03504397|525602254|FG001|Overall Study|Protocol deviation|0|||
145750920|NCT03504397|525602253|FG000|Overall Study|Participants who did not take the study drug|4|||
145750921|NCT03504397|525602254|FG001|Overall Study|Participants who did not take the study drug|4|||
145750922|NCT01277549|525602256|FG000|Overall Study|Failed to meet eligibility criteria|13|||
145750923|NCT01277549|525602257|FG001|Overall Study|Failed to meet eligibility criteria|9|||
145526017|NCT00491556|524785226|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
145750924|NCT01277549|525602256|FG000|Overall Study|Withdrawal by Subject|1|||
145750925|NCT01277549|525602257|FG001|Overall Study|Withdrawal by Subject|3|||
145750926|NCT01277549|525602256|FG000|Overall Study|Protocol Violation|10|||
145750927|NCT01277549|525602257|FG001|Overall Study|Protocol Violation|1|||
145750928|NCT01277549|525602256|FG000|Overall Study|Physician Decision|2|||
145750929|NCT01277549|525602257|FG001|Overall Study|Physician Decision|1|||
145750930|NCT00623428|525602260|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
145750931|NCT00623428|525602261|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
145750932|NCT00623428|525602260|FG000|Treatment Period|Death|0|||
145750933|NCT00623428|525602261|FG001|Treatment Period|Death|1|||
145750934|NCT00623428|525602260|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
145526018|NCT00491556|524785227|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
145526019|NCT04480424|524785228|FG000|Overall Study|Withdrawal by Subject|0|||
145750935|NCT00623428|525602261|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
145750936|NCT00623428|525602260|FG000|Treatment Period|Insufficient therapeutic response|0|||
145750937|NCT00623428|525602261|FG001|Treatment Period|Insufficient therapeutic response|2|||
145750938|NCT00623428|525602260|FG000|Treatment Period|Other|0|||
145750939|NCT00623428|525602261|FG001|Treatment Period|Other|1|||
145750940|NCT00623428|525602260|FG000|Treatment Period|Withdrawal by Subject|0|||
145750941|NCT00623428|525602261|FG001|Treatment Period|Withdrawal by Subject|1|||
145750942|NCT00623428|525602260|FG000|Follow-up Period|Relapse post-treatment|11|||
145750943|NCT00623428|525602261|FG001|Follow-up Period|Relapse post-treatment|3|||
145750944|NCT00623428|525602260|FG000|Follow-up Period|Failure to return|10|||
145750945|NCT00623428|525602261|FG001|Follow-up Period|Failure to return|2|||
145750946|NCT00623428|525602260|FG000|Follow-up Period|Patient withdrew consent|5|||
145750947|NCT00623428|525602261|FG001|Follow-up Period|Patient withdrew consent|4|||
145750948|NCT00623428|525602260|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
145750949|NCT00623428|525602261|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
145750950|NCT00623428|525602260|FG000|Follow-up Period|Did not cooperate|0|||
145750951|NCT00623428|525602261|FG001|Follow-up Period|Did not cooperate|3|||
145750952|NCT00623428|525602260|FG000|Follow-up Period|Reason not specified|1|||
145750953|NCT00623428|525602261|FG001|Follow-up Period|Reason not specified|1|||
145750954|NCT00623428|525602260|FG000|Follow-up Period|Death|0|||
145750955|NCT00623428|525602261|FG001|Follow-up Period|Death|1|||
145750956|NCT01692301|525602264|FG000|Overall Study|Adverse Event|15|||
145750957|NCT01692301|525602265|FG001|Overall Study|Adverse Event|12|||
145750958|NCT01692301|525602264|FG000|Overall Study|Death|1|||
145750959|NCT01692301|525602265|FG001|Overall Study|Death|2|||
145271284|NCT01977482|523839693|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
145271285|NCT01977482|523839694|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
145526020|NCT04480424|524785229|FG001|Overall Study|Withdrawal by Subject|2|||
145750960|NCT01692301|525602264|FG000|Overall Study|Lack of Efficacy|0|||
145750961|NCT01692301|525602265|FG001|Overall Study|Lack of Efficacy|5|||
145750962|NCT01692301|525602264|FG000|Overall Study|Non-compliance with study treatment|1|||
145750963|NCT01692301|525602265|FG001|Overall Study|Non-compliance with study treatment|2|||
145750964|NCT01692301|525602264|FG000|Overall Study|Protocol deviation|9|||
145750965|NCT01692301|525602265|FG001|Overall Study|Protocol deviation|2|||
145750966|NCT01692301|525602264|FG000|Overall Study|Patient/guardian decision|16|||
145750967|NCT01692301|525602265|FG001|Overall Study|Patient/guardian decision|15|||
145750968|NCT01692301|525602264|FG000|Overall Study|Technical problems|0|||
145750969|NCT01692301|525602265|FG001|Overall Study|Technical problems|1|||
145750970|NCT01692301|525602264|FG000|Overall Study|Physician Decision|2|||
145750971|NCT01692301|525602265|FG001|Overall Study|Physician Decision|2|||
145750972|NCT01692301|525602264|FG000|Overall Study|Lost to Follow-up|1|||
145750973|NCT01692301|525602265|FG001|Overall Study|Lost to Follow-up|1|||
145750974|NCT01142726|525602266|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
145750975|NCT01142726|525602267|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
145750976|NCT01142726|525602268|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
145750977|NCT01142726|525602266|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
145750978|NCT01142726|525602267|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
145750979|NCT01142726|525602268|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
145750980|NCT01142726|525602266|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
145750981|NCT01142726|525602267|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
145750982|NCT01142726|525602268|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
145750983|NCT01142726|525602266|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
145750984|NCT01142726|525602267|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
145750985|NCT01142726|525602268|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
145750986|NCT01142726|525602266|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
145750987|NCT01142726|525602267|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
145750988|NCT01142726|525602268|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
145750989|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
145750990|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
145750991|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
145750992|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
145750993|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
145750994|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
145750995|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
145750996|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
145750997|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
145750998|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
145750999|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
145751000|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
145751001|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
145751002|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
145751003|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
145751004|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
145751005|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
145751006|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
145751007|NCT01142726|525602266|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
145751008|NCT01142726|525602267|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
145526021|NCT04480424|524785228|FG000|Overall Study|Lost to Follow-up|3|||
145526022|NCT04480424|524785229|FG001|Overall Study|Lost to Follow-up|3|||
145751009|NCT01142726|525602268|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
145751010|NCT01142726|525602266|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
145751011|NCT01142726|525602267|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
145751012|NCT01142726|525602268|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
145751013|NCT01142726|525602266|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
145751014|NCT01142726|525602267|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
145751015|NCT01142726|525602268|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
145751016|NCT01142726|525602266|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
145751017|NCT01142726|525602267|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
145751018|NCT01142726|525602268|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
145751019|NCT01142726|525602266|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
145751020|NCT01142726|525602267|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
145751021|NCT01142726|525602268|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
145526023|NCT04480424|524785228|FG000|Overall Study|Death|14|||
145526024|NCT04480424|524785229|FG001|Overall Study|Death|16|||
145526025|NCT04480424|524785228|FG000|Overall Study|Reason not Specified|5|||
145526026|NCT04480424|524785229|FG001|Overall Study|Reason not Specified|5|||
145526027|NCT00734747|524785233|FG000|SRS Procedure|No staples placed|3|||
145526028|NCT00734747|524785233|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
145526029|NCT03670836|524785234|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
145526030|NCT03670836|524785235|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
145526031|NCT03670836|524785234|FG000|Per Protocol Population (PP)|Physician Decision|9|||
145526032|NCT03670836|524785235|FG001|Per Protocol Population (PP)|Physician Decision|10|||
145526033|NCT03670836|524785234|FG000|Per Protocol Population (PP)|Physician Decision|4|||
145526034|NCT03670836|524785235|FG001|Per Protocol Population (PP)|Physician Decision|6|||
145526035|NCT03670836|524785234|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
145751022|NCT00293579|525602272|FG000|Overall Study|Withdrawal by Subject|1|||
145751023|NCT00419380|525602273|FG000|Overall Study|Lack of Efficacy|1|||
145751024|NCT00419380|525602274|FG001|Overall Study|Lack of Efficacy|7|||
145751025|NCT00419380|525602273|FG000|Overall Study|Physician Decision|0|||
145751026|NCT00419380|525602274|FG001|Overall Study|Physician Decision|1|||
145751027|NCT00419380|525602273|FG000|Overall Study|Lost to Follow-up|0|||
145751028|NCT00419380|525602274|FG001|Overall Study|Lost to Follow-up|1|||
145751029|NCT00419380|525602273|FG000|Overall Study|Withdrawal by Subject|0|||
145751030|NCT00419380|525602274|FG001|Overall Study|Withdrawal by Subject|1|||
145751031|NCT03099707|525602275|FG000|Overall Study|Withdrawal by Subject|0|||
145751032|NCT03099707|525602276|FG001|Overall Study|Withdrawal by Subject|3|||
145751033|NCT03099707|525602275|FG000|Overall Study|Lost to Follow-up|0|||
145751034|NCT03099707|525602276|FG001|Overall Study|Lost to Follow-up|1|||
145751035|NCT03215771|525602285|FG000|Overall Study|Withdrawal by Subject|2|||
145751036|NCT03215771|525602285|FG000|Overall Study|Physician Decision|1|||
145751037|NCT00574275|525602290|FG000|Overall Study|Randomized but not treated|2|||
145751038|NCT00574275|525602291|FG001|Overall Study|Randomized but not treated|3|||
145751039|NCT00574275|525602290|FG000|Overall Study|Adverse Event|32|||
145751040|NCT00574275|525602291|FG001|Overall Study|Adverse Event|76|||
145751041|NCT00574275|525602290|FG000|Overall Study|Disease progression|160|||
145751042|NCT00574275|525602291|FG001|Overall Study|Disease progression|146|||
145751043|NCT00574275|525602290|FG000|Overall Study|Lost to Follow-up|2|||
145751044|NCT00574275|525602291|FG001|Overall Study|Lost to Follow-up|1|||
145751045|NCT00574275|525602290|FG000|Overall Study|Study stopped based on DMC decision|62|||
145751046|NCT00574275|525602291|FG001|Overall Study|Study stopped based on DMC decision|23|||
145751047|NCT00574275|525602290|FG000|Overall Study|Withdrawal by Subject|15|||
145751048|NCT00574275|525602291|FG001|Overall Study|Withdrawal by Subject|17|||
145751049|NCT00574275|525602290|FG000|Overall Study|Error calculating tumor measurement|1|||
145751050|NCT00574275|525602291|FG001|Overall Study|Error calculating tumor measurement|0|||
145751051|NCT00574275|525602290|FG000|Overall Study|Physician Decision|1|||
145751052|NCT00574275|525602291|FG001|Overall Study|Physician Decision|1|||
145751053|NCT00574275|525602290|FG000|Overall Study|Protocol Violation|0|||
145751054|NCT00574275|525602291|FG001|Overall Study|Protocol Violation|1|||
145751055|NCT00574275|525602290|FG000|Overall Study|Patient and Investigator decision|0|||
145751056|NCT00574275|525602291|FG001|Overall Study|Patient and Investigator decision|1|||
145751057|NCT00574275|525602290|FG000|Overall Study|Insurance change|0|||
145751058|NCT00574275|525602291|FG001|Overall Study|Insurance change|1|||
145751059|NCT00574275|525602290|FG000|Overall Study|Operation for curative intent|0|||
145751060|NCT00574275|525602291|FG001|Overall Study|Operation for curative intent|1|||
145751061|NCT02703311|525602292|FG000|Overall Study|Death|5|||
145751062|NCT02703311|525602292|FG000|Overall Study|Withdrawal by Subject|3|||
145751063|NCT01967537|525602295|FG000|Overall Study|Withdrawal by Subject|52|||
145751064|NCT01967537|525602295|FG000|Overall Study|Refuse treatment|2|||
145751065|NCT01967537|525602295|FG000|Overall Study|Lost to Follow-up|6|||
145751066|NCT00137111|525602296|FG000|Total Therapy|Death|35|||
145751067|NCT00137111|525602297|FG001|Total Therapy|Death|0|||
145751068|NCT00137111|525602298|FG002|Total Therapy|Death|0|||
145751069|NCT00137111|525602299|FG003|Total Therapy|Death|0|||
145751070|NCT00137111|525602296|FG000|Total Therapy|Non Compliance|5|||
145751071|NCT00137111|525602297|FG001|Total Therapy|Non Compliance|0|||
145751072|NCT00137111|525602298|FG002|Total Therapy|Non Compliance|0|||
145751073|NCT00137111|525602299|FG003|Total Therapy|Non Compliance|0|||
145751074|NCT00562354|525602300|FG000|Overall Study|Physician Decision|0|||
145526036|NCT03670836|524785235|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
145526037|NCT03287635|524785236|FG000|Overall Study|Lost to Follow-up|5|||
145526038|NCT03287635|524785236|FG000|Overall Study|Withdrawal by Subject|1|||
145526039|NCT03287635|524785236|FG000|Overall Study|Physician Decision|1|||
145751075|NCT00562354|525602301|FG001|Overall Study|Physician Decision|1|||
145751076|NCT00562354|525602300|FG000|Overall Study|Lost to Follow-up|0|||
145751077|NCT00562354|525602301|FG001|Overall Study|Lost to Follow-up|1|||
145751078|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
145751079|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
145751080|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
145751081|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
145751082|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
145751083|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
145526040|NCT00323869|524785239|FG000|Overall Study|Death|1|||
145526041|NCT03868124|524786798|FG000|Overall Study|Withdrawal by Subject|4|||
145526042|NCT03868124|524786799|FG001|Overall Study|Withdrawal by Subject|0|||
145526043|NCT03868124|524786800|FG002|Overall Study|Withdrawal by Subject|1|||
145526044|NCT03868124|524786798|FG000|Overall Study|Physician Decision|1|||
145526045|NCT03868124|524786799|FG001|Overall Study|Physician Decision|0|||
145751084|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
145751085|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
145751086|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
145751087|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
145751088|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
145751089|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
145751090|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
145751091|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
145751092|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
145751093|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
145751094|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
145751095|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
145751096|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
145751097|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
145751098|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
145751099|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
145751100|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
145751101|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
145751102|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
145526046|NCT03868124|524786800|FG002|Overall Study|Physician Decision|1|||
145526047|NCT03868124|524786798|FG000|Overall Study|Lost to Follow-up|1|||
145526048|NCT03868124|524786799|FG001|Overall Study|Lost to Follow-up|1|||
145526049|NCT03868124|524786800|FG002|Overall Study|Lost to Follow-up|2|||
145526050|NCT03868124|524786798|FG000|Overall Study|Death|1|||
145526051|NCT03868124|524786799|FG001|Overall Study|Death|1|||
145526052|NCT03868124|524786800|FG002|Overall Study|Death|2|||
145526053|NCT03868124|524786798|FG000|Overall Study|Adverse Event|0|||
145526054|NCT03868124|524786799|FG001|Overall Study|Adverse Event|0|||
145526055|NCT03868124|524786800|FG002|Overall Study|Adverse Event|3|||
145751103|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
145526056|NCT03868124|524786798|FG000|Overall Study|Explanted|2|||
145751104|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
145751105|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
145751106|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
145751107|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
145751108|NCT00784654|525602302|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
145526057|NCT03868124|524786799|FG001|Overall Study|Explanted|1|||
145526058|NCT03868124|524786800|FG002|Overall Study|Explanted|0|||
145526059|NCT03868124|524786798|FG000|Overall Study|Ongoing in study|176|||
145526060|NCT03868124|524786799|FG001|Overall Study|Ongoing in study|180|||
145526061|NCT03868124|524786800|FG002|Overall Study|Ongoing in study|183|||
145526062|NCT00427960|524786801|FG000|Overall Study|Adverse Event|2|||
145526063|NCT00427960|524786802|FG001|Overall Study|Adverse Event|0|||
145526064|NCT00427960|524786801|FG000|Overall Study|Withdrawal by Subject|0|||
145526065|NCT00427960|524786802|FG001|Overall Study|Withdrawal by Subject|3|||
145526066|NCT00427960|524786801|FG000|Overall Study|Other|0|||
145526067|NCT00427960|524786802|FG001|Overall Study|Other|1|||
145526068|NCT00423670|524786803|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
145526069|NCT00423670|524786804|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
145526070|NCT00423670|524786805|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
145526071|NCT00423670|524786806|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
145526072|NCT00423670|524786807|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
145751109|NCT00784654|525602303|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
145751110|NCT00784654|525602304|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
145751111|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
145751112|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
145751113|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
145751114|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
145751115|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
145751116|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
145751117|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145751118|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
145751119|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
145751120|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
145751121|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
145751122|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
145526073|NCT00423670|524786808|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
145526074|NCT00423670|524786809|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
145751123|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Adverse Event|0|||
145751124|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Adverse Event|1|||
145751125|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Adverse Event|1|||
145751126|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
145526075|NCT00423670|524786810|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
145526076|NCT00423670|524786803|FG000|Treatment Period|Adverse Event|8|||
145526077|NCT00423670|524786804|FG001|Treatment Period|Adverse Event|12|||
145526078|NCT00423670|524786805|FG002|Treatment Period|Adverse Event|15|||
145526079|NCT00423670|524786806|FG003|Treatment Period|Adverse Event|20|||
145751127|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
145751128|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
145751129|NCT00784654|525602302|FG000|Randomized Withdrawal Period|Family reasons|0|||
145751130|NCT00784654|525602303|FG001|Randomized Withdrawal Period|Family reasons|0|||
145751131|NCT00784654|525602304|FG002|Randomized Withdrawal Period|Family reasons|1|||
145751132|NCT00317109|525602305|FG000|Overall Study|Withdrawal by Subject|2|||
145751133|NCT00317109|525602306|FG001|Overall Study|Withdrawal by Subject|0|||
145751134|NCT00317109|525602305|FG000|Overall Study|Migated/moved from study area|1|||
145751135|NCT00317109|525602306|FG001|Overall Study|Migated/moved from study area|0|||
145751136|NCT01026831|525602307|FG000|Overall Study|Adverse Event|4|||
145751137|NCT01026831|525602308|FG001|Overall Study|Adverse Event|3|||
145751138|NCT01026831|525602307|FG000|Overall Study|Lost to Follow-up|2|||
145526080|NCT00423670|524786807|FG004|Treatment Period|Adverse Event|9|||
145526081|NCT00423670|524786808|FG005|Treatment Period|Adverse Event|4|||
145526082|NCT00423670|524786809|FG006|Treatment Period|Adverse Event|7|||
145526083|NCT00423670|524786810|FG007|Treatment Period|Adverse Event|2|||
145526084|NCT00423670|524786803|FG000|Treatment Period|Protocol-defined clinical event|0|||
145526085|NCT00423670|524786804|FG001|Treatment Period|Protocol-defined clinical event|7|||
145526086|NCT00423670|524786805|FG002|Treatment Period|Protocol-defined clinical event|4|||
145526087|NCT00423670|524786806|FG003|Treatment Period|Protocol-defined clinical event|12|||
145526088|NCT00423670|524786807|FG004|Treatment Period|Protocol-defined clinical event|5|||
145526089|NCT00423670|524786808|FG005|Treatment Period|Protocol-defined clinical event|4|||
145526090|NCT00423670|524786809|FG006|Treatment Period|Protocol-defined clinical event|16|||
145526091|NCT00423670|524786810|FG007|Treatment Period|Protocol-defined clinical event|15|||
145526092|NCT00423670|524786803|FG000|Treatment Period|Lost to Follow-up|2|||
145526093|NCT00423670|524786804|FG001|Treatment Period|Lost to Follow-up|1|||
145526094|NCT00423670|524786805|FG002|Treatment Period|Lost to Follow-up|3|||
145526095|NCT00423670|524786806|FG003|Treatment Period|Lost to Follow-up|1|||
145526096|NCT00423670|524786807|FG004|Treatment Period|Lost to Follow-up|6|||
145526097|NCT00423670|524786808|FG005|Treatment Period|Lost to Follow-up|0|||
145526098|NCT00423670|524786809|FG006|Treatment Period|Lost to Follow-up|3|||
145526099|NCT00423670|524786810|FG007|Treatment Period|Lost to Follow-up|1|||
145526100|NCT00423670|524786803|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
145526101|NCT00423670|524786804|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
145526102|NCT00423670|524786805|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
145526103|NCT00423670|524786806|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
145526104|NCT00423670|524786807|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
145526105|NCT00423670|524786808|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
145526106|NCT00423670|524786809|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
145526107|NCT00423670|524786810|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
145526108|NCT00423670|524786803|FG000|Treatment Period|Investigator decision|0|||
145526109|NCT00423670|524786804|FG001|Treatment Period|Investigator decision|0|||
145526110|NCT00423670|524786805|FG002|Treatment Period|Investigator decision|0|||
145526111|NCT00423670|524786806|FG003|Treatment Period|Investigator decision|0|||
145526112|NCT00423670|524786807|FG004|Treatment Period|Investigator decision|0|||
145526113|NCT00423670|524786808|FG005|Treatment Period|Investigator decision|0|||
145526114|NCT00423670|524786809|FG006|Treatment Period|Investigator decision|0|||
145751139|NCT01026831|525602308|FG001|Overall Study|Lost to Follow-up|0|||
145751140|NCT01026831|525602307|FG000|Overall Study|Physician Decision|1|||
145751141|NCT01026831|525602308|FG001|Overall Study|Physician Decision|1|||
145751142|NCT01026831|525602307|FG000|Overall Study|Protocol Violation|0|||
145751143|NCT01026831|525602308|FG001|Overall Study|Protocol Violation|2|||
145751144|NCT01026831|525602307|FG000|Overall Study|Withdrawal by Subject|7|||
145751145|NCT01026831|525602308|FG001|Overall Study|Withdrawal by Subject|5|||
145751146|NCT01079182|525602309|FG000|Overall Study|Lost to Follow-up|1634|||
145751147|NCT01079182|525602309|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
145751148|NCT01079182|525602309|FG000|Overall Study|Lack of Efficacy|514|||
145751149|NCT01079182|525602309|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
145751150|NCT01079182|525602309|FG000|Overall Study|Reasons not Evaluated|271|||
145751151|NCT04417894|525602311|FG000|Overall Study|Lost to Follow-up|3|||
145751152|NCT04417894|525602312|FG001|Overall Study|Lost to Follow-up|0|||
145751153|NCT04417894|525602311|FG000|Overall Study|Withdrawal by Subject|7|||
145751154|NCT04417894|525602312|FG001|Overall Study|Withdrawal by Subject|6|||
145751155|NCT04417894|525602311|FG000|Overall Study|Lack of Efficacy|3|||
145751156|NCT04417894|525602312|FG001|Overall Study|Lack of Efficacy|1|||
145751157|NCT01508702|525602313|FG000|Overall Study|Adverse Event|7|||
145526115|NCT00423670|524786810|FG007|Treatment Period|Investigator decision|1|||
145751158|NCT01508702|525602314|FG001|Overall Study|Adverse Event|3|||
145751159|NCT01508702|525602313|FG000|Overall Study|Gout flare|2|||
145751160|NCT01508702|525602314|FG001|Overall Study|Gout flare|0|||
145751161|NCT01508702|525602313|FG000|Overall Study|Protocol Violation|2|||
145751162|NCT01508702|525602314|FG001|Overall Study|Protocol Violation|1|||
145751163|NCT01508702|525602313|FG000|Overall Study|Lost to Follow-up|1|||
145751164|NCT01508702|525602314|FG001|Overall Study|Lost to Follow-up|2|||
145751165|NCT01508702|525602313|FG000|Overall Study|Withdrawal by Subject|11|||
145751166|NCT01508702|525602314|FG001|Overall Study|Withdrawal by Subject|7|||
145751167|NCT03461757|525602315|FG000|Overall Study|Adverse Event|1|||
145751168|NCT03461757|525602316|FG001|Overall Study|Adverse Event|0|||
145751169|NCT03461757|525602315|FG000|Overall Study|Lost to Follow-up|13|||
145751170|NCT03461757|525602316|FG001|Overall Study|Lost to Follow-up|7|||
145751171|NCT03461757|525602315|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
145751172|NCT03461757|525602316|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
145751173|NCT03461757|525602315|FG000|Overall Study|Non-compliance with study treatment|0|||
145751174|NCT03461757|525602316|FG001|Overall Study|Non-compliance with study treatment|1|||
145751175|NCT03461757|525602315|FG000|Overall Study|Pregnancy|2|||
145526116|NCT00423670|524786803|FG000|Treatment Period|Non-compliance with protocol|3|||
145526117|NCT00423670|524786804|FG001|Treatment Period|Non-compliance with protocol|1|||
145526118|NCT00423670|524786805|FG002|Treatment Period|Non-compliance with protocol|1|||
145526119|NCT00423670|524786806|FG003|Treatment Period|Non-compliance with protocol|3|||
145526120|NCT00423670|524786807|FG004|Treatment Period|Non-compliance with protocol|2|||
145526121|NCT00423670|524786808|FG005|Treatment Period|Non-compliance with protocol|0|||
145526122|NCT00423670|524786809|FG006|Treatment Period|Non-compliance with protocol|2|||
145526123|NCT00423670|524786810|FG007|Treatment Period|Non-compliance with protocol|2|||
145526124|NCT00423670|524786803|FG000|Follow-up Period|Lost to Follow-up|0|||
145526125|NCT00423670|524786804|FG001|Follow-up Period|Lost to Follow-up|12|||
145526126|NCT00423670|524786805|FG002|Follow-up Period|Lost to Follow-up|8|||
145751176|NCT03461757|525602316|FG001|Overall Study|Pregnancy|0|||
145751177|NCT03461757|525602315|FG000|Overall Study|Protocol Violation|1|||
145751178|NCT03461757|525602316|FG001|Overall Study|Protocol Violation|1|||
145751179|NCT03461757|525602315|FG000|Overall Study|Withdrawal by Subject|7|||
145402657|NCT01274351|524330811|FG000|Overall Study|Pregnancy|1|||
145526127|NCT00423670|524786806|FG003|Follow-up Period|Lost to Follow-up|3|||
145526128|NCT00423670|524786807|FG004|Follow-up Period|Lost to Follow-up|1|||
145526129|NCT00423670|524786808|FG005|Follow-up Period|Lost to Follow-up|0|||
145751180|NCT03461757|525602316|FG001|Overall Study|Withdrawal by Subject|7|||
145402658|NCT01274351|524330811|FG000|Overall Study|Death|2|||
145751181|NCT03461757|525602315|FG000|Overall Study|Other Reasons|1|||
145751182|NCT03461757|525602316|FG001|Overall Study|Other Reasons|4|||
145526130|NCT00423670|524786809|FG006|Follow-up Period|Lost to Follow-up|5|||
145526131|NCT00423670|524786810|FG007|Follow-up Period|Lost to Follow-up|0|||
145526132|NCT00423670|524786803|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
145526133|NCT00423670|524786804|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
145526134|NCT00423670|524786805|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
145526135|NCT00423670|524786806|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
145526136|NCT00423670|524786807|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
145526137|NCT00423670|524786808|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
145526138|NCT00423670|524786809|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
145526139|NCT00423670|524786810|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
145526140|NCT00423670|524786803|FG000|Follow-up Period|Non-compliance with protocol|2|||
145526141|NCT00423670|524786804|FG001|Follow-up Period|Non-compliance with protocol|0|||
145526142|NCT00423670|524786805|FG002|Follow-up Period|Non-compliance with protocol|1|||
145526143|NCT00423670|524786806|FG003|Follow-up Period|Non-compliance with protocol|1|||
145526144|NCT00423670|524786807|FG004|Follow-up Period|Non-compliance with protocol|0|||
145526145|NCT00423670|524786808|FG005|Follow-up Period|Non-compliance with protocol|0|||
145526146|NCT00423670|524786809|FG006|Follow-up Period|Non-compliance with protocol|3|||
145526147|NCT00423670|524786810|FG007|Follow-up Period|Non-compliance with protocol|2|||
145526148|NCT01052844|524786819|FG000|Overall Study|Adverse Event|0|||
145526149|NCT01052844|524786820|FG001|Overall Study|Adverse Event|1|||
145526150|NCT01241240|524786821|FG000|Overall Study|Adverse Event|5|||
145526151|NCT01241240|524786822|FG001|Overall Study|Adverse Event|4|||
145526152|NCT01241240|524786821|FG000|Overall Study|Lost to Follow-up|2|||
145526153|NCT01241240|524786822|FG001|Overall Study|Lost to Follow-up|4|||
145526154|NCT01241240|524786821|FG000|Overall Study|Personal Reasons|1|||
145526155|NCT01241240|524786822|FG001|Overall Study|Personal Reasons|1|||
145526156|NCT01466595|524786823|FG000|Overall Study|Withdrawal by Subject|0|||
145526157|NCT01466595|524786824|FG001|Overall Study|Withdrawal by Subject|1|||
145526158|NCT02376829|524786827|FG000|Overall Study|Withdrawal by Subject|27|||
145526159|NCT02376829|524786828|FG001|Overall Study|Withdrawal by Subject|44|||
145526160|NCT01439347|524786829|FG000|Overall Study|Death|10|||
145526161|NCT01439347|524786830|FG001|Overall Study|Death|9|||
145526162|NCT01439347|524786829|FG000|Overall Study|Withdrawal by Subject|0|||
145526163|NCT01439347|524786830|FG001|Overall Study|Withdrawal by Subject|1|||
145526164|NCT01439347|524786829|FG000|Overall Study|Physician Decision|1|||
145526165|NCT01439347|524786830|FG001|Overall Study|Physician Decision|0|||
145526166|NCT01439347|524786829|FG000|Overall Study|Sponsor Terminated Study|2|||
145526167|NCT01439347|524786830|FG001|Overall Study|Sponsor Terminated Study|3|||
145526168|NCT00542451|524786831|FG000|Overall Study|Adverse Event|31|||
145526169|NCT00542451|524786831|FG000|Overall Study|Withdrawal by Subject|30|||
145526170|NCT00542451|524786831|FG000|Overall Study|Physician Decision|4|||
145526171|NCT00542451|524786831|FG000|Overall Study|Recurrent disease|1|||
145526172|NCT00542451|524786831|FG000|Overall Study|unknown reason|1|||
145526173|NCT00542451|524786831|FG000|Overall Study|Death|2|||
145526174|NCT00542451|524786831|FG000|Overall Study|Lost to Follow-up|10|||
145526175|NCT01309893|524786833|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
145526176|NCT01309893|524786834|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
145526177|NCT01309893|524786833|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
145526178|NCT01309893|524786834|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
145526179|NCT01369485|524786835|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
145526180|NCT01369485|524786836|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
145526181|NCT01369485|524786835|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
145751183|NCT02425826|525602317|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
145751184|NCT02425826|525602318|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
145751185|NCT02425826|525602319|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
145751186|NCT02425826|525602317|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
145751187|NCT02425826|525602318|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
145751188|NCT02425826|525602319|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
145751189|NCT02425826|525602317|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
145526182|NCT01369485|524786836|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
145526183|NCT01369485|524786835|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
145526184|NCT01369485|524786836|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
145751190|NCT02425826|525602318|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
145526185|NCT01369485|524786835|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
145526186|NCT01369485|524786836|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
145526187|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
145526188|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
145751191|NCT02425826|525602319|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
145751192|NCT02425826|525602317|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
145751193|NCT02425826|525602318|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
145751194|NCT02425826|525602319|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
145751195|NCT02425826|525602317|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
145751196|NCT02425826|525602318|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
145751197|NCT02425826|525602319|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
145751198|NCT02425826|525602317|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
145751199|NCT02425826|525602318|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
145751200|NCT02425826|525602319|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
145751201|NCT02425826|525602317|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
145751202|NCT02425826|525602318|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
145402659|NCT01274351|524330811|FG000|Overall Study|Withdrawal by Subject|3|||
145402660|NCT01274351|524330811|FG000|Overall Study|Adverse Event|8|||
145526189|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
145751203|NCT02425826|525602319|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
145751204|NCT02425826|525602317|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
145402661|NCT01274351|524330811|FG000|Overall Study|progression of disease|3|||
145751205|NCT02425826|525602318|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
145402662|NCT01274351|524330811|FG000|Overall Study|hospitalization|1|||
145526190|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
145526191|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
145526192|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
145526193|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
145526194|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
145526195|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
145526196|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
145526197|NCT01369485|524786835|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
145526198|NCT01369485|524786836|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
145526199|NCT00873860|524786837|FG000|Overall Study|Lost to Follow-up|1|||
145526200|NCT00873860|524786838|FG001|Overall Study|Lost to Follow-up|0|||
145526201|NCT00873860|524786839|FG002|Overall Study|Lost to Follow-up|0|||
145526202|NCT00873860|524786840|FG003|Overall Study|Lost to Follow-up|1|||
145526203|NCT00873860|524786837|FG000|Overall Study|Withdrawal by Subject|1|||
145526204|NCT00873860|524786838|FG001|Overall Study|Withdrawal by Subject|0|||
145526205|NCT00873860|524786839|FG002|Overall Study|Withdrawal by Subject|2|||
145751206|NCT02425826|525602319|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
145751207|NCT02425826|525602317|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
145751208|NCT02425826|525602318|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
145751209|NCT02425826|525602319|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
145526206|NCT00873860|524786840|FG003|Overall Study|Withdrawal by Subject|0|||
145526207|NCT00873860|524786837|FG000|Overall Study|Death|1|||
145526208|NCT00873860|524786838|FG001|Overall Study|Death|0|||
145526209|NCT00873860|524786839|FG002|Overall Study|Death|0|||
145526210|NCT00873860|524786840|FG003|Overall Study|Death|0|||
145526211|NCT00873860|524786837|FG000|Overall Study|Other|1|||
145526212|NCT00873860|524786838|FG001|Overall Study|Other|0|||
145526213|NCT00873860|524786839|FG002|Overall Study|Other|1|||
145526214|NCT00873860|524786840|FG003|Overall Study|Other|0|||
145526215|NCT00704808|524786844|FG000|Overall Study|Discontinued prior to starting treatment|14|||
145526216|NCT00704808|524786844|FG000|Overall Study|Death|7|||
145526217|NCT00704808|524786844|FG000|Overall Study|Tumor progression|80|||
145526218|NCT00704808|524786844|FG000|Overall Study|Patient's decision|11|||
145526219|NCT00704808|524786844|FG000|Overall Study|Early therapy discontinuation|16|||
145526220|NCT00704808|524786844|FG000|Overall Study|Adverse Event|1|||
145526221|NCT00704808|524786844|FG000|Overall Study|Lost to Follow-up|1|||
145526222|NCT00704808|524786844|FG000|Overall Study|Treatment change|1|||
145526223|NCT05308290|524786850|FG000|Overall Study|Death|1|||
145526224|NCT05308290|524786851|FG001|Overall Study|Death|0|||
145526225|NCT05308290|524786850|FG000|Overall Study|Lost to Follow-up|2|||
145526226|NCT05308290|524786851|FG001|Overall Study|Lost to Follow-up|1|||
145526227|NCT05308290|524786850|FG000|Overall Study|still in study followup|0|||
145526228|NCT05308290|524786851|FG001|Overall Study|still in study followup|1|||
145526229|NCT01017575|524786855|FG000|Overall Study|Lack of Efficacy|0|||
145526230|NCT01017575|524786856|FG001|Overall Study|Lack of Efficacy|1|||
145526231|NCT01017575|524786857|FG002|Overall Study|Lack of Efficacy|0|||
145526232|NCT01017575|524786858|FG003|Overall Study|Lack of Efficacy|1|||
145526233|NCT01017575|524786859|FG004|Overall Study|Lack of Efficacy|1|||
145526234|NCT01017575|524786855|FG000|Overall Study|Adverse Event|0|||
145526235|NCT01017575|524786856|FG001|Overall Study|Adverse Event|1|||
145526236|NCT01017575|524786857|FG002|Overall Study|Adverse Event|0|||
145526237|NCT01017575|524786858|FG003|Overall Study|Adverse Event|0|||
145526238|NCT01017575|524786859|FG004|Overall Study|Adverse Event|2|||
145526239|NCT01017575|524786855|FG000|Overall Study|Withdrawal by Subject|1|||
145751210|NCT02425826|525602317|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
145751211|NCT02425826|525602318|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
145751212|NCT02425826|525602319|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
145526240|NCT01017575|524786856|FG001|Overall Study|Withdrawal by Subject|0|||
145526241|NCT01017575|524786857|FG002|Overall Study|Withdrawal by Subject|0|||
145526242|NCT01017575|524786858|FG003|Overall Study|Withdrawal by Subject|0|||
145526243|NCT01017575|524786859|FG004|Overall Study|Withdrawal by Subject|0|||
145526244|NCT03500679|524786866|FG000|Overall Study|Lost to Follow-up|6|||
145526245|NCT03500679|524786867|FG001|Overall Study|Lost to Follow-up|3|||
145526246|NCT03500679|524786866|FG000|Overall Study|Withdrawal by Subject|3|||
145526247|NCT03500679|524786867|FG001|Overall Study|Withdrawal by Subject|0|||
145526248|NCT00095628|524786868|FG000|Overall Study|Disease progression prior to treatment|1|||
145526249|NCT00744471|524786872|FG000|Overall Study|Randomized but not treated|1|||
145526250|NCT00744471|524786873|FG001|Overall Study|Randomized but not treated|1|||
145526251|NCT00744471|524786874|FG002|Overall Study|Randomized but not treated|4|||
145751213|NCT01344876|525602321|FG000|Overall Study|Adverse Event|0|||
145526252|NCT00744471|524786875|FG003|Overall Study|Randomized but not treated|0|||
145526253|NCT00744471|524786872|FG000|Overall Study|Death|0|||
145526254|NCT00744471|524786873|FG001|Overall Study|Death|0|||
145526255|NCT00744471|524786874|FG002|Overall Study|Death|0|||
145526256|NCT00744471|524786875|FG003|Overall Study|Death|1|||
145751214|NCT01344876|525602322|FG001|Overall Study|Adverse Event|0|||
145751215|NCT01344876|525602323|FG002|Overall Study|Adverse Event|0|||
145751216|NCT01344876|525602324|FG003|Overall Study|Adverse Event|0|||
145751217|NCT01344876|525602325|FG004|Overall Study|Adverse Event|1|||
145751218|NCT01344876|525602321|FG000|Overall Study|Withdrawal by Subject|0|||
145751219|NCT01344876|525602322|FG001|Overall Study|Withdrawal by Subject|0|||
145526257|NCT00744471|524786872|FG000|Overall Study|Adverse Event|6|||
145526258|NCT00744471|524786873|FG001|Overall Study|Adverse Event|7|||
145526259|NCT00744471|524786874|FG002|Overall Study|Adverse Event|5|||
145526260|NCT00744471|524786875|FG003|Overall Study|Adverse Event|9|||
145526261|NCT00744471|524786872|FG000|Overall Study|Withdrawal by Subject|9|||
145526262|NCT00744471|524786873|FG001|Overall Study|Withdrawal by Subject|9|||
145526263|NCT00744471|524786874|FG002|Overall Study|Withdrawal by Subject|15|||
145526264|NCT00744471|524786875|FG003|Overall Study|Withdrawal by Subject|12|||
145526265|NCT00744471|524786872|FG000|Overall Study|Protocol Violation|1|||
145526266|NCT00744471|524786873|FG001|Overall Study|Protocol Violation|4|||
145526267|NCT00744471|524786874|FG002|Overall Study|Protocol Violation|1|||
145526268|NCT00744471|524786875|FG003|Overall Study|Protocol Violation|2|||
145526269|NCT00744471|524786872|FG000|Overall Study|Entered extension study|41|||
145526270|NCT00744471|524786873|FG001|Overall Study|Entered extension study|84|||
145526271|NCT00744471|524786874|FG002|Overall Study|Entered extension study|100|||
145526272|NCT00744471|524786875|FG003|Overall Study|Entered extension study|91|||
145526273|NCT00744471|524786872|FG000|Overall Study|Other|2|||
145526274|NCT00744471|524786873|FG001|Overall Study|Other|3|||
145526275|NCT00744471|524786874|FG002|Overall Study|Other|6|||
145526276|NCT00744471|524786875|FG003|Overall Study|Other|2|||
145526277|NCT00744471|524786872|FG000|Overall Study|Lack of Efficacy|83|||
145526278|NCT00744471|524786873|FG001|Overall Study|Lack of Efficacy|37|||
145526279|NCT00744471|524786874|FG002|Overall Study|Lack of Efficacy|19|||
145526280|NCT00744471|524786875|FG003|Overall Study|Lack of Efficacy|31|||
145526281|NCT00744471|524786872|FG000|Overall Study|Lost to Follow-up|0|||
145526282|NCT00744471|524786873|FG001|Overall Study|Lost to Follow-up|0|||
145526283|NCT00744471|524786874|FG002|Overall Study|Lost to Follow-up|2|||
145751220|NCT01344876|525602323|FG002|Overall Study|Withdrawal by Subject|1|||
145751221|NCT01344876|525602324|FG003|Overall Study|Withdrawal by Subject|0|||
145526284|NCT00744471|524786875|FG003|Overall Study|Lost to Follow-up|0|||
145526285|NCT03224546|524786876|FG000|Overall Study|Lost to Follow-up|9|||
145526286|NCT03224546|524786877|FG001|Overall Study|Lost to Follow-up|8|||
145526287|NCT03224546|524786878|FG002|Overall Study|Lost to Follow-up|3|||
145526288|NCT03224546|524786876|FG000|Overall Study|Withdrawal by Subject|7|||
145526289|NCT03224546|524786877|FG001|Overall Study|Withdrawal by Subject|14|||
145526290|NCT03224546|524786878|FG002|Overall Study|Withdrawal by Subject|12|||
145526291|NCT04706416|524786879|FG000|Overall Study|Lost to Follow-up|2|||
145271286|NCT01977482|523839695|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
145271287|NCT01977482|523839690|FG000|Overall Study|Withdrawal by Subject|2|||
145271288|NCT01977482|523839691|FG001|Overall Study|Withdrawal by Subject|4|||
145751222|NCT01344876|525602325|FG004|Overall Study|Withdrawal by Subject|0|||
145751223|NCT01344876|525602321|FG000|Overall Study|Definite progression of primary disease|1|||
145751224|NCT01344876|525602322|FG001|Overall Study|Definite progression of primary disease|0|||
145751225|NCT01344876|525602323|FG002|Overall Study|Definite progression of primary disease|0|||
145271289|NCT01977482|523839692|FG002|Overall Study|Withdrawal by Subject|1|||
145271290|NCT01977482|523839693|FG003|Overall Study|Withdrawal by Subject|3|||
145271291|NCT01977482|523839694|FG004|Overall Study|Withdrawal by Subject|1|||
145271292|NCT01977482|523839695|FG005|Overall Study|Withdrawal by Subject|5|||
145271293|NCT00209560|523839696|FG000|Overall Study|Lack of Efficacy|1|||
145271294|NCT00209560|523839697|FG001|Overall Study|Lack of Efficacy|0|||
145751226|NCT01344876|525602324|FG003|Overall Study|Definite progression of primary disease|3|||
145271295|NCT03222856|523839700|FG000|Overall Study|Adverse Event|6|||
145271296|NCT03222856|523839700|FG000|Overall Study|Death|1|||
145271297|NCT01721369|523839701|FG000|Overall Study|Not initial etiological diagnosis|12|||
145271298|NCT01325701|523840849|FG000|Overall Study|Adverse Event|12|||
145271299|NCT01325701|523840850|FG001|Overall Study|Adverse Event|0|||
145751227|NCT01344876|525602325|FG004|Overall Study|Definite progression of primary disease|0|||
145526292|NCT04706416|524786880|FG001|Overall Study|Lost to Follow-up|0|||
145526293|NCT00976573|524786884|FG000|Overall Study|Ineligible|0|||
145526294|NCT00976573|524786885|FG001|Overall Study|Ineligible|1|||
145526295|NCT00976573|524786884|FG000|Overall Study|Cancel prior to receiving treatment|4|||
145526296|NCT00976573|524786885|FG001|Overall Study|Cancel prior to receiving treatment|2|||
145751228|NCT04428424|525602326|FG000|Overall Study|Does not meet entrance criteria|132|||
145751229|NCT04428424|525602326|FG000|Overall Study|Lost to Follow-up|115|||
145751230|NCT05107765|525602327|FG000|Overall Study|Lost to Follow-up|4|||
145751231|NCT05107765|525602328|FG001|Overall Study|Lost to Follow-up|1|||
145751232|NCT05107765|525602327|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
145751233|NCT05107765|525602328|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
145751234|NCT05107765|525602327|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
145751235|NCT05107765|525602328|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
145751236|NCT02049944|525603911|FG000|Overall Study|Protocol Violation|2|||
145751237|NCT01765673|525603912|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
145751238|NCT01284114|525603913|FG000|Overall Study|viral infection|1|||
145526297|NCT02117427|524786886|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
145526298|NCT02117427|524786887|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
145526299|NCT02117427|524786888|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
145526300|NCT02117427|524786886|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
145526301|NCT02117427|524786887|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
145526302|NCT02117427|524786888|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
145526303|NCT02117427|524786886|FG000|Overall Study|Physician Decision|0|||
145526304|NCT02117427|524786887|FG001|Overall Study|Physician Decision|2|||
145526305|NCT02117427|524786888|FG002|Overall Study|Physician Decision|0|||
145526306|NCT02117427|524786886|FG000|Overall Study|No longer meets inclusion criteria|0|||
145526307|NCT02117427|524786887|FG001|Overall Study|No longer meets inclusion criteria|1|||
145526308|NCT02117427|524786888|FG002|Overall Study|No longer meets inclusion criteria|0|||
145751239|NCT01284114|525603913|FG000|Overall Study|From the results of ALLTITUDE study|1|||
145751240|NCT01284114|525603913|FG000|Overall Study|Symptomatic hypotension|1|||
145751241|NCT01284114|525603913|FG000|Overall Study|dizziness|1|||
145751242|NCT04872101|525603914|FG000|Overall Study|Withdrawal by Subject|10|||
145751243|NCT04872101|525603915|FG001|Overall Study|Withdrawal by Subject|16|||
145751244|NCT04872101|525603914|FG000|Overall Study|Lack of Efficacy|6|||
145751245|NCT04872101|525603915|FG001|Overall Study|Lack of Efficacy|14|||
145271300|NCT01325701|523840849|FG000|Overall Study|Protocol Violation|1|||
145271301|NCT01325701|523840850|FG001|Overall Study|Protocol Violation|0|||
145271302|NCT01325701|523840849|FG000|Overall Study|Physician Decision|2|||
145271303|NCT01325701|523840850|FG001|Overall Study|Physician Decision|2|||
145526309|NCT02117427|524786886|FG000|Overall Study|Death|0|||
145526310|NCT02117427|524786887|FG001|Overall Study|Death|1|||
145526311|NCT02117427|524786888|FG002|Overall Study|Death|0|||
145751246|NCT04872101|525603914|FG000|Overall Study|Adverse Event|1|||
145751247|NCT04872101|525603915|FG001|Overall Study|Adverse Event|6|||
145271304|NCT01325701|523840849|FG000|Overall Study|Withdrawal by Subject|2|||
145526312|NCT02730208|524786889|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
145526313|NCT02730208|524786890|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
145526314|NCT00995865|524786891|FG000|Overall Study|Protocol Violation|2|||
145526315|NCT00995865|524786892|FG001|Overall Study|Protocol Violation|0|||
145526316|NCT00995865|524786893|FG002|Overall Study|Protocol Violation|0|||
145271305|NCT01325701|523840850|FG001|Overall Study|Withdrawal by Subject|1|||
145751248|NCT04872101|525603914|FG000|Overall Study|Lost to Follow-up|2|||
145751249|NCT04872101|525603915|FG001|Overall Study|Lost to Follow-up|1|||
145751250|NCT04872101|525603914|FG000|Overall Study|Pregnancy|2|||
145751251|NCT04872101|525603915|FG001|Overall Study|Pregnancy|0|||
145751252|NCT04872101|525603914|FG000|Overall Study|Prohibited Medication|1|||
145751253|NCT04872101|525603915|FG001|Overall Study|Prohibited Medication|0|||
145751254|NCT04872101|525603914|FG000|Overall Study|Not dosed|1|||
145751255|NCT04872101|525603915|FG001|Overall Study|Not dosed|0|||
145751256|NCT03691974|525603916|FG000|Overall Study|Physician Decision|1|||
145751257|NCT03691974|525603917|FG001|Overall Study|Physician Decision|0|||
145751258|NCT03691974|525603916|FG000|Overall Study|Adverse Event|1|||
145751259|NCT03691974|525603917|FG001|Overall Study|Adverse Event|0|||
145751260|NCT03691974|525603916|FG000|Overall Study|Withdrawal by Subject|11|||
145751261|NCT03691974|525603917|FG001|Overall Study|Withdrawal by Subject|9|||
145751262|NCT03691974|525603916|FG000|Overall Study|Protocol Violation|1|||
145751263|NCT03691974|525603917|FG001|Overall Study|Protocol Violation|0|||
145751264|NCT03691974|525603916|FG000|Overall Study|Lost to Follow-up|8|||
145751265|NCT03691974|525603917|FG001|Overall Study|Lost to Follow-up|7|||
145751266|NCT00691483|525603918|FG000|Overall Study|Adverse Event|14|||
145751267|NCT00691483|525603919|FG001|Overall Study|Adverse Event|6|||
145751268|NCT00691483|525603918|FG000|Overall Study|Lost to Follow-up|17|||
145751269|NCT00691483|525603919|FG001|Overall Study|Lost to Follow-up|10|||
145751270|NCT00691483|525603918|FG000|Overall Study|Withdrawal by Subject|24|||
145751271|NCT00691483|525603919|FG001|Overall Study|Withdrawal by Subject|7|||
145751272|NCT00691483|525603918|FG000|Overall Study|Other known cause|6|||
145751273|NCT00691483|525603919|FG001|Overall Study|Other known cause|1|||
145751274|NCT00691483|525603918|FG000|Overall Study|Randomized by not treated|7|||
145751275|NCT00691483|525603919|FG001|Overall Study|Randomized by not treated|1|||
145751276|NCT03860961|525603921|FG000|Overall Study|Withdrawal by Subject|6|||
145751277|NCT03860961|525603922|FG001|Overall Study|Withdrawal by Subject|11|||
145751278|NCT03860961|525603921|FG000|Overall Study|Death|10|||
145751279|NCT03860961|525603922|FG001|Overall Study|Death|6|||
145751280|NCT03860961|525603921|FG000|Overall Study|Incomplete two-year data|4|||
145526317|NCT00995865|524786891|FG000|Overall Study|Lost to Follow-up|0|||
145526318|NCT00995865|524786892|FG001|Overall Study|Lost to Follow-up|0|||
145526319|NCT00995865|524786893|FG002|Overall Study|Lost to Follow-up|1|||
145526320|NCT00410202|524786895|FG000|On-Treatment|Continuing treatment|69|||
145526321|NCT00410202|524786896|FG001|On-Treatment|Continuing treatment|71|||
145526322|NCT00410202|524786897|FG002|On-Treatment|Continuing treatment|66|||
145526323|NCT00410202|524786895|FG000|On-Treatment|Adverse Event|1|||
145526324|NCT00410202|524786896|FG001|On-Treatment|Adverse Event|3|||
145526325|NCT00410202|524786897|FG002|On-Treatment|Adverse Event|2|||
145526326|NCT00410202|524786895|FG000|On-Treatment|Death|1|||
145526327|NCT00410202|524786896|FG001|On-Treatment|Death|0|||
145751281|NCT03860961|525603922|FG001|Overall Study|Incomplete two-year data|0|||
145751282|NCT02475681|525603923|FG000|Overall Study|Death|16|||
145751283|NCT02475681|525603924|FG001|Overall Study|Death|6|||
145526328|NCT00410202|524786897|FG002|On-Treatment|Death|0|||
145526329|NCT00410202|524786895|FG000|On-Treatment|Lost to Follow-up|1|||
145526330|NCT00410202|524786896|FG001|On-Treatment|Lost to Follow-up|0|||
145751284|NCT02475681|525603925|FG002|Overall Study|Death|9|||
145751285|NCT02475681|525603923|FG000|Overall Study|Physician Decision|0|||
145751286|NCT02475681|525603924|FG001|Overall Study|Physician Decision|3|||
145526331|NCT00410202|524786897|FG002|On-Treatment|Lost to Follow-up|1|||
145751287|NCT02475681|525603925|FG002|Overall Study|Physician Decision|1|||
145751288|NCT02475681|525603923|FG000|Overall Study|Withdrawal by Subject|12|||
145751289|NCT02475681|525603924|FG001|Overall Study|Withdrawal by Subject|6|||
145402663|NCT01296412|524330814|FG000|Overall Study|Adverse Event|8|||
145526332|NCT00410202|524786895|FG000|On-Treatment|Lack of Efficacy|1|||
145751290|NCT02475681|525603925|FG002|Overall Study|Withdrawal by Subject|9|||
145751291|NCT02475681|525603923|FG000|Overall Study|Lost to Follow-up|2|||
145751292|NCT02475681|525603924|FG001|Overall Study|Lost to Follow-up|1|||
145751293|NCT02475681|525603925|FG002|Overall Study|Lost to Follow-up|3|||
145751294|NCT02475681|525603923|FG000|Overall Study|Ongoing in Study|0|||
145751295|NCT02475681|525603924|FG001|Overall Study|Ongoing in Study|163|||
145526333|NCT00410202|524786896|FG001|On-Treatment|Lack of Efficacy|4|||
145526334|NCT00410202|524786897|FG002|On-Treatment|Lack of Efficacy|0|||
145526335|NCT00410202|524786895|FG000|On-Treatment|Withdrawal by Subject|2|||
145526336|NCT00410202|524786896|FG001|On-Treatment|Withdrawal by Subject|1|||
145526337|NCT00410202|524786897|FG002|On-Treatment|Withdrawal by Subject|1|||
145526338|NCT00410202|524786895|FG000|On-Treatment|Other Reason|0|||
145526339|NCT00410202|524786896|FG001|On-Treatment|Other Reason|0|||
145526340|NCT00410202|524786897|FG002|On-Treatment|Other Reason|1|||
145526341|NCT00410202|524786895|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
145526342|NCT00410202|524786896|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
145526343|NCT00410202|524786897|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
145526344|NCT00410202|524786895|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
145526345|NCT00410202|524786896|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
145526346|NCT00410202|524786897|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
145526347|NCT00410202|524786895|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
145526348|NCT00410202|524786896|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
145526349|NCT00410202|524786897|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
145526350|NCT00144027|524786898|FG000|Overall Study|Lost to Follow-up|1|||
145526351|NCT00144027|524786899|FG001|Overall Study|Lost to Follow-up|3|||
145526352|NCT00144027|524786898|FG000|Overall Study|Withdrawal by Subject|2|||
145526353|NCT00144027|524786899|FG001|Overall Study|Withdrawal by Subject|2|||
145526354|NCT00144027|524786898|FG000|Overall Study|did not complete baseline assessment|0|||
145526355|NCT00144027|524786899|FG001|Overall Study|did not complete baseline assessment|6|||
145751296|NCT02475681|525603925|FG002|Overall Study|Ongoing in Study|157|||
145751297|NCT02475681|525603923|FG000|Overall Study|Reasons other than above listed|2|||
145751298|NCT02475681|525603924|FG001|Overall Study|Reasons other than above listed|0|||
145526356|NCT05080660|524786900|FG000|Overall Study|Adverse Event|4|||
145526357|NCT05080660|524786901|FG001|Overall Study|Adverse Event|0|||
145526358|NCT05080660|524786900|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
145526359|NCT05080660|524786901|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
145526360|NCT05080660|524786900|FG000|Overall Study|Physician Decision|1|||
145526361|NCT05080660|524786901|FG001|Overall Study|Physician Decision|0|||
145526362|NCT05080660|524786900|FG000|Overall Study|Protocol Deviation|2|||
145526363|NCT05080660|524786901|FG001|Overall Study|Protocol Deviation|0|||
145526364|NCT05080660|524786900|FG000|Overall Study|Withdrawal by Subject|5|||
145526365|NCT05080660|524786901|FG001|Overall Study|Withdrawal by Subject|2|||
145526366|NCT02021656|524786921|FG000|Overall Study|Adverse Event|1|||
145526367|NCT02021656|524786921|FG000|Overall Study|Lack of Efficacy|2|||
145526368|NCT02021656|524786921|FG000|Overall Study|Lost to Follow-up|1|||
145751299|NCT02475681|525603925|FG002|Overall Study|Reasons other than above listed|0|||
145271306|NCT01325701|523840849|FG000|Overall Study|Rollerover Extension Study|4|||
145526369|NCT02021656|524786921|FG000|Overall Study|Withdrew Consent|2|||
145271307|NCT01325701|523840850|FG001|Overall Study|Rollerover Extension Study|0|||
145271308|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
145271309|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
145271310|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
145271311|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
145271312|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
145271313|NCT01179191|523840861|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
145271314|NCT01179191|523840861|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
145271315|NCT01179191|523840861|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
145271316|NCT01179191|523840861|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
145271317|NCT01179191|523840861|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
145271318|NCT01179191|523840861|FG000|Maintenance Phase (8 Weeks)|Other|66|||
145271319|NCT00572910|523840862|FG000|Overall Study|Adverse Event|1|||
145271320|NCT00572910|523840863|FG001|Overall Study|Adverse Event|2|||
145271321|NCT00572910|523840864|FG002|Overall Study|Adverse Event|0|||
145271322|NCT00572910|523840865|FG003|Overall Study|Adverse Event|2|||
145526370|NCT00510952|524786924|FG000|Overall Study|Adverse Event|1|||
145526371|NCT00510952|524786925|FG001|Overall Study|Adverse Event|0|||
145526372|NCT00510952|524786924|FG000|Overall Study|Entry Criteria Not Met|3|||
145751300|NCT02105454|525603936|FG000|Overall Study|Withdrawal by Subject|1|||
145751301|NCT00493870|525603937|FG000|Overall Study|Lost to Follow-up|12|||
145751302|NCT00493870|525603938|FG001|Overall Study|Lost to Follow-up|15|||
145751303|NCT02721355|525603939|FG000|Overall Study|Lost to Follow-up|6|||
145751304|NCT02721355|525603940|FG001|Overall Study|Lost to Follow-up|1|||
145271323|NCT00572910|523840866|FG004|Overall Study|Adverse Event|0|||
145271324|NCT00572910|523840867|FG005|Overall Study|Adverse Event|0|||
145271325|NCT00572910|523840868|FG006|Overall Study|Adverse Event|4|||
145271326|NCT00572910|523840869|FG007|Overall Study|Adverse Event|2|||
145271327|NCT00572910|523840870|FG008|Overall Study|Adverse Event|1|||
145271328|NCT00572910|523840871|FG009|Overall Study|Adverse Event|3|||
145271329|NCT00572910|523840872|FG010|Overall Study|Adverse Event|2|||
145271330|NCT00572910|523840862|FG000|Overall Study|Lost to Follow-up|0|||
145271331|NCT00572910|523840863|FG001|Overall Study|Lost to Follow-up|1|||
145271332|NCT00572910|523840864|FG002|Overall Study|Lost to Follow-up|1|||
145271333|NCT00572910|523840865|FG003|Overall Study|Lost to Follow-up|2|||
145271334|NCT00572910|523840866|FG004|Overall Study|Lost to Follow-up|1|||
145271335|NCT00572910|523840867|FG005|Overall Study|Lost to Follow-up|0|||
145271336|NCT00572910|523840868|FG006|Overall Study|Lost to Follow-up|0|||
145271337|NCT00572910|523840869|FG007|Overall Study|Lost to Follow-up|0|||
145271338|NCT00572910|523840870|FG008|Overall Study|Lost to Follow-up|0|||
145271339|NCT00572910|523840871|FG009|Overall Study|Lost to Follow-up|1|||
145271340|NCT00572910|523840872|FG010|Overall Study|Lost to Follow-up|0|||
145271341|NCT00572910|523840862|FG000|Overall Study|Withdrawal by Subject|3|||
145271342|NCT00572910|523840863|FG001|Overall Study|Withdrawal by Subject|0|||
145271343|NCT00572910|523840864|FG002|Overall Study|Withdrawal by Subject|1|||
145271344|NCT00572910|523840865|FG003|Overall Study|Withdrawal by Subject|0|||
145526373|NCT00510952|524786925|FG001|Overall Study|Entry Criteria Not Met|1|||
145526374|NCT00510952|524786924|FG000|Overall Study|Lost to Follow-up|5|||
145526375|NCT00510952|524786925|FG001|Overall Study|Lost to Follow-up|3|||
145271345|NCT00572910|523840866|FG004|Overall Study|Withdrawal by Subject|1|||
145271346|NCT00572910|523840867|FG005|Overall Study|Withdrawal by Subject|3|||
145271347|NCT00572910|523840868|FG006|Overall Study|Withdrawal by Subject|0|||
145271348|NCT00572910|523840869|FG007|Overall Study|Withdrawal by Subject|2|||
145526376|NCT00510952|524786924|FG000|Overall Study|Physician Decision|1|||
145526377|NCT00510952|524786925|FG001|Overall Study|Physician Decision|1|||
145751305|NCT00883337|525603943|FG000|Core Treatment Period|Adverse Event|9|||
145526378|NCT00510952|524786924|FG000|Overall Study|Protocol Violation|7|||
145526379|NCT00510952|524786925|FG001|Overall Study|Protocol Violation|4|||
145526380|NCT00510952|524786924|FG000|Overall Study|Sponsor Decision|1|||
145526381|NCT00510952|524786925|FG001|Overall Study|Sponsor Decision|0|||
145526382|NCT00510952|524786924|FG000|Overall Study|Withdrawal by Subject|6|||
145526383|NCT00510952|524786925|FG001|Overall Study|Withdrawal by Subject|7|||
145526384|NCT00510952|524786924|FG000|Overall Study|Did Not Receive Study Drug|2|||
145526385|NCT00510952|524786925|FG001|Overall Study|Did Not Receive Study Drug|0|||
145526386|NCT02101112|524786931|FG000|Overall Study|Adverse Event|0|||
145526387|NCT02101112|524786932|FG001|Overall Study|Adverse Event|0|||
145526388|NCT02101112|524786933|FG002|Overall Study|Adverse Event|1|||
145526389|NCT02101112|524786934|FG003|Overall Study|Adverse Event|0|||
145526390|NCT02101112|524786935|FG004|Overall Study|Adverse Event|0|||
145526391|NCT02101112|524786936|FG005|Overall Study|Adverse Event|0|||
145526392|NCT02101112|524786931|FG000|Overall Study|Withdrawal by Subject|0|||
145526393|NCT02101112|524786932|FG001|Overall Study|Withdrawal by Subject|0|||
145526394|NCT02101112|524786933|FG002|Overall Study|Withdrawal by Subject|0|||
145526395|NCT02101112|524786934|FG003|Overall Study|Withdrawal by Subject|0|||
145526396|NCT02101112|524786935|FG004|Overall Study|Withdrawal by Subject|1|||
145526397|NCT02101112|524786936|FG005|Overall Study|Withdrawal by Subject|0|||
145526398|NCT00782795|524786939|FG000|Overall Study|Withdrawal by Subject|1|||
145526399|NCT00782795|524786940|FG001|Overall Study|Withdrawal by Subject|2|||
145751306|NCT00883337|525603944|FG001|Core Treatment Period|Adverse Event|12|||
145751307|NCT00883337|525603945|FG002|Core Treatment Period|Adverse Event|22|||
145526400|NCT02782923|524786941|FG000|Overall Study|Lost to Follow-up|15|||
145526401|NCT02418156|524786942|FG000|Overall Study|Lost to Follow-up|12|||
145526402|NCT02418156|524786942|FG000|Overall Study|Death|2|||
145526403|NCT02418156|524786942|FG000|Overall Study|Physician Decision|1|||
145526404|NCT02418156|524786942|FG000|Overall Study|Withdrawal by Subject|1|||
145526405|NCT02418156|524786942|FG000|Overall Study|Subject refused to return|1|||
145526406|NCT03437512|524788867|FG000|Randomized|Withdrawal by Subject|0|||
145526407|NCT03437512|524788868|FG001|Randomized|Withdrawal by Subject|2|||
145526408|NCT03437512|524788867|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
145526409|NCT03437512|524788868|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
145526410|NCT01897714|524788869|FG000|Phase I (Dose Escalation)|Disease progression|3|||
145526411|NCT01897714|524788870|FG001|Phase I (Dose Escalation)|Disease progression|5|||
145526412|NCT01897714|524788871|FG002|Phase I (Dose Escalation)|Disease progression|1|||
145526413|NCT01897714|524788872|FG003|Phase I (Dose Escalation)|Disease progression|3|||
145526414|NCT01897714|524788873|FG004|Phase I (Dose Escalation)|Disease progression|0|||
145526415|NCT01897714|524788874|FG005|Phase I (Dose Escalation)|Disease progression|0|||
145526416|NCT01897714|524788869|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
145526417|NCT01897714|524788870|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
145526418|NCT01897714|524788871|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
145271349|NCT00572910|523840870|FG008|Overall Study|Withdrawal by Subject|2|||
145526419|NCT01897714|524788872|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
145526420|NCT01897714|524788873|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
145526421|NCT01897714|524788874|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
145526422|NCT01897714|524788869|FG000|Phase I (Dose Escalation)|Other|0|||
145526423|NCT01897714|524788870|FG001|Phase I (Dose Escalation)|Other|1|||
145526424|NCT01897714|524788871|FG002|Phase I (Dose Escalation)|Other|0|||
145526425|NCT01897714|524788872|FG003|Phase I (Dose Escalation)|Other|0|||
145526426|NCT01897714|524788873|FG004|Phase I (Dose Escalation)|Other|0|||
145526427|NCT01897714|524788874|FG005|Phase I (Dose Escalation)|Other|0|||
145526428|NCT01897714|524788869|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
145751308|NCT00883337|525603943|FG000|Core Treatment Period|Lack of Efficacy|7|||
145526429|NCT01897714|524788870|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
145526430|NCT01897714|524788871|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
145271350|NCT00572910|523840871|FG009|Overall Study|Withdrawal by Subject|2|||
145271351|NCT00572910|523840872|FG010|Overall Study|Withdrawal by Subject|1|||
145271352|NCT01260194|523840873|FG000|Overall Study|Withdrawal of Consent|1|||
145271353|NCT04054011|523840874|FG000|Overall Study|COVID|3|||
145271354|NCT00592007|523840875|FG000|Overall Study|Withdrawal by Subject|1|||
145271355|NCT00592007|523840875|FG000|Overall Study|patient ineligible (out of lab range)|1|||
145271356|NCT00595127|523840876|FG000|Overall Study|Death|6|||
145271357|NCT00595127|523840876|FG000|Overall Study|Relapsed|3|||
145271358|NCT00595127|523840876|FG000|Overall Study|joined another trial|1|||
145271359|NCT01569074|523840877|FG000|Overall Study|Study stopped|6|||
145271360|NCT01569074|523840878|FG001|Overall Study|Study stopped|6|||
145271361|NCT01569074|523840879|FG002|Overall Study|Study stopped|8|||
145271362|NCT01569074|523840880|FG003|Overall Study|Study stopped|7|||
145271363|NCT01569074|523840881|FG004|Overall Study|Study stopped|7|||
145271364|NCT01569074|523840877|FG000|Overall Study|Study-specific discontinuation criteria|0|||
145271365|NCT01569074|523840878|FG001|Overall Study|Study-specific discontinuation criteria|1|||
145271366|NCT01569074|523840879|FG002|Overall Study|Study-specific discontinuation criteria|0|||
145271367|NCT01569074|523840880|FG003|Overall Study|Study-specific discontinuation criteria|0|||
145271368|NCT01569074|523840881|FG004|Overall Study|Study-specific discontinuation criteria|0|||
145271369|NCT01569074|523840877|FG000|Overall Study|Severe non-compliance to protocol|0|||
145271370|NCT01569074|523840878|FG001|Overall Study|Severe non-compliance to protocol|0|||
145271371|NCT01569074|523840879|FG002|Overall Study|Severe non-compliance to protocol|1|||
145271372|NCT01569074|523840880|FG003|Overall Study|Severe non-compliance to protocol|0|||
145271373|NCT01569074|523840881|FG004|Overall Study|Severe non-compliance to protocol|0|||
145271374|NCT01569074|523840877|FG000|Overall Study|eg change in circumstances|0|||
145271375|NCT01569074|523840878|FG001|Overall Study|eg change in circumstances|2|||
145271376|NCT01569074|523840879|FG002|Overall Study|eg change in circumstances|0|||
145271377|NCT01569074|523840880|FG003|Overall Study|eg change in circumstances|1|||
145271378|NCT01569074|523840881|FG004|Overall Study|eg change in circumstances|1|||
145271379|NCT01569074|523840877|FG000|Overall Study|Adverse Event|1|||
145271380|NCT01569074|523840878|FG001|Overall Study|Adverse Event|0|||
145271381|NCT01569074|523840879|FG002|Overall Study|Adverse Event|3|||
145271382|NCT01569074|523840880|FG003|Overall Study|Adverse Event|0|||
145271383|NCT01569074|523840881|FG004|Overall Study|Adverse Event|0|||
145271384|NCT01036594|523840884|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
145526431|NCT01897714|524788872|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
145526432|NCT01897714|524788873|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
145526433|NCT01897714|524788874|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
145526434|NCT01897714|524788869|FG000|Phase II (MTD)|Lost to Follow-up|0|||
145271385|NCT01036594|523840885|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
145271386|NCT01036594|523840884|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
145271387|NCT01036594|523840885|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
145271388|NCT01036594|523840884|FG000|Week 12 Evaluation|Adverse Event|5|||
145271389|NCT01036594|523840885|FG001|Week 12 Evaluation|Adverse Event|0|||
145271390|NCT01036594|523840884|FG000|Week 12 Evaluation|Physician Decision|1|||
145271391|NCT01036594|523840885|FG001|Week 12 Evaluation|Physician Decision|0|||
145271392|NCT01036594|523840884|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
145271393|NCT01036594|523840885|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
145526435|NCT01897714|524788870|FG001|Phase II (MTD)|Lost to Follow-up|0|||
145526436|NCT01897714|524788871|FG002|Phase II (MTD)|Lost to Follow-up|0|||
145526437|NCT01897714|524788872|FG003|Phase II (MTD)|Lost to Follow-up|0|||
145526438|NCT01897714|524788873|FG004|Phase II (MTD)|Lost to Follow-up|1|||
145526439|NCT01897714|524788874|FG005|Phase II (MTD)|Lost to Follow-up|0|||
145526440|NCT01897714|524788869|FG000|Phase II (MTD)|Death|0|||
145526441|NCT01897714|524788870|FG001|Phase II (MTD)|Death|0|||
145526442|NCT01897714|524788871|FG002|Phase II (MTD)|Death|0|||
145526443|NCT01897714|524788872|FG003|Phase II (MTD)|Death|0|||
145526444|NCT01897714|524788873|FG004|Phase II (MTD)|Death|25|||
145526445|NCT01897714|524788874|FG005|Phase II (MTD)|Death|10|||
145526446|NCT01897714|524788869|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
145526447|NCT01897714|524788870|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
145526448|NCT01897714|524788871|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
145526449|NCT01897714|524788872|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
145526450|NCT01897714|524788873|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
145526451|NCT01897714|524788874|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
145751309|NCT00883337|525603944|FG001|Core Treatment Period|Lack of Efficacy|4|||
145526452|NCT01897714|524788869|FG000|Phase II (MTD)|Other|0|||
145526453|NCT01897714|524788870|FG001|Phase II (MTD)|Other|0|||
145751310|NCT00883337|525603945|FG002|Core Treatment Period|Lack of Efficacy|2|||
145751311|NCT00883337|525603943|FG000|Core Treatment Period|Lost to Follow-up|1|||
145751312|NCT00883337|525603944|FG001|Core Treatment Period|Lost to Follow-up|1|||
145751313|NCT00883337|525603945|FG002|Core Treatment Period|Lost to Follow-up|0|||
145751314|NCT00883337|525603943|FG000|Core Treatment Period|Withdrawal by Subject|2|||
145751315|NCT00883337|525603944|FG001|Core Treatment Period|Withdrawal by Subject|2|||
145751316|NCT00883337|525603945|FG002|Core Treatment Period|Withdrawal by Subject|6|||
145751317|NCT00883337|525603943|FG000|Core Treatment Period|Wish to be pregnant|1|||
145751318|NCT00883337|525603944|FG001|Core Treatment Period|Wish to be pregnant|2|||
145751319|NCT00883337|525603945|FG002|Core Treatment Period|Wish to be pregnant|1|||
145751320|NCT00883337|525603943|FG000|Core Treatment Period|Poor compliance to protocol|0|||
145751321|NCT00883337|525603944|FG001|Core Treatment Period|Poor compliance to protocol|0|||
145751322|NCT00883337|525603945|FG002|Core Treatment Period|Poor compliance to protocol|1|||
145751323|NCT00883337|525603943|FG000|Core Treatment Period|Other than above|0|||
145751324|NCT00883337|525603944|FG001|Core Treatment Period|Other than above|1|||
145751325|NCT00883337|525603945|FG002|Core Treatment Period|Other than above|1|||
145526454|NCT01897714|524788871|FG002|Phase II (MTD)|Other|0|||
145526455|NCT01897714|524788872|FG003|Phase II (MTD)|Other|0|||
145526456|NCT01897714|524788873|FG004|Phase II (MTD)|Other|3|||
145526457|NCT01897714|524788874|FG005|Phase II (MTD)|Other|0|||
145526458|NCT01994590|524788875|FG000|Overall Study|Adverse Event|1|||
145526459|NCT01994590|524788875|FG000|Overall Study|Trial Terminated|1|||
145526460|NCT01801072|524788876|FG000|Overall Study|Lost to Follow-up|17|||
145526461|NCT01801072|524788877|FG001|Overall Study|Lost to Follow-up|14|||
145526462|NCT01801072|524788876|FG000|Overall Study|Physician Decision|2|||
145751326|NCT00883337|525603943|FG000|Extension Treatment Period|Adverse Event|8|||
145751327|NCT00883337|525603944|FG001|Extension Treatment Period|Adverse Event|5|||
145402664|NCT01296412|524330815|FG001|Overall Study|Adverse Event|29|||
145526463|NCT01801072|524788877|FG001|Overall Study|Physician Decision|3|||
145526464|NCT01801072|524788876|FG000|Overall Study|Withdrawal by Subject|1|||
145526465|NCT01801072|524788877|FG001|Overall Study|Withdrawal by Subject|0|||
145526466|NCT01801072|524788876|FG000|Overall Study|Protocol Violation|2|||
145526467|NCT01801072|524788877|FG001|Overall Study|Protocol Violation|0|||
145526468|NCT01801072|524788876|FG000|Overall Study|Death|7|||
145526469|NCT01801072|524788877|FG001|Overall Study|Death|8|||
145526470|NCT03693170|524788878|FG000|Overall Study|Disease Progression|48|||
145526471|NCT03693170|524788878|FG000|Overall Study|Adverse Event|16|||
145526472|NCT03693170|524788878|FG000|Overall Study|Physician Decision|6|||
145526473|NCT03693170|524788878|FG000|Overall Study|Protocol Violation|2|||
145526474|NCT03693170|524788878|FG000|Overall Study|Death|1|||
145526475|NCT03693170|524788878|FG000|Overall Study|Non compliance with study drug|1|||
145526476|NCT03693170|524788878|FG000|Overall Study|Withdrawal by Subject|1|||
145526477|NCT03581786|524788879|FG000|Overall Study|Death|67|||
145526478|NCT03581786|524788880|FG001|Overall Study|Death|47|||
145526479|NCT03581786|524788879|FG000|Overall Study|Withdrawal by Subject|2|||
145526480|NCT03581786|524788880|FG001|Overall Study|Withdrawal by Subject|5|||
145526481|NCT03581786|524788879|FG000|Overall Study|Lost to Follow-up|7|||
145526482|NCT03581786|524788880|FG001|Overall Study|Lost to Follow-up|4|||
145526483|NCT03581786|524788879|FG000|Overall Study|reason other than specified above|0|||
145526484|NCT03581786|524788880|FG001|Overall Study|reason other than specified above|1|||
145526485|NCT00510874|524788881|FG000|Overall Study|Withdrawal by Subject|1|||
145526486|NCT00510874|524788882|FG001|Overall Study|Withdrawal by Subject|1|||
145526487|NCT00510874|524788883|FG002|Overall Study|Withdrawal by Subject|0|||
145526488|NCT00510874|524788884|FG003|Overall Study|Withdrawal by Subject|0|||
145526489|NCT00510874|524788885|FG004|Overall Study|Withdrawal by Subject|3|||
145526490|NCT00510874|524788886|FG005|Overall Study|Withdrawal by Subject|0|||
145526491|NCT00510874|524788887|FG006|Overall Study|Withdrawal by Subject|0|||
145526492|NCT00510874|524788881|FG000|Overall Study|Lost to Follow-up|2|||
145526493|NCT00510874|524788882|FG001|Overall Study|Lost to Follow-up|3|||
145526494|NCT00510874|524788883|FG002|Overall Study|Lost to Follow-up|1|||
145526495|NCT00510874|524788884|FG003|Overall Study|Lost to Follow-up|3|||
145526496|NCT00510874|524788885|FG004|Overall Study|Lost to Follow-up|4|||
145526497|NCT00510874|524788886|FG005|Overall Study|Lost to Follow-up|0|||
145526498|NCT00510874|524788887|FG006|Overall Study|Lost to Follow-up|1|||
145526499|NCT02806973|524788891|FG000|Period 1|Withdrawal by Subject|0|||
145526500|NCT02806973|524788892|FG001|Period 1|Withdrawal by Subject|2|||
145526501|NCT02806973|524788893|FG002|Period 1|Withdrawal by Subject|1|||
145526502|NCT02806973|524788894|FG003|Period 1|Withdrawal by Subject|1|||
145526503|NCT02806973|524788891|FG000|Period 1|Adverse Event|0|||
145526504|NCT02806973|524788892|FG001|Period 1|Adverse Event|0|||
145526505|NCT02806973|524788893|FG002|Period 1|Adverse Event|0|||
145526506|NCT02806973|524788894|FG003|Period 1|Adverse Event|1|||
145526507|NCT02806973|524788891|FG000|Period 3|Withdrawal by Subject|0|||
145526508|NCT02806973|524788892|FG001|Period 3|Withdrawal by Subject|0|||
145526509|NCT02806973|524788893|FG002|Period 3|Withdrawal by Subject|0|||
145526510|NCT02806973|524788894|FG003|Period 3|Withdrawal by Subject|3|||
145526511|NCT02806973|524788891|FG000|Period 3|Adverse Event|0|||
145526512|NCT02806973|524788892|FG001|Period 3|Adverse Event|0|||
145526513|NCT02806973|524788893|FG002|Period 3|Adverse Event|1|||
145271394|NCT01036594|523840884|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
145271395|NCT01036594|523840885|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
145271396|NCT01036594|523840884|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
145526514|NCT02806973|524788894|FG003|Period 3|Adverse Event|0|||
145526515|NCT04209426|524788897|FG000|Overall Study|Lost to Follow-up|3|||
145526516|NCT04209426|524788898|FG001|Overall Study|Lost to Follow-up|2|||
145526517|NCT01751802|524788904|FG000|Overall Study|Adverse Event|4|||
145526518|NCT01751802|524788905|FG001|Overall Study|Adverse Event|2|||
145526519|NCT00521001|524788907|FG000|Overall Study|Ineligible|1|||
145526520|NCT02821910|524788908|FG000|Overall Study|Withdrawal by Subject|0|||
145526521|NCT02821910|524788909|FG001|Overall Study|Withdrawal by Subject|0|||
145526522|NCT02821910|524788910|FG002|Overall Study|Withdrawal by Subject|1|||
145271397|NCT01036594|523840885|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
145271398|NCT01036594|523840884|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
145271399|NCT01036594|523840885|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
145271400|NCT01036594|523840884|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
145271401|NCT01036594|523840885|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
145271402|NCT00244881|523840886|FG000|Overall Study|Withdrawal by Subject|3|||
145271403|NCT03345485|523840887|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
145271404|NCT03345485|523840888|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
145271405|NCT03345485|523840889|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
145271406|NCT03345485|523840890|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
145271407|NCT03345485|523840891|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
145271408|NCT03345485|523840892|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
145271409|NCT03345485|523840893|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
145271410|NCT03345485|523840894|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
145271411|NCT03345485|523840895|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
145271412|NCT03345485|523840896|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
145271413|NCT03345485|523840897|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
145271414|NCT03345485|523840898|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
145271415|NCT03345485|523840899|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
145271416|NCT01610284|523840900|FG000|Randomization Phase|Adverse Event|1|||
145271417|NCT01610284|523840901|FG001|Randomization Phase|Adverse Event|0|||
145271418|NCT01610284|523840900|FG000|Randomization Phase|Physician Decision|1|||
145271419|NCT01610284|523840901|FG001|Randomization Phase|Physician Decision|1|||
145271420|NCT01610284|523840900|FG000|Randomization Phase|Death|0|||
145271421|NCT01610284|523840901|FG001|Randomization Phase|Death|1|||
145271422|NCT01610284|523840900|FG000|Treatment Phase|Adverse Event|80|||
145271423|NCT01610284|523840901|FG001|Treatment Phase|Adverse Event|12|||
145271424|NCT01610284|523840900|FG000|Treatment Phase|Lost to Follow-up|1|||
145271425|NCT01610284|523840901|FG001|Treatment Phase|Lost to Follow-up|0|||
145526523|NCT02821910|524788911|FG003|Overall Study|Withdrawal by Subject|0|||
145526524|NCT02821910|524788912|FG004|Overall Study|Withdrawal by Subject|0|||
145526525|NCT02821910|524788913|FG005|Overall Study|Withdrawal by Subject|1|||
145526526|NCT02821910|524788908|FG000|Overall Study|Other than specified|1|||
145271426|NCT01610284|523840900|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
145271427|NCT01610284|523840901|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
145271428|NCT01610284|523840900|FG000|Treatment Phase|Physician Decision|27|||
145526527|NCT02821910|524788909|FG001|Overall Study|Other than specified|0|||
145526528|NCT02821910|524788910|FG002|Overall Study|Other than specified|1|||
145526529|NCT02821910|524788911|FG003|Overall Study|Other than specified|0|||
145526530|NCT02821910|524788912|FG004|Overall Study|Other than specified|0|||
145526531|NCT02821910|524788913|FG005|Overall Study|Other than specified|0|||
145526532|NCT00900601|524788914|FG000|Overall Study|Physician Decision|1|||
145526533|NCT01082640|524788915|FG000|Overall Study|Adverse Event|9|||
145526534|NCT01082640|524788916|FG001|Overall Study|Adverse Event|5|||
145526535|NCT01082640|524788917|FG002|Overall Study|Adverse Event|3|||
145526536|NCT01082640|524788915|FG000|Overall Study|Withdrawal by Subject|3|||
145526537|NCT01082640|524788916|FG001|Overall Study|Withdrawal by Subject|3|||
145526538|NCT01082640|524788917|FG002|Overall Study|Withdrawal by Subject|2|||
145402665|NCT01296412|524330814|FG000|Overall Study|Lack of Efficacy|1|||
145526539|NCT01082640|524788915|FG000|Overall Study|Major protocol deviation|3|||
145526540|NCT01082640|524788916|FG001|Overall Study|Major protocol deviation|3|||
145402666|NCT01296412|524330815|FG001|Overall Study|Lack of Efficacy|0|||
145402667|NCT01296412|524330814|FG000|Overall Study|Lost to Follow-up|10|||
145526541|NCT01082640|524788917|FG002|Overall Study|Major protocol deviation|0|||
145271429|NCT01610284|523840901|FG001|Treatment Phase|Physician Decision|24|||
145271430|NCT01610284|523840900|FG000|Treatment Phase|Progressive Disease|377|||
145271431|NCT01610284|523840901|FG001|Treatment Phase|Progressive Disease|486|||
145271432|NCT01610284|523840900|FG000|Treatment Phase|Protocol Deviation|2|||
145271433|NCT01610284|523840901|FG001|Treatment Phase|Protocol Deviation|3|||
145271434|NCT01610284|523840900|FG000|Treatment Phase|Study terminated by Sponsor|18|||
145271435|NCT01610284|523840901|FG001|Treatment Phase|Study terminated by Sponsor|15|||
145271436|NCT01610284|523840900|FG000|Treatment Phase|Subject/Guardian Decision|55|||
145271437|NCT01610284|523840901|FG001|Treatment Phase|Subject/Guardian Decision|23|||
145271438|NCT01610284|523840900|FG000|Treatment Phase|Death|6|||
145271439|NCT01610284|523840901|FG001|Treatment Phase|Death|5|||
145271440|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
145271441|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145271442|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
145271443|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
145271444|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
145271445|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
145271446|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
145271447|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
145271448|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
145271449|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
145271450|NCT01610284|523840900|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
145271451|NCT01610284|523840901|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
145271452|NCT01125358|523840905|FG000|Overall Study|Adverse Event|3|||
145271453|NCT01125358|523840906|FG001|Overall Study|Adverse Event|0|||
145271454|NCT01125358|523840907|FG002|Overall Study|Adverse Event|0|||
145271455|NCT01125358|523840908|FG003|Overall Study|Adverse Event|2|||
145271456|NCT01125358|523840905|FG000|Overall Study|Perceived Lack of Efficacy|6|||
145271457|NCT01125358|523840906|FG001|Overall Study|Perceived Lack of Efficacy|3|||
145271458|NCT01125358|523840907|FG002|Overall Study|Perceived Lack of Efficacy|7|||
145271459|NCT01125358|523840908|FG003|Overall Study|Perceived Lack of Efficacy|4|||
145271460|NCT01125358|523840905|FG000|Overall Study|Protocol Violation|1|||
145271461|NCT01125358|523840906|FG001|Overall Study|Protocol Violation|0|||
145271462|NCT01125358|523840907|FG002|Overall Study|Protocol Violation|0|||
145271463|NCT01125358|523840908|FG003|Overall Study|Protocol Violation|0|||
145271464|NCT01125358|523840905|FG000|Overall Study|Sponsor Decision|0|||
145271465|NCT01125358|523840906|FG001|Overall Study|Sponsor Decision|0|||
145271466|NCT01125358|523840907|FG002|Overall Study|Sponsor Decision|1|||
145271467|NCT01125358|523840908|FG003|Overall Study|Sponsor Decision|1|||
145271468|NCT01125358|523840905|FG000|Overall Study|Withdrawal by Subject|2|||
145271469|NCT01125358|523840906|FG001|Overall Study|Withdrawal by Subject|1|||
145271470|NCT01125358|523840907|FG002|Overall Study|Withdrawal by Subject|1|||
145271471|NCT01125358|523840908|FG003|Overall Study|Withdrawal by Subject|1|||
145271472|NCT01060007|523840909|FG000|Overall Study|Withdrawal by Subject|1|||
145271473|NCT01060007|523840909|FG000|Overall Study|Inevaluable for response at surgery|3|||
145271474|NCT05168657|523840910|FG000|Overall Study|Adverse Event|0|||
145271475|NCT05168657|523840911|FG001|Overall Study|Adverse Event|0|||
145271476|NCT05168657|523840912|FG002|Overall Study|Adverse Event|1|||
145271477|NCT05168657|523840913|FG003|Overall Study|Adverse Event|0|||
145271478|NCT05168657|523840914|FG004|Overall Study|Adverse Event|0|||
145271479|NCT05168657|523840915|FG005|Overall Study|Adverse Event|0|||
145271480|NCT05168657|523840916|FG006|Overall Study|Adverse Event|0|||
145271481|NCT05168657|523840917|FG007|Overall Study|Adverse Event|0|||
145271482|NCT03159611|523840920|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
145271483|NCT03159611|523840921|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
145271484|NCT03159611|523840920|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
145271485|NCT03159611|523840921|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
145271486|NCT03159611|523840920|FG000|Overall Study|Protocol Violation|7|||
145271487|NCT03159611|523840921|FG001|Overall Study|Protocol Violation|4|||
145526542|NCT01082640|524788915|FG000|Overall Study|Lost to Follow-up|0|||
145526543|NCT01082640|524788916|FG001|Overall Study|Lost to Follow-up|3|||
145271488|NCT03159611|523840920|FG000|Overall Study|Adverse Event|1|||
145271489|NCT03159611|523840921|FG001|Overall Study|Adverse Event|0|||
145271490|NCT03159611|523840920|FG000|Overall Study|Withdrawal by Subject|1|||
145526544|NCT01082640|524788917|FG002|Overall Study|Lost to Follow-up|0|||
145526545|NCT01082640|524788915|FG000|Overall Study|Other|2|||
145271491|NCT03159611|523840921|FG001|Overall Study|Withdrawal by Subject|1|||
145271492|NCT03159611|523840920|FG000|Overall Study|Non-compliance with protocol requirement|3|||
145271493|NCT03159611|523840921|FG001|Overall Study|Non-compliance with protocol requirement|2|||
145526546|NCT01082640|524788916|FG001|Overall Study|Other|1|||
145526547|NCT01082640|524788917|FG002|Overall Study|Other|3|||
145271494|NCT03159611|523840920|FG000|Overall Study|Inability to perform procedures|1|||
145271495|NCT03159611|523840921|FG001|Overall Study|Inability to perform procedures|0|||
145526548|NCT01025154|524788922|FG000|Overall Study|Lost to Follow-up|1|||
145526549|NCT01025154|524788922|FG000|Overall Study|Withdrawal by Subject|1|||
145526550|NCT05153473|524788924|FG000|Overall Study|Death|46|||
145526551|NCT05153473|524788924|FG000|Overall Study|Lost to Follow-up|3|||
145526552|NCT02788474|524788925|FG000|Double Blind Treatment Period|Not treated|1|||
145526553|NCT02788474|524788926|FG001|Double Blind Treatment Period|Not treated|0|||
145526554|NCT02788474|524788925|FG000|Double Blind Treatment Period|Patient's refusal|3|||
145271496|NCT01984229|523840922|FG000|Safety Follow-up Period|Adverse Event|1|||
145402668|NCT01296412|524330815|FG001|Overall Study|Lost to Follow-up|7|||
145526555|NCT02788474|524788926|FG001|Double Blind Treatment Period|Patient's refusal|0|||
145526556|NCT02788474|524788925|FG000|Double Blind Treatment Period|Adverse Event|6|||
145526557|NCT02788474|524788926|FG001|Double Blind Treatment Period|Adverse Event|4|||
145526558|NCT02788474|524788925|FG000|Open Label Treatment Period|Adverse Event|29|||
145526559|NCT02788474|524788926|FG001|Open Label Treatment Period|Adverse Event|9|||
145526560|NCT02788474|524788925|FG000|Open Label Treatment Period|Other than reason specified|1|||
145526561|NCT02788474|524788926|FG001|Open Label Treatment Period|Other than reason specified|0|||
145526562|NCT02788474|524788925|FG000|Open Label Treatment Period|Patient's refusal|1|||
145526563|NCT02788474|524788926|FG001|Open Label Treatment Period|Patient's refusal|3|||
145526564|NCT02788474|524788925|FG000|Open Label Treatment Period|Non-compliance|1|||
145526565|NCT02788474|524788926|FG001|Open Label Treatment Period|Non-compliance|0|||
145526566|NCT00048061|524788927|FG000|Overall Study|Adverse Event|41|||
145526567|NCT00048061|524788928|FG001|Overall Study|Adverse Event|32|||
145526568|NCT00048061|524788929|FG002|Overall Study|Adverse Event|44|||
145526569|NCT00048061|524788930|FG003|Overall Study|Adverse Event|37|||
145526570|NCT00048061|524788927|FG000|Overall Study|Lost to Follow-up|3|||
145526571|NCT00048061|524788928|FG001|Overall Study|Lost to Follow-up|2|||
145526572|NCT00048061|524788929|FG002|Overall Study|Lost to Follow-up|4|||
145526573|NCT00048061|524788930|FG003|Overall Study|Lost to Follow-up|5|||
145526574|NCT00048061|524788927|FG000|Overall Study|Withdrawal by Subject|20|||
145526575|NCT00048061|524788928|FG001|Overall Study|Withdrawal by Subject|29|||
145271497|NCT01984229|523840923|FG001|Safety Follow-up Period|Adverse Event|1|||
145271498|NCT01984229|523840922|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
145271499|NCT01984229|523840923|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
145271500|NCT02072174|523840924|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
145271501|NCT02072174|523840925|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
145271502|NCT02072174|523840924|FG000|Overall Study|Protocol Violation|16|||
145271503|NCT02072174|523840925|FG001|Overall Study|Protocol Violation|23|||
145271504|NCT02072174|523840924|FG000|Overall Study|Physician Decision|0|||
145271505|NCT02072174|523840925|FG001|Overall Study|Physician Decision|1|||
145271506|NCT02072174|523840924|FG000|Overall Study|Non-compliance with protocol requirement|2|||
145271507|NCT02072174|523840925|FG001|Overall Study|Non-compliance with protocol requirement|0|||
145271508|NCT01418365|523840930|FG000|First Intervention|Withdrawal by Subject|0|||
145271509|NCT01418365|523840931|FG001|First Intervention|Withdrawal by Subject|1|||
145271510|NCT01418365|523840930|FG000|First Intervention|Non-compliance|1|||
145526576|NCT00048061|524788929|FG002|Overall Study|Withdrawal by Subject|29|||
145526577|NCT00048061|524788930|FG003|Overall Study|Withdrawal by Subject|32|||
145271511|NCT01418365|523840931|FG001|First Intervention|Non-compliance|0|||
145271512|NCT01418365|523840930|FG000|Second Intervention|Withdrawal by Subject|0|||
145271513|NCT01418365|523840931|FG001|Second Intervention|Withdrawal by Subject|1|||
145271514|NCT03319368|523840936|FG000|Overall Study|Discharge swabs not collected from resident|57|||
145271515|NCT03319368|523840937|FG001|Overall Study|Discharge swabs not collected from resident|46|||
145271516|NCT00824993|523840942|FG000|Overall Study|Withdrawal by Subject|1|||
145271517|NCT00824993|523840943|FG001|Overall Study|Withdrawal by Subject|1|||
145271518|NCT00824993|523840942|FG000|Overall Study|Malignancy Relapse|9|||
145271519|NCT00824993|523840943|FG001|Overall Study|Malignancy Relapse|10|||
145271520|NCT00824993|523840942|FG000|Overall Study|Rapid Bone Loss|0|||
145271521|NCT00824993|523840943|FG001|Overall Study|Rapid Bone Loss|1|||
145271522|NCT00824993|523840942|FG000|Overall Study|Non-Compliant|2|||
145271523|NCT00824993|523840943|FG001|Overall Study|Non-Compliant|1|||
145271524|NCT00824993|523840942|FG000|Overall Study|Insurance Issue|2|||
145271525|NCT00824993|523840943|FG001|Overall Study|Insurance Issue|1|||
145271526|NCT00824993|523840942|FG000|Overall Study|Death|0|||
145271527|NCT00824993|523840943|FG001|Overall Study|Death|3|||
145271528|NCT00518011|523840944|FG000|Overall Study|Death|1|||
145271529|NCT00518011|523840945|FG001|Overall Study|Death|1|||
145271530|NCT00518011|523840944|FG000|Overall Study|Adverse Event|2|||
145271531|NCT00518011|523840945|FG001|Overall Study|Adverse Event|3|||
145271532|NCT00518011|523840944|FG000|Overall Study|Disease Progression|2|||
145271533|NCT00518011|523840945|FG001|Overall Study|Disease Progression|2|||
145271534|NCT00518011|523840944|FG000|Overall Study|Other Reasons|3|||
145271535|NCT00518011|523840945|FG001|Overall Study|Other Reasons|2|||
145271536|NCT00518011|523840944|FG000|Overall Study|Withdrawal by Subject|1|||
145271537|NCT00518011|523840945|FG001|Overall Study|Withdrawal by Subject|0|||
145271538|NCT03409328|523840946|FG000|Overall Study|Lost to Follow-up|6|||
145526578|NCT00048061|524788927|FG000|Overall Study|Did not follow-up|5|||
145526579|NCT00048061|524788928|FG001|Overall Study|Did not follow-up|5|||
145526580|NCT00048061|524788929|FG002|Overall Study|Did not follow-up|4|||
145526581|NCT00048061|524788930|FG003|Overall Study|Did not follow-up|5|||
145526582|NCT00048061|524788927|FG000|Overall Study|Early improvement|6|||
145526583|NCT00048061|524788928|FG001|Overall Study|Early improvement|5|||
145526584|NCT00048061|524788929|FG002|Overall Study|Early improvement|3|||
145526585|NCT00048061|524788930|FG003|Overall Study|Early improvement|0|||
145526586|NCT03555435|524788931|FG000|Overall Study|Lost to Follow-up|17|||
145271539|NCT03409328|523840947|FG001|Overall Study|Lost to Follow-up|3|||
145271540|NCT02998645|523840948|FG000|Treatment Period 1|Adverse Event|6|||
145271541|NCT02998645|523840948|FG000|Treatment Period 1|Death|5|||
145271542|NCT02998645|523840948|FG000|Treatment Period 1|Technical Problems|4|||
145271543|NCT02998645|523840948|FG000|Treatment Period 1|Lack of Efficacy|2|||
145271544|NCT02998645|523840948|FG000|Treatment Period 1|Progressive disease|1|||
145271545|NCT02998645|523840948|FG000|Treatment Period 1|Subject/guardian decision|1|||
145271546|NCT02998645|523840948|FG000|Treatment Period 2|Lack of Efficacy|5|||
145271547|NCT02998645|523840948|FG000|Treatment Period 2|Adverse Event|2|||
145526587|NCT03555435|524788932|FG001|Overall Study|Lost to Follow-up|19|||
145526588|NCT03555435|524788933|FG002|Overall Study|Lost to Follow-up|8|||
145526589|NCT01058265|524788936|FG000|Overall Study|Lost to Follow-up|11|||
145526590|NCT01058265|524788937|FG001|Overall Study|Lost to Follow-up|12|||
145526591|NCT02869438|524788938|FG000|Overall Study|Lost to Follow-up|1|||
145271548|NCT02998645|523840948|FG000|Treatment Period 2|Progressive disease|2|||
145271549|NCT02998645|523840948|FG000|Treatment Period 2|Physician Decision|1|||
145271550|NCT03930615|523840950|FG000|Overall Study|Death|9|||
145271551|NCT03930615|523840951|FG001|Overall Study|Death|3|||
145271552|NCT03930615|523840950|FG000|Overall Study|Lost to Follow-up|1|||
145271553|NCT03930615|523840951|FG001|Overall Study|Lost to Follow-up|2|||
145271554|NCT03930615|523840950|FG000|Overall Study|Physician Decision|3|||
145271555|NCT03930615|523840951|FG001|Overall Study|Physician Decision|4|||
145271556|NCT03930615|523840950|FG000|Overall Study|Withdrawal by Subject|13|||
145271557|NCT03930615|523840951|FG001|Overall Study|Withdrawal by Subject|2|||
145271558|NCT03930615|523840950|FG000|Overall Study|Not treated|1|||
145271559|NCT03930615|523840951|FG001|Overall Study|Not treated|1|||
145271560|NCT00358670|523840952|FG000|Overall Study|Adverse Event|26|||
145271561|NCT00358670|523840953|FG001|Overall Study|Adverse Event|29|||
145271562|NCT00358670|523840952|FG000|Overall Study|Lack of Efficacy|20|||
145271563|NCT00358670|523840953|FG001|Overall Study|Lack of Efficacy|23|||
145271564|NCT00358670|523840952|FG000|Overall Study|Protocol Violation|6|||
145271565|NCT00358670|523840953|FG001|Overall Study|Protocol Violation|9|||
145271566|NCT00358670|523840952|FG000|Overall Study|Lost to Follow-up|4|||
145271567|NCT00358670|523840953|FG001|Overall Study|Lost to Follow-up|5|||
145271568|NCT00358670|523840952|FG000|Overall Study|Withdrawal by Subject|13|||
145271569|NCT00358670|523840953|FG001|Overall Study|Withdrawal by Subject|24|||
145271570|NCT00358670|523840952|FG000|Overall Study|Protocol Defined Clinical Event|0|||
145271571|NCT00358670|523840953|FG001|Overall Study|Protocol Defined Clinical Event|1|||
145271572|NCT00358670|523840952|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
145271573|NCT00358670|523840953|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
145271574|NCT00358670|523840952|FG000|Overall Study|Administrative|153|||
145271575|NCT00358670|523840953|FG001|Overall Study|Administrative|125|||
145271576|NCT00905437|523840956|FG000|Overall Study|Adverse Event|3|||
145271577|NCT00905437|523840957|FG001|Overall Study|Adverse Event|2|||
145271578|NCT00905437|523840956|FG000|Overall Study|Lost to Follow-up|0|||
145271579|NCT00905437|523840957|FG001|Overall Study|Lost to Follow-up|1|||
145271580|NCT00905437|523840956|FG000|Overall Study|Withdrawal by Subject|0|||
145271581|NCT00905437|523840957|FG001|Overall Study|Withdrawal by Subject|1|||
145271582|NCT00905437|523840956|FG000|Overall Study|Other|5|||
145271583|NCT00905437|523840957|FG001|Overall Study|Other|6|||
145271584|NCT03252015|523840960|FG000|Overall Study|Withdrawal by Subject|0|||
145271585|NCT03252015|523840961|FG001|Overall Study|Withdrawal by Subject|1|||
145271586|NCT03252015|523840962|FG002|Overall Study|Withdrawal by Subject|1|||
145271587|NCT03252015|523840963|FG003|Overall Study|Withdrawal by Subject|0|||
145271588|NCT03252015|523840960|FG000|Overall Study|Adverse Event|1|||
145271589|NCT03252015|523840961|FG001|Overall Study|Adverse Event|0|||
145271590|NCT03252015|523840962|FG002|Overall Study|Adverse Event|0|||
145271591|NCT03252015|523840963|FG003|Overall Study|Adverse Event|1|||
145271592|NCT03128931|523840964|FG000|Overall Study|Physician Decision|1|||
145271593|NCT03128931|523840964|FG000|Overall Study|Equipment Issues|3|||
145271594|NCT04993339|523840965|FG000|Overall Study|Lost to Follow-up|0|||
145271595|NCT04993339|523840966|FG001|Overall Study|Lost to Follow-up|1|||
145271596|NCT04993339|523840965|FG000|Overall Study|no MRI scan|3|||
145271597|NCT04993339|523840966|FG001|Overall Study|no MRI scan|1|||
145271598|NCT01071278|523840967|FG000|Overall Study|Premature Discontinuation|254|||
145271599|NCT01071278|523840967|FG000|Overall Study|Completion Status Unknown|459|||
145526592|NCT02869438|524788939|FG001|Overall Study|Lost to Follow-up|0|||
145526593|NCT02869438|524788938|FG000|Overall Study|Adverse Event|1|||
145526594|NCT02869438|524788939|FG001|Overall Study|Adverse Event|0|||
145271600|NCT00903409|523840968|FG000|Overall Study|Adverse Event|11|||
145271601|NCT00903409|523840969|FG001|Overall Study|Adverse Event|9|||
145271602|NCT00903409|523840968|FG000|Overall Study|Non-compliance with Protocol|1|||
145271603|NCT00903409|523840969|FG001|Overall Study|Non-compliance with Protocol|1|||
145271604|NCT00903409|523840968|FG000|Overall Study|Laboratory Abnormality|2|||
145271605|NCT00903409|523840969|FG001|Overall Study|Laboratory Abnormality|0|||
145526595|NCT02869438|524788938|FG000|Overall Study|Withdrawal by Subject|1|||
145271606|NCT00903409|523840968|FG000|Overall Study|Withdrawal by Subject|8|||
145271607|NCT00903409|523840969|FG001|Overall Study|Withdrawal by Subject|8|||
145271608|NCT00903409|523840968|FG000|Overall Study|Other|2|||
145271609|NCT00903409|523840969|FG001|Overall Study|Other|3|||
145271610|NCT00903409|523840968|FG000|Overall Study|Lost to Follow-up|2|||
145271611|NCT00903409|523840969|FG001|Overall Study|Lost to Follow-up|6|||
145271612|NCT03539952|523840971|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
145271613|NCT03539952|523840972|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
145271614|NCT03539952|523840971|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
145271615|NCT03539952|523840972|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
145271616|NCT03539952|523840971|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
145271617|NCT03539952|523840972|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
145271618|NCT03539952|523840971|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
145526596|NCT02869438|524788939|FG001|Overall Study|Withdrawal by Subject|2|||
145271619|NCT03539952|523840972|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
145271620|NCT03539952|523840971|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
145271621|NCT03539952|523840972|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
145271622|NCT03539952|523840971|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
145271623|NCT03539952|523840972|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
145271624|NCT03539952|523840971|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
145271625|NCT03539952|523840972|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
145271626|NCT02184988|523840973|FG000|Overall Study|Pregnancy|2|||
145271627|NCT02184988|523840973|FG000|Overall Study|Adverse Event|2|||
145271628|NCT02184988|523840973|FG000|Overall Study|moving away/travelling/unable to complet|6|||
145271629|NCT02184988|523840973|FG000|Overall Study|work scheduling issues|4|||
145271630|NCT02184988|523840973|FG000|Overall Study|various other reasons|9|||
145271631|NCT02184988|523840973|FG000|Overall Study|Lost to Follow-up|32|||
145271632|NCT03075215|523840974|FG000|12-Month Primary Endpoint|Death|152|||
145271633|NCT03075215|523840974|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
145271634|NCT03075215|523840974|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
145271635|NCT03075215|523840974|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
145271636|NCT01608321|523840989|FG000|Overall Study|Withdrawal by Subject|1|||
145271637|NCT01608321|523840990|FG001|Overall Study|Withdrawal by Subject|0|||
145271638|NCT01819467|523842640|FG000|Overall Study|Physician Decision|20|||
145271639|NCT01819467|523842641|FG001|Overall Study|Physician Decision|9|||
145271640|NCT03256526|523842642|FG000|Overall Study|Adverse Event|1|||
145271641|NCT03256526|523842643|FG001|Overall Study|Adverse Event|0|||
145271642|NCT03256526|523842644|FG002|Overall Study|Adverse Event|1|||
145271643|NCT03256526|523842642|FG000|Overall Study|Lost to Follow-up|1|||
145271644|NCT03256526|523842643|FG001|Overall Study|Lost to Follow-up|0|||
145271645|NCT03256526|523842644|FG002|Overall Study|Lost to Follow-up|2|||
145271646|NCT01607398|523842647|FG000|Overall Study|Adverse Event|0|||
145271647|NCT01607398|523842648|FG001|Overall Study|Adverse Event|2|||
145271648|NCT01607398|523842647|FG000|Overall Study|Severe COPD|2|||
145271649|NCT01607398|523842648|FG001|Overall Study|Severe COPD|0|||
145271650|NCT03926728|523842649|FG000|Overall Study|Withdrawal by Subject|0|||
145271651|NCT03926728|523842650|FG001|Overall Study|Withdrawal by Subject|1|||
145271652|NCT03926728|523842651|FG002|Overall Study|Withdrawal by Subject|1|||
145271653|NCT03926728|523842652|FG003|Overall Study|Withdrawal by Subject|0|||
145271654|NCT03926728|523842653|FG004|Overall Study|Withdrawal by Subject|0|||
145271655|NCT03926728|523842654|FG005|Overall Study|Withdrawal by Subject|1|||
145271656|NCT03926728|523842655|FG006|Overall Study|Withdrawal by Subject|1|||
145271657|NCT03926728|523842656|FG007|Overall Study|Withdrawal by Subject|0|||
145271658|NCT03926728|523842657|FG008|Overall Study|Withdrawal by Subject|0|||
145526597|NCT02964507|524788943|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526598|NCT02964507|524788944|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
145526599|NCT02964507|524788945|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526600|NCT02964507|524788946|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526601|NCT02964507|524788947|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
145526602|NCT02964507|524788948|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526603|NCT02964507|524788949|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526604|NCT02964507|524788950|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
145526605|NCT02964507|524788943|FG000|Overall Study|Study terminated by Sponsor|9|||
145526606|NCT02964507|524788944|FG001|Overall Study|Study terminated by Sponsor|1|||
145526607|NCT02964507|524788945|FG002|Overall Study|Study terminated by Sponsor|9|||
145526608|NCT02964507|524788946|FG003|Overall Study|Study terminated by Sponsor|3|||
145526609|NCT02964507|524788947|FG004|Overall Study|Study terminated by Sponsor|3|||
145271659|NCT03926728|523842658|FG009|Overall Study|Withdrawal by Subject|1|||
145271660|NCT03926728|523842659|FG010|Overall Study|Withdrawal by Subject|0|||
145271661|NCT03926728|523842660|FG011|Overall Study|Withdrawal by Subject|0|||
145271662|NCT03993288|523842661|FG000|Overall Study|Lost to Follow-up|2|||
145271663|NCT03993288|523842662|FG001|Overall Study|Lost to Follow-up|1|||
145271664|NCT03993288|523842661|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
145271665|NCT03993288|523842662|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
145271666|NCT03993288|523842661|FG000|Overall Study|wrong randomization|0|||
145271667|NCT03993288|523842662|FG001|Overall Study|wrong randomization|1|||
145271668|NCT03993288|523842661|FG000|Overall Study|improper enrollment|0|||
145526610|NCT02964507|524788948|FG005|Overall Study|Study terminated by Sponsor|2|||
145526611|NCT02964507|524788949|FG006|Overall Study|Study terminated by Sponsor|0|||
145526612|NCT02964507|524788950|FG007|Overall Study|Study terminated by Sponsor|0|||
145526613|NCT02964507|524788943|FG000|Overall Study|Other|3|||
145526614|NCT02964507|524788944|FG001|Overall Study|Other|0|||
145271669|NCT03993288|523842662|FG001|Overall Study|improper enrollment|1|||
145271670|NCT03993288|523842661|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
145271671|NCT03993288|523842662|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
145526615|NCT02964507|524788945|FG002|Overall Study|Other|0|||
145526616|NCT02964507|524788946|FG003|Overall Study|Other|0|||
145271672|NCT03993288|523842661|FG000|Overall Study|developed SAE|2|||
145271673|NCT03993288|523842662|FG001|Overall Study|developed SAE|0|||
145526617|NCT02964507|524788947|FG004|Overall Study|Other|1|||
145526618|NCT02964507|524788948|FG005|Overall Study|Other|0|||
145526619|NCT02964507|524788949|FG006|Overall Study|Other|0|||
145526620|NCT02964507|524788950|FG007|Overall Study|Other|0|||
145526621|NCT02964507|524788943|FG000|Overall Study|Death|11|||
145526622|NCT02964507|524788944|FG001|Overall Study|Death|9|||
145526623|NCT02964507|524788945|FG002|Overall Study|Death|12|||
145526624|NCT02964507|524788946|FG003|Overall Study|Death|2|||
145526625|NCT02964507|524788947|FG004|Overall Study|Death|10|||
145526626|NCT02964507|524788948|FG005|Overall Study|Death|5|||
145526627|NCT02964507|524788949|FG006|Overall Study|Death|0|||
145526628|NCT02964507|524788950|FG007|Overall Study|Death|0|||
145526629|NCT02964507|524788943|FG000|Overall Study|Withdrawal by Subject|1|||
145526630|NCT02964507|524788944|FG001|Overall Study|Withdrawal by Subject|0|||
145526631|NCT02964507|524788945|FG002|Overall Study|Withdrawal by Subject|1|||
145526632|NCT02964507|524788946|FG003|Overall Study|Withdrawal by Subject|1|||
145526633|NCT02964507|524788947|FG004|Overall Study|Withdrawal by Subject|0|||
145526634|NCT02964507|524788948|FG005|Overall Study|Withdrawal by Subject|1|||
145526635|NCT02964507|524788949|FG006|Overall Study|Withdrawal by Subject|0|||
145526636|NCT02964507|524788950|FG007|Overall Study|Withdrawal by Subject|0|||
145402669|NCT01296412|524330814|FG000|Overall Study|Non-compliance with study drug|1|||
145402670|NCT01296412|524330815|FG001|Overall Study|Non-compliance with study drug|2|||
145402671|NCT01296412|524330814|FG000|Overall Study|Other reason not specified|20|||
145402672|NCT01296412|524330815|FG001|Overall Study|Other reason not specified|15|||
145402673|NCT01296412|524330814|FG000|Overall Study|Physician Decision|1|||
145402674|NCT01296412|524330815|FG001|Overall Study|Physician Decision|3|||
145402675|NCT01296412|524330814|FG000|Overall Study|Pregnancy|0|||
145402676|NCT01296412|524330815|FG001|Overall Study|Pregnancy|1|||
145402677|NCT01296412|524330814|FG000|Overall Study|Withdrawal by Subject|10|||
145402678|NCT01296412|524330815|FG001|Overall Study|Withdrawal by Subject|13|||
145402679|NCT02160626|524330816|FG000|Overall Study|Adverse Event|1|||
145402680|NCT02160626|524330817|FG001|Overall Study|Adverse Event|0|||
145402681|NCT02160626|524330818|FG002|Overall Study|Adverse Event|0|||
145402682|NCT02160626|524330816|FG000|Overall Study|Schedule not conducive to study visits|0|||
145402683|NCT02160626|524330817|FG001|Overall Study|Schedule not conducive to study visits|0|||
145402684|NCT02160626|524330818|FG002|Overall Study|Schedule not conducive to study visits|1|||
145402685|NCT02160626|524330816|FG000|Overall Study|Withdrawal by Subject|0|||
145402686|NCT02160626|524330817|FG001|Overall Study|Withdrawal by Subject|1|||
145402687|NCT02160626|524330818|FG002|Overall Study|Withdrawal by Subject|0|||
145402688|NCT04239924|524330824|FG000|Overall Study|Lost to Follow-up|2|||
145402689|NCT00666237|524330825|FG000|Overall Study|Death|5|||
145402690|NCT00666237|524330826|FG001|Overall Study|Death|5|||
145526637|NCT02964507|524788943|FG000|Overall Study|Physician Decision|2|||
145526638|NCT02964507|524788944|FG001|Overall Study|Physician Decision|0|||
145526639|NCT02964507|524788945|FG002|Overall Study|Physician Decision|3|||
145526640|NCT02964507|524788946|FG003|Overall Study|Physician Decision|0|||
145526641|NCT02964507|524788947|FG004|Overall Study|Physician Decision|1|||
145402691|NCT00666237|524330825|FG000|Overall Study|Lost to Follow-up|29|||
145402692|NCT00666237|524330826|FG001|Overall Study|Lost to Follow-up|25|||
145271674|NCT03993288|523842661|FG000|Overall Study|consent withdrawal|1|||
145271675|NCT03993288|523842662|FG001|Overall Study|consent withdrawal|0|||
145271676|NCT03993288|523842661|FG000|Overall Study|did not follow the treatment schedule|1|||
145271677|NCT03993288|523842662|FG001|Overall Study|did not follow the treatment schedule|0|||
145271678|NCT03993288|523842661|FG000|Overall Study|did not follow the treatment regimen|1|||
145271679|NCT03993288|523842662|FG001|Overall Study|did not follow the treatment regimen|0|||
145271680|NCT03993288|523842661|FG000|Overall Study|Adverse Event|1|||
145271681|NCT03993288|523842662|FG001|Overall Study|Adverse Event|0|||
145271682|NCT03993288|523842661|FG000|Overall Study|Withdrawal by Subject|1|||
145271683|NCT03993288|523842662|FG001|Overall Study|Withdrawal by Subject|1|||
145271684|NCT02729545|523842663|FG000|Overall Study|Pregnancy|1|||
145271685|NCT02729545|523842664|FG001|Overall Study|Pregnancy|1|||
145271686|NCT02729545|523842663|FG000|Overall Study|Lost to Follow-up|0|||
145271687|NCT02729545|523842664|FG001|Overall Study|Lost to Follow-up|1|||
145271688|NCT02729545|523842663|FG000|Overall Study|Withdrawal by Subject|2|||
145271689|NCT02729545|523842664|FG001|Overall Study|Withdrawal by Subject|3|||
145271690|NCT00915473|523842665|FG000|Screening|Withdrawal by Subject|1|||
145526642|NCT02964507|524788948|FG005|Overall Study|Physician Decision|0|||
145526643|NCT02964507|524788949|FG006|Overall Study|Physician Decision|0|||
145526644|NCT02964507|524788950|FG007|Overall Study|Physician Decision|0|||
145271691|NCT00915473|523842666|FG001|Screening|Withdrawal by Subject|0|||
145271692|NCT00915473|523842665|FG000|4-week Follow Up|Lost to Follow-up|1|||
145271693|NCT00915473|523842666|FG001|4-week Follow Up|Lost to Follow-up|5|||
145526645|NCT04341662|524788951|FG000|Overall Study|Did not have source-verified blood loss data|423|||
145526646|NCT04341662|524788952|FG001|Overall Study|Did not have source-verified blood loss data|514|||
145526647|NCT03614975|524788953|FG000|Overall Study|Physician Decision|7|||
145526648|NCT03614975|524788954|FG001|Overall Study|Physician Decision|5|||
145526649|NCT03614975|524788953|FG000|Overall Study|Withdrawal by Subject|2|||
145526650|NCT03614975|524788954|FG001|Overall Study|Withdrawal by Subject|2|||
145526651|NCT03614975|524788953|FG000|Overall Study|Specimens not in lab batch shipment|1|||
145526652|NCT03614975|524788954|FG001|Overall Study|Specimens not in lab batch shipment|1|||
145526653|NCT01569464|524788955|FG000|Overall Study|Adverse Event|4|||
145526654|NCT01569464|524788956|FG001|Overall Study|Adverse Event|0|||
145526655|NCT01569464|524788955|FG000|Overall Study|Lack of Efficacy|1|||
145526656|NCT01569464|524788956|FG001|Overall Study|Lack of Efficacy|0|||
145526657|NCT01569464|524788955|FG000|Overall Study|Protocol Violation|1|||
145526658|NCT01569464|524788956|FG001|Overall Study|Protocol Violation|0|||
145526659|NCT01569464|524788955|FG000|Overall Study|Lost to Follow-up|2|||
145526660|NCT01569464|524788956|FG001|Overall Study|Lost to Follow-up|3|||
145526661|NCT01569464|524788955|FG000|Overall Study|Withdrawal by Subject|1|||
145526662|NCT01569464|524788956|FG001|Overall Study|Withdrawal by Subject|1|||
145526663|NCT01569464|524788955|FG000|Overall Study|Other|1|||
145526664|NCT01569464|524788956|FG001|Overall Study|Other|1|||
145526665|NCT02273739|524788957|FG000|Overall Study|Progression of Disease|3|||
145526666|NCT02273739|524788958|FG001|Overall Study|Progression of Disease|4|||
145526667|NCT02273739|524788959|FG002|Overall Study|Progression of Disease|5|||
145526668|NCT02273739|524788960|FG003|Overall Study|Progression of Disease|2|||
145526669|NCT02273739|524788957|FG000|Overall Study|Death|0|||
145526670|NCT02273739|524788958|FG001|Overall Study|Death|0|||
145526671|NCT02273739|524788959|FG002|Overall Study|Death|0|||
145526672|NCT02273739|524788960|FG003|Overall Study|Death|2|||
145526673|NCT02273739|524788957|FG000|Overall Study|Adverse Event|0|||
145526674|NCT02273739|524788958|FG001|Overall Study|Adverse Event|0|||
145526675|NCT02273739|524788959|FG002|Overall Study|Adverse Event|0|||
145526676|NCT02273739|524788960|FG003|Overall Study|Adverse Event|1|||
145526677|NCT02273739|524788957|FG000|Overall Study|Withdrawal by Subject|0|||
145526678|NCT02273739|524788958|FG001|Overall Study|Withdrawal by Subject|0|||
145526679|NCT02273739|524788959|FG002|Overall Study|Withdrawal by Subject|2|||
145526680|NCT02273739|524788960|FG003|Overall Study|Withdrawal by Subject|1|||
145526681|NCT02273739|524788957|FG000|Overall Study|Physician Decision|0|||
145271694|NCT01389024|523842667|FG000|Overall Study|Withdrawal by Subject|0|||
145526682|NCT02273739|524788958|FG001|Overall Study|Physician Decision|0|||
145526683|NCT02273739|524788959|FG002|Overall Study|Physician Decision|0|||
145526684|NCT02273739|524788960|FG003|Overall Study|Physician Decision|1|||
145526685|NCT04718103|524788961|FG000|Overall Study|Adverse Event|1|||
145526686|NCT04718103|524788962|FG001|Overall Study|Adverse Event|1|||
145526687|NCT04718103|524788961|FG000|Overall Study|Lack of Efficacy|4|||
145526688|NCT04718103|524788962|FG001|Overall Study|Lack of Efficacy|1|||
145526689|NCT04718103|524788961|FG000|Overall Study|Lost to Follow-up|2|||
145271695|NCT01389024|523842668|FG001|Overall Study|Withdrawal by Subject|1|||
145271696|NCT01389024|523842667|FG000|Overall Study|Lost to Follow-up|1|||
145271697|NCT01389024|523842668|FG001|Overall Study|Lost to Follow-up|0|||
145526690|NCT04718103|524788962|FG001|Overall Study|Lost to Follow-up|2|||
145526691|NCT04718103|524788961|FG000|Overall Study|Physician Decision|2|||
145526692|NCT04718103|524788962|FG001|Overall Study|Physician Decision|0|||
145526693|NCT04718103|524788961|FG000|Overall Study|Pregnancy|0|||
145526694|NCT04718103|524788962|FG001|Overall Study|Pregnancy|1|||
145526695|NCT04718103|524788961|FG000|Overall Study|Withdrawal by Subject|10|||
145526696|NCT04718103|524788962|FG001|Overall Study|Withdrawal by Subject|6|||
145526697|NCT04718103|524788961|FG000|Overall Study|Randomized, not treated|4|||
145526698|NCT04718103|524788962|FG001|Overall Study|Randomized, not treated|1|||
145526699|NCT04718103|524788961|FG000|Overall Study|GCP violations|7|||
145526700|NCT04718103|524788962|FG001|Overall Study|GCP violations|5|||
145526701|NCT01343901|524788963|FG000|Overall Study|Death|85|||
145526702|NCT01343901|524788963|FG000|Overall Study|Physician Decision|4|||
145526703|NCT01343901|524788963|FG000|Overall Study|Lost to Follow-up|12|||
145526704|NCT01343901|524788963|FG000|Overall Study|Management by another medical team|11|||
145526705|NCT01343901|524788963|FG000|Overall Study|Participant decision|1|||
145526706|NCT01484938|524788969|FG000|Overall Study|Adverse Event|2|||
145526707|NCT01484938|524788969|FG000|Overall Study|Lost to Follow-up|1|||
145526708|NCT01484938|524788969|FG000|Overall Study|Noncompliance|1|||
145526709|NCT00938964|524788971|FG000|Overall Study|Death|3|||
145526710|NCT00938964|524788972|FG001|Overall Study|Death|3|||
145526711|NCT00938964|524788971|FG000|Overall Study|Lost to Follow-up|2|||
145526712|NCT00938964|524788972|FG001|Overall Study|Lost to Follow-up|3|||
145526713|NCT00938964|524788971|FG000|Overall Study|Withdrawal by Subject|22|||
145526714|NCT00938964|524788972|FG001|Overall Study|Withdrawal by Subject|18|||
145526715|NCT00938964|524788971|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
145526716|NCT00938964|524788972|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
145526717|NCT01858636|524788973|FG000|Overall Study|No Device Deployment Attempted|24|||
145526718|NCT01858636|524788973|FG000|Overall Study|Physician Decision|1|||
145526719|NCT01858636|524788973|FG000|Overall Study|Death|1|||
145526720|NCT01858636|524788973|FG000|Overall Study|Lost to Follow-up|1|||
145526721|NCT01858636|524788973|FG000|Overall Study|Withdrawal by Subject|1|||
145526722|NCT01172275|524788976|FG000|Overall Study|Lost to Follow-up|1|||
145526723|NCT01172275|524788977|FG001|Overall Study|Lost to Follow-up|0|||
145526724|NCT01172275|524788976|FG000|Overall Study|Protocol Violation|1|||
145526725|NCT01172275|524788977|FG001|Overall Study|Protocol Violation|0|||
145526726|NCT01227564|524788979|FG000|Overall Study|No Longer Willing to Participate|4|||
145526727|NCT01227564|524788980|FG001|Overall Study|No Longer Willing to Participate|2|||
145526728|NCT01227564|524788981|FG002|Overall Study|No Longer Willing to Participate|5|||
145526729|NCT01227564|524788979|FG000|Overall Study|Participant moved to another town|0|||
145526730|NCT01227564|524788980|FG001|Overall Study|Participant moved to another town|0|||
145526731|NCT01227564|524788981|FG002|Overall Study|Participant moved to another town|1|||
145526732|NCT04650854|524788994|FG000|Overall Study|Adverse Event|1|||
145526733|NCT04650854|524788995|FG001|Overall Study|Adverse Event|12|||
145526734|NCT04650854|524788996|FG002|Overall Study|Adverse Event|14|||
145526735|NCT04650854|524788994|FG000|Overall Study|Lack of Efficacy|1|||
145526736|NCT04650854|524788995|FG001|Overall Study|Lack of Efficacy|3|||
145526737|NCT04650854|524788996|FG002|Overall Study|Lack of Efficacy|6|||
145526738|NCT04650854|524788994|FG000|Overall Study|Lost to Follow-up|1|||
145526739|NCT04650854|524788995|FG001|Overall Study|Lost to Follow-up|1|||
145526740|NCT04650854|524788996|FG002|Overall Study|Lost to Follow-up|0|||
145526741|NCT04650854|524788994|FG000|Overall Study|Withdrawal by Subject|2|||
145526742|NCT04650854|524788995|FG001|Overall Study|Withdrawal by Subject|17|||
145526743|NCT04650854|524788996|FG002|Overall Study|Withdrawal by Subject|9|||
145526744|NCT04650854|524788994|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
145526745|NCT04650854|524788995|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
145526746|NCT04650854|524788996|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
145526747|NCT04650854|524788994|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
145526748|NCT04650854|524788995|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
145526749|NCT04650854|524788996|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
145526750|NCT04650854|524788994|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
145526751|NCT04650854|524788995|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
145526752|NCT04650854|524788996|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
145526753|NCT04650854|524788994|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
145526754|NCT04650854|524788995|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
145526755|NCT04650854|524788996|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
145526756|NCT04650854|524788994|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
145526757|NCT04650854|524788995|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
145526758|NCT04650854|524788996|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
145526759|NCT04650854|524788994|FG000|Overall Study|Use of Rescue Medication|0|||
145526760|NCT04650854|524788995|FG001|Overall Study|Use of Rescue Medication|0|||
145526761|NCT04650854|524788996|FG002|Overall Study|Use of Rescue Medication|1|||
145526762|NCT04650854|524788994|FG000|Overall Study|Last Treatment Per Sponsor|0|||
145526763|NCT04650854|524788995|FG001|Overall Study|Last Treatment Per Sponsor|0|||
145526764|NCT04650854|524788996|FG002|Overall Study|Last Treatment Per Sponsor|2|||
145526765|NCT04650854|524788994|FG000|Overall Study|Rescue Medication|0|||
145526766|NCT04650854|524788995|FG001|Overall Study|Rescue Medication|0|||
145526767|NCT04650854|524788996|FG002|Overall Study|Rescue Medication|1|||
145526768|NCT04650854|524788994|FG000|Overall Study|Participant Want to Start a Family|0|||
145526769|NCT04650854|524788995|FG001|Overall Study|Participant Want to Start a Family|0|||
145526770|NCT04650854|524788996|FG002|Overall Study|Participant Want to Start a Family|1|||
145526771|NCT04650854|524788994|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
145526772|NCT04650854|524788995|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
145526773|NCT04650854|524788996|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
145526774|NCT04650854|524788994|FG000|Overall Study|Participant Screened For MG0020|0|||
145526775|NCT04650854|524788995|FG001|Overall Study|Participant Screened For MG0020|2|||
145526776|NCT04650854|524788996|FG002|Overall Study|Participant Screened For MG0020|3|||
145526777|NCT04650854|524788994|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
145526778|NCT04650854|524788995|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
145526779|NCT04650854|524788996|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
145526780|NCT04650854|524788994|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
145526781|NCT04650854|524788995|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
145526782|NCT04650854|524788996|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
145526783|NCT04650854|524788994|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
145526784|NCT04650854|524788995|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
145526785|NCT04650854|524788996|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
145526786|NCT04650854|524788994|FG000|Overall Study|End Of Study|0|||
145526787|NCT04650854|524788995|FG001|Overall Study|End Of Study|2|||
145526788|NCT04650854|524788996|FG002|Overall Study|End Of Study|1|||
145526789|NCT04650854|524788994|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
145526790|NCT04650854|524788995|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
145526791|NCT04650854|524788996|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
145526792|NCT04650854|524788994|FG000|Overall Study|Participant Received Rescue Medication|0|||
145526793|NCT04650854|524788995|FG001|Overall Study|Participant Received Rescue Medication|1|||
145526794|NCT04650854|524788996|FG002|Overall Study|Participant Received Rescue Medication|0|||
145526795|NCT04650854|524788994|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
145526796|NCT04650854|524788995|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
145526797|NCT04650854|524788996|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
145526798|NCT04650854|524788994|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
145526799|NCT04650854|524788995|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
145526800|NCT04650854|524788996|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
145526801|NCT04650854|524788994|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
145526802|NCT04650854|524788995|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
145526803|NCT04650854|524788996|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
145526804|NCT04650854|524788994|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
145526805|NCT04650854|524788995|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
145526806|NCT04650854|524788996|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
145526807|NCT04650854|524788994|FG000|Overall Study|Enrollment Cup|0|||
145526808|NCT04650854|524788995|FG001|Overall Study|Enrollment Cup|0|||
145526809|NCT04650854|524788996|FG002|Overall Study|Enrollment Cup|1|||
145526810|NCT02862600|524788997|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
145526811|NCT02862600|524788997|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
145526812|NCT02862600|524788997|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
145526813|NCT02862600|524788997|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
145526814|NCT01285960|524789006|FG000|Overall Study|Withdrawal by Subject|2|||
145526815|NCT01285960|524789006|FG000|Overall Study|Lost to Follow-up|2|||
145526816|NCT01285960|524789006|FG000|Overall Study|2 subjects received less 10 sonications|2|||
145526817|NCT00667420|524789007|FG000|Overall Study|Adverse Event|2|||
145526818|NCT00667420|524789007|FG000|Overall Study|Lack of Efficacy|5|||
145526819|NCT00667420|524789007|FG000|Overall Study|Physician Decision|1|||
145526820|NCT00667420|524789007|FG000|Overall Study|Withdrawal by Subject|2|||
145526821|NCT04437368|524789008|FG000|Overall Study|Death|3|||
145526822|NCT04437368|524789009|FG001|Overall Study|Death|0|||
145526823|NCT04437368|524789010|FG002|Overall Study|Death|2|||
145526824|NCT04437368|524789008|FG000|Overall Study|Study terminated by sponsor|16|||
145526825|NCT04437368|524789009|FG001|Overall Study|Study terminated by sponsor|1|||
145526826|NCT04437368|524789010|FG002|Overall Study|Study terminated by sponsor|25|||
145526827|NCT04437368|524789008|FG000|Overall Study|Withdrawal by Subject|4|||
145526828|NCT04437368|524789009|FG001|Overall Study|Withdrawal by Subject|0|||
145526829|NCT04437368|524789010|FG002|Overall Study|Withdrawal by Subject|3|||
145526830|NCT04437368|524789008|FG000|Overall Study|Sponsor instructions|23|||
145526831|NCT04437368|524789009|FG001|Overall Study|Sponsor instructions|0|||
145526832|NCT04437368|524789010|FG002|Overall Study|Sponsor instructions|0|||
145526833|NCT04271280|524789011|FG000|Overall Study|Lost to Follow-up|300|||
145526834|NCT04271280|524789011|FG000|Overall Study|Death|153|||
145526835|NCT04271280|524789011|FG000|Overall Study|Withdrawal of consent by patient|59|||
145526836|NCT04271280|524789011|FG000|Overall Study|Other|51|||
145526837|NCT04271280|524789011|FG000|Overall Study|No end of study information|42|||
145526838|NCT01539317|524789012|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
145526839|NCT01539317|524789013|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
145526840|NCT01674634|524789017|FG000|Overall Study|Withdrawal by Subject|3|||
145526841|NCT01674634|524789017|FG000|Overall Study|Lost to Follow-up|3|||
145526842|NCT00937391|524789018|FG000|Stage 2|Withdrawal by Subject|1|||
145526843|NCT04221230|524789019|FG000|Overall Study|Lost to Follow-up|12|||
145526844|NCT04221230|524789020|FG001|Overall Study|Lost to Follow-up|12|||
145526845|NCT04221230|524789019|FG000|Overall Study|Protocol Violation|2|||
145526846|NCT04221230|524789020|FG001|Overall Study|Protocol Violation|2|||
145526847|NCT04221230|524789019|FG000|Overall Study|Adverse Event|0|||
145526848|NCT04221230|524789020|FG001|Overall Study|Adverse Event|8|||
145526849|NCT04221230|524789019|FG000|Overall Study|Physician Decision|1|||
145271698|NCT03443973|523842671|FG000|Double-blind Treatment Period|Adverse Event|5|||
145526850|NCT04221230|524789020|FG001|Overall Study|Physician Decision|0|||
145526851|NCT04221230|524789019|FG000|Overall Study|Withdrawal by Subject|13|||
145526852|NCT04221230|524789020|FG001|Overall Study|Withdrawal by Subject|11|||
145526853|NCT04221230|524789019|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145271699|NCT03443973|523842672|FG001|Double-blind Treatment Period|Adverse Event|19|||
145271700|NCT03443973|523842673|FG002|Double-blind Treatment Period|Adverse Event|0|||
145271701|NCT03443973|523842674|FG003|Double-blind Treatment Period|Adverse Event|0|||
145271702|NCT03443973|523842671|FG000|Double-blind Treatment Period|Death|5|||
145271703|NCT03443973|523842672|FG001|Double-blind Treatment Period|Death|7|||
145271704|NCT03443973|523842673|FG002|Double-blind Treatment Period|Death|0|||
145271705|NCT03443973|523842674|FG003|Double-blind Treatment Period|Death|0|||
145526854|NCT04221230|524789020|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145526855|NCT04221230|524789019|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145526856|NCT04221230|524789020|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145526857|NCT04221230|524789019|FG000|Overall Study|Pregnancy|0|||
145526858|NCT04221230|524789020|FG001|Overall Study|Pregnancy|1|||
145526859|NCT04221230|524789019|FG000|Overall Study|Other|1|||
145526860|NCT04221230|524789020|FG001|Overall Study|Other|2|||
145271706|NCT03443973|523842671|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
145271707|NCT03443973|523842672|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
145526861|NCT02359851|524789023|FG000|Overall Study|Death|1|||
145526862|NCT02359851|524789023|FG000|Overall Study|Disease progression|1|||
145526863|NCT00055471|524789024|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
145526864|NCT00055471|524789025|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
145526865|NCT00055471|524789026|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
145526866|NCT00055471|524789024|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
145526867|NCT00055471|524789025|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
145526868|NCT00055471|524789026|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
145526869|NCT00055471|524789024|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
145526870|NCT00055471|524789025|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
145526871|NCT00055471|524789026|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
145526872|NCT01854944|524789027|FG000|Overall Study|Withdrawal by Subject|0|||
145526873|NCT01854944|524789028|FG001|Overall Study|Withdrawal by Subject|0|||
145526874|NCT01854944|524789029|FG002|Overall Study|Withdrawal by Subject|1|||
145526875|NCT00993044|524789030|FG000|Irinotecan 50 mg|Physician Decision|1|||
145526876|NCT05063318|524789033|FG000|Overall Study|Progressive disease|2|||
145526877|NCT05063318|524789034|FG001|Overall Study|Progressive disease|0|||
145526878|NCT05063318|524789035|FG002|Overall Study|Progressive disease|3|||
145526879|NCT05063318|524789033|FG000|Overall Study|Compassionate use|1|||
145526880|NCT05063318|524789034|FG001|Overall Study|Compassionate use|3|||
145526881|NCT05063318|524789035|FG002|Overall Study|Compassionate use|3|||
145526882|NCT05063318|524789033|FG000|Overall Study|Adverse Event|0|||
145526883|NCT05063318|524789034|FG001|Overall Study|Adverse Event|1|||
145526884|NCT05063318|524789035|FG002|Overall Study|Adverse Event|0|||
145526885|NCT05063318|524789033|FG000|Overall Study|Withdrawal by Subject|0|||
145526886|NCT05063318|524789034|FG001|Overall Study|Withdrawal by Subject|1|||
145526887|NCT05063318|524789035|FG002|Overall Study|Withdrawal by Subject|0|||
145526888|NCT02237911|524790752|FG000|Overall Study|Withdrawal by Subject|4|||
145526889|NCT02237911|524790753|FG001|Overall Study|Withdrawal by Subject|7|||
145526890|NCT02237911|524790754|FG002|Overall Study|Withdrawal by Subject|2|||
145526891|NCT02237911|524790752|FG000|Overall Study|Lost to Follow-up|3|||
145526892|NCT02237911|524790753|FG001|Overall Study|Lost to Follow-up|1|||
145526893|NCT02237911|524790754|FG002|Overall Study|Lost to Follow-up|1|||
145526894|NCT00397943|524790755|FG000|Overall Study|Unspecified reasons|12|||
145526895|NCT00397943|524790756|FG001|Overall Study|Unspecified reasons|9|||
145526896|NCT00397943|524790757|FG002|Overall Study|Unspecified reasons|0|||
145526897|NCT00397943|524790758|FG003|Overall Study|Unspecified reasons|0|||
145526898|NCT00397943|524790759|FG004|Overall Study|Unspecified reasons|0|||
145271708|NCT03443973|523842673|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
145271709|NCT03443973|523842674|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
145526899|NCT04521777|524790760|FG000|Overall Study|Death|2|||
145526900|NCT04521777|524790760|FG000|Overall Study|Withdrawal by Subject|2|||
145526901|NCT01869725|524790762|FG000|Overall Study|ineligible after registration|1|||
145526902|NCT01869725|524790762|FG000|Overall Study|Death|1|||
145526903|NCT01869725|524790762|FG000|Overall Study|Lost to Follow-up|2|||
145526904|NCT01143207|524790763|FG000|Overall Study|Lost to Follow-up|2|||
145526905|NCT00057954|524790768|FG000|Overall Study|Death|1|||
145526906|NCT00057954|524790768|FG000|Overall Study|Disease progression|1|||
145526907|NCT00559754|524790769|FG000|Overall Study|Disease progression|1|||
145526908|NCT00559754|524790769|FG000|Overall Study|Adverse Event|5|||
145526909|NCT00559754|524790769|FG000|Overall Study|Protocol Violation|1|||
145526910|NCT00559754|524790769|FG000|Overall Study|Investigator criteria|2|||
145526911|NCT00559754|524790769|FG000|Overall Study|Withdrawal by Subject|2|||
145526912|NCT02663687|524790770|FG000|Overall Study|Adverse Event|1|||
145526913|NCT02663687|524790771|FG001|Overall Study|Adverse Event|0|||
145526914|NCT02663687|524790772|FG002|Overall Study|Adverse Event|0|||
145526915|NCT02663687|524790773|FG003|Overall Study|Adverse Event|0|||
145526916|NCT02663687|524790774|FG004|Overall Study|Adverse Event|0|||
145526917|NCT02663687|524790770|FG000|Overall Study|Other|1|||
145526918|NCT02663687|524790771|FG001|Overall Study|Other|0|||
145526919|NCT02663687|524790772|FG002|Overall Study|Other|1|||
145526920|NCT02663687|524790773|FG003|Overall Study|Other|0|||
145526921|NCT02663687|524790774|FG004|Overall Study|Other|0|||
145526922|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
145526923|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
145526924|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
145526925|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
145526926|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
145526927|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
145526928|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
145526929|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
145526930|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
145526931|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
145526932|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
145751328|NCT00883337|525603945|FG002|Extension Treatment Period|Adverse Event|5|||
145751329|NCT00883337|525603943|FG000|Extension Treatment Period|Lack of Efficacy|8|||
145751330|NCT00883337|525603944|FG001|Extension Treatment Period|Lack of Efficacy|8|||
145751331|NCT00883337|525603945|FG002|Extension Treatment Period|Lack of Efficacy|8|||
145526933|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
145526934|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
145526935|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
145526936|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
145751332|NCT00883337|525603943|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
145751333|NCT00883337|525603944|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
145526937|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
145526938|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Program Termination|3|||
145526939|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Program Termination|0|||
145526940|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Program Termination|1|||
145526941|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Program Termination|1|||
145526942|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
145526943|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
145526944|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
145271710|NCT03443973|523842671|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145271711|NCT03443973|523842672|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
145271712|NCT03443973|523842673|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145271713|NCT03443973|523842674|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145271714|NCT03443973|523842671|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
145271715|NCT03443973|523842672|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
145271716|NCT03443973|523842673|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
145271717|NCT03443973|523842674|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
145271718|NCT03443973|523842671|FG000|Double-blind Treatment Period|Physician Decision|5|||
145271719|NCT03443973|523842672|FG001|Double-blind Treatment Period|Physician Decision|6|||
145271720|NCT03443973|523842673|FG002|Double-blind Treatment Period|Physician Decision|0|||
145271721|NCT03443973|523842674|FG003|Double-blind Treatment Period|Physician Decision|0|||
145271722|NCT03443973|523842671|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
145271723|NCT03443973|523842672|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
145271724|NCT03443973|523842673|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
145271725|NCT03443973|523842674|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
145271726|NCT03443973|523842671|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
145271727|NCT03443973|523842672|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
145271728|NCT03443973|523842673|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145271729|NCT03443973|523842674|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
145271730|NCT03443973|523842671|FG000|Open-label Extension Period|Reason Not Specified|0|||
145271731|NCT03443973|523842672|FG001|Open-label Extension Period|Reason Not Specified|0|||
145271732|NCT03443973|523842673|FG002|Open-label Extension Period|Reason Not Specified|3|||
145271733|NCT03443973|523842674|FG003|Open-label Extension Period|Reason Not Specified|0|||
145271734|NCT03443973|523842671|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
145271735|NCT03443973|523842672|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
145271736|NCT03443973|523842673|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
145271737|NCT03443973|523842674|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
145271738|NCT00398632|523842677|FG000|Overall Study|Withdrawal by Subject|1|||
145271739|NCT00398632|523842677|FG000|Overall Study|Lack of Efficacy|1|||
145271740|NCT00640614|523842681|FG000|Overall Study|Lost to Follow-up|1|||
145271741|NCT00640614|523842682|FG001|Overall Study|Lost to Follow-up|0|||
145271742|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
145271743|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
145271744|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
145271745|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Death|1|||
145271746|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
145271747|NCT00529802|523842683|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
145271748|NCT00529802|523842683|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
145271749|NCT02209454|523842687|FG000|Second Period|Adverse Event|1|||
145271750|NCT02209454|523842688|FG001|Second Period|Adverse Event|0|||
145271751|NCT02545868|523842691|FG000|Overall Study|Lack of Efficacy|1|||
145271752|NCT02545868|523842692|FG001|Overall Study|Lack of Efficacy|1|||
145271753|NCT02545868|523842693|FG002|Overall Study|Lack of Efficacy|0|||
145271754|NCT02545868|523842691|FG000|Overall Study|Lost to Follow-up|1|||
145271755|NCT02545868|523842692|FG001|Overall Study|Lost to Follow-up|5|||
145271756|NCT02545868|523842693|FG002|Overall Study|Lost to Follow-up|1|||
145271757|NCT02545868|523842691|FG000|Overall Study|Non-compliance|1|||
145271758|NCT02545868|523842692|FG001|Overall Study|Non-compliance|1|||
145271759|NCT02545868|523842693|FG002|Overall Study|Non-compliance|1|||
145271760|NCT02545868|523842691|FG000|Overall Study|Treatment change|21|||
145271761|NCT02545868|523842692|FG001|Overall Study|Treatment change|19|||
145271762|NCT02545868|523842693|FG002|Overall Study|Treatment change|22|||
145271763|NCT02545868|523842691|FG000|Overall Study|Physician Decision|1|||
145271764|NCT02545868|523842692|FG001|Overall Study|Physician Decision|1|||
145271765|NCT02545868|523842693|FG002|Overall Study|Physician Decision|1|||
145271766|NCT02545868|523842691|FG000|Overall Study|Withdrawal by Subject|6|||
145271767|NCT02545868|523842692|FG001|Overall Study|Withdrawal by Subject|7|||
145271768|NCT02545868|523842693|FG002|Overall Study|Withdrawal by Subject|9|||
145271769|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
145271770|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
145271771|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
145271772|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
145271773|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
145271774|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
145271775|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
145271776|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
145271777|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
145271778|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
145271779|NCT01777191|523842694|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
145271780|NCT01777191|523842695|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
145402693|NCT05399680|524332449|FG000|Overall Study|Lost to Follow-up|1|||
145402694|NCT05399680|524332450|FG001|Overall Study|Lost to Follow-up|0|||
145271781|NCT01777191|523842694|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
145271782|NCT01777191|523842695|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
145271783|NCT01777191|523842694|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
145271784|NCT01777191|523842695|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
145271785|NCT01777191|523842694|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
145271786|NCT01777191|523842695|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
145271787|NCT01777191|523842694|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
145271788|NCT01777191|523842695|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
145271789|NCT01777191|523842694|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
145271790|NCT01777191|523842695|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
145271791|NCT04465916|523842700|FG000|Overall Study|Withdrawal by Subject|0|||
145271792|NCT04465916|523842701|FG001|Overall Study|Withdrawal by Subject|1|||
145271793|NCT00740480|523842706|FG000|Overall Study|Adverse Event|1|||
145271794|NCT00740480|523842706|FG000|Overall Study|Physician Decision|1|||
145271795|NCT01856686|523842711|FG000|Overall Study|Lost to Follow-up|5|||
145271796|NCT01856686|523842712|FG001|Overall Study|Lost to Follow-up|11|||
145271797|NCT00602979|523842713|FG000|Overall Study|Lost to Follow-up|3|||
145271798|NCT00602979|523842714|FG001|Overall Study|Lost to Follow-up|2|||
145271799|NCT00602979|523842715|FG002|Overall Study|Lost to Follow-up|3|||
145271800|NCT00602979|523842716|FG003|Overall Study|Lost to Follow-up|2|||
145271801|NCT00602979|523842717|FG004|Overall Study|Lost to Follow-up|3|||
145271802|NCT00602979|523842713|FG000|Overall Study|Failed Intubation|0|||
145271803|NCT00602979|523842714|FG001|Overall Study|Failed Intubation|1|||
145271804|NCT00602979|523842715|FG002|Overall Study|Failed Intubation|0|||
145271805|NCT00602979|523842716|FG003|Overall Study|Failed Intubation|1|||
145271806|NCT00602979|523842717|FG004|Overall Study|Failed Intubation|0|||
145271807|NCT00468312|523842718|FG000|Overall Study|Adverse Event|2|||
145271808|NCT00468312|523842719|FG001|Overall Study|Adverse Event|1|||
145271809|NCT00468312|523842718|FG000|Overall Study|Lack of Efficacy|0|||
145271810|NCT00468312|523842719|FG001|Overall Study|Lack of Efficacy|1|||
145271811|NCT00468312|523842718|FG000|Overall Study|Withdrawal by Subject|0|||
145271812|NCT00468312|523842719|FG001|Overall Study|Withdrawal by Subject|1|||
145271813|NCT00468312|523842718|FG000|Overall Study|Protocol Violation|2|||
145271814|NCT00468312|523842719|FG001|Overall Study|Protocol Violation|1|||
145271815|NCT00468312|523842718|FG000|Overall Study|Did not meet protocol eligibility|0|||
145271816|NCT00468312|523842719|FG001|Overall Study|Did not meet protocol eligibility|1|||
145271817|NCT00568776|523842728|FG000|Overall Study|Adverse Event|8|||
145271818|NCT00568776|523842729|FG001|Overall Study|Adverse Event|8|||
145271819|NCT00568776|523842730|FG002|Overall Study|Adverse Event|10|||
145271820|NCT00568776|523842731|FG003|Overall Study|Adverse Event|8|||
145271821|NCT00568776|523842728|FG000|Overall Study|Death|0|||
145271822|NCT00568776|523842729|FG001|Overall Study|Death|1|||
145271823|NCT00568776|523842730|FG002|Overall Study|Death|4|||
145271824|NCT00568776|523842731|FG003|Overall Study|Death|3|||
145271825|NCT00568776|523842728|FG000|Overall Study|Physician Decision|0|||
145271826|NCT00568776|523842729|FG001|Overall Study|Physician Decision|2|||
145271827|NCT00568776|523842730|FG002|Overall Study|Physician Decision|0|||
145271828|NCT00568776|523842731|FG003|Overall Study|Physician Decision|0|||
145271829|NCT00568776|523842728|FG000|Overall Study|Lack of Efficacy|2|||
145271830|NCT00568776|523842729|FG001|Overall Study|Lack of Efficacy|2|||
145271831|NCT00568776|523842730|FG002|Overall Study|Lack of Efficacy|2|||
145271832|NCT00568776|523842731|FG003|Overall Study|Lack of Efficacy|4|||
145271833|NCT00568776|523842728|FG000|Overall Study|Lost to Follow-up|1|||
145271834|NCT00568776|523842729|FG001|Overall Study|Lost to Follow-up|1|||
145271835|NCT00568776|523842730|FG002|Overall Study|Lost to Follow-up|1|||
145271836|NCT00568776|523842731|FG003|Overall Study|Lost to Follow-up|1|||
145271837|NCT00568776|523842728|FG000|Overall Study|Protocol Violation|1|||
145271838|NCT00568776|523842729|FG001|Overall Study|Protocol Violation|0|||
145271839|NCT00568776|523842730|FG002|Overall Study|Protocol Violation|1|||
145751334|NCT00883337|525603945|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
145751335|NCT00883337|525603943|FG000|Extension Treatment Period|Lost to Follow-up|1|||
145271840|NCT00568776|523842731|FG003|Overall Study|Protocol Violation|1|||
145271841|NCT00568776|523842728|FG000|Overall Study|Withdrawal by Subject|13|||
145271842|NCT00568776|523842729|FG001|Overall Study|Withdrawal by Subject|15|||
145271843|NCT00568776|523842730|FG002|Overall Study|Withdrawal by Subject|13|||
145271844|NCT00568776|523842731|FG003|Overall Study|Withdrawal by Subject|7|||
145271845|NCT00568776|523842728|FG000|Overall Study|Loss of Caregiver|0|||
145271846|NCT00568776|523842729|FG001|Overall Study|Loss of Caregiver|2|||
145271847|NCT00568776|523842730|FG002|Overall Study|Loss of Caregiver|1|||
145271848|NCT00568776|523842731|FG003|Overall Study|Loss of Caregiver|2|||
145271849|NCT00568776|523842728|FG000|Overall Study|Sponsor Decision|2|||
145271850|NCT00568776|523842729|FG001|Overall Study|Sponsor Decision|2|||
145271851|NCT00568776|523842730|FG002|Overall Study|Sponsor Decision|41|||
145271852|NCT00568776|523842731|FG003|Overall Study|Sponsor Decision|42|||
145271853|NCT00568776|523842728|FG000|Overall Study|Miscellaeneous|3|||
145271854|NCT00568776|523842729|FG001|Overall Study|Miscellaeneous|3|||
145751336|NCT00883337|525603944|FG001|Extension Treatment Period|Lost to Follow-up|0|||
145402695|NCT05399680|524332449|FG000|Overall Study|Death|0|||
145271855|NCT00568776|523842730|FG002|Overall Study|Miscellaeneous|1|||
145271856|NCT00568776|523842731|FG003|Overall Study|Miscellaeneous|4|||
145271857|NCT01005680|523842732|FG000|Overall Study|Lost to Follow-up|4|||
145271858|NCT01005680|523842733|FG001|Overall Study|Lost to Follow-up|6|||
145271859|NCT01005680|523842732|FG000|Overall Study|Withdrawal by Subject|1|||
145271860|NCT01005680|523842733|FG001|Overall Study|Withdrawal by Subject|4|||
145271861|NCT01005680|523842732|FG000|Overall Study|Physician Decision|1|||
145271862|NCT01005680|523842733|FG001|Overall Study|Physician Decision|1|||
145271863|NCT00916617|523842739|FG000|Overall Study|Adverse Event|3|||
145271864|NCT00916617|523842740|FG001|Overall Study|Adverse Event|2|||
145271865|NCT00916617|523842741|FG002|Overall Study|Adverse Event|6|||
145271866|NCT00916617|523842742|FG003|Overall Study|Adverse Event|3|||
145271867|NCT00916617|523842739|FG000|Overall Study|Withdrawal by Subject|3|||
145271868|NCT00916617|523842740|FG001|Overall Study|Withdrawal by Subject|2|||
145271869|NCT00916617|523842741|FG002|Overall Study|Withdrawal by Subject|0|||
145271870|NCT00916617|523842742|FG003|Overall Study|Withdrawal by Subject|1|||
145271871|NCT00916617|523842739|FG000|Overall Study|Caregiver Request|3|||
145271872|NCT00916617|523842740|FG001|Overall Study|Caregiver Request|2|||
145271873|NCT00916617|523842741|FG002|Overall Study|Caregiver Request|1|||
145271874|NCT00916617|523842742|FG003|Overall Study|Caregiver Request|0|||
145271875|NCT00916617|523842739|FG000|Overall Study|Physician Decision|1|||
145271876|NCT00916617|523842740|FG001|Overall Study|Physician Decision|1|||
145271877|NCT00916617|523842741|FG002|Overall Study|Physician Decision|0|||
145271878|NCT00916617|523842742|FG003|Overall Study|Physician Decision|0|||
145271879|NCT00916617|523842739|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
145271880|NCT00916617|523842740|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
145271881|NCT00916617|523842741|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
145271882|NCT00916617|523842742|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
145271883|NCT00916617|523842739|FG000|Overall Study|Lost to Follow-up|2|||
145271884|NCT00916617|523842740|FG001|Overall Study|Lost to Follow-up|1|||
145271885|NCT00916617|523842741|FG002|Overall Study|Lost to Follow-up|0|||
145271886|NCT00916617|523842742|FG003|Overall Study|Lost to Follow-up|0|||
145271887|NCT00916617|523842739|FG000|Overall Study|Lack of Efficacy|1|||
145271888|NCT00916617|523842740|FG001|Overall Study|Lack of Efficacy|0|||
145271889|NCT00916617|523842741|FG002|Overall Study|Lack of Efficacy|0|||
145271890|NCT00916617|523842742|FG003|Overall Study|Lack of Efficacy|0|||
145271891|NCT00916617|523842739|FG000|Overall Study|Other|2|||
145271892|NCT00916617|523842740|FG001|Overall Study|Other|0|||
145271893|NCT00916617|523842741|FG002|Overall Study|Other|0|||
145271894|NCT00916617|523842742|FG003|Overall Study|Other|2|||
145271895|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
145271896|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
145271897|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
145271898|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
145271899|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
145271900|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
145271901|NCT00566631|523842744|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
145271902|NCT00566631|523842744|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
145271903|NCT00566631|523842744|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
145271904|NCT00566631|523842744|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
145271905|NCT00566631|523842744|FG000|Part 2: Extension Phase|Adverse Event|11|||
145271906|NCT00566631|523842744|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
145271907|NCT00566631|523842744|FG000|Part 2: Extension Phase|Death|1|||
145271908|NCT00566631|523842744|FG000|Part 2: Extension Phase|Other|5|||
145271909|NCT02723786|523842746|FG000|Overall Study|Lost to Follow-up|1|||
145271910|NCT03170271|523842751|FG000|Overall Study|Adverse Event|7|||
145271911|NCT03170271|523842752|FG001|Overall Study|Adverse Event|2|||
145271912|NCT03170271|523842751|FG000|Overall Study|Lost to Follow-up|0|||
145271913|NCT03170271|523842752|FG001|Overall Study|Lost to Follow-up|1|||
145271914|NCT03170271|523842751|FG000|Overall Study|Physician Decision|1|||
145271915|NCT03170271|523842752|FG001|Overall Study|Physician Decision|0|||
145271916|NCT03170271|523842751|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
145402696|NCT05399680|524332450|FG001|Overall Study|Death|1|||
145271917|NCT03170271|523842752|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
145271918|NCT03170271|523842751|FG000|Overall Study|Withdrawal by Subject|17|||
145271919|NCT03170271|523842752|FG001|Overall Study|Withdrawal by Subject|5|||
145271920|NCT03170271|523842751|FG000|Overall Study|Other|2|||
145271921|NCT03170271|523842752|FG001|Overall Study|Other|2|||
145271922|NCT03170271|523842751|FG000|Overall Study|Randomized in error|4|||
145271923|NCT03170271|523842752|FG001|Overall Study|Randomized in error|0|||
145402697|NCT02659865|524332451|FG000|Period 1|Withdrawal by Subject|1|||
145271924|NCT03466060|523842768|FG000|Period 1|Test Lens Damage|0|||
145271925|NCT03466060|523842769|FG001|Period 1|Test Lens Damage|2|||
145271926|NCT03466060|523842770|FG002|Period 1|Test Lens Damage|0|||
145271927|NCT03466060|523842771|FG003|Period 1|Test Lens Damage|0|||
145271928|NCT03466060|523842772|FG004|Period 1|Test Lens Damage|0|||
145271929|NCT03466060|523842773|FG005|Period 1|Test Lens Damage|0|||
145271930|NCT03466060|523842768|FG000|Period 1|Withdrawal by Subject|0|||
145271931|NCT03466060|523842769|FG001|Period 1|Withdrawal by Subject|0|||
145271932|NCT03466060|523842770|FG002|Period 1|Withdrawal by Subject|2|||
145271933|NCT03466060|523842771|FG003|Period 1|Withdrawal by Subject|0|||
145271934|NCT03466060|523842772|FG004|Period 1|Withdrawal by Subject|0|||
145271935|NCT03466060|523842773|FG005|Period 1|Withdrawal by Subject|0|||
145271936|NCT03466060|523842768|FG000|Period 1|Lost to Follow-up|0|||
145271937|NCT03466060|523842769|FG001|Period 1|Lost to Follow-up|0|||
145271938|NCT03466060|523842770|FG002|Period 1|Lost to Follow-up|0|||
145271939|NCT03466060|523842771|FG003|Period 1|Lost to Follow-up|1|||
145271940|NCT03466060|523842772|FG004|Period 1|Lost to Follow-up|0|||
145271941|NCT03466060|523842773|FG005|Period 1|Lost to Follow-up|0|||
145271942|NCT03466060|523842768|FG000|Period 1|Grade 2 Conjunctivitis|0|||
145271943|NCT03466060|523842769|FG001|Period 1|Grade 2 Conjunctivitis|0|||
145271944|NCT03466060|523842770|FG002|Period 1|Grade 2 Conjunctivitis|1|||
145271945|NCT03466060|523842771|FG003|Period 1|Grade 2 Conjunctivitis|0|||
145271946|NCT03466060|523842772|FG004|Period 1|Grade 2 Conjunctivitis|0|||
145271947|NCT03466060|523842773|FG005|Period 1|Grade 2 Conjunctivitis|0|||
145271948|NCT03466060|523842768|FG000|Period 2|Lens Handling Difficulties|0|||
145271949|NCT03466060|523842769|FG001|Period 2|Lens Handling Difficulties|0|||
145271950|NCT03466060|523842770|FG002|Period 2|Lens Handling Difficulties|1|||
145271951|NCT03466060|523842771|FG003|Period 2|Lens Handling Difficulties|0|||
145271952|NCT03466060|523842772|FG004|Period 2|Lens Handling Difficulties|0|||
145271953|NCT03466060|523842773|FG005|Period 2|Lens Handling Difficulties|0|||
145271954|NCT00956813|523842776|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
145271955|NCT00956813|523842777|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
145271956|NCT00956813|523842776|FG000|Flaxseed and Placebo|Ineligible|3|||
145271957|NCT00956813|523842777|FG001|Flaxseed and Placebo|Ineligible|1|||
145271958|NCT04797637|523842778|FG000|Overall Study|Lost to Follow-up|23|||
145271959|NCT04797637|523842779|FG001|Overall Study|Lost to Follow-up|32|||
145271960|NCT04797637|523842778|FG000|Overall Study|Withdrawal by Subject|0|||
145271961|NCT04797637|523842779|FG001|Overall Study|Withdrawal by Subject|1|||
145271962|NCT02392377|523842784|FG000|Overall Study|Withdrawal by Subject|0|||
145271963|NCT02392377|523842785|FG001|Overall Study|Withdrawal by Subject|1|||
145271964|NCT01126359|523842788|FG000|First Intervention (20-minutes)|Physician Decision|0|||
145271965|NCT01126359|523842789|FG001|First Intervention (20-minutes)|Physician Decision|1|||
145271966|NCT00902486|523842790|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
145271967|NCT00902486|523842791|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
145271968|NCT00902486|523842792|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
145271969|NCT00902486|523842793|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
145271970|NCT00902486|523842794|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
145271971|NCT00902486|523842795|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
145271972|NCT00902486|523842790|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
145271973|NCT00902486|523842791|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
145271974|NCT00902486|523842792|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
145271975|NCT00902486|523842793|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
145271976|NCT00902486|523842794|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
145271977|NCT00902486|523842795|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
145271978|NCT00902486|523842790|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
145751337|NCT00883337|525603945|FG002|Extension Treatment Period|Lost to Follow-up|0|||
145271979|NCT00902486|523842791|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
145271980|NCT00902486|523842792|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
145271981|NCT00902486|523842793|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
145271982|NCT00902486|523842794|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
145271983|NCT00902486|523842795|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
145271984|NCT00902486|523842790|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
145271985|NCT00902486|523842791|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
145271986|NCT00902486|523842792|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
145271987|NCT00902486|523842793|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
145271988|NCT00902486|523842794|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
145271989|NCT00902486|523842795|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
145271990|NCT00902486|523842790|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
145271991|NCT00902486|523842791|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
145271992|NCT00902486|523842792|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
145271993|NCT00902486|523842793|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
145271994|NCT00902486|523842794|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
145271995|NCT00902486|523842795|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
145271996|NCT00902486|523842790|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
145271997|NCT00902486|523842791|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
145271998|NCT00902486|523842792|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
145271999|NCT00902486|523842793|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
145272000|NCT00902486|523842794|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
145272001|NCT00902486|523842795|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
145272002|NCT00902486|523842790|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
145272003|NCT00902486|523842791|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
145272004|NCT00902486|523842792|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
145272005|NCT00902486|523842793|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
145272006|NCT00902486|523842794|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
145272007|NCT00902486|523842795|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
145272008|NCT00902486|523842790|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
145272009|NCT00902486|523842791|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
145272010|NCT00902486|523842792|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
145272011|NCT00902486|523842793|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
145272012|NCT00902486|523842794|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
145272013|NCT00902486|523842795|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
145272014|NCT00902486|523842790|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
145272015|NCT00902486|523842791|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
145272016|NCT00902486|523842792|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
145272017|NCT00902486|523842793|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
145272018|NCT00902486|523842794|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
145272019|NCT00902486|523842795|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
145272020|NCT00902486|523842790|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
145272021|NCT00902486|523842791|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
145272022|NCT00902486|523842792|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
145272023|NCT00902486|523842793|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
145272024|NCT00902486|523842794|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
145272025|NCT00902486|523842795|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
145272026|NCT00902486|523842790|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
145272027|NCT00902486|523842791|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
145272028|NCT00902486|523842792|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
145272029|NCT00902486|523842793|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
145272030|NCT00902486|523842794|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
145272031|NCT00902486|523842795|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
145272032|NCT00526227|523842796|FG000|Overall Study|Device not implanted|1|||
145272033|NCT00526227|523842796|FG000|Overall Study|Death|1|||
145272034|NCT01525407|523842797|FG000|Overall Study|Change in recipient treatment plan|2|||
145272035|NCT01525407|523842798|FG001|Overall Study|Change in recipient treatment plan|2|||
145272036|NCT01525407|523842797|FG000|Overall Study|Withdrawal by Subject|0|||
145272037|NCT01525407|523842798|FG001|Overall Study|Withdrawal by Subject|1|||
145272038|NCT01525407|523842797|FG000|Overall Study|Transplant was delayed|0|||
145272039|NCT01525407|523842798|FG001|Overall Study|Transplant was delayed|1|||
145272040|NCT01525407|523842797|FG000|Overall Study|Delay in Transplant|1|||
145272041|NCT01525407|523842798|FG001|Overall Study|Delay in Transplant|0|||
145272042|NCT05378269|523844541|FG000|Overall Study|Protocol Violation|1|||
145272043|NCT05378269|523844542|FG001|Overall Study|Protocol Violation|0|||
145272044|NCT05378269|523844543|FG002|Overall Study|Protocol Violation|2|||
145272045|NCT05378269|523844544|FG003|Overall Study|Protocol Violation|0|||
145272046|NCT05378269|523844545|FG004|Overall Study|Protocol Violation|0|||
145272047|NCT00684645|523844546|FG000|Overall Study|Death|2|||
145272048|NCT00684645|523844546|FG000|Overall Study|Progressive disease|67|||
145272049|NCT00684645|523844546|FG000|Overall Study|Adverse Event|27|||
145272050|NCT00684645|523844546|FG000|Overall Study|Lost to Follow-up|3|||
145272051|NCT00684645|523844546|FG000|Overall Study|Other|15|||
145272052|NCT01186744|523844550|FG000|Overall Study|Lack of Efficacy|156|||
145272053|NCT01186744|523844551|FG001|Overall Study|Lack of Efficacy|99|||
145272054|NCT01186744|523844552|FG002|Overall Study|Lack of Efficacy|0|||
145272055|NCT01186744|523844553|FG003|Overall Study|Lack of Efficacy|2|||
145272056|NCT01186744|523844554|FG004|Overall Study|Lack of Efficacy|2|||
145272057|NCT01186744|523844555|FG005|Overall Study|Lack of Efficacy|5|||
145272058|NCT01186744|523844550|FG000|Overall Study|Protocol Violation|1|||
145526945|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
145526946|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
145526947|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
145526948|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
145526949|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
145526950|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
145751338|NCT00883337|525603943|FG000|Extension Treatment Period|Other than above|10|||
145272059|NCT01186744|523844551|FG001|Overall Study|Protocol Violation|2|||
145272060|NCT01186744|523844552|FG002|Overall Study|Protocol Violation|0|||
145526951|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
145751339|NCT00883337|525603944|FG001|Extension Treatment Period|Other than above|9|||
145526952|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
145526953|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
145526954|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
145751340|NCT00883337|525603945|FG002|Extension Treatment Period|Other than above|5|||
145751341|NCT01652287|525603947|FG000|Overall Study|Withdrawal by Subject|2|||
145751342|NCT01652287|525603948|FG001|Overall Study|Withdrawal by Subject|0|||
145751343|NCT00763139|525603954|FG000|Overall Study|Adverse Event|4|||
145751344|NCT00763139|525603955|FG001|Overall Study|Adverse Event|2|||
145751345|NCT00763139|525603954|FG000|Overall Study|Withdrawal by Subject|0|||
145751346|NCT00763139|525603955|FG001|Overall Study|Withdrawal by Subject|1|||
145751347|NCT00763139|525603954|FG000|Overall Study|med change not allowed by protocol|1|||
145751348|NCT00763139|525603955|FG001|Overall Study|med change not allowed by protocol|0|||
145751349|NCT01592760|525603956|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
145751350|NCT01592760|525603957|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
145526955|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
145526956|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
145751351|NCT01592760|525603958|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
145526957|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
145526958|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
145402698|NCT02659865|524332452|FG001|Period 1|Withdrawal by Subject|0|||
145402699|NCT02659865|524332453|FG002|Period 1|Withdrawal by Subject|0|||
145526959|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
145751352|NCT04312009|525603959|FG000|Overall Study|Withdrawal by Subject|2|||
145751353|NCT04312009|525603960|FG001|Overall Study|Withdrawal by Subject|1|||
145751354|NCT01363986|525603963|FG000|Overall Study|Disease progression|1|||
145751355|NCT01637142|525603964|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
145526960|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
145526961|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
145526962|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
145526963|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
145526964|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
145526965|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
145526966|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
145526967|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
145526968|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
145526969|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
145526970|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
145526971|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
145526972|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
145526973|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
145526974|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
145526975|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
145526976|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
145526977|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
145526978|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
145526979|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
145526980|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
145526981|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
145526982|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
145526983|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
145526984|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
145526985|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
145526986|NCT03739840|524790775|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
145526987|NCT03739840|524790776|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
145526988|NCT03739840|524790777|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
145526989|NCT03739840|524790778|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
145526990|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
145526991|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
145526992|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
145526993|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
145526994|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
145526995|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
145526996|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
145526997|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
145526998|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
145526999|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
145527000|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
145527001|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
145527002|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
145527003|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
145527004|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
145527005|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
145527006|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
145527007|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
145527008|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
145527009|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
145527010|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
145527011|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
145527012|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
145527013|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
145527014|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
145527015|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
145527016|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
145527017|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
145527018|NCT03739840|524790775|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
145527019|NCT03739840|524790776|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
145527020|NCT03739840|524790777|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
145527021|NCT03739840|524790778|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
145527022|NCT02962765|524790781|FG000|Overall Study|Protocol Violation|9|||
145527023|NCT02962765|524790781|FG000|Overall Study|Withdrawal by Subject|3|||
145527024|NCT02962765|524790781|FG000|Overall Study|Lost to Follow-up|1|||
145751356|NCT02354703|525603965|FG000|Overall Study|Withdrawal by Subject|1|||
145751357|NCT02354703|525603966|FG001|Overall Study|Withdrawal by Subject|1|||
145751358|NCT02354703|525603967|FG002|Overall Study|Withdrawal by Subject|1|||
145751359|NCT02354703|525603968|FG003|Overall Study|Withdrawal by Subject|1|||
145751360|NCT02354703|525603965|FG000|Overall Study|Lost to Follow-up|2|||
145751361|NCT02354703|525603966|FG001|Overall Study|Lost to Follow-up|7|||
145751362|NCT02354703|525603967|FG002|Overall Study|Lost to Follow-up|9|||
145751363|NCT02354703|525603968|FG003|Overall Study|Lost to Follow-up|2|||
145751364|NCT02354703|525603965|FG000|Overall Study|Adverse Event|0|||
145751365|NCT02354703|525603966|FG001|Overall Study|Adverse Event|0|||
145751366|NCT02354703|525603967|FG002|Overall Study|Adverse Event|1|||
145751367|NCT02354703|525603968|FG003|Overall Study|Adverse Event|0|||
145751368|NCT04681170|525603973|FG000|Stratified Enrolment & run-in|Death|1|||
145751369|NCT04681170|525603974|FG001|Stratified Enrolment & run-in|Death|0|||
145751370|NCT04681170|525603973|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
145751371|NCT04681170|525603974|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
145751372|NCT04681170|525603973|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
145272061|NCT01186744|523844553|FG003|Overall Study|Protocol Violation|1|||
145272062|NCT01186744|523844554|FG004|Overall Study|Protocol Violation|1|||
145272063|NCT01186744|523844555|FG005|Overall Study|Protocol Violation|2|||
145272064|NCT01186744|523844550|FG000|Overall Study|Lost to Follow-up|15|||
145272065|NCT01186744|523844551|FG001|Overall Study|Lost to Follow-up|16|||
145272066|NCT01186744|523844552|FG002|Overall Study|Lost to Follow-up|2|||
145272067|NCT01186744|523844553|FG003|Overall Study|Lost to Follow-up|1|||
145272068|NCT01186744|523844554|FG004|Overall Study|Lost to Follow-up|1|||
145272069|NCT01186744|523844555|FG005|Overall Study|Lost to Follow-up|4|||
145272070|NCT01186744|523844550|FG000|Overall Study|Screen failure|1|||
145272071|NCT01186744|523844551|FG001|Overall Study|Screen failure|1|||
145272072|NCT01186744|523844552|FG002|Overall Study|Screen failure|0|||
145272073|NCT01186744|523844553|FG003|Overall Study|Screen failure|1|||
145272074|NCT01186744|523844554|FG004|Overall Study|Screen failure|0|||
145272075|NCT01186744|523844555|FG005|Overall Study|Screen failure|0|||
145272076|NCT01186744|523844550|FG000|Overall Study|Withdrawal by Subject|14|||
145272077|NCT01186744|523844551|FG001|Overall Study|Withdrawal by Subject|10|||
145272078|NCT01186744|523844552|FG002|Overall Study|Withdrawal by Subject|2|||
145272079|NCT01186744|523844553|FG003|Overall Study|Withdrawal by Subject|5|||
145272080|NCT01186744|523844554|FG004|Overall Study|Withdrawal by Subject|0|||
145272081|NCT01186744|523844555|FG005|Overall Study|Withdrawal by Subject|6|||
145272082|NCT01186744|523844550|FG000|Overall Study|Study terminated by Sponsor|1|||
145272083|NCT01186744|523844551|FG001|Overall Study|Study terminated by Sponsor|0|||
145272084|NCT01186744|523844552|FG002|Overall Study|Study terminated by Sponsor|0|||
145272085|NCT01186744|523844553|FG003|Overall Study|Study terminated by Sponsor|0|||
145272086|NCT01186744|523844554|FG004|Overall Study|Study terminated by Sponsor|0|||
145272087|NCT01186744|523844555|FG005|Overall Study|Study terminated by Sponsor|0|||
145272088|NCT01186744|523844550|FG000|Overall Study|Other|9|||
145272089|NCT01186744|523844551|FG001|Overall Study|Other|10|||
145272090|NCT01186744|523844552|FG002|Overall Study|Other|1|||
145272091|NCT01186744|523844553|FG003|Overall Study|Other|2|||
145272092|NCT01186744|523844554|FG004|Overall Study|Other|1|||
145272093|NCT01186744|523844555|FG005|Overall Study|Other|5|||
145272094|NCT01186744|523844550|FG000|Overall Study|Adverse Event|10|||
145272095|NCT01186744|523844551|FG001|Overall Study|Adverse Event|14|||
145272096|NCT01186744|523844552|FG002|Overall Study|Adverse Event|1|||
145272097|NCT01186744|523844553|FG003|Overall Study|Adverse Event|0|||
145272098|NCT01186744|523844554|FG004|Overall Study|Adverse Event|1|||
145272099|NCT01186744|523844555|FG005|Overall Study|Adverse Event|4|||
145272100|NCT01186744|523844550|FG000|Overall Study|Death|1|||
145272101|NCT01186744|523844551|FG001|Overall Study|Death|0|||
145272102|NCT01186744|523844552|FG002|Overall Study|Death|0|||
145527025|NCT02962765|524790781|FG000|Overall Study|Death|1|||
145527026|NCT02962765|524790781|FG000|Overall Study|Limited access to study medication|3|||
145527027|NCT00750880|524790786|FG000|Overall Study|Adverse Event|76|||
145527028|NCT00750880|524790786|FG000|Overall Study|Death|4|||
145272103|NCT01186744|523844553|FG003|Overall Study|Death|0|||
145272104|NCT01186744|523844554|FG004|Overall Study|Death|0|||
145527029|NCT00750880|524790786|FG000|Overall Study|Lack of Efficacy|46|||
145751373|NCT04681170|525603974|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
145751374|NCT04681170|525603973|FG000|Open Label Efficacy Phase|Adverse Event|0|||
145751375|NCT04681170|525603974|FG001|Open Label Efficacy Phase|Adverse Event|2|||
145751376|NCT04681170|525603973|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
145751377|NCT04681170|525603974|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
145751378|NCT04681170|525603973|FG000|Open Label Safety Phase|AEs and none compliance|0|||
145751379|NCT04681170|525603974|FG001|Open Label Safety Phase|AEs and none compliance|1|||
145751380|NCT02468648|525603975|FG000|Overall Study|Death|1|||
145751381|NCT04232696|525603976|FG000|Overall Study|Implant attempted but not completed|5|||
145272105|NCT01186744|523844555|FG005|Overall Study|Death|0|||
145272106|NCT02325401|523844559|FG000|Overall Study|Withdrawal by Subject|0|||
145272107|NCT02325401|523844560|FG001|Overall Study|Withdrawal by Subject|1|||
145272108|NCT02325401|523844561|FG002|Overall Study|Withdrawal by Subject|1|||
145751382|NCT04232696|525603977|FG001|Overall Study|Implant attempted but not completed|2|||
145751383|NCT04232696|525603976|FG000|Overall Study|Not satisfied with therapy outcome|0|||
145751384|NCT04232696|525603977|FG001|Overall Study|Not satisfied with therapy outcome|8|||
145751385|NCT04232696|525603976|FG000|Overall Study|Adverse Event|0|||
145751386|NCT04232696|525603977|FG001|Overall Study|Adverse Event|3|||
145527030|NCT00750880|524790786|FG000|Overall Study|Lost to Follow-up|10|||
145527031|NCT00750880|524790786|FG000|Overall Study|Protocol Violation|15|||
145751387|NCT04232696|525603976|FG000|Overall Study|Withdrawal by Subject|0|||
145751388|NCT04232696|525603977|FG001|Overall Study|Withdrawal by Subject|3|||
145527032|NCT00750880|524790786|FG000|Overall Study|Withdrawal by Subject|33|||
145527033|NCT00750880|524790786|FG000|Overall Study|Physician Decision|20|||
145527034|NCT00750880|524790786|FG000|Overall Study|Administrative|11|||
145527035|NCT02169284|524790787|FG000|Overall Study|Physician Decision|0|||
145527036|NCT02169284|524790788|FG001|Overall Study|Physician Decision|1|||
145527037|NCT03583073|524790789|FG000|Overall Study|Lost to Follow-up|8|||
145527038|NCT03583073|524790790|FG001|Overall Study|Lost to Follow-up|12|||
145527039|NCT05323656|524790794|FG000|Overall Study|Still On-Treatment|6|||
145527040|NCT05323656|524790795|FG001|Overall Study|Still On-Treatment|6|||
145527041|NCT05323656|524790794|FG000|Overall Study|Progressive Disease|15|||
145527042|NCT05323656|524790795|FG001|Overall Study|Progressive Disease|14|||
145527043|NCT05323656|524790794|FG000|Overall Study|Adverse Event|2|||
145527044|NCT05323656|524790795|FG001|Overall Study|Adverse Event|3|||
145527045|NCT05323656|524790794|FG000|Overall Study|Death|1|||
145527046|NCT05323656|524790795|FG001|Overall Study|Death|2|||
145527047|NCT05323656|524790794|FG000|Overall Study|Withdrawal by Subject|1|||
145527048|NCT05323656|524790795|FG001|Overall Study|Withdrawal by Subject|0|||
145527049|NCT05323656|524790794|FG000|Overall Study|Clinical disease progression|0|||
145527050|NCT05323656|524790795|FG001|Overall Study|Clinical disease progression|1|||
145527051|NCT05323656|524790794|FG000|Overall Study|Patient and Investigator decision|1|||
145527052|NCT05323656|524790795|FG001|Overall Study|Patient and Investigator decision|0|||
145527053|NCT05323656|524790794|FG000|Overall Study|Physician Decision|0|||
145527054|NCT05323656|524790795|FG001|Overall Study|Physician Decision|1|||
145527055|NCT02495233|524790798|FG000|Overall Study|Miscellaneous|0|||
145527056|NCT02495233|524790799|FG001|Overall Study|Miscellaneous|1|||
145527057|NCT03880461|524790801|FG000|Overall Study|Determined ineligible after enrollment|45|||
145527058|NCT03880461|524790802|FG001|Overall Study|Determined ineligible after enrollment|44|||
145527059|NCT03880461|524790801|FG000|Overall Study|No weight measurement after enrollment|24|||
145527060|NCT03880461|524790802|FG001|Overall Study|No weight measurement after enrollment|17|||
145527061|NCT02325791|524790804|FG000|Overall Study|Adverse Event|0|||
145527062|NCT02325791|524790805|FG001|Overall Study|Adverse Event|1|||
145527063|NCT02325791|524790806|FG002|Overall Study|Adverse Event|1|||
145527064|NCT02325791|524790807|FG003|Overall Study|Adverse Event|0|||
145527065|NCT02325791|524790804|FG000|Overall Study|Death|0|||
145527066|NCT02325791|524790805|FG001|Overall Study|Death|3|||
145527067|NCT02325791|524790806|FG002|Overall Study|Death|0|||
145527068|NCT02325791|524790807|FG003|Overall Study|Death|1|||
145527069|NCT02325791|524790804|FG000|Overall Study|Lost to Follow-up|0|||
145527070|NCT02325791|524790805|FG001|Overall Study|Lost to Follow-up|15|||
145527071|NCT02325791|524790806|FG002|Overall Study|Lost to Follow-up|14|||
145527072|NCT02325791|524790807|FG003|Overall Study|Lost to Follow-up|9|||
145527073|NCT02325791|524790804|FG000|Overall Study|Physician Decision|0|||
145527074|NCT02325791|524790805|FG001|Overall Study|Physician Decision|1|||
145527075|NCT02325791|524790806|FG002|Overall Study|Physician Decision|1|||
145527076|NCT02325791|524790807|FG003|Overall Study|Physician Decision|0|||
145527077|NCT02325791|524790804|FG000|Overall Study|Protocol Violation|0|||
145272109|NCT03526679|523844562|FG000|Overall Study|still under treatment|2|||
145527078|NCT02325791|524790805|FG001|Overall Study|Protocol Violation|0|||
145527079|NCT02325791|524790806|FG002|Overall Study|Protocol Violation|1|||
145527080|NCT02325791|524790807|FG003|Overall Study|Protocol Violation|0|||
145527081|NCT02325791|524790804|FG000|Overall Study|Withdrawal by Subject|0|||
145527082|NCT02325791|524790805|FG001|Overall Study|Withdrawal by Subject|5|||
145751389|NCT04232696|525603976|FG000|Overall Study|Missed Visit|0|||
145751390|NCT04232696|525603977|FG001|Overall Study|Missed Visit|2|||
145527083|NCT02325791|524790806|FG002|Overall Study|Withdrawal by Subject|8|||
145527084|NCT02325791|524790807|FG003|Overall Study|Withdrawal by Subject|16|||
145751391|NCT04232696|525603976|FG000|Overall Study|Other reason|0|||
145751392|NCT04232696|525603977|FG001|Overall Study|Other reason|1|||
145527085|NCT01028378|524790809|FG000|Overall Study|Lost to Follow-up|12|||
145751393|NCT02787863|525603978|FG000|Overall Study|Death|1|||
145751394|NCT02787863|525603979|FG001|Overall Study|Death|0|||
145751395|NCT02787863|525603980|FG002|Overall Study|Death|1|||
145527086|NCT01028378|524790809|FG000|Overall Study|Withdrawal by Subject|1|||
145527087|NCT01028378|524790809|FG000|Overall Study|Adminstrative Reasons|4|||
145527088|NCT01298193|524790810|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
145527089|NCT01298193|524790810|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
145527090|NCT01298193|524790810|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
145527091|NCT01298193|524790810|FG000|Efficacy Phase (Second Cycle)|Death|1|||
145527092|NCT01115803|524790814|FG000|Overall Study|Withdrawal by Subject|0|||
145527093|NCT01115803|524790815|FG001|Overall Study|Withdrawal by Subject|0|||
145527094|NCT01115803|524790816|FG002|Overall Study|Withdrawal by Subject|0|||
145527095|NCT01115803|524790817|FG003|Overall Study|Withdrawal by Subject|0|||
145751396|NCT02787863|525603981|FG003|Overall Study|Death|0|||
145751397|NCT02787863|525603982|FG004|Overall Study|Death|0|||
145751398|NCT02787863|525603983|FG005|Overall Study|Death|0|||
145751399|NCT02787863|525603984|FG006|Overall Study|Death|0|||
145751400|NCT02787863|525603985|FG007|Overall Study|Death|0|||
145527096|NCT01115803|524790818|FG004|Overall Study|Withdrawal by Subject|0|||
145527097|NCT01115803|524790819|FG005|Overall Study|Withdrawal by Subject|0|||
145751401|NCT02787863|525603978|FG000|Overall Study|Withdrawal by Subject|0|||
145751402|NCT02787863|525603979|FG001|Overall Study|Withdrawal by Subject|1|||
145751403|NCT02787863|525603980|FG002|Overall Study|Withdrawal by Subject|1|||
145751404|NCT02787863|525603981|FG003|Overall Study|Withdrawal by Subject|0|||
145751405|NCT02787863|525603982|FG004|Overall Study|Withdrawal by Subject|0|||
145751406|NCT02787863|525603983|FG005|Overall Study|Withdrawal by Subject|0|||
145527098|NCT01115803|524790820|FG006|Overall Study|Withdrawal by Subject|1|||
145527099|NCT01115803|524790814|FG000|Overall Study|Lost to Follow-up|0|||
145751407|NCT02787863|525603984|FG006|Overall Study|Withdrawal by Subject|0|||
145751408|NCT02787863|525603985|FG007|Overall Study|Withdrawal by Subject|0|||
145751409|NCT01368835|525603986|FG000|Overall Study|Inclusion criteria/photography quality|22|||
145751410|NCT01368835|525603986|FG000|Overall Study|Lost to Follow-up|11|||
145527100|NCT01115803|524790815|FG001|Overall Study|Lost to Follow-up|0|||
145527101|NCT01115803|524790816|FG002|Overall Study|Lost to Follow-up|1|||
145527102|NCT01115803|524790817|FG003|Overall Study|Lost to Follow-up|0|||
145527103|NCT01115803|524790818|FG004|Overall Study|Lost to Follow-up|0|||
145527104|NCT01115803|524790819|FG005|Overall Study|Lost to Follow-up|0|||
145527105|NCT01115803|524790820|FG006|Overall Study|Lost to Follow-up|0|||
145527106|NCT01115803|524790814|FG000|Overall Study|Progressive Disease during Cycle1|0|||
145527107|NCT01115803|524790815|FG001|Overall Study|Progressive Disease during Cycle1|0|||
145751411|NCT01678144|525603987|FG000|Stage 1: MAR Classic|Adverse Event|1|||
145751412|NCT03118297|525603988|FG000|Overall Study|Lost to Follow-up|0|||
145527108|NCT01115803|524790816|FG002|Overall Study|Progressive Disease during Cycle1|0|||
145527109|NCT01115803|524790817|FG003|Overall Study|Progressive Disease during Cycle1|0|||
145527110|NCT01115803|524790818|FG004|Overall Study|Progressive Disease during Cycle1|0|||
145527111|NCT01115803|524790819|FG005|Overall Study|Progressive Disease during Cycle1|0|||
145527112|NCT01115803|524790820|FG006|Overall Study|Progressive Disease during Cycle1|1|||
145527113|NCT00064298|524790821|FG000|Overall Study|Withdrawal by Subject|2|||
145527114|NCT00064298|524790822|FG001|Overall Study|Withdrawal by Subject|1|||
145527115|NCT00064298|524790821|FG000|Overall Study|Lost to Follow-up|2|||
145527116|NCT00064298|524790822|FG001|Overall Study|Lost to Follow-up|2|||
145527117|NCT00064298|524790821|FG000|Overall Study|Death|0|||
145527118|NCT00064298|524790822|FG001|Overall Study|Death|1|||
145527119|NCT00064298|524790821|FG000|Overall Study|Disease Progression|2|||
145527120|NCT00064298|524790822|FG001|Overall Study|Disease Progression|1|||
145527121|NCT00450385|524790823|FG000|Overall Study|Death|3|||
145527122|NCT00450385|524790823|FG000|Overall Study|Protocol Violation|1|||
145527123|NCT00450385|524790823|FG000|Overall Study|Withdrawal by Subject|2|||
145527124|NCT00450385|524790823|FG000|Overall Study|Lack of Efficacy|2|||
145527125|NCT00450385|524790823|FG000|Overall Study|Adverse Event|1|||
145527126|NCT00450385|524790823|FG000|Overall Study|Physician Decision|1|||
145527127|NCT00450385|524790823|FG000|Overall Study|Other|3|||
145527128|NCT03475875|524790824|FG000|Period 1|Lost to Follow-up|1|||
145527129|NCT03475875|524790825|FG001|Period 1|Lost to Follow-up|0|||
145527130|NCT03475875|524790824|FG000|Period 1|Adverse Event|2|||
145527131|NCT03475875|524790825|FG001|Period 1|Adverse Event|1|||
145527132|NCT03475875|524790824|FG000|Period 2|Adverse Event|3|||
145527133|NCT03475875|524790825|FG001|Period 2|Adverse Event|0|||
145527134|NCT03475875|524790824|FG000|Period 2|Protocol Violation|0|||
145527135|NCT03475875|524790825|FG001|Period 2|Protocol Violation|1|||
145527136|NCT01390220|524790826|FG000|Test Dose Phase|Adverse Event|17|||
145527137|NCT01390220|524790827|FG001|Test Dose Phase|Adverse Event|0|||
145527138|NCT01390220|524790828|FG002|Test Dose Phase|Adverse Event|0|||
145527139|NCT01390220|524790826|FG000|Test Dose Phase|Withdrawal by Subject|8|||
145527140|NCT01390220|524790827|FG001|Test Dose Phase|Withdrawal by Subject|0|||
145527141|NCT01390220|524790828|FG002|Test Dose Phase|Withdrawal by Subject|0|||
145527142|NCT01390220|524790826|FG000|Test Dose Phase|Lost to Follow-up|2|||
145527143|NCT01390220|524790827|FG001|Test Dose Phase|Lost to Follow-up|0|||
145527144|NCT01390220|524790828|FG002|Test Dose Phase|Lost to Follow-up|0|||
145527145|NCT01390220|524790826|FG000|Test Dose Phase|Protocol Violation|8|||
145527146|NCT01390220|524790827|FG001|Test Dose Phase|Protocol Violation|0|||
145527147|NCT01390220|524790828|FG002|Test Dose Phase|Protocol Violation|0|||
145527148|NCT01390220|524790826|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
145527149|NCT01390220|524790827|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
145527150|NCT01390220|524790828|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
145527151|NCT01390220|524790826|FG000|Test Dose Phase|Study/Site closure|6|||
145527152|NCT01390220|524790827|FG001|Test Dose Phase|Study/Site closure|0|||
145527153|NCT01390220|524790828|FG002|Test Dose Phase|Study/Site closure|0|||
145527154|NCT01390220|524790826|FG000|Test Dose Phase|Caregiver no longer available|5|||
145527155|NCT01390220|524790827|FG001|Test Dose Phase|Caregiver no longer available|0|||
145527156|NCT01390220|524790828|FG002|Test Dose Phase|Caregiver no longer available|0|||
145527157|NCT01390220|524790826|FG000|Test Dose Phase|Noncompliance|2|||
145527158|NCT01390220|524790827|FG001|Test Dose Phase|Noncompliance|0|||
145527159|NCT01390220|524790828|FG002|Test Dose Phase|Noncompliance|0|||
145527160|NCT01390220|524790826|FG000|Test Dose Phase|Logistical|6|||
145527161|NCT01390220|524790827|FG001|Test Dose Phase|Logistical|0|||
145527162|NCT01390220|524790828|FG002|Test Dose Phase|Logistical|0|||
145527163|NCT01390220|524790826|FG000|Comparative Phase|Withdrawal by Subject|0|||
145527164|NCT01390220|524790827|FG001|Comparative Phase|Withdrawal by Subject|1|||
145527165|NCT01390220|524790828|FG002|Comparative Phase|Withdrawal by Subject|0|||
145527166|NCT04025710|524790829|FG000|Overall Study|Death|3|||
145527167|NCT04025710|524790829|FG000|Overall Study|Lost to Follow-up|5|||
145527168|NCT04025710|524790829|FG000|Overall Study|Withdrawal by Subject|1|||
145527169|NCT04025710|524790829|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
145527170|NCT04025710|524790829|FG000|Overall Study|Drop-out according to protocol|34|||
145527171|NCT03533686|524790832|FG000|Overall Study|Withdrawal by Subject|1|||
145527172|NCT03533686|524790833|FG001|Overall Study|Withdrawal by Subject|0|||
145527173|NCT03533686|524790834|FG002|Overall Study|Withdrawal by Subject|0|||
145527174|NCT03533686|524790835|FG003|Overall Study|Withdrawal by Subject|3|||
145527175|NCT03533686|524790836|FG004|Overall Study|Withdrawal by Subject|5|||
145527176|NCT03533686|524790837|FG005|Overall Study|Withdrawal by Subject|1|||
145527177|NCT03533686|524790832|FG000|Overall Study|Lost to Follow-up|0|||
145527178|NCT03533686|524790833|FG001|Overall Study|Lost to Follow-up|1|||
145527179|NCT03533686|524790834|FG002|Overall Study|Lost to Follow-up|0|||
145527180|NCT03533686|524790835|FG003|Overall Study|Lost to Follow-up|0|||
145527181|NCT03533686|524790836|FG004|Overall Study|Lost to Follow-up|2|||
145527182|NCT03533686|524790837|FG005|Overall Study|Lost to Follow-up|0|||
145527183|NCT03533686|524790832|FG000|Overall Study|Screen Failure|0|||
145527184|NCT03533686|524790833|FG001|Overall Study|Screen Failure|0|||
145527185|NCT03533686|524790834|FG002|Overall Study|Screen Failure|0|||
145527186|NCT03533686|524790835|FG003|Overall Study|Screen Failure|2|||
145527187|NCT03533686|524790836|FG004|Overall Study|Screen Failure|0|||
145527188|NCT03533686|524790837|FG005|Overall Study|Screen Failure|0|||
145527189|NCT00245583|524790838|FG000|Overall Study|Lost to Follow-up|1|||
145527190|NCT00245583|524790839|FG001|Overall Study|Lost to Follow-up|5|||
145527191|NCT00245583|524790838|FG000|Overall Study|Adverse Event|2|||
145527192|NCT00245583|524790839|FG001|Overall Study|Adverse Event|1|||
145527193|NCT00245583|524790838|FG000|Overall Study|Lack of Efficacy|1|||
145527194|NCT00245583|524790839|FG001|Overall Study|Lack of Efficacy|0|||
145527195|NCT00245583|524790838|FG000|Overall Study|Withdrawal by Subject|2|||
145527196|NCT00245583|524790839|FG001|Overall Study|Withdrawal by Subject|3|||
145527197|NCT00136604|524790840|FG000|Overall Study|Lost to Follow-up|1|||
145527198|NCT00136604|524790841|FG001|Overall Study|Lost to Follow-up|0|||
145527199|NCT00136604|524790842|FG002|Overall Study|Lost to Follow-up|0|||
145527200|NCT00136604|524790843|FG003|Overall Study|Lost to Follow-up|0|||
145527201|NCT00136604|524790844|FG004|Overall Study|Lost to Follow-up|1|||
145527202|NCT00136604|524790840|FG000|Overall Study|Migrated/moved from study area|0|||
145527203|NCT00136604|524790841|FG001|Overall Study|Migrated/moved from study area|1|||
145527204|NCT00136604|524790842|FG002|Overall Study|Migrated/moved from study area|0|||
145527205|NCT00136604|524790843|FG003|Overall Study|Migrated/moved from study area|0|||
145527206|NCT00136604|524790844|FG004|Overall Study|Migrated/moved from study area|0|||
145527207|NCT02017171|524790845|FG000|Overall Study|Death|10|||
145527208|NCT02017171|524790846|FG001|Overall Study|Death|4|||
145527209|NCT02017171|524790845|FG000|Overall Study|Withdrawal by Subject|23|||
145527210|NCT02017171|524790846|FG001|Overall Study|Withdrawal by Subject|17|||
145527211|NCT02017171|524790845|FG000|Overall Study|Lost to Follow-up|21|||
145527212|NCT02017171|524790846|FG001|Overall Study|Lost to Follow-up|20|||
145527213|NCT02017171|524790845|FG000|Overall Study|ESKD|6|||
145527214|NCT02017171|524790846|FG001|Overall Study|ESKD|2|||
145527215|NCT02017171|524790845|FG000|Overall Study|Miscellaneous|2|||
145527216|NCT02017171|524790846|FG001|Overall Study|Miscellaneous|3|||
145527217|NCT01562873|524790847|FG000|Overall Study|Disease Progression per RECIST|10|||
145527218|NCT01562873|524790848|FG001|Overall Study|Disease Progression per RECIST|0|||
145527219|NCT01562873|524790847|FG000|Overall Study|Adverse Event|1|||
145527220|NCT01562873|524790848|FG001|Overall Study|Adverse Event|0|||
145527221|NCT01562873|524790847|FG000|Overall Study|Clinical Disease Progression|9|||
145527222|NCT01562873|524790848|FG001|Overall Study|Clinical Disease Progression|0|||
145527223|NCT01562873|524790847|FG000|Overall Study|Clinical PD and adverse event|1|||
145527224|NCT01562873|524790848|FG001|Overall Study|Clinical PD and adverse event|0|||
145527225|NCT02536833|524790849|FG000|Overall Study|Discontinued Before Treatment|0|||
145527226|NCT02536833|524790850|FG001|Overall Study|Discontinued Before Treatment|0|||
145527227|NCT02536833|524790851|FG002|Overall Study|Discontinued Before Treatment|1|||
145527228|NCT02536833|524790852|FG003|Overall Study|Discontinued Before Treatment|2|||
145527229|NCT02536833|524790849|FG000|Overall Study|Adverse Event|1|||
145527230|NCT02536833|524790850|FG001|Overall Study|Adverse Event|3|||
145527231|NCT02536833|524790851|FG002|Overall Study|Adverse Event|4|||
145527232|NCT02536833|524790852|FG003|Overall Study|Adverse Event|1|||
145527233|NCT02536833|524790849|FG000|Overall Study|Lost to Follow-up|2|||
145527234|NCT02536833|524790850|FG001|Overall Study|Lost to Follow-up|1|||
145527235|NCT02536833|524790851|FG002|Overall Study|Lost to Follow-up|2|||
145527236|NCT02536833|524790852|FG003|Overall Study|Lost to Follow-up|2|||
145527237|NCT02536833|524790849|FG000|Overall Study|Physician Decision|0|||
145527238|NCT02536833|524790850|FG001|Overall Study|Physician Decision|0|||
145527239|NCT02536833|524790851|FG002|Overall Study|Physician Decision|0|||
145527240|NCT02536833|524790852|FG003|Overall Study|Physician Decision|1|||
145527241|NCT02536833|524790849|FG000|Overall Study|Site Terminated by Sponsor|2|||
145527242|NCT02536833|524790850|FG001|Overall Study|Site Terminated by Sponsor|2|||
145527243|NCT02536833|524790851|FG002|Overall Study|Site Terminated by Sponsor|2|||
145527244|NCT02536833|524790852|FG003|Overall Study|Site Terminated by Sponsor|2|||
145527245|NCT02536833|524790849|FG000|Overall Study|Subject Non-Compliance|0|||
145527246|NCT02536833|524790850|FG001|Overall Study|Subject Non-Compliance|1|||
145527247|NCT02536833|524790851|FG002|Overall Study|Subject Non-Compliance|1|||
145527248|NCT02536833|524790852|FG003|Overall Study|Subject Non-Compliance|0|||
145527249|NCT02536833|524790849|FG000|Overall Study|Withdrawal by Subject|4|||
145527250|NCT02536833|524790850|FG001|Overall Study|Withdrawal by Subject|3|||
145527251|NCT02536833|524790851|FG002|Overall Study|Withdrawal by Subject|5|||
145527252|NCT02536833|524790852|FG003|Overall Study|Withdrawal by Subject|11|||
145527253|NCT03370289|524790853|FG000|Overall Study|Screen Failure|1|||
145527254|NCT03370289|524790853|FG000|Overall Study|Sample Size Sufficient|4|||
145527255|NCT02220998|524790855|FG000|Overall Study|Randomized but Never Treated|1|||
145527256|NCT02220998|524790856|FG001|Overall Study|Randomized but Never Treated|2|||
145527257|NCT02220998|524790855|FG000|Overall Study|Death|2|||
145527258|NCT02220998|524790856|FG001|Overall Study|Death|0|||
145527259|NCT02220998|524790855|FG000|Overall Study|Lack of Efficacy|0|||
145527260|NCT02220998|524790856|FG001|Overall Study|Lack of Efficacy|5|||
145751413|NCT03118297|525603989|FG001|Overall Study|Lost to Follow-up|2|||
145751414|NCT02754726|525603990|FG000|Overall Study|Progressive Disease by RECIST|13|||
145751415|NCT02754726|525603990|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
145751416|NCT02754726|525603990|FG000|Overall Study|Clinical Disease Progression|5|||
145751417|NCT02754726|525603990|FG000|Overall Study|Adverse Event|3|||
145751418|NCT02754726|525603990|FG000|Overall Study|Withdrawal by Subject|1|||
145527261|NCT02220998|524790855|FG000|Overall Study|Lost to Follow-up|4|||
145527262|NCT02220998|524790856|FG001|Overall Study|Lost to Follow-up|4|||
145527263|NCT02764190|524790857|FG000|Overall Study|Lost to Follow-up|17|||
145527264|NCT02764190|524790858|FG001|Overall Study|Lost to Follow-up|13|||
145402700|NCT02659865|524332454|FG003|Period 1|Withdrawal by Subject|0|||
145402701|NCT02659865|524332455|FG004|Period 1|Withdrawal by Subject|0|||
145527265|NCT02140775|524790860|FG000|Overall Study|Withdrawal by Subject|30|||
145527266|NCT02140775|524790861|FG001|Overall Study|Withdrawal by Subject|7|||
145527267|NCT02942576|524790862|FG000|Overall Study|Adverse Event|28|||
145527268|NCT02942576|524790863|FG001|Overall Study|Adverse Event|6|||
145527269|NCT02942576|524790862|FG000|Overall Study|Withdrawal by Subject|7|||
145527270|NCT02942576|524790863|FG001|Overall Study|Withdrawal by Subject|5|||
145527271|NCT02942576|524790862|FG000|Overall Study|Physician Decision|1|||
145527272|NCT02942576|524790863|FG001|Overall Study|Physician Decision|4|||
145527273|NCT02942576|524790862|FG000|Overall Study|Other|10|||
145527274|NCT02942576|524790863|FG001|Overall Study|Other|8|||
145527275|NCT00194675|524790869|FG000|Overall Study|Lost to Follow-up|1|||
145527276|NCT00194675|524790870|FG001|Overall Study|Lost to Follow-up|1|||
145527277|NCT00194675|524790869|FG000|Overall Study|lack of interest|1|||
145527278|NCT00194675|524790870|FG001|Overall Study|lack of interest|1|||
145527279|NCT00194675|524790869|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
145527280|NCT00194675|524790870|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
145527281|NCT00194675|524790869|FG000|Overall Study|Protocol Violation|1|||
145527282|NCT00194675|524790870|FG001|Overall Study|Protocol Violation|0|||
145527283|NCT00194675|524790869|FG000|Overall Study|Death|1|||
145527284|NCT00194675|524790870|FG001|Overall Study|Death|0|||
145527285|NCT00473746|524790871|FG000|Period 1 (Phase 1)|Adverse Event|1|||
145527286|NCT00473746|524790872|FG001|Period 1 (Phase 1)|Adverse Event|0|||
145527287|NCT00473746|524790873|FG002|Period 1 (Phase 1)|Adverse Event|0|||
145527288|NCT00473746|524790874|FG003|Period 1 (Phase 1)|Adverse Event|0|||
145527289|NCT00473746|524790875|FG004|Period 1 (Phase 1)|Adverse Event|0|||
145527290|NCT00473746|524790871|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
145527291|NCT00473746|524790872|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
145527292|NCT00473746|524790873|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
145527293|NCT00473746|524790874|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
145527294|NCT00473746|524790875|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
145527295|NCT00473746|524790871|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
145527296|NCT00473746|524790872|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
145527297|NCT00473746|524790873|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
145527298|NCT00473746|524790874|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
145527299|NCT00473746|524790875|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
145527300|NCT00473746|524790871|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
145527301|NCT00473746|524790872|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
145527302|NCT00473746|524790873|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
145527303|NCT00473746|524790874|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
145527304|NCT00473746|524790875|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
145527305|NCT00473746|524790871|FG000|Period 1 (Phase 1)|Reason not specified|0|||
145527306|NCT00473746|524790872|FG001|Period 1 (Phase 1)|Reason not specified|1|||
145527307|NCT00473746|524790873|FG002|Period 1 (Phase 1)|Reason not specified|0|||
145527308|NCT00473746|524790874|FG003|Period 1 (Phase 1)|Reason not specified|0|||
145527309|NCT00473746|524790875|FG004|Period 1 (Phase 1)|Reason not specified|0|||
145527310|NCT00473746|524790871|FG000|Period 2 (Phase 2)|Adverse Event|0|||
145527311|NCT00473746|524790872|FG001|Period 2 (Phase 2)|Adverse Event|0|||
145527312|NCT00473746|524790873|FG002|Period 2 (Phase 2)|Adverse Event|0|||
145527313|NCT00473746|524790874|FG003|Period 2 (Phase 2)|Adverse Event|0|||
145527314|NCT00473746|524790875|FG004|Period 2 (Phase 2)|Adverse Event|3|||
145527315|NCT00473746|524790871|FG000|Period 2 (Phase 2)|Death|0|||
145527316|NCT00473746|524790872|FG001|Period 2 (Phase 2)|Death|0|||
145527317|NCT00473746|524790873|FG002|Period 2 (Phase 2)|Death|0|||
145527318|NCT00473746|524790874|FG003|Period 2 (Phase 2)|Death|0|||
145527319|NCT00473746|524790875|FG004|Period 2 (Phase 2)|Death|1|||
145527320|NCT00473746|524790871|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
145527321|NCT00473746|524790872|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
145527322|NCT00473746|524790873|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
145272110|NCT01956123|523844563|FG000|COS Cycle 2|Protocol Violation|8|||
145272111|NCT01956123|523844564|FG001|COS Cycle 2|Protocol Violation|3|||
145272112|NCT01956123|523844565|FG002|COS Cycle 2|Protocol Violation|0|||
145272113|NCT01956123|523844566|FG003|COS Cycle 2|Protocol Violation|0|||
145272114|NCT01956123|523844563|FG000|COS Cycle 2|Adverse Event|3|||
145272115|NCT01956123|523844564|FG001|COS Cycle 2|Adverse Event|4|||
145272116|NCT01956123|523844565|FG002|COS Cycle 2|Adverse Event|0|||
145527323|NCT00473746|524790874|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
145527324|NCT00473746|524790875|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
145527325|NCT00473746|524790871|FG000|Period 2 (Phase 2)|Reason not specified|0|||
145527326|NCT00473746|524790872|FG001|Period 2 (Phase 2)|Reason not specified|0|||
145527327|NCT00473746|524790873|FG002|Period 2 (Phase 2)|Reason not specified|0|||
145527328|NCT00473746|524790874|FG003|Period 2 (Phase 2)|Reason not specified|0|||
145527329|NCT00473746|524790875|FG004|Period 2 (Phase 2)|Reason not specified|3|||
145527330|NCT02280473|524790879|FG000|Overall Study|Adverse Event|1|||
145527331|NCT02280473|524790880|FG001|Overall Study|Adverse Event|1|||
145272117|NCT01956123|523844566|FG003|COS Cycle 2|Adverse Event|0|||
145272118|NCT01956123|523844563|FG000|COS Cycle 2|Personal Reasons|2|||
145272119|NCT01956123|523844564|FG001|COS Cycle 2|Personal Reasons|0|||
145527332|NCT02280473|524790879|FG000|Overall Study|Lack of Efficacy|0|||
145527333|NCT02280473|524790880|FG001|Overall Study|Lack of Efficacy|1|||
145527334|NCT02280473|524790879|FG000|Overall Study|Lost to Follow-up|0|||
145527335|NCT02280473|524790880|FG001|Overall Study|Lost to Follow-up|1|||
145527336|NCT01280955|524790885|FG000|Overall Study|Death|2|||
145527337|NCT01280955|524790885|FG000|Overall Study|Withdrawal by Subject|1|||
145527338|NCT01484054|524790888|FG000|Period 1|Withdrawal by Subject|0|||
145527339|NCT01484054|524790889|FG001|Period 1|Withdrawal by Subject|1|||
145527340|NCT04223232|524790890|FG000|Overall Study|Withdrawal by Subject|1|||
145527341|NCT00364130|524790891|FG000|Intervention Period|Lost to Follow-up|4|||
145527342|NCT00364130|524790892|FG001|Intervention Period|Lost to Follow-up|3|||
145527343|NCT00364130|524790891|FG000|Intervention Period|Pregnancy|1|||
145527344|NCT00364130|524790892|FG001|Intervention Period|Pregnancy|0|||
145527345|NCT00364130|524790891|FG000|Intervention Period|Withdrawal by Subject|4|||
145527346|NCT00364130|524790892|FG001|Intervention Period|Withdrawal by Subject|5|||
145272120|NCT01956123|523844565|FG002|COS Cycle 2|Personal Reasons|0|||
145272121|NCT01956123|523844566|FG003|COS Cycle 2|Personal Reasons|0|||
145527347|NCT00364130|524790891|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
145527348|NCT00364130|524790892|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
145527349|NCT05281601|524790900|FG000|Overall Study|Physician Decision|2|||
145527350|NCT05281601|524790901|FG001|Overall Study|Physician Decision|0|||
145527351|NCT05281601|524790900|FG000|Overall Study|Lost to Follow-up|2|||
145527352|NCT05281601|524790901|FG001|Overall Study|Lost to Follow-up|0|||
145527353|NCT05281601|524790900|FG000|Overall Study|Death|1|||
145527354|NCT05281601|524790901|FG001|Overall Study|Death|0|||
145527355|NCT05281601|524790900|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145527356|NCT05281601|524790901|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145527357|NCT00901927|524790902|FG000|Overall Study|Lack of Efficacy|1|||
145527358|NCT00901927|524790902|FG000|Overall Study|Protocol Violation|3|||
145527359|NCT00901927|524790902|FG000|Overall Study|Withdrawal by Subject|2|||
145527360|NCT03172910|524792496|FG000|Overall Study|Adverse Event|0|||
145527361|NCT03172910|524792497|FG001|Overall Study|Adverse Event|0|||
145527362|NCT03172910|524792498|FG002|Overall Study|Adverse Event|0|||
145527363|NCT03172910|524792499|FG003|Overall Study|Adverse Event|0|||
145527364|NCT03172910|524792500|FG004|Overall Study|Adverse Event|1|||
145527365|NCT00451451|524792509|FG000|Overall Study|Adverse Event|11|||
145527366|NCT00451451|524792510|FG001|Overall Study|Adverse Event|21|||
145527367|NCT00451451|524792511|FG002|Overall Study|Adverse Event|26|||
145527368|NCT00451451|524792512|FG003|Overall Study|Adverse Event|10|||
145527369|NCT00451451|524792509|FG000|Overall Study|Lost to Follow-up|11|||
145527370|NCT00451451|524792510|FG001|Overall Study|Lost to Follow-up|9|||
145527371|NCT00451451|524792511|FG002|Overall Study|Lost to Follow-up|8|||
145527372|NCT00451451|524792512|FG003|Overall Study|Lost to Follow-up|11|||
145527373|NCT00451451|524792509|FG000|Overall Study|Consent Withdrawn|14|||
145527374|NCT00451451|524792510|FG001|Overall Study|Consent Withdrawn|9|||
145527375|NCT00451451|524792511|FG002|Overall Study|Consent Withdrawn|17|||
145527376|NCT00451451|524792512|FG003|Overall Study|Consent Withdrawn|17|||
145527377|NCT00451451|524792509|FG000|Overall Study|Investigator Decision|6|||
145527378|NCT00451451|524792510|FG001|Overall Study|Investigator Decision|2|||
145527379|NCT00451451|524792511|FG002|Overall Study|Investigator Decision|1|||
145527380|NCT00451451|524792512|FG003|Overall Study|Investigator Decision|2|||
145527381|NCT00451451|524792509|FG000|Overall Study|Subject Non-Compliance|8|||
145527382|NCT00451451|524792510|FG001|Overall Study|Subject Non-Compliance|4|||
145527383|NCT00451451|524792511|FG002|Overall Study|Subject Non-Compliance|3|||
145527384|NCT00451451|524792512|FG003|Overall Study|Subject Non-Compliance|3|||
145527385|NCT00451451|524792509|FG000|Overall Study|Death|1|||
145527386|NCT00451451|524792510|FG001|Overall Study|Death|0|||
145527387|NCT00451451|524792511|FG002|Overall Study|Death|0|||
145527388|NCT00451451|524792512|FG003|Overall Study|Death|1|||
145527389|NCT00451451|524792509|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
145527390|NCT00451451|524792510|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
145527391|NCT00451451|524792511|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
145751419|NCT02754726|525603990|FG000|Overall Study|Tolerability|1|||
145751420|NCT01885000|525603991|FG000|Overall Study|Adverse Event|1|||
145751421|NCT01885000|525603992|FG001|Overall Study|Adverse Event|0|||
145751422|NCT01885000|525603991|FG000|Overall Study|Withdrawal by Subject|1|||
145527392|NCT00451451|524792512|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
145527393|NCT00122278|524792513|FG000|Overall Study|Lost to Follow-up|2|||
145527394|NCT00122278|524792514|FG001|Overall Study|Lost to Follow-up|0|||
145527395|NCT01002482|524792515|FG000|Overall Study|Withdrawal by Subject|14|||
145527396|NCT01002482|524792516|FG001|Overall Study|Withdrawal by Subject|21|||
145527397|NCT01002482|524792515|FG000|Overall Study|Included twice|1|||
145527398|NCT01002482|524792516|FG001|Overall Study|Included twice|0|||
145527399|NCT01865084|524792517|FG000|Double Blind Period (DB)|Adverse Event|2|||
145527400|NCT01865084|524792518|FG001|Double Blind Period (DB)|Adverse Event|2|||
145527401|NCT01865084|524792519|FG002|Double Blind Period (DB)|Adverse Event|1|||
145527402|NCT01865084|524792517|FG000|Double Blind Period (DB)|Protocol Violation|0|||
145527403|NCT01865084|524792518|FG001|Double Blind Period (DB)|Protocol Violation|0|||
145527404|NCT01865084|524792519|FG002|Double Blind Period (DB)|Protocol Violation|1|||
145527405|NCT01865084|524792517|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
145527406|NCT01865084|524792518|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
145527407|NCT01865084|524792519|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
145527408|NCT01865084|524792517|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
145527409|NCT01865084|524792518|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
145527410|NCT01865084|524792519|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
145527411|NCT01865084|524792517|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
145527412|NCT01865084|524792518|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
145527413|NCT01865084|524792519|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
145527414|NCT01865084|524792517|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
145527415|NCT01865084|524792518|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
145527416|NCT01865084|524792519|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
145527417|NCT01865084|524792517|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
145527418|NCT01865084|524792518|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
145527419|NCT01865084|524792519|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
145527420|NCT01865084|524792517|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
145527421|NCT01865084|524792518|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
145527422|NCT01865084|524792519|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
145527423|NCT01865084|524792517|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
145527424|NCT01865084|524792518|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
145527425|NCT01865084|524792519|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
145527426|NCT02247531|524792523|FG000|Overall Study|Adverse Event|3|||
145527427|NCT02247531|524792524|FG001|Overall Study|Adverse Event|4|||
145527428|NCT02247531|524792525|FG002|Overall Study|Adverse Event|9|||
145527429|NCT02247531|524792523|FG000|Overall Study|Death|8|||
145527430|NCT02247531|524792524|FG001|Overall Study|Death|9|||
145527431|NCT02247531|524792525|FG002|Overall Study|Death|5|||
145527432|NCT02247531|524792523|FG000|Overall Study|Lost to Follow-up|1|||
145527433|NCT02247531|524792524|FG001|Overall Study|Lost to Follow-up|8|||
145527434|NCT02247531|524792525|FG002|Overall Study|Lost to Follow-up|3|||
145527435|NCT02247531|524792523|FG000|Overall Study|Non-compliance|2|||
145527436|NCT02247531|524792524|FG001|Overall Study|Non-compliance|2|||
145527437|NCT02247531|524792525|FG002|Overall Study|Non-compliance|0|||
145527438|NCT02247531|524792523|FG000|Overall Study|Withdrawal by Subject|26|||
145527439|NCT02247531|524792524|FG001|Overall Study|Withdrawal by Subject|31|||
145527440|NCT02247531|524792525|FG002|Overall Study|Withdrawal by Subject|25|||
145272122|NCT01956123|523844563|FG000|COS Cycle 2|Withdrawal by Subject|1|||
145272123|NCT01956123|523844564|FG001|COS Cycle 2|Withdrawal by Subject|0|||
145272124|NCT01956123|523844565|FG002|COS Cycle 2|Withdrawal by Subject|0|||
145272125|NCT01956123|523844566|FG003|COS Cycle 2|Withdrawal by Subject|0|||
145272126|NCT01956123|523844563|FG000|COS Cycle 3|Protocol Violation|0|||
145272127|NCT01956123|523844564|FG001|COS Cycle 3|Protocol Violation|0|||
145272128|NCT01956123|523844565|FG002|COS Cycle 3|Protocol Violation|2|||
145272129|NCT01956123|523844566|FG003|COS Cycle 3|Protocol Violation|1|||
145272130|NCT01956123|523844563|FG000|COS Cycle 3|Adverse Event|0|||
145272131|NCT01956123|523844564|FG001|COS Cycle 3|Adverse Event|0|||
145272132|NCT01956123|523844565|FG002|COS Cycle 3|Adverse Event|3|||
145402702|NCT02659865|524332451|FG000|Period 1|Adverse Event|0|||
145527441|NCT02247531|524792523|FG000|Overall Study|Study Terminated by Sponsor|64|||
145527442|NCT02247531|524792524|FG001|Overall Study|Study Terminated by Sponsor|66|||
145527443|NCT02247531|524792525|FG002|Overall Study|Study Terminated by Sponsor|62|||
145527444|NCT02247531|524792523|FG000|Overall Study|Physician Decision|0|||
145527445|NCT02247531|524792524|FG001|Overall Study|Physician Decision|2|||
145527446|NCT02247531|524792525|FG002|Overall Study|Physician Decision|2|||
145527447|NCT02247531|524792523|FG000|Overall Study|Unspecified Reason|2|||
145527448|NCT02247531|524792524|FG001|Overall Study|Unspecified Reason|3|||
145527449|NCT02247531|524792525|FG002|Overall Study|Unspecified Reason|4|||
145527450|NCT03875118|524792530|FG000|Overall Study|Withdrawal by Subject|4|||
145527451|NCT03875118|524792531|FG001|Overall Study|Withdrawal by Subject|4|||
145527452|NCT02423109|524792532|FG000|Lens 1|Adverse Event|1|||
145527453|NCT02423109|524792533|FG001|Lens 1|Adverse Event|0|||
145272133|NCT01956123|523844566|FG003|COS Cycle 3|Adverse Event|0|||
145272134|NCT01956123|523844563|FG000|COS Cycle 3|Personal Reasons|0|||
145272135|NCT01956123|523844564|FG001|COS Cycle 3|Personal Reasons|0|||
145272136|NCT01956123|523844565|FG002|COS Cycle 3|Personal Reasons|1|||
145272137|NCT01956123|523844566|FG003|COS Cycle 3|Personal Reasons|0|||
145272138|NCT01956123|523844563|FG000|COS Cycle 3|Withdrawal by Subject|0|||
145527454|NCT03468985|524792534|FG000|Overall Study|Adverse Event|0|||
145527455|NCT03468985|524792535|FG001|Overall Study|Adverse Event|2|||
145527456|NCT03468985|524792536|FG002|Overall Study|Adverse Event|0|||
145527457|NCT03468985|524792537|FG003|Overall Study|Adverse Event|0|||
145527458|NCT03468985|524792534|FG000|Overall Study|Withdrawal by Subject|0|||
145527459|NCT03468985|524792535|FG001|Overall Study|Withdrawal by Subject|0|||
145527460|NCT03468985|524792536|FG002|Overall Study|Withdrawal by Subject|0|||
145527461|NCT03468985|524792537|FG003|Overall Study|Withdrawal by Subject|1|||
145527462|NCT04060862|524792538|FG000|Overall Study|Symptomatic Deterioration|1|||
145527463|NCT04060862|524792538|FG000|Overall Study|Un-specified|6|||
145527464|NCT04060862|524792538|FG000|Overall Study|Progressive disease|12|||
145527465|NCT04060862|524792538|FG000|Overall Study|Physician Decision|1|||
145527466|NCT03416374|524792544|FG000|Between Treatment Period I and II|Other|0|||
145527467|NCT03416374|524792545|FG001|Between Treatment Period I and II|Other|9|||
145527468|NCT03416374|524792544|FG000|Treatment Period II|Lack of Efficacy|3|||
145527469|NCT03416374|524792545|FG001|Treatment Period II|Lack of Efficacy|11|||
145527470|NCT03416374|524792544|FG000|Treatment Period II|Adverse Event|1|||
145527471|NCT03416374|524792545|FG001|Treatment Period II|Adverse Event|4|||
145527472|NCT03416374|524792544|FG000|Treatment Period II|Death|0|||
145527473|NCT03416374|524792545|FG001|Treatment Period II|Death|1|||
145527474|NCT03416374|524792544|FG000|Treatment Period II|Other|0|||
145527475|NCT03416374|524792545|FG001|Treatment Period II|Other|2|||
145527476|NCT03463031|524792548|FG000|Overall Study|Withdrawal by Subject|4|||
145527477|NCT03463031|524792549|FG001|Overall Study|Withdrawal by Subject|2|||
145527478|NCT03463031|524792548|FG000|Overall Study|Investigator/Sponsor Decision|0|||
145527479|NCT03463031|524792549|FG001|Overall Study|Investigator/Sponsor Decision|1|||
145527480|NCT03463031|524792548|FG000|Overall Study|Lost to Follow-up|1|||
145527481|NCT03463031|524792549|FG001|Overall Study|Lost to Follow-up|1|||
145527482|NCT03463031|524792548|FG000|Overall Study|Adverse Event|4|||
145527483|NCT03463031|524792549|FG001|Overall Study|Adverse Event|1|||
145527484|NCT03463031|524792548|FG000|Overall Study|Use of prohibited medication by subject|1|||
145527485|NCT03463031|524792549|FG001|Overall Study|Use of prohibited medication by subject|0|||
145527486|NCT01810432|524792550|FG000|Washout|Protocol Violation|0|||
145527487|NCT01810432|524792551|FG001|Washout|Protocol Violation|1|||
145527488|NCT01810432|524792550|FG000|Washout|Adverse Event|1|||
145527489|NCT01810432|524792551|FG001|Washout|Adverse Event|0|||
145527490|NCT01810432|524792550|FG000|Period 2|Withdrawal by Subject|2|||
145527491|NCT01810432|524792551|FG001|Period 2|Withdrawal by Subject|1|||
145527492|NCT01810432|524792550|FG000|Period 2|Physician Decision|1|||
145527493|NCT01810432|524792551|FG001|Period 2|Physician Decision|0|||
145527494|NCT01810432|524792550|FG000|Period 2|Lost to Follow-up|1|||
145527495|NCT01810432|524792551|FG001|Period 2|Lost to Follow-up|1|||
145527496|NCT01264016|524792552|FG000|Overall Study|Withdrawal by Subject|1|||
145527497|NCT01264016|524792552|FG000|Overall Study|Felt faint at sight of blood|1|||
145527498|NCT01629706|524792553|FG000|Phase 1 PureVision|Screen Failure|4|||
145402703|NCT02659865|524332452|FG001|Period 1|Adverse Event|0|||
145527499|NCT01629706|524792553|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
145527500|NCT01629706|524792553|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
145527501|NCT01629706|524792553|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
145527502|NCT01629706|524792553|FG000|Phase 2 Habitual|Screen Failure|6|||
145527503|NCT01629706|524792553|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
145527504|NCT01629706|524792553|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
145527505|NCT01629706|524792553|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
145527506|NCT01629706|524792553|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
145527507|NCT02117414|524792554|FG000|Overall Study|Death|5|||
145527508|NCT02117414|524792555|FG001|Overall Study|Death|2|||
145527509|NCT02117414|524792554|FG000|Overall Study|Withdrawal by Subject|10|||
145527510|NCT02117414|524792555|FG001|Overall Study|Withdrawal by Subject|4|||
145527511|NCT02537574|524792556|FG000|Overall Study|Adverse Event|1|||
145527512|NCT02537574|524792557|FG001|Overall Study|Adverse Event|3|||
145527513|NCT02537574|524792558|FG002|Overall Study|Adverse Event|2|||
145527514|NCT02537574|524792556|FG000|Overall Study|Lost to Follow-up|40|||
145527515|NCT02537574|524792557|FG001|Overall Study|Lost to Follow-up|51|||
145527516|NCT02537574|524792558|FG002|Overall Study|Lost to Follow-up|55|||
145527517|NCT02537574|524792556|FG000|Overall Study|Noncompliance with study drug|0|||
145527518|NCT02537574|524792557|FG001|Overall Study|Noncompliance with study drug|1|||
145527519|NCT02537574|524792558|FG002|Overall Study|Noncompliance with study drug|1|||
145527520|NCT02537574|524792556|FG000|Overall Study|Physician Decision|2|||
145527521|NCT02537574|524792557|FG001|Overall Study|Physician Decision|0|||
145527522|NCT02537574|524792558|FG002|Overall Study|Physician Decision|0|||
145527523|NCT02537574|524792556|FG000|Overall Study|Protocol Violation|4|||
145527524|NCT02537574|524792557|FG001|Overall Study|Protocol Violation|2|||
145527525|NCT02537574|524792558|FG002|Overall Study|Protocol Violation|3|||
145527526|NCT02537574|524792556|FG000|Overall Study|Withdrawal by Subject|37|||
145527527|NCT02537574|524792557|FG001|Overall Study|Withdrawal by Subject|27|||
145527528|NCT02537574|524792558|FG002|Overall Study|Withdrawal by Subject|29|||
145527529|NCT02537574|524792556|FG000|Overall Study|Lack of Efficacy|14|||
145527530|NCT02537574|524792557|FG001|Overall Study|Lack of Efficacy|16|||
145527531|NCT02537574|524792558|FG002|Overall Study|Lack of Efficacy|15|||
145527532|NCT02537574|524792556|FG000|Overall Study|Duplicate Patient|1|||
145527533|NCT02537574|524792557|FG001|Overall Study|Duplicate Patient|0|||
145527534|NCT02537574|524792558|FG002|Overall Study|Duplicate Patient|0|||
145527535|NCT02537574|524792556|FG000|Overall Study|Patient not Stable|0|||
145527536|NCT02537574|524792557|FG001|Overall Study|Patient not Stable|1|||
145527537|NCT02537574|524792558|FG002|Overall Study|Patient not Stable|0|||
145527538|NCT02537574|524792556|FG000|Overall Study|Incarceration|0|||
145527539|NCT02537574|524792557|FG001|Overall Study|Incarceration|1|||
145527540|NCT02537574|524792558|FG002|Overall Study|Incarceration|0|||
145527541|NCT02537574|524792556|FG000|Overall Study|Failed Naloxone Challenge|0|||
145527542|NCT02537574|524792557|FG001|Overall Study|Failed Naloxone Challenge|1|||
145527543|NCT02537574|524792558|FG002|Overall Study|Failed Naloxone Challenge|0|||
145527544|NCT02537574|524792556|FG000|Overall Study|Transportation Issues|0|||
145527545|NCT02537574|524792557|FG001|Overall Study|Transportation Issues|0|||
145527546|NCT02537574|524792558|FG002|Overall Study|Transportation Issues|1|||
145527547|NCT02537574|524792556|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
145527548|NCT02537574|524792557|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
145527549|NCT02537574|524792558|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
145527550|NCT02537574|524792556|FG000|Overall Study|Noncompliance with Protocol|0|||
145527551|NCT02537574|524792557|FG001|Overall Study|Noncompliance with Protocol|0|||
145527552|NCT02537574|524792558|FG002|Overall Study|Noncompliance with Protocol|1|||
145527553|NCT01151098|524792559|FG000|Overall Study|Adverse Event|82|||
145527554|NCT01151098|524792559|FG000|Overall Study|Lost to Follow-up|6|||
145527555|NCT01151098|524792559|FG000|Overall Study|Lack of Efficacy|15|||
145527556|NCT01151098|524792559|FG000|Overall Study|Protocol Violation|1|||
145527557|NCT01151098|524792559|FG000|Overall Study|Miscellaneous|13|||
145527558|NCT03343067|524792562|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
145527559|NCT03343067|524792563|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
145527560|NCT03343067|524792564|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
145527561|NCT00116168|524792565|FG000|Overall Study|Lost to Follow-up|6|||
145527562|NCT00116168|524792566|FG001|Overall Study|Lost to Follow-up|5|||
145527563|NCT00116168|524792567|FG002|Overall Study|Lost to Follow-up|0|||
145527564|NCT00116168|524792568|FG003|Overall Study|Lost to Follow-up|0|||
145527565|NCT01323946|524792569|FG000|Overall Study|Lost to Follow-up|0|||
145527566|NCT01323946|524792570|FG001|Overall Study|Lost to Follow-up|1|||
145527567|NCT01323946|524792571|FG002|Overall Study|Lost to Follow-up|0|||
145527568|NCT01323946|524792569|FG000|Overall Study|Parents refused the last blood draw|1|||
145527569|NCT01323946|524792570|FG001|Overall Study|Parents refused the last blood draw|0|||
145527570|NCT01323946|524792571|FG002|Overall Study|Parents refused the last blood draw|0|||
145527571|NCT01323946|524792569|FG000|Overall Study|Withdrawal by Subject|2|||
145527572|NCT01323946|524792570|FG001|Overall Study|Withdrawal by Subject|2|||
145527573|NCT01323946|524792571|FG002|Overall Study|Withdrawal by Subject|0|||
145527574|NCT01243671|524792572|FG000|Overall Study|Adverse Event|3|||
145527575|NCT01243671|524792572|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
145527576|NCT01243671|524792572|FG000|Overall Study|Other|1|||
145527577|NCT05342532|524792576|FG000|Overall Study|Adverse Event|5|||
145527578|NCT05342532|524792577|FG001|Overall Study|Adverse Event|20|||
145527579|NCT05342532|524792576|FG000|Overall Study|Lost to Follow-up|10|||
145527580|NCT05342532|524792577|FG001|Overall Study|Lost to Follow-up|15|||
145527581|NCT02675231|524792578|FG000|Overall Study|Withdrawal by Subject|2|||
145527582|NCT02675231|524792579|FG001|Overall Study|Withdrawal by Subject|4|||
145527583|NCT02675231|524792580|FG002|Overall Study|Withdrawal by Subject|2|||
145527584|NCT02675231|524792578|FG000|Overall Study|Lost to Follow-up|3|||
145527585|NCT02675231|524792579|FG001|Overall Study|Lost to Follow-up|4|||
145527586|NCT02675231|524792580|FG002|Overall Study|Lost to Follow-up|3|||
145527587|NCT02652767|524792581|FG000|Overall Study|Death|2|||
145527588|NCT02652767|524792581|FG000|Overall Study|Lost to Follow-up|1|||
145527589|NCT02652767|524792581|FG000|Overall Study|Withdrawal by Subject|1|||
145527590|NCT00887744|524792590|FG000|Overall Study|Adverse Event|3|||
145527591|NCT00887744|524792590|FG000|Overall Study|Death|1|||
145527592|NCT00887744|524792590|FG000|Overall Study|Lost to Follow-up|3|||
145527593|NCT00887744|524792590|FG000|Overall Study|Withdrawal by Subject|18|||
145527594|NCT00887744|524792590|FG000|Overall Study|Various reasons|9|||
145527595|NCT00586846|524792592|FG000|Overall Study|Physician Decision|1|||
145527596|NCT00586846|524792592|FG000|Overall Study|Death|1|||
145527597|NCT00586846|524792592|FG000|Overall Study|Evaluable for Toxicity Only|4|||
145527598|NCT05298306|524792593|FG000|Overall Study|Physician Decision|0|||
145527599|NCT05298306|524792594|FG001|Overall Study|Physician Decision|0|||
145751423|NCT01885000|525603992|FG001|Overall Study|Withdrawal by Subject|1|||
145751424|NCT01885000|525603991|FG000|Overall Study|Protocol Violation|0|||
145751425|NCT01885000|525603992|FG001|Overall Study|Protocol Violation|1|||
145751426|NCT02162732|525603993|FG000|Overall Study|Biopsy not performed.|18|||
145751427|NCT02363686|525603994|FG000|Overall Study|Withdrawal by Subject|22|||
145751428|NCT02363686|525603994|FG000|Overall Study|incomplete FEES examinations|13|||
145751429|NCT03446885|525604003|FG000|Overall Study|Lost to Follow-up|1|||
145751430|NCT03446885|525604004|FG001|Overall Study|Lost to Follow-up|0|||
145751431|NCT03446885|525604003|FG000|Overall Study|Did not complete entire visit|1|||
145751432|NCT03446885|525604004|FG001|Overall Study|Did not complete entire visit|0|||
145751433|NCT05882318|525604011|FG000|Overall Study|Withdrawal by Subject|1|||
145751434|NCT05882318|525604012|FG001|Overall Study|Withdrawal by Subject|0|||
145751435|NCT05882318|525604011|FG000|Overall Study|Protocol Violation|0|||
145751436|NCT05882318|525604012|FG001|Overall Study|Protocol Violation|1|||
145527600|NCT05298306|524792595|FG002|Overall Study|Physician Decision|0|||
145527601|NCT05298306|524792596|FG003|Overall Study|Physician Decision|1|||
145527602|NCT05298306|524792597|FG004|Overall Study|Physician Decision|0|||
145527603|NCT05298306|524792598|FG005|Overall Study|Physician Decision|0|||
145527604|NCT01702571|524792605|FG000|Overall Study|Death|1067|||
145527605|NCT01702571|524792606|FG001|Overall Study|Death|76|||
145527606|NCT01702571|524792605|FG000|Overall Study|Lost to Follow-up|144|||
145751437|NCT03557359|525604015|FG000|Dose 1: 240 mg|Adverse Event|1|||
145751438|NCT03557359|525604016|FG001|Dose 1: 240 mg|Adverse Event|0|||
145751439|NCT03092726|525604017|FG000|Overall Study|Adverse Event|3|||
145751440|NCT03092726|525604018|FG001|Overall Study|Adverse Event|10|||
145751441|NCT03092726|525604017|FG000|Overall Study|Lack of Efficacy|0|||
145751442|NCT03092726|525604018|FG001|Overall Study|Lack of Efficacy|1|||
145527607|NCT01702571|524792606|FG001|Overall Study|Lost to Follow-up|10|||
145527608|NCT01702571|524792605|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
145527609|NCT01702571|524792606|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
145527610|NCT01702571|524792605|FG000|Overall Study|Investigator Decision|5|||
145527611|NCT01702571|524792606|FG001|Overall Study|Investigator Decision|0|||
145527612|NCT01702571|524792605|FG000|Overall Study|Not Classifiable|1|||
145751443|NCT03092726|525604017|FG000|Overall Study|Lost to Follow-up|1|||
145751444|NCT03092726|525604018|FG001|Overall Study|Lost to Follow-up|0|||
145751445|NCT03092726|525604017|FG000|Overall Study|Withdrawal by Subject|5|||
145751446|NCT03092726|525604018|FG001|Overall Study|Withdrawal by Subject|3|||
145751447|NCT01294800|525604019|FG000|Overall Study|Adverse Event|7|||
145751448|NCT01294800|525604020|FG001|Overall Study|Adverse Event|6|||
145527613|NCT01702571|524792606|FG001|Overall Study|Not Classifiable|0|||
145527614|NCT01702571|524792605|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
145527615|NCT01702571|524792606|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
145527616|NCT01702571|524792605|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
145527617|NCT01702571|524792606|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
145527618|NCT01702571|524792605|FG000|Overall Study|Progressive Disease|3|||
145527619|NCT01702571|524792606|FG001|Overall Study|Progressive Disease|0|||
145527620|NCT01702571|524792605|FG000|Overall Study|Protocol Violation|2|||
145527621|NCT01702571|524792606|FG001|Overall Study|Protocol Violation|0|||
145527622|NCT01702571|524792605|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
145527623|NCT01702571|524792606|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
145527624|NCT01702571|524792605|FG000|Overall Study|Termination By Sponsor|4|||
145527625|NCT01702571|524792606|FG001|Overall Study|Termination By Sponsor|0|||
145527626|NCT01702571|524792605|FG000|Overall Study|Withdrawal by Subject|177|||
145527627|NCT01702571|524792606|FG001|Overall Study|Withdrawal by Subject|29|||
145751449|NCT01294800|525604021|FG002|Overall Study|Adverse Event|12|||
145527628|NCT00191646|524792607|FG000|Overall Study|Toxicity|26|||
145527629|NCT00191646|524792608|FG001|Overall Study|Toxicity|37|||
145527630|NCT00191646|524792607|FG000|Overall Study|Disease Progression|5|||
145527631|NCT00191646|524792608|FG001|Overall Study|Disease Progression|6|||
145527632|NCT00191646|524792607|FG000|Overall Study|Physician Decision|20|||
145527633|NCT00191646|524792608|FG001|Overall Study|Physician Decision|11|||
145527634|NCT00191646|524792607|FG000|Overall Study|Withdrawal by Subject|58|||
145527635|NCT00191646|524792608|FG001|Overall Study|Withdrawal by Subject|39|||
145527636|NCT00191646|524792607|FG000|Overall Study|Protocol Violation|5|||
145527637|NCT00191646|524792608|FG001|Overall Study|Protocol Violation|7|||
145527638|NCT00191646|524792607|FG000|Overall Study|Death|6|||
145527639|NCT00191646|524792608|FG001|Overall Study|Death|8|||
145527640|NCT00191646|524792607|FG000|Overall Study|Other|33|||
145527641|NCT00191646|524792608|FG001|Overall Study|Other|34|||
145527642|NCT00191646|524792607|FG000|Overall Study|Missing Data|18|||
145527643|NCT00191646|524792608|FG001|Overall Study|Missing Data|11|||
145527644|NCT03194490|524792614|FG000|Overall Study|Lost to Follow-up|1|||
145527645|NCT03194490|524792615|FG001|Overall Study|Lost to Follow-up|3|||
145527646|NCT03194490|524792614|FG000|Overall Study|participant developed specific neck pain|1|||
145527647|NCT03194490|524792615|FG001|Overall Study|participant developed specific neck pain|0|||
145527648|NCT01574079|524792616|FG000|Overall Study|Physician Decision|0|||
145527649|NCT01574079|524792617|FG001|Overall Study|Physician Decision|2|||
145527650|NCT01574079|524792616|FG000|Overall Study|Lost to Follow-up|1|||
145527651|NCT01574079|524792617|FG001|Overall Study|Lost to Follow-up|0|||
145527652|NCT00406718|524792618|FG000|Overall Study|Withdrawal by Subject|2|||
145527653|NCT00406718|524792619|FG001|Overall Study|Withdrawal by Subject|9|||
145527654|NCT00406718|524792620|FG002|Overall Study|Withdrawal by Subject|4|||
145527655|NCT00406718|524792618|FG000|Overall Study|Lost to Follow-up|2|||
145527656|NCT00406718|524792619|FG001|Overall Study|Lost to Follow-up|5|||
145527657|NCT00406718|524792620|FG002|Overall Study|Lost to Follow-up|4|||
145527658|NCT03640559|524792621|FG000|Overall Study|Physician Decision|1|||
145527659|NCT03640559|524792622|FG001|Overall Study|Physician Decision|1|||
145527660|NCT03640559|524792621|FG000|Overall Study|Withdrawal by Subject|1|||
145527661|NCT03640559|524792622|FG001|Overall Study|Withdrawal by Subject|0|||
145527662|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
145527663|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
145527664|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
145527665|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
145527666|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
145527667|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
145527668|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
145527669|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
145527670|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
145527671|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
145527672|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
145527673|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
145527674|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
145527675|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145527676|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
145527677|NCT01436162|524792623|FG000|Single-blind Lead-in Phase|Other|107|||
145527678|NCT01436162|524792624|FG001|Single-blind Lead-in Phase|Other|0|||
145527679|NCT01436162|524792625|FG002|Single-blind Lead-in Phase|Other|0|||
145527680|NCT01436162|524792623|FG000|Randomized Phase|Adverse Event|1|||
145527681|NCT01436162|524792624|FG001|Randomized Phase|Adverse Event|5|||
145527682|NCT01436162|524792625|FG002|Randomized Phase|Adverse Event|6|||
145527683|NCT01436162|524792623|FG000|Randomized Phase|Protocol Violation|4|||
145527684|NCT01436162|524792624|FG001|Randomized Phase|Protocol Violation|4|||
145527685|NCT01436162|524792625|FG002|Randomized Phase|Protocol Violation|2|||
145527686|NCT01436162|524792623|FG000|Randomized Phase|Withdrawal by Subject|16|||
145527687|NCT01436162|524792624|FG001|Randomized Phase|Withdrawal by Subject|9|||
145527688|NCT01436162|524792625|FG002|Randomized Phase|Withdrawal by Subject|8|||
145527689|NCT01436162|524792623|FG000|Randomized Phase|Lost to Follow-up|17|||
145527690|NCT01436162|524792624|FG001|Randomized Phase|Lost to Follow-up|5|||
145527691|NCT01436162|524792625|FG002|Randomized Phase|Lost to Follow-up|4|||
145527692|NCT01436162|524792623|FG000|Randomized Phase|Lack of Efficacy|0|||
145527693|NCT01436162|524792624|FG001|Randomized Phase|Lack of Efficacy|1|||
145527694|NCT01436162|524792625|FG002|Randomized Phase|Lack of Efficacy|1|||
145527695|NCT01436162|524792623|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
145527696|NCT01436162|524792624|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
145527697|NCT01436162|524792625|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
145751450|NCT01294800|525604022|FG003|Overall Study|Adverse Event|5|||
145751451|NCT01294800|525604019|FG000|Overall Study|Subject Withdrew Consent|2|||
145751452|NCT01294800|525604020|FG001|Overall Study|Subject Withdrew Consent|2|||
145527698|NCT01436162|524792623|FG000|Randomized Phase|Other|2|||
145751453|NCT01294800|525604021|FG002|Overall Study|Subject Withdrew Consent|2|||
145527699|NCT01436162|524792624|FG001|Randomized Phase|Other|5|||
145527700|NCT01436162|524792625|FG002|Randomized Phase|Other|4|||
145527701|NCT01888003|524792626|FG000|Overall Study|Study Terminated|5|||
145527702|NCT01888003|524792627|FG001|Overall Study|Study Terminated|6|||
145527703|NCT01888003|524792628|FG002|Overall Study|Study Terminated|40|||
145527704|NCT03187756|524792629|FG000|Overall Study|Termination of study|4|||
145527705|NCT01931202|524792633|FG000|Overall Study|Withdrawal by Subject|0|||
145527706|NCT01931202|524792634|FG001|Overall Study|Withdrawal by Subject|0|||
145527707|NCT01931202|524792635|FG002|Overall Study|Withdrawal by Subject|2|||
145527708|NCT01931202|524792633|FG000|Overall Study|Lost to Follow-up|0|||
145527709|NCT01931202|524792634|FG001|Overall Study|Lost to Follow-up|5|||
145527710|NCT01931202|524792635|FG002|Overall Study|Lost to Follow-up|2|||
145527711|NCT04597918|524792638|FG000|Overall Study|Withdrawal by Subject|6|||
145527712|NCT04597918|524792638|FG000|Overall Study|Lost to Follow-up|3|||
145527713|NCT04597918|524792638|FG000|Overall Study|Death|1|||
145527714|NCT01876810|524792639|FG000|Overall Study|Physician Decision|0|||
145527715|NCT01876810|524792640|FG001|Overall Study|Physician Decision|1|||
145527716|NCT05140382|524792643|FG000|Overall Study|Death|3|||
145527717|NCT05140382|524792644|FG001|Overall Study|Death|0|||
145527718|NCT05140382|524792645|FG002|Overall Study|Death|0|||
145527719|NCT05140382|524792643|FG000|Overall Study|Investigator decision|1|||
145527720|NCT05140382|524792644|FG001|Overall Study|Investigator decision|0|||
145527721|NCT05140382|524792645|FG002|Overall Study|Investigator decision|0|||
145527722|NCT05140382|524792643|FG000|Overall Study|Other|4|||
145527723|NCT05140382|524792644|FG001|Overall Study|Other|0|||
145527724|NCT05140382|524792645|FG002|Overall Study|Other|1|||
145527725|NCT05140382|524792643|FG000|Overall Study|Progressive disease|20|||
145527726|NCT05140382|524792644|FG001|Overall Study|Progressive disease|1|||
145527727|NCT05140382|524792645|FG002|Overall Study|Progressive disease|12|||
145527728|NCT05140382|524792643|FG000|Overall Study|Subjective disease progression|2|||
145527729|NCT05140382|524792644|FG001|Overall Study|Subjective disease progression|1|||
145527730|NCT05140382|524792645|FG002|Overall Study|Subjective disease progression|0|||
145527731|NCT05140382|524792643|FG000|Overall Study|Unknown at data cut-off|0|||
145527732|NCT05140382|524792644|FG001|Overall Study|Unknown at data cut-off|0|||
145527733|NCT05140382|524792645|FG002|Overall Study|Unknown at data cut-off|1|||
145527734|NCT05140382|524792643|FG000|Overall Study|Withdrawal by Subject|1|||
145527735|NCT05140382|524792644|FG001|Overall Study|Withdrawal by Subject|0|||
145527736|NCT05140382|524792645|FG002|Overall Study|Withdrawal by Subject|4|||
145527737|NCT05140382|524792643|FG000|Overall Study|Withdrawal of consent|0|||
145527738|NCT05140382|524792644|FG001|Overall Study|Withdrawal of consent|0|||
145527739|NCT05140382|524792645|FG002|Overall Study|Withdrawal of consent|1|||
145527740|NCT01442038|524794315|FG000|Overall Study|Death|35|||
145751454|NCT01294800|525604022|FG003|Overall Study|Subject Withdrew Consent|11|||
145751455|NCT01294800|525604019|FG000|Overall Study|Lost to Follow-up|0|||
145751456|NCT01294800|525604020|FG001|Overall Study|Lost to Follow-up|0|||
145751457|NCT01294800|525604021|FG002|Overall Study|Lost to Follow-up|1|||
145751458|NCT01294800|525604022|FG003|Overall Study|Lost to Follow-up|0|||
145751459|NCT01294800|525604019|FG000|Overall Study|Non-compliance With Protocol|0|||
145751460|NCT01294800|525604020|FG001|Overall Study|Non-compliance With Protocol|1|||
145751461|NCT01294800|525604021|FG002|Overall Study|Non-compliance With Protocol|1|||
145751462|NCT01294800|525604022|FG003|Overall Study|Non-compliance With Protocol|0|||
145751463|NCT01294800|525604019|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
145751464|NCT01294800|525604020|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
145751465|NCT01294800|525604021|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
145527741|NCT01442038|524794316|FG001|Overall Study|Death|29|||
145527742|NCT01442038|524794315|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
145527743|NCT01442038|524794316|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
145527744|NCT01442038|524794315|FG000|Overall Study|Participant Withdrew Consent|137|||
145527745|NCT01442038|524794316|FG001|Overall Study|Participant Withdrew Consent|102|||
145527746|NCT01442038|524794315|FG000|Overall Study|Lost to Follow-up|37|||
145527747|NCT01442038|524794316|FG001|Overall Study|Lost to Follow-up|51|||
145527748|NCT01442038|524794315|FG000|Overall Study|Adverse Event|26|||
145527749|NCT01442038|524794316|FG001|Overall Study|Adverse Event|15|||
145527750|NCT01442038|524794315|FG000|Overall Study|Protocol Deviation|9|||
145527751|NCT01442038|524794316|FG001|Overall Study|Protocol Deviation|20|||
145751466|NCT01294800|525604022|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
145751467|NCT00493038|525604023|FG000|Treatment|Adverse Event|8|||
145751468|NCT00493038|525604024|FG001|Treatment|Adverse Event|4|||
145751469|NCT00493038|525604023|FG000|Treatment|Lost to Follow-up|5|||
145751470|NCT00493038|525604024|FG001|Treatment|Lost to Follow-up|3|||
145751471|NCT00493038|525604023|FG000|Treatment|Withdrawal by Subject|11|||
145751472|NCT00493038|525604024|FG001|Treatment|Withdrawal by Subject|12|||
145751473|NCT00493038|525604023|FG000|Treatment|Other|0|||
145527752|NCT01442038|524794315|FG000|Overall Study|Investigator's Discretion|13|||
145527753|NCT01442038|524794316|FG001|Overall Study|Investigator's Discretion|16|||
145527754|NCT01442038|524794315|FG000|Overall Study|Study Terminated By Sponsor|2|||
145527755|NCT01442038|524794316|FG001|Overall Study|Study Terminated By Sponsor|3|||
145527756|NCT00089284|524794317|FG000|Overall Study|Adverse event before starting treatment|0|||
145527757|NCT00089284|524794318|FG001|Overall Study|Adverse event before starting treatment|0|||
145527758|NCT00089284|524794319|FG002|Overall Study|Adverse event before starting treatment|0|||
145527759|NCT00089284|524794320|FG003|Overall Study|Adverse event before starting treatment|0|||
145527760|NCT00089284|524794321|FG004|Overall Study|Adverse event before starting treatment|0|||
145527761|NCT00089284|524794322|FG005|Overall Study|Adverse event before starting treatment|0|||
145527762|NCT00089284|524794323|FG006|Overall Study|Adverse event before starting treatment|1|||
145527763|NCT02428608|524794325|FG000|Overall Study|Pregnancy|2|||
145527764|NCT02428608|524794325|FG000|Overall Study|Lost to Follow-up|37|||
145527765|NCT02428608|524794325|FG000|Overall Study|Withdrawal by Subject|2|||
145527766|NCT02428608|524794325|FG000|Overall Study|scheduling conflicts|15|||
145527767|NCT02428608|524794325|FG000|Overall Study|moved away|10|||
145527768|NCT02428608|524794325|FG000|Overall Study|Death|1|||
145527769|NCT02428608|524794325|FG000|Overall Study|various|16|||
145527770|NCT01092507|524794326|FG000|Overall Study|Withdrawal by Subject|2|||
145527771|NCT01092507|524794327|FG001|Overall Study|Withdrawal by Subject|0|||
145527772|NCT00417482|524794332|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
145527773|NCT00417482|524794333|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
145751474|NCT00493038|525604024|FG001|Treatment|Other|1|||
145527774|NCT00417482|524794334|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
145527775|NCT00417482|524794332|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
145527776|NCT00417482|524794333|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
145527777|NCT00417482|524794334|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
145527778|NCT00417482|524794332|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
145527779|NCT00417482|524794333|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
145527780|NCT00417482|524794334|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
145527781|NCT00417482|524794332|FG000|Phase B 1st 16 Weeks|Death|1|||
145527782|NCT00417482|524794333|FG001|Phase B 1st 16 Weeks|Death|0|||
145527783|NCT00417482|524794334|FG002|Phase B 1st 16 Weeks|Death|0|||
145527784|NCT00417482|524794332|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
145527785|NCT00417482|524794333|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
145527786|NCT00417482|524794334|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
145527787|NCT00417482|524794332|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
145527788|NCT00417482|524794333|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
145527789|NCT00417482|524794334|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
145527790|NCT00417482|524794332|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
145527791|NCT00417482|524794333|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
145527792|NCT00417482|524794334|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
145527793|NCT00417482|524794332|FG000|Phase B 2nd 16 Weeks|Death|1|||
145527794|NCT00417482|524794333|FG001|Phase B 2nd 16 Weeks|Death|1|||
145527795|NCT00417482|524794334|FG002|Phase B 2nd 16 Weeks|Death|0|||
145527796|NCT06400979|524794335|FG000|Overall Study|Lost to Follow-up|29|||
145527797|NCT06400979|524794335|FG000|Overall Study|Withdrawal by Subject|1|||
145527798|NCT00117286|524794338|FG000|Overall Study|Adverse Event|12|||
145527799|NCT00117286|524794339|FG001|Overall Study|Adverse Event|6|||
145527800|NCT00117286|524794338|FG000|Overall Study|Lost to Follow-up|2|||
145527801|NCT00117286|524794339|FG001|Overall Study|Lost to Follow-up|0|||
145527802|NCT00117286|524794338|FG000|Overall Study|Protocol Violation|3|||
145527803|NCT00117286|524794339|FG001|Overall Study|Protocol Violation|3|||
145527804|NCT00117286|524794338|FG000|Overall Study|Withdrawal by Subject|6|||
145527805|NCT00117286|524794339|FG001|Overall Study|Withdrawal by Subject|2|||
145527806|NCT00117286|524794338|FG000|Overall Study|Physician Decision|3|||
145527807|NCT00117286|524794339|FG001|Overall Study|Physician Decision|7|||
145527808|NCT00117286|524794338|FG000|Overall Study|Lack of Efficacy|2|||
145527809|NCT00117286|524794339|FG001|Overall Study|Lack of Efficacy|1|||
145527810|NCT00117286|524794338|FG000|Overall Study|Research site closing|0|||
145527811|NCT00117286|524794339|FG001|Overall Study|Research site closing|2|||
145527812|NCT01272661|524794340|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
145527813|NCT01272661|524794341|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
145527814|NCT01272661|524794342|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
145527815|NCT01367119|524794343|FG000|Overall Study|Adverse Event|1|||
145527816|NCT01367119|524794344|FG001|Overall Study|Adverse Event|0|||
145527817|NCT01367119|524794343|FG000|Overall Study|Withdrawal by Subject|1|||
145527818|NCT01367119|524794344|FG001|Overall Study|Withdrawal by Subject|1|||
145527819|NCT03953183|524794345|FG000|Overall Study|Physician Decision|0|||
145527820|NCT03953183|524794346|FG001|Overall Study|Physician Decision|1|||
145527821|NCT03953183|524794345|FG000|Overall Study|Withdrawal by Subject|0|||
145527822|NCT03953183|524794346|FG001|Overall Study|Withdrawal by Subject|1|||
145527823|NCT02314143|524794347|FG000|Overall Study|Adverse Event|0|||
145527824|NCT02314143|524794348|FG001|Overall Study|Adverse Event|6|||
145527825|NCT02314143|524794349|FG002|Overall Study|Adverse Event|4|||
145527826|NCT02314143|524794347|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
145527827|NCT02314143|524794348|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
145527828|NCT02314143|524794349|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
145527829|NCT02314143|524794347|FG000|Overall Study|Physician Decision|2|||
145527830|NCT02314143|524794348|FG001|Overall Study|Physician Decision|1|||
145527831|NCT02314143|524794349|FG002|Overall Study|Physician Decision|0|||
145527832|NCT02314143|524794347|FG000|Overall Study|Withdrawal by Subject|1|||
145527833|NCT02314143|524794348|FG001|Overall Study|Withdrawal by Subject|0|||
145527834|NCT02314143|524794349|FG002|Overall Study|Withdrawal by Subject|1|||
145527835|NCT00089674|524794350|FG000|Overall Study|Physician Decision|4|||
145527836|NCT00089674|524794351|FG001|Overall Study|Physician Decision|2|||
145527837|NCT00089674|524794350|FG000|Overall Study|Adverse Event|23|||
145527838|NCT00089674|524794351|FG001|Overall Study|Adverse Event|29|||
145527839|NCT00089674|524794350|FG000|Overall Study|Withdrawal by Subject|143|||
145527840|NCT00089674|524794351|FG001|Overall Study|Withdrawal by Subject|127|||
145527841|NCT00089674|524794350|FG000|Overall Study|Death|43|||
145527842|NCT00089674|524794351|FG001|Overall Study|Death|43|||
145527843|NCT00089674|524794350|FG000|Overall Study|Disease progression|21|||
145527844|NCT00089674|524794351|FG001|Overall Study|Disease progression|23|||
145527845|NCT00089674|524794350|FG000|Overall Study|Ineligibility determined|8|||
145527846|NCT00089674|524794351|FG001|Overall Study|Ineligibility determined|10|||
145527847|NCT00089674|524794350|FG000|Overall Study|Lost to Follow-up|21|||
145527848|NCT00089674|524794351|FG001|Overall Study|Lost to Follow-up|17|||
145527849|NCT00089674|524794350|FG000|Overall Study|Noncompliance|7|||
145527850|NCT00089674|524794351|FG001|Overall Study|Noncompliance|3|||
145527851|NCT00089674|524794350|FG000|Overall Study|Other|5|||
145527852|NCT00089674|524794351|FG001|Overall Study|Other|9|||
145527853|NCT00089674|524794350|FG000|Overall Study|Requirement for alternative therapy|14|||
145527854|NCT00089674|524794351|FG001|Overall Study|Requirement for alternative therapy|4|||
145527855|NCT03963401|524794352|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
145527856|NCT03963401|524794353|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
145527857|NCT03963401|524794354|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
145527858|NCT03963401|524794355|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
145527859|NCT03963401|524794356|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
145527860|NCT03963401|524794357|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
145527861|NCT03963401|524794352|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
145527862|NCT03963401|524794353|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
145527863|NCT03963401|524794354|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
145527864|NCT03963401|524794355|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
145527865|NCT03963401|524794356|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
145527866|NCT03963401|524794357|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
145527867|NCT03963401|524794352|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
145527868|NCT03963401|524794353|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
145527869|NCT03963401|524794354|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
145527870|NCT03963401|524794355|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
145527871|NCT03963401|524794356|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
145527872|NCT03963401|524794357|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
145527873|NCT03963401|524794352|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
145527874|NCT03963401|524794353|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
145527875|NCT03963401|524794354|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
145527876|NCT03963401|524794355|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
145527877|NCT03963401|524794356|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
145527878|NCT03963401|524794357|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
145527879|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
145527880|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
145527881|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
145527882|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
145527883|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
145527884|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
145527885|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
145527886|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
145527887|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
145527888|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
145527889|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
145527890|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
145527891|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
145527892|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
145527893|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
145527894|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
145527895|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
145527896|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
145527897|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
145527898|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
145527899|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
145527900|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
145527901|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
145527902|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
145527903|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
145527904|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
145527905|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
145527906|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
145527907|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
145527908|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
145527909|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
145527910|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
145527911|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
145527912|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
145527913|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
145527914|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
145527915|NCT03963401|524794352|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
145527916|NCT03963401|524794353|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
145527917|NCT03963401|524794354|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
145527918|NCT03963401|524794355|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
145527919|NCT03963401|524794356|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
145527920|NCT03963401|524794357|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
145527921|NCT01982331|524794358|FG000|Received Vaccination 2|Adverse Event|1|||
145527922|NCT01982331|524794359|FG001|Received Vaccination 2|Adverse Event|2|||
145527923|NCT01982331|524794358|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
145527924|NCT01982331|524794359|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
145527925|NCT01982331|524794358|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
145527926|NCT01982331|524794359|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
145527927|NCT01528215|524794360|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
145527928|NCT01528215|524794361|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
145527929|NCT01528215|524794360|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
145527930|NCT01528215|524794361|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
145527931|NCT01528215|524794360|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
145527932|NCT01528215|524794361|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
145527933|NCT01528215|524794360|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
145527934|NCT01528215|524794361|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
145527935|NCT01610271|524794362|FG000|Overall Study|Surgery not complete|0|||
145527936|NCT01610271|524794363|FG001|Overall Study|Surgery not complete|1|||
145527937|NCT01610271|524794362|FG000|Overall Study|Prosthesis not implanted|2|||
145527938|NCT01610271|524794363|FG001|Overall Study|Prosthesis not implanted|3|||
145527939|NCT02961218|524794364|FG000|Overall Study|Lost to Follow-up|0|||
145527940|NCT02961218|524794365|FG001|Overall Study|Lost to Follow-up|2|||
145527941|NCT02961218|524794364|FG000|Overall Study|Physician Decision|0|||
145527942|NCT02961218|524794365|FG001|Overall Study|Physician Decision|2|||
145527943|NCT02961218|524794364|FG000|Overall Study|Subject/Guardian Decision|3|||
145527944|NCT02961218|524794365|FG001|Overall Study|Subject/Guardian Decision|1|||
145527945|NCT01462227|524794366|FG000|Second Assignment|Lost to Follow-up|1|||
145527946|NCT01462227|524794367|FG001|Second Assignment|Lost to Follow-up|0|||
145527947|NCT01462227|524794368|FG002|Second Assignment|Lost to Follow-up|0|||
145527948|NCT01462227|524794369|FG003|Second Assignment|Lost to Follow-up|0|||
145527949|NCT01462227|524794366|FG000|Second Assignment|Protocol Violation|0|||
145527950|NCT01462227|524794367|FG001|Second Assignment|Protocol Violation|1|||
145527951|NCT01462227|524794368|FG002|Second Assignment|Protocol Violation|1|||
145527952|NCT01462227|524794369|FG003|Second Assignment|Protocol Violation|0|||
145527953|NCT00591266|524794370|FG000|Overall Study|Adverse Event|2|||
145527954|NCT00591266|524794371|FG001|Overall Study|Adverse Event|2|||
145527955|NCT00591266|524794372|FG002|Overall Study|Adverse Event|3|||
145527956|NCT00591266|524794370|FG000|Overall Study|Lost to Follow-up|0|||
145527957|NCT00591266|524794371|FG001|Overall Study|Lost to Follow-up|1|||
145527958|NCT00591266|524794372|FG002|Overall Study|Lost to Follow-up|0|||
145527959|NCT00591266|524794370|FG000|Overall Study|Protocol Violation|0|||
145527960|NCT00591266|524794371|FG001|Overall Study|Protocol Violation|0|||
145527961|NCT00591266|524794372|FG002|Overall Study|Protocol Violation|1|||
145527962|NCT00591266|524794370|FG000|Overall Study|Withdrawal by Subject|6|||
145527963|NCT00591266|524794371|FG001|Overall Study|Withdrawal by Subject|2|||
145527964|NCT00591266|524794372|FG002|Overall Study|Withdrawal by Subject|5|||
145527965|NCT00591266|524794370|FG000|Overall Study|Lack of Efficacy|0|||
145527966|NCT00591266|524794371|FG001|Overall Study|Lack of Efficacy|2|||
145527967|NCT00591266|524794372|FG002|Overall Study|Lack of Efficacy|0|||
145527968|NCT00591266|524794370|FG000|Overall Study|Other|1|||
145527969|NCT00591266|524794371|FG001|Overall Study|Other|4|||
145527970|NCT00591266|524794372|FG002|Overall Study|Other|5|||
145527971|NCT01178073|524794377|FG000|Overall Study|Adverse Event|34|||
145527972|NCT01178073|524794378|FG001|Overall Study|Adverse Event|27|||
145527973|NCT01178073|524794379|FG002|Overall Study|Adverse Event|24|||
145527974|NCT01178073|524794377|FG000|Overall Study|Protocol Violation|1|||
145527975|NCT01178073|524794378|FG001|Overall Study|Protocol Violation|1|||
145527976|NCT01178073|524794379|FG002|Overall Study|Protocol Violation|1|||
145527977|NCT01178073|524794377|FG000|Overall Study|Lost to Follow-up|2|||
145527978|NCT01178073|524794378|FG001|Overall Study|Lost to Follow-up|0|||
145527979|NCT01178073|524794379|FG002|Overall Study|Lost to Follow-up|3|||
145527980|NCT01178073|524794377|FG000|Overall Study|Physician Decision|14|||
145527981|NCT01178073|524794378|FG001|Overall Study|Physician Decision|10|||
145527982|NCT01178073|524794379|FG002|Overall Study|Physician Decision|10|||
145527983|NCT01178073|524794377|FG000|Overall Study|Withdrawal by Subject|10|||
145527984|NCT01178073|524794378|FG001|Overall Study|Withdrawal by Subject|6|||
145527985|NCT01178073|524794379|FG002|Overall Study|Withdrawal by Subject|8|||
145527986|NCT01178073|524794377|FG000|Overall Study|Missing Completion Status|1|||
145527987|NCT01178073|524794378|FG001|Overall Study|Missing Completion Status|0|||
145527988|NCT01178073|524794379|FG002|Overall Study|Missing Completion Status|0|||
145527989|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
145527990|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
145527991|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
145527992|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
145527993|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
145527994|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
145527995|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
145527996|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
145527997|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
145527998|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
145527999|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
145528000|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
145528001|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
145528002|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
145528003|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
145528004|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
145528005|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
145528006|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
145528007|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
145528008|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
145528009|NCT01226043|524794383|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
145528010|NCT01226043|524794384|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
145528011|NCT01226043|524794385|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
145528012|NCT01226043|524794386|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
145528013|NCT01226043|524794383|FG000|6-week Re-randomization Phase|Adverse Event|0|||
145528014|NCT01226043|524794384|FG001|6-week Re-randomization Phase|Adverse Event|0|||
145528015|NCT01226043|524794385|FG002|6-week Re-randomization Phase|Adverse Event|1|||
145528016|NCT01226043|524794386|FG003|6-week Re-randomization Phase|Adverse Event|1|||
145528017|NCT01226043|524794383|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
145528018|NCT01226043|524794384|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
145528019|NCT01226043|524794385|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
145528020|NCT01226043|524794386|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
145528021|NCT01226043|524794383|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
145528022|NCT01226043|524794384|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
145528023|NCT01226043|524794385|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
145528024|NCT01226043|524794386|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
145528025|NCT01226043|524794383|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
145528026|NCT01226043|524794384|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
145528027|NCT01226043|524794385|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
145528028|NCT01226043|524794386|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
145528029|NCT01226043|524794383|FG000|6-week Re-randomization Phase|Physician Decision|0|||
145528030|NCT01226043|524794384|FG001|6-week Re-randomization Phase|Physician Decision|0|||
145528031|NCT01226043|524794385|FG002|6-week Re-randomization Phase|Physician Decision|3|||
145528032|NCT01226043|524794386|FG003|6-week Re-randomization Phase|Physician Decision|2|||
145528033|NCT01226043|524794383|FG000|6-week Re-randomization Phase|completed in error|0|||
145528034|NCT01226043|524794384|FG001|6-week Re-randomization Phase|completed in error|0|||
145528035|NCT01226043|524794385|FG002|6-week Re-randomization Phase|completed in error|0|||
145528036|NCT01226043|524794386|FG003|6-week Re-randomization Phase|completed in error|1|||
145528037|NCT01226043|524794383|FG000|30-week Observational Phase|Adverse Event|0|||
145528038|NCT01226043|524794384|FG001|30-week Observational Phase|Adverse Event|0|||
145528039|NCT01226043|524794385|FG002|30-week Observational Phase|Adverse Event|1|||
145528040|NCT01226043|524794386|FG003|30-week Observational Phase|Adverse Event|1|||
145528041|NCT01226043|524794383|FG000|30-week Observational Phase|Protocol Violation|0|||
145528042|NCT01226043|524794384|FG001|30-week Observational Phase|Protocol Violation|0|||
145528043|NCT01226043|524794385|FG002|30-week Observational Phase|Protocol Violation|0|||
145528044|NCT01226043|524794386|FG003|30-week Observational Phase|Protocol Violation|1|||
145528045|NCT01226043|524794383|FG000|30-week Observational Phase|Lost to Follow-up|0|||
145528046|NCT01226043|524794384|FG001|30-week Observational Phase|Lost to Follow-up|0|||
145528047|NCT01226043|524794385|FG002|30-week Observational Phase|Lost to Follow-up|2|||
145528048|NCT01226043|524794386|FG003|30-week Observational Phase|Lost to Follow-up|2|||
145528049|NCT01226043|524794383|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
145528050|NCT01226043|524794384|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
145528051|NCT01226043|524794385|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
145528052|NCT01226043|524794386|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
145528053|NCT01226043|524794383|FG000|30-week Observational Phase|Physician Decision|0|||
145528054|NCT01226043|524794384|FG001|30-week Observational Phase|Physician Decision|0|||
145528055|NCT01226043|524794385|FG002|30-week Observational Phase|Physician Decision|2|||
145528056|NCT01226043|524794386|FG003|30-week Observational Phase|Physician Decision|2|||
145528057|NCT00910988|524794387|FG000|Overall Study|Lost to Follow-up|2|||
145528058|NCT00910988|524794388|FG001|Overall Study|Lost to Follow-up|4|||
145528059|NCT00910988|524794389|FG002|Overall Study|Lost to Follow-up|3|||
145528060|NCT00910988|524794390|FG003|Overall Study|Lost to Follow-up|0|||
145272139|NCT01956123|523844564|FG001|COS Cycle 3|Withdrawal by Subject|0|||
145751475|NCT00493038|525604023|FG000|Follow-up|Lost to Follow-up|1|||
145528061|NCT01977937|524794393|FG000|Overall Study|Withdrawal by Subject|2|||
145528062|NCT01977937|524794394|FG001|Overall Study|Withdrawal by Subject|1|||
145528063|NCT01977937|524794393|FG000|Overall Study|Adverse Event|1|||
145528064|NCT01977937|524794394|FG001|Overall Study|Adverse Event|0|||
145528065|NCT01977937|524794393|FG000|Overall Study|Physician Decision|0|||
145528066|NCT01977937|524794394|FG001|Overall Study|Physician Decision|1|||
145528067|NCT03004443|524794398|FG000|Overall Study|Pregnancy|0|||
145528068|NCT03004443|524794399|FG001|Overall Study|Pregnancy|1|||
145528069|NCT00828854|524794400|FG000|Overall Study|Disease Progression|17|||
145528070|NCT00828854|524794400|FG000|Overall Study|Adverse Event|9|||
145528071|NCT00828854|524794400|FG000|Overall Study|Reason not Specified|1|||
145528072|NCT00915356|524794401|FG000|Overall Study|Withdrawal by Subject|1|||
145528073|NCT00915356|524794402|FG001|Overall Study|Withdrawal by Subject|0|||
145528074|NCT00915356|524794403|FG002|Overall Study|Withdrawal by Subject|0|||
145528075|NCT00915356|524794404|FG003|Overall Study|Withdrawal by Subject|0|||
145528076|NCT00915356|524794405|FG004|Overall Study|Withdrawal by Subject|0|||
145528077|NCT05211284|524794411|FG000|Overall Study|Study Terminated|3|||
145528078|NCT05211284|524794412|FG001|Overall Study|Study Terminated|1|||
145528079|NCT03911843|524794418|FG000|Overall Study|Adverse Event|2|||
145528080|NCT03911843|524794419|FG001|Overall Study|Adverse Event|0|||
145528081|NCT03911843|524794418|FG000|Overall Study|Protocol Violation|2|||
145528082|NCT03911843|524794419|FG001|Overall Study|Protocol Violation|0|||
145528083|NCT03911843|524794418|FG000|Overall Study|Lost to Follow-up|0|||
145528084|NCT03911843|524794419|FG001|Overall Study|Lost to Follow-up|1|||
145528085|NCT02819518|524794420|FG000|Overall Study|Death|9|||
145528086|NCT02819518|524794421|FG001|Overall Study|Death|12|||
145528087|NCT02819518|524794422|FG002|Overall Study|Death|9|||
145528088|NCT02819518|524794423|FG003|Overall Study|Death|475|||
145528089|NCT02819518|524794424|FG004|Overall Study|Death|244|||
145528090|NCT02819518|524794420|FG000|Overall Study|Withdrawal by Subject|0|||
145528091|NCT02819518|524794421|FG001|Overall Study|Withdrawal by Subject|0|||
145528092|NCT02819518|524794422|FG002|Overall Study|Withdrawal by Subject|0|||
145528093|NCT02819518|524794423|FG003|Overall Study|Withdrawal by Subject|25|||
145528094|NCT02819518|524794424|FG004|Overall Study|Withdrawal by Subject|8|||
145528095|NCT02819518|524794420|FG000|Overall Study|Lost to Follow-up|0|||
145528096|NCT02819518|524794421|FG001|Overall Study|Lost to Follow-up|0|||
145528097|NCT02819518|524794422|FG002|Overall Study|Lost to Follow-up|0|||
145528098|NCT02819518|524794423|FG003|Overall Study|Lost to Follow-up|0|||
145528099|NCT02819518|524794424|FG004|Overall Study|Lost to Follow-up|1|||
145528100|NCT02819518|524794420|FG000|Overall Study|Sponsor Decision|1|||
145528101|NCT02819518|524794421|FG001|Overall Study|Sponsor Decision|1|||
145528102|NCT02819518|524794422|FG002|Overall Study|Sponsor Decision|0|||
145528103|NCT02819518|524794423|FG003|Overall Study|Sponsor Decision|34|||
145528104|NCT02819518|524794424|FG004|Overall Study|Sponsor Decision|17|||
145528105|NCT02819518|524794420|FG000|Overall Study|Transferred to extension study|1|||
145528106|NCT02819518|524794421|FG001|Overall Study|Transferred to extension study|1|||
145528107|NCT02819518|524794422|FG002|Overall Study|Transferred to extension study|1|||
145528108|NCT02819518|524794423|FG003|Overall Study|Transferred to extension study|32|||
145528109|NCT02819518|524794424|FG004|Overall Study|Transferred to extension study|11|||
145528110|NCT00880165|524794425|FG000|Overall Study|Withdrawal by Subject|27|||
145528111|NCT00880165|524794426|FG001|Overall Study|Withdrawal by Subject|23|||
145528112|NCT00880165|524794425|FG000|Overall Study|Not diagnosed with OSA|14|||
145528113|NCT00880165|524794426|FG001|Overall Study|Not diagnosed with OSA|8|||
145528114|NCT00880165|524794425|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
145528115|NCT00880165|524794426|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
145528116|NCT00880165|524794425|FG000|Overall Study|Lost to follow|9|||
145528117|NCT00880165|524794426|FG001|Overall Study|Lost to follow|15|||
145528118|NCT01505647|524794427|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
145528119|NCT01505647|524794428|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
145528120|NCT01505647|524794427|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
145528121|NCT01505647|524794428|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
145528122|NCT01505647|524794427|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
145528123|NCT01505647|524794428|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
145528124|NCT01505647|524794427|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
145528125|NCT01505647|524794428|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
145528126|NCT01505647|524794427|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
145528127|NCT01505647|524794428|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
145528128|NCT01907100|524794429|FG000|Overall Study|PD based on modified RECIST criteria|31|||
145528129|NCT01907100|524794430|FG001|Overall Study|PD based on modified RECIST criteria|32|||
145528130|NCT01907100|524794431|FG002|Overall Study|PD based on modified RECIST criteria|95|||
145528131|NCT01907100|524794432|FG003|Overall Study|PD based on modified RECIST criteria|92|||
145528132|NCT01907100|524794429|FG000|Overall Study|Withdrawal by Subject|2|||
145528133|NCT01907100|524794430|FG001|Overall Study|Withdrawal by Subject|5|||
145528134|NCT01907100|524794431|FG002|Overall Study|Withdrawal by Subject|10|||
145528135|NCT01907100|524794432|FG003|Overall Study|Withdrawal by Subject|13|||
145528136|NCT01907100|524794429|FG000|Overall Study|Protocol Violation|0|||
145528137|NCT01907100|524794430|FG001|Overall Study|Protocol Violation|0|||
145528138|NCT01907100|524794431|FG002|Overall Study|Protocol Violation|1|||
145528139|NCT01907100|524794432|FG003|Overall Study|Protocol Violation|1|||
145528140|NCT01907100|524794429|FG000|Overall Study|Lost to Follow-up|0|||
145528141|NCT01907100|524794430|FG001|Overall Study|Lost to Follow-up|0|||
145528142|NCT01907100|524794431|FG002|Overall Study|Lost to Follow-up|0|||
145528143|NCT01907100|524794432|FG003|Overall Study|Lost to Follow-up|1|||
145528144|NCT01907100|524794429|FG000|Overall Study|Not treated|2|||
145528145|NCT01907100|524794430|FG001|Overall Study|Not treated|0|||
145528146|NCT01907100|524794431|FG002|Overall Study|Not treated|1|||
145528147|NCT01907100|524794432|FG003|Overall Study|Not treated|2|||
145528148|NCT01907100|524794429|FG000|Overall Study|Other than reasons specified|1|||
145528149|NCT01907100|524794430|FG001|Overall Study|Other than reasons specified|0|||
145528150|NCT01907100|524794431|FG002|Overall Study|Other than reasons specified|10|||
145528151|NCT01907100|524794432|FG003|Overall Study|Other than reasons specified|6|||
145528152|NCT01907100|524794429|FG000|Overall Study|Adverse event (AE)|6|||
145528153|NCT01907100|524794430|FG001|Overall Study|Adverse event (AE)|3|||
145528154|NCT01907100|524794431|FG002|Overall Study|Adverse event (AE)|22|||
145528155|NCT01907100|524794432|FG003|Overall Study|Adverse event (AE)|23|||
145528156|NCT01907100|524794429|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
145528157|NCT01907100|524794430|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
145528158|NCT01907100|524794431|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
145528159|NCT01907100|524794432|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
145528160|NCT01758289|524794433|FG000|Overall Study|Premature Study Termination|44|||
145528161|NCT01758289|524794433|FG000|Overall Study|Adverse Event|9|||
145528162|NCT00667602|524794436|FG000|Overall Study|Withdrawal by Subject|4|||
145528163|NCT00667602|524794437|FG001|Overall Study|Withdrawal by Subject|9|||
145528164|NCT00667602|524794438|FG002|Overall Study|Withdrawal by Subject|10|||
145528165|NCT00667602|524794436|FG000|Overall Study|Lost to Follow-up|4|||
145528166|NCT00667602|524794437|FG001|Overall Study|Lost to Follow-up|5|||
145528167|NCT00667602|524794438|FG002|Overall Study|Lost to Follow-up|6|||
145528168|NCT00667602|524794436|FG000|Overall Study|Administrative reason|0|||
145528169|NCT00667602|524794437|FG001|Overall Study|Administrative reason|0|||
145528170|NCT00667602|524794438|FG002|Overall Study|Administrative reason|2|||
145528171|NCT00667602|524794436|FG000|Overall Study|Protocol Violation|0|||
145528172|NCT00667602|524794437|FG001|Overall Study|Protocol Violation|1|||
145528173|NCT00667602|524794438|FG002|Overall Study|Protocol Violation|0|||
145528174|NCT00395538|524794446|FG000|Overall Study|Did not re-consent to revised protocol|1|||
145528175|NCT00395538|524794447|FG001|Overall Study|Did not re-consent to revised protocol|10|||
145528176|NCT00395538|524794448|FG002|Overall Study|Did not re-consent to revised protocol|0|||
145528177|NCT00395538|524794446|FG000|Overall Study|FDA partial hold on PTH|0|||
145528178|NCT00395538|524794447|FG001|Overall Study|FDA partial hold on PTH|0|||
145528179|NCT00395538|524794448|FG002|Overall Study|FDA partial hold on PTH|11|||
145528180|NCT00395538|524794446|FG000|Overall Study|Failed screening|0|||
145528181|NCT00395538|524794447|FG001|Overall Study|Failed screening|0|||
145528182|NCT00395538|524794448|FG002|Overall Study|Failed screening|4|||
145528183|NCT00395538|524794446|FG000|Overall Study|Switch to Natpara|0|||
145528184|NCT00395538|524794447|FG001|Overall Study|Switch to Natpara|0|||
145528185|NCT00395538|524794448|FG002|Overall Study|Switch to Natpara|3|||
145528186|NCT00395538|524794446|FG000|Overall Study|Adverse Event|1|||
145528187|NCT00395538|524794447|FG001|Overall Study|Adverse Event|0|||
145528188|NCT00395538|524794448|FG002|Overall Study|Adverse Event|2|||
145528189|NCT00395538|524794446|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
145528190|NCT00395538|524794447|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
145528191|NCT00395538|524794448|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
145528192|NCT00395538|524794446|FG000|Overall Study|Non-compliance with study protocol|0|||
145528193|NCT00395538|524794447|FG001|Overall Study|Non-compliance with study protocol|1|||
145528194|NCT00395538|524794448|FG002|Overall Study|Non-compliance with study protocol|0|||
145528195|NCT00395538|524794446|FG000|Overall Study|PTH resistance|0|||
145528196|NCT00395538|524794447|FG001|Overall Study|PTH resistance|0|||
145528197|NCT00395538|524794448|FG002|Overall Study|PTH resistance|1|||
145528198|NCT00395538|524794446|FG000|Overall Study|Pregnancy|1|||
145528199|NCT00395538|524794447|FG001|Overall Study|Pregnancy|0|||
145528200|NCT00395538|524794448|FG002|Overall Study|Pregnancy|0|||
145528201|NCT00395538|524794446|FG000|Overall Study|Partial recovery of parathyroid function|0|||
145528202|NCT00395538|524794447|FG001|Overall Study|Partial recovery of parathyroid function|0|||
145528203|NCT00395538|524794448|FG002|Overall Study|Partial recovery of parathyroid function|1|||
145528204|NCT00395538|524794446|FG000|Overall Study|Participant elected to discontinue|0|||
145528205|NCT00395538|524794447|FG001|Overall Study|Participant elected to discontinue|0|||
145528206|NCT00395538|524794448|FG002|Overall Study|Participant elected to discontinue|1|||
145528207|NCT01857583|524794449|FG000|Overall Study|Adverse Event|0|||
145528208|NCT01857583|524794450|FG001|Overall Study|Adverse Event|0|||
145528209|NCT01857583|524794451|FG002|Overall Study|Adverse Event|1|||
145528210|NCT01857583|524794452|FG003|Overall Study|Adverse Event|1|||
145528211|NCT01857583|524794449|FG000|Overall Study|Death|0|||
145528212|NCT01857583|524794450|FG001|Overall Study|Death|1|||
145528213|NCT01857583|524794451|FG002|Overall Study|Death|1|||
145528214|NCT01857583|524794452|FG003|Overall Study|Death|0|||
145528215|NCT01857583|524794449|FG000|Overall Study|Physician Decision|0|||
145528216|NCT01857583|524794450|FG001|Overall Study|Physician Decision|0|||
145528217|NCT01857583|524794451|FG002|Overall Study|Physician Decision|0|||
145528218|NCT01857583|524794452|FG003|Overall Study|Physician Decision|1|||
145528219|NCT01857583|524794449|FG000|Overall Study|Withdrawal by Subject|1|||
145528220|NCT01857583|524794450|FG001|Overall Study|Withdrawal by Subject|0|||
145528221|NCT01857583|524794451|FG002|Overall Study|Withdrawal by Subject|1|||
145528222|NCT01857583|524794452|FG003|Overall Study|Withdrawal by Subject|2|||
145528223|NCT02211638|524794453|FG000|Overall Study|Case Report Forms Uncollected|291|||
145528224|NCT02211638|524794453|FG000|Overall Study|Protocol Violation|692|||
145528225|NCT02775903|524794458|FG000|Overall Study|Death|7|||
145528226|NCT02775903|524794459|FG001|Overall Study|Death|11|||
145528227|NCT02775903|524794460|FG002|Overall Study|Death|12|||
145528228|NCT02775903|524794461|FG003|Overall Study|Death|11|||
145528229|NCT02775903|524794458|FG000|Overall Study|Adverse Event|0|||
145528230|NCT02775903|524794459|FG001|Overall Study|Adverse Event|1|||
145528231|NCT02775903|524794460|FG002|Overall Study|Adverse Event|12|||
145528232|NCT02775903|524794461|FG003|Overall Study|Adverse Event|3|||
145528233|NCT02775903|524794458|FG000|Overall Study|Progressive disease|15|||
145528234|NCT02775903|524794459|FG001|Overall Study|Progressive disease|14|||
145528235|NCT02775903|524794460|FG002|Overall Study|Progressive disease|30|||
145528236|NCT02775903|524794461|FG003|Overall Study|Progressive disease|20|||
145528237|NCT02775903|524794458|FG000|Overall Study|Lack of Efficacy|2|||
145528238|NCT02775903|524794459|FG001|Overall Study|Lack of Efficacy|2|||
145528239|NCT02775903|524794460|FG002|Overall Study|Lack of Efficacy|2|||
145528240|NCT02775903|524794461|FG003|Overall Study|Lack of Efficacy|6|||
145528241|NCT02775903|524794458|FG000|Overall Study|Withdrawal by Subject|7|||
145528242|NCT02775903|524794459|FG001|Overall Study|Withdrawal by Subject|5|||
145528243|NCT02775903|524794460|FG002|Overall Study|Withdrawal by Subject|5|||
145528244|NCT02775903|524794461|FG003|Overall Study|Withdrawal by Subject|8|||
145528245|NCT02775903|524794458|FG000|Overall Study|Other reasons|7|||
145528246|NCT02775903|524794459|FG001|Overall Study|Other reasons|8|||
145528247|NCT02775903|524794460|FG002|Overall Study|Other reasons|2|||
145528248|NCT02775903|524794461|FG003|Overall Study|Other reasons|12|||
145528249|NCT04041700|524794462|FG000|Overall Study|Pregnancy|1|||
145528250|NCT04041700|524794462|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
145528251|NCT00458536|524794465|FG000|Overall Study|Disease progression prior to treatment|7|||
145528252|NCT00458536|524794465|FG000|Overall Study|Unable to make vaccine|3|||
145528253|NCT00458536|524794465|FG000|Overall Study|No measurable disease after surgery|2|||
145528254|NCT00458536|524794465|FG000|Overall Study|Did not have renal cell carcinoma|2|||
145528255|NCT00458536|524794465|FG000|Overall Study|Patient did not have surgery|1|||
145528256|NCT00458536|524794465|FG000|Overall Study|Ineligible due to toxicity|1|||
145528257|NCT00458536|524794465|FG000|Overall Study|Withdrawal by Subject|1|||
145528258|NCT00458536|524794465|FG000|Overall Study|Progressive disease during treatment|2|||
145528259|NCT00285207|524794466|FG000|Overall Study|Lost to Follow-up|3|||
145528260|NCT00285207|524794467|FG001|Overall Study|Lost to Follow-up|2|||
145528261|NCT00285207|524794466|FG000|Overall Study|Withdrawal by Subject|5|||
145528262|NCT00285207|524794467|FG001|Overall Study|Withdrawal by Subject|2|||
145528263|NCT00285207|524794466|FG000|Overall Study|Pregnancy|1|||
145528264|NCT00285207|524794467|FG001|Overall Study|Pregnancy|1|||
145528265|NCT00285207|524794466|FG000|Overall Study|non-compliance|0|||
145528266|NCT00285207|524794467|FG001|Overall Study|non-compliance|1|||
145272140|NCT01956123|523844565|FG002|COS Cycle 3|Withdrawal by Subject|0|||
145528267|NCT04571515|524794468|FG000|Overall Study|Physician Decision|0|||
145528268|NCT04571515|524794469|FG001|Overall Study|Physician Decision|0|||
145528269|NCT04571515|524794470|FG002|Overall Study|Physician Decision|0|||
145528270|NCT04571515|524794471|FG003|Overall Study|Physician Decision|0|||
145528271|NCT04571515|524794472|FG004|Overall Study|Physician Decision|1|||
145528272|NCT04571515|524794468|FG000|Overall Study|Withdrawal by Subject|0|||
145528273|NCT04571515|524794469|FG001|Overall Study|Withdrawal by Subject|0|||
145528274|NCT04571515|524794470|FG002|Overall Study|Withdrawal by Subject|0|||
145528275|NCT04571515|524794471|FG003|Overall Study|Withdrawal by Subject|0|||
145528276|NCT04571515|524794472|FG004|Overall Study|Withdrawal by Subject|1|||
145528277|NCT04571515|524794468|FG000|Overall Study|insufficient pain|1|||
145528278|NCT04571515|524794469|FG001|Overall Study|insufficient pain|0|||
145528279|NCT04571515|524794470|FG002|Overall Study|insufficient pain|0|||
145528280|NCT04571515|524794471|FG003|Overall Study|insufficient pain|0|||
145528281|NCT04571515|524794472|FG004|Overall Study|insufficient pain|1|||
145528282|NCT01659658|524795965|FG000|Overall Study|Withdrawal by Patient|18|||
145528283|NCT01659658|524795966|FG001|Overall Study|Withdrawal by Patient|4|||
145528284|NCT01659658|524795967|FG002|Overall Study|Withdrawal by Patient|2|||
145528285|NCT01659658|524795968|FG003|Overall Study|Withdrawal by Patient|0|||
145528286|NCT01659658|524795969|FG004|Overall Study|Withdrawal by Patient|11|||
145528287|NCT01659658|524795965|FG000|Overall Study|Study Terminated by Sponsor|9|||
145528288|NCT01659658|524795966|FG001|Overall Study|Study Terminated by Sponsor|7|||
145528289|NCT01659658|524795967|FG002|Overall Study|Study Terminated by Sponsor|0|||
145528290|NCT01659658|524795968|FG003|Overall Study|Study Terminated by Sponsor|1|||
145528291|NCT01659658|524795969|FG004|Overall Study|Study Terminated by Sponsor|4|||
145528292|NCT01659658|524795965|FG000|Overall Study|Reason not Specified|61|||
145528293|NCT01659658|524795966|FG001|Overall Study|Reason not Specified|15|||
145528294|NCT01659658|524795967|FG002|Overall Study|Reason not Specified|8|||
145528295|NCT01659658|524795968|FG003|Overall Study|Reason not Specified|1|||
145528296|NCT01659658|524795969|FG004|Overall Study|Reason not Specified|34|||
145528297|NCT01659658|524795965|FG000|Overall Study|Lost to Follow-up|2|||
145528298|NCT01659658|524795966|FG001|Overall Study|Lost to Follow-up|0|||
145528299|NCT01659658|524795967|FG002|Overall Study|Lost to Follow-up|0|||
145528300|NCT01659658|524795968|FG003|Overall Study|Lost to Follow-up|0|||
145528301|NCT01659658|524795969|FG004|Overall Study|Lost to Follow-up|0|||
145528302|NCT01927341|524795971|FG000|Phase 1b|Lost to Follow-up|1|||
145528303|NCT01927341|524795972|FG001|Phase 1b|Lost to Follow-up|0|||
145528304|NCT01927341|524795973|FG002|Phase 1b|Lost to Follow-up|0|||
145528305|NCT01927341|524795974|FG003|Phase 1b|Lost to Follow-up|0|||
145528306|NCT01927341|524795975|FG004|Phase 1b|Lost to Follow-up|0|||
145528307|NCT01927341|524795971|FG000|Phase 1b|Death|2|||
145528308|NCT01927341|524795972|FG001|Phase 1b|Death|0|||
145528309|NCT01927341|524795973|FG002|Phase 1b|Death|0|||
145528310|NCT01927341|524795974|FG003|Phase 1b|Death|0|||
145528311|NCT01927341|524795975|FG004|Phase 1b|Death|0|||
145528312|NCT01927341|524795971|FG000|Phase 1b|Follow-up completed|7|||
145528313|NCT01927341|524795972|FG001|Phase 1b|Follow-up completed|0|||
145528314|NCT01927341|524795973|FG002|Phase 1b|Follow-up completed|0|||
145528315|NCT01927341|524795974|FG003|Phase 1b|Follow-up completed|0|||
145528316|NCT01927341|524795975|FG004|Phase 1b|Follow-up completed|0|||
145528317|NCT01927341|524795971|FG000|Phase 2|Lost to Follow-up|0|||
145528318|NCT01927341|524795972|FG001|Phase 2|Lost to Follow-up|1|||
145528319|NCT01927341|524795973|FG002|Phase 2|Lost to Follow-up|0|||
145528320|NCT01927341|524795974|FG003|Phase 2|Lost to Follow-up|0|||
145528321|NCT01927341|524795975|FG004|Phase 2|Lost to Follow-up|0|||
145528322|NCT01927341|524795971|FG000|Phase 2|Participant withdrew consent|0|||
145528323|NCT01927341|524795972|FG001|Phase 2|Participant withdrew consent|2|||
145528324|NCT01927341|524795973|FG002|Phase 2|Participant withdrew consent|1|||
145528325|NCT01927341|524795974|FG003|Phase 2|Participant withdrew consent|2|||
145528326|NCT01927341|524795975|FG004|Phase 2|Participant withdrew consent|3|||
145528327|NCT01927341|524795971|FG000|Phase 2|Death|0|||
145528328|NCT01927341|524795972|FG001|Phase 2|Death|4|||
145528329|NCT01927341|524795973|FG002|Phase 2|Death|0|||
145528330|NCT01927341|524795974|FG003|Phase 2|Death|3|||
145528331|NCT01927341|524795975|FG004|Phase 2|Death|2|||
145528332|NCT01927341|524795971|FG000|Phase 2|New cancer therapy|0|||
145528333|NCT01927341|524795972|FG001|Phase 2|New cancer therapy|1|||
145528334|NCT01927341|524795973|FG002|Phase 2|New cancer therapy|0|||
145528335|NCT01927341|524795974|FG003|Phase 2|New cancer therapy|4|||
145528336|NCT01927341|524795975|FG004|Phase 2|New cancer therapy|1|||
145528337|NCT01927341|524795971|FG000|Phase 2|Disease progression|0|||
145528338|NCT01927341|524795972|FG001|Phase 2|Disease progression|1|||
145528339|NCT01927341|524795973|FG002|Phase 2|Disease progression|1|||
145528340|NCT01927341|524795974|FG003|Phase 2|Disease progression|1|||
145528341|NCT01927341|524795975|FG004|Phase 2|Disease progression|0|||
145528342|NCT01927341|524795971|FG000|Phase 2|Follow-up completed|0|||
145528343|NCT01927341|524795972|FG001|Phase 2|Follow-up completed|6|||
145528344|NCT01927341|524795973|FG002|Phase 2|Follow-up completed|3|||
145528345|NCT01927341|524795974|FG003|Phase 2|Follow-up completed|5|||
145528346|NCT01927341|524795975|FG004|Phase 2|Follow-up completed|2|||
145528347|NCT01397201|524795976|FG000|Overall Study|Not treated|0|||
145528348|NCT01397201|524795977|FG001|Overall Study|Not treated|0|||
145528349|NCT01397201|524795978|FG002|Overall Study|Not treated|1|||
145528350|NCT01397201|524795979|FG003|Overall Study|Not treated|0|||
145528351|NCT01397201|524795980|FG004|Overall Study|Not treated|0|||
145528352|NCT01397201|524795976|FG000|Overall Study|Not yet defined|3|||
145528353|NCT01397201|524795977|FG001|Overall Study|Not yet defined|6|||
145528354|NCT01397201|524795978|FG002|Overall Study|Not yet defined|5|||
145528355|NCT01397201|524795979|FG003|Overall Study|Not yet defined|5|||
145528356|NCT01397201|524795980|FG004|Overall Study|Not yet defined|4|||
145528357|NCT01397201|524795976|FG000|Overall Study|Adverse Event|2|||
145528358|NCT01397201|524795977|FG001|Overall Study|Adverse Event|0|||
145528359|NCT01397201|524795978|FG002|Overall Study|Adverse Event|0|||
145528360|NCT01397201|524795979|FG003|Overall Study|Adverse Event|0|||
145528361|NCT01397201|524795980|FG004|Overall Study|Adverse Event|0|||
145528362|NCT03956056|524795981|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
145528363|NCT03956056|524795981|FG000|Overall Study|Lack of Efficacy|1|||
145528364|NCT01298531|524795984|FG000|Overall Study|Lack of Efficacy|0|||
145528365|NCT01298531|524795985|FG001|Overall Study|Lack of Efficacy|1|||
145528366|NCT01298531|524795984|FG000|Overall Study|Lost to Follow-up|2|||
145528367|NCT01298531|524795985|FG001|Overall Study|Lost to Follow-up|0|||
145528368|NCT01298531|524795984|FG000|Overall Study|Protocol Violation|1|||
145528369|NCT01298531|524795985|FG001|Overall Study|Protocol Violation|1|||
145528370|NCT01298531|524795984|FG000|Overall Study|Adverse Event|4|||
145528371|NCT01298531|524795985|FG001|Overall Study|Adverse Event|3|||
145528372|NCT01298531|524795984|FG000|Overall Study|Does not meet entrance criteria|0|||
145528373|NCT01298531|524795985|FG001|Overall Study|Does not meet entrance criteria|1|||
145528374|NCT01298531|524795984|FG000|Overall Study|Other|2|||
145528375|NCT01298531|524795985|FG001|Overall Study|Other|1|||
145528376|NCT03646643|524795986|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
145528377|NCT03646643|524795987|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
145528378|NCT03646643|524795986|FG000|Overall Study|Lost to Follow-up|0|||
145528379|NCT03646643|524795987|FG001|Overall Study|Lost to Follow-up|1|||
145528380|NCT04629508|524795990|FG000|Overall Study|Adverse Event|1|||
145528381|NCT04629508|524795990|FG000|Overall Study|Death|2|||
145528382|NCT04629508|524795990|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
145528383|NCT04073368|524795995|FG000|Overall Study|Adverse Event|2|||
145528384|NCT04073368|524795996|FG001|Overall Study|Adverse Event|0|||
145528385|NCT04073368|524795997|FG002|Overall Study|Adverse Event|1|||
145528386|NCT04073368|524795998|FG003|Overall Study|Adverse Event|1|||
145528387|NCT04073368|524795995|FG000|Overall Study|Withdrawal by Subject|2|||
145528388|NCT04073368|524795996|FG001|Overall Study|Withdrawal by Subject|2|||
145528389|NCT04073368|524795997|FG002|Overall Study|Withdrawal by Subject|1|||
145528390|NCT04073368|524795998|FG003|Overall Study|Withdrawal by Subject|1|||
145528391|NCT04073368|524795995|FG000|Overall Study|Lost to Follow-up|1|||
145528392|NCT04073368|524795996|FG001|Overall Study|Lost to Follow-up|1|||
145528393|NCT04073368|524795997|FG002|Overall Study|Lost to Follow-up|1|||
145528394|NCT04073368|524795998|FG003|Overall Study|Lost to Follow-up|0|||
145528395|NCT04073368|524795995|FG000|Overall Study|Protocol Violation|0|||
145528396|NCT04073368|524795996|FG001|Overall Study|Protocol Violation|1|||
145528397|NCT04073368|524795997|FG002|Overall Study|Protocol Violation|0|||
145528398|NCT04073368|524795998|FG003|Overall Study|Protocol Violation|0|||
145528399|NCT04073368|524795995|FG000|Overall Study|Subject noncompliance|7|||
145528400|NCT04073368|524795996|FG001|Overall Study|Subject noncompliance|4|||
145528401|NCT04073368|524795997|FG002|Overall Study|Subject noncompliance|0|||
145528402|NCT04073368|524795998|FG003|Overall Study|Subject noncompliance|0|||
145528403|NCT00145600|524795999|FG000|Overall Study|Death|1|||
145528404|NCT00145600|524796000|FG001|Overall Study|Death|2|||
145528405|NCT00145600|524796001|FG002|Overall Study|Death|2|||
145528406|NCT00145600|524796002|FG003|Overall Study|Death|6|||
145528407|NCT00145600|524795999|FG000|Overall Study|Ineligible|3|||
145528408|NCT00145600|524796000|FG001|Overall Study|Ineligible|0|||
145528409|NCT00145600|524796001|FG002|Overall Study|Ineligible|1|||
145528410|NCT00145600|524796002|FG003|Overall Study|Ineligible|5|||
145528411|NCT00145600|524795999|FG000|Overall Study|Lost to Follow-up|2|||
145528412|NCT00145600|524796000|FG001|Overall Study|Lost to Follow-up|6|||
145528413|NCT00145600|524796001|FG002|Overall Study|Lost to Follow-up|2|||
145528414|NCT00145600|524796002|FG003|Overall Study|Lost to Follow-up|4|||
145528415|NCT00145600|524795999|FG000|Overall Study|Noncompliance|1|||
145528416|NCT00145600|524796000|FG001|Overall Study|Noncompliance|0|||
145528417|NCT00145600|524796001|FG002|Overall Study|Noncompliance|0|||
145528418|NCT00145600|524796002|FG003|Overall Study|Noncompliance|0|||
145528419|NCT00145600|524795999|FG000|Overall Study|Withdrawal by Subject|1|||
145528420|NCT00145600|524796000|FG001|Overall Study|Withdrawal by Subject|2|||
145528421|NCT00145600|524796001|FG002|Overall Study|Withdrawal by Subject|0|||
145528422|NCT00145600|524796002|FG003|Overall Study|Withdrawal by Subject|1|||
145528423|NCT01229397|524796003|FG000|Overall Study|Withdrawal by Subject|3|||
145528424|NCT01229397|524796004|FG001|Overall Study|Withdrawal by Subject|3|||
145528425|NCT01229397|524796003|FG000|Overall Study|Lost to Follow-up|7|||
145528426|NCT01229397|524796004|FG001|Overall Study|Lost to Follow-up|6|||
145528427|NCT01229397|524796003|FG000|Overall Study|Migrated/moved from study area|1|||
145528428|NCT01229397|524796004|FG001|Overall Study|Migrated/moved from study area|0|||
145528429|NCT00608543|524796005|FG000|Overall Study|Adverse Event|4|||
145528430|NCT04087213|524796010|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
145528431|NCT04087213|524796010|FG000|In-Facility Introduction|Adverse Event|1|||
145528432|NCT04087213|524796010|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
145528433|NCT04087213|524796010|FG000|Assisted Evaluable Period|Personal reasons|3|||
145528434|NCT04087213|524796010|FG000|Transition Period B|Renal Transplantation|1|||
145528435|NCT01134315|524796012|FG000|Overall Study|Adverse Event|1|||
145528436|NCT01134315|524796013|FG001|Overall Study|Adverse Event|2|||
145528437|NCT01134315|524796012|FG000|Overall Study|Other Reason|8|||
145528438|NCT01134315|524796013|FG001|Overall Study|Other Reason|17|||
145528439|NCT02545075|524796016|FG000|Randomization|Lost to Follow-up|0|||
145528440|NCT02545075|524796017|FG001|Randomization|Lost to Follow-up|1|||
145528441|NCT02545075|524796016|FG000|Randomization|Withdrawal by Subject|0|||
145528442|NCT02545075|524796017|FG001|Randomization|Withdrawal by Subject|6|||
145528443|NCT02545075|524796016|FG000|Treatment|Disease progression|71|||
145528444|NCT02545075|524796017|FG001|Treatment|Disease progression|32|||
145528445|NCT02545075|524796016|FG000|Treatment|Participant dicontinued study treatment|7|||
145528446|NCT02545075|524796017|FG001|Treatment|Participant dicontinued study treatment|9|||
145528447|NCT02545075|524796016|FG000|Treatment|Withdrawal by Subject|1|||
145528448|NCT02545075|524796017|FG001|Treatment|Withdrawal by Subject|0|||
145528449|NCT02545075|524796016|FG000|Treatment|Adverse event not related to study drug|1|||
145528450|NCT02545075|524796017|FG001|Treatment|Adverse event not related to study drug|0|||
145528451|NCT02545075|524796016|FG000|Treatment|Death|1|||
145528452|NCT02545075|524796017|FG001|Treatment|Death|0|||
145528453|NCT02545075|524796016|FG000|Treatment|Participant drug toxicity|1|||
145528454|NCT02545075|524796017|FG001|Treatment|Participant drug toxicity|0|||
145528455|NCT02545075|524796016|FG000|Treatment|Completed treatment|40|||
145528456|NCT02545075|524796017|FG001|Treatment|Completed treatment|12|||
145528457|NCT05246397|524796021|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
145528458|NCT01251744|524796022|FG000|Overall Study|Lost to Follow-up|1|||
145528459|NCT01251744|524796023|FG001|Overall Study|Lost to Follow-up|0|||
145528460|NCT01068652|524796024|FG000|Overall Study|Adverse Event|4|||
145528461|NCT01068652|524796025|FG001|Overall Study|Adverse Event|0|||
145528462|NCT01068652|524796024|FG000|Overall Study|Lack of Efficacy|0|||
145528463|NCT01068652|524796025|FG001|Overall Study|Lack of Efficacy|2|||
145528464|NCT01068652|524796024|FG000|Overall Study|Lost to Follow-up|2|||
145528465|NCT01068652|524796025|FG001|Overall Study|Lost to Follow-up|1|||
145528466|NCT01068652|524796024|FG000|Overall Study|Protocol Violation|3|||
145528467|NCT01068652|524796025|FG001|Overall Study|Protocol Violation|6|||
145528468|NCT01068652|524796024|FG000|Overall Study|Withdrawal criteria|1|||
145528469|NCT01068652|524796025|FG001|Overall Study|Withdrawal criteria|2|||
145528470|NCT01068652|524796024|FG000|Overall Study|Patient was not eligible|1|||
145528471|NCT01068652|524796025|FG001|Overall Study|Patient was not eligible|0|||
145528472|NCT01068652|524796024|FG000|Overall Study|Unclassified|7|||
145528473|NCT01068652|524796025|FG001|Overall Study|Unclassified|4|||
145528474|NCT02147184|524796026|FG000|Overall Study|Lost to Follow-up|28|||
145528475|NCT02147184|524796027|FG001|Overall Study|Lost to Follow-up|15|||
145528476|NCT02147184|524796026|FG000|Overall Study|Study Burden|11|||
145528477|NCT02147184|524796027|FG001|Overall Study|Study Burden|7|||
145528478|NCT02147184|524796026|FG000|Overall Study|Pregnancy|6|||
145528479|NCT02147184|524796027|FG001|Overall Study|Pregnancy|0|||
145528480|NCT02147184|524796026|FG000|Overall Study|Moved out of state|3|||
145528481|NCT02147184|524796027|FG001|Overall Study|Moved out of state|3|||
145528482|NCT02147184|524796026|FG000|Overall Study|Physician Decision|0|||
145528483|NCT02147184|524796027|FG001|Overall Study|Physician Decision|2|||
145528484|NCT02147184|524796026|FG000|Overall Study|Other|1|||
145528485|NCT02147184|524796027|FG001|Overall Study|Other|0|||
145528486|NCT04505540|524796030|FG000|Baseline|Protocol Violation|10|||
145528487|NCT04505540|524796030|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
145528488|NCT04505540|524796030|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
145528489|NCT04505540|524796030|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
145528490|NCT04505540|524796030|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
145528491|NCT04505540|524796030|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
145528492|NCT04505540|524796030|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
145528493|NCT04505540|524796030|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
145528494|NCT04505540|524796030|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
145528495|NCT04505540|524796030|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
145528496|NCT04505540|524796030|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
145528497|NCT04505540|524796030|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
145528498|NCT04505540|524796030|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
145528499|NCT02057393|524796031|FG000|Overall Study|Withdrawal by Subject|1|||
145528500|NCT02057393|524796031|FG000|Overall Study|Patient did not meet criteria|1|||
145528501|NCT03091777|524796034|FG000|Overall Study|Pregnancy|2|||
145528502|NCT03091777|524796035|FG001|Overall Study|Pregnancy|1|||
145528503|NCT03091777|524796036|FG002|Overall Study|Pregnancy|0|||
145528504|NCT03091777|524796034|FG000|Overall Study|Adverse Event|2|||
145528505|NCT03091777|524796035|FG001|Overall Study|Adverse Event|1|||
145528506|NCT03091777|524796036|FG002|Overall Study|Adverse Event|4|||
145528507|NCT03091777|524796034|FG000|Overall Study|Withdrawal by Subject|4|||
145528508|NCT03091777|524796035|FG001|Overall Study|Withdrawal by Subject|2|||
145528509|NCT03091777|524796036|FG002|Overall Study|Withdrawal by Subject|6|||
145528510|NCT03091777|524796034|FG000|Overall Study|Protocol Violation|2|||
145528511|NCT03091777|524796035|FG001|Overall Study|Protocol Violation|1|||
145528512|NCT03091777|524796036|FG002|Overall Study|Protocol Violation|1|||
145528513|NCT03091777|524796034|FG000|Overall Study|Lost to Follow-up|12|||
145528514|NCT03091777|524796035|FG001|Overall Study|Lost to Follow-up|14|||
145528515|NCT03091777|524796036|FG002|Overall Study|Lost to Follow-up|7|||
145528516|NCT03091777|524796034|FG000|Overall Study|Lack of Efficacy|0|||
145528517|NCT03091777|524796035|FG001|Overall Study|Lack of Efficacy|0|||
145528518|NCT03091777|524796036|FG002|Overall Study|Lack of Efficacy|5|||
145528519|NCT03091777|524796034|FG000|Overall Study|Noncompliance with study drug|2|||
145528520|NCT03091777|524796035|FG001|Overall Study|Noncompliance with study drug|3|||
145528521|NCT03091777|524796036|FG002|Overall Study|Noncompliance with study drug|1|||
145528522|NCT03091777|524796034|FG000|Overall Study|Physician Decision|1|||
145528523|NCT03091777|524796035|FG001|Overall Study|Physician Decision|0|||
145528524|NCT03091777|524796036|FG002|Overall Study|Physician Decision|1|||
145528525|NCT03091777|524796034|FG000|Overall Study|Abnormal Laboratory Value|7|||
145528526|NCT03091777|524796035|FG001|Overall Study|Abnormal Laboratory Value|11|||
145528527|NCT03091777|524796036|FG002|Overall Study|Abnormal Laboratory Value|12|||
145528528|NCT01437878|524796038|FG000|Overall Study|Withdrawal by Subject|1|||
145528529|NCT01437878|524796039|FG001|Overall Study|Withdrawal by Subject|0|||
145528530|NCT01070043|524796040|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
145528531|NCT01070043|524796041|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
145528532|NCT01070043|524796042|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
145528533|NCT01070043|524796040|FG000|Double-Blind Treatment|Adverse Event|0|||
145528534|NCT01070043|524796041|FG001|Double-Blind Treatment|Adverse Event|0|||
145528535|NCT01070043|524796042|FG002|Double-Blind Treatment|Adverse Event|2|||
145528536|NCT01476644|524796047|FG000|Overall Study|Death|5|||
145528537|NCT01476644|524796047|FG000|Overall Study|moved to another state|2|||
145528538|NCT01476644|524796047|FG000|Overall Study|Lost to Follow-up|19|||
145528539|NCT01476644|524796047|FG000|Overall Study|Withdrawal by Subject|13|||
145528540|NCT02393690|524796048|FG000|Overall Study|Ineligible|0|||
145528541|NCT02393690|524796049|FG001|Overall Study|Ineligible|1|||
145528542|NCT03488927|524796050|FG000|Overall Study|Withdrawal by Subject|44|||
145528543|NCT03488927|524796051|FG001|Overall Study|Withdrawal by Subject|118|||
145528544|NCT03488927|524796052|FG002|Overall Study|Withdrawal by Subject|217|||
145528545|NCT00586066|524796058|FG000|Overall Study|Lost to Follow-up|6|||
145528546|NCT00586066|524796059|FG001|Overall Study|Lost to Follow-up|3|||
145528547|NCT00586066|524796058|FG000|Overall Study|Lack of Efficacy|5|||
145528548|NCT00586066|524796059|FG001|Overall Study|Lack of Efficacy|3|||
145528549|NCT00586066|524796058|FG000|Overall Study|Adverse Event|2|||
145528550|NCT00586066|524796059|FG001|Overall Study|Adverse Event|2|||
145528551|NCT00586066|524796058|FG000|Overall Study|Physician Decision|1|||
145528552|NCT00586066|524796059|FG001|Overall Study|Physician Decision|0|||
145528553|NCT00586066|524796058|FG000|Overall Study|Withdrawal of consent|4|||
145528554|NCT00586066|524796059|FG001|Overall Study|Withdrawal of consent|2|||
145528555|NCT02676466|524796060|FG000|Overall Study|Death|0|||
145528556|NCT02676466|524796061|FG001|Overall Study|Death|2|||
145528557|NCT02676466|524796062|FG002|Overall Study|Death|1|||
145528558|NCT02676466|524796063|FG003|Overall Study|Death|0|||
145528559|NCT02676466|524796064|FG004|Overall Study|Death|0|||
145528560|NCT02676466|524796065|FG005|Overall Study|Death|0|||
145528561|NCT02676466|524796066|FG006|Overall Study|Death|0|||
145528562|NCT02676466|524796067|FG007|Overall Study|Death|0|||
145528563|NCT02676466|524796060|FG000|Overall Study|Withdrawal by Subject|4|||
145528564|NCT02676466|524796061|FG001|Overall Study|Withdrawal by Subject|3|||
145528565|NCT02676466|524796062|FG002|Overall Study|Withdrawal by Subject|1|||
145528566|NCT02676466|524796063|FG003|Overall Study|Withdrawal by Subject|0|||
145528567|NCT02676466|524796064|FG004|Overall Study|Withdrawal by Subject|3|||
145528568|NCT02676466|524796065|FG005|Overall Study|Withdrawal by Subject|1|||
145528569|NCT02676466|524796066|FG006|Overall Study|Withdrawal by Subject|1|||
145528570|NCT02676466|524796067|FG007|Overall Study|Withdrawal by Subject|1|||
145528571|NCT03497676|524796068|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
145528572|NCT03497676|524796069|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
145528573|NCT03497676|524796070|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
145528574|NCT03497676|524796071|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
145402704|NCT02659865|524332453|FG002|Period 1|Adverse Event|0|||
145528575|NCT03497676|524796068|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
145528576|NCT03497676|524796069|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
145528577|NCT03497676|524796070|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
145528578|NCT03497676|524796071|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
145607547|NCT02296190|525079201|FG002|Overall Study|Withdrawal by Subject|0|||
145607548|NCT02296190|525079202|FG003|Overall Study|Withdrawal by Subject|0|||
145607549|NCT02296190|525079203|FG004|Overall Study|Withdrawal by Subject|0|||
145607550|NCT02296190|525079204|FG005|Overall Study|Withdrawal by Subject|0|||
145528579|NCT03497676|524796068|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
145528580|NCT03497676|524796069|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
145528581|NCT03497676|524796070|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
145528582|NCT03497676|524796071|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
145528583|NCT03497676|524796068|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
145528584|NCT03497676|524796069|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
145528585|NCT03497676|524796070|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
145528586|NCT03497676|524796071|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
145528587|NCT03497676|524796068|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
145528588|NCT03497676|524796069|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
145528589|NCT03497676|524796070|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
145528590|NCT03497676|524796071|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
145528591|NCT03497676|524796068|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
145528592|NCT03497676|524796069|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
145528593|NCT03497676|524796070|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
145528594|NCT03497676|524796071|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
145528595|NCT03497676|524796068|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
145528596|NCT03497676|524796069|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
145528597|NCT03497676|524796070|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
145528598|NCT03497676|524796071|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
145528599|NCT03497676|524796068|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
145528600|NCT03497676|524796069|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
145528601|NCT03497676|524796070|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
145528602|NCT03497676|524796071|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
145528603|NCT00237185|524796072|FG000|Core|Adverse Event|3|||
145528604|NCT00237185|524796073|FG001|Core|Adverse Event|4|||
145528605|NCT00237185|524796072|FG000|Core|Abnormal laboratory value|0|||
145528606|NCT00237185|524796073|FG001|Core|Abnormal laboratory value|4|||
145528607|NCT00237185|524796072|FG000|Core|Abnormal test procedure results|1|||
145528608|NCT00237185|524796073|FG001|Core|Abnormal test procedure results|0|||
145528609|NCT00237185|524796072|FG000|Core|Lack of Efficacy|30|||
145528610|NCT00237185|524796073|FG001|Core|Lack of Efficacy|23|||
145528611|NCT00237185|524796072|FG000|Core|Protocol Violation|1|||
145528612|NCT00237185|524796073|FG001|Core|Protocol Violation|1|||
145528613|NCT00237185|524796072|FG000|Core|Withdrawal by Subject|4|||
145528614|NCT00237185|524796073|FG001|Core|Withdrawal by Subject|4|||
145528615|NCT00237185|524796072|FG000|Core|Administrative problems|0|||
145528616|NCT00237185|524796073|FG001|Core|Administrative problems|1|||
145528617|NCT00237185|524796072|FG000|Core|Death|4|||
145528618|NCT00237185|524796073|FG001|Core|Death|0|||
145528619|NCT00237185|524796072|FG000|Core|Determined ineligible post randomization|1|||
145528620|NCT00237185|524796073|FG001|Core|Determined ineligible post randomization|0|||
145528621|NCT00237185|524796072|FG000|Extension|Adverse Event|1|||
145528622|NCT00237185|524796073|FG001|Extension|Adverse Event|0|||
145528623|NCT00237185|524796072|FG000|Extension|Abnormal laboratory value|0|||
145528624|NCT00237185|524796073|FG001|Extension|Abnormal laboratory value|1|||
145528625|NCT00237185|524796072|FG000|Extension|Lack of Efficacy|9|||
145528626|NCT00237185|524796073|FG001|Extension|Lack of Efficacy|14|||
145528627|NCT00237185|524796072|FG000|Extension|Condition no longer required study drug|0|||
145528628|NCT00237185|524796073|FG001|Extension|Condition no longer required study drug|1|||
145528629|NCT00237185|524796072|FG000|Extension|Withdrawal by Subject|3|||
145272141|NCT01956123|523844566|FG003|COS Cycle 3|Withdrawal by Subject|1|||
145272142|NCT00267020|523844567|FG000|Overall Study|Adverse Event|22|||
145272143|NCT00267020|523844568|FG001|Overall Study|Adverse Event|5|||
145272144|NCT00267020|523844567|FG000|Overall Study|Death|2|||
145528630|NCT00237185|524796073|FG001|Extension|Withdrawal by Subject|2|||
145272145|NCT00267020|523844568|FG001|Overall Study|Death|1|||
145528631|NCT00237185|524796072|FG000|Extension|Lost to Follow-up|1|||
145528632|NCT00237185|524796073|FG001|Extension|Lost to Follow-up|0|||
145607551|NCT02296190|525079199|FG000|Overall Study|PSVT < 5 minutes|5|||
145272146|NCT00267020|523844567|FG000|Overall Study|Withdrawal by Subject|17|||
145272147|NCT00267020|523844568|FG001|Overall Study|Withdrawal by Subject|7|||
145272148|NCT00267020|523844567|FG000|Overall Study|Physician Decision|3|||
145272149|NCT00267020|523844568|FG001|Overall Study|Physician Decision|2|||
145528633|NCT00237185|524796072|FG000|Extension|Administrative problems|1|||
145528634|NCT00237185|524796073|FG001|Extension|Administrative problems|0|||
145528635|NCT00237185|524796072|FG000|Extension|Death|1|||
145528636|NCT00237185|524796073|FG001|Extension|Death|1|||
145528637|NCT02204007|524796074|FG000|Overall Study|Surgery Canceled|1|||
145528638|NCT02204007|524796075|FG001|Overall Study|Surgery Canceled|1|||
145528639|NCT00760084|524796076|FG000|Overall Study|Physician Decision|5|||
145528640|NCT00760084|524796076|FG000|Overall Study|Withdrawal by Subject|2|||
145528641|NCT00760084|524796076|FG000|Overall Study|Progressive Disease|3|||
145528642|NCT02750943|524796079|FG000|Overall Study|Lost to Follow-up|1|||
145528643|NCT02750943|524796080|FG001|Overall Study|Lost to Follow-up|2|||
145528644|NCT02750943|524796079|FG000|Overall Study|Withdrawal by Subject|5|||
145528645|NCT02750943|524796080|FG001|Overall Study|Withdrawal by Subject|7|||
145528646|NCT04382755|524796081|FG000|Overall Study|Withdrawal by Subject|1|||
145528647|NCT04382755|524796082|FG001|Overall Study|Withdrawal by Subject|0|||
145528648|NCT04382755|524796081|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
145528649|NCT04382755|524796082|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
145528650|NCT04382755|524796081|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
145528651|NCT04382755|524796082|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
145528652|NCT03552965|524796086|FG000|Overall Study|Death|1|||
145528653|NCT03552965|524796087|FG001|Overall Study|Death|1|||
145528654|NCT03552965|524796086|FG000|Overall Study|Lost to Follow-up|1|||
145528655|NCT03552965|524796087|FG001|Overall Study|Lost to Follow-up|1|||
145528656|NCT03552965|524796086|FG000|Overall Study|Physician Decision|1|||
145528657|NCT03552965|524796087|FG001|Overall Study|Physician Decision|1|||
145528658|NCT03552965|524796086|FG000|Overall Study|Withdrawal by Subject|0|||
145528659|NCT03552965|524796087|FG001|Overall Study|Withdrawal by Subject|2|||
145528660|NCT03552965|524796086|FG000|Overall Study|Continuation not in patient best interest|1|||
145528661|NCT03552965|524796087|FG001|Overall Study|Continuation not in patient best interest|0|||
145528662|NCT03552965|524796086|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
145528663|NCT03552965|524796087|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
145528664|NCT03120624|524796088|FG000|Overall Study|Withdrawal by Subject|0|||
145528665|NCT03120624|524796089|FG001|Overall Study|Withdrawal by Subject|1|||
145528666|NCT03120624|524796090|FG002|Overall Study|Withdrawal by Subject|0|||
145528667|NCT03120624|524796091|FG003|Overall Study|Withdrawal by Subject|0|||
145528668|NCT03120624|524796092|FG004|Overall Study|Withdrawal by Subject|0|||
145528669|NCT03120624|524796093|FG005|Overall Study|Withdrawal by Subject|0|||
145528670|NCT03120624|524796094|FG006|Overall Study|Withdrawal by Subject|0|||
145528671|NCT03120624|524796095|FG007|Overall Study|Withdrawal by Subject|0|||
145528672|NCT00084838|524797454|FG000|Overall Study|Death|1|||
145528673|NCT00084838|524797454|FG000|Overall Study|Adverse Event|2|||
145528674|NCT00084838|524797454|FG000|Overall Study|Withdrawal by Subject|1|||
145528675|NCT00084838|524797454|FG000|Overall Study|Progressive Disease|4|||
145528676|NCT00084838|524797454|FG000|Overall Study|Pt Non-Compliance|1|||
145528677|NCT00084838|524797454|FG000|Overall Study|Ineligible|4|||
145528678|NCT00401531|524797455|FG000|Overall Study|Adverse Event|2|||
145528679|NCT00401531|524797456|FG001|Overall Study|Adverse Event|0|||
145528680|NCT00401531|524797455|FG000|Overall Study|Protocol Violation|3|||
145528681|NCT00401531|524797456|FG001|Overall Study|Protocol Violation|7|||
145528682|NCT00401531|524797455|FG000|Overall Study|Lost to Follow-up|1|||
145528683|NCT00401531|524797456|FG001|Overall Study|Lost to Follow-up|1|||
145528684|NCT00401531|524797455|FG000|Overall Study|Withdrawal by Subject|3|||
145751476|NCT00493038|525604024|FG001|Follow-up|Lost to Follow-up|0|||
145751477|NCT03345472|525604025|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
145528685|NCT00401531|524797456|FG001|Overall Study|Withdrawal by Subject|2|||
145528686|NCT01614600|524797457|FG000|Overall Study|Unacceptable fit|1|||
145528687|NCT01614600|524797457|FG000|Overall Study|Discomfort|1|||
145528688|NCT01614600|524797457|FG000|Overall Study|Unable to remove lens at the end of day|1|||
145528689|NCT01614600|524797457|FG000|Overall Study|Protocol deviation|1|||
145528690|NCT02437513|524797458|FG000|Overall Study|Withdrawal by Subject|2|||
145528691|NCT03347188|524797461|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
145528692|NCT03347188|524797462|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
145528693|NCT03347188|524797461|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
145528694|NCT03347188|524797462|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
145751478|NCT03345472|525604025|FG000|Implant to 3 Months|Physician Decision|1|||
145751479|NCT03345472|525604025|FG000|Implant to 3 Months|Adverse Event|1|||
145751480|NCT03345472|525604025|FG000|3 Months to 12 Months|Physician Decision|3|||
145751481|NCT03345472|525604025|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
145751482|NCT03345472|525604025|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
145751483|NCT03345472|525604025|FG000|3 Months to 12 Months|Adverse Event|1|||
145751484|NCT03345472|525604025|FG000|3 Months to 12 Months|Death|1|||
145751485|NCT02728830|525604028|FG000|Overall Study|Exclusionary Surgery|9|||
145528695|NCT03347188|524797461|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
145528696|NCT03347188|524797462|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
145751486|NCT02728830|525604028|FG000|Overall Study|Exclusionary Pathology|6|||
145751487|NCT02728830|525604028|FG000|Overall Study|Physician Decision|3|||
145751488|NCT02728830|525604028|FG000|Overall Study|Withdrawal by Subject|2|||
145751489|NCT02728830|525604028|FG000|Overall Study|Lost to Follow-up|1|||
145751490|NCT02728830|525604028|FG000|Overall Study|Exclusionary Lab Values|1|||
145751491|NCT02728830|525604028|FG000|Overall Study|Contraindicated Illness|1|||
145751492|NCT02728830|525604028|FG000|Overall Study|Language Barrier|1|||
145751493|NCT01180660|525604029|FG000|Overall Study|Changed to open surgery|1|||
145751494|NCT01180660|525604030|FG001|Overall Study|Changed to open surgery|0|||
145751495|NCT00088374|525604033|FG000|Overall Study|patient did not receive any 17AAG|1|||
145528697|NCT03347188|524797461|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
145528698|NCT03347188|524797462|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
145528699|NCT03347188|524797461|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
145528700|NCT03347188|524797462|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
145528701|NCT03347188|524797461|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
145528702|NCT03347188|524797462|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
145528703|NCT03347188|524797461|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
145528704|NCT03347188|524797462|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
145528705|NCT03347188|524797461|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
145528706|NCT03347188|524797462|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
145528707|NCT03403374|524797463|FG000|Overall Study|Lost to Follow-up|1|||
145528708|NCT04879225|524797464|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
145528709|NCT04879225|524797464|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
145528710|NCT00736957|524797467|FG000|Overall Study|Adverse Event|43|||
145528711|NCT00736957|524797467|FG000|Overall Study|Withdrawal by Subject|49|||
145528712|NCT00736957|524797467|FG000|Overall Study|violation of eligibility criteria|2|||
145528713|NCT00736957|524797467|FG000|Overall Study|did not attend hospital appointments|1|||
145528714|NCT00736957|524797467|FG000|Overall Study|not eligible for Treatment Period I|22|||
145528715|NCT00736957|524797467|FG000|Overall Study|Physician Decision|5|||
145528716|NCT01409434|524797468|FG000|Overall Study|Protocol Violation|4|||
145528717|NCT02213042|524797469|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
145528718|NCT02213042|524797470|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
145528719|NCT02213042|524797471|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
145528720|NCT02213042|524797469|FG000|Overall Study|Adverse Event|2|||
145528721|NCT02213042|524797470|FG001|Overall Study|Adverse Event|1|||
145528722|NCT02213042|524797471|FG002|Overall Study|Adverse Event|0|||
145528723|NCT02213042|524797469|FG000|Overall Study|Withdrawal by Subject|0|||
145528724|NCT02213042|524797470|FG001|Overall Study|Withdrawal by Subject|1|||
145528725|NCT02213042|524797471|FG002|Overall Study|Withdrawal by Subject|1|||
145528726|NCT02213042|524797469|FG000|Overall Study|Protocol Violation|1|||
145528727|NCT02213042|524797470|FG001|Overall Study|Protocol Violation|0|||
145528728|NCT02213042|524797471|FG002|Overall Study|Protocol Violation|0|||
145528729|NCT02213042|524797469|FG000|Overall Study|Investigator discretion|0|||
145528730|NCT02213042|524797470|FG001|Overall Study|Investigator discretion|0|||
145528731|NCT02213042|524797471|FG002|Overall Study|Investigator discretion|1|||
145528732|NCT04622735|524797472|FG000|Overall Study|Lost to Follow-up|1|||
145528733|NCT04622735|524797473|FG001|Overall Study|Lost to Follow-up|2|||
145528734|NCT04622735|524797474|FG002|Overall Study|Lost to Follow-up|1|||
145528735|NCT04622735|524797472|FG000|Overall Study|Adverse Event|0|||
145528736|NCT04622735|524797473|FG001|Overall Study|Adverse Event|0|||
145528737|NCT04622735|524797474|FG002|Overall Study|Adverse Event|1|||
145528738|NCT04622735|524797472|FG000|Overall Study|Protocol Violation|1|||
145528739|NCT04622735|524797473|FG001|Overall Study|Protocol Violation|0|||
145528740|NCT04622735|524797474|FG002|Overall Study|Protocol Violation|0|||
145528741|NCT05314478|524797475|FG000|Overall Study|Physician Decision|1|||
145528742|NCT02007512|524797476|FG000|Double Blind Treatment Period|Adverse Event|4|||
145528743|NCT02007512|524797477|FG001|Double Blind Treatment Period|Adverse Event|6|||
145528744|NCT02007512|524797478|FG002|Double Blind Treatment Period|Adverse Event|2|||
145528745|NCT02007512|524797479|FG003|Double Blind Treatment Period|Adverse Event|2|||
145528746|NCT02007512|524797476|FG000|Double Blind Treatment Period|Death|1|||
145528747|NCT02007512|524797477|FG001|Double Blind Treatment Period|Death|0|||
145528748|NCT02007512|524797478|FG002|Double Blind Treatment Period|Death|0|||
145528749|NCT02007512|524797479|FG003|Double Blind Treatment Period|Death|0|||
145528750|NCT02007512|524797476|FG000|Double Blind Treatment Period|Disease progression|51|||
145528751|NCT02007512|524797477|FG001|Double Blind Treatment Period|Disease progression|50|||
145528752|NCT02007512|524797478|FG002|Double Blind Treatment Period|Disease progression|57|||
145528753|NCT02007512|524797479|FG003|Double Blind Treatment Period|Disease progression|52|||
145528754|NCT02007512|524797476|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528755|NCT02007512|524797477|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528756|NCT02007512|524797478|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528757|NCT02007512|524797479|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528758|NCT02007512|524797476|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145528759|NCT02007512|524797477|FG001|Double Blind Treatment Period|Protocol Violation|0|||
145528760|NCT02007512|524797478|FG002|Double Blind Treatment Period|Protocol Violation|0|||
145528761|NCT02007512|524797479|FG003|Double Blind Treatment Period|Protocol Violation|1|||
145528762|NCT02007512|524797476|FG000|Double Blind Treatment Period|Other|2|||
145528763|NCT02007512|524797477|FG001|Double Blind Treatment Period|Other|1|||
145528764|NCT02007512|524797478|FG002|Double Blind Treatment Period|Other|1|||
145528765|NCT02007512|524797479|FG003|Double Blind Treatment Period|Other|2|||
145528766|NCT02007512|524797476|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
145528767|NCT02007512|524797477|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
145528768|NCT02007512|524797478|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
145528769|NCT02007512|524797479|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
145528770|NCT02007512|524797476|FG000|Open Label Treatment Period|Adverse Event|1|||
145528771|NCT02007512|524797477|FG001|Open Label Treatment Period|Adverse Event|0|||
145528772|NCT02007512|524797478|FG002|Open Label Treatment Period|Adverse Event|0|||
145528773|NCT02007512|524797479|FG003|Open Label Treatment Period|Adverse Event|0|||
145528774|NCT02007512|524797476|FG000|Open Label Treatment Period|Other|1|||
145528775|NCT02007512|524797477|FG001|Open Label Treatment Period|Other|1|||
145528776|NCT02007512|524797478|FG002|Open Label Treatment Period|Other|0|||
145528777|NCT02007512|524797479|FG003|Open Label Treatment Period|Other|0|||
145528778|NCT02007512|524797476|FG000|Open Label Treatment Period|Disease progression|23|||
145528779|NCT02007512|524797477|FG001|Open Label Treatment Period|Disease progression|11|||
145528780|NCT02007512|524797478|FG002|Open Label Treatment Period|Disease progression|0|||
145528781|NCT02007512|524797479|FG003|Open Label Treatment Period|Disease progression|0|||
145528782|NCT03026088|524797480|FG000|Overall Study|Study termination|20|||
145528783|NCT03960554|524797487|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
145528784|NCT03960554|524797488|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
145528785|NCT00736879|524797489|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
145528786|NCT00736879|524797490|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
145528787|NCT00736879|524797491|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
145528788|NCT00736879|524797492|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
145528789|NCT00736879|524797489|FG000|Double Blind Treatment Period|Adverse Event|0|||
145528790|NCT00736879|524797490|FG001|Double Blind Treatment Period|Adverse Event|1|||
145528791|NCT00736879|524797491|FG002|Double Blind Treatment Period|Adverse Event|1|||
145528792|NCT00736879|524797492|FG003|Double Blind Treatment Period|Adverse Event|0|||
145528793|NCT00736879|524797489|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
145528794|NCT00736879|524797490|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
145528795|NCT00736879|524797491|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528796|NCT00736879|524797492|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
145528797|NCT00736879|524797489|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
145528798|NCT00736879|524797490|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
145528799|NCT00736879|524797491|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
145528800|NCT00736879|524797492|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
145528801|NCT00736879|524797489|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
145528802|NCT00736879|524797490|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
145528803|NCT00736879|524797491|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
145528804|NCT00736879|524797492|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
145528805|NCT00736879|524797489|FG000|Double Blind Treatment Period|No longer met criteria|0|||
145528806|NCT00736879|524797490|FG001|Double Blind Treatment Period|No longer met criteria|1|||
145528807|NCT00736879|524797491|FG002|Double Blind Treatment Period|No longer met criteria|0|||
145528808|NCT00736879|524797492|FG003|Double Blind Treatment Period|No longer met criteria|0|||
145528809|NCT00736879|524797489|FG000|Double Blind Treatment Period|non-specified|0|||
145528810|NCT00736879|524797490|FG001|Double Blind Treatment Period|non-specified|1|||
145528811|NCT00736879|524797491|FG002|Double Blind Treatment Period|non-specified|0|||
145528812|NCT00736879|524797492|FG003|Double Blind Treatment Period|non-specified|0|||
145528813|NCT00736879|524797489|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
145528814|NCT00736879|524797490|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
145528815|NCT00736879|524797491|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
145528816|NCT00736879|524797492|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
145528817|NCT00736879|524797489|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
145528818|NCT00736879|524797490|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
145528819|NCT00736879|524797491|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
145528820|NCT00736879|524797492|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
145528821|NCT02360111|524797493|FG000|Overall Study|Death|2|||
145528822|NCT00214500|524797504|FG000|Treatment Period|Adverse Event|1|||
145528823|NCT00214500|524797504|FG000|Extension Period|Withdrawal by Subject|2|||
145528824|NCT00147251|524797505|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
145528825|NCT00147251|524797506|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
145528826|NCT00751621|524797507|FG000|Overall Study|Adverse Event|1|||
145528827|NCT00751621|524797507|FG000|Overall Study|Withdrawal by Subject|1|||
145528828|NCT00751621|524797507|FG000|Overall Study|Subject moved to another country|1|||
145528829|NCT00751621|524797507|FG000|Overall Study|Poor adherence to asthma treatment|1|||
145528830|NCT02694523|524797511|FG000|Part A|Adverse Event|7|||
145528831|NCT02694523|524797512|FG001|Part A|Adverse Event|3|||
145528832|NCT02694523|524797513|FG002|Part A|Adverse Event|0|||
145528833|NCT02694523|524797514|FG003|Part A|Adverse Event|0|||
145528834|NCT02694523|524797515|FG004|Part A|Adverse Event|0|||
145528835|NCT02694523|524797516|FG005|Part A|Adverse Event|0|||
145528836|NCT02694523|524797517|FG006|Part A|Adverse Event|0|||
145528837|NCT02694523|524797511|FG000|Part A|Protocol Violation|1|||
145528838|NCT02694523|524797512|FG001|Part A|Protocol Violation|0|||
145528839|NCT02694523|524797513|FG002|Part A|Protocol Violation|0|||
145528840|NCT02694523|524797514|FG003|Part A|Protocol Violation|0|||
145528841|NCT02694523|524797515|FG004|Part A|Protocol Violation|0|||
145528842|NCT02694523|524797516|FG005|Part A|Protocol Violation|0|||
145528843|NCT02694523|524797517|FG006|Part A|Protocol Violation|0|||
145528844|NCT02694523|524797511|FG000|Part A|Lost to Follow-up|1|||
145528845|NCT02694523|524797512|FG001|Part A|Lost to Follow-up|2|||
145528846|NCT02694523|524797513|FG002|Part A|Lost to Follow-up|0|||
145528847|NCT02694523|524797514|FG003|Part A|Lost to Follow-up|0|||
145528848|NCT02694523|524797515|FG004|Part A|Lost to Follow-up|0|||
145528849|NCT02694523|524797516|FG005|Part A|Lost to Follow-up|0|||
145528850|NCT02694523|524797517|FG006|Part A|Lost to Follow-up|0|||
145528851|NCT02694523|524797511|FG000|Part A|Withdrawal by Subject|3|||
145528852|NCT02694523|524797512|FG001|Part A|Withdrawal by Subject|1|||
145528853|NCT02694523|524797513|FG002|Part A|Withdrawal by Subject|0|||
145528854|NCT02694523|524797514|FG003|Part A|Withdrawal by Subject|0|||
145528855|NCT02694523|524797515|FG004|Part A|Withdrawal by Subject|0|||
145528856|NCT02694523|524797516|FG005|Part A|Withdrawal by Subject|0|||
145528857|NCT02694523|524797517|FG006|Part A|Withdrawal by Subject|0|||
145528858|NCT02694523|524797511|FG000|Part A|Other|1|||
145528859|NCT02694523|524797512|FG001|Part A|Other|1|||
145528860|NCT02694523|524797513|FG002|Part A|Other|0|||
145528861|NCT02694523|524797514|FG003|Part A|Other|0|||
145528862|NCT02694523|524797515|FG004|Part A|Other|0|||
145528863|NCT02694523|524797516|FG005|Part A|Other|0|||
145528864|NCT02694523|524797517|FG006|Part A|Other|0|||
145528865|NCT02694523|524797511|FG000|Part B|Adverse Event|0|||
145528866|NCT02694523|524797512|FG001|Part B|Adverse Event|0|||
145528867|NCT02694523|524797513|FG002|Part B|Adverse Event|7|||
145528868|NCT02694523|524797514|FG003|Part B|Adverse Event|1|||
145528869|NCT02694523|524797515|FG004|Part B|Adverse Event|1|||
145528870|NCT02694523|524797516|FG005|Part B|Adverse Event|2|||
145528871|NCT02694523|524797517|FG006|Part B|Adverse Event|0|||
145528872|NCT02694523|524797511|FG000|Part B|Protocol Violation|0|||
145528873|NCT02694523|524797512|FG001|Part B|Protocol Violation|0|||
145528874|NCT02694523|524797513|FG002|Part B|Protocol Violation|1|||
145528875|NCT02694523|524797514|FG003|Part B|Protocol Violation|0|||
145528876|NCT02694523|524797515|FG004|Part B|Protocol Violation|0|||
145528877|NCT02694523|524797516|FG005|Part B|Protocol Violation|0|||
145528878|NCT02694523|524797517|FG006|Part B|Protocol Violation|0|||
145528879|NCT02694523|524797511|FG000|Part B|Lost to Follow-up|0|||
145528880|NCT02694523|524797512|FG001|Part B|Lost to Follow-up|0|||
145528881|NCT02694523|524797513|FG002|Part B|Lost to Follow-up|2|||
145528882|NCT02694523|524797514|FG003|Part B|Lost to Follow-up|3|||
145528883|NCT02694523|524797515|FG004|Part B|Lost to Follow-up|2|||
145528884|NCT02694523|524797516|FG005|Part B|Lost to Follow-up|0|||
145528885|NCT02694523|524797517|FG006|Part B|Lost to Follow-up|1|||
145528886|NCT02694523|524797511|FG000|Part B|Withdrawal by Subject|0|||
145528887|NCT02694523|524797512|FG001|Part B|Withdrawal by Subject|0|||
145528888|NCT02694523|524797513|FG002|Part B|Withdrawal by Subject|9|||
145528889|NCT02694523|524797514|FG003|Part B|Withdrawal by Subject|0|||
145528890|NCT02694523|524797515|FG004|Part B|Withdrawal by Subject|1|||
145528891|NCT02694523|524797516|FG005|Part B|Withdrawal by Subject|3|||
145528892|NCT02694523|524797517|FG006|Part B|Withdrawal by Subject|0|||
145528893|NCT02694523|524797511|FG000|Part B|Other|0|||
145528894|NCT02694523|524797512|FG001|Part B|Other|0|||
145528895|NCT02694523|524797513|FG002|Part B|Other|1|||
145528896|NCT02694523|524797514|FG003|Part B|Other|0|||
145528897|NCT02694523|524797515|FG004|Part B|Other|0|||
145528898|NCT02694523|524797516|FG005|Part B|Other|0|||
145528899|NCT02694523|524797517|FG006|Part B|Other|1|||
145528900|NCT01086423|524797518|FG000|Overall Study|Protocol Violation|0|||
145528901|NCT01086423|524797519|FG001|Overall Study|Protocol Violation|0|||
145528902|NCT01086423|524797520|FG002|Overall Study|Protocol Violation|1|||
145528903|NCT01086423|524797518|FG000|Overall Study|Migrated/moved from study area|2|||
145528904|NCT01086423|524797519|FG001|Overall Study|Migrated/moved from study area|0|||
145528905|NCT01086423|524797520|FG002|Overall Study|Migrated/moved from study area|4|||
145528906|NCT01086423|524797518|FG000|Overall Study|Adverse event, fatal|1|||
145528907|NCT01086423|524797519|FG001|Overall Study|Adverse event, fatal|1|||
145528908|NCT01086423|524797520|FG002|Overall Study|Adverse event, fatal|0|||
145528909|NCT01086423|524797518|FG000|Overall Study|Adverse event, non-fatal|2|||
145528910|NCT01086423|524797519|FG001|Overall Study|Adverse event, non-fatal|1|||
145528911|NCT01086423|524797520|FG002|Overall Study|Adverse event, non-fatal|0|||
145528912|NCT01086423|524797518|FG000|Overall Study|Withdrawal by Subject|5|||
145528913|NCT01086423|524797519|FG001|Overall Study|Withdrawal by Subject|1|||
145528914|NCT01086423|524797520|FG002|Overall Study|Withdrawal by Subject|3|||
145528915|NCT01086423|524797518|FG000|Overall Study|Lost to Follow-up|0|||
145528916|NCT01086423|524797519|FG001|Overall Study|Lost to Follow-up|0|||
145528917|NCT01086423|524797520|FG002|Overall Study|Lost to Follow-up|1|||
145528918|NCT00984568|524797522|FG000|Overall Study|Withdrawal by Subject|1|||
145528919|NCT00984568|524797523|FG001|Overall Study|Withdrawal by Subject|2|||
145528920|NCT00984568|524797522|FG000|Overall Study|Lack of Efficacy|2|||
145528921|NCT00984568|524797523|FG001|Overall Study|Lack of Efficacy|0|||
145528922|NCT00984568|524797522|FG000|Overall Study|Adverse Event|2|||
145528923|NCT00984568|524797523|FG001|Overall Study|Adverse Event|0|||
145528924|NCT00984568|524797522|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
145528925|NCT00984568|524797523|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
145528926|NCT00984568|524797522|FG000|Overall Study|Lost to Follow-up|0|||
145528927|NCT00984568|524797523|FG001|Overall Study|Lost to Follow-up|1|||
145528928|NCT00984568|524797522|FG000|Overall Study|Opportunistic Infection|1|||
145528929|NCT00984568|524797523|FG001|Overall Study|Opportunistic Infection|0|||
145528930|NCT00984568|524797522|FG000|Overall Study|Unknown Reason|1|||
145528931|NCT00984568|524797523|FG001|Overall Study|Unknown Reason|3|||
145528932|NCT00573248|524797524|FG000|Overall Study|scheduling conflicts|15|||
145528933|NCT00573248|524797525|FG001|Overall Study|scheduling conflicts|11|||
145528934|NCT02791594|524797528|FG000|Overall Study|Physician Decision|2|||
145528935|NCT03180684|524797531|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
145528936|NCT03180684|524797532|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
145528937|NCT03180684|524797531|FG000|Overall Study|Physician Decision|1|||
145528938|NCT03180684|524797532|FG001|Overall Study|Physician Decision|0|||
145528939|NCT03180684|524797531|FG000|Overall Study|Lost to Follow-up|1|||
145528940|NCT03180684|524797532|FG001|Overall Study|Lost to Follow-up|0|||
145528941|NCT03180684|524797531|FG000|Overall Study|Progressive Disease|1|||
145528942|NCT03180684|524797532|FG001|Overall Study|Progressive Disease|0|||
145528943|NCT04950166|524797533|FG000|Overall Study|Withdrawal by Subject|1|||
145607552|NCT02296190|525079200|FG001|Overall Study|PSVT < 5 minutes|6|||
145528944|NCT05896748|524797534|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
145528945|NCT05896748|524797534|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
145528946|NCT05896748|524797534|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
145528947|NCT05896748|524797534|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
145528948|NCT05896748|524797534|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
145528949|NCT00857415|524797542|FG000|Overall Study|Image acquisition failure|2|||
145528950|NCT00857415|524797543|FG001|Overall Study|Image acquisition failure|0|||
145528951|NCT00857415|524797542|FG000|Overall Study|Invalid image or not imaged|3|||
145528952|NCT00857415|524797543|FG001|Overall Study|Invalid image or not imaged|0|||
145528953|NCT00857415|524797542|FG000|Overall Study|Subject still living at end of study|110|||
145528954|NCT00857415|524797543|FG001|Overall Study|Subject still living at end of study|0|||
145528955|NCT00857415|524797542|FG000|Overall Study|Deceased with no autopsy|2|||
145528956|NCT00857415|524797543|FG001|Overall Study|Deceased with no autopsy|0|||
145528957|NCT01130103|524797544|FG000|Randomized Treatment|Adverse Event|1|||
145528958|NCT01130103|524797545|FG001|Randomized Treatment|Adverse Event|1|||
145528959|NCT01130103|524797544|FG000|Randomized Treatment|Lost to Follow-up|1|||
145528960|NCT01130103|524797545|FG001|Randomized Treatment|Lost to Follow-up|0|||
145528961|NCT01130103|524797544|FG000|Randomized Treatment|Protocol Violation|3|||
145528962|NCT01130103|524797545|FG001|Randomized Treatment|Protocol Violation|2|||
145528963|NCT01130103|524797544|FG000|Randomized Treatment|Withdrawal by Subject|1|||
145528964|NCT01130103|524797545|FG001|Randomized Treatment|Withdrawal by Subject|2|||
145528965|NCT01130103|524797544|FG000|Maintenance Treatment|Lack of Efficacy|0|||
145528966|NCT01130103|524797545|FG001|Maintenance Treatment|Lack of Efficacy|1|||
145528967|NCT01130103|524797544|FG000|Maintenance Treatment|Lost to Follow-up|1|||
145528968|NCT01130103|524797545|FG001|Maintenance Treatment|Lost to Follow-up|1|||
145528969|NCT01130103|524797544|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
145528970|NCT01130103|524797545|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
145528971|NCT04508140|524797546|FG000|Overall Study|Adverse Event|2|||
145528972|NCT04508140|524797547|FG001|Overall Study|Adverse Event|2|||
145528973|NCT04508140|524797546|FG000|Overall Study|Withdrawal by Subject|0|||
145528974|NCT04508140|524797547|FG001|Overall Study|Withdrawal by Subject|2|||
145528975|NCT04508140|524797546|FG000|Overall Study|progressive disease|9|||
145528976|NCT04508140|524797547|FG001|Overall Study|progressive disease|3|||
145528977|NCT01822678|524797550|FG000|Overall Study|Withdrawal by Subject|5|||
145528978|NCT01822678|524797551|FG001|Overall Study|Withdrawal by Subject|4|||
145528979|NCT01822678|524797552|FG002|Overall Study|Withdrawal by Subject|4|||
145528980|NCT01822678|524797550|FG000|Overall Study|Adverse Event|4|||
145528981|NCT01822678|524797551|FG001|Overall Study|Adverse Event|3|||
145528982|NCT01822678|524797552|FG002|Overall Study|Adverse Event|1|||
145528983|NCT01822678|524797550|FG000|Overall Study|Lack of Efficacy|3|||
145528984|NCT01822678|524797551|FG001|Overall Study|Lack of Efficacy|6|||
145528985|NCT01822678|524797552|FG002|Overall Study|Lack of Efficacy|5|||
145528986|NCT01822678|524797550|FG000|Overall Study|Lost to Follow-up|0|||
145528987|NCT01822678|524797551|FG001|Overall Study|Lost to Follow-up|2|||
145528988|NCT01822678|524797552|FG002|Overall Study|Lost to Follow-up|1|||
145528989|NCT04795622|524797558|FG000|Overall Study|Adverse Event|1|||
145528990|NCT04795622|524797559|FG001|Overall Study|Adverse Event|0|||
145528991|NCT04795622|524797558|FG000|Overall Study|Withdrawal by Subject|3|||
145528992|NCT04795622|524797559|FG001|Overall Study|Withdrawal by Subject|3|||
145528993|NCT04795622|524797558|FG000|Overall Study|Protocol Violation|0|||
145528994|NCT04795622|524797559|FG001|Overall Study|Protocol Violation|2|||
145528995|NCT04795622|524797558|FG000|Overall Study|Lost to Follow-up|2|||
145528996|NCT04795622|524797559|FG001|Overall Study|Lost to Follow-up|3|||
145528997|NCT04795622|524797558|FG000|Overall Study|Other|7|||
145528998|NCT04795622|524797559|FG001|Overall Study|Other|8|||
145528999|NCT03309046|524797560|FG000|Overall Study|Withdrawal by Subject|4|||
145529000|NCT03309046|524797561|FG001|Overall Study|Withdrawal by Subject|17|||
145529001|NCT02059005|524797566|FG000|Overall Study|Death|1|||
145529002|NCT02059005|524797567|FG001|Overall Study|Death|3|||
145529003|NCT02059005|524797566|FG000|Overall Study|Lost to Follow-up|19|||
145529004|NCT02059005|524797567|FG001|Overall Study|Lost to Follow-up|19|||
145529005|NCT02059005|524797566|FG000|Overall Study|Incarceration|0|||
145529006|NCT02059005|524797567|FG001|Overall Study|Incarceration|1|||
145529007|NCT02059005|524797566|FG000|Overall Study|Inpatient|0|||
145529008|NCT02059005|524797567|FG001|Overall Study|Inpatient|1|||
145529009|NCT00739596|524797568|FG000|Overall Study|Adverse Event|12|||
145529010|NCT00739596|524797569|FG001|Overall Study|Adverse Event|6|||
145529011|NCT00739596|524797568|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
145607553|NCT02296190|525079201|FG002|Overall Study|PSVT < 5 minutes|6|||
145529012|NCT00739596|524797569|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145529013|NCT00739596|524797568|FG000|Overall Study|Patient Withdrew Consent|8|||
145529014|NCT00739596|524797569|FG001|Overall Study|Patient Withdrew Consent|8|||
145529015|NCT00739596|524797568|FG000|Overall Study|Lost to Follow-up|0|||
145529016|NCT00739596|524797569|FG001|Overall Study|Lost to Follow-up|2|||
145529017|NCT00739596|524797568|FG000|Overall Study|Protocol Deviation|1|||
145529018|NCT00739596|524797569|FG001|Overall Study|Protocol Deviation|1|||
145529019|NCT00908011|524797570|FG000|Overall Study|Withdrawal by Subject|2|||
145529020|NCT00908011|524797571|FG001|Overall Study|Withdrawal by Subject|2|||
145529021|NCT02301988|524797577|FG000|Overall Study|Withdrawal by Subject|2|||
145529022|NCT02301988|524797578|FG001|Overall Study|Withdrawal by Subject|1|||
145529023|NCT02301988|524797577|FG000|Overall Study|Physician Decision|2|||
145529024|NCT02301988|524797578|FG001|Overall Study|Physician Decision|2|||
145529025|NCT02301988|524797577|FG000|Overall Study|Unknown Reason|1|||
145529026|NCT02301988|524797578|FG001|Overall Study|Unknown Reason|3|||
145529027|NCT02301988|524797577|FG000|Overall Study|Lack of Efficacy|3|||
145529028|NCT02301988|524797578|FG001|Overall Study|Lack of Efficacy|2|||
145529029|NCT02301988|524797577|FG000|Overall Study|Death|1|||
145529030|NCT02301988|524797578|FG001|Overall Study|Death|0|||
145529031|NCT02301988|524797577|FG000|Overall Study|Adverse Event|1|||
145529032|NCT02301988|524797578|FG001|Overall Study|Adverse Event|1|||
145529033|NCT04669535|524797579|FG000|Overall Study|Death|1|||
145529034|NCT04669535|524797580|FG001|Overall Study|Death|1|||
145529035|NCT04669535|524797581|FG002|Overall Study|Death|0|||
145529036|NCT04669535|524797582|FG003|Overall Study|Death|0|||
145529037|NCT05169567|524797584|FG000|Overall Study|On study treatment|116|||
145529038|NCT05169567|524797585|FG001|Overall Study|On study treatment|128|||
145529039|NCT05169567|524797584|FG000|Overall Study|Lost to Follow-up|1|||
145529040|NCT05169567|524797585|FG001|Overall Study|Lost to Follow-up|0|||
145529041|NCT05169567|524797584|FG000|Overall Study|Withdrawal by Subject|25|||
145529042|NCT05169567|524797585|FG001|Overall Study|Withdrawal by Subject|21|||
145529043|NCT05069259|524797589|FG000|Overall Study|Withdrawal by Subject|1|||
145529044|NCT05069259|524797589|FG000|Overall Study|Sponsor decision|1|||
145529045|NCT01828320|524797591|FG000|Overall Study|Lost to Follow-up|1|||
145529046|NCT01828320|524797592|FG001|Overall Study|Lost to Follow-up|3|||
145529047|NCT01828320|524797591|FG000|Overall Study|Withdrawal by Subject|7|||
145529048|NCT01828320|524797592|FG001|Overall Study|Withdrawal by Subject|2|||
145529049|NCT02160782|524798871|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
145529050|NCT02160782|524798872|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
145529051|NCT02160782|524798873|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
145529052|NCT02160782|524798874|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
145529053|NCT02160782|524798875|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
145529054|NCT02160782|524798871|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
145529055|NCT02160782|524798872|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
145529056|NCT02160782|524798873|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
145529057|NCT02160782|524798874|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
145529058|NCT02160782|524798875|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
145529059|NCT02160782|524798871|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
145529060|NCT02160782|524798872|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
145529061|NCT02160782|524798873|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
145529062|NCT02160782|524798874|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
145529063|NCT02160782|524798875|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
145529064|NCT02160782|524798871|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
145529065|NCT02160782|524798872|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
145529066|NCT02160782|524798873|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
145529067|NCT02160782|524798874|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
145529068|NCT02160782|524798875|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
145529069|NCT02160782|524798871|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
145529070|NCT02160782|524798872|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
145529071|NCT02160782|524798873|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
145529072|NCT02160782|524798874|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
145529073|NCT02160782|524798875|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
145529074|NCT02160782|524798871|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
145529075|NCT02160782|524798872|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
145529076|NCT02160782|524798873|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
145529077|NCT02160782|524798874|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
145529078|NCT02160782|524798875|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
145529079|NCT02160782|524798871|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
145529080|NCT02160782|524798872|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
145529081|NCT02160782|524798873|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
145529082|NCT02160782|524798874|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
145529083|NCT02160782|524798875|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
145529084|NCT01104701|524798880|FG000|Overall Study|Withdrawal by Subject|0|||
145529085|NCT01104701|524798881|FG001|Overall Study|Withdrawal by Subject|1|||
145529086|NCT01104701|524798882|FG002|Overall Study|Withdrawal by Subject|2|||
145529087|NCT01104701|524798883|FG003|Overall Study|Withdrawal by Subject|1|||
145529088|NCT01104701|524798880|FG000|Overall Study|Adverse Event|0|||
145529089|NCT01104701|524798881|FG001|Overall Study|Adverse Event|0|||
145529090|NCT01104701|524798882|FG002|Overall Study|Adverse Event|0|||
145529091|NCT01104701|524798883|FG003|Overall Study|Adverse Event|1|||
145529092|NCT01104701|524798880|FG000|Overall Study|Physician Decision|0|||
145529093|NCT01104701|524798881|FG001|Overall Study|Physician Decision|2|||
145529094|NCT01104701|524798882|FG002|Overall Study|Physician Decision|0|||
145529095|NCT01104701|524798883|FG003|Overall Study|Physician Decision|0|||
145529096|NCT00891462|524798884|FG000|Overall Study|Withdrawal by Subject|9|||
145529097|NCT00891462|524798885|FG001|Overall Study|Withdrawal by Subject|6|||
145529098|NCT00891462|524798886|FG002|Overall Study|Withdrawal by Subject|7|||
145529099|NCT00891462|524798884|FG000|Overall Study|Adverse Event|7|||
145529100|NCT00891462|524798885|FG001|Overall Study|Adverse Event|8|||
145529101|NCT00891462|524798886|FG002|Overall Study|Adverse Event|7|||
145529102|NCT00891462|524798884|FG000|Overall Study|Lack of Efficacy|10|||
145529103|NCT00891462|524798885|FG001|Overall Study|Lack of Efficacy|5|||
145529104|NCT00891462|524798886|FG002|Overall Study|Lack of Efficacy|1|||
145529105|NCT00891462|524798884|FG000|Overall Study|COPD exacerbation|7|||
145529106|NCT00891462|524798885|FG001|Overall Study|COPD exacerbation|4|||
145529107|NCT00891462|524798886|FG002|Overall Study|COPD exacerbation|1|||
145529108|NCT00891462|524798884|FG000|Overall Study|Other Reason|2|||
145529109|NCT00891462|524798885|FG001|Overall Study|Other Reason|5|||
145529110|NCT00891462|524798886|FG002|Overall Study|Other Reason|3|||
145529111|NCT00891462|524798884|FG000|Overall Study|Protocol Violation|2|||
145529112|NCT00891462|524798885|FG001|Overall Study|Protocol Violation|1|||
145529113|NCT00891462|524798886|FG002|Overall Study|Protocol Violation|3|||
145529114|NCT00891462|524798884|FG000|Overall Study|Inclusion/exclusion criteria|0|||
145529115|NCT00891462|524798885|FG001|Overall Study|Inclusion/exclusion criteria|2|||
145529116|NCT00891462|524798886|FG002|Overall Study|Inclusion/exclusion criteria|2|||
145529117|NCT00891462|524798884|FG000|Overall Study|Lost to Follow-up|0|||
145529118|NCT00891462|524798885|FG001|Overall Study|Lost to Follow-up|2|||
145529119|NCT00891462|524798886|FG002|Overall Study|Lost to Follow-up|0|||
145529120|NCT00423722|524798890|FG000|Overall Study|Death|4|||
145529121|NCT00423722|524798891|FG001|Overall Study|Death|4|||
145529122|NCT00423722|524798890|FG000|Overall Study|Declined to participate|2|||
145529123|NCT00423722|524798891|FG001|Overall Study|Declined to participate|3|||
145529124|NCT00423722|524798890|FG000|Overall Study|Unable to complete questionnaires|4|||
145529125|NCT00423722|524798891|FG001|Overall Study|Unable to complete questionnaires|4|||
145529126|NCT00423722|524798890|FG000|Overall Study|Withdrawal by Subject|4|||
145529127|NCT00423722|524798891|FG001|Overall Study|Withdrawal by Subject|2|||
145529128|NCT00215683|524798894|FG000|Overall Study|Adverse Event|15|||
145529129|NCT00215683|524798895|FG001|Overall Study|Adverse Event|16|||
145529130|NCT00215683|524798896|FG002|Overall Study|Adverse Event|15|||
145529131|NCT00215683|524798894|FG000|Overall Study|Lack of Efficacy|5|||
145529132|NCT00215683|524798895|FG001|Overall Study|Lack of Efficacy|1|||
145529133|NCT00215683|524798896|FG002|Overall Study|Lack of Efficacy|2|||
145529134|NCT00215683|524798894|FG000|Overall Study|Lost to Follow-up|0|||
145529135|NCT00215683|524798895|FG001|Overall Study|Lost to Follow-up|2|||
145529136|NCT00215683|524798896|FG002|Overall Study|Lost to Follow-up|1|||
145529137|NCT00215683|524798894|FG000|Overall Study|Withdrawal by Subject|9|||
145529138|NCT00215683|524798895|FG001|Overall Study|Withdrawal by Subject|4|||
145529139|NCT00215683|524798896|FG002|Overall Study|Withdrawal by Subject|13|||
145529140|NCT00215683|524798894|FG000|Overall Study|Physician Decision|0|||
145529141|NCT00215683|524798895|FG001|Overall Study|Physician Decision|0|||
145529142|NCT00215683|524798896|FG002|Overall Study|Physician Decision|1|||
145529143|NCT00215683|524798894|FG000|Overall Study|Difficult to attend visits|0|||
145529144|NCT00215683|524798895|FG001|Overall Study|Difficult to attend visits|1|||
145272150|NCT00267020|523844567|FG000|Overall Study|Disease Progression|39|||
145529145|NCT00215683|524798896|FG002|Overall Study|Difficult to attend visits|0|||
145529146|NCT00215683|524798894|FG000|Overall Study|No study drug available|0|||
145529147|NCT00215683|524798895|FG001|Overall Study|No study drug available|1|||
145529148|NCT00215683|524798896|FG002|Overall Study|No study drug available|0|||
145529149|NCT00215683|524798894|FG000|Overall Study|Intermittent therapy required|0|||
145529150|NCT00215683|524798895|FG001|Overall Study|Intermittent therapy required|1|||
145529151|NCT00215683|524798896|FG002|Overall Study|Intermittent therapy required|0|||
145529152|NCT01083485|524798897|FG000|Overall Study|Adverse Event|0|||
145529153|NCT01083485|524798898|FG001|Overall Study|Adverse Event|1|||
145529154|NCT01083485|524798897|FG000|Overall Study|Protocol Violation|1|||
145529155|NCT01083485|524798898|FG001|Overall Study|Protocol Violation|0|||
145529156|NCT01083485|524798897|FG000|Overall Study|Withdrawal by Subject|5|||
145529157|NCT01083485|524798898|FG001|Overall Study|Withdrawal by Subject|2|||
145529158|NCT01083485|524798897|FG000|Overall Study|Other|1|||
145529159|NCT01083485|524798898|FG001|Overall Study|Other|0|||
145529160|NCT02171065|524798899|FG000|Overall Study|Withdrawal by Subject|1|||
145529161|NCT02171065|524798900|FG001|Overall Study|Withdrawal by Subject|0|||
145529162|NCT02171065|524798901|FG002|Overall Study|Withdrawal by Subject|0|||
145529163|NCT02171065|524798899|FG000|Overall Study|Lost to Follow-up|0|||
145529164|NCT02171065|524798900|FG001|Overall Study|Lost to Follow-up|0|||
145529165|NCT02171065|524798901|FG002|Overall Study|Lost to Follow-up|1|||
145529166|NCT04493333|524798902|FG000|Overall Study|Withdrawal by Subject|1|||
145529167|NCT04493333|524798903|FG001|Overall Study|Withdrawal by Subject|1|||
145529168|NCT04493333|524798902|FG000|Overall Study|Ineligible|0|||
145529169|NCT04493333|524798903|FG001|Overall Study|Ineligible|1|||
145529170|NCT04493333|524798902|FG000|Overall Study|Noncompliance|2|||
145529171|NCT04493333|524798903|FG001|Overall Study|Noncompliance|1|||
145529172|NCT00518687|524798906|FG000|Overall Study|Adverse Event|201|||
145529173|NCT00518687|524798907|FG001|Overall Study|Adverse Event|177|||
145529174|NCT00518687|524798906|FG000|Overall Study|Lost to Follow-up|144|||
145529175|NCT00518687|524798907|FG001|Overall Study|Lost to Follow-up|155|||
145529176|NCT00518687|524798906|FG000|Overall Study|Physician Decision|42|||
145529177|NCT00518687|524798907|FG001|Overall Study|Physician Decision|48|||
145529178|NCT00518687|524798906|FG000|Overall Study|Progressive disease|2|||
145529179|NCT00518687|524798907|FG001|Overall Study|Progressive disease|2|||
145529180|NCT00518687|524798906|FG000|Overall Study|Protocol Violation|8|||
145529181|NCT00518687|524798907|FG001|Overall Study|Protocol Violation|10|||
145529182|NCT00518687|524798906|FG000|Overall Study|Study terminated by sponsor|930|||
145529183|NCT00518687|524798907|FG001|Overall Study|Study terminated by sponsor|918|||
145529184|NCT00518687|524798906|FG000|Overall Study|Withdrawal by Subject|110|||
145529185|NCT00518687|524798907|FG001|Overall Study|Withdrawal by Subject|110|||
145529186|NCT02598960|524798908|FG000|Treatment Period|Disease Progression|4|||
145529187|NCT02598960|524798909|FG001|Treatment Period|Disease Progression|4|||
145529188|NCT02598960|524798910|FG002|Treatment Period|Disease Progression|4|||
145529189|NCT02598960|524798911|FG003|Treatment Period|Disease Progression|6|||
145529190|NCT02598960|524798912|FG004|Treatment Period|Disease Progression|8|||
145529191|NCT02598960|524798913|FG005|Treatment Period|Disease Progression|2|||
145529192|NCT02598960|524798914|FG006|Treatment Period|Disease Progression|2|||
145529193|NCT02598960|524798915|FG007|Treatment Period|Disease Progression|3|||
145529194|NCT02598960|524798916|FG008|Treatment Period|Disease Progression|7|||
145529195|NCT02598960|524798917|FG009|Treatment Period|Disease Progression|9|||
145529196|NCT02598960|524798918|FG010|Treatment Period|Disease Progression|7|||
145529197|NCT02598960|524798919|FG011|Treatment Period|Disease Progression|143|||
145529198|NCT02598960|524798920|FG012|Treatment Period|Disease Progression|23|||
145272151|NCT00267020|523844568|FG001|Overall Study|Disease Progression|25|||
145272152|NCT00267020|523844567|FG000|Overall Study|Unrelated Complication|1|||
145272153|NCT00267020|523844568|FG001|Overall Study|Unrelated Complication|1|||
145272154|NCT00267020|523844567|FG000|Overall Study|Sponsor Request|1|||
145272155|NCT00267020|523844568|FG001|Overall Study|Sponsor Request|0|||
145272156|NCT00267020|523844567|FG000|Overall Study|Other|1|||
145272157|NCT00267020|523844568|FG001|Overall Study|Other|2|||
145272158|NCT01461369|523844569|FG000|Overall Study|Lack of Efficacy|2|||
145272159|NCT01461369|523844570|FG001|Overall Study|Lack of Efficacy|0|||
145272160|NCT01461369|523844571|FG002|Overall Study|Lack of Efficacy|6|||
145529199|NCT02598960|524798908|FG000|Treatment Period|Study drug toxicity|0|||
145529200|NCT02598960|524798909|FG001|Treatment Period|Study drug toxicity|0|||
145529201|NCT02598960|524798910|FG002|Treatment Period|Study drug toxicity|0|||
145529202|NCT02598960|524798911|FG003|Treatment Period|Study drug toxicity|0|||
145529203|NCT02598960|524798912|FG004|Treatment Period|Study drug toxicity|0|||
145529204|NCT02598960|524798913|FG005|Treatment Period|Study drug toxicity|0|||
145529205|NCT02598960|524798914|FG006|Treatment Period|Study drug toxicity|0|||
145529206|NCT02598960|524798915|FG007|Treatment Period|Study drug toxicity|0|||
145529207|NCT02598960|524798916|FG008|Treatment Period|Study drug toxicity|0|||
145529208|NCT02598960|524798917|FG009|Treatment Period|Study drug toxicity|1|||
145529209|NCT02598960|524798918|FG010|Treatment Period|Study drug toxicity|0|||
145529210|NCT02598960|524798919|FG011|Treatment Period|Study drug toxicity|3|||
145529211|NCT02598960|524798920|FG012|Treatment Period|Study drug toxicity|0|||
145529212|NCT02598960|524798908|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
145529213|NCT02598960|524798909|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
145529214|NCT02598960|524798910|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
145529215|NCT02598960|524798911|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
145529216|NCT02598960|524798912|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
145529217|NCT02598960|524798913|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
145529218|NCT02598960|524798914|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
145529219|NCT02598960|524798915|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
145529220|NCT02598960|524798916|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
145529221|NCT02598960|524798917|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
145529222|NCT02598960|524798918|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
145529223|NCT02598960|524798919|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
145529224|NCT02598960|524798920|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
145529225|NCT02598960|524798908|FG000|Treatment Period|participant request to discontinue|0|||
145529226|NCT02598960|524798909|FG001|Treatment Period|participant request to discontinue|1|||
145529227|NCT02598960|524798910|FG002|Treatment Period|participant request to discontinue|0|||
145529228|NCT02598960|524798911|FG003|Treatment Period|participant request to discontinue|0|||
145529229|NCT02598960|524798912|FG004|Treatment Period|participant request to discontinue|1|||
145529230|NCT02598960|524798913|FG005|Treatment Period|participant request to discontinue|0|||
145529231|NCT02598960|524798914|FG006|Treatment Period|participant request to discontinue|0|||
145529232|NCT02598960|524798915|FG007|Treatment Period|participant request to discontinue|0|||
145529233|NCT02598960|524798916|FG008|Treatment Period|participant request to discontinue|0|||
145529234|NCT02598960|524798917|FG009|Treatment Period|participant request to discontinue|0|||
145529235|NCT02598960|524798918|FG010|Treatment Period|participant request to discontinue|1|||
145529236|NCT02598960|524798919|FG011|Treatment Period|participant request to discontinue|4|||
145529237|NCT02598960|524798920|FG012|Treatment Period|participant request to discontinue|0|||
145529238|NCT02598960|524798908|FG000|Treatment Period|participant withdrew consent|0|||
145529239|NCT02598960|524798909|FG001|Treatment Period|participant withdrew consent|0|||
145529240|NCT02598960|524798910|FG002|Treatment Period|participant withdrew consent|0|||
145529241|NCT02598960|524798911|FG003|Treatment Period|participant withdrew consent|0|||
145529242|NCT02598960|524798912|FG004|Treatment Period|participant withdrew consent|0|||
145529243|NCT02598960|524798913|FG005|Treatment Period|participant withdrew consent|0|||
145529244|NCT02598960|524798914|FG006|Treatment Period|participant withdrew consent|0|||
145529245|NCT02598960|524798915|FG007|Treatment Period|participant withdrew consent|0|||
145529246|NCT02598960|524798916|FG008|Treatment Period|participant withdrew consent|0|||
145529247|NCT02598960|524798917|FG009|Treatment Period|participant withdrew consent|0|||
145529248|NCT02598960|524798918|FG010|Treatment Period|participant withdrew consent|0|||
145529249|NCT02598960|524798919|FG011|Treatment Period|participant withdrew consent|3|||
145529250|NCT02598960|524798920|FG012|Treatment Period|participant withdrew consent|0|||
145529251|NCT02598960|524798908|FG000|Treatment Period|No longer meets study criteria|0|||
145529252|NCT02598960|524798909|FG001|Treatment Period|No longer meets study criteria|0|||
145529253|NCT02598960|524798910|FG002|Treatment Period|No longer meets study criteria|0|||
145529254|NCT02598960|524798911|FG003|Treatment Period|No longer meets study criteria|0|||
145529255|NCT02598960|524798912|FG004|Treatment Period|No longer meets study criteria|0|||
145529256|NCT02598960|524798913|FG005|Treatment Period|No longer meets study criteria|0|||
145529257|NCT02598960|524798914|FG006|Treatment Period|No longer meets study criteria|0|||
145529258|NCT02598960|524798915|FG007|Treatment Period|No longer meets study criteria|0|||
145529259|NCT02598960|524798916|FG008|Treatment Period|No longer meets study criteria|0|||
145529260|NCT02598960|524798917|FG009|Treatment Period|No longer meets study criteria|0|||
145529261|NCT02598960|524798918|FG010|Treatment Period|No longer meets study criteria|0|||
145529262|NCT02598960|524798919|FG011|Treatment Period|No longer meets study criteria|1|||
145529263|NCT02598960|524798920|FG012|Treatment Period|No longer meets study criteria|0|||
145402705|NCT02659865|524332454|FG003|Period 1|Adverse Event|0|||
145529264|NCT02598960|524798908|FG000|Treatment Period|Other Reasons|0|||
145529265|NCT02598960|524798909|FG001|Treatment Period|Other Reasons|0|||
145529266|NCT02598960|524798910|FG002|Treatment Period|Other Reasons|0|||
145529267|NCT02598960|524798911|FG003|Treatment Period|Other Reasons|0|||
145529268|NCT02598960|524798912|FG004|Treatment Period|Other Reasons|0|||
145529269|NCT02598960|524798913|FG005|Treatment Period|Other Reasons|0|||
145529270|NCT02598960|524798914|FG006|Treatment Period|Other Reasons|0|||
145529271|NCT02598960|524798915|FG007|Treatment Period|Other Reasons|0|||
145402706|NCT02659865|524332455|FG004|Period 1|Adverse Event|1|||
145529272|NCT02598960|524798916|FG008|Treatment Period|Other Reasons|0|||
145529273|NCT02598960|524798917|FG009|Treatment Period|Other Reasons|0|||
145529274|NCT02598960|524798918|FG010|Treatment Period|Other Reasons|0|||
145529275|NCT02598960|524798919|FG011|Treatment Period|Other Reasons|0|||
145529276|NCT02598960|524798920|FG012|Treatment Period|Other Reasons|1|||
145402707|NCT03370172|524332456|FG000|Overall Study|Withdrawal by Subject|0|||
145529277|NCT02598960|524798908|FG000|Participants Entering Follow Up Period|Death|1|||
145529278|NCT02598960|524798909|FG001|Participants Entering Follow Up Period|Death|0|||
145529279|NCT02598960|524798910|FG002|Participants Entering Follow Up Period|Death|0|||
145529280|NCT02598960|524798911|FG003|Participants Entering Follow Up Period|Death|0|||
145529281|NCT02598960|524798912|FG004|Participants Entering Follow Up Period|Death|0|||
145529282|NCT02598960|524798913|FG005|Participants Entering Follow Up Period|Death|0|||
145529283|NCT02598960|524798914|FG006|Participants Entering Follow Up Period|Death|0|||
145529284|NCT02598960|524798915|FG007|Participants Entering Follow Up Period|Death|0|||
145529285|NCT02598960|524798916|FG008|Participants Entering Follow Up Period|Death|0|||
145529286|NCT02598960|524798917|FG009|Participants Entering Follow Up Period|Death|1|||
145529287|NCT02598960|524798918|FG010|Participants Entering Follow Up Period|Death|0|||
145529288|NCT02598960|524798919|FG011|Participants Entering Follow Up Period|Death|11|||
145529289|NCT02598960|524798920|FG012|Participants Entering Follow Up Period|Death|2|||
145529290|NCT02598960|524798908|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529291|NCT02598960|524798909|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529292|NCT02598960|524798910|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529293|NCT02598960|524798911|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529294|NCT02598960|524798912|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529295|NCT02598960|524798913|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529296|NCT02598960|524798914|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529297|NCT02598960|524798915|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529298|NCT02598960|524798916|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529299|NCT02598960|524798917|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529300|NCT02598960|524798918|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
145607554|NCT02296190|525079202|FG003|Overall Study|PSVT < 5 minutes|6|||
145751496|NCT00088374|525604033|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
145751497|NCT00852995|525604034|FG000|Overall Study|Adverse Event|1|||
145751498|NCT00852995|525604035|FG001|Overall Study|Adverse Event|0|||
145751499|NCT00852995|525604036|FG002|Overall Study|Adverse Event|4|||
145751500|NCT00852995|525604037|FG003|Overall Study|Adverse Event|0|||
145751501|NCT00852995|525604038|FG004|Overall Study|Adverse Event|0|||
145751502|NCT00852995|525604034|FG000|Overall Study|Lost to Follow-up|0|||
145751503|NCT00852995|525604035|FG001|Overall Study|Lost to Follow-up|1|||
145751504|NCT00852995|525604036|FG002|Overall Study|Lost to Follow-up|1|||
145751505|NCT00852995|525604037|FG003|Overall Study|Lost to Follow-up|0|||
145751506|NCT00852995|525604038|FG004|Overall Study|Lost to Follow-up|0|||
145751507|NCT00852995|525604034|FG000|Overall Study|Withdrawal by Subject|4|||
145751508|NCT00852995|525604035|FG001|Overall Study|Withdrawal by Subject|0|||
145751509|NCT00852995|525604036|FG002|Overall Study|Withdrawal by Subject|0|||
145751510|NCT00852995|525604037|FG003|Overall Study|Withdrawal by Subject|1|||
145751511|NCT00852995|525604038|FG004|Overall Study|Withdrawal by Subject|2|||
145751512|NCT00852995|525604034|FG000|Overall Study|Non-Compliance|0|||
145751513|NCT00852995|525604035|FG001|Overall Study|Non-Compliance|0|||
145751514|NCT00852995|525604036|FG002|Overall Study|Non-Compliance|0|||
145751515|NCT00852995|525604037|FG003|Overall Study|Non-Compliance|2|||
145751516|NCT00852995|525604038|FG004|Overall Study|Non-Compliance|0|||
145751517|NCT00852995|525604034|FG000|Overall Study|Progressive Disease|1|||
145751518|NCT00852995|525604035|FG001|Overall Study|Progressive Disease|0|||
145751519|NCT00852995|525604036|FG002|Overall Study|Progressive Disease|0|||
145751520|NCT00852995|525604037|FG003|Overall Study|Progressive Disease|2|||
145751521|NCT00852995|525604038|FG004|Overall Study|Progressive Disease|1|||
145751522|NCT00852995|525604034|FG000|Overall Study|Physician Decision|1|||
145751523|NCT00852995|525604035|FG001|Overall Study|Physician Decision|0|||
145751524|NCT00852995|525604036|FG002|Overall Study|Physician Decision|0|||
145751525|NCT00852995|525604037|FG003|Overall Study|Physician Decision|0|||
145751526|NCT00852995|525604038|FG004|Overall Study|Physician Decision|0|||
145751527|NCT00852995|525604034|FG000|Overall Study|Protocol Violation|0|||
145751528|NCT00852995|525604035|FG001|Overall Study|Protocol Violation|0|||
145751529|NCT00852995|525604036|FG002|Overall Study|Protocol Violation|0|||
145751530|NCT00852995|525604037|FG003|Overall Study|Protocol Violation|0|||
145751531|NCT00852995|525604038|FG004|Overall Study|Protocol Violation|1|||
145751532|NCT00852995|525604034|FG000|Overall Study|Moved Out of Area|1|||
145751533|NCT00852995|525604035|FG001|Overall Study|Moved Out of Area|0|||
145751534|NCT00852995|525604036|FG002|Overall Study|Moved Out of Area|0|||
145751535|NCT00852995|525604037|FG003|Overall Study|Moved Out of Area|0|||
145751536|NCT00852995|525604038|FG004|Overall Study|Moved Out of Area|0|||
145751537|NCT03595553|525604039|FG000|Overall Study|Withdrawal by Subject|20|||
145751538|NCT03595553|525604040|FG001|Overall Study|Withdrawal by Subject|8|||
145751539|NCT03595553|525604039|FG000|Overall Study|Physician Decision|3|||
145751540|NCT03595553|525604040|FG001|Overall Study|Physician Decision|2|||
145751541|NCT03595553|525604039|FG000|Overall Study|Adverse Event|2|||
145751542|NCT03595553|525604040|FG001|Overall Study|Adverse Event|5|||
145751543|NCT03595553|525604039|FG000|Overall Study|Death|24|||
145751544|NCT03595553|525604040|FG001|Overall Study|Death|22|||
145751545|NCT03595553|525604039|FG000|Overall Study|Lost to Follow-up|6|||
145751546|NCT03595553|525604040|FG001|Overall Study|Lost to Follow-up|7|||
145751547|NCT03595553|525604039|FG000|Overall Study|Other as indicated in CSR|3|||
145751548|NCT03595553|525604040|FG001|Overall Study|Other as indicated in CSR|3|||
145751549|NCT03595553|525604039|FG000|Overall Study|Sponsor Decision|0|||
145751550|NCT03595553|525604040|FG001|Overall Study|Sponsor Decision|1|||
145529301|NCT02598960|524798919|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
145529302|NCT02598960|524798920|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
145529303|NCT02598960|524798908|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
145529304|NCT02598960|524798909|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
145529305|NCT02598960|524798910|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
145529306|NCT02598960|524798911|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
145529307|NCT02598960|524798912|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
145529308|NCT02598960|524798913|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
145529309|NCT02598960|524798914|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
145529310|NCT02598960|524798915|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
145529311|NCT02598960|524798916|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
145529312|NCT02598960|524798917|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
145529313|NCT02598960|524798918|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
145529314|NCT02598960|524798919|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
145529315|NCT02598960|524798920|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
145529316|NCT02598960|524798908|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529317|NCT02598960|524798909|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529318|NCT02598960|524798910|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529319|NCT02598960|524798911|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529320|NCT02598960|524798912|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529321|NCT02598960|524798913|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529322|NCT02598960|524798914|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529323|NCT02598960|524798915|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529324|NCT02598960|524798916|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529325|NCT02598960|524798917|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529326|NCT02598960|524798918|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529327|NCT02598960|524798919|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
145529328|NCT02598960|524798920|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
145529329|NCT02598960|524798908|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
145529330|NCT02598960|524798909|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
145529331|NCT02598960|524798910|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
145529332|NCT02598960|524798911|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
145529333|NCT02598960|524798912|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
145529334|NCT02598960|524798913|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
145751551|NCT02158091|525604047|FG000|Overall Study|DLT|2|||
145751552|NCT02158091|525604048|FG001|Overall Study|DLT|1|||
145751553|NCT02158091|525604049|FG002|Overall Study|DLT|0|||
145529335|NCT02598960|524798914|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
145529336|NCT02598960|524798915|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
145751554|NCT04518462|525604050|FG000|Overall Study|Withdrawal by Subject|0|||
145751555|NCT04518462|525604051|FG001|Overall Study|Withdrawal by Subject|0|||
145751556|NCT04518462|525604052|FG002|Overall Study|Withdrawal by Subject|1|||
145751557|NCT04518462|525604050|FG000|Overall Study|Physician Decision|1|||
145751558|NCT04518462|525604051|FG001|Overall Study|Physician Decision|1|||
145751559|NCT04518462|525604052|FG002|Overall Study|Physician Decision|0|||
145751560|NCT01003210|525604053|FG000|Overall Study|Lost to Follow-up|1|||
145751561|NCT01003210|525604054|FG001|Overall Study|Lost to Follow-up|3|||
145751562|NCT00271817|525604055|FG000|Part 1|Adverse Event|68|||
145751563|NCT00271817|525604056|FG001|Part 1|Adverse Event|25|||
145751564|NCT00271817|525604057|FG002|Part 1|Adverse Event|156|||
145751565|NCT00271817|525604055|FG000|Part 1|Lost to Follow-up|6|||
145751566|NCT00271817|525604056|FG001|Part 1|Lost to Follow-up|8|||
145751567|NCT00271817|525604057|FG002|Part 1|Lost to Follow-up|24|||
145751568|NCT00271817|525604055|FG000|Part 1|Protocol Violation|5|||
145751569|NCT00271817|525604056|FG001|Part 1|Protocol Violation|4|||
145751570|NCT00271817|525604057|FG002|Part 1|Protocol Violation|7|||
145272161|NCT01461369|523844569|FG000|Overall Study|Lost to Follow-up|0|||
145272162|NCT01461369|523844570|FG001|Overall Study|Lost to Follow-up|0|||
145272163|NCT01461369|523844571|FG002|Overall Study|Lost to Follow-up|3|||
145751571|NCT00271817|525604055|FG000|Part 1|Patient Moved|3|||
145751572|NCT00271817|525604056|FG001|Part 1|Patient Moved|1|||
145751573|NCT00271817|525604057|FG002|Part 1|Patient Moved|5|||
145751574|NCT00271817|525604055|FG000|Part 1|Withdrawal by Subject|23|||
145751575|NCT00271817|525604056|FG001|Part 1|Withdrawal by Subject|17|||
145751576|NCT00271817|525604057|FG002|Part 1|Withdrawal by Subject|45|||
145751577|NCT00271817|525604055|FG000|Part 1|LDL < 50 mg/dL|1|||
145751578|NCT00271817|525604056|FG001|Part 1|LDL < 50 mg/dL|4|||
145751579|NCT00271817|525604057|FG002|Part 1|LDL < 50 mg/dL|48|||
145751580|NCT00271817|525604055|FG000|Part 2|Adverse Event|0|||
145751581|NCT00271817|525604056|FG001|Part 2|Adverse Event|17|||
145751582|NCT00271817|525604057|FG002|Part 2|Adverse Event|33|||
145751583|NCT00271817|525604055|FG000|Part 2|Lack of Efficacy|0|||
145529337|NCT02598960|524798916|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
145529338|NCT02598960|524798917|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
145529339|NCT02598960|524798918|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
145529340|NCT02598960|524798919|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
145529341|NCT02598960|524798920|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
145529342|NCT05036369|524798922|FG000|Overall Study|Run In non compliance|1|||
145529343|NCT05036369|524798923|FG001|Overall Study|Run In non compliance|2|||
145529344|NCT05036369|524798922|FG000|Overall Study|Change in eligibility criteria|0|||
145529345|NCT05036369|524798923|FG001|Overall Study|Change in eligibility criteria|1|||
145529346|NCT01846104|524798924|FG000|Overall Study|Withdrawal by Subject|1|||
145529347|NCT00851630|524798925|FG000|Overall Study|Death|2|||
145529348|NCT00851630|524798926|FG001|Overall Study|Death|1|||
145751584|NCT00271817|525604056|FG001|Part 2|Lack of Efficacy|1|||
145751585|NCT00271817|525604057|FG002|Part 2|Lack of Efficacy|6|||
145751586|NCT00271817|525604055|FG000|Part 2|Lost to Follow-up|0|||
145751587|NCT00271817|525604056|FG001|Part 2|Lost to Follow-up|6|||
145751588|NCT00271817|525604057|FG002|Part 2|Lost to Follow-up|18|||
145751589|NCT00271817|525604055|FG000|Part 2|Protocol Violation|0|||
145529349|NCT00851630|524798925|FG000|Overall Study|Clinical failure|0|||
145529350|NCT00851630|524798926|FG001|Overall Study|Clinical failure|1|||
145529351|NCT00398411|524798927|FG000|Overall Study|Death|0|||
145529352|NCT00398411|524798928|FG001|Overall Study|Death|1|||
145272164|NCT01461369|523844569|FG000|Overall Study|Adverse Event|9|||
145272165|NCT01461369|523844570|FG001|Overall Study|Adverse Event|12|||
145272166|NCT01461369|523844571|FG002|Overall Study|Adverse Event|4|||
145272167|NCT01461369|523844569|FG000|Overall Study|Protocol Violation|1|||
145751590|NCT00271817|525604056|FG001|Part 2|Protocol Violation|3|||
145272168|NCT01461369|523844570|FG001|Overall Study|Protocol Violation|2|||
145272169|NCT01461369|523844571|FG002|Overall Study|Protocol Violation|2|||
145529353|NCT02095223|524798931|FG000|Overall Study|Withdrawal by Subject|1|||
145529354|NCT02095223|524798932|FG001|Overall Study|Withdrawal by Subject|0|||
145529355|NCT01397162|524798933|FG000|Overall Study|Adverse Event|4|||
145529356|NCT01397162|524798934|FG001|Overall Study|Adverse Event|0|||
145529357|NCT01397162|524798935|FG002|Overall Study|Adverse Event|0|||
145272170|NCT01461369|523844569|FG000|Overall Study|Withdrawal by Subject|1|||
145272171|NCT01461369|523844570|FG001|Overall Study|Withdrawal by Subject|3|||
145272172|NCT01461369|523844571|FG002|Overall Study|Withdrawal by Subject|2|||
145272173|NCT00734617|523844574|FG000|Overall Study|Adverse Event|4|||
145272174|NCT00734617|523844575|FG001|Overall Study|Adverse Event|7|||
145272175|NCT00734617|523844574|FG000|Overall Study|Withdrawal by Subject|103|||
145272176|NCT00734617|523844575|FG001|Overall Study|Withdrawal by Subject|95|||
145272177|NCT00556166|523844578|FG000|Overall Study|Withdrawal by Subject|1|||
145272178|NCT01612780|523844579|FG000|Overall Study|Treatment not completed|1|||
145272179|NCT01612780|523844579|FG000|Overall Study|Withdrawal by Subject|5|||
145272180|NCT02985515|523844582|FG000|Olfaction Testing|Lost to Follow-up|0|||
145272181|NCT02985515|523844583|FG001|Olfaction Testing|Lost to Follow-up|5|||
145529358|NCT01397162|524798936|FG003|Overall Study|Adverse Event|0|||
145529359|NCT01397162|524798937|FG004|Overall Study|Adverse Event|0|||
145529360|NCT01397162|524798933|FG000|Overall Study|Not yet defined|3|||
145529361|NCT01397162|524798934|FG001|Overall Study|Not yet defined|4|||
145529362|NCT01397162|524798935|FG002|Overall Study|Not yet defined|3|||
145529363|NCT01397162|524798936|FG003|Overall Study|Not yet defined|5|||
145529364|NCT01397162|524798937|FG004|Overall Study|Not yet defined|3|||
145529365|NCT03906461|524798940|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
145529366|NCT03906461|524798940|FG000|Completed 12-month Follow-up|Missed Visit|6|||
145529367|NCT00426231|524798943|FG000|Overall Study|Withdrawal by Subject|9|||
145272182|NCT02985515|523844582|FG000|Olfaction Testing|Protocol Violation|0|||
145272183|NCT02985515|523844583|FG001|Olfaction Testing|Protocol Violation|3|||
145751591|NCT00271817|525604057|FG002|Part 2|Protocol Violation|5|||
145751592|NCT00271817|525604055|FG000|Part 2|Patient Moved|0|||
145751593|NCT00271817|525604056|FG001|Part 2|Patient Moved|0|||
145751594|NCT00271817|525604057|FG002|Part 2|Patient Moved|5|||
145272184|NCT03359473|523844584|FG000|Overall Study|Adverse Event|0|||
145272185|NCT03359473|523844585|FG001|Overall Study|Adverse Event|2|||
145272186|NCT03359473|523844586|FG002|Overall Study|Adverse Event|5|||
145751595|NCT00271817|525604055|FG000|Part 2|Withdrawal by Subject|0|||
145751596|NCT00271817|525604056|FG001|Part 2|Withdrawal by Subject|2|||
145529368|NCT00426231|524798944|FG001|Overall Study|Withdrawal by Subject|12|||
145529369|NCT01795638|524798945|FG000|Overall Study|Death|0|||
145529370|NCT01795638|524798946|FG001|Overall Study|Death|3|||
145529371|NCT01795638|524798945|FG000|Overall Study|transferred to quaternary hospital|2|||
145529372|NCT01795638|524798946|FG001|Overall Study|transferred to quaternary hospital|3|||
145529373|NCT01795638|524798945|FG000|Overall Study|Protocol Violation|3|||
145529374|NCT01795638|524798946|FG001|Overall Study|Protocol Violation|0|||
145529375|NCT01795638|524798945|FG000|Overall Study|discharged from hospital|7|||
145529376|NCT01795638|524798946|FG001|Overall Study|discharged from hospital|5|||
145529377|NCT01795638|524798945|FG000|Overall Study|Withdrawal by Subject|1|||
145529378|NCT01795638|524798946|FG001|Overall Study|Withdrawal by Subject|0|||
145529379|NCT03061097|524798947|FG000|Overall Study|Withdrawal by Subject|0|||
145529380|NCT03061097|524798948|FG001|Overall Study|Withdrawal by Subject|3|||
145529381|NCT00595465|524798955|FG000|Overall Study|Adverse Event|4|||
145751597|NCT00271817|525604057|FG002|Part 2|Withdrawal by Subject|13|||
145751598|NCT00271817|525604055|FG000|Part 2|LDL < 50 mg/dL|0|||
145529382|NCT00595465|524798956|FG001|Overall Study|Adverse Event|3|||
145529383|NCT00595465|524798957|FG002|Overall Study|Adverse Event|3|||
145529384|NCT00595465|524798955|FG000|Overall Study|Pregnancy|0|||
145529385|NCT00595465|524798956|FG001|Overall Study|Pregnancy|0|||
145529386|NCT00595465|524798957|FG002|Overall Study|Pregnancy|1|||
145529387|NCT00595465|524798955|FG000|Overall Study|Protocol Violation|2|||
145529388|NCT00595465|524798956|FG001|Overall Study|Protocol Violation|1|||
145529389|NCT00595465|524798957|FG002|Overall Study|Protocol Violation|0|||
145529390|NCT00595465|524798955|FG000|Overall Study|Lost to Follow-up|0|||
145529391|NCT00595465|524798956|FG001|Overall Study|Lost to Follow-up|0|||
145529392|NCT00595465|524798957|FG002|Overall Study|Lost to Follow-up|2|||
145529393|NCT00595465|524798955|FG000|Overall Study|administrative reason|0|||
145529394|NCT00595465|524798956|FG001|Overall Study|administrative reason|0|||
145529395|NCT00595465|524798957|FG002|Overall Study|administrative reason|1|||
145529396|NCT00107783|524798958|FG000|Overall Study|Adverse Event|0|||
145529397|NCT00107783|524798959|FG001|Overall Study|Adverse Event|2|||
145529398|NCT00107783|524798958|FG000|Overall Study|Death|0|||
145529399|NCT00107783|524798959|FG001|Overall Study|Death|1|||
145529400|NCT00107783|524798958|FG000|Overall Study|Withdrawal by Subject|2|||
145529401|NCT00107783|524798959|FG001|Overall Study|Withdrawal by Subject|0|||
145529402|NCT00107783|524798958|FG000|Overall Study|Second hip replacement|1|||
145529403|NCT00107783|524798959|FG001|Overall Study|Second hip replacement|1|||
145529404|NCT00422097|524798960|FG000|Dose Level 2|Still on treatment|0|||
145529405|NCT00422097|524798961|FG001|Dose Level 2|Still on treatment|1|||
145529406|NCT00422097|524798962|FG002|Dose Level 2|Still on treatment|0|||
145529407|NCT00422097|524798963|FG003|Dose Level 2|Still on treatment|0|||
145529408|NCT00422097|524798964|FG004|Dose Level 2|Still on treatment|0|||
145529409|NCT00422097|524798965|FG005|Dose Level 2|Still on treatment|0|||
145529410|NCT00422097|524798966|FG006|Dose Level 2|Still on treatment|0|||
145529411|NCT00422097|524798967|FG007|Dose Level 2|Still on treatment|0|||
145529412|NCT02360995|524798968|FG000|Overall Study|Lost to Follow-up|2|||
145529413|NCT02360995|524798969|FG001|Overall Study|Lost to Follow-up|0|||
145529414|NCT02360995|524798970|FG002|Overall Study|Lost to Follow-up|2|||
145529415|NCT02360995|524798968|FG000|Overall Study|Withdrawal by Subject|0|||
145529416|NCT02360995|524798969|FG001|Overall Study|Withdrawal by Subject|1|||
145529417|NCT02360995|524798970|FG002|Overall Study|Withdrawal by Subject|0|||
145529418|NCT04131556|524798978|FG000|Overall Study|Adverse Event|1|||
145529419|NCT04131556|524798978|FG000|Overall Study|Withdrawal by Subject|1|||
145529420|NCT01229371|524798981|FG000|Overall Study|Withdrawal by Subject|0|||
145529421|NCT01229371|524798982|FG001|Overall Study|Withdrawal by Subject|1|||
145529422|NCT01229371|524798983|FG002|Overall Study|Withdrawal by Subject|0|||
145529423|NCT01229371|524798984|FG003|Overall Study|Withdrawal by Subject|0|||
145529424|NCT00760214|524798986|FG000|Overall Study|Adverse Event|8|||
145529425|NCT00760214|524798987|FG001|Overall Study|Adverse Event|9|||
145529426|NCT00760214|524798988|FG002|Overall Study|Adverse Event|12|||
145529427|NCT00760214|524798986|FG000|Overall Study|Protocol Violation|3|||
145529428|NCT00760214|524798987|FG001|Overall Study|Protocol Violation|0|||
145529429|NCT00760214|524798988|FG002|Overall Study|Protocol Violation|3|||
145529430|NCT00760214|524798986|FG000|Overall Study|Lost to Follow-up|0|||
145272187|NCT03359473|523844587|FG003|Overall Study|Adverse Event|3|||
145529431|NCT00760214|524798987|FG001|Overall Study|Lost to Follow-up|0|||
145272188|NCT03359473|523844584|FG000|Overall Study|Lost to Follow-up|0|||
145402708|NCT03370172|524332457|FG001|Overall Study|Withdrawal by Subject|1|||
145529432|NCT00760214|524798988|FG002|Overall Study|Lost to Follow-up|1|||
145529433|NCT00760214|524798986|FG000|Overall Study|Withdrawal by Subject|12|||
145529434|NCT00760214|524798987|FG001|Overall Study|Withdrawal by Subject|14|||
145529435|NCT00760214|524798988|FG002|Overall Study|Withdrawal by Subject|13|||
145529436|NCT00760214|524798986|FG000|Overall Study|Lack of Efficacy|3|||
145529437|NCT00760214|524798987|FG001|Overall Study|Lack of Efficacy|2|||
145529438|NCT00760214|524798988|FG002|Overall Study|Lack of Efficacy|4|||
145529439|NCT00760214|524798986|FG000|Overall Study|Pregnancy|0|||
145529440|NCT00760214|524798987|FG001|Overall Study|Pregnancy|0|||
145529441|NCT00760214|524798988|FG002|Overall Study|Pregnancy|1|||
145529442|NCT00760214|524798986|FG000|Overall Study|Physician Decision|1|||
145529443|NCT00760214|524798987|FG001|Overall Study|Physician Decision|1|||
145529444|NCT00760214|524798988|FG002|Overall Study|Physician Decision|1|||
145529445|NCT00760214|524798986|FG000|Overall Study|Other|3|||
145529446|NCT00760214|524798987|FG001|Overall Study|Other|4|||
145529447|NCT00760214|524798988|FG002|Overall Study|Other|6|||
145529448|NCT01933217|524798994|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
145529449|NCT01933217|524798995|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
145529450|NCT01933217|524798994|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
145529451|NCT01933217|524798995|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
145529452|NCT03923738|524798998|FG000|Period 1|Adverse Event|1|||
145529453|NCT03923738|524798998|FG000|Period 1|Withdrawal by Subject|1|||
145529454|NCT03583164|524799001|FG000|Overall Study|Death in Main Phase|35|||
145529455|NCT03583164|524799001|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
145529456|NCT03583164|524799001|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
145529457|NCT03583164|524799001|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
145529458|NCT03583164|524799001|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
145529459|NCT03583164|524799001|FG000|Overall Study|Physician decision in Main Phase|1|||
145529460|NCT03583164|524799001|FG000|Overall Study|Physician decision in Extended Phase|2|||
145529461|NCT03583164|524799001|FG000|Overall Study|Death in Extended Phase|13|||
145529462|NCT03583164|524799001|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
145529463|NCT03583164|524799001|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
145529464|NCT03583164|524799001|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
145529465|NCT03583164|524799001|FG000|Overall Study|Treatment failure in Main Phase|2|||
145529466|NCT03583164|524799001|FG000|Overall Study|Treatment failure in Extended Phase|4|||
145529467|NCT03583164|524799001|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
145529468|NCT03583164|524799001|FG000|Overall Study|Other not specified reason in Main Phase|2|||
145529469|NCT00735254|524799002|FG000|Overall Study|Protocol Violation|1|||
145529470|NCT00735254|524799003|FG001|Overall Study|Protocol Violation|1|||
145529471|NCT00735254|524799004|FG002|Overall Study|Protocol Violation|1|||
145529472|NCT00735254|524799005|FG003|Overall Study|Protocol Violation|0|||
145529473|NCT01369615|524799015|FG000|Overall Study|Withdrawal by Subject|0|||
145529474|NCT01369615|524799016|FG001|Overall Study|Withdrawal by Subject|1|||
145529475|NCT01369615|524799015|FG000|Overall Study|Lost to Follow-up|0|||
145529476|NCT01369615|524799016|FG001|Overall Study|Lost to Follow-up|1|||
145529477|NCT04263454|524799017|FG000|Overall Study|Adverse Event|0|||
145529478|NCT04263454|524799018|FG001|Overall Study|Adverse Event|2|||
145529479|NCT04263454|524799017|FG000|Overall Study|Physician Decision|3|||
145529480|NCT04263454|524799018|FG001|Overall Study|Physician Decision|5|||
145529481|NCT04263454|524799017|FG000|Overall Study|Poor Data Quality|0|||
145529482|NCT04263454|524799018|FG001|Overall Study|Poor Data Quality|1|||
145529483|NCT00986479|524799020|FG000|Period 1|Improved mood|1|||
145529484|NCT00986479|524799021|FG001|Period 1|Improved mood|0|||
145529485|NCT00986479|524799020|FG000|Period 1|Administrative reasons|1|||
145529486|NCT00986479|524799021|FG001|Period 1|Administrative reasons|0|||
145529487|NCT01721070|524799022|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
145529488|NCT02035475|524799023|FG000|Overall Study|Withdrawal by Subject|4|||
145751599|NCT00271817|525604056|FG001|Part 2|LDL < 50 mg/dL|3|||
145751600|NCT00271817|525604057|FG002|Part 2|LDL < 50 mg/dL|4|||
145751601|NCT01471782|525604058|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
145751602|NCT01471782|525604059|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
145751603|NCT01471782|525604060|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
145751604|NCT01471782|525604061|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
145751605|NCT01471782|525604062|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
145751606|NCT01471782|525604063|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
145272189|NCT03359473|523844585|FG001|Overall Study|Lost to Follow-up|1|||
145272190|NCT03359473|523844586|FG002|Overall Study|Lost to Follow-up|0|||
145272191|NCT03359473|523844587|FG003|Overall Study|Lost to Follow-up|0|||
145272192|NCT03359473|523844584|FG000|Overall Study|Physician Decision|0|||
145272193|NCT03359473|523844585|FG001|Overall Study|Physician Decision|1|||
145272194|NCT03359473|523844586|FG002|Overall Study|Physician Decision|0|||
145272195|NCT03359473|523844587|FG003|Overall Study|Physician Decision|1|||
145272196|NCT03359473|523844584|FG000|Overall Study|Withdrawal by Subject|1|||
145272197|NCT03359473|523844585|FG001|Overall Study|Withdrawal by Subject|2|||
145751607|NCT01471782|525604058|FG000|Overall Study|Lack of Efficacy|1|||
145751608|NCT01471782|525604059|FG001|Overall Study|Lack of Efficacy|2|||
145751609|NCT01471782|525604060|FG002|Overall Study|Lack of Efficacy|1|||
145751610|NCT01471782|525604061|FG003|Overall Study|Lack of Efficacy|1|||
145751611|NCT01471782|525604062|FG004|Overall Study|Lack of Efficacy|5|||
145751612|NCT01471782|525604063|FG005|Overall Study|Lack of Efficacy|18|||
145751613|NCT01471782|525604058|FG000|Overall Study|Adverse Event|1|||
145751614|NCT01471782|525604059|FG001|Overall Study|Adverse Event|1|||
145272198|NCT03359473|523844586|FG002|Overall Study|Withdrawal by Subject|1|||
145272199|NCT03359473|523844587|FG003|Overall Study|Withdrawal by Subject|0|||
145751615|NCT01471782|525604060|FG002|Overall Study|Adverse Event|2|||
145751616|NCT01471782|525604061|FG003|Overall Study|Adverse Event|2|||
145751617|NCT01471782|525604062|FG004|Overall Study|Adverse Event|3|||
145529489|NCT02035475|524799023|FG000|Overall Study|Physician Decision|1|||
145529490|NCT02035475|524799023|FG000|Overall Study|Equipment Error|1|||
145529491|NCT02047227|524799024|FG000|Overall Study|Adverse Event|2|||
145751618|NCT01471782|525604063|FG005|Overall Study|Adverse Event|1|||
145751619|NCT01471782|525604058|FG000|Overall Study|Other|0|||
145751620|NCT01471782|525604059|FG001|Overall Study|Other|0|||
145751621|NCT01471782|525604060|FG002|Overall Study|Other|1|||
145751622|NCT01471782|525604061|FG003|Overall Study|Other|1|||
145751623|NCT01471782|525604062|FG004|Overall Study|Other|6|||
145751624|NCT01471782|525604063|FG005|Overall Study|Other|5|||
145751625|NCT01471782|525604058|FG000|Overall Study|Change of Chemotherapy|1|||
145751626|NCT01471782|525604059|FG001|Overall Study|Change of Chemotherapy|1|||
145751627|NCT01471782|525604060|FG002|Overall Study|Change of Chemotherapy|0|||
145751628|NCT01471782|525604061|FG003|Overall Study|Change of Chemotherapy|0|||
145751629|NCT01471782|525604062|FG004|Overall Study|Change of Chemotherapy|1|||
145751630|NCT01471782|525604063|FG005|Overall Study|Change of Chemotherapy|4|||
145751631|NCT01471782|525604058|FG000|Overall Study|Disease Relapse|0|||
145751632|NCT01471782|525604059|FG001|Overall Study|Disease Relapse|0|||
145751633|NCT01471782|525604060|FG002|Overall Study|Disease Relapse|0|||
145751634|NCT01471782|525604061|FG003|Overall Study|Disease Relapse|1|||
145751635|NCT01471782|525604062|FG004|Overall Study|Disease Relapse|2|||
145751636|NCT01471782|525604063|FG005|Overall Study|Disease Relapse|1|||
145751637|NCT01471782|525604058|FG000|Overall Study|Physician Decision|0|||
145751638|NCT01471782|525604059|FG001|Overall Study|Physician Decision|0|||
145751639|NCT01471782|525604060|FG002|Overall Study|Physician Decision|0|||
145751640|NCT01471782|525604061|FG003|Overall Study|Physician Decision|0|||
145751641|NCT01471782|525604062|FG004|Overall Study|Physician Decision|3|||
145751642|NCT01471782|525604063|FG005|Overall Study|Physician Decision|8|||
145751643|NCT01471782|525604058|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145751644|NCT01471782|525604059|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145529492|NCT02047227|524799025|FG001|Overall Study|Adverse Event|4|||
145529493|NCT02047227|524799024|FG000|Overall Study|Lost to Follow-up|0|||
145529494|NCT02047227|524799025|FG001|Overall Study|Lost to Follow-up|3|||
145529495|NCT02047227|524799024|FG000|Overall Study|Protocol Violation|1|||
145529496|NCT02047227|524799025|FG001|Overall Study|Protocol Violation|0|||
145529497|NCT02047227|524799024|FG000|Overall Study|Spontaneous pregnancy|1|||
145529498|NCT02047227|524799025|FG001|Overall Study|Spontaneous pregnancy|0|||
145529499|NCT02047227|524799024|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
145529500|NCT02047227|524799025|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
145529501|NCT02047227|524799024|FG000|Overall Study|No oocytes retrieved|21|||
145529502|NCT02047227|524799025|FG001|Overall Study|No oocytes retrieved|20|||
145529503|NCT02047227|524799024|FG000|Overall Study|No fertilization|61|||
145529504|NCT02047227|524799025|FG001|Overall Study|No fertilization|51|||
145529505|NCT02047227|524799024|FG000|Overall Study|Intention to freeze all embryos|1|||
145529506|NCT02047227|524799025|FG001|Overall Study|Intention to freeze all embryos|0|||
145529507|NCT02047227|524799024|FG000|Overall Study|All embryos discarded|12|||
145529508|NCT02047227|524799025|FG001|Overall Study|All embryos discarded|11|||
145529509|NCT02047227|524799024|FG000|Overall Study|Other|10|||
145529510|NCT02047227|524799025|FG001|Overall Study|Other|9|||
145529511|NCT02567552|524799034|FG000|Overall Study|Adverse Event|0|||
145529512|NCT02567552|524799035|FG001|Overall Study|Adverse Event|1|||
145529513|NCT02891161|524799036|FG000|Study Treatment|Disease Progression|2|||
145529514|NCT02891161|524799037|FG001|Study Treatment|Disease Progression|4|||
145529515|NCT02891161|524799036|FG000|Study Treatment|AE/Side Effects/Complications|1|||
145529516|NCT02891161|524799037|FG001|Study Treatment|AE/Side Effects/Complications|5|||
145529517|NCT02891161|524799036|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
145529518|NCT02891161|524799037|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
145529519|NCT02891161|524799036|FG000|Follow up|Death|4|||
145529520|NCT02891161|524799037|FG001|Follow up|Death|8|||
145529521|NCT02891161|524799036|FG000|Follow up|Refused to Follow up|0|||
145529522|NCT02891161|524799037|FG001|Follow up|Refused to Follow up|2|||
145529523|NCT02891161|524799036|FG000|Follow up|Symptomatic deterioration|0|||
145529524|NCT02891161|524799037|FG001|Follow up|Symptomatic deterioration|1|||
145529525|NCT02891161|524799036|FG000|Follow up|Study terminated|0|||
145529526|NCT02891161|524799037|FG001|Follow up|Study terminated|6|||
145529527|NCT05419908|524799039|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
145529528|NCT05419908|524799040|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
145529529|NCT05419908|524799039|FG000|Overall Study|Serious Adverse Event|0|||
145529530|NCT05419908|524799040|FG001|Overall Study|Serious Adverse Event|2|||
145529531|NCT05419908|524799039|FG000|Overall Study|Withdrawal by Subject|2|||
145529532|NCT05419908|524799040|FG001|Overall Study|Withdrawal by Subject|0|||
145529533|NCT05419908|524799039|FG000|Overall Study|Miscellaneous|1|||
145529534|NCT05419908|524799040|FG001|Overall Study|Miscellaneous|1|||
145529535|NCT00674973|524800808|FG000|Overall Study|Insufficient Therapeutic Response|77|||
145529536|NCT00674973|524800809|FG001|Overall Study|Insufficient Therapeutic Response|72|||
145529537|NCT00674973|524800808|FG000|Overall Study|Refused Treatment|1|||
145529538|NCT00674973|524800809|FG001|Overall Study|Refused Treatment|5|||
145529539|NCT00674973|524800808|FG000|Overall Study|Failure to Return|1|||
145529540|NCT00674973|524800809|FG001|Overall Study|Failure to Return|0|||
145529541|NCT00674973|524800808|FG000|Overall Study|Adverse Event|2|||
145529542|NCT00674973|524800809|FG001|Overall Study|Adverse Event|9|||
145529543|NCT00674973|524800808|FG000|Overall Study|Death|19|||
145529544|NCT00674973|524800809|FG001|Overall Study|Death|15|||
145529545|NCT00674973|524800808|FG000|Overall Study|Protocol Violation|0|||
145529546|NCT00674973|524800809|FG001|Overall Study|Protocol Violation|1|||
145529547|NCT05108922|524800811|FG000|Overall Study|Adverse Event|2|||
145529548|NCT05108922|524800812|FG001|Overall Study|Adverse Event|3|||
145529549|NCT05108922|524800811|FG000|Overall Study|Lost to Follow-up|2|||
145529550|NCT05108922|524800812|FG001|Overall Study|Lost to Follow-up|1|||
145529551|NCT05108922|524800811|FG000|Overall Study|Inadvertent enrollment|0|||
145529552|NCT05108922|524800812|FG001|Overall Study|Inadvertent enrollment|1|||
145529553|NCT05108922|524800811|FG000|Overall Study|Physician Decision|2|||
145529554|NCT05108922|524800812|FG001|Overall Study|Physician Decision|3|||
145529555|NCT05108922|524800811|FG000|Overall Study|Protocol deviation|1|||
145529556|NCT05108922|524800812|FG001|Overall Study|Protocol deviation|0|||
145529557|NCT05108922|524800811|FG000|Overall Study|Screen failure|1|||
145529558|NCT05108922|524800812|FG001|Overall Study|Screen failure|0|||
145529559|NCT05108922|524800811|FG000|Overall Study|Withdrawal by Subject|11|||
145529560|NCT05108922|524800812|FG001|Overall Study|Withdrawal by Subject|8|||
145529561|NCT02572388|524800817|FG000|Overall Study|Withdrawal by Subject|1|||
145529562|NCT02572388|524800818|FG001|Overall Study|Withdrawal by Subject|1|||
145529563|NCT02572388|524800819|FG002|Overall Study|Withdrawal by Subject|2|||
145529564|NCT02572388|524800820|FG003|Overall Study|Withdrawal by Subject|2|||
145529565|NCT01051466|524800821|FG000|Overall Study|Adverse Event|1|||
145529566|NCT01051466|524800822|FG001|Overall Study|Adverse Event|0|||
145529567|NCT01051466|524800821|FG000|Overall Study|Lost to Follow-up|1|||
145529568|NCT01051466|524800822|FG001|Overall Study|Lost to Follow-up|1|||
145529569|NCT01051466|524800821|FG000|Overall Study|Withdrawal by Subject|5|||
145529570|NCT01051466|524800822|FG001|Overall Study|Withdrawal by Subject|1|||
145529571|NCT01051466|524800821|FG000|Overall Study|Entry Criteria Not Met|0|||
145529572|NCT01051466|524800822|FG001|Overall Study|Entry Criteria Not Met|3|||
145529573|NCT01051466|524800821|FG000|Overall Study|Physician Decision|1|||
145529574|NCT01051466|524800822|FG001|Overall Study|Physician Decision|0|||
145529575|NCT02231918|524800823|FG000|Overall Study|Withdrawal by Subject|0|||
145529576|NCT02231918|524800824|FG001|Overall Study|Withdrawal by Subject|1|||
145529577|NCT02231918|524800825|FG002|Overall Study|Withdrawal by Subject|0|||
145529578|NCT02231918|524800823|FG000|Overall Study|Adverse Event|0|||
145529579|NCT02231918|524800824|FG001|Overall Study|Adverse Event|0|||
145529580|NCT02231918|524800825|FG002|Overall Study|Adverse Event|1|||
145529581|NCT00331864|524800826|FG000|Overall Study|Adverse Event|30|||
145529582|NCT00331864|524800827|FG001|Overall Study|Adverse Event|1|||
145529583|NCT00331864|524800826|FG000|Overall Study|Lack of Efficacy|4|||
145529584|NCT00331864|524800827|FG001|Overall Study|Lack of Efficacy|0|||
145529585|NCT00331864|524800826|FG000|Overall Study|Protocol Violation|3|||
145529586|NCT00331864|524800827|FG001|Overall Study|Protocol Violation|0|||
145529587|NCT00331864|524800826|FG000|Overall Study|Withdrawal by Subject|10|||
145529588|NCT00331864|524800827|FG001|Overall Study|Withdrawal by Subject|0|||
145529589|NCT00331864|524800826|FG000|Overall Study|Lost to Follow-up|4|||
145529590|NCT00331864|524800827|FG001|Overall Study|Lost to Follow-up|3|||
145529591|NCT00331864|524800826|FG000|Overall Study|Administrative Problems|1|||
145529592|NCT00331864|524800827|FG001|Overall Study|Administrative Problems|0|||
145529593|NCT00331864|524800826|FG000|Overall Study|Death|6|||
145529594|NCT00331864|524800827|FG001|Overall Study|Death|0|||
145529595|NCT00137631|524800828|FG000|Overall Study|Lost to Follow-up|37|||
145529596|NCT00137631|524800829|FG001|Overall Study|Lost to Follow-up|41|||
145529597|NCT02395666|524800830|FG000|Overall Study|Physician Decision|3|||
145529598|NCT02395666|524800831|FG001|Overall Study|Physician Decision|0|||
145529599|NCT02395666|524800830|FG000|Overall Study|Lost to Follow-up|1|||
145529600|NCT02395666|524800831|FG001|Overall Study|Lost to Follow-up|0|||
145529601|NCT02395666|524800830|FG000|Overall Study|Withdrawal by Subject|2|||
145529602|NCT02395666|524800831|FG001|Overall Study|Withdrawal by Subject|1|||
145529603|NCT02611960|524800832|FG000|Overall Study|Adverse Event|7|||
145529604|NCT02611960|524800833|FG001|Overall Study|Adverse Event|8|||
145529605|NCT02611960|524800832|FG000|Overall Study|Death|98|||
145529606|NCT02611960|524800833|FG001|Overall Study|Death|92|||
145529607|NCT02611960|524800832|FG000|Overall Study|Withdrawal by Subject|1|||
145529608|NCT02611960|524800833|FG001|Overall Study|Withdrawal by Subject|5|||
145529609|NCT02611960|524800832|FG000|Overall Study|Sponsor Decision|11|||
145529610|NCT02611960|524800833|FG001|Overall Study|Sponsor Decision|11|||
145529611|NCT00085709|524800845|FG000|Overall Study|Adverse Event|8|||
145529612|NCT00085709|524800846|FG001|Overall Study|Adverse Event|0|||
145529613|NCT00085709|524800845|FG000|Overall Study|Death|8|||
145529614|NCT00085709|524800846|FG001|Overall Study|Death|2|||
145529615|NCT00085709|524800845|FG000|Overall Study|Refusal unrelated to adverse events|1|||
145529616|NCT00085709|524800846|FG001|Overall Study|Refusal unrelated to adverse events|2|||
145529617|NCT00085709|524800845|FG000|Overall Study|Progression|3|||
145529618|NCT00085709|524800846|FG001|Overall Study|Progression|4|||
145529619|NCT00085709|524800845|FG000|Overall Study|Not protocol specified|12|||
145529620|NCT00085709|524800846|FG001|Overall Study|Not protocol specified|22|||
145529621|NCT00085709|524800845|FG000|Overall Study|Not eligible|19|||
145529622|NCT00085709|524800846|FG001|Overall Study|Not eligible|19|||
145529623|NCT00085709|524800845|FG000|Overall Study|Withdrawal by Subject|2|||
145529624|NCT00085709|524800846|FG001|Overall Study|Withdrawal by Subject|1|||
145529625|NCT00293215|524800847|FG000|Overall Study|Progressive disease|3|||
145529626|NCT00293215|524800848|FG001|Overall Study|Progressive disease|1|||
145529627|NCT00293215|524800847|FG000|Overall Study|Adverse Event|2|||
145529628|NCT00293215|524800848|FG001|Overall Study|Adverse Event|2|||
145529629|NCT00761579|524800850|FG000|Overall Study|Adverse Event|10|||
145529630|NCT00761579|524800850|FG000|Overall Study|Death|2|||
145529631|NCT00761579|524800850|FG000|Overall Study|Lack of Efficacy|21|||
145529632|NCT00761579|524800850|FG000|Overall Study|Lost to Follow-up|16|||
145529633|NCT00761579|524800850|FG000|Overall Study|Pregnancy|1|||
145529634|NCT00761579|524800850|FG000|Overall Study|Withdrawal by Subject|34|||
145529635|NCT00761579|524800850|FG000|Overall Study|Lack of compliance|2|||
145529636|NCT00761579|524800850|FG000|Overall Study|Protocol deviation|1|||
145529637|NCT00761579|524800850|FG000|Overall Study|Drug overdose|1|||
145529638|NCT00761579|524800850|FG000|Overall Study|Aggravation of depression|1|||
145529639|NCT00761579|524800850|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
145529640|NCT00761579|524800850|FG000|Overall Study|Lost survey form|1|||
145529641|NCT00761579|524800850|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
145529642|NCT03611010|524800851|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
145529643|NCT03611010|524800852|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
145529644|NCT03611010|524800853|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
145529645|NCT03611010|524800854|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
145529646|NCT00950911|524800856|FG000|Overall Study|Adverse Event|0|||
145529647|NCT00950911|524800857|FG001|Overall Study|Adverse Event|2|||
145529648|NCT00950911|524800856|FG000|Overall Study|Death|4|||
145529649|NCT00950911|524800857|FG001|Overall Study|Death|6|||
145529650|NCT00950911|524800856|FG000|Overall Study|Disease progression|2|||
145529651|NCT00950911|524800857|FG001|Overall Study|Disease progression|2|||
145529652|NCT00950911|524800856|FG000|Overall Study|Consent withdrawn|1|||
145529653|NCT00950911|524800857|FG001|Overall Study|Consent withdrawn|3|||
145529654|NCT00950911|524800856|FG000|Overall Study|Administrative decision|3|||
145529655|NCT00950911|524800857|FG001|Overall Study|Administrative decision|1|||
145529656|NCT00950911|524800856|FG000|Overall Study|Ineligibility determined|1|||
145529657|NCT00950911|524800857|FG001|Overall Study|Ineligibility determined|0|||
145529658|NCT00950911|524800856|FG000|Overall Study|Noncompliance|1|||
145529659|NCT00950911|524800857|FG001|Overall Study|Noncompliance|0|||
145529660|NCT00950911|524800856|FG000|Overall Study|Poor performance status|0|||
145529661|NCT00950911|524800857|FG001|Overall Study|Poor performance status|1|||
145529662|NCT02476422|524800858|FG000|Overall Study|Subject/guardian decision|0|||
145529663|NCT02476422|524800859|FG001|Overall Study|Subject/guardian decision|1|||
145751645|NCT01471782|525604060|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145751646|NCT01471782|525604061|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145529664|NCT01859143|524800860|FG000|Overall Study|Lost to Follow-up|2|||
145529665|NCT01859143|524800861|FG001|Overall Study|Lost to Follow-up|0|||
145529666|NCT02413372|524800865|FG000|Treatment|Lost to Follow-up|0|||
145529667|NCT02413372|524800866|FG001|Treatment|Lost to Follow-up|2|||
145529668|NCT02413372|524800867|FG002|Treatment|Lost to Follow-up|1|||
145751647|NCT01471782|525604062|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
145751648|NCT01471782|525604063|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145751649|NCT01471782|525604058|FG000|Overall Study|Death|0|||
145751650|NCT01471782|525604059|FG001|Overall Study|Death|0|||
145402709|NCT00753519|524332459|FG000|Overall Study|Withdrawal by Subject|0|||
145751651|NCT01471782|525604060|FG002|Overall Study|Death|0|||
145402710|NCT00753519|524332460|FG001|Overall Study|Withdrawal by Subject|2|||
145529669|NCT02413372|524800865|FG000|Treatment|Withdrawal by Subject|1|||
145751652|NCT01471782|525604061|FG003|Overall Study|Death|0|||
145529670|NCT02413372|524800866|FG001|Treatment|Withdrawal by Subject|0|||
145529671|NCT02413372|524800867|FG002|Treatment|Withdrawal by Subject|0|||
145529672|NCT02413372|524800865|FG000|Follow-up|Lost to Follow-up|1|||
145751653|NCT01471782|525604062|FG004|Overall Study|Death|0|||
145751654|NCT01471782|525604063|FG005|Overall Study|Death|1|||
145751655|NCT00936208|525604064|FG000|Overall Study|Protocol Violation|37|||
145751656|NCT00936208|525604065|FG001|Overall Study|Protocol Violation|22|||
145751657|NCT00861744|525604066|FG000|Overall Study|Adverse Event|0|||
145751658|NCT00861744|525604067|FG001|Overall Study|Adverse Event|0|||
145529673|NCT02413372|524800866|FG001|Follow-up|Lost to Follow-up|1|||
145529674|NCT02413372|524800867|FG002|Follow-up|Lost to Follow-up|0|||
145529675|NCT02413372|524800865|FG000|Follow-up|Subject Withdrew Consent|1|||
145529676|NCT02413372|524800866|FG001|Follow-up|Subject Withdrew Consent|0|||
145529677|NCT02413372|524800867|FG002|Follow-up|Subject Withdrew Consent|1|||
145529678|NCT02413372|524800865|FG000|Follow-up|Subject unable to return for visit|0|||
145529679|NCT02413372|524800866|FG001|Follow-up|Subject unable to return for visit|0|||
145529680|NCT02413372|524800867|FG002|Follow-up|Subject unable to return for visit|1|||
145529681|NCT04587271|524800870|FG000|Overall Study|Lost to Follow-up|2|||
145529682|NCT04587271|524800871|FG001|Overall Study|Lost to Follow-up|2|||
145529683|NCT04587271|524800872|FG002|Overall Study|Lost to Follow-up|0|||
145529684|NCT04587271|524800873|FG003|Overall Study|Lost to Follow-up|2|||
145529685|NCT04587271|524800874|FG004|Overall Study|Lost to Follow-up|2|||
145529686|NCT04587271|524800875|FG005|Overall Study|Lost to Follow-up|0|||
145529687|NCT04587271|524800870|FG000|Overall Study|Caregiver brought child to visits|0|||
145529688|NCT04587271|524800871|FG001|Overall Study|Caregiver brought child to visits|0|||
145529689|NCT04587271|524800872|FG002|Overall Study|Caregiver brought child to visits|0|||
145529690|NCT04587271|524800873|FG003|Overall Study|Caregiver brought child to visits|1|||
145529691|NCT04587271|524800874|FG004|Overall Study|Caregiver brought child to visits|0|||
145529692|NCT04587271|524800875|FG005|Overall Study|Caregiver brought child to visits|0|||
145529693|NCT02180165|524800876|FG000|Overall Study|Not Treated|0|||
145529694|NCT02180165|524800877|FG001|Overall Study|Not Treated|0|||
145529695|NCT02180165|524800878|FG002|Overall Study|Not Treated|1|||
145529696|NCT02180165|524800879|FG003|Overall Study|Not Treated|0|||
145529697|NCT02180165|524800876|FG000|Overall Study|Adverse Event|7|||
145529698|NCT02180165|524800877|FG001|Overall Study|Adverse Event|0|||
145529699|NCT02180165|524800878|FG002|Overall Study|Adverse Event|18|||
145529700|NCT02180165|524800879|FG003|Overall Study|Adverse Event|3|||
145529701|NCT02180165|524800876|FG000|Overall Study|Lack of Efficacy|0|||
145529702|NCT02180165|524800877|FG001|Overall Study|Lack of Efficacy|1|||
145529703|NCT02180165|524800878|FG002|Overall Study|Lack of Efficacy|3|||
145529704|NCT02180165|524800879|FG003|Overall Study|Lack of Efficacy|2|||
145529705|NCT02180165|524800876|FG000|Overall Study|Physician Decision|1|||
145529706|NCT02180165|524800877|FG001|Overall Study|Physician Decision|0|||
145529707|NCT02180165|524800878|FG002|Overall Study|Physician Decision|5|||
145751659|NCT00861744|525604068|FG002|Overall Study|Adverse Event|0|||
145751660|NCT00861744|525604069|FG003|Overall Study|Adverse Event|1|||
145751661|NCT00861744|525604066|FG000|Overall Study|Lost to Follow-up|7|||
145751662|NCT00861744|525604067|FG001|Overall Study|Lost to Follow-up|19|||
145751663|NCT00861744|525604068|FG002|Overall Study|Lost to Follow-up|17|||
145751664|NCT00861744|525604069|FG003|Overall Study|Lost to Follow-up|12|||
145751665|NCT00861744|525604066|FG000|Overall Study|Withdrawal by Subject|10|||
145751666|NCT00861744|525604067|FG001|Overall Study|Withdrawal by Subject|6|||
145751667|NCT00861744|525604068|FG002|Overall Study|Withdrawal by Subject|6|||
145751668|NCT00861744|525604069|FG003|Overall Study|Withdrawal by Subject|19|||
145751669|NCT00861744|525604066|FG000|Overall Study|Protocol Violation|0|||
145751670|NCT00861744|525604067|FG001|Overall Study|Protocol Violation|1|||
145751671|NCT00861744|525604068|FG002|Overall Study|Protocol Violation|0|||
145751672|NCT00861744|525604069|FG003|Overall Study|Protocol Violation|0|||
145751673|NCT00861744|525604066|FG000|Overall Study|Migration from study area|0|||
145751674|NCT00861744|525604067|FG001|Overall Study|Migration from study area|3|||
145751675|NCT00861744|525604068|FG002|Overall Study|Migration from study area|1|||
145751676|NCT00861744|525604069|FG003|Overall Study|Migration from study area|0|||
145751677|NCT00861744|525604066|FG000|Overall Study|Blood draws|0|||
145751678|NCT00861744|525604067|FG001|Overall Study|Blood draws|0|||
145751679|NCT00861744|525604068|FG002|Overall Study|Blood draws|0|||
145751680|NCT00861744|525604069|FG003|Overall Study|Blood draws|1|||
145751681|NCT01411085|525604070|FG000|Overall Study|Physician Decision|1|||
145751682|NCT01411085|525604070|FG000|Overall Study|Protocol Violation|1|||
145751683|NCT01411085|525604070|FG000|Overall Study|Adverse Event|1|||
145751684|NCT04818593|525604071|FG000|Overall Study|Low Oocyte Yield|8|||
145751685|NCT04818593|525604072|FG001|Overall Study|Low Oocyte Yield|8|||
145751686|NCT04818593|525604071|FG000|Overall Study|Not ICSI Insemination|7|||
145751687|NCT04818593|525604072|FG001|Overall Study|Not ICSI Insemination|7|||
145751688|NCT04818593|525604071|FG000|Overall Study|Poor Sperm Quality|2|||
145751689|NCT04818593|525604072|FG001|Overall Study|Poor Sperm Quality|2|||
145751690|NCT04818593|525604071|FG000|Overall Study|Withdrawal by Subject|2|||
145751691|NCT04818593|525604072|FG001|Overall Study|Withdrawal by Subject|2|||
145751692|NCT04818593|525604071|FG000|Overall Study|Conversion to IUI due to low response|1|||
145751693|NCT04818593|525604072|FG001|Overall Study|Conversion to IUI due to low response|1|||
145751694|NCT01564862|525604073|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
145751695|NCT01564862|525604074|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
145751696|NCT01564862|525604075|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
145751697|NCT01564862|525604073|FG000|Overall Study|Major Protocol Deviation|3|||
145529708|NCT02180165|524800879|FG003|Overall Study|Physician Decision|0|||
145529709|NCT02180165|524800876|FG000|Overall Study|Withdrawal by Subject|3|||
145529710|NCT02180165|524800877|FG001|Overall Study|Withdrawal by Subject|0|||
145529711|NCT02180165|524800878|FG002|Overall Study|Withdrawal by Subject|2|||
145529712|NCT02180165|524800879|FG003|Overall Study|Withdrawal by Subject|1|||
145529713|NCT01031381|524800880|FG000|Overall Study|Physician Decision|3|||
145751698|NCT01564862|525604074|FG001|Overall Study|Major Protocol Deviation|3|||
145751699|NCT01564862|525604075|FG002|Overall Study|Major Protocol Deviation|4|||
145751700|NCT01564862|525604073|FG000|Overall Study|Lost to Follow-up|10|||
145751701|NCT01564862|525604074|FG001|Overall Study|Lost to Follow-up|8|||
145751702|NCT01564862|525604075|FG002|Overall Study|Lost to Follow-up|6|||
145751703|NCT01564862|525604073|FG000|Overall Study|Voluntary Withdrawal|9|||
145751704|NCT01564862|525604074|FG001|Overall Study|Voluntary Withdrawal|6|||
145751705|NCT01564862|525604075|FG002|Overall Study|Voluntary Withdrawal|8|||
145751706|NCT01564862|525604073|FG000|Overall Study|Lack of Efficacy|1|||
145751707|NCT01564862|525604074|FG001|Overall Study|Lack of Efficacy|5|||
145751708|NCT01564862|525604075|FG002|Overall Study|Lack of Efficacy|6|||
145751709|NCT01564862|525604073|FG000|Overall Study|Other reason(s)|1|||
145751710|NCT01564862|525604074|FG001|Overall Study|Other reason(s)|0|||
145751711|NCT01564862|525604075|FG002|Overall Study|Other reason(s)|0|||
145751712|NCT01662440|525606073|FG000|Overall Study|Adverse Event|1|||
145751713|NCT01662440|525606074|FG001|Overall Study|Adverse Event|0|||
145751714|NCT01662440|525606075|FG002|Overall Study|Adverse Event|0|||
145751715|NCT01662440|525606076|FG003|Overall Study|Adverse Event|1|||
145751716|NCT01662440|525606073|FG000|Overall Study|Death|0|||
145751717|NCT01662440|525606074|FG001|Overall Study|Death|1|||
145751718|NCT01662440|525606075|FG002|Overall Study|Death|0|||
145751719|NCT01662440|525606076|FG003|Overall Study|Death|0|||
145751720|NCT01662440|525606073|FG000|Overall Study|Lost to Follow-up|2|||
145751721|NCT01662440|525606074|FG001|Overall Study|Lost to Follow-up|2|||
145751722|NCT01662440|525606075|FG002|Overall Study|Lost to Follow-up|4|||
145751723|NCT01662440|525606076|FG003|Overall Study|Lost to Follow-up|1|||
145751724|NCT01662440|525606073|FG000|Overall Study|Subject moved to another country.|0|||
145751725|NCT01662440|525606074|FG001|Overall Study|Subject moved to another country.|1|||
145751726|NCT01662440|525606075|FG002|Overall Study|Subject moved to another country.|0|||
145751727|NCT01662440|525606076|FG003|Overall Study|Subject moved to another country.|0|||
145751728|NCT01662440|525606073|FG000|Overall Study|Protocol Violation|1|||
145751729|NCT01662440|525606074|FG001|Overall Study|Protocol Violation|0|||
145751730|NCT01662440|525606075|FG002|Overall Study|Protocol Violation|0|||
145751731|NCT01662440|525606076|FG003|Overall Study|Protocol Violation|0|||
145751732|NCT01662440|525606073|FG000|Overall Study|Withdrawal by Subject|5|||
145751733|NCT01662440|525606074|FG001|Overall Study|Withdrawal by Subject|2|||
145751734|NCT01662440|525606075|FG002|Overall Study|Withdrawal by Subject|2|||
145751735|NCT01662440|525606076|FG003|Overall Study|Withdrawal by Subject|2|||
145751736|NCT01745146|525606077|FG000|Overall Study|Withdrawal by Subject|1|||
145751737|NCT01745146|525606078|FG001|Overall Study|Withdrawal by Subject|3|||
145751738|NCT01745146|525606077|FG000|Overall Study|Lost to Follow-up|2|||
145751739|NCT01745146|525606078|FG001|Overall Study|Lost to Follow-up|0|||
145751740|NCT04623242|525606079|FG000|Overall Study|Withdrawal by Subject|7|||
145751741|NCT04623242|525606080|FG001|Overall Study|Withdrawal by Subject|12|||
145751742|NCT04623242|525606081|FG002|Overall Study|Withdrawal by Subject|5|||
145751743|NCT04623242|525606082|FG003|Overall Study|Withdrawal by Subject|7|||
145751744|NCT04623242|525606083|FG004|Overall Study|Withdrawal by Subject|0|||
145751745|NCT04623242|525606079|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
145751746|NCT04623242|525606080|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
145751747|NCT04623242|525606081|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
145751748|NCT04623242|525606082|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
145751749|NCT04623242|525606083|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
145751750|NCT04623242|525606079|FG000|Overall Study|Subject unblinded to mutation status|0|||
145751751|NCT04623242|525606080|FG001|Overall Study|Subject unblinded to mutation status|0|||
145751752|NCT04623242|525606081|FG002|Overall Study|Subject unblinded to mutation status|0|||
145751753|NCT04623242|525606082|FG003|Overall Study|Subject unblinded to mutation status|13|||
145751754|NCT04623242|525606083|FG004|Overall Study|Subject unblinded to mutation status|0|||
145751755|NCT00326898|525606084|FG000|Overall Study|Disease progression|52|||
145751756|NCT00326898|525606085|FG001|Overall Study|Disease progression|54|||
145751757|NCT00326898|525606086|FG002|Overall Study|Disease progression|102|||
145751758|NCT00326898|525606084|FG000|Overall Study|Adverse Event|124|||
145751759|NCT00326898|525606085|FG001|Overall Study|Adverse Event|128|||
145529714|NCT01031381|524800880|FG000|Overall Study|Withdrawal by Subject|6|||
145607555|NCT02296190|525079203|FG004|Overall Study|PSVT < 5 minutes|5|||
145751760|NCT00326898|525606086|FG002|Overall Study|Adverse Event|33|||
145751761|NCT00326898|525606084|FG000|Overall Study|Death|2|||
145751762|NCT00326898|525606085|FG001|Overall Study|Death|0|||
145751763|NCT00326898|525606086|FG002|Overall Study|Death|0|||
145751764|NCT00326898|525606084|FG000|Overall Study|Withdrawal by Subject|134|||
145751765|NCT00326898|525606085|FG001|Overall Study|Withdrawal by Subject|128|||
145751766|NCT00326898|525606086|FG002|Overall Study|Withdrawal by Subject|32|||
145751767|NCT00326898|525606084|FG000|Overall Study|Alternative therapy|1|||
145751768|NCT00326898|525606085|FG001|Overall Study|Alternative therapy|0|||
145751769|NCT00326898|525606086|FG002|Overall Study|Alternative therapy|0|||
145751770|NCT00326898|525606084|FG000|Overall Study|Other complicating disease|5|||
145751771|NCT00326898|525606085|FG001|Overall Study|Other complicating disease|5|||
145751772|NCT00326898|525606086|FG002|Overall Study|Other complicating disease|4|||
145751773|NCT00326898|525606084|FG000|Overall Study|Other/Missing/Unknown|33|||
145751774|NCT00326898|525606085|FG001|Overall Study|Other/Missing/Unknown|28|||
145751775|NCT00326898|525606086|FG002|Overall Study|Other/Missing/Unknown|32|||
145751776|NCT03847987|525606087|FG000|Overall Study|Lost to Follow-up|1|||
145751777|NCT03847987|525606088|FG001|Overall Study|Lost to Follow-up|0|||
145751778|NCT03847987|525606087|FG000|Overall Study|Adverse Event|2|||
145751779|NCT03847987|525606088|FG001|Overall Study|Adverse Event|0|||
145751780|NCT02605642|525606092|FG000|Overall Study|Other|11|||
145751781|NCT02605642|525606093|FG001|Overall Study|Other|1|||
145751782|NCT02605642|525606092|FG000|Overall Study|Participant non-compliance|2|||
145751783|NCT02605642|525606093|FG001|Overall Study|Participant non-compliance|4|||
145751784|NCT02605642|525606092|FG000|Overall Study|Physician Decision|10|||
145751785|NCT02605642|525606093|FG001|Overall Study|Physician Decision|0|||
145751786|NCT02605642|525606092|FG000|Overall Study|Lost to Follow-up|12|||
145751787|NCT02605642|525606093|FG001|Overall Study|Lost to Follow-up|1|||
145751788|NCT02605642|525606092|FG000|Overall Study|Adverse Event|14|||
145751789|NCT02605642|525606093|FG001|Overall Study|Adverse Event|2|||
145751790|NCT02605642|525606092|FG000|Overall Study|Withdrawal by Subject|23|||
145751791|NCT02605642|525606093|FG001|Overall Study|Withdrawal by Subject|2|||
145751792|NCT02605642|525606092|FG000|Overall Study|Lack of response|24|||
145751793|NCT02605642|525606093|FG001|Overall Study|Lack of response|11|||
145751794|NCT02111564|525606102|FG000|Overall Study|Death|109|||
145751795|NCT02111564|525606103|FG001|Overall Study|Death|120|||
145751796|NCT02111564|525606102|FG000|Overall Study|Lost to Follow-up|2|||
145751797|NCT02111564|525606103|FG001|Overall Study|Lost to Follow-up|3|||
145751798|NCT02111564|525606102|FG000|Overall Study|Withdrawal by Subject|20|||
145751799|NCT02111564|525606103|FG001|Overall Study|Withdrawal by Subject|20|||
145751800|NCT00687362|525606104|FG000|Overall Study|Protocol Violation|2|||
145751801|NCT00687362|525606104|FG000|Overall Study|Withdrawal by Subject|1|||
145751802|NCT00699348|525606109|FG000|Overall Study|Death|6|||
145751803|NCT00699348|525606109|FG000|Overall Study|Adverse Event|15|||
145751804|NCT00699348|525606109|FG000|Overall Study|Withdrawal by Subject|11|||
145751805|NCT00699348|525606109|FG000|Overall Study|Protocol Violation|10|||
145751806|NCT00699348|525606109|FG000|Overall Study|Lack of Efficacy|8|||
145751807|NCT00699348|525606109|FG000|Overall Study|Failure to return|1|||
145751808|NCT00699348|525606109|FG000|Overall Study|Blood transfusion|24|||
145751809|NCT00699348|525606109|FG000|Overall Study|Renal transplantation|10|||
145751810|NCT00699348|525606109|FG000|Overall Study|Other|5|||
145751811|NCT01268293|525606110|FG000|Overall Study|Disease progression|7|||
145751812|NCT01268293|525606110|FG000|Overall Study|Adverse Event|1|||
145751813|NCT01268293|525606110|FG000|Overall Study|Subject choice|1|||
145751814|NCT02597855|525606113|FG000|Overall Study|Lost to Follow-up|2|||
145751815|NCT02597855|525606114|FG001|Overall Study|Lost to Follow-up|1|||
145751816|NCT03704194|525606120|FG000|Overall Study|Withdrawal by Subject|0|||
145751817|NCT03704194|525606121|FG001|Overall Study|Withdrawal by Subject|1|||
145751818|NCT00925015|525606122|FG000|Overall Study|Adverse Event|1|||
145751819|NCT00925015|525606123|FG001|Overall Study|Adverse Event|2|||
145751820|NCT00925015|525606124|FG002|Overall Study|Adverse Event|1|||
145751821|NCT00925015|525606122|FG000|Overall Study|Physician Decision|0|||
145751822|NCT00925015|525606123|FG001|Overall Study|Physician Decision|1|||
145751823|NCT00925015|525606124|FG002|Overall Study|Physician Decision|0|||
145751824|NCT00925015|525606122|FG000|Overall Study|Progressive Disease|7|||
145751825|NCT00925015|525606123|FG001|Overall Study|Progressive Disease|3|||
145751826|NCT00925015|525606124|FG002|Overall Study|Progressive Disease|4|||
145751827|NCT00925015|525606122|FG000|Overall Study|Withdrawal by Subject|0|||
145751828|NCT00925015|525606123|FG001|Overall Study|Withdrawal by Subject|0|||
145751829|NCT00925015|525606124|FG002|Overall Study|Withdrawal by Subject|1|||
145751830|NCT01407926|525606125|FG000|Overall Study|Lost to Follow-up|55|||
145751831|NCT02814565|525606126|FG000|Overall Study|Lack of Efficacy|0|||
145751832|NCT02814565|525606127|FG001|Overall Study|Lack of Efficacy|1|||
145751833|NCT02814565|525606126|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
145751834|NCT02814565|525606127|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
145751835|NCT02469090|525606130|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
145751836|NCT02469090|525606131|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
145751837|NCT02469090|525606132|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
145751838|NCT02469090|525606130|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
145751839|NCT02469090|525606131|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
145751840|NCT02469090|525606132|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
145751841|NCT02469090|525606130|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
145751842|NCT02469090|525606131|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
145751843|NCT02469090|525606132|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
145751844|NCT02469090|525606130|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
145751845|NCT02469090|525606131|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
145751846|NCT02469090|525606132|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
145751847|NCT02469090|525606130|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
145751848|NCT02469090|525606131|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
145751849|NCT02469090|525606132|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
145751850|NCT02469090|525606130|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
145751851|NCT02469090|525606131|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
145751852|NCT02469090|525606132|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
145751853|NCT02469090|525606130|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
145751854|NCT02469090|525606131|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
145751855|NCT02469090|525606132|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
145751856|NCT02469090|525606130|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
145751857|NCT02469090|525606131|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
145751858|NCT02469090|525606132|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
145751859|NCT03823391|525606138|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
145751860|NCT03823391|525606139|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
145751861|NCT03823391|525606138|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
145751862|NCT03823391|525606139|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
145751863|NCT05030311|525606140|FG000|Overall Study|Technical problems|0|||
145751864|NCT05030311|525606141|FG001|Overall Study|Technical problems|1|||
145751865|NCT05030311|525606140|FG000|Overall Study|Withdrawal by Subject|31|||
145751866|NCT05030311|525606141|FG001|Overall Study|Withdrawal by Subject|17|||
145751867|NCT05030311|525606140|FG000|Overall Study|Adverse Event|13|||
145751868|NCT05030311|525606141|FG001|Overall Study|Adverse Event|5|||
145751869|NCT05030311|525606140|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145272200|NCT03359473|523844584|FG000|Overall Study|Protocol-defined stopping criteria|1|||
145272201|NCT03359473|523844585|FG001|Overall Study|Protocol-defined stopping criteria|0|||
145272202|NCT03359473|523844586|FG002|Overall Study|Protocol-defined stopping criteria|0|||
145272203|NCT03359473|523844587|FG003|Overall Study|Protocol-defined stopping criteria|1|||
145272204|NCT05302414|523844588|FG000|Pretest to Posttest|Lost to Follow-up|12|||
145751870|NCT05030311|525606141|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145272205|NCT05302414|523844589|FG001|Pretest to Posttest|Lost to Follow-up|8|||
145272206|NCT05302414|523844590|FG002|Pretest to Posttest|Lost to Follow-up|8|||
145272207|NCT05302414|523844588|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
145272208|NCT05302414|523844589|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
145272209|NCT05302414|523844590|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
145272210|NCT01071083|523844596|FG000|Overall Study|Adverse Event|1|||
145272211|NCT01071083|523844597|FG001|Overall Study|Adverse Event|0|||
145272212|NCT01071083|523844598|FG002|Overall Study|Adverse Event|1|||
145272213|NCT01071083|523844599|FG003|Overall Study|Adverse Event|0|||
145272214|NCT01071083|523844600|FG004|Overall Study|Adverse Event|1|||
145272215|NCT01071083|523844596|FG000|Overall Study|Withdrawal by Subject|3|||
145272216|NCT01071083|523844597|FG001|Overall Study|Withdrawal by Subject|0|||
145272217|NCT01071083|523844598|FG002|Overall Study|Withdrawal by Subject|2|||
145272218|NCT01071083|523844599|FG003|Overall Study|Withdrawal by Subject|0|||
145272219|NCT01071083|523844600|FG004|Overall Study|Withdrawal by Subject|3|||
145272220|NCT01071083|523844596|FG000|Overall Study|Physician Decision|1|||
145272221|NCT01071083|523844597|FG001|Overall Study|Physician Decision|0|||
145272222|NCT01071083|523844598|FG002|Overall Study|Physician Decision|0|||
145272223|NCT01071083|523844599|FG003|Overall Study|Physician Decision|1|||
145529715|NCT00723398|524800881|FG000|Overall Study|Withdrawal by Subject|2|||
145529716|NCT00723398|524800882|FG001|Overall Study|Withdrawal by Subject|6|||
145751871|NCT05030311|525606140|FG000|Overall Study|Physician Decision|5|||
145751872|NCT05030311|525606141|FG001|Overall Study|Physician Decision|2|||
145751873|NCT05030311|525606140|FG000|Overall Study|Lost to Follow-up|5|||
145751874|NCT05030311|525606141|FG001|Overall Study|Lost to Follow-up|1|||
145751875|NCT05030311|525606140|FG000|Overall Study|Protocol Violation|4|||
145751876|NCT05030311|525606141|FG001|Overall Study|Protocol Violation|4|||
145751877|NCT03042468|525606143|FG000|Overall Study|Death|0|||
145272224|NCT01071083|523844600|FG004|Overall Study|Physician Decision|1|||
145272225|NCT01071083|523844596|FG000|Overall Study|Early Rescue|1|||
145272226|NCT01071083|523844597|FG001|Overall Study|Early Rescue|0|||
145751878|NCT03042468|525606144|FG001|Overall Study|Death|1|||
145751879|NCT03042468|525606145|FG002|Overall Study|Death|1|||
145272227|NCT01071083|523844598|FG002|Overall Study|Early Rescue|0|||
145751880|NCT03042468|525606146|FG003|Overall Study|Death|0|||
145751881|NCT03042468|525606147|FG004|Overall Study|Death|0|||
145751882|NCT03042468|525606148|FG005|Overall Study|Death|0|||
145751883|NCT03042468|525606143|FG000|Overall Study|Withdrawal by Subject|0|||
145751884|NCT03042468|525606144|FG001|Overall Study|Withdrawal by Subject|0|||
145751885|NCT03042468|525606145|FG002|Overall Study|Withdrawal by Subject|0|||
145751886|NCT03042468|525606146|FG003|Overall Study|Withdrawal by Subject|0|||
145751887|NCT03042468|525606147|FG004|Overall Study|Withdrawal by Subject|0|||
145751888|NCT03042468|525606148|FG005|Overall Study|Withdrawal by Subject|1|||
145751889|NCT03042468|525606143|FG000|Overall Study|Lost to Follow-up|0|||
145751890|NCT03042468|525606144|FG001|Overall Study|Lost to Follow-up|0|||
145751891|NCT03042468|525606145|FG002|Overall Study|Lost to Follow-up|0|||
145751892|NCT03042468|525606146|FG003|Overall Study|Lost to Follow-up|0|||
145751893|NCT03042468|525606147|FG004|Overall Study|Lost to Follow-up|1|||
145751894|NCT03042468|525606148|FG005|Overall Study|Lost to Follow-up|1|||
145751895|NCT01568593|525606179|FG000|Overall Study|Lack of Efficacy|4|||
145751896|NCT01568593|525606180|FG001|Overall Study|Lack of Efficacy|1|||
145751897|NCT01568593|525606179|FG000|Overall Study|Adverse Event|3|||
145751898|NCT01568593|525606180|FG001|Overall Study|Adverse Event|2|||
145751899|NCT02780648|525606181|FG000|Overall Study|Disease Progression|1|||
145751900|NCT02780648|525606182|FG001|Overall Study|Disease Progression|0|||
145751901|NCT03167073|525606187|FG000|Overall Study|Stillbirth|1|||
145751902|NCT03167073|525606188|FG001|Overall Study|Stillbirth|0|||
145751903|NCT01276236|525606189|FG000|Overall Study|Lack of Efficacy|2|||
145751904|NCT01276236|525606189|FG000|Overall Study|Withdrawal by Subject|4|||
145751905|NCT03127384|525606191|FG000|Overall Study|Lost to Follow-up|4|||
145751906|NCT03127384|525606191|FG000|Overall Study|Subject request|2|||
145751907|NCT01294579|525606192|FG000|Overall Study|Disease progression|12|||
145751908|NCT01294579|525606192|FG000|Overall Study|Adverse Event|11|||
145751909|NCT01294579|525606192|FG000|Overall Study|Study closed/terminated|3|||
145751910|NCT01294579|525606192|FG000|Overall Study|Lost to Follow-up|1|||
145751911|NCT01294579|525606192|FG000|Overall Study|Physician Decision|3|||
145751912|NCT01294579|525606192|FG000|Overall Study|Withdrawal by Subject|5|||
145751913|NCT00262873|525606193|FG000|Overall Study|Adverse Event|3|||
145751914|NCT00262873|525606193|FG000|Overall Study|Withdrawal by Subject|5|||
145751915|NCT00844753|525606194|FG000|Overall Study|Lack of Efficacy|1|||
145751916|NCT00844753|525606195|FG001|Overall Study|Lack of Efficacy|0|||
145751917|NCT00844753|525606196|FG002|Overall Study|Lack of Efficacy|2|||
145751918|NCT00844753|525606197|FG003|Overall Study|Lack of Efficacy|2|||
145751919|NCT00844753|525606194|FG000|Overall Study|Adverse Event|3|||
145751920|NCT00844753|525606195|FG001|Overall Study|Adverse Event|2|||
145751921|NCT00844753|525606196|FG002|Overall Study|Adverse Event|5|||
145751922|NCT00844753|525606197|FG003|Overall Study|Adverse Event|5|||
145529717|NCT00723398|524800883|FG002|Overall Study|Withdrawal by Subject|4|||
145529718|NCT00723398|524800884|FG003|Overall Study|Withdrawal by Subject|4|||
145529719|NCT00723398|524800885|FG004|Overall Study|Withdrawal by Subject|4|||
145529720|NCT00723398|524800881|FG000|Overall Study|Protocol Violation|2|||
145529721|NCT00723398|524800882|FG001|Overall Study|Protocol Violation|1|||
145529722|NCT00723398|524800883|FG002|Overall Study|Protocol Violation|5|||
145529723|NCT00723398|524800884|FG003|Overall Study|Protocol Violation|0|||
145529724|NCT00723398|524800885|FG004|Overall Study|Protocol Violation|0|||
145529725|NCT00723398|524800881|FG000|Overall Study|Physician Decision|2|||
145529726|NCT00723398|524800882|FG001|Overall Study|Physician Decision|2|||
145529727|NCT00723398|524800883|FG002|Overall Study|Physician Decision|5|||
145529728|NCT00723398|524800884|FG003|Overall Study|Physician Decision|0|||
145529729|NCT00723398|524800885|FG004|Overall Study|Physician Decision|1|||
145529730|NCT00723398|524800881|FG000|Overall Study|Adverse Event|0|||
145529731|NCT00723398|524800882|FG001|Overall Study|Adverse Event|5|||
145529732|NCT00723398|524800883|FG002|Overall Study|Adverse Event|3|||
145529733|NCT00723398|524800884|FG003|Overall Study|Adverse Event|1|||
145529734|NCT00723398|524800885|FG004|Overall Study|Adverse Event|4|||
145529735|NCT00723398|524800881|FG000|Overall Study|Lost to Follow-up|0|||
145529736|NCT00723398|524800882|FG001|Overall Study|Lost to Follow-up|1|||
145529737|NCT00723398|524800883|FG002|Overall Study|Lost to Follow-up|0|||
145529738|NCT00723398|524800884|FG003|Overall Study|Lost to Follow-up|0|||
145529739|NCT00723398|524800885|FG004|Overall Study|Lost to Follow-up|0|||
145529740|NCT00267189|524800890|FG000|Overall Study|Patient withdrew consent|1|||
145529741|NCT00267189|524800891|FG001|Overall Study|Patient withdrew consent|1|||
145751923|NCT00844753|525606194|FG000|Overall Study|Lost to Follow-up|1|||
145751924|NCT00844753|525606195|FG001|Overall Study|Lost to Follow-up|1|||
145751925|NCT00844753|525606196|FG002|Overall Study|Lost to Follow-up|0|||
145751926|NCT00844753|525606197|FG003|Overall Study|Lost to Follow-up|1|||
145529742|NCT00267189|524800890|FG000|Overall Study|Death|1|||
145529743|NCT00267189|524800891|FG001|Overall Study|Death|0|||
145751927|NCT00844753|525606194|FG000|Overall Study|could not swallow medication|2|||
145529744|NCT00267189|524800890|FG000|Overall Study|Missing|3|||
145529745|NCT00267189|524800891|FG001|Overall Study|Missing|0|||
145529746|NCT04137224|524800893|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
145607556|NCT02296190|525079204|FG005|Overall Study|PSVT < 5 minutes|0|||
145751928|NCT00844753|525606195|FG001|Overall Study|could not swallow medication|0|||
145751929|NCT00844753|525606196|FG002|Overall Study|could not swallow medication|0|||
145751930|NCT00844753|525606197|FG003|Overall Study|could not swallow medication|0|||
145751931|NCT00844753|525606194|FG000|Overall Study|Withdrawal by Subject|1|||
145751932|NCT00844753|525606195|FG001|Overall Study|Withdrawal by Subject|0|||
145751933|NCT00844753|525606196|FG002|Overall Study|Withdrawal by Subject|0|||
145751934|NCT00844753|525606197|FG003|Overall Study|Withdrawal by Subject|3|||
145751935|NCT03440814|525606198|FG000|Overall Study|Adverse Event|2|||
145751936|NCT03440814|525606199|FG001|Overall Study|Adverse Event|1|||
145751937|NCT03440814|525606198|FG000|Overall Study|Lost to Follow-up|2|||
145751938|NCT03440814|525606199|FG001|Overall Study|Lost to Follow-up|0|||
145751939|NCT03440814|525606198|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
145751940|NCT03440814|525606199|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
145751941|NCT00371865|525606206|FG000|Overall Study|Lack of Efficacy|0|||
145751942|NCT00371865|525606207|FG001|Overall Study|Lack of Efficacy|2|||
145751943|NCT00371865|525606206|FG000|Overall Study|Protocol Violation|3|||
145751944|NCT00371865|525606207|FG001|Overall Study|Protocol Violation|2|||
145751945|NCT00371865|525606206|FG000|Overall Study|Withdrawal by Subject|12|||
145751946|NCT00371865|525606207|FG001|Overall Study|Withdrawal by Subject|10|||
145751947|NCT05073458|525606211|FG000|24-week Double-blind Period|Adverse Event|1|||
145751948|NCT05073458|525606212|FG001|24-week Double-blind Period|Adverse Event|0|||
145751949|NCT05073458|525606211|FG000|24-week Double-blind Period|Physician Decision|1|||
145751950|NCT05073458|525606212|FG001|24-week Double-blind Period|Physician Decision|0|||
145751951|NCT05073458|525606211|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
145751952|NCT05073458|525606212|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
145751953|NCT05073458|525606211|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
145751954|NCT05073458|525606212|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
145751955|NCT05073458|525606211|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
145751956|NCT05073458|525606212|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
145751957|NCT05073458|525606211|FG000|24-week Open-label Period|Adverse Event|1|||
145751958|NCT05073458|525606212|FG001|24-week Open-label Period|Adverse Event|2|||
145751959|NCT01632566|525606213|FG000|Overall Study|Withdrawal by Subject|0|||
145751960|NCT01632566|525606214|FG001|Overall Study|Withdrawal by Subject|1|||
145751961|NCT01632566|525606215|FG002|Overall Study|Withdrawal by Subject|0|||
145751962|NCT01632566|525606216|FG003|Overall Study|Withdrawal by Subject|0|||
145751963|NCT01632566|525606217|FG004|Overall Study|Withdrawal by Subject|0|||
145751964|NCT01632566|525606213|FG000|Overall Study|Sponsor Decision|0|||
145751965|NCT01632566|525606214|FG001|Overall Study|Sponsor Decision|2|||
145751966|NCT01632566|525606215|FG002|Overall Study|Sponsor Decision|9|||
145751967|NCT01632566|525606216|FG003|Overall Study|Sponsor Decision|2|||
145751968|NCT01632566|525606217|FG004|Overall Study|Sponsor Decision|2|||
145751969|NCT01627899|525606226|FG000|Overall Study|Study terminated early by sponsor.|5|||
145751970|NCT05103332|525606227|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751971|NCT05103332|525606228|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
145751972|NCT05103332|525606229|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
145751973|NCT05103332|525606230|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751974|NCT05103332|525606231|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751975|NCT05103332|525606232|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
145751976|NCT05103332|525606233|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751977|NCT05103332|525606234|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751978|NCT05103332|525606235|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751979|NCT05103332|525606236|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751980|NCT05103332|525606237|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751981|NCT05103332|525606238|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751982|NCT05103332|525606239|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751983|NCT05103332|525606240|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751984|NCT05103332|525606241|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751985|NCT05103332|525606242|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751986|NCT05103332|525606243|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751987|NCT05103332|525606244|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
145751988|NCT05103332|525606227|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751989|NCT05103332|525606228|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
145751990|NCT05103332|525606229|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751991|NCT05103332|525606230|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
145751992|NCT05103332|525606231|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751993|NCT05103332|525606232|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751994|NCT05103332|525606233|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751995|NCT05103332|525606234|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751996|NCT05103332|525606235|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751997|NCT05103332|525606236|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751998|NCT05103332|525606237|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
145751999|NCT05103332|525606238|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752000|NCT05103332|525606239|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752001|NCT05103332|525606240|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752002|NCT05103332|525606241|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752003|NCT05103332|525606242|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752004|NCT05103332|525606243|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752005|NCT05103332|525606244|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
145752006|NCT05103332|525606227|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
145752007|NCT05103332|525606228|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
145752008|NCT05103332|525606229|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
145752009|NCT05103332|525606230|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
145752010|NCT05103332|525606231|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
145752011|NCT05103332|525606232|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
145752012|NCT05103332|525606233|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752013|NCT05103332|525606234|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752014|NCT05103332|525606235|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752015|NCT05103332|525606236|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752016|NCT05103332|525606237|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752017|NCT05103332|525606238|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752018|NCT05103332|525606239|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752019|NCT05103332|525606240|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752020|NCT05103332|525606241|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752021|NCT05103332|525606242|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752022|NCT05103332|525606243|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752023|NCT05103332|525606244|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752024|NCT05103332|525606227|FG000|DB Period (6 Months=168 Days)|Other|0|||
145752025|NCT05103332|525606228|FG001|DB Period (6 Months=168 Days)|Other|0|||
145752026|NCT05103332|525606229|FG002|DB Period (6 Months=168 Days)|Other|0|||
145752027|NCT05103332|525606230|FG003|DB Period (6 Months=168 Days)|Other|1|||
145752028|NCT05103332|525606231|FG004|DB Period (6 Months=168 Days)|Other|0|||
145752029|NCT05103332|525606232|FG005|DB Period (6 Months=168 Days)|Other|0|||
145752030|NCT05103332|525606233|FG006|DB Period (6 Months=168 Days)|Other|0|||
145529747|NCT04137224|524800894|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
145529748|NCT04137224|524800893|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
145529749|NCT04137224|524800894|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
145529750|NCT04137224|524800893|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
145529751|NCT04137224|524800894|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
145529752|NCT01225887|524800895|FG000|Overall Study|Ineligible:required test not done|2|||
145529753|NCT01225887|524800895|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
145529754|NCT01225887|524800895|FG000|Overall Study|Ineligible:inadequate pathology|2|||
145529755|NCT00566501|524800896|FG000|Overall Study|Adverse Event|68|||
145529756|NCT00566501|524800897|FG001|Overall Study|Adverse Event|59|||
145529757|NCT00566501|524800896|FG000|Overall Study|Medication Non-compliance|5|||
145529758|NCT00566501|524800897|FG001|Overall Study|Medication Non-compliance|0|||
145529759|NCT00566501|524800896|FG000|Overall Study|Protocol Violation|2|||
145529760|NCT00566501|524800897|FG001|Overall Study|Protocol Violation|2|||
145529761|NCT00566501|524800896|FG000|Overall Study|Request of Investigator or Sponsor|6|||
145752031|NCT05103332|525606234|FG007|DB Period (6 Months=168 Days)|Other|0|||
145752032|NCT05103332|525606235|FG008|DB Period (6 Months=168 Days)|Other|0|||
145752033|NCT05103332|525606236|FG009|DB Period (6 Months=168 Days)|Other|0|||
145752034|NCT05103332|525606237|FG010|DB Period (6 Months=168 Days)|Other|0|||
145752035|NCT05103332|525606238|FG011|DB Period (6 Months=168 Days)|Other|0|||
145752036|NCT05103332|525606239|FG012|DB Period (6 Months=168 Days)|Other|0|||
145752037|NCT05103332|525606240|FG013|DB Period (6 Months=168 Days)|Other|0|||
145752038|NCT05103332|525606241|FG014|DB Period (6 Months=168 Days)|Other|0|||
145752039|NCT05103332|525606242|FG015|DB Period (6 Months=168 Days)|Other|0|||
145752040|NCT05103332|525606243|FG016|DB Period (6 Months=168 Days)|Other|0|||
145752041|NCT05103332|525606244|FG017|DB Period (6 Months=168 Days)|Other|0|||
145752042|NCT05103332|525606227|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752043|NCT05103332|525606228|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752044|NCT05103332|525606229|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752045|NCT05103332|525606230|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752046|NCT05103332|525606231|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752047|NCT05103332|525606232|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752048|NCT05103332|525606233|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752049|NCT05103332|525606234|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752050|NCT05103332|525606235|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752051|NCT05103332|525606236|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752052|NCT05103332|525606237|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
145752053|NCT05103332|525606238|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752054|NCT05103332|525606239|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752055|NCT05103332|525606240|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752056|NCT05103332|525606241|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752057|NCT05103332|525606242|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752058|NCT05103332|525606243|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752059|NCT05103332|525606244|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
145752060|NCT05103332|525606227|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752061|NCT05103332|525606228|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752062|NCT05103332|525606229|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752063|NCT05103332|525606230|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752064|NCT05103332|525606231|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752065|NCT05103332|525606232|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752066|NCT05103332|525606233|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752067|NCT05103332|525606234|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752068|NCT05103332|525606235|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
145752069|NCT05103332|525606236|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752070|NCT05103332|525606237|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752071|NCT05103332|525606238|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752072|NCT05103332|525606239|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752073|NCT05103332|525606240|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752074|NCT05103332|525606241|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752075|NCT05103332|525606242|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752076|NCT05103332|525606243|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752077|NCT05103332|525606244|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
145752078|NCT05103332|525606227|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752079|NCT05103332|525606228|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752080|NCT05103332|525606229|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752081|NCT05103332|525606230|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752082|NCT05103332|525606231|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752083|NCT05103332|525606232|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752084|NCT05103332|525606233|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752085|NCT05103332|525606234|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752086|NCT05103332|525606235|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752087|NCT05103332|525606236|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752088|NCT05103332|525606237|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752089|NCT05103332|525606238|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
145752090|NCT05103332|525606239|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752091|NCT05103332|525606240|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752092|NCT05103332|525606241|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752093|NCT05103332|525606242|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752094|NCT05103332|525606243|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752095|NCT05103332|525606244|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
145752096|NCT05103332|525606227|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752097|NCT05103332|525606228|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752098|NCT05103332|525606229|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752099|NCT05103332|525606230|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752100|NCT05103332|525606231|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752101|NCT05103332|525606232|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752102|NCT05103332|525606233|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
145752103|NCT05103332|525606234|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
145752104|NCT05103332|525606235|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752105|NCT05103332|525606236|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
145752106|NCT05103332|525606237|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
145752107|NCT05103332|525606238|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
145752108|NCT05103332|525606239|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752109|NCT05103332|525606240|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752110|NCT05103332|525606241|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752111|NCT05103332|525606242|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752112|NCT05103332|525606243|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752113|NCT05103332|525606244|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
145752114|NCT05103332|525606227|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752115|NCT05103332|525606228|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752116|NCT05103332|525606229|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752117|NCT05103332|525606230|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752118|NCT05103332|525606231|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752119|NCT05103332|525606232|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752120|NCT05103332|525606233|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752121|NCT05103332|525606234|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752122|NCT05103332|525606235|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752123|NCT05103332|525606236|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752124|NCT05103332|525606237|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752125|NCT05103332|525606238|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
145752126|NCT05103332|525606239|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
145752127|NCT05103332|525606240|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
145752128|NCT05103332|525606241|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
145752129|NCT05103332|525606242|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
145752130|NCT05103332|525606243|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
145752131|NCT05103332|525606244|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
145752132|NCT05103332|525606227|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752133|NCT05103332|525606228|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752134|NCT05103332|525606229|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752135|NCT05103332|525606230|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752136|NCT05103332|525606231|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752137|NCT05103332|525606232|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752138|NCT05103332|525606233|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752139|NCT05103332|525606234|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752140|NCT05103332|525606235|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752141|NCT05103332|525606236|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752142|NCT05103332|525606237|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752143|NCT05103332|525606238|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752144|NCT05103332|525606239|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752145|NCT05103332|525606240|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752146|NCT05103332|525606241|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752147|NCT05103332|525606242|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752148|NCT05103332|525606243|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
145752149|NCT05103332|525606244|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
145752150|NCT05103332|525606227|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752151|NCT05103332|525606228|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752152|NCT05103332|525606229|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752153|NCT05103332|525606230|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752154|NCT05103332|525606231|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752155|NCT05103332|525606232|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752156|NCT05103332|525606233|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752157|NCT05103332|525606234|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752158|NCT05103332|525606235|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752159|NCT05103332|525606236|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752160|NCT05103332|525606237|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752161|NCT05103332|525606238|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
145752162|NCT05103332|525606239|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
145752163|NCT05103332|525606240|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
145752164|NCT05103332|525606241|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
145752165|NCT05103332|525606242|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
145752166|NCT05103332|525606243|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
145752167|NCT05103332|525606244|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
145752168|NCT05103332|525606227|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752169|NCT05103332|525606228|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752170|NCT05103332|525606229|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752171|NCT05103332|525606230|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752172|NCT05103332|525606231|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752173|NCT05103332|525606232|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752174|NCT05103332|525606233|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752175|NCT05103332|525606234|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752176|NCT05103332|525606235|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752177|NCT05103332|525606236|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752178|NCT05103332|525606237|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752179|NCT05103332|525606238|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752180|NCT05103332|525606239|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752181|NCT05103332|525606240|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752182|NCT05103332|525606241|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
145752183|NCT05103332|525606242|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
145752184|NCT05103332|525606243|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
145752185|NCT05103332|525606244|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
145752186|NCT05103332|525606227|FG000|SFU Period (6 Months=168 Days)|Death|0|||
145752187|NCT05103332|525606228|FG001|SFU Period (6 Months=168 Days)|Death|0|||
145752188|NCT05103332|525606229|FG002|SFU Period (6 Months=168 Days)|Death|0|||
145752189|NCT05103332|525606230|FG003|SFU Period (6 Months=168 Days)|Death|0|||
145752190|NCT05103332|525606231|FG004|SFU Period (6 Months=168 Days)|Death|0|||
145752191|NCT05103332|525606232|FG005|SFU Period (6 Months=168 Days)|Death|0|||
145752192|NCT05103332|525606233|FG006|SFU Period (6 Months=168 Days)|Death|0|||
145752193|NCT05103332|525606234|FG007|SFU Period (6 Months=168 Days)|Death|0|||
145752194|NCT05103332|525606235|FG008|SFU Period (6 Months=168 Days)|Death|0|||
145752195|NCT05103332|525606236|FG009|SFU Period (6 Months=168 Days)|Death|0|||
145752196|NCT05103332|525606237|FG010|SFU Period (6 Months=168 Days)|Death|0|||
145752197|NCT05103332|525606238|FG011|SFU Period (6 Months=168 Days)|Death|0|||
145752198|NCT05103332|525606239|FG012|SFU Period (6 Months=168 Days)|Death|0|||
145752199|NCT05103332|525606240|FG013|SFU Period (6 Months=168 Days)|Death|0|||
145272228|NCT01071083|523844599|FG003|Overall Study|Early Rescue|0|||
145272229|NCT01071083|523844600|FG004|Overall Study|Early Rescue|1|||
145272230|NCT01071083|523844596|FG000|Overall Study|Subject Moved|0|||
145272231|NCT01071083|523844597|FG001|Overall Study|Subject Moved|1|||
145272232|NCT01071083|523844598|FG002|Overall Study|Subject Moved|0|||
145272233|NCT01071083|523844599|FG003|Overall Study|Subject Moved|0|||
145272234|NCT01071083|523844600|FG004|Overall Study|Subject Moved|0|||
145272235|NCT01071083|523844596|FG000|Overall Study|Images Not Usable (Motion)|0|||
145272236|NCT01071083|523844597|FG001|Overall Study|Images Not Usable (Motion)|1|||
145752200|NCT05103332|525606241|FG014|SFU Period (6 Months=168 Days)|Death|1|||
145752201|NCT05103332|525606242|FG015|SFU Period (6 Months=168 Days)|Death|0|||
145752202|NCT05103332|525606243|FG016|SFU Period (6 Months=168 Days)|Death|0|||
145272237|NCT01071083|523844598|FG002|Overall Study|Images Not Usable (Motion)|0|||
145272238|NCT01071083|523844599|FG003|Overall Study|Images Not Usable (Motion)|0|||
145272239|NCT01071083|523844600|FG004|Overall Study|Images Not Usable (Motion)|0|||
145272240|NCT01071083|523844596|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
145752203|NCT05103332|525606244|FG017|SFU Period (6 Months=168 Days)|Death|1|||
145752204|NCT04428476|525606245|FG000|Overall Study|Withdrawal by Subject|1|||
145752205|NCT04428476|525606245|FG000|Overall Study|Still on treatment|12|||
145752206|NCT04982250|525606246|FG000|Overall Study|Lost to Follow-up|0|||
145752207|NCT04982250|525606247|FG001|Overall Study|Lost to Follow-up|26|||
145272241|NCT01071083|523844597|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
145272242|NCT01071083|523844598|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
145272243|NCT01071083|523844599|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
145272244|NCT01071083|523844600|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
145272245|NCT01071083|523844596|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
145272246|NCT01071083|523844597|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
145272247|NCT01071083|523844598|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
145272248|NCT01071083|523844599|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
145272249|NCT01071083|523844600|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
145272250|NCT01071083|523844596|FG000|Overall Study|Subject Refused to Continue|1|||
145529762|NCT00566501|524800897|FG001|Overall Study|Request of Investigator or Sponsor|7|||
145752208|NCT04982250|525606248|FG002|Overall Study|Lost to Follow-up|0|||
145752209|NCT04982250|525606249|FG003|Overall Study|Lost to Follow-up|0|||
145752210|NCT04982250|525606250|FG004|Overall Study|Lost to Follow-up|72|||
145752211|NCT04982250|525606251|FG005|Overall Study|Lost to Follow-up|69|||
145752212|NCT04982250|525606246|FG000|Overall Study|Not Eligible to Enroll|0|||
145752213|NCT04982250|525606247|FG001|Overall Study|Not Eligible to Enroll|0|||
145752214|NCT04982250|525606248|FG002|Overall Study|Not Eligible to Enroll|0|||
145752215|NCT04982250|525606249|FG003|Overall Study|Not Eligible to Enroll|0|||
145752216|NCT04982250|525606250|FG004|Overall Study|Not Eligible to Enroll|10|||
145752217|NCT04982250|525606251|FG005|Overall Study|Not Eligible to Enroll|7|||
145752218|NCT01358864|525606257|FG000|Overall Study|Adverse Event|0|||
145752219|NCT01358864|525606258|FG001|Overall Study|Adverse Event|6|||
145752220|NCT01358864|525606259|FG002|Overall Study|Adverse Event|9|||
145752221|NCT01358864|525606260|FG003|Overall Study|Adverse Event|0|||
145752222|NCT01358864|525606261|FG004|Overall Study|Adverse Event|4|||
145752223|NCT01358864|525606262|FG005|Overall Study|Adverse Event|8|||
145752224|NCT01358864|525606263|FG006|Overall Study|Adverse Event|12|||
145752225|NCT01358864|525606264|FG007|Overall Study|Adverse Event|7|||
145752226|NCT01358864|525606257|FG000|Overall Study|Lack of Efficacy|26|||
145752227|NCT01358864|525606258|FG001|Overall Study|Lack of Efficacy|3|||
145752228|NCT01358864|525606259|FG002|Overall Study|Lack of Efficacy|4|||
145752229|NCT01358864|525606260|FG003|Overall Study|Lack of Efficacy|19|||
145752230|NCT01358864|525606261|FG004|Overall Study|Lack of Efficacy|7|||
145752231|NCT01358864|525606262|FG005|Overall Study|Lack of Efficacy|4|||
145752232|NCT01358864|525606263|FG006|Overall Study|Lack of Efficacy|49|||
145752233|NCT01358864|525606264|FG007|Overall Study|Lack of Efficacy|44|||
145752234|NCT01358864|525606257|FG000|Overall Study|Lost to Follow-up|0|||
145752235|NCT01358864|525606258|FG001|Overall Study|Lost to Follow-up|0|||
145752236|NCT01358864|525606259|FG002|Overall Study|Lost to Follow-up|1|||
145752237|NCT01358864|525606260|FG003|Overall Study|Lost to Follow-up|0|||
145752238|NCT01358864|525606261|FG004|Overall Study|Lost to Follow-up|0|||
145752239|NCT01358864|525606262|FG005|Overall Study|Lost to Follow-up|0|||
145752240|NCT01358864|525606263|FG006|Overall Study|Lost to Follow-up|0|||
145752241|NCT01358864|525606264|FG007|Overall Study|Lost to Follow-up|1|||
145752242|NCT01358864|525606257|FG000|Overall Study|Withdrawal by Subject|3|||
145752243|NCT01358864|525606258|FG001|Overall Study|Withdrawal by Subject|4|||
145752244|NCT01358864|525606259|FG002|Overall Study|Withdrawal by Subject|2|||
145752245|NCT01358864|525606260|FG003|Overall Study|Withdrawal by Subject|0|||
145752246|NCT01358864|525606261|FG004|Overall Study|Withdrawal by Subject|0|||
145752247|NCT01358864|525606262|FG005|Overall Study|Withdrawal by Subject|1|||
145752248|NCT01358864|525606263|FG006|Overall Study|Withdrawal by Subject|1|||
145752249|NCT01358864|525606264|FG007|Overall Study|Withdrawal by Subject|3|||
145752250|NCT01358864|525606257|FG000|Overall Study|Other reason not defined above|2|||
145752251|NCT01358864|525606258|FG001|Overall Study|Other reason not defined above|0|||
145752252|NCT01358864|525606259|FG002|Overall Study|Other reason not defined above|0|||
145752253|NCT01358864|525606260|FG003|Overall Study|Other reason not defined above|0|||
145752254|NCT01358864|525606261|FG004|Overall Study|Other reason not defined above|0|||
145752255|NCT01358864|525606262|FG005|Overall Study|Other reason not defined above|0|||
145752256|NCT01358864|525606263|FG006|Overall Study|Other reason not defined above|2|||
145752257|NCT01358864|525606264|FG007|Overall Study|Other reason not defined above|0|||
145752258|NCT01358864|525606257|FG000|Overall Study|Not treated|0|||
145752259|NCT01358864|525606258|FG001|Overall Study|Not treated|0|||
145752260|NCT01358864|525606259|FG002|Overall Study|Not treated|0|||
145752261|NCT01358864|525606260|FG003|Overall Study|Not treated|0|||
145752262|NCT01358864|525606261|FG004|Overall Study|Not treated|0|||
145752263|NCT01358864|525606262|FG005|Overall Study|Not treated|0|||
145752264|NCT01358864|525606263|FG006|Overall Study|Not treated|1|||
145752265|NCT01358864|525606264|FG007|Overall Study|Not treated|0|||
145752266|NCT04042103|525606271|FG000|Overall Study|Lost to Follow-up|1|||
145752267|NCT04042103|525606271|FG000|Overall Study|Withdrawal by Subject|1|||
145752268|NCT04209855|525606273|FG000|Overall Study|Death|161|||
145752269|NCT04209855|525606274|FG001|Overall Study|Death|177|||
145752270|NCT04209855|525606273|FG000|Overall Study|PI Discretion|1|||
145752271|NCT04209855|525606274|FG001|Overall Study|PI Discretion|1|||
145752272|NCT04209855|525606273|FG000|Overall Study|Lost to Follow-up|5|||
145752273|NCT04209855|525606274|FG001|Overall Study|Lost to Follow-up|2|||
145752274|NCT04209855|525606273|FG000|Overall Study|Withdrew consent|10|||
145752275|NCT04209855|525606274|FG001|Overall Study|Withdrew consent|24|||
145752276|NCT04209855|525606273|FG000|Overall Study|Sponsor decision|44|||
145752277|NCT04209855|525606274|FG001|Overall Study|Sponsor decision|18|||
145752278|NCT04209855|525606273|FG000|Overall Study|Other than specified|6|||
145752279|NCT04209855|525606274|FG001|Overall Study|Other than specified|4|||
145752280|NCT03809611|525606275|FG000|Overall Study|Withdrawal by Subject|1|||
145752281|NCT03809611|525606276|FG001|Overall Study|Withdrawal by Subject|1|||
145752282|NCT02193074|525606279|FG000|Overall Study|Withdrawal by Subject|1|||
145752283|NCT02193074|525606280|FG001|Overall Study|Withdrawal by Subject|2|||
145752284|NCT02193074|525606279|FG000|Overall Study|Adverse Event|16|||
145752285|NCT02193074|525606280|FG001|Overall Study|Adverse Event|13|||
145752286|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
145752287|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
145752288|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
145752289|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
145752290|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
145752291|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
145752292|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
145752293|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
145752294|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
145752295|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
145752296|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
145752297|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
145752298|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
145752299|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
145752300|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
145752301|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
145752302|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
145752303|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
145752304|NCT02600494|525606288|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
145752305|NCT02600494|525606289|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
145752306|NCT02600494|525606290|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
145752307|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
145752308|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
145752309|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
145752310|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
145752311|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
145752312|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
145752313|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
145752314|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
145752315|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
145752316|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
145752317|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
145752318|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
145752319|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
145752320|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
145752321|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
145752322|NCT02600494|525606288|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
145272251|NCT01071083|523844597|FG001|Overall Study|Subject Refused to Continue|0|||
145272252|NCT01071083|523844598|FG002|Overall Study|Subject Refused to Continue|0|||
145272253|NCT01071083|523844599|FG003|Overall Study|Subject Refused to Continue|0|||
145272254|NCT01071083|523844600|FG004|Overall Study|Subject Refused to Continue|0|||
145272255|NCT01523301|523844601|FG000|Overall Study|Adverse Event|25|||
145272256|NCT01523301|523844602|FG001|Overall Study|Adverse Event|16|||
145272257|NCT01523301|523844601|FG000|Overall Study|Lack of Efficacy|0|||
145272258|NCT01523301|523844602|FG001|Overall Study|Lack of Efficacy|2|||
145272259|NCT01523301|523844601|FG000|Overall Study|Protocol Violation|3|||
145272260|NCT01523301|523844602|FG001|Overall Study|Protocol Violation|4|||
145272261|NCT01523301|523844601|FG000|Overall Study|Lost to Follow-up|1|||
145272262|NCT01523301|523844602|FG001|Overall Study|Lost to Follow-up|0|||
145272263|NCT01523301|523844601|FG000|Overall Study|Withdrawal by Subject|6|||
145272264|NCT01523301|523844602|FG001|Overall Study|Withdrawal by Subject|8|||
145272265|NCT01523301|523844601|FG000|Overall Study|Other Reason|0|||
145272266|NCT01523301|523844602|FG001|Overall Study|Other Reason|2|||
145529763|NCT00566501|524800896|FG000|Overall Study|Withdrawal by Subject|33|||
145529764|NCT00566501|524800897|FG001|Overall Study|Withdrawal by Subject|30|||
145529765|NCT00566501|524800896|FG000|Overall Study|Lack of Efficacy|8|||
145529766|NCT00566501|524800897|FG001|Overall Study|Lack of Efficacy|3|||
145529767|NCT00566501|524800896|FG000|Overall Study|Other|25|||
145529768|NCT00566501|524800897|FG001|Overall Study|Other|21|||
145529769|NCT00925990|524800898|FG000|Overall Study|Adverse Event|1|||
145529770|NCT00925990|524800899|FG001|Overall Study|Adverse Event|3|||
145752323|NCT02600494|525606289|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
145752324|NCT02600494|525606290|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
145752325|NCT03124563|525606291|FG000|Overall Study|Lost to Follow-up|1|||
145272267|NCT01339000|523844603|FG000|Overall Study|study closed due to lack of drug supply|1|||
145272268|NCT01339000|523844604|FG001|Overall Study|study closed due to lack of drug supply|0|||
145272269|NCT00728988|523844605|FG000|Overall Study|Not Treated|2|||
145529771|NCT00925990|524800898|FG000|Overall Study|Withdrawal by Subject|2|||
145529772|NCT00925990|524800899|FG001|Overall Study|Withdrawal by Subject|2|||
145529773|NCT00925990|524800898|FG000|Overall Study|Lost to Follow-up|1|||
145529774|NCT00925990|524800899|FG001|Overall Study|Lost to Follow-up|3|||
145272270|NCT00728988|523844606|FG001|Overall Study|Not Treated|2|||
145752326|NCT03124563|525606292|FG001|Overall Study|Lost to Follow-up|1|||
145752327|NCT03124563|525606291|FG000|Overall Study|Withdrawal by Subject|1|||
145752328|NCT03124563|525606292|FG001|Overall Study|Withdrawal by Subject|1|||
145752329|NCT01262365|525608141|FG000|Overall Study|Lack of Efficacy|35|||
145752330|NCT01262365|525608142|FG001|Overall Study|Lack of Efficacy|30|||
145752331|NCT01262365|525608143|FG002|Overall Study|Lack of Efficacy|47|||
145752332|NCT01262365|525608141|FG000|Overall Study|Protocol Violation|3|||
145752333|NCT01262365|525608142|FG001|Overall Study|Protocol Violation|1|||
145752334|NCT01262365|525608143|FG002|Overall Study|Protocol Violation|1|||
145752335|NCT01262365|525608141|FG000|Overall Study|Lost to Follow-up|3|||
145752336|NCT01262365|525608142|FG001|Overall Study|Lost to Follow-up|7|||
145752337|NCT01262365|525608143|FG002|Overall Study|Lost to Follow-up|6|||
145752338|NCT01262365|525608141|FG000|Overall Study|Withdrawal by Subject|17|||
145752339|NCT01262365|525608142|FG001|Overall Study|Withdrawal by Subject|22|||
145752340|NCT01262365|525608143|FG002|Overall Study|Withdrawal by Subject|22|||
145752341|NCT01262365|525608141|FG000|Overall Study|Death|1|||
145752342|NCT01262365|525608142|FG001|Overall Study|Death|2|||
145752343|NCT01262365|525608143|FG002|Overall Study|Death|1|||
145752344|NCT01262365|525608141|FG000|Overall Study|Adverse Event|26|||
145752345|NCT01262365|525608142|FG001|Overall Study|Adverse Event|16|||
145752346|NCT01262365|525608143|FG002|Overall Study|Adverse Event|11|||
145272271|NCT00728988|523844605|FG000|Overall Study|Death|1|||
145272272|NCT00728988|523844606|FG001|Overall Study|Death|1|||
145272273|NCT00728988|523844605|FG000|Overall Study|Adverse Event|3|||
145272274|NCT00728988|523844606|FG001|Overall Study|Adverse Event|2|||
145272275|NCT00728988|523844605|FG000|Overall Study|Other|85|||
145272276|NCT00728988|523844606|FG001|Overall Study|Other|77|||
145272277|NCT00728988|523844605|FG000|Overall Study|Withdrawal by Subject|2|||
145272278|NCT00728988|523844606|FG001|Overall Study|Withdrawal by Subject|6|||
145752347|NCT01262365|525608141|FG000|Overall Study|sponsor decision|1|||
145752348|NCT01262365|525608142|FG001|Overall Study|sponsor decision|1|||
145752349|NCT01262365|525608143|FG002|Overall Study|sponsor decision|0|||
145752350|NCT01262365|525608141|FG000|Overall Study|Randomization error|1|||
145752351|NCT01262365|525608142|FG001|Overall Study|Randomization error|0|||
145752352|NCT01262365|525608143|FG002|Overall Study|Randomization error|2|||
145752353|NCT01262365|525608141|FG000|Overall Study|Non-compliance|1|||
145752354|NCT01262365|525608142|FG001|Overall Study|Non-compliance|0|||
145752355|NCT01262365|525608143|FG002|Overall Study|Non-compliance|2|||
145752356|NCT01262365|525608141|FG000|Overall Study|Suspected pregnancy|1|||
145752357|NCT01262365|525608142|FG001|Overall Study|Suspected pregnancy|0|||
145752358|NCT01262365|525608143|FG002|Overall Study|Suspected pregnancy|0|||
145752359|NCT01262365|525608141|FG000|Overall Study|Patient pregnant|1|||
145752360|NCT01262365|525608142|FG001|Overall Study|Patient pregnant|0|||
145752361|NCT01262365|525608143|FG002|Overall Study|Patient pregnant|1|||
145752362|NCT01262365|525608141|FG000|Overall Study|Toxicity related to study drug|0|||
145752363|NCT01262365|525608142|FG001|Overall Study|Toxicity related to study drug|1|||
145752364|NCT01262365|525608143|FG002|Overall Study|Toxicity related to study drug|0|||
145752365|NCT01262365|525608141|FG000|Overall Study|Cannot tolerate the protocol|0|||
145752366|NCT01262365|525608142|FG001|Overall Study|Cannot tolerate the protocol|1|||
145752367|NCT01262365|525608143|FG002|Overall Study|Cannot tolerate the protocol|0|||
145752368|NCT01262365|525608141|FG000|Overall Study|Patient unavailable|0|||
145752369|NCT01262365|525608142|FG001|Overall Study|Patient unavailable|0|||
145752370|NCT01262365|525608143|FG002|Overall Study|Patient unavailable|1|||
145752371|NCT02322710|525608146|FG000|Overall Study|No efficacy assessment post-baseline|0|||
145752372|NCT02322710|525608147|FG001|Overall Study|No efficacy assessment post-baseline|1|||
145752373|NCT02322710|525608146|FG000|Overall Study|Protocol Violation|20|||
145752374|NCT02322710|525608147|FG001|Overall Study|Protocol Violation|25|||
145752375|NCT01191697|525608159|FG000|Overall Study|Death|1|||
145752376|NCT01191697|525608159|FG000|Overall Study|Physician Decision|2|||
145752377|NCT01191697|525608159|FG000|Overall Study|Pursue chemoradiation|2|||
145752378|NCT01191697|525608159|FG000|Overall Study|Break from chemotherapy|2|||
145752379|NCT01191697|525608159|FG000|Overall Study|Withdrawal by Subject|1|||
145752380|NCT01191697|525608159|FG000|Overall Study|Surveillance|1|||
145272279|NCT05674721|523844609|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
145272280|NCT05674721|523844610|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
145272281|NCT05674721|523844609|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
145529775|NCT00925990|524800898|FG000|Overall Study|Physician Decision|1|||
145529776|NCT00925990|524800899|FG001|Overall Study|Physician Decision|1|||
145752381|NCT01191697|525608159|FG000|Overall Study|Adverse Event|2|||
145752382|NCT01191697|525608159|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
145752383|NCT01191697|525608159|FG000|Overall Study|Not completed but analyzed|25|||
145752384|NCT04227899|525608162|FG000|Overall Study|Withdrawal by Subject|6|||
145752385|NCT04227899|525608163|FG001|Overall Study|Withdrawal by Subject|3|||
145752386|NCT04227899|525608162|FG000|Overall Study|Death|12|||
145752387|NCT04227899|525608163|FG001|Overall Study|Death|6|||
145752388|NCT04227899|525608162|FG000|Overall Study|Lost to Follow-up|2|||
145752389|NCT04227899|525608163|FG001|Overall Study|Lost to Follow-up|1|||
145752390|NCT02479802|525608164|FG000|Overall Study|Lost to Follow-up|1|||
145752391|NCT02479802|525608164|FG000|Overall Study|Adverse Event|1|||
145752392|NCT02792842|525608167|FG000|Overall Study|Adverse Event|4|||
145752393|NCT02792842|525608168|FG001|Overall Study|Adverse Event|2|||
145752394|NCT02792842|525608169|FG002|Overall Study|Adverse Event|3|||
145752395|NCT02792842|525608167|FG000|Overall Study|Withdrawal by Subject|0|||
145752396|NCT02792842|525608168|FG001|Overall Study|Withdrawal by Subject|1|||
145752397|NCT02792842|525608169|FG002|Overall Study|Withdrawal by Subject|2|||
145752398|NCT02792842|525608167|FG000|Overall Study|Lost to Follow-up|0|||
145752399|NCT02792842|525608168|FG001|Overall Study|Lost to Follow-up|0|||
145752400|NCT02792842|525608169|FG002|Overall Study|Lost to Follow-up|1|||
145752401|NCT02792842|525608167|FG000|Overall Study|Schedule delay|0|||
145752402|NCT02792842|525608168|FG001|Overall Study|Schedule delay|1|||
145752403|NCT02792842|525608169|FG002|Overall Study|Schedule delay|1|||
145752404|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
145752405|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
145752406|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
145752407|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
145752408|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
145752409|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
145752410|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
145752411|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
145752412|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
145752413|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
145752414|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
145752415|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
145752416|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
145752417|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
145752418|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
145752419|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
145752420|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
145752421|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
145752422|NCT04418765|525608170|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
145752423|NCT04418765|525608171|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
145752424|NCT04418765|525608172|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
145752425|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
145752426|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
145752427|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
145752428|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
145752429|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
145752430|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
145752431|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
145752432|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
145752433|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
145752434|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
145752435|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
145752436|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
145752437|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
145752438|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
145752439|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
145752440|NCT04418765|525608170|FG000|Extension Period (48 Weeks)|Other than specified|0|||
145752441|NCT04418765|525608171|FG001|Extension Period (48 Weeks)|Other than specified|5|||
145752442|NCT04418765|525608172|FG002|Extension Period (48 Weeks)|Other than specified|2|||
145752443|NCT01926782|525608173|FG000|Overall Study|Participant moved|2|||
145752444|NCT01926782|525608174|FG001|Overall Study|Participant moved|0|||
145752445|NCT01926782|525608175|FG002|Overall Study|Participant moved|1|||
145752446|NCT01926782|525608176|FG003|Overall Study|Participant moved|1|||
145752447|NCT01926782|525608177|FG004|Overall Study|Participant moved|0|||
145752448|NCT01926782|525608178|FG005|Overall Study|Participant moved|3|||
145752449|NCT01926782|525608173|FG000|Overall Study|Physician Decision|0|||
145752450|NCT01926782|525608174|FG001|Overall Study|Physician Decision|2|||
145752451|NCT01926782|525608175|FG002|Overall Study|Physician Decision|1|||
145752452|NCT01926782|525608176|FG003|Overall Study|Physician Decision|1|||
145752453|NCT01926782|525608177|FG004|Overall Study|Physician Decision|0|||
145752454|NCT01926782|525608178|FG005|Overall Study|Physician Decision|0|||
145752455|NCT01926782|525608173|FG000|Overall Study|Other than specified|2|||
145752456|NCT01926782|525608174|FG001|Overall Study|Other than specified|3|||
145752457|NCT01926782|525608175|FG002|Overall Study|Other than specified|5|||
145752458|NCT01926782|525608176|FG003|Overall Study|Other than specified|12|||
145752459|NCT01926782|525608177|FG004|Overall Study|Other than specified|4|||
145752460|NCT01926782|525608178|FG005|Overall Study|Other than specified|11|||
145752461|NCT01926782|525608173|FG000|Overall Study|Adverse Event|13|||
145752462|NCT01926782|525608174|FG001|Overall Study|Adverse Event|4|||
145752463|NCT01926782|525608175|FG002|Overall Study|Adverse Event|17|||
145752464|NCT01926782|525608176|FG003|Overall Study|Adverse Event|4|||
145752465|NCT01926782|525608177|FG004|Overall Study|Adverse Event|3|||
145752466|NCT01926782|525608178|FG005|Overall Study|Adverse Event|14|||
145752467|NCT01926782|525608173|FG000|Overall Study|Poor compliance to protocol|5|||
145752468|NCT01926782|525608174|FG001|Overall Study|Poor compliance to protocol|3|||
145752469|NCT01926782|525608175|FG002|Overall Study|Poor compliance to protocol|8|||
145752470|NCT01926782|525608176|FG003|Overall Study|Poor compliance to protocol|0|||
145752471|NCT01926782|525608177|FG004|Overall Study|Poor compliance to protocol|1|||
145752472|NCT01926782|525608178|FG005|Overall Study|Poor compliance to protocol|6|||
145752473|NCT01926782|525608173|FG000|Overall Study|Randomized and not treated|0|||
145752474|NCT01926782|525608174|FG001|Overall Study|Randomized and not treated|0|||
145752475|NCT01926782|525608175|FG002|Overall Study|Randomized and not treated|0|||
145752476|NCT01926782|525608176|FG003|Overall Study|Randomized and not treated|1|||
145752477|NCT01926782|525608177|FG004|Overall Study|Randomized and not treated|0|||
145752478|NCT01926782|525608178|FG005|Overall Study|Randomized and not treated|0|||
145752479|NCT01926782|525608173|FG000|Overall Study|Withdrawal by Subject|6|||
145752480|NCT01926782|525608174|FG001|Overall Study|Withdrawal by Subject|1|||
145752481|NCT01926782|525608175|FG002|Overall Study|Withdrawal by Subject|8|||
145752482|NCT01926782|525608176|FG003|Overall Study|Withdrawal by Subject|1|||
145752483|NCT01926782|525608177|FG004|Overall Study|Withdrawal by Subject|0|||
145752484|NCT01926782|525608178|FG005|Overall Study|Withdrawal by Subject|5|||
145752485|NCT01926782|525608173|FG000|Overall Study|Related to study drug administration|0|||
145752486|NCT01926782|525608174|FG001|Overall Study|Related to study drug administration|0|||
145752487|NCT01926782|525608175|FG002|Overall Study|Related to study drug administration|0|||
145752488|NCT01926782|525608176|FG003|Overall Study|Related to study drug administration|0|||
145752489|NCT01926782|525608177|FG004|Overall Study|Related to study drug administration|0|||
145752490|NCT01926782|525608178|FG005|Overall Study|Related to study drug administration|2|||
145752491|NCT01100944|525608179|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
145752492|NCT01100944|525608180|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
145752493|NCT01100944|525608181|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
145752494|NCT01100944|525608179|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
145752495|NCT01100944|525608180|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
145752496|NCT01100944|525608181|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
145752497|NCT01100944|525608179|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
145752498|NCT01100944|525608180|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
145752499|NCT01100944|525608181|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
145752500|NCT01100944|525608179|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
145752501|NCT01100944|525608180|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
145752502|NCT01100944|525608181|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
145752503|NCT00577993|525608182|FG000|Overall Study|Adverse Event|1|||
145752504|NCT00577993|525608183|FG001|Overall Study|Adverse Event|0|||
145752505|NCT00577993|525608184|FG002|Overall Study|Adverse Event|0|||
145752506|NCT00577993|525608182|FG000|Overall Study|Death|0|||
145752507|NCT00577993|525608183|FG001|Overall Study|Death|1|||
145752508|NCT00577993|525608184|FG002|Overall Study|Death|1|||
145752509|NCT00577993|525608182|FG000|Overall Study|Lack of Efficacy|0|||
145752510|NCT00577993|525608183|FG001|Overall Study|Lack of Efficacy|1|||
145752511|NCT00577993|525608184|FG002|Overall Study|Lack of Efficacy|0|||
145752512|NCT00577993|525608182|FG000|Overall Study|Protocol Violation|2|||
145752513|NCT00577993|525608183|FG001|Overall Study|Protocol Violation|3|||
145752514|NCT00577993|525608184|FG002|Overall Study|Protocol Violation|0|||
145272282|NCT05674721|523844610|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
145272283|NCT05013749|523844616|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
145292747|NCT06179108|523922228|FG002|Overall Study|Withdrawal by Subject|10|||
145529777|NCT00925990|524800898|FG000|Overall Study|moved out of state, missed medication|0|||
145529778|NCT00925990|524800899|FG001|Overall Study|moved out of state, missed medication|2|||
145529779|NCT01368432|524800902|FG000|Overall Study|Lost to Follow-up|0|||
145529780|NCT01368432|524800903|FG001|Overall Study|Lost to Follow-up|1|||
145529781|NCT02310321|524800918|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
145529782|NCT02310321|524800919|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
145529783|NCT02310321|524800920|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
145752515|NCT00577993|525608182|FG000|Overall Study|Withdrawal by Subject|1|||
145752516|NCT00577993|525608183|FG001|Overall Study|Withdrawal by Subject|0|||
145752517|NCT00577993|525608184|FG002|Overall Study|Withdrawal by Subject|2|||
145752518|NCT00577993|525608182|FG000|Overall Study|Conversion|2|||
145752519|NCT00577993|525608183|FG001|Overall Study|Conversion|5|||
145752520|NCT00577993|525608184|FG002|Overall Study|Conversion|0|||
145752521|NCT00577993|525608182|FG000|Overall Study|Uninsured|1|||
145752522|NCT00577993|525608183|FG001|Overall Study|Uninsured|0|||
145752523|NCT00577993|525608184|FG002|Overall Study|Uninsured|0|||
145752524|NCT02296242|525608185|FG000|Overall Study|Death|1|||
145752525|NCT02296242|525608186|FG001|Overall Study|Death|1|||
145752526|NCT02296242|525608187|FG002|Overall Study|Death|1|||
145752527|NCT02296242|525608188|FG003|Overall Study|Death|1|||
145752528|NCT02296242|525608189|FG004|Overall Study|Death|1|||
145752529|NCT02296242|525608185|FG000|Overall Study|Withdrawal by Subject|0|||
145752530|NCT02296242|525608186|FG001|Overall Study|Withdrawal by Subject|0|||
145752531|NCT02296242|525608187|FG002|Overall Study|Withdrawal by Subject|1|||
145752532|NCT02296242|525608188|FG003|Overall Study|Withdrawal by Subject|1|||
145752533|NCT02296242|525608189|FG004|Overall Study|Withdrawal by Subject|3|||
145752534|NCT02296242|525608185|FG000|Overall Study|Disease Progression|1|||
145752535|NCT02296242|525608186|FG001|Overall Study|Disease Progression|3|||
145752536|NCT02296242|525608187|FG002|Overall Study|Disease Progression|2|||
145752537|NCT02296242|525608188|FG003|Overall Study|Disease Progression|8|||
145752538|NCT02296242|525608189|FG004|Overall Study|Disease Progression|11|||
145752539|NCT02296242|525608185|FG000|Overall Study|Unacceptable Toxicity|0|||
145752540|NCT02296242|525608186|FG001|Overall Study|Unacceptable Toxicity|0|||
145752541|NCT02296242|525608187|FG002|Overall Study|Unacceptable Toxicity|0|||
145752542|NCT02296242|525608188|FG003|Overall Study|Unacceptable Toxicity|0|||
145752543|NCT02296242|525608189|FG004|Overall Study|Unacceptable Toxicity|1|||
145752544|NCT02296242|525608185|FG000|Overall Study|Patient Condition Changed|0|||
145752545|NCT02296242|525608186|FG001|Overall Study|Patient Condition Changed|0|||
145752546|NCT02296242|525608187|FG002|Overall Study|Patient Condition Changed|2|||
145752547|NCT02296242|525608188|FG003|Overall Study|Patient Condition Changed|0|||
145752548|NCT02296242|525608189|FG004|Overall Study|Patient Condition Changed|1|||
145752549|NCT02296242|525608185|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
145752550|NCT02296242|525608186|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
145752551|NCT02296242|525608187|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
145752552|NCT02296242|525608188|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
145752553|NCT02296242|525608189|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
145752554|NCT02296242|525608185|FG000|Overall Study|Lost to Follow-up|1|||
145752555|NCT02296242|525608186|FG001|Overall Study|Lost to Follow-up|0|||
145752556|NCT02296242|525608187|FG002|Overall Study|Lost to Follow-up|0|||
145752557|NCT02296242|525608188|FG003|Overall Study|Lost to Follow-up|0|||
145752558|NCT02296242|525608189|FG004|Overall Study|Lost to Follow-up|0|||
145752559|NCT02296242|525608185|FG000|Overall Study|Need for Hydroxyurea|2|||
145752560|NCT02296242|525608186|FG001|Overall Study|Need for Hydroxyurea|0|||
145752561|NCT02296242|525608187|FG002|Overall Study|Need for Hydroxyurea|0|||
145752562|NCT02296242|525608188|FG003|Overall Study|Need for Hydroxyurea|0|||
145752563|NCT02296242|525608189|FG004|Overall Study|Need for Hydroxyurea|0|||
145752564|NCT02296242|525608185|FG000|Overall Study|Screened for Other Protocol|0|||
145752565|NCT02296242|525608186|FG001|Overall Study|Screened for Other Protocol|1|||
145752566|NCT02296242|525608187|FG002|Overall Study|Screened for Other Protocol|0|||
145752567|NCT02296242|525608188|FG003|Overall Study|Screened for Other Protocol|0|||
145752568|NCT02296242|525608189|FG004|Overall Study|Screened for Other Protocol|0|||
145752569|NCT02296242|525608185|FG000|Overall Study|Physician Decision|0|||
145752570|NCT02296242|525608186|FG001|Overall Study|Physician Decision|1|||
145752571|NCT02296242|525608187|FG002|Overall Study|Physician Decision|0|||
145752572|NCT02296242|525608188|FG003|Overall Study|Physician Decision|1|||
145752573|NCT02296242|525608189|FG004|Overall Study|Physician Decision|0|||
145752574|NCT02296242|525608185|FG000|Overall Study|Alternative Treatment|0|||
145752575|NCT02296242|525608186|FG001|Overall Study|Alternative Treatment|0|||
145752576|NCT02296242|525608187|FG002|Overall Study|Alternative Treatment|0|||
145752577|NCT02296242|525608188|FG003|Overall Study|Alternative Treatment|1|||
145752578|NCT02296242|525608189|FG004|Overall Study|Alternative Treatment|0|||
145752579|NCT02296242|525608185|FG000|Overall Study|Adverse Event|0|||
145752580|NCT02296242|525608186|FG001|Overall Study|Adverse Event|0|||
145529784|NCT02310321|524800918|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
145752581|NCT02296242|525608187|FG002|Overall Study|Adverse Event|0|||
145529785|NCT02310321|524800919|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
145529786|NCT02310321|524800920|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
145529787|NCT02310321|524800918|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
145752582|NCT02296242|525608188|FG003|Overall Study|Adverse Event|1|||
145752583|NCT02296242|525608189|FG004|Overall Study|Adverse Event|0|||
145752584|NCT02296242|525608185|FG000|Overall Study|Lack of Efficacy|0|||
145752585|NCT02296242|525608186|FG001|Overall Study|Lack of Efficacy|0|||
145752586|NCT02296242|525608187|FG002|Overall Study|Lack of Efficacy|0|||
145752587|NCT02296242|525608188|FG003|Overall Study|Lack of Efficacy|0|||
145752588|NCT02296242|525608189|FG004|Overall Study|Lack of Efficacy|3|||
145752589|NCT02217566|525608190|FG000|Overall Study|Lost to Follow-up|2|||
145752590|NCT02217566|525608190|FG000|Overall Study|Death|3|||
145752591|NCT02217566|525608190|FG000|Overall Study|Early study termination|6|||
145752592|NCT01639833|525608192|FG000|Overall Study|Death|4|||
145752593|NCT01639833|525608193|FG001|Overall Study|Death|2|||
145752594|NCT01639833|525608192|FG000|Overall Study|Withdrawal by Subject|2|||
145752595|NCT01639833|525608193|FG001|Overall Study|Withdrawal by Subject|2|||
145752596|NCT00070941|525608194|FG000|Overall Study|Adverse Event|10|||
145752597|NCT00070941|525608195|FG001|Overall Study|Adverse Event|8|||
145752598|NCT00070941|525608196|FG002|Overall Study|Adverse Event|4|||
145752599|NCT02064387|525608197|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752600|NCT02064387|525608198|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752601|NCT02064387|525608199|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752602|NCT02064387|525608200|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752603|NCT02064387|525608201|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752604|NCT02064387|525608202|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752605|NCT02064387|525608203|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752606|NCT02064387|525608204|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
145752607|NCT02064387|525608205|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752608|NCT02064387|525608206|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
145752609|NCT02064387|525608207|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752610|NCT02064387|525608208|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
145752611|NCT02064387|525608197|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752612|NCT02064387|525608198|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752613|NCT02064387|525608199|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752614|NCT02064387|525608200|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752615|NCT02064387|525608201|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752616|NCT02064387|525608202|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752617|NCT02064387|525608203|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752618|NCT02064387|525608204|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
145752619|NCT02064387|525608205|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752620|NCT02064387|525608206|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752621|NCT02064387|525608207|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752622|NCT02064387|525608208|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
145752623|NCT02064387|525608197|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752624|NCT02064387|525608198|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752625|NCT02064387|525608199|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752626|NCT02064387|525608200|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752627|NCT02064387|525608201|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752628|NCT02064387|525608202|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752629|NCT02064387|525608203|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752630|NCT02064387|525608204|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752631|NCT02064387|525608205|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
145752632|NCT02064387|525608206|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752633|NCT02064387|525608207|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752634|NCT02064387|525608208|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
145752635|NCT02064387|525608197|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
145752636|NCT02064387|525608198|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
145752637|NCT02064387|525608199|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
145752638|NCT02064387|525608200|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
145752639|NCT02064387|525608201|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
145752640|NCT02064387|525608202|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
145752641|NCT02064387|525608203|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
145752642|NCT02064387|525608204|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
145752643|NCT02064387|525608205|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
145752644|NCT02064387|525608206|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
145752645|NCT02064387|525608207|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
145752646|NCT02064387|525608208|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
145752647|NCT02064387|525608197|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752648|NCT02064387|525608198|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752649|NCT02064387|525608199|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752650|NCT02064387|525608200|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752651|NCT02064387|525608201|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752652|NCT02064387|525608202|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752653|NCT02064387|525608203|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752654|NCT02064387|525608204|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752655|NCT02064387|525608205|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752656|NCT02064387|525608206|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752657|NCT02064387|525608207|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
145752658|NCT02064387|525608208|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
145752659|NCT02499029|525608209|FG000|Overall Study|Lost to Follow-up|2|||
145752660|NCT02499029|525608210|FG001|Overall Study|Lost to Follow-up|2|||
145752661|NCT02499029|525608209|FG000|Overall Study|Physician Decision|2|||
145752662|NCT02499029|525608210|FG001|Overall Study|Physician Decision|1|||
145752663|NCT02499029|525608209|FG000|Overall Study|Death|1|||
145752664|NCT02499029|525608210|FG001|Overall Study|Death|0|||
145752665|NCT01707693|525608211|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
145752666|NCT01707693|525608212|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
145752667|NCT01707693|525608211|FG000|Overall Study Allocation|Protocol Violation|4|||
145752668|NCT01707693|525608212|FG001|Overall Study Allocation|Protocol Violation|3|||
145752669|NCT01707693|525608211|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
145752670|NCT01707693|525608212|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
145752671|NCT01707693|525608211|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
145752672|NCT01707693|525608212|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
145752673|NCT03115151|525608213|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
145752674|NCT03115151|525608214|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
145752675|NCT03115151|525608213|FG000|Overall Study|Epidural catheter removal|1|||
145752676|NCT03115151|525608214|FG001|Overall Study|Epidural catheter removal|0|||
145752677|NCT03115151|525608213|FG000|Overall Study|Withdrawal by Subject|0|||
145752678|NCT03115151|525608214|FG001|Overall Study|Withdrawal by Subject|1|||
145752679|NCT03115151|525608213|FG000|Overall Study|Intervention not received according to the protocol.|1|||
145752680|NCT03115151|525608214|FG001|Overall Study|Intervention not received according to the protocol.|1|||
145752681|NCT03115151|525608213|FG000|Overall Study|Physician Decision|1|||
145752682|NCT03115151|525608214|FG001|Overall Study|Physician Decision|0|||
145752683|NCT03115151|525608213|FG000|Overall Study|Randomization not applied|1|||
145752684|NCT03115151|525608214|FG001|Overall Study|Randomization not applied|1|||
145752685|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
145752686|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
145752687|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
145752688|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
145752689|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145752690|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145752691|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
145752692|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145752693|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
145752694|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145752695|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145752696|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145752697|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
145752698|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
145752699|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
145752700|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
145752701|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
145752702|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
145752703|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
145752704|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
145752705|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
145752706|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
145752707|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
145752708|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
145752709|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
145752710|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
145752711|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
145752712|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
145752713|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
145752714|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
145752715|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
145752716|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
145752717|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
145752718|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
145752719|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
145752720|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
145752721|NCT03403205|525608215|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
145752722|NCT03403205|525608216|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
145752723|NCT03403205|525608217|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
145752724|NCT03403205|525608218|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
145752725|NCT03403205|525608219|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
145752726|NCT03403205|525608220|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
145752727|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
145752728|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
145752729|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
145752730|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
145752731|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
145752732|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
145752733|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
145752734|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
145752735|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
145752736|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
145752737|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
145752738|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
145752739|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Death|1|||
145752740|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Death|0|||
145752741|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Death|0|||
145752742|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Death|0|||
145752743|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Death|0|||
145752744|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Death|0|||
145752745|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
145752746|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
145752747|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
145752748|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
145752749|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
145752750|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
145752751|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
145752752|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
145752753|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
145752754|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
145752755|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
145752756|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
145752757|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
145752758|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
145752759|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
145752760|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
145752761|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
145752762|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
145752763|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
145752764|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
145752765|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
145752766|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
145752767|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
145752768|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
145752769|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
145752770|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
145752771|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
145752772|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
145752773|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
145752774|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
145752775|NCT03403205|525608215|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
145752776|NCT03403205|525608216|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
145752777|NCT03403205|525608217|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
145752778|NCT03403205|525608218|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
145752779|NCT03403205|525608219|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
145752780|NCT03403205|525608220|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
145752781|NCT05779072|525608221|FG000|Overall Study|Lost to Follow-up|0|||
145752782|NCT05779072|525608222|FG001|Overall Study|Lost to Follow-up|1|||
145752783|NCT05779072|525608221|FG000|Overall Study|Withdrawal by Subject|1|||
145752784|NCT05779072|525608222|FG001|Overall Study|Withdrawal by Subject|5|||
145752785|NCT02682901|525608223|FG000|Overall Study|Adverse Event|10|||
145752786|NCT02682901|525608224|FG001|Overall Study|Adverse Event|3|||
145529788|NCT02310321|524800919|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
145752787|NCT02682901|525608223|FG000|Overall Study|Lack of Efficacy|0|||
145752788|NCT02682901|525608224|FG001|Overall Study|Lack of Efficacy|1|||
145752789|NCT03713944|525608225|FG000|Study Treatment|Patient non-compliance|1|||
145752790|NCT03713944|525608225|FG000|Study Treatment|Alternative Cancer Therapy|3|||
145752791|NCT03713944|525608225|FG000|Study Treatment|Disease Progression|18|||
145752792|NCT03713944|525608225|FG000|Study Treatment|AE/Side Effects/Complications|2|||
145752793|NCT03713944|525608225|FG000|Study Treatment|Death|2|||
145752794|NCT03713944|525608225|FG000|Study Treatment|Withdrawal by Subject|1|||
145752795|NCT03713944|525608225|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
145752796|NCT03713944|525608225|FG000|Study Treatment|Symptomatic Deterioration|2|||
145752797|NCT03713944|525608225|FG000|Follow up|Withdrawal by Subject|2|||
145752798|NCT03713944|525608225|FG000|Follow up|Death|11|||
145752799|NCT03713944|525608225|FG000|Follow up|Study Terminated|3|||
145752800|NCT03847610|525608226|FG000|Overall Study|Withdrawal by Subject|1|||
145752801|NCT03298022|525608227|FG000|Overall Study|Lack of Efficacy|4|||
145752802|NCT03298022|525608227|FG000|Overall Study|Withdrawal by Subject|7|||
145752803|NCT03298022|525608227|FG000|Overall Study|Adverse Event|1|||
145752804|NCT03298022|525608227|FG000|Overall Study|disease relapse|1|||
145752805|NCT01445769|525608228|FG000|Overall Study|Consent Withdrawn|2|||
145752806|NCT01445769|525608228|FG000|Overall Study|Disease Progression|1|||
145752807|NCT01445769|525608228|FG000|Overall Study|Lost to Follow-up|5|||
145752808|NCT00044512|525608229|FG000|Follow Up|Lost to Follow-up|2|||
145752809|NCT00343889|525608237|FG000|Overall Study|Lost to Follow-up|2|||
145752810|NCT00343889|525608238|FG001|Overall Study|Lost to Follow-up|0|||
145752811|NCT00343889|525608237|FG000|Overall Study|Withdrawal by Subject|0|||
145752812|NCT00343889|525608238|FG001|Overall Study|Withdrawal by Subject|1|||
145752813|NCT00343889|525608237|FG000|Overall Study|Protocol Violation|1|||
145752814|NCT00343889|525608238|FG001|Overall Study|Protocol Violation|0|||
145752815|NCT04472429|525608241|FG000|Randomized Period|Ongoing|90|||
145752816|NCT04472429|525608242|FG001|Randomized Period|Ongoing|40|||
145752817|NCT04472429|525608243|FG002|Randomized Period|Ongoing|0|||
145752818|NCT04472429|525608241|FG000|Randomized Period|Death|52|||
145752819|NCT04472429|525608242|FG001|Randomized Period|Death|37|||
145752820|NCT04472429|525608243|FG002|Randomized Period|Death|0|||
145752821|NCT04472429|525608241|FG000|Randomized Period|Lost to Follow-up|4|||
145752822|NCT04472429|525608242|FG001|Randomized Period|Lost to Follow-up|0|||
145752823|NCT04472429|525608243|FG002|Randomized Period|Lost to Follow-up|0|||
145752824|NCT04472429|525608241|FG000|Randomized Period|Physician Decision|1|||
145752825|NCT04472429|525608242|FG001|Randomized Period|Physician Decision|2|||
145752826|NCT04472429|525608243|FG002|Randomized Period|Physician Decision|0|||
145752827|NCT04472429|525608241|FG000|Randomized Period|Withdrawal by Subject|6|||
145752828|NCT04472429|525608242|FG001|Randomized Period|Withdrawal by Subject|5|||
145752829|NCT04472429|525608243|FG002|Randomized Period|Withdrawal by Subject|0|||
145752830|NCT04472429|525608241|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
145752831|NCT04472429|525608242|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
145752832|NCT04472429|525608243|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
145752833|NCT04472429|525608241|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
145752834|NCT04472429|525608242|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
145752835|NCT04472429|525608243|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
145752836|NCT04472429|525608241|FG000|Open-label Monotherapy Period|Ongoing|0|||
145529789|NCT02310321|524800920|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
145529790|NCT02310321|524800918|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
145529791|NCT02310321|524800919|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
145529792|NCT02310321|524800920|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
145529793|NCT02310321|524800918|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
145529794|NCT02310321|524800919|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
145529795|NCT02310321|524800920|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
145529796|NCT02310321|524800918|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
145529797|NCT02310321|524800919|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
145529798|NCT02310321|524800920|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
145752837|NCT04472429|525608242|FG001|Open-label Monotherapy Period|Ongoing|0|||
145752838|NCT04472429|525608243|FG002|Open-label Monotherapy Period|Ongoing|32|||
145752839|NCT04472429|525608241|FG000|Open-label Monotherapy Period|Death|0|||
145752840|NCT04472429|525608242|FG001|Open-label Monotherapy Period|Death|0|||
145752841|NCT04472429|525608243|FG002|Open-label Monotherapy Period|Death|35|||
145752842|NCT04472429|525608241|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
145752843|NCT04472429|525608242|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
145752844|NCT04472429|525608243|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
145752845|NCT05130463|525608244|FG000|Overall Study|Unspecified reasons|2|||
145752846|NCT05130463|525608244|FG000|Overall Study|off-label indication dose|435|||
145752847|NCT03652662|525608245|FG000|Overall Study|Withdrawal by Subject|2|||
145752848|NCT03652662|525608246|FG001|Overall Study|Withdrawal by Subject|1|||
145752849|NCT03652662|525608245|FG000|Overall Study|Lost to Follow-up|1|||
145752850|NCT03652662|525608246|FG001|Overall Study|Lost to Follow-up|0|||
145752851|NCT00487539|525608247|FG000|Overall Study|Adverse Event|3|||
145752852|NCT00487539|525608248|FG001|Overall Study|Adverse Event|2|||
145752853|NCT00487539|525608249|FG002|Overall Study|Adverse Event|1|||
145752854|NCT00487539|525608250|FG003|Overall Study|Adverse Event|1|||
145752855|NCT00487539|525608247|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145752856|NCT00487539|525608248|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145752857|NCT00487539|525608249|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145752858|NCT00487539|525608250|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
145752859|NCT00487539|525608247|FG000|Overall Study|Other|3|||
145752860|NCT00487539|525608248|FG001|Overall Study|Other|1|||
145752861|NCT00487539|525608249|FG002|Overall Study|Other|2|||
145752862|NCT00487539|525608250|FG003|Overall Study|Other|2|||
145752863|NCT02695628|525608251|FG000|Overall Study|Withdrawal by Subject|1|||
145752864|NCT02751502|525608252|FG000|Overall Study|Lack of funding|4|||
145752865|NCT02678390|525608253|FG000|AE (1 Day)|Withdrawal by Subject|0|||
145752866|NCT02678390|525608254|FG001|AE (1 Day)|Withdrawal by Subject|1|||
145752867|NCT01687712|525608255|FG000|Cycle 1|Not Biochemically Pregnant|386|||
145752868|NCT01687712|525608256|FG001|Cycle 1|Not Biochemically Pregnant|348|||
145752869|NCT01687712|525608255|FG000|Cycle 1|Early Pregnancy Loss|43|||
145752870|NCT01687712|525608256|FG001|Cycle 1|Early Pregnancy Loss|60|||
145752871|NCT01687712|525608255|FG000|Cycle 1|Ectopic Pregnancy|5|||
145752872|NCT01687712|525608256|FG001|Cycle 1|Ectopic Pregnancy|5|||
145752873|NCT01687712|525608255|FG000|Cycle 1|Heterotropic Pregnancy|1|||
145752874|NCT01687712|525608256|FG001|Cycle 1|Heterotropic Pregnancy|0|||
145752875|NCT01687712|525608255|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
145752876|NCT01687712|525608256|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
145752877|NCT01687712|525608255|FG000|Cycle 1|Abortion|3|||
145752878|NCT01687712|525608256|FG001|Cycle 1|Abortion|0|||
145752879|NCT01687712|525608255|FG000|Cycle 1|Intrauterine Fetal Death|0|||
145752880|NCT01687712|525608256|FG001|Cycle 1|Intrauterine Fetal Death|1|||
145752881|NCT01687712|525608255|FG000|Cycle 1|Lost to Follow-up|1|||
145752882|NCT01687712|525608256|FG001|Cycle 1|Lost to Follow-up|1|||
145752883|NCT01687712|525608255|FG000|Cycle 2|Not Biochemically Pregnant|74|||
145752884|NCT01687712|525608256|FG001|Cycle 2|Not Biochemically Pregnant|77|||
145752885|NCT01687712|525608255|FG000|Cycle 2|Early Pregnancy Loss|18|||
145752886|NCT01687712|525608256|FG001|Cycle 2|Early Pregnancy Loss|16|||
145752887|NCT01687712|525608255|FG000|Cycle 2|Ectopic Pregnancy|0|||
145752888|NCT01687712|525608256|FG001|Cycle 2|Ectopic Pregnancy|1|||
145752889|NCT01687712|525608255|FG000|Cycle 2|Still Birth|1|||
145752890|NCT01687712|525608256|FG001|Cycle 2|Still Birth|0|||
145752891|NCT01687712|525608255|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
145752892|NCT01687712|525608256|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
145752893|NCT01687712|525608255|FG000|Cycle 3|Not Biochemically Pregnant|21|||
145752894|NCT01687712|525608256|FG001|Cycle 3|Not Biochemically Pregnant|22|||
145752895|NCT01687712|525608255|FG000|Cycle 3|Early Pregnancy Loss|1|||
145752896|NCT01687712|525608256|FG001|Cycle 3|Early Pregnancy Loss|2|||
145752897|NCT01687712|525608255|FG000|Cycle 3|Ectopic Pregnancy|1|||
145752898|NCT01687712|525608256|FG001|Cycle 3|Ectopic Pregnancy|0|||
145752899|NCT01687712|525608255|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
145752900|NCT01687712|525608256|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
145752901|NCT02573155|525608257|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
145752902|NCT02573155|525608258|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
145752903|NCT02573155|525608257|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
145752904|NCT02573155|525608258|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
145752905|NCT02573155|525608257|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
145752906|NCT02573155|525608258|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
145752907|NCT02573155|525608257|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
145752908|NCT02573155|525608258|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
145752909|NCT02573155|525608257|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
145752910|NCT02573155|525608258|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
145752911|NCT02573155|525608257|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
145752912|NCT02573155|525608258|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
145752913|NCT02573155|525608257|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
145752914|NCT02573155|525608258|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
145752915|NCT02573155|525608257|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
145752916|NCT02573155|525608258|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
145752917|NCT01681433|525608259|FG000|Overall Study|Lack of Efficacy|23|||
145752918|NCT01681433|525608260|FG001|Overall Study|Lack of Efficacy|23|||
145752919|NCT01681433|525608259|FG000|Overall Study|Withdrawal by Subject|5|||
145752920|NCT01681433|525608260|FG001|Overall Study|Withdrawal by Subject|5|||
145752921|NCT01681433|525608259|FG000|Overall Study|Protocol Violation|2|||
145752922|NCT01681433|525608260|FG001|Overall Study|Protocol Violation|0|||
145752923|NCT01681433|525608259|FG000|Overall Study|Adverse Event|2|||
145752924|NCT01681433|525608260|FG001|Overall Study|Adverse Event|4|||
145752925|NCT01681433|525608259|FG000|Overall Study|Lost to Follow-up|0|||
145752926|NCT01681433|525608260|FG001|Overall Study|Lost to Follow-up|1|||
145752927|NCT00903929|525608261|FG000|Overall Study|Withdrawal by Subject|0|||
145752928|NCT00903929|525608262|FG001|Overall Study|Withdrawal by Subject|0|||
145752929|NCT00903929|525608263|FG002|Overall Study|Withdrawal by Subject|1|||
145752930|NCT00903929|525608264|FG003|Overall Study|Withdrawal by Subject|2|||
145752931|NCT00903929|525608261|FG000|Overall Study|Adverse Event|0|||
145752932|NCT00903929|525608262|FG001|Overall Study|Adverse Event|0|||
145752933|NCT00903929|525608263|FG002|Overall Study|Adverse Event|0|||
145752934|NCT00903929|525608264|FG003|Overall Study|Adverse Event|1|||
145752935|NCT05913232|525608265|FG000|Overall Study|Adverse Event|0|||
145752936|NCT05913232|525608266|FG001|Overall Study|Adverse Event|2|||
145752937|NCT05913232|525608267|FG002|Overall Study|Adverse Event|1|||
145752938|NCT05913232|525608268|FG003|Overall Study|Adverse Event|1|||
145752939|NCT01318109|525608269|FG000|Overall Study|Adverse Event|0|||
145752940|NCT01318109|525608270|FG001|Overall Study|Adverse Event|2|||
145752941|NCT01318109|525608271|FG002|Overall Study|Adverse Event|0|||
145752942|NCT01318109|525608269|FG000|Overall Study|Withdrawal by Subject|1|||
145752943|NCT01318109|525608270|FG001|Overall Study|Withdrawal by Subject|0|||
145752944|NCT01318109|525608271|FG002|Overall Study|Withdrawal by Subject|0|||
145752945|NCT01318109|525608269|FG000|Overall Study|Schedule Conflict|0|||
145752946|NCT01318109|525608270|FG001|Overall Study|Schedule Conflict|1|||
145752947|NCT01318109|525608271|FG002|Overall Study|Schedule Conflict|0|||
145752948|NCT01328951|525608272|FG000|Overall Study|Disease Progression|17|||
145752949|NCT01328951|525608273|FG001|Overall Study|Disease Progression|14|||
145752950|NCT01328951|525608272|FG000|Overall Study|Adverse Event|2|||
145752951|NCT01328951|525608273|FG001|Overall Study|Adverse Event|0|||
145752952|NCT01328951|525608272|FG000|Overall Study|Death|243|||
145752953|NCT01328951|525608273|FG001|Overall Study|Death|258|||
145752954|NCT01328951|525608272|FG000|Overall Study|Lost to Follow-up|6|||
145752955|NCT01328951|525608273|FG001|Overall Study|Lost to Follow-up|7|||
145752956|NCT01328951|525608272|FG000|Overall Study|Withdrawal by Subject|6|||
145752957|NCT01328951|525608273|FG001|Overall Study|Withdrawal by Subject|6|||
145752958|NCT01328951|525608272|FG000|Overall Study|Study Closed by the Sponsor|36|||
145752959|NCT01328951|525608273|FG001|Overall Study|Study Closed by the Sponsor|31|||
145752960|NCT01328951|525608272|FG000|Overall Study|Other|11|||
145752961|NCT01328951|525608273|FG001|Overall Study|Other|6|||
145752962|NCT02289950|525608279|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
145752963|NCT02289950|525608280|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
145752964|NCT02289950|525608279|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
145752965|NCT02289950|525608280|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
145752966|NCT02289950|525608279|FG000|Overall Study|Lost to Follow-up|1|||
145752967|NCT02289950|525608280|FG001|Overall Study|Lost to Follow-up|0|||
145752968|NCT02289950|525608279|FG000|Overall Study|Physician Decision|9|||
145752969|NCT02289950|525608280|FG001|Overall Study|Physician Decision|3|||
145752970|NCT02289950|525608279|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
145752971|NCT02289950|525608280|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
145752972|NCT02289950|525608279|FG000|Overall Study|Withdrawal by Subject|1|||
145752973|NCT02289950|525608280|FG001|Overall Study|Withdrawal by Subject|3|||
145752974|NCT02289950|525608279|FG000|Overall Study|Test article held for greater than 28 days|0|||
145752975|NCT02289950|525608280|FG001|Overall Study|Test article held for greater than 28 days|1|||
145752976|NCT02289950|525608279|FG000|Overall Study|Adverse Event|11|||
145752977|NCT02289950|525608280|FG001|Overall Study|Adverse Event|3|||
145752978|NCT02289950|525608279|FG000|Overall Study|Death|1|||
145752979|NCT02289950|525608280|FG001|Overall Study|Death|1|||
145752980|NCT02289950|525608279|FG000|Overall Study|Other|5|||
145752981|NCT02289950|525608280|FG001|Overall Study|Other|2|||
145752982|NCT02289950|525608279|FG000|Overall Study|Not Treated|2|||
145752983|NCT02289950|525608280|FG001|Overall Study|Not Treated|1|||
145752984|NCT04153188|525608285|FG000|Overall Study|Lost to Follow-up|1|||
145752985|NCT04153188|525608286|FG001|Overall Study|Lost to Follow-up|1|||
145752986|NCT04153188|525608285|FG000|Overall Study|Withdrawal by Subject|2|||
145752987|NCT04153188|525608286|FG001|Overall Study|Withdrawal by Subject|0|||
145752988|NCT04153188|525608285|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
145752989|NCT04153188|525608286|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
145752990|NCT01314716|525608288|FG000|Double-Blind Phase|Randomized but not treated|1|||
145752991|NCT01314716|525608289|FG001|Double-Blind Phase|Randomized but not treated|1|||
145752992|NCT01314716|525608288|FG000|Double-Blind Phase|Adverse Event|10|||
145752993|NCT01314716|525608289|FG001|Double-Blind Phase|Adverse Event|4|||
145752994|NCT01314716|525608288|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
145752995|NCT01314716|525608289|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
145752996|NCT01314716|525608288|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145752997|NCT01314716|525608289|FG001|Double-Blind Phase|Lost to Follow-up|1|||
145752998|NCT01314716|525608288|FG000|Double-Blind Phase|Sponsor request|1|||
145752999|NCT01314716|525608289|FG001|Double-Blind Phase|Sponsor request|2|||
145753000|NCT01314716|525608288|FG000|Double-Blind Phase|Physician Decision|0|||
145753001|NCT01314716|525608289|FG001|Double-Blind Phase|Physician Decision|1|||
145753002|NCT01314716|525608288|FG000|Open-Label Phase|Adverse Event|4|||
145753003|NCT01314716|525608289|FG001|Open-Label Phase|Adverse Event|6|||
145753004|NCT01314716|525608288|FG000|Open-Label Phase|Withdrawal by Subject|1|||
145753005|NCT01314716|525608289|FG001|Open-Label Phase|Withdrawal by Subject|2|||
145753006|NCT01314716|525608288|FG000|Open-Label Phase|Physician Decision|5|||
145753007|NCT01314716|525608289|FG001|Open-Label Phase|Physician Decision|4|||
145753008|NCT00700271|525608290|FG000|Overall Study|Adverse Event|4|||
145753009|NCT00700271|525608291|FG001|Overall Study|Adverse Event|6|||
145753010|NCT00700271|525608290|FG000|Overall Study|Protocol Violation|1|||
145753011|NCT00700271|525608291|FG001|Overall Study|Protocol Violation|0|||
145753012|NCT00700271|525608290|FG000|Overall Study|Administrative Reasons|1|||
145753013|NCT00700271|525608291|FG001|Overall Study|Administrative Reasons|0|||
145753014|NCT00700271|525608290|FG000|Overall Study|Withdrawal by Subject|6|||
145753015|NCT00700271|525608291|FG001|Overall Study|Withdrawal by Subject|4|||
145753016|NCT00700271|525608290|FG000|Overall Study|Lost to Follow-up|2|||
145753017|NCT00700271|525608291|FG001|Overall Study|Lost to Follow-up|2|||
145753018|NCT02028455|525608294|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753019|NCT02028455|525608295|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753020|NCT02028455|525608296|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753021|NCT02028455|525608297|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753022|NCT02028455|525608298|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753023|NCT02028455|525608299|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
145753024|NCT02028455|525608300|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
145753025|NCT02028455|525608301|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
145753026|NCT02028455|525608294|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
145753027|NCT02028455|525608295|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
145753028|NCT02028455|525608296|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
145753029|NCT02028455|525608297|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
145753030|NCT02028455|525608298|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
145753031|NCT02028455|525608299|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
145753032|NCT02028455|525608300|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
145753033|NCT02028455|525608301|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
145753034|NCT02028455|525608294|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753035|NCT02028455|525608295|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753036|NCT02028455|525608296|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753037|NCT02028455|525608297|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753038|NCT02028455|525608298|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753039|NCT02028455|525608299|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
145753040|NCT02028455|525608300|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
145753041|NCT02028455|525608301|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
145753042|NCT02028455|525608294|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
145753043|NCT02028455|525608295|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
145753044|NCT02028455|525608296|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
145753045|NCT02028455|525608297|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
145753046|NCT02028455|525608298|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
145753047|NCT02028455|525608299|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
145753048|NCT02028455|525608300|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
145753049|NCT02028455|525608301|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
145753050|NCT02396589|525608307|FG000|Intervention|Lost to Follow-up|1|||
145753051|NCT02396589|525608308|FG001|Intervention|Lost to Follow-up|0|||
145753052|NCT02396589|525608307|FG000|6 Month Follow-up|change in health status|0|||
145753053|NCT02396589|525608308|FG001|6 Month Follow-up|change in health status|1|||
145753054|NCT02396589|525608307|FG000|9 Month Follow-up|Death|0|||
145753055|NCT02396589|525608308|FG001|9 Month Follow-up|Death|1|||
145753056|NCT02396589|525608307|FG000|12 Month Follow up|Lost to Follow-up|0|||
145753057|NCT02396589|525608308|FG001|12 Month Follow up|Lost to Follow-up|2|||
145753058|NCT04179175|525610216|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
145753059|NCT04179175|525610217|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
145753060|NCT04179175|525610218|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
145753061|NCT04179175|525610219|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
145753062|NCT04179175|525610220|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
145753063|NCT04179175|525610221|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
145753064|NCT04179175|525610216|FG000|Overall Study|Adverse Event|5|||
145753065|NCT04179175|525610217|FG001|Overall Study|Adverse Event|3|||
145753066|NCT04179175|525610218|FG002|Overall Study|Adverse Event|3|||
145753067|NCT04179175|525610219|FG003|Overall Study|Adverse Event|4|||
145753068|NCT04179175|525610220|FG004|Overall Study|Adverse Event|6|||
145272284|NCT05013749|523844617|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
145272285|NCT05013749|523844616|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
145272286|NCT05013749|523844617|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
145272287|NCT02017535|523844620|FG000|Overall Study|Withdrawal by Subject|1|||
145402711|NCT00959751|524332461|FG000|Overall Study|Lost to Follow-up|2|||
145529799|NCT02310321|524800918|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
145529800|NCT02310321|524800919|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
145529801|NCT02310321|524800920|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
145529802|NCT02310321|524800918|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
145529803|NCT02310321|524800919|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
145753069|NCT04179175|525610221|FG005|Overall Study|Adverse Event|6|||
145753070|NCT04179175|525610216|FG000|Overall Study|Lack of Efficacy|5|||
145753071|NCT04179175|525610217|FG001|Overall Study|Lack of Efficacy|1|||
145529804|NCT02310321|524800920|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
145529805|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
145529806|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
145753072|NCT04179175|525610218|FG002|Overall Study|Lack of Efficacy|3|||
145753073|NCT04179175|525610219|FG003|Overall Study|Lack of Efficacy|2|||
145753074|NCT04179175|525610220|FG004|Overall Study|Lack of Efficacy|18|||
145753075|NCT04179175|525610221|FG005|Overall Study|Lack of Efficacy|7|||
145753076|NCT04179175|525610216|FG000|Overall Study|Lost to Follow-up|5|||
145753077|NCT04179175|525610217|FG001|Overall Study|Lost to Follow-up|3|||
145753078|NCT04179175|525610218|FG002|Overall Study|Lost to Follow-up|2|||
145753079|NCT04179175|525610219|FG003|Overall Study|Lost to Follow-up|2|||
145753080|NCT04179175|525610220|FG004|Overall Study|Lost to Follow-up|4|||
145753081|NCT04179175|525610221|FG005|Overall Study|Lost to Follow-up|5|||
145753082|NCT04179175|525610216|FG000|Overall Study|Physician Decision|2|||
145753083|NCT04179175|525610217|FG001|Overall Study|Physician Decision|0|||
145753084|NCT04179175|525610218|FG002|Overall Study|Physician Decision|2|||
145753085|NCT04179175|525610219|FG003|Overall Study|Physician Decision|3|||
145753086|NCT04179175|525610220|FG004|Overall Study|Physician Decision|1|||
145753087|NCT04179175|525610221|FG005|Overall Study|Physician Decision|1|||
145753088|NCT04179175|525610216|FG000|Overall Study|Pregnancy|3|||
145753089|NCT04179175|525610217|FG001|Overall Study|Pregnancy|0|||
145753090|NCT04179175|525610218|FG002|Overall Study|Pregnancy|3|||
145753091|NCT04179175|525610219|FG003|Overall Study|Pregnancy|0|||
145753092|NCT04179175|525610220|FG004|Overall Study|Pregnancy|1|||
145753093|NCT04179175|525610221|FG005|Overall Study|Pregnancy|2|||
145753094|NCT04179175|525610216|FG000|Overall Study|Withdrawal by Subject|22|||
145753095|NCT04179175|525610217|FG001|Overall Study|Withdrawal by Subject|10|||
145753096|NCT04179175|525610218|FG002|Overall Study|Withdrawal by Subject|12|||
145753097|NCT04179175|525610219|FG003|Overall Study|Withdrawal by Subject|8|||
145753098|NCT04179175|525610220|FG004|Overall Study|Withdrawal by Subject|23|||
145753099|NCT04179175|525610221|FG005|Overall Study|Withdrawal by Subject|31|||
145753100|NCT04179175|525610216|FG000|Overall Study|Technical problems|0|||
145753101|NCT04179175|525610217|FG001|Overall Study|Technical problems|0|||
145753102|NCT04179175|525610218|FG002|Overall Study|Technical problems|1|||
145753103|NCT04179175|525610219|FG003|Overall Study|Technical problems|1|||
145753104|NCT04179175|525610220|FG004|Overall Study|Technical problems|0|||
145753105|NCT04179175|525610221|FG005|Overall Study|Technical problems|0|||
145753106|NCT05593016|525610222|FG000|Overall Study|Death|1|||
145753107|NCT05593016|525610223|FG001|Overall Study|Death|1|||
145753108|NCT05593016|525610224|FG002|Overall Study|Death|1|||
145753109|NCT05593016|525610225|FG003|Overall Study|Death|0|||
145753110|NCT05593016|525610226|FG004|Overall Study|Death|0|||
145753111|NCT05593016|525610222|FG000|Overall Study|Lost to Follow-up|1|||
145753112|NCT05593016|525610223|FG001|Overall Study|Lost to Follow-up|1|||
145753113|NCT05593016|525610224|FG002|Overall Study|Lost to Follow-up|1|||
145753114|NCT05593016|525610225|FG003|Overall Study|Lost to Follow-up|2|||
145753115|NCT05593016|525610226|FG004|Overall Study|Lost to Follow-up|0|||
145753116|NCT04705051|525610227|FG000|Overall Study|Enrolled but not treated|1|||
145753117|NCT04705051|525610227|FG000|Overall Study|Study terminated by sponsor|23|||
145753118|NCT00598975|525610228|FG000|Overall Study|Adverse Event|1|||
145753119|NCT00598975|525610229|FG001|Overall Study|Adverse Event|1|||
145753120|NCT00598975|525610228|FG000|Overall Study|Brain metastases|1|||
145753121|NCT00598975|525610229|FG001|Overall Study|Brain metastases|0|||
145753122|NCT00598975|525610228|FG000|Overall Study|Withdrawal by Subject|1|||
145753123|NCT00598975|525610229|FG001|Overall Study|Withdrawal by Subject|1|||
145753124|NCT00598975|525610228|FG000|Overall Study|Withdrawal of consent|0|||
145753125|NCT00598975|525610229|FG001|Overall Study|Withdrawal of consent|1|||
145753126|NCT00598975|525610228|FG000|Overall Study|Disease progression|8|||
145753127|NCT00598975|525610229|FG001|Overall Study|Disease progression|3|||
145753128|NCT00598975|525610228|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
145753129|NCT00598975|525610229|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
145753130|NCT01178138|525610230|FG000|Overall Study|Lost to Follow-up|8|||
145753131|NCT01178138|525610230|FG000|Overall Study|Withdrawal by Subject|7|||
145753132|NCT01178138|525610230|FG000|Overall Study|Physician Decision|8|||
145753133|NCT01241708|525610231|FG000|Overall Study|Withdrawal by Subject|6|||
145753134|NCT01241708|525610231|FG000|Overall Study|Screen Failure|6|||
145753135|NCT01241708|525610231|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
145753136|NCT01241708|525610231|FG000|Overall Study|Lost to Follow-up|5|||
145753137|NCT02968810|525610234|FG000|Overall Study|Lost to Follow-up|1|||
145753138|NCT02968810|525610235|FG001|Overall Study|Lost to Follow-up|0|||
145753139|NCT02968810|525610234|FG000|Overall Study|Physician Decision|1|||
145753140|NCT02968810|525610235|FG001|Overall Study|Physician Decision|0|||
145753141|NCT02968810|525610234|FG000|Overall Study|Withdrawal by Subject|1|||
145753142|NCT02968810|525610235|FG001|Overall Study|Withdrawal by Subject|3|||
145753143|NCT02968810|525610234|FG000|Overall Study|Disease Progression|0|||
145753144|NCT02968810|525610235|FG001|Overall Study|Disease Progression|1|||
145753145|NCT01790503|525610236|FG000|Overall Study|Adverse Event|1|||
145753146|NCT01790503|525610237|FG001|Overall Study|Adverse Event|0|||
145753147|NCT01790503|525610238|FG002|Overall Study|Adverse Event|0|||
145753148|NCT01790503|525610239|FG003|Overall Study|Adverse Event|0|||
145753149|NCT01790503|525610240|FG004|Overall Study|Adverse Event|0|||
145753150|NCT01790503|525610241|FG005|Overall Study|Adverse Event|2|||
145753151|NCT01790503|525610242|FG006|Overall Study|Adverse Event|0|||
145753152|NCT01790503|525610243|FG007|Overall Study|Adverse Event|0|||
145753153|NCT01790503|525610244|FG008|Overall Study|Adverse Event|2|||
145753154|NCT01790503|525610245|FG009|Overall Study|Adverse Event|4|||
145753155|NCT01790503|525610246|FG010|Overall Study|Adverse Event|7|||
145753156|NCT01790503|525610236|FG000|Overall Study|Withdrawal by Subject|0|||
145753157|NCT01790503|525610237|FG001|Overall Study|Withdrawal by Subject|0|||
145753158|NCT01790503|525610238|FG002|Overall Study|Withdrawal by Subject|1|||
145753159|NCT01790503|525610239|FG003|Overall Study|Withdrawal by Subject|1|||
145753160|NCT01790503|525610240|FG004|Overall Study|Withdrawal by Subject|1|||
145753161|NCT01790503|525610241|FG005|Overall Study|Withdrawal by Subject|2|||
145753162|NCT01790503|525610242|FG006|Overall Study|Withdrawal by Subject|1|||
145753163|NCT01790503|525610243|FG007|Overall Study|Withdrawal by Subject|0|||
145753164|NCT01790503|525610244|FG008|Overall Study|Withdrawal by Subject|0|||
145753165|NCT01790503|525610245|FG009|Overall Study|Withdrawal by Subject|0|||
145753166|NCT01790503|525610246|FG010|Overall Study|Withdrawal by Subject|1|||
145753167|NCT01790503|525610236|FG000|Overall Study|Disease progression|2|||
145753168|NCT01790503|525610237|FG001|Overall Study|Disease progression|1|||
145753169|NCT01790503|525610238|FG002|Overall Study|Disease progression|0|||
145753170|NCT01790503|525610239|FG003|Overall Study|Disease progression|1|||
145753171|NCT01790503|525610240|FG004|Overall Study|Disease progression|2|||
145753172|NCT01790503|525610241|FG005|Overall Study|Disease progression|1|||
145753173|NCT01790503|525610242|FG006|Overall Study|Disease progression|0|||
145753174|NCT01790503|525610243|FG007|Overall Study|Disease progression|1|||
145753175|NCT01790503|525610244|FG008|Overall Study|Disease progression|0|||
145753176|NCT01790503|525610245|FG009|Overall Study|Disease progression|17|||
145529807|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
145529808|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
145529809|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
145529810|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
145753177|NCT01790503|525610246|FG010|Overall Study|Disease progression|7|||
145753178|NCT01790503|525610236|FG000|Overall Study|Protocol Violation|0|||
145753179|NCT01790503|525610237|FG001|Overall Study|Protocol Violation|0|||
145753180|NCT01790503|525610238|FG002|Overall Study|Protocol Violation|0|||
145753181|NCT01790503|525610239|FG003|Overall Study|Protocol Violation|0|||
145753182|NCT01790503|525610240|FG004|Overall Study|Protocol Violation|0|||
145753183|NCT01790503|525610241|FG005|Overall Study|Protocol Violation|0|||
145753184|NCT01790503|525610242|FG006|Overall Study|Protocol Violation|0|||
145753185|NCT01790503|525610243|FG007|Overall Study|Protocol Violation|0|||
145753186|NCT01790503|525610244|FG008|Overall Study|Protocol Violation|0|||
145753187|NCT01790503|525610245|FG009|Overall Study|Protocol Violation|1|||
145753188|NCT01790503|525610246|FG010|Overall Study|Protocol Violation|0|||
145753189|NCT01790503|525610236|FG000|Overall Study|Physician Decision|0|||
145753190|NCT01790503|525610237|FG001|Overall Study|Physician Decision|0|||
145753191|NCT01790503|525610238|FG002|Overall Study|Physician Decision|0|||
145753192|NCT01790503|525610239|FG003|Overall Study|Physician Decision|0|||
145753193|NCT01790503|525610240|FG004|Overall Study|Physician Decision|0|||
145753194|NCT01790503|525610241|FG005|Overall Study|Physician Decision|0|||
145753195|NCT01790503|525610242|FG006|Overall Study|Physician Decision|0|||
145753196|NCT01790503|525610243|FG007|Overall Study|Physician Decision|0|||
145753197|NCT01790503|525610244|FG008|Overall Study|Physician Decision|0|||
145753198|NCT01790503|525610245|FG009|Overall Study|Physician Decision|1|||
145753199|NCT01790503|525610246|FG010|Overall Study|Physician Decision|1|||
145753200|NCT01790503|525610236|FG000|Overall Study|Death|0|||
145753201|NCT01790503|525610237|FG001|Overall Study|Death|0|||
145753202|NCT01790503|525610238|FG002|Overall Study|Death|0|||
145753203|NCT01790503|525610239|FG003|Overall Study|Death|0|||
145753204|NCT01790503|525610240|FG004|Overall Study|Death|0|||
145753205|NCT01790503|525610241|FG005|Overall Study|Death|0|||
145753206|NCT01790503|525610242|FG006|Overall Study|Death|0|||
145753207|NCT01790503|525610243|FG007|Overall Study|Death|0|||
145753208|NCT01790503|525610244|FG008|Overall Study|Death|0|||
145753209|NCT01790503|525610245|FG009|Overall Study|Death|1|||
145753210|NCT01790503|525610246|FG010|Overall Study|Death|0|||
145753211|NCT01790503|525610236|FG000|Overall Study|Non Compliance|0|||
145753212|NCT01790503|525610237|FG001|Overall Study|Non Compliance|0|||
145753213|NCT01790503|525610238|FG002|Overall Study|Non Compliance|0|||
145753214|NCT01790503|525610239|FG003|Overall Study|Non Compliance|0|||
145753215|NCT01790503|525610240|FG004|Overall Study|Non Compliance|1|||
145753216|NCT01790503|525610241|FG005|Overall Study|Non Compliance|0|||
145753217|NCT01790503|525610242|FG006|Overall Study|Non Compliance|0|||
145753218|NCT01790503|525610243|FG007|Overall Study|Non Compliance|0|||
145753219|NCT01790503|525610244|FG008|Overall Study|Non Compliance|0|||
145753220|NCT01790503|525610245|FG009|Overall Study|Non Compliance|0|||
145753221|NCT01790503|525610246|FG010|Overall Study|Non Compliance|0|||
145753222|NCT01790503|525610236|FG000|Overall Study|Other|0|||
145753223|NCT01790503|525610237|FG001|Overall Study|Other|0|||
145753224|NCT01790503|525610238|FG002|Overall Study|Other|0|||
145753225|NCT01790503|525610239|FG003|Overall Study|Other|0|||
145753226|NCT01790503|525610240|FG004|Overall Study|Other|1|||
145753227|NCT01790503|525610241|FG005|Overall Study|Other|0|||
145753228|NCT01790503|525610242|FG006|Overall Study|Other|0|||
145753229|NCT01790503|525610243|FG007|Overall Study|Other|0|||
145753230|NCT01790503|525610244|FG008|Overall Study|Other|1|||
145753231|NCT01790503|525610245|FG009|Overall Study|Other|2|||
145753232|NCT01790503|525610246|FG010|Overall Study|Other|0|||
145753233|NCT00049673|525610247|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
145753234|NCT00049673|525610248|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
145753235|NCT01535729|525610249|FG000|Overall Study|Withdrawal by Subject|2|||
145753236|NCT01535729|525610249|FG000|Overall Study|Disease progression|230|||
145753237|NCT01535729|525610249|FG000|Overall Study|Discontinued treatment|25|||
145753238|NCT01535729|525610249|FG000|Overall Study|Lost to Follow-up|8|||
145753239|NCT01535729|525610249|FG000|Overall Study|Death|52|||
145753240|NCT01535729|525610249|FG000|Overall Study|Other|19|||
145753241|NCT01535729|525610249|FG000|Overall Study|Did not sign informed consent|1|||
145753242|NCT01535729|525610249|FG000|Overall Study|No previous chemotherapy|33|||
145272288|NCT02017535|523844621|FG001|Overall Study|Withdrawal by Subject|0|||
145753243|NCT01535729|525610249|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
145753244|NCT01535729|525610249|FG000|Overall Study|Protocol Violation|11|||
145272289|NCT02017535|523844622|FG002|Overall Study|Withdrawal by Subject|0|||
145272290|NCT02017535|523844623|FG003|Overall Study|Withdrawal by Subject|0|||
145272291|NCT03506425|523844624|FG000|Overall Study|Adverse Event|1|||
145272292|NCT03506425|523844625|FG001|Overall Study|Adverse Event|3|||
145272293|NCT03506425|523844626|FG002|Overall Study|Adverse Event|0|||
145272294|NCT03506425|523844624|FG000|Overall Study|Death|1|||
145272295|NCT03506425|523844625|FG001|Overall Study|Death|0|||
145272296|NCT03506425|523844626|FG002|Overall Study|Death|0|||
145272297|NCT03506425|523844624|FG000|Overall Study|Withdrawal by Subject|0|||
145272298|NCT03506425|523844625|FG001|Overall Study|Withdrawal by Subject|0|||
145272299|NCT03506425|523844626|FG002|Overall Study|Withdrawal by Subject|1|||
145272300|NCT03701516|523844627|FG000|Period 1|Lost to Follow-up|0|||
145272301|NCT03701516|523844628|FG001|Period 1|Lost to Follow-up|1|||
145272302|NCT03701516|523844627|FG000|Period 1|Adverse Event|0|||
145272303|NCT03701516|523844628|FG001|Period 1|Adverse Event|2|||
145272304|NCT03701516|523844627|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
145272305|NCT03701516|523844628|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
145272306|NCT03701516|523844627|FG000|Period 1|Non Compliance to Protocol|2|||
145272307|NCT03701516|523844628|FG001|Period 1|Non Compliance to Protocol|1|||
145272308|NCT03701516|523844627|FG000|Period 1|Withdrawal by Subject|0|||
145272309|NCT03701516|523844628|FG001|Period 1|Withdrawal by Subject|1|||
145272310|NCT03701516|523844627|FG000|Period 2|failed to meet all eligibility creiteria|1|||
145272311|NCT03701516|523844628|FG001|Period 2|failed to meet all eligibility creiteria|0|||
145272312|NCT03701516|523844627|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
145272313|NCT03701516|523844628|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
145272314|NCT03644927|523844631|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
145272315|NCT03644927|523844632|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
145272316|NCT02864953|523844635|FG000|Overall Study|Adverse Event|22|||
145272317|NCT02864953|523844636|FG001|Overall Study|Adverse Event|19|||
145272318|NCT02864953|523844635|FG000|Overall Study|Withdrawal by Subject|1|||
145272319|NCT02864953|523844636|FG001|Overall Study|Withdrawal by Subject|0|||
145272320|NCT02864953|523844635|FG000|Overall Study|Physician Decision|4|||
145272321|NCT02864953|523844636|FG001|Overall Study|Physician Decision|2|||
145272322|NCT02864953|523844635|FG000|Overall Study|Death|3|||
145272323|NCT02864953|523844636|FG001|Overall Study|Death|13|||
145272324|NCT02864953|523844635|FG000|Overall Study|Reason not specified|14|||
145272325|NCT02864953|523844636|FG001|Overall Study|Reason not specified|12|||
145272326|NCT02864953|523844635|FG000|Overall Study|Withdrew Prior to Dosing|9|||
145272327|NCT02864953|523844636|FG001|Overall Study|Withdrew Prior to Dosing|8|||
145272328|NCT00981019|523844637|FG000|Overall Study|Did not respond|65|||
145272329|NCT00981019|523844637|FG000|Overall Study|Did not match target population|94|||
145272330|NCT00981019|523844637|FG000|Overall Study|Inadvertent exclusion|239|||
145272331|NCT00981019|523844637|FG000|Overall Study|Hit the survey after closure|79|||
145272332|NCT05083559|523844638|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
145272333|NCT05083559|523844639|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
145272334|NCT05083559|523844638|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
145272335|NCT05083559|523844639|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
145272336|NCT05083559|523844638|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
145753245|NCT01535729|525610249|FG000|Overall Study|Screening failure|1|||
145753246|NCT01535729|525610249|FG000|Overall Study|Not treated|9|||
145272337|NCT05083559|523844639|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
145272338|NCT00621309|523844641|FG000|Overall Study|Withdrawal by Subject|2|||
145272339|NCT00621309|523844642|FG001|Overall Study|Withdrawal by Subject|0|||
145753247|NCT01535729|525610249|FG000|Overall Study|No participant record available|5|||
145753248|NCT02787850|525610252|FG000|Overall Study|Withdrawal by Subject|0|||
145753249|NCT02787850|525610253|FG001|Overall Study|Withdrawal by Subject|1|||
145753250|NCT00494091|525610254|FG000|Overall Study|Death|5|||
145272340|NCT00621309|523844643|FG002|Overall Study|Withdrawal by Subject|1|||
145272341|NCT00621309|523844644|FG003|Overall Study|Withdrawal by Subject|1|||
145272342|NCT00621309|523844645|FG004|Overall Study|Withdrawal by Subject|1|||
145272343|NCT00621309|523844646|FG005|Overall Study|Withdrawal by Subject|1|||
145272344|NCT01306968|523844647|FG000|Overall Study|Lost to Follow-up|1|||
145272345|NCT01306968|523844648|FG001|Overall Study|Lost to Follow-up|1|||
145753251|NCT00494091|525610255|FG001|Overall Study|Death|54|||
145272346|NCT01306968|523844649|FG002|Overall Study|Lost to Follow-up|0|||
145753252|NCT00494091|525610254|FG000|Overall Study|Lost to Follow-up|0|||
145753253|NCT00494091|525610255|FG001|Overall Study|Lost to Follow-up|4|||
145753254|NCT00494091|525610254|FG000|Overall Study|Other|1|||
145753255|NCT00494091|525610255|FG001|Overall Study|Other|11|||
145753256|NCT00494091|525610254|FG000|Overall Study|Withdrawal by Subject|0|||
145753257|NCT00494091|525610255|FG001|Overall Study|Withdrawal by Subject|7|||
145753258|NCT04161131|525610256|FG000|Overall Study|Ineligible|2|||
145753259|NCT04161131|525610256|FG000|Overall Study|Lost to Follow-up|4|||
145753260|NCT03733392|525610260|FG000|Overall Study|Withdrawal by Subject|11|||
145753261|NCT03733392|525610261|FG001|Overall Study|Withdrawal by Subject|1|||
145753262|NCT03733392|525610260|FG000|Overall Study|Death|1|||
145753263|NCT03733392|525610261|FG001|Overall Study|Death|0|||
145753264|NCT03733392|525610260|FG000|Overall Study|Lost to Follow-up|5|||
145753265|NCT03733392|525610261|FG001|Overall Study|Lost to Follow-up|0|||
145753266|NCT03733392|525610260|FG000|Overall Study|Protocol Violation|0|||
145753267|NCT03733392|525610261|FG001|Overall Study|Protocol Violation|1|||
145753268|NCT03733392|525610260|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
145753269|NCT03733392|525610261|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
145753270|NCT03733392|525610260|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
145753271|NCT03733392|525610261|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
145753272|NCT03733392|525610260|FG000|Overall Study|Patient Non-Compliance|2|||
145753273|NCT03733392|525610261|FG001|Overall Study|Patient Non-Compliance|1|||
145529811|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
145529812|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
145529813|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
145529814|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
145529815|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
145753274|NCT03733392|525610260|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
145753275|NCT03733392|525610261|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
145753276|NCT03733392|525610260|FG000|Overall Study|Withdrawal prior to procedure|5|||
145753277|NCT03733392|525610261|FG001|Overall Study|Withdrawal prior to procedure|2|||
145753278|NCT00130832|525610262|FG000|Overall Study|Adverse Event|1|||
145753279|NCT00130832|525610263|FG001|Overall Study|Adverse Event|1|||
145753280|NCT00130832|525610262|FG000|Overall Study|Lost to Follow-up|1|||
145753281|NCT00130832|525610263|FG001|Overall Study|Lost to Follow-up|2|||
145753282|NCT00130832|525610262|FG000|Overall Study|Protocol Violation|6|||
145753283|NCT00130832|525610263|FG001|Overall Study|Protocol Violation|8|||
145753284|NCT00130832|525610262|FG000|Overall Study|Withdrawal by Subject|6|||
145753285|NCT00130832|525610263|FG001|Overall Study|Withdrawal by Subject|1|||
145753286|NCT00130832|525610262|FG000|Overall Study|Moved|2|||
145753287|NCT00130832|525610263|FG001|Overall Study|Moved|2|||
145753288|NCT00130832|525610262|FG000|Overall Study|Other|0|||
145753289|NCT00130832|525610263|FG001|Overall Study|Other|3|||
145753290|NCT03905863|525610264|FG000|Overall Study|Adverse Event|2|||
145753291|NCT03905863|525610265|FG001|Overall Study|Adverse Event|4|||
145753292|NCT03905863|525610264|FG000|Overall Study|Withdrawal by Subject|2|||
145753293|NCT03905863|525610265|FG001|Overall Study|Withdrawal by Subject|2|||
145753294|NCT03905863|525610264|FG000|Overall Study|Physician Decision|0|||
145753295|NCT03905863|525610265|FG001|Overall Study|Physician Decision|3|||
145753296|NCT03905863|525610264|FG000|Overall Study|Lost to Follow-up|1|||
145753297|NCT03905863|525610265|FG001|Overall Study|Lost to Follow-up|0|||
145753298|NCT03905863|525610264|FG000|Overall Study|Protocol Violation|0|||
145753299|NCT03905863|525610265|FG001|Overall Study|Protocol Violation|2|||
145753300|NCT03905863|525610264|FG000|Overall Study|Death|0|||
145753301|NCT03905863|525610265|FG001|Overall Study|Death|1|||
145753302|NCT00984204|525610267|FG000|Overall Study|Death|1|||
145753303|NCT00984204|525610267|FG000|Overall Study|Lost to Follow-up|4|||
145753304|NCT00984204|525610267|FG000|Overall Study|Lack of Efficacy|10|||
145753305|NCT04401267|525610274|FG000|Overall Study|Death|0|||
145753306|NCT04401267|525610275|FG001|Overall Study|Death|1|||
145753307|NCT04401267|525610274|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
145753308|NCT04401267|525610275|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
145753309|NCT04401267|525610274|FG000|Overall Study|Found to be Ineligible|1|||
145753310|NCT04401267|525610275|FG001|Overall Study|Found to be Ineligible|0|||
145753311|NCT00559507|525610276|FG000|Overall Study|Not treated, patient ineligible|3|||
145753312|NCT05702515|525610277|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
145753313|NCT01784965|525610278|FG000|Overall Study|Withdrawal by Subject|6|||
145753314|NCT01784965|525610279|FG001|Overall Study|Withdrawal by Subject|3|||
145753315|NCT01784965|525610278|FG000|Overall Study|Adverse Event|0|||
145753316|NCT01784965|525610279|FG001|Overall Study|Adverse Event|8|||
145753317|NCT03757988|525610282|FG000|Overall Study|Withdrawal by Subject|1|||
145753318|NCT03806127|525610283|FG000|Overall Study|Withdrawal by Subject|4|||
145753319|NCT03806127|525610284|FG001|Overall Study|Withdrawal by Subject|5|||
145753320|NCT03806127|525610283|FG000|Overall Study|Protocol Violation|3|||
145753321|NCT03806127|525610284|FG001|Overall Study|Protocol Violation|1|||
145753322|NCT03806127|525610283|FG000|Overall Study|Adverse Event|3|||
145753323|NCT03806127|525610284|FG001|Overall Study|Adverse Event|0|||
145753324|NCT03806127|525610283|FG000|Overall Study|Unable to Complete Procedures|0|||
145753325|NCT03806127|525610284|FG001|Overall Study|Unable to Complete Procedures|1|||
145753326|NCT03806127|525610283|FG000|Overall Study|Pregnancy|0|||
145753327|NCT03806127|525610284|FG001|Overall Study|Pregnancy|1|||
145753328|NCT03806127|525610283|FG000|Overall Study|Lost to Follow-up|5|||
145753329|NCT03806127|525610284|FG001|Overall Study|Lost to Follow-up|1|||
145753330|NCT03806127|525610283|FG000|Overall Study|Physician Decision|1|||
145753331|NCT03806127|525610284|FG001|Overall Study|Physician Decision|1|||
145753332|NCT03806127|525610283|FG000|Overall Study|Could Not Come Due to Covid|1|||
145753333|NCT03806127|525610284|FG001|Overall Study|Could Not Come Due to Covid|0|||
145753334|NCT03806127|525610283|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
145753335|NCT03806127|525610284|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
145753336|NCT03806127|525610283|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
145753337|NCT03806127|525610284|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
145753338|NCT03806127|525610283|FG000|Overall Study|Covid 19 Restrictions|2|||
145753339|NCT03806127|525610284|FG001|Overall Study|Covid 19 Restrictions|0|||
145753340|NCT03806127|525610283|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
145753341|NCT03806127|525610284|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
145753342|NCT03806127|525610283|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
145753343|NCT03806127|525610284|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
145753344|NCT01121393|525610285|FG000|Overall Study|Progressive disease|201|||
145753345|NCT01121393|525610286|FG001|Overall Study|Progressive disease|20|||
145753346|NCT01121393|525610285|FG000|Overall Study|Other Adverse events|24|||
145753347|NCT01121393|525610286|FG001|Overall Study|Other Adverse events|45|||
145753348|NCT01121393|525610285|FG000|Overall Study|Non-compliant with protocol|0|||
145753349|NCT01121393|525610286|FG001|Overall Study|Non-compliant with protocol|3|||
145753350|NCT01121393|525610285|FG000|Overall Study|Lost to Follow-up|1|||
145753351|NCT01121393|525610286|FG001|Overall Study|Lost to Follow-up|0|||
145753352|NCT01121393|525610285|FG000|Overall Study|Refused cont. medication|7|||
145753353|NCT01121393|525610286|FG001|Overall Study|Refused cont. medication|7|||
145753354|NCT01121393|525610285|FG000|Overall Study|Not treated|3|||
145753355|NCT01121393|525610286|FG001|Overall Study|Not treated|9|||
145753356|NCT01121393|525610285|FG000|Overall Study|Other than listed|6|||
145753357|NCT01121393|525610286|FG001|Overall Study|Other than listed|0|||
145753358|NCT04372927|525610289|FG000|Overall Study|Death|1|||
145753359|NCT01847885|525610296|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
145753360|NCT01847885|525610297|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
145753361|NCT01847885|525610298|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
145753362|NCT01847885|525610296|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
145753363|NCT01847885|525610297|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
145753364|NCT01847885|525610298|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
145753365|NCT01847885|525610296|FG000|Initial Enrollment (Consented)|Screen failure|39|||
145753366|NCT01847885|525610297|FG001|Initial Enrollment (Consented)|Screen failure|0|||
145753367|NCT01847885|525610298|FG002|Initial Enrollment (Consented)|Screen failure|0|||
145529816|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
145529817|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
145529818|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
145529819|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
145529820|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
145529821|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
145529822|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
145529823|NCT02310321|524800918|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
145529824|NCT02310321|524800919|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
145529825|NCT02310321|524800920|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
145529826|NCT02310321|524800918|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
145529827|NCT02310321|524800919|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
145529828|NCT02310321|524800920|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
145529829|NCT02310321|524800918|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
145529830|NCT02310321|524800919|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
145529831|NCT02310321|524800920|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
145529832|NCT02310321|524800918|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
145529833|NCT02310321|524800919|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
145529834|NCT02310321|524800920|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
145529835|NCT02310321|524800918|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
145529836|NCT02310321|524800919|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
145529837|NCT02310321|524800920|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
145529838|NCT02310321|524800918|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
145529839|NCT02310321|524800919|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
145529840|NCT02310321|524800920|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
145529841|NCT02310321|524800918|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
145529842|NCT02310321|524800919|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
145529843|NCT02310321|524800920|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
145529844|NCT02310321|524800918|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
145529845|NCT02310321|524800919|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
145529846|NCT02310321|524800920|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
145529847|NCT02310321|524800918|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
145529848|NCT02310321|524800919|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
145529849|NCT02310321|524800920|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
145529850|NCT01698905|524800921|FG000|Overall Study|Adverse Event|4|||
145529851|NCT01698905|524800921|FG000|Overall Study|Physician Decision|2|||
145529852|NCT01698905|524800921|FG000|Overall Study|Pregnancy|1|||
145529853|NCT01698905|524800921|FG000|Overall Study|Protocol Violation|1|||
145529854|NCT01698905|524800921|FG000|Overall Study|Subject/guardian decision|2|||
145529855|NCT01698905|524800921|FG000|Overall Study|Death|1|||
145529856|NCT00764504|524800923|FG000|Overall Study|Death|12|||
145529857|NCT00764504|524800924|FG001|Overall Study|Death|6|||
145529858|NCT00764504|524800925|FG002|Overall Study|Death|13|||
145529859|NCT00764504|524800923|FG000|Overall Study|Revision of Device|12|||
145529860|NCT00764504|524800924|FG001|Overall Study|Revision of Device|23|||
145529861|NCT00764504|524800925|FG002|Overall Study|Revision of Device|14|||
145529862|NCT00764504|524800923|FG000|Overall Study|Physician Decision|1|||
145529863|NCT00764504|524800924|FG001|Overall Study|Physician Decision|0|||
145529864|NCT00764504|524800925|FG002|Overall Study|Physician Decision|0|||
145529865|NCT00764504|524800923|FG000|Overall Study|Withdrawal by Subject|1|||
145529866|NCT00764504|524800924|FG001|Overall Study|Withdrawal by Subject|7|||
145529867|NCT00764504|524800925|FG002|Overall Study|Withdrawal by Subject|4|||
145529868|NCT00764504|524800923|FG000|Overall Study|Lost to Follow-up|40|||
145529869|NCT00764504|524800924|FG001|Overall Study|Lost to Follow-up|34|||
145529870|NCT00764504|524800925|FG002|Overall Study|Lost to Follow-up|72|||
145529871|NCT02456103|524800926|FG000|Overall Study|Study Closure|207|||
145529872|NCT02456103|524800926|FG000|Overall Study|Physician Decision|1|||
145529873|NCT02456103|524800926|FG000|Overall Study|Required prohibited medications|5|||
145529874|NCT02456103|524800926|FG000|Overall Study|Protocol Violation|1|||
145529875|NCT02456103|524800926|FG000|Overall Study|Adverse Event|5|||
145529876|NCT02456103|524800926|FG000|Overall Study|Abnormal Laboratory Value|2|||
145529877|NCT02456103|524800926|FG000|Overall Study|Lost to Follow-up|1|||
145529878|NCT02456103|524800926|FG000|Overall Study|Withdrawal by Subject|24|||
145529879|NCT04010539|524800927|FG000|Overall Study|Withdrawal by Subject|4|||
145753368|NCT01847885|525610296|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
145753369|NCT01847885|525610297|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
145753370|NCT01847885|525610298|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
145753371|NCT01847885|525610296|FG000|Randomization|Protocol Violation|0|||
145272347|NCT01306968|523844650|FG003|Overall Study|Lost to Follow-up|0|||
145272348|NCT01306968|523844647|FG000|Overall Study|Physician Decision|0|||
145272349|NCT01306968|523844648|FG001|Overall Study|Physician Decision|1|||
145272350|NCT01306968|523844649|FG002|Overall Study|Physician Decision|0|||
145272351|NCT01306968|523844650|FG003|Overall Study|Physician Decision|0|||
145272352|NCT01306968|523844647|FG000|Overall Study|Relocated and left active duty|0|||
145272353|NCT01306968|523844648|FG001|Overall Study|Relocated and left active duty|1|||
145272354|NCT01306968|523844649|FG002|Overall Study|Relocated and left active duty|1|||
145272355|NCT01306968|523844650|FG003|Overall Study|Relocated and left active duty|1|||
145272356|NCT01306968|523844647|FG000|Overall Study|Withdrew - time commitment|0|||
145272357|NCT01306968|523844648|FG001|Overall Study|Withdrew - time commitment|0|||
145272358|NCT01306968|523844649|FG002|Overall Study|Withdrew - time commitment|0|||
145272359|NCT01306968|523844650|FG003|Overall Study|Withdrew - time commitment|2|||
145272360|NCT01306968|523844647|FG000|Overall Study|Withdrew over privacy concerns|0|||
145272361|NCT01306968|523844648|FG001|Overall Study|Withdrew over privacy concerns|0|||
145272362|NCT01306968|523844649|FG002|Overall Study|Withdrew over privacy concerns|0|||
145272363|NCT01306968|523844650|FG003|Overall Study|Withdrew over privacy concerns|1|||
145272364|NCT01329562|523844651|FG000|Overall Study|Protocol Violation|5|||
145272365|NCT01329562|523844652|FG001|Overall Study|Protocol Violation|3|||
145272366|NCT01329562|523844651|FG000|Overall Study|Lost to Follow-up|1|||
145272367|NCT01329562|523844652|FG001|Overall Study|Lost to Follow-up|1|||
145272368|NCT01329562|523844651|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
145272369|NCT01329562|523844652|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
145272370|NCT01329562|523844651|FG000|Overall Study|Physician Decision|0|||
145272371|NCT01329562|523844652|FG001|Overall Study|Physician Decision|1|||
145272372|NCT00061568|523844653|FG000|Overall Study|Lost to Follow-up|12|||
145272373|NCT00061568|523844654|FG001|Overall Study|Lost to Follow-up|0|||
145272374|NCT00061568|523844653|FG000|Overall Study|Death|6|||
145272375|NCT00061568|523844654|FG001|Overall Study|Death|0|||
145272376|NCT00061568|523844653|FG000|Overall Study|Withdrawal by Subject|1|||
145272377|NCT00061568|523844654|FG001|Overall Study|Withdrawal by Subject|0|||
145272378|NCT01381068|523844655|FG000|Overall Study|Death|1|||
145272379|NCT01381068|523844656|FG001|Overall Study|Death|0|||
145272380|NCT00797316|523844657|FG000|Overall Study|Administrative problems|1|||
145272381|NCT00797316|523844658|FG001|Overall Study|Administrative problems|0|||
145272382|NCT00797316|523844657|FG000|Overall Study|Adverse Event|5|||
145272383|NCT00797316|523844658|FG001|Overall Study|Adverse Event|3|||
145272384|NCT00797316|523844657|FG000|Overall Study|Lost to Follow-up|4|||
145272385|NCT00797316|523844658|FG001|Overall Study|Lost to Follow-up|8|||
145272386|NCT00797316|523844657|FG000|Overall Study|Protocol Deviation|1|||
145272387|NCT00797316|523844658|FG001|Overall Study|Protocol Deviation|2|||
145272388|NCT00797316|523844657|FG000|Overall Study|Patient withdrew consent|12|||
145272389|NCT00797316|523844658|FG001|Overall Study|Patient withdrew consent|6|||
145272390|NCT00797316|523844657|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145272391|NCT00797316|523844658|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145272392|NCT03239340|523844665|FG000|Overall Study|Other|26|||
145272393|NCT03239340|523844665|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
145272394|NCT03239340|523844665|FG000|Overall Study|Death|40|||
145272395|NCT03239340|523844665|FG000|Overall Study|Lost to Follow-up|2|||
145272396|NCT03239340|523844665|FG000|Overall Study|Physician Decision|16|||
145272397|NCT03239340|523844665|FG000|Overall Study|Withdrawal by Subject|27|||
145272398|NCT02061293|523844671|FG000|Overall Study|Elevated Blood Pressure|1|||
145272399|NCT02061293|523844672|FG001|Overall Study|Elevated Blood Pressure|1|||
145272400|NCT00690573|523844674|FG000|Overall Study|Lack of Efficacy|8|||
145402712|NCT00959751|524332462|FG001|Overall Study|Lost to Follow-up|3|||
145402713|NCT00959751|524332461|FG000|Overall Study|Consent Withdrawn|0|||
145402714|NCT00959751|524332462|FG001|Overall Study|Consent Withdrawn|1|||
145529880|NCT04010539|524800928|FG001|Overall Study|Withdrawal by Subject|1|||
145529881|NCT04010539|524800927|FG000|Overall Study|Physician Decision|0|||
145529882|NCT04010539|524800928|FG001|Overall Study|Physician Decision|2|||
145529883|NCT04010539|524800927|FG000|Overall Study|Lost to Follow-up|10|||
145753372|NCT01847885|525610297|FG001|Randomization|Protocol Violation|1|||
145753373|NCT01847885|525610298|FG002|Randomization|Protocol Violation|0|||
145272401|NCT00690573|523844674|FG000|Overall Study|Withdrawal by Subject|1|||
145272402|NCT02332655|523844675|FG000|Overall Study|Lack of Efficacy|1|||
145272403|NCT01298661|523844676|FG000|Overall Study|Withdrawal by Subject|2|||
145529884|NCT04010539|524800928|FG001|Overall Study|Lost to Follow-up|14|||
145753374|NCT01847885|525610296|FG000|Randomization|Withdrawal by Subject|0|||
145272404|NCT01298661|523844677|FG001|Overall Study|Withdrawal by Subject|0|||
145272405|NCT01298661|523844678|FG002|Overall Study|Withdrawal by Subject|2|||
145272406|NCT02886494|523846164|FG000|Overall Study|Adverse Event|1|||
145272407|NCT02886494|523846165|FG001|Overall Study|Adverse Event|0|||
145402715|NCT00959751|524332461|FG000|Overall Study|Non-compliance to Study Procedures|0|||
145529885|NCT04010539|524800927|FG000|Overall Study|Adverse Event|3|||
145529886|NCT04010539|524800928|FG001|Overall Study|Adverse Event|0|||
145529887|NCT04010539|524800927|FG000|Overall Study|Participant Did Not Receive IP|0|||
145529888|NCT04010539|524800928|FG001|Overall Study|Participant Did Not Receive IP|1|||
145529889|NCT04010539|524800927|FG000|Overall Study|Protocol Deviation|0|||
145529890|NCT04010539|524800928|FG001|Overall Study|Protocol Deviation|1|||
145529891|NCT04010539|524800927|FG000|Overall Study|Randomized in Error/ Mistake|2|||
145529892|NCT04010539|524800928|FG001|Overall Study|Randomized in Error/ Mistake|0|||
145529893|NCT04010539|524800927|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
145529894|NCT04010539|524800928|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
145529895|NCT00249288|524800929|FG000|Overall Study|Lost to Follow-up|3|||
145529896|NCT00249288|524800930|FG001|Overall Study|Lost to Follow-up|3|||
145529897|NCT00249288|524800929|FG000|Overall Study|Withdrawal by Subject|2|||
145529898|NCT00249288|524800930|FG001|Overall Study|Withdrawal by Subject|2|||
145529899|NCT03059446|524800931|FG000|Overall Study|Adverse Event|11|||
145529900|NCT03059446|524800931|FG000|Overall Study|Withdrawal of Consent|16|||
145529901|NCT03059446|524800931|FG000|Overall Study|Lost to Follow-up|3|||
145529902|NCT03059446|524800931|FG000|Overall Study|Protocol Violation|1|||
145529903|NCT03059446|524800931|FG000|Overall Study|Study Terminated by Sponsor|131|||
145529904|NCT03059446|524800931|FG000|Overall Study|Reason not Specified|5|||
145529905|NCT02001181|524800937|FG000|Overall Study|Adverse Event|0|||
145529906|NCT02001181|524800938|FG001|Overall Study|Adverse Event|2|||
145529907|NCT02001181|524800937|FG000|Overall Study|Lost to Follow-up|1|||
145529908|NCT02001181|524800938|FG001|Overall Study|Lost to Follow-up|0|||
145529909|NCT02001181|524800937|FG000|Overall Study|Withdrawal by Subject|0|||
145529910|NCT02001181|524800938|FG001|Overall Study|Withdrawal by Subject|1|||
145529911|NCT01090973|524800939|FG000|Overall Study|Disease progression|1|||
145529912|NCT02766465|524800940|FG000|Overall Study|Withdrawal by Subject|0|||
145529913|NCT02766465|524800941|FG001|Overall Study|Withdrawal by Subject|10|||
145529914|NCT02435069|524800942|FG000|Dose Response - First Intervention|Adverse Event|0|||
145529915|NCT02435069|524800943|FG001|Dose Response - First Intervention|Adverse Event|1|||
145529916|NCT02435069|524800944|FG002|Dose Response - First Intervention|Adverse Event|1|||
145529917|NCT02435069|524800945|FG003|Dose Response - First Intervention|Adverse Event|0|||
145529918|NCT02435069|524800946|FG004|Dose Response - First Intervention|Adverse Event|0|||
145529919|NCT02435069|524800942|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
145529920|NCT02435069|524800943|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
145529921|NCT02435069|524800944|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
145529922|NCT02435069|524800945|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
145529923|NCT02435069|524800946|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
145529924|NCT00171054|524800954|FG000|Overall Study|Protocol Violation|1|||
145529925|NCT00171054|524800955|FG001|Overall Study|Protocol Violation|2|||
145529926|NCT00171054|524800954|FG000|Overall Study|Patient withdrew consent|1|||
145529927|NCT00171054|524800955|FG001|Overall Study|Patient withdrew consent|0|||
145529928|NCT00171054|524800954|FG000|Overall Study|Lost to Follow-up|0|||
145529929|NCT00171054|524800955|FG001|Overall Study|Lost to Follow-up|1|||
145529930|NCT00171054|524800954|FG000|Overall Study|Adverse Event|8|||
145529931|NCT00171054|524800955|FG001|Overall Study|Adverse Event|8|||
145529932|NCT00171054|524800954|FG000|Overall Study|Condition no longer required study drug|0|||
145529933|NCT00171054|524800955|FG001|Overall Study|Condition no longer required study drug|1|||
145529934|NCT01074047|524800962|FG000|Treatment Phase|Adverse Event|89|||
145529935|NCT01074047|524800963|FG001|Treatment Phase|Adverse Event|66|||
145529936|NCT01074047|524800962|FG000|Treatment Phase|Disease Progression|16|||
145529937|NCT01074047|524800963|FG001|Treatment Phase|Disease Progression|21|||
145529938|NCT01074047|524800962|FG000|Treatment Phase|Withdrawal by Subject|27|||
145529939|NCT01074047|524800963|FG001|Treatment Phase|Withdrawal by Subject|48|||
145529940|NCT01074047|524800962|FG000|Treatment Phase|Death|53|||
145529941|NCT01074047|524800963|FG001|Treatment Phase|Death|58|||
145529942|NCT01074047|524800962|FG000|Treatment Phase|Lost to Follow-up|0|||
145529943|NCT01074047|524800963|FG001|Treatment Phase|Lost to Follow-up|1|||
145529944|NCT01074047|524800962|FG000|Treatment Phase|Protocol Violation|0|||
145529945|NCT01074047|524800963|FG001|Treatment Phase|Protocol Violation|1|||
145529946|NCT01074047|524800962|FG000|Treatment Phase|Miscellaneous|32|||
145529947|NCT01074047|524800963|FG001|Treatment Phase|Miscellaneous|39|||
145529948|NCT01074047|524800962|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
145529949|NCT01074047|524800963|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
145529950|NCT01074047|524800962|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
145529951|NCT01074047|524800963|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
145529952|NCT01074047|524800962|FG000|Survival Follow-Up Phase|Death|116|||
145529953|NCT01074047|524800963|FG001|Survival Follow-Up Phase|Death|124|||
145529954|NCT01074047|524800962|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
145753375|NCT01847885|525610297|FG001|Randomization|Withdrawal by Subject|0|||
145529955|NCT01074047|524800963|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
145529956|NCT01074047|524800962|FG000|Extension Phase|Physician Decision|1|||
145529957|NCT01074047|524800963|FG001|Extension Phase|Physician Decision|0|||
145529958|NCT01074047|524800962|FG000|Extension Phase|Adverse Event|5|||
145529959|NCT01074047|524800963|FG001|Extension Phase|Adverse Event|0|||
145529960|NCT01074047|524800962|FG000|Extension Phase|Disease Progression|9|||
145529961|NCT01074047|524800963|FG001|Extension Phase|Disease Progression|0|||
145529962|NCT01074047|524800962|FG000|Extension Phase|Withdrawal by Subject|2|||
145529963|NCT01074047|524800963|FG001|Extension Phase|Withdrawal by Subject|0|||
145529964|NCT01074047|524800962|FG000|Extension Phase|Death|5|||
145529965|NCT01074047|524800963|FG001|Extension Phase|Death|0|||
145529966|NCT03635788|524800965|FG000|Step 1|Death|1|||
145529967|NCT03635788|524800966|FG001|Step 1|Death|0|||
145529968|NCT03635788|524800967|FG002|Step 1|Death|0|||
145529969|NCT03635788|524800965|FG000|Step 1|Lost to Follow-up|31|||
145529970|NCT03635788|524800966|FG001|Step 1|Lost to Follow-up|0|||
145529971|NCT03635788|524800967|FG002|Step 1|Lost to Follow-up|0|||
145529972|NCT03635788|524800965|FG000|Step 1|Pregnancy|1|||
145529973|NCT03635788|524800966|FG001|Step 1|Pregnancy|0|||
145529974|NCT03635788|524800967|FG002|Step 1|Pregnancy|0|||
145529975|NCT03635788|524800965|FG000|Step 1|Protocol Violation|8|||
145529976|NCT03635788|524800966|FG001|Step 1|Protocol Violation|0|||
145529977|NCT03635788|524800967|FG002|Step 1|Protocol Violation|0|||
145529978|NCT03635788|524800965|FG000|Step 1|Withdrawal by Subject|13|||
145529979|NCT03635788|524800966|FG001|Step 1|Withdrawal by Subject|0|||
145529980|NCT03635788|524800967|FG002|Step 1|Withdrawal by Subject|0|||
145529981|NCT03635788|524800965|FG000|Step 1|Other reasons|12|||
145529982|NCT03635788|524800966|FG001|Step 1|Other reasons|0|||
145529983|NCT03635788|524800967|FG002|Step 1|Other reasons|0|||
145529984|NCT03635788|524800965|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
145529985|NCT03635788|524800966|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
145529986|NCT03635788|524800967|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
145529987|NCT03635788|524800965|FG000|Step 2|Lost to Follow-up|0|||
145529988|NCT03635788|524800966|FG001|Step 2|Lost to Follow-up|8|||
145529989|NCT03635788|524800967|FG002|Step 2|Lost to Follow-up|15|||
145529990|NCT03635788|524800965|FG000|Step 2|Withdrawal by Subject|0|||
145529991|NCT03635788|524800966|FG001|Step 2|Withdrawal by Subject|6|||
145529992|NCT03635788|524800967|FG002|Step 2|Withdrawal by Subject|6|||
145529993|NCT03635788|524800965|FG000|Step 2|Death|0|||
145529994|NCT03635788|524800966|FG001|Step 2|Death|2|||
145529995|NCT03635788|524800967|FG002|Step 2|Death|0|||
145529996|NCT03635788|524800965|FG000|Step 2|Incarceration|0|||
145529997|NCT03635788|524800966|FG001|Step 2|Incarceration|2|||
145529998|NCT03635788|524800967|FG002|Step 2|Incarceration|0|||
145529999|NCT03635788|524800965|FG000|Step 2|Non-Compliance With Study Requirements|0|||
145530000|NCT03635788|524800966|FG001|Step 2|Non-Compliance With Study Requirements|1|||
145530001|NCT03635788|524800967|FG002|Step 2|Non-Compliance With Study Requirements|1|||
145530002|NCT03635788|524800965|FG000|Step 2|Confounding Medical Condition|0|||
145530003|NCT03635788|524800966|FG001|Step 2|Confounding Medical Condition|0|||
145530004|NCT03635788|524800967|FG002|Step 2|Confounding Medical Condition|1|||
145530005|NCT03635788|524800965|FG000|Step 2|Out Of State With No Plan To Return|0|||
145530006|NCT03635788|524800966|FG001|Step 2|Out Of State With No Plan To Return|1|||
145530007|NCT03635788|524800967|FG002|Step 2|Out Of State With No Plan To Return|0|||
145530008|NCT03635788|524800965|FG000|Step 2|Switched To Injectables|0|||
145530009|NCT03635788|524800966|FG001|Step 2|Switched To Injectables|0|||
145530010|NCT03635788|524800967|FG002|Step 2|Switched To Injectables|1|||
145530011|NCT03635788|524800965|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
145530012|NCT03635788|524800966|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
145530013|NCT03635788|524800967|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
145530014|NCT01015131|524800968|FG000|Overall Study|Physician Decision|1|||
145530015|NCT01015131|524800968|FG000|Overall Study|Protocol Violation|1|||
145753376|NCT01847885|525610298|FG002|Randomization|Withdrawal by Subject|2|||
145753377|NCT01847885|525610296|FG000|Randomization|Screen Failure|0|||
145753378|NCT01847885|525610297|FG001|Randomization|Screen Failure|3|||
145753379|NCT01847885|525610298|FG002|Randomization|Screen Failure|0|||
145753380|NCT03033745|525610301|FG000|Overall Study|Protocol Violation|0|||
145753381|NCT03033745|525610302|FG001|Overall Study|Protocol Violation|0|||
145753382|NCT03033745|525610303|FG002|Overall Study|Protocol Violation|1|||
145530016|NCT01015131|524800968|FG000|Overall Study|Withdrawal by Subject|2|||
145753383|NCT03033745|525610301|FG000|Overall Study|Adverse Event|1|||
145753384|NCT03033745|525610302|FG001|Overall Study|Adverse Event|0|||
145530017|NCT01015131|524800968|FG000|Overall Study|Other Protocol Specified Criteria|4|||
145530018|NCT05521906|524800973|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
145530019|NCT05521906|524800974|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
145530020|NCT00810108|524801946|FG000|Overall Study|Withdrawal by Subject|1|||
145530021|NCT00810108|524801947|FG001|Overall Study|Withdrawal by Subject|0|||
145530022|NCT02923427|524801951|FG000|Overall Study|convert to laparatomy|2|||
145530023|NCT02923427|524801952|FG001|Overall Study|convert to laparatomy|2|||
145530024|NCT02923427|524801951|FG000|Overall Study|destaturation|1|||
145530025|NCT02923427|524801952|FG001|Overall Study|destaturation|0|||
145530026|NCT02923427|524801951|FG000|Overall Study|can not replace LMA|1|||
145530027|NCT02923427|524801952|FG001|Overall Study|can not replace LMA|0|||
145530028|NCT01325623|524801953|FG000|Overall Study|Withdrawal by Subject|3|||
145530029|NCT01539642|524801958|FG000|Overall Study|Lack of Efficacy|20|||
145272408|NCT02886494|523846164|FG000|Overall Study|Withdrawal by Subject|12|||
145272409|NCT02886494|523846165|FG001|Overall Study|Withdrawal by Subject|3|||
145272410|NCT02886494|523846164|FG000|Overall Study|Protocol Violation|4|||
145272411|NCT02886494|523846165|FG001|Overall Study|Protocol Violation|1|||
145272412|NCT00499252|523846171|FG000|Overall Study|Adverse Event|3|||
145272413|NCT00499252|523846171|FG000|Overall Study|Refused further treatment|2|||
145272414|NCT00499252|523846171|FG000|Overall Study|Ineligible|4|||
145272415|NCT00499252|523846171|FG000|Overall Study|<no further label>|3|||
145272416|NCT01988337|523846172|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
145272417|NCT02742818|523846173|FG000|Overall Study|Adverse Event|0|||
145272418|NCT02742818|523846174|FG001|Overall Study|Adverse Event|1|||
145272419|NCT02742818|523846173|FG000|Overall Study|Protocol Violation|0|||
145272420|NCT02742818|523846174|FG001|Overall Study|Protocol Violation|1|||
145272421|NCT00457418|523846175|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
145272422|NCT00457418|523846175|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
145272423|NCT00457418|523846175|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
145272424|NCT00457418|523846175|FG000|Post PK Maintenance|Adverse Event|10|||
145272425|NCT00457418|523846175|FG000|Post PK Maintenance|Progression of Disease|6|||
145272426|NCT00457418|523846175|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
145272427|NCT00457418|523846175|FG000|Post PK Maintenance|Lost to Follow-up|1|||
145272428|NCT01785472|523846176|FG000|Overall Study|Adverse Event|5|||
145272429|NCT01785472|523846177|FG001|Overall Study|Adverse Event|4|||
145272430|NCT01785472|523846178|FG002|Overall Study|Adverse Event|6|||
145272431|NCT01785472|523846176|FG000|Overall Study|Lack of Efficacy|2|||
145530030|NCT01539642|524801959|FG001|Overall Study|Lack of Efficacy|18|||
145753385|NCT03033745|525610303|FG002|Overall Study|Adverse Event|1|||
145753386|NCT03033745|525610301|FG000|Overall Study|Withdrawal by Subject|0|||
145753387|NCT03033745|525610302|FG001|Overall Study|Withdrawal by Subject|1|||
145753388|NCT03033745|525610303|FG002|Overall Study|Withdrawal by Subject|0|||
145753389|NCT00608985|525610304|FG000|Overall Study|Adverse Event|2|||
145753390|NCT00608985|525610305|FG001|Overall Study|Adverse Event|7|||
145753391|NCT00608985|525610306|FG002|Overall Study|Adverse Event|4|||
145753392|NCT00608985|525610307|FG003|Overall Study|Adverse Event|6|||
145753393|NCT00608985|525610304|FG000|Overall Study|Administrative/Other|7|||
145753394|NCT00608985|525610305|FG001|Overall Study|Administrative/Other|4|||
145753395|NCT00608985|525610306|FG002|Overall Study|Administrative/Other|1|||
145753396|NCT00608985|525610307|FG003|Overall Study|Administrative/Other|2|||
145272432|NCT01785472|523846177|FG001|Overall Study|Lack of Efficacy|0|||
145272433|NCT01785472|523846178|FG002|Overall Study|Lack of Efficacy|1|||
145272434|NCT01785472|523846176|FG000|Overall Study|Lost to Follow-up|1|||
145402716|NCT00959751|524332462|FG001|Overall Study|Non-compliance to Study Procedures|1|||
145402717|NCT00959751|524332461|FG000|Overall Study|No migraine headache without aura|7|||
145402718|NCT00959751|524332462|FG001|Overall Study|No migraine headache without aura|7|||
145402719|NCT03255187|524332463|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
145402720|NCT03255187|524332464|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
145530031|NCT01539642|524801958|FG000|Overall Study|Patient ready for early discharge|8|||
145530032|NCT01539642|524801959|FG001|Overall Study|Patient ready for early discharge|7|||
145753397|NCT00608985|525610304|FG000|Overall Study|Withdrawal of Consent|5|||
145753398|NCT00608985|525610305|FG001|Overall Study|Withdrawal of Consent|1|||
145753399|NCT00608985|525610306|FG002|Overall Study|Withdrawal of Consent|1|||
145753400|NCT00608985|525610307|FG003|Overall Study|Withdrawal of Consent|1|||
145753401|NCT00608985|525610304|FG000|Overall Study|Lost to Follow-up|2|||
145753402|NCT00608985|525610305|FG001|Overall Study|Lost to Follow-up|1|||
145272435|NCT01785472|523846177|FG001|Overall Study|Lost to Follow-up|2|||
145272436|NCT01785472|523846178|FG002|Overall Study|Lost to Follow-up|0|||
145402721|NCT03255187|524332463|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
145402722|NCT03255187|524332464|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
145402723|NCT02934178|524332465|FG000|Received Vaccination 2|Death|0|||
145402724|NCT02934178|524332466|FG001|Received Vaccination 2|Death|1|||
145402725|NCT02934178|524332465|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
145402726|NCT02934178|524332466|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
145402727|NCT01898078|524332469|FG000|Overall Study|Progressive Disease|1|||
145402728|NCT01898078|524332470|FG001|Overall Study|Progressive Disease|5|||
145402729|NCT01898078|524332469|FG000|Overall Study|Adverse Event|2|||
145402730|NCT01898078|524332470|FG001|Overall Study|Adverse Event|1|||
145402731|NCT01898078|524332469|FG000|Overall Study|Withdrawal by Subject|1|||
145402732|NCT01898078|524332470|FG001|Overall Study|Withdrawal by Subject|1|||
145402733|NCT01898078|524332469|FG000|Overall Study|Symptomatic Deterioration|2|||
145402734|NCT01898078|524332470|FG001|Overall Study|Symptomatic Deterioration|0|||
145402735|NCT01898078|524332469|FG000|Overall Study|Reason not Specified|0|||
145402736|NCT01898078|524332470|FG001|Overall Study|Reason not Specified|1|||
145402737|NCT01075048|524332472|FG000|Overall Study|Death|4|||
145402738|NCT01075048|524332473|FG001|Overall Study|Death|17|||
145402739|NCT01075048|524332474|FG002|Overall Study|Death|12|||
145753403|NCT00608985|525610306|FG002|Overall Study|Lost to Follow-up|0|||
145753404|NCT00608985|525610307|FG003|Overall Study|Lost to Follow-up|0|||
145753405|NCT00094055|525610309|FG000|Overall Study|Adverse Event|11|||
145753406|NCT00094055|525610309|FG000|Overall Study|Death|4|||
145753407|NCT00094055|525610309|FG000|Overall Study|Lack of Efficacy|17|||
145753408|NCT00094055|525610309|FG000|Overall Study|Lost to Follow-up|2|||
145753409|NCT00094055|525610309|FG000|Overall Study|progressive disease|2|||
145753410|NCT00094055|525610309|FG000|Overall Study|clinical progression|1|||
145753411|NCT00094055|525610309|FG000|Overall Study|roll-over to another study|14|||
145753412|NCT00094055|525610309|FG000|Overall Study|Withdrawal by Subject|9|||
145753413|NCT02462473|525610310|FG000|Overall Study|Death|1|||
145753414|NCT02462473|525610310|FG000|Overall Study|Other|3|||
145753415|NCT00661271|525610311|FG000|Overall Study|Lost to Follow-up|28|||
145753416|NCT00661271|525610312|FG001|Overall Study|Lost to Follow-up|25|||
145753417|NCT03728309|525610316|FG000|Overall Study|Randomized but not Treated|0|||
145753418|NCT03728309|525610317|FG001|Overall Study|Randomized but not Treated|1|||
145753419|NCT03728309|525610316|FG000|Overall Study|Adverse Event|0|||
145753420|NCT03728309|525610317|FG001|Overall Study|Adverse Event|1|||
145753421|NCT03728309|525610316|FG000|Overall Study|Withdrawal by Subject|2|||
145402740|NCT01075048|524332472|FG000|Overall Study|Start of other or new therapy|4|||
145402741|NCT01075048|524332473|FG001|Overall Study|Start of other or new therapy|36|||
145402742|NCT01075048|524332474|FG002|Overall Study|Start of other or new therapy|46|||
145402743|NCT01075048|524332472|FG000|Overall Study|Withdrawal by Subject|1|||
145753422|NCT03728309|525610317|FG001|Overall Study|Withdrawal by Subject|8|||
145530033|NCT01539642|524801958|FG000|Overall Study|Adverse Event|6|||
145530034|NCT01539642|524801959|FG001|Overall Study|Adverse Event|4|||
145530035|NCT01539642|524801958|FG000|Overall Study|Withdrawal by Subject|2|||
145530036|NCT01539642|524801959|FG001|Overall Study|Withdrawal by Subject|2|||
145530037|NCT00598702|524801960|FG000|Overall Study|Other|0|||
145530038|NCT00598702|524801961|FG001|Overall Study|Other|2|||
145530039|NCT00598702|524801962|FG002|Overall Study|Other|0|||
145530040|NCT00598702|524801963|FG003|Overall Study|Other|0|||
145530041|NCT00598702|524801964|FG004|Overall Study|Other|0|||
145530042|NCT00598702|524801965|FG005|Overall Study|Other|1|||
145530043|NCT00598702|524801966|FG006|Overall Study|Other|0|||
145530044|NCT00598702|524801967|FG007|Overall Study|Other|0|||
145530045|NCT00598702|524801960|FG000|Overall Study|Early discharge from hospital|0|||
145530046|NCT00598702|524801961|FG001|Overall Study|Early discharge from hospital|0|||
145530047|NCT00598702|524801962|FG002|Overall Study|Early discharge from hospital|2|||
145530048|NCT00598702|524801963|FG003|Overall Study|Early discharge from hospital|5|||
145530049|NCT00598702|524801964|FG004|Overall Study|Early discharge from hospital|0|||
145530050|NCT00598702|524801965|FG005|Overall Study|Early discharge from hospital|10|||
145530051|NCT00598702|524801966|FG006|Overall Study|Early discharge from hospital|1|||
145753423|NCT03728309|525610316|FG000|Overall Study|Lost to Follow-up|9|||
145753424|NCT03728309|525610317|FG001|Overall Study|Lost to Follow-up|10|||
145753425|NCT03728309|525610316|FG000|Overall Study|Protocol Deviation|0|||
145753426|NCT03728309|525610317|FG001|Overall Study|Protocol Deviation|1|||
145753427|NCT03728309|525610316|FG000|Overall Study|Due to COVID|1|||
145530052|NCT00598702|524801967|FG007|Overall Study|Early discharge from hospital|0|||
145530053|NCT00598702|524801960|FG000|Overall Study|Adverse Event|0|||
145530054|NCT00598702|524801961|FG001|Overall Study|Adverse Event|0|||
145530055|NCT00598702|524801962|FG002|Overall Study|Adverse Event|0|||
145530056|NCT00598702|524801963|FG003|Overall Study|Adverse Event|1|||
145530057|NCT00598702|524801964|FG004|Overall Study|Adverse Event|0|||
145530058|NCT00598702|524801965|FG005|Overall Study|Adverse Event|0|||
145530059|NCT00598702|524801966|FG006|Overall Study|Adverse Event|0|||
145530060|NCT00598702|524801967|FG007|Overall Study|Adverse Event|0|||
145530061|NCT00598702|524801960|FG000|Overall Study|Withdrawal by Subject|0|||
145530062|NCT00598702|524801961|FG001|Overall Study|Withdrawal by Subject|0|||
145530063|NCT00598702|524801962|FG002|Overall Study|Withdrawal by Subject|0|||
145530064|NCT00598702|524801963|FG003|Overall Study|Withdrawal by Subject|1|||
145530065|NCT00598702|524801964|FG004|Overall Study|Withdrawal by Subject|1|||
145530066|NCT00598702|524801965|FG005|Overall Study|Withdrawal by Subject|0|||
145530067|NCT00598702|524801966|FG006|Overall Study|Withdrawal by Subject|0|||
145530068|NCT00598702|524801967|FG007|Overall Study|Withdrawal by Subject|0|||
145530069|NCT00598702|524801960|FG000|Overall Study|Physician Decision|0|||
145530070|NCT00598702|524801961|FG001|Overall Study|Physician Decision|0|||
145530071|NCT00598702|524801962|FG002|Overall Study|Physician Decision|0|||
145530072|NCT00598702|524801963|FG003|Overall Study|Physician Decision|0|||
145530073|NCT00598702|524801964|FG004|Overall Study|Physician Decision|1|||
145530074|NCT00598702|524801965|FG005|Overall Study|Physician Decision|0|||
145530075|NCT00598702|524801966|FG006|Overall Study|Physician Decision|0|||
145530076|NCT00598702|524801967|FG007|Overall Study|Physician Decision|0|||
145530077|NCT00598702|524801960|FG000|Overall Study|Dose limiting toxicity|0|||
145530078|NCT00598702|524801961|FG001|Overall Study|Dose limiting toxicity|0|||
145530079|NCT00598702|524801962|FG002|Overall Study|Dose limiting toxicity|0|||
145530080|NCT00598702|524801963|FG003|Overall Study|Dose limiting toxicity|1|||
145530081|NCT00598702|524801964|FG004|Overall Study|Dose limiting toxicity|1|||
145530082|NCT00598702|524801965|FG005|Overall Study|Dose limiting toxicity|1|||
145530083|NCT00598702|524801966|FG006|Overall Study|Dose limiting toxicity|0|||
145530084|NCT00598702|524801967|FG007|Overall Study|Dose limiting toxicity|0|||
145530085|NCT02063880|524801968|FG000|Overall Study|Death|21|||
145530086|NCT02063880|524801969|FG001|Overall Study|Death|18|||
145530087|NCT02063880|524801968|FG000|Overall Study|Lost to Follow-up|7|||
145530088|NCT02063880|524801969|FG001|Overall Study|Lost to Follow-up|7|||
145753428|NCT03728309|525610317|FG001|Overall Study|Due to COVID|3|||
145753429|NCT02436876|525610320|FG000|Overall Study|Lost to Follow-up|0|||
145530089|NCT02063880|524801968|FG000|Overall Study|Ineligible|0|||
145530090|NCT02063880|524801969|FG001|Overall Study|Ineligible|2|||
145530091|NCT02600351|524801970|FG000|Overall Study|Lack of Efficacy|3|||
145530092|NCT02600351|524801971|FG001|Overall Study|Lack of Efficacy|0|||
145753430|NCT02436876|525610321|FG001|Overall Study|Lost to Follow-up|1|||
145272437|NCT01785472|523846176|FG000|Overall Study|Physician Decision|1|||
145530093|NCT02600351|524801972|FG002|Overall Study|Lack of Efficacy|5|||
145530094|NCT02600351|524801973|FG003|Overall Study|Lack of Efficacy|2|||
145530095|NCT02600351|524801970|FG000|Overall Study|Lost to Follow-up|1|||
145753431|NCT02436876|525610322|FG002|Overall Study|Lost to Follow-up|1|||
145753432|NCT02436876|525610323|FG003|Overall Study|Lost to Follow-up|1|||
145753433|NCT02436876|525610320|FG000|Overall Study|Withdrawal by Subject|1|||
145753434|NCT02436876|525610321|FG001|Overall Study|Withdrawal by Subject|0|||
145530096|NCT02600351|524801971|FG001|Overall Study|Lost to Follow-up|0|||
145530097|NCT02600351|524801972|FG002|Overall Study|Lost to Follow-up|0|||
145530098|NCT02600351|524801973|FG003|Overall Study|Lost to Follow-up|0|||
145753435|NCT02436876|525610322|FG002|Overall Study|Withdrawal by Subject|0|||
145753436|NCT02436876|525610323|FG003|Overall Study|Withdrawal by Subject|1|||
145753437|NCT02436876|525610320|FG000|Overall Study|Physician Decision|0|||
145272438|NCT01785472|523846177|FG001|Overall Study|Physician Decision|1|||
145272439|NCT01785472|523846178|FG002|Overall Study|Physician Decision|1|||
145272440|NCT01785472|523846176|FG000|Overall Study|Protocol deviation|0|||
145272441|NCT01785472|523846177|FG001|Overall Study|Protocol deviation|2|||
145272442|NCT01785472|523846178|FG002|Overall Study|Protocol deviation|2|||
145753438|NCT02436876|525610321|FG001|Overall Study|Physician Decision|2|||
145753439|NCT02436876|525610322|FG002|Overall Study|Physician Decision|1|||
145272443|NCT01785472|523846176|FG000|Overall Study|Subject/guardian decision|15|||
145272444|NCT01785472|523846177|FG001|Overall Study|Subject/guardian decision|10|||
145272445|NCT01785472|523846178|FG002|Overall Study|Subject/guardian decision|11|||
145272446|NCT01785472|523846176|FG000|Overall Study|Technical problems|0|||
145272447|NCT01785472|523846177|FG001|Overall Study|Technical problems|0|||
145272448|NCT01785472|523846178|FG002|Overall Study|Technical problems|1|||
145272449|NCT02086968|523846180|FG000|Overall Study|Adverse Event|1|||
145272450|NCT02086968|523846181|FG001|Overall Study|Adverse Event|5|||
145272451|NCT02086968|523846180|FG000|Overall Study|Lost to Follow-up|2|||
145272452|NCT02086968|523846181|FG001|Overall Study|Lost to Follow-up|3|||
145272453|NCT02086968|523846180|FG000|Overall Study|Study drug received outside protocol|0|||
145272454|NCT02086968|523846181|FG001|Overall Study|Study drug received outside protocol|1|||
145272455|NCT02086968|523846180|FG000|Overall Study|Physician Decision|4|||
145272456|NCT02086968|523846181|FG001|Overall Study|Physician Decision|0|||
145272457|NCT02086968|523846180|FG000|Overall Study|Withdrawal by Subject|1|||
145272458|NCT02086968|523846181|FG001|Overall Study|Withdrawal by Subject|4|||
145272459|NCT03387735|523846185|FG000|Overall Study|Lost to Follow-up|4|||
145272460|NCT03387735|523846186|FG001|Overall Study|Lost to Follow-up|8|||
145272461|NCT03387735|523846185|FG000|Overall Study|Death|4|||
145272462|NCT03387735|523846186|FG001|Overall Study|Death|8|||
145272463|NCT03099161|523846187|FG000|Overall Study|Adverse Event|0|||
145272464|NCT03099161|523846188|FG001|Overall Study|Adverse Event|0|||
145272465|NCT03099161|523846189|FG002|Overall Study|Adverse Event|2|||
145272466|NCT03099161|523846187|FG000|Overall Study|Physician Decision|2|||
145272467|NCT03099161|523846188|FG001|Overall Study|Physician Decision|0|||
145272468|NCT03099161|523846189|FG002|Overall Study|Physician Decision|0|||
145272469|NCT03099161|523846187|FG000|Overall Study|Progressive Disease|1|||
145272470|NCT03099161|523846188|FG001|Overall Study|Progressive Disease|4|||
145272471|NCT03099161|523846189|FG002|Overall Study|Progressive Disease|1|||
145272472|NCT00110084|523846190|FG000|Overall Study|Adverse Event|9|||
145272473|NCT00110084|523846190|FG000|Overall Study|Death|1|||
145272474|NCT00110084|523846190|FG000|Overall Study|Patient Refusal|10|||
145272475|NCT00110084|523846190|FG000|Overall Study|Alternate Therapy|5|||
145272476|NCT00110084|523846190|FG000|Overall Study|Intercurrent Illness|1|||
145272477|NCT00110084|523846190|FG000|Overall Study|Other|2|||
145272478|NCT04854707|523846192|FG000|Overall Study|Lack of Efficacy|78|||
145272479|NCT04854707|523846193|FG001|Overall Study|Lack of Efficacy|59|||
145272480|NCT04854707|523846194|FG002|Overall Study|Lack of Efficacy|30|||
145272481|NCT00537056|523846195|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
145272482|NCT01257737|523846197|FG000|Overall Study|Lost to Follow-up|1|||
145272483|NCT01257737|523846198|FG001|Overall Study|Lost to Follow-up|2|||
145272484|NCT01257737|523846197|FG000|Overall Study|Liver transplant|1|||
145272485|NCT01257737|523846198|FG001|Overall Study|Liver transplant|0|||
145272486|NCT01257737|523846197|FG000|Overall Study|Relocation out of the country|0|||
145272487|NCT01257737|523846198|FG001|Overall Study|Relocation out of the country|1|||
145272488|NCT01257737|523846197|FG000|Overall Study|Withdrew from study|0|||
145272489|NCT01257737|523846198|FG001|Overall Study|Withdrew from study|1|||
145272490|NCT03020966|523846207|FG000|Overall Study|Withdrawal by Subject|2|||
145272491|NCT03020966|523846208|FG001|Overall Study|Withdrawal by Subject|0|||
145272492|NCT00962013|523846216|FG000|Overall Study|Did not have surgery|1|||
145272493|NCT00962013|523846216|FG000|Overall Study|Death|8|||
145272494|NCT00962013|523846216|FG000|Overall Study|Lost to Follow-up|12|||
145272495|NCT00962013|523846216|FG000|Overall Study|Unable/Unwilling to return|6|||
145272496|NCT00962013|523846216|FG000|Overall Study|Withdrawal by Subject|8|||
145272497|NCT00962013|523846216|FG000|Overall Study|Removal of study device|3|||
145272498|NCT00962013|523846216|FG000|Overall Study|Site Termination|24|||
145272499|NCT00962013|523846216|FG000|Overall Study|No 5 year evaluation|6|||
145272500|NCT02628418|523846217|FG000|Overall Study|Lost to Follow-up|1|||
145272501|NCT02628418|523846218|FG001|Overall Study|Lost to Follow-up|2|||
145272502|NCT00424632|523846219|FG000|Overall Study|Death|0|||
145272503|NCT00424632|523846220|FG001|Overall Study|Death|0|||
145272504|NCT00424632|523846221|FG002|Overall Study|Death|0|||
145530099|NCT02600351|524801970|FG000|Overall Study|Randomized but Not Treated|1|||
145530100|NCT02600351|524801971|FG001|Overall Study|Randomized but Not Treated|0|||
145272505|NCT00424632|523846222|FG003|Overall Study|Death|0|||
145272506|NCT00424632|523846223|FG004|Overall Study|Death|0|||
145272507|NCT00424632|523846224|FG005|Overall Study|Death|2|||
145272508|NCT00424632|523846225|FG006|Overall Study|Death|0|||
145272509|NCT00424632|523846226|FG007|Overall Study|Death|0|||
145272510|NCT00424632|523846227|FG008|Overall Study|Death|0|||
145272511|NCT00424632|523846228|FG009|Overall Study|Death|0|||
145530101|NCT02600351|524801972|FG002|Overall Study|Randomized but Not Treated|1|||
145272512|NCT00424632|523846219|FG000|Overall Study|Adverse Event|0|||
145272513|NCT00424632|523846220|FG001|Overall Study|Adverse Event|0|||
145272514|NCT00424632|523846221|FG002|Overall Study|Adverse Event|0|||
145272515|NCT00424632|523846222|FG003|Overall Study|Adverse Event|0|||
145272516|NCT00424632|523846223|FG004|Overall Study|Adverse Event|0|||
145272517|NCT00424632|523846224|FG005|Overall Study|Adverse Event|0|||
145272518|NCT00424632|523846225|FG006|Overall Study|Adverse Event|0|||
145272519|NCT00424632|523846226|FG007|Overall Study|Adverse Event|0|||
145530102|NCT02600351|524801973|FG003|Overall Study|Randomized but Not Treated|3|||
145530103|NCT00567593|524801974|FG000|Overall Study|Adverse Event|1|||
145530104|NCT00567593|524801974|FG000|Overall Study|Physician Decision|1|||
145530105|NCT02106910|524801975|FG000|Overall Study|Lost to Follow-up|1|||
145530106|NCT02106910|524801976|FG001|Overall Study|Lost to Follow-up|1|||
145530107|NCT00700570|524801979|FG000|Overall Study|Adverse Event|2|||
145530108|NCT00700570|524801980|FG001|Overall Study|Adverse Event|6|||
145530109|NCT00700570|524801979|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
145530110|NCT00700570|524801980|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
145530111|NCT00700570|524801979|FG000|Overall Study|Disease Progression|8|||
145530112|NCT00700570|524801980|FG001|Overall Study|Disease Progression|11|||
145530113|NCT00700570|524801979|FG000|Overall Study|Withdrawal by Subject|1|||
145530114|NCT00700570|524801980|FG001|Overall Study|Withdrawal by Subject|6|||
145530115|NCT02556203|524801981|FG000|Overall Study|Withdrawal by Subject|21|||
145530116|NCT02556203|524801982|FG001|Overall Study|Withdrawal by Subject|21|||
145530117|NCT02556203|524801981|FG000|Overall Study|Lost to Follow-up|5|||
145530118|NCT02556203|524801982|FG001|Overall Study|Lost to Follow-up|5|||
145530119|NCT02556203|524801981|FG000|Overall Study|Adverse Event|1|||
145530120|NCT02556203|524801982|FG001|Overall Study|Adverse Event|0|||
145530121|NCT02943460|524801988|FG000|Blinded Study Phase|Adverse Event|3|||
145530122|NCT02943460|524801989|FG001|Blinded Study Phase|Adverse Event|0|||
145530123|NCT02943460|524801990|FG002|Blinded Study Phase|Adverse Event|0|||
145530124|NCT02943460|524801988|FG000|Blinded Study Phase|Withdrew Consent|0|||
145530125|NCT02943460|524801989|FG001|Blinded Study Phase|Withdrew Consent|1|||
145530126|NCT02943460|524801990|FG002|Blinded Study Phase|Withdrew Consent|0|||
145530127|NCT02943460|524801988|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
145530128|NCT02943460|524801989|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
145530129|NCT02943460|524801990|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
145530130|NCT02943460|524801988|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
145530131|NCT02943460|524801989|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
145530132|NCT02943460|524801990|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
145530133|NCT02943460|524801988|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
145530134|NCT02943460|524801989|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
145530135|NCT02943460|524801990|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
145753440|NCT02436876|525610323|FG003|Overall Study|Physician Decision|0|||
145753441|NCT02436876|525610320|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
145753442|NCT02436876|525610321|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
145753443|NCT02436876|525610322|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
145753444|NCT02436876|525610323|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
145753445|NCT00953758|525610324|FG000|Overall Study|Death|2|||
145753446|NCT00953758|525610325|FG001|Overall Study|Death|0|||
145753447|NCT00953758|525610326|FG002|Overall Study|Death|1|||
145753448|NCT00953758|525610327|FG003|Overall Study|Death|1|||
145753449|NCT00953758|525610328|FG004|Overall Study|Death|1|||
145753450|NCT00953758|525610329|FG005|Overall Study|Death|1|||
145753451|NCT00953758|525610330|FG006|Overall Study|Death|1|||
145753452|NCT00953758|525610331|FG007|Overall Study|Death|3|||
145753453|NCT00953758|525610332|FG008|Overall Study|Death|1|||
145753454|NCT00953758|525610333|FG009|Overall Study|Death|0|||
145753455|NCT00953758|525610324|FG000|Overall Study|Participant refused further follow-up|0|||
145753456|NCT00953758|525610325|FG001|Overall Study|Participant refused further follow-up|0|||
145753457|NCT00953758|525610326|FG002|Overall Study|Participant refused further follow-up|1|||
145753458|NCT00953758|525610327|FG003|Overall Study|Participant refused further follow-up|0|||
145753459|NCT00953758|525610328|FG004|Overall Study|Participant refused further follow-up|3|||
145753460|NCT00953758|525610329|FG005|Overall Study|Participant refused further follow-up|0|||
145753461|NCT00953758|525610330|FG006|Overall Study|Participant refused further follow-up|0|||
145753462|NCT00953758|525610331|FG007|Overall Study|Participant refused further follow-up|0|||
145753463|NCT00953758|525610332|FG008|Overall Study|Participant refused further follow-up|1|||
145753464|NCT00953758|525610333|FG009|Overall Study|Participant refused further follow-up|0|||
145753465|NCT00953758|525610324|FG000|Overall Study|Lost to Follow-up|0|||
145753466|NCT00953758|525610325|FG001|Overall Study|Lost to Follow-up|0|||
145753467|NCT00953758|525610326|FG002|Overall Study|Lost to Follow-up|0|||
145753468|NCT00953758|525610327|FG003|Overall Study|Lost to Follow-up|1|||
145753469|NCT00953758|525610328|FG004|Overall Study|Lost to Follow-up|0|||
145402744|NCT01075048|524332473|FG001|Overall Study|Withdrawal by Subject|6|||
145402745|NCT01075048|524332474|FG002|Overall Study|Withdrawal by Subject|3|||
145530136|NCT03875768|524801991|FG000|Overall Study|Lost to Follow-up|16|||
145530137|NCT03875768|524801992|FG001|Overall Study|Lost to Follow-up|13|||
145753470|NCT00953758|525610329|FG005|Overall Study|Lost to Follow-up|0|||
145402746|NCT01075048|524332472|FG000|Overall Study|Lost to Follow-up|0|||
145530138|NCT03875768|524801991|FG000|Overall Study|Withdrawal by Subject|10|||
145530139|NCT03875768|524801992|FG001|Overall Study|Withdrawal by Subject|21|||
145530140|NCT03875768|524801991|FG000|Overall Study|Did not complete assessment|21|||
145530141|NCT03875768|524801992|FG001|Overall Study|Did not complete assessment|12|||
145530142|NCT03875768|524801991|FG000|Overall Study|Became ineligible|1|||
145530143|NCT03875768|524801992|FG001|Overall Study|Became ineligible|0|||
145530144|NCT01925274|524801993|FG000|Overall Study|Death|1|||
145530145|NCT01925274|524801994|FG001|Overall Study|Death|0|||
145530146|NCT01925274|524801995|FG002|Overall Study|Death|0|||
145530147|NCT01925274|524801993|FG000|Overall Study|Lost to Follow-up|0|||
145530148|NCT01925274|524801994|FG001|Overall Study|Lost to Follow-up|1|||
145530149|NCT01925274|524801995|FG002|Overall Study|Lost to Follow-up|0|||
145530150|NCT01925274|524801993|FG000|Overall Study|Withdrawal by Subject|1|||
145530151|NCT01925274|524801994|FG001|Overall Study|Withdrawal by Subject|2|||
145530152|NCT01925274|524801995|FG002|Overall Study|Withdrawal by Subject|0|||
145530153|NCT01925274|524801993|FG000|Overall Study|Study terminated by sponsor|4|||
145530154|NCT01925274|524801994|FG001|Overall Study|Study terminated by sponsor|0|||
145530155|NCT01925274|524801995|FG002|Overall Study|Study terminated by sponsor|0|||
145530156|NCT01925274|524801993|FG000|Overall Study|Protocol amendment|1|||
145530157|NCT01925274|524801994|FG001|Overall Study|Protocol amendment|3|||
145530158|NCT01925274|524801995|FG002|Overall Study|Protocol amendment|6|||
145530159|NCT04327674|524801996|FG000|Overall Study|Protocol Violation|19|||
145530160|NCT00437320|524802001|FG000|Overall Study|Participant request|2|||
145530161|NCT00437320|524802002|FG001|Overall Study|Participant request|1|||
145530162|NCT00437320|524802003|FG002|Overall Study|Participant request|4|||
145530163|NCT01400815|524802005|FG000|Overall Study|Adverse Event|3|||
145530164|NCT01400815|524802006|FG001|Overall Study|Adverse Event|0|||
145530165|NCT01400815|524802005|FG000|Overall Study|Death|0|||
145530166|NCT01400815|524802006|FG001|Overall Study|Death|1|||
145530167|NCT01400815|524802005|FG000|Overall Study|Lost to Follow-up|18|||
145530168|NCT01400815|524802006|FG001|Overall Study|Lost to Follow-up|11|||
145530169|NCT01400815|524802005|FG000|Overall Study|Protocol Violation|0|||
145530170|NCT01400815|524802006|FG001|Overall Study|Protocol Violation|1|||
145530171|NCT01400815|524802005|FG000|Overall Study|Physician Decision|1|||
145530172|NCT01400815|524802006|FG001|Overall Study|Physician Decision|0|||
145530173|NCT01400815|524802005|FG000|Overall Study|Withdrawal by Subject|15|||
145530174|NCT01400815|524802006|FG001|Overall Study|Withdrawal by Subject|8|||
145530175|NCT01400815|524802005|FG000|Overall Study|Subject in jail|1|||
145530176|NCT01400815|524802006|FG001|Overall Study|Subject in jail|0|||
145530177|NCT01123850|524802007|FG000|Overall Study|Slow enrollment|45|||
145530178|NCT00470847|524802010|FG000|Overall Study|Pt still receiving treatment|1|||
145530179|NCT00381381|524802011|FG000|Overall Study|Adverse Event|3|||
145530180|NCT00381381|524802011|FG000|Overall Study|Lost to Follow-up|52|||
145530181|NCT00381381|524802011|FG000|Overall Study|Withdrawal by Subject|9|||
145530182|NCT00568685|524802014|FG000|Overall Study|Adverse Event|2|||
145530183|NCT00568685|524802015|FG001|Overall Study|Adverse Event|3|||
145530184|NCT00568685|524802016|FG002|Overall Study|Adverse Event|3|||
145530185|NCT00568685|524802014|FG000|Overall Study|Withdrawal by Subject|7|||
145530186|NCT00568685|524802015|FG001|Overall Study|Withdrawal by Subject|2|||
145530187|NCT00568685|524802016|FG002|Overall Study|Withdrawal by Subject|2|||
145530188|NCT00568685|524802014|FG000|Overall Study|Protocol Violation|1|||
145530189|NCT00568685|524802015|FG001|Overall Study|Protocol Violation|0|||
145530190|NCT00568685|524802016|FG002|Overall Study|Protocol Violation|0|||
145530191|NCT01638819|524802018|FG000|Overall Study|Lost to Follow-up|1|||
145530192|NCT01638819|524802019|FG001|Overall Study|Lost to Follow-up|0|||
145530193|NCT00471146|524802022|FG000|Overall Study|Adverse Event|32|||
145530194|NCT00471146|524802023|FG001|Overall Study|Adverse Event|33|||
145530195|NCT00471146|524802022|FG000|Overall Study|Withdrawal by Subject|14|||
145530196|NCT00471146|524802023|FG001|Overall Study|Withdrawal by Subject|11|||
145530197|NCT00471146|524802022|FG000|Overall Study|Death|11|||
145530198|NCT00471146|524802023|FG001|Overall Study|Death|12|||
145530199|NCT00471146|524802022|FG000|Overall Study|Lost to Follow-up|4|||
145530200|NCT00471146|524802023|FG001|Overall Study|Lost to Follow-up|2|||
145530201|NCT00471146|524802022|FG000|Overall Study|Protocol Violation|2|||
145530202|NCT00471146|524802023|FG001|Overall Study|Protocol Violation|2|||
145530203|NCT00471146|524802022|FG000|Overall Study|Objective progression or relapse|84|||
145530204|NCT00471146|524802023|FG001|Overall Study|Objective progression or relapse|87|||
145530205|NCT00471146|524802022|FG000|Overall Study|Global deterioration of health status|12|||
145530206|NCT00471146|524802023|FG001|Overall Study|Global deterioration of health status|14|||
145530207|NCT00471146|524802022|FG000|Overall Study|Randomized but not treated|9|||
145530208|NCT00471146|524802023|FG001|Overall Study|Randomized but not treated|8|||
145530209|NCT00471146|524802022|FG000|Overall Study|Other|4|||
145530210|NCT00471146|524802023|FG001|Overall Study|Other|5|||
145530211|NCT03538431|524802024|FG000|Overall Study|Physician Decision|0|||
145530212|NCT03538431|524802025|FG001|Overall Study|Physician Decision|1|||
145530213|NCT03538431|524802024|FG000|Overall Study|Withdrawal by Subject|1|||
145530214|NCT03538431|524802025|FG001|Overall Study|Withdrawal by Subject|0|||
145530215|NCT00467610|524802028|FG000|Overall Study|Withdrawal by Subject|1|||
145530216|NCT00445978|524802031|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
145530217|NCT00445978|524802031|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
145530218|NCT00445978|524802031|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
145530219|NCT00445978|524802031|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
145530220|NCT00445978|524802031|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
145530221|NCT00445978|524802031|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
145530222|NCT00445978|524802031|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
145530223|NCT00445978|524802031|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
145530224|NCT00445978|524802031|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
145530225|NCT03112590|524802034|FG000|Overall Study|Adverse Event|0|||
145530226|NCT03112590|524802035|FG001|Overall Study|Adverse Event|1|||
145530227|NCT03112590|524802036|FG002|Overall Study|Adverse Event|0|||
145530228|NCT02520661|524802037|FG000|Overall Study|Lost to Follow-up|7|||
145530229|NCT02520661|524802038|FG001|Overall Study|Lost to Follow-up|3|||
145530230|NCT02520661|524802037|FG000|Overall Study|Admitted from ED|49|||
145753471|NCT00953758|525610330|FG006|Overall Study|Lost to Follow-up|0|||
145753472|NCT00953758|525610331|FG007|Overall Study|Lost to Follow-up|1|||
145753473|NCT00953758|525610332|FG008|Overall Study|Lost to Follow-up|0|||
145753474|NCT00953758|525610333|FG009|Overall Study|Lost to Follow-up|1|||
145530231|NCT02520661|524802038|FG001|Overall Study|Admitted from ED|48|||
145753475|NCT00953758|525610324|FG000|Overall Study|Physician Decision|0|||
145530232|NCT02520661|524802037|FG000|Overall Study|ED greater than 24 hours|29|||
145753476|NCT00953758|525610325|FG001|Overall Study|Physician Decision|0|||
145753477|NCT00953758|525610326|FG002|Overall Study|Physician Decision|0|||
145530233|NCT02520661|524802038|FG001|Overall Study|ED greater than 24 hours|38|||
145530234|NCT02520661|524802037|FG000|Overall Study|other ineligibility|14|||
145530235|NCT02520661|524802038|FG001|Overall Study|other ineligibility|22|||
145530236|NCT02520661|524802037|FG000|Overall Study|Withdrawal by Subject|7|||
145753478|NCT00953758|525610327|FG003|Overall Study|Physician Decision|0|||
145530237|NCT02520661|524802038|FG001|Overall Study|Withdrawal by Subject|16|||
145530238|NCT00843726|524802039|FG000|Overall Study|Death|1|||
145530239|NCT00843726|524802040|FG001|Overall Study|Death|0|||
145530240|NCT00843726|524802039|FG000|Overall Study|Withdrawal by Subject|0|||
145530241|NCT00843726|524802040|FG001|Overall Study|Withdrawal by Subject|1|||
145530242|NCT02898116|524802043|FG000|Overall Study|Adverse Event|1|||
145530243|NCT02898116|524802043|FG000|Overall Study|Progressive disease|1|||
145753479|NCT00953758|525610328|FG004|Overall Study|Physician Decision|1|||
145753480|NCT00953758|525610329|FG005|Overall Study|Physician Decision|0|||
145753481|NCT00953758|525610330|FG006|Overall Study|Physician Decision|0|||
145753482|NCT00953758|525610331|FG007|Overall Study|Physician Decision|0|||
145753483|NCT00953758|525610332|FG008|Overall Study|Physician Decision|0|||
145753484|NCT00953758|525610333|FG009|Overall Study|Physician Decision|0|||
145753485|NCT00953758|525610324|FG000|Overall Study|Disease progression|0|||
145753486|NCT00953758|525610325|FG001|Overall Study|Disease progression|0|||
145753487|NCT00953758|525610326|FG002|Overall Study|Disease progression|0|||
145753488|NCT00953758|525610327|FG003|Overall Study|Disease progression|0|||
145753489|NCT00953758|525610328|FG004|Overall Study|Disease progression|1|||
145753490|NCT00953758|525610329|FG005|Overall Study|Disease progression|0|||
145753491|NCT00953758|525610330|FG006|Overall Study|Disease progression|0|||
145753492|NCT00953758|525610331|FG007|Overall Study|Disease progression|0|||
145753493|NCT00953758|525610332|FG008|Overall Study|Disease progression|0|||
145753494|NCT00953758|525610333|FG009|Overall Study|Disease progression|0|||
145753495|NCT00953758|525610324|FG000|Overall Study|Participant went for transplant|0|||
145753496|NCT00953758|525610325|FG001|Overall Study|Participant went for transplant|0|||
145753497|NCT00953758|525610326|FG002|Overall Study|Participant went for transplant|0|||
145753498|NCT00953758|525610327|FG003|Overall Study|Participant went for transplant|0|||
145753499|NCT00953758|525610328|FG004|Overall Study|Participant went for transplant|0|||
145753500|NCT00953758|525610329|FG005|Overall Study|Participant went for transplant|0|||
145753501|NCT00953758|525610330|FG006|Overall Study|Participant went for transplant|0|||
145753502|NCT00953758|525610331|FG007|Overall Study|Participant went for transplant|0|||
145753503|NCT00953758|525610332|FG008|Overall Study|Participant went for transplant|1|||
145753504|NCT00953758|525610333|FG009|Overall Study|Participant went for transplant|0|||
145753505|NCT01536860|525610334|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
145753506|NCT01536860|525610335|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
145753507|NCT01536860|525610336|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
145753508|NCT01164722|525610337|FG000|Overall Study|Adverse Event|0|||
145753509|NCT01164722|525610338|FG001|Overall Study|Adverse Event|1|||
145753510|NCT01164722|525610337|FG000|Overall Study|Withdrawal by Subject|3|||
145753511|NCT01164722|525610338|FG001|Overall Study|Withdrawal by Subject|4|||
145753512|NCT01164722|525610337|FG000|Overall Study|Lost to Follow-up|3|||
145753513|NCT01164722|525610338|FG001|Overall Study|Lost to Follow-up|6|||
145753514|NCT01164722|525610337|FG000|Overall Study|met protocol criteria for non-treatment|11|||
145753515|NCT01164722|525610338|FG001|Overall Study|met protocol criteria for non-treatment|1|||
145753516|NCT01164722|525610337|FG000|Overall Study|enrolled on other study, concomitant med|1|||
145753517|NCT01164722|525610338|FG001|Overall Study|enrolled on other study, concomitant med|3|||
145753518|NCT00999908|525610339|FG000|Treatment Period 1|Subject withdrew consent|2|||
145753519|NCT00999908|525610340|FG001|Treatment Period 1|Subject withdrew consent|0|||
145753520|NCT00999908|525610341|FG002|Treatment Period 1|Subject withdrew consent|0|||
145753521|NCT00999908|525610339|FG000|Treatment Period 2|Protocol Violation|1|||
145753522|NCT00999908|525610340|FG001|Treatment Period 2|Protocol Violation|0|||
145753523|NCT00999908|525610341|FG002|Treatment Period 2|Protocol Violation|0|||
145753524|NCT00927095|525610343|FG000|Overall Study|Adverse Event|3|||
145753525|NCT00927095|525610344|FG001|Overall Study|Adverse Event|1|||
145753526|NCT00927095|525610345|FG002|Overall Study|Adverse Event|0|||
145753527|NCT00927095|525610343|FG000|Overall Study|Withdrawal by Subject|2|||
145753528|NCT00927095|525610344|FG001|Overall Study|Withdrawal by Subject|1|||
145753529|NCT00927095|525610345|FG002|Overall Study|Withdrawal by Subject|1|||
145753530|NCT00927095|525610343|FG000|Overall Study|Physician Decision|1|||
145753531|NCT00927095|525610344|FG001|Overall Study|Physician Decision|2|||
145753532|NCT00927095|525610345|FG002|Overall Study|Physician Decision|1|||
145753533|NCT01290692|525610350|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
145753534|NCT00706030|525610354|FG000|Overall Study|Disease Progression|4|||
145753535|NCT00706030|525610355|FG001|Overall Study|Disease Progression|6|||
145753536|NCT00706030|525610356|FG002|Overall Study|Disease Progression|46|||
145753537|NCT00706030|525610357|FG003|Overall Study|Disease Progression|12|||
145753538|NCT00706030|525610354|FG000|Overall Study|Adverse Event|1|||
145753539|NCT00706030|525610355|FG001|Overall Study|Adverse Event|0|||
145753540|NCT00706030|525610356|FG002|Overall Study|Adverse Event|4|||
145753541|NCT00706030|525610357|FG003|Overall Study|Adverse Event|2|||
145753542|NCT00706030|525610354|FG000|Overall Study|Withdrawal by Subject|1|||
145753543|NCT00706030|525610355|FG001|Overall Study|Withdrawal by Subject|0|||
145753544|NCT00706030|525610356|FG002|Overall Study|Withdrawal by Subject|2|||
145753545|NCT00706030|525610357|FG003|Overall Study|Withdrawal by Subject|0|||
145753546|NCT00706030|525610354|FG000|Overall Study|Physician Decision|0|||
145753547|NCT00706030|525610355|FG001|Overall Study|Physician Decision|0|||
145753548|NCT00706030|525610356|FG002|Overall Study|Physician Decision|2|||
145753549|NCT00706030|525610357|FG003|Overall Study|Physician Decision|0|||
145753550|NCT00706030|525610354|FG000|Overall Study|Not recorded|0|||
145753551|NCT00706030|525610355|FG001|Overall Study|Not recorded|0|||
145753552|NCT00706030|525610356|FG002|Overall Study|Not recorded|2|||
145753553|NCT00706030|525610357|FG003|Overall Study|Not recorded|0|||
145753554|NCT00706030|525610354|FG000|Overall Study|Protocol Violation|0|||
145753555|NCT00706030|525610355|FG001|Overall Study|Protocol Violation|0|||
145753556|NCT00706030|525610356|FG002|Overall Study|Protocol Violation|1|||
145753557|NCT00706030|525610357|FG003|Overall Study|Protocol Violation|1|||
145753558|NCT00706030|525610354|FG000|Overall Study|Failed to return|0|||
145753559|NCT00706030|525610355|FG001|Overall Study|Failed to return|0|||
145753560|NCT00706030|525610356|FG002|Overall Study|Failed to return|1|||
145753561|NCT00706030|525610357|FG003|Overall Study|Failed to return|0|||
145753562|NCT00706030|525610354|FG000|Overall Study|Symptomatic Deterioration|0|||
145753563|NCT00706030|525610355|FG001|Overall Study|Symptomatic Deterioration|0|||
145753564|NCT00706030|525610356|FG002|Overall Study|Symptomatic Deterioration|1|||
145753565|NCT00706030|525610357|FG003|Overall Study|Symptomatic Deterioration|0|||
145753566|NCT00706030|525610354|FG000|Overall Study|No treatment received|0|||
145753567|NCT00706030|525610355|FG001|Overall Study|No treatment received|0|||
145753568|NCT00706030|525610356|FG002|Overall Study|No treatment received|0|||
145753569|NCT00706030|525610357|FG003|Overall Study|No treatment received|1|||
145753570|NCT00706030|525610354|FG000|Overall Study|Death|0|||
145753571|NCT00706030|525610355|FG001|Overall Study|Death|0|||
145753572|NCT00706030|525610356|FG002|Overall Study|Death|1|||
145753573|NCT00706030|525610357|FG003|Overall Study|Death|0|||
145753574|NCT03694925|525610358|FG000|Overall Study|Inadequate laboratory testing|0|||
145753575|NCT03694925|525610359|FG001|Overall Study|Inadequate laboratory testing|3|||
145753576|NCT03694925|525610360|FG002|Overall Study|Inadequate laboratory testing|0|||
145753577|NCT02799069|525610363|FG000|Overall Study|Adverse Event|0|||
145753578|NCT02799069|525610364|FG001|Overall Study|Adverse Event|2|||
145753579|NCT02799069|525610365|FG002|Overall Study|Adverse Event|2|||
145753580|NCT02799069|525610363|FG000|Overall Study|Lack of Efficacy|2|||
145753581|NCT02799069|525610364|FG001|Overall Study|Lack of Efficacy|0|||
145753582|NCT02799069|525610365|FG002|Overall Study|Lack of Efficacy|0|||
145753583|NCT02799069|525610363|FG000|Overall Study|Lost to Follow-up|1|||
145753584|NCT02799069|525610364|FG001|Overall Study|Lost to Follow-up|1|||
145753585|NCT02799069|525610365|FG002|Overall Study|Lost to Follow-up|0|||
145753586|NCT02799069|525610363|FG000|Overall Study|Withdrawal by Subject|4|||
145753587|NCT02799069|525610364|FG001|Overall Study|Withdrawal by Subject|4|||
145753588|NCT02799069|525610365|FG002|Overall Study|Withdrawal by Subject|3|||
145753589|NCT02799069|525610363|FG000|Overall Study|Protocol Violation|1|||
145753590|NCT02799069|525610364|FG001|Overall Study|Protocol Violation|0|||
145753591|NCT02799069|525610365|FG002|Overall Study|Protocol Violation|2|||
145753592|NCT03499028|525610368|FG000|Overall Study|Lost to Follow-up|12|||
145753593|NCT03499028|525610369|FG001|Overall Study|Lost to Follow-up|9|||
145753594|NCT03499028|525610368|FG000|Overall Study|Withdrawal by Subject|5|||
145753595|NCT03499028|525610369|FG001|Overall Study|Withdrawal by Subject|8|||
145753596|NCT03499028|525610368|FG000|Overall Study|Unplanned SNF discharge|5|||
145753597|NCT03499028|525610369|FG001|Overall Study|Unplanned SNF discharge|8|||
145753598|NCT00720109|525610370|FG000|Induction Period|Did not meet eligibility criteria|3|||
145753599|NCT00720109|525610371|FG001|Induction Period|Did not meet eligibility criteria|0|||
145753600|NCT00720109|525610372|FG002|Induction Period|Did not meet eligibility criteria|0|||
145753601|NCT00720109|525610370|FG000|Induction Period|Bone Marrow Transplant|2|||
145753602|NCT00720109|525610371|FG001|Induction Period|Bone Marrow Transplant|0|||
145753603|NCT00720109|525610372|FG002|Induction Period|Bone Marrow Transplant|0|||
145753604|NCT00720109|525610370|FG000|Induction Period|Physician Decision|1|||
145753605|NCT00720109|525610371|FG001|Induction Period|Physician Decision|0|||
145753606|NCT00720109|525610372|FG002|Induction Period|Physician Decision|0|||
145753607|NCT00720109|525610370|FG000|Risk Stratification Period|Adverse Event|0|||
145753608|NCT00720109|525610371|FG001|Risk Stratification Period|Adverse Event|1|||
145753609|NCT00720109|525610372|FG002|Risk Stratification Period|Adverse Event|0|||
145753610|NCT00720109|525610370|FG000|Risk Stratification Period|Physician Decision|0|||
145753611|NCT00720109|525610371|FG001|Risk Stratification Period|Physician Decision|2|||
145753612|NCT00720109|525610372|FG002|Risk Stratification Period|Physician Decision|1|||
145272520|NCT00424632|523846227|FG008|Overall Study|Adverse Event|3|||
145753613|NCT00720109|525610370|FG000|Risk Stratification Period|Bone marrow transplant|0|||
145753614|NCT00720109|525610371|FG001|Risk Stratification Period|Bone marrow transplant|9|||
145753615|NCT00720109|525610372|FG002|Risk Stratification Period|Bone marrow transplant|7|||
145753616|NCT00720109|525610370|FG000|Risk Stratification Period|Disease progression or relapse|0|||
145753617|NCT00720109|525610371|FG001|Risk Stratification Period|Disease progression or relapse|2|||
145753618|NCT00720109|525610372|FG002|Risk Stratification Period|Disease progression or relapse|0|||
145753619|NCT00720109|525610370|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
145753620|NCT00720109|525610371|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
145753621|NCT00720109|525610372|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
145753622|NCT01110200|525610373|FG000|Overall Study|Adverse Event|28|||
145753623|NCT01110200|525610374|FG001|Overall Study|Adverse Event|28|||
145753624|NCT01110200|525610373|FG000|Overall Study|Withdrawal by Subject|25|||
145753625|NCT01110200|525610374|FG001|Overall Study|Withdrawal by Subject|32|||
145530244|NCT03148275|524802045|FG000|Overall Study|Death|6|||
145530245|NCT03148275|524802045|FG000|Overall Study|Adverse Event|3|||
145530246|NCT03148275|524802045|FG000|Overall Study|Liver transplant|2|||
145530247|NCT03148275|524802045|FG000|Overall Study|Patient decision|5|||
145530248|NCT03148275|524802045|FG000|Overall Study|transition to commercial drug|1|||
145530249|NCT03148275|524802045|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
145530250|NCT05098938|524802046|FG000|Overall Study|Adverse Event|4|||
145530251|NCT05098938|524802047|FG001|Overall Study|Adverse Event|3|||
145753626|NCT01110200|525610373|FG000|Overall Study|Lack of Efficacy|16|||
145753627|NCT01110200|525610374|FG001|Overall Study|Lack of Efficacy|25|||
145753628|NCT01110200|525610373|FG000|Overall Study|Protocol Violation|14|||
145530252|NCT05098938|524802046|FG000|Overall Study|inclusion/exclusion criteria change|11|||
145530253|NCT05098938|524802047|FG001|Overall Study|inclusion/exclusion criteria change|5|||
145530254|NCT05098938|524802046|FG000|Overall Study|lack of compliance|26|||
145530255|NCT05098938|524802047|FG001|Overall Study|lack of compliance|19|||
145530256|NCT05098938|524802046|FG000|Overall Study|Lost to Follow-up|37|||
145530257|NCT05098938|524802047|FG001|Overall Study|Lost to Follow-up|40|||
145530258|NCT05098938|524802046|FG000|Overall Study|Lost in treatment period|17|||
145530259|NCT05098938|524802047|FG001|Overall Study|Lost in treatment period|13|||
145530260|NCT05098938|524802046|FG000|Overall Study|Met an exclusion criterion|0|||
145530261|NCT05098938|524802047|FG001|Overall Study|Met an exclusion criterion|3|||
145530262|NCT05098938|524802046|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
145530263|NCT05098938|524802047|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
145530264|NCT05098938|524802046|FG000|Overall Study|Physician Decision|25|||
145530265|NCT05098938|524802047|FG001|Overall Study|Physician Decision|32|||
145530266|NCT05098938|524802046|FG000|Overall Study|Run in failure in treatment phase|1|||
145530267|NCT05098938|524802047|FG001|Overall Study|Run in failure in treatment phase|1|||
145530268|NCT05098938|524802046|FG000|Overall Study|Withdrawal by Subject|0|||
145530269|NCT05098938|524802047|FG001|Overall Study|Withdrawal by Subject|3|||
145530270|NCT05098938|524802046|FG000|Overall Study|Run-in Failure in early study|505|||
145530271|NCT05098938|524802047|FG001|Overall Study|Run-in Failure in early study|514|||
145530272|NCT05098938|524802046|FG000|Overall Study|IMP delivery missed|1|||
145530273|NCT05098938|524802047|FG001|Overall Study|IMP delivery missed|5|||
145530274|NCT05098938|524802046|FG000|Overall Study|6 months visit was missed|2|||
145530275|NCT05098938|524802047|FG001|Overall Study|6 months visit was missed|0|||
145530276|NCT05098938|524802046|FG000|Overall Study|fit for use was not completed within window|3|||
145530277|NCT05098938|524802047|FG001|Overall Study|fit for use was not completed within window|0|||
145530278|NCT05098938|524802046|FG000|Overall Study|V2 visit was not completed within window|0|||
145530279|NCT05098938|524802047|FG001|Overall Study|V2 visit was not completed within window|1|||
145530280|NCT05098938|524802046|FG000|Overall Study|exclusionary medication use|1|||
145530281|NCT05098938|524802047|FG001|Overall Study|exclusionary medication use|2|||
145530282|NCT05098938|524802046|FG000|Overall Study|change in medication|1|||
145530283|NCT05098938|524802047|FG001|Overall Study|change in medication|0|||
145530284|NCT05098938|524802046|FG000|Overall Study|treatment failure|2|||
145530285|NCT05098938|524802047|FG001|Overall Study|treatment failure|1|||
145530286|NCT03803683|524802048|FG000|Overall Study|Lost to Follow-up|41|||
145530287|NCT03803683|524802049|FG001|Overall Study|Lost to Follow-up|18|||
145530288|NCT03803683|524802050|FG002|Overall Study|Lost to Follow-up|12|||
145530289|NCT03803683|524802048|FG000|Overall Study|Withdrawal by Subject|9|||
145753629|NCT01110200|525610374|FG001|Overall Study|Protocol Violation|12|||
145753630|NCT01110200|525610373|FG000|Overall Study|Physician Decision|13|||
145753631|NCT01110200|525610374|FG001|Overall Study|Physician Decision|17|||
145753632|NCT01110200|525610373|FG000|Overall Study|Lost to Follow-up|10|||
145753633|NCT01110200|525610374|FG001|Overall Study|Lost to Follow-up|7|||
145753634|NCT03467958|525610375|FG000|Overall Study|Adverse Event|20|||
145753635|NCT03467958|525610376|FG001|Overall Study|Adverse Event|32|||
145753636|NCT03467958|525610377|FG002|Overall Study|Adverse Event|5|||
145753637|NCT03467958|525610378|FG003|Overall Study|Adverse Event|3|||
145530290|NCT03803683|524802049|FG001|Overall Study|Withdrawal by Subject|1|||
145530291|NCT03803683|524802050|FG002|Overall Study|Withdrawal by Subject|4|||
145530292|NCT00492050|524802051|FG000|Overall Study|Adverse Event|1|||
145530293|NCT00492050|524802051|FG000|Overall Study|Lack of Efficacy|1|||
145530294|NCT00492050|524802051|FG000|Overall Study|Withdrawal by Subject|3|||
145530295|NCT00492050|524802051|FG000|Overall Study|Unable to collect SCT|2|||
145530296|NCT00492050|524802051|FG000|Overall Study|Progressive Disease|2|||
145530297|NCT02349061|524803797|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
145530298|NCT02349061|524803798|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
145530299|NCT02349061|524803799|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
145530300|NCT02349061|524803797|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
145530301|NCT02349061|524803798|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
145530302|NCT02349061|524803799|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
145530303|NCT02349061|524803797|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
145530304|NCT02349061|524803798|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
145530305|NCT02349061|524803799|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
145530306|NCT02349061|524803797|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
145530307|NCT02349061|524803798|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
145530308|NCT02349061|524803799|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
145753638|NCT03467958|525610379|FG004|Overall Study|Adverse Event|3|||
145530309|NCT02349061|524803797|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
145530310|NCT02349061|524803798|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
145530311|NCT02349061|524803799|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
145530312|NCT02349061|524803797|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
145753639|NCT03467958|525610380|FG005|Overall Study|Adverse Event|3|||
145530313|NCT02349061|524803798|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
145530314|NCT02349061|524803799|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
145530315|NCT02349061|524803797|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
145530316|NCT02349061|524803798|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
145530317|NCT02349061|524803799|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
145530318|NCT02349061|524803797|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
145530319|NCT02349061|524803798|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
145530320|NCT02349061|524803799|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
145530321|NCT02349061|524803797|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
145530322|NCT02349061|524803798|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
145530323|NCT02349061|524803799|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
145530324|NCT02349061|524803797|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
145530325|NCT02349061|524803798|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
145530326|NCT02349061|524803799|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
145530327|NCT02349061|524803797|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
145530328|NCT02349061|524803798|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
145530329|NCT02349061|524803799|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
145753640|NCT03467958|525610381|FG006|Overall Study|Adverse Event|6|||
145753641|NCT03467958|525610382|FG007|Overall Study|Adverse Event|5|||
145753642|NCT03467958|525610383|FG008|Overall Study|Adverse Event|0|||
145753643|NCT03467958|525610375|FG000|Overall Study|Lack of Efficacy|59|||
145753644|NCT03467958|525610376|FG001|Overall Study|Lack of Efficacy|120|||
145753645|NCT03467958|525610377|FG002|Overall Study|Lack of Efficacy|6|||
145753646|NCT03467958|525610378|FG003|Overall Study|Lack of Efficacy|9|||
145753647|NCT03467958|525610379|FG004|Overall Study|Lack of Efficacy|8|||
145753648|NCT03467958|525610380|FG005|Overall Study|Lack of Efficacy|9|||
145753649|NCT03467958|525610381|FG006|Overall Study|Lack of Efficacy|11|||
145753650|NCT03467958|525610382|FG007|Overall Study|Lack of Efficacy|9|||
145753651|NCT03467958|525610383|FG008|Overall Study|Lack of Efficacy|3|||
145753652|NCT03467958|525610375|FG000|Overall Study|Lost to Follow-up|1|||
145753653|NCT03467958|525610376|FG001|Overall Study|Lost to Follow-up|2|||
145753654|NCT03467958|525610377|FG002|Overall Study|Lost to Follow-up|1|||
145753655|NCT03467958|525610378|FG003|Overall Study|Lost to Follow-up|0|||
145753656|NCT03467958|525610379|FG004|Overall Study|Lost to Follow-up|4|||
145753657|NCT03467958|525610380|FG005|Overall Study|Lost to Follow-up|0|||
145753658|NCT03467958|525610381|FG006|Overall Study|Lost to Follow-up|0|||
145753659|NCT03467958|525610382|FG007|Overall Study|Lost to Follow-up|0|||
145753660|NCT03467958|525610383|FG008|Overall Study|Lost to Follow-up|0|||
145272521|NCT00424632|523846228|FG009|Overall Study|Adverse Event|2|||
145530330|NCT02349061|524803797|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
145530331|NCT02349061|524803798|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
145753661|NCT03467958|525610375|FG000|Overall Study|Other reasons|8|||
145753662|NCT03467958|525610376|FG001|Overall Study|Other reasons|14|||
145753663|NCT03467958|525610377|FG002|Overall Study|Other reasons|2|||
145753664|NCT03467958|525610378|FG003|Overall Study|Other reasons|1|||
145753665|NCT03467958|525610379|FG004|Overall Study|Other reasons|4|||
145753666|NCT03467958|525610380|FG005|Overall Study|Other reasons|0|||
145753667|NCT03467958|525610381|FG006|Overall Study|Other reasons|1|||
145530332|NCT02349061|524803799|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
145530333|NCT02349061|524803797|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
145530334|NCT02349061|524803798|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
145530335|NCT02349061|524803799|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
145530336|NCT02339285|524803800|FG000|Overall Study|Withdrawal by Subject|0|||
145530337|NCT02339285|524803801|FG001|Overall Study|Withdrawal by Subject|1|||
145530338|NCT02339285|524803802|FG002|Overall Study|Withdrawal by Subject|1|||
145530339|NCT02339285|524803800|FG000|Overall Study|Lost to Follow-up|1|||
145530340|NCT02339285|524803801|FG001|Overall Study|Lost to Follow-up|1|||
145530341|NCT02339285|524803802|FG002|Overall Study|Lost to Follow-up|1|||
145530342|NCT02339285|524803800|FG000|Overall Study|Protocol Deviation|0|||
145530343|NCT02339285|524803801|FG001|Overall Study|Protocol Deviation|1|||
145530344|NCT02339285|524803802|FG002|Overall Study|Protocol Deviation|0|||
145272522|NCT00424632|523846219|FG000|Overall Study|Global deterioration of health status|0|||
145530345|NCT00282412|524803807|FG000|Overall Study|Death|2|||
145530346|NCT01507298|524803810|FG000|Overall Study|Protocol Violation|0|||
145530347|NCT01507298|524803811|FG001|Overall Study|Protocol Violation|6|||
145530348|NCT00537238|524803812|FG000|Overall Study|Death|1|||
145530349|NCT00537238|524803813|FG001|Overall Study|Death|2|||
145530350|NCT00537238|524803812|FG000|Overall Study|Adverse Event|31|||
145530351|NCT00537238|524803813|FG001|Overall Study|Adverse Event|22|||
145530352|NCT00537238|524803812|FG000|Overall Study|Lack of Efficacy|20|||
145530353|NCT00537238|524803813|FG001|Overall Study|Lack of Efficacy|21|||
145530354|NCT00537238|524803812|FG000|Overall Study|Lost to Follow-up|12|||
145530355|NCT00537238|524803813|FG001|Overall Study|Lost to Follow-up|8|||
145530356|NCT00537238|524803812|FG000|Overall Study|Withdrawal by Subject|51|||
145530357|NCT00537238|524803813|FG001|Overall Study|Withdrawal by Subject|47|||
145530358|NCT00537238|524803812|FG000|Overall Study|Protocol Violation|15|||
145530359|NCT00537238|524803813|FG001|Overall Study|Protocol Violation|19|||
145530360|NCT00537238|524803812|FG000|Overall Study|Does not meet entrance criteria|0|||
145530361|NCT00537238|524803813|FG001|Overall Study|Does not meet entrance criteria|2|||
145530362|NCT00537238|524803812|FG000|Overall Study|Other|44|||
145530363|NCT00537238|524803813|FG001|Overall Study|Other|52|||
145530364|NCT01920555|524803814|FG000|Overall Study|Physician Decision|1|||
145530365|NCT01920555|524803815|FG001|Overall Study|Physician Decision|2|||
145530366|NCT01920555|524803816|FG002|Overall Study|Physician Decision|1|||
145530367|NCT01920555|524803817|FG003|Overall Study|Physician Decision|2|||
145530368|NCT01920555|524803818|FG004|Overall Study|Physician Decision|0|||
145530369|NCT01920555|524803814|FG000|Overall Study|Lack of Efficacy|2|||
145530370|NCT01920555|524803815|FG001|Overall Study|Lack of Efficacy|0|||
145530371|NCT01920555|524803816|FG002|Overall Study|Lack of Efficacy|0|||
145530372|NCT01920555|524803817|FG003|Overall Study|Lack of Efficacy|0|||
145530373|NCT01920555|524803818|FG004|Overall Study|Lack of Efficacy|0|||
145530374|NCT01920555|524803814|FG000|Overall Study|Travel Difficulties|1|||
145530375|NCT01920555|524803815|FG001|Overall Study|Travel Difficulties|1|||
145530376|NCT01920555|524803816|FG002|Overall Study|Travel Difficulties|0|||
145530377|NCT01920555|524803817|FG003|Overall Study|Travel Difficulties|0|||
145530378|NCT01920555|524803818|FG004|Overall Study|Travel Difficulties|1|||
145530379|NCT01920555|524803814|FG000|Overall Study|Lost to Follow-up|0|||
145530380|NCT01920555|524803815|FG001|Overall Study|Lost to Follow-up|1|||
145530381|NCT01920555|524803816|FG002|Overall Study|Lost to Follow-up|0|||
145530382|NCT01920555|524803817|FG003|Overall Study|Lost to Follow-up|1|||
145530383|NCT01920555|524803818|FG004|Overall Study|Lost to Follow-up|0|||
145530384|NCT03911713|524803821|FG000|Overall Study|Lost to Follow-up|0|||
145530385|NCT03911713|524803822|FG001|Overall Study|Lost to Follow-up|2|||
145530386|NCT03911713|524803823|FG002|Overall Study|Lost to Follow-up|0|||
145753668|NCT03467958|525610382|FG007|Overall Study|Other reasons|0|||
145753669|NCT03467958|525610383|FG008|Overall Study|Other reasons|1|||
145753670|NCT03467958|525610375|FG000|Overall Study|Pregnancy|1|||
145753671|NCT03467958|525610376|FG001|Overall Study|Pregnancy|0|||
145753672|NCT03467958|525610377|FG002|Overall Study|Pregnancy|0|||
145753673|NCT03467958|525610378|FG003|Overall Study|Pregnancy|0|||
145753674|NCT03467958|525610379|FG004|Overall Study|Pregnancy|0|||
145753675|NCT03467958|525610380|FG005|Overall Study|Pregnancy|1|||
145753676|NCT03467958|525610381|FG006|Overall Study|Pregnancy|0|||
145753677|NCT03467958|525610382|FG007|Overall Study|Pregnancy|0|||
145753678|NCT03467958|525610383|FG008|Overall Study|Pregnancy|0|||
145753679|NCT03467958|525610375|FG000|Overall Study|Study terminated by sponsor|65|||
145753680|NCT03467958|525610376|FG001|Overall Study|Study terminated by sponsor|117|||
145753681|NCT03467958|525610377|FG002|Overall Study|Study terminated by sponsor|45|||
145753682|NCT03467958|525610378|FG003|Overall Study|Study terminated by sponsor|64|||
145753683|NCT03467958|525610379|FG004|Overall Study|Study terminated by sponsor|66|||
145753684|NCT03467958|525610380|FG005|Overall Study|Study terminated by sponsor|17|||
145753685|NCT03467958|525610381|FG006|Overall Study|Study terminated by sponsor|11|||
145753686|NCT03467958|525610382|FG007|Overall Study|Study terminated by sponsor|5|||
145753687|NCT03467958|525610383|FG008|Overall Study|Study terminated by sponsor|5|||
145753688|NCT03467958|525610375|FG000|Overall Study|Withdrawal by Subject|25|||
145753689|NCT03467958|525610376|FG001|Overall Study|Withdrawal by Subject|44|||
145753690|NCT03467958|525610377|FG002|Overall Study|Withdrawal by Subject|7|||
145753691|NCT03467958|525610378|FG003|Overall Study|Withdrawal by Subject|8|||
145753692|NCT03467958|525610379|FG004|Overall Study|Withdrawal by Subject|6|||
145753693|NCT03467958|525610380|FG005|Overall Study|Withdrawal by Subject|8|||
145753694|NCT03467958|525610381|FG006|Overall Study|Withdrawal by Subject|4|||
145753695|NCT03467958|525610382|FG007|Overall Study|Withdrawal by Subject|1|||
145753696|NCT03467958|525610383|FG008|Overall Study|Withdrawal by Subject|4|||
145753697|NCT02925156|525610385|FG000|Overall Study|Lost to Follow-up|27|||
145753698|NCT02925156|525610386|FG001|Overall Study|Lost to Follow-up|53|||
145753699|NCT02925156|525610387|FG002|Overall Study|Lost to Follow-up|51|||
145753700|NCT02925156|525610388|FG003|Overall Study|Lost to Follow-up|59|||
145753701|NCT02925156|525610389|FG004|Overall Study|Lost to Follow-up|89|||
145753702|NCT02925156|525610390|FG005|Overall Study|Lost to Follow-up|107|||
145753703|NCT02925156|525610391|FG006|Overall Study|Lost to Follow-up|34|||
145753704|NCT02925156|525610392|FG007|Overall Study|Lost to Follow-up|36|||
145753705|NCT02925156|525610393|FG008|Overall Study|Lost to Follow-up|73|||
145753706|NCT02925156|525610394|FG009|Overall Study|Lost to Follow-up|34|||
145753707|NCT00866307|525610395|FG000|Induction|Adverse Event|5|||
145753708|NCT00866307|525610396|FG001|Induction|Adverse Event|0|||
145753709|NCT00866307|525610397|FG002|Induction|Adverse Event|0|||
145753710|NCT00866307|525610395|FG000|Induction|Death|2|||
145753711|NCT00866307|525610396|FG001|Induction|Death|0|||
145753712|NCT00866307|525610397|FG002|Induction|Death|0|||
145753713|NCT00866307|525610395|FG000|Induction|Physician Decision|5|||
145753714|NCT00866307|525610396|FG001|Induction|Physician Decision|0|||
145753715|NCT00866307|525610397|FG002|Induction|Physician Decision|0|||
145753716|NCT00866307|525610395|FG000|Induction|Progressive Disease|1|||
145753717|NCT00866307|525610396|FG001|Induction|Progressive Disease|0|||
145753718|NCT00866307|525610397|FG002|Induction|Progressive Disease|0|||
145272523|NCT00424632|523846220|FG001|Overall Study|Global deterioration of health status|0|||
145272524|NCT00424632|523846221|FG002|Overall Study|Global deterioration of health status|0|||
145272525|NCT00424632|523846222|FG003|Overall Study|Global deterioration of health status|1|||
145272526|NCT00424632|523846223|FG004|Overall Study|Global deterioration of health status|1|||
145272527|NCT00424632|523846224|FG005|Overall Study|Global deterioration of health status|0|||
145272528|NCT00424632|523846225|FG006|Overall Study|Global deterioration of health status|0|||
145753719|NCT00866307|525610395|FG000|Induction|Identification of Patients with Day 29 M|3|||
145753720|NCT00866307|525610396|FG001|Induction|Identification of Patients with Day 29 M|0|||
145753721|NCT00866307|525610397|FG002|Induction|Identification of Patients with Day 29 M|0|||
145753722|NCT00866307|525610395|FG000|Induction|Inadequate cytognetic samples th|1|||
145753723|NCT00866307|525610396|FG001|Induction|Inadequate cytognetic samples th|0|||
145753724|NCT00866307|525610397|FG002|Induction|Inadequate cytognetic samples th|0|||
145753725|NCT00866307|525610395|FG000|Induction|Improper post-induction consent|2|||
145272529|NCT00424632|523846226|FG007|Overall Study|Global deterioration of health status|0|||
145530387|NCT03911713|524803824|FG003|Overall Study|Lost to Follow-up|0|||
145753726|NCT00866307|525610396|FG001|Induction|Improper post-induction consent|0|||
145753727|NCT00866307|525610397|FG002|Induction|Improper post-induction consent|0|||
145753728|NCT00866307|525610395|FG000|Induction|Study was closed at the time|1|||
145753729|NCT00866307|525610396|FG001|Induction|Study was closed at the time|0|||
145753730|NCT00866307|525610397|FG002|Induction|Study was closed at the time|0|||
145402747|NCT01075048|524332473|FG001|Overall Study|Lost to Follow-up|1|||
145753731|NCT00866307|525610395|FG000|Consolidation/Maintenance|Adverse Event|0|||
145753732|NCT00866307|525610396|FG001|Consolidation/Maintenance|Adverse Event|0|||
145753733|NCT00866307|525610397|FG002|Consolidation/Maintenance|Adverse Event|8|||
145753734|NCT00866307|525610395|FG000|Consolidation/Maintenance|Death|0|||
145753735|NCT00866307|525610396|FG001|Consolidation/Maintenance|Death|0|||
145753736|NCT00866307|525610397|FG002|Consolidation/Maintenance|Death|1|||
145753737|NCT00866307|525610395|FG000|Consolidation/Maintenance|Physician Decision|0|||
145753738|NCT00866307|525610396|FG001|Consolidation/Maintenance|Physician Decision|3|||
145753739|NCT00866307|525610397|FG002|Consolidation/Maintenance|Physician Decision|2|||
145753740|NCT00866307|525610395|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
145753741|NCT00866307|525610396|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
145753742|NCT00866307|525610397|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
145272530|NCT00424632|523846227|FG008|Overall Study|Global deterioration of health status|0|||
145272531|NCT00424632|523846228|FG009|Overall Study|Global deterioration of health status|0|||
145272532|NCT00424632|523846219|FG000|Overall Study|Objective progression or relapse|1|||
145272533|NCT00424632|523846220|FG001|Overall Study|Objective progression or relapse|1|||
145272534|NCT00424632|523846221|FG002|Overall Study|Objective progression or relapse|1|||
145272535|NCT00424632|523846222|FG003|Overall Study|Objective progression or relapse|2|||
145272536|NCT00424632|523846223|FG004|Overall Study|Objective progression or relapse|2|||
145272537|NCT00424632|523846224|FG005|Overall Study|Objective progression or relapse|13|||
145272538|NCT00424632|523846225|FG006|Overall Study|Objective progression or relapse|7|||
145272539|NCT00424632|523846226|FG007|Overall Study|Objective progression or relapse|3|||
145272540|NCT00424632|523846227|FG008|Overall Study|Objective progression or relapse|12|||
145272541|NCT00424632|523846228|FG009|Overall Study|Objective progression or relapse|4|||
145272542|NCT00424632|523846219|FG000|Overall Study|Other|0|||
145272543|NCT00424632|523846220|FG001|Overall Study|Other|0|||
145272544|NCT00424632|523846221|FG002|Overall Study|Other|0|||
145272545|NCT00424632|523846222|FG003|Overall Study|Other|1|||
145272546|NCT00424632|523846223|FG004|Overall Study|Other|0|||
145272547|NCT00424632|523846224|FG005|Overall Study|Other|0|||
145272548|NCT00424632|523846225|FG006|Overall Study|Other|0|||
145272549|NCT00424632|523846226|FG007|Overall Study|Other|0|||
145272550|NCT00424632|523846227|FG008|Overall Study|Other|1|||
145272551|NCT00424632|523846228|FG009|Overall Study|Other|0|||
145272552|NCT03972709|523846235|FG000|Overall Study|Withdrawal by Subject|18|||
145272553|NCT03972709|523846236|FG001|Overall Study|Withdrawal by Subject|7|||
145272554|NCT03972709|523846237|FG002|Overall Study|Withdrawal by Subject|14|||
145272555|NCT03972709|523846235|FG000|Overall Study|Study Terminated by Sponsor|48|||
145272556|NCT03972709|523846236|FG001|Overall Study|Study Terminated by Sponsor|25|||
145272557|NCT03972709|523846237|FG002|Overall Study|Study Terminated by Sponsor|50|||
145272558|NCT03972709|523846235|FG000|Overall Study|Physician Decision|1|||
145272559|NCT03972709|523846236|FG001|Overall Study|Physician Decision|0|||
145272560|NCT03972709|523846237|FG002|Overall Study|Physician Decision|0|||
145272561|NCT03972709|523846235|FG000|Overall Study|COVID-19|0|||
145272562|NCT03972709|523846236|FG001|Overall Study|COVID-19|1|||
145272563|NCT03972709|523846237|FG002|Overall Study|COVID-19|1|||
145272564|NCT03972709|523846235|FG000|Overall Study|Lost to Follow-up|6|||
145272565|NCT03972709|523846236|FG001|Overall Study|Lost to Follow-up|1|||
145272566|NCT03972709|523846237|FG002|Overall Study|Lost to Follow-up|2|||
145272567|NCT03972709|523846235|FG000|Overall Study|Death|5|||
145272568|NCT03972709|523846236|FG001|Overall Study|Death|1|||
145272569|NCT03972709|523846237|FG002|Overall Study|Death|4|||
145272570|NCT03972709|523846235|FG000|Overall Study|Adverse Event|3|||
145272571|NCT03972709|523846236|FG001|Overall Study|Adverse Event|1|||
145272572|NCT03972709|523846237|FG002|Overall Study|Adverse Event|4|||
145272573|NCT03972709|523846235|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
145272574|NCT03972709|523846236|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
145272575|NCT03972709|523846237|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
145272576|NCT03972709|523846235|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
145530388|NCT03911713|524803825|FG004|Overall Study|Lost to Follow-up|0|||
145530389|NCT03911713|524803821|FG000|Overall Study|Other|0|||
145530390|NCT03911713|524803822|FG001|Overall Study|Other|0|||
145530391|NCT03911713|524803823|FG002|Overall Study|Other|0|||
145530392|NCT03911713|524803824|FG003|Overall Study|Other|1|||
145753743|NCT00866307|525610395|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
145272577|NCT03972709|523846236|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
145530393|NCT03911713|524803825|FG004|Overall Study|Other|0|||
145753744|NCT00866307|525610396|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
145753745|NCT00866307|525610397|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
145753746|NCT00866307|525610395|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
145753747|NCT00866307|525610396|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
145753748|NCT00866307|525610397|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
145753749|NCT00866307|525610395|FG000|Consolidation/Maintenance|Therapy error|0|||
145753750|NCT00866307|525610396|FG001|Consolidation/Maintenance|Therapy error|1|||
145753751|NCT00866307|525610397|FG002|Consolidation/Maintenance|Therapy error|0|||
145272578|NCT03972709|523846237|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
145272579|NCT03972709|523846235|FG000|Overall Study|Subject Unable to be Contacted|0|||
145530394|NCT03911713|524803821|FG000|Overall Study|Randomized, Never Dosed|1|||
145272580|NCT03972709|523846236|FG001|Overall Study|Subject Unable to be Contacted|1|||
145272581|NCT03972709|523846237|FG002|Overall Study|Subject Unable to be Contacted|0|||
145272582|NCT03972709|523846235|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
145272583|NCT03972709|523846236|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
145272584|NCT03972709|523846237|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
145272585|NCT03972709|523846235|FG000|Overall Study|Subject Moved|0|||
145272586|NCT03972709|523846236|FG001|Overall Study|Subject Moved|1|||
145272587|NCT03972709|523846237|FG002|Overall Study|Subject Moved|0|||
145272588|NCT03972709|523846235|FG000|Overall Study|Missed Study Visits|1|||
145272589|NCT03972709|523846236|FG001|Overall Study|Missed Study Visits|0|||
145272590|NCT03972709|523846237|FG002|Overall Study|Missed Study Visits|0|||
145753752|NCT00866307|525610395|FG000|Consolidation/Maintenance|Non-compliance|0|||
145753753|NCT00866307|525610396|FG001|Consolidation/Maintenance|Non-compliance|0|||
145753754|NCT00866307|525610397|FG002|Consolidation/Maintenance|Non-compliance|1|||
145753755|NCT00866307|525610395|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
145753756|NCT00866307|525610396|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
145753757|NCT00866307|525610397|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
145753758|NCT00730639|525610398|FG000|Overall Study|Adverse Event|3|||
145753759|NCT00730639|525610399|FG001|Overall Study|Adverse Event|0|||
145272591|NCT01393626|523846242|FG000|Overall Study|Adverse Event|2|||
145272592|NCT01393626|523846243|FG001|Overall Study|Adverse Event|1|||
145272593|NCT01393626|523846244|FG002|Overall Study|Adverse Event|5|||
145272594|NCT01393626|523846245|FG003|Overall Study|Adverse Event|0|||
145272595|NCT01393626|523846242|FG000|Overall Study|Did not meet entrance criteria|1|||
145272596|NCT01393626|523846243|FG001|Overall Study|Did not meet entrance criteria|0|||
145272597|NCT01393626|523846244|FG002|Overall Study|Did not meet entrance criteria|0|||
145272598|NCT01393626|523846245|FG003|Overall Study|Did not meet entrance criteria|0|||
145272599|NCT01393626|523846242|FG000|Overall Study|Lack of Efficacy|6|||
145272600|NCT01393626|523846243|FG001|Overall Study|Lack of Efficacy|6|||
145272601|NCT01393626|523846244|FG002|Overall Study|Lack of Efficacy|4|||
145272602|NCT01393626|523846245|FG003|Overall Study|Lack of Efficacy|1|||
145272603|NCT01393626|523846242|FG000|Overall Study|Lost to Follow-up|1|||
145272604|NCT01393626|523846243|FG001|Overall Study|Lost to Follow-up|1|||
145272605|NCT01393626|523846244|FG002|Overall Study|Lost to Follow-up|1|||
145272606|NCT01393626|523846245|FG003|Overall Study|Lost to Follow-up|0|||
145272607|NCT01393626|523846242|FG000|Overall Study|Withdrawal by Subject|6|||
145272608|NCT01393626|523846243|FG001|Overall Study|Withdrawal by Subject|4|||
145272609|NCT01393626|523846244|FG002|Overall Study|Withdrawal by Subject|0|||
145272610|NCT01393626|523846245|FG003|Overall Study|Withdrawal by Subject|0|||
145272611|NCT01393626|523846242|FG000|Overall Study|Other|1|||
145272612|NCT01393626|523846243|FG001|Overall Study|Other|0|||
145272613|NCT01393626|523846244|FG002|Overall Study|Other|0|||
145272614|NCT01393626|523846245|FG003|Overall Study|Other|0|||
145272615|NCT01393626|523846242|FG000|Overall Study|Protocol Violation|1|||
145272616|NCT01393626|523846243|FG001|Overall Study|Protocol Violation|0|||
145272617|NCT01393626|523846244|FG002|Overall Study|Protocol Violation|2|||
145272618|NCT01393626|523846245|FG003|Overall Study|Protocol Violation|0|||
145272619|NCT02426125|523846246|FG000|Overall Study|Lost to Follow-up|14|||
145272620|NCT02426125|523846247|FG001|Overall Study|Lost to Follow-up|12|||
145272621|NCT02426125|523846246|FG000|Overall Study|Withdrawal by Subject|13|||
145272622|NCT02426125|523846247|FG001|Overall Study|Withdrawal by Subject|14|||
145272623|NCT02426125|523846246|FG000|Overall Study|Death|185|||
145272624|NCT02426125|523846247|FG001|Overall Study|Death|200|||
145272625|NCT02426125|523846246|FG000|Overall Study|Randomized, But Never Treated|5|||
145272626|NCT02426125|523846247|FG001|Overall Study|Randomized, But Never Treated|2|||
145272627|NCT02858076|523846248|FG000|Overall Study|Death|6|||
145272628|NCT02858076|523846249|FG001|Overall Study|Death|3|||
145272629|NCT02858076|523846248|FG000|Overall Study|Withdrawal by Subject|1|||
145530395|NCT03911713|524803822|FG001|Overall Study|Randomized, Never Dosed|0|||
145753760|NCT00730639|525610400|FG002|Overall Study|Adverse Event|9|||
145753761|NCT00730639|525610401|FG003|Overall Study|Adverse Event|8|||
145272630|NCT02858076|523846249|FG001|Overall Study|Withdrawal by Subject|5|||
145272631|NCT02858076|523846248|FG000|Overall Study|Lost to Follow-up|2|||
145272632|NCT02858076|523846249|FG001|Overall Study|Lost to Follow-up|7|||
145272633|NCT02858076|523846248|FG000|Overall Study|Completed Out of Window|1|||
145272634|NCT02858076|523846249|FG001|Overall Study|Completed Out of Window|3|||
145272635|NCT00938015|523846257|FG000|Overall Study|Death|2|||
145272636|NCT00938015|523846257|FG000|Overall Study|Lost to Follow-up|32|||
145272637|NCT00938015|523846257|FG000|Overall Study|Adverse Event|32|||
145272638|NCT00938015|523846257|FG000|Overall Study|Non-responder|52|||
145272639|NCT00938015|523846257|FG000|Overall Study|Reason not related to Etanercept|29|||
145272640|NCT02341482|523846258|FG000|Overall Study|Adverse Event|1|||
145272641|NCT03186794|523846259|FG000|Overall Study|Physician Decision|2|||
145272642|NCT03186794|523846259|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
145272643|NCT00664066|523846266|FG000|Overall Study|Study terminated|3|||
145272644|NCT02180659|523846267|FG000|Overall Study|Adverse Event|1|||
145530396|NCT03911713|524803823|FG002|Overall Study|Randomized, Never Dosed|0|||
145530397|NCT03911713|524803824|FG003|Overall Study|Randomized, Never Dosed|1|||
145530398|NCT03911713|524803825|FG004|Overall Study|Randomized, Never Dosed|0|||
145530399|NCT01193660|524803828|FG000|Overall Study|Withdrawal by Subject|2|||
145530400|NCT01193660|524803829|FG001|Overall Study|Withdrawal by Subject|3|||
145530401|NCT01193660|524803830|FG002|Overall Study|Withdrawal by Subject|1|||
145530402|NCT01193660|524803828|FG000|Overall Study|Death|1|||
145530403|NCT01193660|524803829|FG001|Overall Study|Death|0|||
145530404|NCT01193660|524803830|FG002|Overall Study|Death|0|||
145530405|NCT01193660|524803828|FG000|Overall Study|Physician Decision|1|||
145530406|NCT01193660|524803829|FG001|Overall Study|Physician Decision|0|||
145530407|NCT01193660|524803830|FG002|Overall Study|Physician Decision|1|||
145530408|NCT01845818|524803831|FG000|Overall Study|Withdrawal by Subject|0|||
145530409|NCT01845818|524803832|FG001|Overall Study|Withdrawal by Subject|1|||
145530410|NCT01845818|524803831|FG000|Overall Study|Lost to Follow-up|7|||
145530411|NCT01845818|524803832|FG001|Overall Study|Lost to Follow-up|5|||
145530412|NCT01845818|524803831|FG000|Overall Study|Administrative Reasons|3|||
145530413|NCT01845818|524803832|FG001|Overall Study|Administrative Reasons|1|||
145530414|NCT01845818|524803831|FG000|Overall Study|Serious Adverse Event|1|||
145530415|NCT01845818|524803832|FG001|Overall Study|Serious Adverse Event|1|||
145530416|NCT01845818|524803831|FG000|Overall Study|Other|25|||
145530417|NCT01845818|524803832|FG001|Overall Study|Other|8|||
145530418|NCT01845818|524803831|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
145530419|NCT01845818|524803832|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
145530420|NCT01845818|524803831|FG000|Overall Study|No Follow-Up Data Available|4|||
145530421|NCT01845818|524803832|FG001|Overall Study|No Follow-Up Data Available|1|||
145530422|NCT01680965|524803833|FG000|Overall Study|Death|0|||
145530423|NCT01680965|524803834|FG001|Overall Study|Death|0|||
145530424|NCT01680965|524803835|FG002|Overall Study|Death|0|||
145530425|NCT01680965|524803836|FG003|Overall Study|Death|6|||
145530426|NCT00195273|524803837|FG000|Overall Study|Adverse Event|9|||
145530427|NCT00195273|524803838|FG001|Overall Study|Adverse Event|9|||
145530428|NCT00195273|524803837|FG000|Overall Study|Protocol deviation|0|||
145530429|NCT00195273|524803838|FG001|Overall Study|Protocol deviation|1|||
145530430|NCT00195273|524803837|FG000|Overall Study|Lack of Efficacy|3|||
145530431|NCT00195273|524803838|FG001|Overall Study|Lack of Efficacy|1|||
145530432|NCT00195273|524803837|FG000|Overall Study|Procedural complications|9|||
145530433|NCT00195273|524803838|FG001|Overall Study|Procedural complications|3|||
145530434|NCT02595970|524803839|FG000|Overall Study|Withdrawal by Subject|2|||
145530435|NCT02595970|524803839|FG000|Overall Study|Physician Decision|2|||
145530436|NCT02595970|524803839|FG000|Overall Study|Protocol Violation|4|||
145530437|NCT02595970|524803839|FG000|Overall Study|Adverse Event|5|||
145530438|NCT02595970|524803839|FG000|Overall Study|Lack of Efficacy|7|||
145530439|NCT02367131|524803840|FG000|Overall Study|Adverse Event|64|||
145530440|NCT02367131|524803840|FG000|Overall Study|No visit since the first visit|3|||
145530441|NCT02367131|524803840|FG000|Overall Study|Request by patient|53|||
145530442|NCT02367131|524803840|FG000|Overall Study|Improvement/remission|2|||
145530443|NCT02367131|524803840|FG000|Overall Study|No change/progressive disease|78|||
145530444|NCT02367131|524803840|FG000|Overall Study|Other than stated above|20|||
145530445|NCT02367131|524803840|FG000|Overall Study|Not treated|2|||
145530446|NCT02570074|524803841|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
145530447|NCT02570074|524803842|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
145530448|NCT05061966|524803843|FG000|Overall Study|Lost to Follow-up|13|||
145530449|NCT05061966|524803844|FG001|Overall Study|Lost to Follow-up|13|||
145530450|NCT01675427|524803849|FG000|Overall Study|Withdrawal by Subject|7|||
145530451|NCT01675427|524803849|FG000|Overall Study|Participant Refused Sample Collection|18|||
145530452|NCT01675427|524803849|FG000|Overall Study|Sample not Collected by Mistake|2|||
145530453|NCT01675427|524803849|FG000|Overall Study|Lost to Follow-up|5|||
145530454|NCT01675427|524803849|FG000|Overall Study|Other|2|||
145530455|NCT00611533|524803850|FG000|First Intervention (6 Weeks)|Never started study|0|||
145753762|NCT00730639|525610402|FG004|Overall Study|Adverse Event|23|||
145530456|NCT00611533|524803851|FG001|First Intervention (6 Weeks)|Never started study|1|||
145530457|NCT00611533|524803850|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
145530458|NCT00611533|524803851|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
145753763|NCT00730639|525610398|FG000|Overall Study|Complete Response|0|||
145753764|NCT00730639|525610399|FG001|Overall Study|Complete Response|0|||
145753765|NCT00730639|525610400|FG002|Overall Study|Complete Response|2|||
145530459|NCT00611533|524803850|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
145530460|NCT00611533|524803851|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
145530461|NCT04171765|524803855|FG000|Overall Study|Adverse Event|2|||
145530462|NCT04171765|524803856|FG001|Overall Study|Adverse Event|0|||
145530463|NCT04171765|524803857|FG002|Overall Study|Adverse Event|1|||
145530464|NCT04171765|524803858|FG003|Overall Study|Adverse Event|0|||
145530465|NCT04171765|524803855|FG000|Overall Study|Lost to Follow-up|0|||
145530466|NCT04171765|524803856|FG001|Overall Study|Lost to Follow-up|2|||
145530467|NCT04171765|524803857|FG002|Overall Study|Lost to Follow-up|2|||
145530468|NCT04171765|524803858|FG003|Overall Study|Lost to Follow-up|2|||
145530469|NCT04171765|524803855|FG000|Overall Study|Week 58 visit missed|0|||
145272645|NCT02180659|523846268|FG001|Overall Study|Adverse Event|0|||
145272646|NCT02180659|523846267|FG000|Overall Study|Lost to Follow-up|4|||
145272647|NCT02180659|523846268|FG001|Overall Study|Lost to Follow-up|2|||
145272648|NCT02180659|523846267|FG000|Overall Study|Subject incarcerated during conduct|1|||
145272649|NCT02180659|523846268|FG001|Overall Study|Subject incarcerated during conduct|0|||
145272650|NCT02180659|523846267|FG000|Overall Study|Withdrawal by Subject|0|||
145272651|NCT02180659|523846268|FG001|Overall Study|Withdrawal by Subject|2|||
145272652|NCT02180659|523846267|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
145272653|NCT02180659|523846268|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
145272654|NCT03000075|523846269|FG000|Part A|Adverse Event|4|||
145272655|NCT03000075|523846270|FG001|Part A|Adverse Event|0|||
145272656|NCT03000075|523846271|FG002|Part A|Adverse Event|0|||
145272657|NCT03000075|523846272|FG003|Part A|Adverse Event|0|||
145272658|NCT03000075|523846273|FG004|Part A|Adverse Event|0|||
145272659|NCT03000075|523846274|FG005|Part A|Adverse Event|0|||
145272660|NCT03000075|523846275|FG006|Part A|Adverse Event|0|||
145272661|NCT03000075|523846269|FG000|Part B|Not dosed due to AE|0|||
145272662|NCT03000075|523846270|FG001|Part B|Not dosed due to AE|0|||
145272663|NCT03000075|523846271|FG002|Part B|Not dosed due to AE|0|||
145272664|NCT03000075|523846272|FG003|Part B|Not dosed due to AE|0|||
145272665|NCT03000075|523846273|FG004|Part B|Not dosed due to AE|0|||
145272666|NCT03000075|523846274|FG005|Part B|Not dosed due to AE|2|||
145272667|NCT03000075|523846275|FG006|Part B|Not dosed due to AE|1|||
145272668|NCT03000075|523846269|FG000|Part B|Adverse Event|0|||
145272669|NCT03000075|523846270|FG001|Part B|Adverse Event|0|||
145272670|NCT03000075|523846271|FG002|Part B|Adverse Event|0|||
145272671|NCT03000075|523846272|FG003|Part B|Adverse Event|0|||
145272672|NCT03000075|523846273|FG004|Part B|Adverse Event|1|||
145272673|NCT03000075|523846274|FG005|Part B|Adverse Event|0|||
145272674|NCT03000075|523846275|FG006|Part B|Adverse Event|0|||
145272675|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
145272676|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
145272677|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Death|5|||
145272678|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Death|2|||
145272679|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
145272680|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
145272681|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
145272682|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
145272683|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
145272684|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
145272685|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Relapse|1|||
145272686|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Relapse|0|||
145272687|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
145272688|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
145272689|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
145272690|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
145272691|NCT00111007|523846276|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
145272692|NCT00111007|523846277|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
145272693|NCT00111007|523846276|FG000|Active Follow-up|Adverse Event|1|||
145272694|NCT00111007|523846277|FG001|Active Follow-up|Adverse Event|0|||
145272695|NCT00111007|523846276|FG000|Active Follow-up|Death|2|||
145272696|NCT00111007|523846277|FG001|Active Follow-up|Death|0|||
145272697|NCT00111007|523846276|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
145272698|NCT00111007|523846277|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
145272699|NCT00111007|523846276|FG000|Long Term Follow-up|Death|34|||
145272700|NCT00111007|523846277|FG001|Long Term Follow-up|Death|39|||
145272701|NCT00111007|523846276|FG000|Long Term Follow-up|Lost to Follow-up|1|||
145272702|NCT00111007|523846277|FG001|Long Term Follow-up|Lost to Follow-up|1|||
145272703|NCT00111007|523846276|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
145272704|NCT00111007|523846277|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
145272705|NCT00111007|523846276|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
145272706|NCT00111007|523846277|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
145272707|NCT00111007|523846276|FG000|Long Term Follow-up|Missing|10|||
145272708|NCT00111007|523846277|FG001|Long Term Follow-up|Missing|3|||
145272709|NCT00440193|523846278|FG000|Treatment Period|Adverse Event|74|||
145272710|NCT00440193|523846279|FG001|Treatment Period|Adverse Event|67|||
145272711|NCT00440193|523846278|FG000|Treatment Period|Death|19|||
145272712|NCT00440193|523846279|FG001|Treatment Period|Death|22|||
145272713|NCT00440193|523846278|FG000|Treatment Period|Lack of Efficacy|0|||
145272714|NCT00440193|523846279|FG001|Treatment Period|Lack of Efficacy|1|||
145272715|NCT00440193|523846278|FG000|Treatment Period|Lost to Follow-up|12|||
145272716|NCT00440193|523846279|FG001|Treatment Period|Lost to Follow-up|18|||
145272717|NCT00440193|523846278|FG000|Treatment Period|Physician Decision|3|||
145272718|NCT00440193|523846279|FG001|Treatment Period|Physician Decision|6|||
145272719|NCT00440193|523846278|FG000|Treatment Period|Protocol Violation|16|||
145272720|NCT00440193|523846279|FG001|Treatment Period|Protocol Violation|19|||
145753766|NCT00730639|525610401|FG003|Overall Study|Complete Response|2|||
145753767|NCT00730639|525610402|FG004|Overall Study|Complete Response|1|||
145753768|NCT00730639|525610398|FG000|Overall Study|Completed Maximum Cycles|0|||
145753769|NCT00730639|525610399|FG001|Overall Study|Completed Maximum Cycles|0|||
145753770|NCT00730639|525610400|FG002|Overall Study|Completed Maximum Cycles|11|||
145753771|NCT00730639|525610401|FG003|Overall Study|Completed Maximum Cycles|3|||
145753772|NCT00730639|525610402|FG004|Overall Study|Completed Maximum Cycles|6|||
145753773|NCT00730639|525610398|FG000|Overall Study|Death|0|||
145753774|NCT00730639|525610399|FG001|Overall Study|Death|0|||
145753775|NCT00730639|525610400|FG002|Overall Study|Death|0|||
145753776|NCT00730639|525610401|FG003|Overall Study|Death|0|||
145753777|NCT00730639|525610402|FG004|Overall Study|Death|2|||
145753778|NCT00730639|525610398|FG000|Overall Study|Disease Progression|12|||
145753779|NCT00730639|525610399|FG001|Overall Study|Disease Progression|13|||
145753780|NCT00730639|525610400|FG002|Overall Study|Disease Progression|48|||
145753781|NCT00730639|525610401|FG003|Overall Study|Disease Progression|32|||
145753782|NCT00730639|525610402|FG004|Overall Study|Disease Progression|88|||
145753783|NCT00730639|525610398|FG000|Overall Study|non-specified|0|||
145402748|NCT01075048|524332474|FG002|Overall Study|Lost to Follow-up|1|||
145530470|NCT04171765|524803856|FG001|Overall Study|Week 58 visit missed|0|||
145530471|NCT04171765|524803857|FG002|Overall Study|Week 58 visit missed|1|||
145530472|NCT04171765|524803858|FG003|Overall Study|Week 58 visit missed|0|||
145530473|NCT04171765|524803855|FG000|Overall Study|Study terminated by sponsor|2|||
145753784|NCT00730639|525610399|FG001|Overall Study|non-specified|0|||
145753785|NCT00730639|525610400|FG002|Overall Study|non-specified|4|||
145753786|NCT00730639|525610401|FG003|Overall Study|non-specified|2|||
145753787|NCT00730639|525610402|FG004|Overall Study|non-specified|3|||
145753788|NCT00730639|525610398|FG000|Overall Study|Protocol Violation|0|||
145753789|NCT00730639|525610399|FG001|Overall Study|Protocol Violation|0|||
145753790|NCT00730639|525610400|FG002|Overall Study|Protocol Violation|1|||
145753791|NCT00730639|525610401|FG003|Overall Study|Protocol Violation|0|||
145753792|NCT00730639|525610402|FG004|Overall Study|Protocol Violation|0|||
145753793|NCT00730639|525610398|FG000|Overall Study|Withdrawal by Subject|0|||
145753794|NCT00730639|525610399|FG001|Overall Study|Withdrawal by Subject|0|||
145753795|NCT00730639|525610400|FG002|Overall Study|Withdrawal by Subject|6|||
145753796|NCT00730639|525610401|FG003|Overall Study|Withdrawal by Subject|3|||
145753797|NCT00730639|525610402|FG004|Overall Study|Withdrawal by Subject|4|||
145753798|NCT00730639|525610398|FG000|Overall Study|Treatment on-going|2|||
145753799|NCT00730639|525610399|FG001|Overall Study|Treatment on-going|5|||
145753800|NCT00730639|525610400|FG002|Overall Study|Treatment on-going|5|||
145753801|NCT00730639|525610401|FG003|Overall Study|Treatment on-going|4|||
145753802|NCT00730639|525610402|FG004|Overall Study|Treatment on-going|4|||
145753803|NCT04947800|525610404|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
145753804|NCT04947800|525610405|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
145753805|NCT04947800|525610406|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
145753806|NCT03977467|525610407|FG000|Overall Study|Disease Progression|1|||
145753807|NCT03977467|525610408|FG001|Overall Study|Disease Progression|1|||
145753808|NCT03977467|525610409|FG002|Overall Study|Disease Progression|30|||
145753809|NCT03977467|525610410|FG003|Overall Study|Disease Progression|0|||
145753810|NCT03977467|525610407|FG000|Overall Study|Adverse Event|0|||
145753811|NCT03977467|525610408|FG001|Overall Study|Adverse Event|1|||
145753812|NCT03977467|525610409|FG002|Overall Study|Adverse Event|0|||
145753813|NCT03977467|525610410|FG003|Overall Study|Adverse Event|0|||
145753814|NCT03977467|525610407|FG000|Overall Study|Death|0|||
145753815|NCT03977467|525610408|FG001|Overall Study|Death|0|||
145753816|NCT03977467|525610409|FG002|Overall Study|Death|3|||
145753817|NCT03977467|525610410|FG003|Overall Study|Death|0|||
145753818|NCT03977467|525610407|FG000|Overall Study|Lack of Efficacy|0|||
145753819|NCT03977467|525610408|FG001|Overall Study|Lack of Efficacy|0|||
145753820|NCT03977467|525610409|FG002|Overall Study|Lack of Efficacy|1|||
145753821|NCT03977467|525610410|FG003|Overall Study|Lack of Efficacy|0|||
145753822|NCT03977467|525610407|FG000|Overall Study|Withdrawal by Subject|2|||
145753823|NCT03977467|525610408|FG001|Overall Study|Withdrawal by Subject|1|||
145753824|NCT03977467|525610409|FG002|Overall Study|Withdrawal by Subject|4|||
145753825|NCT03977467|525610410|FG003|Overall Study|Withdrawal by Subject|0|||
145753826|NCT03977467|525610407|FG000|Overall Study|Study Terminated|1|||
145753827|NCT03977467|525610408|FG001|Overall Study|Study Terminated|0|||
145753828|NCT03977467|525610409|FG002|Overall Study|Study Terminated|0|||
145753829|NCT03977467|525610410|FG003|Overall Study|Study Terminated|1|||
145753830|NCT04899232|525610413|FG000|Screening Period|Physician Decision|1|||
145753831|NCT04899232|525610414|FG001|Screening Period|Physician Decision|0|||
145753832|NCT04899232|525610415|FG002|Screening Period|Physician Decision|0|||
145530474|NCT04171765|524803856|FG001|Overall Study|Study terminated by sponsor|0|||
145753833|NCT04899232|525610413|FG000|Screening Period|Withdrawal by Subject|1|||
145753834|NCT04899232|525610414|FG001|Screening Period|Withdrawal by Subject|0|||
145753835|NCT04899232|525610415|FG002|Screening Period|Withdrawal by Subject|0|||
145753836|NCT04899232|525610413|FG000|Screening Period|Participant discharged before receiving intervention|3|||
145753837|NCT04899232|525610414|FG001|Screening Period|Participant discharged before receiving intervention|0|||
145753838|NCT04899232|525610415|FG002|Screening Period|Participant discharged before receiving intervention|0|||
145753839|NCT04440592|525610416|FG000|Overall Study|Adverse Event|8|||
145753840|NCT04440592|525610417|FG001|Overall Study|Adverse Event|0|||
145753841|NCT04440592|525610416|FG000|Overall Study|Lost to Follow-up|1|||
145753842|NCT04440592|525610417|FG001|Overall Study|Lost to Follow-up|0|||
145753843|NCT04440592|525610416|FG000|Overall Study|Withdrawal by Subject|1|||
145753844|NCT04440592|525610417|FG001|Overall Study|Withdrawal by Subject|1|||
145753845|NCT04440592|525610416|FG000|Overall Study|Other therapy needed|0|||
145753846|NCT04440592|525610417|FG001|Overall Study|Other therapy needed|1|||
145753847|NCT03087955|525612565|FG000|Overall Study|Death|4|||
145753848|NCT03087955|525612566|FG001|Overall Study|Death|0|||
145753849|NCT03087955|525612565|FG000|Overall Study|Lack of Efficacy|2|||
145753850|NCT03087955|525612566|FG001|Overall Study|Lack of Efficacy|0|||
145753851|NCT03087955|525612565|FG000|Overall Study|Lost to Follow-up|1|||
145753852|NCT03087955|525612566|FG001|Overall Study|Lost to Follow-up|0|||
145753853|NCT04441905|525612567|FG000|Overall Study|Lost to Follow-up|1|||
145753854|NCT04441905|525612568|FG001|Overall Study|Lost to Follow-up|0|||
145753855|NCT04441905|525612569|FG002|Overall Study|Lost to Follow-up|0|||
145753856|NCT04441905|525612570|FG003|Overall Study|Lost to Follow-up|0|||
145753857|NCT04441905|525612571|FG004|Overall Study|Lost to Follow-up|0|||
145753858|NCT04441905|525612572|FG005|Overall Study|Lost to Follow-up|0|||
145753859|NCT04441905|525612567|FG000|Overall Study|Enrolled but treatment not administered|0|||
145753860|NCT04441905|525612568|FG001|Overall Study|Enrolled but treatment not administered|1|||
145753861|NCT04441905|525612569|FG002|Overall Study|Enrolled but treatment not administered|0|||
145753862|NCT04441905|525612570|FG003|Overall Study|Enrolled but treatment not administered|0|||
145753863|NCT04441905|525612571|FG004|Overall Study|Enrolled but treatment not administered|0|||
145753864|NCT04441905|525612572|FG005|Overall Study|Enrolled but treatment not administered|0|||
145753865|NCT04441905|525612567|FG000|Overall Study|Became ineligible after enrollment|0|||
145753866|NCT04441905|525612568|FG001|Overall Study|Became ineligible after enrollment|0|||
145753867|NCT04441905|525612569|FG002|Overall Study|Became ineligible after enrollment|0|||
145753868|NCT04441905|525612570|FG003|Overall Study|Became ineligible after enrollment|0|||
145753869|NCT04441905|525612571|FG004|Overall Study|Became ineligible after enrollment|1|||
145753870|NCT04441905|525612572|FG005|Overall Study|Became ineligible after enrollment|0|||
145753871|NCT02392429|525612573|FG000|Screening|Screen failure|15|||
145753872|NCT02392429|525612573|FG000|Enrolled Participants|Ineligible due to disease|3|||
145753873|NCT02392429|525612573|FG000|Enrolled Participants|Withdrawal by Subject|4|||
145753874|NCT02392429|525612573|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
145753875|NCT02392429|525612573|FG000|Evaluable|Death|5|||
145753876|NCT02392429|525612573|FG000|Evaluable|Withdrawal by Subject|1|||
145753877|NCT02392429|525612573|FG000|Evaluable|Adverse Event|1|||
145753878|NCT02392429|525612573|FG000|Evaluable|remission bone marrow biopsy|3|||
145753879|NCT04183335|525612577|FG000|Overall Study|Adverse Event|1|||
145753880|NCT04183335|525612578|FG001|Overall Study|Adverse Event|0|||
145753881|NCT04183335|525612577|FG000|Overall Study|Withdrawal by Subject|12|||
145753882|NCT04183335|525612578|FG001|Overall Study|Withdrawal by Subject|3|||
145753883|NCT02740478|525612580|FG000|Overall Study|Withdrawal by Subject|1|||
145753884|NCT02944448|525612581|FG000|Overall Study|Adverse Event|37|||
145753885|NCT02944448|525612582|FG001|Overall Study|Adverse Event|6|||
145753886|NCT02944448|525612581|FG000|Overall Study|Lack of Efficacy|8|||
145753887|NCT02944448|525612582|FG001|Overall Study|Lack of Efficacy|5|||
145753888|NCT02944448|525612581|FG000|Overall Study|Lost to Follow-up|3|||
145753889|NCT02944448|525612582|FG001|Overall Study|Lost to Follow-up|1|||
145753890|NCT02944448|525612581|FG000|Overall Study|Protocol Violation|25|||
145753891|NCT02944448|525612582|FG001|Overall Study|Protocol Violation|7|||
145753892|NCT02944448|525612581|FG000|Overall Study|Withdrawal by Subject|14|||
145753893|NCT02944448|525612582|FG001|Overall Study|Withdrawal by Subject|4|||
145753894|NCT02944448|525612581|FG000|Overall Study|Sponsor did not supply drug in time|0|||
145753895|NCT02944448|525612582|FG001|Overall Study|Sponsor did not supply drug in time|1|||
145753896|NCT02944448|525612581|FG000|Overall Study|Noncompliant with dosing|1|||
145753897|NCT02944448|525612582|FG001|Overall Study|Noncompliant with dosing|0|||
145753898|NCT02944448|525612581|FG000|Overall Study|Abnormal laboratory values|1|||
145753899|NCT02944448|525612582|FG001|Overall Study|Abnormal laboratory values|0|||
145753900|NCT00618748|525612583|FG000|Overall Study|Adverse Event|4|||
145753901|NCT00618748|525612584|FG001|Overall Study|Adverse Event|3|||
145753902|NCT00618748|525612585|FG002|Overall Study|Adverse Event|8|||
145753903|NCT00618748|525612583|FG000|Overall Study|Physician Decision|3|||
145753904|NCT00618748|525612584|FG001|Overall Study|Physician Decision|1|||
145753905|NCT00618748|525612585|FG002|Overall Study|Physician Decision|1|||
145753906|NCT00618748|525612583|FG000|Overall Study|Withdrawal by Subject|4|||
145753907|NCT00618748|525612584|FG001|Overall Study|Withdrawal by Subject|1|||
145753908|NCT00618748|525612585|FG002|Overall Study|Withdrawal by Subject|5|||
145753909|NCT05499559|525612590|FG000|Overall Study|Lost to Follow-up|467|||
145753910|NCT02770326|525612595|FG000|Overall Study|Death|3|||
145753911|NCT02770326|525612595|FG000|Overall Study|Lost to Follow-up|1|||
145753912|NCT03124784|525612597|FG000|Overall Study|Adverse Event|1|||
145753913|NCT03124784|525612597|FG000|Overall Study|Computer/Equip Malfunction|1|||
145753914|NCT01467492|525612598|FG000|Overall Study|Withdrawal by Subject|6|||
145753915|NCT01467492|525612599|FG001|Overall Study|Withdrawal by Subject|4|||
145753916|NCT01467492|525612598|FG000|Overall Study|Study Terminated by Sponsor|6|||
145753917|NCT01467492|525612599|FG001|Overall Study|Study Terminated by Sponsor|4|||
145753918|NCT01467492|525612598|FG000|Overall Study|Adverse Event|4|||
145753919|NCT01467492|525612599|FG001|Overall Study|Adverse Event|3|||
145753920|NCT01467492|525612598|FG000|Overall Study|Lost to Follow-up|3|||
145753921|NCT01467492|525612599|FG001|Overall Study|Lost to Follow-up|2|||
145753922|NCT01467492|525612598|FG000|Overall Study|Undefined|2|||
145753923|NCT01467492|525612599|FG001|Overall Study|Undefined|0|||
145753924|NCT01467492|525612598|FG000|Overall Study|Enrolled But Not Treated|1|||
145753925|NCT01467492|525612599|FG001|Overall Study|Enrolled But Not Treated|0|||
145753926|NCT02450487|525612600|FG000|Overall Study|Lost to Follow-up|3|||
145753927|NCT03132636|525612601|FG000|Overall Study|Adverse Event|1|||
145753928|NCT03132636|525612602|FG001|Overall Study|Adverse Event|2|||
145753929|NCT03132636|525612601|FG000|Overall Study|Death|4|||
145753930|NCT03132636|525612602|FG001|Overall Study|Death|7|||
145753931|NCT03132636|525612601|FG000|Overall Study|Lost to Follow-up|3|||
145753932|NCT03132636|525612602|FG001|Overall Study|Lost to Follow-up|2|||
145753933|NCT03132636|525612601|FG000|Overall Study|Non compliance with protocol by participant|1|||
145753934|NCT03132636|525612602|FG001|Overall Study|Non compliance with protocol by participant|1|||
145753935|NCT03132636|525612601|FG000|Overall Study|Subject decision|1|||
145753936|NCT03132636|525612602|FG001|Overall Study|Subject decision|9|||
145753937|NCT03132636|525612601|FG000|Overall Study|Sponsor decision|0|||
145753938|NCT03132636|525612602|FG001|Overall Study|Sponsor decision|1|||
145753939|NCT03132636|525612601|FG000|Overall Study|Physician Decision|1|||
145753940|NCT03132636|525612602|FG001|Overall Study|Physician Decision|0|||
145753941|NCT03132636|525612601|FG000|Overall Study|Progressive disease|33|||
145753942|NCT03132636|525612602|FG001|Overall Study|Progressive disease|36|||
145753943|NCT03132636|525612601|FG000|Overall Study|Withdrawal of consent|2|||
145753944|NCT03132636|525612602|FG001|Overall Study|Withdrawal of consent|5|||
145753945|NCT03132636|525612601|FG000|Overall Study|Did not re-consent|1|||
145753946|NCT03132636|525612602|FG001|Overall Study|Did not re-consent|0|||
145753947|NCT03132636|525612601|FG000|Overall Study|Lost insurance coverage|1|||
145753948|NCT03132636|525612602|FG001|Overall Study|Lost insurance coverage|0|||
145753949|NCT03132636|525612601|FG000|Overall Study|Related to radiological outcomes|0|||
145753950|NCT03132636|525612602|FG001|Overall Study|Related to radiological outcomes|1|||
145753951|NCT03132636|525612601|FG000|Overall Study|Unable to come to site for continued visits|0|||
145753952|NCT03132636|525612602|FG001|Overall Study|Unable to come to site for continued visits|1|||
145753953|NCT01415752|525612603|FG000|Induction (Step 1)|Ineligible|4|||
145530475|NCT04171765|524803857|FG002|Overall Study|Study terminated by sponsor|0|||
145530476|NCT04171765|524803858|FG003|Overall Study|Study terminated by sponsor|0|||
145530477|NCT04171765|524803855|FG000|Overall Study|Withdrawal by Subject|1|||
145753954|NCT01415752|525612604|FG001|Induction (Step 1)|Ineligible|3|||
145530478|NCT04171765|524803856|FG001|Overall Study|Withdrawal by Subject|0|||
145530479|NCT04171765|524803857|FG002|Overall Study|Withdrawal by Subject|0|||
145753955|NCT01415752|525612605|FG002|Induction (Step 1)|Ineligible|4|||
145753956|NCT01415752|525612606|FG003|Induction (Step 1)|Ineligible|4|||
145753957|NCT01415752|525612603|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
145753958|NCT01415752|525612604|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
145753959|NCT01415752|525612605|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
145753960|NCT01415752|525612606|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
145753961|NCT01415752|525612603|FG000|Maintenance (Step 2)|Adverse Event|3|||
145753962|NCT01415752|525612604|FG001|Maintenance (Step 2)|Adverse Event|4|||
145753963|NCT01415752|525612605|FG002|Maintenance (Step 2)|Adverse Event|9|||
145753964|NCT01415752|525612606|FG003|Maintenance (Step 2)|Adverse Event|6|||
145753965|NCT01415752|525612603|FG000|Maintenance (Step 2)|Death|1|||
145753966|NCT01415752|525612604|FG001|Maintenance (Step 2)|Death|1|||
145753967|NCT01415752|525612605|FG002|Maintenance (Step 2)|Death|2|||
145753968|NCT01415752|525612606|FG003|Maintenance (Step 2)|Death|0|||
145753969|NCT01415752|525612603|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
145753970|NCT01415752|525612604|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
145753971|NCT01415752|525612605|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
145753972|NCT01415752|525612606|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
145753973|NCT01415752|525612603|FG000|Maintenance (Step 2)|Alternative therapy|0|||
145753974|NCT01415752|525612604|FG001|Maintenance (Step 2)|Alternative therapy|1|||
145753975|NCT01415752|525612605|FG002|Maintenance (Step 2)|Alternative therapy|0|||
145753976|NCT01415752|525612606|FG003|Maintenance (Step 2)|Alternative therapy|0|||
145753977|NCT01415752|525612603|FG000|Maintenance (Step 2)|Other reasons|3|||
145753978|NCT01415752|525612604|FG001|Maintenance (Step 2)|Other reasons|6|||
145753979|NCT01415752|525612605|FG002|Maintenance (Step 2)|Other reasons|4|||
145753980|NCT01415752|525612606|FG003|Maintenance (Step 2)|Other reasons|6|||
145753981|NCT01415752|525612603|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
145753982|NCT01415752|525612604|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
145753983|NCT01415752|525612605|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
145753984|NCT01415752|525612606|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
145753985|NCT01415752|525612603|FG000|Maintenance (Step 2)|ineligible|1|||
145753986|NCT01415752|525612604|FG001|Maintenance (Step 2)|ineligible|1|||
145753987|NCT01415752|525612605|FG002|Maintenance (Step 2)|ineligible|1|||
145753988|NCT01415752|525612606|FG003|Maintenance (Step 2)|ineligible|0|||
145753989|NCT01415752|525612603|FG000|Maintenance (Step 2)|Missing|4|||
145753990|NCT01415752|525612604|FG001|Maintenance (Step 2)|Missing|1|||
145753991|NCT01415752|525612605|FG002|Maintenance (Step 2)|Missing|4|||
145753992|NCT01415752|525612606|FG003|Maintenance (Step 2)|Missing|3|||
145753993|NCT03286842|525612607|FG000|Overall Study|Patients rolled over to another study|80|||
145753994|NCT01391507|525612611|FG000|Overall Study|Death|0|||
145753995|NCT01391507|525612612|FG001|Overall Study|Death|0|||
145753996|NCT01391507|525612613|FG002|Overall Study|Death|0|||
145753997|NCT01391507|525612614|FG003|Overall Study|Death|1|||
145753998|NCT01391507|525612611|FG000|Overall Study|Adverse Event|1|||
145753999|NCT01391507|525612612|FG001|Overall Study|Adverse Event|1|||
145754000|NCT01391507|525612613|FG002|Overall Study|Adverse Event|2|||
145754001|NCT01391507|525612614|FG003|Overall Study|Adverse Event|2|||
145754002|NCT01391507|525612611|FG000|Overall Study|Withdrawal by Subject|1|||
145754003|NCT01391507|525612612|FG001|Overall Study|Withdrawal by Subject|2|||
145754004|NCT01391507|525612613|FG002|Overall Study|Withdrawal by Subject|1|||
145754005|NCT01391507|525612614|FG003|Overall Study|Withdrawal by Subject|1|||
145754006|NCT01391507|525612611|FG000|Overall Study|Lack of Efficacy|0|||
145754007|NCT01391507|525612612|FG001|Overall Study|Lack of Efficacy|0|||
145754008|NCT01391507|525612613|FG002|Overall Study|Lack of Efficacy|0|||
145754009|NCT01391507|525612614|FG003|Overall Study|Lack of Efficacy|1|||
145754010|NCT01391507|525612611|FG000|Overall Study|Protocol Violation|2|||
145754011|NCT01391507|525612612|FG001|Overall Study|Protocol Violation|1|||
145754012|NCT01391507|525612613|FG002|Overall Study|Protocol Violation|1|||
145754013|NCT01391507|525612614|FG003|Overall Study|Protocol Violation|2|||
145754014|NCT01453855|525612615|FG000|Overall Study|Adverse Event|3|||
145754015|NCT01453855|525612616|FG001|Overall Study|Adverse Event|4|||
145754016|NCT01453855|525612615|FG000|Overall Study|Lost to Follow-up|2|||
145754017|NCT01453855|525612616|FG001|Overall Study|Lost to Follow-up|1|||
145754018|NCT01453855|525612615|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
145754019|NCT01453855|525612616|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
145754020|NCT01453855|525612615|FG000|Overall Study|Noncompliance|1|||
145754021|NCT01453855|525612616|FG001|Overall Study|Noncompliance|0|||
145754022|NCT01453855|525612615|FG000|Overall Study|Inadequate Control of IOP|1|||
145754023|NCT01453855|525612616|FG001|Overall Study|Inadequate Control of IOP|5|||
145754024|NCT01453855|525612615|FG000|Overall Study|Other|0|||
145754025|NCT01453855|525612616|FG001|Overall Study|Other|1|||
145754026|NCT01285908|525612619|FG000|Baseline Measurement|unable to insert catheter|1|||
145754027|NCT01285908|525612620|FG001|Baseline Measurement|unable to insert catheter|0|||
145754028|NCT01285908|525612621|FG002|Baseline Measurement|unable to insert catheter|0|||
145754029|NCT01285908|525612619|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
145754030|NCT01285908|525612620|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
145754031|NCT01285908|525612621|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
145754032|NCT01285908|525612619|FG000|Baseline Measurement|unable to tolerate procedure|1|||
145754033|NCT01285908|525612620|FG001|Baseline Measurement|unable to tolerate procedure|0|||
145754034|NCT01285908|525612621|FG002|Baseline Measurement|unable to tolerate procedure|0|||
145754035|NCT01562548|525612622|FG000|Overall Study|Lost to Follow-up|0|||
145754036|NCT01562548|525612623|FG001|Overall Study|Lost to Follow-up|0|||
145754037|NCT01562548|525612624|FG002|Overall Study|Lost to Follow-up|1|||
145272721|NCT00440193|523846278|FG000|Treatment Period|Withdrawal by Subject|36|||
145272722|NCT00440193|523846279|FG001|Treatment Period|Withdrawal by Subject|77|||
145272723|NCT00440193|523846278|FG000|Treatment Period|Clinical endpoint reached|28|||
145272724|NCT00440193|523846279|FG001|Treatment Period|Clinical endpoint reached|25|||
145272725|NCT00440193|523846278|FG000|Treatment Period|Study terminated by sponsor|102|||
145272726|NCT00440193|523846279|FG001|Treatment Period|Study terminated by sponsor|94|||
145272727|NCT00440193|523846278|FG000|Treatment Period|Protocol driven decision point|2|||
145272728|NCT00440193|523846279|FG001|Treatment Period|Protocol driven decision point|2|||
145272729|NCT00440193|523846278|FG000|Treatment Period|Switch to commercial drug|0|||
145272730|NCT00440193|523846279|FG001|Treatment Period|Switch to commercial drug|2|||
145272731|NCT00440193|523846278|FG000|Treatment Period|Technical problems|1|||
145272732|NCT00440193|523846279|FG001|Treatment Period|Technical problems|1|||
145272733|NCT00440193|523846278|FG000|Treatment Period|Participant convenience|5|||
145272734|NCT00440193|523846279|FG001|Treatment Period|Participant convenience|2|||
145402749|NCT00296244|524332479|FG000|Overall Study|Underwent retransplant|0|||
145402750|NCT00296244|524332480|FG001|Overall Study|Underwent retransplant|1|||
145402751|NCT03617588|524332481|FG000|Overall Study|Withdrawal by Subject|1|||
145754038|NCT01562548|525612625|FG003|Overall Study|Lost to Follow-up|0|||
145754039|NCT03529773|525612626|FG000|Overall Study|Adverse Event|0|||
145754040|NCT03529773|525612627|FG001|Overall Study|Adverse Event|0|||
145754041|NCT03529773|525612628|FG002|Overall Study|Adverse Event|0|||
145754042|NCT03529773|525612629|FG003|Overall Study|Adverse Event|0|||
145754043|NCT03529773|525612630|FG004|Overall Study|Adverse Event|0|||
145754044|NCT03529773|525612631|FG005|Overall Study|Adverse Event|0|||
145754045|NCT03529773|525612632|FG006|Overall Study|Adverse Event|0|||
145754046|NCT03529773|525612633|FG007|Overall Study|Adverse Event|0|||
145754047|NCT03529773|525612634|FG008|Overall Study|Adverse Event|0|||
145754048|NCT03529773|525612635|FG009|Overall Study|Adverse Event|0|||
145754049|NCT03529773|525612636|FG010|Overall Study|Adverse Event|0|||
145754050|NCT03529773|525612637|FG011|Overall Study|Adverse Event|0|||
145754051|NCT03529773|525612638|FG012|Overall Study|Adverse Event|0|||
145754052|NCT03529773|525612639|FG013|Overall Study|Adverse Event|0|||
145754053|NCT03529773|525612640|FG014|Overall Study|Adverse Event|0|||
145754054|NCT03529773|525612641|FG015|Overall Study|Adverse Event|0|||
145754055|NCT03529773|525612642|FG016|Overall Study|Adverse Event|0|||
145754056|NCT03529773|525612643|FG017|Overall Study|Adverse Event|0|||
145754057|NCT03529773|525612644|FG018|Overall Study|Adverse Event|0|||
145754058|NCT03529773|525612645|FG019|Overall Study|Adverse Event|0|||
145754059|NCT03529773|525612646|FG020|Overall Study|Adverse Event|0|||
145754060|NCT03529773|525612647|FG021|Overall Study|Adverse Event|0|||
145754061|NCT03529773|525612648|FG022|Overall Study|Adverse Event|0|||
145754062|NCT03529773|525612649|FG023|Overall Study|Adverse Event|0|||
145754063|NCT03529773|525612650|FG024|Overall Study|Adverse Event|0|||
145754064|NCT03529773|525612651|FG025|Overall Study|Adverse Event|0|||
145754065|NCT03529773|525612652|FG026|Overall Study|Adverse Event|0|||
145754066|NCT03529773|525612653|FG027|Overall Study|Adverse Event|0|||
145754067|NCT03529773|525612654|FG028|Overall Study|Adverse Event|0|||
145754068|NCT03529773|525612655|FG029|Overall Study|Adverse Event|0|||
145754069|NCT03529773|525612656|FG030|Overall Study|Adverse Event|1|||
145754070|NCT03529773|525612657|FG031|Overall Study|Adverse Event|0|||
145754071|NCT03529773|525612658|FG032|Overall Study|Adverse Event|0|||
145754072|NCT03529773|525612659|FG033|Overall Study|Adverse Event|0|||
145754073|NCT03529773|525612660|FG034|Overall Study|Adverse Event|0|||
145754074|NCT03529773|525612661|FG035|Overall Study|Adverse Event|1|||
145754075|NCT03529773|525612662|FG036|Overall Study|Adverse Event|0|||
145754076|NCT03529773|525612663|FG037|Overall Study|Adverse Event|0|||
145754077|NCT03529773|525612664|FG038|Overall Study|Adverse Event|1|||
145754078|NCT03529773|525612665|FG039|Overall Study|Adverse Event|1|||
145754079|NCT03529773|525612626|FG000|Overall Study|Death|0|||
145754080|NCT03529773|525612627|FG001|Overall Study|Death|0|||
145754081|NCT03529773|525612628|FG002|Overall Study|Death|0|||
145754082|NCT03529773|525612629|FG003|Overall Study|Death|0|||
145754083|NCT03529773|525612630|FG004|Overall Study|Death|0|||
145754084|NCT03529773|525612631|FG005|Overall Study|Death|0|||
145754085|NCT03529773|525612632|FG006|Overall Study|Death|0|||
145754086|NCT03529773|525612633|FG007|Overall Study|Death|0|||
145754087|NCT03529773|525612634|FG008|Overall Study|Death|0|||
145272735|NCT00440193|523846278|FG000|Treatment Period|Participant did not receive treatment|7|||
145272736|NCT00440193|523846279|FG001|Treatment Period|Participant did not receive treatment|13|||
145272737|NCT00440193|523846278|FG000|Treatment Period|Site closed by investigator|0|||
145272738|NCT00440193|523846279|FG001|Treatment Period|Site closed by investigator|2|||
145402752|NCT03617588|524332482|FG001|Overall Study|Withdrawal by Subject|0|||
145754088|NCT03529773|525612635|FG009|Overall Study|Death|0|||
145754089|NCT03529773|525612636|FG010|Overall Study|Death|0|||
145754090|NCT03529773|525612637|FG011|Overall Study|Death|0|||
145754091|NCT03529773|525612638|FG012|Overall Study|Death|1|||
145754092|NCT03529773|525612639|FG013|Overall Study|Death|0|||
145754093|NCT03529773|525612640|FG014|Overall Study|Death|0|||
145754094|NCT03529773|525612641|FG015|Overall Study|Death|0|||
145754095|NCT03529773|525612642|FG016|Overall Study|Death|0|||
145754096|NCT03529773|525612643|FG017|Overall Study|Death|0|||
145754097|NCT03529773|525612644|FG018|Overall Study|Death|0|||
145754098|NCT03529773|525612645|FG019|Overall Study|Death|1|||
145754099|NCT03529773|525612646|FG020|Overall Study|Death|0|||
145754100|NCT03529773|525612647|FG021|Overall Study|Death|0|||
145754101|NCT03529773|525612648|FG022|Overall Study|Death|1|||
145754102|NCT03529773|525612649|FG023|Overall Study|Death|0|||
145754103|NCT03529773|525612650|FG024|Overall Study|Death|0|||
145754104|NCT03529773|525612651|FG025|Overall Study|Death|0|||
145754105|NCT03529773|525612652|FG026|Overall Study|Death|0|||
145754106|NCT03529773|525612653|FG027|Overall Study|Death|0|||
145754107|NCT03529773|525612654|FG028|Overall Study|Death|0|||
145754108|NCT03529773|525612655|FG029|Overall Study|Death|0|||
145754109|NCT03529773|525612656|FG030|Overall Study|Death|0|||
145754110|NCT03529773|525612657|FG031|Overall Study|Death|0|||
145754111|NCT03529773|525612658|FG032|Overall Study|Death|0|||
145754112|NCT03529773|525612659|FG033|Overall Study|Death|1|||
145754113|NCT03529773|525612660|FG034|Overall Study|Death|1|||
145754114|NCT03529773|525612661|FG035|Overall Study|Death|0|||
145754115|NCT03529773|525612662|FG036|Overall Study|Death|1|||
145754116|NCT03529773|525612663|FG037|Overall Study|Death|0|||
145754117|NCT03529773|525612664|FG038|Overall Study|Death|0|||
145754118|NCT03529773|525612665|FG039|Overall Study|Death|0|||
145754119|NCT03529773|525612626|FG000|Overall Study|Lost to Follow-up|0|||
145754120|NCT03529773|525612627|FG001|Overall Study|Lost to Follow-up|0|||
145754121|NCT03529773|525612628|FG002|Overall Study|Lost to Follow-up|1|||
145754122|NCT03529773|525612629|FG003|Overall Study|Lost to Follow-up|0|||
145754123|NCT03529773|525612630|FG004|Overall Study|Lost to Follow-up|1|||
145754124|NCT03529773|525612631|FG005|Overall Study|Lost to Follow-up|1|||
145754125|NCT03529773|525612632|FG006|Overall Study|Lost to Follow-up|0|||
145754126|NCT03529773|525612633|FG007|Overall Study|Lost to Follow-up|0|||
145754127|NCT03529773|525612634|FG008|Overall Study|Lost to Follow-up|0|||
145754128|NCT03529773|525612635|FG009|Overall Study|Lost to Follow-up|0|||
145754129|NCT03529773|525612636|FG010|Overall Study|Lost to Follow-up|0|||
145754130|NCT03529773|525612637|FG011|Overall Study|Lost to Follow-up|0|||
145754131|NCT03529773|525612638|FG012|Overall Study|Lost to Follow-up|0|||
145530480|NCT04171765|524803858|FG003|Overall Study|Withdrawal by Subject|3|||
145530481|NCT00122109|524803859|FG000|Overall Study|Did not meet criteria|6|||
145530482|NCT00122109|524803860|FG001|Overall Study|Did not meet criteria|7|||
145530483|NCT00100178|524803861|FG000|Overall Study|Lost to Follow-up|0|||
145530484|NCT00100178|524803862|FG001|Overall Study|Lost to Follow-up|6|||
145754132|NCT03529773|525612639|FG013|Overall Study|Lost to Follow-up|1|||
145754133|NCT03529773|525612640|FG014|Overall Study|Lost to Follow-up|4|||
145754134|NCT03529773|525612641|FG015|Overall Study|Lost to Follow-up|1|||
145754135|NCT03529773|525612642|FG016|Overall Study|Lost to Follow-up|1|||
145754136|NCT03529773|525612643|FG017|Overall Study|Lost to Follow-up|0|||
145754137|NCT03529773|525612644|FG018|Overall Study|Lost to Follow-up|1|||
145754138|NCT03529773|525612645|FG019|Overall Study|Lost to Follow-up|1|||
145754139|NCT03529773|525612646|FG020|Overall Study|Lost to Follow-up|2|||
145754140|NCT03529773|525612647|FG021|Overall Study|Lost to Follow-up|4|||
145754141|NCT03529773|525612648|FG022|Overall Study|Lost to Follow-up|3|||
145754142|NCT03529773|525612649|FG023|Overall Study|Lost to Follow-up|4|||
145754143|NCT03529773|525612650|FG024|Overall Study|Lost to Follow-up|3|||
145754144|NCT03529773|525612651|FG025|Overall Study|Lost to Follow-up|5|||
145754145|NCT03529773|525612652|FG026|Overall Study|Lost to Follow-up|5|||
145754146|NCT03529773|525612653|FG027|Overall Study|Lost to Follow-up|0|||
145754147|NCT03529773|525612654|FG028|Overall Study|Lost to Follow-up|0|||
145754148|NCT03529773|525612655|FG029|Overall Study|Lost to Follow-up|0|||
145754149|NCT03529773|525612656|FG030|Overall Study|Lost to Follow-up|1|||
145754150|NCT03529773|525612657|FG031|Overall Study|Lost to Follow-up|0|||
145754151|NCT03529773|525612658|FG032|Overall Study|Lost to Follow-up|0|||
145754152|NCT03529773|525612659|FG033|Overall Study|Lost to Follow-up|1|||
145754153|NCT03529773|525612660|FG034|Overall Study|Lost to Follow-up|1|||
145754154|NCT03529773|525612661|FG035|Overall Study|Lost to Follow-up|0|||
145754155|NCT03529773|525612662|FG036|Overall Study|Lost to Follow-up|0|||
145754156|NCT03529773|525612663|FG037|Overall Study|Lost to Follow-up|3|||
145754157|NCT03529773|525612664|FG038|Overall Study|Lost to Follow-up|1|||
145754158|NCT03529773|525612665|FG039|Overall Study|Lost to Follow-up|1|||
145754159|NCT03529773|525612626|FG000|Overall Study|No longer meets eligibility criteria|0|||
145754160|NCT03529773|525612627|FG001|Overall Study|No longer meets eligibility criteria|0|||
145754161|NCT03529773|525612628|FG002|Overall Study|No longer meets eligibility criteria|0|||
145754162|NCT03529773|525612629|FG003|Overall Study|No longer meets eligibility criteria|0|||
145754163|NCT03529773|525612630|FG004|Overall Study|No longer meets eligibility criteria|0|||
145754164|NCT03529773|525612631|FG005|Overall Study|No longer meets eligibility criteria|0|||
145754165|NCT03529773|525612632|FG006|Overall Study|No longer meets eligibility criteria|0|||
145754166|NCT03529773|525612633|FG007|Overall Study|No longer meets eligibility criteria|0|||
145754167|NCT03529773|525612634|FG008|Overall Study|No longer meets eligibility criteria|0|||
145754168|NCT03529773|525612635|FG009|Overall Study|No longer meets eligibility criteria|0|||
145754169|NCT03529773|525612636|FG010|Overall Study|No longer meets eligibility criteria|0|||
145754170|NCT03529773|525612637|FG011|Overall Study|No longer meets eligibility criteria|0|||
145754171|NCT03529773|525612638|FG012|Overall Study|No longer meets eligibility criteria|0|||
145754172|NCT03529773|525612639|FG013|Overall Study|No longer meets eligibility criteria|0|||
145530485|NCT00100178|524803863|FG002|Overall Study|Lost to Follow-up|5|||
145530486|NCT00100178|524803861|FG000|Overall Study|Adverse Event|2|||
145530487|NCT00100178|524803862|FG001|Overall Study|Adverse Event|2|||
145754173|NCT03529773|525612640|FG014|Overall Study|No longer meets eligibility criteria|0|||
145754174|NCT03529773|525612641|FG015|Overall Study|No longer meets eligibility criteria|0|||
145754175|NCT03529773|525612642|FG016|Overall Study|No longer meets eligibility criteria|0|||
145754176|NCT03529773|525612643|FG017|Overall Study|No longer meets eligibility criteria|0|||
145754177|NCT03529773|525612644|FG018|Overall Study|No longer meets eligibility criteria|0|||
145754178|NCT03529773|525612645|FG019|Overall Study|No longer meets eligibility criteria|0|||
145754179|NCT03529773|525612646|FG020|Overall Study|No longer meets eligibility criteria|0|||
145754180|NCT03529773|525612647|FG021|Overall Study|No longer meets eligibility criteria|0|||
145754181|NCT03529773|525612648|FG022|Overall Study|No longer meets eligibility criteria|1|||
145530488|NCT00100178|524803863|FG002|Overall Study|Adverse Event|1|||
145530489|NCT00100178|524803861|FG000|Overall Study|Withdrawal by Subject|1|||
145530490|NCT00100178|524803862|FG001|Overall Study|Withdrawal by Subject|1|||
145530491|NCT00100178|524803863|FG002|Overall Study|Withdrawal by Subject|1|||
145530492|NCT00100178|524803861|FG000|Overall Study|Physician Decision|6|||
145530493|NCT00100178|524803862|FG001|Overall Study|Physician Decision|1|||
145530494|NCT00100178|524803863|FG002|Overall Study|Physician Decision|3|||
145530495|NCT01439568|524803866|FG000|Overall Study|Lost to Follow-up|1|||
145530496|NCT01439568|524803867|FG001|Overall Study|Lost to Follow-up|0|||
145530497|NCT01439568|524803866|FG000|Overall Study|Withdrawal by Subject|2|||
145530498|NCT01439568|524803867|FG001|Overall Study|Withdrawal by Subject|2|||
145530499|NCT01669928|524803868|FG000|First Intervention|Withdrawal by Subject|3|||
145530500|NCT01669928|524803869|FG001|First Intervention|Withdrawal by Subject|5|||
145530501|NCT01465191|524803872|FG000|Overall Study|Protocol Violation|6|||
145530502|NCT01465191|524803873|FG001|Overall Study|Protocol Violation|3|||
145530503|NCT01465191|524803874|FG002|Overall Study|Protocol Violation|3|||
145530504|NCT01465191|524803872|FG000|Overall Study|Lost to Follow-up|3|||
145530505|NCT01465191|524803873|FG001|Overall Study|Lost to Follow-up|6|||
145530506|NCT01465191|524803874|FG002|Overall Study|Lost to Follow-up|4|||
145530507|NCT02448810|524803875|FG000|Overall Study|Adverse Event|0|||
145530508|NCT02448810|524803876|FG001|Overall Study|Adverse Event|0|||
145530509|NCT02448810|524803877|FG002|Overall Study|Adverse Event|1|||
145530510|NCT02448810|524803878|FG003|Overall Study|Adverse Event|0|||
145530511|NCT02448810|524803879|FG004|Overall Study|Adverse Event|0|||
145530512|NCT02448810|524803880|FG005|Overall Study|Adverse Event|0|||
145530513|NCT02448810|524803881|FG006|Overall Study|Adverse Event|0|||
145530514|NCT02448810|524803882|FG007|Overall Study|Adverse Event|0|||
145530515|NCT02448810|524803875|FG000|Overall Study|Withdrawal by Subject|0|||
145530516|NCT02448810|524803876|FG001|Overall Study|Withdrawal by Subject|0|||
145530517|NCT02448810|524803877|FG002|Overall Study|Withdrawal by Subject|1|||
145530518|NCT02448810|524803878|FG003|Overall Study|Withdrawal by Subject|0|||
145530519|NCT02448810|524803879|FG004|Overall Study|Withdrawal by Subject|3|||
145530520|NCT02448810|524803880|FG005|Overall Study|Withdrawal by Subject|5|||
145530521|NCT02448810|524803881|FG006|Overall Study|Withdrawal by Subject|0|||
145530522|NCT02448810|524803882|FG007|Overall Study|Withdrawal by Subject|2|||
145530523|NCT02448810|524803875|FG000|Overall Study|Other (study terminated by sponsor)|0|||
145530524|NCT02448810|524803876|FG001|Overall Study|Other (study terminated by sponsor)|0|||
145530525|NCT02448810|524803877|FG002|Overall Study|Other (study terminated by sponsor)|0|||
145530526|NCT02448810|524803878|FG003|Overall Study|Other (study terminated by sponsor)|0|||
145530527|NCT02448810|524803879|FG004|Overall Study|Other (study terminated by sponsor)|4|||
145530528|NCT02448810|524803880|FG005|Overall Study|Other (study terminated by sponsor)|2|||
145530529|NCT02448810|524803881|FG006|Overall Study|Other (study terminated by sponsor)|2|||
145530530|NCT02448810|524803882|FG007|Overall Study|Other (study terminated by sponsor)|1|||
145530531|NCT02448810|524803875|FG000|Overall Study|Death|1|||
145530532|NCT02448810|524803876|FG001|Overall Study|Death|0|||
145754182|NCT03529773|525612649|FG023|Overall Study|No longer meets eligibility criteria|0|||
145530533|NCT02448810|524803877|FG002|Overall Study|Death|1|||
145530534|NCT02448810|524803878|FG003|Overall Study|Death|0|||
145530535|NCT02448810|524803879|FG004|Overall Study|Death|1|||
145530536|NCT02448810|524803880|FG005|Overall Study|Death|0|||
145530537|NCT02448810|524803881|FG006|Overall Study|Death|0|||
145530538|NCT02448810|524803882|FG007|Overall Study|Death|0|||
145530539|NCT02448810|524803875|FG000|Overall Study|Other (Progressive disease)|2|||
145530540|NCT02448810|524803876|FG001|Overall Study|Other (Progressive disease)|2|||
145530541|NCT02448810|524803877|FG002|Overall Study|Other (Progressive disease)|0|||
145530542|NCT02448810|524803878|FG003|Overall Study|Other (Progressive disease)|3|||
145530543|NCT02448810|524803879|FG004|Overall Study|Other (Progressive disease)|23|||
145530544|NCT02448810|524803880|FG005|Overall Study|Other (Progressive disease)|9|||
145530545|NCT02448810|524803881|FG006|Overall Study|Other (Progressive disease)|14|||
145530546|NCT02448810|524803882|FG007|Overall Study|Other (Progressive disease)|5|||
145530547|NCT02448810|524803875|FG000|Overall Study|Lost to Follow-up|0|||
145530548|NCT02448810|524803876|FG001|Overall Study|Lost to Follow-up|1|||
145530549|NCT02448810|524803877|FG002|Overall Study|Lost to Follow-up|0|||
145530550|NCT02448810|524803878|FG003|Overall Study|Lost to Follow-up|0|||
145530551|NCT02448810|524803879|FG004|Overall Study|Lost to Follow-up|0|||
145754183|NCT03529773|525612650|FG024|Overall Study|No longer meets eligibility criteria|0|||
145754184|NCT03529773|525612651|FG025|Overall Study|No longer meets eligibility criteria|0|||
145754185|NCT03529773|525612652|FG026|Overall Study|No longer meets eligibility criteria|0|||
145754186|NCT03529773|525612653|FG027|Overall Study|No longer meets eligibility criteria|0|||
145754187|NCT03529773|525612654|FG028|Overall Study|No longer meets eligibility criteria|0|||
145754188|NCT03529773|525612655|FG029|Overall Study|No longer meets eligibility criteria|0|||
145754189|NCT03529773|525612656|FG030|Overall Study|No longer meets eligibility criteria|0|||
145754190|NCT03529773|525612657|FG031|Overall Study|No longer meets eligibility criteria|0|||
145754191|NCT03529773|525612658|FG032|Overall Study|No longer meets eligibility criteria|0|||
145754192|NCT03529773|525612659|FG033|Overall Study|No longer meets eligibility criteria|0|||
145754193|NCT03529773|525612660|FG034|Overall Study|No longer meets eligibility criteria|0|||
145754194|NCT03529773|525612661|FG035|Overall Study|No longer meets eligibility criteria|0|||
145754195|NCT03529773|525612662|FG036|Overall Study|No longer meets eligibility criteria|0|||
145754196|NCT03529773|525612663|FG037|Overall Study|No longer meets eligibility criteria|0|||
145754197|NCT03529773|525612664|FG038|Overall Study|No longer meets eligibility criteria|1|||
145754198|NCT03529773|525612665|FG039|Overall Study|No longer meets eligibility criteria|0|||
145754199|NCT03529773|525612626|FG000|Overall Study|Other|0|||
145754200|NCT03529773|525612627|FG001|Overall Study|Other|0|||
145754201|NCT03529773|525612628|FG002|Overall Study|Other|0|||
145754202|NCT03529773|525612629|FG003|Overall Study|Other|0|||
145754203|NCT03529773|525612630|FG004|Overall Study|Other|0|||
145754204|NCT03529773|525612631|FG005|Overall Study|Other|0|||
145754205|NCT03529773|525612632|FG006|Overall Study|Other|0|||
145754206|NCT03529773|525612633|FG007|Overall Study|Other|0|||
145754207|NCT03529773|525612634|FG008|Overall Study|Other|0|||
145754208|NCT03529773|525612635|FG009|Overall Study|Other|0|||
145754209|NCT03529773|525612636|FG010|Overall Study|Other|0|||
145754210|NCT03529773|525612637|FG011|Overall Study|Other|0|||
145754211|NCT03529773|525612638|FG012|Overall Study|Other|1|||
145754212|NCT03529773|525612639|FG013|Overall Study|Other|0|||
145530552|NCT02448810|524803880|FG005|Overall Study|Lost to Follow-up|0|||
145754213|NCT03529773|525612640|FG014|Overall Study|Other|2|||
145754214|NCT03529773|525612641|FG015|Overall Study|Other|0|||
145754215|NCT03529773|525612642|FG016|Overall Study|Other|0|||
145530553|NCT02448810|524803881|FG006|Overall Study|Lost to Follow-up|0|||
145530554|NCT02448810|524803882|FG007|Overall Study|Lost to Follow-up|0|||
145754216|NCT03529773|525612643|FG017|Overall Study|Other|3|||
145754217|NCT03529773|525612644|FG018|Overall Study|Other|0|||
145754218|NCT03529773|525612645|FG019|Overall Study|Other|0|||
145402753|NCT00900562|524332485|FG000|Overall Study|Progressive disease|9|||
145530555|NCT02448810|524803875|FG000|Overall Study|Other (unspecified)|0|||
145530556|NCT02448810|524803876|FG001|Overall Study|Other (unspecified)|0|||
145754219|NCT03529773|525612646|FG020|Overall Study|Other|1|||
145754220|NCT03529773|525612647|FG021|Overall Study|Other|0|||
145754221|NCT03529773|525612648|FG022|Overall Study|Other|1|||
145754222|NCT03529773|525612649|FG023|Overall Study|Other|0|||
145754223|NCT03529773|525612650|FG024|Overall Study|Other|3|||
145754224|NCT03529773|525612651|FG025|Overall Study|Other|2|||
145754225|NCT03529773|525612652|FG026|Overall Study|Other|2|||
145754226|NCT03529773|525612653|FG027|Overall Study|Other|0|||
145754227|NCT03529773|525612654|FG028|Overall Study|Other|0|||
145754228|NCT03529773|525612655|FG029|Overall Study|Other|0|||
145754229|NCT03529773|525612656|FG030|Overall Study|Other|0|||
145754230|NCT03529773|525612657|FG031|Overall Study|Other|0|||
145754231|NCT03529773|525612658|FG032|Overall Study|Other|0|||
145754232|NCT03529773|525612659|FG033|Overall Study|Other|0|||
145754233|NCT03529773|525612660|FG034|Overall Study|Other|1|||
145754234|NCT03529773|525612661|FG035|Overall Study|Other|1|||
145754235|NCT03529773|525612662|FG036|Overall Study|Other|0|||
145754236|NCT03529773|525612663|FG037|Overall Study|Other|0|||
145754237|NCT03529773|525612664|FG038|Overall Study|Other|0|||
145754238|NCT03529773|525612665|FG039|Overall Study|Other|0|||
145530557|NCT02448810|524803877|FG002|Overall Study|Other (unspecified)|0|||
145754239|NCT03529773|525612626|FG000|Overall Study|Physician Decision|0|||
145754240|NCT03529773|525612627|FG001|Overall Study|Physician Decision|0|||
145754241|NCT03529773|525612628|FG002|Overall Study|Physician Decision|0|||
145754242|NCT03529773|525612629|FG003|Overall Study|Physician Decision|0|||
145754243|NCT03529773|525612630|FG004|Overall Study|Physician Decision|0|||
145754244|NCT03529773|525612631|FG005|Overall Study|Physician Decision|0|||
145754245|NCT03529773|525612632|FG006|Overall Study|Physician Decision|0|||
145754246|NCT03529773|525612633|FG007|Overall Study|Physician Decision|0|||
145754247|NCT03529773|525612634|FG008|Overall Study|Physician Decision|0|||
145754248|NCT03529773|525612635|FG009|Overall Study|Physician Decision|0|||
145754249|NCT03529773|525612636|FG010|Overall Study|Physician Decision|0|||
145754250|NCT03529773|525612637|FG011|Overall Study|Physician Decision|0|||
145754251|NCT03529773|525612638|FG012|Overall Study|Physician Decision|0|||
145754252|NCT03529773|525612639|FG013|Overall Study|Physician Decision|0|||
145754253|NCT03529773|525612640|FG014|Overall Study|Physician Decision|0|||
145754254|NCT03529773|525612641|FG015|Overall Study|Physician Decision|0|||
145754255|NCT03529773|525612642|FG016|Overall Study|Physician Decision|0|||
145754256|NCT03529773|525612643|FG017|Overall Study|Physician Decision|0|||
145754257|NCT03529773|525612644|FG018|Overall Study|Physician Decision|0|||
145754258|NCT03529773|525612645|FG019|Overall Study|Physician Decision|1|||
145754259|NCT03529773|525612646|FG020|Overall Study|Physician Decision|1|||
145754260|NCT03529773|525612647|FG021|Overall Study|Physician Decision|0|||
145754261|NCT03529773|525612648|FG022|Overall Study|Physician Decision|0|||
145754262|NCT03529773|525612649|FG023|Overall Study|Physician Decision|0|||
145754263|NCT03529773|525612650|FG024|Overall Study|Physician Decision|0|||
145754264|NCT03529773|525612651|FG025|Overall Study|Physician Decision|0|||
145754265|NCT03529773|525612652|FG026|Overall Study|Physician Decision|0|||
145754266|NCT03529773|525612653|FG027|Overall Study|Physician Decision|0|||
145754267|NCT03529773|525612654|FG028|Overall Study|Physician Decision|0|||
145754268|NCT03529773|525612655|FG029|Overall Study|Physician Decision|0|||
145754269|NCT03529773|525612656|FG030|Overall Study|Physician Decision|0|||
145754270|NCT03529773|525612657|FG031|Overall Study|Physician Decision|0|||
145754271|NCT03529773|525612658|FG032|Overall Study|Physician Decision|0|||
145754272|NCT03529773|525612659|FG033|Overall Study|Physician Decision|0|||
145754273|NCT03529773|525612660|FG034|Overall Study|Physician Decision|0|||
145754274|NCT03529773|525612661|FG035|Overall Study|Physician Decision|0|||
145754275|NCT03529773|525612662|FG036|Overall Study|Physician Decision|0|||
145754276|NCT03529773|525612663|FG037|Overall Study|Physician Decision|0|||
145754277|NCT03529773|525612664|FG038|Overall Study|Physician Decision|0|||
145754278|NCT03529773|525612665|FG039|Overall Study|Physician Decision|0|||
145754279|NCT03529773|525612626|FG000|Overall Study|Protocol Violation|0|||
145754280|NCT03529773|525612627|FG001|Overall Study|Protocol Violation|0|||
145754281|NCT03529773|525612628|FG002|Overall Study|Protocol Violation|0|||
145754282|NCT03529773|525612629|FG003|Overall Study|Protocol Violation|0|||
145754283|NCT03529773|525612630|FG004|Overall Study|Protocol Violation|0|||
145754284|NCT03529773|525612631|FG005|Overall Study|Protocol Violation|0|||
145754285|NCT03529773|525612632|FG006|Overall Study|Protocol Violation|0|||
145530558|NCT02448810|524803878|FG003|Overall Study|Other (unspecified)|0|||
145754286|NCT03529773|525612633|FG007|Overall Study|Protocol Violation|0|||
145754287|NCT03529773|525612634|FG008|Overall Study|Protocol Violation|0|||
145754288|NCT03529773|525612635|FG009|Overall Study|Protocol Violation|0|||
145754289|NCT03529773|525612636|FG010|Overall Study|Protocol Violation|0|||
145754290|NCT03529773|525612637|FG011|Overall Study|Protocol Violation|0|||
145754291|NCT03529773|525612638|FG012|Overall Study|Protocol Violation|0|||
145754292|NCT03529773|525612639|FG013|Overall Study|Protocol Violation|0|||
145754293|NCT03529773|525612640|FG014|Overall Study|Protocol Violation|0|||
145754294|NCT03529773|525612641|FG015|Overall Study|Protocol Violation|0|||
145530559|NCT02448810|524803879|FG004|Overall Study|Other (unspecified)|0|||
145530560|NCT02448810|524803880|FG005|Overall Study|Other (unspecified)|0|||
145530561|NCT02448810|524803881|FG006|Overall Study|Other (unspecified)|2|||
145530562|NCT02448810|524803882|FG007|Overall Study|Other (unspecified)|0|||
145530563|NCT01916967|524803886|FG000|Overall Study|Adverse Event|0|||
145530564|NCT01916967|524803887|FG001|Overall Study|Adverse Event|0|||
145530565|NCT01916967|524803888|FG002|Overall Study|Adverse Event|2|||
145530566|NCT01916967|524803886|FG000|Overall Study|Lack of Efficacy|0|||
145530567|NCT01916967|524803887|FG001|Overall Study|Lack of Efficacy|0|||
145530568|NCT01916967|524803888|FG002|Overall Study|Lack of Efficacy|6|||
145530569|NCT01916967|524803886|FG000|Overall Study|Physician Decision|0|||
145530570|NCT01916967|524803887|FG001|Overall Study|Physician Decision|0|||
145530571|NCT01916967|524803888|FG002|Overall Study|Physician Decision|1|||
145530572|NCT01916967|524803886|FG000|Overall Study|Protocol Violation|0|||
145530573|NCT01916967|524803887|FG001|Overall Study|Protocol Violation|1|||
145530574|NCT01916967|524803888|FG002|Overall Study|Protocol Violation|0|||
145530575|NCT00620464|524803889|FG000|Overall Study|Adverse Event|15|||
145530576|NCT00620464|524803890|FG001|Overall Study|Adverse Event|17|||
145530577|NCT00620464|524803889|FG000|Overall Study|Lost to Follow-up|1|||
145530578|NCT00620464|524803890|FG001|Overall Study|Lost to Follow-up|1|||
145530579|NCT00620464|524803889|FG000|Overall Study|Planning Pregnancy|1|||
145530580|NCT00620464|524803890|FG001|Overall Study|Planning Pregnancy|4|||
145530581|NCT00620464|524803889|FG000|Overall Study|Personal|2|||
145530582|NCT00620464|524803890|FG001|Overall Study|Personal|2|||
145530583|NCT00620464|524803889|FG000|Overall Study|Used prohibited medication|1|||
145530584|NCT00620464|524803890|FG001|Overall Study|Used prohibited medication|0|||
145530585|NCT01231347|524803891|FG000|Overall Study|Full Consent withdrawn|19|||
145530586|NCT01231347|524803892|FG001|Overall Study|Full Consent withdrawn|19|||
145530587|NCT01231347|524803893|FG002|Overall Study|Full Consent withdrawn|11|||
145530588|NCT01231347|524803891|FG000|Overall Study|Lost to Follow-up|4|||
145530589|NCT01231347|524803892|FG001|Overall Study|Lost to Follow-up|2|||
145530590|NCT01231347|524803893|FG002|Overall Study|Lost to Follow-up|2|||
145530591|NCT01231347|524803891|FG000|Overall Study|Death|202|||
145530592|NCT01231347|524803892|FG001|Overall Study|Death|210|||
145530593|NCT01231347|524803893|FG002|Overall Study|Death|101|||
145530594|NCT01231347|524803891|FG000|Overall Study|other event|7|||
145530595|NCT01231347|524803892|FG001|Overall Study|other event|9|||
145530596|NCT01231347|524803893|FG002|Overall Study|other event|3|||
145530597|NCT02322021|524803894|FG000|Core Phase|Adverse Event|1|||
145530598|NCT02322021|524803895|FG001|Core Phase|Adverse Event|3|||
145530599|NCT02322021|524803896|FG002|Core Phase|Adverse Event|4|||
145530600|NCT02322021|524803897|FG003|Core Phase|Adverse Event|2|||
145530601|NCT02322021|524803898|FG004|Core Phase|Adverse Event|0|||
145530602|NCT02322021|524803894|FG000|Core Phase|Participant Choice|4|||
145530603|NCT02322021|524803895|FG001|Core Phase|Participant Choice|5|||
145530604|NCT02322021|524803896|FG002|Core Phase|Participant Choice|4|||
145530605|NCT02322021|524803897|FG003|Core Phase|Participant Choice|2|||
145530606|NCT02322021|524803898|FG004|Core Phase|Participant Choice|0|||
145530607|NCT02322021|524803894|FG000|Core Phase|Lost to Follow-up|0|||
145530608|NCT02322021|524803895|FG001|Core Phase|Lost to Follow-up|0|||
145530609|NCT02322021|524803896|FG002|Core Phase|Lost to Follow-up|0|||
145530610|NCT02322021|524803897|FG003|Core Phase|Lost to Follow-up|1|||
145530611|NCT02322021|524803898|FG004|Core Phase|Lost to Follow-up|0|||
145530612|NCT02322021|524803894|FG000|Core Phase|Other|0|||
145530613|NCT02322021|524803895|FG001|Core Phase|Other|0|||
145530614|NCT02322021|524803896|FG002|Core Phase|Other|1|||
145530615|NCT02322021|524803897|FG003|Core Phase|Other|0|||
145530616|NCT02322021|524803898|FG004|Core Phase|Other|0|||
145530617|NCT02322021|524803894|FG000|Extension Phase|Adverse Event|0|||
145530618|NCT02322021|524803895|FG001|Extension Phase|Adverse Event|0|||
145530619|NCT02322021|524803896|FG002|Extension Phase|Adverse Event|0|||
145530620|NCT02322021|524803897|FG003|Extension Phase|Adverse Event|0|||
145530621|NCT02322021|524803898|FG004|Extension Phase|Adverse Event|3|||
145530622|NCT02322021|524803894|FG000|Extension Phase|Participant Choice|0|||
145530623|NCT02322021|524803895|FG001|Extension Phase|Participant Choice|0|||
145530624|NCT02322021|524803896|FG002|Extension Phase|Participant Choice|0|||
145530625|NCT02322021|524803897|FG003|Extension Phase|Participant Choice|0|||
145530626|NCT02322021|524803898|FG004|Extension Phase|Participant Choice|6|||
145530627|NCT02322021|524803894|FG000|Extension Phase|Other|0|||
145530628|NCT02322021|524803895|FG001|Extension Phase|Other|0|||
145530629|NCT02322021|524803896|FG002|Extension Phase|Other|0|||
145530630|NCT02322021|524803897|FG003|Extension Phase|Other|0|||
145530631|NCT02322021|524803898|FG004|Extension Phase|Other|3|||
145530632|NCT02322021|524803894|FG000|Extension Phase|Lost to Follow-up|0|||
145530633|NCT02322021|524803895|FG001|Extension Phase|Lost to Follow-up|0|||
145530634|NCT02322021|524803896|FG002|Extension Phase|Lost to Follow-up|0|||
145530635|NCT02322021|524803897|FG003|Extension Phase|Lost to Follow-up|0|||
145530636|NCT02322021|524803898|FG004|Extension Phase|Lost to Follow-up|1|||
145530637|NCT02322021|524803894|FG000|Extension Phase|Study terminated by sponsor|0|||
145530638|NCT02322021|524803895|FG001|Extension Phase|Study terminated by sponsor|0|||
145530639|NCT02322021|524803896|FG002|Extension Phase|Study terminated by sponsor|0|||
145530640|NCT02322021|524803897|FG003|Extension Phase|Study terminated by sponsor|0|||
145530641|NCT02322021|524803898|FG004|Extension Phase|Study terminated by sponsor|28|||
145530642|NCT01385371|524803911|FG000|Overall Study|Adverse Event|54|||
145530643|NCT01385371|524803912|FG001|Overall Study|Adverse Event|19|||
145530644|NCT01385371|524803911|FG000|Overall Study|Lost to Follow-up|16|||
145530645|NCT01385371|524803912|FG001|Overall Study|Lost to Follow-up|16|||
145530646|NCT01385371|524803911|FG000|Overall Study|Withdrawal by Subject|52|||
145530647|NCT01385371|524803912|FG001|Overall Study|Withdrawal by Subject|39|||
145530648|NCT01385371|524803911|FG000|Overall Study|Protocol Violation|25|||
145530649|NCT01385371|524803912|FG001|Overall Study|Protocol Violation|21|||
145754295|NCT03529773|525612642|FG016|Overall Study|Protocol Violation|0|||
145754296|NCT03529773|525612643|FG017|Overall Study|Protocol Violation|0|||
145754297|NCT03529773|525612644|FG018|Overall Study|Protocol Violation|0|||
145754298|NCT03529773|525612645|FG019|Overall Study|Protocol Violation|0|||
145754299|NCT03529773|525612646|FG020|Overall Study|Protocol Violation|0|||
145754300|NCT03529773|525612647|FG021|Overall Study|Protocol Violation|0|||
145754301|NCT03529773|525612648|FG022|Overall Study|Protocol Violation|0|||
145754302|NCT03529773|525612649|FG023|Overall Study|Protocol Violation|0|||
145754303|NCT03529773|525612650|FG024|Overall Study|Protocol Violation|0|||
145754304|NCT03529773|525612651|FG025|Overall Study|Protocol Violation|0|||
145754305|NCT03529773|525612652|FG026|Overall Study|Protocol Violation|0|||
145754306|NCT03529773|525612653|FG027|Overall Study|Protocol Violation|0|||
145754307|NCT03529773|525612654|FG028|Overall Study|Protocol Violation|0|||
145530650|NCT01385371|524803911|FG000|Overall Study|Administrative|2|||
145530651|NCT01385371|524803912|FG001|Overall Study|Administrative|2|||
145530652|NCT02979197|524803918|FG000|Overall Study|Adverse Event|4|||
145530653|NCT02979197|524803919|FG001|Overall Study|Adverse Event|2|||
145530654|NCT02979197|524803920|FG002|Overall Study|Adverse Event|0|||
145530655|NCT02979197|524803918|FG000|Overall Study|Protocol Violation|0|||
145530656|NCT02979197|524803919|FG001|Overall Study|Protocol Violation|1|||
145530657|NCT02979197|524803920|FG002|Overall Study|Protocol Violation|0|||
145530658|NCT02979197|524803918|FG000|Overall Study|Subject unable to commit to study dates|0|||
145530659|NCT02979197|524803919|FG001|Overall Study|Subject unable to commit to study dates|1|||
145530660|NCT02979197|524803920|FG002|Overall Study|Subject unable to commit to study dates|0|||
145754308|NCT03529773|525612655|FG029|Overall Study|Protocol Violation|0|||
145754309|NCT03529773|525612656|FG030|Overall Study|Protocol Violation|1|||
145754310|NCT03529773|525612657|FG031|Overall Study|Protocol Violation|0|||
145530661|NCT03643159|524803921|FG000|Overall Study|Adverse Event|1|||
145530662|NCT03643159|524803921|FG000|Overall Study|Withdrawal by Subject|1|||
145530663|NCT03438383|524803922|FG000|Overall Study|Protocol Violation|9|||
145530664|NCT03438383|524803923|FG001|Overall Study|Protocol Violation|3|||
145530665|NCT01631812|524803924|FG000|Overall Study|Adverse Event|25|||
145530666|NCT01631812|524803924|FG000|Overall Study|Lack of Efficacy|5|||
145530667|NCT01631812|524803924|FG000|Overall Study|Withdrawal by Subject|4|||
145530668|NCT01631812|524803924|FG000|Overall Study|Physician Decision|3|||
145530669|NCT01528033|524803925|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
145530670|NCT01528033|524803926|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
145530671|NCT01528033|524803925|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
145530672|NCT01528033|524803926|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
145530673|NCT01528033|524803925|FG000|Primary Endpoint Assessment ITT|Death|2|||
145530674|NCT01528033|524803926|FG001|Primary Endpoint Assessment ITT|Death|2|||
145530675|NCT01528033|524803925|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
145530676|NCT01528033|524803926|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
145530677|NCT01528033|524803925|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
145530678|NCT01528033|524803926|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
145530679|NCT01528033|524803925|FG000|Follow Up|No data available|46|||
145530680|NCT01528033|524803926|FG001|Follow Up|No data available|44|||
145530681|NCT02030938|524803929|FG000|Overall Study|Lost to Follow-up|4|||
145530682|NCT02030938|524803929|FG000|Overall Study|Withdrawal by Subject|1|||
145530683|NCT01414608|524803934|FG000|Overall Study|Ineligible|5|||
145530684|NCT01414608|524803935|FG001|Overall Study|Ineligible|2|||
145530685|NCT05156073|524803936|FG000|Overall Study|Patient canceled appointment with PCP|1|||
145530686|NCT00973349|524803937|FG000|Overall Study|Adverse Event|0|||
145530687|NCT00973349|524803938|FG001|Overall Study|Adverse Event|0|||
145754311|NCT03529773|525612658|FG032|Overall Study|Protocol Violation|0|||
145754312|NCT03529773|525612659|FG033|Overall Study|Protocol Violation|0|||
145754313|NCT03529773|525612660|FG034|Overall Study|Protocol Violation|0|||
145754314|NCT03529773|525612661|FG035|Overall Study|Protocol Violation|0|||
145754315|NCT03529773|525612662|FG036|Overall Study|Protocol Violation|0|||
145754316|NCT03529773|525612663|FG037|Overall Study|Protocol Violation|0|||
145754317|NCT03529773|525612664|FG038|Overall Study|Protocol Violation|0|||
145754318|NCT03529773|525612665|FG039|Overall Study|Protocol Violation|0|||
145754319|NCT03529773|525612626|FG000|Overall Study|Withdrawal by Subject|0|||
145754320|NCT03529773|525612627|FG001|Overall Study|Withdrawal by Subject|0|||
145754321|NCT03529773|525612628|FG002|Overall Study|Withdrawal by Subject|0|||
145754322|NCT03529773|525612629|FG003|Overall Study|Withdrawal by Subject|0|||
145754323|NCT03529773|525612630|FG004|Overall Study|Withdrawal by Subject|0|||
145754324|NCT03529773|525612631|FG005|Overall Study|Withdrawal by Subject|0|||
145754325|NCT03529773|525612632|FG006|Overall Study|Withdrawal by Subject|0|||
145530688|NCT00973349|524803939|FG002|Overall Study|Adverse Event|0|||
145530689|NCT00973349|524803940|FG003|Overall Study|Adverse Event|0|||
145530690|NCT00973349|524803941|FG004|Overall Study|Adverse Event|1|||
145530691|NCT00973349|524803942|FG005|Overall Study|Adverse Event|0|||
145530692|NCT00973349|524803943|FG006|Overall Study|Adverse Event|0|||
145530693|NCT00973349|524803944|FG007|Overall Study|Adverse Event|0|||
145754326|NCT03529773|525612633|FG007|Overall Study|Withdrawal by Subject|1|||
145754327|NCT03529773|525612634|FG008|Overall Study|Withdrawal by Subject|0|||
145754328|NCT03529773|525612635|FG009|Overall Study|Withdrawal by Subject|1|||
145754329|NCT03529773|525612636|FG010|Overall Study|Withdrawal by Subject|1|||
145754330|NCT03529773|525612637|FG011|Overall Study|Withdrawal by Subject|0|||
145754331|NCT03529773|525612638|FG012|Overall Study|Withdrawal by Subject|0|||
145754332|NCT03529773|525612639|FG013|Overall Study|Withdrawal by Subject|0|||
145754333|NCT03529773|525612640|FG014|Overall Study|Withdrawal by Subject|0|||
145754334|NCT03529773|525612641|FG015|Overall Study|Withdrawal by Subject|3|||
145754335|NCT03529773|525612642|FG016|Overall Study|Withdrawal by Subject|0|||
145754336|NCT03529773|525612643|FG017|Overall Study|Withdrawal by Subject|2|||
145754337|NCT03529773|525612644|FG018|Overall Study|Withdrawal by Subject|3|||
145754338|NCT03529773|525612645|FG019|Overall Study|Withdrawal by Subject|1|||
145754339|NCT03529773|525612646|FG020|Overall Study|Withdrawal by Subject|3|||
145754340|NCT03529773|525612647|FG021|Overall Study|Withdrawal by Subject|1|||
145754341|NCT03529773|525612648|FG022|Overall Study|Withdrawal by Subject|1|||
145754342|NCT03529773|525612649|FG023|Overall Study|Withdrawal by Subject|2|||
145754343|NCT03529773|525612650|FG024|Overall Study|Withdrawal by Subject|2|||
145754344|NCT03529773|525612651|FG025|Overall Study|Withdrawal by Subject|4|||
145754345|NCT03529773|525612652|FG026|Overall Study|Withdrawal by Subject|2|||
145754346|NCT03529773|525612653|FG027|Overall Study|Withdrawal by Subject|1|||
145754347|NCT03529773|525612654|FG028|Overall Study|Withdrawal by Subject|1|||
145754348|NCT03529773|525612655|FG029|Overall Study|Withdrawal by Subject|0|||
145754349|NCT03529773|525612656|FG030|Overall Study|Withdrawal by Subject|0|||
145754350|NCT03529773|525612657|FG031|Overall Study|Withdrawal by Subject|0|||
145754351|NCT03529773|525612658|FG032|Overall Study|Withdrawal by Subject|0|||
145754352|NCT03529773|525612659|FG033|Overall Study|Withdrawal by Subject|0|||
145754353|NCT03529773|525612660|FG034|Overall Study|Withdrawal by Subject|1|||
145754354|NCT03529773|525612661|FG035|Overall Study|Withdrawal by Subject|2|||
145754355|NCT03529773|525612662|FG036|Overall Study|Withdrawal by Subject|0|||
145754356|NCT03529773|525612663|FG037|Overall Study|Withdrawal by Subject|2|||
145754357|NCT03529773|525612664|FG038|Overall Study|Withdrawal by Subject|1|||
145754358|NCT03529773|525612665|FG039|Overall Study|Withdrawal by Subject|1|||
145754359|NCT03529773|525612626|FG000|Overall Study|Screen Failure|0|||
145754360|NCT03529773|525612627|FG001|Overall Study|Screen Failure|0|||
145754361|NCT03529773|525612628|FG002|Overall Study|Screen Failure|0|||
145754362|NCT03529773|525612629|FG003|Overall Study|Screen Failure|0|||
145754363|NCT03529773|525612630|FG004|Overall Study|Screen Failure|0|||
145754364|NCT03529773|525612631|FG005|Overall Study|Screen Failure|0|||
145754365|NCT03529773|525612632|FG006|Overall Study|Screen Failure|0|||
145754366|NCT03529773|525612633|FG007|Overall Study|Screen Failure|0|||
145754367|NCT03529773|525612634|FG008|Overall Study|Screen Failure|0|||
145754368|NCT03529773|525612635|FG009|Overall Study|Screen Failure|0|||
145754369|NCT03529773|525612636|FG010|Overall Study|Screen Failure|0|||
145754370|NCT03529773|525612637|FG011|Overall Study|Screen Failure|0|||
145754371|NCT03529773|525612638|FG012|Overall Study|Screen Failure|0|||
145754372|NCT03529773|525612639|FG013|Overall Study|Screen Failure|0|||
145754373|NCT03529773|525612640|FG014|Overall Study|Screen Failure|0|||
145754374|NCT03529773|525612641|FG015|Overall Study|Screen Failure|0|||
145754375|NCT03529773|525612642|FG016|Overall Study|Screen Failure|0|||
145754376|NCT03529773|525612643|FG017|Overall Study|Screen Failure|0|||
145754377|NCT03529773|525612644|FG018|Overall Study|Screen Failure|0|||
145754378|NCT03529773|525612645|FG019|Overall Study|Screen Failure|0|||
145754379|NCT03529773|525612646|FG020|Overall Study|Screen Failure|0|||
145754380|NCT03529773|525612647|FG021|Overall Study|Screen Failure|0|||
145754381|NCT03529773|525612648|FG022|Overall Study|Screen Failure|0|||
145754382|NCT03529773|525612649|FG023|Overall Study|Screen Failure|0|||
145754383|NCT03529773|525612650|FG024|Overall Study|Screen Failure|0|||
145754384|NCT03529773|525612651|FG025|Overall Study|Screen Failure|0|||
145754385|NCT03529773|525612652|FG026|Overall Study|Screen Failure|0|||
145754386|NCT03529773|525612653|FG027|Overall Study|Screen Failure|0|||
145754387|NCT03529773|525612654|FG028|Overall Study|Screen Failure|0|||
145754388|NCT03529773|525612655|FG029|Overall Study|Screen Failure|0|||
145754389|NCT03529773|525612656|FG030|Overall Study|Screen Failure|0|||
145754390|NCT03529773|525612657|FG031|Overall Study|Screen Failure|0|||
145754391|NCT03529773|525612658|FG032|Overall Study|Screen Failure|0|||
145754392|NCT03529773|525612659|FG033|Overall Study|Screen Failure|0|||
145530694|NCT00973349|524803945|FG008|Overall Study|Adverse Event|1|||
145530695|NCT00973349|524803946|FG009|Overall Study|Adverse Event|0|||
145530696|NCT00973349|524803947|FG010|Overall Study|Adverse Event|0|||
145530697|NCT00973349|524803948|FG011|Overall Study|Adverse Event|0|||
145530698|NCT00973349|524803949|FG012|Overall Study|Adverse Event|0|||
145530699|NCT00973349|524803950|FG013|Overall Study|Adverse Event|0|||
145530700|NCT00973349|524803951|FG014|Overall Study|Adverse Event|1|||
145754393|NCT03529773|525612660|FG034|Overall Study|Screen Failure|0|||
145754394|NCT03529773|525612661|FG035|Overall Study|Screen Failure|0|||
145754395|NCT03529773|525612662|FG036|Overall Study|Screen Failure|1|||
145754396|NCT03529773|525612663|FG037|Overall Study|Screen Failure|1|||
145754397|NCT03529773|525612664|FG038|Overall Study|Screen Failure|0|||
145754398|NCT03529773|525612665|FG039|Overall Study|Screen Failure|1|||
145754399|NCT03529773|525612626|FG000|Overall Study|Randomized but not vaccinated|0|||
145754400|NCT03529773|525612627|FG001|Overall Study|Randomized but not vaccinated|0|||
145754401|NCT03529773|525612628|FG002|Overall Study|Randomized but not vaccinated|0|||
145754402|NCT03529773|525612629|FG003|Overall Study|Randomized but not vaccinated|0|||
145754403|NCT03529773|525612630|FG004|Overall Study|Randomized but not vaccinated|0|||
145754404|NCT03529773|525612631|FG005|Overall Study|Randomized but not vaccinated|0|||
145754405|NCT03529773|525612632|FG006|Overall Study|Randomized but not vaccinated|0|||
145754406|NCT03529773|525612633|FG007|Overall Study|Randomized but not vaccinated|0|||
145754407|NCT03529773|525612634|FG008|Overall Study|Randomized but not vaccinated|0|||
145754408|NCT03529773|525612635|FG009|Overall Study|Randomized but not vaccinated|0|||
145754409|NCT03529773|525612636|FG010|Overall Study|Randomized but not vaccinated|0|||
145754410|NCT03529773|525612637|FG011|Overall Study|Randomized but not vaccinated|0|||
145754411|NCT03529773|525612638|FG012|Overall Study|Randomized but not vaccinated|0|||
145754412|NCT03529773|525612639|FG013|Overall Study|Randomized but not vaccinated|0|||
145754413|NCT03529773|525612640|FG014|Overall Study|Randomized but not vaccinated|0|||
145754414|NCT03529773|525612641|FG015|Overall Study|Randomized but not vaccinated|0|||
145754415|NCT03529773|525612642|FG016|Overall Study|Randomized but not vaccinated|0|||
145754416|NCT03529773|525612643|FG017|Overall Study|Randomized but not vaccinated|1|||
145754417|NCT03529773|525612644|FG018|Overall Study|Randomized but not vaccinated|0|||
145754418|NCT03529773|525612645|FG019|Overall Study|Randomized but not vaccinated|0|||
145754419|NCT03529773|525612646|FG020|Overall Study|Randomized but not vaccinated|0|||
145754420|NCT03529773|525612647|FG021|Overall Study|Randomized but not vaccinated|0|||
145754421|NCT03529773|525612648|FG022|Overall Study|Randomized but not vaccinated|0|||
145754422|NCT03529773|525612649|FG023|Overall Study|Randomized but not vaccinated|0|||
145754423|NCT03529773|525612650|FG024|Overall Study|Randomized but not vaccinated|0|||
145754424|NCT03529773|525612651|FG025|Overall Study|Randomized but not vaccinated|0|||
145754425|NCT03529773|525612652|FG026|Overall Study|Randomized but not vaccinated|0|||
145754426|NCT03529773|525612653|FG027|Overall Study|Randomized but not vaccinated|1|||
145754427|NCT03529773|525612654|FG028|Overall Study|Randomized but not vaccinated|0|||
145754428|NCT03529773|525612655|FG029|Overall Study|Randomized but not vaccinated|0|||
145754429|NCT03529773|525612656|FG030|Overall Study|Randomized but not vaccinated|0|||
145754430|NCT03529773|525612657|FG031|Overall Study|Randomized but not vaccinated|0|||
145754431|NCT03529773|525612658|FG032|Overall Study|Randomized but not vaccinated|0|||
145754432|NCT03529773|525612659|FG033|Overall Study|Randomized but not vaccinated|0|||
145754433|NCT03529773|525612660|FG034|Overall Study|Randomized but not vaccinated|0|||
145754434|NCT03529773|525612661|FG035|Overall Study|Randomized but not vaccinated|0|||
145754435|NCT03529773|525612662|FG036|Overall Study|Randomized but not vaccinated|0|||
145754436|NCT03529773|525612663|FG037|Overall Study|Randomized but not vaccinated|0|||
145754437|NCT03529773|525612664|FG038|Overall Study|Randomized but not vaccinated|0|||
145754438|NCT03529773|525612665|FG039|Overall Study|Randomized but not vaccinated|0|||
145754439|NCT01496066|525612667|FG000|Overall Study|Lost to Follow-up|8|||
145754440|NCT01496066|525612668|FG001|Overall Study|Lost to Follow-up|5|||
145754441|NCT01496066|525612667|FG000|Overall Study|Explant|3|||
145754442|NCT01496066|525612668|FG001|Overall Study|Explant|0|||
145754443|NCT01496066|525612667|FG000|Overall Study|Death|1|||
145754444|NCT01496066|525612668|FG001|Overall Study|Death|4|||
145754445|NCT02926209|525612669|FG000|Study Cohort|Poor Bowel Preparation|1|||
145754446|NCT02926209|525612670|FG001|Study Cohort|Poor Bowel Preparation|0|||
145754447|NCT01239160|525612671|FG000|Overall Study|Lost to Follow-up|3|||
145754448|NCT01239160|525612672|FG001|Overall Study|Lost to Follow-up|5|||
145530701|NCT00973349|524803952|FG015|Overall Study|Adverse Event|0|||
145530702|NCT00973349|524803937|FG000|Overall Study|Withdrawal by Subject|1|||
145530703|NCT00973349|524803938|FG001|Overall Study|Withdrawal by Subject|2|||
145530704|NCT00973349|524803939|FG002|Overall Study|Withdrawal by Subject|2|||
145754449|NCT01239160|525612673|FG002|Overall Study|Lost to Follow-up|0|||
145754450|NCT01239160|525612671|FG000|Overall Study|Withdrawal by Subject|17|||
145754451|NCT01239160|525612672|FG001|Overall Study|Withdrawal by Subject|6|||
145754452|NCT01239160|525612673|FG002|Overall Study|Withdrawal by Subject|2|||
145754453|NCT01239160|525612671|FG000|Overall Study|Physician Decision|5|||
145754454|NCT01239160|525612672|FG001|Overall Study|Physician Decision|7|||
145754455|NCT01239160|525612673|FG002|Overall Study|Physician Decision|2|||
145754456|NCT01239160|525612671|FG000|Overall Study|Early Termination Due to Study Closure|0|||
145754457|NCT01239160|525612672|FG001|Overall Study|Early Termination Due to Study Closure|1|||
145754458|NCT01239160|525612673|FG002|Overall Study|Early Termination Due to Study Closure|6|||
145754459|NCT01764633|525612674|FG000|Overall Study|Withdrawal by Subject|105|||
145754460|NCT01764633|525612675|FG001|Overall Study|Withdrawal by Subject|88|||
145754461|NCT01764633|525612674|FG000|Overall Study|Lost to Follow-up|13|||
145754462|NCT01764633|525612675|FG001|Overall Study|Lost to Follow-up|5|||
145754463|NCT04781816|525612681|FG000|Overall Study|Adverse Event|0|||
145754464|NCT04781816|525612682|FG001|Overall Study|Adverse Event|1|||
145754465|NCT04781816|525612681|FG000|Overall Study|Withdrawal by Subject|1|||
145754466|NCT04781816|525612682|FG001|Overall Study|Withdrawal by Subject|1|||
145754467|NCT04781816|525612681|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
145754468|NCT04781816|525612682|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
145754469|NCT02062658|525612683|FG000|Overall Study|Withdrawal by Subject|1|||
145754470|NCT02062658|525612683|FG000|Overall Study|Lack of Efficacy|1|||
145754471|NCT01789970|525612684|FG000|Open-label Titration Period|Adverse Event|68|||
145754472|NCT01789970|525612685|FG001|Open-label Titration Period|Adverse Event|0|||
145754473|NCT01789970|525612686|FG002|Open-label Titration Period|Adverse Event|0|||
145754474|NCT01789970|525612684|FG000|Open-label Titration Period|Lack of Efficacy|31|||
145754475|NCT01789970|525612685|FG001|Open-label Titration Period|Lack of Efficacy|0|||
145754476|NCT01789970|525612686|FG002|Open-label Titration Period|Lack of Efficacy|0|||
145754477|NCT01789970|525612684|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
145754478|NCT01789970|525612685|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
145754479|NCT01789970|525612686|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
145754480|NCT01789970|525612684|FG000|Open-label Titration Period|Protocol Violation|18|||
145754481|NCT01789970|525612685|FG001|Open-label Titration Period|Protocol Violation|0|||
145754482|NCT01789970|525612686|FG002|Open-label Titration Period|Protocol Violation|0|||
145754483|NCT01789970|525612684|FG000|Open-label Titration Period|Lost to Follow-up|5|||
145754484|NCT01789970|525612685|FG001|Open-label Titration Period|Lost to Follow-up|0|||
145754485|NCT01789970|525612686|FG002|Open-label Titration Period|Lost to Follow-up|0|||
145754486|NCT01789970|525612684|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
145754487|NCT01789970|525612685|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
145754488|NCT01789970|525612686|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
145754489|NCT01789970|525612684|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
145754490|NCT01789970|525612685|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
145754491|NCT01789970|525612686|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
145754492|NCT01789970|525612684|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
145754493|NCT01789970|525612685|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
145754494|NCT01789970|525612686|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
145754495|NCT01789970|525612684|FG000|Open-label Titration Period|Pregnancy|2|||
145754496|NCT01789970|525612685|FG001|Open-label Titration Period|Pregnancy|0|||
145754497|NCT01789970|525612686|FG002|Open-label Titration Period|Pregnancy|0|||
145754498|NCT01789970|525612684|FG000|Open-label Titration Period|Other|76|||
145754499|NCT01789970|525612685|FG001|Open-label Titration Period|Other|0|||
145754500|NCT01789970|525612686|FG002|Open-label Titration Period|Other|0|||
145754501|NCT01789970|525612684|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
145754502|NCT01789970|525612685|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
145754503|NCT01789970|525612686|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
145754504|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
145754505|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
145754506|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
145754507|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145754508|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
145754509|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
145754510|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145754511|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
145754512|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
145754513|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
145754514|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
145754515|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
145754516|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
145754517|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
145754518|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
145754519|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
145754520|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
145754521|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
145754522|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145754523|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145754524|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
145754525|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
145530705|NCT00973349|524803940|FG003|Overall Study|Withdrawal by Subject|3|||
145530706|NCT00973349|524803941|FG004|Overall Study|Withdrawal by Subject|2|||
145530707|NCT00973349|524803942|FG005|Overall Study|Withdrawal by Subject|0|||
145530708|NCT00973349|524803943|FG006|Overall Study|Withdrawal by Subject|2|||
145530709|NCT00973349|524803944|FG007|Overall Study|Withdrawal by Subject|2|||
145530710|NCT00973349|524803945|FG008|Overall Study|Withdrawal by Subject|0|||
145530711|NCT00973349|524803946|FG009|Overall Study|Withdrawal by Subject|2|||
145530712|NCT00973349|524803947|FG010|Overall Study|Withdrawal by Subject|0|||
145530713|NCT00973349|524803948|FG011|Overall Study|Withdrawal by Subject|1|||
145530714|NCT00973349|524803949|FG012|Overall Study|Withdrawal by Subject|0|||
145530715|NCT00973349|524803950|FG013|Overall Study|Withdrawal by Subject|0|||
145530716|NCT00973349|524803951|FG014|Overall Study|Withdrawal by Subject|0|||
145530717|NCT00973349|524803952|FG015|Overall Study|Withdrawal by Subject|0|||
145530718|NCT00973349|524803937|FG000|Overall Study|Lost to Follow-up|3|||
145530719|NCT00973349|524803938|FG001|Overall Study|Lost to Follow-up|1|||
145530720|NCT00973349|524803939|FG002|Overall Study|Lost to Follow-up|2|||
145530721|NCT00973349|524803940|FG003|Overall Study|Lost to Follow-up|2|||
145530722|NCT00973349|524803941|FG004|Overall Study|Lost to Follow-up|1|||
145530723|NCT00973349|524803942|FG005|Overall Study|Lost to Follow-up|3|||
145530724|NCT00973349|524803943|FG006|Overall Study|Lost to Follow-up|0|||
145754526|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
145530725|NCT00973349|524803944|FG007|Overall Study|Lost to Follow-up|1|||
145530726|NCT00973349|524803945|FG008|Overall Study|Lost to Follow-up|2|||
145754527|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
145754528|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
145754529|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
145754530|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
145754531|NCT01789970|525612684|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
145754532|NCT01789970|525612685|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
145754533|NCT01789970|525612686|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
145754534|NCT02574637|525612687|FG000|Double-blind Period|Adverse Event|1|||
145754535|NCT02574637|525612688|FG001|Double-blind Period|Adverse Event|0|||
145754536|NCT02574637|525612689|FG002|Double-blind Period|Adverse Event|0|||
145754537|NCT02574637|525612690|FG003|Double-blind Period|Adverse Event|0|||
145754538|NCT02574637|525612691|FG004|Double-blind Period|Adverse Event|0|||
145754539|NCT02574637|525612692|FG005|Double-blind Period|Adverse Event|0|||
145754540|NCT02574637|525612693|FG006|Double-blind Period|Adverse Event|0|||
145754541|NCT02574637|525612694|FG007|Double-blind Period|Adverse Event|0|||
145754542|NCT02574637|525612695|FG008|Double-blind Period|Adverse Event|0|||
145754543|NCT02574637|525612696|FG009|Double-blind Period|Adverse Event|0|||
145754544|NCT02574637|525612687|FG000|Double-blind Period|Lack of Efficacy|0|||
145754545|NCT02574637|525612688|FG001|Double-blind Period|Lack of Efficacy|0|||
145754546|NCT02574637|525612689|FG002|Double-blind Period|Lack of Efficacy|2|||
145754547|NCT02574637|525612690|FG003|Double-blind Period|Lack of Efficacy|0|||
145754548|NCT02574637|525612691|FG004|Double-blind Period|Lack of Efficacy|0|||
145754549|NCT02574637|525612692|FG005|Double-blind Period|Lack of Efficacy|0|||
145754550|NCT02574637|525612693|FG006|Double-blind Period|Lack of Efficacy|0|||
145754551|NCT02574637|525612694|FG007|Double-blind Period|Lack of Efficacy|0|||
145754552|NCT02574637|525612695|FG008|Double-blind Period|Lack of Efficacy|0|||
145754553|NCT02574637|525612696|FG009|Double-blind Period|Lack of Efficacy|0|||
145754554|NCT02574637|525612687|FG000|Double-blind Period|Protocol Deviation|1|||
145754555|NCT02574637|525612688|FG001|Double-blind Period|Protocol Deviation|0|||
145754556|NCT02574637|525612689|FG002|Double-blind Period|Protocol Deviation|0|||
145754557|NCT02574637|525612690|FG003|Double-blind Period|Protocol Deviation|0|||
145754558|NCT02574637|525612691|FG004|Double-blind Period|Protocol Deviation|0|||
145754559|NCT02574637|525612692|FG005|Double-blind Period|Protocol Deviation|0|||
145754560|NCT02574637|525612693|FG006|Double-blind Period|Protocol Deviation|0|||
145754561|NCT02574637|525612694|FG007|Double-blind Period|Protocol Deviation|0|||
145754562|NCT02574637|525612695|FG008|Double-blind Period|Protocol Deviation|0|||
145754563|NCT02574637|525612696|FG009|Double-blind Period|Protocol Deviation|0|||
145754564|NCT02574637|525612687|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
145754565|NCT02574637|525612688|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
145754566|NCT02574637|525612689|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
145754567|NCT02574637|525612690|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
145754568|NCT02574637|525612691|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
145754569|NCT02574637|525612692|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
145754570|NCT02574637|525612693|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
145754571|NCT02574637|525612694|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
145754572|NCT02574637|525612695|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
145754573|NCT02574637|525612696|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
145754574|NCT02574637|525612687|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
145754575|NCT02574637|525612688|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
145754576|NCT02574637|525612689|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
145754577|NCT02574637|525612690|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
145754578|NCT02574637|525612691|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
145754579|NCT02574637|525612692|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
145754580|NCT02574637|525612693|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
145754581|NCT02574637|525612694|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
145754582|NCT02574637|525612695|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
145754583|NCT02574637|525612696|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
145754584|NCT02574637|525612687|FG000|Double-blind Period|Reason Not Specified|0|||
145754585|NCT02574637|525612688|FG001|Double-blind Period|Reason Not Specified|0|||
145754586|NCT02574637|525612689|FG002|Double-blind Period|Reason Not Specified|0|||
145754587|NCT02574637|525612690|FG003|Double-blind Period|Reason Not Specified|1|||
145754588|NCT02574637|525612691|FG004|Double-blind Period|Reason Not Specified|0|||
145754589|NCT02574637|525612692|FG005|Double-blind Period|Reason Not Specified|0|||
145754590|NCT02574637|525612693|FG006|Double-blind Period|Reason Not Specified|0|||
145754591|NCT02574637|525612694|FG007|Double-blind Period|Reason Not Specified|0|||
145754592|NCT02574637|525612695|FG008|Double-blind Period|Reason Not Specified|0|||
145754593|NCT02574637|525612696|FG009|Double-blind Period|Reason Not Specified|0|||
145754594|NCT02574637|525612687|FG000|Open-label (OL) Period|Adverse Event|0|||
145754595|NCT02574637|525612688|FG001|Open-label (OL) Period|Adverse Event|0|||
145754596|NCT02574637|525612689|FG002|Open-label (OL) Period|Adverse Event|0|||
145754597|NCT02574637|525612690|FG003|Open-label (OL) Period|Adverse Event|0|||
145754598|NCT02574637|525612691|FG004|Open-label (OL) Period|Adverse Event|0|||
145754599|NCT02574637|525612692|FG005|Open-label (OL) Period|Adverse Event|0|||
145754600|NCT02574637|525612693|FG006|Open-label (OL) Period|Adverse Event|0|||
145754601|NCT02574637|525612694|FG007|Open-label (OL) Period|Adverse Event|0|||
145754602|NCT02574637|525612695|FG008|Open-label (OL) Period|Adverse Event|1|||
145754603|NCT02574637|525612696|FG009|Open-label (OL) Period|Adverse Event|0|||
145272739|NCT00440193|523846278|FG000|Observational Period|Adverse Event|2|||
145272740|NCT00440193|523846279|FG001|Observational Period|Adverse Event|2|||
145272741|NCT00440193|523846278|FG000|Observational Period|Death|15|||
145272742|NCT00440193|523846279|FG001|Observational Period|Death|20|||
145272743|NCT00440193|523846278|FG000|Observational Period|Lost to Follow-up|12|||
145272744|NCT00440193|523846279|FG001|Observational Period|Lost to Follow-up|8|||
145272745|NCT00440193|523846278|FG000|Observational Period|Protocol Violation|1|||
145272746|NCT00440193|523846279|FG001|Observational Period|Protocol Violation|0|||
145272747|NCT00440193|523846278|FG000|Observational Period|Withdrawal by Subject|11|||
145272748|NCT00440193|523846279|FG001|Observational Period|Withdrawal by Subject|8|||
145272749|NCT00440193|523846278|FG000|Observational Period|Physician Decision|1|||
145272750|NCT00440193|523846279|FG001|Observational Period|Physician Decision|0|||
145272751|NCT00440193|523846278|FG000|Observational Period|Clinical endpoint reached|1|||
145272752|NCT00440193|523846279|FG001|Observational Period|Clinical endpoint reached|0|||
145272753|NCT00440193|523846278|FG000|Observational Period|Participant convenience|2|||
145272754|NCT00440193|523846279|FG001|Observational Period|Participant convenience|0|||
145272755|NCT00834366|523846280|FG000|Treatment Period 1|Adverse Event|1|||
145272756|NCT00834366|523846281|FG001|Treatment Period 1|Adverse Event|1|||
145272757|NCT03014570|523846282|FG000|Overall Study|COVID-19 Restrictions|38|||
145272758|NCT03014570|523846283|FG001|Overall Study|COVID-19 Restrictions|24|||
145272759|NCT03014570|523846282|FG000|Overall Study|Death|70|||
145272760|NCT03014570|523846283|FG001|Overall Study|Death|79|||
145272761|NCT03014570|523846282|FG000|Overall Study|Transfer from facility|11|||
145272762|NCT03014570|523846283|FG001|Overall Study|Transfer from facility|14|||
145272763|NCT03014570|523846282|FG000|Overall Study|Hospitalized|5|||
145272764|NCT03014570|523846283|FG001|Overall Study|Hospitalized|3|||
145272765|NCT03014570|523846282|FG000|Overall Study|Transfer within facility|1|||
145272766|NCT03014570|523846283|FG001|Overall Study|Transfer within facility|0|||
145272767|NCT03014570|523846282|FG000|Overall Study|Site refusal|0|||
145272768|NCT03014570|523846283|FG001|Overall Study|Site refusal|11|||
145272769|NCT00090259|523846284|FG000|Overall Study|Lost to Follow-up|30|||
145272770|NCT00090259|523846285|FG001|Overall Study|Lost to Follow-up|26|||
145272771|NCT00090259|523846284|FG000|Overall Study|Withdrawal by Subject|21|||
145272772|NCT00090259|523846285|FG001|Overall Study|Withdrawal by Subject|15|||
145272773|NCT00090259|523846284|FG000|Overall Study|Investigator site closed|11|||
145272774|NCT00090259|523846285|FG001|Overall Study|Investigator site closed|7|||
145272775|NCT00478673|523846286|FG000|30-Days Post-Procedure|Death|2|||
145272776|NCT00478673|523846286|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
145272777|NCT00478673|523846286|FG000|30-Days Post-Procedure|Missed Visit|7|||
145272778|NCT00478673|523846286|FG000|12-Months Post-Procedure|Death|23|||
145272779|NCT00478673|523846286|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
145272780|NCT00478673|523846286|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
145530727|NCT00973349|524803946|FG009|Overall Study|Lost to Follow-up|1|||
145272781|NCT00478673|523846286|FG000|12-Months Post-Procedure|Missed Visit|25|||
145272782|NCT00478673|523846286|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
145272783|NCT02380248|523846290|FG000|Overall Study|Lost to Follow-up|11|||
145272784|NCT02380248|523846290|FG000|Overall Study|Withdrawal by Subject|3|||
145272785|NCT03083639|523846291|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
145272786|NCT03083639|523846292|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
145272787|NCT03083639|523846291|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
145530728|NCT00973349|524803947|FG010|Overall Study|Lost to Follow-up|0|||
145754604|NCT02574637|525612687|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
145754605|NCT02574637|525612688|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
145754606|NCT02574637|525612689|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
145754607|NCT02574637|525612690|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
145272788|NCT03083639|523846292|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
145530729|NCT00973349|524803948|FG011|Overall Study|Lost to Follow-up|1|||
145530730|NCT00973349|524803949|FG012|Overall Study|Lost to Follow-up|0|||
145754608|NCT02574637|525612691|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
145754609|NCT02574637|525612692|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
145754610|NCT02574637|525612693|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
145754611|NCT02574637|525612694|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
145754612|NCT02574637|525612695|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
145754613|NCT02574637|525612696|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
145754614|NCT02574637|525612687|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754615|NCT02574637|525612688|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754616|NCT02574637|525612689|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754617|NCT02574637|525612690|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754618|NCT02574637|525612691|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754619|NCT02574637|525612692|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
145754620|NCT02574637|525612693|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
145754621|NCT02574637|525612694|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
145754622|NCT02574637|525612695|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
145754623|NCT02574637|525612696|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
145754624|NCT04016311|525612698|FG000|Overall Study|Withdrawal by Subject|1|||
145754625|NCT04016311|525612699|FG001|Overall Study|Withdrawal by Subject|0|||
145754626|NCT04029519|525612701|FG000|Overall Study|Protocol Violation|1|||
145754627|NCT04029519|525612701|FG000|Overall Study|Withdrawal by Subject|3|||
145754628|NCT04029519|525612701|FG000|Overall Study|Lost to Follow-up|1|||
145754629|NCT02706730|525612704|FG000|Overall Study|Adverse Event|3|||
145754630|NCT02706730|525612704|FG000|Overall Study|Lack of Efficacy|5|||
145754631|NCT02706730|525612704|FG000|Overall Study|Withdrawal by Subject|11|||
145754632|NCT02706730|525612704|FG000|Overall Study|Study Terminated by Sponsor|11|||
145754633|NCT02706730|525612704|FG000|Overall Study|Subject chose not to receive injection|3|||
145754634|NCT01999582|525612711|FG000|Overall Study|Withdrawal by Subject|0|||
145754635|NCT01999582|525612712|FG001|Overall Study|Withdrawal by Subject|0|||
145754636|NCT01999582|525612713|FG002|Overall Study|Withdrawal by Subject|0|||
145754637|NCT01999582|525612714|FG003|Overall Study|Withdrawal by Subject|1|||
145754638|NCT01999582|525612715|FG004|Overall Study|Withdrawal by Subject|0|||
145754639|NCT01999582|525612716|FG005|Overall Study|Withdrawal by Subject|0|||
145754640|NCT01999582|525612711|FG000|Overall Study|Adverse Event|0|||
145754641|NCT01999582|525612712|FG001|Overall Study|Adverse Event|0|||
145754642|NCT01999582|525612713|FG002|Overall Study|Adverse Event|3|||
145754643|NCT01999582|525612714|FG003|Overall Study|Adverse Event|0|||
145754644|NCT01999582|525612715|FG004|Overall Study|Adverse Event|1|||
145754645|NCT01999582|525612716|FG005|Overall Study|Adverse Event|0|||
145754646|NCT01999582|525612711|FG000|Overall Study|Other Reasons|1|||
145754647|NCT01999582|525612712|FG001|Overall Study|Other Reasons|0|||
145754648|NCT01999582|525612713|FG002|Overall Study|Other Reasons|3|||
145754649|NCT01999582|525612714|FG003|Overall Study|Other Reasons|1|||
145754650|NCT01999582|525612715|FG004|Overall Study|Other Reasons|1|||
145754651|NCT01999582|525612716|FG005|Overall Study|Other Reasons|2|||
145754652|NCT01999582|525612711|FG000|Overall Study|Protocol Violation|1|||
145754653|NCT01999582|525612712|FG001|Overall Study|Protocol Violation|0|||
145754654|NCT01999582|525612713|FG002|Overall Study|Protocol Violation|0|||
145754655|NCT01999582|525612714|FG003|Overall Study|Protocol Violation|0|||
145754656|NCT01999582|525612715|FG004|Overall Study|Protocol Violation|0|||
145754657|NCT01999582|525612716|FG005|Overall Study|Protocol Violation|1|||
145754658|NCT01999582|525612711|FG000|Overall Study|Lack of Efficacy|1|||
145754659|NCT01999582|525612712|FG001|Overall Study|Lack of Efficacy|3|||
145754660|NCT01999582|525612713|FG002|Overall Study|Lack of Efficacy|0|||
145754661|NCT01999582|525612714|FG003|Overall Study|Lack of Efficacy|1|||
145754662|NCT01999582|525612715|FG004|Overall Study|Lack of Efficacy|0|||
145754663|NCT01999582|525612716|FG005|Overall Study|Lack of Efficacy|0|||
145754664|NCT01081795|525612719|FG000|Overall Study|Adverse Event|18|||
145754665|NCT01081795|525612720|FG001|Overall Study|Adverse Event|23|||
145754666|NCT01081795|525612721|FG002|Overall Study|Adverse Event|6|||
145754667|NCT01081795|525612719|FG000|Overall Study|Lack of Efficacy|7|||
145754668|NCT01081795|525612720|FG001|Overall Study|Lack of Efficacy|5|||
145754669|NCT01081795|525612721|FG002|Overall Study|Lack of Efficacy|19|||
145754670|NCT01081795|525612719|FG000|Overall Study|Subject's schedule|1|||
145754671|NCT01081795|525612720|FG001|Overall Study|Subject's schedule|1|||
145754672|NCT01081795|525612721|FG002|Overall Study|Subject's schedule|2|||
145754673|NCT01081795|525612719|FG000|Overall Study|Revocation of informed consent|2|||
145754674|NCT01081795|525612720|FG001|Overall Study|Revocation of informed consent|0|||
145754675|NCT01081795|525612721|FG002|Overall Study|Revocation of informed consent|0|||
145530731|NCT00973349|524803950|FG013|Overall Study|Lost to Follow-up|0|||
145530732|NCT00973349|524803951|FG014|Overall Study|Lost to Follow-up|0|||
145530733|NCT00973349|524803952|FG015|Overall Study|Lost to Follow-up|1|||
145754676|NCT01081795|525612719|FG000|Overall Study|Ineligible for participation|1|||
145754677|NCT01081795|525612720|FG001|Overall Study|Ineligible for participation|0|||
145754678|NCT01081795|525612721|FG002|Overall Study|Ineligible for participation|0|||
145754679|NCT01081795|525612719|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
145754680|NCT01081795|525612720|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
145754681|NCT01081795|525612721|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
145754682|NCT01081795|525612719|FG000|Overall Study|Using drug with restricted days of use|2|||
145530734|NCT00973349|524803937|FG000|Overall Study|Inappropriate enrolment|0|||
145754683|NCT01081795|525612720|FG001|Overall Study|Using drug with restricted days of use|3|||
145402754|NCT00900562|524332486|FG001|Overall Study|Progressive disease|5|||
145402755|NCT00900562|524332485|FG000|Overall Study|Toxicity|1|||
145402756|NCT00900562|524332486|FG001|Overall Study|Toxicity|0|||
145402757|NCT00900562|524332485|FG000|Overall Study|Death|1|||
145402758|NCT00900562|524332486|FG001|Overall Study|Death|1|||
145754684|NCT01081795|525612721|FG002|Overall Study|Using drug with restricted days of use|2|||
145754685|NCT01081795|525612719|FG000|Overall Study|Other|1|||
145754686|NCT01081795|525612720|FG001|Overall Study|Other|2|||
145754687|NCT01081795|525612721|FG002|Overall Study|Other|0|||
145754688|NCT04673786|525612723|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
145754689|NCT04673786|525612724|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
145754690|NCT04673786|525612725|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
145754691|NCT04673786|525612723|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
145754692|NCT04673786|525612724|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
145754693|NCT04673786|525612725|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
145754694|NCT04673786|525612723|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
145754695|NCT04673786|525612724|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
145754696|NCT04673786|525612725|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
145754697|NCT04673786|525612723|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
145754698|NCT04673786|525612724|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
145754699|NCT04673786|525612725|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
145754700|NCT04673786|525612723|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
145754701|NCT04673786|525612724|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
145754702|NCT04673786|525612725|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
145754703|NCT04673786|525612723|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
145754704|NCT04673786|525612724|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
145754705|NCT04673786|525612725|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
145754706|NCT02902120|525612726|FG000|Overall Study|Lack of Efficacy|1|||
145754707|NCT01422239|525612729|FG000|Overall Study|Lost to Follow-up|4|||
145754708|NCT01422239|525612730|FG001|Overall Study|Lost to Follow-up|3|||
145754709|NCT01844895|525612736|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
145754710|NCT01844895|525612736|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
145754711|NCT01844895|525612736|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
145754712|NCT01844895|525612736|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
145754713|NCT01844895|525612736|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
145754714|NCT01844895|525612736|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
145754715|NCT01844895|525612736|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
145754716|NCT02508194|525612739|FG000|Overall Study|Death|5|||
145754717|NCT02508194|525612740|FG001|Overall Study|Death|3|||
145754718|NCT02508194|525612739|FG000|Overall Study|Lost to Follow-up|25|||
145754719|NCT02508194|525612740|FG001|Overall Study|Lost to Follow-up|18|||
145754720|NCT02508194|525612739|FG000|Overall Study|Withdrawal by Subject|20|||
145754721|NCT02508194|525612740|FG001|Overall Study|Withdrawal by Subject|18|||
145754722|NCT02508194|525612739|FG000|Overall Study|Error in Randomization|1|||
145754723|NCT02508194|525612740|FG001|Overall Study|Error in Randomization|3|||
145754724|NCT02508194|525612739|FG000|Overall Study|Principal Investigator Decision|1|||
145754725|NCT02508194|525612740|FG001|Overall Study|Principal Investigator Decision|2|||
145754726|NCT00511355|525612744|FG000|Overall Study|Adverse Event|4|||
145754727|NCT00511355|525612745|FG001|Overall Study|Adverse Event|4|||
145754728|NCT00511355|525612744|FG000|Overall Study|Pregnancy Wish|1|||
145754729|NCT00511355|525612745|FG001|Overall Study|Pregnancy Wish|0|||
145754730|NCT00511355|525612744|FG000|Overall Study|Lost to Follow-up|2|||
145754731|NCT00511355|525612745|FG001|Overall Study|Lost to Follow-up|1|||
145754732|NCT00511355|525612744|FG000|Overall Study|Other Reason|0|||
145754733|NCT00511355|525612745|FG001|Overall Study|Other Reason|1|||
145402759|NCT00900562|524332485|FG000|Overall Study|Withdrawal by Subject|0|||
145402760|NCT00900562|524332486|FG001|Overall Study|Withdrawal by Subject|1|||
145402761|NCT00900562|524332485|FG000|Overall Study|Unrelated adverse event|1|||
145754734|NCT00511355|525612744|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
145754735|NCT00511355|525612745|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
145754736|NCT00511355|525612744|FG000|Overall Study|Withdrawal of informed consent|0|||
145754737|NCT00511355|525612745|FG001|Overall Study|Withdrawal of informed consent|1|||
145754738|NCT00511355|525612744|FG000|Overall Study|Other reason pre-treatment|0|||
145754739|NCT00511355|525612745|FG001|Overall Study|Other reason pre-treatment|1|||
145754740|NCT00454805|525612746|FG000|Overall Study|Withdrawal by Subject|9|||
145754741|NCT00454805|525612747|FG001|Overall Study|Withdrawal by Subject|2|||
145754742|NCT00454805|525612746|FG000|Overall Study|Death|0|||
145754743|NCT00454805|525612747|FG001|Overall Study|Death|2|||
145754744|NCT00454805|525612746|FG000|Overall Study|Disease progression|16|||
145754745|NCT00454805|525612747|FG001|Overall Study|Disease progression|19|||
145754746|NCT00454805|525612746|FG000|Overall Study|In order to begin radiotherapy|1|||
145754747|NCT00454805|525612747|FG001|Overall Study|In order to begin radiotherapy|0|||
145754748|NCT00217087|525612748|FG000|Overall Study|decided to have esophagectomy|1|||
145754749|NCT00217087|525612749|FG001|Overall Study|decided to have esophagectomy|2|||
145754750|NCT00217087|525612748|FG000|Overall Study|completed less than 12 months return|10|||
145754751|NCT00217087|525612749|FG001|Overall Study|completed less than 12 months return|18|||
145754752|NCT03208231|525612754|FG000|Overall Study|Death|1|||
145754753|NCT03208231|525612755|FG001|Overall Study|Death|2|||
145754754|NCT03208231|525612754|FG000|Overall Study|Moved and unable to get to clinic|1|||
145754755|NCT03208231|525612755|FG001|Overall Study|Moved and unable to get to clinic|0|||
145754756|NCT03208231|525612754|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
145754757|NCT03208231|525612755|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
145402762|NCT00900562|524332486|FG001|Overall Study|Unrelated adverse event|0|||
145402763|NCT03157089|524332487|FG000|Overall Study|Treated only with pembrolizumab|1|||
145402764|NCT03157089|524332488|FG001|Overall Study|Treated only with pembrolizumab|0|||
145402765|NCT03157089|524332487|FG000|Overall Study|Adverse Event|5|||
145754758|NCT04158648|525612765|FG000|Overall Study|Ongoing in the Study|69|||
145402766|NCT03157089|524332488|FG001|Overall Study|Adverse Event|4|||
145530735|NCT00973349|524803938|FG001|Overall Study|Inappropriate enrolment|0|||
145754759|NCT04158648|525612765|FG000|Overall Study|Withdrawal by Subject|4|||
145754760|NCT01250379|525612768|FG000|Overall Study|Death|141|||
145754761|NCT01250379|525612769|FG001|Overall Study|Death|148|||
145754762|NCT01250379|525612768|FG000|Overall Study|Withdrawal by Subject|32|||
145754763|NCT01250379|525612769|FG001|Overall Study|Withdrawal by Subject|20|||
145754764|NCT01250379|525612768|FG000|Overall Study|Physician Decision|11|||
145754765|NCT01250379|525612769|FG001|Overall Study|Physician Decision|3|||
145402767|NCT03157089|524332487|FG000|Overall Study|Progressive disease|6|||
145402768|NCT03157089|524332488|FG001|Overall Study|Progressive disease|8|||
145754766|NCT01250379|525612768|FG000|Overall Study|Protocol Violation|2|||
145754767|NCT01250379|525612769|FG001|Overall Study|Protocol Violation|8|||
145754768|NCT01250379|525612768|FG000|Overall Study|Lost to Follow-up|9|||
145754769|NCT01250379|525612769|FG001|Overall Study|Lost to Follow-up|6|||
145754770|NCT01250379|525612768|FG000|Overall Study|Adverse Event|5|||
145754771|NCT01250379|525612769|FG001|Overall Study|Adverse Event|4|||
145754772|NCT01250379|525612768|FG000|Overall Study|Other|0|||
145754773|NCT01250379|525612769|FG001|Overall Study|Other|4|||
145754774|NCT01250379|525612768|FG000|Overall Study|Participant noncompliance|2|||
145754775|NCT01250379|525612769|FG001|Overall Study|Participant noncompliance|0|||
145754776|NCT01489527|525612770|FG000|Overall Study|Pregnancy|9|||
145754777|NCT01489527|525612771|FG001|Overall Study|Pregnancy|14|||
145754778|NCT01489527|525612770|FG000|Overall Study|Participant moved|6|||
145754779|NCT01489527|525612771|FG001|Overall Study|Participant moved|7|||
145754780|NCT01489527|525612770|FG000|Overall Study|Withdrawal by Subject|0|||
145754781|NCT01489527|525612771|FG001|Overall Study|Withdrawal by Subject|4|||
145754782|NCT01489527|525612770|FG000|Overall Study|Lost to Follow-up|5|||
145754783|NCT01489527|525612771|FG001|Overall Study|Lost to Follow-up|1|||
145754784|NCT01489527|525612770|FG000|Overall Study|Procedures|1|||
145754785|NCT01489527|525612771|FG001|Overall Study|Procedures|0|||
145754786|NCT01489527|525612770|FG000|Overall Study|Not compliant|1|||
145754787|NCT01489527|525612771|FG001|Overall Study|Not compliant|0|||
145754788|NCT01984268|525612772|FG000|Overall Study|Study Terminated|15|||
145754789|NCT04622046|525612776|FG000|Intervention Period|Adverse Event|1|||
145754790|NCT04622046|525612776|FG000|Intervention Period|Withdrawal by Subject|2|||
145754791|NCT04622046|525612776|FG000|Extension Period|Ongoing in the Extension Period|21|||
145754792|NCT05061719|525612777|FG000|Overall Study|Adverse Event|60|||
145754793|NCT05061719|525612777|FG000|Overall Study|Death|1|||
145754794|NCT05061719|525612777|FG000|Overall Study|Lack of Efficacy|7|||
145754795|NCT05061719|525612777|FG000|Overall Study|Lost to Follow-up|5|||
145754796|NCT05061719|525612777|FG000|Overall Study|Pregnancy|1|||
145754797|NCT05061719|525612777|FG000|Overall Study|Protocol Violation|8|||
145754798|NCT05061719|525612777|FG000|Overall Study|Withdrawal by Subject|41|||
145754799|NCT05061719|525612777|FG000|Overall Study|Site Closure|2|||
145754800|NCT04341948|525612778|FG000|Overall Study|Adverse Event|0|||
145754801|NCT04341948|525612779|FG001|Overall Study|Adverse Event|1|||
145754802|NCT04341948|525612778|FG000|Overall Study|Lost to Follow-up|6|||
145754803|NCT04341948|525612779|FG001|Overall Study|Lost to Follow-up|1|||
145754804|NCT04341948|525612778|FG000|Overall Study|Physician Decision|1|||
145754805|NCT04341948|525612779|FG001|Overall Study|Physician Decision|2|||
145754806|NCT04341948|525612778|FG000|Overall Study|Withdrawal by Participant|6|||
145754807|NCT04341948|525612779|FG001|Overall Study|Withdrawal by Participant|3|||
145754808|NCT04341948|525612778|FG000|Overall Study|Lack of compliance by Participant|1|||
145754809|NCT04341948|525612779|FG001|Overall Study|Lack of compliance by Participant|0|||
145754810|NCT04137887|525614859|FG000|Overall Study|Death|102|||
145754811|NCT04137887|525614860|FG001|Overall Study|Death|92|||
145754812|NCT04137887|525614859|FG000|Overall Study|Withdrawal by Subject|2|||
145754813|NCT04137887|525614860|FG001|Overall Study|Withdrawal by Subject|3|||
145754814|NCT04137887|525614859|FG000|Overall Study|Randomized but not treated|0|||
145754815|NCT04137887|525614860|FG001|Overall Study|Randomized but not treated|1|||
145754816|NCT01072344|525614862|FG000|Overall Study|Relasped-reached end point|7|||
145754817|NCT01072344|525614863|FG001|Overall Study|Relasped-reached end point|12|||
145754818|NCT01072344|525614862|FG000|Overall Study|Protocol Violation|1|||
145754819|NCT01072344|525614863|FG001|Overall Study|Protocol Violation|2|||
145754820|NCT01072344|525614862|FG000|Overall Study|Lost to Follow-up|3|||
145754821|NCT01072344|525614863|FG001|Overall Study|Lost to Follow-up|4|||
145754822|NCT01934140|525614864|FG000|Persistence Phase (Year 6-10)|Other|24|||
145754823|NCT01934140|525614865|FG001|Persistence Phase (Year 6-10)|Other|6|||
145754824|NCT01934140|525614864|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
145754825|NCT01934140|525614865|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
145754826|NCT01934140|525614864|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
145754827|NCT01934140|525614865|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
145754828|NCT01934140|525614864|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
145754829|NCT01934140|525614865|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
145754830|NCT01934140|525614864|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
145754831|NCT01934140|525614865|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
145754832|NCT01934140|525614864|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
145754833|NCT01934140|525614865|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
145754834|NCT01934140|525614864|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
145754835|NCT01934140|525614865|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
145754836|NCT01934140|525614864|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
145754837|NCT01934140|525614865|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
145754838|NCT00808444|525614868|FG000|Overall Study|Withdrawal by Subject|1|||
145754839|NCT00808444|525614869|FG001|Overall Study|Withdrawal by Subject|0|||
145754840|NCT00808444|525614868|FG000|Overall Study|Lost to Follow-up|0|||
145754841|NCT00808444|525614869|FG001|Overall Study|Lost to Follow-up|1|||
145754842|NCT00223496|525614873|FG000|Overall Study|screen failure|9|||
145754843|NCT00223496|525614873|FG000|Overall Study|Lost to Follow-up|4|||
145754844|NCT00223496|525614873|FG000|Overall Study|Lack of Efficacy|6|||
145754845|NCT00223496|525614873|FG000|Overall Study|Withdrawal by Subject|1|||
145754846|NCT00223496|525614873|FG000|Overall Study|Physician Decision|2|||
145754847|NCT02889796|525614874|FG000|Overall Study|Withdrew Consent|18|||
145530736|NCT00973349|524803939|FG002|Overall Study|Inappropriate enrolment|1|||
145530737|NCT00973349|524803940|FG003|Overall Study|Inappropriate enrolment|0|||
145530738|NCT00973349|524803941|FG004|Overall Study|Inappropriate enrolment|0|||
145530739|NCT00973349|524803942|FG005|Overall Study|Inappropriate enrolment|0|||
145530740|NCT00973349|524803943|FG006|Overall Study|Inappropriate enrolment|0|||
145530741|NCT00973349|524803944|FG007|Overall Study|Inappropriate enrolment|0|||
145530742|NCT00973349|524803945|FG008|Overall Study|Inappropriate enrolment|0|||
145530743|NCT00973349|524803946|FG009|Overall Study|Inappropriate enrolment|2|||
145402769|NCT00977197|524332493|FG000|Overall Study|Withdrawal by Subject|3|||
145530744|NCT00973349|524803947|FG010|Overall Study|Inappropriate enrolment|0|||
145530745|NCT00973349|524803948|FG011|Overall Study|Inappropriate enrolment|0|||
145530746|NCT00973349|524803949|FG012|Overall Study|Inappropriate enrolment|1|||
145530747|NCT00973349|524803950|FG013|Overall Study|Inappropriate enrolment|0|||
145530748|NCT00973349|524803951|FG014|Overall Study|Inappropriate enrolment|1|||
145530749|NCT00973349|524803952|FG015|Overall Study|Inappropriate enrolment|1|||
145530750|NCT00973349|524803937|FG000|Overall Study|Protocol Violation|0|||
145530751|NCT00973349|524803938|FG001|Overall Study|Protocol Violation|0|||
145530752|NCT00973349|524803939|FG002|Overall Study|Protocol Violation|0|||
145530753|NCT00973349|524803940|FG003|Overall Study|Protocol Violation|0|||
145530754|NCT00973349|524803941|FG004|Overall Study|Protocol Violation|0|||
145530755|NCT00973349|524803942|FG005|Overall Study|Protocol Violation|0|||
145530756|NCT00973349|524803943|FG006|Overall Study|Protocol Violation|0|||
145530757|NCT00973349|524803944|FG007|Overall Study|Protocol Violation|0|||
145530758|NCT00973349|524803945|FG008|Overall Study|Protocol Violation|1|||
145530759|NCT00973349|524803946|FG009|Overall Study|Protocol Violation|0|||
145530760|NCT00973349|524803947|FG010|Overall Study|Protocol Violation|0|||
145530761|NCT00973349|524803948|FG011|Overall Study|Protocol Violation|0|||
145530762|NCT00973349|524803949|FG012|Overall Study|Protocol Violation|0|||
145530763|NCT00973349|524803950|FG013|Overall Study|Protocol Violation|0|||
145530764|NCT00973349|524803951|FG014|Overall Study|Protocol Violation|0|||
145530765|NCT00973349|524803952|FG015|Overall Study|Protocol Violation|0|||
145530766|NCT00973349|524803937|FG000|Overall Study|Unable to classify|0|||
145530767|NCT00973349|524803938|FG001|Overall Study|Unable to classify|0|||
145530768|NCT00973349|524803939|FG002|Overall Study|Unable to classify|0|||
145530769|NCT00973349|524803940|FG003|Overall Study|Unable to classify|0|||
145530770|NCT00973349|524803941|FG004|Overall Study|Unable to classify|1|||
145530771|NCT00973349|524803942|FG005|Overall Study|Unable to classify|1|||
145530772|NCT00973349|524803943|FG006|Overall Study|Unable to classify|0|||
145272789|NCT02666768|523846293|FG000|Overall Study|Withdrawal by Subject|4|||
145272790|NCT01023022|523846294|FG000|Overall Study|Death|5|||
145272791|NCT01023022|523846294|FG000|Overall Study|Lost to Follow-up|7|||
145272792|NCT01023022|523846294|FG000|Overall Study|due to technical issues|2|||
145272793|NCT03728257|523846295|FG000|Overall Study|Death|3|||
145272794|NCT03728257|523846296|FG001|Overall Study|Death|0|||
145272795|NCT03868059|523846301|FG000|Overall Study|Adverse Event|3|||
145272796|NCT03868059|523846301|FG000|Overall Study|Lost to Follow-up|3|||
145272797|NCT03868059|523846301|FG000|Overall Study|Withdrawal by Subject|6|||
145272798|NCT03205163|523846302|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
145272799|NCT03205163|523846303|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
145272800|NCT04502862|523846304|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
145272801|NCT04502862|523846305|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
145272802|NCT04502862|523846304|FG000|Overall Study|Withdrawal by Subject|1|||
145272803|NCT04502862|523846305|FG001|Overall Study|Withdrawal by Subject|0|||
145272804|NCT04502862|523846304|FG000|Overall Study|Adverse Event|1|||
145272805|NCT04502862|523846305|FG001|Overall Study|Adverse Event|1|||
145272806|NCT01563029|523848187|FG000|Overall Study|Adverse Event|1|||
145272807|NCT01563029|523848188|FG001|Overall Study|Adverse Event|0|||
145272808|NCT01563029|523848189|FG002|Overall Study|Adverse Event|1|||
145272809|NCT01563029|523848190|FG003|Overall Study|Adverse Event|2|||
145272810|NCT01563029|523848191|FG004|Overall Study|Adverse Event|1|||
145272811|NCT01563029|523848187|FG000|Overall Study|Lack of Efficacy|42|||
145272812|NCT01563029|523848188|FG001|Overall Study|Lack of Efficacy|16|||
145272813|NCT01563029|523848189|FG002|Overall Study|Lack of Efficacy|23|||
145272814|NCT01563029|523848190|FG003|Overall Study|Lack of Efficacy|21|||
145272815|NCT01563029|523848191|FG004|Overall Study|Lack of Efficacy|19|||
145530773|NCT00973349|524803944|FG007|Overall Study|Unable to classify|0|||
145530774|NCT00973349|524803945|FG008|Overall Study|Unable to classify|0|||
145530775|NCT00973349|524803946|FG009|Overall Study|Unable to classify|1|||
145530776|NCT00973349|524803947|FG010|Overall Study|Unable to classify|0|||
145530777|NCT00973349|524803948|FG011|Overall Study|Unable to classify|0|||
145530778|NCT00973349|524803949|FG012|Overall Study|Unable to classify|0|||
145272816|NCT01563029|523848187|FG000|Overall Study|Protocol Violation|1|||
145272817|NCT01563029|523848188|FG001|Overall Study|Protocol Violation|2|||
145272818|NCT01563029|523848189|FG002|Overall Study|Protocol Violation|3|||
145272819|NCT01563029|523848190|FG003|Overall Study|Protocol Violation|1|||
145272820|NCT01563029|523848191|FG004|Overall Study|Protocol Violation|3|||
145607557|NCT02296190|525079199|FG000|Overall Study|Patient was given Propofol|0|||
145607558|NCT02296190|525079200|FG001|Overall Study|Patient was given Propofol|1|||
145607559|NCT02296190|525079201|FG002|Overall Study|Patient was given Propofol|0|||
145607560|NCT02296190|525079202|FG003|Overall Study|Patient was given Propofol|1|||
145607561|NCT02296190|525079203|FG004|Overall Study|Patient was given Propofol|0|||
145607562|NCT02296190|525079204|FG005|Overall Study|Patient was given Propofol|0|||
145607563|NCT02296190|525079199|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
145607564|NCT02296190|525079200|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
145607565|NCT02296190|525079201|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
145607566|NCT02296190|525079202|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
145607567|NCT02296190|525079203|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
145607568|NCT02296190|525079204|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
145607569|NCT02296190|525079199|FG000|Overall Study|Blood pressure <100 after sedation|0|||
145607570|NCT02296190|525079200|FG001|Overall Study|Blood pressure <100 after sedation|0|||
145754848|NCT02889796|525614875|FG001|Overall Study|Withdrew Consent|29|||
145754849|NCT02889796|525614876|FG002|Overall Study|Withdrew Consent|20|||
145754850|NCT02889796|525614877|FG003|Overall Study|Withdrew Consent|1|||
145754851|NCT02889796|525614878|FG004|Overall Study|Withdrew Consent|2|||
145754852|NCT02889796|525614879|FG005|Overall Study|Withdrew Consent|35|||
145754853|NCT02889796|525614874|FG000|Overall Study|Investigator's Discretion|10|||
145754854|NCT02889796|525614875|FG001|Overall Study|Investigator's Discretion|9|||
145754855|NCT02889796|525614876|FG002|Overall Study|Investigator's Discretion|10|||
145754856|NCT02889796|525614877|FG003|Overall Study|Investigator's Discretion|3|||
145754857|NCT02889796|525614878|FG004|Overall Study|Investigator's Discretion|0|||
145754858|NCT02889796|525614879|FG005|Overall Study|Investigator's Discretion|15|||
145754859|NCT02889796|525614874|FG000|Overall Study|Adverse Event|17|||
145754860|NCT02889796|525614875|FG001|Overall Study|Adverse Event|8|||
145754861|NCT02889796|525614876|FG002|Overall Study|Adverse Event|8|||
145754862|NCT02889796|525614877|FG003|Overall Study|Adverse Event|4|||
145754863|NCT02889796|525614878|FG004|Overall Study|Adverse Event|1|||
145754864|NCT02889796|525614879|FG005|Overall Study|Adverse Event|7|||
145754865|NCT02889796|525614874|FG000|Overall Study|Lost to Follow-up|5|||
145754866|NCT02889796|525614875|FG001|Overall Study|Lost to Follow-up|7|||
145754867|NCT02889796|525614876|FG002|Overall Study|Lost to Follow-up|2|||
145754868|NCT02889796|525614877|FG003|Overall Study|Lost to Follow-up|0|||
145754869|NCT02889796|525614878|FG004|Overall Study|Lost to Follow-up|2|||
145754870|NCT02889796|525614879|FG005|Overall Study|Lost to Follow-up|6|||
145754871|NCT02889796|525614874|FG000|Overall Study|Protocol Violation|0|||
145754872|NCT02889796|525614875|FG001|Overall Study|Protocol Violation|1|||
145754873|NCT02889796|525614876|FG002|Overall Study|Protocol Violation|3|||
145754874|NCT02889796|525614877|FG003|Overall Study|Protocol Violation|0|||
145754875|NCT02889796|525614878|FG004|Overall Study|Protocol Violation|0|||
145754876|NCT02889796|525614879|FG005|Overall Study|Protocol Violation|4|||
145754877|NCT02889796|525614874|FG000|Overall Study|Non-compliance With Study Drug|0|||
145754878|NCT02889796|525614875|FG001|Overall Study|Non-compliance With Study Drug|2|||
145754879|NCT02889796|525614876|FG002|Overall Study|Non-compliance With Study Drug|0|||
145754880|NCT02889796|525614877|FG003|Overall Study|Non-compliance With Study Drug|0|||
145754881|NCT02889796|525614878|FG004|Overall Study|Non-compliance With Study Drug|1|||
145754882|NCT02889796|525614879|FG005|Overall Study|Non-compliance With Study Drug|2|||
145754883|NCT02889796|525614874|FG000|Overall Study|Death|1|||
145754884|NCT02889796|525614875|FG001|Overall Study|Death|1|||
145754885|NCT02889796|525614876|FG002|Overall Study|Death|0|||
145754886|NCT02889796|525614877|FG003|Overall Study|Death|1|||
145754887|NCT02889796|525614878|FG004|Overall Study|Death|0|||
145754888|NCT02889796|525614879|FG005|Overall Study|Death|1|||
145754889|NCT02889796|525614874|FG000|Overall Study|Pregnancy|0|||
145754890|NCT02889796|525614875|FG001|Overall Study|Pregnancy|1|||
145754891|NCT02889796|525614876|FG002|Overall Study|Pregnancy|1|||
145754892|NCT02889796|525614877|FG003|Overall Study|Pregnancy|0|||
145754893|NCT02889796|525614878|FG004|Overall Study|Pregnancy|0|||
145754894|NCT02889796|525614879|FG005|Overall Study|Pregnancy|0|||
145754895|NCT02889796|525614874|FG000|Overall Study|Randomized but not Dosed|2|||
145754896|NCT02889796|525614875|FG001|Overall Study|Randomized but not Dosed|0|||
145754897|NCT02889796|525614876|FG002|Overall Study|Randomized but not Dosed|0|||
145754898|NCT02889796|525614877|FG003|Overall Study|Randomized but not Dosed|0|||
145754899|NCT02889796|525614878|FG004|Overall Study|Randomized but not Dosed|0|||
145754900|NCT02889796|525614879|FG005|Overall Study|Randomized but not Dosed|2|||
145754901|NCT04294459|525614880|FG000|Overall Study|Adverse Event|0|||
145754902|NCT04294459|525614881|FG001|Overall Study|Adverse Event|1|||
145754903|NCT04033367|525614882|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
145754904|NCT04033367|525614883|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
145754905|NCT04033367|525614882|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
145754906|NCT04033367|525614883|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
145754907|NCT04033367|525614882|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
145754908|NCT04033367|525614883|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
145607571|NCT02296190|525079201|FG002|Overall Study|Blood pressure <100 after sedation|0|||
145754909|NCT04033367|525614882|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
145530779|NCT00973349|524803950|FG013|Overall Study|Unable to classify|0|||
145530780|NCT00973349|524803951|FG014|Overall Study|Unable to classify|0|||
145530781|NCT00973349|524803952|FG015|Overall Study|Unable to classify|0|||
145530782|NCT05597020|524803956|FG000|Washout|Forbidden medication|2|||
145530783|NCT05597020|524803957|FG001|Washout|Forbidden medication|0|||
145530784|NCT05597020|524803956|FG000|Treatment Period II|Advice from primary care physician|1|||
145530785|NCT05597020|524803957|FG001|Treatment Period II|Advice from primary care physician|0|||
145530786|NCT05597020|524803956|FG000|Treatment Period II|Subject lost investigational product|1|||
145530787|NCT05597020|524803957|FG001|Treatment Period II|Subject lost investigational product|0|||
145530788|NCT05597020|524803956|FG000|Treatment Period II|Private reasons|0|||
145530789|NCT05597020|524803957|FG001|Treatment Period II|Private reasons|1|||
145530790|NCT05430022|524803958|FG000|Overall Study|Withdrawal by Subject|4|||
145530791|NCT05430022|524803959|FG001|Overall Study|Withdrawal by Subject|4|||
145530792|NCT02718300|524803962|FG000|Overall Study|Death|4|||
145530793|NCT02718300|524803963|FG001|Overall Study|Death|5|||
145530794|NCT02718300|524803964|FG002|Overall Study|Death|17|||
145530795|NCT02718300|524803962|FG000|Overall Study|Lost to Follow-up|1|||
145530796|NCT02718300|524803963|FG001|Overall Study|Lost to Follow-up|0|||
145530797|NCT02718300|524803964|FG002|Overall Study|Lost to Follow-up|2|||
145530798|NCT02718300|524803962|FG000|Overall Study|Physician Decision|1|||
145607572|NCT02296190|525079202|FG003|Overall Study|Blood pressure <100 after sedation|1|||
145530799|NCT02718300|524803963|FG001|Overall Study|Physician Decision|0|||
145530800|NCT02718300|524803964|FG002|Overall Study|Physician Decision|2|||
145530801|NCT02718300|524803962|FG000|Overall Study|Study Terminated by Sponsor|6|||
145530802|NCT02718300|524803963|FG001|Overall Study|Study Terminated by Sponsor|3|||
145530803|NCT02718300|524803964|FG002|Overall Study|Study Terminated by Sponsor|4|||
145754910|NCT04033367|525614883|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
145754911|NCT04656652|525614884|FG000|Overall Study|Lost to Follow-up|2|||
145754912|NCT04656652|525614885|FG001|Overall Study|Lost to Follow-up|2|||
145754913|NCT04656652|525614884|FG000|Overall Study|Death|213|||
145754914|NCT04656652|525614885|FG001|Overall Study|Death|212|||
145754915|NCT04656652|525614884|FG000|Overall Study|Other|1|||
145754916|NCT04656652|525614885|FG001|Overall Study|Other|0|||
145754917|NCT04656652|525614884|FG000|Overall Study|Withdrawal by Subject|15|||
145754918|NCT04656652|525614885|FG001|Overall Study|Withdrawal by Subject|29|||
145754919|NCT02908880|525614886|FG000|Overall Study|Lost to Follow-up|4|||
145754920|NCT02908880|525614886|FG000|Overall Study|Explantation of the device|1|||
145754921|NCT02908880|525614886|FG000|Overall Study|Withdrawal by Subject|17|||
145754922|NCT02908880|525614886|FG000|Overall Study|Death|5|||
145754923|NCT02421887|525614887|FG000|Overall Study|Lost to Follow-up|5|||
145754924|NCT02421887|525614888|FG001|Overall Study|Lost to Follow-up|0|||
145754925|NCT02421887|525614887|FG000|Overall Study|Withdrawal by Subject|8|||
145754926|NCT02421887|525614888|FG001|Overall Study|Withdrawal by Subject|5|||
145754927|NCT02421887|525614887|FG000|Overall Study|Physician Decision|2|||
145754928|NCT02421887|525614888|FG001|Overall Study|Physician Decision|4|||
145754929|NCT02421887|525614887|FG000|Overall Study|Adverse Event|2|||
145530804|NCT02718300|524803962|FG000|Overall Study|Withdrawal by Subject|0|||
145530805|NCT02718300|524803963|FG001|Overall Study|Withdrawal by Subject|4|||
145530806|NCT02718300|524803964|FG002|Overall Study|Withdrawal by Subject|3|||
145530807|NCT02718300|524803962|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
145754930|NCT02421887|525614888|FG001|Overall Study|Adverse Event|0|||
145754931|NCT01882907|525614889|FG000|Overall Study|Adverse Event|3|||
145754932|NCT01882907|525614890|FG001|Overall Study|Adverse Event|1|||
145754933|NCT01882907|525614889|FG000|Overall Study|Lack of Efficacy|0|||
145754934|NCT01882907|525614890|FG001|Overall Study|Lack of Efficacy|3|||
145754935|NCT01882907|525614889|FG000|Overall Study|Lost to Follow-up|1|||
145754936|NCT01882907|525614890|FG001|Overall Study|Lost to Follow-up|4|||
145754937|NCT01882907|525614889|FG000|Overall Study|Protocol Violation|10|||
145754938|NCT01882907|525614890|FG001|Overall Study|Protocol Violation|14|||
145530808|NCT02718300|524803963|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
145754939|NCT01882907|525614889|FG000|Overall Study|Withdrawal by Subject|0|||
145754940|NCT01882907|525614890|FG001|Overall Study|Withdrawal by Subject|6|||
145754941|NCT01978093|525614893|FG000|Overall Study|Death|1|||
145754942|NCT01978093|525614894|FG001|Overall Study|Death|0|||
145754943|NCT01978093|525614893|FG000|Overall Study|Adverse Event|0|||
145754944|NCT01978093|525614894|FG001|Overall Study|Adverse Event|5|||
145754945|NCT01978093|525614893|FG000|Overall Study|Protocol Violation|8|||
145530809|NCT02718300|524803964|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
145754946|NCT01978093|525614894|FG001|Overall Study|Protocol Violation|2|||
145754947|NCT01978093|525614893|FG000|Overall Study|Withdrawal by Subject|29|||
145754948|NCT01978093|525614894|FG001|Overall Study|Withdrawal by Subject|25|||
145754949|NCT01978093|525614893|FG000|Overall Study|Lost to Follow-up|11|||
145754950|NCT01978093|525614894|FG001|Overall Study|Lost to Follow-up|15|||
145754951|NCT01978093|525614893|FG000|Overall Study|Migrated/moved from study area|11|||
145754952|NCT01978093|525614894|FG001|Overall Study|Migrated/moved from study area|13|||
145754953|NCT01978093|525614893|FG000|Overall Study|Loss of kaiser coverage|4|||
145754954|NCT01978093|525614894|FG001|Overall Study|Loss of kaiser coverage|10|||
145754955|NCT01978093|525614893|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
145754956|NCT01978093|525614894|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
145754957|NCT01978093|525614893|FG000|Overall Study|Mother lost custody of child|0|||
145754958|NCT01978093|525614894|FG001|Overall Study|Mother lost custody of child|1|||
145754959|NCT01978093|525614893|FG000|Overall Study|Child was in care of grandmother|0|||
145754960|NCT01978093|525614894|FG001|Overall Study|Child was in care of grandmother|1|||
145754961|NCT01978093|525614893|FG000|Overall Study|N/A for vaccine administration|0|||
145754962|NCT01978093|525614894|FG001|Overall Study|N/A for vaccine administration|1|||
145754963|NCT01396005|525614897|FG000|Overall Study|Withdrawal by Subject|0|||
145754964|NCT01396005|525614898|FG001|Overall Study|Withdrawal by Subject|1|||
145754965|NCT01396005|525614897|FG000|Overall Study|Non-compliance with protocol|0|||
145754966|NCT01396005|525614898|FG001|Overall Study|Non-compliance with protocol|1|||
145754967|NCT04269395|525614899|FG000|Overall Study|Lost to Follow-up|1|||
145754968|NCT04269395|525614900|FG001|Overall Study|Lost to Follow-up|0|||
145754969|NCT04269395|525614899|FG000|Overall Study|Study terminated by Sponsor|13|||
145754970|NCT04269395|525614900|FG001|Overall Study|Study terminated by Sponsor|10|||
145754971|NCT01491178|525614901|FG000|Overall Study|Adverse Event|1016|||
145754972|NCT01491178|525614901|FG000|Overall Study|Improvement of NVAF|210|||
145754973|NCT01491178|525614901|FG000|Overall Study|To conduct invasive treatment|59|||
145754974|NCT01491178|525614901|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
145754975|NCT01491178|525614901|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
145754976|NCT01491178|525614901|FG000|Overall Study|To take a contraindication|20|||
145754977|NCT01491178|525614901|FG000|Overall Study|Other than specified above|657|||
145754978|NCT05689047|525614904|FG000|Overall Study|Lost to Follow-up|0|||
145754979|NCT05689047|525614905|FG001|Overall Study|Lost to Follow-up|1|||
145754980|NCT05689047|525614904|FG000|Overall Study|Protocol Deviation|1|||
145754981|NCT05689047|525614905|FG001|Overall Study|Protocol Deviation|0|||
145754982|NCT01604512|525614906|FG000|Overall Study|Withdrawal by Subject|3|||
145754983|NCT01604512|525614906|FG000|Overall Study|Not treated|4|||
145754984|NCT00209339|525614913|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
145754985|NCT00209339|525614913|FG000|At 12 Months Follow-up|Death|1|||
145754986|NCT00209339|525614913|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
145754987|NCT00209339|525614913|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
145754988|NCT00209339|525614913|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
145754989|NCT00209339|525614913|FG000|At 24 Months Follow-up|Death|1|||
145754990|NCT00209339|525614913|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
145754991|NCT00209339|525614913|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
145754992|NCT00209339|525614913|FG000|At 4 Years Follow-up|Death|1|||
145754993|NCT00209339|525614913|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
145754994|NCT00209339|525614913|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
145754995|NCT00209339|525614913|FG000|At 5 Years Follow-up|Death|1|||
145754996|NCT00429858|525614914|FG000|Overall Study|Withdrawal by Subject|1|||
145754997|NCT00429858|525614914|FG000|Overall Study|Study Termination|1|||
145754998|NCT01587079|525614915|FG000|Overall Study|Protocol-specified criteria|9|||
145754999|NCT01587079|525614915|FG000|Overall Study|Protocol Violation|5|||
145755000|NCT01587079|525614915|FG000|Overall Study|Lost to Follow-up|2|||
145755001|NCT01587079|525614915|FG000|Overall Study|Physician Decision|2|||
145755002|NCT01587079|525614915|FG000|Overall Study|Withdrawal by Subject|7|||
145755003|NCT01587079|525614915|FG000|Overall Study|Adverse Event|14|||
145530810|NCT02452697|524803965|FG000|Overall Study|Physician Decision|4|||
145530811|NCT02452697|524803966|FG001|Overall Study|Physician Decision|4|||
145755004|NCT02268058|525614917|FG000|Overall Study|Protocol Violation|1|||
145755005|NCT02268058|525614918|FG001|Overall Study|Protocol Violation|0|||
145530812|NCT02452697|524803967|FG002|Overall Study|Physician Decision|3|||
145530813|NCT02452697|524803968|FG003|Overall Study|Physician Decision|2|||
145755006|NCT02268058|525614919|FG002|Overall Study|Protocol Violation|0|||
145755007|NCT02268058|525614920|FG003|Overall Study|Protocol Violation|0|||
145755008|NCT04142983|525614921|FG000|Overall Study|Lost to Follow-up|73|||
145755009|NCT04142983|525614921|FG000|Overall Study|Withdrawal by Subject|10|||
145755010|NCT04142983|525614921|FG000|Overall Study|Physician Decision|1|||
145530814|NCT02452697|524803965|FG000|Overall Study|Withdrawal by Subject|1|||
145755011|NCT04142983|525614921|FG000|Overall Study|Adverse Event|1|||
145755012|NCT04142983|525614921|FG000|Overall Study|No longer eligible|4|||
145755013|NCT04142983|525614921|FG000|Overall Study|Screen Failure|10|||
145755014|NCT00643994|525614923|FG000|Overall Study|Death|24|||
145530815|NCT02452697|524803966|FG001|Overall Study|Withdrawal by Subject|0|||
145530816|NCT02452697|524803967|FG002|Overall Study|Withdrawal by Subject|0|||
145530817|NCT02452697|524803968|FG003|Overall Study|Withdrawal by Subject|0|||
145530818|NCT02452697|524803965|FG000|Overall Study|still in follow-up|2|||
145530819|NCT02452697|524803966|FG001|Overall Study|still in follow-up|2|||
145530820|NCT02452697|524803967|FG002|Overall Study|still in follow-up|1|||
145530821|NCT02452697|524803968|FG003|Overall Study|still in follow-up|3|||
145530822|NCT02887859|524803971|FG000|Overall Study|Ongoing|6|||
145530823|NCT02887859|524803971|FG000|Overall Study|Adverse Event|7|||
145530824|NCT02887859|524803971|FG000|Overall Study|Death|1|||
145530825|NCT02887859|524803971|FG000|Overall Study|Physician Decision|1|||
145530826|NCT01973569|524806522|FG000|Overall Study|Adverse Event|9|||
145530827|NCT01973569|524806523|FG001|Overall Study|Adverse Event|2|||
145530828|NCT01973569|524806524|FG002|Overall Study|Adverse Event|4|||
145755015|NCT00643994|525614923|FG000|Overall Study|Lost to Follow-up|72|||
145755016|NCT02347176|525614933|FG000|Overall Study|Lost to Follow-up|2|||
145530829|NCT01973569|524806522|FG000|Overall Study|Protocol Violation|2|||
145530830|NCT01973569|524806523|FG001|Overall Study|Protocol Violation|1|||
145530831|NCT01973569|524806524|FG002|Overall Study|Protocol Violation|3|||
145530832|NCT01973569|524806522|FG000|Overall Study|Withdrawal by Subject|7|||
145530833|NCT01973569|524806523|FG001|Overall Study|Withdrawal by Subject|5|||
145530834|NCT01973569|524806524|FG002|Overall Study|Withdrawal by Subject|2|||
145530835|NCT01973569|524806522|FG000|Overall Study|Invasive dental treatment|3|||
145530836|NCT01973569|524806523|FG001|Overall Study|Invasive dental treatment|5|||
145755017|NCT02347176|525614934|FG001|Overall Study|Lost to Follow-up|3|||
145755018|NCT02347176|525614935|FG002|Overall Study|Lost to Follow-up|1|||
145755019|NCT02347176|525614936|FG003|Overall Study|Lost to Follow-up|1|||
145755020|NCT02347176|525614933|FG000|Overall Study|Withdrawal by Subject|9|||
145755021|NCT02347176|525614934|FG001|Overall Study|Withdrawal by Subject|5|||
145755022|NCT02347176|525614935|FG002|Overall Study|Withdrawal by Subject|5|||
145755023|NCT02347176|525614936|FG003|Overall Study|Withdrawal by Subject|3|||
145755024|NCT02347176|525614933|FG000|Overall Study|Other|1|||
145755025|NCT02347176|525614934|FG001|Overall Study|Other|2|||
145755026|NCT02347176|525614935|FG002|Overall Study|Other|2|||
145755027|NCT02347176|525614936|FG003|Overall Study|Other|0|||
145755028|NCT00699907|525614941|FG000|Overall Study|Withdrawal by Subject|2|||
145755029|NCT00699907|525614942|FG001|Overall Study|Withdrawal by Subject|1|||
145755030|NCT00699907|525614943|FG002|Overall Study|Withdrawal by Subject|0|||
145755031|NCT00699907|525614941|FG000|Overall Study|No usable sample|0|||
145755032|NCT00699907|525614942|FG001|Overall Study|No usable sample|9|||
145755033|NCT00699907|525614943|FG002|Overall Study|No usable sample|8|||
145755034|NCT02161211|525614944|FG000|Overall Study|Lost to Follow-up|21|||
145755035|NCT02161211|525614945|FG001|Overall Study|Lost to Follow-up|27|||
145755036|NCT02161211|525614946|FG002|Overall Study|Lost to Follow-up|21|||
145755037|NCT02161211|525614944|FG000|Overall Study|Dropped|12|||
145755038|NCT02161211|525614945|FG001|Overall Study|Dropped|5|||
145755039|NCT02161211|525614946|FG002|Overall Study|Dropped|9|||
145755040|NCT00430508|525614948|FG000|Overall Study|Adverse Event|2|||
145755041|NCT00430508|525614949|FG001|Overall Study|Adverse Event|3|||
145755042|NCT00430508|525614950|FG002|Overall Study|Adverse Event|5|||
145755043|NCT00430508|525614951|FG003|Overall Study|Adverse Event|3|||
145755044|NCT00430508|525614948|FG000|Overall Study|Withdrawal by Subject|0|||
145755045|NCT00430508|525614949|FG001|Overall Study|Withdrawal by Subject|1|||
145755046|NCT00430508|525614950|FG002|Overall Study|Withdrawal by Subject|1|||
145755047|NCT00430508|525614951|FG003|Overall Study|Withdrawal by Subject|1|||
145755048|NCT00430508|525614948|FG000|Overall Study|responder at visit 4|0|||
145755049|NCT00430508|525614949|FG001|Overall Study|responder at visit 4|0|||
145755050|NCT00430508|525614950|FG002|Overall Study|responder at visit 4|2|||
145755051|NCT00430508|525614951|FG003|Overall Study|responder at visit 4|0|||
145755052|NCT00430508|525614948|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
145755053|NCT00430508|525614949|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
145755054|NCT00430508|525614950|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
145755055|NCT00430508|525614951|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
145755056|NCT00430508|525614948|FG000|Overall Study|Other|1|||
145530837|NCT01973569|524806524|FG002|Overall Study|Invasive dental treatment|6|||
145530838|NCT01973569|524806522|FG000|Overall Study|Prohibited concomitant d|1|||
145530839|NCT01973569|524806523|FG001|Overall Study|Prohibited concomitant d|5|||
145530840|NCT01973569|524806524|FG002|Overall Study|Prohibited concomitant d|0|||
145530841|NCT01973569|524806522|FG000|Overall Study|Disease progression|0|||
145530842|NCT01973569|524806523|FG001|Overall Study|Disease progression|3|||
145755057|NCT00430508|525614949|FG001|Overall Study|Other|1|||
145755058|NCT00430508|525614950|FG002|Overall Study|Other|3|||
145755059|NCT00430508|525614951|FG003|Overall Study|Other|0|||
145755060|NCT01703858|525614955|FG000|Overall Study|Withdrawal by Subject|0|||
145755061|NCT01703858|525614956|FG001|Overall Study|Withdrawal by Subject|1|||
145755062|NCT01703858|525614957|FG002|Overall Study|Withdrawal by Subject|0|||
145755063|NCT02556255|525614959|FG000|Overall Study|Lost to Follow-up|4|||
145755064|NCT00993031|525614960|FG000|Overall Study|Death|0|||
145530843|NCT01973569|524806524|FG002|Overall Study|Disease progression|0|||
145755065|NCT00993031|525614961|FG001|Overall Study|Death|1|||
145755066|NCT00993031|525614960|FG000|Overall Study|Physician Decision|0|||
145755067|NCT00993031|525614961|FG001|Overall Study|Physician Decision|2|||
145755068|NCT00993031|525614960|FG000|Overall Study|Withdrawal by Subject|3|||
145755069|NCT00993031|525614961|FG001|Overall Study|Withdrawal by Subject|3|||
145755070|NCT00993031|525614960|FG000|Overall Study|Lost to Follow-up|19|||
145755071|NCT00993031|525614961|FG001|Overall Study|Lost to Follow-up|13|||
145755072|NCT01543087|525614967|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
145755073|NCT01543087|525614968|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
145755074|NCT01543087|525614969|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
145755075|NCT01543087|525614970|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
145755076|NCT01543087|525614971|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
145755077|NCT01543087|525614972|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
145755078|NCT01543087|525614967|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
145755079|NCT01543087|525614968|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
145755080|NCT01543087|525614969|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
145755081|NCT01543087|525614970|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
145755082|NCT01543087|525614971|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
145755083|NCT01543087|525614972|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
145755084|NCT01543087|525614967|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
145755085|NCT01543087|525614968|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
145755086|NCT01543087|525614969|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
145755087|NCT01543087|525614970|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
145755088|NCT01543087|525614971|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
145755089|NCT01543087|525614972|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
145755090|NCT01543087|525614967|FG000|Stage 1 (48 Months)|Other than specified|5|||
145755091|NCT01543087|525614968|FG001|Stage 1 (48 Months)|Other than specified|0|||
145755092|NCT01543087|525614969|FG002|Stage 1 (48 Months)|Other than specified|9|||
145755093|NCT01543087|525614970|FG003|Stage 1 (48 Months)|Other than specified|0|||
145755094|NCT01543087|525614971|FG004|Stage 1 (48 Months)|Other than specified|0|||
145755095|NCT01543087|525614972|FG005|Stage 1 (48 Months)|Other than specified|0|||
145755096|NCT01543087|525614967|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
145755097|NCT01543087|525614968|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
145755098|NCT01543087|525614969|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
145755099|NCT01543087|525614970|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
145755100|NCT01543087|525614971|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
145755101|NCT01543087|525614972|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
145755102|NCT01543087|525614967|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
145755103|NCT01543087|525614968|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
145755104|NCT01543087|525614969|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
145755105|NCT01543087|525614970|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
145755106|NCT01543087|525614971|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
145755107|NCT01543087|525614972|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
145755108|NCT01543087|525614967|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
145530844|NCT01973569|524806522|FG000|Overall Study|Other|1|||
145530845|NCT01973569|524806523|FG001|Overall Study|Other|1|||
145530846|NCT01973569|524806524|FG002|Overall Study|Other|0|||
145530847|NCT01973569|524806522|FG000|Overall Study|Did not receive study drug|6|||
145530848|NCT01973569|524806523|FG001|Overall Study|Did not receive study drug|3|||
145530849|NCT01973569|524806524|FG002|Overall Study|Did not receive study drug|3|||
145530850|NCT03793556|524806529|FG000|Overall Study|Withdrawal by Subject|12|||
145530851|NCT03793556|524806530|FG001|Overall Study|Withdrawal by Subject|1|||
145530852|NCT03793556|524806529|FG000|Overall Study|Lost to Follow-up|1|||
145530853|NCT03793556|524806530|FG001|Overall Study|Lost to Follow-up|1|||
145530854|NCT01461980|524806533|FG000|Overall Study|Other|9|||
145530855|NCT01461980|524806534|FG001|Overall Study|Other|8|||
145755109|NCT01543087|525614968|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
145755110|NCT01543087|525614969|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
145755111|NCT01543087|525614970|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
145755112|NCT01543087|525614971|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
145755113|NCT01543087|525614972|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
145755114|NCT00143455|525614974|FG000|Cohort 1|Adverse Event|8|||
145402770|NCT00977197|524332494|FG001|Overall Study|Withdrawal by Subject|4|||
145530856|NCT01461980|524806535|FG002|Overall Study|Other|6|||
145530857|NCT01461980|524806533|FG000|Overall Study|Medication error|7|||
145530858|NCT01461980|524806534|FG001|Overall Study|Medication error|5|||
145530859|NCT01461980|524806535|FG002|Overall Study|Medication error|6|||
145530860|NCT01461980|524806533|FG000|Overall Study|Adverse Event|12|||
145530861|NCT01461980|524806534|FG001|Overall Study|Adverse Event|5|||
145530862|NCT01461980|524806535|FG002|Overall Study|Adverse Event|6|||
145530863|NCT01461980|524806533|FG000|Overall Study|Protocol Violation|12|||
145530864|NCT01461980|524806534|FG001|Overall Study|Protocol Violation|19|||
145530865|NCT01461980|524806535|FG002|Overall Study|Protocol Violation|16|||
145530866|NCT01461980|524806533|FG000|Overall Study|No longer meets eligibility criteria|18|||
145530867|NCT01461980|524806534|FG001|Overall Study|No longer meets eligibility criteria|9|||
145530868|NCT01461980|524806535|FG002|Overall Study|No longer meets eligibility criteria|19|||
145530869|NCT01461980|524806533|FG000|Overall Study|Lost to Follow-up|52|||
145530870|NCT01461980|524806534|FG001|Overall Study|Lost to Follow-up|53|||
145530871|NCT01461980|524806535|FG002|Overall Study|Lost to Follow-up|51|||
145530872|NCT01461980|524806533|FG000|Overall Study|No longer willing to participate|52|||
145530873|NCT01461980|524806534|FG001|Overall Study|No longer willing to participate|38|||
145530874|NCT01461980|524806535|FG002|Overall Study|No longer willing to participate|54|||
145530875|NCT01461980|524806533|FG000|Overall Study|Randomized but not vaccinated|4|||
145530876|NCT01461980|524806534|FG001|Overall Study|Randomized but not vaccinated|8|||
145530877|NCT01461980|524806535|FG002|Overall Study|Randomized but not vaccinated|7|||
145530878|NCT00809354|524806539|FG000|Overall Study|Adverse Event|32|||
145530879|NCT00809354|524806540|FG001|Overall Study|Adverse Event|45|||
145530880|NCT00809354|524806541|FG002|Overall Study|Adverse Event|37|||
145530881|NCT00809354|524806542|FG003|Overall Study|Adverse Event|53|||
145530882|NCT00809354|524806543|FG004|Overall Study|Adverse Event|26|||
145530883|NCT00809354|524806544|FG005|Overall Study|Adverse Event|33|||
145530884|NCT00809354|524806545|FG006|Overall Study|Adverse Event|44|||
145530885|NCT00809354|524806546|FG007|Overall Study|Adverse Event|40|||
145530886|NCT00809354|524806547|FG008|Overall Study|Adverse Event|46|||
145530887|NCT00809354|524806548|FG009|Overall Study|Adverse Event|26|||
145530888|NCT00809354|524806539|FG000|Overall Study|Lack of Efficacy|23|||
145530889|NCT00809354|524806540|FG001|Overall Study|Lack of Efficacy|23|||
145530890|NCT00809354|524806541|FG002|Overall Study|Lack of Efficacy|22|||
145530891|NCT00809354|524806542|FG003|Overall Study|Lack of Efficacy|15|||
145530892|NCT00809354|524806543|FG004|Overall Study|Lack of Efficacy|40|||
145530893|NCT00809354|524806544|FG005|Overall Study|Lack of Efficacy|19|||
145530894|NCT00809354|524806545|FG006|Overall Study|Lack of Efficacy|21|||
145530895|NCT00809354|524806546|FG007|Overall Study|Lack of Efficacy|15|||
145530896|NCT00809354|524806547|FG008|Overall Study|Lack of Efficacy|18|||
145530897|NCT00809354|524806548|FG009|Overall Study|Lack of Efficacy|38|||
145530898|NCT00809354|524806539|FG000|Overall Study|Lost to Follow-up|10|||
145530899|NCT00809354|524806540|FG001|Overall Study|Lost to Follow-up|11|||
145530900|NCT00809354|524806541|FG002|Overall Study|Lost to Follow-up|8|||
145530901|NCT00809354|524806542|FG003|Overall Study|Lost to Follow-up|13|||
145530902|NCT00809354|524806543|FG004|Overall Study|Lost to Follow-up|6|||
145530903|NCT00809354|524806544|FG005|Overall Study|Lost to Follow-up|2|||
145530904|NCT00809354|524806545|FG006|Overall Study|Lost to Follow-up|0|||
145530905|NCT00809354|524806546|FG007|Overall Study|Lost to Follow-up|5|||
145530906|NCT00809354|524806547|FG008|Overall Study|Lost to Follow-up|4|||
145530907|NCT00809354|524806548|FG009|Overall Study|Lost to Follow-up|0|||
145530908|NCT00809354|524806539|FG000|Overall Study|Protocol Violation|7|||
145530909|NCT00809354|524806540|FG001|Overall Study|Protocol Violation|14|||
145530910|NCT00809354|524806541|FG002|Overall Study|Protocol Violation|14|||
145755115|NCT00143455|525614975|FG001|Cohort 1|Adverse Event|4|||
145755116|NCT00143455|525614976|FG002|Cohort 1|Adverse Event|0|||
145755117|NCT00143455|525614977|FG003|Cohort 1|Adverse Event|0|||
145530911|NCT00809354|524806542|FG003|Overall Study|Protocol Violation|12|||
145530912|NCT00809354|524806543|FG004|Overall Study|Protocol Violation|14|||
145530913|NCT00809354|524806544|FG005|Overall Study|Protocol Violation|6|||
145530914|NCT00809354|524806545|FG006|Overall Study|Protocol Violation|4|||
145530915|NCT00809354|524806546|FG007|Overall Study|Protocol Violation|6|||
145530916|NCT00809354|524806547|FG008|Overall Study|Protocol Violation|9|||
145530917|NCT00809354|524806548|FG009|Overall Study|Protocol Violation|3|||
145530918|NCT00809354|524806539|FG000|Overall Study|Withdrawal by Subject|32|||
145530919|NCT00809354|524806540|FG001|Overall Study|Withdrawal by Subject|27|||
145530920|NCT00809354|524806541|FG002|Overall Study|Withdrawal by Subject|31|||
145530921|NCT00809354|524806542|FG003|Overall Study|Withdrawal by Subject|33|||
145530922|NCT00809354|524806543|FG004|Overall Study|Withdrawal by Subject|34|||
145530923|NCT00809354|524806544|FG005|Overall Study|Withdrawal by Subject|29|||
145530924|NCT00809354|524806545|FG006|Overall Study|Withdrawal by Subject|27|||
145530925|NCT00809354|524806546|FG007|Overall Study|Withdrawal by Subject|19|||
145755118|NCT00143455|525614974|FG000|Cohort 1|Death|5|||
145755119|NCT00143455|525614975|FG001|Cohort 1|Death|2|||
145755120|NCT00143455|525614976|FG002|Cohort 1|Death|0|||
145755121|NCT00143455|525614977|FG003|Cohort 1|Death|0|||
145755122|NCT00143455|525614974|FG000|Cohort 1|Progressive Disease|0|||
145755123|NCT00143455|525614975|FG001|Cohort 1|Progressive Disease|6|||
145272821|NCT01563029|523848187|FG000|Overall Study|Protocol defined stopping criteria|1|||
145272822|NCT01563029|523848188|FG001|Overall Study|Protocol defined stopping criteria|0|||
145272823|NCT01563029|523848189|FG002|Overall Study|Protocol defined stopping criteria|0|||
145272824|NCT01563029|523848190|FG003|Overall Study|Protocol defined stopping criteria|0|||
145272825|NCT01563029|523848191|FG004|Overall Study|Protocol defined stopping criteria|0|||
145272826|NCT01563029|523848187|FG000|Overall Study|Lost to Follow-up|1|||
145272827|NCT01563029|523848188|FG001|Overall Study|Lost to Follow-up|0|||
145272828|NCT01563029|523848189|FG002|Overall Study|Lost to Follow-up|1|||
145272829|NCT01563029|523848190|FG003|Overall Study|Lost to Follow-up|1|||
145272830|NCT01563029|523848191|FG004|Overall Study|Lost to Follow-up|1|||
145272831|NCT01563029|523848187|FG000|Overall Study|Physician Decision|3|||
145272832|NCT01563029|523848188|FG001|Overall Study|Physician Decision|5|||
145272833|NCT01563029|523848189|FG002|Overall Study|Physician Decision|2|||
145272834|NCT01563029|523848190|FG003|Overall Study|Physician Decision|4|||
145272835|NCT01563029|523848191|FG004|Overall Study|Physician Decision|2|||
145272836|NCT01563029|523848187|FG000|Overall Study|Withdrawal by Subject|4|||
145272837|NCT01563029|523848188|FG001|Overall Study|Withdrawal by Subject|1|||
145272838|NCT01563029|523848189|FG002|Overall Study|Withdrawal by Subject|3|||
145272839|NCT01563029|523848190|FG003|Overall Study|Withdrawal by Subject|4|||
145272840|NCT01563029|523848191|FG004|Overall Study|Withdrawal by Subject|3|||
145272841|NCT01569594|523848192|FG000|Overall Study|Physician Decision|4|||
145272842|NCT01569594|523848192|FG000|Overall Study|Death|13|||
145272843|NCT01569594|523848192|FG000|Overall Study|Lost to Follow-up|22|||
145272844|NCT01569594|523848192|FG000|Overall Study|Adverse Event|2|||
145272845|NCT01569594|523848192|FG000|Overall Study|Withdrawal by Subject|13|||
145272846|NCT01569594|523848192|FG000|Overall Study|Other|4|||
145272847|NCT01569594|523848192|FG000|Overall Study|No ECM used|9|||
145272848|NCT03069365|523848193|FG000|Overall Study|Adverse Event|1|||
145272849|NCT02861534|523848194|FG000|Overall Study|Death|541|||
145272850|NCT02861534|523848195|FG001|Overall Study|Death|552|||
145272851|NCT02861534|523848194|FG000|Overall Study|Lost to Follow-up|14|||
145272852|NCT02861534|523848195|FG001|Overall Study|Lost to Follow-up|14|||
145272853|NCT02861534|523848194|FG000|Overall Study|Site Terminated by Sponsor|4|||
145272854|NCT02861534|523848195|FG001|Overall Study|Site Terminated by Sponsor|3|||
145272855|NCT02861534|523848194|FG000|Overall Study|Withdrawal by Subject|15|||
145272856|NCT02861534|523848195|FG001|Overall Study|Withdrawal by Subject|18|||
145272857|NCT02780115|523848196|FG000|Overall Study|Withdrawal by Subject|0|||
145272858|NCT02780115|523848197|FG001|Overall Study|Withdrawal by Subject|1|||
145272859|NCT02780115|523848198|FG002|Overall Study|Withdrawal by Subject|1|||
145272860|NCT02780115|523848199|FG003|Overall Study|Withdrawal by Subject|0|||
145272861|NCT02780115|523848200|FG004|Overall Study|Withdrawal by Subject|0|||
145272862|NCT02780115|523848196|FG000|Overall Study|Adverse Event|0|||
145272863|NCT02780115|523848197|FG001|Overall Study|Adverse Event|0|||
145272864|NCT02780115|523848198|FG002|Overall Study|Adverse Event|0|||
145272865|NCT02780115|523848199|FG003|Overall Study|Adverse Event|1|||
145272866|NCT02780115|523848200|FG004|Overall Study|Adverse Event|1|||
145272867|NCT00742859|523848205|FG000|Overall Study|Adverse Event|5|||
145272868|NCT00742859|523848206|FG001|Overall Study|Adverse Event|6|||
145272869|NCT00742859|523848207|FG002|Overall Study|Adverse Event|3|||
145272870|NCT00742859|523848208|FG003|Overall Study|Adverse Event|1|||
145530926|NCT00809354|524806547|FG008|Overall Study|Withdrawal by Subject|18|||
145530927|NCT00809354|524806548|FG009|Overall Study|Withdrawal by Subject|20|||
145755124|NCT00143455|525614976|FG002|Cohort 1|Progressive Disease|0|||
145755125|NCT00143455|525614977|FG003|Cohort 1|Progressive Disease|0|||
145755126|NCT00143455|525614974|FG000|Cohort 1|Withdrawal by Subject|1|||
145755127|NCT00143455|525614975|FG001|Cohort 1|Withdrawal by Subject|4|||
145755128|NCT00143455|525614976|FG002|Cohort 1|Withdrawal by Subject|0|||
145755129|NCT00143455|525614977|FG003|Cohort 1|Withdrawal by Subject|0|||
145755130|NCT00143455|525614974|FG000|Cohort 1|Randomized But Not Treated|0|||
145755131|NCT00143455|525614975|FG001|Cohort 1|Randomized But Not Treated|1|||
145755132|NCT00143455|525614976|FG002|Cohort 1|Randomized But Not Treated|0|||
145755133|NCT00143455|525614977|FG003|Cohort 1|Randomized But Not Treated|0|||
145272871|NCT00742859|523848205|FG000|Overall Study|Death|1|||
145272872|NCT00742859|523848206|FG001|Overall Study|Death|0|||
145272873|NCT00742859|523848207|FG002|Overall Study|Death|0|||
145755134|NCT00143455|525614974|FG000|Cohort 2|Adverse Event|0|||
145272874|NCT00742859|523848208|FG003|Overall Study|Death|1|||
145272875|NCT00742859|523848205|FG000|Overall Study|Physician Decision|1|||
145272876|NCT00742859|523848206|FG001|Overall Study|Physician Decision|2|||
145272877|NCT00742859|523848207|FG002|Overall Study|Physician Decision|0|||
145272878|NCT00742859|523848208|FG003|Overall Study|Physician Decision|0|||
145272879|NCT00742859|523848205|FG000|Overall Study|Withdrawal by Subject|4|||
145272880|NCT00742859|523848206|FG001|Overall Study|Withdrawal by Subject|2|||
145272881|NCT00742859|523848207|FG002|Overall Study|Withdrawal by Subject|4|||
145272882|NCT00742859|523848208|FG003|Overall Study|Withdrawal by Subject|1|||
145755135|NCT00143455|525614975|FG001|Cohort 2|Adverse Event|0|||
145755136|NCT00143455|525614976|FG002|Cohort 2|Adverse Event|42|||
145755137|NCT00143455|525614977|FG003|Cohort 2|Adverse Event|30|||
145755138|NCT00143455|525614974|FG000|Cohort 2|No Longer Required Study Treatment|0|||
145755139|NCT00143455|525614975|FG001|Cohort 2|No Longer Required Study Treatment|0|||
145755140|NCT00143455|525614976|FG002|Cohort 2|No Longer Required Study Treatment|1|||
145755141|NCT00143455|525614977|FG003|Cohort 2|No Longer Required Study Treatment|0|||
145402771|NCT00977197|524332493|FG000|Overall Study|Adverse Event|3|||
145530928|NCT00809354|524806539|FG000|Overall Study|Other|10|||
145530929|NCT00809354|524806540|FG001|Overall Study|Other|2|||
145530930|NCT00809354|524806541|FG002|Overall Study|Other|7|||
145530931|NCT00809354|524806542|FG003|Overall Study|Other|10|||
145530932|NCT00809354|524806543|FG004|Overall Study|Other|5|||
145530933|NCT00809354|524806544|FG005|Overall Study|Other|3|||
145530934|NCT00809354|524806545|FG006|Overall Study|Other|2|||
145530935|NCT00809354|524806546|FG007|Overall Study|Other|3|||
145530936|NCT00809354|524806547|FG008|Overall Study|Other|4|||
145530937|NCT00809354|524806548|FG009|Overall Study|Other|3|||
145530938|NCT00809354|524806539|FG000|Overall Study|Study terminated by sponsor|138|||
145530939|NCT00809354|524806540|FG001|Overall Study|Study terminated by sponsor|134|||
145530940|NCT00809354|524806541|FG002|Overall Study|Study terminated by sponsor|129|||
145530941|NCT00809354|524806542|FG003|Overall Study|Study terminated by sponsor|120|||
145530942|NCT00809354|524806543|FG004|Overall Study|Study terminated by sponsor|126|||
145530943|NCT00809354|524806544|FG005|Overall Study|Study terminated by sponsor|133|||
145530944|NCT00809354|524806545|FG006|Overall Study|Study terminated by sponsor|124|||
145530945|NCT00809354|524806546|FG007|Overall Study|Study terminated by sponsor|148|||
145530946|NCT00809354|524806547|FG008|Overall Study|Study terminated by sponsor|127|||
145530947|NCT00809354|524806548|FG009|Overall Study|Study terminated by sponsor|135|||
145530948|NCT00809354|524806539|FG000|Overall Study|Withdrawn due to pregnancy|0|||
145530949|NCT00809354|524806540|FG001|Overall Study|Withdrawn due to pregnancy|1|||
145530950|NCT00809354|524806541|FG002|Overall Study|Withdrawn due to pregnancy|0|||
145530951|NCT00809354|524806542|FG003|Overall Study|Withdrawn due to pregnancy|0|||
145530952|NCT00809354|524806543|FG004|Overall Study|Withdrawn due to pregnancy|0|||
145530953|NCT00809354|524806544|FG005|Overall Study|Withdrawn due to pregnancy|0|||
145530954|NCT00809354|524806545|FG006|Overall Study|Withdrawn due to pregnancy|0|||
145530955|NCT00809354|524806546|FG007|Overall Study|Withdrawn due to pregnancy|0|||
145530956|NCT00809354|524806547|FG008|Overall Study|Withdrawn due to pregnancy|0|||
145530957|NCT00809354|524806548|FG009|Overall Study|Withdrawn due to pregnancy|0|||
145530958|NCT00809354|524806539|FG000|Overall Study|Randomized but not Treated|3|||
145530959|NCT00809354|524806540|FG001|Overall Study|Randomized but not Treated|1|||
145530960|NCT00809354|524806541|FG002|Overall Study|Randomized but not Treated|6|||
145530961|NCT00809354|524806542|FG003|Overall Study|Randomized but not Treated|0|||
145530962|NCT00809354|524806543|FG004|Overall Study|Randomized but not Treated|5|||
145530963|NCT00809354|524806544|FG005|Overall Study|Randomized but not Treated|0|||
145530964|NCT00809354|524806545|FG006|Overall Study|Randomized but not Treated|1|||
145530965|NCT00809354|524806546|FG007|Overall Study|Randomized but not Treated|1|||
145755142|NCT00143455|525614974|FG000|Cohort 2|Protocol Violation|0|||
145530966|NCT00809354|524806547|FG008|Overall Study|Randomized but not Treated|2|||
145530967|NCT00809354|524806548|FG009|Overall Study|Randomized but not Treated|1|||
145530968|NCT00809354|524806539|FG000|Overall Study|Death|0|||
145530969|NCT00809354|524806540|FG001|Overall Study|Death|0|||
145530970|NCT00809354|524806541|FG002|Overall Study|Death|0|||
145530971|NCT00809354|524806542|FG003|Overall Study|Death|0|||
145530972|NCT00809354|524806543|FG004|Overall Study|Death|0|||
145530973|NCT00809354|524806544|FG005|Overall Study|Death|0|||
145530974|NCT00809354|524806545|FG006|Overall Study|Death|0|||
145530975|NCT00809354|524806546|FG007|Overall Study|Death|1|||
145530976|NCT00809354|524806547|FG008|Overall Study|Death|0|||
145530977|NCT00809354|524806548|FG009|Overall Study|Death|0|||
145530978|NCT02477839|524806553|FG000|Overall Study|Adverse Event|0|||
145530979|NCT02477839|524806554|FG001|Overall Study|Adverse Event|1|||
145530980|NCT02477839|524806553|FG000|Overall Study|Protocol Violation|0|||
145530981|NCT02477839|524806554|FG001|Overall Study|Protocol Violation|2|||
145530982|NCT02477839|524806553|FG000|Overall Study|Withdrawal by Subject|3|||
145530983|NCT02477839|524806554|FG001|Overall Study|Withdrawal by Subject|3|||
145530984|NCT02477839|524806553|FG000|Overall Study|Participant had PGS during V6|0|||
145530985|NCT02477839|524806554|FG001|Overall Study|Participant had PGS during V6|1|||
145530986|NCT02477839|524806553|FG000|Overall Study|Parents decided to stop medication|0|||
145530987|NCT02477839|524806554|FG001|Overall Study|Parents decided to stop medication|1|||
145530988|NCT02477839|524806553|FG000|Overall Study|Lack of tolerability|0|||
145530989|NCT02477839|524806554|FG001|Overall Study|Lack of tolerability|1|||
145530990|NCT02477839|524806553|FG000|Overall Study|Exclusion criterion|0|||
145530991|NCT02477839|524806554|FG001|Overall Study|Exclusion criterion|1|||
145530992|NCT00631696|524806557|FG000|Overall Study|Entered, not randomized to treatment|1|||
145530993|NCT00631696|524806558|FG001|Overall Study|Entered, not randomized to treatment|1|||
145530994|NCT00631696|524806557|FG000|Overall Study|Discontinued after database release date|1|||
145530995|NCT00631696|524806558|FG001|Overall Study|Discontinued after database release date|0|||
145530996|NCT00631696|524806557|FG000|Overall Study|Follow up after database release date|1|||
145530997|NCT00631696|524806558|FG001|Overall Study|Follow up after database release date|0|||
145530998|NCT00631696|524806557|FG000|Overall Study|Lost to Follow-up|7|||
145530999|NCT00631696|524806558|FG001|Overall Study|Lost to Follow-up|10|||
145531000|NCT00631696|524806557|FG000|Overall Study|Withdrawal by Subject|2|||
145531001|NCT00631696|524806558|FG001|Overall Study|Withdrawal by Subject|9|||
145531002|NCT00631696|524806557|FG000|Overall Study|Other|8|||
145531003|NCT00631696|524806558|FG001|Overall Study|Other|8|||
145531004|NCT00631696|524806557|FG000|Overall Study|Protocol Violation|9|||
145531005|NCT00631696|524806558|FG001|Overall Study|Protocol Violation|9|||
145531006|NCT00631696|524806557|FG000|Overall Study|Study terminated by sponsor|3|||
145531007|NCT00631696|524806558|FG001|Overall Study|Study terminated by sponsor|3|||
145531008|NCT00631696|524806557|FG000|Overall Study|Adverse Event|5|||
145531009|NCT00631696|524806558|FG001|Overall Study|Adverse Event|0|||
145531010|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
145531011|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
145402772|NCT00977197|524332494|FG001|Overall Study|Adverse Event|1|||
145402773|NCT00977197|524332493|FG000|Overall Study|Lack of Efficacy|1|||
145531012|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
145531013|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
145531014|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
145531015|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
145531016|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
145531017|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
145531018|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
145531019|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
145531020|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
145531021|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
145531022|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
145531023|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
145531024|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
145531025|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
145531026|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
145402774|NCT00977197|524332494|FG001|Overall Study|Lack of Efficacy|0|||
145402775|NCT00977197|524332493|FG000|Overall Study|Lost to Follow-up|1|||
145531027|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
145531028|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
145531029|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
145531030|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
145531031|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
145531032|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
145531033|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
145531034|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Death|2|||
145531035|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Death|1|||
145531036|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Death|0|||
145531037|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Death|0|||
145531038|NCT02607930|524806560|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
145531039|NCT02607930|524806561|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
145531040|NCT02607930|524806562|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
145531041|NCT02607930|524806563|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
145531042|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145531043|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145531044|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
145531045|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
145531046|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
145531047|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
145531048|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
145531049|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
145531050|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
145531051|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
145531052|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
145531053|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
145531054|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
145531055|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
145755143|NCT00143455|525614975|FG001|Cohort 2|Protocol Violation|0|||
145755144|NCT00143455|525614976|FG002|Cohort 2|Protocol Violation|1|||
145755145|NCT00143455|525614977|FG003|Cohort 2|Protocol Violation|1|||
145755146|NCT00143455|525614974|FG000|Cohort 2|Lost to Follow-up|0|||
145531056|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
145531057|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
145531058|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
145531059|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
145531060|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
145531061|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
145531062|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
145531063|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
145531064|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
145531065|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
145531066|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
145531067|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
145531068|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
145531069|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
145531070|NCT02607930|524806560|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
145531071|NCT02607930|524806561|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
145531072|NCT02607930|524806562|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
145531073|NCT02607930|524806563|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
145531074|NCT01578330|524806566|FG000|Overall Study|Adverse Event|2|||
145531075|NCT01578330|524806566|FG000|Overall Study|Protocol Violation|5|||
145531076|NCT01134731|524806567|FG000|Overall Study|Adverse Event|3|||
145531077|NCT01134731|524806568|FG001|Overall Study|Adverse Event|2|||
145531078|NCT01134731|524806569|FG002|Overall Study|Adverse Event|1|||
145531079|NCT01134731|524806567|FG000|Overall Study|Physician Decision|2|||
145755147|NCT00143455|525614975|FG001|Cohort 2|Lost to Follow-up|0|||
145755148|NCT00143455|525614976|FG002|Cohort 2|Lost to Follow-up|1|||
145755149|NCT00143455|525614977|FG003|Cohort 2|Lost to Follow-up|4|||
145755150|NCT00143455|525614974|FG000|Cohort 2|Death|0|||
145755151|NCT00143455|525614975|FG001|Cohort 2|Death|0|||
145755152|NCT00143455|525614976|FG002|Cohort 2|Death|20|||
145755153|NCT00143455|525614977|FG003|Cohort 2|Death|12|||
145755154|NCT00143455|525614974|FG000|Cohort 2|Progressive Disease|0|||
145755155|NCT00143455|525614975|FG001|Cohort 2|Progressive Disease|0|||
145755156|NCT00143455|525614976|FG002|Cohort 2|Progressive Disease|20|||
145755157|NCT00143455|525614977|FG003|Cohort 2|Progressive Disease|27|||
145755158|NCT00143455|525614974|FG000|Cohort 2|Withdrawal by Subject|0|||
145755159|NCT00143455|525614975|FG001|Cohort 2|Withdrawal by Subject|0|||
145755160|NCT00143455|525614976|FG002|Cohort 2|Withdrawal by Subject|13|||
145755161|NCT00143455|525614977|FG003|Cohort 2|Withdrawal by Subject|12|||
145755162|NCT00143455|525614974|FG000|Cohort 2|Other|0|||
145755163|NCT00143455|525614975|FG001|Cohort 2|Other|0|||
145755164|NCT00143455|525614976|FG002|Cohort 2|Other|7|||
145755165|NCT00143455|525614977|FG003|Cohort 2|Other|6|||
145755166|NCT00143455|525614974|FG000|Cohort 2|Randomized But Not Treated|0|||
145755167|NCT00143455|525614975|FG001|Cohort 2|Randomized But Not Treated|0|||
145755168|NCT00143455|525614976|FG002|Cohort 2|Randomized But Not Treated|1|||
145755169|NCT00143455|525614977|FG003|Cohort 2|Randomized But Not Treated|1|||
145755170|NCT01325428|525614978|FG000|Part A|Progressive disease according to RECIST|9|||
145755171|NCT01325428|525614978|FG000|Part A|Clinical signs, symptoms of progression|2|||
145755172|NCT01325428|525614978|FG000|Part A|Other adverse event|1|||
145755173|NCT01325428|525614978|FG000|Part A|Refused continue taking trial medication|2|||
145755174|NCT01325428|525614978|FG000|Part A|Other reason not defined above|2|||
145755175|NCT01325428|525614978|FG000|Part B|Refused continue taking trial medication|2|||
145755176|NCT01325428|525614978|FG000|Part B|Other reason not defined above|1|||
145755177|NCT02004873|525614980|FG000|Overall Study|Implant unsuccessful|6|||
145755178|NCT02004873|525614980|FG000|Overall Study|Awaiting 6-month visit|390|||
145755179|NCT02004873|525614980|FG000|Overall Study|Missed 6-month visit|4|||
145755180|NCT02004873|525614980|FG000|Overall Study|Death|23|||
145755181|NCT02004873|525614980|FG000|Overall Study|Withdrawal by Subject|1|||
145755182|NCT02665286|525614994|FG000|Overall Study|Lost to Follow-up|3|||
145755183|NCT02665286|525614995|FG001|Overall Study|Lost to Follow-up|2|||
145755184|NCT02665286|525614996|FG002|Overall Study|Lost to Follow-up|1|||
145755185|NCT02926950|525614999|FG000|Overall Study|Adverse Event|4|||
145755186|NCT02926950|525615000|FG001|Overall Study|Adverse Event|6|||
145755187|NCT02926950|525614999|FG000|Overall Study|At the participant's own request|21|||
145755188|NCT02926950|525615000|FG001|Overall Study|At the participant's own request|25|||
145755189|NCT02926950|525614999|FG000|Overall Study|Reason not Specified|17|||
145755190|NCT02926950|525615000|FG001|Overall Study|Reason not Specified|9|||
145755191|NCT02926950|525614999|FG000|Overall Study|Lost to Follow-up|7|||
145755192|NCT02926950|525615000|FG001|Overall Study|Lost to Follow-up|8|||
145755193|NCT05036083|525615001|FG000|Overall Study|Physician Decision|1|||
145755194|NCT05036083|525615001|FG000|Overall Study|Withdrawal by Subject|1|||
145755195|NCT05036083|525615001|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
145755196|NCT05036083|525615001|FG000|Overall Study|IV not sustainable|1|||
145755197|NCT03505021|525615002|FG000|Overall Study|Protocol Violation|1|||
145755198|NCT03505021|525615003|FG001|Overall Study|Protocol Violation|0|||
145755199|NCT03505021|525615002|FG000|Overall Study|Death|9|||
145755200|NCT03505021|525615003|FG001|Overall Study|Death|8|||
145755201|NCT03505021|525615002|FG000|Overall Study|Consent withdrawn by subject|6|||
145755202|NCT03505021|525615003|FG001|Overall Study|Consent withdrawn by subject|1|||
145755203|NCT03505021|525615002|FG000|Overall Study|Lost to Follow-up|5|||
145755204|NCT03505021|525615003|FG001|Overall Study|Lost to Follow-up|3|||
145755205|NCT03505021|525615002|FG000|Overall Study|Adverse Event|26|||
145755206|NCT03505021|525615003|FG001|Overall Study|Adverse Event|9|||
145755207|NCT03505021|525615002|FG000|Overall Study|Disease progression|33|||
145755208|NCT03505021|525615003|FG001|Overall Study|Disease progression|17|||
145755209|NCT03505021|525615002|FG000|Overall Study|Other|11|||
145755210|NCT03505021|525615003|FG001|Overall Study|Other|5|||
145755211|NCT03505021|525615002|FG000|Overall Study|Personal reason|21|||
145755212|NCT03505021|525615003|FG001|Overall Study|Personal reason|12|||
145755213|NCT03266016|525616400|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
145755214|NCT03266016|525616401|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
145755215|NCT03266016|525616402|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
145755216|NCT03266016|525616403|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
145755217|NCT03266016|525616400|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
145755218|NCT03266016|525616401|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
145755219|NCT03266016|525616402|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
145755220|NCT03266016|525616403|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
145755221|NCT00482014|525616404|FG000|Overall Study|Withdrawal by Subject|1|||
145755222|NCT00482014|525616405|FG001|Overall Study|Withdrawal by Subject|2|||
145755223|NCT00482014|525616406|FG002|Overall Study|Withdrawal by Subject|3|||
145755224|NCT00482014|525616407|FG003|Overall Study|Withdrawal by Subject|4|||
145755225|NCT00482014|525616404|FG000|Overall Study|Adverse Event|3|||
145755226|NCT00482014|525616405|FG001|Overall Study|Adverse Event|0|||
145755227|NCT00482014|525616406|FG002|Overall Study|Adverse Event|2|||
145755228|NCT00482014|525616407|FG003|Overall Study|Adverse Event|8|||
145755229|NCT00482014|525616404|FG000|Overall Study|Death|1|||
145755230|NCT00482014|525616405|FG001|Overall Study|Death|2|||
145755231|NCT00482014|525616406|FG002|Overall Study|Death|1|||
145755232|NCT00482014|525616407|FG003|Overall Study|Death|4|||
145755233|NCT00482014|525616404|FG000|Overall Study|Lack of Efficacy|1|||
145755234|NCT00482014|525616405|FG001|Overall Study|Lack of Efficacy|0|||
145755235|NCT00482014|525616406|FG002|Overall Study|Lack of Efficacy|4|||
145755236|NCT00482014|525616407|FG003|Overall Study|Lack of Efficacy|6|||
145755237|NCT00482014|525616404|FG000|Overall Study|Sponsor Decision|1|||
145755238|NCT00482014|525616405|FG001|Overall Study|Sponsor Decision|2|||
145755239|NCT00482014|525616406|FG002|Overall Study|Sponsor Decision|1|||
145755240|NCT00482014|525616407|FG003|Overall Study|Sponsor Decision|1|||
145755241|NCT03686397|525616408|FG000|Overall Study|Lack of Efficacy|3|||
145755242|NCT03686397|525616409|FG001|Overall Study|Lack of Efficacy|5|||
145755243|NCT03686397|525616408|FG000|Overall Study|Adverse Event|0|||
145755244|NCT03686397|525616409|FG001|Overall Study|Adverse Event|1|||
145755245|NCT03686397|525616408|FG000|Overall Study|Protocol Violation|0|||
145755246|NCT03686397|525616409|FG001|Overall Study|Protocol Violation|1|||
145755247|NCT03686397|525616408|FG000|Overall Study|Withdrawal by Subject|0|||
145755248|NCT03686397|525616409|FG001|Overall Study|Withdrawal by Subject|1|||
145755249|NCT03686397|525616408|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
145755250|NCT03686397|525616409|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
145755251|NCT03718143|525616415|FG000|Overall Study|Death|1|||
145755252|NCT03718143|525616416|FG001|Overall Study|Death|0|||
145755253|NCT03718143|525616417|FG002|Overall Study|Death|0|||
145755254|NCT03718143|525616415|FG000|Overall Study|Progression of Disease|1|||
145755255|NCT03718143|525616416|FG001|Overall Study|Progression of Disease|0|||
145755256|NCT03718143|525616417|FG002|Overall Study|Progression of Disease|0|||
145755257|NCT03718143|525616415|FG000|Overall Study|Withdrawal of Informed Consent|1|||
145755258|NCT03718143|525616416|FG001|Overall Study|Withdrawal of Informed Consent|2|||
145755259|NCT03718143|525616417|FG002|Overall Study|Withdrawal of Informed Consent|1|||
145755260|NCT05064059|525616418|FG000|Overall Study|Death|199|||
145755261|NCT05064059|525616419|FG001|Overall Study|Death|196|||
145755262|NCT05064059|525616418|FG000|Overall Study|Physician Decision|4|||
145755263|NCT05064059|525616419|FG001|Overall Study|Physician Decision|2|||
145755264|NCT05064059|525616418|FG000|Overall Study|Sponsor Decision|14|||
145755265|NCT05064059|525616419|FG001|Overall Study|Sponsor Decision|11|||
145755266|NCT05064059|525616418|FG000|Overall Study|Withdrawal by Subject|4|||
145755267|NCT05064059|525616419|FG001|Overall Study|Withdrawal by Subject|11|||
145755268|NCT02615990|525616420|FG000|Overall Study|study terminated|1|||
145755269|NCT02615990|525616421|FG001|Overall Study|study terminated|1|||
145755270|NCT04316585|525616422|FG000|Overall Study|Adverse Event|2|||
145755271|NCT04316585|525616423|FG001|Overall Study|Adverse Event|1|||
145755272|NCT04316585|525616422|FG000|Overall Study|Lost to Follow-up|1|||
145755273|NCT04316585|525616423|FG001|Overall Study|Lost to Follow-up|0|||
145755274|NCT04316585|525616422|FG000|Overall Study|Withdrawal by Subject|2|||
145755275|NCT04316585|525616423|FG001|Overall Study|Withdrawal by Subject|3|||
145755276|NCT04316585|525616422|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
145755277|NCT04316585|525616423|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
145755278|NCT04316585|525616422|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
145755279|NCT04316585|525616423|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
145755280|NCT01461044|525616431|FG000|Overall Study|Death|58|||
145755281|NCT01461044|525616432|FG001|Overall Study|Death|35|||
145755282|NCT01461044|525616431|FG000|Overall Study|Lost to Follow-up|12|||
145755283|NCT01461044|525616432|FG001|Overall Study|Lost to Follow-up|5|||
145755284|NCT00716976|525616433|FG000|Overall Study|Adverse Event|2|||
145755285|NCT00716976|525616434|FG001|Overall Study|Adverse Event|0|||
145755286|NCT00716976|525616433|FG000|Overall Study|Death|1|||
145755287|NCT00716976|525616434|FG001|Overall Study|Death|0|||
145755288|NCT00716976|525616433|FG000|Overall Study|Physician Decision|2|||
145755289|NCT00716976|525616434|FG001|Overall Study|Physician Decision|2|||
145755290|NCT00716976|525616433|FG000|Overall Study|Withdrawal by Subject|5|||
145755291|NCT00716976|525616434|FG001|Overall Study|Withdrawal by Subject|1|||
145755292|NCT00716976|525616433|FG000|Overall Study|Premature discontinuation cisplatin|5|||
145755293|NCT00716976|525616434|FG001|Overall Study|Premature discontinuation cisplatin|4|||
145755294|NCT00716976|525616433|FG000|Overall Study|Radiation during protocol|1|||
145531080|NCT01134731|524806568|FG001|Overall Study|Physician Decision|2|||
145531081|NCT01134731|524806569|FG002|Overall Study|Physician Decision|2|||
145531082|NCT01134731|524806567|FG000|Overall Study|Lack of Efficacy|0|||
145531083|NCT01134731|524806568|FG001|Overall Study|Lack of Efficacy|0|||
145755295|NCT00716976|525616434|FG001|Overall Study|Radiation during protocol|0|||
145755296|NCT00716976|525616433|FG000|Overall Study|Ineligibles|4|||
145755297|NCT00716976|525616434|FG001|Overall Study|Ineligibles|2|||
145755298|NCT00122135|525616435|FG000|Overall Study|Withdrawal by Subject|3|||
145755299|NCT00122135|525616436|FG001|Overall Study|Withdrawal by Subject|0|||
145755300|NCT03269344|525616437|FG000|Overall Study|Protocol Violation|4|||
145755301|NCT03269344|525616438|FG001|Overall Study|Protocol Violation|3|||
145755302|NCT00200850|525616439|FG000|Overall Study|relocation|1|||
145755303|NCT00200850|525616440|FG001|Overall Study|relocation|0|||
145755304|NCT00200850|525616441|FG002|Overall Study|relocation|1|||
145755305|NCT00200850|525616439|FG000|Overall Study|too busy|1|||
145755306|NCT00200850|525616440|FG001|Overall Study|too busy|0|||
145755307|NCT00200850|525616441|FG002|Overall Study|too busy|0|||
145272883|NCT00742859|523848205|FG000|Overall Study|Endpoint|0|||
145272884|NCT00742859|523848206|FG001|Overall Study|Endpoint|1|||
145272885|NCT00742859|523848207|FG002|Overall Study|Endpoint|1|||
145272886|NCT00742859|523848208|FG003|Overall Study|Endpoint|2|||
145272887|NCT00742859|523848205|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
145272888|NCT00742859|523848206|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
145272889|NCT00742859|523848207|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
145272890|NCT00742859|523848208|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
145272891|NCT00742859|523848205|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
145272892|NCT00742859|523848206|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
145272893|NCT00742859|523848207|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
145272894|NCT00742859|523848208|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
145755308|NCT00200850|525616439|FG000|Overall Study|Pregnancy|0|||
145755309|NCT00200850|525616440|FG001|Overall Study|Pregnancy|0|||
145755310|NCT00200850|525616441|FG002|Overall Study|Pregnancy|1|||
145755311|NCT00200850|525616439|FG000|Overall Study|Poor adherence|0|||
145755312|NCT00200850|525616440|FG001|Overall Study|Poor adherence|0|||
145755313|NCT00200850|525616441|FG002|Overall Study|Poor adherence|1|||
145755314|NCT00200850|525616439|FG000|Overall Study|optic neuritis|0|||
145755315|NCT00200850|525616440|FG001|Overall Study|optic neuritis|0|||
145755316|NCT00200850|525616441|FG002|Overall Study|optic neuritis|1|||
145755317|NCT00200850|525616439|FG000|Overall Study|Adverse Event|1|||
145755318|NCT00200850|525616440|FG001|Overall Study|Adverse Event|1|||
145272895|NCT00742859|523848205|FG000|Overall Study|Sponsor request patient out of town|0|||
145272896|NCT00742859|523848206|FG001|Overall Study|Sponsor request patient out of town|0|||
145272897|NCT00742859|523848207|FG002|Overall Study|Sponsor request patient out of town|1|||
145272898|NCT00742859|523848208|FG003|Overall Study|Sponsor request patient out of town|1|||
145272899|NCT00742859|523848205|FG000|Overall Study|Site error|0|||
145272900|NCT00742859|523848206|FG001|Overall Study|Site error|0|||
145531084|NCT01134731|524806569|FG002|Overall Study|Lack of Efficacy|1|||
145531085|NCT01134731|524806567|FG000|Overall Study|Withdrawal by Subject|3|||
145531086|NCT01134731|524806568|FG001|Overall Study|Withdrawal by Subject|3|||
145531087|NCT01134731|524806569|FG002|Overall Study|Withdrawal by Subject|1|||
145531088|NCT01134731|524806567|FG000|Overall Study|Lost to Follow-up|5|||
145531089|NCT01134731|524806568|FG001|Overall Study|Lost to Follow-up|4|||
145531090|NCT01134731|524806569|FG002|Overall Study|Lost to Follow-up|3|||
145531091|NCT01050543|524806570|FG000|Overall Study|Withdrawal by Subject|0|||
145531092|NCT01050543|524806571|FG001|Overall Study|Withdrawal by Subject|2|||
145531093|NCT01050543|524806570|FG000|Overall Study|Protocol Violation|0|||
145531094|NCT01050543|524806571|FG001|Overall Study|Protocol Violation|1|||
145531095|NCT01050543|524806570|FG000|Overall Study|Administrative|4|||
145531096|NCT01050543|524806571|FG001|Overall Study|Administrative|1|||
145531097|NCT03053271|524806574|FG000|Overall Study|Did not meet randomization criteria|3|||
145531098|NCT03053271|524806574|FG000|Overall Study|Withdrawal by Subject|1|||
145755319|NCT00200850|525616441|FG002|Overall Study|Adverse Event|2|||
145755320|NCT00805740|525616451|FG000|Overall Study|Death|7|||
145402776|NCT00977197|524332494|FG001|Overall Study|Lost to Follow-up|3|||
145531099|NCT00570765|524806575|FG000|DB Phase|Withdrawal by Subject|1|||
145531100|NCT00570765|524806576|FG001|DB Phase|Withdrawal by Subject|0|||
145531101|NCT00570765|524806577|FG002|DB Phase|Withdrawal by Subject|0|||
145531102|NCT00570765|524806578|FG003|DB Phase|Withdrawal by Subject|0|||
145755321|NCT00805740|525616452|FG001|Overall Study|Death|4|||
145755322|NCT00805740|525616451|FG000|Overall Study|Withdrawal by Subject|1|||
145755323|NCT00805740|525616452|FG001|Overall Study|Withdrawal by Subject|0|||
145755324|NCT00805740|525616451|FG000|Overall Study|Lost to Follow-up|1|||
145272901|NCT00742859|523848207|FG002|Overall Study|Site error|1|||
145272902|NCT00742859|523848208|FG003|Overall Study|Site error|1|||
145272903|NCT00445458|523848220|FG000|Overall Study|Disease Progression|3|||
145272904|NCT00445458|523848221|FG001|Overall Study|Disease Progression|4|||
145402777|NCT00977197|524332493|FG000|Overall Study|Nonadherence|1|||
145755325|NCT00805740|525616452|FG001|Overall Study|Lost to Follow-up|0|||
145755326|NCT00805740|525616451|FG000|Overall Study|Randomized, but not treated|2|||
145755327|NCT00805740|525616452|FG001|Overall Study|Randomized, but not treated|0|||
145755328|NCT01449708|525616453|FG000|Overall Study|Protocol Violation|0|||
145755329|NCT01449708|525616454|FG001|Overall Study|Protocol Violation|1|||
145755330|NCT01449708|525616453|FG000|Overall Study|surgical complication|1|||
145755331|NCT01449708|525616454|FG001|Overall Study|surgical complication|2|||
145755332|NCT01449708|525616453|FG000|Overall Study|respiratory failure|1|||
145755333|NCT01449708|525616454|FG001|Overall Study|respiratory failure|0|||
145755334|NCT05227690|525616460|FG000|Overall Study|Adverse Event|5|||
145755335|NCT05227690|525616461|FG001|Overall Study|Adverse Event|6|||
145755336|NCT05227690|525616462|FG002|Overall Study|Adverse Event|10|||
145272905|NCT00445458|523848222|FG002|Overall Study|Disease Progression|54|||
145272906|NCT00445458|523848223|FG003|Overall Study|Disease Progression|27|||
145755337|NCT05227690|525616460|FG000|Overall Study|Lack of Efficacy|2|||
145755338|NCT05227690|525616461|FG001|Overall Study|Lack of Efficacy|4|||
145755339|NCT05227690|525616462|FG002|Overall Study|Lack of Efficacy|1|||
145755340|NCT05227690|525616460|FG000|Overall Study|Physician Decision|6|||
145755341|NCT05227690|525616461|FG001|Overall Study|Physician Decision|0|||
145755342|NCT05227690|525616462|FG002|Overall Study|Physician Decision|4|||
145272907|NCT00445458|523848220|FG000|Overall Study|Withdrawal by Subject|0|||
145272908|NCT00445458|523848221|FG001|Overall Study|Withdrawal by Subject|0|||
145272909|NCT00445458|523848222|FG002|Overall Study|Withdrawal by Subject|7|||
145272910|NCT00445458|523848223|FG003|Overall Study|Withdrawal by Subject|0|||
145272911|NCT00445458|523848220|FG000|Overall Study|Adverse Event|0|||
145272912|NCT00445458|523848221|FG001|Overall Study|Adverse Event|0|||
145272913|NCT00445458|523848222|FG002|Overall Study|Adverse Event|3|||
145272914|NCT00445458|523848223|FG003|Overall Study|Adverse Event|0|||
145272915|NCT00445458|523848220|FG000|Overall Study|Death|0|||
145272916|NCT00445458|523848221|FG001|Overall Study|Death|1|||
145272917|NCT00445458|523848222|FG002|Overall Study|Death|2|||
145272918|NCT00445458|523848223|FG003|Overall Study|Death|0|||
145272919|NCT00445458|523848220|FG000|Overall Study|Physician Decision|0|||
145272920|NCT00445458|523848221|FG001|Overall Study|Physician Decision|0|||
145272921|NCT00445458|523848222|FG002|Overall Study|Physician Decision|1|||
145272922|NCT00445458|523848223|FG003|Overall Study|Physician Decision|1|||
145272923|NCT00445458|523848220|FG000|Overall Study|Surgery|0|||
145272924|NCT00445458|523848221|FG001|Overall Study|Surgery|0|||
145272925|NCT00445458|523848222|FG002|Overall Study|Surgery|1|||
145272926|NCT00445458|523848223|FG003|Overall Study|Surgery|0|||
145272927|NCT04732728|523848224|FG000|Overall Study|Death|12|||
145272928|NCT04732728|523848224|FG000|Overall Study|Withdrawn|136|||
145272929|NCT01495793|523848229|FG000|Overall Study|Lost to Follow-up|1|||
145272930|NCT01495793|523848229|FG000|Overall Study|Violation of inclusion criteria|1|||
145272931|NCT01154673|523848230|FG000|Overall Study|Lost to Follow-up|1|||
145272932|NCT01154673|523848231|FG001|Overall Study|Lost to Follow-up|0|||
145272933|NCT01154673|523848230|FG000|Overall Study|moved out of province|1|||
145272934|NCT01154673|523848231|FG001|Overall Study|moved out of province|0|||
145272935|NCT01275170|523848237|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
145272936|NCT01275170|523848238|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
145272937|NCT01275170|523848239|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
145531103|NCT00570765|524806575|FG000|DB Phase|Protocol Violation|0|||
145531104|NCT00570765|524806576|FG001|DB Phase|Protocol Violation|1|||
145531105|NCT00570765|524806577|FG002|DB Phase|Protocol Violation|0|||
145531106|NCT00570765|524806578|FG003|DB Phase|Protocol Violation|0|||
145531107|NCT00570765|524806575|FG000|DB Phase|Adverse Event|3|||
145531108|NCT00570765|524806576|FG001|DB Phase|Adverse Event|6|||
145531109|NCT00570765|524806577|FG002|DB Phase|Adverse Event|0|||
145531110|NCT00570765|524806578|FG003|DB Phase|Adverse Event|0|||
145531111|NCT00570765|524806575|FG000|DB Phase|Did Not Receive Study Drug|0|||
145531112|NCT00570765|524806576|FG001|DB Phase|Did Not Receive Study Drug|0|||
145531113|NCT00570765|524806577|FG002|DB Phase|Did Not Receive Study Drug|1|||
145755343|NCT05227690|525616460|FG000|Overall Study|Withdrawal of consent|28|||
145755344|NCT05227690|525616461|FG001|Overall Study|Withdrawal of consent|27|||
145402778|NCT00977197|524332494|FG001|Overall Study|Nonadherence|1|||
145531114|NCT00570765|524806578|FG003|DB Phase|Did Not Receive Study Drug|0|||
145272938|NCT01275170|523848240|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
145272939|NCT01275170|523848241|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
145272940|NCT01275170|523848242|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
145272941|NCT01275170|523848243|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
145531115|NCT00570765|524806575|FG000|LTSE Phase|Withdrawal by Subject|0|||
145755345|NCT05227690|525616462|FG002|Overall Study|Withdrawal of consent|21|||
145755346|NCT05227690|525616460|FG000|Overall Study|Other, not specified|2|||
145272942|NCT01275170|523848244|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
145272943|NCT00960687|523848248|FG000|Washout Period of 7 Days|Adverse Event|3|||
145272944|NCT00960687|523848249|FG001|Washout Period of 7 Days|Adverse Event|2|||
145272945|NCT00960687|523848248|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
145272946|NCT00960687|523848249|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145272947|NCT02362646|523848250|FG000|Overall Study|Death|15|||
145272948|NCT02362646|523848251|FG001|Overall Study|Death|8|||
145272949|NCT02362646|523848250|FG000|Overall Study|Withdrawal by Subject|2|||
145272950|NCT02362646|523848251|FG001|Overall Study|Withdrawal by Subject|2|||
145272951|NCT02362646|523848250|FG000|Overall Study|received transplant|21|||
145272952|NCT02362646|523848251|FG001|Overall Study|received transplant|14|||
145272953|NCT00865306|523848252|FG000|Controlled Trial|Lost to Follow-up|1|||
145272954|NCT00865306|523848253|FG001|Controlled Trial|Lost to Follow-up|1|||
145272955|NCT00865306|523848252|FG000|Controlled Trial|Difficulty commuting|2|||
145272956|NCT00865306|523848253|FG001|Controlled Trial|Difficulty commuting|0|||
145272957|NCT00865306|523848252|FG000|Controlled Trial|Improved btw baseline and first session|1|||
145272958|NCT00865306|523848253|FG001|Controlled Trial|Improved btw baseline and first session|0|||
145272959|NCT00865306|523848252|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
145272960|NCT00865306|523848253|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
145272961|NCT00865306|523848252|FG000|Controlled Trial|Withdrawal by Subject|0|||
145272962|NCT00865306|523848253|FG001|Controlled Trial|Withdrawal by Subject|1|||
145272963|NCT02704130|523848258|FG000|Overall Study|Physician Decision|5|||
145755347|NCT05227690|525616461|FG001|Overall Study|Other, not specified|2|||
145755348|NCT05227690|525616462|FG002|Overall Study|Other, not specified|1|||
145755349|NCT02723201|525616465|FG000|Second Intervention Period|Protocol Violation|1|||
145755350|NCT02723201|525616466|FG001|Second Intervention Period|Protocol Violation|0|||
145755351|NCT02723201|525616467|FG002|Second Intervention Period|Protocol Violation|0|||
145755352|NCT02723201|525616465|FG000|Second Intervention Period|Adverse Event|1|||
145755353|NCT02723201|525616466|FG001|Second Intervention Period|Adverse Event|0|||
145755354|NCT02723201|525616467|FG002|Second Intervention Period|Adverse Event|0|||
145755355|NCT01414257|525616468|FG000|Overall Study|No Visit After First Day of Treatment|12|||
145755356|NCT01414257|525616468|FG000|Overall Study|Protocol Violation|10|||
145755357|NCT02634580|525616469|FG000|Double-blind Treatment Period|Subject Request|1|||
145755358|NCT02634580|525616470|FG001|Double-blind Treatment Period|Subject Request|0|||
145755359|NCT02634580|525616471|FG002|Double-blind Treatment Period|Subject Request|1|||
145755360|NCT02634580|525616472|FG003|Double-blind Treatment Period|Subject Request|1|||
145755361|NCT02634580|525616469|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
145755362|NCT02634580|525616470|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
145755363|NCT02634580|525616471|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
145755364|NCT02634580|525616472|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
145755365|NCT00424827|525616476|FG000|Overall Study|Adverse Event|1|||
145755366|NCT00491179|525616479|FG000|Overall Study|Adverse Event|5|||
145755367|NCT00491179|525616480|FG001|Overall Study|Adverse Event|1|||
145755368|NCT00491179|525616479|FG000|Overall Study|Withdrawal by Subject|2|||
145755369|NCT00491179|525616480|FG001|Overall Study|Withdrawal by Subject|1|||
145755370|NCT01790048|525616482|FG000|Overall Study|Incorrect Age|9|||
145755371|NCT01790048|525616483|FG001|Overall Study|Incorrect Age|14|||
145755372|NCT01790048|525616482|FG000|Overall Study|data entry error|0|||
145755373|NCT01790048|525616483|FG001|Overall Study|data entry error|1|||
145755374|NCT01790048|525616482|FG000|Overall Study|Other|0|||
145755375|NCT01790048|525616483|FG001|Overall Study|Other|2|||
145755376|NCT01790048|525616482|FG000|Overall Study|SAM at Enrollment|2|||
145755377|NCT01790048|525616483|FG001|Overall Study|SAM at Enrollment|0|||
145755378|NCT01790048|525616482|FG000|Overall Study|Measurement error|1|||
145755379|NCT01790048|525616483|FG001|Overall Study|Measurement error|0|||
145755380|NCT00584233|525616484|FG000|Overall Study|Withdrawal by Subject|5|||
145755381|NCT00584233|525616484|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
145755382|NCT00159432|525616485|FG000|Overall Study|Adverse Event|1|||
145755383|NCT00159432|525616485|FG000|Overall Study|Death|1|||
145755384|NCT00159432|525616485|FG000|Overall Study|Lack of Efficacy|8|||
145755385|NCT03083886|525616486|FG000|Overall Study|Withdrawal by Subject|51|||
145755386|NCT03083886|525616487|FG001|Overall Study|Withdrawal by Subject|73|||
145755387|NCT03083886|525616488|FG002|Overall Study|Withdrawal by Subject|104|||
145755388|NCT03083886|525616486|FG000|Overall Study|Missing Baseline data|43|||
145755389|NCT03083886|525616487|FG001|Overall Study|Missing Baseline data|42|||
145755390|NCT03083886|525616488|FG002|Overall Study|Missing Baseline data|31|||
145402779|NCT01432951|524332495|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
145402780|NCT00853385|524332496|FG000|Overall Study|Death|0|||
145402781|NCT00853385|524332497|FG001|Overall Study|Death|0|||
145755391|NCT03083886|525616486|FG000|Overall Study|Investigator terminated|1|||
145755392|NCT03083886|525616487|FG001|Overall Study|Investigator terminated|6|||
145755393|NCT03083886|525616488|FG002|Overall Study|Investigator terminated|3|||
145755394|NCT02475655|525616489|FG000|Overall Study|Lost to Follow-up|0|||
145755395|NCT02475655|525616490|FG001|Overall Study|Lost to Follow-up|1|||
145755396|NCT00257010|525616491|FG000|Overall Study|Lack of Efficacy|11|||
145755397|NCT00257010|525616491|FG000|Overall Study|Lost to Follow-up|53|||
145272964|NCT02704130|523848259|FG001|Overall Study|Physician Decision|3|||
145272965|NCT01216319|523848262|FG000|Overall Study|Lost to Follow-up|2|||
145272966|NCT01216319|523848262|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
145755398|NCT00257010|525616491|FG000|Overall Study|Withdrawal by Subject|34|||
145272967|NCT03611751|523848266|FG000|Pre-treatment|Randomized but not treated|1|||
145402782|NCT00853385|524332498|FG002|Overall Study|Death|0|||
145402783|NCT00853385|524332499|FG003|Overall Study|Death|0|||
145531116|NCT00570765|524806576|FG001|LTSE Phase|Withdrawal by Subject|0|||
145531117|NCT00570765|524806577|FG002|LTSE Phase|Withdrawal by Subject|0|||
145531118|NCT00570765|524806578|FG003|LTSE Phase|Withdrawal by Subject|1|||
145531119|NCT00570765|524806575|FG000|LTSE Phase|Adverse Event|0|||
145531120|NCT00570765|524806576|FG001|LTSE Phase|Adverse Event|0|||
145531121|NCT00570765|524806577|FG002|LTSE Phase|Adverse Event|0|||
145531122|NCT00570765|524806578|FG003|LTSE Phase|Adverse Event|7|||
145531123|NCT00570765|524806575|FG000|LTSE Phase|Physician Decision|0|||
145531124|NCT00570765|524806576|FG001|LTSE Phase|Physician Decision|0|||
145531125|NCT00570765|524806577|FG002|LTSE Phase|Physician Decision|0|||
145531126|NCT00570765|524806578|FG003|LTSE Phase|Physician Decision|4|||
145531127|NCT02517866|524806579|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145531128|NCT02517866|524806580|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
145531129|NCT02517866|524806581|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145531130|NCT02517866|524806579|FG000|Overall Study|Significant Protocol Deviation|4|||
145531131|NCT02517866|524806580|FG001|Overall Study|Significant Protocol Deviation|1|||
145531132|NCT02517866|524806581|FG002|Overall Study|Significant Protocol Deviation|0|||
145531133|NCT02517866|524806579|FG000|Overall Study|Lost to Follow-up|1|||
145531134|NCT02517866|524806580|FG001|Overall Study|Lost to Follow-up|0|||
145531135|NCT02517866|524806581|FG002|Overall Study|Lost to Follow-up|0|||
145531136|NCT02517866|524806579|FG000|Overall Study|Voluntary Withdrawal|2|||
145531137|NCT02517866|524806580|FG001|Overall Study|Voluntary Withdrawal|2|||
145531138|NCT02517866|524806581|FG002|Overall Study|Voluntary Withdrawal|0|||
145531139|NCT02517866|524806579|FG000|Overall Study|Investigator Decision|2|||
145531140|NCT02517866|524806580|FG001|Overall Study|Investigator Decision|1|||
145531141|NCT02517866|524806581|FG002|Overall Study|Investigator Decision|0|||
145755399|NCT00257010|525616491|FG000|Overall Study|Adverse Event|10|||
145755400|NCT00257010|525616491|FG000|Overall Study|various|11|||
145755401|NCT00257010|525616491|FG000|Overall Study|no headache reported|9|||
145755402|NCT04823949|525616492|FG000|Overall Study|Withdrawal by Subject|0|||
145755403|NCT04823949|525616493|FG001|Overall Study|Withdrawal by Subject|4|||
145755404|NCT04823949|525616492|FG000|Overall Study|Physician Decision|0|||
145755405|NCT04823949|525616493|FG001|Overall Study|Physician Decision|1|||
145755406|NCT00756938|525616494|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
145755407|NCT00756938|525616495|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
145755408|NCT00756938|525616496|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
145755409|NCT00756938|525616497|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
145272968|NCT03611751|523848267|FG001|Pre-treatment|Randomized but not treated|1|||
145531142|NCT02517866|524806579|FG000|Overall Study|Reason not specified|2|||
145531143|NCT02517866|524806580|FG001|Overall Study|Reason not specified|0|||
145531144|NCT02517866|524806581|FG002|Overall Study|Reason not specified|0|||
145531145|NCT03114488|524806582|FG000|Time Period 2|Withdrawal by Subject|1|||
145531146|NCT03114488|524806583|FG001|Time Period 2|Withdrawal by Subject|3|||
145531147|NCT03711266|524806586|FG000|Overall Study|Lost to Follow-up|10|||
145531148|NCT01954342|524806589|FG000|Overall Study|Missing data from 13-16week study visit|0|||
145607573|NCT02296190|525079203|FG004|Overall Study|Blood pressure <100 after sedation|0|||
145755410|NCT00756938|525616494|FG000|12-week Base Study|Protocol Violation|0|||
145755411|NCT00756938|525616495|FG001|12-week Base Study|Protocol Violation|0|||
145755412|NCT00756938|525616496|FG002|12-week Base Study|Protocol Violation|1|||
145755413|NCT00756938|525616497|FG003|12-week Base Study|Protocol Violation|0|||
145755414|NCT00756938|525616494|FG000|12-week Base Study|Lost to Follow-up|1|||
145531149|NCT01954342|524806590|FG001|Overall Study|Missing data from 13-16week study visit|0|||
145531150|NCT01954342|524806591|FG002|Overall Study|Missing data from 13-16week study visit|0|||
145531151|NCT01954342|524806592|FG003|Overall Study|Missing data from 13-16week study visit|1|||
145531152|NCT01954342|524806589|FG000|Overall Study|Miscarriage|0|||
145531153|NCT01954342|524806590|FG001|Overall Study|Miscarriage|0|||
145531154|NCT01954342|524806591|FG002|Overall Study|Miscarriage|0|||
145531155|NCT01954342|524806592|FG003|Overall Study|Miscarriage|3|||
145531156|NCT01954342|524806589|FG000|Overall Study|Lost to Follow-up|0|||
145531157|NCT01954342|524806590|FG001|Overall Study|Lost to Follow-up|0|||
145531158|NCT01954342|524806591|FG002|Overall Study|Lost to Follow-up|0|||
145531159|NCT01954342|524806592|FG003|Overall Study|Lost to Follow-up|5|||
145531160|NCT01954342|524806589|FG000|Overall Study|Preterm delivery|0|||
145531161|NCT01954342|524806590|FG001|Overall Study|Preterm delivery|0|||
145531162|NCT01954342|524806591|FG002|Overall Study|Preterm delivery|0|||
145531163|NCT01954342|524806592|FG003|Overall Study|Preterm delivery|3|||
145531164|NCT01954342|524806589|FG000|Overall Study|Pre-eclampsia|0|||
145531165|NCT01954342|524806590|FG001|Overall Study|Pre-eclampsia|0|||
145531166|NCT01954342|524806591|FG002|Overall Study|Pre-eclampsia|0|||
145531167|NCT01954342|524806592|FG003|Overall Study|Pre-eclampsia|4|||
145531168|NCT01954342|524806589|FG000|Overall Study|Unreliable Data|0|||
145531169|NCT01954342|524806590|FG001|Overall Study|Unreliable Data|0|||
145531170|NCT01954342|524806591|FG002|Overall Study|Unreliable Data|0|||
145531171|NCT01954342|524806592|FG003|Overall Study|Unreliable Data|2|||
145531172|NCT01646073|524806593|FG000|Period A (12 Weeks)|Adverse Event|0|||
145531173|NCT01646073|524806594|FG001|Period A (12 Weeks)|Adverse Event|2|||
145531174|NCT01646073|524806593|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
145531175|NCT01646073|524806594|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
145531176|NCT01646073|524806593|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
145531177|NCT01646073|524806594|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
145531178|NCT01646073|524806593|FG000|Period A (12 Weeks)|Protocol Violation|0|||
145531179|NCT01646073|524806594|FG001|Period A (12 Weeks)|Protocol Violation|1|||
145531180|NCT01646073|524806593|FG000|Period A (12 Weeks)|Other|0|||
145531181|NCT01646073|524806594|FG001|Period A (12 Weeks)|Other|1|||
145531182|NCT01646073|524806593|FG000|Period B (12 Weeks)|Adverse Event|0|||
145531183|NCT01646073|524806594|FG001|Period B (12 Weeks)|Adverse Event|7|||
145531184|NCT01646073|524806593|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
145531185|NCT01646073|524806594|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
145531186|NCT01646073|524806593|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
145531187|NCT01646073|524806594|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
145531188|NCT00057876|524806597|FG000|Overall Study|Adverse Event|8|||
145531189|NCT00057876|524806598|FG001|Overall Study|Adverse Event|8|||
145531190|NCT00057876|524806597|FG000|Overall Study|Death|2|||
145531191|NCT00057876|524806598|FG001|Overall Study|Death|1|||
145531192|NCT00057876|524806597|FG000|Overall Study|Withdrawal by Subject|5|||
145531193|NCT00057876|524806598|FG001|Overall Study|Withdrawal by Subject|6|||
145531194|NCT00057876|524806597|FG000|Overall Study|Lack of Efficacy|10|||
145531195|NCT00057876|524806598|FG001|Overall Study|Lack of Efficacy|8|||
145531196|NCT00057876|524806597|FG000|Overall Study|Ineligible|1|||
145531197|NCT00057876|524806598|FG001|Overall Study|Ineligible|2|||
145531198|NCT00057876|524806597|FG000|Overall Study|other reason|2|||
145531199|NCT00057876|524806598|FG001|Overall Study|other reason|2|||
145531200|NCT00057876|524806597|FG000|Overall Study|other complicating disease|1|||
145531201|NCT00057876|524806598|FG001|Overall Study|other complicating disease|0|||
145531202|NCT05095454|524806599|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
145531203|NCT05095454|524806600|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
145531204|NCT00679055|524806601|FG000|Overall Study|Adverse Event|0|||
145531205|NCT00679055|524806602|FG001|Overall Study|Adverse Event|1|||
145531206|NCT00679055|524806601|FG000|Overall Study|Other|0|||
145531207|NCT00679055|524806602|FG001|Overall Study|Other|3|||
145531208|NCT00679055|524806601|FG000|Overall Study|Study Terminated|2|||
145531209|NCT00679055|524806602|FG001|Overall Study|Study Terminated|1|||
145531210|NCT00853073|524806603|FG000|Overall Study|Withdrawal by Subject|3|||
145531211|NCT00853073|524806604|FG001|Overall Study|Withdrawal by Subject|2|||
145531212|NCT02758171|524806605|FG000|Wash-out|Withdrawal by Subject|1|||
145531213|NCT02758171|524806606|FG001|Wash-out|Withdrawal by Subject|0|||
145531214|NCT02758171|524806605|FG000|Wash-out|Other reason|1|||
145531215|NCT02758171|524806606|FG001|Wash-out|Other reason|0|||
145531216|NCT01999114|524806607|FG000|Overall Study|Adverse Event|8|||
145531217|NCT01999114|524806608|FG001|Overall Study|Adverse Event|7|||
145531218|NCT01999114|524806609|FG002|Overall Study|Adverse Event|2|||
145531219|NCT01999114|524806610|FG003|Overall Study|Adverse Event|2|||
145531220|NCT01999114|524806611|FG004|Overall Study|Adverse Event|1|||
145531221|NCT01999114|524806607|FG000|Overall Study|Withdrawal by Subject|0|||
145531222|NCT01999114|524806608|FG001|Overall Study|Withdrawal by Subject|0|||
145531223|NCT01999114|524806609|FG002|Overall Study|Withdrawal by Subject|1|||
145531224|NCT01999114|524806610|FG003|Overall Study|Withdrawal by Subject|0|||
145531225|NCT01999114|524806611|FG004|Overall Study|Withdrawal by Subject|1|||
145531226|NCT01999114|524806607|FG000|Overall Study|Lost to Follow-up|0|||
145531227|NCT01999114|524806608|FG001|Overall Study|Lost to Follow-up|0|||
145531228|NCT01999114|524806609|FG002|Overall Study|Lost to Follow-up|1|||
145531229|NCT01999114|524806610|FG003|Overall Study|Lost to Follow-up|0|||
145531230|NCT01999114|524806611|FG004|Overall Study|Lost to Follow-up|0|||
145531231|NCT01999114|524806607|FG000|Overall Study|Administrative|0|||
145531232|NCT01999114|524806608|FG001|Overall Study|Administrative|0|||
145531233|NCT01999114|524806609|FG002|Overall Study|Administrative|1|||
145531234|NCT01999114|524806610|FG003|Overall Study|Administrative|1|||
145531235|NCT01999114|524806611|FG004|Overall Study|Administrative|2|||
145531236|NCT01199731|524806614|FG000|Overall Study|Adverse Event|0|||
145531237|NCT01199731|524806615|FG001|Overall Study|Adverse Event|1|||
145531238|NCT01199731|524806616|FG002|Overall Study|Adverse Event|0|||
145531239|NCT01199731|524806614|FG000|Overall Study|Study closed/terminated|7|||
145531240|NCT01199731|524806615|FG001|Overall Study|Study closed/terminated|9|||
145531241|NCT01199731|524806616|FG002|Overall Study|Study closed/terminated|7|||
145531242|NCT01199731|524806614|FG000|Overall Study|Lost to Follow-up|0|||
145531243|NCT01199731|524806615|FG001|Overall Study|Lost to Follow-up|0|||
145755415|NCT00756938|525616495|FG001|12-week Base Study|Lost to Follow-up|0|||
145755416|NCT00756938|525616496|FG002|12-week Base Study|Lost to Follow-up|0|||
145755417|NCT00756938|525616497|FG003|12-week Base Study|Lost to Follow-up|0|||
145755418|NCT00756938|525616494|FG000|Optional Extension|Lack of Efficacy|0|||
145755419|NCT00756938|525616495|FG001|Optional Extension|Lack of Efficacy|0|||
145755420|NCT00756938|525616496|FG002|Optional Extension|Lack of Efficacy|0|||
145531244|NCT01199731|524806616|FG002|Overall Study|Lost to Follow-up|2|||
145531245|NCT01199731|524806614|FG000|Overall Study|Physician Decision|0|||
145531246|NCT01199731|524806615|FG001|Overall Study|Physician Decision|1|||
145531247|NCT01199731|524806616|FG002|Overall Study|Physician Decision|1|||
145531248|NCT01199731|524806614|FG000|Overall Study|Withdrawal by Subject|2|||
145531249|NCT01199731|524806615|FG001|Overall Study|Withdrawal by Subject|0|||
145531250|NCT01199731|524806616|FG002|Overall Study|Withdrawal by Subject|0|||
145531251|NCT00943124|524806617|FG000|Period 1|Withdrawal by Subject|1|||
145531252|NCT00943124|524806618|FG001|Period 1|Withdrawal by Subject|1|||
145755421|NCT00756938|525616497|FG003|Optional Extension|Lack of Efficacy|1|||
145755422|NCT00756938|525616494|FG000|Optional Extension|End of Study|0|||
145755423|NCT00756938|525616495|FG001|Optional Extension|End of Study|0|||
145755424|NCT00756938|525616496|FG002|Optional Extension|End of Study|0|||
145755425|NCT00756938|525616497|FG003|Optional Extension|End of Study|11|||
145755426|NCT00756938|525616494|FG000|Optional Extension|Protocol-specific criteria met|0|||
145755427|NCT00756938|525616495|FG001|Optional Extension|Protocol-specific criteria met|0|||
145755428|NCT00756938|525616496|FG002|Optional Extension|Protocol-specific criteria met|0|||
145755429|NCT00756938|525616497|FG003|Optional Extension|Protocol-specific criteria met|9|||
145755430|NCT00756938|525616494|FG000|Optional Extension|Physician Decision|0|||
145755431|NCT00756938|525616495|FG001|Optional Extension|Physician Decision|0|||
145755432|NCT00756938|525616496|FG002|Optional Extension|Physician Decision|0|||
145755433|NCT00756938|525616497|FG003|Optional Extension|Physician Decision|3|||
145755434|NCT00756938|525616494|FG000|Optional Extension|Lost to Follow-up|0|||
145755435|NCT00756938|525616495|FG001|Optional Extension|Lost to Follow-up|0|||
145755436|NCT00756938|525616496|FG002|Optional Extension|Lost to Follow-up|0|||
145755437|NCT00756938|525616497|FG003|Optional Extension|Lost to Follow-up|1|||
145755438|NCT00756938|525616494|FG000|Optional Extension|Protocol Violation|0|||
145755439|NCT00756938|525616495|FG001|Optional Extension|Protocol Violation|0|||
145755440|NCT00756938|525616496|FG002|Optional Extension|Protocol Violation|0|||
145755441|NCT00756938|525616497|FG003|Optional Extension|Protocol Violation|1|||
145755442|NCT00756938|525616494|FG000|Optional Extension|Withdrawal by Subject|0|||
145755443|NCT00756938|525616495|FG001|Optional Extension|Withdrawal by Subject|0|||
145755444|NCT00756938|525616496|FG002|Optional Extension|Withdrawal by Subject|0|||
145755445|NCT00756938|525616497|FG003|Optional Extension|Withdrawal by Subject|10|||
145755446|NCT00756938|525616494|FG000|Optional Extension|Adverse Event|0|||
145755447|NCT00756938|525616495|FG001|Optional Extension|Adverse Event|0|||
145755448|NCT00756938|525616496|FG002|Optional Extension|Adverse Event|0|||
145755449|NCT00756938|525616497|FG003|Optional Extension|Adverse Event|1|||
145755450|NCT00441545|525616499|FG000|First Intervention|Adverse Event|6|||
145755451|NCT00441545|525616500|FG001|First Intervention|Adverse Event|5|||
145755452|NCT00441545|525616499|FG000|First Intervention|Protocol Violation|2|||
145755453|NCT00441545|525616500|FG001|First Intervention|Protocol Violation|2|||
145755454|NCT00441545|525616499|FG000|First Intervention|Withdrawal by Subject|3|||
145755455|NCT00441545|525616500|FG001|First Intervention|Withdrawal by Subject|3|||
145755456|NCT00441545|525616499|FG000|First Intervention|Kidney transplant|1|||
145755457|NCT00441545|525616500|FG001|First Intervention|Kidney transplant|1|||
145755458|NCT00441545|525616499|FG000|First Intervention|Lack of Efficacy|2|||
145755459|NCT00441545|525616500|FG001|First Intervention|Lack of Efficacy|0|||
145755460|NCT00441545|525616499|FG000|First Intervention|Subject exceeded safety criteria|0|||
145755461|NCT00441545|525616500|FG001|First Intervention|Subject exceeded safety criteria|1|||
145755462|NCT00441545|525616499|FG000|First Intervention|Subject met an exclusionary criteria|1|||
145272969|NCT03611751|523848268|FG002|Pre-treatment|Randomized but not treated|0|||
145755463|NCT00441545|525616500|FG001|First Intervention|Subject met an exclusionary criteria|0|||
145755464|NCT00441545|525616499|FG000|First Intervention|Extended hospitalization|1|||
145755465|NCT00441545|525616500|FG001|First Intervention|Extended hospitalization|0|||
145755466|NCT00441545|525616499|FG000|First Intervention|Site error|1|||
145755467|NCT00441545|525616500|FG001|First Intervention|Site error|0|||
145755468|NCT00441545|525616499|FG000|First Intervention|Sponsor's request|1|||
145755469|NCT00441545|525616500|FG001|First Intervention|Sponsor's request|0|||
145755470|NCT00441545|525616499|FG000|Second Intervention|Adverse Event|5|||
145531253|NCT00943124|524806617|FG000|Period 1|Did Not Follow Study Procedures|1|||
145531254|NCT00943124|524806618|FG001|Period 1|Did Not Follow Study Procedures|0|||
145531255|NCT00943124|524806617|FG000|Period 1|Personal Reasons|0|||
145272970|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
145272971|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
145531256|NCT00943124|524806618|FG001|Period 1|Personal Reasons|1|||
145531257|NCT02992132|524806619|FG000|Overall Study|Adverse Event|4|||
145531258|NCT02992132|524806620|FG001|Overall Study|Adverse Event|1|||
145531259|NCT02992132|524806621|FG002|Overall Study|Adverse Event|3|||
145531260|NCT02992132|524806619|FG000|Overall Study|Lack of Efficacy|2|||
145531261|NCT02992132|524806620|FG001|Overall Study|Lack of Efficacy|0|||
145531262|NCT02992132|524806621|FG002|Overall Study|Lack of Efficacy|0|||
145531263|NCT02992132|524806619|FG000|Overall Study|Non-compliance with study drug|2|||
145531264|NCT02992132|524806620|FG001|Overall Study|Non-compliance with study drug|0|||
145531265|NCT02992132|524806621|FG002|Overall Study|Non-compliance with study drug|0|||
145531266|NCT02992132|524806619|FG000|Overall Study|Progressive disease|1|||
145531267|NCT02992132|524806620|FG001|Overall Study|Progressive disease|0|||
145531268|NCT02992132|524806621|FG002|Overall Study|Progressive disease|0|||
145531269|NCT02992132|524806619|FG000|Overall Study|Protocol Violation|2|||
145531270|NCT02992132|524806620|FG001|Overall Study|Protocol Violation|2|||
145531271|NCT02992132|524806621|FG002|Overall Study|Protocol Violation|0|||
145531272|NCT02992132|524806619|FG000|Overall Study|Caregiver withdrew consent|2|||
145531273|NCT02992132|524806620|FG001|Overall Study|Caregiver withdrew consent|3|||
145531274|NCT02992132|524806621|FG002|Overall Study|Caregiver withdrew consent|2|||
145531275|NCT02992132|524806619|FG000|Overall Study|Withdrawal by Subject|0|||
145531276|NCT02992132|524806620|FG001|Overall Study|Withdrawal by Subject|2|||
145531277|NCT02992132|524806621|FG002|Overall Study|Withdrawal by Subject|1|||
145531278|NCT02992132|524806619|FG000|Overall Study|Physician Decision|0|||
145531279|NCT02992132|524806620|FG001|Overall Study|Physician Decision|0|||
145531280|NCT02992132|524806621|FG002|Overall Study|Physician Decision|1|||
145531281|NCT01104155|524806634|FG000|Overall Study|Adverse Event|15|||
145531282|NCT01104155|524806635|FG001|Overall Study|Adverse Event|8|||
145531283|NCT01104155|524806634|FG000|Overall Study|Participant choice|6|||
145531284|NCT01104155|524806635|FG001|Overall Study|Participant choice|5|||
145531285|NCT01104155|524806634|FG000|Overall Study|Withdrawal of consent|1|||
145531286|NCT01104155|524806635|FG001|Overall Study|Withdrawal of consent|1|||
145531287|NCT01104155|524806634|FG000|Overall Study|Other|3|||
145531288|NCT01104155|524806635|FG001|Overall Study|Other|4|||
145531289|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Adverse Event|10|||
145531290|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Adverse Event|0|||
145531291|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
145755471|NCT00441545|525616500|FG001|Second Intervention|Adverse Event|2|||
145755472|NCT00441545|525616499|FG000|Second Intervention|Protocol Violation|4|||
145272972|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
145272973|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
145272974|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
145531292|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
145531293|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
145531294|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
145531295|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
145755473|NCT00441545|525616500|FG001|Second Intervention|Protocol Violation|1|||
145272975|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
145755474|NCT00441545|525616499|FG000|Second Intervention|Withdrawal by Subject|1|||
145755475|NCT00441545|525616500|FG001|Second Intervention|Withdrawal by Subject|1|||
145755476|NCT00441545|525616499|FG000|Second Intervention|Kidney Transplant|1|||
145531296|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
145531297|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
145531298|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
145531299|NCT02787551|524806641|FG000|Core Period: 26 Weeks|Other than specified|3|||
145531300|NCT02787551|524806642|FG001|Core Period: 26 Weeks|Other than specified|1|||
145531301|NCT02787551|524806641|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
145531302|NCT02787551|524806642|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
145531303|NCT02787551|524806641|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
145531304|NCT02787551|524806642|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
145531305|NCT02787551|524806641|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
145531306|NCT02787551|524806642|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
145531307|NCT03799211|524806643|FG000|Overall Study|Lost to Follow-up|2|||
145531308|NCT03799211|524806644|FG001|Overall Study|Lost to Follow-up|13|||
145531309|NCT03799211|524806643|FG000|Overall Study|Withdrawal by Subject|2|||
145531310|NCT03799211|524806644|FG001|Overall Study|Withdrawal by Subject|0|||
145531311|NCT00764491|524806645|FG000|Overall Study|Lost to Follow-up|35|||
145531312|NCT00764491|524806646|FG001|Overall Study|Lost to Follow-up|17|||
145531313|NCT00923936|524806647|FG000|Overall Study|progressive disease on study|2|||
145531314|NCT00923936|524806648|FG001|Overall Study|progressive disease on study|1|||
145531315|NCT00923936|524806647|FG000|Overall Study|Adverse Event|2|||
145531316|NCT00923936|524806648|FG001|Overall Study|Adverse Event|1|||
145531317|NCT00923936|524806647|FG000|Overall Study|Lost to follow up|2|||
145531318|NCT00923936|524806648|FG001|Overall Study|Lost to follow up|0|||
145531319|NCT00923936|524806647|FG000|Overall Study|Continuing in follow up period|2|||
145531320|NCT00923936|524806648|FG001|Overall Study|Continuing in follow up period|1|||
145531321|NCT02038452|524806650|FG000|Overall Study|Withdrawal by Subject|7|||
145531322|NCT02038452|524806651|FG001|Overall Study|Withdrawal by Subject|9|||
145531323|NCT02038452|524806650|FG000|Overall Study|Lost to Follow-up|31|||
145531324|NCT02038452|524806651|FG001|Overall Study|Lost to Follow-up|28|||
145531325|NCT03139279|524806652|FG000|Overall Study|Physician Decision|2|||
145531326|NCT03139279|524806653|FG001|Overall Study|Physician Decision|0|||
145531327|NCT03139279|524806652|FG000|Overall Study|Protocol Violation|5|||
145531328|NCT03139279|524806653|FG001|Overall Study|Protocol Violation|4|||
145531329|NCT03139279|524806652|FG000|Overall Study|Withdrawal by Subject|0|||
145531330|NCT03139279|524806653|FG001|Overall Study|Withdrawal by Subject|2|||
145531331|NCT05394350|524806654|FG000|Overall Study|Death|2|||
145531332|NCT05394350|524806655|FG001|Overall Study|Death|2|||
145531333|NCT05394350|524806656|FG002|Overall Study|Death|4|||
145531334|NCT05394350|524806657|FG003|Overall Study|Death|0|||
145531335|NCT05394350|524806658|FG004|Overall Study|Death|1|||
145531336|NCT05394350|524806659|FG005|Overall Study|Death|0|||
145531337|NCT05394350|524806654|FG000|Overall Study|Study terminated by sponsor|1|||
145531338|NCT05394350|524806655|FG001|Overall Study|Study terminated by sponsor|1|||
145531339|NCT05394350|524806656|FG002|Overall Study|Study terminated by sponsor|7|||
145531340|NCT05394350|524806657|FG003|Overall Study|Study terminated by sponsor|3|||
145531341|NCT05394350|524806658|FG004|Overall Study|Study terminated by sponsor|2|||
145531342|NCT05394350|524806659|FG005|Overall Study|Study terminated by sponsor|4|||
145531343|NCT01336569|524806660|FG000|Overall Study|Lost to Follow-up|4|||
145531344|NCT02337738|524806663|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
145531345|NCT02337738|524806664|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
145531346|NCT02337738|524806665|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
145531347|NCT02337738|524806663|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145531348|NCT02337738|524806664|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
145531349|NCT02337738|524806665|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
145531350|NCT02337738|524806663|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
145531351|NCT02337738|524806664|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
145531352|NCT02337738|524806665|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
145531353|NCT02337738|524806663|FG000|Overall Study|Voluntary Withdrawal|10|||
145531354|NCT02337738|524806664|FG001|Overall Study|Voluntary Withdrawal|5|||
145531355|NCT02337738|524806665|FG002|Overall Study|Voluntary Withdrawal|2|||
145531356|NCT02337738|524806663|FG000|Overall Study|Lack of Efficacy|2|||
145531357|NCT02337738|524806664|FG001|Overall Study|Lack of Efficacy|4|||
145531358|NCT02337738|524806665|FG002|Overall Study|Lack of Efficacy|0|||
145531359|NCT02337738|524806663|FG000|Overall Study|Investigator's Judgment|1|||
145531360|NCT02337738|524806664|FG001|Overall Study|Investigator's Judgment|1|||
145531361|NCT02337738|524806665|FG002|Overall Study|Investigator's Judgment|3|||
145531362|NCT03911154|524806666|FG000|Overall Study|Withdrawal by Subject|1|||
145531363|NCT00406354|524806667|FG000|All Randomized Patients|Protocol Violation|0|||
145531364|NCT00406354|524806668|FG001|All Randomized Patients|Protocol Violation|0|||
145531365|NCT00406354|524806669|FG002|All Randomized Patients|Protocol Violation|1|||
145531366|NCT00406354|524806667|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
145531367|NCT00406354|524806668|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
145531368|NCT00406354|524806669|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
145531369|NCT00406354|524806667|FG000|All Randomized and Treated Patients|Adverse Event|6|||
145531370|NCT00406354|524806668|FG001|All Randomized and Treated Patients|Adverse Event|2|||
145531371|NCT00406354|524806669|FG002|All Randomized and Treated Patients|Adverse Event|1|||
145531372|NCT00406354|524806667|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
145531373|NCT00406354|524806668|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
145531374|NCT00406354|524806669|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
145531375|NCT00406354|524806667|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
145531376|NCT00406354|524806668|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
145755477|NCT00441545|525616500|FG001|Second Intervention|Kidney Transplant|1|||
145755478|NCT00441545|525616499|FG000|Second Intervention|Lack of Efficacy|0|||
145755479|NCT00441545|525616500|FG001|Second Intervention|Lack of Efficacy|1|||
145755480|NCT00441545|525616499|FG000|Second Intervention|Subject exceeded safety criteria|1|||
145755481|NCT00441545|525616500|FG001|Second Intervention|Subject exceeded safety criteria|0|||
145755482|NCT00441545|525616499|FG000|Second Intervention|Subject moved|0|||
145755483|NCT00441545|525616500|FG001|Second Intervention|Subject moved|1|||
145755484|NCT00411554|525616501|FG000|Overall Study|Adverse Event|2|||
145755485|NCT00411554|525616502|FG001|Overall Study|Adverse Event|4|||
145755486|NCT00411554|525616501|FG000|Overall Study|Lack of Efficacy|2|||
145755487|NCT00411554|525616502|FG001|Overall Study|Lack of Efficacy|5|||
145755488|NCT00411554|525616501|FG000|Overall Study|Withdrawal by Subject|3|||
145755489|NCT00411554|525616502|FG001|Overall Study|Withdrawal by Subject|0|||
145755490|NCT00411554|525616501|FG000|Overall Study|Patient Moved|1|||
145755491|NCT00411554|525616502|FG001|Overall Study|Patient Moved|0|||
145755492|NCT03889639|525616503|FG000|Overall Study|Withdrawal by Subject|0|||
145755493|NCT03889639|525616504|FG001|Overall Study|Withdrawal by Subject|0|||
145755494|NCT03889639|525616505|FG002|Overall Study|Withdrawal by Subject|0|||
145755495|NCT03889639|525616506|FG003|Overall Study|Withdrawal by Subject|0|||
145755496|NCT03889639|525616507|FG004|Overall Study|Withdrawal by Subject|0|||
145755497|NCT03889639|525616508|FG005|Overall Study|Withdrawal by Subject|0|||
145755498|NCT03889639|525616509|FG006|Overall Study|Withdrawal by Subject|0|||
145755499|NCT03889639|525616510|FG007|Overall Study|Withdrawal by Subject|1|||
145755500|NCT01834729|525616511|FG000|Overall Study|Did not return bowel diaries|0|||
145755501|NCT01834729|525616512|FG001|Overall Study|Did not return bowel diaries|0|||
145755502|NCT01834729|525616513|FG002|Overall Study|Did not return bowel diaries|3|||
145755503|NCT01834729|525616514|FG003|Overall Study|Did not return bowel diaries|0|||
145755504|NCT01834729|525616511|FG000|Overall Study|Withdrawal by Subject|1|||
145755505|NCT01834729|525616512|FG001|Overall Study|Withdrawal by Subject|1|||
145755506|NCT01834729|525616513|FG002|Overall Study|Withdrawal by Subject|0|||
145755507|NCT01834729|525616514|FG003|Overall Study|Withdrawal by Subject|0|||
145755508|NCT01834729|525616511|FG000|Overall Study|Adverse Event|0|||
145755509|NCT01834729|525616512|FG001|Overall Study|Adverse Event|0|||
145755510|NCT01834729|525616513|FG002|Overall Study|Adverse Event|0|||
145755511|NCT01834729|525616514|FG003|Overall Study|Adverse Event|2|||
145755512|NCT00288080|525616515|FG000|Overall Study|Withdrawal by Subject|1|||
145755513|NCT00288080|525616516|FG001|Overall Study|Withdrawal by Subject|3|||
145755514|NCT00288080|525616515|FG000|Overall Study|Protocol Violation|25|||
145755515|NCT00288080|525616516|FG001|Overall Study|Protocol Violation|20|||
145755516|NCT03403192|525616517|FG000|Overall Study|Lost to Follow-up|1|||
145607574|NCT02296190|525079204|FG005|Overall Study|Blood pressure <100 after sedation|0|||
145755517|NCT03403192|525616518|FG001|Overall Study|Lost to Follow-up|2|||
145755518|NCT03403192|525616519|FG002|Overall Study|Lost to Follow-up|0|||
145755519|NCT03403192|525616520|FG003|Overall Study|Lost to Follow-up|0|||
145755520|NCT03403192|525616517|FG000|Overall Study|Unable to respond|0|||
145755521|NCT03403192|525616518|FG001|Overall Study|Unable to respond|1|||
145755522|NCT03403192|525616519|FG002|Overall Study|Unable to respond|0|||
145755523|NCT03403192|525616520|FG003|Overall Study|Unable to respond|0|||
145755524|NCT03403192|525616517|FG000|Overall Study|Incomplete|3|||
145755525|NCT03403192|525616518|FG001|Overall Study|Incomplete|1|||
145755526|NCT03403192|525616519|FG002|Overall Study|Incomplete|3|||
145755527|NCT03403192|525616520|FG003|Overall Study|Incomplete|6|||
145755528|NCT01298492|525616522|FG000|Overall Study|Death|2|||
145755529|NCT01298492|525616522|FG000|Overall Study|Insufficient Clinical Response|22|||
145755530|NCT01298492|525616522|FG000|Overall Study|Lost to Follow-up|12|||
145755531|NCT01298492|525616522|FG000|Overall Study|Withdrawal by Subject|47|||
145755532|NCT01298492|525616522|FG000|Overall Study|Other (Unspecified)|7|||
145755533|NCT01298492|525616522|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
145755534|NCT01298492|525616522|FG000|Overall Study|Protocol Violation|2|||
145755535|NCT01298492|525616522|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
145755536|NCT01298492|525616522|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
145755537|NCT03870555|525616523|FG000|Period 3 (2 Days)|Adverse Event|1|||
145755538|NCT03870555|525616524|FG001|Period 3 (2 Days)|Adverse Event|0|||
145755539|NCT03870555|525616525|FG002|Period 3 (2 Days)|Adverse Event|0|||
145755540|NCT01353703|525616526|FG000|Overall Study|Migrated/moved from study area|1|||
145531377|NCT00406354|524806669|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
145531378|NCT00406354|524806667|FG000|All Randomized and Treated Patients|Physician Decision|0|||
145531379|NCT00406354|524806668|FG001|All Randomized and Treated Patients|Physician Decision|0|||
145531380|NCT00406354|524806669|FG002|All Randomized and Treated Patients|Physician Decision|1|||
145531381|NCT01460368|524806670|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531382|NCT01460368|524806671|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531383|NCT01460368|524806672|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531384|NCT01460368|524806673|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531385|NCT01460368|524806674|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
145531386|NCT01460368|524806675|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531387|NCT01460368|524806676|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
145531388|NCT01460368|524806670|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
145531389|NCT01460368|524806671|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
145755541|NCT01353703|525616527|FG001|Overall Study|Migrated/moved from study area|0|||
145755542|NCT03033875|525616543|FG000|Overall Study|Withdrawal by Subject|5|||
145755543|NCT03033875|525616544|FG001|Overall Study|Withdrawal by Subject|9|||
145755544|NCT03033875|525616545|FG002|Overall Study|Withdrawal by Subject|4|||
145755545|NCT03033875|525616543|FG000|Overall Study|Other|14|||
145531390|NCT01460368|524806672|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
145531391|NCT01460368|524806673|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
145531392|NCT01460368|524806674|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
145531393|NCT01460368|524806675|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
145531394|NCT01460368|524806676|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
145531395|NCT01460368|524806670|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531396|NCT01460368|524806671|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
145402784|NCT00853385|524332500|FG004|Overall Study|Death|1|||
145402785|NCT00853385|524332496|FG000|Overall Study|Adverse Event|24|||
145402786|NCT00853385|524332497|FG001|Overall Study|Adverse Event|24|||
145402787|NCT00853385|524332498|FG002|Overall Study|Adverse Event|2|||
145402788|NCT00853385|524332499|FG003|Overall Study|Adverse Event|5|||
145531397|NCT01460368|524806672|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531398|NCT01460368|524806673|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531399|NCT01460368|524806674|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531400|NCT01460368|524806675|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531401|NCT01460368|524806676|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
145531402|NCT01460368|524806670|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531403|NCT01460368|524806671|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531404|NCT01460368|524806672|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
145531405|NCT01460368|524806673|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531406|NCT01460368|524806674|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531407|NCT01460368|524806675|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531408|NCT01460368|524806676|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
145531409|NCT01460368|524806670|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
145531410|NCT01460368|524806671|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
145531411|NCT01460368|524806672|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
145531412|NCT01460368|524806673|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
145531413|NCT01460368|524806674|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
145531414|NCT01460368|524806675|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
145531415|NCT01460368|524806676|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
145531416|NCT00292318|524806679|FG000|Overall Study|Study terminated by officials|2|||
145402789|NCT00853385|524332500|FG004|Overall Study|Adverse Event|22|||
145402790|NCT00853385|524332496|FG000|Overall Study|Lack of Efficacy|6|||
145531417|NCT00292318|524806680|FG001|Overall Study|Study terminated by officials|1|||
145531418|NCT02027376|524806681|FG000|Overall Study|Death|1|||
145531419|NCT02027376|524806682|FG001|Overall Study|Death|0|||
145402791|NCT00853385|524332497|FG001|Overall Study|Lack of Efficacy|7|||
145402792|NCT00853385|524332498|FG002|Overall Study|Lack of Efficacy|3|||
145402793|NCT00853385|524332499|FG003|Overall Study|Lack of Efficacy|3|||
145531420|NCT02027376|524806683|FG002|Overall Study|Death|0|||
145531421|NCT01278160|524806685|FG000|Overall Study|Adverse Event|1|||
145531422|NCT01278160|524806686|FG001|Overall Study|Adverse Event|1|||
145531423|NCT01278160|524806685|FG000|Overall Study|Lost to Follow-up|0|||
145531424|NCT01278160|524806686|FG001|Overall Study|Lost to Follow-up|1|||
145531425|NCT01278160|524806685|FG000|Overall Study|Withdrawal by Subject|3|||
145402794|NCT00853385|524332500|FG004|Overall Study|Lack of Efficacy|6|||
145402795|NCT00853385|524332496|FG000|Overall Study|Lost to Follow-up|2|||
145402796|NCT00853385|524332497|FG001|Overall Study|Lost to Follow-up|1|||
145531426|NCT01278160|524806686|FG001|Overall Study|Withdrawal by Subject|2|||
145531427|NCT01278160|524806685|FG000|Overall Study|Unclassified|1|||
145755546|NCT03033875|525616544|FG001|Overall Study|Other|15|||
145755547|NCT03033875|525616545|FG002|Overall Study|Other|8|||
145755548|NCT04925752|525616547|FG000|Overall Study|Still on Study|1826|||
145755549|NCT04925752|525616548|FG001|Overall Study|Still on Study|926|||
145755550|NCT04925752|525616547|FG000|Overall Study|Withdrew Consent|128|||
145755551|NCT04925752|525616548|FG001|Overall Study|Withdrew Consent|59|||
145755552|NCT04925752|525616547|FG000|Overall Study|Lost to Follow-up|73|||
145755553|NCT04925752|525616548|FG001|Overall Study|Lost to Follow-up|47|||
145755554|NCT04925752|525616547|FG000|Overall Study|Randomized but Never Treated|12|||
145755555|NCT04925752|525616548|FG001|Overall Study|Randomized but Never Treated|9|||
145755556|NCT04925752|525616547|FG000|Overall Study|Hiv-1 Infection|6|||
145755557|NCT04925752|525616548|FG001|Overall Study|Hiv-1 Infection|7|||
145755558|NCT04925752|525616547|FG000|Overall Study|Investigator's discretion|8|||
145755559|NCT04925752|525616548|FG001|Overall Study|Investigator's discretion|5|||
145755560|NCT04925752|525616547|FG000|Overall Study|Non-compliance with Study Drug|8|||
145755561|NCT04925752|525616548|FG001|Overall Study|Non-compliance with Study Drug|5|||
145755562|NCT04925752|525616547|FG000|Overall Study|Adverse Event|5|||
145755563|NCT04925752|525616548|FG001|Overall Study|Adverse Event|2|||
145755564|NCT04925752|525616547|FG000|Overall Study|Death|4|||
145755565|NCT04925752|525616548|FG001|Overall Study|Death|2|||
145755566|NCT04925752|525616547|FG000|Overall Study|Protocol Violation|1|||
145755567|NCT04925752|525616548|FG001|Overall Study|Protocol Violation|3|||
145755568|NCT04925752|525616547|FG000|Overall Study|Withdrew Assent|1|||
145755569|NCT04925752|525616548|FG001|Overall Study|Withdrew Assent|0|||
145755570|NCT00516737|525616549|FG000|Overall Study|Lost to Follow-up|2|||
145755571|NCT00516737|525616550|FG001|Overall Study|Lost to Follow-up|0|||
145755572|NCT00516737|525616549|FG000|Overall Study|Physician Decision|0|||
145755573|NCT00516737|525616550|FG001|Overall Study|Physician Decision|1|||
145755574|NCT00516737|525616549|FG000|Overall Study|Withdrawal by Subject|0|||
145755575|NCT00516737|525616550|FG001|Overall Study|Withdrawal by Subject|1|||
145755576|NCT00516737|525616549|FG000|Overall Study|Lack of Qualifying Event|9|||
145755577|NCT00516737|525616550|FG001|Overall Study|Lack of Qualifying Event|6|||
145755578|NCT00512798|525616551|FG000|Overall Study|Death|0|||
145755579|NCT00512798|525616552|FG001|Overall Study|Death|3|||
145755580|NCT00512798|525616551|FG000|Overall Study|Adverse Event|2|||
145755581|NCT00512798|525616552|FG001|Overall Study|Adverse Event|4|||
145755582|NCT00512798|525616551|FG000|Overall Study|Progression of disease|14|||
145755583|NCT00512798|525616552|FG001|Overall Study|Progression of disease|20|||
145755584|NCT00512798|525616551|FG000|Overall Study|Withdrawal by Subject|3|||
145755585|NCT00512798|525616552|FG001|Overall Study|Withdrawal by Subject|0|||
145755586|NCT02775851|525618204|FG000|Overall Study|Adverse Event|1|||
145755587|NCT02775851|525618205|FG001|Overall Study|Adverse Event|10|||
145755588|NCT02775851|525618204|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
145755589|NCT02775851|525618205|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
145755590|NCT02775851|525618204|FG000|Overall Study|Progression/Relapse|0|||
145755591|NCT02775851|525618205|FG001|Overall Study|Progression/Relapse|4|||
145755592|NCT02775851|525618204|FG000|Overall Study|Other - Not Protocol Specified|0|||
145755593|NCT02775851|525618205|FG001|Overall Study|Other - Not Protocol Specified|7|||
145755594|NCT02775851|525618204|FG000|Overall Study|Withdrawal by Subject|1|||
145755595|NCT02775851|525618205|FG001|Overall Study|Withdrawal by Subject|0|||
145531428|NCT01278160|524806686|FG001|Overall Study|Unclassified|2|||
145531429|NCT00304239|524806689|FG000|Overall Study|Protocol Deviations/Violations|15|||
145531430|NCT00304239|524806690|FG001|Overall Study|Protocol Deviations/Violations|0|||
145531431|NCT00304239|524806689|FG000|Overall Study|Adverse Event|2|||
145531432|NCT00304239|524806690|FG001|Overall Study|Adverse Event|0|||
145531433|NCT00932737|524806693|FG000|Overall Study|Not treated in second episode|1|||
145531434|NCT00932737|524806694|FG001|Overall Study|Not treated in second episode|0|||
145531435|NCT00932737|524806693|FG000|Overall Study|Adverse Event|0|||
145531436|NCT00932737|524806694|FG001|Overall Study|Adverse Event|1|||
145531437|NCT02906332|524806697|FG000|Overall Study|Withdrawal by Subject|1|||
145531438|NCT02949700|524806698|FG000|Phase I|Withdrawal by Subject|1|||
145531439|NCT02949700|524806699|FG001|Phase I|Withdrawal by Subject|1|||
145531440|NCT02949700|524806700|FG002|Phase I|Withdrawal by Subject|0|||
145531441|NCT02949700|524806701|FG003|Phase I|Withdrawal by Subject|0|||
145531442|NCT02949700|524806698|FG000|Phase I|Protocol Violation|1|||
145531443|NCT02949700|524806699|FG001|Phase I|Protocol Violation|0|||
145531444|NCT02949700|524806700|FG002|Phase I|Protocol Violation|0|||
145531445|NCT02949700|524806701|FG003|Phase I|Protocol Violation|0|||
145531446|NCT02949700|524806698|FG000|Phase II|Withdrawal by Subject|0|||
145531447|NCT02949700|524806699|FG001|Phase II|Withdrawal by Subject|0|||
145531448|NCT02949700|524806700|FG002|Phase II|Withdrawal by Subject|0|||
145531449|NCT02949700|524806701|FG003|Phase II|Withdrawal by Subject|2|||
145531450|NCT02949700|524806698|FG000|Phase II|Protocol Violation|0|||
145531451|NCT02949700|524806699|FG001|Phase II|Protocol Violation|0|||
145531452|NCT02949700|524806700|FG002|Phase II|Protocol Violation|1|||
145531453|NCT02949700|524806701|FG003|Phase II|Protocol Violation|3|||
145531454|NCT00257608|524808291|FG000|Chemotherapy Phase|Adverse Event|138|||
145531455|NCT00257608|524808292|FG001|Chemotherapy Phase|Adverse Event|0|||
145531456|NCT00257608|524808293|FG002|Chemotherapy Phase|Adverse Event|0|||
145531457|NCT00257608|524808291|FG000|Chemotherapy Phase|Disease progression|139|||
145531458|NCT00257608|524808292|FG001|Chemotherapy Phase|Disease progression|0|||
145531459|NCT00257608|524808293|FG002|Chemotherapy Phase|Disease progression|0|||
145531460|NCT00257608|524808291|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
145531461|NCT00257608|524808292|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
145531462|NCT00257608|524808293|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
145531463|NCT00257608|524808291|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
145531464|NCT00257608|524808292|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
145531465|NCT00257608|524808293|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
145531466|NCT00257608|524808291|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
145531467|NCT00257608|524808292|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
145531468|NCT00257608|524808293|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
145531469|NCT00257608|524808291|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
145531470|NCT00257608|524808292|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
145531471|NCT00257608|524808293|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
145531472|NCT00257608|524808291|FG000|Chemotherapy Phase|Physician Decision|28|||
145531473|NCT00257608|524808292|FG001|Chemotherapy Phase|Physician Decision|0|||
145531474|NCT00257608|524808293|FG002|Chemotherapy Phase|Physician Decision|0|||
145531475|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Adverse Event|0|||
145531476|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Adverse Event|34|||
145531477|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Adverse Event|38|||
145531478|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Disease progression|0|||
145531479|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Disease progression|204|||
145531480|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Disease progression|168|||
145531481|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
145531482|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
145531483|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
145531484|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
145531485|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
145531486|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
145531487|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
145531488|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
145531489|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
145531490|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
145531491|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
145531492|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
145531493|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
145531494|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
145531495|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
145531496|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Physician Decision|0|||
145531497|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Physician Decision|8|||
145531498|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Physician Decision|11|||
145531499|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
145531500|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
145531501|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
145531502|NCT00257608|524808291|FG000|Post Chemotherapy Phase|Not treated|0|||
145531503|NCT00257608|524808292|FG001|Post Chemotherapy Phase|Not treated|4|||
145531504|NCT00257608|524808293|FG002|Post Chemotherapy Phase|Not treated|7|||
145531505|NCT00866788|524808294|FG000|Overall Study|Adverse Event|0|||
145531506|NCT00866788|524808295|FG001|Overall Study|Adverse Event|2|||
145531507|NCT00866788|524808296|FG002|Overall Study|Adverse Event|0|||
145531508|NCT00866788|524808297|FG003|Overall Study|Adverse Event|1|||
145531509|NCT00866788|524808294|FG000|Overall Study|Lost to Follow-up|1|||
145531510|NCT00866788|524808295|FG001|Overall Study|Lost to Follow-up|1|||
145531511|NCT00866788|524808296|FG002|Overall Study|Lost to Follow-up|0|||
145531512|NCT00866788|524808297|FG003|Overall Study|Lost to Follow-up|2|||
145531513|NCT00866788|524808294|FG000|Overall Study|Withdrawal by Subject|2|||
145531514|NCT00866788|524808295|FG001|Overall Study|Withdrawal by Subject|1|||
145531515|NCT00866788|524808296|FG002|Overall Study|Withdrawal by Subject|0|||
145531516|NCT00866788|524808297|FG003|Overall Study|Withdrawal by Subject|1|||
145531517|NCT00866788|524808294|FG000|Overall Study|Pregnancy|0|||
145531518|NCT00866788|524808295|FG001|Overall Study|Pregnancy|1|||
145531519|NCT00866788|524808296|FG002|Overall Study|Pregnancy|0|||
145531520|NCT00866788|524808297|FG003|Overall Study|Pregnancy|0|||
145531521|NCT00866788|524808294|FG000|Overall Study|Disease progression|3|||
145531522|NCT00866788|524808295|FG001|Overall Study|Disease progression|1|||
145531523|NCT00866788|524808296|FG002|Overall Study|Disease progression|1|||
145531524|NCT00866788|524808297|FG003|Overall Study|Disease progression|0|||
145531525|NCT00866788|524808294|FG000|Overall Study|Physician Decision|0|||
145531526|NCT00866788|524808295|FG001|Overall Study|Physician Decision|0|||
145531527|NCT00866788|524808296|FG002|Overall Study|Physician Decision|1|||
145531528|NCT00866788|524808297|FG003|Overall Study|Physician Decision|1|||
145531529|NCT01854658|524808298|FG000|Overall Study|Protocol Violation|6|||
145531530|NCT01854658|524808299|FG001|Overall Study|Protocol Violation|2|||
145531531|NCT01854658|524808300|FG002|Overall Study|Protocol Violation|2|||
145531532|NCT01854658|524808301|FG003|Overall Study|Protocol Violation|1|||
145531533|NCT01854658|524808298|FG000|Overall Study|Physician Decision|7|||
145531534|NCT01854658|524808299|FG001|Overall Study|Physician Decision|5|||
145531535|NCT01854658|524808300|FG002|Overall Study|Physician Decision|2|||
145531536|NCT01854658|524808301|FG003|Overall Study|Physician Decision|4|||
145531537|NCT01854658|524808298|FG000|Overall Study|Lost to Follow-up|8|||
145531538|NCT01854658|524808299|FG001|Overall Study|Lost to Follow-up|9|||
145531539|NCT01854658|524808300|FG002|Overall Study|Lost to Follow-up|8|||
145531540|NCT01854658|524808301|FG003|Overall Study|Lost to Follow-up|4|||
145531541|NCT01854658|524808298|FG000|Overall Study|Withdrawal by Subject|28|||
145531542|NCT01854658|524808299|FG001|Overall Study|Withdrawal by Subject|21|||
145531543|NCT01854658|524808300|FG002|Overall Study|Withdrawal by Subject|29|||
145531544|NCT01854658|524808301|FG003|Overall Study|Withdrawal by Subject|15|||
145531545|NCT01854658|524808298|FG000|Overall Study|Protocol-specified criteria|15|||
145531546|NCT01854658|524808299|FG001|Overall Study|Protocol-specified criteria|15|||
145531547|NCT01854658|524808300|FG002|Overall Study|Protocol-specified criteria|10|||
145531548|NCT01854658|524808301|FG003|Overall Study|Protocol-specified criteria|7|||
145531549|NCT01854658|524808298|FG000|Overall Study|Lack of Efficacy|3|||
145531550|NCT01854658|524808299|FG001|Overall Study|Lack of Efficacy|8|||
145531551|NCT01854658|524808300|FG002|Overall Study|Lack of Efficacy|4|||
145531552|NCT01854658|524808301|FG003|Overall Study|Lack of Efficacy|7|||
145531553|NCT01854658|524808298|FG000|Overall Study|Adverse Event|21|||
145531554|NCT01854658|524808299|FG001|Overall Study|Adverse Event|14|||
145531555|NCT01854658|524808300|FG002|Overall Study|Adverse Event|23|||
145531556|NCT01854658|524808301|FG003|Overall Study|Adverse Event|19|||
145531557|NCT01854658|524808298|FG000|Overall Study|Administrative reasons|5|||
145531558|NCT01854658|524808299|FG001|Overall Study|Administrative reasons|1|||
145531559|NCT01854658|524808300|FG002|Overall Study|Administrative reasons|2|||
145531560|NCT01854658|524808301|FG003|Overall Study|Administrative reasons|2|||
145531561|NCT00697073|524808302|FG000|Overall Study|Withdrawal by Subject|2|||
145531562|NCT00697073|524808302|FG000|Overall Study|Pregnancy|1|||
145531563|NCT00697073|524808302|FG000|Overall Study|non compliance and other|6|||
145531564|NCT03265665|524808303|FG000|24-week Data Collection|Withdrawal by Subject|2|||
145531565|NCT03265665|524808304|FG001|24-week Data Collection|Withdrawal by Subject|2|||
145531566|NCT03265665|524808303|FG000|24-week Data Collection|Lost to Follow-up|4|||
145531567|NCT03265665|524808304|FG001|24-week Data Collection|Lost to Follow-up|5|||
145531568|NCT03265665|524808303|FG000|36-week Data Collection|Lost to Follow-up|6|||
145531569|NCT03265665|524808304|FG001|36-week Data Collection|Lost to Follow-up|8|||
145531570|NCT02486302|524808311|FG000|Overall Study|Discontinued prematurely|410|||
145531571|NCT02486302|524808311|FG000|Overall Study|Documentation not completed|255|||
145531572|NCT02486302|524808311|FG000|Overall Study|Excluded due to legal reasons|8|||
145755596|NCT00403260|525618213|FG000|Overall Study|Adverse Event|5|||
145755597|NCT00403260|525618214|FG001|Overall Study|Adverse Event|4|||
145755598|NCT00403260|525618213|FG000|Overall Study|Withdrawal by Subject|5|||
145755599|NCT00403260|525618214|FG001|Overall Study|Withdrawal by Subject|6|||
145755600|NCT00403260|525618213|FG000|Overall Study|Lost to Follow-up|49|||
145755601|NCT00403260|525618214|FG001|Overall Study|Lost to Follow-up|25|||
145755602|NCT00403260|525618213|FG000|Overall Study|Re-appearance of P. falciparum|34|||
145755603|NCT00403260|525618214|FG001|Overall Study|Re-appearance of P. falciparum|25|||
145755604|NCT00403260|525618213|FG000|Overall Study|P. vivax infection|26|||
145755605|NCT00403260|525618214|FG001|Overall Study|P. vivax infection|4|||
145755606|NCT00403260|525618213|FG000|Overall Study|Mixed infection with P. vivax|2|||
145755607|NCT00403260|525618214|FG001|Overall Study|Mixed infection with P. vivax|0|||
145755608|NCT00403260|525618213|FG000|Overall Study|Mixed infection with P. falciparum|1|||
145755609|NCT00403260|525618214|FG001|Overall Study|Mixed infection with P. falciparum|0|||
145755610|NCT00403260|525618213|FG000|Overall Study|P. vivax infection at screening|1|||
145755611|NCT00403260|525618214|FG001|Overall Study|P. vivax infection at screening|0|||
145755612|NCT00403260|525618213|FG000|Overall Study|P. ovale infection|1|||
145755613|NCT00403260|525618214|FG001|Overall Study|P. ovale infection|0|||
145755614|NCT00403260|525618213|FG000|Overall Study|Gametocyte re-appearance|1|||
145755615|NCT00403260|525618214|FG001|Overall Study|Gametocyte re-appearance|1|||
145402797|NCT00853385|524332498|FG002|Overall Study|Lost to Follow-up|0|||
145531573|NCT02486302|524808311|FG000|Overall Study|Not treated|3|||
145531574|NCT01871142|524808312|FG000|Overall Study|Adverse Event|1|||
145531575|NCT04416633|524808321|FG000|Overall Study|Death|1|||
145531576|NCT04416633|524808321|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
145531577|NCT04416633|524808321|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
145531578|NCT04416633|524808321|FG000|Overall Study|Adverse Event|6|||
145531579|NCT04416633|524808321|FG000|Overall Study|Withdrawal by Subject|6|||
145531580|NCT00785928|524808322|FG000|Treatment Phase|Adverse Event|1|||
145531581|NCT00785928|524808323|FG001|Treatment Phase|Adverse Event|1|||
145531582|NCT00785928|524808324|FG002|Treatment Phase|Adverse Event|2|||
145531583|NCT00785928|524808325|FG003|Treatment Phase|Adverse Event|0|||
145531584|NCT00785928|524808326|FG004|Treatment Phase|Adverse Event|0|||
145531585|NCT00785928|524808327|FG005|Treatment Phase|Adverse Event|0|||
145531586|NCT00785928|524808328|FG006|Treatment Phase|Adverse Event|2|||
145531587|NCT00785928|524808322|FG000|Treatment Phase|Inadequate Response|0|||
145531588|NCT00785928|524808323|FG001|Treatment Phase|Inadequate Response|1|||
145531589|NCT00785928|524808324|FG002|Treatment Phase|Inadequate Response|0|||
145531590|NCT00785928|524808325|FG003|Treatment Phase|Inadequate Response|0|||
145531591|NCT00785928|524808326|FG004|Treatment Phase|Inadequate Response|0|||
145531592|NCT00785928|524808327|FG005|Treatment Phase|Inadequate Response|0|||
145531593|NCT00785928|524808328|FG006|Treatment Phase|Inadequate Response|0|||
145531594|NCT00785928|524808322|FG000|Treatment Phase|Lack of Efficacy|0|||
145531595|NCT00785928|524808323|FG001|Treatment Phase|Lack of Efficacy|1|||
145531596|NCT00785928|524808324|FG002|Treatment Phase|Lack of Efficacy|1|||
145531597|NCT00785928|524808325|FG003|Treatment Phase|Lack of Efficacy|0|||
145531598|NCT00785928|524808326|FG004|Treatment Phase|Lack of Efficacy|0|||
145531599|NCT00785928|524808327|FG005|Treatment Phase|Lack of Efficacy|0|||
145531600|NCT00785928|524808328|FG006|Treatment Phase|Lack of Efficacy|0|||
145531601|NCT00785928|524808322|FG000|Treatment Phase|Physician Decision|0|||
145531602|NCT00785928|524808323|FG001|Treatment Phase|Physician Decision|0|||
145531603|NCT00785928|524808324|FG002|Treatment Phase|Physician Decision|0|||
145531604|NCT00785928|524808325|FG003|Treatment Phase|Physician Decision|0|||
145531605|NCT00785928|524808326|FG004|Treatment Phase|Physician Decision|1|||
145531606|NCT00785928|524808327|FG005|Treatment Phase|Physician Decision|0|||
145531607|NCT00785928|524808328|FG006|Treatment Phase|Physician Decision|0|||
145531608|NCT00785928|524808322|FG000|Treatment Phase|Sponsor Decision|1|||
145531609|NCT00785928|524808323|FG001|Treatment Phase|Sponsor Decision|0|||
145531610|NCT00785928|524808324|FG002|Treatment Phase|Sponsor Decision|0|||
145531611|NCT00785928|524808325|FG003|Treatment Phase|Sponsor Decision|0|||
145531612|NCT00785928|524808326|FG004|Treatment Phase|Sponsor Decision|0|||
145531613|NCT00785928|524808327|FG005|Treatment Phase|Sponsor Decision|0|||
145531614|NCT00785928|524808328|FG006|Treatment Phase|Sponsor Decision|1|||
145531615|NCT00785928|524808322|FG000|Treatment Phase|Withdrawal by Subject|1|||
145531616|NCT00785928|524808323|FG001|Treatment Phase|Withdrawal by Subject|2|||
145531617|NCT00785928|524808324|FG002|Treatment Phase|Withdrawal by Subject|0|||
145531618|NCT00785928|524808325|FG003|Treatment Phase|Withdrawal by Subject|0|||
145531619|NCT00785928|524808326|FG004|Treatment Phase|Withdrawal by Subject|1|||
145531620|NCT00785928|524808327|FG005|Treatment Phase|Withdrawal by Subject|0|||
145755616|NCT00403260|525618213|FG000|Overall Study|Withdrawn from study accidentally|0|||
145531621|NCT00785928|524808328|FG006|Treatment Phase|Withdrawal by Subject|0|||
145531622|NCT05021081|524808335|FG000|Phase 2|Subject enrolled in error|1|||
145531623|NCT05021081|524808336|FG001|Phase 2|Subject enrolled in error|1|||
145531624|NCT05021081|524808337|FG002|Phase 2|Subject enrolled in error|0|||
145531625|NCT02651467|524808338|FG000|Overall Study|Withdrawal by Subject|0|||
145531626|NCT02651467|524808339|FG001|Overall Study|Withdrawal by Subject|0|||
145531627|NCT02651467|524808340|FG002|Overall Study|Withdrawal by Subject|2|||
145755617|NCT00403260|525618214|FG001|Overall Study|Withdrawn from study accidentally|1|||
145755618|NCT01534676|525618219|FG000|Overall Study|Study closed due to poor enrollment|2|||
145755619|NCT01534676|525618220|FG001|Overall Study|Study closed due to poor enrollment|1|||
145755620|NCT05425563|525618221|FG000|Overall Study|Withdrawal by Subject|17|||
145755621|NCT03178487|525618222|FG000|Period 1|Adverse Event|1|||
145755622|NCT03178487|525618223|FG001|Period 1|Adverse Event|2|||
145755623|NCT03178487|525618222|FG000|Period 1|Withdrawal by Subject|2|||
145755624|NCT03178487|525618223|FG001|Period 1|Withdrawal by Subject|1|||
145755625|NCT03178487|525618222|FG000|Period 1|Lost to Follow-up|1|||
145755626|NCT03178487|525618223|FG001|Period 1|Lost to Follow-up|0|||
145755627|NCT03178487|525618222|FG000|Period 1|Other|0|||
145755628|NCT03178487|525618223|FG001|Period 1|Other|1|||
145755629|NCT03178487|525618222|FG000|Period 2|Adverse Event|4|||
145755630|NCT03178487|525618223|FG001|Period 2|Adverse Event|4|||
145755631|NCT03178487|525618222|FG000|Period 2|Withdrawal by Subject|6|||
145755632|NCT03178487|525618223|FG001|Period 2|Withdrawal by Subject|6|||
145755633|NCT03178487|525618222|FG000|Period 2|Lost to Follow-up|2|||
145755634|NCT03178487|525618223|FG001|Period 2|Lost to Follow-up|2|||
145755635|NCT03178487|525618222|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
145755636|NCT03178487|525618223|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
145755637|NCT03178487|525618222|FG000|Period 2|Other|8|||
145755638|NCT03178487|525618223|FG001|Period 2|Other|7|||
145755639|NCT04161495|525618224|FG000|Overall Study|Withdrawal by Subject|3|||
145755640|NCT04161495|525618225|FG001|Overall Study|Withdrawal by Subject|0|||
145755641|NCT04161495|525618224|FG000|Overall Study|Protocol Violation|1|||
145755642|NCT04161495|525618225|FG001|Overall Study|Protocol Violation|0|||
145755643|NCT04161495|525618224|FG000|Overall Study|Prohibited concomitant medication|3|||
145755644|NCT04161495|525618225|FG001|Overall Study|Prohibited concomitant medication|0|||
145755645|NCT04161495|525618224|FG000|Overall Study|Adverse Event|1|||
145755646|NCT04161495|525618225|FG001|Overall Study|Adverse Event|0|||
145755647|NCT04161495|525618224|FG000|Overall Study|Other - Unspecified|1|||
145755648|NCT04161495|525618225|FG001|Overall Study|Other - Unspecified|0|||
145755649|NCT04161495|525618224|FG000|Overall Study|Death|0|||
145755650|NCT04161495|525618225|FG001|Overall Study|Death|1|||
145755651|NCT03655756|525618226|FG000|Overall Study|Death|1|||
145755652|NCT01340209|525618227|FG000|Overall Study|Adverse Event|1|||
145755653|NCT01340209|525618228|FG001|Overall Study|Adverse Event|1|||
145755654|NCT01340209|525618229|FG002|Overall Study|Adverse Event|2|||
145755655|NCT01340209|525618227|FG000|Overall Study|Protocol Violation|1|||
145755656|NCT01340209|525618228|FG001|Overall Study|Protocol Violation|2|||
145755657|NCT01340209|525618229|FG002|Overall Study|Protocol Violation|1|||
145755658|NCT01340209|525618227|FG000|Overall Study|Withdrawal by Subject|0|||
145755659|NCT01340209|525618228|FG001|Overall Study|Withdrawal by Subject|0|||
145755660|NCT01340209|525618229|FG002|Overall Study|Withdrawal by Subject|1|||
145755661|NCT01340209|525618227|FG000|Overall Study|Other reason not defined above|3|||
145755662|NCT01340209|525618228|FG001|Overall Study|Other reason not defined above|5|||
145755663|NCT01340209|525618229|FG002|Overall Study|Other reason not defined above|4|||
145755664|NCT00253630|525618230|FG000|Overall Study|ineligible|2|||
145755665|NCT00704964|525618232|FG000|Overall Study|Not completed on time|328|||
145755666|NCT02161562|525618233|FG000|Overall Study|Withdrawal by Subject|5|||
145755667|NCT02161562|525618234|FG001|Overall Study|Withdrawal by Subject|8|||
145755668|NCT02161562|525618233|FG000|Overall Study|Protocol Violation|9|||
145755669|NCT02161562|525618234|FG001|Overall Study|Protocol Violation|4|||
145755670|NCT02161562|525618233|FG000|Overall Study|Pregnancy|1|||
145755671|NCT02161562|525618234|FG001|Overall Study|Pregnancy|2|||
145755672|NCT02161562|525618233|FG000|Overall Study|Lost to Follow-up|3|||
145755673|NCT02161562|525618234|FG001|Overall Study|Lost to Follow-up|1|||
145755674|NCT02161562|525618233|FG000|Overall Study|Lack of Efficacy|4|||
145755675|NCT02161562|525618234|FG001|Overall Study|Lack of Efficacy|1|||
145755676|NCT02161562|525618233|FG000|Overall Study|Adverse Event|1|||
145755677|NCT02161562|525618234|FG001|Overall Study|Adverse Event|1|||
145755678|NCT02161562|525618233|FG000|Overall Study|Participant moved back to home country|1|||
145755679|NCT02161562|525618234|FG001|Overall Study|Participant moved back to home country|0|||
145755680|NCT02161562|525618233|FG000|Overall Study|Withdrew due to being out of the country|1|||
145755681|NCT02161562|525618234|FG001|Overall Study|Withdrew due to being out of the country|0|||
145755682|NCT02161562|525618233|FG000|Overall Study|Participant moved out of province|1|||
145755683|NCT02161562|525618234|FG001|Overall Study|Participant moved out of province|0|||
145755684|NCT01699087|525618248|FG000|Overall Study|Lost to Follow-up|7|||
145755685|NCT01699087|525618248|FG000|Overall Study|Screen failure (prior to treatment)|15|||
145755686|NCT01699087|525618248|FG000|Overall Study|Unable to make future visits|2|||
145755687|NCT00094757|525618249|FG000|Overall Study|Adverse Event|11|||
145755688|NCT00094757|525618250|FG001|Overall Study|Adverse Event|9|||
145755689|NCT00094757|525618251|FG002|Overall Study|Adverse Event|6|||
145755690|NCT00094757|525618249|FG000|Overall Study|Lack of Efficacy|11|||
145755691|NCT00094757|525618250|FG001|Overall Study|Lack of Efficacy|15|||
145755692|NCT00094757|525618251|FG002|Overall Study|Lack of Efficacy|8|||
145755693|NCT00094757|525618249|FG000|Overall Study|Lost to Follow-up|3|||
145755694|NCT00094757|525618250|FG001|Overall Study|Lost to Follow-up|5|||
145531628|NCT02651467|524808338|FG000|Overall Study|Other (Not specified)|1|||
145531629|NCT02651467|524808339|FG001|Overall Study|Other (Not specified)|0|||
145531630|NCT02651467|524808340|FG002|Overall Study|Other (Not specified)|2|||
145531631|NCT00408629|524808341|FG000|Overall Study|Adverse Event|13|||
145531632|NCT00408629|524808342|FG001|Overall Study|Adverse Event|27|||
145531633|NCT00408629|524808341|FG000|Overall Study|Withdrawal by Subject|8|||
145531634|NCT00408629|524808342|FG001|Overall Study|Withdrawal by Subject|4|||
145531635|NCT00408629|524808341|FG000|Overall Study|Lost to Follow-up|1|||
145531636|NCT00408629|524808342|FG001|Overall Study|Lost to Follow-up|1|||
145531637|NCT00408629|524808341|FG000|Overall Study|Lack of Efficacy|63|||
145531638|NCT00408629|524808342|FG001|Overall Study|Lack of Efficacy|73|||
145531639|NCT00408629|524808341|FG000|Overall Study|Protocol Violation|1|||
145531640|NCT00408629|524808342|FG001|Overall Study|Protocol Violation|5|||
145531641|NCT00408629|524808341|FG000|Overall Study|Miscellaneous|11|||
145531642|NCT00408629|524808342|FG001|Overall Study|Miscellaneous|15|||
145531643|NCT00573937|524808343|FG000|Overall Study|Study Terminated|0|||
145531644|NCT00573937|524808344|FG001|Overall Study|Study Terminated|1|||
145531645|NCT00333801|524808345|FG000|Overall Study|Moved to another state|5|||
145607575|NCT02296190|525079199|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
145607576|NCT02296190|525079200|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
145755695|NCT00094757|525618251|FG002|Overall Study|Lost to Follow-up|6|||
145755696|NCT00094757|525618249|FG000|Overall Study|Patient Moved|2|||
145755697|NCT00094757|525618250|FG001|Overall Study|Patient Moved|1|||
145755698|NCT00094757|525618251|FG002|Overall Study|Patient Moved|1|||
145755699|NCT00094757|525618249|FG000|Overall Study|Protocol Violation|8|||
145755700|NCT00094757|525618250|FG001|Overall Study|Protocol Violation|5|||
145755701|NCT00094757|525618251|FG002|Overall Study|Protocol Violation|3|||
145755702|NCT00094757|525618249|FG000|Overall Study|Withdrawal by Subject|14|||
145755703|NCT00094757|525618250|FG001|Overall Study|Withdrawal by Subject|21|||
145755704|NCT00094757|525618251|FG002|Overall Study|Withdrawal by Subject|5|||
145755705|NCT00094757|525618249|FG000|Overall Study|Other|3|||
145755706|NCT00094757|525618250|FG001|Overall Study|Other|3|||
145755707|NCT00094757|525618251|FG002|Overall Study|Other|1|||
145755708|NCT00094757|525618249|FG000|Overall Study|Protocol specified discontinuation|1|||
145755709|NCT00094757|525618250|FG001|Overall Study|Protocol specified discontinuation|3|||
145755710|NCT00094757|525618251|FG002|Overall Study|Protocol specified discontinuation|0|||
145755711|NCT04317274|525618252|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
145755712|NCT04317274|525618253|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
145755713|NCT04317274|525618254|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
145755714|NCT04317274|525618255|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
145755715|NCT00797823|525618258|FG000|First Period (Initial Randomization)|Physician Decision|1|||
145755716|NCT00797823|525618259|FG001|First Period (Initial Randomization)|Physician Decision|0|||
145755717|NCT00797823|525618260|FG002|First Period (Initial Randomization)|Physician Decision|0|||
145755718|NCT02387580|525618265|FG000|Overall Study|Withdrawal by Subject|0|||
145755719|NCT02387580|525618266|FG001|Overall Study|Withdrawal by Subject|0|||
145607577|NCT02296190|525079201|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
145607578|NCT02296190|525079202|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
145607579|NCT02296190|525079203|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
145607580|NCT02296190|525079204|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
145755720|NCT02387580|525618267|FG002|Overall Study|Withdrawal by Subject|0|||
145755721|NCT02387580|525618268|FG003|Overall Study|Withdrawal by Subject|1|||
145755722|NCT02387580|525618269|FG004|Overall Study|Withdrawal by Subject|0|||
145755723|NCT02387580|525618270|FG005|Overall Study|Withdrawal by Subject|0|||
145531646|NCT00333801|524808346|FG001|Overall Study|Moved to another state|3|||
145531647|NCT00333801|524808345|FG000|Overall Study|Lost to Follow-up|2|||
145531648|NCT00333801|524808346|FG001|Overall Study|Lost to Follow-up|0|||
145531649|NCT00333801|524808345|FG000|Overall Study|Incarcerated|1|||
145531650|NCT00333801|524808346|FG001|Overall Study|Incarcerated|2|||
145607581|NCT02296190|525079199|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
145531651|NCT00333801|524808345|FG000|Overall Study|Withdrawal by Subject|0|||
145531652|NCT00333801|524808346|FG001|Overall Study|Withdrawal by Subject|1|||
145531653|NCT03633617|524808347|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
145531654|NCT03633617|524808348|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
145531655|NCT03633617|524808349|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145755724|NCT02340663|525618271|FG000|Overall Study|Lost to Follow-up|1|||
145755725|NCT02340663|525618272|FG001|Overall Study|Lost to Follow-up|0|||
145755726|NCT02340663|525618271|FG000|Overall Study|Protocol Violation|1|||
145755727|NCT02340663|525618272|FG001|Overall Study|Protocol Violation|0|||
145755728|NCT02340663|525618271|FG000|Overall Study|Withdrawal by Subject|3|||
145755729|NCT02340663|525618272|FG001|Overall Study|Withdrawal by Subject|1|||
145755730|NCT00087646|525618273|FG000|Overall Study|Adverse Event|37|||
145755731|NCT00087646|525618274|FG001|Overall Study|Adverse Event|6|||
145755732|NCT00087646|525618275|FG002|Overall Study|Adverse Event|18|||
145755733|NCT00087646|525618276|FG003|Overall Study|Adverse Event|20|||
145755734|NCT00087646|525618273|FG000|Overall Study|Death|0|||
145755735|NCT00087646|525618274|FG001|Overall Study|Death|1|||
145755736|NCT00087646|525618275|FG002|Overall Study|Death|0|||
145755737|NCT00087646|525618276|FG003|Overall Study|Death|0|||
145755738|NCT00087646|525618273|FG000|Overall Study|Withdrawal by Subject|6|||
145272976|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
145272977|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
145272978|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
145272979|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
145272980|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
145272981|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
145272982|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
145272983|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
145272984|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
145272985|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
145272986|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
145272987|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
145272988|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
145607582|NCT02296190|525079200|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
145755739|NCT00087646|525618274|FG001|Overall Study|Withdrawal by Subject|1|||
145755740|NCT00087646|525618275|FG002|Overall Study|Withdrawal by Subject|2|||
145755741|NCT00087646|525618276|FG003|Overall Study|Withdrawal by Subject|2|||
145755742|NCT00087646|525618273|FG000|Overall Study|Insufficient therapeutic response|64|||
145755743|NCT00087646|525618274|FG001|Overall Study|Insufficient therapeutic response|24|||
145755744|NCT00087646|525618275|FG002|Overall Study|Insufficient therapeutic response|38|||
145755745|NCT00087646|525618276|FG003|Overall Study|Insufficient therapeutic response|51|||
145755746|NCT00087646|525618273|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
145755747|NCT00087646|525618274|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
145755748|NCT00087646|525618275|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
145755749|NCT00087646|525618276|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
145755750|NCT00087646|525618273|FG000|Overall Study|Failure to Return|5|||
145755751|NCT00087646|525618274|FG001|Overall Study|Failure to Return|2|||
145755752|NCT00087646|525618275|FG002|Overall Study|Failure to Return|2|||
145755753|NCT00087646|525618276|FG003|Overall Study|Failure to Return|3|||
145755754|NCT00087646|525618273|FG000|Overall Study|Administrative/Other|6|||
145755755|NCT00087646|525618274|FG001|Overall Study|Administrative/Other|1|||
145755756|NCT00087646|525618275|FG002|Overall Study|Administrative/Other|1|||
145755757|NCT00087646|525618276|FG003|Overall Study|Administrative/Other|2|||
145755758|NCT00087646|525618273|FG000|Overall Study|Other Protocol Violation|3|||
145755759|NCT00087646|525618274|FG001|Overall Study|Other Protocol Violation|1|||
145755760|NCT00087646|525618275|FG002|Overall Study|Other Protocol Violation|0|||
145755761|NCT00087646|525618276|FG003|Overall Study|Other Protocol Violation|0|||
145755762|NCT00087646|525618273|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
145755763|NCT00087646|525618274|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
145272989|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
145272990|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
145607583|NCT02296190|525079201|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
145755764|NCT00087646|525618275|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
145755765|NCT00087646|525618276|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
145755766|NCT00357500|525618279|FG000|Overall Study|Adverse Event|3|||
145755767|NCT00357500|525618279|FG000|Overall Study|Withdrawal by Subject|5|||
145755768|NCT00357500|525618279|FG000|Overall Study|Progressive Disease|65|||
145755769|NCT00357500|525618279|FG000|Overall Study|Not Started Protocol Therapy|4|||
145531656|NCT03633617|524808350|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145531657|NCT03633617|524808351|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145755770|NCT02286947|525618280|FG000|Overall Study|Withdrawal by Subject|2|||
145755771|NCT01614093|525618287|FG000|Overall Study|Withdrawal by Subject|1|||
145755772|NCT00848354|525618288|FG000|Phase 1|Adverse Event|5|||
145755773|NCT00848354|525618289|FG001|Phase 1|Adverse Event|4|||
145755774|NCT00848354|525618288|FG000|Phase 1|Discontinuation of study by sponsor|2|||
145755775|NCT00848354|525618289|FG001|Phase 1|Discontinuation of study by sponsor|1|||
145755776|NCT00848354|525618288|FG000|Phase 1|Failed to return|0|||
145755777|NCT00848354|525618289|FG001|Phase 1|Failed to return|1|||
145755778|NCT00848354|525618288|FG000|Phase 1|Lost to Follow-up|1|||
145755779|NCT00848354|525618289|FG001|Phase 1|Lost to Follow-up|1|||
145755780|NCT00848354|525618288|FG000|Phase 1|Unspecified Reason|1|||
145402798|NCT00853385|524332499|FG003|Overall Study|Lost to Follow-up|0|||
145531658|NCT03633617|524808352|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145531659|NCT03633617|524808353|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145755781|NCT00848354|525618289|FG001|Phase 1|Unspecified Reason|1|||
145755782|NCT00848354|525618288|FG000|Phase 1|Protocol Violation|1|||
145755783|NCT00848354|525618289|FG001|Phase 1|Protocol Violation|1|||
145755784|NCT00848354|525618288|FG000|Phase 1|Withdrawal by Subject|2|||
145755785|NCT00848354|525618289|FG001|Phase 1|Withdrawal by Subject|4|||
145755786|NCT00848354|525618288|FG000|Phase 1|Lack of Efficacy|0|||
145755787|NCT00848354|525618289|FG001|Phase 1|Lack of Efficacy|1|||
145755788|NCT00848354|525618288|FG000|Phase 2 Year 1|Adverse Event|7|||
145755789|NCT00848354|525618289|FG001|Phase 2 Year 1|Adverse Event|2|||
145755790|NCT00848354|525618288|FG000|Phase 2 Year 1|Death|1|||
145755791|NCT00848354|525618289|FG001|Phase 2 Year 1|Death|0|||
145755792|NCT00848354|525618288|FG000|Phase 2 Year 1|Failed to Return|1|||
145755793|NCT00848354|525618289|FG001|Phase 2 Year 1|Failed to Return|1|||
145755794|NCT00848354|525618288|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
145755795|NCT00848354|525618289|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
145755796|NCT00848354|525618288|FG000|Phase 2 Year 1|Unspecified Reason|3|||
145755797|NCT00848354|525618289|FG001|Phase 2 Year 1|Unspecified Reason|0|||
145755798|NCT00848354|525618288|FG000|Phase 2 Year 1|Protocol Violation|4|||
145755799|NCT00848354|525618289|FG001|Phase 2 Year 1|Protocol Violation|1|||
145755800|NCT00848354|525618288|FG000|Phase 2 Year 1|Subject Request|1|||
145755801|NCT00848354|525618289|FG001|Phase 2 Year 1|Subject Request|2|||
145755802|NCT00848354|525618288|FG000|Phase 2 Year 2|Adverse Event|12|||
145755803|NCT00848354|525618289|FG001|Phase 2 Year 2|Adverse Event|2|||
145755804|NCT00848354|525618288|FG000|Phase 2 Year 2|Death|2|||
145755805|NCT00848354|525618289|FG001|Phase 2 Year 2|Death|0|||
145755806|NCT00848354|525618288|FG000|Phase 2 Year 2|Failed to return|3|||
145755807|NCT00848354|525618289|FG001|Phase 2 Year 2|Failed to return|0|||
145755808|NCT00848354|525618288|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
145755809|NCT00848354|525618289|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
145755810|NCT00848354|525618288|FG000|Phase 2 Year 2|Unspecified Reason|1|||
145531660|NCT03633617|524808354|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145531661|NCT03633617|524808355|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145531662|NCT03633617|524808356|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145755811|NCT00848354|525618289|FG001|Phase 2 Year 2|Unspecified Reason|0|||
145531663|NCT03633617|524808357|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
145531664|NCT03633617|524808347|FG000|Part A|Unconfirmed early termination visit|1|||
145531665|NCT03633617|524808348|FG001|Part A|Unconfirmed early termination visit|0|||
145531666|NCT03633617|524808349|FG002|Part A|Unconfirmed early termination visit|0|||
145531667|NCT03633617|524808350|FG003|Part A|Unconfirmed early termination visit|0|||
145531668|NCT03633617|524808351|FG004|Part A|Unconfirmed early termination visit|0|||
145531669|NCT03633617|524808352|FG005|Part A|Unconfirmed early termination visit|0|||
145531670|NCT03633617|524808353|FG006|Part A|Unconfirmed early termination visit|0|||
145531671|NCT03633617|524808354|FG007|Part A|Unconfirmed early termination visit|0|||
145531672|NCT03633617|524808355|FG008|Part A|Unconfirmed early termination visit|0|||
145531673|NCT03633617|524808356|FG009|Part A|Unconfirmed early termination visit|0|||
145531674|NCT03633617|524808357|FG010|Part A|Unconfirmed early termination visit|0|||
145531675|NCT03633617|524808347|FG000|Part A|Adverse Event|0|||
145755812|NCT00848354|525618288|FG000|Phase 2 Year 2|Protocol Violation|1|||
145755813|NCT00848354|525618289|FG001|Phase 2 Year 2|Protocol Violation|1|||
145755814|NCT00848354|525618288|FG000|Phase 2 Year 2|Subject Request|1|||
145755815|NCT00848354|525618289|FG001|Phase 2 Year 2|Subject Request|1|||
145755816|NCT00848354|525618288|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
145755817|NCT00848354|525618289|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
145755818|NCT00915343|525618292|FG000|Part B - Open Label Period|Treatment switch|0|||
145755819|NCT00915343|525618293|FG001|Part B - Open Label Period|Treatment switch|0|||
145402799|NCT00853385|524332500|FG004|Overall Study|Lost to Follow-up|0|||
145531676|NCT03633617|524808348|FG001|Part A|Adverse Event|1|||
145531677|NCT03633617|524808349|FG002|Part A|Adverse Event|0|||
145531678|NCT03633617|524808350|FG003|Part A|Adverse Event|0|||
145531679|NCT03633617|524808351|FG004|Part A|Adverse Event|0|||
145531680|NCT03633617|524808352|FG005|Part A|Adverse Event|0|||
145531681|NCT03633617|524808353|FG006|Part A|Adverse Event|0|||
145531682|NCT03633617|524808354|FG007|Part A|Adverse Event|0|||
145531683|NCT03633617|524808355|FG008|Part A|Adverse Event|0|||
145531684|NCT03633617|524808356|FG009|Part A|Adverse Event|0|||
145531685|NCT03633617|524808357|FG010|Part A|Adverse Event|0|||
145755820|NCT00915343|525618294|FG002|Part B - Open Label Period|Treatment switch|1|||
145755821|NCT00915343|525618292|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
145531686|NCT03633617|524808347|FG000|Part A|Pregnancy|1|||
145531687|NCT03633617|524808348|FG001|Part A|Pregnancy|0|||
145531688|NCT03633617|524808349|FG002|Part A|Pregnancy|0|||
145531689|NCT03633617|524808350|FG003|Part A|Pregnancy|0|||
145531690|NCT03633617|524808351|FG004|Part A|Pregnancy|0|||
145531691|NCT03633617|524808352|FG005|Part A|Pregnancy|0|||
145531692|NCT03633617|524808353|FG006|Part A|Pregnancy|0|||
145531693|NCT03633617|524808354|FG007|Part A|Pregnancy|0|||
145531694|NCT03633617|524808355|FG008|Part A|Pregnancy|0|||
145531695|NCT03633617|524808356|FG009|Part A|Pregnancy|0|||
145531696|NCT03633617|524808357|FG010|Part A|Pregnancy|0|||
145531697|NCT03633617|524808347|FG000|Part A|Withdrawal by Subject|0|||
145531698|NCT03633617|524808348|FG001|Part A|Withdrawal by Subject|1|||
145531699|NCT03633617|524808349|FG002|Part A|Withdrawal by Subject|0|||
145531700|NCT03633617|524808350|FG003|Part A|Withdrawal by Subject|0|||
145531701|NCT03633617|524808351|FG004|Part A|Withdrawal by Subject|0|||
145531702|NCT03633617|524808352|FG005|Part A|Withdrawal by Subject|0|||
145531703|NCT03633617|524808353|FG006|Part A|Withdrawal by Subject|0|||
145531704|NCT03633617|524808354|FG007|Part A|Withdrawal by Subject|0|||
145531705|NCT03633617|524808355|FG008|Part A|Withdrawal by Subject|0|||
145531706|NCT03633617|524808356|FG009|Part A|Withdrawal by Subject|0|||
145531707|NCT03633617|524808357|FG010|Part A|Withdrawal by Subject|0|||
145531708|NCT03633617|524808347|FG000|Part B|Adverse Event|0|||
145531709|NCT03633617|524808348|FG001|Part B|Adverse Event|0|||
145531710|NCT03633617|524808349|FG002|Part B|Adverse Event|2|||
145531711|NCT03633617|524808350|FG003|Part B|Adverse Event|2|||
145531712|NCT03633617|524808351|FG004|Part B|Adverse Event|1|||
145531713|NCT03633617|524808352|FG005|Part B|Adverse Event|0|||
145531714|NCT03633617|524808353|FG006|Part B|Adverse Event|0|||
145531715|NCT03633617|524808354|FG007|Part B|Adverse Event|0|||
145531716|NCT03633617|524808355|FG008|Part B|Adverse Event|0|||
145272991|NCT03611751|523848266|FG000|Treatment Week 0 - Week 16|Death|0|||
145272992|NCT03611751|523848267|FG001|Treatment Week 0 - Week 16|Death|0|||
145272993|NCT03611751|523848268|FG002|Treatment Week 0 - Week 16|Death|1|||
145272994|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
145272995|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
145272996|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
145272997|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
145272998|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
145272999|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
145273000|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
145273001|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
145273002|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
145273003|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
145273004|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
145273005|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
145273006|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
145273007|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
145273008|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
145273009|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
145273010|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
145273011|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
145273012|NCT03611751|523848266|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
145273013|NCT03611751|523848267|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
145273014|NCT03611751|523848268|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
145273015|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
145273016|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
145273017|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
145531717|NCT03633617|524808356|FG009|Part B|Adverse Event|0|||
145531718|NCT03633617|524808357|FG010|Part B|Adverse Event|0|||
145531719|NCT03633617|524808347|FG000|Part B|Withdrawal by Subject|0|||
145531720|NCT03633617|524808348|FG001|Part B|Withdrawal by Subject|0|||
145531721|NCT03633617|524808349|FG002|Part B|Withdrawal by Subject|1|||
145531722|NCT03633617|524808350|FG003|Part B|Withdrawal by Subject|0|||
145531723|NCT03633617|524808351|FG004|Part B|Withdrawal by Subject|2|||
145531724|NCT03633617|524808352|FG005|Part B|Withdrawal by Subject|0|||
145531725|NCT03633617|524808353|FG006|Part B|Withdrawal by Subject|0|||
145531726|NCT03633617|524808354|FG007|Part B|Withdrawal by Subject|0|||
145531727|NCT03633617|524808355|FG008|Part B|Withdrawal by Subject|0|||
145273018|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
145531728|NCT03633617|524808356|FG009|Part B|Withdrawal by Subject|0|||
145531729|NCT03633617|524808357|FG010|Part B|Withdrawal by Subject|0|||
145531730|NCT03633617|524808347|FG000|Part B|Lost to Follow-up|0|||
145531731|NCT03633617|524808348|FG001|Part B|Lost to Follow-up|0|||
145531732|NCT03633617|524808349|FG002|Part B|Lost to Follow-up|0|||
145531733|NCT03633617|524808350|FG003|Part B|Lost to Follow-up|0|||
145531734|NCT03633617|524808351|FG004|Part B|Lost to Follow-up|1|||
145531735|NCT03633617|524808352|FG005|Part B|Lost to Follow-up|0|||
145531736|NCT03633617|524808353|FG006|Part B|Lost to Follow-up|0|||
145531737|NCT03633617|524808354|FG007|Part B|Lost to Follow-up|0|||
145531738|NCT03633617|524808355|FG008|Part B|Lost to Follow-up|0|||
145755822|NCT00915343|525618293|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
145755823|NCT00915343|525618294|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
145755824|NCT03434977|525618298|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
145755825|NCT03434977|525618299|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
145755826|NCT03920670|525618300|FG000|Overall Study|Protocol Violation|2|||
145755827|NCT03920670|525618301|FG001|Overall Study|Protocol Violation|2|||
145755828|NCT03920670|525618300|FG000|Overall Study|Adverse Event|1|||
145755829|NCT03920670|525618301|FG001|Overall Study|Adverse Event|0|||
145755830|NCT03687502|525618307|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
145755831|NCT03687502|525618307|FG000|Overall Study|Lumason not available|1|||
145531739|NCT03633617|524808356|FG009|Part B|Lost to Follow-up|0|||
145531740|NCT03633617|524808357|FG010|Part B|Lost to Follow-up|0|||
145531741|NCT03633617|524808347|FG000|Part B|Physician Decision|0|||
145531742|NCT03633617|524808348|FG001|Part B|Physician Decision|0|||
145531743|NCT03633617|524808349|FG002|Part B|Physician Decision|0|||
145755832|NCT01724528|525618311|FG000|Overall Study|Death|3|||
145755833|NCT01724528|525618312|FG001|Overall Study|Death|0|||
145531744|NCT03633617|524808350|FG003|Part B|Physician Decision|0|||
145755834|NCT01724528|525618311|FG000|Overall Study|Withdrawal by Subject|0|||
145755835|NCT01724528|525618312|FG001|Overall Study|Withdrawal by Subject|2|||
145755836|NCT01724528|525618311|FG000|Overall Study|Protocol Violation|0|||
145755837|NCT01724528|525618312|FG001|Overall Study|Protocol Violation|1|||
145755838|NCT01724528|525618311|FG000|Overall Study|Patient refused to attend last visit|1|||
145755839|NCT01724528|525618312|FG001|Overall Study|Patient refused to attend last visit|0|||
145755840|NCT05574062|525618316|FG000|Pre Run-In|Screening failure|3|||
145755841|NCT05574062|525618317|FG001|Pre Run-In|Screening failure|0|||
145755842|NCT05574062|525618318|FG002|Pre Run-In|Screening failure|0|||
145755843|NCT05574062|525618319|FG003|Pre Run-In|Screening failure|0|||
145755844|NCT05574062|525618320|FG004|Pre Run-In|Screening failure|0|||
145755845|NCT05574062|525618316|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
145755846|NCT05574062|525618317|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
145755847|NCT05574062|525618318|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
145755848|NCT05574062|525618319|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
145755849|NCT05574062|525618320|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
145755850|NCT05574062|525618316|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
145755851|NCT05574062|525618317|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
145755852|NCT05574062|525618318|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
145755853|NCT05574062|525618319|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
145755854|NCT05574062|525618320|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
145755855|NCT05574062|525618316|FG000|Continuation Phase Period 1|Physician Decision|1|||
145755856|NCT05574062|525618317|FG001|Continuation Phase Period 1|Physician Decision|0|||
145755857|NCT05574062|525618318|FG002|Continuation Phase Period 1|Physician Decision|0|||
145755858|NCT05574062|525618319|FG003|Continuation Phase Period 1|Physician Decision|0|||
145755859|NCT05574062|525618320|FG004|Continuation Phase Period 1|Physician Decision|0|||
145755860|NCT05574062|525618316|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
145755861|NCT05574062|525618317|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
145755862|NCT05574062|525618318|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
145755863|NCT05574062|525618319|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
145755864|NCT05574062|525618320|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
145755865|NCT05574062|525618316|FG000|Continuation Phase Period 1|Adverse Event|1|||
145755866|NCT05574062|525618317|FG001|Continuation Phase Period 1|Adverse Event|0|||
145755867|NCT05574062|525618318|FG002|Continuation Phase Period 1|Adverse Event|0|||
145755868|NCT05574062|525618319|FG003|Continuation Phase Period 1|Adverse Event|0|||
145755869|NCT05574062|525618320|FG004|Continuation Phase Period 1|Adverse Event|0|||
145755870|NCT05574062|525618316|FG000|Continuation Phase Period 1|Death|1|||
145755871|NCT05574062|525618317|FG001|Continuation Phase Period 1|Death|0|||
145755872|NCT05574062|525618318|FG002|Continuation Phase Period 1|Death|0|||
145755873|NCT05574062|525618319|FG003|Continuation Phase Period 1|Death|0|||
145755874|NCT05574062|525618320|FG004|Continuation Phase Period 1|Death|0|||
145755875|NCT05574062|525618316|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
145755876|NCT05574062|525618317|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
145755877|NCT05574062|525618318|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
145755878|NCT05574062|525618319|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
145755879|NCT05574062|525618320|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
145755880|NCT04820309|525618323|FG000|Overall Study|Adverse Event|96|||
145755881|NCT04820309|525618323|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
145755882|NCT04820309|525618323|FG000|Overall Study|Consent Withdrawn|93|||
145755883|NCT04820309|525618323|FG000|Overall Study|failure to adhere to protocol|32|||
145755884|NCT04820309|525618323|FG000|Overall Study|alcohol or drug use|6|||
145755885|NCT04820309|525618323|FG000|Overall Study|Lost to Follow-up|46|||
145755886|NCT04820309|525618323|FG000|Overall Study|Death|2|||
145755887|NCT04820309|525618323|FG000|Overall Study|Pregnancy|1|||
145755888|NCT04820309|525618323|FG000|Overall Study|Other reasons|12|||
145755889|NCT04811716|525618326|FG000|Overall Study|Withdrawal by Subject|2|||
145755890|NCT04811716|525618327|FG001|Overall Study|Withdrawal by Subject|0|||
145755891|NCT04202679|525618328|FG000|Overall Study|Adverse Event|2|||
145755892|NCT04202679|525618329|FG001|Overall Study|Adverse Event|0|||
145755893|NCT04202679|525618328|FG000|Overall Study|Poor compliance to protocol|1|||
145755894|NCT04202679|525618329|FG001|Overall Study|Poor compliance to protocol|0|||
145755895|NCT04202679|525618328|FG000|Overall Study|Withdrawal by Subject|23|||
145755896|NCT04202679|525618329|FG001|Overall Study|Withdrawal by Subject|6|||
145755897|NCT05902364|525618330|FG000|Overall Study|Adverse Event|1|||
145755898|NCT05902364|525618331|FG001|Overall Study|Adverse Event|0|||
145755899|NCT02270242|525618332|FG000|Overall Study|Withdrawal by Subject|18|||
145755900|NCT02270242|525618333|FG001|Overall Study|Withdrawal by Subject|25|||
145755901|NCT02270242|525618332|FG000|Overall Study|Lost to Follow-up|41|||
145755902|NCT02270242|525618333|FG001|Overall Study|Lost to Follow-up|27|||
145755903|NCT02270242|525618332|FG000|Overall Study|Physician Decision|0|||
145755904|NCT02270242|525618333|FG001|Overall Study|Physician Decision|1|||
145755905|NCT03864653|525618334|FG000|Overall Study|Withdrawal by Subject|1|||
145755906|NCT03048422|525618335|FG000|Overall Study|Death|1|||
145755907|NCT03048422|525618336|FG001|Overall Study|Death|0|||
145755908|NCT03048422|525618337|FG002|Overall Study|Death|0|||
145755909|NCT03048422|525618335|FG000|Overall Study|Lost to Follow-up|5|||
145755910|NCT03048422|525618336|FG001|Overall Study|Lost to Follow-up|0|||
145755911|NCT03048422|525618337|FG002|Overall Study|Lost to Follow-up|1|||
145755912|NCT03048422|525618335|FG000|Overall Study|Withdrawal by Subject|5|||
145755913|NCT03048422|525618336|FG001|Overall Study|Withdrawal by Subject|7|||
145755914|NCT03048422|525618337|FG002|Overall Study|Withdrawal by Subject|4|||
145755915|NCT03048422|525618335|FG000|Overall Study|Moved|3|||
145755916|NCT03048422|525618336|FG001|Overall Study|Moved|2|||
145755917|NCT03048422|525618337|FG002|Overall Study|Moved|2|||
145755918|NCT03048422|525618335|FG000|Overall Study|Noncompliant with Study Requirements|2|||
145755919|NCT03048422|525618336|FG001|Overall Study|Noncompliant with Study Requirements|1|||
145755920|NCT03048422|525618337|FG002|Overall Study|Noncompliant with Study Requirements|2|||
145755921|NCT03048422|525618335|FG000|Overall Study|Not Able to Get to Clinic|1|||
145755922|NCT03048422|525618336|FG001|Overall Study|Not Able to Get to Clinic|0|||
145755923|NCT03048422|525618337|FG002|Overall Study|Not Able to Get to Clinic|0|||
145755924|NCT02482129|525618338|FG000|Overall Study|Adverse Event-prior to treatment|0|||
145755925|NCT02482129|525618339|FG001|Overall Study|Adverse Event-prior to treatment|1|||
145755926|NCT02482129|525618338|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
145755927|NCT02482129|525618339|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
145755928|NCT02482129|525618338|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
145755929|NCT02482129|525618339|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
145531745|NCT03633617|524808351|FG004|Part B|Physician Decision|1|||
145755930|NCT02482129|525618338|FG000|Overall Study|Criteria not met-prior to treatment|1|||
145755931|NCT02482129|525618339|FG001|Overall Study|Criteria not met-prior to treatment|0|||
145755932|NCT02482129|525618338|FG000|Overall Study|Adverse Event|1|||
145755933|NCT02482129|525618339|FG001|Overall Study|Adverse Event|0|||
145755934|NCT02482129|525618338|FG000|Overall Study|Withdrawal by Subject|2|||
145755935|NCT02482129|525618339|FG001|Overall Study|Withdrawal by Subject|0|||
145755936|NCT02482129|525618338|FG000|Overall Study|Criteria not met|1|||
145755937|NCT02482129|525618339|FG001|Overall Study|Criteria not met|0|||
145755938|NCT00429585|525618342|FG000|Overall Study|Death|1|||
145755939|NCT00429585|525618343|FG001|Overall Study|Death|0|||
145755940|NCT00429585|525618342|FG000|Overall Study|Lost to Follow-up|27|||
145755941|NCT00429585|525618343|FG001|Overall Study|Lost to Follow-up|20|||
145755942|NCT00429585|525618342|FG000|Overall Study|Physician Decision|2|||
145531746|NCT03633617|524808352|FG005|Part B|Physician Decision|0|||
145531747|NCT03633617|524808353|FG006|Part B|Physician Decision|0|||
145531748|NCT03633617|524808354|FG007|Part B|Physician Decision|0|||
145531749|NCT03633617|524808355|FG008|Part B|Physician Decision|0|||
145755943|NCT00429585|525618343|FG001|Overall Study|Physician Decision|0|||
145755944|NCT01299766|525619795|FG000|Overall Study|Death|5|||
145531750|NCT03633617|524808356|FG009|Part B|Physician Decision|0|||
145531751|NCT03633617|524808357|FG010|Part B|Physician Decision|0|||
145755945|NCT01299766|525619796|FG001|Overall Study|Death|4|||
145755946|NCT01299766|525619795|FG000|Overall Study|Withdrawal by Subject|29|||
145755947|NCT01299766|525619796|FG001|Overall Study|Withdrawal by Subject|19|||
145531752|NCT03633617|524808347|FG000|Part B|COVID-19 Restrictions|0|||
145531753|NCT03633617|524808348|FG001|Part B|COVID-19 Restrictions|0|||
145755948|NCT03160560|525619799|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
145755949|NCT03160560|525619800|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145755950|NCT03160560|525619801|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145755951|NCT03160560|525619802|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
145755952|NCT03160560|525619799|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
145755953|NCT03160560|525619800|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
145755954|NCT03160560|525619801|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
145755955|NCT03160560|525619802|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
145755956|NCT01354028|525619813|FG000|Overall Study|Physician Decision|0|||
145755957|NCT01354028|525619814|FG001|Overall Study|Physician Decision|2|||
145755958|NCT01354028|525619813|FG000|Overall Study|Discharged before study start|2|||
145755959|NCT01354028|525619814|FG001|Overall Study|Discharged before study start|2|||
145755960|NCT01354028|525619813|FG000|Overall Study|No quiet alert state|0|||
145755961|NCT01354028|525619814|FG001|Overall Study|No quiet alert state|1|||
145755962|NCT01777763|525619815|FG000|Overall Study|Adverse Event|2|||
145755963|NCT01777763|525619816|FG001|Overall Study|Adverse Event|32|||
145755964|NCT01777763|525619815|FG000|Overall Study|Protocol Violation|1|||
145755965|NCT01777763|525619816|FG001|Overall Study|Protocol Violation|7|||
145755966|NCT01777763|525619815|FG000|Overall Study|Withdrawal by Subject|0|||
145755967|NCT01777763|525619816|FG001|Overall Study|Withdrawal by Subject|2|||
145755968|NCT01777763|525619815|FG000|Overall Study|Treatment Failure|1|||
145755969|NCT01777763|525619816|FG001|Overall Study|Treatment Failure|6|||
145755970|NCT00935883|525619819|FG000|Treatment Period|Physician Decision|1|||
145755971|NCT00935883|525619820|FG001|Treatment Period|Physician Decision|0|||
145755972|NCT00935883|525619819|FG000|Treatment Period|Withdrawal by Subject|0|||
145755973|NCT00935883|525619820|FG001|Treatment Period|Withdrawal by Subject|2|||
145755974|NCT00975156|525619821|FG000|Overall Study|Protocol Violation|0|||
145755975|NCT00975156|525619822|FG001|Overall Study|Protocol Violation|1|||
145755976|NCT02971202|525619825|FG000|Overall Study|Pregnancy|1|||
145755977|NCT02971202|525619826|FG001|Overall Study|Pregnancy|0|||
145755978|NCT02971202|525619827|FG002|Overall Study|Pregnancy|0|||
145755979|NCT02971202|525619825|FG000|Overall Study|screen fail after consent|1|||
145755980|NCT02971202|525619826|FG001|Overall Study|screen fail after consent|0|||
145755981|NCT02971202|525619827|FG002|Overall Study|screen fail after consent|1|||
145755982|NCT03472560|525619828|FG000|Overall Study|Subject transfer to continuation protocol|0|||
145755983|NCT03472560|525619829|FG001|Overall Study|Subject transfer to continuation protocol|1|||
145755984|NCT03472560|525619828|FG000|Overall Study|Withdrawal by Subject|4|||
145755985|NCT03472560|525619829|FG001|Overall Study|Withdrawal by Subject|0|||
145755986|NCT03472560|525619828|FG000|Overall Study|Progressive disease|24|||
145755987|NCT03472560|525619829|FG001|Overall Study|Progressive disease|8|||
145755988|NCT03472560|525619828|FG000|Overall Study|Physician Decision|1|||
145755989|NCT03472560|525619829|FG001|Overall Study|Physician Decision|0|||
145755990|NCT03472560|525619828|FG000|Overall Study|Death|7|||
145755991|NCT03472560|525619829|FG001|Overall Study|Death|4|||
145755992|NCT03472560|525619828|FG000|Overall Study|Adverse Event|5|||
145755993|NCT03472560|525619829|FG001|Overall Study|Adverse Event|3|||
145755994|NCT03472560|525619828|FG000|Overall Study|Global deterioration of health status|0|||
145755995|NCT03472560|525619829|FG001|Overall Study|Global deterioration of health status|4|||
145755996|NCT01946178|525619830|FG000|Overall Study|Pregnancy|1|||
145755997|NCT01946178|525619830|FG000|Overall Study|Lost to Follow-up|1|||
145755998|NCT02009878|525619832|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
145755999|NCT02009878|525619833|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
145756000|NCT02009878|525619834|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
145756001|NCT02222714|525619835|FG000|Overall Study|Death|0|||
145756002|NCT02222714|525619836|FG001|Overall Study|Death|2|||
145756003|NCT02222714|525619837|FG002|Overall Study|Death|3|||
145273019|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
145273020|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
145273021|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
145273022|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
145273023|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
145273024|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
145273025|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
145273026|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
145273027|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
145273028|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
145273029|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
145756004|NCT02222714|525619838|FG003|Overall Study|Death|4|||
145756005|NCT02222714|525619839|FG004|Overall Study|Death|6|||
145756006|NCT02222714|525619835|FG000|Overall Study|Withdrawal by Subject|0|||
145756007|NCT02222714|525619836|FG001|Overall Study|Withdrawal by Subject|0|||
145756008|NCT02222714|525619837|FG002|Overall Study|Withdrawal by Subject|1|||
145756009|NCT02222714|525619838|FG003|Overall Study|Withdrawal by Subject|0|||
145756010|NCT02222714|525619839|FG004|Overall Study|Withdrawal by Subject|1|||
145756011|NCT04537208|525619842|FG000|Overall Study|Adverse Event|0|||
145273030|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
145531754|NCT03633617|524808349|FG002|Part B|COVID-19 Restrictions|1|||
145531755|NCT03633617|524808350|FG003|Part B|COVID-19 Restrictions|0|||
145531756|NCT03633617|524808351|FG004|Part B|COVID-19 Restrictions|0|||
145756012|NCT04537208|525619843|FG001|Overall Study|Adverse Event|0|||
145756013|NCT04537208|525619844|FG002|Overall Study|Adverse Event|0|||
145756014|NCT04537208|525619845|FG003|Overall Study|Adverse Event|0|||
145756015|NCT04537208|525619846|FG004|Overall Study|Adverse Event|0|||
145756016|NCT04537208|525619847|FG005|Overall Study|Adverse Event|0|||
145756017|NCT04537208|525619848|FG006|Overall Study|Adverse Event|0|||
145756018|NCT04537208|525619849|FG007|Overall Study|Adverse Event|0|||
145756019|NCT04537208|525619850|FG008|Overall Study|Adverse Event|1|||
145756020|NCT04537208|525619851|FG009|Overall Study|Adverse Event|0|||
145756021|NCT04537208|525619852|FG010|Overall Study|Adverse Event|0|||
145756022|NCT04537208|525619842|FG000|Overall Study|Protocol deviation|0|||
145756023|NCT04537208|525619843|FG001|Overall Study|Protocol deviation|0|||
145756024|NCT04537208|525619844|FG002|Overall Study|Protocol deviation|2|||
145756025|NCT04537208|525619845|FG003|Overall Study|Protocol deviation|0|||
145756026|NCT04537208|525619846|FG004|Overall Study|Protocol deviation|0|||
145756027|NCT04537208|525619847|FG005|Overall Study|Protocol deviation|2|||
145756028|NCT04537208|525619848|FG006|Overall Study|Protocol deviation|4|||
145756029|NCT04537208|525619849|FG007|Overall Study|Protocol deviation|0|||
145756030|NCT04537208|525619850|FG008|Overall Study|Protocol deviation|1|||
145756031|NCT04537208|525619851|FG009|Overall Study|Protocol deviation|0|||
145756032|NCT04537208|525619852|FG010|Overall Study|Protocol deviation|2|||
145756033|NCT04537208|525619842|FG000|Overall Study|Withdrawal by Subject|4|||
145756034|NCT04537208|525619843|FG001|Overall Study|Withdrawal by Subject|2|||
145756035|NCT04537208|525619844|FG002|Overall Study|Withdrawal by Subject|1|||
145756036|NCT04537208|525619845|FG003|Overall Study|Withdrawal by Subject|3|||
145756037|NCT04537208|525619846|FG004|Overall Study|Withdrawal by Subject|5|||
145756038|NCT04537208|525619847|FG005|Overall Study|Withdrawal by Subject|1|||
145756039|NCT04537208|525619848|FG006|Overall Study|Withdrawal by Subject|6|||
145531757|NCT03633617|524808352|FG005|Part B|COVID-19 Restrictions|0|||
145756040|NCT04537208|525619849|FG007|Overall Study|Withdrawal by Subject|1|||
145531758|NCT03633617|524808353|FG006|Part B|COVID-19 Restrictions|0|||
145756041|NCT04537208|525619850|FG008|Overall Study|Withdrawal by Subject|7|||
145756042|NCT04537208|525619851|FG009|Overall Study|Withdrawal by Subject|2|||
145756043|NCT04537208|525619852|FG010|Overall Study|Withdrawal by Subject|4|||
145756044|NCT04537208|525619842|FG000|Overall Study|Lost to Follow-up|4|||
145756045|NCT04537208|525619843|FG001|Overall Study|Lost to Follow-up|1|||
145756046|NCT04537208|525619844|FG002|Overall Study|Lost to Follow-up|3|||
145756047|NCT04537208|525619845|FG003|Overall Study|Lost to Follow-up|4|||
145756048|NCT04537208|525619846|FG004|Overall Study|Lost to Follow-up|3|||
145756049|NCT04537208|525619847|FG005|Overall Study|Lost to Follow-up|2|||
145756050|NCT04537208|525619848|FG006|Overall Study|Lost to Follow-up|3|||
145756051|NCT04537208|525619849|FG007|Overall Study|Lost to Follow-up|2|||
145756052|NCT04537208|525619850|FG008|Overall Study|Lost to Follow-up|7|||
145756053|NCT04537208|525619851|FG009|Overall Study|Lost to Follow-up|2|||
145756054|NCT04537208|525619852|FG010|Overall Study|Lost to Follow-up|2|||
145756055|NCT03237065|525619855|FG000|Overall Study|Adverse Event|0|||
145756056|NCT03237065|525619856|FG001|Overall Study|Adverse Event|2|||
145756057|NCT03237065|525619855|FG000|Overall Study|Protocol Violation|0|||
145756058|NCT03237065|525619856|FG001|Overall Study|Protocol Violation|1|||
145756059|NCT03237065|525619855|FG000|Overall Study|Withdrawal by Subject|3|||
145756060|NCT03237065|525619856|FG001|Overall Study|Withdrawal by Subject|0|||
145756061|NCT03237065|525619855|FG000|Overall Study|Lost to Follow-up|1|||
145756062|NCT03237065|525619856|FG001|Overall Study|Lost to Follow-up|0|||
145756063|NCT03237065|525619855|FG000|Overall Study|Unable to obtain venous access|0|||
145756064|NCT03237065|525619856|FG001|Overall Study|Unable to obtain venous access|1|||
145756065|NCT02918019|525619857|FG000|Overall Study|Death|0|||
145756066|NCT02918019|525619858|FG001|Overall Study|Death|0|||
145756067|NCT02918019|525619859|FG002|Overall Study|Death|1|||
145756068|NCT02918019|525619860|FG003|Overall Study|Death|0|||
145756069|NCT02918019|525619857|FG000|Overall Study|Lost to Follow-up|1|||
145756070|NCT02918019|525619858|FG001|Overall Study|Lost to Follow-up|1|||
145756071|NCT02918019|525619859|FG002|Overall Study|Lost to Follow-up|0|||
145756072|NCT02918019|525619860|FG003|Overall Study|Lost to Follow-up|1|||
145756073|NCT02918019|525619857|FG000|Overall Study|Principal investigator request|0|||
145756074|NCT02918019|525619858|FG001|Overall Study|Principal investigator request|0|||
145756075|NCT02918019|525619859|FG002|Overall Study|Principal investigator request|0|||
145756076|NCT02918019|525619860|FG003|Overall Study|Principal investigator request|1|||
145756077|NCT02918019|525619857|FG000|Overall Study|Physician Decision|1|||
145273031|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
145756078|NCT02918019|525619858|FG001|Overall Study|Physician Decision|3|||
145756079|NCT02918019|525619859|FG002|Overall Study|Physician Decision|2|||
145756080|NCT02918019|525619860|FG003|Overall Study|Physician Decision|0|||
145756081|NCT02918019|525619857|FG000|Overall Study|Protocol deviation|1|||
145756082|NCT02918019|525619858|FG001|Overall Study|Protocol deviation|1|||
145756083|NCT02918019|525619859|FG002|Overall Study|Protocol deviation|0|||
145756084|NCT02918019|525619860|FG003|Overall Study|Protocol deviation|2|||
145756085|NCT02918019|525619857|FG000|Overall Study|Withdrawal by Subject|3|||
145756086|NCT02918019|525619858|FG001|Overall Study|Withdrawal by Subject|4|||
145756087|NCT02918019|525619859|FG002|Overall Study|Withdrawal by Subject|6|||
145756088|NCT02918019|525619860|FG003|Overall Study|Withdrawal by Subject|4|||
145756089|NCT02918019|525619857|FG000|Overall Study|Adverse Event|0|||
145756090|NCT02918019|525619858|FG001|Overall Study|Adverse Event|1|||
145756091|NCT02918019|525619859|FG002|Overall Study|Adverse Event|0|||
145756092|NCT02918019|525619860|FG003|Overall Study|Adverse Event|1|||
145756093|NCT02474082|525619861|FG000|Overall Study|Adverse Event|2|||
145756094|NCT02474082|525619862|FG001|Overall Study|Adverse Event|32|||
145756095|NCT02474082|525619861|FG000|Overall Study|Withdrawal of informed consent|1|||
145756096|NCT02474082|525619862|FG001|Overall Study|Withdrawal of informed consent|11|||
145756097|NCT02474082|525619861|FG000|Overall Study|Lost to Follow-up|2|||
145756098|NCT02474082|525619862|FG001|Overall Study|Lost to Follow-up|2|||
145756099|NCT02474082|525619861|FG000|Overall Study|Dose tapering not achieved|0|||
145756100|NCT02474082|525619862|FG001|Overall Study|Dose tapering not achieved|4|||
145756101|NCT02474082|525619861|FG000|Overall Study|Participant/guardian decision|1|||
145756102|NCT02474082|525619862|FG001|Overall Study|Participant/guardian decision|2|||
145756103|NCT02474082|525619861|FG000|Overall Study|Non-compliance with study treatment|0|||
145756104|NCT02474082|525619862|FG001|Overall Study|Non-compliance with study treatment|2|||
145756105|NCT02474082|525619861|FG000|Overall Study|Protocol deviation|0|||
145756106|NCT02474082|525619862|FG001|Overall Study|Protocol deviation|1|||
145756107|NCT00939692|525619869|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
145756108|NCT00939692|525619870|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
145756109|NCT00939692|525619869|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
145756110|NCT00939692|525619870|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
145756111|NCT04849780|525619878|FG000|Period 1|Covid-19 Related|1|||
145756112|NCT04849780|525619879|FG001|Period 1|Covid-19 Related|0|||
145756113|NCT04849780|525619878|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
145756114|NCT04849780|525619879|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
145756115|NCT04849780|525619878|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
145756116|NCT04849780|525619879|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
145756117|NCT01580397|525619880|FG000|Overall Study|Lack of Efficacy|14|||
145756118|NCT01972074|525619887|FG000|Overall Study|Adverse Event|4|||
145756119|NCT01972074|525619888|FG001|Overall Study|Adverse Event|1|||
145756120|NCT01972074|525619889|FG002|Overall Study|Adverse Event|0|||
145756121|NCT01972074|525619887|FG000|Overall Study|Lack of Efficacy|1|||
145756122|NCT01972074|525619888|FG001|Overall Study|Lack of Efficacy|1|||
145756123|NCT01972074|525619889|FG002|Overall Study|Lack of Efficacy|0|||
145756124|NCT01972074|525619887|FG000|Overall Study|Lost to Follow-up|0|||
145756125|NCT01972074|525619888|FG001|Overall Study|Lost to Follow-up|1|||
145756126|NCT01972074|525619889|FG002|Overall Study|Lost to Follow-up|1|||
145756127|NCT01972074|525619887|FG000|Overall Study|Withdrawal by Subject|1|||
145756128|NCT01972074|525619888|FG001|Overall Study|Withdrawal by Subject|1|||
145756129|NCT01972074|525619889|FG002|Overall Study|Withdrawal by Subject|1|||
145756130|NCT01972074|525619887|FG000|Overall Study|Scanner Unavailable|0|||
145756131|NCT01972074|525619888|FG001|Overall Study|Scanner Unavailable|0|||
145756132|NCT01972074|525619889|FG002|Overall Study|Scanner Unavailable|1|||
145756133|NCT02317562|525619890|FG000|Overall Study|Physician Decision|1|||
145756134|NCT02317562|525619890|FG000|Overall Study|early termination of the study|8|||
145756135|NCT02317562|525619890|FG000|Overall Study|Lack of Efficacy|4|||
145756136|NCT02317562|525619890|FG000|Overall Study|Withdrawal by Subject|1|||
145756137|NCT00626093|525619891|FG000|Overall Study|Lost to Follow-up|5|||
145756138|NCT00626093|525619891|FG000|Overall Study|Death|1|||
145756139|NCT00626093|525619891|FG000|Overall Study|Physician Decision|4|||
145756140|NCT00626093|525619891|FG000|Overall Study|Withdrawal by Subject|6|||
145756141|NCT00626093|525619891|FG000|Overall Study|Protocol Violation|1|||
145756142|NCT00626093|525619891|FG000|Overall Study|One of the required devices not implante|6|||
145756143|NCT00603915|525619892|FG000|Overall Study|Physician Decision|1|||
145756144|NCT00911989|525619893|FG000|Overall Study|Adverse Event|1|||
145756145|NCT03064841|525619894|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
145756146|NCT03064841|525619894|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
145756147|NCT03064841|525619894|FG000|Overall Study|Screen failure|2|||
145756148|NCT01145066|525619895|FG000|Overall Study|To resume NSAIDs|2|||
145756149|NCT01145066|525619896|FG001|Overall Study|To resume NSAIDs|2|||
145756150|NCT01145066|525619897|FG002|Overall Study|To resume NSAIDs|1|||
145756151|NCT01145066|525619895|FG000|Overall Study|Non-related surgery|0|||
145756152|NCT01145066|525619896|FG001|Overall Study|Non-related surgery|0|||
145756153|NCT01145066|525619897|FG002|Overall Study|Non-related surgery|1|||
145756154|NCT01145066|525619895|FG000|Overall Study|Withdrawal by Subject|0|||
145756155|NCT01145066|525619896|FG001|Overall Study|Withdrawal by Subject|0|||
145756156|NCT01145066|525619897|FG002|Overall Study|Withdrawal by Subject|2|||
145756157|NCT01145066|525619895|FG000|Overall Study|To start new med|1|||
145756158|NCT01145066|525619896|FG001|Overall Study|To start new med|0|||
145756159|NCT01145066|525619897|FG002|Overall Study|To start new med|0|||
145756160|NCT01145066|525619895|FG000|Overall Study|problems swallowing capsule|1|||
145756161|NCT01145066|525619896|FG001|Overall Study|problems swallowing capsule|0|||
145756162|NCT01145066|525619897|FG002|Overall Study|problems swallowing capsule|0|||
145756163|NCT01145066|525619895|FG000|Overall Study|Abdominal discomfort|0|||
145756164|NCT01145066|525619896|FG001|Overall Study|Abdominal discomfort|1|||
145756165|NCT01145066|525619897|FG002|Overall Study|Abdominal discomfort|0|||
145756166|NCT01145066|525619895|FG000|Overall Study|Low platelet count|0|||
145756167|NCT01145066|525619896|FG001|Overall Study|Low platelet count|1|||
145756168|NCT01145066|525619897|FG002|Overall Study|Low platelet count|0|||
145756169|NCT01777581|525619898|FG000|Overall Study|Lost to Follow-up|1|||
145756170|NCT01777581|525619899|FG001|Overall Study|Lost to Follow-up|1|||
145756171|NCT01777581|525619898|FG000|Overall Study|Adverse Event|2|||
145756172|NCT01777581|525619899|FG001|Overall Study|Adverse Event|0|||
145756173|NCT01777581|525619898|FG000|Overall Study|Lack of Efficacy|0|||
145756174|NCT01777581|525619899|FG001|Overall Study|Lack of Efficacy|1|||
145756175|NCT02321436|525619906|FG000|Overall Study|Withdrawal by Subject|1|||
145756176|NCT02321436|525619907|FG001|Overall Study|Withdrawal by Subject|0|||
145756177|NCT02321436|525619906|FG000|Overall Study|Lost to Follow-up|0|||
145756178|NCT02321436|525619907|FG001|Overall Study|Lost to Follow-up|1|||
145756179|NCT00644787|525619908|FG000|Period 1: Titration Phase|Adverse Event|11|||
145756180|NCT00644787|525619909|FG001|Period 1: Titration Phase|Adverse Event|0|||
145756181|NCT00644787|525619910|FG002|Period 1: Titration Phase|Adverse Event|0|||
145756182|NCT00644787|525619908|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
145756183|NCT00644787|525619909|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
145756184|NCT00644787|525619910|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
145756185|NCT00644787|525619908|FG000|Period 1: Titration Phase|Physician Decision|1|||
145756186|NCT00644787|525619909|FG001|Period 1: Titration Phase|Physician Decision|0|||
145531759|NCT03633617|524808354|FG007|Part B|COVID-19 Restrictions|0|||
145756187|NCT00644787|525619910|FG002|Period 1: Titration Phase|Physician Decision|0|||
145756188|NCT00644787|525619908|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
145756189|NCT00644787|525619909|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
145756190|NCT00644787|525619910|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
145756191|NCT00644787|525619908|FG000|Period 1: Titration Phase|Worsening of complications|1|||
145756192|NCT00644787|525619909|FG001|Period 1: Titration Phase|Worsening of complications|0|||
145756193|NCT00644787|525619910|FG002|Period 1: Titration Phase|Worsening of complications|0|||
145531760|NCT03633617|524808355|FG008|Part B|COVID-19 Restrictions|0|||
145756194|NCT00644787|525619908|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
145756195|NCT00644787|525619909|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
145756196|NCT00644787|525619910|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
145756197|NCT00644787|525619908|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
145756198|NCT00644787|525619909|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
145756199|NCT00644787|525619910|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
145756200|NCT00644787|525619908|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
145756201|NCT00644787|525619909|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
145756202|NCT00644787|525619910|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
145756203|NCT00644787|525619908|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
145756204|NCT00644787|525619909|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
145531761|NCT03633617|524808356|FG009|Part B|COVID-19 Restrictions|0|||
145531762|NCT03633617|524808357|FG010|Part B|COVID-19 Restrictions|0|||
145531763|NCT03633617|524808347|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145756205|NCT00644787|525619910|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
145756206|NCT00644787|525619908|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
145756207|NCT00644787|525619909|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
145756208|NCT00644787|525619910|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
145756209|NCT00644787|525619908|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
145273032|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
145273033|NCT03611751|523848266|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
145273034|NCT03611751|523848267|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
145273035|NCT03611751|523848268|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
145273036|NCT00929864|523848269|FG000|Overall Study|Death|1|||
145273037|NCT00929864|523848270|FG001|Overall Study|Death|1|||
145273038|NCT00929864|523848269|FG000|Overall Study|Adverse Event|11|||
145273039|NCT00929864|523848270|FG001|Overall Study|Adverse Event|30|||
145273040|NCT00929864|523848269|FG000|Overall Study|Lack of Efficacy|19|||
145273041|NCT00929864|523848270|FG001|Overall Study|Lack of Efficacy|16|||
145273042|NCT00929864|523848269|FG000|Overall Study|Lost to Follow-up|7|||
145273043|NCT00929864|523848270|FG001|Overall Study|Lost to Follow-up|12|||
145273044|NCT00929864|523848269|FG000|Overall Study|Withdrawal by Subject|20|||
145273045|NCT00929864|523848270|FG001|Overall Study|Withdrawal by Subject|9|||
145273046|NCT00929864|523848269|FG000|Overall Study|No longer met criteria|2|||
145273047|NCT00929864|523848270|FG001|Overall Study|No longer met criteria|1|||
145273048|NCT00929864|523848269|FG000|Overall Study|Poor or non-compliance|3|||
145273049|NCT00929864|523848270|FG001|Overall Study|Poor or non-compliance|3|||
145273050|NCT00929864|523848269|FG000|Overall Study|Pregnancy|0|||
145273051|NCT00929864|523848270|FG001|Overall Study|Pregnancy|3|||
145273052|NCT00929864|523848269|FG000|Overall Study|Administrative reason by Sponsor|1|||
145273053|NCT00929864|523848270|FG001|Overall Study|Administrative reason by Sponsor|1|||
145273054|NCT00929864|523848269|FG000|Overall Study|Non-specified|2|||
145273055|NCT00929864|523848270|FG001|Overall Study|Non-specified|7|||
145273056|NCT03940742|523848275|FG000|Overall Study|Lost to Follow-up|0|||
145273057|NCT03940742|523848276|FG001|Overall Study|Lost to Follow-up|0|||
145273058|NCT03940742|523848277|FG002|Overall Study|Lost to Follow-up|0|||
145273059|NCT03940742|523848278|FG003|Overall Study|Lost to Follow-up|1|||
145273060|NCT02032823|523848279|FG000|Overall Study|Death|75|||
145273061|NCT02032823|523848280|FG001|Overall Study|Death|109|||
145273062|NCT02032823|523848279|FG000|Overall Study|Lost to Follow-up|18|||
145273063|NCT02032823|523848280|FG001|Overall Study|Lost to Follow-up|17|||
145273064|NCT02032823|523848279|FG000|Overall Study|Withdrawal by Subject|70|||
145273065|NCT02032823|523848280|FG001|Overall Study|Withdrawal by Subject|53|||
145273066|NCT02032823|523848279|FG000|Overall Study|Ongoing study at data cut-off|755|||
145273067|NCT02032823|523848280|FG001|Overall Study|Ongoing study at data cut-off|731|||
145273068|NCT02032823|523848279|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
145273069|NCT02032823|523848280|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
145273070|NCT03428217|523848281|FG000|Overall Study|Death|89|||
145273071|NCT03428217|523848282|FG001|Overall Study|Death|93|||
145273072|NCT03428217|523848281|FG000|Overall Study|Withdrawal by Subject|8|||
145273073|NCT03428217|523848282|FG001|Overall Study|Withdrawal by Subject|7|||
145273074|NCT03428217|523848281|FG000|Overall Study|Lost to Follow-up|1|||
145273075|NCT03428217|523848282|FG001|Overall Study|Lost to Follow-up|3|||
145273076|NCT03428217|523848281|FG000|Overall Study|Study terminated by sponsor|124|||
145273077|NCT03428217|523848282|FG001|Overall Study|Study terminated by sponsor|118|||
145273078|NCT03428217|523848281|FG000|Overall Study|Other, Not Specified|1|||
145273079|NCT03428217|523848282|FG001|Overall Study|Other, Not Specified|0|||
145273080|NCT03889197|523848283|FG000|Overall Study|Withdrawal by Subject|1|||
145273081|NCT03889197|523848284|FG001|Overall Study|Withdrawal by Subject|0|||
145273082|NCT03889197|523848283|FG000|Overall Study|Physician Decision|0|||
145273083|NCT03889197|523848284|FG001|Overall Study|Physician Decision|1|||
145273084|NCT03889197|523848283|FG000|Overall Study|met exclusion criteria|0|||
145273085|NCT03889197|523848284|FG001|Overall Study|met exclusion criteria|1|||
145273086|NCT03889197|523848283|FG000|Overall Study|Protocol Violation|1|||
145273087|NCT03889197|523848284|FG001|Overall Study|Protocol Violation|0|||
145273088|NCT05246111|523848285|FG000|Period 01|NOT ELIGIBLE IC5|1|||
145273089|NCT05246111|523848286|FG001|Period 01|NOT ELIGIBLE IC5|0|||
145273090|NCT03151226|523848287|FG000|Overall Study|Withdrawal by Subject|2|||
145273091|NCT03151226|523848287|FG000|Overall Study|not wear device correctly|1|||
145273092|NCT00402779|523848288|FG000|Overall Study|Screen Failure|77|||
145273093|NCT00402779|523848289|FG001|Overall Study|Screen Failure|76|||
145273094|NCT05004181|523848293|FG000|Overall Study|Withdrawal of consent|0|||
145273095|NCT05004181|523848294|FG001|Overall Study|Withdrawal of consent|0|||
145273096|NCT05004181|523848295|FG002|Overall Study|Withdrawal of consent|1|||
145273097|NCT05004181|523848296|FG003|Overall Study|Withdrawal of consent|3|||
145273098|NCT05004181|523848297|FG004|Overall Study|Withdrawal of consent|3|||
145756210|NCT00644787|525619909|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
145273099|NCT05004181|523848298|FG005|Overall Study|Withdrawal of consent|0|||
145273100|NCT05004181|523848299|FG006|Overall Study|Withdrawal of consent|30|||
145273101|NCT05004181|523848300|FG007|Overall Study|Withdrawal of consent|9|||
145273102|NCT05004181|523848301|FG008|Overall Study|Withdrawal of consent|3|||
145273103|NCT05004181|523848302|FG009|Overall Study|Withdrawal of consent|2|||
145273104|NCT05004181|523848303|FG010|Overall Study|Withdrawal of consent|5|||
145273105|NCT05004181|523848304|FG011|Overall Study|Withdrawal of consent|1|||
145273106|NCT05004181|523848293|FG000|Overall Study|Lost to Follow-up|2|||
145756211|NCT00644787|525619910|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
145273107|NCT05004181|523848294|FG001|Overall Study|Lost to Follow-up|4|||
145273108|NCT05004181|523848295|FG002|Overall Study|Lost to Follow-up|2|||
145273109|NCT05004181|523848296|FG003|Overall Study|Lost to Follow-up|3|||
145273110|NCT05004181|523848297|FG004|Overall Study|Lost to Follow-up|5|||
145273111|NCT05004181|523848298|FG005|Overall Study|Lost to Follow-up|2|||
145273112|NCT05004181|523848299|FG006|Overall Study|Lost to Follow-up|15|||
145273113|NCT05004181|523848300|FG007|Overall Study|Lost to Follow-up|12|||
145273114|NCT05004181|523848301|FG008|Overall Study|Lost to Follow-up|38|||
145273115|NCT05004181|523848302|FG009|Overall Study|Lost to Follow-up|6|||
145273116|NCT05004181|523848303|FG010|Overall Study|Lost to Follow-up|6|||
145273117|NCT05004181|523848304|FG011|Overall Study|Lost to Follow-up|0|||
145273118|NCT05004181|523848293|FG000|Overall Study|Death|0|||
145273119|NCT05004181|523848294|FG001|Overall Study|Death|0|||
145756212|NCT00644787|525619908|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
145756213|NCT00644787|525619909|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
145756214|NCT00644787|525619910|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
145756215|NCT01928381|525619913|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
145756216|NCT01928381|525619914|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756217|NCT01928381|525619915|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756218|NCT01928381|525619916|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756219|NCT01928381|525619917|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756220|NCT01928381|525619918|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756221|NCT01928381|525619919|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
145756222|NCT01928381|525619913|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
145756223|NCT01928381|525619914|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
145756224|NCT01928381|525619915|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
145756225|NCT01928381|525619916|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
145756226|NCT01928381|525619917|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
145756227|NCT01928381|525619918|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
145756228|NCT01928381|525619919|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
145756229|NCT01928381|525619913|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
145756230|NCT01928381|525619914|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756231|NCT01928381|525619915|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756232|NCT01928381|525619916|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756233|NCT01928381|525619917|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756234|NCT01928381|525619918|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756235|NCT01928381|525619919|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
145756236|NCT01928381|525619913|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
145756237|NCT01928381|525619914|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
145756238|NCT01928381|525619915|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
145756239|NCT01928381|525619916|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
145756240|NCT01928381|525619917|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
145756241|NCT01928381|525619918|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
145756242|NCT01928381|525619919|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
145756243|NCT01928381|525619913|FG000|Part 1 - Pain Training|Protocol Violation|1|||
145756244|NCT01928381|525619914|FG001|Part 1 - Pain Training|Protocol Violation|0|||
145756245|NCT01928381|525619915|FG002|Part 1 - Pain Training|Protocol Violation|0|||
145756246|NCT01928381|525619916|FG003|Part 1 - Pain Training|Protocol Violation|0|||
145756247|NCT01928381|525619917|FG004|Part 1 - Pain Training|Protocol Violation|0|||
145756248|NCT01928381|525619918|FG005|Part 1 - Pain Training|Protocol Violation|0|||
145756249|NCT01928381|525619919|FG006|Part 1 - Pain Training|Protocol Violation|0|||
145756250|NCT01928381|525619913|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
145756251|NCT01928381|525619914|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756252|NCT01928381|525619915|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756253|NCT01928381|525619916|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756254|NCT01928381|525619917|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756255|NCT01928381|525619918|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756256|NCT01928381|525619919|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
145756257|NCT01928381|525619913|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
145273120|NCT05004181|523848295|FG002|Overall Study|Death|0|||
145402800|NCT00853385|524332496|FG000|Overall Study|Withdrawal by Subject|4|||
145402801|NCT00853385|524332497|FG001|Overall Study|Withdrawal by Subject|2|||
145756258|NCT01928381|525619914|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145273121|NCT05004181|523848296|FG003|Overall Study|Death|0|||
145273122|NCT05004181|523848297|FG004|Overall Study|Death|0|||
145273123|NCT05004181|523848298|FG005|Overall Study|Death|0|||
145273124|NCT05004181|523848299|FG006|Overall Study|Death|1|||
145402802|NCT00853385|524332498|FG002|Overall Study|Withdrawal by Subject|0|||
145756259|NCT01928381|525619915|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145756260|NCT01928381|525619916|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145273125|NCT05004181|523848300|FG007|Overall Study|Death|0|||
145756261|NCT01928381|525619917|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145756262|NCT01928381|525619918|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145756263|NCT01928381|525619919|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
145756264|NCT01928381|525619913|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
145756265|NCT01928381|525619914|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756266|NCT01928381|525619915|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756267|NCT01928381|525619916|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756268|NCT01928381|525619917|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756269|NCT01928381|525619918|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756270|NCT01928381|525619919|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
145756271|NCT01928381|525619913|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
145756272|NCT01928381|525619914|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756273|NCT01928381|525619915|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756274|NCT01928381|525619916|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756275|NCT01928381|525619917|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756276|NCT01928381|525619918|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756277|NCT01928381|525619919|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
145756278|NCT01928381|525619913|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756279|NCT01928381|525619914|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756280|NCT01928381|525619915|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
145756281|NCT01928381|525619916|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756282|NCT01928381|525619917|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756283|NCT01928381|525619918|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756284|NCT01928381|525619919|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
145756285|NCT01928381|525619913|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756286|NCT01928381|525619914|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756287|NCT01928381|525619915|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
145756288|NCT01928381|525619916|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756289|NCT01928381|525619917|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756290|NCT01928381|525619918|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756291|NCT01928381|525619919|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
145756292|NCT01928381|525619913|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
145756293|NCT01928381|525619914|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
145756294|NCT01928381|525619915|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
145756295|NCT01928381|525619916|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
145756296|NCT01928381|525619917|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
145402803|NCT00853385|524332499|FG003|Overall Study|Withdrawal by Subject|1|||
145756297|NCT01928381|525619918|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
145756298|NCT01928381|525619919|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
145756299|NCT01928381|525619913|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
145756300|NCT01928381|525619914|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
145756301|NCT01928381|525619915|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
145558231|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
145756302|NCT01928381|525619916|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
145756303|NCT01928381|525619917|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
145756304|NCT01928381|525619918|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
145756305|NCT01928381|525619919|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
145756306|NCT01928381|525619913|FG000|Washout First Intervention|Protocol Violation|0|||
145756307|NCT01928381|525619914|FG001|Washout First Intervention|Protocol Violation|0|||
145756308|NCT01928381|525619915|FG002|Washout First Intervention|Protocol Violation|0|||
145756309|NCT01928381|525619916|FG003|Washout First Intervention|Protocol Violation|0|||
145756310|NCT01928381|525619917|FG004|Washout First Intervention|Protocol Violation|1|||
145756311|NCT01928381|525619918|FG005|Washout First Intervention|Protocol Violation|0|||
145756312|NCT01928381|525619919|FG006|Washout First Intervention|Protocol Violation|0|||
145756313|NCT01928381|525619913|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
145756314|NCT01928381|525619914|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
145756315|NCT01928381|525619915|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
145756316|NCT01928381|525619916|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
145756317|NCT01928381|525619917|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
145756318|NCT01928381|525619918|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
145756319|NCT01928381|525619919|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
145756320|NCT01928381|525619913|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
145756321|NCT01928381|525619914|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
145756322|NCT01928381|525619915|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
145756323|NCT01928381|525619916|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
145756324|NCT01928381|525619917|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
145756325|NCT01928381|525619918|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
145531764|NCT03633617|524808348|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531765|NCT03633617|524808349|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
145531766|NCT03633617|524808350|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531767|NCT03633617|524808351|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531768|NCT03633617|524808352|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531769|NCT03633617|524808353|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145756326|NCT01928381|525619919|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
145756327|NCT01877083|525619920|FG000|Treatment Phase|Disease Progression|10|||
145756328|NCT01877083|525619920|FG000|Treatment Phase|Clinical Progression|1|||
145273126|NCT05004181|523848301|FG008|Overall Study|Death|2|||
145273127|NCT05004181|523848302|FG009|Overall Study|Death|0|||
145273128|NCT05004181|523848303|FG010|Overall Study|Death|0|||
145273129|NCT05004181|523848304|FG011|Overall Study|Death|0|||
145273130|NCT05004181|523848293|FG000|Overall Study|Physician Decision|0|||
145756329|NCT01877083|525619920|FG000|Treatment Phase|Adverse Event|6|||
145273131|NCT05004181|523848294|FG001|Overall Study|Physician Decision|0|||
145531770|NCT03633617|524808354|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531771|NCT03633617|524808355|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531772|NCT03633617|524808356|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531773|NCT03633617|524808357|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
145531774|NCT03633617|524808347|FG000|Part C (& Follow-up)|Adverse Event|0|||
145756330|NCT01877083|525619920|FG000|Treatment Phase|Withdrawal by Subject|2|||
145273132|NCT05004181|523848295|FG002|Overall Study|Physician Decision|0|||
145273133|NCT05004181|523848296|FG003|Overall Study|Physician Decision|0|||
145531775|NCT03633617|524808348|FG001|Part C (& Follow-up)|Adverse Event|0|||
145531776|NCT03633617|524808349|FG002|Part C (& Follow-up)|Adverse Event|0|||
145531777|NCT03633617|524808350|FG003|Part C (& Follow-up)|Adverse Event|0|||
145531778|NCT03633617|524808351|FG004|Part C (& Follow-up)|Adverse Event|0|||
145531779|NCT03633617|524808352|FG005|Part C (& Follow-up)|Adverse Event|1|||
145531780|NCT03633617|524808353|FG006|Part C (& Follow-up)|Adverse Event|0|||
145531781|NCT03633617|524808354|FG007|Part C (& Follow-up)|Adverse Event|1|||
145531782|NCT03633617|524808355|FG008|Part C (& Follow-up)|Adverse Event|0|||
145756331|NCT01877083|525619920|FG000|Treatment Phase|Lost to Follow-up|1|||
145531783|NCT03633617|524808356|FG009|Part C (& Follow-up)|Adverse Event|0|||
145531784|NCT03633617|524808357|FG010|Part C (& Follow-up)|Adverse Event|0|||
145531785|NCT03633617|524808347|FG000|Part C (& Follow-up)|Pregnancy|0|||
145531786|NCT03633617|524808348|FG001|Part C (& Follow-up)|Pregnancy|0|||
145531787|NCT03633617|524808349|FG002|Part C (& Follow-up)|Pregnancy|0|||
145756332|NCT01877083|525619920|FG000|Extension Phase|Disease Progression|3|||
145756333|NCT01877083|525619920|FG000|Extension Phase|Adverse Event|2|||
145531788|NCT03633617|524808350|FG003|Part C (& Follow-up)|Pregnancy|0|||
145531789|NCT03633617|524808351|FG004|Part C (& Follow-up)|Pregnancy|0|||
145531790|NCT03633617|524808352|FG005|Part C (& Follow-up)|Pregnancy|0|||
145273134|NCT05004181|523848297|FG004|Overall Study|Physician Decision|0|||
145273135|NCT05004181|523848298|FG005|Overall Study|Physician Decision|0|||
145273136|NCT05004181|523848299|FG006|Overall Study|Physician Decision|2|||
145273137|NCT05004181|523848300|FG007|Overall Study|Physician Decision|0|||
145273138|NCT05004181|523848301|FG008|Overall Study|Physician Decision|7|||
145273139|NCT05004181|523848302|FG009|Overall Study|Physician Decision|0|||
145273140|NCT05004181|523848303|FG010|Overall Study|Physician Decision|0|||
145273141|NCT05004181|523848304|FG011|Overall Study|Physician Decision|0|||
145273142|NCT05004181|523848293|FG000|Overall Study|Withdrawal by Subject|2|||
145273143|NCT05004181|523848294|FG001|Overall Study|Withdrawal by Subject|3|||
145273144|NCT05004181|523848295|FG002|Overall Study|Withdrawal by Subject|2|||
145273145|NCT05004181|523848296|FG003|Overall Study|Withdrawal by Subject|2|||
145273146|NCT05004181|523848297|FG004|Overall Study|Withdrawal by Subject|4|||
145273147|NCT05004181|523848298|FG005|Overall Study|Withdrawal by Subject|2|||
145273148|NCT05004181|523848299|FG006|Overall Study|Withdrawal by Subject|4|||
145273149|NCT05004181|523848300|FG007|Overall Study|Withdrawal by Subject|22|||
145273150|NCT05004181|523848301|FG008|Overall Study|Withdrawal by Subject|8|||
145273151|NCT05004181|523848302|FG009|Overall Study|Withdrawal by Subject|1|||
145273152|NCT05004181|523848303|FG010|Overall Study|Withdrawal by Subject|3|||
145273153|NCT05004181|523848304|FG011|Overall Study|Withdrawal by Subject|2|||
145273154|NCT05004181|523848293|FG000|Overall Study|Protocol Violation|2|||
145273155|NCT05004181|523848294|FG001|Overall Study|Protocol Violation|3|||
145273156|NCT05004181|523848295|FG002|Overall Study|Protocol Violation|0|||
145273157|NCT05004181|523848296|FG003|Overall Study|Protocol Violation|0|||
145273158|NCT05004181|523848297|FG004|Overall Study|Protocol Violation|1|||
145273159|NCT05004181|523848298|FG005|Overall Study|Protocol Violation|0|||
145273160|NCT05004181|523848299|FG006|Overall Study|Protocol Violation|16|||
145273161|NCT05004181|523848300|FG007|Overall Study|Protocol Violation|18|||
145273162|NCT05004181|523848301|FG008|Overall Study|Protocol Violation|2|||
145273163|NCT05004181|523848302|FG009|Overall Study|Protocol Violation|2|||
145273164|NCT05004181|523848303|FG010|Overall Study|Protocol Violation|2|||
145273165|NCT05004181|523848304|FG011|Overall Study|Protocol Violation|1|||
145273166|NCT05004181|523848293|FG000|Overall Study|Not further specified|1|||
145273167|NCT05004181|523848294|FG001|Overall Study|Not further specified|0|||
145273168|NCT05004181|523848295|FG002|Overall Study|Not further specified|0|||
145273169|NCT05004181|523848296|FG003|Overall Study|Not further specified|0|||
145273170|NCT05004181|523848297|FG004|Overall Study|Not further specified|0|||
145273171|NCT05004181|523848298|FG005|Overall Study|Not further specified|0|||
145273172|NCT05004181|523848299|FG006|Overall Study|Not further specified|1|||
145273173|NCT05004181|523848300|FG007|Overall Study|Not further specified|0|||
145273174|NCT05004181|523848301|FG008|Overall Study|Not further specified|2|||
145273175|NCT05004181|523848302|FG009|Overall Study|Not further specified|1|||
145273176|NCT05004181|523848303|FG010|Overall Study|Not further specified|0|||
145273177|NCT05004181|523848304|FG011|Overall Study|Not further specified|1|||
145273178|NCT04066894|523848305|FG000|Overall Study|Lack of Efficacy|1|||
145273179|NCT04066894|523848305|FG000|Overall Study|Screen Failure|1|||
145273180|NCT02949219|523848306|FG000|Overall Study|Withdrawal by Subject|1|||
145531791|NCT03633617|524808353|FG006|Part C (& Follow-up)|Pregnancy|0|||
145531792|NCT03633617|524808354|FG007|Part C (& Follow-up)|Pregnancy|0|||
145531793|NCT03633617|524808355|FG008|Part C (& Follow-up)|Pregnancy|0|||
145531794|NCT03633617|524808356|FG009|Part C (& Follow-up)|Pregnancy|1|||
145531795|NCT03633617|524808357|FG010|Part C (& Follow-up)|Pregnancy|0|||
145531796|NCT03633617|524808347|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531797|NCT03633617|524808348|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531798|NCT03633617|524808349|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531799|NCT03633617|524808350|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531800|NCT03633617|524808351|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531801|NCT03633617|524808352|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
145531802|NCT03633617|524808353|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
145531803|NCT03633617|524808354|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
145531804|NCT03633617|524808355|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
145531805|NCT03633617|524808356|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
145273181|NCT04278872|523848307|FG000|Overall Study|Adverse Event|1|||
145531806|NCT03633617|524808357|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
145273182|NCT04278872|523848308|FG001|Overall Study|Adverse Event|0|||
145273183|NCT04278872|523848307|FG000|Overall Study|Protocol Violation|0|||
145531807|NCT03633617|524808347|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
145531808|NCT03633617|524808348|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
145531809|NCT03633617|524808349|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
145273184|NCT04278872|523848308|FG001|Overall Study|Protocol Violation|1|||
145273185|NCT04278872|523848307|FG000|Overall Study|Study Termination|2|||
145273186|NCT04278872|523848308|FG001|Overall Study|Study Termination|0|||
145531810|NCT03633617|524808350|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
145531811|NCT03633617|524808351|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
145273187|NCT03494816|523848309|FG000|Overall Study|Protocol Violation|2|||
145273188|NCT03494816|523848309|FG000|Overall Study|Physician Decision|2|||
145273189|NCT03494816|523848309|FG000|Overall Study|Did not start trial treatment|1|||
145756334|NCT01582308|525619921|FG000|Period 1|Withdrawal by Subject|0|||
145273190|NCT03494816|523848309|FG000|Overall Study|Adverse Event|1|||
145273191|NCT00096031|523848314|FG000|Overall Study|Adverse Event|3|||
145273192|NCT00096031|523848314|FG000|Overall Study|Lack of Efficacy|42|||
145273193|NCT00096031|523848314|FG000|Overall Study|Death|4|||
145273194|NCT00096031|523848314|FG000|Overall Study|Withdrawal by Subject|1|||
145273195|NCT00096031|523848314|FG000|Overall Study|Ineligible|8|||
145273196|NCT00096031|523848314|FG000|Overall Study|Not protocol specified|5|||
145273197|NCT01283282|523848315|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
145273198|NCT01283282|523848316|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
145273199|NCT01283282|523848315|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
145273200|NCT01283282|523848316|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
145273201|NCT01283282|523848315|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
145273202|NCT01283282|523848316|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
145756335|NCT01582308|525619922|FG001|Period 1|Withdrawal by Subject|0|||
145756336|NCT01582308|525619923|FG002|Period 1|Withdrawal by Subject|0|||
145756337|NCT01582308|525619924|FG003|Period 1|Withdrawal by Subject|0|||
145756338|NCT01582308|525619925|FG004|Period 1|Withdrawal by Subject|0|||
145756339|NCT01582308|525619926|FG005|Period 1|Withdrawal by Subject|0|||
145756340|NCT01582308|525619927|FG006|Period 1|Withdrawal by Subject|1|||
145756341|NCT01582308|525619928|FG007|Period 1|Withdrawal by Subject|0|||
145756342|NCT01582308|525619929|FG008|Period 1|Withdrawal by Subject|0|||
145756343|NCT01582308|525619930|FG009|Period 1|Withdrawal by Subject|0|||
145273203|NCT00777920|523848317|FG000|Overall Study|Adverse Event|39|||
145273204|NCT00777920|523848317|FG000|Overall Study|Withdrawal of Consent|4|||
145273205|NCT00777920|523848317|FG000|Overall Study|Lost to Follow-up|1|||
145273206|NCT00777920|523848317|FG000|Overall Study|Investigator's discretion|1|||
145273207|NCT00777920|523848317|FG000|Overall Study|Clinical status did not improve|1|||
145273208|NCT00777920|523848317|FG000|Overall Study|Other, not specified|4|||
145273209|NCT00483717|523848318|FG000|Overall Study|Protocol Violation|5|||
145273210|NCT00483717|523848319|FG001|Overall Study|Protocol Violation|7|||
145273211|NCT00483717|523848318|FG000|Overall Study|Time of dosing missing|1|||
145273212|NCT00483717|523848319|FG001|Overall Study|Time of dosing missing|1|||
145273213|NCT00483717|523848318|FG000|Overall Study|No treatment for migraine|16|||
145273214|NCT00483717|523848319|FG001|Overall Study|No treatment for migraine|13|||
145273215|NCT00483717|523848318|FG000|Overall Study|Lost to Follow-up|1|||
145273216|NCT00483717|523848319|FG001|Overall Study|Lost to Follow-up|0|||
145273217|NCT00483717|523848318|FG000|Overall Study|Withdrawal by Subject|1|||
145273218|NCT00483717|523848319|FG001|Overall Study|Withdrawal by Subject|0|||
145273219|NCT00083226|523848320|FG000|Overall Study|Lack of Efficacy|19|||
145273220|NCT00083226|523848320|FG000|Overall Study|Adverse Event|9|||
145273221|NCT00083226|523848320|FG000|Overall Study|Death|4|||
145273222|NCT00083226|523848320|FG000|Overall Study|Withdrawal by Subject|4|||
145273223|NCT00083226|523848320|FG000|Overall Study|Other|2|||
145273224|NCT00083226|523848320|FG000|Overall Study|ineligible or not receiving treatment|4|||
145273225|NCT00909857|523848321|FG000|Overall Study|Withdrawal by Subject|6|||
145273226|NCT00909857|523848322|FG001|Overall Study|Withdrawal by Subject|10|||
145273227|NCT00909857|523848321|FG000|Overall Study|Adverse Event|5|||
145273228|NCT00909857|523848322|FG001|Overall Study|Adverse Event|5|||
145273229|NCT00909857|523848321|FG000|Overall Study|Lost to Follow-up|2|||
145273230|NCT00909857|523848322|FG001|Overall Study|Lost to Follow-up|5|||
145273231|NCT00909857|523848321|FG000|Overall Study|Protocol Violation|2|||
145273232|NCT00909857|523848322|FG001|Overall Study|Protocol Violation|1|||
145273233|NCT00909857|523848321|FG000|Overall Study|Pregnancy|1|||
145273234|NCT00909857|523848322|FG001|Overall Study|Pregnancy|0|||
145273235|NCT00909857|523848321|FG000|Overall Study|Other|1|||
145273236|NCT00909857|523848322|FG001|Overall Study|Other|0|||
145273237|NCT00909857|523848321|FG000|Overall Study|Did not receive study medication|19|||
145273238|NCT00909857|523848322|FG001|Overall Study|Did not receive study medication|24|||
145273239|NCT03878108|523848323|FG000|Overall Study|Adverse Event|1|||
145273240|NCT03878108|523848324|FG001|Overall Study|Adverse Event|0|||
145273241|NCT00604175|523848331|FG000|Entry Through Week 28|Death|2|||
145273242|NCT00604175|523848332|FG001|Entry Through Week 28|Death|0|||
145273243|NCT00604175|523848333|FG002|Entry Through Week 28|Death|0|||
145273244|NCT00604175|523848331|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
145273245|NCT00604175|523848332|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
145531812|NCT03633617|524808352|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
145273246|NCT00604175|523848333|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
145273247|NCT00604175|523848331|FG000|Entry Through Week 28|Lost to Follow-up|4|||
145273248|NCT00604175|523848332|FG001|Entry Through Week 28|Lost to Follow-up|3|||
145756344|NCT01582308|525619921|FG000|10-day Washout Following Period 1|Physician Decision|0|||
145756345|NCT01582308|525619922|FG001|10-day Washout Following Period 1|Physician Decision|0|||
145273249|NCT00604175|523848333|FG002|Entry Through Week 28|Lost to Follow-up|0|||
145273250|NCT00604175|523848331|FG000|Entry Through Week 28|Ineligible|1|||
145273251|NCT00604175|523848332|FG001|Entry Through Week 28|Ineligible|0|||
145531813|NCT03633617|524808353|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
145273252|NCT00604175|523848333|FG002|Entry Through Week 28|Ineligible|0|||
145756346|NCT01582308|525619923|FG002|10-day Washout Following Period 1|Physician Decision|0|||
145273253|NCT00604175|523848331|FG000|Entry Through Week 28|Did not start intervention|2|||
145273254|NCT00604175|523848332|FG001|Entry Through Week 28|Did not start intervention|0|||
145273255|NCT00604175|523848333|FG002|Entry Through Week 28|Did not start intervention|1|||
145273256|NCT00604175|523848331|FG000|Week 29 Through Week 72|Death|0|||
145273257|NCT00604175|523848332|FG001|Week 29 Through Week 72|Death|0|||
145273258|NCT00604175|523848333|FG002|Week 29 Through Week 72|Death|1|||
145273259|NCT00604175|523848331|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
145273260|NCT00604175|523848332|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
145273261|NCT00604175|523848333|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
145273262|NCT00604175|523848331|FG000|Week 29 Through Week 72|Site closure|0|||
145273263|NCT00604175|523848332|FG001|Week 29 Through Week 72|Site closure|1|||
145273264|NCT00604175|523848333|FG002|Week 29 Through Week 72|Site closure|0|||
145273265|NCT00604175|523848331|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
145273266|NCT00604175|523848332|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
145273267|NCT00604175|523848333|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
145273268|NCT01682681|523848334|FG000|Overall Study|Lack of Efficacy|62|||
145273269|NCT01682681|523848334|FG000|Overall Study|Withdrawal by Subject|1|||
145273270|NCT01682681|523848334|FG000|Overall Study|Moved to other hospital|10|||
145273271|NCT01682681|523848334|FG000|Overall Study|Lost to Follow-up|174|||
145273272|NCT01682681|523848334|FG000|Overall Study|Adverse Event|46|||
145273273|NCT01682681|523848334|FG000|Overall Study|tapering of topiramate|5|||
145273274|NCT01682681|523848334|FG000|Overall Study|Other|21|||
145273275|NCT01682681|523848334|FG000|Overall Study|Low compliance|13|||
145273276|NCT02044094|523848337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
145273277|NCT02044094|523848337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
145273278|NCT02044094|523848337|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
145273279|NCT02044094|523848337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
145273280|NCT02044094|523848337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
145273281|NCT02044094|523848337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
145273282|NCT02044094|523848337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
145273283|NCT02044094|523848337|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
145273284|NCT03353415|523848338|FG000|Masked CGM Wear|Lost to Follow-up|2|||
145273285|NCT03353415|523848338|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
145273286|NCT00975000|523848339|FG000|Overall Study|Other|1|||
145273287|NCT00975000|523848340|FG001|Overall Study|Other|0|||
145273288|NCT00975000|523848339|FG000|Overall Study|Adverse Event|1|||
145273289|NCT00975000|523848340|FG001|Overall Study|Adverse Event|1|||
145273290|NCT00975000|523848339|FG000|Overall Study|Withdrawal by Subject|2|||
145273291|NCT00975000|523848340|FG001|Overall Study|Withdrawal by Subject|2|||
145273292|NCT00975000|523848339|FG000|Overall Study|Lost to Follow-up|0|||
145273293|NCT00975000|523848340|FG001|Overall Study|Lost to Follow-up|1|||
145273294|NCT00975000|523848339|FG000|Overall Study|Protocol-specified Criteria|1|||
145273295|NCT00975000|523848340|FG001|Overall Study|Protocol-specified Criteria|0|||
145273296|NCT00975000|523848339|FG000|Overall Study|Non-compliance|0|||
145273297|NCT00975000|523848340|FG001|Overall Study|Non-compliance|1|||
145273298|NCT05257109|523848341|FG000|Overall Study|Withdrawal by Subject|1|||
145273299|NCT05257109|523848342|FG001|Overall Study|Withdrawal by Subject|0|||
145273300|NCT05257109|523848343|FG002|Overall Study|Withdrawal by Subject|0|||
145273301|NCT05257109|523848344|FG003|Overall Study|Withdrawal by Subject|0|||
145273302|NCT03515837|523850002|FG000|Overall Study|Death|219|||
145273303|NCT03515837|523850003|FG001|Overall Study|Death|227|||
145273304|NCT03515837|523850002|FG000|Overall Study|Lost to Follow-up|0|||
145273305|NCT03515837|523850003|FG001|Overall Study|Lost to Follow-up|1|||
145273306|NCT03515837|523850002|FG000|Overall Study|Withdrawal by Subject|0|||
145273307|NCT03515837|523850003|FG001|Overall Study|Withdrawal by Subject|4|||
145756347|NCT01582308|525619924|FG003|10-day Washout Following Period 1|Physician Decision|0|||
145756348|NCT01582308|525619925|FG004|10-day Washout Following Period 1|Physician Decision|1|||
145756349|NCT01582308|525619926|FG005|10-day Washout Following Period 1|Physician Decision|0|||
145756350|NCT01582308|525619927|FG006|10-day Washout Following Period 1|Physician Decision|0|||
145756351|NCT01582308|525619928|FG007|10-day Washout Following Period 1|Physician Decision|0|||
145756352|NCT01582308|525619929|FG008|10-day Washout Following Period 1|Physician Decision|0|||
145756353|NCT01582308|525619930|FG009|10-day Washout Following Period 1|Physician Decision|0|||
145273308|NCT03515837|523850002|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
145273309|NCT03515837|523850003|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
145531814|NCT03633617|524808354|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
145273310|NCT01964898|523850004|FG000|Overall Study|ineligible post-randomization|1|||
145273311|NCT01964898|523850005|FG001|Overall Study|ineligible post-randomization|1|||
145273312|NCT01964898|523850004|FG000|Overall Study|did not receive the allocated interventi|2|||
145273313|NCT01964898|523850005|FG001|Overall Study|did not receive the allocated interventi|1|||
145273314|NCT01964898|523850004|FG000|Overall Study|Lost to Follow-up|3|||
145531815|NCT03633617|524808355|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
145756354|NCT01582308|525619921|FG000|Period 4|Physician Decision|1|||
145273315|NCT01964898|523850005|FG001|Overall Study|Lost to Follow-up|5|||
145273316|NCT01964898|523850004|FG000|Overall Study|Withdrawal by Subject|1|||
145273317|NCT01964898|523850005|FG001|Overall Study|Withdrawal by Subject|0|||
145273318|NCT02957682|523850008|FG000|Overall Study|Adverse Event|64|||
145273319|NCT02957682|523850009|FG001|Overall Study|Adverse Event|67|||
145273320|NCT02957682|523850008|FG000|Overall Study|Poor Compliance to Protocol|30|||
145273321|NCT02957682|523850009|FG001|Overall Study|Poor Compliance to Protocol|26|||
145273322|NCT02957682|523850008|FG000|Overall Study|Physician Decision|4|||
145273323|NCT02957682|523850009|FG001|Overall Study|Physician Decision|4|||
145273324|NCT02957682|523850008|FG000|Overall Study|Study Terminated by Sponsor|4|||
145273325|NCT02957682|523850009|FG001|Overall Study|Study Terminated by Sponsor|3|||
145273326|NCT02957682|523850008|FG000|Overall Study|Subject Moved|10|||
145273327|NCT02957682|523850009|FG001|Overall Study|Subject Moved|16|||
145273328|NCT02957682|523850008|FG000|Overall Study|Withdrawal by Subject|64|||
145273329|NCT02957682|523850009|FG001|Overall Study|Withdrawal by Subject|33|||
145273330|NCT02957682|523850008|FG000|Overall Study|Related to IMP Administration|3|||
145273331|NCT02957682|523850009|FG001|Overall Study|Related to IMP Administration|6|||
145273332|NCT02957682|523850008|FG000|Overall Study|Non-disclosed|16|||
145273333|NCT02957682|523850009|FG001|Overall Study|Non-disclosed|12|||
145273334|NCT02957682|523850008|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
145273335|NCT02957682|523850009|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
145273336|NCT02953262|523850017|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
145273337|NCT02953262|523850018|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
145273338|NCT02953262|523850019|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
145273339|NCT02953262|523850020|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
145273340|NCT00934622|523850021|FG000|Overall Study|Lost to Follow-up|7|||
145273341|NCT00934622|523850021|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
145273342|NCT03284424|523850022|FG000|Overall Study|Death|70|||
145273343|NCT03284424|523850023|FG001|Overall Study|Death|24|||
145273344|NCT03284424|523850022|FG000|Overall Study|Lost to Follow-up|3|||
145273345|NCT03284424|523850023|FG001|Overall Study|Lost to Follow-up|1|||
145273346|NCT03284424|523850022|FG000|Overall Study|Physician Decision|1|||
145273347|NCT03284424|523850023|FG001|Overall Study|Physician Decision|2|||
145273348|NCT03284424|523850022|FG000|Overall Study|Withdrawal by Subject|4|||
145273349|NCT03284424|523850023|FG001|Overall Study|Withdrawal by Subject|5|||
145273350|NCT03284424|523850022|FG000|Overall Study|Sponsor's decision|27|||
145273351|NCT03284424|523850023|FG001|Overall Study|Sponsor's decision|22|||
145273352|NCT03349437|523850026|FG000|Screening|Screen Fail|4|||
145273353|NCT03349437|523850027|FG001|Screening|Screen Fail|0|||
145273354|NCT03349437|523850028|FG002|Screening|Screen Fail|0|||
145273355|NCT03349437|523850026|FG000|Screening|Withdrawn|1|||
145273356|NCT03349437|523850027|FG001|Screening|Withdrawn|0|||
145273357|NCT03349437|523850028|FG002|Screening|Withdrawn|0|||
145273358|NCT02406742|523850029|FG000|Overall Study|Progression of Disease|5|||
145273359|NCT02406742|523850030|FG001|Overall Study|Progression of Disease|1|||
145273360|NCT02406742|523850031|FG002|Overall Study|Progression of Disease|6|||
145273361|NCT02406742|523850029|FG000|Overall Study|Adverse Event|3|||
145273362|NCT02406742|523850030|FG001|Overall Study|Adverse Event|0|||
145273363|NCT02406742|523850031|FG002|Overall Study|Adverse Event|2|||
145273364|NCT02406742|523850029|FG000|Overall Study|Death|1|||
145273365|NCT02406742|523850030|FG001|Overall Study|Death|0|||
145273366|NCT02406742|523850031|FG002|Overall Study|Death|0|||
145273367|NCT02406742|523850029|FG000|Overall Study|Lack of Efficacy|0|||
145273368|NCT02406742|523850030|FG001|Overall Study|Lack of Efficacy|0|||
145273369|NCT02406742|523850031|FG002|Overall Study|Lack of Efficacy|1|||
145273370|NCT02406742|523850029|FG000|Overall Study|Withdrawal by Participant|1|||
145273371|NCT02406742|523850030|FG001|Overall Study|Withdrawal by Participant|2|||
145273372|NCT02406742|523850031|FG002|Overall Study|Withdrawal by Participant|0|||
145273373|NCT02406742|523850029|FG000|Overall Study|Physician Decision|1|||
145273374|NCT02406742|523850030|FG001|Overall Study|Physician Decision|2|||
145273375|NCT02406742|523850031|FG002|Overall Study|Physician Decision|1|||
145273376|NCT02406742|523850029|FG000|Overall Study|Transition to other treatment|2|||
145273377|NCT02406742|523850030|FG001|Overall Study|Transition to other treatment|0|||
145273378|NCT02406742|523850031|FG002|Overall Study|Transition to other treatment|1|||
145273379|NCT02406742|523850029|FG000|Overall Study|Other Reasons|1|||
145273380|NCT02406742|523850030|FG001|Overall Study|Other Reasons|11|||
145402804|NCT00853385|524332500|FG004|Overall Study|Withdrawal by Subject|1|||
145402805|NCT00853385|524332496|FG000|Overall Study|Other|18|||
145402806|NCT00853385|524332497|FG001|Overall Study|Other|9|||
145273381|NCT02406742|523850031|FG002|Overall Study|Other Reasons|5|||
145273382|NCT00765999|523850032|FG000|Overall Study|Adverse Event|203|||
145273383|NCT00765999|523850032|FG000|Overall Study|Insufficient Therapeutic Response|100|||
145273384|NCT00765999|523850032|FG000|Overall Study|Protocol Violation|95|||
145273385|NCT00765999|523850032|FG000|Overall Study|Consent Withdrawn|202|||
145273386|NCT00765999|523850032|FG000|Overall Study|Lost to Follow-up|131|||
145273387|NCT00765999|523850032|FG000|Overall Study|Study Terminated by Sponsor|2|||
145402807|NCT00853385|524332498|FG002|Overall Study|Other|4|||
145402808|NCT00853385|524332499|FG003|Overall Study|Other|4|||
145273388|NCT00765999|523850032|FG000|Overall Study|Other Miscellaneous Reasons|51|||
145402809|NCT00853385|524332500|FG004|Overall Study|Other|12|||
145402810|NCT03248037|524332501|FG000|Overall Study|Withdrawal by Subject|6|||
145756355|NCT01582308|525619922|FG001|Period 4|Physician Decision|0|||
145756356|NCT01582308|525619923|FG002|Period 4|Physician Decision|0|||
145273389|NCT02367729|523850033|FG000|Overall Study|Organic disorder diagnosed|2|||
145273390|NCT02367729|523850034|FG001|Overall Study|Organic disorder diagnosed|1|||
145273391|NCT02367729|523850033|FG000|Overall Study|Adverse Event|1|||
145273392|NCT02367729|523850034|FG001|Overall Study|Adverse Event|2|||
145273393|NCT02367729|523850033|FG000|Overall Study|Withdrawal by Subject|0|||
145273394|NCT02367729|523850034|FG001|Overall Study|Withdrawal by Subject|5|||
145273395|NCT00759174|523850039|FG000|Overall Study|Other|0|||
145273396|NCT00759174|523850040|FG001|Overall Study|Other|2|||
145273397|NCT01890109|523850041|FG000|Overall Study|Withdrawal by Subject|0|||
145273398|NCT01890109|523850042|FG001|Overall Study|Withdrawal by Subject|3|||
145273399|NCT01890109|523850041|FG000|Overall Study|Lost to Follow-up|1|||
145273400|NCT01890109|523850042|FG001|Overall Study|Lost to Follow-up|2|||
145273401|NCT01643928|523850043|FG000|Overall Study|Lost to Follow-up|1|||
145273402|NCT01643928|523850044|FG001|Overall Study|Lost to Follow-up|0|||
145273403|NCT01643928|523850045|FG002|Overall Study|Lost to Follow-up|2|||
145273404|NCT01643928|523850046|FG003|Overall Study|Lost to Follow-up|0|||
145273405|NCT01643928|523850047|FG004|Overall Study|Lost to Follow-up|0|||
145273406|NCT01643928|523850043|FG000|Overall Study|Withdrawal by Subject|2|||
145273407|NCT01643928|523850044|FG001|Overall Study|Withdrawal by Subject|0|||
145273408|NCT01643928|523850045|FG002|Overall Study|Withdrawal by Subject|0|||
145273409|NCT01643928|523850046|FG003|Overall Study|Withdrawal by Subject|1|||
145273410|NCT01643928|523850047|FG004|Overall Study|Withdrawal by Subject|0|||
145273411|NCT01643928|523850043|FG000|Overall Study|Pregnancy|0|||
145273412|NCT01643928|523850044|FG001|Overall Study|Pregnancy|0|||
145273413|NCT01643928|523850045|FG002|Overall Study|Pregnancy|0|||
145273414|NCT01643928|523850046|FG003|Overall Study|Pregnancy|1|||
145273415|NCT01643928|523850047|FG004|Overall Study|Pregnancy|0|||
145273416|NCT01643928|523850043|FG000|Overall Study|Other|5|||
145273417|NCT01643928|523850044|FG001|Overall Study|Other|1|||
145273418|NCT01643928|523850045|FG002|Overall Study|Other|1|||
145273419|NCT01643928|523850046|FG003|Overall Study|Other|0|||
145273420|NCT01643928|523850047|FG004|Overall Study|Other|0|||
145273421|NCT01643928|523850043|FG000|Overall Study|Adverse Event|2|||
145273422|NCT01643928|523850044|FG001|Overall Study|Adverse Event|1|||
145273423|NCT01643928|523850045|FG002|Overall Study|Adverse Event|0|||
145273424|NCT01643928|523850046|FG003|Overall Study|Adverse Event|1|||
145273425|NCT01643928|523850047|FG004|Overall Study|Adverse Event|2|||
145273426|NCT03692078|523850049|FG000|Overall Study|Adverse Event|0|||
145273427|NCT03692078|523850050|FG001|Overall Study|Adverse Event|0|||
145273428|NCT03692078|523850051|FG002|Overall Study|Adverse Event|0|||
145273429|NCT03692078|523850052|FG003|Overall Study|Adverse Event|0|||
145273430|NCT03692078|523850053|FG004|Overall Study|Adverse Event|0|||
145273431|NCT03692078|523850054|FG005|Overall Study|Adverse Event|1|||
145273432|NCT03692078|523850055|FG006|Overall Study|Adverse Event|0|||
145273433|NCT03692078|523850049|FG000|Overall Study|Enrollment Closed|5|||
145273434|NCT03692078|523850050|FG001|Overall Study|Enrollment Closed|0|||
145273435|NCT03692078|523850051|FG002|Overall Study|Enrollment Closed|0|||
145273436|NCT03692078|523850052|FG003|Overall Study|Enrollment Closed|0|||
145273437|NCT03692078|523850053|FG004|Overall Study|Enrollment Closed|0|||
145273438|NCT03692078|523850054|FG005|Overall Study|Enrollment Closed|0|||
145273439|NCT03692078|523850055|FG006|Overall Study|Enrollment Closed|0|||
145273440|NCT03692078|523850049|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
145273441|NCT03692078|523850050|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
145273442|NCT03692078|523850051|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
145273443|NCT03692078|523850052|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
145273444|NCT03692078|523850053|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
145273445|NCT03692078|523850054|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
145273446|NCT03692078|523850055|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
145273447|NCT03692078|523850049|FG000|Overall Study|Withdrawal by Subject|0|||
145273448|NCT03692078|523850050|FG001|Overall Study|Withdrawal by Subject|2|||
145273449|NCT03692078|523850051|FG002|Overall Study|Withdrawal by Subject|0|||
145273450|NCT03692078|523850052|FG003|Overall Study|Withdrawal by Subject|1|||
145273451|NCT03692078|523850053|FG004|Overall Study|Withdrawal by Subject|5|||
145273452|NCT03692078|523850054|FG005|Overall Study|Withdrawal by Subject|3|||
145273453|NCT03692078|523850055|FG006|Overall Study|Withdrawal by Subject|3|||
145273454|NCT05723835|523850058|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
145273455|NCT05723835|523850059|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
145273456|NCT05723835|523850060|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
145273457|NCT05723835|523850061|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
145273458|NCT05723835|523850062|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
145273459|NCT05723835|523850063|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
145273460|NCT05723835|523850064|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
145273461|NCT05723835|523850065|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
145273462|NCT05226286|523850066|FG000|Overall Study|Screen failures prior to implant|62|||
145273463|NCT05226286|523850066|FG000|Overall Study|Withdrawal by Subject|13|||
145273464|NCT05226286|523850066|FG000|Overall Study|Lost to Follow-up|3|||
145273465|NCT05226286|523850066|FG000|Overall Study|Physician Decision|1|||
145756357|NCT01582308|525619924|FG003|Period 4|Physician Decision|0|||
145756358|NCT01582308|525619925|FG004|Period 4|Physician Decision|0|||
145273466|NCT05226286|523850066|FG000|Overall Study|Adverse Event|1|||
145273467|NCT05226286|523850066|FG000|Overall Study|Death|1|||
145273468|NCT05226286|523850066|FG000|Overall Study|Device explant with no planned replacement|1|||
145531816|NCT03633617|524808356|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
145531817|NCT03633617|524808357|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
145531818|NCT03633617|524808347|FG000|Part C (& Follow-up)|Physician Decision|0|||
145531819|NCT03633617|524808348|FG001|Part C (& Follow-up)|Physician Decision|0|||
145531820|NCT03633617|524808349|FG002|Part C (& Follow-up)|Physician Decision|0|||
145531821|NCT03633617|524808350|FG003|Part C (& Follow-up)|Physician Decision|0|||
145531822|NCT03633617|524808351|FG004|Part C (& Follow-up)|Physician Decision|0|||
145531823|NCT03633617|524808352|FG005|Part C (& Follow-up)|Physician Decision|0|||
145531824|NCT03633617|524808353|FG006|Part C (& Follow-up)|Physician Decision|0|||
145531825|NCT03633617|524808354|FG007|Part C (& Follow-up)|Physician Decision|1|||
145531826|NCT03633617|524808355|FG008|Part C (& Follow-up)|Physician Decision|0|||
145531827|NCT03633617|524808356|FG009|Part C (& Follow-up)|Physician Decision|0|||
145531828|NCT03633617|524808357|FG010|Part C (& Follow-up)|Physician Decision|1|||
145531829|NCT03633617|524808347|FG000|Part C (& Follow-up)|COVID-19 related|0|||
145531830|NCT03633617|524808348|FG001|Part C (& Follow-up)|COVID-19 related|0|||
145531831|NCT03633617|524808349|FG002|Part C (& Follow-up)|COVID-19 related|0|||
145531832|NCT03633617|524808350|FG003|Part C (& Follow-up)|COVID-19 related|0|||
145531833|NCT03633617|524808351|FG004|Part C (& Follow-up)|COVID-19 related|0|||
145531834|NCT03633617|524808352|FG005|Part C (& Follow-up)|COVID-19 related|1|||
145531835|NCT03633617|524808353|FG006|Part C (& Follow-up)|COVID-19 related|0|||
145531836|NCT03633617|524808354|FG007|Part C (& Follow-up)|COVID-19 related|0|||
145531837|NCT03633617|524808355|FG008|Part C (& Follow-up)|COVID-19 related|0|||
145531838|NCT03633617|524808356|FG009|Part C (& Follow-up)|COVID-19 related|0|||
145531839|NCT03633617|524808357|FG010|Part C (& Follow-up)|COVID-19 related|0|||
145531840|NCT03633617|524808347|FG000|Part C (& Follow-up)|Protocol Violation|0|||
145531841|NCT03633617|524808348|FG001|Part C (& Follow-up)|Protocol Violation|0|||
145531842|NCT03633617|524808349|FG002|Part C (& Follow-up)|Protocol Violation|0|||
145531843|NCT03633617|524808350|FG003|Part C (& Follow-up)|Protocol Violation|0|||
145531844|NCT03633617|524808351|FG004|Part C (& Follow-up)|Protocol Violation|0|||
145531845|NCT03633617|524808352|FG005|Part C (& Follow-up)|Protocol Violation|0|||
145531846|NCT03633617|524808353|FG006|Part C (& Follow-up)|Protocol Violation|0|||
145531847|NCT03633617|524808354|FG007|Part C (& Follow-up)|Protocol Violation|0|||
145531848|NCT03633617|524808355|FG008|Part C (& Follow-up)|Protocol Violation|0|||
145756359|NCT01582308|525619926|FG005|Period 4|Physician Decision|1|||
145531849|NCT03633617|524808356|FG009|Part C (& Follow-up)|Protocol Violation|3|||
145531850|NCT03633617|524808357|FG010|Part C (& Follow-up)|Protocol Violation|1|||
145531851|NCT03633617|524808347|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
145531852|NCT03633617|524808348|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
145531853|NCT03633617|524808349|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
145531854|NCT03633617|524808350|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
145756360|NCT01582308|525619927|FG006|Period 4|Physician Decision|0|||
145756361|NCT01582308|525619928|FG007|Period 4|Physician Decision|0|||
145756362|NCT01582308|525619929|FG008|Period 4|Physician Decision|0|||
145531855|NCT03633617|524808351|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
145531856|NCT03633617|524808352|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
145531857|NCT03633617|524808353|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
145531858|NCT03633617|524808354|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
145531859|NCT03633617|524808355|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
145531860|NCT03633617|524808356|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
145531861|NCT03633617|524808357|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
145531862|NCT01890746|524808358|FG000|Overall Study|Death|39|||
145531863|NCT01890746|524808359|FG001|Overall Study|Death|30|||
145531864|NCT01890746|524808358|FG000|Overall Study|Adverse Event|1|||
145531865|NCT01890746|524808359|FG001|Overall Study|Adverse Event|0|||
145531866|NCT01890746|524808358|FG000|Overall Study|Lost to Follow-up|4|||
145531867|NCT01890746|524808359|FG001|Overall Study|Lost to Follow-up|1|||
145531868|NCT01890746|524808358|FG000|Overall Study|Physician Decision|3|||
145531869|NCT01890746|524808359|FG001|Overall Study|Physician Decision|2|||
145531870|NCT01890746|524808358|FG000|Overall Study|Withdrawal by Subject|5|||
145531871|NCT01890746|524808359|FG001|Overall Study|Withdrawal by Subject|8|||
145531872|NCT00777205|524808362|FG000|Overall Study|Lost to Follow-up|25|||
145531873|NCT00777205|524808363|FG001|Overall Study|Lost to Follow-up|9|||
145531874|NCT00777205|524808362|FG000|Overall Study|Withdrawal by Subject|6|||
145531875|NCT00777205|524808363|FG001|Overall Study|Withdrawal by Subject|4|||
145531876|NCT00777205|524808362|FG000|Overall Study|Death|0|||
145531877|NCT00777205|524808363|FG001|Overall Study|Death|2|||
145531878|NCT00777205|524808362|FG000|Overall Study|Protocol Violation|0|||
145531879|NCT00777205|524808363|FG001|Overall Study|Protocol Violation|56|||
145531880|NCT03257371|524808364|FG000|Overall Study|Lost to Follow-up|1|||
145531881|NCT03198078|524808367|FG000|Overall Study|Adverse Event|0|||
145531882|NCT03198078|524808368|FG001|Overall Study|Adverse Event|1|||
145531883|NCT03198078|524808369|FG002|Overall Study|Adverse Event|2|||
145531884|NCT03198078|524808367|FG000|Overall Study|Lack of Efficacy|0|||
145531885|NCT03198078|524808368|FG001|Overall Study|Lack of Efficacy|0|||
145531886|NCT03198078|524808369|FG002|Overall Study|Lack of Efficacy|3|||
145531887|NCT03198078|524808367|FG000|Overall Study|Lost to Follow-up|1|||
145531888|NCT03198078|524808368|FG001|Overall Study|Lost to Follow-up|0|||
145531889|NCT03198078|524808369|FG002|Overall Study|Lost to Follow-up|0|||
145531890|NCT03198078|524808367|FG000|Overall Study|Pregnancy|0|||
145531891|NCT03198078|524808368|FG001|Overall Study|Pregnancy|1|||
145531892|NCT03198078|524808369|FG002|Overall Study|Pregnancy|0|||
145531893|NCT03198078|524808367|FG000|Overall Study|Withdrawal by Subject|1|||
145531894|NCT03198078|524808368|FG001|Overall Study|Withdrawal by Subject|0|||
145531895|NCT03198078|524808369|FG002|Overall Study|Withdrawal by Subject|2|||
145531896|NCT03198078|524808367|FG000|Overall Study|Withdrawal by Caregiver|1|||
145531897|NCT03198078|524808368|FG001|Overall Study|Withdrawal by Caregiver|3|||
145531898|NCT03198078|524808369|FG002|Overall Study|Withdrawal by Caregiver|5|||
145531899|NCT01676727|524808370|FG000|Overall Study|Death|18|||
145531900|NCT01676727|524808370|FG000|Overall Study|Withdrawal by Subject|6|||
145531901|NCT01676727|524808370|FG000|Overall Study|Screening failure|5|||
145531902|NCT01676727|524808370|FG000|Overall Study|Not willing to attend 1-year visit|2|||
145531903|NCT01676727|524808370|FG000|Overall Study|Valve explanted|1|||
145531904|NCT00580970|524808371|FG000|Pre-treatment|Non-compliance|1|||
145273469|NCT05226286|523850066|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
145273470|NCT05226286|523850066|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
145273471|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
145273472|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
145273473|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
145273474|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
145273475|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
145273476|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
145273477|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
145273478|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
145273479|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
145531905|NCT00580970|524808371|FG000|Treatment (Lovastatin)|Non-compliance|6|||
145531906|NCT00580970|524808371|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
145531907|NCT00580970|524808371|FG000|Treatment (Lovastatin)|Physician Decision|4|||
145531908|NCT00580970|524808371|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
145531909|NCT00580970|524808371|FG000|Treatment (Lovastatin)|Death|1|||
145531910|NCT03161093|524808374|FG000|Overall Study|Protocol Violation|11|||
145531911|NCT03161093|524808375|FG001|Overall Study|Protocol Violation|14|||
145531912|NCT03161093|524808376|FG002|Overall Study|Protocol Violation|6|||
145531913|NCT03161093|524808377|FG003|Overall Study|Protocol Violation|13|||
145531914|NCT03161093|524808378|FG004|Overall Study|Protocol Violation|1|||
145531915|NCT03161093|524808379|FG005|Overall Study|Protocol Violation|0|||
145531916|NCT03161093|524808374|FG000|Overall Study|Adverse Event|5|||
145531917|NCT03161093|524808375|FG001|Overall Study|Adverse Event|21|||
145531918|NCT03161093|524808376|FG002|Overall Study|Adverse Event|16|||
145531919|NCT03161093|524808377|FG003|Overall Study|Adverse Event|35|||
145273480|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
145402811|NCT03248037|524332502|FG001|Overall Study|Withdrawal by Subject|9|||
145402812|NCT03248037|524332501|FG000|Overall Study|Adverse Event|15|||
145402813|NCT03248037|524332502|FG001|Overall Study|Adverse Event|0|||
145531920|NCT03161093|524808378|FG004|Overall Study|Adverse Event|2|||
145531921|NCT03161093|524808379|FG005|Overall Study|Adverse Event|1|||
145531922|NCT03161093|524808374|FG000|Overall Study|Lack of Efficacy|9|||
145531923|NCT03161093|524808375|FG001|Overall Study|Lack of Efficacy|13|||
145531924|NCT03161093|524808376|FG002|Overall Study|Lack of Efficacy|9|||
145531925|NCT03161093|524808377|FG003|Overall Study|Lack of Efficacy|24|||
145531926|NCT03161093|524808378|FG004|Overall Study|Lack of Efficacy|4|||
145402814|NCT02897349|524332506|FG000|Overall Study|Lost to Follow-up|2|||
145402815|NCT02897349|524332507|FG001|Overall Study|Lost to Follow-up|2|||
145402816|NCT02897349|524332506|FG000|Overall Study|Adverse Event|3|||
145402817|NCT02897349|524332507|FG001|Overall Study|Adverse Event|3|||
145402818|NCT02897349|524332506|FG000|Overall Study|Other than listed above|0|||
145402819|NCT02897349|524332507|FG001|Overall Study|Other than listed above|1|||
145402820|NCT03435055|524332510|FG000|Screening|Physician Decision|2|||
145402821|NCT03435055|524332510|FG000|Received Intervention|Did not complete nitrous administration|3|||
145402822|NCT01027949|524332515|FG000|Overall Study|Death|174|||
145402823|NCT01027949|524332515|FG000|Overall Study|Progressive Disease|163|||
145402824|NCT01027949|524332515|FG000|Overall Study|Adverse Event|172|||
145402825|NCT01027949|524332515|FG000|Overall Study|Withdrawal by Subject|113|||
145402826|NCT01027949|524332515|FG000|Overall Study|Lost to Follow-up|17|||
145402827|NCT01027949|524332515|FG000|Overall Study|Protocol Violation|13|||
145402828|NCT01027949|524332515|FG000|Overall Study|PI Decision|8|||
145402829|NCT01027949|524332515|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
145402830|NCT01027949|524332515|FG000|Overall Study|Non-compliance with Study Procedures|7|||
145402831|NCT01027949|524332515|FG000|Overall Study|Lung Transplant|5|||
145402832|NCT01027949|524332515|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
145402833|NCT01027949|524332515|FG000|Overall Study|Use of Excluded Medication|2|||
145402834|NCT01027949|524332515|FG000|Overall Study|Patient Self-discontinuation|1|||
145402835|NCT01027949|524332515|FG000|Overall Study|Pregnancy|1|||
145402836|NCT01027949|524332515|FG000|Overall Study|Surgery|1|||
145402837|NCT02765035|524332518|FG000|First Intervention (90 Days)|Adverse Event|1|||
145402838|NCT02765035|524332519|FG001|First Intervention (90 Days)|Adverse Event|1|||
145402839|NCT02765035|524332518|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
145402840|NCT02765035|524332519|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
145402841|NCT00671749|524332523|FG000|Overall Study|Adverse Event|2|||
145402842|NCT00671749|524332523|FG000|Overall Study|Withdrawal by Subject|4|||
145273481|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
145273482|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
145273483|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
145273484|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
145273485|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
145273486|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
145273487|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
145273488|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
145273489|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
145273490|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
145273491|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
145273492|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
145273493|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
145273494|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
145273495|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
145273496|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
145273497|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
145402843|NCT00671749|524332523|FG000|Overall Study|Protocol Violation|1|||
145402844|NCT00671749|524332523|FG000|Overall Study|Lost to Follow-up|1|||
145402845|NCT01259245|524332529|FG000|Overall Study|Withdrawal by Subject|27|||
145402846|NCT01259245|524332530|FG001|Overall Study|Withdrawal by Subject|24|||
145402847|NCT01259245|524332529|FG000|Overall Study|Death|1|||
145402848|NCT01259245|524332530|FG001|Overall Study|Death|2|||
145402849|NCT03451071|524332533|FG000|First Vaccine|Withdrawal by Subject|1|||
145402850|NCT03451071|524332533|FG000|Second Vaccine|Lost to Follow-up|19|||
145402851|NCT03451071|524332533|FG000|Third Vaccine|Lost to Follow-up|22|||
145607584|NCT02296190|525079202|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
145756363|NCT01582308|525619930|FG009|Period 4|Physician Decision|1|||
145756364|NCT00772668|525619938|FG000|Overall Study|Physician Decision|3|||
145756365|NCT01844986|525619939|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
145756366|NCT01844986|525619940|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
145756367|NCT01844986|525619939|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
145756368|NCT01844986|525619940|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
145756369|NCT01844986|525619939|FG000|Overall Study (Global Cohort)|Death|55|||
145756370|NCT01844986|525619940|FG001|Overall Study (Global Cohort)|Death|26|||
145756371|NCT01844986|525619939|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
145756372|NCT01844986|525619940|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
145756373|NCT01844986|525619939|FG000|Overall Study (China Cohort)|Death|10|||
145756374|NCT01844986|525619940|FG001|Overall Study (China Cohort)|Death|6|||
145756375|NCT03406897|525619941|FG000|Overall Study|Lost to Follow-up|1|||
145756376|NCT03406897|525619942|FG001|Overall Study|Lost to Follow-up|2|||
145756377|NCT03406897|525619941|FG000|Overall Study|Withdrawal by Subject|4|||
145756378|NCT03406897|525619942|FG001|Overall Study|Withdrawal by Subject|4|||
145756379|NCT03406897|525619941|FG000|Overall Study|Physician Decision|0|||
145756380|NCT03406897|525619942|FG001|Overall Study|Physician Decision|1|||
145756381|NCT01641939|525622035|FG000|Overall Study|Death|90|||
145756382|NCT01641939|525622036|FG001|Overall Study|Death|187|||
145756383|NCT01641939|525622037|FG002|Overall Study|Death|61|||
145756384|NCT01641939|525622035|FG000|Overall Study|Lost to Follow-up|3|||
145756385|NCT01641939|525622036|FG001|Overall Study|Lost to Follow-up|2|||
145756386|NCT01641939|525622037|FG002|Overall Study|Lost to Follow-up|1|||
145756387|NCT01641939|525622035|FG000|Overall Study|Withdrawal by Subject|14|||
145756388|NCT01641939|525622036|FG001|Overall Study|Withdrawal by Subject|11|||
145607585|NCT02296190|525079203|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
145756389|NCT01641939|525622037|FG002|Overall Study|Withdrawal by Subject|5|||
145756390|NCT01641939|525622035|FG000|Overall Study|Study Terminated by Sponsor|10|||
145756391|NCT01641939|525622036|FG001|Overall Study|Study Terminated by Sponsor|28|||
145756392|NCT01641939|525622037|FG002|Overall Study|Study Terminated by Sponsor|3|||
145756393|NCT02894840|525622038|FG000|Overall Study|Lost to Follow-up|1|||
145756394|NCT02894840|525622039|FG001|Overall Study|Lost to Follow-up|0|||
145756395|NCT02894840|525622040|FG002|Overall Study|Lost to Follow-up|3|||
145756396|NCT02894840|525622041|FG003|Overall Study|Lost to Follow-up|0|||
145756397|NCT01337973|525622045|FG000|Overall Study|Lost to Follow-up|2|||
145756398|NCT01337973|525622046|FG001|Overall Study|Lost to Follow-up|4|||
145756399|NCT01337973|525622047|FG002|Overall Study|Lost to Follow-up|3|||
145756400|NCT01337973|525622045|FG000|Overall Study|Death|1|||
145756401|NCT01337973|525622046|FG001|Overall Study|Death|2|||
145756402|NCT01337973|525622047|FG002|Overall Study|Death|1|||
145756403|NCT01337973|525622045|FG000|Overall Study|Withdrawal by Subject|10|||
145756404|NCT01337973|525622046|FG001|Overall Study|Withdrawal by Subject|8|||
145756405|NCT01337973|525622047|FG002|Overall Study|Withdrawal by Subject|4|||
145756406|NCT01337973|525622045|FG000|Overall Study|missing data on primary outcome|3|||
145756407|NCT01337973|525622046|FG001|Overall Study|missing data on primary outcome|1|||
145756408|NCT01337973|525622047|FG002|Overall Study|missing data on primary outcome|3|||
145756409|NCT01537211|525622054|FG000|Overall Study|Lost to Follow-up|0|||
145756410|NCT01537211|525622055|FG001|Overall Study|Lost to Follow-up|1|||
145756411|NCT00343512|525622061|FG000|Overall Study|Withdrawal by Subject|2|||
145756412|NCT00197054|525622062|FG000|Overall Study|Withdrawal by Subject|9|||
145756413|NCT00197054|525622063|FG001|Overall Study|Withdrawal by Subject|3|||
145756414|NCT00197054|525622064|FG002|Overall Study|Withdrawal by Subject|3|||
145756415|NCT00197054|525622062|FG000|Overall Study|Moved from area|7|||
145756416|NCT00197054|525622063|FG001|Overall Study|Moved from area|14|||
145756417|NCT00197054|525622064|FG002|Overall Study|Moved from area|9|||
145756418|NCT00197054|525622062|FG000|Overall Study|Lost to Follow-up|1|||
145756419|NCT00197054|525622063|FG001|Overall Study|Lost to Follow-up|4|||
145756420|NCT00197054|525622064|FG002|Overall Study|Lost to Follow-up|0|||
145756421|NCT00323557|525622065|FG000|Overall Study|Physician Decision|1|||
145756422|NCT00323557|525622066|FG001|Overall Study|Physician Decision|0|||
145273498|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
145756423|NCT00684515|525622067|FG000|Overall Study|Adverse Event|3|||
145531927|NCT03161093|524808379|FG005|Overall Study|Lack of Efficacy|1|||
145531928|NCT03161093|524808374|FG000|Overall Study|Physician Decision|0|||
145531929|NCT03161093|524808375|FG001|Overall Study|Physician Decision|1|||
145531930|NCT03161093|524808376|FG002|Overall Study|Physician Decision|0|||
145531931|NCT03161093|524808377|FG003|Overall Study|Physician Decision|2|||
145531932|NCT03161093|524808378|FG004|Overall Study|Physician Decision|17|||
145756424|NCT00684515|525622068|FG001|Overall Study|Adverse Event|3|||
145756425|NCT00684515|525622069|FG002|Overall Study|Adverse Event|1|||
145756426|NCT00684515|525622067|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
145756427|NCT00684515|525622068|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
145756428|NCT00684515|525622069|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
145756429|NCT02450578|525622070|FG000|Overall Study|ECG abnormality so not treated|1|||
145756430|NCT02450578|525622071|FG001|Overall Study|ECG abnormality so not treated|0|||
145756431|NCT02450578|525622072|FG002|Overall Study|ECG abnormality so not treated|0|||
145756432|NCT02450578|525622073|FG003|Overall Study|ECG abnormality so not treated|0|||
145756433|NCT04428411|525622076|FG000|Overall Study|Lost to Follow-up|114|||
145756434|NCT00662792|525622077|FG000|Period 1|Personal Reasons|0|||
145756435|NCT00662792|525622078|FG001|Period 1|Personal Reasons|0|||
145756436|NCT00662792|525622079|FG002|Period 1|Personal Reasons|1|||
145756437|NCT00662792|525622080|FG003|Period 1|Personal Reasons|0|||
145756438|NCT00662792|525622077|FG000|Period 1|Refused continuing medication|0|||
145756439|NCT00662792|525622078|FG001|Period 1|Refused continuing medication|1|||
145756440|NCT00662792|525622079|FG002|Period 1|Refused continuing medication|1|||
145756441|NCT00662792|525622080|FG003|Period 1|Refused continuing medication|0|||
145756442|NCT00662792|525622077|FG000|Period 1|Lost to Follow-up|1|||
145756443|NCT00662792|525622078|FG001|Period 1|Lost to Follow-up|0|||
145756444|NCT00662792|525622079|FG002|Period 1|Lost to Follow-up|0|||
145756445|NCT00662792|525622080|FG003|Period 1|Lost to Follow-up|0|||
145756446|NCT00662792|525622077|FG000|Period 1|Other adverse event (AE)|0|||
145756447|NCT00662792|525622078|FG001|Period 1|Other adverse event (AE)|2|||
145756448|NCT00662792|525622079|FG002|Period 1|Other adverse event (AE)|0|||
145756449|NCT00662792|525622080|FG003|Period 1|Other adverse event (AE)|0|||
145756450|NCT00662792|525622077|FG000|Period 1|Worsening of disease under study (AE)|1|||
145756451|NCT00662792|525622078|FG001|Period 1|Worsening of disease under study (AE)|3|||
145756452|NCT00662792|525622079|FG002|Period 1|Worsening of disease under study (AE)|2|||
145756453|NCT00662792|525622080|FG003|Period 1|Worsening of disease under study (AE)|0|||
145756454|NCT00662792|525622077|FG000|Period 1|Not treated|0|||
145531933|NCT03161093|524808379|FG005|Overall Study|Physician Decision|15|||
145531934|NCT03161093|524808374|FG000|Overall Study|Withdrawal by Subject|24|||
145531935|NCT03161093|524808375|FG001|Overall Study|Withdrawal by Subject|73|||
145531936|NCT03161093|524808376|FG002|Overall Study|Withdrawal by Subject|44|||
145756455|NCT00662792|525622078|FG001|Period 1|Not treated|1|||
145756456|NCT00662792|525622079|FG002|Period 1|Not treated|0|||
145756457|NCT00662792|525622080|FG003|Period 1|Not treated|0|||
145756458|NCT00662792|525622077|FG000|Period 2|Worsening of disease under study|1|||
145531937|NCT03161093|524808377|FG003|Overall Study|Withdrawal by Subject|97|||
145531938|NCT03161093|524808378|FG004|Overall Study|Withdrawal by Subject|11|||
145756459|NCT00662792|525622078|FG001|Period 2|Worsening of disease under study|0|||
145756460|NCT00662792|525622079|FG002|Period 2|Worsening of disease under study|0|||
145756461|NCT00662792|525622080|FG003|Period 2|Worsening of disease under study|3|||
145756462|NCT00662792|525622077|FG000|Period 3|Refused continuing medication|1|||
145756463|NCT00662792|525622078|FG001|Period 3|Refused continuing medication|0|||
145756464|NCT00662792|525622079|FG002|Period 3|Refused continuing medication|1|||
145756465|NCT00662792|525622080|FG003|Period 3|Refused continuing medication|0|||
145756466|NCT00662792|525622077|FG000|Period 3|Other adverse event (AE)|0|||
145756467|NCT00662792|525622078|FG001|Period 3|Other adverse event (AE)|0|||
145531939|NCT03161093|524808379|FG005|Overall Study|Withdrawal by Subject|10|||
145531940|NCT03161093|524808374|FG000|Overall Study|Lost to Follow-up|3|||
145531941|NCT03161093|524808375|FG001|Overall Study|Lost to Follow-up|12|||
145531942|NCT03161093|524808376|FG002|Overall Study|Lost to Follow-up|4|||
145531943|NCT03161093|524808377|FG003|Overall Study|Lost to Follow-up|7|||
145531944|NCT03161093|524808378|FG004|Overall Study|Lost to Follow-up|8|||
145531945|NCT03161093|524808379|FG005|Overall Study|Lost to Follow-up|13|||
145531946|NCT03161093|524808374|FG000|Overall Study|Death|3|||
145531947|NCT03161093|524808375|FG001|Overall Study|Death|9|||
145531948|NCT03161093|524808376|FG002|Overall Study|Death|7|||
145531949|NCT03161093|524808377|FG003|Overall Study|Death|9|||
145531950|NCT03161093|524808378|FG004|Overall Study|Death|0|||
145531951|NCT03161093|524808379|FG005|Overall Study|Death|0|||
145531952|NCT03161093|524808374|FG000|Overall Study|Unknown - Not reported|0|||
145531953|NCT03161093|524808375|FG001|Overall Study|Unknown - Not reported|1|||
145531954|NCT03161093|524808376|FG002|Overall Study|Unknown - Not reported|0|||
145531955|NCT03161093|524808377|FG003|Overall Study|Unknown - Not reported|0|||
145531956|NCT03161093|524808378|FG004|Overall Study|Unknown - Not reported|0|||
145531957|NCT03161093|524808379|FG005|Overall Study|Unknown - Not reported|1|||
145531958|NCT01031706|524808380|FG000|Overall Study|Adverse Event|1|||
145531959|NCT01031706|524808381|FG001|Overall Study|Adverse Event|0|||
145531960|NCT01031706|524808380|FG000|Overall Study|Withdrawal by Subject|1|||
145531961|NCT01031706|524808381|FG001|Overall Study|Withdrawal by Subject|1|||
145531962|NCT02124161|524808382|FG000|Overall Study|Other unspecified|0|||
145531963|NCT02124161|524808383|FG001|Overall Study|Other unspecified|1|||
145531964|NCT02124161|524808382|FG000|Overall Study|Death|1|||
145531965|NCT02124161|524808383|FG001|Overall Study|Death|0|||
145531966|NCT02124161|524808382|FG000|Overall Study|Protocol Violation|2|||
145531967|NCT02124161|524808383|FG001|Overall Study|Protocol Violation|1|||
145531968|NCT02124161|524808382|FG000|Overall Study|Withdrawal by Subject|1|||
145531969|NCT02124161|524808383|FG001|Overall Study|Withdrawal by Subject|2|||
145531970|NCT02124161|524808382|FG000|Overall Study|Adverse Event|2|||
145531971|NCT02124161|524808383|FG001|Overall Study|Adverse Event|0|||
145531972|NCT02124161|524808382|FG000|Overall Study|Does not meet entrance criteria|2|||
145531973|NCT02124161|524808383|FG001|Overall Study|Does not meet entrance criteria|3|||
145531974|NCT02124161|524808382|FG000|Overall Study|No longer meets eligibility criteria|5|||
145531975|NCT02124161|524808383|FG001|Overall Study|No longer meets eligibility criteria|4|||
145531976|NCT02124161|524808382|FG000|Overall Study|Lost to Follow-up|3|||
145531977|NCT02124161|524808383|FG001|Overall Study|Lost to Follow-up|4|||
145531978|NCT01008150|524808385|FG000|Overall Study|did not receive study drug|1|||
145607586|NCT02296190|525079204|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
145607587|NCT02296190|525079199|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
145756468|NCT00662792|525622079|FG002|Period 3|Other adverse event (AE)|1|||
145756469|NCT00662792|525622080|FG003|Period 3|Other adverse event (AE)|1|||
145756470|NCT00662792|525622077|FG000|Period 4|Refused continuing medication|0|||
145756471|NCT00662792|525622078|FG001|Period 4|Refused continuing medication|1|||
145756472|NCT00662792|525622079|FG002|Period 4|Refused continuing medication|0|||
145756473|NCT00662792|525622080|FG003|Period 4|Refused continuing medication|0|||
145756474|NCT00662792|525622077|FG000|Period 4|Other adverse event (AE)|1|||
145756475|NCT00662792|525622078|FG001|Period 4|Other adverse event (AE)|0|||
145756476|NCT00662792|525622079|FG002|Period 4|Other adverse event (AE)|0|||
145756477|NCT00662792|525622080|FG003|Period 4|Other adverse event (AE)|0|||
145756478|NCT00662792|525622077|FG000|Period 4|Worsening of disease under study (AE)|0|||
145756479|NCT00662792|525622078|FG001|Period 4|Worsening of disease under study (AE)|0|||
145756480|NCT00662792|525622079|FG002|Period 4|Worsening of disease under study (AE)|0|||
145756481|NCT00662792|525622080|FG003|Period 4|Worsening of disease under study (AE)|1|||
145756482|NCT03021642|525622083|FG000|Washout Period (21 Days)|Adverse Event|1|||
145756483|NCT03021642|525622084|FG001|Washout Period (21 Days)|Adverse Event|1|||
145756484|NCT00090545|525622088|FG000|Overall Study|Disease progression on study|21|||
145756485|NCT00090545|525622089|FG001|Overall Study|Disease progression on study|17|||
145756486|NCT00090545|525622088|FG000|Overall Study|Refused further treatment|1|||
145756487|NCT00090545|525622089|FG001|Overall Study|Refused further treatment|4|||
145756488|NCT00090545|525622088|FG000|Overall Study|Death|0|||
145531979|NCT01008150|524808386|FG001|Overall Study|did not receive study drug|1|||
145531980|NCT01008150|524808387|FG002|Overall Study|did not receive study drug|1|||
145531981|NCT01008150|524808388|FG003|Overall Study|did not receive study drug|0|||
145531982|NCT01309165|524808390|FG000|Overall Study|Lost to Follow-up|4|||
145531983|NCT01309165|524808391|FG001|Overall Study|Lost to Follow-up|3|||
145531984|NCT01309165|524808390|FG000|Overall Study|Return to work|1|||
145531985|NCT01309165|524808391|FG001|Overall Study|Return to work|2|||
145531986|NCT01309165|524808390|FG000|Overall Study|Left country|0|||
145531987|NCT01309165|524808391|FG001|Overall Study|Left country|1|||
145531988|NCT01309165|524808390|FG000|Overall Study|No transportation|0|||
145531989|NCT01309165|524808391|FG001|Overall Study|No transportation|1|||
145531990|NCT01309165|524808390|FG000|Overall Study|Admitted to hospital for second stroke|1|||
145531991|NCT01309165|524808391|FG001|Overall Study|Admitted to hospital for second stroke|0|||
145531992|NCT01497275|524808392|FG000|Overall Study|Death|1|||
145531993|NCT01497275|524808392|FG000|Overall Study|Adverse Event|1|||
145531994|NCT01626495|524808395|FG000|Overall Study|Adverse Event|3|||
145531995|NCT01626495|524808395|FG000|Overall Study|Disease progression|27|||
145531996|NCT01626495|524808395|FG000|Overall Study|Withdrawal by Subject|1|||
145531997|NCT01626495|524808395|FG000|Overall Study|Administrative problem|1|||
145531998|NCT01626495|524808395|FG000|Overall Study|Death|2|||
145531999|NCT01626495|524808395|FG000|Overall Study|Physician Decision|1|||
145532000|NCT01626495|524808395|FG000|Overall Study|New cancer therapy|16|||
145532001|NCT01626495|524808395|FG000|Overall Study|Manufacturing failure|1|||
145532002|NCT01565642|524808396|FG000|Overall Study|Withdrawal by Subject|2|||
145532003|NCT01565642|524808397|FG001|Overall Study|Withdrawal by Subject|1|||
145532004|NCT01934972|524808398|FG000|Overall Study|Withdrawal by Subject|9|||
145532005|NCT01934972|524808399|FG001|Overall Study|Withdrawal by Subject|6|||
145532006|NCT02436681|524808401|FG000|Overall Study|Lost to Follow-up|10|||
145532007|NCT02436681|524808401|FG000|Overall Study|Withdrawal by Subject|2|||
145532008|NCT02436681|524808401|FG000|Overall Study|Death|2|||
145532009|NCT03954132|524808403|FG000|Overall Study|Adverse Event|2|||
145532010|NCT03954132|524808404|FG001|Overall Study|Adverse Event|0|||
145532011|NCT03954132|524808403|FG000|Overall Study|Patient's wish|5|||
145532012|NCT03954132|524808404|FG001|Overall Study|Patient's wish|0|||
145532013|NCT03954132|524808403|FG000|Overall Study|Lost to Follow-up|10|||
145532014|NCT03954132|524808404|FG001|Overall Study|Lost to Follow-up|0|||
145532015|NCT03954132|524808403|FG000|Overall Study|Screening failure|0|||
145532016|NCT03954132|524808404|FG001|Overall Study|Screening failure|1|||
145532017|NCT03954132|524808403|FG000|Overall Study|No registration after Visit 1|5|||
145532018|NCT03954132|524808404|FG001|Overall Study|No registration after Visit 1|2|||
145532019|NCT03954132|524808403|FG000|Overall Study|Other reason than listed|2|||
145532020|NCT03954132|524808404|FG001|Overall Study|Other reason than listed|2|||
145532021|NCT03954132|524808403|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
145532022|NCT03954132|524808404|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
145532023|NCT03954132|524808403|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
145532024|NCT03954132|524808404|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
145532025|NCT00560885|524808408|FG000|Overall Study|Death|7|||
145532026|NCT00560885|524808408|FG000|Overall Study|Withdrawal by Subject|1|||
145532027|NCT01554397|524808409|FG000|Overall Study|Withdrawal by Subject|1|||
145532028|NCT01554397|524808410|FG001|Overall Study|Withdrawal by Subject|0|||
145532029|NCT01554397|524808409|FG000|Overall Study|Ineligible|7|||
145532030|NCT01554397|524808410|FG001|Overall Study|Ineligible|0|||
145532031|NCT01896050|524810000|FG000|Overall Study|Adverse Event|37|||
145532032|NCT01896050|524810001|FG001|Overall Study|Adverse Event|2|||
145532033|NCT01896050|524810000|FG000|Overall Study|Death|1|||
145532034|NCT01896050|524810001|FG001|Overall Study|Death|0|||
145532035|NCT03693300|524810002|FG000|Overall Study|Withdrawal by Subject|6|||
145532036|NCT03693300|524810003|FG001|Overall Study|Withdrawal by Subject|0|||
145532037|NCT03693300|524810002|FG000|Overall Study|Death|50|||
145532038|NCT03693300|524810003|FG001|Overall Study|Death|2|||
145532039|NCT03693300|524810002|FG000|Overall Study|Lost to Follow-up|2|||
145532040|NCT03693300|524810003|FG001|Overall Study|Lost to Follow-up|0|||
145532041|NCT02206048|524810004|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
145532042|NCT01858376|524810005|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
145532043|NCT00108433|524810009|FG000|Overall Study|Lack of Efficacy|1|||
145532044|NCT00108433|524810010|FG001|Overall Study|Lack of Efficacy|2|||
145532045|NCT00108433|524810009|FG000|Overall Study|Death|3|||
145532046|NCT00108433|524810010|FG001|Overall Study|Death|0|||
145532047|NCT00108433|524810009|FG000|Overall Study|Adverse Event|3|||
145532048|NCT00108433|524810010|FG001|Overall Study|Adverse Event|1|||
145532049|NCT00108433|524810009|FG000|Overall Study|Other|14|||
145532050|NCT00108433|524810010|FG001|Overall Study|Other|14|||
145532051|NCT02203071|524810011|FG000|Overall Study|Lost to Follow-up|3|||
145532052|NCT02203071|524810012|FG001|Overall Study|Lost to Follow-up|1|||
145532053|NCT01886716|524810015|FG000|Week 1|Lost to Follow-up|0|||
145532054|NCT01886716|524810016|FG001|Week 1|Lost to Follow-up|0|||
145532055|NCT01886716|524810017|FG002|Week 1|Lost to Follow-up|2|||
145532056|NCT01886716|524810018|FG003|Week 1|Lost to Follow-up|2|||
145532057|NCT01886716|524810015|FG000|Week 2|Lost to Follow-up|3|||
145532058|NCT01886716|524810016|FG001|Week 2|Lost to Follow-up|2|||
145532059|NCT01886716|524810017|FG002|Week 2|Lost to Follow-up|1|||
145532060|NCT01886716|524810018|FG003|Week 2|Lost to Follow-up|3|||
145532061|NCT01886716|524810015|FG000|Week 3|Lost to Follow-up|1|||
145532062|NCT01886716|524810016|FG001|Week 3|Lost to Follow-up|1|||
145532063|NCT01886716|524810017|FG002|Week 3|Lost to Follow-up|0|||
145532064|NCT01886716|524810018|FG003|Week 3|Lost to Follow-up|1|||
145532065|NCT03894046|524810019|FG000|Overall Study|Protocol Violation|1|||
145532066|NCT03894046|524810020|FG001|Overall Study|Protocol Violation|0|||
145532067|NCT03894046|524810021|FG002|Overall Study|Protocol Violation|0|||
145532068|NCT03894046|524810019|FG000|Overall Study|Adverse Event|0|||
145532069|NCT03894046|524810020|FG001|Overall Study|Adverse Event|1|||
145532070|NCT03894046|524810021|FG002|Overall Study|Adverse Event|0|||
145532071|NCT03894046|524810019|FG000|Overall Study|Withdrawal by Subject|2|||
145273499|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
145273500|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
145273501|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
145273502|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
145273503|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
145273504|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
145273505|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
145273506|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
145273507|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
145273508|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
145273509|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
145273510|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
145273511|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
145273512|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
145273513|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
145273514|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
145273515|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
145273516|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
145273517|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
145273518|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
145532072|NCT03894046|524810020|FG001|Overall Study|Withdrawal by Subject|3|||
145532073|NCT03894046|524810021|FG002|Overall Study|Withdrawal by Subject|1|||
145532074|NCT03894046|524810019|FG000|Overall Study|Death|15|||
145532075|NCT03894046|524810020|FG001|Overall Study|Death|21|||
145532076|NCT03894046|524810021|FG002|Overall Study|Death|4|||
145532077|NCT03894046|524810019|FG000|Overall Study|No growth of ABC|2|||
145532078|NCT03894046|524810020|FG001|Overall Study|No growth of ABC|1|||
145532079|NCT03894046|524810021|FG002|Overall Study|No growth of ABC|0|||
145532080|NCT03894046|524810019|FG000|Overall Study|Physician Decision|1|||
145532081|NCT03894046|524810020|FG001|Overall Study|Physician Decision|1|||
145532082|NCT03894046|524810021|FG002|Overall Study|Physician Decision|1|||
145532083|NCT03894046|524810019|FG000|Overall Study|Prohibited concomitant medication|1|||
145532084|NCT03894046|524810020|FG001|Overall Study|Prohibited concomitant medication|0|||
145532085|NCT03894046|524810021|FG002|Overall Study|Prohibited concomitant medication|0|||
145532086|NCT03894046|524810019|FG000|Overall Study|Transferred to other arm/group|1|||
145532087|NCT03894046|524810020|FG001|Overall Study|Transferred to other arm/group|1|||
145532088|NCT03894046|524810021|FG002|Overall Study|Transferred to other arm/group|0|||
145532089|NCT04806503|524810024|FG000|Overall Study|Lost to Follow-up|0|||
145532090|NCT04806503|524810025|FG001|Overall Study|Lost to Follow-up|0|||
145532091|NCT04806503|524810026|FG002|Overall Study|Lost to Follow-up|1|||
145532092|NCT04806503|524810027|FG003|Overall Study|Lost to Follow-up|0|||
145532093|NCT04806503|524810028|FG004|Overall Study|Lost to Follow-up|0|||
145532094|NCT04806503|524810024|FG000|Overall Study|Withdrawal by Subject|1|||
145532095|NCT04806503|524810025|FG001|Overall Study|Withdrawal by Subject|0|||
145532096|NCT04806503|524810026|FG002|Overall Study|Withdrawal by Subject|1|||
145532097|NCT04806503|524810027|FG003|Overall Study|Withdrawal by Subject|1|||
145532098|NCT04806503|524810028|FG004|Overall Study|Withdrawal by Subject|1|||
145532099|NCT04806503|524810024|FG000|Overall Study|Adverse Event|1|||
145532100|NCT04806503|524810025|FG001|Overall Study|Adverse Event|1|||
145532101|NCT04806503|524810026|FG002|Overall Study|Adverse Event|0|||
145532102|NCT04806503|524810027|FG003|Overall Study|Adverse Event|1|||
145532103|NCT04806503|524810028|FG004|Overall Study|Adverse Event|0|||
145532104|NCT03589469|524810029|FG000|Overall Study|Withdrawal by Subject|8|||
145532105|NCT03589469|524810029|FG000|Overall Study|Physician Decision|20|||
145607588|NCT02296190|525079200|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
145532106|NCT03589469|524810029|FG000|Overall Study|Death|97|||
145532107|NCT03589469|524810029|FG000|Overall Study|Lost to Follow-up|8|||
145532108|NCT03589469|524810029|FG000|Overall Study|Miscellaneous|1|||
145607589|NCT02296190|525079201|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
145756489|NCT00090545|525622089|FG001|Overall Study|Death|1|||
145756490|NCT00090545|525622088|FG000|Overall Study|Adverse Event|0|||
145756491|NCT00090545|525622089|FG001|Overall Study|Adverse Event|2|||
145756492|NCT01463098|525622090|FG000|Part A (11 Days)|Participant Choice|2|||
145756493|NCT01463098|525622091|FG001|Part A (11 Days)|Participant Choice|0|||
145756494|NCT01463098|525622092|FG002|Part A (11 Days)|Participant Choice|0|||
145756495|NCT01463098|525622093|FG003|Part A (11 Days)|Participant Choice|0|||
145756496|NCT01463098|525622094|FG004|Part A (11 Days)|Participant Choice|0|||
145756497|NCT01463098|525622095|FG005|Part A (11 Days)|Participant Choice|0|||
145756498|NCT01463098|525622096|FG006|Part A (11 Days)|Participant Choice|0|||
145756499|NCT01463098|525622097|FG007|Part A (11 Days)|Participant Choice|0|||
145756500|NCT01463098|525622098|FG008|Part A (11 Days)|Participant Choice|1|||
145756501|NCT01463098|525622099|FG009|Part A (11 Days)|Participant Choice|0|||
145756502|NCT01463098|525622100|FG010|Part A (11 Days)|Participant Choice|0|||
145756503|NCT01463098|525622101|FG011|Part A (11 Days)|Participant Choice|0|||
145756504|NCT01463098|525622102|FG012|Part A (11 Days)|Participant Choice|0|||
145756505|NCT01463098|525622103|FG013|Part A (11 Days)|Participant Choice|0|||
145756506|NCT01463098|525622090|FG000|Part A (11 Days)|Lost to Follow-up|0|||
145756507|NCT01463098|525622091|FG001|Part A (11 Days)|Lost to Follow-up|0|||
145756508|NCT01463098|525622092|FG002|Part A (11 Days)|Lost to Follow-up|0|||
145756509|NCT01463098|525622093|FG003|Part A (11 Days)|Lost to Follow-up|0|||
145756510|NCT01463098|525622094|FG004|Part A (11 Days)|Lost to Follow-up|1|||
145756511|NCT01463098|525622095|FG005|Part A (11 Days)|Lost to Follow-up|0|||
145756512|NCT01463098|525622096|FG006|Part A (11 Days)|Lost to Follow-up|0|||
145756513|NCT01463098|525622097|FG007|Part A (11 Days)|Lost to Follow-up|0|||
145756514|NCT01463098|525622098|FG008|Part A (11 Days)|Lost to Follow-up|0|||
145756515|NCT01463098|525622099|FG009|Part A (11 Days)|Lost to Follow-up|0|||
145756516|NCT01463098|525622100|FG010|Part A (11 Days)|Lost to Follow-up|0|||
145756517|NCT01463098|525622101|FG011|Part A (11 Days)|Lost to Follow-up|0|||
145756518|NCT01463098|525622102|FG012|Part A (11 Days)|Lost to Follow-up|0|||
145756519|NCT01463098|525622103|FG013|Part A (11 Days)|Lost to Follow-up|0|||
145756520|NCT01463098|525622090|FG000|Part B (11 Days)|Participant Choice|0|||
145756521|NCT01463098|525622091|FG001|Part B (11 Days)|Participant Choice|0|||
145756522|NCT01463098|525622092|FG002|Part B (11 Days)|Participant Choice|0|||
145756523|NCT01463098|525622093|FG003|Part B (11 Days)|Participant Choice|0|||
145756524|NCT01463098|525622094|FG004|Part B (11 Days)|Participant Choice|0|||
145756525|NCT01463098|525622095|FG005|Part B (11 Days)|Participant Choice|0|||
145756526|NCT01463098|525622096|FG006|Part B (11 Days)|Participant Choice|0|||
145756527|NCT01463098|525622097|FG007|Part B (11 Days)|Participant Choice|0|||
145273519|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
145273520|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
145273521|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
145273522|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
145273523|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
145273524|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
145273525|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
145402852|NCT03451071|524332533|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
145402853|NCT02834975|524332534|FG000|Overall Study|Physician Decision|2|||
145402854|NCT02834975|524332534|FG000|Overall Study|Adverse Event|1|||
145402855|NCT02834975|524332534|FG000|Overall Study|Withdrawal by Subject|1|||
145402856|NCT02834975|524332534|FG000|Overall Study|Lack of Efficacy|1|||
145402857|NCT03363906|524332540|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
145402858|NCT03363906|524332541|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
145402859|NCT03363906|524332540|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
145402860|NCT03363906|524332541|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
145402861|NCT03363906|524332540|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
145756528|NCT01463098|525622098|FG008|Part B (11 Days)|Participant Choice|0|||
145756529|NCT01463098|525622099|FG009|Part B (11 Days)|Participant Choice|0|||
145402862|NCT03363906|524332541|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
145402863|NCT03363906|524332540|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
145756530|NCT01463098|525622100|FG010|Part B (11 Days)|Participant Choice|0|||
145756531|NCT01463098|525622101|FG011|Part B (11 Days)|Participant Choice|1|||
145402864|NCT03363906|524332541|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
145402865|NCT02065557|524332544|FG000|Induction Period|Withdrawal by Subject|2|||
145756532|NCT01463098|525622102|FG012|Part B (11 Days)|Participant Choice|0|||
145756533|NCT01463098|525622103|FG013|Part B (11 Days)|Participant Choice|0|||
145756534|NCT01528787|525622104|FG000|Overall Study|Withdrawal by Subject|0|||
145756535|NCT01528787|525622105|FG001|Overall Study|Withdrawal by Subject|0|||
145756536|NCT01528787|525622106|FG002|Overall Study|Withdrawal by Subject|0|||
145756537|NCT01528787|525622107|FG003|Overall Study|Withdrawal by Subject|1|||
145756538|NCT01528787|525622104|FG000|Overall Study|Family Emergency|0|||
145756539|NCT01528787|525622105|FG001|Overall Study|Family Emergency|0|||
145756540|NCT01528787|525622106|FG002|Overall Study|Family Emergency|1|||
145756541|NCT01528787|525622107|FG003|Overall Study|Family Emergency|0|||
145756542|NCT03433781|525622108|FG000|Overall Study|Progression of Disease|1|||
145756543|NCT03433781|525622109|FG001|Overall Study|Progression of Disease|0|||
145756544|NCT03433781|525622110|FG002|Overall Study|Progression of Disease|0|||
145756545|NCT03433781|525622108|FG000|Overall Study|Physician Decision|0|||
145756546|NCT03433781|525622109|FG001|Overall Study|Physician Decision|1|||
145756547|NCT03433781|525622110|FG002|Overall Study|Physician Decision|0|||
145756548|NCT02568046|525622111|FG000|Overall Study|Adverse Event|0|||
145756549|NCT02568046|525622112|FG001|Overall Study|Adverse Event|1|||
145756550|NCT02568046|525622111|FG000|Overall Study|Death|2|||
145756551|NCT02568046|525622112|FG001|Overall Study|Death|0|||
145756552|NCT02568046|525622111|FG000|Overall Study|Progressive Disease|1|||
145756553|NCT02568046|525622112|FG001|Overall Study|Progressive Disease|0|||
145756554|NCT02568046|525622111|FG000|Overall Study|Withdrawal by Subject|2|||
145756555|NCT02568046|525622112|FG001|Overall Study|Withdrawal by Subject|1|||
145756556|NCT02568046|525622111|FG000|Overall Study|Other Events|0|||
145756557|NCT02568046|525622112|FG001|Overall Study|Other Events|1|||
145756558|NCT00744874|525622113|FG000|Overall Study|Lost to Follow-up|1|||
145756559|NCT00744874|525622113|FG000|Overall Study|Withdrawal by Subject|1|||
145756560|NCT00744874|525622113|FG000|Overall Study|Study Device not available at procedure|1|||
145756561|NCT00744874|525622113|FG000|Overall Study|Unable to accomodate schedule|1|||
145756562|NCT02971670|525622116|FG000|Overall Study|Withdrawal by Subject|4|||
145756563|NCT02971670|525622117|FG001|Overall Study|Withdrawal by Subject|1|||
145756564|NCT02971670|525622118|FG002|Overall Study|Withdrawal by Subject|1|||
145756565|NCT02971670|525622119|FG003|Overall Study|Withdrawal by Subject|2|||
145756566|NCT02435849|525622120|FG000|Overall Study|Death|23|||
145756567|NCT02435849|525622121|FG001|Overall Study|Death|0|||
145756568|NCT02435849|525622120|FG000|Overall Study|Lack of Efficacy|10|||
145273526|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
145273527|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
145273528|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
145756569|NCT02435849|525622121|FG001|Overall Study|Lack of Efficacy|0|||
145756570|NCT02435849|525622120|FG000|Overall Study|New therapy for study indication|8|||
145756571|NCT02435849|525622121|FG001|Overall Study|New therapy for study indication|0|||
145756572|NCT02435849|525622120|FG000|Overall Study|Subject/guardian decision|5|||
145756573|NCT02435849|525622121|FG001|Overall Study|Subject/guardian decision|1|||
145756574|NCT02435849|525622120|FG000|Overall Study|Lost to Follow-up|1|||
145756575|NCT02435849|525622121|FG001|Overall Study|Lost to Follow-up|0|||
145756576|NCT02435849|525622120|FG000|Overall Study|Physician Decision|1|||
145756577|NCT02435849|525622121|FG001|Overall Study|Physician Decision|0|||
145756578|NCT03175549|525622122|FG000|Overall Study|Lost to Follow-up|2|||
145756579|NCT03175549|525622123|FG001|Overall Study|Lost to Follow-up|2|||
145273529|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
145273530|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
145273531|NCT03395197|523850067|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
145273532|NCT03395197|523850068|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
145273533|NCT03395197|523850069|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
145273534|NCT03395197|523850070|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
145273535|NCT03395197|523850071|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
145273536|NCT03395197|523850072|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
145273537|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Death|0|||
145273538|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Death|0|||
145273539|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Death|0|||
145273540|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Death|0|||
145273541|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Death|1|||
145273542|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Death|4|||
145273543|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
145273544|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
145756580|NCT03175549|525622122|FG000|Overall Study|Medication non-compliance|2|||
145756581|NCT03175549|525622123|FG001|Overall Study|Medication non-compliance|2|||
145756582|NCT02486757|525622124|FG000|Overall Study|Lost to Follow-up|1|||
145756583|NCT02793232|525622125|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756584|NCT02793232|525622126|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756585|NCT02793232|525622127|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756586|NCT02793232|525622128|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756587|NCT02793232|525622129|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
145756588|NCT02793232|525622130|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756589|NCT02793232|525622131|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
145756590|NCT02793232|525622132|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756591|NCT02793232|525622133|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
145756592|NCT00725075|525622134|FG000|Overall Study|Use of Excluded Medication|0|||
145756593|NCT00725075|525622135|FG001|Overall Study|Use of Excluded Medication|1|||
145756594|NCT00725075|525622136|FG002|Overall Study|Use of Excluded Medication|0|||
145756595|NCT00725075|525622134|FG000|Overall Study|Protocol Violation|0|||
145756596|NCT00725075|525622135|FG001|Overall Study|Protocol Violation|0|||
145756597|NCT00725075|525622136|FG002|Overall Study|Protocol Violation|1|||
145756598|NCT00725075|525622134|FG000|Overall Study|Lost to Follow-up|1|||
145756599|NCT00725075|525622135|FG001|Overall Study|Lost to Follow-up|0|||
145756600|NCT00725075|525622136|FG002|Overall Study|Lost to Follow-up|0|||
145756601|NCT00725075|525622134|FG000|Overall Study|Withdrawal by Subject|4|||
145756602|NCT00725075|525622135|FG001|Overall Study|Withdrawal by Subject|5|||
145756603|NCT00725075|525622136|FG002|Overall Study|Withdrawal by Subject|4|||
145756604|NCT00725075|525622134|FG000|Overall Study|Adverse Event|2|||
145756605|NCT00725075|525622135|FG001|Overall Study|Adverse Event|1|||
145756606|NCT00725075|525622136|FG002|Overall Study|Adverse Event|1|||
145756607|NCT00725075|525622134|FG000|Overall Study|Worsening of Disease|2|||
145756608|NCT00725075|525622135|FG001|Overall Study|Worsening of Disease|1|||
145756609|NCT00725075|525622136|FG002|Overall Study|Worsening of Disease|2|||
145756610|NCT00725075|525622134|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
145756611|NCT00725075|525622135|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
145756612|NCT00725075|525622136|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
145756613|NCT00725075|525622134|FG000|Overall Study|Other|1|||
145756614|NCT00725075|525622135|FG001|Overall Study|Other|0|||
145756615|NCT00725075|525622136|FG002|Overall Study|Other|0|||
145756616|NCT00352105|525622137|FG000|Overall Study|Death|5|||
145756617|NCT00352105|525622137|FG000|Overall Study|Withdrawal by Subject|5|||
145756618|NCT00352105|525622137|FG000|Overall Study|Lack of Efficacy|9|||
145756619|NCT00352105|525622137|FG000|Overall Study|Adverse Event|19|||
145756620|NCT00352105|525622137|FG000|Overall Study|Protocol Violation|2|||
145756621|NCT02979431|525622138|FG000|Overall Study|Parent/guardian withdrew consent|2|||
145756622|NCT02979431|525622139|FG001|Overall Study|Parent/guardian withdrew consent|1|||
145756623|NCT02979431|525622140|FG002|Overall Study|Parent/guardian withdrew consent|1|||
145756624|NCT02979431|525622141|FG003|Overall Study|Parent/guardian withdrew consent|1|||
145756625|NCT02979431|525622138|FG000|Overall Study|Randomized but received no study drug|1|||
145756626|NCT02979431|525622139|FG001|Overall Study|Randomized but received no study drug|1|||
145756627|NCT02979431|525622140|FG002|Overall Study|Randomized but received no study drug|0|||
145756628|NCT02979431|525622141|FG003|Overall Study|Randomized but received no study drug|0|||
145756629|NCT02979431|525622138|FG000|Overall Study|Adverse Event|0|||
145756630|NCT02979431|525622139|FG001|Overall Study|Adverse Event|0|||
145756631|NCT02979431|525622140|FG002|Overall Study|Adverse Event|1|||
145756632|NCT02979431|525622141|FG003|Overall Study|Adverse Event|0|||
145756633|NCT02979431|525622138|FG000|Overall Study|Subject left country after Day14|1|||
145756634|NCT02979431|525622139|FG001|Overall Study|Subject left country after Day14|0|||
145756635|NCT02979431|525622140|FG002|Overall Study|Subject left country after Day14|0|||
145756636|NCT02979431|525622141|FG003|Overall Study|Subject left country after Day14|0|||
145756637|NCT01235962|525622142|FG000|Overall Study|Withdrawal by Subject|20|||
145756638|NCT01235962|525622143|FG001|Overall Study|Withdrawal by Subject|19|||
145756639|NCT01235962|525622144|FG002|Overall Study|Withdrawal by Subject|62|||
145756640|NCT01235962|525622145|FG003|Overall Study|Withdrawal by Subject|49|||
145756641|NCT01235962|525622142|FG000|Overall Study|Lost to Follow-up|21|||
145756642|NCT01235962|525622143|FG001|Overall Study|Lost to Follow-up|16|||
145756643|NCT01235962|525622144|FG002|Overall Study|Lost to Follow-up|47|||
145756644|NCT01235962|525622145|FG003|Overall Study|Lost to Follow-up|32|||
145756645|NCT01235962|525622142|FG000|Overall Study|Physician Decision|5|||
145756646|NCT01235962|525622143|FG001|Overall Study|Physician Decision|0|||
145756647|NCT01235962|525622144|FG002|Overall Study|Physician Decision|9|||
145756648|NCT01235962|525622145|FG003|Overall Study|Physician Decision|5|||
145756649|NCT01405053|525622146|FG000|Overall Study|Adverse Event|3|||
145756650|NCT01405053|525622147|FG001|Overall Study|Adverse Event|0|||
145756651|NCT01405053|525622146|FG000|Overall Study|Lost to Follow-up|0|||
145756652|NCT01405053|525622147|FG001|Overall Study|Lost to Follow-up|1|||
145756653|NCT01405053|525622146|FG000|Overall Study|Participant choice|2|||
145756654|NCT01405053|525622147|FG001|Overall Study|Participant choice|1|||
145756655|NCT01405053|525622146|FG000|Overall Study|Inadequate therapeutic effect|2|||
145756656|NCT01405053|525622147|FG001|Overall Study|Inadequate therapeutic effect|1|||
145756657|NCT01405053|525622146|FG000|Overall Study|Withdrawal by Subject|3|||
145756658|NCT01405053|525622147|FG001|Overall Study|Withdrawal by Subject|4|||
145756659|NCT01405053|525622146|FG000|Overall Study|Other|0|||
145756660|NCT01405053|525622147|FG001|Overall Study|Other|1|||
145756661|NCT03979274|525622169|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145756662|NCT03979274|525622170|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145756663|NCT02301403|525622171|FG000|Overall Study|Withdrawal by Subject|28|||
145756664|NCT02301403|525622172|FG001|Overall Study|Withdrawal by Subject|41|||
145756665|NCT01060059|525622173|FG000|Overall Study|Adverse Event|1|||
145756666|NCT01060059|525622174|FG001|Overall Study|Adverse Event|1|||
145756667|NCT01060059|525622173|FG000|Overall Study|Death|2|||
145756668|NCT01060059|525622174|FG001|Overall Study|Death|3|||
145756669|NCT01060059|525622173|FG000|Overall Study|Lost to Follow-up|18|||
145756670|NCT01060059|525622174|FG001|Overall Study|Lost to Follow-up|34|||
145756671|NCT01060059|525622173|FG000|Overall Study|entry criteria not met|4|||
145756672|NCT01060059|525622174|FG001|Overall Study|entry criteria not met|3|||
145756673|NCT01060059|525622173|FG000|Overall Study|Withdrawal by Subject|35|||
145756674|NCT01060059|525622174|FG001|Overall Study|Withdrawal by Subject|23|||
145756675|NCT01060059|525622173|FG000|Overall Study|lack of glycemic control|2|||
145756676|NCT01060059|525622174|FG001|Overall Study|lack of glycemic control|1|||
145756677|NCT01060059|525622173|FG000|Overall Study|lack of compliance|5|||
145756678|NCT01060059|525622174|FG001|Overall Study|lack of compliance|2|||
145756679|NCT01816243|525622175|FG000|Overall Study|Adverse Event|6|||
145756680|NCT01816243|525622175|FG000|Overall Study|Lost to Follow-up|1|||
145756681|NCT01816243|525622175|FG000|Overall Study|Lack of Efficacy|1|||
145756682|NCT01816243|525622175|FG000|Overall Study|Not eligible for the study|1|||
145756683|NCT01816243|525622175|FG000|Overall Study|Amputation|3|||
145756684|NCT01920711|525622176|FG000|Overall Study|Death|347|||
145273545|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
145756685|NCT01920711|525622177|FG001|Overall Study|Death|356|||
145756686|NCT01920711|525622176|FG000|Overall Study|Lost to Follow-up|13|||
145756687|NCT01920711|525622177|FG001|Overall Study|Lost to Follow-up|14|||
145273546|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
145756688|NCT01920711|525622176|FG000|Overall Study|Withdrawal by Subject|4|||
145756689|NCT01920711|525622177|FG001|Overall Study|Withdrawal by Subject|3|||
145756690|NCT02319044|525622180|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
145756691|NCT02319044|525622181|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
145756692|NCT02319044|525622182|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
145756693|NCT02319044|525622180|FG000|Overall Study|Withdrawal by Subject|3|||
145756694|NCT02319044|525622181|FG001|Overall Study|Withdrawal by Subject|3|||
145756695|NCT02319044|525622182|FG002|Overall Study|Withdrawal by Subject|6|||
145756696|NCT02319044|525622180|FG000|Overall Study|Condition under investigation worsened|100|||
145756697|NCT02319044|525622181|FG001|Overall Study|Condition under investigation worsened|50|||
145756698|NCT02319044|525622182|FG002|Overall Study|Condition under investigation worsened|46|||
145756699|NCT02319044|525622180|FG000|Overall Study|Adverse Event|17|||
145756700|NCT02319044|525622181|FG001|Overall Study|Adverse Event|2|||
145756701|NCT02319044|525622182|FG002|Overall Study|Adverse Event|8|||
145756702|NCT02319044|525622180|FG000|Overall Study|Study specific discontinuation criteria|2|||
145756703|NCT02319044|525622181|FG001|Overall Study|Study specific discontinuation criteria|2|||
145756704|NCT02319044|525622182|FG002|Overall Study|Study specific discontinuation criteria|1|||
145756705|NCT02319044|525622180|FG000|Overall Study|Not treated|0|||
145756706|NCT02319044|525622181|FG001|Overall Study|Not treated|2|||
145756707|NCT02319044|525622182|FG002|Overall Study|Not treated|2|||
145756708|NCT03551743|525622183|FG000|Overall Study|Adverse Event|1|||
145756709|NCT03551743|525622184|FG001|Overall Study|Adverse Event|0|||
145756710|NCT03551743|525622185|FG002|Overall Study|Adverse Event|0|||
145756711|NCT03551743|525622186|FG003|Overall Study|Adverse Event|0|||
145756712|NCT03551743|525622183|FG000|Overall Study|Withdrawal by Subject|1|||
145756713|NCT03551743|525622184|FG001|Overall Study|Withdrawal by Subject|0|||
145756714|NCT03551743|525622185|FG002|Overall Study|Withdrawal by Subject|0|||
145756715|NCT03551743|525622186|FG003|Overall Study|Withdrawal by Subject|0|||
145756716|NCT00573794|525622191|FG000|Overall Study|Adverse Event|81|||
145756717|NCT00573794|525622191|FG000|Overall Study|Withdrew Consent|90|||
145756718|NCT00573794|525622191|FG000|Overall Study|Lost to Follow-up|13|||
145756719|NCT00573794|525622191|FG000|Overall Study|Protocol Violation|6|||
145756720|NCT00573794|525622191|FG000|Overall Study|Lack of Efficacy|94|||
145756721|NCT00573794|525622191|FG000|Overall Study|Other|46|||
145756722|NCT00500682|525622197|FG000|Overall Study|Adverse Event|37|||
145756723|NCT00500682|525622198|FG001|Overall Study|Adverse Event|29|||
145756724|NCT00500682|525622197|FG000|Overall Study|Death|25|||
145756725|NCT00500682|525622198|FG001|Overall Study|Death|16|||
145756726|NCT00500682|525622197|FG000|Overall Study|Lost to Follow-up|11|||
145756727|NCT00500682|525622198|FG001|Overall Study|Lost to Follow-up|11|||
145756728|NCT00500682|525622197|FG000|Overall Study|Physician Decision|6|||
145756729|NCT00500682|525622198|FG001|Overall Study|Physician Decision|10|||
145756730|NCT00500682|525622197|FG000|Overall Study|Pregnancy|2|||
145756731|NCT00500682|525622198|FG001|Overall Study|Pregnancy|0|||
145756732|NCT00500682|525622197|FG000|Overall Study|Protocol Violation|1|||
145756733|NCT00500682|525622198|FG001|Overall Study|Protocol Violation|3|||
145756734|NCT00500682|525622197|FG000|Overall Study|Withdrawal by Subject|80|||
145756735|NCT00500682|525622198|FG001|Overall Study|Withdrawal by Subject|74|||
145756736|NCT00500682|525622197|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
145756737|NCT00500682|525622198|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
145756738|NCT02531646|525622199|FG000|Overall Study|equip. image processing issue|5|||
145756739|NCT02531646|525622200|FG001|Overall Study|equip. image processing issue|1|||
145756740|NCT02531646|525622201|FG002|Overall Study|equip. image processing issue|0|||
145756741|NCT03631706|525622205|FG000|Overall Study|Randomized, not treated|1|||
145756742|NCT03631706|525622206|FG001|Overall Study|Randomized, not treated|0|||
145756743|NCT00865020|525622213|FG000|Overall Study|Withdrawal by Subject|22|||
145532109|NCT02202837|524810030|FG000|Overall Study|Enbrel treatment discontinued|36|||
145532110|NCT02202837|524810031|FG001|Overall Study|Enbrel treatment discontinued|4|||
145756744|NCT00865020|525622214|FG001|Overall Study|Withdrawal by Subject|16|||
145756745|NCT00865020|525622213|FG000|Overall Study|Adverse Event|9|||
145532111|NCT02202837|524810030|FG000|Overall Study|Other|10|||
145532112|NCT02202837|524810031|FG001|Overall Study|Other|0|||
145532113|NCT02202837|524810030|FG000|Overall Study|Lost to Follow-up|7|||
145532114|NCT02202837|524810031|FG001|Overall Study|Lost to Follow-up|1|||
145532115|NCT00734474|524810035|FG000|Overall Study|Entry Criteria Not Met|0|||
145532116|NCT00734474|524810036|FG001|Overall Study|Entry Criteria Not Met|0|||
145756746|NCT00865020|525622214|FG001|Overall Study|Adverse Event|14|||
145756747|NCT00865020|525622213|FG000|Overall Study|Abnormal test procedure result(s)|6|||
145756748|NCT00865020|525622214|FG001|Overall Study|Abnormal test procedure result(s)|8|||
145756749|NCT00865020|525622213|FG000|Overall Study|Lost to Follow-up|6|||
145756750|NCT00865020|525622214|FG001|Overall Study|Lost to Follow-up|4|||
145756751|NCT00865020|525622213|FG000|Overall Study|Protocol deviation|4|||
145756752|NCT00865020|525622214|FG001|Overall Study|Protocol deviation|1|||
145756753|NCT00865020|525622213|FG000|Overall Study|Administrative problems|0|||
145756754|NCT00865020|525622214|FG001|Overall Study|Administrative problems|2|||
145756755|NCT00865020|525622213|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145756756|NCT00865020|525622214|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145756757|NCT00865020|525622213|FG000|Overall Study|Death|0|||
145273547|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
145273548|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
145273549|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
145273550|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
145273551|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
145273552|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
145273553|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
145273554|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
145273555|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
145273556|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
145273557|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
145273558|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
145273559|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
145273560|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
145273561|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
145273562|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
145273563|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
145273564|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
145273565|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
145273566|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
145273567|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
145273568|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
145273569|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
145273570|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
145273571|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
145273572|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
145273573|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
145273574|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
145273575|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
145273576|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
145273577|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
145273578|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
145273579|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Other|0|||
145273580|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Other|0|||
145273581|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Other|0|||
145273582|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Other|0|||
145273583|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Other|3|||
145273584|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Other|3|||
145273585|NCT03395197|523850067|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
145273586|NCT03395197|523850068|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
145273587|NCT03395197|523850069|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
145273588|NCT03395197|523850070|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
145273589|NCT03395197|523850071|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
145273590|NCT03395197|523850072|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
145273591|NCT04701658|523850073|FG000|Overall Study|Lost to Follow-up|6|||
145273592|NCT04101721|523850077|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
145273593|NCT04101721|523850078|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
145273594|NCT04101721|523850077|FG000|Overall Study|Death|0|||
145273595|NCT04101721|523850078|FG001|Overall Study|Death|1|||
145273596|NCT04101721|523850077|FG000|Overall Study|Lost to Follow-up|0|||
145273597|NCT04101721|523850078|FG001|Overall Study|Lost to Follow-up|3|||
145273598|NCT00756652|523850079|FG000|Original Phase|Withdrawal by Subject|864|||
145273599|NCT00756652|523850080|FG001|Original Phase|Withdrawal by Subject|23|||
145273600|NCT00756652|523850079|FG000|Original Phase|Lost to Follow-up|601|||
145756758|NCT00865020|525622214|FG001|Overall Study|Death|1|||
145273601|NCT00756652|523850080|FG001|Original Phase|Lost to Follow-up|0|||
145273602|NCT00756652|523850079|FG000|Original Phase|Other Discontinuation|797|||
145273603|NCT00756652|523850080|FG001|Original Phase|Other Discontinuation|5|||
145402866|NCT02065557|524332545|FG001|Induction Period|Withdrawal by Subject|1|||
145402867|NCT02065557|524332546|FG002|Induction Period|Withdrawal by Subject|0|||
145532117|NCT00734474|524810037|FG002|Overall Study|Entry Criteria Not Met|5|||
145532118|NCT00734474|524810038|FG003|Overall Study|Entry Criteria Not Met|0|||
145532119|NCT00734474|524810039|FG004|Overall Study|Entry Criteria Not Met|3|||
145402868|NCT02065557|524332547|FG003|Induction Period|Withdrawal by Subject|0|||
145402869|NCT02065557|524332548|FG004|Induction Period|Withdrawal by Subject|0|||
145532120|NCT00734474|524810040|FG005|Overall Study|Entry Criteria Not Met|1|||
145532121|NCT00734474|524810041|FG006|Overall Study|Entry Criteria Not Met|0|||
145756759|NCT00865020|525622213|FG000|Overall Study|Randomized but discontinued|2|||
145756760|NCT00865020|525622214|FG001|Overall Study|Randomized but discontinued|4|||
145756761|NCT01227902|525623544|FG000|Overall Study|Adverse Event|12|||
145756762|NCT01227902|525623545|FG001|Overall Study|Adverse Event|8|||
145756763|NCT01227902|525623546|FG002|Overall Study|Adverse Event|11|||
145756764|NCT01227902|525623547|FG003|Overall Study|Adverse Event|4|||
145756765|NCT01227902|525623544|FG000|Overall Study|Lack of Efficacy|1|||
145756766|NCT01227902|525623545|FG001|Overall Study|Lack of Efficacy|2|||
145756767|NCT01227902|525623546|FG002|Overall Study|Lack of Efficacy|2|||
145756768|NCT01227902|525623547|FG003|Overall Study|Lack of Efficacy|1|||
145756769|NCT01227902|525623544|FG000|Overall Study|Protocol Violation|1|||
145756770|NCT01227902|525623545|FG001|Overall Study|Protocol Violation|0|||
145756771|NCT01227902|525623546|FG002|Overall Study|Protocol Violation|0|||
145756772|NCT01227902|525623547|FG003|Overall Study|Protocol Violation|0|||
145756773|NCT01227902|525623544|FG000|Overall Study|Lost to Follow-up|0|||
145756774|NCT01227902|525623545|FG001|Overall Study|Lost to Follow-up|0|||
145756775|NCT01227902|525623546|FG002|Overall Study|Lost to Follow-up|1|||
145756776|NCT01227902|525623547|FG003|Overall Study|Lost to Follow-up|2|||
145756777|NCT01227902|525623544|FG000|Overall Study|Physician Decision|0|||
145756778|NCT01227902|525623545|FG001|Overall Study|Physician Decision|1|||
145756779|NCT01227902|525623546|FG002|Overall Study|Physician Decision|1|||
145756780|NCT01227902|525623547|FG003|Overall Study|Physician Decision|0|||
145756781|NCT01227902|525623544|FG000|Overall Study|Withdrawal by Subject|4|||
145756782|NCT01227902|525623545|FG001|Overall Study|Withdrawal by Subject|2|||
145756783|NCT01227902|525623546|FG002|Overall Study|Withdrawal by Subject|4|||
145756784|NCT01227902|525623547|FG003|Overall Study|Withdrawal by Subject|3|||
145756785|NCT05280756|525623548|FG000|Overall Study|Lost to Follow-up|1|||
145756786|NCT05280756|525623549|FG001|Overall Study|Lost to Follow-up|1|||
145756787|NCT00930059|525623550|FG000|Overall Study|Death|1|||
145756788|NCT00930059|525623551|FG001|Overall Study|Death|0|||
145756789|NCT00930059|525623550|FG000|Overall Study|Did not meet entrance criteria|1|||
145756790|NCT00930059|525623551|FG001|Overall Study|Did not meet entrance criteria|1|||
145756791|NCT00930059|525623550|FG000|Overall Study|Withdrawal by Subject|3|||
145756792|NCT00930059|525623551|FG001|Overall Study|Withdrawal by Subject|4|||
145756793|NCT00930059|525623550|FG000|Overall Study|Other|1|||
145756794|NCT00930059|525623551|FG001|Overall Study|Other|0|||
145756795|NCT00930059|525623550|FG000|Overall Study|1 site terminated by sponsor|1|||
145756796|NCT00930059|525623551|FG001|Overall Study|1 site terminated by sponsor|1|||
145756797|NCT00930059|525623550|FG000|Overall Study|Adverse Event|1|||
145756798|NCT00930059|525623551|FG001|Overall Study|Adverse Event|6|||
145756799|NCT03064763|525623552|FG000|Overall Study|Lost to Follow-up|1|||
145756800|NCT03064763|525623552|FG000|Overall Study|Death|8|||
145756801|NCT00619502|525623553|FG000|Overall Study|Lost to Follow-up|8|||
145756802|NCT00619502|525623554|FG001|Overall Study|Lost to Follow-up|10|||
145756803|NCT03968419|525623555|FG000|Treatment Period|Adverse Event|0|||
145756804|NCT03968419|525623556|FG001|Treatment Period|Adverse Event|0|||
145756805|NCT03968419|525623557|FG002|Treatment Period|Adverse Event|1|||
145532122|NCT00734474|524810042|FG007|Overall Study|Entry Criteria Not Met|1|||
145532123|NCT00734474|524810043|FG008|Overall Study|Entry Criteria Not Met|1|||
145532124|NCT00734474|524810035|FG000|Overall Study|Lost to Follow-up|1|||
145532125|NCT00734474|524810036|FG001|Overall Study|Lost to Follow-up|0|||
145532126|NCT00734474|524810037|FG002|Overall Study|Lost to Follow-up|13|||
145532127|NCT00734474|524810038|FG003|Overall Study|Lost to Follow-up|0|||
145756806|NCT03968419|525623555|FG000|Safety Follow-up Period|Death|3|||
145756807|NCT03968419|525623556|FG001|Safety Follow-up Period|Death|2|||
145756808|NCT03968419|525623557|FG002|Safety Follow-up Period|Death|1|||
145756809|NCT03968419|525623555|FG000|Safety Follow-up Period|Subject Decision|2|||
145756810|NCT03968419|525623556|FG001|Safety Follow-up Period|Subject Decision|1|||
145756811|NCT03968419|525623557|FG002|Safety Follow-up Period|Subject Decision|0|||
145756812|NCT00804687|525623558|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
145756813|NCT00804687|525623559|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
145756814|NCT00804687|525623560|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
145756815|NCT00804687|525623561|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
145756816|NCT00804687|525623562|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
145756817|NCT00804687|525623563|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
145756818|NCT00804687|525623558|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
145756819|NCT00804687|525623559|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
145756820|NCT00804687|525623560|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
145756821|NCT00804687|525623561|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
145756822|NCT00804687|525623562|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
145273604|NCT00756652|523850079|FG000|Original Phase|Participant Noncompliance|18622|||
145273605|NCT00756652|523850080|FG001|Original Phase|Participant Noncompliance|424|||
145273606|NCT00756652|523850079|FG000|Original Phase|Unknown Discontinuation Reason|2|||
145273607|NCT00756652|523850080|FG001|Original Phase|Unknown Discontinuation Reason|0|||
145273608|NCT00756652|523850079|FG000|Original Phase|Participants without data|3259|||
145273609|NCT00756652|523850080|FG001|Original Phase|Participants without data|466|||
145273610|NCT00756652|523850079|FG000|Original Phase|Death|168|||
145273611|NCT00756652|523850080|FG001|Original Phase|Death|1|||
145273612|NCT00756652|523850079|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
145273613|NCT00756652|523850080|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
145273614|NCT00756652|523850079|FG000|Re-Op Phase|Withdrawal by Subject|62|||
145273615|NCT00756652|523850080|FG001|Re-Op Phase|Withdrawal by Subject|0|||
145273616|NCT00756652|523850079|FG000|Re-Op Phase|Death|6|||
145273617|NCT00756652|523850080|FG001|Re-Op Phase|Death|0|||
145273618|NCT00756652|523850079|FG000|Re-Op Phase|Lost to Follow-up|340|||
145273619|NCT00756652|523850080|FG001|Re-Op Phase|Lost to Follow-up|0|||
145273620|NCT00756652|523850079|FG000|Re-Op Phase|Site Closed|2454|||
145273621|NCT00756652|523850080|FG001|Re-Op Phase|Site Closed|0|||
145273622|NCT00756652|523850079|FG000|Re-Op Phase|Withdrawn after explant|14|||
145273623|NCT00756652|523850080|FG001|Re-Op Phase|Withdrawn after explant|0|||
145273624|NCT02564952|523850081|FG000|Overall Study|Adverse Event|6|||
145273625|NCT02564952|523850081|FG000|Overall Study|Lost to Follow-up|1|||
145273626|NCT02564952|523850081|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
145273627|NCT02564952|523850081|FG000|Overall Study|Withdrawal by Subject|1|||
145273628|NCT02564952|523850081|FG000|Overall Study|Low Efficacy|1|||
145756823|NCT00804687|525623563|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
145756824|NCT00804687|525623558|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
145756825|NCT00804687|525623559|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
145756826|NCT00804687|525623560|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
145756827|NCT00804687|525623561|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
145756828|NCT00804687|525623562|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
145756829|NCT00804687|525623563|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
145756830|NCT00804687|525623558|FG000|Period 5: Treatment Period|Positive drug test|1|||
145756831|NCT00804687|525623559|FG001|Period 5: Treatment Period|Positive drug test|0|||
145756832|NCT00804687|525623560|FG002|Period 5: Treatment Period|Positive drug test|0|||
145273629|NCT02564952|523850081|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
145273630|NCT01215955|523850082|FG000|Overall Study|Adverse Event|1|||
145273631|NCT01215955|523850083|FG001|Overall Study|Adverse Event|4|||
145273632|NCT01215955|523850084|FG002|Overall Study|Adverse Event|2|||
145273633|NCT01215955|523850085|FG003|Overall Study|Adverse Event|3|||
145273634|NCT01215955|523850082|FG000|Overall Study|Death|2|||
145273635|NCT01215955|523850083|FG001|Overall Study|Death|0|||
145273636|NCT01215955|523850084|FG002|Overall Study|Death|1|||
145273637|NCT01215955|523850085|FG003|Overall Study|Death|3|||
145756833|NCT00804687|525623561|FG003|Period 5: Treatment Period|Positive drug test|0|||
145756834|NCT00804687|525623562|FG004|Period 5: Treatment Period|Positive drug test|0|||
145756835|NCT00804687|525623563|FG005|Period 5: Treatment Period|Positive drug test|0|||
145756836|NCT02397473|525623568|FG000|Treatment Phase|Adverse Event|1|||
145756837|NCT02397473|525623569|FG001|Treatment Phase|Adverse Event|2|||
145756838|NCT02397473|525623568|FG000|Treatment Phase|Lack of Efficacy|8|||
145756839|NCT02397473|525623569|FG001|Treatment Phase|Lack of Efficacy|1|||
145756840|NCT02397473|525623568|FG000|Treatment Phase|Lost to Follow-up|1|||
145756841|NCT02397473|525623569|FG001|Treatment Phase|Lost to Follow-up|0|||
145756842|NCT02397473|525623568|FG000|Treatment Phase|Withdrawal by Subject|2|||
145756843|NCT02397473|525623569|FG001|Treatment Phase|Withdrawal by Subject|1|||
145756844|NCT02397473|525623568|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
145756845|NCT02397473|525623569|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
145756846|NCT02397473|525623568|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
145756847|NCT02397473|525623569|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
145273638|NCT01215955|523850082|FG000|Overall Study|Entry Criteria Not Met|1|||
145273639|NCT01215955|523850083|FG001|Overall Study|Entry Criteria Not Met|3|||
145273640|NCT01215955|523850084|FG002|Overall Study|Entry Criteria Not Met|4|||
145273641|NCT01215955|523850085|FG003|Overall Study|Entry Criteria Not Met|7|||
145273642|NCT01215955|523850082|FG000|Overall Study|Lack of Efficacy|1|||
145273643|NCT01215955|523850083|FG001|Overall Study|Lack of Efficacy|2|||
145402870|NCT02065557|524332549|FG005|Induction Period|Withdrawal by Subject|0|||
145756848|NCT02397473|525623568|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
145756849|NCT02397473|525623569|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
145273644|NCT01215955|523850084|FG002|Overall Study|Lack of Efficacy|1|||
145273645|NCT01215955|523850085|FG003|Overall Study|Lack of Efficacy|0|||
145273646|NCT01215955|523850082|FG000|Overall Study|Lost to Follow-up|4|||
145756850|NCT02397473|525623568|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
145756851|NCT02397473|525623569|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
145756852|NCT02397473|525623568|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
145756853|NCT02397473|525623569|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
145756854|NCT01001702|525623571|FG000|Overall Study|Lost to Follow-up|7|||
145756855|NCT01001702|525623571|FG000|Overall Study|Adverse Event|7|||
145756856|NCT01001702|525623571|FG000|Overall Study|Sponsor Discontinued Study|4|||
145756857|NCT01001702|525623571|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
145756858|NCT01001702|525623571|FG000|Overall Study|Investigator withdrew Subject|10|||
145756859|NCT01001702|525623571|FG000|Overall Study|Withdrawal by Subject|19|||
145756860|NCT01001702|525623571|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
145756861|NCT02494596|525623574|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145756862|NCT02494596|525623575|FG001|Overall Study|Insufficient Therapeutic Response|3|||
145756863|NCT02494596|525623576|FG002|Overall Study|Insufficient Therapeutic Response|1|||
145756864|NCT02494596|525623574|FG000|Overall Study|Adverse Event|0|||
145756865|NCT02494596|525623575|FG001|Overall Study|Adverse Event|1|||
145756866|NCT02494596|525623576|FG002|Overall Study|Adverse Event|0|||
145756867|NCT02494596|525623574|FG000|Overall Study|Refused Treatment|0|||
145756868|NCT02494596|525623575|FG001|Overall Study|Refused Treatment|1|||
145756869|NCT02494596|525623576|FG002|Overall Study|Refused Treatment|0|||
145756870|NCT00634569|525623579|FG000|Overall Study|Withdrawal by Subject|0|||
145756871|NCT00634569|525623580|FG001|Overall Study|Withdrawal by Subject|4|||
145756872|NCT00634569|525623579|FG000|Overall Study|Physician Decision|0|||
145756873|NCT00634569|525623580|FG001|Overall Study|Physician Decision|1|||
145756874|NCT01163786|525623581|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
145756875|NCT01163786|525623581|FG000|Treatment With Bortezomib|Adverse Event|2|||
145532128|NCT00734474|524810039|FG004|Overall Study|Lost to Follow-up|11|||
145756876|NCT01163786|525623581|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
145756877|NCT01212185|525623582|FG000|Overall Study|Protocol Violation|2|||
145756878|NCT01212185|525623583|FG001|Overall Study|Protocol Violation|1|||
145756879|NCT02809833|525623586|FG000|Overall Study|Death|3|||
145756880|NCT02809833|525623586|FG000|Overall Study|Intolerance|54|||
145756881|NCT02809833|525623586|FG000|Overall Study|Lack of Efficacy|89|||
145756882|NCT02809833|525623586|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
145756883|NCT02809833|525623586|FG000|Overall Study|Noncompliance|1|||
145756884|NCT02809833|525623586|FG000|Overall Study|Withdrawal by Subject|34|||
145756885|NCT02809833|525623586|FG000|Overall Study|Lost to Follow-up|35|||
145756886|NCT02809833|525623586|FG000|Overall Study|Adverse Event (AE)|24|||
145756887|NCT02809833|525623586|FG000|Overall Study|Other|5|||
145756888|NCT02809833|525623586|FG000|Overall Study|Missing Information|52|||
145756889|NCT00523991|525623587|FG000|Overall Study|Adverse Event|6|||
145756890|NCT00523991|525623588|FG001|Overall Study|Adverse Event|5|||
145756891|NCT00523991|525623587|FG000|Overall Study|Protocol Violation|1|||
145756892|NCT00523991|525623588|FG001|Overall Study|Protocol Violation|4|||
145756893|NCT00523991|525623587|FG000|Overall Study|Lost to Follow-up|4|||
145756894|NCT00523991|525623588|FG001|Overall Study|Lost to Follow-up|1|||
145756895|NCT00523991|525623587|FG000|Overall Study|Withdrawal by Subject|7|||
145756896|NCT00523991|525623588|FG001|Overall Study|Withdrawal by Subject|17|||
145756897|NCT00523991|525623587|FG000|Overall Study|Other reason (not specified)|3|||
145756898|NCT00523991|525623588|FG001|Overall Study|Other reason (not specified)|0|||
145756899|NCT00193063|525623589|FG000|Overall Study|Lack of Efficacy|3|||
145756900|NCT00193063|525623589|FG000|Overall Study|Adverse Event|1|||
145756901|NCT01700192|525623590|FG000|Overall Study|Adverse Event|73|||
145756902|NCT01700192|525623591|FG001|Overall Study|Adverse Event|18|||
145756903|NCT01700192|525623590|FG000|Overall Study|Lack of Efficacy|1|||
145756904|NCT01700192|525623591|FG001|Overall Study|Lack of Efficacy|0|||
145756905|NCT01700192|525623590|FG000|Overall Study|Lost to Follow-up|42|||
145532129|NCT00734474|524810040|FG005|Overall Study|Lost to Follow-up|1|||
145532130|NCT00734474|524810041|FG006|Overall Study|Lost to Follow-up|0|||
145532131|NCT00734474|524810042|FG007|Overall Study|Lost to Follow-up|9|||
145532132|NCT00734474|524810043|FG008|Overall Study|Lost to Follow-up|4|||
145756906|NCT01700192|525623591|FG001|Overall Study|Lost to Follow-up|29|||
145756907|NCT01700192|525623590|FG000|Overall Study|Noncompliance with study drug|0|||
145756908|NCT01700192|525623591|FG001|Overall Study|Noncompliance with study drug|5|||
145756909|NCT01700192|525623590|FG000|Overall Study|Physician Decision|2|||
145756910|NCT01700192|525623591|FG001|Overall Study|Physician Decision|3|||
145756911|NCT01700192|525623590|FG000|Overall Study|Pregnancy|1|||
145756912|NCT01700192|525623591|FG001|Overall Study|Pregnancy|4|||
145756913|NCT01700192|525623590|FG000|Overall Study|Progressive disease|1|||
145756914|NCT01700192|525623591|FG001|Overall Study|Progressive disease|0|||
145756915|NCT01700192|525623590|FG000|Overall Study|Protocol Violation|3|||
145756916|NCT01700192|525623591|FG001|Overall Study|Protocol Violation|4|||
145756917|NCT01700192|525623590|FG000|Overall Study|Technical problems|0|||
145756918|NCT01700192|525623591|FG001|Overall Study|Technical problems|1|||
145756919|NCT01700192|525623590|FG000|Overall Study|Withdrawal by Subject|56|||
145756920|NCT01700192|525623591|FG001|Overall Study|Withdrawal by Subject|64|||
145756921|NCT01700192|525623590|FG000|Overall Study|Never received study drug|1|||
145756922|NCT01700192|525623591|FG001|Overall Study|Never received study drug|0|||
145756923|NCT00379795|525623596|FG000|Overall Study|Death|31|||
145756924|NCT00379795|525623597|FG001|Overall Study|Death|8|||
145756925|NCT00379795|525623598|FG002|Overall Study|Death|6|||
145756926|NCT00379795|525623599|FG003|Overall Study|Death|4|||
145756927|NCT00379795|525623600|FG004|Overall Study|Death|7|||
145756928|NCT00379795|525623596|FG000|Overall Study|Adverse Event|17|||
145756929|NCT00379795|525623597|FG001|Overall Study|Adverse Event|3|||
145756930|NCT00379795|525623598|FG002|Overall Study|Adverse Event|3|||
145756931|NCT00379795|525623599|FG003|Overall Study|Adverse Event|1|||
145756932|NCT00379795|525623600|FG004|Overall Study|Adverse Event|4|||
145756933|NCT00379795|525623596|FG000|Overall Study|Lost to Follow-up|8|||
145756934|NCT00379795|525623597|FG001|Overall Study|Lost to Follow-up|1|||
145756935|NCT00379795|525623598|FG002|Overall Study|Lost to Follow-up|2|||
145756936|NCT00379795|525623599|FG003|Overall Study|Lost to Follow-up|1|||
145756937|NCT00379795|525623600|FG004|Overall Study|Lost to Follow-up|4|||
145756938|NCT00379795|525623596|FG000|Overall Study|Physician Decision|25|||
145756939|NCT00379795|525623597|FG001|Overall Study|Physician Decision|0|||
145756940|NCT00379795|525623598|FG002|Overall Study|Physician Decision|2|||
145756941|NCT00379795|525623599|FG003|Overall Study|Physician Decision|2|||
145756942|NCT00379795|525623600|FG004|Overall Study|Physician Decision|2|||
145756943|NCT00379795|525623596|FG000|Overall Study|Withdrawal by Subject|94|||
145756944|NCT00379795|525623597|FG001|Overall Study|Withdrawal by Subject|11|||
145756945|NCT00379795|525623598|FG002|Overall Study|Withdrawal by Subject|19|||
145756946|NCT00379795|525623599|FG003|Overall Study|Withdrawal by Subject|7|||
145756947|NCT00379795|525623600|FG004|Overall Study|Withdrawal by Subject|14|||
145756948|NCT00379795|525623596|FG000|Overall Study|Subject non-compliance|7|||
145756949|NCT00379795|525623597|FG001|Overall Study|Subject non-compliance|2|||
145756950|NCT00379795|525623598|FG002|Overall Study|Subject non-compliance|0|||
145756951|NCT00379795|525623599|FG003|Overall Study|Subject non-compliance|0|||
145756952|NCT00379795|525623600|FG004|Overall Study|Subject non-compliance|1|||
145756953|NCT00379795|525623596|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
145756954|NCT00379795|525623597|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
145756955|NCT00379795|525623598|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
145756956|NCT00379795|525623599|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
145756957|NCT00379795|525623600|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
145756958|NCT00379795|525623596|FG000|Overall Study|Subjects condition mandated intervention|34|||
145756959|NCT00379795|525623597|FG001|Overall Study|Subjects condition mandated intervention|9|||
145756960|NCT00379795|525623598|FG002|Overall Study|Subjects condition mandated intervention|7|||
145756961|NCT00379795|525623599|FG003|Overall Study|Subjects condition mandated intervention|5|||
145756962|NCT00379795|525623600|FG004|Overall Study|Subjects condition mandated intervention|7|||
145756963|NCT00379795|525623596|FG000|Overall Study|Sponsor's decision|257|||
145756964|NCT00379795|525623597|FG001|Overall Study|Sponsor's decision|17|||
145756965|NCT00379795|525623598|FG002|Overall Study|Sponsor's decision|54|||
145756966|NCT00379795|525623599|FG003|Overall Study|Sponsor's decision|47|||
145756967|NCT00379795|525623600|FG004|Overall Study|Sponsor's decision|10|||
145756968|NCT01127165|525623601|FG000|Overall Study|Adverse Event|2|||
145756969|NCT01127165|525623602|FG001|Overall Study|Adverse Event|2|||
145756970|NCT01127165|525623601|FG000|Overall Study|Lack of Efficacy|10|||
145756971|NCT01127165|525623602|FG001|Overall Study|Lack of Efficacy|8|||
145756972|NCT01127165|525623601|FG000|Overall Study|Lost to Follow-up|3|||
145756973|NCT01127165|525623602|FG001|Overall Study|Lost to Follow-up|5|||
145756974|NCT01127165|525623601|FG000|Overall Study|Withdrawal by Subject|1|||
145756975|NCT01127165|525623602|FG001|Overall Study|Withdrawal by Subject|3|||
145756976|NCT01127165|525623601|FG000|Overall Study|Protocol Violation|0|||
145756977|NCT01127165|525623602|FG001|Overall Study|Protocol Violation|1|||
145756978|NCT00763321|525623603|FG000|Open-label Period|Adverse Event|24|||
145756979|NCT00763321|525623604|FG001|Open-label Period|Adverse Event|0|||
145756980|NCT00763321|525623605|FG002|Open-label Period|Adverse Event|0|||
145756981|NCT00763321|525623603|FG000|Open-label Period|Lost to Follow-up|14|||
145273647|NCT01215955|523850083|FG001|Overall Study|Lost to Follow-up|4|||
145273648|NCT01215955|523850084|FG002|Overall Study|Lost to Follow-up|8|||
145273649|NCT01215955|523850085|FG003|Overall Study|Lost to Follow-up|9|||
145273650|NCT01215955|523850082|FG000|Overall Study|Physician Decision|4|||
145273651|NCT01215955|523850083|FG001|Overall Study|Physician Decision|10|||
145273652|NCT01215955|523850084|FG002|Overall Study|Physician Decision|8|||
145273653|NCT01215955|523850085|FG003|Overall Study|Physician Decision|11|||
145273654|NCT01215955|523850082|FG000|Overall Study|Protocol Violation|17|||
145273655|NCT01215955|523850083|FG001|Overall Study|Protocol Violation|13|||
145273656|NCT01215955|523850084|FG002|Overall Study|Protocol Violation|8|||
145532133|NCT00734474|524810035|FG000|Overall Study|Withdrawal by Subject|2|||
145532134|NCT00734474|524810036|FG001|Overall Study|Withdrawal by Subject|1|||
145532135|NCT00734474|524810037|FG002|Overall Study|Withdrawal by Subject|18|||
145532136|NCT00734474|524810038|FG003|Overall Study|Withdrawal by Subject|0|||
145532137|NCT00734474|524810039|FG004|Overall Study|Withdrawal by Subject|24|||
145532138|NCT00734474|524810040|FG005|Overall Study|Withdrawal by Subject|2|||
145532139|NCT00734474|524810041|FG006|Overall Study|Withdrawal by Subject|0|||
145532140|NCT00734474|524810042|FG007|Overall Study|Withdrawal by Subject|36|||
145532141|NCT00734474|524810043|FG008|Overall Study|Withdrawal by Subject|21|||
145532142|NCT00734474|524810035|FG000|Overall Study|Physician Decision|0|||
145532143|NCT00734474|524810036|FG001|Overall Study|Physician Decision|0|||
145532144|NCT00734474|524810037|FG002|Overall Study|Physician Decision|4|||
145532145|NCT00734474|524810038|FG003|Overall Study|Physician Decision|1|||
145532146|NCT00734474|524810039|FG004|Overall Study|Physician Decision|11|||
145532147|NCT00734474|524810040|FG005|Overall Study|Physician Decision|0|||
145532148|NCT00734474|524810041|FG006|Overall Study|Physician Decision|0|||
145532149|NCT00734474|524810042|FG007|Overall Study|Physician Decision|9|||
145532150|NCT00734474|524810043|FG008|Overall Study|Physician Decision|9|||
145532151|NCT00734474|524810035|FG000|Overall Study|Adverse Event|4|||
145532152|NCT00734474|524810036|FG001|Overall Study|Adverse Event|4|||
145532153|NCT00734474|524810037|FG002|Overall Study|Adverse Event|63|||
145532154|NCT00734474|524810038|FG003|Overall Study|Adverse Event|1|||
145532155|NCT00734474|524810039|FG004|Overall Study|Adverse Event|64|||
145532156|NCT00734474|524810040|FG005|Overall Study|Adverse Event|0|||
145532157|NCT00734474|524810041|FG006|Overall Study|Adverse Event|1|||
145532158|NCT00734474|524810042|FG007|Overall Study|Adverse Event|65|||
145532159|NCT00734474|524810043|FG008|Overall Study|Adverse Event|39|||
145532160|NCT00734474|524810035|FG000|Overall Study|Protocol Violation|0|||
145532161|NCT00734474|524810036|FG001|Overall Study|Protocol Violation|0|||
145532162|NCT00734474|524810037|FG002|Overall Study|Protocol Violation|4|||
145532163|NCT00734474|524810038|FG003|Overall Study|Protocol Violation|0|||
145532164|NCT00734474|524810039|FG004|Overall Study|Protocol Violation|3|||
145532165|NCT00734474|524810040|FG005|Overall Study|Protocol Violation|0|||
145532166|NCT00734474|524810041|FG006|Overall Study|Protocol Violation|0|||
145532167|NCT00734474|524810042|FG007|Overall Study|Protocol Violation|3|||
145532168|NCT00734474|524810043|FG008|Overall Study|Protocol Violation|1|||
145532169|NCT00734474|524810035|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
145532170|NCT00734474|524810036|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
145532171|NCT00734474|524810037|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
145532172|NCT00734474|524810038|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
145532173|NCT00734474|524810039|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
145532174|NCT00734474|524810040|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
145532175|NCT00734474|524810041|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
145532176|NCT00734474|524810042|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
145532177|NCT00734474|524810043|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
145532178|NCT00734474|524810035|FG000|Overall Study|Sponsor Decision|0|||
145532179|NCT00734474|524810036|FG001|Overall Study|Sponsor Decision|0|||
145532180|NCT00734474|524810037|FG002|Overall Study|Sponsor Decision|0|||
145532181|NCT00734474|524810038|FG003|Overall Study|Sponsor Decision|0|||
145532182|NCT00734474|524810039|FG004|Overall Study|Sponsor Decision|2|||
145607590|NCT02296190|525079202|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
145607591|NCT02296190|525079203|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
145756982|NCT00763321|525623604|FG001|Open-label Period|Lost to Follow-up|0|||
145273657|NCT01215955|523850085|FG003|Overall Study|Protocol Violation|8|||
145273658|NCT01215955|523850082|FG000|Overall Study|Sponsor Decision|1|||
145402871|NCT02065557|524332544|FG000|Induction Period|Lack of Efficacy|2|||
145532183|NCT00734474|524810040|FG005|Overall Study|Sponsor Decision|0|||
145532184|NCT00734474|524810041|FG006|Overall Study|Sponsor Decision|0|||
145532185|NCT00734474|524810042|FG007|Overall Study|Sponsor Decision|0|||
145532186|NCT00734474|524810043|FG008|Overall Study|Sponsor Decision|0|||
145532187|NCT00734474|524810035|FG000|Overall Study|Death|0|||
145532188|NCT00734474|524810036|FG001|Overall Study|Death|0|||
145532189|NCT00734474|524810037|FG002|Overall Study|Death|1|||
145532190|NCT00734474|524810038|FG003|Overall Study|Death|0|||
145532191|NCT00734474|524810039|FG004|Overall Study|Death|0|||
145532192|NCT00734474|524810040|FG005|Overall Study|Death|0|||
145532193|NCT00734474|524810041|FG006|Overall Study|Death|0|||
145532194|NCT00734474|524810042|FG007|Overall Study|Death|2|||
145532195|NCT00734474|524810043|FG008|Overall Study|Death|1|||
145756983|NCT00763321|525623605|FG002|Open-label Period|Lost to Follow-up|0|||
145756984|NCT00763321|525623603|FG000|Open-label Period|Withdrawal by Subject|7|||
145756985|NCT00763321|525623604|FG001|Open-label Period|Withdrawal by Subject|0|||
145756986|NCT00763321|525623605|FG002|Open-label Period|Withdrawal by Subject|0|||
145756987|NCT00763321|525623603|FG000|Open-label Period|Subject noncompliant|7|||
145756988|NCT00763321|525623604|FG001|Open-label Period|Subject noncompliant|0|||
145756989|NCT00763321|525623605|FG002|Open-label Period|Subject noncompliant|0|||
145756990|NCT00763321|525623603|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
145756991|NCT00763321|525623604|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
145756992|NCT00763321|525623605|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
145756993|NCT00763321|525623603|FG000|Open-label Period|Lack of Efficacy|2|||
145756994|NCT00763321|525623604|FG001|Open-label Period|Lack of Efficacy|0|||
145756995|NCT00763321|525623605|FG002|Open-label Period|Lack of Efficacy|0|||
145756996|NCT00763321|525623603|FG000|Open-label Period|Other|4|||
145756997|NCT00763321|525623604|FG001|Open-label Period|Other|0|||
145756998|NCT00763321|525623605|FG002|Open-label Period|Other|0|||
145756999|NCT00763321|525623603|FG000|Double-blind Period|Lack of Efficacy|0|||
145757000|NCT00763321|525623604|FG001|Double-blind Period|Lack of Efficacy|9|||
145757001|NCT00763321|525623605|FG002|Double-blind Period|Lack of Efficacy|17|||
145757002|NCT00763321|525623603|FG000|Double-blind Period|Adverse Event|0|||
145757003|NCT00763321|525623604|FG001|Double-blind Period|Adverse Event|4|||
145757004|NCT00763321|525623605|FG002|Double-blind Period|Adverse Event|4|||
145757005|NCT00763321|525623603|FG000|Double-blind Period|Lost to Follow-up|0|||
145757006|NCT00763321|525623604|FG001|Double-blind Period|Lost to Follow-up|4|||
145757007|NCT00763321|525623605|FG002|Double-blind Period|Lost to Follow-up|2|||
145757008|NCT00763321|525623603|FG000|Double-blind Period|Withdrawal by Subject|0|||
145757009|NCT00763321|525623604|FG001|Double-blind Period|Withdrawal by Subject|2|||
145757010|NCT00763321|525623605|FG002|Double-blind Period|Withdrawal by Subject|3|||
145757011|NCT00763321|525623603|FG000|Double-blind Period|Other|0|||
145757012|NCT00763321|525623604|FG001|Double-blind Period|Other|2|||
145757013|NCT00763321|525623605|FG002|Double-blind Period|Other|3|||
145757014|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
145757015|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145757016|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145757017|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145757018|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145757019|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
145757020|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
145757021|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
145757022|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
145757023|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
145757024|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
145757025|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
145757026|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
145757027|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
145757028|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
145757029|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
145757030|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145757031|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145757032|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145757033|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145757034|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
145757035|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
145757036|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
145757037|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
145757038|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
145757039|NCT01017952|525623606|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
145757040|NCT01017952|525623607|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145757041|NCT01017952|525623608|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145757042|NCT01017952|525623609|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145757043|NCT01017952|525623610|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145757044|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
145757045|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
145757046|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
145757047|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
145757048|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
145757049|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145757050|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
145757051|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
145757052|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
145757053|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
145757054|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
145757055|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
145757056|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
145757057|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
145757058|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
145273659|NCT01215955|523850083|FG001|Overall Study|Sponsor Decision|2|||
145532196|NCT00734474|524810035|FG000|Overall Study|Lack of Efficacy|0|||
145532197|NCT00734474|524810036|FG001|Overall Study|Lack of Efficacy|0|||
145532198|NCT00734474|524810037|FG002|Overall Study|Lack of Efficacy|4|||
145757059|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
145757060|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
145757061|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
145273660|NCT01215955|523850084|FG002|Overall Study|Sponsor Decision|0|||
145273661|NCT01215955|523850085|FG003|Overall Study|Sponsor Decision|1|||
145532199|NCT00734474|524810038|FG003|Overall Study|Lack of Efficacy|0|||
145532200|NCT00734474|524810039|FG004|Overall Study|Lack of Efficacy|0|||
145532201|NCT00734474|524810040|FG005|Overall Study|Lack of Efficacy|0|||
145532202|NCT00734474|524810041|FG006|Overall Study|Lack of Efficacy|0|||
145757062|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
145757063|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
145757064|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
145757065|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
145757066|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
145757067|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
145757068|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
145757069|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145757070|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
145757071|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
145757072|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145757073|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145757074|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145757075|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
145757076|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
145757077|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
145757078|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
145757079|NCT01017952|525623606|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
145757080|NCT01017952|525623607|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
145757081|NCT01017952|525623608|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
145757082|NCT01017952|525623609|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
145757083|NCT01017952|525623610|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
145757084|NCT01064167|525623611|FG000|Overall Study|Protocol Violation|14|||
145757085|NCT01064167|525623612|FG001|Overall Study|Protocol Violation|15|||
145757086|NCT03984305|525623614|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
145757087|NCT03984305|525623615|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
145757088|NCT03984305|525623614|FG000|Overall Study|Withdrawal by Subject|3|||
145757089|NCT03984305|525623615|FG001|Overall Study|Withdrawal by Subject|3|||
145757090|NCT03984305|525623614|FG000|Overall Study|Lost to Follow-up|1|||
145757091|NCT03984305|525623615|FG001|Overall Study|Lost to Follow-up|0|||
145757092|NCT01656434|525623616|FG000|Overall Study|Adverse Event|199|||
145757093|NCT01656434|525623617|FG001|Overall Study|Adverse Event|63|||
145757094|NCT01656434|525623616|FG000|Overall Study|Enrollment terminated at trial site|2|||
145757095|NCT01656434|525623617|FG001|Overall Study|Enrollment terminated at trial site|0|||
145757096|NCT01656434|525623616|FG000|Overall Study|Lost to Follow-up|309|||
145757097|NCT01656434|525623617|FG001|Overall Study|Lost to Follow-up|76|||
145757098|NCT01656434|525623616|FG000|Overall Study|Site discontinued study participation|24|||
145757099|NCT01656434|525623617|FG001|Overall Study|Site discontinued study participation|9|||
145757100|NCT01656434|525623616|FG000|Overall Study|Screen failure|2|||
145757101|NCT01656434|525623617|FG001|Overall Study|Screen failure|0|||
145757102|NCT01656434|525623616|FG000|Overall Study|Protocol Violation|7|||
145757103|NCT01656434|525623617|FG001|Overall Study|Protocol Violation|0|||
145757104|NCT01656434|525623616|FG000|Overall Study|Pregnancy wish|18|||
145532203|NCT00734474|524810042|FG007|Overall Study|Lack of Efficacy|4|||
145532204|NCT00734474|524810043|FG008|Overall Study|Lack of Efficacy|6|||
145757105|NCT01656434|525623617|FG001|Overall Study|Pregnancy wish|6|||
145757106|NCT01656434|525623616|FG000|Overall Study|Pregnancy|45|||
145757107|NCT01656434|525623617|FG001|Overall Study|Pregnancy|10|||
145757108|NCT01656434|525623616|FG000|Overall Study|Physician Decision|7|||
145757109|NCT01656434|525623617|FG001|Overall Study|Physician Decision|2|||
145757110|NCT01656434|525623616|FG000|Overall Study|Non-compliance with study drug|48|||
145757111|NCT01656434|525623617|FG001|Overall Study|Non-compliance with study drug|9|||
145757112|NCT01656434|525623616|FG000|Overall Study|Study terminated by sponsor|1501|||
145757113|NCT01656434|525623617|FG001|Overall Study|Study terminated by sponsor|348|||
145757114|NCT01656434|525623616|FG000|Overall Study|Participant discontinued; drug related|13|||
145757115|NCT01656434|525623617|FG001|Overall Study|Participant discontinued; drug related|4|||
145757116|NCT01656434|525623616|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
145757117|NCT01656434|525623617|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
145757118|NCT01656434|525623616|FG000|Overall Study|Non-compliance with protocol|39|||
145757119|NCT01656434|525623617|FG001|Overall Study|Non-compliance with protocol|15|||
145757120|NCT01656434|525623616|FG000|Overall Study|Participant moved|40|||
145757121|NCT01656434|525623617|FG001|Overall Study|Participant moved|12|||
145532205|NCT00231842|524810044|FG000|Overall Study|Withdrawal by Subject|3|||
145757122|NCT01656434|525623616|FG000|Overall Study|Participant withdrew consent|28|||
145757123|NCT01656434|525623617|FG001|Overall Study|Participant withdrew consent|9|||
145757124|NCT01656434|525623616|FG000|Overall Study|Withdrawal by Subject|64|||
145757125|NCT01656434|525623617|FG001|Overall Study|Withdrawal by Subject|7|||
145757126|NCT06098729|525623627|FG000|Overall Study|Withdrawal by Subject|1|||
145757127|NCT00993928|525623628|FG000|Overall Study|Withdrawal by Subject|4|||
145757128|NCT00993928|525623629|FG001|Overall Study|Withdrawal by Subject|7|||
145757129|NCT00993928|525623628|FG000|Overall Study|ineligible|1|||
145757130|NCT00993928|525623629|FG001|Overall Study|ineligible|0|||
145757131|NCT02302963|525623630|FG000|Overall Study|Withdrawal by Subject|2|||
145757132|NCT02302963|525623631|FG001|Overall Study|Withdrawal by Subject|1|||
145757133|NCT02302963|525623630|FG000|Overall Study|Steroid injection|0|||
145757134|NCT02302963|525623631|FG001|Overall Study|Steroid injection|1|||
145757135|NCT02302963|525623630|FG000|Overall Study|Physician Decision|1|||
145757136|NCT02302963|525623631|FG001|Overall Study|Physician Decision|0|||
145757137|NCT03891901|525623636|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
145757138|NCT03891901|525623637|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757139|NCT03891901|525623638|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757140|NCT03891901|525623639|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757141|NCT03891901|525623640|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757142|NCT03891901|525623641|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757143|NCT03891901|525623642|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757144|NCT03891901|525623643|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757145|NCT03891901|525623644|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
145757146|NCT03891901|525623636|FG000|Overall Study|Adverse Event|2|||
145757147|NCT03891901|525623637|FG001|Overall Study|Adverse Event|2|||
145757148|NCT03891901|525623638|FG002|Overall Study|Adverse Event|0|||
145532206|NCT00231842|524810044|FG000|Overall Study|Did not complete the last 3 cycle|8|||
145757149|NCT03891901|525623639|FG003|Overall Study|Adverse Event|0|||
145757150|NCT03891901|525623640|FG004|Overall Study|Adverse Event|0|||
145532207|NCT00639678|524810045|FG000|Overall Study|Withdrawal by Subject|3|||
145532208|NCT00639678|524810046|FG001|Overall Study|Withdrawal by Subject|0|||
145532209|NCT00639678|524810047|FG002|Overall Study|Withdrawal by Subject|4|||
145757151|NCT03891901|525623641|FG005|Overall Study|Adverse Event|0|||
145757152|NCT03891901|525623642|FG006|Overall Study|Adverse Event|0|||
145757153|NCT03891901|525623643|FG007|Overall Study|Adverse Event|0|||
145757154|NCT03891901|525623644|FG008|Overall Study|Adverse Event|0|||
145757155|NCT03891901|525623636|FG000|Overall Study|Poor venous access|1|||
145532210|NCT00639678|524810048|FG003|Overall Study|Withdrawal by Subject|0|||
145757156|NCT03891901|525623637|FG001|Overall Study|Poor venous access|0|||
145757157|NCT03891901|525623638|FG002|Overall Study|Poor venous access|0|||
145757158|NCT03891901|525623639|FG003|Overall Study|Poor venous access|0|||
145757159|NCT03891901|525623640|FG004|Overall Study|Poor venous access|0|||
145757160|NCT03891901|525623641|FG005|Overall Study|Poor venous access|0|||
145757161|NCT03891901|525623642|FG006|Overall Study|Poor venous access|0|||
145757162|NCT03891901|525623643|FG007|Overall Study|Poor venous access|0|||
145757163|NCT03891901|525623644|FG008|Overall Study|Poor venous access|0|||
145757164|NCT03891901|525623636|FG000|Overall Study|Withdrawal by Subject|0|||
145757165|NCT03891901|525623637|FG001|Overall Study|Withdrawal by Subject|2|||
145757166|NCT03891901|525623638|FG002|Overall Study|Withdrawal by Subject|0|||
145757167|NCT03891901|525623639|FG003|Overall Study|Withdrawal by Subject|0|||
145757168|NCT03891901|525623640|FG004|Overall Study|Withdrawal by Subject|0|||
145757169|NCT03891901|525623641|FG005|Overall Study|Withdrawal by Subject|0|||
145757170|NCT03891901|525623642|FG006|Overall Study|Withdrawal by Subject|0|||
145757171|NCT03891901|525623643|FG007|Overall Study|Withdrawal by Subject|0|||
145757172|NCT03891901|525623644|FG008|Overall Study|Withdrawal by Subject|0|||
145757173|NCT05702736|525623647|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
145757174|NCT05702736|525623648|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
145757175|NCT05702736|525623647|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
145757176|NCT05702736|525623648|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
145757177|NCT03110900|525623651|FG000|Overall Study|Sponsor withdrew|1|||
145757178|NCT03110900|525623652|FG001|Overall Study|Sponsor withdrew|1|||
145757179|NCT03355300|525623653|FG000|Overall Study|Physician Decision|0|||
145757180|NCT03355300|525623654|FG001|Overall Study|Physician Decision|1|||
145757181|NCT03355300|525623653|FG000|Overall Study|Lack of Efficacy|2|||
145757182|NCT03355300|525623654|FG001|Overall Study|Lack of Efficacy|1|||
145757183|NCT03355300|525623653|FG000|Overall Study|Other reason|1|||
145757184|NCT03355300|525623654|FG001|Overall Study|Other reason|0|||
145757185|NCT00546052|525623655|FG000|Overall Study|Adverse Event|47|||
145757186|NCT00546052|525623655|FG000|Overall Study|Lost to Follow-up|144|||
145757187|NCT00546052|525623655|FG000|Overall Study|Protocol Violation|9|||
145757188|NCT00546052|525623655|FG000|Overall Study|Withdrawal by Subject|20|||
145757189|NCT00546052|525623655|FG000|Overall Study|Non Compliance|7|||
145757190|NCT01031446|525623663|FG000|Overall Study|Disease Progression|38|||
145532211|NCT00639678|524810045|FG000|Overall Study|Lost to Follow-up|1|||
145532212|NCT00639678|524810046|FG001|Overall Study|Lost to Follow-up|0|||
145532213|NCT00639678|524810047|FG002|Overall Study|Lost to Follow-up|6|||
145757191|NCT01031446|525623663|FG000|Overall Study|Adverse Event|9|||
145757192|NCT01031446|525623663|FG000|Overall Study|Physician Decision|4|||
145757193|NCT01031446|525623663|FG000|Overall Study|Withdrawal by Subject|3|||
145757194|NCT01031446|525623663|FG000|Overall Study|Still on treatment|1|||
145757195|NCT03344003|525623666|FG000|Overall Study|Switched to alternative treatment|1|||
145757196|NCT03344003|525623667|FG001|Overall Study|Switched to alternative treatment|0|||
145757197|NCT03344003|525623666|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
145273662|NCT01215955|523850082|FG000|Overall Study|Withdrawal by Subject|14|||
145273663|NCT01215955|523850083|FG001|Overall Study|Withdrawal by Subject|15|||
145273664|NCT01215955|523850084|FG002|Overall Study|Withdrawal by Subject|13|||
145273665|NCT01215955|523850085|FG003|Overall Study|Withdrawal by Subject|9|||
145273666|NCT01215955|523850082|FG000|Overall Study|Quality Issues|0|||
145273667|NCT01215955|523850083|FG001|Overall Study|Quality Issues|0|||
145273668|NCT01215955|523850084|FG002|Overall Study|Quality Issues|3|||
145273669|NCT01215955|523850085|FG003|Overall Study|Quality Issues|2|||
145273670|NCT00038467|523850086|FG000|Overall Study|Adverse Event|170|||
145273671|NCT00038467|523850087|FG001|Overall Study|Adverse Event|145|||
145273672|NCT00038467|523850086|FG000|Overall Study|Withdrawal by Subject|150|||
145273673|NCT00038467|523850087|FG001|Overall Study|Withdrawal by Subject|107|||
145273674|NCT00038467|523850086|FG000|Overall Study|Protocol Violation|19|||
145273675|NCT00038467|523850087|FG001|Overall Study|Protocol Violation|22|||
145273676|NCT00038467|523850086|FG000|Overall Study|Death|22|||
145273677|NCT00038467|523850087|FG001|Overall Study|Death|16|||
145273678|NCT00038467|523850086|FG000|Overall Study|Lost to Follow-up|15|||
145273679|NCT00038467|523850087|FG001|Overall Study|Lost to Follow-up|10|||
145273680|NCT00038467|523850086|FG000|Overall Study|Recurrence|109|||
145273681|NCT00038467|523850087|FG001|Overall Study|Recurrence|179|||
145273682|NCT00038467|523850086|FG000|Overall Study|Randomized, but not treated|31|||
145273683|NCT00038467|523850087|FG001|Overall Study|Randomized, but not treated|35|||
145273684|NCT00038467|523850086|FG000|Overall Study|Other|26|||
145273685|NCT00038467|523850087|FG001|Overall Study|Other|28|||
145273686|NCT01787188|523850088|FG000|Overall Study|Adverse Event|2|||
145273687|NCT01787188|523850089|FG001|Overall Study|Adverse Event|4|||
145273688|NCT01787188|523850090|FG002|Overall Study|Adverse Event|6|||
145273689|NCT01787188|523850088|FG000|Overall Study|Lack of Efficacy|7|||
145273690|NCT01787188|523850089|FG001|Overall Study|Lack of Efficacy|3|||
145273691|NCT01787188|523850090|FG002|Overall Study|Lack of Efficacy|5|||
145273692|NCT01787188|523850088|FG000|Overall Study|Non-compliance with Study Drug|0|||
145757198|NCT03344003|525623667|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
145273693|NCT01787188|523850089|FG001|Overall Study|Non-compliance with Study Drug|1|||
145273694|NCT01787188|523850090|FG002|Overall Study|Non-compliance with Study Drug|0|||
145273695|NCT01787188|523850088|FG000|Overall Study|Withdrawal by Subject|4|||
145273696|NCT01787188|523850089|FG001|Overall Study|Withdrawal by Subject|3|||
145273697|NCT01787188|523850090|FG002|Overall Study|Withdrawal by Subject|2|||
145273698|NCT01787188|523850088|FG000|Overall Study|Protocol Violation|3|||
145273699|NCT01787188|523850089|FG001|Overall Study|Protocol Violation|2|||
145273700|NCT01787188|523850090|FG002|Overall Study|Protocol Violation|3|||
145273701|NCT01787188|523850088|FG000|Overall Study|Lost to Follow-up|1|||
145273702|NCT01787188|523850089|FG001|Overall Study|Lost to Follow-up|2|||
145273703|NCT01787188|523850090|FG002|Overall Study|Lost to Follow-up|2|||
145273704|NCT01787188|523850088|FG000|Overall Study|Other, including patient moved|0|||
145273705|NCT01787188|523850089|FG001|Overall Study|Other, including patient moved|3|||
145273706|NCT01787188|523850090|FG002|Overall Study|Other, including patient moved|0|||
145273707|NCT05511428|523850091|FG000|Overall Study|Withdrawal by Subject|1|||
145273708|NCT05511428|523850091|FG000|Overall Study|Adverse Event|1|||
145273709|NCT02643394|523850092|FG000|Overall Study|Protocol Violation|4|||
145273710|NCT02643394|523850093|FG001|Overall Study|Protocol Violation|5|||
145273711|NCT00943384|523850094|FG000|Overall Study|Dispositioned prior to treatment|23|||
145273712|NCT00943384|523850094|FG000|Overall Study|Treated off protocol-protocol violation|5|||
145273713|NCT00943384|523850094|FG000|Overall Study|Lost to Follow-up|16|||
145273714|NCT00943384|523850094|FG000|Overall Study|Withdrawal by Subject|5|||
145273715|NCT04088734|523850095|FG000|Overall Study|Other, Not Specified|5|||
145273716|NCT00096200|523850096|FG000|Overall Study|Adverse Event|0|||
145273717|NCT00096200|523850097|FG001|Overall Study|Adverse Event|4|||
145273718|NCT00096200|523850098|FG002|Overall Study|Adverse Event|0|||
145273719|NCT00096200|523850096|FG000|Overall Study|Withdrawal by Subject|1|||
145273720|NCT00096200|523850097|FG001|Overall Study|Withdrawal by Subject|2|||
145273721|NCT00096200|523850098|FG002|Overall Study|Withdrawal by Subject|0|||
145273722|NCT00096200|523850096|FG000|Overall Study|Ineligible pathology|0|||
145273723|NCT00096200|523850097|FG001|Overall Study|Ineligible pathology|1|||
145273724|NCT00096200|523850098|FG002|Overall Study|Ineligible pathology|0|||
145273725|NCT00835068|523850099|FG000|Overall Study|Death|1|||
145273726|NCT00835068|523850100|FG001|Overall Study|Death|0|||
145273727|NCT00835068|523850099|FG000|Overall Study|Adverse Event|0|||
145273728|NCT00835068|523850100|FG001|Overall Study|Adverse Event|1|||
145273729|NCT00835068|523850099|FG000|Overall Study|Other|8|||
145273730|NCT00835068|523850100|FG001|Overall Study|Other|0|||
145273731|NCT00835068|523850099|FG000|Overall Study|Withdrawal by Subject|1|||
145273732|NCT00835068|523850100|FG001|Overall Study|Withdrawal by Subject|0|||
145273733|NCT02575807|523850101|FG000|Overall Study|Death|8|||
145273734|NCT02575807|523850102|FG001|Overall Study|Death|3|||
145273735|NCT02575807|523850103|FG002|Overall Study|Death|7|||
145273736|NCT02575807|523850104|FG003|Overall Study|Death|0|||
145273737|NCT02575807|523850105|FG004|Overall Study|Death|1|||
145273738|NCT02575807|523850101|FG000|Overall Study|Study terminated by Sponsor|0|||
145532214|NCT00639678|524810048|FG003|Overall Study|Lost to Follow-up|0|||
145532215|NCT00639678|524810045|FG000|Overall Study|Adverse Event|0|||
145532216|NCT00639678|524810046|FG001|Overall Study|Adverse Event|1|||
145532217|NCT00639678|524810047|FG002|Overall Study|Adverse Event|0|||
145532218|NCT00639678|524810048|FG003|Overall Study|Adverse Event|0|||
145532219|NCT00639678|524810045|FG000|Overall Study|Lack of Compliance|0|||
145757199|NCT00684957|525623672|FG000|Overall Study|Withdrawal by Subject|1|||
145757200|NCT00684957|525623673|FG001|Overall Study|Withdrawal by Subject|1|||
145757201|NCT00684957|525623672|FG000|Overall Study|Lost to Follow-up|1|||
145757202|NCT00684957|525623673|FG001|Overall Study|Lost to Follow-up|0|||
145757203|NCT04484285|525625521|FG000|Overall Study|Unable to operate stimulator|3|||
145757204|NCT04484285|525625522|FG001|Overall Study|Unable to operate stimulator|0|||
145757205|NCT02363478|525625523|FG000|Overall Study|Lost to Follow-up|4|||
145757206|NCT02363478|525625523|FG000|Overall Study|Adverse Event|4|||
145757207|NCT00768898|525625524|FG000|Overall Study|Unrelated injury|1|||
145757208|NCT00768898|525625524|FG000|Overall Study|Headache|1|||
145757209|NCT02527707|525625525|FG000|Overall Study|Adverse Event|1|||
145757210|NCT02527707|525625525|FG000|Overall Study|Adverse Event|1|||
145757211|NCT04002310|525625526|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
145757212|NCT04002310|525625527|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
145757213|NCT04002310|525625528|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
145757214|NCT04002310|525625529|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
145757215|NCT04002310|525625530|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
145757216|NCT00542997|525625531|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
145757217|NCT00542997|525625531|FG000|Wash in / Wash Out Period|Adverse Event|3|||
145757218|NCT00542997|525625531|FG000|Efficacy Period|Adverse Event|3|||
145757219|NCT00352534|525625532|FG000|Initial Staging|Ineligible|8|||
145757220|NCT00352534|525625533|FG001|Initial Staging|Ineligible|9|||
145757221|NCT00352534|525625534|FG002|Initial Staging|Ineligible|0|||
145757222|NCT00352534|525625535|FG003|Initial Staging|Ineligible|0|||
145757223|NCT00352534|525625536|FG004|Initial Staging|Ineligible|0|||
145757224|NCT00352534|525625537|FG005|Initial Staging|Ineligible|0|||
145757225|NCT00352534|525625538|FG006|Initial Staging|Ineligible|0|||
145532220|NCT00639678|524810046|FG001|Overall Study|Lack of Compliance|0|||
145757226|NCT00352534|525625532|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
145757227|NCT00352534|525625533|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
145757228|NCT00352534|525625534|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
145757229|NCT00352534|525625535|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
145757230|NCT00352534|525625536|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
145757231|NCT00352534|525625537|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
145757232|NCT00352534|525625538|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
145757233|NCT00352534|525625532|FG000|Final Risk Group Assignment|Physician Decision|0|||
145757234|NCT00352534|525625533|FG001|Final Risk Group Assignment|Physician Decision|0|||
145757235|NCT00352534|525625534|FG002|Final Risk Group Assignment|Physician Decision|0|||
145757236|NCT00352534|525625535|FG003|Final Risk Group Assignment|Physician Decision|0|||
145757237|NCT00352534|525625536|FG004|Final Risk Group Assignment|Physician Decision|0|||
145757238|NCT00352534|525625537|FG005|Final Risk Group Assignment|Physician Decision|8|||
145757239|NCT00352534|525625538|FG006|Final Risk Group Assignment|Physician Decision|0|||
145757240|NCT00352534|525625532|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757241|NCT00352534|525625533|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757242|NCT00352534|525625534|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757243|NCT00352534|525625535|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757244|NCT00352534|525625536|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757245|NCT00352534|525625537|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
145757246|NCT00352534|525625538|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
145757247|NCT00352534|525625532|FG000|Final Risk Group Assignment|Ineligible|0|||
145757248|NCT00352534|525625533|FG001|Final Risk Group Assignment|Ineligible|0|||
145757249|NCT00352534|525625534|FG002|Final Risk Group Assignment|Ineligible|3|||
145757250|NCT00352534|525625535|FG003|Final Risk Group Assignment|Ineligible|1|||
145757251|NCT00352534|525625536|FG004|Final Risk Group Assignment|Ineligible|0|||
145757252|NCT00352534|525625537|FG005|Final Risk Group Assignment|Ineligible|13|||
145757253|NCT00352534|525625538|FG006|Final Risk Group Assignment|Ineligible|0|||
145757254|NCT00352534|525625532|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757255|NCT00352534|525625533|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757256|NCT00352534|525625534|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757257|NCT00352534|525625535|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757258|NCT00352534|525625536|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757259|NCT00352534|525625537|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
145757260|NCT00352534|525625538|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
145757261|NCT00352534|525625532|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757262|NCT00352534|525625533|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757263|NCT00352534|525625534|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757264|NCT00352534|525625535|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757265|NCT00352534|525625536|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757266|NCT00352534|525625537|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
145757267|NCT00352534|525625538|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
145757268|NCT00352534|525625532|FG000|Final Risk Group Assignment|Death|0|||
145757269|NCT00352534|525625533|FG001|Final Risk Group Assignment|Death|0|||
145757270|NCT00352534|525625534|FG002|Final Risk Group Assignment|Death|0|||
145757271|NCT00352534|525625535|FG003|Final Risk Group Assignment|Death|0|||
145757272|NCT00352534|525625536|FG004|Final Risk Group Assignment|Death|0|||
145757273|NCT00352534|525625537|FG005|Final Risk Group Assignment|Death|2|||
145757274|NCT00352534|525625538|FG006|Final Risk Group Assignment|Death|0|||
145273739|NCT02575807|523850102|FG001|Overall Study|Study terminated by Sponsor|1|||
145273740|NCT02575807|523850103|FG002|Overall Study|Study terminated by Sponsor|7|||
145273741|NCT02575807|523850104|FG003|Overall Study|Study terminated by Sponsor|0|||
145273742|NCT02575807|523850105|FG004|Overall Study|Study terminated by Sponsor|1|||
145273743|NCT02575807|523850101|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
145273744|NCT02575807|523850102|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
145273745|NCT02575807|523850103|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
145273746|NCT02575807|523850104|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
145273747|NCT02575807|523850105|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
145273748|NCT02575807|523850101|FG000|Overall Study|Terminated due to physician decision|0|||
145532221|NCT00639678|524810047|FG002|Overall Study|Lack of Compliance|1|||
145532222|NCT00639678|524810048|FG003|Overall Study|Lack of Compliance|0|||
145757275|NCT00680836|525625541|FG000|Overall Study|Withdrawal by Subject|3|||
145532223|NCT02436304|524810049|FG000|Overall Study|Lost to Follow-up|0|||
145532224|NCT02436304|524810050|FG001|Overall Study|Lost to Follow-up|1|||
145757276|NCT00680836|525625542|FG001|Overall Study|Withdrawal by Subject|0|||
145757277|NCT00680836|525625541|FG000|Overall Study|Lost to Follow-up|3|||
145273749|NCT02575807|523850102|FG001|Overall Study|Terminated due to physician decision|0|||
145273750|NCT02575807|523850103|FG002|Overall Study|Terminated due to physician decision|1|||
145273751|NCT02575807|523850104|FG003|Overall Study|Terminated due to physician decision|0|||
145273752|NCT02575807|523850105|FG004|Overall Study|Terminated due to physician decision|0|||
145757278|NCT00680836|525625542|FG001|Overall Study|Lost to Follow-up|1|||
145757279|NCT00680836|525625541|FG000|Overall Study|Physician Decision|2|||
145757280|NCT00680836|525625542|FG001|Overall Study|Physician Decision|1|||
145532225|NCT02436304|524810051|FG002|Overall Study|Lost to Follow-up|0|||
145532226|NCT02436304|524810049|FG000|Overall Study|Withdrawal by Subject|0|||
145757281|NCT03786432|525625543|FG000|Overall Study|Screen Failure after consent|1|||
145757282|NCT03786432|525625543|FG000|Overall Study|Lost to Follow-up|4|||
145757283|NCT03786432|525625543|FG000|Overall Study|did not complete 12 month CT scan|1|||
145757284|NCT03038308|525625544|FG000|Overall Study|Surgical resection|1|||
145757285|NCT03038308|525625544|FG000|Overall Study|Withdrawal by Subject|2|||
145757286|NCT03038308|525625544|FG000|Overall Study|Lost to Follow-up|1|||
145757287|NCT00544869|525625546|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
145757288|NCT00544869|525625547|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
145757289|NCT00544869|525625548|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
145757290|NCT00544869|525625546|FG000|Overall Study|Adverse Event|6|||
145757291|NCT00544869|525625547|FG001|Overall Study|Adverse Event|1|||
145757292|NCT00544869|525625548|FG002|Overall Study|Adverse Event|0|||
145757293|NCT00544869|525625546|FG000|Overall Study|Lack of Efficacy|1|||
145757294|NCT00544869|525625547|FG001|Overall Study|Lack of Efficacy|1|||
145757295|NCT00544869|525625548|FG002|Overall Study|Lack of Efficacy|0|||
145757296|NCT00544869|525625546|FG000|Overall Study|Physician Decision|2|||
145757297|NCT00544869|525625547|FG001|Overall Study|Physician Decision|0|||
145757298|NCT00544869|525625548|FG002|Overall Study|Physician Decision|0|||
145757299|NCT00167245|525625549|FG000|Overall Study|Lost to Follow-up|20|||
145757300|NCT00167245|525625550|FG001|Overall Study|Lost to Follow-up|31|||
145757301|NCT00167245|525625549|FG000|Overall Study|Withdrawal by Subject|5|||
145757302|NCT00167245|525625550|FG001|Overall Study|Withdrawal by Subject|8|||
145757303|NCT00167245|525625549|FG000|Overall Study|Incarcerated|3|||
145757304|NCT00167245|525625550|FG001|Overall Study|Incarcerated|2|||
145757305|NCT00167245|525625549|FG000|Overall Study|Drowsy|1|||
145757306|NCT00167245|525625550|FG001|Overall Study|Drowsy|0|||
145757307|NCT01220414|525625553|FG000|Overall Study|Withdrawal by Subject|1|||
145757308|NCT01220414|525625554|FG001|Overall Study|Withdrawal by Subject|0|||
145757309|NCT01220414|525625555|FG002|Overall Study|Withdrawal by Subject|0|||
145757310|NCT01220414|525625556|FG003|Overall Study|Withdrawal by Subject|1|||
145757311|NCT01748071|525625565|FG000|Overall Study|Adverse Event|2|||
145757312|NCT01748071|525625566|FG001|Overall Study|Adverse Event|2|||
145757313|NCT01748071|525625567|FG002|Overall Study|Adverse Event|0|||
145757314|NCT01505894|525625568|FG000|Overall Study|Adverse Event|1|||
145757315|NCT01505894|525625569|FG001|Overall Study|Adverse Event|0|||
145757316|NCT01505894|525625570|FG002|Overall Study|Adverse Event|0|||
145757317|NCT01505894|525625571|FG003|Overall Study|Adverse Event|0|||
145757318|NCT01505894|525625572|FG004|Overall Study|Adverse Event|0|||
145757319|NCT01505894|525625573|FG005|Overall Study|Adverse Event|0|||
145757320|NCT01505894|525625574|FG006|Overall Study|Adverse Event|0|||
145757321|NCT01505894|525625575|FG007|Overall Study|Adverse Event|0|||
145757322|NCT01505894|525625576|FG008|Overall Study|Adverse Event|0|||
145757323|NCT01505894|525625568|FG000|Overall Study|Other than specified|0|||
145757324|NCT01505894|525625569|FG001|Overall Study|Other than specified|0|||
145757325|NCT01505894|525625570|FG002|Overall Study|Other than specified|0|||
145757326|NCT01505894|525625571|FG003|Overall Study|Other than specified|0|||
145757327|NCT01505894|525625572|FG004|Overall Study|Other than specified|1|||
145757328|NCT01505894|525625573|FG005|Overall Study|Other than specified|0|||
145757329|NCT01505894|525625574|FG006|Overall Study|Other than specified|0|||
145757330|NCT01505894|525625575|FG007|Overall Study|Other than specified|0|||
145757331|NCT01505894|525625576|FG008|Overall Study|Other than specified|0|||
145757332|NCT02624492|525625580|FG000|Overall Study|Adverse Event|2|||
145757333|NCT02624492|525625581|FG001|Overall Study|Adverse Event|2|||
145757334|NCT02624492|525625582|FG002|Overall Study|Adverse Event|2|||
145757335|NCT02624492|525625580|FG000|Overall Study|Progressive disease|0|||
145757336|NCT02624492|525625581|FG001|Overall Study|Progressive disease|2|||
145757337|NCT02624492|525625582|FG002|Overall Study|Progressive disease|3|||
145757338|NCT00191451|525625590|FG000|Overall Study|Withdrawal by Subject|2|||
145757339|NCT00191451|525625591|FG001|Overall Study|Withdrawal by Subject|3|||
145757340|NCT00191451|525625592|FG002|Overall Study|Withdrawal by Subject|5|||
145757341|NCT00191451|525625590|FG000|Overall Study|Physician Decision|2|||
145757342|NCT00191451|525625591|FG001|Overall Study|Physician Decision|9|||
145757343|NCT00191451|525625592|FG002|Overall Study|Physician Decision|6|||
145757344|NCT00191451|525625590|FG000|Overall Study|Sponsor Decision|1|||
145757345|NCT00191451|525625591|FG001|Overall Study|Sponsor Decision|0|||
145757346|NCT00191451|525625592|FG002|Overall Study|Sponsor Decision|0|||
145757347|NCT00191451|525625590|FG000|Overall Study|Ineligible|0|||
145532227|NCT02436304|524810050|FG001|Overall Study|Withdrawal by Subject|1|||
145532228|NCT02436304|524810051|FG002|Overall Study|Withdrawal by Subject|0|||
145532229|NCT02436304|524810049|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
145532230|NCT02436304|524810050|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
145532231|NCT02436304|524810051|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
145532232|NCT00369122|524810060|FG000|Overall Study|Ineligible|10|||
145532233|NCT00369122|524810060|FG000|Overall Study|No protocol treatment|1|||
145532234|NCT00191906|524810063|FG000|Study Period II|Adverse Event|0|||
145532235|NCT00191906|524810064|FG001|Study Period II|Adverse Event|1|||
145532236|NCT00191906|524810065|FG002|Study Period II|Adverse Event|0|||
145532237|NCT00191906|524810066|FG003|Study Period II|Adverse Event|0|||
145532238|NCT00191906|524810063|FG000|Study Period II|Withdrawal by Subject|0|||
145532239|NCT00191906|524810064|FG001|Study Period II|Withdrawal by Subject|3|||
145532240|NCT00191906|524810065|FG002|Study Period II|Withdrawal by Subject|0|||
145532241|NCT00191906|524810066|FG003|Study Period II|Withdrawal by Subject|0|||
145532242|NCT00191906|524810063|FG000|Study Period II|Parent/Caregiver Decision|0|||
145532243|NCT00191906|524810064|FG001|Study Period II|Parent/Caregiver Decision|1|||
145532244|NCT00191906|524810065|FG002|Study Period II|Parent/Caregiver Decision|0|||
145532245|NCT00191906|524810066|FG003|Study Period II|Parent/Caregiver Decision|0|||
145532246|NCT00191906|524810063|FG000|Study Period II|Entry Criteria Exclusion|0|||
145532247|NCT00191906|524810064|FG001|Study Period II|Entry Criteria Exclusion|0|||
145532248|NCT00191906|524810065|FG002|Study Period II|Entry Criteria Exclusion|1|||
145532249|NCT00191906|524810066|FG003|Study Period II|Entry Criteria Exclusion|0|||
145532250|NCT00191906|524810063|FG000|Study Period III|Adverse Event|1|||
145532251|NCT00191906|524810064|FG001|Study Period III|Adverse Event|0|||
145532252|NCT00191906|524810065|FG002|Study Period III|Adverse Event|0|||
145532253|NCT00191906|524810066|FG003|Study Period III|Adverse Event|0|||
145532254|NCT00191906|524810063|FG000|Study Period III|Lost to Follow-up|0|||
145532255|NCT00191906|524810064|FG001|Study Period III|Lost to Follow-up|1|||
145532256|NCT00191906|524810065|FG002|Study Period III|Lost to Follow-up|0|||
145532257|NCT00191906|524810066|FG003|Study Period III|Lost to Follow-up|0|||
145532258|NCT00191906|524810063|FG000|Study Period III|Parent/Caregiver Decision|1|||
145532259|NCT00191906|524810064|FG001|Study Period III|Parent/Caregiver Decision|0|||
145532260|NCT00191906|524810065|FG002|Study Period III|Parent/Caregiver Decision|0|||
145532261|NCT00191906|524810066|FG003|Study Period III|Parent/Caregiver Decision|0|||
145532262|NCT00191906|524810063|FG000|Study Period III|Lack of Efficacy|3|||
145532263|NCT00191906|524810064|FG001|Study Period III|Lack of Efficacy|3|||
145532264|NCT00191906|524810065|FG002|Study Period III|Lack of Efficacy|0|||
145532265|NCT00191906|524810066|FG003|Study Period III|Lack of Efficacy|0|||
145532266|NCT03387683|524810068|FG000|Overall Study|In receipt of disallowed medication|1|||
145532267|NCT03387683|524810069|FG001|Overall Study|In receipt of disallowed medication|0|||
145532268|NCT03387683|524810068|FG000|Overall Study|Did not receive treatment|1|||
145532269|NCT03387683|524810069|FG001|Overall Study|Did not receive treatment|0|||
145532270|NCT01393301|524810070|FG000|Overall Study|Lost to Follow-up|5|||
145532271|NCT01393301|524810071|FG001|Overall Study|Lost to Follow-up|3|||
145532272|NCT01393301|524810070|FG000|Overall Study|Withdrawal by Subject|2|||
145532273|NCT01393301|524810071|FG001|Overall Study|Withdrawal by Subject|0|||
145532274|NCT01393301|524810070|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
145532275|NCT01393301|524810071|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
145532276|NCT03342963|524810072|FG000|Overall Study|Adverse Event|1|||
145532277|NCT03342963|524810073|FG001|Overall Study|Adverse Event|2|||
145532278|NCT03342963|524810074|FG002|Overall Study|Adverse Event|0|||
145532279|NCT03342963|524810075|FG003|Overall Study|Adverse Event|0|||
145532280|NCT03342963|524810072|FG000|Overall Study|Withdrawal by Subject|1|||
145532281|NCT03342963|524810073|FG001|Overall Study|Withdrawal by Subject|0|||
145532282|NCT03342963|524810074|FG002|Overall Study|Withdrawal by Subject|0|||
145532283|NCT03342963|524810075|FG003|Overall Study|Withdrawal by Subject|0|||
145532284|NCT00722423|524810076|FG000|Overall Study|Protocol Violation|0|||
145532285|NCT00722423|524810077|FG001|Overall Study|Protocol Violation|1|||
145532286|NCT01950169|524810078|FG000|Overall Study|Withdrawal by Subject|2|||
145532287|NCT01950169|524810079|FG001|Overall Study|Withdrawal by Subject|8|||
145532288|NCT01950169|524810080|FG002|Overall Study|Withdrawal by Subject|1|||
145532289|NCT01950169|524810078|FG000|Overall Study|Death|1|||
145757348|NCT00191451|525625591|FG001|Overall Study|Ineligible|1|||
145757349|NCT00191451|525625592|FG002|Overall Study|Ineligible|0|||
145757350|NCT00191451|525625590|FG000|Overall Study|Reason Not Specified|2|||
145757351|NCT00191451|525625591|FG001|Overall Study|Reason Not Specified|1|||
145757352|NCT00191451|525625592|FG002|Overall Study|Reason Not Specified|3|||
145757353|NCT03555266|525625598|FG000|Overall Study|Protocol Violation|6|||
145757354|NCT03555266|525625599|FG001|Overall Study|Protocol Violation|4|||
145757355|NCT03370770|525625600|FG000|Overall Study|Patient was followed in another hospital center|1|||
145757356|NCT03370770|525625600|FG000|Overall Study|Progressive Disease|98|||
145757357|NCT03370770|525625600|FG000|Overall Study|Adverse Event|2|||
145757358|NCT03370770|525625600|FG000|Overall Study|Death|5|||
145757359|NCT02167945|525625604|FG000|Overall Study|Adverse Event|16|||
145757360|NCT02167945|525625604|FG000|Overall Study|Withdrew Consent|42|||
145757361|NCT02167945|525625604|FG000|Overall Study|Lost to Follow-up|122|||
145757362|NCT02167945|525625604|FG000|Overall Study|COVID-19 logistical restrictions|6|||
145757363|NCT02167945|525625604|FG000|Overall Study|Other, not specified|63|||
145757364|NCT00132730|525625605|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
145757365|NCT00132730|525625606|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
145757366|NCT00132730|525625607|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
145757367|NCT00132730|525625608|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
145757368|NCT00132730|525625609|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
145757369|NCT00132730|525625610|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
145757370|NCT00132730|525625605|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
145757371|NCT00132730|525625606|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
145757372|NCT00132730|525625607|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
145532290|NCT01950169|524810079|FG001|Overall Study|Death|0|||
145532291|NCT01950169|524810080|FG002|Overall Study|Death|0|||
145757373|NCT00132730|525625608|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
145757374|NCT00132730|525625609|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
145757375|NCT00132730|525625610|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
145757376|NCT00132730|525625605|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
145757377|NCT00132730|525625606|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
145532292|NCT01938573|524810081|FG000|Overall Study|Lack of Efficacy|1|||
145757378|NCT00132730|525625607|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
145757379|NCT00132730|525625608|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
145757380|NCT00132730|525625609|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
145757381|NCT00132730|525625610|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
145757382|NCT00132730|525625605|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
145757383|NCT00132730|525625606|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
145532293|NCT01938573|524810082|FG001|Overall Study|Lack of Efficacy|0|||
145532294|NCT01938573|524810081|FG000|Overall Study|Operation at other hospital|1|||
145532295|NCT01938573|524810082|FG001|Overall Study|Operation at other hospital|0|||
145532296|NCT00737438|524810090|FG000|Overall Study|Withdrawal by Subject|2|||
145532297|NCT00737438|524810090|FG000|Overall Study|Patient ineligible|1|||
145532298|NCT02410551|524810091|FG000|Overall Study|Adverse Event|1|||
145532299|NCT02410551|524810091|FG000|Overall Study|Withdrawal by Subject|1|||
145532300|NCT02410551|524810091|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
145532301|NCT01739309|524810092|FG000|Overall Study|Adverse Event|1|||
145532302|NCT01739309|524810092|FG000|Overall Study|Withdrawal by Subject|1|||
145532303|NCT05085730|524810095|FG000|Overall Study|Withdrawal by Subject|4|||
145532304|NCT05085730|524810095|FG000|Overall Study|Physician Decision|1|||
145532305|NCT05447897|524810096|FG000|Overall Study|Did not participate in survey|2|||
145532306|NCT04553679|524810097|FG000|Overall Study|Withdrawal by Subject|2|||
145532307|NCT04553679|524810098|FG001|Overall Study|Withdrawal by Subject|0|||
145532308|NCT04553679|524810097|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
145532309|NCT04553679|524810098|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
145532310|NCT01649804|524810099|FG000|Overall Study|Administrative/Other|8|||
145757384|NCT00132730|525625607|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
145757385|NCT00132730|525625608|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
145757386|NCT00132730|525625609|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
145757387|NCT00132730|525625610|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
145757388|NCT00132730|525625605|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
145757389|NCT00132730|525625606|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
145757390|NCT00132730|525625607|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
145757391|NCT00132730|525625608|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
145757392|NCT00132730|525625609|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
145757393|NCT00132730|525625610|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
145757394|NCT00132730|525625605|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145757395|NCT00132730|525625606|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145757396|NCT00132730|525625607|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145757397|NCT00132730|525625608|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
145757398|NCT00132730|525625609|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145757399|NCT00132730|525625610|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
145757400|NCT00132730|525625605|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
145757401|NCT00132730|525625606|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
145757402|NCT00132730|525625607|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
145532311|NCT03719586|524810100|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
145532312|NCT03719586|524810101|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
145532313|NCT03719586|524810102|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
145532314|NCT03719586|524810103|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
145607592|NCT02296190|525079204|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
145607593|NCT02296190|525079199|FG000|Overall Study|Lab result not available in time|1|||
145607594|NCT02296190|525079200|FG001|Overall Study|Lab result not available in time|0|||
145607595|NCT02296190|525079201|FG002|Overall Study|Lab result not available in time|0|||
145757403|NCT00132730|525625608|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
145757404|NCT00132730|525625609|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
145757405|NCT00132730|525625610|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
145757406|NCT00132730|525625605|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
145532315|NCT00178633|524810104|FG000|Overall Study|Lost to Follow-up|6|||
145532316|NCT03845543|524810105|FG000|Overall Study|Death|25|||
145532317|NCT03845543|524810105|FG000|Overall Study|Withdrawal by Subject|2|||
145532318|NCT03845543|524810105|FG000|Overall Study|Lost to Follow-up|12|||
145532319|NCT03845543|524810105|FG000|Overall Study|Adverse Event|17|||
145607596|NCT02296190|525079202|FG003|Overall Study|Lab result not available in time|0|||
145607597|NCT02296190|525079203|FG004|Overall Study|Lab result not available in time|0|||
145607598|NCT02296190|525079204|FG005|Overall Study|Lab result not available in time|0|||
145607599|NCT03682705|525079205|FG000|Overall Study|Adverse Event|1|||
145607600|NCT03682705|525079206|FG001|Overall Study|Adverse Event|1|||
145607601|NCT03682705|525079207|FG002|Overall Study|Adverse Event|1|||
145607602|NCT03682705|525079208|FG003|Overall Study|Adverse Event|0|||
145607603|NCT03682705|525079209|FG004|Overall Study|Adverse Event|1|||
145607604|NCT03682705|525079210|FG005|Overall Study|Adverse Event|1|||
145607605|NCT03682705|525079205|FG000|Overall Study|Withdrawal by Subject|1|||
145607606|NCT03682705|525079206|FG001|Overall Study|Withdrawal by Subject|3|||
145607607|NCT03682705|525079207|FG002|Overall Study|Withdrawal by Subject|2|||
145532320|NCT02028871|524810114|FG000|Overall Study|Positive urine drug screen|1|||
145532321|NCT02028871|524810115|FG001|Overall Study|Positive urine drug screen|1|||
145757407|NCT00132730|525625606|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
145532322|NCT02028871|524810114|FG000|Overall Study|Withdrawal by Subject|1|||
145532323|NCT02028871|524810115|FG001|Overall Study|Withdrawal by Subject|2|||
145532324|NCT02028871|524810114|FG000|Overall Study|IV placement difficulty|1|||
145607608|NCT03682705|525079208|FG003|Overall Study|Withdrawal by Subject|4|||
145532325|NCT02028871|524810115|FG001|Overall Study|IV placement difficulty|0|||
145532326|NCT02028871|524810114|FG000|Overall Study|Current Illness|1|||
145532327|NCT02028871|524810115|FG001|Overall Study|Current Illness|0|||
145532328|NCT02633501|524810118|FG000|Overall Study|Adverse Event|0|||
145532329|NCT02633501|524810119|FG001|Overall Study|Adverse Event|0|||
145273753|NCT02575807|523850101|FG000|Overall Study|Subject ineligible - medical implant|0|||
145273754|NCT02575807|523850102|FG001|Overall Study|Subject ineligible - medical implant|0|||
145273755|NCT02575807|523850103|FG002|Overall Study|Subject ineligible - medical implant|0|||
145273756|NCT02575807|523850104|FG003|Overall Study|Subject ineligible - medical implant|1|||
145273757|NCT02575807|523850105|FG004|Overall Study|Subject ineligible - medical implant|0|||
145273758|NCT02575807|523850101|FG000|Overall Study|Withdrawal by Subject|0|||
145273759|NCT02575807|523850102|FG001|Overall Study|Withdrawal by Subject|0|||
145273760|NCT02575807|523850103|FG002|Overall Study|Withdrawal by Subject|1|||
145273761|NCT02575807|523850104|FG003|Overall Study|Withdrawal by Subject|1|||
145273762|NCT02575807|523850105|FG004|Overall Study|Withdrawal by Subject|2|||
145273763|NCT05264506|523850108|FG000|Overall Study|Adverse Event|59|||
145273764|NCT05264506|523850108|FG000|Overall Study|Lost to Follow-up|204|||
145273765|NCT05264506|523850108|FG000|Overall Study|Protocol Violation|185|||
145273766|NCT05264506|523850108|FG000|Overall Study|Pregnancy|60|||
145273767|NCT05264506|523850108|FG000|Overall Study|Physician Decision|6|||
145273768|NCT05264506|523850108|FG000|Overall Study|Non-compliance with Study Drug|29|||
145273769|NCT05264506|523850108|FG000|Overall Study|Study termination|677|||
145273770|NCT05264506|523850108|FG000|Overall Study|Withdrawal by Subject|208|||
145273771|NCT05264506|523850108|FG000|Overall Study|Discontinued prior treatment|89|||
145273772|NCT00005879|523850109|FG000|Overall Study|Withdrawal by Subject|8|||
145532330|NCT02633501|524810120|FG002|Overall Study|Adverse Event|1|||
145532331|NCT02633501|524810121|FG003|Overall Study|Adverse Event|0|||
145532332|NCT02633501|524810122|FG004|Overall Study|Adverse Event|1|||
145273773|NCT00005879|523850110|FG001|Overall Study|Withdrawal by Subject|10|||
145273774|NCT01238172|523850111|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
145273775|NCT01238172|523850112|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
145273776|NCT01238172|523850111|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
145273777|NCT01238172|523850112|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
145273778|NCT05022121|523850113|FG000|Overall Study|Lack of Efficacy|1|||
145273779|NCT05022121|523850114|FG001|Overall Study|Lack of Efficacy|0|||
145273780|NCT05022121|523850113|FG000|Overall Study|Lost to Follow-up|0|||
145273781|NCT05022121|523850114|FG001|Overall Study|Lost to Follow-up|2|||
145273782|NCT00359073|523850910|FG000|Overall Study|Withdrawal by Subject|1|||
145273783|NCT00359073|523850911|FG001|Overall Study|Withdrawal by Subject|1|||
145273784|NCT00359073|523850910|FG000|Overall Study|Eligibility criteria no longer met|3|||
145273785|NCT00359073|523850911|FG001|Overall Study|Eligibility criteria no longer met|0|||
145273786|NCT00359073|523850910|FG000|Overall Study|developed RV16 antibody|0|||
145273787|NCT00359073|523850911|FG001|Overall Study|developed RV16 antibody|1|||
145273788|NCT01371006|523850912|FG000|Overall Study|Adverse Event|1|||
145273789|NCT01371006|523850913|FG001|Overall Study|Adverse Event|0|||
145273790|NCT00891527|523850914|FG000|Overall Study|Withdrawal by Subject|2|||
145273791|NCT03978117|523850918|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
145273792|NCT03978117|523850919|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
145273793|NCT03978117|523850918|FG000|Overall Study|Lost to Follow-up|4|||
145273794|NCT03978117|523850919|FG001|Overall Study|Lost to Follow-up|4|||
145273795|NCT00791154|523850920|FG000|Overall Study|Noncompliance|0|||
145273796|NCT00791154|523850921|FG001|Overall Study|Noncompliance|1|||
145273797|NCT00791154|523850922|FG002|Overall Study|Noncompliance|0|||
145273798|NCT00791154|523850923|FG003|Overall Study|Noncompliance|0|||
145273799|NCT00791154|523850924|FG004|Overall Study|Noncompliance|1|||
145273800|NCT00791154|523850925|FG005|Overall Study|Noncompliance|1|||
145273801|NCT00791154|523850926|FG006|Overall Study|Noncompliance|1|||
145532333|NCT02633501|524810123|FG005|Overall Study|Adverse Event|1|||
145532334|NCT02633501|524810118|FG000|Overall Study|Withdrawal by Subject|2|||
145532335|NCT02633501|524810119|FG001|Overall Study|Withdrawal by Subject|1|||
145532336|NCT02633501|524810120|FG002|Overall Study|Withdrawal by Subject|2|||
145532337|NCT02633501|524810121|FG003|Overall Study|Withdrawal by Subject|2|||
145532338|NCT02633501|524810122|FG004|Overall Study|Withdrawal by Subject|1|||
145532339|NCT02633501|524810123|FG005|Overall Study|Withdrawal by Subject|3|||
145273802|NCT00791154|523850920|FG000|Overall Study|Adverse Event|0|||
145273803|NCT00791154|523850921|FG001|Overall Study|Adverse Event|0|||
145273804|NCT00791154|523850922|FG002|Overall Study|Adverse Event|0|||
145273805|NCT00791154|523850923|FG003|Overall Study|Adverse Event|0|||
145273806|NCT00791154|523850924|FG004|Overall Study|Adverse Event|2|||
145273807|NCT00791154|523850925|FG005|Overall Study|Adverse Event|0|||
145273808|NCT00791154|523850926|FG006|Overall Study|Adverse Event|1|||
145273809|NCT00791154|523850920|FG000|Overall Study|Full Consent withdrawn|1|||
145273810|NCT00791154|523850921|FG001|Overall Study|Full Consent withdrawn|3|||
145273811|NCT00791154|523850922|FG002|Overall Study|Full Consent withdrawn|0|||
145532340|NCT02633501|524810118|FG000|Overall Study|Various other reasons|0|||
145532341|NCT02633501|524810119|FG001|Overall Study|Various other reasons|2|||
145273812|NCT00791154|523850923|FG003|Overall Study|Full Consent withdrawn|0|||
145273813|NCT00791154|523850924|FG004|Overall Study|Full Consent withdrawn|1|||
145273814|NCT00791154|523850925|FG005|Overall Study|Full Consent withdrawn|3|||
145273815|NCT00791154|523850926|FG006|Overall Study|Full Consent withdrawn|1|||
145273816|NCT00791154|523850920|FG000|Overall Study|Lost to Follow-up|0|||
145273817|NCT00791154|523850921|FG001|Overall Study|Lost to Follow-up|0|||
145273818|NCT00791154|523850922|FG002|Overall Study|Lost to Follow-up|0|||
145273819|NCT00791154|523850923|FG003|Overall Study|Lost to Follow-up|1|||
145273820|NCT00791154|523850924|FG004|Overall Study|Lost to Follow-up|2|||
145273821|NCT00791154|523850925|FG005|Overall Study|Lost to Follow-up|0|||
145273822|NCT00791154|523850926|FG006|Overall Study|Lost to Follow-up|4|||
145273823|NCT00791154|523850920|FG000|Overall Study|Death|5|||
145273824|NCT00791154|523850921|FG001|Overall Study|Death|4|||
145273825|NCT00791154|523850922|FG002|Overall Study|Death|4|||
145273826|NCT00791154|523850923|FG003|Overall Study|Death|7|||
145273827|NCT00791154|523850924|FG004|Overall Study|Death|54|||
145273828|NCT00791154|523850925|FG005|Overall Study|Death|54|||
145273829|NCT00791154|523850926|FG006|Overall Study|Death|52|||
145273830|NCT00791154|523850920|FG000|Overall Study|Other event|0|||
145273831|NCT00791154|523850921|FG001|Overall Study|Other event|0|||
145273832|NCT00791154|523850922|FG002|Overall Study|Other event|2|||
145273833|NCT00791154|523850923|FG003|Overall Study|Other event|0|||
145273834|NCT00791154|523850924|FG004|Overall Study|Other event|2|||
145273835|NCT00791154|523850925|FG005|Overall Study|Other event|4|||
145273836|NCT00791154|523850926|FG006|Overall Study|Other event|2|||
145273837|NCT01652573|523850927|FG000|Overall Study|Adverse Event|0|||
145273838|NCT01652573|523850928|FG001|Overall Study|Adverse Event|1|||
145273839|NCT01052038|523850932|FG000|Overall Study|Lost to Follow-up|2|||
145273840|NCT01052038|523850933|FG001|Overall Study|Lost to Follow-up|3|||
145273841|NCT01052038|523850934|FG002|Overall Study|Lost to Follow-up|1|||
145273842|NCT01052038|523850932|FG000|Overall Study|Protocol Violation|2|||
145273843|NCT01052038|523850933|FG001|Overall Study|Protocol Violation|3|||
145273844|NCT01052038|523850934|FG002|Overall Study|Protocol Violation|3|||
145273845|NCT03976076|523850935|FG000|Overall Study|Withdrawal by Subject|2|||
145273846|NCT00602641|523850937|FG000|Overall Study|Never started protocol therapy|6|||
145273847|NCT00602641|523850938|FG001|Overall Study|Never started protocol therapy|2|||
145273848|NCT00602641|523850937|FG000|Overall Study|Still on treatment at time of analysis|8|||
145273849|NCT00602641|523850938|FG001|Overall Study|Still on treatment at time of analysis|15|||
145273850|NCT00602641|523850937|FG000|Overall Study|Adverse Event|62|||
145273851|NCT00602641|523850938|FG001|Overall Study|Adverse Event|53|||
145273852|NCT00602641|523850937|FG000|Overall Study|Disease progression|38|||
145273853|NCT00602641|523850938|FG001|Overall Study|Disease progression|55|||
145273854|NCT00602641|523850937|FG000|Overall Study|Death|6|||
145273855|NCT00602641|523850938|FG001|Overall Study|Death|5|||
145273856|NCT00602641|523850937|FG000|Overall Study|Withdrawal by Subject|15|||
145273857|NCT00602641|523850938|FG001|Overall Study|Withdrawal by Subject|12|||
145273858|NCT00602641|523850937|FG000|Overall Study|Alternative therapy|5|||
145273859|NCT00602641|523850938|FG001|Overall Study|Alternative therapy|2|||
145273860|NCT00602641|523850937|FG000|Overall Study|Other Complicating Disease|5|||
145273861|NCT00602641|523850938|FG001|Overall Study|Other Complicating Disease|2|||
145273862|NCT00602641|523850937|FG000|Overall Study|Physician Decision|5|||
145273863|NCT00602641|523850938|FG001|Overall Study|Physician Decision|4|||
145273864|NCT00602641|523850937|FG000|Overall Study|Administrative Closure|1|||
145273865|NCT00602641|523850938|FG001|Overall Study|Administrative Closure|1|||
145273866|NCT00602641|523850937|FG000|Overall Study|Other|3|||
145273867|NCT00602641|523850938|FG001|Overall Study|Other|1|||
145273868|NCT03901352|523850940|FG000|Double-blind Phase|Adverse Event|6|||
145273869|NCT03901352|523850941|FG001|Double-blind Phase|Adverse Event|4|||
145273870|NCT03901352|523850940|FG000|Double-blind Phase|Death|1|||
145273871|NCT03901352|523850941|FG001|Double-blind Phase|Death|0|||
145273872|NCT03901352|523850940|FG000|Double-blind Phase|Lack of Efficacy|0|||
145273873|NCT03901352|523850941|FG001|Double-blind Phase|Lack of Efficacy|1|||
145532342|NCT02633501|524810120|FG002|Overall Study|Various other reasons|4|||
145532343|NCT02633501|524810121|FG003|Overall Study|Various other reasons|1|||
145532344|NCT02633501|524810122|FG004|Overall Study|Various other reasons|7|||
145532345|NCT02633501|524810123|FG005|Overall Study|Various other reasons|11|||
145273874|NCT03901352|523850940|FG000|Double-blind Phase|Protocol Violation|0|||
145273875|NCT03901352|523850941|FG001|Double-blind Phase|Protocol Violation|1|||
145273876|NCT03901352|523850940|FG000|Double-blind Phase|Withdrawal by Subject|10|||
145273877|NCT03901352|523850941|FG001|Double-blind Phase|Withdrawal by Subject|8|||
145273878|NCT03901352|523850940|FG000|Open-label Extension Phase|Adverse Event|24|||
145273879|NCT03901352|523850941|FG001|Open-label Extension Phase|Adverse Event|0|||
145273880|NCT03901352|523850940|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
145273881|NCT03901352|523850941|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
145532346|NCT02633501|524810118|FG000|Overall Study|Lost to Follow-up|0|||
145532347|NCT02633501|524810119|FG001|Overall Study|Lost to Follow-up|0|||
145273882|NCT03901352|523850940|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
145273883|NCT03901352|523850941|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
145273884|NCT03901352|523850940|FG000|Open-label Extension Phase|Other|1|||
145532348|NCT02633501|524810120|FG002|Overall Study|Lost to Follow-up|0|||
145757408|NCT00132730|525625607|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
145757409|NCT00132730|525625608|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
145757410|NCT00132730|525625609|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
145757411|NCT00132730|525625610|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
145757412|NCT00132730|525625605|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
145757413|NCT00132730|525625606|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
145757414|NCT00132730|525625607|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
145757415|NCT00132730|525625608|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
145757416|NCT00132730|525625609|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
145757417|NCT00132730|525625610|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
145757418|NCT00132730|525625605|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
145757419|NCT00132730|525625606|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
145757420|NCT00132730|525625607|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
145757421|NCT00132730|525625608|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
145757422|NCT00132730|525625609|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
145757423|NCT00132730|525625610|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
145757424|NCT00132730|525625605|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
145273885|NCT03901352|523850941|FG001|Open-label Extension Phase|Other|0|||
145757425|NCT00132730|525625606|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
145757426|NCT00132730|525625607|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
145757427|NCT00132730|525625608|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
145757428|NCT00132730|525625609|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
145757429|NCT00132730|525625610|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
145757430|NCT00132730|525625605|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
145757431|NCT00132730|525625606|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
145757432|NCT00132730|525625607|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
145757433|NCT00132730|525625608|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
145757434|NCT00132730|525625609|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
145757435|NCT00132730|525625610|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
145273886|NCT01826201|523850944|FG000|Overall Study|Non compliance with protocol|4|||
145273887|NCT01615822|523850945|FG000|Period 1|Withdrawal by Subject|0|||
145757436|NCT01192347|525625611|FG000|Overall Study|Death|3|||
145757437|NCT01192347|525625611|FG000|Overall Study|Lost to Follow-up|3|||
145757438|NCT01192347|525625611|FG000|Overall Study|Withdrawal by Subject|1|||
145757439|NCT01192347|525625611|FG000|Overall Study|Adverse Event|1|||
145757440|NCT01192347|525625611|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
145757441|NCT01192347|525625611|FG000|Overall Study|Patient seen in different hospital|1|||
145757442|NCT01192347|525625611|FG000|Overall Study|Patient not visiting hospital regularly|1|||
145757443|NCT01192347|525625611|FG000|Overall Study|Patient did not show up for visits|1|||
145757444|NCT02623335|525625612|FG000|Overall Study|Death|8|||
145757445|NCT02623335|525625613|FG001|Overall Study|Death|7|||
145757446|NCT02623335|525625612|FG000|Overall Study|Lost to Follow-up|15|||
145757447|NCT02623335|525625613|FG001|Overall Study|Lost to Follow-up|23|||
145757448|NCT02623335|525625612|FG000|Overall Study|Withdrawal by Subject|2|||
145757449|NCT02623335|525625613|FG001|Overall Study|Withdrawal by Subject|5|||
145757450|NCT02623335|525625612|FG000|Overall Study|Protocol Violation|2|||
145757451|NCT02623335|525625613|FG001|Overall Study|Protocol Violation|1|||
145757452|NCT03739528|525625614|FG000|Overall Study|Not treated|8|||
145757453|NCT03739528|525625615|FG001|Overall Study|Not treated|12|||
145757454|NCT03739528|525625614|FG000|Overall Study|Treatment and study discontinued|6|||
145757455|NCT03739528|525625615|FG001|Overall Study|Treatment and study discontinued|2|||
145757456|NCT03739528|525625614|FG000|Overall Study|Treatment discontinued + study completed|1|||
145757457|NCT03739528|525625615|FG001|Overall Study|Treatment discontinued + study completed|3|||
145757458|NCT00395967|525625616|FG000|Treatment Period|Failed Mobilization|1|||
145757459|NCT00395967|525625616|FG000|Follow-up Period|Death|1|||
145757460|NCT00395967|525625616|FG000|Follow-up Period|Lost to Follow-up|1|||
145757461|NCT01109940|525625617|FG000|Overall Study|Administrative problems|2|||
145757462|NCT01109940|525625618|FG001|Overall Study|Administrative problems|0|||
145757463|NCT01109940|525625619|FG002|Overall Study|Administrative problems|0|||
145757464|NCT01109940|525625620|FG003|Overall Study|Administrative problems|0|||
145757465|NCT01109940|525625617|FG000|Overall Study|Serious Adverse Event|2|||
145757466|NCT01109940|525625618|FG001|Overall Study|Serious Adverse Event|1|||
145757467|NCT01109940|525625619|FG002|Overall Study|Serious Adverse Event|0|||
145757468|NCT01109940|525625620|FG003|Overall Study|Serious Adverse Event|0|||
145757469|NCT01109940|525625617|FG000|Overall Study|Lost to Follow-up|1|||
145757470|NCT01109940|525625618|FG001|Overall Study|Lost to Follow-up|0|||
145757471|NCT01109940|525625619|FG002|Overall Study|Lost to Follow-up|0|||
145757472|NCT01109940|525625620|FG003|Overall Study|Lost to Follow-up|0|||
145273888|NCT01615822|523850946|FG001|Period 1|Withdrawal by Subject|1|||
145273889|NCT01615822|523850947|FG002|Period 1|Withdrawal by Subject|0|||
145757473|NCT01109940|525625617|FG000|Overall Study|Patient withdrew consent|1|||
145757474|NCT01109940|525625618|FG001|Overall Study|Patient withdrew consent|1|||
145757475|NCT01109940|525625619|FG002|Overall Study|Patient withdrew consent|0|||
145757476|NCT01109940|525625620|FG003|Overall Study|Patient withdrew consent|0|||
145273890|NCT01615822|523850945|FG000|Period 1|Adverse Event|1|||
145273891|NCT01615822|523850946|FG001|Period 1|Adverse Event|1|||
145402872|NCT02065557|524332545|FG001|Induction Period|Lack of Efficacy|1|||
145757477|NCT01109940|525625617|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145757478|NCT01109940|525625618|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145757479|NCT01109940|525625619|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
145757480|NCT01109940|525625620|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145757481|NCT00179959|525625621|FG000|Overall Study|Lost to Follow-up|3|||
145757482|NCT00179959|525625622|FG001|Overall Study|Lost to Follow-up|1|||
145757483|NCT00179959|525625621|FG000|Overall Study|Withdrawal by Subject|3|||
145757484|NCT00179959|525625622|FG001|Overall Study|Withdrawal by Subject|2|||
145757485|NCT01262976|525625623|FG000|Up to Month 2|Serious Adverse Event|0|||
145757486|NCT01262976|525625624|FG001|Up to Month 2|Serious Adverse Event|0|||
145757487|NCT01262976|525625625|FG002|Up to Month 2|Serious Adverse Event|1|||
145757488|NCT01262976|525625626|FG003|Up to Month 2|Serious Adverse Event|0|||
145757489|NCT01262976|525625627|FG004|Up to Month 2|Serious Adverse Event|0|||
145757490|NCT01262976|525625628|FG005|Up to Month 2|Serious Adverse Event|0|||
145757491|NCT01262976|525625623|FG000|Up to Month 2|Withdrawal by Subject|1|||
145757492|NCT01262976|525625624|FG001|Up to Month 2|Withdrawal by Subject|0|||
145757493|NCT01262976|525625625|FG002|Up to Month 2|Withdrawal by Subject|0|||
145757494|NCT01262976|525625626|FG003|Up to Month 2|Withdrawal by Subject|0|||
145757495|NCT01262976|525625627|FG004|Up to Month 2|Withdrawal by Subject|0|||
145757496|NCT01262976|525625628|FG005|Up to Month 2|Withdrawal by Subject|0|||
145757497|NCT01262976|525625623|FG000|Up to Month 2|Migrated/moved from study area|0|||
145757498|NCT01262976|525625624|FG001|Up to Month 2|Migrated/moved from study area|1|||
145757499|NCT01262976|525625625|FG002|Up to Month 2|Migrated/moved from study area|0|||
145757500|NCT01262976|525625626|FG003|Up to Month 2|Migrated/moved from study area|0|||
145757501|NCT01262976|525625627|FG004|Up to Month 2|Migrated/moved from study area|1|||
145757502|NCT01262976|525625628|FG005|Up to Month 2|Migrated/moved from study area|1|||
145757503|NCT01262976|525625623|FG000|Up to Month 2|Lost to Follow-up|1|||
145757504|NCT01262976|525625624|FG001|Up to Month 2|Lost to Follow-up|0|||
145757505|NCT01262976|525625625|FG002|Up to Month 2|Lost to Follow-up|0|||
145757506|NCT01262976|525625626|FG003|Up to Month 2|Lost to Follow-up|1|||
145757507|NCT01262976|525625627|FG004|Up to Month 2|Lost to Follow-up|1|||
145757508|NCT01262976|525625628|FG005|Up to Month 2|Lost to Follow-up|1|||
145757509|NCT01262976|525625623|FG000|Up to Month 2|Other|1|||
145757510|NCT01262976|525625624|FG001|Up to Month 2|Other|0|||
145757511|NCT01262976|525625625|FG002|Up to Month 2|Other|0|||
145757512|NCT01262976|525625626|FG003|Up to Month 2|Other|1|||
145757513|NCT01262976|525625627|FG004|Up to Month 2|Other|0|||
145757514|NCT01262976|525625628|FG005|Up to Month 2|Other|2|||
145757515|NCT01262976|525625623|FG000|Up to Month 7|Serious Adverse Event|0|||
145757516|NCT01262976|525625624|FG001|Up to Month 7|Serious Adverse Event|0|||
145757517|NCT01262976|525625625|FG002|Up to Month 7|Serious Adverse Event|2|||
145757518|NCT01262976|525625626|FG003|Up to Month 7|Serious Adverse Event|0|||
145757519|NCT01262976|525625627|FG004|Up to Month 7|Serious Adverse Event|0|||
145757520|NCT01262976|525625628|FG005|Up to Month 7|Serious Adverse Event|0|||
145273892|NCT01615822|523850947|FG002|Period 1|Adverse Event|0|||
145757521|NCT01262976|525625623|FG000|Up to Month 7|Withdrawal by Subject|1|||
145757522|NCT01262976|525625624|FG001|Up to Month 7|Withdrawal by Subject|0|||
145532349|NCT02633501|524810121|FG003|Overall Study|Lost to Follow-up|1|||
145532350|NCT02633501|524810122|FG004|Overall Study|Lost to Follow-up|2|||
145532351|NCT02633501|524810123|FG005|Overall Study|Lost to Follow-up|0|||
145532352|NCT01912963|524810124|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
145532353|NCT01912963|524810125|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
145532354|NCT01912963|524810126|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
145532355|NCT01912963|524810124|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
145757523|NCT01262976|525625625|FG002|Up to Month 7|Withdrawal by Subject|0|||
145273893|NCT01615822|523850945|FG000|Period 2|Lost to Follow-up|0|||
145273894|NCT01615822|523850946|FG001|Period 2|Lost to Follow-up|1|||
145273895|NCT01615822|523850947|FG002|Period 2|Lost to Follow-up|2|||
145273896|NCT03901339|523850948|FG000|Overall Study|Death|220|||
145273897|NCT03901339|523850949|FG001|Overall Study|Death|192|||
145273898|NCT03901339|523850948|FG000|Overall Study|Informed consent withdrawn|13|||
145273899|NCT03901339|523850949|FG001|Overall Study|Informed consent withdrawn|40|||
145273900|NCT03901339|523850948|FG000|Overall Study|Sponsor request|30|||
145273901|NCT03901339|523850949|FG001|Overall Study|Sponsor request|23|||
145273902|NCT03901339|523850948|FG000|Overall Study|Reason not specified|5|||
145273903|NCT03901339|523850949|FG001|Overall Study|Reason not specified|7|||
145273904|NCT03901339|523850948|FG000|Overall Study|Lost to Follow-up|4|||
145273905|NCT03901339|523850949|FG001|Overall Study|Lost to Follow-up|7|||
145273906|NCT03901339|523850948|FG000|Overall Study|Covid19|0|||
145273907|NCT03901339|523850949|FG001|Overall Study|Covid19|2|||
145273908|NCT03981614|523850950|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
145273909|NCT03981614|523850951|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
145273910|NCT03981614|523850952|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
145273911|NCT01346501|523850953|FG000|Overall Study|Initiated Other Biological Agents|3|||
145273912|NCT01346501|523850954|FG001|Overall Study|Initiated Other Biological Agents|1|||
145273913|NCT01346501|523850953|FG000|Overall Study|Other|8|||
145273914|NCT01346501|523850954|FG001|Overall Study|Other|12|||
145273915|NCT04971226|523850957|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
145273916|NCT04971226|523850958|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
145273917|NCT04971226|523850959|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
145273918|NCT04971226|523850960|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
145273919|NCT04971226|523850957|FG000|Overall Study|Adverse Event|6|||
145273920|NCT04971226|523850958|FG001|Overall Study|Adverse Event|5|||
145273921|NCT04971226|523850959|FG002|Overall Study|Adverse Event|11|||
145273922|NCT04971226|523850960|FG003|Overall Study|Adverse Event|10|||
145273923|NCT04971226|523850957|FG000|Overall Study|Progressive disease|2|||
145273924|NCT04971226|523850958|FG001|Overall Study|Progressive disease|0|||
145273925|NCT04971226|523850959|FG002|Overall Study|Progressive disease|3|||
145273926|NCT04971226|523850960|FG003|Overall Study|Progressive disease|1|||
145273927|NCT04971226|523850957|FG000|Overall Study|Protocol Deviation|1|||
145273928|NCT04971226|523850958|FG001|Overall Study|Protocol Deviation|0|||
145273929|NCT04971226|523850959|FG002|Overall Study|Protocol Deviation|1|||
145273930|NCT04971226|523850960|FG003|Overall Study|Protocol Deviation|1|||
145273931|NCT04971226|523850957|FG000|Overall Study|Subject Decision|0|||
145273932|NCT04971226|523850958|FG001|Overall Study|Subject Decision|1|||
145273933|NCT04971226|523850959|FG002|Overall Study|Subject Decision|1|||
145273934|NCT04971226|523850960|FG003|Overall Study|Subject Decision|1|||
145273935|NCT04971226|523850957|FG000|Overall Study|Pregnancy|0|||
145273936|NCT04971226|523850958|FG001|Overall Study|Pregnancy|0|||
145273937|NCT04971226|523850959|FG002|Overall Study|Pregnancy|0|||
145273938|NCT04971226|523850960|FG003|Overall Study|Pregnancy|1|||
145273939|NCT04971226|523850957|FG000|Overall Study|Participants not treated|1|||
145273940|NCT04971226|523850958|FG001|Overall Study|Participants not treated|0|||
145273941|NCT04971226|523850959|FG002|Overall Study|Participants not treated|2|||
145273942|NCT04971226|523850960|FG003|Overall Study|Participants not treated|1|||
145273943|NCT04439149|523850961|FG000|Overall Study|Ineligible|1|||
145273944|NCT04439149|523850961|FG000|Overall Study|Never start protocol therapy|1|||
145273945|NCT04439149|523850961|FG000|Overall Study|Adverse Event|4|||
145273946|NCT04439149|523850961|FG000|Overall Study|Disease Progression|14|||
145273947|NCT04439149|523850961|FG000|Overall Study|Complicating disease|1|||
145273948|NCT04439149|523850961|FG000|Overall Study|Withdrawal by Subject|3|||
145273949|NCT05919823|523850969|FG000|Pre-Treatment Period|Screen failure|1|||
145273950|NCT05919823|523850970|FG001|Pre-Treatment Period|Screen failure|0|||
145273951|NCT05919823|523850971|FG002|Pre-Treatment Period|Screen failure|0|||
145273952|NCT05919823|523850972|FG003|Pre-Treatment Period|Screen failure|0|||
145273953|NCT05919823|523850969|FG000|Pre-Treatment Period|Protocol Violation|0|||
145273954|NCT05919823|523850970|FG001|Pre-Treatment Period|Protocol Violation|1|||
145273955|NCT05919823|523850971|FG002|Pre-Treatment Period|Protocol Violation|0|||
145273956|NCT05919823|523850972|FG003|Pre-Treatment Period|Protocol Violation|0|||
145273957|NCT05919823|523850969|FG000|Double-Blind Period|Adverse Event|8|||
145273958|NCT05919823|523850970|FG001|Double-Blind Period|Adverse Event|9|||
145273959|NCT05919823|523850971|FG002|Double-Blind Period|Adverse Event|0|||
145273960|NCT05919823|523850972|FG003|Double-Blind Period|Adverse Event|0|||
145273961|NCT05919823|523850969|FG000|Double-Blind Period|Protocol Violation|2|||
145273962|NCT05919823|523850970|FG001|Double-Blind Period|Protocol Violation|1|||
145273963|NCT05919823|523850971|FG002|Double-Blind Period|Protocol Violation|0|||
145273964|NCT05919823|523850972|FG003|Double-Blind Period|Protocol Violation|0|||
145273965|NCT05919823|523850969|FG000|Double-Blind Period|Participant withdrew consent|11|||
145273966|NCT05919823|523850970|FG001|Double-Blind Period|Participant withdrew consent|7|||
145273967|NCT05919823|523850971|FG002|Double-Blind Period|Participant withdrew consent|0|||
145273968|NCT05919823|523850972|FG003|Double-Blind Period|Participant withdrew consent|0|||
145273969|NCT05919823|523850969|FG000|Double-Blind Period|Other reasons|2|||
145273970|NCT05919823|523850970|FG001|Double-Blind Period|Other reasons|3|||
145757524|NCT01262976|525625626|FG003|Up to Month 7|Withdrawal by Subject|0|||
145757525|NCT01262976|525625627|FG004|Up to Month 7|Withdrawal by Subject|0|||
145757526|NCT01262976|525625628|FG005|Up to Month 7|Withdrawal by Subject|0|||
145757527|NCT01262976|525625623|FG000|Up to Month 7|Migrated/moved from study area|0|||
145757528|NCT01262976|525625624|FG001|Up to Month 7|Migrated/moved from study area|0|||
145757529|NCT01262976|525625625|FG002|Up to Month 7|Migrated/moved from study area|1|||
145757530|NCT01262976|525625626|FG003|Up to Month 7|Migrated/moved from study area|3|||
145757531|NCT01262976|525625627|FG004|Up to Month 7|Migrated/moved from study area|1|||
145757532|NCT01262976|525625628|FG005|Up to Month 7|Migrated/moved from study area|1|||
145273971|NCT05919823|523850971|FG002|Double-Blind Period|Other reasons|0|||
145757533|NCT01262976|525625623|FG000|Up to Month 7|Lost to Follow-up|1|||
145757534|NCT01262976|525625624|FG001|Up to Month 7|Lost to Follow-up|0|||
145757535|NCT01262976|525625625|FG002|Up to Month 7|Lost to Follow-up|1|||
145757536|NCT01262976|525625626|FG003|Up to Month 7|Lost to Follow-up|3|||
145757537|NCT01262976|525625627|FG004|Up to Month 7|Lost to Follow-up|1|||
145757538|NCT01262976|525625628|FG005|Up to Month 7|Lost to Follow-up|3|||
145757539|NCT01262976|525625623|FG000|Up to Month 7|Other|3|||
145757540|NCT01262976|525625624|FG001|Up to Month 7|Other|0|||
145757541|NCT01262976|525625625|FG002|Up to Month 7|Other|2|||
145757542|NCT01262976|525625626|FG003|Up to Month 7|Other|0|||
145757543|NCT01262976|525625627|FG004|Up to Month 7|Other|0|||
145757544|NCT01262976|525625628|FG005|Up to Month 7|Other|0|||
145757545|NCT01262976|525625623|FG000|Up to Year 1|Serious Adverse Event|0|||
145757546|NCT01262976|525625624|FG001|Up to Year 1|Serious Adverse Event|0|||
145757547|NCT01262976|525625625|FG002|Up to Year 1|Serious Adverse Event|2|||
145757548|NCT01262976|525625626|FG003|Up to Year 1|Serious Adverse Event|0|||
145757549|NCT01262976|525625627|FG004|Up to Year 1|Serious Adverse Event|0|||
145757550|NCT01262976|525625628|FG005|Up to Year 1|Serious Adverse Event|0|||
145757551|NCT01262976|525625623|FG000|Up to Year 1|Withdrawal by Subject|1|||
145757552|NCT01262976|525625624|FG001|Up to Year 1|Withdrawal by Subject|0|||
145757553|NCT01262976|525625625|FG002|Up to Year 1|Withdrawal by Subject|0|||
145757554|NCT01262976|525625626|FG003|Up to Year 1|Withdrawal by Subject|0|||
145757555|NCT01262976|525625627|FG004|Up to Year 1|Withdrawal by Subject|0|||
145757556|NCT01262976|525625628|FG005|Up to Year 1|Withdrawal by Subject|0|||
145757557|NCT01262976|525625623|FG000|Up to Year 1|Migrated/moved from study area|1|||
145757558|NCT01262976|525625624|FG001|Up to Year 1|Migrated/moved from study area|0|||
145757559|NCT01262976|525625625|FG002|Up to Year 1|Migrated/moved from study area|0|||
145757560|NCT01262976|525625626|FG003|Up to Year 1|Migrated/moved from study area|3|||
145757561|NCT01262976|525625627|FG004|Up to Year 1|Migrated/moved from study area|3|||
145757562|NCT01262976|525625628|FG005|Up to Year 1|Migrated/moved from study area|2|||
145757563|NCT01262976|525625623|FG000|Up to Year 1|Lost to Follow-up|4|||
145757564|NCT01262976|525625624|FG001|Up to Year 1|Lost to Follow-up|0|||
145757565|NCT01262976|525625625|FG002|Up to Year 1|Lost to Follow-up|0|||
145757566|NCT01262976|525625626|FG003|Up to Year 1|Lost to Follow-up|1|||
145757567|NCT01262976|525625627|FG004|Up to Year 1|Lost to Follow-up|6|||
145757568|NCT01262976|525625628|FG005|Up to Year 1|Lost to Follow-up|5|||
145757569|NCT01262976|525625623|FG000|Up to Year 1|Other|3|||
145757570|NCT01262976|525625624|FG001|Up to Year 1|Other|1|||
145757571|NCT01262976|525625625|FG002|Up to Year 1|Other|0|||
145757572|NCT01262976|525625626|FG003|Up to Year 1|Other|0|||
145757573|NCT01262976|525625627|FG004|Up to Year 1|Other|2|||
145757574|NCT01262976|525625628|FG005|Up to Year 1|Other|1|||
145757575|NCT01262976|525625623|FG000|Up to Year 1|Subjects with unknown completion status|0|||
145757576|NCT01262976|525625624|FG001|Up to Year 1|Subjects with unknown completion status|0|||
145757577|NCT01262976|525625625|FG002|Up to Year 1|Subjects with unknown completion status|1|||
145757578|NCT01262976|525625626|FG003|Up to Year 1|Subjects with unknown completion status|0|||
145757579|NCT01262976|525625627|FG004|Up to Year 1|Subjects with unknown completion status|0|||
145757580|NCT01262976|525625628|FG005|Up to Year 1|Subjects with unknown completion status|1|||
145757581|NCT01262976|525625623|FG000|Up to Year 2|Serious Adverse Event|0|||
145757582|NCT01262976|525625624|FG001|Up to Year 2|Serious Adverse Event|0|||
145757583|NCT01262976|525625625|FG002|Up to Year 2|Serious Adverse Event|2|||
145757584|NCT01262976|525625626|FG003|Up to Year 2|Serious Adverse Event|0|||
145757585|NCT01262976|525625627|FG004|Up to Year 2|Serious Adverse Event|0|||
145757586|NCT01262976|525625628|FG005|Up to Year 2|Serious Adverse Event|0|||
145757587|NCT01262976|525625623|FG000|Up to Year 2|Withdrawal by Subject|1|||
145757588|NCT01262976|525625624|FG001|Up to Year 2|Withdrawal by Subject|0|||
145757589|NCT01262976|525625625|FG002|Up to Year 2|Withdrawal by Subject|0|||
145757590|NCT01262976|525625626|FG003|Up to Year 2|Withdrawal by Subject|0|||
145757591|NCT01262976|525625627|FG004|Up to Year 2|Withdrawal by Subject|0|||
145757592|NCT01262976|525625628|FG005|Up to Year 2|Withdrawal by Subject|0|||
145757593|NCT01262976|525625623|FG000|Up to Year 2|Migrated/moved from study area|0|||
145757594|NCT01262976|525625624|FG001|Up to Year 2|Migrated/moved from study area|0|||
145757595|NCT01262976|525625625|FG002|Up to Year 2|Migrated/moved from study area|0|||
145757596|NCT01262976|525625626|FG003|Up to Year 2|Migrated/moved from study area|2|||
145757597|NCT01262976|525625627|FG004|Up to Year 2|Migrated/moved from study area|1|||
145757598|NCT01262976|525625628|FG005|Up to Year 2|Migrated/moved from study area|2|||
145757599|NCT01262976|525625623|FG000|Up to Year 2|Lost to Follow-up|1|||
145757600|NCT01262976|525625624|FG001|Up to Year 2|Lost to Follow-up|1|||
145757601|NCT01262976|525625625|FG002|Up to Year 2|Lost to Follow-up|2|||
145757602|NCT01262976|525625626|FG003|Up to Year 2|Lost to Follow-up|2|||
145757603|NCT01262976|525625627|FG004|Up to Year 2|Lost to Follow-up|3|||
145757604|NCT01262976|525625628|FG005|Up to Year 2|Lost to Follow-up|3|||
145273972|NCT05919823|523850972|FG003|Double-Blind Period|Other reasons|0|||
145757605|NCT01262976|525625623|FG000|Up to Year 2|Subjects with unknown completion status|0|||
145757606|NCT01262976|525625624|FG001|Up to Year 2|Subjects with unknown completion status|0|||
145757607|NCT01262976|525625625|FG002|Up to Year 2|Subjects with unknown completion status|1|||
145757608|NCT01262976|525625626|FG003|Up to Year 2|Subjects with unknown completion status|0|||
145757609|NCT01262976|525625627|FG004|Up to Year 2|Subjects with unknown completion status|0|||
145757610|NCT01262976|525625628|FG005|Up to Year 2|Subjects with unknown completion status|0|||
145757611|NCT01262976|525625623|FG000|Up to Year 2|Other|3|||
145757612|NCT01262976|525625624|FG001|Up to Year 2|Other|0|||
145757613|NCT01262976|525625625|FG002|Up to Year 2|Other|0|||
145757614|NCT01262976|525625626|FG003|Up to Year 2|Other|0|||
145757615|NCT01262976|525625627|FG004|Up to Year 2|Other|0|||
145757616|NCT01262976|525625628|FG005|Up to Year 2|Other|0|||
145757617|NCT01262976|525625623|FG000|Up to Year 3|Serious Adverse Event|0|||
145757618|NCT01262976|525625624|FG001|Up to Year 3|Serious Adverse Event|0|||
145757619|NCT01262976|525625625|FG002|Up to Year 3|Serious Adverse Event|2|||
145757620|NCT01262976|525625626|FG003|Up to Year 3|Serious Adverse Event|0|||
145757621|NCT01262976|525625627|FG004|Up to Year 3|Serious Adverse Event|0|||
145757622|NCT01262976|525625628|FG005|Up to Year 3|Serious Adverse Event|0|||
145757623|NCT01262976|525625623|FG000|Up to Year 3|Withdrawal by Subject|1|||
145757624|NCT01262976|525625624|FG001|Up to Year 3|Withdrawal by Subject|0|||
145757625|NCT01262976|525625625|FG002|Up to Year 3|Withdrawal by Subject|0|||
145757626|NCT01262976|525625626|FG003|Up to Year 3|Withdrawal by Subject|0|||
145757627|NCT01262976|525625627|FG004|Up to Year 3|Withdrawal by Subject|0|||
145757628|NCT01262976|525625628|FG005|Up to Year 3|Withdrawal by Subject|0|||
145757629|NCT01262976|525625623|FG000|Up to Year 3|Migrated/moved from study area|0|||
145757630|NCT01262976|525625624|FG001|Up to Year 3|Migrated/moved from study area|0|||
145757631|NCT01262976|525625625|FG002|Up to Year 3|Migrated/moved from study area|0|||
145757632|NCT01262976|525625626|FG003|Up to Year 3|Migrated/moved from study area|2|||
145757633|NCT01262976|525625627|FG004|Up to Year 3|Migrated/moved from study area|1|||
145607609|NCT03682705|525079209|FG004|Overall Study|Withdrawal by Subject|0|||
145757634|NCT01262976|525625628|FG005|Up to Year 3|Migrated/moved from study area|1|||
145757635|NCT01262976|525625623|FG000|Up to Year 3|Lost to Follow-up|2|||
145757636|NCT01262976|525625624|FG001|Up to Year 3|Lost to Follow-up|2|||
145757637|NCT01262976|525625625|FG002|Up to Year 3|Lost to Follow-up|4|||
145757638|NCT01262976|525625626|FG003|Up to Year 3|Lost to Follow-up|3|||
145757639|NCT01262976|525625627|FG004|Up to Year 3|Lost to Follow-up|1|||
145757640|NCT01262976|525625628|FG005|Up to Year 3|Lost to Follow-up|3|||
145757641|NCT01262976|525625623|FG000|Up to Year 3|Subjects with unknown completion status|0|||
145757642|NCT01262976|525625624|FG001|Up to Year 3|Subjects with unknown completion status|0|||
145757643|NCT01262976|525625625|FG002|Up to Year 3|Subjects with unknown completion status|1|||
145757644|NCT01262976|525625626|FG003|Up to Year 3|Subjects with unknown completion status|0|||
145757645|NCT01262976|525625627|FG004|Up to Year 3|Subjects with unknown completion status|0|||
145757646|NCT01262976|525625628|FG005|Up to Year 3|Subjects with unknown completion status|0|||
145757647|NCT01262976|525625623|FG000|Up to Year 3|Other|3|||
145757648|NCT01262976|525625624|FG001|Up to Year 3|Other|0|||
145757649|NCT01262976|525625625|FG002|Up to Year 3|Other|0|||
145757650|NCT01262976|525625626|FG003|Up to Year 3|Other|0|||
145757651|NCT01262976|525625627|FG004|Up to Year 3|Other|0|||
145757652|NCT01262976|525625628|FG005|Up to Year 3|Other|0|||
145757653|NCT02400255|525625629|FG000|Overall Study|Relapse|4|||
145757654|NCT02400255|525625630|FG001|Overall Study|Relapse|1|||
145757655|NCT02400255|525625631|FG002|Overall Study|Relapse|1|||
145757656|NCT02400255|525625632|FG003|Overall Study|Relapse|2|||
145757657|NCT02400255|525625629|FG000|Overall Study|Adverse Event|6|||
145757658|NCT02400255|525625630|FG001|Overall Study|Adverse Event|3|||
145757659|NCT02400255|525625631|FG002|Overall Study|Adverse Event|0|||
145757660|NCT02400255|525625632|FG003|Overall Study|Adverse Event|0|||
145757661|NCT02400255|525625629|FG000|Overall Study|Physician Decision|6|||
145607610|NCT03682705|525079210|FG005|Overall Study|Withdrawal by Subject|1|||
145757662|NCT02400255|525625630|FG001|Overall Study|Physician Decision|0|||
145757663|NCT02400255|525625631|FG002|Overall Study|Physician Decision|0|||
145757664|NCT02400255|525625632|FG003|Overall Study|Physician Decision|0|||
145757665|NCT02400255|525625629|FG000|Overall Study|Loss of insurance|1|||
145757666|NCT02400255|525625630|FG001|Overall Study|Loss of insurance|0|||
145757667|NCT02400255|525625631|FG002|Overall Study|Loss of insurance|0|||
145757668|NCT02400255|525625632|FG003|Overall Study|Loss of insurance|0|||
145757669|NCT01961544|525625633|FG000|Overall Study|Protocol Violation|1|||
145757670|NCT01961544|525625633|FG000|Overall Study|Withdrawal by Subject|7|||
145757671|NCT01961544|525625633|FG000|Overall Study|Adverse Event|1|||
145757672|NCT01961544|525625633|FG000|Overall Study|Physician Decision|2|||
145757673|NCT01961544|525625633|FG000|Overall Study|Poor Tolerance|1|||
145757674|NCT01961544|525625633|FG000|Overall Study|Aggravation of Steral Pain|1|||
145757675|NCT03261531|525625634|FG000|Overall Study|Withdrawal by Subject|4|||
145757676|NCT02435914|525625640|FG000|Overall Study|Ocular Adverse Event|1|||
145757677|NCT02435914|525625641|FG001|Overall Study|Ocular Adverse Event|0|||
145757678|NCT02435914|525625642|FG002|Overall Study|Ocular Adverse Event|0|||
145757679|NCT02435914|525625643|FG003|Overall Study|Ocular Adverse Event|0|||
145757680|NCT02435914|525625640|FG000|Overall Study|Withdrawal by Subject|0|||
145757681|NCT02435914|525625641|FG001|Overall Study|Withdrawal by Subject|1|||
145757682|NCT02435914|525625642|FG002|Overall Study|Withdrawal by Subject|0|||
145757683|NCT02435914|525625643|FG003|Overall Study|Withdrawal by Subject|0|||
145757684|NCT02435914|525625640|FG000|Overall Study|Other Miscellaneous Reason|0|||
145757685|NCT02435914|525625641|FG001|Overall Study|Other Miscellaneous Reason|0|||
145757686|NCT02435914|525625642|FG002|Overall Study|Other Miscellaneous Reason|1|||
145757687|NCT02435914|525625643|FG003|Overall Study|Other Miscellaneous Reason|0|||
145757688|NCT01818726|525625648|FG000|Overall Study|Administrative reasons|5|||
145757689|NCT01818726|525625649|FG001|Overall Study|Administrative reasons|1|||
145757690|NCT01818726|525625648|FG000|Overall Study|Withdrawal by Subject|0|||
145757691|NCT01818726|525625649|FG001|Overall Study|Withdrawal by Subject|1|||
145757692|NCT01818726|525625648|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
145757693|NCT01818726|525625649|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
145757694|NCT04871711|525625650|FG000|Overall Study|Withdrawal by Subject|11|||
145757695|NCT04871711|525625651|FG001|Overall Study|Withdrawal by Subject|5|||
145757696|NCT04871711|525625650|FG000|Overall Study|Lack of Efficacy|5|||
145532356|NCT01912963|524810125|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
145532357|NCT01912963|524810126|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
145532358|NCT01912963|524810124|FG000|Overall Study|Adverse Event|0|||
145532359|NCT01912963|524810125|FG001|Overall Study|Adverse Event|1|||
145532360|NCT01912963|524810126|FG002|Overall Study|Adverse Event|1|||
145532361|NCT01912963|524810124|FG000|Overall Study|Withdrawal by Subject|0|||
145532362|NCT01912963|524810125|FG001|Overall Study|Withdrawal by Subject|1|||
145532363|NCT01912963|524810126|FG002|Overall Study|Withdrawal by Subject|0|||
145532364|NCT01912963|524810124|FG000|Overall Study|Sought treatment locally|0|||
145532365|NCT01912963|524810125|FG001|Overall Study|Sought treatment locally|1|||
145532366|NCT01912963|524810126|FG002|Overall Study|Sought treatment locally|0|||
145532367|NCT01147172|524810132|FG000|Overall Study|Withdrawal by Subject|2|||
145532368|NCT01147172|524810132|FG000|Overall Study|Lost to Follow-up|2|||
145532369|NCT01069627|524810133|FG000|Overall Study|Disease progression|7|||
145532370|NCT01069627|524810133|FG000|Overall Study|Adverse Event|12|||
145532371|NCT01069627|524810133|FG000|Overall Study|Protocol Violation|1|||
145532372|NCT02963935|524810138|FG000|Overall Study|Adverse Event|12|||
145532373|NCT02963935|524810139|FG001|Overall Study|Adverse Event|6|||
145532374|NCT02963935|524810138|FG000|Overall Study|Protocol Violation|2|||
145532375|NCT02963935|524810139|FG001|Overall Study|Protocol Violation|1|||
145532376|NCT02963935|524810138|FG000|Overall Study|Lack of Efficacy|0|||
145532377|NCT02963935|524810139|FG001|Overall Study|Lack of Efficacy|2|||
145532378|NCT02963935|524810138|FG000|Overall Study|Lost to Follow-up|1|||
145532379|NCT02963935|524810139|FG001|Overall Study|Lost to Follow-up|6|||
145532380|NCT02963935|524810138|FG000|Overall Study|Unclassified|13|||
145532381|NCT02963935|524810139|FG001|Overall Study|Unclassified|22|||
145532382|NCT00464269|524810140|FG000|Overall Study|Lack of Efficacy|1|||
145532383|NCT00464269|524810141|FG001|Overall Study|Lack of Efficacy|0|||
145532384|NCT00464269|524810142|FG002|Overall Study|Lack of Efficacy|0|||
145532385|NCT00464269|524810143|FG003|Overall Study|Lack of Efficacy|0|||
145532386|NCT00464269|524810140|FG000|Overall Study|Lost to Follow-up|0|||
145532387|NCT00464269|524810141|FG001|Overall Study|Lost to Follow-up|4|||
145532388|NCT00464269|524810142|FG002|Overall Study|Lost to Follow-up|0|||
145532389|NCT00464269|524810143|FG003|Overall Study|Lost to Follow-up|1|||
145532390|NCT00464269|524810140|FG000|Overall Study|Withdrawal by Subject|0|||
145532391|NCT00464269|524810141|FG001|Overall Study|Withdrawal by Subject|2|||
145532392|NCT00464269|524810142|FG002|Overall Study|Withdrawal by Subject|1|||
145532393|NCT00464269|524810143|FG003|Overall Study|Withdrawal by Subject|1|||
145532394|NCT00464269|524810140|FG000|Overall Study|Other reason|3|||
145532395|NCT00464269|524810141|FG001|Overall Study|Other reason|3|||
145532396|NCT00464269|524810142|FG002|Overall Study|Other reason|1|||
145757697|NCT04871711|525625651|FG001|Overall Study|Lack of Efficacy|7|||
145757698|NCT04871711|525625650|FG000|Overall Study|Adverse Event|2|||
145757699|NCT04871711|525625651|FG001|Overall Study|Adverse Event|6|||
145757700|NCT04871711|525625650|FG000|Overall Study|Various reasons|2|||
145757701|NCT04871711|525625651|FG001|Overall Study|Various reasons|1|||
145532397|NCT00464269|524810143|FG003|Overall Study|Other reason|1|||
145532398|NCT00464269|524810140|FG000|Overall Study|AE, serious fatal|0|||
145532399|NCT00464269|524810141|FG001|Overall Study|AE, serious fatal|0|||
145532400|NCT00464269|524810142|FG002|Overall Study|AE, serious fatal|1|||
145532401|NCT00464269|524810143|FG003|Overall Study|AE, serious fatal|1|||
145532402|NCT00464269|524810140|FG000|Overall Study|SAE, non-fatal|0|||
145532403|NCT00464269|524810141|FG001|Overall Study|SAE, non-fatal|0|||
145532404|NCT00464269|524810142|FG002|Overall Study|SAE, non-fatal|0|||
145532405|NCT00464269|524810143|FG003|Overall Study|SAE, non-fatal|1|||
145757702|NCT04871711|525625650|FG000|Overall Study|Lost to Follow-up|0|||
145757703|NCT04871711|525625651|FG001|Overall Study|Lost to Follow-up|2|||
145757704|NCT01665144|525625652|FG000|Core Part|Withdrawal by Subject|96|||
145532406|NCT00464269|524810140|FG000|Overall Study|AE, non-serious non-fatal|2|||
145532407|NCT00464269|524810141|FG001|Overall Study|AE, non-serious non-fatal|8|||
145532408|NCT00464269|524810142|FG002|Overall Study|AE, non-serious non-fatal|3|||
145532409|NCT00464269|524810143|FG003|Overall Study|AE, non-serious non-fatal|4|||
145532410|NCT00464269|524810140|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145757705|NCT01665144|525625653|FG001|Core Part|Withdrawal by Subject|77|||
145757706|NCT01665144|525625654|FG002|Core Part|Withdrawal by Subject|0|||
145757707|NCT01665144|525625652|FG000|Core Part|Adverse Event|45|||
145757708|NCT01665144|525625653|FG001|Core Part|Adverse Event|18|||
145757709|NCT01665144|525625654|FG002|Core Part|Adverse Event|0|||
145757710|NCT01665144|525625652|FG000|Core Part|Lack of Efficacy|16|||
145757711|NCT01665144|525625653|FG001|Core Part|Lack of Efficacy|11|||
145757712|NCT01665144|525625654|FG002|Core Part|Lack of Efficacy|0|||
145757713|NCT01665144|525625652|FG000|Core Part|Lost to Follow-up|9|||
145757714|NCT01665144|525625653|FG001|Core Part|Lost to Follow-up|8|||
145757715|NCT01665144|525625654|FG002|Core Part|Lost to Follow-up|0|||
145757716|NCT01665144|525625652|FG000|Core Part|Physician Decision|13|||
145757717|NCT01665144|525625653|FG001|Core Part|Physician Decision|1|||
145757718|NCT01665144|525625654|FG002|Core Part|Physician Decision|0|||
145757719|NCT01665144|525625652|FG000|Core Part|Progressive disease|8|||
145757720|NCT01665144|525625653|FG001|Core Part|Progressive disease|4|||
145757721|NCT01665144|525625654|FG002|Core Part|Progressive disease|0|||
145757722|NCT01665144|525625652|FG000|Core Part|Non-compliance with study treatment|5|||
145757723|NCT01665144|525625653|FG001|Core Part|Non-compliance with study treatment|0|||
145757724|NCT01665144|525625654|FG002|Core Part|Non-compliance with study treatment|0|||
145757725|NCT01665144|525625652|FG000|Core Part|Death|3|||
145757726|NCT01665144|525625653|FG001|Core Part|Death|1|||
145757727|NCT01665144|525625654|FG002|Core Part|Death|0|||
145757728|NCT01665144|525625652|FG000|Core Part|Protocol deviation|3|||
145757729|NCT01665144|525625653|FG001|Core Part|Protocol deviation|1|||
145757730|NCT01665144|525625654|FG002|Core Part|Protocol deviation|0|||
145757731|NCT01665144|525625652|FG000|Core Part|New therapy for study indication|2|||
145757732|NCT01665144|525625653|FG001|Core Part|New therapy for study indication|1|||
145757733|NCT01665144|525625654|FG002|Core Part|New therapy for study indication|0|||
145757734|NCT01665144|525625652|FG000|Core Part|Technical problems|2|||
145757735|NCT01665144|525625653|FG001|Core Part|Technical problems|0|||
145757736|NCT01665144|525625654|FG002|Core Part|Technical problems|0|||
145757737|NCT01665144|525625652|FG000|Extension Part|Patient/guardian decision|180|||
145757738|NCT01665144|525625653|FG001|Extension Part|Patient/guardian decision|0|||
145757739|NCT01665144|525625654|FG002|Extension Part|Patient/guardian decision|98|||
145757740|NCT01665144|525625652|FG000|Extension Part|Adverse Event|104|||
145757741|NCT01665144|525625653|FG001|Extension Part|Adverse Event|0|||
145757742|NCT01665144|525625654|FG002|Extension Part|Adverse Event|59|||
145757743|NCT01665144|525625652|FG000|Extension Part|Study closed early|42|||
145757744|NCT01665144|525625653|FG001|Extension Part|Study closed early|0|||
145757745|NCT01665144|525625654|FG002|Extension Part|Study closed early|19|||
145757746|NCT01665144|525625652|FG000|Extension Part|Progressive disease|36|||
145757747|NCT01665144|525625653|FG001|Extension Part|Progressive disease|0|||
145757748|NCT01665144|525625654|FG002|Extension Part|Progressive disease|14|||
145757749|NCT01665144|525625652|FG000|Extension Part|Lack of Efficacy|37|||
145757750|NCT01665144|525625653|FG001|Extension Part|Lack of Efficacy|0|||
145757751|NCT01665144|525625654|FG002|Extension Part|Lack of Efficacy|12|||
145757752|NCT01665144|525625652|FG000|Extension Part|Physician Decision|29|||
145757753|NCT01665144|525625653|FG001|Extension Part|Physician Decision|0|||
145757754|NCT01665144|525625654|FG002|Extension Part|Physician Decision|13|||
145757755|NCT01665144|525625652|FG000|Extension Part|Technical problems|20|||
145757756|NCT01665144|525625653|FG001|Extension Part|Technical problems|0|||
145757757|NCT01665144|525625654|FG002|Extension Part|Technical problems|8|||
145757758|NCT01665144|525625652|FG000|Extension Part|Death|20|||
145757759|NCT01665144|525625653|FG001|Extension Part|Death|0|||
145757760|NCT01665144|525625654|FG002|Extension Part|Death|4|||
145757761|NCT01665144|525625652|FG000|Extension Part|Missing|12|||
145757762|NCT01665144|525625653|FG001|Extension Part|Missing|0|||
145757763|NCT01665144|525625654|FG002|Extension Part|Missing|6|||
145757764|NCT01665144|525625652|FG000|Extension Part|Lost to Follow-up|9|||
145757765|NCT01665144|525625653|FG001|Extension Part|Lost to Follow-up|0|||
145757766|NCT01665144|525625654|FG002|Extension Part|Lost to Follow-up|5|||
145757767|NCT01665144|525625652|FG000|Extension Part|New therapy for study indication|3|||
145757768|NCT01665144|525625653|FG001|Extension Part|New therapy for study indication|0|||
145757769|NCT01665144|525625654|FG002|Extension Part|New therapy for study indication|2|||
145757770|NCT01665144|525625652|FG000|Extension Part|Protocol deviation|3|||
145757771|NCT01665144|525625653|FG001|Extension Part|Protocol deviation|0|||
145757772|NCT01665144|525625654|FG002|Extension Part|Protocol deviation|0|||
145757773|NCT01913483|525625655|FG000|Overall Study|Withdrawal by Subject|1|||
145757774|NCT01913483|525625656|FG001|Overall Study|Withdrawal by Subject|2|||
145757775|NCT01913483|525625655|FG000|Overall Study|Lost to Follow-up|6|||
145757776|NCT01913483|525625656|FG001|Overall Study|Lost to Follow-up|3|||
145757777|NCT01913483|525625655|FG000|Overall Study|Death|14|||
145757778|NCT01913483|525625656|FG001|Overall Study|Death|17|||
145757779|NCT03434379|525625660|FG000|Global Period|Lost to Follow-up|3|||
145757780|NCT03434379|525625661|FG001|Global Period|Lost to Follow-up|6|||
145757781|NCT03434379|525625662|FG002|Global Period|Lost to Follow-up|0|||
145757782|NCT03434379|525625663|FG003|Global Period|Lost to Follow-up|0|||
145757783|NCT03434379|525625660|FG000|Global Period|Death|115|||
145757784|NCT03434379|525625661|FG001|Global Period|Death|228|||
145757785|NCT03434379|525625662|FG002|Global Period|Death|0|||
145757786|NCT03434379|525625663|FG003|Global Period|Death|0|||
145757787|NCT03434379|525625660|FG000|Global Period|Withdrawal by Subject|20|||
145757788|NCT03434379|525625661|FG001|Global Period|Withdrawal by Subject|21|||
145757789|NCT03434379|525625662|FG002|Global Period|Withdrawal by Subject|0|||
145757790|NCT03434379|525625663|FG003|Global Period|Withdrawal by Subject|0|||
145757791|NCT03434379|525625660|FG000|Global Period|Reason Unspecified|0|||
145757792|NCT03434379|525625661|FG001|Global Period|Reason Unspecified|1|||
145757793|NCT03434379|525625662|FG002|Global Period|Reason Unspecified|0|||
145757794|NCT03434379|525625663|FG003|Global Period|Reason Unspecified|0|||
145757795|NCT03434379|525625660|FG000|Global Period|Study Ended by Sponsor|26|||
145757796|NCT03434379|525625661|FG001|Global Period|Study Ended by Sponsor|80|||
145757797|NCT03434379|525625662|FG002|Global Period|Study Ended by Sponsor|0|||
145757798|NCT03434379|525625663|FG003|Global Period|Study Ended by Sponsor|0|||
145757799|NCT03434379|525625660|FG000|Global Period|Physician Decision|1|||
145757800|NCT03434379|525625661|FG001|Global Period|Physician Decision|0|||
145757801|NCT03434379|525625662|FG002|Global Period|Physician Decision|0|||
145757802|NCT03434379|525625663|FG003|Global Period|Physician Decision|0|||
145757803|NCT03434379|525625660|FG000|China Extension Period|Lost to Follow-up|0|||
145757804|NCT03434379|525625661|FG001|China Extension Period|Lost to Follow-up|0|||
145757805|NCT03434379|525625662|FG002|China Extension Period|Lost to Follow-up|2|||
145757806|NCT03434379|525625663|FG003|China Extension Period|Lost to Follow-up|3|||
145757807|NCT03434379|525625660|FG000|China Extension Period|Death|0|||
145757808|NCT03434379|525625661|FG001|China Extension Period|Death|0|||
145757809|NCT03434379|525625662|FG002|China Extension Period|Death|46|||
145757810|NCT03434379|525625663|FG003|China Extension Period|Death|88|||
145757811|NCT03434379|525625660|FG000|China Extension Period|Withdrawal by Subject|0|||
145757812|NCT03434379|525625661|FG001|China Extension Period|Withdrawal by Subject|0|||
145757813|NCT03434379|525625662|FG002|China Extension Period|Withdrawal by Subject|8|||
145757814|NCT03434379|525625663|FG003|China Extension Period|Withdrawal by Subject|6|||
145757815|NCT03434379|525625660|FG000|China Extension Period|Study Ended by Sponsor|0|||
145757816|NCT03434379|525625661|FG001|China Extension Period|Study Ended by Sponsor|0|||
145757817|NCT03434379|525625662|FG002|China Extension Period|Study Ended by Sponsor|5|||
145757818|NCT03434379|525625663|FG003|China Extension Period|Study Ended by Sponsor|36|||
145757819|NCT02026063|525625665|FG000|Overall Study|Physician Decision|0|||
145757820|NCT02026063|525625666|FG001|Overall Study|Physician Decision|10|||
145757821|NCT02026063|525625665|FG000|Overall Study|Noncompliance with Study Drug|1|||
145757822|NCT02026063|525625666|FG001|Overall Study|Noncompliance with Study Drug|1|||
145757823|NCT02026063|525625665|FG000|Overall Study|Withdrawal of Consent|1|||
145757824|NCT02026063|525625666|FG001|Overall Study|Withdrawal of Consent|6|||
145757825|NCT02026063|525625665|FG000|Overall Study|Adverse Event|5|||
145757826|NCT02026063|525625666|FG001|Overall Study|Adverse Event|20|||
145757827|NCT02026063|525625665|FG000|Overall Study|Lack of Efficacy|0|||
145757828|NCT02026063|525625666|FG001|Overall Study|Lack of Efficacy|4|||
145757829|NCT02026063|525625665|FG000|Overall Study|Lost to Follow-up|0|||
145757830|NCT02026063|525625666|FG001|Overall Study|Lost to Follow-up|1|||
145757831|NCT02026063|525625665|FG000|Overall Study|Reason not Specified|2|||
145757832|NCT02026063|525625666|FG001|Overall Study|Reason not Specified|7|||
145757833|NCT02154087|525625671|FG000|Overall Study|Study Termination|1|||
145757834|NCT00486278|525625676|FG000|Overall Study|Adverse Event|5|||
145757835|NCT00486278|525625676|FG000|Overall Study|Withdrawal by Subject|2|||
145607611|NCT03682705|525079205|FG000|Overall Study|Other, not specified|0|||
145757836|NCT00486278|525625676|FG000|Overall Study|Physician Decision|2|||
145757837|NCT02183519|525625682|FG000|Overall Study|computer error|3|||
145757838|NCT02183519|525625683|FG001|Overall Study|computer error|0|||
145757839|NCT02183519|525625682|FG000|Overall Study|Did not respond to cough inducter|0|||
145757840|NCT02183519|525625683|FG001|Overall Study|Did not respond to cough inducter|3|||
145757841|NCT04556617|525625684|FG000|Overall Study|progressive disease|0|||
145757842|NCT04556617|525625685|FG001|Overall Study|progressive disease|2|||
145757843|NCT04556617|525625686|FG002|Overall Study|progressive disease|2|||
145757844|NCT04556617|525625687|FG003|Overall Study|progressive disease|1|||
145757845|NCT04556617|525625688|FG004|Overall Study|progressive disease|1|||
145757846|NCT04556617|525625684|FG000|Overall Study|Physician Decision|0|||
145757847|NCT04556617|525625685|FG001|Overall Study|Physician Decision|0|||
145757848|NCT04556617|525625686|FG002|Overall Study|Physician Decision|2|||
145757849|NCT04556617|525625687|FG003|Overall Study|Physician Decision|0|||
145757850|NCT04556617|525625688|FG004|Overall Study|Physician Decision|0|||
145757851|NCT04556617|525625684|FG000|Overall Study|Adverse Event|0|||
145757852|NCT04556617|525625685|FG001|Overall Study|Adverse Event|0|||
145757853|NCT04556617|525625686|FG002|Overall Study|Adverse Event|2|||
145757854|NCT04556617|525625687|FG003|Overall Study|Adverse Event|3|||
145757855|NCT04556617|525625688|FG004|Overall Study|Adverse Event|0|||
145757856|NCT04556617|525625684|FG000|Overall Study|Withdrawal by Subject|0|||
145757857|NCT04556617|525625685|FG001|Overall Study|Withdrawal by Subject|2|||
145757858|NCT04556617|525625686|FG002|Overall Study|Withdrawal by Subject|1|||
145757859|NCT04556617|525625687|FG003|Overall Study|Withdrawal by Subject|1|||
145757860|NCT04556617|525625688|FG004|Overall Study|Withdrawal by Subject|0|||
145757861|NCT04556617|525625684|FG000|Overall Study|PSA increase|0|||
145757862|NCT04556617|525625685|FG001|Overall Study|PSA increase|1|||
145757863|NCT04556617|525625686|FG002|Overall Study|PSA increase|0|||
145757864|NCT04556617|525625687|FG003|Overall Study|PSA increase|0|||
145757865|NCT04556617|525625688|FG004|Overall Study|PSA increase|0|||
145757866|NCT04556617|525625684|FG000|Overall Study|Sponsor study termination|1|||
145757867|NCT04556617|525625685|FG001|Overall Study|Sponsor study termination|0|||
145757868|NCT04556617|525625686|FG002|Overall Study|Sponsor study termination|0|||
145757869|NCT04556617|525625687|FG003|Overall Study|Sponsor study termination|0|||
145757870|NCT04556617|525625688|FG004|Overall Study|Sponsor study termination|0|||
145757871|NCT05168267|525625689|FG000|Overall Study|Withdrawal by Subject|2|||
145757872|NCT05168267|525625690|FG001|Overall Study|Withdrawal by Subject|1|||
145757873|NCT05168267|525625689|FG000|Overall Study|Withdrawn by Therapist|1|||
145757874|NCT05168267|525625690|FG001|Overall Study|Withdrawn by Therapist|1|||
145757875|NCT05168267|525625689|FG000|Overall Study|Left Facility|1|||
145757876|NCT05168267|525625690|FG001|Overall Study|Left Facility|0|||
145757877|NCT00695565|525625691|FG000|Overall Study|Lost to Follow-up|4|||
145757878|NCT00695565|525625692|FG001|Overall Study|Lost to Follow-up|4|||
145757879|NCT00695565|525625691|FG000|Overall Study|Adverse Event|3|||
145757880|NCT00695565|525625692|FG001|Overall Study|Adverse Event|1|||
145757881|NCT00695565|525625691|FG000|Overall Study|Protocol Violation|3|||
145757882|NCT00695565|525625692|FG001|Overall Study|Protocol Violation|1|||
145757883|NCT00695565|525625691|FG000|Overall Study|Withdrawal by Subject|1|||
145757884|NCT00695565|525625692|FG001|Overall Study|Withdrawal by Subject|1|||
145757885|NCT00695565|525625691|FG000|Overall Study|Lack of Efficacy|1|||
145757886|NCT00695565|525625692|FG001|Overall Study|Lack of Efficacy|1|||
145757887|NCT00695565|525625691|FG000|Overall Study|Subject did not follow instructions|1|||
145757888|NCT00695565|525625692|FG001|Overall Study|Subject did not follow instructions|1|||
145757889|NCT02937350|525625693|FG000|Overall Study|Withdrawal by Subject|0|||
145757890|NCT02937350|525625694|FG001|Overall Study|Withdrawal by Subject|1|||
145757891|NCT02937350|525625695|FG002|Overall Study|Withdrawal by Subject|0|||
145757892|NCT01462266|525625696|FG000|Overall Study|Adverse Event|7|||
145757893|NCT01462266|525625697|FG001|Overall Study|Adverse Event|6|||
145757894|NCT01462266|525625696|FG000|Overall Study|Death|2|||
145757895|NCT01462266|525625697|FG001|Overall Study|Death|1|||
145757896|NCT01462266|525625696|FG000|Overall Study|Lack of Efficacy|0|||
145757897|NCT01462266|525625697|FG001|Overall Study|Lack of Efficacy|2|||
145757898|NCT01462266|525625696|FG000|Overall Study|Lost to Follow-up|4|||
145757899|NCT01462266|525625697|FG001|Overall Study|Lost to Follow-up|3|||
145757900|NCT01462266|525625696|FG000|Overall Study|Non-compliance with study drug|3|||
145757901|NCT01462266|525625697|FG001|Overall Study|Non-compliance with study drug|0|||
145757902|NCT01462266|525625696|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
145757903|NCT01462266|525625697|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
145757904|NCT01462266|525625696|FG000|Overall Study|Physician Decision|2|||
145757905|NCT01462266|525625697|FG001|Overall Study|Physician Decision|5|||
145757906|NCT01462266|525625696|FG000|Overall Study|Protocol Violation|1|||
145402873|NCT02065557|524332546|FG002|Induction Period|Lack of Efficacy|1|||
145402874|NCT02065557|524332547|FG003|Induction Period|Lack of Efficacy|0|||
145757907|NCT01462266|525625697|FG001|Overall Study|Protocol Violation|3|||
145757908|NCT01462266|525625696|FG000|Overall Study|Withdrawal by Subject|7|||
145757909|NCT01462266|525625697|FG001|Overall Study|Withdrawal by Subject|2|||
145757910|NCT01462266|525625696|FG000|Overall Study|Screen failure|1|||
145757911|NCT01462266|525625697|FG001|Overall Study|Screen failure|1|||
145757912|NCT01106846|525625698|FG000|Overall Study|Change in surgical procedure|0|||
145757913|NCT01106846|525625699|FG001|Overall Study|Change in surgical procedure|1|||
145757914|NCT00803179|525625702|FG000|Overall Study|Lost to Follow-up|3|||
145757915|NCT02419508|525625706|FG000|Overall Study|Adverse Event|9|||
145757916|NCT02419508|525625707|FG001|Overall Study|Adverse Event|3|||
145757917|NCT02419508|525625706|FG000|Overall Study|Withdrawal by Subject|1|||
145757918|NCT02419508|525625707|FG001|Overall Study|Withdrawal by Subject|0|||
145757919|NCT02419508|525625706|FG000|Overall Study|Other - Reason not specified|0|||
145757920|NCT02419508|525625707|FG001|Overall Study|Other - Reason not specified|1|||
145757921|NCT02320487|525625710|FG000|Overall Study|Reason not Specified|1|||
145757922|NCT02320487|525625710|FG000|Overall Study|Physician Decision|5|||
145757923|NCT02320487|525625710|FG000|Overall Study|Withdrawal by Subject|1|||
145757924|NCT02320487|525625710|FG000|Overall Study|Death|3|||
145757925|NCT02320487|525625710|FG000|Overall Study|Adverse Event|11|||
145757926|NCT06228586|525625711|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
145757927|NCT06228586|525625712|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
145757928|NCT01182428|525625713|FG000|Overall Study|Physician Decision|1|||
145757929|NCT01182428|525625714|FG001|Overall Study|Physician Decision|0|||
145757930|NCT01182428|525625713|FG000|Overall Study|Lost to Follow-up|9|||
145757931|NCT01182428|525625714|FG001|Overall Study|Lost to Follow-up|1|||
145757932|NCT01182428|525625713|FG000|Overall Study|Withdrawal by Subject|1|||
145757933|NCT01182428|525625714|FG001|Overall Study|Withdrawal by Subject|0|||
145757934|NCT06272370|525627514|FG000|Overall Study|Lost to Follow-up|0|||
145757935|NCT06272370|525627515|FG001|Overall Study|Lost to Follow-up|3|||
145757936|NCT06272370|525627516|FG002|Overall Study|Lost to Follow-up|1|||
145757937|NCT06272370|525627517|FG003|Overall Study|Lost to Follow-up|1|||
145757938|NCT02324270|525627518|FG000|Overall Study|Withdrawal by Subject|0|||
145757939|NCT02324270|525627519|FG001|Overall Study|Withdrawal by Subject|1|||
145757940|NCT02324270|525627520|FG002|Overall Study|Withdrawal by Subject|0|||
145757941|NCT02324270|525627518|FG000|Overall Study|Lost to Follow-up|4|||
145757942|NCT02324270|525627519|FG001|Overall Study|Lost to Follow-up|3|||
145757943|NCT02324270|525627520|FG002|Overall Study|Lost to Follow-up|4|||
145757944|NCT02324270|525627518|FG000|Overall Study|Protocol Violation|0|||
145757945|NCT02324270|525627519|FG001|Overall Study|Protocol Violation|1|||
145757946|NCT02324270|525627520|FG002|Overall Study|Protocol Violation|1|||
145757947|NCT02324270|525627518|FG000|Overall Study|Non Compliance with Study Drug|1|||
145757948|NCT02324270|525627519|FG001|Overall Study|Non Compliance with Study Drug|2|||
145757949|NCT02324270|525627520|FG002|Overall Study|Non Compliance with Study Drug|0|||
145757950|NCT00546364|525627521|FG000|Overall Study|Disease progression|5|||
145757951|NCT00546364|525627522|FG001|Overall Study|Disease progression|11|||
145757952|NCT00546364|525627523|FG002|Overall Study|Disease progression|8|||
145757953|NCT00546364|525627521|FG000|Overall Study|Completed and off treatment|1|||
145757954|NCT00546364|525627522|FG001|Overall Study|Completed and off treatment|0|||
145757955|NCT00546364|525627523|FG002|Overall Study|Completed and off treatment|2|||
145757956|NCT00546364|525627521|FG000|Overall Study|Administrative reason by sponsor|1|||
145757957|NCT00546364|525627522|FG001|Overall Study|Administrative reason by sponsor|0|||
145757958|NCT00546364|525627523|FG002|Overall Study|Administrative reason by sponsor|0|||
145757959|NCT00546364|525627521|FG000|Overall Study|Poor compliance/noncompliance|0|||
145757960|NCT00546364|525627522|FG001|Overall Study|Poor compliance/noncompliance|0|||
145757961|NCT00546364|525627523|FG002|Overall Study|Poor compliance/noncompliance|1|||
145757962|NCT00546364|525627521|FG000|Overall Study|No longer meets study criteria|1|||
145757963|NCT00546364|525627522|FG001|Overall Study|No longer meets study criteria|1|||
145757964|NCT00546364|525627523|FG002|Overall Study|No longer meets study criteria|0|||
145757965|NCT00546364|525627521|FG000|Overall Study|Withdrawal by Subject|5|||
145757966|NCT00546364|525627522|FG001|Overall Study|Withdrawal by Subject|6|||
145757967|NCT00546364|525627523|FG002|Overall Study|Withdrawal by Subject|3|||
145757968|NCT00546364|525627521|FG000|Overall Study|Prior taxotere|1|||
145757969|NCT00546364|525627522|FG001|Overall Study|Prior taxotere|0|||
145757970|NCT00546364|525627523|FG002|Overall Study|Prior taxotere|0|||
145757971|NCT00546364|525627521|FG000|Overall Study|Mixed response|1|||
145757972|NCT00546364|525627522|FG001|Overall Study|Mixed response|0|||
145757973|NCT00546364|525627523|FG002|Overall Study|Mixed response|0|||
145757974|NCT00546364|525627521|FG000|Overall Study|Palliative treatment|1|||
145757975|NCT00546364|525627522|FG001|Overall Study|Palliative treatment|0|||
145757976|NCT00546364|525627523|FG002|Overall Study|Palliative treatment|1|||
145757977|NCT00546364|525627521|FG000|Overall Study|Target lesions resected|1|||
145757978|NCT00546364|525627522|FG001|Overall Study|Target lesions resected|0|||
145757979|NCT00546364|525627523|FG002|Overall Study|Target lesions resected|0|||
145757980|NCT00546364|525627521|FG000|Overall Study|Physician Decision|0|||
145757981|NCT00546364|525627522|FG001|Overall Study|Physician Decision|0|||
145757982|NCT00546364|525627523|FG002|Overall Study|Physician Decision|1|||
145757983|NCT00546364|525627521|FG000|Overall Study|Sponsor decision|0|||
145757984|NCT00546364|525627522|FG001|Overall Study|Sponsor decision|0|||
145757985|NCT00546364|525627523|FG002|Overall Study|Sponsor decision|1|||
145757986|NCT03521791|525627524|FG000|Overall Study|Protocol Violation|7|||
145757987|NCT03521791|525627525|FG001|Overall Study|Protocol Violation|17|||
145757988|NCT02090855|525627526|FG000|Overall Study|no evaluable Standard of Truth results|2|||
145757989|NCT01475734|525627527|FG000|Overall Study|Withdrawal by Subject|1|||
145757990|NCT01475734|525627528|FG001|Overall Study|Withdrawal by Subject|0|||
145757991|NCT01475734|525627527|FG000|Overall Study|Protocol Violation|1|||
145757992|NCT01475734|525627528|FG001|Overall Study|Protocol Violation|0|||
145757993|NCT01475734|525627527|FG000|Overall Study|Physician Decision|0|||
145757994|NCT01475734|525627528|FG001|Overall Study|Physician Decision|1|||
145757995|NCT00771472|525627529|FG000|Overall Study|Physician Decision|2|||
145757996|NCT00771472|525627530|FG001|Overall Study|Physician Decision|3|||
145757997|NCT00771472|525627529|FG000|Overall Study|Progressive Disease|3|||
145757998|NCT00771472|525627530|FG001|Overall Study|Progressive Disease|1|||
145757999|NCT00771472|525627529|FG000|Overall Study|Protocol Violation|1|||
145758000|NCT00771472|525627530|FG001|Overall Study|Protocol Violation|0|||
145758001|NCT00880750|525627537|FG000|First Intervention|Adverse Event|1|||
145758002|NCT00880750|525627538|FG001|First Intervention|Adverse Event|0|||
145758003|NCT00880750|525627537|FG000|First Intervention|Unable to collect urine|4|||
145758004|NCT00880750|525627538|FG001|First Intervention|Unable to collect urine|0|||
145758005|NCT00880750|525627537|FG000|First Intervention|Non-compliance with meals|0|||
145758006|NCT00880750|525627538|FG001|First Intervention|Non-compliance with meals|1|||
145758007|NCT00880750|525627537|FG000|First Intervention|Withdrawal by Subject|2|||
145758008|NCT00880750|525627538|FG001|First Intervention|Withdrawal by Subject|0|||
145758009|NCT00880750|525627537|FG000|First Intervention|Lost to Follow-up|2|||
145758010|NCT00880750|525627538|FG001|First Intervention|Lost to Follow-up|0|||
145758011|NCT00880750|525627537|FG000|Second Intervention|Withdrawal by Subject|2|||
145758012|NCT00880750|525627538|FG001|Second Intervention|Withdrawal by Subject|2|||
145758013|NCT00880750|525627537|FG000|Second Intervention|Protocol Violation|1|||
145758014|NCT00880750|525627538|FG001|Second Intervention|Protocol Violation|0|||
145758015|NCT00880750|525627537|FG000|Second Intervention|Unable to collect urine|1|||
145758016|NCT00880750|525627538|FG001|Second Intervention|Unable to collect urine|0|||
145758017|NCT00667576|525627539|FG000|Overall Study|Withdrawal by Subject|1|||
145758018|NCT00667576|525627540|FG001|Overall Study|Withdrawal by Subject|0|||
145758019|NCT00667576|525627541|FG002|Overall Study|Withdrawal by Subject|1|||
145758020|NCT00667576|525627542|FG003|Overall Study|Withdrawal by Subject|1|||
145758021|NCT00667576|525627543|FG004|Overall Study|Withdrawal by Subject|1|||
145758022|NCT00667576|525627539|FG000|Overall Study|Adverse Event|1|||
145758023|NCT00667576|525627540|FG001|Overall Study|Adverse Event|1|||
145758024|NCT00667576|525627541|FG002|Overall Study|Adverse Event|0|||
145758025|NCT00667576|525627542|FG003|Overall Study|Adverse Event|0|||
145758026|NCT00667576|525627543|FG004|Overall Study|Adverse Event|0|||
145758027|NCT00667576|525627539|FG000|Overall Study|Lost to Follow-up|0|||
145758028|NCT00667576|525627540|FG001|Overall Study|Lost to Follow-up|0|||
145758029|NCT00667576|525627541|FG002|Overall Study|Lost to Follow-up|1|||
145758030|NCT00667576|525627542|FG003|Overall Study|Lost to Follow-up|0|||
145758031|NCT00667576|525627543|FG004|Overall Study|Lost to Follow-up|0|||
145758032|NCT00667576|525627539|FG000|Overall Study|Protocol Violation|0|||
145758033|NCT00667576|525627540|FG001|Overall Study|Protocol Violation|0|||
145758034|NCT00667576|525627541|FG002|Overall Study|Protocol Violation|0|||
145758035|NCT00667576|525627542|FG003|Overall Study|Protocol Violation|1|||
145758036|NCT00667576|525627543|FG004|Overall Study|Protocol Violation|0|||
145758037|NCT00667576|525627539|FG000|Overall Study|Physician Decision|0|||
145758038|NCT00667576|525627540|FG001|Overall Study|Physician Decision|0|||
145758039|NCT00667576|525627541|FG002|Overall Study|Physician Decision|0|||
145758040|NCT00667576|525627542|FG003|Overall Study|Physician Decision|1|||
145758041|NCT00667576|525627543|FG004|Overall Study|Physician Decision|0|||
145758042|NCT00667576|525627539|FG000|Overall Study|Missed Visit|0|||
145758043|NCT00667576|525627540|FG001|Overall Study|Missed Visit|0|||
145758044|NCT00667576|525627541|FG002|Overall Study|Missed Visit|0|||
145758045|NCT00667576|525627542|FG003|Overall Study|Missed Visit|1|||
145758046|NCT00667576|525627543|FG004|Overall Study|Missed Visit|0|||
145758047|NCT01390389|525627544|FG000|Overall Study|Withdrawal by Subject|2|||
145758048|NCT01390389|525627545|FG001|Overall Study|Withdrawal by Subject|0|||
145758049|NCT01390389|525627544|FG000|Overall Study|Screen Fail|2|||
145758050|NCT01390389|525627545|FG001|Overall Study|Screen Fail|1|||
145758051|NCT01583179|525627546|FG000|Overall Study|Screen failure|1|||
145758052|NCT01583179|525627547|FG001|Overall Study|Screen failure|2|||
145758053|NCT01246206|525627548|FG000|Overall Study|Patient did not receive study regiments.|1|||
145758054|NCT02002975|525627549|FG000|Overall Study|Case Report Forms Uncollected|135|||
145758055|NCT02002975|525627549|FG000|Overall Study|Protocol Deviation|437|||
145758056|NCT01430442|525627550|FG000|Overall Study|Subject Withdrew Consent|3|||
145758057|NCT01430442|525627551|FG001|Overall Study|Subject Withdrew Consent|0|||
145758058|NCT01430442|525627552|FG002|Overall Study|Subject Withdrew Consent|1|||
145758059|NCT01430442|525627553|FG003|Overall Study|Subject Withdrew Consent|0|||
145758060|NCT01430442|525627554|FG004|Overall Study|Subject Withdrew Consent|2|||
145758061|NCT01430442|525627555|FG005|Overall Study|Subject Withdrew Consent|1|||
145758062|NCT01430442|525627556|FG006|Overall Study|Subject Withdrew Consent|5|||
145758063|NCT01430442|525627557|FG007|Overall Study|Subject Withdrew Consent|2|||
145758064|NCT01430442|525627550|FG000|Overall Study|Lost to Follow-up|2|||
145758065|NCT01430442|525627551|FG001|Overall Study|Lost to Follow-up|0|||
145758066|NCT01430442|525627552|FG002|Overall Study|Lost to Follow-up|1|||
145758067|NCT01430442|525627553|FG003|Overall Study|Lost to Follow-up|2|||
145758068|NCT01430442|525627554|FG004|Overall Study|Lost to Follow-up|2|||
145758069|NCT01430442|525627555|FG005|Overall Study|Lost to Follow-up|1|||
145273973|NCT05919823|523850969|FG000|Open Label Period|Adverse Event|0|||
145758070|NCT01430442|525627556|FG006|Overall Study|Lost to Follow-up|5|||
145758071|NCT01430442|525627557|FG007|Overall Study|Lost to Follow-up|1|||
145758072|NCT01430442|525627550|FG000|Overall Study|Pregnancy|1|||
145758073|NCT01430442|525627551|FG001|Overall Study|Pregnancy|0|||
145758074|NCT01430442|525627552|FG002|Overall Study|Pregnancy|0|||
145758075|NCT01430442|525627553|FG003|Overall Study|Pregnancy|0|||
145758076|NCT01430442|525627554|FG004|Overall Study|Pregnancy|0|||
145758077|NCT01430442|525627555|FG005|Overall Study|Pregnancy|1|||
145758078|NCT01430442|525627556|FG006|Overall Study|Pregnancy|0|||
145758079|NCT01430442|525627557|FG007|Overall Study|Pregnancy|0|||
145758080|NCT01430442|525627550|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
145758081|NCT01430442|525627551|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
145758082|NCT01430442|525627552|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
145758083|NCT01430442|525627553|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
145758084|NCT01430442|525627554|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
145758085|NCT01430442|525627555|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
145758086|NCT01430442|525627556|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
145758087|NCT01430442|525627557|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
145758088|NCT00772629|525627559|FG000|Overall Study|Subject was not vaccinated|1|||
145758089|NCT00772629|525627560|FG001|Overall Study|Subject was not vaccinated|0|||
145758090|NCT03609619|525627564|FG000|Overall Study|Adverse Event|1|||
145758091|NCT03609619|525627565|FG001|Overall Study|Adverse Event|0|||
145758092|NCT03609619|525627564|FG000|Overall Study|Lack of Efficacy|1|||
145758093|NCT03609619|525627565|FG001|Overall Study|Lack of Efficacy|2|||
145758094|NCT03609619|525627564|FG000|Overall Study|Protocol Violation|5|||
145758095|NCT03609619|525627565|FG001|Overall Study|Protocol Violation|0|||
145758096|NCT03609619|525627564|FG000|Overall Study|Withdrawal by Subject|2|||
145758097|NCT03609619|525627565|FG001|Overall Study|Withdrawal by Subject|3|||
145758098|NCT03609619|525627564|FG000|Overall Study|Lost to Follow-up|1|||
145758099|NCT03609619|525627565|FG001|Overall Study|Lost to Follow-up|1|||
145758100|NCT00568555|525627568|FG000|Overall Study|Withdrawal by Subject|1|||
145758101|NCT00568555|525627569|FG001|Overall Study|Withdrawal by Subject|1|||
145758102|NCT01871090|525627570|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
145758103|NCT01871090|525627571|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
145758104|NCT01871090|525627570|FG000|Overall Study|Interrogation not completed correctly|1|||
145758105|NCT01871090|525627571|FG001|Overall Study|Interrogation not completed correctly|0|||
145758106|NCT01871090|525627570|FG000|Overall Study|Subject Non-Compliance|0|||
145758107|NCT01871090|525627571|FG001|Overall Study|Subject Non-Compliance|1|||
145758108|NCT01231555|525627572|FG000|Overall Study|Study terminated|8|||
145758109|NCT01231555|525627573|FG001|Overall Study|Study terminated|5|||
145758110|NCT01231555|525627574|FG002|Overall Study|Study terminated|8|||
145758111|NCT01231555|525627572|FG000|Overall Study|Withdrawal by Subject|0|||
145758112|NCT01231555|525627573|FG001|Overall Study|Withdrawal by Subject|2|||
145758113|NCT01231555|525627574|FG002|Overall Study|Withdrawal by Subject|0|||
145758114|NCT01773421|525627575|FG000|Treatment Phase|Other|0|||
145758115|NCT01773421|525627576|FG001|Treatment Phase|Other|0|||
145758116|NCT01773421|525627577|FG002|Treatment Phase|Other|2|||
145758117|NCT01773421|525627578|FG003|Treatment Phase|Other|0|||
145758118|NCT01773421|525627579|FG004|Treatment Phase|Other|0|||
145758119|NCT01773421|525627580|FG005|Treatment Phase|Other|0|||
145758120|NCT01773421|525627581|FG006|Treatment Phase|Other|0|||
145758121|NCT01773421|525627575|FG000|Treatment Phase|Adverse Event|0|||
145758122|NCT01773421|525627576|FG001|Treatment Phase|Adverse Event|0|||
145758123|NCT01773421|525627577|FG002|Treatment Phase|Adverse Event|3|||
145758124|NCT01773421|525627578|FG003|Treatment Phase|Adverse Event|1|||
145758125|NCT01773421|525627579|FG004|Treatment Phase|Adverse Event|0|||
145758126|NCT01773421|525627580|FG005|Treatment Phase|Adverse Event|0|||
145758127|NCT01773421|525627581|FG006|Treatment Phase|Adverse Event|0|||
145758128|NCT01773421|525627575|FG000|Treatment Phase|Withdrawal by Subject|0|||
145273974|NCT05919823|523850970|FG001|Open Label Period|Adverse Event|0|||
145273975|NCT05919823|523850971|FG002|Open Label Period|Adverse Event|2|||
145273976|NCT05919823|523850972|FG003|Open Label Period|Adverse Event|4|||
145273977|NCT05919823|523850969|FG000|Open Label Period|Lost to Follow-up|0|||
145607612|NCT03682705|525079206|FG001|Overall Study|Other, not specified|0|||
145607613|NCT03682705|525079207|FG002|Overall Study|Other, not specified|0|||
145758129|NCT01773421|525627576|FG001|Treatment Phase|Withdrawal by Subject|0|||
145758130|NCT01773421|525627577|FG002|Treatment Phase|Withdrawal by Subject|1|||
145758131|NCT01773421|525627578|FG003|Treatment Phase|Withdrawal by Subject|1|||
145758132|NCT01773421|525627579|FG004|Treatment Phase|Withdrawal by Subject|0|||
145758133|NCT01773421|525627580|FG005|Treatment Phase|Withdrawal by Subject|0|||
145758134|NCT01773421|525627581|FG006|Treatment Phase|Withdrawal by Subject|0|||
145758135|NCT01773421|525627575|FG000|Extension Phase|Other|0|||
145758136|NCT01773421|525627576|FG001|Extension Phase|Other|0|||
145758137|NCT01773421|525627577|FG002|Extension Phase|Other|0|||
145758138|NCT01773421|525627578|FG003|Extension Phase|Other|0|||
145758139|NCT01773421|525627579|FG004|Extension Phase|Other|1|||
145758140|NCT01773421|525627580|FG005|Extension Phase|Other|2|||
145758141|NCT01773421|525627581|FG006|Extension Phase|Other|0|||
145758142|NCT01773421|525627575|FG000|Extension Phase|Adverse Event|0|||
145402875|NCT02065557|524332548|FG004|Induction Period|Lack of Efficacy|0|||
145273978|NCT05919823|523850970|FG001|Open Label Period|Lost to Follow-up|0|||
145758143|NCT01773421|525627576|FG001|Extension Phase|Adverse Event|0|||
145758144|NCT01773421|525627577|FG002|Extension Phase|Adverse Event|0|||
145758145|NCT01773421|525627578|FG003|Extension Phase|Adverse Event|0|||
145758146|NCT01773421|525627579|FG004|Extension Phase|Adverse Event|2|||
145758147|NCT01773421|525627580|FG005|Extension Phase|Adverse Event|0|||
145758148|NCT01773421|525627581|FG006|Extension Phase|Adverse Event|0|||
145758149|NCT00688909|525627582|FG000|Overall Study|Adverse Event|28|||
145758150|NCT00688909|525627582|FG000|Overall Study|Patient withdrew consent|2|||
145758151|NCT00688909|525627582|FG000|Overall Study|Administrative problems|1|||
145758152|NCT00688909|525627582|FG000|Overall Study|Protocol Violation|2|||
145758153|NCT02472847|525627583|FG000|Overall Study|Withdrawal by Subject|1|||
145758154|NCT02472847|525627584|FG001|Overall Study|Withdrawal by Subject|5|||
145758155|NCT00669617|525627586|FG000|Period 1|Withdrawal by Subject|0|||
145758156|NCT00669617|525627587|FG001|Period 1|Withdrawal by Subject|0|||
145758157|NCT00669617|525627588|FG002|Period 1|Withdrawal by Subject|1|||
145758158|NCT00669617|525627589|FG003|Period 1|Withdrawal by Subject|0|||
145758159|NCT00669617|525627590|FG004|Period 1|Withdrawal by Subject|0|||
145758160|NCT00669617|525627586|FG000|Period 1|Protocol Deviation|0|||
145758161|NCT00669617|525627587|FG001|Period 1|Protocol Deviation|0|||
145758162|NCT00669617|525627588|FG002|Period 1|Protocol Deviation|0|||
145758163|NCT00669617|525627589|FG003|Period 1|Protocol Deviation|0|||
145758164|NCT00669617|525627590|FG004|Period 1|Protocol Deviation|1|||
145758165|NCT00669617|525627586|FG000|Period 3|Lost to Follow-up|1|||
145758166|NCT00669617|525627587|FG001|Period 3|Lost to Follow-up|0|||
145758167|NCT00669617|525627588|FG002|Period 3|Lost to Follow-up|0|||
145758168|NCT00669617|525627589|FG003|Period 3|Lost to Follow-up|0|||
145758169|NCT00669617|525627590|FG004|Period 3|Lost to Follow-up|0|||
145758170|NCT00623831|525627591|FG000|Overall Study|Withdrawal by Subject|1|||
145758171|NCT00623831|525627592|FG001|Overall Study|Withdrawal by Subject|0|||
145758172|NCT00623831|525627591|FG000|Overall Study|Progressive Disease|0|||
145758173|NCT00623831|525627592|FG001|Overall Study|Progressive Disease|1|||
145758174|NCT01276821|525627593|FG000|Overall Study|Protocol Violation|0|||
145758175|NCT01276821|525627594|FG001|Overall Study|Protocol Violation|1|||
145758176|NCT03068325|525627595|FG000|Overall Study|Lost to Follow-up|5|||
145758177|NCT00700180|525627596|FG000|Overall Study|Death|99|||
145758178|NCT00700180|525627597|FG001|Overall Study|Death|114|||
145758179|NCT00700180|525627596|FG000|Overall Study|Alive on treatment|5|||
145758180|NCT00700180|525627597|FG001|Overall Study|Alive on treatment|3|||
145758181|NCT00700180|525627596|FG000|Overall Study|Alive in follow-up|46|||
145758182|NCT00700180|525627597|FG001|Overall Study|Alive in follow-up|27|||
145758183|NCT00700180|525627596|FG000|Overall Study|Lost to Follow-up|4|||
145758184|NCT00700180|525627597|FG001|Overall Study|Lost to Follow-up|5|||
145758185|NCT01613326|525627598|FG000|Overall Study|Adverse Event|7|||
145758186|NCT01613326|525627599|FG001|Overall Study|Adverse Event|5|||
145758187|NCT01613326|525627598|FG000|Overall Study|Withdrawal by Subject|3|||
145758188|NCT01613326|525627599|FG001|Overall Study|Withdrawal by Subject|4|||
145758189|NCT01613326|525627598|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145758190|NCT01613326|525627599|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145758191|NCT01613326|525627598|FG000|Overall Study|inability to use device|1|||
145758192|NCT01613326|525627599|FG001|Overall Study|inability to use device|0|||
145758193|NCT01613326|525627598|FG000|Overall Study|Lack of Efficacy|0|||
145758194|NCT01613326|525627599|FG001|Overall Study|Lack of Efficacy|1|||
145758195|NCT01613326|525627598|FG000|Overall Study|Lost to Follow-up|0|||
145758196|NCT01613326|525627599|FG001|Overall Study|Lost to Follow-up|1|||
145758197|NCT01613326|525627598|FG000|Overall Study|Administrative|0|||
145758198|NCT01613326|525627599|FG001|Overall Study|Administrative|2|||
145758199|NCT01613326|525627598|FG000|Overall Study|Protocol Violation|0|||
145758200|NCT01613326|525627599|FG001|Overall Study|Protocol Violation|1|||
145758201|NCT03980938|525627602|FG000|Treatment Period 1|Study Terminated|1|||
145758202|NCT03980938|525627603|FG001|Treatment Period 1|Study Terminated|1|||
145758203|NCT03980938|525627602|FG000|Treatment Period 2|Study Terminated|2|||
145758204|NCT03980938|525627603|FG001|Treatment Period 2|Study Terminated|2|||
145758205|NCT00605267|525627604|FG000|Overall Study|Adverse Event|0|||
145758206|NCT00605267|525627605|FG001|Overall Study|Adverse Event|1|||
145758207|NCT00605267|525627604|FG000|Overall Study|Lack of Efficacy|1|||
145758208|NCT00605267|525627605|FG001|Overall Study|Lack of Efficacy|5|||
145532411|NCT00464269|524810141|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145532412|NCT00464269|524810142|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
145758209|NCT00605267|525627604|FG000|Overall Study|Withdrawal by Subject|2|||
145758210|NCT00605267|525627605|FG001|Overall Study|Withdrawal by Subject|3|||
145532413|NCT00464269|524810143|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145532414|NCT02955797|524810146|FG000|Overall Study|Protocol Violation|1|||
145758211|NCT03569202|525627611|FG000|Part 3|Physician Decision|1|||
145758212|NCT03569202|525627612|FG001|Part 3|Physician Decision|0|||
145758213|NCT03569202|525627611|FG000|Part 3|Other|1|||
145758214|NCT03569202|525627612|FG001|Part 3|Other|1|||
145758215|NCT00420511|525627613|FG000|Overall Study|Adverse Event|1|||
145758216|NCT00420511|525627614|FG001|Overall Study|Adverse Event|1|||
145758217|NCT00420511|525627613|FG000|Overall Study|Lost to Follow-up|1|||
145758218|NCT00420511|525627614|FG001|Overall Study|Lost to Follow-up|0|||
145758219|NCT00454779|525627616|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
145758220|NCT00454779|525627617|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
145758221|NCT00454779|525627616|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
145758222|NCT00454779|525627617|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
145758223|NCT00454779|525627616|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
145758224|NCT00454779|525627617|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
145758225|NCT00454779|525627616|FG000|First-line Treatment Phase|Protocol Violation|0|||
145758226|NCT00454779|525627617|FG001|First-line Treatment Phase|Protocol Violation|1|||
145758227|NCT00454779|525627616|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
145758228|NCT00454779|525627617|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
145758229|NCT00454779|525627616|FG000|First-line Treatment Phase|Ongoing|1|||
145758230|NCT00454779|525627617|FG001|First-line Treatment Phase|Ongoing|0|||
145758231|NCT00454779|525627616|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
145758232|NCT00454779|525627617|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
145758233|NCT00454779|525627616|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
145758234|NCT00454779|525627617|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
145758235|NCT00454779|525627616|FG000|Second-line Treatment Phase|Ongoing|0|||
145758236|NCT00454779|525627617|FG001|Second-line Treatment Phase|Ongoing|1|||
145758237|NCT00168831|525627618|FG000|Overall Study|Adverse Event|36|||
145758238|NCT00168831|525627619|FG001|Overall Study|Adverse Event|47|||
145758239|NCT00168831|525627620|FG002|Overall Study|Adverse Event|74|||
145758240|NCT00168831|525627618|FG000|Overall Study|Lost to Follow-up|5|||
145758241|NCT00168831|525627619|FG001|Overall Study|Lost to Follow-up|6|||
145758242|NCT00168831|525627620|FG002|Overall Study|Lost to Follow-up|4|||
145758243|NCT00168831|525627618|FG000|Overall Study|Withdrawal by Subject|7|||
145758244|NCT00168831|525627619|FG001|Overall Study|Withdrawal by Subject|14|||
145758245|NCT00168831|525627620|FG002|Overall Study|Withdrawal by Subject|19|||
145758246|NCT00168831|525627618|FG000|Overall Study|Protocol Violation|6|||
145758247|NCT00168831|525627619|FG001|Overall Study|Protocol Violation|11|||
145758248|NCT00168831|525627620|FG002|Overall Study|Protocol Violation|11|||
145758249|NCT00168831|525627618|FG000|Overall Study|Other|6|||
145758250|NCT00168831|525627619|FG001|Overall Study|Other|3|||
145758251|NCT00168831|525627620|FG002|Overall Study|Other|6|||
145758252|NCT01622569|525627621|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
145758253|NCT01622569|525627622|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
145758254|NCT01622569|525627623|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
145758255|NCT01622569|525627624|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
145758256|NCT01622569|525627621|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
145758257|NCT01622569|525627622|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
145758258|NCT01622569|525627623|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
145758259|NCT01622569|525627624|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
145758260|NCT01622569|525627621|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
145758261|NCT01622569|525627622|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
145758262|NCT01622569|525627623|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
145758263|NCT01622569|525627624|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
145758264|NCT01622569|525627621|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
145273979|NCT05919823|523850971|FG002|Open Label Period|Lost to Follow-up|1|||
145273980|NCT05919823|523850972|FG003|Open Label Period|Lost to Follow-up|0|||
145758265|NCT01622569|525627622|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
145273981|NCT05919823|523850969|FG000|Open Label Period|Protocol Violation|0|||
145758266|NCT01622569|525627623|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
145758267|NCT01622569|525627624|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
145758268|NCT01622569|525627621|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
145758269|NCT01622569|525627622|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
145532415|NCT02955797|524810147|FG001|Overall Study|Protocol Violation|0|||
145532416|NCT02955797|524810148|FG002|Overall Study|Protocol Violation|0|||
145532417|NCT02955797|524810149|FG003|Overall Study|Protocol Violation|1|||
145532418|NCT02955797|524810146|FG000|Overall Study|Withdrawal by Subject|2|||
145532419|NCT02955797|524810147|FG001|Overall Study|Withdrawal by Subject|2|||
145532420|NCT02955797|524810148|FG002|Overall Study|Withdrawal by Subject|0|||
145758270|NCT01622569|525627623|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
145758271|NCT01622569|525627624|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
145758272|NCT01622569|525627621|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
145758273|NCT01622569|525627622|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
145758274|NCT01622569|525627623|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
145758275|NCT01622569|525627624|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
145758276|NCT01622569|525627621|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
145758277|NCT01622569|525627622|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
145758278|NCT01622569|525627623|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
145758279|NCT01622569|525627624|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
145758280|NCT01622569|525627621|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145758281|NCT01622569|525627622|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145758282|NCT01622569|525627623|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
145758283|NCT01622569|525627624|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
145758284|NCT02522767|525627626|FG000|Double-blind|Withdrawal by Subject|8|||
145758285|NCT02522767|525627627|FG001|Double-blind|Withdrawal by Subject|11|||
145532421|NCT02955797|524810149|FG003|Overall Study|Withdrawal by Subject|1|||
145532422|NCT02955797|524810146|FG000|Overall Study|Lost to Follow-up|0|||
145532423|NCT02955797|524810147|FG001|Overall Study|Lost to Follow-up|1|||
145532424|NCT02955797|524810148|FG002|Overall Study|Lost to Follow-up|0|||
145758286|NCT02522767|525627626|FG000|Double-blind|Lost to Follow-up|1|||
145758287|NCT02522767|525627627|FG001|Double-blind|Lost to Follow-up|0|||
145532425|NCT02955797|524810149|FG003|Overall Study|Lost to Follow-up|0|||
145532426|NCT03131453|524810150|FG000|Overall Study|Study terminated by Sponsor|424|||
145532427|NCT03131453|524810151|FG001|Overall Study|Study terminated by Sponsor|222|||
145758288|NCT02522767|525627626|FG000|Double-blind|Adverse Event|1|||
145758289|NCT02522767|525627627|FG001|Double-blind|Adverse Event|10|||
145758290|NCT02522767|525627626|FG000|Double-blind|Protocol Violation|0|||
145758291|NCT02522767|525627627|FG001|Double-blind|Protocol Violation|1|||
145758292|NCT02522767|525627626|FG000|Double-blind|Lack of Efficacy|0|||
145758293|NCT02522767|525627627|FG001|Double-blind|Lack of Efficacy|2|||
145758294|NCT02522767|525627626|FG000|Double-blind|Protocol Deviation|1|||
145758295|NCT02522767|525627627|FG001|Double-blind|Protocol Deviation|0|||
145758296|NCT02522767|525627626|FG000|Open-label|Withdrawal by Subject|2|||
145758297|NCT02522767|525627627|FG001|Open-label|Withdrawal by Subject|3|||
145758298|NCT02522767|525627626|FG000|Open-label|Lost to Follow-up|0|||
145758299|NCT02522767|525627627|FG001|Open-label|Lost to Follow-up|1|||
145758300|NCT02522767|525627626|FG000|Open-label|Adverse Event|2|||
145532428|NCT03131453|524810152|FG002|Overall Study|Study terminated by Sponsor|438|||
145532429|NCT03131453|524810150|FG000|Overall Study|Withdrawal by Subject|18|||
145532430|NCT03131453|524810151|FG001|Overall Study|Withdrawal by Subject|7|||
145532431|NCT03131453|524810152|FG002|Overall Study|Withdrawal by Subject|13|||
145532432|NCT03131453|524810150|FG000|Overall Study|Adverse Event|10|||
145532433|NCT03131453|524810151|FG001|Overall Study|Adverse Event|3|||
145532434|NCT03131453|524810152|FG002|Overall Study|Adverse Event|3|||
145532435|NCT03131453|524810150|FG000|Overall Study|Lost to Follow-up|1|||
145532436|NCT03131453|524810151|FG001|Overall Study|Lost to Follow-up|0|||
145532437|NCT03131453|524810152|FG002|Overall Study|Lost to Follow-up|1|||
145532438|NCT03131453|524810150|FG000|Overall Study|Physician Decision|1|||
145532439|NCT03131453|524810151|FG001|Overall Study|Physician Decision|0|||
145532440|NCT03131453|524810152|FG002|Overall Study|Physician Decision|1|||
145532441|NCT03131453|524810150|FG000|Overall Study|Non-compliance with study treatment|1|||
145532442|NCT03131453|524810151|FG001|Overall Study|Non-compliance with study treatment|0|||
145532443|NCT03131453|524810152|FG002|Overall Study|Non-compliance with study treatment|0|||
145532444|NCT03131453|524810150|FG000|Overall Study|Technical problems|1|||
145532445|NCT03131453|524810151|FG001|Overall Study|Technical problems|0|||
145532446|NCT03131453|524810152|FG002|Overall Study|Technical problems|0|||
145532447|NCT03131453|524810150|FG000|Overall Study|Protocol deviation|0|||
145532448|NCT03131453|524810151|FG001|Overall Study|Protocol deviation|1|||
145532449|NCT03131453|524810152|FG002|Overall Study|Protocol deviation|0|||
145532450|NCT02081183|524810153|FG000|Overall Study|Lost to Follow-up|0|||
145532451|NCT02081183|524810154|FG001|Overall Study|Lost to Follow-up|1|||
145532452|NCT02081183|524810153|FG000|Overall Study|Protocol Violation|1|||
145532453|NCT02081183|524810154|FG001|Overall Study|Protocol Violation|0|||
145532454|NCT02081183|524810153|FG000|Overall Study|Other|3|||
145532455|NCT02081183|524810154|FG001|Overall Study|Other|3|||
145532456|NCT04176705|524810155|FG000|Overall Study|Withdrawal by Subject|4|||
145532457|NCT04176705|524810156|FG001|Overall Study|Withdrawal by Subject|4|||
145532458|NCT04176705|524810155|FG000|Overall Study|Death|1|||
145532459|NCT04176705|524810156|FG001|Overall Study|Death|1|||
145532460|NCT04176705|524810155|FG000|Overall Study|Lost to Follow-up|3|||
145532461|NCT04176705|524810156|FG001|Overall Study|Lost to Follow-up|3|||
145532462|NCT02024555|524810157|FG000|Overall Study|Lost to Follow-up|1|||
145532463|NCT02024555|524810158|FG001|Overall Study|Lost to Follow-up|1|||
145532464|NCT02024555|524810157|FG000|Overall Study|Withdrawal by Subject|5|||
145532465|NCT02024555|524810158|FG001|Overall Study|Withdrawal by Subject|1|||
145532466|NCT03805646|524810171|FG000|Overall Study|Death|40|||
145532467|NCT03805646|524810172|FG001|Overall Study|Death|49|||
145532468|NCT03805646|524810171|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
145532469|NCT03805646|524810172|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
145532470|NCT04195906|524811612|FG000|Part 1|Adverse Event|3|||
145532471|NCT04195906|524811613|FG001|Part 1|Adverse Event|7|||
145532472|NCT04195906|524811612|FG000|Part 1|Withdrawal by Subject|0|||
145532473|NCT04195906|524811613|FG001|Part 1|Withdrawal by Subject|1|||
145532474|NCT04195906|524811612|FG000|Part 2|Adverse Event|1|||
145532475|NCT04195906|524811613|FG001|Part 2|Adverse Event|1|||
145532476|NCT04195906|524811612|FG000|Part 2|Withdrawal by Subject|0|||
145532477|NCT04195906|524811613|FG001|Part 2|Withdrawal by Subject|3|||
145532478|NCT04195906|524811612|FG000|Part 2|Other|1|||
145532479|NCT04195906|524811613|FG001|Part 2|Other|3|||
145532480|NCT00371826|524811616|FG000|Core Phase (12 Months)|Adverse Event|15|||
145532481|NCT00371826|524811617|FG001|Core Phase (12 Months)|Adverse Event|4|||
145532482|NCT00371826|524811618|FG002|Core Phase (12 Months)|Adverse Event|9|||
145532483|NCT00371826|524811616|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
145532484|NCT00371826|524811617|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
145758301|NCT02522767|525627627|FG001|Open-label|Adverse Event|1|||
145758302|NCT02522767|525627626|FG000|Open-label|Lack of Efficacy|1|||
145758303|NCT02522767|525627627|FG001|Open-label|Lack of Efficacy|1|||
145758304|NCT02522767|525627626|FG000|Open-label|Protocol Violation|0|||
145758305|NCT02522767|525627627|FG001|Open-label|Protocol Violation|1|||
145758306|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
145758307|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
145758308|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
145758309|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
145758310|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
145758311|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
145758312|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
145758313|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
145758314|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
145758315|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
145758316|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
145532485|NCT00371826|524811618|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
145758317|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
145758318|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
145758319|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
145758320|NCT02288247|525627628|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
145758321|NCT02288247|525627629|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
145758322|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
145758323|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
145758324|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
145758325|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
145758326|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
145758327|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
145758328|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
145758329|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
145758330|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
145758331|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
145758332|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
145758333|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
145758334|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
145758335|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
145758336|NCT02288247|525627628|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
145758337|NCT02288247|525627629|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
145758338|NCT03634800|525627630|FG000|Overall Study|Adverse Event|1|||
145758339|NCT03634800|525627630|FG000|Overall Study|Disease Progression|4|||
145758340|NCT03634800|525627630|FG000|Overall Study|Withdrawal by Subject|1|||
145758341|NCT00236080|525627631|FG000|Overall Study|Adverse Event|0|||
145758342|NCT00236080|525627632|FG001|Overall Study|Adverse Event|0|||
145758343|NCT00236080|525627633|FG002|Overall Study|Adverse Event|3|||
145758344|NCT00236080|525627634|FG003|Overall Study|Adverse Event|1|||
145758345|NCT00236080|525627635|FG004|Overall Study|Adverse Event|0|||
145758346|NCT00236080|525627631|FG000|Overall Study|Lost to Follow-up|0|||
145758347|NCT00236080|525627632|FG001|Overall Study|Lost to Follow-up|1|||
145758348|NCT00236080|525627633|FG002|Overall Study|Lost to Follow-up|0|||
145758349|NCT00236080|525627634|FG003|Overall Study|Lost to Follow-up|0|||
145758350|NCT00236080|525627635|FG004|Overall Study|Lost to Follow-up|0|||
145758351|NCT00236080|525627631|FG000|Overall Study|Physician Decision|1|||
145758352|NCT00236080|525627632|FG001|Overall Study|Physician Decision|0|||
145758353|NCT00236080|525627633|FG002|Overall Study|Physician Decision|1|||
145758354|NCT00236080|525627634|FG003|Overall Study|Physician Decision|1|||
145758355|NCT00236080|525627635|FG004|Overall Study|Physician Decision|1|||
145758356|NCT00236080|525627631|FG000|Overall Study|Withdrawal by Subject|1|||
145758357|NCT00236080|525627632|FG001|Overall Study|Withdrawal by Subject|0|||
145532486|NCT00371826|524811616|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
145758358|NCT00236080|525627633|FG002|Overall Study|Withdrawal by Subject|0|||
145758359|NCT00236080|525627634|FG003|Overall Study|Withdrawal by Subject|0|||
145758360|NCT00236080|525627635|FG004|Overall Study|Withdrawal by Subject|0|||
145758361|NCT00236080|525627631|FG000|Overall Study|Miscellaneous|0|||
145758362|NCT00236080|525627632|FG001|Overall Study|Miscellaneous|0|||
145758363|NCT00236080|525627633|FG002|Overall Study|Miscellaneous|1|||
145758364|NCT00236080|525627634|FG003|Overall Study|Miscellaneous|0|||
145758365|NCT00236080|525627635|FG004|Overall Study|Miscellaneous|0|||
145758366|NCT03543410|525627636|FG000|Overall Study|Adverse Event|10|||
145758367|NCT03543410|525627637|FG001|Overall Study|Adverse Event|8|||
145758368|NCT03543410|525627638|FG002|Overall Study|Adverse Event|2|||
145758369|NCT03543410|525627636|FG000|Overall Study|Lack of Efficacy|0|||
145758370|NCT03543410|525627637|FG001|Overall Study|Lack of Efficacy|1|||
145758371|NCT03543410|525627638|FG002|Overall Study|Lack of Efficacy|0|||
145758372|NCT03543410|525627636|FG000|Overall Study|Lost to Follow-up|0|||
145758373|NCT03543410|525627637|FG001|Overall Study|Lost to Follow-up|1|||
145758374|NCT03543410|525627638|FG002|Overall Study|Lost to Follow-up|0|||
145758375|NCT03543410|525627636|FG000|Overall Study|Withdrawal by Subject|5|||
145758376|NCT03543410|525627637|FG001|Overall Study|Withdrawal by Subject|2|||
145758377|NCT03543410|525627638|FG002|Overall Study|Withdrawal by Subject|8|||
145758378|NCT03543410|525627636|FG000|Overall Study|Protocol Violation|0|||
145758379|NCT03543410|525627637|FG001|Overall Study|Protocol Violation|1|||
145758380|NCT03543410|525627638|FG002|Overall Study|Protocol Violation|0|||
145758381|NCT03543410|525627636|FG000|Overall Study|Due to COVID-19|4|||
145758382|NCT03543410|525627637|FG001|Overall Study|Due to COVID-19|0|||
145758383|NCT03543410|525627638|FG002|Overall Study|Due to COVID-19|2|||
145532487|NCT00371826|524811617|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
145532488|NCT00371826|524811618|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
145758384|NCT03543410|525627636|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
145758385|NCT03543410|525627637|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
145758386|NCT03543410|525627638|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
145758387|NCT03543410|525627636|FG000|Overall Study|Not Due to COVID-19|2|||
145758388|NCT03543410|525627637|FG001|Overall Study|Not Due to COVID-19|0|||
145758389|NCT03543410|525627638|FG002|Overall Study|Not Due to COVID-19|1|||
145758390|NCT02883244|525627639|FG000|Overall Study|Lost to Follow-up|0|||
145758391|NCT02883244|525627640|FG001|Overall Study|Lost to Follow-up|1|||
145758392|NCT01727258|525627641|FG000|Overall Study|Adverse Event|0|||
145758393|NCT01727258|525627642|FG001|Overall Study|Adverse Event|2|||
145758394|NCT01727258|525627643|FG002|Overall Study|Adverse Event|0|||
145758395|NCT01727258|525627641|FG000|Overall Study|Noncompliance with Study Drug|0|||
145758396|NCT01727258|525627642|FG001|Overall Study|Noncompliance with Study Drug|0|||
145758397|NCT01727258|525627643|FG002|Overall Study|Noncompliance with Study Drug|1|||
145758398|NCT01727258|525627641|FG000|Overall Study|Withdrawal by Subject|1|||
145758399|NCT01727258|525627642|FG001|Overall Study|Withdrawal by Subject|1|||
145758400|NCT01727258|525627643|FG002|Overall Study|Withdrawal by Subject|0|||
145758401|NCT01727258|525627641|FG000|Overall Study|Lost to Follow-up|1|||
145758402|NCT01727258|525627642|FG001|Overall Study|Lost to Follow-up|0|||
145758403|NCT01727258|525627643|FG002|Overall Study|Lost to Follow-up|0|||
145758404|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
145758405|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
145758406|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
145758407|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Death|28|||
145758408|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Death|0|||
145758409|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Death|0|||
145758410|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
145758411|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
145758412|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
145758413|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
145758414|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
145758415|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
145758416|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
145758417|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
145758418|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
145758419|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
145758420|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
145758421|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
145758422|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
145758423|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
145758424|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
145758425|NCT00820755|525627644|FG000|Period 1: Combination Therapy Phase|Other|11|||
145758426|NCT00820755|525627645|FG001|Period 1: Combination Therapy Phase|Other|0|||
145758427|NCT00820755|525627646|FG002|Period 1: Combination Therapy Phase|Other|0|||
145273982|NCT05919823|523850970|FG001|Open Label Period|Protocol Violation|0|||
145532489|NCT00371826|524811616|FG000|Core Phase (12 Months)|Protocol Violation|1|||
145532490|NCT00371826|524811617|FG001|Core Phase (12 Months)|Protocol Violation|0|||
145532491|NCT00371826|524811618|FG002|Core Phase (12 Months)|Protocol Violation|1|||
145532492|NCT00371826|524811616|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
145758428|NCT00820755|525627644|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
145758429|NCT00820755|525627645|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
145758430|NCT00820755|525627646|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
145758431|NCT03604445|525627649|FG000|Overall Study|Death|0|||
145758432|NCT03604445|525627650|FG001|Overall Study|Death|0|||
145758433|NCT03604445|525627651|FG002|Overall Study|Death|0|||
145758434|NCT03604445|525627652|FG003|Overall Study|Death|0|||
145758435|NCT03604445|525627653|FG004|Overall Study|Death|0|||
145758436|NCT03604445|525627654|FG005|Overall Study|Death|0|||
145758437|NCT03604445|525627655|FG006|Overall Study|Death|0|||
145758438|NCT03604445|525627656|FG007|Overall Study|Death|0|||
145273983|NCT05919823|523850971|FG002|Open Label Period|Protocol Violation|0|||
145758439|NCT03604445|525627657|FG008|Overall Study|Death|1|||
145758440|NCT03604445|525627649|FG000|Overall Study|Withdrawal by Subject|0|||
145758441|NCT03604445|525627650|FG001|Overall Study|Withdrawal by Subject|0|||
145758442|NCT03604445|525627651|FG002|Overall Study|Withdrawal by Subject|0|||
145758443|NCT03604445|525627652|FG003|Overall Study|Withdrawal by Subject|0|||
145758444|NCT03604445|525627653|FG004|Overall Study|Withdrawal by Subject|0|||
145758445|NCT03604445|525627654|FG005|Overall Study|Withdrawal by Subject|0|||
145758446|NCT03604445|525627655|FG006|Overall Study|Withdrawal by Subject|1|||
145758447|NCT03604445|525627656|FG007|Overall Study|Withdrawal by Subject|0|||
145758448|NCT03604445|525627657|FG008|Overall Study|Withdrawal by Subject|0|||
145758449|NCT03604445|525627649|FG000|Overall Study|Missing visit|0|||
145758450|NCT03604445|525627650|FG001|Overall Study|Missing visit|0|||
145758451|NCT03604445|525627651|FG002|Overall Study|Missing visit|0|||
145758452|NCT03604445|525627652|FG003|Overall Study|Missing visit|0|||
145758453|NCT03604445|525627653|FG004|Overall Study|Missing visit|0|||
145758454|NCT03604445|525627654|FG005|Overall Study|Missing visit|1|||
145758455|NCT03604445|525627655|FG006|Overall Study|Missing visit|0|||
145758456|NCT03604445|525627656|FG007|Overall Study|Missing visit|1|||
145758457|NCT03604445|525627657|FG008|Overall Study|Missing visit|0|||
145758458|NCT03604445|525627649|FG000|Overall Study|Adverse Event|0|||
145758459|NCT03604445|525627650|FG001|Overall Study|Adverse Event|0|||
145758460|NCT03604445|525627651|FG002|Overall Study|Adverse Event|0|||
145758461|NCT03604445|525627652|FG003|Overall Study|Adverse Event|1|||
145758462|NCT03604445|525627653|FG004|Overall Study|Adverse Event|0|||
145758463|NCT03604445|525627654|FG005|Overall Study|Adverse Event|0|||
145758464|NCT03604445|525627655|FG006|Overall Study|Adverse Event|0|||
145758465|NCT03604445|525627656|FG007|Overall Study|Adverse Event|0|||
145758466|NCT03604445|525627657|FG008|Overall Study|Adverse Event|1|||
145758467|NCT00773279|525627658|FG000|Period 1|Adverse Event|2|||
145758468|NCT00773279|525627659|FG001|Period 1|Adverse Event|1|||
145758469|NCT00773279|525627658|FG000|Period 1|Lack of Efficacy|0|||
145758470|NCT00773279|525627659|FG001|Period 1|Lack of Efficacy|2|||
145758471|NCT00773279|525627658|FG000|Period 1|Unclassified|5|||
145758472|NCT00773279|525627659|FG001|Period 1|Unclassified|1|||
145758473|NCT00773279|525627658|FG000|Period 2|Adverse Event|0|||
145758474|NCT00773279|525627659|FG001|Period 2|Adverse Event|1|||
145758475|NCT00773279|525627658|FG000|Period 2|Lack of Efficacy|1|||
145758476|NCT00773279|525627659|FG001|Period 2|Lack of Efficacy|0|||
145758477|NCT00773279|525627658|FG000|Period 2|Protocol Violation|0|||
145758478|NCT00773279|525627659|FG001|Period 2|Protocol Violation|3|||
145758479|NCT00773279|525627658|FG000|Period 2|Unclassified|2|||
145758480|NCT00773279|525627659|FG001|Period 2|Unclassified|2|||
145758481|NCT02251912|525627661|FG000|Overall Study|Withdrawal by Subject|2|||
145758482|NCT02251912|525627662|FG001|Overall Study|Withdrawal by Subject|3|||
145758483|NCT02251912|525627661|FG000|Overall Study|Adverse Event|0|||
145758484|NCT02251912|525627662|FG001|Overall Study|Adverse Event|2|||
145758485|NCT02551159|525627663|FG000|Overall Study|Death|352|||
145758486|NCT02551159|525627664|FG001|Overall Study|Death|174|||
145758487|NCT02551159|525627665|FG002|Overall Study|Death|161|||
145758488|NCT02551159|525627663|FG000|Overall Study|Withdrawal by Subject|8|||
145758489|NCT02551159|525627664|FG001|Overall Study|Withdrawal by Subject|5|||
145758490|NCT02551159|525627665|FG002|Overall Study|Withdrawal by Subject|16|||
145758491|NCT02551159|525627663|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
145758492|NCT02551159|525627664|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
145758493|NCT02551159|525627665|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
145758494|NCT02175680|525627666|FG000|Overall Study|non-compliance|1|||
145758495|NCT02175680|525627666|FG000|Overall Study|other non-medical reason|1|||
145758496|NCT04506294|525627667|FG000|Overall Study|Lost to Follow-up|70|||
145273984|NCT05919823|523850972|FG003|Open Label Period|Protocol Violation|1|||
145273985|NCT05919823|523850969|FG000|Open Label Period|Participant withdrew consent|0|||
145758497|NCT04506294|525627668|FG001|Overall Study|Lost to Follow-up|20|||
145758498|NCT04506294|525627667|FG000|Overall Study|Withdrawal by Subject|16|||
145758499|NCT04506294|525627668|FG001|Overall Study|Withdrawal by Subject|2|||
145758500|NCT01469000|525627672|FG000|Overall Study|Withdrawal by Subject|16|||
145758501|NCT01469000|525627673|FG001|Overall Study|Withdrawal by Subject|3|||
145758502|NCT01469000|525627672|FG000|Overall Study|Sponsor Decision|4|||
145758503|NCT01469000|525627673|FG001|Overall Study|Sponsor Decision|1|||
145758504|NCT04949841|525627675|FG000|Overall Study|Adverse Event|7|||
145758505|NCT04949841|525627675|FG000|Overall Study|Death|1|||
145758506|NCT04949841|525627675|FG000|Overall Study|Withdrawal by Subject|52|||
145758507|NCT04949841|525627675|FG000|Overall Study|Pregnancy|4|||
145758508|NCT04949841|525627675|FG000|Overall Study|Lost to Follow-up|9|||
145758509|NCT04949841|525627675|FG000|Overall Study|Lack of Efficacy|55|||
145758510|NCT04949841|525627675|FG000|Overall Study|Various reasons|9|||
145758511|NCT03179436|525627676|FG000|Overall Study|Withdrawal by Subject|1|||
145758512|NCT03179436|525627677|FG001|Overall Study|Withdrawal by Subject|0|||
145758513|NCT03179436|525627678|FG002|Overall Study|Withdrawal by Subject|0|||
145758514|NCT03179436|525627679|FG003|Overall Study|Withdrawal by Subject|4|||
145758515|NCT03179436|525627680|FG004|Overall Study|Withdrawal by Subject|2|||
145758516|NCT03179436|525627681|FG005|Overall Study|Withdrawal by Subject|2|||
145758517|NCT03179436|525627682|FG006|Overall Study|Withdrawal by Subject|5|||
145758518|NCT03179436|525627683|FG007|Overall Study|Withdrawal by Subject|0|||
145758519|NCT03179436|525627684|FG008|Overall Study|Withdrawal by Subject|3|||
145758520|NCT03179436|525627685|FG009|Overall Study|Withdrawal by Subject|0|||
145758521|NCT03179436|525627686|FG010|Overall Study|Withdrawal by Subject|0|||
145758522|NCT03179436|525627687|FG011|Overall Study|Withdrawal by Subject|0|||
145758523|NCT03179436|525627676|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145758524|NCT03179436|525627677|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145758525|NCT03179436|525627678|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145758526|NCT03179436|525627679|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145758527|NCT03179436|525627680|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145758528|NCT03179436|525627681|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145758529|NCT03179436|525627682|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
145758530|NCT03179436|525627683|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
145758531|NCT03179436|525627684|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
145758532|NCT03179436|525627685|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
145758533|NCT03179436|525627686|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
145758534|NCT03179436|525627687|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
145758535|NCT03179436|525627676|FG000|Overall Study|Sponsor Decision|0|||
145758536|NCT03179436|525627677|FG001|Overall Study|Sponsor Decision|0|||
145758537|NCT03179436|525627678|FG002|Overall Study|Sponsor Decision|1|||
145758538|NCT03179436|525627679|FG003|Overall Study|Sponsor Decision|3|||
145758539|NCT03179436|525627680|FG004|Overall Study|Sponsor Decision|9|||
145758540|NCT03179436|525627681|FG005|Overall Study|Sponsor Decision|7|||
145758541|NCT03179436|525627682|FG006|Overall Study|Sponsor Decision|2|||
145758542|NCT03179436|525627683|FG007|Overall Study|Sponsor Decision|4|||
145758543|NCT03179436|525627684|FG008|Overall Study|Sponsor Decision|23|||
145758544|NCT03179436|525627685|FG009|Overall Study|Sponsor Decision|6|||
145758545|NCT03179436|525627686|FG010|Overall Study|Sponsor Decision|7|||
145758546|NCT03179436|525627687|FG011|Overall Study|Sponsor Decision|5|||
145758547|NCT03179436|525627676|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758548|NCT03179436|525627677|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
145758549|NCT03179436|525627678|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758550|NCT03179436|525627679|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758551|NCT03179436|525627680|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758552|NCT03179436|525627681|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
145758553|NCT03179436|525627682|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758554|NCT03179436|525627683|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758555|NCT03179436|525627684|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758556|NCT03179436|525627685|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758557|NCT03179436|525627686|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758558|NCT03179436|525627687|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
145758559|NCT03179436|525627676|FG000|Overall Study|Lost to Follow-up|1|||
145758560|NCT03179436|525627677|FG001|Overall Study|Lost to Follow-up|0|||
145758561|NCT03179436|525627678|FG002|Overall Study|Lost to Follow-up|0|||
145758562|NCT03179436|525627679|FG003|Overall Study|Lost to Follow-up|1|||
145758563|NCT03179436|525627680|FG004|Overall Study|Lost to Follow-up|0|||
145758564|NCT03179436|525627681|FG005|Overall Study|Lost to Follow-up|1|||
145758565|NCT03179436|525627682|FG006|Overall Study|Lost to Follow-up|0|||
145758566|NCT03179436|525627683|FG007|Overall Study|Lost to Follow-up|0|||
145758567|NCT03179436|525627684|FG008|Overall Study|Lost to Follow-up|1|||
145758568|NCT03179436|525627685|FG009|Overall Study|Lost to Follow-up|1|||
145758569|NCT03179436|525627686|FG010|Overall Study|Lost to Follow-up|0|||
145758570|NCT03179436|525627687|FG011|Overall Study|Lost to Follow-up|0|||
145758571|NCT03179436|525627676|FG000|Overall Study|Death|12|||
145758572|NCT03179436|525627677|FG001|Overall Study|Death|17|||
145758573|NCT03179436|525627678|FG002|Overall Study|Death|7|||
145758574|NCT03179436|525627679|FG003|Overall Study|Death|32|||
145758575|NCT03179436|525627680|FG004|Overall Study|Death|29|||
145758576|NCT03179436|525627681|FG005|Overall Study|Death|30|||
145758577|NCT03179436|525627682|FG006|Overall Study|Death|33|||
145758578|NCT03179436|525627683|FG007|Overall Study|Death|9|||
145758579|NCT03179436|525627684|FG008|Overall Study|Death|84|||
145758580|NCT03179436|525627685|FG009|Overall Study|Death|33|||
145758581|NCT03179436|525627686|FG010|Overall Study|Death|22|||
145273986|NCT05919823|523850970|FG001|Open Label Period|Participant withdrew consent|0|||
145273987|NCT05919823|523850971|FG002|Open Label Period|Participant withdrew consent|8|||
145273988|NCT05919823|523850972|FG003|Open Label Period|Participant withdrew consent|6|||
145273989|NCT05919823|523850969|FG000|Open Label Period|Death|0|||
145273990|NCT05919823|523850970|FG001|Open Label Period|Death|0|||
145273991|NCT05919823|523850971|FG002|Open Label Period|Death|0|||
145273992|NCT05919823|523850972|FG003|Open Label Period|Death|1|||
145273993|NCT05919823|523850969|FG000|Open Label Period|Other reasons|0|||
145273994|NCT05919823|523850970|FG001|Open Label Period|Other reasons|0|||
145273995|NCT05919823|523850971|FG002|Open Label Period|Other reasons|9|||
145273996|NCT05919823|523850972|FG003|Open Label Period|Other reasons|5|||
145273997|NCT06065176|523850973|FG000|Overall Study|Lost to Follow-up|11|||
145273998|NCT06065176|523850974|FG001|Overall Study|Lost to Follow-up|11|||
145758582|NCT03179436|525627687|FG011|Overall Study|Death|15|||
145758583|NCT01634555|525627696|FG000|Overall Study|Adverse Event|3|||
145758584|NCT01634555|525627696|FG000|Overall Study|Physician Decision|1|||
145273999|NCT06065176|523850975|FG002|Overall Study|Lost to Follow-up|10|||
145274000|NCT06065176|523850973|FG000|Overall Study|Withdrawal by Subject|1|||
145402876|NCT02065557|524332549|FG005|Induction Period|Lack of Efficacy|0|||
145274001|NCT06065176|523850974|FG001|Overall Study|Withdrawal by Subject|1|||
145274002|NCT06065176|523850975|FG002|Overall Study|Withdrawal by Subject|2|||
145758585|NCT01738971|525627701|FG000|Overall Study|Lost to Follow-up|19|||
145758586|NCT01738971|525627702|FG001|Overall Study|Lost to Follow-up|30|||
145758587|NCT01738971|525627703|FG002|Overall Study|Lost to Follow-up|17|||
145758588|NCT04698629|525627706|FG000|Overall Study|Adverse Event|1|||
145758589|NCT02949128|525629740|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
145758590|NCT02949128|525629740|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
145758591|NCT02949128|525629740|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
145758592|NCT02949128|525629740|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
145758593|NCT02949128|525629740|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
145758594|NCT02949128|525629740|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
145758595|NCT02949128|525629740|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
145758596|NCT02949128|525629740|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
145758597|NCT02949128|525629740|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
145758598|NCT02949128|525629740|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
145758599|NCT01602341|525629741|FG000|Overall Study|Adverse Event|0|||
145758600|NCT01602341|525629742|FG001|Overall Study|Adverse Event|1|||
145758601|NCT02152345|525629743|FG000|Overall Study|Case Cancellations|2|||
145758602|NCT02152345|525629744|FG001|Overall Study|Case Cancellations|4|||
145758603|NCT02152345|525629743|FG000|Overall Study|Withdrawal by Subject|2|||
145758604|NCT02152345|525629744|FG001|Overall Study|Withdrawal by Subject|1|||
145758605|NCT02554929|525629746|FG000|Overall Study|Lost to Follow-up|4|||
145758606|NCT02554929|525629747|FG001|Overall Study|Lost to Follow-up|4|||
145758607|NCT02554929|525629746|FG000|Overall Study|Withdrawal by Subject|2|||
145758608|NCT02554929|525629747|FG001|Overall Study|Withdrawal by Subject|8|||
145758609|NCT01916980|525629748|FG000|Overall Study|Adverse Event|4|||
145758610|NCT01916980|525629749|FG001|Overall Study|Adverse Event|2|||
145758611|NCT01916980|525629748|FG000|Overall Study|Lack of Efficacy|2|||
145758612|NCT01916980|525629749|FG001|Overall Study|Lack of Efficacy|2|||
145758613|NCT01916980|525629748|FG000|Overall Study|Withdrawal by Subject|1|||
145758614|NCT01916980|525629749|FG001|Overall Study|Withdrawal by Subject|0|||
145758615|NCT03593915|525629752|FG000|Overall Study|Adverse Event|0|||
145758616|NCT03593915|525629753|FG001|Overall Study|Adverse Event|0|||
145758617|NCT03593915|525629754|FG002|Overall Study|Adverse Event|0|||
145758618|NCT03593915|525629755|FG003|Overall Study|Adverse Event|1|||
145758619|NCT03593915|525629756|FG004|Overall Study|Adverse Event|0|||
145758620|NCT03593915|525629757|FG005|Overall Study|Adverse Event|0|||
145758621|NCT03593915|525629752|FG000|Overall Study|Physician Decision|0|||
145758622|NCT03593915|525629753|FG001|Overall Study|Physician Decision|0|||
145758623|NCT03593915|525629754|FG002|Overall Study|Physician Decision|0|||
145758624|NCT03593915|525629755|FG003|Overall Study|Physician Decision|0|||
145758625|NCT03593915|525629756|FG004|Overall Study|Physician Decision|0|||
145758626|NCT03593915|525629757|FG005|Overall Study|Physician Decision|1|||
145758627|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
145758628|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
145758629|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
145758630|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
145758631|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
145758632|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
145758633|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
145758634|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
145758635|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
145758636|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
145758637|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
145758638|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
145758639|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
145758640|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
145758641|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
145758642|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
145758643|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
145758644|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
145758645|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
145758646|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
145758647|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
145758648|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
145758649|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
145758650|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
145758651|NCT04660643|525629758|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
145274003|NCT06065176|523850973|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
145758652|NCT04660643|525629759|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
145758653|NCT04660643|525629760|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
145758654|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
145758655|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
145758656|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
145758657|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
145758658|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
145758659|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
145758660|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
145758661|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
145758662|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
145758663|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
145758664|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
145758665|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
145758666|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
145758667|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
145758668|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
145758669|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
145758670|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
145758671|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
145758672|NCT04660643|525629758|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
145758673|NCT04660643|525629759|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
145758674|NCT04660643|525629760|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
145758675|NCT03988907|525629761|FG000|Overall Study|Unable to complete visit|0|||
145758676|NCT03988907|525629762|FG001|Overall Study|Unable to complete visit|1|||
145758677|NCT03502330|525629768|FG000|Overall Study|Adverse Event|2|||
145758678|NCT03502330|525629769|FG001|Overall Study|Adverse Event|1|||
145758679|NCT03502330|525629770|FG002|Overall Study|Adverse Event|0|||
145758680|NCT03502330|525629771|FG003|Overall Study|Adverse Event|0|||
145758681|NCT03502330|525629772|FG004|Overall Study|Adverse Event|1|||
145758682|NCT03502330|525629773|FG005|Overall Study|Adverse Event|0|||
145758683|NCT03502330|525629774|FG006|Overall Study|Adverse Event|1|||
145758684|NCT03502330|525629775|FG007|Overall Study|Adverse Event|1|||
145758685|NCT03502330|525629776|FG008|Overall Study|Adverse Event|0|||
145758686|NCT03502330|525629768|FG000|Overall Study|Lack of Efficacy|1|||
145758687|NCT03502330|525629769|FG001|Overall Study|Lack of Efficacy|5|||
145758688|NCT03502330|525629770|FG002|Overall Study|Lack of Efficacy|3|||
145758689|NCT03502330|525629771|FG003|Overall Study|Lack of Efficacy|5|||
145758690|NCT03502330|525629772|FG004|Overall Study|Lack of Efficacy|1|||
145758691|NCT03502330|525629773|FG005|Overall Study|Lack of Efficacy|5|||
145758692|NCT03502330|525629774|FG006|Overall Study|Lack of Efficacy|5|||
145758693|NCT03502330|525629775|FG007|Overall Study|Lack of Efficacy|6|||
145758694|NCT03502330|525629776|FG008|Overall Study|Lack of Efficacy|0|||
145758695|NCT03502330|525629768|FG000|Overall Study|Physician Decision|0|||
145758696|NCT03502330|525629769|FG001|Overall Study|Physician Decision|0|||
145758697|NCT03502330|525629770|FG002|Overall Study|Physician Decision|0|||
145758698|NCT03502330|525629771|FG003|Overall Study|Physician Decision|0|||
145758699|NCT03502330|525629772|FG004|Overall Study|Physician Decision|1|||
145758700|NCT03502330|525629773|FG005|Overall Study|Physician Decision|0|||
145758701|NCT03502330|525629774|FG006|Overall Study|Physician Decision|0|||
145758702|NCT03502330|525629775|FG007|Overall Study|Physician Decision|0|||
145758703|NCT03502330|525629776|FG008|Overall Study|Physician Decision|0|||
145758704|NCT03502330|525629768|FG000|Overall Study|Withdrawal by Subject|0|||
145758705|NCT03502330|525629769|FG001|Overall Study|Withdrawal by Subject|0|||
145758706|NCT03502330|525629770|FG002|Overall Study|Withdrawal by Subject|0|||
145758707|NCT03502330|525629771|FG003|Overall Study|Withdrawal by Subject|0|||
145758708|NCT03502330|525629772|FG004|Overall Study|Withdrawal by Subject|0|||
145758709|NCT03502330|525629773|FG005|Overall Study|Withdrawal by Subject|1|||
145402877|NCT02065557|524332544|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145532493|NCT00371826|524811617|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
145532494|NCT00371826|524811618|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
145532495|NCT00371826|524811616|FG000|Core Phase (12 Months)|Administrative problems|1|||
145532496|NCT00371826|524811617|FG001|Core Phase (12 Months)|Administrative problems|0|||
145758710|NCT03502330|525629774|FG006|Overall Study|Withdrawal by Subject|0|||
145758711|NCT03502330|525629775|FG007|Overall Study|Withdrawal by Subject|1|||
145758712|NCT03502330|525629776|FG008|Overall Study|Withdrawal by Subject|0|||
145758713|NCT03502330|525629768|FG000|Overall Study|Death|0|||
145758714|NCT03502330|525629769|FG001|Overall Study|Death|0|||
145758715|NCT03502330|525629770|FG002|Overall Study|Death|0|||
145758716|NCT03502330|525629771|FG003|Overall Study|Death|0|||
145758717|NCT03502330|525629772|FG004|Overall Study|Death|0|||
145758718|NCT03502330|525629773|FG005|Overall Study|Death|0|||
145758719|NCT03502330|525629774|FG006|Overall Study|Death|2|||
145758720|NCT03502330|525629775|FG007|Overall Study|Death|0|||
145758721|NCT03502330|525629776|FG008|Overall Study|Death|0|||
145758722|NCT00066690|525629782|FG000|Overall Study|Adverse Event|145|||
145758723|NCT00066690|525629783|FG001|Overall Study|Adverse Event|58|||
145758724|NCT00066690|525629784|FG002|Overall Study|Adverse Event|126|||
145758725|NCT00066690|525629782|FG000|Overall Study|Death|3|||
145758726|NCT00066690|525629783|FG001|Overall Study|Death|0|||
145758727|NCT00066690|525629784|FG002|Overall Study|Death|2|||
145758728|NCT00066690|525629782|FG000|Overall Study|Lack of Efficacy|114|||
145758729|NCT00066690|525629783|FG001|Overall Study|Lack of Efficacy|110|||
145758730|NCT00066690|525629784|FG002|Overall Study|Lack of Efficacy|76|||
145758731|NCT00066690|525629782|FG000|Overall Study|Lost to Follow-up|40|||
145758732|NCT00066690|525629783|FG001|Overall Study|Lost to Follow-up|21|||
145758733|NCT00066690|525629784|FG002|Overall Study|Lost to Follow-up|29|||
145758734|NCT00066690|525629782|FG000|Overall Study|Withdrawal by Subject|50|||
145758735|NCT00066690|525629783|FG001|Overall Study|Withdrawal by Subject|55|||
145758736|NCT00066690|525629784|FG002|Overall Study|Withdrawal by Subject|49|||
145758737|NCT00066690|525629782|FG000|Overall Study|Treatment Ongoing|246|||
145758738|NCT00066690|525629783|FG001|Overall Study|Treatment Ongoing|278|||
145758739|NCT00066690|525629784|FG002|Overall Study|Treatment Ongoing|282|||
145758740|NCT02939131|525629785|FG000|Overall Study|Unable to get to clinic|6|||
145758741|NCT02939131|525629786|FG001|Overall Study|Unable to get to clinic|4|||
145758742|NCT02939131|525629785|FG000|Overall Study|Lost to Follow-up|2|||
145758743|NCT02939131|525629786|FG001|Overall Study|Lost to Follow-up|4|||
145758744|NCT02939131|525629785|FG000|Overall Study|severe debilitation|1|||
145758745|NCT02939131|525629786|FG001|Overall Study|severe debilitation|0|||
145758746|NCT02939131|525629785|FG000|Overall Study|Other|0|||
145758747|NCT02939131|525629786|FG001|Overall Study|Other|1|||
145758748|NCT02939131|525629785|FG000|Overall Study|not willing to adhere to protocol|2|||
145758749|NCT02939131|525629786|FG001|Overall Study|not willing to adhere to protocol|0|||
145758750|NCT00840827|525629787|FG000|Overall Study|Adverse Event|1|||
145758751|NCT00840827|525629787|FG000|Overall Study|Lack of Efficacy|4|||
145758752|NCT00840827|525629787|FG000|Overall Study|Physician Decision|1|||
145758753|NCT01445535|525629788|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
145758754|NCT01445535|525629789|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
145758755|NCT01445535|525629790|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
145758756|NCT01445535|525629791|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
145758757|NCT01445535|525629788|FG000|Overall Study|Disease progression|1|||
145758758|NCT01445535|525629789|FG001|Overall Study|Disease progression|0|||
145758759|NCT01445535|525629790|FG002|Overall Study|Disease progression|1|||
145758760|NCT01445535|525629791|FG003|Overall Study|Disease progression|0|||
145758761|NCT01445535|525629788|FG000|Overall Study|PI discretion|0|||
145758762|NCT01445535|525629789|FG001|Overall Study|PI discretion|0|||
145758763|NCT01445535|525629790|FG002|Overall Study|PI discretion|0|||
145758764|NCT01445535|525629791|FG003|Overall Study|PI discretion|1|||
145758765|NCT02415712|525629792|FG000|Overall Study|Protocol Violation|16|||
145758766|NCT01668654|525629793|FG000|Overall Study|Study Closed/Terminated|3|||
145758767|NCT01668654|525629793|FG000|Overall Study|Withdrawal by Subject|1|||
145758768|NCT04557384|525629794|FG000|Overall Study|Study Terminated by Sponsor|1|||
145758769|NCT04557384|525629794|FG000|Overall Study|Death|1|||
145758770|NCT04173741|525629796|FG000|Overall Study|IVC measurement cannot be done|1|||
145758771|NCT04173741|525629797|FG001|Overall Study|IVC measurement cannot be done|1|||
145758772|NCT00254566|525629798|FG000|Overall Study|Death|1|||
145758773|NCT00254566|525629799|FG001|Overall Study|Death|0|||
145758774|NCT00254566|525629798|FG000|Overall Study|Adverse Event|5|||
145758775|NCT00254566|525629799|FG001|Overall Study|Adverse Event|4|||
145758776|NCT00254566|525629798|FG000|Overall Study|Lack of Efficacy|12|||
145758777|NCT00254566|525629799|FG001|Overall Study|Lack of Efficacy|9|||
145758778|NCT00254566|525629798|FG000|Overall Study|Other|1|||
145758779|NCT00254566|525629799|FG001|Overall Study|Other|5|||
145758780|NCT00254566|525629798|FG000|Overall Study|Withdrawal by Subject|5|||
145758781|NCT00254566|525629799|FG001|Overall Study|Withdrawal by Subject|6|||
145758782|NCT00254566|525629798|FG000|Overall Study|Lost to Follow-up|7|||
145758783|NCT00254566|525629799|FG001|Overall Study|Lost to Follow-up|2|||
145758784|NCT00059202|525629801|FG000|Overall Study|Withdrawal by Subject|5|||
145758785|NCT00059202|525629802|FG001|Overall Study|Withdrawal by Subject|9|||
145758786|NCT00059202|525629801|FG000|Overall Study|Protocol Violation|1|||
145758787|NCT00059202|525629802|FG001|Overall Study|Protocol Violation|3|||
145758788|NCT00059202|525629801|FG000|Overall Study|drug toxicity|0|||
145758789|NCT00059202|525629802|FG001|Overall Study|drug toxicity|3|||
145758790|NCT00548548|525629805|FG000|Overall Study|Death|345|||
145758791|NCT00548548|525629806|FG001|Overall Study|Death|348|||
145758792|NCT00548548|525629805|FG000|Overall Study|Lost to Follow-up|17|||
145758793|NCT00548548|525629806|FG001|Overall Study|Lost to Follow-up|18|||
145758794|NCT01705691|525629808|FG000|Overall Study|Death|1|||
145758795|NCT01705691|525629809|FG001|Overall Study|Death|2|||
145758796|NCT01705691|525629808|FG000|Overall Study|Withdrawal by Subject|1|||
145758797|NCT01705691|525629809|FG001|Overall Study|Withdrawal by Subject|2|||
145758798|NCT01705691|525629808|FG000|Overall Study|Lost to Follow-up|1|||
145758799|NCT01705691|525629809|FG001|Overall Study|Lost to Follow-up|1|||
145758800|NCT01705691|525629808|FG000|Overall Study|Other|0|||
145758801|NCT01705691|525629809|FG001|Overall Study|Other|1|||
145758802|NCT02658448|525629810|FG000|Overall Study|Lost to Follow-up|1|||
145758803|NCT03106779|525629811|FG000|Overall Study|Lack of Efficacy|33|||
145758804|NCT03106779|525629812|FG001|Overall Study|Lack of Efficacy|24|||
145758805|NCT03106779|525629811|FG000|Overall Study|Adverse Event|8|||
145758806|NCT03106779|525629812|FG001|Overall Study|Adverse Event|16|||
145758807|NCT03106779|525629811|FG000|Overall Study|Physician Decision|10|||
145758808|NCT03106779|525629812|FG001|Overall Study|Physician Decision|6|||
145758809|NCT03106779|525629811|FG000|Overall Study|Patient/guardian decision|4|||
145758810|NCT03106779|525629812|FG001|Overall Study|Patient/guardian decision|3|||
145758811|NCT03106779|525629811|FG000|Overall Study|Progressive disease|1|||
145758812|NCT03106779|525629812|FG001|Overall Study|Progressive disease|3|||
145758813|NCT03106779|525629811|FG000|Overall Study|Lost to Follow-up|1|||
145758814|NCT03106779|525629812|FG001|Overall Study|Lost to Follow-up|2|||
145758815|NCT03106779|525629811|FG000|Overall Study|Death|1|||
145758816|NCT03106779|525629812|FG001|Overall Study|Death|0|||
145758817|NCT03106779|525629811|FG000|Overall Study|Protocol Violation|1|||
145758818|NCT03106779|525629812|FG001|Overall Study|Protocol Violation|0|||
145758819|NCT03106779|525629811|FG000|Overall Study|Not treated|1|||
145758820|NCT03106779|525629812|FG001|Overall Study|Not treated|0|||
145758821|NCT04088409|525629813|FG000|Part A|Withdrawal by Subject|2|||
145758822|NCT04088409|525629814|FG001|Part A|Withdrawal by Subject|1|||
145758823|NCT04088409|525629813|FG000|Part A|Did Not Meet Randomization Criteria|2|||
145758824|NCT04088409|525629814|FG001|Part A|Did Not Meet Randomization Criteria|0|||
145758825|NCT04088409|525629813|FG000|Part A|Lack of Efficacy|9|||
145758826|NCT04088409|525629814|FG001|Part A|Lack of Efficacy|0|||
145758827|NCT04088409|525629813|FG000|Part A|Lost to Follow-up|1|||
145758828|NCT04088409|525629814|FG001|Part A|Lost to Follow-up|0|||
145758829|NCT04088409|525629813|FG000|Part A|Adverse Event|1|||
145758830|NCT04088409|525629814|FG001|Part A|Adverse Event|0|||
145758831|NCT04088409|525629813|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
145758832|NCT04088409|525629814|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
145758833|NCT04088409|525629813|FG000|Part B|Ongoing Treatment|10|||
145758834|NCT04088409|525629814|FG001|Part B|Ongoing Treatment|0|||
145758835|NCT04233229|525629815|FG000|Overall Study|Withdrawal by Subject|0|||
145758836|NCT04233229|525629816|FG001|Overall Study|Withdrawal by Subject|1|||
145758837|NCT04233229|525629815|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
145758838|NCT04233229|525629816|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
145758839|NCT04233229|525629815|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
145758840|NCT04233229|525629816|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
145758841|NCT04652804|525629817|FG000|Overall Study|Ineligible post randomization|1|||
145758842|NCT04652804|525629818|FG001|Overall Study|Ineligible post randomization|0|||
145758843|NCT04652804|525629819|FG002|Overall Study|Ineligible post randomization|1|||
145758844|NCT04652804|525629820|FG003|Overall Study|Ineligible post randomization|0|||
145758845|NCT04652804|525629821|FG004|Overall Study|Ineligible post randomization|1|||
145758846|NCT04652804|525629822|FG005|Overall Study|Ineligible post randomization|1|||
145758847|NCT04652804|525629817|FG000|Overall Study|Missing SVR lab results|2|||
145758848|NCT04652804|525629818|FG001|Overall Study|Missing SVR lab results|0|||
145758849|NCT04652804|525629819|FG002|Overall Study|Missing SVR lab results|0|||
145532497|NCT00371826|524811618|FG002|Core Phase (12 Months)|Administrative problems|8|||
145532498|NCT00371826|524811616|FG000|Core Phase (12 Months)|Graft Loss|0|||
145532499|NCT00371826|524811617|FG001|Core Phase (12 Months)|Graft Loss|1|||
145532500|NCT00371826|524811618|FG002|Core Phase (12 Months)|Graft Loss|0|||
145532501|NCT00371826|524811616|FG000|Extension Phase (24 Months)|Adverse Event|4|||
145532502|NCT00371826|524811617|FG001|Extension Phase (24 Months)|Adverse Event|5|||
145532503|NCT00371826|524811618|FG002|Extension Phase (24 Months)|Adverse Event|0|||
145532504|NCT00371826|524811616|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
145758850|NCT04652804|525629820|FG003|Overall Study|Missing SVR lab results|0|||
145758851|NCT04652804|525629821|FG004|Overall Study|Missing SVR lab results|0|||
145758852|NCT04652804|525629822|FG005|Overall Study|Missing SVR lab results|0|||
145758853|NCT00584194|525629823|FG000|Overall Study|Other|135|||
145758854|NCT04093531|525629824|FG000|Overall Study|failed screening|4|||
145758855|NCT00841763|525629825|FG000|Overall Study|Withdrawal by Subject|60|||
145758856|NCT00841763|525629826|FG001|Overall Study|Withdrawal by Subject|17|||
145758857|NCT00841763|525629827|FG002|Overall Study|Withdrawal by Subject|4|||
145532505|NCT00371826|524811617|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
145532506|NCT00371826|524811618|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
145532507|NCT00371826|524811616|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
145758858|NCT00841763|525629828|FG003|Overall Study|Withdrawal by Subject|1|||
145758859|NCT00841763|525629825|FG000|Overall Study|Adverse Event|9|||
145758860|NCT00841763|525629826|FG001|Overall Study|Adverse Event|10|||
145758861|NCT00841763|525629827|FG002|Overall Study|Adverse Event|3|||
145758862|NCT00841763|525629828|FG003|Overall Study|Adverse Event|2|||
145758863|NCT00841763|525629825|FG000|Overall Study|Lost to Follow-up|63|||
145758864|NCT00841763|525629826|FG001|Overall Study|Lost to Follow-up|25|||
145758865|NCT00841763|525629827|FG002|Overall Study|Lost to Follow-up|0|||
145758866|NCT00841763|525629828|FG003|Overall Study|Lost to Follow-up|0|||
145758867|NCT00841763|525629825|FG000|Overall Study|Protocol Violation|20|||
145758868|NCT00841763|525629826|FG001|Overall Study|Protocol Violation|3|||
145758869|NCT00841763|525629827|FG002|Overall Study|Protocol Violation|1|||
145758870|NCT00841763|525629828|FG003|Overall Study|Protocol Violation|0|||
145758871|NCT00841763|525629825|FG000|Overall Study|Administrative Reasons|3|||
145758872|NCT00841763|525629826|FG001|Overall Study|Administrative Reasons|1|||
145758873|NCT00841763|525629827|FG002|Overall Study|Administrative Reasons|0|||
145758874|NCT00841763|525629828|FG003|Overall Study|Administrative Reasons|0|||
145758875|NCT00841763|525629825|FG000|Overall Study|Unable to Classify|7|||
145758876|NCT00841763|525629826|FG001|Overall Study|Unable to Classify|1|||
145758877|NCT00841763|525629827|FG002|Overall Study|Unable to Classify|0|||
145758878|NCT00841763|525629828|FG003|Overall Study|Unable to Classify|0|||
145758879|NCT00927368|525629831|FG000|Overall Study|enrollment in another study|1|||
145758880|NCT00927368|525629832|FG001|Overall Study|enrollment in another study|1|||
145758881|NCT00927368|525629833|FG002|Overall Study|enrollment in another study|2|||
145758882|NCT00927368|525629831|FG000|Overall Study|Lost to Follow-up|4|||
145758883|NCT00927368|525629832|FG001|Overall Study|Lost to Follow-up|0|||
145758884|NCT00927368|525629833|FG002|Overall Study|Lost to Follow-up|0|||
145758885|NCT00927368|525629831|FG000|Overall Study|equipment failure|1|||
145758886|NCT00927368|525629832|FG001|Overall Study|equipment failure|0|||
145758887|NCT00927368|525629833|FG002|Overall Study|equipment failure|0|||
145758888|NCT00927368|525629831|FG000|Overall Study|ineligible post randomization|0|||
145758889|NCT00927368|525629832|FG001|Overall Study|ineligible post randomization|3|||
145758890|NCT00927368|525629833|FG002|Overall Study|ineligible post randomization|1|||
145758891|NCT00927368|525629831|FG000|Overall Study|cancellation of surgery|0|||
145758892|NCT00927368|525629832|FG001|Overall Study|cancellation of surgery|1|||
145758893|NCT00927368|525629833|FG002|Overall Study|cancellation of surgery|2|||
145758894|NCT00364689|525629834|FG000|Overall Study|Lost to Follow-up|1|||
145758895|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
145758896|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
145758897|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
145758898|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
145758899|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
145274004|NCT06065176|523850974|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
145274005|NCT06065176|523850975|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
145274006|NCT04521608|523850976|FG000|Overall Study|Death|8|||
145274007|NCT04521608|523850977|FG001|Overall Study|Death|9|||
145274008|NCT04521608|523850976|FG000|Overall Study|Withdrawal by Subject|25|||
145274009|NCT04521608|523850977|FG001|Overall Study|Withdrawal by Subject|18|||
145274010|NCT04521608|523850976|FG000|Overall Study|Disease Progression|3|||
145274011|NCT04521608|523850977|FG001|Overall Study|Disease Progression|10|||
145274012|NCT04521608|523850976|FG000|Overall Study|Complicating Disease|6|||
145758900|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
145758901|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
145758902|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
145758903|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
145758904|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
145758905|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
145758906|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
145758907|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
145758908|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
145274013|NCT04521608|523850977|FG001|Overall Study|Complicating Disease|3|||
145274014|NCT04521608|523850976|FG000|Overall Study|Lost Contact|25|||
145532508|NCT00371826|524811617|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
145274015|NCT04521608|523850977|FG001|Overall Study|Lost Contact|27|||
145274016|NCT04521608|523850976|FG000|Overall Study|Ineligible|1|||
145758909|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
145758910|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
145758911|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
145758912|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
145758913|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
145758914|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
145758915|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
145758916|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
145758917|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
145758918|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
145758919|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Death|2|||
145758920|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Death|1|||
145758921|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Death|2|||
145758922|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Graft loss|0|||
145758923|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Graft loss|2|||
145758924|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Graft loss|0|||
145758925|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
145758926|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
145758927|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
145758928|NCT01114529|525629842|FG000|Completed Study Medication at Month 24|Missing|2|||
145758929|NCT01114529|525629843|FG001|Completed Study Medication at Month 24|Missing|0|||
145758930|NCT01114529|525629844|FG002|Completed Study Medication at Month 24|Missing|0|||
145758931|NCT01114529|525629842|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
145758932|NCT01114529|525629843|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
145758933|NCT01114529|525629844|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
145758934|NCT01114529|525629842|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
145758935|NCT01114529|525629843|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
145758936|NCT01114529|525629844|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
145758937|NCT01114529|525629842|FG000|Completed Study Phase at Month 24|Death|8|||
145758938|NCT01114529|525629843|FG001|Completed Study Phase at Month 24|Death|5|||
145758939|NCT01114529|525629844|FG002|Completed Study Phase at Month 24|Death|4|||
145758940|NCT01114529|525629842|FG000|Completed Study Phase at Month 24|Other|2|||
145758941|NCT01114529|525629843|FG001|Completed Study Phase at Month 24|Other|0|||
145758942|NCT01114529|525629844|FG002|Completed Study Phase at Month 24|Other|0|||
145758943|NCT01114529|525629842|FG000|Completed Study Phase at Month 24|Missing|2|||
145758944|NCT01114529|525629843|FG001|Completed Study Phase at Month 24|Missing|0|||
145758945|NCT01114529|525629844|FG002|Completed Study Phase at Month 24|Missing|0|||
145758946|NCT01482910|525629846|FG000|Overall Study|Adverse Event|6|||
145758947|NCT01482910|525629847|FG001|Overall Study|Adverse Event|5|||
145758948|NCT01482910|525629846|FG000|Overall Study|Lost to Follow-up|0|||
145758949|NCT01482910|525629847|FG001|Overall Study|Lost to Follow-up|1|||
145758950|NCT01482910|525629846|FG000|Overall Study|Protocol Violation|1|||
145758951|NCT01482910|525629847|FG001|Overall Study|Protocol Violation|1|||
145758952|NCT01482910|525629846|FG000|Overall Study|Withdrawal by Subject|7|||
145758953|NCT01482910|525629847|FG001|Overall Study|Withdrawal by Subject|2|||
145758954|NCT01482910|525629846|FG000|Overall Study|Death|1|||
145758955|NCT01482910|525629847|FG001|Overall Study|Death|0|||
145758956|NCT00272987|525629848|FG000|Overall Study|Adverse Event|1|||
145758957|NCT00272987|525629849|FG001|Overall Study|Adverse Event|0|||
145758958|NCT00272987|525629850|FG002|Overall Study|Adverse Event|0|||
145532509|NCT00371826|524811618|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
145532510|NCT00371826|524811616|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
145532511|NCT00371826|524811617|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
145532512|NCT00371826|524811618|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
145532513|NCT00371826|524811616|FG000|Extension Phase (24 Months)|Administrative problems|0|||
145758959|NCT00272987|525629848|FG000|Overall Study|Lost to Follow-up|3|||
145758960|NCT00272987|525629849|FG001|Overall Study|Lost to Follow-up|1|||
145758961|NCT00272987|525629850|FG002|Overall Study|Lost to Follow-up|1|||
145758962|NCT00272987|525629848|FG000|Overall Study|Withdrawal by Subject|1|||
145758963|NCT00272987|525629849|FG001|Overall Study|Withdrawal by Subject|0|||
145758964|NCT00272987|525629850|FG002|Overall Study|Withdrawal by Subject|3|||
145758965|NCT00272987|525629848|FG000|Overall Study|Sponsor Terminated study|0|||
145758966|NCT00272987|525629849|FG001|Overall Study|Sponsor Terminated study|1|||
145758967|NCT00272987|525629850|FG002|Overall Study|Sponsor Terminated study|1|||
145758968|NCT00272987|525629848|FG000|Overall Study|Disease progression|1|||
145758969|NCT00272987|525629849|FG001|Overall Study|Disease progression|1|||
145758970|NCT00272987|525629850|FG002|Overall Study|Disease progression|2|||
145758971|NCT00272987|525629848|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
145758972|NCT00272987|525629849|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
145758973|NCT00272987|525629850|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
145758974|NCT00272987|525629848|FG000|Overall Study|Death|1|||
145758975|NCT00272987|525629849|FG001|Overall Study|Death|0|||
145758976|NCT00272987|525629850|FG002|Overall Study|Death|0|||
145758977|NCT00331409|525629851|FG000|Overall Study|Lack of Efficacy|4|||
145758978|NCT03222349|525629854|FG000|Overall Study|Treatment B not done|5|||
145758979|NCT03222349|525629855|FG001|Overall Study|Treatment B not done|0|||
145758980|NCT03222349|525629854|FG000|Overall Study|Lost to Follow-up|1|||
145758981|NCT03222349|525629855|FG001|Overall Study|Lost to Follow-up|2|||
145758982|NCT03222349|525629854|FG000|Overall Study|Withdrawal by Subject|1|||
145758983|NCT03222349|525629855|FG001|Overall Study|Withdrawal by Subject|0|||
145758984|NCT03222349|525629854|FG000|Overall Study|Treatment A not done|0|||
145758985|NCT03222349|525629855|FG001|Overall Study|Treatment A not done|5|||
145758986|NCT03222349|525629854|FG000|Overall Study|Study terminated by sponsor|1|||
145758987|NCT03222349|525629855|FG001|Overall Study|Study terminated by sponsor|0|||
145758988|NCT02614079|525629856|FG000|Overall Study|Withdrawal by Subject|1|||
145758989|NCT03072160|525629859|FG000|Overall Study|Adverse Event|3|||
145758990|NCT03072160|525629860|FG001|Overall Study|Adverse Event|1|||
145758991|NCT03072160|525629859|FG000|Overall Study|Refused further treatment|6|||
145758992|NCT03072160|525629860|FG001|Overall Study|Refused further treatment|1|||
145758993|NCT03072160|525629859|FG000|Overall Study|Physician Decision|1|||
145758994|NCT03072160|525629860|FG001|Overall Study|Physician Decision|0|||
145758995|NCT03072160|525629859|FG000|Overall Study|Disease progression on study|1|||
145758996|NCT03072160|525629860|FG001|Overall Study|Disease progression on study|1|||
145758997|NCT03072160|525629859|FG000|Overall Study|No contact|0|||
145758998|NCT03072160|525629860|FG001|Overall Study|No contact|1|||
145532514|NCT00371826|524811617|FG001|Extension Phase (24 Months)|Administrative problems|0|||
145758999|NCT01214044|525629861|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
145759000|NCT01214044|525629861|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
145759001|NCT01214044|525629861|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
145759002|NCT01214044|525629861|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
145759003|NCT01214044|525629861|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
145759004|NCT01214044|525629861|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
145759005|NCT00408694|525629862|FG000|Overall Study|Ineligible|1|||
145759006|NCT00408694|525629862|FG000|Overall Study|No protocol treatment|1|||
145759007|NCT01890421|525629863|FG000|Overall Study|Adverse Event|1|||
145759008|NCT01890421|525629863|FG000|Overall Study|Other reason|10|||
145759009|NCT02526550|525629865|FG000|Overall Study|Lost to Follow-up|1|||
145759010|NCT03969888|525629866|FG000|Overall Study|Never Received Study Drug|0|||
145759011|NCT03969888|525629867|FG001|Overall Study|Never Received Study Drug|0|||
145759012|NCT03969888|525629868|FG002|Overall Study|Never Received Study Drug|1|||
145759013|NCT03969888|525629869|FG003|Overall Study|Never Received Study Drug|0|||
145759014|NCT03969888|525629870|FG004|Overall Study|Never Received Study Drug|0|||
145532515|NCT00371826|524811618|FG002|Extension Phase (24 Months)|Administrative problems|2|||
145532516|NCT00428792|524811619|FG000|Overall Study|Lack of Efficacy|1|||
145532517|NCT00428792|524811620|FG001|Overall Study|Lack of Efficacy|3|||
145759015|NCT03969888|525629871|FG005|Overall Study|Never Received Study Drug|0|||
145759016|NCT03969888|525629872|FG006|Overall Study|Never Received Study Drug|1|||
145532518|NCT00428792|524811619|FG000|Overall Study|Lost to Follow-up|0|||
145532519|NCT00428792|524811620|FG001|Overall Study|Lost to Follow-up|1|||
145759017|NCT03969888|525629873|FG007|Overall Study|Never Received Study Drug|0|||
145759018|NCT03969888|525629866|FG000|Overall Study|Reason Not Specified|0|||
145759019|NCT03969888|525629867|FG001|Overall Study|Reason Not Specified|0|||
145759020|NCT03969888|525629868|FG002|Overall Study|Reason Not Specified|0|||
145759021|NCT03969888|525629869|FG003|Overall Study|Reason Not Specified|0|||
145759022|NCT03969888|525629870|FG004|Overall Study|Reason Not Specified|0|||
145759023|NCT03969888|525629871|FG005|Overall Study|Reason Not Specified|0|||
145759024|NCT03969888|525629872|FG006|Overall Study|Reason Not Specified|0|||
145759025|NCT03969888|525629873|FG007|Overall Study|Reason Not Specified|1|||
145759026|NCT00091832|525629877|FG000|Overall Study|Physician Decision|1|||
145759027|NCT00091832|525629878|FG001|Overall Study|Physician Decision|0|||
145759028|NCT00091832|525629879|FG002|Overall Study|Physician Decision|0|||
145759029|NCT00091832|525629880|FG003|Overall Study|Physician Decision|0|||
145759030|NCT00091832|525629881|FG004|Overall Study|Physician Decision|0|||
145759031|NCT00091832|525629882|FG005|Overall Study|Physician Decision|0|||
145759032|NCT00091832|525629877|FG000|Overall Study|Adverse Event|0|||
145759033|NCT00091832|525629878|FG001|Overall Study|Adverse Event|0|||
145759034|NCT00091832|525629879|FG002|Overall Study|Adverse Event|0|||
145759035|NCT00091832|525629880|FG003|Overall Study|Adverse Event|1|||
145759036|NCT00091832|525629881|FG004|Overall Study|Adverse Event|3|||
145759037|NCT00091832|525629882|FG005|Overall Study|Adverse Event|0|||
145759038|NCT00091832|525629877|FG000|Overall Study|Withdrawal by Subject|4|||
145759039|NCT00091832|525629878|FG001|Overall Study|Withdrawal by Subject|5|||
145759040|NCT00091832|525629879|FG002|Overall Study|Withdrawal by Subject|0|||
145759041|NCT00091832|525629880|FG003|Overall Study|Withdrawal by Subject|1|||
145759042|NCT00091832|525629881|FG004|Overall Study|Withdrawal by Subject|3|||
145759043|NCT00091832|525629882|FG005|Overall Study|Withdrawal by Subject|1|||
145759044|NCT00091832|525629877|FG000|Overall Study|Death|6|||
145274017|NCT04521608|523850977|FG001|Overall Study|Ineligible|0|||
145759045|NCT00091832|525629878|FG001|Overall Study|Death|4|||
145759046|NCT00091832|525629879|FG002|Overall Study|Death|5|||
145759047|NCT00091832|525629880|FG003|Overall Study|Death|8|||
145759048|NCT00091832|525629881|FG004|Overall Study|Death|5|||
145274018|NCT04521608|523850976|FG000|Overall Study|Refused Further Study Participation|13|||
145274019|NCT04521608|523850977|FG001|Overall Study|Refused Further Study Participation|7|||
145274020|NCT02588651|523850978|FG000|Overall Study|Adverse Event|1|||
145274021|NCT02588651|523850978|FG000|Overall Study|Withdrawal by Subject|2|||
145274022|NCT02588651|523850978|FG000|Overall Study|Death|1|||
145274023|NCT02588651|523850978|FG000|Overall Study|Lack of Efficacy|13|||
145274024|NCT02588651|523850978|FG000|Overall Study|Lost to Follow-up|1|||
145274025|NCT02588651|523850978|FG000|Overall Study|Physician Decision|1|||
145532520|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Death|1|||
145759049|NCT00091832|525629882|FG005|Overall Study|Death|6|||
145759050|NCT00091832|525629877|FG000|Overall Study|Disease Progression|2|||
145759051|NCT00091832|525629878|FG001|Overall Study|Disease Progression|0|||
145759052|NCT00091832|525629879|FG002|Overall Study|Disease Progression|0|||
145759053|NCT00091832|525629880|FG003|Overall Study|Disease Progression|1|||
145759054|NCT00091832|525629881|FG004|Overall Study|Disease Progression|1|||
145759055|NCT00091832|525629882|FG005|Overall Study|Disease Progression|2|||
145759056|NCT00091832|525629877|FG000|Overall Study|Ineligibility Determined|0|||
145759057|NCT00091832|525629878|FG001|Overall Study|Ineligibility Determined|0|||
145759058|NCT00091832|525629879|FG002|Overall Study|Ineligibility Determined|1|||
145759059|NCT00091832|525629880|FG003|Overall Study|Ineligibility Determined|0|||
145759060|NCT00091832|525629881|FG004|Overall Study|Ineligibility Determined|1|||
145759061|NCT00091832|525629882|FG005|Overall Study|Ineligibility Determined|0|||
145759062|NCT00091832|525629877|FG000|Overall Study|Lost to Follow-up|1|||
145759063|NCT00091832|525629878|FG001|Overall Study|Lost to Follow-up|0|||
145759064|NCT00091832|525629879|FG002|Overall Study|Lost to Follow-up|3|||
145759065|NCT00091832|525629880|FG003|Overall Study|Lost to Follow-up|3|||
145759066|NCT00091832|525629881|FG004|Overall Study|Lost to Follow-up|2|||
145759067|NCT00091832|525629882|FG005|Overall Study|Lost to Follow-up|1|||
145759068|NCT00091832|525629877|FG000|Overall Study|Noncompliance|0|||
145759069|NCT00091832|525629878|FG001|Overall Study|Noncompliance|1|||
145759070|NCT00091832|525629879|FG002|Overall Study|Noncompliance|0|||
145759071|NCT00091832|525629880|FG003|Overall Study|Noncompliance|0|||
145759072|NCT00091832|525629881|FG004|Overall Study|Noncompliance|0|||
145759073|NCT00091832|525629882|FG005|Overall Study|Noncompliance|0|||
145759074|NCT00091832|525629877|FG000|Overall Study|Other|0|||
145759075|NCT00091832|525629878|FG001|Overall Study|Other|1|||
145759076|NCT00091832|525629879|FG002|Overall Study|Other|2|||
145759077|NCT00091832|525629880|FG003|Overall Study|Other|0|||
145759078|NCT00091832|525629881|FG004|Overall Study|Other|0|||
145274026|NCT02588651|523850978|FG000|Overall Study|Disease progression|2|||
145274027|NCT04083378|523850981|FG000|Overall Study|Death|18|||
145532521|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Death|1|||
145532522|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Death|0|||
145532523|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Death|0|||
145532524|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
145532525|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
145532526|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
145532527|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
145274028|NCT04083378|523850982|FG001|Overall Study|Death|4|||
145274029|NCT04083378|523850981|FG000|Overall Study|Lost to Follow-up|4|||
145274030|NCT04083378|523850982|FG001|Overall Study|Lost to Follow-up|0|||
145759079|NCT00091832|525629882|FG005|Overall Study|Other|0|||
145759080|NCT00091832|525629877|FG000|Overall Study|Protocol Violation|0|||
145759081|NCT00091832|525629878|FG001|Overall Study|Protocol Violation|0|||
145759082|NCT00091832|525629879|FG002|Overall Study|Protocol Violation|1|||
145759083|NCT00091832|525629880|FG003|Overall Study|Protocol Violation|0|||
145759084|NCT00091832|525629881|FG004|Overall Study|Protocol Violation|0|||
145759085|NCT00091832|525629882|FG005|Overall Study|Protocol Violation|1|||
145759086|NCT01557166|525629890|FG000|Overall Study|Adverse Event|20|||
145759087|NCT01557166|525629891|FG001|Overall Study|Adverse Event|6|||
145759088|NCT01557166|525629890|FG000|Overall Study|Lack of Efficacy|2|||
145759089|NCT01557166|525629891|FG001|Overall Study|Lack of Efficacy|1|||
145759090|NCT01557166|525629890|FG000|Overall Study|Protocol Violation|8|||
145759091|NCT01557166|525629891|FG001|Overall Study|Protocol Violation|5|||
145759092|NCT01557166|525629890|FG000|Overall Study|Withdrawn consent|12|||
145759093|NCT01557166|525629891|FG001|Overall Study|Withdrawn consent|20|||
145759094|NCT01557166|525629890|FG000|Overall Study|Target dose not tolerated|1|||
145759095|NCT01557166|525629891|FG001|Overall Study|Target dose not tolerated|0|||
145759096|NCT01557166|525629890|FG000|Overall Study|Psychiatric disorder|1|||
145759097|NCT01557166|525629891|FG001|Overall Study|Psychiatric disorder|0|||
145759098|NCT01557166|525629890|FG000|Overall Study|Unclassified|2|||
145759099|NCT01557166|525629891|FG001|Overall Study|Unclassified|5|||
145759100|NCT00946309|525629892|FG000|Overall Study|Protocol Violation|1|||
145759101|NCT00946309|525629893|FG001|Overall Study|Protocol Violation|0|||
145759102|NCT00946309|525629892|FG000|Overall Study|Lost to Follow-up|0|||
145759103|NCT00946309|525629893|FG001|Overall Study|Lost to Follow-up|1|||
145759104|NCT00946309|525629892|FG000|Overall Study|Procedure cancelled/discontinued|0|||
145759105|NCT00946309|525629893|FG001|Overall Study|Procedure cancelled/discontinued|3|||
145759106|NCT01465659|525629895|FG000|Completed 1 Cycle of Treatment|Death|0|||
145759107|NCT01465659|525629896|FG001|Completed 1 Cycle of Treatment|Death|1|||
145759108|NCT01465659|525629897|FG002|Completed 1 Cycle of Treatment|Death|0|||
145759109|NCT01465659|525629898|FG003|Completed 1 Cycle of Treatment|Death|0|||
145759110|NCT01465659|525629895|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
145759111|NCT01465659|525629896|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
145759112|NCT01465659|525629897|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
145759113|NCT01465659|525629898|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
145759114|NCT01465659|525629895|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
145759115|NCT01465659|525629896|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
145759116|NCT01465659|525629897|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
145759117|NCT01465659|525629898|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
145759118|NCT01465659|525629895|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
145759119|NCT01465659|525629896|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
145759120|NCT01465659|525629897|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
145759121|NCT01465659|525629898|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
145759122|NCT01465659|525629895|FG000|Completed Follow for 1 Year|Death|6|||
145759123|NCT01465659|525629896|FG001|Completed Follow for 1 Year|Death|3|||
145759124|NCT01465659|525629897|FG002|Completed Follow for 1 Year|Death|2|||
145759125|NCT01465659|525629898|FG003|Completed Follow for 1 Year|Death|4|||
145759126|NCT02445586|525629902|FG000|Overall Study|Death|14|||
145759127|NCT02445586|525629902|FG000|Overall Study|Withdrawal by Subject|13|||
145759128|NCT02445586|525629902|FG000|Overall Study|Disease Progression|10|||
145759129|NCT02445586|525629902|FG000|Overall Study|Protocol Violation|1|||
145759130|NCT02445586|525629902|FG000|Overall Study|Medical Condition|1|||
145759131|NCT00428597|525629903|FG000|Overall Study|Randomized but not treated|3|||
145759132|NCT00428597|525629904|FG001|Overall Study|Randomized but not treated|3|||
145759133|NCT00428597|525629903|FG000|Overall Study|Objective Progression or Relapse|19|||
145759134|NCT00428597|525629904|FG001|Overall Study|Objective Progression or Relapse|47|||
145759135|NCT00428597|525629903|FG000|Overall Study|Study Terminated by Sponsor|41|||
145759136|NCT00428597|525629904|FG001|Overall Study|Study Terminated by Sponsor|16|||
145759137|NCT00428597|525629903|FG000|Overall Study|Adverse Event|15|||
145759138|NCT00428597|525629904|FG001|Overall Study|Adverse Event|7|||
145759139|NCT00428597|525629903|FG000|Overall Study|Global Deterioration of Health Status|1|||
145759140|NCT00428597|525629904|FG001|Overall Study|Global Deterioration of Health Status|5|||
145759141|NCT00428597|525629903|FG000|Overall Study|Protocol Violation|2|||
145759142|NCT00428597|525629904|FG001|Overall Study|Protocol Violation|1|||
145759143|NCT00428597|525629903|FG000|Overall Study|Withdrawal by Subject|2|||
145759144|NCT00428597|525629904|FG001|Overall Study|Withdrawal by Subject|1|||
145759145|NCT00428597|525629903|FG000|Overall Study|Other|1|||
145759146|NCT00428597|525629904|FG001|Overall Study|Other|1|||
145759147|NCT00428597|525629903|FG000|Overall Study|Lost to Follow-up|0|||
145759148|NCT00428597|525629904|FG001|Overall Study|Lost to Follow-up|1|||
145759149|NCT00428597|525629903|FG000|Overall Study|Pregnancy|1|||
145759150|NCT00428597|525629904|FG001|Overall Study|Pregnancy|0|||
145759151|NCT00428597|525629903|FG000|Overall Study|Death|1|||
145759152|NCT00428597|525629904|FG001|Overall Study|Death|3|||
145759153|NCT00769119|525629910|FG000|Overall Study|Voluntary discontinuation|0|||
145759154|NCT00769119|525629911|FG001|Overall Study|Voluntary discontinuation|2|||
145759155|NCT00769119|525629910|FG000|Overall Study|Adverse Event|1|||
145759156|NCT00769119|525629911|FG001|Overall Study|Adverse Event|1|||
145759157|NCT00769119|525629910|FG000|Overall Study|Disallowed medication|1|||
145759158|NCT00769119|525629911|FG001|Overall Study|Disallowed medication|0|||
145759159|NCT00686647|525629912|FG000|Overall Study|Lost to Follow-up|1|||
145759160|NCT00686647|525629912|FG000|Overall Study|Death|1|||
145759161|NCT01116544|525629913|FG000|Overall Study|Protocol Violation|1|||
145759162|NCT01116544|525629914|FG001|Overall Study|Protocol Violation|0|||
145759163|NCT01116544|525629913|FG000|Overall Study|Withdrawal by Subject|1|||
145759164|NCT01116544|525629914|FG001|Overall Study|Withdrawal by Subject|1|||
145759165|NCT00578643|525629915|FG000|Overall Study|Death|1|||
145759166|NCT00578643|525629915|FG000|Overall Study|Lost to Follow-up|1|||
145759167|NCT01725750|525629916|FG000|Overall Study|Adverse Event|1|||
145759168|NCT01725750|525629917|FG001|Overall Study|Adverse Event|0|||
145759169|NCT01725750|525629916|FG000|Overall Study|Lost to Follow-up|1|||
145759170|NCT01725750|525629917|FG001|Overall Study|Lost to Follow-up|1|||
145759171|NCT01725750|525629916|FG000|Overall Study|Withdrawal by Subject|0|||
145759172|NCT01725750|525629917|FG001|Overall Study|Withdrawal by Subject|9|||
145759173|NCT01990261|525629924|FG000|Overall Study|Death Before Treatment Start|2|||
145759174|NCT01990261|525629924|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
145759175|NCT01990261|525629924|FG000|Overall Study|Death From other Causes|1|||
145759176|NCT01990261|525629924|FG000|Overall Study|Disease Progression (PD)|8|||
145759177|NCT01990261|525629924|FG000|Overall Study|PD Before Treatment Start|1|||
145759178|NCT01990261|525629924|FG000|Overall Study|Dossier not Approved|1|||
145759179|NCT01990261|525629924|FG000|Overall Study|Lost to Follow-up|2|||
145759180|NCT02887521|525629925|FG000|Overall Study|Withdrawal by Subject|0|||
145759181|NCT02887521|525629926|FG001|Overall Study|Withdrawal by Subject|3|||
145759182|NCT02447848|525629927|FG000|Overall Study|Patient discharged|3|||
145759183|NCT02447848|525629927|FG000|Overall Study|Lack of Efficacy|4|||
145759184|NCT02447848|525629927|FG000|Overall Study|Withdrawal by Subject|4|||
145759185|NCT02307370|525629928|FG000|Overall Study|Death|5|||
145759186|NCT02307370|525629928|FG000|Overall Study|Lost to Follow-up|1|||
145759187|NCT02307370|525629928|FG000|Overall Study|Withdrawal by Subject|1|||
145759188|NCT02307370|525629928|FG000|Overall Study|Declined Addendum ICF|6|||
145759189|NCT02307370|525629928|FG000|Overall Study|No response during telephone contact|5|||
145759190|NCT02307370|525629928|FG000|Overall Study|Protocol Violation|1|||
145759191|NCT05888103|525631989|FG000|Overall Study|Participant decision|3|||
145759192|NCT05888103|525631990|FG001|Overall Study|Participant decision|3|||
145759193|NCT05900115|525631991|FG000|Overall Study|Lost to Follow-up|129|||
145759194|NCT05900115|525631992|FG001|Overall Study|Lost to Follow-up|98|||
145759195|NCT00388947|525631994|FG000|Overall Study|Protocol Violation|47|||
145759196|NCT04187092|525631995|FG000|Overall Study|Lost to Follow-up|1|||
145759197|NCT04187092|525631996|FG001|Overall Study|Lost to Follow-up|1|||
145759198|NCT04187092|525631995|FG000|Overall Study|Withdrawal by Subject|1|||
145759199|NCT04187092|525631996|FG001|Overall Study|Withdrawal by Subject|1|||
145759200|NCT04187092|525631995|FG000|Overall Study|Adverse Event|0|||
145759201|NCT04187092|525631996|FG001|Overall Study|Adverse Event|1|||
145759202|NCT00483327|525632006|FG000|Overall Study|Adverse Event|1|||
145759203|NCT00483327|525632006|FG000|Overall Study|Withdrawal by Subject|3|||
145759204|NCT00483327|525632006|FG000|Overall Study|Lost to Follow-up|4|||
145759205|NCT00483327|525632006|FG000|Overall Study|Patient Non Compliance|2|||
145759206|NCT00618722|525632007|FG000|Overall Study|Refusal of Treatment|0|||
145759207|NCT00618722|525632008|FG001|Overall Study|Refusal of Treatment|0|||
145759208|NCT00618722|525632009|FG002|Overall Study|Refusal of Treatment|1|||
145759209|NCT00618722|525632010|FG003|Overall Study|Refusal of Treatment|0|||
145759210|NCT00618722|525632007|FG000|Overall Study|Patient Request|1|||
145759211|NCT00618722|525632008|FG001|Overall Study|Patient Request|1|||
145759212|NCT00618722|525632009|FG002|Overall Study|Patient Request|1|||
145759213|NCT00618722|525632010|FG003|Overall Study|Patient Request|1|||
145759214|NCT00618722|525632007|FG000|Overall Study|Inability to Complete Study Procedure|0|||
145759215|NCT00618722|525632008|FG001|Overall Study|Inability to Complete Study Procedure|1|||
145759216|NCT00618722|525632009|FG002|Overall Study|Inability to Complete Study Procedure|0|||
145759217|NCT00618722|525632010|FG003|Overall Study|Inability to Complete Study Procedure|0|||
145759218|NCT00618722|525632007|FG000|Overall Study|Lost to Follow-up|2|||
145759219|NCT00618722|525632008|FG001|Overall Study|Lost to Follow-up|0|||
145759220|NCT00618722|525632009|FG002|Overall Study|Lost to Follow-up|0|||
145759221|NCT00618722|525632010|FG003|Overall Study|Lost to Follow-up|2|||
145759222|NCT00618722|525632007|FG000|Overall Study|Miscellaneous Reasons|0|||
145759223|NCT00618722|525632008|FG001|Overall Study|Miscellaneous Reasons|0|||
145759224|NCT00618722|525632009|FG002|Overall Study|Miscellaneous Reasons|1|||
145759225|NCT00618722|525632010|FG003|Overall Study|Miscellaneous Reasons|1|||
145759226|NCT00200057|525632011|FG000|Overall Study|Lack of Efficacy|3|||
145759227|NCT00200057|525632011|FG000|Overall Study|Exited due to terminal illness of PI|2|||
145759228|NCT00200057|525632011|FG000|Overall Study|Withdrawal by Subject|1|||
145759229|NCT00200057|525632011|FG000|Overall Study|Change in medical condition|1|||
145759230|NCT00200057|525632011|FG000|Overall Study|Infection|1|||
145759231|NCT00200057|525632011|FG000|Overall Study|Death|1|||
145759232|NCT05512949|525632012|FG000|Overall Study|Lost to Follow-up|4|||
145759233|NCT05512949|525632013|FG001|Overall Study|Lost to Follow-up|6|||
145759234|NCT05512949|525632014|FG002|Overall Study|Lost to Follow-up|2|||
145759235|NCT05512949|525632012|FG000|Overall Study|Protocol Violation|0|||
145759236|NCT05512949|525632013|FG001|Overall Study|Protocol Violation|0|||
145759237|NCT05512949|525632014|FG002|Overall Study|Protocol Violation|1|||
145759238|NCT05512949|525632012|FG000|Overall Study|Withdrawal by Subject|1|||
145759239|NCT05512949|525632013|FG001|Overall Study|Withdrawal by Subject|1|||
145759240|NCT05512949|525632014|FG002|Overall Study|Withdrawal by Subject|2|||
145759241|NCT05512949|525632012|FG000|Overall Study|Completion status unknown|1|||
145759242|NCT05512949|525632013|FG001|Overall Study|Completion status unknown|3|||
145759243|NCT05512949|525632014|FG002|Overall Study|Completion status unknown|0|||
145759244|NCT02810964|525632015|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
145759245|NCT02810964|525632016|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
145759246|NCT02810964|525632015|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
145759247|NCT02810964|525632016|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
145759248|NCT02810964|525632015|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
145759249|NCT02810964|525632016|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
145759250|NCT02810964|525632015|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
145759251|NCT02810964|525632016|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
145759252|NCT03523351|525632017|FG000|Overall Study|Death|13|||
145759253|NCT03523351|525632018|FG001|Overall Study|Death|11|||
145759254|NCT03523351|525632017|FG000|Overall Study|Lost to Follow-up|2|||
145759255|NCT03523351|525632018|FG001|Overall Study|Lost to Follow-up|3|||
145759256|NCT03523351|525632017|FG000|Overall Study|Withdrawal by Subject|4|||
145759257|NCT03523351|525632018|FG001|Overall Study|Withdrawal by Subject|0|||
145759258|NCT03523351|525632017|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
145759259|NCT03523351|525632018|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
145759260|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
145759261|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
145532528|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
145532529|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
145532530|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
145532531|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
145532532|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
145532533|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
145532534|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
145532535|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
145532536|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
145532537|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
145532538|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
145532539|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
145759262|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
145759263|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145759264|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145759265|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145759266|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145759267|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145759268|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
145759269|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
145759270|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
145759271|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145759272|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145759273|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145759274|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145759275|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145759276|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
145759277|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
145759278|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
145759279|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145759280|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145759281|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145759282|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145759283|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145759284|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
145759285|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
145759286|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
145759287|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145759288|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145759289|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145759290|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145759291|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145759292|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
145759293|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
145759294|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
145759295|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145759296|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145759297|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145759298|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145759299|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145759300|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
145759301|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
145759302|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759303|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759304|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759305|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759306|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759307|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145759308|NCT01097629|525632022|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
145759309|NCT01097629|525632023|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
145759310|NCT01097629|525632024|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
145759311|NCT01097629|525632025|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145759312|NCT01097629|525632026|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145759313|NCT01097629|525632027|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145759314|NCT01097629|525632028|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145759315|NCT01097629|525632029|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145532540|NCT04612790|524811626|FG000|DB Period (Up to 36 Weeks)|Other|1|||
145402878|NCT02065557|524332545|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145532541|NCT04612790|524811627|FG001|DB Period (Up to 36 Weeks)|Other|0|||
145532542|NCT04612790|524811628|FG002|DB Period (Up to 36 Weeks)|Other|0|||
145759316|NCT01097629|525632022|FG000|DB RO Phase|Withdrawal by Subject|0|||
145759317|NCT01097629|525632023|FG001|DB RO Phase|Withdrawal by Subject|0|||
145759318|NCT01097629|525632024|FG002|DB RO Phase|Withdrawal by Subject|0|||
145759319|NCT01097629|525632025|FG003|DB RO Phase|Withdrawal by Subject|0|||
145759320|NCT01097629|525632026|FG004|DB RO Phase|Withdrawal by Subject|0|||
145759321|NCT01097629|525632027|FG005|DB RO Phase|Withdrawal by Subject|0|||
145759322|NCT01097629|525632028|FG006|DB RO Phase|Withdrawal by Subject|0|||
145759323|NCT01097629|525632029|FG007|DB RO Phase|Withdrawal by Subject|1|||
145759324|NCT01097629|525632022|FG000|DB RO Phase|Protocol Violation|0|||
145759325|NCT01097629|525632023|FG001|DB RO Phase|Protocol Violation|0|||
145759326|NCT01097629|525632024|FG002|DB RO Phase|Protocol Violation|0|||
145759327|NCT01097629|525632025|FG003|DB RO Phase|Protocol Violation|1|||
145759328|NCT01097629|525632026|FG004|DB RO Phase|Protocol Violation|0|||
145759329|NCT01097629|525632027|FG005|DB RO Phase|Protocol Violation|1|||
145759330|NCT01097629|525632028|FG006|DB RO Phase|Protocol Violation|1|||
145759331|NCT01097629|525632029|FG007|DB RO Phase|Protocol Violation|0|||
145759332|NCT01097629|525632022|FG000|DB RO Phase|Lost to Follow-up|0|||
145759333|NCT01097629|525632023|FG001|DB RO Phase|Lost to Follow-up|0|||
145759334|NCT01097629|525632024|FG002|DB RO Phase|Lost to Follow-up|0|||
145759335|NCT01097629|525632025|FG003|DB RO Phase|Lost to Follow-up|0|||
145759336|NCT01097629|525632026|FG004|DB RO Phase|Lost to Follow-up|0|||
145759337|NCT01097629|525632027|FG005|DB RO Phase|Lost to Follow-up|0|||
145759338|NCT01097629|525632028|FG006|DB RO Phase|Lost to Follow-up|2|||
145759339|NCT01097629|525632029|FG007|DB RO Phase|Lost to Follow-up|0|||
145759340|NCT00132041|525632032|FG000|Baseline|Ineligible|6|||
145759341|NCT00132041|525632032|FG000|3 Months Post Ablation|Transplant|1|||
145759342|NCT00132041|525632032|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
145759343|NCT00132041|525632032|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
145759344|NCT00132041|525632032|FG000|6 Months Post Ablation|Death|2|||
145759345|NCT00132041|525632032|FG000|6 Months Post Ablation|Transplant|6|||
145759346|NCT00132041|525632032|FG000|9 Months Post Ablation|Death|1|||
145759347|NCT00132041|525632032|FG000|9 Months Post Ablation|Transplant|1|||
145759348|NCT00132041|525632032|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
145759349|NCT00132041|525632032|FG000|12 Months Post Ablation|Death|1|||
145759350|NCT00132041|525632032|FG000|12 Months Post Ablation|Transplant|1|||
145759351|NCT00132041|525632032|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
145759352|NCT00132041|525632032|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
145759353|NCT00132041|525632032|FG000|15 Months Post Ablation|Death|1|||
145759354|NCT00132041|525632032|FG000|15 Months Post Ablation|Transplant|5|||
145759355|NCT00132041|525632032|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
145759356|NCT00132041|525632032|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
145759357|NCT00132041|525632032|FG000|18 Months Post Ablation|Transplant|1|||
145759358|NCT00132041|525632032|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
145759359|NCT00132041|525632032|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
145759360|NCT05162066|525632033|FG000|Overall Study|Adverse Event|1|||
145759361|NCT05162066|525632034|FG001|Overall Study|Adverse Event|0|||
145759362|NCT05162066|525632035|FG002|Overall Study|Adverse Event|0|||
145759363|NCT05162066|525632033|FG000|Overall Study|Perceived lack of efficacy|1|||
145607614|NCT03682705|525079208|FG003|Overall Study|Other, not specified|1|||
145607615|NCT03682705|525079209|FG004|Overall Study|Other, not specified|2|||
145759364|NCT05162066|525632034|FG001|Overall Study|Perceived lack of efficacy|0|||
145759365|NCT05162066|525632035|FG002|Overall Study|Perceived lack of efficacy|0|||
145759366|NCT01171820|525632036|FG000|Overall Study|Death|3|||
145759367|NCT01171820|525632037|FG001|Overall Study|Death|3|||
145759368|NCT01171820|525632036|FG000|Overall Study|Lost to Follow-up|0|||
145759369|NCT01171820|525632037|FG001|Overall Study|Lost to Follow-up|1|||
145759370|NCT01171820|525632036|FG000|Overall Study|Withdrawal by Subject|2|||
145759371|NCT01171820|525632037|FG001|Overall Study|Withdrawal by Subject|0|||
145759372|NCT01171820|525632036|FG000|Overall Study|Physician Decision|0|||
145759373|NCT01171820|525632037|FG001|Overall Study|Physician Decision|1|||
145759374|NCT01171820|525632036|FG000|Overall Study|1-Year Missed Visit|1|||
145759375|NCT01171820|525632037|FG001|Overall Study|1-Year Missed Visit|1|||
145759376|NCT03969875|525632038|FG000|Overall Study|did not receive allocated intervention|3|||
145759377|NCT03969875|525632039|FG001|Overall Study|did not receive allocated intervention|3|||
145274031|NCT00285012|523850983|FG000|Assigned to Study Treatment (Tx)|Other|2|||
145274032|NCT00285012|523850984|FG001|Assigned to Study Treatment (Tx)|Other|3|||
145274033|NCT00285012|523850983|FG000|Received Study Tx|Death|2|||
145274034|NCT00285012|523850984|FG001|Received Study Tx|Death|1|||
145274035|NCT00285012|523850983|FG000|Received Study Tx|Adverse Event|5|||
145274036|NCT00285012|523850984|FG001|Received Study Tx|Adverse Event|11|||
145274037|NCT00285012|523850983|FG000|Received Study Tx|Lack of Efficacy|0|||
145274038|NCT00285012|523850984|FG001|Received Study Tx|Lack of Efficacy|3|||
145274039|NCT00285012|523850983|FG000|Received Study Tx|Lost to Follow-up|29|||
145274040|NCT00285012|523850984|FG001|Received Study Tx|Lost to Follow-up|31|||
145274041|NCT00285012|523850983|FG000|Received Study Tx|Withdrawal by Subject|31|||
145274042|NCT00285012|523850984|FG001|Received Study Tx|Withdrawal by Subject|43|||
145274043|NCT00285012|523850983|FG000|Received Study Tx|Other|5|||
145274044|NCT00285012|523850984|FG001|Received Study Tx|Other|5|||
145274045|NCT04050293|523850987|FG000|Overall Study|Lost to Follow-up|1|||
145274046|NCT04050293|523850988|FG001|Overall Study|Lost to Follow-up|2|||
145274047|NCT04050293|523850987|FG000|Overall Study|Withdrawal by Subject|2|||
145274048|NCT04050293|523850988|FG001|Overall Study|Withdrawal by Subject|0|||
145274049|NCT04256759|523851877|FG000|Overall Study|Physician Decision|1|||
145274050|NCT04256759|523851877|FG000|Overall Study|Lack of Efficacy|1|||
145274051|NCT04075292|523851884|FG000|Overall Study|Withdrawal by Subject|1|||
145274052|NCT04075292|523851885|FG001|Overall Study|Withdrawal by Subject|9|||
145274053|NCT04075292|523851884|FG000|Overall Study|Death|2|||
145274054|NCT04075292|523851885|FG001|Overall Study|Death|5|||
145274055|NCT04075292|523851884|FG000|Overall Study|Remained on study at time of DCO|74|||
145274056|NCT04075292|523851885|FG001|Overall Study|Remained on study at time of DCO|64|||
145274057|NCT03829462|523851887|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
145274058|NCT03829462|523851888|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
145274059|NCT03829462|523851887|FG000|Overall Study|No treatment due to progression disease|0|||
145274060|NCT03829462|523851888|FG001|Overall Study|No treatment due to progression disease|1|||
145274061|NCT00569127|523851895|FG000|Overall Study|Adverse Event|57|||
145274062|NCT00569127|523851896|FG001|Overall Study|Adverse Event|47|||
145274063|NCT00569127|523851895|FG000|Overall Study|Withdrawal by Subject|13|||
145274064|NCT00569127|523851896|FG001|Overall Study|Withdrawal by Subject|27|||
145274065|NCT00569127|523851895|FG000|Overall Study|Progression|99|||
145274066|NCT00569127|523851896|FG001|Overall Study|Progression|100|||
145274067|NCT00569127|523851895|FG000|Overall Study|Death|4|||
145274068|NCT00569127|523851896|FG001|Overall Study|Death|3|||
145274069|NCT00569127|523851895|FG000|Overall Study|Other|20|||
145759378|NCT03969875|525632040|FG002|Overall Study|did not receive allocated intervention|4|||
145274070|NCT00569127|523851896|FG001|Overall Study|Other|19|||
145274071|NCT00569127|523851895|FG000|Overall Study|Lost to Follow-up|0|||
145274072|NCT00569127|523851896|FG001|Overall Study|Lost to Follow-up|3|||
145274073|NCT00569127|523851895|FG000|Overall Study|Not Eligible|14|||
145274074|NCT00569127|523851896|FG001|Overall Study|Not Eligible|11|||
145274075|NCT00569127|523851895|FG000|Overall Study|Still on Treatment|7|||
145274076|NCT00569127|523851896|FG001|Overall Study|Still on Treatment|3|||
145274077|NCT04803214|523851897|FG000|Overall Study|Adverse Event|1|||
145274078|NCT04803214|523851898|FG001|Overall Study|Adverse Event|0|||
145532543|NCT04612790|524811629|FG003|DB Period (Up to 36 Weeks)|Other|0|||
145759379|NCT03969875|525632038|FG000|Overall Study|Protocol Violation|4|||
145759380|NCT03969875|525632039|FG001|Overall Study|Protocol Violation|2|||
145759381|NCT03969875|525632040|FG002|Overall Study|Protocol Violation|2|||
145759382|NCT01307033|525632041|FG000|8-week Double-blind Period|Adverse Event|2|||
145759383|NCT01307033|525632042|FG001|8-week Double-blind Period|Adverse Event|0|||
145759384|NCT01307033|525632043|FG002|8-week Double-blind Period|Adverse Event|0|||
145759385|NCT01307033|525632044|FG003|8-week Double-blind Period|Adverse Event|0|||
145759386|NCT01307033|525632041|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
145759387|NCT01307033|525632042|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
145759388|NCT01307033|525632043|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
145759389|NCT01307033|525632044|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
145759390|NCT01307033|525632041|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
145759391|NCT01307033|525632042|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
145759392|NCT01307033|525632043|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
145759393|NCT01307033|525632044|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
145759394|NCT01307033|525632041|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
145759395|NCT01307033|525632042|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
145759396|NCT01307033|525632043|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
145759397|NCT01307033|525632044|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
145759398|NCT01307033|525632041|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
145759399|NCT01307033|525632042|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
145759400|NCT01307033|525632043|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
145759401|NCT01307033|525632044|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
145759402|NCT01307033|525632041|FG000|44-week Open-label Extension|Adverse Event|0|||
145759403|NCT01307033|525632042|FG001|44-week Open-label Extension|Adverse Event|0|||
145759404|NCT01307033|525632043|FG002|44-week Open-label Extension|Adverse Event|2|||
145759405|NCT01307033|525632044|FG003|44-week Open-label Extension|Adverse Event|1|||
145759406|NCT01307033|525632041|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
145759407|NCT01307033|525632042|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
145759408|NCT01307033|525632043|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
145759409|NCT01307033|525632044|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
145759410|NCT01307033|525632041|FG000|44-week Open-label Extension|Physician Decision|0|||
145759411|NCT01307033|525632042|FG001|44-week Open-label Extension|Physician Decision|0|||
145759412|NCT01307033|525632043|FG002|44-week Open-label Extension|Physician Decision|1|||
145759413|NCT01307033|525632044|FG003|44-week Open-label Extension|Physician Decision|0|||
145759414|NCT01307033|525632041|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
145759415|NCT01307033|525632042|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
145759416|NCT01307033|525632043|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
145759417|NCT01307033|525632044|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
145759418|NCT01307033|525632041|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
145759419|NCT01307033|525632042|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
145759420|NCT01307033|525632043|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
145759421|NCT01307033|525632044|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
145759422|NCT01307033|525632041|FG000|44-week Open-label Extension|Death|0|||
145759423|NCT01307033|525632042|FG001|44-week Open-label Extension|Death|0|||
145759424|NCT01307033|525632043|FG002|44-week Open-label Extension|Death|0|||
145759425|NCT01307033|525632044|FG003|44-week Open-label Extension|Death|1|||
145759426|NCT02327260|525632046|FG000|Overall Study|Lost to Follow-up|2|||
145759427|NCT02327260|525632047|FG001|Overall Study|Lost to Follow-up|3|||
145759428|NCT02327260|525632048|FG002|Overall Study|Lost to Follow-up|2|||
145759429|NCT02327260|525632046|FG000|Overall Study|invalid phone number|1|||
145759430|NCT02327260|525632047|FG001|Overall Study|invalid phone number|1|||
145759431|NCT02327260|525632048|FG002|Overall Study|invalid phone number|0|||
145759432|NCT02327260|525632046|FG000|Overall Study|non-adherence to protocol|2|||
145759433|NCT02327260|525632047|FG001|Overall Study|non-adherence to protocol|0|||
145759434|NCT02327260|525632048|FG002|Overall Study|non-adherence to protocol|0|||
145759435|NCT02327260|525632046|FG000|Overall Study|cognitive concerns|1|||
145759436|NCT02327260|525632047|FG001|Overall Study|cognitive concerns|0|||
145759437|NCT02327260|525632048|FG002|Overall Study|cognitive concerns|0|||
145759438|NCT02804763|525632051|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
145759439|NCT02804763|525632052|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
145759440|NCT02804763|525632053|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
145759441|NCT02804763|525632054|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
145759442|NCT02804763|525632051|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
145759443|NCT02804763|525632052|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
145759444|NCT02804763|525632053|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
145759445|NCT02804763|525632054|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
145759446|NCT02804763|525632051|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
145759447|NCT02804763|525632052|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
145759448|NCT02804763|525632053|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
145759449|NCT02804763|525632054|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
145759450|NCT02804763|525632051|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
145759451|NCT02804763|525632052|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
145759452|NCT02804763|525632053|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
145759453|NCT02804763|525632054|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
145759454|NCT02804763|525632051|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
145759455|NCT02804763|525632052|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
145759456|NCT02804763|525632053|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
145759457|NCT02804763|525632054|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
145759458|NCT02804763|525632051|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
145759459|NCT02804763|525632052|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
145759460|NCT02804763|525632053|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
145759461|NCT02804763|525632054|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
145759462|NCT00860158|525632055|FG000|Overall Study|Study Terminated|1|||
145759463|NCT05499520|525632056|FG000|Overall Study|Lost to Follow-up|0|||
145759464|NCT05499520|525632057|FG001|Overall Study|Lost to Follow-up|0|||
145759465|NCT05499520|525632058|FG002|Overall Study|Lost to Follow-up|38|||
145759466|NCT05499520|525632059|FG003|Overall Study|Lost to Follow-up|41|||
145759467|NCT05499520|525632060|FG004|Overall Study|Lost to Follow-up|46|||
145759468|NCT05499520|525632061|FG005|Overall Study|Lost to Follow-up|0|||
145759469|NCT05499520|525632062|FG006|Overall Study|Lost to Follow-up|31|||
145759470|NCT05499520|525632063|FG007|Overall Study|Lost to Follow-up|45|||
145759471|NCT05499520|525632064|FG008|Overall Study|Lost to Follow-up|42|||
145759472|NCT05499520|525632065|FG009|Overall Study|Lost to Follow-up|0|||
145759473|NCT05499520|525632066|FG010|Overall Study|Lost to Follow-up|0|||
145607616|NCT03682705|525079210|FG005|Overall Study|Other, not specified|0|||
145607617|NCT03682705|525079205|FG000|Overall Study|Lost to Follow-up|0|||
145759474|NCT05499520|525632067|FG011|Overall Study|Lost to Follow-up|37|||
145759475|NCT05499520|525632068|FG012|Overall Study|Lost to Follow-up|53|||
145759476|NCT05499520|525632069|FG013|Overall Study|Lost to Follow-up|49|||
145759477|NCT05499520|525632070|FG014|Overall Study|Lost to Follow-up|0|||
145759478|NCT05499520|525632071|FG015|Overall Study|Lost to Follow-up|36|||
145759479|NCT05499520|525632072|FG016|Overall Study|Lost to Follow-up|58|||
145759480|NCT05499520|525632073|FG017|Overall Study|Lost to Follow-up|53|||
145402879|NCT02065557|524332546|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
145759481|NCT03588741|525632074|FG000|Overall Study|Withdrawal by Subject|1|||
145607618|NCT03682705|525079206|FG001|Overall Study|Lost to Follow-up|0|||
145759482|NCT00793793|525632076|FG000|Overall Study|Adverse Event|0|||
145759483|NCT00793793|525632077|FG001|Overall Study|Adverse Event|0|||
145759484|NCT00793793|525632078|FG002|Overall Study|Adverse Event|1|||
145759485|NCT00793793|525632079|FG003|Overall Study|Adverse Event|1|||
145759486|NCT00793793|525632080|FG004|Overall Study|Adverse Event|0|||
145759487|NCT00793793|525632081|FG005|Overall Study|Adverse Event|1|||
145759488|NCT00793793|525632082|FG006|Overall Study|Adverse Event|2|||
145759489|NCT00793793|525632083|FG007|Overall Study|Adverse Event|0|||
145759490|NCT00793793|525632084|FG008|Overall Study|Adverse Event|0|||
145759491|NCT00793793|525632085|FG009|Overall Study|Adverse Event|0|||
145759492|NCT00793793|525632086|FG010|Overall Study|Adverse Event|0|||
145759493|NCT00793793|525632087|FG011|Overall Study|Adverse Event|2|||
145759494|NCT00793793|525632076|FG000|Overall Study|Protocol Violation|0|||
145759495|NCT00793793|525632077|FG001|Overall Study|Protocol Violation|0|||
145759496|NCT00793793|525632078|FG002|Overall Study|Protocol Violation|0|||
145759497|NCT00793793|525632079|FG003|Overall Study|Protocol Violation|1|||
145759498|NCT00793793|525632080|FG004|Overall Study|Protocol Violation|0|||
145759499|NCT00793793|525632081|FG005|Overall Study|Protocol Violation|0|||
145759500|NCT00793793|525632082|FG006|Overall Study|Protocol Violation|0|||
145759501|NCT00793793|525632083|FG007|Overall Study|Protocol Violation|0|||
145759502|NCT00793793|525632084|FG008|Overall Study|Protocol Violation|0|||
145759503|NCT00793793|525632085|FG009|Overall Study|Protocol Violation|0|||
145759504|NCT00793793|525632086|FG010|Overall Study|Protocol Violation|0|||
145759505|NCT00793793|525632087|FG011|Overall Study|Protocol Violation|0|||
145759506|NCT00793793|525632076|FG000|Overall Study|Lost to Follow-up|0|||
145759507|NCT00793793|525632077|FG001|Overall Study|Lost to Follow-up|0|||
145759508|NCT00793793|525632078|FG002|Overall Study|Lost to Follow-up|1|||
145759509|NCT00793793|525632079|FG003|Overall Study|Lost to Follow-up|0|||
145759510|NCT00793793|525632080|FG004|Overall Study|Lost to Follow-up|0|||
145759511|NCT00793793|525632081|FG005|Overall Study|Lost to Follow-up|0|||
145759512|NCT00793793|525632082|FG006|Overall Study|Lost to Follow-up|0|||
145759513|NCT00793793|525632083|FG007|Overall Study|Lost to Follow-up|0|||
145759514|NCT00793793|525632084|FG008|Overall Study|Lost to Follow-up|1|||
145759515|NCT00793793|525632085|FG009|Overall Study|Lost to Follow-up|3|||
145759516|NCT00793793|525632086|FG010|Overall Study|Lost to Follow-up|1|||
145759517|NCT00793793|525632087|FG011|Overall Study|Lost to Follow-up|0|||
145759518|NCT00793793|525632076|FG000|Overall Study|Withdrawal by Subject|0|||
145759519|NCT00793793|525632077|FG001|Overall Study|Withdrawal by Subject|0|||
145759520|NCT00793793|525632078|FG002|Overall Study|Withdrawal by Subject|0|||
145759521|NCT00793793|525632079|FG003|Overall Study|Withdrawal by Subject|0|||
145759522|NCT00793793|525632080|FG004|Overall Study|Withdrawal by Subject|1|||
145759523|NCT00793793|525632081|FG005|Overall Study|Withdrawal by Subject|0|||
145759524|NCT00793793|525632082|FG006|Overall Study|Withdrawal by Subject|0|||
145759525|NCT00793793|525632083|FG007|Overall Study|Withdrawal by Subject|0|||
145759526|NCT00793793|525632084|FG008|Overall Study|Withdrawal by Subject|1|||
145759527|NCT00793793|525632085|FG009|Overall Study|Withdrawal by Subject|0|||
145759528|NCT00793793|525632086|FG010|Overall Study|Withdrawal by Subject|0|||
145759529|NCT00793793|525632087|FG011|Overall Study|Withdrawal by Subject|0|||
145759530|NCT00793793|525632076|FG000|Overall Study|reason not specified|0|||
145759531|NCT00793793|525632077|FG001|Overall Study|reason not specified|1|||
145759532|NCT00793793|525632078|FG002|Overall Study|reason not specified|0|||
145759533|NCT00793793|525632079|FG003|Overall Study|reason not specified|1|||
145759534|NCT00793793|525632080|FG004|Overall Study|reason not specified|1|||
145532544|NCT04612790|524811626|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
145532545|NCT04612790|524811627|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
145532546|NCT04612790|524811628|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
145532547|NCT04612790|524811629|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
145532548|NCT04612790|524811626|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
145532549|NCT04612790|524811627|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
145759535|NCT00793793|525632081|FG005|Overall Study|reason not specified|1|||
145759536|NCT00793793|525632082|FG006|Overall Study|reason not specified|2|||
145759537|NCT00793793|525632083|FG007|Overall Study|reason not specified|0|||
145759538|NCT00793793|525632084|FG008|Overall Study|reason not specified|7|||
145759539|NCT00793793|525632085|FG009|Overall Study|reason not specified|6|||
145759540|NCT00793793|525632086|FG010|Overall Study|reason not specified|2|||
145759541|NCT00793793|525632087|FG011|Overall Study|reason not specified|4|||
145759542|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
145759543|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
145759544|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
145532550|NCT04612790|524811628|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
145759545|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
145759546|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
145759547|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
145759548|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
145532551|NCT04612790|524811629|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
145532552|NCT04612790|524811626|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
145532553|NCT04612790|524811627|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
145532554|NCT04612790|524811628|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
145532555|NCT04612790|524811629|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
145532556|NCT04612790|524811626|FG000|OLE Period (Up to 1 Year)|Other|0|||
145532557|NCT04612790|524811627|FG001|OLE Period (Up to 1 Year)|Other|0|||
145532558|NCT04612790|524811628|FG002|OLE Period (Up to 1 Year)|Other|0|||
145532559|NCT04612790|524811629|FG003|OLE Period (Up to 1 Year)|Other|1|||
145532560|NCT02497612|524811630|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
145532561|NCT02497612|524811631|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
145532562|NCT02497612|524811632|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
145532563|NCT02497612|524811633|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
145532564|NCT02497612|524811630|FG000|Overall Study|Participant's request|2|||
145532565|NCT02497612|524811631|FG001|Overall Study|Participant's request|3|||
145759549|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
145759550|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145759551|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
145759552|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145759553|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
145759554|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
145759555|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145759556|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145759557|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
145759558|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
145759559|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
145759560|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
145759561|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
145759562|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
145759563|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
145759564|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
145759565|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
145759566|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
145759567|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
145759568|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
145759569|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
145532566|NCT02497612|524811632|FG002|Overall Study|Participant's request|4|||
145532567|NCT02497612|524811633|FG003|Overall Study|Participant's request|1|||
145532568|NCT02497612|524811630|FG000|Overall Study|Investigator's judgement|1|||
145532569|NCT02497612|524811631|FG001|Overall Study|Investigator's judgement|0|||
145532570|NCT02497612|524811632|FG002|Overall Study|Investigator's judgement|0|||
145532571|NCT02497612|524811633|FG003|Overall Study|Investigator's judgement|2|||
145759570|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
145759571|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
145759572|NCT05195528|525632089|FG000|Placebo-controlled Treatment Period|Other|0|||
145532572|NCT02497612|524811630|FG000|Overall Study|Adverse Event|3|||
145402880|NCT02065557|524332547|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145532573|NCT02497612|524811631|FG001|Overall Study|Adverse Event|1|||
145532574|NCT02497612|524811632|FG002|Overall Study|Adverse Event|4|||
145532575|NCT02497612|524811633|FG003|Overall Study|Adverse Event|1|||
145532576|NCT02497612|524811630|FG000|Overall Study|Lost to Follow-up|1|||
145532577|NCT02497612|524811631|FG001|Overall Study|Lost to Follow-up|1|||
145759573|NCT05195528|525632090|FG001|Placebo-controlled Treatment Period|Other|0|||
145759574|NCT05195528|525632091|FG002|Placebo-controlled Treatment Period|Other|1|||
145759575|NCT05195528|525632092|FG003|Placebo-controlled Treatment Period|Other|0|||
145759576|NCT05195528|525632093|FG004|Placebo-controlled Treatment Period|Other|0|||
145759577|NCT05195528|525632089|FG000|Extension Period|PTE or AE or SAE|0|||
145759578|NCT05195528|525632090|FG001|Extension Period|PTE or AE or SAE|4|||
145759579|NCT05195528|525632091|FG002|Extension Period|PTE or AE or SAE|5|||
145759580|NCT05195528|525632092|FG003|Extension Period|PTE or AE or SAE|4|||
145759581|NCT05195528|525632093|FG004|Extension Period|PTE or AE or SAE|4|||
145759582|NCT05195528|525632089|FG000|Extension Period|Protocol Violation|0|||
145759583|NCT05195528|525632090|FG001|Extension Period|Protocol Violation|2|||
145759584|NCT05195528|525632091|FG002|Extension Period|Protocol Violation|1|||
145759585|NCT05195528|525632092|FG003|Extension Period|Protocol Violation|0|||
145759586|NCT05195528|525632093|FG004|Extension Period|Protocol Violation|1|||
145759587|NCT05195528|525632089|FG000|Extension Period|Lost to Follow-up|0|||
145759588|NCT05195528|525632090|FG001|Extension Period|Lost to Follow-up|6|||
145759589|NCT05195528|525632091|FG002|Extension Period|Lost to Follow-up|13|||
145759590|NCT05195528|525632092|FG003|Extension Period|Lost to Follow-up|3|||
145759591|NCT05195528|525632093|FG004|Extension Period|Lost to Follow-up|7|||
145759592|NCT05195528|525632089|FG000|Extension Period|Withdrawal by Subject|0|||
145759593|NCT05195528|525632090|FG001|Extension Period|Withdrawal by Subject|12|||
145759594|NCT05195528|525632091|FG002|Extension Period|Withdrawal by Subject|9|||
145759595|NCT05195528|525632092|FG003|Extension Period|Withdrawal by Subject|6|||
145759596|NCT05195528|525632093|FG004|Extension Period|Withdrawal by Subject|5|||
145759597|NCT05195528|525632089|FG000|Extension Period|Lack of Efficacy|0|||
145759598|NCT05195528|525632090|FG001|Extension Period|Lack of Efficacy|3|||
145759599|NCT05195528|525632091|FG002|Extension Period|Lack of Efficacy|0|||
145759600|NCT05195528|525632092|FG003|Extension Period|Lack of Efficacy|0|||
145759601|NCT05195528|525632093|FG004|Extension Period|Lack of Efficacy|2|||
145759602|NCT05195528|525632089|FG000|Extension Period|Not Treated|0|||
145759603|NCT05195528|525632090|FG001|Extension Period|Not Treated|0|||
145759604|NCT05195528|525632091|FG002|Extension Period|Not Treated|2|||
145759605|NCT05195528|525632092|FG003|Extension Period|Not Treated|3|||
145759606|NCT05195528|525632093|FG004|Extension Period|Not Treated|0|||
145274079|NCT04803214|523851897|FG000|Overall Study|Withdrawal by Subject|1|||
145274080|NCT04803214|523851898|FG001|Overall Study|Withdrawal by Subject|2|||
145274081|NCT04803214|523851897|FG000|Overall Study|Lost to Follow-up|2|||
145274082|NCT04803214|523851898|FG001|Overall Study|Lost to Follow-up|4|||
145274083|NCT04803214|523851897|FG000|Overall Study|Physician Decision|1|||
145274084|NCT04803214|523851898|FG001|Overall Study|Physician Decision|1|||
145274085|NCT04803214|523851897|FG000|Overall Study|Missed 12 month visit|0|||
145274086|NCT04803214|523851898|FG001|Overall Study|Missed 12 month visit|3|||
145274087|NCT00644228|523851899|FG000|Randomization & Eligibility|Ineligible|31|||
145274088|NCT00644228|523851900|FG001|Randomization & Eligibility|Ineligible|21|||
145274089|NCT00644228|523851899|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
145274090|NCT00644228|523851900|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
145274091|NCT00644228|523851899|FG000|Randomization & Eligibility|Invalid Consent|0|||
145274092|NCT00644228|523851900|FG001|Randomization & Eligibility|Invalid Consent|1|||
145274093|NCT00644228|523851899|FG000|Induction Therapy|Adverse Event|22|||
145274094|NCT00644228|523851900|FG001|Induction Therapy|Adverse Event|55|||
145274095|NCT00644228|523851899|FG000|Induction Therapy|Withdrawal by Subject|10|||
145274096|NCT00644228|523851900|FG001|Induction Therapy|Withdrawal by Subject|3|||
145274097|NCT00644228|523851899|FG000|Induction Therapy|Progression/Relapse|24|||
145274098|NCT00644228|523851900|FG001|Induction Therapy|Progression/Relapse|12|||
145274099|NCT00644228|523851899|FG000|Induction Therapy|Death|3|||
145274100|NCT00644228|523851900|FG001|Induction Therapy|Death|7|||
145274101|NCT00644228|523851899|FG000|Induction Therapy|Not Protocol-Specified|24|||
145274102|NCT00644228|523851900|FG001|Induction Therapy|Not Protocol-Specified|28|||
145274103|NCT00644228|523851899|FG000|Maintenance|Adverse Event|27|||
145274104|NCT00644228|523851900|FG001|Maintenance|Adverse Event|31|||
145274105|NCT00644228|523851899|FG000|Maintenance|Withdrawal by Subject|6|||
145274106|NCT00644228|523851900|FG001|Maintenance|Withdrawal by Subject|4|||
145607619|NCT03682705|525079207|FG002|Overall Study|Lost to Follow-up|0|||
145607620|NCT03682705|525079208|FG003|Overall Study|Lost to Follow-up|0|||
145607621|NCT03682705|525079209|FG004|Overall Study|Lost to Follow-up|3|||
145607622|NCT03682705|525079210|FG005|Overall Study|Lost to Follow-up|0|||
145607623|NCT00094328|525079211|FG000|Overall Study|Lost to Follow-up|1|||
145607624|NCT01483937|525079212|FG000|Overall Study|Withdrawal by Subject|4|||
145607625|NCT01483937|525079213|FG001|Overall Study|Withdrawal by Subject|3|||
145274107|NCT00644228|523851899|FG000|Maintenance|Progression/Relapse|67|||
145274108|NCT00644228|523851900|FG001|Maintenance|Progression/Relapse|42|||
145274109|NCT00644228|523851899|FG000|Maintenance|Death|3|||
145274110|NCT00644228|523851900|FG001|Maintenance|Death|3|||
145274111|NCT00644228|523851899|FG000|Maintenance|Not Protocol-Specified|14|||
145274112|NCT00644228|523851900|FG001|Maintenance|Not Protocol-Specified|15|||
145274113|NCT00644228|523851899|FG000|Maintenance|On Treatment|26|||
145274114|NCT00644228|523851900|FG001|Maintenance|On Treatment|40|||
145274115|NCT06078124|523851901|FG000|Overall Study|Lost to Follow-up|14|||
145274116|NCT06078124|523851902|FG001|Overall Study|Lost to Follow-up|14|||
145274117|NCT05824273|523851903|FG000|Overall Study|Lost to Follow-up|16|||
145274118|NCT05824273|523851904|FG001|Overall Study|Lost to Follow-up|13|||
145274119|NCT02736695|523851905|FG000|Overall Study|Ineligible|6|||
145274120|NCT02736695|523851906|FG001|Overall Study|Ineligible|0|||
145274121|NCT05631093|523851910|FG000|Overall Study|Death|0|||
145274122|NCT05631093|523851911|FG001|Overall Study|Death|1|||
145274123|NCT05631093|523851910|FG000|Overall Study|Lost to Follow-up|1|||
145274124|NCT05631093|523851911|FG001|Overall Study|Lost to Follow-up|2|||
145274125|NCT05631093|523851910|FG000|Overall Study|Physician Decision|1|||
145274126|NCT05631093|523851911|FG001|Overall Study|Physician Decision|0|||
145274127|NCT05631093|523851910|FG000|Overall Study|Withdrawal by Subject|4|||
145607626|NCT02213328|525079214|FG000|Overall Study|Withdrawal by Subject|10|||
145759607|NCT05195528|525632089|FG000|Extension Period|Other|0|||
145759608|NCT05195528|525632090|FG001|Extension Period|Other|1|||
145402881|NCT02065557|524332548|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145759609|NCT05195528|525632091|FG002|Extension Period|Other|1|||
145759610|NCT05195528|525632092|FG003|Extension Period|Other|0|||
145274128|NCT05631093|523851911|FG001|Overall Study|Withdrawal by Subject|1|||
145274129|NCT05631093|523851910|FG000|Overall Study|Ongoing|353|||
145607627|NCT02213328|525079214|FG000|Overall Study|Physician Decision|2|||
145759611|NCT05195528|525632093|FG004|Extension Period|Other|0|||
145759612|NCT01552902|525632094|FG000|Overall Study|Adverse Event|1|||
145759613|NCT01552902|525632095|FG001|Overall Study|Adverse Event|15|||
145274130|NCT05631093|523851911|FG001|Overall Study|Ongoing|177|||
145607628|NCT02213328|525079214|FG000|Overall Study|Lost to Follow-up|16|||
145607629|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
145759614|NCT01552902|525632096|FG002|Overall Study|Adverse Event|14|||
145532578|NCT02497612|524811632|FG002|Overall Study|Lost to Follow-up|0|||
145532579|NCT02497612|524811633|FG003|Overall Study|Lost to Follow-up|1|||
145532580|NCT02497612|524811630|FG000|Overall Study|Other unspecified|1|||
145532581|NCT02497612|524811631|FG001|Overall Study|Other unspecified|1|||
145532582|NCT02497612|524811632|FG002|Overall Study|Other unspecified|2|||
145532583|NCT02497612|524811633|FG003|Overall Study|Other unspecified|0|||
145532584|NCT02497612|524811630|FG000|Overall Study|Not eligible|1|||
145532585|NCT02497612|524811631|FG001|Overall Study|Not eligible|0|||
145532586|NCT02497612|524811632|FG002|Overall Study|Not eligible|0|||
145532587|NCT02497612|524811633|FG003|Overall Study|Not eligible|1|||
145532588|NCT00629772|524811636|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
145532589|NCT00629772|524811637|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
145532590|NCT00629772|524811636|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
145532591|NCT00629772|524811637|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
145532592|NCT01495975|524811638|FG000|Overall Study|Lost to Follow-up|1|||
145532593|NCT01495975|524811639|FG001|Overall Study|Lost to Follow-up|0|||
145532594|NCT01254292|524811640|FG000|Comparative Phase|Adverse Event|25|||
145532595|NCT01254292|524811641|FG001|Comparative Phase|Adverse Event|25|||
145759615|NCT01552902|525632094|FG000|Overall Study|Protocol Violation|3|||
145759616|NCT01552902|525632095|FG001|Overall Study|Protocol Violation|3|||
145274131|NCT05631093|523851910|FG000|Overall Study|Adverse Event|0|||
145607630|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
145607631|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
145607632|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
145607633|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
145607634|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
145607635|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
145607636|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
145607637|NCT01336621|525079215|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
145607638|NCT01336621|525079215|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
145607639|NCT01336621|525079215|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
145607640|NCT01336621|525079215|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
145607641|NCT01336621|525079215|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
145607642|NCT01336621|525079215|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
145607643|NCT01126060|525079218|FG000|Overall Study|Protocol Violation|0|||
145607644|NCT01126060|525079219|FG001|Overall Study|Protocol Violation|2|||
145607645|NCT00402337|525079224|FG000|Overall Study|Adverse Event|0|||
145607646|NCT00402337|525079225|FG001|Overall Study|Adverse Event|2|||
145607647|NCT00402337|525079226|FG002|Overall Study|Adverse Event|2|||
145607648|NCT00402337|525079227|FG003|Overall Study|Adverse Event|3|||
145607649|NCT00402337|525079228|FG004|Overall Study|Adverse Event|2|||
145607650|NCT00402337|525079224|FG000|Overall Study|Noncompliance|0|||
145607651|NCT00402337|525079225|FG001|Overall Study|Noncompliance|0|||
145607652|NCT00402337|525079226|FG002|Overall Study|Noncompliance|0|||
145607653|NCT00402337|525079227|FG003|Overall Study|Noncompliance|0|||
145607654|NCT00402337|525079228|FG004|Overall Study|Noncompliance|2|||
145607655|NCT00402337|525079224|FG000|Overall Study|Withdrawal by Subject|5|||
145607656|NCT00402337|525079225|FG001|Overall Study|Withdrawal by Subject|3|||
145607657|NCT00402337|525079226|FG002|Overall Study|Withdrawal by Subject|1|||
145607658|NCT00402337|525079227|FG003|Overall Study|Withdrawal by Subject|6|||
145607659|NCT00402337|525079228|FG004|Overall Study|Withdrawal by Subject|4|||
145607660|NCT00402337|525079224|FG000|Overall Study|Lost to Follow-up|0|||
145607661|NCT00402337|525079225|FG001|Overall Study|Lost to Follow-up|0|||
145607662|NCT00402337|525079226|FG002|Overall Study|Lost to Follow-up|1|||
145607663|NCT00402337|525079227|FG003|Overall Study|Lost to Follow-up|2|||
145607664|NCT00402337|525079228|FG004|Overall Study|Lost to Follow-up|0|||
145607665|NCT00402337|525079224|FG000|Overall Study|Physician Decision|0|||
145607666|NCT00402337|525079225|FG001|Overall Study|Physician Decision|0|||
145607667|NCT00402337|525079226|FG002|Overall Study|Physician Decision|0|||
145607668|NCT00402337|525079227|FG003|Overall Study|Physician Decision|1|||
145532596|NCT01254292|524811640|FG000|Comparative Phase|Lost to Follow-up|3|||
145532597|NCT01254292|524811641|FG001|Comparative Phase|Lost to Follow-up|21|||
145532598|NCT01254292|524811640|FG000|Comparative Phase|Pregnancy|2|||
145532599|NCT01254292|524811641|FG001|Comparative Phase|Pregnancy|6|||
145532600|NCT01254292|524811640|FG000|Comparative Phase|Withdrawal by Subject|20|||
145532601|NCT01254292|524811641|FG001|Comparative Phase|Withdrawal by Subject|21|||
145532602|NCT01254292|524811640|FG000|Comparative Phase|Protocol Violation|1|||
145532603|NCT01254292|524811641|FG001|Comparative Phase|Protocol Violation|2|||
145532604|NCT01254292|524811640|FG000|Comparative Phase|Wish for pregnancy|4|||
145532605|NCT01254292|524811641|FG001|Comparative Phase|Wish for pregnancy|6|||
145532606|NCT01254292|524811640|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
145532607|NCT01254292|524811641|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
145532608|NCT01254292|524811640|FG000|LCS12 Extension Phase|Adverse Event|9|||
145532609|NCT01254292|524811641|FG001|LCS12 Extension Phase|Adverse Event|0|||
145532610|NCT01254292|524811640|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
145532611|NCT01254292|524811641|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
145532612|NCT01254292|524811640|FG000|LCS12 Extension Phase|Other unknown|4|||
145532613|NCT01254292|524811641|FG001|LCS12 Extension Phase|Other unknown|0|||
145532614|NCT01254292|524811640|FG000|LCS12 Extension Phase|Pregnancy|2|||
145532615|NCT01254292|524811641|FG001|LCS12 Extension Phase|Pregnancy|0|||
145532616|NCT01254292|524811640|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
145532617|NCT01254292|524811641|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
145532618|NCT01484132|524811642|FG000|Overall Study|Lost to Follow-up|8|||
145532619|NCT01484132|524811642|FG000|Overall Study|Difficulty with time commitment|2|||
145532620|NCT01484132|524811642|FG000|Overall Study|Ineligible|1|||
145532621|NCT01484132|524811642|FG000|Overall Study|No pre-treatment urine sample collected|1|||
145532622|NCT01484132|524811642|FG000|Overall Study|No post-treatment urine sample collected|10|||
145532623|NCT01697358|524811650|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
145532624|NCT01697358|524811651|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
145532625|NCT01697358|524811650|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
145532626|NCT01697358|524811651|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
145532627|NCT01697358|524811650|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
145532628|NCT01697358|524811651|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
145532629|NCT01697358|524811650|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
145532630|NCT01697358|524811651|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
145532631|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
145532632|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
145532633|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
145532634|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
145532635|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
145532636|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
145532637|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
145532638|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
145532639|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
145532640|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
145532641|NCT01697358|524811650|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
145532642|NCT01697358|524811651|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
145532643|NCT05055128|524811652|FG000|Overall Study|Adverse Event|0|||
145532644|NCT05055128|524811653|FG001|Overall Study|Adverse Event|0|||
145532645|NCT05055128|524811654|FG002|Overall Study|Adverse Event|0|||
145402882|NCT02065557|524332549|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
145532646|NCT05055128|524811655|FG003|Overall Study|Adverse Event|1|||
145532647|NCT05055128|524811656|FG004|Overall Study|Adverse Event|1|||
145532648|NCT05055128|524811652|FG000|Overall Study|Protocol Violation|0|||
145274132|NCT05631093|523851911|FG001|Overall Study|Adverse Event|1|||
145402883|NCT02065557|524332544|FG000|Induction Period|Non-Responder at Week 8|4|||
145402884|NCT02065557|524332545|FG001|Induction Period|Non-Responder at Week 8|4|||
145402885|NCT02065557|524332546|FG002|Induction Period|Non-Responder at Week 8|0|||
145532649|NCT05055128|524811653|FG001|Overall Study|Protocol Violation|0|||
145532650|NCT05055128|524811654|FG002|Overall Study|Protocol Violation|0|||
145402886|NCT02065557|524332547|FG003|Induction Period|Non-Responder at Week 8|0|||
145402887|NCT02065557|524332548|FG004|Induction Period|Non-Responder at Week 8|0|||
145607669|NCT00402337|525079228|FG004|Overall Study|Physician Decision|0|||
145532651|NCT05055128|524811655|FG003|Overall Study|Protocol Violation|1|||
145532652|NCT05055128|524811656|FG004|Overall Study|Protocol Violation|0|||
145532653|NCT05055128|524811652|FG000|Overall Study|Withdrawal by Subject|5|||
145274133|NCT04223193|523851912|FG000|Overall Study|Adverse Event|6|||
145274134|NCT04223193|523851913|FG001|Overall Study|Adverse Event|36|||
145274135|NCT04223193|523851912|FG000|Overall Study|Lack of Efficacy|2|||
145274136|NCT04223193|523851913|FG001|Overall Study|Lack of Efficacy|2|||
145274137|NCT04223193|523851912|FG000|Overall Study|Lost to Follow-up|1|||
145274138|NCT04223193|523851913|FG001|Overall Study|Lost to Follow-up|1|||
145274139|NCT04223193|523851912|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
145274140|NCT04223193|523851913|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
145274141|NCT04223193|523851912|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
145274142|NCT04223193|523851913|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
145274143|NCT04223193|523851912|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145274144|NCT04223193|523851913|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145274145|NCT04223193|523851912|FG000|Overall Study|Physician Decision|0|||
145274146|NCT04223193|523851913|FG001|Overall Study|Physician Decision|1|||
145274147|NCT04223193|523851912|FG000|Overall Study|Protocol Violation|1|||
145274148|NCT04223193|523851913|FG001|Overall Study|Protocol Violation|1|||
145274149|NCT04223193|523851912|FG000|Overall Study|Site Terminated by Sponsor|1|||
145274150|NCT04223193|523851913|FG001|Overall Study|Site Terminated by Sponsor|3|||
145274151|NCT04223193|523851912|FG000|Overall Study|Withdrawal by Subject|5|||
145274152|NCT04223193|523851913|FG001|Overall Study|Withdrawal by Subject|6|||
145274153|NCT04223193|523851912|FG000|Overall Study|Other|3|||
145274154|NCT04223193|523851913|FG001|Overall Study|Other|6|||
145274155|NCT03193190|523851916|FG000|Stage 1|Arm Terminated by Sponsor|0|||
145274156|NCT03193190|523851917|FG001|Stage 1|Arm Terminated by Sponsor|0|||
145274157|NCT03193190|523851918|FG002|Stage 1|Arm Terminated by Sponsor|0|||
145274158|NCT03193190|523851919|FG003|Stage 1|Arm Terminated by Sponsor|1|||
145274159|NCT03193190|523851920|FG004|Stage 1|Arm Terminated by Sponsor|0|||
145274160|NCT03193190|523851921|FG005|Stage 1|Arm Terminated by Sponsor|2|||
145274161|NCT03193190|523851922|FG006|Stage 1|Arm Terminated by Sponsor|0|||
145274162|NCT03193190|523851923|FG007|Stage 1|Arm Terminated by Sponsor|0|||
145274163|NCT03193190|523851924|FG008|Stage 1|Arm Terminated by Sponsor|0|||
145274164|NCT03193190|523851925|FG009|Stage 1|Arm Terminated by Sponsor|0|||
145274165|NCT03193190|523851926|FG010|Stage 1|Arm Terminated by Sponsor|0|||
145274166|NCT03193190|523851927|FG011|Stage 1|Arm Terminated by Sponsor|0|||
145274167|NCT03193190|523851928|FG012|Stage 1|Arm Terminated by Sponsor|0|||
145274168|NCT03193190|523851929|FG013|Stage 1|Arm Terminated by Sponsor|0|||
145274169|NCT03193190|523851930|FG014|Stage 1|Arm Terminated by Sponsor|0|||
145274170|NCT03193190|523851931|FG015|Stage 1|Arm Terminated by Sponsor|0|||
145274171|NCT03193190|523851916|FG000|Stage 1|Death|22|||
145274172|NCT03193190|523851917|FG001|Stage 1|Death|8|||
145274173|NCT03193190|523851918|FG002|Stage 1|Death|23|||
145274174|NCT03193190|523851919|FG003|Stage 1|Death|14|||
145274175|NCT03193190|523851920|FG004|Stage 1|Death|34|||
145274176|NCT03193190|523851921|FG005|Stage 1|Death|28|||
145274177|NCT03193190|523851922|FG006|Stage 1|Death|19|||
145274178|NCT03193190|523851923|FG007|Stage 1|Death|21|||
145274179|NCT03193190|523851924|FG008|Stage 1|Death|14|||
145274180|NCT03193190|523851925|FG009|Stage 1|Death|10|||
145274181|NCT03193190|523851926|FG010|Stage 1|Death|59|||
145274182|NCT03193190|523851927|FG011|Stage 1|Death|14|||
145274183|NCT03193190|523851928|FG012|Stage 1|Death|14|||
145274184|NCT03193190|523851929|FG013|Stage 1|Death|0|||
145274185|NCT03193190|523851930|FG014|Stage 1|Death|0|||
145274186|NCT03193190|523851931|FG015|Stage 1|Death|0|||
145274187|NCT03193190|523851916|FG000|Stage 1|Lost to Follow-up|2|||
145274188|NCT03193190|523851917|FG001|Stage 1|Lost to Follow-up|1|||
145274189|NCT03193190|523851918|FG002|Stage 1|Lost to Follow-up|1|||
145274190|NCT03193190|523851919|FG003|Stage 1|Lost to Follow-up|0|||
145274191|NCT03193190|523851920|FG004|Stage 1|Lost to Follow-up|0|||
145274192|NCT03193190|523851921|FG005|Stage 1|Lost to Follow-up|0|||
145532654|NCT05055128|524811653|FG001|Overall Study|Withdrawal by Subject|2|||
145532655|NCT05055128|524811654|FG002|Overall Study|Withdrawal by Subject|2|||
145532656|NCT05055128|524811655|FG003|Overall Study|Withdrawal by Subject|4|||
145532657|NCT05055128|524811656|FG004|Overall Study|Withdrawal by Subject|2|||
145532658|NCT05055128|524811652|FG000|Overall Study|Randomized By Mistake|0|||
145274193|NCT03193190|523851922|FG006|Stage 1|Lost to Follow-up|1|||
145274194|NCT03193190|523851923|FG007|Stage 1|Lost to Follow-up|0|||
145274195|NCT03193190|523851924|FG008|Stage 1|Lost to Follow-up|0|||
145274196|NCT03193190|523851925|FG009|Stage 1|Lost to Follow-up|0|||
145274197|NCT03193190|523851926|FG010|Stage 1|Lost to Follow-up|0|||
145274198|NCT03193190|523851927|FG011|Stage 1|Lost to Follow-up|0|||
145274199|NCT03193190|523851928|FG012|Stage 1|Lost to Follow-up|0|||
145274200|NCT03193190|523851929|FG013|Stage 1|Lost to Follow-up|0|||
145274201|NCT03193190|523851930|FG014|Stage 1|Lost to Follow-up|0|||
145532659|NCT05055128|524811653|FG001|Overall Study|Randomized By Mistake|1|||
145274202|NCT03193190|523851931|FG015|Stage 1|Lost to Follow-up|0|||
145274203|NCT03193190|523851916|FG000|Stage 1|Reason not Specified|1|||
145274204|NCT03193190|523851917|FG001|Stage 1|Reason not Specified|0|||
145274205|NCT03193190|523851918|FG002|Stage 1|Reason not Specified|0|||
145274206|NCT03193190|523851919|FG003|Stage 1|Reason not Specified|1|||
145274207|NCT03193190|523851920|FG004|Stage 1|Reason not Specified|0|||
145274208|NCT03193190|523851921|FG005|Stage 1|Reason not Specified|1|||
145274209|NCT03193190|523851922|FG006|Stage 1|Reason not Specified|2|||
145759617|NCT01552902|525632096|FG002|Overall Study|Protocol Violation|3|||
145759618|NCT01552902|525632094|FG000|Overall Study|Lack of Efficacy|4|||
145759619|NCT01552902|525632095|FG001|Overall Study|Lack of Efficacy|3|||
145759620|NCT01552902|525632096|FG002|Overall Study|Lack of Efficacy|1|||
145759621|NCT01552902|525632094|FG000|Overall Study|Withdrawal by Subject|1|||
145759622|NCT01552902|525632095|FG001|Overall Study|Withdrawal by Subject|9|||
145759623|NCT01552902|525632096|FG002|Overall Study|Withdrawal by Subject|6|||
145759624|NCT01552902|525632094|FG000|Overall Study|Lost to Follow-up|1|||
145607670|NCT00402337|525079224|FG000|Overall Study|Other Reason|0|||
145607671|NCT00402337|525079225|FG001|Overall Study|Other Reason|1|||
145607672|NCT00402337|525079226|FG002|Overall Study|Other Reason|0|||
145402888|NCT02065557|524332549|FG005|Induction Period|Non-Responder at Week 8|0|||
145607673|NCT00402337|525079227|FG003|Overall Study|Other Reason|0|||
145607674|NCT00402337|525079228|FG004|Overall Study|Other Reason|0|||
145607675|NCT02178566|525079229|FG000|Overall Study|patient did not complete due to noncompliance|0|||
145607676|NCT02178566|525079230|FG001|Overall Study|patient did not complete due to noncompliance|1|||
145607677|NCT00682643|525079236|FG000|Overall Study|Adverse Event|12|||
145759625|NCT01552902|525632095|FG001|Overall Study|Lost to Follow-up|3|||
145759626|NCT01552902|525632096|FG002|Overall Study|Lost to Follow-up|6|||
145759627|NCT01552902|525632094|FG000|Overall Study|Other|3|||
145759628|NCT01552902|525632095|FG001|Overall Study|Other|4|||
145759629|NCT01552902|525632096|FG002|Overall Study|Other|3|||
145759630|NCT02487108|525632099|FG000|Overall Study|Adverse Event|1|||
145759631|NCT02487108|525632100|FG001|Overall Study|Adverse Event|6|||
145759632|NCT02487108|525632101|FG002|Overall Study|Adverse Event|12|||
145759633|NCT02487108|525632102|FG003|Overall Study|Adverse Event|6|||
145759634|NCT02487108|525632099|FG000|Overall Study|Withdrawal by Subject|8|||
145759635|NCT02487108|525632100|FG001|Overall Study|Withdrawal by Subject|5|||
145759636|NCT02487108|525632101|FG002|Overall Study|Withdrawal by Subject|5|||
145759637|NCT02487108|525632102|FG003|Overall Study|Withdrawal by Subject|0|||
145759638|NCT02487108|525632099|FG000|Overall Study|Non-compliance to study medication|3|||
145759639|NCT02487108|525632100|FG001|Overall Study|Non-compliance to study medication|2|||
145759640|NCT02487108|525632101|FG002|Overall Study|Non-compliance to study medication|5|||
145759641|NCT02487108|525632102|FG003|Overall Study|Non-compliance to study medication|4|||
145759642|NCT02487108|525632099|FG000|Overall Study|Protocol Violation|1|||
145759643|NCT02487108|525632100|FG001|Overall Study|Protocol Violation|1|||
145759644|NCT02487108|525632101|FG002|Overall Study|Protocol Violation|2|||
145759645|NCT02487108|525632102|FG003|Overall Study|Protocol Violation|0|||
145759646|NCT02487108|525632099|FG000|Overall Study|Non-compliance to study procedures|0|||
145759647|NCT02487108|525632100|FG001|Overall Study|Non-compliance to study procedures|0|||
145759648|NCT02487108|525632101|FG002|Overall Study|Non-compliance to study procedures|0|||
145759649|NCT02487108|525632102|FG003|Overall Study|Non-compliance to study procedures|1|||
145759650|NCT02487108|525632099|FG000|Overall Study|Other than specified|3|||
145759651|NCT02487108|525632100|FG001|Overall Study|Other than specified|2|||
145759652|NCT02487108|525632101|FG002|Overall Study|Other than specified|2|||
145759653|NCT02487108|525632102|FG003|Overall Study|Other than specified|0|||
145759654|NCT03653390|525632103|FG000|Overall Study|Lost to Follow-up|12|||
145759655|NCT03653390|525632104|FG001|Overall Study|Lost to Follow-up|8|||
145759656|NCT03653390|525632105|FG002|Overall Study|Lost to Follow-up|7|||
145759657|NCT03653390|525632103|FG000|Overall Study|Withdrawal by Subject|6|||
145759658|NCT03653390|525632104|FG001|Overall Study|Withdrawal by Subject|1|||
145759659|NCT03653390|525632105|FG002|Overall Study|Withdrawal by Subject|1|||
145759660|NCT03653390|525632103|FG000|Overall Study|Death|1|||
145759661|NCT03653390|525632104|FG001|Overall Study|Death|0|||
145759662|NCT03653390|525632105|FG002|Overall Study|Death|0|||
145759663|NCT03653390|525632103|FG000|Overall Study|Paper Survey Lost|1|||
145759664|NCT03653390|525632104|FG001|Overall Study|Paper Survey Lost|0|||
145759665|NCT03653390|525632105|FG002|Overall Study|Paper Survey Lost|0|||
145759666|NCT02769624|525632106|FG000|Overall Study|Lost to Follow-up|0|||
145759667|NCT02769624|525632107|FG001|Overall Study|Lost to Follow-up|1|||
145759668|NCT00448708|525632109|FG000|Overall Study|Death|21|||
145759669|NCT00448708|525632110|FG001|Overall Study|Death|17|||
145759670|NCT00448708|525632109|FG000|Overall Study|Withdrawal by Subject|8|||
145759671|NCT00448708|525632110|FG001|Overall Study|Withdrawal by Subject|4|||
145759672|NCT00448708|525632109|FG000|Overall Study|Lost to Follow-up|6|||
145759673|NCT00448708|525632110|FG001|Overall Study|Lost to Follow-up|8|||
145759674|NCT00448708|525632109|FG000|Overall Study|not listed|0|||
145759675|NCT00448708|525632110|FG001|Overall Study|not listed|2|||
145759676|NCT04698525|525632111|FG000|Overall Study|Lost to Follow-up|1|||
145759677|NCT04698525|525632112|FG001|Overall Study|Lost to Follow-up|2|||
145759678|NCT04698525|525632111|FG000|Overall Study|Three suffered of Covid-19|2|||
145759679|NCT04698525|525632112|FG001|Overall Study|Three suffered of Covid-19|1|||
145759680|NCT00354601|525632113|FG000|Overall Study|Protocol Violation|1|||
145759681|NCT00354601|525632113|FG000|Overall Study|progression|1|||
145759682|NCT03603652|525632114|FG000|Overall Study|Death|2|||
145759683|NCT02908516|525632117|FG000|Overall Study|Study Terminated|3|||
145759684|NCT02908516|525632118|FG001|Overall Study|Study Terminated|3|||
145759685|NCT01225562|525632119|FG000|Overall Study|Withdrawal by Subject|52|||
145759686|NCT01225562|525632120|FG001|Overall Study|Withdrawal by Subject|50|||
145759687|NCT01225562|525632121|FG002|Overall Study|Withdrawal by Subject|52|||
145759688|NCT01225562|525632119|FG000|Overall Study|Lost to Follow-up|3|||
145759689|NCT01225562|525632120|FG001|Overall Study|Lost to Follow-up|6|||
145759690|NCT01225562|525632121|FG002|Overall Study|Lost to Follow-up|1|||
145759691|NCT01481896|525632122|FG000|Overall Study|Lost to Follow-up|12|||
145759692|NCT01162421|525632123|FG000|Overall Study|Did not receive study drug|2|||
145759693|NCT01162421|525632124|FG001|Overall Study|Did not receive study drug|1|||
145759694|NCT01162421|525632123|FG000|Overall Study|Adverse Event|2|||
145402889|NCT02065557|524332544|FG000|Induction Period|Adverse Event|1|||
145402890|NCT02065557|524332545|FG001|Induction Period|Adverse Event|1|||
145402891|NCT02065557|524332546|FG002|Induction Period|Adverse Event|0|||
145402892|NCT02065557|524332547|FG003|Induction Period|Adverse Event|0|||
145274210|NCT03193190|523851923|FG007|Stage 1|Reason not Specified|2|||
145274211|NCT03193190|523851924|FG008|Stage 1|Reason not Specified|0|||
145274212|NCT03193190|523851925|FG009|Stage 1|Reason not Specified|1|||
145274213|NCT03193190|523851926|FG010|Stage 1|Reason not Specified|3|||
145274214|NCT03193190|523851927|FG011|Stage 1|Reason not Specified|0|||
145274215|NCT03193190|523851928|FG012|Stage 1|Reason not Specified|1|||
145274216|NCT03193190|523851929|FG013|Stage 1|Reason not Specified|0|||
145274217|NCT03193190|523851930|FG014|Stage 1|Reason not Specified|0|||
145274218|NCT03193190|523851931|FG015|Stage 1|Reason not Specified|0|||
145532660|NCT05055128|524811654|FG002|Overall Study|Randomized By Mistake|0|||
145532661|NCT05055128|524811655|FG003|Overall Study|Randomized By Mistake|0|||
145532662|NCT05055128|524811656|FG004|Overall Study|Randomized By Mistake|0|||
145532663|NCT05055128|524811652|FG000|Overall Study|Other|1|||
145274219|NCT03193190|523851916|FG000|Stage 1|Physician Decision|0|||
145274220|NCT03193190|523851917|FG001|Stage 1|Physician Decision|0|||
145274221|NCT03193190|523851918|FG002|Stage 1|Physician Decision|0|||
145274222|NCT03193190|523851919|FG003|Stage 1|Physician Decision|0|||
145274223|NCT03193190|523851920|FG004|Stage 1|Physician Decision|0|||
145274224|NCT03193190|523851921|FG005|Stage 1|Physician Decision|0|||
145274225|NCT03193190|523851922|FG006|Stage 1|Physician Decision|0|||
145274226|NCT03193190|523851923|FG007|Stage 1|Physician Decision|0|||
145274227|NCT03193190|523851924|FG008|Stage 1|Physician Decision|0|||
145274228|NCT03193190|523851925|FG009|Stage 1|Physician Decision|0|||
145274229|NCT03193190|523851926|FG010|Stage 1|Physician Decision|0|||
145274230|NCT03193190|523851927|FG011|Stage 1|Physician Decision|1|||
145274231|NCT03193190|523851928|FG012|Stage 1|Physician Decision|0|||
145274232|NCT03193190|523851929|FG013|Stage 1|Physician Decision|0|||
145274233|NCT03193190|523851930|FG014|Stage 1|Physician Decision|0|||
145274234|NCT03193190|523851931|FG015|Stage 1|Physician Decision|0|||
145274235|NCT03193190|523851916|FG000|Stage 1|Progressive Disease|1|||
145274236|NCT03193190|523851917|FG001|Stage 1|Progressive Disease|0|||
145274237|NCT03193190|523851918|FG002|Stage 1|Progressive Disease|0|||
145274238|NCT03193190|523851919|FG003|Stage 1|Progressive Disease|0|||
145274239|NCT03193190|523851920|FG004|Stage 1|Progressive Disease|0|||
145274240|NCT03193190|523851921|FG005|Stage 1|Progressive Disease|0|||
145274241|NCT03193190|523851922|FG006|Stage 1|Progressive Disease|0|||
145274242|NCT03193190|523851923|FG007|Stage 1|Progressive Disease|0|||
145274243|NCT03193190|523851924|FG008|Stage 1|Progressive Disease|0|||
145274244|NCT03193190|523851925|FG009|Stage 1|Progressive Disease|0|||
145274245|NCT03193190|523851926|FG010|Stage 1|Progressive Disease|0|||
145274246|NCT03193190|523851927|FG011|Stage 1|Progressive Disease|0|||
145274247|NCT03193190|523851928|FG012|Stage 1|Progressive Disease|0|||
145274248|NCT03193190|523851929|FG013|Stage 1|Progressive Disease|0|||
145274249|NCT03193190|523851930|FG014|Stage 1|Progressive Disease|0|||
145274250|NCT03193190|523851931|FG015|Stage 1|Progressive Disease|0|||
145274251|NCT03193190|523851916|FG000|Stage 1|Study Terminated By Sponsor|3|||
145274252|NCT03193190|523851917|FG001|Stage 1|Study Terminated By Sponsor|0|||
145274253|NCT03193190|523851918|FG002|Stage 1|Study Terminated By Sponsor|0|||
145274254|NCT03193190|523851919|FG003|Stage 1|Study Terminated By Sponsor|0|||
145274255|NCT03193190|523851920|FG004|Stage 1|Study Terminated By Sponsor|6|||
145274256|NCT03193190|523851921|FG005|Stage 1|Study Terminated By Sponsor|0|||
145274257|NCT03193190|523851922|FG006|Stage 1|Study Terminated By Sponsor|0|||
145274258|NCT03193190|523851923|FG007|Stage 1|Study Terminated By Sponsor|0|||
145274259|NCT03193190|523851924|FG008|Stage 1|Study Terminated By Sponsor|0|||
145274260|NCT03193190|523851925|FG009|Stage 1|Study Terminated By Sponsor|0|||
145274261|NCT03193190|523851926|FG010|Stage 1|Study Terminated By Sponsor|0|||
145274262|NCT03193190|523851927|FG011|Stage 1|Study Terminated By Sponsor|0|||
145532664|NCT05055128|524811653|FG001|Overall Study|Other|0|||
145532665|NCT05055128|524811654|FG002|Overall Study|Other|0|||
145532666|NCT05055128|524811655|FG003|Overall Study|Other|0|||
145532667|NCT05055128|524811656|FG004|Overall Study|Other|0|||
145532668|NCT00747461|524811663|FG000|Overall Study|study terminated by sponsor|5|||
145532669|NCT02149875|524811664|FG000|Overall Study|Lost to Follow-up|3|||
145274263|NCT03193190|523851928|FG012|Stage 1|Study Terminated By Sponsor|0|||
145274264|NCT03193190|523851929|FG013|Stage 1|Study Terminated By Sponsor|0|||
145274265|NCT03193190|523851930|FG014|Stage 1|Study Terminated By Sponsor|0|||
145274266|NCT03193190|523851931|FG015|Stage 1|Study Terminated By Sponsor|0|||
145532670|NCT02149875|524811665|FG001|Overall Study|Lost to Follow-up|4|||
145759695|NCT01162421|525632124|FG001|Overall Study|Adverse Event|5|||
145274267|NCT03193190|523851916|FG000|Stage 1|Withdrawal by Subject|6|||
145274268|NCT03193190|523851917|FG001|Stage 1|Withdrawal by Subject|0|||
145532671|NCT02149875|524811666|FG002|Overall Study|Lost to Follow-up|5|||
145274269|NCT03193190|523851918|FG002|Stage 1|Withdrawal by Subject|1|||
145274270|NCT03193190|523851919|FG003|Stage 1|Withdrawal by Subject|0|||
145274271|NCT03193190|523851920|FG004|Stage 1|Withdrawal by Subject|2|||
145274272|NCT03193190|523851921|FG005|Stage 1|Withdrawal by Subject|0|||
145274273|NCT03193190|523851922|FG006|Stage 1|Withdrawal by Subject|3|||
145274274|NCT03193190|523851923|FG007|Stage 1|Withdrawal by Subject|2|||
145274275|NCT03193190|523851924|FG008|Stage 1|Withdrawal by Subject|2|||
145274276|NCT03193190|523851925|FG009|Stage 1|Withdrawal by Subject|4|||
145532672|NCT02149875|524811664|FG000|Overall Study|Withdrawal by Subject|3|||
145532673|NCT02149875|524811665|FG001|Overall Study|Withdrawal by Subject|2|||
145532674|NCT02149875|524811666|FG002|Overall Study|Withdrawal by Subject|2|||
145532675|NCT02149875|524811664|FG000|Overall Study|Physician Decision|1|||
145532676|NCT02149875|524811665|FG001|Overall Study|Physician Decision|2|||
145532677|NCT02149875|524811666|FG002|Overall Study|Physician Decision|2|||
145532678|NCT00299182|524811667|FG000|Overall Study|Withdrawal by Subject|0|||
145532679|NCT00299182|524811668|FG001|Overall Study|Withdrawal by Subject|0|||
145532680|NCT00299182|524811669|FG002|Overall Study|Withdrawal by Subject|1|||
145532681|NCT00299182|524811670|FG003|Overall Study|Withdrawal by Subject|0|||
145607678|NCT00682643|525079237|FG001|Overall Study|Adverse Event|23|||
145274277|NCT03193190|523851926|FG010|Stage 1|Withdrawal by Subject|9|||
145274278|NCT03193190|523851927|FG011|Stage 1|Withdrawal by Subject|1|||
145274279|NCT03193190|523851928|FG012|Stage 1|Withdrawal by Subject|0|||
145274280|NCT03193190|523851929|FG013|Stage 1|Withdrawal by Subject|0|||
145274281|NCT03193190|523851930|FG014|Stage 1|Withdrawal by Subject|0|||
145759696|NCT01162421|525632123|FG000|Overall Study|Lost to Follow-up|0|||
145759697|NCT01162421|525632124|FG001|Overall Study|Lost to Follow-up|2|||
145759698|NCT01162421|525632123|FG000|Overall Study|Lack of Efficacy|2|||
145759699|NCT01162421|525632124|FG001|Overall Study|Lack of Efficacy|2|||
145759700|NCT01162421|525632123|FG000|Overall Study|Other|2|||
145759701|NCT01162421|525632124|FG001|Overall Study|Other|3|||
145759702|NCT03336502|525632125|FG000|Overall Study|Physician Decision|0|||
145759703|NCT03336502|525632126|FG001|Overall Study|Physician Decision|1|||
145759704|NCT03336502|525632125|FG000|Overall Study|Prohibited Drugs|1|||
145759705|NCT03336502|525632126|FG001|Overall Study|Prohibited Drugs|1|||
145759706|NCT03336502|525632125|FG000|Overall Study|Death|1|||
145759707|NCT03336502|525632126|FG001|Overall Study|Death|2|||
145759708|NCT03336502|525632125|FG000|Overall Study|Adverse Event|2|||
145759709|NCT03336502|525632126|FG001|Overall Study|Adverse Event|5|||
145759710|NCT00480857|525632128|FG000|Overall Study|Lack of Efficacy|2|||
145759711|NCT00611247|525632129|FG000|Overall Study|Death|1|||
145759712|NCT00611247|525632130|FG001|Overall Study|Death|5|||
145759713|NCT00611247|525632129|FG000|Overall Study|Lack of Efficacy|1|||
145759714|NCT00611247|525632130|FG001|Overall Study|Lack of Efficacy|16|||
145759715|NCT01107444|525632131|FG000|Overall Study|Withdrawal by Subject|8|||
145759716|NCT01107444|525632132|FG001|Overall Study|Withdrawal by Subject|12|||
145759717|NCT01107444|525632131|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
145759718|NCT01107444|525632132|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
145759719|NCT01948830|525632135|FG000|Overall Study|Physician Decision|1|||
145759720|NCT01948830|525632136|FG001|Overall Study|Physician Decision|3|||
145759721|NCT01948830|525632135|FG000|Overall Study|Protocol deviation|1|||
145759722|NCT01948830|525632136|FG001|Overall Study|Protocol deviation|2|||
145759723|NCT01948830|525632135|FG000|Overall Study|Lost to Follow-up|5|||
145759724|NCT01948830|525632136|FG001|Overall Study|Lost to Follow-up|4|||
145759725|NCT01948830|525632135|FG000|Overall Study|Withdrawal by Subject|14|||
145759726|NCT01948830|525632136|FG001|Overall Study|Withdrawal by Subject|17|||
145759727|NCT01948830|525632135|FG000|Overall Study|Adverse Event|9|||
145759728|NCT01948830|525632136|FG001|Overall Study|Adverse Event|2|||
145759729|NCT01948830|525632135|FG000|Overall Study|Death|3|||
145759730|NCT01948830|525632136|FG001|Overall Study|Death|4|||
145759731|NCT00243659|525632137|FG000|Overall Study|Withdrawal by Subject|1|||
145759732|NCT00243659|525632138|FG001|Overall Study|Withdrawal by Subject|1|||
145759733|NCT00243659|525632137|FG000|Overall Study|Protocol Violation|1|||
145759734|NCT00243659|525632138|FG001|Overall Study|Protocol Violation|2|||
145759735|NCT00268242|525632139|FG000|Overall Study|Death|1|||
145759736|NCT00464178|525632140|FG000|Overall Study|Protocol Violation|1|||
145759737|NCT00464178|525632140|FG000|Overall Study|Withdrawal by Subject|1|||
145759738|NCT03828487|525632144|FG000|Overall Study|Physician Decision|1|||
145759739|NCT01940484|525634164|FG000|Overall Study|Withdrawal by Subject|3|||
145759740|NCT01940484|525634164|FG000|Overall Study|Underwent transplantation|4|||
145759741|NCT01940484|525634164|FG000|Overall Study|Death|2|||
145759742|NCT01940484|525634164|FG000|Overall Study|Adverse Event|1|||
145274282|NCT03193190|523851931|FG015|Stage 1|Withdrawal by Subject|0|||
145274283|NCT03193190|523851916|FG000|Stage 2|Death|0|||
145274284|NCT03193190|523851917|FG001|Stage 2|Death|0|||
145607679|NCT00682643|525079236|FG000|Overall Study|Lack of Efficacy|2|||
145607680|NCT00682643|525079237|FG001|Overall Study|Lack of Efficacy|0|||
145607681|NCT00682643|525079236|FG000|Overall Study|Protocol Violation|38|||
145607682|NCT00682643|525079237|FG001|Overall Study|Protocol Violation|76|||
145759743|NCT03118947|525634173|FG000|Overall Study|Adverse Event|7|||
145274285|NCT03193190|523851918|FG002|Stage 2|Death|0|||
145759744|NCT03118947|525634173|FG000|Overall Study|Death|3|||
145759745|NCT03118947|525634173|FG000|Overall Study|Lack of Efficacy|4|||
145759746|NCT03118947|525634173|FG000|Overall Study|Non-compliance with study drug|1|||
145759747|NCT03118947|525634173|FG000|Overall Study|Protocol Violation|2|||
145759748|NCT03118947|525634173|FG000|Overall Study|Withdrawal by Subject|3|||
145759749|NCT03118947|525634173|FG000|Overall Study|Withdrawal by caregiver|3|||
145759750|NCT03118947|525634173|FG000|Overall Study|Change in patient's living situation|4|||
145274286|NCT03193190|523851919|FG003|Stage 2|Death|0|||
145759751|NCT03118947|525634173|FG000|Overall Study|Lost to Follow-up|2|||
145759752|NCT04451330|525634176|FG000|Overall Study|Adverse Event|1|||
145759753|NCT04451330|525634177|FG001|Overall Study|Adverse Event|2|||
145759754|NCT04451330|525634176|FG000|Overall Study|Lost to Follow-up|5|||
145759755|NCT04451330|525634177|FG001|Overall Study|Lost to Follow-up|0|||
145759756|NCT04451330|525634176|FG000|Overall Study|Withdrawal by Subject|3|||
145759757|NCT04451330|525634177|FG001|Overall Study|Withdrawal by Subject|1|||
145759758|NCT04451330|525634176|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145759759|NCT04451330|525634177|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145759760|NCT04451330|525634176|FG000|Overall Study|Other than specified|0|||
145759761|NCT04451330|525634177|FG001|Overall Study|Other than specified|1|||
145759762|NCT05099640|525634178|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
145759763|NCT05099640|525634179|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
145759764|NCT05099640|525634180|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
145759765|NCT05099640|525634178|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
145759766|NCT05099640|525634179|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
145759767|NCT05099640|525634180|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
145759768|NCT05099640|525634178|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
145759769|NCT05099640|525634179|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
145759770|NCT05099640|525634180|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
145759771|NCT05099640|525634178|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
145759772|NCT05099640|525634179|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
145759773|NCT05099640|525634180|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
145759774|NCT05099640|525634178|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
145759775|NCT05099640|525634179|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
145759776|NCT05099640|525634180|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
145759777|NCT05099640|525634178|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
145759778|NCT05099640|525634179|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
145759779|NCT05099640|525634180|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
145759780|NCT02690194|525634181|FG000|Overall Study|Withdrawal by Subject|1|||
145759781|NCT02690194|525634182|FG001|Overall Study|Withdrawal by Subject|4|||
145759782|NCT02690194|525634183|FG002|Overall Study|Withdrawal by Subject|0|||
145759783|NCT01552681|525634184|FG000|Overall Study|Withdrawal by Subject|4|||
145759784|NCT01552681|525634185|FG001|Overall Study|Withdrawal by Subject|0|||
145759785|NCT01552681|525634184|FG000|Overall Study|Physician Decision|1|||
145759786|NCT01552681|525634185|FG001|Overall Study|Physician Decision|0|||
145759787|NCT01552681|525634184|FG000|Overall Study|Subject moved away|0|||
145759788|NCT01552681|525634185|FG001|Overall Study|Subject moved away|1|||
145759789|NCT01987908|525634186|FG000|Placebo Lead-in Period|Adverse Event|2|||
145759790|NCT01987908|525634187|FG001|Placebo Lead-in Period|Adverse Event|0|||
145759791|NCT01987908|525634188|FG002|Placebo Lead-in Period|Adverse Event|0|||
145532682|NCT00299182|524811671|FG004|Overall Study|Withdrawal by Subject|1|||
145759792|NCT01987908|525634186|FG000|Placebo Lead-in Period|Physician Decision|2|||
145759793|NCT01987908|525634187|FG001|Placebo Lead-in Period|Physician Decision|0|||
145759794|NCT01987908|525634188|FG002|Placebo Lead-in Period|Physician Decision|0|||
145759795|NCT01987908|525634186|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
145759796|NCT01987908|525634187|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
145759797|NCT01987908|525634188|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
145759798|NCT01987908|525634186|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
145759799|NCT01987908|525634187|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
145759800|NCT01987908|525634188|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
145759801|NCT01987908|525634186|FG000|Treatment Period|Adverse Event|0|||
145759802|NCT01987908|525634187|FG001|Treatment Period|Adverse Event|1|||
145759803|NCT01987908|525634188|FG002|Treatment Period|Adverse Event|1|||
145759804|NCT01987908|525634186|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
145759805|NCT01987908|525634187|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
145759806|NCT01987908|525634188|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
145759807|NCT01987908|525634186|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
145759808|NCT01987908|525634187|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
145759809|NCT01987908|525634188|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
145759810|NCT00189462|525634189|FG000|Overall Study|Lack of Efficacy|5|||
145759811|NCT00189462|525634190|FG001|Overall Study|Lack of Efficacy|1|||
145759812|NCT00189462|525634189|FG000|Overall Study|Lost to Follow-up|18|||
145759813|NCT00189462|525634190|FG001|Overall Study|Lost to Follow-up|20|||
145759814|NCT02772757|525634194|FG000|Overall Study|Withdrawal by Subject|1|||
145759815|NCT02772757|525634195|FG001|Overall Study|Withdrawal by Subject|0|||
145759816|NCT02772757|525634196|FG002|Overall Study|Withdrawal by Subject|1|||
145759817|NCT02772757|525634194|FG000|Overall Study|Protocol Violation|0|||
145759818|NCT02772757|525634195|FG001|Overall Study|Protocol Violation|0|||
145759819|NCT02772757|525634196|FG002|Overall Study|Protocol Violation|1|||
145759820|NCT02772757|525634194|FG000|Overall Study|Physician Decision|0|||
145759821|NCT02772757|525634195|FG001|Overall Study|Physician Decision|3|||
145759822|NCT02772757|525634196|FG002|Overall Study|Physician Decision|3|||
145532683|NCT00299182|524811672|FG005|Overall Study|Withdrawal by Subject|2|||
145759823|NCT03486392|525634197|FG000|Overall Study|Lost to Follow-up|0|||
145759824|NCT03486392|525634198|FG001|Overall Study|Lost to Follow-up|0|||
145759825|NCT03486392|525634199|FG002|Overall Study|Lost to Follow-up|8|||
145759826|NCT03486392|525634200|FG003|Overall Study|Lost to Follow-up|5|||
145759827|NCT03486392|525634201|FG004|Overall Study|Lost to Follow-up|2|||
145759828|NCT03486392|525634197|FG000|Overall Study|Withdrawal by Subject|3|||
145759829|NCT03486392|525634198|FG001|Overall Study|Withdrawal by Subject|0|||
145759830|NCT03486392|525634199|FG002|Overall Study|Withdrawal by Subject|6|||
145759831|NCT03486392|525634200|FG003|Overall Study|Withdrawal by Subject|4|||
145759832|NCT03486392|525634201|FG004|Overall Study|Withdrawal by Subject|1|||
145759833|NCT03486392|525634197|FG000|Overall Study|Death|0|||
145759834|NCT03486392|525634198|FG001|Overall Study|Death|0|||
145759835|NCT03486392|525634199|FG002|Overall Study|Death|0|||
145759836|NCT03486392|525634200|FG003|Overall Study|Death|0|||
145759837|NCT03486392|525634201|FG004|Overall Study|Death|1|||
145759838|NCT00441792|525634204|FG000|Overall Study|Lost to Follow-up|0|||
145759839|NCT00441792|525634205|FG001|Overall Study|Lost to Follow-up|2|||
145759840|NCT01731678|525634206|FG000|Overall Study|Withdrawal by Subject|3|||
145532684|NCT00299182|524811673|FG006|Overall Study|Withdrawal by Subject|0|||
145532685|NCT00299182|524811667|FG000|Overall Study|Chemotherapy Changed|0|||
145759841|NCT01731678|525634206|FG000|Overall Study|Did not meet inclusion criteria|1|||
145759842|NCT01731678|525634206|FG000|Overall Study|RMT too high, making TMS difficult|3|||
145759843|NCT03665285|525634209|FG000|Overall Study|Started New Anticancer Treatment|1|||
145759844|NCT03665285|525634210|FG001|Overall Study|Started New Anticancer Treatment|1|||
145759845|NCT03665285|525634211|FG002|Overall Study|Started New Anticancer Treatment|2|||
145759846|NCT03665285|525634212|FG003|Overall Study|Started New Anticancer Treatment|4|||
145759847|NCT03665285|525634213|FG004|Overall Study|Started New Anticancer Treatment|1|||
145759848|NCT03665285|525634214|FG005|Overall Study|Started New Anticancer Treatment|1|||
145759849|NCT03665285|525634215|FG006|Overall Study|Started New Anticancer Treatment|2|||
145759850|NCT03665285|525634216|FG007|Overall Study|Started New Anticancer Treatment|15|||
145759851|NCT03665285|525634217|FG008|Overall Study|Started New Anticancer Treatment|1|||
145759852|NCT03665285|525634209|FG000|Overall Study|Disease Progression|0|||
145759853|NCT03665285|525634210|FG001|Overall Study|Disease Progression|0|||
145759854|NCT03665285|525634211|FG002|Overall Study|Disease Progression|3|||
145759855|NCT03665285|525634212|FG003|Overall Study|Disease Progression|1|||
145759856|NCT03665285|525634213|FG004|Overall Study|Disease Progression|0|||
145759857|NCT03665285|525634214|FG005|Overall Study|Disease Progression|0|||
145759858|NCT03665285|525634215|FG006|Overall Study|Disease Progression|0|||
145759859|NCT03665285|525634216|FG007|Overall Study|Disease Progression|7|||
145759860|NCT03665285|525634217|FG008|Overall Study|Disease Progression|1|||
145759861|NCT03665285|525634209|FG000|Overall Study|Hospice|0|||
145759862|NCT03665285|525634210|FG001|Overall Study|Hospice|0|||
145759863|NCT03665285|525634211|FG002|Overall Study|Hospice|0|||
145759864|NCT03665285|525634212|FG003|Overall Study|Hospice|0|||
145759865|NCT03665285|525634213|FG004|Overall Study|Hospice|0|||
145759866|NCT03665285|525634214|FG005|Overall Study|Hospice|0|||
145759867|NCT03665285|525634215|FG006|Overall Study|Hospice|0|||
145759868|NCT03665285|525634216|FG007|Overall Study|Hospice|2|||
145759869|NCT03665285|525634217|FG008|Overall Study|Hospice|0|||
145759870|NCT03665285|525634209|FG000|Overall Study|Withdrawal by Subject|0|||
145759871|NCT03665285|525634210|FG001|Overall Study|Withdrawal by Subject|0|||
145759872|NCT03665285|525634211|FG002|Overall Study|Withdrawal by Subject|0|||
145759873|NCT03665285|525634212|FG003|Overall Study|Withdrawal by Subject|0|||
145759874|NCT03665285|525634213|FG004|Overall Study|Withdrawal by Subject|1|||
145759875|NCT03665285|525634214|FG005|Overall Study|Withdrawal by Subject|0|||
145759876|NCT03665285|525634215|FG006|Overall Study|Withdrawal by Subject|0|||
145759877|NCT03665285|525634216|FG007|Overall Study|Withdrawal by Subject|2|||
145759878|NCT03665285|525634217|FG008|Overall Study|Withdrawal by Subject|0|||
145759879|NCT03665285|525634209|FG000|Overall Study|Physician Decision|0|||
145759880|NCT03665285|525634210|FG001|Overall Study|Physician Decision|0|||
145759881|NCT03665285|525634211|FG002|Overall Study|Physician Decision|0|||
145759882|NCT03665285|525634212|FG003|Overall Study|Physician Decision|0|||
145759883|NCT03665285|525634213|FG004|Overall Study|Physician Decision|0|||
145759884|NCT03665285|525634214|FG005|Overall Study|Physician Decision|0|||
145759885|NCT03665285|525634215|FG006|Overall Study|Physician Decision|0|||
145759886|NCT03665285|525634216|FG007|Overall Study|Physician Decision|2|||
145759887|NCT03665285|525634217|FG008|Overall Study|Physician Decision|0|||
145759888|NCT00888355|525634218|FG000|Overall Study|Adverse Event|10|||
145759889|NCT00888355|525634219|FG001|Overall Study|Adverse Event|0|||
145759890|NCT00888355|525634220|FG002|Overall Study|Adverse Event|3|||
145759891|NCT00888355|525634221|FG003|Overall Study|Adverse Event|3|||
145759892|NCT00888355|525634218|FG000|Overall Study|Lack of Efficacy|9|||
145759893|NCT00888355|525634219|FG001|Overall Study|Lack of Efficacy|2|||
145759894|NCT00888355|525634220|FG002|Overall Study|Lack of Efficacy|5|||
145759895|NCT00888355|525634221|FG003|Overall Study|Lack of Efficacy|2|||
145759896|NCT00888355|525634218|FG000|Overall Study|Lost to Follow-up|0|||
145759897|NCT00888355|525634219|FG001|Overall Study|Lost to Follow-up|2|||
145759898|NCT00888355|525634220|FG002|Overall Study|Lost to Follow-up|2|||
145759899|NCT00888355|525634221|FG003|Overall Study|Lost to Follow-up|0|||
145759900|NCT00888355|525634218|FG000|Overall Study|Protocol Violation|3|||
145274287|NCT03193190|523851920|FG004|Stage 2|Death|0|||
145274288|NCT03193190|523851921|FG005|Stage 2|Death|0|||
145274289|NCT03193190|523851922|FG006|Stage 2|Death|0|||
145274290|NCT03193190|523851923|FG007|Stage 2|Death|0|||
145274291|NCT03193190|523851924|FG008|Stage 2|Death|0|||
145274292|NCT03193190|523851925|FG009|Stage 2|Death|0|||
145274293|NCT03193190|523851926|FG010|Stage 2|Death|0|||
145274294|NCT03193190|523851927|FG011|Stage 2|Death|0|||
145274295|NCT03193190|523851928|FG012|Stage 2|Death|0|||
145274296|NCT03193190|523851929|FG013|Stage 2|Death|14|||
145274297|NCT03193190|523851930|FG014|Stage 2|Death|4|||
145274298|NCT03193190|523851931|FG015|Stage 2|Death|1|||
145274299|NCT03193190|523851916|FG000|Stage 2|Lost to Follow-up|0|||
145274300|NCT03193190|523851917|FG001|Stage 2|Lost to Follow-up|0|||
145274301|NCT03193190|523851918|FG002|Stage 2|Lost to Follow-up|0|||
145274302|NCT03193190|523851919|FG003|Stage 2|Lost to Follow-up|0|||
145274303|NCT03193190|523851920|FG004|Stage 2|Lost to Follow-up|0|||
145274304|NCT03193190|523851921|FG005|Stage 2|Lost to Follow-up|0|||
145274305|NCT03193190|523851922|FG006|Stage 2|Lost to Follow-up|0|||
145274306|NCT03193190|523851923|FG007|Stage 2|Lost to Follow-up|0|||
145274307|NCT03193190|523851924|FG008|Stage 2|Lost to Follow-up|0|||
145274308|NCT03193190|523851925|FG009|Stage 2|Lost to Follow-up|0|||
145274309|NCT03193190|523851926|FG010|Stage 2|Lost to Follow-up|0|||
145274310|NCT03193190|523851927|FG011|Stage 2|Lost to Follow-up|0|||
145274311|NCT03193190|523851928|FG012|Stage 2|Lost to Follow-up|0|||
145274312|NCT03193190|523851929|FG013|Stage 2|Lost to Follow-up|0|||
145274313|NCT03193190|523851930|FG014|Stage 2|Lost to Follow-up|1|||
145274314|NCT03193190|523851931|FG015|Stage 2|Lost to Follow-up|0|||
145274315|NCT03193190|523851916|FG000|Stage 2|Withdrawal by Subject|0|||
145274316|NCT03193190|523851917|FG001|Stage 2|Withdrawal by Subject|0|||
145274317|NCT03193190|523851918|FG002|Stage 2|Withdrawal by Subject|0|||
145274318|NCT03193190|523851919|FG003|Stage 2|Withdrawal by Subject|0|||
145274319|NCT03193190|523851920|FG004|Stage 2|Withdrawal by Subject|0|||
145274320|NCT03193190|523851921|FG005|Stage 2|Withdrawal by Subject|0|||
145274321|NCT03193190|523851922|FG006|Stage 2|Withdrawal by Subject|0|||
145274322|NCT03193190|523851923|FG007|Stage 2|Withdrawal by Subject|0|||
145274323|NCT03193190|523851924|FG008|Stage 2|Withdrawal by Subject|0|||
145274324|NCT03193190|523851925|FG009|Stage 2|Withdrawal by Subject|0|||
145274325|NCT03193190|523851926|FG010|Stage 2|Withdrawal by Subject|0|||
145759901|NCT00888355|525634219|FG001|Overall Study|Protocol Violation|2|||
145759902|NCT00888355|525634220|FG002|Overall Study|Protocol Violation|1|||
145759903|NCT00888355|525634221|FG003|Overall Study|Protocol Violation|2|||
145759904|NCT00888355|525634218|FG000|Overall Study|Withdrawal by Subject|0|||
145759905|NCT00888355|525634219|FG001|Overall Study|Withdrawal by Subject|3|||
145274326|NCT03193190|523851927|FG011|Stage 2|Withdrawal by Subject|0|||
145274327|NCT03193190|523851928|FG012|Stage 2|Withdrawal by Subject|0|||
145274328|NCT03193190|523851929|FG013|Stage 2|Withdrawal by Subject|1|||
145274329|NCT03193190|523851930|FG014|Stage 2|Withdrawal by Subject|1|||
145607683|NCT00682643|525079236|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
145759906|NCT00888355|525634220|FG002|Overall Study|Withdrawal by Subject|1|||
145274330|NCT03193190|523851931|FG015|Stage 2|Withdrawal by Subject|0|||
145274331|NCT03532295|523851932|FG000|Overall Study|Did not start treatment|0|||
145274332|NCT03532295|523851933|FG001|Overall Study|Did not start treatment|2|||
145274333|NCT03732677|523851937|FG000|Overall Study|Terminated the study|154|||
145274334|NCT03732677|523851938|FG001|Overall Study|Terminated the study|197|||
145274335|NCT03732677|523851937|FG000|Overall Study|Continuing study off treatment|379|||
145759907|NCT00888355|525634221|FG003|Overall Study|Withdrawal by Subject|3|||
145274336|NCT03732677|523851938|FG001|Overall Study|Continuing study off treatment|333|||
145274337|NCT04644237|523851939|FG000|Overall Study|Death|4|||
145274338|NCT04644237|523851940|FG001|Overall Study|Death|2|||
145274339|NCT04644237|523851939|FG000|Overall Study|Adverse Event|18|||
145274340|NCT04644237|523851940|FG001|Overall Study|Adverse Event|19|||
145759908|NCT00331006|525634225|FG000|Screening Phase|Withdrawal by Subject|1|||
145274341|NCT04644237|523851939|FG000|Overall Study|Progressive Disease|61|||
145274342|NCT04644237|523851940|FG001|Overall Study|Progressive Disease|23|||
145274343|NCT04644237|523851939|FG000|Overall Study|Clinical Progression|4|||
145274344|NCT04644237|523851940|FG001|Overall Study|Clinical Progression|1|||
145274345|NCT04644237|523851939|FG000|Overall Study|Withdrawal by Subject|4|||
145759909|NCT00331006|525634225|FG000|Screening Phase|enrollment halted|1|||
145759910|NCT00331006|525634225|FG000|Screening Phase|Lost to Follow-up|1|||
145759911|NCT00331006|525634225|FG000|Screening Phase|Ineligible for treatment phase|4|||
145759912|NCT00331006|525634225|FG000|Treatment Phase|Withdrawal by Subject|1|||
145759913|NCT00331006|525634225|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
145759914|NCT00331006|525634225|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
145759915|NCT03213366|525634228|FG000|Overall Study|Lost to Follow-up|9|||
145759916|NCT03213366|525634229|FG001|Overall Study|Lost to Follow-up|4|||
145759917|NCT02532855|525634230|FG000|Overall Study|Lost to Follow-up|4|||
145759918|NCT02532855|525634231|FG001|Overall Study|Lost to Follow-up|3|||
145759919|NCT02532855|525634230|FG000|Overall Study|Withdrawal by Subject|4|||
145759920|NCT02532855|525634231|FG001|Overall Study|Withdrawal by Subject|8|||
145759921|NCT00666926|525634232|FG000|Overall Study|Adverse Event|0|||
145759922|NCT00666926|525634233|FG001|Overall Study|Adverse Event|0|||
145759923|NCT00666926|525634234|FG002|Overall Study|Adverse Event|0|||
145759924|NCT00666926|525634235|FG003|Overall Study|Adverse Event|0|||
145759925|NCT00666926|525634236|FG004|Overall Study|Adverse Event|0|||
145759926|NCT00666926|525634237|FG005|Overall Study|Adverse Event|0|||
145759927|NCT00666926|525634238|FG006|Overall Study|Adverse Event|0|||
145759928|NCT00666926|525634239|FG007|Overall Study|Adverse Event|0|||
145759929|NCT00666926|525634240|FG008|Overall Study|Adverse Event|0|||
145759930|NCT00666926|525634241|FG009|Overall Study|Adverse Event|2|||
145759931|NCT00666926|525634242|FG010|Overall Study|Adverse Event|2|||
145759932|NCT00666926|525634243|FG011|Overall Study|Adverse Event|2|||
145759933|NCT00666926|525634244|FG012|Overall Study|Adverse Event|0|||
145759934|NCT00666926|525634245|FG013|Overall Study|Adverse Event|1|||
145759935|NCT00666926|525634246|FG014|Overall Study|Adverse Event|0|||
145759936|NCT00666926|525634247|FG015|Overall Study|Adverse Event|0|||
145759937|NCT00666926|525634232|FG000|Overall Study|Laboratory abnormality|0|||
145759938|NCT00666926|525634233|FG001|Overall Study|Laboratory abnormality|0|||
145759939|NCT00666926|525634234|FG002|Overall Study|Laboratory abnormality|0|||
145759940|NCT00666926|525634235|FG003|Overall Study|Laboratory abnormality|0|||
145759941|NCT00666926|525634236|FG004|Overall Study|Laboratory abnormality|0|||
145759942|NCT00666926|525634237|FG005|Overall Study|Laboratory abnormality|0|||
145759943|NCT00666926|525634238|FG006|Overall Study|Laboratory abnormality|0|||
145759944|NCT00666926|525634239|FG007|Overall Study|Laboratory abnormality|0|||
145759945|NCT00666926|525634240|FG008|Overall Study|Laboratory abnormality|0|||
145759946|NCT00666926|525634241|FG009|Overall Study|Laboratory abnormality|0|||
145759947|NCT00666926|525634242|FG010|Overall Study|Laboratory abnormality|1|||
145759948|NCT00666926|525634243|FG011|Overall Study|Laboratory abnormality|0|||
145759949|NCT00666926|525634244|FG012|Overall Study|Laboratory abnormality|0|||
145759950|NCT00666926|525634245|FG013|Overall Study|Laboratory abnormality|0|||
145759951|NCT00666926|525634246|FG014|Overall Study|Laboratory abnormality|0|||
145759952|NCT00666926|525634247|FG015|Overall Study|Laboratory abnormality|1|||
145759953|NCT00666926|525634232|FG000|Overall Study|Lack of Efficacy|0|||
145759954|NCT00666926|525634233|FG001|Overall Study|Lack of Efficacy|0|||
145759955|NCT00666926|525634234|FG002|Overall Study|Lack of Efficacy|0|||
145759956|NCT00666926|525634235|FG003|Overall Study|Lack of Efficacy|0|||
145759957|NCT00666926|525634236|FG004|Overall Study|Lack of Efficacy|0|||
145759958|NCT00666926|525634237|FG005|Overall Study|Lack of Efficacy|1|||
145759959|NCT00666926|525634238|FG006|Overall Study|Lack of Efficacy|0|||
145532686|NCT00299182|524811668|FG001|Overall Study|Chemotherapy Changed|0|||
145532687|NCT00299182|524811669|FG002|Overall Study|Chemotherapy Changed|1|||
145759960|NCT00666926|525634239|FG007|Overall Study|Lack of Efficacy|0|||
145759961|NCT00666926|525634240|FG008|Overall Study|Lack of Efficacy|0|||
145759962|NCT00666926|525634241|FG009|Overall Study|Lack of Efficacy|0|||
145759963|NCT00666926|525634242|FG010|Overall Study|Lack of Efficacy|0|||
145759964|NCT00666926|525634243|FG011|Overall Study|Lack of Efficacy|1|||
145759965|NCT00666926|525634244|FG012|Overall Study|Lack of Efficacy|0|||
145759966|NCT00666926|525634245|FG013|Overall Study|Lack of Efficacy|0|||
145759967|NCT00666926|525634246|FG014|Overall Study|Lack of Efficacy|0|||
145759968|NCT00666926|525634247|FG015|Overall Study|Lack of Efficacy|0|||
145759969|NCT00666926|525634232|FG000|Overall Study|Lost to Follow-up|0|||
145759970|NCT00666926|525634233|FG001|Overall Study|Lost to Follow-up|0|||
145532688|NCT00299182|524811670|FG003|Overall Study|Chemotherapy Changed|0|||
145759971|NCT00666926|525634234|FG002|Overall Study|Lost to Follow-up|0|||
145759972|NCT00666926|525634235|FG003|Overall Study|Lost to Follow-up|1|||
145759973|NCT00666926|525634236|FG004|Overall Study|Lost to Follow-up|0|||
145759974|NCT00666926|525634237|FG005|Overall Study|Lost to Follow-up|0|||
145759975|NCT00666926|525634238|FG006|Overall Study|Lost to Follow-up|0|||
145532689|NCT00299182|524811671|FG004|Overall Study|Chemotherapy Changed|1|||
145532690|NCT00299182|524811672|FG005|Overall Study|Chemotherapy Changed|0|||
145759976|NCT00666926|525634239|FG007|Overall Study|Lost to Follow-up|0|||
145759977|NCT00666926|525634240|FG008|Overall Study|Lost to Follow-up|0|||
145759978|NCT00666926|525634241|FG009|Overall Study|Lost to Follow-up|0|||
145759979|NCT00666926|525634242|FG010|Overall Study|Lost to Follow-up|0|||
145759980|NCT00666926|525634243|FG011|Overall Study|Lost to Follow-up|0|||
145759981|NCT00666926|525634244|FG012|Overall Study|Lost to Follow-up|0|||
145759982|NCT00666926|525634245|FG013|Overall Study|Lost to Follow-up|0|||
145759983|NCT00666926|525634246|FG014|Overall Study|Lost to Follow-up|0|||
145532691|NCT00299182|524811673|FG006|Overall Study|Chemotherapy Changed|1|||
145532692|NCT00299182|524811667|FG000|Overall Study|Adverse Event|0|||
145532693|NCT00299182|524811668|FG001|Overall Study|Adverse Event|0|||
145532694|NCT00299182|524811669|FG002|Overall Study|Adverse Event|0|||
145532695|NCT00299182|524811670|FG003|Overall Study|Adverse Event|0|||
145532696|NCT00299182|524811671|FG004|Overall Study|Adverse Event|0|||
145532697|NCT00299182|524811672|FG005|Overall Study|Adverse Event|1|||
145532698|NCT00299182|524811673|FG006|Overall Study|Adverse Event|0|||
145532699|NCT00299182|524811667|FG000|Overall Study|Not Eligible|0|||
145532700|NCT00299182|524811668|FG001|Overall Study|Not Eligible|0|||
145532701|NCT00299182|524811669|FG002|Overall Study|Not Eligible|0|||
145759984|NCT00666926|525634247|FG015|Overall Study|Lost to Follow-up|0|||
145759985|NCT00666926|525634232|FG000|Overall Study|Other|2|||
145759986|NCT00666926|525634233|FG001|Overall Study|Other|4|||
145759987|NCT00666926|525634234|FG002|Overall Study|Other|3|||
145759988|NCT00666926|525634235|FG003|Overall Study|Other|3|||
145759989|NCT00666926|525634236|FG004|Overall Study|Other|3|||
145759990|NCT00666926|525634237|FG005|Overall Study|Other|3|||
145759991|NCT00666926|525634238|FG006|Overall Study|Other|4|||
145759992|NCT00666926|525634239|FG007|Overall Study|Other|0|||
145759993|NCT00666926|525634240|FG008|Overall Study|Other|3|||
145759994|NCT00666926|525634241|FG009|Overall Study|Other|5|||
145759995|NCT00666926|525634242|FG010|Overall Study|Other|3|||
145759996|NCT00666926|525634243|FG011|Overall Study|Other|26|||
145759997|NCT00666926|525634244|FG012|Overall Study|Other|3|||
145759998|NCT00666926|525634245|FG013|Overall Study|Other|2|||
145759999|NCT00666926|525634246|FG014|Overall Study|Other|4|||
145760000|NCT00666926|525634247|FG015|Overall Study|Other|4|||
145760001|NCT00666926|525634232|FG000|Overall Study|Withdrawal by Subject|0|||
145760002|NCT00666926|525634233|FG001|Overall Study|Withdrawal by Subject|0|||
145760003|NCT00666926|525634234|FG002|Overall Study|Withdrawal by Subject|0|||
145760004|NCT00666926|525634235|FG003|Overall Study|Withdrawal by Subject|0|||
145760005|NCT00666926|525634236|FG004|Overall Study|Withdrawal by Subject|0|||
145760006|NCT00666926|525634237|FG005|Overall Study|Withdrawal by Subject|0|||
145760007|NCT00666926|525634238|FG006|Overall Study|Withdrawal by Subject|0|||
145760008|NCT00666926|525634239|FG007|Overall Study|Withdrawal by Subject|1|||
145760009|NCT00666926|525634240|FG008|Overall Study|Withdrawal by Subject|0|||
145760010|NCT00666926|525634241|FG009|Overall Study|Withdrawal by Subject|3|||
145760011|NCT00666926|525634242|FG010|Overall Study|Withdrawal by Subject|0|||
145760012|NCT00666926|525634243|FG011|Overall Study|Withdrawal by Subject|3|||
145760013|NCT00666926|525634244|FG012|Overall Study|Withdrawal by Subject|0|||
145760014|NCT00666926|525634245|FG013|Overall Study|Withdrawal by Subject|1|||
145760015|NCT00666926|525634246|FG014|Overall Study|Withdrawal by Subject|3|||
145760016|NCT00666926|525634247|FG015|Overall Study|Withdrawal by Subject|3|||
145760017|NCT00666926|525634232|FG000|Overall Study|Death|0|||
145760018|NCT00666926|525634233|FG001|Overall Study|Death|0|||
145760019|NCT00666926|525634234|FG002|Overall Study|Death|0|||
145760020|NCT00666926|525634235|FG003|Overall Study|Death|0|||
145760021|NCT00666926|525634236|FG004|Overall Study|Death|0|||
145760022|NCT00666926|525634237|FG005|Overall Study|Death|0|||
145760023|NCT00666926|525634238|FG006|Overall Study|Death|0|||
145760024|NCT00666926|525634239|FG007|Overall Study|Death|0|||
145760025|NCT00666926|525634240|FG008|Overall Study|Death|0|||
145760026|NCT00666926|525634241|FG009|Overall Study|Death|0|||
145760027|NCT00666926|525634242|FG010|Overall Study|Death|0|||
145760028|NCT00666926|525634243|FG011|Overall Study|Death|1|||
145760029|NCT00666926|525634244|FG012|Overall Study|Death|0|||
145760030|NCT00666926|525634245|FG013|Overall Study|Death|0|||
145760031|NCT00666926|525634246|FG014|Overall Study|Death|0|||
145760032|NCT00666926|525634247|FG015|Overall Study|Death|0|||
145760033|NCT01960855|525634248|FG000|Overall Study|Subject noncompliant|1|||
145760034|NCT01960855|525634249|FG001|Overall Study|Subject noncompliant|0|||
145760035|NCT01960855|525634250|FG002|Overall Study|Subject noncompliant|0|||
145760036|NCT01960855|525634251|FG003|Overall Study|Subject noncompliant|0|||
145760037|NCT01960855|525634252|FG004|Overall Study|Subject noncompliant|0|||
145760038|NCT01960855|525634248|FG000|Overall Study|Adverse Event|2|||
145760039|NCT01960855|525634249|FG001|Overall Study|Adverse Event|0|||
145760040|NCT01960855|525634250|FG002|Overall Study|Adverse Event|6|||
145760041|NCT01960855|525634251|FG003|Overall Study|Adverse Event|2|||
145760042|NCT01960855|525634252|FG004|Overall Study|Adverse Event|2|||
145760043|NCT01960855|525634248|FG000|Overall Study|Lack of Efficacy|1|||
145760044|NCT01960855|525634249|FG001|Overall Study|Lack of Efficacy|1|||
145760045|NCT01960855|525634250|FG002|Overall Study|Lack of Efficacy|0|||
145760046|NCT01960855|525634251|FG003|Overall Study|Lack of Efficacy|0|||
145760047|NCT01960855|525634252|FG004|Overall Study|Lack of Efficacy|0|||
145760048|NCT01960855|525634248|FG000|Overall Study|Other|2|||
145760049|NCT01960855|525634249|FG001|Overall Study|Other|1|||
145760050|NCT01960855|525634250|FG002|Overall Study|Other|1|||
145760051|NCT01960855|525634251|FG003|Overall Study|Other|1|||
145760052|NCT01960855|525634252|FG004|Overall Study|Other|0|||
145760053|NCT01960855|525634248|FG000|Overall Study|Consent withdrawn by subject|3|||
145760054|NCT01960855|525634249|FG001|Overall Study|Consent withdrawn by subject|1|||
145760055|NCT01960855|525634250|FG002|Overall Study|Consent withdrawn by subject|2|||
145760056|NCT01960855|525634251|FG003|Overall Study|Consent withdrawn by subject|1|||
145760057|NCT01960855|525634252|FG004|Overall Study|Consent withdrawn by subject|1|||
145760058|NCT01960855|525634248|FG000|Overall Study|Lost to Follow-up|2|||
145760059|NCT01960855|525634249|FG001|Overall Study|Lost to Follow-up|1|||
145760060|NCT01960855|525634250|FG002|Overall Study|Lost to Follow-up|0|||
145760061|NCT01960855|525634251|FG003|Overall Study|Lost to Follow-up|0|||
145760062|NCT01960855|525634252|FG004|Overall Study|Lost to Follow-up|2|||
145760063|NCT02058147|525634253|FG000|Overall Study|Randomized but not treated|0|||
145760064|NCT02058147|525634254|FG001|Overall Study|Randomized but not treated|0|||
145760065|NCT02058147|525634255|FG002|Overall Study|Randomized but not treated|1|||
145760066|NCT02058147|525634253|FG000|Overall Study|Adverse Event|12|||
145760067|NCT02058147|525634254|FG001|Overall Study|Adverse Event|9|||
145760068|NCT02058147|525634255|FG002|Overall Study|Adverse Event|21|||
145760069|NCT02058147|525634253|FG000|Overall Study|Lack of Efficacy|1|||
145760070|NCT02058147|525634254|FG001|Overall Study|Lack of Efficacy|0|||
145760071|NCT02058147|525634255|FG002|Overall Study|Lack of Efficacy|3|||
145760072|NCT02058147|525634253|FG000|Overall Study|Poor compliance to protocol|8|||
145760073|NCT02058147|525634254|FG001|Overall Study|Poor compliance to protocol|9|||
145760074|NCT02058147|525634255|FG002|Overall Study|Poor compliance to protocol|4|||
145760075|NCT02058147|525634253|FG000|Overall Study|Other than specified|8|||
145760076|NCT02058147|525634254|FG001|Overall Study|Other than specified|9|||
145760077|NCT02058147|525634255|FG002|Overall Study|Other than specified|0|||
145760078|NCT01486199|525634258|FG000|Two Year Period Between Study Days|Physician Decision|1|||
145760079|NCT01486199|525634259|FG001|Two Year Period Between Study Days|Physician Decision|0|||
145760080|NCT02471716|525634260|FG000|Overall Study|Withdrawal by Subject|0|||
145760081|NCT02471716|525634261|FG001|Overall Study|Withdrawal by Subject|1|||
145760082|NCT02471716|525634262|FG002|Overall Study|Withdrawal by Subject|0|||
145760083|NCT02471716|525634263|FG003|Overall Study|Withdrawal by Subject|2|||
145760084|NCT02471716|525634264|FG004|Overall Study|Withdrawal by Subject|5|||
145760085|NCT02471716|525634260|FG000|Overall Study|Study Terminiated by sponsor|0|||
145760086|NCT02471716|525634261|FG001|Overall Study|Study Terminiated by sponsor|0|||
145760087|NCT02471716|525634262|FG002|Overall Study|Study Terminiated by sponsor|0|||
145760088|NCT02471716|525634263|FG003|Overall Study|Study Terminiated by sponsor|1|||
145760089|NCT02471716|525634264|FG004|Overall Study|Study Terminiated by sponsor|0|||
145760090|NCT02471716|525634260|FG000|Overall Study|Lost to Follow-up|0|||
145760091|NCT02471716|525634261|FG001|Overall Study|Lost to Follow-up|0|||
145760092|NCT02471716|525634262|FG002|Overall Study|Lost to Follow-up|0|||
145760093|NCT02471716|525634263|FG003|Overall Study|Lost to Follow-up|3|||
145760094|NCT02471716|525634264|FG004|Overall Study|Lost to Follow-up|2|||
145760095|NCT02471716|525634260|FG000|Overall Study|Death|0|||
145760096|NCT02471716|525634261|FG001|Overall Study|Death|0|||
145760097|NCT02471716|525634262|FG002|Overall Study|Death|0|||
145760098|NCT02471716|525634263|FG003|Overall Study|Death|1|||
145760099|NCT02471716|525634264|FG004|Overall Study|Death|0|||
145760100|NCT02471716|525634260|FG000|Overall Study|Other|0|||
145760101|NCT02471716|525634261|FG001|Overall Study|Other|0|||
145760102|NCT02471716|525634262|FG002|Overall Study|Other|0|||
145760103|NCT02471716|525634263|FG003|Overall Study|Other|8|||
145760104|NCT02471716|525634264|FG004|Overall Study|Other|9|||
145760105|NCT00130286|525634267|FG000|Overall Study|Withdrawal by Subject|0|||
145760106|NCT00130286|525634268|FG001|Overall Study|Withdrawal by Subject|1|||
145760107|NCT00130286|525634269|FG002|Overall Study|Withdrawal by Subject|2|||
145760108|NCT00130286|525634270|FG003|Overall Study|Withdrawal by Subject|2|||
145760109|NCT00130286|525634267|FG000|Overall Study|Adverse Event|0|||
145760110|NCT00130286|525634268|FG001|Overall Study|Adverse Event|0|||
145760111|NCT00130286|525634269|FG002|Overall Study|Adverse Event|2|||
145760112|NCT00130286|525634270|FG003|Overall Study|Adverse Event|0|||
145760113|NCT00130286|525634267|FG000|Overall Study|Missing lab specimens|0|||
145760114|NCT00130286|525634268|FG001|Overall Study|Missing lab specimens|2|||
145760115|NCT00130286|525634269|FG002|Overall Study|Missing lab specimens|0|||
145760116|NCT00130286|525634270|FG003|Overall Study|Missing lab specimens|0|||
145760117|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
145532702|NCT00299182|524811670|FG003|Overall Study|Not Eligible|0|||
145532703|NCT00299182|524811671|FG004|Overall Study|Not Eligible|1|||
145532704|NCT00299182|524811672|FG005|Overall Study|Not Eligible|0|||
145532705|NCT00299182|524811673|FG006|Overall Study|Not Eligible|0|||
145532706|NCT00771316|524811678|FG000|Overall Study|Adverse Event|0|||
145532707|NCT00771316|524811679|FG001|Overall Study|Adverse Event|1|||
145760118|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
145760119|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
145760120|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
145760121|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
145760122|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
145760123|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
145760124|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
145760125|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
145760126|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
145760127|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
145760128|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
145760129|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
145760130|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
145760131|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
145760132|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
145760133|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
145760134|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
145760135|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
145760136|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
145760137|NCT01360645|525634279|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
145760138|NCT01360645|525634280|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
145760139|NCT01360645|525634281|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
145760140|NCT01360645|525634282|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
145760141|NCT01360645|525634279|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
145760142|NCT01360645|525634280|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
145760143|NCT01360645|525634281|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
145760144|NCT01360645|525634282|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
145760145|NCT01360645|525634279|FG000|Phase B (6 Weeks)|Adverse Event|0|||
145760146|NCT01360645|525634280|FG001|Phase B (6 Weeks)|Adverse Event|6|||
145760147|NCT01360645|525634281|FG002|Phase B (6 Weeks)|Adverse Event|0|||
145760148|NCT01360645|525634282|FG003|Phase B (6 Weeks)|Adverse Event|0|||
145760149|NCT01360645|525634279|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
145760150|NCT01360645|525634280|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
145760151|NCT01360645|525634281|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
145760152|NCT01360645|525634282|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
145760153|NCT01360645|525634279|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
145760154|NCT01360645|525634280|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
145760155|NCT01360645|525634281|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
145760156|NCT01360645|525634282|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
145760157|NCT01360645|525634279|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
145760158|NCT01360645|525634280|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
145760159|NCT01360645|525634281|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
145760160|NCT01360645|525634282|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
145760161|NCT01360645|525634279|FG000|Phase A+|Lost to Follow-up|0|||
145760162|NCT01360645|525634280|FG001|Phase A+|Lost to Follow-up|0|||
145760163|NCT01360645|525634281|FG002|Phase A+|Lost to Follow-up|0|||
145760164|NCT01360645|525634282|FG003|Phase A+|Lost to Follow-up|7|||
145760165|NCT01360645|525634279|FG000|Phase A+|Adverse Event|0|||
145760166|NCT01360645|525634280|FG001|Phase A+|Adverse Event|0|||
145760167|NCT01360645|525634281|FG002|Phase A+|Adverse Event|0|||
145760168|NCT01360645|525634282|FG003|Phase A+|Adverse Event|2|||
145760169|NCT01360645|525634279|FG000|Phase A+|Met Withdrawal Criteria|0|||
145760170|NCT01360645|525634280|FG001|Phase A+|Met Withdrawal Criteria|0|||
145760171|NCT01360645|525634281|FG002|Phase A+|Met Withdrawal Criteria|0|||
145760172|NCT01360645|525634282|FG003|Phase A+|Met Withdrawal Criteria|4|||
145760173|NCT01360645|525634279|FG000|Phase A+|Physician Decision|0|||
145402893|NCT02065557|524332548|FG004|Induction Period|Adverse Event|0|||
145760174|NCT01360645|525634280|FG001|Phase A+|Physician Decision|0|||
145760175|NCT01360645|525634281|FG002|Phase A+|Physician Decision|0|||
145760176|NCT01360645|525634282|FG003|Phase A+|Physician Decision|2|||
145760177|NCT01360645|525634279|FG000|Phase A+|Withdrawal by Subject|0|||
145760178|NCT01360645|525634280|FG001|Phase A+|Withdrawal by Subject|0|||
145760179|NCT01360645|525634281|FG002|Phase A+|Withdrawal by Subject|0|||
145760180|NCT01360645|525634282|FG003|Phase A+|Withdrawal by Subject|5|||
145760181|NCT01360645|525634279|FG000|Phase A+|Protocol Deviation|0|||
145760182|NCT01360645|525634280|FG001|Phase A+|Protocol Deviation|0|||
145760183|NCT01360645|525634281|FG002|Phase A+|Protocol Deviation|0|||
145760184|NCT01360645|525634282|FG003|Phase A+|Protocol Deviation|4|||
145760185|NCT01014585|525634283|FG000|Overall Study|Adverse Event|0|||
145760186|NCT01014585|525634284|FG001|Overall Study|Adverse Event|2|||
145760187|NCT01014585|525634285|FG002|Overall Study|Adverse Event|0|||
145760188|NCT01014585|525634286|FG003|Overall Study|Adverse Event|3|||
145760189|NCT01014585|525634283|FG000|Overall Study|Withdrawal by Subject|2|||
145760190|NCT01014585|525634284|FG001|Overall Study|Withdrawal by Subject|0|||
145760191|NCT01014585|525634285|FG002|Overall Study|Withdrawal by Subject|1|||
145760192|NCT01014585|525634286|FG003|Overall Study|Withdrawal by Subject|3|||
145760193|NCT01014585|525634283|FG000|Overall Study|Lost to Follow-up|0|||
145760194|NCT01014585|525634284|FG001|Overall Study|Lost to Follow-up|0|||
145760195|NCT01014585|525634285|FG002|Overall Study|Lost to Follow-up|0|||
145760196|NCT01014585|525634286|FG003|Overall Study|Lost to Follow-up|2|||
145760197|NCT01014585|525634283|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
145760198|NCT01014585|525634284|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
145760199|NCT01014585|525634285|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
145760200|NCT01014585|525634286|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
145760201|NCT02154425|525634287|FG000|Screening Period|Adverse Event|1|||
145760202|NCT04178772|525634297|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
145760203|NCT04178772|525634297|FG000|Overall Study|study terminated early due to COVID-19|7|||
145760204|NCT02211261|525634300|FG000|Overall Study|Withdrawal by Subject|0|||
145760205|NCT02211261|525634301|FG001|Overall Study|Withdrawal by Subject|0|||
145760206|NCT02211261|525634302|FG002|Overall Study|Withdrawal by Subject|1|||
145760207|NCT02211261|525634303|FG003|Overall Study|Withdrawal by Subject|0|||
145760208|NCT02211261|525634304|FG004|Overall Study|Withdrawal by Subject|2|||
145760209|NCT02211261|525634305|FG005|Overall Study|Withdrawal by Subject|0|||
145760210|NCT02211261|525634306|FG006|Overall Study|Withdrawal by Subject|0|||
145760211|NCT02211261|525634307|FG007|Overall Study|Withdrawal by Subject|0|||
145760212|NCT02211261|525634308|FG008|Overall Study|Withdrawal by Subject|0|||
145760213|NCT02211261|525634309|FG009|Overall Study|Withdrawal by Subject|0|||
145760214|NCT02211261|525634310|FG010|Overall Study|Withdrawal by Subject|0|||
145760215|NCT02211261|525634300|FG000|Overall Study|Other|0|||
145760216|NCT02211261|525634301|FG001|Overall Study|Other|0|||
145760217|NCT02211261|525634302|FG002|Overall Study|Other|0|||
145760218|NCT02211261|525634303|FG003|Overall Study|Other|0|||
145760219|NCT02211261|525634304|FG004|Overall Study|Other|0|||
145760220|NCT02211261|525634305|FG005|Overall Study|Other|1|||
145760221|NCT02211261|525634306|FG006|Overall Study|Other|0|||
145274346|NCT04644237|523851940|FG001|Overall Study|Withdrawal by Subject|2|||
145274347|NCT04644237|523851939|FG000|Overall Study|Physician Decision|4|||
145274348|NCT04644237|523851940|FG001|Overall Study|Physician Decision|0|||
145274349|NCT04644237|523851939|FG000|Overall Study|Other|6|||
145274350|NCT04644237|523851940|FG001|Overall Study|Other|3|||
145274351|NCT04644237|523851939|FG000|Overall Study|Randomized but not Treated|1|||
145274352|NCT04644237|523851940|FG001|Overall Study|Randomized but not Treated|0|||
145274353|NCT03131817|523851941|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
145532708|NCT00771316|524811678|FG000|Overall Study|Patient withdrew consent|1|||
145532709|NCT00771316|524811679|FG001|Overall Study|Patient withdrew consent|0|||
145532710|NCT00771316|524811678|FG000|Overall Study|Discontinued due to early termination|1|||
145532711|NCT00771316|524811679|FG001|Overall Study|Discontinued due to early termination|0|||
145532712|NCT00936611|524811680|FG000|Overall Study|Progressive Disease|3|||
145532713|NCT00936611|524811680|FG000|Overall Study|New Systemic Therapy|22|||
145532714|NCT00936611|524811680|FG000|Overall Study|Lost to Follow-up|1|||
145532715|NCT00936611|524811680|FG000|Overall Study|Withdrawal by Subject|2|||
145532716|NCT00936611|524811680|FG000|Overall Study|Still on Follow-up|1|||
145274354|NCT05838755|523851951|FG000|Overall Study|Adverse Event|1|||
145274355|NCT05838755|523851952|FG001|Overall Study|Adverse Event|0|||
145274356|NCT05838755|523851953|FG002|Overall Study|Adverse Event|0|||
145274357|NCT05838755|523851951|FG000|Overall Study|Lack of Efficacy|1|||
145274358|NCT05838755|523851952|FG001|Overall Study|Lack of Efficacy|0|||
145274359|NCT05838755|523851953|FG002|Overall Study|Lack of Efficacy|1|||
145274360|NCT05838755|523851951|FG000|Overall Study|Lost to Follow-up|0|||
145274361|NCT05838755|523851952|FG001|Overall Study|Lost to Follow-up|1|||
145274362|NCT05838755|523851953|FG002|Overall Study|Lost to Follow-up|4|||
145274363|NCT05838755|523851951|FG000|Overall Study|Withdrawal by Subject|0|||
145274364|NCT05838755|523851952|FG001|Overall Study|Withdrawal by Subject|2|||
145274365|NCT05838755|523851953|FG002|Overall Study|Withdrawal by Subject|0|||
145274366|NCT05838755|523851951|FG000|Overall Study|Study terminated by sponsor|26|||
145532717|NCT00936611|524811680|FG000|Overall Study|Still on Active Therapy|7|||
145532718|NCT00936611|524811680|FG000|Overall Study|Ineligible for Study Drug|3|||
145532719|NCT01822496|524811684|FG000|Overall Study|Protocol Violation|2|||
145532720|NCT01822496|524811685|FG001|Overall Study|Protocol Violation|2|||
145532721|NCT01822496|524811686|FG002|Overall Study|Protocol Violation|0|||
145532722|NCT01822496|524811687|FG003|Overall Study|Protocol Violation|1|||
145532723|NCT01822496|524811684|FG000|Overall Study|Withdrawal by Subject|0|||
145274367|NCT05838755|523851952|FG001|Overall Study|Study terminated by sponsor|27|||
145274368|NCT05838755|523851953|FG002|Overall Study|Study terminated by sponsor|26|||
145274369|NCT05838755|523851951|FG000|Overall Study|Randomized, not treated|2|||
145402894|NCT02065557|524332549|FG005|Induction Period|Adverse Event|0|||
145532724|NCT01822496|524811685|FG001|Overall Study|Withdrawal by Subject|0|||
145607684|NCT00682643|525079237|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
145760222|NCT02211261|525634307|FG007|Overall Study|Other|0|||
145760223|NCT02211261|525634308|FG008|Overall Study|Other|0|||
145760224|NCT02211261|525634309|FG009|Overall Study|Other|2|||
145760225|NCT02211261|525634310|FG010|Overall Study|Other|0|||
145760226|NCT02211261|525634300|FG000|Overall Study|Lost to Follow-up|0|||
145760227|NCT02211261|525634301|FG001|Overall Study|Lost to Follow-up|0|||
145760228|NCT02211261|525634302|FG002|Overall Study|Lost to Follow-up|0|||
145760229|NCT02211261|525634303|FG003|Overall Study|Lost to Follow-up|0|||
145760230|NCT02211261|525634304|FG004|Overall Study|Lost to Follow-up|0|||
145760231|NCT02211261|525634305|FG005|Overall Study|Lost to Follow-up|0|||
145760232|NCT02211261|525634306|FG006|Overall Study|Lost to Follow-up|0|||
145760233|NCT02211261|525634307|FG007|Overall Study|Lost to Follow-up|1|||
145760234|NCT02211261|525634308|FG008|Overall Study|Lost to Follow-up|0|||
145760235|NCT02211261|525634309|FG009|Overall Study|Lost to Follow-up|0|||
145760236|NCT02211261|525634310|FG010|Overall Study|Lost to Follow-up|0|||
145274370|NCT05838755|523851952|FG001|Overall Study|Randomized, not treated|0|||
145274371|NCT05838755|523851953|FG002|Overall Study|Randomized, not treated|1|||
145274372|NCT05838755|523851951|FG000|Overall Study|Pregnancy|0|||
145274373|NCT05838755|523851952|FG001|Overall Study|Pregnancy|1|||
145274374|NCT05838755|523851953|FG002|Overall Study|Pregnancy|0|||
145274375|NCT04439110|523851954|FG000|Overall Study|Ineligible|2|||
145274376|NCT04439110|523851954|FG000|Overall Study|Adverse Event|4|||
145274377|NCT04439110|523851954|FG000|Overall Study|Death|2|||
145274378|NCT04439110|523851954|FG000|Overall Study|Disease proression|25|||
145274379|NCT04439110|523851954|FG000|Overall Study|Withdrawal by Subject|1|||
145274380|NCT04439110|523851954|FG000|Overall Study|Alternative therapy|1|||
145274381|NCT04439110|523851954|FG000|Overall Study|Other complicating disease|1|||
145274382|NCT04439110|523851954|FG000|Overall Study|Personal reasons|1|||
145274383|NCT04439110|523851954|FG000|Overall Study|Still on treatment|1|||
145532725|NCT01822496|524811686|FG002|Overall Study|Withdrawal by Subject|0|||
145532726|NCT01822496|524811687|FG003|Overall Study|Withdrawal by Subject|3|||
145532727|NCT03841448|524811690|FG000|Double-blind Treatment (DBT) Period|Death|1|||
145532728|NCT03841448|524811691|FG001|Double-blind Treatment (DBT) Period|Death|1|||
145532729|NCT03841448|524811692|FG002|Double-blind Treatment (DBT) Period|Death|0|||
145532730|NCT03841448|524811693|FG003|Double-blind Treatment (DBT) Period|Death|0|||
145532731|NCT03841448|524811690|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
145532732|NCT03841448|524811691|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
145532733|NCT03841448|524811692|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
145532734|NCT03841448|524811693|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
145532735|NCT03841448|524811690|FG000|Open-Label Extension (OLE) Period|Death|0|||
145532736|NCT03841448|524811691|FG001|Open-Label Extension (OLE) Period|Death|0|||
145532737|NCT03841448|524811692|FG002|Open-Label Extension (OLE) Period|Death|0|||
145532738|NCT03841448|524811693|FG003|Open-Label Extension (OLE) Period|Death|1|||
145532739|NCT03841448|524811690|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
145532740|NCT03841448|524811691|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
145532741|NCT03841448|524811692|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
145532742|NCT03841448|524811693|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
145532743|NCT03841448|524811690|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
145532744|NCT03841448|524811691|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
145532745|NCT03841448|524811692|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
145532746|NCT03841448|524811693|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
145274384|NCT04647253|523851961|FG000|Overall Study|Death ≤ 365 Days|16|||
145532747|NCT03841448|524811690|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
145532748|NCT03841448|524811691|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
145532749|NCT03841448|524811692|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
145532750|NCT03841448|524811693|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
145532751|NCT00543543|524811694|FG000|Base Study|Adverse Event|1|||
145532752|NCT00543543|524811695|FG001|Base Study|Adverse Event|11|||
145532753|NCT00543543|524811696|FG002|Base Study|Adverse Event|0|||
145532754|NCT00543543|524811697|FG003|Base Study|Adverse Event|5|||
145760237|NCT01737931|525634311|FG000|Overall Study|Withdrawal by Subject|0|||
145274385|NCT04647253|523851962|FG001|Overall Study|Death ≤ 365 Days|7|||
145274386|NCT04647253|523851961|FG000|Overall Study|Physician Decision|0|||
145274387|NCT04647253|523851962|FG001|Overall Study|Physician Decision|1|||
145274388|NCT04647253|523851961|FG000|Overall Study|Withdrawal by Subject|7|||
145532755|NCT00543543|524811694|FG000|Base Study|Lost to Follow-up|12|||
145532756|NCT00543543|524811695|FG001|Base Study|Lost to Follow-up|749|||
145532757|NCT00543543|524811696|FG002|Base Study|Lost to Follow-up|9|||
145532758|NCT00543543|524811697|FG003|Base Study|Lost to Follow-up|701|||
145532759|NCT00543543|524811694|FG000|Base Study|Physician Decision|0|||
145532760|NCT00543543|524811695|FG001|Base Study|Physician Decision|4|||
145532761|NCT00543543|524811696|FG002|Base Study|Physician Decision|0|||
145532762|NCT00543543|524811697|FG003|Base Study|Physician Decision|7|||
145532763|NCT00543543|524811694|FG000|Base Study|Protocol Violation|0|||
145532764|NCT00543543|524811695|FG001|Base Study|Protocol Violation|6|||
145532765|NCT00543543|524811696|FG002|Base Study|Protocol Violation|0|||
145532766|NCT00543543|524811697|FG003|Base Study|Protocol Violation|6|||
145532767|NCT00543543|524811694|FG000|Base Study|Withdrawal by Subject|7|||
145532768|NCT00543543|524811695|FG001|Base Study|Withdrawal by Subject|482|||
145532769|NCT00543543|524811696|FG002|Base Study|Withdrawal by Subject|5|||
145532770|NCT00543543|524811697|FG003|Base Study|Withdrawal by Subject|503|||
145532771|NCT00543543|524811694|FG000|Extension Study|Adverse Event|0|||
145532772|NCT00543543|524811695|FG001|Extension Study|Adverse Event|0|||
145532773|NCT00543543|524811696|FG002|Extension Study|Adverse Event|0|||
145532774|NCT00543543|524811697|FG003|Extension Study|Adverse Event|5|||
145532775|NCT00543543|524811694|FG000|Extension Study|Lost to Follow-up|0|||
145532776|NCT00543543|524811695|FG001|Extension Study|Lost to Follow-up|0|||
145532777|NCT00543543|524811696|FG002|Extension Study|Lost to Follow-up|0|||
145532778|NCT00543543|524811697|FG003|Extension Study|Lost to Follow-up|77|||
145532779|NCT00543543|524811694|FG000|Extension Study|Physician Decision|0|||
145532780|NCT00543543|524811695|FG001|Extension Study|Physician Decision|0|||
145532781|NCT00543543|524811696|FG002|Extension Study|Physician Decision|0|||
145532782|NCT00543543|524811697|FG003|Extension Study|Physician Decision|7|||
145532783|NCT00543543|524811694|FG000|Extension Study|Pregnancy|0|||
145532784|NCT00543543|524811695|FG001|Extension Study|Pregnancy|0|||
145532785|NCT00543543|524811696|FG002|Extension Study|Pregnancy|0|||
145532786|NCT00543543|524811697|FG003|Extension Study|Pregnancy|6|||
145532787|NCT00543543|524811694|FG000|Extension Study|Protocol Violation|0|||
145532788|NCT00543543|524811695|FG001|Extension Study|Protocol Violation|0|||
145532789|NCT00543543|524811696|FG002|Extension Study|Protocol Violation|0|||
145532790|NCT00543543|524811697|FG003|Extension Study|Protocol Violation|11|||
145760238|NCT01737931|525634312|FG001|Overall Study|Withdrawal by Subject|1|||
145760239|NCT01737931|525634313|FG002|Overall Study|Withdrawal by Subject|1|||
145760240|NCT01737931|525634311|FG000|Overall Study|Physician Decision|0|||
145760241|NCT01737931|525634312|FG001|Overall Study|Physician Decision|1|||
145760242|NCT01737931|525634313|FG002|Overall Study|Physician Decision|0|||
145760243|NCT02817087|525634314|FG000|Overall Study|Withdrawal by Subject|2|||
145274389|NCT04647253|523851962|FG001|Overall Study|Withdrawal by Subject|2|||
145532791|NCT00543543|524811694|FG000|Extension Study|Withdrawal by Subject|0|||
145532792|NCT00543543|524811695|FG001|Extension Study|Withdrawal by Subject|0|||
145532793|NCT00543543|524811696|FG002|Extension Study|Withdrawal by Subject|0|||
145532794|NCT00543543|524811697|FG003|Extension Study|Withdrawal by Subject|120|||
145532795|NCT04308304|524811698|FG000|Overall Study|Withdrawal by Subject|4|||
145532796|NCT04308304|524811699|FG001|Overall Study|Withdrawal by Subject|0|||
145532797|NCT04308304|524811698|FG000|Overall Study|Protocol Violation|1|||
145532798|NCT04308304|524811699|FG001|Overall Study|Protocol Violation|0|||
145532799|NCT00945555|524811700|FG000|Overall Study|Referred to another hospital|5|||
145532800|NCT00945555|524811700|FG000|Overall Study|Worsening condition, intensive care unit|1|||
145532801|NCT00945555|524811700|FG000|Overall Study|Withdrawal by Subject|2|||
145532802|NCT00945555|524811700|FG000|Overall Study|Participant continued treatment at home|1|||
145532803|NCT00945555|524811700|FG000|Overall Study|Death|18|||
145532804|NCT00945555|524811700|FG000|Overall Study|Other|1|||
145532805|NCT04502979|524811702|FG000|Overall Study|Lost to Follow-up|1|||
145532806|NCT04502979|524811703|FG001|Overall Study|Lost to Follow-up|3|||
145760244|NCT02817087|525634315|FG001|Overall Study|Withdrawal by Subject|0|||
145760245|NCT00880256|525634316|FG000|Overall Study|Lost to Follow-up|28|||
145760246|NCT00802360|525634317|FG000|Overall Study|Stimulation failure|4|||
145760247|NCT00802360|525634318|FG001|Overall Study|Stimulation failure|0|||
145760248|NCT00802360|525634319|FG002|Overall Study|Stimulation failure|3|||
145760249|NCT00802360|525634320|FG003|Overall Study|Stimulation failure|3|||
145760250|NCT00802360|525634317|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
145760251|NCT00802360|525634318|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
145760252|NCT00802360|525634319|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
145760253|NCT00802360|525634320|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
145760254|NCT00802360|525634317|FG000|Overall Study|Cycle cancelled|0|||
145760255|NCT00802360|525634318|FG001|Overall Study|Cycle cancelled|1|||
145760256|NCT00802360|525634319|FG002|Overall Study|Cycle cancelled|1|||
145760257|NCT00802360|525634320|FG003|Overall Study|Cycle cancelled|1|||
145760258|NCT00802360|525634317|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
145760259|NCT00802360|525634318|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
145760260|NCT00802360|525634319|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
145760261|NCT00802360|525634320|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
145760262|NCT00802360|525634317|FG000|Overall Study|No positive serum pregnancy|17|||
145760263|NCT00802360|525634318|FG001|Overall Study|No positive serum pregnancy|20|||
145760264|NCT00802360|525634319|FG002|Overall Study|No positive serum pregnancy|14|||
145760265|NCT00802360|525634320|FG003|Overall Study|No positive serum pregnancy|10|||
145760266|NCT00802360|525634317|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
145760267|NCT00802360|525634318|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
145760268|NCT00802360|525634319|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
145760269|NCT00802360|525634320|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
145760270|NCT00802360|525634317|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
145760271|NCT00802360|525634318|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
145760272|NCT00802360|525634319|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
145760273|NCT00802360|525634320|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
145760274|NCT00802360|525634317|FG000|Overall Study|Other|2|||
145760275|NCT00802360|525634318|FG001|Overall Study|Other|3|||
145760276|NCT00802360|525634319|FG002|Overall Study|Other|6|||
145760277|NCT00802360|525634320|FG003|Overall Study|Other|3|||
145760278|NCT02041962|525634321|FG000|Overall Study|Lost Aetna Coverage|43|||
145760279|NCT02041962|525634322|FG001|Overall Study|Lost Aetna Coverage|40|||
145760280|NCT02041962|525634321|FG000|Overall Study|Death|1|||
145760281|NCT02041962|525634322|FG001|Overall Study|Death|1|||
145760282|NCT02041962|525634321|FG000|Overall Study|Lost to Follow-up|37|||
145760283|NCT02041962|525634322|FG001|Overall Study|Lost to Follow-up|32|||
145760284|NCT02041962|525634321|FG000|Overall Study|Withdrawal by Subject|0|||
145760285|NCT02041962|525634322|FG001|Overall Study|Withdrawal by Subject|11|||
145760286|NCT00330187|525634323|FG000|Overall Study|Lost to Follow-up|12|||
145760287|NCT00330187|525634324|FG001|Overall Study|Lost to Follow-up|13|||
145760288|NCT00330187|525634325|FG002|Overall Study|Lost to Follow-up|14|||
145760289|NCT00330187|525634326|FG003|Overall Study|Lost to Follow-up|10|||
145274390|NCT04647253|523851961|FG000|Overall Study|Missed 12-Month Visit|9|||
145274391|NCT04647253|523851962|FG001|Overall Study|Missed 12-Month Visit|7|||
145274392|NCT04647253|523851961|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
145274393|NCT04647253|523851962|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
145274394|NCT02706353|523851963|FG000|Dose Level 1|Disease Progression|1|||
145532807|NCT04502979|524811702|FG000|Overall Study|Withdrawal by Subject|2|||
145532808|NCT04502979|524811703|FG001|Overall Study|Withdrawal by Subject|1|||
145532809|NCT00165984|524811708|FG000|Overall Study|Death|15|||
145532810|NCT03945266|524811709|FG000|Overall Study|Withdrawal by Subject|1|||
145532811|NCT03945266|524811710|FG001|Overall Study|Withdrawal by Subject|0|||
145532812|NCT03945266|524811709|FG000|Overall Study|Miscarriage|0|||
145532813|NCT03945266|524811710|FG001|Overall Study|Miscarriage|2|||
145532814|NCT03945266|524811709|FG000|Overall Study|Lost to Follow-up|1|||
145532815|NCT03945266|524811710|FG001|Overall Study|Lost to Follow-up|0|||
145274395|NCT02706353|523851964|FG001|Dose Level 1|Disease Progression|0|||
145274396|NCT02706353|523851965|FG002|Dose Level 1|Disease Progression|0|||
145532816|NCT01686828|524811711|FG000|Overall Study|Physician Decision|1|||
145532817|NCT01686828|524811712|FG001|Overall Study|Physician Decision|0|||
145532818|NCT01686828|524811713|FG002|Overall Study|Physician Decision|0|||
145532819|NCT01686828|524811714|FG003|Overall Study|Physician Decision|0|||
145274397|NCT02706353|523851966|FG003|Dose Level 1|Disease Progression|0|||
145274398|NCT02706353|523851967|FG004|Dose Level 1|Disease Progression|0|||
145274399|NCT02706353|523851968|FG005|Dose Level 1|Disease Progression|0|||
145274400|NCT02706353|523851963|FG000|Dose Level 3|Disease Progression|0|||
145274401|NCT02706353|523851964|FG001|Dose Level 3|Disease Progression|0|||
145532820|NCT01686828|524811711|FG000|Overall Study|New Job|0|||
145532821|NCT01686828|524811712|FG001|Overall Study|New Job|1|||
145532822|NCT01686828|524811713|FG002|Overall Study|New Job|0|||
145532823|NCT01686828|524811714|FG003|Overall Study|New Job|0|||
145532824|NCT01686828|524811711|FG000|Overall Study|Weight Loss|0|||
145532825|NCT01686828|524811712|FG001|Overall Study|Weight Loss|0|||
145532826|NCT01686828|524811713|FG002|Overall Study|Weight Loss|1|||
145532827|NCT01686828|524811714|FG003|Overall Study|Weight Loss|0|||
145532828|NCT01736124|524811727|FG000|Post-intervention Assessment|Death|2|||
145274402|NCT02706353|523851965|FG002|Dose Level 3|Disease Progression|2|||
145532829|NCT01736124|524811728|FG001|Post-intervention Assessment|Death|2|||
145532830|NCT01736124|524811727|FG000|Post-intervention Assessment|lost computer access|1|||
145760290|NCT00330187|525634323|FG000|Overall Study|Withdrawal by Subject|8|||
145760291|NCT00330187|525634324|FG001|Overall Study|Withdrawal by Subject|5|||
145760292|NCT00330187|525634325|FG002|Overall Study|Withdrawal by Subject|4|||
145760293|NCT00330187|525634326|FG003|Overall Study|Withdrawal by Subject|4|||
145760294|NCT01446419|525634335|FG000|Overall Study|Death|1|||
145760295|NCT01446419|525634336|FG001|Overall Study|Death|0|||
145760296|NCT01446419|525634335|FG000|Overall Study|Withdrawal by Subject|1|||
145760297|NCT01446419|525634336|FG001|Overall Study|Withdrawal by Subject|1|||
145760298|NCT01446419|525634335|FG000|Overall Study|Terminated per protocol|3|||
145532831|NCT01736124|524811728|FG001|Post-intervention Assessment|lost computer access|1|||
145532832|NCT01736124|524811727|FG000|Post-intervention Assessment|Moved away|3|||
145532833|NCT01736124|524811728|FG001|Post-intervention Assessment|Moved away|1|||
145532834|NCT01736124|524811727|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
145402895|NCT02065557|524332544|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145532835|NCT01736124|524811728|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
145532836|NCT01736124|524811727|FG000|Post-intervention Assessment|Illness|3|||
145532837|NCT01736124|524811728|FG001|Post-intervention Assessment|Illness|2|||
145532838|NCT01736124|524811727|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
145402896|NCT02065557|524332545|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145532839|NCT01736124|524811728|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
145532840|NCT01736124|524811727|FG000|Post-intervention Assessment|Temporarily away|3|||
145532841|NCT01736124|524811728|FG001|Post-intervention Assessment|Temporarily away|1|||
145532842|NCT01736124|524811727|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
145532843|NCT01736124|524811728|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
145532844|NCT01736124|524811727|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
145532845|NCT01736124|524811728|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
145532846|NCT01736124|524811727|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
145532847|NCT01736124|524811728|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
145532848|NCT01736124|524811727|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
145532849|NCT01736124|524811728|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
145532850|NCT01736124|524811727|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
145532851|NCT01736124|524811728|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
145532852|NCT01736124|524811727|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
145532853|NCT01736124|524811728|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
145532854|NCT01736124|524811727|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
145532855|NCT01736124|524811728|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
145532856|NCT01736124|524811727|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
145532857|NCT01736124|524811728|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
145532858|NCT01736124|524811727|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
145532859|NCT01736124|524811728|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
145532860|NCT02734433|524811729|FG000|Overall Study|Disease progression|1|||
145532861|NCT02734433|524811730|FG001|Overall Study|Disease progression|5|||
145532862|NCT02734433|524811729|FG000|Overall Study|Clinical progression|0|||
145532863|NCT02734433|524811730|FG001|Overall Study|Clinical progression|1|||
145532864|NCT02734433|524811729|FG000|Overall Study|Withdrawal by Subject|1|||
145532865|NCT02734433|524811730|FG001|Overall Study|Withdrawal by Subject|2|||
145532866|NCT02628769|524811731|FG000|First Intervention|Adverse Event|1|||
145532867|NCT02628769|524811732|FG001|First Intervention|Adverse Event|0|||
145532868|NCT02628769|524811731|FG000|First Intervention|Withdrawal by Subject|0|||
145532869|NCT02628769|524811732|FG001|First Intervention|Withdrawal by Subject|1|||
145532870|NCT02628769|524811731|FG000|Second Intervention|Adverse Event|2|||
145532871|NCT02628769|524811732|FG001|Second Intervention|Adverse Event|0|||
145532872|NCT02628769|524811731|FG000|Second Intervention|Physician Decision|0|||
145532873|NCT02628769|524811732|FG001|Second Intervention|Physician Decision|1|||
145532874|NCT01066000|524811736|FG000|Overall Study|Protocol Violation|4|||
145532875|NCT01066000|524811736|FG000|Overall Study|Death|3|||
145532876|NCT01066000|524811736|FG000|Overall Study|Withdrawal by Subject|1|||
145532877|NCT01066000|524811736|FG000|Overall Study|Adverse Event|1|||
145532878|NCT03817879|524813351|FG000|Overall Study|Drop out|5|||
145532879|NCT03817879|524813352|FG001|Overall Study|Drop out|12|||
145532880|NCT03817879|524813351|FG000|Overall Study|Withdrawal by Subject|0|||
145532881|NCT03817879|524813352|FG001|Overall Study|Withdrawal by Subject|1|||
145532882|NCT01543698|524813357|FG000|Phase 1b|Disease progression|2|||
145532883|NCT01543698|524813358|FG001|Phase 1b|Disease progression|4|||
145532884|NCT01543698|524813359|FG002|Phase 1b|Disease progression|3|||
145532885|NCT01543698|524813360|FG003|Phase 1b|Disease progression|2|||
145532886|NCT01543698|524813361|FG004|Phase 1b|Disease progression|10|||
145532887|NCT01543698|524813362|FG005|Phase 1b|Disease progression|6|||
145532888|NCT01543698|524813363|FG006|Phase 1b|Disease progression|5|||
145532889|NCT01543698|524813364|FG007|Phase 1b|Disease progression|3|||
145532890|NCT01543698|524813365|FG008|Phase 1b|Disease progression|4|||
145532891|NCT01543698|524813366|FG009|Phase 1b|Disease progression|5|||
145607685|NCT00682643|525079236|FG000|Overall Study|Lost to Follow-up|1|||
145532892|NCT01543698|524813367|FG010|Phase 1b|Disease progression|1|||
145532893|NCT01543698|524813368|FG011|Phase 1b|Disease progression|0|||
145532894|NCT01543698|524813369|FG012|Phase 1b|Disease progression|0|||
145532895|NCT01543698|524813370|FG013|Phase 1b|Disease progression|0|||
145532896|NCT01543698|524813371|FG014|Phase 1b|Disease progression|0|||
145532897|NCT01543698|524813357|FG000|Phase 1b|Death|0|||
145532898|NCT01543698|524813358|FG001|Phase 1b|Death|0|||
145532899|NCT01543698|524813359|FG002|Phase 1b|Death|1|||
145532900|NCT01543698|524813360|FG003|Phase 1b|Death|1|||
145532901|NCT01543698|524813361|FG004|Phase 1b|Death|0|||
145532902|NCT01543698|524813362|FG005|Phase 1b|Death|0|||
145532903|NCT01543698|524813363|FG006|Phase 1b|Death|0|||
145760299|NCT01446419|525634336|FG001|Overall Study|Terminated per protocol|0|||
145760300|NCT02542072|525634339|FG000|First Intervention (1 Month)|Adverse Event|1|||
145532904|NCT01543698|524813364|FG007|Phase 1b|Death|0|||
145532905|NCT01543698|524813365|FG008|Phase 1b|Death|0|||
145532906|NCT01543698|524813366|FG009|Phase 1b|Death|0|||
145532907|NCT01543698|524813367|FG010|Phase 1b|Death|1|||
145532908|NCT01543698|524813368|FG011|Phase 1b|Death|0|||
145532909|NCT01543698|524813369|FG012|Phase 1b|Death|0|||
145532910|NCT01543698|524813370|FG013|Phase 1b|Death|0|||
145532911|NCT01543698|524813371|FG014|Phase 1b|Death|0|||
145532912|NCT01543698|524813357|FG000|Phase 1b|Withdrawal by Subject|0|||
145532913|NCT01543698|524813358|FG001|Phase 1b|Withdrawal by Subject|1|||
145532914|NCT01543698|524813359|FG002|Phase 1b|Withdrawal by Subject|0|||
145532915|NCT01543698|524813360|FG003|Phase 1b|Withdrawal by Subject|1|||
145532916|NCT01543698|524813361|FG004|Phase 1b|Withdrawal by Subject|0|||
145532917|NCT01543698|524813362|FG005|Phase 1b|Withdrawal by Subject|0|||
145532918|NCT01543698|524813363|FG006|Phase 1b|Withdrawal by Subject|1|||
145532919|NCT01543698|524813364|FG007|Phase 1b|Withdrawal by Subject|0|||
145532920|NCT01543698|524813365|FG008|Phase 1b|Withdrawal by Subject|0|||
145532921|NCT01543698|524813366|FG009|Phase 1b|Withdrawal by Subject|0|||
145532922|NCT01543698|524813367|FG010|Phase 1b|Withdrawal by Subject|0|||
145532923|NCT01543698|524813368|FG011|Phase 1b|Withdrawal by Subject|0|||
145532924|NCT01543698|524813369|FG012|Phase 1b|Withdrawal by Subject|0|||
145532925|NCT01543698|524813370|FG013|Phase 1b|Withdrawal by Subject|0|||
145532926|NCT01543698|524813371|FG014|Phase 1b|Withdrawal by Subject|0|||
145532927|NCT01543698|524813357|FG000|Phase 1b|Adverse Event|1|||
145532928|NCT01543698|524813358|FG001|Phase 1b|Adverse Event|0|||
145532929|NCT01543698|524813359|FG002|Phase 1b|Adverse Event|0|||
145532930|NCT01543698|524813360|FG003|Phase 1b|Adverse Event|1|||
145532931|NCT01543698|524813361|FG004|Phase 1b|Adverse Event|2|||
145532932|NCT01543698|524813362|FG005|Phase 1b|Adverse Event|2|||
145532933|NCT01543698|524813363|FG006|Phase 1b|Adverse Event|0|||
145532934|NCT01543698|524813364|FG007|Phase 1b|Adverse Event|0|||
145532935|NCT01543698|524813365|FG008|Phase 1b|Adverse Event|1|||
145532936|NCT01543698|524813366|FG009|Phase 1b|Adverse Event|1|||
145532937|NCT01543698|524813367|FG010|Phase 1b|Adverse Event|2|||
145532938|NCT01543698|524813368|FG011|Phase 1b|Adverse Event|0|||
145532939|NCT01543698|524813369|FG012|Phase 1b|Adverse Event|0|||
145532940|NCT01543698|524813370|FG013|Phase 1b|Adverse Event|0|||
145532941|NCT01543698|524813371|FG014|Phase 1b|Adverse Event|0|||
145532942|NCT01543698|524813357|FG000|Phase 1b|Administrative problems|1|||
145532943|NCT01543698|524813358|FG001|Phase 1b|Administrative problems|0|||
145532944|NCT01543698|524813359|FG002|Phase 1b|Administrative problems|0|||
145532945|NCT01543698|524813360|FG003|Phase 1b|Administrative problems|0|||
145532946|NCT01543698|524813361|FG004|Phase 1b|Administrative problems|1|||
145532947|NCT01543698|524813362|FG005|Phase 1b|Administrative problems|0|||
145532948|NCT01543698|524813363|FG006|Phase 1b|Administrative problems|0|||
145532949|NCT01543698|524813364|FG007|Phase 1b|Administrative problems|1|||
145532950|NCT01543698|524813365|FG008|Phase 1b|Administrative problems|0|||
145532951|NCT01543698|524813366|FG009|Phase 1b|Administrative problems|0|||
145532952|NCT01543698|524813367|FG010|Phase 1b|Administrative problems|2|||
145532953|NCT01543698|524813368|FG011|Phase 1b|Administrative problems|0|||
145532954|NCT01543698|524813369|FG012|Phase 1b|Administrative problems|0|||
145532955|NCT01543698|524813370|FG013|Phase 1b|Administrative problems|0|||
145532956|NCT01543698|524813371|FG014|Phase 1b|Administrative problems|0|||
145532957|NCT01543698|524813357|FG000|Phase 1b|Protocol Violation|2|||
145532958|NCT01543698|524813358|FG001|Phase 1b|Protocol Violation|0|||
145532959|NCT01543698|524813359|FG002|Phase 1b|Protocol Violation|0|||
145532960|NCT01543698|524813360|FG003|Phase 1b|Protocol Violation|0|||
145532961|NCT01543698|524813361|FG004|Phase 1b|Protocol Violation|0|||
145532962|NCT01543698|524813362|FG005|Phase 1b|Protocol Violation|0|||
145532963|NCT01543698|524813363|FG006|Phase 1b|Protocol Violation|0|||
145532964|NCT01543698|524813364|FG007|Phase 1b|Protocol Violation|0|||
145532965|NCT01543698|524813365|FG008|Phase 1b|Protocol Violation|0|||
145532966|NCT01543698|524813366|FG009|Phase 1b|Protocol Violation|0|||
145532967|NCT01543698|524813367|FG010|Phase 1b|Protocol Violation|0|||
145532968|NCT01543698|524813368|FG011|Phase 1b|Protocol Violation|0|||
145532969|NCT01543698|524813369|FG012|Phase 1b|Protocol Violation|0|||
145760301|NCT02542072|525634340|FG001|First Intervention (1 Month)|Adverse Event|1|||
145760302|NCT02542072|525634339|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
145274403|NCT02706353|523851966|FG003|Dose Level 3|Disease Progression|0|||
145274404|NCT02706353|523851967|FG004|Dose Level 3|Disease Progression|0|||
145274405|NCT02706353|523851968|FG005|Dose Level 3|Disease Progression|0|||
145274406|NCT02706353|523851963|FG000|Dose Level 4|Disease Progression|0|||
145274407|NCT02706353|523851964|FG001|Dose Level 4|Disease Progression|0|||
145274408|NCT02706353|523851965|FG002|Dose Level 4|Disease Progression|0|||
145274409|NCT02706353|523851966|FG003|Dose Level 4|Disease Progression|1|||
145274410|NCT02706353|523851967|FG004|Dose Level 4|Disease Progression|0|||
145274411|NCT02706353|523851968|FG005|Dose Level 4|Disease Progression|0|||
145274412|NCT02706353|523851963|FG000|Dose Level 4|Toxicity|0|||
145274413|NCT02706353|523851964|FG001|Dose Level 4|Toxicity|0|||
145274414|NCT02706353|523851965|FG002|Dose Level 4|Toxicity|0|||
145274415|NCT02706353|523851966|FG003|Dose Level 4|Toxicity|1|||
145274416|NCT02706353|523851967|FG004|Dose Level 4|Toxicity|0|||
145274417|NCT02706353|523851968|FG005|Dose Level 4|Toxicity|0|||
145274418|NCT02706353|523851963|FG000|Dose Level 4|Death|0|||
145274419|NCT02706353|523851964|FG001|Dose Level 4|Death|0|||
145274420|NCT02706353|523851965|FG002|Dose Level 4|Death|0|||
145274421|NCT02706353|523851966|FG003|Dose Level 4|Death|1|||
145274422|NCT02706353|523851967|FG004|Dose Level 4|Death|0|||
145274423|NCT02706353|523851968|FG005|Dose Level 4|Death|0|||
145274424|NCT02706353|523851963|FG000|Dose Level 5|Toxicity|0|||
145274425|NCT02706353|523851964|FG001|Dose Level 5|Toxicity|0|||
145274426|NCT02706353|523851965|FG002|Dose Level 5|Toxicity|0|||
145274427|NCT02706353|523851966|FG003|Dose Level 5|Toxicity|0|||
145274428|NCT02706353|523851967|FG004|Dose Level 5|Toxicity|1|||
145274429|NCT02706353|523851968|FG005|Dose Level 5|Toxicity|0|||
145274430|NCT02706353|523851963|FG000|Dose Level 5|Disease Progression|0|||
145274431|NCT02706353|523851964|FG001|Dose Level 5|Disease Progression|0|||
145274432|NCT02706353|523851965|FG002|Dose Level 5|Disease Progression|0|||
145274433|NCT02706353|523851966|FG003|Dose Level 5|Disease Progression|0|||
145274434|NCT02706353|523851967|FG004|Dose Level 5|Disease Progression|3|||
145274435|NCT02706353|523851968|FG005|Dose Level 5|Disease Progression|2|||
145274436|NCT02706353|523851963|FG000|Dose Level 5|Death|0|||
145274437|NCT02706353|523851964|FG001|Dose Level 5|Death|0|||
145274438|NCT02706353|523851965|FG002|Dose Level 5|Death|0|||
145274439|NCT02706353|523851966|FG003|Dose Level 5|Death|0|||
145274440|NCT02706353|523851967|FG004|Dose Level 5|Death|1|||
145274441|NCT02706353|523851968|FG005|Dose Level 5|Death|6|||
145274442|NCT02706353|523851963|FG000|Dose Level 5|Withdrawal by Subject|0|||
145274443|NCT02706353|523851964|FG001|Dose Level 5|Withdrawal by Subject|0|||
145274444|NCT02706353|523851965|FG002|Dose Level 5|Withdrawal by Subject|0|||
145274445|NCT02706353|523851966|FG003|Dose Level 5|Withdrawal by Subject|0|||
145274446|NCT02706353|523851967|FG004|Dose Level 5|Withdrawal by Subject|0|||
145274447|NCT02706353|523851968|FG005|Dose Level 5|Withdrawal by Subject|2|||
145274448|NCT03560466|523851969|FG000|Overall Study|Adverse Event|1|||
145274449|NCT03560466|523851970|FG001|Overall Study|Adverse Event|2|||
145274450|NCT03560466|523851971|FG002|Overall Study|Adverse Event|0|||
145274451|NCT03560466|523851969|FG000|Overall Study|Poor Compliance to Protocol|0|||
145274452|NCT03560466|523851970|FG001|Overall Study|Poor Compliance to Protocol|2|||
145274453|NCT03560466|523851971|FG002|Overall Study|Poor Compliance to Protocol|0|||
145760303|NCT02542072|525634340|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
145274454|NCT03560466|523851969|FG000|Overall Study|Other|6|||
145274455|NCT03560466|523851970|FG001|Overall Study|Other|8|||
145274456|NCT03560466|523851971|FG002|Overall Study|Other|1|||
145274457|NCT03703297|523851972|FG000|Overall Study|Death|115|||
145274458|NCT03703297|523851973|FG001|Overall Study|Death|0|||
145274459|NCT03703297|523851974|FG002|Overall Study|Death|144|||
145274460|NCT03703297|523851972|FG000|Overall Study|Withdrawal by Subject|9|||
145274461|NCT03703297|523851973|FG001|Overall Study|Withdrawal by Subject|0|||
145274462|NCT03703297|523851974|FG002|Overall Study|Withdrawal by Subject|11|||
145274463|NCT03703297|523851972|FG000|Overall Study|Ongoing at the time of DCO|140|||
145274464|NCT03703297|523851973|FG001|Overall Study|Ongoing at the time of DCO|200|||
145274465|NCT03703297|523851974|FG002|Overall Study|Ongoing at the time of DCO|111|||
145532970|NCT01543698|524813370|FG013|Phase 1b|Protocol Violation|0|||
145532971|NCT01543698|524813371|FG014|Phase 1b|Protocol Violation|0|||
145532972|NCT01543698|524813357|FG000|Phase 2|Protocol Violation|0|||
145274466|NCT02038959|523853326|FG000|Overall Study|Withdrawal by Subject|6|||
145274467|NCT02038959|523853327|FG001|Overall Study|Withdrawal by Subject|8|||
145274468|NCT00819091|523853333|FG000|Overall Study|Adverse Event|3|||
145274469|NCT00819091|523853334|FG001|Overall Study|Adverse Event|5|||
145274470|NCT00819091|523853333|FG000|Overall Study|Protocol Violation|0|||
145274471|NCT00819091|523853334|FG001|Overall Study|Protocol Violation|1|||
145274472|NCT00819091|523853333|FG000|Overall Study|Lost to Follow-up|2|||
145274473|NCT00819091|523853334|FG001|Overall Study|Lost to Follow-up|0|||
145274474|NCT00819091|523853333|FG000|Overall Study|Withdrawal by Subject|1|||
145532973|NCT01543698|524813358|FG001|Phase 2|Protocol Violation|0|||
145532974|NCT01543698|524813359|FG002|Phase 2|Protocol Violation|0|||
145532975|NCT01543698|524813360|FG003|Phase 2|Protocol Violation|0|||
145532976|NCT01543698|524813361|FG004|Phase 2|Protocol Violation|0|||
145532977|NCT01543698|524813362|FG005|Phase 2|Protocol Violation|0|||
145532978|NCT01543698|524813363|FG006|Phase 2|Protocol Violation|0|||
145532979|NCT01543698|524813364|FG007|Phase 2|Protocol Violation|0|||
145532980|NCT01543698|524813365|FG008|Phase 2|Protocol Violation|0|||
145532981|NCT01543698|524813366|FG009|Phase 2|Protocol Violation|0|||
145532982|NCT01543698|524813367|FG010|Phase 2|Protocol Violation|0|||
145532983|NCT01543698|524813368|FG011|Phase 2|Protocol Violation|0|||
145532984|NCT01543698|524813369|FG012|Phase 2|Protocol Violation|1|||
145532985|NCT01543698|524813370|FG013|Phase 2|Protocol Violation|0|||
145532986|NCT01543698|524813371|FG014|Phase 2|Protocol Violation|0|||
145532987|NCT01543698|524813357|FG000|Phase 2|Disease progression|0|||
145532988|NCT01543698|524813358|FG001|Phase 2|Disease progression|0|||
145532989|NCT01543698|524813359|FG002|Phase 2|Disease progression|0|||
145532990|NCT01543698|524813360|FG003|Phase 2|Disease progression|0|||
145760304|NCT02542072|525634339|FG000|First Intervention (1 Month)|Lens discomfort|1|||
145760305|NCT02542072|525634340|FG001|First Intervention (1 Month)|Lens discomfort|2|||
145760306|NCT02542072|525634339|FG000|First Intervention (1 Month)|Protocol Violation|1|||
145760307|NCT02542072|525634340|FG001|First Intervention (1 Month)|Protocol Violation|0|||
145760308|NCT02542072|525634339|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
145760309|NCT02542072|525634340|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
145760310|NCT02542072|525634339|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
145760311|NCT02542072|525634340|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
145760312|NCT00654498|525634341|FG000|Overall Study|Not Treated|1|||
145760313|NCT00654498|525634342|FG001|Overall Study|Not Treated|0|||
145760314|NCT00654498|525634341|FG000|Overall Study|Adverse Event|6|||
145760315|NCT00654498|525634342|FG001|Overall Study|Adverse Event|1|||
145760316|NCT00654498|525634341|FG000|Overall Study|Protocol Violation|1|||
145760317|NCT00654498|525634342|FG001|Overall Study|Protocol Violation|1|||
145760318|NCT00654498|525634341|FG000|Overall Study|Lost to Follow-up|1|||
145760319|NCT00654498|525634342|FG001|Overall Study|Lost to Follow-up|5|||
145760320|NCT00654498|525634341|FG000|Overall Study|Withdrawal by Subject|1|||
145760321|NCT00654498|525634342|FG001|Overall Study|Withdrawal by Subject|0|||
145760322|NCT00654498|525634341|FG000|Overall Study|Other reason not defined above|4|||
145760323|NCT00654498|525634342|FG001|Overall Study|Other reason not defined above|5|||
145760324|NCT01609842|525634343|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
145760325|NCT01609842|525634344|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
145760326|NCT02474329|525634346|FG000|Overall Study|Withdraw or did not contribute data.|13|||
145760327|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
145760328|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
145760329|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
145760330|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760331|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760332|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760333|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760334|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760335|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145760336|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
145760337|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
145760338|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
145760339|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760340|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760341|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760342|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760343|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760344|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145760345|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
145760346|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
145760347|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145760348|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145760349|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145760350|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145274475|NCT00819091|523853334|FG001|Overall Study|Withdrawal by Subject|2|||
145532991|NCT01543698|524813361|FG004|Phase 2|Disease progression|0|||
145532992|NCT01543698|524813362|FG005|Phase 2|Disease progression|0|||
145532993|NCT01543698|524813363|FG006|Phase 2|Disease progression|0|||
145532994|NCT01543698|524813364|FG007|Phase 2|Disease progression|0|||
145274476|NCT00819091|523853333|FG000|Overall Study|Other|1|||
145532995|NCT01543698|524813365|FG008|Phase 2|Disease progression|0|||
145532996|NCT01543698|524813366|FG009|Phase 2|Disease progression|0|||
145532997|NCT01543698|524813367|FG010|Phase 2|Disease progression|0|||
145532998|NCT01543698|524813368|FG011|Phase 2|Disease progression|10|||
145532999|NCT01543698|524813369|FG012|Phase 2|Disease progression|21|||
145533000|NCT01543698|524813370|FG013|Phase 2|Disease progression|30|||
145533001|NCT01543698|524813371|FG014|Phase 2|Disease progression|25|||
145533002|NCT01543698|524813357|FG000|Phase 2|Death|0|||
145533003|NCT01543698|524813358|FG001|Phase 2|Death|0|||
145533004|NCT01543698|524813359|FG002|Phase 2|Death|0|||
145533005|NCT01543698|524813360|FG003|Phase 2|Death|0|||
145533006|NCT01543698|524813361|FG004|Phase 2|Death|0|||
145533007|NCT01543698|524813362|FG005|Phase 2|Death|0|||
145533008|NCT01543698|524813363|FG006|Phase 2|Death|0|||
145533009|NCT01543698|524813364|FG007|Phase 2|Death|0|||
145533010|NCT01543698|524813365|FG008|Phase 2|Death|0|||
145533011|NCT01543698|524813366|FG009|Phase 2|Death|0|||
145533012|NCT01543698|524813367|FG010|Phase 2|Death|0|||
145533013|NCT01543698|524813368|FG011|Phase 2|Death|0|||
145533014|NCT01543698|524813369|FG012|Phase 2|Death|1|||
145533015|NCT01543698|524813370|FG013|Phase 2|Death|1|||
145760351|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145274477|NCT00819091|523853334|FG001|Overall Study|Other|2|||
145274478|NCT03911960|523853336|FG000|Overall Study|Lost to Follow-up|5|||
145274479|NCT03911960|523853337|FG001|Overall Study|Lost to Follow-up|3|||
145274480|NCT00391092|523853338|FG000|Overall Study|Death|78|||
145274481|NCT00391092|523853339|FG001|Overall Study|Death|81|||
145274482|NCT00391092|523853338|FG000|Overall Study|Lost to Follow-up|13|||
145274483|NCT00391092|523853339|FG001|Overall Study|Lost to Follow-up|18|||
145274484|NCT00391092|523853338|FG000|Overall Study|Alive on treatment|29|||
145274485|NCT00391092|523853339|FG001|Overall Study|Alive on treatment|33|||
145274486|NCT00391092|523853338|FG000|Overall Study|Alive in follow-up|88|||
145274487|NCT00391092|523853339|FG001|Overall Study|Alive in follow-up|84|||
145274488|NCT00424515|523853342|FG000|Overall Study|Progressive Disease|10|||
145274489|NCT00424515|523853343|FG001|Overall Study|Progressive Disease|11|||
145274490|NCT00424515|523853342|FG000|Overall Study|Adverse Event|0|||
145274491|NCT00424515|523853343|FG001|Overall Study|Adverse Event|1|||
145274492|NCT00424515|523853342|FG000|Overall Study|Intercurrent Illness|0|||
145274493|NCT00424515|523853343|FG001|Overall Study|Intercurrent Illness|1|||
145274494|NCT00424515|523853342|FG000|Overall Study|Withdrawal by Subject|1|||
145274495|NCT00424515|523853343|FG001|Overall Study|Withdrawal by Subject|0|||
145274496|NCT04071366|523853344|FG000|Part 1: Open-label (29 Days)|Death|4|||
145274497|NCT04071366|523853345|FG001|Part 1: Open-label (29 Days)|Death|2|||
145274498|NCT04071366|523853346|FG002|Part 1: Open-label (29 Days)|Death|8|||
145274499|NCT04071366|523853347|FG003|Part 1: Open-label (29 Days)|Death|0|||
145274500|NCT04071366|523853348|FG004|Part 1: Open-label (29 Days)|Death|0|||
145274501|NCT04071366|523853344|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
145274502|NCT04071366|523853345|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
145274503|NCT04071366|523853346|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
145274504|NCT04071366|523853347|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
145274505|NCT04071366|523853348|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
145274506|NCT04071366|523853344|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
145274507|NCT04071366|523853345|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
145274508|NCT04071366|523853346|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
145274509|NCT04071366|523853347|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
145274510|NCT04071366|523853348|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
145274511|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Death|0|||
145274512|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Death|0|||
145274513|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Death|0|||
145274514|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Death|2|||
145533016|NCT01543698|524813371|FG014|Phase 2|Death|1|||
145533017|NCT01543698|524813357|FG000|Phase 2|Administrative problems|0|||
145533018|NCT01543698|524813358|FG001|Phase 2|Administrative problems|0|||
145760352|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145760353|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145274515|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Death|2|||
145274516|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
145274517|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
145274518|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
145274519|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
145274520|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
145274521|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
145533019|NCT01543698|524813359|FG002|Phase 2|Administrative problems|0|||
145533020|NCT01543698|524813360|FG003|Phase 2|Administrative problems|0|||
145533021|NCT01543698|524813361|FG004|Phase 2|Administrative problems|0|||
145607686|NCT00682643|525079237|FG001|Overall Study|Lost to Follow-up|6|||
145533022|NCT01543698|524813362|FG005|Phase 2|Administrative problems|0|||
145533023|NCT01543698|524813363|FG006|Phase 2|Administrative problems|0|||
145533024|NCT01543698|524813364|FG007|Phase 2|Administrative problems|0|||
145533025|NCT01543698|524813365|FG008|Phase 2|Administrative problems|0|||
145533026|NCT01543698|524813366|FG009|Phase 2|Administrative problems|0|||
145533027|NCT01543698|524813367|FG010|Phase 2|Administrative problems|0|||
145533028|NCT01543698|524813368|FG011|Phase 2|Administrative problems|0|||
145533029|NCT01543698|524813369|FG012|Phase 2|Administrative problems|0|||
145533030|NCT01543698|524813370|FG013|Phase 2|Administrative problems|3|||
145533031|NCT01543698|524813371|FG014|Phase 2|Administrative problems|1|||
145533032|NCT01543698|524813357|FG000|Phase 2|Withdrawal by Subject|0|||
145760354|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
145760355|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
145760356|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
145760357|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145760358|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145760359|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145760360|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145760361|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145533033|NCT01543698|524813358|FG001|Phase 2|Withdrawal by Subject|0|||
145533034|NCT01543698|524813359|FG002|Phase 2|Withdrawal by Subject|0|||
145533035|NCT01543698|524813360|FG003|Phase 2|Withdrawal by Subject|0|||
145533036|NCT01543698|524813361|FG004|Phase 2|Withdrawal by Subject|0|||
145533037|NCT01543698|524813362|FG005|Phase 2|Withdrawal by Subject|0|||
145533038|NCT01543698|524813363|FG006|Phase 2|Withdrawal by Subject|0|||
145533039|NCT01543698|524813364|FG007|Phase 2|Withdrawal by Subject|0|||
145533040|NCT01543698|524813365|FG008|Phase 2|Withdrawal by Subject|0|||
145533041|NCT01543698|524813366|FG009|Phase 2|Withdrawal by Subject|0|||
145533042|NCT01543698|524813367|FG010|Phase 2|Withdrawal by Subject|0|||
145533043|NCT01543698|524813368|FG011|Phase 2|Withdrawal by Subject|0|||
145533044|NCT01543698|524813369|FG012|Phase 2|Withdrawal by Subject|0|||
145533045|NCT01543698|524813370|FG013|Phase 2|Withdrawal by Subject|3|||
145533046|NCT01543698|524813371|FG014|Phase 2|Withdrawal by Subject|1|||
145533047|NCT01543698|524813357|FG000|Phase 2|Adverse Event|0|||
145533048|NCT01543698|524813358|FG001|Phase 2|Adverse Event|0|||
145760362|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145760363|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
145760364|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
145760365|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760366|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760367|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760368|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760369|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760370|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760371|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
145760372|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760373|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760374|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
145760375|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760376|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760377|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760378|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760379|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760380|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145760381|NCT01583374|525634347|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
145533049|NCT01543698|524813359|FG002|Phase 2|Adverse Event|0|||
145533050|NCT01543698|524813360|FG003|Phase 2|Adverse Event|0|||
145533051|NCT01543698|524813361|FG004|Phase 2|Adverse Event|0|||
145533052|NCT01543698|524813362|FG005|Phase 2|Adverse Event|0|||
145533053|NCT01543698|524813363|FG006|Phase 2|Adverse Event|0|||
145533054|NCT01543698|524813364|FG007|Phase 2|Adverse Event|0|||
145533055|NCT01543698|524813365|FG008|Phase 2|Adverse Event|0|||
145533056|NCT01543698|524813366|FG009|Phase 2|Adverse Event|0|||
145533057|NCT01543698|524813367|FG010|Phase 2|Adverse Event|0|||
145533058|NCT01543698|524813368|FG011|Phase 2|Adverse Event|1|||
145760382|NCT01583374|525634348|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
145760383|NCT01583374|525634349|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
145760384|NCT01583374|525634350|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
145533059|NCT01543698|524813369|FG012|Phase 2|Adverse Event|3|||
145533060|NCT01543698|524813370|FG013|Phase 2|Adverse Event|5|||
145533061|NCT01543698|524813371|FG014|Phase 2|Adverse Event|14|||
145533062|NCT00217620|524813372|FG000|Overall Study|Adverse Event|2|||
145533063|NCT00217620|524813372|FG000|Overall Study|Progression|31|||
145533064|NCT00217620|524813372|FG000|Overall Study|Not Protocol Specified|4|||
145533065|NCT00217620|524813372|FG000|Overall Study|Ineligible|13|||
145533066|NCT00217620|524813372|FG000|Overall Study|Never received treatment|1|||
145533067|NCT02925923|524813373|FG000|Overall Study|blood samples hemolyzed|0|||
145533068|NCT02925923|524813374|FG001|Overall Study|blood samples hemolyzed|2|||
145760385|NCT01583374|525634351|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
145402897|NCT02065557|524332546|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145533069|NCT01863953|524813375|FG000|Overall Study|Adverse Event|0|||
145760386|NCT01583374|525634352|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
145760387|NCT01583374|525634353|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
145760388|NCT01583374|525634354|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
145760389|NCT01583374|525634355|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
145760390|NCT01583374|525634347|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145760391|NCT01583374|525634348|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145760392|NCT01583374|525634349|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145533070|NCT01863953|524813376|FG001|Overall Study|Adverse Event|0|||
145533071|NCT01863953|524813377|FG002|Overall Study|Adverse Event|1|||
145533072|NCT01824342|524813384|FG000|Overall Study|Withdrawal by Subject|0|||
145533073|NCT01824342|524813385|FG001|Overall Study|Withdrawal by Subject|3|||
145533074|NCT01824342|524813384|FG000|Overall Study|Adverse Event|1|||
145533075|NCT01824342|524813385|FG001|Overall Study|Adverse Event|1|||
145607687|NCT00682643|525079236|FG000|Overall Study|Physician Decision|2|||
145607688|NCT00682643|525079237|FG001|Overall Study|Physician Decision|6|||
145607689|NCT00682643|525079236|FG000|Overall Study|Withdrawal by Subject|19|||
145607690|NCT00682643|525079237|FG001|Overall Study|Withdrawal by Subject|53|||
145607691|NCT00682643|525079236|FG000|Overall Study|Did Not Receive Study Drug|1|||
145607692|NCT00682643|525079237|FG001|Overall Study|Did Not Receive Study Drug|1|||
145607693|NCT01875185|525079238|FG000|Overall Study|study was terminated|52|||
145607694|NCT01875185|525079239|FG001|Overall Study|study was terminated|48|||
145607695|NCT01521884|525079240|FG000|Overall Study|Non Responders|10|||
145607696|NCT01521884|525079240|FG000|Overall Study|Adverse Event|5|||
145607697|NCT01521884|525079240|FG000|Overall Study|Pregnancy|1|||
145607698|NCT01521884|525079240|FG000|Overall Study|Withdrawal by Subject|1|||
145607699|NCT01521884|525079240|FG000|Overall Study|Physician Decision|2|||
145607700|NCT01521884|525079240|FG000|Overall Study|Protocol Violation|3|||
145607701|NCT01521884|525079240|FG000|Overall Study|Participant non-eligible|1|||
145760393|NCT01583374|525634350|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145760394|NCT01583374|525634351|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145533076|NCT01824342|524813384|FG000|Overall Study|Disease Progression|1|||
145533077|NCT01824342|524813385|FG001|Overall Study|Disease Progression|1|||
145533078|NCT01824342|524813384|FG000|Overall Study|Physician Decision|5|||
145607702|NCT01521884|525079240|FG000|Overall Study|Lost to Follow-up|4|||
145607703|NCT03565068|525079241|FG000|Overall Study|Protocol Violation|0|||
145760395|NCT01583374|525634352|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145533079|NCT01824342|524813385|FG001|Overall Study|Physician Decision|0|||
145533080|NCT01824342|524813384|FG000|Overall Study|Death|2|||
145533081|NCT01824342|524813385|FG001|Overall Study|Death|0|||
145533082|NCT02104752|524813392|FG000|Overall Study|Withdrawal by Subject|1|||
145533083|NCT02104752|524813393|FG001|Overall Study|Withdrawal by Subject|0|||
145533084|NCT02104752|524813392|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
145607704|NCT03565068|525079242|FG001|Overall Study|Protocol Violation|0|||
145607705|NCT03565068|525079243|FG002|Overall Study|Protocol Violation|0|||
145760396|NCT01583374|525634353|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145760397|NCT01583374|525634354|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
145760398|NCT01583374|525634355|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145760399|NCT01583374|525634347|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
145760400|NCT01583374|525634348|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
145760401|NCT01583374|525634349|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
145760402|NCT01583374|525634350|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
145760403|NCT01583374|525634351|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
145760404|NCT01583374|525634352|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
145760405|NCT01583374|525634353|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
145760406|NCT01583374|525634354|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
145607706|NCT03565068|525079244|FG003|Overall Study|Protocol Violation|0|||
145607707|NCT03565068|525079245|FG004|Overall Study|Protocol Violation|1|||
145760407|NCT01583374|525634355|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
145760408|NCT01583374|525634347|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
145760409|NCT01583374|525634348|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
145607708|NCT03565068|525079246|FG005|Overall Study|Protocol Violation|0|||
145760410|NCT01583374|525634349|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
145760411|NCT01583374|525634350|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
145533085|NCT02104752|524813393|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
145533086|NCT00385762|524813394|FG000|Overall Study|Adverse Event|1|||
145533087|NCT00385762|524813394|FG000|Overall Study|Lost to Follow-up|1|||
145533088|NCT02422303|524813397|FG000|Overall Study|Lost to Follow-up|1|||
145533089|NCT02422303|524813398|FG001|Overall Study|Lost to Follow-up|1|||
145533090|NCT02899299|524813400|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
145533091|NCT02899299|524813401|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
145533092|NCT02899299|524813400|FG000|Pre-treatment|Participant withdrew consent|1|||
145533093|NCT02899299|524813401|FG001|Pre-treatment|Participant withdrew consent|11|||
145533094|NCT02899299|524813400|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
145533095|NCT02899299|524813401|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
145533096|NCT02899299|524813400|FG000|Pre-treatment|Not reported|0|||
145533097|NCT02899299|524813401|FG001|Pre-treatment|Not reported|1|||
145760412|NCT01583374|525634351|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
145533098|NCT02899299|524813400|FG000|Treatment|Disease Progression|182|||
145533099|NCT02899299|524813401|FG001|Treatment|Disease Progression|43|||
145533100|NCT02899299|524813400|FG000|Treatment|Study Drug Toxicity|60|||
145533101|NCT02899299|524813401|FG001|Treatment|Study Drug Toxicity|24|||
145533102|NCT02899299|524813400|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
145533103|NCT02899299|524813401|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
145533104|NCT02899299|524813400|FG000|Treatment|Participant request to discontinue Study treatment|4|||
145533105|NCT02899299|524813401|FG001|Treatment|Participant request to discontinue Study treatment|10|||
145607709|NCT03565068|525079247|FG006|Overall Study|Protocol Violation|0|||
145533106|NCT02899299|524813400|FG000|Treatment|Participant withdrew consent|6|||
145533107|NCT02899299|524813401|FG001|Treatment|Participant withdrew consent|3|||
145533108|NCT02899299|524813400|FG000|Treatment|Lost to Follow-up|0|||
145533109|NCT02899299|524813401|FG001|Treatment|Lost to Follow-up|2|||
145533110|NCT02899299|524813400|FG000|Treatment|Maximum Clinical Benefit|11|||
145533111|NCT02899299|524813401|FG001|Treatment|Maximum Clinical Benefit|2|||
145533112|NCT02899299|524813400|FG000|Treatment|Poor/Non-compliance|1|||
145533113|NCT02899299|524813401|FG001|Treatment|Poor/Non-compliance|0|||
145533114|NCT02899299|524813400|FG000|Treatment|Participant no longer meets Study criteria|4|||
145533115|NCT02899299|524813401|FG001|Treatment|Participant no longer meets Study criteria|0|||
145533116|NCT02899299|524813400|FG000|Treatment|Administrative reason by Sponsor|2|||
145533117|NCT02899299|524813401|FG001|Treatment|Administrative reason by Sponsor|0|||
145274522|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
145274523|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
145274524|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
145274525|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
145274526|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
145274527|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
145274528|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
145274529|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
145274530|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
145274531|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
145274532|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
145274533|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
145274534|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
145274535|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
145274536|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
145274537|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
145274538|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
145274539|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
145274540|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
145274541|NCT04071366|523853344|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
145274542|NCT04071366|523853345|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
145274543|NCT04071366|523853346|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
145274544|NCT04071366|523853347|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
145274545|NCT04071366|523853348|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
145274546|NCT02239692|523853349|FG000|Overall Study|Incomplete colonoscopy|1|||
145274547|NCT02239692|523853350|FG001|Overall Study|Incomplete colonoscopy|2|||
145274548|NCT02239692|523853349|FG000|Overall Study|Adverse Event|0|||
145274549|NCT02239692|523853350|FG001|Overall Study|Adverse Event|1|||
145274550|NCT02239692|523853349|FG000|Overall Study|Physician Decision|0|||
145274551|NCT02239692|523853350|FG001|Overall Study|Physician Decision|1|||
145274552|NCT02239692|523853349|FG000|Overall Study|Lost to Follow-up|1|||
145274553|NCT02239692|523853350|FG001|Overall Study|Lost to Follow-up|4|||
145274554|NCT02239692|523853349|FG000|Overall Study|Withdrawal by Subject|3|||
145274555|NCT02239692|523853350|FG001|Overall Study|Withdrawal by Subject|5|||
145274556|NCT02239692|523853349|FG000|Overall Study|Other reason|1|||
145274557|NCT02239692|523853350|FG001|Overall Study|Other reason|0|||
145274558|NCT00858234|523853351|FG000|Overall Study|Adverse Event|6|||
145274559|NCT00858234|523853351|FG000|Overall Study|Progressive disease|2|||
145274560|NCT00858234|523853351|FG000|Overall Study|Status unknown|1|||
145274561|NCT04318535|523853352|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
145274562|NCT04318535|523853353|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
145274563|NCT04318535|523853354|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
145274564|NCT01678924|523853355|FG000|Overall Study|Adverse Event|1|||
145274565|NCT01678924|523853356|FG001|Overall Study|Adverse Event|1|||
145533118|NCT02899299|524813400|FG000|Treatment|Other reasons|12|||
145533119|NCT02899299|524813401|FG001|Treatment|Other reasons|2|||
145274566|NCT01678924|523853357|FG002|Overall Study|Adverse Event|0|||
145274567|NCT01678924|523853358|FG003|Overall Study|Adverse Event|1|||
145274568|NCT01678924|523853355|FG000|Overall Study|Lack of Efficacy|7|||
145274569|NCT01678924|523853356|FG001|Overall Study|Lack of Efficacy|2|||
145274570|NCT01678924|523853357|FG002|Overall Study|Lack of Efficacy|0|||
145274571|NCT01678924|523853358|FG003|Overall Study|Lack of Efficacy|5|||
145533120|NCT02899299|524813400|FG000|Treatment|Not reported|7|||
145533121|NCT02899299|524813401|FG001|Treatment|Not reported|0|||
145533122|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
145533123|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
145274572|NCT01678924|523853355|FG000|Overall Study|Lost to Follow-up|0|||
145533124|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
145533125|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
145533126|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
145533127|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
145533128|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
145533129|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
145533130|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
145533131|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
145533132|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
145533133|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
145533134|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
145533135|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
145760413|NCT01583374|525634352|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
145760414|NCT01583374|525634353|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
145760415|NCT01583374|525634354|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
145760416|NCT01583374|525634355|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
145533136|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
145533137|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
145533138|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
145533139|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
145607710|NCT03565068|525079248|FG007|Overall Study|Protocol Violation|1|||
145607711|NCT03565068|525079249|FG008|Overall Study|Protocol Violation|0|||
145607712|NCT03565068|525079241|FG000|Overall Study|Sponsor decision|0|||
145607713|NCT03565068|525079242|FG001|Overall Study|Sponsor decision|0|||
145607714|NCT03565068|525079243|FG002|Overall Study|Sponsor decision|0|||
145607715|NCT03565068|525079244|FG003|Overall Study|Sponsor decision|0|||
145607716|NCT03565068|525079245|FG004|Overall Study|Sponsor decision|1|||
145607717|NCT03565068|525079246|FG005|Overall Study|Sponsor decision|1|||
145607718|NCT03565068|525079247|FG006|Overall Study|Sponsor decision|0|||
145607719|NCT03565068|525079248|FG007|Overall Study|Sponsor decision|0|||
145607720|NCT03565068|525079249|FG008|Overall Study|Sponsor decision|0|||
145607721|NCT03565068|525079241|FG000|Overall Study|Withdrawal by Subject|0|||
145607722|NCT03565068|525079242|FG001|Overall Study|Withdrawal by Subject|0|||
145533140|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
145533141|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
145533142|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
145533143|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
145533144|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
145533145|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
145533146|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
145533147|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
145533148|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
145533149|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
145533150|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
145533151|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
145533152|NCT00313300|524813402|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
145533153|NCT00313300|524813403|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
145533154|NCT00313300|524813404|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
145533155|NCT00313300|524813405|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
145533156|NCT00313300|524813406|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
145533157|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
145533158|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
145533159|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
145533160|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
145533161|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
145533162|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
145533163|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
145533164|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
145533165|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
145533166|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
145533167|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
145533168|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
145533169|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
145533170|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
145533171|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
145533172|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
145533173|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
145533174|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
145533175|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
145533176|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
145533177|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
145533178|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
145533179|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
145533180|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
145533181|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
145533182|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
145533183|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
145533184|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
145533185|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
145533186|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
145760417|NCT01583374|525634347|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145533187|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
145533188|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
145533189|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
145533190|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
145533191|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
145533192|NCT00313300|524813402|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
145533193|NCT00313300|524813403|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
145533194|NCT00313300|524813404|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
145533195|NCT00313300|524813405|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
145533196|NCT00313300|524813406|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
145533197|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
145533198|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
145533199|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
145533200|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
145533201|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
145533202|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
145533203|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
145533204|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
145533205|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
145533206|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
145533207|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
145533208|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
145533209|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
145533210|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
145533211|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
145533212|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
145533213|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
145533214|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
145533215|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
145533216|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
145533217|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
145533218|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
145533219|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
145533220|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
145533221|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
145760418|NCT01583374|525634348|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
145760419|NCT01583374|525634349|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
145760420|NCT01583374|525634350|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145760421|NCT01583374|525634351|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
145760422|NCT01583374|525634352|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145760423|NCT01583374|525634353|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145760424|NCT01583374|525634354|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145760425|NCT01583374|525634355|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
145760426|NCT01583374|525634347|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760427|NCT01583374|525634348|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760428|NCT01583374|525634349|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
145760429|NCT01583374|525634350|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760430|NCT01583374|525634351|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
145760431|NCT01583374|525634352|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
145760432|NCT01583374|525634353|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760433|NCT01583374|525634354|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760434|NCT01583374|525634355|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145760435|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
145760436|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
145760437|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
145760438|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
145760439|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
145760440|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
145760441|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
145760442|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
145760443|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
145760444|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
145760445|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
145760446|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
145760447|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
145760448|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
145760449|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
145760450|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
145533222|NCT00313300|524813402|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
145533223|NCT00313300|524813403|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
145533224|NCT00313300|524813404|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
145760451|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
145760452|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
145760453|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760454|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760455|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760456|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760457|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
145760458|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760459|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
145760460|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
145760461|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
145760462|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
145760463|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
145760464|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
145760465|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
145760466|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
145760467|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
145760468|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
145760469|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
145760470|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
145760471|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760472|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760473|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760474|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760475|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
145760476|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760477|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
145760478|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760479|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
145760480|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
145760481|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
145760482|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
145760483|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
145760484|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
145760485|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
145760486|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
145760487|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
145760488|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
145760489|NCT01583374|525634347|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
145760490|NCT01583374|525634348|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
145760491|NCT01583374|525634349|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
145760492|NCT01583374|525634350|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
145760493|NCT01583374|525634351|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
145760494|NCT01583374|525634352|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
145760495|NCT01583374|525634353|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
145760496|NCT01583374|525634354|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
145760497|NCT01583374|525634355|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
145760498|NCT01506882|525634356|FG000|Overall Study|Lack of Efficacy|4|||
145760499|NCT01506882|525634357|FG001|Overall Study|Lack of Efficacy|3|||
145760500|NCT01506882|525634356|FG000|Overall Study|Lost to Follow-up|1|||
145760501|NCT01506882|525634357|FG001|Overall Study|Lost to Follow-up|0|||
145760502|NCT01506882|525634356|FG000|Overall Study|Withdrawal by Subject|9|||
145760503|NCT01506882|525634357|FG001|Overall Study|Withdrawal by Subject|3|||
145760504|NCT01506882|525634356|FG000|Overall Study|SAE, non-fatal|2|||
145760505|NCT01506882|525634357|FG001|Overall Study|SAE, non-fatal|0|||
145760506|NCT01506882|525634356|FG000|Overall Study|AE, non-serious non-fatal|3|||
145760507|NCT01506882|525634357|FG001|Overall Study|AE, non-serious non-fatal|1|||
145760508|NCT01506882|525634356|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
145760509|NCT01506882|525634357|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
145760510|NCT01506882|525634356|FG000|Overall Study|Other Reason|2|||
145760511|NCT01506882|525634357|FG001|Overall Study|Other Reason|0|||
145760512|NCT00670007|525636456|FG000|Overall Study|Drug abuse|1|||
145760513|NCT00670007|525636456|FG000|Overall Study|Lung transplant|1|||
145760514|NCT00670007|525636456|FG000|Overall Study|Travel/Vacation|1|||
145760515|NCT00670007|525636456|FG000|Overall Study|Adverse event, serious fatal|1|||
145760516|NCT00670007|525636456|FG000|Overall Study|Adverse Event|1|||
145760517|NCT00670007|525636456|FG000|Overall Study|Withdrawal by Subject|4|||
145760518|NCT04188197|525636457|FG000|Overall Study|Lost to Follow-up|4|||
145760519|NCT04188197|525636458|FG001|Overall Study|Lost to Follow-up|1|||
145760520|NCT04188197|525636457|FG000|Overall Study|Withdrawal by Subject|1|||
145760521|NCT04188197|525636458|FG001|Overall Study|Withdrawal by Subject|1|||
145760522|NCT04188197|525636457|FG000|Overall Study|Pregnancy|0|||
145760523|NCT04188197|525636458|FG001|Overall Study|Pregnancy|1|||
145760524|NCT00956943|525636463|FG000|Overall Study|Lost to Follow-up|9|||
145760525|NCT00956943|525636464|FG001|Overall Study|Lost to Follow-up|10|||
145760526|NCT02613208|525636465|FG000|Overall Study|Withdrawal by Subject|1|||
145760527|NCT02613208|525636465|FG000|Overall Study|Change of address|2|||
145760528|NCT02613208|525636465|FG000|Overall Study|Physician Decision|2|||
145760529|NCT02613208|525636465|FG000|Overall Study|Lost to Follow-up|5|||
145760530|NCT02613208|525636465|FG000|Overall Study|Death|37|||
145533225|NCT00313300|524813405|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
145533226|NCT00313300|524813406|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
145760531|NCT02663895|525636466|FG000|Overall Study|Adverse Event|3|||
145760532|NCT02663895|525636466|FG000|Overall Study|Physician Decision|2|||
145760533|NCT02663895|525636466|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
145760534|NCT02663895|525636466|FG000|Overall Study|Withdrawal by Subject|1|||
145760535|NCT02911688|525636467|FG000|Washout|Lost to Follow-up|1|||
145760536|NCT02911688|525636468|FG001|Washout|Lost to Follow-up|1|||
145760537|NCT02911688|525636467|FG000|Washout|Withdrawal by Subject|0|||
145760538|NCT02911688|525636468|FG001|Washout|Withdrawal by Subject|1|||
145760539|NCT00282243|525636471|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
145760540|NCT00282243|525636471|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
145760541|NCT00282243|525636471|FG000|Extension Treatment Period|Adverse Event|15|||
145760542|NCT00282243|525636471|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
145760543|NCT00282243|525636471|FG000|Extension Treatment Period|Non-compliance|2|||
145760544|NCT00282243|525636471|FG000|Extension Treatment Period|Physician Decision|1|||
145760545|NCT00851903|525636472|FG000|Overall Study|Withdrawal by Subject|2|||
145760546|NCT00270894|525636473|FG000|Overall Study|Adverse Event|1|||
145760547|NCT00270894|525636473|FG000|Overall Study|Withdrawal by Subject|1|||
145533227|NCT02336373|524813407|FG000|Overall Study|Protocol closed early|4|||
145533228|NCT02336373|524813407|FG000|Overall Study|Physician Decision|14|||
145533229|NCT00850343|524813408|FG000|Overall Study|Withdrawal by Subject|11|||
145533230|NCT00850343|524813409|FG001|Overall Study|Withdrawal by Subject|0|||
145533231|NCT00850343|524813410|FG002|Overall Study|Withdrawal by Subject|3|||
145533232|NCT00850343|524813411|FG003|Overall Study|Withdrawal by Subject|2|||
145533233|NCT00850343|524813408|FG000|Overall Study|Adverse Event|15|||
145533234|NCT00850343|524813409|FG001|Overall Study|Adverse Event|2|||
145533235|NCT00850343|524813410|FG002|Overall Study|Adverse Event|6|||
145533236|NCT00850343|524813411|FG003|Overall Study|Adverse Event|6|||
145533237|NCT00850343|524813408|FG000|Overall Study|Pregnancy|0|||
145533238|NCT00850343|524813409|FG001|Overall Study|Pregnancy|0|||
145533239|NCT00850343|524813410|FG002|Overall Study|Pregnancy|0|||
145533240|NCT00850343|524813411|FG003|Overall Study|Pregnancy|1|||
145533241|NCT00850343|524813408|FG000|Overall Study|Lack of Efficacy|17|||
145533242|NCT00850343|524813409|FG001|Overall Study|Lack of Efficacy|0|||
145760548|NCT01070329|525636474|FG000|Overall Study|Adverse Event|13|||
145760549|NCT01070329|525636475|FG001|Overall Study|Adverse Event|10|||
145760550|NCT01070329|525636474|FG000|Overall Study|Lost to Follow-up|22|||
145760551|NCT01070329|525636475|FG001|Overall Study|Lost to Follow-up|12|||
145760552|NCT01070329|525636474|FG000|Overall Study|Withdrawal by Subject|9|||
145274573|NCT01678924|523853356|FG001|Overall Study|Lost to Follow-up|4|||
145274574|NCT01678924|523853357|FG002|Overall Study|Lost to Follow-up|0|||
145274575|NCT01678924|523853358|FG003|Overall Study|Lost to Follow-up|2|||
145533243|NCT00850343|524813410|FG002|Overall Study|Lack of Efficacy|3|||
145533244|NCT00850343|524813411|FG003|Overall Study|Lack of Efficacy|2|||
145533245|NCT00850343|524813408|FG000|Overall Study|Non-compliance with Study Procedures|1|||
145533246|NCT00850343|524813409|FG001|Overall Study|Non-compliance with Study Procedures|0|||
145533247|NCT00850343|524813410|FG002|Overall Study|Non-compliance with Study Procedures|1|||
145533248|NCT00850343|524813411|FG003|Overall Study|Non-compliance with Study Procedures|1|||
145533249|NCT00850343|524813408|FG000|Overall Study|Physician Decision|2|||
145533250|NCT00850343|524813409|FG001|Overall Study|Physician Decision|1|||
145533251|NCT00850343|524813410|FG002|Overall Study|Physician Decision|1|||
145533252|NCT00850343|524813411|FG003|Overall Study|Physician Decision|1|||
145533253|NCT00004635|524813412|FG000|Period One|refused|2|||
145533254|NCT00004635|524813413|FG001|Period One|refused|1|||
145533255|NCT00004635|524813412|FG000|Period One|Withdrawal by Subject|1|||
145533256|NCT00004635|524813413|FG001|Period One|Withdrawal by Subject|1|||
145533257|NCT00004635|524813412|FG000|Period One|Protocol Violation|1|||
145533258|NCT00004635|524813413|FG001|Period One|Protocol Violation|0|||
145533259|NCT00004635|524813412|FG000|Period One|PSA did not go <5 ng/mL|1|||
145533260|NCT00004635|524813413|FG001|Period One|PSA did not go <5 ng/mL|0|||
145533261|NCT00004635|524813412|FG000|Period One|second malignancy|1|||
145533262|NCT00004635|524813413|FG001|Period One|second malignancy|0|||
145533263|NCT00004635|524813412|FG000|Period One|progressed|0|||
145533264|NCT00004635|524813413|FG001|Period One|progressed|2|||
145760553|NCT01070329|525636475|FG001|Overall Study|Withdrawal by Subject|11|||
145760554|NCT01070329|525636474|FG000|Overall Study|Protocol Violation|3|||
145274576|NCT01678924|523853355|FG000|Overall Study|Personal Reasons|2|||
145274577|NCT01678924|523853356|FG001|Overall Study|Personal Reasons|2|||
145760555|NCT01070329|525636475|FG001|Overall Study|Protocol Violation|8|||
145274578|NCT01678924|523853357|FG002|Overall Study|Personal Reasons|2|||
145533265|NCT00004635|524813412|FG000|Period One|health problem|0|||
145533266|NCT00004635|524813413|FG001|Period One|health problem|1|||
145760556|NCT01070329|525636474|FG000|Overall Study|Lack of Efficacy|2|||
145760557|NCT01070329|525636475|FG001|Overall Study|Lack of Efficacy|6|||
145760558|NCT01070329|525636474|FG000|Overall Study|Physician Decision|2|||
145274579|NCT01678924|523853358|FG003|Overall Study|Personal Reasons|7|||
145274580|NCT01678924|523853355|FG000|Overall Study|Withdrawal by Subject|0|||
145533267|NCT00004635|524813412|FG000|Period One|discrepancy in data entry|0|||
145533268|NCT00004635|524813413|FG001|Period One|discrepancy in data entry|1|||
145533269|NCT00004635|524813412|FG000|Period Two|progression|2|||
145533270|NCT00004635|524813413|FG001|Period Two|progression|3|||
145533271|NCT00004635|524813412|FG000|Period Two|Adverse Event|1|||
145533272|NCT00004635|524813413|FG001|Period Two|Adverse Event|0|||
145533273|NCT00004635|524813412|FG000|Period Two|refused|0|||
145533274|NCT00004635|524813413|FG001|Period Two|refused|2|||
145274581|NCT01678924|523853356|FG001|Overall Study|Withdrawal by Subject|3|||
145533275|NCT00004635|524813412|FG000|Period Two|health problem|1|||
145533276|NCT00004635|524813413|FG001|Period Two|health problem|1|||
145533277|NCT00004635|524813412|FG000|Period Two|travel issues|0|||
145533278|NCT00004635|524813413|FG001|Period Two|travel issues|1|||
145533279|NCT00004635|524813412|FG000|Period Two|secondary malignancy|1|||
145533280|NCT00004635|524813413|FG001|Period Two|secondary malignancy|1|||
145533281|NCT00004635|524813412|FG000|Period Two|Lost to Follow-up|1|||
145533282|NCT00004635|524813413|FG001|Period Two|Lost to Follow-up|0|||
145533283|NCT00004635|524813412|FG000|Period Two|discrepancy in data entry|0|||
145533284|NCT00004635|524813413|FG001|Period Two|discrepancy in data entry|1|||
145533285|NCT01788046|524813414|FG000|Overall Study|Withdrawal by Subject|12|||
145533286|NCT01788046|524813415|FG001|Overall Study|Withdrawal by Subject|12|||
145533287|NCT01788046|524813414|FG000|Overall Study|Lost to Follow-up|12|||
145533288|NCT01788046|524813415|FG001|Overall Study|Lost to Follow-up|19|||
145760559|NCT01070329|525636475|FG001|Overall Study|Physician Decision|1|||
145760560|NCT01070329|525636474|FG000|Overall Study|Entry Criteria Not Met|1|||
145760561|NCT01070329|525636475|FG001|Overall Study|Entry Criteria Not Met|0|||
145533289|NCT01788046|524813414|FG000|Overall Study|Death|7|||
145533290|NCT01788046|524813415|FG001|Overall Study|Death|5|||
145533291|NCT01788046|524813414|FG000|Overall Study|Protocol Specified Criteria|25|||
145533292|NCT01788046|524813415|FG001|Overall Study|Protocol Specified Criteria|1|||
145533293|NCT03840174|524813416|FG000|Overall Study|Withdrawal by Subject|1|||
145533294|NCT03840174|524813417|FG001|Overall Study|Withdrawal by Subject|0|||
145533295|NCT03840174|524813418|FG002|Overall Study|Withdrawal by Subject|0|||
145533296|NCT03840174|524813419|FG003|Overall Study|Withdrawal by Subject|0|||
145533297|NCT00808483|524813422|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
145533298|NCT00808483|524813423|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
145533299|NCT00808483|524813422|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
145533300|NCT00808483|524813423|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
145533301|NCT00808483|524813422|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
145533302|NCT00808483|524813423|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
145533303|NCT02038881|524813424|FG000|Overall Study|Withdrawal by Subject|0|||
145533304|NCT02038881|524813425|FG001|Overall Study|Withdrawal by Subject|0|||
145533305|NCT02038881|524813426|FG002|Overall Study|Withdrawal by Subject|1|||
145533306|NCT02038881|524813424|FG000|Overall Study|Lost to Follow-up|2|||
145533307|NCT02038881|524813425|FG001|Overall Study|Lost to Follow-up|0|||
145533308|NCT02038881|524813426|FG002|Overall Study|Lost to Follow-up|0|||
145533309|NCT02038881|524813424|FG000|Overall Study|incarcerated|1|||
145533310|NCT02038881|524813425|FG001|Overall Study|incarcerated|0|||
145533311|NCT02038881|524813426|FG002|Overall Study|incarcerated|0|||
145533312|NCT00333840|524813427|FG000|First-line Treatment Period|Adverse Event|38|||
145533313|NCT00333840|524813428|FG001|First-line Treatment Period|Adverse Event|37|||
145760562|NCT01070329|525636474|FG000|Overall Study|Sponsor Decision|0|||
145760563|NCT01070329|525636475|FG001|Overall Study|Sponsor Decision|1|||
145760564|NCT02863848|525636476|FG000|Overall Study|Lost to Follow-up|1|||
145274582|NCT01678924|523853357|FG002|Overall Study|Withdrawal by Subject|0|||
145533314|NCT00333840|524813429|FG002|First-line Treatment Period|Adverse Event|0|||
145533315|NCT00333840|524813430|FG003|First-line Treatment Period|Adverse Event|0|||
145533316|NCT00333840|524813427|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
145533317|NCT00333840|524813428|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
145533318|NCT00333840|524813429|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
145533319|NCT00333840|524813430|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
145533320|NCT00333840|524813427|FG000|First-line Treatment Period|Abnormal procedure|2|||
145760565|NCT02863848|525636477|FG001|Overall Study|Lost to Follow-up|1|||
145533321|NCT00333840|524813428|FG001|First-line Treatment Period|Abnormal procedure|0|||
145533322|NCT00333840|524813429|FG002|First-line Treatment Period|Abnormal procedure|0|||
145533323|NCT00333840|524813430|FG003|First-line Treatment Period|Abnormal procedure|0|||
145533324|NCT00333840|524813427|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
145533325|NCT00333840|524813428|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
145533326|NCT00333840|524813429|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
145533327|NCT00333840|524813430|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
145533328|NCT00333840|524813427|FG000|First-line Treatment Period|No longer required study drug|21|||
145533329|NCT00333840|524813428|FG001|First-line Treatment Period|No longer required study drug|8|||
145533330|NCT00333840|524813429|FG002|First-line Treatment Period|No longer required study drug|0|||
145533331|NCT00333840|524813430|FG003|First-line Treatment Period|No longer required study drug|0|||
145533332|NCT00333840|524813427|FG000|First-line Treatment Period|Protocol Violation|17|||
145533333|NCT00333840|524813428|FG001|First-line Treatment Period|Protocol Violation|17|||
145533334|NCT00333840|524813429|FG002|First-line Treatment Period|Protocol Violation|0|||
145533335|NCT00333840|524813430|FG003|First-line Treatment Period|Protocol Violation|0|||
145533336|NCT00333840|524813427|FG000|First-line Treatment Period|Subject withdrew consent|57|||
145533337|NCT00333840|524813428|FG001|First-line Treatment Period|Subject withdrew consent|77|||
145533338|NCT00333840|524813429|FG002|First-line Treatment Period|Subject withdrew consent|0|||
145533339|NCT00333840|524813430|FG003|First-line Treatment Period|Subject withdrew consent|0|||
145533340|NCT00333840|524813427|FG000|First-line Treatment Period|Lost to Follow-up|15|||
145533341|NCT00333840|524813428|FG001|First-line Treatment Period|Lost to Follow-up|6|||
145533342|NCT00333840|524813429|FG002|First-line Treatment Period|Lost to Follow-up|0|||
145533343|NCT00333840|524813430|FG003|First-line Treatment Period|Lost to Follow-up|0|||
145533344|NCT00333840|524813427|FG000|First-line Treatment Period|Administrative problems|12|||
145533345|NCT00333840|524813428|FG001|First-line Treatment Period|Administrative problems|6|||
145533346|NCT00333840|524813429|FG002|First-line Treatment Period|Administrative problems|0|||
145533347|NCT00333840|524813430|FG003|First-line Treatment Period|Administrative problems|0|||
145533348|NCT00333840|524813427|FG000|First-line Treatment Period|Death|19|||
145533349|NCT00333840|524813428|FG001|First-line Treatment Period|Death|2|||
145533350|NCT00333840|524813429|FG002|First-line Treatment Period|Death|0|||
145533351|NCT00333840|524813430|FG003|First-line Treatment Period|Death|0|||
145533352|NCT00333840|524813427|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
145533353|NCT00333840|524813428|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
145533354|NCT00333840|524813429|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
145533355|NCT00333840|524813430|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
145533356|NCT00333840|524813427|FG000|Second-line Treatment Period|Adverse Event|0|||
145533357|NCT00333840|524813428|FG001|Second-line Treatment Period|Adverse Event|0|||
145533358|NCT00333840|524813429|FG002|Second-line Treatment Period|Adverse Event|3|||
145533359|NCT00333840|524813430|FG003|Second-line Treatment Period|Adverse Event|34|||
145533360|NCT00333840|524813427|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
145533361|NCT00333840|524813428|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
145533362|NCT00333840|524813429|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
145533363|NCT00333840|524813430|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
145533364|NCT00333840|524813427|FG000|Second-line Treatment Period|Abnormal procedure|0|||
145533365|NCT00333840|524813428|FG001|Second-line Treatment Period|Abnormal procedure|0|||
145533366|NCT00333840|524813429|FG002|Second-line Treatment Period|Abnormal procedure|0|||
145760566|NCT02863848|525636476|FG000|Overall Study|Protocol Violation|1|||
145760567|NCT02863848|525636477|FG001|Overall Study|Protocol Violation|2|||
145533367|NCT00333840|524813430|FG003|Second-line Treatment Period|Abnormal procedure|1|||
145533368|NCT00333840|524813427|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
145533369|NCT00333840|524813428|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
145533370|NCT00333840|524813429|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
145533371|NCT00333840|524813430|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
145533372|NCT00333840|524813427|FG000|Second-line Treatment Period|No longer required study drug|0|||
145533373|NCT00333840|524813428|FG001|Second-line Treatment Period|No longer required study drug|0|||
145533374|NCT00333840|524813429|FG002|Second-line Treatment Period|No longer required study drug|1|||
145533375|NCT00333840|524813430|FG003|Second-line Treatment Period|No longer required study drug|14|||
145533376|NCT00333840|524813427|FG000|Second-line Treatment Period|Protocol Violation|0|||
145533377|NCT00333840|524813428|FG001|Second-line Treatment Period|Protocol Violation|0|||
145533378|NCT00333840|524813429|FG002|Second-line Treatment Period|Protocol Violation|1|||
145533379|NCT00333840|524813430|FG003|Second-line Treatment Period|Protocol Violation|10|||
145533380|NCT00333840|524813427|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
145533381|NCT00333840|524813428|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
145533382|NCT00333840|524813429|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
145533383|NCT00333840|524813430|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
145533384|NCT00333840|524813427|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
145533385|NCT00333840|524813428|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
145533386|NCT00333840|524813429|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
145533387|NCT00333840|524813430|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
145533388|NCT00333840|524813427|FG000|Second-line Treatment Period|Administrative problems|0|||
145533389|NCT00333840|524813428|FG001|Second-line Treatment Period|Administrative problems|0|||
145533390|NCT00333840|524813429|FG002|Second-line Treatment Period|Administrative problems|0|||
145533391|NCT00333840|524813430|FG003|Second-line Treatment Period|Administrative problems|7|||
145533392|NCT00333840|524813427|FG000|Second-line Treatment Period|Death|0|||
145274583|NCT01678924|523853358|FG003|Overall Study|Withdrawal by Subject|2|||
145533393|NCT00333840|524813428|FG001|Second-line Treatment Period|Death|0|||
145533394|NCT00333840|524813429|FG002|Second-line Treatment Period|Death|0|||
145533395|NCT00333840|524813430|FG003|Second-line Treatment Period|Death|9|||
145533396|NCT01453725|524813431|FG000|Overall Study|Adverse Event|3|||
145533397|NCT01453725|524813432|FG001|Overall Study|Adverse Event|3|||
145533398|NCT01453725|524813431|FG000|Overall Study|Lost to Follow-up|4|||
145533399|NCT01453725|524813432|FG001|Overall Study|Lost to Follow-up|0|||
145533400|NCT01453725|524813431|FG000|Overall Study|Non-compliance With Protocol|1|||
145533401|NCT01453725|524813432|FG001|Overall Study|Non-compliance With Protocol|2|||
145607723|NCT03565068|525079243|FG002|Overall Study|Withdrawal by Subject|1|||
145760568|NCT00686127|525636480|FG000|Overall Study|Withdrawal by Subject|14|||
145533402|NCT01453725|524813431|FG000|Overall Study|Protocol Violation|1|||
145533403|NCT01453725|524813432|FG001|Overall Study|Protocol Violation|0|||
145533404|NCT01453725|524813431|FG000|Overall Study|Withdrawal by Subject|2|||
145533405|NCT01453725|524813432|FG001|Overall Study|Withdrawal by Subject|3|||
145533406|NCT01453725|524813431|FG000|Overall Study|Pregnancy Wish|0|||
145533407|NCT01453725|524813432|FG001|Overall Study|Pregnancy Wish|2|||
145533408|NCT01453725|524813431|FG000|Overall Study|Pregnancy|1|||
145533409|NCT01453725|524813432|FG001|Overall Study|Pregnancy|0|||
145533410|NCT01453725|524813431|FG000|Overall Study|Physician Decision|1|||
145533411|NCT01453725|524813432|FG001|Overall Study|Physician Decision|1|||
145533412|NCT03945214|524813433|FG000|Overall Study|Lost to Follow-up|3|||
145533413|NCT03945214|524813434|FG001|Overall Study|Lost to Follow-up|4|||
145533414|NCT03945214|524813435|FG002|Overall Study|Lost to Follow-up|7|||
145533415|NCT03945214|524813436|FG003|Overall Study|Lost to Follow-up|4|||
145533416|NCT01436396|524813447|FG000|Overall Study|Protocol Violation|7|||
145533417|NCT01436396|524813448|FG001|Overall Study|Protocol Violation|5|||
145533418|NCT01436396|524813447|FG000|Overall Study|Adverse Event|1|||
145760569|NCT00686127|525636481|FG001|Overall Study|Withdrawal by Subject|6|||
145760570|NCT06441877|525636482|FG000|Overall Study|Withdrawal by Subject|0|||
145760571|NCT06441877|525636483|FG001|Overall Study|Withdrawal by Subject|2|||
145760572|NCT06441877|525636484|FG002|Overall Study|Withdrawal by Subject|0|||
145274584|NCT01678924|523853355|FG000|Overall Study|Unable to attend scheduled visits|0|||
145274585|NCT01678924|523853356|FG001|Overall Study|Unable to attend scheduled visits|0|||
145274586|NCT01678924|523853357|FG002|Overall Study|Unable to attend scheduled visits|0|||
145274587|NCT01678924|523853358|FG003|Overall Study|Unable to attend scheduled visits|1|||
145274588|NCT02675426|523853363|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
145274589|NCT02675426|523853364|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
145274590|NCT02675426|523853365|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
145274591|NCT02675426|523853366|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
145274592|NCT02675426|523853363|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
145274593|NCT02675426|523853364|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
145274594|NCT02675426|523853365|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
145274595|NCT02675426|523853366|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
145274596|NCT02675426|523853363|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
145274597|NCT02675426|523853364|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
145274598|NCT02675426|523853365|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
145274599|NCT02675426|523853366|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
145274600|NCT02675426|523853363|FG000|Period 1: Week 1 to Week 12|Other|2|||
145274601|NCT02675426|523853364|FG001|Period 1: Week 1 to Week 12|Other|1|||
145274602|NCT02675426|523853365|FG002|Period 1: Week 1 to Week 12|Other|0|||
145274603|NCT02675426|523853366|FG003|Period 1: Week 1 to Week 12|Other|2|||
145274604|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
145760573|NCT06441877|525636485|FG003|Overall Study|Withdrawal by Subject|0|||
145760574|NCT03706365|525636492|FG000|Overall Study|Lost to Follow-up|7|||
145760575|NCT03706365|525636493|FG001|Overall Study|Lost to Follow-up|0|||
145760576|NCT03706365|525636492|FG000|Overall Study|Withdrawal by Subject|17|||
145760577|NCT03706365|525636493|FG001|Overall Study|Withdrawal by Subject|15|||
145760578|NCT03706365|525636492|FG000|Overall Study|On Study Treatment|51|||
145274605|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
145274606|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
145274607|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
145274608|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
145274609|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
145274610|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
145274611|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
145274612|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
145274613|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
145274614|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
145274615|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
145274616|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
145274617|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
145274618|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
145274619|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
145274620|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
145274621|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
145274622|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
145274623|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
145533419|NCT01436396|524813448|FG001|Overall Study|Adverse Event|2|||
145533420|NCT01436396|524813447|FG000|Overall Study|Withdrawal by Subject|19|||
145760579|NCT03706365|525636493|FG001|Overall Study|On Study Treatment|51|||
145760580|NCT03116113|525636494|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145274624|NCT02675426|523853363|FG000|Period 2: Week 12 to Week 260|Other|8|||
145760581|NCT03116113|525636495|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760582|NCT03116113|525636496|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760583|NCT03116113|525636497|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760584|NCT03116113|525636498|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760585|NCT03116113|525636499|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760586|NCT03116113|525636500|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
145760587|NCT03116113|525636501|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
145760588|NCT03116113|525636502|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
145760589|NCT02159807|525636503|FG000|Overall Study|Adverse Event|0|||
145760590|NCT02159807|525636504|FG001|Overall Study|Adverse Event|0|||
145760591|NCT02159807|525636505|FG002|Overall Study|Adverse Event|1|||
145760592|NCT02159807|525636503|FG000|Overall Study|No CSF|1|||
145760593|NCT02159807|525636504|FG001|Overall Study|No CSF|1|||
145760594|NCT02159807|525636505|FG002|Overall Study|No CSF|1|||
145274625|NCT02675426|523853364|FG001|Period 2: Week 12 to Week 260|Other|12|||
145274626|NCT02675426|523853365|FG002|Period 2: Week 12 to Week 260|Other|23|||
145274627|NCT02675426|523853366|FG003|Period 2: Week 12 to Week 260|Other|15|||
145274628|NCT02428231|523853369|FG000|Overall Study|Other|10|||
145274629|NCT02428231|523853370|FG001|Overall Study|Other|16|||
145760595|NCT02159807|525636503|FG000|Overall Study|elevated blood pressure|0|||
145760596|NCT02159807|525636504|FG001|Overall Study|elevated blood pressure|0|||
145760597|NCT02159807|525636505|FG002|Overall Study|elevated blood pressure|1|||
145760598|NCT00950170|525636506|FG000|Overall Study|Parent/Legal Guardian Request|1|||
145760599|NCT00950170|525636506|FG000|Overall Study|Adverse Event|2|||
145760600|NCT00950170|525636506|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
145760601|NCT01254669|525636507|FG000|Overall Study|Withdrawal by Subject|0|||
145760602|NCT01254669|525636508|FG001|Overall Study|Withdrawal by Subject|1|||
145760603|NCT01254669|525636507|FG000|Overall Study|time constraint|2|||
145760604|NCT01254669|525636508|FG001|Overall Study|time constraint|2|||
145760605|NCT01254669|525636507|FG000|Overall Study|called to clinic during intervention|1|||
145760606|NCT01254669|525636508|FG001|Overall Study|called to clinic during intervention|1|||
145760607|NCT02720757|525636509|FG000|Overall Study|Other reason|5|||
145760608|NCT02720757|525636509|FG000|Overall Study|Loss of contact|4|||
145760609|NCT02720757|525636509|FG000|Overall Study|Informed consent withdrawal|1|||
145760610|NCT02720757|525636509|FG000|Overall Study|Patients wish to withdraw|2|||
145760611|NCT02720757|525636509|FG000|Overall Study|Missing|3|||
145760612|NCT02720757|525636509|FG000|Overall Study|General exclusion|3|||
145760613|NCT00883493|525636510|FG000|Overall Study|Adverse Event|11|||
145760614|NCT00883493|525636511|FG001|Overall Study|Adverse Event|12|||
145760615|NCT00883493|525636510|FG000|Overall Study|Lack of Efficacy|4|||
145760616|NCT00883493|525636511|FG001|Overall Study|Lack of Efficacy|3|||
145760617|NCT00883493|525636510|FG000|Overall Study|Lost to Follow-up|7|||
145760618|NCT00883493|525636511|FG001|Overall Study|Lost to Follow-up|6|||
145274630|NCT02428231|523853369|FG000|Overall Study|Required Symptomatic Therapy|0|||
145274631|NCT02428231|523853370|FG001|Overall Study|Required Symptomatic Therapy|1|||
145274632|NCT02428231|523853369|FG000|Overall Study|Adverse Event|3|||
145274633|NCT02428231|523853370|FG001|Overall Study|Adverse Event|0|||
145274634|NCT02156466|523853373|FG000|Overall Study|Adverse Event|0|||
145274635|NCT02156466|523853374|FG001|Overall Study|Adverse Event|0|||
145274636|NCT02156466|523853375|FG002|Overall Study|Adverse Event|1|||
145274637|NCT02156466|523853376|FG003|Overall Study|Adverse Event|1|||
145274638|NCT02156466|523853377|FG004|Overall Study|Adverse Event|0|||
145274639|NCT02156466|523853373|FG000|Overall Study|Quantiferon Positivity|0|||
145274640|NCT02156466|523853374|FG001|Overall Study|Quantiferon Positivity|0|||
145274641|NCT02156466|523853375|FG002|Overall Study|Quantiferon Positivity|0|||
145274642|NCT02156466|523853376|FG003|Overall Study|Quantiferon Positivity|1|||
145274643|NCT02156466|523853377|FG004|Overall Study|Quantiferon Positivity|0|||
145274644|NCT02237118|523853378|FG000|Overall Study|Protocol Violation|0|||
145274645|NCT02237118|523853379|FG001|Overall Study|Protocol Violation|1|||
145274646|NCT02237118|523853378|FG000|Overall Study|consent withdrawn|1|||
145274647|NCT02237118|523853379|FG001|Overall Study|consent withdrawn|0|||
145760619|NCT00883493|525636510|FG000|Overall Study|Withdrawal by Subject|11|||
145760620|NCT00883493|525636511|FG001|Overall Study|Withdrawal by Subject|20|||
145760621|NCT00883493|525636510|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
145760622|NCT00883493|525636511|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
145760623|NCT00883493|525636510|FG000|Overall Study|Study specific disc. criteria|2|||
145760624|NCT00883493|525636511|FG001|Overall Study|Study specific disc. criteria|0|||
145760625|NCT00883493|525636510|FG000|Overall Study|Other|5|||
145760626|NCT00883493|525636511|FG001|Overall Study|Other|3|||
145760627|NCT02357420|525636512|FG000|Overall Study|Adverse Event|3|||
145760628|NCT02357420|525636513|FG001|Overall Study|Adverse Event|3|||
145760629|NCT02357420|525636514|FG002|Overall Study|Adverse Event|8|||
145274648|NCT00080288|523853380|FG000|Overall Study|Adverse Event|7|||
145402898|NCT02065557|524332547|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
145274649|NCT00080288|523853381|FG001|Overall Study|Adverse Event|4|||
145274650|NCT00080288|523853380|FG000|Overall Study|Lost to Follow-up|3|||
145274651|NCT00080288|523853381|FG001|Overall Study|Lost to Follow-up|5|||
145274652|NCT00080288|523853380|FG000|Overall Study|Physician Decision|6|||
145760630|NCT02357420|525636515|FG003|Overall Study|Adverse Event|9|||
145760631|NCT02357420|525636512|FG000|Overall Study|Investigator Decision|1|||
145760632|NCT02357420|525636513|FG001|Overall Study|Investigator Decision|0|||
145760633|NCT02357420|525636514|FG002|Overall Study|Investigator Decision|0|||
145760634|NCT02357420|525636515|FG003|Overall Study|Investigator Decision|0|||
145760635|NCT02357420|525636512|FG000|Overall Study|Prohibited Medication|1|||
145760636|NCT02357420|525636513|FG001|Overall Study|Prohibited Medication|1|||
145760637|NCT02357420|525636514|FG002|Overall Study|Prohibited Medication|0|||
145274653|NCT00080288|523853381|FG001|Overall Study|Physician Decision|2|||
145274654|NCT00080288|523853380|FG000|Overall Study|Withdrawal by Subject|3|||
145274655|NCT00080288|523853381|FG001|Overall Study|Withdrawal by Subject|16|||
145274656|NCT00080288|523853380|FG000|Overall Study|Miscellaneous|11|||
145274657|NCT00080288|523853381|FG001|Overall Study|Miscellaneous|11|||
145274658|NCT02253654|523853382|FG000|Overall Study|Withdrawal by Subject|12|||
145274659|NCT02253654|523853383|FG001|Overall Study|Withdrawal by Subject|4|||
145274660|NCT02253654|523853382|FG000|Overall Study|Decision by Sponsor|1|||
145274661|NCT02253654|523853383|FG001|Overall Study|Decision by Sponsor|1|||
145274662|NCT02253654|523853382|FG000|Overall Study|Lost to Follow-up|2|||
145274663|NCT02253654|523853383|FG001|Overall Study|Lost to Follow-up|5|||
145274664|NCT02253654|523853382|FG000|Overall Study|Death|4|||
145274665|NCT02253654|523853383|FG001|Overall Study|Death|7|||
145274666|NCT02253654|523853382|FG000|Overall Study|Did Not Receive Study Treatment|4|||
145274667|NCT02253654|523853383|FG001|Overall Study|Did Not Receive Study Treatment|1|||
145274668|NCT03044431|523853386|FG000|Overall Study|Lost to Follow-up|59|||
145274669|NCT03456726|523853387|FG000|Overall Study|Disease Progression|6|||
145274670|NCT03456726|523853388|FG001|Overall Study|Disease Progression|1|||
145274671|NCT03456726|523853387|FG000|Overall Study|Adverse Event|4|||
145274672|NCT03456726|523853388|FG001|Overall Study|Adverse Event|2|||
145274673|NCT03456726|523853387|FG000|Overall Study|Withdrawal by Subject|1|||
145274674|NCT03456726|523853388|FG001|Overall Study|Withdrawal by Subject|0|||
145274675|NCT03456726|523853387|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
145274676|NCT03456726|523853388|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
145274677|NCT04470622|523853389|FG000|Overall Study|Withdrawal by Subject|0|||
145274678|NCT04470622|523853390|FG001|Overall Study|Withdrawal by Subject|1|||
145274679|NCT04470622|523853389|FG000|Overall Study|Screen Failure|0|||
145274680|NCT04470622|523853390|FG001|Overall Study|Screen Failure|1|||
145274681|NCT04470622|523853389|FG000|Overall Study|Death|0|||
145274682|NCT04470622|523853390|FG001|Overall Study|Death|1|||
145274683|NCT00399490|523853391|FG000|Overall Study|Adverse Event|19|||
145274684|NCT00399490|523853391|FG000|Overall Study|Lack of Efficacy|31|||
145274685|NCT00399490|523853391|FG000|Overall Study|Lost to Follow-up|5|||
145274686|NCT00399490|523853391|FG000|Overall Study|Withdrawal by Subject|18|||
145274687|NCT00399490|523853391|FG000|Overall Study|Other|25|||
145274688|NCT02576054|523853395|FG000|Overall Study|Withdrawal by Subject|1|||
145274689|NCT01586624|523853397|FG000|Overall Study|Adverse Event|3|||
145274690|NCT01586624|523853398|FG001|Overall Study|Adverse Event|0|||
145274691|NCT01586624|523853399|FG002|Overall Study|Adverse Event|2|||
145274692|NCT01586624|523853400|FG003|Overall Study|Adverse Event|1|||
145274693|NCT01586624|523853401|FG004|Overall Study|Adverse Event|3|||
145274694|NCT01586624|523853402|FG005|Overall Study|Adverse Event|3|||
145274695|NCT01586624|523853403|FG006|Overall Study|Adverse Event|2|||
145274696|NCT01586624|523853404|FG007|Overall Study|Adverse Event|3|||
145274697|NCT01586624|523853397|FG000|Overall Study|Physician Decision|0|||
145274698|NCT01586624|523853398|FG001|Overall Study|Physician Decision|1|||
145274699|NCT01586624|523853399|FG002|Overall Study|Physician Decision|1|||
145274700|NCT01586624|523853400|FG003|Overall Study|Physician Decision|0|||
145274701|NCT01586624|523853401|FG004|Overall Study|Physician Decision|2|||
145274702|NCT01586624|523853402|FG005|Overall Study|Physician Decision|0|||
145274703|NCT01586624|523853403|FG006|Overall Study|Physician Decision|1|||
145274704|NCT01586624|523853404|FG007|Overall Study|Physician Decision|1|||
145274705|NCT01586624|523853397|FG000|Overall Study|Withdrawal by Subject|0|||
145274706|NCT01586624|523853398|FG001|Overall Study|Withdrawal by Subject|0|||
145274707|NCT01586624|523853399|FG002|Overall Study|Withdrawal by Subject|0|||
145274708|NCT01586624|523853400|FG003|Overall Study|Withdrawal by Subject|1|||
145274709|NCT01586624|523853401|FG004|Overall Study|Withdrawal by Subject|0|||
145274710|NCT01586624|523853402|FG005|Overall Study|Withdrawal by Subject|0|||
145274711|NCT01586624|523853403|FG006|Overall Study|Withdrawal by Subject|0|||
145274712|NCT01586624|523853404|FG007|Overall Study|Withdrawal by Subject|0|||
145274713|NCT01586624|523853397|FG000|Overall Study|Evidence of disease progression|1|||
145274714|NCT01586624|523853398|FG001|Overall Study|Evidence of disease progression|3|||
145274715|NCT01586624|523853399|FG002|Overall Study|Evidence of disease progression|2|||
145274716|NCT01586624|523853400|FG003|Overall Study|Evidence of disease progression|5|||
145274717|NCT01586624|523853401|FG004|Overall Study|Evidence of disease progression|3|||
145274718|NCT01586624|523853402|FG005|Overall Study|Evidence of disease progression|5|||
145274719|NCT01586624|523853403|FG006|Overall Study|Evidence of disease progression|4|||
145274720|NCT01586624|523853404|FG007|Overall Study|Evidence of disease progression|6|||
145274721|NCT01586624|523853397|FG000|Overall Study|Screen failure (no treatment received)|0|||
145760638|NCT02357420|525636515|FG003|Overall Study|Prohibited Medication|0|||
145760639|NCT02357420|525636512|FG000|Overall Study|Protocol Non-compliance|0|||
145760640|NCT02357420|525636513|FG001|Overall Study|Protocol Non-compliance|0|||
145760641|NCT02357420|525636514|FG002|Overall Study|Protocol Non-compliance|0|||
145274722|NCT01586624|523853398|FG001|Overall Study|Screen failure (no treatment received)|0|||
145274723|NCT01586624|523853399|FG002|Overall Study|Screen failure (no treatment received)|0|||
145274724|NCT01586624|523853400|FG003|Overall Study|Screen failure (no treatment received)|0|||
145274725|NCT01586624|523853401|FG004|Overall Study|Screen failure (no treatment received)|0|||
145274726|NCT01586624|523853402|FG005|Overall Study|Screen failure (no treatment received)|0|||
145274727|NCT01586624|523853403|FG006|Overall Study|Screen failure (no treatment received)|1|||
145274728|NCT01586624|523853404|FG007|Overall Study|Screen failure (no treatment received)|0|||
145274729|NCT00953927|523853405|FG000|Overall Study|Lost to Follow-up|61|||
145274730|NCT00953927|523853406|FG001|Overall Study|Lost to Follow-up|65|||
145274731|NCT00953927|523853405|FG000|Overall Study|Withdrawal by Subject|36|||
145274732|NCT00953927|523853406|FG001|Overall Study|Withdrawal by Subject|25|||
145274733|NCT00953927|523853405|FG000|Overall Study|Death|7|||
145274734|NCT00953927|523853406|FG001|Overall Study|Death|4|||
145274735|NCT00953927|523853405|FG000|Overall Study|Other study discontinuation|1|||
145274736|NCT00953927|523853406|FG001|Overall Study|Other study discontinuation|1|||
145274737|NCT01396161|523853407|FG000|Overall Study|Withdrawal by Subject|0|||
145274738|NCT01396161|523853408|FG001|Overall Study|Withdrawal by Subject|0|||
145274739|NCT01396161|523853409|FG002|Overall Study|Withdrawal by Subject|0|||
145274740|NCT01396161|523853410|FG003|Overall Study|Withdrawal by Subject|0|||
145274741|NCT01396161|523853411|FG004|Overall Study|Withdrawal by Subject|1|||
145274742|NCT01396161|523853412|FG005|Overall Study|Withdrawal by Subject|0|||
145274743|NCT01396161|523853413|FG006|Overall Study|Withdrawal by Subject|0|||
145274744|NCT01396161|523853407|FG000|Overall Study|Other|0|||
145274745|NCT01396161|523853408|FG001|Overall Study|Other|0|||
145274746|NCT01396161|523853409|FG002|Overall Study|Other|0|||
145274747|NCT01396161|523853410|FG003|Overall Study|Other|0|||
145274748|NCT01396161|523853411|FG004|Overall Study|Other|0|||
145274749|NCT01396161|523853412|FG005|Overall Study|Other|0|||
145274750|NCT01396161|523853413|FG006|Overall Study|Other|1|||
145274751|NCT02962739|523853418|FG000|Overall Study|Withdrawal by Subject|0|||
145274752|NCT02962739|523853419|FG001|Overall Study|Withdrawal by Subject|1|||
145274753|NCT02962739|523853420|FG002|Overall Study|Withdrawal by Subject|0|||
145274754|NCT02962739|523853421|FG003|Overall Study|Withdrawal by Subject|0|||
145274755|NCT02962739|523853422|FG004|Overall Study|Withdrawal by Subject|0|||
145274756|NCT02962739|523853423|FG005|Overall Study|Withdrawal by Subject|0|||
145274757|NCT02962739|523853418|FG000|Overall Study|Protocol Violation|0|||
145274758|NCT02962739|523853419|FG001|Overall Study|Protocol Violation|0|||
145274759|NCT02962739|523853420|FG002|Overall Study|Protocol Violation|1|||
145274760|NCT02962739|523853421|FG003|Overall Study|Protocol Violation|0|||
145274761|NCT02962739|523853422|FG004|Overall Study|Protocol Violation|1|||
145274762|NCT02962739|523853423|FG005|Overall Study|Protocol Violation|0|||
145274763|NCT00817778|523853427|FG000|Overall Study|Adverse Event|1|||
145274764|NCT00817778|523853428|FG001|Overall Study|Adverse Event|0|||
145274765|NCT00817778|523853427|FG000|Overall Study|Withdrawal by Subject|1|||
145274766|NCT00817778|523853428|FG001|Overall Study|Withdrawal by Subject|1|||
145274767|NCT00817778|523853427|FG000|Overall Study|Protocol Violation|0|||
145274768|NCT00817778|523853428|FG001|Overall Study|Protocol Violation|1|||
145274769|NCT00817778|523853427|FG000|Overall Study|Study-specific discontinuation criteria|0|||
145274770|NCT00817778|523853428|FG001|Overall Study|Study-specific discontinuation criteria|1|||
145274771|NCT00817778|523853427|FG000|Overall Study|Poor venous access|1|||
145274772|NCT00817778|523853428|FG001|Overall Study|Poor venous access|0|||
145274773|NCT03343054|523853429|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
145274774|NCT03343054|523853430|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
145274775|NCT03343054|523853431|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
145274776|NCT03343054|523853429|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
145274777|NCT03343054|523853430|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
145274778|NCT03343054|523853431|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
145274779|NCT03343054|523853429|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
145274780|NCT03343054|523853430|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
145274781|NCT03343054|523853431|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
145274782|NCT03343054|523853429|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
145274783|NCT03343054|523853430|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
145274784|NCT03343054|523853431|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
145274785|NCT05349188|523853432|FG000|Overall Study|Withdrawal by Subject|1|||
145274786|NCT05349188|523853433|FG001|Overall Study|Withdrawal by Subject|0|||
145274787|NCT02756078|523853434|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
145274788|NCT02756078|523853435|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
145274789|NCT02756078|523853434|FG000|Period 1|Lost to Follow-up|0|||
145274790|NCT02756078|523853435|FG001|Period 1|Lost to Follow-up|2|||
145274791|NCT02756078|523853434|FG000|Period 1|Protocol Violation|0|||
145274792|NCT02756078|523853435|FG001|Period 1|Protocol Violation|1|||
145274793|NCT02756078|523853434|FG000|Period 1|Adverse Event|1|||
145274794|NCT02756078|523853435|FG001|Period 1|Adverse Event|10|||
145760642|NCT02357420|525636515|FG003|Overall Study|Protocol Non-compliance|1|||
145274795|NCT02756078|523853434|FG000|Period 1|Withdrawal by Subject|6|||
145760643|NCT02357420|525636512|FG000|Overall Study|Withdrawn Consent|4|||
145274796|NCT02756078|523853435|FG001|Period 1|Withdrawal by Subject|6|||
145274797|NCT02756078|523853434|FG000|Period 1|Lens Discomfort|2|||
145274798|NCT02756078|523853435|FG001|Period 1|Lens Discomfort|2|||
145274799|NCT02756078|523853434|FG000|Period 2|Adverse Event|3|||
145274800|NCT02756078|523853435|FG001|Period 2|Adverse Event|5|||
145274801|NCT02756078|523853434|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
145274802|NCT02756078|523853435|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
145274803|NCT02756078|523853434|FG000|Period 2|Withdrawal by Subject|3|||
145274804|NCT02756078|523853435|FG001|Period 2|Withdrawal by Subject|1|||
145274805|NCT02268045|523853436|FG000|Overall Study|Death|4|||
145274806|NCT02268045|523853437|FG001|Overall Study|Death|4|||
145274807|NCT02268045|523853436|FG000|Overall Study|Disease Progression|2|||
145274808|NCT02268045|523853437|FG001|Overall Study|Disease Progression|1|||
145274809|NCT02268045|523853436|FG000|Overall Study|Adverse Event|7|||
145274810|NCT02268045|523853437|FG001|Overall Study|Adverse Event|7|||
145274811|NCT02268045|523853436|FG000|Overall Study|Withdrawal by Subject|2|||
145274812|NCT02268045|523853437|FG001|Overall Study|Withdrawal by Subject|6|||
145274813|NCT02268045|523853436|FG000|Overall Study|Physician Decision|0|||
145274814|NCT02268045|523853437|FG001|Overall Study|Physician Decision|1|||
145274815|NCT02268045|523853436|FG000|Overall Study|Protocol Violation|1|||
145274816|NCT02268045|523853437|FG001|Overall Study|Protocol Violation|1|||
145274817|NCT00481871|523853440|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
145274818|NCT00481871|523853441|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
145274819|NCT00481871|523853442|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
145274820|NCT00481871|523853443|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
145274821|NCT00481871|523853444|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
145274822|NCT03853213|523855381|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
145274823|NCT03853213|523855382|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
145274824|NCT03853213|523855381|FG000|Overall Study|Other (e.g., too busy)|0|||
145274825|NCT03853213|523855382|FG001|Overall Study|Other (e.g., too busy)|2|||
145274826|NCT01788163|523855383|FG000|Overall Study|Other|53|||
145274827|NCT01788163|523855384|FG001|Overall Study|Other|0|||
145274828|NCT01788163|523855385|FG002|Overall Study|Other|0|||
145274829|NCT01788163|523855386|FG003|Overall Study|Other|0|||
145274830|NCT01788163|523855387|FG004|Overall Study|Other|0|||
145274831|NCT01788163|523855388|FG005|Overall Study|Other|7|||
145274832|NCT01788163|523855389|FG006|Overall Study|Other|1|||
145274833|NCT01788163|523855390|FG007|Overall Study|Other|48|||
145274834|NCT01788163|523855391|FG008|Overall Study|Other|15|||
145760644|NCT02357420|525636513|FG001|Overall Study|Withdrawn Consent|8|||
145760645|NCT02357420|525636514|FG002|Overall Study|Withdrawn Consent|6|||
145760646|NCT02357420|525636515|FG003|Overall Study|Withdrawn Consent|6|||
145274835|NCT01788163|523855383|FG000|Overall Study|Withdrawal by Subject|2|||
145274836|NCT01788163|523855384|FG001|Overall Study|Withdrawal by Subject|0|||
145274837|NCT01788163|523855385|FG002|Overall Study|Withdrawal by Subject|0|||
145274838|NCT01788163|523855386|FG003|Overall Study|Withdrawal by Subject|0|||
145274839|NCT01788163|523855387|FG004|Overall Study|Withdrawal by Subject|0|||
145274840|NCT01788163|523855388|FG005|Overall Study|Withdrawal by Subject|0|||
145274841|NCT01788163|523855389|FG006|Overall Study|Withdrawal by Subject|0|||
145274842|NCT01788163|523855390|FG007|Overall Study|Withdrawal by Subject|0|||
145274843|NCT01788163|523855391|FG008|Overall Study|Withdrawal by Subject|1|||
145274844|NCT00545441|523855392|FG000|Overall Study|Fistula draining at 6 months|2|||
145274845|NCT00545441|523855393|FG001|Overall Study|Fistula draining at 6 months|4|||
145274846|NCT00545441|523855392|FG000|Overall Study|Lost to Follow-up|9|||
145274847|NCT00545441|523855393|FG001|Overall Study|Lost to Follow-up|5|||
145274848|NCT00545441|523855392|FG000|Overall Study|Technical failure|0|||
145274849|NCT00545441|523855393|FG001|Overall Study|Technical failure|1|||
145274850|NCT00545441|523855392|FG000|Overall Study|Withdrawal by Subject|1|||
145274851|NCT00545441|523855393|FG001|Overall Study|Withdrawal by Subject|1|||
145274852|NCT00545441|523855392|FG000|Overall Study|Persistence or recurrence of fistula|5|||
145274853|NCT00545441|523855393|FG001|Overall Study|Persistence or recurrence of fistula|2|||
145274854|NCT00545441|523855392|FG000|Overall Study|Patients were not treated|1|||
145274855|NCT00545441|523855393|FG001|Overall Study|Patients were not treated|3|||
145274856|NCT00265239|523855394|FG000|Overall Study|Adverse Event|2|||
145274857|NCT00265239|523855395|FG001|Overall Study|Adverse Event|1|||
145274858|NCT02803138|523855396|FG000|Overall Study|Failure to return|38|||
145274859|NCT02803138|523855396|FG000|Overall Study|Insufficient virological response|2|||
145274860|NCT02803138|523855396|FG000|Overall Study|Withdrawn consent|1|||
145274861|NCT02803138|523855396|FG000|Overall Study|Death|1|||
145274862|NCT02803138|523855396|FG000|Overall Study|Other, not specified|28|||
145274863|NCT00021229|523855397|FG000|Overall Study|Adverse Event|10|||
145274864|NCT00021229|523855398|FG001|Overall Study|Adverse Event|5|||
145274865|NCT00021229|523855399|FG002|Overall Study|Adverse Event|2|||
145274866|NCT00021229|523855397|FG000|Overall Study|Death|0|||
145274867|NCT00021229|523855398|FG001|Overall Study|Death|1|||
145274868|NCT00021229|523855399|FG002|Overall Study|Death|0|||
145274869|NCT00021229|523855397|FG000|Overall Study|Withdrawal by Subject|7|||
145274870|NCT00021229|523855398|FG001|Overall Study|Withdrawal by Subject|7|||
145274871|NCT00021229|523855399|FG002|Overall Study|Withdrawal by Subject|1|||
145274872|NCT00021229|523855397|FG000|Overall Study|Progressive Disease|15|||
145274873|NCT00021229|523855398|FG001|Overall Study|Progressive Disease|19|||
145274874|NCT00021229|523855399|FG002|Overall Study|Progressive Disease|12|||
145274875|NCT00021229|523855397|FG000|Overall Study|Protocol Violation|1|||
145760647|NCT02357420|525636512|FG000|Overall Study|Lost to Follow-up|3|||
145760648|NCT02357420|525636513|FG001|Overall Study|Lost to Follow-up|0|||
145760649|NCT02357420|525636514|FG002|Overall Study|Lost to Follow-up|2|||
145760650|NCT02357420|525636515|FG003|Overall Study|Lost to Follow-up|3|||
145760651|NCT01061008|525636516|FG000|Overall Study|Badiocephalic fistula failed|3|||
145760652|NCT01061008|525636517|FG001|Overall Study|Badiocephalic fistula failed|2|||
145760653|NCT01061008|525636516|FG000|Overall Study|Death|1|||
145760654|NCT01061008|525636517|FG001|Overall Study|Death|0|||
145274876|NCT00021229|523855398|FG001|Overall Study|Protocol Violation|1|||
145274877|NCT00021229|523855399|FG002|Overall Study|Protocol Violation|0|||
145274878|NCT00021229|523855397|FG000|Overall Study|Physician Decision|0|||
145274879|NCT00021229|523855398|FG001|Overall Study|Physician Decision|0|||
145274880|NCT00021229|523855399|FG002|Overall Study|Physician Decision|1|||
145274881|NCT00021229|523855397|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
145274882|NCT00021229|523855398|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
145274883|NCT00021229|523855399|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
145274884|NCT01858558|523855403|FG000|Overall Study|Death|1|||
145274885|NCT01858558|523855404|FG001|Overall Study|Death|1|||
145274886|NCT01858558|523855403|FG000|Overall Study|Lost to Follow-up|1|||
145274887|NCT01858558|523855404|FG001|Overall Study|Lost to Follow-up|0|||
145274888|NCT01858558|523855403|FG000|Overall Study|Disease progression|3|||
145274889|NCT01858558|523855404|FG001|Overall Study|Disease progression|1|||
145274890|NCT01858558|523855403|FG000|Overall Study|Product contamination|2|||
145274891|NCT01858558|523855404|FG001|Overall Study|Product contamination|0|||
145274892|NCT01858558|523855403|FG000|Overall Study|Failed expansion of cell product|2|||
145274893|NCT01858558|523855404|FG001|Overall Study|Failed expansion of cell product|0|||
145274894|NCT01784419|523855405|FG000|Overall Study|Adverse Event|3|||
145274895|NCT02328547|523855406|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
145274896|NCT02328547|523855407|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
145274897|NCT02328547|523855406|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
145274898|NCT02328547|523855407|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
145274899|NCT00414011|523855408|FG000|Overall Study|Physician Decision|3|||
145274900|NCT00414011|523855408|FG000|Overall Study|Withdrawal by Subject|2|||
145274901|NCT00306852|523855411|FG000|Overall Study|Death|14|||
145274902|NCT00306852|523855412|FG001|Overall Study|Death|14|||
145274903|NCT00306852|523855411|FG000|Overall Study|Lost to Follow-up|15|||
145274904|NCT00306852|523855412|FG001|Overall Study|Lost to Follow-up|24|||
145274905|NCT03578276|523855413|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
145274906|NCT03578276|523855414|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
145760655|NCT01061008|525636516|FG000|Overall Study|Withdrawal by Subject|1|||
145760656|NCT01061008|525636517|FG001|Overall Study|Withdrawal by Subject|3|||
145760657|NCT01061008|525636516|FG000|Overall Study|Unable to exercise following surgery|1|||
145760658|NCT01061008|525636517|FG001|Overall Study|Unable to exercise following surgery|0|||
145274907|NCT02360397|523855417|FG000|Overall Study|Incomplete screening|3|||
145274908|NCT02360397|523855417|FG000|Overall Study|Adverse Event|1|||
145274909|NCT01537549|523855418|FG000|Overall Study|Lost to Follow-up|1|||
145274910|NCT01537549|523855418|FG000|Overall Study|Withdrawal by Subject|2|||
145402899|NCT02065557|524332548|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
145760659|NCT01061008|525636516|FG000|Overall Study|Adverse Event|0|||
145274911|NCT00883740|523855421|FG000|First Intervention|Lost to Follow-up|1|||
145274912|NCT00883740|523855422|FG001|First Intervention|Lost to Follow-up|0|||
145274913|NCT00883740|523855421|FG000|First Intervention|No longer willing to participate|2|||
145274914|NCT00883740|523855422|FG001|First Intervention|No longer willing to participate|0|||
145274915|NCT00883740|523855421|FG000|First Intervention|Protocol Violation|3|||
145274916|NCT00883740|523855422|FG001|First Intervention|Protocol Violation|6|||
145274917|NCT00883740|523855421|FG000|First Intervention|Adverse Event|1|||
145274918|NCT00883740|523855422|FG001|First Intervention|Adverse Event|2|||
145274919|NCT00883740|523855421|FG000|Second Intervention|Protocol Violation|1|||
145274920|NCT00883740|523855422|FG001|Second Intervention|Protocol Violation|0|||
145274921|NCT00883740|523855421|FG000|Second Intervention|No longer willing to participate|0|||
145274922|NCT00883740|523855422|FG001|Second Intervention|No longer willing to participate|1|||
145274923|NCT01286207|523855425|FG000|Overall Study|Adverse Event|27|||
145274924|NCT01286207|523855426|FG001|Overall Study|Adverse Event|41|||
145274925|NCT01286207|523855427|FG002|Overall Study|Adverse Event|8|||
145274926|NCT01286207|523855425|FG000|Overall Study|Lost to Follow-up|49|||
145274927|NCT01286207|523855426|FG001|Overall Study|Lost to Follow-up|43|||
145274928|NCT01286207|523855427|FG002|Overall Study|Lost to Follow-up|20|||
145274929|NCT01286207|523855425|FG000|Overall Study|Withdrawal by Subject|93|||
145274930|NCT01286207|523855426|FG001|Overall Study|Withdrawal by Subject|79|||
145274931|NCT01286207|523855427|FG002|Overall Study|Withdrawal by Subject|41|||
145274932|NCT01286207|523855425|FG000|Overall Study|Lack of Response|92|||
145274933|NCT01286207|523855426|FG001|Overall Study|Lack of Response|38|||
145274934|NCT01286207|523855427|FG002|Overall Study|Lack of Response|8|||
145274935|NCT01286207|523855425|FG000|Overall Study|Other|37|||
145274936|NCT01286207|523855426|FG001|Overall Study|Other|47|||
145274937|NCT01286207|523855427|FG002|Overall Study|Other|13|||
145274938|NCT00981409|523855428|FG000|Overall Study|Adverse Event|4|||
145274939|NCT00981409|523855429|FG001|Overall Study|Adverse Event|0|||
145274940|NCT00981409|523855428|FG000|Overall Study|Protocol Violation|0|||
145274941|NCT00981409|523855429|FG001|Overall Study|Protocol Violation|1|||
145274942|NCT00981409|523855428|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
145274943|NCT00981409|523855429|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
145274944|NCT00450177|523855430|FG000|Overall Study|Adverse Event|7|||
145274945|NCT00450177|523855431|FG001|Overall Study|Adverse Event|4|||
145274946|NCT00450177|523855430|FG000|Overall Study|Withdrawal by Subject|1|||
145274947|NCT00450177|523855431|FG001|Overall Study|Withdrawal by Subject|6|||
145274948|NCT00450177|523855430|FG000|Overall Study|Withdrawal by Primary Team|1|||
145274949|NCT00450177|523855431|FG001|Overall Study|Withdrawal by Primary Team|1|||
145274950|NCT02923115|523855432|FG000|Overall Study|Lost to Follow-up|0|||
145274951|NCT02923115|523855433|FG001|Overall Study|Lost to Follow-up|0|||
145274952|NCT02923115|523855434|FG002|Overall Study|Lost to Follow-up|0|||
145274953|NCT02923115|523855435|FG003|Overall Study|Lost to Follow-up|1|||
145274954|NCT02923115|523855436|FG004|Overall Study|Lost to Follow-up|0|||
145274955|NCT02923115|523855437|FG005|Overall Study|Lost to Follow-up|0|||
145274956|NCT02923115|523855432|FG000|Overall Study|Withdrawal by Subject|0|||
145274957|NCT02923115|523855433|FG001|Overall Study|Withdrawal by Subject|1|||
145274958|NCT02923115|523855434|FG002|Overall Study|Withdrawal by Subject|0|||
145274959|NCT02923115|523855435|FG003|Overall Study|Withdrawal by Subject|0|||
145274960|NCT02923115|523855436|FG004|Overall Study|Withdrawal by Subject|0|||
145274961|NCT02923115|523855437|FG005|Overall Study|Withdrawal by Subject|0|||
145274962|NCT02923115|523855432|FG000|Overall Study|Randomized, but not dosed|0|||
145274963|NCT02923115|523855433|FG001|Overall Study|Randomized, but not dosed|0|||
145274964|NCT02923115|523855434|FG002|Overall Study|Randomized, but not dosed|3|||
145274965|NCT02923115|523855435|FG003|Overall Study|Randomized, but not dosed|1|||
145274966|NCT02923115|523855436|FG004|Overall Study|Randomized, but not dosed|5|||
145274967|NCT02923115|523855437|FG005|Overall Study|Randomized, but not dosed|0|||
145274968|NCT03869684|523855440|FG000|Overall Study|Adverse Event|0|||
145274969|NCT03869684|523855441|FG001|Overall Study|Adverse Event|3|||
145274970|NCT03869684|523855442|FG002|Overall Study|Adverse Event|1|||
145274971|NCT03869684|523855440|FG000|Overall Study|Withdrawal by Subject|1|||
145274972|NCT03869684|523855441|FG001|Overall Study|Withdrawal by Subject|0|||
145274973|NCT03869684|523855442|FG002|Overall Study|Withdrawal by Subject|0|||
145274974|NCT03869684|523855440|FG000|Overall Study|Lost to Follow-up|1|||
145274975|NCT03869684|523855441|FG001|Overall Study|Lost to Follow-up|0|||
145274976|NCT03869684|523855442|FG002|Overall Study|Lost to Follow-up|0|||
145274977|NCT03869684|523855440|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
145274978|NCT03869684|523855441|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
145274979|NCT03869684|523855442|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
145274980|NCT04056299|523855443|FG000|Overall Study|Sponsor discontinued study|3|||
145274981|NCT04056299|523855444|FG001|Overall Study|Sponsor discontinued study|3|||
145274982|NCT01296152|523855451|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
145274983|NCT04840901|523855452|FG000|Overall Study|Lost to Follow-up|3|||
145274984|NCT04840901|523855453|FG001|Overall Study|Lost to Follow-up|1|||
145274985|NCT04840901|523855452|FG000|Overall Study|Moved|1|||
145274986|NCT04840901|523855453|FG001|Overall Study|Moved|0|||
145274987|NCT04840901|523855452|FG000|Overall Study|Unable to comply with study schedule|0|||
145274988|NCT04840901|523855453|FG001|Overall Study|Unable to comply with study schedule|1|||
145274989|NCT04840901|523855452|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
145274990|NCT04840901|523855453|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
145274991|NCT01268683|523855454|FG000|Overall Study|Lost to Follow-up|1|||
145274992|NCT01268683|523855454|FG000|Overall Study|Death|1|||
145274993|NCT01988493|523855455|FG000|Overall Study|Randomized but not treated|0|||
145274994|NCT01988493|523855456|FG001|Overall Study|Randomized but not treated|0|||
145274995|NCT01988493|523855457|FG002|Overall Study|Randomized but not treated|0|||
145274996|NCT01988493|523855458|FG003|Overall Study|Randomized but not treated|0|||
145274997|NCT01988493|523855459|FG004|Overall Study|Randomized but not treated|1|||
145274998|NCT00627458|523855468|FG000|Overall Study|Migrated from study area|1|||
145274999|NCT00627458|523855469|FG001|Overall Study|Migrated from study area|0|||
145275000|NCT00627458|523855470|FG002|Overall Study|Migrated from study area|1|||
145275001|NCT00627458|523855468|FG000|Overall Study|Withdrawal by Subject|2|||
145275002|NCT00627458|523855469|FG001|Overall Study|Withdrawal by Subject|6|||
145275003|NCT00627458|523855470|FG002|Overall Study|Withdrawal by Subject|5|||
145275004|NCT00627458|523855468|FG000|Overall Study|Lost to Follow-up|1|||
145275005|NCT00627458|523855469|FG001|Overall Study|Lost to Follow-up|1|||
145402900|NCT02065557|524332549|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
145275006|NCT00627458|523855470|FG002|Overall Study|Lost to Follow-up|0|||
145275007|NCT03891875|523855471|FG000|Overall Study|Withdrawal by Subject|20|||
145275008|NCT03891875|523855472|FG001|Overall Study|Withdrawal by Subject|3|||
145275009|NCT03891875|523855471|FG000|Overall Study|Adverse Event|10|||
145275010|NCT03891875|523855472|FG001|Overall Study|Adverse Event|4|||
145275011|NCT03891875|523855471|FG000|Overall Study|Physician Decision|1|||
145275012|NCT03891875|523855472|FG001|Overall Study|Physician Decision|1|||
145402901|NCT02065557|524332544|FG000|Maintenance Period|Withdrawal by Subject|0|||
145275013|NCT03891875|523855471|FG000|Overall Study|Protocol Violation|1|||
145275014|NCT03891875|523855472|FG001|Overall Study|Protocol Violation|0|||
145275015|NCT03891875|523855471|FG000|Overall Study|Lost to Follow-up|1|||
145275016|NCT03891875|523855472|FG001|Overall Study|Lost to Follow-up|0|||
145275017|NCT03891875|523855471|FG000|Overall Study|COVID-19 infection|1|||
145275018|NCT03891875|523855472|FG001|Overall Study|COVID-19 infection|0|||
145275019|NCT03332212|523855475|FG000|Overall Study|Not treated|0|||
145275020|NCT03332212|523855476|FG001|Overall Study|Not treated|1|||
145275021|NCT03332212|523855477|FG002|Overall Study|Not treated|0|||
145275022|NCT03332212|523855478|FG003|Overall Study|Not treated|0|||
145275023|NCT03332212|523855475|FG000|Overall Study|Adverse Event|0|||
145275024|NCT03332212|523855476|FG001|Overall Study|Adverse Event|0|||
145275025|NCT03332212|523855477|FG002|Overall Study|Adverse Event|0|||
145275026|NCT03332212|523855478|FG003|Overall Study|Adverse Event|1|||
145275027|NCT03332212|523855475|FG000|Overall Study|worsening of disease under study|1|||
145275028|NCT03332212|523855476|FG001|Overall Study|worsening of disease under study|1|||
145275029|NCT03332212|523855477|FG002|Overall Study|worsening of disease under study|0|||
145275030|NCT03332212|523855478|FG003|Overall Study|worsening of disease under study|0|||
145275031|NCT01308762|523855482|FG000|Overall Study|Protocol Violation|0|||
145275032|NCT01308762|523855483|FG001|Overall Study|Protocol Violation|1|||
145275033|NCT01308762|523855484|FG002|Overall Study|Protocol Violation|0|||
145275034|NCT01556490|523855485|FG000|Randomized Patients Summary|Protocol Violation|22|||
145275035|NCT01556490|523855486|FG001|Randomized Patients Summary|Protocol Violation|23|||
145275036|NCT01556490|523855485|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
145275037|NCT01556490|523855486|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
145275038|NCT02058368|523855487|FG000|Overall Study|Adverse Event|15|||
145275039|NCT02058368|523855488|FG001|Overall Study|Adverse Event|20|||
145275040|NCT02058368|523855487|FG000|Overall Study|Lack of Efficacy|0|||
145275041|NCT02058368|523855488|FG001|Overall Study|Lack of Efficacy|1|||
145275042|NCT02058368|523855487|FG000|Overall Study|Protocol Violation|0|||
145275043|NCT02058368|523855488|FG001|Overall Study|Protocol Violation|4|||
145275044|NCT02058368|523855487|FG000|Overall Study|Lost to Follow-up|2|||
145275045|NCT02058368|523855488|FG001|Overall Study|Lost to Follow-up|0|||
145275046|NCT02058368|523855487|FG000|Overall Study|Physician Decision|2|||
145275047|NCT02058368|523855488|FG001|Overall Study|Physician Decision|3|||
145275048|NCT02058368|523855487|FG000|Overall Study|Withdrawal by Subject|22|||
145275049|NCT02058368|523855488|FG001|Overall Study|Withdrawal by Subject|26|||
145275050|NCT01652872|523855489|FG000|Overall Study|Death|36|||
145275051|NCT01652872|523855490|FG001|Overall Study|Death|39|||
145275052|NCT01652872|523855489|FG000|Overall Study|Lost to Follow-up|28|||
145275053|NCT01652872|523855490|FG001|Overall Study|Lost to Follow-up|23|||
145275054|NCT01652872|523855489|FG000|Overall Study|Decision by sponsor|5|||
145275055|NCT01652872|523855490|FG001|Overall Study|Decision by sponsor|7|||
145275056|NCT01652872|523855489|FG000|Overall Study|Withdrawal by Subject|76|||
145275057|NCT01652872|523855490|FG001|Overall Study|Withdrawal by Subject|84|||
145275058|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
145275059|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
145275060|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
145275061|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
145275062|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
145275063|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
145275064|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
145275065|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
145275066|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
145275067|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
145275068|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
145275069|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
145275070|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
145275071|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
145760660|NCT01061008|525636517|FG001|Overall Study|Adverse Event|1|||
145275072|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
145275073|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
145275074|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
145275075|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
145275076|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
145275077|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
145275078|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
145275079|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
145275080|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
145275081|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
145275082|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
145275083|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
145275084|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
145275085|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
145275086|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
145275087|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
145275088|NCT03985293|523855493|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
145275089|NCT03985293|523855494|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
145275090|NCT03985293|523855495|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
145275091|NCT03985293|523855496|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
145275092|NCT03985293|523855497|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
145275093|NCT03985293|523855498|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
145275094|NCT03985293|523855493|FG000|FOLLOW-UP|Lost to Follow-up|0|||
145275095|NCT03985293|523855494|FG001|FOLLOW-UP|Lost to Follow-up|0|||
145275096|NCT03985293|523855495|FG002|FOLLOW-UP|Lost to Follow-up|1|||
145275097|NCT03985293|523855496|FG003|FOLLOW-UP|Lost to Follow-up|0|||
145275098|NCT03985293|523855497|FG004|FOLLOW-UP|Lost to Follow-up|0|||
145275099|NCT03985293|523855498|FG005|FOLLOW-UP|Lost to Follow-up|0|||
145275100|NCT05899218|523855499|FG000|Overall Study|Lost to Follow-up|2|||
145275101|NCT05899218|523855500|FG001|Overall Study|Lost to Follow-up|2|||
145275102|NCT05899218|523855499|FG000|Overall Study|deemed ineligible out of country|1|||
145275103|NCT05899218|523855500|FG001|Overall Study|deemed ineligible out of country|0|||
145275104|NCT03107715|523855501|FG000|Overall Study|did not deliver at the home hospital|4|||
145275105|NCT03107715|523855502|FG001|Overall Study|did not deliver at the home hospital|6|||
145275106|NCT03107715|523855501|FG000|Overall Study|infant stillborn|0|||
145275107|NCT03107715|523855502|FG001|Overall Study|infant stillborn|1|||
145275108|NCT03594175|523855503|FG000|Overall Study|Not treated|8|||
145275109|NCT03594175|523855504|FG001|Overall Study|Not treated|1|||
145275110|NCT03594175|523855505|FG002|Overall Study|Not treated|5|||
145275111|NCT03594175|523855503|FG000|Overall Study|Adverse Event|3|||
145275112|NCT03594175|523855504|FG001|Overall Study|Adverse Event|0|||
145275113|NCT03594175|523855505|FG002|Overall Study|Adverse Event|0|||
145275114|NCT03594175|523855503|FG000|Overall Study|Withdrawal by Subject|3|||
145275115|NCT03594175|523855504|FG001|Overall Study|Withdrawal by Subject|0|||
145275116|NCT03594175|523855505|FG002|Overall Study|Withdrawal by Subject|0|||
145275117|NCT03594175|523855503|FG000|Overall Study|Protocol Violation|2|||
145275118|NCT03594175|523855504|FG001|Overall Study|Protocol Violation|2|||
145275119|NCT03594175|523855505|FG002|Overall Study|Protocol Violation|2|||
145275120|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275121|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275122|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275123|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
145275124|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
145275125|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275126|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275127|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275128|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275129|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
145275130|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275131|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275132|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
145275133|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
145275134|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
145275135|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
145275136|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
145275137|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
145275138|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
145275139|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275140|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275141|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275142|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275143|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275144|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
145275145|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275146|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275147|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275148|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
145275149|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275150|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275151|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275152|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
145275153|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
145275154|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
145275155|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
145275156|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
145275157|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
145275158|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
145275159|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275160|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275161|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275162|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275163|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
145275164|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275165|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275166|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275167|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275168|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275169|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275170|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275171|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275172|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
145275173|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275174|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275175|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
145275176|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
145275177|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275178|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275179|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275180|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275181|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275182|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275183|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275184|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275185|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275186|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275187|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
145275188|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275189|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275190|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
145275191|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275192|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275193|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
145275194|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
145275195|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
145275196|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
145275197|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
145275198|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275199|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
145275200|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275201|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145292748|NCT06179108|523922229|FG003|Overall Study|Withdrawal by Subject|11|||
145760661|NCT02908100|525636519|FG000|Overall Study|Adverse Event|7|||
145275202|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
145275203|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275204|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275205|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275206|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
145275207|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275208|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
145275209|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
145275210|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
145275211|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
145275212|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
145275213|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
145275214|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
145275215|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275216|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275217|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
145275218|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275219|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275220|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275221|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275222|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275223|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275224|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275225|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275226|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275227|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275228|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275229|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275230|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
145275231|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
145275232|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
145275233|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
145275234|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275235|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275236|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275237|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275238|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
145275239|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275240|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145607724|NCT03565068|525079244|FG003|Overall Study|Withdrawal by Subject|0|||
145607725|NCT03565068|525079245|FG004|Overall Study|Withdrawal by Subject|2|||
145607726|NCT03565068|525079246|FG005|Overall Study|Withdrawal by Subject|0|||
145607727|NCT03565068|525079247|FG006|Overall Study|Withdrawal by Subject|1|||
145607728|NCT03565068|525079248|FG007|Overall Study|Withdrawal by Subject|5|||
145607729|NCT03565068|525079249|FG008|Overall Study|Withdrawal by Subject|1|||
145607730|NCT03565068|525079241|FG000|Overall Study|Physician Decision|0|||
145607731|NCT03565068|525079242|FG001|Overall Study|Physician Decision|0|||
145607732|NCT03565068|525079243|FG002|Overall Study|Physician Decision|0|||
145607733|NCT03565068|525079244|FG003|Overall Study|Physician Decision|0|||
145607734|NCT03565068|525079245|FG004|Overall Study|Physician Decision|0|||
145607735|NCT03565068|525079246|FG005|Overall Study|Physician Decision|0|||
145607736|NCT03565068|525079247|FG006|Overall Study|Physician Decision|0|||
145607737|NCT03565068|525079248|FG007|Overall Study|Physician Decision|1|||
145607738|NCT03565068|525079249|FG008|Overall Study|Physician Decision|0|||
145607739|NCT03565068|525079241|FG000|Overall Study|Lost to Follow-up|0|||
145607740|NCT03565068|525079242|FG001|Overall Study|Lost to Follow-up|0|||
145607741|NCT03565068|525079243|FG002|Overall Study|Lost to Follow-up|0|||
145607742|NCT03565068|525079244|FG003|Overall Study|Lost to Follow-up|0|||
145607743|NCT03565068|525079245|FG004|Overall Study|Lost to Follow-up|0|||
145607744|NCT03565068|525079246|FG005|Overall Study|Lost to Follow-up|0|||
145275241|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275242|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145607745|NCT03565068|525079247|FG006|Overall Study|Lost to Follow-up|0|||
145607746|NCT03565068|525079248|FG007|Overall Study|Lost to Follow-up|1|||
145607747|NCT03565068|525079249|FG008|Overall Study|Lost to Follow-up|0|||
145607748|NCT05778526|525079250|FG000|Overall Study|Lost to Follow-up|0|||
145607749|NCT05778526|525079251|FG001|Overall Study|Lost to Follow-up|1|||
145607750|NCT05778526|525079252|FG002|Overall Study|Lost to Follow-up|3|||
145607751|NCT05778526|525079250|FG000|Overall Study|Protocol Violation|0|||
145402902|NCT02065557|524332545|FG001|Maintenance Period|Withdrawal by Subject|0|||
145402903|NCT02065557|524332546|FG002|Maintenance Period|Withdrawal by Subject|0|||
145275243|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
145275244|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275245|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275246|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275247|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275248|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275249|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275250|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275251|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275252|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
145275253|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
145275254|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275255|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275256|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275257|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275258|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
145275259|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275260|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275261|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275262|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275263|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
145275264|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275265|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275266|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
145275267|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
145275268|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
145607752|NCT05778526|525079251|FG001|Overall Study|Protocol Violation|0|||
145760662|NCT02908100|525636520|FG001|Overall Study|Adverse Event|6|||
145275269|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
145275270|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
145275271|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
145275272|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275273|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275274|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275275|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275276|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275277|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275278|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275279|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275280|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275281|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275282|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
145275283|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275284|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275285|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275286|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275287|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275288|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275289|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275290|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
145275291|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
145275292|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
145275293|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275294|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275295|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
145275296|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
145275297|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275298|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
145275299|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275300|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
145275301|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275302|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275303|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
145275304|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
145275305|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
145275306|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
145275307|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
145275308|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
145275309|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
145275310|NCT01915498|523855506|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
145275311|NCT01915498|523855507|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
145275312|NCT01915498|523855508|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
145275313|NCT01915498|523855509|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
145275314|NCT01915498|523855510|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
145275315|NCT01915498|523855511|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
145275316|NCT01915498|523855512|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
145275317|NCT01915498|523855513|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
145275318|NCT01915498|523855514|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
145275319|NCT01915498|523855515|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
145275320|NCT01915498|523855516|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
145275321|NCT01915498|523855517|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
145275322|NCT01915498|523855518|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
145275323|NCT01915498|523855519|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
145760663|NCT02908100|525636521|FG002|Overall Study|Adverse Event|9|||
145760664|NCT02908100|525636519|FG000|Overall Study|Death|2|||
145760665|NCT02908100|525636520|FG001|Overall Study|Death|0|||
145760666|NCT02908100|525636521|FG002|Overall Study|Death|0|||
145760667|NCT02908100|525636519|FG000|Overall Study|Lack of Efficacy|2|||
145760668|NCT02908100|525636520|FG001|Overall Study|Lack of Efficacy|3|||
145760669|NCT02908100|525636521|FG002|Overall Study|Lack of Efficacy|3|||
145760670|NCT02908100|525636519|FG000|Overall Study|Lost to Follow-up|0|||
145760671|NCT02908100|525636520|FG001|Overall Study|Lost to Follow-up|1|||
145275324|NCT01915498|523855520|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
145275325|NCT01915498|523855521|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
145275326|NCT01915498|523855522|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
145275327|NCT01915498|523855523|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
145275328|NCT01915498|523855524|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
145275329|NCT01915498|523855506|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275330|NCT01915498|523855507|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145760672|NCT02908100|525636521|FG002|Overall Study|Lost to Follow-up|2|||
145760673|NCT02908100|525636519|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145760674|NCT02908100|525636520|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145760675|NCT02908100|525636521|FG002|Overall Study|Non-Compliance With Study Drug|2|||
145760676|NCT02908100|525636519|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
145760677|NCT02908100|525636520|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
145402904|NCT02065557|524332547|FG003|Maintenance Period|Withdrawal by Subject|0|||
145275331|NCT01915498|523855508|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275332|NCT01915498|523855509|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275333|NCT01915498|523855510|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275334|NCT01915498|523855511|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275335|NCT01915498|523855512|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275336|NCT01915498|523855513|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275337|NCT01915498|523855514|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275338|NCT01915498|523855515|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275339|NCT01915498|523855516|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275340|NCT01915498|523855517|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275341|NCT01915498|523855518|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275342|NCT01915498|523855519|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275343|NCT01915498|523855520|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275344|NCT01915498|523855521|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275345|NCT01915498|523855522|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275346|NCT01915498|523855523|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
145275347|NCT01915498|523855524|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
145275348|NCT01915498|523855506|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275349|NCT01915498|523855507|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145402905|NCT02065557|524332548|FG004|Maintenance Period|Withdrawal by Subject|2|||
145402906|NCT02065557|524332549|FG005|Maintenance Period|Withdrawal by Subject|1|||
145760678|NCT02908100|525636521|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
145760679|NCT02908100|525636519|FG000|Overall Study|Physician Decision|0|||
145760680|NCT02908100|525636520|FG001|Overall Study|Physician Decision|1|||
145760681|NCT02908100|525636521|FG002|Overall Study|Physician Decision|0|||
145760682|NCT02908100|525636519|FG000|Overall Study|Pregnancy|1|||
145760683|NCT02908100|525636520|FG001|Overall Study|Pregnancy|2|||
145760684|NCT02908100|525636521|FG002|Overall Study|Pregnancy|0|||
145760685|NCT02908100|525636519|FG000|Overall Study|Withdrawal by Subject|8|||
145760686|NCT02908100|525636520|FG001|Overall Study|Withdrawal by Subject|7|||
145760687|NCT02908100|525636521|FG002|Overall Study|Withdrawal by Subject|5|||
145760688|NCT02908100|525636519|FG000|Overall Study|Randomised in Error|1|||
145607753|NCT05778526|525079252|FG002|Overall Study|Protocol Violation|8|||
145607754|NCT00085202|525079253|FG000|Overall Study|Still on therapy|2|||
145607755|NCT00085202|525079254|FG001|Overall Study|Still on therapy|0|||
145760689|NCT02908100|525636520|FG001|Overall Study|Randomised in Error|0|||
145760690|NCT02908100|525636521|FG002|Overall Study|Randomised in Error|0|||
145760691|NCT02024971|525636522|FG000|Overall Study|Data Not Available|30|||
145275350|NCT01915498|523855508|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275351|NCT01915498|523855509|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275352|NCT01915498|523855510|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275353|NCT01915498|523855511|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275354|NCT01915498|523855512|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275355|NCT01915498|523855513|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275356|NCT01915498|523855514|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275357|NCT01915498|523855515|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275358|NCT01915498|523855516|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275359|NCT01915498|523855517|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275360|NCT01915498|523855518|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275361|NCT01915498|523855519|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275362|NCT01915498|523855520|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275363|NCT01915498|523855521|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275364|NCT01915498|523855522|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275365|NCT01915498|523855523|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
145275366|NCT01915498|523855524|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
145275367|NCT01915498|523855506|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275368|NCT01915498|523855507|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275369|NCT01915498|523855508|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275370|NCT01915498|523855509|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275371|NCT01915498|523855510|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275372|NCT01915498|523855511|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275373|NCT01915498|523855512|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275374|NCT01915498|523855513|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275375|NCT01915498|523855514|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275376|NCT01915498|523855515|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275377|NCT01915498|523855516|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275378|NCT01915498|523855517|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275379|NCT01915498|523855518|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275380|NCT01915498|523855519|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275381|NCT01915498|523855520|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275382|NCT01915498|523855521|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275383|NCT01915498|523855522|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275384|NCT01915498|523855523|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
145275385|NCT01915498|523855524|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
145275386|NCT01907516|523855525|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
145275387|NCT01907516|523855526|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
145275388|NCT01907516|523855525|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
145275389|NCT01907516|523855526|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
145275390|NCT01907516|523855525|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
145275391|NCT01907516|523855526|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
145275392|NCT01907516|523855525|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
145275393|NCT01907516|523855526|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
145275394|NCT00131937|523855528|FG000|Overall Study|Adverse Event|3|||
145275395|NCT00131937|523855528|FG000|Overall Study|Withdrawal by Subject|2|||
145275396|NCT00131937|523855528|FG000|Overall Study|Physician Decision|1|||
145275397|NCT00131937|523855528|FG000|Overall Study|Disease Progression|7|||
145275398|NCT00131937|523855528|FG000|Overall Study|Alternative therapy|1|||
145275399|NCT01211613|523857135|FG000|Overall Study|Lost to Follow-up|2|||
145275400|NCT01211613|523857136|FG001|Overall Study|Lost to Follow-up|2|||
145275401|NCT01211613|523857137|FG002|Overall Study|Lost to Follow-up|2|||
145275402|NCT01211613|523857135|FG000|Overall Study|Withdrawal by Subject|1|||
145275403|NCT01211613|523857136|FG001|Overall Study|Withdrawal by Subject|0|||
145275404|NCT01211613|523857137|FG002|Overall Study|Withdrawal by Subject|0|||
145275405|NCT01020773|523857138|FG000|Overall Study|Withdrawal by Subject|4|||
145275406|NCT01020773|523857139|FG001|Overall Study|Withdrawal by Subject|3|||
145275407|NCT03302299|523857140|FG000|Overall Study|Protocol Violation|1|||
145275408|NCT01458132|523857141|FG000|Overall Study|Other|15|||
145402907|NCT02065557|524332544|FG000|Maintenance Period|Lack of Efficacy|0|||
145402908|NCT02065557|524332545|FG001|Maintenance Period|Lack of Efficacy|0|||
145402909|NCT02065557|524332546|FG002|Maintenance Period|Lack of Efficacy|0|||
145275409|NCT01458132|523857142|FG001|Overall Study|Other|3|||
145275410|NCT01227954|523857156|FG000|Overall Study|Protocol Violation|6|||
145275411|NCT01227954|523857156|FG000|Overall Study|No protocol treatment|7|||
145275412|NCT00078312|523857159|FG000|Overall Study|Adverse Event|43|||
145275413|NCT00078312|523857159|FG000|Overall Study|Lack of Efficacy|15|||
145275414|NCT00078312|523857159|FG000|Overall Study|Lost to Follow-up|41|||
145760692|NCT02024971|525636522|FG000|Overall Study|Lost to Follow-up|6|||
145275415|NCT00078312|523857159|FG000|Overall Study|Physician Decision|9|||
145275416|NCT00078312|523857159|FG000|Overall Study|Protocol Violation|3|||
145275417|NCT00078312|523857159|FG000|Overall Study|Withdrawal by Subject|33|||
145275418|NCT00078312|523857159|FG000|Overall Study|Miscellaneous|33|||
145275419|NCT02216214|523857160|FG000|Overall Study|Randomized Never Received Study Drug|1|||
145275420|NCT02216214|523857161|FG001|Overall Study|Randomized Never Received Study Drug|0|||
145275421|NCT02216214|523857160|FG000|Overall Study|Adverse Event|10|||
145275422|NCT02216214|523857161|FG001|Overall Study|Adverse Event|8|||
145275423|NCT02216214|523857160|FG000|Overall Study|Lack of Efficacy|2|||
145275424|NCT02216214|523857161|FG001|Overall Study|Lack of Efficacy|2|||
145275425|NCT02216214|523857160|FG000|Overall Study|Lost to Follow-up|3|||
145275426|NCT02216214|523857161|FG001|Overall Study|Lost to Follow-up|2|||
145275427|NCT02216214|523857160|FG000|Overall Study|Protocol Violation|4|||
145275428|NCT02216214|523857161|FG001|Overall Study|Protocol Violation|2|||
145275429|NCT02216214|523857160|FG000|Overall Study|Withdrawal by Subject|22|||
145275430|NCT02216214|523857161|FG001|Overall Study|Withdrawal by Subject|20|||
145275431|NCT02216214|523857160|FG000|Overall Study|Study Terminated By Sponsor|0|||
145275432|NCT02216214|523857161|FG001|Overall Study|Study Terminated By Sponsor|1|||
145275433|NCT02216214|523857160|FG000|Overall Study|Miscellaneous|1|||
145275434|NCT02216214|523857161|FG001|Overall Study|Miscellaneous|1|||
145275435|NCT01414062|523857162|FG000|Overall Study|Lost to Follow-up|3|||
145275436|NCT01414062|523857163|FG001|Overall Study|Lost to Follow-up|2|||
145275437|NCT01414062|523857162|FG000|Overall Study|Left Country|1|||
145275438|NCT01414062|523857163|FG001|Overall Study|Left Country|1|||
145275439|NCT01414062|523857162|FG000|Overall Study|Family Disapproval|1|||
145275440|NCT01414062|523857163|FG001|Overall Study|Family Disapproval|0|||
145275441|NCT01414062|523857162|FG000|Overall Study|Withdrawal by Subject|0|||
145275442|NCT01414062|523857163|FG001|Overall Study|Withdrawal by Subject|1|||
145275443|NCT04285983|523857164|FG000|Overall Study|Protocol Violation|6|||
145275444|NCT00902265|523857167|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
145275445|NCT00902265|523857167|FG000|Overall Study|Adverse Event|2|||
145275446|NCT00902265|523857167|FG000|Overall Study|Lack of Efficacy|2|||
145275447|NCT00902265|523857167|FG000|Overall Study|Protocol Violation|1|||
145275448|NCT00103259|523857170|FG000|Overall Study|Death|3|||
145275449|NCT00103259|523857171|FG001|Overall Study|Death|2|||
145275450|NCT00103259|523857170|FG000|Overall Study|Withdrawal by Subject|2|||
145275451|NCT00103259|523857171|FG001|Overall Study|Withdrawal by Subject|3|||
145275452|NCT00103259|523857170|FG000|Overall Study|alternative therapy|1|||
145275453|NCT00103259|523857171|FG001|Overall Study|alternative therapy|0|||
145275454|NCT00103259|523857170|FG000|Overall Study|other (reasons were not specified)|2|||
145275455|NCT00103259|523857171|FG001|Overall Study|other (reasons were not specified)|1|||
145275456|NCT00103259|523857170|FG000|Overall Study|ineligible/no protocol therapy|4|||
145275457|NCT00103259|523857171|FG001|Overall Study|ineligible/no protocol therapy|6|||
145275458|NCT03224234|523857176|FG000|Main Study|Lost to Follow-up|5|||
145275459|NCT03224234|523857177|FG001|Main Study|Lost to Follow-up|5|||
145275460|NCT02866695|523857178|FG000|Overall Study|Adverse Event|1|||
145275461|NCT02866695|523857178|FG000|Overall Study|Lost to Follow-up|1|||
145275462|NCT05016765|523857179|FG000|Overall Study|Lost to Follow-up|4|||
145275463|NCT02610842|523857180|FG000|Overall Study|Lost to Follow-up|5|||
145275464|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
145275465|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
145275466|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
145275467|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
145275468|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
145275469|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
145275470|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
145275471|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
145275472|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
145275473|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
145275474|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
145275475|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
145275476|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
145275477|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
145275478|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
145275479|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
145275480|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
145275481|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
145275482|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
145275483|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
145275484|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
145275485|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
145275486|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
145275487|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
145275488|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
145275489|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
145275490|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
145275491|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
145275492|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
145275493|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
145275494|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
145275495|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
145275496|NCT03747939|523857181|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
145275497|NCT03747939|523857182|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
145275498|NCT03747939|523857183|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
145275499|NCT03747939|523857184|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
145275500|NCT03747939|523857181|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
145275501|NCT03747939|523857182|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
145275502|NCT03747939|523857183|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
145275503|NCT03747939|523857184|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
145275504|NCT03747939|523857181|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
145275505|NCT03747939|523857182|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
145275506|NCT03747939|523857183|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
145275507|NCT03747939|523857184|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
145275508|NCT03747939|523857181|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
145275509|NCT03747939|523857182|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
145275510|NCT03747939|523857183|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
145275511|NCT03747939|523857184|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
145275512|NCT03747939|523857181|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
145275513|NCT03747939|523857182|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
145275514|NCT03747939|523857183|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
145275515|NCT03747939|523857184|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
145275516|NCT03747939|523857181|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
145275517|NCT03747939|523857182|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
145275518|NCT03747939|523857183|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
145275519|NCT03747939|523857184|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
145275520|NCT01447628|523857187|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
145275521|NCT01447628|523857188|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
145275522|NCT01447628|523857189|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
145275523|NCT01447628|523857190|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
145275524|NCT00185731|523857191|FG000|Overall Study|Withdrawal by Subject|1|||
145275525|NCT00185731|523857191|FG000|Overall Study|Not Eligible|1|||
145275526|NCT03087773|523857192|FG000|Overall Study|Withdrawal by Subject|8|||
145275527|NCT03087773|523857193|FG001|Overall Study|Withdrawal by Subject|4|||
145275528|NCT03087773|523857192|FG000|Overall Study|Lost to Follow-up|12|||
145275529|NCT03087773|523857193|FG001|Overall Study|Lost to Follow-up|8|||
145275530|NCT02494583|523857196|FG000|Overall Study|Death|224|||
145275531|NCT02494583|523857197|FG001|Overall Study|Death|214|||
145275532|NCT02494583|523857198|FG002|Overall Study|Death|225|||
145275533|NCT02494583|523857196|FG000|Overall Study|Lost to Follow-up|1|||
145275534|NCT02494583|523857197|FG001|Overall Study|Lost to Follow-up|0|||
145275535|NCT02494583|523857198|FG002|Overall Study|Lost to Follow-up|0|||
145275536|NCT02494583|523857196|FG000|Overall Study|Protocol Violation|1|||
145275537|NCT02494583|523857197|FG001|Overall Study|Protocol Violation|2|||
145275538|NCT02494583|523857198|FG002|Overall Study|Protocol Violation|0|||
145275539|NCT02494583|523857196|FG000|Overall Study|Screen Failure|0|||
145607756|NCT00085202|525079253|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
145275540|NCT02494583|523857197|FG001|Overall Study|Screen Failure|1|||
145275541|NCT02494583|523857198|FG002|Overall Study|Screen Failure|0|||
145275542|NCT02494583|523857196|FG000|Overall Study|Transferred to Extension Study|15|||
145275543|NCT02494583|523857197|FG001|Overall Study|Transferred to Extension Study|15|||
145275544|NCT02494583|523857198|FG002|Overall Study|Transferred to Extension Study|6|||
145275545|NCT02494583|523857196|FG000|Overall Study|Did Not Continue on Extension Study|8|||
145275546|NCT02494583|523857197|FG001|Overall Study|Did Not Continue on Extension Study|10|||
145275547|NCT02494583|523857198|FG002|Overall Study|Did Not Continue on Extension Study|4|||
145275548|NCT02494583|523857196|FG000|Overall Study|Withdrawal by Subject|7|||
145275549|NCT02494583|523857197|FG001|Overall Study|Withdrawal by Subject|15|||
145275550|NCT02494583|523857198|FG002|Overall Study|Withdrawal by Subject|15|||
145275551|NCT05144477|523857199|FG000|Overall Study|Withdrawal by Subject|1|||
145275552|NCT05144477|523857200|FG001|Overall Study|Withdrawal by Subject|1|||
145275553|NCT02181842|523857201|FG000|Overall Study|Case Report Forms Uncollected|2|||
145275554|NCT04529096|523857202|FG000|Overall Study|Adverse Event|6|||
145275555|NCT04529096|523857203|FG001|Overall Study|Adverse Event|1|||
145275556|NCT04529096|523857202|FG000|Overall Study|Lack of Efficacy|1|||
145275557|NCT04529096|523857203|FG001|Overall Study|Lack of Efficacy|0|||
145275558|NCT04529096|523857202|FG000|Overall Study|Lost to Follow-up|1|||
145275559|NCT04529096|523857203|FG001|Overall Study|Lost to Follow-up|1|||
145275560|NCT04529096|523857202|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145275561|NCT04529096|523857203|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145275562|NCT04529096|523857202|FG000|Overall Study|Physician Decision|1|||
145275563|NCT04529096|523857203|FG001|Overall Study|Physician Decision|3|||
145275564|NCT04529096|523857202|FG000|Overall Study|Withdrawal by Subject|5|||
145275565|NCT04529096|523857203|FG001|Overall Study|Withdrawal by Subject|0|||
145275566|NCT00758706|523857204|FG000|Overall Study|Adverse Event|4|||
145275567|NCT00758706|523857205|FG001|Overall Study|Adverse Event|4|||
145275568|NCT03454672|523857215|FG000|Overall Study|Adverse Event|1|||
145275569|NCT03454672|523857216|FG001|Overall Study|Adverse Event|1|||
145275570|NCT03454672|523857215|FG000|Overall Study|Lost to Follow-up|1|||
145275571|NCT03454672|523857216|FG001|Overall Study|Lost to Follow-up|3|||
145275572|NCT03454672|523857215|FG000|Overall Study|painful|1|||
145275573|NCT03454672|523857216|FG001|Overall Study|painful|2|||
145275574|NCT03454672|523857215|FG000|Overall Study|Non-compliance|2|||
145275575|NCT03454672|523857216|FG001|Overall Study|Non-compliance|4|||
145275576|NCT03454672|523857215|FG000|Overall Study|personal reasons|3|||
145275577|NCT03454672|523857216|FG001|Overall Study|personal reasons|2|||
145275578|NCT03454672|523857215|FG000|Overall Study|Withdrawal by Subject|1|||
145275579|NCT03454672|523857216|FG001|Overall Study|Withdrawal by Subject|0|||
145275580|NCT01488071|523857220|FG000|Overall Study|Adverse Event|15|||
145275581|NCT01488071|523857221|FG001|Overall Study|Adverse Event|23|||
145275582|NCT01488071|523857220|FG000|Overall Study|Lack of Efficacy|11|||
145275583|NCT01488071|523857221|FG001|Overall Study|Lack of Efficacy|17|||
145275584|NCT01488071|523857220|FG000|Overall Study|Non-compliance with study drug|2|||
145275585|NCT01488071|523857221|FG001|Overall Study|Non-compliance with study drug|0|||
145275586|NCT01488071|523857220|FG000|Overall Study|Protocol Violation|5|||
145275587|NCT01488071|523857221|FG001|Overall Study|Protocol Violation|7|||
145275588|NCT01488071|523857220|FG000|Overall Study|Withdrawal of Consent|14|||
145275589|NCT01488071|523857221|FG001|Overall Study|Withdrawal of Consent|12|||
145275590|NCT01488071|523857220|FG000|Overall Study|Lost to Follow-up|1|||
145275591|NCT01488071|523857221|FG001|Overall Study|Lost to Follow-up|0|||
145275592|NCT01488071|523857220|FG000|Overall Study|Administrative or Other Reason(s)|5|||
145275593|NCT01488071|523857221|FG001|Overall Study|Administrative or Other Reason(s)|4|||
145275594|NCT02139306|523857222|FG000|Overall Study|Withdrawal by Subject|4|||
145275595|NCT02139306|523857223|FG001|Overall Study|Withdrawal by Subject|6|||
145275596|NCT02139306|523857222|FG000|Overall Study|Adverse Event|3|||
145275597|NCT02139306|523857223|FG001|Overall Study|Adverse Event|4|||
145275598|NCT02139306|523857222|FG000|Overall Study|Physician Decision|0|||
145275599|NCT02139306|523857223|FG001|Overall Study|Physician Decision|1|||
145275600|NCT02139306|523857222|FG000|Overall Study|Other Unspecified|2|||
145275601|NCT02139306|523857223|FG001|Overall Study|Other Unspecified|3|||
145275602|NCT02139306|523857222|FG000|Overall Study|Protocol Violation|4|||
145275603|NCT02139306|523857223|FG001|Overall Study|Protocol Violation|0|||
145275604|NCT04449354|523857224|FG000|Overall Study|Withdrawal by Subject|1|||
145275605|NCT02587325|523857225|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
145275606|NCT02587325|523857226|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
145275607|NCT02587325|523857227|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
145275608|NCT02587325|523857228|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
145275609|NCT02587325|523857229|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
145275610|NCT02587325|523857225|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
145275611|NCT02587325|523857226|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
145275612|NCT02587325|523857227|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
145275613|NCT02587325|523857228|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
145275614|NCT02587325|523857229|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
145275615|NCT02587325|523857225|FG000|32-Week Optional Extension Part|Adverse Event|0|||
145275616|NCT02587325|523857226|FG001|32-Week Optional Extension Part|Adverse Event|0|||
145275617|NCT02587325|523857227|FG002|32-Week Optional Extension Part|Adverse Event|1|||
145275618|NCT02587325|523857228|FG003|32-Week Optional Extension Part|Adverse Event|0|||
145275619|NCT02587325|523857229|FG004|32-Week Optional Extension Part|Adverse Event|0|||
145275620|NCT02587325|523857225|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
145275621|NCT02587325|523857226|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
145275622|NCT02587325|523857227|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
145275623|NCT02587325|523857228|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
145275624|NCT02587325|523857229|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
145275625|NCT00390572|523857230|FG000|Overall Study|Lost to Follow-up|8|||
145275626|NCT00390572|523857231|FG001|Overall Study|Lost to Follow-up|4|||
145275627|NCT00390572|523857230|FG000|Overall Study|health condition|0|||
145275628|NCT00390572|523857231|FG001|Overall Study|health condition|1|||
145275629|NCT02913261|523857238|FG000|Overall Study|Technical problems|0|||
145275630|NCT02913261|523857239|FG001|Overall Study|Technical problems|1|||
145275631|NCT02913261|523857238|FG000|Overall Study|Lack of Efficacy|32|||
145275632|NCT02913261|523857239|FG001|Overall Study|Lack of Efficacy|69|||
145275633|NCT02913261|523857238|FG000|Overall Study|Adverse Event|27|||
145275634|NCT02913261|523857239|FG001|Overall Study|Adverse Event|5|||
145275635|NCT02913261|523857238|FG000|Overall Study|Death|25|||
145275636|NCT02913261|523857239|FG001|Overall Study|Death|22|||
145275637|NCT02913261|523857238|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
145275638|NCT02913261|523857239|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
145275639|NCT02913261|523857238|FG000|Overall Study|Disease relapse|8|||
145275640|NCT02913261|523857239|FG001|Overall Study|Disease relapse|13|||
145275641|NCT02913261|523857238|FG000|Overall Study|Physician Decision|8|||
145275642|NCT02913261|523857239|FG001|Overall Study|Physician Decision|9|||
145275643|NCT02913261|523857238|FG000|Overall Study|Subject/guardian decision|4|||
145275644|NCT02913261|523857239|FG001|Overall Study|Subject/guardian decision|6|||
145275645|NCT02913261|523857238|FG000|Overall Study|Graft loss|2|||
145275646|NCT02913261|523857239|FG001|Overall Study|Graft loss|0|||
145275647|NCT02304302|523857242|FG000|Overall Study|Adverse Event|2|||
145275648|NCT02304302|523857243|FG001|Overall Study|Adverse Event|3|||
145275649|NCT02304302|523857242|FG000|Overall Study|Lost to Follow-up|1|||
145275650|NCT02304302|523857243|FG001|Overall Study|Lost to Follow-up|4|||
145275651|NCT02304302|523857242|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
145275652|NCT02304302|523857243|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
145275653|NCT00391118|523857244|FG000|Overall Study|Adverse Event|3|||
145275654|NCT00391118|523857245|FG001|Overall Study|Adverse Event|10|||
145275655|NCT00391118|523857246|FG002|Overall Study|Adverse Event|7|||
145275656|NCT00391118|523857244|FG000|Overall Study|Lost to Follow-up|0|||
145275657|NCT00391118|523857245|FG001|Overall Study|Lost to Follow-up|2|||
145275658|NCT00391118|523857246|FG002|Overall Study|Lost to Follow-up|3|||
145292749|NCT06179108|523922226|FG000|Overall Study|Lost to Follow-up|12|||
145292750|NCT06179108|523922227|FG001|Overall Study|Lost to Follow-up|4|||
145292751|NCT06179108|523922228|FG002|Overall Study|Lost to Follow-up|1|||
145275659|NCT00391118|523857244|FG000|Overall Study|Withdrawal by Subject|0|||
145275660|NCT00391118|523857245|FG001|Overall Study|Withdrawal by Subject|9|||
145275661|NCT00391118|523857246|FG002|Overall Study|Withdrawal by Subject|1|||
145275662|NCT00391118|523857244|FG000|Overall Study|Death|0|||
145275663|NCT00391118|523857245|FG001|Overall Study|Death|1|||
145275664|NCT00391118|523857246|FG002|Overall Study|Death|0|||
145275665|NCT00391118|523857244|FG000|Overall Study|Physician Decision|0|||
145275666|NCT00391118|523857245|FG001|Overall Study|Physician Decision|3|||
145275667|NCT00391118|523857246|FG002|Overall Study|Physician Decision|0|||
145275668|NCT00391118|523857244|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
145275669|NCT00391118|523857245|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
145275670|NCT00391118|523857246|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
145275671|NCT00391118|523857244|FG000|Overall Study|Progressive Disease|7|||
145275672|NCT00391118|523857245|FG001|Overall Study|Progressive Disease|26|||
145275673|NCT00391118|523857246|FG002|Overall Study|Progressive Disease|43|||
145275674|NCT00391118|523857244|FG000|Overall Study|Sponsor Decision|0|||
145275675|NCT00391118|523857245|FG001|Overall Study|Sponsor Decision|1|||
145275676|NCT00391118|523857246|FG002|Overall Study|Sponsor Decision|3|||
145275677|NCT00391118|523857244|FG000|Overall Study|Protocol Violation|1|||
145275678|NCT00391118|523857245|FG001|Overall Study|Protocol Violation|0|||
145275679|NCT00391118|523857246|FG002|Overall Study|Protocol Violation|0|||
145275680|NCT01892020|523857247|FG000|Period 1|Adverse Event|1|||
145275681|NCT01892020|523857248|FG001|Period 1|Adverse Event|1|||
145275682|NCT01892020|523857247|FG000|Period 1|Protocol Violation|2|||
145275683|NCT01892020|523857248|FG001|Period 1|Protocol Violation|4|||
145275684|NCT01892020|523857247|FG000|Period 1|Unclassified|0|||
145275685|NCT01892020|523857248|FG001|Period 1|Unclassified|1|||
145275686|NCT01892020|523857247|FG000|Period 2|Protocol Violation|1|||
145275687|NCT01892020|523857248|FG001|Period 2|Protocol Violation|0|||
145275688|NCT03078192|523857253|FG000|Overall Study|Withdrawal by Subject|2|||
145275689|NCT03078192|523857254|FG001|Overall Study|Withdrawal by Subject|1|||
145275690|NCT03078192|523857253|FG000|Overall Study|screen failure|0|||
145275691|NCT03078192|523857254|FG001|Overall Study|screen failure|3|||
145275692|NCT02873195|523857255|FG000|Overall Study|Ineligible|5|||
145275693|NCT02873195|523857256|FG001|Overall Study|Ineligible|0|||
145275694|NCT02508649|523857257|FG000|Overall Study|Withdrawal by Subject|4|||
145275695|NCT02508649|523857258|FG001|Overall Study|Withdrawal by Subject|6|||
145275696|NCT02508649|523857259|FG002|Overall Study|Withdrawal by Subject|5|||
145275697|NCT02508649|523857260|FG003|Overall Study|Withdrawal by Subject|6|||
145275698|NCT02508649|523857257|FG000|Overall Study|Investigator withdrew the subject|1|||
145607757|NCT00085202|525079254|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
145607758|NCT00085202|525079253|FG000|Overall Study|Excessive toxicity|6|||
145607759|NCT00085202|525079254|FG001|Overall Study|Excessive toxicity|5|||
145607760|NCT00085202|525079253|FG000|Overall Study|Non-specified|3|||
145607761|NCT00085202|525079254|FG001|Overall Study|Non-specified|5|||
145607762|NCT00085202|525079253|FG000|Overall Study|Withdrawal by Subject|2|||
145607763|NCT00085202|525079254|FG001|Overall Study|Withdrawal by Subject|1|||
145607764|NCT00085202|525079253|FG000|Overall Study|Physician Decision|4|||
145607765|NCT00085202|525079254|FG001|Overall Study|Physician Decision|1|||
145607766|NCT00085202|525079253|FG000|Overall Study|Progressive disease|1|||
145607767|NCT00085202|525079254|FG001|Overall Study|Progressive disease|11|||
145760693|NCT05254418|525636524|FG000|Overall Study|Adverse Event|2|||
145760694|NCT02631538|525636525|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
145275699|NCT02508649|523857258|FG001|Overall Study|Investigator withdrew the subject|2|||
145760695|NCT02631538|525636526|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
145275700|NCT02508649|523857259|FG002|Overall Study|Investigator withdrew the subject|1|||
145275701|NCT02508649|523857260|FG003|Overall Study|Investigator withdrew the subject|0|||
145275702|NCT02508649|523857257|FG000|Overall Study|Post randomization screening failure|12|||
145275703|NCT02508649|523857258|FG001|Overall Study|Post randomization screening failure|4|||
145275704|NCT02508649|523857259|FG002|Overall Study|Post randomization screening failure|9|||
145275705|NCT02508649|523857260|FG003|Overall Study|Post randomization screening failure|3|||
145275706|NCT02508649|523857257|FG000|Overall Study|Lost to Follow-up|1|||
145607768|NCT03238300|525079258|FG000|Baseline (Before Intervention)|Physician Decision|0|||
145607769|NCT03238300|525079259|FG001|Baseline (Before Intervention)|Physician Decision|1|||
145607770|NCT03238300|525079258|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
145275707|NCT02508649|523857258|FG001|Overall Study|Lost to Follow-up|1|||
145275708|NCT02508649|523857259|FG002|Overall Study|Lost to Follow-up|0|||
145275709|NCT02508649|523857260|FG003|Overall Study|Lost to Follow-up|1|||
145275710|NCT03252756|523857263|FG000|Overall Study|Protocol Violation|2|||
145275711|NCT03252756|523857264|FG001|Overall Study|Protocol Violation|4|||
145275712|NCT03252756|523857263|FG000|Overall Study|COVID-19 Pandemic|1|||
145275713|NCT03252756|523857264|FG001|Overall Study|COVID-19 Pandemic|1|||
145275714|NCT03252756|523857263|FG000|Overall Study|Study Drug Expiration|0|||
145275715|NCT03252756|523857264|FG001|Overall Study|Study Drug Expiration|1|||
145275716|NCT01966107|523857265|FG000|Overall Study|excluded from FAS|21|||
145275717|NCT01966107|523857266|FG001|Overall Study|excluded from FAS|20|||
145275718|NCT01966107|523857265|FG000|Overall Study|discontinued treatment|345|||
145275719|NCT01966107|523857266|FG001|Overall Study|discontinued treatment|372|||
145275720|NCT01966107|523857265|FG000|Overall Study|due to study closure|164|||
145275721|NCT01966107|523857266|FG001|Overall Study|due to study closure|186|||
145275722|NCT01966107|523857265|FG000|Overall Study|withdrew from the study|272|||
145275723|NCT01966107|523857266|FG001|Overall Study|withdrew from the study|303|||
145275724|NCT00689273|523857267|FG000|Overall Study|Adverse Event|3|||
145275725|NCT00689273|523857268|FG001|Overall Study|Adverse Event|1|||
145275726|NCT00689273|523857267|FG000|Overall Study|Lack of Efficacy|3|||
145275727|NCT00689273|523857268|FG001|Overall Study|Lack of Efficacy|0|||
145275728|NCT00689273|523857267|FG000|Overall Study|Lost to Follow-up|0|||
145275729|NCT00689273|523857268|FG001|Overall Study|Lost to Follow-up|2|||
145275730|NCT00689273|523857267|FG000|Overall Study|Other|6|||
145275731|NCT00689273|523857268|FG001|Overall Study|Other|2|||
145275732|NCT00689273|523857267|FG000|Overall Study|Randomized but not Treated|1|||
145275733|NCT00689273|523857268|FG001|Overall Study|Randomized but not Treated|0|||
145275734|NCT01901146|523859280|FG000|Neoadjuvant Phase|Death|1|||
145275735|NCT01901146|523859281|FG001|Neoadjuvant Phase|Death|2|||
145275736|NCT01901146|523859282|FG002|Neoadjuvant Phase|Death|0|||
145275737|NCT01901146|523859283|FG003|Neoadjuvant Phase|Death|0|||
145275738|NCT01901146|523859284|FG004|Neoadjuvant Phase|Death|0|||
145275739|NCT01901146|523859280|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
145275740|NCT01901146|523859281|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
145760696|NCT02631538|525636527|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
145760697|NCT02631538|525636528|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
145760698|NCT02631538|525636525|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
145760699|NCT02631538|525636526|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
145760700|NCT02631538|525636527|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
145760701|NCT02631538|525636528|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
145760702|NCT02631538|525636525|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
145760703|NCT02631538|525636526|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
145760704|NCT02631538|525636527|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
145760705|NCT02631538|525636528|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
145760706|NCT02631538|525636525|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
145760707|NCT02631538|525636526|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
145760708|NCT02631538|525636527|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
145760709|NCT02631538|525636528|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
145760710|NCT02631538|525636525|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
145760711|NCT02631538|525636526|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
145760712|NCT02631538|525636527|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
145760713|NCT02631538|525636528|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
145760714|NCT02631538|525636525|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
145760715|NCT02631538|525636526|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
145760716|NCT02631538|525636527|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
145760717|NCT02631538|525636528|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
145760718|NCT00400400|525636529|FG000|Overall Study|Adverse Event|9|||
145760719|NCT00400400|525636530|FG001|Overall Study|Adverse Event|8|||
145760720|NCT00400400|525636529|FG000|Overall Study|Protocol Violation|2|||
145760721|NCT00400400|525636530|FG001|Overall Study|Protocol Violation|0|||
145275741|NCT01901146|523859282|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
145275742|NCT01901146|523859283|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
145275743|NCT01901146|523859284|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
145275744|NCT01901146|523859280|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
145275745|NCT01901146|523859281|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
145275746|NCT01901146|523859282|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
145760722|NCT00400400|525636529|FG000|Overall Study|Withdrawal by Subject|1|||
145275747|NCT01901146|523859283|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
145275748|NCT01901146|523859284|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
145275749|NCT01901146|523859280|FG000|Neoadjuvant Phase|Physician Decision|1|||
145275750|NCT01901146|523859281|FG001|Neoadjuvant Phase|Physician Decision|2|||
145275751|NCT01901146|523859282|FG002|Neoadjuvant Phase|Physician Decision|0|||
145275752|NCT01901146|523859283|FG003|Neoadjuvant Phase|Physician Decision|0|||
145275753|NCT01901146|523859284|FG004|Neoadjuvant Phase|Physician Decision|0|||
145275754|NCT01901146|523859280|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
145275755|NCT01901146|523859281|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
145275756|NCT01901146|523859282|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
145275757|NCT01901146|523859283|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
145275758|NCT01901146|523859284|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
145275759|NCT01901146|523859280|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
145275760|NCT01901146|523859281|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
145275761|NCT01901146|523859282|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
145275762|NCT01901146|523859283|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
145275763|NCT01901146|523859284|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
145275764|NCT01901146|523859280|FG000|Adjuvant Phase|Other|0|||
145275765|NCT01901146|523859281|FG001|Adjuvant Phase|Other|0|||
145275766|NCT01901146|523859282|FG002|Adjuvant Phase|Other|1|||
145275767|NCT01901146|523859283|FG003|Adjuvant Phase|Other|0|||
145275768|NCT01901146|523859284|FG004|Adjuvant Phase|Other|0|||
145275769|NCT01901146|523859280|FG000|Adjuvant Phase|Death|0|||
145275770|NCT01901146|523859281|FG001|Adjuvant Phase|Death|0|||
145275771|NCT01901146|523859282|FG002|Adjuvant Phase|Death|0|||
145275772|NCT01901146|523859283|FG003|Adjuvant Phase|Death|0|||
145275773|NCT01901146|523859284|FG004|Adjuvant Phase|Death|3|||
145275774|NCT01901146|523859280|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
145275775|NCT01901146|523859281|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
145275776|NCT01901146|523859282|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
145275777|NCT01901146|523859283|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
145275778|NCT01901146|523859284|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
145275779|NCT01901146|523859280|FG000|Adjuvant Phase|Physician Decision|0|||
145275780|NCT01901146|523859281|FG001|Adjuvant Phase|Physician Decision|0|||
145275781|NCT01901146|523859282|FG002|Adjuvant Phase|Physician Decision|9|||
145275782|NCT01901146|523859283|FG003|Adjuvant Phase|Physician Decision|2|||
145275783|NCT01901146|523859284|FG004|Adjuvant Phase|Physician Decision|4|||
145275784|NCT01901146|523859280|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
145275785|NCT01901146|523859281|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
145275786|NCT01901146|523859282|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
145275787|NCT01901146|523859283|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
145275788|NCT01901146|523859284|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
145275789|NCT00297492|523859285|FG000|Set Quit Date|Lost to Follow-up|7|||
145275790|NCT00297492|523859286|FG001|Set Quit Date|Lost to Follow-up|13|||
145275791|NCT00297492|523859287|FG002|Set Quit Date|Lost to Follow-up|5|||
145275792|NCT00297492|523859285|FG000|6 Month Follow-up|Lost to Follow-up|63|||
145275793|NCT00297492|523859286|FG001|6 Month Follow-up|Lost to Follow-up|49|||
145275794|NCT00297492|523859287|FG002|6 Month Follow-up|Lost to Follow-up|27|||
145275795|NCT03724968|523859288|FG000|Overall Study|Insurance issues|0|||
145275796|NCT03724968|523859289|FG001|Overall Study|Insurance issues|1|||
145275797|NCT03724968|523859288|FG000|Overall Study|Study closed|0|||
145275798|NCT03724968|523859289|FG001|Overall Study|Study closed|1|||
145275799|NCT01336608|523859290|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
145275800|NCT01336608|523859291|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145275801|NCT01336608|523859292|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145275802|NCT01336608|523859293|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145275803|NCT01336608|523859290|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
145275804|NCT01336608|523859291|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145275805|NCT01336608|523859292|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145275806|NCT01336608|523859293|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145275807|NCT01336608|523859290|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
145275808|NCT01336608|523859291|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
145275809|NCT01336608|523859292|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
145275810|NCT01336608|523859293|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
145275811|NCT01336608|523859290|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
145275812|NCT01336608|523859291|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
145275813|NCT01336608|523859292|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
145275814|NCT01336608|523859293|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
145275815|NCT01336608|523859290|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
145275816|NCT01336608|523859291|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145275817|NCT01336608|523859292|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145275818|NCT01336608|523859293|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145275819|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
145275820|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
145275821|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
145275822|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
145275823|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145275824|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
145275825|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145275826|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145275827|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
145275828|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
145275829|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
145275830|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
145275831|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
145275832|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
145275833|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
145275834|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
145275835|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
145275836|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
145275837|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
145275838|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
145275839|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145275840|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
145275841|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145275842|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145275843|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
145275844|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
145275845|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
145275846|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
145275847|NCT01336608|523859290|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145292752|NCT06179108|523922229|FG003|Overall Study|Lost to Follow-up|9|||
145292753|NCT06179108|523922226|FG000|Overall Study|Adverse Event|2|||
145292754|NCT06179108|523922227|FG001|Overall Study|Adverse Event|3|||
145275848|NCT01336608|523859291|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
145275849|NCT01336608|523859292|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
145275850|NCT01336608|523859293|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
145275851|NCT00569231|523859294|FG000|Overall Study|Study unrelated surgery|1|||
145275852|NCT00569231|523859294|FG000|Overall Study|Airfare expense|2|||
145275853|NCT00569231|523859294|FG000|Overall Study|Withdrawal by Subject|1|||
145275854|NCT00569231|523859294|FG000|Overall Study|Car accident injury|1|||
145275855|NCT00569231|523859294|FG000|Overall Study|Non-compliance|2|||
145275856|NCT01614925|523859295|FG000|Overall Study|Withdrawal by Subject|1|||
145275857|NCT01614925|523859296|FG001|Overall Study|Withdrawal by Subject|0|||
145275858|NCT01614925|523859295|FG000|Overall Study|Protocol Violation|3|||
145275859|NCT01614925|523859296|FG001|Overall Study|Protocol Violation|2|||
145275860|NCT02437890|523859301|FG000|Overall Study|Non-compliance to study drug|0|||
145275861|NCT02437890|523859302|FG001|Overall Study|Non-compliance to study drug|1|||
145275862|NCT02437890|523859303|FG002|Overall Study|Non-compliance to study drug|0|||
145275863|NCT02437890|523859304|FG003|Overall Study|Non-compliance to study drug|0|||
145275864|NCT02437890|523859305|FG004|Overall Study|Non-compliance to study drug|1|||
145275865|NCT02437890|523859301|FG000|Overall Study|Sponsor's decision|1|||
145275866|NCT02437890|523859302|FG001|Overall Study|Sponsor's decision|1|||
145275867|NCT02437890|523859303|FG002|Overall Study|Sponsor's decision|4|||
145275868|NCT02437890|523859304|FG003|Overall Study|Sponsor's decision|0|||
145275869|NCT02437890|523859305|FG004|Overall Study|Sponsor's decision|2|||
145275870|NCT02437890|523859301|FG000|Overall Study|Physician Decision|0|||
145275871|NCT02437890|523859302|FG001|Overall Study|Physician Decision|0|||
145275872|NCT02437890|523859303|FG002|Overall Study|Physician Decision|0|||
145275873|NCT02437890|523859304|FG003|Overall Study|Physician Decision|1|||
145275874|NCT02437890|523859305|FG004|Overall Study|Physician Decision|0|||
145275875|NCT02437890|523859301|FG000|Overall Study|Unable to attend visit(s)|1|||
145275876|NCT02437890|523859302|FG001|Overall Study|Unable to attend visit(s)|0|||
145275877|NCT02437890|523859303|FG002|Overall Study|Unable to attend visit(s)|0|||
145275878|NCT02437890|523859304|FG003|Overall Study|Unable to attend visit(s)|0|||
145275879|NCT02437890|523859305|FG004|Overall Study|Unable to attend visit(s)|0|||
145275880|NCT02437890|523859301|FG000|Overall Study|Lack of Efficacy|1|||
145275881|NCT02437890|523859302|FG001|Overall Study|Lack of Efficacy|3|||
145275882|NCT02437890|523859303|FG002|Overall Study|Lack of Efficacy|0|||
145275883|NCT02437890|523859304|FG003|Overall Study|Lack of Efficacy|3|||
145275884|NCT02437890|523859305|FG004|Overall Study|Lack of Efficacy|1|||
145275885|NCT02437890|523859301|FG000|Overall Study|Adverse Event|4|||
145275886|NCT02437890|523859302|FG001|Overall Study|Adverse Event|9|||
145275887|NCT02437890|523859303|FG002|Overall Study|Adverse Event|5|||
145275888|NCT02437890|523859304|FG003|Overall Study|Adverse Event|11|||
145275889|NCT02437890|523859305|FG004|Overall Study|Adverse Event|7|||
145275890|NCT02437890|523859301|FG000|Overall Study|Withdrawal by Subject|1|||
145275891|NCT02437890|523859302|FG001|Overall Study|Withdrawal by Subject|2|||
145275892|NCT02437890|523859303|FG002|Overall Study|Withdrawal by Subject|6|||
145275893|NCT02437890|523859304|FG003|Overall Study|Withdrawal by Subject|5|||
145275894|NCT02437890|523859305|FG004|Overall Study|Withdrawal by Subject|5|||
145275895|NCT02437890|523859301|FG000|Overall Study|Death|0|||
145275896|NCT02437890|523859302|FG001|Overall Study|Death|0|||
145275897|NCT02437890|523859303|FG002|Overall Study|Death|0|||
145275898|NCT02437890|523859304|FG003|Overall Study|Death|2|||
145275899|NCT02437890|523859305|FG004|Overall Study|Death|0|||
145275900|NCT00344305|523859306|FG000|Overall Study|Lost to Follow-up|2|||
145275901|NCT00344305|523859307|FG001|Overall Study|Lost to Follow-up|0|||
145275902|NCT00344305|523859306|FG000|Overall Study|Participant was not contacted in window|0|||
145275903|NCT00344305|523859307|FG001|Overall Study|Participant was not contacted in window|1|||
145275904|NCT01190098|523859308|FG000|Overall Study|Adverse Event|2|||
145275905|NCT01190098|523859309|FG001|Overall Study|Adverse Event|0|||
145275906|NCT01190098|523859308|FG000|Overall Study|Patient coomorbidity|0|||
145275907|NCT01190098|523859309|FG001|Overall Study|Patient coomorbidity|1|||
145275908|NCT01190098|523859308|FG000|Overall Study|Lack of transportation|1|||
145275909|NCT01190098|523859309|FG001|Overall Study|Lack of transportation|0|||
145275910|NCT01190098|523859308|FG000|Overall Study|Other|0|||
145275911|NCT01190098|523859309|FG001|Overall Study|Other|1|||
145275912|NCT04723173|523859314|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
145275913|NCT02996448|523859315|FG000|Overall Study|Study terminated due to adverse effects|3|||
145275914|NCT01160198|523859316|FG000|Overall Study|Withdrawal by Subject|2|||
145275915|NCT01160198|523859317|FG001|Overall Study|Withdrawal by Subject|1|||
145275916|NCT01160198|523859318|FG002|Overall Study|Withdrawal by Subject|0|||
145275917|NCT01160198|523859316|FG000|Overall Study|Adverse Event|0|||
145275918|NCT01160198|523859317|FG001|Overall Study|Adverse Event|1|||
145402910|NCT02065557|524332547|FG003|Maintenance Period|Lack of Efficacy|0|||
145402911|NCT02065557|524332548|FG004|Maintenance Period|Lack of Efficacy|5|||
145275919|NCT01160198|523859318|FG002|Overall Study|Adverse Event|0|||
145275920|NCT01160198|523859316|FG000|Overall Study|Lost to Follow-up|0|||
145275921|NCT01160198|523859317|FG001|Overall Study|Lost to Follow-up|1|||
145275922|NCT01160198|523859318|FG002|Overall Study|Lost to Follow-up|0|||
145292755|NCT06179108|523922228|FG002|Overall Study|Adverse Event|3|||
145760723|NCT00400400|525636530|FG001|Overall Study|Withdrawal by Subject|3|||
145760724|NCT00400400|525636529|FG000|Overall Study|Administrative Problem|1|||
145760725|NCT00400400|525636530|FG001|Overall Study|Administrative Problem|0|||
145760726|NCT00400400|525636529|FG000|Overall Study|Lost to Follow-up|0|||
145760727|NCT00400400|525636530|FG001|Overall Study|Lost to Follow-up|1|||
145760728|NCT00400400|525636529|FG000|Overall Study|Did not receive study drug|1|||
145760729|NCT00400400|525636530|FG001|Overall Study|Did not receive study drug|3|||
145760730|NCT00648167|525636531|FG000|Overall Study|Adverse Event|6|||
145760731|NCT00648167|525636531|FG000|Overall Study|unable to swallow tablets|1|||
145760732|NCT01688050|525636532|FG000|Overall Study|Death|7|||
145760733|NCT01688050|525636532|FG000|Overall Study|Conversion to open repair|1|||
145760734|NCT01688050|525636532|FG000|Overall Study|Lost to Follow-up|13|||
145760735|NCT01688050|525636532|FG000|Overall Study|Withdrawal by Subject|10|||
145607771|NCT03238300|525079259|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
145607772|NCT03238300|525079258|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
145275923|NCT01160198|523859316|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
145607773|NCT03238300|525079259|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
145607774|NCT03238300|525079258|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
145607775|NCT03238300|525079259|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
145607776|NCT01435655|525079262|FG000|Overall Study|Death|2|||
145607777|NCT01435655|525079262|FG000|Overall Study|Other|1|||
145607778|NCT01436201|525079264|FG000|Overall Study|Adverse Event|2|||
145607779|NCT01436201|525079264|FG000|Overall Study|Withdrawal by Subject|1|||
145607780|NCT01436201|525079264|FG000|Overall Study|Protocol Violation|1|||
145607781|NCT00110890|525079265|FG000|Overall Study|Adverse Event|30|||
145607782|NCT00110890|525079266|FG001|Overall Study|Adverse Event|7|||
145607783|NCT00110890|525079265|FG000|Overall Study|Death|16|||
145607784|NCT00110890|525079266|FG001|Overall Study|Death|9|||
145607785|NCT00110890|525079265|FG000|Overall Study|Lost to Follow-up|3|||
145607786|NCT00110890|525079266|FG001|Overall Study|Lost to Follow-up|1|||
145607787|NCT00110890|525079265|FG000|Overall Study|Physician Decision|4|||
145607788|NCT00110890|525079266|FG001|Overall Study|Physician Decision|5|||
145607789|NCT00110890|525079265|FG000|Overall Study|Withdrawal by Subject|17|||
145607790|NCT00110890|525079266|FG001|Overall Study|Withdrawal by Subject|5|||
145607791|NCT00110890|525079265|FG000|Overall Study|Protocol Deviation|1|||
145607792|NCT00110890|525079266|FG001|Overall Study|Protocol Deviation|0|||
145607793|NCT00110890|525079265|FG000|Overall Study|Noncompliance|10|||
145607794|NCT00110890|525079266|FG001|Overall Study|Noncompliance|0|||
145607795|NCT00110890|525079265|FG000|Overall Study|Kidney Transplant|16|||
145607796|NCT00110890|525079266|FG001|Overall Study|Kidney Transplant|12|||
145607797|NCT00110890|525079265|FG000|Overall Study|Invest. Product Commercially Available|217|||
145607798|NCT00110890|525079266|FG001|Overall Study|Invest. Product Commercially Available|110|||
145607799|NCT00110890|525079265|FG000|Overall Study|Other|34|||
145607800|NCT00110890|525079266|FG001|Overall Study|Other|23|||
145607801|NCT00110890|525079265|FG000|Overall Study|Ineligibility determined|3|||
145607802|NCT00110890|525079266|FG001|Overall Study|Ineligibility determined|0|||
145607803|NCT00110890|525079265|FG000|Overall Study|Requirement for alternative therapy|0|||
145607804|NCT00110890|525079266|FG001|Overall Study|Requirement for alternative therapy|1|||
145607805|NCT00110890|525079265|FG000|Overall Study|Disease progression|0|||
145607806|NCT00110890|525079266|FG001|Overall Study|Disease progression|1|||
145607807|NCT00110890|525079265|FG000|Overall Study|Parathyroidectomy|0|||
145607808|NCT00110890|525079266|FG001|Overall Study|Parathyroidectomy|1|||
145607809|NCT00110890|525079265|FG000|Overall Study|Did not enter follow-up phase|10|||
145607810|NCT00110890|525079266|FG001|Overall Study|Did not enter follow-up phase|4|||
145607811|NCT01686581|525079267|FG000|Overall Study|Side-effects or Health Problems|15|||
145607812|NCT01686581|525079267|FG000|Overall Study|Lack of Efficacy|90|||
145607813|NCT01686581|525079267|FG000|Overall Study|Participant Concerned about Risks|6|||
145607814|NCT01686581|525079267|FG000|Overall Study|Thinks Injections Too Painful|8|||
145607815|NCT01686581|525079267|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
145607816|NCT01686581|525079267|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
145607817|NCT01686581|525079267|FG000|Overall Study|Thinks it is Inconvenient|17|||
145607818|NCT01686581|525079267|FG000|Overall Study|Other Miscellaneous Reasons|36|||
145607819|NCT01686581|525079267|FG000|Overall Study|Reason Missing|1|||
145275924|NCT01160198|523859317|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
145275925|NCT01160198|523859318|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
145275926|NCT00563524|523859320|FG000|Overall Study|Adverse Event|0|||
145275927|NCT00563524|523859321|FG001|Overall Study|Adverse Event|1|||
145275928|NCT00563524|523859322|FG002|Overall Study|Adverse Event|0|||
145275929|NCT00563524|523859323|FG003|Overall Study|Adverse Event|0|||
145275930|NCT00563524|523859324|FG004|Overall Study|Adverse Event|2|||
145275931|NCT00563524|523859325|FG005|Overall Study|Adverse Event|0|||
145275932|NCT00563524|523859320|FG000|Overall Study|Lost to Follow-up|1|||
145275933|NCT00563524|523859321|FG001|Overall Study|Lost to Follow-up|0|||
145275934|NCT00563524|523859322|FG002|Overall Study|Lost to Follow-up|0|||
145607820|NCT01975220|525079268|FG000|Test Period 1|Not treated|0|||
145607821|NCT01975220|525079269|FG001|Test Period 1|Not treated|1|||
145607822|NCT01975220|525079270|FG002|Test Period 1|Not treated|0|||
145607823|NCT01975220|525079271|FG003|Test Period 1|Not treated|0|||
145607824|NCT01975220|525079272|FG004|Test Period 1|Not treated|0|||
145607825|NCT01975220|525079273|FG005|Test Period 1|Not treated|0|||
145607826|NCT02839343|525079274|FG000|Overall Study|Withdrawal by Subject|3|||
145275935|NCT00563524|523859323|FG003|Overall Study|Lost to Follow-up|0|||
145607827|NCT02839343|525079275|FG001|Overall Study|Withdrawal by Subject|1|||
145275936|NCT00563524|523859324|FG004|Overall Study|Lost to Follow-up|0|||
145275937|NCT00563524|523859325|FG005|Overall Study|Lost to Follow-up|0|||
145402912|NCT02065557|524332549|FG005|Maintenance Period|Lack of Efficacy|2|||
145607828|NCT02839343|525079274|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
145607829|NCT02839343|525079275|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
145607830|NCT02839343|525079274|FG000|Overall Study|Adverse Event|1|||
145607831|NCT02839343|525079275|FG001|Overall Study|Adverse Event|0|||
145760736|NCT01554579|525636533|FG000|Overall Study|Adverse Event|6|||
145760737|NCT01554579|525636534|FG001|Overall Study|Adverse Event|25|||
145760738|NCT01554579|525636533|FG000|Overall Study|Lack of Efficacy|2|||
145760739|NCT01554579|525636534|FG001|Overall Study|Lack of Efficacy|1|||
145760740|NCT01554579|525636533|FG000|Overall Study|Withdrawal by Subject|2|||
145760741|NCT01554579|525636534|FG001|Overall Study|Withdrawal by Subject|1|||
145760742|NCT00234039|525636535|FG000|Overall Study|Adverse Event|2|||
145760743|NCT00234039|525636535|FG000|Overall Study|Progression/relapse|34|||
145760744|NCT00234039|525636535|FG000|Overall Study|Other - Not Protocol Specified|3|||
145760745|NCT00234039|525636535|FG000|Overall Study|Ineligible|9|||
145760746|NCT00234039|525636535|FG000|Overall Study|No Protocol Treatment Received|2|||
145760747|NCT00110019|525636536|FG000|Overall Study|Lack of Efficacy|253|||
145760748|NCT00110019|525636537|FG001|Overall Study|Lack of Efficacy|285|||
145760749|NCT00110019|525636536|FG000|Overall Study|Adverse Event|61|||
145760750|NCT00110019|525636537|FG001|Overall Study|Adverse Event|40|||
145760751|NCT00110019|525636536|FG000|Overall Study|Death|13|||
145760752|NCT00110019|525636537|FG001|Overall Study|Death|15|||
145760753|NCT00110019|525636536|FG000|Overall Study|Withdrawal by Subject|21|||
145760754|NCT00110019|525636537|FG001|Overall Study|Withdrawal by Subject|9|||
145760755|NCT00110019|525636536|FG000|Overall Study|alternative therapy|5|||
145760756|NCT00110019|525636537|FG001|Overall Study|alternative therapy|1|||
145760757|NCT00110019|525636536|FG000|Overall Study|complicating disease|1|||
145760758|NCT00110019|525636537|FG001|Overall Study|complicating disease|1|||
145760759|NCT00110019|525636536|FG000|Overall Study|symptom deterioration|13|||
145760760|NCT00110019|525636537|FG001|Overall Study|symptom deterioration|16|||
145760761|NCT00110019|525636536|FG000|Overall Study|Not start protocol therapy|17|||
145760762|NCT00110019|525636537|FG001|Overall Study|Not start protocol therapy|16|||
145760763|NCT00110019|525636536|FG000|Overall Study|other reasons|22|||
145760764|NCT00110019|525636537|FG001|Overall Study|other reasons|30|||
145760765|NCT02239263|525636540|FG000|Overall Study|Protocol Violation|6|||
145760766|NCT01046695|525636541|FG000|Overall Study|Subject had a pacemaker|0|||
145760767|NCT01046695|525636542|FG001|Overall Study|Subject had a pacemaker|1|||
145760768|NCT01046695|525636541|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
145760769|NCT01046695|525636542|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
145760770|NCT04426695|525636543|FG000|Overall Study|Death|2|||
145760771|NCT04426695|525636544|FG001|Overall Study|Death|0|||
145760772|NCT04426695|525636545|FG002|Overall Study|Death|1|||
145760773|NCT04426695|525636546|FG003|Overall Study|Death|27|||
145760774|NCT04426695|525636547|FG004|Overall Study|Death|25|||
145760775|NCT04426695|525636548|FG005|Overall Study|Death|21|||
145760776|NCT04426695|525636549|FG006|Overall Study|Death|42|||
145760777|NCT04426695|525636550|FG007|Overall Study|Death|23|||
145760778|NCT04426695|525636551|FG008|Overall Study|Death|37|||
145760779|NCT04426695|525636552|FG009|Overall Study|Death|14|||
145760780|NCT04426695|525636553|FG010|Overall Study|Death|8|||
145760781|NCT04426695|525636554|FG011|Overall Study|Death|7|||
145760782|NCT04426695|525636555|FG012|Overall Study|Death|13|||
145760783|NCT04426695|525636556|FG013|Overall Study|Death|25|||
145760784|NCT04426695|525636557|FG014|Overall Study|Death|19|||
145760785|NCT04426695|525636558|FG015|Overall Study|Death|7|||
145760786|NCT04426695|525636559|FG016|Overall Study|Death|8|||
145760787|NCT04426695|525636560|FG017|Overall Study|Death|4|||
145760788|NCT04426695|525636543|FG000|Overall Study|Lost to Follow-up|2|||
145760789|NCT04426695|525636544|FG001|Overall Study|Lost to Follow-up|4|||
145760790|NCT04426695|525636545|FG002|Overall Study|Lost to Follow-up|1|||
145760791|NCT04426695|525636546|FG003|Overall Study|Lost to Follow-up|19|||
145760792|NCT04426695|525636547|FG004|Overall Study|Lost to Follow-up|10|||
145760793|NCT04426695|525636548|FG005|Overall Study|Lost to Follow-up|14|||
145760794|NCT04426695|525636549|FG006|Overall Study|Lost to Follow-up|5|||
145760795|NCT04426695|525636550|FG007|Overall Study|Lost to Follow-up|14|||
145760796|NCT04426695|525636551|FG008|Overall Study|Lost to Follow-up|10|||
145760797|NCT04426695|525636552|FG009|Overall Study|Lost to Follow-up|11|||
145760798|NCT04426695|525636553|FG010|Overall Study|Lost to Follow-up|12|||
145760799|NCT04426695|525636554|FG011|Overall Study|Lost to Follow-up|6|||
145760800|NCT04426695|525636555|FG012|Overall Study|Lost to Follow-up|2|||
145760801|NCT04426695|525636556|FG013|Overall Study|Lost to Follow-up|2|||
145760802|NCT04426695|525636557|FG014|Overall Study|Lost to Follow-up|2|||
145760803|NCT04426695|525636558|FG015|Overall Study|Lost to Follow-up|0|||
145760804|NCT04426695|525636559|FG016|Overall Study|Lost to Follow-up|0|||
145760805|NCT04426695|525636560|FG017|Overall Study|Lost to Follow-up|0|||
145760806|NCT04426695|525636543|FG000|Overall Study|Participant Decision|1|||
145760807|NCT04426695|525636544|FG001|Overall Study|Participant Decision|2|||
145760808|NCT04426695|525636545|FG002|Overall Study|Participant Decision|2|||
145760809|NCT04426695|525636546|FG003|Overall Study|Participant Decision|12|||
145760810|NCT04426695|525636547|FG004|Overall Study|Participant Decision|18|||
145760811|NCT04426695|525636548|FG005|Overall Study|Participant Decision|22|||
145760812|NCT04426695|525636549|FG006|Overall Study|Participant Decision|13|||
145760813|NCT04426695|525636550|FG007|Overall Study|Participant Decision|13|||
145760814|NCT04426695|525636551|FG008|Overall Study|Participant Decision|10|||
145760815|NCT04426695|525636552|FG009|Overall Study|Participant Decision|15|||
145760816|NCT04426695|525636553|FG010|Overall Study|Participant Decision|16|||
145760817|NCT04426695|525636554|FG011|Overall Study|Participant Decision|17|||
145760818|NCT04426695|525636555|FG012|Overall Study|Participant Decision|2|||
145760819|NCT04426695|525636556|FG013|Overall Study|Participant Decision|1|||
145760820|NCT04426695|525636557|FG014|Overall Study|Participant Decision|2|||
145760821|NCT04426695|525636558|FG015|Overall Study|Participant Decision|0|||
145760822|NCT04426695|525636559|FG016|Overall Study|Participant Decision|0|||
145760823|NCT04426695|525636560|FG017|Overall Study|Participant Decision|0|||
145760824|NCT04426695|525636543|FG000|Overall Study|Adverse Event|0|||
145760825|NCT04426695|525636544|FG001|Overall Study|Adverse Event|0|||
145760826|NCT04426695|525636545|FG002|Overall Study|Adverse Event|0|||
145760827|NCT04426695|525636546|FG003|Overall Study|Adverse Event|0|||
145760828|NCT04426695|525636547|FG004|Overall Study|Adverse Event|0|||
145760829|NCT04426695|525636548|FG005|Overall Study|Adverse Event|0|||
145760830|NCT04426695|525636549|FG006|Overall Study|Adverse Event|0|||
145760831|NCT04426695|525636550|FG007|Overall Study|Adverse Event|1|||
145760832|NCT04426695|525636551|FG008|Overall Study|Adverse Event|0|||
145760833|NCT04426695|525636552|FG009|Overall Study|Adverse Event|0|||
145760834|NCT04426695|525636553|FG010|Overall Study|Adverse Event|1|||
145760835|NCT04426695|525636554|FG011|Overall Study|Adverse Event|1|||
145760836|NCT04426695|525636555|FG012|Overall Study|Adverse Event|0|||
145760837|NCT04426695|525636556|FG013|Overall Study|Adverse Event|0|||
145760838|NCT04426695|525636557|FG014|Overall Study|Adverse Event|0|||
145760839|NCT04426695|525636558|FG015|Overall Study|Adverse Event|0|||
145760840|NCT04426695|525636559|FG016|Overall Study|Adverse Event|0|||
145760841|NCT04426695|525636560|FG017|Overall Study|Adverse Event|0|||
145760842|NCT04426695|525636543|FG000|Overall Study|Sponsor Request|0|||
145760843|NCT04426695|525636544|FG001|Overall Study|Sponsor Request|0|||
145760844|NCT04426695|525636545|FG002|Overall Study|Sponsor Request|0|||
145760845|NCT04426695|525636546|FG003|Overall Study|Sponsor Request|0|||
145760846|NCT04426695|525636547|FG004|Overall Study|Sponsor Request|0|||
145760847|NCT04426695|525636548|FG005|Overall Study|Sponsor Request|0|||
145760848|NCT04426695|525636549|FG006|Overall Study|Sponsor Request|1|||
145760849|NCT04426695|525636550|FG007|Overall Study|Sponsor Request|0|||
145760850|NCT04426695|525636551|FG008|Overall Study|Sponsor Request|0|||
145760851|NCT04426695|525636552|FG009|Overall Study|Sponsor Request|0|||
145760852|NCT04426695|525636553|FG010|Overall Study|Sponsor Request|0|||
145760853|NCT04426695|525636554|FG011|Overall Study|Sponsor Request|0|||
145760854|NCT04426695|525636555|FG012|Overall Study|Sponsor Request|0|||
145760855|NCT04426695|525636556|FG013|Overall Study|Sponsor Request|0|||
145760856|NCT04426695|525636557|FG014|Overall Study|Sponsor Request|0|||
145760857|NCT04426695|525636558|FG015|Overall Study|Sponsor Request|0|||
145760858|NCT04426695|525636559|FG016|Overall Study|Sponsor Request|0|||
145760859|NCT04426695|525636560|FG017|Overall Study|Sponsor Request|0|||
145760860|NCT04426695|525636543|FG000|Overall Study|Physician Decision|0|||
145275938|NCT00563524|523859320|FG000|Overall Study|Protocol Violation|0|||
145275939|NCT00563524|523859321|FG001|Overall Study|Protocol Violation|1|||
145275940|NCT00563524|523859322|FG002|Overall Study|Protocol Violation|0|||
145275941|NCT00563524|523859323|FG003|Overall Study|Protocol Violation|0|||
145275942|NCT00563524|523859324|FG004|Overall Study|Protocol Violation|0|||
145275943|NCT00563524|523859325|FG005|Overall Study|Protocol Violation|0|||
145275944|NCT00563524|523859320|FG000|Overall Study|Withdrawal by Subject|1|||
145275945|NCT00563524|523859321|FG001|Overall Study|Withdrawal by Subject|1|||
145275946|NCT00563524|523859322|FG002|Overall Study|Withdrawal by Subject|3|||
145275947|NCT00563524|523859323|FG003|Overall Study|Withdrawal by Subject|0|||
145275948|NCT00563524|523859324|FG004|Overall Study|Withdrawal by Subject|0|||
145275949|NCT00563524|523859325|FG005|Overall Study|Withdrawal by Subject|1|||
145275950|NCT03543046|523859331|FG000|Overall Study|Adverse Event|1|||
145275951|NCT03543046|523859332|FG001|Overall Study|Adverse Event|1|||
145275952|NCT03543046|523859331|FG000|Overall Study|Physician Decision|1|||
145275953|NCT03543046|523859332|FG001|Overall Study|Physician Decision|1|||
145275954|NCT03543046|523859331|FG000|Overall Study|Protocol Violation|1|||
145275955|NCT03543046|523859332|FG001|Overall Study|Protocol Violation|0|||
145275956|NCT00520494|523859342|FG000|Overall Study|Withdrawal by Subject|1|||
145275957|NCT04247594|523859343|FG000|Overall Study|Withdrawal by Subject|4|||
145275958|NCT02748616|523859347|FG000|Overall Study|Lost to Follow-up|1|||
145275959|NCT02748616|523859347|FG000|Overall Study|Withdrawal by Subject|2|||
145275960|NCT02748616|523859347|FG000|Overall Study|Physician Decision|2|||
145275961|NCT02748616|523859347|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
145275962|NCT01875991|523859351|FG000|Overall Study|Withdrawal by Subject|6|||
145275963|NCT01875991|523859352|FG001|Overall Study|Withdrawal by Subject|6|||
145275964|NCT01875991|523859351|FG000|Overall Study|Sponsor Decision|1|||
145275965|NCT01875991|523859352|FG001|Overall Study|Sponsor Decision|0|||
145275966|NCT05354206|523859353|FG000|Overall Study|Withdrawal by Subject|1|||
145275967|NCT05354206|523859354|FG001|Overall Study|Withdrawal by Subject|0|||
145275968|NCT04936334|523859355|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
145275969|NCT00422058|523859356|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
145275970|NCT00422058|523859357|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
145275971|NCT00422058|523859358|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
145275972|NCT00422058|523859359|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
145275973|NCT00422058|523859360|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
145275974|NCT00422058|523859361|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
145275975|NCT00422058|523859356|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
145275976|NCT00422058|523859357|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
145275977|NCT00422058|523859358|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
145275978|NCT00422058|523859359|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
145275979|NCT00422058|523859360|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
145275980|NCT00422058|523859361|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
145275981|NCT00422058|523859356|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
145275982|NCT00422058|523859357|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
145275983|NCT00422058|523859358|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
145275984|NCT00422058|523859359|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
145275985|NCT00422058|523859360|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
145275986|NCT00422058|523859361|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
145275987|NCT00422058|523859356|FG000|Double-Blind, Week 0-20|Other|11|||
145275988|NCT00422058|523859357|FG001|Double-Blind, Week 0-20|Other|3|||
145275989|NCT00422058|523859358|FG002|Double-Blind, Week 0-20|Other|8|||
145275990|NCT00422058|523859359|FG003|Double-Blind, Week 0-20|Other|8|||
145275991|NCT00422058|523859360|FG004|Double-Blind, Week 0-20|Other|4|||
145275992|NCT00422058|523859361|FG005|Double-Blind, Week 0-20|Other|10|||
145275993|NCT00422058|523859356|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
145275994|NCT00422058|523859357|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
145275995|NCT00422058|523859358|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
145275996|NCT00422058|523859359|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
145275997|NCT00422058|523859360|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
145275998|NCT00422058|523859361|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
145275999|NCT00422058|523859356|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
145276000|NCT00422058|523859357|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
145276001|NCT00422058|523859358|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
145276002|NCT00422058|523859359|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
145276003|NCT00422058|523859360|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
145276004|NCT00422058|523859361|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
145276005|NCT00422058|523859356|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
145276006|NCT00422058|523859357|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
145276007|NCT00422058|523859358|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
145276008|NCT00422058|523859359|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
145276009|NCT00422058|523859360|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
145276010|NCT00422058|523859361|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
145760861|NCT04426695|525636544|FG001|Overall Study|Physician Decision|0|||
145760862|NCT04426695|525636545|FG002|Overall Study|Physician Decision|0|||
145760863|NCT04426695|525636546|FG003|Overall Study|Physician Decision|0|||
145760864|NCT04426695|525636547|FG004|Overall Study|Physician Decision|0|||
145760865|NCT04426695|525636548|FG005|Overall Study|Physician Decision|0|||
145760866|NCT04426695|525636549|FG006|Overall Study|Physician Decision|0|||
145760867|NCT04426695|525636550|FG007|Overall Study|Physician Decision|0|||
145760868|NCT04426695|525636551|FG008|Overall Study|Physician Decision|0|||
145760869|NCT04426695|525636552|FG009|Overall Study|Physician Decision|1|||
145760870|NCT04426695|525636553|FG010|Overall Study|Physician Decision|0|||
145760871|NCT04426695|525636554|FG011|Overall Study|Physician Decision|0|||
145760872|NCT04426695|525636555|FG012|Overall Study|Physician Decision|1|||
145760873|NCT04426695|525636556|FG013|Overall Study|Physician Decision|0|||
145760874|NCT04426695|525636557|FG014|Overall Study|Physician Decision|0|||
145760875|NCT04426695|525636558|FG015|Overall Study|Physician Decision|0|||
145760876|NCT04426695|525636559|FG016|Overall Study|Physician Decision|0|||
145760877|NCT04426695|525636560|FG017|Overall Study|Physician Decision|0|||
145760878|NCT04426695|525636543|FG000|Overall Study|Randomized but Never Treated|3|||
145760879|NCT04426695|525636544|FG001|Overall Study|Randomized but Never Treated|1|||
145760880|NCT04426695|525636545|FG002|Overall Study|Randomized but Never Treated|0|||
145760881|NCT04426695|525636546|FG003|Overall Study|Randomized but Never Treated|4|||
145760882|NCT04426695|525636547|FG004|Overall Study|Randomized but Never Treated|5|||
145760883|NCT04426695|525636548|FG005|Overall Study|Randomized but Never Treated|5|||
145760884|NCT04426695|525636549|FG006|Overall Study|Randomized but Never Treated|4|||
145760885|NCT04426695|525636550|FG007|Overall Study|Randomized but Never Treated|6|||
145760886|NCT04426695|525636551|FG008|Overall Study|Randomized but Never Treated|6|||
145760887|NCT04426695|525636552|FG009|Overall Study|Randomized but Never Treated|3|||
145760888|NCT04426695|525636553|FG010|Overall Study|Randomized but Never Treated|3|||
145760889|NCT04426695|525636554|FG011|Overall Study|Randomized but Never Treated|6|||
145760890|NCT04426695|525636555|FG012|Overall Study|Randomized but Never Treated|1|||
145760891|NCT04426695|525636556|FG013|Overall Study|Randomized but Never Treated|2|||
145760892|NCT04426695|525636557|FG014|Overall Study|Randomized but Never Treated|0|||
145760893|NCT04426695|525636558|FG015|Overall Study|Randomized but Never Treated|0|||
145760894|NCT04426695|525636559|FG016|Overall Study|Randomized but Never Treated|0|||
145760895|NCT04426695|525636560|FG017|Overall Study|Randomized but Never Treated|0|||
145760896|NCT04303000|525636561|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
145760897|NCT04303000|525636562|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
145760898|NCT04303000|525636563|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
145760899|NCT04276207|525636565|FG000|Period 1|Withdrawal by Subject|0|||
145760900|NCT04276207|525636566|FG001|Period 1|Withdrawal by Subject|1|||
145760901|NCT05655377|525636567|FG000|Overall Study|Withdrawal by Subject|2|||
145760902|NCT01256177|525636568|FG000|Overall Study|Withdrawal by Subject|23|||
145760903|NCT01256177|525636569|FG001|Overall Study|Withdrawal by Subject|22|||
145760904|NCT01256177|525636568|FG000|Overall Study|Lost to Follow-up|2|||
145760905|NCT01256177|525636569|FG001|Overall Study|Lost to Follow-up|2|||
145760906|NCT01256177|525636568|FG000|Overall Study|Adverse Event|8|||
145760907|NCT01256177|525636569|FG001|Overall Study|Adverse Event|9|||
145760908|NCT01256177|525636568|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
145760909|NCT01256177|525636569|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
145760910|NCT01256177|525636568|FG000|Overall Study|Condition under Investigation Worsened|1|||
145760911|NCT01256177|525636569|FG001|Overall Study|Condition under Investigation Worsened|0|||
145760912|NCT01256177|525636568|FG000|Overall Study|Lack of Efficacy|11|||
145760913|NCT01256177|525636569|FG001|Overall Study|Lack of Efficacy|2|||
145760914|NCT01256177|525636568|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
145760915|NCT01256177|525636569|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
145760916|NCT00849667|525636582|FG000|Overall Study|Withdrawal by Subject|16|||
145760917|NCT00849667|525636583|FG001|Overall Study|Withdrawal by Subject|33|||
145760918|NCT00849667|525636584|FG002|Overall Study|Withdrawal by Subject|35|||
145760919|NCT00849667|525636582|FG000|Overall Study|Lost to Follow-up|8|||
145760920|NCT00849667|525636583|FG001|Overall Study|Lost to Follow-up|8|||
145760921|NCT00849667|525636584|FG002|Overall Study|Lost to Follow-up|8|||
145760922|NCT00849667|525636582|FG000|Overall Study|Adverse Event|1|||
145760923|NCT00849667|525636583|FG001|Overall Study|Adverse Event|2|||
145760924|NCT00849667|525636584|FG002|Overall Study|Adverse Event|0|||
145760925|NCT00849667|525636582|FG000|Overall Study|Other|18|||
145760926|NCT00849667|525636583|FG001|Overall Study|Other|19|||
145760927|NCT00849667|525636584|FG002|Overall Study|Other|18|||
145760928|NCT00849667|525636582|FG000|Overall Study|Progressive disease|119|||
145533421|NCT01436396|524813448|FG001|Overall Study|Withdrawal by Subject|29|||
145760929|NCT00849667|525636583|FG001|Overall Study|Progressive disease|100|||
145760930|NCT00849667|525636584|FG002|Overall Study|Progressive disease|112|||
145760931|NCT00849667|525636582|FG000|Overall Study|Sponsor decision|208|||
145760932|NCT00849667|525636583|FG001|Overall Study|Sponsor decision|204|||
145760933|NCT00849667|525636584|FG002|Overall Study|Sponsor decision|190|||
145760934|NCT00849667|525636582|FG000|Overall Study|Investigator discretion|0|||
145760935|NCT00849667|525636583|FG001|Overall Study|Investigator discretion|0|||
145760936|NCT00849667|525636584|FG002|Overall Study|Investigator discretion|1|||
145760937|NCT00553462|525636585|FG000|Overall Study|Adverse Event|4|||
145760938|NCT00553462|525636585|FG000|Overall Study|Progression|4|||
145760939|NCT00553462|525636585|FG000|Overall Study|Withdrawal by Subject|5|||
145760940|NCT00553462|525636585|FG000|Overall Study|Physician Decision|1|||
145760941|NCT01262625|525636588|FG000|Overall Study|Administrative Error|1|||
145760942|NCT01262625|525636589|FG001|Overall Study|Administrative Error|1|||
145760943|NCT01262625|525636588|FG000|Overall Study|Site Closed|1|||
145760944|NCT01262625|525636589|FG001|Overall Study|Site Closed|0|||
145760945|NCT01869348|525636590|FG000|Overall Study|Withdrawal by Subject|1|||
145760946|NCT01869348|525636591|FG001|Overall Study|Withdrawal by Subject|1|||
145760947|NCT02789657|525636593|FG000|Overall Study|Withdrawal by Subject|2|||
145760948|NCT02789657|525636594|FG001|Overall Study|Withdrawal by Subject|0|||
145760949|NCT02789657|525636595|FG002|Overall Study|Withdrawal by Subject|0|||
145760950|NCT02789657|525636596|FG003|Overall Study|Withdrawal by Subject|0|||
145760951|NCT03075163|525636597|FG000|Overall Study|not eligible for treatment limb|138|||
145760952|NCT03075163|525636598|FG001|Overall Study|not eligible for treatment limb|138|||
145760953|NCT04398732|525636599|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
145760954|NCT03882424|525636600|FG000|Overall Study|Lost to Follow-up|3|||
145760955|NCT03882424|525636601|FG001|Overall Study|Lost to Follow-up|0|||
145760956|NCT03882424|525636602|FG002|Overall Study|Lost to Follow-up|0|||
145760957|NCT03882424|525636600|FG000|Overall Study|schedule conflict|1|||
145760958|NCT03882424|525636601|FG001|Overall Study|schedule conflict|0|||
145760959|NCT03882424|525636602|FG002|Overall Study|schedule conflict|0|||
145760960|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Adverse Event|21|||
145760961|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Adverse Event|6|||
145760962|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
145760963|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
145760964|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
145760965|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
145760966|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
145760967|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
145760968|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Physician Decision|0|||
145760969|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Physician Decision|3|||
145760970|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
145760971|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
145760972|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
145760973|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
145760974|NCT00510276|525636611|FG000|Acute Double-Blind Phase|Subject Decision|26|||
145760975|NCT00510276|525636612|FG001|Acute Double-Blind Phase|Subject Decision|28|||
145760976|NCT00510276|525636611|FG000|Extension Open-Label Phase|Adverse Event|9|||
145760977|NCT00510276|525636612|FG001|Extension Open-Label Phase|Adverse Event|18|||
145760978|NCT00510276|525636611|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
145760979|NCT00510276|525636612|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
145760980|NCT00510276|525636611|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
145760981|NCT00510276|525636612|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
145760982|NCT00510276|525636611|FG000|Extension Open-Label Phase|Physician Decision|2|||
145760983|NCT00510276|525636612|FG001|Extension Open-Label Phase|Physician Decision|3|||
145760984|NCT00510276|525636611|FG000|Extension Open-Label Phase|Protocol Violation|0|||
145760985|NCT00510276|525636612|FG001|Extension Open-Label Phase|Protocol Violation|1|||
145760986|NCT00510276|525636611|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
145760987|NCT00510276|525636612|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
145760988|NCT00510276|525636611|FG000|Extension Open-Label Phase|Subject Decision|7|||
145760989|NCT00510276|525636612|FG001|Extension Open-Label Phase|Subject Decision|9|||
145760990|NCT01500057|525636613|FG000|Overall Study|Lost to Follow-up|6|||
145760991|NCT01500057|525636614|FG001|Overall Study|Lost to Follow-up|4|||
145760992|NCT01318122|525636622|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145760993|NCT01318122|525636623|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145760994|NCT01318122|525636624|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
145760995|NCT01318122|525636625|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
145760996|NCT01318122|525636622|FG000|Enrolled - Long-Term Extension Study|Other|1|||
145760997|NCT01318122|525636623|FG001|Enrolled - Long-Term Extension Study|Other|0|||
145760998|NCT01318122|525636624|FG002|Enrolled - Long-Term Extension Study|Other|0|||
145760999|NCT01318122|525636625|FG003|Enrolled - Long-Term Extension Study|Other|0|||
145761000|NCT01318122|525636622|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
145761001|NCT01318122|525636623|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
145761002|NCT01318122|525636624|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
145761003|NCT01318122|525636625|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
145761004|NCT01318122|525636622|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
145607832|NCT01852058|525079276|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
145761005|NCT01318122|525636623|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145761006|NCT01318122|525636624|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145761007|NCT01318122|525636625|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145761008|NCT01318122|525636622|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145761009|NCT01318122|525636623|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
145761010|NCT01318122|525636624|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145761011|NCT01318122|525636625|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145761012|NCT01318122|525636622|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145761013|NCT01318122|525636623|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
145761014|NCT01318122|525636624|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
145761015|NCT01318122|525636625|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145761016|NCT04897867|525636626|FG000|Overall Study|Withdrawal of Consent|1|||
145761017|NCT04897867|525636626|FG000|Overall Study|Pregnancy|1|||
145761018|NCT04897867|525636626|FG000|Overall Study|Lost to Follow-up|7|||
145761019|NCT04897867|525636626|FG000|Overall Study|Reason not Specified|2|||
145761020|NCT00508391|525636627|FG000|First Treatment|Withdrawal by Subject|6|||
145761021|NCT00508391|525636628|FG001|First Treatment|Withdrawal by Subject|3|||
145761022|NCT00508391|525636627|FG000|Second Treatment|Withdrawal by Subject|2|||
145761023|NCT00508391|525636628|FG001|Second Treatment|Withdrawal by Subject|0|||
145761024|NCT02601573|525636629|FG000|Overall Study|Lost to Follow-up|0|||
145761025|NCT02601573|525636630|FG001|Overall Study|Lost to Follow-up|3|||
145761026|NCT02601573|525636631|FG002|Overall Study|Lost to Follow-up|1|||
145761027|NCT02601573|525636632|FG003|Overall Study|Lost to Follow-up|0|||
145761028|NCT02601573|525636633|FG004|Overall Study|Lost to Follow-up|2|||
145761029|NCT02601573|525636629|FG000|Overall Study|Withdrawal by Subject|0|||
145761030|NCT02601573|525636630|FG001|Overall Study|Withdrawal by Subject|1|||
145761031|NCT02601573|525636631|FG002|Overall Study|Withdrawal by Subject|0|||
145761032|NCT02601573|525636632|FG003|Overall Study|Withdrawal by Subject|1|||
145761033|NCT02601573|525636633|FG004|Overall Study|Withdrawal by Subject|0|||
145761034|NCT03310970|525636634|FG000|Overall Study|Withdrawal by Subject|0|||
145761035|NCT03310970|525636635|FG001|Overall Study|Withdrawal by Subject|1|||
145761036|NCT01133171|525636636|FG000|Overall Study|Withdrawal by Subject|1|||
145761037|NCT01133171|525636637|FG001|Overall Study|Withdrawal by Subject|2|||
145761038|NCT01133171|525636638|FG002|Overall Study|Withdrawal by Subject|0|||
145761039|NCT04062214|525636639|FG000|Week 12|Death|1|||
145761040|NCT04062214|525636640|FG001|Week 12|Death|1|||
145761041|NCT04062214|525636639|FG000|Week 12|Withdrawal by Subject|14|||
145761042|NCT04062214|525636640|FG001|Week 12|Withdrawal by Subject|13|||
145761043|NCT04062214|525636639|FG000|Week 12|Lost to Follow-up|55|||
145761044|NCT04062214|525636640|FG001|Week 12|Lost to Follow-up|68|||
145761045|NCT04062214|525636639|FG000|Week 12|Intermittent missing|31|||
145761046|NCT04062214|525636640|FG001|Week 12|Intermittent missing|29|||
145761047|NCT04062214|525636639|FG000|Week 36|Withdrawal by Subject|4|||
145761048|NCT04062214|525636640|FG001|Week 36|Withdrawal by Subject|5|||
145761049|NCT04062214|525636639|FG000|Week 36|Lost to Follow-up|50|||
145761050|NCT04062214|525636640|FG001|Week 36|Lost to Follow-up|46|||
145761051|NCT04062214|525636639|FG000|Week 36|Death|0|||
145607833|NCT01852058|525079277|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145607834|NCT01852058|525079278|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145761052|NCT04062214|525636640|FG001|Week 36|Death|1|||
145761053|NCT01356589|525636644|FG000|Overall Study|Enrolled, but not treated|3|||
145761054|NCT01356589|525636644|FG000|Overall Study|Dose data not recorded|2|||
145761055|NCT04343651|525636645|FG000|Overall Study|Physician Decision|2|||
145761056|NCT04343651|525636646|FG001|Overall Study|Physician Decision|1|||
145761057|NCT04343651|525636645|FG000|Overall Study|Lost to Follow-up|2|||
145761058|NCT04343651|525636646|FG001|Overall Study|Lost to Follow-up|1|||
145761059|NCT04343651|525636645|FG000|Overall Study|Protocol Violation|4|||
145761060|NCT04343651|525636646|FG001|Overall Study|Protocol Violation|6|||
145761061|NCT04343651|525636645|FG000|Overall Study|Missing|3|||
145761062|NCT04343651|525636646|FG001|Overall Study|Missing|9|||
145761063|NCT04343651|525636645|FG000|Overall Study|Withdrawal by Subject|0|||
145761064|NCT04343651|525636646|FG001|Overall Study|Withdrawal by Subject|4|||
145761065|NCT04343651|525636645|FG000|Overall Study|Death|0|||
145761066|NCT04343651|525636646|FG001|Overall Study|Death|1|||
145761067|NCT04343651|525636645|FG000|Overall Study|Did not start treatment|1|||
145761068|NCT04343651|525636646|FG001|Overall Study|Did not start treatment|1|||
145761069|NCT04343651|525636645|FG000|Overall Study|Patient did not complete visits 3-6|0|||
145761070|NCT04343651|525636646|FG001|Overall Study|Patient did not complete visits 3-6|1|||
145761071|NCT00821678|525636652|FG000|Overall Study|Withdrawal by Subject|8|||
145761072|NCT00821678|525636653|FG001|Overall Study|Withdrawal by Subject|0|||
145761073|NCT00821678|525636652|FG000|Overall Study|Lost to Follow-up|13|||
145761074|NCT00821678|525636653|FG001|Overall Study|Lost to Follow-up|12|||
145761075|NCT00821678|525636652|FG000|Overall Study|Death|0|||
145761076|NCT00821678|525636653|FG001|Overall Study|Death|2|||
145761077|NCT00925600|525638366|FG000|Overall Study|Withdrawal by Subject|16|||
145761078|NCT00925600|525638367|FG001|Overall Study|Withdrawal by Subject|14|||
145761079|NCT00925600|525638366|FG000|Overall Study|Death|4|||
145761080|NCT00925600|525638367|FG001|Overall Study|Death|3|||
145761081|NCT00925600|525638366|FG000|Overall Study|Lost to Follow-up|2|||
145761082|NCT00925600|525638367|FG001|Overall Study|Lost to Follow-up|2|||
145761083|NCT00925600|525638366|FG000|Overall Study|Disease Progression|1|||
145761084|NCT00925600|525638367|FG001|Overall Study|Disease Progression|3|||
145761085|NCT00925600|525638366|FG000|Overall Study|Administrative Decision|1|||
145761086|NCT00925600|525638367|FG001|Overall Study|Administrative Decision|1|||
145761087|NCT00925600|525638366|FG000|Overall Study|Noncompliance|2|||
145761088|NCT00925600|525638367|FG001|Overall Study|Noncompliance|0|||
145761089|NCT00925600|525638366|FG000|Overall Study|Ineligibility Determined|2|||
145761090|NCT00925600|525638367|FG001|Overall Study|Ineligibility Determined|0|||
145761091|NCT00925600|525638366|FG000|Overall Study|Protocol Deviation|0|||
145761092|NCT00925600|525638367|FG001|Overall Study|Protocol Deviation|1|||
145761093|NCT00925600|525638366|FG000|Overall Study|Requirement for Alternative Therapy|0|||
145761094|NCT00925600|525638367|FG001|Overall Study|Requirement for Alternative Therapy|1|||
145761095|NCT00925600|525638366|FG000|Overall Study|Other|3|||
145276011|NCT00422058|523859356|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
145276012|NCT00422058|523859357|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
145761096|NCT00925600|525638367|FG001|Overall Study|Other|1|||
145761097|NCT00925600|525638366|FG000|Overall Study|Adverse Event|1|||
145761098|NCT00925600|525638367|FG001|Overall Study|Adverse Event|2|||
145761099|NCT00127127|525638372|FG000|Overall Study|Adverse Event|0|||
145761100|NCT00127127|525638373|FG001|Overall Study|Adverse Event|2|||
145276013|NCT00422058|523859358|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
145276014|NCT00422058|523859359|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
145276015|NCT00422058|523859360|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
145761101|NCT00127127|525638374|FG002|Overall Study|Adverse Event|0|||
145761102|NCT00127127|525638375|FG003|Overall Study|Adverse Event|1|||
145761103|NCT00127127|525638372|FG000|Overall Study|Lack of Efficacy|1|||
145761104|NCT00127127|525638373|FG001|Overall Study|Lack of Efficacy|3|||
145761105|NCT00127127|525638374|FG002|Overall Study|Lack of Efficacy|0|||
145761106|NCT00127127|525638375|FG003|Overall Study|Lack of Efficacy|2|||
145761107|NCT01059448|525638377|FG000|Overall Study|Adverse Event|1|||
145761108|NCT01059448|525638378|FG001|Overall Study|Adverse Event|3|||
145761109|NCT01059448|525638379|FG002|Overall Study|Adverse Event|0|||
145761110|NCT01059448|525638380|FG003|Overall Study|Adverse Event|1|||
145761111|NCT01059448|525638377|FG000|Overall Study|Withdrawal by Subject|2|||
145761112|NCT01059448|525638378|FG001|Overall Study|Withdrawal by Subject|0|||
145761113|NCT01059448|525638379|FG002|Overall Study|Withdrawal by Subject|2|||
145761114|NCT01059448|525638380|FG003|Overall Study|Withdrawal by Subject|4|||
145761115|NCT01059448|525638377|FG000|Overall Study|Disease Progression|2|||
145761116|NCT01059448|525638378|FG001|Overall Study|Disease Progression|1|||
145761117|NCT01059448|525638379|FG002|Overall Study|Disease Progression|4|||
145761118|NCT01059448|525638380|FG003|Overall Study|Disease Progression|2|||
145761119|NCT01059448|525638377|FG000|Overall Study|Administrative Decision|43|||
145761120|NCT01059448|525638378|FG001|Overall Study|Administrative Decision|49|||
145761121|NCT01059448|525638379|FG002|Overall Study|Administrative Decision|45|||
145761122|NCT01059448|525638380|FG003|Overall Study|Administrative Decision|46|||
145761123|NCT01059448|525638377|FG000|Overall Study|Lost to Follow-up|0|||
145761124|NCT01059448|525638378|FG001|Overall Study|Lost to Follow-up|0|||
145761125|NCT01059448|525638379|FG002|Overall Study|Lost to Follow-up|2|||
145761126|NCT01059448|525638380|FG003|Overall Study|Lost to Follow-up|0|||
145761127|NCT01059448|525638377|FG000|Overall Study|Death|0|||
145761128|NCT01059448|525638378|FG001|Overall Study|Death|1|||
145761129|NCT01059448|525638379|FG002|Overall Study|Death|0|||
145761130|NCT01059448|525638380|FG003|Overall Study|Death|0|||
145761131|NCT01059448|525638377|FG000|Overall Study|Other|1|||
145761132|NCT01059448|525638378|FG001|Overall Study|Other|1|||
145761133|NCT01059448|525638379|FG002|Overall Study|Other|0|||
145761134|NCT01059448|525638380|FG003|Overall Study|Other|1|||
145761135|NCT00778830|525638381|FG000|Overall Study|Ongoing at data cut-off|0|||
145761136|NCT00778830|525638382|FG001|Overall Study|Ongoing at data cut-off|1|||
145761137|NCT01891643|525638383|FG000|Overall Study|Adverse event unrelated to study drug|2|||
145761138|NCT01891643|525638384|FG001|Overall Study|Adverse event unrelated to study drug|5|||
145761139|NCT01891643|525638383|FG000|Overall Study|Disease Progression|4|||
145761140|NCT01891643|525638384|FG001|Overall Study|Disease Progression|3|||
145761141|NCT01891643|525638383|FG000|Overall Study|Study Drug Toxicity|3|||
145761142|NCT01891643|525638384|FG001|Overall Study|Study Drug Toxicity|0|||
145761143|NCT01891643|525638383|FG000|Overall Study|Maximum Clinical Benefit|0|||
145761144|NCT01891643|525638384|FG001|Overall Study|Maximum Clinical Benefit|1|||
145761145|NCT01891643|525638383|FG000|Overall Study|Poor/Non-compliance|0|||
145761146|NCT01891643|525638384|FG001|Overall Study|Poor/Non-compliance|1|||
145761147|NCT01891643|525638383|FG000|Overall Study|Participant request to discontinue|1|||
145761148|NCT01891643|525638384|FG001|Overall Study|Participant request to discontinue|0|||
145761149|NCT02591615|525638387|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
145761150|NCT02591615|525638388|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
145761151|NCT02591615|525638389|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
145761152|NCT02591615|525638390|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
145761153|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
145761154|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
145761155|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
145761156|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
145761157|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
145761158|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
145761159|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
145761160|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
145761161|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
145607835|NCT01852058|525079279|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145607836|NCT01852058|525079280|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145761162|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
145761163|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
145761164|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
145761165|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
145761166|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
145761167|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
145761168|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
145761169|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
145761170|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
145761171|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
145761172|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
145761173|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
145607837|NCT01852058|525079281|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145761174|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
145761175|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
145276016|NCT00422058|523859361|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
145276017|NCT00422058|523859356|FG000|Open-Label Extension, Week 20-104|Other|13|||
145276018|NCT00422058|523859357|FG001|Open-Label Extension, Week 20-104|Other|14|||
145276019|NCT00422058|523859358|FG002|Open-Label Extension, Week 20-104|Other|6|||
145276020|NCT00422058|523859359|FG003|Open-Label Extension, Week 20-104|Other|13|||
145276021|NCT00422058|523859360|FG004|Open-Label Extension, Week 20-104|Other|16|||
145276022|NCT00422058|523859361|FG005|Open-Label Extension, Week 20-104|Other|18|||
145276023|NCT00713830|523859362|FG000|Overall Study|Adverse Event|23|||
145276024|NCT00713830|523859363|FG001|Overall Study|Adverse Event|71|||
145276025|NCT00713830|523859362|FG000|Overall Study|Lack of Efficacy|24|||
145276026|NCT00713830|523859363|FG001|Overall Study|Lack of Efficacy|16|||
145276027|NCT00713830|523859362|FG000|Overall Study|Lost to Follow-up|2|||
145276028|NCT00713830|523859363|FG001|Overall Study|Lost to Follow-up|9|||
145276029|NCT00713830|523859362|FG000|Overall Study|Withdrawal by Subject|13|||
145276030|NCT00713830|523859363|FG001|Overall Study|Withdrawal by Subject|23|||
145276031|NCT00713830|523859362|FG000|Overall Study|Poor Compliance to Protocol|7|||
145276032|NCT00713830|523859363|FG001|Overall Study|Poor Compliance to Protocol|14|||
145276033|NCT00713830|523859362|FG000|Overall Study|Familial and Personal Reasons|9|||
145276034|NCT00713830|523859363|FG001|Overall Study|Familial and Personal Reasons|34|||
145276035|NCT00713830|523859362|FG000|Overall Study|Sponsor Decision|4|||
145276036|NCT00713830|523859363|FG001|Overall Study|Sponsor Decision|10|||
145276037|NCT02787785|523859366|FG000|Overall Study|Death|3|||
145276038|NCT02787785|523859367|FG001|Overall Study|Death|4|||
145276039|NCT02787785|523859366|FG000|Overall Study|Lost to Follow-up|1|||
145276040|NCT02787785|523859367|FG001|Overall Study|Lost to Follow-up|1|||
145276041|NCT02787785|523859366|FG000|Overall Study|Withdrawal by Subject|0|||
145276042|NCT02787785|523859367|FG001|Overall Study|Withdrawal by Subject|5|||
145276043|NCT02030834|523859368|FG000|Overall Study|Death|4|||
145276044|NCT02030834|523859369|FG001|Overall Study|Death|0|||
145276045|NCT02030834|523859370|FG002|Overall Study|Death|0|||
145276046|NCT02030834|523859368|FG000|Overall Study|Manufacturing failure|2|||
145276047|NCT02030834|523859369|FG001|Overall Study|Manufacturing failure|0|||
145276048|NCT02030834|523859370|FG002|Overall Study|Manufacturing failure|1|||
145276049|NCT02030834|523859368|FG000|Overall Study|Disease progression|2|||
145276050|NCT02030834|523859369|FG001|Overall Study|Disease progression|0|||
145276051|NCT02030834|523859370|FG002|Overall Study|Disease progression|2|||
145276052|NCT02030834|523859368|FG000|Overall Study|Lost to Follow-up|1|||
145276053|NCT02030834|523859369|FG001|Overall Study|Lost to Follow-up|0|||
145276054|NCT02030834|523859370|FG002|Overall Study|Lost to Follow-up|0|||
145276055|NCT02030834|523859368|FG000|Overall Study|Withdrawal by Subject|1|||
145276056|NCT02030834|523859369|FG001|Overall Study|Withdrawal by Subject|0|||
145276057|NCT02030834|523859370|FG002|Overall Study|Withdrawal by Subject|0|||
145276058|NCT02030834|523859368|FG000|Overall Study|Lack of funding|1|||
145276059|NCT02030834|523859369|FG001|Overall Study|Lack of funding|0|||
145276060|NCT02030834|523859370|FG002|Overall Study|Lack of funding|0|||
145276061|NCT01766310|523859374|FG000|Overall Study|Lost to Follow-up|1|||
145276062|NCT01766310|523859375|FG001|Overall Study|Lost to Follow-up|3|||
145276063|NCT03151707|523859376|FG000|Overall Study|Lost to Follow-up|6|||
145276064|NCT01591499|523859378|FG000|Baseline Visit|Withdrawal by Subject|0|||
145276065|NCT01591499|523859379|FG001|Baseline Visit|Withdrawal by Subject|2|||
145276066|NCT01591499|523859380|FG002|Baseline Visit|Withdrawal by Subject|0|||
145276067|NCT01591499|523859381|FG003|Baseline Visit|Withdrawal by Subject|2|||
145276068|NCT01591499|523859378|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
145276069|NCT01591499|523859379|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
145276070|NCT01591499|523859380|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
145276071|NCT01591499|523859381|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
145276072|NCT01591499|523859378|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
145276073|NCT01591499|523859379|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
145276074|NCT01591499|523859380|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
145276075|NCT01591499|523859381|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
145276076|NCT02125734|523859382|FG000|Period 2|Adverse Event|0|||
145276077|NCT02125734|523859383|FG001|Period 2|Adverse Event|1|||
145276078|NCT00646282|523859384|FG000|Overall Study|Protocol terminated|4|||
145276079|NCT00646282|523859385|FG001|Overall Study|Protocol terminated|4|||
145276080|NCT02617446|523859386|FG000|Overall Study|Withdrawal by Subject|0|||
145276081|NCT02617446|523859387|FG001|Overall Study|Withdrawal by Subject|2|||
145276082|NCT02617446|523859388|FG002|Overall Study|Withdrawal by Subject|0|||
145276083|NCT02617446|523859386|FG000|Overall Study|Adverse Event|1|||
145276084|NCT02617446|523859387|FG001|Overall Study|Adverse Event|0|||
145402913|NCT02065557|524332544|FG000|Maintenance Period|Subject Non-Compliance|0|||
145276085|NCT02617446|523859388|FG002|Overall Study|Adverse Event|5|||
145276086|NCT02617446|523859386|FG000|Overall Study|Lost to Follow-up|3|||
145276087|NCT02617446|523859387|FG001|Overall Study|Lost to Follow-up|0|||
145276088|NCT02617446|523859388|FG002|Overall Study|Lost to Follow-up|0|||
145276089|NCT02617446|523859386|FG000|Overall Study|Death|0|||
145276090|NCT02617446|523859387|FG001|Overall Study|Death|0|||
145276091|NCT02617446|523859388|FG002|Overall Study|Death|2|||
145761176|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
145761177|NCT02591615|525638387|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
145761178|NCT02591615|525638388|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
145761179|NCT02591615|525638389|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
145761180|NCT02591615|525638390|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
145761181|NCT02591615|525638387|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
145761182|NCT02591615|525638388|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
145761183|NCT02591615|525638389|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
145761184|NCT02591615|525638390|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
145761185|NCT02591615|525638387|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
145761186|NCT02591615|525638388|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
145761187|NCT02591615|525638389|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
145761188|NCT02591615|525638390|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
145761189|NCT02591615|525638387|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
145761190|NCT02591615|525638388|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
145761191|NCT02591615|525638389|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
145761192|NCT02591615|525638390|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
145761193|NCT02591615|525638387|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
145761194|NCT02591615|525638388|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
145761195|NCT02591615|525638389|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
145761196|NCT02591615|525638390|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
145761197|NCT02591615|525638387|FG000|Maintenance MK-3475|Adverse Event|0|||
145761198|NCT02591615|525638388|FG001|Maintenance MK-3475|Adverse Event|3|||
145761199|NCT02591615|525638389|FG002|Maintenance MK-3475|Adverse Event|1|||
145761200|NCT02591615|525638390|FG003|Maintenance MK-3475|Adverse Event|2|||
145761201|NCT02591615|525638387|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
145761202|NCT02591615|525638388|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
145761203|NCT02591615|525638389|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
145761204|NCT02591615|525638390|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
145761205|NCT02591615|525638387|FG000|Maintenance MK-3475|Death|0|||
145761206|NCT02591615|525638388|FG001|Maintenance MK-3475|Death|1|||
145761207|NCT02591615|525638389|FG002|Maintenance MK-3475|Death|1|||
145761208|NCT02591615|525638390|FG003|Maintenance MK-3475|Death|0|||
145761209|NCT02591615|525638387|FG000|Maintenance MK-3475|Physician discretion|0|||
145761210|NCT02591615|525638388|FG001|Maintenance MK-3475|Physician discretion|0|||
145761211|NCT02591615|525638389|FG002|Maintenance MK-3475|Physician discretion|1|||
145761212|NCT02591615|525638390|FG003|Maintenance MK-3475|Physician discretion|0|||
145761213|NCT02591615|525638387|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
145761214|NCT02591615|525638388|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
145761215|NCT02591615|525638389|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
145761216|NCT02591615|525638390|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
145761217|NCT02591615|525638387|FG000|Maintenance MK-3475|In active treatment|2|||
145761218|NCT02591615|525638388|FG001|Maintenance MK-3475|In active treatment|0|||
145761219|NCT02591615|525638389|FG002|Maintenance MK-3475|In active treatment|0|||
145761220|NCT02591615|525638390|FG003|Maintenance MK-3475|In active treatment|1|||
145761221|NCT00809328|525638399|FG000|Overall Study|Lack of Efficacy|18|||
145761222|NCT00809328|525638399|FG000|Overall Study|Adverse Event|6|||
145761223|NCT00809328|525638399|FG000|Overall Study|Protocol Violation|3|||
145761224|NCT00809328|525638399|FG000|Overall Study|Withdrawal by Subject|2|||
145761225|NCT01400932|525638400|FG000|Overall Study|Adverse Event|10|||
145761226|NCT01400932|525638401|FG001|Overall Study|Adverse Event|5|||
145761227|NCT01400932|525638400|FG000|Overall Study|Lack of Efficacy|0|||
145761228|NCT01400932|525638401|FG001|Overall Study|Lack of Efficacy|3|||
145761229|NCT01400932|525638400|FG000|Overall Study|Withdrawal by Subject|2|||
145761230|NCT01400932|525638401|FG001|Overall Study|Withdrawal by Subject|6|||
145761231|NCT01400932|525638400|FG000|Overall Study|Lost to Follow-up|1|||
145761232|NCT01400932|525638401|FG001|Overall Study|Lost to Follow-up|0|||
145761233|NCT01400932|525638400|FG000|Overall Study|Protocol Deviation|0|||
145761234|NCT01400932|525638401|FG001|Overall Study|Protocol Deviation|1|||
145761235|NCT01400932|525638400|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145761236|NCT01400932|525638401|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145761237|NCT04656990|525638402|FG000|Baseline|pandemic|20|||
145761238|NCT04656990|525638403|FG001|Baseline|pandemic|24|||
145761239|NCT04656990|525638402|FG000|Follow Up Period|Lost to Follow-up|61|||
145761240|NCT04656990|525638403|FG001|Follow Up Period|Lost to Follow-up|73|||
145761241|NCT03244059|525638404|FG000|Specific Aim 1|Physician Decision|1|||
145761242|NCT03244059|525638405|FG001|Specific Aim 1|Physician Decision|0|||
145761243|NCT03244059|525638404|FG000|Specific Aim 2|Physician Decision|1|||
145761244|NCT03244059|525638405|FG001|Specific Aim 2|Physician Decision|0|||
145761245|NCT00600171|525638407|FG000|Overall Study|Adverse Event|0|||
145761246|NCT00600171|525638408|FG001|Overall Study|Adverse Event|1|||
145761247|NCT00600171|525638409|FG002|Overall Study|Adverse Event|0|||
145761248|NCT00600171|525638410|FG003|Overall Study|Adverse Event|0|||
145761249|NCT00600171|525638411|FG004|Overall Study|Adverse Event|1|||
145761250|NCT00600171|525638412|FG005|Overall Study|Adverse Event|0|||
145761251|NCT00600171|525638407|FG000|Overall Study|Lack of Efficacy|9|||
145761252|NCT00600171|525638408|FG001|Overall Study|Lack of Efficacy|12|||
145276092|NCT00530088|523859397|FG000|Overall Study|Disease Progression|4|||
145276093|NCT00530088|523859397|FG000|Overall Study|Physician Decision|4|||
145276094|NCT00530088|523859397|FG000|Overall Study|Other Not Specified|2|||
145276095|NCT00902278|523859398|FG000|Overall Study|Physician Decision|1|||
145276096|NCT00902278|523859399|FG001|Overall Study|Physician Decision|0|||
145276097|NCT00902278|523859400|FG002|Overall Study|Physician Decision|2|||
145276098|NCT00902278|523859401|FG003|Overall Study|Physician Decision|0|||
145276099|NCT00902278|523859402|FG004|Overall Study|Physician Decision|1|||
145276100|NCT00902278|523859398|FG000|Overall Study|Lost to Follow-up|3|||
145276101|NCT00902278|523859399|FG001|Overall Study|Lost to Follow-up|2|||
145276102|NCT00902278|523859400|FG002|Overall Study|Lost to Follow-up|3|||
145276103|NCT00902278|523859401|FG003|Overall Study|Lost to Follow-up|0|||
145276104|NCT00902278|523859402|FG004|Overall Study|Lost to Follow-up|1|||
145276105|NCT02149199|523859435|FG000|Overall Study|Study specific withdrawal criteria|4|||
145276106|NCT02149199|523859436|FG001|Overall Study|Study specific withdrawal criteria|21|||
145276107|NCT02149199|523859437|FG002|Overall Study|Study specific withdrawal criteria|6|||
145276108|NCT02149199|523859435|FG000|Overall Study|Other|20|||
145607838|NCT01852058|525079282|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145276109|NCT02149199|523859436|FG001|Overall Study|Other|25|||
145276110|NCT02149199|523859437|FG002|Overall Study|Other|20|||
145761253|NCT00600171|525638409|FG002|Overall Study|Lack of Efficacy|3|||
145761254|NCT00600171|525638410|FG003|Overall Study|Lack of Efficacy|5|||
145761255|NCT00600171|525638411|FG004|Overall Study|Lack of Efficacy|4|||
145761256|NCT00600171|525638412|FG005|Overall Study|Lack of Efficacy|0|||
145761257|NCT00600171|525638407|FG000|Overall Study|Protocol Violation|1|||
145761258|NCT00600171|525638408|FG001|Overall Study|Protocol Violation|2|||
145761259|NCT00600171|525638409|FG002|Overall Study|Protocol Violation|0|||
145761260|NCT00600171|525638410|FG003|Overall Study|Protocol Violation|1|||
145761261|NCT00600171|525638411|FG004|Overall Study|Protocol Violation|0|||
145761262|NCT00600171|525638412|FG005|Overall Study|Protocol Violation|0|||
145761263|NCT00600171|525638407|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
145276111|NCT02149199|523859435|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
145276112|NCT02149199|523859436|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
145761264|NCT00600171|525638408|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145276113|NCT02149199|523859437|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
145276114|NCT02149199|523859435|FG000|Overall Study|Withdrawal by Subject|75|||
145276115|NCT02149199|523859436|FG001|Overall Study|Withdrawal by Subject|93|||
145276116|NCT02149199|523859437|FG002|Overall Study|Withdrawal by Subject|77|||
145276117|NCT02149199|523859435|FG000|Overall Study|Protocol Violation|16|||
145276118|NCT02149199|523859436|FG001|Overall Study|Protocol Violation|13|||
145276119|NCT02149199|523859437|FG002|Overall Study|Protocol Violation|15|||
145276120|NCT02149199|523859435|FG000|Overall Study|Lost to Follow-up|3|||
145276121|NCT02149199|523859436|FG001|Overall Study|Lost to Follow-up|12|||
145276122|NCT02149199|523859437|FG002|Overall Study|Lost to Follow-up|11|||
145276123|NCT02149199|523859435|FG000|Overall Study|Death|0|||
145276124|NCT02149199|523859436|FG001|Overall Study|Death|0|||
145276125|NCT02149199|523859437|FG002|Overall Study|Death|1|||
145276126|NCT02149199|523859435|FG000|Overall Study|Adverse Event|6|||
145276127|NCT02149199|523859436|FG001|Overall Study|Adverse Event|15|||
145276128|NCT02149199|523859437|FG002|Overall Study|Adverse Event|9|||
145276129|NCT04881448|523859438|FG000|Overall Study|Study cancelled by sponsor|220|||
145276130|NCT04881448|523859438|FG000|Overall Study|Withdrawal by Subject|2|||
145761265|NCT00600171|525638409|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
145761266|NCT00600171|525638410|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
145761267|NCT00600171|525638411|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
145761268|NCT00600171|525638412|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
145761269|NCT00600171|525638407|FG000|Overall Study|Withdrawal by Subject|3|||
145761270|NCT00600171|525638408|FG001|Overall Study|Withdrawal by Subject|0|||
145761271|NCT00600171|525638409|FG002|Overall Study|Withdrawal by Subject|0|||
145276131|NCT04881448|523859438|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
145276132|NCT00532779|523859439|FG000|Overall Study|Adverse Event|122|||
145276133|NCT00532779|523859440|FG001|Overall Study|Adverse Event|112|||
145276134|NCT00532779|523859441|FG002|Overall Study|Adverse Event|56|||
145276135|NCT00532779|523859439|FG000|Overall Study|Lost to Follow-up|76|||
145276136|NCT00532779|523859440|FG001|Overall Study|Lost to Follow-up|65|||
145276137|NCT00532779|523859441|FG002|Overall Study|Lost to Follow-up|66|||
145276138|NCT00532779|523859439|FG000|Overall Study|Withdrawal by Subject|63|||
145276139|NCT00532779|523859440|FG001|Overall Study|Withdrawal by Subject|60|||
145276140|NCT00532779|523859441|FG002|Overall Study|Withdrawal by Subject|90|||
145276141|NCT00532779|523859439|FG000|Overall Study|Lack of Efficacy|12|||
145276142|NCT00532779|523859440|FG001|Overall Study|Lack of Efficacy|12|||
145276143|NCT00532779|523859441|FG002|Overall Study|Lack of Efficacy|40|||
145276144|NCT00532779|523859439|FG000|Overall Study|Protocol Violation|5|||
145276145|NCT00532779|523859440|FG001|Overall Study|Protocol Violation|9|||
145276146|NCT00532779|523859441|FG002|Overall Study|Protocol Violation|7|||
145276147|NCT00532779|523859439|FG000|Overall Study|Pregnancy|2|||
145276148|NCT00532779|523859440|FG001|Overall Study|Pregnancy|5|||
145276149|NCT00532779|523859441|FG002|Overall Study|Pregnancy|3|||
145276150|NCT00532779|523859439|FG000|Overall Study|Death|0|||
145276151|NCT00532779|523859440|FG001|Overall Study|Death|1|||
145276152|NCT00532779|523859441|FG002|Overall Study|Death|0|||
145276153|NCT00532779|523859439|FG000|Overall Study|Drug noncompliance, moved, other|14|||
145276154|NCT00532779|523859440|FG001|Overall Study|Drug noncompliance, moved, other|23|||
145276155|NCT00532779|523859441|FG002|Overall Study|Drug noncompliance, moved, other|29|||
145276156|NCT02662556|523859442|FG000|Overall Study|Adverse Event|4|||
145276157|NCT02662556|523859442|FG000|Overall Study|Lack of Efficacy|4|||
145276158|NCT02531698|523859450|FG000|Overall Study|Adverse Event|2|||
145276159|NCT02531698|523859451|FG001|Overall Study|Adverse Event|1|||
145276160|NCT02531698|523859450|FG000|Overall Study|Withdrawal by Subject|6|||
145276161|NCT02531698|523859451|FG001|Overall Study|Withdrawal by Subject|1|||
145276162|NCT02531698|523859450|FG000|Overall Study|Protocol Violation|2|||
145276163|NCT02531698|523859451|FG001|Overall Study|Protocol Violation|0|||
145276164|NCT02531698|523859450|FG000|Overall Study|Lost to Follow-up|1|||
145276165|NCT02531698|523859451|FG001|Overall Study|Lost to Follow-up|0|||
145276166|NCT02395536|523859452|FG000|Overall Study|Lost to Follow-up|4|||
145276167|NCT02395536|523859453|FG001|Overall Study|Lost to Follow-up|4|||
145276168|NCT02395536|523859452|FG000|Overall Study|Death|2|||
145276169|NCT02395536|523859453|FG001|Overall Study|Death|0|||
145761272|NCT00600171|525638410|FG003|Overall Study|Withdrawal by Subject|1|||
145276170|NCT02395536|523859452|FG000|Overall Study|Physician Decision|4|||
145276171|NCT02395536|523859453|FG001|Overall Study|Physician Decision|6|||
145276172|NCT02395536|523859452|FG000|Overall Study|Withdrawal by Subject|9|||
145276173|NCT02395536|523859453|FG001|Overall Study|Withdrawal by Subject|17|||
145276174|NCT02395536|523859452|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
145761273|NCT00600171|525638411|FG004|Overall Study|Withdrawal by Subject|1|||
145761274|NCT00600171|525638412|FG005|Overall Study|Withdrawal by Subject|1|||
145276175|NCT02395536|523859453|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
145276176|NCT02395536|523859452|FG000|Overall Study|Insurance issue|0|||
145276177|NCT02395536|523859453|FG001|Overall Study|Insurance issue|1|||
145276178|NCT00701558|523859454|FG000|Overall Study|Death|7|||
145276179|NCT00701558|523859454|FG000|Overall Study|Lost to Follow-up|8|||
145276180|NCT01422720|523861002|FG000|Overall Study|Adverse Event|16|||
145761275|NCT00600171|525638407|FG000|Overall Study|Physician Decision|0|||
145761276|NCT00600171|525638408|FG001|Overall Study|Physician Decision|1|||
145761277|NCT00600171|525638409|FG002|Overall Study|Physician Decision|0|||
145761278|NCT00600171|525638410|FG003|Overall Study|Physician Decision|1|||
145761279|NCT00600171|525638411|FG004|Overall Study|Physician Decision|0|||
145761280|NCT00600171|525638412|FG005|Overall Study|Physician Decision|2|||
145761281|NCT00600171|525638407|FG000|Overall Study|Lost to Follow-up|0|||
145761282|NCT00600171|525638408|FG001|Overall Study|Lost to Follow-up|0|||
145761283|NCT00600171|525638409|FG002|Overall Study|Lost to Follow-up|0|||
145761284|NCT00600171|525638410|FG003|Overall Study|Lost to Follow-up|1|||
145761285|NCT00600171|525638411|FG004|Overall Study|Lost to Follow-up|0|||
145761286|NCT00600171|525638412|FG005|Overall Study|Lost to Follow-up|0|||
145761287|NCT02367521|525638413|FG000|Overall Study|severe headache after intervention|2|||
145761288|NCT02367521|525638414|FG001|Overall Study|severe headache after intervention|0|||
145761289|NCT02367521|525638413|FG000|Overall Study|unable to find transportation|2|||
145761290|NCT02367521|525638414|FG001|Overall Study|unable to find transportation|0|||
145761291|NCT00542191|525638418|FG000|Overall Study|Death|3|||
145761292|NCT00469612|525638419|FG000|Overall Study|Study terminated before data collected|2|||
145761293|NCT00469612|525638420|FG001|Overall Study|Study terminated before data collected|0|||
145761294|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761295|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
145761296|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761297|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761298|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761299|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
145761300|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
145761301|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
145761302|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
145761303|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
145761304|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
145761305|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
145761306|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761307|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
145761308|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
145761309|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
145761310|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
145761311|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
145761312|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
145276181|NCT01422720|523861002|FG000|Overall Study|Lack of Efficacy|1|||
145276182|NCT01422720|523861002|FG000|Overall Study|Withdrawal by Subject|4|||
145276183|NCT01422720|523861002|FG000|Overall Study|Ineligibility|1|||
145276184|NCT00606801|523861003|FG000|Intervention|Protocol Violation|3|||
145276185|NCT00606801|523861004|FG001|Intervention|Protocol Violation|3|||
145276186|NCT00303316|523861009|FG000|Overall Study|Protocol Violation|1|||
145276187|NCT00303316|523861010|FG001|Overall Study|Protocol Violation|0|||
145276188|NCT00303316|523861009|FG000|Overall Study|Lost to Follow-up|0|||
145276189|NCT00303316|523861010|FG001|Overall Study|Lost to Follow-up|1|||
145276190|NCT00303316|523861009|FG000|Overall Study|Withdrawal by Subject|1|||
145276191|NCT00303316|523861010|FG001|Overall Study|Withdrawal by Subject|2|||
145276192|NCT01726335|523861011|FG000|Overall Study|Lost to Follow-up|2|||
145276193|NCT01726335|523861011|FG000|Overall Study|Withdrawal by Subject|15|||
145276194|NCT01726335|523861011|FG000|Overall Study|Adverse Event|4|||
145276195|NCT01726335|523861011|FG000|Overall Study|Lost to Follow-up|2|||
145276196|NCT01726335|523861011|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
145276197|NCT01074307|523861016|FG000|Overall Study|No primary endpoint evaluation|14|||
145276198|NCT01074307|523861017|FG001|Overall Study|No primary endpoint evaluation|6|||
145276199|NCT01074307|523861016|FG000|Overall Study|Exclusion criterion|0|||
145276200|NCT01074307|523861017|FG001|Overall Study|Exclusion criterion|1|||
145276201|NCT01074307|523861016|FG000|Overall Study|Protocol Violation|8|||
145276202|NCT01074307|523861017|FG001|Overall Study|Protocol Violation|5|||
145276203|NCT02162511|523861023|FG000|Overall Study|Lack of Efficacy|0|||
145276204|NCT02162511|523861024|FG001|Overall Study|Lack of Efficacy|0|||
145276205|NCT02162511|523861025|FG002|Overall Study|Lack of Efficacy|2|||
145276206|NCT01796860|523861027|FG000|Overall Study|Withdrawal by Subject|3|||
145276207|NCT02703454|523861031|FG000|Overall Study|Not treated|1|||
145276208|NCT02703454|523861032|FG001|Overall Study|Not treated|3|||
145276209|NCT02703454|523861031|FG000|Overall Study|Withdrawal by Subject|4|||
145276210|NCT02703454|523861032|FG001|Overall Study|Withdrawal by Subject|3|||
145761313|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
145276211|NCT02703454|523861031|FG000|Overall Study|Lost to Follow-up|1|||
145276212|NCT02703454|523861032|FG001|Overall Study|Lost to Follow-up|2|||
145276213|NCT02703454|523861031|FG000|Overall Study|Study discontinuation|5|||
145276214|NCT02703454|523861032|FG001|Overall Study|Study discontinuation|8|||
145761314|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761315|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761316|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761317|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
145761318|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761319|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
145761320|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
145761321|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
145761322|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
145761323|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
145761324|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
145761325|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
145761326|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
145761327|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
145761328|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
145761329|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
145761330|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
145761331|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
145761332|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
145761333|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
145761334|NCT00289913|525638423|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
145761335|NCT00289913|525638424|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761336|NCT00289913|525638425|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
145761337|NCT00289913|525638426|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761338|NCT00289913|525638427|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761339|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761340|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761341|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
145761342|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761343|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761344|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
145761345|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
145761346|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
145761347|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
145761348|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
145761349|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
145761350|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
145761351|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
145761352|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
145761353|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
145761354|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
145761355|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
145761356|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
145761357|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761358|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761359|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
145276215|NCT02284373|523861033|FG000|Overall Study|Withdrawal by Subject|0|||
145276216|NCT02284373|523861034|FG001|Overall Study|Withdrawal by Subject|1|||
145276217|NCT02284373|523861035|FG002|Overall Study|Withdrawal by Subject|0|||
145276218|NCT02284373|523861033|FG000|Overall Study|Other|0|||
145276219|NCT02284373|523861034|FG001|Overall Study|Other|1|||
145276220|NCT02284373|523861035|FG002|Overall Study|Other|0|||
145276221|NCT02284373|523861033|FG000|Overall Study|Lost to Follow-up|0|||
145276222|NCT02284373|523861034|FG001|Overall Study|Lost to Follow-up|1|||
145276223|NCT02284373|523861035|FG002|Overall Study|Lost to Follow-up|0|||
145761360|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761361|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
145761362|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761363|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761364|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
145761365|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
145761366|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
145761367|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
145761368|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
145761369|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
145761370|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
145761371|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
145761372|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
145761373|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
145761374|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
145761375|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
145761376|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
145761377|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
145761378|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
145761379|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
145276224|NCT02016755|523861037|FG000|Overall Study|Major amputation of index limb|2|||
145276225|NCT02016755|523861037|FG000|Overall Study|Adverse Event|2|||
145276226|NCT02016755|523861037|FG000|Overall Study|Physician Decision|1|||
145276227|NCT02016755|523861037|FG000|Overall Study|Death|2|||
145276228|NCT02499406|523861039|FG000|Overall Study|missed 3 treatment sessions|4|||
145276229|NCT00552617|523861043|FG000|Overall Study|Not Treated|0|||
145276230|NCT00552617|523861044|FG001|Overall Study|Not Treated|0|||
145276231|NCT00552617|523861045|FG002|Overall Study|Not Treated|1|||
145276232|NCT00552617|523861046|FG003|Overall Study|Not Treated|0|||
145276233|NCT00552617|523861047|FG004|Overall Study|Not Treated|0|||
145276234|NCT00552617|523861048|FG005|Overall Study|Not Treated|0|||
145276235|NCT00552617|523861049|FG006|Overall Study|Not Treated|0|||
145276236|NCT00552617|523861050|FG007|Overall Study|Not Treated|0|||
145276237|NCT00552617|523861051|FG008|Overall Study|Not Treated|0|||
145276238|NCT00552617|523861052|FG009|Overall Study|Not Treated|1|||
145276239|NCT00552617|523861043|FG000|Overall Study|Lost to Follow-up|0|||
145276240|NCT00552617|523861044|FG001|Overall Study|Lost to Follow-up|0|||
145276241|NCT00552617|523861045|FG002|Overall Study|Lost to Follow-up|0|||
145276242|NCT00552617|523861046|FG003|Overall Study|Lost to Follow-up|1|||
145276243|NCT00552617|523861047|FG004|Overall Study|Lost to Follow-up|0|||
145276244|NCT00552617|523861048|FG005|Overall Study|Lost to Follow-up|2|||
145276245|NCT00552617|523861049|FG006|Overall Study|Lost to Follow-up|0|||
145276246|NCT00552617|523861050|FG007|Overall Study|Lost to Follow-up|0|||
145276247|NCT00552617|523861051|FG008|Overall Study|Lost to Follow-up|2|||
145276248|NCT00552617|523861052|FG009|Overall Study|Lost to Follow-up|0|||
145276249|NCT04651218|523861053|FG000|Overall Study|Withdrawal by Subject|0|||
145276250|NCT04651218|523861054|FG001|Overall Study|Withdrawal by Subject|2|||
145276251|NCT02476851|523861055|FG000|Overall Study|Protocol Violation|1|||
145276252|NCT02476851|523861056|FG001|Overall Study|Protocol Violation|1|||
145276253|NCT01399125|523861068|FG000|Overall Study|Adverse Event|32|||
145276254|NCT01399125|523861069|FG001|Overall Study|Adverse Event|30|||
145276255|NCT01399125|523861068|FG000|Overall Study|Abnormal Lab values|0|||
145276256|NCT01399125|523861069|FG001|Overall Study|Abnormal Lab values|1|||
145276257|NCT01399125|523861068|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145276258|NCT01399125|523861069|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
145276259|NCT01399125|523861068|FG000|Overall Study|Withdrawal by Subject|5|||
145276260|NCT01399125|523861069|FG001|Overall Study|Withdrawal by Subject|8|||
145276261|NCT01399125|523861068|FG000|Overall Study|Lost to Follow-up|2|||
145276262|NCT01399125|523861069|FG001|Overall Study|Lost to Follow-up|3|||
145276263|NCT01399125|523861068|FG000|Overall Study|Administrative Problems|7|||
145276264|NCT01399125|523861069|FG001|Overall Study|Administrative Problems|11|||
145276265|NCT01399125|523861068|FG000|Overall Study|Death|0|||
145276266|NCT01399125|523861069|FG001|Overall Study|Death|1|||
145761380|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
145761381|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
145761382|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
145276267|NCT01399125|523861068|FG000|Overall Study|Protocol Deviation|5|||
145761383|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
145276268|NCT01399125|523861069|FG001|Overall Study|Protocol Deviation|2|||
145276269|NCT00854607|523861072|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
145276270|NCT00965263|523861073|FG000|Overall Study|Physician Decision|2|||
145276271|NCT00965263|523861074|FG001|Overall Study|Physician Decision|0|||
145402914|NCT02065557|524332545|FG001|Maintenance Period|Subject Non-Compliance|0|||
145276272|NCT00965263|523861073|FG000|Overall Study|Family emergency|0|||
145276273|NCT00965263|523861074|FG001|Overall Study|Family emergency|1|||
145276274|NCT00965263|523861073|FG000|Overall Study|Protocol Violation|0|||
145402915|NCT02065557|524332546|FG002|Maintenance Period|Subject Non-Compliance|0|||
145276275|NCT00965263|523861074|FG001|Overall Study|Protocol Violation|2|||
145276276|NCT03959137|523861075|FG000|Overall Study|Protocol Violation|6|||
145276277|NCT00995488|523861077|FG000|Overall Study|Withdrawal by Subject|1|||
145276278|NCT01289990|523861078|FG000|Overall Study|Death|0|||
145276279|NCT01289990|523861079|FG001|Overall Study|Death|0|||
145276280|NCT01289990|523861080|FG002|Overall Study|Death|0|||
145402916|NCT02065557|524332547|FG003|Maintenance Period|Subject Non-Compliance|0|||
145276281|NCT01289990|523861081|FG003|Overall Study|Death|1|||
145276282|NCT01289990|523861082|FG004|Overall Study|Death|2|||
145276283|NCT01289990|523861083|FG005|Overall Study|Death|1|||
145276284|NCT01289990|523861084|FG006|Overall Study|Death|0|||
145276285|NCT01289990|523861085|FG007|Overall Study|Death|0|||
145276286|NCT01289990|523861086|FG008|Overall Study|Death|0|||
145276287|NCT01289990|523861087|FG009|Overall Study|Death|0|||
145276288|NCT01289990|523861088|FG010|Overall Study|Death|0|||
145276289|NCT01289990|523861089|FG011|Overall Study|Death|1|||
145276290|NCT01289990|523861090|FG012|Overall Study|Death|0|||
145276291|NCT01289990|523861078|FG000|Overall Study|Lost to Follow-up|3|||
145276292|NCT01289990|523861079|FG001|Overall Study|Lost to Follow-up|2|||
145276293|NCT01289990|523861080|FG002|Overall Study|Lost to Follow-up|5|||
145276294|NCT01289990|523861081|FG003|Overall Study|Lost to Follow-up|5|||
145276295|NCT01289990|523861082|FG004|Overall Study|Lost to Follow-up|3|||
145276296|NCT01289990|523861083|FG005|Overall Study|Lost to Follow-up|4|||
145276297|NCT01289990|523861084|FG006|Overall Study|Lost to Follow-up|2|||
145276298|NCT01289990|523861085|FG007|Overall Study|Lost to Follow-up|2|||
145276299|NCT01289990|523861086|FG008|Overall Study|Lost to Follow-up|1|||
145276300|NCT01289990|523861087|FG009|Overall Study|Lost to Follow-up|4|||
145276301|NCT01289990|523861088|FG010|Overall Study|Lost to Follow-up|2|||
145276302|NCT01289990|523861089|FG011|Overall Study|Lost to Follow-up|1|||
145276303|NCT01289990|523861090|FG012|Overall Study|Lost to Follow-up|2|||
145276304|NCT01289990|523861078|FG000|Overall Study|Withdrawal by Subject|15|||
145276305|NCT01289990|523861079|FG001|Overall Study|Withdrawal by Subject|14|||
145276306|NCT01289990|523861080|FG002|Overall Study|Withdrawal by Subject|12|||
145276307|NCT01289990|523861081|FG003|Overall Study|Withdrawal by Subject|13|||
145276308|NCT01289990|523861082|FG004|Overall Study|Withdrawal by Subject|8|||
145276309|NCT01289990|523861083|FG005|Overall Study|Withdrawal by Subject|7|||
145276310|NCT01289990|523861084|FG006|Overall Study|Withdrawal by Subject|13|||
145276311|NCT01289990|523861085|FG007|Overall Study|Withdrawal by Subject|9|||
145276312|NCT01289990|523861086|FG008|Overall Study|Withdrawal by Subject|12|||
145276313|NCT01289990|523861087|FG009|Overall Study|Withdrawal by Subject|13|||
145276314|NCT01289990|523861088|FG010|Overall Study|Withdrawal by Subject|11|||
145276315|NCT01289990|523861089|FG011|Overall Study|Withdrawal by Subject|13|||
145276316|NCT01289990|523861090|FG012|Overall Study|Withdrawal by Subject|16|||
145276317|NCT01289990|523861078|FG000|Overall Study|discontinued in preceding trial|18|||
145276318|NCT01289990|523861079|FG001|Overall Study|discontinued in preceding trial|20|||
145276319|NCT01289990|523861080|FG002|Overall Study|discontinued in preceding trial|41|||
145276320|NCT01289990|523861081|FG003|Overall Study|discontinued in preceding trial|17|||
145276321|NCT01289990|523861082|FG004|Overall Study|discontinued in preceding trial|11|||
145276322|NCT01289990|523861083|FG005|Overall Study|discontinued in preceding trial|12|||
145276323|NCT01289990|523861084|FG006|Overall Study|discontinued in preceding trial|18|||
145276324|NCT01289990|523861085|FG007|Overall Study|discontinued in preceding trial|8|||
145276325|NCT01289990|523861086|FG008|Overall Study|discontinued in preceding trial|17|||
145276326|NCT01289990|523861087|FG009|Overall Study|discontinued in preceding trial|21|||
145276327|NCT01289990|523861088|FG010|Overall Study|discontinued in preceding trial|17|||
145276328|NCT01289990|523861089|FG011|Overall Study|discontinued in preceding trial|17|||
145276329|NCT01289990|523861090|FG012|Overall Study|discontinued in preceding trial|24|||
145276330|NCT01289990|523861078|FG000|Overall Study|did not continue in extension|41|||
145276331|NCT01289990|523861079|FG001|Overall Study|did not continue in extension|45|||
145276332|NCT01289990|523861080|FG002|Overall Study|did not continue in extension|51|||
145276333|NCT01289990|523861081|FG003|Overall Study|did not continue in extension|51|||
145276334|NCT01289990|523861082|FG004|Overall Study|did not continue in extension|48|||
145276335|NCT01289990|523861083|FG005|Overall Study|did not continue in extension|50|||
145276336|NCT01289990|523861084|FG006|Overall Study|did not continue in extension|54|||
145276337|NCT01289990|523861085|FG007|Overall Study|did not continue in extension|36|||
145276338|NCT01289990|523861086|FG008|Overall Study|did not continue in extension|44|||
145761384|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
145761385|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
145761386|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
145761387|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
145276339|NCT01289990|523861087|FG009|Overall Study|did not continue in extension|48|||
145276340|NCT01289990|523861088|FG010|Overall Study|did not continue in extension|45|||
145276341|NCT01289990|523861089|FG011|Overall Study|did not continue in extension|34|||
145276342|NCT01289990|523861090|FG012|Overall Study|did not continue in extension|56|||
145276343|NCT01289990|523861078|FG000|Overall Study|Not treated|0|||
145276344|NCT01289990|523861079|FG001|Overall Study|Not treated|0|||
145276345|NCT01289990|523861080|FG002|Overall Study|Not treated|0|||
145276346|NCT01289990|523861081|FG003|Overall Study|Not treated|0|||
145276347|NCT01289990|523861082|FG004|Overall Study|Not treated|0|||
145276348|NCT01289990|523861083|FG005|Overall Study|Not treated|0|||
145276349|NCT01289990|523861084|FG006|Overall Study|Not treated|1|||
145276350|NCT01289990|523861085|FG007|Overall Study|Not treated|0|||
145276351|NCT01289990|523861086|FG008|Overall Study|Not treated|1|||
145276352|NCT01289990|523861087|FG009|Overall Study|Not treated|0|||
145761388|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
145761389|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
145761390|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
145761391|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
145761392|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
145761393|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
145761394|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
145761395|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
145761396|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
145761397|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
145761398|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
145761399|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
145276353|NCT01289990|523861088|FG010|Overall Study|Not treated|1|||
145761400|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
145761401|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
145761402|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
145761403|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
145761404|NCT00289913|525638423|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
145761405|NCT00289913|525638424|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
145761406|NCT00289913|525638425|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
145761407|NCT00289913|525638426|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
145761408|NCT00289913|525638427|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
145761409|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761410|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
145761411|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761412|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761413|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
145761414|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
145761415|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
145761416|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
145761417|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
145761418|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
145761419|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761420|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761421|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761422|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
145761423|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
145761424|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761425|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761426|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761427|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
145761428|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
145761429|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
145761430|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
145761431|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
145402917|NCT02065557|524332548|FG004|Maintenance Period|Subject Non-Compliance|0|||
145761432|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
145761433|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
145761434|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
145276354|NCT01289990|523861089|FG011|Overall Study|Not treated|2|||
145761435|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
145761436|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
145761437|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
145761438|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
145761439|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
145761440|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
145761441|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
145761442|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
145761443|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
145761444|NCT00289913|525638423|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761445|NCT00289913|525638424|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
145761446|NCT00289913|525638425|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761447|NCT00289913|525638426|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761448|NCT00289913|525638427|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
145761449|NCT00440726|525638430|FG000|Phase 1|Dose-Limiting Toxicity|0|||
145761450|NCT00440726|525638431|FG001|Phase 1|Dose-Limiting Toxicity|1|||
145761451|NCT00440726|525638432|FG002|Phase 1|Dose-Limiting Toxicity|0|||
145761452|NCT00440726|525638430|FG000|Phase 1|Physician Decision|1|||
145761453|NCT00440726|525638431|FG001|Phase 1|Physician Decision|0|||
145761454|NCT00440726|525638432|FG002|Phase 1|Physician Decision|0|||
145761455|NCT00440726|525638430|FG000|Phase 2|Death|0|||
145761456|NCT00440726|525638431|FG001|Phase 2|Death|0|||
145761457|NCT00440726|525638432|FG002|Phase 2|Death|1|||
145761458|NCT00440726|525638430|FG000|Phase 2|Adverse Event|0|||
145761459|NCT00440726|525638431|FG001|Phase 2|Adverse Event|0|||
145761460|NCT00440726|525638432|FG002|Phase 2|Adverse Event|1|||
145761461|NCT01808612|525638433|FG000|Treatment Period|Adverse Event|8|||
145761462|NCT01808612|525638434|FG001|Treatment Period|Adverse Event|4|||
145761463|NCT01808612|525638435|FG002|Treatment Period|Adverse Event|3|||
145761464|NCT01808612|525638433|FG000|Treatment Period|Lost to Follow-up|2|||
145761465|NCT01808612|525638434|FG001|Treatment Period|Lost to Follow-up|2|||
145761466|NCT01808612|525638435|FG002|Treatment Period|Lost to Follow-up|1|||
145761467|NCT01808612|525638433|FG000|Treatment Period|Protocol Violation|1|||
145761468|NCT01808612|525638434|FG001|Treatment Period|Protocol Violation|0|||
145761469|NCT01808612|525638435|FG002|Treatment Period|Protocol Violation|0|||
145761470|NCT01808612|525638433|FG000|Treatment Period|Withdrawal by Subject|1|||
145276355|NCT01289990|523861090|FG012|Overall Study|Not treated|0|||
145607839|NCT01852058|525079283|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145276356|NCT00683904|523861091|FG000|Dose Level 1|Disease progression|2|||
145276357|NCT00683904|523861092|FG001|Dose Level 1|Disease progression|0|||
145761471|NCT01808612|525638434|FG001|Treatment Period|Withdrawal by Subject|0|||
145761472|NCT01808612|525638435|FG002|Treatment Period|Withdrawal by Subject|4|||
145761473|NCT01808612|525638433|FG000|Treatment Period|Physician Decision|1|||
145402918|NCT02065557|524332549|FG005|Maintenance Period|Subject Non-Compliance|1|||
145276358|NCT00683904|523861091|FG000|Dose Level 1|Adverse Event|1|||
145761474|NCT01808612|525638434|FG001|Treatment Period|Physician Decision|0|||
145761475|NCT01808612|525638435|FG002|Treatment Period|Physician Decision|4|||
145761476|NCT01808612|525638433|FG000|Treatment Period|Sponsor Decision|1|||
145761477|NCT01808612|525638434|FG001|Treatment Period|Sponsor Decision|0|||
145761478|NCT01808612|525638435|FG002|Treatment Period|Sponsor Decision|0|||
145761479|NCT01808612|525638433|FG000|Treatment Period|Lack of Efficacy|1|||
145761480|NCT01808612|525638434|FG001|Treatment Period|Lack of Efficacy|1|||
145761481|NCT01808612|525638435|FG002|Treatment Period|Lack of Efficacy|2|||
145276359|NCT00683904|523861092|FG001|Dose Level 1|Adverse Event|0|||
145276360|NCT00683904|523861091|FG000|Dose Level 2|Adverse Event|0|||
145276361|NCT00683904|523861092|FG001|Dose Level 2|Adverse Event|2|||
145276362|NCT01220128|523861093|FG000|Overall Study|Progressive disease|0|||
145276363|NCT01220128|523861094|FG001|Overall Study|Progressive disease|0|||
145276364|NCT01220128|523861095|FG002|Overall Study|Progressive disease|2|||
145276365|NCT01220128|523861096|FG003|Overall Study|Progressive disease|0|||
145761482|NCT01808612|525638433|FG000|Discontinuation Period|Adverse Event|1|||
145761483|NCT01808612|525638434|FG001|Discontinuation Period|Adverse Event|0|||
145761484|NCT01808612|525638435|FG002|Discontinuation Period|Adverse Event|0|||
145761485|NCT01808612|525638433|FG000|Discontinuation Period|Physician Decision|1|||
145761486|NCT01808612|525638434|FG001|Discontinuation Period|Physician Decision|0|||
145761487|NCT01808612|525638435|FG002|Discontinuation Period|Physician Decision|0|||
145761488|NCT01808612|525638433|FG000|Discontinuation Period|Lost to Follow-up|0|||
145761489|NCT01808612|525638434|FG001|Discontinuation Period|Lost to Follow-up|1|||
145761490|NCT01808612|525638435|FG002|Discontinuation Period|Lost to Follow-up|0|||
145761491|NCT03683394|525638436|FG000|Overall Study|Withdrawal by Subject|4|||
145761492|NCT03683394|525638437|FG001|Overall Study|Withdrawal by Subject|8|||
145761493|NCT03683394|525638436|FG000|Overall Study|Lost to Follow-up|7|||
145761494|NCT03683394|525638437|FG001|Overall Study|Lost to Follow-up|0|||
145761495|NCT03683394|525638436|FG000|Overall Study|Death|3|||
145276366|NCT01220128|523861097|FG004|Overall Study|Progressive disease|0|||
145276367|NCT01220128|523861098|FG005|Overall Study|Progressive disease|0|||
145402919|NCT01200355|524332550|FG000|Overall Study|Death|7|||
145276368|NCT01220128|523861099|FG006|Overall Study|Progressive disease|0|||
145276369|NCT01220128|523861093|FG000|Overall Study|Sponsor study termination|0|||
145276370|NCT01220128|523861094|FG001|Overall Study|Sponsor study termination|1|||
145761496|NCT03683394|525638437|FG001|Overall Study|Death|1|||
145761497|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Adverse Event|11|||
145276371|NCT01220128|523861095|FG002|Overall Study|Sponsor study termination|0|||
145276372|NCT01220128|523861096|FG003|Overall Study|Sponsor study termination|0|||
145276373|NCT01220128|523861097|FG004|Overall Study|Sponsor study termination|0|||
145276374|NCT01220128|523861098|FG005|Overall Study|Sponsor study termination|0|||
145276375|NCT01220128|523861099|FG006|Overall Study|Sponsor study termination|1|||
145276376|NCT01220128|523861093|FG000|Overall Study|Adverse event, serious fatal|2|||
145276377|NCT01220128|523861094|FG001|Overall Study|Adverse event, serious fatal|0|||
145276378|NCT01220128|523861095|FG002|Overall Study|Adverse event, serious fatal|0|||
145276379|NCT01220128|523861096|FG003|Overall Study|Adverse event, serious fatal|0|||
145276380|NCT01220128|523861097|FG004|Overall Study|Adverse event, serious fatal|0|||
145276381|NCT01220128|523861098|FG005|Overall Study|Adverse event, serious fatal|0|||
145276382|NCT01220128|523861099|FG006|Overall Study|Adverse event, serious fatal|1|||
145276383|NCT01220128|523861093|FG000|Overall Study|Adverse event, non-fatal|1|||
145276384|NCT01220128|523861094|FG001|Overall Study|Adverse event, non-fatal|0|||
145276385|NCT01220128|523861095|FG002|Overall Study|Adverse event, non-fatal|0|||
145276386|NCT01220128|523861096|FG003|Overall Study|Adverse event, non-fatal|0|||
145276387|NCT01220128|523861097|FG004|Overall Study|Adverse event, non-fatal|0|||
145276388|NCT01220128|523861098|FG005|Overall Study|Adverse event, non-fatal|0|||
145276389|NCT01220128|523861099|FG006|Overall Study|Adverse event, non-fatal|3|||
145276390|NCT01220128|523861093|FG000|Overall Study|Other|0|||
145276391|NCT01220128|523861094|FG001|Overall Study|Other|0|||
145276392|NCT01220128|523861095|FG002|Overall Study|Other|1|||
145276393|NCT01220128|523861096|FG003|Overall Study|Other|0|||
145276394|NCT01220128|523861097|FG004|Overall Study|Other|0|||
145276395|NCT01220128|523861098|FG005|Overall Study|Other|0|||
145276396|NCT01220128|523861099|FG006|Overall Study|Other|0|||
145276397|NCT01220128|523861093|FG000|Overall Study|Consent withdrawn by subject|1|||
145276398|NCT01220128|523861094|FG001|Overall Study|Consent withdrawn by subject|0|||
145276399|NCT01220128|523861095|FG002|Overall Study|Consent withdrawn by subject|0|||
145276400|NCT01220128|523861096|FG003|Overall Study|Consent withdrawn by subject|0|||
145276401|NCT01220128|523861097|FG004|Overall Study|Consent withdrawn by subject|0|||
145276402|NCT01220128|523861098|FG005|Overall Study|Consent withdrawn by subject|0|||
145276403|NCT01220128|523861099|FG006|Overall Study|Consent withdrawn by subject|0|||
145276404|NCT02392559|523861100|FG000|Overall Study|Withdrawal by Subject|0|||
145276405|NCT02392559|523861101|FG001|Overall Study|Withdrawal by Subject|1|||
145276406|NCT01500434|523861105|FG000|Overall Study|Death|1|||
145276407|NCT01500434|523861105|FG000|Overall Study|Withdrawal by Subject|1|||
145276408|NCT01500434|523861105|FG000|Overall Study|Missed 12-month follow-up|5|||
145276409|NCT00752895|523861109|FG000|Overall Study|Withdrawal by Subject|8|||
145276410|NCT00752895|523861110|FG001|Overall Study|Withdrawal by Subject|3|||
145402920|NCT01200355|524332551|FG001|Overall Study|Death|2|||
145276411|NCT00633217|523861111|FG000|Overall Study|Adverse Event|5|||
145276412|NCT00633217|523861112|FG001|Overall Study|Adverse Event|9|||
145276413|NCT00633217|523861111|FG000|Overall Study|Lack of Efficacy|0|||
145276414|NCT00633217|523861112|FG001|Overall Study|Lack of Efficacy|2|||
145276415|NCT00633217|523861111|FG000|Overall Study|Protocol Violation|3|||
145276416|NCT00633217|523861112|FG001|Overall Study|Protocol Violation|7|||
145276417|NCT00633217|523861111|FG000|Overall Study|Lost to Follow-up|2|||
145276418|NCT00633217|523861112|FG001|Overall Study|Lost to Follow-up|2|||
145761498|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Adverse Event|15|||
145761499|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
145761500|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
145761501|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
145761502|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
145761503|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
145292756|NCT06179108|523922229|FG003|Overall Study|Adverse Event|2|||
145402921|NCT00250588|524332552|FG000|Overall Study|Withdrawal by Subject|3|||
145276419|NCT00633217|523861111|FG000|Overall Study|Investigator Discretion|2|||
145276420|NCT00633217|523861112|FG001|Overall Study|Investigator Discretion|0|||
145276421|NCT00633217|523861111|FG000|Overall Study|Withdrew Consent|3|||
145276422|NCT00633217|523861112|FG001|Overall Study|Withdrew Consent|3|||
145276423|NCT00314262|523861113|FG000|Overall Study|Adverse Event|2|||
145276424|NCT00314262|523861113|FG000|Overall Study|Withdrawal by Subject|2|||
145276425|NCT00314262|523861113|FG000|Overall Study|Physician Decision|1|||
145276426|NCT00828516|523861120|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
145276427|NCT01556165|523861121|FG000|Overall Study|Adverse Event|5|||
145276428|NCT01556165|523861122|FG001|Overall Study|Adverse Event|3|||
145276429|NCT01556165|523861121|FG000|Overall Study|Protocol Violation|0|||
145276430|NCT01556165|523861122|FG001|Overall Study|Protocol Violation|3|||
145276431|NCT01556165|523861121|FG000|Overall Study|Withdrawal of Consent|7|||
145276432|NCT01556165|523861122|FG001|Overall Study|Withdrawal of Consent|1|||
145276433|NCT02787746|523861128|FG000|Overall Study|Adverse Event|42|||
145276434|NCT02787746|523861128|FG000|Overall Study|Withdrawal by Subject|65|||
145276435|NCT02787746|523861128|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
145276436|NCT04822701|523861131|FG000|Overall Study|Not treated|2|||
145276437|NCT04822701|523861132|FG001|Overall Study|Not treated|0|||
145276438|NCT04822701|523861131|FG000|Overall Study|Lost to Follow-up|1|||
145276439|NCT04822701|523861132|FG001|Overall Study|Lost to Follow-up|0|||
145276440|NCT04822701|523861131|FG000|Overall Study|Withdrawal by Subject|1|||
145276441|NCT04822701|523861132|FG001|Overall Study|Withdrawal by Subject|0|||
145276442|NCT00700310|523862997|FG000|Overall Study|Adverse Event|6|||
145276443|NCT00700310|523862998|FG001|Overall Study|Adverse Event|10|||
145276444|NCT00700310|523862999|FG002|Overall Study|Adverse Event|5|||
145276445|NCT00700310|523863000|FG003|Overall Study|Adverse Event|11|||
145276446|NCT00700310|523862997|FG000|Overall Study|Lost to Follow-up|4|||
145276447|NCT00700310|523862998|FG001|Overall Study|Lost to Follow-up|1|||
145276448|NCT00700310|523862999|FG002|Overall Study|Lost to Follow-up|0|||
145276449|NCT00700310|523863000|FG003|Overall Study|Lost to Follow-up|1|||
145276450|NCT00700310|523862997|FG000|Overall Study|Withdrawal by Subject|8|||
145276451|NCT00700310|523862998|FG001|Overall Study|Withdrawal by Subject|9|||
145276452|NCT00700310|523862999|FG002|Overall Study|Withdrawal by Subject|8|||
145276453|NCT00700310|523863000|FG003|Overall Study|Withdrawal by Subject|8|||
145276454|NCT00700310|523862997|FG000|Overall Study|Lack of Efficacy|0|||
145276455|NCT00700310|523862998|FG001|Overall Study|Lack of Efficacy|3|||
145276456|NCT00700310|523862999|FG002|Overall Study|Lack of Efficacy|0|||
145276457|NCT00700310|523863000|FG003|Overall Study|Lack of Efficacy|1|||
145276458|NCT00700310|523862997|FG000|Overall Study|Administrative/Other|1|||
145276459|NCT00700310|523862998|FG001|Overall Study|Administrative/Other|3|||
145276460|NCT00700310|523862999|FG002|Overall Study|Administrative/Other|1|||
145276461|NCT00700310|523863000|FG003|Overall Study|Administrative/Other|3|||
145276462|NCT00700310|523862997|FG000|Overall Study|Randomized, Not Treated|2|||
145276463|NCT00700310|523862998|FG001|Overall Study|Randomized, Not Treated|0|||
145276464|NCT00700310|523862999|FG002|Overall Study|Randomized, Not Treated|2|||
145276465|NCT00700310|523863000|FG003|Overall Study|Randomized, Not Treated|2|||
145276466|NCT02082262|523863001|FG000|Overall Study|Withdrawal by Subject|3|||
145276467|NCT02082262|523863001|FG000|Overall Study|Adverse Event|48|||
145276468|NCT01408576|523863003|FG000|Overall Study|Lack of Efficacy|17|||
145276469|NCT01408576|523863004|FG001|Overall Study|Lack of Efficacy|30|||
145276470|NCT01408576|523863005|FG002|Overall Study|Lack of Efficacy|48|||
145276471|NCT01408576|523863003|FG000|Overall Study|Protocol Violation|1|||
145276472|NCT01408576|523863004|FG001|Overall Study|Protocol Violation|2|||
145276473|NCT01408576|523863005|FG002|Overall Study|Protocol Violation|2|||
145276474|NCT01408576|523863003|FG000|Overall Study|Lost to Follow-up|10|||
145276475|NCT01408576|523863004|FG001|Overall Study|Lost to Follow-up|9|||
145276476|NCT01408576|523863005|FG002|Overall Study|Lost to Follow-up|17|||
145276477|NCT01408576|523863003|FG000|Overall Study|Withdrawal by Subject|34|||
145276478|NCT01408576|523863004|FG001|Overall Study|Withdrawal by Subject|60|||
145276479|NCT01408576|523863005|FG002|Overall Study|Withdrawal by Subject|66|||
145276480|NCT01408576|523863003|FG000|Overall Study|Sponsor terminated study|89|||
145276481|NCT01408576|523863004|FG001|Overall Study|Sponsor terminated study|333|||
145276482|NCT01408576|523863005|FG002|Overall Study|Sponsor terminated study|330|||
145276483|NCT01408576|523863003|FG000|Overall Study|AE, serious fatal|4|||
145276484|NCT01408576|523863004|FG001|Overall Study|AE, serious fatal|4|||
145276485|NCT01408576|523863005|FG002|Overall Study|AE, serious fatal|1|||
145276486|NCT01408576|523863003|FG000|Overall Study|SAE, non-fatal|11|||
145276487|NCT01408576|523863004|FG001|Overall Study|SAE, non-fatal|23|||
145276488|NCT01408576|523863005|FG002|Overall Study|SAE, non-fatal|14|||
145276489|NCT01408576|523863003|FG000|Overall Study|AE, non-serious non-fatal|12|||
145276490|NCT01408576|523863004|FG001|Overall Study|AE, non-serious non-fatal|19|||
145276491|NCT01408576|523863005|FG002|Overall Study|AE, non-serious non-fatal|11|||
145276492|NCT01408576|523863003|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145276493|NCT01408576|523863004|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145276494|NCT01408576|523863005|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145276495|NCT01408576|523863003|FG000|Overall Study|AE, unknown type|0|||
145276496|NCT01408576|523863004|FG001|Overall Study|AE, unknown type|1|||
145276497|NCT01408576|523863005|FG002|Overall Study|AE, unknown type|0|||
145276498|NCT01408576|523863003|FG000|Overall Study|Other|10|||
145276499|NCT01408576|523863004|FG001|Overall Study|Other|16|||
145276500|NCT01408576|523863005|FG002|Overall Study|Other|18|||
145276501|NCT00802529|523863006|FG000|Overall Study|Lost to Follow-up|0|||
145276502|NCT00802529|523863007|FG001|Overall Study|Lost to Follow-up|1|||
145276503|NCT00337129|523863008|FG000|Overall Study|Adverse Event|4|||
145276504|NCT00337129|523863008|FG000|Overall Study|Withdrawal by Subject|1|||
145276505|NCT00337129|523863008|FG000|Overall Study|Lack of Efficacy|32|||
145276506|NCT00337129|523863008|FG000|Overall Study|Death|2|||
145276507|NCT00337129|523863008|FG000|Overall Study|not protocol specified|1|||
145276508|NCT00647426|523863009|FG000|Overall Study|Withdrawal by Subject|2|||
145276509|NCT01467570|523863011|FG000|Overall Study|Lost to Follow-up|8|||
145276510|NCT01467570|523863012|FG001|Overall Study|Lost to Follow-up|9|||
145276511|NCT02626182|523863015|FG000|Overall Study|Adverse Event|2|||
145276512|NCT02626182|523863016|FG001|Overall Study|Adverse Event|0|||
145276513|NCT01084603|523863021|FG000|Baseline|Withdrawal by Subject|2|||
145276514|NCT01084603|523863021|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
145276515|NCT01084603|523863021|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
145276516|NCT01084603|523863021|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
145276517|NCT01084603|523863021|FG000|Washout Period 4|Adverse Event|1|||
145276518|NCT03836729|523863030|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
145276519|NCT00948025|523863032|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
145276520|NCT00948025|523863033|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
145276521|NCT00948025|523863032|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
145276522|NCT00948025|523863033|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
145276523|NCT00948025|523863032|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
145276524|NCT00948025|523863033|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
145276525|NCT00763269|523863036|FG000|Overall Study|Lost to Follow-up|12|||
145276526|NCT00763269|523863037|FG001|Overall Study|Lost to Follow-up|13|||
145276527|NCT00589693|523863045|FG000|Overall Study|randomized in error|12|||
145276528|NCT00589693|523863046|FG001|Overall Study|randomized in error|6|||
145276529|NCT00589693|523863045|FG000|Overall Study|Adverse Event|4|||
145276530|NCT00589693|523863046|FG001|Overall Study|Adverse Event|4|||
145276531|NCT00589693|523863045|FG000|Overall Study|Death|26|||
145276532|NCT00589693|523863046|FG001|Overall Study|Death|16|||
145276533|NCT00589693|523863045|FG000|Overall Study|Lack of Efficacy|0|||
145276534|NCT00589693|523863046|FG001|Overall Study|Lack of Efficacy|1|||
145276535|NCT00589693|523863045|FG000|Overall Study|Lost to Follow-up|1|||
145276536|NCT00589693|523863046|FG001|Overall Study|Lost to Follow-up|0|||
145276537|NCT00589693|523863045|FG000|Overall Study|Physician Decision|0|||
145276538|NCT00589693|523863046|FG001|Overall Study|Physician Decision|1|||
145276539|NCT00589693|523863045|FG000|Overall Study|Protocol Violation|1|||
145276540|NCT00589693|523863046|FG001|Overall Study|Protocol Violation|1|||
145276541|NCT03231709|523863047|FG000|Treatment Period 1|Reason not Specified|0|||
145276542|NCT03231709|523863048|FG001|Treatment Period 1|Reason not Specified|1|||
145276543|NCT03231709|523863047|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
145276544|NCT03231709|523863048|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
145276545|NCT02609178|523863049|FG000|First Crown|Withdrawal by Subject|0|||
145276546|NCT02609178|523863050|FG001|First Crown|Withdrawal by Subject|0|||
145276547|NCT02609178|523863051|FG002|First Crown|Withdrawal by Subject|1|||
145276548|NCT02609178|523863052|FG003|First Crown|Withdrawal by Subject|1|||
145276549|NCT02609178|523863053|FG004|First Crown|Withdrawal by Subject|0|||
145276550|NCT02609178|523863054|FG005|First Crown|Withdrawal by Subject|0|||
145276551|NCT01128153|523863055|FG000|Overall Study|Adverse Event|1|||
145276552|NCT01128153|523863056|FG001|Overall Study|Adverse Event|3|||
145276553|NCT01128153|523863055|FG000|Overall Study|Condition under investigation worsened|8|||
145276554|NCT01128153|523863056|FG001|Overall Study|Condition under investigation worsened|7|||
145276555|NCT01128153|523863055|FG000|Overall Study|Withdrawal by Subject|2|||
145276556|NCT01128153|523863056|FG001|Overall Study|Withdrawal by Subject|3|||
145276557|NCT01128153|523863055|FG000|Overall Study|Incorrect enrolment to study|2|||
145276558|NCT01128153|523863056|FG001|Overall Study|Incorrect enrolment to study|1|||
145276559|NCT01128153|523863055|FG000|Overall Study|Protocol Violation|2|||
145276560|NCT01128153|523863056|FG001|Overall Study|Protocol Violation|0|||
145276561|NCT01128153|523863055|FG000|Overall Study|Developed discontinuation criteria|1|||
145276562|NCT01128153|523863056|FG001|Overall Study|Developed discontinuation criteria|1|||
145276563|NCT01954082|523863057|FG000|Overall Study|Study Suspension|42|||
145276564|NCT01954082|523863058|FG001|Overall Study|Study Suspension|36|||
145276565|NCT01954082|523863057|FG000|Overall Study|Adverse Event|10|||
145276566|NCT01954082|523863058|FG001|Overall Study|Adverse Event|4|||
145276567|NCT01954082|523863057|FG000|Overall Study|Intolerance|0|||
145276568|NCT01954082|523863058|FG001|Overall Study|Intolerance|1|||
145276569|NCT01954082|523863057|FG000|Overall Study|Non-compliance|6|||
145276570|NCT01954082|523863058|FG001|Overall Study|Non-compliance|4|||
145276571|NCT01954082|523863057|FG000|Overall Study|Physician Decision|2|||
145276572|NCT01954082|523863058|FG001|Overall Study|Physician Decision|0|||
145276573|NCT01954082|523863057|FG000|Overall Study|Parent Decision|1|||
145276574|NCT01954082|523863058|FG001|Overall Study|Parent Decision|0|||
145276575|NCT01954082|523863057|FG000|Overall Study|Withdrawal by Subject|0|||
145276576|NCT01954082|523863058|FG001|Overall Study|Withdrawal by Subject|1|||
145276577|NCT01954082|523863057|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
145276578|NCT01954082|523863058|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
145761504|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
145761505|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145761506|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
145761507|NCT01058096|525638438|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
145761508|NCT01058096|525638439|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
145761509|NCT00559273|525638440|FG000|Correction Period (20 Weeks)|Death|3|||
145276579|NCT01954082|523863057|FG000|Overall Study|Redirection of Care|0|||
145276580|NCT01954082|523863058|FG001|Overall Study|Redirection of Care|2|||
145761510|NCT00559273|525638441|FG001|Correction Period (20 Weeks)|Death|4|||
145761511|NCT00559273|525638440|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
145761512|NCT00559273|525638441|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
145761513|NCT00559273|525638440|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
145761514|NCT00559273|525638441|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
145761515|NCT00559273|525638440|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
145761516|NCT00559273|525638441|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
145276581|NCT01954082|523863057|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
145276582|NCT01954082|523863058|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
145276583|NCT01954082|523863057|FG000|Overall Study|Comfort Care|0|||
145276584|NCT01954082|523863058|FG001|Overall Study|Comfort Care|1|||
145276585|NCT01954082|523863057|FG000|Overall Study|Infant Moved|0|||
145276586|NCT01954082|523863058|FG001|Overall Study|Infant Moved|1|||
145276587|NCT01954082|523863057|FG000|Overall Study|Randomized not Treated|4|||
145276588|NCT01954082|523863058|FG001|Overall Study|Randomized not Treated|2|||
145276589|NCT02419469|523863059|FG000|Overall Study|Withdrawal by Subject|1|||
145276590|NCT01682512|523863060|FG000|Overall Study|Adverse Event|6|||
145276591|NCT01682512|523863061|FG001|Overall Study|Adverse Event|5|||
145276592|NCT01682512|523863062|FG002|Overall Study|Adverse Event|2|||
145276593|NCT01682512|523863060|FG000|Overall Study|Withdrawal by Subject|2|||
145276594|NCT01682512|523863061|FG001|Overall Study|Withdrawal by Subject|6|||
145276595|NCT01682512|523863062|FG002|Overall Study|Withdrawal by Subject|3|||
145276596|NCT01682512|523863060|FG000|Overall Study|Physician Decision|0|||
145276597|NCT01682512|523863061|FG001|Overall Study|Physician Decision|2|||
145761517|NCT00559273|525638440|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
145761518|NCT00559273|525638441|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
145761519|NCT00559273|525638440|FG000|Evaluation Period (8 Weeks)|Death|1|||
145761520|NCT00559273|525638441|FG001|Evaluation Period (8 Weeks)|Death|3|||
145761521|NCT00559273|525638440|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
145761522|NCT00559273|525638441|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
145761523|NCT00559273|525638440|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
145276598|NCT01682512|523863062|FG002|Overall Study|Physician Decision|0|||
145276599|NCT01682512|523863060|FG000|Overall Study|Study terminated by sponsor|46|||
145276600|NCT01682512|523863061|FG001|Overall Study|Study terminated by sponsor|43|||
145276601|NCT01682512|523863062|FG002|Overall Study|Study terminated by sponsor|0|||
145276602|NCT01682512|523863060|FG000|Overall Study|Lost to Follow-up|3|||
145276603|NCT01682512|523863061|FG001|Overall Study|Lost to Follow-up|0|||
145276604|NCT01682512|523863062|FG002|Overall Study|Lost to Follow-up|2|||
145276605|NCT01682512|523863060|FG000|Overall Study|Protocol Violation|2|||
145276606|NCT01682512|523863061|FG001|Overall Study|Protocol Violation|3|||
145276607|NCT01682512|523863062|FG002|Overall Study|Protocol Violation|2|||
145276608|NCT01682512|523863060|FG000|Overall Study|Primary lack of efficacy|10|||
145276609|NCT01682512|523863061|FG001|Overall Study|Primary lack of efficacy|7|||
145276610|NCT01682512|523863062|FG002|Overall Study|Primary lack of efficacy|7|||
145276611|NCT01682512|523863060|FG000|Overall Study|Secondary lack of efficacy|1|||
145761524|NCT00559273|525638441|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
145276612|NCT01682512|523863061|FG001|Overall Study|Secondary lack of efficacy|1|||
145276613|NCT01682512|523863062|FG002|Overall Study|Secondary lack of efficacy|0|||
145276614|NCT01682512|523863060|FG000|Overall Study|Other than stated above|2|||
145276615|NCT01682512|523863061|FG001|Overall Study|Other than stated above|4|||
145276616|NCT01682512|523863062|FG002|Overall Study|Other than stated above|2|||
145276617|NCT01377233|523863063|FG000|Open-label|Adverse Event|1|||
145276618|NCT01377233|523863064|FG001|Open-label|Adverse Event|0|||
145276619|NCT01377233|523863065|FG002|Open-label|Adverse Event|0|||
145276620|NCT01377233|523863066|FG003|Open-label|Adverse Event|0|||
145761525|NCT00559273|525638440|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
145761526|NCT00559273|525638441|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
145276621|NCT01377233|523863067|FG004|Open-label|Adverse Event|0|||
145276622|NCT01377233|523863063|FG000|Open-label|Withdrawal by Subject|3|||
145276623|NCT01377233|523863064|FG001|Open-label|Withdrawal by Subject|0|||
145402922|NCT00250588|524332553|FG001|Overall Study|Withdrawal by Subject|6|||
145276624|NCT01377233|523863065|FG002|Open-label|Withdrawal by Subject|0|||
145276625|NCT01377233|523863066|FG003|Open-label|Withdrawal by Subject|0|||
145761527|NCT01299727|525638446|FG000|Overall Study|Withdrawal by Subject|1|||
145761528|NCT01299727|525638447|FG001|Overall Study|Withdrawal by Subject|0|||
145761529|NCT01299727|525638448|FG002|Overall Study|Withdrawal by Subject|0|||
145761530|NCT01299727|525638446|FG000|Overall Study|Adverse Event|0|||
145761531|NCT01299727|525638447|FG001|Overall Study|Adverse Event|0|||
145761532|NCT01299727|525638448|FG002|Overall Study|Adverse Event|1|||
145761533|NCT01299727|525638446|FG000|Overall Study|Completed the Treatment Period|3|||
145761534|NCT01299727|525638447|FG001|Overall Study|Completed the Treatment Period|4|||
145761535|NCT01299727|525638448|FG002|Overall Study|Completed the Treatment Period|3|||
145761536|NCT00944034|525638451|FG000|Overall Study|Inappropriate enrollment|0|||
145761537|NCT00944034|525638452|FG001|Overall Study|Inappropriate enrollment|1|||
145761538|NCT00944034|525638453|FG002|Overall Study|Inappropriate enrollment|0|||
145761539|NCT00944034|525638454|FG003|Overall Study|Inappropriate enrollment|1|||
145761540|NCT00944034|525638455|FG004|Overall Study|Inappropriate enrollment|2|||
145761541|NCT00944034|525638456|FG005|Overall Study|Inappropriate enrollment|1|||
145761542|NCT00944034|525638457|FG006|Overall Study|Inappropriate enrollment|0|||
145761543|NCT00944034|525638458|FG007|Overall Study|Inappropriate enrollment|0|||
145761544|NCT00944034|525638459|FG008|Overall Study|Inappropriate enrollment|1|||
145761545|NCT00944034|525638460|FG009|Overall Study|Inappropriate enrollment|1|||
145761546|NCT00944034|525638461|FG010|Overall Study|Inappropriate enrollment|0|||
145761547|NCT00944034|525638462|FG011|Overall Study|Inappropriate enrollment|0|||
145761548|NCT00944034|525638451|FG000|Overall Study|Withdrawal by Subject|3|||
145761549|NCT00944034|525638452|FG001|Overall Study|Withdrawal by Subject|2|||
145761550|NCT00944034|525638453|FG002|Overall Study|Withdrawal by Subject|6|||
145761551|NCT00944034|525638454|FG003|Overall Study|Withdrawal by Subject|2|||
145761552|NCT00944034|525638455|FG004|Overall Study|Withdrawal by Subject|5|||
145761553|NCT00944034|525638456|FG005|Overall Study|Withdrawal by Subject|8|||
145761554|NCT00944034|525638457|FG006|Overall Study|Withdrawal by Subject|2|||
145761555|NCT00944034|525638458|FG007|Overall Study|Withdrawal by Subject|2|||
145761556|NCT00944034|525638459|FG008|Overall Study|Withdrawal by Subject|3|||
145761557|NCT00944034|525638460|FG009|Overall Study|Withdrawal by Subject|4|||
145761558|NCT00944034|525638461|FG010|Overall Study|Withdrawal by Subject|0|||
145761559|NCT00944034|525638462|FG011|Overall Study|Withdrawal by Subject|4|||
145761560|NCT00944034|525638451|FG000|Overall Study|Lost to Follow-up|0|||
145761561|NCT00944034|525638452|FG001|Overall Study|Lost to Follow-up|4|||
145761562|NCT00944034|525638453|FG002|Overall Study|Lost to Follow-up|2|||
145761563|NCT00944034|525638454|FG003|Overall Study|Lost to Follow-up|0|||
145761564|NCT00944034|525638455|FG004|Overall Study|Lost to Follow-up|5|||
145761565|NCT00944034|525638456|FG005|Overall Study|Lost to Follow-up|7|||
145761566|NCT00944034|525638457|FG006|Overall Study|Lost to Follow-up|0|||
145761567|NCT00944034|525638458|FG007|Overall Study|Lost to Follow-up|1|||
145761568|NCT00944034|525638459|FG008|Overall Study|Lost to Follow-up|5|||
145761569|NCT00944034|525638460|FG009|Overall Study|Lost to Follow-up|1|||
145761570|NCT00944034|525638461|FG010|Overall Study|Lost to Follow-up|1|||
145761571|NCT00944034|525638462|FG011|Overall Study|Lost to Follow-up|0|||
145761572|NCT00944034|525638451|FG000|Overall Study|Death|0|||
145761573|NCT00944034|525638452|FG001|Overall Study|Death|0|||
145761574|NCT00944034|525638453|FG002|Overall Study|Death|1|||
145761575|NCT00944034|525638454|FG003|Overall Study|Death|0|||
145761576|NCT00944034|525638455|FG004|Overall Study|Death|0|||
145761577|NCT00944034|525638456|FG005|Overall Study|Death|0|||
145761578|NCT00944034|525638457|FG006|Overall Study|Death|0|||
145761579|NCT00944034|525638458|FG007|Overall Study|Death|0|||
145761580|NCT00944034|525638459|FG008|Overall Study|Death|0|||
145761581|NCT00944034|525638460|FG009|Overall Study|Death|0|||
145761582|NCT00944034|525638461|FG010|Overall Study|Death|0|||
145761583|NCT00944034|525638462|FG011|Overall Study|Death|0|||
145761584|NCT00944034|525638451|FG000|Overall Study|Protocol Violation|2|||
145761585|NCT00944034|525638452|FG001|Overall Study|Protocol Violation|0|||
145761586|NCT00944034|525638453|FG002|Overall Study|Protocol Violation|0|||
145761587|NCT00944034|525638454|FG003|Overall Study|Protocol Violation|1|||
145761588|NCT00944034|525638455|FG004|Overall Study|Protocol Violation|2|||
145761589|NCT00944034|525638456|FG005|Overall Study|Protocol Violation|3|||
145761590|NCT00944034|525638457|FG006|Overall Study|Protocol Violation|0|||
145761591|NCT00944034|525638458|FG007|Overall Study|Protocol Violation|1|||
145761592|NCT00944034|525638459|FG008|Overall Study|Protocol Violation|1|||
145761593|NCT00944034|525638460|FG009|Overall Study|Protocol Violation|4|||
145761594|NCT00944034|525638461|FG010|Overall Study|Protocol Violation|0|||
145276626|NCT01377233|523863067|FG004|Open-label|Withdrawal by Subject|0|||
145761595|NCT00944034|525638462|FG011|Overall Study|Protocol Violation|0|||
145761596|NCT00944034|525638451|FG000|Overall Study|Unable to classify|0|||
145761597|NCT00944034|525638452|FG001|Overall Study|Unable to classify|0|||
145761598|NCT00944034|525638453|FG002|Overall Study|Unable to classify|0|||
145761599|NCT00944034|525638454|FG003|Overall Study|Unable to classify|0|||
145761600|NCT00944034|525638455|FG004|Overall Study|Unable to classify|0|||
145761601|NCT00944034|525638456|FG005|Overall Study|Unable to classify|1|||
145761602|NCT00944034|525638457|FG006|Overall Study|Unable to classify|1|||
145761603|NCT00944034|525638458|FG007|Overall Study|Unable to classify|1|||
145761604|NCT00944034|525638459|FG008|Overall Study|Unable to classify|0|||
145761605|NCT00944034|525638460|FG009|Overall Study|Unable to classify|0|||
145276627|NCT01377233|523863063|FG000|Double-blind|Adverse Event|0|||
145276628|NCT01377233|523863064|FG001|Double-blind|Adverse Event|1|||
145276629|NCT01377233|523863065|FG002|Double-blind|Adverse Event|2|||
145276630|NCT01377233|523863066|FG003|Double-blind|Adverse Event|2|||
145276631|NCT01377233|523863067|FG004|Double-blind|Adverse Event|0|||
145276632|NCT01377233|523863063|FG000|Double-blind|Protocol Violation|0|||
145276633|NCT01377233|523863064|FG001|Double-blind|Protocol Violation|0|||
145276634|NCT01377233|523863065|FG002|Double-blind|Protocol Violation|0|||
145276635|NCT01377233|523863066|FG003|Double-blind|Protocol Violation|0|||
145276636|NCT01377233|523863067|FG004|Double-blind|Protocol Violation|1|||
145276637|NCT01377233|523863063|FG000|Double-blind|Withdrawal by Subject|0|||
145276638|NCT01377233|523863064|FG001|Double-blind|Withdrawal by Subject|0|||
145276639|NCT01377233|523863065|FG002|Double-blind|Withdrawal by Subject|0|||
145276640|NCT01377233|523863066|FG003|Double-blind|Withdrawal by Subject|1|||
145276641|NCT01377233|523863067|FG004|Double-blind|Withdrawal by Subject|0|||
145276642|NCT01377233|523863063|FG000|Double-blind|Administrative or other|0|||
145761606|NCT00944034|525638461|FG010|Overall Study|Unable to classify|0|||
145761607|NCT00944034|525638462|FG011|Overall Study|Unable to classify|0|||
145761608|NCT00944034|525638451|FG000|Overall Study|Administrative reason|0|||
145761609|NCT00944034|525638452|FG001|Overall Study|Administrative reason|0|||
145761610|NCT00944034|525638453|FG002|Overall Study|Administrative reason|0|||
145761611|NCT00944034|525638454|FG003|Overall Study|Administrative reason|0|||
145761612|NCT00944034|525638455|FG004|Overall Study|Administrative reason|0|||
145761613|NCT00944034|525638456|FG005|Overall Study|Administrative reason|0|||
145761614|NCT00944034|525638457|FG006|Overall Study|Administrative reason|1|||
145761615|NCT00944034|525638458|FG007|Overall Study|Administrative reason|0|||
145761616|NCT00944034|525638459|FG008|Overall Study|Administrative reason|0|||
145761617|NCT00944034|525638460|FG009|Overall Study|Administrative reason|0|||
145761618|NCT00944034|525638461|FG010|Overall Study|Administrative reason|0|||
145761619|NCT00944034|525638462|FG011|Overall Study|Administrative reason|0|||
145761620|NCT01596257|525638465|FG000|Overall Study|Inadequate Collection|23|||
145761621|NCT01596257|525638466|FG001|Overall Study|Inadequate Collection|19|||
145761622|NCT00531960|525638473|FG000|Overall Study|Adverse Event|5|||
145761623|NCT00531960|525638474|FG001|Overall Study|Adverse Event|4|||
145761624|NCT00531960|525638473|FG000|Overall Study|Death|3|||
145761625|NCT00531960|525638474|FG001|Overall Study|Death|2|||
145761626|NCT00531960|525638473|FG000|Overall Study|Lack of Efficacy|42|||
145761627|NCT00531960|525638474|FG001|Overall Study|Lack of Efficacy|41|||
145761628|NCT00531960|525638473|FG000|Overall Study|Violation of Selection Criteria|2|||
145761629|NCT00531960|525638474|FG001|Overall Study|Violation of Selection Criteria|0|||
145761630|NCT00531960|525638473|FG000|Overall Study|Refused Treatment|5|||
145761631|NCT00531960|525638474|FG001|Overall Study|Refused Treatment|6|||
145761632|NCT00531960|525638473|FG000|Overall Study|Other|4|||
145761633|NCT00531960|525638474|FG001|Overall Study|Other|10|||
145761634|NCT03157531|525638478|FG000|Overall Study|Death|2|||
145761635|NCT03157531|525638478|FG000|Overall Study|Lost to Follow-up|4|||
145761636|NCT01879410|525638481|FG000|Overall Study|Adverse Event|9|||
145761637|NCT01879410|525638482|FG001|Overall Study|Adverse Event|14|||
145276643|NCT01377233|523863064|FG001|Double-blind|Administrative or other|0|||
145276644|NCT01377233|523863065|FG002|Double-blind|Administrative or other|0|||
145276645|NCT01377233|523863066|FG003|Double-blind|Administrative or other|1|||
145276646|NCT01377233|523863067|FG004|Double-blind|Administrative or other|1|||
145276647|NCT01785875|523863068|FG000|Overall Study|Withdrawal by Subject|41|||
145276648|NCT01785875|523863069|FG001|Overall Study|Withdrawal by Subject|34|||
145761638|NCT01879410|525638481|FG000|Overall Study|Lack of Efficacy|4|||
145761639|NCT01879410|525638482|FG001|Overall Study|Lack of Efficacy|6|||
145761640|NCT01879410|525638481|FG000|Overall Study|Protocol Violation|1|||
145761641|NCT01879410|525638482|FG001|Overall Study|Protocol Violation|7|||
145761642|NCT01879410|525638481|FG000|Overall Study|Lost to Follow-up|2|||
145761643|NCT01879410|525638482|FG001|Overall Study|Lost to Follow-up|1|||
145761644|NCT01879410|525638481|FG000|Overall Study|Withdrawal by Subject|7|||
145761645|NCT01879410|525638482|FG001|Overall Study|Withdrawal by Subject|8|||
145761646|NCT01879410|525638481|FG000|Overall Study|Randomised in Error|1|||
145761647|NCT01879410|525638482|FG001|Overall Study|Randomised in Error|2|||
145761648|NCT00713219|525638491|FG000|Overall Study|Death|1|||
145761649|NCT00713219|525638491|FG000|Overall Study|Protocol Violation|1|||
145761650|NCT03183128|525638495|FG000|Overall Study|Adverse Event|1|||
145761651|NCT03183128|525638496|FG001|Overall Study|Adverse Event|2|||
145761652|NCT03183128|525638495|FG000|Overall Study|Withdrawal by Subject|1|||
145761653|NCT03183128|525638496|FG001|Overall Study|Withdrawal by Subject|8|||
145276649|NCT01785875|523863070|FG002|Overall Study|Withdrawal by Subject|36|||
145276650|NCT01785875|523863068|FG000|Overall Study|Lost to Follow-up|19|||
145276651|NCT01785875|523863069|FG001|Overall Study|Lost to Follow-up|22|||
145761654|NCT03183128|525638495|FG000|Overall Study|Protocol Violation|2|||
145761655|NCT03183128|525638496|FG001|Overall Study|Protocol Violation|0|||
145761656|NCT03183128|525638495|FG000|Overall Study|Lack of Efficacy|4|||
145761657|NCT03183128|525638496|FG001|Overall Study|Lack of Efficacy|27|||
145761658|NCT03183128|525638495|FG000|Overall Study|Lost to Follow-up|1|||
145761659|NCT03183128|525638496|FG001|Overall Study|Lost to Follow-up|0|||
145761660|NCT03183128|525638495|FG000|Overall Study|Death|2|||
145761661|NCT03183128|525638496|FG001|Overall Study|Death|0|||
145761662|NCT03183128|525638495|FG000|Overall Study|Physician Decision|1|||
145761663|NCT03183128|525638496|FG001|Overall Study|Physician Decision|0|||
145761664|NCT01686568|525638499|FG000|Main Study|Withdrawal by Subject|1|||
145761665|NCT01686568|525638500|FG001|Main Study|Withdrawal by Subject|3|||
145761666|NCT01686568|525638499|FG000|Main Study|Noncompliance with protocol|0|||
145761667|NCT01686568|525638500|FG001|Main Study|Noncompliance with protocol|1|||
145761668|NCT01686568|525638499|FG000|Main Study|Liver enzymes above range of exclusion|1|||
145761669|NCT01686568|525638500|FG001|Main Study|Liver enzymes above range of exclusion|0|||
145761670|NCT01686568|525638499|FG000|Sub-Study|Not consented for sub-study|2|||
145761671|NCT01686568|525638500|FG001|Sub-Study|Not consented for sub-study|2|||
145761672|NCT03258814|525638501|FG000|Overall Study|Early Termination|4|||
145761673|NCT03258814|525638502|FG001|Overall Study|Early Termination|3|||
145761674|NCT03258814|525638503|FG002|Overall Study|Early Termination|10|||
145761675|NCT01573910|525638504|FG000|Overall Study|Adverse Event|4|||
145761676|NCT01573910|525638505|FG001|Overall Study|Adverse Event|4|||
145761677|NCT01573910|525638504|FG000|Overall Study|Lost to Follow-up|2|||
145761678|NCT01573910|525638505|FG001|Overall Study|Lost to Follow-up|1|||
145761679|NCT01573910|525638504|FG000|Overall Study|Withdrawal by Subject|0|||
145761680|NCT01573910|525638505|FG001|Overall Study|Withdrawal by Subject|1|||
145761681|NCT01573910|525638504|FG000|Overall Study|Protocol Violation|3|||
145761682|NCT01573910|525638505|FG001|Overall Study|Protocol Violation|0|||
145761683|NCT01573910|525638504|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
145761684|NCT01573910|525638505|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
145761685|NCT00364182|525638506|FG000|First Intervention|Secondary prophylaxis|1|||
145761686|NCT00364182|525638507|FG001|First Intervention|Secondary prophylaxis|0|||
145761687|NCT00364182|525638508|FG002|First Intervention|Secondary prophylaxis|0|||
145761688|NCT00364182|525638506|FG000|First Intervention|Withdrawal by Subject|2|||
145761689|NCT00364182|525638507|FG001|First Intervention|Withdrawal by Subject|0|||
145761690|NCT00364182|525638508|FG002|First Intervention|Withdrawal by Subject|0|||
145761691|NCT00364182|525638506|FG000|Second Intervention|non-compliance|0|||
145761692|NCT00364182|525638507|FG001|Second Intervention|non-compliance|1|||
145761693|NCT00364182|525638508|FG002|Second Intervention|non-compliance|1|||
145761694|NCT00364182|525638506|FG000|Second Intervention|Protocol Violation|0|||
145761695|NCT00364182|525638507|FG001|Second Intervention|Protocol Violation|1|||
145761696|NCT00364182|525638508|FG002|Second Intervention|Protocol Violation|0|||
145761697|NCT00364182|525638506|FG000|Second Intervention|Adverse Event|0|||
145761698|NCT00364182|525638507|FG001|Second Intervention|Adverse Event|0|||
145761699|NCT00364182|525638508|FG002|Second Intervention|Adverse Event|1|||
145761700|NCT00364182|525638506|FG000|Third Intervention|non-compliance|0|||
145761701|NCT00364182|525638507|FG001|Third Intervention|non-compliance|1|||
145761702|NCT00364182|525638508|FG002|Third Intervention|non-compliance|0|||
145761703|NCT00364182|525638506|FG000|Third Intervention|Lost to Follow-up|0|||
145761704|NCT00364182|525638507|FG001|Third Intervention|Lost to Follow-up|0|||
145761705|NCT00364182|525638508|FG002|Third Intervention|Lost to Follow-up|1|||
145761706|NCT02921425|525638510|FG000|Overall Study|Protocol Violation|9|||
145761707|NCT03403400|525638511|FG000|Overall Study|Lost to Follow-up|1|||
145761708|NCT03403400|525638512|FG001|Overall Study|Lost to Follow-up|0|||
145761709|NCT03403400|525638513|FG002|Overall Study|Lost to Follow-up|1|||
145761710|NCT03403400|525638511|FG000|Overall Study|Hospitalization|1|||
145761711|NCT03403400|525638512|FG001|Overall Study|Hospitalization|0|||
145761712|NCT03403400|525638513|FG002|Overall Study|Hospitalization|0|||
145761713|NCT03403400|525638511|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
145761714|NCT03403400|525638512|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
145761715|NCT03403400|525638513|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
145761716|NCT00565617|525638517|FG000|Overall Study|Withdrawal by Subject|1|||
145276652|NCT01785875|523863070|FG002|Overall Study|Lost to Follow-up|6|||
145276653|NCT01785875|523863068|FG000|Overall Study|Death|27|||
145276654|NCT01785875|523863069|FG001|Overall Study|Death|16|||
145276655|NCT01785875|523863070|FG002|Overall Study|Death|7|||
145761717|NCT01145560|525638518|FG000|Overall Study|Withdrawal by Subject|2|||
145761718|NCT01145560|525638519|FG001|Overall Study|Withdrawal by Subject|1|||
145761719|NCT01145560|525638520|FG002|Overall Study|Withdrawal by Subject|0|||
145761720|NCT01145560|525638518|FG000|Overall Study|Lost to Follow-up|1|||
145761721|NCT01145560|525638519|FG001|Overall Study|Lost to Follow-up|1|||
145761722|NCT01145560|525638520|FG002|Overall Study|Lost to Follow-up|1|||
145761723|NCT01145560|525638518|FG000|Overall Study|No study drug by 24h after organ failure|1|||
145761724|NCT01145560|525638519|FG001|Overall Study|No study drug by 24h after organ failure|0|||
145761725|NCT01145560|525638520|FG002|Overall Study|No study drug by 24h after organ failure|0|||
145761726|NCT01145560|525638518|FG000|Overall Study|Accidental unblinding of study treatment|0|||
145761727|NCT01145560|525638519|FG001|Overall Study|Accidental unblinding of study treatment|1|||
145761728|NCT01145560|525638520|FG002|Overall Study|Accidental unblinding of study treatment|0|||
145276656|NCT01785875|523863068|FG000|Overall Study|Sponsor Decision|0|||
145761729|NCT01145560|525638518|FG000|Overall Study|False insurance information|0|||
145761730|NCT01145560|525638519|FG001|Overall Study|False insurance information|1|||
145761731|NCT01145560|525638520|FG002|Overall Study|False insurance information|0|||
145761732|NCT01145560|525638518|FG000|Overall Study|Withdrawal of therapy|0|||
145761733|NCT01145560|525638519|FG001|Overall Study|Withdrawal of therapy|0|||
145761734|NCT01145560|525638520|FG002|Overall Study|Withdrawal of therapy|1|||
145761735|NCT01439945|525638538|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
145761736|NCT01439945|525638539|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
145761737|NCT01439945|525638540|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
145761738|NCT01439945|525638541|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
145761739|NCT01439945|525638538|FG000|Double-Blind Treatment Phase|Ineligible|1|||
145761740|NCT01439945|525638539|FG001|Double-Blind Treatment Phase|Ineligible|2|||
145761741|NCT01439945|525638540|FG002|Double-Blind Treatment Phase|Ineligible|0|||
145761742|NCT01439945|525638541|FG003|Double-Blind Treatment Phase|Ineligible|1|||
145761743|NCT05501119|525638544|FG000|Overall Study|Withdrawal by Subject|2|||
145761744|NCT05501119|525638544|FG000|Overall Study|Lost to Follow-up|5|||
145761745|NCT01752023|525638545|FG000|Overall Study|Physician Decision|2|||
145761746|NCT01752023|525638546|FG001|Overall Study|Physician Decision|1|||
145761747|NCT01445678|525638547|FG000|Overall Study|Adverse Event|12|||
145761748|NCT01445678|525638548|FG001|Overall Study|Adverse Event|8|||
145761749|NCT01445678|525638547|FG000|Overall Study|Lack of Efficacy|0|||
145761750|NCT01445678|525638548|FG001|Overall Study|Lack of Efficacy|2|||
145761751|NCT01445678|525638547|FG000|Overall Study|Lost to Follow-up|8|||
145761752|NCT01445678|525638548|FG001|Overall Study|Lost to Follow-up|5|||
145761753|NCT01445678|525638547|FG000|Overall Study|Protocol Violation|1|||
145761754|NCT01445678|525638548|FG001|Overall Study|Protocol Violation|1|||
145761755|NCT01445678|525638547|FG000|Overall Study|Withdrawal by Subject|9|||
145761756|NCT01445678|525638548|FG001|Overall Study|Withdrawal by Subject|5|||
145761757|NCT04025632|525639924|FG000|Overall Study|Adverse Event|1|||
145761758|NCT04025632|525639925|FG001|Overall Study|Adverse Event|1|||
145761759|NCT04025632|525639924|FG000|Overall Study|Withdrawal by Subject|1|||
145761760|NCT04025632|525639925|FG001|Overall Study|Withdrawal by Subject|1|||
145761761|NCT04025632|525639924|FG000|Overall Study|Study Terminated by Sponsor|10|||
145761762|NCT04025632|525639925|FG001|Overall Study|Study Terminated by Sponsor|9|||
145761763|NCT04025632|525639924|FG000|Overall Study|Physician Decision|3|||
145761764|NCT04025632|525639925|FG001|Overall Study|Physician Decision|1|||
145761765|NCT00376961|525639926|FG000|Initial Registration|Adverse Event|1|||
145761766|NCT00376961|525639927|FG001|Initial Registration|Adverse Event|0|||
145761767|NCT00376961|525639926|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
145761768|NCT00376961|525639927|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145761769|NCT00376961|525639926|FG000|Initial Registration|Progression/relapse|1|||
145761770|NCT00376961|525639927|FG001|Initial Registration|Progression/relapse|0|||
145761771|NCT00376961|525639926|FG000|Initial Registration|Ineligible|3|||
145761772|NCT00376961|525639927|FG001|Initial Registration|Ineligible|0|||
145761773|NCT00376961|525639926|FG000|Maintenance|Adverse Event|0|||
145761774|NCT00376961|525639927|FG001|Maintenance|Adverse Event|1|||
145761775|NCT00376961|525639926|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
145761776|NCT00376961|525639927|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
145761777|NCT00376961|525639926|FG000|Maintenance|Progression/relapse|0|||
145761778|NCT00376961|525639927|FG001|Maintenance|Progression/relapse|18|||
145761779|NCT00376961|525639926|FG000|Maintenance|Ineligible|0|||
145761780|NCT00376961|525639927|FG001|Maintenance|Ineligible|3|||
145761781|NCT00947531|525639930|FG000|Overall Study|Withdrawal by Subject|10|||
145761782|NCT00947531|525639931|FG001|Overall Study|Withdrawal by Subject|7|||
145761783|NCT00947531|525639930|FG000|Overall Study|Administrative Reason|0|||
145761784|NCT00947531|525639931|FG001|Overall Study|Administrative Reason|1|||
145761785|NCT00947531|525639930|FG000|Overall Study|Adverse Event|2|||
145761786|NCT00947531|525639931|FG001|Overall Study|Adverse Event|2|||
145761787|NCT00947531|525639930|FG000|Overall Study|Lack of Efficacy|1|||
145761788|NCT00947531|525639931|FG001|Overall Study|Lack of Efficacy|0|||
145761789|NCT00947531|525639930|FG000|Overall Study|Other|1|||
145761790|NCT00947531|525639931|FG001|Overall Study|Other|1|||
145761791|NCT01570244|525639932|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
145761792|NCT02978222|525639944|FG000|Overall Study|Withdrawal by Subject|2|||
145761793|NCT02978222|525639945|FG001|Overall Study|Withdrawal by Subject|2|||
145761794|NCT02978222|525639944|FG000|Overall Study|Physician Decision|2|||
145761795|NCT02978222|525639945|FG001|Overall Study|Physician Decision|0|||
145761796|NCT02978222|525639944|FG000|Overall Study|Adverse Event|0|||
145761797|NCT02978222|525639945|FG001|Overall Study|Adverse Event|1|||
145761798|NCT02978222|525639944|FG000|Overall Study|Death|1|||
145761799|NCT02978222|525639945|FG001|Overall Study|Death|0|||
145761800|NCT02978222|525639944|FG000|Overall Study|Disease Progression|32|||
145761801|NCT02978222|525639945|FG001|Overall Study|Disease Progression|32|||
145761802|NCT02978222|525639944|FG000|Overall Study|Early Study Termination|24|||
145761803|NCT02978222|525639945|FG001|Overall Study|Early Study Termination|21|||
145761804|NCT01413958|525639946|FG000|Overall Study|Lost to Follow-up|0|||
145761805|NCT01413958|525639947|FG001|Overall Study|Lost to Follow-up|1|||
145761806|NCT01900002|525639948|FG000|Overall Study|Withdrawal by Subject|2|||
145761807|NCT01900002|525639948|FG000|Overall Study|ineligible for Y-90|4|||
145761808|NCT02928952|525639957|FG000|Overall Study|Lost to Follow-up|5|||
145761809|NCT02928952|525639958|FG001|Overall Study|Lost to Follow-up|5|||
145761810|NCT02928952|525639957|FG000|Overall Study|Withdrawal by Subject|5|||
145761811|NCT02928952|525639958|FG001|Overall Study|Withdrawal by Subject|1|||
145761812|NCT02928952|525639957|FG000|Overall Study|Physician Decision|0|||
145761813|NCT02928952|525639958|FG001|Overall Study|Physician Decision|1|||
145761814|NCT00974220|525639959|FG000|Treatment Period 1|Adverse Event|2|||
145761815|NCT00974220|525639960|FG001|Treatment Period 1|Adverse Event|1|||
145761816|NCT00974220|525639959|FG000|Treatment Period 1|noncompliant subjects|0|||
145761817|NCT00974220|525639960|FG001|Treatment Period 1|noncompliant subjects|1|||
145761818|NCT01850615|525639961|FG000|Overall Study|Protocol Violation|4|||
145761819|NCT01850615|525639962|FG001|Overall Study|Protocol Violation|1|||
145761820|NCT01850615|525639961|FG000|Overall Study|Adverse Event|2|||
145761821|NCT01850615|525639962|FG001|Overall Study|Adverse Event|1|||
145761822|NCT01850615|525639961|FG000|Overall Study|Withdrawal by Subject|3|||
145761823|NCT01850615|525639962|FG001|Overall Study|Withdrawal by Subject|1|||
145761824|NCT01850615|525639961|FG000|Overall Study|Lost to Follow-up|0|||
145761825|NCT01850615|525639962|FG001|Overall Study|Lost to Follow-up|1|||
145761826|NCT01850615|525639961|FG000|Overall Study|Unclassified|0|||
145761827|NCT01850615|525639962|FG001|Overall Study|Unclassified|1|||
145761828|NCT01227967|525639963|FG000|Overall Study|Protocol Violation|3|||
145761829|NCT01227967|525639964|FG001|Overall Study|Protocol Violation|1|||
145761830|NCT01227967|525639963|FG000|Overall Study|Death|0|||
145761831|NCT01227967|525639964|FG001|Overall Study|Death|1|||
145761832|NCT01227967|525639963|FG000|Overall Study|Lost to Follow-up|8|||
145761833|NCT01227967|525639964|FG001|Overall Study|Lost to Follow-up|3|||
145761834|NCT01227967|525639963|FG000|Overall Study|Withdrawal by Subject|4|||
145761835|NCT01227967|525639964|FG001|Overall Study|Withdrawal by Subject|3|||
145761836|NCT01227967|525639963|FG000|Overall Study|Physician Decision|0|||
145761837|NCT01227967|525639964|FG001|Overall Study|Physician Decision|1|||
145761838|NCT01227967|525639963|FG000|Overall Study|Never Started Treatment|0|||
145761839|NCT01227967|525639964|FG001|Overall Study|Never Started Treatment|4|||
145761840|NCT01227967|525639963|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
145761841|NCT01227967|525639964|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
145761842|NCT00712348|525639965|FG000|Overall Study|Withdrawal by Subject|1|||
145761843|NCT01273064|525639966|FG000|Overall Study|Adverse Event|5|||
145761844|NCT01273064|525639967|FG001|Overall Study|Adverse Event|1|||
145761845|NCT01273064|525639968|FG002|Overall Study|Adverse Event|3|||
145761846|NCT01273064|525639969|FG003|Overall Study|Adverse Event|2|||
145761847|NCT01273064|525639970|FG004|Overall Study|Adverse Event|1|||
145761848|NCT01273064|525639966|FG000|Overall Study|Withdrawal by Subject|4|||
145761849|NCT01273064|525639967|FG001|Overall Study|Withdrawal by Subject|2|||
145761850|NCT01273064|525639968|FG002|Overall Study|Withdrawal by Subject|2|||
145761851|NCT01273064|525639969|FG003|Overall Study|Withdrawal by Subject|2|||
145761852|NCT01273064|525639970|FG004|Overall Study|Withdrawal by Subject|0|||
145761853|NCT01273064|525639966|FG000|Overall Study|Study Termination|13|||
145761854|NCT01273064|525639967|FG001|Overall Study|Study Termination|27|||
145761855|NCT01273064|525639968|FG002|Overall Study|Study Termination|26|||
145761856|NCT01273064|525639969|FG003|Overall Study|Study Termination|16|||
145761857|NCT01273064|525639970|FG004|Overall Study|Study Termination|8|||
145761858|NCT01273064|525639966|FG000|Overall Study|Lost to Follow-up|1|||
145761859|NCT01273064|525639967|FG001|Overall Study|Lost to Follow-up|0|||
145761860|NCT01273064|525639968|FG002|Overall Study|Lost to Follow-up|0|||
145761861|NCT01273064|525639969|FG003|Overall Study|Lost to Follow-up|0|||
145761862|NCT01273064|525639970|FG004|Overall Study|Lost to Follow-up|0|||
145761863|NCT01273064|525639966|FG000|Overall Study|Physician Decision|0|||
145761864|NCT01273064|525639967|FG001|Overall Study|Physician Decision|0|||
145761865|NCT01273064|525639968|FG002|Overall Study|Physician Decision|0|||
145761866|NCT01273064|525639969|FG003|Overall Study|Physician Decision|0|||
145761867|NCT01273064|525639970|FG004|Overall Study|Physician Decision|1|||
145761868|NCT01375764|525639971|FG000|Overall Study|Lost to Follow-up|0|||
145761869|NCT01375764|525639972|FG001|Overall Study|Lost to Follow-up|1|||
145761870|NCT01375764|525639973|FG002|Overall Study|Lost to Follow-up|0|||
145761871|NCT01375764|525639974|FG003|Overall Study|Lost to Follow-up|0|||
145761872|NCT01375764|525639975|FG004|Overall Study|Lost to Follow-up|0|||
145761873|NCT01375764|525639971|FG000|Overall Study|Withdrawal by Subject|2|||
145761874|NCT01375764|525639972|FG001|Overall Study|Withdrawal by Subject|0|||
145761875|NCT01375764|525639973|FG002|Overall Study|Withdrawal by Subject|0|||
145761876|NCT01375764|525639974|FG003|Overall Study|Withdrawal by Subject|0|||
145761877|NCT01375764|525639975|FG004|Overall Study|Withdrawal by Subject|1|||
145761878|NCT01375764|525639971|FG000|Overall Study|Other|0|||
145761879|NCT01375764|525639972|FG001|Overall Study|Other|0|||
145761880|NCT01375764|525639973|FG002|Overall Study|Other|0|||
145761881|NCT01375764|525639974|FG003|Overall Study|Other|1|||
145761882|NCT01375764|525639975|FG004|Overall Study|Other|0|||
145761883|NCT02867761|525639979|FG000|Overall Study|Participant withdrawn by investigator|0|||
145761884|NCT02867761|525639980|FG001|Overall Study|Participant withdrawn by investigator|1|||
145761885|NCT02867761|525639979|FG000|Overall Study|Lost to Follow-up|25|||
145761886|NCT02867761|525639980|FG001|Overall Study|Lost to Follow-up|18|||
145761887|NCT02867761|525639979|FG000|Overall Study|Unable to complete protocol|3|||
145761888|NCT02867761|525639980|FG001|Overall Study|Unable to complete protocol|7|||
145761889|NCT03595280|525639981|FG000|Overall Study|Lost to Follow-up|6|||
145761890|NCT03595280|525639982|FG001|Overall Study|Lost to Follow-up|9|||
145761891|NCT03595280|525639983|FG002|Overall Study|Lost to Follow-up|15|||
145761892|NCT01512264|525639984|FG000|Overall Study|Lost to Follow-up|0|||
145761893|NCT01512264|525639985|FG001|Overall Study|Lost to Follow-up|0|||
145761894|NCT01512264|525639986|FG002|Overall Study|Lost to Follow-up|0|||
145761895|NCT01512264|525639987|FG003|Overall Study|Lost to Follow-up|1|||
145761896|NCT01194440|525639988|FG000|Baseline (First Dose)|Reason not specified|4|||
145761897|NCT01194440|525639988|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
145761898|NCT01194440|525639988|FG000|Baseline (First Dose)|Change in therapy|1|||
145761899|NCT01194440|525639988|FG000|Baseline (First Dose)|Adverse Event|1|||
145761900|NCT01194440|525639988|FG000|6-months (2nd Dose)|Change in therapy|4|||
145761901|NCT00854828|525639989|FG000|Overall Study|Death|1|||
145761902|NCT00854828|525639990|FG001|Overall Study|Death|0|||
145761903|NCT00854828|525639991|FG002|Overall Study|Death|0|||
145761904|NCT00854828|525639992|FG003|Overall Study|Death|0|||
145761905|NCT00854828|525639989|FG000|Overall Study|Withdrawal by Subject|1|||
145761906|NCT00854828|525639990|FG001|Overall Study|Withdrawal by Subject|1|||
145761907|NCT00854828|525639991|FG002|Overall Study|Withdrawal by Subject|0|||
145761908|NCT00854828|525639992|FG003|Overall Study|Withdrawal by Subject|9|||
145761909|NCT00854828|525639989|FG000|Overall Study|Missed 24mo visit|1|||
145761910|NCT00854828|525639990|FG001|Overall Study|Missed 24mo visit|1|||
145761911|NCT00854828|525639991|FG002|Overall Study|Missed 24mo visit|8|||
145761912|NCT00854828|525639992|FG003|Overall Study|Missed 24mo visit|8|||
145761913|NCT01931059|525639993|FG000|Day 1|Pregnancy|0|||
145761914|NCT01931059|525639994|FG001|Day 1|Pregnancy|1|||
145761915|NCT01931059|525639993|FG000|Day3|Lost to Follow-up|1|||
145761916|NCT01931059|525639994|FG001|Day3|Lost to Follow-up|0|||
145761917|NCT02292212|525639995|FG000|ViE Phase|Withdrawal by Subject|1|||
145761918|NCT02292212|525639995|FG000|ViE Phase|Protocol Violation|2|||
145761919|NCT02675075|525639996|FG000|Overall Study|Lost to Follow-up|3|||
145761920|NCT02675075|525639997|FG001|Overall Study|Lost to Follow-up|0|||
145761921|NCT02411747|525639998|FG000|Overall Study|Withdrawal by Subject|1|||
145761922|NCT02411747|525639999|FG001|Overall Study|Withdrawal by Subject|0|||
145761923|NCT02411747|525639998|FG000|Overall Study|Protocol Violation|2|||
145761924|NCT02411747|525639999|FG001|Overall Study|Protocol Violation|4|||
145761925|NCT02149810|525640000|FG000|Overall Study|Physician Decision|1|||
145761926|NCT02149810|525640001|FG001|Overall Study|Physician Decision|2|||
145761927|NCT02149810|525640000|FG000|Overall Study|Lost to Follow-up|2|||
145761928|NCT02149810|525640001|FG001|Overall Study|Lost to Follow-up|1|||
145761929|NCT02149810|525640000|FG000|Overall Study|Withdrawal by Subject|5|||
145761930|NCT02149810|525640001|FG001|Overall Study|Withdrawal by Subject|1|||
145761931|NCT01176916|525640002|FG000|Overall Study|Adverse Event|61|||
145761932|NCT01176916|525640002|FG000|Overall Study|Death|1|||
145761933|NCT01176916|525640002|FG000|Overall Study|Lost to Follow-up|15|||
145761934|NCT01176916|525640002|FG000|Overall Study|Objective progression or relapse|17|||
145761935|NCT01176916|525640002|FG000|Overall Study|Protocol Violation|24|||
145761936|NCT01176916|525640002|FG000|Overall Study|Withdrawal by Subject|37|||
145761937|NCT01176916|525640002|FG000|Overall Study|Other|6|||
145761938|NCT01176916|525640002|FG000|Overall Study|Withdrawal prior to Treatment|6|||
145761939|NCT00675597|525640003|FG000|Overall Study|Withdrawal by Subject|3|||
145761940|NCT03158220|525640004|FG000|Overall Study|Screen Failure|0|||
145761941|NCT03158220|525640005|FG001|Overall Study|Screen Failure|1|||
145761942|NCT03158220|525640004|FG000|Overall Study|Withdrawal by Subject|8|||
145761943|NCT03158220|525640005|FG001|Overall Study|Withdrawal by Subject|9|||
145761944|NCT03158220|525640004|FG000|Overall Study|Status unknown|0|||
145761945|NCT03158220|525640005|FG001|Overall Study|Status unknown|1|||
145761946|NCT03158220|525640004|FG000|Overall Study|Lost to Follow-up|8|||
145761947|NCT03158220|525640005|FG001|Overall Study|Lost to Follow-up|5|||
145607840|NCT01852058|525079284|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145607841|NCT01852058|525079285|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145761948|NCT03158220|525640004|FG000|Overall Study|Physician Decision|1|||
145761949|NCT03158220|525640005|FG001|Overall Study|Physician Decision|0|||
145761950|NCT00848120|525640008|FG000|Overall Study|Adverse Event|1|||
145761951|NCT00560755|525640009|FG000|Overall Study|Protocol Violation|15|||
145761952|NCT00560755|525640009|FG000|Overall Study|Withdrawal by Subject|26|||
145761953|NCT00560755|525640009|FG000|Overall Study|Lost to Follow-up|9|||
145761954|NCT00560755|525640009|FG000|Overall Study|Adverse Event|8|||
145761955|NCT00560755|525640009|FG000|Overall Study|Physician Decision|2|||
145761956|NCT01961115|525640019|FG000|Overall Study|Disease Progression|1|||
145761957|NCT01961115|525640020|FG001|Overall Study|Disease Progression|0|||
145761958|NCT01961115|525640021|FG002|Overall Study|Disease Progression|3|||
145761959|NCT01961115|525640019|FG000|Overall Study|Adverse Event|1|||
145761960|NCT01961115|525640020|FG001|Overall Study|Adverse Event|0|||
145761961|NCT01961115|525640021|FG002|Overall Study|Adverse Event|1|||
145761962|NCT04082663|525640022|FG000|Overall Study|Adverse Event|6|||
145761963|NCT04082663|525640022|FG000|Overall Study|Lost to Follow-up|1|||
145761964|NCT00705263|525640023|FG000|Overall Study|Withdrawal by Subject|2|||
145761965|NCT02959814|525640025|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
145761966|NCT02959814|525640025|FG000|Overall Study|Excluded based on anatomical criteria|2|||
145761967|NCT02959814|525640025|FG000|Overall Study|Protocol Violation|7|||
145761968|NCT02959814|525640025|FG000|Overall Study|FFR not measured|2|||
145761969|NCT02959814|525640025|FG000|Overall Study|In-procedure QFR not computed|6|||
145761970|NCT02959814|525640025|FG000|Overall Study|Excluded by FFR core-lab|24|||
145761971|NCT01078805|525640035|FG000|Overall Study|Clinically significant abnormal lab|5|||
145761972|NCT01078805|525640035|FG000|Overall Study|Death|134|||
145761973|NCT01078805|525640035|FG000|Overall Study|Lost to Follow-up|676|||
145761974|NCT01078805|525640035|FG000|Overall Study|Physician Decision|169|||
145761975|NCT01078805|525640035|FG000|Overall Study|Serious adverse event|26|||
145761976|NCT01078805|525640035|FG000|Overall Study|Sponsor decision|46|||
145761977|NCT01078805|525640035|FG000|Overall Study|Withdrawal by Subject|739|||
145761978|NCT01078805|525640035|FG000|Overall Study|Other|173|||
145761979|NCT01078805|525640035|FG000|Overall Study|Didn't take study drug|82|||
145761980|NCT02246621|525640043|FG000|Overall Study|Withdrawal by Subject|28|||
145761981|NCT02246621|525640044|FG001|Overall Study|Withdrawal by Subject|16|||
145761982|NCT02246621|525640043|FG000|Overall Study|Lost to Follow-up|1|||
145761983|NCT02246621|525640044|FG001|Overall Study|Lost to Follow-up|0|||
145761984|NCT02246621|525640043|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
145761985|NCT02246621|525640044|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
145761986|NCT01292057|525640045|FG000|Overall Study|Protocol Violation|1|||
145761987|NCT01292057|525640046|FG001|Overall Study|Protocol Violation|1|||
145761988|NCT01292057|525640045|FG000|Overall Study|Lost to Follow-up|1|||
145761989|NCT01292057|525640046|FG001|Overall Study|Lost to Follow-up|1|||
145761990|NCT01459614|525640047|FG000|Overall Study|Adverse Event|1|||
145761991|NCT01459614|525640048|FG001|Overall Study|Adverse Event|0|||
145761992|NCT02078219|525640058|FG000|Overall Study|Other|2|||
145761993|NCT02078219|525640059|FG001|Overall Study|Other|2|||
145761994|NCT02078219|525640060|FG002|Overall Study|Other|3|||
145761995|NCT02078219|525640061|FG003|Overall Study|Other|0|||
145761996|NCT02078219|525640062|FG004|Overall Study|Other|1|||
145761997|NCT02078219|525640058|FG000|Overall Study|Withdrawal by Subject|0|||
145761998|NCT02078219|525640059|FG001|Overall Study|Withdrawal by Subject|1|||
145761999|NCT02078219|525640060|FG002|Overall Study|Withdrawal by Subject|0|||
145762000|NCT02078219|525640061|FG003|Overall Study|Withdrawal by Subject|1|||
145762001|NCT02078219|525640062|FG004|Overall Study|Withdrawal by Subject|1|||
145762002|NCT02078219|525640058|FG000|Overall Study|Protocol Violation|0|||
145762003|NCT02078219|525640059|FG001|Overall Study|Protocol Violation|0|||
145762004|NCT02078219|525640060|FG002|Overall Study|Protocol Violation|0|||
145762005|NCT02078219|525640061|FG003|Overall Study|Protocol Violation|1|||
145762006|NCT02078219|525640062|FG004|Overall Study|Protocol Violation|0|||
145762007|NCT02078219|525640058|FG000|Overall Study|Death|0|||
145762008|NCT02078219|525640059|FG001|Overall Study|Death|0|||
145762009|NCT02078219|525640060|FG002|Overall Study|Death|0|||
145762010|NCT02078219|525640061|FG003|Overall Study|Death|1|||
145762011|NCT02078219|525640062|FG004|Overall Study|Death|0|||
145762012|NCT02078219|525640058|FG000|Overall Study|Adverse Event|1|||
145762013|NCT02078219|525640059|FG001|Overall Study|Adverse Event|1|||
145762014|NCT02078219|525640060|FG002|Overall Study|Adverse Event|3|||
145762015|NCT02078219|525640061|FG003|Overall Study|Adverse Event|1|||
145762016|NCT02078219|525640062|FG004|Overall Study|Adverse Event|0|||
145762017|NCT03283085|525640063|FG000|Overall Study|Adverse Event|18|||
145762018|NCT03283085|525640064|FG001|Overall Study|Adverse Event|3|||
145762019|NCT03283085|525640065|FG002|Overall Study|Adverse Event|13|||
145762020|NCT03283085|525640066|FG003|Overall Study|Adverse Event|0|||
145762021|NCT03283085|525640067|FG004|Overall Study|Adverse Event|0|||
145762022|NCT03283085|525640068|FG005|Overall Study|Adverse Event|5|||
145762023|NCT03283085|525640063|FG000|Overall Study|Death|0|||
145762024|NCT03283085|525640064|FG001|Overall Study|Death|0|||
145762025|NCT03283085|525640065|FG002|Overall Study|Death|3|||
145762026|NCT03283085|525640066|FG003|Overall Study|Death|1|||
145762027|NCT03283085|525640067|FG004|Overall Study|Death|0|||
145762028|NCT03283085|525640068|FG005|Overall Study|Death|0|||
145762029|NCT03283085|525640063|FG000|Overall Study|Withdrawal by Subject|42|||
145762030|NCT03283085|525640064|FG001|Overall Study|Withdrawal by Subject|21|||
145762031|NCT03283085|525640065|FG002|Overall Study|Withdrawal by Subject|66|||
145762032|NCT03283085|525640066|FG003|Overall Study|Withdrawal by Subject|3|||
145762033|NCT03283085|525640067|FG004|Overall Study|Withdrawal by Subject|3|||
145762034|NCT03283085|525640068|FG005|Overall Study|Withdrawal by Subject|5|||
145762035|NCT03283085|525640063|FG000|Overall Study|Physician Decision|14|||
145762036|NCT03283085|525640064|FG001|Overall Study|Physician Decision|8|||
145762037|NCT03283085|525640065|FG002|Overall Study|Physician Decision|19|||
145762038|NCT03283085|525640066|FG003|Overall Study|Physician Decision|0|||
145762039|NCT03283085|525640067|FG004|Overall Study|Physician Decision|0|||
145762040|NCT03283085|525640068|FG005|Overall Study|Physician Decision|2|||
145762041|NCT03283085|525640063|FG000|Overall Study|Site Terminated by Sponsor|1|||
145762042|NCT03283085|525640064|FG001|Overall Study|Site Terminated by Sponsor|0|||
145762043|NCT03283085|525640065|FG002|Overall Study|Site Terminated by Sponsor|3|||
145762044|NCT03283085|525640066|FG003|Overall Study|Site Terminated by Sponsor|0|||
145762045|NCT03283085|525640067|FG004|Overall Study|Site Terminated by Sponsor|0|||
145762046|NCT03283085|525640068|FG005|Overall Study|Site Terminated by Sponsor|0|||
145762047|NCT03283085|525640063|FG000|Overall Study|Lost to Follow-up|2|||
145762048|NCT03283085|525640064|FG001|Overall Study|Lost to Follow-up|0|||
145762049|NCT03283085|525640065|FG002|Overall Study|Lost to Follow-up|2|||
145762050|NCT03283085|525640066|FG003|Overall Study|Lost to Follow-up|0|||
145762051|NCT03283085|525640067|FG004|Overall Study|Lost to Follow-up|0|||
145762052|NCT03283085|525640068|FG005|Overall Study|Lost to Follow-up|1|||
145762053|NCT03283085|525640063|FG000|Overall Study|Pregnancy|0|||
145762054|NCT03283085|525640064|FG001|Overall Study|Pregnancy|0|||
145762055|NCT03283085|525640065|FG002|Overall Study|Pregnancy|1|||
145762056|NCT03283085|525640066|FG003|Overall Study|Pregnancy|0|||
145762057|NCT03283085|525640067|FG004|Overall Study|Pregnancy|0|||
145762058|NCT03283085|525640068|FG005|Overall Study|Pregnancy|0|||
145762059|NCT03283085|525640063|FG000|Overall Study|Lack of Efficacy|12|||
145762060|NCT03283085|525640064|FG001|Overall Study|Lack of Efficacy|6|||
145762061|NCT03283085|525640065|FG002|Overall Study|Lack of Efficacy|24|||
145762062|NCT03283085|525640066|FG003|Overall Study|Lack of Efficacy|1|||
145762063|NCT03283085|525640067|FG004|Overall Study|Lack of Efficacy|1|||
145762064|NCT03283085|525640068|FG005|Overall Study|Lack of Efficacy|0|||
145762065|NCT03283085|525640063|FG000|Overall Study|Reason not Specified|0|||
145762066|NCT03283085|525640064|FG001|Overall Study|Reason not Specified|4|||
145762067|NCT03283085|525640065|FG002|Overall Study|Reason not Specified|8|||
145762068|NCT03283085|525640066|FG003|Overall Study|Reason not Specified|0|||
145762069|NCT03283085|525640067|FG004|Overall Study|Reason not Specified|0|||
145762070|NCT03283085|525640068|FG005|Overall Study|Reason not Specified|1|||
145402923|NCT00250588|524332554|FG002|Overall Study|Withdrawal by Subject|0|||
145762071|NCT03136107|525640069|FG000|Overall Study|Other (Not specified)|1|||
145762072|NCT03641560|525640070|FG000|Overall Study|Withdrawal by Subject|6|||
145402924|NCT00250588|524332552|FG000|Overall Study|Lost to Follow-up|6|||
145762073|NCT03641560|525640070|FG000|Overall Study|Progressive disease|40|||
145762074|NCT03641560|525640070|FG000|Overall Study|Death|6|||
145762075|NCT01974817|525642267|FG000|Overall Study|Death|4|||
145762076|NCT01974817|525642267|FG000|Overall Study|Lost to Follow-up|2|||
145762077|NCT01974817|525642267|FG000|Overall Study|Protocol Violation|2|||
145762078|NCT04047797|525642273|FG000|Overall Study|Progressive Disease|1|||
145762079|NCT01793792|525642274|FG000|Overall Study|Death|5|||
145762080|NCT01793792|525642274|FG000|Overall Study|Lost to Follow-up|5|||
145762081|NCT01793792|525642274|FG000|Overall Study|Withdrawal by Subject|1|||
145762082|NCT01793792|525642274|FG000|Overall Study|Device Not Implanted|1|||
145762083|NCT05742984|525642279|FG000|Overall Study|Adverse Event|0|||
145762084|NCT05742984|525642280|FG001|Overall Study|Adverse Event|0|||
145762085|NCT05742984|525642281|FG002|Overall Study|Adverse Event|1|||
145762086|NCT05742984|525642282|FG003|Overall Study|Adverse Event|0|||
145762087|NCT05742984|525642283|FG004|Overall Study|Adverse Event|1|||
145762088|NCT05742984|525642284|FG005|Overall Study|Adverse Event|1|||
145762089|NCT05742984|525642279|FG000|Overall Study|Withdrawal by Subject|0|||
145762090|NCT05742984|525642280|FG001|Overall Study|Withdrawal by Subject|1|||
145762091|NCT05742984|525642281|FG002|Overall Study|Withdrawal by Subject|0|||
145762092|NCT05742984|525642282|FG003|Overall Study|Withdrawal by Subject|0|||
145762093|NCT05742984|525642283|FG004|Overall Study|Withdrawal by Subject|0|||
145762094|NCT05742984|525642284|FG005|Overall Study|Withdrawal by Subject|2|||
145762095|NCT02162862|525642285|FG000|Overall Study|Lost to Follow-up|0|||
145762096|NCT02162862|525642286|FG001|Overall Study|Lost to Follow-up|11|||
145762097|NCT02162862|525642287|FG002|Overall Study|Lost to Follow-up|0|||
145762098|NCT02162862|525642285|FG000|Overall Study|Subject did not feel the med was needed|0|||
145762099|NCT02162862|525642286|FG001|Overall Study|Subject did not feel the med was needed|0|||
145762100|NCT02162862|525642287|FG002|Overall Study|Subject did not feel the med was needed|4|||
145762101|NCT00988247|525642290|FG000|Overall Study|Adverse Event|17|||
145762102|NCT00988247|525642291|FG001|Overall Study|Adverse Event|3|||
145762103|NCT00988247|525642290|FG000|Overall Study|Withdrawal by Subject|44|||
145762104|NCT00988247|525642291|FG001|Overall Study|Withdrawal by Subject|13|||
145762105|NCT00988247|525642290|FG000|Overall Study|Pregnancy|1|||
145762106|NCT00988247|525642291|FG001|Overall Study|Pregnancy|2|||
145762107|NCT00988247|525642290|FG000|Overall Study|Lost to Follow-up|11|||
145762108|NCT00988247|525642291|FG001|Overall Study|Lost to Follow-up|2|||
145762109|NCT00988247|525642290|FG000|Overall Study|Protocol Violation|4|||
145762110|NCT00988247|525642291|FG001|Overall Study|Protocol Violation|5|||
145762111|NCT00988247|525642290|FG000|Overall Study|Sponsor requested withdrawal|3|||
145762112|NCT00988247|525642291|FG001|Overall Study|Sponsor requested withdrawal|1|||
145762113|NCT00988247|525642290|FG000|Overall Study|Other|3|||
145762114|NCT00988247|525642291|FG001|Overall Study|Other|0|||
145762115|NCT03822884|525642292|FG000|Overall Study|Withdrawal by Subject|0|||
145762116|NCT03822884|525642293|FG001|Overall Study|Withdrawal by Subject|0|||
145762117|NCT03822884|525642294|FG002|Overall Study|Withdrawal by Subject|0|||
145762118|NCT03822884|525642295|FG003|Overall Study|Withdrawal by Subject|0|||
145762119|NCT03822884|525642296|FG004|Overall Study|Withdrawal by Subject|1|||
145762120|NCT03822884|525642297|FG005|Overall Study|Withdrawal by Subject|0|||
145762121|NCT01427309|525642303|FG000|Overall Study|Lost to Follow-up|130|||
145762122|NCT01427309|525642304|FG001|Overall Study|Lost to Follow-up|145|||
145762123|NCT01427309|525642305|FG002|Overall Study|Lost to Follow-up|122|||
145762124|NCT01427309|525642306|FG003|Overall Study|Lost to Follow-up|135|||
145762125|NCT01427309|525642303|FG000|Overall Study|Protocol Violation|42|||
145762126|NCT01427309|525642304|FG001|Overall Study|Protocol Violation|69|||
145762127|NCT01427309|525642305|FG002|Overall Study|Protocol Violation|125|||
145762128|NCT01427309|525642306|FG003|Overall Study|Protocol Violation|124|||
145762129|NCT01427309|525642303|FG000|Overall Study|Adverse Event|0|||
145762130|NCT01427309|525642304|FG001|Overall Study|Adverse Event|0|||
145762131|NCT01427309|525642305|FG002|Overall Study|Adverse Event|3|||
145762132|NCT01427309|525642306|FG003|Overall Study|Adverse Event|1|||
145762133|NCT01427309|525642303|FG000|Overall Study|Serious adverse event|52|||
145762134|NCT01427309|525642304|FG001|Overall Study|Serious adverse event|45|||
145762135|NCT01427309|525642305|FG002|Overall Study|Serious adverse event|50|||
145762136|NCT01427309|525642306|FG003|Overall Study|Serious adverse event|61|||
145762137|NCT01427309|525642303|FG000|Overall Study|Withdrawal by Subject|148|||
145762138|NCT01427309|525642304|FG001|Overall Study|Withdrawal by Subject|148|||
145762139|NCT01427309|525642305|FG002|Overall Study|Withdrawal by Subject|61|||
145762140|NCT01427309|525642306|FG003|Overall Study|Withdrawal by Subject|55|||
145762141|NCT03617705|525642309|FG000|Overall Study|Withdrawal by Subject|2|||
145762142|NCT03617705|525642309|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
145762143|NCT03617705|525642309|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
145762144|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
145762145|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
145762146|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
145762147|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
145762148|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
145762149|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
145762150|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
145762151|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
145762152|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
145762153|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
145762154|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
145762155|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
145762156|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
145762157|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
145762158|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
145762159|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
145762160|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
145762161|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
145762162|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
145762163|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
145762164|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
145762165|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
145762166|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
145762167|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
145762168|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
145762169|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
145762170|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
145762171|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
145762172|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
145762173|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
145762174|NCT00849017|525642310|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
145762175|NCT00849017|525642311|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
145762176|NCT00849017|525642312|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
145762177|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
145762178|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
145762179|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
145762180|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
145762181|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
145762182|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
145762183|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
145762184|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
145762185|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
145762186|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
145762187|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
145762188|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
145762189|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
145762190|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
145762191|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
145762192|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
145762193|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
145762194|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
145762195|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
145762196|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
145762197|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
145762198|NCT00849017|525642310|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
145762199|NCT00849017|525642311|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
145762200|NCT00849017|525642312|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
145762201|NCT00214461|525642313|FG000|Overall Study|Adverse Event|0|||
145762202|NCT00214461|525642314|FG001|Overall Study|Adverse Event|0|||
145762203|NCT00214461|525642315|FG002|Overall Study|Adverse Event|1|||
145762204|NCT00214461|525642316|FG003|Overall Study|Adverse Event|1|||
145762205|NCT00214461|525642313|FG000|Overall Study|Withdrawal by Subject|0|||
145762206|NCT00214461|525642314|FG001|Overall Study|Withdrawal by Subject|0|||
145762207|NCT00214461|525642315|FG002|Overall Study|Withdrawal by Subject|1|||
145762208|NCT00214461|525642316|FG003|Overall Study|Withdrawal by Subject|0|||
145762209|NCT02913313|525642317|FG000|Overall Study|DISEASE PROGRESSION|1|||
145762210|NCT02913313|525642318|FG001|Overall Study|DISEASE PROGRESSION|2|||
145762211|NCT02913313|525642319|FG002|Overall Study|DISEASE PROGRESSION|2|||
145762212|NCT02913313|525642320|FG003|Overall Study|DISEASE PROGRESSION|4|||
145762213|NCT02913313|525642321|FG004|Overall Study|DISEASE PROGRESSION|6|||
145762214|NCT02913313|525642322|FG005|Overall Study|DISEASE PROGRESSION|4|||
145762215|NCT02913313|525642323|FG006|Overall Study|DISEASE PROGRESSION|19|||
145762216|NCT02913313|525642324|FG007|Overall Study|DISEASE PROGRESSION|3|||
145762217|NCT02913313|525642325|FG008|Overall Study|DISEASE PROGRESSION|4|||
145762218|NCT02913313|525642326|FG009|Overall Study|DISEASE PROGRESSION|4|||
145762219|NCT02913313|525642327|FG010|Overall Study|DISEASE PROGRESSION|11|||
145762220|NCT02913313|525642328|FG011|Overall Study|DISEASE PROGRESSION|5|||
145762221|NCT02913313|525642329|FG012|Overall Study|DISEASE PROGRESSION|14|||
145762222|NCT02913313|525642330|FG013|Overall Study|DISEASE PROGRESSION|3|||
145762223|NCT02913313|525642317|FG000|Overall Study|Not Reported|0|||
145762224|NCT02913313|525642318|FG001|Overall Study|Not Reported|0|||
145762225|NCT02913313|525642319|FG002|Overall Study|Not Reported|0|||
145762226|NCT02913313|525642320|FG003|Overall Study|Not Reported|0|||
145762227|NCT02913313|525642321|FG004|Overall Study|Not Reported|1|||
145762228|NCT02913313|525642322|FG005|Overall Study|Not Reported|0|||
145762229|NCT02913313|525642323|FG006|Overall Study|Not Reported|0|||
145762230|NCT02913313|525642324|FG007|Overall Study|Not Reported|0|||
145762231|NCT02913313|525642325|FG008|Overall Study|Not Reported|0|||
145762232|NCT02913313|525642326|FG009|Overall Study|Not Reported|0|||
145762233|NCT02913313|525642327|FG010|Overall Study|Not Reported|4|||
145762234|NCT02913313|525642328|FG011|Overall Study|Not Reported|0|||
145762235|NCT02913313|525642329|FG012|Overall Study|Not Reported|0|||
145762236|NCT02913313|525642330|FG013|Overall Study|Not Reported|0|||
145762237|NCT02913313|525642317|FG000|Overall Study|Other reasons|0|||
145762238|NCT02913313|525642318|FG001|Overall Study|Other reasons|0|||
145762239|NCT02913313|525642319|FG002|Overall Study|Other reasons|0|||
145762240|NCT02913313|525642320|FG003|Overall Study|Other reasons|0|||
145762241|NCT02913313|525642321|FG004|Overall Study|Other reasons|1|||
145762242|NCT02913313|525642322|FG005|Overall Study|Other reasons|0|||
145762243|NCT02913313|525642323|FG006|Overall Study|Other reasons|0|||
145762244|NCT02913313|525642324|FG007|Overall Study|Other reasons|0|||
145762245|NCT02913313|525642325|FG008|Overall Study|Other reasons|0|||
145762246|NCT02913313|525642326|FG009|Overall Study|Other reasons|0|||
145276657|NCT01785875|523863069|FG001|Overall Study|Sponsor Decision|2|||
145276658|NCT01785875|523863070|FG002|Overall Study|Sponsor Decision|0|||
145276659|NCT01785875|523863068|FG000|Overall Study|Protocol Specified Criteria|207|||
145276660|NCT01785875|523863069|FG001|Overall Study|Protocol Specified Criteria|214|||
145276661|NCT01785875|523863070|FG002|Overall Study|Protocol Specified Criteria|55|||
145276662|NCT01785875|523863068|FG000|Overall Study|Missing|0|||
145276663|NCT01785875|523863069|FG001|Overall Study|Missing|1|||
145276664|NCT01785875|523863070|FG002|Overall Study|Missing|3|||
145276665|NCT00417027|523863073|FG000|Overall Study|Protocol Violation|0|||
145276666|NCT00417027|523863074|FG001|Overall Study|Protocol Violation|5|||
145762247|NCT02913313|525642327|FG010|Overall Study|Other reasons|1|||
145762248|NCT02913313|525642328|FG011|Overall Study|Other reasons|0|||
145276667|NCT00417027|523863075|FG002|Overall Study|Protocol Violation|5|||
145276668|NCT03137082|523863076|FG000|Overall Study|Withdrawal by Subject|1|||
145276669|NCT03137082|523863077|FG001|Overall Study|Withdrawal by Subject|1|||
145276670|NCT03137082|523863076|FG000|Overall Study|Lost to Follow-up|1|||
145276671|NCT03137082|523863077|FG001|Overall Study|Lost to Follow-up|0|||
145276672|NCT00707174|523863078|FG000|Overall Study|Adverse Event|1|||
145276673|NCT00707174|523863079|FG001|Overall Study|Adverse Event|6|||
145762249|NCT02913313|525642329|FG012|Overall Study|Other reasons|0|||
145762250|NCT02913313|525642330|FG013|Overall Study|Other reasons|0|||
145762251|NCT02913313|525642317|FG000|Overall Study|Withdrawal by Subject|0|||
145762252|NCT02913313|525642318|FG001|Overall Study|Withdrawal by Subject|0|||
145762253|NCT02913313|525642319|FG002|Overall Study|Withdrawal by Subject|1|||
145762254|NCT02913313|525642320|FG003|Overall Study|Withdrawal by Subject|0|||
145762255|NCT02913313|525642321|FG004|Overall Study|Withdrawal by Subject|0|||
145762256|NCT02913313|525642322|FG005|Overall Study|Withdrawal by Subject|0|||
145762257|NCT02913313|525642323|FG006|Overall Study|Withdrawal by Subject|1|||
145762258|NCT02913313|525642324|FG007|Overall Study|Withdrawal by Subject|1|||
145762259|NCT02913313|525642325|FG008|Overall Study|Withdrawal by Subject|0|||
145276674|NCT00707174|523863078|FG000|Overall Study|Withdrawal by Subject|4|||
145762260|NCT02913313|525642326|FG009|Overall Study|Withdrawal by Subject|0|||
145762261|NCT02913313|525642327|FG010|Overall Study|Withdrawal by Subject|1|||
145762262|NCT02913313|525642328|FG011|Overall Study|Withdrawal by Subject|0|||
145762263|NCT02913313|525642329|FG012|Overall Study|Withdrawal by Subject|0|||
145762264|NCT02913313|525642330|FG013|Overall Study|Withdrawal by Subject|0|||
145762265|NCT02913313|525642317|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145276675|NCT00707174|523863079|FG001|Overall Study|Withdrawal by Subject|1|||
145762266|NCT02913313|525642318|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762267|NCT02913313|525642319|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762268|NCT02913313|525642320|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762269|NCT02913313|525642321|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762270|NCT02913313|525642322|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762271|NCT02913313|525642323|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762272|NCT02913313|525642324|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762273|NCT02913313|525642325|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762274|NCT02913313|525642326|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762275|NCT02913313|525642327|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
145762276|NCT02913313|525642328|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
145762277|NCT02913313|525642329|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
145762278|NCT02913313|525642330|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
145762279|NCT02913313|525642317|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
145762280|NCT02913313|525642318|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
145276676|NCT00544557|523863080|FG000|Overall Study|Adverse Event|140|||
145276677|NCT00544557|523863080|FG000|Overall Study|Lack of Efficacy|196|||
145276678|NCT00544557|523863080|FG000|Overall Study|Other|98|||
145276679|NCT04057118|523863083|FG000|Overall Study|Adverse Event|1|||
145276680|NCT04057118|523863084|FG001|Overall Study|Adverse Event|0|||
145276681|NCT04057118|523863085|FG002|Overall Study|Adverse Event|1|||
145276682|NCT04057118|523863086|FG003|Overall Study|Adverse Event|1|||
145276683|NCT04057118|523863083|FG000|Overall Study|Physician Decision|0|||
145276684|NCT04057118|523863084|FG001|Overall Study|Physician Decision|0|||
145276685|NCT04057118|523863085|FG002|Overall Study|Physician Decision|1|||
145276686|NCT04057118|523863086|FG003|Overall Study|Physician Decision|1|||
145276687|NCT04057118|523863083|FG000|Overall Study|Withdrawal by Subject|2|||
145276688|NCT04057118|523863084|FG001|Overall Study|Withdrawal by Subject|2|||
145276689|NCT04057118|523863085|FG002|Overall Study|Withdrawal by Subject|0|||
145276690|NCT04057118|523863086|FG003|Overall Study|Withdrawal by Subject|2|||
145276691|NCT04057118|523863083|FG000|Overall Study|Not Specific|0|||
145276692|NCT04057118|523863084|FG001|Overall Study|Not Specific|0|||
145276693|NCT04057118|523863085|FG002|Overall Study|Not Specific|1|||
145276694|NCT04057118|523863086|FG003|Overall Study|Not Specific|1|||
145276695|NCT04333199|523863094|FG000|Evaluated Patients|Lost to Follow-up|0|||
145276696|NCT04333199|523863095|FG001|Evaluated Patients|Lost to Follow-up|1|||
145276697|NCT04333199|523863096|FG002|Evaluated Patients|Lost to Follow-up|2|||
145276698|NCT05789420|523863104|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
145276699|NCT05789420|523863104|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
145276700|NCT05473247|523863105|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
145276701|NCT02340078|523863111|FG000|Overall Study|Protocol Violation|1|||
145276702|NCT01831596|523863112|FG000|Overall Study|Other|8|||
145276703|NCT00446134|523863113|FG000|Overall Study|Adverse Event|7|||
145276704|NCT00446134|523863114|FG001|Overall Study|Adverse Event|17|||
145276705|NCT00446134|523863115|FG002|Overall Study|Adverse Event|13|||
145276706|NCT00446134|523863116|FG003|Overall Study|Adverse Event|18|||
145276707|NCT00446134|523863113|FG000|Overall Study|Lack of Efficacy|19|||
145276708|NCT00446134|523863114|FG001|Overall Study|Lack of Efficacy|19|||
145276709|NCT00446134|523863115|FG002|Overall Study|Lack of Efficacy|24|||
145276710|NCT00446134|523863116|FG003|Overall Study|Lack of Efficacy|19|||
145276711|NCT00446134|523863113|FG000|Overall Study|Protocol Violation|0|||
145276712|NCT00446134|523863114|FG001|Overall Study|Protocol Violation|2|||
145276713|NCT00446134|523863115|FG002|Overall Study|Protocol Violation|1|||
145276714|NCT00446134|523863116|FG003|Overall Study|Protocol Violation|0|||
145276715|NCT00446134|523863113|FG000|Overall Study|Lost to Follow-up|1|||
145276716|NCT00446134|523863114|FG001|Overall Study|Lost to Follow-up|3|||
145276717|NCT00446134|523863115|FG002|Overall Study|Lost to Follow-up|1|||
145276718|NCT00446134|523863116|FG003|Overall Study|Lost to Follow-up|1|||
145276719|NCT00446134|523863113|FG000|Overall Study|Withdrawal by Subject|3|||
145276720|NCT00446134|523863114|FG001|Overall Study|Withdrawal by Subject|3|||
145276721|NCT00446134|523863115|FG002|Overall Study|Withdrawal by Subject|1|||
145276722|NCT00446134|523863116|FG003|Overall Study|Withdrawal by Subject|3|||
145276723|NCT00446134|523863113|FG000|Overall Study|Physician Decision|0|||
145276724|NCT00446134|523863114|FG001|Overall Study|Physician Decision|0|||
145276725|NCT00446134|523863115|FG002|Overall Study|Physician Decision|0|||
145276726|NCT00446134|523863116|FG003|Overall Study|Physician Decision|2|||
145276727|NCT00446134|523863113|FG000|Overall Study|Adverse Event-Diarrhea|1|||
145276728|NCT00446134|523863114|FG001|Overall Study|Adverse Event-Diarrhea|1|||
145276729|NCT00446134|523863115|FG002|Overall Study|Adverse Event-Diarrhea|2|||
145276730|NCT00446134|523863116|FG003|Overall Study|Adverse Event-Diarrhea|0|||
145276731|NCT00446134|523863113|FG000|Overall Study|Reason Not Completed|3|||
145276732|NCT00446134|523863114|FG001|Overall Study|Reason Not Completed|0|||
145276733|NCT00446134|523863115|FG002|Overall Study|Reason Not Completed|1|||
145276734|NCT00446134|523863116|FG003|Overall Study|Reason Not Completed|2|||
145276735|NCT01311505|523863117|FG000|First Intervention Period|Protocol Violation|0|||
145402925|NCT00250588|524332553|FG001|Overall Study|Lost to Follow-up|13|||
145762281|NCT02913313|525642319|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
145276736|NCT01311505|523863118|FG001|First Intervention Period|Protocol Violation|1|||
145276737|NCT00567996|523863122|FG000|Overall Study|Adverse Event|18|||
145762282|NCT02913313|525642320|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
145276738|NCT00567996|523863123|FG001|Overall Study|Adverse Event|16|||
145762283|NCT02913313|525642321|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
145762284|NCT02913313|525642322|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
145762285|NCT02913313|525642323|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
145762286|NCT02913313|525642324|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
145762287|NCT02913313|525642325|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
145762288|NCT02913313|525642326|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
145762289|NCT02913313|525642327|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
145762290|NCT02913313|525642328|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
145762291|NCT02913313|525642329|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
145762292|NCT02913313|525642330|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
145762293|NCT06118385|525642331|FG000|Overall Study|Protocol Violation|0|||
145762294|NCT06118385|525642332|FG001|Overall Study|Protocol Violation|0|||
145762295|NCT06118385|525642333|FG002|Overall Study|Protocol Violation|0|||
145762296|NCT06118385|525642334|FG003|Overall Study|Protocol Violation|0|||
145762297|NCT06118385|525642335|FG004|Overall Study|Protocol Violation|0|||
145762298|NCT06118385|525642336|FG005|Overall Study|Protocol Violation|0|||
145762299|NCT06118385|525642337|FG006|Overall Study|Protocol Violation|0|||
145762300|NCT06118385|525642338|FG007|Overall Study|Protocol Violation|0|||
145762301|NCT06118385|525642339|FG008|Overall Study|Protocol Violation|1|||
145762302|NCT06118385|525642340|FG009|Overall Study|Protocol Violation|0|||
145762303|NCT06118385|525642341|FG010|Overall Study|Protocol Violation|0|||
145762304|NCT06118385|525642342|FG011|Overall Study|Protocol Violation|0|||
145762305|NCT06118385|525642331|FG000|Overall Study|Out-of-range blood tests|0|||
145762306|NCT06118385|525642332|FG001|Overall Study|Out-of-range blood tests|0|||
145762307|NCT06118385|525642333|FG002|Overall Study|Out-of-range blood tests|0|||
145762308|NCT06118385|525642334|FG003|Overall Study|Out-of-range blood tests|0|||
145762309|NCT06118385|525642335|FG004|Overall Study|Out-of-range blood tests|0|||
145762310|NCT06118385|525642336|FG005|Overall Study|Out-of-range blood tests|0|||
145762311|NCT06118385|525642337|FG006|Overall Study|Out-of-range blood tests|0|||
145762312|NCT06118385|525642338|FG007|Overall Study|Out-of-range blood tests|0|||
145762313|NCT06118385|525642339|FG008|Overall Study|Out-of-range blood tests|1|||
145762314|NCT06118385|525642340|FG009|Overall Study|Out-of-range blood tests|0|||
145762315|NCT06118385|525642341|FG010|Overall Study|Out-of-range blood tests|0|||
145762316|NCT06118385|525642342|FG011|Overall Study|Out-of-range blood tests|0|||
145762317|NCT03624946|525642345|FG000|Overall Study|Lost to Follow-up|0|||
145762318|NCT03624946|525642346|FG001|Overall Study|Lost to Follow-up|1|||
145762319|NCT01925209|525642347|FG000|Treatment Epoch|Physician Decision|1|||
145762320|NCT01925209|525642348|FG001|Treatment Epoch|Physician Decision|0|||
145762321|NCT01925209|525642349|FG002|Treatment Epoch|Physician Decision|0|||
145762322|NCT01925209|525642350|FG003|Treatment Epoch|Physician Decision|0|||
145762323|NCT01925209|525642347|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
145762324|NCT01925209|525642348|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
145762325|NCT01925209|525642349|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
145762326|NCT01925209|525642350|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
145762327|NCT01925209|525642347|FG000|Treatment Epoch|Death|1|||
145762328|NCT01925209|525642348|FG001|Treatment Epoch|Death|0|||
145762329|NCT01925209|525642349|FG002|Treatment Epoch|Death|0|||
145762330|NCT01925209|525642350|FG003|Treatment Epoch|Death|0|||
145762331|NCT01925209|525642347|FG000|Treatment Epoch|Protocol deviation|0|||
145762332|NCT01925209|525642348|FG001|Treatment Epoch|Protocol deviation|0|||
145762333|NCT01925209|525642349|FG002|Treatment Epoch|Protocol deviation|1|||
145762334|NCT01925209|525642350|FG003|Treatment Epoch|Protocol deviation|1|||
145762335|NCT01925209|525642347|FG000|Treatment Epoch|Withdrawal by Subject|4|||
145762336|NCT01925209|525642348|FG001|Treatment Epoch|Withdrawal by Subject|3|||
145762337|NCT01925209|525642349|FG002|Treatment Epoch|Withdrawal by Subject|3|||
145762338|NCT01925209|525642350|FG003|Treatment Epoch|Withdrawal by Subject|2|||
145762339|NCT01925209|525642347|FG000|Treatment Epoch|Adverse Event|3|||
145762340|NCT01925209|525642348|FG001|Treatment Epoch|Adverse Event|5|||
145762341|NCT01925209|525642349|FG002|Treatment Epoch|Adverse Event|3|||
145762342|NCT01925209|525642350|FG003|Treatment Epoch|Adverse Event|1|||
145762343|NCT01925209|525642347|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
145762344|NCT01925209|525642348|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
145762345|NCT01925209|525642349|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
145762346|NCT01925209|525642350|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
145762347|NCT01925209|525642347|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
145762348|NCT01925209|525642348|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
145762349|NCT01925209|525642349|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
145762350|NCT01925209|525642350|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
145762351|NCT01925209|525642347|FG000|Follow-up|Adverse Event|1|||
145762352|NCT01925209|525642348|FG001|Follow-up|Adverse Event|4|||
145762353|NCT01925209|525642349|FG002|Follow-up|Adverse Event|0|||
145276739|NCT00567996|523863124|FG002|Overall Study|Adverse Event|13|||
145276740|NCT00567996|523863122|FG000|Overall Study|Protocol Deviation|9|||
145276741|NCT00567996|523863123|FG001|Overall Study|Protocol Deviation|11|||
145276742|NCT00567996|523863124|FG002|Overall Study|Protocol Deviation|13|||
145276743|NCT00567996|523863122|FG000|Overall Study|Withdrawal by Subject|8|||
145762354|NCT01925209|525642350|FG003|Follow-up|Adverse Event|1|||
145762355|NCT01925209|525642347|FG000|Follow-up|Physician Decision|0|||
145762356|NCT01925209|525642348|FG001|Follow-up|Physician Decision|0|||
145762357|NCT01925209|525642349|FG002|Follow-up|Physician Decision|1|||
145762358|NCT01925209|525642350|FG003|Follow-up|Physician Decision|0|||
145762359|NCT01925209|525642347|FG000|Follow-up|Non-compliance with study treatment|0|||
145762360|NCT01925209|525642348|FG001|Follow-up|Non-compliance with study treatment|0|||
145762361|NCT01925209|525642349|FG002|Follow-up|Non-compliance with study treatment|0|||
145762362|NCT01925209|525642350|FG003|Follow-up|Non-compliance with study treatment|1|||
145762363|NCT01925209|525642347|FG000|Follow-up|Withdrawal by Subject|0|||
145762364|NCT01925209|525642348|FG001|Follow-up|Withdrawal by Subject|2|||
145762365|NCT01925209|525642349|FG002|Follow-up|Withdrawal by Subject|0|||
145762366|NCT01925209|525642350|FG003|Follow-up|Withdrawal by Subject|2|||
145762367|NCT00675025|525642351|FG000|Overall Study|Study Terminated by Sponsor|38|||
145762368|NCT00675025|525642352|FG001|Overall Study|Study Terminated by Sponsor|42|||
145762369|NCT00675025|525642351|FG000|Overall Study|Adverse Event|6|||
145762370|NCT00675025|525642352|FG001|Overall Study|Adverse Event|11|||
145762371|NCT00675025|525642351|FG000|Overall Study|Lost to Follow-up|6|||
145762372|NCT00675025|525642352|FG001|Overall Study|Lost to Follow-up|4|||
145762373|NCT00675025|525642351|FG000|Overall Study|Withdrawal by Subject|4|||
145762374|NCT00675025|525642352|FG001|Overall Study|Withdrawal by Subject|6|||
145762375|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
145762376|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
145762377|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|Death|1|||
145762378|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|Death|0|||
145276744|NCT00567996|523863123|FG001|Overall Study|Withdrawal by Subject|12|||
145276745|NCT00567996|523863124|FG002|Overall Study|Withdrawal by Subject|22|||
145607842|NCT01852058|525079286|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145607843|NCT01852058|525079287|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
145762379|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
145762380|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
145762381|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
145762382|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
145762383|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
145762384|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
145762385|NCT00110994|525642353|FG000|Double-blind (DB) Treatment|other reasons|2|||
145762386|NCT00110994|525642354|FG001|Double-blind (DB) Treatment|other reasons|3|||
145762387|NCT00110994|525642353|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
145762388|NCT00110994|525642354|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
145762389|NCT00110994|525642353|FG000|Active Follow-up|Other reasons|0|||
145762390|NCT00110994|525642354|FG001|Active Follow-up|Other reasons|2|||
145762391|NCT00110994|525642353|FG000|Long Term Follow-up|Death|19|||
145762392|NCT00110994|525642354|FG001|Long Term Follow-up|Death|17|||
145762393|NCT01551693|525642356|FG000|Overall Study|Disease Progression|1|||
145762394|NCT01551693|525642357|FG001|Overall Study|Disease Progression|0|||
145762395|NCT01551693|525642356|FG000|Overall Study|Adverse Event|0|||
145762396|NCT01551693|525642357|FG001|Overall Study|Adverse Event|1|||
145762397|NCT01551693|525642356|FG000|Overall Study|Withdrawal by Subject|0|||
145762398|NCT01551693|525642357|FG001|Overall Study|Withdrawal by Subject|1|||
145762399|NCT04134494|525642358|FG000|Overall Study|Lost to Follow-up|2|||
145762400|NCT01950819|525642359|FG000|Overall Study|Graft Loss|35|||
145762401|NCT01950819|525642360|FG001|Overall Study|Graft Loss|30|||
145762402|NCT01950819|525642359|FG000|Overall Study|Death|29|||
145762403|NCT01950819|525642360|FG001|Overall Study|Death|34|||
145762404|NCT01950819|525642359|FG000|Overall Study|Subject / Gardian decision|54|||
145276746|NCT00567996|523863122|FG000|Overall Study|Abnormal Lab value(s)|2|||
145276747|NCT00567996|523863123|FG001|Overall Study|Abnormal Lab value(s)|1|||
145276748|NCT00567996|523863124|FG002|Overall Study|Abnormal Lab value(s)|2|||
145607844|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145762405|NCT01950819|525642360|FG001|Overall Study|Subject / Gardian decision|51|||
145762406|NCT01950819|525642359|FG000|Overall Study|technical problems|2|||
145762407|NCT01950819|525642360|FG001|Overall Study|technical problems|0|||
145762408|NCT01950819|525642359|FG000|Overall Study|Pregnancy|0|||
145276749|NCT00567996|523863122|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145762409|NCT01950819|525642360|FG001|Overall Study|Pregnancy|2|||
145762410|NCT01950819|525642359|FG000|Overall Study|Lost to Follow-up|9|||
145762411|NCT01950819|525642360|FG001|Overall Study|Lost to Follow-up|17|||
145762412|NCT00781365|525642361|FG000|Overall Study|Withdrawal by Subject|13|||
145762413|NCT00781365|525642362|FG001|Overall Study|Withdrawal by Subject|8|||
145762414|NCT00781365|525642361|FG000|Overall Study|Did Not Attend Visit|20|||
145762415|NCT00781365|525642362|FG001|Overall Study|Did Not Attend Visit|28|||
145762416|NCT00781365|525642361|FG000|Overall Study|Language barrier|1|||
145762417|NCT00781365|525642362|FG001|Overall Study|Language barrier|0|||
145762418|NCT00238264|525642363|FG000|Overall Study|Death|7|||
145762419|NCT00238264|525642363|FG000|Overall Study|Lost to Follow-up|18|||
145762420|NCT00238264|525642363|FG000|Overall Study|Withdrawal by Subject|4|||
145762421|NCT00238264|525642363|FG000|Overall Study|Ineligible|7|||
145276750|NCT00567996|523863123|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145276751|NCT00567996|523863124|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145276752|NCT00567996|523863122|FG000|Overall Study|Lost to Follow-up|2|||
145276753|NCT00567996|523863123|FG001|Overall Study|Lost to Follow-up|5|||
145762422|NCT01756456|525642366|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
145762423|NCT01756456|525642367|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
145762424|NCT01756456|525642368|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
145762425|NCT01756456|525642369|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
145762426|NCT01756456|525642370|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
145762427|NCT01756456|525642371|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
145762428|NCT01756456|525642366|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
145762429|NCT01756456|525642367|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
145762430|NCT01756456|525642368|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
145762431|NCT01756456|525642369|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
145762432|NCT01756456|525642370|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
145762433|NCT01756456|525642371|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
145762434|NCT01756456|525642366|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
145276754|NCT00567996|523863124|FG002|Overall Study|Lost to Follow-up|2|||
145276755|NCT00567996|523863122|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145276756|NCT00567996|523863123|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145276757|NCT00567996|523863124|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
145276758|NCT00567996|523863122|FG000|Overall Study|Administrative problems|1|||
145276759|NCT00567996|523863123|FG001|Overall Study|Administrative problems|1|||
145276760|NCT00567996|523863124|FG002|Overall Study|Administrative problems|0|||
145276761|NCT00567996|523863122|FG000|Overall Study|Death|1|||
145762435|NCT01756456|525642367|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
145762436|NCT01756456|525642368|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
145276762|NCT00567996|523863123|FG001|Overall Study|Death|0|||
145276763|NCT00567996|523863124|FG002|Overall Study|Death|2|||
145276764|NCT00567996|523863122|FG000|Overall Study|Patient's inability to use the device|0|||
145276765|NCT00567996|523863123|FG001|Overall Study|Patient's inability to use the device|1|||
145276766|NCT00567996|523863124|FG002|Overall Study|Patient's inability to use the device|0|||
145276767|NCT02956005|523863125|FG000|Overall Study|Not eligible|1|||
145276768|NCT02956005|523863125|FG000|Overall Study|Withdrawal by Subject|3|||
145276769|NCT02956005|523863125|FG000|Overall Study|Physician Decision|12|||
145276770|NCT02524665|523863128|FG000|Overall Study|Lost to Follow-up|1|||
145276771|NCT02602080|523863131|FG000|Overall Study|Protocol Violation|6|||
145276772|NCT02602080|523863132|FG001|Overall Study|Protocol Violation|1|||
145276773|NCT02602080|523863133|FG002|Overall Study|Protocol Violation|3|||
145762437|NCT01756456|525642369|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
145762438|NCT01756456|525642370|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
145762439|NCT01756456|525642371|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
145762440|NCT01756456|525642366|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
145762441|NCT01756456|525642367|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
145762442|NCT01756456|525642368|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
145762443|NCT01756456|525642369|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
145762444|NCT01756456|525642370|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
145762445|NCT01756456|525642371|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
145762446|NCT01756456|525642366|FG000|Treatment Period: Phase I/II|Other causes|0|||
145762447|NCT01756456|525642367|FG001|Treatment Period: Phase I/II|Other causes|0|||
145762448|NCT01756456|525642368|FG002|Treatment Period: Phase I/II|Other causes|0|||
145762449|NCT01756456|525642369|FG003|Treatment Period: Phase I/II|Other causes|1|||
145762450|NCT01756456|525642370|FG004|Treatment Period: Phase I/II|Other causes|2|||
145762451|NCT01756456|525642371|FG005|Treatment Period: Phase I/II|Other causes|2|||
145762452|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
145762453|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
145762454|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
145762455|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
145762456|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
145762457|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
145762458|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
145762459|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
145762460|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
145276774|NCT01066039|523863139|FG000|Overall Study|Adverse Event|6|||
145276775|NCT01066039|523863139|FG000|Overall Study|Withdrawal by Subject|17|||
145276776|NCT01066039|523863139|FG000|Overall Study|Protocol Violation|2|||
145762461|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
145762462|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
145276777|NCT01066039|523863139|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
145762463|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
145762464|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
145762465|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
145762466|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
145762467|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
145762468|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
145762469|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
145762470|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
145762471|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
145762472|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
145762473|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
145762474|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
145762475|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
145762476|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
145762477|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
145762478|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
145762479|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
145762480|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
145762481|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
145762482|NCT01756456|525642366|FG000|Follow Up Period Phase I/II|Other causes|0|||
145762483|NCT01756456|525642367|FG001|Follow Up Period Phase I/II|Other causes|0|||
145762484|NCT01756456|525642368|FG002|Follow Up Period Phase I/II|Other causes|0|||
145276778|NCT01066039|523863139|FG000|Overall Study|Investigator's Request|1|||
145276779|NCT01066039|523863139|FG000|Overall Study|Dropout due to Insulin Administration|1|||
145276780|NCT01066039|523863139|FG000|Overall Study|Additional Antihypertensive Required|4|||
145276781|NCT01066039|523863139|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
145276782|NCT01066039|523863139|FG000|Overall Study|Failure to Control Blood Pressure|1|||
145276783|NCT01066039|523863139|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
145276784|NCT02574260|523863140|FG000|Overall Study|Disease Progression|1|||
145276785|NCT03022799|523863144|FG000|Overall Study|Adverse Event|0|||
145276786|NCT03022799|523863145|FG001|Overall Study|Adverse Event|0|||
145276787|NCT03022799|523863146|FG002|Overall Study|Adverse Event|0|||
145762485|NCT01756456|525642369|FG003|Follow Up Period Phase I/II|Other causes|1|||
145762486|NCT01756456|525642370|FG004|Follow Up Period Phase I/II|Other causes|3|||
145762487|NCT01756456|525642371|FG005|Follow Up Period Phase I/II|Other causes|5|||
145762488|NCT01838044|525642372|FG000|Overall Study|Adverse Event|4|||
145762489|NCT01838044|525642373|FG001|Overall Study|Adverse Event|6|||
145762490|NCT01838044|525642372|FG000|Overall Study|Protocol Violation|3|||
145276788|NCT03022799|523863147|FG003|Overall Study|Adverse Event|0|||
145762491|NCT01838044|525642373|FG001|Overall Study|Protocol Violation|3|||
145762492|NCT01838044|525642372|FG000|Overall Study|Withdrawal by Subject|0|||
145762493|NCT01838044|525642373|FG001|Overall Study|Withdrawal by Subject|2|||
145762494|NCT01838044|525642372|FG000|Overall Study|Insufficient clinical response|1|||
145762495|NCT01838044|525642373|FG001|Overall Study|Insufficient clinical response|2|||
145762496|NCT01838044|525642372|FG000|Overall Study|Medication error without associated AE|0|||
145762497|NCT01838044|525642373|FG001|Overall Study|Medication error without associated AE|1|||
145762498|NCT01838044|525642372|FG000|Overall Study|Lost to Follow-up|0|||
145762499|NCT01838044|525642373|FG001|Overall Study|Lost to Follow-up|2|||
145762500|NCT01662648|525642374|FG000|Overall Study|Death|1|||
145762501|NCT01662648|525642375|FG001|Overall Study|Death|3|||
145762502|NCT01662648|525642374|FG000|Overall Study|Adverse Event|40|||
145762503|NCT01662648|525642375|FG001|Overall Study|Adverse Event|37|||
145762504|NCT01662648|525642374|FG000|Overall Study|Lack of Efficacy|17|||
145762505|NCT01662648|525642375|FG001|Overall Study|Lack of Efficacy|16|||
145762506|NCT01662648|525642374|FG000|Overall Study|Participant ineligible to continue trial|1|||
145762507|NCT01662648|525642375|FG001|Overall Study|Participant ineligible to continue trial|1|||
145762508|NCT01662648|525642374|FG000|Overall Study|Lost to Follow-up|24|||
145762509|NCT01662648|525642375|FG001|Overall Study|Lost to Follow-up|36|||
145762510|NCT01662648|525642374|FG000|Overall Study|Withdrawal by Subject|36|||
145762511|NCT01662648|525642375|FG001|Overall Study|Withdrawal by Subject|53|||
145762512|NCT01662648|525642374|FG000|Overall Study|Participant non-compliant|16|||
145762513|NCT01662648|525642375|FG001|Overall Study|Participant non-compliant|20|||
145762514|NCT01662648|525642374|FG000|Overall Study|Other|8|||
145762515|NCT01662648|525642375|FG001|Overall Study|Other|11|||
145762516|NCT01662648|525642374|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
145762517|NCT01662648|525642375|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
145762518|NCT01662648|525642374|FG000|Overall Study|LOE and other reason unspecified|1|||
145762519|NCT01662648|525642375|FG001|Overall Study|LOE and other reason unspecified|0|||
145762520|NCT01662648|525642374|FG000|Overall Study|LOE and Participant non-compliant|0|||
145762521|NCT01662648|525642375|FG001|Overall Study|LOE and Participant non-compliant|1|||
145762522|NCT00706628|525642376|FG000|Overall Study|Other Adverse Event|16|||
145762523|NCT00706628|525642377|FG001|Overall Study|Other Adverse Event|5|||
145276789|NCT03022799|523863148|FG004|Overall Study|Adverse Event|0|||
145276790|NCT03022799|523863149|FG005|Overall Study|Adverse Event|0|||
145762524|NCT00706628|525642378|FG002|Overall Study|Other Adverse Event|5|||
145762525|NCT00706628|525642379|FG003|Overall Study|Other Adverse Event|2|||
145762526|NCT00706628|525642376|FG000|Overall Study|Non compliant with protocol|0|||
145762527|NCT00706628|525642377|FG001|Overall Study|Non compliant with protocol|1|||
145762528|NCT00706628|525642378|FG002|Overall Study|Non compliant with protocol|0|||
145762529|NCT00706628|525642379|FG003|Overall Study|Non compliant with protocol|0|||
145762530|NCT00706628|525642376|FG000|Overall Study|Consent withdrawn|6|||
145762531|NCT00706628|525642377|FG001|Overall Study|Consent withdrawn|1|||
145762532|NCT00706628|525642378|FG002|Overall Study|Consent withdrawn|3|||
145762533|NCT00706628|525642379|FG003|Overall Study|Consent withdrawn|0|||
145762534|NCT00706628|525642376|FG000|Overall Study|Progressive disease|20|||
145762535|NCT00706628|525642377|FG001|Overall Study|Progressive disease|13|||
145762536|NCT00706628|525642378|FG002|Overall Study|Progressive disease|8|||
145762537|NCT00706628|525642379|FG003|Overall Study|Progressive disease|1|||
145762538|NCT00706628|525642376|FG000|Overall Study|Other than those stated above|4|||
145762539|NCT00706628|525642377|FG001|Overall Study|Other than those stated above|0|||
145762540|NCT00706628|525642378|FG002|Overall Study|Other than those stated above|0|||
145762541|NCT00706628|525642379|FG003|Overall Study|Other than those stated above|0|||
145762542|NCT00706628|525642376|FG000|Overall Study|Not treated|1|||
145762543|NCT00706628|525642377|FG001|Overall Study|Not treated|1|||
145762544|NCT00706628|525642378|FG002|Overall Study|Not treated|0|||
145762545|NCT00706628|525642379|FG003|Overall Study|Not treated|0|||
145762546|NCT02266433|525642383|FG000|Overall Study|Lost to Follow-up|54|||
145762547|NCT02266433|525642384|FG001|Overall Study|Lost to Follow-up|46|||
145762548|NCT02266433|525642383|FG000|Overall Study|Withdrawal by Subject|5|||
145762549|NCT02266433|525642384|FG001|Overall Study|Withdrawal by Subject|7|||
145762550|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762551|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762552|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762553|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
145762554|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762555|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
145762556|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762557|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762558|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762559|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762560|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762561|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762562|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762563|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762564|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762565|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762566|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762567|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762568|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762569|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762570|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762571|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762572|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
145762573|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
145762574|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
145762575|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
145762576|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
145762577|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
145762578|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
145762579|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
145762580|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762581|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762582|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762583|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762584|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762585|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762586|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762587|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762588|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762589|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762590|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762591|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762592|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762593|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762594|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762595|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
145762596|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
145762597|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
145762598|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
145762599|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
145762600|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
145762601|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
145762602|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
145762603|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
145762604|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762605|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762606|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762607|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762608|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762609|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762610|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762611|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762612|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762613|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762614|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762615|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762616|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762617|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762618|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
145762619|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762620|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762621|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
145762622|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762623|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
145762624|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762625|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762626|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762627|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762628|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762629|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762630|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762631|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762632|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762633|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762634|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762635|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762636|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762637|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762638|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762639|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762640|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762641|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
145762642|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
145762643|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762644|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762645|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
145762646|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762647|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762648|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762649|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762650|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762651|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762652|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762653|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762654|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762655|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762656|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762657|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762658|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762659|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762660|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762661|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762662|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762663|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762664|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
145762665|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762666|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762667|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
145762668|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762669|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762670|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762671|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762672|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762673|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762674|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762675|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762676|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762677|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762678|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762679|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762680|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762681|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762682|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762683|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762684|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762685|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762686|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762687|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
145762688|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762689|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762690|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
145762691|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762692|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762693|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762694|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762695|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762696|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762697|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762698|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762699|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762700|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762701|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762702|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762703|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762704|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762705|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762706|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762707|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762708|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762709|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762710|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
145762711|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762712|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762713|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762714|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
145762715|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762716|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762717|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145276791|NCT03022799|523863150|FG006|Overall Study|Adverse Event|0|||
145276792|NCT03022799|523863151|FG007|Overall Study|Adverse Event|0|||
145276793|NCT03022799|523863152|FG008|Overall Study|Adverse Event|0|||
145276794|NCT03022799|523863153|FG009|Overall Study|Adverse Event|1|||
145276795|NCT03022799|523863154|FG010|Overall Study|Adverse Event|1|||
145276796|NCT03022799|523863155|FG011|Overall Study|Adverse Event|0|||
145276797|NCT03022799|523863156|FG012|Overall Study|Adverse Event|0|||
145276798|NCT00883129|523863160|FG000|Overall Study|Adverse Event|7|||
145276799|NCT00883129|523863161|FG001|Overall Study|Adverse Event|15|||
145276800|NCT00883129|523863160|FG000|Overall Study|Withdrawal by Subject|8|||
145276801|NCT00883129|523863161|FG001|Overall Study|Withdrawal by Subject|9|||
145276802|NCT00883129|523863160|FG000|Overall Study|Non-compliance|3|||
145276803|NCT00883129|523863161|FG001|Overall Study|Non-compliance|6|||
145276804|NCT00883129|523863160|FG000|Overall Study|Lost to Follow-up|1|||
145276805|NCT00883129|523863161|FG001|Overall Study|Lost to Follow-up|2|||
145276806|NCT00883129|523863160|FG000|Overall Study|Death|1|||
145276807|NCT00883129|523863161|FG001|Overall Study|Death|2|||
145276808|NCT00883129|523863160|FG000|Overall Study|Defined Treatment Failure|0|||
145276809|NCT00883129|523863161|FG001|Overall Study|Defined Treatment Failure|2|||
145276810|NCT03273257|523863162|FG000|Overall Study|Death|0|||
145276811|NCT03273257|523863163|FG001|Overall Study|Death|1|||
145276812|NCT03273257|523863162|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
145276813|NCT03273257|523863163|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
145762718|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762719|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762720|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762721|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762722|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762723|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762724|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762725|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762726|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762727|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762728|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762729|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762730|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762731|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762732|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762733|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
145762734|NCT00896532|525642388|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762735|NCT00896532|525642389|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
145762736|NCT00896532|525642390|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762737|NCT00896532|525642391|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
145762738|NCT00896532|525642392|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
145762739|NCT00896532|525642393|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762740|NCT00896532|525642394|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762741|NCT00896532|525642395|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762742|NCT00896532|525642396|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762743|NCT00896532|525642397|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762744|NCT00896532|525642398|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762745|NCT00896532|525642399|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762746|NCT00896532|525642400|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762747|NCT00896532|525642401|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762748|NCT00896532|525642402|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762749|NCT00896532|525642403|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762750|NCT00896532|525642404|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762751|NCT00896532|525642405|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762752|NCT00896532|525642406|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762753|NCT00896532|525642407|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762754|NCT00896532|525642408|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762755|NCT00896532|525642409|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762756|NCT00896532|525642410|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
145762757|NCT00896532|525642388|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762758|NCT00896532|525642389|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762759|NCT00896532|525642390|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762760|NCT00896532|525642391|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762761|NCT00896532|525642392|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762762|NCT00896532|525642393|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762763|NCT00896532|525642394|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762764|NCT00896532|525642395|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762765|NCT00896532|525642396|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
145762766|NCT00896532|525642397|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762767|NCT00896532|525642398|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762768|NCT00896532|525642399|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762769|NCT00896532|525642400|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762770|NCT00896532|525642401|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762771|NCT00896532|525642402|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762772|NCT00896532|525642403|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762773|NCT00896532|525642404|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762774|NCT00896532|525642405|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762775|NCT00896532|525642406|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145276814|NCT03273257|523863162|FG000|Overall Study|Study terminated|3|||
145276815|NCT03273257|523863163|FG001|Overall Study|Study terminated|2|||
145762776|NCT00896532|525642407|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762777|NCT00896532|525642408|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762778|NCT00896532|525642409|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145276816|NCT01185639|523863165|FG000|Overall Study|Progressed and didn't receive therapy|2|||
145276817|NCT02200614|523863166|FG000|Double Blind Treatment|Adverse Event|86|||
145276818|NCT02200614|523863167|FG001|Double Blind Treatment|Adverse Event|48|||
145276819|NCT02200614|523863166|FG000|Double Blind Treatment|Confirmed metastasis|120|||
145276820|NCT02200614|523863167|FG001|Double Blind Treatment|Confirmed metastasis|140|||
145276821|NCT02200614|523863166|FG000|Double Blind Treatment|Judgment of the investigator|59|||
145276822|NCT02200614|523863167|FG001|Double Blind Treatment|Judgment of the investigator|99|||
145276823|NCT02200614|523863166|FG000|Double Blind Treatment|Metastasis by local reading|1|||
145276824|NCT02200614|523863167|FG001|Double Blind Treatment|Metastasis by local reading|3|||
145276825|NCT02200614|523863166|FG000|Double Blind Treatment|Other reason|6|||
145276826|NCT02200614|523863167|FG001|Double Blind Treatment|Other reason|2|||
145276827|NCT02200614|523863166|FG000|Double Blind Treatment|Personal reason|77|||
145762779|NCT00896532|525642410|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
145762780|NCT00896532|525642388|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762781|NCT00896532|525642389|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762782|NCT00896532|525642390|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762783|NCT00896532|525642391|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762784|NCT00896532|525642392|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762785|NCT00896532|525642393|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762786|NCT00896532|525642394|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762787|NCT00896532|525642395|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762788|NCT00896532|525642396|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762789|NCT00896532|525642397|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762790|NCT00896532|525642398|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762791|NCT00896532|525642399|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762792|NCT00896532|525642400|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
145762793|NCT00896532|525642401|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145276828|NCT02200614|523863167|FG001|Double Blind Treatment|Personal reason|85|||
145276829|NCT02200614|523863166|FG000|Double Blind Treatment|Protocol deviation|14|||
145276830|NCT02200614|523863167|FG001|Double Blind Treatment|Protocol deviation|7|||
145276831|NCT02200614|523863166|FG000|Double Blind Treatment|Not treated|1|||
145276832|NCT02200614|523863167|FG001|Double Blind Treatment|Not treated|0|||
145276833|NCT02200614|523863166|FG000|Open Label|Adverse Event|41|||
145276834|NCT02200614|523863167|FG001|Open Label|Adverse Event|11|||
145276835|NCT02200614|523863166|FG000|Open Label|Confirmed metastasis|1|||
145276836|NCT02200614|523863167|FG001|Open Label|Confirmed metastasis|0|||
145276837|NCT02200614|523863166|FG000|Open Label|Judgment of the investigator|29|||
145762794|NCT00896532|525642402|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762795|NCT00896532|525642403|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762796|NCT00896532|525642404|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762797|NCT00896532|525642405|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762798|NCT00896532|525642406|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762799|NCT00896532|525642407|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762800|NCT00896532|525642408|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762801|NCT00896532|525642409|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762802|NCT00896532|525642410|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
145762803|NCT00896532|525642388|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762804|NCT00896532|525642389|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762805|NCT00896532|525642390|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762806|NCT00896532|525642391|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762807|NCT00896532|525642392|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762808|NCT00896532|525642393|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762809|NCT00896532|525642394|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762810|NCT00896532|525642395|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145276838|NCT02200614|523863167|FG001|Open Label|Judgment of the investigator|2|||
145276839|NCT02200614|523863166|FG000|Open Label|Metastasis by local reading|138|||
145276840|NCT02200614|523863167|FG001|Open Label|Metastasis by local reading|27|||
145276841|NCT02200614|523863166|FG000|Open Label|Other reason|22|||
145276842|NCT02200614|523863167|FG001|Open Label|Other reason|4|||
145276843|NCT02200614|523863166|FG000|Open Label|Personal reason|60|||
145276844|NCT02200614|523863167|FG001|Open Label|Personal reason|8|||
145276845|NCT02200614|523863166|FG000|Open Label|Protocol deviation|3|||
145762811|NCT00896532|525642396|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762812|NCT00896532|525642397|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762813|NCT00896532|525642398|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
145762814|NCT00896532|525642399|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762815|NCT00896532|525642400|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
145762816|NCT00896532|525642401|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762817|NCT00896532|525642402|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762818|NCT00896532|525642403|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762819|NCT00896532|525642404|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762820|NCT00896532|525642405|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762821|NCT00896532|525642406|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762822|NCT00896532|525642407|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762823|NCT00896532|525642408|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762824|NCT00896532|525642409|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762825|NCT00896532|525642410|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
145762826|NCT00896532|525642388|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762827|NCT00896532|525642389|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762828|NCT00896532|525642390|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762829|NCT00896532|525642391|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762830|NCT00896532|525642392|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762831|NCT00896532|525642393|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762832|NCT00896532|525642394|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762833|NCT00896532|525642395|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762834|NCT00896532|525642396|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762835|NCT00896532|525642397|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762836|NCT00896532|525642398|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762837|NCT00896532|525642399|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762838|NCT00896532|525642400|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
145762839|NCT00896532|525642401|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
145762840|NCT00896532|525642402|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762841|NCT00896532|525642403|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762842|NCT00896532|525642404|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762843|NCT00896532|525642405|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762844|NCT00896532|525642406|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762845|NCT00896532|525642407|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762846|NCT00896532|525642408|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762847|NCT00896532|525642409|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762848|NCT00896532|525642410|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
145762849|NCT00896532|525642388|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
145762850|NCT00896532|525642389|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
145762851|NCT00896532|525642390|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
145762852|NCT00896532|525642391|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
145762853|NCT00896532|525642392|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
145762854|NCT00896532|525642393|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
145762855|NCT00896532|525642394|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
145762856|NCT00896532|525642395|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
145762857|NCT00896532|525642396|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
145762858|NCT00896532|525642397|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
145762859|NCT00896532|525642398|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
145762860|NCT00896532|525642399|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
145762861|NCT00896532|525642400|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
145762862|NCT00896532|525642401|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
145762863|NCT00896532|525642402|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
145762864|NCT00896532|525642403|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
145762865|NCT00896532|525642404|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
145762866|NCT00896532|525642405|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
145762867|NCT00896532|525642406|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
145762868|NCT00896532|525642407|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
145762869|NCT00896532|525642408|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
145762870|NCT00896532|525642409|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
145762871|NCT00896532|525642410|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
145762872|NCT00896532|525642388|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762873|NCT00896532|525642389|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762874|NCT00896532|525642390|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762875|NCT00896532|525642391|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762876|NCT00896532|525642392|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762877|NCT00896532|525642393|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762878|NCT00896532|525642394|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762879|NCT00896532|525642395|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762880|NCT00896532|525642396|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762881|NCT00896532|525642397|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762882|NCT00896532|525642398|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762883|NCT00896532|525642399|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762884|NCT00896532|525642400|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762885|NCT00896532|525642401|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762886|NCT00896532|525642402|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762887|NCT00896532|525642403|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
145762888|NCT00896532|525642404|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
145762889|NCT00896532|525642405|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762890|NCT00896532|525642406|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762891|NCT00896532|525642407|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762892|NCT00896532|525642408|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762893|NCT00896532|525642409|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762894|NCT00896532|525642410|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
145762895|NCT00896532|525642388|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762896|NCT00896532|525642389|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762897|NCT00896532|525642390|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762898|NCT00896532|525642391|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762899|NCT00896532|525642392|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762900|NCT00896532|525642393|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762901|NCT00896532|525642394|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762902|NCT00896532|525642395|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762903|NCT00896532|525642396|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762904|NCT00896532|525642397|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762905|NCT00896532|525642398|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762906|NCT00896532|525642399|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762907|NCT00896532|525642400|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762908|NCT00896532|525642401|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762909|NCT00896532|525642402|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762910|NCT00896532|525642403|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
145762911|NCT00896532|525642404|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
145762912|NCT00896532|525642405|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
145762913|NCT00896532|525642406|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762914|NCT00896532|525642407|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762915|NCT00896532|525642408|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145276846|NCT02200614|523863167|FG001|Open Label|Protocol deviation|2|||
145276847|NCT02200614|523863166|FG000|Open Label|Missing|2|||
145762916|NCT00896532|525642409|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145276848|NCT02200614|523863167|FG001|Open Label|Missing|2|||
145762917|NCT00896532|525642410|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
145762918|NCT00896532|525642388|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762919|NCT00896532|525642389|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762920|NCT00896532|525642390|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762921|NCT00896532|525642391|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762922|NCT00896532|525642392|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762923|NCT00896532|525642393|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762924|NCT00896532|525642394|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762925|NCT00896532|525642395|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762926|NCT00896532|525642396|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762927|NCT00896532|525642397|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762928|NCT00896532|525642398|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762929|NCT00896532|525642399|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762930|NCT00896532|525642400|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762931|NCT00896532|525642401|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762932|NCT00896532|525642402|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762933|NCT00896532|525642403|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762934|NCT00896532|525642404|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
145762935|NCT00896532|525642405|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762936|NCT00896532|525642406|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762937|NCT00896532|525642407|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762938|NCT00896532|525642408|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762939|NCT00896532|525642409|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762940|NCT00896532|525642410|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
145762941|NCT00896532|525642388|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
145762942|NCT00896532|525642389|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
145762943|NCT00896532|525642390|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
145762944|NCT00896532|525642391|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
145762945|NCT00896532|525642392|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
145762946|NCT00896532|525642393|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
145762947|NCT00896532|525642394|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
145762948|NCT00896532|525642395|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
145762949|NCT00896532|525642396|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
145762950|NCT00896532|525642397|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
145762951|NCT00896532|525642398|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
145762952|NCT00896532|525642399|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
145762953|NCT00896532|525642400|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
145762954|NCT00896532|525642401|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
145762955|NCT00896532|525642402|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
145762956|NCT00896532|525642403|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
145762957|NCT00896532|525642404|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
145762958|NCT00896532|525642405|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
145762959|NCT00896532|525642406|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
145762960|NCT00896532|525642407|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
145762961|NCT00896532|525642408|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
145762962|NCT00896532|525642409|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
145762963|NCT00896532|525642410|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
145762964|NCT00896532|525642388|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762965|NCT00896532|525642389|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762966|NCT00896532|525642390|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762967|NCT00896532|525642391|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762968|NCT00896532|525642392|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762969|NCT00896532|525642393|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762970|NCT00896532|525642394|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762971|NCT00896532|525642395|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762972|NCT00896532|525642396|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762973|NCT00896532|525642397|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762974|NCT00896532|525642398|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762975|NCT00896532|525642399|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762976|NCT00896532|525642400|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762977|NCT00896532|525642401|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762978|NCT00896532|525642402|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762979|NCT00896532|525642403|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762980|NCT00896532|525642404|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
145762981|NCT00896532|525642405|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762982|NCT00896532|525642406|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762983|NCT00896532|525642407|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762984|NCT00896532|525642408|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762985|NCT00896532|525642409|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762986|NCT00896532|525642410|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
145762987|NCT00896532|525642388|FG000|Months 48-72: Follow-on Phase|Death|0|||
145762988|NCT00896532|525642389|FG001|Months 48-72: Follow-on Phase|Death|0|||
145762989|NCT00896532|525642390|FG002|Months 48-72: Follow-on Phase|Death|0|||
145762990|NCT00896532|525642391|FG003|Months 48-72: Follow-on Phase|Death|0|||
145762991|NCT00896532|525642392|FG004|Months 48-72: Follow-on Phase|Death|0|||
145762992|NCT00896532|525642393|FG005|Months 48-72: Follow-on Phase|Death|0|||
145762993|NCT00896532|525642394|FG006|Months 48-72: Follow-on Phase|Death|0|||
145762994|NCT00896532|525642395|FG007|Months 48-72: Follow-on Phase|Death|0|||
145762995|NCT00896532|525642396|FG008|Months 48-72: Follow-on Phase|Death|0|||
145762996|NCT00896532|525642397|FG009|Months 48-72: Follow-on Phase|Death|0|||
145762997|NCT00896532|525642398|FG010|Months 48-72: Follow-on Phase|Death|0|||
145762998|NCT00896532|525642399|FG011|Months 48-72: Follow-on Phase|Death|0|||
145762999|NCT00896532|525642400|FG012|Months 48-72: Follow-on Phase|Death|0|||
145763000|NCT00896532|525642401|FG013|Months 48-72: Follow-on Phase|Death|0|||
145763001|NCT00896532|525642402|FG014|Months 48-72: Follow-on Phase|Death|0|||
145763002|NCT00896532|525642403|FG015|Months 48-72: Follow-on Phase|Death|0|||
145763003|NCT00896532|525642404|FG016|Months 48-72: Follow-on Phase|Death|0|||
145763004|NCT00896532|525642405|FG017|Months 48-72: Follow-on Phase|Death|0|||
145763005|NCT00896532|525642406|FG018|Months 48-72: Follow-on Phase|Death|1|||
145763006|NCT00896532|525642407|FG019|Months 48-72: Follow-on Phase|Death|0|||
145763007|NCT00896532|525642408|FG020|Months 48-72: Follow-on Phase|Death|0|||
145763008|NCT00896532|525642409|FG021|Months 48-72: Follow-on Phase|Death|0|||
145763009|NCT00896532|525642410|FG022|Months 48-72: Follow-on Phase|Death|0|||
145763010|NCT00896532|525642388|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763011|NCT00896532|525642389|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763012|NCT00896532|525642390|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763013|NCT00896532|525642391|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763014|NCT00896532|525642392|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763015|NCT00896532|525642393|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763016|NCT00896532|525642394|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145276849|NCT01898884|523863168|FG000|Multiple Dose Period|Adverse Event|0|||
145276850|NCT01898884|523863169|FG001|Multiple Dose Period|Adverse Event|0|||
145276851|NCT01898884|523863170|FG002|Multiple Dose Period|Adverse Event|0|||
145276852|NCT01898884|523863171|FG003|Multiple Dose Period|Adverse Event|0|||
145276853|NCT01898884|523863172|FG004|Multiple Dose Period|Adverse Event|0|||
145276854|NCT01898884|523863173|FG005|Multiple Dose Period|Adverse Event|0|||
145292757|NCT06179108|523922226|FG000|Overall Study|Protocol Violation|0|||
145763017|NCT00896532|525642395|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763018|NCT00896532|525642396|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763019|NCT00896532|525642397|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763020|NCT00896532|525642398|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763021|NCT00896532|525642399|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763022|NCT00896532|525642400|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763023|NCT00896532|525642401|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763024|NCT00896532|525642402|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763025|NCT00896532|525642403|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763026|NCT00896532|525642404|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763027|NCT00896532|525642405|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763028|NCT00896532|525642406|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763029|NCT00896532|525642407|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763030|NCT00896532|525642408|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763031|NCT00896532|525642409|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
145763032|NCT00896532|525642410|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
145763033|NCT00896532|525642388|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763034|NCT00896532|525642389|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763035|NCT00896532|525642390|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763036|NCT00896532|525642391|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763037|NCT00896532|525642392|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763038|NCT00896532|525642393|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763039|NCT00896532|525642394|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763040|NCT00896532|525642395|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763041|NCT00896532|525642396|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763042|NCT00896532|525642397|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763043|NCT00896532|525642398|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763044|NCT00896532|525642399|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763045|NCT00896532|525642400|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763046|NCT00896532|525642401|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763047|NCT00896532|525642402|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763048|NCT00896532|525642403|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763049|NCT00896532|525642404|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763050|NCT00896532|525642405|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763051|NCT00896532|525642406|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763052|NCT00896532|525642407|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763053|NCT00896532|525642408|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763054|NCT00896532|525642409|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
145763055|NCT00896532|525642410|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
145763056|NCT00996203|525642413|FG000|Overall Study|Adverse Event|3|||
145763057|NCT00996203|525642413|FG000|Overall Study|Lost to Follow-up|1|||
145763058|NCT00996203|525642413|FG000|Overall Study|Lack of Efficacy|1|||
145763059|NCT00996203|525642413|FG000|Overall Study|Protocol Violation|2|||
145763060|NCT01671280|525642414|FG000|Overall Study|Withdrawal by Subject|2|||
145763061|NCT01959165|525642415|FG000|Overall Study|Adverse Event|0|||
145763062|NCT01959165|525642416|FG001|Overall Study|Adverse Event|0|||
145763063|NCT01959165|525642417|FG002|Overall Study|Adverse Event|0|||
145763064|NCT01959165|525642418|FG003|Overall Study|Adverse Event|1|||
145763065|NCT01959165|525642415|FG000|Overall Study|Lack of Efficacy|1|||
145763066|NCT01959165|525642416|FG001|Overall Study|Lack of Efficacy|0|||
145763067|NCT01959165|525642417|FG002|Overall Study|Lack of Efficacy|0|||
145763068|NCT01959165|525642418|FG003|Overall Study|Lack of Efficacy|0|||
145763069|NCT01959165|525642415|FG000|Overall Study|overdose|0|||
145763070|NCT01959165|525642416|FG001|Overall Study|overdose|0|||
145763071|NCT01959165|525642417|FG002|Overall Study|overdose|0|||
145763072|NCT01959165|525642418|FG003|Overall Study|overdose|1|||
145763073|NCT01959165|525642415|FG000|Overall Study|Welfare recipient|0|||
145763074|NCT01959165|525642416|FG001|Overall Study|Welfare recipient|1|||
145763075|NCT01959165|525642417|FG002|Overall Study|Welfare recipient|0|||
145763076|NCT01959165|525642418|FG003|Overall Study|Welfare recipient|0|||
145763077|NCT03686969|525642419|FG000|Overall Study|Study terminated|1|||
145763078|NCT03686969|525642420|FG001|Overall Study|Study terminated|0|||
145763079|NCT01988090|525642423|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
145763080|NCT01988090|525642424|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
145763081|NCT01988090|525642423|FG000|Start Treament After Randomization|Protocol Violation|0|||
145763082|NCT01988090|525642424|FG001|Start Treament After Randomization|Protocol Violation|1|||
145763083|NCT01988090|525642423|FG000|Complete Study After Start|Withdrawal by Subject|2|||
145763084|NCT01988090|525642424|FG001|Complete Study After Start|Withdrawal by Subject|0|||
145763085|NCT01988090|525642423|FG000|Complete Study After Start|Protocol Violation|1|||
145763086|NCT01988090|525642424|FG001|Complete Study After Start|Protocol Violation|1|||
145763087|NCT03094195|525642425|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
145763088|NCT03094195|525642426|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
145763089|NCT03094195|525642427|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
145763090|NCT03094195|525642428|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145763091|NCT03094195|525642429|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145763092|NCT03094195|525642430|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145763093|NCT03094195|525642431|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145763094|NCT03094195|525642432|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145763095|NCT03094195|525642425|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
145763096|NCT03094195|525642426|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
145763097|NCT03094195|525642427|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
145763098|NCT03094195|525642428|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145763099|NCT03094195|525642429|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145763100|NCT03094195|525642430|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145763101|NCT03094195|525642431|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145763102|NCT03094195|525642432|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145763103|NCT03094195|525642425|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763104|NCT03094195|525642426|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763105|NCT03094195|525642427|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
145763106|NCT03094195|525642428|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763107|NCT03094195|525642429|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763108|NCT03094195|525642430|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763109|NCT03094195|525642431|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763110|NCT03094195|525642432|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145763111|NCT03094195|525642425|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763112|NCT03094195|525642426|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
145763113|NCT03094195|525642427|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
145763114|NCT03094195|525642428|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763115|NCT03094195|525642429|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763116|NCT03094195|525642430|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763117|NCT03094195|525642431|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763118|NCT03094195|525642432|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145763119|NCT03887130|525642440|FG000|Overall Study|Progressive disease|23|||
145763120|NCT03887130|525642441|FG001|Overall Study|Progressive disease|14|||
145763121|NCT03887130|525642442|FG002|Overall Study|Progressive disease|7|||
145763122|NCT03887130|525642440|FG000|Overall Study|Protocol Violation|3|||
145763123|NCT03887130|525642441|FG001|Overall Study|Protocol Violation|1|||
145763124|NCT03887130|525642442|FG002|Overall Study|Protocol Violation|2|||
145763125|NCT03887130|525642440|FG000|Overall Study|Drug related toxicity|7|||
145763126|NCT03887130|525642441|FG001|Overall Study|Drug related toxicity|7|||
145763127|NCT03887130|525642442|FG002|Overall Study|Drug related toxicity|13|||
145763128|NCT03887130|525642440|FG000|Overall Study|Non drug related toxicity|3|||
145763129|NCT03887130|525642441|FG001|Overall Study|Non drug related toxicity|0|||
145763130|NCT03887130|525642442|FG002|Overall Study|Non drug related toxicity|0|||
145763131|NCT03887130|525642440|FG000|Overall Study|Death|2|||
145763132|NCT03887130|525642441|FG001|Overall Study|Death|2|||
145763133|NCT03887130|525642442|FG002|Overall Study|Death|1|||
145763134|NCT03887130|525642440|FG000|Overall Study|Withdrawal by Subject|7|||
145763135|NCT03887130|525642441|FG001|Overall Study|Withdrawal by Subject|6|||
145763136|NCT03887130|525642442|FG002|Overall Study|Withdrawal by Subject|11|||
145763137|NCT03887130|525642440|FG000|Overall Study|other reason|6|||
145763138|NCT03887130|525642441|FG001|Overall Study|other reason|20|||
145763139|NCT03887130|525642442|FG002|Overall Study|other reason|17|||
145763140|NCT00927563|525642443|FG000|Overall Study|Lost to Follow-up|1|||
145763141|NCT00927563|525642443|FG000|Overall Study|Withdrawal by Subject|1|||
145763142|NCT02440581|525642446|FG000|Overall Study|Death|0|||
145763143|NCT02440581|525642447|FG001|Overall Study|Death|0|||
145763144|NCT02440581|525642448|FG002|Overall Study|Death|7|||
145763145|NCT02440581|525642449|FG003|Overall Study|Death|5|||
145763146|NCT02440581|525642446|FG000|Overall Study|Transplanted|1|||
145763147|NCT02440581|525642447|FG001|Overall Study|Transplanted|0|||
145763148|NCT02440581|525642448|FG002|Overall Study|Transplanted|3|||
145763149|NCT02440581|525642449|FG003|Overall Study|Transplanted|2|||
145763150|NCT02440581|525642446|FG000|Overall Study|Withdrawal by Subject|4|||
145763151|NCT02440581|525642447|FG001|Overall Study|Withdrawal by Subject|11|||
145763152|NCT02440581|525642448|FG002|Overall Study|Withdrawal by Subject|3|||
145763153|NCT02440581|525642449|FG003|Overall Study|Withdrawal by Subject|7|||
145763154|NCT00787787|525642450|FG000|Overall Study|Lack of Efficacy|4|||
145763155|NCT00787787|525642450|FG000|Overall Study|Adverse Event|3|||
145763156|NCT01468987|525642451|FG000|Overall Study|Adverse Event|12|||
145763157|NCT01468987|525642452|FG001|Overall Study|Adverse Event|9|||
145763158|NCT01468987|525642451|FG000|Overall Study|Death|4|||
145763159|NCT01468987|525642452|FG001|Overall Study|Death|1|||
145763160|NCT01468987|525642451|FG000|Overall Study|Lost to Follow-up|10|||
145763161|NCT01468987|525642452|FG001|Overall Study|Lost to Follow-up|5|||
145763162|NCT01468987|525642451|FG000|Overall Study|Protocol Violation|8|||
145763163|NCT01468987|525642452|FG001|Overall Study|Protocol Violation|2|||
145763164|NCT01468987|525642451|FG000|Overall Study|Withdrawal by Subject|28|||
145763165|NCT01468987|525642452|FG001|Overall Study|Withdrawal by Subject|28|||
145763166|NCT01468987|525642451|FG000|Overall Study|Physician Decision|8|||
145763167|NCT01468987|525642452|FG001|Overall Study|Physician Decision|15|||
145763168|NCT01468987|525642451|FG000|Overall Study|Sponsor Decision|1|||
145763169|NCT01468987|525642452|FG001|Overall Study|Sponsor Decision|0|||
145763170|NCT05032950|525642454|FG000|Overall Study|Adverse Event|0|||
145763171|NCT05032950|525642455|FG001|Overall Study|Adverse Event|0|||
145763172|NCT05032950|525642456|FG002|Overall Study|Adverse Event|1|||
145763173|NCT05032950|525642457|FG003|Overall Study|Adverse Event|1|||
145763174|NCT05032950|525642458|FG004|Overall Study|Adverse Event|0|||
145763175|NCT05032950|525642459|FG005|Overall Study|Adverse Event|0|||
145763176|NCT03430986|525642460|FG000|24-week Control Period|Adverse Event|1|||
145763177|NCT03430986|525642461|FG001|24-week Control Period|Adverse Event|0|||
145763178|NCT03430986|525642460|FG000|24-week Control Period|Lost to Follow-up|2|||
145763179|NCT03430986|525642461|FG001|24-week Control Period|Lost to Follow-up|2|||
145763180|NCT03430986|525642460|FG000|24-week Control Period|Withdrawal by Participant|5|||
145763181|NCT03430986|525642461|FG001|24-week Control Period|Withdrawal by Participant|0|||
145763182|NCT03430986|525642460|FG000|24-week Control Period|Protocol Deviation|0|||
145763183|NCT03430986|525642461|FG001|24-week Control Period|Protocol Deviation|2|||
145763184|NCT03430986|525642460|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
145763185|NCT03430986|525642461|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
145763186|NCT03430986|525642460|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
145763187|NCT03430986|525642461|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
145763188|NCT01245673|525642465|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
145763189|NCT04722991|525642466|FG000|Overall Study|Adverse Event|12|||
145763190|NCT04722991|525642467|FG001|Overall Study|Adverse Event|4|||
145763191|NCT04722991|525642466|FG000|Overall Study|Death|2|||
145763192|NCT04722991|525642467|FG001|Overall Study|Death|0|||
145763193|NCT04722991|525642466|FG000|Overall Study|Lost to Follow-up|1|||
145763194|NCT04722991|525642467|FG001|Overall Study|Lost to Follow-up|1|||
145763195|NCT04722991|525642466|FG000|Overall Study|Withdrawal cirterion met|2|||
145763196|NCT04722991|525642467|FG001|Overall Study|Withdrawal cirterion met|2|||
145763197|NCT04722991|525642466|FG000|Overall Study|Other|1|||
145763198|NCT04722991|525642467|FG001|Overall Study|Other|0|||
145763199|NCT04722991|525642466|FG000|Overall Study|Non-compliance|0|||
145763200|NCT04722991|525642467|FG001|Overall Study|Non-compliance|1|||
145763201|NCT04722991|525642466|FG000|Overall Study|Withdrawal by Subject|0|||
145763202|NCT04722991|525642467|FG001|Overall Study|Withdrawal by Subject|1|||
145763203|NCT03186989|525642468|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763204|NCT03186989|525642469|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763205|NCT03186989|525642470|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
145763206|NCT03186989|525642471|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
145763207|NCT03186989|525642472|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
145276855|NCT01898884|523863174|FG006|Multiple Dose Period|Adverse Event|1|||
145276856|NCT01898884|523863175|FG007|Multiple Dose Period|Adverse Event|0|||
145276857|NCT01898884|523863176|FG008|Multiple Dose Period|Adverse Event|0|||
145276858|NCT01898884|523863168|FG000|Multiple Dose Period|Randomized Not Treated|0|||
145276859|NCT01898884|523863169|FG001|Multiple Dose Period|Randomized Not Treated|0|||
145276860|NCT01898884|523863170|FG002|Multiple Dose Period|Randomized Not Treated|0|||
145276861|NCT01898884|523863171|FG003|Multiple Dose Period|Randomized Not Treated|0|||
145276862|NCT01898884|523863172|FG004|Multiple Dose Period|Randomized Not Treated|0|||
145276863|NCT01898884|523863173|FG005|Multiple Dose Period|Randomized Not Treated|0|||
145276864|NCT01898884|523863174|FG006|Multiple Dose Period|Randomized Not Treated|0|||
145276865|NCT01898884|523863175|FG007|Multiple Dose Period|Randomized Not Treated|0|||
145276866|NCT01898884|523863176|FG008|Multiple Dose Period|Randomized Not Treated|1|||
145276867|NCT00759759|523863177|FG000|Overall Study|didn't return for period 2|1|||
145276868|NCT00759759|523863178|FG001|Overall Study|didn't return for period 2|0|||
145276869|NCT00759759|523863177|FG000|Overall Study|Didn't receive drug in period 2|1|||
145276870|NCT00759759|523863178|FG001|Overall Study|Didn't receive drug in period 2|0|||
145276871|NCT00759759|523863177|FG000|Overall Study|Withdrawal by Subject|2|||
145276872|NCT00759759|523863178|FG001|Overall Study|Withdrawal by Subject|1|||
145276873|NCT01640964|523863184|FG000|Overall Study|Lost to Follow-up|0|||
145276874|NCT01640964|523863185|FG001|Overall Study|Lost to Follow-up|0|||
145276875|NCT01640964|523863186|FG002|Overall Study|Lost to Follow-up|1|||
145276876|NCT01640964|523863184|FG000|Overall Study|Protocol Deviation|1|||
145276877|NCT01640964|523863185|FG001|Overall Study|Protocol Deviation|1|||
145276878|NCT01640964|523863186|FG002|Overall Study|Protocol Deviation|2|||
145276879|NCT02766088|523864639|FG000|Overall Study|Sponsor study termination|498|||
145276880|NCT02766088|523864639|FG000|Overall Study|Migrated/moved from the study area|1|||
145276881|NCT02766088|523864639|FG000|Overall Study|Lost to Follow-up|5|||
145276882|NCT02766088|523864639|FG000|Overall Study|Other|1|||
145276883|NCT02766088|523864639|FG000|Overall Study|Death|1|||
145276884|NCT01222715|523864640|FG000|Overall Study|Adverse Event|0|||
145276885|NCT01222715|523864641|FG001|Overall Study|Adverse Event|4|||
145276886|NCT01222715|523864640|FG000|Overall Study|Death|0|||
145276887|NCT01222715|523864641|FG001|Overall Study|Death|1|||
145276888|NCT01222715|523864640|FG000|Overall Study|Lack of Efficacy|22|||
145276889|NCT01222715|523864641|FG001|Overall Study|Lack of Efficacy|14|||
145276890|NCT01222715|523864640|FG000|Overall Study|Physician Decision|12|||
145276891|NCT01222715|523864641|FG001|Overall Study|Physician Decision|2|||
145276892|NCT01222715|523864640|FG000|Overall Study|Refusal of further protocol therapy|0|||
145276893|NCT01222715|523864641|FG001|Overall Study|Refusal of further protocol therapy|4|||
145276894|NCT01222715|523864640|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
145276895|NCT01222715|523864641|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
145276896|NCT01222715|523864640|FG000|Overall Study|Ineligible|0|||
145276897|NCT01222715|523864641|FG001|Overall Study|Ineligible|1|||
145276898|NCT01222715|523864640|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
145276899|NCT01222715|523864641|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
145276900|NCT03555890|523864652|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145276901|NCT03555890|523864653|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145276902|NCT03555890|523864654|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145276903|NCT03555890|523864655|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
145276904|NCT03372369|523864656|FG000|Qualification Period|Withdrawal by Subject|16|||
145276905|NCT03372369|523864657|FG001|Qualification Period|Withdrawal by Subject|13|||
145276906|NCT03372369|523864656|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
145276907|NCT03372369|523864657|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
145276908|NCT03372369|523864656|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
145276909|NCT03372369|523864657|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
145276910|NCT02239601|523864658|FG000|Overall Study|Withdrawal by Subject|3|||
145276911|NCT02239601|523864659|FG001|Overall Study|Withdrawal by Subject|4|||
145276912|NCT02239601|523864658|FG000|Overall Study|Protocol Violation|4|||
145276913|NCT02239601|523864659|FG001|Overall Study|Protocol Violation|2|||
145276914|NCT01508325|523864660|FG000|Overall Study|Withdrawal by Subject|8|||
145276915|NCT01508325|523864661|FG001|Overall Study|Withdrawal by Subject|9|||
145276916|NCT01508325|523864660|FG000|Overall Study|Protocol Violation|0|||
145276917|NCT01508325|523864661|FG001|Overall Study|Protocol Violation|3|||
145276918|NCT01508325|523864660|FG000|Overall Study|Physician Decision|2|||
145276919|NCT01508325|523864661|FG001|Overall Study|Physician Decision|1|||
145276920|NCT01508325|523864660|FG000|Overall Study|Adverse Event|1|||
145276921|NCT01508325|523864661|FG001|Overall Study|Adverse Event|0|||
145276922|NCT01508325|523864660|FG000|Overall Study|Lost to Follow-up|5|||
145276923|NCT01508325|523864661|FG001|Overall Study|Lost to Follow-up|6|||
145276924|NCT01508325|523864660|FG000|Overall Study|Other|2|||
145276925|NCT01508325|523864661|FG001|Overall Study|Other|2|||
145276926|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
145292758|NCT06179108|523922227|FG001|Overall Study|Protocol Violation|1|||
145292759|NCT06179108|523922228|FG002|Overall Study|Protocol Violation|0|||
145292760|NCT06179108|523922229|FG003|Overall Study|Protocol Violation|1|||
145763208|NCT03186989|525642473|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763209|NCT03186989|525642474|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763210|NCT03186989|525642475|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763211|NCT03186989|525642476|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763212|NCT03186989|525642477|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763213|NCT03186989|525642478|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
145763214|NCT03186989|525642468|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763215|NCT03186989|525642469|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763216|NCT03186989|525642470|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763217|NCT03186989|525642471|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763218|NCT03186989|525642472|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763219|NCT03186989|525642473|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
145763220|NCT03186989|525642474|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763221|NCT03186989|525642475|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763222|NCT03186989|525642476|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763223|NCT03186989|525642477|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763224|NCT03186989|525642478|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
145763225|NCT03186989|525642468|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763226|NCT03186989|525642469|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763227|NCT03186989|525642470|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763228|NCT03186989|525642471|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763229|NCT03186989|525642472|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763230|NCT03186989|525642473|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763231|NCT03186989|525642474|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
145763232|NCT03186989|525642475|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763233|NCT03186989|525642476|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763234|NCT03186989|525642477|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763235|NCT03186989|525642478|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
145763236|NCT03186989|525642468|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763237|NCT03186989|525642469|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763238|NCT03186989|525642470|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763239|NCT03186989|525642471|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763240|NCT03186989|525642472|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763241|NCT03186989|525642473|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
145763242|NCT03186989|525642474|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
145763243|NCT03186989|525642475|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763244|NCT03186989|525642476|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
145763245|NCT03186989|525642477|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763246|NCT03186989|525642478|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
145763247|NCT02425098|525642484|FG000|Overall Study|Lost to Follow-up|7|||
145763248|NCT02425098|525642485|FG001|Overall Study|Lost to Follow-up|7|||
145763249|NCT02425098|525642484|FG000|Overall Study|Withdrawal by Subject|4|||
145763250|NCT02425098|525642485|FG001|Overall Study|Withdrawal by Subject|8|||
145763251|NCT02425098|525642484|FG000|Overall Study|Pregnancy|2|||
145763252|NCT02425098|525642485|FG001|Overall Study|Pregnancy|0|||
145763253|NCT02425098|525642484|FG000|Overall Study|Reason not Specified|0|||
145763254|NCT02425098|525642485|FG001|Overall Study|Reason not Specified|1|||
145763255|NCT01468311|525642492|FG000|Overall Study|mobilization failure|1|||
145763256|NCT01468311|525642492|FG000|Overall Study|Withdrawal by Subject|1|||
145763257|NCT02689492|525644396|FG000|Overall Study|Lost to Follow-up|61|||
145763258|NCT02689492|525644396|FG000|Overall Study|Withdrawal by Subject|11|||
145763259|NCT02689492|525644396|FG000|Overall Study|Death|9|||
145276927|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
145763260|NCT02689492|525644396|FG000|Overall Study|Physician Decision|2|||
145763261|NCT02689492|525644396|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
145763262|NCT02689492|525644396|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
145763263|NCT02689492|525644396|FG000|Overall Study|Other than listed|1|||
145276928|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
145763264|NCT02732951|525644397|FG000|Overall Study|Other than listed|1|||
145763265|NCT02732951|525644398|FG001|Overall Study|Other than listed|0|||
145763266|NCT02732951|525644397|FG000|Overall Study|Lost to Follow-up|0|||
145763267|NCT02732951|525644398|FG001|Overall Study|Lost to Follow-up|1|||
145763268|NCT02732951|525644397|FG000|Overall Study|Adverse Event|4|||
145763269|NCT02732951|525644398|FG001|Overall Study|Adverse Event|4|||
145763270|NCT02732951|525644397|FG000|Overall Study|Protocol Violation|0|||
145763271|NCT02732951|525644398|FG001|Overall Study|Protocol Violation|1|||
145763272|NCT00110305|525644400|FG000|Overall Study|Adverse Event|46|||
145763273|NCT00110305|525644401|FG001|Overall Study|Adverse Event|13|||
145763274|NCT00110305|525644400|FG000|Overall Study|Sponsors Decision|1|||
145763275|NCT00110305|525644401|FG001|Overall Study|Sponsors Decision|0|||
145763276|NCT00110305|525644400|FG000|Overall Study|Subject Non-Compliant|9|||
145763277|NCT00110305|525644401|FG001|Overall Study|Subject Non-Compliant|2|||
145763278|NCT00110305|525644400|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
145763279|NCT00110305|525644401|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
145763280|NCT00110305|525644400|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
145763281|NCT00110305|525644401|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
145763282|NCT00110305|525644400|FG000|Overall Study|Protocol Violation|0|||
145763283|NCT00110305|525644401|FG001|Overall Study|Protocol Violation|1|||
145763284|NCT00110305|525644400|FG000|Overall Study|Withdrawal by Subject|7|||
145763285|NCT00110305|525644401|FG001|Overall Study|Withdrawal by Subject|7|||
145763286|NCT00110305|525644400|FG000|Overall Study|Lost to Follow-up|20|||
145763287|NCT00110305|525644401|FG001|Overall Study|Lost to Follow-up|3|||
145763288|NCT00110305|525644400|FG000|Overall Study|Other|8|||
145763289|NCT00110305|525644401|FG001|Overall Study|Other|2|||
145763290|NCT05047523|525644402|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
145763291|NCT05047523|525644403|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
145763292|NCT05047523|525644404|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
145763293|NCT05047523|525644405|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
145763294|NCT05047523|525644406|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
145763295|NCT05047523|525644407|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
145763296|NCT05047523|525644402|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145763297|NCT05047523|525644403|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
145763298|NCT05047523|525644404|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145763299|NCT05047523|525644405|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145763300|NCT05047523|525644406|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145763301|NCT05047523|525644407|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
145763302|NCT05047523|525644402|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
145763303|NCT05047523|525644403|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
145763304|NCT05047523|525644404|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
145763305|NCT05047523|525644405|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
145763306|NCT05047523|525644406|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
145763307|NCT05047523|525644407|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
145763308|NCT05047523|525644402|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
145763309|NCT05047523|525644403|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145763310|NCT05047523|525644404|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145763311|NCT05047523|525644405|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145763312|NCT05047523|525644406|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145763313|NCT05047523|525644407|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
145763314|NCT05047523|525644402|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
145763315|NCT05047523|525644403|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
145763316|NCT05047523|525644404|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
145763317|NCT05047523|525644405|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
145763318|NCT05047523|525644406|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
145763319|NCT05047523|525644407|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
145763320|NCT05047523|525644402|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
145763321|NCT05047523|525644403|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
145763322|NCT05047523|525644404|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
145276929|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
145276930|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
145276931|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
145276932|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
145276933|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
145276934|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145276935|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145276936|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
145276937|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145276938|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145276939|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145276940|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145276941|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
145276942|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
145276943|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
145276944|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
145276945|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
145276946|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
145276947|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
145276948|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
145276949|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
145276950|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
145276951|NCT04682639|523864662|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
145276952|NCT04682639|523864663|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
145276953|NCT04682639|523864664|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
145276954|NCT04682639|523864665|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145276955|NCT04682639|523864666|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145276956|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
145276957|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
145276958|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
145276959|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
145276960|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
145276961|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Other|1|||
145763323|NCT05047523|525644405|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
145763324|NCT05047523|525644406|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
145763325|NCT05047523|525644407|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
145763326|NCT00365989|525644408|FG000|Overall Study|Withdrawal by Subject|1|||
145763327|NCT00365989|525644408|FG000|Overall Study|Non-compliance|1|||
145763328|NCT00832819|525644411|FG000|Overall Study|Adverse Event|0|||
145763329|NCT00832819|525644412|FG001|Overall Study|Adverse Event|1|||
145763330|NCT00832819|525644413|FG002|Overall Study|Adverse Event|0|||
145763331|NCT00832819|525644411|FG000|Overall Study|Protocol Violation|0|||
145763332|NCT00832819|525644412|FG001|Overall Study|Protocol Violation|0|||
145763333|NCT00832819|525644413|FG002|Overall Study|Protocol Violation|1|||
145763334|NCT00317044|525644414|FG000|Overall Study|Protocol Violation|28|||
145763335|NCT00317044|525644415|FG001|Overall Study|Protocol Violation|22|||
145763336|NCT00317044|525644416|FG002|Overall Study|Protocol Violation|20|||
145276962|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Other|2|||
145276963|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Other|0|||
145276964|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Other|0|||
145276965|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Other|1|||
145276966|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
145276967|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
145276968|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
145276969|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
145276970|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
145276971|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
145276972|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
145276973|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145276974|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145533422|NCT01436396|524813447|FG000|Overall Study|Serious adverse event|2|||
145276975|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145276976|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
145276977|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
145276978|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145402926|NCT00250588|524332554|FG002|Overall Study|Lost to Follow-up|13|||
145763337|NCT00317044|525644414|FG000|Overall Study|Adverse Event|4|||
145763338|NCT00317044|525644415|FG001|Overall Study|Adverse Event|7|||
145763339|NCT00317044|525644416|FG002|Overall Study|Adverse Event|4|||
145763340|NCT00317044|525644414|FG000|Overall Study|Withdrawal by Subject|10|||
145763341|NCT00317044|525644415|FG001|Overall Study|Withdrawal by Subject|7|||
145763342|NCT00317044|525644416|FG002|Overall Study|Withdrawal by Subject|12|||
145763343|NCT00317044|525644414|FG000|Overall Study|Lost to Follow-up|0|||
145763344|NCT00317044|525644415|FG001|Overall Study|Lost to Follow-up|2|||
145763345|NCT00317044|525644416|FG002|Overall Study|Lost to Follow-up|3|||
145763346|NCT00317044|525644414|FG000|Overall Study|Multiple Reasons|6|||
145763347|NCT00317044|525644415|FG001|Overall Study|Multiple Reasons|2|||
145763348|NCT00317044|525644416|FG002|Overall Study|Multiple Reasons|6|||
145276979|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145276980|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145276981|NCT04682639|523864662|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
145276982|NCT04682639|523864663|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
145276983|NCT04682639|523864664|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
145276984|NCT04682639|523864665|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
145763349|NCT02318095|525644417|FG000|Overall Study|Adverse Event|1|||
145763350|NCT01717638|525644418|FG000|Overall Study|Lost to Follow-up|0|||
145763351|NCT01717638|525644419|FG001|Overall Study|Lost to Follow-up|0|||
145763352|NCT01717638|525644420|FG002|Overall Study|Lost to Follow-up|0|||
145763353|NCT01717638|525644421|FG003|Overall Study|Lost to Follow-up|0|||
145763354|NCT01717638|525644422|FG004|Overall Study|Lost to Follow-up|0|||
145763355|NCT01717638|525644423|FG005|Overall Study|Lost to Follow-up|1|||
145763356|NCT01717638|525644424|FG006|Overall Study|Lost to Follow-up|0|||
145763357|NCT01717638|525644425|FG007|Overall Study|Lost to Follow-up|0|||
145763358|NCT01717638|525644426|FG008|Overall Study|Lost to Follow-up|0|||
145763359|NCT01717638|525644427|FG009|Overall Study|Lost to Follow-up|0|||
145763360|NCT01717638|525644428|FG010|Overall Study|Lost to Follow-up|0|||
145763361|NCT01717638|525644429|FG011|Overall Study|Lost to Follow-up|0|||
145763362|NCT01717638|525644430|FG012|Overall Study|Lost to Follow-up|0|||
145763363|NCT01717638|525644418|FG000|Overall Study|Father in hospital|0|||
145763364|NCT01717638|525644419|FG001|Overall Study|Father in hospital|0|||
145763365|NCT01717638|525644420|FG002|Overall Study|Father in hospital|0|||
145763366|NCT01717638|525644421|FG003|Overall Study|Father in hospital|0|||
145763367|NCT01717638|525644422|FG004|Overall Study|Father in hospital|0|||
145763368|NCT01717638|525644423|FG005|Overall Study|Father in hospital|0|||
145763369|NCT01717638|525644424|FG006|Overall Study|Father in hospital|0|||
145763370|NCT01717638|525644425|FG007|Overall Study|Father in hospital|0|||
145763371|NCT01717638|525644426|FG008|Overall Study|Father in hospital|0|||
145763372|NCT01717638|525644427|FG009|Overall Study|Father in hospital|0|||
145763373|NCT01717638|525644428|FG010|Overall Study|Father in hospital|0|||
145763374|NCT01717638|525644429|FG011|Overall Study|Father in hospital|0|||
145763375|NCT01717638|525644430|FG012|Overall Study|Father in hospital|1|||
145763376|NCT01717638|525644418|FG000|Overall Study|Withdrawal by Subject|0|||
145763377|NCT01717638|525644419|FG001|Overall Study|Withdrawal by Subject|1|||
145763378|NCT01717638|525644420|FG002|Overall Study|Withdrawal by Subject|1|||
145763379|NCT01717638|525644421|FG003|Overall Study|Withdrawal by Subject|0|||
145763380|NCT01717638|525644422|FG004|Overall Study|Withdrawal by Subject|1|||
145276985|NCT04682639|523864666|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
145276986|NCT01392170|523864667|FG000|Overall Study|Withdrawal by Subject|1|||
145276987|NCT01392170|523864667|FG000|Overall Study|Ineligible|1|||
145763381|NCT01717638|525644423|FG005|Overall Study|Withdrawal by Subject|0|||
145763382|NCT01717638|525644424|FG006|Overall Study|Withdrawal by Subject|2|||
145763383|NCT01717638|525644425|FG007|Overall Study|Withdrawal by Subject|1|||
145763384|NCT01717638|525644426|FG008|Overall Study|Withdrawal by Subject|2|||
145763385|NCT01717638|525644427|FG009|Overall Study|Withdrawal by Subject|1|||
145763386|NCT01717638|525644428|FG010|Overall Study|Withdrawal by Subject|0|||
145763387|NCT01717638|525644429|FG011|Overall Study|Withdrawal by Subject|0|||
145763388|NCT01717638|525644430|FG012|Overall Study|Withdrawal by Subject|18|||
145763389|NCT01719757|525644432|FG000|Overall Study|Adverse Event|38|||
145763390|NCT01719757|525644432|FG000|Overall Study|Withdrawal by Subject|15|||
145763391|NCT01719757|525644432|FG000|Overall Study|Lost to Follow-up|20|||
145763392|NCT01719757|525644432|FG000|Overall Study|Protocol Violation|1|||
145763393|NCT01719757|525644432|FG000|Overall Study|well controlled pain|27|||
145763394|NCT02626338|525644433|FG000|Overall Study|Lack of Efficacy|3|||
145763395|NCT02626338|525644434|FG001|Overall Study|Lack of Efficacy|2|||
145763396|NCT02626338|525644435|FG002|Overall Study|Lack of Efficacy|0|||
145763397|NCT01901224|525644436|FG000|Overall Study|study was not funded and terminated|2|||
145763398|NCT02300129|525644437|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
145763399|NCT02300129|525644438|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
145763400|NCT02300129|525644439|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
145763401|NCT02300129|525644440|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
145763402|NCT02300129|525644437|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
145763403|NCT02300129|525644438|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
145763404|NCT02300129|525644439|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
145763405|NCT02300129|525644440|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
145763406|NCT02300129|525644437|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
145763407|NCT02300129|525644438|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
145763408|NCT02300129|525644439|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
145763409|NCT02300129|525644440|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
145763410|NCT00522392|525644444|FG000|Overall Study|Disease progression|0|||
145763411|NCT00522392|525644445|FG001|Overall Study|Disease progression|3|||
145763412|NCT00522392|525644444|FG000|Overall Study|Adverse Event|7|||
145763413|NCT00522392|525644445|FG001|Overall Study|Adverse Event|7|||
145763414|NCT00522392|525644444|FG000|Overall Study|Withdrawal by Subject|1|||
145763415|NCT00522392|525644445|FG001|Overall Study|Withdrawal by Subject|1|||
145763416|NCT00522392|525644444|FG000|Overall Study|Physician Decision|0|||
145763417|NCT00522392|525644445|FG001|Overall Study|Physician Decision|1|||
145763418|NCT00522392|525644444|FG000|Overall Study|Non-compliance|0|||
145763419|NCT00522392|525644445|FG001|Overall Study|Non-compliance|1|||
145763420|NCT00430755|525644451|FG000|Overall Study|Withdrawal by Subject|53|||
145763421|NCT00103012|525644454|FG000|Overall Study|Withdrawal by Subject|2|||
145763422|NCT00103012|525644455|FG001|Overall Study|Withdrawal by Subject|1|||
145763423|NCT00103012|525644456|FG002|Overall Study|Withdrawal by Subject|2|||
145763424|NCT00103012|525644454|FG000|Overall Study|Pregnancy|1|||
145763425|NCT00103012|525644455|FG001|Overall Study|Pregnancy|0|||
145763426|NCT00103012|525644456|FG002|Overall Study|Pregnancy|0|||
145763427|NCT00103012|525644454|FG000|Overall Study|Adverse Event|0|||
145763428|NCT00103012|525644455|FG001|Overall Study|Adverse Event|0|||
145763429|NCT00103012|525644456|FG002|Overall Study|Adverse Event|1|||
145763430|NCT00103012|525644454|FG000|Overall Study|Subject non-compliant with medications|0|||
145763431|NCT00103012|525644455|FG001|Overall Study|Subject non-compliant with medications|0|||
145763432|NCT00103012|525644456|FG002|Overall Study|Subject non-compliant with medications|1|||
145763433|NCT05211336|525644461|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
145763434|NCT05211336|525644462|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
145763435|NCT05211336|525644461|FG000|Overall Study|Progressive disease|0|||
145763436|NCT05211336|525644462|FG001|Overall Study|Progressive disease|4|||
145763437|NCT05211336|525644461|FG000|Overall Study|Death due to myocardial infarction|0|||
145763438|NCT05211336|525644462|FG001|Overall Study|Death due to myocardial infarction|1|||
145763439|NCT05211336|525644461|FG000|Overall Study|Death due to unknown cause|0|||
145763440|NCT05211336|525644462|FG001|Overall Study|Death due to unknown cause|1|||
145763441|NCT05211336|525644461|FG000|Overall Study|Worsening kidney function and quality of response|0|||
145763442|NCT05211336|525644462|FG001|Overall Study|Worsening kidney function and quality of response|1|||
145763443|NCT00393718|525644467|FG000|Overall Study|Adverse Event|20|||
145763444|NCT00393718|525644468|FG001|Overall Study|Adverse Event|8|||
145763445|NCT00393718|525644467|FG000|Overall Study|Protocol Violation|1|||
145763446|NCT00393718|525644468|FG001|Overall Study|Protocol Violation|2|||
145763447|NCT00393718|525644467|FG000|Overall Study|Lack of Efficacy|10|||
145763448|NCT00393718|525644468|FG001|Overall Study|Lack of Efficacy|9|||
145763449|NCT00393718|525644467|FG000|Overall Study|Hypoglycaemia|3|||
145763450|NCT00393718|525644468|FG001|Overall Study|Hypoglycaemia|2|||
145763451|NCT00393718|525644467|FG000|Overall Study|Subject decision|5|||
145763452|NCT00393718|525644468|FG001|Overall Study|Subject decision|0|||
145763453|NCT00393718|525644467|FG000|Overall Study|Withdrawal of consent|2|||
145763454|NCT00393718|525644468|FG001|Overall Study|Withdrawal of consent|1|||
145763455|NCT00393718|525644467|FG000|Overall Study|Missed measurement|1|||
145763456|NCT00393718|525644468|FG001|Overall Study|Missed measurement|0|||
145763457|NCT00393718|525644467|FG000|Overall Study|Move|1|||
145763458|NCT00393718|525644468|FG001|Overall Study|Move|0|||
145763459|NCT01084551|525644473|FG000|Overall Study|Adverse Event|2|||
145763460|NCT01084551|525644474|FG001|Overall Study|Adverse Event|9|||
145763461|NCT01084551|525644475|FG002|Overall Study|Adverse Event|4|||
145763462|NCT01084551|525644473|FG000|Overall Study|Lack of Efficacy|2|||
145763463|NCT01084551|525644474|FG001|Overall Study|Lack of Efficacy|0|||
145763464|NCT01084551|525644475|FG002|Overall Study|Lack of Efficacy|1|||
145763465|NCT01084551|525644473|FG000|Overall Study|Withdrawal by Subject|2|||
145763466|NCT01084551|525644474|FG001|Overall Study|Withdrawal by Subject|1|||
145763467|NCT01084551|525644475|FG002|Overall Study|Withdrawal by Subject|0|||
145763468|NCT01084551|525644473|FG000|Overall Study|Protocol Violation|2|||
145763469|NCT01084551|525644474|FG001|Overall Study|Protocol Violation|4|||
145763470|NCT01084551|525644475|FG002|Overall Study|Protocol Violation|0|||
145763471|NCT01084551|525644473|FG000|Overall Study|Lost to Follow-up|0|||
145763472|NCT01084551|525644474|FG001|Overall Study|Lost to Follow-up|0|||
145763473|NCT01084551|525644475|FG002|Overall Study|Lost to Follow-up|3|||
145763474|NCT01084551|525644473|FG000|Overall Study|Physician Decision|1|||
145763475|NCT01084551|525644474|FG001|Overall Study|Physician Decision|0|||
145763476|NCT01084551|525644475|FG002|Overall Study|Physician Decision|0|||
145763477|NCT03575104|525644476|FG000|Overall Study|Adverse Event|4|||
145763478|NCT03575104|525644477|FG001|Overall Study|Adverse Event|3|||
145763479|NCT03575104|525644478|FG002|Overall Study|Adverse Event|4|||
145763480|NCT03575104|525644476|FG000|Overall Study|Withdrawal by Subject|13|||
145763481|NCT03575104|525644477|FG001|Overall Study|Withdrawal by Subject|16|||
145763482|NCT03575104|525644478|FG002|Overall Study|Withdrawal by Subject|11|||
145763483|NCT03575104|525644476|FG000|Overall Study|Other reasons|6|||
145763484|NCT03575104|525644477|FG001|Overall Study|Other reasons|8|||
145763485|NCT03575104|525644478|FG002|Overall Study|Other reasons|6|||
145763486|NCT03575104|525644476|FG000|Overall Study|Lost to Follow-up|1|||
145763487|NCT03575104|525644477|FG001|Overall Study|Lost to Follow-up|2|||
145763488|NCT03575104|525644478|FG002|Overall Study|Lost to Follow-up|1|||
145763489|NCT04684420|525644479|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145763490|NCT04684420|525644480|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145763491|NCT04684420|525644481|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
145763492|NCT04684420|525644482|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
145763493|NCT04684420|525644479|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
145763494|NCT04684420|525644480|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
145763495|NCT04684420|525644481|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
145763496|NCT04684420|525644482|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
145763497|NCT00463476|525644483|FG000|Overall Study|Withdrawal by Subject|1|||
145763498|NCT00463476|525644484|FG001|Overall Study|Withdrawal by Subject|2|||
145763499|NCT00463476|525644483|FG000|Overall Study|Lost to Follow-up|1|||
145763500|NCT00463476|525644484|FG001|Overall Study|Lost to Follow-up|1|||
145763501|NCT01409928|525644487|FG000|Overall Study|Physician Decision|12|||
145763502|NCT01703000|525644488|FG000|Overall Study|Death|1|||
145763503|NCT01279057|525644489|FG000|Overall Study|Adverse Event|1|||
145763504|NCT01279057|525644490|FG001|Overall Study|Adverse Event|0|||
145763505|NCT01279057|525644491|FG002|Overall Study|Adverse Event|1|||
145763506|NCT01279057|525644489|FG000|Overall Study|Insufficient therapeutic response|0|||
145763507|NCT01279057|525644490|FG001|Overall Study|Insufficient therapeutic response|0|||
145763508|NCT01279057|525644491|FG002|Overall Study|Insufficient therapeutic response|1|||
145763509|NCT01279057|525644489|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
145763510|NCT01279057|525644490|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
145763511|NCT01279057|525644491|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
145763512|NCT01279057|525644489|FG000|Overall Study|Withdrew consent|2|||
145763513|NCT01279057|525644490|FG001|Overall Study|Withdrew consent|0|||
145763514|NCT01279057|525644491|FG002|Overall Study|Withdrew consent|1|||
145763515|NCT01279057|525644489|FG000|Overall Study|Pregnancy|0|||
145763516|NCT01279057|525644490|FG001|Overall Study|Pregnancy|1|||
145763517|NCT01279057|525644491|FG002|Overall Study|Pregnancy|0|||
145763518|NCT01279057|525644489|FG000|Overall Study|Other|3|||
145763519|NCT01279057|525644490|FG001|Overall Study|Other|3|||
145763520|NCT01279057|525644491|FG002|Overall Study|Other|0|||
145763521|NCT03502187|525644494|FG000|Overall Study|Withdrawal by Subject|4|||
145763522|NCT03502187|525644495|FG001|Overall Study|Withdrawal by Subject|3|||
145763523|NCT03502187|525644496|FG002|Overall Study|Withdrawal by Subject|3|||
145763524|NCT03502187|525644494|FG000|Overall Study|Lost to Follow-up|5|||
145763525|NCT03502187|525644495|FG001|Overall Study|Lost to Follow-up|4|||
145763526|NCT03502187|525644496|FG002|Overall Study|Lost to Follow-up|5|||
145763527|NCT02411448|525644500|FG000|Overall Study|Withdrawal by Subject|1|||
145763528|NCT02411448|525644501|FG001|Overall Study|Withdrawal by Subject|14|||
145763529|NCT02411448|525644502|FG002|Overall Study|Withdrawal by Subject|9|||
145763530|NCT02411448|525644500|FG000|Overall Study|Other|0|||
145763531|NCT02411448|525644501|FG001|Overall Study|Other|2|||
145763532|NCT02411448|525644502|FG002|Overall Study|Other|0|||
145763533|NCT02411448|525644500|FG000|Overall Study|Did not receive study treatment|0|||
145763534|NCT02411448|525644501|FG001|Overall Study|Did not receive study treatment|3|||
145763535|NCT02411448|525644502|FG002|Overall Study|Did not receive study treatment|0|||
145763536|NCT02411448|525644500|FG000|Overall Study|Alive on study treatment|3|||
145763537|NCT02411448|525644501|FG001|Overall Study|Alive on study treatment|64|||
145763538|NCT02411448|525644502|FG002|Overall Study|Alive on study treatment|43|||
145763539|NCT01848145|525644503|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
145763540|NCT01848145|525644503|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
145763541|NCT01848145|525644503|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
145763542|NCT01848145|525644503|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
145763543|NCT01848145|525644503|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
145763544|NCT01848145|525644503|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
145763545|NCT01848145|525644503|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
145763546|NCT01728779|525644504|FG000|Overall Study|Withdrawal by Subject|1|||
145763547|NCT00624520|525644505|FG000|Overall Study|Withdrawal by Subject|12|||
145763548|NCT00624520|525644506|FG001|Overall Study|Withdrawal by Subject|7|||
145763549|NCT00624520|525644505|FG000|Overall Study|Death|0|||
145763550|NCT00624520|525644506|FG001|Overall Study|Death|1|||
145763551|NCT00556426|525644510|FG000|Overall Study|Withdrawal by Subject|3|||
145763552|NCT00556426|525644510|FG000|Overall Study|Death|6|||
145763553|NCT02429856|525644514|FG000|Overall Study|Death|12|||
145763554|NCT02429856|525644515|FG001|Overall Study|Death|13|||
145533423|NCT01436396|524813448|FG001|Overall Study|Serious adverse event|3|||
145763555|NCT02429856|525644514|FG000|Overall Study|Lost to Follow-up|6|||
145763556|NCT02429856|525644515|FG001|Overall Study|Lost to Follow-up|5|||
145533424|NCT01436396|524813447|FG000|Overall Study|Lost to Follow-up|3|||
145763557|NCT02429856|525644514|FG000|Overall Study|Withdrawal by Subject|1|||
145763558|NCT02429856|525644515|FG001|Overall Study|Withdrawal by Subject|1|||
145763559|NCT02649634|525644516|FG000|Overall Study|Withdrawal by Subject|3|||
145763560|NCT02649634|525644517|FG001|Overall Study|Withdrawal by Subject|5|||
145763561|NCT02649634|525644516|FG000|Overall Study|Lost to Follow-up|0|||
145763562|NCT02649634|525644517|FG001|Overall Study|Lost to Follow-up|1|||
145763563|NCT02507349|525644518|FG000|Overall Study|Death|12|||
145763564|NCT02507349|525644519|FG001|Overall Study|Death|16|||
145763565|NCT02507349|525644518|FG000|Overall Study|Withdrawal by Subject|1|||
145607845|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607846|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607847|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607848|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
145607849|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607850|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607851|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607852|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607853|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607854|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607855|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
145607856|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607857|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607858|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607859|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607860|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
145607861|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
145607862|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607863|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607864|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607865|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607866|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607867|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
145607868|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607869|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607870|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607871|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607872|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
145607873|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145763566|NCT02507349|525644519|FG001|Overall Study|Withdrawal by Subject|1|||
145763567|NCT02507349|525644518|FG000|Overall Study|Lost to Follow-up|174|||
145763568|NCT02507349|525644519|FG001|Overall Study|Lost to Follow-up|144|||
145763569|NCT00348140|525644530|FG000|Overall Study|Adverse Event|46|||
145763570|NCT00348140|525644531|FG001|Overall Study|Adverse Event|49|||
145763571|NCT00348140|525644532|FG002|Overall Study|Adverse Event|78|||
145763572|NCT00348140|525644530|FG000|Overall Study|Lost to Follow-up|4|||
145763573|NCT00348140|525644531|FG001|Overall Study|Lost to Follow-up|4|||
145763574|NCT00348140|525644532|FG002|Overall Study|Lost to Follow-up|4|||
145763575|NCT00348140|525644530|FG000|Overall Study|Protocol Violation|12|||
145763576|NCT00348140|525644531|FG001|Overall Study|Protocol Violation|13|||
145763577|NCT00348140|525644532|FG002|Overall Study|Protocol Violation|14|||
145763578|NCT00348140|525644530|FG000|Overall Study|Withdrawal by Subject|32|||
145763579|NCT00348140|525644531|FG001|Overall Study|Withdrawal by Subject|40|||
145763580|NCT00348140|525644532|FG002|Overall Study|Withdrawal by Subject|40|||
145763581|NCT00348140|525644530|FG000|Overall Study|Non-compliance|8|||
145763582|NCT00348140|525644531|FG001|Overall Study|Non-compliance|13|||
145763583|NCT00348140|525644532|FG002|Overall Study|Non-compliance|5|||
145763584|NCT00348140|525644530|FG000|Overall Study|Participant at risk due to study drug|2|||
145763585|NCT00348140|525644531|FG001|Overall Study|Participant at risk due to study drug|0|||
145763586|NCT00348140|525644532|FG002|Overall Study|Participant at risk due to study drug|0|||
145763587|NCT00348140|525644530|FG000|Overall Study|Conditional medication increased dose|1|||
145763588|NCT00348140|525644531|FG001|Overall Study|Conditional medication increased dose|0|||
145763589|NCT00348140|525644532|FG002|Overall Study|Conditional medication increased dose|0|||
145763590|NCT00348140|525644530|FG000|Overall Study|Caregiver related|4|||
145763591|NCT00348140|525644531|FG001|Overall Study|Caregiver related|7|||
145763592|NCT00348140|525644532|FG002|Overall Study|Caregiver related|3|||
145763593|NCT00348140|525644530|FG000|Overall Study|Participant hospitalised|3|||
145763594|NCT00348140|525644531|FG001|Overall Study|Participant hospitalised|0|||
145763595|NCT00348140|525644532|FG002|Overall Study|Participant hospitalised|0|||
145763596|NCT00348140|525644530|FG000|Overall Study|Efficacy related|1|||
145763597|NCT00348140|525644531|FG001|Overall Study|Efficacy related|1|||
145763598|NCT00348140|525644532|FG002|Overall Study|Efficacy related|0|||
145763599|NCT00348140|525644530|FG000|Overall Study|Administration related|3|||
145763600|NCT00348140|525644531|FG001|Overall Study|Administration related|1|||
145763601|NCT00348140|525644532|FG002|Overall Study|Administration related|1|||
145763602|NCT00348140|525644530|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
145763603|NCT00348140|525644531|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
145763604|NCT00348140|525644532|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
145763605|NCT00348140|525644530|FG000|Overall Study|Participant unwell|1|||
145763606|NCT00348140|525644531|FG001|Overall Study|Participant unwell|0|||
145763607|NCT00348140|525644532|FG002|Overall Study|Participant unwell|0|||
145763608|NCT00348140|525644530|FG000|Overall Study|Screen failure|1|||
145763609|NCT00348140|525644531|FG001|Overall Study|Screen failure|0|||
145763610|NCT00348140|525644532|FG002|Overall Study|Screen failure|0|||
145763611|NCT00348140|525644530|FG000|Overall Study|Investigator decided to discontinue|4|||
145763612|NCT00348140|525644531|FG001|Overall Study|Investigator decided to discontinue|1|||
145763613|NCT00348140|525644532|FG002|Overall Study|Investigator decided to discontinue|4|||
145763614|NCT00348140|525644530|FG000|Overall Study|Decided to discontinue on their own|1|||
145763615|NCT00348140|525644531|FG001|Overall Study|Decided to discontinue on their own|4|||
145763616|NCT00348140|525644532|FG002|Overall Study|Decided to discontinue on their own|1|||
145763617|NCT00348140|525644530|FG000|Overall Study|Use of prohibited drug|1|||
145763618|NCT00348140|525644531|FG001|Overall Study|Use of prohibited drug|0|||
145763619|NCT00348140|525644532|FG002|Overall Study|Use of prohibited drug|2|||
145763620|NCT00348140|525644530|FG000|Overall Study|Disease progression|1|||
145763621|NCT00348140|525644531|FG001|Overall Study|Disease progression|2|||
145763622|NCT00348140|525644532|FG002|Overall Study|Disease progression|5|||
145276988|NCT01383954|523864668|FG000|Overall Study|Lack of Efficacy|2|||
145276989|NCT01383954|523864668|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
145276990|NCT01383954|523864668|FG000|Overall Study|Adverse Event|1|||
145276991|NCT01383954|523864668|FG000|Overall Study|Reason Not Specified|9|||
145276992|NCT03174925|523864675|FG000|Overall Study|Elastographic images not retrievable|2|||
145533425|NCT01436396|524813448|FG001|Overall Study|Lost to Follow-up|3|||
145763623|NCT00348140|525644530|FG000|Overall Study|Increased risk of cardiac infarction|0|||
145763624|NCT00348140|525644531|FG001|Overall Study|Increased risk of cardiac infarction|1|||
145763625|NCT00348140|525644532|FG002|Overall Study|Increased risk of cardiac infarction|0|||
145763626|NCT00348140|525644530|FG000|Overall Study|Serious adverse event|0|||
145763627|NCT00348140|525644531|FG001|Overall Study|Serious adverse event|1|||
145763628|NCT00348140|525644532|FG002|Overall Study|Serious adverse event|0|||
145763629|NCT00348140|525644530|FG000|Overall Study|Abnormal ECG|0|||
145763630|NCT00348140|525644531|FG001|Overall Study|Abnormal ECG|1|||
145763631|NCT00348140|525644532|FG002|Overall Study|Abnormal ECG|3|||
145763632|NCT00348140|525644530|FG000|Overall Study|Participant died|0|||
145763633|NCT00348140|525644531|FG001|Overall Study|Participant died|1|||
145763634|NCT00348140|525644532|FG002|Overall Study|Participant died|0|||
145763635|NCT00348140|525644530|FG000|Overall Study|Exclusion criteria met|0|||
145763636|NCT00348140|525644531|FG001|Overall Study|Exclusion criteria met|0|||
145292761|NCT06179108|523922226|FG000|Overall Study|Physician Decision|1|||
145763637|NCT00348140|525644532|FG002|Overall Study|Exclusion criteria met|1|||
145763638|NCT00348140|525644530|FG000|Overall Study|Memory declined|0|||
145763639|NCT00348140|525644531|FG001|Overall Study|Memory declined|0|||
145763640|NCT00348140|525644532|FG002|Overall Study|Memory declined|1|||
145763641|NCT00619957|525644535|FG000|Month 24 Double-Blind|Adverse Event|9|||
145763642|NCT00619957|525644536|FG001|Month 24 Double-Blind|Adverse Event|7|||
145763643|NCT00619957|525644535|FG000|Month 24 Double-Blind|Protocol Violation|1|||
145763644|NCT00619957|525644536|FG001|Month 24 Double-Blind|Protocol Violation|0|||
145763645|NCT00619957|525644535|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
145763646|NCT00619957|525644536|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
145763647|NCT00619957|525644535|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
145763648|NCT00619957|525644536|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
145763649|NCT00619957|525644535|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
145763650|NCT00619957|525644536|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
145763651|NCT00619957|525644535|FG000|Month 48 Open-Label|Adverse Event|4|||
145763652|NCT00619957|525644536|FG001|Month 48 Open-Label|Adverse Event|4|||
145763653|NCT00619957|525644535|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
145763654|NCT00619957|525644536|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
145763655|NCT00619957|525644535|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
145763656|NCT00619957|525644536|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
145763657|NCT00723957|525644537|FG000|Overall Study|Adverse event unrelated to study drug|1|||
145763658|NCT00723957|525644538|FG001|Overall Study|Adverse event unrelated to study drug|4|||
145763659|NCT00723957|525644537|FG000|Overall Study|Death|3|||
145763660|NCT00723957|525644538|FG001|Overall Study|Death|4|||
145763661|NCT00723957|525644537|FG000|Overall Study|Disease progression|27|||
145763662|NCT00723957|525644538|FG001|Overall Study|Disease progression|25|||
145763663|NCT00723957|525644537|FG000|Overall Study|Maximum clinical benefit|4|||
145763664|NCT00723957|525644538|FG001|Overall Study|Maximum clinical benefit|5|||
145763665|NCT00723957|525644537|FG000|Overall Study|Investigator decision|1|||
145763666|NCT00723957|525644538|FG001|Overall Study|Investigator decision|1|||
145763667|NCT00723957|525644537|FG000|Overall Study|Study drug toxicity|4|||
145763668|NCT00723957|525644538|FG001|Overall Study|Study drug toxicity|6|||
145763669|NCT00723957|525644537|FG000|Overall Study|Withdrawal by Subject|7|||
145763670|NCT00723957|525644538|FG001|Overall Study|Withdrawal by Subject|5|||
145763671|NCT00723957|525644537|FG000|Overall Study|Reason not analyzed|1|||
145763672|NCT00723957|525644538|FG001|Overall Study|Reason not analyzed|0|||
145763673|NCT00723957|525644537|FG000|Overall Study|Never received treatment|3|||
145763674|NCT00723957|525644538|FG001|Overall Study|Never received treatment|3|||
145763675|NCT04666038|525644545|FG000|Overall Study|Progressive Disease|2|||
145763676|NCT04666038|525644546|FG001|Overall Study|Progressive Disease|0|||
145763677|NCT04666038|525644545|FG000|Overall Study|Death|38|||
145763678|NCT04666038|525644546|FG001|Overall Study|Death|32|||
145763679|NCT04666038|525644545|FG000|Overall Study|Withdrawal by Subject|10|||
145763680|NCT04666038|525644546|FG001|Overall Study|Withdrawal by Subject|19|||
145763681|NCT04666038|525644545|FG000|Overall Study|Lost to Follow-up|0|||
145763682|NCT04666038|525644546|FG001|Overall Study|Lost to Follow-up|2|||
145763683|NCT04666038|525644545|FG000|Overall Study|On Study Treatment|46|||
145763684|NCT04666038|525644546|FG001|Overall Study|On Study Treatment|5|||
145763685|NCT04666038|525644545|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
145763686|NCT04666038|525644546|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
145763687|NCT02658812|525644547|FG000|Overall Study|Disease Progression|7|||
145763688|NCT02658812|525644547|FG000|Overall Study|Unrelated to study treatment|1|||
145763689|NCT02658812|525644547|FG000|Overall Study|Adverse Event|1|||
145763690|NCT04957290|525644559|FG000|Overall Study|Progressive disease|3|||
145763691|NCT04957290|525644560|FG001|Overall Study|Progressive disease|3|||
145763692|NCT04957290|525644561|FG002|Overall Study|Progressive disease|2|||
145763693|NCT04957290|525644562|FG003|Overall Study|Progressive disease|0|||
145763694|NCT04957290|525644563|FG004|Overall Study|Progressive disease|0|||
145763695|NCT04957290|525644564|FG005|Overall Study|Progressive disease|0|||
145763696|NCT04957290|525644559|FG000|Overall Study|Withdrawal by Subject|1|||
145763697|NCT04957290|525644560|FG001|Overall Study|Withdrawal by Subject|0|||
145763698|NCT04957290|525644561|FG002|Overall Study|Withdrawal by Subject|1|||
145763699|NCT04957290|525644562|FG003|Overall Study|Withdrawal by Subject|0|||
145763700|NCT04957290|525644563|FG004|Overall Study|Withdrawal by Subject|0|||
145763701|NCT04957290|525644564|FG005|Overall Study|Withdrawal by Subject|0|||
145763702|NCT04957290|525644559|FG000|Overall Study|Death|0|||
145763703|NCT04957290|525644560|FG001|Overall Study|Death|2|||
145763704|NCT04957290|525644561|FG002|Overall Study|Death|1|||
145763705|NCT04957290|525644562|FG003|Overall Study|Death|0|||
145763706|NCT04957290|525644563|FG004|Overall Study|Death|0|||
145763707|NCT04957290|525644564|FG005|Overall Study|Death|0|||
145763708|NCT04957290|525644559|FG000|Overall Study|non compliance with study drug|0|||
145763709|NCT04957290|525644560|FG001|Overall Study|non compliance with study drug|1|||
145763710|NCT04957290|525644561|FG002|Overall Study|non compliance with study drug|0|||
145763711|NCT04957290|525644562|FG003|Overall Study|non compliance with study drug|0|||
145763712|NCT04957290|525644563|FG004|Overall Study|non compliance with study drug|0|||
145763713|NCT04957290|525644564|FG005|Overall Study|non compliance with study drug|0|||
145763714|NCT04957290|525644559|FG000|Overall Study|none specified.|0|||
145763715|NCT04957290|525644560|FG001|Overall Study|none specified.|1|||
145763716|NCT04957290|525644561|FG002|Overall Study|none specified.|2|||
145763717|NCT04957290|525644562|FG003|Overall Study|none specified.|0|||
145763718|NCT04957290|525644563|FG004|Overall Study|none specified.|0|||
145763719|NCT04957290|525644564|FG005|Overall Study|none specified.|0|||
145763720|NCT04957290|525644559|FG000|Overall Study|unacceptable toxicity|0|||
145763721|NCT04957290|525644560|FG001|Overall Study|unacceptable toxicity|0|||
145276993|NCT03174925|523864675|FG000|Overall Study|Elastography image not interpretable|1|||
145276994|NCT01791127|523864676|FG000|Overall Study|Death|356|||
145276995|NCT01791127|523864676|FG000|Overall Study|Patient has withdrawn from study|293|||
145276996|NCT01791127|523864676|FG000|Overall Study|Lost to Follow-up|42|||
145276997|NCT01791127|523864676|FG000|Overall Study|All Siello leads are explanted|31|||
145276998|NCT01791127|523864676|FG000|Overall Study|Completion of 30 day safety registry|1|||
145276999|NCT01791127|523864676|FG000|Overall Study|Study terminated for EP Passion|749|||
145277000|NCT03471182|523864677|FG000|Overall Study|Withdrawal by Subject|1|||
145277001|NCT03471182|523864678|FG001|Overall Study|Withdrawal by Subject|1|||
145277002|NCT03471182|523864679|FG002|Overall Study|Withdrawal by Subject|0|||
145277003|NCT03471182|523864677|FG000|Overall Study|Technical failure|2|||
145277004|NCT03471182|523864678|FG001|Overall Study|Technical failure|0|||
145277005|NCT03471182|523864679|FG002|Overall Study|Technical failure|0|||
145277006|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
145277007|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
145277008|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
145607874|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145763722|NCT04957290|525644561|FG002|Overall Study|unacceptable toxicity|1|||
145763723|NCT04957290|525644562|FG003|Overall Study|unacceptable toxicity|0|||
145607875|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607876|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607877|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607878|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607879|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
145607880|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607881|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607882|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607883|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607884|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
145607885|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
145607886|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607887|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607888|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607889|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607890|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607891|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
145607892|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607893|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607894|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145763724|NCT04957290|525644563|FG004|Overall Study|unacceptable toxicity|0|||
145763725|NCT04957290|525644564|FG005|Overall Study|unacceptable toxicity|0|||
145763726|NCT04957290|525644559|FG000|Overall Study|Adverse Event|0|||
145763727|NCT04957290|525644560|FG001|Overall Study|Adverse Event|0|||
145277009|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
145277010|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
145277011|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
145277012|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
145277013|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
145277014|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277015|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277016|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277017|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
145277018|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
145277019|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277020|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277021|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
145277022|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
145763728|NCT04957290|525644561|FG002|Overall Study|Adverse Event|1|||
145277023|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
145763729|NCT04957290|525644562|FG003|Overall Study|Adverse Event|0|||
145763730|NCT04957290|525644563|FG004|Overall Study|Adverse Event|0|||
145763731|NCT04957290|525644564|FG005|Overall Study|Adverse Event|0|||
145763732|NCT04957290|525644559|FG000|Overall Study|study terminated by sponsor|0|||
145763733|NCT04957290|525644560|FG001|Overall Study|study terminated by sponsor|0|||
145763734|NCT04957290|525644561|FG002|Overall Study|study terminated by sponsor|2|||
145763735|NCT04957290|525644562|FG003|Overall Study|study terminated by sponsor|0|||
145763736|NCT04957290|525644563|FG004|Overall Study|study terminated by sponsor|0|||
145763737|NCT04957290|525644564|FG005|Overall Study|study terminated by sponsor|0|||
145763738|NCT01282229|525644565|FG000|Overall Study|Protocol Violation|2|||
145763739|NCT02899156|525644566|FG000|Overall Study|Death|1|||
145763740|NCT02899156|525644567|FG001|Overall Study|Death|0|||
145763741|NCT02899156|525644566|FG000|Overall Study|Physician Decision|0|||
145763742|NCT02899156|525644567|FG001|Overall Study|Physician Decision|1|||
145763743|NCT02116621|525644571|FG000|Baseline|Withdrawal by Subject|0|||
145763744|NCT02116621|525644572|FG001|Baseline|Withdrawal by Subject|4|||
145763745|NCT02116621|525644571|FG000|Three Month Follow-up|Death|1|||
145763746|NCT02116621|525644572|FG001|Three Month Follow-up|Death|1|||
145763747|NCT02116621|525644571|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
145763748|NCT02116621|525644572|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
145763749|NCT02116621|525644571|FG000|Three Month Follow-up|Lost to Follow-up|0|||
145763750|NCT02116621|525644572|FG001|Three Month Follow-up|Lost to Follow-up|1|||
145763751|NCT02116621|525644571|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
145763752|NCT02116621|525644572|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
145763753|NCT02116621|525644571|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
145763754|NCT02116621|525644572|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
145763755|NCT02116621|525644571|FG000|Six Month Follow-up|Lost to Follow-up|2|||
145763756|NCT02116621|525644572|FG001|Six Month Follow-up|Lost to Follow-up|1|||
145763757|NCT02116621|525644571|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
145277024|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
145277025|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
145277026|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
145277027|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
145277028|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
145533426|NCT00875979|524813449|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
145763758|NCT02116621|525644572|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
145763759|NCT02116621|525644571|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
145763760|NCT02116621|525644572|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
145763761|NCT02116621|525644571|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
145763762|NCT02116621|525644572|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
145763763|NCT02116621|525644571|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
145763764|NCT02116621|525644572|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
145763765|NCT02116621|525644571|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
145763766|NCT02116621|525644572|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
145763767|NCT00961961|525644573|FG000|Phase I|Withdrawal by Subject|7|||
145763768|NCT00961961|525644574|FG001|Phase I|Withdrawal by Subject|0|||
145763769|NCT00961961|525644575|FG002|Phase I|Withdrawal by Subject|0|||
145763770|NCT00961961|525644576|FG003|Phase I|Withdrawal by Subject|0|||
145763771|NCT00961961|525644573|FG000|Phase I|Lost to Follow-up|10|||
145763772|NCT00961961|525644574|FG001|Phase I|Lost to Follow-up|0|||
145763773|NCT00961961|525644575|FG002|Phase I|Lost to Follow-up|0|||
145763774|NCT00961961|525644576|FG003|Phase I|Lost to Follow-up|0|||
145763775|NCT00961961|525644573|FG000|Phase I|Lack of Efficacy|94|||
145763776|NCT00961961|525644574|FG001|Phase I|Lack of Efficacy|0|||
145763777|NCT00961961|525644575|FG002|Phase I|Lack of Efficacy|0|||
145763778|NCT00961961|525644576|FG003|Phase I|Lack of Efficacy|0|||
145763779|NCT00961961|525644573|FG000|Phase I|Adverse Event|7|||
145763780|NCT00961961|525644574|FG001|Phase I|Adverse Event|0|||
145763781|NCT00961961|525644575|FG002|Phase I|Adverse Event|0|||
145763782|NCT00961961|525644576|FG003|Phase I|Adverse Event|0|||
145763783|NCT00961961|525644573|FG000|Phase I|Physician Decision|8|||
145763784|NCT00961961|525644574|FG001|Phase I|Physician Decision|0|||
145763785|NCT00961961|525644575|FG002|Phase I|Physician Decision|0|||
145763786|NCT00961961|525644576|FG003|Phase I|Physician Decision|0|||
145763787|NCT00961961|525644573|FG000|Phase II|Lost to Follow-up|0|||
145763788|NCT00961961|525644574|FG001|Phase II|Lost to Follow-up|0|||
145763789|NCT00961961|525644575|FG002|Phase II|Lost to Follow-up|10|||
145763790|NCT00961961|525644576|FG003|Phase II|Lost to Follow-up|7|||
145763791|NCT00961961|525644573|FG000|Phase II|Adverse Event|0|||
145607895|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
145607896|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607897|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607898|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607899|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607900|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607901|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607902|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607903|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
145607904|NCT01852058|525079276|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607905|NCT01852058|525079277|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607906|NCT01852058|525079278|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607907|NCT01852058|525079279|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607908|NCT01852058|525079280|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
145607909|NCT01852058|525079281|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
145607910|NCT01852058|525079282|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607911|NCT01852058|525079283|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607912|NCT01852058|525079284|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145607913|NCT01852058|525079285|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145763792|NCT00961961|525644574|FG001|Phase II|Adverse Event|0|||
145763793|NCT00961961|525644575|FG002|Phase II|Adverse Event|0|||
145763794|NCT00961961|525644576|FG003|Phase II|Adverse Event|1|||
145763795|NCT00961961|525644573|FG000|Phase II|Physician Decision|0|||
145763796|NCT00961961|525644574|FG001|Phase II|Physician Decision|0|||
145763797|NCT00961961|525644575|FG002|Phase II|Physician Decision|1|||
145763798|NCT00961961|525644576|FG003|Phase II|Physician Decision|0|||
145763799|NCT00961961|525644573|FG000|Phase II|Withdrawal by Subject|0|||
145763800|NCT00961961|525644574|FG001|Phase II|Withdrawal by Subject|0|||
145763801|NCT00961961|525644575|FG002|Phase II|Withdrawal by Subject|1|||
145763802|NCT00961961|525644576|FG003|Phase II|Withdrawal by Subject|0|||
145763803|NCT01412957|525644577|FG000|Overall Study|Withdrawal by Subject|6|||
145763804|NCT01412957|525644578|FG001|Overall Study|Withdrawal by Subject|22|||
145763805|NCT01412957|525644577|FG000|Overall Study|Lost to Follow-up|7|||
145763806|NCT01412957|525644578|FG001|Overall Study|Lost to Follow-up|2|||
145763807|NCT01412957|525644577|FG000|Overall Study|Death|136|||
145763808|NCT01412957|525644578|FG001|Overall Study|Death|133|||
145763809|NCT00484315|525644579|FG000|12-Month Clinical Follow-up|Death|6|||
145763810|NCT00484315|525644580|FG001|12-Month Clinical Follow-up|Death|2|||
145763811|NCT00484315|525644579|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
145763812|NCT00484315|525644580|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
145763813|NCT00484315|525644579|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
145763814|NCT00484315|525644580|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
145763815|NCT00484315|525644579|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
145763816|NCT00484315|525644580|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
145763817|NCT00484315|525644579|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
145763818|NCT00484315|525644580|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
145763819|NCT00484315|525644579|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
145763820|NCT00484315|525644580|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
145763821|NCT00484315|525644579|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
145763822|NCT00484315|525644580|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
145763823|NCT00943683|525644581|FG000|Overall Study|Adverse Event|3|||
145763824|NCT00943683|525644582|FG001|Overall Study|Adverse Event|3|||
145763825|NCT00943683|525644581|FG000|Overall Study|Lost to Follow-up|1|||
145763826|NCT00943683|525644582|FG001|Overall Study|Lost to Follow-up|1|||
145763827|NCT00943683|525644581|FG000|Overall Study|Protocol Violation|1|||
145763828|NCT00943683|525644582|FG001|Overall Study|Protocol Violation|2|||
145763829|NCT00943683|525644581|FG000|Overall Study|Withdrawal by Subject|1|||
145763830|NCT00943683|525644582|FG001|Overall Study|Withdrawal by Subject|0|||
145763831|NCT00943683|525644581|FG000|Overall Study|Patient Moved|1|||
145763832|NCT00943683|525644582|FG001|Overall Study|Patient Moved|0|||
145763833|NCT00413959|525644583|FG000|Overall Study|Pt had only one cycle.|1|||
145763834|NCT00630331|525644584|FG000|Overall Study|Death|2|||
145763835|NCT00630331|525644585|FG001|Overall Study|Death|1|||
145763836|NCT00630331|525644586|FG002|Overall Study|Death|1|||
145763837|NCT00630331|525644584|FG000|Overall Study|Adverse Event|1|||
145763838|NCT00630331|525644585|FG001|Overall Study|Adverse Event|0|||
145763839|NCT00630331|525644586|FG002|Overall Study|Adverse Event|0|||
145763840|NCT00630331|525644584|FG000|Overall Study|Withdrawal by Subject|12|||
145763841|NCT00630331|525644585|FG001|Overall Study|Withdrawal by Subject|7|||
145763842|NCT00630331|525644586|FG002|Overall Study|Withdrawal by Subject|5|||
145763843|NCT00630331|525644584|FG000|Overall Study|Lost to Follow-up|175|||
145763844|NCT00630331|525644585|FG001|Overall Study|Lost to Follow-up|143|||
145763845|NCT00630331|525644586|FG002|Overall Study|Lost to Follow-up|170|||
145763846|NCT00630331|525644584|FG000|Overall Study|Inappropriate enrollment|3|||
145763847|NCT00630331|525644585|FG001|Overall Study|Inappropriate enrollment|6|||
145763848|NCT00630331|525644586|FG002|Overall Study|Inappropriate enrollment|3|||
145763849|NCT00630331|525644584|FG000|Overall Study|Unable to classify|9|||
145763850|NCT00630331|525644585|FG001|Overall Study|Unable to classify|4|||
145763851|NCT00630331|525644586|FG002|Overall Study|Unable to classify|3|||
145763852|NCT00630331|525644584|FG000|Overall Study|Protocol Violation|4|||
145763853|NCT00630331|525644585|FG001|Overall Study|Protocol Violation|5|||
145763854|NCT00630331|525644586|FG002|Overall Study|Protocol Violation|6|||
145763855|NCT02292771|525644595|FG000|Overall Study|Withdrawal by Subject|2|||
145763856|NCT02292771|525644596|FG001|Overall Study|Withdrawal by Subject|1|||
145763857|NCT02292771|525644595|FG000|Overall Study|Lost to Follow-up|2|||
145763858|NCT02292771|525644596|FG001|Overall Study|Lost to Follow-up|1|||
145763859|NCT03219164|525646785|FG000|Overall Study|Study Terminated by Sponsor|16|||
145763860|NCT03219164|525646786|FG001|Overall Study|Study Terminated by Sponsor|12|||
145763861|NCT03219164|525646785|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
145533427|NCT00875979|524813450|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
145763862|NCT03219164|525646786|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
145763863|NCT03219164|525646785|FG000|Overall Study|Lost to Follow-up|1|||
145763864|NCT03219164|525646786|FG001|Overall Study|Lost to Follow-up|1|||
145763865|NCT03219164|525646785|FG000|Overall Study|Adverse Event|1|||
145763866|NCT03219164|525646786|FG001|Overall Study|Adverse Event|0|||
145763867|NCT03219164|525646785|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145763868|NCT03219164|525646786|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145763869|NCT03219164|525646785|FG000|Overall Study|Protocol Violation|0|||
145763870|NCT03219164|525646786|FG001|Overall Study|Protocol Violation|1|||
145763871|NCT03219164|525646785|FG000|Overall Study|Withdrew Assent|1|||
145763872|NCT03219164|525646786|FG001|Overall Study|Withdrew Assent|0|||
145763873|NCT01750918|525646787|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
145763874|NCT01750918|525646788|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
145763875|NCT01750918|525646789|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
145763876|NCT01750918|525646790|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
145763877|NCT01750918|525646791|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
145763878|NCT01750918|525646792|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
145763879|NCT01750918|525646793|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
145763880|NCT01750918|525646794|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
145763881|NCT01750918|525646787|FG000|Overall Study|Lost to Follow-up|0|||
145763882|NCT01750918|525646788|FG001|Overall Study|Lost to Follow-up|0|||
145763883|NCT01750918|525646789|FG002|Overall Study|Lost to Follow-up|2|||
145763884|NCT01750918|525646790|FG003|Overall Study|Lost to Follow-up|2|||
145763885|NCT01750918|525646791|FG004|Overall Study|Lost to Follow-up|0|||
145763886|NCT01750918|525646792|FG005|Overall Study|Lost to Follow-up|0|||
145763887|NCT01750918|525646793|FG006|Overall Study|Lost to Follow-up|0|||
145763888|NCT01750918|525646794|FG007|Overall Study|Lost to Follow-up|1|||
145763889|NCT01750918|525646787|FG000|Overall Study|Withdrawal by Subject|0|||
145763890|NCT01750918|525646788|FG001|Overall Study|Withdrawal by Subject|0|||
145763891|NCT01750918|525646789|FG002|Overall Study|Withdrawal by Subject|1|||
145763892|NCT01750918|525646790|FG003|Overall Study|Withdrawal by Subject|2|||
145763893|NCT01750918|525646791|FG004|Overall Study|Withdrawal by Subject|1|||
145763894|NCT01750918|525646792|FG005|Overall Study|Withdrawal by Subject|1|||
145763895|NCT01750918|525646793|FG006|Overall Study|Withdrawal by Subject|2|||
145763896|NCT01750918|525646794|FG007|Overall Study|Withdrawal by Subject|2|||
145763897|NCT00224016|525646810|FG000|Titration Period|Withdrawal by Subject|0|||
145763898|NCT00224016|525646811|FG001|Titration Period|Withdrawal by Subject|1|||
145763899|NCT00224016|525646810|FG000|Titration Period|Lost to Follow-up|1|||
145763900|NCT00224016|525646811|FG001|Titration Period|Lost to Follow-up|0|||
145763901|NCT00224016|525646810|FG000|Maintenance Period|Withdrawal by Subject|2|||
145763902|NCT00224016|525646811|FG001|Maintenance Period|Withdrawal by Subject|0|||
145763903|NCT00224016|525646810|FG000|Maintenance Period|Lost to Follow-up|0|||
145763904|NCT00224016|525646811|FG001|Maintenance Period|Lost to Follow-up|1|||
145763905|NCT01524991|525646814|FG000|Overall Study|Adverse Event|12|||
145763906|NCT01524991|525646814|FG000|Overall Study|Death|1|||
145763907|NCT01524991|525646814|FG000|Overall Study|Disease ProgressionDu|17|||
145763908|NCT01524991|525646814|FG000|Overall Study|Other complicating disease|1|||
145763909|NCT01524991|525646814|FG000|Overall Study|Withdrawal by Subject|2|||
145763910|NCT01524991|525646814|FG000|Overall Study|Symptomatic Deterioration|1|||
145763911|NCT01805180|525646815|FG000|Lead-in Donor Phase|screen failure|1|||
145763912|NCT01805180|525646816|FG001|Lead-in Donor Phase|screen failure|0|||
145763913|NCT01805180|525646817|FG002|Lead-in Donor Phase|screen failure|0|||
145763914|NCT04574999|525646820|FG000|Overall Study|Adverse Event|1|||
145763915|NCT04574999|525646821|FG001|Overall Study|Adverse Event|0|||
145277029|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
145277030|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
145277031|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
145277032|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
145763916|NCT04574999|525646820|FG000|Overall Study|Lack of Efficacy|2|||
145763917|NCT04574999|525646821|FG001|Overall Study|Lack of Efficacy|3|||
145763918|NCT04574999|525646820|FG000|Overall Study|Protocol Violation|1|||
145763919|NCT04574999|525646821|FG001|Overall Study|Protocol Violation|0|||
145763920|NCT04574999|525646820|FG000|Overall Study|Withdrawal by Subject|2|||
145763921|NCT04574999|525646821|FG001|Overall Study|Withdrawal by Subject|2|||
145763922|NCT04574999|525646820|FG000|Overall Study|Lost to Follow-up|1|||
145763923|NCT04574999|525646821|FG001|Overall Study|Lost to Follow-up|0|||
145763924|NCT04574999|525646820|FG000|Overall Study|Personal problems|1|||
145763925|NCT04574999|525646821|FG001|Overall Study|Personal problems|0|||
145763926|NCT04574999|525646820|FG000|Overall Study|Previous planned surgery|1|||
145763927|NCT04574999|525646821|FG001|Overall Study|Previous planned surgery|0|||
145277033|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
145277034|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
145277035|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
145277036|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
145763928|NCT00206726|525646825|FG000|Overall Study|Delayed recovery of blood counts|1|||
145763929|NCT00206726|525646825|FG000|Overall Study|Progressive disease or relapsed disease|18|||
145763930|NCT00206726|525646825|FG000|Overall Study|Placed on new protocol|1|||
145763931|NCT00206726|525646825|FG000|Overall Study|Bone marrow transplant|1|||
145763932|NCT00206726|525646825|FG000|Overall Study|Adverse Event|17|||
145763933|NCT00206726|525646825|FG000|Overall Study|Death|4|||
145763934|NCT00206726|525646825|FG000|Overall Study|Protocol Violation|1|||
145763935|NCT00206726|525646825|FG000|Overall Study|Withdrawal by Subject|8|||
145763936|NCT00008385|525646842|FG000|Overall Study|Off treatment reasons not reported|79|||
145763937|NCT00008385|525646843|FG001|Overall Study|Off treatment reasons not reported|70|||
145763938|NCT00008385|525646842|FG000|Overall Study|Progressive disease|52|||
145763939|NCT00008385|525646843|FG001|Overall Study|Progressive disease|117|||
145763940|NCT00008385|525646842|FG000|Overall Study|Adverse Event|8|||
145763941|NCT00008385|525646843|FG001|Overall Study|Adverse Event|20|||
145763942|NCT00008385|525646842|FG000|Overall Study|Death|12|||
145763943|NCT00008385|525646843|FG001|Overall Study|Death|18|||
145763944|NCT00008385|525646842|FG000|Overall Study|Withdrawal by Subject|67|||
145763945|NCT00008385|525646843|FG001|Overall Study|Withdrawal by Subject|157|||
145763946|NCT00008385|525646842|FG000|Overall Study|Start non-protocol therapy|3|||
145277037|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
145277038|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
145277039|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
145277040|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
145277041|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
145277042|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
145277043|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
145277044|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
145277045|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
145277046|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
145277047|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
145277048|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
145277049|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
145277050|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
145277051|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
145277052|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
145277053|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
145277054|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
145277055|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
145277056|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
145277057|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
145277058|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
145277059|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
145277060|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
145277061|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
145277062|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
145277063|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
145277064|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
145277065|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
145277066|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
145277067|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
145277068|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
145277069|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
145277070|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
145277071|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
145277072|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
145277073|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
145277074|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
145277075|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
145277076|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
145402927|NCT00706797|524332555|FG000|Overall Study|Lack of Efficacy|3|||
145763947|NCT00008385|525646843|FG001|Overall Study|Start non-protocol therapy|1|||
145763948|NCT00008385|525646842|FG000|Overall Study|Other complicating disease|17|||
145763949|NCT00008385|525646843|FG001|Overall Study|Other complicating disease|30|||
145763950|NCT00008385|525646842|FG000|Overall Study|Maximum dose reached|0|||
145763951|NCT00008385|525646843|FG001|Overall Study|Maximum dose reached|2|||
145763952|NCT00008385|525646842|FG000|Overall Study|Other|105|||
145763953|NCT00008385|525646843|FG001|Overall Study|Other|212|||
145763954|NCT00008385|525646842|FG000|Overall Study|Not start protocol therapy|44|||
145763955|NCT00008385|525646843|FG001|Overall Study|Not start protocol therapy|175|||
145763956|NCT05148884|525646844|FG000|Overall Study|Withdrawal by Subject|3|||
145763957|NCT05148884|525646845|FG001|Overall Study|Withdrawal by Subject|0|||
145763958|NCT05148884|525646844|FG000|Overall Study|Deep brain stimulation operation|0|||
145763959|NCT05148884|525646845|FG001|Overall Study|Deep brain stimulation operation|1|||
145763960|NCT00582556|525646846|FG000|Overall Study|Withdrawal by Subject|0|||
145763961|NCT00582556|525646847|FG001|Overall Study|Withdrawal by Subject|1|||
145763962|NCT00582556|525646848|FG002|Overall Study|Withdrawal by Subject|1|||
145763963|NCT00582556|525646846|FG000|Overall Study|Physician Decision|0|||
145763964|NCT00582556|525646847|FG001|Overall Study|Physician Decision|0|||
145763965|NCT00582556|525646848|FG002|Overall Study|Physician Decision|1|||
145763966|NCT01993888|525646851|FG000|Overall Study|Death|1|||
145763967|NCT01993888|525646852|FG001|Overall Study|Death|1|||
145763968|NCT01993888|525646851|FG000|Overall Study|Lost to Follow-up|1|||
145763969|NCT01993888|525646852|FG001|Overall Study|Lost to Follow-up|1|||
145763970|NCT01993888|525646851|FG000|Overall Study|Withdrawal by Subject|0|||
145763971|NCT01993888|525646852|FG001|Overall Study|Withdrawal by Subject|1|||
145763972|NCT01341457|525646853|FG000|Overall Study|Adverse Event|2|||
145763973|NCT01341457|525646854|FG001|Overall Study|Adverse Event|0|||
145763974|NCT03902080|525646859|FG000|Overall Study|Adverse Event|17|||
145763975|NCT03902080|525646860|FG001|Overall Study|Adverse Event|15|||
145763976|NCT03902080|525646859|FG000|Overall Study|Withdrawal by Subject|28|||
145763977|NCT03902080|525646860|FG001|Overall Study|Withdrawal by Subject|35|||
145763978|NCT03902080|525646859|FG000|Overall Study|Lost to Follow-up|6|||
145763979|NCT03902080|525646860|FG001|Overall Study|Lost to Follow-up|7|||
145763980|NCT03902080|525646859|FG000|Overall Study|Other|3|||
145763981|NCT03902080|525646860|FG001|Overall Study|Other|5|||
145763982|NCT03902080|525646859|FG000|Overall Study|Non compliance|4|||
145763983|NCT03902080|525646860|FG001|Overall Study|Non compliance|3|||
145763984|NCT03902080|525646859|FG000|Overall Study|Physician Decision|5|||
145763985|NCT03902080|525646860|FG001|Overall Study|Physician Decision|1|||
145763986|NCT03902080|525646859|FG000|Overall Study|Protocol Violation|3|||
145763987|NCT03902080|525646860|FG001|Overall Study|Protocol Violation|3|||
145763988|NCT03902080|525646859|FG000|Overall Study|Lack of Efficacy|1|||
145763989|NCT03902080|525646860|FG001|Overall Study|Lack of Efficacy|3|||
145763990|NCT03902080|525646859|FG000|Overall Study|Withdrawn prior to dosing|0|||
145763991|NCT03902080|525646860|FG001|Overall Study|Withdrawn prior to dosing|1|||
145763992|NCT02661594|525646861|FG000|Overall Study|Protocol Violation|1|||
145763993|NCT02661594|525646862|FG001|Overall Study|Protocol Violation|0|||
145763994|NCT02661594|525646863|FG002|Overall Study|Protocol Violation|1|||
145763995|NCT02661594|525646864|FG003|Overall Study|Protocol Violation|0|||
145763996|NCT00434967|525646867|FG000|Overall Study|Adverse Event|2|||
145763997|NCT00434967|525646868|FG001|Overall Study|Adverse Event|4|||
145763998|NCT00434967|525646869|FG002|Overall Study|Adverse Event|3|||
145292762|NCT06179108|523922227|FG001|Overall Study|Physician Decision|1|||
145763999|NCT00434967|525646870|FG003|Overall Study|Adverse Event|3|||
145292763|NCT06179108|523922228|FG002|Overall Study|Physician Decision|0|||
145764000|NCT00434967|525646867|FG000|Overall Study|Lost to Follow-up|0|||
145764001|NCT00434967|525646868|FG001|Overall Study|Lost to Follow-up|0|||
145764002|NCT00434967|525646869|FG002|Overall Study|Lost to Follow-up|1|||
145764003|NCT00434967|525646870|FG003|Overall Study|Lost to Follow-up|0|||
145764004|NCT00434967|525646867|FG000|Overall Study|Withdrawal by Subject|2|||
145764005|NCT00434967|525646868|FG001|Overall Study|Withdrawal by Subject|2|||
145764006|NCT00434967|525646869|FG002|Overall Study|Withdrawal by Subject|4|||
145764007|NCT00434967|525646870|FG003|Overall Study|Withdrawal by Subject|6|||
145764008|NCT00434967|525646867|FG000|Overall Study|Randomized in error|0|||
145764009|NCT00434967|525646868|FG001|Overall Study|Randomized in error|0|||
145764010|NCT00434967|525646869|FG002|Overall Study|Randomized in error|0|||
145764011|NCT00434967|525646870|FG003|Overall Study|Randomized in error|1|||
145764012|NCT00434967|525646867|FG000|Overall Study|Protocol Violation|0|||
145764013|NCT00434967|525646868|FG001|Overall Study|Protocol Violation|1|||
145764014|NCT00434967|525646869|FG002|Overall Study|Protocol Violation|0|||
145764015|NCT00434967|525646870|FG003|Overall Study|Protocol Violation|1|||
145764016|NCT00434967|525646867|FG000|Overall Study|Physician Decision|1|||
145764017|NCT00434967|525646868|FG001|Overall Study|Physician Decision|1|||
145764018|NCT00434967|525646869|FG002|Overall Study|Physician Decision|1|||
145764019|NCT00434967|525646870|FG003|Overall Study|Physician Decision|0|||
145764020|NCT00434967|525646867|FG000|Overall Study|Patient Disposition Challenges|2|||
145764021|NCT00434967|525646868|FG001|Overall Study|Patient Disposition Challenges|0|||
145764022|NCT00434967|525646869|FG002|Overall Study|Patient Disposition Challenges|0|||
145764023|NCT00434967|525646870|FG003|Overall Study|Patient Disposition Challenges|3|||
145764024|NCT01169779|525646871|FG000|Overall Study|Adverse Event|3|||
145764025|NCT01169779|525646872|FG001|Overall Study|Adverse Event|11|||
145764026|NCT01169779|525646871|FG000|Overall Study|Lack of Efficacy|1|||
145764027|NCT01169779|525646872|FG001|Overall Study|Lack of Efficacy|0|||
145764028|NCT01169779|525646871|FG000|Overall Study|Protocol Violation|1|||
145764029|NCT01169779|525646872|FG001|Overall Study|Protocol Violation|1|||
145764030|NCT01169779|525646871|FG000|Overall Study|Withdrawal by Subject|3|||
145764031|NCT01169779|525646872|FG001|Overall Study|Withdrawal by Subject|2|||
145764032|NCT01169779|525646871|FG000|Overall Study|Familial and personal reasons|3|||
145764033|NCT01169779|525646872|FG001|Overall Study|Familial and personal reasons|3|||
145764034|NCT00432237|525646873|FG000|Overall Study|Adverse Event|0|||
145764035|NCT00432237|525646874|FG001|Overall Study|Adverse Event|0|||
145764036|NCT00432237|525646875|FG002|Overall Study|Adverse Event|0|||
145764037|NCT00432237|525646876|FG003|Overall Study|Adverse Event|1|||
145764038|NCT00432237|525646873|FG000|Overall Study|Lack of Efficacy|0|||
145764039|NCT00432237|525646874|FG001|Overall Study|Lack of Efficacy|0|||
145764040|NCT00432237|525646875|FG002|Overall Study|Lack of Efficacy|0|||
145764041|NCT00432237|525646876|FG003|Overall Study|Lack of Efficacy|1|||
145764042|NCT00432237|525646873|FG000|Overall Study|Lost to Follow-up|10|||
145764043|NCT00432237|525646874|FG001|Overall Study|Lost to Follow-up|10|||
145764044|NCT00432237|525646875|FG002|Overall Study|Lost to Follow-up|18|||
145764045|NCT00432237|525646876|FG003|Overall Study|Lost to Follow-up|18|||
145764046|NCT00432237|525646873|FG000|Overall Study|Physician Decision|1|||
145764047|NCT00432237|525646874|FG001|Overall Study|Physician Decision|3|||
145764048|NCT00432237|525646875|FG002|Overall Study|Physician Decision|2|||
145764049|NCT00432237|525646876|FG003|Overall Study|Physician Decision|1|||
145764050|NCT00432237|525646873|FG000|Overall Study|Pregnancy|0|||
145764051|NCT00432237|525646874|FG001|Overall Study|Pregnancy|1|||
145764052|NCT00432237|525646875|FG002|Overall Study|Pregnancy|0|||
145764053|NCT00432237|525646876|FG003|Overall Study|Pregnancy|0|||
145764054|NCT00432237|525646873|FG000|Overall Study|Protocol Violation|13|||
145764055|NCT00432237|525646874|FG001|Overall Study|Protocol Violation|10|||
145764056|NCT00432237|525646875|FG002|Overall Study|Protocol Violation|11|||
145764057|NCT00432237|525646876|FG003|Overall Study|Protocol Violation|8|||
145764058|NCT00432237|525646873|FG000|Overall Study|Withdrawal by Subject|5|||
145764059|NCT00432237|525646874|FG001|Overall Study|Withdrawal by Subject|6|||
145764060|NCT00432237|525646875|FG002|Overall Study|Withdrawal by Subject|9|||
145764061|NCT00432237|525646876|FG003|Overall Study|Withdrawal by Subject|11|||
145764062|NCT00432237|525646873|FG000|Overall Study|Lack of Qualifying Event|38|||
145764063|NCT00432237|525646874|FG001|Overall Study|Lack of Qualifying Event|71|||
145764064|NCT00432237|525646875|FG002|Overall Study|Lack of Qualifying Event|69|||
145764065|NCT00432237|525646876|FG003|Overall Study|Lack of Qualifying Event|84|||
145764066|NCT01354132|525646877|FG000|Randomization|Physician Decision|1|||
145764067|NCT01354132|525646878|FG001|Randomization|Physician Decision|0|||
145764068|NCT01354132|525646877|FG000|Randomization|Withdrawal by Subject|0|||
145764069|NCT01354132|525646878|FG001|Randomization|Withdrawal by Subject|1|||
145764070|NCT01354132|525646877|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
145764071|NCT01354132|525646878|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
145764072|NCT01354132|525646877|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
145764073|NCT01354132|525646878|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
145764074|NCT01354132|525646877|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
145764075|NCT01354132|525646878|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
145764076|NCT00928070|525646879|FG000|Overall Study|Lost to Follow-up|1|||
145764077|NCT00928070|525646880|FG001|Overall Study|Lost to Follow-up|2|||
145764078|NCT00928070|525646879|FG000|Overall Study|Withdrawal by Subject|10|||
145764079|NCT00928070|525646880|FG001|Overall Study|Withdrawal by Subject|3|||
145764080|NCT00928070|525646879|FG000|Overall Study|Adverse Event|14|||
145764081|NCT00928070|525646880|FG001|Overall Study|Adverse Event|26|||
145277077|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
145277078|NCT04440163|523864682|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
145277079|NCT04440163|523864683|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
145277080|NCT04440163|523864684|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
145277081|NCT04440163|523864685|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
145277082|NCT04440163|523864686|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
145277083|NCT04440163|523864687|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
145277084|NCT04440163|523864688|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
145277085|NCT04440163|523864689|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
145277086|NCT04440163|523864682|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
145277087|NCT04440163|523864683|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
145277088|NCT04440163|523864684|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
145277089|NCT04440163|523864685|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
145277090|NCT04440163|523864686|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
145277091|NCT04440163|523864687|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
145277092|NCT04440163|523864688|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
145277093|NCT04440163|523864689|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
145277094|NCT04440163|523864682|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277095|NCT04440163|523864683|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277096|NCT04440163|523864684|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277097|NCT04440163|523864685|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
145277098|NCT04440163|523864686|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277099|NCT04440163|523864687|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277100|NCT04440163|523864688|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277101|NCT04440163|523864689|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
145277102|NCT00068406|523864692|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
145277103|NCT00068406|523864692|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
145277104|NCT02018042|523864693|FG000|Overall Study|Withdrawal by Subject|1|||
145277105|NCT01850108|523864697|FG000|Overall Study|Lost to Follow-up|4|||
145277106|NCT01850108|523864697|FG000|Overall Study|Not eligible|1|||
145277107|NCT01850108|523864697|FG000|Overall Study|Failed engraftment|2|||
145277108|NCT01850108|523864697|FG000|Overall Study|Physician Decision|1|||
145277109|NCT03273712|523864701|FG000|Overall Study|Death|5|||
145277110|NCT03273712|523864701|FG000|Overall Study|Adverse Event|1|||
145277111|NCT03273712|523864701|FG000|Overall Study|Disease Progression|1|||
145277112|NCT00810615|523864714|FG000|Overall Study|Withdrawal by Subject|1|||
145277113|NCT00810615|523864715|FG001|Overall Study|Withdrawal by Subject|1|||
145277114|NCT02567266|523864716|FG000|Overall Study|Withdrawal by Subject|10|||
145277115|NCT02567266|523864717|FG001|Overall Study|Withdrawal by Subject|7|||
145277116|NCT02567266|523864718|FG002|Overall Study|Withdrawal by Subject|6|||
145277117|NCT02567266|523864716|FG000|Overall Study|Lost to Follow-up|13|||
145277118|NCT02567266|523864717|FG001|Overall Study|Lost to Follow-up|8|||
145277119|NCT02567266|523864718|FG002|Overall Study|Lost to Follow-up|10|||
145277120|NCT00068445|523864722|FG000|Randomization|Cancel|1|||
145277121|NCT00068445|523864723|FG001|Randomization|Cancel|3|||
145277122|NCT00068445|523864722|FG000|Randomization|Ineligible|1|||
145277123|NCT00068445|523864723|FG001|Randomization|Ineligible|1|||
145277124|NCT00068445|523864722|FG000|Treatment|Refused Further Treatment|13|||
145277125|NCT00068445|523864723|FG001|Treatment|Refused Further Treatment|10|||
145277126|NCT00068445|523864722|FG000|Treatment|Adverse Event|7|||
145277127|NCT00068445|523864723|FG001|Treatment|Adverse Event|1|||
145277128|NCT00068445|523864722|FG000|Treatment|Other (Specifics not available)|9|||
145277129|NCT00068445|523864723|FG001|Treatment|Other (Specifics not available)|5|||
145277130|NCT01155284|523864724|FG000|Overall Study|Withdrawal by Subject|4|||
145277131|NCT01155284|523864725|FG001|Overall Study|Withdrawal by Subject|3|||
145277132|NCT01155284|523864724|FG000|Overall Study|Lost to Follow-up|1|||
145277133|NCT01155284|523864725|FG001|Overall Study|Lost to Follow-up|2|||
145277134|NCT01155284|523864724|FG000|Overall Study|Physician Decision|1|||
145277135|NCT01155284|523864725|FG001|Overall Study|Physician Decision|0|||
145277136|NCT01155284|523864724|FG000|Overall Study|Adverse Event|1|||
145277137|NCT01155284|523864725|FG001|Overall Study|Adverse Event|0|||
145277138|NCT01896700|523864726|FG000|Overall Study|Adverse Event|4|||
145277139|NCT01896700|523864727|FG001|Overall Study|Adverse Event|5|||
145277140|NCT01896700|523864726|FG000|Overall Study|Withdrawal by Subject|0|||
145277141|NCT01896700|523864727|FG001|Overall Study|Withdrawal by Subject|1|||
145277142|NCT00423488|523864730|FG000|Overall Study|No evidence of study drug intake|2|||
145277143|NCT00423488|523864731|FG001|Overall Study|No evidence of study drug intake|1|||
145277144|NCT00423488|523864730|FG000|Overall Study|No post baseline data|3|||
145277145|NCT00423488|523864731|FG001|Overall Study|No post baseline data|0|||
145277146|NCT00886782|523864732|FG000|Overall Study|Disease progression|3|||
145277147|NCT00886782|523864733|FG001|Overall Study|Disease progression|3|||
145277148|NCT00886782|523864734|FG002|Overall Study|Disease progression|3|||
145277149|NCT00886782|523864732|FG000|Overall Study|Study drug toxicity|0|||
145764082|NCT00928070|525646879|FG000|Overall Study|Lack of Efficacy|9|||
145764083|NCT00928070|525646880|FG001|Overall Study|Lack of Efficacy|5|||
145764084|NCT00928070|525646879|FG000|Overall Study|Did not meet entrance criteria|16|||
145764085|NCT00928070|525646880|FG001|Overall Study|Did not meet entrance criteria|9|||
145764086|NCT00928070|525646879|FG000|Overall Study|Protocol Violation|6|||
145764087|NCT00928070|525646880|FG001|Overall Study|Protocol Violation|5|||
145277150|NCT00886782|523864733|FG001|Overall Study|Study drug toxicity|0|||
145764088|NCT00928070|525646879|FG000|Overall Study|Randomized but not treated|2|||
145764089|NCT00928070|525646880|FG001|Overall Study|Randomized but not treated|2|||
145764090|NCT00928070|525646879|FG000|Overall Study|Other|5|||
145764091|NCT00928070|525646880|FG001|Overall Study|Other|5|||
145764092|NCT00191854|525646881|FG000|Overall Study|Death|26|||
145764093|NCT00191854|525646882|FG001|Overall Study|Death|23|||
145764094|NCT00191854|525646883|FG002|Overall Study|Death|29|||
145764095|NCT00191854|525646881|FG000|Overall Study|Lost to Follow-up|7|||
145764096|NCT00191854|525646882|FG001|Overall Study|Lost to Follow-up|5|||
145764097|NCT00191854|525646883|FG002|Overall Study|Lost to Follow-up|5|||
145764098|NCT00191854|525646881|FG000|Overall Study|Withdrawal by Subject|4|||
145764099|NCT00191854|525646882|FG001|Overall Study|Withdrawal by Subject|2|||
145764100|NCT00191854|525646883|FG002|Overall Study|Withdrawal by Subject|3|||
145277151|NCT00886782|523864734|FG002|Overall Study|Study drug toxicity|1|||
145277152|NCT00886782|523864732|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
145277153|NCT00886782|523864733|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
145277154|NCT00886782|523864734|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
145277155|NCT01255722|523864735|FG000|Overall Study|Adverse Event|0|||
145277156|NCT01255722|523864736|FG001|Overall Study|Adverse Event|1|||
145277157|NCT01255722|523864737|FG002|Overall Study|Adverse Event|1|||
145277158|NCT01255722|523864735|FG000|Overall Study|asymptomatic patient|1|||
145277159|NCT01255722|523864736|FG001|Overall Study|asymptomatic patient|0|||
145277160|NCT01255722|523864737|FG002|Overall Study|asymptomatic patient|0|||
145277161|NCT01255722|523864735|FG000|Overall Study|beta-blocker contraindicated|2|||
145277162|NCT01255722|523864736|FG001|Overall Study|beta-blocker contraindicated|0|||
145277163|NCT01255722|523864737|FG002|Overall Study|beta-blocker contraindicated|0|||
145277164|NCT03835975|523864740|FG000|Overall Study|Lost to Follow-up|1|||
145277165|NCT03835975|523864741|FG001|Overall Study|Lost to Follow-up|1|||
145277166|NCT03835975|523864742|FG002|Overall Study|Lost to Follow-up|0|||
145277167|NCT03835975|523864743|FG003|Overall Study|Lost to Follow-up|0|||
145277168|NCT03835975|523864744|FG004|Overall Study|Lost to Follow-up|0|||
145277169|NCT03835975|523864740|FG000|Overall Study|No longer met eligibility criteria|0|||
145277170|NCT03835975|523864741|FG001|Overall Study|No longer met eligibility criteria|1|||
145277171|NCT03835975|523864742|FG002|Overall Study|No longer met eligibility criteria|0|||
145277172|NCT03835975|523864743|FG003|Overall Study|No longer met eligibility criteria|0|||
145277173|NCT03835975|523864744|FG004|Overall Study|No longer met eligibility criteria|0|||
145277174|NCT03835975|523864740|FG000|Overall Study|Protocol Violation|1|||
145277175|NCT03835975|523864741|FG001|Overall Study|Protocol Violation|1|||
145277176|NCT03835975|523864742|FG002|Overall Study|Protocol Violation|2|||
145277177|NCT03835975|523864743|FG003|Overall Study|Protocol Violation|0|||
145277178|NCT03835975|523864744|FG004|Overall Study|Protocol Violation|0|||
145277179|NCT03835975|523864740|FG000|Overall Study|Withdrawal by Subject|1|||
145277180|NCT03835975|523864741|FG001|Overall Study|Withdrawal by Subject|0|||
145277181|NCT03835975|523864742|FG002|Overall Study|Withdrawal by Subject|1|||
145402928|NCT00706797|524332556|FG001|Overall Study|Lack of Efficacy|0|||
145764101|NCT00191854|525646881|FG000|Overall Study|Sponsor Decision|0|||
145764102|NCT00191854|525646882|FG001|Overall Study|Sponsor Decision|0|||
145402929|NCT00706797|524332555|FG000|Overall Study|Adverse Event|0|||
145764103|NCT00191854|525646883|FG002|Overall Study|Sponsor Decision|1|||
145764104|NCT00191854|525646881|FG000|Overall Study|Screen Failure|0|||
145764105|NCT00191854|525646882|FG001|Overall Study|Screen Failure|0|||
145277182|NCT03835975|523864743|FG003|Overall Study|Withdrawal by Subject|1|||
145277183|NCT03835975|523864744|FG004|Overall Study|Withdrawal by Subject|0|||
145277184|NCT00370396|523864745|FG000|Overall Study|Withdrawal by Subject|0|||
145277185|NCT00370396|523864746|FG001|Overall Study|Withdrawal by Subject|0|||
145277186|NCT00370396|523864747|FG002|Overall Study|Withdrawal by Subject|1|||
145277187|NCT00370396|523864745|FG000|Overall Study|Lost to Follow-up|11|||
145764106|NCT00191854|525646883|FG002|Overall Study|Screen Failure|1|||
145764107|NCT01323478|525646885|FG000|Overall Study|Adverse Event|7|||
145764108|NCT01323478|525646885|FG000|Overall Study|Lack of Efficacy|4|||
145764109|NCT01323478|525646885|FG000|Overall Study|Non-compliance With Study Product|3|||
145764110|NCT01323478|525646885|FG000|Overall Study|Protocol Violation|1|||
145764111|NCT01323478|525646885|FG000|Overall Study|Withdrawal of Consent|1|||
145764112|NCT01323478|525646885|FG000|Overall Study|Administrative or Other Reasons|8|||
145764113|NCT02771522|525646888|FG000|Overall Study|Lost to Follow-up|3|||
145764114|NCT02771522|525646888|FG000|Overall Study|Withdrawal by Subject|2|||
145764115|NCT02771522|525646888|FG000|Overall Study|No white spot lesions|3|||
145764116|NCT00862251|525646889|FG000|Overall Study|Adverse Event|8|||
145764117|NCT00862251|525646890|FG001|Overall Study|Adverse Event|3|||
145764118|NCT00862251|525646891|FG002|Overall Study|Adverse Event|1|||
145764119|NCT00862251|525646889|FG000|Overall Study|Lost to Follow-up|0|||
145764120|NCT00862251|525646890|FG001|Overall Study|Lost to Follow-up|0|||
145764121|NCT00862251|525646891|FG002|Overall Study|Lost to Follow-up|1|||
145764122|NCT00862251|525646889|FG000|Overall Study|Protocol Violation|2|||
145764123|NCT00862251|525646890|FG001|Overall Study|Protocol Violation|0|||
145764124|NCT00862251|525646891|FG002|Overall Study|Protocol Violation|1|||
145764125|NCT00862251|525646889|FG000|Overall Study|Withdrawal by Subject|9|||
145764126|NCT00862251|525646890|FG001|Overall Study|Withdrawal by Subject|2|||
145764127|NCT00862251|525646891|FG002|Overall Study|Withdrawal by Subject|6|||
145764128|NCT02054702|525646898|FG000|Overall Study|Lost to Follow-up|3|||
145764129|NCT02054702|525646899|FG001|Overall Study|Lost to Follow-up|5|||
145764130|NCT02054702|525646898|FG000|Overall Study|Adverse Event|3|||
145764131|NCT02054702|525646899|FG001|Overall Study|Adverse Event|1|||
145764132|NCT02054702|525646898|FG000|Overall Study|Met Withdrawal Criteria|4|||
145764133|NCT02054702|525646899|FG001|Overall Study|Met Withdrawal Criteria|1|||
145764134|NCT02054702|525646898|FG000|Overall Study|Physician Decision|0|||
145764135|NCT02054702|525646899|FG001|Overall Study|Physician Decision|1|||
145764136|NCT02054702|525646898|FG000|Overall Study|Withdrawal by Subject|14|||
145764137|NCT02054702|525646899|FG001|Overall Study|Withdrawal by Subject|4|||
145764138|NCT02347631|525646900|FG000|First Intervention (2 Months)|Adverse Event|1|||
145764139|NCT02347631|525646901|FG001|First Intervention (2 Months)|Adverse Event|1|||
145764140|NCT02347631|525646900|FG000|First Intervention (2 Months)|Pregnancy|1|||
145764141|NCT02347631|525646901|FG001|First Intervention (2 Months)|Pregnancy|0|||
145764142|NCT02347631|525646900|FG000|First Intervention (2 Months)|Moved out of area|0|||
145764143|NCT02347631|525646901|FG001|First Intervention (2 Months)|Moved out of area|2|||
145764144|NCT02347631|525646900|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
145764145|NCT02347631|525646901|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
145764146|NCT02347631|525646900|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
145764147|NCT02347631|525646901|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
145764148|NCT02347631|525646900|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
145764149|NCT02347631|525646901|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
145764150|NCT02347631|525646900|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
145764151|NCT02347631|525646901|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
145764152|NCT02347631|525646900|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
145764153|NCT02347631|525646901|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
145764154|NCT02318784|525646903|FG000|Overall Study|Adverse Event|13|||
145764155|NCT02318784|525646903|FG000|Overall Study|Death|2|||
145764156|NCT02318784|525646903|FG000|Overall Study|Progressive Disease|37|||
145764157|NCT02318784|525646903|FG000|Overall Study|Withdrawal by Subject|10|||
145764158|NCT00934102|525646904|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
145764159|NCT00934102|525646905|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
145764160|NCT00934102|525646906|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
145764161|NCT02304926|525646907|FG000|Overall Study|Lost to Follow-up|2|||
145764162|NCT02304926|525646908|FG001|Overall Study|Lost to Follow-up|1|||
145764163|NCT04258579|525646914|FG000|Overall Study|Withdrawal by Subject|7|||
145764164|NCT04258579|525646914|FG000|Overall Study|Lost to Follow-up|3|||
145764165|NCT04258579|525646914|FG000|Overall Study|Protocol Violation|2|||
145764166|NCT04258579|525646914|FG000|Overall Study|Adverse Event|1|||
145764167|NCT04007159|525646915|FG000|Induction Phase|(missed study visits)|16|||
145764168|NCT04007159|525646915|FG000|Induction Phase|Withdrawal by Subject|4|||
145764169|NCT04007159|525646915|FG000|Induction Phase|Adverse Event|2|||
145764170|NCT04007159|525646915|FG000|Challenge Phase|missed study visits|3|||
145764171|NCT02388295|525646916|FG000|Dose Escalation Week 1|Adverse Event|1|||
145764172|NCT02388295|525646917|FG001|Dose Escalation Week 1|Adverse Event|2|||
145764173|NCT02388295|525646918|FG002|Dose Escalation Week 1|Adverse Event|1|||
145764174|NCT02388295|525646916|FG000|Dose Escalation Week 1|Determined not eligible|1|||
145764175|NCT02388295|525646917|FG001|Dose Escalation Week 1|Determined not eligible|1|||
145764176|NCT02388295|525646918|FG002|Dose Escalation Week 1|Determined not eligible|1|||
145764177|NCT02388295|525646916|FG000|Dose Escalation Week 2|Protocol Violation|0|||
145764178|NCT02388295|525646917|FG001|Dose Escalation Week 2|Protocol Violation|1|||
145764179|NCT02388295|525646918|FG002|Dose Escalation Week 2|Protocol Violation|0|||
145764180|NCT02388295|525646916|FG000|Dose Escalation Week 2|Determined not eligible|1|||
145764181|NCT02388295|525646917|FG001|Dose Escalation Week 2|Determined not eligible|1|||
145764182|NCT02388295|525646918|FG002|Dose Escalation Week 2|Determined not eligible|1|||
145764183|NCT02388295|525646916|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
145764184|NCT02388295|525646917|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
145764185|NCT02388295|525646918|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
145764186|NCT02076165|525646920|FG000|Overall Study|Lost to Follow-up|7|||
145764187|NCT02076165|525646921|FG001|Overall Study|Lost to Follow-up|5|||
145764188|NCT02076165|525646920|FG000|Overall Study|Refused follow-up assessment|1|||
145764189|NCT02076165|525646921|FG001|Overall Study|Refused follow-up assessment|1|||
145764190|NCT03804684|525646922|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
145764191|NCT03804684|525646923|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
145764192|NCT00486603|525646925|FG000|Overall Study|Withdrawal by Subject|1|||
145764193|NCT00486603|525646926|FG001|Overall Study|Withdrawal by Subject|0|||
145764194|NCT00486603|525646927|FG002|Overall Study|Withdrawal by Subject|0|||
145764195|NCT00486603|525646928|FG003|Overall Study|Withdrawal by Subject|0|||
145764196|NCT00486603|525646929|FG004|Overall Study|Withdrawal by Subject|0|||
145764197|NCT00486603|525646925|FG000|Overall Study|Physician Decision|0|||
145764198|NCT00486603|525646926|FG001|Overall Study|Physician Decision|1|||
145764199|NCT00486603|525646927|FG002|Overall Study|Physician Decision|0|||
145764200|NCT00486603|525646928|FG003|Overall Study|Physician Decision|0|||
145764201|NCT00486603|525646929|FG004|Overall Study|Physician Decision|0|||
145764202|NCT00763009|525646930|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
145764203|NCT01355289|525646931|FG000|Core Study|Adverse Event, Non-Fatal|1|||
145764204|NCT01355289|525646932|FG001|Core Study|Adverse Event, Non-Fatal|0|||
145764205|NCT01355289|525646933|FG002|Core Study|Adverse Event, Non-Fatal|0|||
145764206|NCT01355289|525646934|FG003|Core Study|Adverse Event, Non-Fatal|0|||
145764207|NCT01355289|525646935|FG004|Core Study|Adverse Event, Non-Fatal|0|||
145764208|NCT01355289|525646931|FG000|Core Study|Inadequate Therapeutic Effect|0|||
145764209|NCT01355289|525646932|FG001|Core Study|Inadequate Therapeutic Effect|0|||
145764210|NCT01355289|525646933|FG002|Core Study|Inadequate Therapeutic Effect|0|||
145764211|NCT01355289|525646934|FG003|Core Study|Inadequate Therapeutic Effect|1|||
145764212|NCT01355289|525646935|FG004|Core Study|Inadequate Therapeutic Effect|0|||
145764213|NCT01355289|525646931|FG000|Core Study|Other|0|||
145764214|NCT01355289|525646932|FG001|Core Study|Other|0|||
145764215|NCT01355289|525646933|FG002|Core Study|Other|0|||
145764216|NCT01355289|525646934|FG003|Core Study|Other|1|||
145764217|NCT01355289|525646935|FG004|Core Study|Other|0|||
145764218|NCT01355289|525646931|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
145764219|NCT01355289|525646932|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
145764220|NCT01355289|525646933|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
145764221|NCT01355289|525646934|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
145764222|NCT01355289|525646935|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
145764223|NCT01355289|525646931|FG000|Open Label Extension|Lost to Follow-up|0|||
145764224|NCT01355289|525646932|FG001|Open Label Extension|Lost to Follow-up|0|||
145764225|NCT01355289|525646933|FG002|Open Label Extension|Lost to Follow-up|0|||
145764226|NCT01355289|525646934|FG003|Open Label Extension|Lost to Follow-up|0|||
145764227|NCT01355289|525646935|FG004|Open Label Extension|Lost to Follow-up|1|||
145764228|NCT01355289|525646931|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
145764229|NCT01355289|525646932|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
145764230|NCT01355289|525646933|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
145764231|NCT01355289|525646934|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
145764232|NCT01355289|525646935|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
145764233|NCT01355289|525646931|FG000|Open Label Extension|Other|0|||
145764234|NCT01355289|525646932|FG001|Open Label Extension|Other|0|||
145764235|NCT01355289|525646933|FG002|Open Label Extension|Other|0|||
145764236|NCT01355289|525646934|FG003|Open Label Extension|Other|0|||
145764237|NCT01355289|525646935|FG004|Open Label Extension|Other|3|||
145764238|NCT02706938|525646938|FG000|First Period, 6 Weeks|Adverse Event|8|||
145764239|NCT02706938|525646939|FG001|First Period, 6 Weeks|Adverse Event|0|||
145764240|NCT02706938|525646938|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
145764241|NCT02706938|525646939|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
145764242|NCT02706938|525646938|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
145764243|NCT02706938|525646939|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
145764244|NCT02706938|525646938|FG000|Second Period, 6 Weeks|Adverse Event|0|||
145764245|NCT02706938|525646939|FG001|Second Period, 6 Weeks|Adverse Event|7|||
145764246|NCT02706938|525646938|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
145764247|NCT02706938|525646939|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
145764248|NCT03838484|525646945|FG000|Overall Study|Lost to Follow-up|0|||
145764249|NCT03838484|525646946|FG001|Overall Study|Lost to Follow-up|1|||
145764250|NCT03838484|525646947|FG002|Overall Study|Lost to Follow-up|0|||
145764251|NCT03838484|525646948|FG003|Overall Study|Lost to Follow-up|0|||
145764252|NCT00813995|525646949|FG000|Overall Study|Clinical adverse event|9|||
145277188|NCT00370396|523864746|FG001|Overall Study|Lost to Follow-up|1|||
145764253|NCT00813995|525646950|FG001|Overall Study|Clinical adverse event|3|||
145764254|NCT00813995|525646949|FG000|Overall Study|Laboratory adverse event|0|||
145764255|NCT00813995|525646950|FG001|Overall Study|Laboratory adverse event|2|||
145277189|NCT00370396|523864747|FG002|Overall Study|Lost to Follow-up|0|||
145277190|NCT04529499|523864748|FG000|Overall Study|Withdrawal by Subject|9|||
145277191|NCT04529499|523864749|FG001|Overall Study|Withdrawal by Subject|11|||
145277192|NCT04529499|523864748|FG000|Overall Study|Physician Decision|1|||
145277193|NCT04529499|523864749|FG001|Overall Study|Physician Decision|2|||
145277194|NCT04529499|523864748|FG000|Overall Study|Adverse Event|4|||
145277195|NCT04529499|523864749|FG001|Overall Study|Adverse Event|4|||
145277196|NCT04529499|523864748|FG000|Overall Study|Death|14|||
145277197|NCT04529499|523864749|FG001|Overall Study|Death|11|||
145277198|NCT04529499|523864748|FG000|Overall Study|Lost to Follow-up|1|||
145277199|NCT04529499|523864749|FG001|Overall Study|Lost to Follow-up|1|||
145277200|NCT04529499|523864748|FG000|Overall Study|Others|7|||
145277201|NCT04529499|523864749|FG001|Overall Study|Others|11|||
145277202|NCT02441179|523864751|FG000|Overall Study|Withdrawal by Subject|1|||
145277203|NCT02441179|523864752|FG001|Overall Study|Withdrawal by Subject|1|||
145277204|NCT02702271|523864753|FG000|Overall Study|Death|36|||
145277205|NCT02702271|523864754|FG001|Overall Study|Death|7|||
145277206|NCT02702271|523864753|FG000|Overall Study|Lost to Follow-up|12|||
145277207|NCT02702271|523864754|FG001|Overall Study|Lost to Follow-up|0|||
145277208|NCT02702271|523864753|FG000|Overall Study|Withdrawal by Subject|8|||
145277209|NCT02702271|523864754|FG001|Overall Study|Withdrawal by Subject|1|||
145277210|NCT02702271|523864753|FG000|Overall Study|Physician Decision|2|||
145277211|NCT02702271|523864754|FG001|Overall Study|Physician Decision|0|||
145277212|NCT02702271|523864753|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
145277213|NCT02702271|523864754|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
145277214|NCT01494649|523864755|FG000|Overall Study|Lost to Follow-up|0|||
145277215|NCT01494649|523864756|FG001|Overall Study|Lost to Follow-up|1|||
145277216|NCT03091400|523864757|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
145277217|NCT03091400|523864758|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
145277218|NCT03467971|523864759|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145277219|NCT03467971|523864760|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145277220|NCT01656967|523864761|FG000|Overall Study|faulty monitor|1|||
145277221|NCT01656967|523864762|FG001|Overall Study|faulty monitor|0|||
145277222|NCT01656967|523864761|FG000|Overall Study|unsuccessful ETT insertion|3|||
145277223|NCT01656967|523864762|FG001|Overall Study|unsuccessful ETT insertion|2|||
145277224|NCT00479765|523864763|FG000|Overall Study|study terminated|4|||
145277225|NCT05166512|523864764|FG000|Randomized|Lost to Follow-up|2|||
145277226|NCT05166512|523864765|FG001|Randomized|Lost to Follow-up|0|||
145277227|NCT05166512|523864764|FG000|Randomized|Withdrawal by Subject|1|||
145277228|NCT05166512|523864765|FG001|Randomized|Withdrawal by Subject|0|||
145277229|NCT05166512|523864764|FG000|Baseline Data Collection|Lost to Follow-up|0|||
145277230|NCT05166512|523864765|FG001|Baseline Data Collection|Lost to Follow-up|3|||
145277231|NCT05166512|523864764|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
145277232|NCT05166512|523864765|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
145277233|NCT05166512|523864764|FG000|Baseline Data Collection|Protocol Violation|2|||
145277234|NCT05166512|523864765|FG001|Baseline Data Collection|Protocol Violation|0|||
145277235|NCT05166512|523864764|FG000|4 Month Data Collection|Lost to Follow-up|1|||
145277236|NCT05166512|523864765|FG001|4 Month Data Collection|Lost to Follow-up|0|||
145277237|NCT05166512|523864764|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
145277238|NCT05166512|523864765|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
145277239|NCT05166512|523864764|FG000|12 Month Data Collection|Lost to Follow-up|3|||
145277240|NCT05166512|523864765|FG001|12 Month Data Collection|Lost to Follow-up|1|||
145277241|NCT05166512|523864764|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
145277242|NCT05166512|523864765|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
145277243|NCT00420849|523864766|FG000|Overall Study|Lack of Efficacy|154|||
145277244|NCT00420849|523864766|FG000|Overall Study|Adverse Event|107|||
145277245|NCT00420849|523864766|FG000|Overall Study|Withdrawal by Subject|28|||
145277246|NCT00420849|523864766|FG000|Overall Study|Death|18|||
145277247|NCT00420849|523864766|FG000|Overall Study|Other|14|||
145277248|NCT00420849|523864766|FG000|Overall Study|Transplant|8|||
145277249|NCT00420849|523864766|FG000|Overall Study|Protocol Violation|1|||
145277250|NCT00420849|523864766|FG000|Overall Study|Lost to Follow-up|1|||
145277251|NCT01345058|523864767|FG000|Overall Study|Withdrawal by Subject|1|||
145277252|NCT01345058|523864768|FG001|Overall Study|Withdrawal by Subject|0|||
145277253|NCT01345058|523864767|FG000|Overall Study|Participant Reported Increase in Events|1|||
145277254|NCT01345058|523864768|FG001|Overall Study|Participant Reported Increase in Events|0|||
145277255|NCT01345058|523864767|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
145277256|NCT01345058|523864768|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
145277257|NCT01345058|523864767|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
145277258|NCT01345058|523864768|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
145277259|NCT01345058|523864767|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
145277260|NCT01345058|523864768|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
145277261|NCT00000135|523864769|FG000|Overall Study|Death|27|||
145277262|NCT00000135|523864770|FG001|Overall Study|Death|14|||
145277263|NCT00944125|523864771|FG000|3 to 6 Months|Withdrawal by Subject|0|||
145277264|NCT00944125|523864772|FG001|3 to 6 Months|Withdrawal by Subject|2|||
145764256|NCT00813995|525646949|FG000|Overall Study|Lack of Efficacy|1|||
145764257|NCT00813995|525646950|FG001|Overall Study|Lack of Efficacy|0|||
145764258|NCT00813995|525646949|FG000|Overall Study|Lost to Follow-up|4|||
145277265|NCT00944125|523864771|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
145277266|NCT00944125|523864772|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
145764259|NCT00813995|525646950|FG001|Overall Study|Lost to Follow-up|2|||
145277267|NCT03125629|523864773|FG000|Overall Study|Withdrawal by Subject|2|||
145764260|NCT00813995|525646949|FG000|Overall Study|Other reason|2|||
145764261|NCT00813995|525646950|FG001|Overall Study|Other reason|2|||
145764262|NCT00813995|525646949|FG000|Overall Study|Protocol Violation|3|||
145764263|NCT00813995|525646950|FG001|Overall Study|Protocol Violation|2|||
145764264|NCT00813995|525646949|FG000|Overall Study|Subject moved|4|||
145764265|NCT00813995|525646950|FG001|Overall Study|Subject moved|0|||
145764266|NCT00813995|525646949|FG000|Overall Study|Withdrawal by Subject|0|||
145277268|NCT03125629|523864773|FG000|Overall Study|Equipment malfunction|1|||
145277269|NCT04816877|523864774|FG000|Overall Study|Withdrawal by Subject|1|||
145764267|NCT00813995|525646950|FG001|Overall Study|Withdrawal by Subject|5|||
145764268|NCT01614964|525646951|FG000|Overall Study|Withdrawal by Subject|2|||
145277270|NCT04816877|523864775|FG001|Overall Study|Withdrawal by Subject|0|||
145277271|NCT02989610|523864776|FG000|Overall Study|Withdrawal by Subject|20|||
145277272|NCT02989610|523864776|FG000|Overall Study|Departure of PI from Site|8|||
145277273|NCT02989610|523864776|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
145277274|NCT02989610|523864776|FG000|Overall Study|Lost to Follow-up|3|||
145277275|NCT02989610|523864776|FG000|Overall Study|Death|3|||
145277276|NCT02989610|523864776|FG000|Overall Study|System Explant|3|||
145277277|NCT02989610|523864776|FG000|Overall Study|Subject Non-Compliance|2|||
145277278|NCT02989610|523864776|FG000|Overall Study|System Revision|2|||
145277279|NCT02989610|523864776|FG000|Overall Study|PI Left, Study Closing|1|||
145277280|NCT02989610|523864776|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
145277281|NCT02989610|523864776|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
145277282|NCT04508621|523864779|FG000|Overall Study|Adverse Event|39|||
145277283|NCT04508621|523864780|FG001|Overall Study|Adverse Event|16|||
145277284|NCT04508621|523864779|FG000|Overall Study|Lack of Efficacy|2|||
145277285|NCT04508621|523864780|FG001|Overall Study|Lack of Efficacy|8|||
145277286|NCT04508621|523864779|FG000|Overall Study|Physician Decision|0|||
145277287|NCT04508621|523864780|FG001|Overall Study|Physician Decision|1|||
145277288|NCT04508621|523864779|FG000|Overall Study|Withdrawal by Subject|10|||
145764269|NCT01614964|525646952|FG001|Overall Study|Withdrawal by Subject|0|||
145764270|NCT01614964|525646951|FG000|Overall Study|Lost to Follow-up|3|||
145764271|NCT01614964|525646952|FG001|Overall Study|Lost to Follow-up|0|||
145764272|NCT00860470|525646953|FG000|Overall Study|Death|6|||
145764273|NCT00860470|525646954|FG001|Overall Study|Death|10|||
145764274|NCT00860470|525646953|FG000|Overall Study|Moved away|8|||
145764275|NCT00860470|525646954|FG001|Overall Study|Moved away|10|||
145764276|NCT00860470|525646953|FG000|Overall Study|Lost to Follow-up|34|||
145764277|NCT00860470|525646954|FG001|Overall Study|Lost to Follow-up|39|||
145764278|NCT00888238|525646956|FG000|Washout Period After Period 2|Adverse Event|0|||
145764279|NCT00888238|525646957|FG001|Washout Period After Period 2|Adverse Event|0|||
145764280|NCT00888238|525646958|FG002|Washout Period After Period 2|Adverse Event|1|||
145764281|NCT02700984|525646959|FG000|Overall Study|Death|2|||
145764282|NCT02700984|525646960|FG001|Overall Study|Death|1|||
145764283|NCT02700984|525646959|FG000|Overall Study|Lost to Follow-up|2|||
145764284|NCT02700984|525646960|FG001|Overall Study|Lost to Follow-up|1|||
145764285|NCT02700984|525646959|FG000|Overall Study|Physician Decision|0|||
145764286|NCT02700984|525646960|FG001|Overall Study|Physician Decision|1|||
145764287|NCT02700984|525646959|FG000|Overall Study|Withdrawal by Subject|8|||
145764288|NCT02700984|525646960|FG001|Overall Study|Withdrawal by Subject|9|||
145764289|NCT02700984|525646959|FG000|Overall Study|Reason not specified|3|||
145764290|NCT02700984|525646960|FG001|Overall Study|Reason not specified|2|||
145277289|NCT04508621|523864780|FG001|Overall Study|Withdrawal by Subject|14|||
145277290|NCT04508621|523864779|FG000|Overall Study|Lost to Follow-up|12|||
145277291|NCT04508621|523864780|FG001|Overall Study|Lost to Follow-up|9|||
145277292|NCT04508621|523864779|FG000|Overall Study|COVID-19 related crisis|3|||
145277293|NCT04508621|523864780|FG001|Overall Study|COVID-19 related crisis|0|||
145277294|NCT04508621|523864779|FG000|Overall Study|Subject non-compliance|1|||
145277295|NCT04508621|523864780|FG001|Overall Study|Subject non-compliance|0|||
145277296|NCT04355767|523864781|FG000|Overall Study|Withdrawal by Subject|2|||
145277297|NCT04355767|523864782|FG001|Overall Study|Withdrawal by Subject|2|||
145277298|NCT04355767|523864781|FG000|Overall Study|Death|5|||
145277299|NCT04355767|523864782|FG001|Overall Study|Death|1|||
145277300|NCT01999322|523864783|FG000|Overall Study|Adverse Event|1|||
145277301|NCT01999322|523864784|FG001|Overall Study|Adverse Event|0|||
145277302|NCT00434148|523864785|FG000|Overall Study|Adverse Event|18|||
145277303|NCT00434148|523864786|FG001|Overall Study|Adverse Event|18|||
145277304|NCT00434148|523864785|FG000|Overall Study|Lack of Efficacy|25|||
145277305|NCT00434148|523864786|FG001|Overall Study|Lack of Efficacy|28|||
145277306|NCT00434148|523864785|FG000|Overall Study|Withdrawal by Subject|15|||
145277307|NCT00434148|523864786|FG001|Overall Study|Withdrawal by Subject|15|||
145277308|NCT00434148|523864785|FG000|Overall Study|Protocol Violation|4|||
145277309|NCT00434148|523864786|FG001|Overall Study|Protocol Violation|0|||
145277310|NCT00434148|523864785|FG000|Overall Study|Administrative problems|6|||
145277311|NCT00434148|523864786|FG001|Overall Study|Administrative problems|10|||
145277312|NCT00434148|523864785|FG000|Overall Study|Lost to Follow-up|0|||
145277313|NCT00434148|523864786|FG001|Overall Study|Lost to Follow-up|1|||
145277314|NCT00434148|523864785|FG000|Overall Study|Condition no longer requires study drug|1|||
145402930|NCT00706797|524332556|FG001|Overall Study|Adverse Event|3|||
145764291|NCT01032629|525646962|FG000|Overall Study|Closed Site|21|||
145764292|NCT01032629|525646963|FG001|Overall Study|Closed Site|18|||
145764293|NCT01032629|525646964|FG002|Overall Study|Closed Site|16|||
145764294|NCT01032629|525646962|FG000|Overall Study|Withdrawal by Subject|50|||
145277315|NCT00434148|523864786|FG001|Overall Study|Condition no longer requires study drug|0|||
145277316|NCT00434148|523864785|FG000|Overall Study|Abnormal test procedure result|0|||
145277317|NCT00434148|523864786|FG001|Overall Study|Abnormal test procedure result|1|||
145277318|NCT01861717|523864788|FG000|Overall Study|Lost to Follow-up|1|||
145764295|NCT01032629|525646963|FG001|Overall Study|Withdrawal by Subject|36|||
145764296|NCT01032629|525646964|FG002|Overall Study|Withdrawal by Subject|35|||
145277319|NCT01861717|523864788|FG000|Overall Study|Withdrawal by Subject|1|||
145764297|NCT01032629|525646962|FG000|Overall Study|Lost to Follow-up|74|||
145764298|NCT01032629|525646963|FG001|Overall Study|Lost to Follow-up|47|||
145764299|NCT01032629|525646964|FG002|Overall Study|Lost to Follow-up|37|||
145764300|NCT02868892|525646965|FG000|Overall Study|Investigator left site and no follow-up|6|||
145764301|NCT00868790|525646967|FG000|Period 1|Adverse Event|1|||
145764302|NCT00868790|525646968|FG001|Period 1|Adverse Event|0|||
145764303|NCT00868790|525646969|FG002|Period 1|Adverse Event|0|||
145764304|NCT00868790|525646970|FG003|Period 1|Adverse Event|0|||
145764305|NCT00868790|525646971|FG004|Period 1|Adverse Event|0|||
145764306|NCT00868790|525646972|FG005|Period 1|Adverse Event|0|||
145764307|NCT00868790|525646973|FG006|Period 1|Adverse Event|0|||
145764308|NCT00868790|525646974|FG007|Period 1|Adverse Event|3|||
145764309|NCT00868790|525646975|FG008|Period 1|Adverse Event|1|||
145764310|NCT00868790|525646976|FG009|Period 1|Adverse Event|0|||
145764311|NCT00868790|525646977|FG010|Period 1|Adverse Event|0|||
145764312|NCT00868790|525646978|FG011|Period 1|Adverse Event|0|||
145764313|NCT00868790|525646979|FG012|Period 1|Adverse Event|0|||
145764314|NCT00868790|525646980|FG013|Period 1|Adverse Event|1|||
145764315|NCT00868790|525646967|FG000|Period 1|Protocol Violation|1|||
145764316|NCT00868790|525646968|FG001|Period 1|Protocol Violation|0|||
145764317|NCT00868790|525646969|FG002|Period 1|Protocol Violation|0|||
145764318|NCT00868790|525646970|FG003|Period 1|Protocol Violation|0|||
145764319|NCT00868790|525646971|FG004|Period 1|Protocol Violation|0|||
145764320|NCT00868790|525646972|FG005|Period 1|Protocol Violation|0|||
145764321|NCT00868790|525646973|FG006|Period 1|Protocol Violation|0|||
145764322|NCT00868790|525646974|FG007|Period 1|Protocol Violation|0|||
145764323|NCT00868790|525646975|FG008|Period 1|Protocol Violation|0|||
145764324|NCT00868790|525646976|FG009|Period 1|Protocol Violation|0|||
145764325|NCT00868790|525646977|FG010|Period 1|Protocol Violation|0|||
145764326|NCT00868790|525646978|FG011|Period 1|Protocol Violation|0|||
145764327|NCT00868790|525646979|FG012|Period 1|Protocol Violation|0|||
145764328|NCT00868790|525646980|FG013|Period 1|Protocol Violation|0|||
145764329|NCT00868790|525646967|FG000|Period 1|Withdrawal by Subject|0|||
145764330|NCT00868790|525646968|FG001|Period 1|Withdrawal by Subject|1|||
145764331|NCT00868790|525646969|FG002|Period 1|Withdrawal by Subject|0|||
145764332|NCT00868790|525646970|FG003|Period 1|Withdrawal by Subject|0|||
145764333|NCT00868790|525646971|FG004|Period 1|Withdrawal by Subject|0|||
145764334|NCT00868790|525646972|FG005|Period 1|Withdrawal by Subject|0|||
145764335|NCT00868790|525646973|FG006|Period 1|Withdrawal by Subject|0|||
145764336|NCT00868790|525646974|FG007|Period 1|Withdrawal by Subject|0|||
145764337|NCT00868790|525646975|FG008|Period 1|Withdrawal by Subject|0|||
145764338|NCT00868790|525646976|FG009|Period 1|Withdrawal by Subject|0|||
145764339|NCT00868790|525646977|FG010|Period 1|Withdrawal by Subject|0|||
145764340|NCT00868790|525646978|FG011|Period 1|Withdrawal by Subject|0|||
145764341|NCT00868790|525646979|FG012|Period 1|Withdrawal by Subject|0|||
145764342|NCT00868790|525646980|FG013|Period 1|Withdrawal by Subject|1|||
145764343|NCT00868790|525646967|FG000|Period 1|Abnormal Triglycerides|0|||
145764344|NCT00868790|525646968|FG001|Period 1|Abnormal Triglycerides|0|||
145764345|NCT00868790|525646969|FG002|Period 1|Abnormal Triglycerides|0|||
145764346|NCT00868790|525646970|FG003|Period 1|Abnormal Triglycerides|0|||
145764347|NCT00868790|525646971|FG004|Period 1|Abnormal Triglycerides|1|||
145764348|NCT00868790|525646972|FG005|Period 1|Abnormal Triglycerides|0|||
145764349|NCT00868790|525646973|FG006|Period 1|Abnormal Triglycerides|0|||
145764350|NCT00868790|525646974|FG007|Period 1|Abnormal Triglycerides|0|||
145277320|NCT00833976|523867076|FG000|Overall Study|Withdrawal by Subject|5|||
145277321|NCT00833976|523867076|FG000|Overall Study|Lost to Follow-up|4|||
145764351|NCT00868790|525646975|FG008|Period 1|Abnormal Triglycerides|0|||
145764352|NCT00868790|525646976|FG009|Period 1|Abnormal Triglycerides|0|||
145764353|NCT00868790|525646977|FG010|Period 1|Abnormal Triglycerides|0|||
145764354|NCT00868790|525646978|FG011|Period 1|Abnormal Triglycerides|0|||
145764355|NCT00868790|525646979|FG012|Period 1|Abnormal Triglycerides|0|||
145764356|NCT00868790|525646980|FG013|Period 1|Abnormal Triglycerides|0|||
145764357|NCT00868790|525646967|FG000|Period 1|Lost to Follow-up|0|||
145764358|NCT00868790|525646968|FG001|Period 1|Lost to Follow-up|0|||
145764359|NCT00868790|525646969|FG002|Period 1|Lost to Follow-up|0|||
145764360|NCT00868790|525646970|FG003|Period 1|Lost to Follow-up|0|||
145764361|NCT00868790|525646971|FG004|Period 1|Lost to Follow-up|0|||
145764362|NCT00868790|525646972|FG005|Period 1|Lost to Follow-up|1|||
145764363|NCT00868790|525646973|FG006|Period 1|Lost to Follow-up|0|||
145764364|NCT00868790|525646974|FG007|Period 1|Lost to Follow-up|0|||
145764365|NCT00868790|525646975|FG008|Period 1|Lost to Follow-up|0|||
145764366|NCT00868790|525646976|FG009|Period 1|Lost to Follow-up|0|||
145764367|NCT00868790|525646977|FG010|Period 1|Lost to Follow-up|0|||
145764368|NCT00868790|525646978|FG011|Period 1|Lost to Follow-up|0|||
145764369|NCT00868790|525646979|FG012|Period 1|Lost to Follow-up|0|||
145764370|NCT00868790|525646980|FG013|Period 1|Lost to Follow-up|0|||
145764371|NCT00868790|525646967|FG000|Period 2|Adverse Event|0|||
145764372|NCT00868790|525646968|FG001|Period 2|Adverse Event|0|||
145764373|NCT00868790|525646969|FG002|Period 2|Adverse Event|0|||
145764374|NCT00868790|525646970|FG003|Period 2|Adverse Event|0|||
145764375|NCT00868790|525646971|FG004|Period 2|Adverse Event|0|||
145764376|NCT00868790|525646972|FG005|Period 2|Adverse Event|0|||
145764377|NCT00868790|525646973|FG006|Period 2|Adverse Event|0|||
145764378|NCT00868790|525646974|FG007|Period 2|Adverse Event|0|||
145764379|NCT00868790|525646975|FG008|Period 2|Adverse Event|1|||
145764380|NCT00868790|525646976|FG009|Period 2|Adverse Event|0|||
145764381|NCT00868790|525646977|FG010|Period 2|Adverse Event|0|||
145764382|NCT00868790|525646978|FG011|Period 2|Adverse Event|0|||
145764383|NCT00868790|525646979|FG012|Period 2|Adverse Event|0|||
145764384|NCT00868790|525646980|FG013|Period 2|Adverse Event|0|||
145764385|NCT00868790|525646967|FG000|Period 2|Lost to Follow-up|0|||
145764386|NCT00868790|525646968|FG001|Period 2|Lost to Follow-up|1|||
145764387|NCT00868790|525646969|FG002|Period 2|Lost to Follow-up|0|||
145764388|NCT00868790|525646970|FG003|Period 2|Lost to Follow-up|0|||
145764389|NCT00868790|525646971|FG004|Period 2|Lost to Follow-up|0|||
145764390|NCT00868790|525646972|FG005|Period 2|Lost to Follow-up|1|||
145764391|NCT00868790|525646973|FG006|Period 2|Lost to Follow-up|0|||
145764392|NCT00868790|525646974|FG007|Period 2|Lost to Follow-up|0|||
145764393|NCT00868790|525646975|FG008|Period 2|Lost to Follow-up|0|||
145764394|NCT00868790|525646976|FG009|Period 2|Lost to Follow-up|0|||
145764395|NCT00868790|525646977|FG010|Period 2|Lost to Follow-up|0|||
145764396|NCT00868790|525646978|FG011|Period 2|Lost to Follow-up|0|||
145764397|NCT00868790|525646979|FG012|Period 2|Lost to Follow-up|0|||
145764398|NCT00868790|525646980|FG013|Period 2|Lost to Follow-up|0|||
145764399|NCT00868790|525646967|FG000|Period 2|Withdrawal by Subject|0|||
145764400|NCT00868790|525646968|FG001|Period 2|Withdrawal by Subject|0|||
145764401|NCT00868790|525646969|FG002|Period 2|Withdrawal by Subject|0|||
145764402|NCT00868790|525646970|FG003|Period 2|Withdrawal by Subject|0|||
145764403|NCT00868790|525646971|FG004|Period 2|Withdrawal by Subject|0|||
145764404|NCT00868790|525646972|FG005|Period 2|Withdrawal by Subject|0|||
145764405|NCT00868790|525646973|FG006|Period 2|Withdrawal by Subject|0|||
145764406|NCT00868790|525646974|FG007|Period 2|Withdrawal by Subject|0|||
145764407|NCT00868790|525646975|FG008|Period 2|Withdrawal by Subject|1|||
145764408|NCT00868790|525646976|FG009|Period 2|Withdrawal by Subject|0|||
145764409|NCT00868790|525646977|FG010|Period 2|Withdrawal by Subject|0|||
145764410|NCT00868790|525646978|FG011|Period 2|Withdrawal by Subject|0|||
145764411|NCT00868790|525646979|FG012|Period 2|Withdrawal by Subject|0|||
145764412|NCT00868790|525646980|FG013|Period 2|Withdrawal by Subject|1|||
145764413|NCT00868790|525646967|FG000|Period 3|Adverse Event|0|||
145764414|NCT00868790|525646968|FG001|Period 3|Adverse Event|0|||
145764415|NCT00868790|525646969|FG002|Period 3|Adverse Event|0|||
145764416|NCT00868790|525646970|FG003|Period 3|Adverse Event|0|||
145764417|NCT00868790|525646971|FG004|Period 3|Adverse Event|0|||
145764418|NCT00868790|525646972|FG005|Period 3|Adverse Event|0|||
145764419|NCT00868790|525646973|FG006|Period 3|Adverse Event|0|||
145764420|NCT00868790|525646974|FG007|Period 3|Adverse Event|0|||
145764421|NCT00868790|525646975|FG008|Period 3|Adverse Event|0|||
145764422|NCT00868790|525646976|FG009|Period 3|Adverse Event|1|||
145764423|NCT00868790|525646977|FG010|Period 3|Adverse Event|0|||
145764424|NCT00868790|525646978|FG011|Period 3|Adverse Event|0|||
145764425|NCT00868790|525646979|FG012|Period 3|Adverse Event|0|||
145764426|NCT00868790|525646980|FG013|Period 3|Adverse Event|0|||
145277322|NCT00833976|523867076|FG000|Overall Study|Did not meet eligibility criteria|41|||
145764427|NCT00868790|525646967|FG000|Period 3|Protocol Violation|0|||
145764428|NCT00868790|525646968|FG001|Period 3|Protocol Violation|0|||
145277323|NCT00833976|523867076|FG000|Overall Study|Physician Decision|1|||
145277324|NCT01142466|523867080|FG000|Overall Study|Adverse Event|2|||
145764429|NCT00868790|525646969|FG002|Period 3|Protocol Violation|0|||
145764430|NCT00868790|525646970|FG003|Period 3|Protocol Violation|0|||
145764431|NCT00868790|525646971|FG004|Period 3|Protocol Violation|0|||
145764432|NCT00868790|525646972|FG005|Period 3|Protocol Violation|0|||
145764433|NCT00868790|525646973|FG006|Period 3|Protocol Violation|0|||
145277325|NCT01142466|523867081|FG001|Overall Study|Adverse Event|1|||
145764434|NCT00868790|525646974|FG007|Period 3|Protocol Violation|0|||
145764435|NCT00868790|525646975|FG008|Period 3|Protocol Violation|0|||
145764436|NCT00868790|525646976|FG009|Period 3|Protocol Violation|0|||
145764437|NCT00868790|525646977|FG010|Period 3|Protocol Violation|1|||
145764438|NCT00868790|525646978|FG011|Period 3|Protocol Violation|0|||
145764439|NCT00868790|525646979|FG012|Period 3|Protocol Violation|0|||
145764440|NCT00868790|525646980|FG013|Period 3|Protocol Violation|0|||
145764441|NCT00868790|525646967|FG000|Period 3|Study Terminated by Sponsor|0|||
145764442|NCT00868790|525646968|FG001|Period 3|Study Terminated by Sponsor|0|||
145764443|NCT00868790|525646969|FG002|Period 3|Study Terminated by Sponsor|0|||
145764444|NCT00868790|525646970|FG003|Period 3|Study Terminated by Sponsor|1|||
145764445|NCT00868790|525646971|FG004|Period 3|Study Terminated by Sponsor|0|||
145764446|NCT00868790|525646972|FG005|Period 3|Study Terminated by Sponsor|0|||
145764447|NCT00868790|525646973|FG006|Period 3|Study Terminated by Sponsor|0|||
145764448|NCT00868790|525646974|FG007|Period 3|Study Terminated by Sponsor|0|||
145764449|NCT00868790|525646975|FG008|Period 3|Study Terminated by Sponsor|0|||
145764450|NCT00868790|525646976|FG009|Period 3|Study Terminated by Sponsor|0|||
145764451|NCT00868790|525646977|FG010|Period 3|Study Terminated by Sponsor|0|||
145764452|NCT00868790|525646978|FG011|Period 3|Study Terminated by Sponsor|0|||
145764453|NCT00868790|525646979|FG012|Period 3|Study Terminated by Sponsor|0|||
145764454|NCT00868790|525646980|FG013|Period 3|Study Terminated by Sponsor|0|||
145764455|NCT00868790|525646967|FG000|Period 4|Adverse Event|0|||
145764456|NCT00868790|525646968|FG001|Period 4|Adverse Event|0|||
145764457|NCT00868790|525646969|FG002|Period 4|Adverse Event|0|||
145764458|NCT00868790|525646970|FG003|Period 4|Adverse Event|0|||
145764459|NCT00868790|525646971|FG004|Period 4|Adverse Event|0|||
145764460|NCT00868790|525646972|FG005|Period 4|Adverse Event|0|||
145764461|NCT00868790|525646973|FG006|Period 4|Adverse Event|0|||
145764462|NCT00868790|525646974|FG007|Period 4|Adverse Event|1|||
145764463|NCT00868790|525646975|FG008|Period 4|Adverse Event|0|||
145764464|NCT00868790|525646976|FG009|Period 4|Adverse Event|0|||
145764465|NCT00868790|525646977|FG010|Period 4|Adverse Event|1|||
145764466|NCT00868790|525646978|FG011|Period 4|Adverse Event|0|||
145764467|NCT00868790|525646979|FG012|Period 4|Adverse Event|1|||
145764468|NCT00868790|525646980|FG013|Period 4|Adverse Event|0|||
145764469|NCT00868790|525646967|FG000|Period 4|Lost to Follow-up|0|||
145764470|NCT00868790|525646968|FG001|Period 4|Lost to Follow-up|0|||
145764471|NCT00868790|525646969|FG002|Period 4|Lost to Follow-up|0|||
145764472|NCT00868790|525646970|FG003|Period 4|Lost to Follow-up|0|||
145764473|NCT00868790|525646971|FG004|Period 4|Lost to Follow-up|0|||
145764474|NCT00868790|525646972|FG005|Period 4|Lost to Follow-up|0|||
145764475|NCT00868790|525646973|FG006|Period 4|Lost to Follow-up|0|||
145764476|NCT00868790|525646974|FG007|Period 4|Lost to Follow-up|1|||
145764477|NCT00868790|525646975|FG008|Period 4|Lost to Follow-up|0|||
145764478|NCT00868790|525646976|FG009|Period 4|Lost to Follow-up|0|||
145764479|NCT00868790|525646977|FG010|Period 4|Lost to Follow-up|0|||
145764480|NCT00868790|525646978|FG011|Period 4|Lost to Follow-up|0|||
145764481|NCT00868790|525646979|FG012|Period 4|Lost to Follow-up|0|||
145764482|NCT00868790|525646980|FG013|Period 4|Lost to Follow-up|0|||
145764483|NCT00868790|525646967|FG000|Period 4|Study Terminated by Sponsor|2|||
145764484|NCT00868790|525646968|FG001|Period 4|Study Terminated by Sponsor|0|||
145764485|NCT00868790|525646969|FG002|Period 4|Study Terminated by Sponsor|0|||
145764486|NCT00868790|525646970|FG003|Period 4|Study Terminated by Sponsor|0|||
145764487|NCT00868790|525646971|FG004|Period 4|Study Terminated by Sponsor|0|||
145764488|NCT00868790|525646972|FG005|Period 4|Study Terminated by Sponsor|0|||
145764489|NCT00868790|525646973|FG006|Period 4|Study Terminated by Sponsor|0|||
145764490|NCT00868790|525646974|FG007|Period 4|Study Terminated by Sponsor|1|||
145764491|NCT00868790|525646975|FG008|Period 4|Study Terminated by Sponsor|2|||
145764492|NCT00868790|525646976|FG009|Period 4|Study Terminated by Sponsor|0|||
145764493|NCT00868790|525646977|FG010|Period 4|Study Terminated by Sponsor|2|||
145764494|NCT00868790|525646978|FG011|Period 4|Study Terminated by Sponsor|1|||
145764495|NCT00868790|525646979|FG012|Period 4|Study Terminated by Sponsor|0|||
145764496|NCT00868790|525646980|FG013|Period 4|Study Terminated by Sponsor|1|||
145764497|NCT00868790|525646967|FG000|Period 4|Abnormal ALT/AST|0|||
145764498|NCT00868790|525646968|FG001|Period 4|Abnormal ALT/AST|0|||
145764499|NCT00868790|525646969|FG002|Period 4|Abnormal ALT/AST|1|||
145764500|NCT00868790|525646970|FG003|Period 4|Abnormal ALT/AST|0|||
145764501|NCT00868790|525646971|FG004|Period 4|Abnormal ALT/AST|0|||
145764502|NCT00868790|525646972|FG005|Period 4|Abnormal ALT/AST|0|||
145764503|NCT00868790|525646973|FG006|Period 4|Abnormal ALT/AST|0|||
145764504|NCT00868790|525646974|FG007|Period 4|Abnormal ALT/AST|0|||
145764505|NCT00868790|525646975|FG008|Period 4|Abnormal ALT/AST|0|||
145764506|NCT00868790|525646976|FG009|Period 4|Abnormal ALT/AST|0|||
145764507|NCT00868790|525646977|FG010|Period 4|Abnormal ALT/AST|0|||
145764508|NCT00868790|525646978|FG011|Period 4|Abnormal ALT/AST|0|||
145764509|NCT00868790|525646979|FG012|Period 4|Abnormal ALT/AST|0|||
145764510|NCT00868790|525646980|FG013|Period 4|Abnormal ALT/AST|0|||
145764511|NCT00868790|525646967|FG000|Post-study|Withdrawal by Subject|0|||
145764512|NCT00868790|525646968|FG001|Post-study|Withdrawal by Subject|0|||
145764513|NCT00868790|525646969|FG002|Post-study|Withdrawal by Subject|0|||
145764514|NCT00868790|525646970|FG003|Post-study|Withdrawal by Subject|0|||
145764515|NCT00868790|525646971|FG004|Post-study|Withdrawal by Subject|1|||
145764516|NCT00868790|525646972|FG005|Post-study|Withdrawal by Subject|0|||
145764517|NCT00868790|525646973|FG006|Post-study|Withdrawal by Subject|0|||
145764518|NCT00868790|525646974|FG007|Post-study|Withdrawal by Subject|0|||
145764519|NCT00868790|525646975|FG008|Post-study|Withdrawal by Subject|0|||
145764520|NCT00868790|525646976|FG009|Post-study|Withdrawal by Subject|0|||
145764521|NCT00868790|525646977|FG010|Post-study|Withdrawal by Subject|0|||
145764522|NCT00868790|525646978|FG011|Post-study|Withdrawal by Subject|0|||
145764523|NCT00868790|525646979|FG012|Post-study|Withdrawal by Subject|0|||
145764524|NCT00868790|525646980|FG013|Post-study|Withdrawal by Subject|0|||
145764525|NCT00868790|525646967|FG000|Post-study|Excluded Medication|0|||
145764526|NCT00868790|525646968|FG001|Post-study|Excluded Medication|0|||
145607914|NCT01852058|525079286|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145764527|NCT00868790|525646969|FG002|Post-study|Excluded Medication|0|||
145764528|NCT00868790|525646970|FG003|Post-study|Excluded Medication|0|||
145764529|NCT00868790|525646971|FG004|Post-study|Excluded Medication|0|||
145764530|NCT00868790|525646972|FG005|Post-study|Excluded Medication|0|||
145764531|NCT00868790|525646973|FG006|Post-study|Excluded Medication|0|||
145764532|NCT00868790|525646974|FG007|Post-study|Excluded Medication|2|||
145764533|NCT00868790|525646975|FG008|Post-study|Excluded Medication|0|||
145764534|NCT00868790|525646976|FG009|Post-study|Excluded Medication|1|||
145764535|NCT00868790|525646977|FG010|Post-study|Excluded Medication|0|||
145277326|NCT01142466|523867080|FG000|Overall Study|Withdrawal by Subject|1|||
145277327|NCT01142466|523867081|FG001|Overall Study|Withdrawal by Subject|1|||
145277328|NCT02414854|523867086|FG000|Overall Study|Adverse Event|9|||
145764536|NCT00868790|525646978|FG011|Post-study|Excluded Medication|0|||
145764537|NCT00868790|525646979|FG012|Post-study|Excluded Medication|0|||
145764538|NCT00868790|525646980|FG013|Post-study|Excluded Medication|0|||
145764539|NCT01763164|525646981|FG000|Treatment Phase|Participant/Guardian decision|26|||
145764540|NCT01763164|525646982|FG001|Treatment Phase|Participant/Guardian decision|14|||
145764541|NCT01763164|525646981|FG000|Treatment Phase|Protocol Violation|1|||
145764542|NCT01763164|525646982|FG001|Treatment Phase|Protocol Violation|1|||
145764543|NCT01763164|525646981|FG000|Treatment Phase|Progressive Disease|142|||
145764544|NCT01763164|525646982|FG001|Treatment Phase|Progressive Disease|76|||
145764545|NCT01763164|525646981|FG000|Treatment Phase|Physician Decision|24|||
145764546|NCT01763164|525646982|FG001|Treatment Phase|Physician Decision|13|||
145764547|NCT01763164|525646981|FG000|Treatment Phase|Death|10|||
145764548|NCT01763164|525646982|FG001|Treatment Phase|Death|1|||
145764549|NCT01763164|525646981|FG000|Treatment Phase|Adverse Event|66|||
145764550|NCT01763164|525646982|FG001|Treatment Phase|Adverse Event|8|||
145764551|NCT01763164|525646981|FG000|Treatment Phase|Randomized but not Treated|0|||
145764552|NCT01763164|525646982|FG001|Treatment Phase|Randomized but not Treated|19|||
145764553|NCT01763164|525646981|FG000|Treatment Phase|Other|0|||
145764554|NCT01763164|525646982|FG001|Treatment Phase|Other|1|||
145764555|NCT01763164|525646981|FG000|Follow up Phase|New therapy for study indication|12|||
145764556|NCT01763164|525646982|FG001|Follow up Phase|New therapy for study indication|3|||
145764557|NCT01763164|525646981|FG000|Follow up Phase|Death|21|||
145764558|NCT01763164|525646982|FG001|Follow up Phase|Death|4|||
145764559|NCT01763164|525646981|FG000|Follow up Phase|Subject/guardian decision|9|||
145764560|NCT01763164|525646982|FG001|Follow up Phase|Subject/guardian decision|2|||
145764561|NCT01763164|525646981|FG000|Follow up Phase|Progressive disease|127|||
145277329|NCT02414854|523867087|FG001|Overall Study|Adverse Event|7|||
145277330|NCT02414854|523867088|FG002|Overall Study|Adverse Event|1|||
145277331|NCT02414854|523867089|FG003|Overall Study|Adverse Event|12|||
145277332|NCT02414854|523867086|FG000|Overall Study|Poor compliance to protocol|1|||
145277333|NCT02414854|523867087|FG001|Overall Study|Poor compliance to protocol|1|||
145277334|NCT02414854|523867088|FG002|Overall Study|Poor compliance to protocol|2|||
145277335|NCT02414854|523867089|FG003|Overall Study|Poor compliance to protocol|2|||
145277336|NCT02414854|523867086|FG000|Overall Study|Other than specified above|12|||
145277337|NCT02414854|523867087|FG001|Overall Study|Other than specified above|37|||
145277338|NCT02414854|523867088|FG002|Overall Study|Other than specified above|17|||
145277339|NCT02414854|523867089|FG003|Overall Study|Other than specified above|37|||
145277340|NCT03724916|523867090|FG000|Overall Study|Withdrawal by Subject|0|||
145277341|NCT03724916|523867091|FG001|Overall Study|Withdrawal by Subject|1|||
145277342|NCT03724916|523867092|FG002|Overall Study|Withdrawal by Subject|1|||
145277343|NCT03724916|523867093|FG003|Overall Study|Withdrawal by Subject|2|||
145277344|NCT03724916|523867090|FG000|Overall Study|Randomized but not Treated|1|||
145277345|NCT03724916|523867091|FG001|Overall Study|Randomized but not Treated|0|||
145277346|NCT03724916|523867092|FG002|Overall Study|Randomized but not Treated|0|||
145277347|NCT03724916|523867093|FG003|Overall Study|Randomized but not Treated|0|||
145277348|NCT04575038|523867094|FG000|Overall Study|Withdrawal by Subject|1|||
145277349|NCT04575038|523867095|FG001|Overall Study|Withdrawal by Subject|1|||
145277350|NCT01355523|523867096|FG000|Overall Study|Withdrawal by Subject|1|||
145277351|NCT01355523|523867097|FG001|Overall Study|Withdrawal by Subject|4|||
145277352|NCT01355523|523867096|FG000|Overall Study|Lost to Follow-up|0|||
145277353|NCT01355523|523867097|FG001|Overall Study|Lost to Follow-up|2|||
145764562|NCT01763164|525646982|FG001|Follow up Phase|Progressive disease|62|||
145277354|NCT01355523|523867096|FG000|Overall Study|Protocol Violation|0|||
145277355|NCT01355523|523867097|FG001|Overall Study|Protocol Violation|2|||
145607915|NCT01852058|525079287|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
145764563|NCT01763164|525646981|FG000|Follow up Phase|Physician Decision|10|||
145277356|NCT01355523|523867096|FG000|Overall Study|Adverse Event|0|||
145277357|NCT01355523|523867097|FG001|Overall Study|Adverse Event|2|||
145764564|NCT01763164|525646982|FG001|Follow up Phase|Physician Decision|3|||
145277358|NCT01272193|523867102|FG000|Overall Study|Adverse Event|1|||
145277359|NCT01272193|523867103|FG001|Overall Study|Adverse Event|1|||
145277360|NCT01272193|523867102|FG000|Overall Study|Lack of Efficacy|0|||
145533428|NCT00875979|524813449|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
145764565|NCT01763164|525646981|FG000|Follow up Phase|Lost to Follow-up|1|||
145764566|NCT01763164|525646982|FG001|Follow up Phase|Lost to Follow-up|0|||
145764567|NCT01763164|525646981|FG000|Follow up Phase|Adverse Event|17|||
145764568|NCT01763164|525646982|FG001|Follow up Phase|Adverse Event|1|||
145764569|NCT01264939|525646983|FG000|Overall Study|Adverse Event|1|||
145764570|NCT01264939|525646984|FG001|Overall Study|Adverse Event|3|||
145764571|NCT01264939|525646983|FG000|Overall Study|Lost to Follow-up|0|||
145764572|NCT01264939|525646984|FG001|Overall Study|Lost to Follow-up|3|||
145764573|NCT01264939|525646983|FG000|Overall Study|Physician Decision|1|||
145764574|NCT01264939|525646984|FG001|Overall Study|Physician Decision|1|||
145764575|NCT01264939|525646983|FG000|Overall Study|Patient/Guardian Decision|8|||
145764576|NCT01264939|525646984|FG001|Overall Study|Patient/Guardian Decision|10|||
145764577|NCT01264939|525646983|FG000|Overall Study|Disease Progression|8|||
145764578|NCT01264939|525646984|FG001|Overall Study|Disease Progression|11|||
145764579|NCT03538743|525646985|FG000|Overall Study|Adverse Event|0|||
145764580|NCT03538743|525646986|FG001|Overall Study|Adverse Event|0|||
145764581|NCT03538743|525646987|FG002|Overall Study|Adverse Event|1|||
145764582|NCT03538743|525646988|FG003|Overall Study|Adverse Event|1|||
145764583|NCT03538743|525646989|FG004|Overall Study|Adverse Event|0|||
145764584|NCT03538743|525646990|FG005|Overall Study|Adverse Event|0|||
145764585|NCT03538743|525646991|FG006|Overall Study|Adverse Event|0|||
145764586|NCT03538743|525646992|FG007|Overall Study|Adverse Event|0|||
145764587|NCT03538743|525646993|FG008|Overall Study|Adverse Event|0|||
145764588|NCT03538743|525646985|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
145764589|NCT03538743|525646986|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
145764590|NCT03538743|525646987|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
145764591|NCT03538743|525646988|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
145764592|NCT03538743|525646989|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
145764593|NCT03538743|525646990|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
145764594|NCT03538743|525646991|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
145764595|NCT03538743|525646992|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
145764596|NCT03538743|525646993|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
145764597|NCT03538743|525646985|FG000|Overall Study|Withdrawal by Subject|0|||
145764598|NCT03538743|525646986|FG001|Overall Study|Withdrawal by Subject|0|||
145764599|NCT03538743|525646987|FG002|Overall Study|Withdrawal by Subject|0|||
145764600|NCT03538743|525646988|FG003|Overall Study|Withdrawal by Subject|1|||
145764601|NCT03538743|525646989|FG004|Overall Study|Withdrawal by Subject|0|||
145764602|NCT03538743|525646990|FG005|Overall Study|Withdrawal by Subject|0|||
145764603|NCT03538743|525646991|FG006|Overall Study|Withdrawal by Subject|0|||
145764604|NCT03538743|525646992|FG007|Overall Study|Withdrawal by Subject|0|||
145764605|NCT03538743|525646993|FG008|Overall Study|Withdrawal by Subject|0|||
145764606|NCT01565980|525646995|FG000|Overall Study|Death|1|||
145764607|NCT01565980|525646996|FG001|Overall Study|Death|0|||
145764608|NCT01565980|525646995|FG000|Overall Study|Lost to Follow-up|1|||
145764609|NCT01565980|525646996|FG001|Overall Study|Lost to Follow-up|0|||
145764610|NCT01565980|525646995|FG000|Overall Study|health complications|1|||
145764611|NCT01565980|525646996|FG001|Overall Study|health complications|1|||
145764612|NCT01565980|525646995|FG000|Overall Study|stopped medical treatment|1|||
145764613|NCT01565980|525646996|FG001|Overall Study|stopped medical treatment|0|||
145764614|NCT01565980|525646995|FG000|Overall Study|Withdrawal by Subject|0|||
145764615|NCT01565980|525646996|FG001|Overall Study|Withdrawal by Subject|3|||
145764616|NCT01926626|525647003|FG000|Overall Study|Withdrawal by Subject|15|||
145764617|NCT01926626|525647003|FG000|Overall Study|Lost to Follow-up|7|||
145764618|NCT04840667|525649209|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
145764619|NCT00023322|525649211|FG000|Overall Study|Lost to Follow-up|1|||
145764620|NCT03658889|525649212|FG000|Overall Study|Protocol Violation|2|||
145764621|NCT03658889|525649213|FG001|Overall Study|Protocol Violation|0|||
145277361|NCT01272193|523867103|FG001|Overall Study|Lack of Efficacy|3|||
145764622|NCT04317690|525649215|FG000|Overall Study|did not have complete information for primary outcome|0|||
145764623|NCT04317690|525649216|FG001|Overall Study|did not have complete information for primary outcome|4|||
145764624|NCT04317690|525649217|FG002|Overall Study|did not have complete information for primary outcome|0|||
145764625|NCT04317690|525649218|FG003|Overall Study|did not have complete information for primary outcome|2|||
145277362|NCT01272193|523867102|FG000|Overall Study|Withdrawal Criteria|1|||
145277363|NCT01272193|523867103|FG001|Overall Study|Withdrawal Criteria|1|||
145277364|NCT01272193|523867102|FG000|Overall Study|Unclassified|8|||
145764626|NCT04317690|525649219|FG004|Overall Study|did not have complete information for primary outcome|0|||
145764627|NCT01154101|525649225|FG000|Overall Study|Adverse Event|0|||
145764628|NCT01154101|525649226|FG001|Overall Study|Adverse Event|2|||
145764629|NCT01154101|525649227|FG002|Overall Study|Adverse Event|1|||
145764630|NCT01154101|525649228|FG003|Overall Study|Adverse Event|1|||
145764631|NCT01154101|525649229|FG004|Overall Study|Adverse Event|0|||
145764632|NCT01154101|525649225|FG000|Overall Study|Lost to Follow-up|0|||
145764633|NCT01154101|525649226|FG001|Overall Study|Lost to Follow-up|1|||
145764634|NCT01154101|525649227|FG002|Overall Study|Lost to Follow-up|0|||
145764635|NCT01154101|525649228|FG003|Overall Study|Lost to Follow-up|1|||
145764636|NCT01154101|525649229|FG004|Overall Study|Lost to Follow-up|0|||
145764637|NCT01154101|525649225|FG000|Overall Study|Withdrawal by Subject|0|||
145764638|NCT01154101|525649226|FG001|Overall Study|Withdrawal by Subject|1|||
145764639|NCT01154101|525649227|FG002|Overall Study|Withdrawal by Subject|2|||
145764640|NCT01154101|525649228|FG003|Overall Study|Withdrawal by Subject|0|||
145533429|NCT00875979|524813450|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
145533430|NCT00875979|524813449|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
145764641|NCT01154101|525649229|FG004|Overall Study|Withdrawal by Subject|1|||
145764642|NCT05019131|525649230|FG000|Overall Study|Lost to Follow-up|0|||
145764643|NCT05019131|525649231|FG001|Overall Study|Lost to Follow-up|3|||
145764644|NCT01111604|525649239|FG000|Overall Study|Lost to Follow-up|0|||
145764645|NCT01111604|525649240|FG001|Overall Study|Lost to Follow-up|0|||
145764646|NCT01111604|525649241|FG002|Overall Study|Lost to Follow-up|1|||
145764647|NCT01111604|525649239|FG000|Overall Study|Withdrew Consent|3|||
145764648|NCT01111604|525649240|FG001|Overall Study|Withdrew Consent|0|||
145764649|NCT01111604|525649241|FG002|Overall Study|Withdrew Consent|2|||
145764650|NCT01111604|525649239|FG000|Overall Study|Withdrawal by Subject|2|||
145764651|NCT01111604|525649240|FG001|Overall Study|Withdrawal by Subject|0|||
145764652|NCT01111604|525649241|FG002|Overall Study|Withdrawal by Subject|0|||
145764653|NCT01111604|525649239|FG000|Overall Study|Death|1|||
145764654|NCT01111604|525649240|FG001|Overall Study|Death|0|||
145764655|NCT01111604|525649241|FG002|Overall Study|Death|0|||
145764656|NCT01111604|525649239|FG000|Overall Study|Met Exclusion Criteria|2|||
145764657|NCT01111604|525649240|FG001|Overall Study|Met Exclusion Criteria|0|||
145764658|NCT01111604|525649241|FG002|Overall Study|Met Exclusion Criteria|0|||
145764659|NCT01295125|525649243|FG000|Overall Study|Study stopped prematurely|9|||
145764660|NCT03371355|525649249|FG000|Overall Study|Investigator judgment|0|||
145764661|NCT03371355|525649250|FG001|Overall Study|Investigator judgment|0|||
145764662|NCT03371355|525649251|FG002|Overall Study|Investigator judgment|1|||
145764663|NCT03371355|525649252|FG003|Overall Study|Investigator judgment|1|||
145764664|NCT03371355|525649249|FG000|Overall Study|Voluntary withdrawal|1|||
145764665|NCT03371355|525649250|FG001|Overall Study|Voluntary withdrawal|0|||
145764666|NCT03371355|525649251|FG002|Overall Study|Voluntary withdrawal|1|||
145764667|NCT03371355|525649252|FG003|Overall Study|Voluntary withdrawal|2|||
145764668|NCT03371355|525649249|FG000|Overall Study|Adverse Event|0|||
145764669|NCT03371355|525649250|FG001|Overall Study|Adverse Event|1|||
145764670|NCT03371355|525649251|FG002|Overall Study|Adverse Event|2|||
145764671|NCT03371355|525649252|FG003|Overall Study|Adverse Event|3|||
145764672|NCT03371355|525649249|FG000|Overall Study|Reason not Specified|0|||
145764673|NCT03371355|525649250|FG001|Overall Study|Reason not Specified|1|||
145764674|NCT03371355|525649251|FG002|Overall Study|Reason not Specified|0|||
145764675|NCT03371355|525649252|FG003|Overall Study|Reason not Specified|1|||
145764676|NCT03377634|525649257|FG000|Study Period|Adverse Event|1|||
145764677|NCT03377634|525649258|FG001|Study Period|Adverse Event|0|||
145764678|NCT03377634|525649257|FG000|Study Period|Withdrawal by Subject|1|||
145764679|NCT03377634|525649258|FG001|Study Period|Withdrawal by Subject|0|||
145764680|NCT01454076|525649259|FG000|Overall Study|Other|2|||
145764681|NCT01454076|525649260|FG001|Overall Study|Other|0|||
145764682|NCT01454076|525649261|FG002|Overall Study|Other|0|||
145764683|NCT01454076|525649262|FG003|Overall Study|Other|1|||
145764684|NCT01454076|525649263|FG004|Overall Study|Other|2|||
145764685|NCT01454076|525649259|FG000|Overall Study|Withdrawal by Subject|3|||
145764686|NCT01454076|525649260|FG001|Overall Study|Withdrawal by Subject|4|||
145764687|NCT01454076|525649261|FG002|Overall Study|Withdrawal by Subject|2|||
145764688|NCT01454076|525649262|FG003|Overall Study|Withdrawal by Subject|1|||
145764689|NCT01454076|525649263|FG004|Overall Study|Withdrawal by Subject|2|||
145764690|NCT01454076|525649259|FG000|Overall Study|Adverse Event|8|||
145764691|NCT01454076|525649260|FG001|Overall Study|Adverse Event|2|||
145764692|NCT01454076|525649261|FG002|Overall Study|Adverse Event|7|||
145764693|NCT01454076|525649262|FG003|Overall Study|Adverse Event|0|||
145764694|NCT01454076|525649263|FG004|Overall Study|Adverse Event|2|||
145764695|NCT01384292|525649267|FG000|Part B|Severe non-compliance to protocol|1|||
145764696|NCT01384292|525649268|FG001|Part B|Severe non-compliance to protocol|0|||
145764697|NCT01384292|525649269|FG002|Part B|Severe non-compliance to protocol|0|||
145764698|NCT01171612|525649271|FG000|Overall Study|Lost to Follow-up|51|||
145764699|NCT00737529|525649272|FG000|Overall Study|Disease Progression|95|||
145764700|NCT00737529|525649272|FG000|Overall Study|Adverse Event|24|||
145764701|NCT00737529|525649272|FG000|Overall Study|Withdrawal by Subject|5|||
145764702|NCT00737529|525649272|FG000|Overall Study|Death|4|||
145764703|NCT00737529|525649272|FG000|Overall Study|Protocol Violation|1|||
145764704|NCT00737529|525649272|FG000|Overall Study|Other|4|||
145764705|NCT04525703|525649273|FG000|Overall Study|Lost to Follow-up|6|||
145764706|NCT04525703|525649274|FG001|Overall Study|Lost to Follow-up|15|||
145764707|NCT04525703|525649275|FG002|Overall Study|Lost to Follow-up|8|||
145764708|NCT00291551|525649277|FG000|Overall Study|Death|7|||
145764709|NCT00291551|525649277|FG000|Overall Study|Withdrawal by Subject|6|||
145764710|NCT02452762|525649278|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
145764711|NCT02452762|525649279|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
145764712|NCT02452762|525649278|FG000|Overall Study|Withdrawal by Subject|1|||
145764713|NCT02452762|525649279|FG001|Overall Study|Withdrawal by Subject|0|||
145764714|NCT00584870|525649280|FG000|Overall Study|Adverse Event|4|||
145764715|NCT00584870|525649281|FG001|Overall Study|Adverse Event|3|||
145764716|NCT00584870|525649282|FG002|Overall Study|Adverse Event|2|||
145764717|NCT00584870|525649280|FG000|Overall Study|Lost to Follow-up|4|||
145764718|NCT00584870|525649281|FG001|Overall Study|Lost to Follow-up|1|||
145764719|NCT00584870|525649282|FG002|Overall Study|Lost to Follow-up|1|||
145764720|NCT00584870|525649280|FG000|Overall Study|Lack of Efficacy|7|||
145764721|NCT00584870|525649281|FG001|Overall Study|Lack of Efficacy|14|||
145402931|NCT00706797|524332555|FG000|Overall Study|Withdrawal by Subject|8|||
145402932|NCT00706797|524332556|FG001|Overall Study|Withdrawal by Subject|1|||
145764722|NCT00584870|525649282|FG002|Overall Study|Lack of Efficacy|8|||
145764723|NCT00584870|525649280|FG000|Overall Study|Withdrawal by Subject|10|||
145764724|NCT00584870|525649281|FG001|Overall Study|Withdrawal by Subject|5|||
145764725|NCT00584870|525649282|FG002|Overall Study|Withdrawal by Subject|3|||
145764726|NCT00584870|525649280|FG000|Overall Study|Protocol Violation|1|||
145764727|NCT00584870|525649281|FG001|Overall Study|Protocol Violation|1|||
145764728|NCT00584870|525649282|FG002|Overall Study|Protocol Violation|2|||
145764729|NCT00584870|525649280|FG000|Overall Study|Did not met entrance criteria|1|||
145764730|NCT00584870|525649281|FG001|Overall Study|Did not met entrance criteria|0|||
145764731|NCT00584870|525649282|FG002|Overall Study|Did not met entrance criteria|0|||
145764732|NCT00584870|525649280|FG000|Overall Study|Other|2|||
145764733|NCT00584870|525649281|FG001|Overall Study|Other|0|||
145764734|NCT00584870|525649282|FG002|Overall Study|Other|0|||
145764735|NCT00584870|525649280|FG000|Overall Study|Randomized but not treated|0|||
145764736|NCT00584870|525649281|FG001|Overall Study|Randomized but not treated|1|||
145764737|NCT00584870|525649282|FG002|Overall Study|Randomized but not treated|2|||
145764738|NCT03682120|525649283|FG000|Overall Study|Lost to Follow-up|11|||
145764739|NCT03682120|525649284|FG001|Overall Study|Lost to Follow-up|4|||
145764740|NCT03682120|525649285|FG002|Overall Study|Lost to Follow-up|5|||
145764741|NCT03682120|525649286|FG003|Overall Study|Lost to Follow-up|2|||
145764742|NCT03682120|525649283|FG000|Overall Study|Physician Decision|1|||
145764743|NCT03682120|525649284|FG001|Overall Study|Physician Decision|0|||
145764744|NCT03682120|525649285|FG002|Overall Study|Physician Decision|0|||
145764745|NCT03682120|525649286|FG003|Overall Study|Physician Decision|0|||
145764746|NCT03682120|525649283|FG000|Overall Study|Withdrawal by Subject|1|||
145764747|NCT03682120|525649284|FG001|Overall Study|Withdrawal by Subject|2|||
145764748|NCT03682120|525649285|FG002|Overall Study|Withdrawal by Subject|3|||
145764749|NCT03682120|525649286|FG003|Overall Study|Withdrawal by Subject|0|||
145764750|NCT03682120|525649283|FG000|Overall Study|Death|0|||
145764751|NCT03682120|525649284|FG001|Overall Study|Death|1|||
145764752|NCT03682120|525649285|FG002|Overall Study|Death|0|||
145764753|NCT03682120|525649286|FG003|Overall Study|Death|0|||
145764754|NCT03682120|525649283|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
145764755|NCT03682120|525649284|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
145764756|NCT03682120|525649285|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
145764757|NCT03682120|525649286|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
145764758|NCT01015833|525649287|FG000|Overall Study|Death|1|||
145764759|NCT01015833|525649288|FG001|Overall Study|Death|0|||
145764760|NCT01015833|525649287|FG000|Overall Study|Withdrawal by Subject|3|||
145764761|NCT01015833|525649288|FG001|Overall Study|Withdrawal by Subject|2|||
145764762|NCT01015833|525649287|FG000|Overall Study|Adverse Event|0|||
145764763|NCT01015833|525649288|FG001|Overall Study|Adverse Event|1|||
145764764|NCT01015833|525649287|FG000|Overall Study|Physician Decision|2|||
145764765|NCT01015833|525649288|FG001|Overall Study|Physician Decision|0|||
145764766|NCT01015833|525649287|FG000|Overall Study|Symptomatic deterioration|0|||
145764767|NCT01015833|525649288|FG001|Overall Study|Symptomatic deterioration|1|||
145764768|NCT01015833|525649287|FG000|Overall Study|Other|5|||
145764769|NCT01015833|525649288|FG001|Overall Study|Other|1|||
145764770|NCT01015833|525649287|FG000|Overall Study|Motor Vehicle Accidents|1|||
145764771|NCT01015833|525649288|FG001|Overall Study|Motor Vehicle Accidents|0|||
145764772|NCT01015833|525649287|FG000|Overall Study|Did not start treatment|1|||
145764773|NCT01015833|525649288|FG001|Overall Study|Did not start treatment|0|||
145764774|NCT01957137|525649297|FG000|Randomized Portion|Adverse Event|1|||
145764775|NCT01957137|525649297|FG000|Randomized Portion|Withdrawal by Subject|1|||
145764776|NCT02497001|525649300|FG000|Overall Study|Lost to Follow-up|10|||
145764777|NCT02497001|525649301|FG001|Overall Study|Lost to Follow-up|2|||
145764778|NCT02497001|525649302|FG002|Overall Study|Lost to Follow-up|0|||
145764779|NCT02497001|525649303|FG003|Overall Study|Lost to Follow-up|2|||
145764780|NCT02497001|525649300|FG000|Overall Study|Adverse Event|28|||
145764781|NCT02497001|525649301|FG001|Overall Study|Adverse Event|30|||
145764782|NCT02497001|525649302|FG002|Overall Study|Adverse Event|11|||
145764783|NCT02497001|525649303|FG003|Overall Study|Adverse Event|11|||
145764784|NCT02497001|525649300|FG000|Overall Study|Withdrawal by Subject|14|||
145764785|NCT02497001|525649301|FG001|Overall Study|Withdrawal by Subject|37|||
145764786|NCT02497001|525649302|FG002|Overall Study|Withdrawal by Subject|19|||
145764787|NCT02497001|525649303|FG003|Overall Study|Withdrawal by Subject|15|||
145764788|NCT02497001|525649300|FG000|Overall Study|Physician Decision|5|||
145764789|NCT02497001|525649301|FG001|Overall Study|Physician Decision|11|||
145764790|NCT02497001|525649302|FG002|Overall Study|Physician Decision|5|||
145764791|NCT02497001|525649303|FG003|Overall Study|Physician Decision|1|||
145764792|NCT02497001|525649300|FG000|Overall Study|subjects that were not treated|1|||
145764793|NCT02497001|525649301|FG001|Overall Study|subjects that were not treated|2|||
145764794|NCT02497001|525649302|FG002|Overall Study|subjects that were not treated|2|||
145764795|NCT02497001|525649303|FG003|Overall Study|subjects that were not treated|1|||
145764796|NCT02497001|525649300|FG000|Overall Study|Major Protocol Deviation|3|||
145764797|NCT02497001|525649301|FG001|Overall Study|Major Protocol Deviation|4|||
145764798|NCT02497001|525649302|FG002|Overall Study|Major Protocol Deviation|4|||
145764799|NCT02497001|525649303|FG003|Overall Study|Major Protocol Deviation|4|||
145764800|NCT02497001|525649300|FG000|Overall Study|Lack of Efficacy|10|||
145764801|NCT02497001|525649301|FG001|Overall Study|Lack of Efficacy|16|||
145764802|NCT02497001|525649302|FG002|Overall Study|Lack of Efficacy|6|||
145764803|NCT02497001|525649303|FG003|Overall Study|Lack of Efficacy|6|||
145764804|NCT02497001|525649300|FG000|Overall Study|Protocol Violation|3|||
145764805|NCT02497001|525649301|FG001|Overall Study|Protocol Violation|1|||
145764806|NCT02497001|525649302|FG002|Overall Study|Protocol Violation|3|||
145764807|NCT02497001|525649303|FG003|Overall Study|Protocol Violation|1|||
145764808|NCT01651780|525649304|FG000|Overall Study|Physician decision: No 30-day visit|2|||
145764809|NCT01651780|525649305|FG001|Overall Study|Physician decision: No 30-day visit|1|||
145764810|NCT01651780|525649304|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
145764811|NCT01651780|525649305|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
145764812|NCT01651780|525649304|FG000|Overall Study|Withdrawal by Subject|2|||
145764813|NCT01651780|525649305|FG001|Overall Study|Withdrawal by Subject|0|||
145764814|NCT01651780|525649304|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
145764815|NCT01651780|525649305|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145764816|NCT01651780|525649304|FG000|Overall Study|Lost to Follow-up|1|||
145764817|NCT01651780|525649305|FG001|Overall Study|Lost to Follow-up|2|||
145764818|NCT01651780|525649304|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
145764819|NCT01651780|525649305|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
145764820|NCT03898063|525649306|FG000|Overall Study|Withdrawal by Subject|10|||
145764821|NCT03898063|525649307|FG001|Overall Study|Withdrawal by Subject|8|||
145764822|NCT02949830|525649308|FG000|Overall Study|Adverse Event|1|||
145764823|NCT02949830|525649308|FG000|Overall Study|Withdrawal by Subject|1|||
145764824|NCT00054132|525649309|FG000|Overall Study|Not Treated|1|||
145764825|NCT01628926|525649310|FG000|Overall Study|Adverse Event|13|||
145764826|NCT01628926|525649311|FG001|Overall Study|Adverse Event|11|||
145764827|NCT01628926|525649312|FG002|Overall Study|Adverse Event|9|||
145764828|NCT01628926|525649310|FG000|Overall Study|Lack of Efficacy|2|||
145764829|NCT01628926|525649311|FG001|Overall Study|Lack of Efficacy|1|||
145764830|NCT01628926|525649312|FG002|Overall Study|Lack of Efficacy|5|||
145764831|NCT01628926|525649310|FG000|Overall Study|Withdrawal by Subject|6|||
145764832|NCT01628926|525649311|FG001|Overall Study|Withdrawal by Subject|4|||
145764833|NCT01628926|525649312|FG002|Overall Study|Withdrawal by Subject|2|||
145764834|NCT01628926|525649310|FG000|Overall Study|Protocol Violation|0|||
145607916|NCT01852058|525079276|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607917|NCT01852058|525079277|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145277365|NCT01272193|523867103|FG001|Overall Study|Unclassified|7|||
145277366|NCT00350519|523867112|FG000|Overall Study|Death|0|||
145277367|NCT00350519|523867113|FG001|Overall Study|Death|1|||
145277368|NCT00350519|523867112|FG000|Overall Study|Physician Decision|0|||
145764835|NCT01628926|525649311|FG001|Overall Study|Protocol Violation|1|||
145764836|NCT01628926|525649312|FG002|Overall Study|Protocol Violation|0|||
145764837|NCT01628926|525649310|FG000|Overall Study|Discontinuation criteria|3|||
145764838|NCT01628926|525649311|FG001|Overall Study|Discontinuation criteria|4|||
145277369|NCT00350519|523867113|FG001|Overall Study|Physician Decision|1|||
145277370|NCT00350519|523867112|FG000|Overall Study|Protocol Violation|1|||
145277371|NCT00350519|523867113|FG001|Overall Study|Protocol Violation|2|||
145764839|NCT01628926|525649312|FG002|Overall Study|Discontinuation criteria|0|||
145764840|NCT01628926|525649310|FG000|Overall Study|Physician Decision|2|||
145764841|NCT01628926|525649311|FG001|Overall Study|Physician Decision|2|||
145764842|NCT01628926|525649312|FG002|Overall Study|Physician Decision|1|||
145764843|NCT01889602|525649315|FG000|First Intervention|Adverse Event|1|||
145764844|NCT01889602|525649316|FG001|First Intervention|Adverse Event|1|||
145764845|NCT01889602|525649317|FG002|First Intervention|Adverse Event|1|||
145764846|NCT01889602|525649315|FG000|First Intervention|Protocol Violation|0|||
145764847|NCT01889602|525649316|FG001|First Intervention|Protocol Violation|1|||
145764848|NCT01889602|525649317|FG002|First Intervention|Protocol Violation|1|||
145764849|NCT01889602|525649315|FG000|First Intervention|Study ending|0|||
145764850|NCT01889602|525649316|FG001|First Intervention|Study ending|1|||
145764851|NCT01889602|525649317|FG002|First Intervention|Study ending|0|||
145764852|NCT01889602|525649315|FG000|Second Intervention|Adverse Event|0|||
145764853|NCT01889602|525649316|FG001|Second Intervention|Adverse Event|0|||
145764854|NCT01889602|525649317|FG002|Second Intervention|Adverse Event|1|||
145764855|NCT01889602|525649315|FG000|Second Intervention|Study ending|1|||
145764856|NCT01889602|525649316|FG001|Second Intervention|Study ending|0|||
145764857|NCT01889602|525649317|FG002|Second Intervention|Study ending|0|||
145764858|NCT01889602|525649315|FG000|Second Intervention|Withdrawal by Subject|0|||
145764859|NCT01889602|525649316|FG001|Second Intervention|Withdrawal by Subject|0|||
145764860|NCT01889602|525649317|FG002|Second Intervention|Withdrawal by Subject|1|||
145764861|NCT01889602|525649315|FG000|Third Intervention|Protocol Violation|1|||
145764862|NCT01889602|525649316|FG001|Third Intervention|Protocol Violation|0|||
145764863|NCT01889602|525649317|FG002|Third Intervention|Protocol Violation|0|||
145764864|NCT01889602|525649315|FG000|Third Intervention|Withdrawal by Subject|2|||
145764865|NCT01889602|525649316|FG001|Third Intervention|Withdrawal by Subject|2|||
145764866|NCT01889602|525649317|FG002|Third Intervention|Withdrawal by Subject|0|||
145764867|NCT01551745|525649318|FG000|Overall Study|Withdrawal by Subject|1|||
145764868|NCT01551745|525649318|FG000|Overall Study|Disease Progression|2|||
145764869|NCT03952559|525649327|FG000|Double Blind Treatment Period|Adverse Event|0|||
145764870|NCT03952559|525649328|FG001|Double Blind Treatment Period|Adverse Event|2|||
145764871|NCT03952559|525649329|FG002|Double Blind Treatment Period|Adverse Event|1|||
145764872|NCT03952559|525649330|FG003|Double Blind Treatment Period|Adverse Event|0|||
145764873|NCT03952559|525649331|FG004|Double Blind Treatment Period|Adverse Event|1|||
145764874|NCT03952559|525649327|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
145764875|NCT03952559|525649328|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
145764876|NCT03952559|525649329|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
145764877|NCT03952559|525649330|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
145764878|NCT03952559|525649331|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
145764879|NCT03952559|525649327|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
145764880|NCT03952559|525649328|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
145764881|NCT03952559|525649329|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
145764882|NCT03952559|525649330|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
145764883|NCT03952559|525649331|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
145764884|NCT03952559|525649327|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
145764885|NCT03952559|525649328|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
145764886|NCT03952559|525649329|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
145764887|NCT03952559|525649330|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
145764888|NCT03952559|525649331|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
145764889|NCT02875223|525649332|FG000|Overall Study|Other reasons|0|||
145764890|NCT02875223|525649333|FG001|Overall Study|Other reasons|0|||
145764891|NCT02875223|525649334|FG002|Overall Study|Other reasons|1|||
145764892|NCT02875223|525649335|FG003|Overall Study|Other reasons|0|||
145764893|NCT02875223|525649336|FG004|Overall Study|Other reasons|1|||
145764894|NCT02875223|525649337|FG005|Overall Study|Other reasons|2|||
145764895|NCT02875223|525649338|FG006|Overall Study|Other reasons|0|||
145764896|NCT02875223|525649339|FG007|Overall Study|Other reasons|2|||
145764897|NCT02875223|525649340|FG008|Overall Study|Other reasons|0|||
145764898|NCT02875223|525649341|FG009|Overall Study|Other reasons|0|||
145764899|NCT02875223|525649342|FG010|Overall Study|Other reasons|0|||
145764900|NCT02875223|525649343|FG011|Overall Study|Other reasons|0|||
145277372|NCT00350519|523867112|FG000|Overall Study|Withdrawal by Subject|3|||
145277373|NCT00350519|523867113|FG001|Overall Study|Withdrawal by Subject|2|||
145277374|NCT00289731|523867117|FG000|Overall Study|Adverse Event|1|||
145277375|NCT00289731|523867118|FG001|Overall Study|Adverse Event|2|||
145277376|NCT00289731|523867119|FG002|Overall Study|Adverse Event|2|||
145277377|NCT00289731|523867117|FG000|Overall Study|Other|1|||
145764901|NCT02875223|525649344|FG012|Overall Study|Other reasons|0|||
145764902|NCT02875223|525649332|FG000|Overall Study|Withdrawal by Subject|0|||
145764903|NCT02875223|525649333|FG001|Overall Study|Withdrawal by Subject|0|||
145764904|NCT02875223|525649334|FG002|Overall Study|Withdrawal by Subject|0|||
145764905|NCT02875223|525649335|FG003|Overall Study|Withdrawal by Subject|0|||
145277378|NCT00289731|523867118|FG001|Overall Study|Other|0|||
145277379|NCT00289731|523867119|FG002|Overall Study|Other|0|||
145277380|NCT01830920|523867122|FG000|Overall Study|Adverse Event|1|||
145277381|NCT01830920|523867123|FG001|Overall Study|Adverse Event|0|||
145277382|NCT01830920|523867124|FG002|Overall Study|Adverse Event|1|||
145764906|NCT02875223|525649336|FG004|Overall Study|Withdrawal by Subject|1|||
145764907|NCT02875223|525649337|FG005|Overall Study|Withdrawal by Subject|1|||
145764908|NCT02875223|525649338|FG006|Overall Study|Withdrawal by Subject|0|||
145764909|NCT02875223|525649339|FG007|Overall Study|Withdrawal by Subject|0|||
145764910|NCT02875223|525649340|FG008|Overall Study|Withdrawal by Subject|1|||
145764911|NCT02875223|525649341|FG009|Overall Study|Withdrawal by Subject|0|||
145764912|NCT02875223|525649342|FG010|Overall Study|Withdrawal by Subject|0|||
145764913|NCT02875223|525649343|FG011|Overall Study|Withdrawal by Subject|0|||
145764914|NCT02875223|525649344|FG012|Overall Study|Withdrawal by Subject|0|||
145764915|NCT02875223|525649332|FG000|Overall Study|Progressive disease|0|||
145764916|NCT02875223|525649333|FG001|Overall Study|Progressive disease|0|||
145764917|NCT02875223|525649334|FG002|Overall Study|Progressive disease|1|||
145764918|NCT02875223|525649335|FG003|Overall Study|Progressive disease|0|||
145764919|NCT02875223|525649336|FG004|Overall Study|Progressive disease|0|||
145764920|NCT02875223|525649337|FG005|Overall Study|Progressive disease|0|||
145764921|NCT02875223|525649338|FG006|Overall Study|Progressive disease|0|||
145764922|NCT02875223|525649339|FG007|Overall Study|Progressive disease|0|||
145764923|NCT02875223|525649340|FG008|Overall Study|Progressive disease|0|||
145764924|NCT02875223|525649341|FG009|Overall Study|Progressive disease|12|||
145764925|NCT02875223|525649342|FG010|Overall Study|Progressive disease|2|||
145764926|NCT02875223|525649343|FG011|Overall Study|Progressive disease|3|||
145764927|NCT02875223|525649344|FG012|Overall Study|Progressive disease|6|||
145764928|NCT02875223|525649332|FG000|Overall Study|Death|4|||
145764929|NCT02875223|525649333|FG001|Overall Study|Death|4|||
145764930|NCT02875223|525649334|FG002|Overall Study|Death|3|||
145764931|NCT02875223|525649335|FG003|Overall Study|Death|4|||
145764932|NCT02875223|525649336|FG004|Overall Study|Death|2|||
145764933|NCT02875223|525649337|FG005|Overall Study|Death|3|||
145764934|NCT02875223|525649338|FG006|Overall Study|Death|5|||
145764935|NCT02875223|525649339|FG007|Overall Study|Death|7|||
145764936|NCT02875223|525649340|FG008|Overall Study|Death|3|||
145764937|NCT02875223|525649341|FG009|Overall Study|Death|2|||
145764938|NCT02875223|525649342|FG010|Overall Study|Death|0|||
145764939|NCT02875223|525649343|FG011|Overall Study|Death|0|||
145764940|NCT02875223|525649344|FG012|Overall Study|Death|0|||
145764941|NCT02875223|525649332|FG000|Overall Study|Lost to Follow-up|0|||
145764942|NCT02875223|525649333|FG001|Overall Study|Lost to Follow-up|1|||
145764943|NCT02875223|525649334|FG002|Overall Study|Lost to Follow-up|1|||
145764944|NCT02875223|525649335|FG003|Overall Study|Lost to Follow-up|0|||
145764945|NCT02875223|525649336|FG004|Overall Study|Lost to Follow-up|1|||
145764946|NCT02875223|525649337|FG005|Overall Study|Lost to Follow-up|0|||
145764947|NCT02875223|525649338|FG006|Overall Study|Lost to Follow-up|1|||
145764948|NCT02875223|525649339|FG007|Overall Study|Lost to Follow-up|1|||
145764949|NCT02875223|525649340|FG008|Overall Study|Lost to Follow-up|0|||
145764950|NCT02875223|525649341|FG009|Overall Study|Lost to Follow-up|0|||
145764951|NCT02875223|525649342|FG010|Overall Study|Lost to Follow-up|0|||
145764952|NCT02875223|525649343|FG011|Overall Study|Lost to Follow-up|0|||
145764953|NCT02875223|525649344|FG012|Overall Study|Lost to Follow-up|0|||
145764954|NCT01870739|525649345|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
145764955|NCT01870739|525649346|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
145764956|NCT01870739|525649345|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
145764957|NCT01870739|525649346|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
145764958|NCT01870739|525649345|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
145764959|NCT01870739|525649346|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
145764960|NCT01870739|525649345|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
145764961|NCT01870739|525649346|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
145764962|NCT01870739|525649345|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
145764963|NCT01870739|525649346|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
145764964|NCT01870739|525649345|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
145764965|NCT01870739|525649346|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
145764966|NCT01870739|525649345|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
145764967|NCT01870739|525649346|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
145764968|NCT01986062|525649347|FG000|Overall Study|Lost to Follow-up|1|||
145764969|NCT01986062|525649348|FG001|Overall Study|Lost to Follow-up|0|||
145764970|NCT01986062|525649347|FG000|Overall Study|Withdrawal by Subject|0|||
145764971|NCT01986062|525649348|FG001|Overall Study|Withdrawal by Subject|1|||
145764972|NCT01929135|525649350|FG000|Overall Study|Lost to Follow-up|1|||
145764973|NCT01929135|525649351|FG001|Overall Study|Lost to Follow-up|1|||
145764974|NCT01955707|525649352|FG000|Overall Study|Adverse Event|1|||
145764975|NCT01955707|525649353|FG001|Overall Study|Adverse Event|2|||
145764976|NCT01955707|525649352|FG000|Overall Study|Lost to Follow-up|2|||
145764977|NCT01955707|525649353|FG001|Overall Study|Lost to Follow-up|1|||
145764978|NCT01955707|525649352|FG000|Overall Study|Withdrawal by Subject|0|||
145764979|NCT01955707|525649353|FG001|Overall Study|Withdrawal by Subject|3|||
145764980|NCT01955707|525649352|FG000|Overall Study|Death|13|||
145764981|NCT01955707|525649353|FG001|Overall Study|Death|14|||
145764982|NCT01955707|525649352|FG000|Overall Study|Other|4|||
145764983|NCT01955707|525649353|FG001|Overall Study|Other|2|||
145764984|NCT01817790|525649356|FG000|Overall Study|Adverse Event|0|||
145764985|NCT01817790|525649357|FG001|Overall Study|Adverse Event|2|||
145764986|NCT01817790|525649356|FG000|Overall Study|Lost to Follow-up|0|||
145764987|NCT01817790|525649357|FG001|Overall Study|Lost to Follow-up|1|||
145764988|NCT01817790|525649356|FG000|Overall Study|Protocol Violation|2|||
145764989|NCT01817790|525649357|FG001|Overall Study|Protocol Violation|1|||
145764990|NCT01817790|525649356|FG000|Overall Study|Withdrawal by Subject|1|||
145764991|NCT01817790|525649357|FG001|Overall Study|Withdrawal by Subject|3|||
145764992|NCT01817790|525649356|FG000|Overall Study|Other: Could not attend appointment|1|||
145764993|NCT01817790|525649357|FG001|Overall Study|Other: Could not attend appointment|1|||
145764994|NCT01671345|525649358|FG000|Overall Study|Lost to Follow-up|10|||
145764995|NCT01671345|525649359|FG001|Overall Study|Lost to Follow-up|6|||
145764996|NCT01671345|525649358|FG000|Overall Study|visit with non-participating physician|3|||
145764997|NCT01671345|525649359|FG001|Overall Study|visit with non-participating physician|3|||
145764998|NCT03636906|525649360|FG000|Overall Study|Adverse Event|0|||
145764999|NCT03636906|525649361|FG001|Overall Study|Adverse Event|0|||
145765000|NCT03636906|525649362|FG002|Overall Study|Adverse Event|1|||
145765001|NCT03636906|525649360|FG000|Overall Study|Lost to Follow-up|1|||
145765002|NCT03636906|525649361|FG001|Overall Study|Lost to Follow-up|0|||
145765003|NCT03636906|525649362|FG002|Overall Study|Lost to Follow-up|0|||
145765004|NCT03636906|525649360|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
145765005|NCT03636906|525649361|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
145765006|NCT03636906|525649362|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
145765007|NCT03636906|525649360|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
145765008|NCT03636906|525649361|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
145765009|NCT03636906|525649362|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
145765010|NCT03636906|525649360|FG000|Overall Study|Other|0|||
145765011|NCT03636906|525649361|FG001|Overall Study|Other|0|||
145765012|NCT03636906|525649362|FG002|Overall Study|Other|1|||
145765013|NCT00891202|525649363|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
145765014|NCT00891202|525649364|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
145765015|NCT00891202|525649365|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
145765016|NCT00891202|525649366|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
145765017|NCT00891202|525649363|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
145765018|NCT00891202|525649364|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
145765019|NCT00891202|525649365|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
145765020|NCT00891202|525649366|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
145765021|NCT00891202|525649363|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
145765022|NCT00891202|525649364|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
145765023|NCT00891202|525649365|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
145765024|NCT00891202|525649366|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
145765025|NCT00891202|525649363|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
145765026|NCT00891202|525649364|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
145765027|NCT00891202|525649365|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
145765028|NCT00891202|525649366|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
145765029|NCT03690869|525649368|FG000|Overall Study|Adverse Event|0|||
145765030|NCT03690869|525649369|FG001|Overall Study|Adverse Event|0|||
145765031|NCT03690869|525649370|FG002|Overall Study|Adverse Event|0|||
145765032|NCT03690869|525649371|FG003|Overall Study|Adverse Event|1|||
145765033|NCT03690869|525649372|FG004|Overall Study|Adverse Event|0|||
145765034|NCT03690869|525649373|FG005|Overall Study|Adverse Event|0|||
145765035|NCT03690869|525649374|FG006|Overall Study|Adverse Event|0|||
145765036|NCT03690869|525649375|FG007|Overall Study|Adverse Event|1|||
145765037|NCT03690869|525649376|FG008|Overall Study|Adverse Event|0|||
145765038|NCT03690869|525649377|FG009|Overall Study|Adverse Event|1|||
145765039|NCT03690869|525649368|FG000|Overall Study|Death|1|||
145765040|NCT03690869|525649369|FG001|Overall Study|Death|1|||
145765041|NCT03690869|525649370|FG002|Overall Study|Death|1|||
145765042|NCT03690869|525649371|FG003|Overall Study|Death|4|||
145765043|NCT03690869|525649372|FG004|Overall Study|Death|2|||
145765044|NCT03690869|525649373|FG005|Overall Study|Death|5|||
145765045|NCT03690869|525649374|FG006|Overall Study|Death|3|||
145765046|NCT03690869|525649375|FG007|Overall Study|Death|2|||
145765047|NCT03690869|525649376|FG008|Overall Study|Death|0|||
145765048|NCT03690869|525649377|FG009|Overall Study|Death|3|||
145765049|NCT03690869|525649368|FG000|Overall Study|Lost to Follow-up|0|||
145765050|NCT03690869|525649369|FG001|Overall Study|Lost to Follow-up|0|||
145765051|NCT03690869|525649370|FG002|Overall Study|Lost to Follow-up|1|||
145765052|NCT03690869|525649371|FG003|Overall Study|Lost to Follow-up|0|||
145277383|NCT01830920|523867125|FG003|Overall Study|Adverse Event|0|||
145765053|NCT03690869|525649372|FG004|Overall Study|Lost to Follow-up|0|||
145765054|NCT03690869|525649373|FG005|Overall Study|Lost to Follow-up|0|||
145765055|NCT03690869|525649374|FG006|Overall Study|Lost to Follow-up|0|||
145765056|NCT03690869|525649375|FG007|Overall Study|Lost to Follow-up|0|||
145765057|NCT03690869|525649376|FG008|Overall Study|Lost to Follow-up|0|||
145765058|NCT03690869|525649377|FG009|Overall Study|Lost to Follow-up|0|||
145765059|NCT03690869|525649368|FG000|Overall Study|Other Treatment|1|||
145765060|NCT03690869|525649369|FG001|Overall Study|Other Treatment|1|||
145765061|NCT03690869|525649370|FG002|Overall Study|Other Treatment|1|||
145765062|NCT03690869|525649371|FG003|Overall Study|Other Treatment|2|||
145765063|NCT03690869|525649372|FG004|Overall Study|Other Treatment|3|||
145765064|NCT03690869|525649373|FG005|Overall Study|Other Treatment|1|||
145765065|NCT03690869|525649374|FG006|Overall Study|Other Treatment|2|||
145765066|NCT03690869|525649375|FG007|Overall Study|Other Treatment|7|||
145765067|NCT03690869|525649376|FG008|Overall Study|Other Treatment|0|||
145765068|NCT03690869|525649377|FG009|Overall Study|Other Treatment|3|||
145765069|NCT03690869|525649368|FG000|Overall Study|Physician Decision|0|||
145765070|NCT03690869|525649369|FG001|Overall Study|Physician Decision|1|||
145765071|NCT03690869|525649370|FG002|Overall Study|Physician Decision|0|||
145765072|NCT03690869|525649371|FG003|Overall Study|Physician Decision|0|||
145765073|NCT03690869|525649372|FG004|Overall Study|Physician Decision|0|||
145765074|NCT03690869|525649373|FG005|Overall Study|Physician Decision|0|||
145765075|NCT03690869|525649374|FG006|Overall Study|Physician Decision|0|||
145765076|NCT03690869|525649375|FG007|Overall Study|Physician Decision|0|||
145765077|NCT03690869|525649376|FG008|Overall Study|Physician Decision|0|||
145765078|NCT03690869|525649377|FG009|Overall Study|Physician Decision|0|||
145765079|NCT03690869|525649368|FG000|Overall Study|Progressive Disease|1|||
145765080|NCT03690869|525649369|FG001|Overall Study|Progressive Disease|2|||
145765081|NCT03690869|525649370|FG002|Overall Study|Progressive Disease|0|||
145765082|NCT03690869|525649371|FG003|Overall Study|Progressive Disease|1|||
145765083|NCT03690869|525649372|FG004|Overall Study|Progressive Disease|0|||
145765084|NCT03690869|525649373|FG005|Overall Study|Progressive Disease|0|||
145765085|NCT03690869|525649374|FG006|Overall Study|Progressive Disease|0|||
145765086|NCT03690869|525649375|FG007|Overall Study|Progressive Disease|0|||
145765087|NCT03690869|525649376|FG008|Overall Study|Progressive Disease|1|||
145765088|NCT03690869|525649377|FG009|Overall Study|Progressive Disease|1|||
145765089|NCT03690869|525649368|FG000|Overall Study|Subject Decision|0|||
145765090|NCT03690869|525649369|FG001|Overall Study|Subject Decision|0|||
145765091|NCT03690869|525649370|FG002|Overall Study|Subject Decision|0|||
145765092|NCT03690869|525649371|FG003|Overall Study|Subject Decision|1|||
145765093|NCT03690869|525649372|FG004|Overall Study|Subject Decision|0|||
145765094|NCT03690869|525649373|FG005|Overall Study|Subject Decision|0|||
145765095|NCT03690869|525649374|FG006|Overall Study|Subject Decision|0|||
145765096|NCT03690869|525649375|FG007|Overall Study|Subject Decision|1|||
145765097|NCT03690869|525649376|FG008|Overall Study|Subject Decision|0|||
145765098|NCT03690869|525649377|FG009|Overall Study|Subject Decision|0|||
145765099|NCT04280081|525649379|FG000|Overall Study|Adverse Event|4|||
145765100|NCT04280081|525649379|FG000|Overall Study|Death|2|||
145765101|NCT04280081|525649379|FG000|Overall Study|Progressive Disease|6|||
145765102|NCT06001307|525650576|FG000|Overall Study|Lost to Follow-up|1|||
145765103|NCT06001307|525650577|FG001|Overall Study|Lost to Follow-up|2|||
145765104|NCT03532100|525650578|FG000|Overall Study|Intervention malfunction|1|||
145765105|NCT04439279|525650579|FG000|Overall Study|Adverse Event|7|||
145765106|NCT04439279|525650579|FG000|Overall Study|Death|4|||
145765107|NCT04439279|525650579|FG000|Overall Study|Disease progression|17|||
145765108|NCT04439279|525650579|FG000|Overall Study|Complicating disease|3|||
145765109|NCT04439279|525650579|FG000|Overall Study|Withdrawal by Subject|2|||
145765110|NCT04439279|525650579|FG000|Overall Study|Ineligible|1|||
145765111|NCT04439279|525650579|FG000|Overall Study|Treatment still ongoing|1|||
145765112|NCT02031679|525650580|FG000|Overall Study|Protocol Violation|0|||
145765113|NCT02031679|525650581|FG001|Overall Study|Protocol Violation|1|||
145765114|NCT02031679|525650580|FG000|Overall Study|Lack of Efficacy|0|||
145765115|NCT02031679|525650581|FG001|Overall Study|Lack of Efficacy|1|||
145765116|NCT03263806|525650582|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
145277384|NCT01830920|523867126|FG004|Overall Study|Adverse Event|0|||
145765117|NCT03263806|525650583|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
145765118|NCT03263806|525650582|FG000|Overall Study|Withdrawal by Subject|0|||
145765119|NCT03263806|525650583|FG001|Overall Study|Withdrawal by Subject|1|||
145765120|NCT03263806|525650582|FG000|Overall Study|Study Termination|5|||
145765121|NCT03263806|525650583|FG001|Overall Study|Study Termination|6|||
145765122|NCT02338843|525650590|FG000|Overall Study|Adverse Event|2|||
145765123|NCT02338843|525650591|FG001|Overall Study|Adverse Event|1|||
145765124|NCT02338843|525650590|FG000|Overall Study|Death|40|||
145765125|NCT02338843|525650591|FG001|Overall Study|Death|53|||
145765126|NCT02338843|525650590|FG000|Overall Study|Physician Decision|1|||
145765127|NCT02338843|525650591|FG001|Overall Study|Physician Decision|0|||
145765128|NCT02338843|525650590|FG000|Overall Study|Withdrawal by Subject|0|||
145765129|NCT02338843|525650591|FG001|Overall Study|Withdrawal by Subject|2|||
145765130|NCT02338843|525650590|FG000|Overall Study|Subject Recovered|0|||
145765131|NCT02338843|525650591|FG001|Overall Study|Subject Recovered|2|||
145765132|NCT02338843|525650590|FG000|Overall Study|Discontinued prior to randomizat|1|||
145765133|NCT02338843|525650591|FG001|Overall Study|Discontinued prior to randomizat|0|||
145765134|NCT01609933|525650596|FG000|Overall Study|Adverse Event|1|||
145765135|NCT01609933|525650596|FG000|Overall Study|Withdrawal by Subject|3|||
145277385|NCT01830920|523867122|FG000|Overall Study|Withdrawal by Subject|2|||
145277386|NCT01830920|523867123|FG001|Overall Study|Withdrawal by Subject|2|||
145765136|NCT01252966|525650597|FG000|Overall Study|Lost to Follow-up|16|||
145765137|NCT01252966|525650598|FG001|Overall Study|Lost to Follow-up|10|||
145765138|NCT01252966|525650597|FG000|Overall Study|Withdrawal by Subject|7|||
145765139|NCT01252966|525650598|FG001|Overall Study|Withdrawal by Subject|3|||
145765140|NCT05194345|525650603|FG000|Overall Study|Withdrawal by Subject|6|||
145765141|NCT05194345|525650604|FG001|Overall Study|Withdrawal by Subject|4|||
145765142|NCT05194345|525650605|FG002|Overall Study|Withdrawal by Subject|0|||
145765143|NCT05194345|525650603|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
145765144|NCT05194345|525650604|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
145765145|NCT05194345|525650605|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
145765146|NCT03312218|525650607|FG000|Overall Study|Never signed in to access the app|54|||
145765147|NCT03312218|525650608|FG001|Overall Study|Never signed in to access the app|58|||
145765148|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
145765149|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
145765150|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
145765151|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
145765152|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
145765153|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
145765154|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
145765155|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
145765156|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
145277387|NCT01830920|523867124|FG002|Overall Study|Withdrawal by Subject|1|||
145277388|NCT01830920|523867125|FG003|Overall Study|Withdrawal by Subject|7|||
145765157|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
145765158|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
145765159|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
145765160|NCT02747927|525650609|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
145765161|NCT02747927|525650610|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
145765162|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
145765163|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
145765164|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
145765165|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
145765166|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
145765167|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
145277389|NCT01830920|523867126|FG004|Overall Study|Withdrawal by Subject|1|||
145277390|NCT01830920|523867122|FG000|Overall Study|Death|3|||
145765168|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
145765169|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
145765170|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
145765171|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
145765172|NCT02747927|525650609|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
145765173|NCT02747927|525650610|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
145765174|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
145765175|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
145765176|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
145765177|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
145765178|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
145765179|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
145765180|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
145765181|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
145765182|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
145765183|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
145277391|NCT01830920|523867123|FG001|Overall Study|Death|3|||
145277392|NCT01830920|523867124|FG002|Overall Study|Death|5|||
145277393|NCT01830920|523867125|FG003|Overall Study|Death|4|||
145277394|NCT01830920|523867126|FG004|Overall Study|Death|4|||
145277395|NCT01830920|523867122|FG000|Overall Study|Other|15|||
145277396|NCT01830920|523867123|FG001|Overall Study|Other|1|||
145533431|NCT00875979|524813450|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
145533432|NCT00875979|524813449|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
145765184|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
145765185|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
145765186|NCT02747927|525650609|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
145765187|NCT02747927|525650610|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
145765188|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
145765189|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
145765190|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
145765191|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
145765192|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
145765193|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
145765194|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
145765195|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
145765196|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
145765197|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
145765198|NCT02747927|525650609|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
145277397|NCT01830920|523867124|FG002|Overall Study|Other|1|||
145277398|NCT01830920|523867125|FG003|Overall Study|Other|5|||
145277399|NCT01830920|523867126|FG004|Overall Study|Other|3|||
145277400|NCT01313728|523867127|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
145277401|NCT00736333|523867128|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
145277402|NCT00736333|523867128|FG000|Overall Study|Data Missing|2|||
145277403|NCT00736333|523867128|FG000|Overall Study|Tumor Progression|75|||
145277404|NCT00736333|523867128|FG000|Overall Study|Toxicity|6|||
145277405|NCT00736333|523867128|FG000|Overall Study|Withdrawal by Subject|10|||
145277406|NCT00736333|523867128|FG000|Overall Study|Death|7|||
145277407|NCT00736333|523867128|FG000|Overall Study|Other|4|||
145277408|NCT00572156|523867136|FG000|Overall Study|Adverse Event|3|||
145277409|NCT00572156|523867137|FG001|Overall Study|Adverse Event|1|||
145277410|NCT00572156|523867138|FG002|Overall Study|Adverse Event|5|||
145277411|NCT00572156|523867139|FG003|Overall Study|Adverse Event|1|||
145277412|NCT00572156|523867136|FG000|Overall Study|Lost to Follow-up|1|||
145277413|NCT00572156|523867137|FG001|Overall Study|Lost to Follow-up|1|||
145277414|NCT00572156|523867138|FG002|Overall Study|Lost to Follow-up|1|||
145277415|NCT00572156|523867139|FG003|Overall Study|Lost to Follow-up|0|||
145277416|NCT00572156|523867136|FG000|Overall Study|Protocol Violation|1|||
145277417|NCT00572156|523867137|FG001|Overall Study|Protocol Violation|2|||
145277418|NCT00572156|523867138|FG002|Overall Study|Protocol Violation|0|||
145277419|NCT00572156|523867139|FG003|Overall Study|Protocol Violation|2|||
145277420|NCT00572156|523867136|FG000|Overall Study|Patient/Parent Decision|1|||
145533433|NCT00875979|524813450|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
145277421|NCT00572156|523867137|FG001|Overall Study|Patient/Parent Decision|6|||
145533434|NCT00875979|524813449|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
145533435|NCT00875979|524813450|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
145533436|NCT00875979|524813449|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
145533437|NCT00875979|524813450|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
145533438|NCT00875979|524813449|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
145533439|NCT00875979|524813450|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
145533440|NCT00875979|524813449|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
145533441|NCT00875979|524813450|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
145533442|NCT00875979|524813449|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
145533443|NCT00875979|524813450|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
145533444|NCT03605212|524813453|FG000|Treatment Period|Adverse Event|1|||
145765199|NCT02747927|525650610|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
145765200|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
145277422|NCT00572156|523867138|FG002|Overall Study|Patient/Parent Decision|4|||
145277423|NCT00572156|523867139|FG003|Overall Study|Patient/Parent Decision|3|||
145277424|NCT00572156|523867136|FG000|Overall Study|Sponsor Decision|20|||
145277425|NCT00572156|523867137|FG001|Overall Study|Sponsor Decision|16|||
145277426|NCT00572156|523867138|FG002|Overall Study|Sponsor Decision|17|||
145277427|NCT00572156|523867139|FG003|Overall Study|Sponsor Decision|19|||
145277428|NCT02261974|523867140|FG000|Overall Study|Withdrawal by Subject|3|||
145277429|NCT02261974|523867141|FG001|Overall Study|Withdrawal by Subject|2|||
145277430|NCT02261974|523867140|FG000|Overall Study|Pregnancy|0|||
145277431|NCT02261974|523867141|FG001|Overall Study|Pregnancy|1|||
145277432|NCT02261974|523867140|FG000|Overall Study|Missed treatment cut-off date|6|||
145277433|NCT02261974|523867141|FG001|Overall Study|Missed treatment cut-off date|3|||
145277434|NCT02261974|523867140|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
145533445|NCT03605212|524813454|FG001|Treatment Period|Adverse Event|0|||
145277435|NCT02261974|523867141|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
145277436|NCT02261974|523867140|FG000|Overall Study|Lost to Follow-up|2|||
145277437|NCT02261974|523867141|FG001|Overall Study|Lost to Follow-up|0|||
145533446|NCT03605212|524813455|FG002|Treatment Period|Adverse Event|0|||
145765201|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
145765202|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
145765203|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
145765204|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
145765205|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
145765206|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
145765207|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
145765208|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
145765209|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
145765210|NCT02747927|525650609|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
145765211|NCT02747927|525650610|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
145765212|NCT02360098|525650613|FG000|Overall Study|Physician Decision|7|||
145765213|NCT03293654|525650619|FG000|Overall Study|Lost to Follow-up|0|||
145765214|NCT03293654|525650620|FG001|Overall Study|Lost to Follow-up|1|||
145765215|NCT03293654|525650621|FG002|Overall Study|Lost to Follow-up|0|||
145765216|NCT01919307|525650622|FG000|Overall Study|Withdrawal by Subject|9|||
145765217|NCT06161012|525650624|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
145765218|NCT06161012|525650625|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
145765219|NCT01933932|525650626|FG000|Overall Study|Death|173|||
145765220|NCT01933932|525650627|FG001|Overall Study|Death|163|||
145765221|NCT01933932|525650626|FG000|Overall Study|Withdrawal by Subject|11|||
145765222|NCT01933932|525650627|FG001|Overall Study|Withdrawal by Subject|14|||
145765223|NCT01933932|525650626|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145765224|NCT01933932|525650627|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145765225|NCT00408005|525650628|FG000|Induction|Adverse Event|19|||
145765226|NCT00408005|525650629|FG001|Induction|Adverse Event|3|||
145765227|NCT00408005|525650630|FG002|Induction|Adverse Event|0|||
145765228|NCT00408005|525650631|FG003|Induction|Adverse Event|0|||
145765229|NCT00408005|525650632|FG004|Induction|Adverse Event|0|||
145765230|NCT00408005|525650633|FG005|Induction|Adverse Event|0|||
145765231|NCT00408005|525650634|FG006|Induction|Adverse Event|0|||
145765232|NCT00408005|525650635|FG007|Induction|Adverse Event|0|||
145765233|NCT00408005|525650628|FG000|Induction|Death|6|||
145765234|NCT00408005|525650629|FG001|Induction|Death|0|||
145765235|NCT00408005|525650630|FG002|Induction|Death|0|||
145765236|NCT00408005|525650631|FG003|Induction|Death|0|||
145765237|NCT00408005|525650632|FG004|Induction|Death|0|||
145765238|NCT00408005|525650633|FG005|Induction|Death|0|||
145765239|NCT00408005|525650634|FG006|Induction|Death|0|||
145765240|NCT00408005|525650635|FG007|Induction|Death|0|||
145765241|NCT00408005|525650628|FG000|Induction|Physician Decision|83|||
145765242|NCT00408005|525650629|FG001|Induction|Physician Decision|9|||
145765243|NCT00408005|525650630|FG002|Induction|Physician Decision|0|||
145765244|NCT00408005|525650631|FG003|Induction|Physician Decision|0|||
145765245|NCT00408005|525650632|FG004|Induction|Physician Decision|0|||
145765246|NCT00408005|525650633|FG005|Induction|Physician Decision|0|||
145277438|NCT02261974|523867140|FG000|Overall Study|Adverse Event|1|||
145277439|NCT02261974|523867141|FG001|Overall Study|Adverse Event|0|||
145277440|NCT01440595|523867142|FG000|Overall Study|Lost to Follow-up|0|||
145277441|NCT01440595|523867143|FG001|Overall Study|Lost to Follow-up|1|||
145277442|NCT01440595|523867144|FG002|Overall Study|Lost to Follow-up|0|||
145277443|NCT01440595|523867142|FG000|Overall Study|Study terminated by sponsor.|1|||
145277444|NCT01440595|523867143|FG001|Overall Study|Study terminated by sponsor.|2|||
145277445|NCT01440595|523867144|FG002|Overall Study|Study terminated by sponsor.|1|||
145277446|NCT01347879|523867145|FG000|Overall Study|Adverse Event|0|||
145277447|NCT01347879|523867146|FG001|Overall Study|Adverse Event|12|||
145277448|NCT01347879|523867145|FG000|Overall Study|Lost to Follow-up|2|||
145277449|NCT01347879|523867146|FG001|Overall Study|Lost to Follow-up|0|||
145277450|NCT01347879|523867145|FG000|Overall Study|Withdrawal by Subject|3|||
145277451|NCT01347879|523867146|FG001|Overall Study|Withdrawal by Subject|2|||
145277452|NCT01347879|523867145|FG000|Overall Study|Other|2|||
145277453|NCT01347879|523867146|FG001|Overall Study|Other|3|||
145277454|NCT04736576|523867151|FG000|Overall Study|Progressive disease|3|||
145277455|NCT04736576|523867152|FG001|Overall Study|Progressive disease|1|||
145277456|NCT04736576|523867151|FG000|Overall Study|Death|1|||
145277457|NCT04736576|523867152|FG001|Overall Study|Death|0|||
145765247|NCT00408005|525650634|FG006|Induction|Physician Decision|0|||
145765248|NCT00408005|525650635|FG007|Induction|Physician Decision|0|||
145765249|NCT00408005|525650628|FG000|Induction|Withdrawal by Subject|2|||
145765250|NCT00408005|525650629|FG001|Induction|Withdrawal by Subject|4|||
145765251|NCT00408005|525650630|FG002|Induction|Withdrawal by Subject|0|||
145765252|NCT00408005|525650631|FG003|Induction|Withdrawal by Subject|0|||
145765253|NCT00408005|525650632|FG004|Induction|Withdrawal by Subject|0|||
145765254|NCT00408005|525650633|FG005|Induction|Withdrawal by Subject|0|||
145765255|NCT00408005|525650634|FG006|Induction|Withdrawal by Subject|0|||
145765256|NCT00408005|525650635|FG007|Induction|Withdrawal by Subject|0|||
145765257|NCT00408005|525650628|FG000|Induction|Ineligible|33|||
145765258|NCT00408005|525650629|FG001|Induction|Ineligible|14|||
145765259|NCT00408005|525650630|FG002|Induction|Ineligible|0|||
145765260|NCT00408005|525650631|FG003|Induction|Ineligible|0|||
145765261|NCT00408005|525650632|FG004|Induction|Ineligible|0|||
145765262|NCT00408005|525650633|FG005|Induction|Ineligible|0|||
145765263|NCT00408005|525650634|FG006|Induction|Ineligible|0|||
145765264|NCT00408005|525650635|FG007|Induction|Ineligible|0|||
145765265|NCT00408005|525650628|FG000|Induction|Refusal of Further Protocol Therapy|225|||
145765266|NCT00408005|525650629|FG001|Induction|Refusal of Further Protocol Therapy|44|||
145765267|NCT00408005|525650630|FG002|Induction|Refusal of Further Protocol Therapy|0|||
145765268|NCT00408005|525650631|FG003|Induction|Refusal of Further Protocol Therapy|0|||
145765269|NCT00408005|525650632|FG004|Induction|Refusal of Further Protocol Therapy|0|||
145765270|NCT00408005|525650633|FG005|Induction|Refusal of Further Protocol Therapy|0|||
145765271|NCT00408005|525650634|FG006|Induction|Refusal of Further Protocol Therapy|0|||
145765272|NCT00408005|525650635|FG007|Induction|Refusal of Further Protocol Therapy|0|||
145765273|NCT00408005|525650628|FG000|Induction|Entered another COG therapeutic protocol|4|||
145765274|NCT00408005|525650629|FG001|Induction|Entered another COG therapeutic protocol|0|||
145765275|NCT00408005|525650630|FG002|Induction|Entered another COG therapeutic protocol|0|||
145765276|NCT00408005|525650631|FG003|Induction|Entered another COG therapeutic protocol|0|||
145765277|NCT00408005|525650632|FG004|Induction|Entered another COG therapeutic protocol|0|||
145765278|NCT00408005|525650633|FG005|Induction|Entered another COG therapeutic protocol|0|||
145765279|NCT00408005|525650634|FG006|Induction|Entered another COG therapeutic protocol|0|||
145277458|NCT00720304|523867153|FG000|Overall Study|Withdrawal by Subject|14|||
145765280|NCT00408005|525650635|FG007|Induction|Entered another COG therapeutic protocol|0|||
145765281|NCT00408005|525650628|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
145765282|NCT00408005|525650629|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
145765283|NCT00408005|525650630|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
145765284|NCT00408005|525650631|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
145765285|NCT00408005|525650632|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
145765286|NCT00408005|525650633|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
145765287|NCT00408005|525650634|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
145765288|NCT00408005|525650635|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
145765289|NCT00408005|525650628|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
145765290|NCT00408005|525650629|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
145765291|NCT00408005|525650630|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
145765292|NCT00408005|525650631|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
145765293|NCT00408005|525650632|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
145765294|NCT00408005|525650633|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
145765295|NCT00408005|525650634|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
145765296|NCT00408005|525650635|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
145765297|NCT00408005|525650628|FG000|Induction|Progressive Disease|0|||
145765298|NCT00408005|525650629|FG001|Induction|Progressive Disease|1|||
145765299|NCT00408005|525650630|FG002|Induction|Progressive Disease|0|||
145765300|NCT00408005|525650631|FG003|Induction|Progressive Disease|0|||
145765301|NCT00408005|525650632|FG004|Induction|Progressive Disease|0|||
145765302|NCT00408005|525650633|FG005|Induction|Progressive Disease|0|||
145765303|NCT00408005|525650634|FG006|Induction|Progressive Disease|0|||
145765304|NCT00408005|525650635|FG007|Induction|Progressive Disease|0|||
145765305|NCT00408005|525650628|FG000|Induction|Inevaluable|18|||
145765306|NCT00408005|525650629|FG001|Induction|Inevaluable|14|||
145765307|NCT00408005|525650630|FG002|Induction|Inevaluable|0|||
145765308|NCT00408005|525650631|FG003|Induction|Inevaluable|0|||
145765309|NCT00408005|525650632|FG004|Induction|Inevaluable|0|||
145765310|NCT00408005|525650633|FG005|Induction|Inevaluable|0|||
145765311|NCT00408005|525650634|FG006|Induction|Inevaluable|0|||
145765312|NCT00408005|525650635|FG007|Induction|Inevaluable|0|||
145765313|NCT00408005|525650628|FG000|Induction|Failed to Complete Randomization|3|||
145765314|NCT00408005|525650629|FG001|Induction|Failed to Complete Randomization|2|||
145765315|NCT00408005|525650630|FG002|Induction|Failed to Complete Randomization|0|||
145765316|NCT00408005|525650631|FG003|Induction|Failed to Complete Randomization|0|||
145765317|NCT00408005|525650632|FG004|Induction|Failed to Complete Randomization|0|||
145277459|NCT00720304|523867154|FG001|Overall Study|Withdrawal by Subject|1|||
145277460|NCT00720304|523867153|FG000|Overall Study|Death|1|||
145277461|NCT00720304|523867154|FG001|Overall Study|Death|0|||
145277462|NCT00720304|523867153|FG000|Overall Study|Physician Decision|5|||
145277463|NCT00720304|523867154|FG001|Overall Study|Physician Decision|2|||
145277464|NCT00720304|523867153|FG000|Overall Study|Adverse Event|3|||
145765318|NCT00408005|525650633|FG005|Induction|Failed to Complete Randomization|0|||
145765319|NCT00408005|525650634|FG006|Induction|Failed to Complete Randomization|0|||
145765320|NCT00408005|525650635|FG007|Induction|Failed to Complete Randomization|0|||
145765321|NCT00408005|525650628|FG000|Induction|Protocol Deviation|3|||
145765322|NCT00408005|525650629|FG001|Induction|Protocol Deviation|1|||
145765323|NCT00408005|525650630|FG002|Induction|Protocol Deviation|0|||
145765324|NCT00408005|525650631|FG003|Induction|Protocol Deviation|0|||
145765325|NCT00408005|525650632|FG004|Induction|Protocol Deviation|0|||
145765326|NCT00408005|525650633|FG005|Induction|Protocol Deviation|0|||
145765327|NCT00408005|525650634|FG006|Induction|Protocol Deviation|0|||
145277465|NCT00720304|523867154|FG001|Overall Study|Adverse Event|1|||
145277466|NCT00720304|523867153|FG000|Overall Study|Disease progression|6|||
145277467|NCT00720304|523867154|FG001|Overall Study|Disease progression|1|||
145277468|NCT04330482|523867157|FG000|Overall Study|Lost to Follow-up|2|||
145277469|NCT04330482|523867158|FG001|Overall Study|Lost to Follow-up|1|||
145277470|NCT04330482|523867157|FG000|Overall Study|Withdrawal by Subject|0|||
145277471|NCT04330482|523867158|FG001|Overall Study|Withdrawal by Subject|3|||
145765328|NCT00408005|525650635|FG007|Induction|Protocol Deviation|0|||
145765329|NCT00408005|525650628|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
145765330|NCT00408005|525650629|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765331|NCT00408005|525650630|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765332|NCT00408005|525650631|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765333|NCT00408005|525650632|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765334|NCT00408005|525650633|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765335|NCT00408005|525650634|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765336|NCT00408005|525650635|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
145765337|NCT00408005|525650628|FG000|Induction|Recurrent leukemia|1|||
145765338|NCT00408005|525650629|FG001|Induction|Recurrent leukemia|0|||
145765339|NCT00408005|525650630|FG002|Induction|Recurrent leukemia|0|||
145765340|NCT00408005|525650631|FG003|Induction|Recurrent leukemia|0|||
145765341|NCT00408005|525650632|FG004|Induction|Recurrent leukemia|0|||
145765342|NCT00408005|525650633|FG005|Induction|Recurrent leukemia|0|||
145765343|NCT00408005|525650634|FG006|Induction|Recurrent leukemia|0|||
145765344|NCT00408005|525650635|FG007|Induction|Recurrent leukemia|0|||
145765345|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145765346|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145765347|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
145765348|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
145765349|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
145765350|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
145765351|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
145765352|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145765353|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
145765354|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
145765355|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
145765356|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
145765357|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
145765358|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
145277472|NCT00996918|523867159|FG000|Overall Study|Lack of Efficacy|1|||
145277473|NCT00996918|523867160|FG001|Overall Study|Lack of Efficacy|1|||
145277474|NCT00996918|523867161|FG002|Overall Study|Lack of Efficacy|2|||
145277475|NCT00996918|523867162|FG003|Overall Study|Lack of Efficacy|2|||
145277476|NCT00996918|523867163|FG004|Overall Study|Lack of Efficacy|0|||
145277477|NCT00996918|523867159|FG000|Overall Study|Adverse Event|2|||
145277478|NCT00996918|523867160|FG001|Overall Study|Adverse Event|5|||
145277479|NCT00996918|523867161|FG002|Overall Study|Adverse Event|2|||
145277480|NCT00996918|523867162|FG003|Overall Study|Adverse Event|6|||
145277481|NCT00996918|523867163|FG004|Overall Study|Adverse Event|0|||
145277482|NCT00996918|523867159|FG000|Overall Study|Withdrawal by Subject|1|||
145277483|NCT00996918|523867160|FG001|Overall Study|Withdrawal by Subject|4|||
145277484|NCT00996918|523867161|FG002|Overall Study|Withdrawal by Subject|3|||
145277485|NCT00996918|523867162|FG003|Overall Study|Withdrawal by Subject|3|||
145277486|NCT00996918|523867163|FG004|Overall Study|Withdrawal by Subject|2|||
145277487|NCT00996918|523867159|FG000|Overall Study|Physician Decision|1|||
145277488|NCT00996918|523867160|FG001|Overall Study|Physician Decision|0|||
145277489|NCT00996918|523867161|FG002|Overall Study|Physician Decision|0|||
145277490|NCT00996918|523867162|FG003|Overall Study|Physician Decision|0|||
145277491|NCT00996918|523867163|FG004|Overall Study|Physician Decision|0|||
145277492|NCT00996918|523867159|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
145277493|NCT00996918|523867160|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
145277494|NCT00996918|523867161|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
145277495|NCT00996918|523867162|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
145765359|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
145765360|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
145765361|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145765362|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145765363|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
145765364|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145277496|NCT00996918|523867163|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
145277497|NCT00996918|523867159|FG000|Overall Study|Loss of Caregiver|0|||
145277498|NCT00996918|523867160|FG001|Overall Study|Loss of Caregiver|1|||
145277499|NCT00996918|523867161|FG002|Overall Study|Loss of Caregiver|0|||
145277500|NCT00996918|523867162|FG003|Overall Study|Loss of Caregiver|0|||
145277501|NCT00996918|523867163|FG004|Overall Study|Loss of Caregiver|0|||
145402933|NCT00706797|524332555|FG000|Overall Study|Death|1|||
145765365|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
145765366|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145765367|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145765368|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
145765369|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
145765370|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
145765371|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
145765372|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
145765373|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
145765374|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
145765375|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
145765376|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
145765377|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
145765378|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
145765379|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
145765380|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
145765381|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
145765382|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
145765383|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
145765384|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
145402934|NCT00706797|524332556|FG001|Overall Study|Death|0|||
145402935|NCT00706797|524332555|FG000|Overall Study|Discontinuation of study by sponsor|52|||
145402936|NCT00706797|524332556|FG001|Overall Study|Discontinuation of study by sponsor|63|||
145402937|NCT00706797|524332555|FG000|Overall Study|Protocol Violation|3|||
145402938|NCT00706797|524332556|FG001|Overall Study|Protocol Violation|2|||
145402939|NCT00706797|524332555|FG000|Overall Study|Lost to Follow-up|1|||
145402940|NCT00706797|524332556|FG001|Overall Study|Lost to Follow-up|2|||
145402941|NCT00706797|524332555|FG000|Overall Study|Other|1|||
145402942|NCT00706797|524332556|FG001|Overall Study|Other|0|||
145402943|NCT00485303|524332559|FG000|Overall Study|Adverse Event|5|||
145402944|NCT00485303|524332559|FG000|Overall Study|Progressive Disease|44|||
145402945|NCT00485303|524332559|FG000|Overall Study|Other|3|||
145402946|NCT00485303|524332559|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
145402947|NCT00485303|524332559|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
145402948|NCT01401322|524332563|FG000|Overall Study|Withdrawal by Subject|1|||
145402949|NCT01401322|524332563|FG000|Overall Study|Physician Decision|1|||
145402950|NCT00486044|524332564|FG000|Overall Study|Withdrawal by Subject|2|||
145402951|NCT00486044|524332565|FG001|Overall Study|Withdrawal by Subject|1|||
145765385|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
145402952|NCT00486044|524332564|FG000|Overall Study|Adverse Event|0|||
145402953|NCT00486044|524332565|FG001|Overall Study|Adverse Event|1|||
145402954|NCT00486044|524332564|FG000|Overall Study|Lost to Follow-up|0|||
145402955|NCT00486044|524332565|FG001|Overall Study|Lost to Follow-up|1|||
145402956|NCT00087178|524332567|FG000|Overall Study|No follow up data|5|||
145533447|NCT03605212|524813456|FG003|Treatment Period|Adverse Event|0|||
145533448|NCT03605212|524813457|FG004|Treatment Period|Adverse Event|0|||
145533449|NCT03605212|524813453|FG000|Treatment Period|Physician Decision|0|||
145533450|NCT03605212|524813454|FG001|Treatment Period|Physician Decision|0|||
145533451|NCT03605212|524813455|FG002|Treatment Period|Physician Decision|0|||
145533452|NCT03605212|524813456|FG003|Treatment Period|Physician Decision|0|||
145533453|NCT03605212|524813457|FG004|Treatment Period|Physician Decision|1|||
145533454|NCT02083081|524813458|FG000|Overall Study|Lost to Follow-up|31|||
145533455|NCT02083081|524813459|FG001|Overall Study|Lost to Follow-up|9|||
145533456|NCT04209348|524813463|FG000|Overall Study|Lost to Follow-up|1|||
145533457|NCT04209348|524813464|FG001|Overall Study|Lost to Follow-up|0|||
145533458|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
145533459|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
145533460|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Death|1|||
145533461|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Death|0|||
145533462|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
145533463|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
145533464|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
145533465|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
145533466|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
145533467|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
145533468|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
145533469|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
145533470|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
145765386|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
145765387|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
145765388|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
145765389|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
145765390|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
145765391|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
145765392|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
145765393|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765394|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765395|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765396|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765397|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
145765398|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765399|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145277502|NCT00996918|523867159|FG000|Overall Study|Other|3|||
145277503|NCT00996918|523867160|FG001|Overall Study|Other|1|||
145277504|NCT00996918|523867161|FG002|Overall Study|Other|0|||
145277505|NCT00996918|523867162|FG003|Overall Study|Other|0|||
145277506|NCT00996918|523867163|FG004|Overall Study|Other|0|||
145277507|NCT01333475|523867166|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
145607918|NCT01852058|525079278|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145765400|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
145765401|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
145765402|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
145765403|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
145765404|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
145765405|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
145765406|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
145765407|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
145765408|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
145765409|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
145765410|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
145765411|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
145765412|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
145765413|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
145765414|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
145765415|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
145765416|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
145765417|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765418|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765419|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765420|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765421|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765422|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
145765423|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145277508|NCT01333475|523867167|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
145277509|NCT01333475|523867166|FG000|Overall Study|Toxicity|1|||
145277510|NCT01333475|523867167|FG001|Overall Study|Toxicity|3|||
145277511|NCT04440007|523867168|FG000|Overall Study|Adverse Event|0|||
145607919|NCT01852058|525079279|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607920|NCT01852058|525079280|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145765424|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
145765425|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
145765426|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
145765427|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
145277512|NCT04440007|523867169|FG001|Overall Study|Adverse Event|1|||
145277513|NCT04440007|523867168|FG000|Overall Study|Lost to Follow-up|1|||
145277514|NCT04440007|523867169|FG001|Overall Study|Lost to Follow-up|3|||
145277515|NCT04440007|523867168|FG000|Overall Study|Death|7|||
145277516|NCT04440007|523867169|FG001|Overall Study|Death|2|||
145277517|NCT04440007|523867168|FG000|Overall Study|Physician Decision|1|||
145277518|NCT04440007|523867169|FG001|Overall Study|Physician Decision|1|||
145277519|NCT04440007|523867168|FG000|Overall Study|Withdrawal by Subject|2|||
145277520|NCT04440007|523867169|FG001|Overall Study|Withdrawal by Subject|1|||
145277521|NCT04440007|523867168|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
145277522|NCT04440007|523867169|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
145277523|NCT04440007|523867168|FG000|Overall Study|Discontinued prior to dosing|0|||
145277524|NCT04440007|523867169|FG001|Overall Study|Discontinued prior to dosing|2|||
145277525|NCT01466673|523867170|FG000|Overall Study|Non-compliance with study treatment|2|||
145277526|NCT01466673|523867171|FG001|Overall Study|Non-compliance with study treatment|0|||
145277527|NCT01466673|523867170|FG000|Overall Study|Lost to Follow-up|3|||
145277528|NCT01466673|523867171|FG001|Overall Study|Lost to Follow-up|5|||
145277529|NCT01466673|523867170|FG000|Overall Study|Adverse Event|2|||
145277530|NCT01466673|523867171|FG001|Overall Study|Adverse Event|1|||
145277531|NCT02981602|523867173|FG000|Overall Study|Adverse Event|0|||
145277532|NCT02981602|523867174|FG001|Overall Study|Adverse Event|0|||
145607921|NCT01852058|525079281|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607922|NCT01852058|525079282|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607923|NCT01852058|525079283|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
145277533|NCT02981602|523867175|FG002|Overall Study|Adverse Event|0|||
145277534|NCT02981602|523867176|FG003|Overall Study|Adverse Event|1|||
145765428|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
145765429|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
145765430|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
145765431|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
145765432|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
145765433|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765434|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765435|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765436|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765437|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
145765438|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
145765439|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765440|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
145765441|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
145765442|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
145765443|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
145765444|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
145765445|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
145765446|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
145765447|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
145765448|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
145765449|NCT00408005|525650628|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
145765450|NCT00408005|525650629|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
145765451|NCT00408005|525650630|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
145765452|NCT00408005|525650631|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
145765453|NCT00408005|525650632|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
145765454|NCT00408005|525650633|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
145765455|NCT00408005|525650634|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
145765456|NCT00408005|525650635|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
145765457|NCT02275533|525650636|FG000|Overall Study|Protocol Violation|2|||
145765458|NCT02275533|525650637|FG001|Overall Study|Protocol Violation|0|||
145765459|NCT02275533|525650636|FG000|Overall Study|Never received study treatment|1|||
145765460|NCT02275533|525650637|FG001|Overall Study|Never received study treatment|0|||
145765461|NCT02157883|525650641|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
145765462|NCT02157883|525650641|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
145765463|NCT02157883|525650641|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
145765464|NCT02157883|525650641|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
145765465|NCT02157883|525650641|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
145765466|NCT04454489|525650642|FG000|Overall Study|Disease progression|12|||
145765467|NCT04454489|525650642|FG000|Overall Study|Death|4|||
145765468|NCT04454489|525650642|FG000|Overall Study|Adverse Event|1|||
145765469|NCT04454489|525650642|FG000|Overall Study|Physician Decision|1|||
145765470|NCT03155997|525650643|FG000|Overall Study|Withdrawal by Subject|119|||
145765471|NCT03155997|525650644|FG001|Overall Study|Withdrawal by Subject|134|||
145765472|NCT03155997|525650643|FG000|Overall Study|Lost to Follow-up|12|||
145765473|NCT03155997|525650644|FG001|Overall Study|Lost to Follow-up|13|||
145765474|NCT03155997|525650643|FG000|Overall Study|Missing disposition data|0|||
145765475|NCT03155997|525650644|FG001|Overall Study|Missing disposition data|1|||
145765476|NCT03155997|525650643|FG000|Overall Study|On study treatment|2027|||
145765477|NCT03155997|525650644|FG001|Overall Study|On study treatment|2074|||
145765478|NCT04067518|525650645|FG000|Overall Study|Adverse Event|1|||
145765479|NCT04067518|525650646|FG001|Overall Study|Adverse Event|3|||
145765480|NCT04067518|525650645|FG000|Overall Study|Screen failures|0|||
145765481|NCT04067518|525650646|FG001|Overall Study|Screen failures|1|||
145765482|NCT04067518|525650645|FG000|Overall Study|Enrolled but not treated|0|||
145765483|NCT04067518|525650646|FG001|Overall Study|Enrolled but not treated|1|||
145765484|NCT02796755|525650649|FG000|Overall Study|Adverse Event|2|||
145765485|NCT02796755|525650650|FG001|Overall Study|Adverse Event|0|||
145765486|NCT00792298|525650654|FG000|Treatment Period 1|Adverse Event|0|||
145765487|NCT00792298|525650655|FG001|Treatment Period 1|Adverse Event|1|||
145765488|NCT00792298|525650656|FG002|Treatment Period 1|Adverse Event|0|||
145765489|NCT00792298|525650657|FG003|Treatment Period 1|Adverse Event|1|||
145765490|NCT00792298|525650658|FG004|Treatment Period 1|Adverse Event|0|||
145765491|NCT00792298|525650659|FG005|Treatment Period 1|Adverse Event|1|||
145765492|NCT00792298|525650660|FG006|Treatment Period 1|Adverse Event|1|||
145765493|NCT00792298|525650661|FG007|Treatment Period 1|Adverse Event|0|||
145765494|NCT00792298|525650654|FG000|Treatment Period 1|Lack of Efficacy|0|||
145765495|NCT00792298|525650655|FG001|Treatment Period 1|Lack of Efficacy|0|||
145765496|NCT00792298|525650656|FG002|Treatment Period 1|Lack of Efficacy|1|||
145765497|NCT00792298|525650657|FG003|Treatment Period 1|Lack of Efficacy|0|||
145765498|NCT00792298|525650658|FG004|Treatment Period 1|Lack of Efficacy|0|||
145765499|NCT00792298|525650659|FG005|Treatment Period 1|Lack of Efficacy|0|||
145765500|NCT00792298|525650660|FG006|Treatment Period 1|Lack of Efficacy|0|||
145765501|NCT00792298|525650661|FG007|Treatment Period 1|Lack of Efficacy|0|||
145765502|NCT00792298|525650654|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145277535|NCT02981602|523867177|FG004|Overall Study|Adverse Event|0|||
145277536|NCT02725671|523867178|FG000|Overall Study|Lost to Follow-up|1|||
145277537|NCT00666718|523867179|FG000|Overall Study|Adverse Event|0|||
145277538|NCT00666718|523867180|FG001|Overall Study|Adverse Event|1|||
145277539|NCT00666718|523867179|FG000|Overall Study|Death|1|||
145277540|NCT00666718|523867180|FG001|Overall Study|Death|0|||
145277541|NCT00666718|523867179|FG000|Overall Study|Lost to Follow-up|1|||
145277542|NCT00666718|523867180|FG001|Overall Study|Lost to Follow-up|0|||
145277543|NCT00666718|523867179|FG000|Overall Study|Entry Criteria Not Met|2|||
145277544|NCT00666718|523867180|FG001|Overall Study|Entry Criteria Not Met|0|||
145277545|NCT00666718|523867179|FG000|Overall Study|Protocol Violation|1|||
145277546|NCT00666718|523867180|FG001|Overall Study|Protocol Violation|3|||
145277547|NCT00666718|523867179|FG000|Overall Study|Withdrawal by Subject|7|||
145277548|NCT00666718|523867180|FG001|Overall Study|Withdrawal by Subject|12|||
145277549|NCT00666718|523867179|FG000|Overall Study|Physician Decision|0|||
145277550|NCT00666718|523867180|FG001|Overall Study|Physician Decision|2|||
145277551|NCT00963599|523867181|FG000|Overall Study|Adverse Event|2|||
145277552|NCT00963599|523867182|FG001|Overall Study|Adverse Event|0|||
145277553|NCT00963599|523867183|FG002|Overall Study|Adverse Event|1|||
145277554|NCT00963599|523867184|FG003|Overall Study|Adverse Event|2|||
145277555|NCT00963599|523867181|FG000|Overall Study|Lack of Efficacy|0|||
145277556|NCT00963599|523867182|FG001|Overall Study|Lack of Efficacy|2|||
145277557|NCT00963599|523867183|FG002|Overall Study|Lack of Efficacy|1|||
145533471|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
145277558|NCT00963599|523867184|FG003|Overall Study|Lack of Efficacy|4|||
145277559|NCT00963599|523867181|FG000|Overall Study|Lost to Follow-up|0|||
145277560|NCT00963599|523867182|FG001|Overall Study|Lost to Follow-up|1|||
145277561|NCT00963599|523867183|FG002|Overall Study|Lost to Follow-up|1|||
145277562|NCT00963599|523867184|FG003|Overall Study|Lost to Follow-up|1|||
145277563|NCT00963599|523867181|FG000|Overall Study|Protocol Violation|2|||
145277564|NCT00963599|523867182|FG001|Overall Study|Protocol Violation|2|||
145277565|NCT00963599|523867183|FG002|Overall Study|Protocol Violation|3|||
145533472|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
145277566|NCT00963599|523867184|FG003|Overall Study|Protocol Violation|4|||
145765503|NCT00792298|525650655|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145765504|NCT00792298|525650656|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145765505|NCT00792298|525650657|FG003|Treatment Period 1|Withdrawal by Subject|2|||
145765506|NCT00792298|525650658|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145765507|NCT00792298|525650659|FG005|Treatment Period 1|Withdrawal by Subject|2|||
145765508|NCT00792298|525650660|FG006|Treatment Period 1|Withdrawal by Subject|1|||
145765509|NCT00792298|525650661|FG007|Treatment Period 1|Withdrawal by Subject|0|||
145765510|NCT00792298|525650654|FG000|Treatment Period 1|Lost to Follow-up|0|||
145765511|NCT00792298|525650655|FG001|Treatment Period 1|Lost to Follow-up|0|||
145765512|NCT00792298|525650656|FG002|Treatment Period 1|Lost to Follow-up|0|||
145765513|NCT00792298|525650657|FG003|Treatment Period 1|Lost to Follow-up|0|||
145765514|NCT00792298|525650658|FG004|Treatment Period 1|Lost to Follow-up|0|||
145765515|NCT00792298|525650659|FG005|Treatment Period 1|Lost to Follow-up|0|||
145765516|NCT00792298|525650660|FG006|Treatment Period 1|Lost to Follow-up|1|||
145765517|NCT00792298|525650661|FG007|Treatment Period 1|Lost to Follow-up|0|||
145765518|NCT00792298|525650654|FG000|Treatment Period 1|Physician Decision|0|||
145765519|NCT00792298|525650655|FG001|Treatment Period 1|Physician Decision|0|||
145765520|NCT00792298|525650656|FG002|Treatment Period 1|Physician Decision|0|||
145765521|NCT00792298|525650657|FG003|Treatment Period 1|Physician Decision|1|||
145765522|NCT00792298|525650658|FG004|Treatment Period 1|Physician Decision|0|||
145765523|NCT00792298|525650659|FG005|Treatment Period 1|Physician Decision|0|||
145765524|NCT00792298|525650660|FG006|Treatment Period 1|Physician Decision|1|||
145765525|NCT00792298|525650661|FG007|Treatment Period 1|Physician Decision|0|||
145765526|NCT00792298|525650654|FG000|Treatment Period 1|Protocol Violation|0|||
145765527|NCT00792298|525650655|FG001|Treatment Period 1|Protocol Violation|0|||
145765528|NCT00792298|525650656|FG002|Treatment Period 1|Protocol Violation|0|||
145765529|NCT00792298|525650657|FG003|Treatment Period 1|Protocol Violation|0|||
145765530|NCT00792298|525650658|FG004|Treatment Period 1|Protocol Violation|0|||
145765531|NCT00792298|525650659|FG005|Treatment Period 1|Protocol Violation|0|||
145765532|NCT00792298|525650660|FG006|Treatment Period 1|Protocol Violation|0|||
145765533|NCT00792298|525650661|FG007|Treatment Period 1|Protocol Violation|1|||
145765534|NCT00792298|525650654|FG000|Washout|Adverse Event|0|||
145765535|NCT00792298|525650655|FG001|Washout|Adverse Event|0|||
145765536|NCT00792298|525650656|FG002|Washout|Adverse Event|0|||
145765537|NCT00792298|525650657|FG003|Washout|Adverse Event|0|||
145765538|NCT00792298|525650658|FG004|Washout|Adverse Event|0|||
145765539|NCT00792298|525650659|FG005|Washout|Adverse Event|1|||
145765540|NCT00792298|525650660|FG006|Washout|Adverse Event|0|||
145765541|NCT00792298|525650661|FG007|Washout|Adverse Event|0|||
145765542|NCT00792298|525650654|FG000|Washout|Withdrawal by Subject|0|||
145765543|NCT00792298|525650655|FG001|Washout|Withdrawal by Subject|0|||
145765544|NCT00792298|525650656|FG002|Washout|Withdrawal by Subject|1|||
145765545|NCT00792298|525650657|FG003|Washout|Withdrawal by Subject|0|||
145765546|NCT00792298|525650658|FG004|Washout|Withdrawal by Subject|0|||
145765547|NCT00792298|525650659|FG005|Washout|Withdrawal by Subject|1|||
145765548|NCT00792298|525650660|FG006|Washout|Withdrawal by Subject|0|||
145765549|NCT00792298|525650661|FG007|Washout|Withdrawal by Subject|0|||
145765550|NCT00792298|525650654|FG000|Treatment Period 2|Lack of Efficacy|0|||
145765551|NCT00792298|525650655|FG001|Treatment Period 2|Lack of Efficacy|0|||
145765552|NCT00792298|525650656|FG002|Treatment Period 2|Lack of Efficacy|0|||
145765553|NCT00792298|525650657|FG003|Treatment Period 2|Lack of Efficacy|0|||
145765554|NCT00792298|525650658|FG004|Treatment Period 2|Lack of Efficacy|1|||
145765555|NCT00792298|525650659|FG005|Treatment Period 2|Lack of Efficacy|0|||
145765556|NCT00792298|525650660|FG006|Treatment Period 2|Lack of Efficacy|0|||
145765557|NCT00792298|525650661|FG007|Treatment Period 2|Lack of Efficacy|0|||
145765558|NCT00792298|525650654|FG000|Treatment Period 2|Physician Decision|0|||
145765559|NCT00792298|525650655|FG001|Treatment Period 2|Physician Decision|0|||
145765560|NCT00792298|525650656|FG002|Treatment Period 2|Physician Decision|0|||
145765561|NCT00792298|525650657|FG003|Treatment Period 2|Physician Decision|0|||
145765562|NCT00792298|525650658|FG004|Treatment Period 2|Physician Decision|0|||
145765563|NCT00792298|525650659|FG005|Treatment Period 2|Physician Decision|0|||
145765564|NCT00792298|525650660|FG006|Treatment Period 2|Physician Decision|1|||
145765565|NCT00792298|525650661|FG007|Treatment Period 2|Physician Decision|0|||
145765566|NCT00792298|525650654|FG000|Treatment Period 2|Pregnancy|0|||
145765567|NCT00792298|525650655|FG001|Treatment Period 2|Pregnancy|0|||
145765568|NCT00792298|525650656|FG002|Treatment Period 2|Pregnancy|1|||
145765569|NCT00792298|525650657|FG003|Treatment Period 2|Pregnancy|0|||
145765570|NCT00792298|525650658|FG004|Treatment Period 2|Pregnancy|0|||
145765571|NCT00792298|525650659|FG005|Treatment Period 2|Pregnancy|0|||
145765572|NCT00792298|525650660|FG006|Treatment Period 2|Pregnancy|0|||
145402957|NCT00087178|524332568|FG001|Overall Study|No follow up data|15|||
145402958|NCT00087178|524332567|FG000|Overall Study|No clinical assessment|1|||
145402959|NCT00087178|524332568|FG001|Overall Study|No clinical assessment|2|||
145402960|NCT00087178|524332567|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
145402961|NCT00087178|524332568|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
145402962|NCT03704064|524332569|FG000|Overall Study|Lost to Follow-up|8|||
145402963|NCT03704064|524332570|FG001|Overall Study|Lost to Follow-up|4|||
145402964|NCT03704064|524332569|FG000|Overall Study|Withdrawal by Subject|1|||
145402965|NCT03704064|524332570|FG001|Overall Study|Withdrawal by Subject|1|||
145402966|NCT03704064|524332569|FG000|Overall Study|No longer available for study visits|0|||
145402967|NCT03704064|524332570|FG001|Overall Study|No longer available for study visits|1|||
145402968|NCT03704064|524332569|FG000|Overall Study|Censoring event|1|||
145402969|NCT03704064|524332570|FG001|Overall Study|Censoring event|0|||
145402970|NCT00289276|524332573|FG000|Second Part of FAST Study (Expansion)|Death|0|||
145402971|NCT00289276|524332574|FG001|Second Part of FAST Study (Expansion)|Death|2|||
145402972|NCT00289276|524332573|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
145402973|NCT00289276|524332574|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
145402974|NCT01604785|524332575|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
145402975|NCT01604785|524332576|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
145402976|NCT00726609|524332577|FG000|Overall Study|Adverse Event|10|||
145402977|NCT00726609|524332577|FG000|Overall Study|Withdrawal by Subject|2|||
145402978|NCT00726609|524332577|FG000|Overall Study|Lack of Efficacy|25|||
145402979|NCT00726609|524332577|FG000|Overall Study|Other|16|||
145402980|NCT00726609|524332577|FG000|Overall Study|Missing|42|||
145402981|NCT00726609|524332577|FG000|Overall Study|Other|3|||
145402982|NCT00746551|524332580|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
145402983|NCT00746551|524332581|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
145402984|NCT00746551|524332580|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
145402985|NCT00746551|524332581|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
145402986|NCT00746551|524332580|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
145402987|NCT00746551|524332581|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
145402988|NCT02029417|524332582|FG000|Overall Study|Death|1|||
145402989|NCT02029417|524332582|FG000|Overall Study|Adverse Event|1|||
145402990|NCT02908347|524332584|FG000|Overall Study|Adverse Event|0|||
145402991|NCT02908347|524332585|FG001|Overall Study|Adverse Event|1|||
145402992|NCT02908347|524332584|FG000|Overall Study|Lost to Follow-up|1|||
145402993|NCT02908347|524332585|FG001|Overall Study|Lost to Follow-up|0|||
145402994|NCT03104374|524332586|FG000|Period 1|Adverse Event|7|||
145402995|NCT03104374|524332587|FG001|Period 1|Adverse Event|7|||
145402996|NCT03104374|524332588|FG002|Period 1|Adverse Event|12|||
145402997|NCT03104374|524332589|FG003|Period 1|Adverse Event|14|||
145402998|NCT03104374|524332586|FG000|Period 1|Withdrawal by Subject|18|||
145402999|NCT03104374|524332587|FG001|Period 1|Withdrawal by Subject|9|||
145403000|NCT03104374|524332588|FG002|Period 1|Withdrawal by Subject|10|||
145403001|NCT03104374|524332589|FG003|Period 1|Withdrawal by Subject|17|||
145403002|NCT03104374|524332586|FG000|Period 1|Lost to Follow-up|4|||
145403003|NCT03104374|524332587|FG001|Period 1|Lost to Follow-up|4|||
145403004|NCT03104374|524332588|FG002|Period 1|Lost to Follow-up|6|||
145403005|NCT03104374|524332589|FG003|Period 1|Lost to Follow-up|8|||
145403006|NCT03104374|524332586|FG000|Period 1|Lack of Efficacy|6|||
145403007|NCT03104374|524332587|FG001|Period 1|Lack of Efficacy|7|||
145403008|NCT03104374|524332588|FG002|Period 1|Lack of Efficacy|12|||
145403009|NCT03104374|524332589|FG003|Period 1|Lack of Efficacy|6|||
145403010|NCT03104374|524332586|FG000|Period 1|Other|2|||
145403011|NCT03104374|524332587|FG001|Period 1|Other|2|||
145403012|NCT03104374|524332588|FG002|Period 1|Other|4|||
145403013|NCT03104374|524332589|FG003|Period 1|Other|7|||
145403014|NCT03104374|524332586|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145403015|NCT03104374|524332587|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145403016|NCT03104374|524332588|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
145403017|NCT03104374|524332589|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
145403018|NCT03104374|524332586|FG000|Period 2|Adverse Event|4|||
145403019|NCT03104374|524332587|FG001|Period 2|Adverse Event|7|||
145403020|NCT03104374|524332588|FG002|Period 2|Adverse Event|10|||
145403021|NCT03104374|524332589|FG003|Period 2|Adverse Event|10|||
145403022|NCT03104374|524332586|FG000|Period 2|Withdrawal by Subject|3|||
145403023|NCT03104374|524332587|FG001|Period 2|Withdrawal by Subject|7|||
145403024|NCT03104374|524332588|FG002|Period 2|Withdrawal by Subject|13|||
145403025|NCT03104374|524332589|FG003|Period 2|Withdrawal by Subject|16|||
145403026|NCT03104374|524332586|FG000|Period 2|Lost to Follow-up|2|||
145403027|NCT03104374|524332587|FG001|Period 2|Lost to Follow-up|2|||
145403028|NCT03104374|524332588|FG002|Period 2|Lost to Follow-up|3|||
145403029|NCT03104374|524332589|FG003|Period 2|Lost to Follow-up|5|||
145403030|NCT03104374|524332586|FG000|Period 2|Lack of Efficacy|2|||
145403031|NCT03104374|524332587|FG001|Period 2|Lack of Efficacy|4|||
145403032|NCT03104374|524332588|FG002|Period 2|Lack of Efficacy|7|||
145403033|NCT03104374|524332589|FG003|Period 2|Lack of Efficacy|4|||
145403034|NCT03104374|524332586|FG000|Period 2|COVID-19 Infection|0|||
145403035|NCT03104374|524332587|FG001|Period 2|COVID-19 Infection|0|||
145403036|NCT03104374|524332588|FG002|Period 2|COVID-19 Infection|1|||
145403037|NCT03104374|524332589|FG003|Period 2|COVID-19 Infection|0|||
145403038|NCT03104374|524332586|FG000|Period 2|Other|3|||
145403039|NCT03104374|524332587|FG001|Period 2|Other|2|||
145403040|NCT03104374|524332588|FG002|Period 2|Other|2|||
145403041|NCT03104374|524332589|FG003|Period 2|Other|4|||
145403042|NCT02121210|524332590|FG000|Overall Study|Adverse Event|5|||
145403043|NCT02121210|524332591|FG001|Overall Study|Adverse Event|7|||
145403044|NCT02121210|524332590|FG000|Overall Study|Lack of Efficacy|2|||
145403045|NCT02121210|524332591|FG001|Overall Study|Lack of Efficacy|0|||
145403046|NCT02121210|524332590|FG000|Overall Study|Other than specified above|0|||
145403047|NCT02121210|524332591|FG001|Overall Study|Other than specified above|2|||
145403048|NCT04609514|524332592|FG000|Overall Study|Lost to Follow-up|5|||
145403049|NCT04609514|524332593|FG001|Overall Study|Lost to Follow-up|4|||
145403050|NCT04609514|524332592|FG000|Overall Study|Withdrawal by PI|0|||
145403051|NCT04609514|524332593|FG001|Overall Study|Withdrawal by PI|2|||
145403052|NCT00909870|524332594|FG000|Overall Study|Adverse Event|13|||
145403053|NCT00909870|524332595|FG001|Overall Study|Adverse Event|7|||
145403054|NCT00909870|524332594|FG000|Overall Study|Protocol Violation|1|||
145403055|NCT00909870|524332595|FG001|Overall Study|Protocol Violation|2|||
145403056|NCT00909870|524332594|FG000|Overall Study|Withdrawal by Subject|5|||
145403057|NCT00909870|524332595|FG001|Overall Study|Withdrawal by Subject|8|||
145403058|NCT00909870|524332594|FG000|Overall Study|Lost to Follow-up|3|||
145403059|NCT00909870|524332595|FG001|Overall Study|Lost to Follow-up|3|||
145765573|NCT00792298|525650661|FG007|Treatment Period 2|Pregnancy|0|||
145765574|NCT00792298|525650654|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145765575|NCT00792298|525650655|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145765576|NCT00792298|525650656|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145765577|NCT00792298|525650657|FG003|Treatment Period 2|Withdrawal by Subject|2|||
145765578|NCT00792298|525650658|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145765579|NCT00792298|525650659|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145765580|NCT00792298|525650660|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145765581|NCT00792298|525650661|FG007|Treatment Period 2|Withdrawal by Subject|2|||
145765582|NCT01756274|525650662|FG000|Overall Study|Protocol Violation|2|||
145765583|NCT01756274|525650662|FG000|Overall Study|Laboratory error|1|||
145277567|NCT00963599|523867181|FG000|Overall Study|Withdrawal by Subject|2|||
145277568|NCT00963599|523867182|FG001|Overall Study|Withdrawal by Subject|1|||
145277569|NCT00963599|523867183|FG002|Overall Study|Withdrawal by Subject|3|||
145277570|NCT00963599|523867184|FG003|Overall Study|Withdrawal by Subject|3|||
145277571|NCT00190684|523867185|FG000|Overall Study|Adverse Event|86|||
145277572|NCT00190684|523867185|FG000|Overall Study|Satisfactory response|80|||
145277573|NCT00190684|523867185|FG000|Overall Study|Lack of efficacy|204|||
145277574|NCT00190684|523867185|FG000|Overall Study|Lost to Follow-up|232|||
145403060|NCT00909870|524332594|FG000|Overall Study|Physician Decision|0|||
145403061|NCT00909870|524332595|FG001|Overall Study|Physician Decision|2|||
145765584|NCT03304522|525650663|FG000|Overall Study|Adverse Event|0|||
145765585|NCT03304522|525650664|FG001|Overall Study|Adverse Event|4|||
145765586|NCT03304522|525650663|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
145765587|NCT03304522|525650664|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
145765588|NCT03304522|525650663|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
145765589|NCT03304522|525650664|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
145765590|NCT03304522|525650663|FG000|Overall Study|Other|0|||
145765591|NCT03304522|525650664|FG001|Overall Study|Other|1|||
145765592|NCT00755079|525650669|FG000|Overall Study|Lost to Follow-up|1|||
145403062|NCT00909870|524332594|FG000|Overall Study|Other|1|||
145403063|NCT00909870|524332595|FG001|Overall Study|Other|5|||
145403064|NCT01652690|524332601|FG000|Overall Study|Withdrawal by Subject|16|||
145403065|NCT01652690|524332602|FG001|Overall Study|Withdrawal by Subject|4|||
145765593|NCT00755079|525650670|FG001|Overall Study|Lost to Follow-up|3|||
145765594|NCT00755079|525650669|FG000|Overall Study|Adverse Event|0|||
145765595|NCT00755079|525650670|FG001|Overall Study|Adverse Event|1|||
145765596|NCT00755079|525650669|FG000|Overall Study|Withdrawal by Subject|0|||
145277575|NCT00190684|523867185|FG000|Overall Study|Patient moved|60|||
145403066|NCT01652690|524332601|FG000|Overall Study|Other|8|||
145403067|NCT01652690|524332602|FG001|Overall Study|Other|9|||
145403068|NCT01652690|524332601|FG000|Overall Study|Lost to Follow-up|6|||
145765597|NCT00755079|525650670|FG001|Overall Study|Withdrawal by Subject|2|||
145765598|NCT01526148|525650676|FG000|Overall Study|Adverse Event|6|||
145765599|NCT01526148|525650677|FG001|Overall Study|Adverse Event|5|||
145765600|NCT01526148|525650676|FG000|Overall Study|Lost to Follow-up|3|||
145403069|NCT01652690|524332602|FG001|Overall Study|Lost to Follow-up|6|||
145403070|NCT01652690|524332601|FG000|Overall Study|Death|5|||
145403071|NCT01652690|524332602|FG001|Overall Study|Death|2|||
145403072|NCT03225287|524332603|FG000|Overall Study|Adverse Event|0|||
145403073|NCT03225287|524332604|FG001|Overall Study|Adverse Event|0|||
145403074|NCT03225287|524332605|FG002|Overall Study|Adverse Event|1|||
145765601|NCT01526148|525650677|FG001|Overall Study|Lost to Follow-up|6|||
145277576|NCT00190684|523867185|FG000|Overall Study|Patient Decision|432|||
145277577|NCT00190684|523867185|FG000|Overall Study|Clinical relapse|67|||
145277578|NCT00190684|523867185|FG000|Overall Study|Sponsor's decision|17|||
145277579|NCT00190684|523867185|FG000|Overall Study|Physician Decision|84|||
145277580|NCT00190684|523867185|FG000|Overall Study|Protocol Violation|123|||
145277581|NCT00190684|523867185|FG000|Overall Study|Study Period III Completed|103|||
145277582|NCT00190684|523867185|FG000|Overall Study|Study Period V Completed|1|||
145277583|NCT03496207|523867186|FG000|Base Study|Adverse Event|0|||
145277584|NCT03496207|523867187|FG001|Base Study|Adverse Event|0|||
145277585|NCT03496207|523867188|FG002|Base Study|Adverse Event|1|||
145277586|NCT03496207|523867189|FG003|Base Study|Adverse Event|1|||
145277587|NCT03496207|523867190|FG004|Base Study|Adverse Event|4|||
145277588|NCT03496207|523867186|FG000|Base Study|Death|0|||
145277589|NCT03496207|523867187|FG001|Base Study|Death|0|||
145277590|NCT03496207|523867188|FG002|Base Study|Death|0|||
145277591|NCT03496207|523867189|FG003|Base Study|Death|0|||
145277592|NCT03496207|523867190|FG004|Base Study|Death|1|||
145277593|NCT03496207|523867186|FG000|Base Study|Withdrawal by Subject|0|||
145277594|NCT03496207|523867187|FG001|Base Study|Withdrawal by Subject|0|||
145277595|NCT03496207|523867188|FG002|Base Study|Withdrawal by Subject|1|||
145277596|NCT03496207|523867189|FG003|Base Study|Withdrawal by Subject|0|||
145277597|NCT03496207|523867190|FG004|Base Study|Withdrawal by Subject|1|||
145277598|NCT03496207|523867186|FG000|Extension Period|Adverse Event|0|||
145277599|NCT03496207|523867187|FG001|Extension Period|Adverse Event|0|||
145277600|NCT03496207|523867188|FG002|Extension Period|Adverse Event|0|||
145277601|NCT03496207|523867189|FG003|Extension Period|Adverse Event|1|||
145277602|NCT03496207|523867190|FG004|Extension Period|Adverse Event|1|||
145277603|NCT03496207|523867186|FG000|Extension Period|Death|1|||
145277604|NCT03496207|523867187|FG001|Extension Period|Death|0|||
145277605|NCT03496207|523867188|FG002|Extension Period|Death|0|||
145277606|NCT03496207|523867189|FG003|Extension Period|Death|1|||
145277607|NCT03496207|523867190|FG004|Extension Period|Death|2|||
145277608|NCT03496207|523867186|FG000|Extension Period|Withdrawal by Subject|1|||
145277609|NCT03496207|523867187|FG001|Extension Period|Withdrawal by Subject|0|||
145277610|NCT03496207|523867188|FG002|Extension Period|Withdrawal by Subject|0|||
145277611|NCT03496207|523867189|FG003|Extension Period|Withdrawal by Subject|1|||
145277612|NCT03496207|523867190|FG004|Extension Period|Withdrawal by Subject|1|||
145277613|NCT03496207|523867186|FG000|Extension Period|Elevated hemoglobin levels|0|||
145277614|NCT03496207|523867187|FG001|Extension Period|Elevated hemoglobin levels|0|||
145277615|NCT03496207|523867188|FG002|Extension Period|Elevated hemoglobin levels|0|||
145277616|NCT03496207|523867189|FG003|Extension Period|Elevated hemoglobin levels|0|||
145277617|NCT03496207|523867190|FG004|Extension Period|Elevated hemoglobin levels|1|||
145277618|NCT01706770|523867191|FG000|Overall Study|Lost to Follow-up|1|||
145277619|NCT01706770|523867192|FG001|Overall Study|Lost to Follow-up|0|||
145277620|NCT01706770|523867191|FG000|Overall Study|Physician Decision|1|||
145277621|NCT01706770|523867192|FG001|Overall Study|Physician Decision|0|||
145277622|NCT00123487|523867193|FG000|Randomized|Death prior to starting treatment|0|||
145277623|NCT00123487|523867194|FG001|Randomized|Death prior to starting treatment|1|||
145765602|NCT01526148|525650676|FG000|Overall Study|Withdrawal by Subject|2|||
145765603|NCT01526148|525650677|FG001|Overall Study|Withdrawal by Subject|0|||
145765604|NCT01526148|525650676|FG000|Overall Study|Unstable Medical Condition|1|||
145765605|NCT01526148|525650677|FG001|Overall Study|Unstable Medical Condition|0|||
145765606|NCT01526148|525650676|FG000|Overall Study|Unable to discontinue concomitant med|1|||
145765607|NCT01526148|525650677|FG001|Overall Study|Unable to discontinue concomitant med|0|||
145765608|NCT01526148|525650676|FG000|Overall Study|Moved out of state|1|||
145765609|NCT01526148|525650677|FG001|Overall Study|Moved out of state|0|||
145765610|NCT01526148|525650676|FG000|Overall Study|Incarcerated|0|||
145765611|NCT01526148|525650677|FG001|Overall Study|Incarcerated|2|||
145765612|NCT01173653|525650678|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
145277624|NCT00123487|523867193|FG000|Randomized|SAE prior to starting treatment|1|||
145277625|NCT00123487|523867194|FG001|Randomized|SAE prior to starting treatment|0|||
145403075|NCT03225287|524332603|FG000|Overall Study|Protocol non-compliance|0|||
145403076|NCT03225287|524332604|FG001|Overall Study|Protocol non-compliance|0|||
145403077|NCT03225287|524332605|FG002|Overall Study|Protocol non-compliance|1|||
145607924|NCT01852058|525079284|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145765613|NCT01173653|525650679|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
145765614|NCT03308188|525650680|FG000|Overall Study|Withdrawal by Subject|0|||
145277626|NCT00123487|523867193|FG000|Treated With Study Drug|Adverse Event|23|||
145277627|NCT00123487|523867194|FG001|Treated With Study Drug|Adverse Event|22|||
145277628|NCT00123487|523867193|FG000|Treated With Study Drug|Disease Progression|141|||
145277629|NCT00123487|523867194|FG001|Treated With Study Drug|Disease Progression|122|||
145277630|NCT00123487|523867193|FG000|Treated With Study Drug|Physician Decision|8|||
145277631|NCT00123487|523867194|FG001|Treated With Study Drug|Physician Decision|9|||
145277632|NCT00123487|523867193|FG000|Treated With Study Drug|Other|59|||
145277633|NCT00123487|523867194|FG001|Treated With Study Drug|Other|58|||
145277634|NCT00123487|523867193|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
145277635|NCT00123487|523867194|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
145765615|NCT03308188|525650681|FG001|Overall Study|Withdrawal by Subject|3|||
145765616|NCT03308188|525650680|FG000|Overall Study|Death|0|||
145765617|NCT03308188|525650681|FG001|Overall Study|Death|1|||
145765618|NCT01791855|525650682|FG000|Overall Study|Adverse Event|0|||
145765619|NCT01791855|525650683|FG001|Overall Study|Adverse Event|0|||
145765620|NCT01791855|525650684|FG002|Overall Study|Adverse Event|0|||
145765621|NCT01791855|525650685|FG003|Overall Study|Adverse Event|1|||
145765622|NCT01791855|525650682|FG000|Overall Study|Randomized, not treated|0|||
145765623|NCT01791855|525650683|FG001|Overall Study|Randomized, not treated|1|||
145765624|NCT01791855|525650684|FG002|Overall Study|Randomized, not treated|0|||
145765625|NCT01791855|525650685|FG003|Overall Study|Randomized, not treated|0|||
145765626|NCT00772447|525650686|FG000|Overall Study|Withdrawal by Subject|9|||
145765627|NCT00772447|525650687|FG001|Overall Study|Withdrawal by Subject|5|||
145765628|NCT00772447|525650686|FG000|Overall Study|Physician Decision|4|||
145765629|NCT00772447|525650687|FG001|Overall Study|Physician Decision|8|||
145765630|NCT00772447|525650686|FG000|Overall Study|Lost to Follow-up|2|||
145765631|NCT00772447|525650687|FG001|Overall Study|Lost to Follow-up|4|||
145765632|NCT00772447|525650686|FG000|Overall Study|incorrect enrolment|3|||
145765633|NCT00772447|525650687|FG001|Overall Study|incorrect enrolment|4|||
145765634|NCT00772447|525650686|FG000|Overall Study|Protocol Violation|0|||
145765635|NCT00772447|525650687|FG001|Overall Study|Protocol Violation|1|||
145277636|NCT00123487|523867193|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
145765636|NCT00772447|525650686|FG000|Overall Study|all others|2|||
145765637|NCT00772447|525650687|FG001|Overall Study|all others|2|||
145765638|NCT03529409|525650693|FG000|Randomized|Lost to Follow-up|0|||
145765639|NCT03529409|525650694|FG001|Randomized|Lost to Follow-up|0|||
145765640|NCT03529409|525650695|FG002|Randomized|Lost to Follow-up|4|||
145765641|NCT03529409|525650693|FG000|Randomized|Excluded|0|||
145765642|NCT03529409|525650694|FG001|Randomized|Excluded|0|||
145765643|NCT03529409|525650695|FG002|Randomized|Excluded|1|||
145765644|NCT03529409|525650693|FG000|Post-treatment Assessment|Death|1|||
145765645|NCT03529409|525650694|FG001|Post-treatment Assessment|Death|0|||
145765646|NCT03529409|525650695|FG002|Post-treatment Assessment|Death|0|||
145765647|NCT03529409|525650693|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
145765648|NCT03529409|525650694|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
145765649|NCT03529409|525650695|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
145765650|NCT03529409|525650693|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
145765651|NCT03529409|525650694|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
145765652|NCT03529409|525650695|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
145765653|NCT03529409|525650693|FG000|Follow-up Assessment|Death|1|||
145765654|NCT03529409|525650694|FG001|Follow-up Assessment|Death|0|||
145765655|NCT03529409|525650695|FG002|Follow-up Assessment|Death|0|||
145765656|NCT03529409|525650693|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
145765657|NCT03529409|525650694|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
145765658|NCT03529409|525650695|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
145765659|NCT01497262|525650696|FG000|Overall Study|Abnormal Lab Values|4|||
145765660|NCT01497262|525650696|FG000|Overall Study|Abnormal Test Procedure Result|1|||
145277637|NCT00123487|523867194|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
145277638|NCT00123487|523867193|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
145277639|NCT00123487|523867194|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
145607925|NCT01852058|525079285|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145765661|NCT01497262|525650696|FG000|Overall Study|Physician Decision|1|||
145765662|NCT01497262|525650696|FG000|Overall Study|Withdrawal by Subject|2|||
145765663|NCT01497262|525650696|FG000|Overall Study|Adverse Event|2|||
145765664|NCT01497262|525650696|FG000|Overall Study|Protocol Violation|1|||
145765665|NCT01290887|525650697|FG000|Overall Study|Adverse Event|6|||
145765666|NCT01290887|525650698|FG001|Overall Study|Adverse Event|11|||
145765667|NCT01290887|525650697|FG000|Overall Study|Lack of Efficacy|4|||
145765668|NCT01290887|525650698|FG001|Overall Study|Lack of Efficacy|5|||
145765669|NCT01290887|525650697|FG000|Overall Study|Withdrawal by Subject|26|||
145765670|NCT01290887|525650698|FG001|Overall Study|Withdrawal by Subject|32|||
145765671|NCT01290887|525650697|FG000|Overall Study|Protocol Violation|2|||
145765672|NCT01290887|525650698|FG001|Overall Study|Protocol Violation|1|||
145765673|NCT01290887|525650697|FG000|Overall Study|Lost to Follow-up|4|||
145765674|NCT01290887|525650698|FG001|Overall Study|Lost to Follow-up|4|||
145765675|NCT01290887|525650697|FG000|Overall Study|Non-compliance to study procedures|0|||
145765676|NCT01290887|525650698|FG001|Overall Study|Non-compliance to study procedures|1|||
145765677|NCT01290887|525650697|FG000|Overall Study|Non-compliance to study medications|1|||
145765678|NCT01290887|525650698|FG001|Overall Study|Non-compliance to study medications|0|||
145765679|NCT01290887|525650697|FG000|Overall Study|Sponsor closure of study|420|||
145765680|NCT01290887|525650698|FG001|Overall Study|Sponsor closure of study|476|||
145765681|NCT01290887|525650697|FG000|Overall Study|Other|3|||
145765682|NCT01290887|525650698|FG001|Overall Study|Other|6|||
145765683|NCT02764541|525650699|FG000|Overall Study|Withdrawal by Subject|0|||
145765684|NCT02764541|525650700|FG001|Overall Study|Withdrawal by Subject|0|||
145765685|NCT02764541|525650701|FG002|Overall Study|Withdrawal by Subject|0|||
145765686|NCT02764541|525650702|FG003|Overall Study|Withdrawal by Subject|0|||
145765687|NCT02764541|525650703|FG004|Overall Study|Withdrawal by Subject|1|||
145765688|NCT02764541|525650704|FG005|Overall Study|Withdrawal by Subject|1|||
145765689|NCT02764541|525650705|FG006|Overall Study|Withdrawal by Subject|0|||
145765690|NCT02764541|525650706|FG007|Overall Study|Withdrawal by Subject|1|||
145765691|NCT02764541|525650699|FG000|Overall Study|Adverse Event|1|||
145765692|NCT02764541|525650700|FG001|Overall Study|Adverse Event|0|||
145765693|NCT02764541|525650701|FG002|Overall Study|Adverse Event|0|||
145765694|NCT02764541|525650702|FG003|Overall Study|Adverse Event|0|||
145765695|NCT02764541|525650703|FG004|Overall Study|Adverse Event|0|||
145765696|NCT02764541|525650704|FG005|Overall Study|Adverse Event|0|||
145765697|NCT02764541|525650705|FG006|Overall Study|Adverse Event|1|||
145765698|NCT02764541|525650706|FG007|Overall Study|Adverse Event|0|||
145765699|NCT02764541|525650699|FG000|Overall Study|Metastasis|1|||
145765700|NCT02764541|525650700|FG001|Overall Study|Metastasis|0|||
145765701|NCT02764541|525650701|FG002|Overall Study|Metastasis|0|||
145765702|NCT02764541|525650702|FG003|Overall Study|Metastasis|0|||
145765703|NCT02764541|525650703|FG004|Overall Study|Metastasis|0|||
145765704|NCT02764541|525650704|FG005|Overall Study|Metastasis|0|||
145765705|NCT02764541|525650705|FG006|Overall Study|Metastasis|0|||
145765706|NCT02764541|525650706|FG007|Overall Study|Metastasis|0|||
145765707|NCT02764541|525650699|FG000|Overall Study|Disease progression|1|||
145765708|NCT02764541|525650700|FG001|Overall Study|Disease progression|1|||
145765709|NCT02764541|525650701|FG002|Overall Study|Disease progression|0|||
145765710|NCT02764541|525650702|FG003|Overall Study|Disease progression|0|||
145765711|NCT02764541|525650703|FG004|Overall Study|Disease progression|0|||
145765712|NCT02764541|525650704|FG005|Overall Study|Disease progression|0|||
145765713|NCT02764541|525650705|FG006|Overall Study|Disease progression|0|||
145765714|NCT02764541|525650706|FG007|Overall Study|Disease progression|1|||
145765715|NCT02764541|525650699|FG000|Overall Study|Protocol Violation|0|||
145277640|NCT01783483|523867199|FG000|Overall Study|Death|3|||
145277641|NCT01783483|523867200|FG001|Overall Study|Death|3|||
145277642|NCT01783483|523867199|FG000|Overall Study|Lost to Follow-up|14|||
145277643|NCT01783483|523867200|FG001|Overall Study|Lost to Follow-up|10|||
145277644|NCT01783483|523867199|FG000|Overall Study|Withdrawal by Subject|2|||
145277645|NCT01783483|523867200|FG001|Overall Study|Withdrawal by Subject|1|||
145277646|NCT01783483|523867199|FG000|Overall Study|Physician Decision|1|||
145277647|NCT01783483|523867200|FG001|Overall Study|Physician Decision|1|||
145277648|NCT02065791|523867206|FG000|Overall Study|Closed Site|1|||
145277649|NCT02065791|523867207|FG001|Overall Study|Closed Site|1|||
145277650|NCT02065791|523867206|FG000|Overall Study|Withdrawal by Subject|11|||
145277651|NCT02065791|523867207|FG001|Overall Study|Withdrawal by Subject|5|||
145277652|NCT02065791|523867206|FG000|Overall Study|Lost to Follow-up|13|||
145277653|NCT02065791|523867207|FG001|Overall Study|Lost to Follow-up|9|||
145277654|NCT00975884|523867208|FG000|Overall Study|Adverse Event|1|||
145277655|NCT00975884|523867209|FG001|Overall Study|Adverse Event|0|||
145277656|NCT00975884|523867208|FG000|Overall Study|Lost to Follow-up|5|||
145533473|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
145765716|NCT02764541|525650700|FG001|Overall Study|Protocol Violation|0|||
145765717|NCT02764541|525650701|FG002|Overall Study|Protocol Violation|0|||
145765718|NCT02764541|525650702|FG003|Overall Study|Protocol Violation|1|||
145765719|NCT02764541|525650703|FG004|Overall Study|Protocol Violation|0|||
145765720|NCT02764541|525650704|FG005|Overall Study|Protocol Violation|1|||
145765721|NCT02764541|525650705|FG006|Overall Study|Protocol Violation|0|||
145277657|NCT00975884|523867209|FG001|Overall Study|Lost to Follow-up|3|||
145277658|NCT00975884|523867208|FG000|Overall Study|Withdrawal by Subject|9|||
145277659|NCT00975884|523867209|FG001|Overall Study|Withdrawal by Subject|9|||
145277660|NCT00975884|523867208|FG000|Overall Study|Other|1|||
145277661|NCT00975884|523867209|FG001|Overall Study|Other|3|||
145277662|NCT00051636|523867210|FG000|Period 1 - Core|Adverse Event|2|||
145277663|NCT00051636|523867211|FG001|Period 1 - Core|Adverse Event|2|||
145765722|NCT02764541|525650706|FG007|Overall Study|Protocol Violation|0|||
145765723|NCT02764541|525650699|FG000|Overall Study|Physician Decision|0|||
145765724|NCT02764541|525650700|FG001|Overall Study|Physician Decision|0|||
145765725|NCT02764541|525650701|FG002|Overall Study|Physician Decision|0|||
145765726|NCT02764541|525650702|FG003|Overall Study|Physician Decision|1|||
145765727|NCT02764541|525650703|FG004|Overall Study|Physician Decision|0|||
145765728|NCT02764541|525650704|FG005|Overall Study|Physician Decision|0|||
145765729|NCT02764541|525650705|FG006|Overall Study|Physician Decision|0|||
145765730|NCT02764541|525650706|FG007|Overall Study|Physician Decision|1|||
145765731|NCT02764541|525650699|FG000|Overall Study|Three Cycles completed before surgery|0|||
145765732|NCT02764541|525650700|FG001|Overall Study|Three Cycles completed before surgery|0|||
145765733|NCT02764541|525650701|FG002|Overall Study|Three Cycles completed before surgery|0|||
145765734|NCT02764541|525650702|FG003|Overall Study|Three Cycles completed before surgery|1|||
145765735|NCT02764541|525650703|FG004|Overall Study|Three Cycles completed before surgery|0|||
145533474|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
145533475|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
145533476|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
145765736|NCT02764541|525650704|FG005|Overall Study|Three Cycles completed before surgery|0|||
145765737|NCT02764541|525650705|FG006|Overall Study|Three Cycles completed before surgery|0|||
145765738|NCT02764541|525650706|FG007|Overall Study|Three Cycles completed before surgery|0|||
145765739|NCT02764541|525650699|FG000|Overall Study|Patient Compliance|0|||
145765740|NCT02764541|525650700|FG001|Overall Study|Patient Compliance|0|||
145765741|NCT02764541|525650701|FG002|Overall Study|Patient Compliance|1|||
145765742|NCT02764541|525650702|FG003|Overall Study|Patient Compliance|0|||
145533477|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
145765743|NCT02764541|525650703|FG004|Overall Study|Patient Compliance|0|||
145765744|NCT02764541|525650704|FG005|Overall Study|Patient Compliance|0|||
145765745|NCT02764541|525650705|FG006|Overall Study|Patient Compliance|0|||
145765746|NCT02764541|525650706|FG007|Overall Study|Patient Compliance|0|||
145765747|NCT02764541|525650699|FG000|Overall Study|Death|0|||
145765748|NCT02764541|525650700|FG001|Overall Study|Death|0|||
145765749|NCT02764541|525650701|FG002|Overall Study|Death|0|||
145765750|NCT02764541|525650702|FG003|Overall Study|Death|0|||
145765751|NCT02764541|525650703|FG004|Overall Study|Death|0|||
145765752|NCT02764541|525650704|FG005|Overall Study|Death|0|||
145765753|NCT02764541|525650705|FG006|Overall Study|Death|1|||
145765754|NCT02764541|525650706|FG007|Overall Study|Death|0|||
145765755|NCT02764541|525650699|FG000|Overall Study|Insurance reasons|0|||
145765756|NCT02764541|525650700|FG001|Overall Study|Insurance reasons|0|||
145765757|NCT02764541|525650701|FG002|Overall Study|Insurance reasons|0|||
145765758|NCT02764541|525650702|FG003|Overall Study|Insurance reasons|0|||
145765759|NCT02764541|525650703|FG004|Overall Study|Insurance reasons|0|||
145765760|NCT02764541|525650704|FG005|Overall Study|Insurance reasons|0|||
145765761|NCT02764541|525650705|FG006|Overall Study|Insurance reasons|1|||
145765762|NCT02764541|525650706|FG007|Overall Study|Insurance reasons|0|||
145765763|NCT00749190|525650709|FG000|Overall Study|Adverse Event|0|||
145765764|NCT00749190|525650710|FG001|Overall Study|Adverse Event|2|||
145765765|NCT00749190|525650711|FG002|Overall Study|Adverse Event|0|||
145765766|NCT00749190|525650712|FG003|Overall Study|Adverse Event|4|||
145765767|NCT00749190|525650713|FG004|Overall Study|Adverse Event|0|||
145765768|NCT00749190|525650714|FG005|Overall Study|Adverse Event|3|||
145765769|NCT00749190|525650715|FG006|Overall Study|Adverse Event|0|||
145765770|NCT00749190|525650709|FG000|Overall Study|Lack of Efficacy|3|||
145765771|NCT00749190|525650710|FG001|Overall Study|Lack of Efficacy|1|||
145765772|NCT00749190|525650711|FG002|Overall Study|Lack of Efficacy|1|||
145765773|NCT00749190|525650712|FG003|Overall Study|Lack of Efficacy|0|||
145765774|NCT00749190|525650713|FG004|Overall Study|Lack of Efficacy|0|||
145765775|NCT00749190|525650714|FG005|Overall Study|Lack of Efficacy|1|||
145765776|NCT00749190|525650715|FG006|Overall Study|Lack of Efficacy|0|||
145765777|NCT00749190|525650709|FG000|Overall Study|Withdrawal by Subject|2|||
145765778|NCT00749190|525650710|FG001|Overall Study|Withdrawal by Subject|1|||
145765779|NCT00749190|525650711|FG002|Overall Study|Withdrawal by Subject|0|||
145765780|NCT00749190|525650712|FG003|Overall Study|Withdrawal by Subject|0|||
145765781|NCT00749190|525650713|FG004|Overall Study|Withdrawal by Subject|0|||
145765782|NCT00749190|525650714|FG005|Overall Study|Withdrawal by Subject|1|||
145765783|NCT00749190|525650715|FG006|Overall Study|Withdrawal by Subject|0|||
145765784|NCT00749190|525650709|FG000|Overall Study|Protocol Violation|0|||
145765785|NCT00749190|525650710|FG001|Overall Study|Protocol Violation|1|||
145765786|NCT00749190|525650711|FG002|Overall Study|Protocol Violation|0|||
145765787|NCT00749190|525650712|FG003|Overall Study|Protocol Violation|0|||
145765788|NCT00749190|525650713|FG004|Overall Study|Protocol Violation|0|||
145765789|NCT00749190|525650714|FG005|Overall Study|Protocol Violation|0|||
145765790|NCT00749190|525650715|FG006|Overall Study|Protocol Violation|1|||
145765791|NCT00749190|525650709|FG000|Overall Study|Other reason not defined above|0|||
145765792|NCT00749190|525650710|FG001|Overall Study|Other reason not defined above|0|||
145765793|NCT00749190|525650711|FG002|Overall Study|Other reason not defined above|0|||
145765794|NCT00749190|525650712|FG003|Overall Study|Other reason not defined above|1|||
145765795|NCT00749190|525650713|FG004|Overall Study|Other reason not defined above|0|||
145765796|NCT00749190|525650714|FG005|Overall Study|Other reason not defined above|0|||
145765797|NCT00749190|525650715|FG006|Overall Study|Other reason not defined above|0|||
145765798|NCT00784758|525650716|FG000|Overall Study|Withdrawal by Subject|3|||
145765799|NCT00784758|525650717|FG001|Overall Study|Withdrawal by Subject|0|||
145765800|NCT00784758|525650716|FG000|Overall Study|Adverse Event|1|||
145765801|NCT00784758|525650717|FG001|Overall Study|Adverse Event|0|||
145765802|NCT02040142|525650718|FG000|Overall Study|Lost to Follow-up|5|||
145765803|NCT02040142|525650718|FG000|Overall Study|Death|17|||
145765804|NCT02040142|525650718|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
145765805|NCT04752384|525650719|FG000|Overall Study|Withdrawal by Subject|1|||
145765806|NCT04752384|525650719|FG000|Overall Study|Death|1|||
145765807|NCT02330419|525650724|FG000|Overall Study|Lost to Follow-up|3|||
145765808|NCT02330419|525650725|FG001|Overall Study|Lost to Follow-up|7|||
145765809|NCT03896581|525651932|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
145765810|NCT03896581|525651933|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
145765811|NCT03896581|525651932|FG000|Overall Study|Withdrawal by Subject|4|||
145765812|NCT03896581|525651933|FG001|Overall Study|Withdrawal by Subject|1|||
145765813|NCT03896581|525651932|FG000|Overall Study|Lost to Follow-up|1|||
145765814|NCT03896581|525651933|FG001|Overall Study|Lost to Follow-up|0|||
145765815|NCT03896581|525651932|FG000|Overall Study|Lack of Efficacy|2|||
145765816|NCT03896581|525651933|FG001|Overall Study|Lack of Efficacy|1|||
145765817|NCT03896581|525651932|FG000|Overall Study|Adverse event, non-fatal|0|||
145765818|NCT03896581|525651933|FG001|Overall Study|Adverse event, non-fatal|2|||
145765819|NCT04854499|525651934|FG000|Overall Study|Study Terminated by Sponsor|5|||
145765820|NCT04854499|525651935|FG001|Overall Study|Study Terminated by Sponsor|27|||
145765821|NCT04854499|525651936|FG002|Overall Study|Study Terminated by Sponsor|28|||
145765822|NCT04854499|525651937|FG003|Overall Study|Study Terminated by Sponsor|19|||
145765823|NCT04854499|525651938|FG004|Overall Study|Study Terminated by Sponsor|1|||
145765824|NCT04854499|525651939|FG005|Overall Study|Study Terminated by Sponsor|10|||
145765825|NCT04854499|525651934|FG000|Overall Study|Death|1|||
145765826|NCT04854499|525651935|FG001|Overall Study|Death|23|||
145765827|NCT04854499|525651936|FG002|Overall Study|Death|21|||
145765828|NCT04854499|525651937|FG003|Overall Study|Death|7|||
145765829|NCT04854499|525651938|FG004|Overall Study|Death|6|||
145765830|NCT04854499|525651939|FG005|Overall Study|Death|24|||
145765831|NCT04854499|525651934|FG000|Overall Study|Investigator's Discretion|0|||
145765832|NCT04854499|525651935|FG001|Overall Study|Investigator's Discretion|1|||
145765833|NCT04854499|525651936|FG002|Overall Study|Investigator's Discretion|3|||
145765834|NCT04854499|525651937|FG003|Overall Study|Investigator's Discretion|4|||
145765835|NCT04854499|525651938|FG004|Overall Study|Investigator's Discretion|1|||
145765836|NCT04854499|525651939|FG005|Overall Study|Investigator's Discretion|5|||
145765837|NCT04854499|525651934|FG000|Overall Study|Withdrew Consent|0|||
145765838|NCT04854499|525651935|FG001|Overall Study|Withdrew Consent|1|||
145765839|NCT04854499|525651936|FG002|Overall Study|Withdrew Consent|2|||
145765840|NCT04854499|525651937|FG003|Overall Study|Withdrew Consent|2|||
145765841|NCT04854499|525651938|FG004|Overall Study|Withdrew Consent|0|||
145765842|NCT04854499|525651939|FG005|Overall Study|Withdrew Consent|1|||
145765843|NCT04854499|525651934|FG000|Overall Study|Lost to Follow-up|0|||
145765844|NCT04854499|525651935|FG001|Overall Study|Lost to Follow-up|0|||
145765845|NCT04854499|525651936|FG002|Overall Study|Lost to Follow-up|0|||
145765846|NCT04854499|525651937|FG003|Overall Study|Lost to Follow-up|0|||
145765847|NCT04854499|525651938|FG004|Overall Study|Lost to Follow-up|0|||
145765848|NCT04854499|525651939|FG005|Overall Study|Lost to Follow-up|1|||
145765849|NCT05415449|525651940|FG000|Overall Study|Lost to Follow-up|2|||
145765850|NCT05415449|525651940|FG000|Overall Study|Withdrawal by Subject|4|||
145765851|NCT02185521|525651944|FG000|Overall Study|Withdrawal by Subject|1|||
145765852|NCT02185521|525651944|FG000|Overall Study|Protocol Violation|1|||
145765853|NCT00398112|525651945|FG000|Overall Study|Adverse Event|4|||
145765854|NCT00398112|525651945|FG000|Overall Study|Disease progression|9|||
145765855|NCT00398112|525651945|FG000|Overall Study|Alternative treatment|1|||
145765856|NCT00398112|525651945|FG000|Overall Study|Withdrawal by Subject|3|||
145765857|NCT00398112|525651945|FG000|Overall Study|Death|1|||
145765858|NCT01887912|525651947|FG000|Overall Study|Serious adverse event|400|||
145765859|NCT01887912|525651948|FG001|Overall Study|Serious adverse event|198|||
145765860|NCT01887912|525651947|FG000|Overall Study|Other Adverse Event|34|||
145765861|NCT01887912|525651948|FG001|Overall Study|Other Adverse Event|15|||
145765862|NCT01887912|525651947|FG000|Overall Study|Protocol Violation|67|||
145765863|NCT01887912|525651948|FG001|Overall Study|Protocol Violation|37|||
145765864|NCT01887912|525651947|FG000|Overall Study|Lost to Follow-up|163|||
145765865|NCT01887912|525651948|FG001|Overall Study|Lost to Follow-up|74|||
145765866|NCT01887912|525651947|FG000|Overall Study|Withdrawal by Subject|606|||
145765867|NCT01887912|525651948|FG001|Overall Study|Withdrawal by Subject|349|||
145765868|NCT01887912|525651947|FG000|Overall Study|Other|122|||
145765869|NCT01887912|525651948|FG001|Overall Study|Other|58|||
145765870|NCT00450580|525651952|FG000|Overall Study|Adverse Event|5|||
145765871|NCT00450580|525651953|FG001|Overall Study|Adverse Event|7|||
145765872|NCT00450580|525651952|FG000|Overall Study|Lost to Follow-up|4|||
145765873|NCT00450580|525651953|FG001|Overall Study|Lost to Follow-up|5|||
145765874|NCT00450580|525651952|FG000|Overall Study|Withdrawal by Subject|2|||
145765875|NCT00450580|525651953|FG001|Overall Study|Withdrawal by Subject|2|||
145765876|NCT00450580|525651952|FG000|Overall Study|Protocol Violation|1|||
145765877|NCT00450580|525651953|FG001|Overall Study|Protocol Violation|1|||
145765878|NCT00450580|525651952|FG000|Overall Study|Protocol-defined virologic failure|1|||
145765879|NCT00450580|525651953|FG001|Overall Study|Protocol-defined virologic failure|0|||
145765880|NCT00450580|525651952|FG000|Overall Study|Could not comply with scheduled visits|1|||
145765881|NCT00450580|525651953|FG001|Overall Study|Could not comply with scheduled visits|0|||
145765882|NCT00450580|525651952|FG000|Overall Study|Patient went to Brazil|1|||
145765883|NCT00450580|525651953|FG001|Overall Study|Patient went to Brazil|0|||
145765884|NCT00450580|525651952|FG000|Overall Study|Patient could not swallow Norvir|1|||
145765885|NCT00450580|525651953|FG001|Overall Study|Patient could not swallow Norvir|0|||
145765886|NCT00450580|525651952|FG000|Overall Study|Withdrawal due to pregnancy|0|||
145765887|NCT00450580|525651953|FG001|Overall Study|Withdrawal due to pregnancy|1|||
145765888|NCT03932812|525651958|FG000|Overall Study|Lost to Follow-up|12|||
145765889|NCT03932812|525651959|FG001|Overall Study|Lost to Follow-up|14|||
145765890|NCT03932812|525651958|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
145765891|NCT03932812|525651959|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
145765892|NCT04572633|525651960|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
145765893|NCT00332709|525651961|FG000|Overall Study|Adverse Event|11|||
145765894|NCT00332709|525651962|FG001|Overall Study|Adverse Event|14|||
145765895|NCT00332709|525651961|FG000|Overall Study|Withdrawal by Subject|2|||
145765896|NCT00332709|525651962|FG001|Overall Study|Withdrawal by Subject|3|||
145765897|NCT00332709|525651961|FG000|Overall Study|Lost to Follow-up|2|||
145765898|NCT00332709|525651962|FG001|Overall Study|Lost to Follow-up|0|||
145765899|NCT00332709|525651961|FG000|Overall Study|Administrative Problems|0|||
145765900|NCT00332709|525651962|FG001|Overall Study|Administrative Problems|3|||
145765901|NCT00332709|525651961|FG000|Overall Study|Abnormal test procedure result|1|||
145765902|NCT00332709|525651962|FG001|Overall Study|Abnormal test procedure result|0|||
145765903|NCT03480802|525651963|FG000|Overall Study|Lost to Follow-up|5|||
145765904|NCT03480802|525651964|FG001|Overall Study|Lost to Follow-up|1|||
145765905|NCT03480802|525651963|FG000|Overall Study|Withdrawal by Subject|2|||
145765906|NCT03480802|525651964|FG001|Overall Study|Withdrawal by Subject|1|||
145765907|NCT03480802|525651963|FG000|Overall Study|Relocated|0|||
145765908|NCT03480802|525651964|FG001|Overall Study|Relocated|1|||
145765909|NCT05424276|525651971|FG000|Overall Study|Adverse Event|1|||
145765910|NCT05424276|525651972|FG001|Overall Study|Adverse Event|0|||
145765911|NCT05424276|525651973|FG002|Overall Study|Adverse Event|0|||
145765912|NCT05424276|525651974|FG003|Overall Study|Adverse Event|2|||
145765913|NCT05424276|525651971|FG000|Overall Study|Withdrawal by Subject|0|||
145765914|NCT05424276|525651972|FG001|Overall Study|Withdrawal by Subject|0|||
145765915|NCT05424276|525651973|FG002|Overall Study|Withdrawal by Subject|2|||
145765916|NCT05424276|525651974|FG003|Overall Study|Withdrawal by Subject|0|||
145765917|NCT05424276|525651971|FG000|Overall Study|Protocol Violation|0|||
145765918|NCT05424276|525651972|FG001|Overall Study|Protocol Violation|1|||
145765919|NCT05424276|525651973|FG002|Overall Study|Protocol Violation|0|||
145765920|NCT05424276|525651974|FG003|Overall Study|Protocol Violation|0|||
145765921|NCT05424276|525651971|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
145765922|NCT05424276|525651972|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
145765923|NCT05424276|525651973|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
145765924|NCT05424276|525651974|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
145765925|NCT00501228|525651975|FG000|Overall Study|Withdrawal by Subject|1|||
145765926|NCT01262898|525651976|FG000|Overall Study|Protocol Violation|1|||
145765927|NCT01262898|525651977|FG001|Overall Study|Protocol Violation|1|||
145765928|NCT01262898|525651978|FG002|Overall Study|Protocol Violation|0|||
145765929|NCT01262898|525651979|FG003|Overall Study|Protocol Violation|0|||
145765930|NCT01262898|525651976|FG000|Overall Study|Lost to Follow-up|1|||
145765931|NCT01262898|525651977|FG001|Overall Study|Lost to Follow-up|0|||
145765932|NCT01262898|525651978|FG002|Overall Study|Lost to Follow-up|0|||
145765933|NCT01262898|525651979|FG003|Overall Study|Lost to Follow-up|0|||
145765934|NCT01262898|525651976|FG000|Overall Study|Withdrawal by Subject|1|||
145765935|NCT01262898|525651977|FG001|Overall Study|Withdrawal by Subject|1|||
145765936|NCT01262898|525651978|FG002|Overall Study|Withdrawal by Subject|0|||
145765937|NCT01262898|525651979|FG003|Overall Study|Withdrawal by Subject|0|||
145765938|NCT00885365|525651986|FG000|4 Weeks ON Treatment|Adverse Event|2|||
145765939|NCT00885365|525651987|FG001|4 Weeks ON Treatment|Adverse Event|4|||
145765940|NCT00885365|525651986|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
145765941|NCT00885365|525651987|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
145765942|NCT00885365|525651986|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
145765943|NCT00885365|525651987|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
145765944|NCT01824979|525651988|FG000|Overall Study|Withdrawal by Subject|5|||
145765945|NCT01824979|525651989|FG001|Overall Study|Withdrawal by Subject|0|||
145765946|NCT01824979|525651988|FG000|Overall Study|Physician Decision|2|||
145765947|NCT01824979|525651989|FG001|Overall Study|Physician Decision|0|||
145765948|NCT01824979|525651988|FG000|Overall Study|Protocol Violation|6|||
145765949|NCT01824979|525651989|FG001|Overall Study|Protocol Violation|13|||
145765950|NCT00473876|525651992|FG000|Overall Study|Lost to Follow-up|3|||
145765951|NCT00473876|525651993|FG001|Overall Study|Lost to Follow-up|1|||
145607926|NCT01852058|525079286|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607927|NCT01852058|525079287|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
145607928|NCT01852058|525079276|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607929|NCT01852058|525079277|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145765952|NCT03751111|525651999|FG000|Overall Study|Lack of Efficacy|9|||
145607930|NCT01852058|525079278|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607931|NCT01852058|525079279|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607932|NCT01852058|525079280|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607933|NCT01852058|525079281|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145765953|NCT03751111|525652000|FG001|Overall Study|Lack of Efficacy|30|||
145765954|NCT03751111|525651999|FG000|Overall Study|Adverse Event|3|||
145765955|NCT03751111|525652000|FG001|Overall Study|Adverse Event|2|||
145765956|NCT01360996|525652001|FG000|Overall Study|Withdrawal by Subject|4|||
145765957|NCT01360996|525652002|FG001|Overall Study|Withdrawal by Subject|3|||
145765958|NCT01360996|525652003|FG002|Overall Study|Withdrawal by Subject|2|||
145765959|NCT01360996|525652001|FG000|Overall Study|Noncompliant|2|||
145765960|NCT01360996|525652002|FG001|Overall Study|Noncompliant|0|||
145765961|NCT01360996|525652003|FG002|Overall Study|Noncompliant|0|||
145765962|NCT02965378|525652005|FG000|Overall Study|Progression|16|||
145765963|NCT02965378|525652006|FG001|Overall Study|Progression|4|||
145765964|NCT02965378|525652005|FG000|Overall Study|Adverse Event|5|||
145765965|NCT02965378|525652006|FG001|Overall Study|Adverse Event|2|||
145765966|NCT02965378|525652005|FG000|Overall Study|Death|2|||
145765967|NCT02965378|525652006|FG001|Overall Study|Death|0|||
145765968|NCT02965378|525652005|FG000|Overall Study|Refusal|2|||
145765969|NCT02965378|525652006|FG001|Overall Study|Refusal|1|||
145765970|NCT02965378|525652005|FG000|Overall Study|Not protocol specified|0|||
145765971|NCT02965378|525652006|FG001|Overall Study|Not protocol specified|2|||
145277664|NCT00051636|523867210|FG000|Period 1 - Core|Protocol Violation|1|||
145277665|NCT00051636|523867211|FG001|Period 1 - Core|Protocol Violation|0|||
145277666|NCT00051636|523867210|FG000|Period 1 - Core|Withdrawal by Subject|1|||
145277667|NCT00051636|523867211|FG001|Period 1 - Core|Withdrawal by Subject|2|||
145277668|NCT00051636|523867210|FG000|Period 1 - Core|Lost to Follow-up|0|||
145277669|NCT00051636|523867211|FG001|Period 1 - Core|Lost to Follow-up|2|||
145277670|NCT00051636|523867210|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
145277671|NCT00051636|523867211|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
145277672|NCT00051636|523867210|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
145277673|NCT00051636|523867211|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
145277674|NCT00051636|523867210|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
145277675|NCT00051636|523867211|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
145277676|NCT00051636|523867210|FG000|Period 2- Extended Observation Period|Death|4|||
145277677|NCT00051636|523867211|FG001|Period 2- Extended Observation Period|Death|5|||
145292764|NCT06179108|523922229|FG003|Overall Study|Physician Decision|0|||
145765972|NCT04964258|525652007|FG000|Overall Study|Lost to Follow-up|1|||
145765973|NCT04964258|525652008|FG001|Overall Study|Lost to Follow-up|0|||
145765974|NCT04964258|525652009|FG002|Overall Study|Lost to Follow-up|0|||
145765975|NCT04964258|525652010|FG003|Overall Study|Lost to Follow-up|0|||
145277678|NCT00051636|523867210|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
145277679|NCT00051636|523867211|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
145277680|NCT01174368|523867212|FG000|Overall Study|Withdrawal by Subject|1|||
145277681|NCT00363129|523867217|FG000|Overall Study|Withdrawal by Subject|11|||
145277682|NCT00363129|523867218|FG001|Overall Study|Withdrawal by Subject|18|||
145277683|NCT00363129|523867217|FG000|Overall Study|Adverse Event|8|||
145277684|NCT00363129|523867218|FG001|Overall Study|Adverse Event|3|||
145277685|NCT00363129|523867217|FG000|Overall Study|Alternate Treatment|2|||
145277686|NCT00363129|523867218|FG001|Overall Study|Alternate Treatment|4|||
145277687|NCT00363129|523867217|FG000|Overall Study|Other Medical Problems|2|||
145277688|NCT00363129|523867218|FG001|Overall Study|Other Medical Problems|4|||
145277689|NCT00363129|523867217|FG000|Overall Study|Death|0|||
145277690|NCT00363129|523867218|FG001|Overall Study|Death|1|||
145765976|NCT04964258|525652011|FG004|Overall Study|Lost to Follow-up|0|||
145277691|NCT00363129|523867217|FG000|Overall Study|Other Reasons|6|||
145277692|NCT00363129|523867218|FG001|Overall Study|Other Reasons|3|||
145403078|NCT03225287|524332603|FG000|Overall Study|Subject withdraws consent|3|||
145403079|NCT03225287|524332604|FG001|Overall Study|Subject withdraws consent|0|||
145403080|NCT03225287|524332605|FG002|Overall Study|Subject withdraws consent|0|||
145403081|NCT03225287|524332603|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
145403082|NCT03225287|524332604|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
145403083|NCT03225287|524332605|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
145765977|NCT04964258|525652012|FG005|Overall Study|Lost to Follow-up|1|||
145765978|NCT04964258|525652013|FG006|Overall Study|Lost to Follow-up|0|||
145765979|NCT04964258|525652014|FG007|Overall Study|Lost to Follow-up|0|||
145765980|NCT04964258|525652015|FG008|Overall Study|Lost to Follow-up|0|||
145765981|NCT04964258|525652016|FG009|Overall Study|Lost to Follow-up|0|||
145765982|NCT04964258|525652017|FG010|Overall Study|Lost to Follow-up|0|||
145765983|NCT01285349|525652019|FG000|Overall Study|Lost to Follow-up|27|||
145765984|NCT01285349|525652020|FG001|Overall Study|Lost to Follow-up|20|||
145765985|NCT01285349|525652021|FG002|Overall Study|Lost to Follow-up|27|||
145765986|NCT02909153|525652022|FG000|Overall Study|Withdrawal by Subject|0|||
145765987|NCT02909153|525652023|FG001|Overall Study|Withdrawal by Subject|1|||
145765988|NCT02909153|525652024|FG002|Overall Study|Withdrawal by Subject|0|||
145765989|NCT02909153|525652025|FG003|Overall Study|Withdrawal by Subject|0|||
145765990|NCT02909153|525652026|FG004|Overall Study|Withdrawal by Subject|0|||
145765991|NCT03040024|525652027|FG000|Overall Study|Adverse Event|0|||
145765992|NCT03040024|525652028|FG001|Overall Study|Adverse Event|1|||
145765993|NCT03040024|525652029|FG002|Overall Study|Adverse Event|0|||
145765994|NCT03040024|525652027|FG000|Overall Study|Death|0|||
145765995|NCT03040024|525652028|FG001|Overall Study|Death|1|||
145765996|NCT03040024|525652029|FG002|Overall Study|Death|0|||
145765997|NCT03040024|525652027|FG000|Overall Study|Physician Decision|0|||
145765998|NCT03040024|525652028|FG001|Overall Study|Physician Decision|0|||
145765999|NCT03040024|525652029|FG002|Overall Study|Physician Decision|1|||
145766000|NCT01818297|525652032|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
145766001|NCT01818297|525652033|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
145766002|NCT01818297|525652032|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
145766003|NCT01818297|525652033|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
145766004|NCT01818297|525652032|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
145766005|NCT01818297|525652033|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
145766006|NCT00631137|525652034|FG000|Overall Study|Withdrawal by Subject|1|||
145766007|NCT00631137|525652035|FG001|Overall Study|Withdrawal by Subject|0|||
145766008|NCT04439344|525652036|FG000|Overall Study|Never started threapy|3|||
145766009|NCT04439344|525652036|FG000|Overall Study|Ineligible|3|||
145766010|NCT04439344|525652036|FG000|Overall Study|Adverse Event|13|||
145766011|NCT04439344|525652036|FG000|Overall Study|Death|2|||
145766012|NCT04439344|525652036|FG000|Overall Study|Disease progression|29|||
145766013|NCT04439344|525652036|FG000|Overall Study|Withdrawal by Subject|2|||
145766014|NCT04439344|525652036|FG000|Overall Study|Alternative therapy|1|||
145766015|NCT01795547|525652037|FG000|Overall Study|Adverse Event|16|||
145766016|NCT01795547|525652038|FG001|Overall Study|Adverse Event|27|||
145766017|NCT01795547|525652037|FG000|Overall Study|Lack of Efficacy|8|||
145766018|NCT01795547|525652038|FG001|Overall Study|Lack of Efficacy|3|||
145766019|NCT01795547|525652037|FG000|Overall Study|Protocol Violation|6|||
145766020|NCT01795547|525652038|FG001|Overall Study|Protocol Violation|4|||
145766021|NCT01795547|525652037|FG000|Overall Study|Lost to Follow-up|2|||
145766022|NCT01795547|525652038|FG001|Overall Study|Lost to Follow-up|5|||
145766023|NCT01795547|525652037|FG000|Overall Study|Withdrawal of consent|7|||
145766024|NCT01795547|525652038|FG001|Overall Study|Withdrawal of consent|12|||
145766025|NCT01795547|525652037|FG000|Overall Study|Not Treated|4|||
145766026|NCT01795547|525652038|FG001|Overall Study|Not Treated|10|||
145766027|NCT01795547|525652037|FG000|Overall Study|Non-compliance with IMP|1|||
145766028|NCT01795547|525652038|FG001|Overall Study|Non-compliance with IMP|1|||
145766029|NCT01795547|525652037|FG000|Overall Study|Others|4|||
145766030|NCT01795547|525652038|FG001|Overall Study|Others|1|||
145766031|NCT01795547|525652037|FG000|Overall Study|Not stated|0|||
145766032|NCT01795547|525652038|FG001|Overall Study|Not stated|1|||
145766033|NCT03437447|525652041|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145766034|NCT03437447|525652042|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145766035|NCT03437447|525652043|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145766036|NCT03498521|525652050|FG000|Overall Study|Death|227|||
145766037|NCT03498521|525652051|FG001|Overall Study|Death|79|||
145766038|NCT03498521|525652052|FG002|Overall Study|Death|84|||
145766039|NCT03498521|525652050|FG000|Overall Study|Exclusion criteria|1|||
145766040|NCT03498521|525652051|FG001|Overall Study|Exclusion criteria|0|||
145766041|NCT03498521|525652052|FG002|Overall Study|Exclusion criteria|0|||
145766042|NCT03498521|525652050|FG000|Overall Study|Lost to Follow-up|4|||
145766043|NCT03498521|525652051|FG001|Overall Study|Lost to Follow-up|3|||
145766044|NCT03498521|525652052|FG002|Overall Study|Lost to Follow-up|3|||
145766045|NCT03498521|525652050|FG000|Overall Study|No profile due to technical failure|1|||
145766046|NCT03498521|525652051|FG001|Overall Study|No profile due to technical failure|0|||
145766047|NCT03498521|525652052|FG002|Overall Study|No profile due to technical failure|0|||
145766048|NCT03498521|525652050|FG000|Overall Study|Physician Decision|3|||
145766049|NCT03498521|525652051|FG001|Overall Study|Physician Decision|1|||
145766050|NCT03498521|525652052|FG002|Overall Study|Physician Decision|0|||
145766051|NCT03498521|525652050|FG000|Overall Study|Withdrawal by Subject|11|||
145766052|NCT03498521|525652051|FG001|Overall Study|Withdrawal by Subject|6|||
145403084|NCT03225287|524332603|FG000|Overall Study|Trial drug not effective|0|||
145766053|NCT03498521|525652052|FG002|Overall Study|Withdrawal by Subject|2|||
145766054|NCT03498521|525652050|FG000|Overall Study|Study terminated by sponsor|79|||
145766055|NCT03498521|525652051|FG001|Overall Study|Study terminated by sponsor|21|||
145766056|NCT03498521|525652052|FG002|Overall Study|Study terminated by sponsor|4|||
145766057|NCT04167345|525652055|FG000|Overall Study|Other|1|||
145766058|NCT04167345|525652056|FG001|Overall Study|Other|1|||
145766059|NCT04167345|525652057|FG002|Overall Study|Other|0|||
145766060|NCT04167345|525652058|FG003|Overall Study|Other|0|||
145766061|NCT04167345|525652059|FG004|Overall Study|Other|0|||
145766062|NCT04063384|525652779|FG000|Overall Study|placebo manipulation issue|1|||
145277693|NCT00725725|523867219|FG000|Overall Study|Adverse Event|1|||
145277694|NCT00725725|523867220|FG001|Overall Study|Adverse Event|3|||
145277695|NCT00725725|523867221|FG002|Overall Study|Adverse Event|2|||
145277696|NCT00725725|523867219|FG000|Overall Study|Lost to Follow-up|2|||
145766063|NCT04063384|525652780|FG001|Overall Study|placebo manipulation issue|2|||
145766064|NCT04063384|525652781|FG002|Overall Study|placebo manipulation issue|1|||
145766065|NCT04063384|525652782|FG003|Overall Study|placebo manipulation issue|1|||
145766066|NCT01445171|525652784|FG000|Overall Study|Lost to Follow-up|11|||
145766067|NCT01445171|525652784|FG000|Overall Study|Withdrawal by Subject|16|||
145766068|NCT01445171|525652784|FG000|Overall Study|Death|51|||
145766069|NCT01445171|525652784|FG000|Overall Study|Subjects declined to return for followup|9|||
145766070|NCT01445171|525652784|FG000|Overall Study|Consented but did not receive device|8|||
145766071|NCT00603239|525652791|FG000|Overall Study|Adverse Event|4|||
145766072|NCT00603239|525652792|FG001|Overall Study|Adverse Event|1|||
145766073|NCT00603239|525652791|FG000|Overall Study|Entry criteria not met|0|||
145766074|NCT00603239|525652792|FG001|Overall Study|Entry criteria not met|1|||
145766075|NCT00603239|525652791|FG000|Overall Study|Loss of glucose control|3|||
145766076|NCT00603239|525652792|FG001|Overall Study|Loss of glucose control|0|||
145766077|NCT00603239|525652791|FG000|Overall Study|Lost to Follow-up|2|||
145766078|NCT00603239|525652792|FG001|Overall Study|Lost to Follow-up|1|||
145766079|NCT00603239|525652791|FG000|Overall Study|Physician Decision|2|||
145766080|NCT00603239|525652792|FG001|Overall Study|Physician Decision|0|||
145766081|NCT00603239|525652791|FG000|Overall Study|Protocol Violation|2|||
145766082|NCT00603239|525652792|FG001|Overall Study|Protocol Violation|0|||
145766083|NCT00603239|525652791|FG000|Overall Study|Subject decision|2|||
145766084|NCT00603239|525652792|FG001|Overall Study|Subject decision|1|||
145766085|NCT01562028|525652793|FG000|Overall Study|Withdrawal by Subject|1|||
145766086|NCT01562028|525652794|FG001|Overall Study|Withdrawal by Subject|1|||
145766087|NCT01562028|525652793|FG000|Overall Study|Lost to Follow-up|2|||
145766088|NCT01562028|525652794|FG001|Overall Study|Lost to Follow-up|1|||
145766089|NCT04439266|525652795|FG000|Overall Study|Ineligible|1|||
145766090|NCT04439266|525652795|FG000|Overall Study|Adverse Event|1|||
145766091|NCT04439266|525652795|FG000|Overall Study|Death|1|||
145766092|NCT04439266|525652795|FG000|Overall Study|Disease progression|1|||
145766093|NCT04439266|525652795|FG000|Overall Study|Still on treatment|1|||
145766094|NCT05052723|525652796|FG000|Overall Study|Death|19|||
145766095|NCT05540652|525652797|FG000|Overall Study|Withdrawal by Subject|1|||
145766096|NCT01701258|525652799|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
145766097|NCT01701258|525652800|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
145766098|NCT01701258|525652801|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
145766099|NCT01701258|525652802|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
145766100|NCT01701258|525652803|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
145403085|NCT03225287|524332604|FG001|Overall Study|Trial drug not effective|1|||
145766101|NCT01701258|525652804|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
145766102|NCT01701258|525652805|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
145766103|NCT01701258|525652806|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
145766104|NCT01701258|525652807|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
145766105|NCT01701258|525652808|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
145766106|NCT01701258|525652809|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
145766107|NCT01701258|525652810|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
145766108|NCT01701258|525652811|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
145766109|NCT01701258|525652799|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
145766110|NCT01701258|525652800|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
145766111|NCT01701258|525652801|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
145766112|NCT01701258|525652802|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
145766113|NCT01701258|525652803|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
145766114|NCT01701258|525652804|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
145766115|NCT01701258|525652805|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
145766116|NCT01701258|525652806|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
145766117|NCT01701258|525652807|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
145766118|NCT01701258|525652808|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
145766119|NCT01701258|525652809|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
145766120|NCT01701258|525652810|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
145766121|NCT01701258|525652811|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
145766122|NCT01701258|525652799|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
145766123|NCT01701258|525652800|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
145766124|NCT01701258|525652801|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
145766125|NCT01701258|525652802|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
145766126|NCT01701258|525652803|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
145766127|NCT01701258|525652804|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
145766128|NCT01701258|525652805|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
145766129|NCT01701258|525652806|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
145766130|NCT01701258|525652807|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
145766131|NCT01701258|525652808|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
145766132|NCT01701258|525652809|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
145766133|NCT01701258|525652810|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
145766134|NCT01701258|525652811|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
145766135|NCT01701258|525652799|FG000|Assessment and Scheduling|Investigator Terminated|2|||
145766136|NCT01701258|525652800|FG001|Assessment and Scheduling|Investigator Terminated|0|||
145766137|NCT01701258|525652801|FG002|Assessment and Scheduling|Investigator Terminated|0|||
145766138|NCT01701258|525652802|FG003|Assessment and Scheduling|Investigator Terminated|0|||
145766139|NCT01701258|525652803|FG004|Assessment and Scheduling|Investigator Terminated|0|||
145403086|NCT03225287|524332605|FG002|Overall Study|Trial drug not effective|0|||
145403087|NCT03225287|524332603|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
145403088|NCT03225287|524332604|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
145403089|NCT03225287|524332605|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
145766140|NCT01701258|525652804|FG005|Assessment and Scheduling|Investigator Terminated|0|||
145766141|NCT01701258|525652805|FG006|Assessment and Scheduling|Investigator Terminated|0|||
145766142|NCT01701258|525652806|FG007|Assessment and Scheduling|Investigator Terminated|0|||
145766143|NCT01701258|525652807|FG008|Assessment and Scheduling|Investigator Terminated|0|||
145766144|NCT01701258|525652808|FG009|Assessment and Scheduling|Investigator Terminated|0|||
145766145|NCT01701258|525652809|FG010|Assessment and Scheduling|Investigator Terminated|0|||
145403090|NCT03225287|524332603|FG000|Overall Study|Stem cell transplantation|0|||
145403091|NCT03225287|524332604|FG001|Overall Study|Stem cell transplantation|1|||
145403092|NCT03225287|524332605|FG002|Overall Study|Stem cell transplantation|0|||
145403093|NCT00703534|524334287|FG000|Overall Study|Adverse Event|14|||
145403094|NCT00703534|524334288|FG001|Overall Study|Adverse Event|3|||
145403095|NCT00703534|524334287|FG000|Overall Study|Withdrawal by Subject|8|||
145403096|NCT00703534|524334288|FG001|Overall Study|Withdrawal by Subject|7|||
145403097|NCT00703534|524334287|FG000|Overall Study|Incorrect Enrollment|6|||
145403098|NCT00703534|524334288|FG001|Overall Study|Incorrect Enrollment|6|||
145403099|NCT00703534|524334287|FG000|Overall Study|Lost to Follow-up|1|||
145403100|NCT00703534|524334288|FG001|Overall Study|Lost to Follow-up|4|||
145403101|NCT00703534|524334287|FG000|Overall Study|Severe Non Compliance|1|||
145403102|NCT00703534|524334288|FG001|Overall Study|Severe Non Compliance|5|||
145403103|NCT01649765|524334289|FG000|Overall Study|Adverse Event|5|||
145403104|NCT01649765|524334290|FG001|Overall Study|Adverse Event|3|||
145403105|NCT01649765|524334289|FG000|Overall Study|Lack of Efficacy|1|||
145403106|NCT01649765|524334290|FG001|Overall Study|Lack of Efficacy|1|||
145403107|NCT01649765|524334289|FG000|Overall Study|Physician Decision|0|||
145403108|NCT01649765|524334290|FG001|Overall Study|Physician Decision|3|||
145403109|NCT01649765|524334289|FG000|Overall Study|Protocol Violation|1|||
145403110|NCT01649765|524334290|FG001|Overall Study|Protocol Violation|0|||
145403111|NCT01649765|524334289|FG000|Overall Study|Withdrawal by Subject|2|||
145403112|NCT01649765|524334290|FG001|Overall Study|Withdrawal by Subject|1|||
145403113|NCT00961064|524334291|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
145403114|NCT00961064|524334291|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
145403115|NCT00961064|524334291|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
145403116|NCT00961064|524334291|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
145403117|NCT00961064|524334291|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
145403118|NCT00961064|524334291|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
145403119|NCT00961064|524334291|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
145403120|NCT00961064|524334291|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
145403121|NCT01408641|524334292|FG000|Overall Study|Physician Decision|1|||
145403122|NCT01408641|524334293|FG001|Overall Study|Physician Decision|0|||
145403123|NCT00715208|524334294|FG000|Overall Study|Withdrawal by Subject|1|||
145403124|NCT00715208|524334295|FG001|Overall Study|Withdrawal by Subject|1|||
145403125|NCT00715208|524334294|FG000|Overall Study|Adverse Event|0|||
145403126|NCT00715208|524334295|FG001|Overall Study|Adverse Event|6|||
145403127|NCT00715208|524334294|FG000|Overall Study|Lack of Efficacy|0|||
145403128|NCT00715208|524334295|FG001|Overall Study|Lack of Efficacy|2|||
145403129|NCT01294046|524334296|FG000|Overall Study|Infection and surgical explant|1|||
145766146|NCT01701258|525652810|FG011|Assessment and Scheduling|Investigator Terminated|0|||
145766147|NCT01701258|525652811|FG012|Assessment and Scheduling|Investigator Terminated|0|||
145766148|NCT02542267|525652812|FG000|Overall Study|Withdrawal by Subject|10|||
145766149|NCT02542267|525652812|FG000|Overall Study|Physician Decision|6|||
145766150|NCT02542267|525652812|FG000|Overall Study|Lost to Follow-up|4|||
145766151|NCT02542267|525652812|FG000|Overall Study|Death|13|||
145766152|NCT02542267|525652812|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
145766153|NCT02542267|525652812|FG000|Overall Study|Other|9|||
145766154|NCT03049449|525652813|FG000|Overall Study|Did not receive treatment.|0|||
145403130|NCT01294046|524334296|FG000|Overall Study|Eligibility criteria expanded|1|||
145403131|NCT01294046|524334296|FG000|Overall Study|Stimulation response inadqequate|1|||
145403132|NCT01715298|524334297|FG000|Overall Study|Lost to Follow-up|0|||
145403133|NCT01715298|524334298|FG001|Overall Study|Lost to Follow-up|2|||
145403134|NCT01715298|524334297|FG000|Overall Study|Patient/guardian decision|7|||
145403135|NCT01715298|524334298|FG001|Overall Study|Patient/guardian decision|9|||
145533478|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
145533479|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
145533480|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
145533481|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
145766155|NCT03049449|525652814|FG001|Overall Study|Did not receive treatment.|0|||
145766156|NCT03049449|525652815|FG002|Overall Study|Did not receive treatment.|0|||
145403136|NCT03817528|524334302|FG000|Overall Study|Withdrawal by Subject|1|||
145766157|NCT03049449|525652816|FG003|Overall Study|Did not receive treatment.|0|||
145766158|NCT03049449|525652817|FG004|Overall Study|Did not receive treatment.|0|||
145766159|NCT03049449|525652818|FG005|Overall Study|Did not receive treatment.|0|||
145766160|NCT03049449|525652819|FG006|Overall Study|Did not receive treatment.|0|||
145766161|NCT03049449|525652820|FG007|Overall Study|Did not receive treatment.|0|||
145766162|NCT03049449|525652821|FG008|Overall Study|Did not receive treatment.|1|||
145766163|NCT03049449|525652822|FG009|Overall Study|Did not receive treatment.|0|||
145766164|NCT03049449|525652813|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
145766165|NCT03049449|525652814|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
145766166|NCT03049449|525652815|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
145766167|NCT03049449|525652816|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
145766168|NCT03049449|525652817|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
145766169|NCT03049449|525652818|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
145766170|NCT03049449|525652819|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
145766171|NCT03049449|525652820|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
145766172|NCT03049449|525652821|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
145766173|NCT03049449|525652822|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
145766174|NCT03049449|525652813|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766175|NCT03049449|525652814|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766176|NCT03049449|525652815|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766177|NCT03049449|525652816|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766178|NCT03049449|525652817|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766179|NCT03049449|525652818|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766180|NCT03049449|525652819|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766181|NCT03049449|525652820|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
145766182|NCT03049449|525652821|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
145766183|NCT03049449|525652822|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
145766184|NCT00442598|525652823|FG000|Overall Study|Adverse Event|1|||
145766185|NCT00442598|525652824|FG001|Overall Study|Adverse Event|0|||
145766186|NCT00442598|525652825|FG002|Overall Study|Adverse Event|0|||
145766187|NCT00442598|525652823|FG000|Overall Study|Tumor progression|3|||
145766188|NCT00442598|525652824|FG001|Overall Study|Tumor progression|4|||
145766189|NCT00442598|525652825|FG002|Overall Study|Tumor progression|0|||
145766190|NCT00442598|525652823|FG000|Overall Study|Clinical deterioration|1|||
145766191|NCT00442598|525652824|FG001|Overall Study|Clinical deterioration|2|||
145766192|NCT00442598|525652825|FG002|Overall Study|Clinical deterioration|0|||
145766193|NCT00442598|525652823|FG000|Overall Study|CA125 progression|0|||
145766194|NCT00442598|525652824|FG001|Overall Study|CA125 progression|1|||
145766195|NCT00442598|525652825|FG002|Overall Study|CA125 progression|0|||
145766196|NCT00442598|525652823|FG000|Overall Study|Reduced creatinine clearance|1|||
145766197|NCT00442598|525652824|FG001|Overall Study|Reduced creatinine clearance|0|||
145766198|NCT00442598|525652825|FG002|Overall Study|Reduced creatinine clearance|0|||
145766199|NCT00442598|525652823|FG000|Overall Study|Death|0|||
145766200|NCT00442598|525652824|FG001|Overall Study|Death|1|||
145766201|NCT00442598|525652825|FG002|Overall Study|Death|0|||
145766202|NCT04373460|525652826|FG000|Overall Study|Did not receive tranfusion|18|||
145766203|NCT04373460|525652827|FG001|Overall Study|Did not receive tranfusion|26|||
145766204|NCT00454207|525652828|FG000|Overall Study|Adverse Event|3|||
145766205|NCT00454207|525652829|FG001|Overall Study|Adverse Event|1|||
145766206|NCT00454207|525652828|FG000|Overall Study|Lack of Efficacy|1|||
145766207|NCT00454207|525652829|FG001|Overall Study|Lack of Efficacy|0|||
145766208|NCT00454207|525652828|FG000|Overall Study|Protocol Violation|0|||
145766209|NCT00454207|525652829|FG001|Overall Study|Protocol Violation|1|||
145766210|NCT01672957|525652830|FG000|Overall Study|Protocol Violation|48|||
145766211|NCT01672957|525652830|FG000|Overall Study|Death|2|||
145766212|NCT01672957|525652830|FG000|Overall Study|ICF Signed After Transplantation|5|||
145766213|NCT00151892|525652833|FG000|Overall Study|Lack of Efficacy|50|||
145766214|NCT00151892|525652834|FG001|Overall Study|Lack of Efficacy|57|||
145766215|NCT00151892|525652833|FG000|Overall Study|Patient request|10|||
145766216|NCT00151892|525652834|FG001|Overall Study|Patient request|7|||
145766217|NCT00151892|525652833|FG000|Overall Study|Lost to Follow-up|5|||
145766218|NCT00151892|525652834|FG001|Overall Study|Lost to Follow-up|10|||
145766219|NCT00151892|525652833|FG000|Overall Study|Adverse Event|6|||
145766220|NCT00151892|525652834|FG001|Overall Study|Adverse Event|3|||
145766221|NCT00151892|525652833|FG000|Overall Study|Protocol Violation|3|||
145766222|NCT00151892|525652834|FG001|Overall Study|Protocol Violation|3|||
145766223|NCT00151892|525652833|FG000|Overall Study|Non-compliance|0|||
145277697|NCT00725725|523867220|FG001|Overall Study|Lost to Follow-up|0|||
145277698|NCT00725725|523867221|FG002|Overall Study|Lost to Follow-up|2|||
145766224|NCT00151892|525652834|FG001|Overall Study|Non-compliance|1|||
145766225|NCT00151892|525652833|FG000|Overall Study|Pregnancy|0|||
145766226|NCT00151892|525652834|FG001|Overall Study|Pregnancy|1|||
145766227|NCT00151892|525652833|FG000|Overall Study|Did not return for a visit|1|||
145766228|NCT00151892|525652834|FG001|Overall Study|Did not return for a visit|0|||
145766229|NCT00151892|525652833|FG000|Overall Study|Used prohibited corticosteroids|1|||
145766230|NCT00151892|525652834|FG001|Overall Study|Used prohibited corticosteroids|0|||
145766231|NCT00151892|525652833|FG000|Overall Study|Lack of study medication at center|0|||
145766232|NCT00151892|525652834|FG001|Overall Study|Lack of study medication at center|1|||
145766233|NCT05775289|525652838|FG000|Overall Study|Study Ongoing|20|||
145766234|NCT05775289|525652839|FG001|Overall Study|Study Ongoing|53|||
145766235|NCT05775289|525652840|FG002|Overall Study|Study Ongoing|15|||
145766236|NCT05775289|525652841|FG003|Overall Study|Study Ongoing|55|||
145766237|NCT05775289|525652838|FG000|Overall Study|Death|4|||
145766238|NCT05775289|525652839|FG001|Overall Study|Death|11|||
145766239|NCT05775289|525652840|FG002|Overall Study|Death|8|||
145766240|NCT05775289|525652841|FG003|Overall Study|Death|12|||
145766241|NCT05775289|525652838|FG000|Overall Study|Lost to Follow-up|0|||
145766242|NCT05775289|525652839|FG001|Overall Study|Lost to Follow-up|1|||
145766243|NCT05775289|525652840|FG002|Overall Study|Lost to Follow-up|0|||
145766244|NCT05775289|525652841|FG003|Overall Study|Lost to Follow-up|0|||
145766245|NCT05775289|525652838|FG000|Overall Study|Progressive Disease|0|||
145766246|NCT05775289|525652839|FG001|Overall Study|Progressive Disease|0|||
145766247|NCT05775289|525652840|FG002|Overall Study|Progressive Disease|1|||
145766248|NCT05775289|525652841|FG003|Overall Study|Progressive Disease|0|||
145766249|NCT05775289|525652838|FG000|Overall Study|Withdrawal by Subject|1|||
145766250|NCT05775289|525652839|FG001|Overall Study|Withdrawal by Subject|1|||
145766251|NCT05775289|525652840|FG002|Overall Study|Withdrawal by Subject|0|||
145766252|NCT05775289|525652841|FG003|Overall Study|Withdrawal by Subject|0|||
145766253|NCT04439331|525652842|FG000|Overall Study|Never Start Protocol Therapy|2|||
145766254|NCT04439331|525652842|FG000|Overall Study|Ineligible|2|||
145766255|NCT04439331|525652842|FG000|Overall Study|Mutation Status Not Confirmed|1|||
145766256|NCT04439331|525652842|FG000|Overall Study|Adverse Event|1|||
145766257|NCT04439331|525652842|FG000|Overall Study|Death|1|||
145766258|NCT04439331|525652842|FG000|Overall Study|Disease Progression|20|||
145766259|NCT04439331|525652842|FG000|Overall Study|Withdrawal by Subject|6|||
145766260|NCT04439331|525652842|FG000|Overall Study|Physician Decision|1|||
145766261|NCT04439331|525652842|FG000|Overall Study|Other Complicating Disease|1|||
145766262|NCT03726268|525652843|FG000|Overall Study|Physician Decision|2|||
145766263|NCT03726268|525652844|FG001|Overall Study|Physician Decision|8|||
145766264|NCT03726268|525652845|FG002|Overall Study|Physician Decision|6|||
145766265|NCT03726268|525652846|FG003|Overall Study|Physician Decision|3|||
145766266|NCT03726268|525652843|FG000|Overall Study|Withdrawal by Subject|11|||
145766267|NCT03726268|525652844|FG001|Overall Study|Withdrawal by Subject|5|||
145766268|NCT03726268|525652845|FG002|Overall Study|Withdrawal by Subject|9|||
145766269|NCT03726268|525652846|FG003|Overall Study|Withdrawal by Subject|8|||
145766270|NCT04370509|525652851|FG000|Overall Study|Adverse Event|1|||
145403137|NCT03817528|524334302|FG000|Overall Study|Adverse Event|2|||
145403138|NCT03937778|524334304|FG000|Overall Study|Withdrawal by Subject|1|||
145766271|NCT04370509|525652852|FG001|Overall Study|Adverse Event|0|||
145766272|NCT04370509|525652851|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
145766273|NCT04370509|525652852|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
145766274|NCT04743856|525652853|FG000|Overall Study|Lost to Follow-up|6|||
145766275|NCT04743856|525652854|FG001|Overall Study|Lost to Follow-up|7|||
145766276|NCT04743856|525652853|FG000|Overall Study|Withdrawal by Subject|1|||
145766277|NCT04743856|525652854|FG001|Overall Study|Withdrawal by Subject|0|||
145766278|NCT04439188|525652855|FG000|Overall Study|Ineligible|3|||
145766279|NCT04439188|525652855|FG000|Overall Study|Adverse Event|4|||
145766280|NCT04439188|525652855|FG000|Overall Study|Death|1|||
145766281|NCT04439188|525652855|FG000|Overall Study|Disease Progression|25|||
145407498|NCT01143324|524347018|FG000|Overall Study|Explant of the device|4|||
145766282|NCT04439188|525652855|FG000|Overall Study|Withdrawal by Subject|2|||
145766283|NCT01813890|525652856|FG000|Overall Study|Adverse Event|0|||
145766284|NCT01813890|525652857|FG001|Overall Study|Adverse Event|3|||
145766285|NCT01813890|525652858|FG002|Overall Study|Adverse Event|4|||
145766286|NCT01813890|525652856|FG000|Overall Study|Lack of Efficacy|9|||
145766287|NCT01813890|525652857|FG001|Overall Study|Lack of Efficacy|1|||
145766288|NCT01813890|525652858|FG002|Overall Study|Lack of Efficacy|2|||
145766289|NCT04482647|525652859|FG000|Overall Study|Time constraints|2|||
145766290|NCT04482647|525652859|FG000|Overall Study|Health issues|1|||
145766291|NCT04482647|525652859|FG000|Overall Study|Death in the family|1|||
145766292|NCT04482647|525652859|FG000|Overall Study|Disliked the intervention|1|||
145766293|NCT04482647|525652859|FG000|Overall Study|No reasons specified|7|||
145766294|NCT00391976|525653929|FG000|Overall Study|Adverse Event|0|||
145766295|NCT00391976|525653930|FG001|Overall Study|Adverse Event|0|||
145766296|NCT00391976|525653931|FG002|Overall Study|Adverse Event|1|||
145766297|NCT00391976|525653929|FG000|Overall Study|Withdrawal of consent|0|||
145766298|NCT00391976|525653930|FG001|Overall Study|Withdrawal of consent|1|||
145766299|NCT00391976|525653931|FG002|Overall Study|Withdrawal of consent|1|||
145766300|NCT00391976|525653929|FG000|Overall Study|Lost to Follow-up|1|||
145766301|NCT00391976|525653930|FG001|Overall Study|Lost to Follow-up|2|||
145766302|NCT00391976|525653931|FG002|Overall Study|Lost to Follow-up|0|||
145766303|NCT00391976|525653929|FG000|Overall Study|Inappropriate enrollment|1|||
145766304|NCT00391976|525653930|FG001|Overall Study|Inappropriate enrollment|1|||
145766305|NCT00391976|525653931|FG002|Overall Study|Inappropriate enrollment|0|||
145766306|NCT00391976|525653929|FG000|Overall Study|Protocol deviation/violation|4|||
145766307|NCT00391976|525653930|FG001|Overall Study|Protocol deviation/violation|2|||
145766308|NCT00391976|525653931|FG002|Overall Study|Protocol deviation/violation|1|||
145766309|NCT00391976|525653929|FG000|Overall Study|Recurrence/no eradication of infection|21|||
145766310|NCT00391976|525653930|FG001|Overall Study|Recurrence/no eradication of infection|19|||
145766311|NCT00391976|525653931|FG002|Overall Study|Recurrence/no eradication of infection|0|||
145766312|NCT00391976|525653929|FG000|Overall Study|Unable to classify|0|||
145766313|NCT00391976|525653930|FG001|Overall Study|Unable to classify|0|||
145766314|NCT00391976|525653931|FG002|Overall Study|Unable to classify|1|||
145766315|NCT00391976|525653929|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
145766316|NCT00391976|525653930|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
145766317|NCT00391976|525653931|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
145766318|NCT01147926|525653937|FG000|Overall Study|Subject Withdrew Consent|9|||
145766319|NCT01147926|525653938|FG001|Overall Study|Subject Withdrew Consent|10|||
145766320|NCT01147926|525653937|FG000|Overall Study|Adverse Event|7|||
145766321|NCT01147926|525653938|FG001|Overall Study|Adverse Event|6|||
145766322|NCT01147926|525653937|FG000|Overall Study|Subject Non-Compliant|5|||
145766323|NCT01147926|525653938|FG001|Overall Study|Subject Non-Compliant|4|||
145766324|NCT01147926|525653937|FG000|Overall Study|Principal investigator left hospital|1|||
145766325|NCT01147926|525653938|FG001|Overall Study|Principal investigator left hospital|3|||
145766326|NCT01147926|525653937|FG000|Overall Study|Selection criteria not met|3|||
145766327|NCT01147926|525653938|FG001|Overall Study|Selection criteria not met|1|||
145766328|NCT01147926|525653937|FG000|Overall Study|Lost to Follow-up|0|||
145766329|NCT01147926|525653938|FG001|Overall Study|Lost to Follow-up|2|||
145766330|NCT01147926|525653937|FG000|Overall Study|Sponsor's Decision|0|||
145766331|NCT01147926|525653938|FG001|Overall Study|Sponsor's Decision|1|||
145766332|NCT01147926|525653937|FG000|Overall Study|Lack of Efficacy|1|||
145766333|NCT01147926|525653938|FG001|Overall Study|Lack of Efficacy|0|||
145766334|NCT01147926|525653937|FG000|Overall Study|Too busy, no time for study|1|||
145766335|NCT01147926|525653938|FG001|Overall Study|Too busy, no time for study|0|||
145766336|NCT01147926|525653937|FG000|Overall Study|Went on holiday|0|||
145766337|NCT01147926|525653938|FG001|Overall Study|Went on holiday|1|||
145766338|NCT01147926|525653937|FG000|Overall Study|Colonoscopy result|0|||
145766339|NCT01147926|525653938|FG001|Overall Study|Colonoscopy result|1|||
145766340|NCT01670994|525653940|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
145766341|NCT01670994|525653941|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
145766342|NCT01670994|525653940|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
145766343|NCT01670994|525653941|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
145766344|NCT01670994|525653940|FG000|Overall Study|Patient experienced DLT|0|||
145766345|NCT01670994|525653941|FG001|Overall Study|Patient experienced DLT|1|||
145766346|NCT02013544|525653943|FG000|Overall Study|Adverse Event|5|||
145766347|NCT02013544|525653944|FG001|Overall Study|Adverse Event|5|||
145766348|NCT02013544|525653943|FG000|Overall Study|Lost to Follow-up|2|||
145766349|NCT02013544|525653944|FG001|Overall Study|Lost to Follow-up|3|||
145766350|NCT02013544|525653943|FG000|Overall Study|Withdrawal by Subject|2|||
145766351|NCT02013544|525653944|FG001|Overall Study|Withdrawal by Subject|8|||
145766352|NCT02013544|525653943|FG000|Overall Study|Physician Decision|0|||
145766353|NCT02013544|525653944|FG001|Overall Study|Physician Decision|1|||
145766354|NCT02013544|525653943|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
145766355|NCT02013544|525653944|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
145766356|NCT03514914|525653945|FG000|Overall Study|Death|3|||
145766357|NCT03514914|525653946|FG001|Overall Study|Death|3|||
145766358|NCT03514914|525653945|FG000|Overall Study|Lost to Follow-up|117|||
145766359|NCT03514914|525653946|FG001|Overall Study|Lost to Follow-up|89|||
145766360|NCT00891735|525653947|FG000|Overall Study|Adverse Event|2|||
145766361|NCT00891735|525653948|FG001|Overall Study|Adverse Event|0|||
145766362|NCT00891735|525653949|FG002|Overall Study|Adverse Event|2|||
145766363|NCT00891735|525653950|FG003|Overall Study|Adverse Event|0|||
145766364|NCT00891735|525653947|FG000|Overall Study|Death|8|||
145766365|NCT00891735|525653948|FG001|Overall Study|Death|5|||
145766366|NCT00891735|525653949|FG002|Overall Study|Death|4|||
145766367|NCT00891735|525653950|FG003|Overall Study|Death|5|||
145766368|NCT00891735|525653947|FG000|Overall Study|Lost to Follow-up|2|||
145766369|NCT00891735|525653948|FG001|Overall Study|Lost to Follow-up|2|||
145766370|NCT00891735|525653949|FG002|Overall Study|Lost to Follow-up|2|||
145766371|NCT00891735|525653950|FG003|Overall Study|Lost to Follow-up|2|||
145766372|NCT00891735|525653947|FG000|Overall Study|Physician's decision to withdraw patient|1|||
145766373|NCT00891735|525653948|FG001|Overall Study|Physician's decision to withdraw patient|0|||
145766374|NCT00891735|525653949|FG002|Overall Study|Physician's decision to withdraw patient|0|||
145766375|NCT00891735|525653950|FG003|Overall Study|Physician's decision to withdraw patient|0|||
145766376|NCT00891735|525653947|FG000|Overall Study|Patient's decision to withdraw|4|||
145766377|NCT00891735|525653948|FG001|Overall Study|Patient's decision to withdraw|9|||
145766378|NCT00891735|525653949|FG002|Overall Study|Patient's decision to withdraw|4|||
145766379|NCT00891735|525653950|FG003|Overall Study|Patient's decision to withdraw|8|||
145766380|NCT01276288|525653952|FG000|Overall Study|Adverse Event|1|||
145766381|NCT01276288|525653953|FG001|Overall Study|Adverse Event|1|||
145766382|NCT01276288|525653954|FG002|Overall Study|Adverse Event|0|||
145766383|NCT01276288|525653955|FG003|Overall Study|Adverse Event|0|||
145766384|NCT01276288|525653952|FG000|Overall Study|not treated|1|||
145766385|NCT01276288|525653953|FG001|Overall Study|not treated|0|||
145766386|NCT01276288|525653954|FG002|Overall Study|not treated|0|||
145607934|NCT01852058|525079282|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145766387|NCT01276288|525653955|FG003|Overall Study|not treated|0|||
145766388|NCT01193686|525653960|FG000|Overall Study|Withdrawal by Subject|4|||
145766389|NCT01193686|525653961|FG001|Overall Study|Withdrawal by Subject|1|||
145766390|NCT01193686|525653960|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
145766391|NCT01193686|525653961|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
145766392|NCT03406962|525653964|FG000|Overall Study|Death|2|||
145766393|NCT03406962|525653964|FG000|Overall Study|Adverse Event|1|||
145766394|NCT02209766|525653966|FG000|Overall Study|Withdrawal by Subject|0|||
145766395|NCT02209766|525653967|FG001|Overall Study|Withdrawal by Subject|0|||
145766396|NCT02209766|525653968|FG002|Overall Study|Withdrawal by Subject|0|||
145766397|NCT02209766|525653969|FG003|Overall Study|Withdrawal by Subject|1|||
145766398|NCT02209766|525653970|FG004|Overall Study|Withdrawal by Subject|0|||
145766399|NCT00481065|525653971|FG000|Overall Study|Adverse event or death|1|||
145766400|NCT00481065|525653972|FG001|Overall Study|Adverse event or death|1|||
145766401|NCT00481065|525653973|FG002|Overall Study|Adverse event or death|3|||
145766402|NCT00481065|525653974|FG003|Overall Study|Adverse event or death|0|||
145766403|NCT00481065|525653975|FG004|Overall Study|Adverse event or death|2|||
145766404|NCT00481065|525653976|FG005|Overall Study|Adverse event or death|0|||
145766405|NCT00481065|525653977|FG006|Overall Study|Adverse event or death|1|||
145766406|NCT00481065|525653978|FG007|Overall Study|Adverse event or death|1|||
145766407|NCT00481065|525653971|FG000|Overall Study|Withdrawal by Subject|11|||
145766408|NCT00481065|525653972|FG001|Overall Study|Withdrawal by Subject|12|||
145766409|NCT00481065|525653973|FG002|Overall Study|Withdrawal by Subject|7|||
145766410|NCT00481065|525653974|FG003|Overall Study|Withdrawal by Subject|11|||
145766411|NCT00481065|525653975|FG004|Overall Study|Withdrawal by Subject|13|||
145766412|NCT00481065|525653976|FG005|Overall Study|Withdrawal by Subject|12|||
145766413|NCT00481065|525653977|FG006|Overall Study|Withdrawal by Subject|9|||
145766414|NCT00481065|525653978|FG007|Overall Study|Withdrawal by Subject|10|||
145766415|NCT00481065|525653971|FG000|Overall Study|Lost to Follow-up|4|||
145766416|NCT00481065|525653972|FG001|Overall Study|Lost to Follow-up|2|||
145766417|NCT00481065|525653973|FG002|Overall Study|Lost to Follow-up|4|||
145766418|NCT00481065|525653974|FG003|Overall Study|Lost to Follow-up|3|||
145766419|NCT00481065|525653975|FG004|Overall Study|Lost to Follow-up|3|||
145766420|NCT00481065|525653976|FG005|Overall Study|Lost to Follow-up|3|||
145766421|NCT00481065|525653977|FG006|Overall Study|Lost to Follow-up|2|||
145766422|NCT00481065|525653978|FG007|Overall Study|Lost to Follow-up|5|||
145766423|NCT00481065|525653971|FG000|Overall Study|Inappropriate enrollment|4|||
145766424|NCT00481065|525653972|FG001|Overall Study|Inappropriate enrollment|0|||
145766425|NCT00481065|525653973|FG002|Overall Study|Inappropriate enrollment|2|||
145766426|NCT00481065|525653974|FG003|Overall Study|Inappropriate enrollment|0|||
145766427|NCT00481065|525653975|FG004|Overall Study|Inappropriate enrollment|2|||
145766428|NCT00481065|525653976|FG005|Overall Study|Inappropriate enrollment|1|||
145766429|NCT00481065|525653977|FG006|Overall Study|Inappropriate enrollment|0|||
145766430|NCT00481065|525653978|FG007|Overall Study|Inappropriate enrollment|1|||
145766431|NCT00481065|525653971|FG000|Overall Study|Administrative reason|0|||
145766432|NCT00481065|525653972|FG001|Overall Study|Administrative reason|0|||
145766433|NCT00481065|525653973|FG002|Overall Study|Administrative reason|0|||
145766434|NCT00481065|525653974|FG003|Overall Study|Administrative reason|0|||
145766435|NCT00481065|525653975|FG004|Overall Study|Administrative reason|0|||
145766436|NCT00481065|525653976|FG005|Overall Study|Administrative reason|2|||
145766437|NCT00481065|525653977|FG006|Overall Study|Administrative reason|1|||
145766438|NCT00481065|525653978|FG007|Overall Study|Administrative reason|0|||
145766439|NCT00481065|525653971|FG000|Overall Study|Protocol Violation|2|||
145766440|NCT00481065|525653972|FG001|Overall Study|Protocol Violation|1|||
145766441|NCT00481065|525653973|FG002|Overall Study|Protocol Violation|1|||
145766442|NCT00481065|525653974|FG003|Overall Study|Protocol Violation|1|||
145766443|NCT00481065|525653975|FG004|Overall Study|Protocol Violation|2|||
145766444|NCT00481065|525653976|FG005|Overall Study|Protocol Violation|6|||
145766445|NCT00481065|525653977|FG006|Overall Study|Protocol Violation|3|||
145766446|NCT00481065|525653978|FG007|Overall Study|Protocol Violation|2|||
145766447|NCT00481065|525653971|FG000|Overall Study|Unable to classify|0|||
145766448|NCT00481065|525653972|FG001|Overall Study|Unable to classify|1|||
145766449|NCT00481065|525653973|FG002|Overall Study|Unable to classify|2|||
145766450|NCT00481065|525653974|FG003|Overall Study|Unable to classify|0|||
145766451|NCT00481065|525653975|FG004|Overall Study|Unable to classify|1|||
145766452|NCT00481065|525653976|FG005|Overall Study|Unable to classify|0|||
145766453|NCT00481065|525653977|FG006|Overall Study|Unable to classify|0|||
145766454|NCT00481065|525653978|FG007|Overall Study|Unable to classify|0|||
145766455|NCT03770403|525653979|FG000|Overall Study|Adverse Event|8|||
145766456|NCT03770403|525653979|FG000|Overall Study|Death|5|||
145766457|NCT03770403|525653979|FG000|Overall Study|Physician Decision|1|||
145766458|NCT03770403|525653979|FG000|Overall Study|Sponsor decision|1|||
145766459|NCT03770403|525653979|FG000|Overall Study|Study terminated by Sponsor|1|||
145766460|NCT03770403|525653979|FG000|Overall Study|Withdrawal by Subject|13|||
145766461|NCT03770403|525653979|FG000|Overall Study|Other|88|||
145766462|NCT03896295|525653980|FG000|Overall Study|Adverse Event|0|||
145766463|NCT03896295|525653981|FG001|Overall Study|Adverse Event|1|||
145277699|NCT00725725|523867219|FG000|Overall Study|Withdrawal by Subject|1|||
145277700|NCT00725725|523867220|FG001|Overall Study|Withdrawal by Subject|0|||
145277701|NCT00725725|523867221|FG002|Overall Study|Withdrawal by Subject|1|||
145277702|NCT00725725|523867219|FG000|Overall Study|Protocol Violation|0|||
145277703|NCT00725725|523867220|FG001|Overall Study|Protocol Violation|1|||
145766464|NCT03896295|525653980|FG000|Overall Study|COVID-19|7|||
145277704|NCT00725725|523867221|FG002|Overall Study|Protocol Violation|0|||
145277705|NCT01619085|523867222|FG000|Overall Study|Adverse Event|231|||
145277706|NCT01619085|523867222|FG000|Overall Study|Protocol Violation|4|||
145766465|NCT03896295|525653981|FG001|Overall Study|COVID-19|29|||
145766466|NCT03029832|525653982|FG000|Overall Study|Safety Follow-Up Completed|2|||
145766467|NCT03029832|525653983|FG001|Overall Study|Safety Follow-Up Completed|0|||
145766468|NCT03029832|525653982|FG000|Overall Study|Death due to Disease Progression|1|||
145766469|NCT03029832|525653983|FG001|Overall Study|Death due to Disease Progression|0|||
145766470|NCT03029832|525653982|FG000|Overall Study|Study Terminated By Sponsor|1|||
145766471|NCT03029832|525653983|FG001|Overall Study|Study Terminated By Sponsor|1|||
145766472|NCT01412229|525653984|FG000|Overall Study|Physician Decision|1|||
145766473|NCT00700804|525653987|FG000|Overall Study|Withdrawal by Subject|1|||
145766474|NCT00700804|525653988|FG001|Overall Study|Withdrawal by Subject|2|||
145766475|NCT00700804|525653987|FG000|Overall Study|Protocol Violation|1|||
145766476|NCT00700804|525653988|FG001|Overall Study|Protocol Violation|1|||
145766477|NCT00700804|525653987|FG000|Overall Study|Loose Stools|1|||
145766478|NCT00700804|525653988|FG001|Overall Study|Loose Stools|1|||
145766479|NCT02901431|525653989|FG000|PK Part|Adverse Event|0|||
145403139|NCT03937778|524334304|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
145403140|NCT04810962|524334305|FG000|Overall Study|Adverse Event|0|||
145403141|NCT04810962|524334306|FG001|Overall Study|Adverse Event|1|||
145403142|NCT04810962|524334305|FG000|Overall Study|Lost to Follow-up|2|||
145403143|NCT04810962|524334306|FG001|Overall Study|Lost to Follow-up|1|||
145403144|NCT04810962|524334305|FG000|Overall Study|Physician Decision|1|||
145403145|NCT04810962|524334306|FG001|Overall Study|Physician Decision|0|||
145403146|NCT04810962|524334305|FG000|Overall Study|Withdrawal by Subject|1|||
145403147|NCT04810962|524334306|FG001|Overall Study|Withdrawal by Subject|3|||
145403148|NCT04810962|524334305|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
145403149|NCT04810962|524334306|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
145403150|NCT00368550|524334310|FG000|Overall Study|Adverse Event|7|||
145277707|NCT01619085|523867222|FG000|Overall Study|Lost to Follow-up|3|||
145277708|NCT01619085|523867222|FG000|Overall Study|Withdrawal by Subject|45|||
145403151|NCT00368550|524334311|FG001|Overall Study|Adverse Event|4|||
145277709|NCT01619085|523867222|FG000|Overall Study|Other than specified|96|||
145277710|NCT01619085|523867222|FG000|Overall Study|Not treated|1|||
145277711|NCT01619085|523867222|FG000|Overall Study|Death|145|||
145403152|NCT00368550|524334310|FG000|Overall Study|Lack of Efficacy|4|||
145403153|NCT00368550|524334311|FG001|Overall Study|Lack of Efficacy|9|||
145403154|NCT00368550|524334310|FG000|Overall Study|Withdrawal by Subject|17|||
145403155|NCT00368550|524334311|FG001|Overall Study|Withdrawal by Subject|10|||
145403156|NCT02410629|524334312|FG000|Overall Study|Family cannot commit to the study|2|||
145403157|NCT02410629|524334313|FG001|Overall Study|Family cannot commit to the study|1|||
145403158|NCT02410629|524334312|FG000|Overall Study|Subject returned to work|1|||
145403159|NCT02410629|524334313|FG001|Overall Study|Subject returned to work|0|||
145403160|NCT02410629|524334312|FG000|Overall Study|Subject moved back to home country|0|||
145277712|NCT00743119|523867225|FG000|Overall Study|unreliable|3|||
145277713|NCT00743119|523867225|FG000|Overall Study|Withdrawal by Subject|1|||
145277714|NCT02176642|523867228|FG000|Overall Study|Withdrawal by Subject|0|||
145277715|NCT02176642|523867229|FG001|Overall Study|Withdrawal by Subject|1|||
145277716|NCT00295620|523867231|FG000|Overall Study|Lost to Follow-up|9|||
145277717|NCT00295620|523867232|FG001|Overall Study|Lost to Follow-up|5|||
145277718|NCT00295620|523867231|FG000|Overall Study|Withdrawal by Subject|37|||
145277719|NCT00295620|523867232|FG001|Overall Study|Withdrawal by Subject|50|||
145277720|NCT00295620|523867231|FG000|Overall Study|Death|206|||
145277721|NCT00295620|523867232|FG001|Overall Study|Death|207|||
145277722|NCT00295620|523867231|FG000|Overall Study|Other reasons|10|||
145277723|NCT00295620|523867232|FG001|Overall Study|Other reasons|9|||
145277724|NCT00295620|523867231|FG000|Overall Study|Discontinuation by sponsor|580|||
145277725|NCT00295620|523867232|FG001|Overall Study|Discontinuation by sponsor|593|||
145277726|NCT00295620|523867231|FG000|Overall Study|Protocol Violation|30|||
145277727|NCT00295620|523867232|FG001|Overall Study|Protocol Violation|32|||
145277728|NCT00084617|523867235|FG000|Overall Study|Withdrawal by Subject|7|||
145277729|NCT00084617|523867235|FG000|Overall Study|Lack of Efficacy|1|||
145277730|NCT00084617|523867235|FG000|Overall Study|Protocol Violation|1|||
145403161|NCT02410629|524334313|FG001|Overall Study|Subject moved back to home country|1|||
145403162|NCT02410629|524334312|FG000|Overall Study|Subject underwent heart surgery|0|||
145533482|NCT02927262|524813465|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
145533483|NCT02927262|524813466|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
145277731|NCT01625286|523867236|FG000|Overall Study|Adverse Event|0|||
145403163|NCT02410629|524334313|FG001|Overall Study|Subject underwent heart surgery|1|||
145403164|NCT01206764|524334314|FG000|Overall Study|Adverse Event|20|||
145277732|NCT01625286|523867237|FG001|Overall Study|Adverse Event|0|||
145277733|NCT01625286|523867238|FG002|Overall Study|Adverse Event|0|||
145277734|NCT01625286|523867239|FG003|Overall Study|Adverse Event|0|||
145277735|NCT01625286|523867240|FG004|Overall Study|Adverse Event|1|||
145403165|NCT01206764|524334314|FG000|Overall Study|Abnormal laboratory value|2|||
145277736|NCT01625286|523867241|FG005|Overall Study|Adverse Event|2|||
145277737|NCT01625286|523867242|FG006|Overall Study|Adverse Event|1|||
145277738|NCT01625286|523867236|FG000|Overall Study|Death|0|||
145277739|NCT01625286|523867237|FG001|Overall Study|Death|0|||
145277740|NCT01625286|523867238|FG002|Overall Study|Death|1|||
145277741|NCT01625286|523867239|FG003|Overall Study|Death|1|||
145533484|NCT02927262|524813465|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
145277742|NCT01625286|523867240|FG004|Overall Study|Death|0|||
145533485|NCT02927262|524813466|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
145533486|NCT02927262|524813465|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
145277743|NCT01625286|523867241|FG005|Overall Study|Death|11|||
145766480|NCT02901431|525653990|FG001|PK Part|Adverse Event|1|||
145766481|NCT02901431|525653991|FG002|PK Part|Adverse Event|0|||
145766482|NCT02901431|525653992|FG003|PK Part|Adverse Event|0|||
145766483|NCT02901431|525653993|FG004|PK Part|Adverse Event|0|||
145766484|NCT02901431|525653994|FG005|PK Part|Adverse Event|0|||
145766485|NCT02901431|525653995|FG006|PK Part|Adverse Event|0|||
145766486|NCT02901431|525653996|FG007|PK Part|Adverse Event|0|||
145766487|NCT02901431|525653997|FG008|PK Part|Adverse Event|0|||
145766488|NCT02901431|525653998|FG009|PK Part|Adverse Event|0|||
145766489|NCT02901431|525653999|FG010|PK Part|Adverse Event|0|||
145766490|NCT02901431|525654000|FG011|PK Part|Adverse Event|0|||
145766491|NCT02901431|525654001|FG012|PK Part|Adverse Event|0|||
145766492|NCT02901431|525653989|FG000|PK Part|Lost to Follow-up|0|||
145766493|NCT02901431|525653990|FG001|PK Part|Lost to Follow-up|0|||
145766494|NCT02901431|525653991|FG002|PK Part|Lost to Follow-up|1|||
145766495|NCT02901431|525653992|FG003|PK Part|Lost to Follow-up|0|||
145766496|NCT02901431|525653993|FG004|PK Part|Lost to Follow-up|0|||
145766497|NCT02901431|525653994|FG005|PK Part|Lost to Follow-up|0|||
145766498|NCT02901431|525653995|FG006|PK Part|Lost to Follow-up|0|||
145766499|NCT02901431|525653996|FG007|PK Part|Lost to Follow-up|0|||
145766500|NCT02901431|525653997|FG008|PK Part|Lost to Follow-up|0|||
145766501|NCT02901431|525653998|FG009|PK Part|Lost to Follow-up|0|||
145766502|NCT02901431|525653999|FG010|PK Part|Lost to Follow-up|0|||
145766503|NCT02901431|525654000|FG011|PK Part|Lost to Follow-up|0|||
145766504|NCT02901431|525654001|FG012|PK Part|Lost to Follow-up|0|||
145766505|NCT02901431|525653989|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
145766506|NCT02901431|525653990|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766507|NCT02901431|525653991|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766508|NCT02901431|525653992|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766509|NCT02901431|525653993|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766510|NCT02901431|525653994|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766511|NCT02901431|525653995|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766512|NCT02901431|525653996|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766513|NCT02901431|525653997|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766514|NCT02901431|525653998|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766515|NCT02901431|525653999|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766516|NCT02901431|525654000|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766517|NCT02901431|525654001|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
145766518|NCT02901431|525653989|FG000|PK Part|Pending dose confirmation|0|||
145766519|NCT02901431|525653990|FG001|PK Part|Pending dose confirmation|1|||
145766520|NCT02901431|525653991|FG002|PK Part|Pending dose confirmation|0|||
145766521|NCT02901431|525653992|FG003|PK Part|Pending dose confirmation|0|||
145766522|NCT02901431|525653993|FG004|PK Part|Pending dose confirmation|0|||
145766523|NCT02901431|525653994|FG005|PK Part|Pending dose confirmation|0|||
145766524|NCT02901431|525653995|FG006|PK Part|Pending dose confirmation|0|||
145766525|NCT02901431|525653996|FG007|PK Part|Pending dose confirmation|0|||
145766526|NCT02901431|525653997|FG008|PK Part|Pending dose confirmation|0|||
145766527|NCT02901431|525653998|FG009|PK Part|Pending dose confirmation|0|||
145766528|NCT02901431|525653999|FG010|PK Part|Pending dose confirmation|0|||
145766529|NCT02901431|525654000|FG011|PK Part|Pending dose confirmation|0|||
145766530|NCT02901431|525654001|FG012|PK Part|Pending dose confirmation|0|||
145766531|NCT02901431|525653989|FG000|PK Part|8 weeks of treatment ran out|2|||
145277744|NCT01625286|523867242|FG006|Overall Study|Death|16|||
145277745|NCT01625286|523867236|FG000|Overall Study|Withdrawal by Subject|0|||
145277746|NCT01625286|523867237|FG001|Overall Study|Withdrawal by Subject|1|||
145277747|NCT01625286|523867238|FG002|Overall Study|Withdrawal by Subject|0|||
145277748|NCT01625286|523867239|FG003|Overall Study|Withdrawal by Subject|1|||
145277749|NCT01625286|523867240|FG004|Overall Study|Withdrawal by Subject|0|||
145277750|NCT01625286|523867241|FG005|Overall Study|Withdrawal by Subject|0|||
145277751|NCT01625286|523867242|FG006|Overall Study|Withdrawal by Subject|1|||
145277752|NCT01625286|523867236|FG000|Overall Study|Any reason not specifically recorded|0|||
145766532|NCT02901431|525653990|FG001|PK Part|8 weeks of treatment ran out|0|||
145766533|NCT02901431|525653991|FG002|PK Part|8 weeks of treatment ran out|0|||
145766534|NCT02901431|525653992|FG003|PK Part|8 weeks of treatment ran out|0|||
145766535|NCT02901431|525653993|FG004|PK Part|8 weeks of treatment ran out|0|||
145766536|NCT02901431|525653994|FG005|PK Part|8 weeks of treatment ran out|0|||
145766537|NCT02901431|525653995|FG006|PK Part|8 weeks of treatment ran out|0|||
145766538|NCT02901431|525653996|FG007|PK Part|8 weeks of treatment ran out|0|||
145766539|NCT02901431|525653997|FG008|PK Part|8 weeks of treatment ran out|0|||
145533487|NCT02927262|524813466|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
145277753|NCT01625286|523867237|FG001|Overall Study|Any reason not specifically recorded|0|||
145766540|NCT02901431|525653998|FG009|PK Part|8 weeks of treatment ran out|0|||
145766541|NCT02901431|525653999|FG010|PK Part|8 weeks of treatment ran out|0|||
145766542|NCT02901431|525654000|FG011|PK Part|8 weeks of treatment ran out|0|||
145766543|NCT02901431|525654001|FG012|PK Part|8 weeks of treatment ran out|0|||
145766544|NCT02901431|525653989|FG000|PK Part|Stopped treatment after 8 weeks|1|||
145766545|NCT02901431|525653990|FG001|PK Part|Stopped treatment after 8 weeks|0|||
145766546|NCT02901431|525653991|FG002|PK Part|Stopped treatment after 8 weeks|1|||
145766547|NCT02901431|525653992|FG003|PK Part|Stopped treatment after 8 weeks|0|||
145766548|NCT02901431|525653993|FG004|PK Part|Stopped treatment after 8 weeks|0|||
145277754|NCT01625286|523867238|FG002|Overall Study|Any reason not specifically recorded|0|||
145277755|NCT01625286|523867239|FG003|Overall Study|Any reason not specifically recorded|0|||
145277756|NCT01625286|523867240|FG004|Overall Study|Any reason not specifically recorded|0|||
145277757|NCT01625286|523867241|FG005|Overall Study|Any reason not specifically recorded|1|||
145277758|NCT01625286|523867242|FG006|Overall Study|Any reason not specifically recorded|0|||
145277759|NCT01625286|523867236|FG000|Overall Study|Progressive disease|6|||
145277760|NCT01625286|523867237|FG001|Overall Study|Progressive disease|3|||
145277761|NCT01625286|523867238|FG002|Overall Study|Progressive disease|4|||
145277762|NCT01625286|523867239|FG003|Overall Study|Progressive disease|5|||
145277763|NCT01625286|523867240|FG004|Overall Study|Progressive disease|5|||
145277764|NCT01625286|523867241|FG005|Overall Study|Progressive disease|0|||
145277765|NCT01625286|523867242|FG006|Overall Study|Progressive disease|0|||
145277766|NCT01625286|523867236|FG000|Overall Study|Lost to Follow-up|0|||
145277767|NCT01625286|523867237|FG001|Overall Study|Lost to Follow-up|0|||
145277768|NCT01625286|523867238|FG002|Overall Study|Lost to Follow-up|0|||
145277769|NCT01625286|523867239|FG003|Overall Study|Lost to Follow-up|0|||
145277770|NCT01625286|523867240|FG004|Overall Study|Lost to Follow-up|0|||
145277771|NCT01625286|523867241|FG005|Overall Study|Lost to Follow-up|0|||
145607935|NCT01852058|525079283|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145277772|NCT01625286|523867242|FG006|Overall Study|Lost to Follow-up|1|||
145277773|NCT02598622|523868800|FG000|Overall Study|Withdrawal by Subject|3|||
145277774|NCT02598622|523868801|FG001|Overall Study|Withdrawal by Subject|0|||
145277775|NCT02598622|523868800|FG000|Overall Study|Physician Decision|3|||
145277776|NCT02598622|523868801|FG001|Overall Study|Physician Decision|0|||
145277777|NCT00681824|523868805|FG000|Overall Study|withdrawn by investigator|0|||
145766549|NCT02901431|525653994|FG005|PK Part|Stopped treatment after 8 weeks|0|||
145766550|NCT02901431|525653995|FG006|PK Part|Stopped treatment after 8 weeks|0|||
145766551|NCT02901431|525653996|FG007|PK Part|Stopped treatment after 8 weeks|0|||
145766552|NCT02901431|525653997|FG008|PK Part|Stopped treatment after 8 weeks|0|||
145766553|NCT02901431|525653998|FG009|PK Part|Stopped treatment after 8 weeks|0|||
145766554|NCT02901431|525653999|FG010|PK Part|Stopped treatment after 8 weeks|0|||
145766555|NCT02901431|525654000|FG011|PK Part|Stopped treatment after 8 weeks|0|||
145766556|NCT02901431|525654001|FG012|PK Part|Stopped treatment after 8 weeks|0|||
145766557|NCT02901431|525653989|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
145766558|NCT02901431|525653990|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766559|NCT02901431|525653991|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
145766560|NCT02901431|525653992|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766561|NCT02901431|525653993|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766562|NCT02901431|525653994|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766563|NCT02901431|525653995|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766564|NCT02901431|525653996|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766565|NCT02901431|525653997|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766566|NCT02901431|525653998|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766567|NCT02901431|525653999|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766568|NCT02901431|525654000|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766569|NCT02901431|525654001|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
145766570|NCT02901431|525653989|FG000|PK Part|Discontinued per Sponsor|0|||
145766571|NCT02901431|525653990|FG001|PK Part|Discontinued per Sponsor|3|||
145766572|NCT02901431|525653991|FG002|PK Part|Discontinued per Sponsor|0|||
145766573|NCT02901431|525653992|FG003|PK Part|Discontinued per Sponsor|0|||
145766574|NCT02901431|525653993|FG004|PK Part|Discontinued per Sponsor|0|||
145766575|NCT02901431|525653994|FG005|PK Part|Discontinued per Sponsor|0|||
145766576|NCT02901431|525653995|FG006|PK Part|Discontinued per Sponsor|0|||
145766577|NCT02901431|525653996|FG007|PK Part|Discontinued per Sponsor|0|||
145766578|NCT02901431|525653997|FG008|PK Part|Discontinued per Sponsor|0|||
145766579|NCT02901431|525653998|FG009|PK Part|Discontinued per Sponsor|0|||
145766580|NCT02901431|525653999|FG010|PK Part|Discontinued per Sponsor|0|||
145766581|NCT02901431|525654000|FG011|PK Part|Discontinued per Sponsor|0|||
145766582|NCT02901431|525654001|FG012|PK Part|Discontinued per Sponsor|0|||
145766583|NCT02901431|525653989|FG000|PK Part|Withdrawal by Subject|1|||
145766584|NCT02901431|525653990|FG001|PK Part|Withdrawal by Subject|1|||
145766585|NCT02901431|525653991|FG002|PK Part|Withdrawal by Subject|3|||
145766586|NCT02901431|525653992|FG003|PK Part|Withdrawal by Subject|0|||
145766587|NCT02901431|525653993|FG004|PK Part|Withdrawal by Subject|0|||
145766588|NCT02901431|525653994|FG005|PK Part|Withdrawal by Subject|0|||
145766589|NCT02901431|525653995|FG006|PK Part|Withdrawal by Subject|0|||
145766590|NCT02901431|525653996|FG007|PK Part|Withdrawal by Subject|0|||
145766591|NCT02901431|525653997|FG008|PK Part|Withdrawal by Subject|0|||
145766592|NCT02901431|525653998|FG009|PK Part|Withdrawal by Subject|0|||
145766593|NCT02901431|525653999|FG010|PK Part|Withdrawal by Subject|0|||
145766594|NCT02901431|525654000|FG011|PK Part|Withdrawal by Subject|0|||
145766595|NCT02901431|525654001|FG012|PK Part|Withdrawal by Subject|0|||
145766596|NCT02901431|525653989|FG000|Main Treatment Part|Adverse Event|0|||
145766597|NCT02901431|525653990|FG001|Main Treatment Part|Adverse Event|0|||
145766598|NCT02901431|525653991|FG002|Main Treatment Part|Adverse Event|0|||
145766599|NCT02901431|525653992|FG003|Main Treatment Part|Adverse Event|3|||
145766600|NCT02901431|525653993|FG004|Main Treatment Part|Adverse Event|3|||
145766601|NCT02901431|525653994|FG005|Main Treatment Part|Adverse Event|4|||
145766602|NCT02901431|525653995|FG006|Main Treatment Part|Adverse Event|1|||
145766603|NCT02901431|525653996|FG007|Main Treatment Part|Adverse Event|0|||
145766604|NCT02901431|525653997|FG008|Main Treatment Part|Adverse Event|0|||
145766605|NCT02901431|525653998|FG009|Main Treatment Part|Adverse Event|0|||
145766606|NCT02901431|525653999|FG010|Main Treatment Part|Adverse Event|0|||
145766607|NCT02901431|525654000|FG011|Main Treatment Part|Adverse Event|0|||
145766608|NCT02901431|525654001|FG012|Main Treatment Part|Adverse Event|0|||
145766609|NCT02901431|525653989|FG000|Main Treatment Part|Lack of Efficacy|0|||
145766610|NCT02901431|525653990|FG001|Main Treatment Part|Lack of Efficacy|0|||
145766611|NCT02901431|525653991|FG002|Main Treatment Part|Lack of Efficacy|0|||
145766612|NCT02901431|525653992|FG003|Main Treatment Part|Lack of Efficacy|1|||
145766613|NCT02901431|525653993|FG004|Main Treatment Part|Lack of Efficacy|0|||
145766614|NCT02901431|525653994|FG005|Main Treatment Part|Lack of Efficacy|0|||
145766615|NCT02901431|525653995|FG006|Main Treatment Part|Lack of Efficacy|0|||
145766616|NCT02901431|525653996|FG007|Main Treatment Part|Lack of Efficacy|0|||
145766617|NCT02901431|525653997|FG008|Main Treatment Part|Lack of Efficacy|0|||
145766618|NCT02901431|525653998|FG009|Main Treatment Part|Lack of Efficacy|0|||
145766619|NCT02901431|525653999|FG010|Main Treatment Part|Lack of Efficacy|0|||
145766620|NCT02901431|525654000|FG011|Main Treatment Part|Lack of Efficacy|0|||
145766621|NCT02901431|525654001|FG012|Main Treatment Part|Lack of Efficacy|0|||
145766622|NCT02901431|525653989|FG000|Main Treatment Part|Lost to Follow-up|0|||
145766623|NCT02901431|525653990|FG001|Main Treatment Part|Lost to Follow-up|0|||
145766624|NCT02901431|525653991|FG002|Main Treatment Part|Lost to Follow-up|0|||
145766625|NCT02901431|525653992|FG003|Main Treatment Part|Lost to Follow-up|3|||
145766626|NCT02901431|525653993|FG004|Main Treatment Part|Lost to Follow-up|1|||
145766627|NCT02901431|525653994|FG005|Main Treatment Part|Lost to Follow-up|2|||
145766628|NCT02901431|525653995|FG006|Main Treatment Part|Lost to Follow-up|3|||
145766629|NCT02901431|525653996|FG007|Main Treatment Part|Lost to Follow-up|0|||
145766630|NCT02901431|525653997|FG008|Main Treatment Part|Lost to Follow-up|0|||
145766631|NCT02901431|525653998|FG009|Main Treatment Part|Lost to Follow-up|0|||
145766632|NCT02901431|525653999|FG010|Main Treatment Part|Lost to Follow-up|0|||
145766633|NCT02901431|525654000|FG011|Main Treatment Part|Lost to Follow-up|0|||
145766634|NCT02901431|525654001|FG012|Main Treatment Part|Lost to Follow-up|0|||
145766635|NCT02901431|525653989|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
145766636|NCT02901431|525653990|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
145766637|NCT02901431|525653991|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
145766638|NCT02901431|525653992|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
145766639|NCT02901431|525653993|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
145766640|NCT02901431|525653994|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
145766641|NCT02901431|525653995|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
145766642|NCT02901431|525653996|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
145766643|NCT02901431|525653997|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
145766644|NCT02901431|525653998|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
145766645|NCT02901431|525653999|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
145766646|NCT02901431|525654000|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
145766647|NCT02901431|525654001|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
145766648|NCT02901431|525653989|FG000|Main Treatment Part|Physician Decision|0|||
145766649|NCT02901431|525653990|FG001|Main Treatment Part|Physician Decision|0|||
145766650|NCT02901431|525653991|FG002|Main Treatment Part|Physician Decision|0|||
145766651|NCT02901431|525653992|FG003|Main Treatment Part|Physician Decision|1|||
145766652|NCT02901431|525653993|FG004|Main Treatment Part|Physician Decision|0|||
145766653|NCT02901431|525653994|FG005|Main Treatment Part|Physician Decision|0|||
145766654|NCT02901431|525653995|FG006|Main Treatment Part|Physician Decision|1|||
145766655|NCT02901431|525653996|FG007|Main Treatment Part|Physician Decision|0|||
145766656|NCT02901431|525653997|FG008|Main Treatment Part|Physician Decision|0|||
145766657|NCT02901431|525653998|FG009|Main Treatment Part|Physician Decision|0|||
145766658|NCT02901431|525653999|FG010|Main Treatment Part|Physician Decision|0|||
145766659|NCT02901431|525654000|FG011|Main Treatment Part|Physician Decision|0|||
145766660|NCT02901431|525654001|FG012|Main Treatment Part|Physician Decision|0|||
145766661|NCT02901431|525653989|FG000|Main Treatment Part|Withdrawal by Subject|0|||
145766662|NCT02901431|525653990|FG001|Main Treatment Part|Withdrawal by Subject|0|||
145766663|NCT02901431|525653991|FG002|Main Treatment Part|Withdrawal by Subject|0|||
145766664|NCT02901431|525653992|FG003|Main Treatment Part|Withdrawal by Subject|18|||
145403166|NCT01206764|524334314|FG000|Overall Study|Abnormal test procedure result|1|||
145403167|NCT01206764|524334314|FG000|Overall Study|Patient withdrew consent|5|||
145533488|NCT02927262|524813465|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
145533489|NCT02927262|524813466|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
145766665|NCT02901431|525653993|FG004|Main Treatment Part|Withdrawal by Subject|3|||
145766666|NCT02901431|525653994|FG005|Main Treatment Part|Withdrawal by Subject|5|||
145766667|NCT02901431|525653995|FG006|Main Treatment Part|Withdrawal by Subject|6|||
145766668|NCT02901431|525653996|FG007|Main Treatment Part|Withdrawal by Subject|0|||
145766669|NCT02901431|525653997|FG008|Main Treatment Part|Withdrawal by Subject|0|||
145766670|NCT02901431|525653998|FG009|Main Treatment Part|Withdrawal by Subject|0|||
145766671|NCT02901431|525653999|FG010|Main Treatment Part|Withdrawal by Subject|0|||
145766672|NCT02901431|525654000|FG011|Main Treatment Part|Withdrawal by Subject|0|||
145766673|NCT02901431|525654001|FG012|Main Treatment Part|Withdrawal by Subject|0|||
145766674|NCT02901431|525653989|FG000|Open Label Part|Adverse Event|0|||
145766675|NCT02901431|525653990|FG001|Open Label Part|Adverse Event|0|||
145766676|NCT02901431|525653991|FG002|Open Label Part|Adverse Event|0|||
145766677|NCT02901431|525653992|FG003|Open Label Part|Adverse Event|0|||
145766678|NCT02901431|525653993|FG004|Open Label Part|Adverse Event|0|||
145766679|NCT02901431|525653994|FG005|Open Label Part|Adverse Event|0|||
145766680|NCT02901431|525653995|FG006|Open Label Part|Adverse Event|0|||
145766681|NCT02901431|525653996|FG007|Open Label Part|Adverse Event|0|||
145277778|NCT00681824|523868806|FG001|Overall Study|withdrawn by investigator|0|||
145766682|NCT02901431|525653997|FG008|Open Label Part|Adverse Event|4|||
145766683|NCT02901431|525653998|FG009|Open Label Part|Adverse Event|4|||
145766684|NCT02901431|525653999|FG010|Open Label Part|Adverse Event|0|||
145766685|NCT02901431|525654000|FG011|Open Label Part|Adverse Event|4|||
145766686|NCT02901431|525654001|FG012|Open Label Part|Adverse Event|1|||
145766687|NCT02901431|525653989|FG000|Open Label Part|Lost to Follow-up|0|||
145766688|NCT02901431|525653990|FG001|Open Label Part|Lost to Follow-up|0|||
145766689|NCT02901431|525653991|FG002|Open Label Part|Lost to Follow-up|0|||
145766690|NCT02901431|525653992|FG003|Open Label Part|Lost to Follow-up|0|||
145766691|NCT02901431|525653993|FG004|Open Label Part|Lost to Follow-up|0|||
145766692|NCT02901431|525653994|FG005|Open Label Part|Lost to Follow-up|0|||
145766693|NCT02901431|525653995|FG006|Open Label Part|Lost to Follow-up|0|||
145766694|NCT02901431|525653996|FG007|Open Label Part|Lost to Follow-up|0|||
145766695|NCT02901431|525653997|FG008|Open Label Part|Lost to Follow-up|2|||
145766696|NCT02901431|525653998|FG009|Open Label Part|Lost to Follow-up|2|||
145766697|NCT02901431|525653999|FG010|Open Label Part|Lost to Follow-up|1|||
145766698|NCT02901431|525654000|FG011|Open Label Part|Lost to Follow-up|1|||
145766699|NCT02901431|525654001|FG012|Open Label Part|Lost to Follow-up|1|||
145766700|NCT02901431|525653989|FG000|Open Label Part|Physician Decision|0|||
145766701|NCT02901431|525653990|FG001|Open Label Part|Physician Decision|0|||
145766702|NCT02901431|525653991|FG002|Open Label Part|Physician Decision|0|||
145766703|NCT02901431|525653992|FG003|Open Label Part|Physician Decision|0|||
145766704|NCT02901431|525653993|FG004|Open Label Part|Physician Decision|0|||
145766705|NCT02901431|525653994|FG005|Open Label Part|Physician Decision|0|||
145766706|NCT02901431|525653995|FG006|Open Label Part|Physician Decision|0|||
145766707|NCT02901431|525653996|FG007|Open Label Part|Physician Decision|0|||
145766708|NCT02901431|525653997|FG008|Open Label Part|Physician Decision|1|||
145766709|NCT02901431|525653998|FG009|Open Label Part|Physician Decision|1|||
145766710|NCT02901431|525653999|FG010|Open Label Part|Physician Decision|0|||
145766711|NCT02901431|525654000|FG011|Open Label Part|Physician Decision|0|||
145766712|NCT02901431|525654001|FG012|Open Label Part|Physician Decision|0|||
145766713|NCT02901431|525653989|FG000|Open Label Part|Study Terminated By Sponsor|0|||
145766714|NCT02901431|525653990|FG001|Open Label Part|Study Terminated By Sponsor|0|||
145403168|NCT01206764|524334314|FG000|Overall Study|Lost to Follow-up|6|||
145403169|NCT01206764|524334314|FG000|Overall Study|Death|11|||
145277779|NCT00681824|523868807|FG002|Overall Study|withdrawn by investigator|1|||
145403170|NCT01206764|524334314|FG000|Overall Study|New cancer therapy|2|||
145766715|NCT02901431|525653991|FG002|Open Label Part|Study Terminated By Sponsor|0|||
145766716|NCT02901431|525653992|FG003|Open Label Part|Study Terminated By Sponsor|0|||
145766717|NCT02901431|525653993|FG004|Open Label Part|Study Terminated By Sponsor|0|||
145766718|NCT02901431|525653994|FG005|Open Label Part|Study Terminated By Sponsor|0|||
145766719|NCT02901431|525653995|FG006|Open Label Part|Study Terminated By Sponsor|0|||
145766720|NCT02901431|525653996|FG007|Open Label Part|Study Terminated By Sponsor|0|||
145766721|NCT02901431|525653997|FG008|Open Label Part|Study Terminated By Sponsor|35|||
145766722|NCT02901431|525653998|FG009|Open Label Part|Study Terminated By Sponsor|12|||
145766723|NCT02901431|525653999|FG010|Open Label Part|Study Terminated By Sponsor|21|||
145766724|NCT02901431|525654000|FG011|Open Label Part|Study Terminated By Sponsor|31|||
145766725|NCT02901431|525654001|FG012|Open Label Part|Study Terminated By Sponsor|0|||
145766726|NCT02901431|525653989|FG000|Open Label Part|Withdrawal by Subject|0|||
145766727|NCT02901431|525653990|FG001|Open Label Part|Withdrawal by Subject|0|||
145766728|NCT02901431|525653991|FG002|Open Label Part|Withdrawal by Subject|0|||
145766729|NCT02901431|525653992|FG003|Open Label Part|Withdrawal by Subject|0|||
145766730|NCT02901431|525653993|FG004|Open Label Part|Withdrawal by Subject|0|||
145766731|NCT02901431|525653994|FG005|Open Label Part|Withdrawal by Subject|0|||
145766732|NCT02901431|525653995|FG006|Open Label Part|Withdrawal by Subject|0|||
145766733|NCT02901431|525653996|FG007|Open Label Part|Withdrawal by Subject|0|||
145766734|NCT02901431|525653997|FG008|Open Label Part|Withdrawal by Subject|6|||
145766735|NCT02901431|525653998|FG009|Open Label Part|Withdrawal by Subject|5|||
145766736|NCT02901431|525653999|FG010|Open Label Part|Withdrawal by Subject|7|||
145766737|NCT02901431|525654000|FG011|Open Label Part|Withdrawal by Subject|3|||
145277780|NCT00681824|523868805|FG000|Overall Study|scheduling conflict|1|||
145277781|NCT00681824|523868806|FG001|Overall Study|scheduling conflict|0|||
145277782|NCT00681824|523868807|FG002|Overall Study|scheduling conflict|0|||
145277783|NCT00681824|523868805|FG000|Overall Study|Death|0|||
145277784|NCT00681824|523868806|FG001|Overall Study|Death|1|||
145277785|NCT00681824|523868807|FG002|Overall Study|Death|0|||
145277786|NCT02464059|523868808|FG000|Overall Study|Lost to Follow-up|6|||
145277787|NCT03591107|523868809|FG000|Overall Study|Same patient in both arms|1|||
145277788|NCT03591107|523868810|FG001|Overall Study|Same patient in both arms|1|||
145277789|NCT03591107|523868809|FG000|Overall Study|Sought care at other clinics|0|||
145277790|NCT03591107|523868810|FG001|Overall Study|Sought care at other clinics|2|||
145277791|NCT03591107|523868809|FG000|Overall Study|Discharged from clinic|0|||
145277792|NCT03591107|523868810|FG001|Overall Study|Discharged from clinic|1|||
145277793|NCT03591107|523868809|FG000|Overall Study|Withdrawal by Subject|0|||
145277794|NCT03591107|523868810|FG001|Overall Study|Withdrawal by Subject|1|||
145277795|NCT01902134|523868811|FG000|Overall Study|Adverse Event|3|||
145277796|NCT01902134|523868812|FG001|Overall Study|Adverse Event|1|||
145277797|NCT01902134|523868813|FG002|Overall Study|Adverse Event|2|||
145277798|NCT01902134|523868814|FG003|Overall Study|Adverse Event|1|||
145277799|NCT01902134|523868815|FG004|Overall Study|Adverse Event|1|||
145277800|NCT01902134|523868816|FG005|Overall Study|Adverse Event|3|||
145277801|NCT01902134|523868811|FG000|Overall Study|Lack of Efficacy|0|||
145277802|NCT01902134|523868812|FG001|Overall Study|Lack of Efficacy|0|||
145277803|NCT01902134|523868813|FG002|Overall Study|Lack of Efficacy|2|||
145766738|NCT02901431|525654001|FG012|Open Label Part|Withdrawal by Subject|1|||
145766739|NCT04223609|525654002|FG000|Overall Study|Adverse Event|0|||
145766740|NCT04223609|525654003|FG001|Overall Study|Adverse Event|1|||
145766741|NCT04223609|525654002|FG000|Overall Study|Missed last visit|0|||
145766742|NCT04223609|525654003|FG001|Overall Study|Missed last visit|1|||
145766743|NCT00591734|525654006|FG000|Overall Study|Lack of Efficacy|35|||
145766744|NCT00591734|525654006|FG000|Overall Study|Adverse Event|5|||
145766745|NCT00591734|525654006|FG000|Overall Study|Physician Decision|5|||
145277804|NCT01902134|523868814|FG003|Overall Study|Lack of Efficacy|0|||
145277805|NCT01902134|523868815|FG004|Overall Study|Lack of Efficacy|0|||
145277806|NCT01902134|523868816|FG005|Overall Study|Lack of Efficacy|1|||
145277807|NCT01902134|523868811|FG000|Overall Study|Physician Decision|0|||
145277808|NCT01902134|523868812|FG001|Overall Study|Physician Decision|1|||
145607936|NCT01852058|525079284|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
145766746|NCT00591734|525654006|FG000|Overall Study|Intercurrent Illness|8|||
145766747|NCT02500537|525654007|FG000|Overall Study|Death|2|||
145766748|NCT02500537|525654008|FG001|Overall Study|Death|0|||
145766749|NCT02500537|525654007|FG000|Overall Study|Lost to Follow-up|0|||
145766750|NCT02500537|525654008|FG001|Overall Study|Lost to Follow-up|1|||
145766751|NCT02500537|525654007|FG000|Overall Study|Withdrawal by Subject|1|||
145766752|NCT02500537|525654008|FG001|Overall Study|Withdrawal by Subject|0|||
145766753|NCT01661790|525654009|FG000|Overall Study|Lost to Follow-up|0|||
145766754|NCT01661790|525654010|FG001|Overall Study|Lost to Follow-up|2|||
145766755|NCT00355121|525654015|FG000|Overall Study|Did not receive study vaccine|1|||
145766756|NCT00355121|525654016|FG001|Overall Study|Did not receive study vaccine|0|||
145766757|NCT00355121|525654017|FG002|Overall Study|Did not receive study vaccine|1|||
145766758|NCT00355121|525654015|FG000|Overall Study|Adverse Event|0|||
145766759|NCT00355121|525654016|FG001|Overall Study|Adverse Event|1|||
145766760|NCT00355121|525654017|FG002|Overall Study|Adverse Event|0|||
145766761|NCT00355121|525654015|FG000|Overall Study|Protocol Violation|7|||
145766762|NCT00355121|525654016|FG001|Overall Study|Protocol Violation|9|||
145766763|NCT00355121|525654017|FG002|Overall Study|Protocol Violation|1|||
145766764|NCT00355121|525654015|FG000|Overall Study|Lost to Follow-up|4|||
145766765|NCT00355121|525654016|FG001|Overall Study|Lost to Follow-up|7|||
145766766|NCT00355121|525654017|FG002|Overall Study|Lost to Follow-up|1|||
145766767|NCT00355121|525654015|FG000|Overall Study|Withdrawal by Subject|9|||
145766768|NCT00355121|525654016|FG001|Overall Study|Withdrawal by Subject|10|||
145766769|NCT00355121|525654017|FG002|Overall Study|Withdrawal by Subject|2|||
145766770|NCT00355121|525654015|FG000|Overall Study|Serious adverse events|0|||
145766771|NCT00355121|525654016|FG001|Overall Study|Serious adverse events|2|||
145766772|NCT00355121|525654017|FG002|Overall Study|Serious adverse events|0|||
145766773|NCT04696861|525654019|FG000|Overall Study|Death|1|||
145766774|NCT04696861|525654020|FG001|Overall Study|Death|0|||
145766775|NCT04696861|525654019|FG000|Overall Study|Lost to Follow-up|3|||
145766776|NCT04696861|525654020|FG001|Overall Study|Lost to Follow-up|0|||
145766777|NCT01827384|525654023|FG000|Overall Study|Switched to alternative treatment|0|||
145766778|NCT01827384|525654024|FG001|Overall Study|Switched to alternative treatment|0|||
145766779|NCT01827384|525654025|FG002|Overall Study|Switched to alternative treatment|0|||
145766780|NCT01827384|525654026|FG003|Overall Study|Switched to alternative treatment|0|||
145766781|NCT01827384|525654027|FG004|Overall Study|Switched to alternative treatment|0|||
145766782|NCT01827384|525654028|FG005|Overall Study|Switched to alternative treatment|0|||
145766783|NCT01827384|525654029|FG006|Overall Study|Switched to alternative treatment|0|||
145766784|NCT01827384|525654030|FG007|Overall Study|Switched to alternative treatment|0|||
145766785|NCT01827384|525654031|FG008|Overall Study|Switched to alternative treatment|0|||
145766786|NCT01827384|525654032|FG009|Overall Study|Switched to alternative treatment|0|||
145766787|NCT01827384|525654033|FG010|Overall Study|Switched to alternative treatment|0|||
145766788|NCT01827384|525654034|FG011|Overall Study|Switched to alternative treatment|0|||
145766789|NCT01827384|525654035|FG012|Overall Study|Switched to alternative treatment|0|||
145766790|NCT01827384|525654036|FG013|Overall Study|Switched to alternative treatment|2|||
145766791|NCT01827384|525654023|FG000|Overall Study|Disease progression before treatment|0|||
145766792|NCT01827384|525654024|FG001|Overall Study|Disease progression before treatment|0|||
145766793|NCT01827384|525654025|FG002|Overall Study|Disease progression before treatment|0|||
145766794|NCT01827384|525654026|FG003|Overall Study|Disease progression before treatment|0|||
145766795|NCT01827384|525654027|FG004|Overall Study|Disease progression before treatment|0|||
145766796|NCT01827384|525654028|FG005|Overall Study|Disease progression before treatment|0|||
145766797|NCT01827384|525654029|FG006|Overall Study|Disease progression before treatment|0|||
145766798|NCT01827384|525654030|FG007|Overall Study|Disease progression before treatment|0|||
145766799|NCT01827384|525654031|FG008|Overall Study|Disease progression before treatment|0|||
145766800|NCT01827384|525654032|FG009|Overall Study|Disease progression before treatment|0|||
145766801|NCT01827384|525654033|FG010|Overall Study|Disease progression before treatment|0|||
145766802|NCT01827384|525654034|FG011|Overall Study|Disease progression before treatment|0|||
145766803|NCT01827384|525654035|FG012|Overall Study|Disease progression before treatment|0|||
145766804|NCT01827384|525654036|FG013|Overall Study|Disease progression before treatment|4|||
145766805|NCT01827384|525654023|FG000|Overall Study|Ineligible|0|||
145766806|NCT01827384|525654024|FG001|Overall Study|Ineligible|0|||
145277809|NCT01902134|523868813|FG002|Overall Study|Physician Decision|0|||
145277810|NCT01902134|523868814|FG003|Overall Study|Physician Decision|0|||
145277811|NCT01902134|523868815|FG004|Overall Study|Physician Decision|0|||
145277812|NCT01902134|523868816|FG005|Overall Study|Physician Decision|0|||
145277813|NCT01902134|523868811|FG000|Overall Study|Protocol Violation|0|||
145277814|NCT01902134|523868812|FG001|Overall Study|Protocol Violation|0|||
145277815|NCT01902134|523868813|FG002|Overall Study|Protocol Violation|0|||
145277816|NCT01902134|523868814|FG003|Overall Study|Protocol Violation|0|||
145277817|NCT01902134|523868815|FG004|Overall Study|Protocol Violation|0|||
145277818|NCT01902134|523868816|FG005|Overall Study|Protocol Violation|1|||
145277819|NCT01902134|523868811|FG000|Overall Study|Withdrawal by Subject|4|||
145277820|NCT01902134|523868812|FG001|Overall Study|Withdrawal by Subject|8|||
145277821|NCT01902134|523868813|FG002|Overall Study|Withdrawal by Subject|9|||
145277822|NCT01902134|523868814|FG003|Overall Study|Withdrawal by Subject|1|||
145766807|NCT01827384|525654025|FG002|Overall Study|Ineligible|0|||
145766808|NCT01827384|525654026|FG003|Overall Study|Ineligible|0|||
145766809|NCT01827384|525654027|FG004|Overall Study|Ineligible|0|||
145766810|NCT01827384|525654028|FG005|Overall Study|Ineligible|0|||
145766811|NCT01827384|525654029|FG006|Overall Study|Ineligible|0|||
145766812|NCT01827384|525654030|FG007|Overall Study|Ineligible|0|||
145766813|NCT01827384|525654031|FG008|Overall Study|Ineligible|0|||
145766814|NCT01827384|525654032|FG009|Overall Study|Ineligible|0|||
145766815|NCT01827384|525654033|FG010|Overall Study|Ineligible|0|||
145766816|NCT01827384|525654034|FG011|Overall Study|Ineligible|0|||
145766817|NCT01827384|525654035|FG012|Overall Study|Ineligible|0|||
145766818|NCT01827384|525654036|FG013|Overall Study|Ineligible|19|||
145766819|NCT01827384|525654023|FG000|Overall Study|Participant died before treatment|0|||
145766820|NCT01827384|525654024|FG001|Overall Study|Participant died before treatment|0|||
145766821|NCT01827384|525654025|FG002|Overall Study|Participant died before treatment|0|||
145766822|NCT01827384|525654026|FG003|Overall Study|Participant died before treatment|0|||
145766823|NCT01827384|525654027|FG004|Overall Study|Participant died before treatment|0|||
145766824|NCT01827384|525654028|FG005|Overall Study|Participant died before treatment|0|||
145766825|NCT01827384|525654029|FG006|Overall Study|Participant died before treatment|0|||
145766826|NCT01827384|525654030|FG007|Overall Study|Participant died before treatment|0|||
145766827|NCT01827384|525654031|FG008|Overall Study|Participant died before treatment|0|||
145766828|NCT01827384|525654032|FG009|Overall Study|Participant died before treatment|0|||
145766829|NCT01827384|525654033|FG010|Overall Study|Participant died before treatment|0|||
145766830|NCT01827384|525654034|FG011|Overall Study|Participant died before treatment|0|||
145766831|NCT01827384|525654035|FG012|Overall Study|Participant died before treatment|0|||
145766832|NCT01827384|525654036|FG013|Overall Study|Participant died before treatment|5|||
145766833|NCT01827384|525654023|FG000|Overall Study|Insufficient tumor cells|0|||
145766834|NCT01827384|525654024|FG001|Overall Study|Insufficient tumor cells|0|||
145766835|NCT01827384|525654025|FG002|Overall Study|Insufficient tumor cells|0|||
145766836|NCT01827384|525654026|FG003|Overall Study|Insufficient tumor cells|0|||
145766837|NCT01827384|525654027|FG004|Overall Study|Insufficient tumor cells|0|||
145766838|NCT01827384|525654028|FG005|Overall Study|Insufficient tumor cells|0|||
145766839|NCT01827384|525654029|FG006|Overall Study|Insufficient tumor cells|0|||
145766840|NCT01827384|525654030|FG007|Overall Study|Insufficient tumor cells|0|||
145766841|NCT01827384|525654031|FG008|Overall Study|Insufficient tumor cells|0|||
145766842|NCT01827384|525654032|FG009|Overall Study|Insufficient tumor cells|0|||
145766843|NCT01827384|525654033|FG010|Overall Study|Insufficient tumor cells|0|||
145766844|NCT01827384|525654034|FG011|Overall Study|Insufficient tumor cells|0|||
145766845|NCT01827384|525654035|FG012|Overall Study|Insufficient tumor cells|0|||
145766846|NCT01827384|525654036|FG013|Overall Study|Insufficient tumor cells|13|||
145766847|NCT01827384|525654023|FG000|Overall Study|No actionable mutation|0|||
145766848|NCT01827384|525654024|FG001|Overall Study|No actionable mutation|0|||
145766849|NCT01827384|525654025|FG002|Overall Study|No actionable mutation|0|||
145766850|NCT01827384|525654026|FG003|Overall Study|No actionable mutation|0|||
145766851|NCT01827384|525654027|FG004|Overall Study|No actionable mutation|0|||
145766852|NCT01827384|525654028|FG005|Overall Study|No actionable mutation|0|||
145766853|NCT01827384|525654029|FG006|Overall Study|No actionable mutation|0|||
145766854|NCT01827384|525654030|FG007|Overall Study|No actionable mutation|0|||
145766855|NCT01827384|525654031|FG008|Overall Study|No actionable mutation|0|||
145766856|NCT01827384|525654032|FG009|Overall Study|No actionable mutation|0|||
145766857|NCT01827384|525654033|FG010|Overall Study|No actionable mutation|0|||
145766858|NCT01827384|525654034|FG011|Overall Study|No actionable mutation|0|||
145766859|NCT01827384|525654035|FG012|Overall Study|No actionable mutation|0|||
145766860|NCT01827384|525654036|FG013|Overall Study|No actionable mutation|73|||
145766861|NCT01827384|525654023|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
145766862|NCT01827384|525654024|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
145766863|NCT01827384|525654025|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
145766864|NCT01827384|525654026|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
145766865|NCT01827384|525654027|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
145766866|NCT01827384|525654028|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
145766867|NCT01827384|525654029|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
145766868|NCT01827384|525654030|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
145766869|NCT01827384|525654031|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
145766870|NCT01827384|525654032|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
145766871|NCT01827384|525654033|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
145766872|NCT01827384|525654034|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
145607937|NCT01852058|525079285|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145766873|NCT01827384|525654035|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
145766874|NCT01827384|525654036|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
145766875|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
145766876|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
145766877|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
145766878|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
145766879|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
145766880|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
145766881|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
145766882|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
145766883|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
145766884|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
145766885|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
145766886|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
145766887|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
145766888|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
145766889|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
145766890|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
145766891|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
145766892|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
145766893|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
145766894|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
145766895|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
145766896|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
145766897|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
145766898|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
145766899|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
145766900|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
145766901|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
145766902|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
145766903|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
145766904|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
145766905|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
145766906|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
145766907|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
145766908|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
145766909|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
145766910|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
145766911|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
145766912|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
145766913|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
145766914|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
145766915|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
145766916|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
145766917|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
145766918|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
145766919|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
145766920|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
145766921|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
145766922|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
145766923|NCT01707992|525654039|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
145766924|NCT01707992|525654040|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
145766925|NCT01707992|525654041|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
145766926|NCT01707992|525654042|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
145766927|NCT01707992|525654043|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
145766928|NCT01707992|525654044|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
145766929|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
145766930|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
145766931|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
145766932|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
145766933|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
145766934|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
145766935|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
145766936|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
145766937|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
145607938|NCT01852058|525079286|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607939|NCT01852058|525079287|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
145607940|NCT00263328|525079288|FG000|Overall Study|Death|0|||
145607941|NCT00263328|525079289|FG001|Overall Study|Death|0|||
145607942|NCT00263328|525079290|FG002|Overall Study|Death|1|||
145607943|NCT00263328|525079288|FG000|Overall Study|Lost to Follow-up|1|||
145607944|NCT00263328|525079289|FG001|Overall Study|Lost to Follow-up|1|||
145607945|NCT00263328|525079290|FG002|Overall Study|Lost to Follow-up|0|||
145607946|NCT00263328|525079288|FG000|Overall Study|Withdrawal by Subject|3|||
145766938|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
145766939|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
145766940|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
145766941|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
145766942|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
145766943|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
145766944|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
145766945|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
145766946|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
145766947|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
145766948|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
145766949|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
145766950|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
145607947|NCT00263328|525079289|FG001|Overall Study|Withdrawal by Subject|0|||
145607948|NCT00263328|525079290|FG002|Overall Study|Withdrawal by Subject|1|||
145766951|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
145766952|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
145766953|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
145766954|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
145766955|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
145766956|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
145607949|NCT00263328|525079288|FG000|Overall Study|Other|3|||
145607950|NCT00263328|525079289|FG001|Overall Study|Other|0|||
145607951|NCT00263328|525079290|FG002|Overall Study|Other|1|||
145766957|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
145607952|NCT00263328|525079288|FG000|Overall Study|Adverse Event|1|||
145607953|NCT00263328|525079289|FG001|Overall Study|Adverse Event|1|||
145607954|NCT00263328|525079290|FG002|Overall Study|Adverse Event|4|||
145607955|NCT02613221|525079294|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
145766958|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
145766959|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Death|0|||
145766960|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Death|0|||
145766961|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Death|0|||
145766962|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Death|2|||
145766963|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Death|0|||
145607956|NCT02613221|525079294|FG000|Overall Study|Adverse Event|2|||
145607957|NCT02613221|525079294|FG000|Overall Study|Voluntary Discontinuation|1|||
145607958|NCT02613221|525079294|FG000|Overall Study|Delayed Treatment|1|||
145607959|NCT02613221|525079294|FG000|Overall Study|Enrolled but Not Treated|1|||
145607960|NCT01301274|525079295|FG000|Overall Study|Physician Decision|2|||
145607961|NCT01301274|525079296|FG001|Overall Study|Physician Decision|1|||
145607962|NCT00661661|525079297|FG000|Overall Study|Adverse Event|99|||
145607963|NCT00661661|525079298|FG001|Overall Study|Adverse Event|24|||
145607964|NCT00661661|525079297|FG000|Overall Study|Lack of Efficacy|3|||
145607965|NCT00661661|525079298|FG001|Overall Study|Lack of Efficacy|2|||
145607966|NCT00661661|525079297|FG000|Overall Study|Lost to Follow-up|0|||
145607967|NCT00661661|525079298|FG001|Overall Study|Lost to Follow-up|1|||
145607968|NCT00661661|525079297|FG000|Overall Study|Withdrawal by Subject|15|||
145607969|NCT00661661|525079298|FG001|Overall Study|Withdrawal by Subject|5|||
145607970|NCT00661661|525079297|FG000|Overall Study|Other|22|||
145607971|NCT00661661|525079298|FG001|Overall Study|Other|7|||
145607972|NCT00661661|525079297|FG000|Overall Study|Not assigned treatment|1|||
145607973|NCT00661661|525079298|FG001|Overall Study|Not assigned treatment|0|||
145607974|NCT01893827|525079299|FG000|Overall Study|Lost to Follow-up|19|||
145607975|NCT01893827|525079300|FG001|Overall Study|Lost to Follow-up|26|||
145607976|NCT02917941|525079301|FG000|Treatment Period|Adverse Event|11|||
145766964|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Death|0|||
145766965|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
145607977|NCT02917941|525079301|FG000|Treatment Period|Progressive Disease|11|||
145607978|NCT02917941|525079301|FG000|Treatment Period|Reason not Specified|2|||
145607979|NCT02917941|525079301|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
145766966|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
145766967|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
145766968|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
145766969|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
145766970|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
145766971|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
145766972|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
145766973|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
145766974|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
145766975|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
145766976|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
145766977|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
145766978|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
145766979|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
145766980|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
145766981|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
145766982|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
145766983|NCT01707992|525654039|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
145766984|NCT01707992|525654040|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
145766985|NCT01707992|525654041|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
145766986|NCT01707992|525654042|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
145766987|NCT01707992|525654043|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
145766988|NCT01707992|525654044|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
145766989|NCT03797001|525656482|FG000|Overall Study|Withdrawn due to COVID19|4|||
145766990|NCT03797001|525656483|FG001|Overall Study|Withdrawn due to COVID19|0|||
145766991|NCT03797001|525656482|FG000|Overall Study|Withdrawal by Subject|7|||
145766992|NCT03797001|525656483|FG001|Overall Study|Withdrawal by Subject|6|||
145766993|NCT03797001|525656482|FG000|Overall Study|Adverse Event|0|||
145533490|NCT04043728|524813467|FG000|Overall Study|Lost to Follow-up|1|||
145533491|NCT04043728|524813468|FG001|Overall Study|Lost to Follow-up|2|||
145533492|NCT04043728|524813469|FG002|Overall Study|Lost to Follow-up|0|||
145533493|NCT03698331|524813473|FG000|Overall Study|Adverse Event|2|||
145766994|NCT03797001|525656483|FG001|Overall Study|Adverse Event|1|||
145766995|NCT05630846|525656486|FG000|Overall Study|Death|1|||
145766996|NCT05630846|525656487|FG001|Overall Study|Death|0|||
145766997|NCT05630846|525656488|FG002|Overall Study|Death|0|||
145766998|NCT05630846|525656489|FG003|Overall Study|Death|0|||
145533494|NCT03698331|524813474|FG001|Overall Study|Adverse Event|3|||
145766999|NCT05630846|525656486|FG000|Overall Study|Withdrawal by Subject|3|||
145767000|NCT05630846|525656487|FG001|Overall Study|Withdrawal by Subject|3|||
145767001|NCT05630846|525656488|FG002|Overall Study|Withdrawal by Subject|4|||
145767002|NCT05630846|525656489|FG003|Overall Study|Withdrawal by Subject|1|||
145767003|NCT05630846|525656486|FG000|Overall Study|Lost to Follow-up|6|||
145767004|NCT05630846|525656487|FG001|Overall Study|Lost to Follow-up|5|||
145767005|NCT05630846|525656488|FG002|Overall Study|Lost to Follow-up|2|||
145767006|NCT05630846|525656489|FG003|Overall Study|Lost to Follow-up|5|||
145767007|NCT05630846|525656486|FG000|Overall Study|Other|1|||
145767008|NCT05630846|525656487|FG001|Overall Study|Other|0|||
145767009|NCT05630846|525656488|FG002|Overall Study|Other|0|||
145767010|NCT05630846|525656489|FG003|Overall Study|Other|0|||
145767011|NCT05556616|525656490|FG000|Overall Study|Withdrawal by Subject|1|||
145767012|NCT05556616|525656491|FG001|Overall Study|Withdrawal by Subject|0|||
145767013|NCT05556616|525656492|FG002|Overall Study|Withdrawal by Subject|0|||
145767014|NCT05556616|525656493|FG003|Overall Study|Withdrawal by Subject|0|||
145767015|NCT05556616|525656494|FG004|Overall Study|Withdrawal by Subject|0|||
145767016|NCT05556616|525656495|FG005|Overall Study|Withdrawal by Subject|0|||
145767017|NCT05556616|525656496|FG006|Overall Study|Withdrawal by Subject|0|||
145767018|NCT05556616|525656490|FG000|Overall Study|Death|0|||
145767019|NCT05556616|525656491|FG001|Overall Study|Death|0|||
145767020|NCT05556616|525656492|FG002|Overall Study|Death|2|||
145767021|NCT05556616|525656493|FG003|Overall Study|Death|1|||
145767022|NCT05556616|525656494|FG004|Overall Study|Death|0|||
145767023|NCT05556616|525656495|FG005|Overall Study|Death|0|||
145767024|NCT05556616|525656496|FG006|Overall Study|Death|0|||
145767025|NCT05556616|525656490|FG000|Overall Study|Study Terminated by Sponsor|0|||
145767026|NCT05556616|525656491|FG001|Overall Study|Study Terminated by Sponsor|3|||
145767027|NCT05556616|525656492|FG002|Overall Study|Study Terminated by Sponsor|0|||
145767028|NCT05556616|525656493|FG003|Overall Study|Study Terminated by Sponsor|0|||
145767029|NCT05556616|525656494|FG004|Overall Study|Study Terminated by Sponsor|0|||
145767030|NCT05556616|525656495|FG005|Overall Study|Study Terminated by Sponsor|0|||
145767031|NCT05556616|525656496|FG006|Overall Study|Study Terminated by Sponsor|0|||
145767032|NCT00960076|525656508|FG000|Overall Study|Adverse Event|1|||
145767033|NCT00960076|525656509|FG001|Overall Study|Adverse Event|7|||
145767034|NCT00960076|525656508|FG000|Overall Study|No longer met study criteria|1|||
145767035|NCT00960076|525656509|FG001|Overall Study|No longer met study criteria|5|||
145767036|NCT00960076|525656508|FG000|Overall Study|Withdrawal by Subject|1|||
145767037|NCT00960076|525656509|FG001|Overall Study|Withdrawal by Subject|2|||
145767038|NCT00960076|525656508|FG000|Overall Study|Lost to Follow-up|3|||
145767039|NCT00960076|525656509|FG001|Overall Study|Lost to Follow-up|3|||
145767040|NCT00960076|525656508|FG000|Overall Study|Severe non-compliance to protocol|1|||
145767041|NCT00960076|525656509|FG001|Overall Study|Severe non-compliance to protocol|2|||
145767042|NCT00960076|525656508|FG000|Overall Study|Hyperglycemia|1|||
145767043|NCT00960076|525656509|FG001|Overall Study|Hyperglycemia|5|||
145767044|NCT00960076|525656508|FG000|Overall Study|Did not attend the termination visit|0|||
145767045|NCT00960076|525656509|FG001|Overall Study|Did not attend the termination visit|1|||
145767046|NCT00500266|525656510|FG000|Overall Study|Death|3|||
145767047|NCT00500266|525656510|FG000|Overall Study|Lost to Follow-up|3|||
145767048|NCT00500266|525656510|FG000|Overall Study|Withdrawal by Subject|3|||
145767049|NCT00500266|525656510|FG000|Overall Study|Assigned, not treated|4|||
145767050|NCT01431287|525656511|FG000|Overall Study|not treated|0|||
145767051|NCT01431287|525656512|FG001|Overall Study|not treated|0|||
145767052|NCT01431287|525656513|FG002|Overall Study|not treated|1|||
145767053|NCT01431287|525656514|FG003|Overall Study|not treated|0|||
145767054|NCT01431287|525656515|FG004|Overall Study|not treated|0|||
145767055|NCT01431287|525656511|FG000|Overall Study|Adverse Event|59|||
145767056|NCT01431287|525656512|FG001|Overall Study|Adverse Event|57|||
145767057|NCT01431287|525656513|FG002|Overall Study|Adverse Event|53|||
145767058|NCT01431287|525656514|FG003|Overall Study|Adverse Event|33|||
145767059|NCT01431287|525656515|FG004|Overall Study|Adverse Event|41|||
145767060|NCT01431287|525656511|FG000|Overall Study|Non compliant with protocol|6|||
145767061|NCT01431287|525656512|FG001|Overall Study|Non compliant with protocol|6|||
145767062|NCT01431287|525656513|FG002|Overall Study|Non compliant with protocol|5|||
145767063|NCT01431287|525656514|FG003|Overall Study|Non compliant with protocol|6|||
145767064|NCT01431287|525656515|FG004|Overall Study|Non compliant with protocol|5|||
145767065|NCT01431287|525656511|FG000|Overall Study|Lost to Follow-up|0|||
145767066|NCT01431287|525656512|FG001|Overall Study|Lost to Follow-up|3|||
145767067|NCT01431287|525656513|FG002|Overall Study|Lost to Follow-up|2|||
145767068|NCT01431287|525656514|FG003|Overall Study|Lost to Follow-up|3|||
145767069|NCT01431287|525656515|FG004|Overall Study|Lost to Follow-up|1|||
145767070|NCT01431287|525656511|FG000|Overall Study|Consent withdrawn not due to AE|29|||
145767071|NCT01431287|525656512|FG001|Overall Study|Consent withdrawn not due to AE|30|||
145767072|NCT01431287|525656513|FG002|Overall Study|Consent withdrawn not due to AE|34|||
145767073|NCT01431287|525656514|FG003|Overall Study|Consent withdrawn not due to AE|19|||
145767074|NCT01431287|525656515|FG004|Overall Study|Consent withdrawn not due to AE|29|||
145767075|NCT01431287|525656511|FG000|Overall Study|not stated above|4|||
145767076|NCT01431287|525656512|FG001|Overall Study|not stated above|2|||
145767077|NCT01431287|525656513|FG002|Overall Study|not stated above|2|||
145767078|NCT01431287|525656514|FG003|Overall Study|not stated above|2|||
145767079|NCT01431287|525656515|FG004|Overall Study|not stated above|1|||
145767080|NCT02029976|525656516|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
145767081|NCT02029976|525656517|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
145767082|NCT02029976|525656516|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
145767083|NCT02029976|525656517|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
145767084|NCT02029976|525656516|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
145767085|NCT02029976|525656517|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
145767086|NCT02029976|525656516|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
145767087|NCT02029976|525656517|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
145767088|NCT00075881|525656518|FG000|Overall Study|Lack of Efficacy|18|||
145767089|NCT00075881|525656518|FG000|Overall Study|Adverse Event|7|||
145767090|NCT00075881|525656518|FG000|Overall Study|Death|1|||
145767091|NCT00075881|525656518|FG000|Overall Study|Withdrawal by Subject|2|||
145767092|NCT00075881|525656518|FG000|Overall Study|Protocol Violation|4|||
145767093|NCT00075881|525656518|FG000|Overall Study|other complicating disease|3|||
145767094|NCT00075881|525656518|FG000|Overall Study|other|4|||
145767095|NCT00075881|525656518|FG000|Overall Study|missing data|2|||
145767096|NCT00075881|525656518|FG000|Overall Study|Ineligible|1|||
145767097|NCT00075881|525656518|FG000|Overall Study|never start protocol therapy|1|||
145767098|NCT02224664|525656519|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
145767099|NCT02224664|525656520|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
145767100|NCT02224664|525656521|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
145767101|NCT02224664|525656522|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
145767102|NCT02224664|525656523|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
145767103|NCT02224664|525656519|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
145767104|NCT02224664|525656520|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
145767105|NCT02224664|525656521|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
145767106|NCT02224664|525656522|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
145767107|NCT02224664|525656523|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
145767108|NCT02224664|525656519|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
145767109|NCT02224664|525656520|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
145767110|NCT02224664|525656521|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
145767111|NCT02224664|525656522|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
145767112|NCT02224664|525656523|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
145767113|NCT03019549|525656524|FG000|Washout|DId not meet genotype criteria|11|||
145767114|NCT03019549|525656524|FG000|Period 2|Adverse Event|2|||
145767115|NCT03019549|525656524|FG000|Period 2|Physician Decision|2|||
145767116|NCT03019549|525656524|FG000|Period 2|Withdrawal by Subject|1|||
145767117|NCT03195894|525656527|FG000|Overall Study|"An example is Started other treatment."|4|||
145767118|NCT03195894|525656528|FG001|Overall Study|"An example is Started other treatment."|5|||
145767119|NCT03195894|525656527|FG000|Overall Study|Withdrawal by Subject|15|||
145403171|NCT01206764|524334314|FG000|Overall Study|Disease progression|88|||
145533495|NCT03698331|524813473|FG000|Overall Study|Withdrawal by Subject|1|||
145533496|NCT03698331|524813474|FG001|Overall Study|Withdrawal by Subject|1|||
145533497|NCT03698331|524813473|FG000|Overall Study|Lost to Follow-up|0|||
145767120|NCT03195894|525656528|FG001|Overall Study|Withdrawal by Subject|4|||
145767121|NCT03195894|525656527|FG000|Overall Study|Lost to Follow-up|14|||
145767122|NCT03195894|525656528|FG001|Overall Study|Lost to Follow-up|19|||
145767123|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
145767124|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
145767125|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
145767126|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
145767127|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
145767128|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
145767129|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
145767130|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
145767131|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
145767132|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
145767133|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
145767134|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
145767135|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
145767136|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
145767137|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
145767138|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
145767139|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
145767140|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
145767141|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
145767142|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
145767143|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
145767144|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
145767145|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
145767146|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
145767147|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
145767148|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
145767149|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
145767150|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
145767151|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
145767152|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
145767153|NCT02660580|525656531|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
145767154|NCT02660580|525656532|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
145767155|NCT02660580|525656533|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
145767156|NCT02660580|525656534|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
145767157|NCT02660580|525656535|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
145767158|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
145767159|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
145767160|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
145767161|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
145767162|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
145767163|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
145767164|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
145767165|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
145767166|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
145767167|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
145767168|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
145767169|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
145767170|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
145767171|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
145767172|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
145767173|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
145767174|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
145767175|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
145767176|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
145767177|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
145767178|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
145767179|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
145767180|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
145767181|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
145607980|NCT02917941|525079301|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
145607981|NCT00399763|525079302|FG000|Overall Study|Lost to Follow-up|2|||
145767182|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
145767183|NCT02660580|525656531|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
145767184|NCT02660580|525656532|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
145767185|NCT02660580|525656533|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
145277823|NCT01902134|523868815|FG004|Overall Study|Withdrawal by Subject|5|||
145277824|NCT01902134|523868816|FG005|Overall Study|Withdrawal by Subject|4|||
145277825|NCT01902134|523868811|FG000|Overall Study|no compliance|1|||
145277826|NCT01902134|523868812|FG001|Overall Study|no compliance|0|||
145277827|NCT01902134|523868813|FG002|Overall Study|no compliance|0|||
145277828|NCT01902134|523868814|FG003|Overall Study|no compliance|0|||
145767186|NCT02660580|525656534|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
145767187|NCT02660580|525656535|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
145767188|NCT00215150|525656538|FG000|Open Label Phase|Lost to Follow-up|7|||
145767189|NCT00215150|525656538|FG000|Open Label Phase|Withdrawal by Subject|1|||
145767190|NCT00215150|525656538|FG000|Open Label Phase|Did not complete a post base visit|13|||
145767191|NCT00215150|525656538|FG000|Open Label Phase|Did not meet randomization criteria|9|||
145767192|NCT00215150|525656538|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
145767193|NCT00215150|525656538|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
145767194|NCT00215150|525656538|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
145767195|NCT02251743|525656539|FG000|Overall Study|Withdrawal by Subject|1|||
145767196|NCT02251743|525656540|FG001|Overall Study|Withdrawal by Subject|1|||
145767197|NCT03124459|525656546|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
145767198|NCT03124459|525656547|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
145767199|NCT03124459|525656548|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
145767200|NCT03124459|525656549|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
145767201|NCT03124459|525656550|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
145767202|NCT03124459|525656551|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
145767203|NCT03124459|525656546|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
145767204|NCT03124459|525656547|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
145767205|NCT03124459|525656548|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
145767206|NCT03124459|525656549|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
145767207|NCT03124459|525656550|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
145767208|NCT03124459|525656551|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
145767209|NCT03124459|525656546|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
145277829|NCT01902134|523868815|FG004|Overall Study|no compliance|0|||
145277830|NCT01902134|523868816|FG005|Overall Study|no compliance|0|||
145277831|NCT01902134|523868811|FG000|Overall Study|Other|0|||
145277832|NCT01902134|523868812|FG001|Overall Study|Other|1|||
145767210|NCT03124459|525656547|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
145767211|NCT03124459|525656548|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
145767212|NCT03124459|525656549|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
145767213|NCT03124459|525656550|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
145767214|NCT03124459|525656551|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
145277833|NCT01902134|523868813|FG002|Overall Study|Other|2|||
145277834|NCT01902134|523868814|FG003|Overall Study|Other|0|||
145767215|NCT03124459|525656546|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
145767216|NCT03124459|525656547|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
145767217|NCT03124459|525656548|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
145767218|NCT03124459|525656549|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
145767219|NCT03124459|525656550|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
145767220|NCT03124459|525656551|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
145767221|NCT03124459|525656546|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
145767222|NCT03124459|525656547|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
145767223|NCT03124459|525656548|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
145767224|NCT03124459|525656549|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
145767225|NCT03124459|525656550|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
145767226|NCT03124459|525656551|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
145767227|NCT03124459|525656546|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
145767228|NCT03124459|525656547|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
145767229|NCT03124459|525656548|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
145767230|NCT03124459|525656549|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
145767231|NCT03124459|525656550|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
145767232|NCT03124459|525656551|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
145767233|NCT01028352|525656552|FG000|Overall Study|Ineligible due to baseline average pain|5|||
145767234|NCT01028352|525656552|FG000|Overall Study|Withdrawal by Subject|1|||
145767235|NCT01903876|525656553|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
145767236|NCT01903876|525656554|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
145767237|NCT01903876|525656553|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
145767238|NCT01903876|525656554|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
145767239|NCT02612909|525656555|FG000|Phase 2|Withdrawal by Subject|2|||
145767240|NCT02612909|525656556|FG001|Phase 2|Withdrawal by Subject|5|||
145767241|NCT02612909|525656557|FG002|Phase 2|Withdrawal by Subject|0|||
145767242|NCT02612909|525656558|FG003|Phase 2|Withdrawal by Subject|0|||
145767243|NCT02612909|525656559|FG004|Phase 2|Withdrawal by Subject|0|||
145767244|NCT02612909|525656555|FG000|Phase 2|Pregnancy|0|||
145767245|NCT02612909|525656556|FG001|Phase 2|Pregnancy|0|||
145767246|NCT02612909|525656557|FG002|Phase 2|Pregnancy|1|||
145767247|NCT02612909|525656558|FG003|Phase 2|Pregnancy|0|||
145767248|NCT02612909|525656559|FG004|Phase 2|Pregnancy|0|||
145767249|NCT02612909|525656555|FG000|Phase 3|Withdrawal by Subject|0|||
145767250|NCT02612909|525656556|FG001|Phase 3|Withdrawal by Subject|0|||
145767251|NCT02612909|525656557|FG002|Phase 3|Withdrawal by Subject|0|||
145767252|NCT02612909|525656558|FG003|Phase 3|Withdrawal by Subject|1|||
145767253|NCT02612909|525656559|FG004|Phase 3|Withdrawal by Subject|0|||
145767254|NCT00278629|525656560|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
145767255|NCT00826748|525656563|FG000|Overall Study|Withdrawal by Subject|0|||
145767256|NCT00826748|525656564|FG001|Overall Study|Withdrawal by Subject|0|||
145767257|NCT00826748|525656565|FG002|Overall Study|Withdrawal by Subject|2|||
145767258|NCT00826748|525656563|FG000|Overall Study|Physician Decision|0|||
145767259|NCT00826748|525656564|FG001|Overall Study|Physician Decision|0|||
145767260|NCT00826748|525656565|FG002|Overall Study|Physician Decision|1|||
145767261|NCT00826748|525656563|FG000|Overall Study|Samples Did Not pass QC|0|||
145767262|NCT00826748|525656564|FG001|Overall Study|Samples Did Not pass QC|0|||
145767263|NCT00826748|525656565|FG002|Overall Study|Samples Did Not pass QC|1|||
145767264|NCT05224258|525656568|FG000|Overall Study|Withdrawal by Subject|1|||
145767265|NCT05224258|525656569|FG001|Overall Study|Withdrawal by Subject|1|||
145767266|NCT05224258|525656568|FG000|Overall Study|Physician Decision|1|||
145767267|NCT05224258|525656569|FG001|Overall Study|Physician Decision|1|||
145767268|NCT05224258|525656568|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145767269|NCT05224258|525656569|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145767270|NCT05224258|525656568|FG000|Overall Study|Study Product No Longer in Use|1|||
145767271|NCT05224258|525656569|FG001|Overall Study|Study Product No Longer in Use|0|||
145767272|NCT05224258|525656568|FG000|Overall Study|Adverse Event|0|||
145767273|NCT05224258|525656569|FG001|Overall Study|Adverse Event|1|||
145767274|NCT05224258|525656568|FG000|Overall Study|Protocol Deviation|0|||
145767275|NCT05224258|525656569|FG001|Overall Study|Protocol Deviation|1|||
145767276|NCT05067127|525656570|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
145767277|NCT05067127|525656571|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
145767278|NCT05067127|525656572|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
145767279|NCT05067127|525656573|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
145767280|NCT05067127|525656570|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
145767281|NCT05067127|525656571|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
145767282|NCT05067127|525656572|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
145767283|NCT05067127|525656573|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
145767284|NCT05067127|525656570|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
145767285|NCT05067127|525656571|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
145767286|NCT05067127|525656572|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
145767287|NCT05067127|525656573|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
145767288|NCT05067127|525656570|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
145767289|NCT05067127|525656571|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
145767290|NCT05067127|525656572|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
145767291|NCT05067127|525656573|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
145767292|NCT05067127|525656570|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
145767293|NCT05067127|525656571|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
145767294|NCT05067127|525656572|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
145767295|NCT05067127|525656573|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
145767296|NCT05067127|525656570|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
145767297|NCT05067127|525656571|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
145767298|NCT05067127|525656572|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
145767299|NCT05067127|525656573|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
145767300|NCT05067127|525656570|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
145767301|NCT05067127|525656571|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
145767302|NCT05067127|525656572|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
145767303|NCT05067127|525656573|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
145767304|NCT04462536|525656574|FG000|Overall Study|Withdrawal by Subject|3|||
145767305|NCT04462536|525656575|FG001|Overall Study|Withdrawal by Subject|9|||
145767306|NCT04462536|525656574|FG000|Overall Study|Lost to Follow-up|2|||
145767307|NCT04462536|525656575|FG001|Overall Study|Lost to Follow-up|4|||
145767308|NCT00824564|525656576|FG000|Overall Study|Lost to Follow-up|5|||
145767309|NCT00824564|525656577|FG001|Overall Study|Lost to Follow-up|7|||
145767310|NCT00824564|525656576|FG000|Overall Study|Withdrawal by Subject|1|||
145767311|NCT00824564|525656577|FG001|Overall Study|Withdrawal by Subject|1|||
145767312|NCT00824564|525656576|FG000|Overall Study|Other|1|||
145767313|NCT00824564|525656577|FG001|Overall Study|Other|2|||
145767314|NCT00824564|525656576|FG000|Overall Study|Randomized, but not treated|1|||
145767315|NCT00824564|525656577|FG001|Overall Study|Randomized, but not treated|0|||
145767316|NCT02601950|525656579|FG000|Overall Study|Participant enrolled in rollover study|0|||
145767317|NCT02601950|525656580|FG001|Overall Study|Participant enrolled in rollover study|0|||
145767318|NCT02601950|525656581|FG002|Overall Study|Participant enrolled in rollover study|1|||
145767319|NCT02601950|525656582|FG003|Overall Study|Participant enrolled in rollover study|0|||
145767320|NCT02601950|525656583|FG004|Overall Study|Participant enrolled in rollover study|1|||
145767321|NCT02601950|525656584|FG005|Overall Study|Participant enrolled in rollover study|1|||
145767322|NCT02601950|525656585|FG006|Overall Study|Participant enrolled in rollover study|1|||
145767323|NCT02601950|525656586|FG007|Overall Study|Participant enrolled in rollover study|0|||
145767324|NCT02601950|525656579|FG000|Overall Study|Disease progression - radiological|21|||
145767325|NCT02601950|525656580|FG001|Overall Study|Disease progression - radiological|26|||
145767326|NCT02601950|525656581|FG002|Overall Study|Disease progression - radiological|22|||
145767327|NCT02601950|525656582|FG003|Overall Study|Disease progression - radiological|11|||
145767328|NCT02601950|525656583|FG004|Overall Study|Disease progression - radiological|46|||
145767329|NCT02601950|525656584|FG005|Overall Study|Disease progression - radiological|52|||
145767330|NCT02601950|525656585|FG006|Overall Study|Disease progression - radiological|7|||
145767331|NCT02601950|525656586|FG007|Overall Study|Disease progression - radiological|5|||
145767332|NCT02601950|525656579|FG000|Overall Study|Disease progression - clinical|3|||
145767333|NCT02601950|525656580|FG001|Overall Study|Disease progression - clinical|5|||
145767334|NCT02601950|525656581|FG002|Overall Study|Disease progression - clinical|4|||
145767335|NCT02601950|525656582|FG003|Overall Study|Disease progression - clinical|2|||
145767336|NCT02601950|525656583|FG004|Overall Study|Disease progression - clinical|6|||
145767337|NCT02601950|525656584|FG005|Overall Study|Disease progression - clinical|6|||
145767338|NCT02601950|525656585|FG006|Overall Study|Disease progression - clinical|5|||
145767339|NCT02601950|525656586|FG007|Overall Study|Disease progression - clinical|1|||
145277835|NCT01902134|523868815|FG004|Overall Study|Other|1|||
145277836|NCT01902134|523868816|FG005|Overall Study|Other|0|||
145277837|NCT00305110|523868817|FG000|Overall Study|Missing data|29|||
145277838|NCT01440647|523868820|FG000|Overall Study|Death|2|||
145277839|NCT01440647|523868821|FG001|Overall Study|Death|3|||
145277840|NCT04335110|523868824|FG000|Overall Study|Withdrawal by Subject|1|||
145277841|NCT04335110|523868825|FG001|Overall Study|Withdrawal by Subject|1|||
145767340|NCT02601950|525656579|FG000|Overall Study|Death|6|||
145767341|NCT02601950|525656580|FG001|Overall Study|Death|0|||
145767342|NCT02601950|525656581|FG002|Overall Study|Death|3|||
145767343|NCT02601950|525656582|FG003|Overall Study|Death|1|||
145767344|NCT02601950|525656583|FG004|Overall Study|Death|4|||
145767345|NCT02601950|525656584|FG005|Overall Study|Death|1|||
145277842|NCT04335110|523868824|FG000|Overall Study|Death|0|||
145277843|NCT04335110|523868825|FG001|Overall Study|Death|1|||
145767346|NCT02601950|525656585|FG006|Overall Study|Death|0|||
145767347|NCT02601950|525656586|FG007|Overall Study|Death|0|||
145767348|NCT02601950|525656579|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767349|NCT02601950|525656580|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767350|NCT02601950|525656581|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767351|NCT02601950|525656582|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767352|NCT02601950|525656583|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767353|NCT02601950|525656584|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
145767354|NCT02601950|525656585|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767355|NCT02601950|525656586|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
145767356|NCT02601950|525656579|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
145767357|NCT02601950|525656580|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
145767358|NCT02601950|525656581|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
145767359|NCT02601950|525656582|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
145767360|NCT02601950|525656583|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
145767361|NCT02601950|525656584|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
145767362|NCT02601950|525656585|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
145767363|NCT02601950|525656586|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
145767364|NCT02601950|525656579|FG000|Overall Study|Non-compliance|0|||
145767365|NCT02601950|525656580|FG001|Overall Study|Non-compliance|1|||
145767366|NCT02601950|525656581|FG002|Overall Study|Non-compliance|0|||
145767367|NCT02601950|525656582|FG003|Overall Study|Non-compliance|0|||
145767368|NCT02601950|525656583|FG004|Overall Study|Non-compliance|0|||
145767369|NCT02601950|525656584|FG005|Overall Study|Non-compliance|1|||
145767370|NCT02601950|525656585|FG006|Overall Study|Non-compliance|1|||
145767371|NCT02601950|525656586|FG007|Overall Study|Non-compliance|0|||
145767372|NCT02601950|525656579|FG000|Overall Study|Participant refused further study treatment|0|||
145767373|NCT02601950|525656580|FG001|Overall Study|Participant refused further study treatment|1|||
145767374|NCT02601950|525656581|FG002|Overall Study|Participant refused further study treatment|1|||
145767375|NCT02601950|525656582|FG003|Overall Study|Participant refused further study treatment|0|||
145767376|NCT02601950|525656583|FG004|Overall Study|Participant refused further study treatment|2|||
145767377|NCT02601950|525656584|FG005|Overall Study|Participant refused further study treatment|2|||
145767378|NCT02601950|525656585|FG006|Overall Study|Participant refused further study treatment|2|||
145767379|NCT02601950|525656586|FG007|Overall Study|Participant refused further study treatment|1|||
145767380|NCT02601950|525656579|FG000|Overall Study|Investigator discretion|1|||
145767381|NCT02601950|525656580|FG001|Overall Study|Investigator discretion|0|||
145767382|NCT02601950|525656581|FG002|Overall Study|Investigator discretion|1|||
145767383|NCT02601950|525656582|FG003|Overall Study|Investigator discretion|0|||
145767384|NCT02601950|525656583|FG004|Overall Study|Investigator discretion|1|||
145767385|NCT02601950|525656584|FG005|Overall Study|Investigator discretion|1|||
145767386|NCT02601950|525656585|FG006|Overall Study|Investigator discretion|1|||
145767387|NCT02601950|525656586|FG007|Overall Study|Investigator discretion|0|||
145767388|NCT02601950|525656579|FG000|Overall Study|Other|0|||
145767389|NCT02601950|525656580|FG001|Overall Study|Other|0|||
145767390|NCT02601950|525656581|FG002|Overall Study|Other|0|||
145767391|NCT02601950|525656582|FG003|Overall Study|Other|0|||
145767392|NCT02601950|525656583|FG004|Overall Study|Other|2|||
145767393|NCT02601950|525656584|FG005|Overall Study|Other|2|||
145767394|NCT02601950|525656585|FG006|Overall Study|Other|1|||
145767395|NCT02601950|525656586|FG007|Overall Study|Other|0|||
145767396|NCT05817045|525656587|FG000|Overall Study|Protocol Violation|0|||
145767397|NCT05817045|525656588|FG001|Overall Study|Protocol Violation|3|||
145767398|NCT05817045|525656587|FG000|Overall Study|Withdrawal by Subject|10|||
145767399|NCT05817045|525656588|FG001|Overall Study|Withdrawal by Subject|7|||
145767400|NCT05817045|525656587|FG000|Overall Study|Physician Decision|3|||
145767401|NCT05817045|525656588|FG001|Overall Study|Physician Decision|0|||
145767402|NCT05817045|525656587|FG000|Overall Study|Lost to Follow-up|0|||
145767403|NCT05817045|525656588|FG001|Overall Study|Lost to Follow-up|1|||
145767404|NCT05817045|525656587|FG000|Overall Study|Device Deficiency|1|||
145767405|NCT05817045|525656588|FG001|Overall Study|Device Deficiency|0|||
145767406|NCT05817045|525656587|FG000|Overall Study|System Error|1|||
145767407|NCT05817045|525656588|FG001|Overall Study|System Error|0|||
145767408|NCT05113940|525656589|FG000|Part A (18 Days)|Adverse Event|0|||
145767409|NCT05113940|525656590|FG001|Part A (18 Days)|Adverse Event|0|||
145277844|NCT01637961|523868826|FG000|Overall Study|Ineligible: wrong primary|1|||
145277845|NCT01637961|523868826|FG000|Overall Study|Ineligible: inadequate pathology|1|||
145277846|NCT03101293|523868827|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
145277847|NCT03101293|523868828|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
145277848|NCT04388527|523868829|FG000|Overall Study|Death|14|||
145767410|NCT05113940|525656591|FG002|Part A (18 Days)|Adverse Event|1|||
145767411|NCT05113940|525656592|FG003|Part A (18 Days)|Adverse Event|1|||
145767412|NCT05113940|525656593|FG004|Part A (18 Days)|Adverse Event|1|||
145767413|NCT05113940|525656594|FG005|Part A (18 Days)|Adverse Event|0|||
145767414|NCT05113940|525656595|FG006|Part A (18 Days)|Adverse Event|0|||
145767415|NCT05113940|525656596|FG007|Part A (18 Days)|Adverse Event|0|||
145277849|NCT04388527|523868829|FG000|Overall Study|Withdrawal by Subject|2|||
145767416|NCT05113940|525656597|FG008|Part A (18 Days)|Adverse Event|0|||
145767417|NCT05113940|525656598|FG009|Part A (18 Days)|Adverse Event|0|||
145767418|NCT05113940|525656599|FG010|Part A (18 Days)|Adverse Event|0|||
145767419|NCT05113940|525656600|FG011|Part A (18 Days)|Adverse Event|2|||
145767420|NCT05113940|525656601|FG012|Part A (18 Days)|Adverse Event|0|||
145767421|NCT05113940|525656602|FG013|Part A (18 Days)|Adverse Event|0|||
145767422|NCT05113940|525656603|FG014|Part A (18 Days)|Adverse Event|0|||
145767423|NCT05113940|525656589|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767424|NCT05113940|525656590|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767425|NCT05113940|525656591|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767426|NCT05113940|525656592|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767427|NCT05113940|525656593|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767428|NCT05113940|525656594|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767429|NCT05113940|525656595|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767430|NCT05113940|525656596|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767431|NCT05113940|525656597|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767432|NCT05113940|525656598|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767433|NCT05113940|525656599|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767434|NCT05113940|525656600|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767435|NCT05113940|525656601|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767436|NCT05113940|525656602|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
145767437|NCT05113940|525656603|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
145767438|NCT00382967|525656604|FG000|Overall Study|Protocol Violation|1|||
145767439|NCT00382967|525656605|FG001|Overall Study|Protocol Violation|1|||
145767440|NCT00826514|525656607|FG000|Overall Study|Adverse Event|1|||
145767441|NCT00826514|525656608|FG001|Overall Study|Adverse Event|1|||
145767442|NCT00826514|525656607|FG000|Overall Study|Lack of Efficacy|0|||
145767443|NCT00826514|525656608|FG001|Overall Study|Lack of Efficacy|1|||
145767444|NCT00826514|525656607|FG000|Overall Study|Withdrawal by Subject|2|||
145277850|NCT04388527|523868829|FG000|Overall Study|Lost to Follow-up|1|||
145277851|NCT03451331|523868835|FG000|Overall Study|Withdrawal by Subject|1|||
145277852|NCT03451331|523868836|FG001|Overall Study|Withdrawal by Subject|0|||
145277853|NCT03451331|523868835|FG000|Overall Study|Unable to start treatment.|1|||
145277854|NCT03451331|523868836|FG001|Overall Study|Unable to start treatment.|1|||
145277855|NCT02773446|523868837|FG000|First Admission|Withdrawal by Subject|0|||
145277856|NCT02773446|523868838|FG001|First Admission|Withdrawal by Subject|0|||
145277857|NCT02773446|523868839|FG002|First Admission|Withdrawal by Subject|0|||
145277858|NCT02773446|523868840|FG003|First Admission|Withdrawal by Subject|1|||
145277859|NCT02773446|523868841|FG004|First Admission|Withdrawal by Subject|0|||
145277860|NCT02773446|523868842|FG005|First Admission|Withdrawal by Subject|0|||
145277861|NCT02773446|523868837|FG000|First Admission|Lost to Follow-up|1|||
145277862|NCT02773446|523868838|FG001|First Admission|Lost to Follow-up|0|||
145277863|NCT02773446|523868839|FG002|First Admission|Lost to Follow-up|0|||
145277864|NCT02773446|523868840|FG003|First Admission|Lost to Follow-up|0|||
145767445|NCT00826514|525656608|FG001|Overall Study|Withdrawal by Subject|3|||
145767446|NCT01773473|525656609|FG000|Overall Study|Adverse Event|3|||
145277865|NCT02773446|523868841|FG004|First Admission|Lost to Follow-up|0|||
145277866|NCT02773446|523868842|FG005|First Admission|Lost to Follow-up|0|||
145277867|NCT04023994|523868843|FG000|Overall Study|Lost to Follow-up|0|||
145277868|NCT04023994|523868844|FG001|Overall Study|Lost to Follow-up|1|||
145767447|NCT01773473|525656610|FG001|Overall Study|Adverse Event|2|||
145767448|NCT01773473|525656609|FG000|Overall Study|Protocol Violation|0|||
145767449|NCT01773473|525656610|FG001|Overall Study|Protocol Violation|4|||
145277869|NCT04023994|523868845|FG002|Overall Study|Lost to Follow-up|2|||
145277870|NCT04023994|523868846|FG003|Overall Study|Lost to Follow-up|0|||
145277871|NCT04023994|523868847|FG004|Overall Study|Lost to Follow-up|0|||
145277872|NCT04023994|523868848|FG005|Overall Study|Lost to Follow-up|0|||
145277873|NCT04023994|523868843|FG000|Overall Study|Withdrawal by Subject|0|||
145277874|NCT04023994|523868844|FG001|Overall Study|Withdrawal by Subject|0|||
145533498|NCT03698331|524813474|FG001|Overall Study|Lost to Follow-up|2|||
145533499|NCT03698331|524813473|FG000|Overall Study|Non-compliance with study drug|1|||
145533500|NCT03698331|524813474|FG001|Overall Study|Non-compliance with study drug|0|||
145533501|NCT02130024|524813476|FG000|Overall Study|Adverse Event|10|||
145533502|NCT02130024|524813477|FG001|Overall Study|Adverse Event|11|||
145533503|NCT02130024|524813476|FG000|Overall Study|Death|2|||
145533504|NCT02130024|524813477|FG001|Overall Study|Death|2|||
145533505|NCT02130024|524813476|FG000|Overall Study|Lost to Follow-up|1|||
145533506|NCT02130024|524813477|FG001|Overall Study|Lost to Follow-up|1|||
145533507|NCT02130024|524813476|FG000|Overall Study|Physician Decision|1|||
145533508|NCT02130024|524813477|FG001|Overall Study|Physician Decision|3|||
145533509|NCT02130024|524813476|FG000|Overall Study|Protocol Deviation|4|||
145533510|NCT02130024|524813477|FG001|Overall Study|Protocol Deviation|0|||
145533511|NCT02130024|524813476|FG000|Overall Study|Site Administration Problems|1|||
145533512|NCT02130024|524813477|FG001|Overall Study|Site Administration Problems|0|||
145533513|NCT02130024|524813476|FG000|Overall Study|Subject Withdrew Consent|6|||
145533514|NCT02130024|524813477|FG001|Overall Study|Subject Withdrew Consent|14|||
145533515|NCT01467583|524813478|FG000|Overall Study|Death|1|||
145533516|NCT01467583|524813479|FG001|Overall Study|Death|1|||
145533517|NCT01467583|524813480|FG002|Overall Study|Death|0|||
145533518|NCT01467583|524813478|FG000|Overall Study|Withdrawal by Subject|1|||
145533519|NCT01467583|524813479|FG001|Overall Study|Withdrawal by Subject|0|||
145533520|NCT01467583|524813480|FG002|Overall Study|Withdrawal by Subject|0|||
145533521|NCT01467583|524813478|FG000|Overall Study|Protocol Violation|0|||
145533522|NCT01467583|524813479|FG001|Overall Study|Protocol Violation|0|||
145533523|NCT01467583|524813480|FG002|Overall Study|Protocol Violation|2|||
145533524|NCT05274165|524813481|FG000|Overall Study|Withdrawal by Subject|3|||
145533525|NCT05274165|524813482|FG001|Overall Study|Withdrawal by Subject|3|||
145533526|NCT04916769|524813489|FG000|Period 1|Physician Decision|0|||
145533527|NCT04916769|524813490|FG001|Period 1|Physician Decision|0|||
145533528|NCT04916769|524813491|FG002|Period 1|Physician Decision|0|||
145533529|NCT04916769|524813492|FG003|Period 1|Physician Decision|0|||
145533530|NCT04916769|524813493|FG004|Period 1|Physician Decision|0|||
145533531|NCT04916769|524813494|FG005|Period 1|Physician Decision|1|||
145533532|NCT04916769|524813489|FG000|Period 2|Physician Decision|0|||
145533533|NCT04916769|524813490|FG001|Period 2|Physician Decision|1|||
145533534|NCT04916769|524813491|FG002|Period 2|Physician Decision|0|||
145533535|NCT04916769|524813492|FG003|Period 2|Physician Decision|0|||
145533536|NCT04916769|524813493|FG004|Period 2|Physician Decision|0|||
145533537|NCT04916769|524813494|FG005|Period 2|Physician Decision|0|||
145533538|NCT05736224|524813495|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
145533539|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
145533540|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145533541|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145533542|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145533543|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145533544|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145533545|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
145277875|NCT04023994|523868845|FG002|Overall Study|Withdrawal by Subject|0|||
145277876|NCT04023994|523868846|FG003|Overall Study|Withdrawal by Subject|1|||
145277877|NCT04023994|523868847|FG004|Overall Study|Withdrawal by Subject|0|||
145277878|NCT04023994|523868848|FG005|Overall Study|Withdrawal by Subject|0|||
145533546|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
145533547|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533548|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533549|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533550|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533551|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533552|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
145533553|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
145558232|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
145558233|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
145767450|NCT01773473|525656609|FG000|Overall Study|Physician Decision|3|||
145767451|NCT01773473|525656610|FG001|Overall Study|Physician Decision|5|||
145767452|NCT01773473|525656609|FG000|Overall Study|Sponsor Decision|2|||
145767453|NCT01773473|525656610|FG001|Overall Study|Sponsor Decision|0|||
145767454|NCT01773473|525656609|FG000|Overall Study|Lack of Efficacy|0|||
145767455|NCT01773473|525656610|FG001|Overall Study|Lack of Efficacy|1|||
145767456|NCT01773473|525656609|FG000|Overall Study|Non-Compliance with study drug|1|||
145767457|NCT01773473|525656610|FG001|Overall Study|Non-Compliance with study drug|4|||
145767458|NCT01773473|525656609|FG000|Overall Study|Withdrawal by Subject|5|||
145767459|NCT01773473|525656610|FG001|Overall Study|Withdrawal by Subject|3|||
145767460|NCT01773473|525656609|FG000|Overall Study|Lost to Follow-up|2|||
145767461|NCT01773473|525656610|FG001|Overall Study|Lost to Follow-up|0|||
145767462|NCT01085682|525656611|FG000|Overall Study|Withdrawal by Subject|25|||
145767463|NCT01085682|525656612|FG001|Overall Study|Withdrawal by Subject|25|||
145767464|NCT01451645|525656615|FG000|Overall Study|Protocol Violation|1|||
145767465|NCT01451645|525656616|FG001|Overall Study|Protocol Violation|0|||
145767466|NCT01451645|525656615|FG000|Overall Study|Adverse Event|0|||
145767467|NCT01451645|525656616|FG001|Overall Study|Adverse Event|3|||
145767468|NCT01451645|525656615|FG000|Overall Study|Withdrawal by Subject|4|||
145767469|NCT01451645|525656616|FG001|Overall Study|Withdrawal by Subject|2|||
145767470|NCT01451645|525656615|FG000|Overall Study|Lost to Follow-up|4|||
145767471|NCT01451645|525656616|FG001|Overall Study|Lost to Follow-up|3|||
145767472|NCT00629083|525656621|FG000|Overall Study|Adverse Event|0|||
145767473|NCT00629083|525656622|FG001|Overall Study|Adverse Event|2|||
145767474|NCT00629083|525656621|FG000|Overall Study|Lack of Efficacy|3|||
145767475|NCT00629083|525656622|FG001|Overall Study|Lack of Efficacy|1|||
145767476|NCT00629083|525656621|FG000|Overall Study|Withdrawal by Subject|10|||
145767477|NCT00629083|525656622|FG001|Overall Study|Withdrawal by Subject|2|||
145767478|NCT00629083|525656621|FG000|Overall Study|Lost to Follow-up|12|||
145767479|NCT00629083|525656622|FG001|Overall Study|Lost to Follow-up|8|||
145767480|NCT00629083|525656621|FG000|Overall Study|Moved out of country/state|2|||
145767481|NCT00629083|525656622|FG001|Overall Study|Moved out of country/state|1|||
145767482|NCT00629083|525656621|FG000|Overall Study|Refused to return for 12 month visit|1|||
145767483|NCT00629083|525656622|FG001|Overall Study|Refused to return for 12 month visit|0|||
145767484|NCT03401749|525656623|FG000|Overall Study|Lost to Follow-up|20|||
145767485|NCT03401749|525656624|FG001|Overall Study|Lost to Follow-up|16|||
145767486|NCT03401749|525656625|FG002|Overall Study|Lost to Follow-up|26|||
145767487|NCT01147809|525656626|FG000|Phase I (168 Days)|Adverse Event|0|||
145767488|NCT01147809|525656627|FG001|Phase I (168 Days)|Adverse Event|0|||
145767489|NCT01147809|525656628|FG002|Phase I (168 Days)|Adverse Event|0|||
145767490|NCT01147809|525656629|FG003|Phase I (168 Days)|Adverse Event|1|||
145767491|NCT01147809|525656630|FG004|Phase I (168 Days)|Adverse Event|0|||
145767492|NCT01147809|525656631|FG005|Phase I (168 Days)|Adverse Event|0|||
145767493|NCT01147809|525656626|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
145767494|NCT01147809|525656627|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
145767495|NCT01147809|525656628|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
145767496|NCT01147809|525656629|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
145767497|NCT01147809|525656630|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
145767498|NCT01147809|525656631|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
145767499|NCT01147809|525656626|FG000|Phase I (168 Days)|Physician Decision|0|||
145767500|NCT01147809|525656627|FG001|Phase I (168 Days)|Physician Decision|1|||
145767501|NCT01147809|525656628|FG002|Phase I (168 Days)|Physician Decision|2|||
145767502|NCT01147809|525656629|FG003|Phase I (168 Days)|Physician Decision|0|||
145767503|NCT01147809|525656630|FG004|Phase I (168 Days)|Physician Decision|0|||
145767504|NCT01147809|525656631|FG005|Phase I (168 Days)|Physician Decision|0|||
145767505|NCT01147809|525656626|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
145767506|NCT01147809|525656627|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
145767507|NCT01147809|525656628|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
145767508|NCT01147809|525656629|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
145767509|NCT01147809|525656630|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
145767510|NCT01147809|525656631|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
145767511|NCT01147809|525656626|FG000|Phase II (168 Days)|Adverse Event|0|||
145767512|NCT01147809|525656627|FG001|Phase II (168 Days)|Adverse Event|0|||
145767513|NCT01147809|525656628|FG002|Phase II (168 Days)|Adverse Event|0|||
145767514|NCT01147809|525656629|FG003|Phase II (168 Days)|Adverse Event|0|||
145277879|NCT01613131|523868849|FG000|Overall Study|Withdrawal by Subject|3|||
145767515|NCT01147809|525656630|FG004|Phase II (168 Days)|Adverse Event|3|||
145767516|NCT01147809|525656631|FG005|Phase II (168 Days)|Adverse Event|6|||
145767517|NCT01147809|525656626|FG000|Phase II (168 Days)|Protocol Violation|0|||
145767518|NCT01147809|525656627|FG001|Phase II (168 Days)|Protocol Violation|0|||
145767519|NCT01147809|525656628|FG002|Phase II (168 Days)|Protocol Violation|0|||
145767520|NCT01147809|525656629|FG003|Phase II (168 Days)|Protocol Violation|0|||
145767521|NCT01147809|525656630|FG004|Phase II (168 Days)|Protocol Violation|0|||
145767522|NCT01147809|525656631|FG005|Phase II (168 Days)|Protocol Violation|1|||
145767523|NCT01147809|525656626|FG000|Phase II (168 Days)|Physician Decision|0|||
145767524|NCT01147809|525656627|FG001|Phase II (168 Days)|Physician Decision|0|||
145767525|NCT01147809|525656628|FG002|Phase II (168 Days)|Physician Decision|0|||
145767526|NCT01147809|525656629|FG003|Phase II (168 Days)|Physician Decision|0|||
145767527|NCT01147809|525656630|FG004|Phase II (168 Days)|Physician Decision|5|||
145767528|NCT01147809|525656631|FG005|Phase II (168 Days)|Physician Decision|11|||
145767529|NCT01147809|525656626|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
145767530|NCT01147809|525656627|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
145767531|NCT01147809|525656628|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
145767532|NCT01147809|525656629|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
145767533|NCT01147809|525656630|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
145767534|NCT01147809|525656631|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
145767535|NCT01147809|525656626|FG000|Phase II (168 Days)|Ongoing|0|||
145767536|NCT01147809|525656627|FG001|Phase II (168 Days)|Ongoing|0|||
145767537|NCT01147809|525656628|FG002|Phase II (168 Days)|Ongoing|0|||
145767538|NCT01147809|525656629|FG003|Phase II (168 Days)|Ongoing|0|||
145767539|NCT01147809|525656630|FG004|Phase II (168 Days)|Ongoing|1|||
145767540|NCT01147809|525656631|FG005|Phase II (168 Days)|Ongoing|0|||
145767541|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
145767542|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
145767543|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
145767544|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767545|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767546|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767547|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767548|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767549|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145767550|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
145767551|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
145767552|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
145767553|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767554|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767555|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767556|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767557|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767558|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145767559|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
145767560|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
145767561|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
145767562|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767563|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767564|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767565|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767566|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767567|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145767568|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767569|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767570|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
145767571|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767572|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767573|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767574|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767575|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145558234|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
145767576|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145767577|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
145767578|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
145767579|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
145767580|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767581|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767582|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767583|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767584|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767585|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145767586|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
145767587|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767588|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767589|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767590|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767591|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767592|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767593|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767594|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145767595|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
145767596|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
145767597|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767598|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767599|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767600|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767601|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767602|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767603|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145767604|NCT01307423|525656632|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767605|NCT01307423|525656633|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
145767606|NCT01307423|525656634|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
145767607|NCT01307423|525656635|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767608|NCT01307423|525656636|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767609|NCT01307423|525656637|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767610|NCT01307423|525656638|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767611|NCT01307423|525656639|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767612|NCT01307423|525656640|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
145767613|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
145767614|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
145767615|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
145767616|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
145767617|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
145767618|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
145767619|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
145767620|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
145767621|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
145767622|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
145767623|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
145767624|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
145767625|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
145767626|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
145767627|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
145767628|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
145767629|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
145767630|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
145767631|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767632|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767633|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767634|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767635|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767636|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
145767637|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767638|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767639|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
145767640|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
145767641|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
145767642|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
145767643|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
145767644|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
145767645|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
145767646|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
145767647|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
145767648|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
145767649|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767650|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767651|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767652|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
145767653|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767654|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767655|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767656|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767657|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
145767658|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
145767659|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
145767660|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
145767661|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
145767662|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
145767663|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
145767664|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
145767665|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
145767666|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
145767667|NCT01307423|525656632|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767668|NCT01307423|525656633|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767669|NCT01307423|525656634|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767670|NCT01307423|525656635|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767671|NCT01307423|525656636|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767672|NCT01307423|525656637|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
145767673|NCT01307423|525656638|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767674|NCT01307423|525656639|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767675|NCT01307423|525656640|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
145767676|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145767677|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
145767678|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
145767679|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145767680|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145767681|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145767682|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145767683|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
145767684|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
145767685|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145767686|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
145767687|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
145533554|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145767688|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145767689|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145767690|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145767691|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145767692|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
145767693|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
145767694|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767695|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767696|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
145767697|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767698|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767699|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767700|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767701|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767702|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
145767703|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145767704|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
145767705|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
145767706|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145767707|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145767708|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145767709|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145767710|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
145767711|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
145767712|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767713|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
145767714|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767715|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767716|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767717|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767718|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145767719|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
145767720|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
145767721|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145767722|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
145767723|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
145767724|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145767725|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145767726|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145767727|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145767728|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
145767729|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
145767730|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145767731|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
145767732|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
145767733|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145767734|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145767735|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145767736|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145767737|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
145767738|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
145767739|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767740|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
145767741|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
145767742|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767743|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767744|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767745|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767746|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767747|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
145767748|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145767749|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
145767750|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
145767751|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145767752|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145767753|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145767754|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145767755|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
145767756|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
145767757|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145767758|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
145767759|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
145767760|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145767761|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145767762|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145767763|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145767764|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
145767765|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
145767766|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767767|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
145767768|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767769|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767770|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767771|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767772|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767773|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
145767774|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145767775|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767776|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
145767777|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767778|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767779|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767780|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767781|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767782|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767783|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145767784|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767785|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
145767786|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767787|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767788|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767789|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767790|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767791|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145767792|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
145767793|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145767794|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
145767795|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
145767796|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145767797|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145767798|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145767799|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145767800|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
145767801|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
145767802|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767803|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767804|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
145767805|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767806|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767807|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767808|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767809|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767810|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145767811|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767812|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767813|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767814|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767815|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767816|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145277880|NCT01613131|523868850|FG001|Overall Study|Withdrawal by Subject|5|||
145607982|NCT00399763|525079303|FG001|Overall Study|Lost to Follow-up|3|||
145607983|NCT04182880|525079306|FG000|Overall Study|Pregnancy|1|||
145607984|NCT04182880|525079307|FG001|Overall Study|Pregnancy|0|||
145767817|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767818|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
145767819|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145767820|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767821|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
145767822|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
145277881|NCT01020305|523868851|FG000|Overall Study|Adverse Event|2|||
145607985|NCT03389477|525079308|FG000|Step 1|Withdrawal by Subject|1|||
145767823|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767824|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767825|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767826|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767827|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145767828|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
145767829|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767830|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
145767831|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
145767832|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767833|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767834|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767835|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767836|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767837|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145767838|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767839|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
145767840|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
145767841|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767842|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767843|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767844|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767845|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145767846|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
145767847|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767848|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
145767849|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767850|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767851|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767852|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767853|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767854|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767855|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
145767856|NCT01307423|525656632|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767857|NCT01307423|525656633|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767858|NCT01307423|525656634|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
145767859|NCT01307423|525656635|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767860|NCT01307423|525656636|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767861|NCT01307423|525656637|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767862|NCT01307423|525656638|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145767863|NCT01307423|525656639|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
145767864|NCT01307423|525656640|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
145767865|NCT03853694|525656641|FG000|Overall Study|Protocol Violation|3|||
145767866|NCT03853694|525656642|FG001|Overall Study|Protocol Violation|5|||
145767867|NCT03853694|525656643|FG002|Overall Study|Protocol Violation|3|||
145767868|NCT03853694|525656641|FG000|Overall Study|Delivered early|0|||
145767869|NCT03853694|525656642|FG001|Overall Study|Delivered early|1|||
145767870|NCT03853694|525656643|FG002|Overall Study|Delivered early|0|||
145767871|NCT03853694|525656641|FG000|Overall Study|not suitable to proceed|0|||
145767872|NCT03853694|525656642|FG001|Overall Study|not suitable to proceed|1|||
145767873|NCT03853694|525656643|FG002|Overall Study|not suitable to proceed|0|||
145767874|NCT03853694|525656641|FG000|Overall Study|difficult surgery|0|||
145767875|NCT03853694|525656642|FG001|Overall Study|difficult surgery|0|||
145767876|NCT03853694|525656643|FG002|Overall Study|difficult surgery|1|||
145767877|NCT03853694|525656641|FG000|Overall Study|Lost to Follow-up|0|||
145767878|NCT03853694|525656642|FG001|Overall Study|Lost to Follow-up|1|||
145767879|NCT03853694|525656643|FG002|Overall Study|Lost to Follow-up|0|||
145767880|NCT03853694|525656641|FG000|Overall Study|Withdrawal by Subject|0|||
145767881|NCT03853694|525656642|FG001|Overall Study|Withdrawal by Subject|1|||
145767882|NCT03853694|525656643|FG002|Overall Study|Withdrawal by Subject|0|||
145767883|NCT00064701|525656644|FG000|One Year Post-transplant|Did not receive study drug|7|||
145767884|NCT00064701|525656645|FG001|One Year Post-transplant|Did not receive study drug|12|||
145767885|NCT00064701|525656646|FG002|One Year Post-transplant|Did not receive study drug|11|||
145767886|NCT00064701|525656644|FG000|One Year Post-transplant|Adverse Event|23|||
145767887|NCT00064701|525656645|FG001|One Year Post-transplant|Adverse Event|19|||
145767888|NCT00064701|525656646|FG002|One Year Post-transplant|Adverse Event|37|||
145767889|NCT00064701|525656644|FG000|One Year Post-transplant|Rejection|0|||
145767890|NCT00064701|525656645|FG001|One Year Post-transplant|Rejection|1|||
145767891|NCT00064701|525656646|FG002|One Year Post-transplant|Rejection|16|||
145767892|NCT00064701|525656644|FG000|One Year Post-transplant|Non-compliance|4|||
145767893|NCT00064701|525656645|FG001|One Year Post-transplant|Non-compliance|2|||
145767894|NCT00064701|525656646|FG002|One Year Post-transplant|Non-compliance|5|||
145767895|NCT00064701|525656644|FG000|One Year Post-transplant|Graft Failure|3|||
145767896|NCT00064701|525656645|FG001|One Year Post-transplant|Graft Failure|2|||
145767897|NCT00064701|525656646|FG002|One Year Post-transplant|Graft Failure|1|||
145767898|NCT00064701|525656644|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
145767899|NCT00064701|525656645|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
145767900|NCT00064701|525656646|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
145767901|NCT00064701|525656644|FG000|One Year Post-transplant|Lost to Follow-up|1|||
145767902|NCT00064701|525656645|FG001|One Year Post-transplant|Lost to Follow-up|0|||
145767903|NCT00064701|525656646|FG002|One Year Post-transplant|Lost to Follow-up|0|||
145767904|NCT00064701|525656644|FG000|One Year Post-transplant|Converted to rapamycin|1|||
145767905|NCT00064701|525656645|FG001|One Year Post-transplant|Converted to rapamycin|0|||
145767906|NCT00064701|525656646|FG002|One Year Post-transplant|Converted to rapamycin|0|||
145767907|NCT00064701|525656644|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
145767908|NCT00064701|525656645|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
145767909|NCT00064701|525656646|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
145767910|NCT00064701|525656644|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
145767911|NCT00064701|525656645|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
145767912|NCT00064701|525656646|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
145767913|NCT00064701|525656644|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
145767914|NCT00064701|525656645|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
145767915|NCT00064701|525656646|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
145767916|NCT00064701|525656644|FG000|One Year Post-transplant|Poor absorption|0|||
145767917|NCT00064701|525656645|FG001|One Year Post-transplant|Poor absorption|1|||
145767918|NCT00064701|525656646|FG002|One Year Post-transplant|Poor absorption|0|||
145767919|NCT00064701|525656644|FG000|One Year Post-transplant|Pancreas transplant|0|||
145277882|NCT00467818|523868852|FG000|Overall Study|Adverse Event|1|||
145277883|NCT00467818|523868853|FG001|Overall Study|Adverse Event|0|||
145277884|NCT00467818|523868852|FG000|Overall Study|Lost to Follow-up|2|||
145277885|NCT00467818|523868853|FG001|Overall Study|Lost to Follow-up|2|||
145277886|NCT01017029|523868854|FG000|Overall Study|Lost to Follow-up|1|||
145277887|NCT01017029|523868855|FG001|Overall Study|Lost to Follow-up|0|||
145277888|NCT01017029|523868854|FG000|Overall Study|Administrative problem|0|||
145277889|NCT01017029|523868855|FG001|Overall Study|Administrative problem|1|||
145277890|NCT01017029|523868854|FG000|Overall Study|Death|3|||
145277891|NCT01017029|523868855|FG001|Overall Study|Death|1|||
145277892|NCT00618774|523868858|FG000|Overall Study|Adverse Event|5|||
145277893|NCT00618774|523868859|FG001|Overall Study|Adverse Event|3|||
145277894|NCT00618774|523868858|FG000|Overall Study|Withdrawal by Subject|1|||
145277895|NCT00618774|523868859|FG001|Overall Study|Withdrawal by Subject|0|||
145277896|NCT02753400|523868860|FG000|Overall Study|Adverse Event|3|||
145277897|NCT02753400|523868861|FG001|Overall Study|Adverse Event|0|||
145277898|NCT02753400|523868860|FG000|Overall Study|Withdrawal by Subject|2|||
145277899|NCT02753400|523868861|FG001|Overall Study|Withdrawal by Subject|1|||
145277900|NCT03989115|523868862|FG000|Overall Study|Withdrawal by Subject|2|||
145277901|NCT03989115|523868863|FG001|Overall Study|Withdrawal by Subject|1|||
145767920|NCT00064701|525656645|FG001|One Year Post-transplant|Pancreas transplant|0|||
145767921|NCT00064701|525656646|FG002|One Year Post-transplant|Pancreas transplant|1|||
145767922|NCT00064701|525656644|FG000|Clinical Continuation Phase|Adverse Event|12|||
145767923|NCT00064701|525656645|FG001|Clinical Continuation Phase|Adverse Event|21|||
145767924|NCT00064701|525656646|FG002|Clinical Continuation Phase|Adverse Event|14|||
145767925|NCT00064701|525656644|FG000|Clinical Continuation Phase|Non-compliance|8|||
145277902|NCT03989115|523868864|FG002|Overall Study|Withdrawal by Subject|3|||
145607986|NCT03389477|525079309|FG001|Step 1|Withdrawal by Subject|0|||
145277903|NCT03989115|523868865|FG003|Overall Study|Withdrawal by Subject|0|||
145277904|NCT03989115|523868866|FG004|Overall Study|Withdrawal by Subject|17|||
145277905|NCT03989115|523868867|FG005|Overall Study|Withdrawal by Subject|1|||
145277906|NCT03989115|523868868|FG006|Overall Study|Withdrawal by Subject|0|||
145277907|NCT03989115|523868869|FG007|Overall Study|Withdrawal by Subject|0|||
145767926|NCT00064701|525656645|FG001|Clinical Continuation Phase|Non-compliance|6|||
145767927|NCT00064701|525656646|FG002|Clinical Continuation Phase|Non-compliance|7|||
145767928|NCT00064701|525656644|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
145767929|NCT00064701|525656645|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
145767930|NCT00064701|525656646|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
145767931|NCT00064701|525656644|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
145767932|NCT00064701|525656645|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
145767933|NCT00064701|525656646|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
145767934|NCT00064701|525656644|FG000|Clinical Continuation Phase|Graft Failure|5|||
145767935|NCT00064701|525656645|FG001|Clinical Continuation Phase|Graft Failure|5|||
145767936|NCT00064701|525656646|FG002|Clinical Continuation Phase|Graft Failure|2|||
145767937|NCT00064701|525656644|FG000|Clinical Continuation Phase|Rejection|1|||
145767938|NCT00064701|525656645|FG001|Clinical Continuation Phase|Rejection|2|||
145767939|NCT00064701|525656646|FG002|Clinical Continuation Phase|Rejection|2|||
145767940|NCT00064701|525656644|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
145767941|NCT00064701|525656645|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
145767942|NCT00064701|525656646|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
145767943|NCT00064701|525656644|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
145767944|NCT00064701|525656645|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
145767945|NCT00064701|525656646|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
145277908|NCT03989115|523868862|FG000|Overall Study|Sponsor decision to terminate the study|1|||
145277909|NCT03989115|523868863|FG001|Overall Study|Sponsor decision to terminate the study|1|||
145277910|NCT03989115|523868864|FG002|Overall Study|Sponsor decision to terminate the study|0|||
145277911|NCT03989115|523868865|FG003|Overall Study|Sponsor decision to terminate the study|1|||
145277912|NCT03989115|523868866|FG004|Overall Study|Sponsor decision to terminate the study|11|||
145277913|NCT03989115|523868867|FG005|Overall Study|Sponsor decision to terminate the study|0|||
145277914|NCT03989115|523868868|FG006|Overall Study|Sponsor decision to terminate the study|2|||
145277915|NCT03989115|523868869|FG007|Overall Study|Sponsor decision to terminate the study|1|||
145277916|NCT03989115|523868862|FG000|Overall Study|Lost to Follow-up|2|||
145277917|NCT03989115|523868863|FG001|Overall Study|Lost to Follow-up|0|||
145277918|NCT03989115|523868864|FG002|Overall Study|Lost to Follow-up|0|||
145277919|NCT03989115|523868865|FG003|Overall Study|Lost to Follow-up|0|||
145277920|NCT03989115|523868866|FG004|Overall Study|Lost to Follow-up|1|||
145277921|NCT03989115|523868867|FG005|Overall Study|Lost to Follow-up|0|||
145767946|NCT00064701|525656644|FG000|Clinical Continuation Phase|Physician Decision|1|||
145767947|NCT00064701|525656645|FG001|Clinical Continuation Phase|Physician Decision|3|||
145767948|NCT00064701|525656646|FG002|Clinical Continuation Phase|Physician Decision|0|||
145767949|NCT00064701|525656644|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
145767950|NCT00064701|525656645|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
145767951|NCT00064701|525656646|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
145767952|NCT00064701|525656644|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
145767953|NCT00064701|525656645|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
145767954|NCT00064701|525656646|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
145767955|NCT00064701|525656644|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
145767956|NCT00064701|525656645|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
145767957|NCT00064701|525656646|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
145767958|NCT00064701|525656644|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
145767959|NCT00064701|525656645|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
145767960|NCT00064701|525656646|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
145767961|NCT00064701|525656644|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
145767962|NCT00064701|525656645|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
145767963|NCT00064701|525656646|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
145767964|NCT00064701|525656644|FG000|Clinical Continuation Phase|Patient opted out|0|||
145767965|NCT00064701|525656645|FG001|Clinical Continuation Phase|Patient opted out|0|||
145767966|NCT00064701|525656646|FG002|Clinical Continuation Phase|Patient opted out|1|||
145767967|NCT03440944|525656651|FG000|Overall Study|Physician Decision|1|||
145767968|NCT03440944|525656652|FG001|Overall Study|Physician Decision|0|||
145767969|NCT03440944|525656651|FG000|Overall Study|No Acceptable Vasculature|0|||
145767970|NCT03440944|525656652|FG001|Overall Study|No Acceptable Vasculature|1|||
145767971|NCT04672083|525656653|FG000|Overall Study|Lost to Follow-up|1|||
145767972|NCT04672083|525656654|FG001|Overall Study|Lost to Follow-up|0|||
145277922|NCT03989115|523868868|FG006|Overall Study|Lost to Follow-up|0|||
145533555|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145767973|NCT04672083|525656655|FG002|Overall Study|Lost to Follow-up|0|||
145767974|NCT04672083|525656656|FG003|Overall Study|Lost to Follow-up|0|||
145767975|NCT04672083|525656657|FG004|Overall Study|Lost to Follow-up|0|||
145767976|NCT00998738|525656661|FG000|Overall Study|Uknown|1|||
145277923|NCT03989115|523868869|FG007|Overall Study|Lost to Follow-up|0|||
145277924|NCT03989115|523868862|FG000|Overall Study|Death|2|||
145277925|NCT03989115|523868863|FG001|Overall Study|Death|2|||
145277926|NCT03989115|523868864|FG002|Overall Study|Death|9|||
145767977|NCT03313050|525656663|FG000|Stage 2: 12 Months|Adverse Event|0|||
145767978|NCT03313050|525656664|FG001|Stage 2: 12 Months|Adverse Event|0|||
145767979|NCT03313050|525656665|FG002|Stage 2: 12 Months|Adverse Event|0|||
145767980|NCT03313050|525656666|FG003|Stage 2: 12 Months|Adverse Event|1|||
145767981|NCT03313050|525656663|FG000|Stage 2: 12 Months|Death|0|||
145767982|NCT03313050|525656664|FG001|Stage 2: 12 Months|Death|0|||
145767983|NCT03313050|525656665|FG002|Stage 2: 12 Months|Death|3|||
145767984|NCT03313050|525656666|FG003|Stage 2: 12 Months|Death|0|||
145767985|NCT03313050|525656663|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
145767986|NCT03313050|525656664|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
145767987|NCT03313050|525656665|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
145767988|NCT03313050|525656666|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
145767989|NCT03313050|525656663|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
145767990|NCT03313050|525656664|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
145767991|NCT03313050|525656665|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
145767992|NCT03313050|525656666|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
145767993|NCT03313050|525656663|FG000|Stage 2: 12 Months|Protocol deviation|0|||
145767994|NCT03313050|525656664|FG001|Stage 2: 12 Months|Protocol deviation|0|||
145767995|NCT03313050|525656665|FG002|Stage 2: 12 Months|Protocol deviation|7|||
145767996|NCT03313050|525656666|FG003|Stage 2: 12 Months|Protocol deviation|7|||
145767997|NCT03313050|525656663|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
145767998|NCT03313050|525656664|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
145767999|NCT03313050|525656665|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
145768000|NCT03313050|525656666|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
145768001|NCT03313050|525656663|FG000|Stage 2: 12 Months|Other|0|||
145768002|NCT03313050|525656664|FG001|Stage 2: 12 Months|Other|0|||
145768003|NCT03313050|525656665|FG002|Stage 2: 12 Months|Other|0|||
145768004|NCT03313050|525656666|FG003|Stage 2: 12 Months|Other|1|||
145768005|NCT04211337|525656667|FG000|Overall Study|On Treatment|175|||
145768006|NCT04211337|525656668|FG001|Overall Study|On Treatment|40|||
145768007|NCT04211337|525656667|FG000|Overall Study|Withdrawal by Subject|0|||
145768008|NCT04211337|525656668|FG001|Overall Study|Withdrawal by Subject|2|||
145768009|NCT02847598|525656675|FG000|Overall Study|Adverse Event|0|||
145768010|NCT02847598|525656676|FG001|Overall Study|Adverse Event|0|||
145768011|NCT02847598|525656677|FG002|Overall Study|Adverse Event|0|||
145768012|NCT02847598|525656678|FG003|Overall Study|Adverse Event|0|||
145768013|NCT02847598|525656679|FG004|Overall Study|Adverse Event|0|||
145768014|NCT02847598|525656680|FG005|Overall Study|Adverse Event|0|||
145768015|NCT02847598|525656681|FG006|Overall Study|Adverse Event|0|||
145768016|NCT02847598|525656682|FG007|Overall Study|Adverse Event|1|||
145768017|NCT02847598|525656675|FG000|Overall Study|Consent withdrawn|2|||
145768018|NCT02847598|525656676|FG001|Overall Study|Consent withdrawn|0|||
145768019|NCT02847598|525656677|FG002|Overall Study|Consent withdrawn|0|||
145768020|NCT02847598|525656678|FG003|Overall Study|Consent withdrawn|4|||
145768021|NCT02847598|525656679|FG004|Overall Study|Consent withdrawn|3|||
145768022|NCT02847598|525656680|FG005|Overall Study|Consent withdrawn|2|||
145768023|NCT02847598|525656681|FG006|Overall Study|Consent withdrawn|1|||
145768024|NCT02847598|525656682|FG007|Overall Study|Consent withdrawn|3|||
145768025|NCT02847598|525656675|FG000|Overall Study|Death|3|||
145768026|NCT02847598|525656676|FG001|Overall Study|Death|0|||
145768027|NCT02847598|525656677|FG002|Overall Study|Death|0|||
145277927|NCT03989115|523868865|FG003|Overall Study|Death|6|||
145277928|NCT03989115|523868866|FG004|Overall Study|Death|31|||
145277929|NCT03989115|523868867|FG005|Overall Study|Death|6|||
145533556|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145533557|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145768028|NCT02847598|525656678|FG003|Overall Study|Death|0|||
145768029|NCT02847598|525656679|FG004|Overall Study|Death|0|||
145768030|NCT02847598|525656680|FG005|Overall Study|Death|0|||
145768031|NCT02847598|525656681|FG006|Overall Study|Death|0|||
145768032|NCT02847598|525656682|FG007|Overall Study|Death|0|||
145768033|NCT02847598|525656675|FG000|Overall Study|Lost to Follow-up|0|||
145768034|NCT02847598|525656676|FG001|Overall Study|Lost to Follow-up|0|||
145768035|NCT02847598|525656677|FG002|Overall Study|Lost to Follow-up|0|||
145768036|NCT02847598|525656678|FG003|Overall Study|Lost to Follow-up|0|||
145768037|NCT02847598|525656679|FG004|Overall Study|Lost to Follow-up|0|||
145768038|NCT02847598|525656680|FG005|Overall Study|Lost to Follow-up|1|||
145277930|NCT03989115|523868868|FG006|Overall Study|Death|2|||
145277931|NCT03989115|523868869|FG007|Overall Study|Death|3|||
145768039|NCT02847598|525656681|FG006|Overall Study|Lost to Follow-up|1|||
145768040|NCT02847598|525656682|FG007|Overall Study|Lost to Follow-up|0|||
145768041|NCT02848833|525656683|FG000|Overall Study|subject who are duplicated|1|||
145768042|NCT02848833|525656683|FG000|Overall Study|have not taken the study drug|11|||
145768043|NCT02848833|525656683|FG000|Overall Study|follow-up failure|6|||
145768044|NCT02848833|525656683|FG000|Overall Study|Protocol Violation|119|||
145768045|NCT04980391|525656684|FG000|Overall Study|Death|0|||
145768046|NCT04980391|525656685|FG001|Overall Study|Death|0|||
145768047|NCT04980391|525656686|FG002|Overall Study|Death|1|||
145768048|NCT04980391|525656687|FG003|Overall Study|Death|1|||
145768049|NCT04980391|525656684|FG000|Overall Study|Lost to Follow-up|3|||
145768050|NCT04980391|525656685|FG001|Overall Study|Lost to Follow-up|3|||
145768051|NCT04980391|525656686|FG002|Overall Study|Lost to Follow-up|2|||
145768052|NCT04980391|525656687|FG003|Overall Study|Lost to Follow-up|3|||
145768053|NCT04980391|525656684|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
145768054|NCT04980391|525656685|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
145768055|NCT04980391|525656686|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
145768056|NCT04980391|525656687|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
145768057|NCT04980391|525656684|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145768058|NCT04980391|525656685|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145768059|NCT04980391|525656686|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145768060|NCT04980391|525656687|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145768061|NCT04980391|525656684|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
145768062|NCT04980391|525656685|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
145768063|NCT04980391|525656686|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
145768064|NCT04980391|525656687|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
145768065|NCT04375761|525658738|FG000|Overall Study|Death|1|||
145768066|NCT04375761|525658739|FG001|Overall Study|Death|2|||
145768067|NCT04375761|525658738|FG000|Overall Study|Lost to Follow-up|203|||
145768068|NCT04375761|525658739|FG001|Overall Study|Lost to Follow-up|380|||
145768069|NCT04375761|525658738|FG000|Overall Study|Withdrawal by Subject|47|||
145768070|NCT04375761|525658739|FG001|Overall Study|Withdrawal by Subject|98|||
145768071|NCT04375761|525658738|FG000|Overall Study|Noncompliance with study procedure|121|||
145768072|NCT04375761|525658739|FG001|Overall Study|Noncompliance with study procedure|251|||
145768073|NCT04375761|525658738|FG000|Overall Study|Reimbursement not enough|1|||
145768074|NCT04375761|525658739|FG001|Overall Study|Reimbursement not enough|2|||
145768075|NCT04375761|525658738|FG000|Overall Study|Unforeseen family circumstances|1|||
145768076|NCT04375761|525658739|FG001|Overall Study|Unforeseen family circumstances|3|||
145768077|NCT04375761|525658738|FG000|Overall Study|Test too painful|1|||
145768078|NCT04375761|525658739|FG001|Overall Study|Test too painful|1|||
145768079|NCT04375761|525658738|FG000|Overall Study|Moved|0|||
145768080|NCT04375761|525658739|FG001|Overall Study|Moved|2|||
145768081|NCT04375761|525658738|FG000|Overall Study|Nonresponsive|0|||
145768082|NCT04375761|525658739|FG001|Overall Study|Nonresponsive|5|||
145768083|NCT01412879|525658741|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
145768084|NCT01412879|525658742|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
145768085|NCT01412879|525658743|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
145768086|NCT01412879|525658741|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
145768087|NCT01412879|525658742|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
145768088|NCT01412879|525658743|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
145768089|NCT01412879|525658741|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
145768090|NCT01412879|525658742|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
145768091|NCT01412879|525658743|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
145768092|NCT01412879|525658741|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
145768093|NCT01412879|525658742|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
145768094|NCT01412879|525658743|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
145768095|NCT01412879|525658741|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
145768096|NCT01412879|525658742|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
145768097|NCT01412879|525658743|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
145768098|NCT00162773|525658744|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
145768099|NCT00496366|525658747|FG000|Overall Study|Death|1|||
145768100|NCT00506389|525658751|FG000|In-treatment Period|Other|3|||
145768101|NCT00506389|525658752|FG001|In-treatment Period|Other|3|||
145768102|NCT00506389|525658753|FG002|In-treatment Period|Other|4|||
145768103|NCT00506389|525658751|FG000|In-treatment Period|Lost to Follow-up|0|||
145768104|NCT00506389|525658752|FG001|In-treatment Period|Lost to Follow-up|0|||
145768105|NCT00506389|525658753|FG002|In-treatment Period|Lost to Follow-up|1|||
145768106|NCT00506389|525658751|FG000|In-treatment Period|Lack of compliance|1|||
145768107|NCT00506389|525658752|FG001|In-treatment Period|Lack of compliance|0|||
145768108|NCT00506389|525658753|FG002|In-treatment Period|Lack of compliance|0|||
145768109|NCT00506389|525658751|FG000|In-treatment Period|Reasons not related to trial|4|||
145768110|NCT00506389|525658752|FG001|In-treatment Period|Reasons not related to trial|1|||
145768111|NCT00506389|525658753|FG002|In-treatment Period|Reasons not related to trial|0|||
145768112|NCT00506389|525658751|FG000|In-treatment Period|Withdrawal by Subject|3|||
145768113|NCT00506389|525658752|FG001|In-treatment Period|Withdrawal by Subject|3|||
145768114|NCT00506389|525658753|FG002|In-treatment Period|Withdrawal by Subject|4|||
145768115|NCT00506389|525658751|FG000|In-treatment Period|Lack of Efficacy|0|||
145768116|NCT00506389|525658752|FG001|In-treatment Period|Lack of Efficacy|2|||
145768117|NCT00506389|525658753|FG002|In-treatment Period|Lack of Efficacy|0|||
145768118|NCT00506389|525658751|FG000|In-treatment Period|Adverse Event|11|||
145768119|NCT00506389|525658752|FG001|In-treatment Period|Adverse Event|5|||
145768120|NCT00506389|525658753|FG002|In-treatment Period|Adverse Event|2|||
145768121|NCT00506389|525658751|FG000|In-treatment Period|Randomized but not treated|4|||
145768122|NCT00506389|525658752|FG001|In-treatment Period|Randomized but not treated|1|||
145768123|NCT00506389|525658753|FG002|In-treatment Period|Randomized but not treated|1|||
145768124|NCT03095703|525658755|FG000|Overall Study|Withdrawal by Subject|1|||
145768125|NCT03615222|525658756|FG000|Overall Study|Ineligible|26|||
145768126|NCT03615222|525658756|FG000|Overall Study|Withdrawal by Subject|7|||
145768127|NCT03615222|525658756|FG000|Overall Study|Death|1|||
145768128|NCT00476086|525658757|FG000|Overall Study|Alternative therapy|1|||
145768129|NCT00476086|525658757|FG000|Overall Study|Progressive Disease|4|||
145768130|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
145768131|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
145768132|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
145768133|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
145768134|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
145768135|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
145768136|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
145768137|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
145768138|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
145768139|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
145768140|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
145768141|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
145768142|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
145768143|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
145768144|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
145768145|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
145768146|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
145768147|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
145768148|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
145768149|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
145768150|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
145768151|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
145768152|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
145768153|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
145768154|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
145768155|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
145768156|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
145768157|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
145768158|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
145768159|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
145768160|NCT03895203|525658758|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
145768161|NCT03895203|525658759|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
145768162|NCT03895203|525658760|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
145768163|NCT03895203|525658761|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
145768164|NCT03895203|525658762|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
145768165|NCT03895203|525658763|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
145768166|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
145768167|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
145768168|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
145768169|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
145768170|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
145768171|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
145768172|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
145558235|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
145768173|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
145768174|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
145768175|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
145768176|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
145768177|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
145768178|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
145768179|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
145768180|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
145768181|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
145768182|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
145768183|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
145768184|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
145768185|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
145768186|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
145768187|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
145768188|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
145768189|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
145768190|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
145768191|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
145768192|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
145768193|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
145768194|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
145768195|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
145768196|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
145768197|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
145768198|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
145768199|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
145768200|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
145768201|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
145768202|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
145768203|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
145768204|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
145768205|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
145768206|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
145768207|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
145768208|NCT03895203|525658758|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
145768209|NCT03895203|525658759|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
145768210|NCT03895203|525658760|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
145768211|NCT03895203|525658761|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
145768212|NCT03895203|525658762|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
145768213|NCT03895203|525658763|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
145768214|NCT02731742|525658768|FG000|Overall Study|Death|1|||
145768215|NCT02731742|525658769|FG001|Overall Study|Death|2|||
145768216|NCT02731742|525658770|FG002|Overall Study|Death|5|||
145768217|NCT02731742|525658771|FG003|Overall Study|Death|0|||
145768218|NCT02731742|525658768|FG000|Overall Study|Physician Decision|0|||
145768219|NCT02731742|525658769|FG001|Overall Study|Physician Decision|0|||
145768220|NCT02731742|525658770|FG002|Overall Study|Physician Decision|0|||
145768221|NCT02731742|525658771|FG003|Overall Study|Physician Decision|1|||
145768222|NCT02731742|525658768|FG000|Overall Study|Study Terminated by Sponsor|2|||
145768223|NCT02731742|525658769|FG001|Overall Study|Study Terminated by Sponsor|1|||
145277932|NCT03989115|523868862|FG000|Overall Study|Other|1|||
145277933|NCT03989115|523868863|FG001|Overall Study|Other|2|||
145277934|NCT03989115|523868864|FG002|Overall Study|Other|0|||
145277935|NCT03989115|523868865|FG003|Overall Study|Other|0|||
145277936|NCT03989115|523868866|FG004|Overall Study|Other|5|||
145277937|NCT03989115|523868867|FG005|Overall Study|Other|0|||
145277938|NCT03989115|523868868|FG006|Overall Study|Other|0|||
145277939|NCT03989115|523868869|FG007|Overall Study|Other|0|||
145277940|NCT02525562|523868881|FG000|Overall Study|Death|9|||
145277941|NCT02525562|523868882|FG001|Overall Study|Death|0|||
145277942|NCT02525562|523868883|FG002|Overall Study|Death|0|||
145277943|NCT02525562|523868881|FG000|Overall Study|Lost to Follow-up|19|||
145277944|NCT02525562|523868882|FG001|Overall Study|Lost to Follow-up|0|||
145277945|NCT02525562|523868883|FG002|Overall Study|Lost to Follow-up|0|||
145277946|NCT02525562|523868881|FG000|Overall Study|Withdrawal by Subject|37|||
145277947|NCT02525562|523868882|FG001|Overall Study|Withdrawal by Subject|0|||
145277948|NCT02525562|523868883|FG002|Overall Study|Withdrawal by Subject|0|||
145277949|NCT02525562|523868881|FG000|Overall Study|Revision/Removal of Study Device|4|||
145277950|NCT02525562|523868882|FG001|Overall Study|Revision/Removal of Study Device|0|||
145277951|NCT02525562|523868883|FG002|Overall Study|Revision/Removal of Study Device|0|||
145277952|NCT02525562|523868881|FG000|Overall Study|Study Closed by Sponsor|154|||
145277953|NCT02525562|523868882|FG001|Overall Study|Study Closed by Sponsor|0|||
145277954|NCT02525562|523868883|FG002|Overall Study|Study Closed by Sponsor|0|||
145277955|NCT02983227|523868884|FG000|Overall Study|Adverse Event|21|||
145277956|NCT02983227|523868885|FG001|Overall Study|Adverse Event|3|||
145277957|NCT02983227|523868884|FG000|Overall Study|Death|3|||
145277958|NCT02983227|523868885|FG001|Overall Study|Death|0|||
145277959|NCT02983227|523868884|FG000|Overall Study|Lack of Efficacy|8|||
145277960|NCT02983227|523868885|FG001|Overall Study|Lack of Efficacy|1|||
145277961|NCT02983227|523868884|FG000|Overall Study|Lost to Follow-up|3|||
145277962|NCT02983227|523868885|FG001|Overall Study|Lost to Follow-up|0|||
145277963|NCT02983227|523868884|FG000|Overall Study|Multiple Reasons|2|||
145277964|NCT02983227|523868885|FG001|Overall Study|Multiple Reasons|1|||
145277965|NCT02983227|523868884|FG000|Overall Study|Physician Decision|3|||
145277966|NCT02983227|523868885|FG001|Overall Study|Physician Decision|1|||
145277967|NCT02983227|523868884|FG000|Overall Study|Withdrawal by Subject|19|||
145277968|NCT02983227|523868885|FG001|Overall Study|Withdrawal by Subject|8|||
145277969|NCT02354976|523868886|FG000|Overall Study|Other - reason not specified|1|||
145277970|NCT02354976|523868887|FG001|Overall Study|Other - reason not specified|0|||
145277971|NCT02354976|523868888|FG002|Overall Study|Other - reason not specified|1|||
145277972|NCT02354976|523868886|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
145277973|NCT02354976|523868887|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
145277974|NCT02354976|523868888|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
145277975|NCT02354976|523868886|FG000|Overall Study|Adverse Event|1|||
145277976|NCT02354976|523868887|FG001|Overall Study|Adverse Event|0|||
145277977|NCT02354976|523868888|FG002|Overall Study|Adverse Event|2|||
145277978|NCT03118765|523868889|FG000|Overall Study|Withdrawal by Subject|0|||
145277979|NCT03118765|523868890|FG001|Overall Study|Withdrawal by Subject|0|||
145277980|NCT03118765|523868891|FG002|Overall Study|Withdrawal by Subject|1|||
145277981|NCT03118765|523868892|FG003|Overall Study|Withdrawal by Subject|0|||
145277982|NCT03118765|523868893|FG004|Overall Study|Withdrawal by Subject|0|||
145277983|NCT03118765|523868889|FG000|Overall Study|Adverse Event|1|||
145277984|NCT03118765|523868890|FG001|Overall Study|Adverse Event|1|||
145277985|NCT03118765|523868891|FG002|Overall Study|Adverse Event|1|||
145533558|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145558236|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
145768224|NCT02731742|525658770|FG002|Overall Study|Study Terminated by Sponsor|1|||
145768225|NCT02731742|525658771|FG003|Overall Study|Study Terminated by Sponsor|1|||
145768226|NCT00461175|525658772|FG000|Overall Study|Protocol Violation|522|||
145768227|NCT00461175|525658773|FG001|Overall Study|Protocol Violation|365|||
145768228|NCT00331760|525658774|FG000|Overall Study|Ineligible / no protocol treatment|15|||
145768229|NCT00331760|525658775|FG001|Overall Study|Ineligible / no protocol treatment|8|||
145768230|NCT03093155|525658777|FG000|Overall Study|Not Eligible|1|||
145768231|NCT03093155|525658778|FG001|Overall Study|Not Eligible|0|||
145277986|NCT03118765|523868892|FG003|Overall Study|Adverse Event|1|||
145277987|NCT03118765|523868893|FG004|Overall Study|Adverse Event|1|||
145768232|NCT03093155|525658777|FG000|Overall Study|Withdrawal by Subject|0|||
145277988|NCT03118765|523868889|FG000|Overall Study|Non compliance with Study Procedures|0|||
145277989|NCT03118765|523868890|FG001|Overall Study|Non compliance with Study Procedures|0|||
145277990|NCT03118765|523868891|FG002|Overall Study|Non compliance with Study Procedures|0|||
145277991|NCT03118765|523868892|FG003|Overall Study|Non compliance with Study Procedures|1|||
145277992|NCT03118765|523868893|FG004|Overall Study|Non compliance with Study Procedures|0|||
145277993|NCT03118765|523868889|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
145277994|NCT03118765|523868890|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
145768233|NCT03093155|525658778|FG001|Overall Study|Withdrawal by Subject|1|||
145277995|NCT03118765|523868891|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
145277996|NCT03118765|523868892|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
145277997|NCT03118765|523868893|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
145768234|NCT03417440|525658779|FG000|Overall Study|Lost to Follow-up|0|||
145768235|NCT03417440|525658780|FG001|Overall Study|Lost to Follow-up|1|||
145768236|NCT03417440|525658781|FG002|Overall Study|Lost to Follow-up|0|||
145768237|NCT03417440|525658782|FG003|Overall Study|Lost to Follow-up|0|||
145768238|NCT03417440|525658783|FG004|Overall Study|Lost to Follow-up|1|||
145277998|NCT03118765|523868889|FG000|Overall Study|COPD Exacerbation|1|||
145403172|NCT01206764|524334314|FG000|Overall Study|Protocol deviation|3|||
145768239|NCT03417440|525658784|FG005|Overall Study|Lost to Follow-up|0|||
145768240|NCT03417440|525658785|FG006|Overall Study|Lost to Follow-up|0|||
145768241|NCT03417440|525658786|FG007|Overall Study|Lost to Follow-up|0|||
145768242|NCT03417440|525658779|FG000|Overall Study|Withdrawal by Subject|2|||
145768243|NCT03417440|525658780|FG001|Overall Study|Withdrawal by Subject|0|||
145768244|NCT03417440|525658781|FG002|Overall Study|Withdrawal by Subject|2|||
145768245|NCT03417440|525658782|FG003|Overall Study|Withdrawal by Subject|1|||
145768246|NCT03417440|525658783|FG004|Overall Study|Withdrawal by Subject|1|||
145768247|NCT03417440|525658784|FG005|Overall Study|Withdrawal by Subject|0|||
145768248|NCT03417440|525658785|FG006|Overall Study|Withdrawal by Subject|0|||
145768249|NCT03417440|525658786|FG007|Overall Study|Withdrawal by Subject|1|||
145768250|NCT03367871|525658787|FG000|Overall Study|Lost to Follow-up|1|||
145768251|NCT00316264|525658789|FG000|Overall Study|Lost to Follow-up|0|||
145768252|NCT00316264|525658790|FG001|Overall Study|Lost to Follow-up|1|||
145768253|NCT00316264|525658791|FG002|Overall Study|Lost to Follow-up|0|||
145768254|NCT00316264|525658789|FG000|Overall Study|Withdrawal of Consent|3|||
145768255|NCT00316264|525658790|FG001|Overall Study|Withdrawal of Consent|5|||
145768256|NCT00316264|525658791|FG002|Overall Study|Withdrawal of Consent|6|||
145768257|NCT00316264|525658789|FG000|Overall Study|Death|2|||
145768258|NCT00316264|525658790|FG001|Overall Study|Death|0|||
145768259|NCT00316264|525658791|FG002|Overall Study|Death|0|||
145768260|NCT00316264|525658789|FG000|Overall Study|Other|1|||
145768261|NCT00316264|525658790|FG001|Overall Study|Other|1|||
145768262|NCT00316264|525658791|FG002|Overall Study|Other|0|||
145768263|NCT00607048|525658792|FG000|Overall Study|Adverse Event|0|||
145768264|NCT00607048|525658793|FG001|Overall Study|Adverse Event|1|||
145768265|NCT00607048|525658794|FG002|Overall Study|Adverse Event|0|||
145768266|NCT00607048|525658795|FG003|Overall Study|Adverse Event|0|||
145768267|NCT00607048|525658796|FG004|Overall Study|Adverse Event|4|||
145768268|NCT00607048|525658797|FG005|Overall Study|Adverse Event|0|||
145768269|NCT00607048|525658792|FG000|Overall Study|Global deterioration of health|1|||
145768270|NCT00607048|525658793|FG001|Overall Study|Global deterioration of health|0|||
145768271|NCT00607048|525658794|FG002|Overall Study|Global deterioration of health|0|||
145768272|NCT00607048|525658795|FG003|Overall Study|Global deterioration of health|0|||
145768273|NCT00607048|525658796|FG004|Overall Study|Global deterioration of health|0|||
145768274|NCT00607048|525658797|FG005|Overall Study|Global deterioration of health|0|||
145768275|NCT00607048|525658792|FG000|Overall Study|Objective disease progression - relapse|1|||
145768276|NCT00607048|525658793|FG001|Overall Study|Objective disease progression - relapse|2|||
145768277|NCT00607048|525658794|FG002|Overall Study|Objective disease progression - relapse|4|||
145768278|NCT00607048|525658795|FG003|Overall Study|Objective disease progression - relapse|2|||
145768279|NCT00607048|525658796|FG004|Overall Study|Objective disease progression - relapse|2|||
145768280|NCT00607048|525658797|FG005|Overall Study|Objective disease progression - relapse|2|||
145768281|NCT00607048|525658792|FG000|Overall Study|Withdrawal by Subject|0|||
145768282|NCT00607048|525658793|FG001|Overall Study|Withdrawal by Subject|0|||
145768283|NCT00607048|525658794|FG002|Overall Study|Withdrawal by Subject|0|||
145768284|NCT00607048|525658795|FG003|Overall Study|Withdrawal by Subject|1|||
145768285|NCT00607048|525658796|FG004|Overall Study|Withdrawal by Subject|0|||
145768286|NCT00607048|525658797|FG005|Overall Study|Withdrawal by Subject|2|||
145768287|NCT00607048|525658792|FG000|Overall Study|Other|1|||
145768288|NCT00607048|525658793|FG001|Overall Study|Other|1|||
145768289|NCT00607048|525658794|FG002|Overall Study|Other|0|||
145768290|NCT00607048|525658795|FG003|Overall Study|Other|0|||
145768291|NCT00607048|525658796|FG004|Overall Study|Other|0|||
145768292|NCT00607048|525658797|FG005|Overall Study|Other|1|||
145768293|NCT04336163|525658798|FG000|Overall Study|Lost to Follow-up|55|||
145768294|NCT04336163|525658799|FG001|Overall Study|Lost to Follow-up|0|||
145768295|NCT03926143|525658801|FG000|Overall Study|Physician Decision|3|||
145768296|NCT03926143|525658801|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
145768297|NCT03926143|525658801|FG000|Overall Study|Adverse Event|2|||
145768298|NCT03926143|525658801|FG000|Overall Study|Progressive disease|3|||
145768299|NCT02561156|525658804|FG000|Part 2|Adverse Event|0|||
145768300|NCT02561156|525658805|FG001|Part 2|Adverse Event|0|||
145768301|NCT02561156|525658806|FG002|Part 2|Adverse Event|0|||
145768302|NCT02561156|525658807|FG003|Part 2|Adverse Event|0|||
145768303|NCT02561156|525658808|FG004|Part 2|Adverse Event|0|||
145768304|NCT02561156|525658809|FG005|Part 2|Adverse Event|0|||
145768305|NCT02561156|525658810|FG006|Part 2|Adverse Event|0|||
145768306|NCT02561156|525658811|FG007|Part 2|Adverse Event|0|||
145768307|NCT02561156|525658812|FG008|Part 2|Adverse Event|0|||
145768308|NCT02561156|525658813|FG009|Part 2|Adverse Event|0|||
145768309|NCT02561156|525658814|FG010|Part 2|Adverse Event|0|||
145768310|NCT02561156|525658815|FG011|Part 2|Adverse Event|1|||
145768311|NCT02561156|525658816|FG012|Part 2|Adverse Event|0|||
145768312|NCT01071070|525658823|FG000|Overall Study|Adverse Event|0|||
145768313|NCT01071070|525658824|FG001|Overall Study|Adverse Event|3|||
145768314|NCT01071070|525658823|FG000|Overall Study|Withdrawal by Subject|1|||
145768315|NCT01071070|525658824|FG001|Overall Study|Withdrawal by Subject|0|||
145768316|NCT01071070|525658823|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
145768317|NCT01071070|525658824|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
145768318|NCT01071070|525658823|FG000|Overall Study|Hypercalcemia|1|||
145768319|NCT01071070|525658824|FG001|Overall Study|Hypercalcemia|0|||
145768320|NCT02207907|525658831|FG000|Overall Study|Lost to Follow-up|3|||
145768321|NCT02207907|525658832|FG001|Overall Study|Lost to Follow-up|1|||
145277999|NCT03118765|523868890|FG001|Overall Study|COPD Exacerbation|0|||
145278000|NCT03118765|523868891|FG002|Overall Study|COPD Exacerbation|0|||
145278001|NCT03118765|523868892|FG003|Overall Study|COPD Exacerbation|1|||
145278002|NCT03118765|523868893|FG004|Overall Study|COPD Exacerbation|0|||
145278003|NCT03118765|523868889|FG000|Overall Study|Lost to Follow-up|1|||
145278004|NCT03118765|523868890|FG001|Overall Study|Lost to Follow-up|0|||
145278005|NCT03118765|523868891|FG002|Overall Study|Lost to Follow-up|1|||
145278006|NCT03118765|523868892|FG003|Overall Study|Lost to Follow-up|0|||
145278007|NCT03118765|523868893|FG004|Overall Study|Lost to Follow-up|0|||
145278008|NCT03118765|523868889|FG000|Overall Study|Sponsor Decision|1|||
145278009|NCT03118765|523868890|FG001|Overall Study|Sponsor Decision|0|||
145278010|NCT03118765|523868891|FG002|Overall Study|Sponsor Decision|1|||
145278011|NCT03118765|523868892|FG003|Overall Study|Sponsor Decision|0|||
145278012|NCT03118765|523868893|FG004|Overall Study|Sponsor Decision|1|||
145768322|NCT02207907|525658831|FG000|Overall Study|Withdrawal by Subject|5|||
145768323|NCT02207907|525658832|FG001|Overall Study|Withdrawal by Subject|6|||
145278013|NCT02164539|523868894|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
145278014|NCT02164539|523868895|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
145292765|NCT06179108|523922226|FG000|Overall Study|Lack of Efficacy|0|||
145768324|NCT02207907|525658831|FG000|Overall Study|Did not meet study criteria|3|||
145768325|NCT02207907|525658832|FG001|Overall Study|Did not meet study criteria|0|||
145768326|NCT02207907|525658831|FG000|Overall Study|Pregnancy|0|||
145768327|NCT02207907|525658832|FG001|Overall Study|Pregnancy|1|||
145768328|NCT00158184|525658833|FG000|Overall Study|personal issues|3|||
145768329|NCT00158184|525658834|FG001|Overall Study|personal issues|1|||
145768330|NCT00158184|525658833|FG000|Overall Study|failed for follow unit/study rules|2|||
145768331|NCT00158184|525658834|FG001|Overall Study|failed for follow unit/study rules|0|||
145768332|NCT00158184|525658833|FG000|Overall Study|Adverse Event|1|||
145768333|NCT00158184|525658834|FG001|Overall Study|Adverse Event|1|||
145768334|NCT02620020|525658843|FG000|Overall Study|Adverse Event|8|||
145768335|NCT02620020|525658844|FG001|Overall Study|Adverse Event|4|||
145768336|NCT02620020|525658845|FG002|Overall Study|Adverse Event|3|||
145768337|NCT02620020|525658846|FG003|Overall Study|Adverse Event|5|||
145768338|NCT02620020|525658843|FG000|Overall Study|Lost to Follow-up|4|||
145768339|NCT02620020|525658844|FG001|Overall Study|Lost to Follow-up|8|||
145768340|NCT02620020|525658845|FG002|Overall Study|Lost to Follow-up|1|||
145768341|NCT02620020|525658846|FG003|Overall Study|Lost to Follow-up|4|||
145768342|NCT02620020|525658843|FG000|Overall Study|Physician Decision|7|||
145768343|NCT02620020|525658844|FG001|Overall Study|Physician Decision|4|||
145768344|NCT02620020|525658845|FG002|Overall Study|Physician Decision|3|||
145768345|NCT02620020|525658846|FG003|Overall Study|Physician Decision|4|||
145768346|NCT02620020|525658843|FG000|Overall Study|Protocol Violation|5|||
145768347|NCT02620020|525658844|FG001|Overall Study|Protocol Violation|2|||
145768348|NCT02620020|525658845|FG002|Overall Study|Protocol Violation|1|||
145768349|NCT02620020|525658846|FG003|Overall Study|Protocol Violation|1|||
145768350|NCT02620020|525658843|FG000|Overall Study|Withdrawal by Subject|20|||
145768351|NCT02620020|525658844|FG001|Overall Study|Withdrawal by Subject|16|||
145768352|NCT02620020|525658845|FG002|Overall Study|Withdrawal by Subject|17|||
145768353|NCT02620020|525658846|FG003|Overall Study|Withdrawal by Subject|12|||
145768354|NCT02620020|525658843|FG000|Overall Study|Death|0|||
145768355|NCT02620020|525658844|FG001|Overall Study|Death|1|||
145768356|NCT02620020|525658845|FG002|Overall Study|Death|0|||
145768357|NCT02620020|525658846|FG003|Overall Study|Death|0|||
145768358|NCT01025635|525658854|FG000|Overall Study|Withdrawal by Subject|6|||
145768359|NCT01025635|525658855|FG001|Overall Study|Withdrawal by Subject|7|||
145768360|NCT01025635|525658854|FG000|Overall Study|Protocol Violation|4|||
145768361|NCT01025635|525658855|FG001|Overall Study|Protocol Violation|2|||
145768362|NCT01025635|525658854|FG000|Overall Study|Lack of Efficacy|0|||
145768363|NCT01025635|525658855|FG001|Overall Study|Lack of Efficacy|1|||
145768364|NCT01025635|525658854|FG000|Overall Study|Lost to Follow-up|9|||
145768365|NCT01025635|525658855|FG001|Overall Study|Lost to Follow-up|13|||
145768366|NCT01025635|525658854|FG000|Overall Study|Reason not known|4|||
145768367|NCT01025635|525658855|FG001|Overall Study|Reason not known|2|||
145768368|NCT02393209|525658856|FG000|Overall Study|Study Terminated by Sponsor|1|||
145768369|NCT02393209|525658857|FG001|Overall Study|Study Terminated by Sponsor|1|||
145768370|NCT02393209|525658858|FG002|Overall Study|Study Terminated by Sponsor|0|||
145768371|NCT02393209|525658859|FG003|Overall Study|Study Terminated by Sponsor|0|||
145533559|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
145533560|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
145533561|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145607987|NCT03389477|525079308|FG000|Step 2|Withdrawal by Subject|1|||
145768372|NCT02393209|525658856|FG000|Overall Study|Withdrawal by Patient|1|||
145768373|NCT02393209|525658857|FG001|Overall Study|Withdrawal by Patient|0|||
145768374|NCT02393209|525658858|FG002|Overall Study|Withdrawal by Patient|0|||
145768375|NCT02393209|525658859|FG003|Overall Study|Withdrawal by Patient|0|||
145768376|NCT02393209|525658856|FG000|Overall Study|Death|2|||
145768377|NCT02393209|525658857|FG001|Overall Study|Death|2|||
145768378|NCT02393209|525658858|FG002|Overall Study|Death|0|||
145768379|NCT02393209|525658859|FG003|Overall Study|Death|0|||
145768380|NCT02393209|525658856|FG000|Overall Study|Death due to Disease Progression|2|||
145768381|NCT02393209|525658857|FG001|Overall Study|Death due to Disease Progression|2|||
145768382|NCT02393209|525658858|FG002|Overall Study|Death due to Disease Progression|0|||
145768383|NCT02393209|525658859|FG003|Overall Study|Death due to Disease Progression|0|||
145768384|NCT02393209|525658856|FG000|Overall Study|Death from Legionella Infection|0|||
145768385|NCT02393209|525658857|FG001|Overall Study|Death from Legionella Infection|1|||
145768386|NCT02393209|525658858|FG002|Overall Study|Death from Legionella Infection|0|||
145768387|NCT02393209|525658859|FG003|Overall Study|Death from Legionella Infection|0|||
145768388|NCT02393209|525658856|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
145768389|NCT02393209|525658857|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
145768390|NCT02393209|525658858|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
145768391|NCT02393209|525658859|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
145768392|NCT02393209|525658856|FG000|Overall Study|Lost to Follow-up|0|||
145768393|NCT02393209|525658857|FG001|Overall Study|Lost to Follow-up|1|||
145768394|NCT02393209|525658858|FG002|Overall Study|Lost to Follow-up|0|||
145768395|NCT02393209|525658859|FG003|Overall Study|Lost to Follow-up|0|||
145768396|NCT00727402|525658860|FG000|Overall Study|Physician Decision|116|||
145768397|NCT03545282|525658861|FG000|Overall Study|Lost to Follow-up|15|||
145768398|NCT03545282|525658862|FG001|Overall Study|Lost to Follow-up|10|||
145768399|NCT03545282|525658861|FG000|Overall Study|Withdrawal by Subject|2|||
145768400|NCT03545282|525658862|FG001|Overall Study|Withdrawal by Subject|2|||
145768401|NCT02209506|525658863|FG000|Overall Study|Withdrawal by Subject|0|||
145768402|NCT02209506|525658864|FG001|Overall Study|Withdrawal by Subject|0|||
145768403|NCT02209506|525658865|FG002|Overall Study|Withdrawal by Subject|0|||
145768404|NCT02209506|525658866|FG003|Overall Study|Withdrawal by Subject|0|||
145768405|NCT02209506|525658867|FG004|Overall Study|Withdrawal by Subject|1|||
145768406|NCT02582671|525658868|FG000|Overall Study|Failure to return|1|||
145768407|NCT02582671|525658868|FG000|Overall Study|Other, not specified|1|||
145768408|NCT02537678|525658871|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
145768409|NCT02537678|525658872|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
145768410|NCT02537678|525658871|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
145768411|NCT02537678|525658872|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
145768412|NCT02537678|525658871|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
145768413|NCT02537678|525658872|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
145768414|NCT02537678|525658871|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
145768415|NCT02537678|525658872|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
145768416|NCT02537678|525658871|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
145768417|NCT02537678|525658872|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
145768418|NCT02537678|525658871|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
145768419|NCT02537678|525658872|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
145768420|NCT02537678|525658871|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
145768421|NCT02537678|525658872|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
145768422|NCT01478958|525658873|FG000|Overall Study|Withdrawal by Subject|1|||
145768423|NCT01478958|525658874|FG001|Overall Study|Withdrawal by Subject|1|||
145768424|NCT01478958|525658875|FG002|Overall Study|Withdrawal by Subject|1|||
145768425|NCT01478958|525658873|FG000|Overall Study|Weight loss|1|||
145768426|NCT01478958|525658874|FG001|Overall Study|Weight loss|0|||
145768427|NCT01478958|525658875|FG002|Overall Study|Weight loss|0|||
145768428|NCT01478958|525658873|FG000|Overall Study|Re-located|0|||
145768429|NCT01478958|525658874|FG001|Overall Study|Re-located|1|||
145768430|NCT01478958|525658875|FG002|Overall Study|Re-located|0|||
145768431|NCT01478958|525658873|FG000|Overall Study|Unable to comply|0|||
145768432|NCT01478958|525658874|FG001|Overall Study|Unable to comply|0|||
145533562|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145533563|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145533564|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145533565|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145533566|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
145533567|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
145533568|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145533569|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145533570|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145768433|NCT01478958|525658875|FG002|Overall Study|Unable to comply|2|||
145768434|NCT01499290|525658876|FG000|Overall Study|Withdrawal by Subject|22|||
145768435|NCT01499290|525658877|FG001|Overall Study|Withdrawal by Subject|15|||
145768436|NCT01499290|525658876|FG000|Overall Study|Not specified in study report|11|||
145768437|NCT01499290|525658877|FG001|Overall Study|Not specified in study report|5|||
145768438|NCT01499290|525658876|FG000|Overall Study|Condition improved/subject recovered|1|||
145768439|NCT01499290|525658877|FG001|Overall Study|Condition improved/subject recovered|0|||
145768440|NCT01499290|525658876|FG000|Overall Study|Lack of Efficacy|7|||
145768441|NCT01499290|525658877|FG001|Overall Study|Lack of Efficacy|8|||
145768442|NCT01499290|525658876|FG000|Overall Study|Adverse Event|14|||
145768443|NCT01499290|525658877|FG001|Overall Study|Adverse Event|7|||
145768444|NCT00327444|525658878|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
145768445|NCT00327444|525658879|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
145768446|NCT00327444|525658878|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
145768447|NCT00327444|525658879|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
145768448|NCT00327444|525658878|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
145768449|NCT00327444|525658879|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
145768450|NCT00327444|525658878|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
145768451|NCT00327444|525658879|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
145768452|NCT00327444|525658878|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
145768453|NCT00327444|525658879|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
145768454|NCT00327444|525658878|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
145768455|NCT00327444|525658879|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
145533571|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145533572|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145533573|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
145533574|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
145533575|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533576|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533577|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533578|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533579|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533580|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
145533581|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
145533582|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533583|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533584|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533585|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533586|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533587|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
145533588|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
145533589|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533590|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533591|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533592|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533593|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533594|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
145533595|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
145533596|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533597|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533598|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533599|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533600|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533601|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
145533602|NCT04526509|524813496|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
145607988|NCT03389477|525079309|FG001|Step 2|Withdrawal by Subject|2|||
145607989|NCT03389477|525079308|FG000|Step 2|Disease progression|1|||
145768456|NCT00327444|525658878|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
145768457|NCT00327444|525658879|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
145768458|NCT00327444|525658878|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
145768459|NCT00327444|525658879|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
145533603|NCT04526509|524813497|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533604|NCT04526509|524813498|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533605|NCT04526509|524813499|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533606|NCT04526509|524813500|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533607|NCT04526509|524813501|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533608|NCT04526509|524813502|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
145533609|NCT04526509|524813496|FG000|Enrolled|Study Terminated by Sponsor|0|||
145533610|NCT04526509|524813497|FG001|Enrolled|Study Terminated by Sponsor|0|||
145533611|NCT04526509|524813498|FG002|Enrolled|Study Terminated by Sponsor|0|||
145533612|NCT04526509|524813499|FG003|Enrolled|Study Terminated by Sponsor|0|||
145533613|NCT04526509|524813500|FG004|Enrolled|Study Terminated by Sponsor|0|||
145533614|NCT04526509|524813501|FG005|Enrolled|Study Terminated by Sponsor|0|||
145533615|NCT04526509|524813502|FG006|Enrolled|Study Terminated by Sponsor|1|||
145533616|NCT04526509|524813496|FG000|Enrolled|Death prior to lymphodepletion|0|||
145533617|NCT04526509|524813497|FG001|Enrolled|Death prior to lymphodepletion|0|||
145533618|NCT04526509|524813498|FG002|Enrolled|Death prior to lymphodepletion|0|||
145533619|NCT04526509|524813499|FG003|Enrolled|Death prior to lymphodepletion|1|||
145533620|NCT04526509|524813500|FG004|Enrolled|Death prior to lymphodepletion|0|||
145533621|NCT04526509|524813501|FG005|Enrolled|Death prior to lymphodepletion|0|||
145533622|NCT04526509|524813502|FG006|Enrolled|Death prior to lymphodepletion|0|||
145533623|NCT04526509|524813496|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533624|NCT04526509|524813497|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533625|NCT04526509|524813498|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533626|NCT04526509|524813499|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
145533627|NCT04526509|524813500|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533628|NCT04526509|524813501|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533629|NCT04526509|524813502|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
145533630|NCT04526509|524813496|FG000|Enrolled|Physician Decision|0|||
145533631|NCT04526509|524813497|FG001|Enrolled|Physician Decision|1|||
145533632|NCT04526509|524813498|FG002|Enrolled|Physician Decision|0|||
145533633|NCT04526509|524813499|FG003|Enrolled|Physician Decision|0|||
145533634|NCT04526509|524813500|FG004|Enrolled|Physician Decision|0|||
145533635|NCT04526509|524813501|FG005|Enrolled|Physician Decision|0|||
145533636|NCT04526509|524813502|FG006|Enrolled|Physician Decision|0|||
145533637|NCT02719327|524813505|FG000|Overall Study|Withdrawal by Subject|11|||
145533638|NCT02719327|524813506|FG001|Overall Study|Withdrawal by Subject|8|||
145533639|NCT04340193|524813507|FG000|Overall Study|Other reason|0|||
145533640|NCT04340193|524813508|FG001|Overall Study|Other reason|0|||
145607990|NCT03389477|525079309|FG001|Step 2|Disease progression|0|||
145607991|NCT03389477|525079308|FG000|Step 2|Death|0|||
145607992|NCT03389477|525079309|FG001|Step 2|Death|1|||
145292766|NCT06179108|523922227|FG001|Overall Study|Lack of Efficacy|0|||
145768460|NCT00805207|525658880|FG000|Overall Study|Protocol Violation|0|||
145768461|NCT00805207|525658881|FG001|Overall Study|Protocol Violation|0|||
145768462|NCT00805207|525658882|FG002|Overall Study|Protocol Violation|1|||
145768463|NCT00805207|525658883|FG003|Overall Study|Protocol Violation|0|||
145768464|NCT00805207|525658884|FG004|Overall Study|Protocol Violation|0|||
145768465|NCT00805207|525658885|FG005|Overall Study|Protocol Violation|0|||
145768466|NCT00805207|525658886|FG006|Overall Study|Protocol Violation|0|||
145768467|NCT00805207|525658887|FG007|Overall Study|Protocol Violation|0|||
145768468|NCT00805207|525658888|FG008|Overall Study|Protocol Violation|0|||
145768469|NCT00805207|525658880|FG000|Overall Study|Physician Decision|0|||
145768470|NCT00805207|525658881|FG001|Overall Study|Physician Decision|1|||
145768471|NCT00805207|525658882|FG002|Overall Study|Physician Decision|0|||
145768472|NCT00805207|525658883|FG003|Overall Study|Physician Decision|0|||
145768473|NCT00805207|525658884|FG004|Overall Study|Physician Decision|0|||
145768474|NCT00805207|525658885|FG005|Overall Study|Physician Decision|1|||
145768475|NCT00805207|525658886|FG006|Overall Study|Physician Decision|0|||
145768476|NCT00805207|525658887|FG007|Overall Study|Physician Decision|0|||
145768477|NCT00805207|525658888|FG008|Overall Study|Physician Decision|0|||
145768478|NCT00805207|525658880|FG000|Overall Study|Withdrawal by Subject|0|||
145768479|NCT00805207|525658881|FG001|Overall Study|Withdrawal by Subject|1|||
145768480|NCT00805207|525658882|FG002|Overall Study|Withdrawal by Subject|0|||
145768481|NCT00805207|525658883|FG003|Overall Study|Withdrawal by Subject|0|||
145768482|NCT00805207|525658884|FG004|Overall Study|Withdrawal by Subject|1|||
145768483|NCT00805207|525658885|FG005|Overall Study|Withdrawal by Subject|2|||
145768484|NCT00805207|525658886|FG006|Overall Study|Withdrawal by Subject|0|||
145533641|NCT04340193|524813509|FG002|Overall Study|Other reason|1|||
145533642|NCT04340193|524813507|FG000|Overall Study|Disease recurrence|0|||
145533643|NCT04340193|524813508|FG001|Overall Study|Disease recurrence|1|||
145533644|NCT04340193|524813509|FG002|Overall Study|Disease recurrence|0|||
145533645|NCT04340193|524813507|FG000|Overall Study|Study drug toxicity|1|||
145533646|NCT04340193|524813508|FG001|Overall Study|Study drug toxicity|0|||
145533647|NCT04340193|524813509|FG002|Overall Study|Study drug toxicity|0|||
145533648|NCT04340193|524813507|FG000|Overall Study|Disease progression|1|||
145533649|NCT04340193|524813508|FG001|Overall Study|Disease progression|2|||
145533650|NCT04340193|524813509|FG002|Overall Study|Disease progression|3|||
145533651|NCT04340193|524813507|FG000|Overall Study|Administrative reasons by sponsor|0|||
145533652|NCT04340193|524813508|FG001|Overall Study|Administrative reasons by sponsor|1|||
145533653|NCT04340193|524813509|FG002|Overall Study|Administrative reasons by sponsor|0|||
145533654|NCT04340193|524813507|FG000|Overall Study|Adverse Event|1|||
145533655|NCT04340193|524813508|FG001|Overall Study|Adverse Event|1|||
145533656|NCT04340193|524813509|FG002|Overall Study|Adverse Event|0|||
145533657|NCT03350620|524813510|FG000|Stage 2|Adverse Event|0|||
145533658|NCT03350620|524813511|FG001|Stage 2|Adverse Event|1|||
145533659|NCT03350620|524813512|FG002|Stage 2|Adverse Event|1|||
145533660|NCT03350620|524813510|FG000|Stage 2|Lack of Efficacy|0|||
145533661|NCT03350620|524813511|FG001|Stage 2|Lack of Efficacy|2|||
145533662|NCT03350620|524813512|FG002|Stage 2|Lack of Efficacy|0|||
145533663|NCT03350620|524813510|FG000|Stage 2|Lost to Follow-up|1|||
145533664|NCT03350620|524813511|FG001|Stage 2|Lost to Follow-up|2|||
145533665|NCT03350620|524813512|FG002|Stage 2|Lost to Follow-up|2|||
145533666|NCT03350620|524813510|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
145533667|NCT03350620|524813511|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
145533668|NCT03350620|524813512|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
145533669|NCT01386008|524813515|FG000|Overall Study|exited w/o incident /study discontinued|17|||
145533670|NCT01386008|524813515|FG000|Overall Study|Adverse Event|3|||
145533671|NCT03001882|524813516|FG000|Overall Study|Death|1|||
145533672|NCT03001882|524813517|FG001|Overall Study|Death|0|||
145533673|NCT03001882|524813518|FG002|Overall Study|Death|0|||
145533674|NCT03001882|524813519|FG003|Overall Study|Death|3|||
145533675|NCT03001882|524813516|FG000|Overall Study|Participant withdrew consent|0|||
145533676|NCT03001882|524813517|FG001|Overall Study|Participant withdrew consent|1|||
145533677|NCT03001882|524813518|FG002|Overall Study|Participant withdrew consent|0|||
145533678|NCT03001882|524813519|FG003|Overall Study|Participant withdrew consent|5|||
145533679|NCT03001882|524813516|FG000|Overall Study|Other reasons|1|||
145533680|NCT03001882|524813517|FG001|Overall Study|Other reasons|2|||
145533681|NCT03001882|524813518|FG002|Overall Study|Other reasons|0|||
145533682|NCT03001882|524813519|FG003|Overall Study|Other reasons|5|||
145533683|NCT03001882|524813516|FG000|Overall Study|Administrative reason by sponsor|0|||
145533684|NCT03001882|524813517|FG001|Overall Study|Administrative reason by sponsor|0|||
145533685|NCT03001882|524813518|FG002|Overall Study|Administrative reason by sponsor|0|||
145533686|NCT03001882|524813519|FG003|Overall Study|Administrative reason by sponsor|1|||
145533687|NCT03001882|524813516|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
145768485|NCT00805207|525658887|FG007|Overall Study|Withdrawal by Subject|0|||
145768486|NCT00805207|525658888|FG008|Overall Study|Withdrawal by Subject|0|||
145768487|NCT00552110|525658889|FG000|Overall Study|Serious or Life-Threatening AE|0|||
145768488|NCT00552110|525658890|FG001|Overall Study|Serious or Life-Threatening AE|0|||
145278015|NCT02164539|523868896|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
145768489|NCT00552110|525658891|FG002|Overall Study|Serious or Life-Threatening AE|1|||
145768490|NCT00552110|525658892|FG003|Overall Study|Serious or Life-Threatening AE|0|||
145768491|NCT00552110|525658893|FG004|Overall Study|Serious or Life-Threatening AE|0|||
145768492|NCT00552110|525658889|FG000|Overall Study|Lack of Efficacy|1|||
145768493|NCT00552110|525658890|FG001|Overall Study|Lack of Efficacy|0|||
145768494|NCT00552110|525658891|FG002|Overall Study|Lack of Efficacy|0|||
145768495|NCT00552110|525658892|FG003|Overall Study|Lack of Efficacy|1|||
145768496|NCT00552110|525658893|FG004|Overall Study|Lack of Efficacy|4|||
145768497|NCT00552110|525658889|FG000|Overall Study|Withdrawal by Subject|0|||
145768498|NCT00552110|525658890|FG001|Overall Study|Withdrawal by Subject|2|||
145768499|NCT00552110|525658891|FG002|Overall Study|Withdrawal by Subject|0|||
145768500|NCT00552110|525658892|FG003|Overall Study|Withdrawal by Subject|3|||
145768501|NCT00552110|525658893|FG004|Overall Study|Withdrawal by Subject|2|||
145768502|NCT00552110|525658889|FG000|Overall Study|Lost to Follow-up|0|||
145768503|NCT00552110|525658890|FG001|Overall Study|Lost to Follow-up|0|||
145768504|NCT00552110|525658891|FG002|Overall Study|Lost to Follow-up|0|||
145768505|NCT00552110|525658892|FG003|Overall Study|Lost to Follow-up|1|||
145768506|NCT00552110|525658893|FG004|Overall Study|Lost to Follow-up|1|||
145768507|NCT00552110|525658889|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
145768508|NCT00552110|525658890|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
145768509|NCT00552110|525658891|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
145768510|NCT00552110|525658892|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
145768511|NCT00552110|525658893|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
145768512|NCT00552110|525658889|FG000|Overall Study|Withdrawn per Sponsor|0|||
145768513|NCT00552110|525658890|FG001|Overall Study|Withdrawn per Sponsor|1|||
145768514|NCT00552110|525658891|FG002|Overall Study|Withdrawn per Sponsor|0|||
145768515|NCT00552110|525658892|FG003|Overall Study|Withdrawn per Sponsor|0|||
145768516|NCT00552110|525658893|FG004|Overall Study|Withdrawn per Sponsor|1|||
145768517|NCT00552110|525658889|FG000|Overall Study|Use of Prohibited Medication|1|||
145768518|NCT00552110|525658890|FG001|Overall Study|Use of Prohibited Medication|1|||
145768519|NCT00552110|525658891|FG002|Overall Study|Use of Prohibited Medication|0|||
145768520|NCT00552110|525658892|FG003|Overall Study|Use of Prohibited Medication|0|||
145768521|NCT00552110|525658893|FG004|Overall Study|Use of Prohibited Medication|0|||
145768522|NCT00552110|525658889|FG000|Overall Study|Delay of Study due to Relabeling|0|||
145768523|NCT00552110|525658890|FG001|Overall Study|Delay of Study due to Relabeling|0|||
145768524|NCT00552110|525658891|FG002|Overall Study|Delay of Study due to Relabeling|0|||
145768525|NCT00552110|525658892|FG003|Overall Study|Delay of Study due to Relabeling|1|||
145768526|NCT00552110|525658893|FG004|Overall Study|Delay of Study due to Relabeling|0|||
145768527|NCT00552110|525658889|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
145768528|NCT00552110|525658890|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
145768529|NCT00552110|525658891|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
145768530|NCT00552110|525658892|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
145768531|NCT00552110|525658893|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
145768532|NCT00552110|525658889|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
145768533|NCT00552110|525658890|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
145768534|NCT00552110|525658891|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
145768535|NCT00552110|525658892|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
145768536|NCT00552110|525658893|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
145768537|NCT02048904|525658902|FG000|Overall Study|Withdrawal by Subject|7|||
145768538|NCT02048904|525658902|FG000|Overall Study|Physician Decision|70|||
145768539|NCT03832387|525658903|FG000|Overall Study|Protocol Violation|2|||
145768540|NCT03832387|525658904|FG001|Overall Study|Protocol Violation|6|||
145768541|NCT03832387|525658903|FG000|Overall Study|EXCLUSION CRITERIA|3|||
145768542|NCT03832387|525658904|FG001|Overall Study|EXCLUSION CRITERIA|1|||
145768543|NCT00490542|525658905|FG000|Overall Study|Lost to Follow-up|3|||
145768544|NCT00490542|525658906|FG001|Overall Study|Lost to Follow-up|0|||
145768545|NCT00490542|525658905|FG000|Overall Study|Adverse Event|3|||
145768546|NCT00490542|525658906|FG001|Overall Study|Adverse Event|3|||
145768547|NCT00490542|525658905|FG000|Overall Study|Lack of Efficacy|1|||
145768548|NCT00490542|525658906|FG001|Overall Study|Lack of Efficacy|1|||
145278016|NCT02164539|523868897|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
145533688|NCT03001882|524813517|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
145533689|NCT03001882|524813518|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
145768549|NCT04640766|525658907|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
145768550|NCT00655928|525658908|FG000|Overall Study|Withdrawal by Subject|2|||
145768551|NCT00655928|525658909|FG001|Overall Study|Withdrawal by Subject|1|||
145768552|NCT00655928|525658908|FG000|Overall Study|Physician Decision|1|||
145768553|NCT00655928|525658909|FG001|Overall Study|Physician Decision|1|||
145768554|NCT02654002|525658911|FG000|Overall Study|Adverse Event|0|||
145768555|NCT02654002|525658912|FG001|Overall Study|Adverse Event|0|||
145768556|NCT02654002|525658913|FG002|Overall Study|Adverse Event|0|||
145768557|NCT02654002|525658914|FG003|Overall Study|Adverse Event|0|||
145768558|NCT02654002|525658915|FG004|Overall Study|Adverse Event|0|||
145768559|NCT02654002|525658916|FG005|Overall Study|Adverse Event|0|||
145768560|NCT02654002|525658917|FG006|Overall Study|Adverse Event|1|||
145768561|NCT02654002|525658918|FG007|Overall Study|Adverse Event|0|||
145768562|NCT02654002|525658919|FG008|Overall Study|Adverse Event|0|||
145768563|NCT02654002|525658911|FG000|Overall Study|Withdrew Consent|0|||
145768564|NCT02654002|525658912|FG001|Overall Study|Withdrew Consent|0|||
145768565|NCT02654002|525658913|FG002|Overall Study|Withdrew Consent|0|||
145768566|NCT02654002|525658914|FG003|Overall Study|Withdrew Consent|0|||
145768567|NCT02654002|525658915|FG004|Overall Study|Withdrew Consent|0|||
145768568|NCT02654002|525658916|FG005|Overall Study|Withdrew Consent|1|||
145768569|NCT02654002|525658917|FG006|Overall Study|Withdrew Consent|0|||
145768570|NCT02654002|525658918|FG007|Overall Study|Withdrew Consent|1|||
145768571|NCT02654002|525658919|FG008|Overall Study|Withdrew Consent|0|||
145768572|NCT01587989|525658920|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
145768573|NCT01587989|525658921|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
145768574|NCT01587989|525658922|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
145768575|NCT01587989|525658920|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
145768576|NCT01587989|525658921|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
145768577|NCT01587989|525658922|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
145768578|NCT01587989|525658920|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
145768579|NCT01587989|525658921|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
145768580|NCT01587989|525658922|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
145768581|NCT01587989|525658920|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
145768582|NCT01587989|525658921|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
145768583|NCT01587989|525658922|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
145768584|NCT01587989|525658920|FG000|Randomized Study Treatment|Screening failure|0|||
145768585|NCT01587989|525658921|FG001|Randomized Study Treatment|Screening failure|1|||
145278017|NCT02164539|523868898|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
145278018|NCT02164539|523868899|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
145278019|NCT02164539|523868900|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
145278020|NCT02164539|523868894|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
145278021|NCT02164539|523868895|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
145278022|NCT02164539|523868896|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
145278023|NCT02164539|523868897|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
145278024|NCT02164539|523868898|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
145278025|NCT02164539|523868899|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
145278026|NCT02164539|523868900|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
145278027|NCT02164539|523868894|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
145533690|NCT03001882|524813519|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
145533691|NCT03001882|524813516|FG000|Overall Study|Not reported|0|||
145533692|NCT03001882|524813517|FG001|Overall Study|Not reported|0|||
145768586|NCT01587989|525658922|FG002|Randomized Study Treatment|Screening failure|0|||
145768587|NCT01587989|525658920|FG000|Randomized Study Treatment|Physician Decision|0|||
145768588|NCT01587989|525658921|FG001|Randomized Study Treatment|Physician Decision|0|||
145768589|NCT01587989|525658922|FG002|Randomized Study Treatment|Physician Decision|1|||
145768590|NCT01291017|525658923|FG000|Overall Study|Lost to Follow-up|2|||
145768591|NCT01291017|525658923|FG000|Overall Study|Withdrawal by Subject|3|||
145768592|NCT06119191|525658924|FG000|Overall Study|Adverse Event|0|||
145768593|NCT06119191|525658925|FG001|Overall Study|Adverse Event|1|||
145768594|NCT06119191|525658924|FG000|Overall Study|Protocol Violation|1|||
145768595|NCT06119191|525658925|FG001|Overall Study|Protocol Violation|0|||
145768596|NCT04030195|525662016|FG000|Overall Study|Withdrawal by Subject|2|||
145768597|NCT04030195|525662017|FG001|Overall Study|Withdrawal by Subject|0|||
145768598|NCT04030195|525662018|FG002|Overall Study|Withdrawal by Subject|0|||
145768599|NCT02109029|525662019|FG000|Part B|Adverse Event|0|||
145768600|NCT02109029|525662020|FG001|Part B|Adverse Event|0|||
145768601|NCT02109029|525662021|FG002|Part B|Adverse Event|0|||
145768602|NCT02109029|525662022|FG003|Part B|Adverse Event|0|||
145768603|NCT02109029|525662023|FG004|Part B|Adverse Event|1|||
145768604|NCT02109029|525662024|FG005|Part B|Adverse Event|1|||
145768605|NCT00260208|525662040|FG000|Overall Study|Subject withdrew consent|11|||
145768606|NCT00260208|525662041|FG001|Overall Study|Subject withdrew consent|7|||
145768607|NCT00260208|525662040|FG000|Overall Study|Lost to Follow-up|6|||
145768608|NCT00260208|525662041|FG001|Overall Study|Lost to Follow-up|1|||
145768609|NCT00260208|525662040|FG000|Overall Study|Death|12|||
145768610|NCT00260208|525662041|FG001|Overall Study|Death|10|||
145768611|NCT00260208|525662040|FG000|Overall Study|Missing|18|||
145768612|NCT00260208|525662041|FG001|Overall Study|Missing|16|||
145768613|NCT02091440|525662042|FG000|Overall Study|Death|2|||
145768614|NCT00768222|525662043|FG000|Overall Study|Lost to Follow-up|1|||
145768615|NCT00768222|525662044|FG001|Overall Study|Lost to Follow-up|1|||
145768616|NCT00768222|525662043|FG000|Overall Study|Withdrawal by Subject|3|||
145768617|NCT00768222|525662044|FG001|Overall Study|Withdrawal by Subject|1|||
145768618|NCT00768222|525662043|FG000|Overall Study|Protocol Violation|0|||
145278028|NCT02164539|523868895|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
145533693|NCT03001882|524813518|FG002|Overall Study|Not reported|0|||
145768619|NCT00768222|525662044|FG001|Overall Study|Protocol Violation|2|||
145768620|NCT03323749|525662051|FG000|Double-blind Period|Lost to Follow-up|4|||
145768621|NCT03323749|525662052|FG001|Double-blind Period|Lost to Follow-up|5|||
145768622|NCT03323749|525662051|FG000|Double-blind Period|Adverse Event|3|||
145768623|NCT03323749|525662052|FG001|Double-blind Period|Adverse Event|1|||
145768624|NCT03323749|525662051|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
145768625|NCT03323749|525662052|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
145768626|NCT03323749|525662051|FG000|Open-Label Period|Adverse Event|3|||
145768627|NCT03323749|525662052|FG001|Open-Label Period|Adverse Event|10|||
145768628|NCT03323749|525662051|FG000|Open-Label Period|Withdrawal by Subject|7|||
145768629|NCT03323749|525662052|FG001|Open-Label Period|Withdrawal by Subject|5|||
145768630|NCT03539432|525662054|FG000|Overall Study|Lost to Follow-up|0|||
145768631|NCT03539432|525662055|FG001|Overall Study|Lost to Follow-up|1|||
145768632|NCT02443402|525662058|FG000|Overall Study|Withdrawal by Subject|3|||
145768633|NCT02443402|525662059|FG001|Overall Study|Withdrawal by Subject|1|||
145768634|NCT02443402|525662058|FG000|Overall Study|Screen Failure|1|||
145768635|NCT02443402|525662059|FG001|Overall Study|Screen Failure|2|||
145768636|NCT01934504|525662063|FG000|Overall Study|Protocol Deviation|0|||
145768637|NCT01934504|525662064|FG001|Overall Study|Protocol Deviation|0|||
145768638|NCT01934504|525662065|FG002|Overall Study|Protocol Deviation|0|||
145768639|NCT01934504|525662066|FG003|Overall Study|Protocol Deviation|2|||
145768640|NCT01934504|525662063|FG000|Overall Study|Study Terminated by Sponsor|1|||
145768641|NCT01934504|525662064|FG001|Overall Study|Study Terminated by Sponsor|0|||
145768642|NCT01934504|525662065|FG002|Overall Study|Study Terminated by Sponsor|5|||
145768643|NCT01934504|525662066|FG003|Overall Study|Study Terminated by Sponsor|5|||
145768644|NCT02665689|525662073|FG000|Overall Study|Adverse Event|1|||
145768645|NCT02665689|525662074|FG001|Overall Study|Adverse Event|0|||
145768646|NCT02665689|525662073|FG000|Overall Study|Trial termination|1|||
145768647|NCT02665689|525662074|FG001|Overall Study|Trial termination|1|||
145768648|NCT02665689|525662073|FG000|Overall Study|Lost to Follow-up|0|||
145768649|NCT02665689|525662074|FG001|Overall Study|Lost to Follow-up|1|||
145768650|NCT04125680|525662085|FG000|Overall Study|Lost to Follow-up|15|||
145768651|NCT04938648|525662086|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
145768652|NCT04938648|525662087|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
145768653|NCT04938648|525662086|FG000|Overall Study|Patient too ill|0|||
145768654|NCT04938648|525662087|FG001|Overall Study|Patient too ill|1|||
145768655|NCT04938648|525662086|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
145768656|NCT04938648|525662087|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
145768657|NCT04938648|525662086|FG000|Overall Study|Patient did not have memory problems|1|||
145768658|NCT04938648|525662087|FG001|Overall Study|Patient did not have memory problems|1|||
145768659|NCT04938648|525662086|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
145768660|NCT04938648|525662087|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
145768661|NCT04938648|525662086|FG000|Overall Study|Care partner could not be reached|0|||
145278029|NCT02164539|523868896|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
145278030|NCT02164539|523868897|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
145278031|NCT02164539|523868898|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
145278032|NCT02164539|523868899|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
145278033|NCT02164539|523868900|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
145278034|NCT02164539|523868894|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
145278035|NCT02164539|523868895|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145278036|NCT02164539|523868896|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145278037|NCT02164539|523868897|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145278038|NCT02164539|523868898|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145278039|NCT02164539|523868899|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145278040|NCT02164539|523868900|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
145403173|NCT00997893|524334315|FG000|Overall Study|Adverse Event|1|||
145403174|NCT00997893|524334316|FG001|Overall Study|Adverse Event|0|||
145533694|NCT03001882|524813519|FG003|Overall Study|Not reported|6|||
145533695|NCT03001882|524813516|FG000|Overall Study|Maximum clinical benefit|2|||
145533696|NCT03001882|524813517|FG001|Overall Study|Maximum clinical benefit|3|||
145533697|NCT03001882|524813518|FG002|Overall Study|Maximum clinical benefit|0|||
145768662|NCT04938648|525662087|FG001|Overall Study|Care partner could not be reached|1|||
145768663|NCT04938648|525662086|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
145768664|NCT04938648|525662087|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
145768665|NCT04938648|525662086|FG000|Overall Study|Withdrawal by Subject|2|||
145768666|NCT04938648|525662087|FG001|Overall Study|Withdrawal by Subject|1|||
145278041|NCT02164539|523868894|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
145278042|NCT02164539|523868895|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
145533698|NCT03001882|524813519|FG003|Overall Study|Maximum clinical benefit|10|||
145768667|NCT00364793|525662088|FG000|Overall Study|Adverse Event|2|||
145768668|NCT00364793|525662089|FG001|Overall Study|Adverse Event|0|||
145768669|NCT00364793|525662090|FG002|Overall Study|Adverse Event|0|||
145533699|NCT03001882|524813516|FG000|Overall Study|AE unrelated to study drug|3|||
145768670|NCT00364793|525662091|FG003|Overall Study|Adverse Event|0|||
145768671|NCT00364793|525662088|FG000|Overall Study|Death|1|||
145768672|NCT00364793|525662089|FG001|Overall Study|Death|0|||
145768673|NCT00364793|525662090|FG002|Overall Study|Death|1|||
145768674|NCT00364793|525662091|FG003|Overall Study|Death|0|||
145768675|NCT00364793|525662088|FG000|Overall Study|Lack of Efficacy|3|||
145768676|NCT00364793|525662089|FG001|Overall Study|Lack of Efficacy|3|||
145768677|NCT00364793|525662090|FG002|Overall Study|Lack of Efficacy|1|||
145768678|NCT00364793|525662091|FG003|Overall Study|Lack of Efficacy|1|||
145768679|NCT00364793|525662088|FG000|Overall Study|Lost to Follow-up|1|||
145768680|NCT00364793|525662089|FG001|Overall Study|Lost to Follow-up|0|||
145768681|NCT00364793|525662090|FG002|Overall Study|Lost to Follow-up|2|||
145768682|NCT00364793|525662091|FG003|Overall Study|Lost to Follow-up|0|||
145768683|NCT00364793|525662088|FG000|Overall Study|Poor or non-compliance|1|||
145768684|NCT00364793|525662089|FG001|Overall Study|Poor or non-compliance|1|||
145768685|NCT00364793|525662090|FG002|Overall Study|Poor or non-compliance|0|||
145768686|NCT00364793|525662091|FG003|Overall Study|Poor or non-compliance|1|||
145768687|NCT00364793|525662088|FG000|Overall Study|No longer meets criteria|0|||
145768688|NCT00364793|525662089|FG001|Overall Study|No longer meets criteria|0|||
145768689|NCT00364793|525662090|FG002|Overall Study|No longer meets criteria|0|||
145768690|NCT00364793|525662091|FG003|Overall Study|No longer meets criteria|1|||
145768691|NCT00364793|525662088|FG000|Overall Study|Withdrawal by Subject|0|||
145768692|NCT00364793|525662089|FG001|Overall Study|Withdrawal by Subject|1|||
145768693|NCT00364793|525662090|FG002|Overall Study|Withdrawal by Subject|0|||
145768694|NCT00364793|525662091|FG003|Overall Study|Withdrawal by Subject|0|||
145768695|NCT00049127|525662092|FG000|Overall Study|Withdrawal by Subject|0|||
145768696|NCT00049127|525662093|FG001|Overall Study|Withdrawal by Subject|0|||
145768697|NCT00049127|525662094|FG002|Overall Study|Withdrawal by Subject|1|||
145768698|NCT00049127|525662095|FG003|Overall Study|Withdrawal by Subject|0|||
145768699|NCT00049127|525662096|FG004|Overall Study|Withdrawal by Subject|0|||
145768700|NCT01287754|525662099|FG000|Overall Study|Death|2|||
145768701|NCT01287754|525662100|FG001|Overall Study|Death|12|||
145768702|NCT01287754|525662099|FG000|Overall Study|Lost to Follow-up|1|||
145768703|NCT01287754|525662100|FG001|Overall Study|Lost to Follow-up|6|||
145768704|NCT01287754|525662099|FG000|Overall Study|Protocol Violation|0|||
145768705|NCT01287754|525662100|FG001|Overall Study|Protocol Violation|3|||
145768706|NCT00001337|525662111|FG000|Overall Study|Switched to alternate treatment|2|||
145768707|NCT00001337|525662112|FG001|Overall Study|Switched to alternate treatment|2|||
145768708|NCT00001337|525662113|FG002|Overall Study|Switched to alternate treatment|0|||
145768709|NCT00001337|525662111|FG000|Overall Study|Refused further treatment|2|||
145768710|NCT00001337|525662112|FG001|Overall Study|Refused further treatment|1|||
145768711|NCT00001337|525662113|FG002|Overall Study|Refused further treatment|0|||
145768712|NCT00001337|525662111|FG000|Overall Study|Began other Tx|1|||
145768713|NCT00001337|525662112|FG001|Overall Study|Began other Tx|0|||
145768714|NCT00001337|525662113|FG002|Overall Study|Began other Tx|0|||
145768715|NCT00001337|525662111|FG000|Overall Study|Physician Decision|3|||
145768716|NCT00001337|525662112|FG001|Overall Study|Physician Decision|1|||
145768717|NCT00001337|525662113|FG002|Overall Study|Physician Decision|0|||
145768718|NCT00001337|525662111|FG000|Overall Study|Doesn't have NHL|0|||
145768719|NCT00001337|525662112|FG001|Overall Study|Doesn't have NHL|1|||
145768720|NCT00001337|525662113|FG002|Overall Study|Doesn't have NHL|0|||
145768721|NCT00001337|525662111|FG000|Overall Study|Non protocol tx needed|3|||
145768722|NCT00001337|525662112|FG001|Overall Study|Non protocol tx needed|1|||
145768723|NCT00001337|525662113|FG002|Overall Study|Non protocol tx needed|0|||
145533700|NCT03001882|524813517|FG001|Overall Study|AE unrelated to study drug|3|||
145533701|NCT03001882|524813518|FG002|Overall Study|AE unrelated to study drug|0|||
145533702|NCT03001882|524813519|FG003|Overall Study|AE unrelated to study drug|11|||
145533703|NCT03001882|524813516|FG000|Overall Study|Study Drug Toxicity|8|||
145768724|NCT00001337|525662111|FG000|Overall Study|Protocol change|1|||
145768725|NCT00001337|525662112|FG001|Overall Study|Protocol change|0|||
145768726|NCT00001337|525662113|FG002|Overall Study|Protocol change|0|||
145768727|NCT00001337|525662111|FG000|Overall Study|2nd primary disease|0|||
145533704|NCT03001882|524813517|FG001|Overall Study|Study Drug Toxicity|5|||
145768728|NCT00001337|525662112|FG001|Overall Study|2nd primary disease|0|||
145768729|NCT00001337|525662113|FG002|Overall Study|2nd primary disease|1|||
145768730|NCT00001337|525662111|FG000|Overall Study|Death during follow up period|9|||
145768731|NCT00001337|525662112|FG001|Overall Study|Death during follow up period|4|||
145768732|NCT00001337|525662113|FG002|Overall Study|Death during follow up period|0|||
145768733|NCT00001337|525662111|FG000|Overall Study|Death on study|19|||
145768734|NCT00001337|525662112|FG001|Overall Study|Death on study|9|||
145768735|NCT00001337|525662113|FG002|Overall Study|Death on study|0|||
145768736|NCT00001337|525662111|FG000|Overall Study|Disease progression during follow-up period|3|||
145768737|NCT00001337|525662112|FG001|Overall Study|Disease progression during follow-up period|1|||
145768738|NCT00001337|525662113|FG002|Overall Study|Disease progression during follow-up period|0|||
145768739|NCT00001337|525662111|FG000|Overall Study|Disease progression on study|33|||
145768740|NCT00001337|525662112|FG001|Overall Study|Disease progression on study|41|||
145533705|NCT03001882|524813518|FG002|Overall Study|Study Drug Toxicity|0|||
145768741|NCT00001337|525662113|FG002|Overall Study|Disease progression on study|0|||
145768742|NCT00001337|525662111|FG000|Overall Study|Lost to further follow-up|10|||
145768743|NCT00001337|525662112|FG001|Overall Study|Lost to further follow-up|6|||
145768744|NCT00001337|525662113|FG002|Overall Study|Lost to further follow-up|0|||
145768745|NCT00001337|525662111|FG000|Overall Study|2nd malignancy|1|||
145768746|NCT00001337|525662112|FG001|Overall Study|2nd malignancy|0|||
145768747|NCT00001337|525662113|FG002|Overall Study|2nd malignancy|0|||
145768748|NCT00001337|525662111|FG000|Overall Study|Treatment for second lymphoma|0|||
145768749|NCT00001337|525662112|FG001|Overall Study|Treatment for second lymphoma|1|||
145768750|NCT00001337|525662113|FG002|Overall Study|Treatment for second lymphoma|0|||
145768751|NCT00001337|525662111|FG000|Overall Study|Transfer to transplant|0|||
145768752|NCT00001337|525662112|FG001|Overall Study|Transfer to transplant|1|||
145768753|NCT00001337|525662113|FG002|Overall Study|Transfer to transplant|0|||
145768754|NCT04889209|525662116|FG000|All Cohorts Except 15E|Adverse Event|0|||
145768755|NCT04889209|525662117|FG001|All Cohorts Except 15E|Adverse Event|0|||
145768756|NCT04889209|525662118|FG002|All Cohorts Except 15E|Adverse Event|0|||
145768757|NCT04889209|525662119|FG003|All Cohorts Except 15E|Adverse Event|0|||
145768758|NCT04889209|525662120|FG004|All Cohorts Except 15E|Adverse Event|0|||
145768759|NCT04889209|525662121|FG005|All Cohorts Except 15E|Adverse Event|0|||
145768760|NCT04889209|525662122|FG006|All Cohorts Except 15E|Adverse Event|1|||
145768761|NCT04889209|525662123|FG007|All Cohorts Except 15E|Adverse Event|0|||
145768762|NCT04889209|525662124|FG008|All Cohorts Except 15E|Adverse Event|0|||
145768763|NCT04889209|525662125|FG009|All Cohorts Except 15E|Adverse Event|0|||
145768764|NCT04889209|525662126|FG010|All Cohorts Except 15E|Adverse Event|0|||
145768765|NCT04889209|525662127|FG011|All Cohorts Except 15E|Adverse Event|0|||
145768766|NCT04889209|525662128|FG012|All Cohorts Except 15E|Adverse Event|0|||
145768767|NCT04889209|525662129|FG013|All Cohorts Except 15E|Adverse Event|0|||
145768768|NCT04889209|525662130|FG014|All Cohorts Except 15E|Adverse Event|0|||
145768769|NCT04889209|525662131|FG015|All Cohorts Except 15E|Adverse Event|0|||
145768770|NCT04889209|525662132|FG016|All Cohorts Except 15E|Adverse Event|0|||
145768771|NCT04889209|525662133|FG017|All Cohorts Except 15E|Adverse Event|0|||
145768772|NCT04889209|525662116|FG000|All Cohorts Except 15E|Death|0|||
145768773|NCT04889209|525662117|FG001|All Cohorts Except 15E|Death|1|||
145768774|NCT04889209|525662118|FG002|All Cohorts Except 15E|Death|0|||
145768775|NCT04889209|525662119|FG003|All Cohorts Except 15E|Death|0|||
145768776|NCT04889209|525662120|FG004|All Cohorts Except 15E|Death|0|||
145768777|NCT04889209|525662121|FG005|All Cohorts Except 15E|Death|0|||
145768778|NCT04889209|525662122|FG006|All Cohorts Except 15E|Death|0|||
145768779|NCT04889209|525662123|FG007|All Cohorts Except 15E|Death|0|||
145768780|NCT04889209|525662124|FG008|All Cohorts Except 15E|Death|0|||
145768781|NCT04889209|525662125|FG009|All Cohorts Except 15E|Death|0|||
145768782|NCT04889209|525662126|FG010|All Cohorts Except 15E|Death|0|||
145768783|NCT04889209|525662127|FG011|All Cohorts Except 15E|Death|0|||
145768784|NCT04889209|525662128|FG012|All Cohorts Except 15E|Death|0|||
145768785|NCT04889209|525662129|FG013|All Cohorts Except 15E|Death|0|||
145768786|NCT04889209|525662130|FG014|All Cohorts Except 15E|Death|0|||
145768787|NCT04889209|525662131|FG015|All Cohorts Except 15E|Death|0|||
145768788|NCT04889209|525662132|FG016|All Cohorts Except 15E|Death|0|||
145768789|NCT04889209|525662133|FG017|All Cohorts Except 15E|Death|0|||
145768790|NCT04889209|525662116|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
145768791|NCT04889209|525662117|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
145768792|NCT04889209|525662118|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
145768793|NCT04889209|525662119|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
145768794|NCT04889209|525662120|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
145768795|NCT04889209|525662121|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
145768796|NCT04889209|525662122|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
145768797|NCT04889209|525662123|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
145768798|NCT04889209|525662124|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
145768799|NCT04889209|525662125|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
145768800|NCT04889209|525662126|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
145768801|NCT04889209|525662127|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
145768802|NCT04889209|525662128|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
145768803|NCT04889209|525662129|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
145768804|NCT04889209|525662130|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
145768805|NCT04889209|525662131|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
145768806|NCT04889209|525662132|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
145768807|NCT04889209|525662133|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
145768808|NCT04889209|525662116|FG000|All Cohorts Except 15E|Physician Decision|0|||
145768809|NCT04889209|525662117|FG001|All Cohorts Except 15E|Physician Decision|0|||
145768810|NCT04889209|525662118|FG002|All Cohorts Except 15E|Physician Decision|0|||
145768811|NCT04889209|525662119|FG003|All Cohorts Except 15E|Physician Decision|0|||
145768812|NCT04889209|525662120|FG004|All Cohorts Except 15E|Physician Decision|1|||
145768813|NCT04889209|525662121|FG005|All Cohorts Except 15E|Physician Decision|0|||
145768814|NCT04889209|525662122|FG006|All Cohorts Except 15E|Physician Decision|0|||
145768815|NCT04889209|525662123|FG007|All Cohorts Except 15E|Physician Decision|1|||
145768816|NCT04889209|525662124|FG008|All Cohorts Except 15E|Physician Decision|0|||
145768817|NCT04889209|525662125|FG009|All Cohorts Except 15E|Physician Decision|1|||
145768818|NCT04889209|525662126|FG010|All Cohorts Except 15E|Physician Decision|0|||
145768819|NCT04889209|525662127|FG011|All Cohorts Except 15E|Physician Decision|1|||
145768820|NCT04889209|525662128|FG012|All Cohorts Except 15E|Physician Decision|1|||
145768821|NCT04889209|525662129|FG013|All Cohorts Except 15E|Physician Decision|0|||
145768822|NCT04889209|525662130|FG014|All Cohorts Except 15E|Physician Decision|0|||
145768823|NCT04889209|525662131|FG015|All Cohorts Except 15E|Physician Decision|0|||
145768824|NCT04889209|525662132|FG016|All Cohorts Except 15E|Physician Decision|0|||
145768825|NCT04889209|525662133|FG017|All Cohorts Except 15E|Physician Decision|0|||
145768826|NCT04889209|525662116|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
145768827|NCT04889209|525662117|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
145768828|NCT04889209|525662118|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
145768829|NCT04889209|525662119|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
145768830|NCT04889209|525662120|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
145768831|NCT04889209|525662121|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768832|NCT04889209|525662122|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768833|NCT04889209|525662123|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
145768834|NCT04889209|525662124|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768835|NCT04889209|525662125|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768836|NCT04889209|525662126|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768837|NCT04889209|525662127|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768838|NCT04889209|525662128|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768839|NCT04889209|525662129|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
145768840|NCT04889209|525662130|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
145768841|NCT04889209|525662131|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
145768842|NCT04889209|525662132|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
145768843|NCT04889209|525662133|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
145768844|NCT04889209|525662116|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
145278043|NCT02164539|523868896|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
145278044|NCT02164539|523868897|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
145278045|NCT02164539|523868898|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
145278046|NCT02164539|523868899|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
145278047|NCT02164539|523868900|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
145533706|NCT03001882|524813519|FG003|Overall Study|Study Drug Toxicity|37|||
145533707|NCT03001882|524813516|FG000|Overall Study|Disease progression|16|||
145278048|NCT02164539|523868894|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
145278049|NCT02164539|523868895|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
145278050|NCT02164539|523868896|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
145278051|NCT02164539|523868897|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
145278052|NCT02164539|523868898|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
145278053|NCT02164539|523868899|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
145278054|NCT02164539|523868900|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
145278055|NCT02643966|523868901|FG000|First Screening Round|ineligible|1|||
145278056|NCT02643966|523868901|FG000|First Screening Round|excluded from analysis|2|||
145278057|NCT02643966|523868901|FG000|First Screening Round|Lost to Follow-up|56|||
145278058|NCT02643966|523868901|FG000|First Screening Round|Withdrawal by Subject|28|||
145278059|NCT02643966|523868901|FG000|First Screening Round|Death|1|||
145278060|NCT02643966|523868901|FG000|Between First and Second Screening|Lost to Follow-up|65|||
145278061|NCT02643966|523868901|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
145278062|NCT02643966|523868901|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
145278063|NCT02643966|523868901|FG000|Second Screening Round|Withdrawal by Subject|20|||
145278064|NCT02643966|523868901|FG000|Second Screening Round|Lost to Follow-up|57|||
145278065|NCT02643966|523868901|FG000|Second Screening Round|Physician Decision|2|||
145533708|NCT03001882|524813517|FG001|Overall Study|Disease progression|14|||
145278066|NCT02643966|523868901|FG000|Second Screening Round|Death|4|||
145768845|NCT04889209|525662117|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
145768846|NCT04889209|525662118|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768847|NCT04889209|525662119|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768848|NCT04889209|525662120|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145533709|NCT03001882|524813518|FG002|Overall Study|Disease progression|1|||
145278067|NCT02643966|523868901|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
145278068|NCT02643966|523868901|FG000|Between Second and Third Screening|Death|1|||
145768849|NCT04889209|525662121|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
145768850|NCT04889209|525662122|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768851|NCT04889209|525662123|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
145768852|NCT04889209|525662124|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768853|NCT04889209|525662125|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
145768854|NCT04889209|525662126|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768855|NCT04889209|525662127|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768856|NCT04889209|525662128|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768857|NCT04889209|525662129|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768858|NCT04889209|525662130|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768859|NCT04889209|525662131|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768860|NCT04889209|525662132|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
145768861|NCT04889209|525662133|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
145768862|NCT04889209|525662116|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768863|NCT04889209|525662117|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768864|NCT04889209|525662118|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768865|NCT04889209|525662119|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
145768866|NCT04889209|525662120|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768867|NCT04889209|525662121|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768868|NCT04889209|525662122|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768869|NCT04889209|525662123|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768870|NCT04889209|525662124|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768871|NCT04889209|525662125|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768872|NCT04889209|525662126|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768873|NCT04889209|525662127|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768874|NCT04889209|525662128|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145607993|NCT03389477|525079308|FG000|Step 2|Poor performance status and nutrition|0|||
145768875|NCT04889209|525662129|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768876|NCT04889209|525662130|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768877|NCT04889209|525662131|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768878|NCT04889209|525662132|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768879|NCT04889209|525662133|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
145768880|NCT04889209|525662116|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768881|NCT04889209|525662117|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768882|NCT04889209|525662118|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768883|NCT04889209|525662119|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768884|NCT04889209|525662120|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768885|NCT04889209|525662121|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768886|NCT04889209|525662122|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768887|NCT04889209|525662123|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768888|NCT04889209|525662124|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768889|NCT04889209|525662125|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768890|NCT04889209|525662126|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768891|NCT04889209|525662127|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768892|NCT04889209|525662128|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768893|NCT04889209|525662129|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768894|NCT04889209|525662130|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768895|NCT04889209|525662131|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768896|NCT04889209|525662132|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
145768897|NCT04889209|525662133|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
145768898|NCT04889209|525662116|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768899|NCT04889209|525662117|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768900|NCT04889209|525662118|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768901|NCT04889209|525662119|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145278069|NCT02643966|523868901|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
145768902|NCT04889209|525662120|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768903|NCT04889209|525662121|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768904|NCT04889209|525662122|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768905|NCT04889209|525662123|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768906|NCT04889209|525662124|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768907|NCT04889209|525662125|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768908|NCT04889209|525662126|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768909|NCT04889209|525662127|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768910|NCT04889209|525662128|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768911|NCT04889209|525662129|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768912|NCT04889209|525662130|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768913|NCT04889209|525662131|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768914|NCT04889209|525662132|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
145768915|NCT04889209|525662133|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
145768916|NCT04889209|525662116|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768917|NCT04889209|525662117|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768918|NCT04889209|525662118|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768919|NCT04889209|525662119|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768920|NCT04889209|525662120|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768921|NCT04889209|525662121|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768922|NCT04889209|525662122|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768923|NCT04889209|525662123|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768924|NCT04889209|525662124|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768925|NCT04889209|525662125|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768926|NCT04889209|525662126|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768927|NCT04889209|525662127|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768928|NCT04889209|525662128|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768929|NCT04889209|525662129|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768930|NCT04889209|525662130|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768931|NCT04889209|525662131|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768932|NCT04889209|525662132|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
145768933|NCT04889209|525662133|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
145768934|NCT04889209|525662116|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768935|NCT04889209|525662117|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768936|NCT04889209|525662118|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768937|NCT04889209|525662119|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768938|NCT04889209|525662120|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768939|NCT04889209|525662121|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768940|NCT04889209|525662122|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768941|NCT04889209|525662123|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768942|NCT04889209|525662124|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768943|NCT04889209|525662125|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768944|NCT04889209|525662126|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768945|NCT04889209|525662127|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145278070|NCT02643966|523868901|FG000|Third Screening Round|PI excluded|2|||
145278071|NCT02643966|523868901|FG000|Third Screening Round|Lost to Follow-up|241|||
145768946|NCT04889209|525662128|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768947|NCT04889209|525662129|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768948|NCT04889209|525662130|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
145278072|NCT01612702|523868902|FG000|Overall Study|Protocol Violation|11|||
145278073|NCT01612702|523868903|FG001|Overall Study|Protocol Violation|11|||
145278074|NCT03070431|523868904|FG000|Overall Study|Withdrawal by Subject|2|||
145278075|NCT03070431|523868904|FG000|Overall Study|Lost to Follow-up|2|||
145278076|NCT01542736|523868905|FG000|Overall Study|Death|1|||
145278077|NCT03674827|523868906|FG000|Treatment Phase|Adverse Event|0|||
145278078|NCT03674827|523868907|FG001|Treatment Phase|Adverse Event|0|||
145278079|NCT03674827|523868908|FG002|Treatment Phase|Adverse Event|0|||
145278080|NCT03674827|523868909|FG003|Treatment Phase|Adverse Event|0|||
145533710|NCT03001882|524813519|FG003|Overall Study|Disease progression|90|||
145533711|NCT04449861|524813520|FG000|Overall Study|Withdrawal by Subject|4|||
145533712|NCT04449861|524813520|FG000|Overall Study|Lost to Follow-up|5|||
145533713|NCT04449861|524813520|FG000|Overall Study|Death|112|||
145278081|NCT03674827|523868910|FG004|Treatment Phase|Adverse Event|0|||
145278082|NCT03674827|523868911|FG005|Treatment Phase|Adverse Event|2|||
145278083|NCT03674827|523868906|FG000|Treatment Phase|Death|2|||
145533714|NCT05268055|524813521|FG000|Overall Study|Lost to Follow-up|68|||
145533715|NCT05268055|524813522|FG001|Overall Study|Lost to Follow-up|68|||
145278084|NCT03674827|523868907|FG001|Treatment Phase|Death|0|||
145768949|NCT04889209|525662131|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768950|NCT04889209|525662132|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768951|NCT04889209|525662133|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
145768952|NCT04607408|525662134|FG000|Overall Study|Lost to Follow-up|0|||
145768953|NCT04607408|525662135|FG001|Overall Study|Lost to Follow-up|0|||
145768954|NCT04607408|525662136|FG002|Overall Study|Lost to Follow-up|0|||
145768955|NCT04607408|525662137|FG003|Overall Study|Lost to Follow-up|1|||
145768956|NCT04607408|525662138|FG004|Overall Study|Lost to Follow-up|0|||
145768957|NCT04607408|525662134|FG000|Overall Study|Withdrawal by Subject|0|||
145768958|NCT04607408|525662135|FG001|Overall Study|Withdrawal by Subject|1|||
145768959|NCT04607408|525662136|FG002|Overall Study|Withdrawal by Subject|0|||
145768960|NCT04607408|525662137|FG003|Overall Study|Withdrawal by Subject|1|||
145768961|NCT04607408|525662138|FG004|Overall Study|Withdrawal by Subject|0|||
145768962|NCT01725165|525662141|FG000|Overall Study|Death|11|||
145768963|NCT01725165|525662142|FG001|Overall Study|Death|18|||
145768964|NCT03619213|525662143|FG000|Overall Study|Lost to Follow-up|2|||
145768965|NCT03619213|525662144|FG001|Overall Study|Lost to Follow-up|1|||
145768966|NCT03619213|525662143|FG000|Overall Study|Withdrawal by Subject|8|||
145768967|NCT03619213|525662144|FG001|Overall Study|Withdrawal by Subject|10|||
145768968|NCT03093402|525662145|FG000|Overall Study|Lost to Follow-up|1|||
145768969|NCT03093402|525662146|FG001|Overall Study|Lost to Follow-up|0|||
145768970|NCT03093402|525662147|FG002|Overall Study|Lost to Follow-up|0|||
145768971|NCT03093402|525662148|FG003|Overall Study|Lost to Follow-up|0|||
145768972|NCT03093402|525662145|FG000|Overall Study|Withdrawal by Subject|3|||
145768973|NCT03093402|525662146|FG001|Overall Study|Withdrawal by Subject|3|||
145768974|NCT03093402|525662147|FG002|Overall Study|Withdrawal by Subject|0|||
145768975|NCT03093402|525662148|FG003|Overall Study|Withdrawal by Subject|1|||
145768976|NCT03093402|525662145|FG000|Overall Study|Withdrew prior to dosing|2|||
145768977|NCT03093402|525662146|FG001|Overall Study|Withdrew prior to dosing|1|||
145768978|NCT03093402|525662147|FG002|Overall Study|Withdrew prior to dosing|2|||
145768979|NCT03093402|525662148|FG003|Overall Study|Withdrew prior to dosing|3|||
145768980|NCT03093402|525662145|FG000|Overall Study|Ineligible for study|1|||
145768981|NCT03093402|525662146|FG001|Overall Study|Ineligible for study|0|||
145768982|NCT03093402|525662147|FG002|Overall Study|Ineligible for study|0|||
145768983|NCT03093402|525662148|FG003|Overall Study|Ineligible for study|0|||
145768984|NCT03093402|525662145|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
145768985|NCT03093402|525662146|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
145768986|NCT03093402|525662147|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
145768987|NCT03093402|525662148|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
145768988|NCT02886702|525662149|FG000|Overall Study|Other|4|||
145768989|NCT02886702|525662150|FG001|Overall Study|Other|3|||
145768990|NCT02886702|525662151|FG002|Overall Study|Other|9|||
145768991|NCT02886702|525662149|FG000|Overall Study|Withdrawal by Subject|24|||
145768992|NCT02886702|525662150|FG001|Overall Study|Withdrawal by Subject|18|||
145768993|NCT02886702|525662151|FG002|Overall Study|Withdrawal by Subject|22|||
145768994|NCT02886702|525662149|FG000|Overall Study|Significant Worsening of Condition|0|||
145768995|NCT02886702|525662150|FG001|Overall Study|Significant Worsening of Condition|1|||
145768996|NCT02886702|525662151|FG002|Overall Study|Significant Worsening of Condition|0|||
145768997|NCT02886702|525662149|FG000|Overall Study|Protocol Violation|2|||
145768998|NCT02886702|525662150|FG001|Overall Study|Protocol Violation|2|||
145768999|NCT02886702|525662151|FG002|Overall Study|Protocol Violation|1|||
145769000|NCT02886702|525662149|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145769001|NCT02886702|525662150|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145769002|NCT02886702|525662151|FG002|Overall Study|Non-Compliance With Study Drug|4|||
145769003|NCT02886702|525662149|FG000|Overall Study|Lost to Follow-up|11|||
145769004|NCT02886702|525662150|FG001|Overall Study|Lost to Follow-up|13|||
145769005|NCT02886702|525662151|FG002|Overall Study|Lost to Follow-up|8|||
145769006|NCT02886702|525662149|FG000|Overall Study|Lack of Efficacy|3|||
145533716|NCT05268055|524813521|FG000|Overall Study|Withdrawal by Subject|12|||
145533717|NCT05268055|524813522|FG001|Overall Study|Withdrawal by Subject|8|||
145533718|NCT03507400|524813523|FG000|Overall Study|discontinued|5|||
145533719|NCT03507400|524813524|FG001|Overall Study|discontinued|1|||
145533720|NCT03507400|524813523|FG000|Overall Study|Lost to Follow-up|8|||
145769007|NCT02886702|525662150|FG001|Overall Study|Lack of Efficacy|4|||
145769008|NCT02886702|525662151|FG002|Overall Study|Lack of Efficacy|5|||
145769009|NCT02886702|525662149|FG000|Overall Study|Adverse Event|4|||
145769010|NCT02886702|525662150|FG001|Overall Study|Adverse Event|9|||
145769011|NCT02886702|525662151|FG002|Overall Study|Adverse Event|3|||
145533721|NCT03507400|524813524|FG001|Overall Study|Lost to Follow-up|6|||
145769012|NCT02886702|525662149|FG000|Overall Study|Administrative Reasons|0|||
145769013|NCT02886702|525662150|FG001|Overall Study|Administrative Reasons|0|||
145769014|NCT02886702|525662151|FG002|Overall Study|Administrative Reasons|1|||
145769015|NCT01147497|525662156|FG000|Overall Study|failed insertion|2|||
145769016|NCT01147497|525662157|FG001|Overall Study|failed insertion|0|||
145769017|NCT04026568|525662162|FG000|Overall Study|study terminated|0|||
145769018|NCT04026568|525662163|FG001|Overall Study|study terminated|1|||
145769019|NCT02786901|525662164|FG000|Overall Study|Adverse Event|1|||
145769020|NCT02786901|525662165|FG001|Overall Study|Adverse Event|1|||
145769021|NCT02786901|525662166|FG002|Overall Study|Adverse Event|2|||
145769022|NCT02786901|525662164|FG000|Overall Study|Physician Decision|1|||
145769023|NCT02786901|525662165|FG001|Overall Study|Physician Decision|0|||
145769024|NCT02786901|525662166|FG002|Overall Study|Physician Decision|0|||
145769025|NCT02786901|525662164|FG000|Overall Study|Rescue Therapy Use|71|||
145769026|NCT02786901|525662165|FG001|Overall Study|Rescue Therapy Use|49|||
145769027|NCT02786901|525662166|FG002|Overall Study|Rescue Therapy Use|33|||
145769028|NCT02786901|525662164|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
145769029|NCT02786901|525662165|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
145769030|NCT02786901|525662166|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
145769031|NCT02786901|525662164|FG000|Overall Study|Disallowed medication|1|||
145769032|NCT02786901|525662165|FG001|Overall Study|Disallowed medication|1|||
145769033|NCT02786901|525662166|FG002|Overall Study|Disallowed medication|0|||
145769034|NCT02786901|525662164|FG000|Overall Study|Randomized in error|2|||
145769035|NCT02786901|525662165|FG001|Overall Study|Randomized in error|0|||
145769036|NCT02786901|525662166|FG002|Overall Study|Randomized in error|1|||
145769037|NCT00684814|525662171|FG000|Washout Period of 7 Days|Adverse Event|1|||
145769038|NCT00684814|525662172|FG001|Washout Period of 7 Days|Adverse Event|2|||
145769039|NCT00684814|525662171|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
145769040|NCT00684814|525662172|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
145769041|NCT00684814|525662171|FG000|Second Intervention|Adverse Event|1|||
145769042|NCT00684814|525662172|FG001|Second Intervention|Adverse Event|0|||
145769043|NCT03168867|525662173|FG000|Overall Study|Withdrawal by Subject|1|||
145769044|NCT03168867|525662174|FG001|Overall Study|Withdrawal by Subject|5|||
145769045|NCT04348851|525662175|FG000|Post-Test 1|Withdrawal by Subject|0|||
145769046|NCT04348851|525662176|FG001|Post-Test 1|Withdrawal by Subject|1|||
145769047|NCT04348851|525662177|FG002|Post-Test 1|Withdrawal by Subject|0|||
145769048|NCT04348851|525662178|FG003|Post-Test 1|Withdrawal by Subject|0|||
145769049|NCT04348851|525662175|FG000|Post-Test 1|Lost to Follow-up|0|||
145769050|NCT04348851|525662176|FG001|Post-Test 1|Lost to Follow-up|1|||
145769051|NCT04348851|525662177|FG002|Post-Test 1|Lost to Follow-up|0|||
145769052|NCT04348851|525662178|FG003|Post-Test 1|Lost to Follow-up|0|||
145769053|NCT04348851|525662175|FG000|Post-Test 2|Stroke survivor death|0|||
145769054|NCT04348851|525662176|FG001|Post-Test 2|Stroke survivor death|1|||
145769055|NCT04348851|525662177|FG002|Post-Test 2|Stroke survivor death|0|||
145769056|NCT04348851|525662178|FG003|Post-Test 2|Stroke survivor death|1|||
145769057|NCT00195650|525662179|FG000|Overall Study|Adverse Event|194|||
145769058|NCT00195650|525662179|FG000|Overall Study|Lack of Efficacy|99|||
145769059|NCT00195650|525662179|FG000|Overall Study|Withdrawal by Subject|67|||
145769060|NCT00195650|525662179|FG000|Overall Study|Lost to Follow-up|44|||
145769061|NCT00195650|525662179|FG000|Overall Study|Death|23|||
145769062|NCT00195650|525662179|FG000|Overall Study|Protocol Violation|15|||
145769063|NCT00195650|525662179|FG000|Overall Study|Administrative reasons|83|||
145769064|NCT05292755|525662180|FG000|Overall Study|Lost to Follow-up|5|||
145769065|NCT05292755|525662181|FG001|Overall Study|Lost to Follow-up|9|||
145769066|NCT04052139|525662182|FG000|Overall Study|Lost to Follow-up|2|||
145769067|NCT04052139|525662183|FG001|Overall Study|Lost to Follow-up|0|||
145769068|NCT04052139|525662184|FG002|Overall Study|Lost to Follow-up|0|||
145769069|NCT04052139|525662182|FG000|Overall Study|Withdrawal by Subject|1|||
145769070|NCT04052139|525662183|FG001|Overall Study|Withdrawal by Subject|0|||
145769071|NCT04052139|525662184|FG002|Overall Study|Withdrawal by Subject|0|||
145769072|NCT00707577|525662185|FG000|Overall Study|Withdrawal by Subject|3|||
145769073|NCT00707577|525662186|FG001|Overall Study|Withdrawal by Subject|2|||
145769074|NCT00707577|525662185|FG000|Overall Study|Lost to Follow-up|34|||
145769075|NCT00707577|525662186|FG001|Overall Study|Lost to Follow-up|25|||
145769076|NCT00707577|525662185|FG000|Overall Study|Left employment|13|||
145769077|NCT00707577|525662186|FG001|Overall Study|Left employment|10|||
145769078|NCT00707577|525662185|FG000|Overall Study|Pregnancy|4|||
145769079|NCT00707577|525662186|FG001|Overall Study|Pregnancy|1|||
145769080|NCT00519077|525662187|FG000|Overall Study|Death|6|||
145769081|NCT00519077|525662187|FG000|Overall Study|Other|2|||
145769082|NCT01967225|525662188|FG000|Overall Study|Adverse Event|3|||
145769083|NCT01967225|525662189|FG001|Overall Study|Adverse Event|1|||
145769084|NCT01967225|525662188|FG000|Overall Study|Withdrawal by Subject|2|||
145769085|NCT01967225|525662189|FG001|Overall Study|Withdrawal by Subject|1|||
145769086|NCT01967225|525662188|FG000|Overall Study|Lack of Efficacy|1|||
145769087|NCT01967225|525662189|FG001|Overall Study|Lack of Efficacy|1|||
145769088|NCT01967225|525662188|FG000|Overall Study|Switching to other therapy|2|||
145769089|NCT01967225|525662189|FG001|Overall Study|Switching to other therapy|0|||
145769090|NCT01967225|525662188|FG000|Overall Study|Protocol driven decision point|1|||
145769091|NCT01967225|525662189|FG001|Overall Study|Protocol driven decision point|0|||
145533722|NCT03507400|524813523|FG000|Overall Study|Protocol Violation|0|||
145533723|NCT03507400|524813524|FG001|Overall Study|Protocol Violation|1|||
145533724|NCT01555983|524813525|FG000|Overall Study|Withdrawal by Subject|1|||
145533725|NCT01555983|524813526|FG001|Overall Study|Withdrawal by Subject|0|||
145533726|NCT01555983|524813527|FG002|Overall Study|Withdrawal by Subject|0|||
145533727|NCT01555983|524813528|FG003|Overall Study|Withdrawal by Subject|0|||
145533728|NCT01555983|524813529|FG004|Overall Study|Withdrawal by Subject|1|||
145533729|NCT01555983|524813530|FG005|Overall Study|Withdrawal by Subject|1|||
145533730|NCT03673046|524815319|FG000|Overall Study|Adverse Event|1|||
145533731|NCT03673046|524815320|FG001|Overall Study|Adverse Event|1|||
145533732|NCT03673046|524815319|FG000|Overall Study|Withdrawal by Subject|8|||
145533733|NCT03673046|524815320|FG001|Overall Study|Withdrawal by Subject|2|||
145533734|NCT00392015|524815324|FG000|Overall Study|Lost to Follow-up|2|||
145533735|NCT00392015|524815325|FG001|Overall Study|Lost to Follow-up|0|||
145533736|NCT00392015|524815326|FG002|Overall Study|Lost to Follow-up|2|||
145769092|NCT01967225|525662188|FG000|Overall Study|Logistical difficulties|1|||
145769093|NCT01967225|525662189|FG001|Overall Study|Logistical difficulties|0|||
145769094|NCT01967225|525662188|FG000|Overall Study|Protocol Violation|2|||
145769095|NCT01967225|525662189|FG001|Overall Study|Protocol Violation|0|||
145769096|NCT02305563|525662190|FG000|Treatment Period|Disease progression|0|||
145769097|NCT02305563|525662191|FG001|Treatment Period|Disease progression|0|||
145769098|NCT02305563|525662192|FG002|Treatment Period|Disease progression|15|||
145769099|NCT02305563|525662193|FG003|Treatment Period|Disease progression|6|||
145769100|NCT02305563|525662194|FG004|Treatment Period|Disease progression|6|||
145769101|NCT02305563|525662190|FG000|Treatment Period|Study drug toxicity|0|||
145533737|NCT00392015|524815327|FG003|Overall Study|Lost to Follow-up|1|||
145533738|NCT00392015|524815328|FG004|Overall Study|Lost to Follow-up|1|||
145607994|NCT03389477|525079309|FG001|Step 2|Poor performance status and nutrition|1|||
145769102|NCT02305563|525662191|FG001|Treatment Period|Study drug toxicity|0|||
145533739|NCT00392015|524815329|FG005|Overall Study|Lost to Follow-up|0|||
145533740|NCT00392015|524815324|FG000|Overall Study|Withdrawal by Subject|0|||
145533741|NCT00392015|524815325|FG001|Overall Study|Withdrawal by Subject|0|||
145533742|NCT00392015|524815326|FG002|Overall Study|Withdrawal by Subject|2|||
145769103|NCT02305563|525662192|FG002|Treatment Period|Study drug toxicity|0|||
145769104|NCT02305563|525662193|FG003|Treatment Period|Study drug toxicity|1|||
145769105|NCT02305563|525662194|FG004|Treatment Period|Study drug toxicity|2|||
145769106|NCT02305563|525662190|FG000|Treatment Period|Death|0|||
145769107|NCT02305563|525662191|FG001|Treatment Period|Death|0|||
145769108|NCT02305563|525662192|FG002|Treatment Period|Death|1|||
145769109|NCT02305563|525662193|FG003|Treatment Period|Death|2|||
145769110|NCT02305563|525662194|FG004|Treatment Period|Death|1|||
145769111|NCT02305563|525662190|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
145769112|NCT02305563|525662191|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
145769113|NCT02305563|525662192|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
145769114|NCT02305563|525662193|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
145769115|NCT02305563|525662194|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
145769116|NCT02305563|525662190|FG000|Treatment Period|Participant request to stop therapy|0|||
145769117|NCT02305563|525662191|FG001|Treatment Period|Participant request to stop therapy|2|||
145769118|NCT02305563|525662192|FG002|Treatment Period|Participant request to stop therapy|0|||
145769119|NCT02305563|525662193|FG003|Treatment Period|Participant request to stop therapy|1|||
145769120|NCT02305563|525662194|FG004|Treatment Period|Participant request to stop therapy|0|||
145769121|NCT02305563|525662190|FG000|Treatment Period|Participant withdrew consent|0|||
145769122|NCT02305563|525662191|FG001|Treatment Period|Participant withdrew consent|0|||
145769123|NCT02305563|525662192|FG002|Treatment Period|Participant withdrew consent|1|||
145769124|NCT02305563|525662193|FG003|Treatment Period|Participant withdrew consent|1|||
145769125|NCT02305563|525662194|FG004|Treatment Period|Participant withdrew consent|1|||
145769126|NCT02305563|525662190|FG000|Treatment Period|Maximum clinical benefit|0|||
145769127|NCT02305563|525662191|FG001|Treatment Period|Maximum clinical benefit|0|||
145769128|NCT02305563|525662192|FG002|Treatment Period|Maximum clinical benefit|0|||
145769129|NCT02305563|525662193|FG003|Treatment Period|Maximum clinical benefit|0|||
145769130|NCT02305563|525662194|FG004|Treatment Period|Maximum clinical benefit|1|||
145769131|NCT02305563|525662190|FG000|Treatment Period|Poor/non-compliance|0|||
145769132|NCT02305563|525662191|FG001|Treatment Period|Poor/non-compliance|0|||
145769133|NCT02305563|525662192|FG002|Treatment Period|Poor/non-compliance|0|||
145769134|NCT02305563|525662193|FG003|Treatment Period|Poor/non-compliance|0|||
145769135|NCT02305563|525662194|FG004|Treatment Period|Poor/non-compliance|1|||
145769136|NCT02305563|525662190|FG000|Treatment Period|Administrative reason by Sponsor|0|||
145769137|NCT02305563|525662191|FG001|Treatment Period|Administrative reason by Sponsor|0|||
145769138|NCT02305563|525662192|FG002|Treatment Period|Administrative reason by Sponsor|0|||
145769139|NCT02305563|525662193|FG003|Treatment Period|Administrative reason by Sponsor|0|||
145769140|NCT02305563|525662194|FG004|Treatment Period|Administrative reason by Sponsor|1|||
145769141|NCT02305563|525662190|FG000|Treatment Period|other reason|2|||
145769142|NCT02305563|525662191|FG001|Treatment Period|other reason|0|||
145769143|NCT02305563|525662192|FG002|Treatment Period|other reason|2|||
145769144|NCT02305563|525662193|FG003|Treatment Period|other reason|2|||
145769145|NCT02305563|525662194|FG004|Treatment Period|other reason|1|||
145769146|NCT02305563|525662190|FG000|Treatment Period|Randomized but not treated|0|||
145769147|NCT02305563|525662191|FG001|Treatment Period|Randomized but not treated|0|||
145769148|NCT02305563|525662192|FG002|Treatment Period|Randomized but not treated|0|||
145769149|NCT02305563|525662193|FG003|Treatment Period|Randomized but not treated|0|||
145769150|NCT02305563|525662194|FG004|Treatment Period|Randomized but not treated|2|||
145769151|NCT02305563|525662190|FG000|Treatment Period|added ULO, then disease progression|0|||
145769152|NCT02305563|525662191|FG001|Treatment Period|added ULO, then disease progression|0|||
145769153|NCT02305563|525662192|FG002|Treatment Period|added ULO, then disease progression|0|||
145769154|NCT02305563|525662193|FG003|Treatment Period|added ULO, then disease progression|0|||
145769155|NCT02305563|525662194|FG004|Treatment Period|added ULO, then disease progression|4|||
145769156|NCT02305563|525662190|FG000|Treatment Period|added ULO; then other reason|0|||
145769157|NCT02305563|525662191|FG001|Treatment Period|added ULO; then other reason|0|||
145769158|NCT02305563|525662192|FG002|Treatment Period|added ULO; then other reason|0|||
145769159|NCT02305563|525662193|FG003|Treatment Period|added ULO; then other reason|0|||
145769160|NCT02305563|525662194|FG004|Treatment Period|added ULO; then other reason|1|||
145769161|NCT02305563|525662190|FG000|Treatment Period|added ULO, then request to stop|0|||
145769162|NCT02305563|525662191|FG001|Treatment Period|added ULO, then request to stop|0|||
145769163|NCT02305563|525662192|FG002|Treatment Period|added ULO, then request to stop|0|||
145769164|NCT02305563|525662193|FG003|Treatment Period|added ULO, then request to stop|0|||
145769165|NCT02305563|525662194|FG004|Treatment Period|added ULO, then request to stop|1|||
145607995|NCT03389477|525079308|FG000|Step 3|Withdrawal after 3 cycles|0|||
145769166|NCT02305563|525662190|FG000|Follow-up Period|Death|0|||
145769167|NCT02305563|525662191|FG001|Follow-up Period|Death|0|||
145769168|NCT02305563|525662192|FG002|Follow-up Period|Death|5|||
145769169|NCT02305563|525662193|FG003|Follow-up Period|Death|4|||
145769170|NCT02305563|525662194|FG004|Follow-up Period|Death|7|||
145769171|NCT02305563|525662190|FG000|Follow-up Period|Participant withdrew consent|0|||
145769172|NCT02305563|525662191|FG001|Follow-up Period|Participant withdrew consent|0|||
145769173|NCT02305563|525662192|FG002|Follow-up Period|Participant withdrew consent|2|||
145769174|NCT02305563|525662193|FG003|Follow-up Period|Participant withdrew consent|1|||
145403175|NCT00997893|524334317|FG002|Overall Study|Adverse Event|0|||
145403176|NCT00997893|524334315|FG000|Overall Study|Unable to meet study timelines|1|||
145403177|NCT00997893|524334316|FG001|Overall Study|Unable to meet study timelines|0|||
145403178|NCT00997893|524334317|FG002|Overall Study|Unable to meet study timelines|0|||
145403179|NCT00997893|524334315|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
145403180|NCT00997893|524334316|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
145403181|NCT00997893|524334317|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
145403182|NCT02309359|524334318|FG000|Overall Study|Adverse Event|4|||
145403183|NCT02309359|524334319|FG001|Overall Study|Adverse Event|5|||
145403184|NCT02309359|524334320|FG002|Overall Study|Adverse Event|5|||
145403185|NCT02309359|524334321|FG003|Overall Study|Adverse Event|4|||
145403186|NCT02309359|524334322|FG004|Overall Study|Adverse Event|4|||
145403187|NCT02309359|524334318|FG000|Overall Study|Death|1|||
145403188|NCT02309359|524334319|FG001|Overall Study|Death|0|||
145403189|NCT02309359|524334320|FG002|Overall Study|Death|0|||
145403190|NCT02309359|524334321|FG003|Overall Study|Death|0|||
145403191|NCT02309359|524334322|FG004|Overall Study|Death|0|||
145403192|NCT02309359|524334318|FG000|Overall Study|Withdrawal by Subject|2|||
145403193|NCT02309359|524334319|FG001|Overall Study|Withdrawal by Subject|2|||
145403194|NCT02309359|524334320|FG002|Overall Study|Withdrawal by Subject|4|||
145403195|NCT02309359|524334321|FG003|Overall Study|Withdrawal by Subject|4|||
145403196|NCT02309359|524334322|FG004|Overall Study|Withdrawal by Subject|0|||
145403197|NCT02309359|524334318|FG000|Overall Study|Lack of Efficacy|3|||
145403198|NCT02309359|524334319|FG001|Overall Study|Lack of Efficacy|1|||
145403199|NCT02309359|524334320|FG002|Overall Study|Lack of Efficacy|0|||
145403200|NCT02309359|524334321|FG003|Overall Study|Lack of Efficacy|0|||
145403201|NCT02309359|524334322|FG004|Overall Study|Lack of Efficacy|3|||
145403202|NCT02309359|524334318|FG000|Overall Study|Lost to Follow-up|0|||
145403203|NCT02309359|524334319|FG001|Overall Study|Lost to Follow-up|0|||
145403204|NCT02309359|524334320|FG002|Overall Study|Lost to Follow-up|0|||
145403205|NCT02309359|524334321|FG003|Overall Study|Lost to Follow-up|1|||
145403206|NCT02309359|524334322|FG004|Overall Study|Lost to Follow-up|0|||
145403207|NCT02309359|524334318|FG000|Overall Study|Other|2|||
145403208|NCT02309359|524334319|FG001|Overall Study|Other|0|||
145403209|NCT02309359|524334320|FG002|Overall Study|Other|2|||
145403210|NCT02309359|524334321|FG003|Overall Study|Other|3|||
145403211|NCT02309359|524334322|FG004|Overall Study|Other|2|||
145403212|NCT00701363|524334323|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
145403213|NCT00701363|524334324|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145403214|NCT00701363|524334325|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145403215|NCT00701363|524334326|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
145403216|NCT00701363|524334323|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
145403217|NCT00701363|524334324|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
145403218|NCT00701363|524334325|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
145403219|NCT00701363|524334326|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
145403220|NCT00701363|524334323|FG000|Treatment Phase 1|Adverse Event|7|||
145403221|NCT00701363|524334324|FG001|Treatment Phase 1|Adverse Event|0|||
145403222|NCT00701363|524334325|FG002|Treatment Phase 1|Adverse Event|0|||
145403223|NCT00701363|524334326|FG003|Treatment Phase 1|Adverse Event|0|||
145403224|NCT00701363|524334323|FG000|Treatment Phase 1|Protocol Violation|1|||
145403225|NCT00701363|524334324|FG001|Treatment Phase 1|Protocol Violation|0|||
145403226|NCT00701363|524334325|FG002|Treatment Phase 1|Protocol Violation|0|||
145769175|NCT02305563|525662194|FG004|Follow-up Period|Participant withdrew consent|0|||
145769176|NCT02305563|525662190|FG000|Follow-up Period|other reason|0|||
145278085|NCT03674827|523868908|FG002|Treatment Phase|Death|0|||
145278086|NCT03674827|523868909|FG003|Treatment Phase|Death|0|||
145278087|NCT03674827|523868910|FG004|Treatment Phase|Death|1|||
145278088|NCT03674827|523868911|FG005|Treatment Phase|Death|0|||
145278089|NCT03674827|523868906|FG000|Treatment Phase|Progressive Disease|0|||
145278090|NCT03674827|523868907|FG001|Treatment Phase|Progressive Disease|4|||
145278091|NCT03674827|523868908|FG002|Treatment Phase|Progressive Disease|3|||
145278092|NCT03674827|523868909|FG003|Treatment Phase|Progressive Disease|4|||
145278093|NCT03674827|523868910|FG004|Treatment Phase|Progressive Disease|4|||
145278094|NCT03674827|523868911|FG005|Treatment Phase|Progressive Disease|9|||
145278095|NCT03674827|523868906|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
145278096|NCT03674827|523868907|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
145278097|NCT03674827|523868908|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
145769177|NCT02305563|525662191|FG001|Follow-up Period|other reason|0|||
145278098|NCT03674827|523868909|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
145278099|NCT03674827|523868910|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
145278100|NCT03674827|523868911|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
145403227|NCT00701363|524334326|FG003|Treatment Phase 1|Protocol Violation|0|||
145403228|NCT00701363|524334323|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
145403229|NCT00701363|524334324|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
145403230|NCT00701363|524334325|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
145403231|NCT00701363|524334326|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
145769178|NCT02305563|525662192|FG002|Follow-up Period|other reason|0|||
145533743|NCT00392015|524815327|FG003|Overall Study|Withdrawal by Subject|0|||
145533744|NCT00392015|524815328|FG004|Overall Study|Withdrawal by Subject|0|||
145769179|NCT02305563|525662193|FG003|Follow-up Period|other reason|0|||
145769180|NCT02305563|525662194|FG004|Follow-up Period|other reason|1|||
145769181|NCT02305563|525662190|FG000|Follow-up Period|Followup no longer required per protocol|3|||
145769182|NCT02305563|525662191|FG001|Follow-up Period|Followup no longer required per protocol|3|||
145769183|NCT02305563|525662192|FG002|Follow-up Period|Followup no longer required per protocol|4|||
145769184|NCT02305563|525662193|FG003|Follow-up Period|Followup no longer required per protocol|1|||
145403232|NCT00701363|524334323|FG000|Treatment Phase 1|Lack of Efficacy|1|||
145403233|NCT00701363|524334324|FG001|Treatment Phase 1|Lack of Efficacy|0|||
145403234|NCT00701363|524334325|FG002|Treatment Phase 1|Lack of Efficacy|0|||
145403235|NCT00701363|524334326|FG003|Treatment Phase 1|Lack of Efficacy|0|||
145403236|NCT00701363|524334323|FG000|Treatment Phase 2|Adverse Event|0|||
145403237|NCT00701363|524334324|FG001|Treatment Phase 2|Adverse Event|0|||
145403238|NCT00701363|524334325|FG002|Treatment Phase 2|Adverse Event|1|||
145403239|NCT00701363|524334326|FG003|Treatment Phase 2|Adverse Event|0|||
145403240|NCT00701363|524334323|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
145403241|NCT00701363|524334324|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
145403242|NCT00701363|524334325|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
145403243|NCT00701363|524334326|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
145403244|NCT04759131|524334327|FG000|Overall Study|Investigator's discretion|1|||
145403245|NCT04759131|524334328|FG001|Overall Study|Investigator's discretion|0|||
145403246|NCT04759131|524334327|FG000|Overall Study|Subject withdrawal|1|||
145403247|NCT04759131|524334328|FG001|Overall Study|Subject withdrawal|0|||
145403248|NCT05144945|524334329|FG000|Overall Study|Withdrawal by Subject|1|||
145403249|NCT05144945|524334330|FG001|Overall Study|Withdrawal by Subject|0|||
145403250|NCT05853120|524334331|FG000|Overall Study|Lost to Follow-up|4|||
145403251|NCT05853120|524334332|FG001|Overall Study|Lost to Follow-up|4|||
145403252|NCT05853120|524334331|FG000|Overall Study|Physician Decision|3|||
145403253|NCT05853120|524334332|FG001|Overall Study|Physician Decision|0|||
145403254|NCT05853120|524334331|FG000|Overall Study|Withdrawal by Subject|5|||
145403255|NCT05853120|524334332|FG001|Overall Study|Withdrawal by Subject|2|||
145403256|NCT02592824|524334334|FG000|Overall Study|Protocol Violation|5|||
145403257|NCT02592824|524334335|FG001|Overall Study|Protocol Violation|3|||
145403258|NCT02592824|524334334|FG000|Overall Study|Lost to Follow-up|2|||
145403259|NCT02592824|524334335|FG001|Overall Study|Lost to Follow-up|1|||
145403260|NCT00465517|524334336|FG000|Overall Study|Adverse Event|7|||
145403261|NCT00465517|524334337|FG001|Overall Study|Adverse Event|3|||
145403262|NCT00465517|524334336|FG000|Overall Study|Lost to Follow-up|1|||
145403263|NCT00465517|524334337|FG001|Overall Study|Lost to Follow-up|0|||
145403264|NCT00465517|524334336|FG000|Overall Study|Withdrawal by Subject|4|||
145403265|NCT00465517|524334337|FG001|Overall Study|Withdrawal by Subject|1|||
145403266|NCT00869960|524334338|FG000|Overall Study|Lost to Follow-up|2|||
145403267|NCT03040726|524334342|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
145403268|NCT03040726|524334343|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
145403269|NCT03040726|524334342|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
145403270|NCT03040726|524334343|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
145403271|NCT03040726|524334342|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
145403272|NCT03040726|524334343|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
145403273|NCT03040726|524334342|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
145403274|NCT03040726|524334343|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
145533745|NCT00392015|524815329|FG005|Overall Study|Withdrawal by Subject|0|||
145533746|NCT00392015|524815324|FG000|Overall Study|Adverse Event|0|||
145533747|NCT00392015|524815325|FG001|Overall Study|Adverse Event|0|||
145533748|NCT00392015|524815326|FG002|Overall Study|Adverse Event|0|||
145533749|NCT00392015|524815327|FG003|Overall Study|Adverse Event|0|||
145533750|NCT00392015|524815328|FG004|Overall Study|Adverse Event|1|||
145533751|NCT00392015|524815329|FG005|Overall Study|Adverse Event|0|||
145769185|NCT02305563|525662194|FG004|Follow-up Period|Followup no longer required per protocol|4|||
145769186|NCT00642642|525662197|FG000|Treatment & Follow Up|Adverse Event|2|||
145769187|NCT00642642|525662197|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
145769188|NCT00642642|525662197|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
145769189|NCT01275222|525662200|FG000|Phase l by Treatment|Adverse Event|1|||
145403275|NCT03040726|524334342|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
145403276|NCT03040726|524334343|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
145403277|NCT00465179|524334347|FG000|Overall Study|Adverse Event|4|||
145403278|NCT00465179|524334347|FG000|Overall Study|Withdrawal by Subject|2|||
145403279|NCT00465179|524334347|FG000|Overall Study|Progression of Disease|47|||
145533752|NCT00392015|524815324|FG000|Overall Study|Previous trial recipient|0|||
145533753|NCT00392015|524815325|FG001|Overall Study|Previous trial recipient|0|||
145533754|NCT00392015|524815326|FG002|Overall Study|Previous trial recipient|0|||
145533755|NCT00392015|524815327|FG003|Overall Study|Previous trial recipient|0|||
145607996|NCT03389477|525079309|FG001|Step 3|Withdrawal after 3 cycles|1|||
145769190|NCT01275222|525662201|FG001|Phase l by Treatment|Adverse Event|4|||
145769191|NCT01275222|525662202|FG002|Phase l by Treatment|Adverse Event|2|||
145769192|NCT01275222|525662203|FG003|Phase l by Treatment|Adverse Event|3|||
145769193|NCT01275222|525662204|FG004|Phase l by Treatment|Adverse Event|0|||
145769194|NCT01275222|525662205|FG005|Phase l by Treatment|Adverse Event|0|||
145769195|NCT01275222|525662200|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
145769196|NCT01275222|525662201|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
145769197|NCT01275222|525662202|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
145769198|NCT01275222|525662203|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
145769199|NCT01275222|525662204|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
145769200|NCT01275222|525662205|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
145769201|NCT01275222|525662200|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
145769202|NCT01275222|525662201|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
145769203|NCT01275222|525662202|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
145769204|NCT01275222|525662203|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
145769205|NCT01275222|525662204|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
145769206|NCT01275222|525662205|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
145769207|NCT01275222|525662200|FG000|Phase l by Treatment|Disease progression|12|||
145769208|NCT01275222|525662201|FG001|Phase l by Treatment|Disease progression|8|||
145769209|NCT01275222|525662202|FG002|Phase l by Treatment|Disease progression|2|||
145769210|NCT01275222|525662203|FG003|Phase l by Treatment|Disease progression|5|||
145769211|NCT01275222|525662204|FG004|Phase l by Treatment|Disease progression|0|||
145769212|NCT01275222|525662205|FG005|Phase l by Treatment|Disease progression|0|||
145769213|NCT01275222|525662200|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
145533756|NCT00392015|524815328|FG004|Overall Study|Previous trial recipient|1|||
145533757|NCT00392015|524815329|FG005|Overall Study|Previous trial recipient|0|||
145533758|NCT00717093|524815330|FG000|Overall Study|Adverse Event|19|||
145533759|NCT00717093|524815331|FG001|Overall Study|Adverse Event|9|||
145533760|NCT00717093|524815330|FG000|Overall Study|Lack of Efficacy|3|||
145533761|NCT00717093|524815331|FG001|Overall Study|Lack of Efficacy|13|||
145533762|NCT00717093|524815330|FG000|Overall Study|Lost to Follow-up|9|||
145769214|NCT01275222|525662201|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
145769215|NCT01275222|525662202|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
145769216|NCT01275222|525662203|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
145769217|NCT01275222|525662204|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
145769218|NCT01275222|525662205|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
145769219|NCT01275222|525662200|FG000|Phase l by Treatment|Death|0|||
145769220|NCT01275222|525662201|FG001|Phase l by Treatment|Death|1|||
145769221|NCT01275222|525662202|FG002|Phase l by Treatment|Death|0|||
145769222|NCT01275222|525662203|FG003|Phase l by Treatment|Death|1|||
145769223|NCT01275222|525662204|FG004|Phase l by Treatment|Death|0|||
145769224|NCT01275222|525662205|FG005|Phase l by Treatment|Death|0|||
145769225|NCT01275222|525662200|FG000|Phase ll by Stratum|Adverse Event|0|||
145769226|NCT01275222|525662201|FG001|Phase ll by Stratum|Adverse Event|0|||
145769227|NCT01275222|525662202|FG002|Phase ll by Stratum|Adverse Event|0|||
145769228|NCT01275222|525662203|FG003|Phase ll by Stratum|Adverse Event|0|||
145769229|NCT01275222|525662204|FG004|Phase ll by Stratum|Adverse Event|2|||
145769230|NCT01275222|525662205|FG005|Phase ll by Stratum|Adverse Event|10|||
145769231|NCT01275222|525662200|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
145769232|NCT01275222|525662201|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
145769233|NCT01275222|525662202|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
145769234|NCT01275222|525662203|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
145769235|NCT01275222|525662204|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
145769236|NCT01275222|525662205|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
145769237|NCT01275222|525662200|FG000|Phase ll by Stratum|Disease progression|0|||
145769238|NCT01275222|525662201|FG001|Phase ll by Stratum|Disease progression|0|||
145769239|NCT01275222|525662202|FG002|Phase ll by Stratum|Disease progression|0|||
145769240|NCT01275222|525662203|FG003|Phase ll by Stratum|Disease progression|0|||
145769241|NCT01275222|525662204|FG004|Phase ll by Stratum|Disease progression|23|||
145533763|NCT00717093|524815331|FG001|Overall Study|Lost to Follow-up|6|||
145769242|NCT01275222|525662205|FG005|Phase ll by Stratum|Disease progression|31|||
145533764|NCT00717093|524815330|FG000|Overall Study|Withdrawal by Subject|12|||
145769243|NCT01275222|525662200|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
145769244|NCT01275222|525662201|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
145769245|NCT01275222|525662202|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
145278101|NCT03674827|523868906|FG000|Treatment Phase|Withdrawal by Subject|0|||
145533765|NCT00717093|524815331|FG001|Overall Study|Withdrawal by Subject|19|||
145533766|NCT00717093|524815330|FG000|Overall Study|Other|0|||
145533767|NCT00717093|524815331|FG001|Overall Study|Other|1|||
145533768|NCT00717093|524815330|FG000|Overall Study|Randomized but not treated|1|||
145769246|NCT01275222|525662203|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
145769247|NCT01275222|525662204|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
145769248|NCT01275222|525662205|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
145769249|NCT01275222|525662200|FG000|Phase ll by Stratum|Death|0|||
145769250|NCT01275222|525662201|FG001|Phase ll by Stratum|Death|0|||
145769251|NCT01275222|525662202|FG002|Phase ll by Stratum|Death|0|||
145769252|NCT01275222|525662203|FG003|Phase ll by Stratum|Death|0|||
145769253|NCT01275222|525662204|FG004|Phase ll by Stratum|Death|1|||
145769254|NCT01275222|525662205|FG005|Phase ll by Stratum|Death|1|||
145769255|NCT01511445|525662206|FG000|Overall Study|Lost to Follow-up|3|||
145769256|NCT01511445|525662207|FG001|Overall Study|Lost to Follow-up|1|||
145769257|NCT01511445|525662206|FG000|Overall Study|Protocol Violation|1|||
145769258|NCT01511445|525662207|FG001|Overall Study|Protocol Violation|3|||
145769259|NCT01511445|525662206|FG000|Overall Study|Protocol Violation|1|||
145769260|NCT01511445|525662207|FG001|Overall Study|Protocol Violation|0|||
145769261|NCT01856114|525662208|FG000|Overall Study|Withdrawal by Subject|1|||
145769262|NCT01856114|525662209|FG001|Overall Study|Withdrawal by Subject|0|||
145769263|NCT01856114|525662208|FG000|Overall Study|Adverse Event|1|||
145769264|NCT01856114|525662209|FG001|Overall Study|Adverse Event|0|||
145769265|NCT00144170|525662210|FG000|Overall Study|Adverse Event|84|||
145769266|NCT00144170|525662211|FG001|Overall Study|Adverse Event|41|||
145769267|NCT00144170|525662210|FG000|Overall Study|Protocol Violation|23|||
145769268|NCT00144170|525662211|FG001|Overall Study|Protocol Violation|16|||
145769269|NCT00144170|525662210|FG000|Overall Study|Lost to Follow-up|5|||
145769270|NCT00144170|525662211|FG001|Overall Study|Lost to Follow-up|10|||
145769271|NCT00144170|525662210|FG000|Overall Study|Withdrawal by Subject|29|||
145769272|NCT00144170|525662211|FG001|Overall Study|Withdrawal by Subject|13|||
145769273|NCT00144170|525662210|FG000|Overall Study|Other reason not defined above|211|||
145769274|NCT00144170|525662211|FG001|Overall Study|Other reason not defined above|316|||
145769275|NCT00818259|525662212|FG000|Part I|Withdrawal by Subject|1|||
145769276|NCT00818259|525662213|FG001|Part I|Withdrawal by Subject|0|||
145769277|NCT00818259|525662214|FG002|Part I|Withdrawal by Subject|0|||
145769278|NCT00818259|525662215|FG003|Part I|Withdrawal by Subject|0|||
145769279|NCT00818259|525662216|FG004|Part I|Withdrawal by Subject|0|||
145769280|NCT00818259|525662217|FG005|Part I|Withdrawal by Subject|0|||
145769281|NCT00818259|525662218|FG006|Part I|Withdrawal by Subject|0|||
145769282|NCT00818259|525662219|FG007|Part I|Withdrawal by Subject|0|||
145769283|NCT00818259|525662220|FG008|Part I|Withdrawal by Subject|0|||
145769284|NCT00818259|525662212|FG000|Part II|Physician Decision|0|||
145769285|NCT00818259|525662213|FG001|Part II|Physician Decision|0|||
145769286|NCT00818259|525662214|FG002|Part II|Physician Decision|1|||
145769287|NCT00818259|525662215|FG003|Part II|Physician Decision|0|||
145769288|NCT00818259|525662216|FG004|Part II|Physician Decision|0|||
145769289|NCT00818259|525662217|FG005|Part II|Physician Decision|0|||
145769290|NCT00818259|525662218|FG006|Part II|Physician Decision|0|||
145769291|NCT00818259|525662219|FG007|Part II|Physician Decision|0|||
145769292|NCT00818259|525662220|FG008|Part II|Physician Decision|0|||
145769293|NCT00818259|525662212|FG000|Part II|Lack of Efficacy|0|||
145769294|NCT00818259|525662213|FG001|Part II|Lack of Efficacy|0|||
145769295|NCT00818259|525662214|FG002|Part II|Lack of Efficacy|0|||
145769296|NCT00818259|525662215|FG003|Part II|Lack of Efficacy|1|||
145769297|NCT00818259|525662216|FG004|Part II|Lack of Efficacy|0|||
145769298|NCT00818259|525662217|FG005|Part II|Lack of Efficacy|0|||
145769299|NCT00818259|525662218|FG006|Part II|Lack of Efficacy|0|||
145769300|NCT00818259|525662219|FG007|Part II|Lack of Efficacy|0|||
145769301|NCT00818259|525662220|FG008|Part II|Lack of Efficacy|0|||
145769302|NCT00818259|525662212|FG000|Part II|Not Treated|0|||
145769303|NCT00818259|525662213|FG001|Part II|Not Treated|0|||
145769304|NCT00818259|525662214|FG002|Part II|Not Treated|0|||
145769305|NCT00818259|525662215|FG003|Part II|Not Treated|1|||
145769306|NCT00818259|525662216|FG004|Part II|Not Treated|0|||
145769307|NCT00818259|525662217|FG005|Part II|Not Treated|0|||
145769308|NCT00818259|525662218|FG006|Part II|Not Treated|0|||
145769309|NCT00818259|525662219|FG007|Part II|Not Treated|0|||
145769310|NCT00818259|525662220|FG008|Part II|Not Treated|0|||
145769311|NCT00818259|525662212|FG000|Part IV|Physician Decision|0|||
145769312|NCT00818259|525662213|FG001|Part IV|Physician Decision|0|||
145769313|NCT00818259|525662214|FG002|Part IV|Physician Decision|0|||
145769314|NCT00818259|525662215|FG003|Part IV|Physician Decision|0|||
145769315|NCT00818259|525662216|FG004|Part IV|Physician Decision|0|||
145769316|NCT00818259|525662217|FG005|Part IV|Physician Decision|1|||
145769317|NCT00818259|525662218|FG006|Part IV|Physician Decision|0|||
145769318|NCT00818259|525662219|FG007|Part IV|Physician Decision|0|||
145533769|NCT00717093|524815331|FG001|Overall Study|Randomized but not treated|0|||
145769319|NCT00818259|525662220|FG008|Part IV|Physician Decision|0|||
145769320|NCT00818259|525662212|FG000|Part V|Adverse Event|0|||
145769321|NCT00818259|525662213|FG001|Part V|Adverse Event|0|||
145769322|NCT00818259|525662214|FG002|Part V|Adverse Event|0|||
145769323|NCT00818259|525662215|FG003|Part V|Adverse Event|0|||
145769324|NCT00818259|525662216|FG004|Part V|Adverse Event|0|||
145769325|NCT00818259|525662217|FG005|Part V|Adverse Event|0|||
145769326|NCT00818259|525662218|FG006|Part V|Adverse Event|0|||
145769327|NCT00818259|525662219|FG007|Part V|Adverse Event|1|||
145769328|NCT00818259|525662220|FG008|Part V|Adverse Event|0|||
145769329|NCT00666562|525662221|FG000|Overall Study|Withdrawal by Subject|0|||
145769330|NCT00666562|525662222|FG001|Overall Study|Withdrawal by Subject|1|||
145769331|NCT00666562|525662223|FG002|Overall Study|Withdrawal by Subject|0|||
145769332|NCT00666562|525662221|FG000|Overall Study|Concomitant Medication|0|||
145403280|NCT00833755|524334351|FG000|Overall Study|Physician Decision|4|||
145403281|NCT00833755|524334352|FG001|Overall Study|Physician Decision|4|||
145403282|NCT00833755|524334353|FG002|Overall Study|Physician Decision|2|||
145403283|NCT00833755|524334354|FG003|Overall Study|Physician Decision|6|||
145403284|NCT00833755|524334351|FG000|Overall Study|Subject had scheduling issues|0|||
145403285|NCT00833755|524334352|FG001|Overall Study|Subject had scheduling issues|1|||
145403286|NCT00833755|524334353|FG002|Overall Study|Subject had scheduling issues|0|||
145403287|NCT00833755|524334354|FG003|Overall Study|Subject had scheduling issues|0|||
145403288|NCT00262925|524334355|FG000|Overall Study|Lack of Efficacy|3|||
145403289|NCT00262925|524334355|FG000|Overall Study|Adverse Event|4|||
145403290|NCT00262925|524334355|FG000|Overall Study|Death|2|||
145403291|NCT00262925|524334355|FG000|Overall Study|alternative therapy|1|||
145403292|NCT00262925|524334355|FG000|Overall Study|Other|1|||
145403293|NCT04682301|524334357|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
145403294|NCT04682301|524334357|FG000|Overall Study|Death|2|||
145403295|NCT00560404|524334358|FG000|Overall Study|Adverse Event|2|||
145403296|NCT00560404|524334359|FG001|Overall Study|Adverse Event|3|||
145403297|NCT00560404|524334358|FG000|Overall Study|Death|3|||
145403298|NCT00560404|524334359|FG001|Overall Study|Death|3|||
145403299|NCT00560404|524334358|FG000|Overall Study|Protocol Violation|12|||
145403300|NCT00560404|524334359|FG001|Overall Study|Protocol Violation|7|||
145403301|NCT00560404|524334358|FG000|Overall Study|Administrative Reasons|1|||
145403302|NCT00560404|524334359|FG001|Overall Study|Administrative Reasons|1|||
145769333|NCT00666562|525662222|FG001|Overall Study|Concomitant Medication|1|||
145769334|NCT00666562|525662223|FG002|Overall Study|Concomitant Medication|0|||
145769335|NCT04906707|525662224|FG000|Overall Study|Withdrawal by Subject|2|||
145769336|NCT04906707|525662225|FG001|Overall Study|Withdrawal by Subject|0|||
145769337|NCT04906707|525662224|FG000|Overall Study|Withdrawal due to PI decision|1|||
145769338|NCT04906707|525662225|FG001|Overall Study|Withdrawal due to PI decision|0|||
145769339|NCT04906707|525662224|FG000|Overall Study|Lost to Follow-up|0|||
145769340|NCT04906707|525662225|FG001|Overall Study|Lost to Follow-up|1|||
145769341|NCT01976806|525662226|FG000|Overall Study|Lost to Follow-up|1|||
145769342|NCT01976806|525662227|FG001|Overall Study|Lost to Follow-up|4|||
145769343|NCT01976806|525662226|FG000|Overall Study|Adverse Event|1|||
145769344|NCT01976806|525662227|FG001|Overall Study|Adverse Event|1|||
145769345|NCT01976806|525662226|FG000|Overall Study|Withdrawal by Subject|1|||
145769346|NCT01976806|525662227|FG001|Overall Study|Withdrawal by Subject|1|||
145769347|NCT01769105|525662232|FG000|First Intervention|Protocol Violation|2|||
145769348|NCT01769105|525662233|FG001|First Intervention|Protocol Violation|2|||
145769349|NCT01769105|525662232|FG000|Cross-over|Lost to Follow-up|5|||
145769350|NCT01769105|525662233|FG001|Cross-over|Lost to Follow-up|0|||
145769351|NCT00963807|525662234|FG000|Overall Study|Physician Decision|2|||
145769352|NCT00963807|525662234|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
145769353|NCT00963807|525662234|FG000|Overall Study|Disease progression|15|||
145769354|NCT00684177|525662235|FG000|Overall Study|Adverse Event|4|||
145769355|NCT00684177|525662236|FG001|Overall Study|Adverse Event|3|||
145769356|NCT00684177|525662235|FG000|Overall Study|Lack of Efficacy|10|||
145769357|NCT00684177|525662236|FG001|Overall Study|Lack of Efficacy|15|||
145769358|NCT00684177|525662235|FG000|Overall Study|Protocol Violation|1|||
145769359|NCT00684177|525662236|FG001|Overall Study|Protocol Violation|0|||
145769360|NCT00684177|525662235|FG000|Overall Study|Lost to Follow-up|2|||
145769361|NCT00684177|525662236|FG001|Overall Study|Lost to Follow-up|1|||
145769362|NCT00684177|525662235|FG000|Overall Study|Physician Decision|2|||
145769363|NCT00684177|525662236|FG001|Overall Study|Physician Decision|0|||
145769364|NCT00684177|525662235|FG000|Overall Study|Withdrawal by Subject|1|||
145769365|NCT00684177|525662236|FG001|Overall Study|Withdrawal by Subject|2|||
145769366|NCT00684177|525662235|FG000|Overall Study|Other|1|||
145769367|NCT00684177|525662236|FG001|Overall Study|Other|2|||
145769368|NCT01056107|525664148|FG000|Overall Study|Withdrawal by Subject|0|||
145769369|NCT01056107|525664149|FG001|Overall Study|Withdrawal by Subject|1|||
145769370|NCT01056107|525664150|FG002|Overall Study|Withdrawal by Subject|3|||
145769371|NCT01056107|525664151|FG003|Overall Study|Withdrawal by Subject|0|||
145769372|NCT03263091|525664155|FG000|OL Component|Withdrawal by Subject|1|||
145769373|NCT03263091|525664156|FG001|OL Component|Withdrawal by Subject|1|||
145769374|NCT03263091|525664157|FG002|OL Component|Withdrawal by Subject|0|||
145769375|NCT03263091|525664158|FG003|OL Component|Withdrawal by Subject|0|||
145769376|NCT03263091|525664159|FG004|OL Component|Withdrawal by Subject|0|||
145769377|NCT03263091|525664160|FG005|OL Component|Withdrawal by Subject|0|||
145769378|NCT03263091|525664155|FG000|OL Component|Physician Decision|0|||
145769379|NCT03263091|525664156|FG001|OL Component|Physician Decision|1|||
145769380|NCT03263091|525664157|FG002|OL Component|Physician Decision|2|||
145769381|NCT03263091|525664158|FG003|OL Component|Physician Decision|0|||
145403303|NCT00560404|524334358|FG000|Overall Study|Withdrew Consent|4|||
145403304|NCT00560404|524334359|FG001|Overall Study|Withdrew Consent|0|||
145403305|NCT00560404|524334358|FG000|Overall Study|Failure to return|1|||
145403306|NCT00560404|524334359|FG001|Overall Study|Failure to return|2|||
145403307|NCT00560404|524334358|FG000|Overall Study|Other withdrawal reason|13|||
145769382|NCT03263091|525664159|FG004|OL Component|Physician Decision|0|||
145769383|NCT03263091|525664160|FG005|OL Component|Physician Decision|0|||
145769384|NCT03263091|525664155|FG000|OL Component|Death|1|||
145769385|NCT03263091|525664156|FG001|OL Component|Death|0|||
145769386|NCT03263091|525664157|FG002|OL Component|Death|0|||
145769387|NCT03263091|525664158|FG003|OL Component|Death|0|||
145769388|NCT03263091|525664159|FG004|OL Component|Death|0|||
145769389|NCT03263091|525664160|FG005|OL Component|Death|0|||
145769390|NCT03263091|525664155|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
145769391|NCT03263091|525664156|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
145769392|NCT03263091|525664157|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
145769393|NCT03263091|525664158|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
145769394|NCT03263091|525664159|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
145769395|NCT03263091|525664160|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
145769396|NCT03263091|525664155|FG000|OL High-EPO Component|Physician Decision|0|||
145769397|NCT03263091|525664156|FG001|OL High-EPO Component|Physician Decision|0|||
145769398|NCT03263091|525664157|FG002|OL High-EPO Component|Physician Decision|0|||
145769399|NCT03263091|525664158|FG003|OL High-EPO Component|Physician Decision|1|||
145769400|NCT03263091|525664159|FG004|OL High-EPO Component|Physician Decision|0|||
145769401|NCT03263091|525664160|FG005|OL High-EPO Component|Physician Decision|0|||
145769402|NCT03263091|525664155|FG000|OL High-EPO Component|Death|0|||
145769403|NCT03263091|525664156|FG001|OL High-EPO Component|Death|0|||
145769404|NCT03263091|525664157|FG002|OL High-EPO Component|Death|0|||
145769405|NCT03263091|525664158|FG003|OL High-EPO Component|Death|3|||
145769406|NCT03263091|525664159|FG004|OL High-EPO Component|Death|0|||
145769407|NCT03263091|525664160|FG005|OL High-EPO Component|Death|0|||
145769408|NCT03263091|525664155|FG000|DB Component|Withdrawal by Subject|0|||
145769409|NCT03263091|525664156|FG001|DB Component|Withdrawal by Subject|0|||
145769410|NCT03263091|525664157|FG002|DB Component|Withdrawal by Subject|0|||
145533770|NCT02742441|524815339|FG000|Overall Study|Lost to Follow-up|4|||
145533771|NCT02742441|524815340|FG001|Overall Study|Lost to Follow-up|4|||
145533772|NCT02742441|524815339|FG000|Overall Study|Withdrawal by Subject|2|||
145533773|NCT02742441|524815340|FG001|Overall Study|Withdrawal by Subject|2|||
145533774|NCT02742441|524815339|FG000|Overall Study|Adverse Event|0|||
145533775|NCT02742441|524815340|FG001|Overall Study|Adverse Event|2|||
145533776|NCT02008318|524815346|FG000|Overall Study|Adverse Event|4|||
145533777|NCT02008318|524815347|FG001|Overall Study|Adverse Event|0|||
145533778|NCT02008318|524815346|FG000|Overall Study|Physician Decision|2|||
145533779|NCT02008318|524815347|FG001|Overall Study|Physician Decision|0|||
145533780|NCT02008318|524815346|FG000|Overall Study|Progressive Disease|2|||
145533781|NCT02008318|524815347|FG001|Overall Study|Progressive Disease|0|||
145533782|NCT02008318|524815346|FG000|Overall Study|Protocol Violation|1|||
145533783|NCT02008318|524815347|FG001|Overall Study|Protocol Violation|1|||
145533784|NCT02008318|524815346|FG000|Overall Study|Withdrawal by Subject|3|||
145533785|NCT02008318|524815347|FG001|Overall Study|Withdrawal by Subject|0|||
145533786|NCT02281773|524815349|FG000|Overall Study|Adverse Event|6|||
145533787|NCT02281773|524815350|FG001|Overall Study|Adverse Event|1|||
145533788|NCT02281773|524815351|FG002|Overall Study|Adverse Event|4|||
145533789|NCT02281773|524815352|FG003|Overall Study|Adverse Event|8|||
145533790|NCT02281773|524815353|FG004|Overall Study|Adverse Event|9|||
145533791|NCT02281773|524815349|FG000|Overall Study|Protocol Violation|1|||
145533792|NCT02281773|524815350|FG001|Overall Study|Protocol Violation|0|||
145533793|NCT02281773|524815351|FG002|Overall Study|Protocol Violation|0|||
145533794|NCT02281773|524815352|FG003|Overall Study|Protocol Violation|2|||
145533795|NCT02281773|524815353|FG004|Overall Study|Protocol Violation|2|||
145533796|NCT02281773|524815349|FG000|Overall Study|Lost to Follow-up|2|||
145533797|NCT02281773|524815350|FG001|Overall Study|Lost to Follow-up|2|||
145533798|NCT02281773|524815351|FG002|Overall Study|Lost to Follow-up|6|||
145533799|NCT02281773|524815352|FG003|Overall Study|Lost to Follow-up|2|||
145533800|NCT02281773|524815353|FG004|Overall Study|Lost to Follow-up|10|||
145533801|NCT02281773|524815349|FG000|Overall Study|Withdrawal by Subject|2|||
145533802|NCT02281773|524815350|FG001|Overall Study|Withdrawal by Subject|8|||
145533803|NCT02281773|524815351|FG002|Overall Study|Withdrawal by Subject|6|||
145533804|NCT02281773|524815352|FG003|Overall Study|Withdrawal by Subject|6|||
145533805|NCT02281773|524815353|FG004|Overall Study|Withdrawal by Subject|8|||
145533806|NCT02281773|524815349|FG000|Overall Study|Other Reason|0|||
145769411|NCT03263091|525664158|FG003|DB Component|Withdrawal by Subject|0|||
145769412|NCT03263091|525664159|FG004|DB Component|Withdrawal by Subject|22|||
145769413|NCT03263091|525664160|FG005|DB Component|Withdrawal by Subject|8|||
145769414|NCT03263091|525664155|FG000|DB Component|Physician Decision|0|||
145533807|NCT02281773|524815350|FG001|Overall Study|Other Reason|4|||
145533808|NCT02281773|524815351|FG002|Overall Study|Other Reason|2|||
145533809|NCT02281773|524815352|FG003|Overall Study|Other Reason|3|||
145533810|NCT02281773|524815353|FG004|Overall Study|Other Reason|1|||
145533811|NCT05439941|524815354|FG000|Overall Study|Lack of Efficacy|8|||
145533812|NCT05439941|524815355|FG001|Overall Study|Lack of Efficacy|5|||
145533813|NCT05439941|524815356|FG002|Overall Study|Lack of Efficacy|3|||
145533814|NCT05439941|524815354|FG000|Overall Study|Treatment Failure|0|||
145533815|NCT05439941|524815355|FG001|Overall Study|Treatment Failure|1|||
145533816|NCT05439941|524815356|FG002|Overall Study|Treatment Failure|0|||
145769415|NCT03263091|525664156|FG001|DB Component|Physician Decision|0|||
145769416|NCT03263091|525664157|FG002|DB Component|Physician Decision|0|||
145769417|NCT03263091|525664158|FG003|DB Component|Physician Decision|0|||
145769418|NCT03263091|525664159|FG004|DB Component|Physician Decision|3|||
145769419|NCT03263091|525664160|FG005|DB Component|Physician Decision|1|||
145769420|NCT03263091|525664155|FG000|DB Component|Adverse Event|0|||
145769421|NCT03263091|525664156|FG001|DB Component|Adverse Event|0|||
145769422|NCT03263091|525664157|FG002|DB Component|Adverse Event|0|||
145769423|NCT03263091|525664158|FG003|DB Component|Adverse Event|0|||
145769424|NCT03263091|525664159|FG004|DB Component|Adverse Event|2|||
145769425|NCT03263091|525664160|FG005|DB Component|Adverse Event|1|||
145769426|NCT03263091|525664155|FG000|DB Component|Lost to Follow-up|0|||
145769427|NCT03263091|525664156|FG001|DB Component|Lost to Follow-up|0|||
145769428|NCT03263091|525664157|FG002|DB Component|Lost to Follow-up|0|||
145769429|NCT03263091|525664158|FG003|DB Component|Lost to Follow-up|0|||
145769430|NCT03263091|525664159|FG004|DB Component|Lost to Follow-up|2|||
145769431|NCT03263091|525664160|FG005|DB Component|Lost to Follow-up|1|||
145769432|NCT03263091|525664155|FG000|DB Component|Death|0|||
145769433|NCT03263091|525664156|FG001|DB Component|Death|0|||
145769434|NCT03263091|525664157|FG002|DB Component|Death|0|||
145769435|NCT03263091|525664158|FG003|DB Component|Death|0|||
145769436|NCT03263091|525664159|FG004|DB Component|Death|7|||
145769437|NCT03263091|525664160|FG005|DB Component|Death|4|||
145769438|NCT03263091|525664155|FG000|DB Component|Other than specified|0|||
145769439|NCT03263091|525664156|FG001|DB Component|Other than specified|0|||
145769440|NCT03263091|525664157|FG002|DB Component|Other than specified|0|||
145769441|NCT03263091|525664158|FG003|DB Component|Other than specified|0|||
145769442|NCT03263091|525664159|FG004|DB Component|Other than specified|8|||
145769443|NCT03263091|525664160|FG005|DB Component|Other than specified|6|||
145769444|NCT01821963|525664161|FG000|Overall Study|Adverse Event|1|||
145769445|NCT00783289|525664162|FG000|Overall Study|Protocol Violation|0|||
145769446|NCT00783289|525664163|FG001|Overall Study|Protocol Violation|1|||
145769447|NCT00783289|525664164|FG002|Overall Study|Protocol Violation|0|||
145769448|NCT00783289|525664165|FG003|Overall Study|Protocol Violation|0|||
145769449|NCT01381094|525664167|FG000|Overall Study|Adverse Event|1|||
145769450|NCT01381094|525664168|FG001|Overall Study|Adverse Event|2|||
145769451|NCT01381094|525664169|FG002|Overall Study|Adverse Event|0|||
145769452|NCT01381094|525664170|FG003|Overall Study|Adverse Event|1|||
145769453|NCT01381094|525664171|FG004|Overall Study|Adverse Event|0|||
145769454|NCT01381094|525664167|FG000|Overall Study|Lost to Follow-up|0|||
145769455|NCT01381094|525664168|FG001|Overall Study|Lost to Follow-up|0|||
145769456|NCT01381094|525664169|FG002|Overall Study|Lost to Follow-up|0|||
145769457|NCT01381094|525664170|FG003|Overall Study|Lost to Follow-up|0|||
145769458|NCT01381094|525664171|FG004|Overall Study|Lost to Follow-up|1|||
145769459|NCT01381094|525664167|FG000|Overall Study|Withdrawal of informed consent|0|||
145769460|NCT01381094|525664168|FG001|Overall Study|Withdrawal of informed consent|1|||
145769461|NCT01381094|525664169|FG002|Overall Study|Withdrawal of informed consent|0|||
145769462|NCT01381094|525664170|FG003|Overall Study|Withdrawal of informed consent|0|||
145769463|NCT01381094|525664171|FG004|Overall Study|Withdrawal of informed consent|0|||
145769464|NCT01381094|525664167|FG000|Overall Study|Participant given Aranesp injection|1|||
145769465|NCT01381094|525664168|FG001|Overall Study|Participant given Aranesp injection|0|||
145769466|NCT01381094|525664169|FG002|Overall Study|Participant given Aranesp injection|0|||
145769467|NCT01381094|525664170|FG003|Overall Study|Participant given Aranesp injection|0|||
145769468|NCT01381094|525664171|FG004|Overall Study|Participant given Aranesp injection|0|||
145769469|NCT00486902|525664174|FG000|Overall Study|Withdrawal by Subject|1|||
145769470|NCT00486902|525664175|FG001|Overall Study|Withdrawal by Subject|2|||
145769471|NCT00486902|525664174|FG000|Overall Study|decision for postpartum tubal ligation|3|||
145769472|NCT00486902|525664175|FG001|Overall Study|decision for postpartum tubal ligation|1|||
145769473|NCT00486902|525664174|FG000|Overall Study|spinal anesthetic protocal violation|1|||
145769474|NCT00486902|525664175|FG001|Overall Study|spinal anesthetic protocal violation|1|||
145769475|NCT00486902|525664174|FG000|Overall Study|Did not meet inclusion criteria|1|||
145769476|NCT00486902|525664175|FG001|Overall Study|Did not meet inclusion criteria|0|||
145769477|NCT00486902|525664174|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
145769478|NCT00486902|525664175|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
145769479|NCT01217606|525664178|FG000|Initial Treatment Phase|Other Reasons|0|||
145769480|NCT01217606|525664179|FG001|Initial Treatment Phase|Other Reasons|2|||
145769481|NCT01217606|525664178|FG000|Initial Treatment Phase|Protocol Violation|3|||
145769482|NCT01217606|525664179|FG001|Initial Treatment Phase|Protocol Violation|2|||
145769483|NCT01217606|525664178|FG000|Initial Treatment Phase|Personal Reasons|0|||
145769484|NCT01217606|525664179|FG001|Initial Treatment Phase|Personal Reasons|2|||
145769485|NCT01217606|525664178|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
145769486|NCT01217606|525664179|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
145769487|NCT01217606|525664178|FG000|Initial Treatment Phase|Adverse Event|10|||
145769488|NCT01217606|525664179|FG001|Initial Treatment Phase|Adverse Event|6|||
145769489|NCT01217606|525664178|FG000|9-Month Masked Extension|Adverse Event|3|||
145769490|NCT01217606|525664179|FG001|9-Month Masked Extension|Adverse Event|6|||
145769491|NCT01217606|525664178|FG000|9-Month Masked Extension|Other Reasons|4|||
145769492|NCT01217606|525664179|FG001|9-Month Masked Extension|Other Reasons|4|||
145769493|NCT01217606|525664178|FG000|9-Month Masked Extension|Personal Reasons|2|||
145769494|NCT01217606|525664179|FG001|9-Month Masked Extension|Personal Reasons|1|||
145769495|NCT01217606|525664178|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
145769496|NCT01217606|525664179|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
145769497|NCT01217606|525664178|FG000|9-Month Masked Extension|Pregnancy|1|||
145769498|NCT01217606|525664179|FG001|9-Month Masked Extension|Pregnancy|0|||
145769499|NCT01217606|525664178|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
145769500|NCT01217606|525664179|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
145769501|NCT01552057|525664186|FG000|Overall Study|Adverse Event|14|||
145769502|NCT01552057|525664187|FG001|Overall Study|Adverse Event|15|||
145769503|NCT01552057|525664186|FG000|Overall Study|Lack of Efficacy|8|||
145769504|NCT01552057|525664187|FG001|Overall Study|Lack of Efficacy|23|||
145769505|NCT01552057|525664186|FG000|Overall Study|Withdrawal by Subject|5|||
145769506|NCT01552057|525664187|FG001|Overall Study|Withdrawal by Subject|8|||
145769507|NCT01552057|525664186|FG000|Overall Study|Entry Criteria Not Met|2|||
145769508|NCT01552057|525664187|FG001|Overall Study|Entry Criteria Not Met|2|||
145769509|NCT01552057|525664186|FG000|Overall Study|Physician Decision|1|||
145769510|NCT01552057|525664187|FG001|Overall Study|Physician Decision|0|||
145769511|NCT02900092|525664188|FG000|Overall Study|Adverse Event|1|||
145769512|NCT04178590|525664189|FG000|Overall Study|Pregnancy|1|||
145769513|NCT04178590|525664189|FG000|Overall Study|Lost to Follow-up|1|||
145769514|NCT00996840|525664190|FG000|Overall Study|Adverse Event|0|||
145769515|NCT00996840|525664191|FG001|Overall Study|Adverse Event|1|||
145769516|NCT00996840|525664192|FG002|Overall Study|Adverse Event|0|||
145769517|NCT00996840|525664193|FG003|Overall Study|Adverse Event|0|||
145769518|NCT00996840|525664194|FG004|Overall Study|Adverse Event|0|||
145769519|NCT00996840|525664190|FG000|Overall Study|Physician Decision|0|||
145769520|NCT00996840|525664191|FG001|Overall Study|Physician Decision|0|||
145769521|NCT00996840|525664192|FG002|Overall Study|Physician Decision|1|||
145769522|NCT00996840|525664193|FG003|Overall Study|Physician Decision|1|||
145769523|NCT00996840|525664194|FG004|Overall Study|Physician Decision|2|||
145769524|NCT00996840|525664190|FG000|Overall Study|Withdrawal by Subject|1|||
145769525|NCT00996840|525664191|FG001|Overall Study|Withdrawal by Subject|1|||
145769526|NCT00996840|525664192|FG002|Overall Study|Withdrawal by Subject|0|||
145769527|NCT00996840|525664193|FG003|Overall Study|Withdrawal by Subject|0|||
145769528|NCT00996840|525664194|FG004|Overall Study|Withdrawal by Subject|0|||
145769529|NCT01389245|525664195|FG000|Overall Study|Protocol Violation|10|||
145769530|NCT01389245|525664195|FG000|Overall Study|Lost to Follow-up|3|||
145769531|NCT01389245|525664195|FG000|Overall Study|Withdrawal by Subject|2|||
145769532|NCT02292849|525664196|FG000|Overall Study|Lost to Follow-up|0|||
145769533|NCT02292849|525664197|FG001|Overall Study|Lost to Follow-up|2|||
145769534|NCT02292849|525664198|FG002|Overall Study|Lost to Follow-up|2|||
145769535|NCT02292849|525664196|FG000|Overall Study|Physician Decision|4|||
145769536|NCT02292849|525664197|FG001|Overall Study|Physician Decision|0|||
145769537|NCT02292849|525664198|FG002|Overall Study|Physician Decision|0|||
145769538|NCT00097539|525664199|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
145769539|NCT00097539|525664200|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
145769540|NCT00097539|525664201|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
145769541|NCT00097539|525664202|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
145769542|NCT00097539|525664203|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
145769543|NCT00097539|525664204|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
145769544|NCT00097539|525664205|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
145769545|NCT00097539|525664199|FG000|Overall Study|Withdrawal by Subject|925|||
145769546|NCT00097539|525664200|FG001|Overall Study|Withdrawal by Subject|323|||
145769547|NCT00097539|525664201|FG002|Overall Study|Withdrawal by Subject|346|||
145769548|NCT00097539|525664202|FG003|Overall Study|Withdrawal by Subject|217|||
145769549|NCT00097539|525664203|FG004|Overall Study|Withdrawal by Subject|68|||
145769550|NCT00097539|525664204|FG005|Overall Study|Withdrawal by Subject|229|||
145769551|NCT00097539|525664205|FG006|Overall Study|Withdrawal by Subject|3|||
145769552|NCT00097539|525664199|FG000|Overall Study|Participant Non-compliant|2140|||
145769553|NCT00097539|525664200|FG001|Overall Study|Participant Non-compliant|567|||
145769554|NCT00097539|525664201|FG002|Overall Study|Participant Non-compliant|1067|||
145769555|NCT00097539|525664202|FG003|Overall Study|Participant Non-compliant|353|||
145769556|NCT00097539|525664203|FG004|Overall Study|Participant Non-compliant|136|||
145769557|NCT00097539|525664204|FG005|Overall Study|Participant Non-compliant|543|||
145769558|NCT00097539|525664205|FG006|Overall Study|Participant Non-compliant|18|||
145769559|NCT00097539|525664199|FG000|Overall Study|Lack of Efficacy|249|||
145769560|NCT00097539|525664200|FG001|Overall Study|Lack of Efficacy|122|||
145769561|NCT00097539|525664201|FG002|Overall Study|Lack of Efficacy|202|||
145769562|NCT00097539|525664202|FG003|Overall Study|Lack of Efficacy|105|||
145769563|NCT00097539|525664203|FG004|Overall Study|Lack of Efficacy|45|||
145769564|NCT00097539|525664204|FG005|Overall Study|Lack of Efficacy|228|||
145769565|NCT00097539|525664205|FG006|Overall Study|Lack of Efficacy|5|||
145533817|NCT05439941|524815354|FG000|Overall Study|Adverse Event|1|||
145533818|NCT05439941|524815355|FG001|Overall Study|Adverse Event|3|||
145533819|NCT05439941|524815356|FG002|Overall Study|Adverse Event|0|||
145533820|NCT05439941|524815354|FG000|Overall Study|Adverse Event - Parent Study|1|||
145533821|NCT05439941|524815355|FG001|Overall Study|Adverse Event - Parent Study|0|||
145533822|NCT05439941|524815356|FG002|Overall Study|Adverse Event - Parent Study|0|||
145533823|NCT05439941|524815354|FG000|Overall Study|Pregnancy|1|||
145533824|NCT05439941|524815355|FG001|Overall Study|Pregnancy|0|||
145533825|NCT05439941|524815356|FG002|Overall Study|Pregnancy|0|||
145533826|NCT05439941|524815354|FG000|Overall Study|Withdrawal by Subject|9|||
145533827|NCT05439941|524815355|FG001|Overall Study|Withdrawal by Subject|6|||
145533828|NCT05439941|524815356|FG002|Overall Study|Withdrawal by Subject|10|||
145533829|NCT05439941|524815354|FG000|Overall Study|Non-Compliance|1|||
145533830|NCT05439941|524815355|FG001|Overall Study|Non-Compliance|1|||
145533831|NCT05439941|524815356|FG002|Overall Study|Non-Compliance|1|||
145533832|NCT05439941|524815354|FG000|Overall Study|Lost to Follow-up|2|||
145533833|NCT05439941|524815355|FG001|Overall Study|Lost to Follow-up|2|||
145533834|NCT05439941|524815356|FG002|Overall Study|Lost to Follow-up|0|||
145533835|NCT05439941|524815354|FG000|Overall Study|Physician Decision|1|||
145533836|NCT05439941|524815355|FG001|Overall Study|Physician Decision|0|||
145533837|NCT05439941|524815356|FG002|Overall Study|Physician Decision|0|||
145533838|NCT05439941|524815354|FG000|Overall Study|Trial Termination by Sponsor|78|||
145533839|NCT05439941|524815355|FG001|Overall Study|Trial Termination by Sponsor|83|||
145533840|NCT05439941|524815356|FG002|Overall Study|Trial Termination by Sponsor|65|||
145533841|NCT05439941|524815354|FG000|Overall Study|Other than Reasons Listed|2|||
145533842|NCT05439941|524815355|FG001|Overall Study|Other than Reasons Listed|1|||
145607997|NCT03389477|525079308|FG000|Step 3|Still receiving active treatment|4|||
145607998|NCT03389477|525079309|FG001|Step 3|Still receiving active treatment|0|||
145769566|NCT00097539|525664199|FG000|Overall Study|Adverse Event|78|||
145769567|NCT00097539|525664200|FG001|Overall Study|Adverse Event|133|||
145769568|NCT00097539|525664201|FG002|Overall Study|Adverse Event|37|||
145769569|NCT00097539|525664202|FG003|Overall Study|Adverse Event|27|||
145769570|NCT00097539|525664203|FG004|Overall Study|Adverse Event|30|||
145769571|NCT00097539|525664204|FG005|Overall Study|Adverse Event|59|||
145769572|NCT00097539|525664205|FG006|Overall Study|Adverse Event|1|||
145769573|NCT00097539|525664199|FG000|Overall Study|Death|2|||
145769574|NCT00097539|525664200|FG001|Overall Study|Death|7|||
145769575|NCT00097539|525664201|FG002|Overall Study|Death|0|||
145769576|NCT00097539|525664202|FG003|Overall Study|Death|0|||
145769577|NCT00097539|525664203|FG004|Overall Study|Death|1|||
145769578|NCT00097539|525664204|FG005|Overall Study|Death|3|||
145769579|NCT00097539|525664205|FG006|Overall Study|Death|0|||
145769580|NCT00097539|525664199|FG000|Overall Study|Reasons Other Than Above|3602|||
145769581|NCT00097539|525664200|FG001|Overall Study|Reasons Other Than Above|1382|||
145769582|NCT00097539|525664201|FG002|Overall Study|Reasons Other Than Above|1757|||
145769583|NCT00097539|525664202|FG003|Overall Study|Reasons Other Than Above|692|||
145769584|NCT00097539|525664203|FG004|Overall Study|Reasons Other Than Above|361|||
145769585|NCT00097539|525664204|FG005|Overall Study|Reasons Other Than Above|1244|||
145769586|NCT00097539|525664205|FG006|Overall Study|Reasons Other Than Above|34|||
145533843|NCT05439941|524815356|FG002|Overall Study|Other than Reasons Listed|0|||
145533844|NCT00573183|524815357|FG000|Overall Study|Lost to Follow-up|52|||
145533845|NCT00573183|524815358|FG001|Overall Study|Lost to Follow-up|50|||
145533846|NCT00573183|524815357|FG000|Overall Study|Withdrawal by Subject|8|||
145533847|NCT00573183|524815358|FG001|Overall Study|Withdrawal by Subject|2|||
145769587|NCT00097539|525664199|FG000|Overall Study|Reason not Specified|111|||
145769588|NCT00097539|525664200|FG001|Overall Study|Reason not Specified|49|||
145533848|NCT00573183|524815357|FG000|Overall Study|Death|0|||
145533849|NCT00573183|524815358|FG001|Overall Study|Death|1|||
145769589|NCT00097539|525664201|FG002|Overall Study|Reason not Specified|53|||
145769590|NCT00097539|525664202|FG003|Overall Study|Reason not Specified|21|||
145769591|NCT00097539|525664203|FG004|Overall Study|Reason not Specified|11|||
145769592|NCT00097539|525664204|FG005|Overall Study|Reason not Specified|40|||
145769593|NCT00097539|525664205|FG006|Overall Study|Reason not Specified|2|||
145769594|NCT05127486|525664206|FG000|Overall Study|Adverse Event|2|||
145769595|NCT05127486|525664207|FG001|Overall Study|Adverse Event|4|||
145769596|NCT05127486|525664206|FG000|Overall Study|Lack of Efficacy|1|||
145769597|NCT05127486|525664207|FG001|Overall Study|Lack of Efficacy|0|||
145769598|NCT05127486|525664206|FG000|Overall Study|Pregnancy|0|||
145769599|NCT05127486|525664207|FG001|Overall Study|Pregnancy|1|||
145769600|NCT05127486|525664206|FG000|Overall Study|Physician Decision|4|||
145769601|NCT05127486|525664207|FG001|Overall Study|Physician Decision|1|||
145769602|NCT05127486|525664206|FG000|Overall Study|Withdrawal by Subject|14|||
145769603|NCT05127486|525664207|FG001|Overall Study|Withdrawal by Subject|13|||
145769604|NCT05127486|525664206|FG000|Overall Study|Lost to Follow-up|5|||
145769605|NCT05127486|525664207|FG001|Overall Study|Lost to Follow-up|8|||
145769606|NCT02582515|525664208|FG000|Overall Study|Withdrawal by Subject|0|||
145769607|NCT02582515|525664209|FG001|Overall Study|Withdrawal by Subject|1|||
145769608|NCT00775021|525664210|FG000|First Intervention|Lost to Follow-up|1|||
145769609|NCT00775021|525664211|FG001|First Intervention|Lost to Follow-up|0|||
145769610|NCT00775021|525664210|FG000|Second Intervention|Adverse Event|0|||
145769611|NCT00775021|525664211|FG001|Second Intervention|Adverse Event|1|||
145769612|NCT00363415|525664212|FG000|Overall Study|Progressive Disease|196|||
145769613|NCT00363415|525664213|FG001|Overall Study|Progressive Disease|107|||
145769614|NCT00363415|525664212|FG000|Overall Study|Sponsor Decision|67|||
145769615|NCT00363415|525664213|FG001|Overall Study|Sponsor Decision|31|||
145769616|NCT00363415|525664212|FG000|Overall Study|Death|32|||
145769617|NCT00363415|525664213|FG001|Overall Study|Death|29|||
145769618|NCT00363415|525664212|FG000|Overall Study|Adverse Event|24|||
145769619|NCT00363415|525664213|FG001|Overall Study|Adverse Event|15|||
145769620|NCT00363415|525664212|FG000|Overall Study|Physician Decision|18|||
145769621|NCT00363415|525664213|FG001|Overall Study|Physician Decision|35|||
145769622|NCT00363415|525664212|FG000|Overall Study|Entry Criteria Not Met|11|||
145769623|NCT00363415|525664213|FG001|Overall Study|Entry Criteria Not Met|10|||
145769624|NCT00363415|525664212|FG000|Overall Study|Withdrawal by Subject|9|||
145769625|NCT00363415|525664213|FG001|Overall Study|Withdrawal by Subject|15|||
145769626|NCT00363415|525664212|FG000|Overall Study|Lost to Follow-up|3|||
145769627|NCT00363415|525664213|FG001|Overall Study|Lost to Follow-up|3|||
145769628|NCT00363415|525664212|FG000|Overall Study|Protocol Violation|1|||
145769629|NCT00363415|525664213|FG001|Overall Study|Protocol Violation|4|||
145769630|NCT05027802|525664216|FG000|Overall Study|Adverse Event|2|||
145769631|NCT05027802|525664216|FG000|Overall Study|Withdrawal by Subject|18|||
145769632|NCT05027802|525664216|FG000|Overall Study|Death|2|||
145769633|NCT05027802|525664216|FG000|Overall Study|Other|1|||
145769634|NCT01506141|525664223|FG000|Overall Study|Adverse Event|0|||
145769635|NCT01506141|525664224|FG001|Overall Study|Adverse Event|2|||
145769636|NCT01506141|525664223|FG000|Overall Study|Participation Terminated by Investigator|1|||
145769637|NCT01506141|525664224|FG001|Overall Study|Participation Terminated by Investigator|1|||
145769638|NCT01506141|525664223|FG000|Overall Study|Site Terminated by Sponsor|2|||
145769639|NCT01506141|525664224|FG001|Overall Study|Site Terminated by Sponsor|0|||
145769640|NCT01506141|525664223|FG000|Overall Study|Reason Not Specified|4|||
145769641|NCT01506141|525664224|FG001|Overall Study|Reason Not Specified|2|||
145769642|NCT02725788|525664235|FG000|Overall Study|Lost to Follow-up|1|||
145769643|NCT02725788|525664236|FG001|Overall Study|Lost to Follow-up|1|||
145769644|NCT02725788|525664235|FG000|Overall Study|Protocol Violation|0|||
145769645|NCT02725788|525664236|FG001|Overall Study|Protocol Violation|1|||
145769646|NCT05590377|525664237|FG000|Overall Study|Death|1|||
145769647|NCT05590377|525664238|FG001|Overall Study|Death|1|||
145769648|NCT05590377|525664239|FG002|Overall Study|Death|2|||
145769649|NCT05590377|525664240|FG003|Overall Study|Death|0|||
145769650|NCT05590377|525664241|FG004|Overall Study|Death|0|||
145769651|NCT05590377|525664237|FG000|Overall Study|Study Terminated by Sponsor|1|||
145769652|NCT05590377|525664238|FG001|Overall Study|Study Terminated by Sponsor|5|||
145769653|NCT05590377|525664239|FG002|Overall Study|Study Terminated by Sponsor|4|||
145769654|NCT05590377|525664240|FG003|Overall Study|Study Terminated by Sponsor|0|||
145769655|NCT05590377|525664241|FG004|Overall Study|Study Terminated by Sponsor|0|||
145769656|NCT05590377|525664237|FG000|Overall Study|Withdrawal by Subject|1|||
145769657|NCT05590377|525664238|FG001|Overall Study|Withdrawal by Subject|0|||
145769658|NCT05590377|525664239|FG002|Overall Study|Withdrawal by Subject|0|||
145769659|NCT05590377|525664240|FG003|Overall Study|Withdrawal by Subject|0|||
145769660|NCT05590377|525664241|FG004|Overall Study|Withdrawal by Subject|0|||
145769661|NCT02688647|525664242|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
145769662|NCT02688647|525664243|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
145769663|NCT02688647|525664242|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
145769664|NCT02688647|525664243|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
145769665|NCT02688647|525664242|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
145769666|NCT02688647|525664243|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
145769667|NCT02688647|525664242|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
145769668|NCT02688647|525664243|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
145769669|NCT02688647|525664242|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
145769670|NCT02688647|525664243|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
145769671|NCT02688647|525664242|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
145769672|NCT02688647|525664243|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
145769673|NCT02688647|525664242|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
145769674|NCT02688647|525664243|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
145769675|NCT00828464|525664244|FG000|Overall Study|Withdrawal by Subject|1|||
145769676|NCT02197377|525664248|FG000|Overall Study|Insertion Failure|0|||
145769677|NCT02197377|525664249|FG001|Overall Study|Insertion Failure|3|||
145769678|NCT00502840|525664250|FG000|Overall Study|Adverse Event|5|||
145769679|NCT00502840|525664250|FG000|Overall Study|Additional or changed therapy|48|||
145769680|NCT00502840|525664250|FG000|Overall Study|Lack of Efficacy|11|||
145769681|NCT00502840|525664250|FG000|Overall Study|Protocol Violation|4|||
145769682|NCT00502840|525664250|FG000|Overall Study|Withdrawal by Subject|5|||
145769683|NCT00502840|525664250|FG000|Overall Study|Lost to Follow-up|6|||
145769684|NCT00502840|525664250|FG000|Overall Study|Administrative problems|1|||
145769685|NCT00502840|525664250|FG000|Overall Study|Other|20|||
145769686|NCT01974323|525664251|FG000|Overall Study|Other Reasons|25|||
145769687|NCT01974323|525664252|FG001|Overall Study|Other Reasons|28|||
145769688|NCT01974323|525664251|FG000|Overall Study|Protocol Violation|2|||
145769689|NCT01974323|525664252|FG001|Overall Study|Protocol Violation|2|||
145769690|NCT01974323|525664251|FG000|Overall Study|Personal Reasons|15|||
145769691|NCT01974323|525664252|FG001|Overall Study|Personal Reasons|19|||
145769692|NCT01974323|525664251|FG000|Overall Study|Lost to Follow-up|45|||
145769693|NCT01974323|525664252|FG001|Overall Study|Lost to Follow-up|40|||
145769694|NCT01974323|525664251|FG000|Overall Study|Pregnancy|2|||
145769695|NCT01974323|525664252|FG001|Overall Study|Pregnancy|1|||
145769696|NCT01974323|525664251|FG000|Overall Study|Lack of Efficacy|1|||
145769697|NCT01974323|525664252|FG001|Overall Study|Lack of Efficacy|1|||
145769698|NCT01974323|525664251|FG000|Overall Study|Adverse Event|2|||
145769699|NCT01974323|525664252|FG001|Overall Study|Adverse Event|2|||
145769700|NCT00809133|525664253|FG000|Overall Study|Progressive disease|2|||
145769701|NCT00809133|525664254|FG001|Overall Study|Progressive disease|5|||
145769702|NCT00809133|525664255|FG002|Overall Study|Progressive disease|5|||
145769703|NCT00809133|525664256|FG003|Overall Study|Progressive disease|3|||
145769704|NCT00809133|525664257|FG004|Overall Study|Progressive disease|4|||
145769705|NCT00809133|525664258|FG005|Overall Study|Progressive disease|1|||
145769706|NCT00809133|525664259|FG006|Overall Study|Progressive disease|3|||
145769707|NCT00809133|525664260|FG007|Overall Study|Progressive disease|3|||
145769708|NCT00809133|525664261|FG008|Overall Study|Progressive disease|3|||
145769709|NCT00809133|525664262|FG009|Overall Study|Progressive disease|9|||
145769710|NCT00809133|525664263|FG010|Overall Study|Progressive disease|5|||
145769711|NCT00809133|525664264|FG011|Overall Study|Progressive disease|7|||
145769712|NCT00809133|525664265|FG012|Overall Study|Progressive disease|5|||
145769713|NCT00809133|525664266|FG013|Overall Study|Progressive disease|4|||
145769714|NCT00809133|525664253|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769715|NCT00809133|525664254|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769716|NCT00809133|525664255|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769717|NCT00809133|525664256|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769718|NCT00809133|525664257|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769719|NCT00809133|525664258|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145769720|NCT00809133|525664259|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145769721|NCT00809133|525664260|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145769722|NCT00809133|525664261|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769723|NCT00809133|525664262|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769724|NCT00809133|525664263|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769725|NCT00809133|525664264|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769726|NCT00809133|525664265|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145769727|NCT00809133|525664266|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145769728|NCT00809133|525664253|FG000|Overall Study|Other adverse event|1|||
145769729|NCT00809133|525664254|FG001|Overall Study|Other adverse event|1|||
145769730|NCT00809133|525664255|FG002|Overall Study|Other adverse event|1|||
145769731|NCT00809133|525664256|FG003|Overall Study|Other adverse event|0|||
145769732|NCT00809133|525664257|FG004|Overall Study|Other adverse event|0|||
145769733|NCT00809133|525664258|FG005|Overall Study|Other adverse event|3|||
145769734|NCT00809133|525664259|FG006|Overall Study|Other adverse event|2|||
145769735|NCT00809133|525664260|FG007|Overall Study|Other adverse event|4|||
145292767|NCT06179108|523922228|FG002|Overall Study|Lack of Efficacy|0|||
145769736|NCT00809133|525664261|FG008|Overall Study|Other adverse event|0|||
145769737|NCT00809133|525664262|FG009|Overall Study|Other adverse event|0|||
145769738|NCT00809133|525664263|FG010|Overall Study|Other adverse event|1|||
145769739|NCT00809133|525664264|FG011|Overall Study|Other adverse event|1|||
145769740|NCT00809133|525664265|FG012|Overall Study|Other adverse event|0|||
145769741|NCT00809133|525664266|FG013|Overall Study|Other adverse event|1|||
145769742|NCT00809133|525664253|FG000|Overall Study|Lost to Follow-up|0|||
145769743|NCT00809133|525664254|FG001|Overall Study|Lost to Follow-up|0|||
145769744|NCT00809133|525664255|FG002|Overall Study|Lost to Follow-up|0|||
145769745|NCT00809133|525664256|FG003|Overall Study|Lost to Follow-up|0|||
145769746|NCT00809133|525664257|FG004|Overall Study|Lost to Follow-up|0|||
145769747|NCT00809133|525664258|FG005|Overall Study|Lost to Follow-up|1|||
145769748|NCT00809133|525664259|FG006|Overall Study|Lost to Follow-up|0|||
145769749|NCT00809133|525664260|FG007|Overall Study|Lost to Follow-up|0|||
145769750|NCT00809133|525664261|FG008|Overall Study|Lost to Follow-up|0|||
145769751|NCT00809133|525664262|FG009|Overall Study|Lost to Follow-up|0|||
145769752|NCT00809133|525664263|FG010|Overall Study|Lost to Follow-up|0|||
145769753|NCT00809133|525664264|FG011|Overall Study|Lost to Follow-up|0|||
145769754|NCT00809133|525664265|FG012|Overall Study|Lost to Follow-up|0|||
145769755|NCT00809133|525664266|FG013|Overall Study|Lost to Follow-up|0|||
145769756|NCT00809133|525664253|FG000|Overall Study|Consent withdrawn|0|||
145769757|NCT00809133|525664254|FG001|Overall Study|Consent withdrawn|0|||
145769758|NCT00809133|525664255|FG002|Overall Study|Consent withdrawn|0|||
145607999|NCT03389477|525079308|FG000|Step 3|Progressive disease after 2 cycles|1|||
145769759|NCT00809133|525664256|FG003|Overall Study|Consent withdrawn|0|||
145533850|NCT00573183|524815357|FG000|Overall Study|Adverse Event|2|||
145533851|NCT00573183|524815358|FG001|Overall Study|Adverse Event|0|||
145533852|NCT00573183|524815357|FG000|Overall Study|Incarceration|5|||
145278102|NCT03674827|523868907|FG001|Treatment Phase|Withdrawal by Subject|0|||
145278103|NCT03674827|523868908|FG002|Treatment Phase|Withdrawal by Subject|0|||
145278104|NCT03674827|523868909|FG003|Treatment Phase|Withdrawal by Subject|0|||
145278105|NCT03674827|523868910|FG004|Treatment Phase|Withdrawal by Subject|0|||
145278106|NCT03674827|523868911|FG005|Treatment Phase|Withdrawal by Subject|1|||
145278107|NCT03674827|523868906|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
145278108|NCT03674827|523868907|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
145278109|NCT03674827|523868908|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
145278110|NCT03674827|523868909|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
145278111|NCT03674827|523868910|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
145278112|NCT03674827|523868911|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
145278113|NCT03674827|523868906|FG000|Treatment Phase|Other|0|||
145278114|NCT03674827|523868907|FG001|Treatment Phase|Other|1|||
145278115|NCT03674827|523868908|FG002|Treatment Phase|Other|0|||
145278116|NCT03674827|523868909|FG003|Treatment Phase|Other|0|||
145278117|NCT03674827|523868910|FG004|Treatment Phase|Other|0|||
145278118|NCT03674827|523868911|FG005|Treatment Phase|Other|1|||
145278119|NCT03674827|523868906|FG000|Long-Term Follow-up Phase|Death|2|||
145278120|NCT03674827|523868907|FG001|Long-Term Follow-up Phase|Death|4|||
145278121|NCT03674827|523868908|FG002|Long-Term Follow-up Phase|Death|2|||
145278122|NCT03674827|523868909|FG003|Long-Term Follow-up Phase|Death|3|||
145278123|NCT03674827|523868910|FG004|Long-Term Follow-up Phase|Death|2|||
145278124|NCT03674827|523868911|FG005|Long-Term Follow-up Phase|Death|6|||
145278125|NCT03674827|523868906|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
145278126|NCT03674827|523868907|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
145278127|NCT03674827|523868908|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
145278128|NCT03674827|523868909|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
145278129|NCT03674827|523868910|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
145278130|NCT03674827|523868911|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
145278131|NCT03674827|523868906|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
145278132|NCT03674827|523868907|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
145278133|NCT03674827|523868908|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
145278134|NCT03674827|523868909|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
145278135|NCT03674827|523868910|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
145278136|NCT03674827|523868911|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
145278137|NCT00527397|523868912|FG000|Overall Study|Adverse Event|3|||
145278138|NCT00527397|523868912|FG000|Overall Study|Lack of Efficacy|1|||
145278139|NCT00527397|523868912|FG000|Overall Study|Protocol Violation|1|||
145278140|NCT00527397|523868912|FG000|Overall Study|Withdrawal by Subject|6|||
145278141|NCT00527397|523868912|FG000|Overall Study|Study terminated by sponsor|13|||
145278142|NCT04130919|523868915|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
145278143|NCT04130919|523868916|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
145278144|NCT04130919|523868917|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
145278145|NCT04130919|523868918|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
145278146|NCT04130919|523868919|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
145278147|NCT04130919|523868920|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
145278148|NCT04130919|523868915|FG000|Blinded Treatment Phase|Adverse Event|0|||
145278149|NCT04130919|523868916|FG001|Blinded Treatment Phase|Adverse Event|0|||
145278150|NCT04130919|523868917|FG002|Blinded Treatment Phase|Adverse Event|1|||
145278151|NCT04130919|523868918|FG003|Blinded Treatment Phase|Adverse Event|0|||
145278152|NCT04130919|523868919|FG004|Blinded Treatment Phase|Adverse Event|0|||
145278153|NCT04130919|523868920|FG005|Blinded Treatment Phase|Adverse Event|0|||
145278154|NCT04130919|523868915|FG000|Blinded Treatment Phase|Disease worsening|0|||
145278155|NCT04130919|523868916|FG001|Blinded Treatment Phase|Disease worsening|0|||
145278156|NCT04130919|523868917|FG002|Blinded Treatment Phase|Disease worsening|1|||
145278157|NCT04130919|523868918|FG003|Blinded Treatment Phase|Disease worsening|0|||
145278158|NCT04130919|523868919|FG004|Blinded Treatment Phase|Disease worsening|0|||
145278159|NCT04130919|523868920|FG005|Blinded Treatment Phase|Disease worsening|0|||
145278160|NCT04130919|523868915|FG000|Blinded Treatment Phase|Investigator's decision|0|||
145278161|NCT04130919|523868916|FG001|Blinded Treatment Phase|Investigator's decision|1|||
145278162|NCT04130919|523868917|FG002|Blinded Treatment Phase|Investigator's decision|0|||
145278163|NCT04130919|523868918|FG003|Blinded Treatment Phase|Investigator's decision|0|||
145278164|NCT04130919|523868919|FG004|Blinded Treatment Phase|Investigator's decision|0|||
145278165|NCT04130919|523868920|FG005|Blinded Treatment Phase|Investigator's decision|0|||
145278166|NCT04130919|523868915|FG000|Blinded Treatment Phase|Withdrew consent|1|||
145278167|NCT04130919|523868916|FG001|Blinded Treatment Phase|Withdrew consent|0|||
145278168|NCT04130919|523868917|FG002|Blinded Treatment Phase|Withdrew consent|0|||
145278169|NCT04130919|523868918|FG003|Blinded Treatment Phase|Withdrew consent|0|||
145278170|NCT04130919|523868919|FG004|Blinded Treatment Phase|Withdrew consent|0|||
145278171|NCT04130919|523868920|FG005|Blinded Treatment Phase|Withdrew consent|0|||
145278172|NCT04130919|523868915|FG000|Open-label Treatment Phase|Withdrew consent|0|||
145278173|NCT04130919|523868916|FG001|Open-label Treatment Phase|Withdrew consent|0|||
145278174|NCT04130919|523868917|FG002|Open-label Treatment Phase|Withdrew consent|0|||
145533853|NCT00573183|524815358|FG001|Overall Study|Incarceration|8|||
145533854|NCT00573183|524815357|FG000|Overall Study|Other|5|||
145533855|NCT00573183|524815358|FG001|Overall Study|Other|2|||
145533856|NCT01926015|524815361|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145533857|NCT01926015|524815362|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145533858|NCT01926015|524815361|FG000|Overall Study|Randomized not treated|2|||
145533859|NCT01926015|524815362|FG001|Overall Study|Randomized not treated|0|||
145533860|NCT01364649|524815363|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
145278175|NCT04130919|523868918|FG003|Open-label Treatment Phase|Withdrew consent|1|||
145533861|NCT01364649|524815364|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
145533862|NCT01364649|524815363|FG000|Overall Study|Lack of Efficacy|6|||
145608000|NCT03389477|525079309|FG001|Step 3|Progressive disease after 2 cycles|0|||
145608001|NCT04512066|525079312|FG000|Double-blind Treatment Period|Adverse Event|6|||
145608002|NCT04512066|525079313|FG001|Double-blind Treatment Period|Adverse Event|4|||
145608003|NCT04512066|525079314|FG002|Double-blind Treatment Period|Adverse Event|5|||
145608004|NCT04512066|525079315|FG003|Double-blind Treatment Period|Adverse Event|1|||
145608005|NCT04512066|525079316|FG004|Double-blind Treatment Period|Adverse Event|0|||
145608006|NCT04512066|525079317|FG005|Double-blind Treatment Period|Adverse Event|0|||
145608007|NCT04512066|525079312|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
145278176|NCT04130919|523868919|FG004|Open-label Treatment Phase|Withdrew consent|1|||
145278177|NCT04130919|523868920|FG005|Open-label Treatment Phase|Withdrew consent|1|||
145278178|NCT04130919|523868915|FG000|Open-label Treatment Phase|Disease worsening|0|||
145608008|NCT04512066|525079313|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
145533863|NCT01364649|524815364|FG001|Overall Study|Lack of Efficacy|0|||
145533864|NCT01364649|524815363|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
145278179|NCT04130919|523868916|FG001|Open-label Treatment Phase|Disease worsening|0|||
145278180|NCT04130919|523868917|FG002|Open-label Treatment Phase|Disease worsening|0|||
145278181|NCT04130919|523868918|FG003|Open-label Treatment Phase|Disease worsening|1|||
145278182|NCT04130919|523868919|FG004|Open-label Treatment Phase|Disease worsening|0|||
145278183|NCT04130919|523868920|FG005|Open-label Treatment Phase|Disease worsening|1|||
145278184|NCT04130919|523868915|FG000|Open-label Treatment Phase|Investigator's decision|0|||
145278185|NCT04130919|523868916|FG001|Open-label Treatment Phase|Investigator's decision|0|||
145278186|NCT04130919|523868917|FG002|Open-label Treatment Phase|Investigator's decision|0|||
145278187|NCT04130919|523868918|FG003|Open-label Treatment Phase|Investigator's decision|1|||
145278188|NCT04130919|523868919|FG004|Open-label Treatment Phase|Investigator's decision|0|||
145278189|NCT04130919|523868920|FG005|Open-label Treatment Phase|Investigator's decision|0|||
145278190|NCT04130919|523868915|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
145278191|NCT04130919|523868916|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
145278192|NCT04130919|523868917|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
145278193|NCT04130919|523868918|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
145278194|NCT04130919|523868919|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
145278195|NCT04130919|523868920|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
145403308|NCT00560404|524334359|FG001|Overall Study|Other withdrawal reason|5|||
145403309|NCT05219162|524334360|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
145403310|NCT05219162|524334360|FG000|Overall Study|Withdrawal by Subject|23|||
145403311|NCT02187783|524334369|FG000|Overall Study|Adverse Event|8|||
145403312|NCT02187783|524334369|FG000|Overall Study|Death|3|||
145533865|NCT01364649|524815364|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
145533866|NCT01364649|524815363|FG000|Overall Study|Protocol Deviations|4|||
145533867|NCT01364649|524815364|FG001|Overall Study|Protocol Deviations|8|||
145533868|NCT01364649|524815363|FG000|Overall Study|Withdrawal of Consent|9|||
145278196|NCT04130919|523868915|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
145278197|NCT04130919|523868916|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
145278198|NCT04130919|523868917|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
145278199|NCT04130919|523868918|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
145278200|NCT04130919|523868919|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
145278201|NCT04130919|523868920|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
145278202|NCT02400905|523868921|FG000|Overall Study|Death|24|||
145278203|NCT02400905|523868921|FG000|Overall Study|Lost to Follow-up|18|||
145278204|NCT02400905|523868921|FG000|Overall Study|Withdrawal by Subject|16|||
145278205|NCT02400905|523868921|FG000|Overall Study|Physician Decision|4|||
145278206|NCT02400905|523868921|FG000|Overall Study|Other|1|||
145278207|NCT00061945|523868922|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
145278208|NCT00061945|523868923|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
145278209|NCT00061945|523868922|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
145769760|NCT00809133|525664257|FG004|Overall Study|Consent withdrawn|1|||
145769761|NCT00809133|525664258|FG005|Overall Study|Consent withdrawn|0|||
145278210|NCT00061945|523868923|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
145278211|NCT00061945|523868922|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
145278212|NCT00061945|523868923|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
145278213|NCT00061945|523868922|FG000|Course IV: Alemtuzumab|Early exits|6|||
145278214|NCT00061945|523868923|FG001|Course IV: Alemtuzumab|Early exits|15|||
145278215|NCT01039584|523868924|FG000|Overall Study|Withdrawal by Subject|4|||
145278216|NCT01039584|523868925|FG001|Overall Study|Withdrawal by Subject|2|||
145278217|NCT01039584|523868926|FG002|Overall Study|Withdrawal by Subject|1|||
145278218|NCT01039584|523868924|FG000|Overall Study|Protocol Violation|10|||
145769762|NCT00809133|525664259|FG006|Overall Study|Consent withdrawn|0|||
145769763|NCT00809133|525664260|FG007|Overall Study|Consent withdrawn|0|||
145769764|NCT00809133|525664261|FG008|Overall Study|Consent withdrawn|0|||
145769765|NCT00809133|525664262|FG009|Overall Study|Consent withdrawn|0|||
145769766|NCT00809133|525664263|FG010|Overall Study|Consent withdrawn|0|||
145769767|NCT00809133|525664264|FG011|Overall Study|Consent withdrawn|0|||
145769768|NCT00809133|525664265|FG012|Overall Study|Consent withdrawn|0|||
145769769|NCT00809133|525664266|FG013|Overall Study|Consent withdrawn|0|||
145769770|NCT00809133|525664253|FG000|Overall Study|Other not mentioned above|0|||
145769771|NCT00809133|525664254|FG001|Overall Study|Other not mentioned above|1|||
145769772|NCT00809133|525664255|FG002|Overall Study|Other not mentioned above|0|||
145769773|NCT00809133|525664256|FG003|Overall Study|Other not mentioned above|0|||
145769774|NCT00809133|525664257|FG004|Overall Study|Other not mentioned above|0|||
145769775|NCT00809133|525664258|FG005|Overall Study|Other not mentioned above|1|||
145769776|NCT00809133|525664259|FG006|Overall Study|Other not mentioned above|0|||
145769777|NCT00809133|525664260|FG007|Overall Study|Other not mentioned above|0|||
145769778|NCT00809133|525664261|FG008|Overall Study|Other not mentioned above|0|||
145769779|NCT00809133|525664262|FG009|Overall Study|Other not mentioned above|0|||
145769780|NCT00809133|525664263|FG010|Overall Study|Other not mentioned above|0|||
145769781|NCT00809133|525664264|FG011|Overall Study|Other not mentioned above|0|||
145769782|NCT00809133|525664265|FG012|Overall Study|Other not mentioned above|0|||
145769783|NCT00809133|525664266|FG013|Overall Study|Other not mentioned above|0|||
145769784|NCT03663166|525664267|FG000|Overall Study|Withdrawal by Subject|1|||
145769785|NCT04927312|525664270|FG000|Overall Study|Adverse Event|1|||
145769786|NCT04927312|525664270|FG000|Overall Study|Death|1|||
145769787|NCT04927312|525664270|FG000|Overall Study|Withdrawal by Subject|1|||
145769788|NCT04927312|525664270|FG000|Overall Study|Other|1|||
145769789|NCT04919564|525664278|FG000|Overall Study|Lost to Follow-up|1|||
145769790|NCT04919564|525664279|FG001|Overall Study|Lost to Follow-up|0|||
145278219|NCT01039584|523868925|FG001|Overall Study|Protocol Violation|4|||
145769791|NCT04919564|525664278|FG000|Overall Study|Physician Decision|1|||
145769792|NCT04919564|525664279|FG001|Overall Study|Physician Decision|1|||
145769793|NCT01241786|525664280|FG000|Overall Study|Lack of Efficacy|5|||
145278220|NCT01039584|523868926|FG002|Overall Study|Protocol Violation|6|||
145278221|NCT01039584|523868924|FG000|Overall Study|Lost to Follow-up|5|||
145278222|NCT01039584|523868925|FG001|Overall Study|Lost to Follow-up|3|||
145533869|NCT01364649|524815364|FG001|Overall Study|Withdrawal of Consent|7|||
145533870|NCT01364649|524815363|FG000|Overall Study|Lost to Follow-up|12|||
145533871|NCT01364649|524815364|FG001|Overall Study|Lost to Follow-up|13|||
145533872|NCT01364649|524815363|FG000|Overall Study|Other|4|||
145533873|NCT01364649|524815364|FG001|Overall Study|Other|1|||
145533874|NCT00902668|524815365|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
145533875|NCT00615108|524815366|FG000|Overall Study|Adverse Event|122|||
145533876|NCT00615108|524815366|FG000|Overall Study|Other|370|||
145533877|NCT00615108|524815366|FG000|Overall Study|Lost to Follow-up|15|||
145533878|NCT01914757|524815367|FG000|Overall Study|Severe non-compliance to protocol|3|||
145533879|NCT01914757|524815368|FG001|Overall Study|Severe non-compliance to protocol|1|||
145769794|NCT05340504|525664285|FG000|Overall Study|Withdrawal by Subject|1|||
145769795|NCT05340504|525664286|FG001|Overall Study|Withdrawal by Subject|0|||
145769796|NCT01287104|525664287|FG000|Overall Study|Patient developed progressive disease|1|||
145769797|NCT01287104|525664288|FG001|Overall Study|Patient developed progressive disease|1|||
145769798|NCT01287104|525664289|FG002|Overall Study|Patient developed progressive disease|3|||
145769799|NCT01287104|525664290|FG003|Overall Study|Patient developed progressive disease|2|||
145769800|NCT01287104|525664287|FG000|Overall Study|Donor anaphylaxis|0|||
145769801|NCT01287104|525664288|FG001|Overall Study|Donor anaphylaxis|1|||
145769802|NCT01287104|525664289|FG002|Overall Study|Donor anaphylaxis|0|||
145769803|NCT01287104|525664290|FG003|Overall Study|Donor anaphylaxis|1|||
145769804|NCT01287104|525664287|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
145769805|NCT01287104|525664288|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
145769806|NCT01287104|525664289|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
145769807|NCT01287104|525664290|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
145769808|NCT01287104|525664287|FG000|Overall Study|Low donor chimerism|0|||
145769809|NCT01287104|525664288|FG001|Overall Study|Low donor chimerism|1|||
145769810|NCT01287104|525664289|FG002|Overall Study|Low donor chimerism|0|||
145769811|NCT01287104|525664290|FG003|Overall Study|Low donor chimerism|0|||
145769812|NCT01287104|525664287|FG000|Overall Study|NK cells did not meet release criteria|0|||
145769813|NCT01287104|525664288|FG001|Overall Study|NK cells did not meet release criteria|1|||
145769814|NCT01287104|525664289|FG002|Overall Study|NK cells did not meet release criteria|0|||
145769815|NCT01287104|525664290|FG003|Overall Study|NK cells did not meet release criteria|0|||
145769816|NCT03068715|525664291|FG000|Overall Study|No longer met inclusion criteria|1|||
145769817|NCT03068715|525664292|FG001|Overall Study|No longer met inclusion criteria|0|||
145769818|NCT00098787|525664293|FG000|Overall Study|Never started treatment|3|||
145769819|NCT00098787|525664294|FG001|Overall Study|Never started treatment|2|||
145769820|NCT00098787|525664295|FG002|Overall Study|Never started treatment|1|||
145769821|NCT00098787|525664293|FG000|Overall Study|Ineligible|9|||
145769822|NCT00098787|525664294|FG001|Overall Study|Ineligible|7|||
145769823|NCT00098787|525664295|FG002|Overall Study|Ineligible|3|||
145769824|NCT00098787|525664293|FG000|Overall Study|Disease progression|28|||
145769825|NCT00098787|525664294|FG001|Overall Study|Disease progression|17|||
145769826|NCT00098787|525664295|FG002|Overall Study|Disease progression|23|||
145769827|NCT00098787|525664293|FG000|Overall Study|Adverse Event|8|||
145769828|NCT00098787|525664294|FG001|Overall Study|Adverse Event|17|||
145278223|NCT01039584|523868926|FG002|Overall Study|Lost to Follow-up|4|||
145533880|NCT01914757|524815369|FG002|Overall Study|Severe non-compliance to protocol|2|||
145533881|NCT01914757|524815367|FG000|Overall Study|Lost to Follow-up|5|||
145769829|NCT00098787|525664295|FG002|Overall Study|Adverse Event|8|||
145769830|NCT00098787|525664293|FG000|Overall Study|Death|6|||
145769831|NCT00098787|525664294|FG001|Overall Study|Death|1|||
145769832|NCT00098787|525664295|FG002|Overall Study|Death|0|||
145769833|NCT00098787|525664293|FG000|Overall Study|Withdrawal by Subject|4|||
145769834|NCT00098787|525664294|FG001|Overall Study|Withdrawal by Subject|12|||
145769835|NCT00098787|525664295|FG002|Overall Study|Withdrawal by Subject|6|||
145769836|NCT00098787|525664293|FG000|Overall Study|Alternative therapy|8|||
145769837|NCT00098787|525664294|FG001|Overall Study|Alternative therapy|13|||
145769838|NCT00098787|525664295|FG002|Overall Study|Alternative therapy|13|||
145769839|NCT00098787|525664293|FG000|Overall Study|Other|7|||
145769840|NCT00098787|525664294|FG001|Overall Study|Other|6|||
145769841|NCT00098787|525664295|FG002|Overall Study|Other|9|||
145769842|NCT00686543|525664297|FG000|Overall Study|Adverse Event|9|||
145769843|NCT00686543|525664298|FG001|Overall Study|Adverse Event|1|||
145769844|NCT00686543|525664299|FG002|Overall Study|Adverse Event|3|||
145769845|NCT00686543|525664300|FG003|Overall Study|Adverse Event|2|||
145769846|NCT00686543|525664297|FG000|Overall Study|Withdrawal by Subject|2|||
145769847|NCT00686543|525664298|FG001|Overall Study|Withdrawal by Subject|0|||
145769848|NCT00686543|525664299|FG002|Overall Study|Withdrawal by Subject|0|||
145769849|NCT00686543|525664300|FG003|Overall Study|Withdrawal by Subject|0|||
145769850|NCT00686543|525664297|FG000|Overall Study|Protocol Violation|3|||
145769851|NCT00686543|525664298|FG001|Overall Study|Protocol Violation|0|||
145769852|NCT00686543|525664299|FG002|Overall Study|Protocol Violation|2|||
145769853|NCT00686543|525664300|FG003|Overall Study|Protocol Violation|1|||
145769854|NCT01237951|525664301|FG000|Overall Study|Death|1|||
145769855|NCT00924703|525664304|FG000|Overall Study|Withdrawal by Subject|11|||
145769856|NCT00924703|525664304|FG000|Overall Study|Physician Decision|5|||
145769857|NCT00924703|525664304|FG000|Overall Study|Lost to Follow-up|3|||
145769858|NCT00924703|525664304|FG000|Overall Study|Adverse Event|2|||
145769859|NCT00924703|525664304|FG000|Overall Study|Withdrawal by Sponsor|1|||
145769860|NCT04429022|525664307|FG000|Overall Study|Protocol Violation|18|||
145769861|NCT04429022|525664308|FG001|Overall Study|Protocol Violation|1|||
145769862|NCT00275561|525664309|FG000|Overall Study|Withdrawal by Subject|0|||
145769863|NCT00275561|525664310|FG001|Overall Study|Withdrawal by Subject|1|||
145769864|NCT00275561|525664309|FG000|Overall Study|Travel|1|||
145769865|NCT00275561|525664310|FG001|Overall Study|Travel|1|||
145769866|NCT00275561|525664309|FG000|Overall Study|Scheduling|1|||
145769867|NCT00275561|525664310|FG001|Overall Study|Scheduling|2|||
145769868|NCT00275561|525664309|FG000|Overall Study|Family Issues|0|||
145769869|NCT00275561|525664310|FG001|Overall Study|Family Issues|2|||
145769870|NCT00474240|525665621|FG000|Overall Study|Withdrawal by Subject|1|||
145769871|NCT00474240|525665622|FG001|Overall Study|Withdrawal by Subject|1|||
145769872|NCT00474240|525665623|FG002|Overall Study|Withdrawal by Subject|0|||
145769873|NCT00474240|525665624|FG003|Overall Study|Withdrawal by Subject|2|||
145769874|NCT00474240|525665625|FG004|Overall Study|Withdrawal by Subject|3|||
145769875|NCT00474240|525665626|FG005|Overall Study|Withdrawal by Subject|1|||
145769876|NCT00474240|525665621|FG000|Overall Study|Adverse Event|0|||
145769877|NCT00474240|525665622|FG001|Overall Study|Adverse Event|0|||
145769878|NCT00474240|525665623|FG002|Overall Study|Adverse Event|9|||
145769879|NCT00474240|525665624|FG003|Overall Study|Adverse Event|14|||
145769880|NCT00474240|525665625|FG004|Overall Study|Adverse Event|5|||
145769881|NCT00474240|525665626|FG005|Overall Study|Adverse Event|16|||
145769882|NCT00474240|525665621|FG000|Overall Study|Removed due to lab value|0|||
145769883|NCT00474240|525665622|FG001|Overall Study|Removed due to lab value|0|||
145769884|NCT00474240|525665623|FG002|Overall Study|Removed due to lab value|0|||
145769885|NCT00474240|525665624|FG003|Overall Study|Removed due to lab value|0|||
145769886|NCT00474240|525665625|FG004|Overall Study|Removed due to lab value|0|||
145769887|NCT00474240|525665626|FG005|Overall Study|Removed due to lab value|1|||
145769888|NCT00833092|525665627|FG000|Overall Study|Withdrawal by Subject|2|||
145769889|NCT00833092|525665628|FG001|Overall Study|Withdrawal by Subject|3|||
145769890|NCT00833092|525665627|FG000|Overall Study|Protocol Violation|2|||
145769891|NCT00833092|525665628|FG001|Overall Study|Protocol Violation|1|||
145769892|NCT00833092|525665627|FG000|Overall Study|Diarrhea|0|||
145769893|NCT00833092|525665628|FG001|Overall Study|Diarrhea|2|||
145769894|NCT00833092|525665627|FG000|Overall Study|constipation|0|||
145769895|NCT00833092|525665628|FG001|Overall Study|constipation|1|||
145769896|NCT00619229|525665629|FG000|Overall Study|Withdrawal by Subject|1|||
145769897|NCT00619229|525665630|FG001|Overall Study|Withdrawal by Subject|1|||
145769898|NCT00619229|525665629|FG000|Overall Study|Lost to Follow-up|1|||
145769899|NCT00619229|525665630|FG001|Overall Study|Lost to Follow-up|0|||
145769900|NCT00619229|525665629|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
145769901|NCT00619229|525665630|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
145769902|NCT00619229|525665629|FG000|Overall Study|Investigator planned Cataract Operation|1|||
145769903|NCT00619229|525665630|FG001|Overall Study|Investigator planned Cataract Operation|0|||
145769904|NCT01700829|525665631|FG000|Overall Study|Withdrawal by Subject|1|||
145769905|NCT01700829|525665632|FG001|Overall Study|Withdrawal by Subject|1|||
145769906|NCT01075178|525665633|FG000|Subject Matching|eligible but not matched|130|||
145769907|NCT01075178|525665634|FG001|Subject Matching|eligible but not matched|403|||
145769908|NCT01075178|525665633|FG000|Subject Chart Review|died before chart review period|0|||
145769909|NCT01075178|525665634|FG001|Subject Chart Review|died before chart review period|2|||
145769910|NCT01075178|525665633|FG000|Subject Chart Review|no data collected due to site closure|3|||
145769911|NCT01075178|525665634|FG001|Subject Chart Review|no data collected due to site closure|4|||
145769912|NCT01075178|525665633|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
145769913|NCT01075178|525665634|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
145769914|NCT02983604|525665635|FG000|Overall Study|Enrolled but not Treated|0|||
145769915|NCT02983604|525665636|FG001|Overall Study|Enrolled but not Treated|0|||
145769916|NCT02983604|525665637|FG002|Overall Study|Enrolled but not Treated|1|||
145769917|NCT02983604|525665638|FG003|Overall Study|Enrolled but not Treated|0|||
145769918|NCT00355264|525665639|FG000|Extension (Variable Duration)|Adverse Event|1|||
145769919|NCT00355264|525665639|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
145769920|NCT00699192|525665640|FG000|Overall Study|Missing|1|||
145769921|NCT00699192|525665641|FG001|Overall Study|Missing|1|||
145769922|NCT00699192|525665642|FG002|Overall Study|Missing|1|||
145769923|NCT00699192|525665640|FG000|Overall Study|Adverse Event|9|||
145769924|NCT00699192|525665641|FG001|Overall Study|Adverse Event|4|||
145769925|NCT00699192|525665642|FG002|Overall Study|Adverse Event|3|||
145769926|NCT00699192|525665640|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145769927|NCT00699192|525665641|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145769928|NCT00699192|525665642|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145769929|NCT00699192|525665640|FG000|Overall Study|Lack of Efficacy|0|||
145769930|NCT00699192|525665641|FG001|Overall Study|Lack of Efficacy|0|||
145769931|NCT00699192|525665642|FG002|Overall Study|Lack of Efficacy|1|||
145769932|NCT00699192|525665640|FG000|Overall Study|Withdrawal by Subject|3|||
145769933|NCT00699192|525665641|FG001|Overall Study|Withdrawal by Subject|2|||
145769934|NCT00699192|525665642|FG002|Overall Study|Withdrawal by Subject|4|||
145769935|NCT00699192|525665640|FG000|Overall Study|Administrative problems|1|||
145769936|NCT00699192|525665641|FG001|Overall Study|Administrative problems|3|||
145769937|NCT00699192|525665642|FG002|Overall Study|Administrative problems|1|||
145769938|NCT00699192|525665640|FG000|Overall Study|Protocol Violation|2|||
145769939|NCT00699192|525665641|FG001|Overall Study|Protocol Violation|2|||
145769940|NCT00699192|525665642|FG002|Overall Study|Protocol Violation|0|||
145769941|NCT00929240|525665643|FG000|Initial Treatment Phase|Adverse Event|31|||
145769942|NCT00929240|525665644|FG001|Initial Treatment Phase|Adverse Event|0|||
145769943|NCT00929240|525665645|FG002|Initial Treatment Phase|Adverse Event|0|||
145769944|NCT00929240|525665643|FG000|Initial Treatment Phase|Disease progression|41|||
145769945|NCT00929240|525665644|FG001|Initial Treatment Phase|Disease progression|0|||
145769946|NCT00929240|525665645|FG002|Initial Treatment Phase|Disease progression|0|||
145769947|NCT00929240|525665643|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
145769948|NCT00929240|525665644|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
145769949|NCT00929240|525665645|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
145769950|NCT00929240|525665643|FG000|Initial Treatment Phase|Protocol Violation|5|||
145769951|NCT00929240|525665644|FG001|Initial Treatment Phase|Protocol Violation|0|||
145769952|NCT00929240|525665645|FG002|Initial Treatment Phase|Protocol Violation|0|||
145769953|NCT00929240|525665643|FG000|Initial Treatment Phase|Death|2|||
145769954|NCT00929240|525665644|FG001|Initial Treatment Phase|Death|0|||
145769955|NCT00929240|525665645|FG002|Initial Treatment Phase|Death|0|||
145769956|NCT00929240|525665643|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
145769957|NCT00929240|525665644|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
145769958|NCT00929240|525665645|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
145769959|NCT00929240|525665643|FG000|Initial Treatment Phase|Physician Decision|4|||
145769960|NCT00929240|525665644|FG001|Initial Treatment Phase|Physician Decision|0|||
145769961|NCT00929240|525665645|FG002|Initial Treatment Phase|Physician Decision|0|||
145769962|NCT00929240|525665643|FG000|Maintenance Phase|Disease progression|0|||
145769963|NCT00929240|525665644|FG001|Maintenance Phase|Disease progression|73|||
145769964|NCT00929240|525665645|FG002|Maintenance Phase|Disease progression|60|||
145769965|NCT00929240|525665643|FG000|Maintenance Phase|Adverse Event|0|||
145769966|NCT00929240|525665644|FG001|Maintenance Phase|Adverse Event|9|||
145608009|NCT04512066|525079314|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
145608010|NCT04512066|525079315|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
145769967|NCT00929240|525665645|FG002|Maintenance Phase|Adverse Event|12|||
145769968|NCT00929240|525665643|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145769969|NCT00929240|525665644|FG001|Maintenance Phase|Withdrawal by Subject|2|||
145769970|NCT00929240|525665645|FG002|Maintenance Phase|Withdrawal by Subject|6|||
145769971|NCT00929240|525665643|FG000|Maintenance Phase|Protocol Violation|0|||
145769972|NCT00929240|525665644|FG001|Maintenance Phase|Protocol Violation|1|||
145769973|NCT00929240|525665645|FG002|Maintenance Phase|Protocol Violation|0|||
145769974|NCT00929240|525665643|FG000|Maintenance Phase|Health authority/Study termination|0|||
145769975|NCT00929240|525665644|FG001|Maintenance Phase|Health authority/Study termination|1|||
145769976|NCT00929240|525665645|FG002|Maintenance Phase|Health authority/Study termination|2|||
145769977|NCT00929240|525665643|FG000|Maintenance Phase|Physician Decision|0|||
145769978|NCT00929240|525665644|FG001|Maintenance Phase|Physician Decision|2|||
145769979|NCT00929240|525665645|FG002|Maintenance Phase|Physician Decision|1|||
145769980|NCT00929240|525665643|FG000|Maintenance Phase|Change of treatment|0|||
145769981|NCT00929240|525665644|FG001|Maintenance Phase|Change of treatment|4|||
145769982|NCT00929240|525665645|FG002|Maintenance Phase|Change of treatment|0|||
145292768|NCT06179108|523922229|FG003|Overall Study|Lack of Efficacy|1|||
145769983|NCT00929240|525665643|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
145769984|NCT00929240|525665644|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
145769985|NCT00929240|525665645|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
145769986|NCT00929240|525665643|FG000|Maintenance Phase|Participant not treated|0|||
145769987|NCT00929240|525665644|FG001|Maintenance Phase|Participant not treated|2|||
145769988|NCT00929240|525665645|FG002|Maintenance Phase|Participant not treated|0|||
145769989|NCT02203149|525665650|FG000|Part 1|Adverse Event|0|||
145769990|NCT02203149|525665651|FG001|Part 1|Adverse Event|1|||
145769991|NCT02203149|525665652|FG002|Part 1|Adverse Event|0|||
145769992|NCT02203149|525665653|FG003|Part 1|Adverse Event|0|||
145769993|NCT02203149|525665654|FG004|Part 1|Adverse Event|0|||
145769994|NCT02203149|525665650|FG000|Part 2|Death|0|||
145769995|NCT02203149|525665651|FG001|Part 2|Death|0|||
145769996|NCT02203149|525665652|FG002|Part 2|Death|1|||
145769997|NCT02203149|525665653|FG003|Part 2|Death|1|||
145769998|NCT02203149|525665654|FG004|Part 2|Death|0|||
145769999|NCT02203149|525665650|FG000|Part 2|Withdrawal by Subject|0|||
145770000|NCT02203149|525665651|FG001|Part 2|Withdrawal by Subject|0|||
145770001|NCT02203149|525665652|FG002|Part 2|Withdrawal by Subject|0|||
145770002|NCT02203149|525665653|FG003|Part 2|Withdrawal by Subject|1|||
145770003|NCT02203149|525665654|FG004|Part 2|Withdrawal by Subject|0|||
145770004|NCT02203149|525665650|FG000|Part 2|Adverse Event|0|||
145770005|NCT02203149|525665651|FG001|Part 2|Adverse Event|0|||
145770006|NCT02203149|525665652|FG002|Part 2|Adverse Event|0|||
145770007|NCT02203149|525665653|FG003|Part 2|Adverse Event|1|||
145770008|NCT02203149|525665654|FG004|Part 2|Adverse Event|1|||
145770009|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
145770010|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
145770011|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
145770012|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
145770013|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
145770014|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
145770015|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
145770016|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
145770017|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
145770018|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
145770019|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
145770020|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
145770021|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
145770022|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
145770023|NCT00446030|525665655|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
145770024|NCT00446030|525665656|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
145770025|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
145770026|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
145770027|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
145770028|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
145770029|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
145770030|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
145770031|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
145770032|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
145770033|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
145770034|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
145770035|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
145770036|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
145770037|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
145770038|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
145770039|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
145770040|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
145608011|NCT04512066|525079316|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
145608012|NCT04512066|525079317|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
145608013|NCT04512066|525079312|FG000|Double-blind Treatment Period|Physician Decision|1|||
145770041|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
145770042|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
145770043|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
145770044|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
145770045|NCT00446030|525665655|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
145770046|NCT00446030|525665656|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
145770047|NCT00503399|525665659|FG000|Overall Study|Death|2|||
145770048|NCT00503399|525665660|FG001|Overall Study|Death|1|||
145770049|NCT00503399|525665659|FG000|Overall Study|Protocol Violation|1|||
145770050|NCT00503399|525665660|FG001|Overall Study|Protocol Violation|0|||
145770051|NCT00503399|525665659|FG000|Overall Study|Withdrawal by Subject|4|||
145770052|NCT00503399|525665660|FG001|Overall Study|Withdrawal by Subject|2|||
145608014|NCT04512066|525079313|FG001|Double-blind Treatment Period|Physician Decision|0|||
145770053|NCT00503399|525665659|FG000|Overall Study|Adverse Event|0|||
145770054|NCT00503399|525665660|FG001|Overall Study|Adverse Event|3|||
145770055|NCT00503399|525665659|FG000|Overall Study|Lost to Follow-up|0|||
145770056|NCT00503399|525665660|FG001|Overall Study|Lost to Follow-up|2|||
145770057|NCT00858832|525665661|FG000|Overall Study|became ineligible: delivered vaginally|1|||
145770058|NCT00858832|525665662|FG001|Overall Study|became ineligible: delivered vaginally|0|||
145770059|NCT00858832|525665661|FG000|Overall Study|Adverse Event|0|||
145770060|NCT00858832|525665662|FG001|Overall Study|Adverse Event|1|||
145770061|NCT00432809|525665663|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
145770062|NCT00432809|525665664|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
145770063|NCT00432809|525665665|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
145770064|NCT00432809|525665663|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
145770065|NCT00432809|525665664|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
145770066|NCT00432809|525665665|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
145770067|NCT03075839|525665666|FG000|Overall Study|Lost to Follow-up|4|||
145770068|NCT04433117|525665667|FG000|Overall Study|Withdrawal by Subject|1|||
145770069|NCT04433117|525665668|FG001|Overall Study|Withdrawal by Subject|0|||
145770070|NCT00190775|525665669|FG000|Overall Study|Adverse Event|57|||
145770071|NCT00190775|525665670|FG001|Overall Study|Adverse Event|22|||
145770072|NCT00190775|525665669|FG000|Overall Study|Satisfactory Response|1|||
145770073|NCT00190775|525665670|FG001|Overall Study|Satisfactory Response|0|||
145770074|NCT00190775|525665669|FG000|Overall Study|Lack of Efficacy|28|||
145770075|NCT00190775|525665670|FG001|Overall Study|Lack of Efficacy|32|||
145770076|NCT00190775|525665669|FG000|Overall Study|Lost to Follow-up|31|||
145770077|NCT00190775|525665670|FG001|Overall Study|Lost to Follow-up|23|||
145770078|NCT00190775|525665669|FG000|Overall Study|Participant Moved|0|||
145770079|NCT00190775|525665670|FG001|Overall Study|Participant Moved|1|||
145770080|NCT00190775|525665669|FG000|Overall Study|Withdrawal by Subject|24|||
145770081|NCT00190775|525665670|FG001|Overall Study|Withdrawal by Subject|13|||
145770082|NCT00190775|525665669|FG000|Overall Study|Sponsor Decision|1|||
145770083|NCT00190775|525665670|FG001|Overall Study|Sponsor Decision|0|||
145770084|NCT00190775|525665669|FG000|Overall Study|Physician Decision|3|||
145770085|NCT00190775|525665670|FG001|Overall Study|Physician Decision|0|||
145770086|NCT00190775|525665669|FG000|Overall Study|Noncompliance|3|||
145770087|NCT00190775|525665670|FG001|Overall Study|Noncompliance|5|||
145770088|NCT00190775|525665669|FG000|Overall Study|Protocol Violation|0|||
145770089|NCT00190775|525665670|FG001|Overall Study|Protocol Violation|1|||
145770090|NCT00190775|525665669|FG000|Overall Study|Exclusion Criteria Met|1|||
145770091|NCT00190775|525665670|FG001|Overall Study|Exclusion Criteria Met|3|||
145770092|NCT01491945|525665671|FG000|Overall Study|Death|30|||
145770093|NCT01491945|525665671|FG000|Overall Study|Withdrwan/LTF|16|||
145770094|NCT01491945|525665671|FG000|Overall Study|Conversion|4|||
145770095|NCT01491945|525665671|FG000|Overall Study|Missed Visit|1|||
145770096|NCT01709331|525665674|FG000|Overall Study|Adverse Event|1|||
145770097|NCT04325503|525665689|FG000|Overall Study|Withdrawal by Subject|1|||
145770098|NCT04325503|525665689|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
145770099|NCT01642212|525665690|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
145533882|NCT01914757|524815368|FG001|Overall Study|Lost to Follow-up|8|||
145770100|NCT01642212|525665691|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
145770101|NCT01642212|525665692|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
145770102|NCT01642212|525665693|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
145770103|NCT01642212|525665694|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
145770104|NCT01642212|525665690|FG000|Double-blind Treatment|Other|0|||
145770105|NCT01642212|525665691|FG001|Double-blind Treatment|Other|2|||
145770106|NCT01642212|525665692|FG002|Double-blind Treatment|Other|1|||
145770107|NCT01642212|525665693|FG003|Double-blind Treatment|Other|0|||
145770108|NCT01642212|525665694|FG004|Double-blind Treatment|Other|0|||
145770109|NCT01642212|525665690|FG000|Double-blind Treatment|Non-compliance|0|||
145770110|NCT01642212|525665691|FG001|Double-blind Treatment|Non-compliance|1|||
145770111|NCT01642212|525665692|FG002|Double-blind Treatment|Non-compliance|0|||
145770112|NCT01642212|525665693|FG003|Double-blind Treatment|Non-compliance|0|||
145770113|NCT01642212|525665694|FG004|Double-blind Treatment|Non-compliance|0|||
145770114|NCT01642212|525665690|FG000|Double-blind Treatment|Adverse Event|0|||
145770115|NCT01642212|525665691|FG001|Double-blind Treatment|Adverse Event|0|||
145770116|NCT01642212|525665692|FG002|Double-blind Treatment|Adverse Event|1|||
145770117|NCT01642212|525665693|FG003|Double-blind Treatment|Adverse Event|0|||
145770118|NCT01642212|525665694|FG004|Double-blind Treatment|Adverse Event|0|||
145770119|NCT01642212|525665690|FG000|Open-label Extension|Adverse Event|0|||
145770120|NCT01642212|525665691|FG001|Open-label Extension|Adverse Event|0|||
145770121|NCT01642212|525665692|FG002|Open-label Extension|Adverse Event|0|||
145770122|NCT01642212|525665693|FG003|Open-label Extension|Adverse Event|3|||
145770123|NCT01642212|525665694|FG004|Open-label Extension|Adverse Event|0|||
145770124|NCT01642212|525665690|FG000|Open-label Extension|Sponsor Decision|0|||
145770125|NCT01642212|525665691|FG001|Open-label Extension|Sponsor Decision|0|||
145770126|NCT01642212|525665692|FG002|Open-label Extension|Sponsor Decision|0|||
145770127|NCT01642212|525665693|FG003|Open-label Extension|Sponsor Decision|7|||
145770128|NCT01642212|525665694|FG004|Open-label Extension|Sponsor Decision|4|||
145770129|NCT01642212|525665690|FG000|Open-label Extension|Consent Withdrawn|0|||
145770130|NCT01642212|525665691|FG001|Open-label Extension|Consent Withdrawn|0|||
145770131|NCT01642212|525665692|FG002|Open-label Extension|Consent Withdrawn|0|||
145770132|NCT01642212|525665693|FG003|Open-label Extension|Consent Withdrawn|0|||
145770133|NCT01642212|525665694|FG004|Open-label Extension|Consent Withdrawn|2|||
145770134|NCT01642212|525665690|FG000|Open-label Extension|Lost to Follow-up|0|||
145770135|NCT01642212|525665691|FG001|Open-label Extension|Lost to Follow-up|0|||
145770136|NCT01642212|525665692|FG002|Open-label Extension|Lost to Follow-up|0|||
145770137|NCT01642212|525665693|FG003|Open-label Extension|Lost to Follow-up|0|||
145770138|NCT01642212|525665694|FG004|Open-label Extension|Lost to Follow-up|1|||
145770139|NCT01642212|525665690|FG000|Open-label Extension|Other|0|||
145770140|NCT01642212|525665691|FG001|Open-label Extension|Other|0|||
145770141|NCT01642212|525665692|FG002|Open-label Extension|Other|0|||
145770142|NCT01642212|525665693|FG003|Open-label Extension|Other|0|||
145770143|NCT01642212|525665694|FG004|Open-label Extension|Other|1|||
145770144|NCT01243268|525665695|FG000|Overall Study|Lost to Follow-up|4|||
145770145|NCT01243268|525665695|FG000|Overall Study|Protocol Violation|51|||
145770146|NCT01243268|525665695|FG000|Overall Study|Deviation with contract date|7|||
145770147|NCT01243268|525665695|FG000|Overall Study|Duplicate subject|2|||
145770148|NCT01564784|525665696|FG000|Overall Study|Other|1|||
145770149|NCT01564784|525665697|FG001|Overall Study|Other|0|||
145770150|NCT01564784|525665696|FG000|Overall Study|Subject refused further follow-up|1|||
145770151|NCT01564784|525665697|FG001|Overall Study|Subject refused further follow-up|6|||
145770152|NCT01564784|525665696|FG000|Overall Study|Lost to Follow-up|1|||
145770153|NCT01564784|525665697|FG001|Overall Study|Lost to Follow-up|1|||
145770154|NCT01564784|525665696|FG000|Overall Study|Death|131|||
145770155|NCT01564784|525665697|FG001|Overall Study|Death|126|||
145770156|NCT02272790|525665698|FG000|Overall Study|Physician Decision|0|||
145770157|NCT02272790|525665699|FG001|Overall Study|Physician Decision|1|||
145770158|NCT02272790|525665700|FG002|Overall Study|Physician Decision|0|||
145770159|NCT02272790|525665701|FG003|Overall Study|Physician Decision|0|||
145770160|NCT02272790|525665702|FG004|Overall Study|Physician Decision|0|||
145770161|NCT02272790|525665703|FG005|Overall Study|Physician Decision|0|||
145770162|NCT00332202|525665704|FG000|Overall Study|Adverse Event|72|||
145770163|NCT00332202|525665705|FG001|Overall Study|Adverse Event|28|||
145770164|NCT00332202|525665704|FG000|Overall Study|Lost to Follow-up|2|||
145770165|NCT00332202|525665705|FG001|Overall Study|Lost to Follow-up|1|||
145770166|NCT00332202|525665704|FG000|Overall Study|Physician Decision|6|||
145770167|NCT00332202|525665705|FG001|Overall Study|Physician Decision|8|||
145770168|NCT00332202|525665704|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
145770169|NCT00332202|525665705|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
145770170|NCT00332202|525665704|FG000|Overall Study|Protocol Violation|7|||
145770171|NCT00332202|525665705|FG001|Overall Study|Protocol Violation|2|||
145770172|NCT00332202|525665704|FG000|Overall Study|Sponsor Decision|1|||
145770173|NCT00332202|525665705|FG001|Overall Study|Sponsor Decision|2|||
145770174|NCT00332202|525665704|FG000|Overall Study|Withdrawal by Subject|36|||
145770175|NCT00332202|525665705|FG001|Overall Study|Withdrawal by Subject|17|||
145770176|NCT00332202|525665704|FG000|Overall Study|Progressive Disease|106|||
145770177|NCT00332202|525665705|FG001|Overall Study|Progressive Disease|60|||
145770178|NCT00332202|525665704|FG000|Overall Study|Death|5|||
145770179|NCT00332202|525665705|FG001|Overall Study|Death|2|||
145770180|NCT00957853|525665706|FG000|Overall Study|Withdrawal by Subject|1|||
145770181|NCT00957853|525665707|FG001|Overall Study|Withdrawal by Subject|0|||
145770182|NCT00957853|525665708|FG002|Overall Study|Withdrawal by Subject|0|||
145770183|NCT04091217|525665715|FG000|Overall Study|Lost to Follow-up|2|||
145770184|NCT01822561|525665718|FG000|Overall Study|Withdrawal by Subject|2|||
145770185|NCT02747004|525665719|FG000|Overall Study|Withdrawal by Subject|8|||
145770186|NCT02747004|525665720|FG001|Overall Study|Withdrawal by Subject|5|||
145770187|NCT02747004|525665721|FG002|Overall Study|Withdrawal by Subject|4|||
145770188|NCT02747004|525665719|FG000|Overall Study|Lost to Follow-up|1|||
145770189|NCT02747004|525665720|FG001|Overall Study|Lost to Follow-up|2|||
145770190|NCT02747004|525665721|FG002|Overall Study|Lost to Follow-up|2|||
145770191|NCT02747004|525665719|FG000|Overall Study|on study treatment/follow-up|48|||
145770192|NCT02747004|525665720|FG001|Overall Study|on study treatment/follow-up|42|||
145770193|NCT02747004|525665721|FG002|Overall Study|on study treatment/follow-up|41|||
145770194|NCT01444300|525665722|FG000|Overall Study|Adverse Event|4|||
145770195|NCT01444300|525665723|FG001|Overall Study|Adverse Event|0|||
145770196|NCT00752986|525665731|FG000|Overall Study|Withdrawal by Subject|2|||
145770197|NCT00752986|525665732|FG001|Overall Study|Withdrawal by Subject|1|||
145770198|NCT00752986|525665733|FG002|Overall Study|Withdrawal by Subject|2|||
145770199|NCT00752986|525665731|FG000|Overall Study|Protocol Violation|3|||
145770200|NCT00752986|525665732|FG001|Overall Study|Protocol Violation|0|||
145770201|NCT00752986|525665733|FG002|Overall Study|Protocol Violation|0|||
145770202|NCT01697345|525665737|FG000|Overall Study|Withdrawal by Subject|1|||
145770203|NCT02970929|525665738|FG000|Overall Study|Adverse Event|18|||
145770204|NCT02970929|525665738|FG000|Overall Study|Lack of Efficacy|8|||
145770205|NCT02970929|525665738|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
145770206|NCT02970929|525665738|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
145770207|NCT02970929|525665738|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
145770208|NCT02970929|525665738|FG000|Overall Study|LOST TO FOLLOWUP|6|||
145770209|NCT02970929|525665738|FG000|Overall Study|MOVED OUT OF STATE|1|||
145770210|NCT02970929|525665738|FG000|Overall Study|Withdrawal by Subject|16|||
145292769|NCT06179108|523922226|FG000|Overall Study|Death|0|||
145533883|NCT01914757|524815369|FG002|Overall Study|Lost to Follow-up|6|||
145533884|NCT01914757|524815367|FG000|Overall Study|Withdrawal by Subject|15|||
145533885|NCT01914757|524815368|FG001|Overall Study|Withdrawal by Subject|27|||
145770211|NCT02370121|525665745|FG000|Overall Study|Lost to Follow-up|1|||
145770212|NCT02370121|525665746|FG001|Overall Study|Lost to Follow-up|1|||
145770213|NCT01523873|525665747|FG000|Overall Study|Protocol Violation|422|||
145770214|NCT02582658|525665749|FG000|Overall Study|Failure to Return|10|||
145770215|NCT02582658|525665749|FG000|Overall Study|Insufficient Virological Response|2|||
145770216|NCT02582658|525665749|FG000|Overall Study|Withdrawn Consent|1|||
145770217|NCT02582658|525665749|FG000|Overall Study|Death|1|||
145770218|NCT02582658|525665749|FG000|Overall Study|Not further specified|11|||
145770219|NCT00377962|525667351|FG000|Core Study: 0-12 Months|Adverse Event|18|||
145770220|NCT00377962|525667352|FG001|Core Study: 0-12 Months|Adverse Event|2|||
145770221|NCT00377962|525667351|FG000|Core Study: 0-12 Months|Death|3|||
145770222|NCT00377962|525667352|FG001|Core Study: 0-12 Months|Death|0|||
145770223|NCT00377962|525667351|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
145770224|NCT00377962|525667352|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
145770225|NCT00377962|525667351|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
145770226|NCT00377962|525667352|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
145770227|NCT00377962|525667351|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
145770228|NCT00377962|525667352|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
145770229|NCT00377962|525667351|FG000|Extension Study: 12-24 Months|Death|1|||
145770230|NCT00377962|525667352|FG001|Extension Study: 12-24 Months|Death|1|||
145770231|NCT00377962|525667351|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
145770232|NCT00377962|525667352|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
145770233|NCT00377962|525667351|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
145770234|NCT00377962|525667352|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
145770235|NCT00377962|525667351|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
145770236|NCT00377962|525667352|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
145770237|NCT00374556|525667353|FG000|Overall Study|Lost to Follow-up|1|||
145770238|NCT00374556|525667354|FG001|Overall Study|Lost to Follow-up|0|||
145770239|NCT00374556|525667353|FG000|Overall Study|Removed at baseline due to medical cond|0|||
145770240|NCT00374556|525667354|FG001|Overall Study|Removed at baseline due to medical cond|1|||
145770241|NCT00686205|525667360|FG000|Overall Study|Protocol Violation|127|||
145770242|NCT00686205|525667361|FG001|Overall Study|Protocol Violation|0|||
145770243|NCT00686205|525667360|FG000|Overall Study|Withdrawal by Subject|2|||
145770244|NCT00686205|525667361|FG001|Overall Study|Withdrawal by Subject|0|||
145770245|NCT00686205|525667360|FG000|Overall Study|Specimen handling procedure altered|5878|||
145770246|NCT00686205|525667361|FG001|Overall Study|Specimen handling procedure altered|0|||
145770247|NCT00686205|525667360|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
145770248|NCT00686205|525667361|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
145770249|NCT00265941|525667362|FG000|Overall Study|Protocol Violation|22|||
145770250|NCT00265941|525667363|FG001|Overall Study|Protocol Violation|25|||
145770251|NCT00265941|525667362|FG000|Overall Study|Lost to Follow-up|1|||
145770252|NCT00265941|525667363|FG001|Overall Study|Lost to Follow-up|1|||
145770253|NCT02432807|525667366|FG000|Overall Study|Adverse Event|0|||
145770254|NCT02432807|525667367|FG001|Overall Study|Adverse Event|2|||
145770255|NCT02432807|525667366|FG000|Overall Study|Lost to Follow-up|1|||
145770256|NCT02432807|525667367|FG001|Overall Study|Lost to Follow-up|0|||
145770257|NCT02432807|525667366|FG000|Overall Study|Withdrawal by Subject|1|||
145770258|NCT02432807|525667367|FG001|Overall Study|Withdrawal by Subject|1|||
145770259|NCT02432807|525667366|FG000|Overall Study|Other|1|||
145770260|NCT02432807|525667367|FG001|Overall Study|Other|1|||
145770261|NCT01794780|525667368|FG000|Overall Study|Adverse Event|0|||
145770262|NCT01794780|525667369|FG001|Overall Study|Adverse Event|1|||
145770263|NCT01794780|525667370|FG002|Overall Study|Adverse Event|2|||
145770264|NCT01794780|525667371|FG003|Overall Study|Adverse Event|0|||
145770265|NCT01794780|525667372|FG004|Overall Study|Adverse Event|0|||
145770266|NCT01794780|525667373|FG005|Overall Study|Adverse Event|0|||
145770267|NCT01794780|525667374|FG006|Overall Study|Adverse Event|0|||
145770268|NCT01794780|525667375|FG007|Overall Study|Adverse Event|0|||
145770269|NCT01794780|525667368|FG000|Overall Study|Death|0|||
145770270|NCT01794780|525667369|FG001|Overall Study|Death|2|||
145770271|NCT01794780|525667370|FG002|Overall Study|Death|14|||
145770272|NCT01794780|525667371|FG003|Overall Study|Death|1|||
145770273|NCT01794780|525667372|FG004|Overall Study|Death|0|||
145770274|NCT01794780|525667373|FG005|Overall Study|Death|9|||
145770275|NCT01794780|525667374|FG006|Overall Study|Death|4|||
145770276|NCT01794780|525667375|FG007|Overall Study|Death|0|||
145770277|NCT01794780|525667368|FG000|Overall Study|Lost to Follow-up|10|||
145770278|NCT01794780|525667369|FG001|Overall Study|Lost to Follow-up|64|||
145770279|NCT01794780|525667370|FG002|Overall Study|Lost to Follow-up|165|||
145770280|NCT01794780|525667371|FG003|Overall Study|Lost to Follow-up|53|||
145770281|NCT01794780|525667372|FG004|Overall Study|Lost to Follow-up|2|||
145770282|NCT01794780|525667373|FG005|Overall Study|Lost to Follow-up|99|||
145770283|NCT01794780|525667374|FG006|Overall Study|Lost to Follow-up|30|||
145770284|NCT01794780|525667375|FG007|Overall Study|Lost to Follow-up|5|||
145770285|NCT01794780|525667368|FG000|Overall Study|Withdrew informed consent|7|||
145770286|NCT01794780|525667369|FG001|Overall Study|Withdrew informed consent|17|||
145770287|NCT01794780|525667370|FG002|Overall Study|Withdrew informed consent|36|||
145770288|NCT01794780|525667371|FG003|Overall Study|Withdrew informed consent|9|||
145770289|NCT01794780|525667372|FG004|Overall Study|Withdrew informed consent|0|||
145770290|NCT01794780|525667373|FG005|Overall Study|Withdrew informed consent|48|||
145770291|NCT01794780|525667374|FG006|Overall Study|Withdrew informed consent|4|||
145770292|NCT01794780|525667375|FG007|Overall Study|Withdrew informed consent|3|||
145770293|NCT01794780|525667368|FG000|Overall Study|Other|0|||
145770294|NCT01794780|525667369|FG001|Overall Study|Other|12|||
145770295|NCT01794780|525667370|FG002|Overall Study|Other|25|||
145770296|NCT01794780|525667371|FG003|Overall Study|Other|20|||
145533886|NCT01914757|524815369|FG002|Overall Study|Withdrawal by Subject|19|||
145770297|NCT01794780|525667372|FG004|Overall Study|Other|1|||
145770298|NCT01794780|525667373|FG005|Overall Study|Other|24|||
145770299|NCT01794780|525667374|FG006|Overall Study|Other|4|||
145770300|NCT01794780|525667375|FG007|Overall Study|Other|1|||
145770301|NCT02499952|525667376|FG000|Overall Study|Lost to Follow-up|1|||
145770302|NCT02499952|525667376|FG000|Overall Study|Death|9|||
145770303|NCT05089708|525667377|FG000|Overall Study|Lost to Follow-up|9|||
145770304|NCT05089708|525667378|FG001|Overall Study|Lost to Follow-up|7|||
145770305|NCT05089708|525667377|FG000|Overall Study|Withdrawal by Subject|3|||
145770306|NCT05089708|525667378|FG001|Overall Study|Withdrawal by Subject|1|||
145770307|NCT05089708|525667377|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
145770308|NCT05089708|525667378|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
145770309|NCT05089708|525667377|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
145770310|NCT05089708|525667378|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
145770311|NCT01440101|525667379|FG000|Overall Study|Adverse Event|2|||
145770312|NCT01440101|525667380|FG001|Overall Study|Adverse Event|0|||
145770313|NCT01440101|525667381|FG002|Overall Study|Adverse Event|0|||
145770314|NCT01440101|525667379|FG000|Overall Study|Withdrawal by Subject|0|||
145770315|NCT01440101|525667380|FG001|Overall Study|Withdrawal by Subject|3|||
145770316|NCT01440101|525667381|FG002|Overall Study|Withdrawal by Subject|1|||
145770317|NCT01440101|525667379|FG000|Overall Study|Other|0|||
145770318|NCT01440101|525667380|FG001|Overall Study|Other|1|||
145770319|NCT01440101|525667381|FG002|Overall Study|Other|0|||
145770320|NCT00659438|525667382|FG000|Overall Study|Withdrawal by Subject|2|||
145770321|NCT00659438|525667383|FG001|Overall Study|Withdrawal by Subject|2|||
145770322|NCT00659438|525667382|FG000|Overall Study|Death|11|||
145770323|NCT00659438|525667383|FG001|Overall Study|Death|6|||
145770324|NCT00659438|525667382|FG000|Overall Study|Lost to Follow-up|1|||
145770325|NCT00659438|525667383|FG001|Overall Study|Lost to Follow-up|0|||
145770326|NCT00201851|525667384|FG000|Overall Study|Lost to Follow-up|2|||
145770327|NCT00201851|525667385|FG001|Overall Study|Lost to Follow-up|1|||
145770328|NCT00201851|525667386|FG002|Overall Study|Lost to Follow-up|0|||
145770329|NCT00201851|525667384|FG000|Overall Study|Ineligible post enrollment|6|||
145770330|NCT00201851|525667385|FG001|Overall Study|Ineligible post enrollment|1|||
145770331|NCT00201851|525667386|FG002|Overall Study|Ineligible post enrollment|1|||
145770332|NCT02469246|525667387|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
145770333|NCT02469246|525667388|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
145770334|NCT02469246|525667387|FG000|Double-Blind Phase|Adverse Event|12|||
145770335|NCT02469246|525667388|FG001|Double-Blind Phase|Adverse Event|9|||
145770336|NCT02469246|525667387|FG000|Double-Blind Phase|Death|2|||
145770337|NCT02469246|525667388|FG001|Double-Blind Phase|Death|0|||
145770338|NCT02469246|525667387|FG000|Double-Blind Phase|Lack of Efficacy|2|||
145770339|NCT02469246|525667388|FG001|Double-Blind Phase|Lack of Efficacy|1|||
145770340|NCT02469246|525667387|FG000|Double-Blind Phase|Investigator's Discretion|8|||
145770341|NCT02469246|525667388|FG001|Double-Blind Phase|Investigator's Discretion|8|||
145770342|NCT02469246|525667387|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
145770343|NCT02469246|525667388|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
145770344|NCT02469246|525667387|FG000|Double-Blind Phase|Protocol Violation|1|||
145770345|NCT02469246|525667388|FG001|Double-Blind Phase|Protocol Violation|1|||
145770346|NCT02469246|525667387|FG000|Double-Blind Phase|Withdrew Consent|25|||
145770347|NCT02469246|525667388|FG001|Double-Blind Phase|Withdrew Consent|25|||
145770348|NCT02469246|525667387|FG000|Double-Blind Phase|Lost to Follow-up|9|||
145770349|NCT02469246|525667388|FG001|Double-Blind Phase|Lost to Follow-up|5|||
145770350|NCT00636818|525667392|FG000|Overall Study|Adverse Event|1|||
145770351|NCT00636818|525667392|FG000|Overall Study|Lost to Follow-up|2|||
145770352|NCT00636818|525667392|FG000|Overall Study|Entry Criteria Exclusion|3|||
145770353|NCT00636818|525667392|FG000|Overall Study|Protocol Violation|1|||
145770354|NCT00636818|525667392|FG000|Overall Study|Withdrawal by Subject|4|||
145533887|NCT01914757|524815367|FG000|Overall Study|Death|2|||
145533888|NCT01914757|524815368|FG001|Overall Study|Death|2|||
145533889|NCT01914757|524815369|FG002|Overall Study|Death|1|||
145533890|NCT01914757|524815367|FG000|Overall Study|Adverse Event|4|||
145533891|NCT01914757|524815368|FG001|Overall Study|Adverse Event|3|||
145770355|NCT00074958|525667393|FG000|Overall Study|Adverse Event|1|||
145770356|NCT02700451|525667397|FG000|Overall Study|Protocol Violation|2|||
145533892|NCT01914757|524815369|FG002|Overall Study|Adverse Event|4|||
145770357|NCT02700451|525667398|FG001|Overall Study|Protocol Violation|2|||
145770358|NCT02700451|525667399|FG002|Overall Study|Protocol Violation|3|||
145770359|NCT02700451|525667397|FG000|Overall Study|Discontinued intervention|14|||
145770360|NCT02700451|525667398|FG001|Overall Study|Discontinued intervention|15|||
145770361|NCT02700451|525667399|FG002|Overall Study|Discontinued intervention|14|||
145770362|NCT02690701|525667400|FG000|Treatment Period 1|Adverse Event|2|||
145533893|NCT01914757|524815367|FG000|Overall Study|Study specific withdrawal criteria|0|||
145770363|NCT02690701|525667401|FG001|Treatment Period 1|Adverse Event|2|||
145292770|NCT06179108|523922227|FG001|Overall Study|Death|0|||
145770364|NCT02690701|525667400|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145770365|NCT02690701|525667401|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145403313|NCT02187783|524334369|FG000|Overall Study|Progressive disease|80|||
145403314|NCT02187783|524334369|FG000|Overall Study|Protocol Violation|3|||
145770366|NCT02690701|525667400|FG000|Treatment Period 2|Adverse Event|2|||
145770367|NCT02690701|525667401|FG001|Treatment Period 2|Adverse Event|0|||
145770368|NCT02690701|525667400|FG000|Treatment Period 2|Lack of Efficacy|1|||
145770369|NCT02690701|525667401|FG001|Treatment Period 2|Lack of Efficacy|0|||
145770370|NCT02690701|525667400|FG000|Treatment Period 2|Lost to Follow-up|0|||
145770371|NCT02690701|525667401|FG001|Treatment Period 2|Lost to Follow-up|2|||
145770372|NCT02690701|525667400|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145770373|NCT02690701|525667401|FG001|Treatment Period 2|Withdrawal by Subject|2|||
145770374|NCT02690701|525667400|FG000|Treatment Period 2|Protocol Violation|0|||
145770375|NCT02690701|525667401|FG001|Treatment Period 2|Protocol Violation|1|||
145770376|NCT02115308|525667407|FG000|Overall Study|Safety Screening|2|||
145770377|NCT02115308|525667408|FG001|Overall Study|Safety Screening|2|||
145770378|NCT00404092|525667409|FG000|Overall Study|Death|1|||
145770379|NCT00404092|525667410|FG001|Overall Study|Death|0|||
145770380|NCT00404092|525667411|FG002|Overall Study|Death|0|||
145770381|NCT00404092|525667412|FG003|Overall Study|Death|0|||
145770382|NCT00404092|525667409|FG000|Overall Study|Adverse Event|0|||
145770383|NCT00404092|525667410|FG001|Overall Study|Adverse Event|0|||
145770384|NCT00404092|525667411|FG002|Overall Study|Adverse Event|1|||
145770385|NCT00404092|525667412|FG003|Overall Study|Adverse Event|0|||
145770386|NCT01658514|525667416|FG000|Overall Study|Protocol Violation|1|||
145770387|NCT01658514|525667417|FG001|Overall Study|Protocol Violation|0|||
145770388|NCT01658514|525667418|FG002|Overall Study|Protocol Violation|2|||
145770389|NCT00749203|525667419|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
145770390|NCT00749203|525667420|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
145770391|NCT00749203|525667419|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
145770392|NCT00749203|525667420|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
145770393|NCT00749203|525667419|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
145770394|NCT00749203|525667420|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
145770395|NCT00749203|525667419|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
145770396|NCT00749203|525667420|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
145770397|NCT00749203|525667419|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
145770398|NCT00749203|525667420|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
145770399|NCT00749203|525667419|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
145770400|NCT00749203|525667420|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
145770401|NCT02337387|525667421|FG000|Overall Study|Adverse Event|0|||
145770402|NCT02337387|525667422|FG001|Overall Study|Adverse Event|1|||
145770403|NCT02337387|525667423|FG002|Overall Study|Adverse Event|0|||
145770404|NCT02337387|525667424|FG003|Overall Study|Adverse Event|0|||
145770405|NCT02337387|525667421|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
145770406|NCT02337387|525667422|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
145770407|NCT02337387|525667423|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
145770408|NCT02337387|525667424|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
145770409|NCT02853760|525667425|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
145770410|NCT02853760|525667426|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
145770411|NCT02853760|525667427|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
145770412|NCT02853760|525667428|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
145770413|NCT02853760|525667429|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
145770414|NCT02853760|525667430|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
145770415|NCT00981526|525667431|FG000|Overall Study|Withdrawal by Subject|0|||
145770416|NCT00981526|525667432|FG001|Overall Study|Withdrawal by Subject|2|||
145770417|NCT00981526|525667431|FG000|Overall Study|Physician Decision|4|||
145770418|NCT00981526|525667432|FG001|Overall Study|Physician Decision|4|||
145770419|NCT00702143|525667433|FG000|Overall Study|Lost to Follow-up|0|||
145770420|NCT00702143|525667434|FG001|Overall Study|Lost to Follow-up|0|||
145770421|NCT00702143|525667435|FG002|Overall Study|Lost to Follow-up|1|||
145770422|NCT03871491|525667436|FG000|Overall Study|Withdrawal by Subject|14|||
145770423|NCT03871491|525667437|FG001|Overall Study|Withdrawal by Subject|14|||
145770424|NCT03871491|525667438|FG002|Overall Study|Withdrawal by Subject|14|||
145770425|NCT03871491|525667439|FG003|Overall Study|Withdrawal by Subject|14|||
145770426|NCT03871491|525667436|FG000|Overall Study|Physician Decision|0|||
145403315|NCT02187783|524334369|FG000|Overall Study|Physician Decision|2|||
145403316|NCT02187783|524334369|FG000|Overall Study|Withdrawal by Subject|9|||
145533894|NCT01914757|524815368|FG001|Overall Study|Study specific withdrawal criteria|1|||
145770427|NCT03871491|525667437|FG001|Overall Study|Physician Decision|0|||
145770428|NCT03871491|525667438|FG002|Overall Study|Physician Decision|1|||
145403317|NCT02187783|524334369|FG000|Overall Study|Study terminated by sponsor|1|||
145770429|NCT03871491|525667439|FG003|Overall Study|Physician Decision|1|||
145770430|NCT03871491|525667436|FG000|Overall Study|Lost to Follow-up|50|||
145770431|NCT03871491|525667437|FG001|Overall Study|Lost to Follow-up|15|||
145770432|NCT03871491|525667438|FG002|Overall Study|Lost to Follow-up|36|||
145770433|NCT03871491|525667439|FG003|Overall Study|Lost to Follow-up|11|||
145403318|NCT00171249|524334370|FG000|Overall Study|Withdrawal by Subject|2|||
145770434|NCT05202808|525667440|FG000|Overall Study|Lost to Follow-up|3|||
145770435|NCT05202808|525667441|FG001|Overall Study|Lost to Follow-up|1|||
145770436|NCT04996797|525667442|FG000|Overall Study|Adverse Event|0|||
145770437|NCT04996797|525667443|FG001|Overall Study|Adverse Event|2|||
145770438|NCT04996797|525667444|FG002|Overall Study|Adverse Event|0|||
145770439|NCT04996797|525667445|FG003|Overall Study|Adverse Event|1|||
145770440|NCT04996797|525667442|FG000|Overall Study|Lack of Efficacy|0|||
145770441|NCT04996797|525667443|FG001|Overall Study|Lack of Efficacy|2|||
145770442|NCT04996797|525667444|FG002|Overall Study|Lack of Efficacy|0|||
145770443|NCT04996797|525667445|FG003|Overall Study|Lack of Efficacy|0|||
145770444|NCT04996797|525667442|FG000|Overall Study|Prohibited Medication|0|||
145770445|NCT04996797|525667443|FG001|Overall Study|Prohibited Medication|1|||
145770446|NCT04996797|525667444|FG002|Overall Study|Prohibited Medication|0|||
145770447|NCT04996797|525667445|FG003|Overall Study|Prohibited Medication|0|||
145770448|NCT04996797|525667442|FG000|Overall Study|Ongoing|68|||
145770449|NCT04996797|525667443|FG001|Overall Study|Ongoing|60|||
145770450|NCT04996797|525667444|FG002|Overall Study|Ongoing|22|||
145770451|NCT04996797|525667445|FG003|Overall Study|Ongoing|20|||
145770452|NCT04996797|525667442|FG000|Overall Study|Withdrawal by Subject|0|||
145770453|NCT04996797|525667443|FG001|Overall Study|Withdrawal by Subject|2|||
145770454|NCT04996797|525667444|FG002|Overall Study|Withdrawal by Subject|0|||
145770455|NCT04996797|525667445|FG003|Overall Study|Withdrawal by Subject|0|||
145770456|NCT02793544|525667446|FG000|Overall Study|Death|10|||
145770457|NCT02793544|525667447|FG001|Overall Study|Death|8|||
145770458|NCT02793544|525667446|FG000|Overall Study|Lost to Follow-up|2|||
145770459|NCT02793544|525667447|FG001|Overall Study|Lost to Follow-up|0|||
145770460|NCT02793544|525667446|FG000|Overall Study|Withdrawal by Subject|1|||
145770461|NCT02793544|525667447|FG001|Overall Study|Withdrawal by Subject|0|||
145770462|NCT02495948|525667452|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
145770463|NCT02495948|525667453|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
145770464|NCT02495948|525667452|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
145770465|NCT02495948|525667453|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
145770466|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
145770467|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
145770468|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
145770469|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
145770470|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
145403319|NCT00171249|524334371|FG001|Overall Study|Withdrawal by Subject|0|||
145403320|NCT00171249|524334372|FG002|Overall Study|Withdrawal by Subject|0|||
145403321|NCT00171249|524334373|FG003|Overall Study|Withdrawal by Subject|6|||
145403322|NCT00171249|524334374|FG004|Overall Study|Withdrawal by Subject|0|||
145403323|NCT00171249|524334375|FG005|Overall Study|Withdrawal by Subject|0|||
145403324|NCT00171249|524334376|FG006|Overall Study|Withdrawal by Subject|0|||
145533895|NCT01914757|524815369|FG002|Overall Study|Study specific withdrawal criteria|0|||
145533896|NCT01914757|524815367|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145533897|NCT01914757|524815368|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145770471|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
145770472|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
145770473|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
145770474|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
145770475|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
145770476|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
145770477|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
145770478|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
145770479|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
145770480|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
145770481|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
145770482|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
145770483|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
145770484|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
145770485|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
145770486|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
145770487|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
145770488|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
145770489|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
145770490|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
145403325|NCT00171249|524334370|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
145770491|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
145770492|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
145770493|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
145407499|NCT02774889|524347021|FG000|Overall Study|Lost to Follow-up|2|||
145770494|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
145770495|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
145770496|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
145770497|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
145770498|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
145770499|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
145770500|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
145770501|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
145770502|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
145770503|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
145770504|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
145770505|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
145770506|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
145770507|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
145770508|NCT00100048|525667454|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
145770509|NCT00100048|525667455|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
145770510|NCT00100048|525667456|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
145770511|NCT00100048|525667457|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
145770512|NCT00100048|525667458|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
145770513|NCT00100048|525667459|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
145770514|NCT01624142|525667460|FG000|Overall Study|Withdrawal by Subject|14|||
145770515|NCT01624142|525667461|FG001|Overall Study|Withdrawal by Subject|4|||
145770516|NCT01624142|525667460|FG000|Overall Study|Death|3|||
145770517|NCT01624142|525667461|FG001|Overall Study|Death|6|||
145770518|NCT01624142|525667460|FG000|Overall Study|Study Closure|12|||
145770519|NCT01624142|525667461|FG001|Overall Study|Study Closure|6|||
145770520|NCT01624142|525667460|FG000|Overall Study|Lost to Follow-up|2|||
145770521|NCT01624142|525667461|FG001|Overall Study|Lost to Follow-up|0|||
145770522|NCT01624142|525667460|FG000|Overall Study|Other|1|||
145770523|NCT01624142|525667461|FG001|Overall Study|Other|0|||
145770524|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
145770525|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
145770526|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
145770527|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
145770528|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
145770529|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
145770530|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
145770531|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
145770532|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
145770533|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
145770534|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
145770535|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
145770536|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
145770537|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
145770538|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
145770539|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
145770540|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
145770541|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
145770542|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
145770543|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
145770544|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Death|0|||
145770545|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Death|1|||
145770546|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Death|0|||
145770547|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Death|0|||
145770548|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Death|0|||
145770549|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
145770550|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
145770551|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
145770552|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
145770553|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
145533898|NCT01914757|524815369|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
145533899|NCT01914757|524815367|FG000|Overall Study|Other reasons|5|||
145533900|NCT01914757|524815368|FG001|Overall Study|Other reasons|9|||
145533901|NCT01914757|524815369|FG002|Overall Study|Other reasons|4|||
145533902|NCT01147640|524815370|FG000|Overall Study|Adverse Event|2|||
145770554|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
145533903|NCT01147640|524815371|FG001|Overall Study|Adverse Event|0|||
145770555|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
145770556|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
145770557|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
145770558|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
145770559|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
145770560|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
145770561|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
145770562|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
145770563|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
145770564|NCT05087030|525667462|FG000|Main Period (Week 0 to Week 52)|Other|1|||
145770565|NCT05087030|525667463|FG001|Main Period (Week 0 to Week 52)|Other|2|||
145770566|NCT05087030|525667464|FG002|Main Period (Week 0 to Week 52)|Other|0|||
145770567|NCT05087030|525667465|FG003|Main Period (Week 0 to Week 52)|Other|0|||
145770568|NCT05087030|525667466|FG004|Main Period (Week 0 to Week 52)|Other|0|||
145770569|NCT05087030|525667462|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145770570|NCT05087030|525667463|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145770571|NCT05087030|525667464|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145770572|NCT05087030|525667465|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145770573|NCT05087030|525667466|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
145770574|NCT04826900|525667467|FG000|Overall Study|Family factor|1|||
145770575|NCT04826900|525667468|FG001|Overall Study|Family factor|1|||
145770576|NCT02722044|525667469|FG000|Overall Study|Adverse Event|2|||
145770577|NCT02722044|525667469|FG000|Overall Study|Physician Decision|1|||
145770578|NCT02722044|525667469|FG000|Overall Study|Withdrawal by Subject|1|||
145770579|NCT02722044|525667469|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
145770580|NCT04885257|525667470|FG000|Overall Study|Withdrawal by Subject|1|||
145770581|NCT04885257|525667471|FG001|Overall Study|Withdrawal by Subject|0|||
145770582|NCT02597062|525667472|FG000|Overall Study|Ineligible|1|||
145770583|NCT03372941|525667473|FG000|Overall Study|Lost to Follow-up|2|||
145770584|NCT03372941|525667474|FG001|Overall Study|Lost to Follow-up|4|||
145770585|NCT00741819|525667475|FG000|Overall Study|Adverse Event|3|||
145770586|NCT00741819|525667475|FG000|Overall Study|Withdrawal by Subject|3|||
145770587|NCT00741819|525667475|FG000|Overall Study|Death|1|||
145770588|NCT00741819|525667475|FG000|Overall Study|Disease progression|1|||
145770589|NCT00609622|525667476|FG000|Overall Study|Adverse Event|14|||
145770590|NCT00609622|525667477|FG001|Overall Study|Adverse Event|10|||
145770591|NCT00609622|525667476|FG000|Overall Study|Withdrawal by Subject|4|||
145770592|NCT00609622|525667477|FG001|Overall Study|Withdrawal by Subject|20|||
145770593|NCT00609622|525667476|FG000|Overall Study|Death|1|||
145770594|NCT00609622|525667477|FG001|Overall Study|Death|4|||
145770595|NCT00609622|525667476|FG000|Overall Study|Protocol Violation|1|||
145770596|NCT00609622|525667477|FG001|Overall Study|Protocol Violation|1|||
145770597|NCT00609622|525667476|FG000|Overall Study|Objective progression or relapse|47|||
145770598|NCT00609622|525667477|FG001|Overall Study|Objective progression or relapse|41|||
145770599|NCT00609622|525667476|FG000|Overall Study|Study terminated by sponsor|16|||
145770600|NCT00609622|525667477|FG001|Overall Study|Study terminated by sponsor|3|||
145770601|NCT00609622|525667476|FG000|Overall Study|Other|7|||
145770602|NCT00609622|525667477|FG001|Overall Study|Other|14|||
145770603|NCT00609622|525667476|FG000|Overall Study|Global deterioration of health status|6|||
145770604|NCT00609622|525667477|FG001|Overall Study|Global deterioration of health status|2|||
145770605|NCT01053429|525667478|FG000|Overall Study|Adverse Event|64|||
145770606|NCT01053429|525667478|FG000|Overall Study|Other|309|||
145770607|NCT01708057|525667479|FG000|Overall Study|Withdrawal due to study termination.|1|||
145770608|NCT01708057|525667480|FG001|Overall Study|Withdrawal due to study termination.|1|||
145770609|NCT01708057|525667481|FG002|Overall Study|Withdrawal due to study termination.|1|||
145770610|NCT02382133|525667482|FG000|Overall Study|Death|22|||
145770611|NCT02382133|525667482|FG000|Overall Study|transfer out of ICU|4|||
145770612|NCT02382133|525667482|FG000|Overall Study|Physician Decision|2|||
145770613|NCT02382133|525667482|FG000|Overall Study|arterial catheter loss|4|||
145770614|NCT02382133|525667482|FG000|Overall Study|pressure injury both sites|1|||
145770615|NCT00045032|525667483|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
145770616|NCT00045032|525667484|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
145770617|NCT00045032|525667485|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
145770618|NCT00045032|525667483|FG000|Overall Study|Death|22|||
145770619|NCT00045032|525667484|FG001|Overall Study|Death|24|||
145770620|NCT00045032|525667485|FG002|Overall Study|Death|17|||
145770621|NCT00045032|525667483|FG000|Overall Study|Insufficient Therapeutic Response|542|||
145770622|NCT00045032|525667484|FG001|Overall Study|Insufficient Therapeutic Response|437|||
145770623|NCT00045032|525667485|FG002|Overall Study|Insufficient Therapeutic Response|445|||
145770624|NCT00045032|525667483|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
145770625|NCT00045032|525667484|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
145403326|NCT00171249|524334371|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145770626|NCT00045032|525667485|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
145770627|NCT00045032|525667483|FG000|Overall Study|Other Protocol Violation|2|||
145770628|NCT00045032|525667484|FG001|Overall Study|Other Protocol Violation|0|||
145770629|NCT00045032|525667485|FG002|Overall Study|Other Protocol Violation|1|||
145770630|NCT00045032|525667483|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
145770631|NCT00045032|525667484|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
145770632|NCT00045032|525667485|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
145770633|NCT00045032|525667483|FG000|Overall Study|Failure to Return|57|||
145770634|NCT00045032|525667484|FG001|Overall Study|Failure to Return|62|||
145770635|NCT00045032|525667485|FG002|Overall Study|Failure to Return|61|||
145770636|NCT00045032|525667483|FG000|Overall Study|Other|93|||
145770637|NCT00045032|525667484|FG001|Overall Study|Other|84|||
145770638|NCT00045032|525667485|FG002|Overall Study|Other|105|||
145770639|NCT02770807|525667486|FG000|Overall Study|Adverse Event|3|||
145770640|NCT02770807|525667487|FG001|Overall Study|Adverse Event|3|||
145770641|NCT02770807|525667488|FG002|Overall Study|Adverse Event|1|||
145770642|NCT02770807|525667486|FG000|Overall Study|Withdrawal by Subject|7|||
145770643|NCT02770807|525667487|FG001|Overall Study|Withdrawal by Subject|3|||
145770644|NCT02770807|525667488|FG002|Overall Study|Withdrawal by Subject|4|||
145770645|NCT02770807|525667486|FG000|Overall Study|Other|0|||
145770646|NCT02770807|525667487|FG001|Overall Study|Other|1|||
145770647|NCT02770807|525667488|FG002|Overall Study|Other|0|||
145770648|NCT02770807|525667486|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
145770649|NCT02770807|525667487|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
145770650|NCT02770807|525667488|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
145770651|NCT02770807|525667486|FG000|Overall Study|Physician Decision|0|||
145770652|NCT02770807|525667487|FG001|Overall Study|Physician Decision|0|||
145770653|NCT02770807|525667488|FG002|Overall Study|Physician Decision|1|||
145770654|NCT00222105|525667491|FG000|Overall Study|Removed due to wrong diagnosis|1|||
145770655|NCT00222105|525667491|FG000|Overall Study|Withdrawal by Subject|1|||
145770656|NCT00222105|525667491|FG000|Overall Study|Adverse Event|8|||
145770657|NCT00222105|525667491|FG000|Overall Study|Treatment delays|2|||
145770658|NCT00222105|525667491|FG000|Overall Study|Death|2|||
145770659|NCT03976401|525668898|FG000|Overall Study|Adverse Event|2|||
145770660|NCT03976401|525668899|FG001|Overall Study|Adverse Event|0|||
145770661|NCT03976401|525668900|FG002|Overall Study|Adverse Event|4|||
145770662|NCT03976401|525668901|FG003|Overall Study|Adverse Event|1|||
145770663|NCT03976401|525668902|FG004|Overall Study|Adverse Event|1|||
145770664|NCT03976401|525668903|FG005|Overall Study|Adverse Event|0|||
145770665|NCT03976401|525668898|FG000|Overall Study|Withdrawal by Subject|0|||
145770666|NCT03976401|525668899|FG001|Overall Study|Withdrawal by Subject|1|||
145770667|NCT03976401|525668900|FG002|Overall Study|Withdrawal by Subject|0|||
145770668|NCT03976401|525668901|FG003|Overall Study|Withdrawal by Subject|0|||
145770669|NCT03976401|525668902|FG004|Overall Study|Withdrawal by Subject|0|||
145770670|NCT03976401|525668903|FG005|Overall Study|Withdrawal by Subject|1|||
145770671|NCT03976401|525668898|FG000|Overall Study|Physician Decision|0|||
145770672|NCT03976401|525668899|FG001|Overall Study|Physician Decision|0|||
145770673|NCT03976401|525668900|FG002|Overall Study|Physician Decision|1|||
145770674|NCT03976401|525668901|FG003|Overall Study|Physician Decision|0|||
145770675|NCT03976401|525668902|FG004|Overall Study|Physician Decision|0|||
145770676|NCT03976401|525668903|FG005|Overall Study|Physician Decision|0|||
145770677|NCT03976401|525668898|FG000|Overall Study|Lost to Follow-up|1|||
145770678|NCT03976401|525668899|FG001|Overall Study|Lost to Follow-up|2|||
145770679|NCT03976401|525668900|FG002|Overall Study|Lost to Follow-up|0|||
145770680|NCT03976401|525668901|FG003|Overall Study|Lost to Follow-up|0|||
145770681|NCT03976401|525668902|FG004|Overall Study|Lost to Follow-up|0|||
145770682|NCT03976401|525668903|FG005|Overall Study|Lost to Follow-up|0|||
145770683|NCT03976401|525668898|FG000|Overall Study|Protocol Violation|0|||
145770684|NCT03976401|525668899|FG001|Overall Study|Protocol Violation|1|||
145770685|NCT03976401|525668900|FG002|Overall Study|Protocol Violation|0|||
145770686|NCT03976401|525668901|FG003|Overall Study|Protocol Violation|0|||
145770687|NCT03976401|525668902|FG004|Overall Study|Protocol Violation|0|||
145533904|NCT01147640|524815370|FG000|Overall Study|Physician Decision|1|||
145533905|NCT01147640|524815371|FG001|Overall Study|Physician Decision|0|||
145770688|NCT03976401|525668903|FG005|Overall Study|Protocol Violation|0|||
145770689|NCT03976401|525668898|FG000|Overall Study|Withdrew Consent|0|||
145770690|NCT03976401|525668899|FG001|Overall Study|Withdrew Consent|0|||
145770691|NCT03976401|525668900|FG002|Overall Study|Withdrew Consent|0|||
145770692|NCT03976401|525668901|FG003|Overall Study|Withdrew Consent|1|||
145770693|NCT03976401|525668902|FG004|Overall Study|Withdrew Consent|0|||
145533906|NCT01147640|524815370|FG000|Overall Study|Withdrawal by Subject|1|||
145770694|NCT03976401|525668903|FG005|Overall Study|Withdrew Consent|0|||
145770695|NCT04645797|525668904|FG000|Overall Study|Disease Progression|3|||
145770696|NCT04645797|525668905|FG001|Overall Study|Disease Progression|3|||
145770697|NCT04645797|525668906|FG002|Overall Study|Disease Progression|1|||
145770698|NCT04645797|525668907|FG003|Overall Study|Disease Progression|0|||
145770699|NCT04645797|525668908|FG004|Overall Study|Disease Progression|0|||
145533907|NCT01147640|524815371|FG001|Overall Study|Withdrawal by Subject|0|||
145533908|NCT01147640|524815370|FG000|Overall Study|Lost to Follow-up|0|||
145533909|NCT01147640|524815371|FG001|Overall Study|Lost to Follow-up|1|||
145533910|NCT01147640|524815370|FG000|Overall Study|Didn't meet eligibility criteria|1|||
145533911|NCT01147640|524815371|FG001|Overall Study|Didn't meet eligibility criteria|0|||
145533912|NCT01856907|524815374|FG000|Overall Study|Pregnancy|0|||
145533913|NCT01856907|524815375|FG001|Overall Study|Pregnancy|1|||
145533914|NCT01856907|524815376|FG002|Overall Study|Pregnancy|0|||
145533915|NCT01856907|524815374|FG000|Overall Study|Pregnancy|0|||
145533916|NCT01856907|524815375|FG001|Overall Study|Pregnancy|1|||
145533917|NCT01856907|524815376|FG002|Overall Study|Pregnancy|0|||
145533918|NCT01856907|524815374|FG000|Overall Study|Withdrawal by Subject|0|||
145533919|NCT01856907|524815375|FG001|Overall Study|Withdrawal by Subject|1|||
145533920|NCT01856907|524815376|FG002|Overall Study|Withdrawal by Subject|0|||
145533921|NCT01797731|524815377|FG000|Overall Study|Didn't have proper radiographs required|3|||
145533922|NCT01797731|524815378|FG001|Overall Study|Didn't have proper radiographs required|3|||
145533923|NCT00091442|524815380|FG000|Overall Study|Progressive Disease|220|||
145533924|NCT00091442|524815381|FG001|Overall Study|Progressive Disease|189|||
145533925|NCT00091442|524815380|FG000|Overall Study|Physician Decision|61|||
145533926|NCT00091442|524815381|FG001|Overall Study|Physician Decision|58|||
145533927|NCT00091442|524815380|FG000|Overall Study|Withdrawal by Subject|38|||
145533928|NCT00091442|524815381|FG001|Overall Study|Withdrawal by Subject|46|||
145533929|NCT00091442|524815380|FG000|Overall Study|Adverse Event|29|||
145533930|NCT00091442|524815381|FG001|Overall Study|Adverse Event|48|||
145533931|NCT00091442|524815380|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
145533932|NCT00091442|524815381|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
145533933|NCT00091442|524815380|FG000|Overall Study|Death|9|||
145533934|NCT00091442|524815381|FG001|Overall Study|Death|7|||
145533935|NCT00091442|524815380|FG000|Overall Study|Lost to Follow-up|1|||
145533936|NCT00091442|524815381|FG001|Overall Study|Lost to Follow-up|3|||
145533937|NCT00091442|524815380|FG000|Overall Study|Other|2|||
145533938|NCT00091442|524815381|FG001|Overall Study|Other|6|||
145533939|NCT00917501|524815382|FG000|Overall Study|Lost to Follow-up|4|||
145533940|NCT00917501|524815383|FG001|Overall Study|Lost to Follow-up|1|||
145533941|NCT00917501|524815382|FG000|Overall Study|Withdrawal by Subject|3|||
145533942|NCT00917501|524815383|FG001|Overall Study|Withdrawal by Subject|1|||
145533943|NCT00917501|524815382|FG000|Overall Study|Lack of Efficacy|1|||
145533944|NCT00917501|524815383|FG001|Overall Study|Lack of Efficacy|2|||
145533945|NCT00917501|524815382|FG000|Overall Study|trouble swollowing capsules|0|||
145533946|NCT00917501|524815383|FG001|Overall Study|trouble swollowing capsules|1|||
145533947|NCT00986830|524815392|FG000|Overall Study|Death|1|||
145533948|NCT00986830|524815392|FG000|Overall Study|Lost to Follow-up|1|||
145533949|NCT00986830|524815392|FG000|Overall Study|Lack of Efficacy|1|||
145533950|NCT00986830|524815392|FG000|Overall Study|Unable to access sinus with device|5|||
145533951|NCT00285818|524815393|FG000|Overall Study|Withdrawal by Subject|3|||
145533952|NCT00285818|524815394|FG001|Overall Study|Withdrawal by Subject|2|||
145533953|NCT00285818|524815393|FG000|Overall Study|Lost to Follow-up|1|||
145533954|NCT00285818|524815394|FG001|Overall Study|Lost to Follow-up|0|||
145533955|NCT04041375|524815398|FG000|Intervention Phase|Withdrawal by Subject|2|||
145533956|NCT04041375|524815399|FG001|Intervention Phase|Withdrawal by Subject|2|||
145533957|NCT04041375|524815398|FG000|Follow-up Phase|Death|2|||
145533958|NCT04041375|524815399|FG001|Follow-up Phase|Death|0|||
145770700|NCT04645797|525668909|FG005|Overall Study|Disease Progression|0|||
145770701|NCT04645797|525668910|FG006|Overall Study|Disease Progression|0|||
145770702|NCT04645797|525668904|FG000|Overall Study|Death|3|||
145770703|NCT04645797|525668905|FG001|Overall Study|Death|1|||
145770704|NCT04645797|525668906|FG002|Overall Study|Death|0|||
145770705|NCT04645797|525668907|FG003|Overall Study|Death|0|||
145770706|NCT04645797|525668908|FG004|Overall Study|Death|0|||
145770707|NCT04645797|525668909|FG005|Overall Study|Death|0|||
145770708|NCT04645797|525668910|FG006|Overall Study|Death|0|||
145533959|NCT04041375|524815398|FG000|Follow-up Phase|Lost to Follow-up|2|||
145533960|NCT04041375|524815399|FG001|Follow-up Phase|Lost to Follow-up|1|||
145533961|NCT04041375|524815398|FG000|Follow-up Phase|Too ill|3|||
145533962|NCT04041375|524815399|FG001|Follow-up Phase|Too ill|0|||
145533963|NCT04674644|524815405|FG000|Overall Study|with missing data|37|||
145533964|NCT01230710|524815406|FG000|Overall Study|Disease Progression|41|||
145533965|NCT01230710|524815406|FG000|Overall Study|Lost to Follow-up|3|||
145533966|NCT01230710|524815406|FG000|Overall Study|Death|4|||
145533967|NCT01230710|524815406|FG000|Overall Study|Withdrawal of Consent|1|||
145533968|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
145770709|NCT00942409|525668913|FG000|Overall Study|Lack of Efficacy|1|||
145770710|NCT00942409|525668913|FG000|Overall Study|study drug unavailable|2|||
145533969|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
145533970|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Physician Decision|1|||
145533971|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Physician Decision|0|||
145770711|NCT02966314|525668914|FG000|Overall Study|Lost to Follow-up|1|||
145770712|NCT02966314|525668915|FG001|Overall Study|Lost to Follow-up|0|||
145770713|NCT02015819|525668918|FG000|Overall Study|Rickham catheter was misaligned|0|||
145770714|NCT02015819|525668919|FG001|Overall Study|Rickham catheter was misaligned|0|||
145770715|NCT02015819|525668920|FG002|Overall Study|Rickham catheter was misaligned|0|||
145770716|NCT02015819|525668921|FG003|Overall Study|Rickham catheter was misaligned|1|||
145770717|NCT01697215|525668924|FG000|Overall Study|Physician Decision|5|||
145770718|NCT01697215|525668924|FG000|Overall Study|Malfunction|9|||
145770719|NCT01697215|525668924|FG000|Overall Study|CXR not available|9|||
145770720|NCT00466505|525668926|FG000|Overall Study|disease progression|13|||
145770721|NCT00466505|525668926|FG000|Overall Study|Adverse Event|4|||
145770722|NCT02886715|525668929|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145770723|NCT02886715|525668930|FG001|Overall Study|Non-Compliance With Study Drug|2|||
145770724|NCT02886715|525668931|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145770725|NCT02886715|525668929|FG000|Overall Study|Adverse Event|4|||
145770726|NCT02886715|525668930|FG001|Overall Study|Adverse Event|2|||
145770727|NCT02886715|525668931|FG002|Overall Study|Adverse Event|0|||
145770728|NCT02886715|525668929|FG000|Overall Study|Lack of Efficacy|0|||
145770729|NCT02886715|525668930|FG001|Overall Study|Lack of Efficacy|2|||
145770730|NCT02886715|525668931|FG002|Overall Study|Lack of Efficacy|1|||
145770731|NCT02886715|525668929|FG000|Overall Study|Lost to Follow-up|29|||
145770732|NCT02886715|525668930|FG001|Overall Study|Lost to Follow-up|26|||
145770733|NCT02886715|525668931|FG002|Overall Study|Lost to Follow-up|10|||
145770734|NCT02886715|525668929|FG000|Overall Study|Pregnancy|1|||
145770735|NCT02886715|525668930|FG001|Overall Study|Pregnancy|1|||
145770736|NCT02886715|525668931|FG002|Overall Study|Pregnancy|1|||
145770737|NCT02886715|525668929|FG000|Overall Study|Protocol Violation|3|||
145770738|NCT02886715|525668930|FG001|Overall Study|Protocol Violation|2|||
145770739|NCT02886715|525668931|FG002|Overall Study|Protocol Violation|1|||
145770740|NCT02886715|525668929|FG000|Overall Study|Withdrawal by Subject|20|||
145770741|NCT02886715|525668930|FG001|Overall Study|Withdrawal by Subject|18|||
145770742|NCT02886715|525668931|FG002|Overall Study|Withdrawal by Subject|5|||
145770743|NCT02886715|525668929|FG000|Overall Study|missing|7|||
145770744|NCT02886715|525668930|FG001|Overall Study|missing|2|||
145770745|NCT02886715|525668931|FG002|Overall Study|missing|2|||
145770746|NCT01676961|525668932|FG000|Overall Study|Death|3|||
145770747|NCT01676961|525668932|FG000|Overall Study|Lost to Follow-up|1|||
145770748|NCT01676961|525668932|FG000|Overall Study|Withdrawal by Subject|1|||
145770749|NCT00768560|525668935|FG000|Intervention Set 1|Adverse Event|0|||
145770750|NCT00768560|525668936|FG001|Intervention Set 1|Adverse Event|1|||
145770751|NCT00768560|525668937|FG002|Intervention Set 1|Adverse Event|0|||
145770752|NCT00768560|525668938|FG003|Intervention Set 1|Adverse Event|0|||
145770753|NCT00768560|525668939|FG004|Intervention Set 1|Adverse Event|0|||
145770754|NCT00768560|525668940|FG005|Intervention Set 1|Adverse Event|0|||
145770755|NCT00117312|525668941|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
145770756|NCT00117312|525668942|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
145770757|NCT00117312|525668943|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
145770758|NCT00117312|525668944|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
145770759|NCT00117312|525668941|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
145770760|NCT00117312|525668942|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
145770761|NCT00117312|525668943|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
145770762|NCT00117312|525668944|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
145770763|NCT00117312|525668941|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
145770764|NCT00117312|525668942|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
145770765|NCT00117312|525668943|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
145770766|NCT00117312|525668944|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
145770767|NCT00117312|525668941|FG000|Overall Study|Other|0|||
145770768|NCT00117312|525668942|FG001|Overall Study|Other|1|||
145770769|NCT00117312|525668943|FG002|Overall Study|Other|3|||
145770770|NCT00117312|525668944|FG003|Overall Study|Other|1|||
145770771|NCT00117312|525668941|FG000|Overall Study|Patient choice|0|||
145770772|NCT00117312|525668942|FG001|Overall Study|Patient choice|0|||
145770773|NCT00117312|525668943|FG002|Overall Study|Patient choice|2|||
145770774|NCT00117312|525668944|FG003|Overall Study|Patient choice|1|||
145770775|NCT00117312|525668941|FG000|Overall Study|Adverse Event|0|||
145407500|NCT02774889|524347022|FG001|Overall Study|Lost to Follow-up|1|||
145770776|NCT00117312|525668942|FG001|Overall Study|Adverse Event|2|||
145770777|NCT00117312|525668943|FG002|Overall Study|Adverse Event|0|||
145770778|NCT00117312|525668944|FG003|Overall Study|Adverse Event|0|||
145770779|NCT00117312|525668941|FG000|Overall Study|Protocol Violation|0|||
145770780|NCT00117312|525668942|FG001|Overall Study|Protocol Violation|1|||
145608015|NCT04512066|525079314|FG002|Double-blind Treatment Period|Physician Decision|1|||
145608016|NCT04512066|525079315|FG003|Double-blind Treatment Period|Physician Decision|0|||
145608017|NCT04512066|525079316|FG004|Double-blind Treatment Period|Physician Decision|0|||
145608018|NCT04512066|525079317|FG005|Double-blind Treatment Period|Physician Decision|0|||
145608019|NCT04512066|525079312|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
145608020|NCT04512066|525079313|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
145608021|NCT04512066|525079314|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
145608022|NCT04512066|525079315|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
145608023|NCT04512066|525079316|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
145608024|NCT04512066|525079317|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
145608025|NCT04512066|525079312|FG000|Extension Period|Adverse Event|0|||
145608026|NCT04512066|525079313|FG001|Extension Period|Adverse Event|1|||
145608027|NCT04512066|525079314|FG002|Extension Period|Adverse Event|4|||
145608028|NCT04512066|525079315|FG003|Extension Period|Adverse Event|3|||
145608029|NCT04512066|525079316|FG004|Extension Period|Adverse Event|1|||
145608030|NCT04512066|525079317|FG005|Extension Period|Adverse Event|3|||
145608031|NCT04512066|525079312|FG000|Extension Period|Death|0|||
145608032|NCT04512066|525079313|FG001|Extension Period|Death|0|||
145608033|NCT04512066|525079314|FG002|Extension Period|Death|0|||
145608034|NCT04512066|525079315|FG003|Extension Period|Death|0|||
145608035|NCT04512066|525079316|FG004|Extension Period|Death|0|||
145608036|NCT04512066|525079317|FG005|Extension Period|Death|1|||
145608037|NCT04512066|525079312|FG000|Extension Period|Lack of Efficacy|0|||
145608038|NCT04512066|525079313|FG001|Extension Period|Lack of Efficacy|4|||
145608039|NCT04512066|525079314|FG002|Extension Period|Lack of Efficacy|4|||
145608040|NCT04512066|525079315|FG003|Extension Period|Lack of Efficacy|1|||
145608041|NCT04512066|525079316|FG004|Extension Period|Lack of Efficacy|3|||
145608042|NCT04512066|525079317|FG005|Extension Period|Lack of Efficacy|3|||
145608043|NCT04512066|525079312|FG000|Extension Period|Lost to Follow-up|0|||
145608044|NCT04512066|525079313|FG001|Extension Period|Lost to Follow-up|1|||
145608045|NCT04512066|525079314|FG002|Extension Period|Lost to Follow-up|5|||
145770781|NCT00117312|525668943|FG002|Overall Study|Protocol Violation|3|||
145770782|NCT00117312|525668944|FG003|Overall Study|Protocol Violation|0|||
145770783|NCT00117312|525668941|FG000|Overall Study|PSA decrease <=50%|0|||
145770784|NCT00117312|525668942|FG001|Overall Study|PSA decrease <=50%|2|||
145770785|NCT00117312|525668943|FG002|Overall Study|PSA decrease <=50%|2|||
145770786|NCT00117312|525668944|FG003|Overall Study|PSA decrease <=50%|4|||
145770787|NCT00117312|525668941|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
145770788|NCT00117312|525668942|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
145770789|NCT00117312|525668943|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
145770790|NCT00117312|525668944|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
145770791|NCT00117312|525668941|FG000|Overall Study|Hepatic abnormality|0|||
145770792|NCT00117312|525668942|FG001|Overall Study|Hepatic abnormality|1|||
145770793|NCT00117312|525668943|FG002|Overall Study|Hepatic abnormality|0|||
145770794|NCT00117312|525668944|FG003|Overall Study|Hepatic abnormality|1|||
145770795|NCT00117312|525668941|FG000|Overall Study|Withdrawal by Subject|0|||
145770796|NCT00117312|525668942|FG001|Overall Study|Withdrawal by Subject|2|||
145770797|NCT00117312|525668943|FG002|Overall Study|Withdrawal by Subject|0|||
145770798|NCT00117312|525668944|FG003|Overall Study|Withdrawal by Subject|0|||
145770799|NCT01128387|525668945|FG000|Overall Study|Physician Decision|0|||
145770800|NCT01128387|525668946|FG001|Overall Study|Physician Decision|1|||
145770801|NCT01535235|525668947|FG000|Overall Study|Adverse Event|1|||
145770802|NCT01535235|525668948|FG001|Overall Study|Adverse Event|0|||
145770803|NCT00389207|525668950|FG000|Overall Study|Adverse Event|26|||
145770804|NCT00389207|525668951|FG001|Overall Study|Adverse Event|32|||
145770805|NCT00389207|525668952|FG002|Overall Study|Adverse Event|10|||
145770806|NCT00389207|525668950|FG000|Overall Study|Protocol Violation|3|||
145770807|NCT00389207|525668951|FG001|Overall Study|Protocol Violation|1|||
145770808|NCT00389207|525668952|FG002|Overall Study|Protocol Violation|4|||
145770809|NCT00389207|525668950|FG000|Overall Study|Lost to Follow-up|12|||
145770810|NCT00389207|525668951|FG001|Overall Study|Lost to Follow-up|9|||
145770811|NCT00389207|525668952|FG002|Overall Study|Lost to Follow-up|7|||
145770812|NCT00389207|525668950|FG000|Overall Study|Withdrawal by Subject|5|||
145770813|NCT00389207|525668951|FG001|Overall Study|Withdrawal by Subject|7|||
145770814|NCT00389207|525668952|FG002|Overall Study|Withdrawal by Subject|11|||
145608046|NCT04512066|525079315|FG003|Extension Period|Lost to Follow-up|2|||
145608047|NCT04512066|525079316|FG004|Extension Period|Lost to Follow-up|3|||
145608048|NCT04512066|525079317|FG005|Extension Period|Lost to Follow-up|2|||
145608049|NCT04512066|525079312|FG000|Extension Period|Non-compliance with study drug|0|||
145608050|NCT04512066|525079313|FG001|Extension Period|Non-compliance with study drug|1|||
145770815|NCT00389207|525668950|FG000|Overall Study|Other|17|||
145770816|NCT00389207|525668951|FG001|Overall Study|Other|23|||
145770817|NCT00389207|525668952|FG002|Overall Study|Other|9|||
145770818|NCT00509106|525668955|FG000|Overall Study|Adverse Event|3|||
145770819|NCT00509106|525668956|FG001|Overall Study|Adverse Event|2|||
145770820|NCT00509106|525668955|FG000|Overall Study|Noncompliance|0|||
145608051|NCT04512066|525079314|FG002|Extension Period|Non-compliance with study drug|0|||
145608052|NCT04512066|525079315|FG003|Extension Period|Non-compliance with study drug|0|||
145278224|NCT01039584|523868924|FG000|Overall Study|Negative Baseline culture for Candida|59|||
145278225|NCT01039584|523868925|FG001|Overall Study|Negative Baseline culture for Candida|59|||
145278226|NCT01039584|523868926|FG002|Overall Study|Negative Baseline culture for Candida|24|||
145278227|NCT01039584|523868924|FG000|Overall Study|Lack of Efficacy|7|||
145278228|NCT01039584|523868925|FG001|Overall Study|Lack of Efficacy|6|||
145278229|NCT01039584|523868926|FG002|Overall Study|Lack of Efficacy|10|||
145278230|NCT01039584|523868924|FG000|Overall Study|other|1|||
145278231|NCT01039584|523868925|FG001|Overall Study|other|3|||
145278232|NCT01039584|523868926|FG002|Overall Study|other|1|||
145278233|NCT01039584|523868924|FG000|Overall Study|Pap smear with significant pathology|10|||
145278234|NCT01039584|523868925|FG001|Overall Study|Pap smear with significant pathology|10|||
145278235|NCT01039584|523868926|FG002|Overall Study|Pap smear with significant pathology|3|||
145278236|NCT01039584|523868924|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
145278237|NCT01039584|523868925|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
145278238|NCT01039584|523868926|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
145278239|NCT03707522|523868927|FG000|Overall Study|Lost to Follow-up|24|||
145278240|NCT03707522|523868928|FG001|Overall Study|Lost to Follow-up|27|||
145278241|NCT03707522|523868929|FG002|Overall Study|Lost to Follow-up|41|||
145278242|NCT03707522|523868930|FG003|Overall Study|Lost to Follow-up|36|||
145278243|NCT03001011|523868931|FG000|Overall Study|Adverse Event|9|||
145278244|NCT03001011|523868932|FG001|Overall Study|Adverse Event|3|||
145278245|NCT03001011|523868931|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
145278246|NCT03001011|523868932|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
145278247|NCT03001011|523868931|FG000|Overall Study|Other than specified above|3|||
145278248|NCT03001011|523868932|FG001|Overall Study|Other than specified above|8|||
145278249|NCT00383019|523868933|FG000|Overall Study|Adverse Event|5|||
145278250|NCT00383019|523868934|FG001|Overall Study|Adverse Event|1|||
145278251|NCT00383019|523868933|FG000|Overall Study|Withdrawal by Subject|0|||
145278252|NCT00383019|523868934|FG001|Overall Study|Withdrawal by Subject|1|||
145278253|NCT02278952|523868935|FG000|Overall Study|Insufficient Sample|6|||
145278254|NCT01021137|523868936|FG000|Overall Study|Lost to Follow-up|9|||
145278255|NCT01021137|523868937|FG001|Overall Study|Lost to Follow-up|4|||
145278256|NCT01021137|523868938|FG002|Overall Study|Lost to Follow-up|2|||
145278257|NCT01021137|523868939|FG003|Overall Study|Lost to Follow-up|6|||
145278258|NCT01021137|523868936|FG000|Overall Study|Withdrawal by Subject|1|||
145278259|NCT01021137|523868937|FG001|Overall Study|Withdrawal by Subject|0|||
145278260|NCT01021137|523868938|FG002|Overall Study|Withdrawal by Subject|0|||
145278261|NCT01021137|523868939|FG003|Overall Study|Withdrawal by Subject|3|||
145278262|NCT00659581|523868940|FG000|Overall Study|Adverse Event|1006|||
145278263|NCT00659581|523868940|FG000|Overall Study|Lack of Efficacy|1183|||
145278264|NCT00659581|523868940|FG000|Overall Study|Other|6393|||
145278265|NCT03125915|523868950|FG000|1 Month Follow up|Lost to Follow-up|3|||
145278266|NCT03125915|523868951|FG001|1 Month Follow up|Lost to Follow-up|3|||
145278267|NCT03125915|523868952|FG002|1 Month Follow up|Lost to Follow-up|2|||
145770821|NCT00509106|525668956|FG001|Overall Study|Noncompliance|1|||
145770822|NCT00509106|525668955|FG000|Overall Study|At the request of sponsor/investigator|1|||
145770823|NCT00509106|525668956|FG001|Overall Study|At the request of sponsor/investigator|2|||
145770824|NCT00509106|525668955|FG000|Overall Study|Withdrew consent|4|||
145770825|NCT00509106|525668956|FG001|Overall Study|Withdrew consent|8|||
145278268|NCT03125915|523868953|FG003|1 Month Follow up|Lost to Follow-up|3|||
145278269|NCT03125915|523868950|FG000|3 Month Follow-up|Lost to Follow-up|6|||
145278270|NCT03125915|523868951|FG001|3 Month Follow-up|Lost to Follow-up|4|||
145278271|NCT03125915|523868952|FG002|3 Month Follow-up|Lost to Follow-up|4|||
145278272|NCT03125915|523868953|FG003|3 Month Follow-up|Lost to Follow-up|2|||
145278273|NCT03125915|523868950|FG000|6 Month Follow-up|Lost to Follow-up|7|||
145278274|NCT03125915|523868951|FG001|6 Month Follow-up|Lost to Follow-up|3|||
145278275|NCT03125915|523868952|FG002|6 Month Follow-up|Lost to Follow-up|6|||
145278276|NCT03125915|523868953|FG003|6 Month Follow-up|Lost to Follow-up|3|||
145278277|NCT01309828|523868956|FG000|Overall Study|Adverse Event|10|||
145278278|NCT01309828|523868957|FG001|Overall Study|Adverse Event|11|||
145278279|NCT01309828|523868956|FG000|Overall Study|Voluntary Withdrawal|5|||
145278280|NCT01309828|523868957|FG001|Overall Study|Voluntary Withdrawal|4|||
145278281|NCT01309828|523868956|FG000|Overall Study|Major Protocol Deviation|0|||
145278282|NCT01309828|523868957|FG001|Overall Study|Major Protocol Deviation|1|||
145278283|NCT01309828|523868956|FG000|Overall Study|Other|1|||
145278284|NCT01309828|523868957|FG001|Overall Study|Other|0|||
145278285|NCT00217971|523868958|FG000|Overall Study|Adverse Event|1|||
145278286|NCT00217971|523868959|FG001|Overall Study|Adverse Event|1|||
145278287|NCT00217971|523868958|FG000|Overall Study|Lost to Follow-up|15|||
145278288|NCT00217971|523868959|FG001|Overall Study|Lost to Follow-up|19|||
145278289|NCT00217971|523868958|FG000|Overall Study|Physician Decision|0|||
145278290|NCT00217971|523868959|FG001|Overall Study|Physician Decision|1|||
145278291|NCT00217971|523868958|FG000|Overall Study|Withdrawal by Subject|7|||
145278292|NCT00217971|523868959|FG001|Overall Study|Withdrawal by Subject|12|||
145403327|NCT00171249|524334372|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
145278293|NCT00217971|523868958|FG000|Overall Study|non compliant|1|||
145770826|NCT00509106|525668955|FG000|Overall Study|Lost to Follow-up|16|||
145770827|NCT00509106|525668956|FG001|Overall Study|Lost to Follow-up|10|||
145770828|NCT00509106|525668955|FG000|Overall Study|Other|1|||
145770829|NCT00509106|525668956|FG001|Overall Study|Other|0|||
145770830|NCT00509106|525668955|FG000|Overall Study|Death|6|||
145770831|NCT00509106|525668956|FG001|Overall Study|Death|6|||
145770832|NCT02371629|525668972|FG000|Overall Study|Patient decision|14|||
145770833|NCT02371629|525668973|FG001|Overall Study|Patient decision|10|||
145770834|NCT02371629|525668972|FG000|Overall Study|Adverse Event|8|||
145770835|NCT02371629|525668973|FG001|Overall Study|Adverse Event|8|||
145770836|NCT02371629|525668972|FG000|Overall Study|Physician Decision|2|||
145770837|NCT02371629|525668973|FG001|Overall Study|Physician Decision|3|||
145770838|NCT02371629|525668972|FG000|Overall Study|Death|1|||
145770839|NCT02371629|525668973|FG001|Overall Study|Death|1|||
145770840|NCT02371629|525668972|FG000|Overall Study|Noncompliance with study treatment|1|||
145770841|NCT02371629|525668973|FG001|Overall Study|Noncompliance with study treatment|0|||
145770842|NCT02371629|525668972|FG000|Overall Study|Lack of Efficacy|0|||
145770843|NCT02371629|525668973|FG001|Overall Study|Lack of Efficacy|2|||
145770844|NCT02371629|525668972|FG000|Overall Study|Protocol deviation|0|||
145770845|NCT02371629|525668973|FG001|Overall Study|Protocol deviation|1|||
145770846|NCT01073943|525668974|FG000|Overall Study|Withdrawal by Subject|8|||
145770847|NCT01073943|525668975|FG001|Overall Study|Withdrawal by Subject|2|||
145770848|NCT01073943|525668974|FG000|Overall Study|Protocol Violation|2|||
145770849|NCT01073943|525668975|FG001|Overall Study|Protocol Violation|1|||
145770850|NCT01073943|525668974|FG000|Overall Study|Adverse Event|1|||
145770851|NCT01073943|525668975|FG001|Overall Study|Adverse Event|1|||
145770852|NCT01073943|525668974|FG000|Overall Study|Lost to Follow-up|0|||
145770853|NCT01073943|525668975|FG001|Overall Study|Lost to Follow-up|2|||
145770854|NCT01073943|525668974|FG000|Overall Study|Power outage; colonoscopy not done|1|||
145770855|NCT01073943|525668975|FG001|Overall Study|Power outage; colonoscopy not done|0|||
145770856|NCT01073943|525668974|FG000|Overall Study|Subject forgot|0|||
145770857|NCT01073943|525668975|FG001|Overall Study|Subject forgot|1|||
145770858|NCT01073943|525668974|FG000|Overall Study|Unable to return for follow-up|0|||
145770859|NCT01073943|525668975|FG001|Overall Study|Unable to return for follow-up|1|||
145770860|NCT01073943|525668974|FG000|Overall Study|Could not tolerate prep|1|||
145770861|NCT01073943|525668975|FG001|Overall Study|Could not tolerate prep|0|||
145770862|NCT01051739|525668976|FG000|Overall Study|Death|3|||
145770863|NCT01051739|525668977|FG001|Overall Study|Death|3|||
145770864|NCT01051739|525668976|FG000|Overall Study|Withdrawal by Subject|25|||
145770865|NCT01051739|525668977|FG001|Overall Study|Withdrawal by Subject|10|||
145770866|NCT00824421|525668979|FG000|Overall Study|Adverse Event|6|||
145770867|NCT00824421|525668980|FG001|Overall Study|Adverse Event|6|||
145770868|NCT00824421|525668981|FG002|Overall Study|Adverse Event|6|||
145770869|NCT00824421|525668979|FG000|Overall Study|Death|0|||
145770870|NCT00824421|525668980|FG001|Overall Study|Death|1|||
145770871|NCT00824421|525668981|FG002|Overall Study|Death|0|||
145770872|NCT00824421|525668979|FG000|Overall Study|Lack of Efficacy|5|||
145770873|NCT00824421|525668980|FG001|Overall Study|Lack of Efficacy|7|||
145770874|NCT00824421|525668981|FG002|Overall Study|Lack of Efficacy|4|||
145770875|NCT00824421|525668979|FG000|Overall Study|Lost to Follow-up|2|||
145770876|NCT00824421|525668980|FG001|Overall Study|Lost to Follow-up|3|||
145770877|NCT00824421|525668981|FG002|Overall Study|Lost to Follow-up|0|||
145770878|NCT00824421|525668979|FG000|Overall Study|Pregnancy|1|||
145770879|NCT00824421|525668980|FG001|Overall Study|Pregnancy|0|||
145770880|NCT00824421|525668981|FG002|Overall Study|Pregnancy|1|||
145770881|NCT00824421|525668979|FG000|Overall Study|Withdrawal by Subject|2|||
145770882|NCT00824421|525668980|FG001|Overall Study|Withdrawal by Subject|3|||
145770883|NCT00824421|525668981|FG002|Overall Study|Withdrawal by Subject|3|||
145770884|NCT00824421|525668979|FG000|Overall Study|Randomized but not Treated|1|||
145770885|NCT00824421|525668980|FG001|Overall Study|Randomized but not Treated|1|||
145770886|NCT00824421|525668981|FG002|Overall Study|Randomized but not Treated|0|||
145770887|NCT00824421|525668979|FG000|Overall Study|Other|0|||
145770888|NCT00824421|525668980|FG001|Overall Study|Other|1|||
145770889|NCT00824421|525668981|FG002|Overall Study|Other|0|||
145770890|NCT03527043|525668982|FG000|Overall Study|Withdrawal by Subject|1|||
145770891|NCT03527043|525668983|FG001|Overall Study|Withdrawal by Subject|0|||
145770892|NCT02286102|525668985|FG000|Overall Study|Screen Failure|1|||
145770893|NCT02286102|525668986|FG001|Overall Study|Screen Failure|1|||
145770894|NCT02120417|525668987|FG000|Overall Study|Death|5|||
145770895|NCT02120417|525668988|FG001|Overall Study|Death|1|||
145770896|NCT02120417|525668987|FG000|Overall Study|Adverse Event|3|||
145770897|NCT02120417|525668988|FG001|Overall Study|Adverse Event|9|||
145770898|NCT02120417|525668987|FG000|Overall Study|Participant decision|4|||
145770899|NCT02120417|525668988|FG001|Overall Study|Participant decision|4|||
145770900|NCT02120417|525668987|FG000|Overall Study|Disease progression|41|||
145770901|NCT02120417|525668988|FG001|Overall Study|Disease progression|45|||
145770902|NCT02120417|525668987|FG000|Overall Study|Noncompliance with study treatment|0|||
145770903|NCT02120417|525668988|FG001|Overall Study|Noncompliance with study treatment|2|||
145770904|NCT02120417|525668987|FG000|Overall Study|Physician Decision|2|||
145770905|NCT02120417|525668988|FG001|Overall Study|Physician Decision|3|||
145770906|NCT02120417|525668987|FG000|Overall Study|Other unspecified|5|||
145608053|NCT04512066|525079316|FG004|Extension Period|Non-compliance with study drug|0|||
145770907|NCT02120417|525668988|FG001|Overall Study|Other unspecified|4|||
145770908|NCT00927485|525668989|FG000|Overall Study|Adverse Event|4|||
145770909|NCT00927485|525668990|FG001|Overall Study|Adverse Event|2|||
145608054|NCT04512066|525079317|FG005|Extension Period|Non-compliance with study drug|1|||
145608055|NCT04512066|525079312|FG000|Extension Period|Other|0|||
145770910|NCT00927485|525668989|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
145770911|NCT00927485|525668990|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
145770912|NCT02344576|525668994|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
145770913|NCT02344576|525668995|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
145770914|NCT02344576|525668996|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
145770915|NCT02344576|525668997|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
145770916|NCT02344576|525668994|FG000|1-Month Follow-Up|Death|13|||
145770917|NCT02344576|525668995|FG001|1-Month Follow-Up|Death|8|||
145770918|NCT02344576|525668996|FG002|1-Month Follow-Up|Death|0|||
145770919|NCT02344576|525668997|FG003|1-Month Follow-Up|Death|0|||
145770920|NCT02344576|525668994|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
145770921|NCT02344576|525668995|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
145770922|NCT02344576|525668996|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
145770923|NCT02344576|525668997|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
145770924|NCT02344576|525668994|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
145770925|NCT02344576|525668995|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
145770926|NCT02344576|525668996|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
145770927|NCT02344576|525668997|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
145770928|NCT02344576|525668994|FG000|6-Month Follow-Up|Death|14|||
145770929|NCT02344576|525668995|FG001|6-Month Follow-Up|Death|14|||
145770930|NCT02344576|525668996|FG002|6-Month Follow-Up|Death|0|||
145278294|NCT00217971|523868959|FG001|Overall Study|non compliant|0|||
145278295|NCT00928135|523868969|FG000|Overall Study|Withdrawal by Subject|1|||
145278296|NCT00928135|523868970|FG001|Overall Study|Withdrawal by Subject|0|||
145278297|NCT03338673|523868973|FG000|Overall Study|Lost to Follow-up|1|||
145278298|NCT03338673|523868974|FG001|Overall Study|Lost to Follow-up|1|||
145278299|NCT03053622|523870772|FG000|Overall Study|Lost to Follow-up|0|||
145278300|NCT03053622|523870773|FG001|Overall Study|Lost to Follow-up|0|||
145278301|NCT03053622|523870774|FG002|Overall Study|Lost to Follow-up|0|||
145278302|NCT03053622|523870775|FG003|Overall Study|Lost to Follow-up|1|||
145278303|NCT01416142|523870778|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
145278304|NCT01416142|523870779|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
145278305|NCT01416142|523870780|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
145278306|NCT00678379|523870781|FG000|Overall Study|Injection performed after tonsillectomy|2|||
145278307|NCT00678379|523870782|FG001|Overall Study|Injection performed after tonsillectomy|0|||
145278308|NCT00678379|523870783|FG002|Overall Study|Injection performed after tonsillectomy|1|||
145278309|NCT00678379|523870781|FG000|Overall Study|Incomplete Data|4|||
145278310|NCT00678379|523870782|FG001|Overall Study|Incomplete Data|3|||
145278311|NCT00678379|523870783|FG002|Overall Study|Incomplete Data|3|||
145278312|NCT00736099|523870797|FG000|Overall Study|Adverse Event|61|||
145278313|NCT00736099|523870798|FG001|Overall Study|Adverse Event|18|||
145278314|NCT00736099|523870797|FG000|Overall Study|Protocol Violation|10|||
145278315|NCT00736099|523870798|FG001|Overall Study|Protocol Violation|4|||
145278316|NCT00736099|523870797|FG000|Overall Study|Lost to Follow-up|12|||
145278317|NCT00736099|523870798|FG001|Overall Study|Lost to Follow-up|5|||
145278318|NCT00736099|523870797|FG000|Overall Study|Withdrawal by Subject|42|||
145278319|NCT00736099|523870798|FG001|Overall Study|Withdrawal by Subject|13|||
145608056|NCT04512066|525079313|FG001|Extension Period|Other|2|||
145608057|NCT04512066|525079314|FG002|Extension Period|Other|0|||
145770931|NCT02344576|525668997|FG003|6-Month Follow-Up|Death|0|||
145770932|NCT02344576|525668994|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
145770933|NCT02344576|525668995|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
145770934|NCT02344576|525668996|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
145770935|NCT02344576|525668997|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
145278320|NCT00736099|523870797|FG000|Overall Study|Lack of Efficacy|15|||
145278321|NCT00736099|523870798|FG001|Overall Study|Lack of Efficacy|8|||
145278322|NCT00736099|523870797|FG000|Overall Study|Other reason|43|||
145278323|NCT00736099|523870798|FG001|Overall Study|Other reason|10|||
145278324|NCT04006847|523870801|FG000|Overall Study|Product issue|1|||
145278325|NCT02770716|523870811|FG000|Overall Study|Death|101|||
145278326|NCT02770716|523870812|FG001|Overall Study|Death|45|||
145278327|NCT02770716|523870811|FG000|Overall Study|Withdrawal by Subject|4|||
145278328|NCT02770716|523870812|FG001|Overall Study|Withdrawal by Subject|2|||
145278329|NCT02770716|523870811|FG000|Overall Study|Lost to Follow-up|1|||
145278330|NCT02770716|523870812|FG001|Overall Study|Lost to Follow-up|0|||
145278331|NCT02770716|523870811|FG000|Overall Study|Various reasons|6|||
145608058|NCT04512066|525079315|FG003|Extension Period|Other|0|||
145770936|NCT02344576|525668994|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
145770937|NCT02344576|525668995|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
145770938|NCT02344576|525668996|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
145770939|NCT02344576|525668997|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
145608059|NCT04512066|525079316|FG004|Extension Period|Other|0|||
145770940|NCT04233424|525668999|FG000|Overall Study|Death|15|||
145608060|NCT04512066|525079317|FG005|Extension Period|Other|0|||
145608061|NCT04512066|525079312|FG000|Extension Period|Physician Decision|0|||
145608062|NCT04512066|525079313|FG001|Extension Period|Physician Decision|2|||
145608063|NCT04512066|525079314|FG002|Extension Period|Physician Decision|0|||
145608064|NCT04512066|525079315|FG003|Extension Period|Physician Decision|1|||
145608065|NCT04512066|525079316|FG004|Extension Period|Physician Decision|1|||
145608066|NCT04512066|525079317|FG005|Extension Period|Physician Decision|0|||
145608067|NCT04512066|525079312|FG000|Extension Period|Withdrawal by Subject|0|||
145608068|NCT04512066|525079313|FG001|Extension Period|Withdrawal by Subject|3|||
145608069|NCT04512066|525079314|FG002|Extension Period|Withdrawal by Subject|7|||
145608070|NCT04512066|525079315|FG003|Extension Period|Withdrawal by Subject|11|||
145608071|NCT04512066|525079316|FG004|Extension Period|Withdrawal by Subject|8|||
145608072|NCT04512066|525079317|FG005|Extension Period|Withdrawal by Subject|4|||
145608073|NCT00445679|525079320|FG000|Overall Study|Adverse Event|22|||
145608074|NCT00445679|525079321|FG001|Overall Study|Adverse Event|12|||
145608075|NCT00445679|525079322|FG002|Overall Study|Adverse Event|30|||
145770941|NCT04233424|525669000|FG001|Overall Study|Death|16|||
145770942|NCT04233424|525668999|FG000|Overall Study|Withdrawal by Subject|2|||
145770943|NCT04233424|525669000|FG001|Overall Study|Withdrawal by Subject|8|||
145770944|NCT04233424|525668999|FG000|Overall Study|Physician Decision|1|||
145770945|NCT04233424|525669000|FG001|Overall Study|Physician Decision|3|||
145770946|NCT04233424|525668999|FG000|Overall Study|Protocol Violation|3|||
145770947|NCT04233424|525669000|FG001|Overall Study|Protocol Violation|1|||
145770948|NCT04233424|525668999|FG000|Overall Study|Lost to Follow-up|1|||
145770949|NCT04233424|525669000|FG001|Overall Study|Lost to Follow-up|3|||
145770950|NCT04233424|525668999|FG000|Overall Study|subject refuse to visit site|2|||
145770951|NCT04233424|525669000|FG001|Overall Study|subject refuse to visit site|0|||
145770952|NCT02698189|525669001|FG000|Overall Study|Physician Decision|3|||
145770953|NCT02698189|525669002|FG001|Overall Study|Physician Decision|0|||
145770954|NCT02698189|525669001|FG000|Overall Study|Progressive disease|0|||
145770955|NCT02698189|525669002|FG001|Overall Study|Progressive disease|5|||
145770956|NCT02698189|525669001|FG000|Overall Study|Study terminated by sponsor|0|||
145770957|NCT02698189|525669002|FG001|Overall Study|Study terminated by sponsor|1|||
145770958|NCT02240706|525669003|FG000|Overall Study|Lack of Efficacy|2|||
145770959|NCT02240706|525669004|FG001|Overall Study|Lack of Efficacy|2|||
145770960|NCT02240706|525669005|FG002|Overall Study|Lack of Efficacy|2|||
145770961|NCT02240706|525669006|FG003|Overall Study|Lack of Efficacy|2|||
145770962|NCT02240706|525669007|FG004|Overall Study|Lack of Efficacy|5|||
145770963|NCT02240706|525669008|FG005|Overall Study|Lack of Efficacy|0|||
145770964|NCT02240706|525669009|FG006|Overall Study|Lack of Efficacy|0|||
145770965|NCT02240706|525669003|FG000|Overall Study|Adverse Event|1|||
145770966|NCT02240706|525669004|FG001|Overall Study|Adverse Event|0|||
145770967|NCT02240706|525669005|FG002|Overall Study|Adverse Event|1|||
145770968|NCT02240706|525669006|FG003|Overall Study|Adverse Event|0|||
145770969|NCT02240706|525669007|FG004|Overall Study|Adverse Event|2|||
145770970|NCT02240706|525669008|FG005|Overall Study|Adverse Event|0|||
145770971|NCT02240706|525669009|FG006|Overall Study|Adverse Event|0|||
145770972|NCT02240706|525669003|FG000|Overall Study|Progressive disease|0|||
145770973|NCT02240706|525669004|FG001|Overall Study|Progressive disease|0|||
145770974|NCT02240706|525669005|FG002|Overall Study|Progressive disease|0|||
145608076|NCT00445679|525079323|FG003|Overall Study|Adverse Event|19|||
145608077|NCT00445679|525079320|FG000|Overall Study|Failed to return|1|||
145608078|NCT00445679|525079321|FG001|Overall Study|Failed to return|3|||
145608079|NCT00445679|525079322|FG002|Overall Study|Failed to return|2|||
145608080|NCT00445679|525079323|FG003|Overall Study|Failed to return|2|||
145608081|NCT00445679|525079320|FG000|Overall Study|Physician Decision|0|||
145608082|NCT00445679|525079321|FG001|Overall Study|Physician Decision|0|||
145608083|NCT00445679|525079322|FG002|Overall Study|Physician Decision|1|||
145608084|NCT00445679|525079323|FG003|Overall Study|Physician Decision|0|||
145608085|NCT00445679|525079320|FG000|Overall Study|Lost to Follow-up|10|||
145608086|NCT00445679|525079321|FG001|Overall Study|Lost to Follow-up|6|||
145770975|NCT02240706|525669006|FG003|Overall Study|Progressive disease|0|||
145770976|NCT02240706|525669007|FG004|Overall Study|Progressive disease|1|||
145770977|NCT02240706|525669008|FG005|Overall Study|Progressive disease|0|||
145770978|NCT02240706|525669009|FG006|Overall Study|Progressive disease|0|||
145770979|NCT02240706|525669003|FG000|Overall Study|Dose limiting toxicity|0|||
145770980|NCT02240706|525669004|FG001|Overall Study|Dose limiting toxicity|0|||
145770981|NCT02240706|525669005|FG002|Overall Study|Dose limiting toxicity|0|||
145278332|NCT02770716|523870812|FG001|Overall Study|Various reasons|2|||
145278333|NCT01453374|523870814|FG000|Overall Study|Adverse Event|7|||
145278334|NCT01453374|523870814|FG000|Overall Study|Lack of Efficacy|1|||
145608087|NCT00445679|525079322|FG002|Overall Study|Lost to Follow-up|6|||
145608088|NCT00445679|525079323|FG003|Overall Study|Lost to Follow-up|5|||
145770982|NCT02240706|525669006|FG003|Overall Study|Dose limiting toxicity|0|||
145770983|NCT02240706|525669007|FG004|Overall Study|Dose limiting toxicity|1|||
145770984|NCT02240706|525669008|FG005|Overall Study|Dose limiting toxicity|0|||
145770985|NCT02240706|525669009|FG006|Overall Study|Dose limiting toxicity|0|||
145608089|NCT00445679|525079320|FG000|Overall Study|Compliance|3|||
145770986|NCT02240706|525669003|FG000|Overall Study|Refused to continue taking medication|0|||
145770987|NCT02240706|525669004|FG001|Overall Study|Refused to continue taking medication|1|||
145770988|NCT02240706|525669005|FG002|Overall Study|Refused to continue taking medication|3|||
145770989|NCT02240706|525669006|FG003|Overall Study|Refused to continue taking medication|1|||
145770990|NCT02240706|525669007|FG004|Overall Study|Refused to continue taking medication|2|||
145770991|NCT02240706|525669008|FG005|Overall Study|Refused to continue taking medication|0|||
145770992|NCT02240706|525669009|FG006|Overall Study|Refused to continue taking medication|0|||
145770993|NCT02240706|525669003|FG000|Overall Study|Insurance billing concerns|0|||
145770994|NCT02240706|525669004|FG001|Overall Study|Insurance billing concerns|0|||
145770995|NCT02240706|525669005|FG002|Overall Study|Insurance billing concerns|0|||
145770996|NCT02240706|525669006|FG003|Overall Study|Insurance billing concerns|1|||
145770997|NCT02240706|525669007|FG004|Overall Study|Insurance billing concerns|0|||
145770998|NCT02240706|525669008|FG005|Overall Study|Insurance billing concerns|0|||
145770999|NCT02240706|525669009|FG006|Overall Study|Insurance billing concerns|0|||
145771000|NCT01126580|525669010|FG000|Overall Study|Adverse Event|14|||
145771001|NCT01126580|525669011|FG001|Overall Study|Adverse Event|8|||
145771002|NCT01126580|525669012|FG002|Overall Study|Adverse Event|12|||
145771003|NCT01126580|525669010|FG000|Overall Study|Withdrawal by Subject|11|||
145771004|NCT01126580|525669011|FG001|Overall Study|Withdrawal by Subject|19|||
145771005|NCT01126580|525669012|FG002|Overall Study|Withdrawal by Subject|14|||
145771006|NCT01126580|525669010|FG000|Overall Study|Sponsor Decision|5|||
145771007|NCT01126580|525669011|FG001|Overall Study|Sponsor Decision|4|||
145771008|NCT01126580|525669012|FG002|Overall Study|Sponsor Decision|7|||
145771009|NCT01126580|525669010|FG000|Overall Study|Physician Decision|1|||
145771010|NCT01126580|525669011|FG001|Overall Study|Physician Decision|1|||
145771011|NCT01126580|525669012|FG002|Overall Study|Physician Decision|2|||
145771012|NCT01126580|525669010|FG000|Overall Study|Entry Criteria Not Met|1|||
145771013|NCT01126580|525669011|FG001|Overall Study|Entry Criteria Not Met|1|||
145771014|NCT01126580|525669012|FG002|Overall Study|Entry Criteria Not Met|2|||
145771015|NCT01126580|525669010|FG000|Overall Study|Lack of Efficacy|2|||
145771016|NCT01126580|525669011|FG001|Overall Study|Lack of Efficacy|3|||
145771017|NCT01126580|525669012|FG002|Overall Study|Lack of Efficacy|4|||
145771018|NCT01126580|525669010|FG000|Overall Study|Protocol Violation|0|||
145771019|NCT01126580|525669011|FG001|Overall Study|Protocol Violation|1|||
145771020|NCT01126580|525669012|FG002|Overall Study|Protocol Violation|2|||
145771021|NCT01126580|525669010|FG000|Overall Study|Lost to Follow-up|15|||
145771022|NCT01126580|525669011|FG001|Overall Study|Lost to Follow-up|13|||
145771023|NCT01126580|525669012|FG002|Overall Study|Lost to Follow-up|9|||
145771024|NCT01126580|525669010|FG000|Overall Study|Treatment Non-compliance|0|||
145771025|NCT01126580|525669011|FG001|Overall Study|Treatment Non-compliance|2|||
145771026|NCT01126580|525669012|FG002|Overall Study|Treatment Non-compliance|3|||
145771027|NCT01731002|525669013|FG000|Overall Study|Adverse Event|0|||
145771028|NCT01731002|525669014|FG001|Overall Study|Adverse Event|2|||
145771029|NCT01731002|525669015|FG002|Overall Study|Adverse Event|2|||
145533972|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
145533973|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
145533974|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
145533975|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
145533976|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Adverse Event|15|||
145533977|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Adverse Event|0|||
145533978|NCT03277690|524815407|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
145533979|NCT03277690|524815408|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
145533980|NCT03277690|524815407|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
145533981|NCT03277690|524815408|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
145533982|NCT00747812|524815409|FG000|Overall Study|Research Site Staff Relocation|5|||
145533983|NCT00747812|524815410|FG001|Overall Study|Research Site Staff Relocation|3|||
145533984|NCT01708161|524815411|FG000|Overall Study|Adverse Event|1|||
145533985|NCT01708161|524815412|FG001|Overall Study|Adverse Event|3|||
145533986|NCT01708161|524815413|FG002|Overall Study|Adverse Event|4|||
145533987|NCT01708161|524815414|FG003|Overall Study|Adverse Event|2|||
145771030|NCT01731002|525669013|FG000|Overall Study|Non-Compliant|0|||
145771031|NCT01731002|525669014|FG001|Overall Study|Non-Compliant|1|||
145533988|NCT01708161|524815415|FG004|Overall Study|Adverse Event|3|||
145533989|NCT01708161|524815416|FG005|Overall Study|Adverse Event|0|||
145771032|NCT01731002|525669015|FG002|Overall Study|Non-Compliant|0|||
145771033|NCT01731002|525669013|FG000|Overall Study|Lost to Follow-up|1|||
145771034|NCT01731002|525669014|FG001|Overall Study|Lost to Follow-up|0|||
145771035|NCT01731002|525669015|FG002|Overall Study|Lost to Follow-up|0|||
145771036|NCT01731002|525669013|FG000|Overall Study|Test Agent Discontinuation|0|||
145771037|NCT01731002|525669014|FG001|Overall Study|Test Agent Discontinuation|1|||
145771038|NCT01731002|525669015|FG002|Overall Study|Test Agent Discontinuation|0|||
145771039|NCT01731002|525669013|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
145771040|NCT01731002|525669014|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
145771041|NCT01731002|525669015|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
145533990|NCT01708161|524815411|FG000|Overall Study|Death|0|||
145771042|NCT01731002|525669013|FG000|Overall Study|Elevated IOP|1|||
145771043|NCT01731002|525669014|FG001|Overall Study|Elevated IOP|0|||
145771044|NCT01731002|525669015|FG002|Overall Study|Elevated IOP|0|||
145771045|NCT01731002|525669013|FG000|Overall Study|Inappropriate use of study medications|0|||
145771046|NCT01731002|525669014|FG001|Overall Study|Inappropriate use of study medications|0|||
145771047|NCT01731002|525669015|FG002|Overall Study|Inappropriate use of study medications|1|||
145771048|NCT00947349|525669016|FG000|Triple Treatment Combination Period|Adverse Event|0|||
145771049|NCT00947349|525669017|FG001|Triple Treatment Combination Period|Adverse Event|1|||
145771050|NCT00947349|525669018|FG002|Triple Treatment Combination Period|Adverse Event|0|||
145771051|NCT00947349|525669019|FG003|Triple Treatment Combination Period|Adverse Event|0|||
145771052|NCT00947349|525669016|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
145771053|NCT00947349|525669017|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
145771054|NCT00947349|525669018|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
145771055|NCT00947349|525669019|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
145771056|NCT00947349|525669016|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
145771057|NCT00947349|525669017|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
145771058|NCT00947349|525669018|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
145771059|NCT00947349|525669019|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
145771060|NCT00947349|525669016|FG000|Overall Study Standard of Care|Other|0|||
145771061|NCT00947349|525669017|FG001|Overall Study Standard of Care|Other|0|||
145771062|NCT00947349|525669018|FG002|Overall Study Standard of Care|Other|0|||
145771063|NCT00947349|525669019|FG003|Overall Study Standard of Care|Other|1|||
145771064|NCT03929250|525669026|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
145771065|NCT03929250|525669027|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
145771066|NCT05262764|525669029|FG000|Overall Study|Case report form not collected|9|||
145771067|NCT05262764|525669029|FG000|Overall Study|No patient visits after entry|23|||
145771068|NCT05262764|525669029|FG000|Overall Study|Registration rule not followed|2|||
145771069|NCT05262764|525669029|FG000|Overall Study|Patient of non-chronic heart failure|1|||
145771070|NCT01392183|525669030|FG000|First Drug Administration|Adverse Event|3|||
145771071|NCT01392183|525669031|FG001|First Drug Administration|Adverse Event|2|||
145771072|NCT01392183|525669030|FG000|First Drug Administration|Death|1|||
145771073|NCT01392183|525669031|FG001|First Drug Administration|Death|0|||
145771074|NCT01392183|525669030|FG000|First Drug Administration|Withdrawal by Subject|10|||
145771075|NCT01392183|525669031|FG001|First Drug Administration|Withdrawal by Subject|17|||
145771076|NCT03972488|525669032|FG000|Overall Study|Progressive disease|42|||
145771077|NCT03972488|525669033|FG001|Overall Study|Progressive disease|44|||
145771078|NCT03972488|525669032|FG000|Overall Study|Physician Decision|13|||
145771079|NCT03972488|525669033|FG001|Overall Study|Physician Decision|7|||
145771080|NCT03972488|525669032|FG000|Overall Study|Adverse Event|8|||
145771081|NCT03972488|525669033|FG001|Overall Study|Adverse Event|1|||
145771082|NCT03972488|525669032|FG000|Overall Study|Death|4|||
145771083|NCT03972488|525669033|FG001|Overall Study|Death|4|||
145278335|NCT01453374|523870814|FG000|Overall Study|Lost to Follow-up|3|||
145278336|NCT01453374|523870814|FG000|Overall Study|Withdrawal by Subject|5|||
145278337|NCT01453374|523870814|FG000|Overall Study|Incarcerated|2|||
145278338|NCT01238822|523870817|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
145278339|NCT00849524|523870818|FG000|Overall Study|Lack of Efficacy|3|||
145278340|NCT01027884|523870821|FG000|Overall Study|Adverse Event|2|||
145771084|NCT03972488|525669032|FG000|Overall Study|Withdrawal by Subject|3|||
145771085|NCT03972488|525669033|FG001|Overall Study|Withdrawal by Subject|4|||
145771086|NCT03972488|525669032|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
145771087|NCT03972488|525669033|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
145771088|NCT03277196|525669039|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
145771089|NCT03277196|525669039|FG000|Overall Study|Lost to Follow-up|3|||
145771090|NCT03277196|525669039|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
145771091|NCT03277196|525669039|FG000|Overall Study|Other|2|||
145771092|NCT01024244|525671577|FG000|Overall Study|Adverse Event|1|||
145771093|NCT01024244|525671578|FG001|Overall Study|Adverse Event|2|||
145771094|NCT01024244|525671579|FG002|Overall Study|Adverse Event|0|||
145771095|NCT01024244|525671580|FG003|Overall Study|Adverse Event|1|||
145771096|NCT01024244|525671581|FG004|Overall Study|Adverse Event|2|||
145771097|NCT01024244|525671577|FG000|Overall Study|Entry Criteria Not Met|0|||
145771098|NCT01024244|525671578|FG001|Overall Study|Entry Criteria Not Met|1|||
145771099|NCT01024244|525671579|FG002|Overall Study|Entry Criteria Not Met|0|||
145771100|NCT01024244|525671580|FG003|Overall Study|Entry Criteria Not Met|0|||
145771101|NCT01024244|525671581|FG004|Overall Study|Entry Criteria Not Met|0|||
145771102|NCT01024244|525671577|FG000|Overall Study|Lack of Efficacy|1|||
145278341|NCT01027884|523870822|FG001|Overall Study|Adverse Event|1|||
145278342|NCT01027884|523870821|FG000|Overall Study|Protocol Violation|1|||
145771103|NCT01024244|525671578|FG001|Overall Study|Lack of Efficacy|0|||
145771104|NCT01024244|525671579|FG002|Overall Study|Lack of Efficacy|0|||
145771105|NCT01024244|525671580|FG003|Overall Study|Lack of Efficacy|0|||
145771106|NCT01024244|525671581|FG004|Overall Study|Lack of Efficacy|0|||
145278343|NCT01027884|523870822|FG001|Overall Study|Protocol Violation|0|||
145771107|NCT01024244|525671577|FG000|Overall Study|Protocol Violation|1|||
145771108|NCT01024244|525671578|FG001|Overall Study|Protocol Violation|0|||
145771109|NCT01024244|525671579|FG002|Overall Study|Protocol Violation|0|||
145771110|NCT01024244|525671580|FG003|Overall Study|Protocol Violation|0|||
145771111|NCT01024244|525671581|FG004|Overall Study|Protocol Violation|2|||
145771112|NCT01024244|525671577|FG000|Overall Study|Sponsor Decision|14|||
145771113|NCT01024244|525671578|FG001|Overall Study|Sponsor Decision|7|||
145771114|NCT01024244|525671579|FG002|Overall Study|Sponsor Decision|14|||
145771115|NCT01024244|525671580|FG003|Overall Study|Sponsor Decision|12|||
145771116|NCT01024244|525671581|FG004|Overall Study|Sponsor Decision|10|||
145771117|NCT01024244|525671577|FG000|Overall Study|Withdrawal by Subject|0|||
145771118|NCT01024244|525671578|FG001|Overall Study|Withdrawal by Subject|1|||
145771119|NCT01024244|525671579|FG002|Overall Study|Withdrawal by Subject|0|||
145771120|NCT01024244|525671580|FG003|Overall Study|Withdrawal by Subject|0|||
145771121|NCT01024244|525671581|FG004|Overall Study|Withdrawal by Subject|0|||
145771122|NCT00473694|525671585|FG000|Overall Study|Adverse Event|0|||
145771123|NCT00473694|525671586|FG001|Overall Study|Adverse Event|1|||
145771124|NCT00473694|525671587|FG002|Overall Study|Adverse Event|0|||
145771125|NCT00473694|525671588|FG003|Overall Study|Adverse Event|0|||
145771126|NCT00473694|525671585|FG000|Overall Study|Participants did not receive treatment|11|||
145771127|NCT00473694|525671586|FG001|Overall Study|Participants did not receive treatment|3|||
145771128|NCT00473694|525671587|FG002|Overall Study|Participants did not receive treatment|5|||
145771129|NCT00473694|525671588|FG003|Overall Study|Participants did not receive treatment|6|||
145771130|NCT00473694|525671585|FG000|Overall Study|Lost to Follow-up|0|||
145771131|NCT00473694|525671586|FG001|Overall Study|Lost to Follow-up|0|||
145403328|NCT00171249|524334373|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
145278344|NCT01027884|523870821|FG000|Overall Study|Non-compliance|1|||
145278345|NCT01027884|523870822|FG001|Overall Study|Non-compliance|1|||
145278346|NCT01027884|523870821|FG000|Overall Study|Withdrawal by Subject|0|||
145278347|NCT01027884|523870822|FG001|Overall Study|Withdrawal by Subject|1|||
145278348|NCT01027884|523870821|FG000|Overall Study|Lost to Follow-up|0|||
145278349|NCT01027884|523870822|FG001|Overall Study|Lost to Follow-up|1|||
145278350|NCT01027884|523870821|FG000|Overall Study|Spinal fixation surgery|0|||
145278351|NCT01027884|523870822|FG001|Overall Study|Spinal fixation surgery|3|||
145278352|NCT03636542|523870823|FG000|Overall Study|Lost to Follow-up|1|||
145278353|NCT03636542|523870824|FG001|Overall Study|Lost to Follow-up|1|||
145278354|NCT03636542|523870823|FG000|Overall Study|Physician Decision|0|||
145533991|NCT01708161|524815412|FG001|Overall Study|Death|0|||
145533992|NCT01708161|524815413|FG002|Overall Study|Death|0|||
145533993|NCT01708161|524815414|FG003|Overall Study|Death|1|||
145533994|NCT01708161|524815415|FG004|Overall Study|Death|0|||
145278355|NCT03636542|523870824|FG001|Overall Study|Physician Decision|1|||
145278356|NCT03636542|523870823|FG000|Overall Study|Withdrawal by Subject|1|||
145278357|NCT03636542|523870824|FG001|Overall Study|Withdrawal by Subject|0|||
145278358|NCT02059187|523870825|FG000|Overall Study|Adverse Event|0|||
145278359|NCT02059187|523870826|FG001|Overall Study|Adverse Event|3|||
145278360|NCT02059187|523870825|FG000|Overall Study|Death|1|||
145278361|NCT02059187|523870826|FG001|Overall Study|Death|1|||
145278362|NCT02059187|523870825|FG000|Overall Study|Lost to Follow-up|9|||
145278363|NCT02059187|523870826|FG001|Overall Study|Lost to Follow-up|8|||
145278364|NCT02059187|523870825|FG000|Overall Study|Non-compliance with study drug|1|||
145278365|NCT02059187|523870826|FG001|Overall Study|Non-compliance with study drug|0|||
145278366|NCT02059187|523870825|FG000|Overall Study|Physician Decision|1|||
145278367|NCT02059187|523870826|FG001|Overall Study|Physician Decision|2|||
145278368|NCT02059187|523870825|FG000|Overall Study|Protocol Violation|1|||
145278369|NCT02059187|523870826|FG001|Overall Study|Protocol Violation|0|||
145278370|NCT02059187|523870825|FG000|Overall Study|Withdrawal by Subject|12|||
145533995|NCT01708161|524815416|FG005|Overall Study|Death|1|||
145533996|NCT01708161|524815411|FG000|Overall Study|Withdrawal by Subject|0|||
145608090|NCT00445679|525079321|FG001|Overall Study|Compliance|2|||
145771132|NCT00473694|525671587|FG002|Overall Study|Lost to Follow-up|0|||
145771133|NCT00473694|525671588|FG003|Overall Study|Lost to Follow-up|1|||
145771134|NCT02468193|525671589|FG000|Overall Study|Adverse Event|4|||
145771135|NCT02468193|525671589|FG000|Overall Study|Subject/ Guardian decision|2|||
145771136|NCT00742781|525671590|FG000|Overall Study|Withdrawal by Subject|3|||
145278371|NCT02059187|523870826|FG001|Overall Study|Withdrawal by Subject|8|||
145533997|NCT01708161|524815412|FG001|Overall Study|Withdrawal by Subject|1|||
145533998|NCT01708161|524815413|FG002|Overall Study|Withdrawal by Subject|1|||
145278372|NCT02624518|523870827|FG000|Overall Study|Physician Decision|1|||
145278373|NCT02729194|523870828|FG000|Overall Study|Withdrawal by Subject|3|||
145278374|NCT00845026|523870829|FG000|Study Period III|Adverse Event|23|||
145533999|NCT01708161|524815414|FG003|Overall Study|Withdrawal by Subject|0|||
145534000|NCT01708161|524815415|FG004|Overall Study|Withdrawal by Subject|0|||
145534001|NCT01708161|524815416|FG005|Overall Study|Withdrawal by Subject|0|||
145771137|NCT01416181|525671591|FG000|Part 1|Other|10|||
145771138|NCT01416181|525671592|FG001|Part 1|Other|24|||
145771139|NCT01416181|525671591|FG000|Part 1|Death|0|||
145771140|NCT01416181|525671592|FG001|Part 1|Death|1|||
145771141|NCT01416181|525671591|FG000|Part 1|Investigator Decision|7|||
145771142|NCT01416181|525671592|FG001|Part 1|Investigator Decision|6|||
145771143|NCT01416181|525671591|FG000|Part 1|Withdrawal by Subject|74|||
145771144|NCT01416181|525671592|FG001|Part 1|Withdrawal by Subject|48|||
145771145|NCT01416181|525671591|FG000|Part 1|Lack of Efficacy|16|||
145771146|NCT01416181|525671592|FG001|Part 1|Lack of Efficacy|8|||
145771147|NCT01416181|525671591|FG000|Part 1|Lost to Follow-up|1|||
145771148|NCT01416181|525671592|FG001|Part 1|Lost to Follow-up|1|||
145771149|NCT01416181|525671591|FG000|Part 1|Adverse Event|15|||
145771150|NCT01416181|525671592|FG001|Part 1|Adverse Event|18|||
145771151|NCT01416181|525671591|FG000|Part 1|Ongoing in Follow-Up|14|||
145771152|NCT01416181|525671592|FG001|Part 1|Ongoing in Follow-Up|8|||
145771153|NCT01416181|525671591|FG000|Part 2|Adverse Event|11|||
145771154|NCT01416181|525671592|FG001|Part 2|Adverse Event|4|||
145771155|NCT01416181|525671591|FG000|Part 2|Other|234|||
145771156|NCT01416181|525671592|FG001|Part 2|Other|267|||
145771157|NCT01416181|525671591|FG000|Part 2|Investigator Decision|6|||
145771158|NCT01416181|525671592|FG001|Part 2|Investigator Decision|7|||
145771159|NCT01416181|525671591|FG000|Part 2|Withdrawal by Subject|14|||
145771160|NCT01416181|525671592|FG001|Part 2|Withdrawal by Subject|5|||
145771161|NCT01416181|525671591|FG000|Part 2|Lack of Efficacy|4|||
145771162|NCT01416181|525671592|FG001|Part 2|Lack of Efficacy|1|||
145771163|NCT01416181|525671591|FG000|Part 2|Lost to Follow-up|2|||
145771164|NCT01416181|525671592|FG001|Part 2|Lost to Follow-up|2|||
145534002|NCT01708161|524815411|FG000|Overall Study|Administrative problems|0|||
145771165|NCT03874234|525671593|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771166|NCT03874234|525671594|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771167|NCT03874234|525671595|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771168|NCT03874234|525671596|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
145771169|NCT03874234|525671597|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771170|NCT03874234|525671598|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771171|NCT03874234|525671599|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771172|NCT03874234|525671600|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771173|NCT03874234|525671601|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771174|NCT03874234|525671602|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771175|NCT03874234|525671603|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145534003|NCT01708161|524815412|FG001|Overall Study|Administrative problems|1|||
145534004|NCT01708161|524815413|FG002|Overall Study|Administrative problems|0|||
145278375|NCT00845026|523870830|FG001|Study Period III|Adverse Event|19|||
145278376|NCT00845026|523870829|FG000|Study Period III|Perceived lack of efficacy|27|||
145534005|NCT01708161|524815414|FG003|Overall Study|Administrative problems|0|||
145771176|NCT03874234|525671604|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771177|NCT03874234|525671605|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
145771178|NCT03874234|525671593|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
145771179|NCT03874234|525671594|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771180|NCT03874234|525671595|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771181|NCT03874234|525671596|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771182|NCT03874234|525671597|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771183|NCT03874234|525671598|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145534006|NCT01708161|524815415|FG004|Overall Study|Administrative problems|0|||
145534007|NCT01708161|524815416|FG005|Overall Study|Administrative problems|0|||
145534008|NCT01708161|524815411|FG000|Overall Study|Disease progression|3|||
145534009|NCT01708161|524815412|FG001|Overall Study|Disease progression|5|||
145534010|NCT01708161|524815413|FG002|Overall Study|Disease progression|5|||
145534011|NCT01708161|524815414|FG003|Overall Study|Disease progression|13|||
145534012|NCT01708161|524815415|FG004|Overall Study|Disease progression|3|||
145534013|NCT01708161|524815416|FG005|Overall Study|Disease progression|0|||
145534014|NCT03725852|524815418|FG000|Overall Study|Death|1|||
145534015|NCT03725852|524815419|FG001|Overall Study|Death|0|||
145534016|NCT03725852|524815418|FG000|Overall Study|Withdrawal by Subject|1|||
145534017|NCT03725852|524815419|FG001|Overall Study|Withdrawal by Subject|0|||
145534018|NCT03725852|524815418|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
145534019|NCT03725852|524815419|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
145534020|NCT01986140|524815420|FG000|Overall Study|Withdrawal by Subject|31|||
145534021|NCT01986140|524815421|FG001|Overall Study|Withdrawal by Subject|25|||
145534022|NCT01986140|524815420|FG000|Overall Study|alternative treatment|1|||
145771184|NCT03874234|525671599|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145278377|NCT00845026|523870830|FG001|Study Period III|Perceived lack of efficacy|15|||
145278378|NCT00845026|523870829|FG000|Study Period III|Withdrawal by Subject|19|||
145534023|NCT01986140|524815421|FG001|Overall Study|alternative treatment|1|||
145534024|NCT01986140|524815420|FG000|Overall Study|found not eligible|3|||
145534025|NCT01986140|524815421|FG001|Overall Study|found not eligible|0|||
145534026|NCT01986140|524815420|FG000|Overall Study|Adverse Event|0|||
145771185|NCT03874234|525671600|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771186|NCT03874234|525671601|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771187|NCT03874234|525671602|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771188|NCT03874234|525671603|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771189|NCT03874234|525671604|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771190|NCT03874234|525671605|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
145771191|NCT03874234|525671593|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771192|NCT03874234|525671594|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145278379|NCT00845026|523870830|FG001|Study Period III|Withdrawal by Subject|15|||
145278380|NCT00845026|523870829|FG000|Study Period III|Entry Criteria not met|8|||
145771193|NCT03874234|525671595|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771194|NCT03874234|525671596|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
145771195|NCT03874234|525671597|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771196|NCT03874234|525671598|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771197|NCT03874234|525671599|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771198|NCT03874234|525671600|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771199|NCT03874234|525671601|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771200|NCT03874234|525671602|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771201|NCT03874234|525671603|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771202|NCT03874234|525671604|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771203|NCT03874234|525671605|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
145771204|NCT03874234|525671593|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771205|NCT03874234|525671594|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771206|NCT03874234|525671595|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771207|NCT03874234|525671596|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771208|NCT03874234|525671597|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
145771209|NCT03874234|525671598|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771210|NCT03874234|525671599|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771211|NCT03874234|525671600|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771212|NCT03874234|525671601|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771213|NCT03874234|525671602|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771214|NCT03874234|525671603|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771215|NCT03874234|525671604|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771216|NCT03874234|525671605|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
145771217|NCT03874234|525671593|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771218|NCT03874234|525671594|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771219|NCT03874234|525671595|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771220|NCT03874234|525671596|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771221|NCT03874234|525671597|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771222|NCT03874234|525671598|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771223|NCT03874234|525671599|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771224|NCT03874234|525671600|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
145771225|NCT03874234|525671601|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771226|NCT03874234|525671602|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771227|NCT03874234|525671603|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771228|NCT03874234|525671604|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771229|NCT03874234|525671605|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
145771230|NCT03874234|525671593|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771231|NCT03874234|525671594|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771232|NCT03874234|525671595|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771233|NCT03874234|525671596|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771234|NCT03874234|525671597|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
145771235|NCT03874234|525671598|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
145771236|NCT03874234|525671599|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771237|NCT03874234|525671600|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771238|NCT03874234|525671601|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771239|NCT03874234|525671602|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771240|NCT03874234|525671603|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771241|NCT03874234|525671604|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771242|NCT03874234|525671605|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
145771243|NCT03874234|525671593|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771244|NCT03874234|525671594|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771245|NCT03874234|525671595|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771246|NCT03874234|525671596|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771247|NCT03874234|525671597|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771248|NCT03874234|525671598|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771249|NCT03874234|525671599|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
145771250|NCT03874234|525671600|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771251|NCT03874234|525671601|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771252|NCT03874234|525671602|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771253|NCT03874234|525671603|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771254|NCT03874234|525671604|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771255|NCT03874234|525671605|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
145771256|NCT03874234|525671593|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771257|NCT03874234|525671594|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771258|NCT03874234|525671595|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771259|NCT03874234|525671596|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771260|NCT03874234|525671597|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
145771261|NCT03874234|525671598|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771262|NCT03874234|525671599|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771263|NCT03874234|525671600|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771264|NCT03874234|525671601|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771265|NCT03874234|525671602|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771266|NCT03874234|525671603|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771267|NCT03874234|525671604|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771268|NCT03874234|525671605|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
145771269|NCT01896232|525671608|FG000|Overall Study|Death|6|||
145771270|NCT01896232|525671609|FG001|Overall Study|Death|10|||
145771271|NCT01896232|525671608|FG000|Overall Study|Withdrawal by Subject|32|||
145771272|NCT01896232|525671609|FG001|Overall Study|Withdrawal by Subject|31|||
145771273|NCT01896232|525671608|FG000|Overall Study|Sponsor Decision|2|||
145771274|NCT01896232|525671609|FG001|Overall Study|Sponsor Decision|0|||
145771275|NCT01896232|525671608|FG000|Overall Study|Lost to Follow-up|9|||
145771276|NCT01896232|525671609|FG001|Overall Study|Lost to Follow-up|12|||
145771277|NCT03816995|525671620|FG000|Overall Study|Withdrawal by Subject|3|||
145771278|NCT03816995|525671621|FG001|Overall Study|Withdrawal by Subject|1|||
145771279|NCT03816995|525671620|FG000|Overall Study|Cancelled Surgery|8|||
145771280|NCT03816995|525671621|FG001|Overall Study|Cancelled Surgery|12|||
145771281|NCT03816995|525671620|FG000|Overall Study|No wound protector used|11|||
145771282|NCT03816995|525671621|FG001|Overall Study|No wound protector used|17|||
145771283|NCT03816995|525671620|FG000|Overall Study|Protocol Violation|2|||
145771284|NCT03816995|525671621|FG001|Overall Study|Protocol Violation|3|||
145771285|NCT00541307|525671623|FG000|Overall Study|Death|5|||
145771286|NCT00541307|525671623|FG000|Overall Study|Physician Decision|3|||
145771287|NCT00541307|525671623|FG000|Overall Study|Withdrawal by Subject|6|||
145771288|NCT00541307|525671623|FG000|Overall Study|Lost to Follow-up|4|||
145771289|NCT00541307|525671623|FG000|Overall Study|Subject returned early (outside window)|1|||
145771290|NCT00541307|525671623|FG000|Overall Study|Surgical Bypass|5|||
145771291|NCT04723537|525671624|FG000|Overall Study|Withdrawal by Subject|3|||
145771292|NCT04723537|525671625|FG001|Overall Study|Withdrawal by Subject|0|||
145771293|NCT04723537|525671626|FG002|Overall Study|Withdrawal by Subject|0|||
145771294|NCT04723537|525671624|FG000|Overall Study|Physician Decision|0|||
145771295|NCT04723537|525671625|FG001|Overall Study|Physician Decision|0|||
145771296|NCT04723537|525671626|FG002|Overall Study|Physician Decision|1|||
145771297|NCT04723537|525671624|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
145771298|NCT04723537|525671625|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
145771299|NCT04723537|525671626|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
145771300|NCT01324830|525671627|FG000|Overall Study|Progressive Disease|3|||
145771301|NCT01324830|525671628|FG001|Overall Study|Progressive Disease|2|||
145771302|NCT01324830|525671629|FG002|Overall Study|Progressive Disease|3|||
145608091|NCT00445679|525079322|FG002|Overall Study|Compliance|1|||
145608092|NCT00445679|525079323|FG003|Overall Study|Compliance|2|||
145771303|NCT01324830|525671630|FG003|Overall Study|Progressive Disease|3|||
145771304|NCT01324830|525671631|FG004|Overall Study|Progressive Disease|6|||
145771305|NCT01324830|525671632|FG005|Overall Study|Progressive Disease|6|||
145771306|NCT01324830|525671633|FG006|Overall Study|Progressive Disease|3|||
145771307|NCT01324830|525671634|FG007|Overall Study|Progressive Disease|3|||
145771308|NCT01324830|525671635|FG008|Overall Study|Progressive Disease|3|||
145771309|NCT01324830|525671636|FG009|Overall Study|Progressive Disease|6|||
145771310|NCT01324830|525671637|FG010|Overall Study|Progressive Disease|2|||
145771311|NCT01324830|525671638|FG011|Overall Study|Progressive Disease|1|||
145771312|NCT01324830|525671639|FG012|Overall Study|Progressive Disease|1|||
145771313|NCT01324830|525671640|FG013|Overall Study|Progressive Disease|1|||
145771314|NCT01324830|525671641|FG014|Overall Study|Progressive Disease|1|||
145771315|NCT01324830|525671642|FG015|Overall Study|Progressive Disease|3|||
145771316|NCT01324830|525671643|FG016|Overall Study|Progressive Disease|2|||
145403329|NCT00171249|524334374|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145771317|NCT01324830|525671644|FG017|Overall Study|Progressive Disease|3|||
145771318|NCT01324830|525671645|FG018|Overall Study|Progressive Disease|4|||
145771319|NCT01324830|525671627|FG000|Overall Study|Dose limiting toxicity|0|||
145771320|NCT01324830|525671628|FG001|Overall Study|Dose limiting toxicity|0|||
145771321|NCT01324830|525671629|FG002|Overall Study|Dose limiting toxicity|0|||
145771322|NCT01324830|525671630|FG003|Overall Study|Dose limiting toxicity|0|||
145771323|NCT01324830|525671631|FG004|Overall Study|Dose limiting toxicity|1|||
145771324|NCT01324830|525671632|FG005|Overall Study|Dose limiting toxicity|0|||
145771325|NCT01324830|525671633|FG006|Overall Study|Dose limiting toxicity|0|||
145771326|NCT01324830|525671634|FG007|Overall Study|Dose limiting toxicity|0|||
145771327|NCT01324830|525671635|FG008|Overall Study|Dose limiting toxicity|0|||
145771328|NCT01324830|525671636|FG009|Overall Study|Dose limiting toxicity|0|||
145771329|NCT01324830|525671637|FG010|Overall Study|Dose limiting toxicity|0|||
145771330|NCT01324830|525671638|FG011|Overall Study|Dose limiting toxicity|0|||
145771331|NCT01324830|525671639|FG012|Overall Study|Dose limiting toxicity|0|||
145771332|NCT01324830|525671640|FG013|Overall Study|Dose limiting toxicity|0|||
145771333|NCT01324830|525671641|FG014|Overall Study|Dose limiting toxicity|0|||
145771334|NCT01324830|525671642|FG015|Overall Study|Dose limiting toxicity|0|||
145771335|NCT01324830|525671643|FG016|Overall Study|Dose limiting toxicity|1|||
145771336|NCT01324830|525671644|FG017|Overall Study|Dose limiting toxicity|1|||
145771337|NCT01324830|525671645|FG018|Overall Study|Dose limiting toxicity|1|||
145278381|NCT00845026|523870830|FG001|Study Period III|Entry Criteria not met|11|||
145278382|NCT00845026|523870829|FG000|Study Period III|Lost to Follow-up|4|||
145278383|NCT00845026|523870830|FG001|Study Period III|Lost to Follow-up|5|||
145278384|NCT00845026|523870829|FG000|Study Period III|Protocol Violation|8|||
145278385|NCT00845026|523870830|FG001|Study Period III|Protocol Violation|1|||
145278386|NCT00845026|523870829|FG000|Study Period III|Scheduled conflict|3|||
145278387|NCT00845026|523870830|FG001|Study Period III|Scheduled conflict|1|||
145278388|NCT00845026|523870829|FG000|Study Period III|Subject is moving or has moved|2|||
145278389|NCT00845026|523870830|FG001|Study Period III|Subject is moving or has moved|4|||
145278390|NCT00845026|523870829|FG000|Study Period III|Transportation issues|1|||
145278391|NCT00845026|523870830|FG001|Study Period III|Transportation issues|1|||
145278392|NCT00845026|523870829|FG000|Study Period IV|Adverse Event|4|||
145278393|NCT00845026|523870830|FG001|Study Period IV|Adverse Event|0|||
145278394|NCT00845026|523870829|FG000|Study Period IV|Perceived lack of efficacy|2|||
145278395|NCT00845026|523870830|FG001|Study Period IV|Perceived lack of efficacy|1|||
145278396|NCT00845026|523870829|FG000|Study Period IV|Protocol Violation|3|||
145278397|NCT00845026|523870830|FG001|Study Period IV|Protocol Violation|1|||
145278398|NCT00845026|523870829|FG000|Study Period IV|Lost to Follow-up|1|||
145278399|NCT00845026|523870830|FG001|Study Period IV|Lost to Follow-up|0|||
145278400|NCT00845026|523870829|FG000|Study Period IV|Withdrawal by Subject|4|||
145278401|NCT00845026|523870830|FG001|Study Period IV|Withdrawal by Subject|1|||
145278402|NCT00845026|523870829|FG000|Study Period IV|Entry Criteria Not Met|1|||
145278403|NCT00845026|523870830|FG001|Study Period IV|Entry Criteria Not Met|0|||
145278404|NCT00845026|523870829|FG000|Study Period IV|Subject is moving or has moved|0|||
145278405|NCT00845026|523870830|FG001|Study Period IV|Subject is moving or has moved|1|||
145278406|NCT00845026|523870829|FG000|Study Period IV|Scheduling conflict|1|||
145771338|NCT01324830|525671627|FG000|Overall Study|Reason not mentioned above|0|||
145771339|NCT01324830|525671628|FG001|Overall Study|Reason not mentioned above|0|||
145771340|NCT01324830|525671629|FG002|Overall Study|Reason not mentioned above|0|||
145771341|NCT01324830|525671630|FG003|Overall Study|Reason not mentioned above|0|||
145771342|NCT01324830|525671631|FG004|Overall Study|Reason not mentioned above|0|||
145771343|NCT01324830|525671632|FG005|Overall Study|Reason not mentioned above|0|||
145771344|NCT01324830|525671633|FG006|Overall Study|Reason not mentioned above|0|||
145771345|NCT01324830|525671634|FG007|Overall Study|Reason not mentioned above|0|||
145771346|NCT01324830|525671635|FG008|Overall Study|Reason not mentioned above|0|||
145771347|NCT01324830|525671636|FG009|Overall Study|Reason not mentioned above|0|||
145771348|NCT01324830|525671637|FG010|Overall Study|Reason not mentioned above|0|||
145771349|NCT01324830|525671638|FG011|Overall Study|Reason not mentioned above|0|||
145771350|NCT01324830|525671639|FG012|Overall Study|Reason not mentioned above|0|||
145771351|NCT01324830|525671640|FG013|Overall Study|Reason not mentioned above|0|||
145771352|NCT01324830|525671641|FG014|Overall Study|Reason not mentioned above|0|||
145771353|NCT01324830|525671642|FG015|Overall Study|Reason not mentioned above|0|||
145771354|NCT01324830|525671643|FG016|Overall Study|Reason not mentioned above|0|||
145771355|NCT01324830|525671644|FG017|Overall Study|Reason not mentioned above|1|||
145771356|NCT01324830|525671645|FG018|Overall Study|Reason not mentioned above|0|||
145771357|NCT01324830|525671627|FG000|Overall Study|Adverse Event, serious fatal|0|||
145771358|NCT01324830|525671628|FG001|Overall Study|Adverse Event, serious fatal|1|||
145771359|NCT01324830|525671629|FG002|Overall Study|Adverse Event, serious fatal|0|||
145771360|NCT01324830|525671630|FG003|Overall Study|Adverse Event, serious fatal|0|||
145771361|NCT01324830|525671631|FG004|Overall Study|Adverse Event, serious fatal|0|||
145771362|NCT01324830|525671632|FG005|Overall Study|Adverse Event, serious fatal|0|||
145771363|NCT01324830|525671633|FG006|Overall Study|Adverse Event, serious fatal|0|||
145771364|NCT01324830|525671634|FG007|Overall Study|Adverse Event, serious fatal|0|||
145771365|NCT01324830|525671635|FG008|Overall Study|Adverse Event, serious fatal|0|||
145771366|NCT01324830|525671636|FG009|Overall Study|Adverse Event, serious fatal|0|||
145771367|NCT01324830|525671637|FG010|Overall Study|Adverse Event, serious fatal|0|||
145771368|NCT01324830|525671638|FG011|Overall Study|Adverse Event, serious fatal|0|||
145771369|NCT01324830|525671639|FG012|Overall Study|Adverse Event, serious fatal|0|||
145771370|NCT01324830|525671640|FG013|Overall Study|Adverse Event, serious fatal|0|||
145771371|NCT01324830|525671641|FG014|Overall Study|Adverse Event, serious fatal|0|||
145403330|NCT00171249|524334375|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
145403331|NCT00171249|524334376|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145403332|NCT00171249|524334370|FG000|Overall Study|Death|7|||
145403333|NCT00171249|524334371|FG001|Overall Study|Death|1|||
145771372|NCT01324830|525671642|FG015|Overall Study|Adverse Event, serious fatal|0|||
145403334|NCT00171249|524334372|FG002|Overall Study|Death|0|||
145771373|NCT01324830|525671643|FG016|Overall Study|Adverse Event, serious fatal|0|||
145771374|NCT01324830|525671644|FG017|Overall Study|Adverse Event, serious fatal|0|||
145771375|NCT01324830|525671645|FG018|Overall Study|Adverse Event, serious fatal|0|||
145771376|NCT01324830|525671627|FG000|Overall Study|Adverse Event, non-fatal|0|||
145771377|NCT01324830|525671628|FG001|Overall Study|Adverse Event, non-fatal|0|||
145771378|NCT01324830|525671629|FG002|Overall Study|Adverse Event, non-fatal|0|||
145771379|NCT01324830|525671630|FG003|Overall Study|Adverse Event, non-fatal|0|||
145771380|NCT01324830|525671631|FG004|Overall Study|Adverse Event, non-fatal|0|||
145771381|NCT01324830|525671632|FG005|Overall Study|Adverse Event, non-fatal|0|||
145771382|NCT01324830|525671633|FG006|Overall Study|Adverse Event, non-fatal|0|||
145403335|NCT00171249|524334373|FG003|Overall Study|Death|4|||
145403336|NCT00171249|524334374|FG004|Overall Study|Death|0|||
145403337|NCT00171249|524334375|FG005|Overall Study|Death|3|||
145403338|NCT00171249|524334376|FG006|Overall Study|Death|1|||
145403339|NCT00171249|524334370|FG000|Overall Study|Other|10|||
145403340|NCT00171249|524334371|FG001|Overall Study|Other|0|||
145403341|NCT00171249|524334372|FG002|Overall Study|Other|0|||
145403342|NCT00171249|524334373|FG003|Overall Study|Other|43|||
145403343|NCT00171249|524334374|FG004|Overall Study|Other|0|||
145403344|NCT00171249|524334375|FG005|Overall Study|Other|2|||
145403345|NCT00171249|524334376|FG006|Overall Study|Other|0|||
145403346|NCT00171249|524334370|FG000|Overall Study|No Longer Requires Study Drug|4|||
145403347|NCT00171249|524334371|FG001|Overall Study|No Longer Requires Study Drug|0|||
145403348|NCT00171249|524334372|FG002|Overall Study|No Longer Requires Study Drug|0|||
145403349|NCT00171249|524334373|FG003|Overall Study|No Longer Requires Study Drug|3|||
145403350|NCT00171249|524334374|FG004|Overall Study|No Longer Requires Study Drug|0|||
145403351|NCT00171249|524334375|FG005|Overall Study|No Longer Requires Study Drug|5|||
145403352|NCT00171249|524334376|FG006|Overall Study|No Longer Requires Study Drug|0|||
145534027|NCT01986140|524815421|FG001|Overall Study|Adverse Event|1|||
145534028|NCT01986140|524815420|FG000|Overall Study|progression disease|0|||
145534029|NCT01986140|524815421|FG001|Overall Study|progression disease|1|||
145534030|NCT02913612|524815422|FG000|Overall Study|Lost to Follow-up|6|||
145534031|NCT02913612|524815423|FG001|Overall Study|Lost to Follow-up|5|||
145771383|NCT01324830|525671634|FG007|Overall Study|Adverse Event, non-fatal|0|||
145771384|NCT01324830|525671635|FG008|Overall Study|Adverse Event, non-fatal|2|||
145771385|NCT01324830|525671636|FG009|Overall Study|Adverse Event, non-fatal|0|||
145771386|NCT01324830|525671637|FG010|Overall Study|Adverse Event, non-fatal|1|||
145771387|NCT01324830|525671638|FG011|Overall Study|Adverse Event, non-fatal|0|||
145771388|NCT01324830|525671639|FG012|Overall Study|Adverse Event, non-fatal|0|||
145771389|NCT01324830|525671640|FG013|Overall Study|Adverse Event, non-fatal|0|||
145771390|NCT01324830|525671641|FG014|Overall Study|Adverse Event, non-fatal|0|||
145771391|NCT01324830|525671642|FG015|Overall Study|Adverse Event, non-fatal|0|||
145403353|NCT00171249|524334370|FG000|Overall Study|Administrative Problems|1|||
145403354|NCT00171249|524334371|FG001|Overall Study|Administrative Problems|0|||
145403355|NCT00171249|524334372|FG002|Overall Study|Administrative Problems|0|||
145403356|NCT00171249|524334373|FG003|Overall Study|Administrative Problems|2|||
145771392|NCT01324830|525671643|FG016|Overall Study|Adverse Event, non-fatal|0|||
145771393|NCT01324830|525671644|FG017|Overall Study|Adverse Event, non-fatal|1|||
145403357|NCT00171249|524334374|FG004|Overall Study|Administrative Problems|0|||
145403358|NCT00171249|524334375|FG005|Overall Study|Administrative Problems|0|||
145403359|NCT00171249|524334376|FG006|Overall Study|Administrative Problems|0|||
145403360|NCT00171249|524334370|FG000|Overall Study|Adverse Event|3|||
145403361|NCT00171249|524334371|FG001|Overall Study|Adverse Event|1|||
145403362|NCT00171249|524334372|FG002|Overall Study|Adverse Event|0|||
145403363|NCT00171249|524334373|FG003|Overall Study|Adverse Event|15|||
145403364|NCT00171249|524334374|FG004|Overall Study|Adverse Event|0|||
145403365|NCT00171249|524334375|FG005|Overall Study|Adverse Event|2|||
145771394|NCT01324830|525671645|FG018|Overall Study|Adverse Event, non-fatal|0|||
145403366|NCT00171249|524334376|FG006|Overall Study|Adverse Event|0|||
145534032|NCT02913612|524815424|FG002|Overall Study|Lost to Follow-up|2|||
145534033|NCT02913612|524815425|FG003|Overall Study|Lost to Follow-up|0|||
145403367|NCT00171249|524334370|FG000|Overall Study|Lost to Follow-up|5|||
145403368|NCT00171249|524334371|FG001|Overall Study|Lost to Follow-up|0|||
145771395|NCT01324830|525671627|FG000|Overall Study|Withdrawal by Subject|0|||
145771396|NCT01324830|525671628|FG001|Overall Study|Withdrawal by Subject|0|||
145771397|NCT01324830|525671629|FG002|Overall Study|Withdrawal by Subject|0|||
145771398|NCT01324830|525671630|FG003|Overall Study|Withdrawal by Subject|0|||
145403369|NCT00171249|524334372|FG002|Overall Study|Lost to Follow-up|0|||
145403370|NCT00171249|524334373|FG003|Overall Study|Lost to Follow-up|9|||
145403371|NCT00171249|524334374|FG004|Overall Study|Lost to Follow-up|0|||
145771399|NCT01324830|525671631|FG004|Overall Study|Withdrawal by Subject|0|||
145771400|NCT01324830|525671632|FG005|Overall Study|Withdrawal by Subject|1|||
145771401|NCT01324830|525671633|FG006|Overall Study|Withdrawal by Subject|0|||
145771402|NCT01324830|525671634|FG007|Overall Study|Withdrawal by Subject|0|||
145771403|NCT01324830|525671635|FG008|Overall Study|Withdrawal by Subject|0|||
145771404|NCT01324830|525671636|FG009|Overall Study|Withdrawal by Subject|0|||
145771405|NCT01324830|525671637|FG010|Overall Study|Withdrawal by Subject|1|||
145771406|NCT01324830|525671638|FG011|Overall Study|Withdrawal by Subject|0|||
145771407|NCT01324830|525671639|FG012|Overall Study|Withdrawal by Subject|0|||
145771408|NCT01324830|525671640|FG013|Overall Study|Withdrawal by Subject|0|||
145771409|NCT01324830|525671641|FG014|Overall Study|Withdrawal by Subject|0|||
145771410|NCT01324830|525671642|FG015|Overall Study|Withdrawal by Subject|0|||
145771411|NCT01324830|525671643|FG016|Overall Study|Withdrawal by Subject|0|||
145771412|NCT01324830|525671644|FG017|Overall Study|Withdrawal by Subject|0|||
145771413|NCT01324830|525671645|FG018|Overall Study|Withdrawal by Subject|1|||
145771414|NCT01485614|525671646|FG000|Randomization|Not Treated|1|||
145771415|NCT01485614|525671647|FG001|Randomization|Not Treated|0|||
145771416|NCT01485614|525671648|FG002|Randomization|Not Treated|0|||
145771417|NCT01485614|525671649|FG003|Randomization|Not Treated|0|||
145771418|NCT01485614|525671646|FG000|Weeks 0-20|Lost to Follow-up|2|||
145771419|NCT01485614|525671647|FG001|Weeks 0-20|Lost to Follow-up|0|||
145771420|NCT01485614|525671648|FG002|Weeks 0-20|Lost to Follow-up|0|||
145771421|NCT01485614|525671649|FG003|Weeks 0-20|Lost to Follow-up|0|||
145771422|NCT01485614|525671646|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
145771423|NCT01485614|525671647|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
145771424|NCT01485614|525671648|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
145771425|NCT01485614|525671649|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
145771426|NCT01485614|525671646|FG000|Weeks 0-20|Withdrawal by Subject|3|||
145771427|NCT01485614|525671647|FG001|Weeks 0-20|Withdrawal by Subject|2|||
145771428|NCT01485614|525671648|FG002|Weeks 0-20|Withdrawal by Subject|1|||
145771429|NCT01485614|525671649|FG003|Weeks 0-20|Withdrawal by Subject|0|||
145771430|NCT01485614|525671646|FG000|Weeks 20-54|Lost to Follow-up|4|||
145771431|NCT01485614|525671647|FG001|Weeks 20-54|Lost to Follow-up|3|||
145771432|NCT01485614|525671648|FG002|Weeks 20-54|Lost to Follow-up|1|||
145771433|NCT01485614|525671649|FG003|Weeks 20-54|Lost to Follow-up|0|||
145771434|NCT01485614|525671646|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
145771435|NCT01485614|525671647|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
145771436|NCT01485614|525671648|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
145771437|NCT01485614|525671649|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
145771438|NCT01485614|525671646|FG000|Weeks 20-54|Withdrawal by Subject|5|||
145771439|NCT01485614|525671647|FG001|Weeks 20-54|Withdrawal by Subject|3|||
145771440|NCT01485614|525671648|FG002|Weeks 20-54|Withdrawal by Subject|0|||
145771441|NCT01485614|525671649|FG003|Weeks 20-54|Withdrawal by Subject|0|||
145771442|NCT00733902|525671650|FG000|Overall Study|Death|0|||
145771443|NCT00733902|525671651|FG001|Overall Study|Death|0|||
145771444|NCT00733902|525671652|FG002|Overall Study|Death|0|||
145771445|NCT00733902|525671653|FG003|Overall Study|Death|1|||
145771446|NCT00733902|525671650|FG000|Overall Study|Adverse Event|3|||
145771447|NCT00733902|525671651|FG001|Overall Study|Adverse Event|4|||
145771448|NCT00733902|525671652|FG002|Overall Study|Adverse Event|7|||
145771449|NCT00733902|525671653|FG003|Overall Study|Adverse Event|11|||
145771450|NCT00733902|525671650|FG000|Overall Study|Lack of Efficacy|56|||
145771451|NCT00733902|525671651|FG001|Overall Study|Lack of Efficacy|21|||
145771452|NCT00733902|525671652|FG002|Overall Study|Lack of Efficacy|34|||
145771453|NCT00733902|525671653|FG003|Overall Study|Lack of Efficacy|23|||
145771454|NCT00733902|525671650|FG000|Overall Study|Protocol Violation|4|||
145771455|NCT00733902|525671651|FG001|Overall Study|Protocol Violation|6|||
145771456|NCT00733902|525671652|FG002|Overall Study|Protocol Violation|3|||
145771457|NCT00733902|525671653|FG003|Overall Study|Protocol Violation|3|||
145771458|NCT00733902|525671650|FG000|Overall Study|Withdrawal by Subject|10|||
145771459|NCT00733902|525671651|FG001|Overall Study|Withdrawal by Subject|5|||
145771460|NCT00733902|525671652|FG002|Overall Study|Withdrawal by Subject|4|||
145771461|NCT00733902|525671653|FG003|Overall Study|Withdrawal by Subject|16|||
145771462|NCT00733902|525671650|FG000|Overall Study|Entered extension study|89|||
145771463|NCT00733902|525671651|FG001|Overall Study|Entered extension study|124|||
145771464|NCT00733902|525671652|FG002|Overall Study|Entered extension study|111|||
145771465|NCT00733902|525671653|FG003|Overall Study|Entered extension study|109|||
145771466|NCT00733902|525671650|FG000|Overall Study|Randomized but not treated|2|||
145771467|NCT00733902|525671651|FG001|Overall Study|Randomized but not treated|2|||
145771468|NCT00733902|525671652|FG002|Overall Study|Randomized but not treated|2|||
145771469|NCT00733902|525671653|FG003|Overall Study|Randomized but not treated|1|||
145771470|NCT02210780|525671654|FG000|Overall Study|Adverse Event|0|||
145771471|NCT02210780|525671655|FG001|Overall Study|Adverse Event|5|||
145771472|NCT02210780|525671654|FG000|Overall Study|Lost to Follow-up|2|||
145771473|NCT02210780|525671655|FG001|Overall Study|Lost to Follow-up|1|||
145771474|NCT02210780|525671654|FG000|Overall Study|Withdrawal by Subject|1|||
145771475|NCT02210780|525671655|FG001|Overall Study|Withdrawal by Subject|1|||
145771476|NCT02210780|525671654|FG000|Overall Study|Physician Decision|1|||
145771477|NCT02210780|525671655|FG001|Overall Study|Physician Decision|0|||
145771478|NCT02210780|525671654|FG000|Overall Study|Protocol Violation|1|||
145771479|NCT02210780|525671655|FG001|Overall Study|Protocol Violation|0|||
145771480|NCT02210780|525671654|FG000|Overall Study|Other than specified above|0|||
145771481|NCT02210780|525671655|FG001|Overall Study|Other than specified above|1|||
145771482|NCT01503021|525671660|FG000|Overall Study|Adverse Event|7|||
145771483|NCT01503021|525671661|FG001|Overall Study|Adverse Event|6|||
145771484|NCT01503021|525671660|FG000|Overall Study|Death|0|||
145771485|NCT01503021|525671661|FG001|Overall Study|Death|2|||
145771486|NCT01503021|525671660|FG000|Overall Study|Lost to Follow-up|2|||
145771487|NCT01503021|525671661|FG001|Overall Study|Lost to Follow-up|0|||
145771488|NCT01503021|525671660|FG000|Overall Study|Physician Decision|3|||
145771489|NCT01503021|525671661|FG001|Overall Study|Physician Decision|0|||
145771490|NCT01503021|525671660|FG000|Overall Study|Protocol Violation|1|||
145771491|NCT01503021|525671661|FG001|Overall Study|Protocol Violation|3|||
145771492|NCT01503021|525671660|FG000|Overall Study|Withdrawal by Subject|9|||
145771493|NCT01503021|525671661|FG001|Overall Study|Withdrawal by Subject|8|||
145771494|NCT01503021|525671660|FG000|Overall Study|Moved, received transplant, etc.|5|||
145771495|NCT01503021|525671661|FG001|Overall Study|Moved, received transplant, etc.|7|||
145771496|NCT01242111|525671662|FG000|Overall Study|Adverse Event|1|||
145771497|NCT01242111|525671662|FG000|Overall Study|Withdrawal by Subject|1|||
145771498|NCT01242111|525671662|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
145771499|NCT01929083|525671665|FG000|Intervention 1|Lost to Follow-up|2|||
145771500|NCT01929083|525671666|FG001|Intervention 1|Lost to Follow-up|0|||
145771501|NCT01929083|525671665|FG000|Intervention 1|Nonadherent to study medications|1|||
145771502|NCT01929083|525671666|FG001|Intervention 1|Nonadherent to study medications|0|||
145771503|NCT01929083|525671665|FG000|Intervention 2|Adverse Event|0|||
145771504|NCT01929083|525671666|FG001|Intervention 2|Adverse Event|1|||
145771505|NCT02599402|525671667|FG000|Overall Study|Disease progression|153|||
145771506|NCT02599402|525671667|FG000|Overall Study|Study drug toxicity|201|||
145771507|NCT02599402|525671667|FG000|Overall Study|Death|26|||
145771508|NCT02599402|525671667|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
145771509|NCT02599402|525671667|FG000|Overall Study|Participant request to discontinue study treatment|13|||
145771510|NCT02599402|525671667|FG000|Overall Study|Participant withdrew consent|5|||
145771511|NCT02599402|525671667|FG000|Overall Study|Lost to Follow-up|1|||
145771512|NCT02599402|525671667|FG000|Overall Study|Maximum Clinical Benefit|7|||
145771513|NCT02599402|525671667|FG000|Overall Study|Poor/non-compliance|1|||
145771514|NCT02599402|525671667|FG000|Overall Study|Pregnancy|1|||
145771515|NCT02599402|525671667|FG000|Overall Study|Participant no longer met study criteria|7|||
145771516|NCT02599402|525671667|FG000|Overall Study|Other Reasons|95|||
145771517|NCT00283387|525671672|FG000|First Intervention|Subject non-compliant|1|||
145771518|NCT00283387|525671673|FG001|First Intervention|Subject non-compliant|1|||
145771519|NCT00283387|525671672|FG000|First Intervention|Withdrawal by Subject|0|||
145771520|NCT00283387|525671673|FG001|First Intervention|Withdrawal by Subject|1|||
145771521|NCT00500071|525671675|FG000|Screening and Washout Phase|Protocol Violation|1|||
145771522|NCT00500071|525671675|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
145771523|NCT00500071|525671675|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
145771524|NCT00500071|525671675|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
145771525|NCT00500071|525671675|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
145771526|NCT00500071|525671675|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
145771527|NCT00500071|525671675|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
145771528|NCT01122927|525671676|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
145771529|NCT01122927|525671677|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
145771530|NCT01122927|525671676|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
145771531|NCT01122927|525671677|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
145771532|NCT01122927|525671676|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
145771533|NCT01122927|525671677|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
145771534|NCT01122927|525671676|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
145771535|NCT01122927|525671677|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
145771536|NCT01122927|525671676|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
145771537|NCT01122927|525671677|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
145771538|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
145771539|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
145771540|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
145771541|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
145771542|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
145771543|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
145771544|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
145771545|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
145771546|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
145771547|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
145771548|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
145771549|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
145771550|NCT01122927|525671676|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
145771551|NCT01122927|525671677|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
145771552|NCT03182738|525671678|FG000|Overall Study|Lost to Follow-up|9|||
145771553|NCT03182738|525671679|FG001|Overall Study|Lost to Follow-up|3|||
145771554|NCT03182738|525671678|FG000|Overall Study|Pregnancy|0|||
145771555|NCT03182738|525671679|FG001|Overall Study|Pregnancy|1|||
145771556|NCT03182738|525671678|FG000|Overall Study|Withdrawal by Subject|0|||
145771557|NCT03182738|525671679|FG001|Overall Study|Withdrawal by Subject|1|||
145771558|NCT03584009|525671680|FG000|Overall Study|Death|25|||
145771559|NCT03584009|525671681|FG001|Overall Study|Death|18|||
145771560|NCT03584009|525671680|FG000|Overall Study|Lost to Follow-up|0|||
145771561|NCT03584009|525671681|FG001|Overall Study|Lost to Follow-up|1|||
145771562|NCT03584009|525671680|FG000|Overall Study|Physician Decision|1|||
145771563|NCT03584009|525671681|FG001|Overall Study|Physician Decision|1|||
145771564|NCT03584009|525671680|FG000|Overall Study|Study Terminated by Sponsor|22|||
145771565|NCT03584009|525671681|FG001|Overall Study|Study Terminated by Sponsor|30|||
145771566|NCT03584009|525671680|FG000|Overall Study|Withdrawal by Subject|3|||
145771567|NCT03584009|525671681|FG001|Overall Study|Withdrawal by Subject|2|||
145771568|NCT03812510|525671682|FG000|Overall Study|Lost to Follow-up|39|||
145771569|NCT03812510|525671682|FG000|Overall Study|Withdrawal by Subject|42|||
145771570|NCT03812510|525671682|FG000|Overall Study|Physician Decision|2|||
145771571|NCT03812510|525671682|FG000|Overall Study|Study Terminated by Sponsor|9|||
145771572|NCT03812510|525671682|FG000|Overall Study|Did Not Start Study Medication|55|||
145771573|NCT03812510|525671682|FG000|Overall Study|Adverse Event|5|||
145771574|NCT02635204|525671683|FG000|Overall Study|Adverse Event|1|||
145771575|NCT02635204|525671684|FG001|Overall Study|Adverse Event|0|||
145771576|NCT02635204|525671683|FG000|Overall Study|Lost to Follow-up|1|||
145771577|NCT02635204|525671684|FG001|Overall Study|Lost to Follow-up|1|||
145771578|NCT03830281|525671695|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
145771579|NCT03830281|525671696|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
145771580|NCT03830281|525671695|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
145771581|NCT03830281|525671696|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
145771582|NCT03830281|525671695|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
145771583|NCT03830281|525671696|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
145771584|NCT03830281|525671695|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
145771585|NCT03830281|525671696|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
145771586|NCT03830281|525671695|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
145771587|NCT03830281|525671696|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
145534034|NCT02913612|524815422|FG000|Overall Study|Physician Decision|1|||
145534035|NCT02913612|524815423|FG001|Overall Study|Physician Decision|4|||
145534036|NCT02913612|524815424|FG002|Overall Study|Physician Decision|1|||
145534037|NCT02913612|524815425|FG003|Overall Study|Physician Decision|0|||
145534038|NCT02913612|524815422|FG000|Overall Study|Withdrawal by Subject|2|||
145534039|NCT02913612|524815423|FG001|Overall Study|Withdrawal by Subject|4|||
145534040|NCT02913612|524815424|FG002|Overall Study|Withdrawal by Subject|0|||
145534041|NCT02913612|524815425|FG003|Overall Study|Withdrawal by Subject|0|||
145534042|NCT02913612|524815422|FG000|Overall Study|Hemangioma resolved|1|||
145534043|NCT02913612|524815423|FG001|Overall Study|Hemangioma resolved|0|||
145534044|NCT02913612|524815424|FG002|Overall Study|Hemangioma resolved|0|||
145534045|NCT02913612|524815425|FG003|Overall Study|Hemangioma resolved|0|||
145534046|NCT02913612|524815422|FG000|Overall Study|Local IRB decision|1|||
145534047|NCT02913612|524815423|FG001|Overall Study|Local IRB decision|0|||
145534048|NCT02913612|524815424|FG002|Overall Study|Local IRB decision|0|||
145534049|NCT02913612|524815425|FG003|Overall Study|Local IRB decision|0|||
145534050|NCT02913612|524815422|FG000|Overall Study|Study drug non-compliance|1|||
145534051|NCT02913612|524815423|FG001|Overall Study|Study drug non-compliance|1|||
145771588|NCT03830281|525671695|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
145771589|NCT03830281|525671696|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
145771590|NCT03830281|525671695|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
145771591|NCT03830281|525671696|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
145771592|NCT03830281|525671695|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
145771593|NCT03830281|525671696|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
145771594|NCT03830281|525671695|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
145771595|NCT03830281|525671696|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
145771596|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
145771597|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
145771598|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
145771599|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
145771600|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
145534052|NCT02913612|524815424|FG002|Overall Study|Study drug non-compliance|0|||
145771601|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
145771602|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Personal issues|2|||
145771603|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Personal issues|0|||
145771604|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Personal issues|0|||
145771605|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Too busy|7|||
145771606|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Too busy|1|||
145771607|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Too busy|0|||
145771608|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Pain|2|||
145771609|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Pain|0|||
145771610|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Pain|0|||
145771611|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Moved|1|||
145771612|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Moved|0|||
145771613|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Moved|0|||
145771614|NCT00594399|525671697|FG000|Initial 3 Month Counseling|Family illness|1|||
145771615|NCT00594399|525671698|FG001|Initial 3 Month Counseling|Family illness|0|||
145771616|NCT00594399|525671699|FG002|Initial 3 Month Counseling|Family illness|0|||
145771617|NCT00594399|525671697|FG000|Rerandomization Arm 1 Only|Death|2|||
145771618|NCT00594399|525671698|FG001|Rerandomization Arm 1 Only|Death|1|||
145771619|NCT00594399|525671699|FG002|Rerandomization Arm 1 Only|Death|0|||
145771620|NCT00594399|525671697|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
145771621|NCT00594399|525671698|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
145771622|NCT00594399|525671699|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
145771623|NCT03293680|525671701|FG000|Overall Study|Death|1|||
145771624|NCT03293680|525671701|FG000|Overall Study|Did not meet inclusion criteria|8|||
145771625|NCT00922935|525671702|FG000|Overall Study|Protocol Violation|0|||
145771626|NCT00922935|525671703|FG001|Overall Study|Protocol Violation|3|||
145771627|NCT00922935|525671704|FG002|Overall Study|Protocol Violation|0|||
145771628|NCT00922935|525671702|FG000|Overall Study|Physician Decision|1|||
145771629|NCT00922935|525671703|FG001|Overall Study|Physician Decision|1|||
145771630|NCT00922935|525671704|FG002|Overall Study|Physician Decision|0|||
145771631|NCT00922935|525671702|FG000|Overall Study|Lost to Follow-up|0|||
145771632|NCT00922935|525671703|FG001|Overall Study|Lost to Follow-up|1|||
145608093|NCT00445679|525079320|FG000|Overall Study|Withdrawal of Informed Consent|0|||
145608094|NCT00445679|525079321|FG001|Overall Study|Withdrawal of Informed Consent|0|||
145608095|NCT00445679|525079322|FG002|Overall Study|Withdrawal of Informed Consent|1|||
145608096|NCT00445679|525079323|FG003|Overall Study|Withdrawal of Informed Consent|0|||
145608097|NCT00445679|525079320|FG000|Overall Study|Protocol Violation|2|||
145608098|NCT00445679|525079321|FG001|Overall Study|Protocol Violation|3|||
145608099|NCT00445679|525079322|FG002|Overall Study|Protocol Violation|3|||
145608100|NCT00445679|525079323|FG003|Overall Study|Protocol Violation|1|||
145608101|NCT00445679|525079320|FG000|Overall Study|Withdrawal by Subject|8|||
145608102|NCT00445679|525079321|FG001|Overall Study|Withdrawal by Subject|14|||
145608103|NCT00445679|525079322|FG002|Overall Study|Withdrawal by Subject|20|||
145608104|NCT00445679|525079323|FG003|Overall Study|Withdrawal by Subject|18|||
145608105|NCT00445679|525079320|FG000|Overall Study|Lack of Efficacy|2|||
145608106|NCT00445679|525079321|FG001|Overall Study|Lack of Efficacy|6|||
145608107|NCT00445679|525079322|FG002|Overall Study|Lack of Efficacy|2|||
145608108|NCT00445679|525079323|FG003|Overall Study|Lack of Efficacy|0|||
145608109|NCT01806584|525079324|FG000|Overall Study|Adverse Event|2|||
145608110|NCT01806584|525079325|FG001|Overall Study|Adverse Event|1|||
145608111|NCT01806584|525079324|FG000|Overall Study|Death|1|||
145608112|NCT01806584|525079325|FG001|Overall Study|Death|0|||
145608113|NCT01806584|525079324|FG000|Overall Study|Lost to Follow-up|0|||
145608114|NCT01806584|525079325|FG001|Overall Study|Lost to Follow-up|2|||
145608115|NCT01806584|525079324|FG000|Overall Study|Study terminated by sponsor|9|||
145608116|NCT01806584|525079325|FG001|Overall Study|Study terminated by sponsor|14|||
145771633|NCT00922935|525671704|FG002|Overall Study|Lost to Follow-up|0|||
145771634|NCT02201940|525671705|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
145771635|NCT02201940|525671706|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
145771636|NCT02201940|525671705|FG000|Overall Study|Lack of Efficacy|2|||
145608117|NCT01806584|525079324|FG000|Overall Study|Withdrawal by Subject|1|||
145608118|NCT01806584|525079325|FG001|Overall Study|Withdrawal by Subject|1|||
145771637|NCT02201940|525671706|FG001|Overall Study|Lack of Efficacy|113|||
145771638|NCT02201940|525671705|FG000|Overall Study|Lost to Follow-up|5|||
145608119|NCT01806584|525079324|FG000|Overall Study|Other unspecified|1|||
145771639|NCT02201940|525671706|FG001|Overall Study|Lost to Follow-up|0|||
145771640|NCT02201940|525671705|FG000|Overall Study|Withdrew Consent|2|||
145771641|NCT02201940|525671706|FG001|Overall Study|Withdrew Consent|1|||
145771642|NCT02201940|525671705|FG000|Overall Study|Investigator's Discretion|1|||
145771643|NCT02201940|525671706|FG001|Overall Study|Investigator's Discretion|1|||
145771644|NCT02201940|525671705|FG000|Overall Study|Death|1|||
145771645|NCT02201940|525671706|FG001|Overall Study|Death|0|||
145771646|NCT02201940|525671705|FG000|Overall Study|Adverse Event|0|||
145771647|NCT02201940|525671706|FG001|Overall Study|Adverse Event|1|||
145608120|NCT01806584|525079325|FG001|Overall Study|Other unspecified|0|||
145771648|NCT00424398|525671710|FG000|Overall Study|Withdrawal by Subject|2|||
145608121|NCT00909428|525079326|FG000|Overall Study|Lost to Follow-up|13|||
145771649|NCT00424398|525671711|FG001|Overall Study|Withdrawal by Subject|1|||
145771650|NCT00424398|525671712|FG002|Overall Study|Withdrawal by Subject|0|||
145771651|NCT00424398|525671710|FG000|Overall Study|Subject met exclusion criteria|1|||
145771652|NCT00424398|525671711|FG001|Overall Study|Subject met exclusion criteria|0|||
145771653|NCT00424398|525671712|FG002|Overall Study|Subject met exclusion criteria|0|||
145771654|NCT01309737|525671714|FG000|Week 0 to 16|Death|1|||
145771655|NCT01309737|525671715|FG001|Week 0 to 16|Death|0|||
145771656|NCT01309737|525671716|FG002|Week 0 to 16|Death|1|||
145771657|NCT01309737|525671717|FG003|Week 0 to 16|Death|0|||
145771658|NCT01309737|525671718|FG004|Week 0 to 16|Death|0|||
145771659|NCT01309737|525671714|FG000|Week 0 to 16|Adverse Event|11|||
145771660|NCT01309737|525671715|FG001|Week 0 to 16|Adverse Event|10|||
145771661|NCT01309737|525671716|FG002|Week 0 to 16|Adverse Event|5|||
145771662|NCT01309737|525671717|FG003|Week 0 to 16|Adverse Event|0|||
145771663|NCT01309737|525671718|FG004|Week 0 to 16|Adverse Event|0|||
145771664|NCT01309737|525671714|FG000|Week 0 to 16|Lack of Efficacy|15|||
145771665|NCT01309737|525671715|FG001|Week 0 to 16|Lack of Efficacy|2|||
145771666|NCT01309737|525671716|FG002|Week 0 to 16|Lack of Efficacy|24|||
145771667|NCT01309737|525671717|FG003|Week 0 to 16|Lack of Efficacy|0|||
145771668|NCT01309737|525671718|FG004|Week 0 to 16|Lack of Efficacy|0|||
145771669|NCT01309737|525671714|FG000|Week 0 to 16|Lost to Follow-up|7|||
145771670|NCT01309737|525671715|FG001|Week 0 to 16|Lost to Follow-up|8|||
145771671|NCT01309737|525671716|FG002|Week 0 to 16|Lost to Follow-up|3|||
145771672|NCT01309737|525671717|FG003|Week 0 to 16|Lost to Follow-up|0|||
145771673|NCT01309737|525671718|FG004|Week 0 to 16|Lost to Follow-up|0|||
145771674|NCT01309737|525671714|FG000|Week 0 to 16|Withdrawal by Subject|7|||
145771675|NCT01309737|525671715|FG001|Week 0 to 16|Withdrawal by Subject|6|||
145771676|NCT01309737|525671716|FG002|Week 0 to 16|Withdrawal by Subject|7|||
145771677|NCT01309737|525671717|FG003|Week 0 to 16|Withdrawal by Subject|0|||
145771678|NCT01309737|525671718|FG004|Week 0 to 16|Withdrawal by Subject|0|||
145771679|NCT01309737|525671714|FG000|Week 0 to 16|Other|10|||
145771680|NCT01309737|525671715|FG001|Week 0 to 16|Other|14|||
145771681|NCT01309737|525671716|FG002|Week 0 to 16|Other|4|||
145771682|NCT01309737|525671717|FG003|Week 0 to 16|Other|0|||
145771683|NCT01309737|525671718|FG004|Week 0 to 16|Other|0|||
145771684|NCT01309737|525671714|FG000|Week 0 to 16|Randomized, but not treated|1|||
145771685|NCT01309737|525671715|FG001|Week 0 to 16|Randomized, but not treated|0|||
145771686|NCT01309737|525671716|FG002|Week 0 to 16|Randomized, but not treated|0|||
145771687|NCT01309737|525671717|FG003|Week 0 to 16|Randomized, but not treated|0|||
145771688|NCT01309737|525671718|FG004|Week 0 to 16|Randomized, but not treated|0|||
145771689|NCT01309737|525671714|FG000|Week 16 to 52|Death|0|||
145771690|NCT01309737|525671715|FG001|Week 16 to 52|Death|0|||
145771691|NCT01309737|525671716|FG002|Week 16 to 52|Death|0|||
145771692|NCT01309737|525671717|FG003|Week 16 to 52|Death|0|||
145771693|NCT01309737|525671718|FG004|Week 16 to 52|Death|1|||
145771694|NCT01309737|525671714|FG000|Week 16 to 52|Adverse Event|7|||
145771695|NCT01309737|525671715|FG001|Week 16 to 52|Adverse Event|7|||
145771696|NCT01309737|525671716|FG002|Week 16 to 52|Adverse Event|0|||
145771697|NCT01309737|525671717|FG003|Week 16 to 52|Adverse Event|6|||
145771698|NCT01309737|525671718|FG004|Week 16 to 52|Adverse Event|5|||
145771699|NCT01309737|525671714|FG000|Week 16 to 52|Lack of Efficacy|107|||
145771700|NCT01309737|525671715|FG001|Week 16 to 52|Lack of Efficacy|76|||
145771701|NCT01309737|525671716|FG002|Week 16 to 52|Lack of Efficacy|0|||
145771702|NCT01309737|525671717|FG003|Week 16 to 52|Lack of Efficacy|25|||
145771703|NCT01309737|525671718|FG004|Week 16 to 52|Lack of Efficacy|21|||
145771704|NCT01309737|525671714|FG000|Week 16 to 52|Lost to Follow-up|4|||
145771705|NCT01309737|525671715|FG001|Week 16 to 52|Lost to Follow-up|2|||
145771706|NCT01309737|525671716|FG002|Week 16 to 52|Lost to Follow-up|0|||
145771707|NCT01309737|525671717|FG003|Week 16 to 52|Lost to Follow-up|1|||
145771708|NCT01309737|525671718|FG004|Week 16 to 52|Lost to Follow-up|4|||
145771709|NCT01309737|525671714|FG000|Week 16 to 52|Withdrawal by Subject|5|||
145771710|NCT01309737|525671715|FG001|Week 16 to 52|Withdrawal by Subject|6|||
145771711|NCT01309737|525671716|FG002|Week 16 to 52|Withdrawal by Subject|0|||
145771712|NCT01309737|525671717|FG003|Week 16 to 52|Withdrawal by Subject|0|||
145771713|NCT01309737|525671718|FG004|Week 16 to 52|Withdrawal by Subject|2|||
145771714|NCT01309737|525671714|FG000|Week 16 to 52|Other|10|||
145771715|NCT01309737|525671715|FG001|Week 16 to 52|Other|12|||
145771716|NCT01309737|525671716|FG002|Week 16 to 52|Other|0|||
145771717|NCT01309737|525671717|FG003|Week 16 to 52|Other|2|||
145771718|NCT01309737|525671718|FG004|Week 16 to 52|Other|0|||
145771719|NCT01076179|525671730|FG000|Overall Study|Withdrawal by Subject|1|||
145771720|NCT00986349|525671731|FG000|Overall Study|Unsuccessful implant procedure|3|||
145771721|NCT00986349|525671731|FG000|Overall Study|Adverse Event|2|||
145771722|NCT00986349|525671731|FG000|Overall Study|Physician Decision|1|||
145771723|NCT00986349|525671731|FG000|Overall Study|device migration|1|||
145771724|NCT02299934|525671732|FG000|Overall Study|Termination of study|13|||
145771725|NCT03248128|525671733|FG000|Overall Study|Lost to Follow-up|1|||
145771726|NCT03248128|525671734|FG001|Overall Study|Lost to Follow-up|0|||
145771727|NCT03248128|525671733|FG000|Overall Study|Withdrawal by Subject|16|||
145771728|NCT03248128|525671734|FG001|Overall Study|Withdrawal by Subject|14|||
145771729|NCT03248128|525671733|FG000|Overall Study|Site Closed|4|||
145771730|NCT03248128|525671734|FG001|Overall Study|Site Closed|3|||
145771731|NCT03248128|525671733|FG000|Overall Study|Randomized, but did not receive treatment|1|||
145771732|NCT03248128|525671734|FG001|Overall Study|Randomized, but did not receive treatment|3|||
145771733|NCT00538681|525671748|FG000|Overall Study|Progressive Disease|7|||
145771734|NCT00538681|525671749|FG001|Overall Study|Progressive Disease|0|||
145771735|NCT00538681|525671750|FG002|Overall Study|Progressive Disease|1|||
145771736|NCT00538681|525671751|FG003|Overall Study|Progressive Disease|0|||
145771737|NCT00538681|525671748|FG000|Overall Study|Sponsor Decision|1|||
145771738|NCT00538681|525671749|FG001|Overall Study|Sponsor Decision|3|||
145771739|NCT00538681|525671750|FG002|Overall Study|Sponsor Decision|8|||
145771740|NCT00538681|525671751|FG003|Overall Study|Sponsor Decision|9|||
145771741|NCT00538681|525671748|FG000|Overall Study|Adverse Event|1|||
145771742|NCT00538681|525671749|FG001|Overall Study|Adverse Event|1|||
145771743|NCT00538681|525671750|FG002|Overall Study|Adverse Event|1|||
145771744|NCT00538681|525671751|FG003|Overall Study|Adverse Event|0|||
145771745|NCT00538681|525671748|FG000|Overall Study|Death|0|||
145771746|NCT00538681|525671749|FG001|Overall Study|Death|0|||
145771747|NCT00538681|525671750|FG002|Overall Study|Death|1|||
145771748|NCT00538681|525671751|FG003|Overall Study|Death|1|||
145771749|NCT00538681|525671748|FG000|Overall Study|Investigator Decision|0|||
145771750|NCT00538681|525671749|FG001|Overall Study|Investigator Decision|0|||
145771751|NCT00538681|525671750|FG002|Overall Study|Investigator Decision|0|||
145771752|NCT00538681|525671751|FG003|Overall Study|Investigator Decision|1|||
145771753|NCT00628355|525671752|FG000|Overall Study|Withdrawal by Subject|1|||
145771754|NCT00628355|525671753|FG001|Overall Study|Withdrawal by Subject|1|||
145771755|NCT00140855|525671754|FG000|Overall Study|Progressive disease|2|||
145771756|NCT04865731|525671758|FG000|Overall Study|Physician Decision|2|||
145771757|NCT04865731|525671759|FG001|Overall Study|Physician Decision|1|||
145771758|NCT04865731|525671758|FG000|Overall Study|Adverse Event|1|||
145771759|NCT04865731|525671759|FG001|Overall Study|Adverse Event|0|||
145771760|NCT04865731|525671758|FG000|Overall Study|Withdrawal by Subject|0|||
145771761|NCT04865731|525671759|FG001|Overall Study|Withdrawal by Subject|1|||
145608122|NCT00909428|525079327|FG001|Overall Study|Lost to Follow-up|10|||
145608123|NCT00909428|525079328|FG002|Overall Study|Lost to Follow-up|9|||
145608124|NCT03535337|525079332|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
145608125|NCT03535337|525079333|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
145608126|NCT03535337|525079334|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
145608127|NCT03535337|525079335|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
145608128|NCT03535337|525079336|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
145608129|NCT03535337|525079337|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
145608130|NCT03535337|525079338|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
145608131|NCT03535337|525079339|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
145608132|NCT03535337|525079340|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
145608133|NCT03535337|525079341|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
145608134|NCT00311155|525080928|FG000|Overall Study|Adverse Event|21|||
145608135|NCT00311155|525080928|FG000|Overall Study|Withdrawal by Subject|17|||
145608136|NCT00311155|525080928|FG000|Overall Study|Did not meet entry criteria|55|||
145608137|NCT02764775|525080930|FG000|Overall Study|Death|1|||
145608138|NCT02764775|525080930|FG000|Overall Study|Lost to Follow-up|2|||
145608139|NCT02764775|525080930|FG000|Overall Study|Withdrawal by Subject|3|||
145608140|NCT01992549|525080932|FG000|Overall Study|Lost to Follow-up|2|||
145608141|NCT01992549|525080932|FG000|Overall Study|Serious Adverse Event|1|||
145608142|NCT01992549|525080932|FG000|Overall Study|Product Switch to Extend Half Life|1|||
145608143|NCT00767104|525080934|FG000|Overall Study|Lost to Follow-up|1|||
145608144|NCT00767104|525080935|FG001|Overall Study|Lost to Follow-up|2|||
145771762|NCT00817414|525672983|FG000|Overall Study|Adverse Event|1|||
145771763|NCT00817414|525672984|FG001|Overall Study|Adverse Event|1|||
145771764|NCT00817414|525672985|FG002|Overall Study|Adverse Event|1|||
145771765|NCT00817414|525672986|FG003|Overall Study|Adverse Event|0|||
145771766|NCT00817414|525672987|FG004|Overall Study|Adverse Event|0|||
145771767|NCT00817414|525672983|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
145771768|NCT00817414|525672984|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
145771769|NCT00817414|525672985|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
145771770|NCT00817414|525672986|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
145608145|NCT00840996|525080936|FG000|Overall Study|Withdrawal by Subject|1|||
145608146|NCT00840996|525080937|FG001|Overall Study|Withdrawal by Subject|0|||
145608147|NCT04022889|525080938|FG000|Stage 1: Period 1|Adverse Event|1|||
145771771|NCT00817414|525672987|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
145771772|NCT00817414|525672983|FG000|Overall Study|Withdrawal by Subject|1|||
145771773|NCT00817414|525672984|FG001|Overall Study|Withdrawal by Subject|1|||
145771774|NCT00817414|525672985|FG002|Overall Study|Withdrawal by Subject|0|||
145771775|NCT00817414|525672986|FG003|Overall Study|Withdrawal by Subject|0|||
145771776|NCT00817414|525672987|FG004|Overall Study|Withdrawal by Subject|0|||
145771777|NCT00817414|525672983|FG000|Overall Study|Lost to Follow-up|0|||
145608148|NCT04022889|525080939|FG001|Stage 1: Period 1|Adverse Event|0|||
145771778|NCT00817414|525672984|FG001|Overall Study|Lost to Follow-up|0|||
145771779|NCT00817414|525672985|FG002|Overall Study|Lost to Follow-up|1|||
145771780|NCT00817414|525672986|FG003|Overall Study|Lost to Follow-up|1|||
145771781|NCT00817414|525672987|FG004|Overall Study|Lost to Follow-up|1|||
145771782|NCT00817414|525672983|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
145771783|NCT00817414|525672984|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
145771784|NCT00817414|525672985|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
145771785|NCT00817414|525672986|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
145771786|NCT00817414|525672987|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
145771787|NCT00817414|525672983|FG000|Overall Study|Protocol Violation|0|||
145771788|NCT00817414|525672984|FG001|Overall Study|Protocol Violation|0|||
145771789|NCT00817414|525672985|FG002|Overall Study|Protocol Violation|0|||
145771790|NCT00817414|525672986|FG003|Overall Study|Protocol Violation|0|||
145771791|NCT00817414|525672987|FG004|Overall Study|Protocol Violation|1|||
145771792|NCT00886938|525672988|FG000|Overall Study|Adverse Event|1|||
145771793|NCT00886938|525672988|FG000|Overall Study|Withdrawal by Subject|1|||
145771794|NCT03941548|525672991|FG000|Overall Study|Adverse Event|0|||
145771795|NCT03941548|525672992|FG001|Overall Study|Adverse Event|1|||
145771796|NCT03941548|525672991|FG000|Overall Study|Lost to Follow-up|0|||
145771797|NCT03941548|525672992|FG001|Overall Study|Lost to Follow-up|1|||
145771798|NCT03941548|525672991|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
145771799|NCT03941548|525672992|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
145771800|NCT00870688|525672994|FG000|Overall Study|Lost to Follow-up|2|||
145771801|NCT00870688|525672994|FG000|Overall Study|Death, Unrelated|1|||
145771802|NCT00870688|525672994|FG000|Overall Study|Granules in the Stools|1|||
145771803|NCT03872180|525672995|FG000|Overall Study|Adverse Event|4|||
145771804|NCT03872180|525672995|FG000|Overall Study|Lack of Efficacy|2|||
145771805|NCT02945657|525672996|FG000|Overall Study|Adverse Event|1|||
145771806|NCT02945657|525672996|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
145771807|NCT00087438|525672999|FG000|Overall Study|Ineligible / No protocol treatment|4|||
145771808|NCT01157117|525673000|FG000|Overall Study|Dosing Symptoms|0|||
145771809|NCT01157117|525673001|FG001|Overall Study|Dosing Symptoms|4|||
145771810|NCT01157117|525673002|FG002|Overall Study|Dosing Symptoms|0|||
145771811|NCT01157117|525673000|FG000|Overall Study|Withdrawal by Subject|4|||
145771812|NCT01157117|525673001|FG001|Overall Study|Withdrawal by Subject|1|||
145771813|NCT01157117|525673002|FG002|Overall Study|Withdrawal by Subject|1|||
145771814|NCT01157117|525673000|FG000|Overall Study|Lack of Efficacy|1|||
145771815|NCT01157117|525673001|FG001|Overall Study|Lack of Efficacy|1|||
145771816|NCT01157117|525673002|FG002|Overall Study|Lack of Efficacy|0|||
145771817|NCT01157117|525673000|FG000|Overall Study|Lost to Follow-up|0|||
145771818|NCT01157117|525673001|FG001|Overall Study|Lost to Follow-up|0|||
145771819|NCT01157117|525673002|FG002|Overall Study|Lost to Follow-up|1|||
145771820|NCT01157117|525673000|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
145771821|NCT01157117|525673001|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
145771822|NCT01157117|525673002|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
145771823|NCT01486264|525673003|FG000|Overall Study|Death|1|||
145771824|NCT01486264|525673004|FG001|Overall Study|Death|1|||
145771825|NCT01486264|525673003|FG000|Overall Study|Adverse Event|3|||
145771826|NCT01486264|525673004|FG001|Overall Study|Adverse Event|3|||
145771827|NCT01486264|525673003|FG000|Overall Study|Lack of Efficacy|6|||
145771828|NCT01486264|525673004|FG001|Overall Study|Lack of Efficacy|10|||
145771829|NCT01486264|525673003|FG000|Overall Study|Withdrawal by Subject|7|||
145771830|NCT01486264|525673004|FG001|Overall Study|Withdrawal by Subject|18|||
145771831|NCT01486264|525673003|FG000|Overall Study|Physician Decision|1|||
145771832|NCT01486264|525673004|FG001|Overall Study|Physician Decision|1|||
145771833|NCT01486264|525673003|FG000|Overall Study|Protocol Violation|3|||
145771834|NCT01486264|525673004|FG001|Overall Study|Protocol Violation|0|||
145771835|NCT01486264|525673003|FG000|Overall Study|Lost to Follow-up|3|||
145771836|NCT01486264|525673004|FG001|Overall Study|Lost to Follow-up|2|||
145771837|NCT01486264|525673003|FG000|Overall Study|Other|5|||
145771838|NCT01486264|525673004|FG001|Overall Study|Other|11|||
145771839|NCT01486264|525673003|FG000|Overall Study|Not treated|0|||
145771840|NCT01486264|525673004|FG001|Overall Study|Not treated|1|||
145771841|NCT00728416|525673013|FG000|Overall Study|Adverse Event|1|||
145771842|NCT00728416|525673014|FG001|Overall Study|Adverse Event|1|||
145771843|NCT00728416|525673013|FG000|Overall Study|Treatment Failure|0|||
145771844|NCT00728416|525673014|FG001|Overall Study|Treatment Failure|1|||
145771845|NCT00728416|525673013|FG000|Overall Study|Withdrawal by Subject|1|||
145771846|NCT00728416|525673014|FG001|Overall Study|Withdrawal by Subject|0|||
145771847|NCT03596164|525673015|FG000|Overall Study|Adverse Event|0|||
145771848|NCT03596164|525673016|FG001|Overall Study|Adverse Event|1|||
145771849|NCT03596164|525673015|FG000|Overall Study|Death|1|||
145771850|NCT03596164|525673016|FG001|Overall Study|Death|0|||
145771851|NCT01120626|525673017|FG000|Overall Study|Withdrawal by Subject|1|||
145771852|NCT01120626|525673018|FG001|Overall Study|Withdrawal by Subject|0|||
145771853|NCT00488631|525673019|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
145771854|NCT00488631|525673020|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
145771855|NCT00488631|525673021|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
145771856|NCT00488631|525673022|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
145771857|NCT00488631|525673023|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
145771858|NCT00488631|525673024|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
145771859|NCT00488631|525673025|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
145771860|NCT00488631|525673026|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
145771861|NCT00488631|525673027|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
145771862|NCT00488631|525673028|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
145771863|NCT00488631|525673019|FG000|Double Blind Period (Week 0-54)|Death|0|||
145771864|NCT00488631|525673020|FG001|Double Blind Period (Week 0-54)|Death|0|||
145771865|NCT00488631|525673021|FG002|Double Blind Period (Week 0-54)|Death|0|||
145771866|NCT00488631|525673022|FG003|Double Blind Period (Week 0-54)|Death|0|||
145771867|NCT00488631|525673023|FG004|Double Blind Period (Week 0-54)|Death|0|||
145771868|NCT00488631|525673024|FG005|Double Blind Period (Week 0-54)|Death|1|||
145771869|NCT00488631|525673025|FG006|Double Blind Period (Week 0-54)|Death|0|||
145771870|NCT00488631|525673026|FG007|Double Blind Period (Week 0-54)|Death|0|||
145771871|NCT00488631|525673027|FG008|Double Blind Period (Week 0-54)|Death|0|||
145771872|NCT00488631|525673028|FG009|Double Blind Period (Week 0-54)|Death|0|||
145771873|NCT00488631|525673019|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
145771874|NCT00488631|525673020|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
145771875|NCT00488631|525673021|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
145771876|NCT00488631|525673022|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
145771877|NCT00488631|525673023|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
145771878|NCT00488631|525673024|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
145771879|NCT00488631|525673025|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
145771880|NCT00488631|525673026|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
145771881|NCT00488631|525673027|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
145771882|NCT00488631|525673028|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
145771883|NCT00488631|525673019|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
145771884|NCT00488631|525673020|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
145771885|NCT00488631|525673021|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
145771886|NCT00488631|525673022|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
145771887|NCT00488631|525673023|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
145771888|NCT00488631|525673024|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
145771889|NCT00488631|525673025|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
145771890|NCT00488631|525673026|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
145771891|NCT00488631|525673027|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
145771892|NCT00488631|525673028|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
145771893|NCT00488631|525673019|FG000|Double Blind Period (Week 0-54)|Other|6|||
145771894|NCT00488631|525673020|FG001|Double Blind Period (Week 0-54)|Other|12|||
145771895|NCT00488631|525673021|FG002|Double Blind Period (Week 0-54)|Other|10|||
145771896|NCT00488631|525673022|FG003|Double Blind Period (Week 0-54)|Other|11|||
145771897|NCT00488631|525673023|FG004|Double Blind Period (Week 0-54)|Other|14|||
145771898|NCT00488631|525673024|FG005|Double Blind Period (Week 0-54)|Other|34|||
145771899|NCT00488631|525673025|FG006|Double Blind Period (Week 0-54)|Other|0|||
145771900|NCT00488631|525673026|FG007|Double Blind Period (Week 0-54)|Other|0|||
145771901|NCT00488631|525673027|FG008|Double Blind Period (Week 0-54)|Other|0|||
145771902|NCT00488631|525673028|FG009|Double Blind Period (Week 0-54)|Other|0|||
145771903|NCT00488631|525673019|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771904|NCT00488631|525673020|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145292771|NCT06179108|523922228|FG002|Overall Study|Death|0|||
145771905|NCT00488631|525673021|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771906|NCT00488631|525673022|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771907|NCT00488631|525673023|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771908|NCT00488631|525673024|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771909|NCT00488631|525673025|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
145771910|NCT00488631|525673026|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
145771911|NCT00488631|525673027|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
145771912|NCT00488631|525673028|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
145771913|NCT00488631|525673019|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
145771914|NCT00488631|525673020|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
145771915|NCT00488631|525673021|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
145771916|NCT00488631|525673022|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
145771917|NCT00488631|525673023|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
145771918|NCT00488631|525673024|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
145771919|NCT00488631|525673025|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
145771920|NCT00488631|525673026|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
145771921|NCT00488631|525673027|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
145771922|NCT00488631|525673028|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
145771923|NCT00488631|525673019|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771924|NCT00488631|525673020|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771925|NCT00488631|525673021|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771926|NCT00488631|525673022|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771927|NCT00488631|525673023|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771928|NCT00488631|525673024|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
145771929|NCT00488631|525673025|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
145771930|NCT00488631|525673026|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
145771931|NCT00488631|525673027|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
145771932|NCT00488631|525673028|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
145771933|NCT00488631|525673019|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771934|NCT00488631|525673020|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771935|NCT00488631|525673021|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771936|NCT00488631|525673022|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771937|NCT00488631|525673023|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771938|NCT00488631|525673024|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771939|NCT00488631|525673025|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
145771940|NCT00488631|525673026|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771941|NCT00488631|525673027|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
145771942|NCT00488631|525673028|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
145771943|NCT00488631|525673019|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771944|NCT00488631|525673020|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771945|NCT00488631|525673021|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771946|NCT00488631|525673022|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771947|NCT00488631|525673023|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771948|NCT00488631|525673024|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771949|NCT00488631|525673025|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
145771950|NCT00488631|525673026|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
145771951|NCT00488631|525673027|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
145771952|NCT00488631|525673028|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
145771953|NCT01772134|525673030|FG000|Overall Study|Adverse Event|6|||
145771954|NCT01772134|525673031|FG001|Overall Study|Adverse Event|5|||
145771955|NCT01772134|525673032|FG002|Overall Study|Adverse Event|10|||
145771956|NCT01772134|525673030|FG000|Overall Study|Withdrew Consent|3|||
145771957|NCT01772134|525673031|FG001|Overall Study|Withdrew Consent|1|||
145771958|NCT01772134|525673032|FG002|Overall Study|Withdrew Consent|5|||
145771959|NCT01772134|525673030|FG000|Overall Study|Lost to Follow-up|2|||
145771960|NCT01772134|525673031|FG001|Overall Study|Lost to Follow-up|0|||
145771961|NCT01772134|525673032|FG002|Overall Study|Lost to Follow-up|0|||
145771962|NCT01772134|525673030|FG000|Overall Study|Protocol Deviation|4|||
145771963|NCT01772134|525673031|FG001|Overall Study|Protocol Deviation|3|||
145771964|NCT01772134|525673032|FG002|Overall Study|Protocol Deviation|3|||
145771965|NCT01772134|525673030|FG000|Overall Study|Lack of Efficacy|11|||
145771966|NCT01772134|525673031|FG001|Overall Study|Lack of Efficacy|5|||
145771967|NCT01772134|525673032|FG002|Overall Study|Lack of Efficacy|3|||
145771968|NCT01772134|525673030|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
145278407|NCT00845026|523870830|FG001|Study Period IV|Scheduling conflict|0|||
145278408|NCT03012815|523870831|FG000|Overall Study|Lost to Follow-up|1|||
145278409|NCT03012815|523870832|FG001|Overall Study|Lost to Follow-up|0|||
145278410|NCT03012815|523870831|FG000|Overall Study|Physician Decision|3|||
145278411|NCT03012815|523870832|FG001|Overall Study|Physician Decision|2|||
145278412|NCT03012815|523870831|FG000|Overall Study|Adverse Event|1|||
145278413|NCT03012815|523870832|FG001|Overall Study|Adverse Event|0|||
145278414|NCT01462695|523870833|FG000|Overall Study|Adverse Event|1|||
145278415|NCT01462695|523870834|FG001|Overall Study|Adverse Event|1|||
145278416|NCT01462695|523870833|FG000|Overall Study|Death|2|||
145278417|NCT01462695|523870834|FG001|Overall Study|Death|0|||
145771969|NCT01772134|525673031|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
145771970|NCT01772134|525673032|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
145771971|NCT01772134|525673030|FG000|Overall Study|Randomized Study Medication Not Received|2|||
145771972|NCT01772134|525673031|FG001|Overall Study|Randomized Study Medication Not Received|0|||
145771973|NCT01772134|525673032|FG002|Overall Study|Randomized Study Medication Not Received|1|||
145771974|NCT02333227|525673036|FG000|Overall Study|Lost to Follow-up|137|||
145771975|NCT02333227|525673037|FG001|Overall Study|Lost to Follow-up|106|||
145771976|NCT02333227|525673036|FG000|Overall Study|Pregnancy Interrupted|42|||
145771977|NCT02333227|525673037|FG001|Overall Study|Pregnancy Interrupted|89|||
145771978|NCT02333227|525673036|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
145771979|NCT02333227|525673037|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
145771980|NCT03022461|525673038|FG000|Overall Study|Death|3|||
145771981|NCT01982630|525673039|FG000|Overall Study|Adverse Event|2|||
145771982|NCT01982630|525673040|FG001|Overall Study|Adverse Event|0|||
145771983|NCT01982630|525673041|FG002|Overall Study|Adverse Event|1|||
145771984|NCT01982630|525673042|FG003|Overall Study|Adverse Event|0|||
145771985|NCT01982630|525673043|FG004|Overall Study|Adverse Event|1|||
145771986|NCT01982630|525673044|FG005|Overall Study|Adverse Event|2|||
145771987|NCT01982630|525673045|FG006|Overall Study|Adverse Event|1|||
145771988|NCT01982630|525673046|FG007|Overall Study|Adverse Event|0|||
145771989|NCT01982630|525673039|FG000|Overall Study|Physician Decision|1|||
145771990|NCT01982630|525673040|FG001|Overall Study|Physician Decision|0|||
145771991|NCT01982630|525673041|FG002|Overall Study|Physician Decision|2|||
145771992|NCT01982630|525673042|FG003|Overall Study|Physician Decision|1|||
145771993|NCT01982630|525673043|FG004|Overall Study|Physician Decision|2|||
145771994|NCT01982630|525673044|FG005|Overall Study|Physician Decision|0|||
145771995|NCT01982630|525673045|FG006|Overall Study|Physician Decision|0|||
145771996|NCT01982630|525673046|FG007|Overall Study|Physician Decision|0|||
145771997|NCT01982630|525673039|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145771998|NCT01982630|525673040|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145771999|NCT01982630|525673041|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
145772000|NCT01982630|525673042|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145772001|NCT01982630|525673043|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145772002|NCT01982630|525673044|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145772003|NCT01982630|525673045|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145772004|NCT01982630|525673046|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
145772005|NCT01982630|525673039|FG000|Overall Study|Withdrawal by Subject|0|||
145772006|NCT01982630|525673040|FG001|Overall Study|Withdrawal by Subject|0|||
145772007|NCT01982630|525673041|FG002|Overall Study|Withdrawal by Subject|0|||
145772008|NCT01982630|525673042|FG003|Overall Study|Withdrawal by Subject|0|||
145772009|NCT01982630|525673043|FG004|Overall Study|Withdrawal by Subject|0|||
145772010|NCT01982630|525673044|FG005|Overall Study|Withdrawal by Subject|1|||
145772011|NCT01982630|525673045|FG006|Overall Study|Withdrawal by Subject|0|||
145772012|NCT01982630|525673046|FG007|Overall Study|Withdrawal by Subject|0|||
145772013|NCT03459040|525673047|FG000|Overall Study|Death|8|||
145772014|NCT03459040|525673047|FG000|Overall Study|Withdrawal by Subject|1|||
145772015|NCT01273818|525673048|FG000|Overall Study|Physician Decision|13|||
145772016|NCT01273818|525673049|FG001|Overall Study|Physician Decision|2|||
145772017|NCT01273818|525673050|FG002|Overall Study|Physician Decision|9|||
145772018|NCT03815175|525673051|FG000|Overall Study|Subject Lost to Follow-up|6|||
145772019|NCT03815175|525673051|FG000|Overall Study|Subject Withdrew Consent|48|||
145772020|NCT03815175|525673051|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
145772021|NCT03815175|525673051|FG000|Overall Study|Death|86|||
145772022|NCT03815175|525673051|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
145772023|NCT03815175|525673051|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
145772024|NCT03815175|525673051|FG000|Overall Study|Other Status Change Reason|1|||
145772025|NCT03815175|525673051|FG000|Overall Study|Missed Visit|12|||
145772026|NCT03577990|525673052|FG000|Overall Study|Lost to Follow-up|4|||
145772027|NCT03577990|525673053|FG001|Overall Study|Lost to Follow-up|6|||
145772028|NCT03577990|525673052|FG000|Overall Study|Withdrawal by Subject|4|||
145772029|NCT03577990|525673053|FG001|Overall Study|Withdrawal by Subject|7|||
145772030|NCT03934684|525673054|FG000|Overall Study|Participants continuing in study|11|||
145772031|NCT03934684|525673055|FG001|Overall Study|Participants continuing in study|4|||
145772032|NCT03934684|525673054|FG000|Overall Study|Discontinuation of carfilzomib|20|||
145772033|NCT03934684|525673055|FG001|Overall Study|Discontinuation of carfilzomib|30|||
145772034|NCT03934684|525673054|FG000|Overall Study|Death|2|||
145772035|NCT03934684|525673055|FG001|Overall Study|Death|2|||
145772036|NCT03934684|525673054|FG000|Overall Study|Lost to Follow-up|2|||
145772037|NCT03934684|525673055|FG001|Overall Study|Lost to Follow-up|5|||
145772038|NCT03934684|525673054|FG000|Overall Study|Withdrawal by Subject|7|||
145772039|NCT03934684|525673055|FG001|Overall Study|Withdrawal by Subject|8|||
145772040|NCT05300087|525673056|FG000|Overall Study|Withdrawal by Subject|0|||
145772041|NCT05300087|525673057|FG001|Overall Study|Withdrawal by Subject|1|||
145772042|NCT05662332|525673058|FG000|Overall Study|Death|3|||
145772043|NCT05662332|525673059|FG001|Overall Study|Death|3|||
145772044|NCT05662332|525673058|FG000|Overall Study|Lost to Follow-up|3|||
145772045|NCT05662332|525673059|FG001|Overall Study|Lost to Follow-up|8|||
145772046|NCT05662332|525673058|FG000|Overall Study|Physician Decision|1|||
145772047|NCT05662332|525673059|FG001|Overall Study|Physician Decision|2|||
145772048|NCT05662332|525673058|FG000|Overall Study|Protocol Deviation|2|||
145772049|NCT05662332|525673059|FG001|Overall Study|Protocol Deviation|1|||
145772050|NCT05662332|525673058|FG000|Overall Study|Withdrawal by Subject|14|||
145772051|NCT05662332|525673059|FG001|Overall Study|Withdrawal by Subject|14|||
145772052|NCT05662332|525673058|FG000|Overall Study|Assigned Treatment by Mistake|5|||
145772053|NCT05662332|525673059|FG001|Overall Study|Assigned Treatment by Mistake|7|||
145772054|NCT05662332|525673058|FG000|Overall Study|Non-compliance with study drug|4|||
145772055|NCT05662332|525673059|FG001|Overall Study|Non-compliance with study drug|1|||
145772056|NCT05662332|525673058|FG000|Overall Study|Due to Bariatric surgery|1|||
145772057|NCT05662332|525673059|FG001|Overall Study|Due to Bariatric surgery|0|||
145403372|NCT00171249|524334375|FG005|Overall Study|Lost to Follow-up|0|||
145403373|NCT00171249|524334376|FG006|Overall Study|Lost to Follow-up|0|||
145403374|NCT00471497|524334377|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
145403375|NCT00471497|524334378|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
145772058|NCT05662332|525673058|FG000|Overall Study|Subject Moving out of State|0|||
145772059|NCT05662332|525673059|FG001|Overall Study|Subject Moving out of State|1|||
145772060|NCT05662332|525673058|FG000|Overall Study|Subject Missed the Schedule|1|||
145772061|NCT05662332|525673059|FG001|Overall Study|Subject Missed the Schedule|0|||
145403376|NCT00471497|524334379|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
145403377|NCT00471497|524334377|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
145403378|NCT00471497|524334378|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
145403379|NCT00471497|524334379|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
145403380|NCT00471497|524334377|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
145403381|NCT00471497|524334378|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
145403382|NCT00471497|524334379|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
145403383|NCT00471497|524334377|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
145403384|NCT00471497|524334378|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
145403385|NCT00471497|524334379|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
145403386|NCT00471497|524334377|FG000|Core Treatment Phase|Lost to Follow-up|6|||
145403387|NCT00471497|524334378|FG001|Core Treatment Phase|Lost to Follow-up|6|||
145403388|NCT00471497|524334379|FG002|Core Treatment Phase|Lost to Follow-up|3|||
145403389|NCT00471497|524334377|FG000|Core Treatment Phase|Death|3|||
145403390|NCT00471497|524334378|FG001|Core Treatment Phase|Death|9|||
145403391|NCT00471497|524334379|FG002|Core Treatment Phase|Death|3|||
145403392|NCT00471497|524334377|FG000|Core Treatment Phase|Disease Progression|10|||
145403393|NCT00471497|524334378|FG001|Core Treatment Phase|Disease Progression|2|||
145403394|NCT00471497|524334379|FG002|Core Treatment Phase|Disease Progression|4|||
145403395|NCT00471497|524334377|FG000|Core Treatment Phase|Protocol Violation|6|||
145403396|NCT00471497|524334378|FG001|Core Treatment Phase|Protocol Violation|15|||
145403397|NCT00471497|524334379|FG002|Core Treatment Phase|Protocol Violation|11|||
145403398|NCT00471497|524334377|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
145403399|NCT00471497|524334378|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
145403400|NCT00471497|524334379|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
145403401|NCT00471497|524334377|FG000|Core Treatment Phase|Administrative problems|14|||
145403402|NCT00471497|524334378|FG001|Core Treatment Phase|Administrative problems|14|||
145403403|NCT00471497|524334379|FG002|Core Treatment Phase|Administrative problems|12|||
145403404|NCT00471497|524334377|FG000|Core Treatment Phase|Adverse Event|43|||
145403405|NCT00471497|524334378|FG001|Core Treatment Phase|Adverse Event|53|||
145403406|NCT00471497|524334379|FG002|Core Treatment Phase|Adverse Event|89|||
145403407|NCT00471497|524334377|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
145403408|NCT00471497|524334378|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
145403409|NCT00471497|524334379|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
145403410|NCT00471497|524334377|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
145403411|NCT00471497|524334378|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
145403412|NCT00471497|524334379|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
145403413|NCT00471497|524334377|FG000|Extension Phase|Adverse Event|9|||
145772062|NCT05662332|525673058|FG000|Overall Study|The Patient Moved to Another City|1|||
145772063|NCT05662332|525673059|FG001|Overall Study|The Patient Moved to Another City|0|||
145772064|NCT01914679|525673060|FG000|Overall Study|Lack of Efficacy|1|||
145772065|NCT01914679|525673060|FG000|Overall Study|Sponsor terminated study|4|||
145772066|NCT00256295|525673061|FG000|Overall Study|Withdrawal by Subject|3|||
145772067|NCT00256295|525673061|FG000|Overall Study|Death|1|||
145772068|NCT03542682|525673065|FG000|Overall Study|COVID-19 Protocol|0|||
145403414|NCT00471497|524334378|FG001|Extension Phase|Adverse Event|5|||
145403415|NCT00471497|524334379|FG002|Extension Phase|Adverse Event|1|||
145403416|NCT00471497|524334377|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
145403417|NCT00471497|524334378|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
145608149|NCT04022889|525080940|FG002|Stage 1: Period 1|Adverse Event|0|||
145772069|NCT03542682|525673066|FG001|Overall Study|COVID-19 Protocol|1|||
145772070|NCT04321343|525673068|FG000|Overall Study|Adverse Event|0|||
145772071|NCT04321343|525673069|FG001|Overall Study|Adverse Event|0|||
145772072|NCT04321343|525673070|FG002|Overall Study|Adverse Event|1|||
145772073|NCT04321343|525673071|FG003|Overall Study|Adverse Event|0|||
145772074|NCT04321343|525673068|FG000|Overall Study|Death|0|||
145772075|NCT04321343|525673069|FG001|Overall Study|Death|0|||
145772076|NCT04321343|525673070|FG002|Overall Study|Death|0|||
145772077|NCT04321343|525673071|FG003|Overall Study|Death|1|||
145772078|NCT04321343|525673068|FG000|Overall Study|Pregnancy|1|||
145772079|NCT04321343|525673069|FG001|Overall Study|Pregnancy|0|||
145772080|NCT04321343|525673070|FG002|Overall Study|Pregnancy|0|||
145772081|NCT04321343|525673071|FG003|Overall Study|Pregnancy|0|||
145772082|NCT04321343|525673068|FG000|Overall Study|Protocol Violation|1|||
145772083|NCT04321343|525673069|FG001|Overall Study|Protocol Violation|1|||
145772084|NCT04321343|525673070|FG002|Overall Study|Protocol Violation|1|||
145772085|NCT04321343|525673071|FG003|Overall Study|Protocol Violation|1|||
145772086|NCT04321343|525673068|FG000|Overall Study|Withdrawal by Subject|0|||
145772087|NCT04321343|525673069|FG001|Overall Study|Withdrawal by Subject|6|||
145772088|NCT04321343|525673070|FG002|Overall Study|Withdrawal by Subject|0|||
145278418|NCT01462695|523870833|FG000|Overall Study|Lack of Efficacy|6|||
145278419|NCT01462695|523870834|FG001|Overall Study|Lack of Efficacy|12|||
145278420|NCT01462695|523870833|FG000|Overall Study|Physician Decision|5|||
145278421|NCT01462695|523870834|FG001|Overall Study|Physician Decision|0|||
145278422|NCT01462695|523870833|FG000|Overall Study|Withdrawal by Subject|2|||
145772089|NCT04321343|525673071|FG003|Overall Study|Withdrawal by Subject|2|||
145772090|NCT04321343|525673068|FG000|Overall Study|Lost to Follow-up|2|||
145772091|NCT04321343|525673069|FG001|Overall Study|Lost to Follow-up|2|||
145278423|NCT01462695|523870834|FG001|Overall Study|Withdrawal by Subject|0|||
145278424|NCT01462695|523870833|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
145278425|NCT01462695|523870834|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
145278426|NCT00879970|523870835|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
145278427|NCT00879970|523870836|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
145278428|NCT00879970|523870837|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
145278429|NCT00879970|523870838|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
145278430|NCT00879970|523870839|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
145278431|NCT00879970|523870835|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
145278432|NCT00879970|523870836|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
145278433|NCT00879970|523870837|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
145278434|NCT00879970|523870838|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
145278435|NCT00879970|523870839|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
145278436|NCT00879970|523870835|FG000|Period 1 TZD Randomization|Death|2|||
145278437|NCT00879970|523870836|FG001|Period 1 TZD Randomization|Death|1|||
145278438|NCT00879970|523870837|FG002|Period 1 TZD Randomization|Death|0|||
145278439|NCT00879970|523870838|FG003|Period 1 TZD Randomization|Death|0|||
145278440|NCT00879970|523870839|FG004|Period 1 TZD Randomization|Death|0|||
145278441|NCT00879970|523870835|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
145278442|NCT00879970|523870836|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
145278443|NCT00879970|523870837|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
145534053|NCT02913612|524815425|FG003|Overall Study|Study drug non-compliance|0|||
145534054|NCT02913612|524815422|FG000|Overall Study|Insurance issues|0|||
145772092|NCT04321343|525673070|FG002|Overall Study|Lost to Follow-up|1|||
145772093|NCT04321343|525673071|FG003|Overall Study|Lost to Follow-up|3|||
145278444|NCT00879970|523870838|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
145278445|NCT00879970|523870839|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
145278446|NCT00879970|523870835|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
145278447|NCT00879970|523870836|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
145278448|NCT00879970|523870837|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
145278449|NCT00879970|523870838|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
145278450|NCT00879970|523870839|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
145278451|NCT00879970|523870835|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
145278452|NCT00879970|523870836|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
145278453|NCT00879970|523870837|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
145278454|NCT00879970|523870838|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
145534055|NCT02913612|524815423|FG001|Overall Study|Insurance issues|1|||
145534056|NCT02913612|524815424|FG002|Overall Study|Insurance issues|0|||
145534057|NCT02913612|524815425|FG003|Overall Study|Insurance issues|0|||
145772094|NCT03430310|525673072|FG000|Overall Study|Protocol Violation|2|||
145772095|NCT03430310|525673073|FG001|Overall Study|Protocol Violation|0|||
145772096|NCT03430310|525673072|FG000|Overall Study|Withdrawal by Subject|3|||
145772097|NCT03430310|525673073|FG001|Overall Study|Withdrawal by Subject|2|||
145772098|NCT03430310|525673072|FG000|Overall Study|COVID shutdown March 2020|0|||
145772099|NCT03430310|525673073|FG001|Overall Study|COVID shutdown March 2020|1|||
145772100|NCT01446809|525673075|FG000|Overall Study|Adverse Event|0|||
145772101|NCT01446809|525673076|FG001|Overall Study|Adverse Event|0|||
145403418|NCT00471497|524334379|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
145403419|NCT00471497|524334377|FG000|Extension Phase|Withdrawal by Subject|3|||
145403420|NCT00471497|524334378|FG001|Extension Phase|Withdrawal by Subject|1|||
145403421|NCT00471497|524334379|FG002|Extension Phase|Withdrawal by Subject|0|||
145403422|NCT00471497|524334377|FG000|Extension Phase|Lost to Follow-up|2|||
145403423|NCT00471497|524334378|FG001|Extension Phase|Lost to Follow-up|0|||
145403424|NCT00471497|524334379|FG002|Extension Phase|Lost to Follow-up|0|||
145403425|NCT00471497|524334377|FG000|Extension Phase|Death|1|||
145403426|NCT00471497|524334378|FG001|Extension Phase|Death|0|||
145403427|NCT00471497|524334379|FG002|Extension Phase|Death|0|||
145534058|NCT02913612|524815422|FG000|Overall Study|Needed to treat second hemangioma|0|||
145534059|NCT02913612|524815423|FG001|Overall Study|Needed to treat second hemangioma|1|||
145772102|NCT01446809|525673077|FG002|Overall Study|Adverse Event|1|||
145772103|NCT01446809|525673075|FG000|Overall Study|Failure to complete study procedures|0|||
145772104|NCT01446809|525673076|FG001|Overall Study|Failure to complete study procedures|0|||
145772105|NCT01446809|525673077|FG002|Overall Study|Failure to complete study procedures|1|||
145772106|NCT01331161|525673078|FG000|Overall Study|Physician Decision|1|||
145772107|NCT01331161|525673079|FG001|Overall Study|Physician Decision|0|||
145772108|NCT01331161|525673078|FG000|Overall Study|Lost to Follow-up|0|||
145772109|NCT01331161|525673079|FG001|Overall Study|Lost to Follow-up|1|||
145772110|NCT01331161|525673078|FG000|Overall Study|Pregnancy|0|||
145772111|NCT01331161|525673079|FG001|Overall Study|Pregnancy|1|||
145772112|NCT01682044|525673080|FG000|Overall Study|Death|1|||
145772113|NCT01682044|525673080|FG000|Overall Study|Progression|3|||
145772114|NCT02581995|525673085|FG000|Overall Study|Unspecified other|3|||
145772115|NCT02581995|525673085|FG000|Overall Study|Adverse Event|6|||
145772116|NCT02581995|525673085|FG000|Overall Study|Lost to Follow-up|5|||
145772117|NCT02581995|525673085|FG000|Overall Study|Withdrawal by participant|12|||
145772118|NCT02581995|525673085|FG000|Overall Study|Physician Decision|1|||
145772119|NCT02581995|525673085|FG000|Overall Study|Death|4|||
145772120|NCT02017444|525675003|FG000|Overall Study|Physician Decision|1|||
145772121|NCT02017444|525675004|FG001|Overall Study|Physician Decision|0|||
145772122|NCT02017444|525675003|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
145772123|NCT02017444|525675004|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
145772124|NCT01614457|525675005|FG000|Overall Study|Non-Compliance|1|||
145772125|NCT01614457|525675006|FG001|Overall Study|Non-Compliance|0|||
145772126|NCT01614457|525675005|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
145772127|NCT01614457|525675006|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
145772128|NCT00886821|525675007|FG000|Stage 2|Adverse Event|0|||
145772129|NCT00886821|525675008|FG001|Stage 2|Adverse Event|0|||
145772130|NCT00886821|525675009|FG002|Stage 2|Adverse Event|0|||
145772131|NCT00886821|525675010|FG003|Stage 2|Adverse Event|0|||
145772132|NCT00886821|525675011|FG004|Stage 2|Adverse Event|0|||
145772133|NCT00886821|525675012|FG005|Stage 2|Adverse Event|0|||
145772134|NCT00886821|525675013|FG006|Stage 2|Adverse Event|0|||
145772135|NCT00886821|525675014|FG007|Stage 2|Adverse Event|0|||
145772136|NCT00886821|525675015|FG008|Stage 2|Adverse Event|0|||
145772137|NCT00886821|525675016|FG009|Stage 2|Adverse Event|0|||
145772138|NCT00886821|525675017|FG010|Stage 2|Adverse Event|0|||
145772139|NCT00886821|525675018|FG011|Stage 2|Adverse Event|1|||
145772140|NCT00886821|525675019|FG012|Stage 2|Adverse Event|3|||
145772141|NCT00886821|525675020|FG013|Stage 2|Adverse Event|0|||
145772142|NCT00886821|525675007|FG000|Stage 2|Lost to Follow-up|0|||
145772143|NCT00886821|525675008|FG001|Stage 2|Lost to Follow-up|0|||
145772144|NCT00886821|525675009|FG002|Stage 2|Lost to Follow-up|0|||
145772145|NCT00886821|525675010|FG003|Stage 2|Lost to Follow-up|0|||
145772146|NCT00886821|525675011|FG004|Stage 2|Lost to Follow-up|0|||
145772147|NCT00886821|525675012|FG005|Stage 2|Lost to Follow-up|0|||
145772148|NCT00886821|525675013|FG006|Stage 2|Lost to Follow-up|0|||
145772149|NCT00886821|525675014|FG007|Stage 2|Lost to Follow-up|0|||
145772150|NCT00886821|525675015|FG008|Stage 2|Lost to Follow-up|0|||
145772151|NCT00886821|525675016|FG009|Stage 2|Lost to Follow-up|0|||
145772152|NCT00886821|525675017|FG010|Stage 2|Lost to Follow-up|0|||
145772153|NCT00886821|525675018|FG011|Stage 2|Lost to Follow-up|0|||
145772154|NCT00886821|525675019|FG012|Stage 2|Lost to Follow-up|2|||
145772155|NCT00886821|525675020|FG013|Stage 2|Lost to Follow-up|1|||
145534060|NCT02913612|524815424|FG002|Overall Study|Needed to treat second hemangioma|0|||
145534061|NCT02913612|524815425|FG003|Overall Study|Needed to treat second hemangioma|0|||
145772156|NCT00942162|525675021|FG000|Overall Study|Death|45|||
145772157|NCT00942162|525675022|FG001|Overall Study|Death|35|||
145403428|NCT00471497|524334377|FG000|Extension Phase|Disease progression|2|||
145403429|NCT00471497|524334378|FG001|Extension Phase|Disease progression|0|||
145534062|NCT02913612|524815422|FG000|Overall Study|Study completion criteria not met|0|||
145772158|NCT00942162|525675023|FG002|Overall Study|Death|0|||
145772159|NCT00942162|525675021|FG000|Overall Study|Withdrawal by Subject|7|||
145772160|NCT00942162|525675022|FG001|Overall Study|Withdrawal by Subject|2|||
145772161|NCT00942162|525675023|FG002|Overall Study|Withdrawal by Subject|0|||
145772162|NCT00942162|525675021|FG000|Overall Study|Lost to Follow-up|4|||
145772163|NCT00942162|525675022|FG001|Overall Study|Lost to Follow-up|0|||
145772164|NCT00942162|525675023|FG002|Overall Study|Lost to Follow-up|0|||
145772165|NCT00942162|525675021|FG000|Overall Study|Other|14|||
145772166|NCT00942162|525675022|FG001|Overall Study|Other|13|||
145772167|NCT00942162|525675023|FG002|Overall Study|Other|2|||
145772168|NCT03368859|525675024|FG000|Overall Study|Withdrew Consent|5|||
145772169|NCT03368859|525675025|FG001|Overall Study|Withdrew Consent|4|||
145772170|NCT03368859|525675024|FG000|Overall Study|Death|12|||
145772171|NCT03368859|525675025|FG001|Overall Study|Death|6|||
145772172|NCT03368859|525675024|FG000|Overall Study|Study terminated by Sponsor|18|||
145772173|NCT03368859|525675025|FG001|Overall Study|Study terminated by Sponsor|23|||
145772174|NCT03368859|525675024|FG000|Overall Study|Other|1|||
145772175|NCT03368859|525675025|FG001|Overall Study|Other|1|||
145772176|NCT01713348|525675026|FG000|Overall Study|Withdrawal by Subject|3|||
145772177|NCT01713348|525675027|FG001|Overall Study|Withdrawal by Subject|2|||
145772178|NCT01713348|525675028|FG002|Overall Study|Withdrawal by Subject|2|||
145772179|NCT01713348|525675029|FG003|Overall Study|Withdrawal by Subject|0|||
145772180|NCT01713348|525675026|FG000|Overall Study|Lost to Follow-up|1|||
145772181|NCT01713348|525675027|FG001|Overall Study|Lost to Follow-up|0|||
145772182|NCT01713348|525675028|FG002|Overall Study|Lost to Follow-up|0|||
145772183|NCT01713348|525675029|FG003|Overall Study|Lost to Follow-up|0|||
145772184|NCT00621023|525675030|FG000|Overall Study|Death|5|||
145772185|NCT00621023|525675030|FG000|Overall Study|Follow up discontinued|1|||
145772186|NCT00698516|525675035|FG000|Overall Study|Study Termination|2|||
145772187|NCT00698516|525675035|FG000|Overall Study|Withdrawal by Subject|3|||
145772188|NCT00573131|525675036|FG000|Overall Study|Withdrawal by Subject|10|||
145772189|NCT00573131|525675037|FG001|Overall Study|Withdrawal by Subject|8|||
145772190|NCT03090191|525675038|FG000|Overall Study|Adverse Event|90|||
145772191|NCT03090191|525675039|FG001|Overall Study|Adverse Event|72|||
145772192|NCT03090191|525675038|FG000|Overall Study|Death|365|||
145772193|NCT03090191|525675039|FG001|Overall Study|Death|358|||
145772194|NCT03090191|525675038|FG000|Overall Study|Lost to Follow-up|382|||
145772195|NCT03090191|525675039|FG001|Overall Study|Lost to Follow-up|394|||
145772196|NCT03090191|525675038|FG000|Overall Study|Physician Decision|77|||
145772197|NCT03090191|525675039|FG001|Overall Study|Physician Decision|66|||
145772198|NCT03090191|525675038|FG000|Overall Study|Protocol Violation|43|||
145772199|NCT03090191|525675039|FG001|Overall Study|Protocol Violation|52|||
145772200|NCT03090191|525675038|FG000|Overall Study|Withdrawal by Subject|2160|||
145772201|NCT03090191|525675039|FG001|Overall Study|Withdrawal by Subject|2133|||
145772202|NCT03090191|525675038|FG000|Overall Study|Site terminated|7|||
145772203|NCT03090191|525675039|FG001|Overall Study|Site terminated|8|||
145772204|NCT03090191|525675038|FG000|Overall Study|Other|66|||
145772205|NCT03090191|525675039|FG001|Overall Study|Other|60|||
145772206|NCT03090191|525675038|FG000|Overall Study|Withdrawn before any study vaccination|43|||
145772207|NCT03090191|525675039|FG001|Overall Study|Withdrawn before any study vaccination|52|||
145772208|NCT00811252|525675047|FG000|Overall Study|Adverse Event|6|||
145772209|NCT00811252|525675048|FG001|Overall Study|Adverse Event|10|||
145772210|NCT00811252|525675049|FG002|Overall Study|Adverse Event|15|||
145772211|NCT00811252|525675047|FG000|Overall Study|Lack of Efficacy|7|||
145772212|NCT00811252|525675048|FG001|Overall Study|Lack of Efficacy|2|||
145772213|NCT00811252|525675049|FG002|Overall Study|Lack of Efficacy|0|||
145772214|NCT00811252|525675047|FG000|Overall Study|Protocol Violation|3|||
145772215|NCT00811252|525675048|FG001|Overall Study|Protocol Violation|3|||
145772216|NCT00811252|525675049|FG002|Overall Study|Protocol Violation|2|||
145772217|NCT00811252|525675047|FG000|Overall Study|Withdrawal of Consent|1|||
145534063|NCT02913612|524815423|FG001|Overall Study|Study completion criteria not met|1|||
145772218|NCT00811252|525675048|FG001|Overall Study|Withdrawal of Consent|2|||
145772219|NCT00811252|525675049|FG002|Overall Study|Withdrawal of Consent|2|||
145772220|NCT00811252|525675047|FG000|Overall Study|Lost to Follow-up|0|||
145772221|NCT00811252|525675048|FG001|Overall Study|Lost to Follow-up|0|||
145772222|NCT00811252|525675049|FG002|Overall Study|Lost to Follow-up|2|||
145772223|NCT00811252|525675047|FG000|Overall Study|Administrative or Other Reasons|0|||
145772224|NCT00811252|525675048|FG001|Overall Study|Administrative or Other Reasons|3|||
145534064|NCT02913612|524815424|FG002|Overall Study|Study completion criteria not met|0|||
145534065|NCT02913612|524815425|FG003|Overall Study|Study completion criteria not met|0|||
145534066|NCT02913612|524815422|FG000|Overall Study|Ineligible|0|||
145534067|NCT02913612|524815423|FG001|Overall Study|Ineligible|1|||
145534068|NCT02913612|524815424|FG002|Overall Study|Ineligible|0|||
145534069|NCT02913612|524815425|FG003|Overall Study|Ineligible|0|||
145534070|NCT01898208|524815428|FG000|Overall Study|Positive blood culture|17|||
145534071|NCT01898208|524815429|FG001|Overall Study|Positive blood culture|23|||
145534072|NCT01898208|524815430|FG002|Overall Study|Positive blood culture|15|||
145772225|NCT00811252|525675049|FG002|Overall Study|Administrative or Other Reasons|2|||
145772226|NCT01931865|525675050|FG000|Overall Study|Lost to Follow-up|2|||
145534073|NCT01898208|524815428|FG000|Overall Study|Death/comfort care within 24 hours|10|||
145772227|NCT01931865|525675050|FG000|Overall Study|Withdrawal by Subject|2|||
145772228|NCT01531725|525675057|FG000|Overall Study|Protocol Violation|5|||
145772229|NCT03215277|525675058|FG000|Overall Study|Adverse Event|2|||
145534074|NCT01898208|524815429|FG001|Overall Study|Death/comfort care within 24 hours|9|||
145772230|NCT03215277|525675059|FG001|Overall Study|Adverse Event|3|||
145772231|NCT03215277|525675058|FG000|Overall Study|Death|1|||
145772232|NCT03215277|525675059|FG001|Overall Study|Death|0|||
145772233|NCT03215277|525675058|FG000|Overall Study|Lost to Follow-up|0|||
145772234|NCT03215277|525675059|FG001|Overall Study|Lost to Follow-up|1|||
145772235|NCT03215277|525675058|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
145772236|NCT03215277|525675059|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
145772237|NCT00472303|525675061|FG000|Titration Phase|Adverse Event|22|||
145772238|NCT00472303|525675062|FG001|Titration Phase|Adverse Event|12|||
145772239|NCT00472303|525675063|FG002|Titration Phase|Adverse Event|0|||
145772240|NCT00472303|525675061|FG000|Titration Phase|Death|4|||
145772241|NCT00472303|525675062|FG001|Titration Phase|Death|2|||
145772242|NCT00472303|525675063|FG002|Titration Phase|Death|0|||
145772243|NCT00472303|525675061|FG000|Titration Phase|Lack of Efficacy|10|||
145772244|NCT00472303|525675062|FG001|Titration Phase|Lack of Efficacy|0|||
145772245|NCT00472303|525675063|FG002|Titration Phase|Lack of Efficacy|0|||
145772246|NCT00472303|525675061|FG000|Titration Phase|Withdrawal by Subject|16|||
145772247|NCT00472303|525675062|FG001|Titration Phase|Withdrawal by Subject|13|||
145772248|NCT00472303|525675063|FG002|Titration Phase|Withdrawal by Subject|0|||
145772249|NCT00472303|525675061|FG000|Titration Phase|Trial Medication non-compliant|4|||
145772250|NCT00472303|525675062|FG001|Titration Phase|Trial Medication non-compliant|1|||
145772251|NCT00472303|525675063|FG002|Titration Phase|Trial Medication non-compliant|0|||
145772252|NCT00472303|525675061|FG000|Titration Phase|Other|3|||
145772253|NCT00472303|525675062|FG001|Titration Phase|Other|1|||
145278455|NCT00879970|523870839|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
145534075|NCT01898208|524815430|FG002|Overall Study|Death/comfort care within 24 hours|8|||
145534076|NCT01898208|524815428|FG000|Overall Study|Negative Gram Stain|6|||
145534077|NCT01898208|524815429|FG001|Overall Study|Negative Gram Stain|9|||
145534078|NCT01898208|524815430|FG002|Overall Study|Negative Gram Stain|6|||
145534079|NCT01898208|524815428|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
145534080|NCT01898208|524815429|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
145534081|NCT01898208|524815430|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
145534082|NCT01898208|524815428|FG000|Overall Study|System/Technical Error|1|||
145534083|NCT01898208|524815429|FG001|Overall Study|System/Technical Error|2|||
145534084|NCT01898208|524815430|FG002|Overall Study|System/Technical Error|3|||
145534085|NCT01898208|524815428|FG000|Overall Study|Lost to Follow-up|3|||
145534086|NCT01898208|524815429|FG001|Overall Study|Lost to Follow-up|1|||
145534087|NCT01898208|524815430|FG002|Overall Study|Lost to Follow-up|1|||
145772254|NCT00472303|525675063|FG002|Titration Phase|Other|0|||
145772255|NCT00472303|525675061|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
145278456|NCT00879970|523870835|FG000|Period 2 Vitamin D Randomization|Death|0|||
145278457|NCT00879970|523870836|FG001|Period 2 Vitamin D Randomization|Death|0|||
145278458|NCT00879970|523870837|FG002|Period 2 Vitamin D Randomization|Death|0|||
145278459|NCT00879970|523870838|FG003|Period 2 Vitamin D Randomization|Death|2|||
145278460|NCT00879970|523870839|FG004|Period 2 Vitamin D Randomization|Death|0|||
145278461|NCT03672396|523870844|FG000|Overall Study|Withdrawal by Subject|4|||
145278462|NCT03672396|523870844|FG000|Overall Study|Physician Decision|1|||
145278463|NCT03672396|523870844|FG000|Overall Study|Adverse Event|1|||
145278464|NCT04380701|523870847|FG000|Overall Study|Pregnancy|0|||
145278465|NCT04380701|523870848|FG001|Overall Study|Pregnancy|0|||
145278466|NCT04380701|523870849|FG002|Overall Study|Pregnancy|0|||
145278467|NCT04380701|523870850|FG003|Overall Study|Pregnancy|0|||
145278468|NCT04380701|523870851|FG004|Overall Study|Pregnancy|0|||
145278469|NCT04380701|523870852|FG005|Overall Study|Pregnancy|0|||
145278470|NCT04380701|523870853|FG006|Overall Study|Pregnancy|0|||
145278471|NCT04380701|523870854|FG007|Overall Study|Pregnancy|0|||
145278472|NCT04380701|523870855|FG008|Overall Study|Pregnancy|0|||
145278473|NCT04380701|523870856|FG009|Overall Study|Pregnancy|0|||
145278474|NCT04380701|523870857|FG010|Overall Study|Pregnancy|0|||
145278475|NCT04380701|523870858|FG011|Overall Study|Pregnancy|0|||
145278476|NCT04380701|523870859|FG012|Overall Study|Pregnancy|0|||
145278477|NCT04380701|523870860|FG013|Overall Study|Pregnancy|0|||
145278478|NCT04380701|523870861|FG014|Overall Study|Pregnancy|0|||
145278479|NCT04380701|523870862|FG015|Overall Study|Pregnancy|0|||
145278480|NCT04380701|523870863|FG016|Overall Study|Pregnancy|0|||
145278481|NCT04380701|523870864|FG017|Overall Study|Pregnancy|0|||
145278482|NCT04380701|523870865|FG018|Overall Study|Pregnancy|0|||
145278483|NCT04380701|523870866|FG019|Overall Study|Pregnancy|0|||
145278484|NCT04380701|523870867|FG020|Overall Study|Pregnancy|0|||
145772256|NCT00472303|525675062|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
145772257|NCT00472303|525675063|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
145772258|NCT00472303|525675061|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
145278485|NCT04380701|523870868|FG021|Overall Study|Pregnancy|0|||
145278486|NCT04380701|523870869|FG022|Overall Study|Pregnancy|0|||
145278487|NCT04380701|523870870|FG023|Overall Study|Pregnancy|0|||
145278488|NCT04380701|523870871|FG024|Overall Study|Pregnancy|0|||
145278489|NCT04380701|523870872|FG025|Overall Study|Pregnancy|0|||
145278490|NCT04380701|523870873|FG026|Overall Study|Pregnancy|0|||
145534088|NCT00961649|524815432|FG000|Overall Study|Adverse Event|4|||
145534089|NCT00961649|524815433|FG001|Overall Study|Adverse Event|0|||
145534090|NCT00961649|524815434|FG002|Overall Study|Adverse Event|0|||
145534091|NCT00961649|524815435|FG003|Overall Study|Adverse Event|2|||
145534092|NCT00961649|524815432|FG000|Overall Study|Inadequate control of IOP|0|||
145534093|NCT00961649|524815433|FG001|Overall Study|Inadequate control of IOP|0|||
145534094|NCT00961649|524815434|FG002|Overall Study|Inadequate control of IOP|0|||
145534095|NCT00961649|524815435|FG003|Overall Study|Inadequate control of IOP|1|||
145534096|NCT00961649|524815432|FG000|Overall Study|Patient has travel plans during holidays|0|||
145534097|NCT00961649|524815433|FG001|Overall Study|Patient has travel plans during holidays|0|||
145534098|NCT00961649|524815434|FG002|Overall Study|Patient has travel plans during holidays|1|||
145534099|NCT00961649|524815435|FG003|Overall Study|Patient has travel plans during holidays|0|||
145534100|NCT00961649|524815432|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
145534101|NCT00961649|524815433|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
145534102|NCT00961649|524815434|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
145534103|NCT00961649|524815435|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
145534104|NCT00961649|524815432|FG000|Overall Study|Study terminated by sponsor|4|||
145534105|NCT00961649|524815433|FG001|Overall Study|Study terminated by sponsor|4|||
145534106|NCT00961649|524815434|FG002|Overall Study|Study terminated by sponsor|4|||
145534107|NCT00961649|524815435|FG003|Overall Study|Study terminated by sponsor|1|||
145534108|NCT02711345|524815436|FG000|Overall Study|Adverse Event|0|||
145534109|NCT02711345|524815437|FG001|Overall Study|Adverse Event|0|||
145534110|NCT02711345|524815438|FG002|Overall Study|Adverse Event|0|||
145534111|NCT02711345|524815439|FG003|Overall Study|Adverse Event|1|||
145534112|NCT02711345|524815440|FG004|Overall Study|Adverse Event|1|||
145534113|NCT02711345|524815441|FG005|Overall Study|Adverse Event|2|||
145534114|NCT02711345|524815442|FG006|Overall Study|Adverse Event|1|||
145534115|NCT02711345|524815443|FG007|Overall Study|Adverse Event|0|||
145534116|NCT02711345|524815444|FG008|Overall Study|Adverse Event|0|||
145534117|NCT02711345|524815445|FG009|Overall Study|Adverse Event|2|||
145534118|NCT02711345|524815436|FG000|Overall Study|Physician Decision|0|||
145534119|NCT02711345|524815437|FG001|Overall Study|Physician Decision|0|||
145534120|NCT02711345|524815438|FG002|Overall Study|Physician Decision|1|||
145534121|NCT02711345|524815439|FG003|Overall Study|Physician Decision|0|||
145534122|NCT02711345|524815440|FG004|Overall Study|Physician Decision|0|||
145534123|NCT02711345|524815441|FG005|Overall Study|Physician Decision|0|||
145534124|NCT02711345|524815442|FG006|Overall Study|Physician Decision|0|||
145534125|NCT02711345|524815443|FG007|Overall Study|Physician Decision|0|||
145534126|NCT02711345|524815444|FG008|Overall Study|Physician Decision|1|||
145608150|NCT04022889|525080938|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
145608151|NCT04022889|525080939|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
145534127|NCT02711345|524815445|FG009|Overall Study|Physician Decision|0|||
145534128|NCT02711345|524815436|FG000|Overall Study|Progressive disease|1|||
145534129|NCT02711345|524815437|FG001|Overall Study|Progressive disease|3|||
145534130|NCT02711345|524815438|FG002|Overall Study|Progressive disease|5|||
145534131|NCT02711345|524815439|FG003|Overall Study|Progressive disease|3|||
145534132|NCT02711345|524815440|FG004|Overall Study|Progressive disease|7|||
145534133|NCT02711345|524815441|FG005|Overall Study|Progressive disease|2|||
145534134|NCT02711345|524815442|FG006|Overall Study|Progressive disease|8|||
145534135|NCT02711345|524815443|FG007|Overall Study|Progressive disease|4|||
145534136|NCT02711345|524815444|FG008|Overall Study|Progressive disease|5|||
145534137|NCT02711345|524815445|FG009|Overall Study|Progressive disease|6|||
145772259|NCT00472303|525675062|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
145772260|NCT00472303|525675063|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
145772261|NCT00472303|525675061|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
145772262|NCT00472303|525675062|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
145772263|NCT00472303|525675063|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
145772264|NCT00472303|525675061|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
145772265|NCT00472303|525675062|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
145772266|NCT00472303|525675063|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
145772267|NCT00472303|525675061|FG000|Discontinuations After Titration Phase|Other|5|||
145772268|NCT00472303|525675062|FG001|Discontinuations After Titration Phase|Other|0|||
145534138|NCT02711345|524815436|FG000|Overall Study|Subject/guardian decision|0|||
145534139|NCT02711345|524815437|FG001|Overall Study|Subject/guardian decision|0|||
145534140|NCT02711345|524815438|FG002|Overall Study|Subject/guardian decision|0|||
145534141|NCT02711345|524815439|FG003|Overall Study|Subject/guardian decision|0|||
145534142|NCT02711345|524815440|FG004|Overall Study|Subject/guardian decision|0|||
145534143|NCT02711345|524815441|FG005|Overall Study|Subject/guardian decision|2|||
145278491|NCT04380701|523870874|FG027|Overall Study|Pregnancy|0|||
145278492|NCT04380701|523870875|FG028|Overall Study|Pregnancy|0|||
145278493|NCT04380701|523870876|FG029|Overall Study|Pregnancy|0|||
145278494|NCT04380701|523870877|FG030|Overall Study|Pregnancy|0|||
145278495|NCT04380701|523870878|FG031|Overall Study|Pregnancy|0|||
145278496|NCT04380701|523870879|FG032|Overall Study|Pregnancy|1|||
145278497|NCT04380701|523870880|FG033|Overall Study|Pregnancy|0|||
145278498|NCT04380701|523870847|FG000|Overall Study|Lost to Follow-up|0|||
145278499|NCT04380701|523870848|FG001|Overall Study|Lost to Follow-up|0|||
145278500|NCT04380701|523870849|FG002|Overall Study|Lost to Follow-up|0|||
145278501|NCT04380701|523870850|FG003|Overall Study|Lost to Follow-up|0|||
145403430|NCT00471497|524334379|FG002|Extension Phase|Disease progression|0|||
145403431|NCT00471497|524334377|FG000|Extension Phase|Protocol Violation|2|||
145403432|NCT00471497|524334378|FG001|Extension Phase|Protocol Violation|2|||
145278502|NCT04380701|523870851|FG004|Overall Study|Lost to Follow-up|0|||
145278503|NCT04380701|523870852|FG005|Overall Study|Lost to Follow-up|0|||
145278504|NCT04380701|523870853|FG006|Overall Study|Lost to Follow-up|0|||
145534144|NCT02711345|524815442|FG006|Overall Study|Subject/guardian decision|3|||
145534145|NCT02711345|524815443|FG007|Overall Study|Subject/guardian decision|1|||
145534146|NCT02711345|524815444|FG008|Overall Study|Subject/guardian decision|0|||
145534147|NCT02711345|524815445|FG009|Overall Study|Subject/guardian decision|4|||
145534148|NCT02711345|524815436|FG000|Overall Study|Death|1|||
145534149|NCT02711345|524815437|FG001|Overall Study|Death|0|||
145534150|NCT02711345|524815438|FG002|Overall Study|Death|0|||
145534151|NCT02711345|524815439|FG003|Overall Study|Death|0|||
145534152|NCT02711345|524815440|FG004|Overall Study|Death|0|||
145534153|NCT02711345|524815441|FG005|Overall Study|Death|0|||
145534154|NCT02711345|524815442|FG006|Overall Study|Death|0|||
145534155|NCT02711345|524815443|FG007|Overall Study|Death|1|||
145534156|NCT02711345|524815444|FG008|Overall Study|Death|0|||
145534157|NCT02711345|524815445|FG009|Overall Study|Death|0|||
145534158|NCT01011738|524815446|FG000|Overall Study|Death|12|||
145534159|NCT01011738|524815447|FG001|Overall Study|Death|3|||
145534160|NCT01011738|524815448|FG002|Overall Study|Death|0|||
145534161|NCT01011738|524815446|FG000|Overall Study|Unknown reasons|312|||
145534162|NCT01011738|524815447|FG001|Overall Study|Unknown reasons|291|||
145534163|NCT01011738|524815448|FG002|Overall Study|Unknown reasons|17|||
145534164|NCT00072176|524815451|FG000|Overall Study|Withdrawal by Subject|1|||
145608152|NCT04022889|525080940|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
145772269|NCT00472303|525675063|FG002|Discontinuations After Titration Phase|Other|0|||
145772270|NCT00472303|525675061|FG000|Maintenance Phase|Adverse Event|5|||
145772271|NCT00472303|525675062|FG001|Maintenance Phase|Adverse Event|6|||
145278505|NCT04380701|523870854|FG007|Overall Study|Lost to Follow-up|0|||
145403433|NCT00471497|524334379|FG002|Extension Phase|Protocol Violation|0|||
145534165|NCT00072176|524815452|FG001|Overall Study|Withdrawal by Subject|0|||
145534166|NCT00072176|524815451|FG000|Overall Study|Protocol Violation|0|||
145534167|NCT00072176|524815452|FG001|Overall Study|Protocol Violation|1|||
145608153|NCT04022889|525080938|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
145772272|NCT00472303|525675063|FG002|Maintenance Phase|Adverse Event|6|||
145278506|NCT04380701|523870855|FG008|Overall Study|Lost to Follow-up|0|||
145278507|NCT04380701|523870856|FG009|Overall Study|Lost to Follow-up|0|||
145278508|NCT04380701|523870857|FG010|Overall Study|Lost to Follow-up|0|||
145403434|NCT00392223|524334380|FG000|Overall Study|Adverse Event|5|||
145534168|NCT03181893|524815453|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534169|NCT03181893|524815454|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
145534170|NCT03181893|524815455|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534171|NCT03181893|524815456|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534172|NCT03181893|524815457|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534173|NCT03181893|524815458|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534174|NCT03181893|524815459|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534175|NCT03181893|524815460|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534176|NCT03181893|524815461|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534177|NCT03181893|524815462|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534178|NCT03181893|524815463|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
145534179|NCT03181893|524815453|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
145534180|NCT03181893|524815454|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
145534181|NCT03181893|524815455|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534182|NCT03181893|524815456|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534183|NCT03181893|524815457|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534184|NCT03181893|524815458|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534185|NCT03181893|524815459|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534186|NCT03181893|524815460|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534187|NCT03181893|524815461|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534188|NCT03181893|524815462|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534189|NCT03181893|524815463|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
145534190|NCT03181893|524815453|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534191|NCT03181893|524815454|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534192|NCT03181893|524815455|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534193|NCT03181893|524815456|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534194|NCT03181893|524815457|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534195|NCT03181893|524815458|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534196|NCT03181893|524815459|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534197|NCT03181893|524815460|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
145534198|NCT03181893|524815461|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
145534199|NCT03181893|524815462|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534200|NCT03181893|524815463|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
145534201|NCT03181893|524815453|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534202|NCT03181893|524815454|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534203|NCT03181893|524815455|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534204|NCT03181893|524815456|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534205|NCT03181893|524815457|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534206|NCT03181893|524815458|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534207|NCT03181893|524815459|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534208|NCT03181893|524815460|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534209|NCT03181893|524815461|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534210|NCT03181893|524815462|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
145534211|NCT03181893|524815463|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
145534212|NCT03181893|524815453|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534213|NCT03181893|524815454|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534214|NCT03181893|524815455|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534215|NCT03181893|524815456|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534216|NCT03181893|524815457|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534217|NCT03181893|524815458|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534218|NCT03181893|524815459|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534219|NCT03181893|524815460|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534220|NCT03181893|524815461|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534221|NCT03181893|524815462|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
145534222|NCT03181893|524815463|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
145534223|NCT04128371|524815464|FG000|Overall Study|Lack of Efficacy|1|||
145534224|NCT00968864|524815468|FG000|Overall Study|Protocol exception/ not evaluable|1|||
145534225|NCT00586625|524815469|FG000|Overall Study|Adverse Event|6|||
145534226|NCT00586625|524815470|FG001|Overall Study|Adverse Event|6|||
145534227|NCT00586625|524815469|FG000|Overall Study|Protocol Violation|3|||
145534228|NCT00586625|524815470|FG001|Overall Study|Protocol Violation|0|||
145534229|NCT00586625|524815469|FG000|Overall Study|Withdrawal by Subject|32|||
145534230|NCT00586625|524815470|FG001|Overall Study|Withdrawal by Subject|10|||
145534231|NCT00586625|524815469|FG000|Overall Study|Subject non-compliance|0|||
145534232|NCT00586625|524815470|FG001|Overall Study|Subject non-compliance|1|||
145534233|NCT00586625|524815469|FG000|Overall Study|Subject unable to return for visit|2|||
145534234|NCT00586625|524815470|FG001|Overall Study|Subject unable to return for visit|0|||
145534235|NCT04032652|524815471|FG000|Overall Study|The study was terminated and the PI has|1|||
145534236|NCT04032652|524815472|FG001|Overall Study|The study was terminated and the PI has|1|||
145534237|NCT01558739|524815473|FG000|Overall Study|Adverse Event|7|||
145534238|NCT01558739|524815473|FG000|Overall Study|Withdrawal by Subject|2|||
145534239|NCT01558739|524815473|FG000|Overall Study|Death|3|||
145534240|NCT01558739|524815473|FG000|Overall Study|Disease Progression|4|||
145534241|NCT01558739|524815473|FG000|Overall Study|Protocol Violation|1|||
145534242|NCT02423772|524815475|FG000|Overall Study|Lost to Follow-up|3|||
145534243|NCT02423772|524815476|FG001|Overall Study|Lost to Follow-up|3|||
145772273|NCT00472303|525675061|FG000|Maintenance Phase|Death|3|||
145772274|NCT00472303|525675062|FG001|Maintenance Phase|Death|0|||
145772275|NCT00472303|525675063|FG002|Maintenance Phase|Death|2|||
145772276|NCT00472303|525675061|FG000|Maintenance Phase|Lack of Efficacy|2|||
145772277|NCT00472303|525675062|FG001|Maintenance Phase|Lack of Efficacy|2|||
145772278|NCT00472303|525675063|FG002|Maintenance Phase|Lack of Efficacy|4|||
145772279|NCT00472303|525675061|FG000|Maintenance Phase|Withdrawal by Subject|6|||
145772280|NCT00472303|525675062|FG001|Maintenance Phase|Withdrawal by Subject|7|||
145772281|NCT00472303|525675063|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145772282|NCT00472303|525675061|FG000|Maintenance Phase|Trial medication non-compliant|0|||
145608154|NCT04022889|525080939|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
145608155|NCT04022889|525080940|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
145608156|NCT04022889|525080938|FG000|Stage 2|Screen Failure|0|||
145608157|NCT04022889|525080939|FG001|Stage 2|Screen Failure|0|||
145608158|NCT04022889|525080940|FG002|Stage 2|Screen Failure|3|||
145608159|NCT04022889|525080938|FG000|Stage 2|Ineligible for apheresis donation|0|||
145608160|NCT04022889|525080939|FG001|Stage 2|Ineligible for apheresis donation|0|||
145608161|NCT04022889|525080940|FG002|Stage 2|Ineligible for apheresis donation|2|||
145608162|NCT04022889|525080938|FG000|Stage 2|Adverse Event|0|||
145608163|NCT04022889|525080939|FG001|Stage 2|Adverse Event|0|||
145608164|NCT04022889|525080940|FG002|Stage 2|Adverse Event|2|||
145608165|NCT04022889|525080938|FG000|Stage 2|Protocol Violation|0|||
145608166|NCT04022889|525080939|FG001|Stage 2|Protocol Violation|0|||
145608167|NCT04022889|525080940|FG002|Stage 2|Protocol Violation|1|||
145608168|NCT04022889|525080938|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
145608169|NCT04022889|525080939|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
145608170|NCT04022889|525080940|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
145608171|NCT03285295|525080945|FG000|Alinity s HBsAg|Protocol Violation|11|||
145608172|NCT03285295|525080946|FG001|Alinity s HBsAg|Protocol Violation|0|||
145608173|NCT03285295|525080947|FG002|Alinity s HBsAg|Protocol Violation|0|||
145608174|NCT03285295|525080948|FG003|Alinity s HBsAg|Protocol Violation|0|||
145608175|NCT03285295|525080949|FG004|Alinity s HBsAg|Protocol Violation|0|||
145608176|NCT03285295|525080945|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
145608177|NCT03285295|525080946|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
145608178|NCT03285295|525080947|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
145608179|NCT03285295|525080948|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
145608180|NCT03285295|525080949|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
145608181|NCT03285295|525080945|FG000|Alinity s HBsAg|No Results Generated|74|||
145608182|NCT03285295|525080946|FG001|Alinity s HBsAg|No Results Generated|6|||
145608183|NCT03285295|525080947|FG002|Alinity s HBsAg|No Results Generated|0|||
145608184|NCT03285295|525080948|FG003|Alinity s HBsAg|No Results Generated|0|||
145608185|NCT03285295|525080949|FG004|Alinity s HBsAg|No Results Generated|0|||
145608186|NCT03285295|525080945|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
145608187|NCT03285295|525080946|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
145608188|NCT03285295|525080947|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
145608189|NCT03285295|525080948|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
145608190|NCT03285295|525080949|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
145608191|NCT03285295|525080945|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
145608192|NCT03285295|525080946|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
145608193|NCT03285295|525080947|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
145608194|NCT03285295|525080948|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
145608195|NCT03285295|525080949|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
145608196|NCT03285295|525080945|FG000|Alinity s HTLV I/II|No Results Generated|70|||
145608197|NCT03285295|525080946|FG001|Alinity s HTLV I/II|No Results Generated|0|||
145608198|NCT03285295|525080947|FG002|Alinity s HTLV I/II|No Results Generated|0|||
145608199|NCT03285295|525080948|FG003|Alinity s HTLV I/II|No Results Generated|0|||
145608200|NCT03285295|525080949|FG004|Alinity s HTLV I/II|No Results Generated|0|||
145608201|NCT03285295|525080945|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
145608202|NCT03285295|525080946|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
145608203|NCT03285295|525080947|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
145608204|NCT03285295|525080948|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
145608205|NCT03285295|525080949|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
145608206|NCT03285295|525080945|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
145608207|NCT03285295|525080946|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
145608208|NCT03285295|525080947|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
145772283|NCT00472303|525675062|FG001|Maintenance Phase|Trial medication non-compliant|0|||
145772284|NCT00472303|525675063|FG002|Maintenance Phase|Trial medication non-compliant|1|||
145772285|NCT00472303|525675061|FG000|Maintenance Phase|Resolution of pain|0|||
145772286|NCT00472303|525675062|FG001|Maintenance Phase|Resolution of pain|0|||
145772287|NCT00472303|525675063|FG002|Maintenance Phase|Resolution of pain|1|||
145772288|NCT00472303|525675061|FG000|Maintenance Phase|Other|1|||
145772289|NCT00472303|525675062|FG001|Maintenance Phase|Other|1|||
145772290|NCT00472303|525675063|FG002|Maintenance Phase|Other|0|||
145608209|NCT03285295|525080948|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
145608210|NCT03285295|525080949|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
145772291|NCT04112914|525675065|FG000|Overall Study|Lost to Follow-up|13|||
145608211|NCT03285295|525080945|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
145608212|NCT03285295|525080946|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
145608213|NCT03285295|525080947|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
145608214|NCT03285295|525080948|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
145772292|NCT04112914|525675066|FG001|Overall Study|Lost to Follow-up|9|||
145772293|NCT04112914|525675065|FG000|Overall Study|Withdrawal by Subject|1|||
145608215|NCT03285295|525080949|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
145772294|NCT04112914|525675066|FG001|Overall Study|Withdrawal by Subject|0|||
145772295|NCT01244737|525675074|FG000|Overall Study|Physician Decision|2|||
145772296|NCT01244737|525675075|FG001|Overall Study|Physician Decision|18|||
145772297|NCT01244737|525675076|FG002|Overall Study|Physician Decision|5|||
145772298|NCT01244737|525675074|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
145772299|NCT01244737|525675075|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
145772300|NCT01244737|525675076|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
145772301|NCT01244737|525675074|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
145772302|NCT01244737|525675075|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
145772303|NCT01244737|525675076|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
145772304|NCT01244737|525675074|FG000|Overall Study|MIB immunopathology results not available|3|||
145772305|NCT01244737|525675075|FG001|Overall Study|MIB immunopathology results not available|2|||
145772306|NCT01244737|525675076|FG002|Overall Study|MIB immunopathology results not available|0|||
145772307|NCT01244737|525675074|FG000|Overall Study|PET data failure|0|||
145772308|NCT01244737|525675075|FG001|Overall Study|PET data failure|1|||
145772309|NCT01244737|525675076|FG002|Overall Study|PET data failure|0|||
145772310|NCT01244737|525675074|FG000|Overall Study|Withdrawal by Subject|0|||
145772311|NCT01244737|525675075|FG001|Overall Study|Withdrawal by Subject|0|||
145772312|NCT01244737|525675076|FG002|Overall Study|Withdrawal by Subject|1|||
145772313|NCT02835495|525675081|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
145772314|NCT02835495|525675082|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
145772315|NCT02835495|525675081|FG000|Overall Study|Declined in-person follow-up visit|4|||
145772316|NCT02835495|525675082|FG001|Overall Study|Declined in-person follow-up visit|2|||
145772317|NCT00356915|525675084|FG000|Overall Study|Non compliance|1|||
145772318|NCT00356915|525675085|FG001|Overall Study|Non compliance|2|||
145772319|NCT00356915|525675086|FG002|Overall Study|Non compliance|1|||
145534244|NCT02423772|524815475|FG000|Overall Study|Did not begin intervention|2|||
145772320|NCT00356915|525675084|FG000|Overall Study|Protocol Violation|2|||
145772321|NCT00356915|525675085|FG001|Overall Study|Protocol Violation|3|||
145772322|NCT00356915|525675086|FG002|Overall Study|Protocol Violation|2|||
145772323|NCT00356915|525675084|FG000|Overall Study|Withdrawal by Subject|14|||
145772324|NCT00356915|525675085|FG001|Overall Study|Withdrawal by Subject|14|||
145772325|NCT00356915|525675086|FG002|Overall Study|Withdrawal by Subject|10|||
145772326|NCT00356915|525675084|FG000|Overall Study|Lack of Efficacy|0|||
145772327|NCT00356915|525675085|FG001|Overall Study|Lack of Efficacy|0|||
145772328|NCT00356915|525675086|FG002|Overall Study|Lack of Efficacy|3|||
145772329|NCT00356915|525675084|FG000|Overall Study|Lost to Follow-up|27|||
145772330|NCT00356915|525675085|FG001|Overall Study|Lost to Follow-up|34|||
145772331|NCT00356915|525675086|FG002|Overall Study|Lost to Follow-up|14|||
145772332|NCT00356915|525675084|FG000|Overall Study|Administrative Decision|0|||
145772333|NCT00356915|525675085|FG001|Overall Study|Administrative Decision|0|||
145534245|NCT02423772|524815476|FG001|Overall Study|Did not begin intervention|5|||
145534246|NCT01193842|524815477|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
145772334|NCT00356915|525675086|FG002|Overall Study|Administrative Decision|1|||
145772335|NCT00356915|525675084|FG000|Overall Study|Physician Decision|0|||
145772336|NCT00356915|525675085|FG001|Overall Study|Physician Decision|2|||
145772337|NCT00356915|525675086|FG002|Overall Study|Physician Decision|0|||
145772338|NCT00356915|525675084|FG000|Overall Study|Adverse Event|21|||
145772339|NCT00356915|525675085|FG001|Overall Study|Adverse Event|31|||
145772340|NCT00356915|525675086|FG002|Overall Study|Adverse Event|8|||
145772341|NCT00356915|525675084|FG000|Overall Study|Miscellaneous reasons|11|||
145772342|NCT00356915|525675085|FG001|Overall Study|Miscellaneous reasons|8|||
145772343|NCT00356915|525675086|FG002|Overall Study|Miscellaneous reasons|3|||
145772344|NCT05421754|525675087|FG000|Overall Study|Technical issue with sensor|1|||
145772345|NCT02500550|525675092|FG000|Overall Study|Death|7|||
145772346|NCT02604264|525675098|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
145772347|NCT02604264|525675099|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
145772348|NCT03192904|525675100|FG000|Overall Study|Physician Decision|3|||
145772349|NCT03192904|525675101|FG001|Overall Study|Physician Decision|1|||
145772350|NCT03192904|525675100|FG000|Overall Study|Lost to Follow-up|0|||
145772351|NCT03192904|525675101|FG001|Overall Study|Lost to Follow-up|1|||
145772352|NCT01023789|525675102|FG000|3 - Year Visit|Death|29|||
145534247|NCT01193842|524815478|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
145534248|NCT01193842|524815479|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
145772353|NCT01023789|525675102|FG000|3 - Year Visit|Withdrawal of consent|1|||
145772354|NCT01023789|525675102|FG000|3 - Year Visit|Lost to Follow-up|13|||
145772355|NCT01442181|525675106|FG000|Overall Study|patient refused surgery|1|||
145772356|NCT01442181|525675107|FG001|Overall Study|patient refused surgery|0|||
145772357|NCT01442181|525675106|FG000|Overall Study|no insurance for surgery|1|||
145772358|NCT01442181|525675107|FG001|Overall Study|no insurance for surgery|0|||
145772359|NCT01442181|525675106|FG000|Overall Study|low ejection factor|0|||
145772360|NCT01442181|525675107|FG001|Overall Study|low ejection factor|1|||
145772361|NCT01442181|525675106|FG000|Overall Study|Lost to Follow-up|1|||
145772362|NCT01442181|525675107|FG001|Overall Study|Lost to Follow-up|1|||
145772363|NCT01442181|525675106|FG000|Overall Study|patient in an additional study|1|||
145772364|NCT01442181|525675107|FG001|Overall Study|patient in an additional study|0|||
145772365|NCT01442181|525675106|FG000|Overall Study|atrial fibrillation not noted|0|||
145772366|NCT01442181|525675107|FG001|Overall Study|atrial fibrillation not noted|1|||
145772367|NCT02034123|525675108|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772368|NCT02034123|525675109|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772369|NCT02034123|525675110|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145534249|NCT01193842|524815480|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
145534250|NCT01193842|524815481|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
145534251|NCT01193842|524815477|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
145534252|NCT01193842|524815478|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
145534253|NCT01193842|524815479|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
145534254|NCT01193842|524815480|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
145534255|NCT01193842|524815481|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
145534256|NCT01193842|524815477|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
145534257|NCT01193842|524815478|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
145534258|NCT01193842|524815479|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
145534259|NCT01193842|524815480|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
145534260|NCT01193842|524815481|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
145534261|NCT01193842|524815477|FG000|Phase II: Randomized Groups|Death|0|||
145534262|NCT01193842|524815478|FG001|Phase II: Randomized Groups|Death|0|||
145534263|NCT01193842|524815479|FG002|Phase II: Randomized Groups|Death|0|||
145534264|NCT01193842|524815480|FG003|Phase II: Randomized Groups|Death|1|||
145534265|NCT01193842|524815481|FG004|Phase II: Randomized Groups|Death|1|||
145534266|NCT01193842|524815477|FG000|Phase II: Randomized Groups|Adverse Event|0|||
145534267|NCT01193842|524815478|FG001|Phase II: Randomized Groups|Adverse Event|0|||
145534268|NCT01193842|524815479|FG002|Phase II: Randomized Groups|Adverse Event|0|||
145534269|NCT01193842|524815480|FG003|Phase II: Randomized Groups|Adverse Event|5|||
145534270|NCT01193842|524815481|FG004|Phase II: Randomized Groups|Adverse Event|3|||
145534271|NCT01193842|524815477|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
145534272|NCT01193842|524815478|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
145534273|NCT01193842|524815479|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
145534274|NCT01193842|524815480|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
145534275|NCT01193842|524815481|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
145534276|NCT01193842|524815477|FG000|Phase II: Randomized Groups|Ineligible|0|||
145534277|NCT01193842|524815478|FG001|Phase II: Randomized Groups|Ineligible|0|||
145534278|NCT01193842|524815479|FG002|Phase II: Randomized Groups|Ineligible|0|||
145534279|NCT01193842|524815480|FG003|Phase II: Randomized Groups|Ineligible|0|||
145534280|NCT01193842|524815481|FG004|Phase II: Randomized Groups|Ineligible|1|||
145534281|NCT01193842|524815477|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
145534282|NCT01193842|524815478|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
145534283|NCT01193842|524815479|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
145534284|NCT01193842|524815480|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
145534285|NCT01193842|524815481|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
145534286|NCT02484690|524815483|FG000|Overall Study|Adverse Event|1|||
145534287|NCT02484690|524815484|FG001|Overall Study|Adverse Event|3|||
145534288|NCT02484690|524815485|FG002|Overall Study|Adverse Event|0|||
145534289|NCT02484690|524815486|FG003|Overall Study|Adverse Event|0|||
145534290|NCT02484690|524815487|FG004|Overall Study|Adverse Event|5|||
145534291|NCT02484690|524815483|FG000|Overall Study|Death|0|||
145534292|NCT02484690|524815484|FG001|Overall Study|Death|0|||
145534293|NCT02484690|524815485|FG002|Overall Study|Death|0|||
145534294|NCT02484690|524815486|FG003|Overall Study|Death|0|||
145534295|NCT02484690|524815487|FG004|Overall Study|Death|1|||
145534296|NCT02484690|524815483|FG000|Overall Study|Withdrawal by Subject|1|||
145534297|NCT02484690|524815484|FG001|Overall Study|Withdrawal by Subject|3|||
145608216|NCT03285295|525080945|FG000|Alinity s Anti-HCV|No Results Generated|71|||
145608217|NCT03285295|525080946|FG001|Alinity s Anti-HCV|No Results Generated|0|||
145608218|NCT03285295|525080947|FG002|Alinity s Anti-HCV|No Results Generated|0|||
145608219|NCT03285295|525080948|FG003|Alinity s Anti-HCV|No Results Generated|0|||
145608220|NCT03285295|525080949|FG004|Alinity s Anti-HCV|No Results Generated|0|||
145772370|NCT02034123|525675111|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145534298|NCT02484690|524815485|FG002|Overall Study|Withdrawal by Subject|1|||
145534299|NCT02484690|524815486|FG003|Overall Study|Withdrawal by Subject|2|||
145534300|NCT02484690|524815487|FG004|Overall Study|Withdrawal by Subject|0|||
145534301|NCT02484690|524815483|FG000|Overall Study|Physician Decision|2|||
145534302|NCT02484690|524815484|FG001|Overall Study|Physician Decision|0|||
145772371|NCT02034123|525675112|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
145772372|NCT02034123|525675113|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145534303|NCT02484690|524815485|FG002|Overall Study|Physician Decision|1|||
145534304|NCT02484690|524815486|FG003|Overall Study|Physician Decision|0|||
145608221|NCT03285295|525080945|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
145534305|NCT02484690|524815487|FG004|Overall Study|Physician Decision|0|||
145278509|NCT04380701|523870858|FG011|Overall Study|Lost to Follow-up|0|||
145278510|NCT04380701|523870859|FG012|Overall Study|Lost to Follow-up|0|||
145278511|NCT04380701|523870860|FG013|Overall Study|Lost to Follow-up|0|||
145278512|NCT04380701|523870861|FG014|Overall Study|Lost to Follow-up|0|||
145278513|NCT04380701|523870862|FG015|Overall Study|Lost to Follow-up|0|||
145278514|NCT04380701|523870863|FG016|Overall Study|Lost to Follow-up|0|||
145278515|NCT04380701|523870864|FG017|Overall Study|Lost to Follow-up|0|||
145278516|NCT04380701|523870865|FG018|Overall Study|Lost to Follow-up|0|||
145278517|NCT04380701|523870866|FG019|Overall Study|Lost to Follow-up|0|||
145278518|NCT04380701|523870867|FG020|Overall Study|Lost to Follow-up|1|||
145278519|NCT04380701|523870868|FG021|Overall Study|Lost to Follow-up|0|||
145278520|NCT04380701|523870869|FG022|Overall Study|Lost to Follow-up|0|||
145278521|NCT04380701|523870870|FG023|Overall Study|Lost to Follow-up|1|||
145278522|NCT04380701|523870871|FG024|Overall Study|Lost to Follow-up|0|||
145278523|NCT04380701|523870872|FG025|Overall Study|Lost to Follow-up|0|||
145278524|NCT04380701|523870873|FG026|Overall Study|Lost to Follow-up|0|||
145278525|NCT04380701|523870874|FG027|Overall Study|Lost to Follow-up|0|||
145278526|NCT04380701|523870875|FG028|Overall Study|Lost to Follow-up|0|||
145278527|NCT04380701|523870876|FG029|Overall Study|Lost to Follow-up|1|||
145278528|NCT04380701|523870877|FG030|Overall Study|Lost to Follow-up|0|||
145278529|NCT04380701|523870878|FG031|Overall Study|Lost to Follow-up|0|||
145278530|NCT04380701|523870879|FG032|Overall Study|Lost to Follow-up|0|||
145278531|NCT04380701|523870880|FG033|Overall Study|Lost to Follow-up|1|||
145278532|NCT04380701|523870847|FG000|Overall Study|Private reason(s)|0|||
145278533|NCT04380701|523870848|FG001|Overall Study|Private reason(s)|0|||
145278534|NCT04380701|523870849|FG002|Overall Study|Private reason(s)|0|||
145278535|NCT04380701|523870850|FG003|Overall Study|Private reason(s)|0|||
145278536|NCT04380701|523870851|FG004|Overall Study|Private reason(s)|0|||
145278537|NCT04380701|523870852|FG005|Overall Study|Private reason(s)|0|||
145278538|NCT04380701|523870853|FG006|Overall Study|Private reason(s)|1|||
145278539|NCT04380701|523870854|FG007|Overall Study|Private reason(s)|0|||
145278540|NCT04380701|523870855|FG008|Overall Study|Private reason(s)|1|||
145278541|NCT04380701|523870856|FG009|Overall Study|Private reason(s)|1|||
145278542|NCT04380701|523870857|FG010|Overall Study|Private reason(s)|0|||
145278543|NCT04380701|523870858|FG011|Overall Study|Private reason(s)|0|||
145278544|NCT04380701|523870859|FG012|Overall Study|Private reason(s)|0|||
145278545|NCT04380701|523870860|FG013|Overall Study|Private reason(s)|0|||
145278546|NCT04380701|523870861|FG014|Overall Study|Private reason(s)|0|||
145278547|NCT04380701|523870862|FG015|Overall Study|Private reason(s)|0|||
145278548|NCT04380701|523870863|FG016|Overall Study|Private reason(s)|0|||
145278549|NCT04380701|523870864|FG017|Overall Study|Private reason(s)|0|||
145278550|NCT04380701|523870865|FG018|Overall Study|Private reason(s)|0|||
145278551|NCT04380701|523870866|FG019|Overall Study|Private reason(s)|0|||
145278552|NCT04380701|523870867|FG020|Overall Study|Private reason(s)|0|||
145278553|NCT04380701|523870868|FG021|Overall Study|Private reason(s)|0|||
145278554|NCT04380701|523870869|FG022|Overall Study|Private reason(s)|0|||
145278555|NCT04380701|523870870|FG023|Overall Study|Private reason(s)|1|||
145278556|NCT04380701|523870871|FG024|Overall Study|Private reason(s)|0|||
145278557|NCT04380701|523870872|FG025|Overall Study|Private reason(s)|0|||
145278558|NCT04380701|523870873|FG026|Overall Study|Private reason(s)|0|||
145278559|NCT04380701|523870874|FG027|Overall Study|Private reason(s)|0|||
145278560|NCT04380701|523870875|FG028|Overall Study|Private reason(s)|0|||
145278561|NCT04380701|523870876|FG029|Overall Study|Private reason(s)|1|||
145534306|NCT02484690|524815483|FG000|Overall Study|Lost to Follow-up|0|||
145534307|NCT02484690|524815484|FG001|Overall Study|Lost to Follow-up|0|||
145534308|NCT02484690|524815485|FG002|Overall Study|Lost to Follow-up|1|||
145534309|NCT02484690|524815486|FG003|Overall Study|Lost to Follow-up|0|||
145278562|NCT04380701|523870877|FG030|Overall Study|Private reason(s)|0|||
145278563|NCT04380701|523870878|FG031|Overall Study|Private reason(s)|0|||
145278564|NCT04380701|523870879|FG032|Overall Study|Private reason(s)|0|||
145278565|NCT04380701|523870880|FG033|Overall Study|Private reason(s)|0|||
145278566|NCT04380701|523870847|FG000|Overall Study|Withdrawal by Subject|0|||
145278567|NCT04380701|523870848|FG001|Overall Study|Withdrawal by Subject|0|||
145278568|NCT04380701|523870849|FG002|Overall Study|Withdrawal by Subject|0|||
145278569|NCT04380701|523870850|FG003|Overall Study|Withdrawal by Subject|0|||
145278570|NCT04380701|523870851|FG004|Overall Study|Withdrawal by Subject|0|||
145278571|NCT04380701|523870852|FG005|Overall Study|Withdrawal by Subject|0|||
145772373|NCT02034123|525675114|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772374|NCT02034123|525675115|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
145772375|NCT02034123|525675116|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
145772376|NCT02034123|525675117|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772377|NCT02034123|525675118|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772378|NCT02034123|525675119|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772379|NCT02034123|525675120|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772380|NCT02034123|525675121|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772381|NCT02034123|525675122|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772382|NCT02034123|525675123|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772383|NCT02034123|525675124|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772384|NCT02034123|525675125|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
145772385|NCT02034123|525675108|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772386|NCT02034123|525675109|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772387|NCT02034123|525675110|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772388|NCT02034123|525675111|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
145772389|NCT02034123|525675112|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772390|NCT02034123|525675113|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772391|NCT02034123|525675114|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772392|NCT02034123|525675115|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772393|NCT02034123|525675116|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772394|NCT02034123|525675117|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772395|NCT02034123|525675118|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772396|NCT02034123|525675119|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772397|NCT02034123|525675120|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772398|NCT02034123|525675121|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772399|NCT02034123|525675122|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772400|NCT02034123|525675123|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772401|NCT02034123|525675124|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772402|NCT02034123|525675125|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
145772403|NCT02034123|525675108|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772404|NCT02034123|525675109|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772405|NCT02034123|525675110|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772406|NCT02034123|525675111|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772407|NCT02034123|525675112|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772408|NCT02034123|525675113|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772409|NCT02034123|525675114|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772410|NCT02034123|525675115|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772411|NCT02034123|525675116|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
145772412|NCT02034123|525675117|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772413|NCT02034123|525675118|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772414|NCT02034123|525675119|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772415|NCT02034123|525675120|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772416|NCT02034123|525675121|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772417|NCT02034123|525675122|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772418|NCT02034123|525675123|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772419|NCT02034123|525675124|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772420|NCT02034123|525675125|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
145772421|NCT02034123|525675108|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772422|NCT02034123|525675109|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772423|NCT02034123|525675110|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772424|NCT02034123|525675111|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
145772425|NCT02034123|525675112|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
145772426|NCT02034123|525675113|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772427|NCT02034123|525675114|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772428|NCT02034123|525675115|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772429|NCT02034123|525675116|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772430|NCT02034123|525675117|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772431|NCT02034123|525675118|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772432|NCT02034123|525675119|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772433|NCT02034123|525675120|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145608222|NCT03285295|525080946|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
145534310|NCT02484690|524815487|FG004|Overall Study|Lost to Follow-up|0|||
145534311|NCT03672643|524815488|FG000|Overall Study|Adverse Event|3|||
145534312|NCT03672643|524815488|FG000|Overall Study|Death|2|||
145534313|NCT03672643|524815488|FG000|Overall Study|Withdrawal by Subject|1|||
145534314|NCT03672643|524815488|FG000|Overall Study|Progressive disease|11|||
145534315|NCT03672643|524815488|FG000|Overall Study|Global deterioration of health status|1|||
145534316|NCT03672643|524815488|FG000|Overall Study|Refused further treatment|7|||
145534317|NCT03672643|524815488|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
145534318|NCT00589290|524815489|FG000|Overall Study|Withdrawal by Subject|1|||
145534319|NCT01067976|524815490|FG000|Overall Study|Study drug never administered|20|||
145534320|NCT01067976|524815490|FG000|Overall Study|Study prematurely discontinued|2|||
145534321|NCT00566111|524815491|FG000|Overall Study|Adverse Event|0|||
145534322|NCT00566111|524815492|FG001|Overall Study|Adverse Event|2|||
145772434|NCT02034123|525675121|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772435|NCT02034123|525675122|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772436|NCT02034123|525675123|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772437|NCT02034123|525675124|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772438|NCT02034123|525675125|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
145772439|NCT00246259|525675126|FG000|Overall Study|Other|3|||
145772440|NCT00246259|525675127|FG001|Overall Study|Other|3|||
145772441|NCT00246259|525675126|FG000|Overall Study|Not stable by Week 18|2|||
145772442|NCT00246259|525675127|FG001|Overall Study|Not stable by Week 18|1|||
145772443|NCT00246259|525675126|FG000|Overall Study|Participant non-compliant|4|||
145772444|NCT00246259|525675127|FG001|Overall Study|Participant non-compliant|9|||
145772445|NCT00246259|525675126|FG000|Overall Study|Lack of Efficacy|2|||
145772446|NCT00246259|525675127|FG001|Overall Study|Lack of Efficacy|2|||
145772447|NCT00246259|525675126|FG000|Overall Study|Investigator withdrew participant|2|||
145772448|NCT00246259|525675127|FG001|Overall Study|Investigator withdrew participant|0|||
145772449|NCT00246259|525675126|FG000|Overall Study|Adverse Event|5|||
145772450|NCT00246259|525675127|FG001|Overall Study|Adverse Event|0|||
145772451|NCT00246259|525675126|FG000|Overall Study|Lost to Follow-up|3|||
145772452|NCT00246259|525675127|FG001|Overall Study|Lost to Follow-up|4|||
145772453|NCT00246259|525675126|FG000|Overall Study|Withdrawal by Subject|5|||
145772454|NCT00246259|525675127|FG001|Overall Study|Withdrawal by Subject|1|||
145772455|NCT00246259|525675126|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
145772456|NCT00246259|525675127|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
145772457|NCT00709202|525675128|FG000|Overall Study|Withdrawal by Subject|6|||
145772458|NCT00709202|525675129|FG001|Overall Study|Withdrawal by Subject|6|||
145772459|NCT03301857|525675130|FG000|Overall Study|Death|0|||
145772460|NCT03301857|525675131|FG001|Overall Study|Death|2|||
145772461|NCT03301857|525675130|FG000|Overall Study|Lost to Follow-up|4|||
145772462|NCT03301857|525675131|FG001|Overall Study|Lost to Follow-up|2|||
145772463|NCT03301857|525675130|FG000|Overall Study|Decision by Sponsor|6|||
145772464|NCT03301857|525675131|FG001|Overall Study|Decision by Sponsor|0|||
145772465|NCT03301857|525675130|FG000|Overall Study|Withdrawal by Subject|12|||
145772466|NCT03301857|525675131|FG001|Overall Study|Withdrawal by Subject|4|||
145772467|NCT00855439|525675136|FG000|Overall Study|Withdrawal by Subject|2|||
145772468|NCT00855439|525675137|FG001|Overall Study|Withdrawal by Subject|0|||
145772469|NCT00855439|525675136|FG000|Overall Study|Pregnancy|1|||
145772470|NCT00855439|525675137|FG001|Overall Study|Pregnancy|0|||
145278572|NCT04380701|523870853|FG006|Overall Study|Withdrawal by Subject|1|||
145278573|NCT04380701|523870854|FG007|Overall Study|Withdrawal by Subject|1|||
145278574|NCT04380701|523870855|FG008|Overall Study|Withdrawal by Subject|0|||
145534323|NCT00976677|524815493|FG000|Overall Study|Adverse Event|1|||
145772471|NCT00561353|525675140|FG000|Overall Study|Subject reached a virologic endpoint|2|||
145772472|NCT00561353|525675141|FG001|Overall Study|Subject reached a virologic endpoint|1|||
145772473|NCT00561353|525675142|FG002|Overall Study|Subject reached a virologic endpoint|1|||
145278575|NCT04380701|523870856|FG009|Overall Study|Withdrawal by Subject|0|||
145534324|NCT00976677|524815494|FG001|Overall Study|Adverse Event|0|||
145534325|NCT00976677|524815493|FG000|Overall Study|Withdrawal by Subject|0|||
145403435|NCT00392223|524334381|FG001|Overall Study|Adverse Event|4|||
145403436|NCT00392223|524334380|FG000|Overall Study|Lost to Follow-up|1|||
145403437|NCT00392223|524334381|FG001|Overall Study|Lost to Follow-up|4|||
145403438|NCT00392223|524334380|FG000|Overall Study|Protocol Violation|0|||
145403439|NCT00392223|524334381|FG001|Overall Study|Protocol Violation|3|||
145403440|NCT00392223|524334380|FG000|Overall Study|Withdrawal by Subject|3|||
145403441|NCT00392223|524334381|FG001|Overall Study|Withdrawal by Subject|2|||
145403442|NCT03344757|524334383|FG000|Overall Study|Withdrawal by Subject|18|||
145403443|NCT03344757|524334384|FG001|Overall Study|Withdrawal by Subject|16|||
145403444|NCT03344757|524334383|FG000|Overall Study|Lost to Follow-up|0|||
145403445|NCT03344757|524334384|FG001|Overall Study|Lost to Follow-up|2|||
145403446|NCT00269152|524334387|FG000|Overall Study|Adverse Event|9|||
145403447|NCT00269152|524334388|FG001|Overall Study|Adverse Event|3|||
145403448|NCT00269152|524334387|FG000|Overall Study|Withdrawal by Subject|7|||
145278576|NCT04380701|523870857|FG010|Overall Study|Withdrawal by Subject|0|||
145278577|NCT04380701|523870858|FG011|Overall Study|Withdrawal by Subject|1|||
145278578|NCT04380701|523870859|FG012|Overall Study|Withdrawal by Subject|0|||
145278579|NCT04380701|523870860|FG013|Overall Study|Withdrawal by Subject|1|||
145278580|NCT04380701|523870861|FG014|Overall Study|Withdrawal by Subject|0|||
145278581|NCT04380701|523870862|FG015|Overall Study|Withdrawal by Subject|0|||
145278582|NCT04380701|523870863|FG016|Overall Study|Withdrawal by Subject|1|||
145278583|NCT04380701|523870864|FG017|Overall Study|Withdrawal by Subject|0|||
145278584|NCT04380701|523870865|FG018|Overall Study|Withdrawal by Subject|0|||
145278585|NCT04380701|523870866|FG019|Overall Study|Withdrawal by Subject|0|||
145278586|NCT04380701|523870867|FG020|Overall Study|Withdrawal by Subject|0|||
145278587|NCT04380701|523870868|FG021|Overall Study|Withdrawal by Subject|0|||
145278588|NCT04380701|523870869|FG022|Overall Study|Withdrawal by Subject|2|||
145278589|NCT04380701|523870870|FG023|Overall Study|Withdrawal by Subject|2|||
145278590|NCT04380701|523870871|FG024|Overall Study|Withdrawal by Subject|1|||
145278591|NCT04380701|523870872|FG025|Overall Study|Withdrawal by Subject|1|||
145278592|NCT04380701|523870873|FG026|Overall Study|Withdrawal by Subject|0|||
145278593|NCT04380701|523870874|FG027|Overall Study|Withdrawal by Subject|0|||
145278594|NCT04380701|523870875|FG028|Overall Study|Withdrawal by Subject|0|||
145278595|NCT04380701|523870876|FG029|Overall Study|Withdrawal by Subject|0|||
145278596|NCT04380701|523870877|FG030|Overall Study|Withdrawal by Subject|0|||
145278597|NCT04380701|523870878|FG031|Overall Study|Withdrawal by Subject|0|||
145278598|NCT04380701|523870879|FG032|Overall Study|Withdrawal by Subject|0|||
145278599|NCT04380701|523870880|FG033|Overall Study|Withdrawal by Subject|0|||
145278600|NCT04380701|523870847|FG000|Overall Study|Adverse Event|0|||
145278601|NCT04380701|523870848|FG001|Overall Study|Adverse Event|0|||
145278602|NCT04380701|523870849|FG002|Overall Study|Adverse Event|0|||
145278603|NCT04380701|523870850|FG003|Overall Study|Adverse Event|0|||
145278604|NCT04380701|523870851|FG004|Overall Study|Adverse Event|0|||
145278605|NCT04380701|523870852|FG005|Overall Study|Adverse Event|1|||
145608223|NCT03285295|525080947|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
145608224|NCT03285295|525080948|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
145772474|NCT00561353|525675143|FG003|Overall Study|Subject reached a virologic endpoint|4|||
145772475|NCT00561353|525675144|FG004|Overall Study|Subject reached a virologic endpoint|1|||
145772476|NCT00561353|525675145|FG005|Overall Study|Subject reached a virologic endpoint|3|||
145772477|NCT00561353|525675146|FG006|Overall Study|Subject reached a virologic endpoint|4|||
145772478|NCT00561353|525675147|FG007|Overall Study|Subject reached a virologic endpoint|4|||
145772479|NCT00561353|525675148|FG008|Overall Study|Subject reached a virologic endpoint|5|||
145772480|NCT00561353|525675149|FG009|Overall Study|Subject reached a virologic endpoint|0|||
145772481|NCT00561353|525675140|FG000|Overall Study|Subject ineligible to continue the trial|0|||
145772482|NCT00561353|525675141|FG001|Overall Study|Subject ineligible to continue the trial|0|||
145772483|NCT00561353|525675142|FG002|Overall Study|Subject ineligible to continue the trial|0|||
145772484|NCT00561353|525675143|FG003|Overall Study|Subject ineligible to continue the trial|0|||
145772485|NCT00561353|525675144|FG004|Overall Study|Subject ineligible to continue the trial|0|||
145772486|NCT00561353|525675145|FG005|Overall Study|Subject ineligible to continue the trial|1|||
145772487|NCT00561353|525675146|FG006|Overall Study|Subject ineligible to continue the trial|1|||
145772488|NCT00561353|525675147|FG007|Overall Study|Subject ineligible to continue the trial|0|||
145772489|NCT00561353|525675148|FG008|Overall Study|Subject ineligible to continue the trial|2|||
145278606|NCT04380701|523870853|FG006|Overall Study|Adverse Event|0|||
145278607|NCT04380701|523870854|FG007|Overall Study|Adverse Event|0|||
145278608|NCT04380701|523870855|FG008|Overall Study|Adverse Event|0|||
145278609|NCT04380701|523870856|FG009|Overall Study|Adverse Event|0|||
145278610|NCT04380701|523870857|FG010|Overall Study|Adverse Event|0|||
145278611|NCT04380701|523870858|FG011|Overall Study|Adverse Event|0|||
145278612|NCT04380701|523870859|FG012|Overall Study|Adverse Event|0|||
145278613|NCT04380701|523870860|FG013|Overall Study|Adverse Event|0|||
145403449|NCT00269152|524334388|FG001|Overall Study|Withdrawal by Subject|3|||
145403450|NCT00269152|524334387|FG000|Overall Study|Physician Decision|2|||
145403451|NCT00269152|524334388|FG001|Overall Study|Physician Decision|3|||
145403452|NCT00269152|524334387|FG000|Overall Study|Protocol Violation|0|||
145278614|NCT04380701|523870861|FG014|Overall Study|Adverse Event|0|||
145278615|NCT04380701|523870862|FG015|Overall Study|Adverse Event|1|||
145278616|NCT04380701|523870863|FG016|Overall Study|Adverse Event|0|||
145278617|NCT04380701|523870864|FG017|Overall Study|Adverse Event|0|||
145278618|NCT04380701|523870865|FG018|Overall Study|Adverse Event|0|||
145278619|NCT04380701|523870866|FG019|Overall Study|Adverse Event|1|||
145278620|NCT04380701|523870867|FG020|Overall Study|Adverse Event|0|||
145278621|NCT04380701|523870868|FG021|Overall Study|Adverse Event|0|||
145278622|NCT04380701|523870869|FG022|Overall Study|Adverse Event|0|||
145772490|NCT00561353|525675149|FG009|Overall Study|Subject ineligible to continue the trial|1|||
145278623|NCT04380701|523870870|FG023|Overall Study|Adverse Event|0|||
145278624|NCT04380701|523870871|FG024|Overall Study|Adverse Event|0|||
145278625|NCT04380701|523870872|FG025|Overall Study|Adverse Event|0|||
145278626|NCT04380701|523870873|FG026|Overall Study|Adverse Event|0|||
145278627|NCT04380701|523870874|FG027|Overall Study|Adverse Event|0|||
145278628|NCT04380701|523870875|FG028|Overall Study|Adverse Event|0|||
145278629|NCT04380701|523870876|FG029|Overall Study|Adverse Event|0|||
145278630|NCT04380701|523870877|FG030|Overall Study|Adverse Event|0|||
145278631|NCT04380701|523870878|FG031|Overall Study|Adverse Event|0|||
145278632|NCT04380701|523870879|FG032|Overall Study|Adverse Event|0|||
145278633|NCT04380701|523870880|FG033|Overall Study|Adverse Event|0|||
145278634|NCT04380701|523870847|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
145278635|NCT04380701|523870848|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
145278636|NCT04380701|523870849|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
145278637|NCT04380701|523870850|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
145278638|NCT04380701|523870851|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
145278639|NCT04380701|523870852|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
145278640|NCT04380701|523870853|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
145278641|NCT04380701|523870854|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
145278642|NCT04380701|523870855|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
145278643|NCT04380701|523870856|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
145278644|NCT04380701|523870857|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
145278645|NCT04380701|523870858|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
145278646|NCT04380701|523870859|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
145278647|NCT04380701|523870860|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
145278648|NCT04380701|523870861|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
145278649|NCT04380701|523870862|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
145278650|NCT04380701|523870863|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
145278651|NCT04380701|523870864|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
145278652|NCT04380701|523870865|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
145278653|NCT04380701|523870866|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
145278654|NCT04380701|523870867|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
145278655|NCT04380701|523870868|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
145278656|NCT04380701|523870869|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
145278657|NCT04380701|523870870|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
145278658|NCT04380701|523870871|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
145772491|NCT00561353|525675140|FG000|Overall Study|Other|1|||
145772492|NCT00561353|525675141|FG001|Overall Study|Other|0|||
145772493|NCT00561353|525675142|FG002|Overall Study|Other|1|||
145772494|NCT00561353|525675143|FG003|Overall Study|Other|0|||
145772495|NCT00561353|525675144|FG004|Overall Study|Other|0|||
145772496|NCT00561353|525675145|FG005|Overall Study|Other|2|||
145772497|NCT00561353|525675146|FG006|Overall Study|Other|0|||
145772498|NCT00561353|525675147|FG007|Overall Study|Other|0|||
145772499|NCT00561353|525675148|FG008|Overall Study|Other|0|||
145772500|NCT00561353|525675149|FG009|Overall Study|Other|0|||
145278659|NCT04380701|523870872|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
145608225|NCT03285295|525080949|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
145772501|NCT00561353|525675140|FG000|Overall Study|Adverse Event|0|||
145278660|NCT04380701|523870873|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
145278661|NCT04380701|523870874|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
145278662|NCT04380701|523870875|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
145278663|NCT04380701|523870876|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
145278664|NCT04380701|523870877|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
145278665|NCT04380701|523870878|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
145278666|NCT04380701|523870879|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
145278667|NCT04380701|523870880|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
145278668|NCT04380701|523870847|FG000|Overall Study|Physician Decision|0|||
145278669|NCT04380701|523870848|FG001|Overall Study|Physician Decision|0|||
145278670|NCT04380701|523870849|FG002|Overall Study|Physician Decision|0|||
145278671|NCT04380701|523870850|FG003|Overall Study|Physician Decision|0|||
145278672|NCT04380701|523870851|FG004|Overall Study|Physician Decision|0|||
145772502|NCT00561353|525675141|FG001|Overall Study|Adverse Event|0|||
145772503|NCT00561353|525675142|FG002|Overall Study|Adverse Event|0|||
145772504|NCT00561353|525675143|FG003|Overall Study|Adverse Event|2|||
145772505|NCT00561353|525675144|FG004|Overall Study|Adverse Event|0|||
145278673|NCT04380701|523870852|FG005|Overall Study|Physician Decision|0|||
145278674|NCT04380701|523870853|FG006|Overall Study|Physician Decision|0|||
145278675|NCT04380701|523870854|FG007|Overall Study|Physician Decision|0|||
145278676|NCT04380701|523870855|FG008|Overall Study|Physician Decision|0|||
145278677|NCT04380701|523870856|FG009|Overall Study|Physician Decision|0|||
145278678|NCT04380701|523870857|FG010|Overall Study|Physician Decision|0|||
145278679|NCT04380701|523870858|FG011|Overall Study|Physician Decision|0|||
145278680|NCT04380701|523870859|FG012|Overall Study|Physician Decision|0|||
145278681|NCT04380701|523870860|FG013|Overall Study|Physician Decision|0|||
145278682|NCT04380701|523870861|FG014|Overall Study|Physician Decision|0|||
145278683|NCT04380701|523870862|FG015|Overall Study|Physician Decision|0|||
145278684|NCT04380701|523870863|FG016|Overall Study|Physician Decision|0|||
145278685|NCT04380701|523870864|FG017|Overall Study|Physician Decision|0|||
145278686|NCT04380701|523870865|FG018|Overall Study|Physician Decision|0|||
145278687|NCT04380701|523870866|FG019|Overall Study|Physician Decision|0|||
145278688|NCT04380701|523870867|FG020|Overall Study|Physician Decision|0|||
145278689|NCT04380701|523870868|FG021|Overall Study|Physician Decision|0|||
145278690|NCT04380701|523870869|FG022|Overall Study|Physician Decision|0|||
145278691|NCT04380701|523870870|FG023|Overall Study|Physician Decision|0|||
145278692|NCT04380701|523870871|FG024|Overall Study|Physician Decision|2|||
145278693|NCT04380701|523870872|FG025|Overall Study|Physician Decision|0|||
145278694|NCT04380701|523870873|FG026|Overall Study|Physician Decision|0|||
145278695|NCT04380701|523870874|FG027|Overall Study|Physician Decision|0|||
145278696|NCT04380701|523870875|FG028|Overall Study|Physician Decision|0|||
145278697|NCT04380701|523870876|FG029|Overall Study|Physician Decision|0|||
145278698|NCT04380701|523870877|FG030|Overall Study|Physician Decision|0|||
145278699|NCT04380701|523870878|FG031|Overall Study|Physician Decision|0|||
145278700|NCT04380701|523870879|FG032|Overall Study|Physician Decision|0|||
145278701|NCT04380701|523870880|FG033|Overall Study|Physician Decision|0|||
145772506|NCT00561353|525675145|FG005|Overall Study|Adverse Event|0|||
145772507|NCT00561353|525675146|FG006|Overall Study|Adverse Event|1|||
145772508|NCT00561353|525675147|FG007|Overall Study|Adverse Event|0|||
145772509|NCT00561353|525675148|FG008|Overall Study|Adverse Event|0|||
145772510|NCT00561353|525675149|FG009|Overall Study|Adverse Event|1|||
145772511|NCT00561353|525675140|FG000|Overall Study|Lost to Follow-up|2|||
145772512|NCT00561353|525675141|FG001|Overall Study|Lost to Follow-up|0|||
145772513|NCT00561353|525675142|FG002|Overall Study|Lost to Follow-up|1|||
145772514|NCT00561353|525675143|FG003|Overall Study|Lost to Follow-up|0|||
145772515|NCT00561353|525675144|FG004|Overall Study|Lost to Follow-up|0|||
145772516|NCT00561353|525675145|FG005|Overall Study|Lost to Follow-up|0|||
145772517|NCT00561353|525675146|FG006|Overall Study|Lost to Follow-up|0|||
145772518|NCT00561353|525675147|FG007|Overall Study|Lost to Follow-up|0|||
145772519|NCT00561353|525675148|FG008|Overall Study|Lost to Follow-up|0|||
145772520|NCT00561353|525675149|FG009|Overall Study|Lost to Follow-up|0|||
145772521|NCT00561353|525675140|FG000|Overall Study|Withdrawal by Subject|0|||
145772522|NCT00561353|525675141|FG001|Overall Study|Withdrawal by Subject|2|||
145278702|NCT04380701|523870847|FG000|Overall Study|Death|0|||
145278703|NCT04380701|523870848|FG001|Overall Study|Death|0|||
145278704|NCT04380701|523870849|FG002|Overall Study|Death|0|||
145278705|NCT04380701|523870850|FG003|Overall Study|Death|0|||
145278706|NCT04380701|523870851|FG004|Overall Study|Death|0|||
145278707|NCT04380701|523870852|FG005|Overall Study|Death|0|||
145278708|NCT04380701|523870853|FG006|Overall Study|Death|0|||
145278709|NCT04380701|523870854|FG007|Overall Study|Death|0|||
145534326|NCT00976677|524815494|FG001|Overall Study|Withdrawal by Subject|2|||
145534327|NCT00976677|524815493|FG000|Overall Study|Disease progression|1|||
145534328|NCT00976677|524815494|FG001|Overall Study|Disease progression|1|||
145534329|NCT00976677|524815493|FG000|Overall Study|Trial unblinded|2|||
145534330|NCT00976677|524815494|FG001|Overall Study|Trial unblinded|2|||
145534331|NCT00976677|524815493|FG000|Overall Study|Unknown/Missing|1|||
145772523|NCT00561353|525675142|FG002|Overall Study|Withdrawal by Subject|0|||
145772524|NCT00561353|525675143|FG003|Overall Study|Withdrawal by Subject|0|||
145772525|NCT00561353|525675144|FG004|Overall Study|Withdrawal by Subject|0|||
145772526|NCT00561353|525675145|FG005|Overall Study|Withdrawal by Subject|0|||
145278710|NCT04380701|523870855|FG008|Overall Study|Death|0|||
145278711|NCT04380701|523870856|FG009|Overall Study|Death|0|||
145278712|NCT04380701|523870857|FG010|Overall Study|Death|0|||
145278713|NCT04380701|523870858|FG011|Overall Study|Death|0|||
145278714|NCT04380701|523870859|FG012|Overall Study|Death|0|||
145278715|NCT04380701|523870860|FG013|Overall Study|Death|0|||
145278716|NCT04380701|523870861|FG014|Overall Study|Death|0|||
145278717|NCT04380701|523870862|FG015|Overall Study|Death|0|||
145278718|NCT04380701|523870863|FG016|Overall Study|Death|0|||
145278719|NCT04380701|523870864|FG017|Overall Study|Death|0|||
145278720|NCT04380701|523870865|FG018|Overall Study|Death|0|||
145278721|NCT04380701|523870866|FG019|Overall Study|Death|0|||
145534332|NCT00976677|524815494|FG001|Overall Study|Unknown/Missing|0|||
145534333|NCT02468232|524816910|FG000|Core Part of Study|Adverse Event|0|||
145772527|NCT00561353|525675146|FG006|Overall Study|Withdrawal by Subject|0|||
145772528|NCT00561353|525675147|FG007|Overall Study|Withdrawal by Subject|0|||
145772529|NCT00561353|525675148|FG008|Overall Study|Withdrawal by Subject|0|||
145772530|NCT00561353|525675149|FG009|Overall Study|Withdrawal by Subject|0|||
145772531|NCT05369806|525675153|FG000|Overall Study|Lost to Follow-up|1|||
145772532|NCT01097044|525675157|FG000|Overall Study|Withdrawal by Subject|4|||
145772533|NCT01097044|525675158|FG001|Overall Study|Withdrawal by Subject|4|||
145772534|NCT01097044|525675157|FG000|Overall Study|Lost to Follow-up|1|||
145772535|NCT01097044|525675158|FG001|Overall Study|Lost to Follow-up|0|||
145772536|NCT01097044|525675157|FG000|Overall Study|Withdrawal by Sponsor|0|||
145772537|NCT01097044|525675158|FG001|Overall Study|Withdrawal by Sponsor|1|||
145772538|NCT03232073|525675168|FG000|Overall Study|Death|1|||
145772539|NCT03232073|525675169|FG001|Overall Study|Death|0|||
145772540|NCT03232073|525675168|FG000|Overall Study|Adverse Event|7|||
145772541|NCT03232073|525675169|FG001|Overall Study|Adverse Event|12|||
145772542|NCT03232073|525675168|FG000|Overall Study|Lost to Follow-up|6|||
145772543|NCT03232073|525675169|FG001|Overall Study|Lost to Follow-up|6|||
145772544|NCT03232073|525675168|FG000|Overall Study|Lack of Efficacy|10|||
145772545|NCT03232073|525675169|FG001|Overall Study|Lack of Efficacy|8|||
145772546|NCT03232073|525675168|FG000|Overall Study|Physician Decision|9|||
145772547|NCT03232073|525675169|FG001|Overall Study|Physician Decision|2|||
145772548|NCT03232073|525675168|FG000|Overall Study|Withdrawal by Subject|54|||
145772549|NCT03232073|525675169|FG001|Overall Study|Withdrawal by Subject|39|||
145772550|NCT01672892|525676586|FG000|Overall Study|Protocol Violation|7|||
145772551|NCT01672892|525676587|FG001|Overall Study|Protocol Violation|3|||
145772552|NCT03528681|525676598|FG000|Open-Label Phase|Physician Decision|2|||
145772553|NCT03528681|525676599|FG001|Open-Label Phase|Physician Decision|0|||
145772554|NCT03528681|525676600|FG002|Open-Label Phase|Physician Decision|0|||
145772555|NCT03528681|525676601|FG003|Open-Label Phase|Physician Decision|0|||
145772556|NCT03528681|525676598|FG000|Open-Label Phase|Withdrawal by Subject|8|||
145772557|NCT03528681|525676599|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145772558|NCT03528681|525676600|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145772559|NCT03528681|525676601|FG003|Open-Label Phase|Withdrawal by Subject|0|||
145772560|NCT03528681|525676598|FG000|Open-Label Phase|(Not collected)|4|||
145772561|NCT03528681|525676599|FG001|Open-Label Phase|(Not collected)|0|||
145772562|NCT03528681|525676600|FG002|Open-Label Phase|(Not collected)|0|||
145772563|NCT03528681|525676601|FG003|Open-Label Phase|(Not collected)|0|||
145772564|NCT03528681|525676598|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
145772565|NCT03528681|525676599|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
145772566|NCT03528681|525676600|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
145772567|NCT03528681|525676601|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
145772568|NCT03528681|525676598|FG000|Randomized Treatment Phase|Physician Decision|0|||
145772569|NCT03528681|525676599|FG001|Randomized Treatment Phase|Physician Decision|5|||
145772570|NCT03528681|525676600|FG002|Randomized Treatment Phase|Physician Decision|1|||
145772571|NCT03528681|525676601|FG003|Randomized Treatment Phase|Physician Decision|2|||
145772572|NCT03528681|525676598|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
145772573|NCT03528681|525676599|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
145772574|NCT03528681|525676600|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
145772575|NCT03528681|525676601|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
145772576|NCT03528681|525676598|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
145772577|NCT03528681|525676599|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
145772578|NCT03528681|525676600|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
145772579|NCT03528681|525676601|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
145772580|NCT03528681|525676598|FG000|Randomized Treatment Phase|(Not collected)|0|||
145772581|NCT03528681|525676599|FG001|Randomized Treatment Phase|(Not collected)|4|||
145772582|NCT03528681|525676600|FG002|Randomized Treatment Phase|(Not collected)|6|||
145278722|NCT04380701|523870867|FG020|Overall Study|Death|0|||
145534334|NCT02468232|524816911|FG001|Core Part of Study|Adverse Event|1|||
145534335|NCT02468232|524816912|FG002|Core Part of Study|Adverse Event|0|||
145534336|NCT02468232|524816913|FG003|Core Part of Study|Adverse Event|0|||
145534337|NCT02468232|524816910|FG000|Core Part of Study|Death|20|||
145534338|NCT02468232|524816911|FG001|Core Part of Study|Death|17|||
145534339|NCT02468232|524816912|FG002|Core Part of Study|Death|0|||
145772583|NCT03528681|525676601|FG003|Randomized Treatment Phase|(Not collected)|5|||
145772584|NCT02342171|525676603|FG000|Overall Study|Death|4|||
145772585|NCT02342171|525676604|FG001|Overall Study|Death|87|||
145772586|NCT02342171|525676603|FG000|Overall Study|Received favipiravir|10|||
145772587|NCT02342171|525676604|FG001|Overall Study|Received favipiravir|0|||
145772588|NCT02342171|525676603|FG000|Overall Study|Missing cycle treshold value|1|||
145772589|NCT02342171|525676604|FG001|Overall Study|Missing cycle treshold value|0|||
145772590|NCT02342171|525676603|FG000|Overall Study|Unknown outcome|0|||
145772591|NCT02342171|525676604|FG001|Overall Study|Unknown outcome|1|||
145772592|NCT02342171|525676603|FG000|Overall Study|Missing age data|0|||
145772593|NCT02342171|525676604|FG001|Overall Study|Missing age data|1|||
145772594|NCT03518840|525676607|FG000|Overall Study|Lost to Follow-up|6|||
145772595|NCT00914628|525676610|FG000|Overall Study|Death|35|||
145772596|NCT00914628|525676611|FG001|Overall Study|Death|17|||
145772597|NCT00914628|525676610|FG000|Overall Study|Medical decision|4|||
145772598|NCT00914628|525676611|FG001|Overall Study|Medical decision|0|||
145534340|NCT02468232|524816913|FG003|Core Part of Study|Death|0|||
145772599|NCT00914628|525676610|FG000|Overall Study|Protocol Violation|1|||
145608226|NCT03285295|525080945|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
145608227|NCT03285295|525080946|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
145772600|NCT00914628|525676611|FG001|Overall Study|Protocol Violation|0|||
145772601|NCT00914628|525676610|FG000|Overall Study|Lack of Efficacy|1|||
145534341|NCT02468232|524816910|FG000|Core Part of Study|Technical Problems|1|||
145534342|NCT02468232|524816911|FG001|Core Part of Study|Technical Problems|1|||
145534343|NCT02468232|524816912|FG002|Core Part of Study|Technical Problems|0|||
145534344|NCT02468232|524816913|FG003|Core Part of Study|Technical Problems|0|||
145534345|NCT02468232|524816910|FG000|OLE Part of Study|Adverse Event|0|||
145534346|NCT02468232|524816911|FG001|OLE Part of Study|Adverse Event|0|||
145534347|NCT02468232|524816912|FG002|OLE Part of Study|Adverse Event|4|||
145534348|NCT02468232|524816913|FG003|OLE Part of Study|Adverse Event|5|||
145534349|NCT02468232|524816910|FG000|OLE Part of Study|Death|0|||
145772602|NCT00914628|525676611|FG001|Overall Study|Lack of Efficacy|0|||
145772603|NCT00914628|525676610|FG000|Overall Study|non-randomized|1|||
145772604|NCT00914628|525676611|FG001|Overall Study|non-randomized|0|||
145772605|NCT00914628|525676610|FG000|Overall Study|Relapse|1|||
145772606|NCT00914628|525676611|FG001|Overall Study|Relapse|2|||
145772607|NCT00914628|525676610|FG000|Overall Study|Study terminated by Sponsor|14|||
145772608|NCT00914628|525676611|FG001|Overall Study|Study terminated by Sponsor|8|||
145772609|NCT00914628|525676610|FG000|Overall Study|Patients who did not receive a single dose|7|||
145772610|NCT00914628|525676611|FG001|Overall Study|Patients who did not receive a single dose|1|||
145772611|NCT03311126|525676612|FG000|Induction|Death|1|||
145772612|NCT03311126|525676612|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
145772613|NCT01756157|525676613|FG000|First Intervention Period|Withdrawal by Subject|1|||
145772614|NCT01756157|525676614|FG001|First Intervention Period|Withdrawal by Subject|0|||
145772615|NCT01756157|525676613|FG000|First Intervention Period|Lost to Follow-up|0|||
145772616|NCT01756157|525676614|FG001|First Intervention Period|Lost to Follow-up|2|||
145772617|NCT01584024|525676617|FG000|Overall Study|Lost to Follow-up|10|||
145772618|NCT01584024|525676617|FG000|Overall Study|Withdrawal by Subject|3|||
145772619|NCT00719810|525676623|FG000|Overall Study|Adverse Event|0|||
145772620|NCT00719810|525676624|FG001|Overall Study|Adverse Event|2|||
145772621|NCT00719810|525676625|FG002|Overall Study|Adverse Event|3|||
145772622|NCT00719810|525676623|FG000|Overall Study|Lost to Follow-up|2|||
145772623|NCT00719810|525676624|FG001|Overall Study|Lost to Follow-up|0|||
145772624|NCT00719810|525676625|FG002|Overall Study|Lost to Follow-up|3|||
145772625|NCT00719810|525676623|FG000|Overall Study|Physician Decision|0|||
145772626|NCT00719810|525676624|FG001|Overall Study|Physician Decision|1|||
145772627|NCT00719810|525676625|FG002|Overall Study|Physician Decision|0|||
145772628|NCT00719810|525676623|FG000|Overall Study|Withdrawal by Subject|1|||
145772629|NCT00719810|525676624|FG001|Overall Study|Withdrawal by Subject|1|||
145772630|NCT00719810|525676625|FG002|Overall Study|Withdrawal by Subject|2|||
145772631|NCT04893265|525676628|FG000|Overall Study|Withdrawal by Subject|2|||
145772632|NCT04893265|525676629|FG001|Overall Study|Withdrawal by Subject|5|||
145772633|NCT04893265|525676628|FG000|Overall Study|Lost to Follow-up|0|||
145772634|NCT04893265|525676629|FG001|Overall Study|Lost to Follow-up|4|||
145772635|NCT00893789|525676630|FG000|Overall Study|Withdrawal by Subject|3|||
145772636|NCT00893789|525676631|FG001|Overall Study|Withdrawal by Subject|1|||
145772637|NCT00893789|525676632|FG002|Overall Study|Withdrawal by Subject|3|||
145772638|NCT00893789|525676633|FG003|Overall Study|Withdrawal by Subject|1|||
145772639|NCT00893789|525676630|FG000|Overall Study|Noncompliance With Study Drug|1|||
145772640|NCT00893789|525676631|FG001|Overall Study|Noncompliance With Study Drug|0|||
145772641|NCT00893789|525676632|FG002|Overall Study|Noncompliance With Study Drug|1|||
145403453|NCT00269152|524334388|FG001|Overall Study|Protocol Violation|1|||
145534350|NCT02468232|524816911|FG001|OLE Part of Study|Death|0|||
145772642|NCT00893789|525676633|FG003|Overall Study|Noncompliance With Study Drug|2|||
145772643|NCT00893789|525676630|FG000|Overall Study|Noncompliance With Study Procedures|1|||
145772644|NCT00893789|525676631|FG001|Overall Study|Noncompliance With Study Procedures|0|||
145772645|NCT00893789|525676632|FG002|Overall Study|Noncompliance With Study Procedures|0|||
145772646|NCT00893789|525676633|FG003|Overall Study|Noncompliance With Study Procedures|0|||
145772647|NCT00893789|525676630|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
145278723|NCT04380701|523870868|FG021|Overall Study|Death|0|||
145278724|NCT04380701|523870869|FG022|Overall Study|Death|0|||
145278725|NCT04380701|523870870|FG023|Overall Study|Death|0|||
145403454|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
145403455|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
145403456|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403457|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403458|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403459|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403460|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403461|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403462|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403463|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
145403464|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
145403465|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
145403466|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403467|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403468|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403469|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403470|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403471|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403472|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403473|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
145403474|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
145403475|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403476|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403477|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145534351|NCT02468232|524816912|FG002|OLE Part of Study|Death|4|||
145278726|NCT04380701|523870871|FG024|Overall Study|Death|1|||
145278727|NCT04380701|523870872|FG025|Overall Study|Death|0|||
145278728|NCT04380701|523870873|FG026|Overall Study|Death|0|||
145278729|NCT04380701|523870874|FG027|Overall Study|Death|0|||
145278730|NCT04380701|523870875|FG028|Overall Study|Death|0|||
145278731|NCT04380701|523870876|FG029|Overall Study|Death|0|||
145278732|NCT04380701|523870877|FG030|Overall Study|Death|0|||
145278733|NCT04380701|523870878|FG031|Overall Study|Death|0|||
145278734|NCT04380701|523870879|FG032|Overall Study|Death|0|||
145278735|NCT04380701|523870880|FG033|Overall Study|Death|0|||
145278736|NCT04380701|523870847|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278737|NCT04380701|523870848|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278738|NCT04380701|523870849|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278739|NCT04380701|523870850|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278740|NCT04380701|523870851|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278741|NCT04380701|523870852|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278742|NCT04380701|523870853|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278743|NCT04380701|523870854|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278744|NCT04380701|523870855|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278745|NCT04380701|523870856|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278746|NCT04380701|523870857|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278747|NCT04380701|523870858|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278748|NCT04380701|523870859|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278749|NCT04380701|523870860|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278750|NCT04380701|523870861|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278751|NCT04380701|523870862|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278752|NCT04380701|523870863|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278753|NCT04380701|523870864|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278754|NCT04380701|523870865|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278755|NCT04380701|523870866|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278756|NCT04380701|523870867|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278757|NCT04380701|523870868|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
145278758|NCT04380701|523870869|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
145278759|NCT04380701|523870870|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
145534352|NCT02468232|524816913|FG003|OLE Part of Study|Death|2|||
145534353|NCT02468232|524816910|FG000|OLE Part of Study|Physician Decision|0|||
145534354|NCT02468232|524816911|FG001|OLE Part of Study|Physician Decision|0|||
145534355|NCT02468232|524816912|FG002|OLE Part of Study|Physician Decision|4|||
145278760|NCT04380701|523870871|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
145534356|NCT02468232|524816913|FG003|OLE Part of Study|Physician Decision|0|||
145534357|NCT02468232|524816910|FG000|OLE Part of Study|Subject/Guardian decision|0|||
145534358|NCT02468232|524816911|FG001|OLE Part of Study|Subject/Guardian decision|0|||
145772648|NCT00893789|525676631|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
145772649|NCT00893789|525676632|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
145772650|NCT00893789|525676633|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
145772651|NCT00893789|525676630|FG000|Overall Study|Adverse Event|0|||
145772652|NCT00893789|525676631|FG001|Overall Study|Adverse Event|2|||
145772653|NCT00893789|525676632|FG002|Overall Study|Adverse Event|1|||
145772654|NCT00893789|525676633|FG003|Overall Study|Adverse Event|5|||
145772655|NCT00893789|525676630|FG000|Overall Study|Protocol Violation|0|||
145772656|NCT00893789|525676631|FG001|Overall Study|Protocol Violation|1|||
145772657|NCT00893789|525676632|FG002|Overall Study|Protocol Violation|1|||
145772658|NCT00893789|525676633|FG003|Overall Study|Protocol Violation|4|||
145772659|NCT00893789|525676630|FG000|Overall Study|Lost to Follow-up|0|||
145772660|NCT00893789|525676631|FG001|Overall Study|Lost to Follow-up|0|||
145772661|NCT00893789|525676632|FG002|Overall Study|Lost to Follow-up|0|||
145772662|NCT00893789|525676633|FG003|Overall Study|Lost to Follow-up|1|||
145772663|NCT02024464|525676634|FG000|Overall Study|Discontinued|5|||
145772664|NCT02024464|525676635|FG001|Overall Study|Discontinued|4|||
145772665|NCT02024464|525676634|FG000|Overall Study|Missed Visits|1|||
145772666|NCT02024464|525676635|FG001|Overall Study|Missed Visits|0|||
145772667|NCT02024464|525676634|FG000|Overall Study|Lost to Follow-up|4|||
145772668|NCT02024464|525676635|FG001|Overall Study|Lost to Follow-up|7|||
145772669|NCT04419506|525676638|FG000|Overall Study|Adverse Event|0|||
145772670|NCT04419506|525676639|FG001|Overall Study|Adverse Event|10|||
145772671|NCT04419506|525676640|FG002|Overall Study|Adverse Event|0|||
145772672|NCT04419506|525676641|FG003|Overall Study|Adverse Event|3|||
145772673|NCT04419506|525676638|FG000|Overall Study|Withdrawal by Subject|0|||
145772674|NCT04419506|525676639|FG001|Overall Study|Withdrawal by Subject|0|||
145772675|NCT04419506|525676640|FG002|Overall Study|Withdrawal by Subject|0|||
145772676|NCT04419506|525676641|FG003|Overall Study|Withdrawal by Subject|1|||
145772677|NCT04419506|525676638|FG000|Overall Study|poor-compliance|0|||
145772678|NCT04419506|525676639|FG001|Overall Study|poor-compliance|0|||
145772679|NCT04419506|525676640|FG002|Overall Study|poor-compliance|0|||
145772680|NCT04419506|525676641|FG003|Overall Study|poor-compliance|1|||
145772681|NCT01845025|525676642|FG000|Overall Study|Adverse Event|6|||
145772682|NCT01845025|525676643|FG001|Overall Study|Adverse Event|3|||
145772683|NCT01845025|525676642|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145772684|NCT01845025|525676643|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145772685|NCT01845025|525676642|FG000|Overall Study|Withdrawal by Subject|48|||
145772686|NCT01845025|525676643|FG001|Overall Study|Withdrawal by Subject|44|||
145772687|NCT01845025|525676642|FG000|Overall Study|Lost to Follow-up|13|||
145772688|NCT01845025|525676643|FG001|Overall Study|Lost to Follow-up|13|||
145772689|NCT01845025|525676642|FG000|Overall Study|Administrative problems|8|||
145772690|NCT01845025|525676643|FG001|Overall Study|Administrative problems|8|||
145772691|NCT01845025|525676642|FG000|Overall Study|Death|2|||
145772692|NCT01845025|525676643|FG001|Overall Study|Death|0|||
145772693|NCT01845025|525676642|FG000|Overall Study|Protocol deviation|3|||
145772694|NCT01845025|525676643|FG001|Overall Study|Protocol deviation|6|||
145772695|NCT01845025|525676642|FG000|Overall Study|Missing|1|||
145772696|NCT01845025|525676643|FG001|Overall Study|Missing|1|||
145772697|NCT01973283|525676644|FG000|Overall Study|Lost to Follow-up|4|||
145772698|NCT00900796|525676649|FG000|Phase 1|Lacked sufficient information|4|||
145772699|NCT00900796|525676649|FG000|Phase 1|Missing information at Week 16|7|||
145772700|NCT00900796|525676649|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
145772701|NCT00900796|525676649|FG000|Phase 2|Lost to Follow-up|5|||
145772702|NCT02586805|525676650|FG000|Overall Study|Withdrawal by Subject|3|||
145772703|NCT02586805|525676651|FG001|Overall Study|Withdrawal by Subject|1|||
145772704|NCT02586805|525676652|FG002|Overall Study|Withdrawal by Subject|1|||
145772705|NCT02586805|525676653|FG003|Overall Study|Withdrawal by Subject|2|||
145534359|NCT02468232|524816912|FG002|OLE Part of Study|Subject/Guardian decision|2|||
145534360|NCT02468232|524816913|FG003|OLE Part of Study|Subject/Guardian decision|5|||
145534361|NCT02024529|524816916|FG000|Overall Study|Withdrawal by Subject|11|||
145534362|NCT02024529|524816917|FG001|Overall Study|Withdrawal by Subject|21|||
145534363|NCT02024529|524816916|FG000|Overall Study|Lost to Follow-up|2|||
145534364|NCT02024529|524816917|FG001|Overall Study|Lost to Follow-up|4|||
145534365|NCT00354614|524816918|FG000|Overall Study|Lack of Efficacy|28|||
145534366|NCT03650556|524816919|FG000|Overall Study|Death|2|||
145534367|NCT03650556|524816919|FG000|Overall Study|Withdrawal by Subject|20|||
145534368|NCT03650556|524816919|FG000|Overall Study|Physician Decision|2|||
145534369|NCT03650556|524816919|FG000|Overall Study|Lost to Follow-up|8|||
145534370|NCT03650556|524816919|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
145534371|NCT03650556|524816919|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
145534372|NCT02122458|524816922|FG000|Overall Study|Withdrawal by Subject|0|||
145534373|NCT02122458|524816923|FG001|Overall Study|Withdrawal by Subject|0|||
145534374|NCT02122458|524816924|FG002|Overall Study|Withdrawal by Subject|0|||
145534375|NCT02122458|524816925|FG003|Overall Study|Withdrawal by Subject|4|||
145534376|NCT02122458|524816926|FG004|Overall Study|Withdrawal by Subject|4|||
145534377|NCT02122458|524816927|FG005|Overall Study|Withdrawal by Subject|4|||
145534378|NCT02122458|524816928|FG006|Overall Study|Withdrawal by Subject|0|||
145534379|NCT02122458|524816922|FG000|Overall Study|Lost to Follow-up|1|||
145534380|NCT02122458|524816923|FG001|Overall Study|Lost to Follow-up|3|||
145534381|NCT02122458|524816924|FG002|Overall Study|Lost to Follow-up|0|||
145534382|NCT02122458|524816925|FG003|Overall Study|Lost to Follow-up|7|||
145534383|NCT02122458|524816926|FG004|Overall Study|Lost to Follow-up|5|||
145534384|NCT02122458|524816927|FG005|Overall Study|Lost to Follow-up|15|||
145534385|NCT02122458|524816928|FG006|Overall Study|Lost to Follow-up|1|||
145534386|NCT02122458|524816922|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
145534387|NCT02122458|524816923|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534388|NCT02122458|524816924|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534389|NCT02122458|524816925|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534390|NCT02122458|524816926|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534391|NCT02122458|524816927|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534392|NCT02122458|524816928|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
145534393|NCT02122458|524816922|FG000|Overall Study|Adverse Event|1|||
145534394|NCT02122458|524816923|FG001|Overall Study|Adverse Event|0|||
145534395|NCT02122458|524816924|FG002|Overall Study|Adverse Event|0|||
145534396|NCT02122458|524816925|FG003|Overall Study|Adverse Event|0|||
145534397|NCT02122458|524816926|FG004|Overall Study|Adverse Event|0|||
145534398|NCT02122458|524816927|FG005|Overall Study|Adverse Event|0|||
145534399|NCT02122458|524816928|FG006|Overall Study|Adverse Event|0|||
145534400|NCT02122458|524816922|FG000|Overall Study|Experimental Error|0|||
145534401|NCT02122458|524816923|FG001|Overall Study|Experimental Error|0|||
145534402|NCT02122458|524816924|FG002|Overall Study|Experimental Error|0|||
145534403|NCT02122458|524816925|FG003|Overall Study|Experimental Error|0|||
145534404|NCT02122458|524816926|FG004|Overall Study|Experimental Error|3|||
145534405|NCT02122458|524816927|FG005|Overall Study|Experimental Error|0|||
145534406|NCT02122458|524816928|FG006|Overall Study|Experimental Error|0|||
145534407|NCT02122458|524816922|FG000|Overall Study|Deployed or Moved|0|||
145534408|NCT02122458|524816923|FG001|Overall Study|Deployed or Moved|0|||
145534409|NCT02122458|524816924|FG002|Overall Study|Deployed or Moved|0|||
145534410|NCT02122458|524816925|FG003|Overall Study|Deployed or Moved|0|||
145534411|NCT02122458|524816926|FG004|Overall Study|Deployed or Moved|1|||
145534412|NCT02122458|524816927|FG005|Overall Study|Deployed or Moved|0|||
145534413|NCT02122458|524816928|FG006|Overall Study|Deployed or Moved|0|||
145534414|NCT02122458|524816922|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
145534415|NCT02122458|524816923|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
145534416|NCT02122458|524816924|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
145534417|NCT02122458|524816925|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
145534418|NCT02122458|524816926|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
145534419|NCT02122458|524816927|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
145772706|NCT02586805|525676650|FG000|Overall Study|Adverse Event|2|||
145278761|NCT04380701|523870872|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278762|NCT04380701|523870873|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278763|NCT04380701|523870874|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278764|NCT04380701|523870875|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278765|NCT04380701|523870876|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278766|NCT04380701|523870877|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278767|NCT04380701|523870878|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278768|NCT04380701|523870879|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278769|NCT04380701|523870880|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
145278770|NCT00558519|523870881|FG000|Overall Study|Ph+|20|||
145278771|NCT00558519|523870881|FG000|Overall Study|Ineligible|1|||
145278772|NCT00558519|523870881|FG000|Overall Study|Insufficient data|1|||
145278773|NCT00558519|523870881|FG000|Overall Study|Never received treatment|1|||
145278774|NCT02556632|523870886|FG000|Overall Study|Lost to Follow-up|1|||
145278775|NCT02556632|523870887|FG001|Overall Study|Lost to Follow-up|0|||
145278776|NCT02556632|523870888|FG002|Overall Study|Lost to Follow-up|0|||
145278777|NCT02556632|523870886|FG000|Overall Study|Disliked Intervention|1|||
145278778|NCT02556632|523870887|FG001|Overall Study|Disliked Intervention|1|||
145278779|NCT02556632|523870888|FG002|Overall Study|Disliked Intervention|1|||
145278780|NCT02556632|523870886|FG000|Overall Study|No Reason|1|||
145278781|NCT02556632|523870887|FG001|Overall Study|No Reason|0|||
145278782|NCT02556632|523870888|FG002|Overall Study|No Reason|1|||
145534420|NCT02122458|524816928|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
145534421|NCT02122458|524816922|FG000|Overall Study|Noncompliance|0|||
145534422|NCT02122458|524816923|FG001|Overall Study|Noncompliance|1|||
145534423|NCT02122458|524816924|FG002|Overall Study|Noncompliance|0|||
145534424|NCT02122458|524816925|FG003|Overall Study|Noncompliance|0|||
145534425|NCT02122458|524816926|FG004|Overall Study|Noncompliance|0|||
145534426|NCT02122458|524816927|FG005|Overall Study|Noncompliance|0|||
145534427|NCT02122458|524816928|FG006|Overall Study|Noncompliance|0|||
145772707|NCT02586805|525676651|FG001|Overall Study|Adverse Event|0|||
145772708|NCT02586805|525676652|FG002|Overall Study|Adverse Event|1|||
145772709|NCT02586805|525676653|FG003|Overall Study|Adverse Event|0|||
145772710|NCT02586805|525676650|FG000|Overall Study|Lost to Follow-up|0|||
145772711|NCT02586805|525676651|FG001|Overall Study|Lost to Follow-up|0|||
145772712|NCT02586805|525676652|FG002|Overall Study|Lost to Follow-up|1|||
145772713|NCT02586805|525676653|FG003|Overall Study|Lost to Follow-up|0|||
145772714|NCT02586805|525676650|FG000|Overall Study|Physician Decision|1|||
145772715|NCT02586805|525676651|FG001|Overall Study|Physician Decision|0|||
145772716|NCT02586805|525676652|FG002|Overall Study|Physician Decision|0|||
145772717|NCT02586805|525676653|FG003|Overall Study|Physician Decision|0|||
145772718|NCT01859403|525676654|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
145772719|NCT01859403|525676655|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
145772720|NCT01859403|525676654|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
145772721|NCT01859403|525676655|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
145772722|NCT01859403|525676654|FG000|Primary Endpoint Measure|Physician Decision|0|||
145534428|NCT02833350|524816929|FG000|Overall Study|Adverse Event|0|||
145772723|NCT01859403|525676655|FG001|Primary Endpoint Measure|Physician Decision|1|||
145772724|NCT01859403|525676654|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
145772725|NCT01859403|525676655|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
145772726|NCT00813748|525676657|FG000|Skin Test Substudy|Physician Decision|0|||
145772727|NCT00813748|525676658|FG001|Skin Test Substudy|Physician Decision|1|||
145772728|NCT03185130|525676661|FG000|Overall Study|Withdrawal by Subject|0|||
145772729|NCT03185130|525676662|FG001|Overall Study|Withdrawal by Subject|2|||
145278783|NCT02556632|523870886|FG000|Overall Study|Personal Issues|0|||
145278784|NCT02556632|523870887|FG001|Overall Study|Personal Issues|1|||
145278785|NCT02556632|523870888|FG002|Overall Study|Personal Issues|1|||
145278786|NCT02556632|523870886|FG000|Overall Study|Changed Mind|0|||
145278787|NCT02556632|523870887|FG001|Overall Study|Changed Mind|1|||
145278788|NCT02556632|523870888|FG002|Overall Study|Changed Mind|0|||
145278789|NCT02556632|523870886|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
145278790|NCT02556632|523870887|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
145772730|NCT03486314|525676669|FG000|Part A|Adverse Event|1|||
145278791|NCT02556632|523870888|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
145278792|NCT02556632|523870886|FG000|Overall Study|Unrelated Adverse Event|1|||
145278793|NCT02556632|523870887|FG001|Overall Study|Unrelated Adverse Event|0|||
145278794|NCT02556632|523870888|FG002|Overall Study|Unrelated Adverse Event|3|||
145278795|NCT02556632|523870886|FG000|Overall Study|Related Adverse Event|0|||
145278796|NCT02556632|523870887|FG001|Overall Study|Related Adverse Event|1|||
145534429|NCT02833350|524816930|FG001|Overall Study|Adverse Event|3|||
145278797|NCT02556632|523870888|FG002|Overall Study|Related Adverse Event|0|||
145278798|NCT02556632|523870886|FG000|Overall Study|Possibly Related Adverse Event|0|||
145292772|NCT06179108|523922229|FG003|Overall Study|Death|1|||
145772731|NCT03486314|525676670|FG001|Part A|Adverse Event|0|||
145772732|NCT03486314|525676671|FG002|Part A|Adverse Event|0|||
145772733|NCT03486314|525676669|FG000|Part A|Symptomatic Deterioration|2|||
145772734|NCT03486314|525676670|FG001|Part A|Symptomatic Deterioration|0|||
145772735|NCT03486314|525676671|FG002|Part A|Symptomatic Deterioration|0|||
145772736|NCT00465569|525676672|FG000|Overall Study|persistent eczema during dose escalation|1|||
145772737|NCT00465569|525676673|FG001|Overall Study|persistent eczema during dose escalation|0|||
145772738|NCT01985321|525676675|FG000|Overall Study|Protocol Violation|4|||
145772739|NCT01985321|525676676|FG001|Overall Study|Protocol Violation|3|||
145772740|NCT01985321|525676675|FG000|Overall Study|Withdrawal by Subject|1|||
145772741|NCT01985321|525676676|FG001|Overall Study|Withdrawal by Subject|0|||
145772742|NCT01985321|525676675|FG000|Overall Study|Lost to Follow-up|5|||
145772743|NCT01985321|525676676|FG001|Overall Study|Lost to Follow-up|2|||
145772744|NCT01985321|525676675|FG000|Overall Study|Subject treated wrong type of sore|1|||
145772745|NCT01985321|525676676|FG001|Overall Study|Subject treated wrong type of sore|0|||
145772746|NCT03826914|525676677|FG000|Overall Study|Withdrawal by Subject|1|||
145772747|NCT03826914|525676678|FG001|Overall Study|Withdrawal by Subject|1|||
145772748|NCT04283461|525676681|FG000|Overall Study|Enrolled in separate trial|0|||
145772749|NCT04283461|525676682|FG001|Overall Study|Enrolled in separate trial|0|||
145772750|NCT04283461|525676683|FG002|Overall Study|Enrolled in separate trial|8|||
145772751|NCT04283461|525676684|FG003|Overall Study|Enrolled in separate trial|13|||
145772752|NCT04283461|525676685|FG004|Overall Study|Enrolled in separate trial|12|||
145772753|NCT04283461|525676686|FG005|Overall Study|Enrolled in separate trial|0|||
145772754|NCT04283461|525676687|FG006|Overall Study|Enrolled in separate trial|0|||
145772755|NCT04283461|525676688|FG007|Overall Study|Enrolled in separate trial|8|||
145772756|NCT04283461|525676689|FG008|Overall Study|Enrolled in separate trial|0|||
145772757|NCT04283461|525676690|FG009|Overall Study|Enrolled in separate trial|0|||
145278799|NCT02556632|523870887|FG001|Overall Study|Possibly Related Adverse Event|0|||
145278800|NCT02556632|523870888|FG002|Overall Study|Possibly Related Adverse Event|1|||
145278801|NCT02556632|523870886|FG000|Overall Study|Did Not Start RT|0|||
145278802|NCT02556632|523870887|FG001|Overall Study|Did Not Start RT|1|||
145278803|NCT02556632|523870888|FG002|Overall Study|Did Not Start RT|0|||
145278804|NCT02556632|523870886|FG000|Overall Study|Ineligible|0|||
145278805|NCT02556632|523870887|FG001|Overall Study|Ineligible|1|||
145278806|NCT02556632|523870888|FG002|Overall Study|Ineligible|0|||
145278807|NCT02556632|523870886|FG000|Overall Study|Disliked Study Procedures|0|||
145278808|NCT02556632|523870887|FG001|Overall Study|Disliked Study Procedures|0|||
145278809|NCT02556632|523870888|FG002|Overall Study|Disliked Study Procedures|1|||
145278810|NCT02556632|523870886|FG000|Overall Study|Treatment or Change Delay|0|||
145278811|NCT02556632|523870887|FG001|Overall Study|Treatment or Change Delay|0|||
145278812|NCT02556632|523870888|FG002|Overall Study|Treatment or Change Delay|1|||
145278813|NCT00808015|523870889|FG000|Overall Study|Death|1|||
145278814|NCT00808015|523870889|FG000|Overall Study|Lack of Efficacy|58|||
145278815|NCT00808015|523870889|FG000|Overall Study|Lost to Follow-up|76|||
145278816|NCT00808015|523870889|FG000|Overall Study|Participants not willing to participate|158|||
145278817|NCT00808015|523870889|FG000|Overall Study|Adverse Event|22|||
145278818|NCT00808015|523870889|FG000|Overall Study|Other|25|||
145278819|NCT00808015|523870889|FG000|Overall Study|Enrolled but not treated|4|||
145278820|NCT04556838|523870895|FG000|Overall Study|Withdrawal by Subject|3|||
145278821|NCT04556838|523870896|FG001|Overall Study|Withdrawal by Subject|1|||
145278822|NCT04556838|523870897|FG002|Overall Study|Withdrawal by Subject|2|||
145278823|NCT04556838|523870895|FG000|Overall Study|Adverse Event|0|||
145278824|NCT04556838|523870896|FG001|Overall Study|Adverse Event|1|||
145278825|NCT04556838|523870897|FG002|Overall Study|Adverse Event|1|||
145278826|NCT04556838|523870895|FG000|Overall Study|Lost to Follow-up|0|||
145278827|NCT04556838|523870896|FG001|Overall Study|Lost to Follow-up|0|||
145278828|NCT04556838|523870897|FG002|Overall Study|Lost to Follow-up|2|||
145772758|NCT04283461|525676691|FG010|Overall Study|Enrolled in separate trial|0|||
145772759|NCT04283461|525676692|FG011|Overall Study|Enrolled in separate trial|7|||
145278829|NCT04556838|523870895|FG000|Overall Study|Subject travel|0|||
145278830|NCT04556838|523870896|FG001|Overall Study|Subject travel|1|||
145278831|NCT04556838|523870897|FG002|Overall Study|Subject travel|0|||
145278832|NCT04556838|523870895|FG000|Overall Study|Physician Decision|1|||
145278833|NCT04556838|523870896|FG001|Overall Study|Physician Decision|0|||
145278834|NCT04556838|523870897|FG002|Overall Study|Physician Decision|0|||
145772760|NCT04283461|525676693|FG012|Overall Study|Enrolled in separate trial|0|||
145278835|NCT04523831|523870898|FG000|Overall Study|Lost to Follow-up|15|||
145772761|NCT03133767|525676701|FG000|Overall Study|Lost to Follow-up|38|||
145772762|NCT03133767|525676702|FG001|Overall Study|Lost to Follow-up|24|||
145772763|NCT03133767|525676701|FG000|Overall Study|Protocol Violation|0|||
145772764|NCT03133767|525676702|FG001|Overall Study|Protocol Violation|1|||
145772765|NCT05502289|525676705|FG000|Period 1|Out Of Window|1|||
145772766|NCT05502289|525676706|FG001|Period 1|Out Of Window|0|||
145772767|NCT00613626|525676707|FG000|Overall Study|Ineligible|0|||
145772768|NCT00613626|525676708|FG001|Overall Study|Ineligible|1|||
145772769|NCT00613626|525676709|FG002|Overall Study|Ineligible|0|||
145772770|NCT04375878|525676712|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
145772771|NCT04375878|525676713|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
145772772|NCT04375878|525676714|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
145772773|NCT04375878|525676715|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
145772774|NCT04375878|525676716|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
145772775|NCT04375878|525676717|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
145772776|NCT04375878|525676712|FG000|Crossover First and Second Interventions|Adverse Event|0|||
145772777|NCT04375878|525676713|FG001|Crossover First and Second Interventions|Adverse Event|0|||
145772778|NCT04375878|525676714|FG002|Crossover First and Second Interventions|Adverse Event|1|||
145772779|NCT04375878|525676715|FG003|Crossover First and Second Interventions|Adverse Event|0|||
145772780|NCT04375878|525676716|FG004|Crossover First and Second Interventions|Adverse Event|0|||
145772781|NCT04375878|525676717|FG005|Crossover First and Second Interventions|Adverse Event|0|||
145772782|NCT04375878|525676712|FG000|Extension Phase|Withdrawal by Subject|0|||
145772783|NCT04375878|525676713|FG001|Extension Phase|Withdrawal by Subject|0|||
145772784|NCT04375878|525676714|FG002|Extension Phase|Withdrawal by Subject|0|||
145772785|NCT04375878|525676715|FG003|Extension Phase|Withdrawal by Subject|0|||
145772786|NCT04375878|525676716|FG004|Extension Phase|Withdrawal by Subject|1|||
145772787|NCT04375878|525676717|FG005|Extension Phase|Withdrawal by Subject|0|||
145772788|NCT00816036|525676720|FG000|Overall Study|Death|47|||
145772789|NCT00816036|525676721|FG001|Overall Study|Death|28|||
145772790|NCT00816036|525676720|FG000|Overall Study|Lost to Follow-up|75|||
145772791|NCT00816036|525676721|FG001|Overall Study|Lost to Follow-up|57|||
145772792|NCT00816036|525676720|FG000|Overall Study|Withdrawal by Subject|54|||
145772793|NCT00816036|525676721|FG001|Overall Study|Withdrawal by Subject|23|||
145772794|NCT01299025|525676722|FG000|Overall Study|Withdrawal by Subject|2|||
145772795|NCT01299025|525676723|FG001|Overall Study|Withdrawal by Subject|1|||
145772796|NCT01299025|525676722|FG000|Overall Study|Lost to Follow-up|1|||
145772797|NCT01299025|525676723|FG001|Overall Study|Lost to Follow-up|0|||
145772798|NCT00004980|525676724|FG000|Overall Study|Withdrawal by Subject|1|||
145772799|NCT00004980|525676725|FG001|Overall Study|Withdrawal by Subject|0|||
145772800|NCT00004980|525676724|FG000|Overall Study|memory difficulties|1|||
145772801|NCT00004980|525676725|FG001|Overall Study|memory difficulties|1|||
145772802|NCT00004980|525676724|FG000|Overall Study|Physician Decision|0|||
145772803|NCT00004980|525676725|FG001|Overall Study|Physician Decision|1|||
145772804|NCT01624194|525676726|FG000|Overall Study|Lost to Follow-up|1|||
145772805|NCT01624194|525676727|FG001|Overall Study|Lost to Follow-up|0|||
145772806|NCT01624194|525676726|FG000|Overall Study|Withdrawal by Subject|1|||
145772807|NCT01624194|525676727|FG001|Overall Study|Withdrawal by Subject|0|||
145772808|NCT03212261|525676728|FG000|Overall Study|Became ineligible d/t tech|2|||
145772809|NCT03212261|525676728|FG000|Overall Study|Tech Trouble- No first study visit|1|||
145772810|NCT03212261|525676728|FG000|Overall Study|Lost to Follow-up|7|||
145772811|NCT03212261|525676728|FG000|Overall Study|Family Emergency|1|||
145772812|NCT03212261|525676728|FG000|Overall Study|Too busy/ No time|5|||
145772813|NCT05480514|525676729|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
145772814|NCT05480514|525676730|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
145772815|NCT05480514|525676729|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
145772816|NCT05480514|525676730|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
145772817|NCT05480514|525676729|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145772818|NCT05480514|525676730|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
145772819|NCT05480514|525676729|FG000|Period 1|Covid-19 Related|1|||
145772820|NCT05480514|525676730|FG001|Period 1|Covid-19 Related|0|||
145772821|NCT05480514|525676729|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
145772822|NCT05480514|525676730|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
145772823|NCT00820040|525676731|FG000|Overall Study|Death|1|||
145772824|NCT00820040|525676731|FG000|Overall Study|Sponsor terminated study|1|||
145772825|NCT00820040|525676731|FG000|Overall Study|Screen failure|1|||
145772826|NCT00761215|525676734|FG000|Overall Study|Randomized but didn't receive drug|1|||
145772827|NCT00761215|525676735|FG001|Overall Study|Randomized but didn't receive drug|1|||
145772828|NCT00761215|525676736|FG002|Overall Study|Randomized but didn't receive drug|2|||
145772829|NCT00761215|525676734|FG000|Overall Study|Lost to Follow-up|6|||
145772830|NCT00761215|525676735|FG001|Overall Study|Lost to Follow-up|3|||
145772831|NCT00761215|525676736|FG002|Overall Study|Lost to Follow-up|6|||
145772832|NCT00761215|525676734|FG000|Overall Study|Withdrawal by Subject|1|||
145772833|NCT00761215|525676735|FG001|Overall Study|Withdrawal by Subject|0|||
145772834|NCT00761215|525676736|FG002|Overall Study|Withdrawal by Subject|0|||
145772835|NCT00761215|525676734|FG000|Overall Study|Bacteremia|1|||
145772836|NCT00761215|525676735|FG001|Overall Study|Bacteremia|0|||
145772837|NCT00761215|525676736|FG002|Overall Study|Bacteremia|0|||
145772838|NCT00519532|525676737|FG000|Overall Study|Adverse Event|11|||
145772839|NCT00519532|525676737|FG000|Overall Study|Withdrawal by Subject|5|||
145772840|NCT00519532|525676737|FG000|Overall Study|Lost to Follow-up|2|||
145772841|NCT00667277|525676738|FG000|Overall Study|Withdrawal by Subject|2|||
145772842|NCT03885284|525676740|FG000|Overall Study|Disease Progression|1|||
145772843|NCT03885284|525676741|FG001|Overall Study|Disease Progression|3|||
145772844|NCT03885284|525676740|FG000|Overall Study|Physician Decision|0|||
145772845|NCT03885284|525676741|FG001|Overall Study|Physician Decision|1|||
145772846|NCT00002850|525676746|FG000|Overall Study|Death|4|||
145772847|NCT00002850|525676747|FG001|Overall Study|Death|1|||
145772848|NCT00002850|525676748|FG002|Overall Study|Death|3|||
145772849|NCT00002850|525676746|FG000|Overall Study|Protocol Violation|1|||
145772850|NCT00002850|525676747|FG001|Overall Study|Protocol Violation|0|||
145772851|NCT00002850|525676748|FG002|Overall Study|Protocol Violation|1|||
145772852|NCT00002850|525676746|FG000|Overall Study|Withdrawal by Subject|0|||
145772853|NCT00002850|525676747|FG001|Overall Study|Withdrawal by Subject|1|||
145772854|NCT00002850|525676748|FG002|Overall Study|Withdrawal by Subject|0|||
145772855|NCT02932267|525676749|FG000|Overall Study|Withdrawal by Subject|3|||
145772856|NCT02932267|525676749|FG000|Overall Study|Lost to Follow-up|4|||
145772857|NCT02932267|525676749|FG000|Overall Study|Pregnancy|1|||
145772858|NCT03476239|525676750|FG000|Overall Study|Withdrawal by Subject|10|||
145772859|NCT03476239|525676750|FG000|Overall Study|Death|80|||
145772860|NCT03476239|525676750|FG000|Overall Study|Lost to Follow-up|8|||
145772861|NCT04909463|525678239|FG000|Overall Study|Withdrawal by Subject|0|||
145772862|NCT04909463|525678240|FG001|Overall Study|Withdrawal by Subject|1|||
145772863|NCT04909463|525678241|FG002|Overall Study|Withdrawal by Subject|0|||
145772864|NCT04909463|525678242|FG003|Overall Study|Withdrawal by Subject|0|||
145772865|NCT04909463|525678239|FG000|Overall Study|Lost to Follow-up|2|||
145772866|NCT04909463|525678240|FG001|Overall Study|Lost to Follow-up|1|||
145772867|NCT04909463|525678241|FG002|Overall Study|Lost to Follow-up|1|||
145772868|NCT04909463|525678242|FG003|Overall Study|Lost to Follow-up|0|||
145772869|NCT00853632|525678243|FG000|Overall Study|Death|88|||
145772870|NCT00853632|525678243|FG000|Overall Study|Withdrawal by Subject|45|||
145772871|NCT00853632|525678243|FG000|Overall Study|Lost to Follow-up|30|||
145772872|NCT00853632|525678243|FG000|Overall Study|Reoperation/Explant|17|||
145772873|NCT00853632|525678243|FG000|Overall Study|Exit with other reason|22|||
145772874|NCT04493619|525678245|FG000|Overall Study|Death|4|||
145772875|NCT04493619|525678246|FG001|Overall Study|Death|3|||
145772876|NCT04493619|525678247|FG002|Overall Study|Death|3|||
145772877|NCT04493619|525678248|FG003|Overall Study|Death|4|||
145772878|NCT04493619|525678245|FG000|Overall Study|Study discontinued early|10|||
145772879|NCT04493619|525678246|FG001|Overall Study|Study discontinued early|0|||
145772880|NCT04493619|525678247|FG002|Overall Study|Study discontinued early|4|||
145772881|NCT04493619|525678248|FG003|Overall Study|Study discontinued early|8|||
145772882|NCT04493619|525678245|FG000|Overall Study|Lost to Follow-up|0|||
145772883|NCT04493619|525678246|FG001|Overall Study|Lost to Follow-up|0|||
145772884|NCT04493619|525678247|FG002|Overall Study|Lost to Follow-up|0|||
145772885|NCT04493619|525678248|FG003|Overall Study|Lost to Follow-up|1|||
145772886|NCT00875420|525678259|FG000|Overall Study|Adverse Event|0|||
145772887|NCT00875420|525678260|FG001|Overall Study|Adverse Event|1|||
145772888|NCT00875420|525678261|FG002|Overall Study|Adverse Event|1|||
145772889|NCT00875420|525678262|FG003|Overall Study|Adverse Event|0|||
145772890|NCT00875420|525678263|FG004|Overall Study|Adverse Event|0|||
145772891|NCT00875420|525678259|FG000|Overall Study|Inability to complete study procedures|1|||
145772892|NCT00875420|525678260|FG001|Overall Study|Inability to complete study procedures|0|||
145772893|NCT00875420|525678261|FG002|Overall Study|Inability to complete study procedures|1|||
145772894|NCT00875420|525678262|FG003|Overall Study|Inability to complete study procedures|1|||
145772895|NCT00875420|525678263|FG004|Overall Study|Inability to complete study procedures|1|||
145772896|NCT00875420|525678259|FG000|Overall Study|Lost to Follow-up|1|||
145772897|NCT00875420|525678260|FG001|Overall Study|Lost to Follow-up|0|||
145772898|NCT00875420|525678261|FG002|Overall Study|Lost to Follow-up|0|||
145772899|NCT00875420|525678262|FG003|Overall Study|Lost to Follow-up|0|||
145772900|NCT00875420|525678263|FG004|Overall Study|Lost to Follow-up|0|||
145772901|NCT00875420|525678259|FG000|Overall Study|Personal reason|0|||
145772902|NCT00875420|525678260|FG001|Overall Study|Personal reason|0|||
145772903|NCT00875420|525678261|FG002|Overall Study|Personal reason|0|||
145772904|NCT00875420|525678262|FG003|Overall Study|Personal reason|0|||
145772905|NCT00875420|525678263|FG004|Overall Study|Personal reason|1|||
145772906|NCT00875420|525678259|FG000|Overall Study|Prohibited medication|0|||
145772907|NCT00875420|525678260|FG001|Overall Study|Prohibited medication|0|||
145772908|NCT00875420|525678261|FG002|Overall Study|Prohibited medication|0|||
145772909|NCT00875420|525678262|FG003|Overall Study|Prohibited medication|1|||
145772910|NCT00875420|525678263|FG004|Overall Study|Prohibited medication|0|||
145772911|NCT00875420|525678259|FG000|Overall Study|Sponsor decision|0|||
145772912|NCT00875420|525678260|FG001|Overall Study|Sponsor decision|1|||
145772913|NCT00875420|525678261|FG002|Overall Study|Sponsor decision|0|||
145608228|NCT03285295|525080947|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
145608229|NCT03285295|525080948|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
145608230|NCT03285295|525080949|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
145608231|NCT03285295|525080945|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
145608232|NCT03285295|525080946|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
145608233|NCT03285295|525080947|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
145608234|NCT03285295|525080948|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
145608235|NCT03285295|525080949|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
145608236|NCT03285295|525080945|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
145608237|NCT03285295|525080946|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
145608238|NCT03285295|525080947|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
145608239|NCT03285295|525080948|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
145608240|NCT03285295|525080949|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
145608241|NCT03285295|525080945|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
145608242|NCT03285295|525080946|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
145772914|NCT00875420|525678262|FG003|Overall Study|Sponsor decision|0|||
145772915|NCT00875420|525678263|FG004|Overall Study|Sponsor decision|0|||
145772916|NCT00875420|525678259|FG000|Overall Study|Withdrawal by Subject|0|||
145772917|NCT00875420|525678260|FG001|Overall Study|Withdrawal by Subject|0|||
145772918|NCT00875420|525678261|FG002|Overall Study|Withdrawal by Subject|1|||
145772919|NCT00875420|525678262|FG003|Overall Study|Withdrawal by Subject|0|||
145772920|NCT00875420|525678263|FG004|Overall Study|Withdrawal by Subject|0|||
145772921|NCT03716726|525678264|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
145608243|NCT03285295|525080947|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
145608244|NCT03285295|525080948|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
145608245|NCT03285295|525080949|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
145608246|NCT03285295|525080945|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
145608247|NCT03285295|525080946|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
145608248|NCT03285295|525080947|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
145608249|NCT03285295|525080948|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
145608250|NCT03285295|525080949|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
145608251|NCT03285295|525080945|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
145608252|NCT03285295|525080946|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
145608253|NCT03285295|525080947|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
145608254|NCT03285295|525080948|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
145608255|NCT03285295|525080949|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
145608256|NCT03285295|525080945|FG000|Alinity s Anti-HBc|No Results Generated|70|||
145608257|NCT03285295|525080946|FG001|Alinity s Anti-HBc|No Results Generated|0|||
145608258|NCT03285295|525080947|FG002|Alinity s Anti-HBc|No Results Generated|0|||
145772922|NCT03716726|525678265|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
145772923|NCT03716726|525678264|FG000|12 Months Followup|Lost to Follow-up|10|||
145772924|NCT03716726|525678265|FG001|12 Months Followup|Lost to Follow-up|17|||
145772925|NCT02579603|525678266|FG000|Overall Study|Not treated|1|||
145772926|NCT02579603|525678267|FG001|Overall Study|Not treated|0|||
145772927|NCT02579603|525678266|FG000|Overall Study|Adverse Event|2|||
145772928|NCT02579603|525678267|FG001|Overall Study|Adverse Event|2|||
145772929|NCT02579603|525678266|FG000|Overall Study|Other than stated|1|||
145772930|NCT02579603|525678267|FG001|Overall Study|Other than stated|0|||
145772931|NCT00469079|525678268|FG000|Overall Study|Lack of Efficacy|3|||
145772932|NCT00469079|525678269|FG001|Overall Study|Lack of Efficacy|8|||
145772933|NCT00469079|525678270|FG002|Overall Study|Lack of Efficacy|5|||
145772934|NCT00469079|525678268|FG000|Overall Study|Adverse Event|1|||
145772935|NCT00469079|525678269|FG001|Overall Study|Adverse Event|3|||
145772936|NCT00469079|525678270|FG002|Overall Study|Adverse Event|2|||
145772937|NCT00469079|525678268|FG000|Overall Study|Lost to Follow-up|4|||
145772938|NCT00469079|525678269|FG001|Overall Study|Lost to Follow-up|8|||
145772939|NCT00469079|525678270|FG002|Overall Study|Lost to Follow-up|10|||
145772940|NCT00469079|525678268|FG000|Overall Study|Withdrawal by Subject|1|||
145772941|NCT00469079|525678269|FG001|Overall Study|Withdrawal by Subject|2|||
145772942|NCT00469079|525678270|FG002|Overall Study|Withdrawal by Subject|2|||
145772943|NCT00469079|525678268|FG000|Overall Study|Ineligible|0|||
145772944|NCT00469079|525678269|FG001|Overall Study|Ineligible|1|||
145772945|NCT00469079|525678270|FG002|Overall Study|Ineligible|0|||
145772946|NCT01006356|525678274|FG000|Overall Study|Adverse Event|6|||
145772947|NCT01006356|525678274|FG000|Overall Study|Physician Decision|1|||
145772948|NCT01006356|525678274|FG000|Overall Study|Paticipants did not cooperate|6|||
145772949|NCT01006356|525678274|FG000|Overall Study|Withdrawal by Subject|1|||
145772950|NCT01006356|525678274|FG000|Overall Study|Choice by participants|2|||
145772951|NCT01006356|525678274|FG000|Overall Study|Protocol Violation|3|||
145772952|NCT01006356|525678274|FG000|Overall Study|Other|23|||
145772953|NCT02981472|525678276|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
145772954|NCT02981472|525678277|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
145772955|NCT02981472|525678276|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145772956|NCT02981472|525678277|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145772957|NCT02981472|525678276|FG000|Treatment Period|Adverse Event|6|||
145772958|NCT02981472|525678277|FG001|Treatment Period|Adverse Event|1|||
145772959|NCT02981472|525678276|FG000|Treatment Period|Participant withdrew consent|1|||
145772960|NCT02981472|525678277|FG001|Treatment Period|Participant withdrew consent|0|||
145772961|NCT02981472|525678276|FG000|Treatment Period|Lost to Follow-up|0|||
145772962|NCT02981472|525678277|FG001|Treatment Period|Lost to Follow-up|1|||
145772963|NCT02799381|525678280|FG000|Overall Study|Withdrew consent|3|||
145772964|NCT02799381|525678281|FG001|Overall Study|Withdrew consent|2|||
145772965|NCT02799381|525678280|FG000|Overall Study|Adverse Event|0|||
145772966|NCT02799381|525678281|FG001|Overall Study|Adverse Event|1|||
145772967|NCT02799381|525678280|FG000|Overall Study|Participant did not take any study drug|1|||
145772968|NCT02799381|525678281|FG001|Overall Study|Participant did not take any study drug|0|||
145403478|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145772969|NCT02698410|525678282|FG000|Overall Study|Adverse Event|2|||
145772970|NCT02698410|525678282|FG000|Overall Study|Withdrawal by Subject|1|||
145772971|NCT02698410|525678282|FG000|Overall Study|Other|1|||
145772972|NCT03952130|525678283|FG000|Overall Study|Adverse Event|0|||
145403479|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145608259|NCT03285295|525080948|FG003|Alinity s Anti-HBc|No Results Generated|0|||
145608260|NCT03285295|525080949|FG004|Alinity s Anti-HBc|No Results Generated|0|||
145608261|NCT03285295|525080945|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
145772973|NCT03952130|525678284|FG001|Overall Study|Adverse Event|1|||
145772974|NCT03952130|525678283|FG000|Overall Study|Lost to Follow-up|1|||
145772975|NCT03952130|525678284|FG001|Overall Study|Lost to Follow-up|0|||
145772976|NCT03952130|525678283|FG000|Overall Study|Withdrawal by Subject|1|||
145772977|NCT03952130|525678284|FG001|Overall Study|Withdrawal by Subject|5|||
145772978|NCT02638012|525678286|FG000|Overall Study|Lost to Follow-up|1|||
145772979|NCT02559505|525678292|FG000|Overall Study|Lost to Follow-up|23|||
145772980|NCT02559505|525678293|FG001|Overall Study|Lost to Follow-up|20|||
145772981|NCT02559505|525678292|FG000|Overall Study|Withdrawal by Subject|4|||
145772982|NCT02559505|525678293|FG001|Overall Study|Withdrawal by Subject|2|||
145772983|NCT03523585|525678294|FG000|Overall Study|Progressive Disease|174|||
145772984|NCT03523585|525678295|FG001|Overall Study|Progressive Disease|64|||
145772985|NCT03523585|525678296|FG002|Overall Study|Progressive Disease|77|||
145772986|NCT03523585|525678294|FG000|Overall Study|Adverse Event|74|||
145772987|NCT03523585|525678295|FG001|Overall Study|Adverse Event|5|||
145772988|NCT03523585|525678296|FG002|Overall Study|Adverse Event|9|||
145772989|NCT03523585|525678294|FG000|Overall Study|Withdrawal by Subject|30|||
145772990|NCT03523585|525678295|FG001|Overall Study|Withdrawal by Subject|11|||
145772991|NCT03523585|525678296|FG002|Overall Study|Withdrawal by Subject|6|||
145772992|NCT03523585|525678294|FG000|Overall Study|Clinical Progression|23|||
145772993|NCT03523585|525678295|FG001|Overall Study|Clinical Progression|5|||
145772994|NCT03523585|525678296|FG002|Overall Study|Clinical Progression|10|||
145772995|NCT03523585|525678294|FG000|Overall Study|Death|4|||
145772996|NCT03523585|525678295|FG001|Overall Study|Death|0|||
145772997|NCT03523585|525678296|FG002|Overall Study|Death|1|||
145772998|NCT03523585|525678294|FG000|Overall Study|Physician Decision|2|||
145772999|NCT03523585|525678295|FG001|Overall Study|Physician Decision|1|||
145773000|NCT03523585|525678296|FG002|Overall Study|Physician Decision|0|||
145773001|NCT03523585|525678294|FG000|Overall Study|Lost to Follow-up|1|||
145773002|NCT03523585|525678295|FG001|Overall Study|Lost to Follow-up|0|||
145773003|NCT03523585|525678296|FG002|Overall Study|Lost to Follow-up|0|||
145773004|NCT03523585|525678294|FG000|Overall Study|Miscellaneous|1|||
145773005|NCT03523585|525678295|FG001|Overall Study|Miscellaneous|0|||
145773006|NCT03523585|525678296|FG002|Overall Study|Miscellaneous|0|||
145773007|NCT03523585|525678294|FG000|Overall Study|Protocol Deviation|1|||
145773008|NCT03523585|525678295|FG001|Overall Study|Protocol Deviation|0|||
145773009|NCT03523585|525678296|FG002|Overall Study|Protocol Deviation|1|||
145773010|NCT03523585|525678294|FG000|Overall Study|Randomized But Not Treated|2|||
145773011|NCT03523585|525678295|FG001|Overall Study|Randomized But Not Treated|4|||
145773012|NCT03523585|525678296|FG002|Overall Study|Randomized But Not Treated|3|||
145773013|NCT01473004|525678297|FG000|Overall Study|Incomplete Lobar Treatment|1|||
145773014|NCT01473004|525678298|FG001|Overall Study|Incomplete Lobar Treatment|0|||
145773015|NCT05882890|525678299|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
145773016|NCT00613314|525678300|FG000|Overall Study|Adverse Event|5|||
145773017|NCT00613314|525678300|FG000|Overall Study|Protocol Violation|14|||
145773018|NCT00613314|525678300|FG000|Overall Study|Lost to Follow-up|46|||
145773019|NCT00613314|525678300|FG000|Overall Study|Other reason not defined above|90|||
145773020|NCT04331899|525678301|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
145773021|NCT04331899|525678302|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
145773022|NCT02424539|525678303|FG000|Overall Study|Adverse Event|0|||
145773023|NCT02424539|525678304|FG001|Overall Study|Adverse Event|0|||
145773024|NCT02424539|525678305|FG002|Overall Study|Adverse Event|1|||
145773025|NCT02424539|525678303|FG000|Overall Study|Physician Decision|0|||
145773026|NCT02424539|525678304|FG001|Overall Study|Physician Decision|0|||
145773027|NCT02424539|525678305|FG002|Overall Study|Physician Decision|1|||
145773028|NCT02424539|525678303|FG000|Overall Study|Withdrawal by Subject|3|||
145534430|NCT02833350|524816931|FG002|Overall Study|Adverse Event|4|||
145534431|NCT02833350|524816932|FG003|Overall Study|Adverse Event|4|||
145534432|NCT02833350|524816933|FG004|Overall Study|Adverse Event|1|||
145534433|NCT02833350|524816934|FG005|Overall Study|Adverse Event|0|||
145534434|NCT02833350|524816935|FG006|Overall Study|Adverse Event|1|||
145534435|NCT02833350|524816929|FG000|Overall Study|Death|0|||
145534436|NCT02833350|524816930|FG001|Overall Study|Death|0|||
145534437|NCT02833350|524816931|FG002|Overall Study|Death|1|||
145534438|NCT02833350|524816932|FG003|Overall Study|Death|0|||
145534439|NCT02833350|524816933|FG004|Overall Study|Death|0|||
145534440|NCT02833350|524816934|FG005|Overall Study|Death|0|||
145534441|NCT02833350|524816935|FG006|Overall Study|Death|0|||
145534442|NCT02833350|524816929|FG000|Overall Study|Lack of Efficacy|0|||
145534443|NCT02833350|524816930|FG001|Overall Study|Lack of Efficacy|2|||
145534444|NCT02833350|524816931|FG002|Overall Study|Lack of Efficacy|1|||
145534445|NCT02833350|524816932|FG003|Overall Study|Lack of Efficacy|4|||
145534446|NCT02833350|524816933|FG004|Overall Study|Lack of Efficacy|0|||
145534447|NCT02833350|524816934|FG005|Overall Study|Lack of Efficacy|1|||
145534448|NCT02833350|524816935|FG006|Overall Study|Lack of Efficacy|1|||
145534449|NCT02833350|524816929|FG000|Overall Study|Lost to Follow-up|0|||
145534450|NCT02833350|524816930|FG001|Overall Study|Lost to Follow-up|1|||
145534451|NCT02833350|524816931|FG002|Overall Study|Lost to Follow-up|0|||
145534452|NCT02833350|524816932|FG003|Overall Study|Lost to Follow-up|0|||
145534453|NCT02833350|524816933|FG004|Overall Study|Lost to Follow-up|0|||
145534454|NCT02833350|524816934|FG005|Overall Study|Lost to Follow-up|0|||
145534455|NCT02833350|524816935|FG006|Overall Study|Lost to Follow-up|1|||
145534456|NCT02833350|524816929|FG000|Overall Study|Withdrawal by Subject|3|||
145773029|NCT02424539|525678304|FG001|Overall Study|Withdrawal by Subject|1|||
145773030|NCT02424539|525678305|FG002|Overall Study|Withdrawal by Subject|0|||
145773031|NCT02424539|525678303|FG000|Overall Study|Other: Reached stopping criteria|11|||
145773032|NCT02424539|525678304|FG001|Overall Study|Other: Reached stopping criteria|7|||
145773033|NCT02424539|525678305|FG002|Overall Study|Other: Reached stopping criteria|6|||
145773034|NCT04899271|525678312|FG000|Overall Study|Lost to Follow-up|1|||
145773035|NCT04899271|525678313|FG001|Overall Study|Lost to Follow-up|0|||
145773036|NCT04899271|525678312|FG000|Overall Study|Subject request/consent withdrawal|2|||
145773037|NCT04899271|525678313|FG001|Overall Study|Subject request/consent withdrawal|0|||
145773038|NCT00730236|525678318|FG000|Overall Study|Adverse Event|4|||
145773039|NCT00730236|525678318|FG000|Overall Study|Withdrawal by Subject|1|||
145773040|NCT00730236|525678318|FG000|Overall Study|Non-compliance|1|||
145773041|NCT00482001|525678320|FG000|Overall Study|Protocol Violation|1|||
145773042|NCT00482001|525678321|FG001|Overall Study|Protocol Violation|1|||
145773043|NCT02388776|525678322|FG000|Overall Study|Death|1|||
145773044|NCT02388776|525678322|FG000|Overall Study|Lost to Follow-up|1|||
145773045|NCT00542828|525678323|FG000|Overall Study|Physician Decision|1|||
145773046|NCT00542828|525678323|FG000|Overall Study|Need for Prohibited Treatment|3|||
145773047|NCT00542828|525678323|FG000|Overall Study|Study Prematurely Discontinued|7|||
145773048|NCT00542828|525678323|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
145773049|NCT03953118|525678324|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
145773050|NCT03953118|525678325|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
145773051|NCT05490771|525678326|FG000|Overall Study|Disease progression|18|||
145773052|NCT05490771|525678326|FG000|Overall Study|Adverse Event|3|||
145773053|NCT05490771|525678326|FG000|Overall Study|Other complicating disease|1|||
145773054|NCT05490771|525678326|FG000|Overall Study|Withdrawal by Subject|3|||
145773055|NCT05490771|525678326|FG000|Overall Study|Physician Decision|1|||
145773056|NCT05490771|525678326|FG000|Overall Study|Still on treatment|2|||
145773057|NCT05490771|525678326|FG000|Overall Study|Never start protocol therapy|5|||
145773058|NCT05490771|525678326|FG000|Overall Study|Ineligible|2|||
145773059|NCT04246047|525678327|FG000|Overall Study|Death|50|||
145773060|NCT04246047|525678328|FG001|Overall Study|Death|77|||
145773061|NCT04246047|525678327|FG000|Overall Study|Lost to Follow-up|1|||
145773062|NCT04246047|525678328|FG001|Overall Study|Lost to Follow-up|3|||
145773063|NCT04246047|525678327|FG000|Overall Study|Physician Decision|4|||
145773064|NCT04246047|525678328|FG001|Overall Study|Physician Decision|10|||
145773065|NCT04246047|525678327|FG000|Overall Study|Withdrawal by Subject|19|||
145773066|NCT04246047|525678328|FG001|Overall Study|Withdrawal by Subject|26|||
145773067|NCT04246047|525678327|FG000|Overall Study|Ongoing|169|||
145773068|NCT04246047|525678328|FG001|Overall Study|Ongoing|135|||
145773069|NCT05139030|525678329|FG000|Overall Study|Withdrawal by Subject|1|||
145773070|NCT05139030|525678330|FG001|Overall Study|Withdrawal by Subject|3|||
145773071|NCT05139030|525678329|FG000|Overall Study|Adverse Event|0|||
145773072|NCT05139030|525678330|FG001|Overall Study|Adverse Event|1|||
145773073|NCT05139030|525678329|FG000|Overall Study|Failure to meet continuation criteria|0|||
145608262|NCT03285295|525080946|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
145773074|NCT05139030|525678330|FG001|Overall Study|Failure to meet continuation criteria|1|||
145773075|NCT01259466|525678343|FG000|Overall Study|Withdrawal by Subject|1|||
145773076|NCT01259466|525678344|FG001|Overall Study|Withdrawal by Subject|9|||
145608263|NCT03285295|525080947|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
145608264|NCT03285295|525080948|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
145608265|NCT03285295|525080949|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
145608266|NCT03285295|525080945|FG000|Alinity s Chagas|Protocol Violation|76|||
145608267|NCT03285295|525080946|FG001|Alinity s Chagas|Protocol Violation|0|||
145608268|NCT03285295|525080947|FG002|Alinity s Chagas|Protocol Violation|0|||
145608269|NCT03285295|525080948|FG003|Alinity s Chagas|Protocol Violation|0|||
145608270|NCT03285295|525080949|FG004|Alinity s Chagas|Protocol Violation|0|||
145608271|NCT03285295|525080945|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
145773077|NCT02296840|525678345|FG000|Overall Study|Adverse Event|1|||
145773078|NCT02296840|525678346|FG001|Overall Study|Adverse Event|1|||
145773079|NCT02296840|525678345|FG000|Overall Study|Protocol Violation|2|||
145773080|NCT02296840|525678346|FG001|Overall Study|Protocol Violation|1|||
145773081|NCT02296840|525678345|FG000|Overall Study|Lost to Follow-up|6|||
145773082|NCT02296840|525678346|FG001|Overall Study|Lost to Follow-up|17|||
145773083|NCT00104871|525678347|FG000|Overall Study|Not evaluable|1|||
145773084|NCT00814710|525678355|FG000|Overall Study|Adverse Event|1|||
145773085|NCT00814710|525678356|FG001|Overall Study|Adverse Event|0|||
145773086|NCT00814710|525678355|FG000|Overall Study|Lost to Follow-up|7|||
145773087|NCT00814710|525678356|FG001|Overall Study|Lost to Follow-up|3|||
145773088|NCT00457639|525678357|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
145773089|NCT00457639|525678358|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
145773090|NCT00457639|525678357|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
145773091|NCT00457639|525678358|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
145773092|NCT00457639|525678357|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
145773093|NCT00457639|525678358|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
145773094|NCT02117687|525678359|FG000|Overall Study|Lost to Follow-up|0|||
145773095|NCT02117687|525678360|FG001|Overall Study|Lost to Follow-up|1|||
145773096|NCT02117687|525678359|FG000|Overall Study|Adverse Event|0|||
145403480|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403481|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403482|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403483|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
145403484|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
145403485|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
145403486|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403487|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403488|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403489|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403490|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403491|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403492|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403493|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
145403494|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
145403495|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
145403496|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145608272|NCT03285295|525080946|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
145608273|NCT03285295|525080947|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
145608274|NCT03285295|525080948|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
145608275|NCT03285295|525080949|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
145608276|NCT03285295|525080945|FG000|Alinity s Chagas|No Results Generated|105|||
145608277|NCT03285295|525080946|FG001|Alinity s Chagas|No Results Generated|0|||
145608278|NCT03285295|525080947|FG002|Alinity s Chagas|No Results Generated|0|||
145608279|NCT03285295|525080948|FG003|Alinity s Chagas|No Results Generated|0|||
145608280|NCT03285295|525080949|FG004|Alinity s Chagas|No Results Generated|0|||
145608281|NCT03285295|525080945|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
145773097|NCT02117687|525678360|FG001|Overall Study|Adverse Event|2|||
145773098|NCT02117687|525678359|FG000|Overall Study|Other Reasons|1|||
145773099|NCT02117687|525678360|FG001|Overall Study|Other Reasons|1|||
145403497|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145608282|NCT03285295|525080946|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
145773100|NCT00618956|525678361|FG000|Overall Study|Adverse Event|10|||
145773101|NCT00618956|525678362|FG001|Overall Study|Adverse Event|34|||
145773102|NCT00618956|525678361|FG000|Overall Study|Lack of Efficacy|2|||
145773103|NCT00618956|525678362|FG001|Overall Study|Lack of Efficacy|1|||
145773104|NCT00618956|525678361|FG000|Overall Study|Withdrawal by Subject|5|||
145403498|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145403499|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145608283|NCT03285295|525080947|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
145608284|NCT03285295|525080948|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
145773105|NCT00618956|525678362|FG001|Overall Study|Withdrawal by Subject|7|||
145773106|NCT00618956|525678361|FG000|Overall Study|Lost to Follow-up|4|||
145773107|NCT00618956|525678362|FG001|Overall Study|Lost to Follow-up|5|||
145773108|NCT00618956|525678361|FG000|Overall Study|Protocol Violation|2|||
145773109|NCT00618956|525678362|FG001|Overall Study|Protocol Violation|2|||
145773110|NCT00618956|525678361|FG000|Overall Study|did not meet criteria, non-compliance|2|||
145773111|NCT00618956|525678362|FG001|Overall Study|did not meet criteria, non-compliance|1|||
145773112|NCT00630032|525678363|FG000|Overall Study|Death|55|||
145773113|NCT00630032|525678364|FG001|Overall Study|Death|49|||
145773114|NCT00630032|525678363|FG000|Overall Study|Withdrawal by Subject|3|||
145773115|NCT00630032|525678364|FG001|Overall Study|Withdrawal by Subject|2|||
145773116|NCT00630032|525678363|FG000|Overall Study|Lost to Follow-up|18|||
145773117|NCT00630032|525678364|FG001|Overall Study|Lost to Follow-up|31|||
145773118|NCT00630032|525678363|FG000|Overall Study|Protocol Violation|1|||
145773119|NCT00630032|525678364|FG001|Overall Study|Protocol Violation|0|||
145773120|NCT00630032|525678363|FG000|Overall Study|Patient has moved|1|||
145773121|NCT00630032|525678364|FG001|Overall Study|Patient has moved|1|||
145773122|NCT00630032|525678363|FG000|Overall Study|Disease progression|1|||
145773123|NCT00630032|525678364|FG001|Overall Study|Disease progression|1|||
145773124|NCT00630032|525678363|FG000|Overall Study|End of monitoring in US centers|11|||
145773125|NCT00630032|525678364|FG001|Overall Study|End of monitoring in US centers|11|||
145773126|NCT05405166|525680535|FG000|Overall Study|Death|49|||
145773127|NCT05405166|525680536|FG001|Overall Study|Death|50|||
145773128|NCT05405166|525680535|FG000|Overall Study|Withdrawal by Subject|10|||
145773129|NCT05405166|525680536|FG001|Overall Study|Withdrawal by Subject|3|||
145773130|NCT05405166|525680535|FG000|Overall Study|Ongoing at the time of PCD|209|||
145773131|NCT05405166|525680536|FG001|Overall Study|Ongoing at the time of PCD|210|||
145773132|NCT01386385|525680537|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
145773133|NCT01386385|525680538|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773134|NCT01386385|525680539|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773135|NCT01386385|525680540|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773136|NCT01386385|525680541|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773137|NCT01386385|525680542|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773138|NCT01386385|525680543|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773139|NCT01386385|525680544|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
145773140|NCT01386385|525680537|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
145773141|NCT01386385|525680538|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773142|NCT01386385|525680539|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773143|NCT01386385|525680540|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773144|NCT01386385|525680541|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773145|NCT01386385|525680542|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773146|NCT01386385|525680543|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145278836|NCT04523831|523870899|FG001|Overall Study|Lost to Follow-up|17|||
145278837|NCT04523831|523870898|FG000|Overall Study|Death|0|||
145278838|NCT04523831|523870899|FG001|Overall Study|Death|3|||
145278839|NCT04523831|523870898|FG000|Overall Study|Adverse Event|2|||
145278840|NCT04523831|523870899|FG001|Overall Study|Adverse Event|0|||
145278841|NCT00995930|523870900|FG000|Overall Study|Protocol deviation|2|||
145278842|NCT00995930|523870901|FG001|Overall Study|Protocol deviation|5|||
145278843|NCT00995930|523870900|FG000|Overall Study|Death|0|||
145773147|NCT01386385|525680544|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
145773148|NCT01386385|525680537|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773149|NCT01386385|525680538|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773150|NCT01386385|525680539|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
145773151|NCT01386385|525680540|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773152|NCT01386385|525680541|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773153|NCT01386385|525680542|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773154|NCT01386385|525680543|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773155|NCT01386385|525680544|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
145773156|NCT01386385|525680537|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773157|NCT01386385|525680538|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773158|NCT01386385|525680539|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773159|NCT01386385|525680540|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773160|NCT01386385|525680541|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
145773161|NCT01386385|525680542|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145278844|NCT00995930|523870901|FG001|Overall Study|Death|1|||
145773162|NCT01386385|525680543|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773163|NCT01386385|525680544|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
145773164|NCT01386385|525680537|FG000|Phase II Concurrent CRT|Adverse Event|0|||
145773165|NCT01386385|525680538|FG001|Phase II Concurrent CRT|Adverse Event|0|||
145773166|NCT01386385|525680539|FG002|Phase II Concurrent CRT|Adverse Event|0|||
145773167|NCT01386385|525680540|FG003|Phase II Concurrent CRT|Adverse Event|0|||
145278845|NCT00995930|523870900|FG000|Overall Study|Administrative problems|4|||
145278846|NCT00995930|523870901|FG001|Overall Study|Administrative problems|2|||
145608285|NCT03285295|525080949|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
145534457|NCT02833350|524816930|FG001|Overall Study|Withdrawal by Subject|3|||
145534458|NCT02833350|524816931|FG002|Overall Study|Withdrawal by Subject|2|||
145534459|NCT02833350|524816932|FG003|Overall Study|Withdrawal by Subject|0|||
145534460|NCT02833350|524816933|FG004|Overall Study|Withdrawal by Subject|2|||
145534461|NCT02833350|524816934|FG005|Overall Study|Withdrawal by Subject|0|||
145773168|NCT01386385|525680541|FG004|Phase II Concurrent CRT|Adverse Event|0|||
145773169|NCT01386385|525680542|FG005|Phase II Concurrent CRT|Adverse Event|0|||
145773170|NCT01386385|525680543|FG006|Phase II Concurrent CRT|Adverse Event|3|||
145773171|NCT01386385|525680544|FG007|Phase II Concurrent CRT|Adverse Event|3|||
145773172|NCT01386385|525680537|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773173|NCT01386385|525680538|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773174|NCT01386385|525680539|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773175|NCT01386385|525680540|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773176|NCT01386385|525680541|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773177|NCT01386385|525680542|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773178|NCT01386385|525680543|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
145534462|NCT02833350|524816935|FG006|Overall Study|Withdrawal by Subject|2|||
145534463|NCT01500031|524816936|FG000|Overall Study|Death|1|||
145608286|NCT03015116|525080950|FG000|Overall Study|Lost to Follow-up|3|||
145608287|NCT03015116|525080951|FG001|Overall Study|Lost to Follow-up|0|||
145773179|NCT01386385|525680544|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
145773180|NCT01386385|525680537|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
145773181|NCT01386385|525680538|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
145773182|NCT01386385|525680539|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
145773183|NCT01386385|525680540|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
145773184|NCT01386385|525680541|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
145773185|NCT01386385|525680542|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
145608288|NCT03015116|525080952|FG002|Overall Study|Lost to Follow-up|2|||
145773186|NCT01386385|525680543|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
145773187|NCT01386385|525680544|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
145773188|NCT01386385|525680537|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773189|NCT01386385|525680538|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773190|NCT01386385|525680539|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773191|NCT01386385|525680540|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773192|NCT01386385|525680541|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773193|NCT01386385|525680542|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773194|NCT01386385|525680543|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
145773195|NCT01386385|525680544|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
145773196|NCT01386385|525680537|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773197|NCT01386385|525680538|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773198|NCT01386385|525680539|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773199|NCT01386385|525680540|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773200|NCT01386385|525680541|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773201|NCT01386385|525680542|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
145773202|NCT01386385|525680543|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
145773203|NCT01386385|525680544|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
145773204|NCT01084252|525680545|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773205|NCT01084252|525680546|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773206|NCT01084252|525680547|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773207|NCT01084252|525680548|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773208|NCT01084252|525680549|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773209|NCT01084252|525680550|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145403500|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145403501|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145403502|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145403503|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
145534464|NCT01500031|524816936|FG000|Overall Study|Withdrawal by Subject|4|||
145534465|NCT00216476|524816942|FG000|Overall Study|Withdrawal by Subject|59|||
145608289|NCT03015116|525080950|FG000|Overall Study|Withdrawal by Subject|3|||
145773210|NCT01084252|525680551|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773211|NCT01084252|525680552|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773212|NCT01084252|525680553|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773213|NCT01084252|525680554|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773214|NCT01084252|525680555|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773215|NCT01084252|525680556|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773216|NCT01084252|525680557|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
145773217|NCT01084252|525680558|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
145773218|NCT03395210|525680559|FG000|Overall Study|Other|0|||
145773219|NCT03395210|525680560|FG001|Overall Study|Other|0|||
145773220|NCT03395210|525680561|FG002|Overall Study|Other|0|||
145773221|NCT03395210|525680562|FG003|Overall Study|Other|0|||
145773222|NCT03395210|525680563|FG004|Overall Study|Other|1|||
145773223|NCT03395210|525680559|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
145773224|NCT03395210|525680560|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
145773225|NCT03395210|525680561|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
145773226|NCT03395210|525680562|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
145773227|NCT03395210|525680563|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
145773228|NCT03395210|525680559|FG000|Overall Study|Adverse Event|1|||
145773229|NCT03395210|525680560|FG001|Overall Study|Adverse Event|0|||
145773230|NCT03395210|525680561|FG002|Overall Study|Adverse Event|2|||
145773231|NCT03395210|525680562|FG003|Overall Study|Adverse Event|4|||
145773232|NCT03395210|525680563|FG004|Overall Study|Adverse Event|3|||
145773233|NCT03395210|525680559|FG000|Overall Study|Need of Rescue Medication|1|||
145773234|NCT03395210|525680560|FG001|Overall Study|Need of Rescue Medication|0|||
145773235|NCT03395210|525680561|FG002|Overall Study|Need of Rescue Medication|1|||
145773236|NCT03395210|525680562|FG003|Overall Study|Need of Rescue Medication|4|||
145773237|NCT03395210|525680563|FG004|Overall Study|Need of Rescue Medication|0|||
145534466|NCT00216476|524816943|FG001|Overall Study|Withdrawal by Subject|72|||
145773238|NCT03395210|525680559|FG000|Overall Study|Lack of Response|0|||
145773239|NCT03395210|525680560|FG001|Overall Study|Lack of Response|0|||
145773240|NCT03395210|525680561|FG002|Overall Study|Lack of Response|0|||
145773241|NCT03395210|525680562|FG003|Overall Study|Lack of Response|5|||
145773242|NCT03395210|525680563|FG004|Overall Study|Lack of Response|5|||
145773243|NCT03395210|525680559|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
145773244|NCT03395210|525680560|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
145773245|NCT03395210|525680561|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
145773246|NCT03395210|525680562|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
145773247|NCT03395210|525680563|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
145403504|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
145403505|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
145403506|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403507|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403508|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145773248|NCT03395210|525680559|FG000|Overall Study|Participant Decision|1|||
145773249|NCT03395210|525680560|FG001|Overall Study|Participant Decision|1|||
145773250|NCT03395210|525680561|FG002|Overall Study|Participant Decision|0|||
145773251|NCT03395210|525680562|FG003|Overall Study|Participant Decision|4|||
145773252|NCT03395210|525680563|FG004|Overall Study|Participant Decision|0|||
145773253|NCT03395210|525680559|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
145773254|NCT03395210|525680560|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
145773255|NCT03395210|525680561|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
145773256|NCT03395210|525680562|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
145773257|NCT03395210|525680563|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
145773258|NCT04364854|525680564|FG000|Overall Study|Withdrawal by Subject|1|||
145773259|NCT04364854|525680565|FG001|Overall Study|Withdrawal by Subject|0|||
145773260|NCT04364854|525680566|FG002|Overall Study|Withdrawal by Subject|1|||
145773261|NCT04364854|525680567|FG003|Overall Study|Withdrawal by Subject|3|||
145773262|NCT04364854|525680564|FG000|Overall Study|Death|1|||
145773263|NCT04364854|525680565|FG001|Overall Study|Death|0|||
145773264|NCT04364854|525680566|FG002|Overall Study|Death|0|||
145773265|NCT04364854|525680567|FG003|Overall Study|Death|0|||
145773266|NCT04364854|525680564|FG000|Overall Study|Lost to Follow-up|0|||
145773267|NCT04364854|525680565|FG001|Overall Study|Lost to Follow-up|0|||
145773268|NCT04364854|525680566|FG002|Overall Study|Lost to Follow-up|0|||
145773269|NCT04364854|525680567|FG003|Overall Study|Lost to Follow-up|1|||
145773270|NCT01826214|525680571|FG000|Overall Study|Adverse Event|7|||
145773271|NCT01826214|525680572|FG001|Overall Study|Adverse Event|6|||
145403509|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403510|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403511|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145534467|NCT00216476|524816944|FG002|Overall Study|Withdrawal by Subject|9|||
145773272|NCT01826214|525680571|FG000|Overall Study|Death|3|||
145773273|NCT01826214|525680572|FG001|Overall Study|Death|1|||
145773274|NCT01826214|525680571|FG000|Overall Study|Lost to Follow-up|1|||
145773275|NCT01826214|525680572|FG001|Overall Study|Lost to Follow-up|0|||
145773276|NCT01826214|525680571|FG000|Overall Study|Physician Decision|0|||
145773277|NCT01826214|525680572|FG001|Overall Study|Physician Decision|2|||
145773278|NCT01826214|525680571|FG000|Overall Study|Progressive disease|22|||
145773279|NCT01826214|525680572|FG001|Overall Study|Progressive disease|21|||
145773280|NCT01826214|525680571|FG000|Overall Study|Study terminated by Sponsor|0|||
145773281|NCT01826214|525680572|FG001|Overall Study|Study terminated by Sponsor|1|||
145773282|NCT01826214|525680571|FG000|Overall Study|Subject/guardian decision|2|||
145773283|NCT01826214|525680572|FG001|Overall Study|Subject/guardian decision|3|||
145773284|NCT00955110|525680573|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
145773285|NCT00955110|525680573|FG000|Treatment Phase|Adverse Event|2|||
145773286|NCT00955110|525680573|FG000|Treatment Phase|Administrative reasons|2|||
145773287|NCT00955110|525680573|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
145773288|NCT00955110|525680573|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
145773289|NCT02128490|525680574|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145773290|NCT02128490|525680575|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
145773291|NCT02128490|525680576|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
145773292|NCT02128490|525680577|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
145773293|NCT02128490|525680578|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
145773294|NCT02128490|525680574|FG000|Overall Study|Major Protocol Deviation|1|||
145773295|NCT02128490|525680575|FG001|Overall Study|Major Protocol Deviation|2|||
145773296|NCT02128490|525680576|FG002|Overall Study|Major Protocol Deviation|0|||
145773297|NCT02128490|525680577|FG003|Overall Study|Major Protocol Deviation|2|||
145773298|NCT02128490|525680578|FG004|Overall Study|Major Protocol Deviation|2|||
145773299|NCT02128490|525680574|FG000|Overall Study|Lost to Follow-up|0|||
145773300|NCT02128490|525680575|FG001|Overall Study|Lost to Follow-up|0|||
145773301|NCT02128490|525680576|FG002|Overall Study|Lost to Follow-up|1|||
145773302|NCT02128490|525680577|FG003|Overall Study|Lost to Follow-up|1|||
145773303|NCT02128490|525680578|FG004|Overall Study|Lost to Follow-up|1|||
145773304|NCT02128490|525680574|FG000|Overall Study|Voluntary Withdrawal|3|||
145773305|NCT02128490|525680575|FG001|Overall Study|Voluntary Withdrawal|3|||
145773306|NCT02128490|525680576|FG002|Overall Study|Voluntary Withdrawal|1|||
145773307|NCT02128490|525680577|FG003|Overall Study|Voluntary Withdrawal|1|||
145773308|NCT02128490|525680578|FG004|Overall Study|Voluntary Withdrawal|2|||
145773309|NCT02128490|525680574|FG000|Overall Study|Lack of Efficacy|0|||
145773310|NCT02128490|525680575|FG001|Overall Study|Lack of Efficacy|1|||
145773311|NCT02128490|525680576|FG002|Overall Study|Lack of Efficacy|0|||
145773312|NCT02128490|525680577|FG003|Overall Study|Lack of Efficacy|0|||
145773313|NCT02128490|525680578|FG004|Overall Study|Lack of Efficacy|0|||
145773314|NCT02128490|525680574|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
145534468|NCT00216476|524816942|FG000|Overall Study|Lost to Follow-up|10|||
145534469|NCT00216476|524816943|FG001|Overall Study|Lost to Follow-up|9|||
145534470|NCT00216476|524816944|FG002|Overall Study|Lost to Follow-up|1|||
145534471|NCT00216476|524816942|FG000|Overall Study|Adverse Event|6|||
145534472|NCT00216476|524816943|FG001|Overall Study|Adverse Event|10|||
145534473|NCT00216476|524816944|FG002|Overall Study|Adverse Event|1|||
145534474|NCT00216476|524816942|FG000|Overall Study|Lack of Efficacy|4|||
145534475|NCT00216476|524816943|FG001|Overall Study|Lack of Efficacy|3|||
145534476|NCT00216476|524816944|FG002|Overall Study|Lack of Efficacy|0|||
145773315|NCT02128490|525680575|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
145773316|NCT02128490|525680576|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
145773317|NCT02128490|525680577|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
145773318|NCT02128490|525680578|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
145773319|NCT02128490|525680574|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145773320|NCT02128490|525680575|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145773321|NCT02128490|525680576|FG002|Overall Study|Other Miscellaneous Reasons|2|||
145773322|NCT02128490|525680577|FG003|Overall Study|Other Miscellaneous Reasons|1|||
145773323|NCT02128490|525680578|FG004|Overall Study|Other Miscellaneous Reasons|1|||
145773324|NCT02243176|525680579|FG000|Overall Study|Other reason|1|||
145773325|NCT02243176|525680580|FG001|Overall Study|Other reason|2|||
145773326|NCT02243176|525680579|FG000|Overall Study|protocol specified withdrawal critera|1|||
145773327|NCT02243176|525680580|FG001|Overall Study|protocol specified withdrawal critera|3|||
145773328|NCT02243176|525680579|FG000|Overall Study|Protocol Violation|2|||
145773329|NCT02243176|525680580|FG001|Overall Study|Protocol Violation|1|||
145773330|NCT02243176|525680579|FG000|Overall Study|Withdrawal by Subject|8|||
145773331|NCT02243176|525680580|FG001|Overall Study|Withdrawal by Subject|7|||
145534477|NCT00216476|524816942|FG000|Overall Study|Death|2|||
145773332|NCT02243176|525680579|FG000|Overall Study|Adverse Event|2|||
145773333|NCT02243176|525680580|FG001|Overall Study|Adverse Event|2|||
145608290|NCT03015116|525080951|FG001|Overall Study|Withdrawal by Subject|1|||
145278847|NCT00995930|523870900|FG000|Overall Study|Lost to Follow-up|1|||
145534478|NCT00216476|524816943|FG001|Overall Study|Death|0|||
145773334|NCT01062399|525680592|FG000|Overall Study|Protocol Violation|0|||
145403512|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403513|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
145403514|NCT01232283|524334393|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
145403515|NCT01232283|524334394|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
145773335|NCT01062399|525680593|FG001|Overall Study|Protocol Violation|1|||
145773336|NCT01062399|525680594|FG002|Overall Study|Protocol Violation|0|||
145773337|NCT01062399|525680595|FG003|Overall Study|Protocol Violation|6|||
145403516|NCT01232283|524334395|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403517|NCT01232283|524334396|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403518|NCT01232283|524334397|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403519|NCT01232283|524334398|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403520|NCT01232283|524334399|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403521|NCT01232283|524334400|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403522|NCT01232283|524334401|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403523|NCT01232283|524334402|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
145403524|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403525|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403526|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
145403527|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
145403528|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403529|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403530|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403531|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145403532|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145534479|NCT00216476|524816944|FG002|Overall Study|Death|0|||
145534480|NCT00216476|524816942|FG000|Overall Study|Pregnancy|0|||
145534481|NCT00216476|524816943|FG001|Overall Study|Pregnancy|1|||
145534482|NCT00216476|524816944|FG002|Overall Study|Pregnancy|1|||
145534483|NCT00216476|524816942|FG000|Overall Study|Other|0|||
145534484|NCT00216476|524816943|FG001|Overall Study|Other|0|||
145534485|NCT00216476|524816944|FG002|Overall Study|Other|1|||
145534486|NCT00216476|524816942|FG000|Overall Study|Refuses Injection|11|||
145534487|NCT00216476|524816943|FG001|Overall Study|Refuses Injection|0|||
145534488|NCT00216476|524816944|FG002|Overall Study|Refuses Injection|0|||
145534489|NCT00216476|524816942|FG000|Overall Study|No Further Need for Treatment|3|||
145534490|NCT00216476|524816943|FG001|Overall Study|No Further Need for Treatment|4|||
145534491|NCT00216476|524816944|FG002|Overall Study|No Further Need for Treatment|1|||
145534492|NCT00216476|524816942|FG000|Overall Study|Non-compliance|0|||
145534493|NCT00216476|524816943|FG001|Overall Study|Non-compliance|4|||
145534494|NCT00216476|524816944|FG002|Overall Study|Non-compliance|1|||
145534495|NCT00216476|524816942|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
145534496|NCT00216476|524816943|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
145534497|NCT00216476|524816944|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
145534498|NCT00216476|524816942|FG000|Overall Study|Administrative Reasons|1|||
145534499|NCT00216476|524816943|FG001|Overall Study|Administrative Reasons|1|||
145534500|NCT00216476|524816944|FG002|Overall Study|Administrative Reasons|0|||
145534501|NCT00216476|524816942|FG000|Overall Study|Protocol Deviation|5|||
145534502|NCT00216476|524816943|FG001|Overall Study|Protocol Deviation|1|||
145534503|NCT00216476|524816944|FG002|Overall Study|Protocol Deviation|0|||
145534504|NCT00216476|524816942|FG000|Overall Study|Patient Moved|2|||
145534505|NCT00216476|524816943|FG001|Overall Study|Patient Moved|2|||
145534506|NCT00216476|524816944|FG002|Overall Study|Patient Moved|0|||
145534507|NCT02191137|524816945|FG000|Treatment|Death|4|||
145534508|NCT02191137|524816945|FG000|Treatment|Withdrawal by Subject|3|||
145534509|NCT02191137|524816945|FG000|Treatment|Adverse Event|2|||
145534510|NCT02191137|524816945|FG000|Treatment|Other|1|||
145534511|NCT02191137|524816945|FG000|Follow-up|Lost to Follow-up|2|||
145534512|NCT02191137|524816945|FG000|Follow-up|Ongoing/unknown|2|||
145534513|NCT02191137|524816945|FG000|Follow-up|Adverse Event|1|||
145773338|NCT01062399|525680596|FG004|Overall Study|Protocol Violation|4|||
145773339|NCT05408858|525680617|FG000|Overall Study|no longer met eligibility criteria|1|||
145773340|NCT01021007|525680621|FG000|Overall Study|Lost to Follow-up|1|||
145534514|NCT01332331|524816946|FG000|Overall Study|Lost to Follow-up|0|||
145534515|NCT01332331|524816947|FG001|Overall Study|Lost to Follow-up|1|||
145534516|NCT01332331|524816946|FG000|Overall Study|Adverse Event|1|||
145534517|NCT01332331|524816947|FG001|Overall Study|Adverse Event|1|||
145403533|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
145534518|NCT01332331|524816946|FG000|Overall Study|Physician Decision|1|||
145534519|NCT01332331|524816947|FG001|Overall Study|Physician Decision|0|||
145534520|NCT00538291|524816948|FG000|Overall Study|Adverse Event|2|||
145534521|NCT00538291|524816948|FG000|Overall Study|Withdrawal by Subject|1|||
145534522|NCT00694707|524816949|FG000|Overall Study|Did Not Receive Treatment|0|||
145534523|NCT00694707|524816950|FG001|Overall Study|Did Not Receive Treatment|0|||
145534524|NCT00694707|524816951|FG002|Overall Study|Did Not Receive Treatment|1|||
145534525|NCT00694707|524816952|FG003|Overall Study|Did Not Receive Treatment|1|||
145534526|NCT00694707|524816953|FG004|Overall Study|Did Not Receive Treatment|1|||
145773341|NCT01021007|525680622|FG001|Overall Study|Lost to Follow-up|1|||
145773342|NCT01021007|525680621|FG000|Overall Study|Adverse Event|1|||
145773343|NCT01021007|525680622|FG001|Overall Study|Adverse Event|3|||
145773344|NCT01126619|525680627|FG000|Overall Study|Not eligible for the study|2|||
145773345|NCT01126619|525680627|FG000|Overall Study|Investigator decision|4|||
145773346|NCT01126619|525680627|FG000|Overall Study|Serious adverse event|1|||
145773347|NCT01126619|525680627|FG000|Overall Study|Withdrawal by Subject|9|||
145773348|NCT01126619|525680627|FG000|Overall Study|Non-compliance|1|||
145534527|NCT00694707|524816949|FG000|Overall Study|Adverse Event|22|||
145534528|NCT00694707|524816950|FG001|Overall Study|Adverse Event|14|||
145534529|NCT00694707|524816951|FG002|Overall Study|Adverse Event|8|||
145534530|NCT00694707|524816952|FG003|Overall Study|Adverse Event|12|||
145534531|NCT00694707|524816953|FG004|Overall Study|Adverse Event|13|||
145534532|NCT00694707|524816949|FG000|Overall Study|Insufficient Therapeutic Response|33|||
145534533|NCT00694707|524816950|FG001|Overall Study|Insufficient Therapeutic Response|18|||
145534534|NCT00694707|524816951|FG002|Overall Study|Insufficient Therapeutic Response|17|||
145534535|NCT00694707|524816952|FG003|Overall Study|Insufficient Therapeutic Response|15|||
145534536|NCT00694707|524816953|FG004|Overall Study|Insufficient Therapeutic Response|10|||
145534537|NCT00694707|524816949|FG000|Overall Study|Protocol Violation|1|||
145534538|NCT00694707|524816950|FG001|Overall Study|Protocol Violation|2|||
145534539|NCT00694707|524816951|FG002|Overall Study|Protocol Violation|1|||
145534540|NCT00694707|524816952|FG003|Overall Study|Protocol Violation|3|||
145534541|NCT00694707|524816953|FG004|Overall Study|Protocol Violation|1|||
145534542|NCT00694707|524816949|FG000|Overall Study|Withdrawal of Consent|14|||
145534543|NCT00694707|524816950|FG001|Overall Study|Withdrawal of Consent|18|||
145534544|NCT00694707|524816951|FG002|Overall Study|Withdrawal of Consent|22|||
145534545|NCT00694707|524816952|FG003|Overall Study|Withdrawal of Consent|16|||
145534546|NCT00694707|524816953|FG004|Overall Study|Withdrawal of Consent|15|||
145534547|NCT00694707|524816949|FG000|Overall Study|Lost to Follow-up|0|||
145534548|NCT00694707|524816950|FG001|Overall Study|Lost to Follow-up|1|||
145534549|NCT00694707|524816951|FG002|Overall Study|Lost to Follow-up|2|||
145534550|NCT00694707|524816952|FG003|Overall Study|Lost to Follow-up|0|||
145534551|NCT00694707|524816953|FG004|Overall Study|Lost to Follow-up|0|||
145534552|NCT00694707|524816949|FG000|Overall Study|Jeopardizing Parole Status|1|||
145534553|NCT00694707|524816950|FG001|Overall Study|Jeopardizing Parole Status|0|||
145534554|NCT00694707|524816951|FG002|Overall Study|Jeopardizing Parole Status|0|||
145534555|NCT00694707|524816952|FG003|Overall Study|Jeopardizing Parole Status|0|||
145534556|NCT00694707|524816953|FG004|Overall Study|Jeopardizing Parole Status|0|||
145534557|NCT00694707|524816949|FG000|Overall Study|Death in the Family|1|||
145534558|NCT00694707|524816950|FG001|Overall Study|Death in the Family|0|||
145534559|NCT00694707|524816951|FG002|Overall Study|Death in the Family|0|||
145534560|NCT00694707|524816952|FG003|Overall Study|Death in the Family|0|||
145534561|NCT00694707|524816953|FG004|Overall Study|Death in the Family|0|||
145534562|NCT00694707|524816949|FG000|Overall Study|Arrest by Police|0|||
145534563|NCT00694707|524816950|FG001|Overall Study|Arrest by Police|1|||
145534564|NCT00694707|524816951|FG002|Overall Study|Arrest by Police|0|||
145534565|NCT00694707|524816952|FG003|Overall Study|Arrest by Police|0|||
145534566|NCT00694707|524816953|FG004|Overall Study|Arrest by Police|0|||
145534567|NCT00694707|524816949|FG000|Overall Study|Administrative Reasons|0|||
145534568|NCT00694707|524816950|FG001|Overall Study|Administrative Reasons|1|||
145534569|NCT00694707|524816951|FG002|Overall Study|Administrative Reasons|0|||
145534570|NCT00694707|524816952|FG003|Overall Study|Administrative Reasons|2|||
145534571|NCT00694707|524816953|FG004|Overall Study|Administrative Reasons|0|||
145534572|NCT00694707|524816949|FG000|Overall Study|Notification of Past Head Injury|0|||
145534573|NCT00694707|524816950|FG001|Overall Study|Notification of Past Head Injury|0|||
145534574|NCT00694707|524816951|FG002|Overall Study|Notification of Past Head Injury|0|||
145534575|NCT00694707|524816952|FG003|Overall Study|Notification of Past Head Injury|1|||
145534576|NCT00694707|524816953|FG004|Overall Study|Notification of Past Head Injury|0|||
145534577|NCT01904058|524816960|FG000|Overall Study|Adverse Event|2|||
145534578|NCT01904058|524816961|FG001|Overall Study|Adverse Event|0|||
145534579|NCT01904058|524816962|FG002|Overall Study|Adverse Event|0|||
145534580|NCT01904058|524816963|FG003|Overall Study|Adverse Event|0|||
145608291|NCT03015116|525080952|FG002|Overall Study|Withdrawal by Subject|0|||
145608292|NCT03015116|525080950|FG000|Overall Study|Subject has New Medical Status|1|||
145773349|NCT00947154|525680628|FG000|Overall Study|Lost to Follow-up|1|||
145278848|NCT00995930|523870901|FG001|Overall Study|Lost to Follow-up|2|||
145534581|NCT01904058|524816960|FG000|Overall Study|Withdrawal by Subject|1|||
145534582|NCT01904058|524816961|FG001|Overall Study|Withdrawal by Subject|0|||
145608293|NCT03015116|525080951|FG001|Overall Study|Subject has New Medical Status|0|||
145278849|NCT00995930|523870900|FG000|Overall Study|Withdrawal by Subject|3|||
145534583|NCT01904058|524816962|FG002|Overall Study|Withdrawal by Subject|1|||
145534584|NCT01904058|524816963|FG003|Overall Study|Withdrawal by Subject|0|||
145534585|NCT01904058|524816960|FG000|Overall Study|Pregnancy|0|||
145534586|NCT01904058|524816961|FG001|Overall Study|Pregnancy|0|||
145534587|NCT01904058|524816962|FG002|Overall Study|Pregnancy|0|||
145608294|NCT03015116|525080952|FG002|Overall Study|Subject has New Medical Status|0|||
145534588|NCT01904058|524816963|FG003|Overall Study|Pregnancy|1|||
145534589|NCT03096483|524816967|FG000|Overall Study|Withdrawal by site|1|||
145773350|NCT03293030|525680629|FG000|Overall Study|Withdrawal by Subject|3|||
145773351|NCT01829048|525680630|FG000|Overall Study|Withdrawal by Subject|0|||
145773352|NCT01829048|525680631|FG001|Overall Study|Withdrawal by Subject|0|||
145773353|NCT01829048|525680632|FG002|Overall Study|Withdrawal by Subject|0|||
145773354|NCT01829048|525680633|FG003|Overall Study|Withdrawal by Subject|2|||
145773355|NCT01829048|525680634|FG004|Overall Study|Withdrawal by Subject|0|||
145773356|NCT01121406|525680635|FG000|Overall Study|Progressive disease RECIST|44|||
145773357|NCT01121406|525680636|FG001|Overall Study|Progressive disease RECIST|28|||
145773358|NCT01121406|525680635|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
145403534|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145403535|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145403536|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
145403537|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
145773359|NCT01121406|525680636|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
145773360|NCT01121406|525680635|FG000|Overall Study|Other AE|3|||
145773361|NCT01121406|525680636|FG001|Overall Study|Other AE|10|||
145773362|NCT01121406|525680635|FG000|Overall Study|Non-compliant with protocol|0|||
145773363|NCT01121406|525680636|FG001|Overall Study|Non-compliant with protocol|2|||
145773364|NCT01121406|525680635|FG000|Overall Study|Lost to Follow-up|0|||
145773365|NCT01121406|525680636|FG001|Overall Study|Lost to Follow-up|1|||
145773366|NCT01121406|525680635|FG000|Overall Study|Refused continuation of study med.|1|||
145403538|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145403539|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145403540|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145403541|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145773367|NCT01121406|525680636|FG001|Overall Study|Refused continuation of study med.|2|||
145773368|NCT01121406|525680635|FG000|Overall Study|Reason other than specified above|2|||
145773369|NCT01121406|525680636|FG001|Overall Study|Reason other than specified above|6|||
145773370|NCT01121406|525680635|FG000|Overall Study|Not treated|1|||
145773371|NCT01121406|525680636|FG001|Overall Study|Not treated|0|||
145773372|NCT00504257|525680637|FG000|Overall Study|Withdrawal by Subject|2|||
145773373|NCT00504257|525680637|FG000|Overall Study|ineligible histology|2|||
145773374|NCT00892437|525680638|FG000|Randomized Phase|Randomized but not treated|6|||
145773375|NCT00892437|525680639|FG001|Randomized Phase|Randomized but not treated|0|||
145773376|NCT00892437|525680638|FG000|Randomized Phase|Adverse Event|2|||
145773377|NCT00892437|525680639|FG001|Randomized Phase|Adverse Event|2|||
145773378|NCT00892437|525680638|FG000|Randomized Phase|Lost to Follow-up|1|||
145773379|NCT00892437|525680639|FG001|Randomized Phase|Lost to Follow-up|3|||
145773380|NCT00892437|525680638|FG000|Randomized Phase|Investigator's Discretion|1|||
145773381|NCT00892437|525680639|FG001|Randomized Phase|Investigator's Discretion|0|||
145534590|NCT04810481|524816969|FG000|Overall Study|Disqualified data sets|10|||
145534591|NCT04810481|524816970|FG001|Overall Study|Disqualified data sets|28|||
145534592|NCT00369707|524816975|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
145534593|NCT00369707|524816975|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
145534594|NCT00369707|524816975|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
145773382|NCT00892437|525680638|FG000|Randomized Phase|Withdrew Consent|1|||
145773383|NCT00892437|525680639|FG001|Randomized Phase|Withdrew Consent|0|||
145773384|NCT00892437|525680638|FG000|Open-Label Extension Phase|Adverse Event|4|||
145773385|NCT00892437|525680639|FG001|Open-Label Extension Phase|Adverse Event|2|||
145773386|NCT00892437|525680638|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
145773387|NCT00892437|525680639|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
145773388|NCT00892437|525680638|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
145773389|NCT00892437|525680639|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
145773390|NCT00892437|525680638|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
145773391|NCT00892437|525680639|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
145534595|NCT00369707|524816975|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
145534596|NCT00369707|524816975|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
145534597|NCT00369707|524816975|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
145534598|NCT00369707|524816975|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
145534599|NCT00369707|524816975|FG000|Follow up for 2 Years After Treatment|Death|1|||
145534600|NCT00369707|524816975|FG000|Follow up for 2 Years After Treatment|Other|2|||
145773392|NCT00892437|525680638|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
145403542|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145608295|NCT03015116|525080950|FG000|Overall Study|Physician Decision|0|||
145403543|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
145773393|NCT00892437|525680639|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
145403544|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145773394|NCT02750410|525680642|FG000|Double-Blind Treatment Period|Adverse Event|2|||
145773395|NCT02750410|525680643|FG001|Double-Blind Treatment Period|Adverse Event|2|||
145773396|NCT02750410|525680642|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145773397|NCT02750410|525680643|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145608296|NCT03015116|525080951|FG001|Overall Study|Physician Decision|1|||
145773398|NCT02750410|525680642|FG000|Open-Label Extension Period|Adverse Event|5|||
145773399|NCT02750410|525680643|FG001|Open-Label Extension Period|Adverse Event|3|||
145773400|NCT02750410|525680642|FG000|Open-Label Extension Period|Protocol Violation|0|||
145773401|NCT02750410|525680643|FG001|Open-Label Extension Period|Protocol Violation|1|||
145534601|NCT02046733|524816980|FG000|Overall Study|never initiated 'treatment visits'|6|||
145534602|NCT02046733|524816981|FG001|Overall Study|never initiated 'treatment visits'|0|||
145534603|NCT01756053|524816984|FG000|Period 1 (10 Days)|Protocol Violation|1|||
145534604|NCT01756053|524816985|FG001|Period 1 (10 Days)|Protocol Violation|1|||
145534605|NCT01756053|524816984|FG000|Period 2 (10 Days)|Protocol Violation|0|||
145534606|NCT01756053|524816985|FG001|Period 2 (10 Days)|Protocol Violation|2|||
145534607|NCT02905149|524816988|FG000|Overall Study|Lost to Follow-up|2|||
145534608|NCT02905149|524816989|FG001|Overall Study|Lost to Follow-up|0|||
145534609|NCT02019277|524816990|FG000|Overall Study|Withdrawal by Subject|3|||
145534610|NCT02019277|524816990|FG000|Overall Study|Death|7|||
145534611|NCT02019277|524816990|FG000|Overall Study|Did no Cooperate|1|||
145534612|NCT02019277|524816990|FG000|Overall Study|Adverse Event|1|||
145534613|NCT01268150|524816992|FG000|Treatment Phase|Progression of disease|18|||
145534614|NCT01268150|524816992|FG000|Treatment Phase|Adverse Event|3|||
145534615|NCT01268150|524816992|FG000|Treatment Phase|Withdrawal by Subject|3|||
145534616|NCT01268150|524816992|FG000|Treatment Phase|Other|4|||
145534617|NCT01268150|524816992|FG000|Extension Phase|Adverse Event|3|||
145534618|NCT01268150|524816992|FG000|Extension Phase|Disease progression|18|||
145534619|NCT01268150|524816992|FG000|Extension Phase|Other|6|||
145534620|NCT00395733|524816993|FG000|Period 2|Withdrawal by Subject|1|||
145534621|NCT00395733|524816994|FG001|Period 2|Withdrawal by Subject|2|||
145534622|NCT00395733|524816993|FG000|Period 2|Protocol Violation|0|||
145534623|NCT00395733|524816994|FG001|Period 2|Protocol Violation|1|||
145534624|NCT00395733|524816993|FG000|Period 2|Adverse Event|0|||
145534625|NCT00395733|524816994|FG001|Period 2|Adverse Event|2|||
145534626|NCT00395733|524816993|FG000|Period 2|Technical problems|1|||
145534627|NCT00395733|524816994|FG001|Period 2|Technical problems|0|||
145534628|NCT02808650|524816998|FG000|Overall Study|Death|0|||
145534629|NCT02808650|524816999|FG001|Overall Study|Death|0|||
145534630|NCT02808650|524817000|FG002|Overall Study|Death|0|||
145534631|NCT02808650|524817001|FG003|Overall Study|Death|0|||
145534632|NCT02808650|524817002|FG004|Overall Study|Death|1|||
145534633|NCT02808650|524816998|FG000|Overall Study|Lack of Efficacy|5|||
145534634|NCT02808650|524816999|FG001|Overall Study|Lack of Efficacy|5|||
145534635|NCT02808650|524817000|FG002|Overall Study|Lack of Efficacy|6|||
145534636|NCT02808650|524817001|FG003|Overall Study|Lack of Efficacy|5|||
145534637|NCT02808650|524817002|FG004|Overall Study|Lack of Efficacy|4|||
145534638|NCT02808650|524816998|FG000|Overall Study|Physician Decision|1|||
145534639|NCT02808650|524816999|FG001|Overall Study|Physician Decision|1|||
145534640|NCT02808650|524817000|FG002|Overall Study|Physician Decision|0|||
145534641|NCT02808650|524817001|FG003|Overall Study|Physician Decision|0|||
145534642|NCT02808650|524817002|FG004|Overall Study|Physician Decision|0|||
145534643|NCT02808650|524816998|FG000|Overall Study|Withdrawal by Subject|0|||
145534644|NCT02808650|524816999|FG001|Overall Study|Withdrawal by Subject|0|||
145534645|NCT02808650|524817000|FG002|Overall Study|Withdrawal by Subject|0|||
145534646|NCT02808650|524817001|FG003|Overall Study|Withdrawal by Subject|1|||
145534647|NCT02808650|524817002|FG004|Overall Study|Withdrawal by Subject|1|||
145534648|NCT01672736|524817006|FG000|Overall Study|Available drug expired on 31 May 16|3|||
145534649|NCT02853344|524817009|FG000|Overall Study|Lost to Follow-up|1|||
145534650|NCT02853344|524817010|FG001|Overall Study|Lost to Follow-up|1|||
145534651|NCT02853344|524817009|FG000|Overall Study|Withdrawal by Subject|2|||
145534652|NCT02853344|524817010|FG001|Overall Study|Withdrawal by Subject|4|||
145534653|NCT02853344|524817009|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
145534654|NCT02853344|524817010|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
145534655|NCT02853344|524817009|FG000|Overall Study|Death|70|||
145534656|NCT02853344|524817010|FG001|Overall Study|Death|112|||
145534657|NCT04251273|524817011|FG000|Overall Study|Lost to Follow-up|331|||
145773402|NCT02750410|525680642|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
145534658|NCT04251273|524817012|FG001|Overall Study|Lost to Follow-up|290|||
145534659|NCT00810693|524817013|FG000|Treatment Period|Adverse Event|8|||
145534660|NCT00810693|524817014|FG001|Treatment Period|Adverse Event|1|||
145534661|NCT00810693|524817015|FG002|Treatment Period|Adverse Event|7|||
145773403|NCT02750410|525680643|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
145773404|NCT02504541|525680644|FG000|Overall Study|Adverse Event|4|||
145534662|NCT00810693|524817013|FG000|Treatment Period|Death|0|||
145534663|NCT00810693|524817014|FG001|Treatment Period|Death|1|||
145534664|NCT00810693|524817015|FG002|Treatment Period|Death|2|||
145534665|NCT00810693|524817013|FG000|Treatment Period|Lack of Efficacy|0|||
145773405|NCT02504541|525680644|FG000|Overall Study|Withdrawal by Subject|4|||
145534666|NCT00810693|524817014|FG001|Treatment Period|Lack of Efficacy|0|||
145534667|NCT00810693|524817015|FG002|Treatment Period|Lack of Efficacy|1|||
145534668|NCT00810693|524817013|FG000|Treatment Period|Lost to Follow-up|1|||
145534669|NCT00810693|524817014|FG001|Treatment Period|Lost to Follow-up|0|||
145534670|NCT00810693|524817015|FG002|Treatment Period|Lost to Follow-up|0|||
145534671|NCT00810693|524817013|FG000|Treatment Period|Non-compliance|1|||
145773406|NCT02504541|525680644|FG000|Overall Study|Lost to Follow-up|1|||
145773407|NCT02504541|525680644|FG000|Overall Study|Met Stopping Criteria|1|||
145773408|NCT02504541|525680644|FG000|Overall Study|Protocol Violation|2|||
145773409|NCT02504541|525680644|FG000|Overall Study|Termination by Sponsor|1|||
145773410|NCT02504541|525680644|FG000|Overall Study|Other|2|||
145773411|NCT02504541|525680644|FG000|Overall Study|Multiple|5|||
145773412|NCT02318602|525680648|FG000|Overall Study|Adverse Event|0|||
145773413|NCT02318602|525680649|FG001|Overall Study|Adverse Event|1|||
145773414|NCT02318602|525680650|FG002|Overall Study|Adverse Event|1|||
145773415|NCT02318602|525680648|FG000|Overall Study|Withdrawal by Subject|0|||
145773416|NCT02318602|525680649|FG001|Overall Study|Withdrawal by Subject|3|||
145773417|NCT02318602|525680650|FG002|Overall Study|Withdrawal by Subject|0|||
145773418|NCT02318602|525680648|FG000|Overall Study|Death|1|||
145534672|NCT00810693|524817014|FG001|Treatment Period|Non-compliance|0|||
145534673|NCT00810693|524817015|FG002|Treatment Period|Non-compliance|0|||
145292773|NCT01370408|523922230|FG000|Overall Study|treatment failure|9|||
145534674|NCT00810693|524817013|FG000|Treatment Period|Protocol Violation|1|||
145534675|NCT00810693|524817014|FG001|Treatment Period|Protocol Violation|2|||
145534676|NCT00810693|524817015|FG002|Treatment Period|Protocol Violation|2|||
145534677|NCT00810693|524817013|FG000|Treatment Period|Withdrawal by Subject|6|||
145534678|NCT00810693|524817014|FG001|Treatment Period|Withdrawal by Subject|2|||
145534679|NCT00810693|524817015|FG002|Treatment Period|Withdrawal by Subject|3|||
145534680|NCT00810693|524817013|FG000|Treatment Period|Not treated|0|||
145534681|NCT00810693|524817014|FG001|Treatment Period|Not treated|1|||
145534682|NCT00810693|524817015|FG002|Treatment Period|Not treated|1|||
145534683|NCT00810693|524817013|FG000|Follow-up Period (FUP)|Adverse Event|3|||
145534684|NCT00810693|524817014|FG001|Follow-up Period (FUP)|Adverse Event|1|||
145534685|NCT00810693|524817015|FG002|Follow-up Period (FUP)|Adverse Event|1|||
145534686|NCT00810693|524817013|FG000|Follow-up Period (FUP)|Death|2|||
145534687|NCT00810693|524817014|FG001|Follow-up Period (FUP)|Death|0|||
145534688|NCT00810693|524817015|FG002|Follow-up Period (FUP)|Death|1|||
145534689|NCT00810693|524817013|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
145534690|NCT00810693|524817014|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
145534691|NCT00810693|524817015|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
145534692|NCT00810693|524817013|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
145534693|NCT00810693|524817014|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
145534694|NCT00810693|524817015|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
145534695|NCT00810693|524817013|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
145534696|NCT00810693|524817014|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
145534697|NCT00810693|524817015|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
145534698|NCT01033851|524817025|FG000|Overall Study|Withdrawal by Subject|3|||
145534699|NCT01033851|524817026|FG001|Overall Study|Withdrawal by Subject|7|||
145534700|NCT02919696|524817027|FG000|Overall Study|Adverse Event|1|||
145534701|NCT02919696|524817028|FG001|Overall Study|Adverse Event|2|||
145608297|NCT03015116|525080952|FG002|Overall Study|Physician Decision|0|||
145773419|NCT02318602|525680649|FG001|Overall Study|Death|0|||
145773420|NCT02318602|525680650|FG002|Overall Study|Death|0|||
145773421|NCT02318602|525680648|FG000|Overall Study|Guardian decision to withdraw|0|||
145534702|NCT02919696|524817027|FG000|Overall Study|Withdrawal by Subject|2|||
145534703|NCT02919696|524817028|FG001|Overall Study|Withdrawal by Subject|1|||
145534704|NCT02919696|524817027|FG000|Overall Study|Sponsor Decision|1|||
145534705|NCT02919696|524817028|FG001|Overall Study|Sponsor Decision|1|||
145534706|NCT02919696|524817027|FG000|Overall Study|Never Treated|0|||
145534707|NCT02919696|524817028|FG001|Overall Study|Never Treated|1|||
145534708|NCT01346969|524817029|FG000|Overall Study|Withdrawal by Subject|0|||
145534709|NCT01346969|524817030|FG001|Overall Study|Withdrawal by Subject|0|||
145534710|NCT01346969|524817031|FG002|Overall Study|Withdrawal by Subject|1|||
145534711|NCT01346969|524817032|FG003|Overall Study|Withdrawal by Subject|0|||
145534712|NCT01346969|524817029|FG000|Overall Study|Lost to Follow-up|1|||
145534713|NCT01346969|524817030|FG001|Overall Study|Lost to Follow-up|0|||
145534714|NCT01346969|524817031|FG002|Overall Study|Lost to Follow-up|2|||
145534715|NCT01346969|524817032|FG003|Overall Study|Lost to Follow-up|0|||
145534716|NCT01346969|524817029|FG000|Overall Study|Physician Decision|0|||
145534717|NCT01346969|524817030|FG001|Overall Study|Physician Decision|0|||
145534718|NCT01346969|524817031|FG002|Overall Study|Physician Decision|0|||
145534719|NCT01346969|524817032|FG003|Overall Study|Physician Decision|1|||
145534720|NCT01346969|524817029|FG000|Overall Study|Randomized but not treated|1|||
145534721|NCT01346969|524817030|FG001|Overall Study|Randomized but not treated|0|||
145534722|NCT01346969|524817031|FG002|Overall Study|Randomized but not treated|0|||
145534723|NCT01346969|524817032|FG003|Overall Study|Randomized but not treated|0|||
145534724|NCT03666624|524817033|FG000|Overall Study|participant grieving over recent death of parent|1|||
145534725|NCT03666624|524817034|FG001|Overall Study|participant grieving over recent death of parent|0|||
145773422|NCT02318602|525680649|FG001|Overall Study|Guardian decision to withdraw|0|||
145773423|NCT02318602|525680650|FG002|Overall Study|Guardian decision to withdraw|1|||
145773424|NCT02580058|525680653|FG000|Overall Study|Adverse Event|16|||
145773425|NCT02580058|525680654|FG001|Overall Study|Adverse Event|30|||
145773426|NCT02580058|525680655|FG002|Overall Study|Adverse Event|20|||
145773427|NCT02580058|525680653|FG000|Overall Study|Death|4|||
145773428|NCT02580058|525680654|FG001|Overall Study|Death|4|||
145773429|NCT02580058|525680655|FG002|Overall Study|Death|5|||
145773430|NCT02580058|525680653|FG000|Overall Study|Physician Decision|1|||
145773431|NCT02580058|525680654|FG001|Overall Study|Physician Decision|3|||
145773432|NCT02580058|525680655|FG002|Overall Study|Physician Decision|11|||
145773433|NCT02580058|525680653|FG000|Overall Study|Other|5|||
145773434|NCT02580058|525680654|FG001|Overall Study|Other|1|||
145773435|NCT02580058|525680655|FG002|Overall Study|Other|3|||
145773436|NCT02580058|525680653|FG000|Overall Study|Withdrawal by Subject|4|||
145773437|NCT02580058|525680654|FG001|Overall Study|Withdrawal by Subject|7|||
145773438|NCT02580058|525680655|FG002|Overall Study|Withdrawal by Subject|31|||
145773439|NCT02580058|525680653|FG000|Overall Study|Global Deterioration of Health Status|19|||
145773440|NCT02580058|525680654|FG001|Overall Study|Global Deterioration of Health Status|18|||
145773441|NCT02580058|525680655|FG002|Overall Study|Global Deterioration of Health Status|24|||
145773442|NCT02580058|525680653|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
145773443|NCT02580058|525680654|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145773444|NCT02580058|525680655|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
145773445|NCT02580058|525680653|FG000|Overall Study|Progressive Disease|137|||
145773446|NCT02580058|525680654|FG001|Overall Study|Progressive Disease|125|||
145773447|NCT02580058|525680655|FG002|Overall Study|Progressive Disease|94|||
145773448|NCT02580058|525680653|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145534726|NCT04815031|524817040|FG000|Overall Study|No adverse event information (missing information)|33|||
145534727|NCT02959983|524817041|FG000|Overall Study|Protocol Violation|0|||
145534728|NCT02959983|524817042|FG001|Overall Study|Protocol Violation|1|||
145534729|NCT02959983|524817041|FG000|Overall Study|Lack of Efficacy|0|||
145534730|NCT02959983|524817042|FG001|Overall Study|Lack of Efficacy|1|||
145534731|NCT02959983|524817041|FG000|Overall Study|Lost to Follow-up|12|||
145534732|NCT02959983|524817042|FG001|Overall Study|Lost to Follow-up|9|||
145534733|NCT02959983|524817041|FG000|Overall Study|Other|1|||
145534734|NCT02959983|524817042|FG001|Overall Study|Other|1|||
145534735|NCT02959983|524817041|FG000|Overall Study|Physician Decision|1|||
145534736|NCT02959983|524817042|FG001|Overall Study|Physician Decision|0|||
145773449|NCT02580058|525680654|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145773450|NCT02580058|525680655|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145534737|NCT02959983|524817041|FG000|Overall Study|Adverse Event|5|||
145534738|NCT02959983|524817042|FG001|Overall Study|Adverse Event|1|||
145534739|NCT02959983|524817041|FG000|Overall Study|Withdrawal by Subject|7|||
145534740|NCT02959983|524817042|FG001|Overall Study|Withdrawal by Subject|12|||
145534741|NCT01254630|524817043|FG000|Overall Study|Adverse Event|36|||
145534742|NCT01254630|524817044|FG001|Overall Study|Adverse Event|15|||
145534743|NCT01254630|524817045|FG002|Overall Study|Adverse Event|40|||
145534744|NCT01254630|524817046|FG003|Overall Study|Adverse Event|8|||
145534745|NCT01254630|524817043|FG000|Overall Study|Death|461|||
145534746|NCT01254630|524817044|FG001|Overall Study|Death|151|||
145534747|NCT01254630|524817045|FG002|Overall Study|Death|478|||
145534748|NCT01254630|524817046|FG003|Overall Study|Death|139|||
145534749|NCT01254630|524817043|FG000|Overall Study|Lost to Follow-up|80|||
145534750|NCT01254630|524817044|FG001|Overall Study|Lost to Follow-up|26|||
145534751|NCT01254630|524817045|FG002|Overall Study|Lost to Follow-up|89|||
145534752|NCT01254630|524817046|FG003|Overall Study|Lost to Follow-up|32|||
145534753|NCT01254630|524817043|FG000|Overall Study|Physician Decision|24|||
145534754|NCT01254630|524817044|FG001|Overall Study|Physician Decision|8|||
145534755|NCT01254630|524817045|FG002|Overall Study|Physician Decision|16|||
145534756|NCT01254630|524817046|FG003|Overall Study|Physician Decision|7|||
145534757|NCT01254630|524817043|FG000|Overall Study|Withdrawal by Subject|201|||
145534758|NCT01254630|524817044|FG001|Overall Study|Withdrawal by Subject|94|||
145534759|NCT01254630|524817045|FG002|Overall Study|Withdrawal by Subject|188|||
145534760|NCT01254630|524817046|FG003|Overall Study|Withdrawal by Subject|89|||
145534761|NCT01254630|524817043|FG000|Overall Study|Study terminated by sponsor|0|||
145534762|NCT01254630|524817044|FG001|Overall Study|Study terminated by sponsor|994|||
145534763|NCT01254630|524817045|FG002|Overall Study|Study terminated by sponsor|0|||
145534764|NCT01254630|524817046|FG003|Overall Study|Study terminated by sponsor|1010|||
145534765|NCT01254630|524817043|FG000|Overall Study|Status not recorded|0|||
145534766|NCT01254630|524817044|FG001|Overall Study|Status not recorded|0|||
145534767|NCT01254630|524817045|FG002|Overall Study|Status not recorded|1|||
145534768|NCT01254630|524817046|FG003|Overall Study|Status not recorded|0|||
145534769|NCT00484094|524817047|FG000|Overall Study|Discontinued|39|||
145534770|NCT00484094|524817047|FG000|Overall Study|Other|3|||
145534771|NCT01826604|524818528|FG000|Overall Study|Lost to Follow-up|8|||
145534772|NCT01826604|524818529|FG001|Overall Study|Lost to Follow-up|9|||
145534773|NCT01303861|524818535|FG000|Overall Study|Lost to Follow-up|34|||
145534774|NCT01303861|524818536|FG001|Overall Study|Lost to Follow-up|14|||
145534775|NCT01303861|524818537|FG002|Overall Study|Lost to Follow-up|27|||
145534776|NCT01303861|524818538|FG003|Overall Study|Lost to Follow-up|31|||
145534777|NCT01303861|524818535|FG000|Overall Study|Lack of Efficacy|3|||
145534778|NCT01303861|524818536|FG001|Overall Study|Lack of Efficacy|2|||
145534779|NCT01303861|524818537|FG002|Overall Study|Lack of Efficacy|1|||
145534780|NCT01303861|524818538|FG003|Overall Study|Lack of Efficacy|0|||
145534781|NCT01303861|524818535|FG000|Overall Study|Withdrawal by Subject|16|||
145534782|NCT01303861|524818536|FG001|Overall Study|Withdrawal by Subject|8|||
145534783|NCT01303861|524818537|FG002|Overall Study|Withdrawal by Subject|8|||
145534784|NCT01303861|524818538|FG003|Overall Study|Withdrawal by Subject|23|||
145534785|NCT01303861|524818535|FG000|Overall Study|Adverse Event|4|||
145534786|NCT01303861|524818536|FG001|Overall Study|Adverse Event|1|||
145534787|NCT01303861|524818537|FG002|Overall Study|Adverse Event|0|||
145534788|NCT01303861|524818538|FG003|Overall Study|Adverse Event|5|||
145534789|NCT01303861|524818535|FG000|Overall Study|Pregnancy|1|||
145534790|NCT01303861|524818536|FG001|Overall Study|Pregnancy|0|||
145534791|NCT01303861|524818537|FG002|Overall Study|Pregnancy|0|||
145534792|NCT01303861|524818538|FG003|Overall Study|Pregnancy|0|||
145608298|NCT01289041|525080957|FG000|Overall Study|Adverse Event|24|||
145608299|NCT01289041|525080957|FG000|Overall Study|Physician Decision|1|||
145534793|NCT03270644|524818550|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
145534794|NCT03270644|524818550|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
145534795|NCT01868503|524818551|FG000|Overall Study|Withdrawal by Subject|1|||
145534796|NCT01868503|524818551|FG000|Overall Study|Protocol Violation|1|||
145534797|NCT02476201|524818556|FG000|Overall Study|Unable to program MPP|9|||
145534798|NCT02476201|524818556|FG000|Overall Study|Study echo not performed|5|||
145534799|NCT02476201|524818556|FG000|Overall Study|Adverse Event|4|||
145534800|NCT02476201|524818556|FG000|Overall Study|Death|2|||
145534801|NCT02476201|524818556|FG000|Overall Study|Lost to Follow-up|2|||
145534802|NCT02476201|524818556|FG000|Overall Study|MPP programmed to OFF|2|||
145608300|NCT01289041|525080957|FG000|Overall Study|Progressive Disease|41|||
145773451|NCT01193335|525680656|FG000|After Infant Series|Lost to Follow-up|1|||
145773452|NCT01193335|525680657|FG001|After Infant Series|Lost to Follow-up|2|||
145773453|NCT01193335|525680656|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
145773454|NCT01193335|525680657|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
145773455|NCT01193335|525680656|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
145773456|NCT01193335|525680657|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
145534803|NCT02476201|524818556|FG000|Overall Study|Withdrawal by Subject|1|||
145534804|NCT02476201|524818556|FG000|Overall Study|Unsuccessful implant|1|||
145534805|NCT00691301|524818557|FG000|Overall Study|Adverse Event|10|||
145534806|NCT00691301|524818557|FG000|Overall Study|Death|2|||
145534807|NCT00691301|524818557|FG000|Overall Study|Lack of Efficacy|32|||
145534808|NCT00691301|524818557|FG000|Overall Study|Withdrawal by Subject|4|||
145534809|NCT00691301|524818557|FG000|Overall Study|Concurrent illness|2|||
145534810|NCT00691301|524818557|FG000|Overall Study|other reason|3|||
145534811|NCT00691301|524818557|FG000|Overall Study|Did not initiate study treatment|1|||
145534812|NCT02642029|524818558|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
145534813|NCT02642029|524818559|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
145534814|NCT02642029|524818560|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
145534815|NCT02642029|524818561|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
145534816|NCT02642029|524818562|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
145534817|NCT02642029|524818563|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
145534818|NCT02642029|524818558|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
145534819|NCT02642029|524818559|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
145534820|NCT02642029|524818560|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
145534821|NCT02642029|524818561|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
145534822|NCT02642029|524818562|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
145534823|NCT02642029|524818563|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
145534824|NCT02642029|524818558|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
145534825|NCT02642029|524818559|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
145534826|NCT02642029|524818560|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
145534827|NCT02642029|524818561|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
145534828|NCT02642029|524818562|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
145534829|NCT02642029|524818563|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
145534830|NCT02642029|524818558|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
145534831|NCT02642029|524818559|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
145534832|NCT02642029|524818560|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
145534833|NCT02642029|524818561|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
145534834|NCT02642029|524818562|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
145534835|NCT02642029|524818563|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
145534836|NCT02642029|524818558|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
145534837|NCT02642029|524818559|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
145534838|NCT02642029|524818560|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
145534839|NCT02642029|524818561|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
145534840|NCT02642029|524818562|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
145534841|NCT02642029|524818563|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
145534842|NCT02642029|524818558|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
145534843|NCT02642029|524818559|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
145534844|NCT02642029|524818560|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
145534845|NCT02642029|524818561|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
145534846|NCT02642029|524818562|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
145534847|NCT02642029|524818563|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
145534848|NCT01823146|524818564|FG000|Overall Study|Withdrawal by Subject|0|||
145773457|NCT01193335|525680656|FG000|1-Year Follow-up|Lost to Follow-up|4|||
145773458|NCT01193335|525680657|FG001|1-Year Follow-up|Lost to Follow-up|0|||
145773459|NCT01193335|525680656|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
145773460|NCT01193335|525680657|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
145534849|NCT01823146|524818565|FG001|Overall Study|Withdrawal by Subject|1|||
145534850|NCT01823146|524818564|FG000|Overall Study|Lost to Follow-up|2|||
145534851|NCT01823146|524818565|FG001|Overall Study|Lost to Follow-up|1|||
145534852|NCT00463580|524818567|FG000|Overall Study|Lost to Follow-up|1|||
145534853|NCT00463580|524818568|FG001|Overall Study|Lost to Follow-up|0|||
145534854|NCT00463580|524818567|FG000|Overall Study|Schedule conflict|2|||
145534855|NCT00463580|524818568|FG001|Overall Study|Schedule conflict|0|||
145534856|NCT00463580|524818567|FG000|Overall Study|Medical/psychiatric complications|0|||
145534857|NCT00463580|524818568|FG001|Overall Study|Medical/psychiatric complications|2|||
145534858|NCT03917459|524818569|FG000|Overall Study|Adverse Event|1|||
145773461|NCT01193335|525680656|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
145773462|NCT01193335|525680657|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
145773463|NCT01733329|525680658|FG000|Overall Study|Protocol Violation|1|||
145773464|NCT01733329|525680659|FG001|Overall Study|Protocol Violation|1|||
145773465|NCT01733329|525680658|FG000|Overall Study|Uterine artery injury|1|||
145773466|NCT01733329|525680659|FG001|Overall Study|Uterine artery injury|0|||
145773467|NCT00095303|525680668|FG000|Main Study|Lost to Follow-up|91|||
145773468|NCT00095303|525680669|FG001|Main Study|Lost to Follow-up|87|||
145773469|NCT00095303|525680668|FG000|Follow Up Study|Lost to Follow-up|59|||
145773470|NCT00095303|525680669|FG001|Follow Up Study|Lost to Follow-up|58|||
145773471|NCT01364467|525680672|FG000|Overall Study|Lost to Follow-up|1|||
145773472|NCT01364467|525680673|FG001|Overall Study|Lost to Follow-up|2|||
145773473|NCT03228186|525680674|FG000|Overall Study|Patient never started treatment|1|||
145534859|NCT03917459|524818570|FG001|Overall Study|Adverse Event|0|||
145534860|NCT03917459|524818569|FG000|Overall Study|Withdrawal by Subject|0|||
145534861|NCT03917459|524818570|FG001|Overall Study|Withdrawal by Subject|1|||
145534862|NCT00736944|524818571|FG000|Induction|Death|1|||
145534863|NCT00736944|524818571|FG000|Definitive Treatment|Physician Decision|1|||
145534864|NCT01426438|524818572|FG000|Overall Study|Lost to Follow-up|1|||
145534865|NCT01426438|524818573|FG001|Overall Study|Lost to Follow-up|3|||
145534866|NCT01426438|524818572|FG000|Overall Study|Off study Treatment|9|||
145534867|NCT01426438|524818573|FG001|Overall Study|Off study Treatment|3|||
145534868|NCT01426438|524818572|FG000|Overall Study|Poor scan quality|3|||
145534869|NCT01426438|524818573|FG001|Overall Study|Poor scan quality|2|||
145534870|NCT01426438|524818572|FG000|Overall Study|Missed Scan|2|||
145534871|NCT01426438|524818573|FG001|Overall Study|Missed Scan|2|||
145534872|NCT00676338|524818574|FG000|Overall Study|Adverse Event|6|||
145534873|NCT00676338|524818575|FG001|Overall Study|Adverse Event|6|||
145534874|NCT00676338|524818576|FG002|Overall Study|Adverse Event|5|||
145534875|NCT00676338|524818577|FG003|Overall Study|Adverse Event|1|||
145773474|NCT01634243|525680677|FG000|Overall Study|Adverse Event|5|||
145773475|NCT01634243|525680678|FG001|Overall Study|Adverse Event|5|||
145773476|NCT01634243|525680677|FG000|Overall Study|Lack of Efficacy|1|||
145773477|NCT01634243|525680678|FG001|Overall Study|Lack of Efficacy|0|||
145773478|NCT02502864|525680679|FG000|Overall Study|Withdrawal by Subject|1|||
145773479|NCT01450540|525680683|FG000|Overall Study|Withdrawal by Subject|19|||
145773480|NCT01450540|525680684|FG001|Overall Study|Withdrawal by Subject|13|||
145773481|NCT01450540|525680683|FG000|Overall Study|protocol deviation|3|||
145773482|NCT01450540|525680684|FG001|Overall Study|protocol deviation|23|||
145773483|NCT01687673|525680696|FG000|Overall Study|Physician Decision|1|||
145773484|NCT02234622|525680697|FG000|Overall Study|Withdrawal by Subject|16|||
145773485|NCT02234622|525680698|FG001|Overall Study|Withdrawal by Subject|22|||
145773486|NCT02234622|525680697|FG000|Overall Study|Lost to Follow-up|27|||
145773487|NCT02234622|525680698|FG001|Overall Study|Lost to Follow-up|14|||
145773488|NCT03598777|525680699|FG000|Overall Study|Study Terminated by Sponsor|3|||
145773489|NCT03598777|525680700|FG001|Overall Study|Study Terminated by Sponsor|0|||
145773490|NCT03598777|525680701|FG002|Overall Study|Study Terminated by Sponsor|0|||
145773491|NCT03598777|525680702|FG003|Overall Study|Study Terminated by Sponsor|0|||
145773492|NCT03598777|525680703|FG004|Overall Study|Study Terminated by Sponsor|15|||
145773493|NCT03598777|525680699|FG000|Overall Study|Withdrawal by Subject|1|||
145773494|NCT03598777|525680700|FG001|Overall Study|Withdrawal by Subject|1|||
145773495|NCT03598777|525680701|FG002|Overall Study|Withdrawal by Subject|0|||
145773496|NCT03598777|525680702|FG003|Overall Study|Withdrawal by Subject|0|||
145773497|NCT03598777|525680703|FG004|Overall Study|Withdrawal by Subject|0|||
145773498|NCT03598777|525680699|FG000|Overall Study|Adverse Event|1|||
145773499|NCT03598777|525680700|FG001|Overall Study|Adverse Event|0|||
145773500|NCT03598777|525680701|FG002|Overall Study|Adverse Event|0|||
145773501|NCT03598777|525680702|FG003|Overall Study|Adverse Event|0|||
145773502|NCT03598777|525680703|FG004|Overall Study|Adverse Event|0|||
145773503|NCT03598777|525680699|FG000|Overall Study|Lost to Follow-up|1|||
145773504|NCT03598777|525680700|FG001|Overall Study|Lost to Follow-up|0|||
145773505|NCT03598777|525680701|FG002|Overall Study|Lost to Follow-up|0|||
145773506|NCT03598777|525680702|FG003|Overall Study|Lost to Follow-up|0|||
145534876|NCT00676338|524818574|FG000|Overall Study|Lost to Follow-up|4|||
145534877|NCT00676338|524818575|FG001|Overall Study|Lost to Follow-up|1|||
145534878|NCT00676338|524818576|FG002|Overall Study|Lost to Follow-up|3|||
145534879|NCT00676338|524818577|FG003|Overall Study|Lost to Follow-up|4|||
145534880|NCT00676338|524818574|FG000|Overall Study|Physician Decision|3|||
145534881|NCT00676338|524818575|FG001|Overall Study|Physician Decision|3|||
145534882|NCT00676338|524818576|FG002|Overall Study|Physician Decision|2|||
145773507|NCT03598777|525680703|FG004|Overall Study|Lost to Follow-up|0|||
145773508|NCT02006576|525680704|FG000|Overall Study|Withdrawal by Subject|4|||
145534883|NCT00676338|524818577|FG003|Overall Study|Physician Decision|3|||
145773509|NCT02006576|525680705|FG001|Overall Study|Withdrawal by Subject|6|||
145773510|NCT02006576|525680706|FG002|Overall Study|Withdrawal by Subject|2|||
145773511|NCT02006576|525680704|FG000|Overall Study|Death|0|||
145773512|NCT02006576|525680705|FG001|Overall Study|Death|0|||
145773513|NCT02006576|525680706|FG002|Overall Study|Death|1|||
145773514|NCT02006576|525680704|FG000|Overall Study|Lost to Follow-up|1|||
145292774|NCT05014412|523922232|FG000|Overall Study|Death|11|||
145534884|NCT00676338|524818574|FG000|Overall Study|Protocol Violation|5|||
145773515|NCT02006576|525680705|FG001|Overall Study|Lost to Follow-up|0|||
145773516|NCT02006576|525680706|FG002|Overall Study|Lost to Follow-up|1|||
145773517|NCT02006576|525680704|FG000|Overall Study|Screen Failure, too sick, other|13|||
145773518|NCT02006576|525680705|FG001|Overall Study|Screen Failure, too sick, other|1|||
145773519|NCT02006576|525680706|FG002|Overall Study|Screen Failure, too sick, other|13|||
145773520|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
145773521|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
145773522|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
145773523|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
145773524|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
145773525|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
145773526|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
145773527|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
145773528|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
145773529|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
145773530|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
145773531|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
145773532|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
145773533|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
145773534|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
145773535|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
145773536|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
145773537|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
145773538|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
145773539|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
145773540|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
145773541|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
145773542|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
145773543|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
145773544|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
145773545|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
145773546|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
145773547|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
145773548|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
145773549|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
145773550|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
145773551|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
145773552|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
145773553|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
145773554|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
145773555|NCT00785577|525680707|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
145773556|NCT00785577|525680708|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
145773557|NCT00785577|525680709|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
145773558|NCT00785577|525680710|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
145773559|NCT00785577|525680711|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
145773560|NCT00785577|525680707|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
145773561|NCT00785577|525680708|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
145773562|NCT00785577|525680709|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
145773563|NCT00785577|525680710|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
145773564|NCT00785577|525680711|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
145773565|NCT00785577|525680707|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
145773566|NCT00785577|525680708|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
145773567|NCT00785577|525680709|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
145773568|NCT00785577|525680710|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
145773569|NCT00785577|525680711|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
145773570|NCT01650805|525680714|FG000|Overall Study|Withdrawal by Subject|1|||
145773571|NCT01650805|525680715|FG001|Overall Study|Withdrawal by Subject|0|||
145773572|NCT02452359|525680718|FG000|Overall Study|Adverse Event|1|||
145773573|NCT02452359|525680718|FG000|Overall Study|Lost to Follow-up|15|||
145773574|NCT02452359|525680718|FG000|Overall Study|Pregnancy|1|||
145773575|NCT02452359|525680718|FG000|Overall Study|Withdrawal by Subject|4|||
145773576|NCT01887210|525680719|FG000|Overall Study|Withdrawal by Subject|1|||
145773577|NCT01887210|525680720|FG001|Overall Study|Withdrawal by Subject|3|||
145773578|NCT01887210|525680719|FG000|Overall Study|Lost to Follow-up|0|||
145773579|NCT01887210|525680720|FG001|Overall Study|Lost to Follow-up|1|||
145773580|NCT02515669|525680725|FG000|228 Week Open-Label Phase|Other|0|||
145773581|NCT02515669|525680726|FG001|228 Week Open-Label Phase|Other|0|||
145773582|NCT02515669|525680727|FG002|228 Week Open-Label Phase|Other|1|||
145773583|NCT02515669|525680728|FG003|228 Week Open-Label Phase|Other|4|||
145773584|NCT02515669|525680725|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
145773585|NCT02515669|525680726|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
145292775|NCT05014412|523922233|FG001|Overall Study|Death|7|||
145534885|NCT00676338|524818575|FG001|Overall Study|Protocol Violation|9|||
145534886|NCT00676338|524818576|FG002|Overall Study|Protocol Violation|2|||
145534887|NCT00676338|524818577|FG003|Overall Study|Protocol Violation|5|||
145534888|NCT00676338|524818574|FG000|Overall Study|Withdrawal by Subject|17|||
145534889|NCT00676338|524818575|FG001|Overall Study|Withdrawal by Subject|9|||
145534890|NCT00676338|524818576|FG002|Overall Study|Withdrawal by Subject|12|||
145534891|NCT00676338|524818577|FG003|Overall Study|Withdrawal by Subject|6|||
145534892|NCT00676338|524818574|FG000|Overall Study|Entry Criteria Not Met|0|||
145534893|NCT00676338|524818575|FG001|Overall Study|Entry Criteria Not Met|2|||
145534894|NCT00676338|524818576|FG002|Overall Study|Entry Criteria Not Met|1|||
145534895|NCT00676338|524818577|FG003|Overall Study|Entry Criteria Not Met|1|||
145534896|NCT00676338|524818574|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
145534897|NCT00676338|524818575|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
145534898|NCT00676338|524818576|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
145534899|NCT00676338|524818577|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
145534900|NCT00412542|524818578|FG000|Overall Study|Withdrawal by Subject|0|||
145534901|NCT00412542|524818579|FG001|Overall Study|Withdrawal by Subject|2|||
145534902|NCT00412542|524818578|FG000|Overall Study|Not Eligible|0|||
145534903|NCT00412542|524818579|FG001|Overall Study|Not Eligible|1|||
145534904|NCT01604408|524818584|FG000|Treatment Period 1|Protocol Violation|0|||
145534905|NCT01604408|524818585|FG001|Treatment Period 1|Protocol Violation|1|||
145534906|NCT01604408|524818584|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145534907|NCT01604408|524818585|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145608301|NCT01289041|525080957|FG000|Overall Study|Withdrawal by Subject|3|||
145608302|NCT01289041|525080957|FG000|Overall Study|Death|1|||
145608303|NCT02714868|525080964|FG000|Overall Study|Withdrawal by Subject|3|||
145608304|NCT02714868|525080965|FG001|Overall Study|Withdrawal by Subject|0|||
145608305|NCT02714868|525080964|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
145773586|NCT02515669|525680727|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
145773587|NCT02515669|525680728|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
145773588|NCT02515669|525680725|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
145773589|NCT02515669|525680726|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
145773590|NCT02515669|525680727|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
145773591|NCT02515669|525680728|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
145773592|NCT02515669|525680725|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
145773593|NCT02515669|525680726|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
145773594|NCT02515669|525680727|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
145773595|NCT02515669|525680728|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
145773596|NCT02515669|525680725|FG000|228 Week Open-Label Phase|Missing|0|||
145773597|NCT02515669|525680726|FG001|228 Week Open-Label Phase|Missing|2|||
145773598|NCT02515669|525680727|FG002|228 Week Open-Label Phase|Missing|2|||
145773599|NCT02515669|525680728|FG003|228 Week Open-Label Phase|Missing|2|||
145773600|NCT02332915|525680731|FG000|Overall Study|Moved out of region|3|||
145773601|NCT02332915|525680732|FG001|Overall Study|Moved out of region|0|||
145773602|NCT02332915|525680731|FG000|Overall Study|Unrelated illness|1|||
145773603|NCT02332915|525680732|FG001|Overall Study|Unrelated illness|1|||
145773604|NCT02332915|525680731|FG000|Overall Study|Travel distance prohibitive|0|||
145773605|NCT02332915|525680732|FG001|Overall Study|Travel distance prohibitive|1|||
145773606|NCT02332915|525680731|FG000|Overall Study|did not meet inclusion criteria|2|||
145773607|NCT02332915|525680732|FG001|Overall Study|did not meet inclusion criteria|4|||
145773608|NCT01901328|525680736|FG000|Overall Study|Lost to Follow-up|1|||
145773609|NCT01901328|525680737|FG001|Overall Study|Lost to Follow-up|0|||
145773610|NCT01901328|525680736|FG000|Overall Study|Physician Decision|0|||
145773611|NCT01901328|525680737|FG001|Overall Study|Physician Decision|1|||
145773612|NCT01901328|525680736|FG000|Overall Study|Protocol Violation|1|||
145278850|NCT00995930|523870901|FG001|Overall Study|Withdrawal by Subject|4|||
145278851|NCT00995930|523870900|FG000|Overall Study|Adverse Event|11|||
145278852|NCT00995930|523870901|FG001|Overall Study|Adverse Event|14|||
145278853|NCT01458119|523870902|FG000|Overall Study|Physician Decision|4|||
145278854|NCT01458119|523870902|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
145278855|NCT01458119|523870902|FG000|Overall Study|Pregnancy|1|||
145278856|NCT01458119|523870902|FG000|Overall Study|Death|2|||
145278857|NCT01458119|523870902|FG000|Overall Study|Adverse Event|1|||
145278858|NCT01458119|523870902|FG000|Overall Study|Consent Withdrawn by Participant|8|||
145278859|NCT01458119|523870902|FG000|Overall Study|Non-compliance With Study Drug|3|||
145278860|NCT03033069|523870903|FG000|Overall Study|Adverse Event|6|||
145534908|NCT01604408|524818584|FG000|Treatment Period 2|Protocol Violation|1|||
145534909|NCT01604408|524818585|FG001|Treatment Period 2|Protocol Violation|0|||
145534910|NCT01604408|524818584|FG000|Treatment Period 2|Adverse Event|0|||
145773613|NCT01901328|525680737|FG001|Overall Study|Protocol Violation|1|||
145773614|NCT01901328|525680736|FG000|Overall Study|Study Terminated by Sponsor|19|||
145773615|NCT01901328|525680737|FG001|Overall Study|Study Terminated by Sponsor|16|||
145278861|NCT03033069|523870904|FG001|Overall Study|Adverse Event|7|||
145278862|NCT03033069|523870905|FG002|Overall Study|Adverse Event|4|||
145534911|NCT01604408|524818585|FG001|Treatment Period 2|Adverse Event|1|||
145534912|NCT01604408|524818584|FG000|Treatment Period 3|Protocol Violation|1|||
145534913|NCT01604408|524818585|FG001|Treatment Period 3|Protocol Violation|1|||
145773616|NCT01901328|525680736|FG000|Overall Study|Withdrawal by Subject|1|||
145773617|NCT01901328|525680737|FG001|Overall Study|Withdrawal by Subject|2|||
145773618|NCT01901328|525680736|FG000|Overall Study|Lack of Efficacy|0|||
145773619|NCT01901328|525680737|FG001|Overall Study|Lack of Efficacy|1|||
145773620|NCT05847881|525680738|FG000|Overall Study|Principal Investigator Decision|8|||
145773621|NCT05847881|525680738|FG000|Overall Study|Withdrawal by Subject|2|||
145773622|NCT03746080|525682011|FG000|Overall Study|In follow up|2|||
145773623|NCT03746080|525682011|FG000|Overall Study|Death|15|||
145773624|NCT03199911|525682019|FG000|Overall Study|Lost to Follow-up|5|||
145773625|NCT03199911|525682020|FG001|Overall Study|Lost to Follow-up|5|||
145773626|NCT03199911|525682019|FG000|Overall Study|Did not proceed with surgery|2|||
145773627|NCT03199911|525682020|FG001|Overall Study|Did not proceed with surgery|1|||
145773628|NCT04430348|525682021|FG000|Overall Study|Death|3|||
145773629|NCT04430348|525682022|FG001|Overall Study|Death|2|||
145773630|NCT04430348|525682023|FG002|Overall Study|Death|2|||
145534914|NCT01604408|524818584|FG000|Treatment Period 3|Adverse Event|0|||
145773631|NCT04430348|525682024|FG003|Overall Study|Death|2|||
145773632|NCT04430348|525682025|FG004|Overall Study|Death|2|||
145773633|NCT04430348|525682026|FG005|Overall Study|Death|3|||
145773634|NCT04430348|525682021|FG000|Overall Study|Lost to Follow-up|0|||
145773635|NCT04430348|525682022|FG001|Overall Study|Lost to Follow-up|0|||
145773636|NCT04430348|525682023|FG002|Overall Study|Lost to Follow-up|0|||
145773637|NCT04430348|525682024|FG003|Overall Study|Lost to Follow-up|1|||
145773638|NCT04430348|525682025|FG004|Overall Study|Lost to Follow-up|0|||
145773639|NCT04430348|525682026|FG005|Overall Study|Lost to Follow-up|0|||
145773640|NCT04430348|525682021|FG000|Overall Study|Adverse Event|0|||
145773641|NCT04430348|525682022|FG001|Overall Study|Adverse Event|0|||
145773642|NCT04430348|525682023|FG002|Overall Study|Adverse Event|0|||
145773643|NCT04430348|525682024|FG003|Overall Study|Adverse Event|0|||
145773644|NCT04430348|525682025|FG004|Overall Study|Adverse Event|0|||
145773645|NCT04430348|525682026|FG005|Overall Study|Adverse Event|1|||
145773646|NCT04430348|525682021|FG000|Overall Study|Withdrawal by Subject|0|||
145773647|NCT04430348|525682022|FG001|Overall Study|Withdrawal by Subject|1|||
145773648|NCT04430348|525682023|FG002|Overall Study|Withdrawal by Subject|0|||
145773649|NCT04430348|525682024|FG003|Overall Study|Withdrawal by Subject|0|||
145773650|NCT04430348|525682025|FG004|Overall Study|Withdrawal by Subject|0|||
145773651|NCT04430348|525682026|FG005|Overall Study|Withdrawal by Subject|1|||
145773652|NCT04430348|525682021|FG000|Overall Study|Study Terminated by Sponsor|0|||
145773653|NCT04430348|525682022|FG001|Overall Study|Study Terminated by Sponsor|0|||
145534915|NCT01604408|524818585|FG001|Treatment Period 3|Adverse Event|3|||
145534916|NCT01604408|524818584|FG000|Treatment Period 3|Withdrawal by Subject|3|||
145534917|NCT01604408|524818585|FG001|Treatment Period 3|Withdrawal by Subject|1|||
145534918|NCT01604408|524818584|FG000|Treatment Period 3|Sponsor Decision|1|||
145534919|NCT01604408|524818585|FG001|Treatment Period 3|Sponsor Decision|0|||
145534920|NCT01604408|524818584|FG000|Treatment Period 4|Death|1|||
145534921|NCT01604408|524818585|FG001|Treatment Period 4|Death|0|||
145534922|NCT01604408|524818584|FG000|Treatment Period 4|Withdrawal by Subject|2|||
145534923|NCT01604408|524818585|FG001|Treatment Period 4|Withdrawal by Subject|1|||
145534924|NCT01604408|524818584|FG000|Treatment Period 4|Adverse Event|0|||
145534925|NCT01604408|524818585|FG001|Treatment Period 4|Adverse Event|1|||
145534926|NCT01604408|524818584|FG000|Treatment Period 5|Adverse Event|4|||
145534927|NCT01604408|524818585|FG001|Treatment Period 5|Adverse Event|0|||
145534928|NCT01604408|524818584|FG000|Treatment Period 6|Lost to Follow-up|0|||
145534929|NCT01604408|524818585|FG001|Treatment Period 6|Lost to Follow-up|1|||
145773654|NCT04430348|525682023|FG002|Overall Study|Study Terminated by Sponsor|2|||
145773655|NCT04430348|525682024|FG003|Overall Study|Study Terminated by Sponsor|0|||
145534930|NCT01604408|524818584|FG000|Treatment Period 6|Adverse Event|2|||
145534931|NCT01604408|524818585|FG001|Treatment Period 6|Adverse Event|0|||
145534932|NCT01604408|524818584|FG000|Treatment Period 6|Sponsor decision|0|||
145534933|NCT01604408|524818585|FG001|Treatment Period 6|Sponsor decision|1|||
145534934|NCT01604408|524818584|FG000|Observation Period|Adverse Event|1|||
145534935|NCT01604408|524818585|FG001|Observation Period|Adverse Event|1|||
145534936|NCT01604408|524818584|FG000|Observation Period|Withdrawal by Subject|0|||
145534937|NCT01604408|524818585|FG001|Observation Period|Withdrawal by Subject|2|||
145534938|NCT00075218|524818586|FG000|Double-Blind Treatment|Adverse Event|23|||
145534939|NCT00075218|524818587|FG001|Double-Blind Treatment|Adverse Event|4|||
145773656|NCT04430348|525682025|FG004|Overall Study|Study Terminated by Sponsor|1|||
145773657|NCT04430348|525682026|FG005|Overall Study|Study Terminated by Sponsor|1|||
145773658|NCT02874794|525682029|FG000|Overall Study|Physician Decision|3|||
145773659|NCT02874794|525682030|FG001|Overall Study|Physician Decision|2|||
145773660|NCT02874794|525682029|FG000|Overall Study|Withdrawal by Subject|2|||
145773661|NCT02874794|525682030|FG001|Overall Study|Withdrawal by Subject|8|||
145773662|NCT02874794|525682029|FG000|Overall Study|Death|2|||
145773663|NCT02874794|525682030|FG001|Overall Study|Death|1|||
145773664|NCT04328623|525682031|FG000|Overall Study|Protocol Violation|0|||
145773665|NCT04328623|525682032|FG001|Overall Study|Protocol Violation|1|||
145534940|NCT00075218|524818588|FG002|Double-Blind Treatment|Adverse Event|0|||
145534941|NCT00075218|524818586|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
145534942|NCT00075218|524818587|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
145534943|NCT00075218|524818588|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
145534944|NCT00075218|524818586|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
145534945|NCT00075218|524818587|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
145534946|NCT00075218|524818588|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
145534947|NCT00075218|524818586|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
145534948|NCT00075218|524818587|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
145534949|NCT00075218|524818588|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
145773666|NCT03839524|525682034|FG000|Overall Study|Adverse Event|1|||
145773667|NCT05309668|525682038|FG000|Overall Study|Ongoing at data cut-off|14|||
145773668|NCT05309668|525682039|FG001|Overall Study|Ongoing at data cut-off|17|||
145773669|NCT05309668|525682040|FG002|Overall Study|Ongoing at data cut-off|4|||
145773670|NCT03715465|525682041|FG000|Overall Study|Withdrawal by Subject|1|||
145773671|NCT03715465|525682042|FG001|Overall Study|Withdrawal by Subject|2|||
145773672|NCT02465034|525682050|FG000|Overall Study|Withdrawal by Subject|1|||
145773673|NCT02465034|525682051|FG001|Overall Study|Withdrawal by Subject|1|||
145773674|NCT02465034|525682050|FG000|Overall Study|Screen fail|2|||
145773675|NCT02465034|525682051|FG001|Overall Study|Screen fail|0|||
145773676|NCT02465034|525682050|FG000|Overall Study|Could not be scheduled for study visit|0|||
145773677|NCT02465034|525682051|FG001|Overall Study|Could not be scheduled for study visit|5|||
145773678|NCT02401256|525682057|FG000|Overall Study|Adverse Event|5|||
145773679|NCT02401256|525682057|FG000|Overall Study|Withdrawal by Subject|12|||
145773680|NCT01451515|525682064|FG000|Overall Study|Death|0|||
145773681|NCT01451515|525682065|FG001|Overall Study|Death|1|||
145773682|NCT01451515|525682066|FG002|Overall Study|Death|0|||
145773683|NCT01451515|525682064|FG000|Overall Study|Withdrawal by Subject|0|||
145773684|NCT01451515|525682065|FG001|Overall Study|Withdrawal by Subject|1|||
145773685|NCT01451515|525682066|FG002|Overall Study|Withdrawal by Subject|0|||
145773686|NCT01451515|525682064|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
145773687|NCT01451515|525682065|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
145773688|NCT01451515|525682066|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
145773689|NCT01451515|525682064|FG000|Overall Study|Relapse (except CNS)|1|||
145773690|NCT01451515|525682065|FG001|Overall Study|Relapse (except CNS)|1|||
145773691|NCT01451515|525682066|FG002|Overall Study|Relapse (except CNS)|0|||
145773692|NCT02317510|525682068|FG000|Overall Study|Adverse Event|0|||
145773693|NCT02317510|525682069|FG001|Overall Study|Adverse Event|1|||
145773694|NCT03427073|525682070|FG000|Overall Study|Disease Progression|1|||
145773695|NCT03427073|525682071|FG001|Overall Study|Disease Progression|1|||
145773696|NCT03427073|525682072|FG002|Overall Study|Disease Progression|1|||
145773697|NCT03427073|525682073|FG003|Overall Study|Disease Progression|3|||
145773698|NCT03427073|525682074|FG004|Overall Study|Disease Progression|3|||
145773699|NCT03427073|525682075|FG005|Overall Study|Disease Progression|4|||
145773700|NCT03427073|525682076|FG006|Overall Study|Disease Progression|2|||
145534950|NCT00075218|524818586|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
145534951|NCT00075218|524818587|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
145608306|NCT02714868|525080965|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
145608307|NCT02714868|525080964|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
145608308|NCT02714868|525080965|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
145773701|NCT03427073|525682077|FG007|Overall Study|Disease Progression|3|||
145773702|NCT03427073|525682070|FG000|Overall Study|Physician Decision|0|||
145773703|NCT03427073|525682071|FG001|Overall Study|Physician Decision|0|||
145773704|NCT03427073|525682072|FG002|Overall Study|Physician Decision|0|||
145773705|NCT03427073|525682073|FG003|Overall Study|Physician Decision|0|||
145773706|NCT03427073|525682074|FG004|Overall Study|Physician Decision|0|||
145773707|NCT03427073|525682075|FG005|Overall Study|Physician Decision|0|||
145773708|NCT03427073|525682076|FG006|Overall Study|Physician Decision|1|||
145773709|NCT03427073|525682077|FG007|Overall Study|Physician Decision|1|||
145773710|NCT03047213|525682081|FG000|Overall Study|Withdrawal by Subject|2|||
145773711|NCT03047213|525682082|FG001|Overall Study|Withdrawal by Subject|0|||
145773712|NCT03047213|525682081|FG000|Overall Study|Adverse Event|2|||
145403545|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145534952|NCT00075218|524818588|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
145773713|NCT03047213|525682082|FG001|Overall Study|Adverse Event|0|||
145773714|NCT04786210|525682083|FG000|Overall Study|Lost to Follow-up|2|||
145773715|NCT04786210|525682083|FG000|Overall Study|Withdrawal by Subject|4|||
145773716|NCT04334148|525682084|FG000|Overall Study|positive nasal swab at baseline|0|||
145773717|NCT04334148|525682085|FG001|Overall Study|positive nasal swab at baseline|1|||
145773718|NCT00498173|525682086|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
145773719|NCT00498173|525682087|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
145773720|NCT00498173|525682088|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
145773721|NCT00258154|525682089|FG000|Overall Study|Adverse Event|1|||
145773722|NCT00258154|525682090|FG001|Overall Study|Adverse Event|0|||
145773723|NCT00258154|525682089|FG000|Overall Study|Lost to Follow-up|0|||
145534953|NCT00075218|524818586|FG000|Double-Blind Treatment|No study medication taken|2|||
145534954|NCT00075218|524818587|FG001|Double-Blind Treatment|No study medication taken|0|||
145773724|NCT00258154|525682090|FG001|Overall Study|Lost to Follow-up|1|||
145773725|NCT00258154|525682089|FG000|Overall Study|Protocol Violation|2|||
145773726|NCT00258154|525682090|FG001|Overall Study|Protocol Violation|1|||
145773727|NCT00258154|525682089|FG000|Overall Study|Withdrawal by Subject|3|||
145773728|NCT00258154|525682090|FG001|Overall Study|Withdrawal by Subject|4|||
145773729|NCT00258154|525682089|FG000|Overall Study|Patient Moved|3|||
145773730|NCT00258154|525682090|FG001|Overall Study|Patient Moved|1|||
145773731|NCT03772327|525682091|FG000|Overall Study|Lost to Follow-up|3|||
145773732|NCT03772327|525682092|FG001|Overall Study|Lost to Follow-up|4|||
145773733|NCT03772327|525682091|FG000|Overall Study|Withdrawal by Subject|2|||
145773734|NCT03772327|525682092|FG001|Overall Study|Withdrawal by Subject|3|||
145773735|NCT04689828|525682093|FG000|Overall Study|Subject decision|5|||
145773736|NCT04689828|525682094|FG001|Overall Study|Subject decision|5|||
145773737|NCT04689828|525682093|FG000|Overall Study|Adverse Event|12|||
145773738|NCT04689828|525682094|FG001|Overall Study|Adverse Event|12|||
145773739|NCT04689828|525682093|FG000|Overall Study|Physician Decision|24|||
145773740|NCT04689828|525682094|FG001|Overall Study|Physician Decision|32|||
145773741|NCT04689828|525682093|FG000|Overall Study|Progressive disease|54|||
145773742|NCT04689828|525682094|FG001|Overall Study|Progressive disease|173|||
145773743|NCT04689828|525682093|FG000|Overall Study|Death|0|||
145773744|NCT04689828|525682094|FG001|Overall Study|Death|1|||
145773745|NCT04689828|525682093|FG000|Overall Study|Lost to Follow-up|1|||
145773746|NCT04689828|525682094|FG001|Overall Study|Lost to Follow-up|0|||
145773747|NCT04689828|525682093|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
145773748|NCT04689828|525682094|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
145773749|NCT04689828|525682093|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
145773750|NCT04689828|525682094|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
145773751|NCT04689828|525682093|FG000|Overall Study|Participants not treated|7|||
145773752|NCT04689828|525682094|FG001|Overall Study|Participants not treated|2|||
145773753|NCT02493751|525682095|FG000|Overall Study|Withdrawal by Subject|2|||
145773754|NCT02493751|525682096|FG001|Overall Study|Withdrawal by Subject|8|||
145773755|NCT02493751|525682095|FG000|Overall Study|Death|6|||
145773756|NCT02493751|525682096|FG001|Overall Study|Death|13|||
145773757|NCT02493751|525682095|FG000|Overall Study|Lost to Follow-up|2|||
145773758|NCT02493751|525682096|FG001|Overall Study|Lost to Follow-up|3|||
145773759|NCT02493751|525682095|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
145773760|NCT02493751|525682096|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
145773761|NCT01824602|525682098|FG000|Overall Study|Withdrawal by Subject|0|||
145773762|NCT01824602|525682099|FG001|Overall Study|Withdrawal by Subject|0|||
145773763|NCT01824602|525682100|FG002|Overall Study|Withdrawal by Subject|1|||
145773764|NCT01824602|525682101|FG003|Overall Study|Withdrawal by Subject|2|||
145773765|NCT01824602|525682098|FG000|Overall Study|Patient non-compliance|0|||
145773766|NCT01824602|525682099|FG001|Overall Study|Patient non-compliance|0|||
145773767|NCT01824602|525682100|FG002|Overall Study|Patient non-compliance|1|||
145773768|NCT01824602|525682101|FG003|Overall Study|Patient non-compliance|0|||
145773769|NCT01824602|525682098|FG000|Overall Study|Adverse Event|1|||
145773770|NCT01824602|525682099|FG001|Overall Study|Adverse Event|0|||
145773771|NCT01824602|525682100|FG002|Overall Study|Adverse Event|2|||
145773772|NCT01824602|525682101|FG003|Overall Study|Adverse Event|2|||
145773773|NCT01824602|525682098|FG000|Overall Study|Treatment failure|0|||
145773774|NCT01824602|525682099|FG001|Overall Study|Treatment failure|0|||
145773775|NCT01824602|525682100|FG002|Overall Study|Treatment failure|0|||
145773776|NCT01824602|525682101|FG003|Overall Study|Treatment failure|1|||
145534955|NCT00075218|524818588|FG002|Double-Blind Treatment|No study medication taken|0|||
145534956|NCT00075218|524818586|FG000|Open-Label Treatment|Lack of Efficacy|0|||
145534957|NCT00075218|524818587|FG001|Open-Label Treatment|Lack of Efficacy|0|||
145534958|NCT00075218|524818588|FG002|Open-Label Treatment|Lack of Efficacy|174|||
145534959|NCT00075218|524818586|FG000|Open-Label Treatment|Adverse Event|0|||
145773777|NCT00184054|525682102|FG000|Overall Study|Adverse Event|1|||
145534960|NCT00075218|524818587|FG001|Open-Label Treatment|Adverse Event|0|||
145403546|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
145534961|NCT00075218|524818588|FG002|Open-Label Treatment|Adverse Event|51|||
145773778|NCT02485717|525682107|FG000|Overall Study|Lost to Follow-up|6|||
145773779|NCT02485717|525682108|FG001|Overall Study|Lost to Follow-up|0|||
145773780|NCT02485717|525682109|FG002|Overall Study|Lost to Follow-up|0|||
145773781|NCT02485717|525682107|FG000|Overall Study|Withdrawal by Subject|0|||
145773782|NCT02485717|525682108|FG001|Overall Study|Withdrawal by Subject|0|||
145773783|NCT02485717|525682109|FG002|Overall Study|Withdrawal by Subject|1|||
145773784|NCT02485717|525682107|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
145773785|NCT02485717|525682108|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
145773786|NCT02485717|525682109|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
145773787|NCT02485717|525682107|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
145773788|NCT02485717|525682108|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
145534962|NCT00075218|524818586|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
145534963|NCT00075218|524818587|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
145534964|NCT00075218|524818588|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
145534965|NCT00075218|524818586|FG000|Open-Label Treatment|Decision of Sponsor|0|||
145534966|NCT00075218|524818587|FG001|Open-Label Treatment|Decision of Sponsor|0|||
145534967|NCT00075218|524818588|FG002|Open-Label Treatment|Decision of Sponsor|8|||
145534968|NCT00075218|524818586|FG000|Open-Label Treatment|Protocol Violation|0|||
145534969|NCT00075218|524818587|FG001|Open-Label Treatment|Protocol Violation|0|||
145534970|NCT00075218|524818588|FG002|Open-Label Treatment|Protocol Violation|1|||
145534971|NCT00075218|524818586|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
145534972|NCT00075218|524818587|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
145534973|NCT00075218|524818588|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
145534974|NCT03643575|524818589|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
145534975|NCT03643575|524818590|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
145534976|NCT03643575|524818591|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
145534977|NCT03643575|524818592|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
145534978|NCT03643575|524818593|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
145534979|NCT03643575|524818594|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
145534980|NCT03643575|524818589|FG000|Washout: 7 Days|Adverse Event|1|||
145773789|NCT02485717|525682109|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
145773790|NCT02192359|525682110|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
145773791|NCT02192359|525682111|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
145773792|NCT02192359|525682112|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
145773793|NCT02192359|525682113|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
145773794|NCT02192359|525682110|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
145773795|NCT02192359|525682111|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
145773796|NCT02192359|525682112|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
145773797|NCT02192359|525682113|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
145773798|NCT02192359|525682110|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
145773799|NCT02192359|525682111|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
145773800|NCT02192359|525682112|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
145773801|NCT02192359|525682113|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
145773802|NCT00828451|525682116|FG000|Overall Study|Death|2|||
145773803|NCT00828451|525682116|FG000|Overall Study|Lack of intravenous line|7|||
145773804|NCT00828451|525682116|FG000|Overall Study|Withdrawal by Subject|1|||
145773805|NCT00828451|525682116|FG000|Overall Study|Deterioration in clinical status|1|||
145773806|NCT03256539|525682117|FG000|Overall Study|Withdrawal by Subject|0|||
145773807|NCT03256539|525682118|FG001|Overall Study|Withdrawal by Subject|3|||
145773808|NCT03256539|525682117|FG000|Overall Study|Unexpected closure of study components|8|||
145773809|NCT03256539|525682118|FG001|Overall Study|Unexpected closure of study components|4|||
145773810|NCT02827877|525682119|FG000|Overall Study|Withdrawal by Subject|1|||
145773811|NCT03914300|525682121|FG000|Overall Study|Adverse Event|1|||
145773812|NCT03478683|525682128|FG000|Overall Study|Adverse Event|5|||
145773813|NCT03478683|525682129|FG001|Overall Study|Adverse Event|3|||
145773814|NCT03478683|525682128|FG000|Overall Study|Lost to Follow-up|0|||
145773815|NCT03478683|525682129|FG001|Overall Study|Lost to Follow-up|5|||
145773816|NCT03478683|525682128|FG000|Overall Study|Physician Decision|1|||
145773817|NCT03478683|525682129|FG001|Overall Study|Physician Decision|3|||
145773818|NCT03478683|525682128|FG000|Overall Study|Withdrawal by Subject|7|||
145773819|NCT03478683|525682129|FG001|Overall Study|Withdrawal by Subject|7|||
145773820|NCT00840463|525682132|FG000|Overall Study|Adverse Event|1|||
145534981|NCT03643575|524818590|FG001|Washout: 7 Days|Adverse Event|0|||
145534982|NCT03643575|524818591|FG002|Washout: 7 Days|Adverse Event|0|||
145534983|NCT03643575|524818592|FG003|Washout: 7 Days|Adverse Event|0|||
145534984|NCT03643575|524818593|FG004|Washout: 7 Days|Adverse Event|0|||
145773821|NCT00840463|525682133|FG001|Overall Study|Adverse Event|0|||
145773822|NCT03750838|525682138|FG000|Overall Study|Lost to Follow-up|10|||
145773823|NCT03750838|525682139|FG001|Overall Study|Lost to Follow-up|6|||
145773824|NCT05781542|525683642|FG000|Overall Study|Lost to Follow-up|1|||
145773825|NCT05781542|525683643|FG001|Overall Study|Lost to Follow-up|0|||
145534985|NCT03643575|524818594|FG005|Washout: 7 Days|Adverse Event|0|||
145534986|NCT03643575|524818589|FG000|Washout: 7 Days|Non compliance check in|0|||
145534987|NCT03643575|524818590|FG001|Washout: 7 Days|Non compliance check in|1|||
145534988|NCT03643575|524818591|FG002|Washout: 7 Days|Non compliance check in|0|||
145534989|NCT03643575|524818592|FG003|Washout: 7 Days|Non compliance check in|0|||
145534990|NCT03643575|524818593|FG004|Washout: 7 Days|Non compliance check in|0|||
145773826|NCT05781542|525683644|FG002|Overall Study|Lost to Follow-up|1|||
145773827|NCT05738486|525683647|FG000|Overall Study|Continuing Study|194|||
145773828|NCT05738486|525683648|FG001|Overall Study|Continuing Study|196|||
145534991|NCT03643575|524818594|FG005|Washout: 7 Days|Non compliance check in|0|||
145773829|NCT05738486|525683649|FG002|Overall Study|Continuing Study|193|||
145773830|NCT05738486|525683650|FG003|Overall Study|Continuing Study|191|||
145773831|NCT05738486|525683647|FG000|Overall Study|Withdrawal by Subject|8|||
145773832|NCT05738486|525683648|FG001|Overall Study|Withdrawal by Subject|5|||
145773833|NCT05738486|525683649|FG002|Overall Study|Withdrawal by Subject|7|||
145773834|NCT05738486|525683650|FG003|Overall Study|Withdrawal by Subject|13|||
145773835|NCT05738486|525683647|FG000|Overall Study|Adverse Event|4|||
145773836|NCT05738486|525683648|FG001|Overall Study|Adverse Event|6|||
145773837|NCT05738486|525683649|FG002|Overall Study|Adverse Event|4|||
145773838|NCT05738486|525683650|FG003|Overall Study|Adverse Event|5|||
145773839|NCT05738486|525683647|FG000|Overall Study|Physician Decision|0|||
145773840|NCT05738486|525683648|FG001|Overall Study|Physician Decision|2|||
145773841|NCT05738486|525683649|FG002|Overall Study|Physician Decision|4|||
145773842|NCT05738486|525683650|FG003|Overall Study|Physician Decision|1|||
145773843|NCT05738486|525683647|FG000|Overall Study|Lost to Follow-up|1|||
145773844|NCT05738486|525683648|FG001|Overall Study|Lost to Follow-up|1|||
145773845|NCT05738486|525683649|FG002|Overall Study|Lost to Follow-up|2|||
145773846|NCT05738486|525683650|FG003|Overall Study|Lost to Follow-up|1|||
145773847|NCT05738486|525683647|FG000|Overall Study|Participant was Non-ambulatory|0|||
145773848|NCT05738486|525683648|FG001|Overall Study|Participant was Non-ambulatory|0|||
145773849|NCT05738486|525683649|FG002|Overall Study|Participant was Non-ambulatory|1|||
145773850|NCT05738486|525683650|FG003|Overall Study|Participant was Non-ambulatory|0|||
145773851|NCT05738486|525683647|FG000|Overall Study|Participant had Poor Venous Access|0|||
145773852|NCT05738486|525683648|FG001|Overall Study|Participant had Poor Venous Access|0|||
145773853|NCT05738486|525683649|FG002|Overall Study|Participant had Poor Venous Access|0|||
145773854|NCT05738486|525683650|FG003|Overall Study|Participant had Poor Venous Access|1|||
145773855|NCT05738486|525683647|FG000|Overall Study|Assigned Treatment by Mistake|0|||
145773856|NCT05738486|525683648|FG001|Overall Study|Assigned Treatment by Mistake|0|||
145773857|NCT05738486|525683649|FG002|Overall Study|Assigned Treatment by Mistake|0|||
145773858|NCT05738486|525683650|FG003|Overall Study|Assigned Treatment by Mistake|1|||
145773859|NCT05738486|525683647|FG000|Overall Study|Death|0|||
145773860|NCT05738486|525683648|FG001|Overall Study|Death|0|||
145773861|NCT05738486|525683649|FG002|Overall Study|Death|1|||
145773862|NCT05738486|525683650|FG003|Overall Study|Death|0|||
145773863|NCT05738486|525683647|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
145773864|NCT05738486|525683648|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
145773865|NCT05738486|525683649|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
145773866|NCT05738486|525683650|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
145773867|NCT01843374|525683651|FG000|Overall Study|Death|155|||
145403547|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145403548|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145534992|NCT01189604|524818595|FG000|Overall Study|Impossible to visit|0|||
145534993|NCT01189604|524818596|FG001|Overall Study|Impossible to visit|0|||
145534994|NCT01189604|524818597|FG002|Overall Study|Impossible to visit|0|||
145773868|NCT01843374|525683652|FG001|Overall Study|Death|313|||
145773869|NCT01843374|525683651|FG000|Overall Study|Withdrawal by Subject|14|||
145773870|NCT01843374|525683652|FG001|Overall Study|Withdrawal by Subject|20|||
145773871|NCT01843374|525683651|FG000|Overall Study|Withdrawing due to Other reason|20|||
145773872|NCT01843374|525683652|FG001|Overall Study|Withdrawing due to Other reason|46|||
145773873|NCT03113500|525683653|FG000|Overall Study|Withdrawal by Subject|1|||
145773874|NCT02517515|525683656|FG000|Overall Study|Adverse Event|0|||
145773875|NCT02517515|525683657|FG001|Overall Study|Adverse Event|1|||
145773876|NCT02517515|525683656|FG000|Overall Study|Withdrew Consent|0|||
145773877|NCT02517515|525683657|FG001|Overall Study|Withdrew Consent|1|||
145773878|NCT02517515|525683656|FG000|Overall Study|Lost to Follow-up|1|||
145773879|NCT02517515|525683657|FG001|Overall Study|Lost to Follow-up|0|||
145773880|NCT02517515|525683656|FG000|Overall Study|Other|1|||
145773881|NCT02517515|525683657|FG001|Overall Study|Other|0|||
145773882|NCT06400238|525683660|FG000|Overall Study|Started Protocol Therapy|2|||
145773883|NCT06400238|525683660|FG000|Overall Study|Adverse Event|1|||
145773884|NCT06400238|525683660|FG000|Overall Study|Death|1|||
145773885|NCT06400238|525683660|FG000|Overall Study|Disease Progression|27|||
145773886|NCT06400238|525683660|FG000|Overall Study|Withdrawal by Subject|2|||
145773887|NCT06400238|525683660|FG000|Overall Study|Physician Decision|2|||
145773888|NCT01981187|525683665|FG000|Overall Study|Participant/guardian decision|2|||
145773889|NCT01981187|525683665|FG000|Overall Study|Physician Decision|1|||
145773890|NCT01981187|525683665|FG000|Overall Study|Disease progression|2|||
145773891|NCT01981187|525683665|FG000|Overall Study|Adverse Event|7|||
145773892|NCT01362322|525683666|FG000|Overall Study|Withdrawal by Subject|3|||
145773893|NCT01362322|525683667|FG001|Overall Study|Withdrawal by Subject|1|||
145773894|NCT01362322|525683666|FG000|Overall Study|Lost to Follow-up|2|||
145773895|NCT01362322|525683667|FG001|Overall Study|Lost to Follow-up|6|||
145773896|NCT01009463|525683668|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
145773897|NCT01009463|525683669|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145773898|NCT01009463|525683670|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145773899|NCT01009463|525683671|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145773900|NCT01009463|525683672|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
145773901|NCT01009463|525683668|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
145773902|NCT01009463|525683669|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
145773903|NCT01009463|525683670|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
145773904|NCT01009463|525683671|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
145773905|NCT01009463|525683672|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
145534995|NCT01189604|524818598|FG003|Overall Study|Impossible to visit|0|||
145773906|NCT01009463|525683668|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
145773907|NCT01009463|525683669|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145773908|NCT01009463|525683670|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145773909|NCT01009463|525683671|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145773910|NCT01009463|525683672|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
145773911|NCT01009463|525683668|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
145773912|NCT01009463|525683669|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
145773913|NCT01009463|525683670|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
145773914|NCT01009463|525683671|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
145773915|NCT01009463|525683672|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
145773916|NCT01009463|525683668|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
145773917|NCT01009463|525683669|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145773918|NCT01009463|525683670|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145773919|NCT01009463|525683671|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145773920|NCT01009463|525683672|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
145773921|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
145773922|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
145773923|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
145773924|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
145773925|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
145773926|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145773927|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
145773928|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
145773929|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
145773930|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
145773931|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
145773932|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
145773933|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
145773934|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
145773935|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
145773936|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
145773937|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
145773938|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
145773939|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
145773940|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
145773941|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
145773942|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
145773943|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
145773944|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
145773945|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
145773946|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145773947|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
145773948|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145773949|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
145773950|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
145773951|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145773952|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
145773953|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
145773954|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
145773955|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
145773956|NCT01009463|525683668|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
145773957|NCT01009463|525683669|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
145773958|NCT01009463|525683670|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
145773959|NCT01009463|525683671|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
145773960|NCT01009463|525683672|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
145773961|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
145773962|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
145773963|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
145773964|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
145773965|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
145773966|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
145773967|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
145403549|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145534996|NCT01189604|524818599|FG004|Overall Study|Impossible to visit|0|||
145534997|NCT01189604|524818600|FG005|Overall Study|Impossible to visit|1|||
145534998|NCT01189604|524818601|FG006|Overall Study|Impossible to visit|0|||
145534999|NCT01189604|524818595|FG000|Overall Study|Adverse Event|0|||
145535000|NCT01189604|524818596|FG001|Overall Study|Adverse Event|1|||
145535001|NCT01189604|524818597|FG002|Overall Study|Adverse Event|0|||
145535002|NCT01189604|524818598|FG003|Overall Study|Adverse Event|0|||
145535003|NCT01189604|524818599|FG004|Overall Study|Adverse Event|2|||
145535004|NCT01189604|524818600|FG005|Overall Study|Adverse Event|0|||
145535005|NCT01189604|524818601|FG006|Overall Study|Adverse Event|1|||
145535006|NCT01189604|524818595|FG000|Overall Study|Withdrawal by Subject|1|||
145535007|NCT01189604|524818596|FG001|Overall Study|Withdrawal by Subject|0|||
145535008|NCT01189604|524818597|FG002|Overall Study|Withdrawal by Subject|0|||
145535009|NCT01189604|524818598|FG003|Overall Study|Withdrawal by Subject|0|||
145535010|NCT01189604|524818599|FG004|Overall Study|Withdrawal by Subject|0|||
145535011|NCT01189604|524818600|FG005|Overall Study|Withdrawal by Subject|0|||
145535012|NCT01189604|524818601|FG006|Overall Study|Withdrawal by Subject|0|||
145535013|NCT03626168|524818602|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145535014|NCT03626168|524818603|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145535015|NCT03626168|524818602|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
145535016|NCT03626168|524818603|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
145535017|NCT03626168|524818602|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145535018|NCT03626168|524818603|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
145535019|NCT02357979|524818604|FG000|Overall Study|Lost to Follow-up|5|||
145535020|NCT02357979|524818605|FG001|Overall Study|Lost to Follow-up|5|||
145535021|NCT05047770|524818609|FG000|Overall Study|Withdrawal by Subject|15|||
145535022|NCT05047770|524818610|FG001|Overall Study|Withdrawal by Subject|10|||
145535023|NCT05047770|524818611|FG002|Overall Study|Withdrawal by Subject|6|||
145535024|NCT05047770|524818612|FG003|Overall Study|Withdrawal by Subject|12|||
145535025|NCT05047770|524818609|FG000|Overall Study|Lost to Follow-up|7|||
145535026|NCT05047770|524818610|FG001|Overall Study|Lost to Follow-up|5|||
145535027|NCT05047770|524818611|FG002|Overall Study|Lost to Follow-up|12|||
145535028|NCT05047770|524818612|FG003|Overall Study|Lost to Follow-up|13|||
145535029|NCT05047770|524818609|FG000|Overall Study|Other|1|||
145535030|NCT05047770|524818610|FG001|Overall Study|Other|0|||
145535031|NCT05047770|524818611|FG002|Overall Study|Other|1|||
145535032|NCT05047770|524818612|FG003|Overall Study|Other|0|||
145773968|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
145773969|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
145773970|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
145773971|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
145773972|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
145773973|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
145773974|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
145773975|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
145773976|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
145773977|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
145773978|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
145773979|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Death|0|||
145773980|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Death|1|||
145773981|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Death|0|||
145773982|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
145773983|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
145773984|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
145773985|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
145773986|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
145773987|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
145773988|NCT00430781|525683673|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
145773989|NCT00430781|525683674|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
145773990|NCT00430781|525683675|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
145773991|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
145773992|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
145773993|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
145773994|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
145535033|NCT01772160|524818613|FG000|Overall Study|Death|3|||
145535034|NCT01772160|524818613|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
145773995|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
145773996|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
145773997|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
145535035|NCT01772160|524818613|FG000|Overall Study|Consent withdrawal|3|||
145535036|NCT01772160|524818613|FG000|Overall Study|Migrated / moved from the study area|4|||
145535037|NCT01772160|524818613|FG000|Overall Study|Lost to Follow-up|30|||
145535038|NCT01772160|524818613|FG000|Overall Study|Other|5|||
145535039|NCT00669396|524818617|FG000|Overall Study|Lost to Follow-up|10|||
145535040|NCT00669396|524818618|FG001|Overall Study|Lost to Follow-up|12|||
145608309|NCT00519896|525080978|FG000|Overall Study|Protocol Violation|1|||
145535041|NCT00331422|524818619|FG000|Overall Study|Did not receive entire study regimen|5|||
145535042|NCT02345226|524818620|FG000|Double-Blind Phase|Adverse Event|5|||
145403550|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145403551|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145403552|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145403553|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
145403554|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403555|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403556|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
145403557|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
145403558|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403559|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403560|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403561|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403562|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403563|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
145403564|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403565|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403566|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
145403567|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
145403568|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403569|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403570|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403571|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403572|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403573|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
145403574|NCT01232283|524334393|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
145403575|NCT01232283|524334394|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
145403576|NCT01232283|524334395|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
145403577|NCT01232283|524334396|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
145403578|NCT01232283|524334397|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
145403579|NCT01232283|524334398|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
145403580|NCT01232283|524334399|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
145403581|NCT01232283|524334400|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
145403582|NCT01232283|524334401|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
145403583|NCT01232283|524334402|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
145403584|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403585|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403586|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403587|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403588|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
145403589|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
145403590|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403591|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
145403592|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403593|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
145403594|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403595|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403596|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403597|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403598|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
145403599|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403600|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
145403601|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
145403602|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145403603|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
145535043|NCT02345226|524818621|FG001|Double-Blind Phase|Adverse Event|6|||
145535044|NCT02345226|524818620|FG000|Double-Blind Phase|Death|3|||
145403604|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145535045|NCT02345226|524818621|FG001|Double-Blind Phase|Death|0|||
145535046|NCT02345226|524818620|FG000|Double-Blind Phase|Pregnancy|0|||
145773998|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
145773999|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
145774000|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
145774001|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
145774002|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
145774003|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Other|0|||
145774004|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Other|1|||
145774005|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Other|0|||
145774006|NCT00430781|525683673|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
145774007|NCT00430781|525683674|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
145774008|NCT00430781|525683675|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
145774009|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
145774010|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
145774011|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
145774012|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
145774013|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
145774014|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
145774015|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
145774016|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
145774017|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
145774018|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
145774019|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
145774020|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
145774021|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
145774022|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
145774023|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
145774024|NCT00430781|525683673|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
145774025|NCT00430781|525683674|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
145774026|NCT00430781|525683675|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
145774027|NCT04329949|525683677|FG000|Overall Study|Death|36|||
145774028|NCT04329949|525683677|FG000|Overall Study|Withdrawal by Subject|4|||
145774029|NCT04329949|525683677|FG000|Overall Study|Termination of study by sponsor|3|||
145774030|NCT00917384|525683680|FG000|Overall Study|Lost to Follow-up|4|||
145774031|NCT00917384|525683681|FG001|Overall Study|Lost to Follow-up|2|||
145774032|NCT00917384|525683680|FG000|Overall Study|Withdrawal by Subject|10|||
145774033|NCT00917384|525683681|FG001|Overall Study|Withdrawal by Subject|2|||
145774034|NCT03717922|525683682|FG000|Overall Study|Lost to Follow-up|2|||
145774035|NCT03717922|525683683|FG001|Overall Study|Lost to Follow-up|2|||
145774036|NCT01458340|525683686|FG000|Overall Study|Adverse Event|5|||
145774037|NCT01458340|525683687|FG001|Overall Study|Adverse Event|4|||
145774038|NCT01458340|525683688|FG002|Overall Study|Adverse Event|2|||
145774039|NCT01458340|525683686|FG000|Overall Study|Lost to Follow-up|3|||
145774040|NCT01458340|525683687|FG001|Overall Study|Lost to Follow-up|3|||
145774041|NCT01458340|525683688|FG002|Overall Study|Lost to Follow-up|10|||
145774042|NCT01458340|525683686|FG000|Overall Study|Miscellaneous|0|||
145774043|NCT01458340|525683687|FG001|Overall Study|Miscellaneous|1|||
145774044|NCT01458340|525683688|FG002|Overall Study|Miscellaneous|0|||
145774045|NCT01458340|525683686|FG000|Overall Study|Physician Decision|1|||
145774046|NCT01458340|525683687|FG001|Overall Study|Physician Decision|1|||
145774047|NCT01458340|525683688|FG002|Overall Study|Physician Decision|2|||
145774048|NCT01458340|525683686|FG000|Overall Study|Protocol Violation|6|||
145774049|NCT01458340|525683687|FG001|Overall Study|Protocol Violation|6|||
145774050|NCT01458340|525683688|FG002|Overall Study|Protocol Violation|5|||
145774051|NCT01458340|525683686|FG000|Overall Study|Withdrawal by Subject|12|||
145774052|NCT01458340|525683687|FG001|Overall Study|Withdrawal by Subject|6|||
145774053|NCT01458340|525683688|FG002|Overall Study|Withdrawal by Subject|4|||
145535047|NCT02345226|524818621|FG001|Double-Blind Phase|Pregnancy|1|||
145535048|NCT02345226|524818620|FG000|Double-Blind Phase|Lack of Efficacy|1|||
145535049|NCT02345226|524818621|FG001|Double-Blind Phase|Lack of Efficacy|0|||
145535050|NCT02345226|524818620|FG000|Double-Blind Phase|Investigator's Discretion|4|||
145535051|NCT02345226|524818621|FG001|Double-Blind Phase|Investigator's Discretion|3|||
145535052|NCT02345226|524818620|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
145535053|NCT02345226|524818621|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
145774054|NCT05218499|525683695|FG000|Overall Study|Not treated|1|||
145774055|NCT05218499|525683696|FG001|Overall Study|Not treated|1|||
145774056|NCT05218499|525683697|FG002|Overall Study|Not treated|8|||
145535054|NCT02345226|524818620|FG000|Double-Blind Phase|Withdrew Consent|41|||
145774057|NCT05218499|525683695|FG000|Overall Study|Death|2|||
145774058|NCT05218499|525683696|FG001|Overall Study|Death|0|||
145774059|NCT05218499|525683697|FG002|Overall Study|Death|0|||
145774060|NCT05218499|525683695|FG000|Overall Study|Other than listed|3|||
145774061|NCT05218499|525683696|FG001|Overall Study|Other than listed|7|||
145774062|NCT05218499|525683697|FG002|Overall Study|Other than listed|10|||
145774063|NCT05218499|525683695|FG000|Overall Study|Protocol deviation|5|||
145774064|NCT05218499|525683696|FG001|Overall Study|Protocol deviation|6|||
145535055|NCT02345226|524818621|FG001|Double-Blind Phase|Withdrew Consent|39|||
145535056|NCT02345226|524818620|FG000|Double-Blind Phase|Lost to Follow-up|12|||
145535057|NCT02345226|524818621|FG001|Double-Blind Phase|Lost to Follow-up|16|||
145535058|NCT02345226|524818620|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
145535059|NCT02345226|524818621|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
145535060|NCT02345226|524818620|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145535061|NCT02345226|524818621|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
145535062|NCT01710046|524818624|FG000|Overall Study|Lost to Follow-up|1|||
145535063|NCT01710046|524818625|FG001|Overall Study|Lost to Follow-up|0|||
145535064|NCT03386474|524818626|FG000|Overall Study|Death|1|||
145774065|NCT05218499|525683697|FG002|Overall Study|Protocol deviation|4|||
145774066|NCT05218499|525683695|FG000|Overall Study|Technical problems|0|||
145535065|NCT03386474|524818627|FG001|Overall Study|Death|0|||
145535066|NCT03386474|524818626|FG000|Overall Study|Adverse Event|0|||
145535067|NCT03386474|524818627|FG001|Overall Study|Adverse Event|1|||
145774067|NCT05218499|525683696|FG001|Overall Study|Technical problems|1|||
145774068|NCT05218499|525683697|FG002|Overall Study|Technical problems|0|||
145774069|NCT05218499|525683695|FG000|Overall Study|Burden of trial procedures|0|||
145774070|NCT05218499|525683696|FG001|Overall Study|Burden of trial procedures|1|||
145774071|NCT05218499|525683697|FG002|Overall Study|Burden of trial procedures|2|||
145774072|NCT05218499|525683695|FG000|Overall Study|Clinical disease progression|6|||
145774073|NCT05218499|525683696|FG001|Overall Study|Clinical disease progression|6|||
145774074|NCT05218499|525683697|FG002|Overall Study|Clinical disease progression|11|||
145774075|NCT05218499|525683695|FG000|Overall Study|Objective disease progression|44|||
145403605|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145403606|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145403607|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145403608|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145403609|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145403610|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
145403611|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
145403612|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145403613|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
145403614|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403615|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403616|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403617|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403618|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
145403619|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403620|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403621|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403622|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403623|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
145403624|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403625|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403626|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403627|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403628|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
145403629|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403630|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
145403631|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
145403632|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145403633|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
145535068|NCT02282358|524818632|FG000|Overall Study|Nonevaluable|1|||
145535069|NCT04357782|524818633|FG000|Overall Study|Discharged from hospital|1|||
145774076|NCT05218499|525683696|FG001|Overall Study|Objective disease progression|61|||
145774077|NCT05218499|525683697|FG002|Overall Study|Objective disease progression|42|||
145774078|NCT05218499|525683695|FG000|Overall Study|Adverse Event|11|||
145774079|NCT05218499|525683696|FG001|Overall Study|Adverse Event|36|||
145403634|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145403635|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145535070|NCT04357782|524818634|FG001|Overall Study|Discharged from hospital|0|||
145535071|NCT04357782|524818633|FG000|Overall Study|Death|0|||
145535072|NCT04357782|524818634|FG001|Overall Study|Death|2|||
145535073|NCT03896165|524818636|FG000|Overall Study|Withdrawal by Subject|2|||
145535074|NCT01163266|524818637|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
145774080|NCT05218499|525683697|FG002|Overall Study|Adverse Event|9|||
145774081|NCT05218499|525683695|FG000|Overall Study|On treatment at time of snapshot|18|||
145774082|NCT05218499|525683696|FG001|Overall Study|On treatment at time of snapshot|29|||
145774083|NCT05218499|525683697|FG002|Overall Study|On treatment at time of snapshot|0|||
145774084|NCT01575548|525683698|FG000|Overall Study|Adverse Event|15|||
145774085|NCT01575548|525683699|FG001|Overall Study|Adverse Event|2|||
145774086|NCT01575548|525683698|FG000|Overall Study|Disease progression|12|||
145774087|NCT01575548|525683699|FG001|Overall Study|Disease progression|25|||
145774088|NCT01575548|525683698|FG000|Overall Study|Death|1|||
145774089|NCT01575548|525683699|FG001|Overall Study|Death|0|||
145774090|NCT01575548|525683698|FG000|Overall Study|Other complicating disease|1|||
145774091|NCT01575548|525683699|FG001|Overall Study|Other complicating disease|0|||
145774092|NCT01575548|525683698|FG000|Overall Study|Withdrawal by Subject|7|||
145774093|NCT01575548|525683699|FG001|Overall Study|Withdrawal by Subject|3|||
145774094|NCT01575548|525683698|FG000|Overall Study|Noncompliance|1|||
145774095|NCT01575548|525683699|FG001|Overall Study|Noncompliance|0|||
145774096|NCT01575548|525683698|FG000|Overall Study|Anticipated surgery|0|||
145774097|NCT01575548|525683699|FG001|Overall Study|Anticipated surgery|1|||
145774098|NCT01575548|525683698|FG000|Overall Study|Never started protocol therapy|3|||
145774099|NCT01575548|525683699|FG001|Overall Study|Never started protocol therapy|2|||
145774100|NCT01702805|525683706|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
145774101|NCT01702805|525683707|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
145774102|NCT01702805|525683706|FG000|Overall Study|Incomplete Follow-up|18|||
145774103|NCT01702805|525683707|FG001|Overall Study|Incomplete Follow-up|15|||
145774104|NCT01702805|525683706|FG000|Overall Study|Vital Status Assessment Only|40|||
145774105|NCT01702805|525683707|FG001|Overall Study|Vital Status Assessment Only|39|||
145774106|NCT01702805|525683706|FG000|Overall Study|Lost to Follow-up|5|||
145774107|NCT01702805|525683707|FG001|Overall Study|Lost to Follow-up|5|||
145774108|NCT04876391|525683708|FG000|Overall Study|Withdrawal by Subject|1|||
145774109|NCT04876391|525683709|FG001|Overall Study|Withdrawal by Subject|10|||
145774110|NCT04876391|525683708|FG000|Overall Study|Lost to Follow-up|2|||
145774111|NCT04876391|525683709|FG001|Overall Study|Lost to Follow-up|4|||
145774112|NCT04876391|525683708|FG000|Overall Study|Lack of Efficacy|0|||
145774113|NCT04876391|525683709|FG001|Overall Study|Lack of Efficacy|2|||
145774114|NCT04876391|525683708|FG000|Overall Study|Adverse Event|3|||
145774115|NCT04876391|525683709|FG001|Overall Study|Adverse Event|1|||
145774116|NCT04876391|525683708|FG000|Overall Study|Patient non-compliance|0|||
145774117|NCT04876391|525683709|FG001|Overall Study|Patient non-compliance|1|||
145774118|NCT04876391|525683708|FG000|Overall Study|Personal reasons|0|||
145774119|NCT04876391|525683709|FG001|Overall Study|Personal reasons|1|||
145774120|NCT04876391|525683708|FG000|Overall Study|Withdrawn as per protocol|2|||
145774121|NCT04876391|525683709|FG001|Overall Study|Withdrawn as per protocol|2|||
145774122|NCT02286960|525683712|FG000|Overall Study|Lost to Follow-up|3|||
145774123|NCT02286960|525683713|FG001|Overall Study|Lost to Follow-up|3|||
145774124|NCT01238120|525683715|FG000|Overall Study|Withdrawal by Subject|4|||
145774125|NCT01238120|525683716|FG001|Overall Study|Withdrawal by Subject|1|||
145774126|NCT01238120|525683717|FG002|Overall Study|Withdrawal by Subject|2|||
145774127|NCT01238120|525683718|FG003|Overall Study|Withdrawal by Subject|5|||
145774128|NCT01238120|525683715|FG000|Overall Study|Lost to Follow-up|2|||
145774129|NCT01238120|525683716|FG001|Overall Study|Lost to Follow-up|0|||
145774130|NCT01238120|525683717|FG002|Overall Study|Lost to Follow-up|1|||
145774131|NCT01238120|525683718|FG003|Overall Study|Lost to Follow-up|1|||
145774132|NCT01238120|525683715|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
145774133|NCT01238120|525683716|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
145774134|NCT01238120|525683717|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
145774135|NCT01238120|525683718|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
145774136|NCT00881205|525683719|FG000|Overall Study|Adverse Event|8|||
145774137|NCT00881205|525683720|FG001|Overall Study|Adverse Event|3|||
145774138|NCT00881205|525683719|FG000|Overall Study|Withdrawal by Subject|1|||
145774139|NCT00881205|525683720|FG001|Overall Study|Withdrawal by Subject|2|||
145774140|NCT00881205|525683719|FG000|Overall Study|Lost to Follow-up|0|||
145774141|NCT00881205|525683720|FG001|Overall Study|Lost to Follow-up|1|||
145774142|NCT00881205|525683719|FG000|Overall Study|Administrative problems|1|||
145774143|NCT00881205|525683720|FG001|Overall Study|Administrative problems|1|||
145774144|NCT00881205|525683719|FG000|Overall Study|Condition no longer requires drug|1|||
145774145|NCT00881205|525683720|FG001|Overall Study|Condition no longer requires drug|0|||
145278863|NCT03033069|523870906|FG003|Overall Study|Adverse Event|6|||
145774146|NCT01486238|525683722|FG000|Overall Study|Death|0|||
145774147|NCT01486238|525683723|FG001|Overall Study|Death|2|||
145774148|NCT01486238|525683722|FG000|Overall Study|Withdrawal by Subject|2|||
145774149|NCT01486238|525683723|FG001|Overall Study|Withdrawal by Subject|1|||
145774150|NCT01486238|525683722|FG000|Overall Study|Lost to Follow-up|0|||
145774151|NCT01486238|525683723|FG001|Overall Study|Lost to Follow-up|3|||
145774152|NCT00693706|525683728|FG000|Overall Study|Protocol Violation|0|||
145774153|NCT00693706|525683729|FG001|Overall Study|Protocol Violation|1|||
145774154|NCT02498652|525683731|FG000|Overall Study|Protocol Violation|0|||
145774155|NCT02498652|525683732|FG001|Overall Study|Protocol Violation|1|||
145774156|NCT06129487|525683733|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
145774157|NCT06129487|525683734|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
145774158|NCT00754390|525683735|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
145535075|NCT01163266|524818638|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
145535076|NCT01163266|524818639|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
145774159|NCT00754390|525683735|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
145774160|NCT00754390|525683735|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
145774161|NCT00754390|525683735|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
145774162|NCT00847613|525683736|FG000|Overall Study|Ongoing at cut-off date|250|||
145774163|NCT00847613|525683737|FG001|Overall Study|Ongoing at cut-off date|265|||
145774164|NCT00847613|525683738|FG002|Overall Study|Ongoing at cut-off date|64|||
145774165|NCT00847613|525683739|FG003|Overall Study|Ongoing at cut-off date|64|||
145774166|NCT00847613|525683736|FG000|Overall Study|Death|1|||
145774167|NCT00847613|525683737|FG001|Overall Study|Death|1|||
145774168|NCT00847613|525683738|FG002|Overall Study|Death|0|||
145774169|NCT00847613|525683739|FG003|Overall Study|Death|0|||
145774170|NCT00847613|525683736|FG000|Overall Study|Adverse Event|36|||
145774171|NCT00847613|525683737|FG001|Overall Study|Adverse Event|26|||
145774172|NCT00847613|525683738|FG002|Overall Study|Adverse Event|5|||
145774173|NCT00847613|525683739|FG003|Overall Study|Adverse Event|6|||
145774174|NCT00847613|525683736|FG000|Overall Study|Lack of Efficacy|7|||
145774175|NCT00847613|525683737|FG001|Overall Study|Lack of Efficacy|3|||
145774176|NCT00847613|525683738|FG002|Overall Study|Lack of Efficacy|3|||
145774177|NCT00847613|525683739|FG003|Overall Study|Lack of Efficacy|1|||
145774178|NCT00847613|525683736|FG000|Overall Study|Study terminated by Sponsor|1|||
145774179|NCT00847613|525683737|FG001|Overall Study|Study terminated by Sponsor|0|||
145774180|NCT00847613|525683738|FG002|Overall Study|Study terminated by Sponsor|2|||
145774181|NCT00847613|525683739|FG003|Overall Study|Study terminated by Sponsor|1|||
145774182|NCT00847613|525683736|FG000|Overall Study|Lost to Follow-up|5|||
145774183|NCT00847613|525683737|FG001|Overall Study|Lost to Follow-up|0|||
145774184|NCT00847613|525683738|FG002|Overall Study|Lost to Follow-up|0|||
145774185|NCT00847613|525683739|FG003|Overall Study|Lost to Follow-up|3|||
145774186|NCT00847613|525683736|FG000|Overall Study|Protocol Violation|6|||
145774187|NCT00847613|525683737|FG001|Overall Study|Protocol Violation|6|||
145774188|NCT00847613|525683738|FG002|Overall Study|Protocol Violation|3|||
145774189|NCT00847613|525683739|FG003|Overall Study|Protocol Violation|1|||
145774190|NCT00847613|525683736|FG000|Overall Study|Pregnancy|1|||
145774191|NCT00847613|525683737|FG001|Overall Study|Pregnancy|1|||
145774192|NCT00847613|525683738|FG002|Overall Study|Pregnancy|0|||
145774193|NCT00847613|525683739|FG003|Overall Study|Pregnancy|0|||
145774194|NCT00847613|525683736|FG000|Overall Study|Site closure|1|||
145774195|NCT00847613|525683737|FG001|Overall Study|Site closure|0|||
145774196|NCT00847613|525683738|FG002|Overall Study|Site closure|0|||
145774197|NCT00847613|525683739|FG003|Overall Study|Site closure|1|||
145774198|NCT00847613|525683736|FG000|Overall Study|Withdrawal by Subject|8|||
145774199|NCT00847613|525683737|FG001|Overall Study|Withdrawal by Subject|11|||
145774200|NCT00847613|525683738|FG002|Overall Study|Withdrawal by Subject|2|||
145774201|NCT00847613|525683739|FG003|Overall Study|Withdrawal by Subject|2|||
145774202|NCT00847613|525683736|FG000|Overall Study|Participant moved|4|||
145774203|NCT00847613|525683737|FG001|Overall Study|Participant moved|1|||
145774204|NCT00847613|525683738|FG002|Overall Study|Participant moved|0|||
145774205|NCT00847613|525683739|FG003|Overall Study|Participant moved|0|||
145774206|NCT00847613|525683736|FG000|Overall Study|Sponsor request|0|||
145774207|NCT00847613|525683737|FG001|Overall Study|Sponsor request|1|||
145774208|NCT00847613|525683738|FG002|Overall Study|Sponsor request|0|||
145774209|NCT00847613|525683739|FG003|Overall Study|Sponsor request|0|||
145774210|NCT00847613|525683736|FG000|Overall Study|Randomized, but not treated|0|||
145774211|NCT00847613|525683737|FG001|Overall Study|Randomized, but not treated|3|||
145774212|NCT00847613|525683738|FG002|Overall Study|Randomized, but not treated|0|||
145774213|NCT00847613|525683739|FG003|Overall Study|Randomized, but not treated|0|||
145774214|NCT00847613|525683736|FG000|Overall Study|Other|1|||
145774215|NCT00847613|525683737|FG001|Overall Study|Other|1|||
145403636|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145774216|NCT00847613|525683738|FG002|Overall Study|Other|2|||
145774217|NCT00847613|525683739|FG003|Overall Study|Other|0|||
145774218|NCT05755438|525683745|FG000|12-week DBVC Period|Adverse Event|4|||
145774219|NCT05755438|525683746|FG001|12-week DBVC Period|Adverse Event|1|||
145774220|NCT05755438|525683745|FG000|12-week DBVC Period|Physician Decision|1|||
145774221|NCT05755438|525683746|FG001|12-week DBVC Period|Physician Decision|1|||
145774222|NCT05755438|525683745|FG000|12-week DBVC Period|Protocol Violation|4|||
145774223|NCT05755438|525683746|FG001|12-week DBVC Period|Protocol Violation|2|||
145774224|NCT05755438|525683745|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
145774225|NCT05755438|525683746|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
145774226|NCT05755438|525683745|FG000|12-week DBVC Period|Sponsor Decision|1|||
145774227|NCT05755438|525683746|FG001|12-week DBVC Period|Sponsor Decision|0|||
145774228|NCT05755438|525683745|FG000|40-week OLE Period|Adverse Event|0|||
145774229|NCT05755438|525683746|FG001|40-week OLE Period|Adverse Event|2|||
145278864|NCT03033069|523870903|FG000|Overall Study|Lack of Efficacy|0|||
145774230|NCT05755438|525683745|FG000|40-week OLE Period|Lack of Efficacy|1|||
145774231|NCT05755438|525683746|FG001|40-week OLE Period|Lack of Efficacy|1|||
145774232|NCT05755438|525683745|FG000|40-week OLE Period|Lost to Follow-up|1|||
145774233|NCT05755438|525683746|FG001|40-week OLE Period|Lost to Follow-up|0|||
145535077|NCT01163266|524818637|FG000|Overall Study|Lack of Efficacy|1|||
145535078|NCT01163266|524818638|FG001|Overall Study|Lack of Efficacy|3|||
145535079|NCT01163266|524818639|FG002|Overall Study|Lack of Efficacy|1|||
145535080|NCT01163266|524818637|FG000|Overall Study|Noncompliance with Study Drug|0|||
145535081|NCT01163266|524818638|FG001|Overall Study|Noncompliance with Study Drug|2|||
145535082|NCT01163266|524818639|FG002|Overall Study|Noncompliance with Study Drug|0|||
145535083|NCT01163266|524818637|FG000|Overall Study|Protocol Deviations|2|||
145535084|NCT01163266|524818638|FG001|Overall Study|Protocol Deviations|2|||
145535085|NCT01163266|524818639|FG002|Overall Study|Protocol Deviations|5|||
145535086|NCT01163266|524818637|FG000|Overall Study|Withdrawal of Consent|5|||
145535087|NCT01163266|524818638|FG001|Overall Study|Withdrawal of Consent|7|||
145535088|NCT01163266|524818639|FG002|Overall Study|Withdrawal of Consent|3|||
145535089|NCT01163266|524818637|FG000|Overall Study|Lost to Follow-up|7|||
145535090|NCT01163266|524818638|FG001|Overall Study|Lost to Follow-up|7|||
145774234|NCT05755438|525683745|FG000|40-week OLE Period|Physician Decision|1|||
145774235|NCT05755438|525683746|FG001|40-week OLE Period|Physician Decision|1|||
145774236|NCT05755438|525683745|FG000|40-week OLE Period|Protocol Violation|1|||
145774237|NCT05755438|525683746|FG001|40-week OLE Period|Protocol Violation|1|||
145774238|NCT05755438|525683745|FG000|40-week OLE Period|Withdrawal by Subject|6|||
145774239|NCT05755438|525683746|FG001|40-week OLE Period|Withdrawal by Subject|6|||
145774240|NCT05755438|525683745|FG000|40-week OLE Period|Sponsor Decision|3|||
145774241|NCT05755438|525683746|FG001|40-week OLE Period|Sponsor Decision|0|||
145774242|NCT05755438|525683745|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
145774243|NCT05755438|525683746|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
145774244|NCT05755438|525683745|FG000|40-week OLE Period|Ongoing|46|||
145774245|NCT05755438|525683746|FG001|40-week OLE Period|Ongoing|58|||
145774246|NCT05445843|525683747|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
145774247|NCT05445843|525683748|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
145774248|NCT05445843|525683747|FG000|Overall Study|Progressive disease|17|||
145774249|NCT05445843|525683748|FG001|Overall Study|Progressive disease|9|||
145774250|NCT05445843|525683747|FG000|Overall Study|Physician Decision|16|||
145774251|NCT05445843|525683748|FG001|Overall Study|Physician Decision|4|||
145774252|NCT05445843|525683747|FG000|Overall Study|Death|6|||
145774253|NCT05445843|525683748|FG001|Overall Study|Death|3|||
145774254|NCT05445843|525683747|FG000|Overall Study|Subject decision|6|||
145774255|NCT05445843|525683748|FG001|Overall Study|Subject decision|2|||
145774256|NCT05445843|525683747|FG000|Overall Study|Adverse Event|2|||
145774257|NCT05445843|525683748|FG001|Overall Study|Adverse Event|0|||
145774258|NCT04090164|525683752|FG000|Overall Study|incomplete data on file|245|||
145774259|NCT04090164|525683753|FG001|Overall Study|incomplete data on file|0|||
145774260|NCT03414359|525683754|FG000|Overall Study|Lack of Efficacy|1|||
145774261|NCT03414359|525683755|FG001|Overall Study|Lack of Efficacy|1|||
145774262|NCT03414359|525683754|FG000|Overall Study|Protocol Violation|0|||
145774263|NCT03414359|525683755|FG001|Overall Study|Protocol Violation|1|||
145774264|NCT01877655|525683756|FG000|Overall Study|Death|57|||
145774265|NCT01877655|525683757|FG001|Overall Study|Death|52|||
145774266|NCT01877655|525683756|FG000|Overall Study|Withdrawal by Subject|18|||
145774267|NCT01877655|525683757|FG001|Overall Study|Withdrawal by Subject|26|||
145774268|NCT01877655|525683756|FG000|Overall Study|Physician Decision|11|||
145774269|NCT01877655|525683757|FG001|Overall Study|Physician Decision|10|||
145774270|NCT01877655|525683756|FG000|Overall Study|Miscellaneous|4|||
145774271|NCT01877655|525683757|FG001|Overall Study|Miscellaneous|4|||
145774272|NCT01877655|525683756|FG000|Overall Study|Randomized but Never Received Drug|8|||
145774273|NCT01877655|525683757|FG001|Overall Study|Randomized but Never Received Drug|5|||
145774274|NCT04070378|525683760|FG000|Overall Study|Withdrawal by Subject|2|||
145774275|NCT04070378|525683760|FG000|Overall Study|Screen Failure|6|||
145774276|NCT04070378|525683760|FG000|Overall Study|Physician Decision|1|||
145774277|NCT04070378|525683760|FG000|Overall Study|Adverse Event|1|||
145774278|NCT02462889|525683762|FG000|Overall Study|Withdrawal by Subject|2|||
145774279|NCT02462889|525683763|FG001|Overall Study|Withdrawal by Subject|6|||
145774280|NCT02462889|525683762|FG000|Overall Study|Death|1|||
145278865|NCT03033069|523870904|FG001|Overall Study|Lack of Efficacy|0|||
145774281|NCT02462889|525683763|FG001|Overall Study|Death|5|||
145774282|NCT02277444|525683768|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
145774283|NCT02277444|525683768|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
145535091|NCT01163266|524818639|FG002|Overall Study|Lost to Follow-up|10|||
145535092|NCT01163266|524818637|FG000|Overall Study|Other|1|||
145774284|NCT02277444|525683768|FG000|Treatment Period (Week 0-52)|Other|1|||
145774285|NCT02277444|525683768|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
145774286|NCT02277444|525683768|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
145774287|NCT02277444|525683768|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
145774288|NCT02277444|525683768|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
145774289|NCT02277444|525683768|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
145774290|NCT02277444|525683768|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
145774291|NCT05278104|525683769|FG000|Overall Study|Not treated|1|||
145774292|NCT05278104|525683770|FG001|Overall Study|Not treated|0|||
145774293|NCT05278104|525683769|FG000|Overall Study|Adverse Event|2|||
145774294|NCT05278104|525683770|FG001|Overall Study|Adverse Event|1|||
145774295|NCT05278104|525683769|FG000|Overall Study|Exclusion criteria not met|1|||
145535093|NCT01163266|524818638|FG001|Overall Study|Other|1|||
145535094|NCT01163266|524818639|FG002|Overall Study|Other|2|||
145535095|NCT02586064|524818640|FG000|Overall Study|Other Obligations|6|||
145535096|NCT02586064|524818641|FG001|Overall Study|Other Obligations|6|||
145535097|NCT02586064|524818640|FG000|Overall Study|Other|3|||
145535098|NCT02586064|524818641|FG001|Overall Study|Other|7|||
145535099|NCT02586064|524818640|FG000|Overall Study|Never Started|3|||
145774296|NCT05278104|525683770|FG001|Overall Study|Exclusion criteria not met|0|||
145774297|NCT03439345|525685230|FG000|Overall Study|Lost to Follow-up|0|||
145774298|NCT03439345|525685231|FG001|Overall Study|Lost to Follow-up|1|||
145774299|NCT03439345|525685230|FG000|Overall Study|Consent withdrawn|0|||
145774300|NCT03439345|525685231|FG001|Overall Study|Consent withdrawn|1|||
145774301|NCT03704051|525685234|FG000|Overall Study|Withdrawal by Subject|4|||
145774302|NCT03704051|525685235|FG001|Overall Study|Withdrawal by Subject|0|||
145774303|NCT02495077|525685236|FG000|Overall Study|Adverse Event|0|||
145774304|NCT02495077|525685237|FG001|Overall Study|Adverse Event|1|||
145774305|NCT02495077|525685238|FG002|Overall Study|Adverse Event|1|||
145774306|NCT02495077|525685239|FG003|Overall Study|Adverse Event|0|||
145774307|NCT02495077|525685236|FG000|Overall Study|Death|3|||
145774308|NCT02495077|525685237|FG001|Overall Study|Death|5|||
145774309|NCT02495077|525685238|FG002|Overall Study|Death|0|||
145774310|NCT02495077|525685239|FG003|Overall Study|Death|0|||
145774311|NCT02495077|525685236|FG000|Overall Study|Lost to Follow-up|6|||
145774312|NCT02495077|525685237|FG001|Overall Study|Lost to Follow-up|4|||
145774313|NCT02495077|525685238|FG002|Overall Study|Lost to Follow-up|0|||
145774314|NCT02495077|525685239|FG003|Overall Study|Lost to Follow-up|0|||
145774315|NCT02495077|525685236|FG000|Overall Study|Physician Decision|2|||
145774316|NCT02495077|525685237|FG001|Overall Study|Physician Decision|1|||
145774317|NCT02495077|525685238|FG002|Overall Study|Physician Decision|4|||
145774318|NCT02495077|525685239|FG003|Overall Study|Physician Decision|0|||
145774319|NCT02495077|525685236|FG000|Overall Study|Protocol Violation|0|||
145774320|NCT02495077|525685237|FG001|Overall Study|Protocol Violation|1|||
145774321|NCT02495077|525685238|FG002|Overall Study|Protocol Violation|0|||
145774322|NCT02495077|525685239|FG003|Overall Study|Protocol Violation|0|||
145774323|NCT02495077|525685236|FG000|Overall Study|Screen Failure|0|||
145774324|NCT02495077|525685237|FG001|Overall Study|Screen Failure|0|||
145774325|NCT02495077|525685238|FG002|Overall Study|Screen Failure|0|||
145774326|NCT02495077|525685239|FG003|Overall Study|Screen Failure|48|||
145774327|NCT02495077|525685236|FG000|Overall Study|Withdrawal by Subject|7|||
145774328|NCT02495077|525685237|FG001|Overall Study|Withdrawal by Subject|7|||
145774329|NCT02495077|525685238|FG002|Overall Study|Withdrawal by Subject|7|||
145774330|NCT02495077|525685239|FG003|Overall Study|Withdrawal by Subject|0|||
145774331|NCT02495077|525685236|FG000|Overall Study|Covid-19 research restrictions|1|||
145535100|NCT02586064|524818641|FG001|Overall Study|Never Started|3|||
145535101|NCT02586064|524818640|FG000|Overall Study|Lost Interest|1|||
145535102|NCT02586064|524818641|FG001|Overall Study|Lost Interest|4|||
145535103|NCT02586064|524818640|FG000|Overall Study|Miscellaneous Life Issues|0|||
145774332|NCT02495077|525685237|FG001|Overall Study|Covid-19 research restrictions|0|||
145774333|NCT02495077|525685238|FG002|Overall Study|Covid-19 research restrictions|0|||
145774334|NCT02495077|525685239|FG003|Overall Study|Covid-19 research restrictions|0|||
145774335|NCT02495077|525685236|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
145774336|NCT02495077|525685237|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
145774337|NCT02495077|525685238|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
145774338|NCT02495077|525685239|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
145774339|NCT02495077|525685236|FG000|Overall Study|Incarcerated|0|||
145774340|NCT02495077|525685237|FG001|Overall Study|Incarcerated|1|||
145774341|NCT02495077|525685238|FG002|Overall Study|Incarcerated|0|||
145774342|NCT02495077|525685239|FG003|Overall Study|Incarcerated|0|||
145774343|NCT02495077|525685236|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
145774344|NCT02495077|525685237|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
145774345|NCT02495077|525685238|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
145774346|NCT02495077|525685239|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
145535104|NCT02586064|524818641|FG001|Overall Study|Miscellaneous Life Issues|5|||
145774347|NCT02495077|525685236|FG000|Overall Study|Timing of transplant and randomization|0|||
145535105|NCT02586064|524818640|FG000|Overall Study|Infrequent Attendance|2|||
145535106|NCT02586064|524818641|FG001|Overall Study|Infrequent Attendance|1|||
145535107|NCT02586064|524818640|FG000|Overall Study|Timed Out|2|||
145774348|NCT02495077|525685237|FG001|Overall Study|Timing of transplant and randomization|0|||
145774349|NCT02495077|525685238|FG002|Overall Study|Timing of transplant and randomization|5|||
145774350|NCT02495077|525685239|FG003|Overall Study|Timing of transplant and randomization|0|||
145774351|NCT02742649|525685240|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
145774352|NCT02742649|525685241|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
145774353|NCT02742649|525685242|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
145535108|NCT02586064|524818641|FG001|Overall Study|Timed Out|0|||
145774354|NCT02742649|525685243|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
145774355|NCT02742649|525685244|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
145774356|NCT02742649|525685240|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145774357|NCT02742649|525685241|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145774358|NCT02742649|525685242|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145774359|NCT02742649|525685243|FG003|Double-Blind Treatment Period|Adverse Event|0|||
145774360|NCT02742649|525685244|FG004|Double-Blind Treatment Period|Adverse Event|0|||
145535109|NCT02586064|524818640|FG000|Overall Study|AUD relapse|0|||
145535110|NCT02586064|524818641|FG001|Overall Study|AUD relapse|2|||
145535111|NCT02586064|524818640|FG000|Overall Study|Legal Issue|1|||
145535112|NCT02586064|524818641|FG001|Overall Study|Legal Issue|0|||
145535113|NCT02158975|524818642|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
145535114|NCT00397215|524818647|FG000|Month 0 (Day 0)|Adverse Event|0|||
145535115|NCT00397215|524818648|FG001|Month 0 (Day 0)|Adverse Event|1|||
145535116|NCT00397215|524818649|FG002|Month 0 (Day 0)|Adverse Event|0|||
145535117|NCT00397215|524818650|FG003|Month 0 (Day 0)|Adverse Event|0|||
145535118|NCT00397215|524818647|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
145535119|NCT00397215|524818648|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
145535120|NCT00397215|524818649|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
145535121|NCT00397215|524818650|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
145535122|NCT00397215|524818647|FG000|Month 0 (Day 0)|Other|4|||
145535123|NCT00397215|524818648|FG001|Month 0 (Day 0)|Other|1|||
145535124|NCT00397215|524818649|FG002|Month 0 (Day 0)|Other|3|||
145535125|NCT00397215|524818650|FG003|Month 0 (Day 0)|Other|3|||
145535126|NCT00397215|524818647|FG000|Month 6 (Day 180)|Adverse Event|0|||
145535127|NCT00397215|524818648|FG001|Month 6 (Day 180)|Adverse Event|3|||
145535128|NCT00397215|524818649|FG002|Month 6 (Day 180)|Adverse Event|2|||
145535129|NCT00397215|524818650|FG003|Month 6 (Day 180)|Adverse Event|0|||
145535130|NCT00397215|524818647|FG000|Month 6 (Day 180)|Other|2|||
145535131|NCT00397215|524818648|FG001|Month 6 (Day 180)|Other|0|||
145535132|NCT00397215|524818649|FG002|Month 6 (Day 180)|Other|3|||
145535133|NCT00397215|524818650|FG003|Month 6 (Day 180)|Other|0|||
145535134|NCT01361568|524818651|FG000|Overall Study|Adverse Event|0|||
145774361|NCT02742649|525685240|FG000|Open-Label Period|Lost to Follow-up|0|||
145774362|NCT02742649|525685241|FG001|Open-Label Period|Lost to Follow-up|0|||
145774363|NCT02742649|525685242|FG002|Open-Label Period|Lost to Follow-up|0|||
145774364|NCT02742649|525685243|FG003|Open-Label Period|Lost to Follow-up|0|||
145774365|NCT02742649|525685244|FG004|Open-Label Period|Lost to Follow-up|1|||
145774366|NCT01943539|525685251|FG000|Overall Study|Non-compliance with at-home intervention|4|||
145774367|NCT01943539|525685252|FG001|Overall Study|Non-compliance with at-home intervention|0|||
145774368|NCT02158533|525685255|FG000|Stage 1|Adverse Event|6|||
145774369|NCT02158533|525685256|FG001|Stage 1|Adverse Event|4|||
145774370|NCT02158533|525685257|FG002|Stage 1|Adverse Event|7|||
145774371|NCT02158533|525685258|FG003|Stage 1|Adverse Event|0|||
145774372|NCT02158533|525685259|FG004|Stage 1|Adverse Event|0|||
145774373|NCT02158533|525685260|FG005|Stage 1|Adverse Event|0|||
145774374|NCT02158533|525685255|FG000|Stage 1|Withdrawal by Subject|3|||
145774375|NCT02158533|525685256|FG001|Stage 1|Withdrawal by Subject|2|||
145774376|NCT02158533|525685257|FG002|Stage 1|Withdrawal by Subject|1|||
145774377|NCT02158533|525685258|FG003|Stage 1|Withdrawal by Subject|0|||
145774378|NCT02158533|525685259|FG004|Stage 1|Withdrawal by Subject|0|||
145774379|NCT02158533|525685260|FG005|Stage 1|Withdrawal by Subject|0|||
145774380|NCT02158533|525685255|FG000|Stage 1|Lack of Efficacy|1|||
145774381|NCT02158533|525685256|FG001|Stage 1|Lack of Efficacy|0|||
145774382|NCT02158533|525685257|FG002|Stage 1|Lack of Efficacy|0|||
145535135|NCT01361568|524818652|FG001|Overall Study|Adverse Event|0|||
145535136|NCT01361568|524818653|FG002|Overall Study|Adverse Event|0|||
145535137|NCT01361568|524818654|FG003|Overall Study|Adverse Event|0|||
145535138|NCT01361568|524818655|FG004|Overall Study|Adverse Event|1|||
145535139|NCT01361568|524818656|FG005|Overall Study|Adverse Event|0|||
145535140|NCT01361568|524818651|FG000|Overall Study|Physician Decision|0|||
145774383|NCT02158533|525685258|FG003|Stage 1|Lack of Efficacy|0|||
145774384|NCT02158533|525685259|FG004|Stage 1|Lack of Efficacy|0|||
145774385|NCT02158533|525685260|FG005|Stage 1|Lack of Efficacy|0|||
145535141|NCT01361568|524818652|FG001|Overall Study|Physician Decision|0|||
145535142|NCT01361568|524818653|FG002|Overall Study|Physician Decision|0|||
145535143|NCT01361568|524818654|FG003|Overall Study|Physician Decision|0|||
145535144|NCT01361568|524818655|FG004|Overall Study|Physician Decision|0|||
145535145|NCT01361568|524818656|FG005|Overall Study|Physician Decision|1|||
145535146|NCT01361568|524818651|FG000|Overall Study|Withdrawal by Subject|2|||
145774386|NCT02158533|525685255|FG000|Stage 1|Lost to Follow-up|3|||
145774387|NCT02158533|525685256|FG001|Stage 1|Lost to Follow-up|1|||
145774388|NCT02158533|525685257|FG002|Stage 1|Lost to Follow-up|0|||
145774389|NCT02158533|525685258|FG003|Stage 1|Lost to Follow-up|0|||
145774390|NCT02158533|525685259|FG004|Stage 1|Lost to Follow-up|0|||
145535147|NCT01361568|524818652|FG001|Overall Study|Withdrawal by Subject|1|||
145535148|NCT01361568|524818653|FG002|Overall Study|Withdrawal by Subject|0|||
145535149|NCT01361568|524818654|FG003|Overall Study|Withdrawal by Subject|0|||
145608310|NCT00519896|525080978|FG000|Overall Study|Adverse Event|1|||
145774391|NCT02158533|525685260|FG005|Stage 1|Lost to Follow-up|0|||
145535150|NCT01361568|524818655|FG004|Overall Study|Withdrawal by Subject|0|||
145535151|NCT01361568|524818656|FG005|Overall Study|Withdrawal by Subject|1|||
145535152|NCT02728596|524818661|FG000|Overall Study|Refusal unrelated to adverse event|3|||
145535153|NCT02728596|524818662|FG001|Overall Study|Refusal unrelated to adverse event|6|||
145535154|NCT02728596|524818663|FG002|Overall Study|Refusal unrelated to adverse event|7|||
145774392|NCT02158533|525685255|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
145774393|NCT02158533|525685256|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
145774394|NCT02158533|525685257|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
145774395|NCT02158533|525685258|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
145774396|NCT02158533|525685259|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
145774397|NCT02158533|525685260|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
145774398|NCT02158533|525685255|FG000|Stage 1|Non-compliance with study visits|1|||
145774399|NCT02158533|525685256|FG001|Stage 1|Non-compliance with study visits|0|||
145774400|NCT02158533|525685257|FG002|Stage 1|Non-compliance with study visits|0|||
145774401|NCT02158533|525685258|FG003|Stage 1|Non-compliance with study visits|0|||
145774402|NCT02158533|525685259|FG004|Stage 1|Non-compliance with study visits|0|||
145774403|NCT02158533|525685260|FG005|Stage 1|Non-compliance with study visits|0|||
145774404|NCT02158533|525685255|FG000|Stage 2|Adverse Event|0|||
145774405|NCT02158533|525685256|FG001|Stage 2|Adverse Event|0|||
145774406|NCT02158533|525685257|FG002|Stage 2|Adverse Event|0|||
145774407|NCT02158533|525685258|FG003|Stage 2|Adverse Event|0|||
145774408|NCT02158533|525685259|FG004|Stage 2|Adverse Event|0|||
145403637|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145403638|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145403639|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145774409|NCT02158533|525685260|FG005|Stage 2|Adverse Event|1|||
145774410|NCT02158533|525685255|FG000|Stage 2|Lack of Efficacy|0|||
145774411|NCT02158533|525685256|FG001|Stage 2|Lack of Efficacy|0|||
145774412|NCT02158533|525685257|FG002|Stage 2|Lack of Efficacy|0|||
145774413|NCT02158533|525685258|FG003|Stage 2|Lack of Efficacy|0|||
145774414|NCT02158533|525685259|FG004|Stage 2|Lack of Efficacy|1|||
145774415|NCT02158533|525685260|FG005|Stage 2|Lack of Efficacy|0|||
145774416|NCT02158533|525685255|FG000|Stage 2|Lost to Follow-up|0|||
145774417|NCT02158533|525685256|FG001|Stage 2|Lost to Follow-up|0|||
145774418|NCT02158533|525685257|FG002|Stage 2|Lost to Follow-up|0|||
145774419|NCT02158533|525685258|FG003|Stage 2|Lost to Follow-up|1|||
145774420|NCT02158533|525685259|FG004|Stage 2|Lost to Follow-up|1|||
145774421|NCT02158533|525685260|FG005|Stage 2|Lost to Follow-up|2|||
145774422|NCT02158533|525685255|FG000|Stage 2|Withdrawal by Subject|0|||
145774423|NCT02158533|525685256|FG001|Stage 2|Withdrawal by Subject|0|||
145774424|NCT02158533|525685257|FG002|Stage 2|Withdrawal by Subject|0|||
145774425|NCT02158533|525685258|FG003|Stage 2|Withdrawal by Subject|0|||
145774426|NCT02158533|525685259|FG004|Stage 2|Withdrawal by Subject|1|||
145774427|NCT02158533|525685260|FG005|Stage 2|Withdrawal by Subject|2|||
145774428|NCT02158533|525685255|FG000|Stage 2|Physician Decision|0|||
145774429|NCT02158533|525685256|FG001|Stage 2|Physician Decision|0|||
145774430|NCT02158533|525685257|FG002|Stage 2|Physician Decision|0|||
145774431|NCT02158533|525685258|FG003|Stage 2|Physician Decision|0|||
145774432|NCT02158533|525685259|FG004|Stage 2|Physician Decision|1|||
145774433|NCT02158533|525685260|FG005|Stage 2|Physician Decision|0|||
145774434|NCT02158533|525685255|FG000|Stage 2|Pregnancy|0|||
145774435|NCT02158533|525685256|FG001|Stage 2|Pregnancy|0|||
145774436|NCT02158533|525685257|FG002|Stage 2|Pregnancy|0|||
145774437|NCT02158533|525685258|FG003|Stage 2|Pregnancy|1|||
145774438|NCT02158533|525685259|FG004|Stage 2|Pregnancy|0|||
145774439|NCT02158533|525685260|FG005|Stage 2|Pregnancy|0|||
145774440|NCT02158533|525685255|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
145774441|NCT02158533|525685256|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
145774442|NCT02158533|525685257|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
145774443|NCT02158533|525685258|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
145774444|NCT02158533|525685259|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
145535155|NCT02728596|524818664|FG003|Overall Study|Refusal unrelated to adverse event|7|||
145535156|NCT02728596|524818661|FG000|Overall Study|Death|44|||
145535157|NCT02728596|524818662|FG001|Overall Study|Death|42|||
145535158|NCT02728596|524818663|FG002|Overall Study|Death|123|||
145774445|NCT02158533|525685260|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
145774446|NCT02158533|525685255|FG000|Stage 2|Non-adherence with study visits|0|||
145774447|NCT02158533|525685256|FG001|Stage 2|Non-adherence with study visits|0|||
145774448|NCT02158533|525685257|FG002|Stage 2|Non-adherence with study visits|0|||
145774449|NCT02158533|525685258|FG003|Stage 2|Non-adherence with study visits|0|||
145774450|NCT02158533|525685259|FG004|Stage 2|Non-adherence with study visits|0|||
145774451|NCT02158533|525685260|FG005|Stage 2|Non-adherence with study visits|1|||
145774452|NCT02037919|525685267|FG000|Overall Study|Lost to Follow-up|30|||
145774453|NCT02037919|525685268|FG001|Overall Study|Lost to Follow-up|45|||
145774454|NCT01335971|525685269|FG000|Overall Study|Withdrawal by Subject|1|||
145774455|NCT01335971|525685270|FG001|Overall Study|Withdrawal by Subject|0|||
145774456|NCT01335971|525685271|FG002|Overall Study|Withdrawal by Subject|0|||
145535159|NCT02728596|524818664|FG003|Overall Study|Death|68|||
145535160|NCT03439657|524818665|FG000|Overall Study|Adverse Event|2|||
145774457|NCT01335971|525685269|FG000|Overall Study|Did not complete bronchoscopy|1|||
145774458|NCT01335971|525685270|FG001|Overall Study|Did not complete bronchoscopy|1|||
145774459|NCT01335971|525685271|FG002|Overall Study|Did not complete bronchoscopy|1|||
145774460|NCT00384956|525685272|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
145774461|NCT03180736|525685273|FG000|Overall Study|Adverse Event|3|||
145774462|NCT03180736|525685274|FG001|Overall Study|Adverse Event|4|||
145774463|NCT03180736|525685273|FG000|Overall Study|Death|10|||
145774464|NCT03180736|525685274|FG001|Overall Study|Death|7|||
145774465|NCT03180736|525685273|FG000|Overall Study|Withdrawal by Subject|5|||
145774466|NCT03180736|525685274|FG001|Overall Study|Withdrawal by Subject|12|||
145774467|NCT03180736|525685273|FG000|Overall Study|Lost to Follow-up|1|||
145774468|NCT03180736|525685274|FG001|Overall Study|Lost to Follow-up|0|||
145774469|NCT03180736|525685273|FG000|Overall Study|Lack of Efficacy|66|||
145774470|NCT03180736|525685274|FG001|Overall Study|Lack of Efficacy|87|||
145774471|NCT03180736|525685273|FG000|Overall Study|Physician Decision|4|||
145774472|NCT03180736|525685274|FG001|Overall Study|Physician Decision|7|||
145774473|NCT03180736|525685273|FG000|Overall Study|randomized but not treated|2|||
145774474|NCT03180736|525685274|FG001|Overall Study|randomized but not treated|3|||
145774475|NCT01389128|525685275|FG000|Overall Study|Fetal distress|1|||
145774476|NCT01389128|525685276|FG001|Overall Study|Fetal distress|0|||
145774477|NCT01389128|525685275|FG000|Overall Study|Cervix dilation stop|1|||
145774478|NCT01389128|525685276|FG001|Overall Study|Cervix dilation stop|2|||
145774479|NCT01389128|525685275|FG000|Overall Study|Rapid labor evolution|3|||
145774480|NCT01389128|525685276|FG001|Overall Study|Rapid labor evolution|2|||
145774481|NCT01389128|525685275|FG000|Overall Study|Intolerance to procedure|0|||
145774482|NCT01389128|525685276|FG001|Overall Study|Intolerance to procedure|2|||
145774483|NCT03230097|525685281|FG000|Overall Study|Adverse Event|2|||
145774484|NCT03230097|525685282|FG001|Overall Study|Adverse Event|1|||
145774485|NCT03230097|525685281|FG000|Overall Study|non-compliance|0|||
145535161|NCT03439657|524818666|FG001|Overall Study|Adverse Event|3|||
145535162|NCT03439657|524818665|FG000|Overall Study|Lost to Follow-up|1|||
145535163|NCT03439657|524818666|FG001|Overall Study|Lost to Follow-up|0|||
145535164|NCT03439657|524818665|FG000|Overall Study|Protocol Violation|1|||
145535165|NCT03439657|524818666|FG001|Overall Study|Protocol Violation|1|||
145535166|NCT03439657|524818665|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
145535167|NCT03439657|524818666|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
145535168|NCT00370071|524818668|FG000|Overall Study|Withdrawal by Subject|2|||
145535169|NCT03553927|524818671|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
145535170|NCT03553927|524818672|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
145535171|NCT03553927|524818671|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
145535172|NCT03553927|524818672|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
145535173|NCT02557295|524818674|FG000|Overall Study|Withdrawal by Subject|9|||
145535174|NCT02557295|524818675|FG001|Overall Study|Withdrawal by Subject|2|||
145535175|NCT02557295|524818676|FG002|Overall Study|Withdrawal by Subject|4|||
145535176|NCT02557295|524818677|FG003|Overall Study|Withdrawal by Subject|0|||
145535177|NCT02557295|524818678|FG004|Overall Study|Withdrawal by Subject|0|||
145535178|NCT02557295|524818679|FG005|Overall Study|Withdrawal by Subject|0|||
145535179|NCT02557295|524818680|FG006|Overall Study|Withdrawal by Subject|15|||
145774486|NCT03230097|525685282|FG001|Overall Study|non-compliance|1|||
145774487|NCT03230097|525685281|FG000|Overall Study|Lost to Follow-up|2|||
145774488|NCT03230097|525685282|FG001|Overall Study|Lost to Follow-up|4|||
145774489|NCT03230097|525685281|FG000|Overall Study|Withdrawal by Subject|7|||
145774490|NCT03230097|525685282|FG001|Overall Study|Withdrawal by Subject|3|||
145774491|NCT03230097|525685281|FG000|Overall Study|Trial termination|4|||
145774492|NCT03230097|525685282|FG001|Overall Study|Trial termination|5|||
145774493|NCT03230097|525685281|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
145774494|NCT03230097|525685282|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
145774495|NCT03230097|525685281|FG000|Overall Study|outcome event|0|||
145774496|NCT03230097|525685282|FG001|Overall Study|outcome event|1|||
145774497|NCT03056287|525685283|FG000|Overall Study|Withdrawal by Subject|0|||
145278866|NCT03033069|523870905|FG002|Overall Study|Lack of Efficacy|1|||
145535180|NCT02557295|524818681|FG007|Overall Study|Withdrawal by Subject|1|||
145535181|NCT02557295|524818682|FG008|Overall Study|Withdrawal by Subject|3|||
145535182|NCT02557295|524818674|FG000|Overall Study|Disease Progression|0|||
145535183|NCT02557295|524818675|FG001|Overall Study|Disease Progression|0|||
145774498|NCT03056287|525685284|FG001|Overall Study|Withdrawal by Subject|1|||
145774499|NCT03056287|525685285|FG002|Overall Study|Withdrawal by Subject|0|||
145774500|NCT03056287|525685286|FG003|Overall Study|Withdrawal by Subject|0|||
145774501|NCT03056287|525685283|FG000|Overall Study|move out of area|0|||
145774502|NCT03056287|525685284|FG001|Overall Study|move out of area|0|||
145774503|NCT03056287|525685285|FG002|Overall Study|move out of area|1|||
145774504|NCT03056287|525685286|FG003|Overall Study|move out of area|1|||
145774505|NCT01254344|525685306|FG000|Overall Study|Adverse Event|2|||
145774506|NCT01254344|525685307|FG001|Overall Study|Adverse Event|5|||
145774507|NCT01254344|525685306|FG000|Overall Study|Physician Decision|7|||
145774508|NCT01254344|525685307|FG001|Overall Study|Physician Decision|4|||
145774509|NCT01254344|525685306|FG000|Overall Study|Protocol Violation|1|||
145774510|NCT01254344|525685307|FG001|Overall Study|Protocol Violation|4|||
145774511|NCT01254344|525685306|FG000|Overall Study|Withdrawal by Subject|3|||
145774512|NCT01254344|525685307|FG001|Overall Study|Withdrawal by Subject|6|||
145774513|NCT00845429|525685308|FG000|Overall Study|Protocol Violation|5|||
145774514|NCT00845429|525685309|FG001|Overall Study|Protocol Violation|4|||
145774515|NCT00845429|525685310|FG002|Overall Study|Protocol Violation|7|||
145774516|NCT00845429|525685308|FG000|Overall Study|Lost to Follow-up|7|||
145774517|NCT00845429|525685309|FG001|Overall Study|Lost to Follow-up|9|||
145774518|NCT00845429|525685310|FG002|Overall Study|Lost to Follow-up|10|||
145774519|NCT00845429|525685308|FG000|Overall Study|Withdrawal by Subject|2|||
145774520|NCT00845429|525685309|FG001|Overall Study|Withdrawal by Subject|2|||
145774521|NCT00845429|525685310|FG002|Overall Study|Withdrawal by Subject|2|||
145774522|NCT00845429|525685308|FG000|Overall Study|Serious adverse event|0|||
145774523|NCT00845429|525685309|FG001|Overall Study|Serious adverse event|0|||
145774524|NCT00845429|525685310|FG002|Overall Study|Serious adverse event|1|||
145774525|NCT01480180|525685316|FG000|Main Phase|Withdrawal criteria|12|||
145774526|NCT01480180|525685317|FG001|Main Phase|Withdrawal criteria|1|||
145774527|NCT01480180|525685318|FG002|Main Phase|Withdrawal criteria|0|||
145774528|NCT01480180|525685319|FG003|Main Phase|Withdrawal criteria|0|||
145774529|NCT01480180|525685320|FG004|Main Phase|Withdrawal criteria|0|||
145774530|NCT01480180|525685321|FG005|Main Phase|Withdrawal criteria|0|||
145774531|NCT01480180|525685316|FG000|Main Phase|Lack of Efficacy|1|||
145774532|NCT01480180|525685317|FG001|Main Phase|Lack of Efficacy|0|||
145774533|NCT01480180|525685318|FG002|Main Phase|Lack of Efficacy|0|||
145774534|NCT01480180|525685319|FG003|Main Phase|Lack of Efficacy|0|||
145774535|NCT01480180|525685320|FG004|Main Phase|Lack of Efficacy|0|||
145774536|NCT01480180|525685321|FG005|Main Phase|Lack of Efficacy|0|||
145774537|NCT01480180|525685316|FG000|Main Phase|Non-compliance|3|||
145774538|NCT01480180|525685317|FG001|Main Phase|Non-compliance|0|||
145774539|NCT01480180|525685318|FG002|Main Phase|Non-compliance|0|||
145774540|NCT01480180|525685319|FG003|Main Phase|Non-compliance|0|||
145774541|NCT01480180|525685320|FG004|Main Phase|Non-compliance|0|||
145774542|NCT01480180|525685321|FG005|Main Phase|Non-compliance|0|||
145774543|NCT01480180|525685316|FG000|Main Phase|Unclassified|3|||
145774544|NCT01480180|525685317|FG001|Main Phase|Unclassified|0|||
145774545|NCT01480180|525685318|FG002|Main Phase|Unclassified|0|||
145774546|NCT01480180|525685319|FG003|Main Phase|Unclassified|0|||
145774547|NCT01480180|525685320|FG004|Main Phase|Unclassified|0|||
145774548|NCT01480180|525685321|FG005|Main Phase|Unclassified|0|||
145774549|NCT01480180|525685316|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
145774550|NCT01480180|525685317|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
145774551|NCT01480180|525685318|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
145774552|NCT01480180|525685319|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
145774553|NCT01480180|525685320|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
145774554|NCT01480180|525685321|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
145774555|NCT01480180|525685316|FG000|Extension Phase, Part 1|Unclassified|0|||
145774556|NCT01480180|525685317|FG001|Extension Phase, Part 1|Unclassified|0|||
145774557|NCT01480180|525685318|FG002|Extension Phase, Part 1|Unclassified|1|||
145774558|NCT01480180|525685319|FG003|Extension Phase, Part 1|Unclassified|0|||
145774559|NCT01480180|525685320|FG004|Extension Phase, Part 1|Unclassified|0|||
145774560|NCT01480180|525685321|FG005|Extension Phase, Part 1|Unclassified|0|||
145774561|NCT01480180|525685316|FG000|Extension Phase, Part 1|Adverse Event|0|||
145774562|NCT01480180|525685317|FG001|Extension Phase, Part 1|Adverse Event|0|||
145774563|NCT01480180|525685318|FG002|Extension Phase, Part 1|Adverse Event|4|||
145774564|NCT01480180|525685319|FG003|Extension Phase, Part 1|Adverse Event|1|||
145774565|NCT01480180|525685320|FG004|Extension Phase, Part 1|Adverse Event|0|||
145774566|NCT01480180|525685321|FG005|Extension Phase, Part 1|Adverse Event|0|||
145774567|NCT01480180|525685316|FG000|Extension Phase, Part 1|Change of treatment|0|||
145774568|NCT01480180|525685317|FG001|Extension Phase, Part 1|Change of treatment|0|||
145774569|NCT01480180|525685318|FG002|Extension Phase, Part 1|Change of treatment|0|||
145774570|NCT01480180|525685319|FG003|Extension Phase, Part 1|Change of treatment|9|||
145774571|NCT01480180|525685320|FG004|Extension Phase, Part 1|Change of treatment|0|||
145774572|NCT01480180|525685321|FG005|Extension Phase, Part 1|Change of treatment|0|||
145774573|NCT01480180|525685316|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
145774574|NCT01480180|525685317|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
145774575|NCT01480180|525685318|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
145774576|NCT01480180|525685319|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
145774577|NCT01480180|525685320|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
145774578|NCT01480180|525685321|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
145774579|NCT01480180|525685316|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
145774580|NCT01480180|525685317|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
145774581|NCT01480180|525685318|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
145774582|NCT01480180|525685319|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
145774583|NCT01480180|525685320|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
145774584|NCT01480180|525685321|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
145774585|NCT01480180|525685316|FG000|Extension Phase, Part 2|Unclassified|0|||
145774586|NCT01480180|525685317|FG001|Extension Phase, Part 2|Unclassified|0|||
145774587|NCT01480180|525685318|FG002|Extension Phase, Part 2|Unclassified|3|||
145774588|NCT01480180|525685319|FG003|Extension Phase, Part 2|Unclassified|1|||
145774589|NCT01480180|525685320|FG004|Extension Phase, Part 2|Unclassified|1|||
145403640|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145403641|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
145535184|NCT02557295|524818676|FG002|Overall Study|Disease Progression|0|||
145535185|NCT02557295|524818677|FG003|Overall Study|Disease Progression|0|||
145535186|NCT02557295|524818678|FG004|Overall Study|Disease Progression|0|||
145535187|NCT02557295|524818679|FG005|Overall Study|Disease Progression|0|||
145535188|NCT02557295|524818680|FG006|Overall Study|Disease Progression|1|||
145535189|NCT02557295|524818681|FG007|Overall Study|Disease Progression|0|||
145535190|NCT02557295|524818682|FG008|Overall Study|Disease Progression|0|||
145535191|NCT02557295|524818674|FG000|Overall Study|Lack of Efficacy|24|||
145535192|NCT02557295|524818675|FG001|Overall Study|Lack of Efficacy|1|||
145535193|NCT02557295|524818676|FG002|Overall Study|Lack of Efficacy|3|||
145535194|NCT02557295|524818677|FG003|Overall Study|Lack of Efficacy|0|||
145535195|NCT02557295|524818678|FG004|Overall Study|Lack of Efficacy|0|||
145535196|NCT02557295|524818679|FG005|Overall Study|Lack of Efficacy|0|||
145535197|NCT02557295|524818680|FG006|Overall Study|Lack of Efficacy|12|||
145535198|NCT02557295|524818681|FG007|Overall Study|Lack of Efficacy|1|||
145535199|NCT02557295|524818682|FG008|Overall Study|Lack of Efficacy|0|||
145535200|NCT02557295|524818674|FG000|Overall Study|Adverse Event|16|||
145535201|NCT02557295|524818675|FG001|Overall Study|Adverse Event|2|||
145535202|NCT02557295|524818676|FG002|Overall Study|Adverse Event|3|||
145535203|NCT02557295|524818677|FG003|Overall Study|Adverse Event|0|||
145535204|NCT02557295|524818678|FG004|Overall Study|Adverse Event|0|||
145535205|NCT02557295|524818679|FG005|Overall Study|Adverse Event|0|||
145535206|NCT02557295|524818680|FG006|Overall Study|Adverse Event|2|||
145535207|NCT02557295|524818681|FG007|Overall Study|Adverse Event|1|||
145535208|NCT02557295|524818682|FG008|Overall Study|Adverse Event|1|||
145535209|NCT02557295|524818674|FG000|Overall Study|Lost to Follow-up|4|||
145535210|NCT02557295|524818675|FG001|Overall Study|Lost to Follow-up|0|||
145535211|NCT02557295|524818676|FG002|Overall Study|Lost to Follow-up|0|||
145535212|NCT02557295|524818677|FG003|Overall Study|Lost to Follow-up|0|||
145535213|NCT02557295|524818678|FG004|Overall Study|Lost to Follow-up|0|||
145535214|NCT02557295|524818679|FG005|Overall Study|Lost to Follow-up|0|||
145535215|NCT02557295|524818680|FG006|Overall Study|Lost to Follow-up|9|||
145535216|NCT02557295|524818681|FG007|Overall Study|Lost to Follow-up|0|||
145535217|NCT02557295|524818682|FG008|Overall Study|Lost to Follow-up|0|||
145535218|NCT02557295|524818674|FG000|Overall Study|Study Close|54|||
145535219|NCT02557295|524818675|FG001|Overall Study|Study Close|3|||
145535220|NCT02557295|524818676|FG002|Overall Study|Study Close|5|||
145535221|NCT02557295|524818677|FG003|Overall Study|Study Close|3|||
145535222|NCT02557295|524818678|FG004|Overall Study|Study Close|0|||
145535223|NCT02557295|524818679|FG005|Overall Study|Study Close|0|||
145535224|NCT02557295|524818680|FG006|Overall Study|Study Close|37|||
145535225|NCT02557295|524818681|FG007|Overall Study|Study Close|3|||
145535226|NCT02557295|524818682|FG008|Overall Study|Study Close|19|||
145535227|NCT02557295|524818674|FG000|Overall Study|except for study close|4|||
145535228|NCT02557295|524818675|FG001|Overall Study|except for study close|0|||
145535229|NCT02557295|524818676|FG002|Overall Study|except for study close|0|||
145535230|NCT02557295|524818677|FG003|Overall Study|except for study close|0|||
145535231|NCT02557295|524818678|FG004|Overall Study|except for study close|0|||
145535232|NCT02557295|524818679|FG005|Overall Study|except for study close|0|||
145535233|NCT02557295|524818680|FG006|Overall Study|except for study close|5|||
145535234|NCT02557295|524818681|FG007|Overall Study|except for study close|1|||
145535235|NCT02557295|524818682|FG008|Overall Study|except for study close|0|||
145535236|NCT03487549|524818683|FG000|Overall Study|Protocol Violation|0|||
145535237|NCT03487549|524818684|FG001|Overall Study|Protocol Violation|1|||
145535238|NCT03487549|524818683|FG000|Overall Study|Lost to Follow-up|2|||
145535239|NCT03487549|524818684|FG001|Overall Study|Lost to Follow-up|1|||
145535240|NCT03487549|524818683|FG000|Overall Study|Withdrawal by Subject|2|||
145535241|NCT03487549|524818684|FG001|Overall Study|Withdrawal by Subject|0|||
145774590|NCT01480180|525685321|FG005|Extension Phase, Part 2|Unclassified|0|||
145535242|NCT01313858|524820690|FG000|Overall Study|Premature Treatment Termination|251|||
145774591|NCT01548638|525685324|FG000|Overall Study|Protocol Violation|3|||
145774592|NCT01548638|525685324|FG000|Overall Study|Withdrawal by Subject|1|||
145774593|NCT01919411|525685333|FG000|Overall Study|Lost to Follow-up|2|||
145535243|NCT01313858|524820691|FG001|Overall Study|Premature Treatment Termination|219|||
145535244|NCT01313858|524820692|FG002|Overall Study|Premature Treatment Termination|191|||
145535245|NCT01313858|524820690|FG000|Overall Study|Lost to Follow-up|35|||
145535246|NCT01313858|524820691|FG001|Overall Study|Lost to Follow-up|51|||
145535247|NCT01313858|524820692|FG002|Overall Study|Lost to Follow-up|47|||
145535248|NCT01816074|524820695|FG000|Phase 1|Time commitment issues|0|||
145535249|NCT01816074|524820696|FG001|Phase 1|Time commitment issues|0|||
145535250|NCT01816074|524820697|FG002|Phase 1|Time commitment issues|1|||
145535251|NCT01816074|524820698|FG003|Phase 1|Time commitment issues|0|||
145535252|NCT01816074|524820695|FG000|Phase 2|Time commitment Issues|0|||
145535253|NCT01816074|524820696|FG001|Phase 2|Time commitment Issues|2|||
145774594|NCT01919411|525685334|FG001|Overall Study|Lost to Follow-up|4|||
145774595|NCT01919411|525685333|FG000|Overall Study|Physician Decision|1|||
145774596|NCT01919411|525685334|FG001|Overall Study|Physician Decision|0|||
145774597|NCT01919411|525685333|FG000|Overall Study|Protocol Violation|2|||
145774598|NCT01919411|525685334|FG001|Overall Study|Protocol Violation|1|||
145774599|NCT00144300|525685335|FG000|Overall Study|Adverse Event|18|||
145774600|NCT00144300|525685336|FG001|Overall Study|Adverse Event|16|||
145774601|NCT00144300|525685335|FG000|Overall Study|Protocol Violation|1|||
145774602|NCT00144300|525685336|FG001|Overall Study|Protocol Violation|3|||
145774603|NCT00144300|525685335|FG000|Overall Study|Lost to Follow-up|3|||
145774604|NCT00144300|525685336|FG001|Overall Study|Lost to Follow-up|0|||
145774605|NCT00144300|525685335|FG000|Overall Study|Withdrawal by Subject|6|||
145608311|NCT01077362|525080983|FG000|Overall Study|Lack of Efficacy|13|||
145774606|NCT00144300|525685336|FG001|Overall Study|Withdrawal by Subject|6|||
145774607|NCT00144300|525685335|FG000|Overall Study|Other reason (not specified)|1|||
145774608|NCT00144300|525685336|FG001|Overall Study|Other reason (not specified)|3|||
145774609|NCT02426086|525685339|FG000|Overall Study|Death|33|||
145774610|NCT02426086|525685340|FG001|Overall Study|Death|36|||
145774611|NCT02426086|525685339|FG000|Overall Study|Lost to Follow-up|2|||
145774612|NCT02426086|525685340|FG001|Overall Study|Lost to Follow-up|0|||
145774613|NCT02426086|525685339|FG000|Overall Study|Study Terminated by Sponsor|5|||
145774614|NCT02426086|525685340|FG001|Overall Study|Study Terminated by Sponsor|14|||
145774615|NCT02426086|525685339|FG000|Overall Study|Withdrawal by Subject|8|||
145774616|NCT02426086|525685340|FG001|Overall Study|Withdrawal by Subject|9|||
145774617|NCT00524303|525685341|FG000|Overall Study|Lost to Follow-up|6|||
145774618|NCT00524303|525685342|FG001|Overall Study|Lost to Follow-up|0|||
145774619|NCT00524303|525685343|FG002|Overall Study|Lost to Follow-up|3|||
145774620|NCT00524303|525685341|FG000|Overall Study|Protocol Violation|0|||
145774621|NCT00524303|525685342|FG001|Overall Study|Protocol Violation|1|||
145774622|NCT00524303|525685343|FG002|Overall Study|Protocol Violation|1|||
145774623|NCT00524303|525685341|FG000|Overall Study|Withdrawal by Subject|3|||
145774624|NCT00524303|525685342|FG001|Overall Study|Withdrawal by Subject|0|||
145774625|NCT00524303|525685343|FG002|Overall Study|Withdrawal by Subject|4|||
145774626|NCT00524303|525685341|FG000|Overall Study|Death|0|||
145774627|NCT00524303|525685342|FG001|Overall Study|Death|2|||
145774628|NCT00524303|525685343|FG002|Overall Study|Death|3|||
145774629|NCT00524303|525685341|FG000|Overall Study|Adverse Event|1|||
145774630|NCT00524303|525685342|FG001|Overall Study|Adverse Event|2|||
145774631|NCT00524303|525685343|FG002|Overall Study|Adverse Event|3|||
145774632|NCT00524303|525685341|FG000|Overall Study|Did not Complete Study Dosing|1|||
145774633|NCT00524303|525685342|FG001|Overall Study|Did not Complete Study Dosing|0|||
145774634|NCT00524303|525685343|FG002|Overall Study|Did not Complete Study Dosing|0|||
145535254|NCT01816074|524820697|FG002|Phase 2|Time commitment Issues|0|||
145535255|NCT01816074|524820698|FG003|Phase 2|Time commitment Issues|0|||
145535256|NCT01816074|524820695|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
145535257|NCT01816074|524820696|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
145535258|NCT01816074|524820697|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
145535259|NCT01816074|524820698|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
145535260|NCT01816074|524820695|FG000|Phase 2|Physician Decision|0|||
145608312|NCT01077362|525080984|FG001|Overall Study|Lack of Efficacy|8|||
145774635|NCT00524303|525685341|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
145278867|NCT03033069|523870906|FG003|Overall Study|Lack of Efficacy|0|||
145535261|NCT01816074|524820696|FG001|Phase 2|Physician Decision|0|||
145535262|NCT01816074|524820697|FG002|Phase 2|Physician Decision|0|||
145774636|NCT00524303|525685342|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
145774637|NCT00524303|525685343|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
145774638|NCT00524303|525685341|FG000|Overall Study|Disease Progression|0|||
145774639|NCT00524303|525685342|FG001|Overall Study|Disease Progression|4|||
145774640|NCT00524303|525685343|FG002|Overall Study|Disease Progression|1|||
145774641|NCT00524303|525685341|FG000|Overall Study|Disease Recurrence|0|||
145774642|NCT00524303|525685342|FG001|Overall Study|Disease Recurrence|1|||
145774643|NCT00524303|525685343|FG002|Overall Study|Disease Recurrence|0|||
145774644|NCT00524303|525685341|FG000|Overall Study|Sponsor Request|0|||
145774645|NCT00524303|525685342|FG001|Overall Study|Sponsor Request|0|||
145774646|NCT00524303|525685343|FG002|Overall Study|Sponsor Request|1|||
145774647|NCT00524303|525685341|FG000|Overall Study|Physician Decision|0|||
145774648|NCT00524303|525685342|FG001|Overall Study|Physician Decision|0|||
145535263|NCT01816074|524820698|FG003|Phase 2|Physician Decision|1|||
145535264|NCT01816074|524820695|FG000|Phase 2|Withdrawal by Subject|1|||
145535265|NCT01816074|524820696|FG001|Phase 2|Withdrawal by Subject|0|||
145535266|NCT01816074|524820697|FG002|Phase 2|Withdrawal by Subject|0|||
145535267|NCT01816074|524820698|FG003|Phase 2|Withdrawal by Subject|0|||
145535268|NCT00131508|524820706|FG000|Overall Study|Disease progression|0|||
145535269|NCT00131508|524820707|FG001|Overall Study|Disease progression|2|||
145535270|NCT00131508|524820706|FG000|Overall Study|Non-Compliance|2|||
145535271|NCT00131508|524820707|FG001|Overall Study|Non-Compliance|4|||
145535272|NCT00131508|524820706|FG000|Overall Study|Withdrawal by Subject|1|||
145535273|NCT00131508|524820707|FG001|Overall Study|Withdrawal by Subject|2|||
145535274|NCT01330030|524820708|FG000|Overall Study|Lost to Follow-up|16|||
145535275|NCT01330030|524820709|FG001|Overall Study|Lost to Follow-up|17|||
145535276|NCT00845858|524820710|FG000|Overall Study|Withdrawal by Subject|5|||
145774649|NCT00524303|525685343|FG002|Overall Study|Physician Decision|1|||
145774650|NCT00524303|525685341|FG000|Overall Study|Completed 5 years|0|||
145774651|NCT00524303|525685342|FG001|Overall Study|Completed 5 years|0|||
145774652|NCT00524303|525685343|FG002|Overall Study|Completed 5 years|1|||
145774653|NCT00095121|525685353|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
145774654|NCT00095121|525685354|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
145774655|NCT00095121|525685353|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
145774656|NCT00095121|525685354|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
145774657|NCT03497689|525685360|FG000|Overall Study|Adverse Event|2|||
145774658|NCT03497689|525685360|FG000|Overall Study|Death|1|||
145774659|NCT03497689|525685360|FG000|Overall Study|Physician Decision|1|||
145774660|NCT03497689|525685360|FG000|Overall Study|Withdrawal by Subject|1|||
145774661|NCT03497689|525685360|FG000|Overall Study|Protocol Violation|2|||
145774662|NCT02032875|525685361|FG000|Treatment Period|Adverse Event|1|||
145774663|NCT02032875|525685362|FG001|Treatment Period|Adverse Event|0|||
145774664|NCT02032875|525685361|FG000|Treatment Period|Liver transplant, No extension needed|0|||
145774665|NCT02032875|525685362|FG001|Treatment Period|Liver transplant, No extension needed|1|||
145774666|NCT02032875|525685361|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
145774667|NCT02032875|525685362|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
145774668|NCT02032875|525685361|FG000|Follow-up Period|Death|0|||
145774669|NCT02032875|525685362|FG001|Follow-up Period|Death|1|||
145774670|NCT02032875|525685361|FG000|Follow-up Period|Virologic Relapse|3|||
145774671|NCT02032875|525685362|FG001|Follow-up Period|Virologic Relapse|10|||
145774672|NCT04636177|525685363|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
145774673|NCT04636177|525685364|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
145774674|NCT04636177|525685363|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
145774675|NCT04636177|525685364|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
145774676|NCT04636177|525685363|FG000|Single-arm portion|Withdrawal by Subject|1|||
145774677|NCT04636177|525685364|FG001|Single-arm portion|Withdrawal by Subject|0|||
145774678|NCT04636177|525685363|FG000|Single-arm portion|Adverse Event|1|||
145774679|NCT04636177|525685364|FG001|Single-arm portion|Adverse Event|0|||
145774680|NCT03191786|525685365|FG000|Overall Study|Death|236|||
145774681|NCT03191786|525685366|FG001|Overall Study|Death|127|||
145774682|NCT03191786|525685365|FG000|Overall Study|Lost to Follow-up|9|||
145774683|NCT03191786|525685366|FG001|Overall Study|Lost to Follow-up|3|||
145774684|NCT03191786|525685365|FG000|Overall Study|Physician Decision|1|||
145774685|NCT03191786|525685366|FG001|Overall Study|Physician Decision|0|||
145774686|NCT03191786|525685365|FG000|Overall Study|Moved to Post Trial Access Program|30|||
145774687|NCT03191786|525685366|FG001|Overall Study|Moved to Post Trial Access Program|5|||
145774688|NCT03191786|525685365|FG000|Overall Study|Withdrawal by Subject|26|||
145774689|NCT03191786|525685366|FG001|Overall Study|Withdrawal by Subject|16|||
145278868|NCT03033069|523870903|FG000|Overall Study|Lost to Follow-up|6|||
145403642|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145535277|NCT00845858|524820711|FG001|Overall Study|Withdrawal by Subject|1|||
145535278|NCT00845858|524820712|FG002|Overall Study|Withdrawal by Subject|1|||
145535279|NCT00845858|524820710|FG000|Overall Study|Adverse Event|3|||
145535280|NCT00845858|524820711|FG001|Overall Study|Adverse Event|8|||
145535281|NCT00845858|524820712|FG002|Overall Study|Adverse Event|4|||
145535282|NCT00845858|524820710|FG000|Overall Study|Protocol Violation|0|||
145535283|NCT00845858|524820711|FG001|Overall Study|Protocol Violation|0|||
145535284|NCT00845858|524820712|FG002|Overall Study|Protocol Violation|1|||
145535285|NCT00845858|524820710|FG000|Overall Study|not eligible|0|||
145535286|NCT00845858|524820711|FG001|Overall Study|not eligible|3|||
145535287|NCT00845858|524820712|FG002|Overall Study|not eligible|2|||
145535288|NCT03758443|524820713|FG000|Induction Period|Adverse Event|2|||
145535289|NCT03758443|524820714|FG001|Induction Period|Adverse Event|4|||
145774690|NCT03167619|525687538|FG000|Overall Study|Death|11|||
145774691|NCT03167619|525687539|FG001|Overall Study|Death|8|||
145774692|NCT03167619|525687538|FG000|Overall Study|Withdrawal by Subject|1|||
145774693|NCT03167619|525687539|FG001|Overall Study|Withdrawal by Subject|2|||
145774694|NCT03167619|525687538|FG000|Overall Study|Physician Decision|0|||
145774695|NCT03167619|525687539|FG001|Overall Study|Physician Decision|1|||
145774696|NCT02333331|525687547|FG000|Overall Study|Adverse Event|1|||
145774697|NCT02333331|525687548|FG001|Overall Study|Adverse Event|0|||
145774698|NCT02333331|525687549|FG002|Overall Study|Adverse Event|4|||
145774699|NCT02333331|525687550|FG003|Overall Study|Adverse Event|1|||
145774700|NCT02333331|525687547|FG000|Overall Study|Death|0|||
145535290|NCT03758443|524820715|FG002|Induction Period|Adverse Event|2|||
145535291|NCT03758443|524820716|FG003|Induction Period|Adverse Event|3|||
145535292|NCT03758443|524820713|FG000|Induction Period|Physician Decision|1|||
145535293|NCT03758443|524820714|FG001|Induction Period|Physician Decision|1|||
145774701|NCT02333331|525687548|FG001|Overall Study|Death|0|||
145774702|NCT02333331|525687549|FG002|Overall Study|Death|2|||
145774703|NCT02333331|525687550|FG003|Overall Study|Death|0|||
145774704|NCT02333331|525687547|FG000|Overall Study|Lost to Follow-up|0|||
145774705|NCT02333331|525687548|FG001|Overall Study|Lost to Follow-up|0|||
145774706|NCT02333331|525687549|FG002|Overall Study|Lost to Follow-up|1|||
145774707|NCT02333331|525687550|FG003|Overall Study|Lost to Follow-up|0|||
145774708|NCT02333331|525687547|FG000|Overall Study|Physician Decision|0|||
145774709|NCT02333331|525687548|FG001|Overall Study|Physician Decision|1|||
145774710|NCT02333331|525687549|FG002|Overall Study|Physician Decision|0|||
145774711|NCT02333331|525687550|FG003|Overall Study|Physician Decision|0|||
145774712|NCT02333331|525687547|FG000|Overall Study|Protocol Deviation|0|||
145774713|NCT02333331|525687548|FG001|Overall Study|Protocol Deviation|3|||
145774714|NCT02333331|525687549|FG002|Overall Study|Protocol Deviation|2|||
145774715|NCT02333331|525687550|FG003|Overall Study|Protocol Deviation|1|||
145774716|NCT02333331|525687547|FG000|Overall Study|Patient/Guardian Decision|1|||
145774717|NCT02333331|525687548|FG001|Overall Study|Patient/Guardian Decision|2|||
145535294|NCT03758443|524820715|FG002|Induction Period|Physician Decision|3|||
145535295|NCT03758443|524820716|FG003|Induction Period|Physician Decision|0|||
145535296|NCT03758443|524820713|FG000|Induction Period|Protocol Violation|0|||
145774718|NCT02333331|525687549|FG002|Overall Study|Patient/Guardian Decision|9|||
145774719|NCT02333331|525687550|FG003|Overall Study|Patient/Guardian Decision|1|||
145774720|NCT00345605|525687555|FG000|Arm 1|Adverse Event|0|||
145774721|NCT00345605|525687556|FG001|Arm 1|Adverse Event|1|||
145774722|NCT00345605|525687555|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
145774723|NCT00345605|525687556|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
145774724|NCT01059812|525687557|FG000|Overall Study|Adverse Event|9|||
145774725|NCT01059812|525687558|FG001|Overall Study|Adverse Event|5|||
145774726|NCT01059812|525687557|FG000|Overall Study|Lack of Efficacy|2|||
145774727|NCT01059812|525687558|FG001|Overall Study|Lack of Efficacy|2|||
145774728|NCT01059812|525687557|FG000|Overall Study|Protocol Violation|3|||
145774729|NCT01059812|525687558|FG001|Overall Study|Protocol Violation|1|||
145774730|NCT01059812|525687557|FG000|Overall Study|Withdrawal Criteria|9|||
145774731|NCT01059812|525687558|FG001|Overall Study|Withdrawal Criteria|4|||
145774732|NCT01059812|525687557|FG000|Overall Study|Unclassified|14|||
145774733|NCT01059812|525687558|FG001|Overall Study|Unclassified|4|||
145774734|NCT00174941|525687559|FG000|Overall Study|Adverse Event|1|||
145774735|NCT00174941|525687560|FG001|Overall Study|Adverse Event|10|||
145774736|NCT00174941|525687561|FG002|Overall Study|Adverse Event|2|||
145774737|NCT00174941|525687562|FG003|Overall Study|Adverse Event|13|||
145774738|NCT00174941|525687559|FG000|Overall Study|Protocol Violation|0|||
145774739|NCT00174941|525687560|FG001|Overall Study|Protocol Violation|1|||
145774740|NCT00174941|525687561|FG002|Overall Study|Protocol Violation|0|||
145774741|NCT00174941|525687562|FG003|Overall Study|Protocol Violation|1|||
145774742|NCT00174941|525687559|FG000|Overall Study|Lost to Follow-up|0|||
145774743|NCT00174941|525687560|FG001|Overall Study|Lost to Follow-up|3|||
145774744|NCT00174941|525687561|FG002|Overall Study|Lost to Follow-up|2|||
145774745|NCT00174941|525687562|FG003|Overall Study|Lost to Follow-up|5|||
145774746|NCT00174941|525687559|FG000|Overall Study|Personal Reason(s)|0|||
145774747|NCT00174941|525687560|FG001|Overall Study|Personal Reason(s)|14|||
145774748|NCT00174941|525687561|FG002|Overall Study|Personal Reason(s)|8|||
145774749|NCT00174941|525687562|FG003|Overall Study|Personal Reason(s)|22|||
145403643|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
145403644|NCT01232283|524334393|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145403645|NCT01232283|524334394|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145535297|NCT03758443|524820714|FG001|Induction Period|Protocol Violation|0|||
145774750|NCT00174941|525687559|FG000|Overall Study|Gout Flare|0|||
145403646|NCT01232283|524334395|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145403647|NCT01232283|524334396|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145403648|NCT01232283|524334397|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145535298|NCT03758443|524820715|FG002|Induction Period|Protocol Violation|0|||
145535299|NCT03758443|524820716|FG003|Induction Period|Protocol Violation|1|||
145774751|NCT00174941|525687560|FG001|Overall Study|Gout Flare|4|||
145774752|NCT00174941|525687561|FG002|Overall Study|Gout Flare|4|||
145774753|NCT00174941|525687562|FG003|Overall Study|Gout Flare|8|||
145774754|NCT00174941|525687559|FG000|Overall Study|Reason Not Specified|1|||
145774755|NCT00174941|525687560|FG001|Overall Study|Reason Not Specified|6|||
145774756|NCT00174941|525687561|FG002|Overall Study|Reason Not Specified|2|||
145774757|NCT00174941|525687562|FG003|Overall Study|Reason Not Specified|9|||
145774758|NCT03126227|525687563|FG000|Overall Study|Adverse Event|43|||
145774759|NCT03126227|525687564|FG001|Overall Study|Adverse Event|4|||
145774760|NCT03126227|525687563|FG000|Overall Study|Death|0|||
145774761|NCT03126227|525687564|FG001|Overall Study|Death|1|||
145774762|NCT03126227|525687563|FG000|Overall Study|Lost to Follow-up|0|||
145774763|NCT03126227|525687564|FG001|Overall Study|Lost to Follow-up|1|||
145774764|NCT03126227|525687563|FG000|Overall Study|Physician Decision|2|||
145774765|NCT03126227|525687564|FG001|Overall Study|Physician Decision|0|||
145774766|NCT03126227|525687563|FG000|Overall Study|Protocol Violation|1|||
145774767|NCT03126227|525687564|FG001|Overall Study|Protocol Violation|0|||
145774768|NCT03126227|525687563|FG000|Overall Study|Withdrawal by Subject|19|||
145774769|NCT03126227|525687564|FG001|Overall Study|Withdrawal by Subject|3|||
145535300|NCT03758443|524820713|FG000|Induction Period|Withdrawal by Subject|3|||
145774770|NCT03126227|525687563|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
145774771|NCT03126227|525687564|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
145774772|NCT03126227|525687563|FG000|Overall Study|Lack of dosing compliance|2|||
145774773|NCT03126227|525687564|FG001|Overall Study|Lack of dosing compliance|0|||
145774774|NCT03126227|525687563|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
145774775|NCT03126227|525687564|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
145774776|NCT03126227|525687563|FG000|Overall Study|Scheduling conflict|1|||
145774777|NCT03126227|525687564|FG001|Overall Study|Scheduling conflict|0|||
145774778|NCT00635102|525687573|FG000|Overall Study|Withdrawal by Subject|7|||
145774779|NCT00635102|525687574|FG001|Overall Study|Withdrawal by Subject|8|||
145774780|NCT00440401|525687576|FG000|Overall Study|Adverse Event|2|||
145774781|NCT00440401|525687577|FG001|Overall Study|Adverse Event|1|||
145535301|NCT03758443|524820714|FG001|Induction Period|Withdrawal by Subject|2|||
145535302|NCT03758443|524820715|FG002|Induction Period|Withdrawal by Subject|2|||
145608313|NCT01077362|525080985|FG002|Overall Study|Lack of Efficacy|10|||
145608314|NCT01077362|525080983|FG000|Overall Study|Lost to Follow-up|1|||
145608315|NCT01077362|525080984|FG001|Overall Study|Lost to Follow-up|0|||
145608316|NCT01077362|525080985|FG002|Overall Study|Lost to Follow-up|3|||
145608317|NCT01077362|525080983|FG000|Overall Study|Adverse Event|12|||
145608318|NCT01077362|525080984|FG001|Overall Study|Adverse Event|7|||
145608319|NCT01077362|525080985|FG002|Overall Study|Adverse Event|4|||
145608320|NCT01077362|525080983|FG000|Overall Study|Withdrawal by Subject|5|||
145608321|NCT01077362|525080984|FG001|Overall Study|Withdrawal by Subject|3|||
145608322|NCT01077362|525080985|FG002|Overall Study|Withdrawal by Subject|5|||
145608323|NCT01077362|525080983|FG000|Overall Study|Other|0|||
145608324|NCT01077362|525080984|FG001|Overall Study|Other|1|||
145608325|NCT01077362|525080985|FG002|Overall Study|Other|2|||
145608326|NCT02387216|525080989|FG000|Overall Study|Progressive disease|2|||
145535303|NCT03758443|524820716|FG003|Induction Period|Withdrawal by Subject|4|||
145535304|NCT03758443|524820713|FG000|Extended Induction Period|Adverse Event|1|||
145535305|NCT03758443|524820714|FG001|Extended Induction Period|Adverse Event|1|||
145535306|NCT03758443|524820715|FG002|Extended Induction Period|Adverse Event|0|||
145535307|NCT03758443|524820716|FG003|Extended Induction Period|Adverse Event|1|||
145535308|NCT03758443|524820713|FG000|Extended Induction Period|Lost to Follow-up|1|||
145535309|NCT03758443|524820714|FG001|Extended Induction Period|Lost to Follow-up|0|||
145535310|NCT03758443|524820715|FG002|Extended Induction Period|Lost to Follow-up|0|||
145535311|NCT03758443|524820716|FG003|Extended Induction Period|Lost to Follow-up|0|||
145535312|NCT03758443|524820713|FG000|Extended Induction Period|Physician Decision|2|||
145535313|NCT03758443|524820714|FG001|Extended Induction Period|Physician Decision|1|||
145535314|NCT03758443|524820715|FG002|Extended Induction Period|Physician Decision|2|||
145535315|NCT03758443|524820716|FG003|Extended Induction Period|Physician Decision|2|||
145535316|NCT03758443|524820713|FG000|Extended Induction Period|Protocol Violation|0|||
145535317|NCT03758443|524820714|FG001|Extended Induction Period|Protocol Violation|0|||
145535318|NCT03758443|524820715|FG002|Extended Induction Period|Protocol Violation|0|||
145535319|NCT03758443|524820716|FG003|Extended Induction Period|Protocol Violation|1|||
145535320|NCT03758443|524820713|FG000|Extended Induction Period|Withdrawal by Subject|8|||
145535321|NCT03758443|524820714|FG001|Extended Induction Period|Withdrawal by Subject|1|||
145535322|NCT03758443|524820715|FG002|Extended Induction Period|Withdrawal by Subject|7|||
145535323|NCT03758443|524820716|FG003|Extended Induction Period|Withdrawal by Subject|3|||
145608327|NCT02387216|525080990|FG001|Overall Study|Progressive disease|0|||
145608328|NCT02387216|525080989|FG000|Overall Study|Withdrawal by Subject|3|||
145608329|NCT02387216|525080990|FG001|Overall Study|Withdrawal by Subject|5|||
145608330|NCT02387216|525080989|FG000|Overall Study|Physician Decision|2|||
145774782|NCT00440401|525687576|FG000|Overall Study|Other|2|||
145774783|NCT00440401|525687577|FG001|Overall Study|Other|5|||
145774784|NCT01938625|525687578|FG000|Overall Study|Withdrawal by Subject|0|||
145535324|NCT03758443|524820713|FG000|Extended Induction Period|Miscellaneous|1|||
145535325|NCT03758443|524820714|FG001|Extended Induction Period|Miscellaneous|0|||
145535326|NCT03758443|524820715|FG002|Extended Induction Period|Miscellaneous|0|||
145535327|NCT03758443|524820716|FG003|Extended Induction Period|Miscellaneous|0|||
145535328|NCT03758443|524820713|FG000|Maintenance Period|Adverse Event|1|||
145608331|NCT02387216|525080990|FG001|Overall Study|Physician Decision|0|||
145608332|NCT02387216|525080989|FG000|Overall Study|Sponsor Decision|28|||
145608333|NCT02387216|525080990|FG001|Overall Study|Sponsor Decision|12|||
145608334|NCT02387216|525080989|FG000|Overall Study|Death|60|||
145608335|NCT02387216|525080990|FG001|Overall Study|Death|23|||
145608336|NCT02387216|525080989|FG000|Overall Study|Other|5|||
145608337|NCT02387216|525080990|FG001|Overall Study|Other|4|||
145608338|NCT02387216|525080989|FG000|Overall Study|Lost to Follow-up|0|||
145608339|NCT02387216|525080990|FG001|Overall Study|Lost to Follow-up|3|||
145608340|NCT02306265|525080991|FG000|Overall Study|Withdrawal by Subject|1|||
145608341|NCT04145037|525080997|FG000|Overall Study|Study terminated|2|||
145608342|NCT04145037|525080998|FG001|Overall Study|Study terminated|0|||
145608343|NCT04145037|525080997|FG000|Overall Study|Withdrawal by Subject|1|||
145608344|NCT04145037|525080998|FG001|Overall Study|Withdrawal by Subject|0|||
145608345|NCT04145037|525080997|FG000|Overall Study|Lost to Follow-up|1|||
145608346|NCT04145037|525080998|FG001|Overall Study|Lost to Follow-up|0|||
145608347|NCT00098254|525081003|FG000|Overall Study|Adverse Event|2|||
145608348|NCT00098254|525081003|FG000|Overall Study|Death|1|||
145608349|NCT00744263|525081006|FG000|Overall Study|Death|3006|||
145608350|NCT00744263|525081007|FG001|Overall Study|Death|3005|||
145608351|NCT00744263|525081006|FG000|Overall Study|Lost to Follow-up|2038|||
145608352|NCT00744263|525081007|FG001|Overall Study|Lost to Follow-up|2135|||
145608353|NCT00744263|525081006|FG000|Overall Study|Withdrawal by Subject|166|||
145608354|NCT00744263|525081007|FG001|Overall Study|Withdrawal by Subject|150|||
145608355|NCT00744263|525081006|FG000|Overall Study|Physician Decision|20|||
145608356|NCT00744263|525081007|FG001|Overall Study|Physician Decision|23|||
145608357|NCT00744263|525081006|FG000|Overall Study|Protocol Violation|3|||
145608358|NCT00744263|525081007|FG001|Overall Study|Protocol Violation|5|||
145608359|NCT00744263|525081006|FG000|Overall Study|Adverse Event|1|||
145608360|NCT00744263|525081007|FG001|Overall Study|Adverse Event|0|||
145608361|NCT00744263|525081006|FG000|Overall Study|Other|2|||
145608362|NCT00744263|525081007|FG001|Overall Study|Other|2|||
145608363|NCT03107377|525081008|FG000|Overall Study|Adverse Event|3|||
145608364|NCT03107377|525081009|FG001|Overall Study|Adverse Event|3|||
145608365|NCT03107377|525081008|FG000|Overall Study|Protocol Violation|9|||
145608366|NCT03107377|525081009|FG001|Overall Study|Protocol Violation|12|||
145608367|NCT03107377|525081008|FG000|Overall Study|Physician Decision|3|||
145608368|NCT03107377|525081009|FG001|Overall Study|Physician Decision|6|||
145608369|NCT03107377|525081008|FG000|Overall Study|Pregnancy|7|||
145608370|NCT03107377|525081009|FG001|Overall Study|Pregnancy|7|||
145608371|NCT03107377|525081008|FG000|Overall Study|Withdrawal by Subject|16|||
145608372|NCT03107377|525081009|FG001|Overall Study|Withdrawal by Subject|22|||
145608373|NCT03107377|525081008|FG000|Overall Study|Lost to Follow-up|37|||
145608374|NCT03107377|525081009|FG001|Overall Study|Lost to Follow-up|34|||
145608375|NCT03107377|525081008|FG000|Overall Study|Other reason not specified|16|||
145608376|NCT03107377|525081009|FG001|Overall Study|Other reason not specified|15|||
145608377|NCT00211237|525081010|FG000|Baseline|Withdrew|1|||
145608378|NCT00211237|525081011|FG001|Baseline|Withdrew|3|||
145608379|NCT00211237|525081012|FG002|Baseline|Withdrew|0|||
145608380|NCT00211237|525081010|FG000|Baseline|Refused random assignment|1|||
145608381|NCT00211237|525081011|FG001|Baseline|Refused random assignment|0|||
145608382|NCT00211237|525081012|FG002|Baseline|Refused random assignment|0|||
145608383|NCT00211237|525081010|FG000|1 Month|Death|2|||
145608384|NCT00211237|525081011|FG001|1 Month|Death|1|||
145608385|NCT00211237|525081012|FG002|1 Month|Death|0|||
145608386|NCT00211237|525081010|FG000|1 Month|Lost to Follow-up|0|||
145608387|NCT00211237|525081011|FG001|1 Month|Lost to Follow-up|2|||
145608388|NCT00211237|525081012|FG002|1 Month|Lost to Follow-up|0|||
145608389|NCT00211237|525081010|FG000|1 Month|Withdrew|0|||
145608390|NCT00211237|525081011|FG001|1 Month|Withdrew|4|||
145608391|NCT00211237|525081012|FG002|1 Month|Withdrew|0|||
145608392|NCT00211237|525081010|FG000|1 Month|Additional surgery needed|1|||
145608393|NCT00211237|525081011|FG001|1 Month|Additional surgery needed|0|||
145608394|NCT00211237|525081012|FG002|1 Month|Additional surgery needed|0|||
145608395|NCT00211237|525081010|FG000|1 Month|Non-medical problem|0|||
145608396|NCT00211237|525081011|FG001|1 Month|Non-medical problem|2|||
145608397|NCT00211237|525081012|FG002|1 Month|Non-medical problem|0|||
145608398|NCT00211237|525081010|FG000|3 Months|Death|7|||
145608399|NCT00211237|525081011|FG001|3 Months|Death|3|||
145403649|NCT01232283|524334398|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
145608400|NCT00211237|525081012|FG002|3 Months|Death|0|||
145608401|NCT00211237|525081010|FG000|3 Months|Could not comply with protocol|1|||
145608402|NCT00211237|525081011|FG001|3 Months|Could not comply with protocol|0|||
145608403|NCT00211237|525081012|FG002|3 Months|Could not comply with protocol|0|||
145608404|NCT00211237|525081010|FG000|3 Months|Withdrew|0|||
145608405|NCT00211237|525081011|FG001|3 Months|Withdrew|1|||
145608406|NCT00211237|525081012|FG002|3 Months|Withdrew|0|||
145608407|NCT00211237|525081010|FG000|3 Months|Non-medical problem|0|||
145608408|NCT00211237|525081011|FG001|3 Months|Non-medical problem|0|||
145608409|NCT00211237|525081012|FG002|3 Months|Non-medical problem|1|||
145608410|NCT00211237|525081010|FG000|6 Months|Death|6|||
145608411|NCT00211237|525081011|FG001|6 Months|Death|0|||
145608412|NCT00211237|525081012|FG002|6 Months|Death|3|||
145608413|NCT00211237|525081010|FG000|6 Months|Lost to Follow-up|2|||
145608414|NCT00211237|525081011|FG001|6 Months|Lost to Follow-up|0|||
145608415|NCT00211237|525081012|FG002|6 Months|Lost to Follow-up|0|||
145608416|NCT00211237|525081010|FG000|6 Months|Could not comply with protocol|0|||
145608417|NCT00211237|525081011|FG001|6 Months|Could not comply with protocol|2|||
145608418|NCT00211237|525081012|FG002|6 Months|Could not comply with protocol|0|||
145608419|NCT00211237|525081010|FG000|12 Months|Death|8|||
145608420|NCT00211237|525081011|FG001|12 Months|Death|2|||
145608421|NCT00211237|525081012|FG002|12 Months|Death|3|||
145608422|NCT00211237|525081010|FG000|12 Months|Lost to Follow-up|1|||
145608423|NCT00211237|525081011|FG001|12 Months|Lost to Follow-up|0|||
145608424|NCT00211237|525081012|FG002|12 Months|Lost to Follow-up|1|||
145608425|NCT00211237|525081010|FG000|12 Months|Withdrew|0|||
145608426|NCT00211237|525081011|FG001|12 Months|Withdrew|0|||
145608427|NCT00211237|525081012|FG002|12 Months|Withdrew|1|||
145608428|NCT00211237|525081010|FG000|12 Months|unrelated medical problem|0|||
145608429|NCT00211237|525081011|FG001|12 Months|unrelated medical problem|0|||
145608430|NCT00211237|525081012|FG002|12 Months|unrelated medical problem|1|||
145608431|NCT00453102|525081016|FG000|Overall Study|Withdrawal by Subject|2|||
145608432|NCT04078035|525081017|FG000|Session 2|Lost to Follow-up|3|||
145608433|NCT04078035|525081018|FG001|Session 2|Lost to Follow-up|1|||
145608434|NCT04078035|525081017|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
145608435|NCT04078035|525081018|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
145608436|NCT01650519|525081028|FG000|Overall Study|Withdrawal by Subject|1|||
145608437|NCT01650519|525081029|FG001|Overall Study|Withdrawal by Subject|0|||
145608438|NCT05458024|525081032|FG000|Overall Study|Withdrawal by Subject|1|||
145608439|NCT05458024|525081033|FG001|Overall Study|Withdrawal by Subject|1|||
145608440|NCT02954458|525081035|FG000|Overall Study|Adverse Event|0|||
145608441|NCT02954458|525081036|FG001|Overall Study|Adverse Event|0|||
145608442|NCT02954458|525081037|FG002|Overall Study|Adverse Event|0|||
145608443|NCT02954458|525081038|FG003|Overall Study|Adverse Event|1|||
145608444|NCT02954458|525081035|FG000|Overall Study|Withdrawal by Subject|0|||
145608445|NCT02954458|525081036|FG001|Overall Study|Withdrawal by Subject|0|||
145608446|NCT02954458|525081037|FG002|Overall Study|Withdrawal by Subject|0|||
145608447|NCT02954458|525081038|FG003|Overall Study|Withdrawal by Subject|1|||
145608448|NCT02954458|525081035|FG000|Overall Study|Physician Decision|0|||
145608449|NCT02954458|525081036|FG001|Overall Study|Physician Decision|0|||
145608450|NCT02954458|525081037|FG002|Overall Study|Physician Decision|1|||
145608451|NCT02954458|525081038|FG003|Overall Study|Physician Decision|1|||
145608452|NCT02954458|525081035|FG000|Overall Study|Lost to Follow-up|1|||
145608453|NCT02954458|525081036|FG001|Overall Study|Lost to Follow-up|0|||
145608454|NCT02954458|525081037|FG002|Overall Study|Lost to Follow-up|0|||
145608455|NCT02954458|525081038|FG003|Overall Study|Lost to Follow-up|1|||
145608456|NCT02954458|525081035|FG000|Overall Study|Death|0|||
145608457|NCT02954458|525081036|FG001|Overall Study|Death|0|||
145608458|NCT02954458|525081037|FG002|Overall Study|Death|0|||
145608459|NCT02954458|525081038|FG003|Overall Study|Death|1|||
145608460|NCT02954458|525081035|FG000|Overall Study|Other|0|||
145608461|NCT02954458|525081036|FG001|Overall Study|Other|0|||
145608462|NCT02954458|525081037|FG002|Overall Study|Other|0|||
145608463|NCT02954458|525081038|FG003|Overall Study|Other|7|||
145608464|NCT00747123|525081039|FG000|Overall Study|Investigator's request|0|||
145608465|NCT00747123|525081040|FG001|Overall Study|Investigator's request|0|||
145608466|NCT00747123|525081041|FG002|Overall Study|Investigator's request|1|||
145608467|NCT00747123|525081042|FG003|Overall Study|Investigator's request|0|||
145608468|NCT00747123|525081039|FG000|Overall Study|Withdrew consent|0|||
145608469|NCT00747123|525081040|FG001|Overall Study|Withdrew consent|1|||
145608470|NCT00747123|525081041|FG002|Overall Study|Withdrew consent|0|||
145608471|NCT00747123|525081042|FG003|Overall Study|Withdrew consent|0|||
145608472|NCT00747123|525081039|FG000|Overall Study|Adverse Event|0|||
145608473|NCT00747123|525081040|FG001|Overall Study|Adverse Event|1|||
145608474|NCT00747123|525081041|FG002|Overall Study|Adverse Event|0|||
145608475|NCT00747123|525081042|FG003|Overall Study|Adverse Event|1|||
145403650|NCT01232283|524334399|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145608476|NCT01036022|525081052|FG000|Overall Study|Adverse Event|1|||
145608477|NCT01036022|525081053|FG001|Overall Study|Adverse Event|3|||
145608478|NCT01036022|525081054|FG002|Overall Study|Adverse Event|2|||
145608479|NCT01036022|525081055|FG003|Overall Study|Adverse Event|1|||
145608480|NCT01036022|525081056|FG004|Overall Study|Adverse Event|0|||
145608481|NCT01036022|525081057|FG005|Overall Study|Adverse Event|2|||
145608482|NCT01036022|525081052|FG000|Overall Study|Lack of Efficacy|1|||
145608483|NCT01036022|525081053|FG001|Overall Study|Lack of Efficacy|1|||
145608484|NCT01036022|525081054|FG002|Overall Study|Lack of Efficacy|1|||
145608485|NCT01036022|525081055|FG003|Overall Study|Lack of Efficacy|0|||
145608486|NCT01036022|525081056|FG004|Overall Study|Lack of Efficacy|1|||
145608487|NCT01036022|525081057|FG005|Overall Study|Lack of Efficacy|1|||
145608488|NCT01036022|525081052|FG000|Overall Study|Physician Decision|0|||
145608489|NCT01036022|525081053|FG001|Overall Study|Physician Decision|0|||
145608490|NCT01036022|525081054|FG002|Overall Study|Physician Decision|1|||
145608491|NCT01036022|525081055|FG003|Overall Study|Physician Decision|0|||
145535329|NCT03758443|524820714|FG001|Maintenance Period|Adverse Event|2|||
145535330|NCT03758443|524820715|FG002|Maintenance Period|Adverse Event|0|||
145535331|NCT03758443|524820716|FG003|Maintenance Period|Adverse Event|0|||
145535332|NCT03758443|524820713|FG000|Maintenance Period|Lost to Follow-up|0|||
145535333|NCT03758443|524820714|FG001|Maintenance Period|Lost to Follow-up|0|||
145535334|NCT03758443|524820715|FG002|Maintenance Period|Lost to Follow-up|0|||
145535335|NCT03758443|524820716|FG003|Maintenance Period|Lost to Follow-up|1|||
145535336|NCT03758443|524820713|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
145535337|NCT03758443|524820714|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
145535338|NCT03758443|524820715|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
145535339|NCT03758443|524820716|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
145535340|NCT03758443|524820713|FG000|Maintenance Period|Protocol Violation|0|||
145535341|NCT03758443|524820714|FG001|Maintenance Period|Protocol Violation|1|||
145535342|NCT03758443|524820715|FG002|Maintenance Period|Protocol Violation|0|||
145535343|NCT03758443|524820716|FG003|Maintenance Period|Protocol Violation|0|||
145535344|NCT03758443|524820713|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
145535345|NCT03758443|524820714|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
145535346|NCT03758443|524820715|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
145535347|NCT03758443|524820716|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
145535348|NCT03758443|524820713|FG000|Maintenance Period|Withdrawal by Subject|1|||
145535349|NCT03758443|524820714|FG001|Maintenance Period|Withdrawal by Subject|0|||
145535350|NCT03758443|524820715|FG002|Maintenance Period|Withdrawal by Subject|1|||
145535351|NCT03758443|524820716|FG003|Maintenance Period|Withdrawal by Subject|1|||
145535352|NCT03758443|524820713|FG000|Maintenance Period|Miscellaneous|0|||
145535353|NCT03758443|524820714|FG001|Maintenance Period|Miscellaneous|0|||
145535354|NCT03758443|524820715|FG002|Maintenance Period|Miscellaneous|1|||
145535355|NCT03758443|524820716|FG003|Maintenance Period|Miscellaneous|0|||
145535356|NCT00696800|524820721|FG000|Overall Study|Adverse Event|16|||
145535357|NCT00696800|524820722|FG001|Overall Study|Adverse Event|3|||
145535358|NCT00696800|524820721|FG000|Overall Study|Insufficient compliance with medication|2|||
145535359|NCT00696800|524820722|FG001|Overall Study|Insufficient compliance with medication|1|||
145535360|NCT00696800|524820721|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
145535361|NCT00696800|524820722|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
145535362|NCT00696800|524820721|FG000|Overall Study|Insufficient ovarian response|4|||
145535363|NCT00696800|524820722|FG001|Overall Study|Insufficient ovarian response|1|||
145535364|NCT00696800|524820721|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
145535365|NCT00696800|524820722|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
145535366|NCT00696800|524820721|FG000|Overall Study|Too high ovarian response|6|||
145535367|NCT00696800|524820722|FG001|Overall Study|Too high ovarian response|1|||
145535368|NCT00696800|524820721|FG000|Overall Study|No/too few/bad quality oocytes|4|||
145535369|NCT00696800|524820722|FG001|Overall Study|No/too few/bad quality oocytes|3|||
145535370|NCT00696800|524820721|FG000|Overall Study|No/abnormal fertilization|11|||
145535371|NCT00696800|524820722|FG001|Overall Study|No/abnormal fertilization|13|||
145535372|NCT00696800|524820721|FG000|Overall Study|No/too few/bad quality embryos|24|||
145535373|NCT00696800|524820722|FG001|Overall Study|No/too few/bad quality embryos|18|||
145535374|NCT00696800|524820721|FG000|Overall Study|Other Reasons|5|||
145535375|NCT00696800|524820722|FG001|Overall Study|Other Reasons|3|||
145535376|NCT00696800|524820721|FG000|Overall Study|Not treated|1|||
145535377|NCT00696800|524820722|FG001|Overall Study|Not treated|2|||
145535378|NCT00199875|524820734|FG000|Overall Study|Withdrawal by Subject|0|||
145535379|NCT00199875|524820735|FG001|Overall Study|Withdrawal by Subject|0|||
145535380|NCT00199875|524820736|FG002|Overall Study|Withdrawal by Subject|0|||
145535381|NCT00199875|524820737|FG003|Overall Study|Withdrawal by Subject|0|||
145535382|NCT00199875|524820738|FG004|Overall Study|Withdrawal by Subject|1|||
145535383|NCT02404220|524820740|FG000|Overall Study|Adverse Event|0|||
145535384|NCT02404220|524820741|FG001|Overall Study|Adverse Event|0|||
145535385|NCT02404220|524820742|FG002|Overall Study|Adverse Event|1|||
145535386|NCT02404220|524820743|FG003|Overall Study|Adverse Event|0|||
145535387|NCT02404220|524820740|FG000|Overall Study|Death|5|||
145535388|NCT02404220|524820741|FG001|Overall Study|Death|5|||
145535389|NCT02404220|524820742|FG002|Overall Study|Death|3|||
145535390|NCT02404220|524820743|FG003|Overall Study|Death|8|||
145774785|NCT01938625|525687579|FG001|Overall Study|Withdrawal by Subject|1|||
145774786|NCT01938625|525687578|FG000|Overall Study|Adverse Event|0|||
145774787|NCT01938625|525687579|FG001|Overall Study|Adverse Event|1|||
145535391|NCT02404220|524820740|FG000|Overall Study|Progressive Disease|0|||
145535392|NCT02404220|524820741|FG001|Overall Study|Progressive Disease|0|||
145535393|NCT02404220|524820742|FG002|Overall Study|Progressive Disease|1|||
145535394|NCT02404220|524820743|FG003|Overall Study|Progressive Disease|1|||
145535395|NCT02404220|524820740|FG000|Overall Study|Study Terminated by Sponsor|0|||
145535396|NCT02404220|524820741|FG001|Overall Study|Study Terminated by Sponsor|0|||
145535397|NCT02404220|524820742|FG002|Overall Study|Study Terminated by Sponsor|2|||
145535398|NCT02404220|524820743|FG003|Overall Study|Study Terminated by Sponsor|1|||
145535399|NCT02404220|524820740|FG000|Overall Study|Withdrawal by Subject|0|||
145535400|NCT02404220|524820741|FG001|Overall Study|Withdrawal by Subject|1|||
145535401|NCT02404220|524820742|FG002|Overall Study|Withdrawal by Subject|0|||
145774788|NCT01937312|525687580|FG000|Overall Study|Adverse Event|10|||
145774789|NCT01937312|525687581|FG001|Overall Study|Adverse Event|1|||
145774790|NCT01937312|525687580|FG000|Overall Study|Lack of Efficacy|0|||
145774791|NCT01937312|525687581|FG001|Overall Study|Lack of Efficacy|1|||
145774792|NCT01937312|525687580|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
145774793|NCT01937312|525687581|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
145774794|NCT05309083|525687582|FG000|Overall Study|Withdrawal by Subject|2|||
145774795|NCT01165229|525687583|FG000|Overall Study|Serious Adverse Event|456|||
145774796|NCT01165229|525687584|FG001|Overall Study|Serious Adverse Event|487|||
145774797|NCT01165229|525687583|FG000|Overall Study|Non-Serious Adverse Event|47|||
145774798|NCT01165229|525687584|FG001|Overall Study|Non-Serious Adverse Event|15|||
145774799|NCT01165229|525687583|FG000|Overall Study|Protocol Violation|6|||
145774800|NCT01165229|525687584|FG001|Overall Study|Protocol Violation|8|||
145774801|NCT01165229|525687583|FG000|Overall Study|Withdrawal by Subject|387|||
145774802|NCT01165229|525687584|FG001|Overall Study|Withdrawal by Subject|396|||
145774803|NCT01165229|525687583|FG000|Overall Study|Migrated/moved from study area|51|||
145774804|NCT01165229|525687584|FG001|Overall Study|Migrated/moved from study area|46|||
145774805|NCT01165229|525687583|FG000|Overall Study|Lost to Follow-up|123|||
145774806|NCT01165229|525687584|FG001|Overall Study|Lost to Follow-up|133|||
145774807|NCT01165229|525687583|FG000|Overall Study|Suspected HZ Episode|2|||
145774808|NCT01165229|525687584|FG001|Overall Study|Suspected HZ Episode|2|||
145774809|NCT01165229|525687583|FG000|Overall Study|No reason from the subject|108|||
145774810|NCT01165229|525687584|FG001|Overall Study|No reason from the subject|102|||
145774811|NCT01165229|525687583|FG000|Overall Study|Unknown completion status|0|||
145774812|NCT01165229|525687584|FG001|Overall Study|Unknown completion status|1|||
145774813|NCT00474253|525687585|FG000|Overall Study|Withdrew consent|2|||
145774814|NCT00474253|525687586|FG001|Overall Study|Withdrew consent|0|||
145774815|NCT00474253|525687585|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
145774816|NCT00474253|525687586|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
145774817|NCT00474253|525687585|FG000|Overall Study|Lost to Follow-up|1|||
145774818|NCT00474253|525687586|FG001|Overall Study|Lost to Follow-up|0|||
145774819|NCT00474253|525687585|FG000|Overall Study|Discharged prior to study completion|0|||
145774820|NCT00474253|525687586|FG001|Overall Study|Discharged prior to study completion|1|||
145774821|NCT00550238|525687590|FG000|Overall Study|Adverse Event|88|||
145774822|NCT00550238|525687590|FG000|Overall Study|Death|34|||
145774823|NCT00550238|525687590|FG000|Overall Study|Disease progression|46|||
145774824|NCT00550238|525687590|FG000|Overall Study|Withdrawal by Subject|167|||
145774825|NCT00550238|525687590|FG000|Overall Study|Physician Decision|31|||
145774826|NCT00550238|525687590|FG000|Overall Study|Patient noncompliance|25|||
145535402|NCT02404220|524820743|FG003|Overall Study|Withdrawal by Subject|0|||
145535403|NCT02404220|524820740|FG000|Overall Study|Enrolled but Never Treated|0|||
145535404|NCT02404220|524820741|FG001|Overall Study|Enrolled but Never Treated|2|||
145535405|NCT02404220|524820742|FG002|Overall Study|Enrolled but Never Treated|0|||
145535406|NCT02404220|524820743|FG003|Overall Study|Enrolled but Never Treated|0|||
145535407|NCT03469934|524820746|FG000|Overall Study|Withdrawal by Subject|0|||
145535408|NCT03469934|524820747|FG001|Overall Study|Withdrawal by Subject|1|||
145535409|NCT01024231|524820751|FG000|Overall Study|Other Reasons|1|||
145535410|NCT01024231|524820752|FG001|Overall Study|Other Reasons|2|||
145535411|NCT01024231|524820753|FG002|Overall Study|Other Reasons|0|||
145535412|NCT01024231|524820754|FG003|Overall Study|Other Reasons|0|||
145535413|NCT01024231|524820755|FG004|Overall Study|Other Reasons|2|||
145535414|NCT01024231|524820756|FG005|Overall Study|Other Reasons|0|||
145535415|NCT01024231|524820757|FG006|Overall Study|Other Reasons|1|||
145535416|NCT01024231|524820751|FG000|Overall Study|Maximum Clinical Benefit|1|||
145535417|NCT01024231|524820752|FG001|Overall Study|Maximum Clinical Benefit|2|||
145774827|NCT00550238|525687590|FG000|Overall Study|Lost to Follow-up|13|||
145774828|NCT00550238|525687590|FG000|Overall Study|Sponsor decision|55|||
145774829|NCT03133481|525687591|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
145774830|NCT03133481|525687592|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
145774831|NCT01184989|525687597|FG000|Overall Study|Adverse Event|11|||
145774832|NCT01184989|525687597|FG000|Overall Study|Withdrawal by Subject|1|||
145535418|NCT01024231|524820753|FG002|Overall Study|Maximum Clinical Benefit|0|||
145535419|NCT01024231|524820754|FG003|Overall Study|Maximum Clinical Benefit|1|||
145535420|NCT01024231|524820755|FG004|Overall Study|Maximum Clinical Benefit|1|||
145535421|NCT01024231|524820756|FG005|Overall Study|Maximum Clinical Benefit|0|||
145535422|NCT01024231|524820757|FG006|Overall Study|Maximum Clinical Benefit|0|||
145535423|NCT01024231|524820751|FG000|Overall Study|Disease Progression|3|||
145535424|NCT01024231|524820752|FG001|Overall Study|Disease Progression|1|||
145535425|NCT01024231|524820753|FG002|Overall Study|Disease Progression|3|||
145774833|NCT01570491|525687598|FG000|Overall Study|Lost to Follow-up|3|||
145535426|NCT01024231|524820754|FG003|Overall Study|Disease Progression|0|||
145535427|NCT01024231|524820755|FG004|Overall Study|Disease Progression|4|||
145535428|NCT01024231|524820756|FG005|Overall Study|Disease Progression|11|||
145535429|NCT01024231|524820757|FG006|Overall Study|Disease Progression|6|||
145535430|NCT01024231|524820751|FG000|Overall Study|AE unrelated to Study Drug|0|||
145535431|NCT01024231|524820752|FG001|Overall Study|AE unrelated to Study Drug|1|||
145535432|NCT01024231|524820753|FG002|Overall Study|AE unrelated to Study Drug|0|||
145535433|NCT01024231|524820754|FG003|Overall Study|AE unrelated to Study Drug|0|||
145535434|NCT01024231|524820755|FG004|Overall Study|AE unrelated to Study Drug|0|||
145535435|NCT01024231|524820756|FG005|Overall Study|AE unrelated to Study Drug|0|||
145535436|NCT01024231|524820757|FG006|Overall Study|AE unrelated to Study Drug|0|||
145535437|NCT01024231|524820751|FG000|Overall Study|No longer meets criteria|0|||
145535438|NCT01024231|524820752|FG001|Overall Study|No longer meets criteria|0|||
145535439|NCT01024231|524820753|FG002|Overall Study|No longer meets criteria|0|||
145535440|NCT01024231|524820754|FG003|Overall Study|No longer meets criteria|0|||
145535441|NCT01024231|524820755|FG004|Overall Study|No longer meets criteria|1|||
145535442|NCT01024231|524820756|FG005|Overall Study|No longer meets criteria|0|||
145535443|NCT01024231|524820757|FG006|Overall Study|No longer meets criteria|1|||
145535444|NCT01024231|524820751|FG000|Overall Study|Study Drug Toxicity|1|||
145535445|NCT01024231|524820752|FG001|Overall Study|Study Drug Toxicity|6|||
145535446|NCT01024231|524820753|FG002|Overall Study|Study Drug Toxicity|6|||
145535447|NCT01024231|524820754|FG003|Overall Study|Study Drug Toxicity|4|||
145535448|NCT01024231|524820755|FG004|Overall Study|Study Drug Toxicity|2|||
145535449|NCT01024231|524820756|FG005|Overall Study|Study Drug Toxicity|0|||
145535450|NCT01024231|524820757|FG006|Overall Study|Study Drug Toxicity|7|||
145535451|NCT01024231|524820751|FG000|Overall Study|Death|6|||
145535452|NCT01024231|524820752|FG001|Overall Study|Death|2|||
145535453|NCT01024231|524820753|FG002|Overall Study|Death|1|||
145535454|NCT01024231|524820754|FG003|Overall Study|Death|0|||
145535455|NCT01024231|524820755|FG004|Overall Study|Death|4|||
145608492|NCT01036022|525081056|FG004|Overall Study|Physician Decision|0|||
145608493|NCT01036022|525081057|FG005|Overall Study|Physician Decision|0|||
145774834|NCT01570491|525687599|FG001|Overall Study|Lost to Follow-up|1|||
145774835|NCT01570491|525687598|FG000|Overall Study|treatment: not given or discontinued|2|||
145774836|NCT01570491|525687599|FG001|Overall Study|treatment: not given or discontinued|0|||
145774837|NCT05370157|525687602|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
145774838|NCT05370157|525687603|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
145774839|NCT05370157|525687602|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
145774840|NCT05370157|525687603|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
145774841|NCT01508676|525687604|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
145774842|NCT01508676|525687605|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
145774843|NCT01508676|525687604|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
145774844|NCT01508676|525687605|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
145774845|NCT01508676|525687604|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
145774846|NCT01508676|525687605|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
145774847|NCT01508676|525687604|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
145608494|NCT01036022|525081052|FG000|Overall Study|Withdrawal by Subject|0|||
145608495|NCT01036022|525081053|FG001|Overall Study|Withdrawal by Subject|0|||
145608496|NCT01036022|525081054|FG002|Overall Study|Withdrawal by Subject|0|||
145774848|NCT01508676|525687605|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
145774849|NCT01508676|525687604|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
145774850|NCT01508676|525687605|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
145774851|NCT03700892|525687606|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
145535456|NCT01024231|524820756|FG005|Overall Study|Death|3|||
145535457|NCT01024231|524820757|FG006|Overall Study|Death|5|||
145535458|NCT01024231|524820751|FG000|Overall Study|Lost to Follow-up|0|||
145535459|NCT01024231|524820752|FG001|Overall Study|Lost to Follow-up|0|||
145535460|NCT01024231|524820753|FG002|Overall Study|Lost to Follow-up|0|||
145535461|NCT01024231|524820754|FG003|Overall Study|Lost to Follow-up|0|||
145535462|NCT01024231|524820755|FG004|Overall Study|Lost to Follow-up|0|||
145535463|NCT01024231|524820756|FG005|Overall Study|Lost to Follow-up|0|||
145535464|NCT01024231|524820757|FG006|Overall Study|Lost to Follow-up|1|||
145535465|NCT01024231|524820751|FG000|Overall Study|Withdrew Consent|0|||
145535466|NCT01024231|524820752|FG001|Overall Study|Withdrew Consent|1|||
145535467|NCT01024231|524820753|FG002|Overall Study|Withdrew Consent|0|||
145535468|NCT01024231|524820754|FG003|Overall Study|Withdrew Consent|0|||
145535469|NCT01024231|524820755|FG004|Overall Study|Withdrew Consent|0|||
145535470|NCT01024231|524820756|FG005|Overall Study|Withdrew Consent|0|||
145535471|NCT01024231|524820757|FG006|Overall Study|Withdrew Consent|0|||
145535472|NCT01024231|524820751|FG000|Overall Study|Continuing on Treatment|0|||
145535473|NCT01024231|524820752|FG001|Overall Study|Continuing on Treatment|0|||
145535474|NCT01024231|524820753|FG002|Overall Study|Continuing on Treatment|0|||
145535475|NCT01024231|524820754|FG003|Overall Study|Continuing on Treatment|0|||
145535476|NCT01024231|524820755|FG004|Overall Study|Continuing on Treatment|3|||
145535477|NCT01024231|524820756|FG005|Overall Study|Continuing on Treatment|2|||
145535478|NCT01024231|524820757|FG006|Overall Study|Continuing on Treatment|0|||
145535479|NCT01691898|524820758|FG000|Overall Study|Death|34|||
145774852|NCT03700892|525687607|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
145774853|NCT03700892|525687608|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
145774854|NCT00849212|525687610|FG000|Overall Study|Lack of Efficacy|1|||
145774855|NCT00849212|525687610|FG000|Overall Study|Withdrawal by Subject|3|||
145774856|NCT00849212|525687610|FG000|Overall Study|Adverse Event|2|||
145774857|NCT00849212|525687610|FG000|Overall Study|Miscellaneous|1|||
145774858|NCT04407507|525687611|FG000|Overall Study|Withdrawal by Subject|0|||
145774859|NCT04407507|525687612|FG001|Overall Study|Withdrawal by Subject|1|||
145774860|NCT01499576|525687613|FG000|Overall Study|Physician Decision|12|||
145774861|NCT01499576|525687613|FG000|Overall Study|Withdrawal by Subject|9|||
145774862|NCT00587223|525687617|FG000|Overall Study|Adverse Event|1|||
145774863|NCT00195351|525687618|FG000|Overall Study|Lost to Follow-up|9|||
145774864|NCT00195351|525687619|FG001|Overall Study|Lost to Follow-up|9|||
145774865|NCT00195351|525687618|FG000|Overall Study|Withdrawal by Subject|6|||
145774866|NCT00195351|525687619|FG001|Overall Study|Withdrawal by Subject|3|||
145774867|NCT00195351|525687618|FG000|Overall Study|Protocol Deviation|3|||
145774868|NCT00195351|525687619|FG001|Overall Study|Protocol Deviation|2|||
145774869|NCT00195351|525687618|FG000|Overall Study|Death|3|||
145774870|NCT00195351|525687619|FG001|Overall Study|Death|1|||
145774871|NCT00195351|525687618|FG000|Overall Study|Lack of Efficacy|0|||
145774872|NCT00195351|525687619|FG001|Overall Study|Lack of Efficacy|1|||
145774873|NCT02111369|525687620|FG000|Overall Study|Lost to Follow-up|2|||
145774874|NCT02111369|525687620|FG000|Overall Study|Withdrawal by Subject|1|||
145774875|NCT04332419|525687624|FG000|Overall Study|Withdrawal by Subject|1|||
145774876|NCT00971321|525687625|FG000|Up to Month 7|Withdrawal by Subject|1|||
145774877|NCT00971321|525687626|FG001|Up to Month 7|Withdrawal by Subject|0|||
145774878|NCT00971321|525687625|FG000|Up to Month 7|Migrated/moved from study area|3|||
145774879|NCT00971321|525687626|FG001|Up to Month 7|Migrated/moved from study area|2|||
145774880|NCT00971321|525687625|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
145774881|NCT00971321|525687626|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
145774882|NCT00971321|525687625|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
145774883|NCT00971321|525687626|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
145774884|NCT00971321|525687625|FG000|Up to Month 11-12|Lost to Follow-up|1|||
145774885|NCT00971321|525687626|FG001|Up to Month 11-12|Lost to Follow-up|0|||
145774886|NCT00519623|525687627|FG000|Overall Study|Adverse Event|1|||
145774887|NCT04222725|525687628|FG000|Overall Study|Adverse Event|0|||
145774888|NCT04222725|525687629|FG001|Overall Study|Adverse Event|1|||
145774889|NCT04222725|525687630|FG002|Overall Study|Adverse Event|0|||
145278869|NCT03033069|523870904|FG001|Overall Study|Lost to Follow-up|5|||
145278870|NCT03033069|523870905|FG002|Overall Study|Lost to Follow-up|5|||
145774890|NCT04222725|525687631|FG003|Overall Study|Adverse Event|0|||
145774891|NCT03819140|525687632|FG000|Overall Study|Lost to Follow-up|1|||
145774892|NCT03819140|525687633|FG001|Overall Study|Lost to Follow-up|2|||
145774893|NCT03819140|525687632|FG000|Overall Study|Withdrawal by Subject|3|||
145774894|NCT03819140|525687633|FG001|Overall Study|Withdrawal by Subject|2|||
145774895|NCT03819140|525687632|FG000|Overall Study|Adverse Event|0|||
145774896|NCT03819140|525687633|FG001|Overall Study|Adverse Event|1|||
145774897|NCT03819140|525687632|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
145774898|NCT03819140|525687633|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
145774899|NCT03819140|525687632|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
145774900|NCT03819140|525687633|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
145774901|NCT00658333|525687634|FG000|Overall Study|Adverse Event|2|||
145774902|NCT00658333|525687635|FG001|Overall Study|Adverse Event|1|||
145774903|NCT03519178|525687636|FG000|PF-06873600 Treatment|Adverse Event|0|||
145774904|NCT03519178|525687637|FG001|PF-06873600 Treatment|Adverse Event|0|||
145774905|NCT03519178|525687638|FG002|PF-06873600 Treatment|Adverse Event|0|||
145774906|NCT03519178|525687639|FG003|PF-06873600 Treatment|Adverse Event|0|||
145774907|NCT03519178|525687640|FG004|PF-06873600 Treatment|Adverse Event|0|||
145774908|NCT03519178|525687641|FG005|PF-06873600 Treatment|Adverse Event|0|||
145774909|NCT03519178|525687642|FG006|PF-06873600 Treatment|Adverse Event|0|||
145774910|NCT03519178|525687643|FG007|PF-06873600 Treatment|Adverse Event|2|||
145774911|NCT03519178|525687644|FG008|PF-06873600 Treatment|Adverse Event|1|||
145774912|NCT03519178|525687645|FG009|PF-06873600 Treatment|Adverse Event|0|||
145403651|NCT01232283|524334400|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145403652|NCT01232283|524334401|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145403653|NCT01232283|524334402|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
145774913|NCT03519178|525687646|FG010|PF-06873600 Treatment|Adverse Event|0|||
145774914|NCT03519178|525687647|FG011|PF-06873600 Treatment|Adverse Event|0|||
145774915|NCT03519178|525687648|FG012|PF-06873600 Treatment|Adverse Event|1|||
145774916|NCT03519178|525687649|FG013|PF-06873600 Treatment|Adverse Event|3|||
145774917|NCT03519178|525687650|FG014|PF-06873600 Treatment|Adverse Event|2|||
145774918|NCT03519178|525687636|FG000|PF-06873600 Treatment|Death|0|||
145278871|NCT03033069|523870906|FG003|Overall Study|Lost to Follow-up|6|||
145403654|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145774919|NCT03519178|525687637|FG001|PF-06873600 Treatment|Death|0|||
145774920|NCT03519178|525687638|FG002|PF-06873600 Treatment|Death|0|||
145774921|NCT03519178|525687639|FG003|PF-06873600 Treatment|Death|0|||
145774922|NCT03519178|525687640|FG004|PF-06873600 Treatment|Death|0|||
145774923|NCT03519178|525687641|FG005|PF-06873600 Treatment|Death|0|||
145774924|NCT03519178|525687642|FG006|PF-06873600 Treatment|Death|0|||
145774925|NCT03519178|525687643|FG007|PF-06873600 Treatment|Death|0|||
145774926|NCT03519178|525687644|FG008|PF-06873600 Treatment|Death|1|||
145774927|NCT03519178|525687645|FG009|PF-06873600 Treatment|Death|1|||
145774928|NCT03519178|525687646|FG010|PF-06873600 Treatment|Death|0|||
145774929|NCT03519178|525687647|FG011|PF-06873600 Treatment|Death|0|||
145774930|NCT03519178|525687648|FG012|PF-06873600 Treatment|Death|0|||
145774931|NCT03519178|525687649|FG013|PF-06873600 Treatment|Death|0|||
145774932|NCT03519178|525687650|FG014|PF-06873600 Treatment|Death|1|||
145774933|NCT03519178|525687636|FG000|PF-06873600 Treatment|Physician Decision|0|||
145774934|NCT03519178|525687637|FG001|PF-06873600 Treatment|Physician Decision|0|||
145774935|NCT03519178|525687638|FG002|PF-06873600 Treatment|Physician Decision|0|||
145774936|NCT03519178|525687639|FG003|PF-06873600 Treatment|Physician Decision|0|||
145774937|NCT03519178|525687640|FG004|PF-06873600 Treatment|Physician Decision|0|||
145774938|NCT03519178|525687641|FG005|PF-06873600 Treatment|Physician Decision|0|||
145774939|NCT03519178|525687642|FG006|PF-06873600 Treatment|Physician Decision|0|||
145774940|NCT03519178|525687643|FG007|PF-06873600 Treatment|Physician Decision|1|||
145774941|NCT03519178|525687644|FG008|PF-06873600 Treatment|Physician Decision|0|||
145774942|NCT03519178|525687645|FG009|PF-06873600 Treatment|Physician Decision|0|||
145774943|NCT03519178|525687646|FG010|PF-06873600 Treatment|Physician Decision|1|||
145774944|NCT03519178|525687647|FG011|PF-06873600 Treatment|Physician Decision|0|||
145774945|NCT03519178|525687648|FG012|PF-06873600 Treatment|Physician Decision|0|||
145774946|NCT03519178|525687649|FG013|PF-06873600 Treatment|Physician Decision|4|||
145774947|NCT03519178|525687650|FG014|PF-06873600 Treatment|Physician Decision|1|||
145774948|NCT03519178|525687636|FG000|PF-06873600 Treatment|Progressive disease|1|||
145774949|NCT03519178|525687637|FG001|PF-06873600 Treatment|Progressive disease|1|||
145774950|NCT03519178|525687638|FG002|PF-06873600 Treatment|Progressive disease|1|||
145774951|NCT03519178|525687639|FG003|PF-06873600 Treatment|Progressive disease|1|||
145774952|NCT03519178|525687640|FG004|PF-06873600 Treatment|Progressive disease|6|||
145774953|NCT03519178|525687641|FG005|PF-06873600 Treatment|Progressive disease|7|||
145774954|NCT03519178|525687642|FG006|PF-06873600 Treatment|Progressive disease|3|||
145774955|NCT03519178|525687643|FG007|PF-06873600 Treatment|Progressive disease|7|||
145774956|NCT03519178|525687644|FG008|PF-06873600 Treatment|Progressive disease|3|||
145774957|NCT03519178|525687645|FG009|PF-06873600 Treatment|Progressive disease|5|||
145774958|NCT03519178|525687646|FG010|PF-06873600 Treatment|Progressive disease|4|||
145774959|NCT03519178|525687647|FG011|PF-06873600 Treatment|Progressive disease|3|||
145774960|NCT03519178|525687648|FG012|PF-06873600 Treatment|Progressive disease|4|||
145774961|NCT03519178|525687649|FG013|PF-06873600 Treatment|Progressive disease|28|||
145774962|NCT03519178|525687650|FG014|PF-06873600 Treatment|Progressive disease|8|||
145774963|NCT03519178|525687636|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774964|NCT03519178|525687637|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774965|NCT03519178|525687638|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
145535480|NCT01691898|524820759|FG001|Overall Study|Death|32|||
145535481|NCT01691898|524820760|FG002|Overall Study|Death|6|||
145535482|NCT01691898|524820761|FG003|Overall Study|Death|3|||
145535483|NCT01691898|524820762|FG004|Overall Study|Death|8|||
145535484|NCT01691898|524820763|FG005|Overall Study|Death|31|||
145535485|NCT01691898|524820758|FG000|Overall Study|Adverse Event|0|||
145535486|NCT01691898|524820759|FG001|Overall Study|Adverse Event|1|||
145535487|NCT01691898|524820760|FG002|Overall Study|Adverse Event|0|||
145535488|NCT01691898|524820761|FG003|Overall Study|Adverse Event|1|||
145535489|NCT01691898|524820762|FG004|Overall Study|Adverse Event|1|||
145535490|NCT01691898|524820763|FG005|Overall Study|Adverse Event|0|||
145535491|NCT01691898|524820758|FG000|Overall Study|Progression of Disease|1|||
145535492|NCT01691898|524820759|FG001|Overall Study|Progression of Disease|2|||
145535493|NCT01691898|524820760|FG002|Overall Study|Progression of Disease|1|||
145535494|NCT01691898|524820761|FG003|Overall Study|Progression of Disease|0|||
145535495|NCT01691898|524820762|FG004|Overall Study|Progression of Disease|0|||
145535496|NCT01691898|524820763|FG005|Overall Study|Progression of Disease|1|||
145535497|NCT01691898|524820758|FG000|Overall Study|Lost to Follow-up|3|||
145535498|NCT01691898|524820759|FG001|Overall Study|Lost to Follow-up|1|||
145535499|NCT01691898|524820760|FG002|Overall Study|Lost to Follow-up|0|||
145535500|NCT01691898|524820761|FG003|Overall Study|Lost to Follow-up|0|||
145535501|NCT01691898|524820762|FG004|Overall Study|Lost to Follow-up|1|||
145535502|NCT01691898|524820763|FG005|Overall Study|Lost to Follow-up|0|||
145535503|NCT01691898|524820758|FG000|Overall Study|Withdrawal by Subject|9|||
145535504|NCT01691898|524820759|FG001|Overall Study|Withdrawal by Subject|8|||
145535505|NCT01691898|524820760|FG002|Overall Study|Withdrawal by Subject|2|||
145535506|NCT01691898|524820761|FG003|Overall Study|Withdrawal by Subject|1|||
145535507|NCT01691898|524820762|FG004|Overall Study|Withdrawal by Subject|3|||
145535508|NCT01691898|524820763|FG005|Overall Study|Withdrawal by Subject|3|||
145535509|NCT01691898|524820758|FG000|Overall Study|Non-Compliance|0|||
145535510|NCT01691898|524820759|FG001|Overall Study|Non-Compliance|0|||
145535511|NCT01691898|524820760|FG002|Overall Study|Non-Compliance|0|||
145535512|NCT01691898|524820761|FG003|Overall Study|Non-Compliance|0|||
145535513|NCT01691898|524820762|FG004|Overall Study|Non-Compliance|1|||
145535514|NCT01691898|524820763|FG005|Overall Study|Non-Compliance|0|||
145535515|NCT01013350|524820764|FG000|Overall Study|Lost to Follow-up|15|||
145535516|NCT01013350|524820765|FG001|Overall Study|Lost to Follow-up|95|||
145535517|NCT01013350|524820764|FG000|Overall Study|Adverse Event|0|||
145535518|NCT01013350|524820765|FG001|Overall Study|Adverse Event|1|||
145535519|NCT01013350|524820764|FG000|Overall Study|Physician Decision|4|||
145535520|NCT01013350|524820765|FG001|Overall Study|Physician Decision|20|||
145535521|NCT01013350|524820764|FG000|Overall Study|Withdrawal by Subject|15|||
145535522|NCT01013350|524820765|FG001|Overall Study|Withdrawal by Subject|38|||
145535523|NCT01013350|524820764|FG000|Overall Study|Death|3|||
145535524|NCT01013350|524820765|FG001|Overall Study|Death|5|||
145535525|NCT01013350|524820764|FG000|Overall Study|Participant entered interventional study|0|||
145403655|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145403656|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145535526|NCT01013350|524820765|FG001|Overall Study|Participant entered interventional study|8|||
145535527|NCT01013350|524820764|FG000|Overall Study|Other|1|||
145535528|NCT01013350|524820765|FG001|Overall Study|Other|25|||
145535529|NCT04738734|524820767|FG000|Overall Study|Withdrawal by Subject|2|||
145535530|NCT04738734|524820768|FG001|Overall Study|Withdrawal by Subject|4|||
145535531|NCT04738734|524820767|FG000|Overall Study|Lost to Follow-up|5|||
145535532|NCT04738734|524820768|FG001|Overall Study|Lost to Follow-up|2|||
145535533|NCT04738734|524820767|FG000|Overall Study|Physician Decision|0|||
145535534|NCT04738734|524820768|FG001|Overall Study|Physician Decision|1|||
145535535|NCT04738734|524820767|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
145535536|NCT04738734|524820768|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
145535537|NCT02639546|524820769|FG000|Overall Study|Death|2|||
145535538|NCT02639546|524820770|FG001|Overall Study|Death|2|||
145535539|NCT02639546|524820771|FG002|Overall Study|Death|1|||
145535540|NCT02639546|524820772|FG003|Overall Study|Death|2|||
145535541|NCT02639546|524820773|FG004|Overall Study|Death|2|||
145535542|NCT02639546|524820774|FG005|Overall Study|Death|2|||
145403657|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145535543|NCT02639546|524820775|FG006|Overall Study|Death|0|||
145535544|NCT02639546|524820776|FG007|Overall Study|Death|0|||
145278872|NCT03033069|523870903|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145278873|NCT03033069|523870904|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145535545|NCT02639546|524820769|FG000|Overall Study|Lost to Follow-up|0|||
145535546|NCT02639546|524820770|FG001|Overall Study|Lost to Follow-up|0|||
145535547|NCT02639546|524820771|FG002|Overall Study|Lost to Follow-up|1|||
145535548|NCT02639546|524820772|FG003|Overall Study|Lost to Follow-up|0|||
145535549|NCT02639546|524820773|FG004|Overall Study|Lost to Follow-up|1|||
145535550|NCT02639546|524820774|FG005|Overall Study|Lost to Follow-up|1|||
145535551|NCT02639546|524820775|FG006|Overall Study|Lost to Follow-up|0|||
145535552|NCT02639546|524820776|FG007|Overall Study|Lost to Follow-up|1|||
145535553|NCT02639546|524820769|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
145535554|NCT02639546|524820770|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
145535555|NCT02639546|524820771|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
145535556|NCT02639546|524820772|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
145535557|NCT02639546|524820773|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
145535558|NCT02639546|524820774|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
145774966|NCT03519178|525687639|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774967|NCT03519178|525687640|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
145774968|NCT03519178|525687641|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774969|NCT03519178|525687642|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774970|NCT03519178|525687643|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
145774971|NCT03519178|525687644|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
145774972|NCT03519178|525687645|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
145774973|NCT03519178|525687646|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
145774974|NCT03519178|525687647|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
145774975|NCT03519178|525687648|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
145774976|NCT03519178|525687649|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
145774977|NCT03519178|525687650|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
145774978|NCT03519178|525687636|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
145774979|NCT03519178|525687637|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
145774980|NCT03519178|525687638|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
145774981|NCT03519178|525687639|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
145774982|NCT03519178|525687640|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
145774983|NCT03519178|525687641|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
145774984|NCT03519178|525687642|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
145774985|NCT03519178|525687643|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
145774986|NCT03519178|525687644|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
145774987|NCT03519178|525687645|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
145774988|NCT03519178|525687646|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
145774989|NCT03519178|525687647|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
145774990|NCT03519178|525687648|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
145774991|NCT03519178|525687649|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
145774992|NCT03519178|525687650|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
145774993|NCT03519178|525687636|FG000|PF-06873600 Treatment|Refused further treatment|0|||
145774994|NCT03519178|525687637|FG001|PF-06873600 Treatment|Refused further treatment|1|||
145774995|NCT03519178|525687638|FG002|PF-06873600 Treatment|Refused further treatment|0|||
145774996|NCT03519178|525687639|FG003|PF-06873600 Treatment|Refused further treatment|0|||
145774997|NCT03519178|525687640|FG004|PF-06873600 Treatment|Refused further treatment|1|||
145774998|NCT03519178|525687641|FG005|PF-06873600 Treatment|Refused further treatment|0|||
145774999|NCT03519178|525687642|FG006|PF-06873600 Treatment|Refused further treatment|0|||
145775000|NCT03519178|525687643|FG007|PF-06873600 Treatment|Refused further treatment|0|||
145775001|NCT03519178|525687644|FG008|PF-06873600 Treatment|Refused further treatment|0|||
145775002|NCT03519178|525687645|FG009|PF-06873600 Treatment|Refused further treatment|0|||
145775003|NCT03519178|525687646|FG010|PF-06873600 Treatment|Refused further treatment|0|||
145775004|NCT03519178|525687647|FG011|PF-06873600 Treatment|Refused further treatment|0|||
145775005|NCT03519178|525687648|FG012|PF-06873600 Treatment|Refused further treatment|0|||
145775006|NCT03519178|525687649|FG013|PF-06873600 Treatment|Refused further treatment|0|||
145775007|NCT03519178|525687650|FG014|PF-06873600 Treatment|Refused further treatment|1|||
145775008|NCT03519178|525687636|FG000|PF-06873600 Treatment|Other|0|||
145775009|NCT03519178|525687637|FG001|PF-06873600 Treatment|Other|0|||
145775010|NCT03519178|525687638|FG002|PF-06873600 Treatment|Other|0|||
145775011|NCT03519178|525687639|FG003|PF-06873600 Treatment|Other|0|||
145535559|NCT02639546|524820775|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
145535560|NCT02639546|524820776|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
145535561|NCT02639546|524820769|FG000|Overall Study|Study Terminated By Sponsor|0|||
145535562|NCT02639546|524820770|FG001|Overall Study|Study Terminated By Sponsor|2|||
145535563|NCT02639546|524820771|FG002|Overall Study|Study Terminated By Sponsor|3|||
145535564|NCT02639546|524820772|FG003|Overall Study|Study Terminated By Sponsor|4|||
145535565|NCT02639546|524820773|FG004|Overall Study|Study Terminated By Sponsor|4|||
145535566|NCT02639546|524820774|FG005|Overall Study|Study Terminated By Sponsor|3|||
145608497|NCT01036022|525081055|FG003|Overall Study|Withdrawal by Subject|1|||
145608498|NCT01036022|525081056|FG004|Overall Study|Withdrawal by Subject|2|||
145608499|NCT01036022|525081057|FG005|Overall Study|Withdrawal by Subject|0|||
145608500|NCT02087501|525081058|FG000|Overall Study|Death|7|||
145608501|NCT02087501|525081058|FG000|Overall Study|Open repair of aneurysm|1|||
145403658|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145608502|NCT02087501|525081058|FG000|Overall Study|Lost to Follow-up|2|||
145608503|NCT03520400|525081072|FG000|Overall Study|Physician Decision|15|||
145608504|NCT03520400|525081073|FG001|Overall Study|Physician Decision|7|||
145775012|NCT03519178|525687640|FG004|PF-06873600 Treatment|Other|0|||
145535567|NCT02639546|524820775|FG006|Overall Study|Study Terminated By Sponsor|3|||
145608505|NCT00738101|525081074|FG000|Overall Study|Physician Decision|5|||
145775013|NCT03519178|525687641|FG005|PF-06873600 Treatment|Other|0|||
145775014|NCT03519178|525687642|FG006|PF-06873600 Treatment|Other|0|||
145775015|NCT03519178|525687643|FG007|PF-06873600 Treatment|Other|0|||
145775016|NCT03519178|525687644|FG008|PF-06873600 Treatment|Other|1|||
145775017|NCT03519178|525687645|FG009|PF-06873600 Treatment|Other|0|||
145775018|NCT03519178|525687646|FG010|PF-06873600 Treatment|Other|0|||
145775019|NCT03519178|525687647|FG011|PF-06873600 Treatment|Other|0|||
145775020|NCT03519178|525687648|FG012|PF-06873600 Treatment|Other|0|||
145775021|NCT03519178|525687649|FG013|PF-06873600 Treatment|Other|1|||
145775022|NCT03519178|525687650|FG014|PF-06873600 Treatment|Other|3|||
145775023|NCT03519178|525687636|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
145775024|NCT03519178|525687637|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
145775025|NCT03519178|525687638|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
145775026|NCT03519178|525687639|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
145775027|NCT03519178|525687640|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
145775028|NCT03519178|525687641|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
145775029|NCT03519178|525687642|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
145775030|NCT03519178|525687643|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
145775031|NCT03519178|525687644|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
145775032|NCT03519178|525687645|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
145775033|NCT03519178|525687646|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
145775034|NCT03519178|525687647|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
145775035|NCT03519178|525687648|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
145775036|NCT03519178|525687649|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
145775037|NCT03519178|525687650|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
145775038|NCT03519178|525687636|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775039|NCT03519178|525687637|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775040|NCT03519178|525687638|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775041|NCT03519178|525687639|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775042|NCT03519178|525687640|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775043|NCT03519178|525687641|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775044|NCT03519178|525687642|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775045|NCT03519178|525687643|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775046|NCT03519178|525687644|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775047|NCT03519178|525687645|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775048|NCT03519178|525687646|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775049|NCT03519178|525687647|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775050|NCT03519178|525687648|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
145775051|NCT03519178|525687649|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
145775052|NCT03519178|525687650|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
145775053|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Adverse Event|0|||
145775054|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Adverse Event|0|||
145775055|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Adverse Event|0|||
145775056|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Adverse Event|0|||
145775057|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Adverse Event|0|||
145775058|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Adverse Event|0|||
145775059|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Adverse Event|0|||
145775060|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Adverse Event|0|||
145775061|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Adverse Event|0|||
145535568|NCT02639546|524820776|FG007|Overall Study|Study Terminated By Sponsor|9|||
145775062|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Adverse Event|0|||
145775063|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Adverse Event|0|||
145775064|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Adverse Event|0|||
145775065|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Adverse Event|0|||
145775066|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Adverse Event|1|||
145775067|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Adverse Event|0|||
145775068|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Death|0|||
145775069|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Death|0|||
145775070|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Death|0|||
145775071|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Death|0|||
145775072|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Death|0|||
145775073|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Death|0|||
145775074|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Death|0|||
145775075|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Death|0|||
145535569|NCT02639546|524820769|FG000|Overall Study|Withdrawal by Subject|2|||
145775076|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Death|0|||
145775077|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Death|1|||
145775078|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Death|0|||
145775079|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Death|0|||
145775080|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Death|0|||
145775081|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Death|0|||
145775082|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Death|1|||
145775083|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775084|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775085|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775086|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775087|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775088|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775089|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775090|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775091|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775092|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775093|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775094|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775095|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775096|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
145775097|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
145775098|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Physician Decision|0|||
145775099|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Physician Decision|0|||
145775100|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Physician Decision|0|||
145775101|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Physician Decision|0|||
145775102|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Physician Decision|0|||
145535570|NCT02639546|524820770|FG001|Overall Study|Withdrawal by Subject|2|||
145535571|NCT02639546|524820771|FG002|Overall Study|Withdrawal by Subject|1|||
145535572|NCT02639546|524820772|FG003|Overall Study|Withdrawal by Subject|0|||
145535573|NCT02639546|524820773|FG004|Overall Study|Withdrawal by Subject|0|||
145535574|NCT02639546|524820774|FG005|Overall Study|Withdrawal by Subject|1|||
145535575|NCT02639546|524820775|FG006|Overall Study|Withdrawal by Subject|2|||
145535576|NCT02639546|524820776|FG007|Overall Study|Withdrawal by Subject|1|||
145535577|NCT02478372|524820777|FG000|Overall Study|Protocol Violation|12|||
145535578|NCT02478372|524820778|FG001|Overall Study|Protocol Violation|8|||
145535579|NCT02478372|524820777|FG000|Overall Study|Lost to Follow-up|1|||
145775103|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Physician Decision|0|||
145775104|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Physician Decision|0|||
145775105|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Physician Decision|0|||
145775106|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Physician Decision|0|||
145775107|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Physician Decision|0|||
145775108|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Physician Decision|0|||
145775109|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Physician Decision|0|||
145775110|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Physician Decision|0|||
145775111|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Physician Decision|4|||
145775112|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Physician Decision|2|||
145775113|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Progressive disease|0|||
145775114|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Progressive disease|0|||
145775115|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Progressive disease|0|||
145775116|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Progressive disease|0|||
145775117|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Progressive disease|0|||
145775118|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Progressive disease|0|||
145775119|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Progressive disease|0|||
145775120|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Progressive disease|0|||
145775121|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Progressive disease|0|||
145775122|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Progressive disease|5|||
145775123|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Progressive disease|0|||
145775124|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Progressive disease|0|||
145775125|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Progressive disease|0|||
145775126|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Progressive disease|30|||
145775127|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Progressive disease|8|||
145775128|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775129|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775130|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775131|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775132|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775133|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775134|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775135|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775136|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775137|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775138|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775139|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775140|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
145775141|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
145775142|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
145775143|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775144|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775145|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775146|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775147|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775148|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775149|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775150|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775151|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775152|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
145775153|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775154|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145278874|NCT03033069|523870905|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145278875|NCT03033069|523870906|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145278876|NCT03033069|523870903|FG000|Overall Study|Protocol Deviation|0|||
145278877|NCT03033069|523870904|FG001|Overall Study|Protocol Deviation|1|||
145278878|NCT03033069|523870905|FG002|Overall Study|Protocol Deviation|0|||
145278879|NCT03033069|523870906|FG003|Overall Study|Protocol Deviation|0|||
145278880|NCT03033069|523870903|FG000|Overall Study|Withdrawal by Subject|10|||
145278881|NCT03033069|523870904|FG001|Overall Study|Withdrawal by Subject|10|||
145278882|NCT03033069|523870905|FG002|Overall Study|Withdrawal by Subject|11|||
145278883|NCT03033069|523870906|FG003|Overall Study|Withdrawal by Subject|6|||
145278884|NCT03033069|523870903|FG000|Overall Study|Withdrawal By Caregiver|1|||
145278885|NCT03033069|523870904|FG001|Overall Study|Withdrawal By Caregiver|0|||
145278886|NCT03033069|523870905|FG002|Overall Study|Withdrawal By Caregiver|0|||
145278887|NCT03033069|523870906|FG003|Overall Study|Withdrawal By Caregiver|0|||
145278888|NCT03033069|523870903|FG000|Overall Study|Reason not Specified|0|||
145278889|NCT03033069|523870904|FG001|Overall Study|Reason not Specified|1|||
145278890|NCT03033069|523870905|FG002|Overall Study|Reason not Specified|0|||
145278891|NCT03033069|523870906|FG003|Overall Study|Reason not Specified|1|||
145278892|NCT02623426|523870911|FG000|Overall Study|Lost to Follow-up|0|||
145278893|NCT02623426|523870912|FG001|Overall Study|Lost to Follow-up|0|||
145278894|NCT02623426|523870913|FG002|Overall Study|Lost to Follow-up|1|||
145278895|NCT02623426|523870911|FG000|Overall Study|Withdrawal by Subject|1|||
145278896|NCT02623426|523870912|FG001|Overall Study|Withdrawal by Subject|2|||
145278897|NCT02623426|523870913|FG002|Overall Study|Withdrawal by Subject|2|||
145278898|NCT02094937|523870914|FG000|8 Weeks in Period 1|Adverse Event|9|||
145278899|NCT02094937|523870915|FG001|8 Weeks in Period 1|Adverse Event|0|||
145278900|NCT02094937|523870916|FG002|8 Weeks in Period 1|Adverse Event|0|||
145278901|NCT02094937|523870917|FG003|8 Weeks in Period 1|Adverse Event|0|||
145278902|NCT02094937|523870914|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
145278903|NCT02094937|523870915|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
145278904|NCT02094937|523870916|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
145278905|NCT02094937|523870917|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
145278906|NCT02094937|523870914|FG000|8 Weeks in Period 1|Protocol Violation|2|||
145278907|NCT02094937|523870915|FG001|8 Weeks in Period 1|Protocol Violation|0|||
145278908|NCT02094937|523870916|FG002|8 Weeks in Period 1|Protocol Violation|0|||
145278909|NCT02094937|523870917|FG003|8 Weeks in Period 1|Protocol Violation|0|||
145278910|NCT02094937|523870914|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
145278911|NCT02094937|523870915|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
145278912|NCT02094937|523870916|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
145278913|NCT02094937|523870917|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
145278914|NCT02094937|523870914|FG000|8 Weeks in Period 1|Physician Decision|1|||
145278915|NCT02094937|523870915|FG001|8 Weeks in Period 1|Physician Decision|0|||
145608506|NCT00738101|525081074|FG000|Overall Study|Death|1|||
145608507|NCT00738101|525081074|FG000|Overall Study|Repeat enrollment|1|||
145608508|NCT00709059|525081079|FG000|Overall Study|Lost to Follow-up|34|||
145278916|NCT02094937|523870916|FG002|8 Weeks in Period 1|Physician Decision|0|||
145278917|NCT02094937|523870917|FG003|8 Weeks in Period 1|Physician Decision|0|||
145278918|NCT02094937|523870914|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
145608509|NCT00709059|525081079|FG000|Overall Study|Withdrawal by Subject|19|||
145608510|NCT00709059|525081079|FG000|Overall Study|Physician Decision|7|||
145278919|NCT02094937|523870915|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
145278920|NCT02094937|523870916|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
145278921|NCT02094937|523870917|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
145278922|NCT02094937|523870914|FG000|12 Weeks in Period 2|Adverse Event|0|||
145278923|NCT02094937|523870915|FG001|12 Weeks in Period 2|Adverse Event|2|||
145278924|NCT02094937|523870916|FG002|12 Weeks in Period 2|Adverse Event|4|||
145278925|NCT02094937|523870917|FG003|12 Weeks in Period 2|Adverse Event|1|||
145608511|NCT00709059|525081079|FG000|Overall Study|Disease complication|3|||
145535580|NCT02478372|524820778|FG001|Overall Study|Lost to Follow-up|4|||
145535581|NCT02478372|524820777|FG000|Overall Study|Death|0|||
145535582|NCT02478372|524820778|FG001|Overall Study|Death|2|||
145535583|NCT01262573|524820779|FG000|Overall Study|Withdrawal by Subject|0|||
145278926|NCT02094937|523870914|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
145278927|NCT02094937|523870915|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
145278928|NCT02094937|523870916|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
145278929|NCT02094937|523870917|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
145278930|NCT02094937|523870914|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
145278931|NCT02094937|523870915|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
145278932|NCT02094937|523870916|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
145278933|NCT02094937|523870917|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
145278934|NCT02094937|523870914|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
145535584|NCT01262573|524820780|FG001|Overall Study|Withdrawal by Subject|1|||
145535585|NCT04402060|524820781|FG000|Overall Study|Death|1|||
145278935|NCT02094937|523870915|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
145278936|NCT02094937|523870916|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
145278937|NCT02094937|523870917|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
145278938|NCT02094937|523870914|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
145278939|NCT02094937|523870915|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
145278940|NCT02094937|523870916|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
145278941|NCT02094937|523870917|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
145278942|NCT03751124|523870920|FG000|Overall Study|Adverse Event|4|||
145278943|NCT03751124|523870921|FG001|Overall Study|Adverse Event|3|||
145278944|NCT03751124|523870920|FG000|Overall Study|Protocol Deviation|0|||
145278945|NCT03751124|523870921|FG001|Overall Study|Protocol Deviation|1|||
145278946|NCT03751124|523870920|FG000|Overall Study|Lost to Follow-up|6|||
145278947|NCT03751124|523870921|FG001|Overall Study|Lost to Follow-up|4|||
145278948|NCT03751124|523870920|FG000|Overall Study|Withdrawal by Subject|6|||
145278949|NCT03751124|523870921|FG001|Overall Study|Withdrawal by Subject|8|||
145278950|NCT03751124|523870920|FG000|Overall Study|Lack of Efficacy|1|||
145278951|NCT03751124|523870921|FG001|Overall Study|Lack of Efficacy|1|||
145278952|NCT03751124|523870920|FG000|Overall Study|Pregnancy|0|||
145278953|NCT03751124|523870921|FG001|Overall Study|Pregnancy|1|||
145278954|NCT03751124|523870920|FG000|Overall Study|Other|9|||
145278955|NCT03751124|523870921|FG001|Overall Study|Other|9|||
145278956|NCT03751124|523870920|FG000|Overall Study|Participants who did not receive any study drug|0|||
145278957|NCT03751124|523870921|FG001|Overall Study|Participants who did not receive any study drug|1|||
145278958|NCT00555399|523870932|FG000|Overall Study|Withdrawal by Subject|0|||
145278959|NCT00555399|523870933|FG001|Overall Study|Withdrawal by Subject|0|||
145278960|NCT00555399|523870934|FG002|Overall Study|Withdrawal by Subject|1|||
145278961|NCT00555399|523870935|FG003|Overall Study|Withdrawal by Subject|0|||
145278962|NCT00555399|523870936|FG004|Overall Study|Withdrawal by Subject|0|||
145278963|NCT00555399|523870937|FG005|Overall Study|Withdrawal by Subject|0|||
145278964|NCT00555399|523870938|FG006|Overall Study|Withdrawal by Subject|0|||
145278965|NCT00555399|523870939|FG007|Overall Study|Withdrawal by Subject|0|||
145278966|NCT00555399|523870940|FG008|Overall Study|Withdrawal by Subject|0|||
145278967|NCT00555399|523870941|FG009|Overall Study|Withdrawal by Subject|0|||
145278968|NCT00555399|523870942|FG010|Overall Study|Withdrawal by Subject|0|||
145278969|NCT00555399|523870943|FG011|Overall Study|Withdrawal by Subject|1|||
145278970|NCT00555399|523870932|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
145278971|NCT00555399|523870933|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
145278972|NCT00555399|523870934|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
145278973|NCT00555399|523870935|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
145278974|NCT00555399|523870936|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
145278975|NCT00555399|523870937|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
145535586|NCT04402060|524820782|FG001|Overall Study|Death|12|||
145535587|NCT04402060|524820783|FG002|Overall Study|Death|7|||
145535588|NCT04402060|524820781|FG000|Overall Study|Adverse Event|0|||
145535589|NCT04402060|524820782|FG001|Overall Study|Adverse Event|0|||
145535590|NCT04402060|524820783|FG002|Overall Study|Adverse Event|1|||
145278976|NCT00555399|523870938|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
145278977|NCT00555399|523870939|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
145278978|NCT00555399|523870940|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
145278979|NCT00555399|523870941|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
145535591|NCT04402060|524820781|FG000|Overall Study|Withdrawal by Subject|0|||
145535592|NCT04402060|524820782|FG001|Overall Study|Withdrawal by Subject|1|||
145535593|NCT04402060|524820783|FG002|Overall Study|Withdrawal by Subject|2|||
145278980|NCT00555399|523870942|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
145278981|NCT00555399|523870943|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
145278982|NCT05458895|523870944|FG000|Overall Study|Withdrawal by Subject|8|||
145535594|NCT04402060|524820781|FG000|Overall Study|Sponsor Request|0|||
145535595|NCT04402060|524820782|FG001|Overall Study|Sponsor Request|2|||
145535596|NCT04402060|524820783|FG002|Overall Study|Sponsor Request|0|||
145535597|NCT04402060|524820781|FG000|Overall Study|Physician Decision|0|||
145535598|NCT04402060|524820782|FG001|Overall Study|Physician Decision|0|||
145278983|NCT05458895|523870944|FG000|Overall Study|Lost to Follow-up|17|||
145278984|NCT05458895|523870944|FG000|Overall Study|Pregnancy|2|||
145278985|NCT05458895|523870944|FG000|Overall Study|Withdrawal by Study Team|1|||
145278986|NCT04639310|523870945|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
145278987|NCT04639310|523870946|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
145278988|NCT03862625|523872820|FG000|Overall Study|Lost to Follow-up|0|||
145278989|NCT03862625|523872821|FG001|Overall Study|Lost to Follow-up|1|||
145278990|NCT01326702|523872822|FG000|Overall Study|Other|1|||
145278991|NCT01326702|523872823|FG001|Overall Study|Other|0|||
145278992|NCT01326702|523872824|FG002|Overall Study|Other|0|||
145278993|NCT01326702|523872825|FG003|Overall Study|Other|0|||
145278994|NCT01326702|523872826|FG004|Overall Study|Other|0|||
145278995|NCT01326702|523872827|FG005|Overall Study|Other|1|||
145278996|NCT01326702|523872828|FG006|Overall Study|Other|0|||
145278997|NCT01326702|523872822|FG000|Overall Study|progressive disease|1|||
145278998|NCT01326702|523872823|FG001|Overall Study|progressive disease|1|||
145278999|NCT01326702|523872824|FG002|Overall Study|progressive disease|3|||
145279000|NCT01326702|523872825|FG003|Overall Study|progressive disease|1|||
145279001|NCT01326702|523872826|FG004|Overall Study|progressive disease|3|||
145279002|NCT01326702|523872827|FG005|Overall Study|progressive disease|2|||
145279003|NCT01326702|523872828|FG006|Overall Study|progressive disease|3|||
145279004|NCT01326702|523872822|FG000|Overall Study|Death|0|||
145279005|NCT01326702|523872823|FG001|Overall Study|Death|1|||
145279006|NCT01326702|523872824|FG002|Overall Study|Death|0|||
145279007|NCT01326702|523872825|FG003|Overall Study|Death|0|||
145279008|NCT01326702|523872826|FG004|Overall Study|Death|0|||
145279009|NCT01326702|523872827|FG005|Overall Study|Death|0|||
145279010|NCT01326702|523872828|FG006|Overall Study|Death|0|||
145279011|NCT01326702|523872822|FG000|Overall Study|Adverse Event|0|||
145279012|NCT01326702|523872823|FG001|Overall Study|Adverse Event|0|||
145279013|NCT01326702|523872824|FG002|Overall Study|Adverse Event|1|||
145279014|NCT01326702|523872825|FG003|Overall Study|Adverse Event|1|||
145279015|NCT01326702|523872826|FG004|Overall Study|Adverse Event|0|||
145279016|NCT01326702|523872827|FG005|Overall Study|Adverse Event|3|||
145279017|NCT01326702|523872828|FG006|Overall Study|Adverse Event|1|||
145279018|NCT01326702|523872822|FG000|Overall Study|Withdrawal by Subject|0|||
145279019|NCT01326702|523872823|FG001|Overall Study|Withdrawal by Subject|0|||
145535599|NCT04402060|524820783|FG002|Overall Study|Physician Decision|1|||
145279020|NCT01326702|523872824|FG002|Overall Study|Withdrawal by Subject|1|||
145279021|NCT01326702|523872825|FG003|Overall Study|Withdrawal by Subject|0|||
145279022|NCT01326702|523872826|FG004|Overall Study|Withdrawal by Subject|1|||
145279023|NCT01326702|523872827|FG005|Overall Study|Withdrawal by Subject|1|||
145535600|NCT04402060|524820781|FG000|Overall Study|Other|0|||
145535601|NCT04402060|524820782|FG001|Overall Study|Other|1|||
145279024|NCT01326702|523872828|FG006|Overall Study|Withdrawal by Subject|3|||
145279025|NCT01326702|523872822|FG000|Overall Study|Not Treated|0|||
145279026|NCT01326702|523872823|FG001|Overall Study|Not Treated|0|||
145279027|NCT01326702|523872824|FG002|Overall Study|Not Treated|0|||
145279028|NCT01326702|523872825|FG003|Overall Study|Not Treated|1|||
145279029|NCT01326702|523872826|FG004|Overall Study|Not Treated|0|||
145279030|NCT01326702|523872827|FG005|Overall Study|Not Treated|1|||
145279031|NCT01326702|523872828|FG006|Overall Study|Not Treated|0|||
145279032|NCT02082912|523872829|FG000|Overall Study|Physician Decision|0|||
145279033|NCT02082912|523872830|FG001|Overall Study|Physician Decision|1|||
145279034|NCT01835132|523872837|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
145279035|NCT00856778|523872838|FG000|Overall Study|Adverse Event|7|||
145279036|NCT00856778|523872838|FG000|Overall Study|Withdrawal by Subject|10|||
145535602|NCT04402060|524820783|FG002|Overall Study|Other|0|||
145535603|NCT01297920|524820786|FG000|Overall Study|Adverse Event|42|||
145279037|NCT00856778|523872838|FG000|Overall Study|Study deviation|2|||
145279038|NCT00856778|523872838|FG000|Overall Study|Lost to Follow-up|5|||
145279039|NCT00265083|523872839|FG000|Overall Study|Adverse Event|5|||
145279040|NCT00265083|523872840|FG001|Overall Study|Adverse Event|13|||
145279041|NCT00265083|523872841|FG002|Overall Study|Adverse Event|15|||
145535604|NCT01297920|524820787|FG001|Overall Study|Adverse Event|10|||
145535605|NCT01297920|524820788|FG002|Overall Study|Adverse Event|38|||
145279042|NCT00265083|523872839|FG000|Overall Study|Lost to Follow-up|3|||
145279043|NCT00265083|523872840|FG001|Overall Study|Lost to Follow-up|4|||
145279044|NCT00265083|523872841|FG002|Overall Study|Lost to Follow-up|4|||
145279045|NCT00265083|523872839|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
145279046|NCT00265083|523872840|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145279047|NCT00265083|523872841|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
145279048|NCT00265083|523872839|FG000|Overall Study|Other|1|||
145279049|NCT00265083|523872840|FG001|Overall Study|Other|12|||
145279050|NCT00265083|523872841|FG002|Overall Study|Other|9|||
145279051|NCT03208933|523872842|FG000|Overall Study|Death|3|||
145279052|NCT03208933|523872842|FG000|Overall Study|Withdrawal by Subject|3|||
145775155|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
145775156|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
145775157|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
145775158|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775159|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775160|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775161|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775162|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775163|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775164|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775165|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775166|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775167|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
145775168|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775169|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775170|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775171|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
145775172|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
145775173|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
145775174|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
145775175|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
145775176|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
145775177|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
145775178|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
145775179|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
145775180|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
145775181|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
145775182|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
145775183|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
145775184|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
145775185|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
145775186|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
145775187|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
145775188|NCT03519178|525687636|FG000|Fulvestrant. Treatment|Other|0|||
145775189|NCT03519178|525687637|FG001|Fulvestrant. Treatment|Other|0|||
145775190|NCT03519178|525687638|FG002|Fulvestrant. Treatment|Other|0|||
145775191|NCT03519178|525687639|FG003|Fulvestrant. Treatment|Other|0|||
145775192|NCT03519178|525687640|FG004|Fulvestrant. Treatment|Other|0|||
145775193|NCT03519178|525687641|FG005|Fulvestrant. Treatment|Other|0|||
145775194|NCT03519178|525687642|FG006|Fulvestrant. Treatment|Other|0|||
145775195|NCT03519178|525687643|FG007|Fulvestrant. Treatment|Other|0|||
145279053|NCT03208933|523872842|FG000|Overall Study|Adverse Event|1|||
145775196|NCT03519178|525687644|FG008|Fulvestrant. Treatment|Other|0|||
145775197|NCT03519178|525687645|FG009|Fulvestrant. Treatment|Other|0|||
145775198|NCT03519178|525687646|FG010|Fulvestrant. Treatment|Other|0|||
145775199|NCT03519178|525687647|FG011|Fulvestrant. Treatment|Other|0|||
145775200|NCT03519178|525687648|FG012|Fulvestrant. Treatment|Other|0|||
145775201|NCT03519178|525687649|FG013|Fulvestrant. Treatment|Other|1|||
145775202|NCT03519178|525687650|FG014|Fulvestrant. Treatment|Other|3|||
145775203|NCT03519178|525687636|FG000|Letrozole Treatment|Physician Decision|0|||
145775204|NCT03519178|525687637|FG001|Letrozole Treatment|Physician Decision|0|||
145775205|NCT03519178|525687638|FG002|Letrozole Treatment|Physician Decision|0|||
145775206|NCT03519178|525687639|FG003|Letrozole Treatment|Physician Decision|0|||
145775207|NCT03519178|525687640|FG004|Letrozole Treatment|Physician Decision|0|||
145775208|NCT03519178|525687641|FG005|Letrozole Treatment|Physician Decision|0|||
145775209|NCT03519178|525687642|FG006|Letrozole Treatment|Physician Decision|0|||
145775210|NCT03519178|525687643|FG007|Letrozole Treatment|Physician Decision|0|||
145775211|NCT03519178|525687644|FG008|Letrozole Treatment|Physician Decision|0|||
145775212|NCT03519178|525687645|FG009|Letrozole Treatment|Physician Decision|0|||
145775213|NCT03519178|525687646|FG010|Letrozole Treatment|Physician Decision|1|||
145775214|NCT03519178|525687647|FG011|Letrozole Treatment|Physician Decision|0|||
145775215|NCT03519178|525687648|FG012|Letrozole Treatment|Physician Decision|0|||
145775216|NCT03519178|525687649|FG013|Letrozole Treatment|Physician Decision|0|||
145775217|NCT03519178|525687650|FG014|Letrozole Treatment|Physician Decision|0|||
145775218|NCT03519178|525687636|FG000|Letrozole Treatment|Progressive disease|0|||
145775219|NCT03519178|525687637|FG001|Letrozole Treatment|Progressive disease|0|||
145775220|NCT03519178|525687638|FG002|Letrozole Treatment|Progressive disease|0|||
145775221|NCT03519178|525687639|FG003|Letrozole Treatment|Progressive disease|0|||
145775222|NCT03519178|525687640|FG004|Letrozole Treatment|Progressive disease|0|||
145775223|NCT03519178|525687641|FG005|Letrozole Treatment|Progressive disease|0|||
145775224|NCT03519178|525687642|FG006|Letrozole Treatment|Progressive disease|0|||
145775225|NCT03519178|525687643|FG007|Letrozole Treatment|Progressive disease|0|||
145775226|NCT03519178|525687644|FG008|Letrozole Treatment|Progressive disease|0|||
145775227|NCT03519178|525687645|FG009|Letrozole Treatment|Progressive disease|0|||
145775228|NCT03519178|525687646|FG010|Letrozole Treatment|Progressive disease|4|||
145775229|NCT03519178|525687647|FG011|Letrozole Treatment|Progressive disease|0|||
145775230|NCT03519178|525687648|FG012|Letrozole Treatment|Progressive disease|0|||
145775231|NCT03519178|525687649|FG013|Letrozole Treatment|Progressive disease|0|||
145775232|NCT03519178|525687650|FG014|Letrozole Treatment|Progressive disease|0|||
145775233|NCT03519178|525687636|FG000|Letrozole Treatment|Global deterioration of health status|0|||
145775234|NCT03519178|525687637|FG001|Letrozole Treatment|Global deterioration of health status|0|||
145775235|NCT03519178|525687638|FG002|Letrozole Treatment|Global deterioration of health status|0|||
145775236|NCT03519178|525687639|FG003|Letrozole Treatment|Global deterioration of health status|0|||
145775237|NCT03519178|525687640|FG004|Letrozole Treatment|Global deterioration of health status|0|||
145535606|NCT01297920|524820786|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
145775238|NCT03519178|525687641|FG005|Letrozole Treatment|Global deterioration of health status|0|||
145775239|NCT03519178|525687642|FG006|Letrozole Treatment|Global deterioration of health status|0|||
145775240|NCT03519178|525687643|FG007|Letrozole Treatment|Global deterioration of health status|0|||
145775241|NCT03519178|525687644|FG008|Letrozole Treatment|Global deterioration of health status|0|||
145775242|NCT03519178|525687645|FG009|Letrozole Treatment|Global deterioration of health status|0|||
145775243|NCT03519178|525687646|FG010|Letrozole Treatment|Global deterioration of health status|2|||
145775244|NCT03519178|525687647|FG011|Letrozole Treatment|Global deterioration of health status|0|||
145775245|NCT03519178|525687648|FG012|Letrozole Treatment|Global deterioration of health status|0|||
145775246|NCT03519178|525687649|FG013|Letrozole Treatment|Global deterioration of health status|0|||
145775247|NCT03519178|525687650|FG014|Letrozole Treatment|Global deterioration of health status|0|||
145775248|NCT03519178|525687636|FG000|Follow-Up|Death|0|||
145775249|NCT03519178|525687637|FG001|Follow-Up|Death|0|||
145775250|NCT03519178|525687638|FG002|Follow-Up|Death|0|||
145775251|NCT03519178|525687639|FG003|Follow-Up|Death|0|||
145775252|NCT03519178|525687640|FG004|Follow-Up|Death|0|||
145535607|NCT01297920|524820787|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
145535608|NCT01297920|524820788|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
145535609|NCT01297920|524820786|FG000|Overall Study|Noncompliance|1|||
145535610|NCT01297920|524820787|FG001|Overall Study|Noncompliance|0|||
145535611|NCT01297920|524820788|FG002|Overall Study|Noncompliance|0|||
145775253|NCT03519178|525687641|FG005|Follow-Up|Death|0|||
145775254|NCT03519178|525687642|FG006|Follow-Up|Death|0|||
145775255|NCT03519178|525687643|FG007|Follow-Up|Death|0|||
145775256|NCT03519178|525687644|FG008|Follow-Up|Death|3|||
145775257|NCT03519178|525687645|FG009|Follow-Up|Death|1|||
145775258|NCT03519178|525687646|FG010|Follow-Up|Death|0|||
145775259|NCT03519178|525687647|FG011|Follow-Up|Death|0|||
145775260|NCT03519178|525687648|FG012|Follow-Up|Death|2|||
145535612|NCT01297920|524820786|FG000|Overall Study|Protocol Violation|1|||
145535613|NCT01297920|524820787|FG001|Overall Study|Protocol Violation|3|||
145775261|NCT03519178|525687649|FG013|Follow-Up|Death|0|||
145775262|NCT03519178|525687650|FG014|Follow-Up|Death|0|||
145775263|NCT03519178|525687636|FG000|Follow-Up|Lost to Follow-up|0|||
145775264|NCT03519178|525687637|FG001|Follow-Up|Lost to Follow-up|0|||
145775265|NCT03519178|525687638|FG002|Follow-Up|Lost to Follow-up|0|||
145775266|NCT03519178|525687639|FG003|Follow-Up|Lost to Follow-up|0|||
145775267|NCT03519178|525687640|FG004|Follow-Up|Lost to Follow-up|0|||
145775268|NCT03519178|525687641|FG005|Follow-Up|Lost to Follow-up|3|||
145775269|NCT03519178|525687642|FG006|Follow-Up|Lost to Follow-up|1|||
145775270|NCT03519178|525687643|FG007|Follow-Up|Lost to Follow-up|4|||
145775271|NCT03519178|525687644|FG008|Follow-Up|Lost to Follow-up|1|||
145775272|NCT03519178|525687645|FG009|Follow-Up|Lost to Follow-up|0|||
145775273|NCT03519178|525687646|FG010|Follow-Up|Lost to Follow-up|0|||
145775274|NCT03519178|525687647|FG011|Follow-Up|Lost to Follow-up|0|||
145775275|NCT03519178|525687648|FG012|Follow-Up|Lost to Follow-up|0|||
145775276|NCT03519178|525687649|FG013|Follow-Up|Lost to Follow-up|0|||
145775277|NCT03519178|525687650|FG014|Follow-Up|Lost to Follow-up|0|||
145775278|NCT03519178|525687636|FG000|Follow-Up|Withdrawal by Subject|1|||
145775279|NCT03519178|525687637|FG001|Follow-Up|Withdrawal by Subject|2|||
145775280|NCT03519178|525687638|FG002|Follow-Up|Withdrawal by Subject|2|||
145775281|NCT03519178|525687639|FG003|Follow-Up|Withdrawal by Subject|3|||
145775282|NCT03519178|525687640|FG004|Follow-Up|Withdrawal by Subject|5|||
145775283|NCT03519178|525687641|FG005|Follow-Up|Withdrawal by Subject|1|||
145775284|NCT03519178|525687642|FG006|Follow-Up|Withdrawal by Subject|2|||
145775285|NCT03519178|525687643|FG007|Follow-Up|Withdrawal by Subject|6|||
145775286|NCT03519178|525687644|FG008|Follow-Up|Withdrawal by Subject|5|||
145775287|NCT03519178|525687645|FG009|Follow-Up|Withdrawal by Subject|2|||
145775288|NCT03519178|525687646|FG010|Follow-Up|Withdrawal by Subject|3|||
145775289|NCT03519178|525687647|FG011|Follow-Up|Withdrawal by Subject|5|||
145775290|NCT03519178|525687648|FG012|Follow-Up|Withdrawal by Subject|2|||
145775291|NCT03519178|525687649|FG013|Follow-Up|Withdrawal by Subject|0|||
145775292|NCT03519178|525687650|FG014|Follow-Up|Withdrawal by Subject|0|||
145775293|NCT03519178|525687636|FG000|Follow-Up|Other|0|||
145775294|NCT03519178|525687637|FG001|Follow-Up|Other|0|||
145775295|NCT03519178|525687638|FG002|Follow-Up|Other|0|||
145775296|NCT03519178|525687639|FG003|Follow-Up|Other|0|||
145775297|NCT03519178|525687640|FG004|Follow-Up|Other|0|||
145775298|NCT03519178|525687641|FG005|Follow-Up|Other|0|||
145775299|NCT03519178|525687642|FG006|Follow-Up|Other|0|||
145775300|NCT03519178|525687643|FG007|Follow-Up|Other|1|||
145775301|NCT03519178|525687644|FG008|Follow-Up|Other|0|||
145775302|NCT03519178|525687645|FG009|Follow-Up|Other|0|||
145775303|NCT03519178|525687646|FG010|Follow-Up|Other|0|||
145775304|NCT03519178|525687647|FG011|Follow-Up|Other|0|||
145775305|NCT03519178|525687648|FG012|Follow-Up|Other|0|||
145775306|NCT03519178|525687649|FG013|Follow-Up|Other|0|||
145775307|NCT03519178|525687650|FG014|Follow-Up|Other|0|||
145775308|NCT03519178|525687636|FG000|Long-term Follow-up|Death|0|||
145775309|NCT03519178|525687637|FG001|Long-term Follow-up|Death|0|||
145775310|NCT03519178|525687638|FG002|Long-term Follow-up|Death|0|||
145775311|NCT03519178|525687639|FG003|Long-term Follow-up|Death|0|||
145775312|NCT03519178|525687640|FG004|Long-term Follow-up|Death|0|||
145775313|NCT03519178|525687641|FG005|Long-term Follow-up|Death|0|||
145775314|NCT03519178|525687642|FG006|Long-term Follow-up|Death|0|||
145775315|NCT03519178|525687643|FG007|Long-term Follow-up|Death|0|||
145775316|NCT03519178|525687644|FG008|Long-term Follow-up|Death|0|||
145775317|NCT03519178|525687645|FG009|Long-term Follow-up|Death|0|||
145775318|NCT03519178|525687646|FG010|Long-term Follow-up|Death|0|||
145775319|NCT03519178|525687647|FG011|Long-term Follow-up|Death|0|||
145775320|NCT03519178|525687648|FG012|Long-term Follow-up|Death|0|||
145775321|NCT03519178|525687649|FG013|Long-term Follow-up|Death|4|||
145775322|NCT03519178|525687650|FG014|Long-term Follow-up|Death|4|||
145775323|NCT03519178|525687636|FG000|Long-term Follow-up|Lost to Follow-up|0|||
145775324|NCT03519178|525687637|FG001|Long-term Follow-up|Lost to Follow-up|0|||
145775325|NCT03519178|525687638|FG002|Long-term Follow-up|Lost to Follow-up|0|||
145775326|NCT03519178|525687639|FG003|Long-term Follow-up|Lost to Follow-up|0|||
145775327|NCT03519178|525687640|FG004|Long-term Follow-up|Lost to Follow-up|0|||
145775328|NCT03519178|525687641|FG005|Long-term Follow-up|Lost to Follow-up|0|||
145775329|NCT03519178|525687642|FG006|Long-term Follow-up|Lost to Follow-up|0|||
145775330|NCT03519178|525687643|FG007|Long-term Follow-up|Lost to Follow-up|0|||
145535614|NCT01297920|524820788|FG002|Overall Study|Protocol Violation|0|||
145535615|NCT01297920|524820786|FG000|Overall Study|Inadequate Control of IOP|7|||
145535616|NCT01297920|524820787|FG001|Overall Study|Inadequate Control of IOP|9|||
145535617|NCT01297920|524820788|FG002|Overall Study|Inadequate Control of IOP|17|||
145775331|NCT03519178|525687644|FG008|Long-term Follow-up|Lost to Follow-up|0|||
145775332|NCT03519178|525687645|FG009|Long-term Follow-up|Lost to Follow-up|0|||
145775333|NCT03519178|525687646|FG010|Long-term Follow-up|Lost to Follow-up|0|||
145775334|NCT03519178|525687647|FG011|Long-term Follow-up|Lost to Follow-up|0|||
145775335|NCT03519178|525687648|FG012|Long-term Follow-up|Lost to Follow-up|0|||
145775336|NCT03519178|525687649|FG013|Long-term Follow-up|Lost to Follow-up|1|||
145608512|NCT00709059|525081079|FG000|Overall Study|Side effects|20|||
145775337|NCT03519178|525687650|FG014|Long-term Follow-up|Lost to Follow-up|1|||
145775338|NCT03519178|525687636|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
145775339|NCT03519178|525687637|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
145775340|NCT03519178|525687638|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
145775341|NCT03519178|525687639|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
145775342|NCT03519178|525687640|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
145775343|NCT03519178|525687641|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
145775344|NCT03519178|525687642|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
145775345|NCT03519178|525687643|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
145775346|NCT03519178|525687644|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
145775347|NCT03519178|525687645|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
145775348|NCT03519178|525687646|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
145775349|NCT03519178|525687647|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
145775350|NCT03519178|525687648|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
145775351|NCT03519178|525687649|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
145775352|NCT03519178|525687650|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
145775353|NCT03519178|525687636|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
145775354|NCT03519178|525687637|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
145775355|NCT03519178|525687638|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
145775356|NCT03519178|525687639|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
145775357|NCT03519178|525687640|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
145775358|NCT03519178|525687641|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
145775359|NCT03519178|525687642|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
145775360|NCT03519178|525687643|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
145775361|NCT03519178|525687644|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
145775362|NCT03519178|525687645|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
145775363|NCT03519178|525687646|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
145775364|NCT03519178|525687647|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
145775365|NCT03519178|525687648|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
145775366|NCT03519178|525687649|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
145775367|NCT03519178|525687650|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
145775368|NCT03519178|525687636|FG000|Long-term Follow-up|Other|0|||
145775369|NCT03519178|525687637|FG001|Long-term Follow-up|Other|0|||
145775370|NCT03519178|525687638|FG002|Long-term Follow-up|Other|0|||
145775371|NCT03519178|525687639|FG003|Long-term Follow-up|Other|0|||
145775372|NCT03519178|525687640|FG004|Long-term Follow-up|Other|0|||
145775373|NCT03519178|525687641|FG005|Long-term Follow-up|Other|0|||
145775374|NCT03519178|525687642|FG006|Long-term Follow-up|Other|0|||
145775375|NCT03519178|525687643|FG007|Long-term Follow-up|Other|0|||
145775376|NCT03519178|525687644|FG008|Long-term Follow-up|Other|0|||
145775377|NCT03519178|525687645|FG009|Long-term Follow-up|Other|0|||
145775378|NCT03519178|525687646|FG010|Long-term Follow-up|Other|0|||
145775379|NCT03519178|525687647|FG011|Long-term Follow-up|Other|0|||
145775380|NCT03519178|525687648|FG012|Long-term Follow-up|Other|0|||
145775381|NCT03519178|525687649|FG013|Long-term Follow-up|Other|0|||
145775382|NCT03519178|525687650|FG014|Long-term Follow-up|Other|1|||
145775383|NCT03519178|525687636|FG000|Long-term Follow-up|Global deterioration of health status|0|||
145775384|NCT03519178|525687637|FG001|Long-term Follow-up|Global deterioration of health status|0|||
145775385|NCT03519178|525687638|FG002|Long-term Follow-up|Global deterioration of health status|0|||
145775386|NCT03519178|525687639|FG003|Long-term Follow-up|Global deterioration of health status|0|||
145775387|NCT03519178|525687640|FG004|Long-term Follow-up|Global deterioration of health status|0|||
145775388|NCT03519178|525687641|FG005|Long-term Follow-up|Global deterioration of health status|0|||
145775389|NCT03519178|525687642|FG006|Long-term Follow-up|Global deterioration of health status|0|||
145775390|NCT03519178|525687643|FG007|Long-term Follow-up|Global deterioration of health status|0|||
145775391|NCT03519178|525687644|FG008|Long-term Follow-up|Global deterioration of health status|0|||
145775392|NCT03519178|525687645|FG009|Long-term Follow-up|Global deterioration of health status|0|||
145775393|NCT03519178|525687646|FG010|Long-term Follow-up|Global deterioration of health status|0|||
145775394|NCT03519178|525687647|FG011|Long-term Follow-up|Global deterioration of health status|0|||
145775395|NCT03519178|525687648|FG012|Long-term Follow-up|Global deterioration of health status|0|||
145775396|NCT03519178|525687649|FG013|Long-term Follow-up|Global deterioration of health status|1|||
145775397|NCT03519178|525687650|FG014|Long-term Follow-up|Global deterioration of health status|0|||
145775398|NCT03249350|525687651|FG000|Overall Study|Participant did not initiate treatment|5|||
145775399|NCT03249350|525687652|FG001|Overall Study|Participant did not initiate treatment|8|||
145775400|NCT01591330|525687653|FG000|Period 1|Adverse Event|1|||
145775401|NCT01591330|525687654|FG001|Period 1|Adverse Event|0|||
145775402|NCT01591330|525687655|FG002|Period 1|Adverse Event|0|||
145775403|NCT01591330|525687656|FG003|Period 1|Adverse Event|0|||
145775404|NCT01591330|525687653|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
145775405|NCT01591330|525687654|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
145775406|NCT01591330|525687655|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
145775407|NCT01591330|525687656|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
145775408|NCT01591330|525687653|FG000|Period 2|Adverse Event|1|||
145775409|NCT01591330|525687654|FG001|Period 2|Adverse Event|0|||
145775410|NCT01591330|525687655|FG002|Period 2|Adverse Event|0|||
145775411|NCT01591330|525687656|FG003|Period 2|Adverse Event|0|||
145775412|NCT01450137|525687657|FG000|Up to Week 12|Adverse Event|2|||
145775413|NCT01450137|525687658|FG001|Up to Week 12|Adverse Event|1|||
145775414|NCT01450137|525687657|FG000|Up to Week 12|Withdrawal by Subject|0|||
145775415|NCT01450137|525687658|FG001|Up to Week 12|Withdrawal by Subject|2|||
145775416|NCT01450137|525687657|FG000|Week 12 to Study End|Death|0|||
145775417|NCT01450137|525687658|FG001|Week 12 to Study End|Death|1|||
145775418|NCT01450137|525687657|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
145775419|NCT01450137|525687658|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
145775420|NCT02986373|525687659|FG000|Overall Study|Adverse Event|4|||
145775421|NCT02986373|525687659|FG000|Overall Study|Lost to Follow-up|1|||
145775422|NCT02986373|525687659|FG000|Overall Study|Withdrawal by Subject|10|||
145775423|NCT02986373|525687659|FG000|Overall Study|Other|24|||
145775424|NCT01607892|525687664|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
145775425|NCT01607892|525687665|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
145775426|NCT01607892|525687666|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
145775427|NCT01607892|525687667|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
145775428|NCT01607892|525687668|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
145775429|NCT01607892|525687664|FG000|Overall Study|Death|4|||
145775430|NCT01607892|525687665|FG001|Overall Study|Death|2|||
145775431|NCT01607892|525687666|FG002|Overall Study|Death|8|||
145775432|NCT01607892|525687667|FG003|Overall Study|Death|10|||
145775433|NCT01607892|525687668|FG004|Overall Study|Death|3|||
145775434|NCT01607892|525687664|FG000|Overall Study|Investigator discretion|2|||
145775435|NCT01607892|525687665|FG001|Overall Study|Investigator discretion|4|||
145775436|NCT01607892|525687666|FG002|Overall Study|Investigator discretion|4|||
145775437|NCT01607892|525687667|FG003|Overall Study|Investigator discretion|8|||
145775438|NCT01607892|525687668|FG004|Overall Study|Investigator discretion|0|||
145775439|NCT01607892|525687664|FG000|Overall Study|Other treatments became available|1|||
145775440|NCT01607892|525687665|FG001|Overall Study|Other treatments became available|1|||
145775441|NCT01607892|525687666|FG002|Overall Study|Other treatments became available|0|||
145775442|NCT01607892|525687667|FG003|Overall Study|Other treatments became available|0|||
145775443|NCT01607892|525687668|FG004|Overall Study|Other treatments became available|2|||
145775444|NCT01607892|525687664|FG000|Overall Study|Intercurrent illness|1|||
145775445|NCT01607892|525687665|FG001|Overall Study|Intercurrent illness|0|||
145775446|NCT01607892|525687666|FG002|Overall Study|Intercurrent illness|0|||
145775447|NCT01607892|525687667|FG003|Overall Study|Intercurrent illness|3|||
145775448|NCT01607892|525687668|FG004|Overall Study|Intercurrent illness|0|||
145775449|NCT01607892|525687664|FG000|Overall Study|Non-Compliance with study procedures|0|||
145775450|NCT01607892|525687665|FG001|Overall Study|Non-Compliance with study procedures|0|||
145775451|NCT01607892|525687666|FG002|Overall Study|Non-Compliance with study procedures|1|||
145775452|NCT01607892|525687667|FG003|Overall Study|Non-Compliance with study procedures|0|||
145775453|NCT01607892|525687668|FG004|Overall Study|Non-Compliance with study procedures|0|||
145775454|NCT01607892|525687664|FG000|Overall Study|Consent withdrawn by participant|9|||
145775455|NCT01607892|525687665|FG001|Overall Study|Consent withdrawn by participant|4|||
145775456|NCT01607892|525687666|FG002|Overall Study|Consent withdrawn by participant|24|||
145775457|NCT01607892|525687667|FG003|Overall Study|Consent withdrawn by participant|14|||
145775458|NCT01607892|525687668|FG004|Overall Study|Consent withdrawn by participant|4|||
145775459|NCT01607892|525687664|FG000|Overall Study|Disease progression|38|||
145775460|NCT01607892|525687665|FG001|Overall Study|Disease progression|13|||
145775461|NCT01607892|525687666|FG002|Overall Study|Disease progression|37|||
145775462|NCT01607892|525687667|FG003|Overall Study|Disease progression|57|||
145775463|NCT01607892|525687668|FG004|Overall Study|Disease progression|9|||
145775464|NCT01607892|525687664|FG000|Overall Study|Incidence or severity of Adverse events|3|||
145775465|NCT01607892|525687665|FG001|Overall Study|Incidence or severity of Adverse events|3|||
145775466|NCT01607892|525687666|FG002|Overall Study|Incidence or severity of Adverse events|7|||
145775467|NCT01607892|525687667|FG003|Overall Study|Incidence or severity of Adverse events|2|||
145775468|NCT01607892|525687668|FG004|Overall Study|Incidence or severity of Adverse events|6|||
145775469|NCT02273973|525687671|FG000|Overall Study|Adverse Event|4|||
145775470|NCT02273973|525687672|FG001|Overall Study|Adverse Event|0|||
145775471|NCT02273973|525687671|FG000|Overall Study|Withdrawal by Subject|2|||
145775472|NCT02273973|525687672|FG001|Overall Study|Withdrawal by Subject|3|||
145775473|NCT02273973|525687671|FG000|Overall Study|Death|1|||
145775474|NCT02273973|525687672|FG001|Overall Study|Death|0|||
145775475|NCT02273973|525687671|FG000|Overall Study|Non-compliance|1|||
145775476|NCT02273973|525687672|FG001|Overall Study|Non-compliance|0|||
145775477|NCT02273973|525687671|FG000|Overall Study|Protocol Violation|1|||
145775478|NCT02273973|525687672|FG001|Overall Study|Protocol Violation|0|||
145775479|NCT02273973|525687671|FG000|Overall Study|Progression of disease|0|||
145775480|NCT02273973|525687672|FG001|Overall Study|Progression of disease|2|||
145403659|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145775481|NCT02273973|525687671|FG000|Overall Study|Lost to Follow-up|0|||
145775482|NCT02273973|525687672|FG001|Overall Study|Lost to Follow-up|1|||
145775483|NCT02273973|525687671|FG000|Overall Study|Physician Decision|0|||
145775484|NCT02273973|525687672|FG001|Overall Study|Physician Decision|1|||
145775485|NCT02273973|525687671|FG000|Overall Study|Reason not specified|0|||
145775486|NCT02273973|525687672|FG001|Overall Study|Reason not specified|1|||
145775487|NCT03022422|525687674|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
145775488|NCT03022422|525687675|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
145775489|NCT03022422|525687676|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
145775490|NCT03022422|525687677|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
145775491|NCT03022422|525687678|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
145775492|NCT03022422|525687679|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
145775493|NCT01769404|525687680|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
145775494|NCT01769404|525687681|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
145775495|NCT01769404|525687680|FG000|Treatment Period 1|Withdrawal by Subject|3|||
145775496|NCT01769404|525687681|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145775497|NCT01769404|525687680|FG000|Treatment Period 1|Sponsor decision|1|||
145775498|NCT01769404|525687681|FG001|Treatment Period 1|Sponsor decision|0|||
145775499|NCT01769404|525687680|FG000|Treatment Period 2|Sponsor decision|7|||
145775500|NCT01769404|525687681|FG001|Treatment Period 2|Sponsor decision|0|||
145775501|NCT00538733|525687682|FG000|Overall Study|Adverse Event|8|||
145775502|NCT00538733|525687682|FG000|Overall Study|Death|1|||
145775503|NCT00538733|525687682|FG000|Overall Study|declined to participate|2|||
145775504|NCT00538733|525687682|FG000|Overall Study|still on therapy|1|||
145775505|NCT02032524|525687687|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
145775506|NCT02032524|525687688|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
145775507|NCT02032524|525687689|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
145775508|NCT02032524|525687690|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
145775509|NCT02032524|525687691|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
145775510|NCT02032524|525687692|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
145775511|NCT02032524|525687687|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
145775512|NCT02032524|525687688|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
145775513|NCT02032524|525687689|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
145775514|NCT02032524|525687690|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
145775515|NCT02032524|525687691|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
145775516|NCT02032524|525687692|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
145775517|NCT02032524|525687687|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
145775518|NCT02032524|525687688|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
145775519|NCT02032524|525687689|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
145775520|NCT02032524|525687690|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
145775521|NCT02032524|525687691|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
145775522|NCT02032524|525687692|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
145775523|NCT02032524|525687687|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
145775524|NCT02032524|525687688|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
145775525|NCT02032524|525687689|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
145775526|NCT02032524|525687690|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
145775527|NCT02032524|525687691|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
145775528|NCT02032524|525687692|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
145775529|NCT02032524|525687687|FG000|Period 2: LTS13769 Study|Other|0|||
145775530|NCT02032524|525687688|FG001|Period 2: LTS13769 Study|Other|0|||
145775531|NCT02032524|525687689|FG002|Period 2: LTS13769 Study|Other|0|||
145775532|NCT02032524|525687690|FG003|Period 2: LTS13769 Study|Other|0|||
145775533|NCT02032524|525687691|FG004|Period 2: LTS13769 Study|Other|0|||
145775534|NCT02032524|525687692|FG005|Period 2: LTS13769 Study|Other|1|||
145775535|NCT03567187|525687693|FG000|Overall Study|Lost to Follow-up|18|||
145775536|NCT03596645|525687696|FG000|Overall Study|Adverse Event|17|||
145775537|NCT03596645|525687697|FG001|Overall Study|Adverse Event|0|||
145775538|NCT03596645|525687696|FG000|Overall Study|Lack of Efficacy|8|||
145775539|NCT03596645|525687697|FG001|Overall Study|Lack of Efficacy|0|||
145775540|NCT03596645|525687696|FG000|Overall Study|Lost to Follow-up|1|||
145775541|NCT03596645|525687697|FG001|Overall Study|Lost to Follow-up|1|||
145775542|NCT03596645|525687696|FG000|Overall Study|Physician Decision|1|||
145775543|NCT03596645|525687697|FG001|Overall Study|Physician Decision|1|||
145775544|NCT03596645|525687696|FG000|Overall Study|Protocol Violation|1|||
145775545|NCT03596645|525687697|FG001|Overall Study|Protocol Violation|0|||
145775546|NCT03596645|525687696|FG000|Overall Study|Initiated Prohibited Medication|1|||
145775547|NCT03596645|525687697|FG001|Overall Study|Initiated Prohibited Medication|0|||
145775548|NCT03596645|525687696|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145775549|NCT03596645|525687697|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145775550|NCT03596645|525687696|FG000|Overall Study|No mucosal healing achieved|1|||
145775551|NCT03596645|525687697|FG001|Overall Study|No mucosal healing achieved|0|||
145775552|NCT03596645|525687696|FG000|Overall Study|Disease progression|1|||
145775553|NCT03596645|525687697|FG001|Overall Study|Disease progression|0|||
145775554|NCT03596645|525687696|FG000|Overall Study|Ongoing|37|||
145775555|NCT03596645|525687697|FG001|Overall Study|Ongoing|12|||
145775556|NCT03596645|525687696|FG000|Overall Study|Randomized but not treated|0|||
145775557|NCT03596645|525687697|FG001|Overall Study|Randomized but not treated|1|||
145775558|NCT04358458|525687698|FG000|Overall Study|Death|1|||
145775559|NCT04358458|525687699|FG001|Overall Study|Death|1|||
145775560|NCT04358458|525687700|FG002|Overall Study|Death|3|||
145775561|NCT04358458|525687701|FG003|Overall Study|Death|8|||
145775562|NCT04358458|525687702|FG004|Overall Study|Death|1|||
145775563|NCT04358458|525687703|FG005|Overall Study|Death|6|||
145775564|NCT04358458|525687704|FG006|Overall Study|Death|2|||
145775565|NCT04358458|525687705|FG007|Overall Study|Death|3|||
145775566|NCT04358458|525687698|FG000|Overall Study|Lost to Follow-up|0|||
145775567|NCT04358458|525687699|FG001|Overall Study|Lost to Follow-up|0|||
145775568|NCT04358458|525687700|FG002|Overall Study|Lost to Follow-up|0|||
145775569|NCT04358458|525687701|FG003|Overall Study|Lost to Follow-up|0|||
145775570|NCT04358458|525687702|FG004|Overall Study|Lost to Follow-up|0|||
145775571|NCT04358458|525687703|FG005|Overall Study|Lost to Follow-up|0|||
145775572|NCT04358458|525687704|FG006|Overall Study|Lost to Follow-up|0|||
145775573|NCT04358458|525687705|FG007|Overall Study|Lost to Follow-up|1|||
145775574|NCT04358458|525687698|FG000|Overall Study|Site is closing study participation|0|||
145775575|NCT04358458|525687699|FG001|Overall Study|Site is closing study participation|0|||
145775576|NCT04358458|525687700|FG002|Overall Study|Site is closing study participation|0|||
145775577|NCT04358458|525687701|FG003|Overall Study|Site is closing study participation|1|||
145775578|NCT04358458|525687702|FG004|Overall Study|Site is closing study participation|0|||
145775579|NCT04358458|525687703|FG005|Overall Study|Site is closing study participation|0|||
145775580|NCT04358458|525687704|FG006|Overall Study|Site is closing study participation|0|||
145775581|NCT04358458|525687705|FG007|Overall Study|Site is closing study participation|0|||
145775582|NCT04358458|525687698|FG000|Overall Study|Sponsor request|2|||
145775583|NCT04358458|525687699|FG001|Overall Study|Sponsor request|3|||
145775584|NCT04358458|525687700|FG002|Overall Study|Sponsor request|3|||
145775585|NCT04358458|525687701|FG003|Overall Study|Sponsor request|0|||
145775586|NCT04358458|525687702|FG004|Overall Study|Sponsor request|2|||
145775587|NCT04358458|525687703|FG005|Overall Study|Sponsor request|3|||
145775588|NCT04358458|525687704|FG006|Overall Study|Sponsor request|1|||
145775589|NCT04358458|525687705|FG007|Overall Study|Sponsor request|1|||
145775590|NCT04358458|525687698|FG000|Overall Study|Withdrawal by Subject|0|||
145775591|NCT04358458|525687699|FG001|Overall Study|Withdrawal by Subject|0|||
145775592|NCT04358458|525687700|FG002|Overall Study|Withdrawal by Subject|1|||
145775593|NCT04358458|525687701|FG003|Overall Study|Withdrawal by Subject|1|||
145775594|NCT04358458|525687702|FG004|Overall Study|Withdrawal by Subject|0|||
145775595|NCT04358458|525687703|FG005|Overall Study|Withdrawal by Subject|1|||
145775596|NCT04358458|525687704|FG006|Overall Study|Withdrawal by Subject|0|||
145535618|NCT01297920|524820786|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
145775597|NCT04358458|525687705|FG007|Overall Study|Withdrawal by Subject|1|||
145775598|NCT04513158|525687708|FG000|Overall Study|Screen Failure|1|||
145775599|NCT01348919|525689710|FG000|Overall Study|Adverse Event|3|||
145775600|NCT01348919|525689711|FG001|Overall Study|Adverse Event|1|||
145775601|NCT01348919|525689712|FG002|Overall Study|Adverse Event|0|||
145775602|NCT01348919|525689710|FG000|Overall Study|Withdrawal by Subject|0|||
145775603|NCT01348919|525689711|FG001|Overall Study|Withdrawal by Subject|1|||
145775604|NCT01348919|525689712|FG002|Overall Study|Withdrawal by Subject|0|||
145775605|NCT01348919|525689710|FG000|Overall Study|Disease progression|0|||
145775606|NCT01348919|525689711|FG001|Overall Study|Disease progression|1|||
145775607|NCT01348919|525689712|FG002|Overall Study|Disease progression|1|||
145775608|NCT00443560|525689713|FG000|Overall Study|No intrathecal dose|58|||
145775609|NCT00443560|525689714|FG001|Overall Study|No intrathecal dose|26|||
145775610|NCT00443560|525689713|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
145775611|NCT00443560|525689714|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
145775612|NCT02082184|525689715|FG000|Overall Study|Adverse Event|1|||
145775613|NCT02082184|525689716|FG001|Overall Study|Adverse Event|0|||
145775614|NCT02082184|525689715|FG000|Overall Study|Medical diagnosis|1|||
145775615|NCT02082184|525689716|FG001|Overall Study|Medical diagnosis|2|||
145775616|NCT02082184|525689715|FG000|Overall Study|Device associated symptoms|5|||
145775617|NCT02082184|525689716|FG001|Overall Study|Device associated symptoms|0|||
145535619|NCT01297920|524820787|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
145775618|NCT02082184|525689715|FG000|Overall Study|Withdrawal by Subject|3|||
145535620|NCT01297920|524820788|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
145775619|NCT02082184|525689716|FG001|Overall Study|Withdrawal by Subject|2|||
145775620|NCT02082184|525689715|FG000|Overall Study|Protocol Violation|0|||
145775621|NCT02082184|525689716|FG001|Overall Study|Protocol Violation|6|||
145775622|NCT02082184|525689715|FG000|Overall Study|Lost to Follow-up|0|||
145775623|NCT02082184|525689716|FG001|Overall Study|Lost to Follow-up|2|||
145775624|NCT02082184|525689715|FG000|Overall Study|Subject non-compliance|0|||
145775625|NCT02082184|525689716|FG001|Overall Study|Subject non-compliance|1|||
145775626|NCT02413255|525689721|FG000|Overall Study|Voluntary Withdrawal|0|||
145775627|NCT02413255|525689722|FG001|Overall Study|Voluntary Withdrawal|0|||
145775628|NCT02413255|525689723|FG002|Overall Study|Voluntary Withdrawal|0|||
145775629|NCT02413255|525689724|FG003|Overall Study|Voluntary Withdrawal|0|||
145775630|NCT02413255|525689725|FG004|Overall Study|Voluntary Withdrawal|0|||
145775631|NCT02413255|525689726|FG005|Overall Study|Voluntary Withdrawal|0|||
145775632|NCT02413255|525689727|FG006|Overall Study|Voluntary Withdrawal|0|||
145775633|NCT02413255|525689728|FG007|Overall Study|Voluntary Withdrawal|0|||
145775634|NCT02413255|525689729|FG008|Overall Study|Voluntary Withdrawal|0|||
145775635|NCT02413255|525689730|FG009|Overall Study|Voluntary Withdrawal|0|||
145775636|NCT02413255|525689731|FG010|Overall Study|Voluntary Withdrawal|0|||
145775637|NCT02413255|525689732|FG011|Overall Study|Voluntary Withdrawal|0|||
145775638|NCT02413255|525689733|FG012|Overall Study|Voluntary Withdrawal|0|||
145775639|NCT02413255|525689734|FG013|Overall Study|Voluntary Withdrawal|0|||
145775640|NCT02413255|525689735|FG014|Overall Study|Voluntary Withdrawal|1|||
145775641|NCT02413255|525689736|FG015|Overall Study|Voluntary Withdrawal|0|||
145775642|NCT02413255|525689737|FG016|Overall Study|Voluntary Withdrawal|0|||
145775643|NCT02413398|525689738|FG000|Overall Study|Lost to Follow-up|2|||
145775644|NCT02413398|525689739|FG001|Overall Study|Lost to Follow-up|4|||
145775645|NCT02413398|525689738|FG000|Overall Study|Withdrawal by Subject|1|||
145775646|NCT02413398|525689739|FG001|Overall Study|Withdrawal by Subject|1|||
145775647|NCT02413398|525689738|FG000|Overall Study|Other Eligibility criteria|1|||
145775648|NCT02413398|525689739|FG001|Overall Study|Other Eligibility criteria|2|||
145775649|NCT01494038|525689740|FG000|Overall Study|Protocol Violation|1|||
145775650|NCT01494038|525689741|FG001|Overall Study|Protocol Violation|1|||
145775651|NCT01494038|525689740|FG000|Overall Study|Lost to Follow-up|18|||
145775652|NCT01494038|525689741|FG001|Overall Study|Lost to Follow-up|20|||
145775653|NCT01494038|525689740|FG000|Overall Study|Withdrawal by Subject|44|||
145775654|NCT01494038|525689741|FG001|Overall Study|Withdrawal by Subject|34|||
145775655|NCT01494038|525689740|FG000|Overall Study|Not able to get to clinic|21|||
145775656|NCT01494038|525689741|FG001|Overall Study|Not able to get to clinic|15|||
145775657|NCT01494038|525689740|FG000|Overall Study|Not willing to adhere to reqs|2|||
145775658|NCT01494038|525689741|FG001|Overall Study|Not willing to adhere to reqs|9|||
145775659|NCT01494038|525689740|FG000|Overall Study|Death|2|||
145775660|NCT01494038|525689741|FG001|Overall Study|Death|4|||
145775661|NCT00537940|525689744|FG000|Overall Study|Adverse Event|20|||
145775662|NCT00537940|525689745|FG001|Overall Study|Adverse Event|19|||
145775663|NCT00537940|525689744|FG000|Overall Study|Lack of Efficacy|8|||
145775664|NCT00537940|525689745|FG001|Overall Study|Lack of Efficacy|16|||
145775665|NCT00537940|525689744|FG000|Overall Study|Lost to Follow-up|23|||
145775666|NCT00537940|525689745|FG001|Overall Study|Lost to Follow-up|29|||
145775667|NCT00537940|525689744|FG000|Overall Study|Withdrawal by Subject|113|||
145775668|NCT00537940|525689745|FG001|Overall Study|Withdrawal by Subject|95|||
145775669|NCT00537940|525689744|FG000|Overall Study|Protocol Violation|6|||
145775670|NCT00537940|525689745|FG001|Overall Study|Protocol Violation|4|||
145775671|NCT00537940|525689744|FG000|Overall Study|Pregnancy|1|||
145775672|NCT00537940|525689745|FG001|Overall Study|Pregnancy|1|||
145775673|NCT00537940|525689744|FG000|Overall Study|Study terminated by sponsor|2|||
145775674|NCT00537940|525689745|FG001|Overall Study|Study terminated by sponsor|3|||
145775675|NCT00537940|525689744|FG000|Overall Study|Other|10|||
145775676|NCT00537940|525689745|FG001|Overall Study|Other|12|||
145775677|NCT01978912|525689749|FG000|Overall Study|Adverse Event|0|||
145775678|NCT01978912|525689750|FG001|Overall Study|Adverse Event|1|||
145775679|NCT01978912|525689751|FG002|Overall Study|Adverse Event|0|||
145775680|NCT01978912|525689752|FG003|Overall Study|Adverse Event|0|||
145775681|NCT01978912|525689749|FG000|Overall Study|Lost to Follow-up|1|||
145775682|NCT01978912|525689750|FG001|Overall Study|Lost to Follow-up|1|||
145775683|NCT01978912|525689751|FG002|Overall Study|Lost to Follow-up|0|||
145279054|NCT03208933|523872842|FG000|Overall Study|Lost to Follow-up|2|||
145535621|NCT03212690|524820789|FG000|Overall Study|Protocol Violation|1|||
145535622|NCT02507973|524820791|FG000|Overall Study|Adverse Event|1|||
145535623|NCT00474760|524820792|FG000|Overall Study|Death|0|||
145279055|NCT03208933|523872842|FG000|Overall Study|Physician Decision|3|||
145279056|NCT03208933|523872842|FG000|Overall Study|Protocol Violation|1|||
145279057|NCT03333382|523872847|FG000|Overall Study|Lost to Follow-up|1|||
145279058|NCT03333382|523872848|FG001|Overall Study|Lost to Follow-up|0|||
145279059|NCT00550420|523872849|FG000|Overall Study|Adverse Event|28|||
145535624|NCT00474760|524820793|FG001|Overall Study|Death|0|||
145535625|NCT00474760|524820794|FG002|Overall Study|Death|0|||
145535626|NCT00474760|524820795|FG003|Overall Study|Death|0|||
145775684|NCT01978912|525689752|FG003|Overall Study|Lost to Follow-up|1|||
145775685|NCT01978912|525689749|FG000|Overall Study|Withdrawal by Subject|1|||
145775686|NCT01978912|525689750|FG001|Overall Study|Withdrawal by Subject|0|||
145775687|NCT01978912|525689751|FG002|Overall Study|Withdrawal by Subject|2|||
145775688|NCT01978912|525689752|FG003|Overall Study|Withdrawal by Subject|2|||
145775689|NCT01978912|525689749|FG000|Overall Study|Lumbar Surgery|1|||
145775690|NCT01978912|525689750|FG001|Overall Study|Lumbar Surgery|0|||
145279060|NCT00550420|523872849|FG000|Overall Study|Lost to Follow-up|8|||
145279061|NCT00550420|523872849|FG000|Overall Study|Protocol Violation|11|||
145279062|NCT00550420|523872849|FG000|Overall Study|Withdrawal by Subject|30|||
145535627|NCT00474760|524820796|FG004|Overall Study|Death|2|||
145535628|NCT00474760|524820797|FG005|Overall Study|Death|0|||
145775691|NCT01978912|525689751|FG002|Overall Study|Lumbar Surgery|1|||
145775692|NCT01978912|525689752|FG003|Overall Study|Lumbar Surgery|0|||
145775693|NCT01978912|525689749|FG000|Overall Study|Intradiscal Steroid Injection|0|||
145535629|NCT00474760|524820798|FG006|Overall Study|Death|0|||
145535630|NCT00474760|524820792|FG000|Overall Study|Adverse Event|0|||
145535631|NCT00474760|524820793|FG001|Overall Study|Adverse Event|0|||
145535632|NCT00474760|524820794|FG002|Overall Study|Adverse Event|0|||
145535633|NCT00474760|524820795|FG003|Overall Study|Adverse Event|0|||
145535634|NCT00474760|524820796|FG004|Overall Study|Adverse Event|1|||
145535635|NCT00474760|524820797|FG005|Overall Study|Adverse Event|7|||
145535636|NCT00474760|524820798|FG006|Overall Study|Adverse Event|0|||
145535637|NCT00474760|524820792|FG000|Overall Study|Laboratory abnormality|0|||
145535638|NCT00474760|524820793|FG001|Overall Study|Laboratory abnormality|0|||
145535639|NCT00474760|524820794|FG002|Overall Study|Laboratory abnormality|0|||
145535640|NCT00474760|524820795|FG003|Overall Study|Laboratory abnormality|0|||
145535641|NCT00474760|524820796|FG004|Overall Study|Laboratory abnormality|0|||
145535642|NCT00474760|524820797|FG005|Overall Study|Laboratory abnormality|1|||
145535643|NCT00474760|524820798|FG006|Overall Study|Laboratory abnormality|0|||
145535644|NCT00474760|524820792|FG000|Overall Study|Withdrawal by Subject|0|||
145535645|NCT00474760|524820793|FG001|Overall Study|Withdrawal by Subject|0|||
145535646|NCT00474760|524820794|FG002|Overall Study|Withdrawal by Subject|0|||
145535647|NCT00474760|524820795|FG003|Overall Study|Withdrawal by Subject|1|||
145535648|NCT00474760|524820796|FG004|Overall Study|Withdrawal by Subject|0|||
145535649|NCT00474760|524820797|FG005|Overall Study|Withdrawal by Subject|1|||
145535650|NCT00474760|524820798|FG006|Overall Study|Withdrawal by Subject|1|||
145535651|NCT00474760|524820792|FG000|Overall Study|Other|0|||
145535652|NCT00474760|524820793|FG001|Overall Study|Other|1|||
145535653|NCT00474760|524820794|FG002|Overall Study|Other|0|||
145535654|NCT00474760|524820795|FG003|Overall Study|Other|0|||
145535655|NCT00474760|524820796|FG004|Overall Study|Other|1|||
145535656|NCT00474760|524820797|FG005|Overall Study|Other|0|||
145535657|NCT00474760|524820798|FG006|Overall Study|Other|0|||
145535658|NCT00474760|524820792|FG000|Overall Study|Progressive disease|3|||
145535659|NCT00474760|524820793|FG001|Overall Study|Progressive disease|2|||
145535660|NCT00474760|524820794|FG002|Overall Study|Progressive disease|3|||
145535661|NCT00474760|524820795|FG003|Overall Study|Progressive disease|2|||
145535662|NCT00474760|524820796|FG004|Overall Study|Progressive disease|8|||
145535663|NCT00474760|524820797|FG005|Overall Study|Progressive disease|20|||
145535664|NCT00474760|524820798|FG006|Overall Study|Progressive disease|7|||
145535665|NCT00474760|524820792|FG000|Overall Study|Terminated by sponsor|0|||
145535666|NCT00474760|524820793|FG001|Overall Study|Terminated by sponsor|0|||
145535667|NCT00474760|524820794|FG002|Overall Study|Terminated by sponsor|0|||
145535668|NCT00474760|524820795|FG003|Overall Study|Terminated by sponsor|0|||
145535669|NCT00474760|524820796|FG004|Overall Study|Terminated by sponsor|0|||
145535670|NCT00474760|524820797|FG005|Overall Study|Terminated by sponsor|0|||
145535671|NCT00474760|524820798|FG006|Overall Study|Terminated by sponsor|2|||
145535672|NCT01927627|524820799|FG000|Overall Study|Adverse Event|3|||
145535673|NCT01927627|524820799|FG000|Overall Study|Lack of Efficacy|1|||
145535674|NCT01927627|524820799|FG000|Overall Study|Financial Concerns|1|||
145775694|NCT01978912|525689750|FG001|Overall Study|Intradiscal Steroid Injection|1|||
145775695|NCT01978912|525689751|FG002|Overall Study|Intradiscal Steroid Injection|0|||
145775696|NCT01978912|525689752|FG003|Overall Study|Intradiscal Steroid Injection|0|||
145775697|NCT00685178|525689757|FG000|Overall Study|Adverse Event|1|||
145775698|NCT00685178|525689758|FG001|Overall Study|Adverse Event|5|||
145775699|NCT00685178|525689759|FG002|Overall Study|Adverse Event|2|||
145775700|NCT00685178|525689760|FG003|Overall Study|Adverse Event|4|||
145775701|NCT00685178|525689757|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
145775702|NCT00685178|525689758|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
145775703|NCT00685178|525689759|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
145775704|NCT00685178|525689760|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
145775705|NCT00685178|525689757|FG000|Overall Study|voluntary study discharge|4|||
145775706|NCT00685178|525689758|FG001|Overall Study|voluntary study discharge|5|||
145535675|NCT00910273|524820802|FG000|Overall Study|Lack of Efficacy|6|||
145535676|NCT00910273|524820803|FG001|Overall Study|Lack of Efficacy|9|||
145535677|NCT00910273|524820802|FG000|Overall Study|Adverse Event|1|||
145775707|NCT00685178|525689759|FG002|Overall Study|voluntary study discharge|1|||
145535678|NCT00910273|524820803|FG001|Overall Study|Adverse Event|1|||
145608513|NCT00709059|525081079|FG000|Overall Study|Serious side effects|11|||
145775708|NCT00685178|525689760|FG003|Overall Study|voluntary study discharge|1|||
145775709|NCT00685178|525689757|FG000|Overall Study|incarcerated|1|||
145535679|NCT00910273|524820802|FG000|Overall Study|Withdrawal by Subject|1|||
145535680|NCT00910273|524820803|FG001|Overall Study|Withdrawal by Subject|0|||
145535681|NCT00910273|524820802|FG000|Overall Study|Discontinuation of study by sponsor|8|||
145535682|NCT00910273|524820803|FG001|Overall Study|Discontinuation of study by sponsor|2|||
145535683|NCT00910273|524820802|FG000|Overall Study|Protocol Violation|1|||
145535684|NCT00910273|524820803|FG001|Overall Study|Protocol Violation|0|||
145535685|NCT00910273|524820802|FG000|Overall Study|Lost to Follow-up|1|||
145535686|NCT00910273|524820803|FG001|Overall Study|Lost to Follow-up|1|||
145535687|NCT02155881|524820804|FG000|Overall Study|Withdrawal by Subject|0|||
145775710|NCT00685178|525689758|FG001|Overall Study|incarcerated|3|||
145775711|NCT00685178|525689759|FG002|Overall Study|incarcerated|7|||
145775712|NCT00685178|525689760|FG003|Overall Study|incarcerated|0|||
145535688|NCT02155881|524820805|FG001|Overall Study|Withdrawal by Subject|2|||
145775713|NCT00685178|525689757|FG000|Overall Study|administrative (disciplinary) discharge|0|||
145775714|NCT00685178|525689758|FG001|Overall Study|administrative (disciplinary) discharge|1|||
145775715|NCT00685178|525689759|FG002|Overall Study|administrative (disciplinary) discharge|0|||
145775716|NCT00685178|525689760|FG003|Overall Study|administrative (disciplinary) discharge|2|||
145775717|NCT00685178|525689757|FG000|Overall Study|Pregnancy|0|||
145775718|NCT00685178|525689758|FG001|Overall Study|Pregnancy|0|||
145775719|NCT00685178|525689759|FG002|Overall Study|Pregnancy|0|||
145775720|NCT00685178|525689760|FG003|Overall Study|Pregnancy|1|||
145775721|NCT00077623|525689766|FG000|Overall Study|Adverse Event|1|||
145775722|NCT00077623|525689767|FG001|Overall Study|Adverse Event|0|||
145775723|NCT00077623|525689768|FG002|Overall Study|Adverse Event|1|||
145775724|NCT00077623|525689766|FG000|Overall Study|Withdrawal by Subject|2|||
145775725|NCT00077623|525689767|FG001|Overall Study|Withdrawal by Subject|10|||
145775726|NCT00077623|525689768|FG002|Overall Study|Withdrawal by Subject|1|||
145775727|NCT00077623|525689766|FG000|Overall Study|Other-Non safety reason|18|||
145775728|NCT00077623|525689767|FG001|Overall Study|Other-Non safety reason|15|||
145775729|NCT00077623|525689768|FG002|Overall Study|Other-Non safety reason|19|||
145775730|NCT00077623|525689766|FG000|Overall Study|Insufficient therapeutic response|2|||
145775731|NCT00077623|525689767|FG001|Overall Study|Insufficient therapeutic response|0|||
145775732|NCT00077623|525689768|FG002|Overall Study|Insufficient therapeutic response|0|||
145775733|NCT00077623|525689766|FG000|Overall Study|Death|12|||
145775734|NCT00077623|525689767|FG001|Overall Study|Death|18|||
145535689|NCT02155881|524820804|FG000|Overall Study|Inappropriately randomized|2|||
145535690|NCT02155881|524820805|FG001|Overall Study|Inappropriately randomized|2|||
145535691|NCT01786148|524820806|FG000|Overall Study|Lost to Follow-up|21|||
145775735|NCT00077623|525689768|FG002|Overall Study|Death|11|||
145775736|NCT00077623|525689766|FG000|Overall Study|Failure to return|1|||
145775737|NCT00077623|525689767|FG001|Overall Study|Failure to return|0|||
145775738|NCT00077623|525689768|FG002|Overall Study|Failure to return|0|||
145775739|NCT01334125|525689769|FG000|Overall Study|Lost to Follow-up|3|||
145775740|NCT01334125|525689770|FG001|Overall Study|Lost to Follow-up|3|||
145775741|NCT02138110|525689774|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
145775742|NCT02138110|525689774|FG000|Overall Scaffold Implantation|Death|3|||
145775743|NCT00882713|525689776|FG000|Overall Study|Adverse Event|2|||
145775744|NCT00882713|525689776|FG000|Overall Study|Death|3|||
145775745|NCT00882713|525689776|FG000|Overall Study|Administrative reasons|4|||
145775746|NCT00882713|525689776|FG000|Overall Study|refused treatment/withdrew consent|4|||
145775747|NCT00882713|525689776|FG000|Overall Study|Blood transfusion|2|||
145775748|NCT00882713|525689776|FG000|Overall Study|Insufficient therapeutic response|3|||
145775749|NCT00882713|525689776|FG000|Overall Study|Failure to return|2|||
145775750|NCT00882713|525689776|FG000|Overall Study|Other - Reasons|2|||
145775751|NCT00401973|525689779|FG000|Overall Study|Adverse Event|2|||
145775752|NCT00401973|525689780|FG001|Overall Study|Adverse Event|8|||
145775753|NCT00401973|525689781|FG002|Overall Study|Adverse Event|4|||
145535692|NCT01786148|524820807|FG001|Overall Study|Lost to Follow-up|13|||
145535693|NCT01786148|524820806|FG000|Overall Study|Death|0|||
145535694|NCT01786148|524820807|FG001|Overall Study|Death|1|||
145535695|NCT01786148|524820806|FG000|Overall Study|Withdrawal by Subject|0|||
145535696|NCT01786148|524820807|FG001|Overall Study|Withdrawal by Subject|7|||
145535697|NCT01786148|524820806|FG000|Overall Study|Incarceration|1|||
145535698|NCT01786148|524820807|FG001|Overall Study|Incarceration|1|||
145535699|NCT03780543|524820808|FG000|Overall Study|Adverse Event|1|||
145535700|NCT03780543|524820809|FG001|Overall Study|Adverse Event|0|||
145535701|NCT03780543|524820810|FG002|Overall Study|Adverse Event|2|||
145535702|NCT03780543|524820808|FG000|Overall Study|Lost to Follow-up|2|||
145535703|NCT03780543|524820809|FG001|Overall Study|Lost to Follow-up|0|||
145535704|NCT03780543|524820810|FG002|Overall Study|Lost to Follow-up|1|||
145535705|NCT03780543|524820808|FG000|Overall Study|Study terminated by Sponsor|8|||
145608514|NCT01396317|525081080|FG000|Overall Study|Adverse Event|1|||
145775754|NCT00401973|525689779|FG000|Overall Study|Clinical Relapse|0|||
145775755|NCT00401973|525689780|FG001|Overall Study|Clinical Relapse|1|||
145775756|NCT00401973|525689781|FG002|Overall Study|Clinical Relapse|1|||
145775757|NCT00401973|525689779|FG000|Overall Study|Lack of Efficacy|0|||
145608515|NCT01396317|525081081|FG001|Overall Study|Adverse Event|0|||
145608516|NCT03315130|525081082|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
145775758|NCT00401973|525689780|FG001|Overall Study|Lack of Efficacy|0|||
145279063|NCT00550420|523872849|FG000|Overall Study|Still in study at termination|206|||
145535706|NCT03780543|524820809|FG001|Overall Study|Study terminated by Sponsor|7|||
145535707|NCT03780543|524820810|FG002|Overall Study|Study terminated by Sponsor|13|||
145535708|NCT03780543|524820808|FG000|Overall Study|Withdrawal by Subject|1|||
145535709|NCT03780543|524820809|FG001|Overall Study|Withdrawal by Subject|8|||
145535710|NCT03780543|524820810|FG002|Overall Study|Withdrawal by Subject|1|||
145775759|NCT00401973|525689781|FG002|Overall Study|Lack of Efficacy|3|||
145775760|NCT00401973|525689779|FG000|Overall Study|Lost to Follow-up|2|||
145608517|NCT03315130|525081083|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
145535711|NCT03780543|524820808|FG000|Overall Study|Noncompliance with study drug|1|||
145535712|NCT03780543|524820809|FG001|Overall Study|Noncompliance with study drug|0|||
145535713|NCT03780543|524820810|FG002|Overall Study|Noncompliance with study drug|0|||
145535714|NCT00066729|524820811|FG000|Overall Study|Lost to Follow-up|1|||
145535715|NCT00066729|524820811|FG000|Overall Study|Disease progression|1|||
145535716|NCT02215096|524820812|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
145535717|NCT02215096|524820813|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
145535718|NCT02215096|524820814|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
145535719|NCT02215096|524820815|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
145535720|NCT02215096|524820816|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
145535721|NCT02215096|524820812|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
145535722|NCT02215096|524820813|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
145535723|NCT02215096|524820814|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
145535724|NCT02215096|524820815|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
145535725|NCT02215096|524820816|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
145535726|NCT02215096|524820812|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
145535727|NCT02215096|524820813|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
145535728|NCT02215096|524820814|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
145535729|NCT02215096|524820815|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
145535730|NCT02215096|524820816|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
145775761|NCT00401973|525689780|FG001|Overall Study|Lost to Follow-up|2|||
145775762|NCT00401973|525689781|FG002|Overall Study|Lost to Follow-up|2|||
145775763|NCT00401973|525689779|FG000|Overall Study|Physician Decision|2|||
145775764|NCT00401973|525689780|FG001|Overall Study|Physician Decision|0|||
145775765|NCT00401973|525689781|FG002|Overall Study|Physician Decision|1|||
145775766|NCT00401973|525689779|FG000|Overall Study|Protocol Violation|1|||
145775767|NCT00401973|525689780|FG001|Overall Study|Protocol Violation|2|||
145775768|NCT00401973|525689781|FG002|Overall Study|Protocol Violation|3|||
145775769|NCT00401973|525689779|FG000|Overall Study|Sponsor Decision|0|||
145775770|NCT00401973|525689780|FG001|Overall Study|Sponsor Decision|1|||
145775771|NCT00401973|525689781|FG002|Overall Study|Sponsor Decision|0|||
145775772|NCT00401973|525689779|FG000|Overall Study|Withdrawal by Subject|4|||
145775773|NCT00401973|525689780|FG001|Overall Study|Withdrawal by Subject|12|||
145775774|NCT00401973|525689781|FG002|Overall Study|Withdrawal by Subject|9|||
145775775|NCT01408537|525689782|FG000|Overall Study|Withdrawal by Subject|2|||
145775776|NCT01408537|525689782|FG000|Overall Study|Protocol Violation|3|||
145775777|NCT01408537|525689782|FG000|Overall Study|Lost to Follow-up|3|||
145775778|NCT05523362|525689783|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
145775779|NCT05523362|525689783|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
145775780|NCT05523362|525689783|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
145775781|NCT05523362|525689783|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
145775782|NCT04075604|525689788|FG000|Overall Study|Adverse Event|0|||
145775783|NCT04075604|525689789|FG001|Overall Study|Adverse Event|0|||
145775784|NCT04075604|525689790|FG002|Overall Study|Adverse Event|3|||
145775785|NCT04075604|525689788|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145775786|NCT04075604|525689789|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145775787|NCT04075604|525689790|FG002|Overall Study|Participant request to discontinue study treatment|1|||
145775788|NCT04075604|525689788|FG000|Overall Study|Participant withdrew consent|0|||
145775789|NCT04075604|525689789|FG001|Overall Study|Participant withdrew consent|0|||
145775790|NCT04075604|525689790|FG002|Overall Study|Participant withdrew consent|1|||
145775791|NCT04075604|525689788|FG000|Overall Study|Other reasons|1|||
145535731|NCT02215096|524820812|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
145535732|NCT02215096|524820813|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
145535733|NCT02215096|524820814|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
145535734|NCT02215096|524820815|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
145535735|NCT02215096|524820816|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
145535736|NCT02349542|524820817|FG000|Overall Study|Withdrawal by Subject|5|||
145535737|NCT02840721|524820818|FG000|Treatment Period|Adverse Event|1|||
145535738|NCT02840721|524820818|FG000|Follow-Up|Lack of Efficacy|1|||
145535739|NCT02840721|524820818|FG000|Follow-Up|Withdrawal by Subject|4|||
145535740|NCT02840721|524820818|FG000|Follow-Up|Withdrawal of Consent|2|||
145535741|NCT01967173|524820819|FG000|Overall Study|Lost to Follow-up|5|||
145535742|NCT01967173|524820820|FG001|Overall Study|Lost to Follow-up|3|||
145535743|NCT01967173|524820821|FG002|Overall Study|Lost to Follow-up|2|||
145775792|NCT04075604|525689789|FG001|Overall Study|Other reasons|0|||
145775793|NCT04075604|525689790|FG002|Overall Study|Other reasons|0|||
145775794|NCT04075604|525689788|FG000|Overall Study|Disease progression|0|||
145535744|NCT01967173|524820822|FG003|Overall Study|Lost to Follow-up|4|||
145535745|NCT01967173|524820823|FG004|Overall Study|Lost to Follow-up|8|||
145535746|NCT01967173|524820824|FG005|Overall Study|Lost to Follow-up|12|||
145535747|NCT01967173|524820825|FG006|Overall Study|Lost to Follow-up|6|||
145775795|NCT04075604|525689789|FG001|Overall Study|Disease progression|1|||
145775796|NCT04075604|525689790|FG002|Overall Study|Disease progression|0|||
145535748|NCT01967173|524820826|FG007|Overall Study|Lost to Follow-up|8|||
145535749|NCT01967173|524820819|FG000|Overall Study|Physician Decision|2|||
145535750|NCT01967173|524820820|FG001|Overall Study|Physician Decision|0|||
145535751|NCT01967173|524820821|FG002|Overall Study|Physician Decision|2|||
145535752|NCT01967173|524820822|FG003|Overall Study|Physician Decision|1|||
145535753|NCT01967173|524820823|FG004|Overall Study|Physician Decision|1|||
145535754|NCT01967173|524820824|FG005|Overall Study|Physician Decision|1|||
145535755|NCT01967173|524820825|FG006|Overall Study|Physician Decision|1|||
145535756|NCT01967173|524820826|FG007|Overall Study|Physician Decision|0|||
145535757|NCT01967173|524820819|FG000|Overall Study|Lack of Efficacy|2|||
145535758|NCT01967173|524820820|FG001|Overall Study|Lack of Efficacy|0|||
145535759|NCT01967173|524820821|FG002|Overall Study|Lack of Efficacy|2|||
145535760|NCT01967173|524820822|FG003|Overall Study|Lack of Efficacy|2|||
145535761|NCT01967173|524820823|FG004|Overall Study|Lack of Efficacy|0|||
145535762|NCT01967173|524820824|FG005|Overall Study|Lack of Efficacy|1|||
145535763|NCT01967173|524820825|FG006|Overall Study|Lack of Efficacy|0|||
145535764|NCT01967173|524820826|FG007|Overall Study|Lack of Efficacy|2|||
145535765|NCT01967173|524820819|FG000|Overall Study|Pregnancy|0|||
145535766|NCT01967173|524820820|FG001|Overall Study|Pregnancy|0|||
145535767|NCT01967173|524820821|FG002|Overall Study|Pregnancy|0|||
145535768|NCT01967173|524820822|FG003|Overall Study|Pregnancy|0|||
145535769|NCT01967173|524820823|FG004|Overall Study|Pregnancy|0|||
145535770|NCT01967173|524820824|FG005|Overall Study|Pregnancy|0|||
145535771|NCT01967173|524820825|FG006|Overall Study|Pregnancy|1|||
145535772|NCT01967173|524820826|FG007|Overall Study|Pregnancy|1|||
145535773|NCT01967173|524820819|FG000|Overall Study|Adverse Event|0|||
145535774|NCT01967173|524820820|FG001|Overall Study|Adverse Event|0|||
145535775|NCT01967173|524820821|FG002|Overall Study|Adverse Event|0|||
145535776|NCT01967173|524820822|FG003|Overall Study|Adverse Event|0|||
145535777|NCT01967173|524820823|FG004|Overall Study|Adverse Event|0|||
145608518|NCT03315130|525081084|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
145608519|NCT03315130|525081085|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
145775797|NCT04075604|525689788|FG000|Overall Study|Study drug toxicity|0|||
145775798|NCT04075604|525689789|FG001|Overall Study|Study drug toxicity|5|||
145775799|NCT04075604|525689790|FG002|Overall Study|Study drug toxicity|1|||
145775800|NCT02760602|525689791|FG000|Overall Study|Withdrawal by Subject|1|||
145775801|NCT02760602|525689792|FG001|Overall Study|Withdrawal by Subject|0|||
145775802|NCT02760602|525689791|FG000|Overall Study|Terminated by sponsor|12|||
145775803|NCT02760602|525689792|FG001|Overall Study|Terminated by sponsor|13|||
145775804|NCT05299892|525689797|FG000|Overall Study|Withdrawal by Subject|2|||
145775805|NCT00149214|525689802|FG000|Overall Study|Adverse Event|12|||
145775806|NCT00149214|525689803|FG001|Overall Study|Adverse Event|9|||
145535778|NCT01967173|524820824|FG005|Overall Study|Adverse Event|0|||
145775807|NCT00149214|525689802|FG000|Overall Study|Withdrawal by Subject|4|||
145775808|NCT00149214|525689803|FG001|Overall Study|Withdrawal by Subject|1|||
145775809|NCT00149214|525689802|FG000|Overall Study|Physician Decision|3|||
145775810|NCT00149214|525689803|FG001|Overall Study|Physician Decision|3|||
145775811|NCT00149214|525689802|FG000|Overall Study|Sponsor Decision|0|||
145535779|NCT01967173|524820825|FG006|Overall Study|Adverse Event|0|||
145535780|NCT01967173|524820826|FG007|Overall Study|Adverse Event|1|||
145535781|NCT01967173|524820819|FG000|Overall Study|Withdrawal by Subject|15|||
145535782|NCT01967173|524820820|FG001|Overall Study|Withdrawal by Subject|14|||
145535783|NCT01967173|524820821|FG002|Overall Study|Withdrawal by Subject|10|||
145535784|NCT01967173|524820822|FG003|Overall Study|Withdrawal by Subject|7|||
145535785|NCT01967173|524820823|FG004|Overall Study|Withdrawal by Subject|8|||
145535786|NCT01967173|524820824|FG005|Overall Study|Withdrawal by Subject|9|||
145775812|NCT00149214|525689803|FG001|Overall Study|Sponsor Decision|1|||
145775813|NCT00149214|525689802|FG000|Overall Study|Progressive Disease|7|||
145775814|NCT00149214|525689803|FG001|Overall Study|Progressive Disease|3|||
145775815|NCT00756002|525689804|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
145775816|NCT00756002|525689805|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
145775817|NCT00756002|525689804|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145775818|NCT00756002|525689805|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145775819|NCT00756002|525689804|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
145775820|NCT00756002|525689805|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
145775821|NCT00756002|525689804|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
145775822|NCT00756002|525689805|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
145535787|NCT01967173|524820825|FG006|Overall Study|Withdrawal by Subject|10|||
145535788|NCT01967173|524820826|FG007|Overall Study|Withdrawal by Subject|12|||
145535789|NCT03540030|524820830|FG000|Overall Study|Withdrawal by Subject|2|||
145535790|NCT03540030|524820831|FG001|Overall Study|Withdrawal by Subject|1|||
145535791|NCT03540030|524820830|FG000|Overall Study|screen fail|7|||
145535792|NCT03540030|524820831|FG001|Overall Study|screen fail|1|||
145775823|NCT00756002|525689804|FG000|Double-Blind Treatment Period|Other|2|||
145403660|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145403661|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
145535793|NCT03540030|524820830|FG000|Overall Study|never had surgery after signing consent|9|||
145535794|NCT03540030|524820831|FG001|Overall Study|never had surgery after signing consent|1|||
145535795|NCT03021304|524820832|FG000|Overall Study|Lack of Efficacy|1|||
145535796|NCT04122534|524820833|FG000|Overall Study|Lost to Follow-up|4|||
145775824|NCT00756002|525689805|FG001|Double-Blind Treatment Period|Other|2|||
145775825|NCT04329923|525689809|FG000|Overall Study|Withdrawal by Subject|1|||
145775826|NCT04329923|525689810|FG001|Overall Study|Withdrawal by Subject|4|||
145775827|NCT04329923|525689811|FG002|Overall Study|Withdrawal by Subject|1|||
145775828|NCT04329923|525689812|FG003|Overall Study|Withdrawal by Subject|1|||
145775829|NCT04329923|525689813|FG004|Overall Study|Withdrawal by Subject|1|||
145775830|NCT04329923|525689814|FG005|Overall Study|Withdrawal by Subject|1|||
145775831|NCT04329923|525689809|FG000|Overall Study|early termination of study|0|||
145775832|NCT04329923|525689810|FG001|Overall Study|early termination of study|0|||
145775833|NCT04329923|525689811|FG002|Overall Study|early termination of study|0|||
145775834|NCT04329923|525689812|FG003|Overall Study|early termination of study|0|||
145775835|NCT04329923|525689813|FG004|Overall Study|early termination of study|1|||
145775836|NCT04329923|525689814|FG005|Overall Study|early termination of study|2|||
145775837|NCT04329923|525689809|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
145775838|NCT04329923|525689810|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
145775839|NCT04329923|525689811|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
145775840|NCT04329923|525689812|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
145775841|NCT04329923|525689813|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
145775842|NCT04329923|525689814|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
145775843|NCT01260181|525689818|FG000|Overall Study|Decision of Investigator|1|||
145775844|NCT01588197|525689821|FG000|Overall Study|Lack of Efficacy|0|||
145775845|NCT01588197|525689822|FG001|Overall Study|Lack of Efficacy|1|||
145775846|NCT01588197|525689821|FG000|Overall Study|No MRI|1|||
145775847|NCT01588197|525689822|FG001|Overall Study|No MRI|0|||
145775848|NCT03351244|525689823|FG000|Overall Study|Adverse Event|7|||
145775849|NCT03351244|525689824|FG001|Overall Study|Adverse Event|11|||
145775850|NCT03351244|525689825|FG002|Overall Study|Adverse Event|12|||
145775851|NCT03351244|525689823|FG000|Overall Study|Investigator's decision|0|||
145775852|NCT03351244|525689824|FG001|Overall Study|Investigator's decision|0|||
145775853|NCT03351244|525689825|FG002|Overall Study|Investigator's decision|2|||
145775854|NCT03351244|525689823|FG000|Overall Study|System error|0|||
145775855|NCT03351244|525689824|FG001|Overall Study|System error|0|||
145775856|NCT03351244|525689825|FG002|Overall Study|System error|2|||
145775857|NCT03351244|525689823|FG000|Overall Study|COVID-19 restrictions|3|||
145775858|NCT03351244|525689824|FG001|Overall Study|COVID-19 restrictions|0|||
145775859|NCT03351244|525689825|FG002|Overall Study|COVID-19 restrictions|1|||
145775860|NCT03351244|525689823|FG000|Overall Study|Non-compliance|2|||
145775861|NCT03351244|525689824|FG001|Overall Study|Non-compliance|5|||
145775862|NCT03351244|525689825|FG002|Overall Study|Non-compliance|0|||
145775863|NCT03351244|525689823|FG000|Overall Study|Withdrawal by Subject|11|||
145775864|NCT03351244|525689824|FG001|Overall Study|Withdrawal by Subject|16|||
145775865|NCT03351244|525689825|FG002|Overall Study|Withdrawal by Subject|13|||
145775866|NCT03351244|525689823|FG000|Overall Study|Lost to Follow-up|2|||
145775867|NCT03351244|525689824|FG001|Overall Study|Lost to Follow-up|6|||
145775868|NCT03351244|525689825|FG002|Overall Study|Lost to Follow-up|4|||
145775869|NCT03351244|525689823|FG000|Overall Study|Protocol Violation|2|||
145775870|NCT03351244|525689824|FG001|Overall Study|Protocol Violation|2|||
145775871|NCT03351244|525689825|FG002|Overall Study|Protocol Violation|0|||
145775872|NCT01844076|525689828|FG000|Overall Study|Adverse Event|1|||
145775873|NCT01844076|525689829|FG001|Overall Study|Adverse Event|0|||
145775874|NCT01844076|525689830|FG002|Overall Study|Adverse Event|0|||
145775875|NCT01844076|525689831|FG003|Overall Study|Adverse Event|0|||
145775876|NCT01844076|525689828|FG000|Overall Study|Withdrawal by Subject|1|||
145775877|NCT01844076|525689829|FG001|Overall Study|Withdrawal by Subject|0|||
145775878|NCT01844076|525689830|FG002|Overall Study|Withdrawal by Subject|0|||
145775879|NCT01844076|525689831|FG003|Overall Study|Withdrawal by Subject|0|||
145775880|NCT01925703|525689841|FG000|Overall Study|Physician Decision|1|||
145775881|NCT01925703|525689841|FG000|Overall Study|Lost to Follow-up|2|||
145775882|NCT01925703|525689841|FG000|Overall Study|Discharge prior to full iron repletion|1|||
145775883|NCT00091793|525689842|FG000|Overall Study|Adverse Event|1|||
145775884|NCT00091793|525689843|FG001|Overall Study|Adverse Event|2|||
145775885|NCT00091793|525689842|FG000|Overall Study|Withdrawal by Subject|10|||
145775886|NCT00091793|525689843|FG001|Overall Study|Withdrawal by Subject|15|||
145775887|NCT00091793|525689842|FG000|Overall Study|Ineligibility determined|2|||
145775888|NCT00091793|525689843|FG001|Overall Study|Ineligibility determined|0|||
145775889|NCT00091793|525689842|FG000|Overall Study|Lost to Follow-up|7|||
145775890|NCT00091793|525689843|FG001|Overall Study|Lost to Follow-up|5|||
145775891|NCT00091793|525689842|FG000|Overall Study|Noncompliance|2|||
145775892|NCT00091793|525689843|FG001|Overall Study|Noncompliance|0|||
145775893|NCT00091793|525689842|FG000|Overall Study|Other|2|||
145775894|NCT00091793|525689843|FG001|Overall Study|Other|0|||
145775895|NCT03794986|525689845|FG000|Overall Study|0 Sessions Attended|34|||
145775896|NCT03794986|525689846|FG001|Overall Study|0 Sessions Attended|37|||
145775897|NCT03794986|525689845|FG000|Overall Study|Withdrawal by Subject|4|||
145775898|NCT03794986|525689846|FG001|Overall Study|Withdrawal by Subject|6|||
145775899|NCT03794986|525689845|FG000|Overall Study|Protocol Violation|1|||
145775900|NCT03794986|525689846|FG001|Overall Study|Protocol Violation|0|||
145775901|NCT03114969|525689847|FG000|Overall Study|Lost to Follow-up|0|||
145775902|NCT03114969|525689848|FG001|Overall Study|Lost to Follow-up|0|||
145775903|NCT03114969|525689849|FG002|Overall Study|Lost to Follow-up|3|||
145775904|NCT03114969|525689850|FG003|Overall Study|Lost to Follow-up|2|||
145775905|NCT03114969|525689851|FG004|Overall Study|Lost to Follow-up|0|||
145775906|NCT03114969|525689852|FG005|Overall Study|Lost to Follow-up|0|||
145775907|NCT03114969|525689853|FG006|Overall Study|Lost to Follow-up|0|||
145775908|NCT03114969|525689854|FG007|Overall Study|Lost to Follow-up|0|||
145775909|NCT03114969|525689855|FG008|Overall Study|Lost to Follow-up|0|||
145775910|NCT03114969|525689847|FG000|Overall Study|Adverse Event|0|||
145775911|NCT03114969|525689848|FG001|Overall Study|Adverse Event|0|||
145775912|NCT03114969|525689849|FG002|Overall Study|Adverse Event|1|||
145775913|NCT03114969|525689850|FG003|Overall Study|Adverse Event|0|||
145775914|NCT03114969|525689851|FG004|Overall Study|Adverse Event|0|||
145775915|NCT03114969|525689852|FG005|Overall Study|Adverse Event|1|||
145775916|NCT03114969|525689853|FG006|Overall Study|Adverse Event|1|||
145775917|NCT03114969|525689854|FG007|Overall Study|Adverse Event|0|||
145775918|NCT03114969|525689855|FG008|Overall Study|Adverse Event|2|||
145775919|NCT00624338|525689860|FG000|Overall Study|Adverse Event|14|||
145775920|NCT00624338|525689861|FG001|Overall Study|Adverse Event|14|||
145775921|NCT00624338|525689862|FG002|Overall Study|Adverse Event|18|||
145775922|NCT00624338|525689860|FG000|Overall Study|Lost to Follow-up|1|||
145775923|NCT00624338|525689861|FG001|Overall Study|Lost to Follow-up|0|||
145775924|NCT00624338|525689862|FG002|Overall Study|Lost to Follow-up|0|||
145775925|NCT00624338|525689860|FG000|Overall Study|Lack of Efficacy|11|||
145775926|NCT00624338|525689861|FG001|Overall Study|Lack of Efficacy|3|||
145775927|NCT00624338|525689862|FG002|Overall Study|Lack of Efficacy|14|||
145775928|NCT00624338|525689860|FG000|Overall Study|Protocol Violation|3|||
145775929|NCT00624338|525689861|FG001|Overall Study|Protocol Violation|3|||
145775930|NCT00624338|525689862|FG002|Overall Study|Protocol Violation|2|||
145775931|NCT00624338|525689860|FG000|Overall Study|Death|0|||
145775932|NCT00624338|525689861|FG001|Overall Study|Death|2|||
145775933|NCT00624338|525689862|FG002|Overall Study|Death|0|||
145775934|NCT00624338|525689860|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
145775935|NCT00624338|525689861|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
145775936|NCT00624338|525689862|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
145775937|NCT00624338|525689860|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
145775938|NCT00624338|525689861|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
145775939|NCT00624338|525689862|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
145775940|NCT00624338|525689860|FG000|Overall Study|Other|15|||
145775941|NCT00624338|525689861|FG001|Overall Study|Other|5|||
145775942|NCT00624338|525689862|FG002|Overall Study|Other|9|||
145775943|NCT00624338|525689860|FG000|Overall Study|Randomized but not treated|2|||
145775944|NCT00624338|525689861|FG001|Overall Study|Randomized but not treated|1|||
145775945|NCT00624338|525689862|FG002|Overall Study|Randomized but not treated|3|||
145775946|NCT05897853|525689863|FG000|Overall Study|Lost to Follow-up|2|||
145775947|NCT05897853|525689864|FG001|Overall Study|Lost to Follow-up|0|||
145775948|NCT05897853|525689863|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
145775949|NCT05897853|525689864|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
145775950|NCT01476787|525689868|FG000|Treatment|Progression|64|||
145775951|NCT01476787|525689869|FG001|Treatment|Progression|71|||
145775952|NCT01476787|525689868|FG000|Treatment|Toxicity|44|||
145775953|NCT01476787|525689869|FG001|Treatment|Toxicity|16|||
145775954|NCT01476787|525689868|FG000|Treatment|Death|0|||
145775955|NCT01476787|525689869|FG001|Treatment|Death|1|||
145775956|NCT01476787|525689868|FG000|Treatment|Withdrawal by Subject|3|||
145775957|NCT01476787|525689869|FG001|Treatment|Withdrawal by Subject|14|||
145775958|NCT01476787|525689868|FG000|Treatment|Major protocol violation|1|||
145775959|NCT01476787|525689869|FG001|Treatment|Major protocol violation|6|||
145775960|NCT01476787|525689868|FG000|Treatment|Other reasons|10|||
145775961|NCT01476787|525689869|FG001|Treatment|Other reasons|22|||
145775962|NCT01476787|525689868|FG000|Treatment|Concurrent illness|12|||
145775963|NCT01476787|525689869|FG001|Treatment|Concurrent illness|9|||
145775964|NCT01476787|525689868|FG000|Treatment|Insufficient response|15|||
145775965|NCT01476787|525689869|FG001|Treatment|Insufficient response|3|||
145775966|NCT01476787|525689868|FG000|Treatment|Voluntary treatment discontinuation|8|||
145775967|NCT01476787|525689869|FG001|Treatment|Voluntary treatment discontinuation|4|||
145775968|NCT02782715|525689871|FG000|Overall Study|Withdrawal by Subject|1|||
145775969|NCT04458857|525689872|FG000|Overall Study|Adverse Event|0|||
145775970|NCT04458857|525689873|FG001|Overall Study|Adverse Event|1|||
145775971|NCT04458857|525689874|FG002|Overall Study|Adverse Event|0|||
145775972|NCT04458857|525689872|FG000|Overall Study|Withdrawal by Subject|2|||
145775973|NCT04458857|525689873|FG001|Overall Study|Withdrawal by Subject|0|||
145775974|NCT04458857|525689874|FG002|Overall Study|Withdrawal by Subject|0|||
145775975|NCT04458857|525689872|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145775976|NCT04458857|525689873|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145775977|NCT04458857|525689874|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145775978|NCT04458857|525689872|FG000|Overall Study|Non-compliance with study drug|0|||
145775979|NCT04458857|525689873|FG001|Overall Study|Non-compliance with study drug|1|||
145775980|NCT04458857|525689874|FG002|Overall Study|Non-compliance with study drug|0|||
145775981|NCT04458857|525689872|FG000|Overall Study|Lost to Follow-up|4|||
145775982|NCT04458857|525689873|FG001|Overall Study|Lost to Follow-up|1|||
145775983|NCT04458857|525689874|FG002|Overall Study|Lost to Follow-up|0|||
145775984|NCT04800315|525689883|FG000|Randomization|Did not receive study treatment|1|||
145775985|NCT04800315|525689884|FG001|Randomization|Did not receive study treatment|0|||
145775986|NCT04800315|525689885|FG002|Randomization|Did not receive study treatment|0|||
145775987|NCT04800315|525689886|FG003|Randomization|Did not receive study treatment|0|||
145775988|NCT04800315|525689883|FG000|Treatment Period|Adverse Event|4|||
145775989|NCT04800315|525689884|FG001|Treatment Period|Adverse Event|2|||
145775990|NCT04800315|525689885|FG002|Treatment Period|Adverse Event|1|||
145775991|NCT04800315|525689886|FG003|Treatment Period|Adverse Event|2|||
145775992|NCT04800315|525689883|FG000|Treatment Period|Lack of Efficacy|1|||
145775993|NCT04800315|525689884|FG001|Treatment Period|Lack of Efficacy|0|||
145775994|NCT04800315|525689885|FG002|Treatment Period|Lack of Efficacy|0|||
145775995|NCT04800315|525689886|FG003|Treatment Period|Lack of Efficacy|3|||
145775996|NCT04800315|525689883|FG000|Treatment Period|Lost to Follow-up|0|||
145775997|NCT04800315|525689884|FG001|Treatment Period|Lost to Follow-up|1|||
145775998|NCT04800315|525689885|FG002|Treatment Period|Lost to Follow-up|2|||
145775999|NCT04800315|525689886|FG003|Treatment Period|Lost to Follow-up|2|||
145776000|NCT04800315|525689883|FG000|Treatment Period|Withdrawal by participant|0|||
145776001|NCT04800315|525689884|FG001|Treatment Period|Withdrawal by participant|0|||
145776002|NCT04800315|525689885|FG002|Treatment Period|Withdrawal by participant|0|||
145776003|NCT04800315|525689886|FG003|Treatment Period|Withdrawal by participant|4|||
145776004|NCT04800315|525689883|FG000|Treatment Period|Other Reasons|0|||
145776005|NCT04800315|525689884|FG001|Treatment Period|Other Reasons|2|||
145776006|NCT04800315|525689885|FG002|Treatment Period|Other Reasons|0|||
145776007|NCT04800315|525689886|FG003|Treatment Period|Other Reasons|1|||
145776008|NCT00753922|525689887|FG000|Overall Study|Lost to Follow-up|155|||
145776009|NCT00753922|525689888|FG001|Overall Study|Lost to Follow-up|24|||
145776010|NCT00753922|525689889|FG002|Overall Study|Lost to Follow-up|28|||
145776011|NCT00753922|525689890|FG003|Overall Study|Lost to Follow-up|5|||
145776012|NCT00753922|525689887|FG000|Overall Study|Withdrawal by Subject|9|||
145776013|NCT00753922|525689888|FG001|Overall Study|Withdrawal by Subject|11|||
145776014|NCT00753922|525689889|FG002|Overall Study|Withdrawal by Subject|4|||
145776015|NCT00753922|525689890|FG003|Overall Study|Withdrawal by Subject|2|||
145776016|NCT00753922|525689887|FG000|Overall Study|Patient Non-compliance|55|||
145776017|NCT00753922|525689888|FG001|Overall Study|Patient Non-compliance|22|||
145776018|NCT00753922|525689889|FG002|Overall Study|Patient Non-compliance|14|||
145776019|NCT00753922|525689890|FG003|Overall Study|Patient Non-compliance|11|||
145776020|NCT00753922|525689887|FG000|Overall Study|Patients Not Completing Visit|11|||
145776021|NCT00753922|525689888|FG001|Overall Study|Patients Not Completing Visit|0|||
145776022|NCT00753922|525689889|FG002|Overall Study|Patients Not Completing Visit|1|||
145776023|NCT00753922|525689890|FG003|Overall Study|Patients Not Completing Visit|0|||
145776024|NCT00753922|525689887|FG000|Overall Study|Death|2|||
145776025|NCT00753922|525689888|FG001|Overall Study|Death|23|||
145776026|NCT00753922|525689889|FG002|Overall Study|Death|2|||
145776027|NCT00753922|525689890|FG003|Overall Study|Death|1|||
145776028|NCT00753922|525689887|FG000|Overall Study|Discontinuation Due to Explantation|14|||
145776029|NCT00753922|525689888|FG001|Overall Study|Discontinuation Due to Explantation|14|||
145776030|NCT00753922|525689889|FG002|Overall Study|Discontinuation Due to Explantation|14|||
145776031|NCT00753922|525689890|FG003|Overall Study|Discontinuation Due to Explantation|4|||
145776032|NCT01662999|525689891|FG000|Period 3|Withdrawal by Subject|0|||
145776033|NCT01662999|525689892|FG001|Period 3|Withdrawal by Subject|1|||
145776034|NCT01662999|525689893|FG002|Period 3|Withdrawal by Subject|0|||
145776035|NCT01662999|525689894|FG003|Period 3|Withdrawal by Subject|0|||
145776036|NCT01662999|525689895|FG004|Period 3|Withdrawal by Subject|0|||
145776037|NCT01662999|525689896|FG005|Period 3|Withdrawal by Subject|0|||
145776038|NCT00957372|525689899|FG000|PART I|Lost to Follow-up|0|||
145776039|NCT00957372|525689900|FG001|PART I|Lost to Follow-up|0|||
145776040|NCT00957372|525689901|FG002|PART I|Lost to Follow-up|1|||
145776041|NCT00957372|525689902|FG003|PART I|Lost to Follow-up|0|||
145776042|NCT00957372|525689899|FG000|PART II|Withdrawal by Subject|0|||
145776043|NCT00957372|525689900|FG001|PART II|Withdrawal by Subject|0|||
145776044|NCT00957372|525689901|FG002|PART II|Withdrawal by Subject|0|||
145776045|NCT00957372|525689902|FG003|PART II|Withdrawal by Subject|8|||
145776046|NCT00957372|525689899|FG000|PART II|Physician Decision|0|||
145776047|NCT00957372|525689900|FG001|PART II|Physician Decision|0|||
145403662|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
145535797|NCT02128932|524820842|FG000|Overall Study|Withdrawal by Subject|11|||
145535798|NCT02128932|524820843|FG001|Overall Study|Withdrawal by Subject|7|||
145535799|NCT02128932|524820844|FG002|Overall Study|Withdrawal by Subject|8|||
145776048|NCT00957372|525689901|FG002|PART II|Physician Decision|0|||
145776049|NCT00957372|525689902|FG003|PART II|Physician Decision|1|||
145776050|NCT00957372|525689899|FG000|PART II|Pregnancy|0|||
145776051|NCT00957372|525689900|FG001|PART II|Pregnancy|0|||
145776052|NCT00957372|525689901|FG002|PART II|Pregnancy|0|||
145776053|NCT00957372|525689902|FG003|PART II|Pregnancy|1|||
145776054|NCT00957372|525689899|FG000|PART II|Not Know|0|||
145776055|NCT00957372|525689900|FG001|PART II|Not Know|0|||
145776056|NCT00957372|525689901|FG002|PART II|Not Know|0|||
145535800|NCT02128932|524820842|FG000|Overall Study|Death|2|||
145535801|NCT02128932|524820843|FG001|Overall Study|Death|0|||
145535802|NCT02128932|524820844|FG002|Overall Study|Death|2|||
145535803|NCT02128932|524820842|FG000|Overall Study|Lost to Follow-up|2|||
145535804|NCT02128932|524820843|FG001|Overall Study|Lost to Follow-up|1|||
145535805|NCT02128932|524820844|FG002|Overall Study|Lost to Follow-up|1|||
145535806|NCT02128932|524820842|FG000|Overall Study|No reason for withdrawal|12|||
145535807|NCT02128932|524820843|FG001|Overall Study|No reason for withdrawal|11|||
145535808|NCT02128932|524820844|FG002|Overall Study|No reason for withdrawal|7|||
145535809|NCT02020577|524820845|FG000|Overall Study|Progressive disease|3|||
145535810|NCT02020577|524820846|FG001|Overall Study|Progressive disease|38|||
145535811|NCT02020577|524820845|FG000|Overall Study|Other AE or clinical progression|0|||
145535812|NCT02020577|524820846|FG001|Overall Study|Other AE or clinical progression|15|||
145535813|NCT02020577|524820845|FG000|Overall Study|Withdrawal by Subject|0|||
145535814|NCT02020577|524820846|FG001|Overall Study|Withdrawal by Subject|1|||
145535815|NCT02020577|524820845|FG000|Overall Study|Other than stated above|0|||
145535816|NCT02020577|524820846|FG001|Overall Study|Other than stated above|1|||
145535817|NCT03113916|524820847|FG000|Overall Study|Withdrawal by Subject|9|||
145535818|NCT03113916|524820848|FG001|Overall Study|Withdrawal by Subject|7|||
145535819|NCT03113916|524820847|FG000|Overall Study|Pregnancy|1|||
145535820|NCT03113916|524820848|FG001|Overall Study|Pregnancy|3|||
145535821|NCT03113916|524820847|FG000|Overall Study|Lost to Follow-up|1|||
145535822|NCT03113916|524820848|FG001|Overall Study|Lost to Follow-up|2|||
145535823|NCT02663908|524820849|FG000|Overall Study|Withdrawal by Subject|8|||
145535824|NCT02663908|524820850|FG001|Overall Study|Withdrawal by Subject|5|||
145535825|NCT02663908|524820849|FG000|Overall Study|Lost to Follow-up|1|||
145535826|NCT02663908|524820850|FG001|Overall Study|Lost to Follow-up|5|||
145535827|NCT02663908|524820849|FG000|Overall Study|Adverse Event|13|||
145535828|NCT02663908|524820850|FG001|Overall Study|Adverse Event|11|||
145535829|NCT02663908|524820849|FG000|Overall Study|Protocol Violation|1|||
145535830|NCT02663908|524820850|FG001|Overall Study|Protocol Violation|2|||
145535831|NCT02663908|524820849|FG000|Overall Study|Lack of therapeutic response|2|||
145535832|NCT02663908|524820850|FG001|Overall Study|Lack of therapeutic response|0|||
145535833|NCT02663908|524820849|FG000|Overall Study|COVID-19|1|||
145535834|NCT02663908|524820850|FG001|Overall Study|COVID-19|0|||
145535835|NCT02663908|524820849|FG000|Overall Study|Site closed|1|||
145535836|NCT02663908|524820850|FG001|Overall Study|Site closed|0|||
145535837|NCT02663908|524820849|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
145535838|NCT02663908|524820850|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
145535839|NCT02663908|524820849|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
145535840|NCT02663908|524820850|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
145535841|NCT02663908|524820849|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
145535842|NCT02663908|524820850|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
145535843|NCT02663908|524820849|FG000|Overall Study|Death|1|||
145535844|NCT02663908|524820850|FG001|Overall Study|Death|0|||
145535845|NCT02663908|524820849|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
145535846|NCT02663908|524820850|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
145535847|NCT02663908|524820849|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
145535848|NCT02663908|524820850|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
145535849|NCT00761631|524820851|FG000|Overall Study|Parent/legal guardian request|8|||
145535850|NCT00761631|524820852|FG001|Overall Study|Parent/legal guardian request|3|||
145535851|NCT00761631|524820853|FG002|Overall Study|Parent/legal guardian request|8|||
145535852|NCT00761631|524820854|FG003|Overall Study|Parent/legal guardian request|0|||
145535853|NCT00761631|524820855|FG004|Overall Study|Parent/legal guardian request|5|||
145535854|NCT00761631|524820856|FG005|Overall Study|Parent/legal guardian request|0|||
145535855|NCT00761631|524820851|FG000|Overall Study|Lost to Follow-up|2|||
145535856|NCT00761631|524820852|FG001|Overall Study|Lost to Follow-up|4|||
145535857|NCT00761631|524820853|FG002|Overall Study|Lost to Follow-up|7|||
145535858|NCT00761631|524820854|FG003|Overall Study|Lost to Follow-up|1|||
145535859|NCT00761631|524820855|FG004|Overall Study|Lost to Follow-up|6|||
145535860|NCT00761631|524820856|FG005|Overall Study|Lost to Follow-up|1|||
145535861|NCT00761631|524820851|FG000|Overall Study|Protocol Violation|2|||
145776057|NCT00957372|525689902|FG003|PART II|Not Know|20|||
145535862|NCT00761631|524820852|FG001|Overall Study|Protocol Violation|0|||
145535863|NCT00761631|524820853|FG002|Overall Study|Protocol Violation|0|||
145535864|NCT00761631|524820854|FG003|Overall Study|Protocol Violation|1|||
145535865|NCT00761631|524820855|FG004|Overall Study|Protocol Violation|5|||
145535866|NCT00761631|524820856|FG005|Overall Study|Protocol Violation|1|||
145535867|NCT00761631|524820851|FG000|Overall Study|Randomized, not treated|1|||
145535868|NCT00761631|524820852|FG001|Overall Study|Randomized, not treated|0|||
145535869|NCT00761631|524820853|FG002|Overall Study|Randomized, not treated|0|||
145535870|NCT00761631|524820854|FG003|Overall Study|Randomized, not treated|0|||
145535871|NCT00761631|524820855|FG004|Overall Study|Randomized, not treated|0|||
145535872|NCT00761631|524820856|FG005|Overall Study|Randomized, not treated|0|||
145535873|NCT00761631|524820851|FG000|Overall Study|Failed to return|1|||
145535874|NCT00761631|524820852|FG001|Overall Study|Failed to return|0|||
145535875|NCT00761631|524820853|FG002|Overall Study|Failed to return|1|||
145535876|NCT00761631|524820854|FG003|Overall Study|Failed to return|1|||
145535877|NCT00761631|524820855|FG004|Overall Study|Failed to return|5|||
145535878|NCT00761631|524820856|FG005|Overall Study|Failed to return|2|||
145535879|NCT00761631|524820851|FG000|Overall Study|Physician Decision|1|||
145535880|NCT00761631|524820852|FG001|Overall Study|Physician Decision|0|||
145535881|NCT00761631|524820853|FG002|Overall Study|Physician Decision|0|||
145535882|NCT00761631|524820854|FG003|Overall Study|Physician Decision|0|||
145535883|NCT00761631|524820855|FG004|Overall Study|Physician Decision|0|||
145535884|NCT00761631|524820856|FG005|Overall Study|Physician Decision|0|||
145535885|NCT00761631|524820851|FG000|Overall Study|Other|0|||
145535886|NCT00761631|524820852|FG001|Overall Study|Other|0|||
145535887|NCT00761631|524820853|FG002|Overall Study|Other|0|||
145535888|NCT00761631|524820854|FG003|Overall Study|Other|0|||
145535889|NCT00761631|524820855|FG004|Overall Study|Other|1|||
145535890|NCT00761631|524820856|FG005|Overall Study|Other|1|||
145535891|NCT01999868|524820857|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
145535892|NCT01999868|524820858|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
145535893|NCT01999868|524820859|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
145535894|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
145535895|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
145535896|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
145776058|NCT00957372|525689899|FG000|PART II|Adverse Event|0|||
145776059|NCT00957372|525689900|FG001|PART II|Adverse Event|0|||
145776060|NCT00957372|525689901|FG002|PART II|Adverse Event|0|||
145776061|NCT00957372|525689902|FG003|PART II|Adverse Event|10|||
145776062|NCT00957372|525689899|FG000|PART II|Patient non-compliance|0|||
145776063|NCT00957372|525689900|FG001|PART II|Patient non-compliance|0|||
145776064|NCT00957372|525689901|FG002|PART II|Patient non-compliance|0|||
145776065|NCT00957372|525689902|FG003|PART II|Patient non-compliance|4|||
145776066|NCT02403206|525689903|FG000|Overall Study|Lost to Follow-up|4|||
145776067|NCT02403206|525689904|FG001|Overall Study|Lost to Follow-up|3|||
145776068|NCT02403206|525689903|FG000|Overall Study|Physician Decision|2|||
145403663|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
145403664|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403665|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403666|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145776069|NCT02403206|525689904|FG001|Overall Study|Physician Decision|0|||
145776070|NCT02403206|525689903|FG000|Overall Study|Withdrawal by Subject|3|||
145776071|NCT02403206|525689904|FG001|Overall Study|Withdrawal by Subject|3|||
145776072|NCT02403206|525689903|FG000|Overall Study|Reason not given|2|||
145776073|NCT02403206|525689904|FG001|Overall Study|Reason not given|4|||
145776074|NCT01444391|525689907|FG000|Overall Study|Death|1|||
145776075|NCT05635838|525691524|FG000|16-Week DBVC Period|Adverse Event|2|||
145776076|NCT05635838|525691525|FG001|16-Week DBVC Period|Adverse Event|0|||
145776077|NCT05635838|525691526|FG002|16-Week DBVC Period|Adverse Event|0|||
145776078|NCT05635838|525691527|FG003|16-Week DBVC Period|Adverse Event|0|||
145403667|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403668|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403669|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145535897|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
145535898|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
145535899|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
145535900|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
145535901|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
145535902|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
145535903|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
145535904|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
145535905|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
145535906|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
145535907|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
145535908|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
145535909|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
145535910|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
145535911|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
145535912|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
145776079|NCT05635838|525691524|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
145776080|NCT05635838|525691525|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
145776081|NCT05635838|525691526|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
145279064|NCT00550420|523872849|FG000|Overall Study|Missing|2|||
145535913|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
145776082|NCT05635838|525691527|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
145776083|NCT05635838|525691524|FG000|16-Week DBVC Period|Physician Decision|0|||
145776084|NCT05635838|525691525|FG001|16-Week DBVC Period|Physician Decision|1|||
145776085|NCT05635838|525691526|FG002|16-Week DBVC Period|Physician Decision|0|||
145776086|NCT05635838|525691527|FG003|16-Week DBVC Period|Physician Decision|0|||
145776087|NCT05635838|525691524|FG000|16-Week DBVC Period|Protocol Violation|1|||
145776088|NCT05635838|525691525|FG001|16-Week DBVC Period|Protocol Violation|0|||
145776089|NCT05635838|525691526|FG002|16-Week DBVC Period|Protocol Violation|0|||
145776090|NCT05635838|525691527|FG003|16-Week DBVC Period|Protocol Violation|0|||
145776091|NCT05635838|525691524|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
145776092|NCT05635838|525691525|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
145776093|NCT05635838|525691526|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
145776094|NCT05635838|525691527|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
145776095|NCT05635838|525691524|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
145776096|NCT05635838|525691525|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
145776097|NCT05635838|525691526|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
145776098|NCT05635838|525691527|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
145776099|NCT05635838|525691524|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
145776100|NCT05635838|525691525|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
145776101|NCT05635838|525691526|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
145776102|NCT05635838|525691527|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
145776103|NCT05635838|525691524|FG000|16-Week OLE Period|Adverse Event|0|||
145776104|NCT05635838|525691525|FG001|16-Week OLE Period|Adverse Event|0|||
145776105|NCT05635838|525691526|FG002|16-Week OLE Period|Adverse Event|0|||
145776106|NCT05635838|525691527|FG003|16-Week OLE Period|Adverse Event|2|||
145776107|NCT05635838|525691524|FG000|16-Week OLE Period|Lost to Follow-up|0|||
145776108|NCT05635838|525691525|FG001|16-Week OLE Period|Lost to Follow-up|0|||
145776109|NCT05635838|525691526|FG002|16-Week OLE Period|Lost to Follow-up|1|||
145776110|NCT05635838|525691527|FG003|16-Week OLE Period|Lost to Follow-up|3|||
145776111|NCT05635838|525691524|FG000|16-Week OLE Period|Physician Decision|0|||
145776112|NCT05635838|525691525|FG001|16-Week OLE Period|Physician Decision|0|||
145776113|NCT05635838|525691526|FG002|16-Week OLE Period|Physician Decision|0|||
145776114|NCT05635838|525691527|FG003|16-Week OLE Period|Physician Decision|1|||
145776115|NCT05635838|525691524|FG000|16-Week OLE Period|Protocol Violation|0|||
145776116|NCT05635838|525691525|FG001|16-Week OLE Period|Protocol Violation|0|||
145776117|NCT05635838|525691526|FG002|16-Week OLE Period|Protocol Violation|1|||
145776118|NCT05635838|525691527|FG003|16-Week OLE Period|Protocol Violation|1|||
145776119|NCT05635838|525691524|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
145776120|NCT05635838|525691525|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
145776121|NCT05635838|525691526|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
145776122|NCT05635838|525691527|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
145776123|NCT05635838|525691524|FG000|16-Week OLE Period|Pregnancy|0|||
145776124|NCT05635838|525691525|FG001|16-Week OLE Period|Pregnancy|0|||
145776125|NCT05635838|525691526|FG002|16-Week OLE Period|Pregnancy|1|||
145776126|NCT05635838|525691527|FG003|16-Week OLE Period|Pregnancy|0|||
145776127|NCT05165394|525691529|FG000|Overall Study|Withdrawal by Subject|5|||
145776128|NCT05165394|525691530|FG001|Overall Study|Withdrawal by Subject|1|||
145776129|NCT05165394|525691529|FG000|Overall Study|Lost to Follow-up|1|||
145776130|NCT05165394|525691530|FG001|Overall Study|Lost to Follow-up|2|||
145776131|NCT05165394|525691529|FG000|Overall Study|Other Than Specified|0|||
145776132|NCT05165394|525691530|FG001|Overall Study|Other Than Specified|1|||
145776133|NCT02839746|525691532|FG000|Overall Study|Not met selection criteria|12|||
145776134|NCT02089737|525691533|FG000|Overall Study|Survey form not completed|5|||
145776135|NCT02089737|525691533|FG000|Overall Study|Not treated|1|||
145776136|NCT02767570|525691534|FG000|Overall Study|Lost to Follow-up|3|||
145776137|NCT02767570|525691535|FG001|Overall Study|Lost to Follow-up|0|||
145776138|NCT02767570|525691534|FG000|Overall Study|COVID shutdown|2|||
145776139|NCT02767570|525691535|FG001|Overall Study|COVID shutdown|5|||
145776140|NCT02767570|525691534|FG000|Overall Study|Increased pain|2|||
145776141|NCT02767570|525691535|FG001|Overall Study|Increased pain|0|||
145776142|NCT02767570|525691534|FG000|Overall Study|Withdrawal by Subject|1|||
145776143|NCT02767570|525691535|FG001|Overall Study|Withdrawal by Subject|3|||
145776144|NCT02767570|525691534|FG000|Overall Study|Unrelated medical issue|1|||
145776145|NCT02767570|525691535|FG001|Overall Study|Unrelated medical issue|1|||
145776146|NCT02767570|525691534|FG000|Overall Study|Received intra-articular injection|0|||
145776147|NCT02767570|525691535|FG001|Overall Study|Received intra-articular injection|1|||
145776148|NCT04426630|525691536|FG000|Overall Study|Death|4|||
145776149|NCT04426630|525691536|FG000|Overall Study|Lost to Follow-up|2|||
145776150|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
145279065|NCT00550420|523872849|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
145279066|NCT00550420|523872849|FG000|Overall Study|Investigators opinion|1|||
145776151|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
145776152|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
145776153|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
145776154|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
145776155|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
145776156|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
145776157|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
145776158|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
145776159|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
145776160|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
145776161|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
145776162|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
145776163|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
145776164|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
145776165|NCT01330381|525691537|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
145776166|NCT01330381|525691538|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
145776167|NCT01330381|525691539|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
145776168|NCT01330381|525691537|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
145776169|NCT01330381|525691538|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
145776170|NCT01330381|525691539|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
145776171|NCT01330381|525691537|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
145776172|NCT01330381|525691538|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
145776173|NCT01330381|525691539|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
145776174|NCT01330381|525691537|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
145776175|NCT01330381|525691538|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
145776176|NCT01330381|525691539|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
145776177|NCT01330381|525691537|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
145776178|NCT01330381|525691538|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
145776179|NCT01330381|525691539|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
145776180|NCT03334214|525691541|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145776181|NCT03334214|525691542|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145776182|NCT03334214|525691541|FG000|Overall Study|Withdrawal by Subject|0|||
145776183|NCT03334214|525691542|FG001|Overall Study|Withdrawal by Subject|1|||
145776184|NCT03334214|525691541|FG000|Overall Study|Other|1|||
145776185|NCT03334214|525691542|FG001|Overall Study|Other|0|||
145776186|NCT02088034|525691544|FG000|Overall Study|Lost to Follow-up|1|||
145776187|NCT02088034|525691545|FG001|Overall Study|Lost to Follow-up|1|||
145776188|NCT02088034|525691546|FG002|Overall Study|Lost to Follow-up|0|||
145776189|NCT02088034|525691544|FG000|Overall Study|Pregnancy|2|||
145776190|NCT02088034|525691545|FG001|Overall Study|Pregnancy|1|||
145776191|NCT02088034|525691546|FG002|Overall Study|Pregnancy|2|||
145776192|NCT00308620|525691547|FG000|Overall Study|Death|1|||
145776193|NCT00308620|525691548|FG001|Overall Study|Death|1|||
145776194|NCT00308620|525691549|FG002|Overall Study|Death|0|||
145776195|NCT00308620|525691547|FG000|Overall Study|Lost to Follow-up|0|||
145776196|NCT00308620|525691548|FG001|Overall Study|Lost to Follow-up|0|||
145776197|NCT00308620|525691549|FG002|Overall Study|Lost to Follow-up|1|||
145776198|NCT01025336|525691552|FG000|Overall Study|Protocol Violation|0|||
145776199|NCT01025336|525691553|FG001|Overall Study|Protocol Violation|0|||
145776200|NCT01025336|525691554|FG002|Overall Study|Protocol Violation|0|||
145776201|NCT01025336|525691555|FG003|Overall Study|Protocol Violation|2|||
145776202|NCT01025336|525691556|FG004|Overall Study|Protocol Violation|0|||
145776203|NCT00637728|525691560|FG000|Double-blind Phase|Adverse Event|1|||
145776204|NCT00637728|525691561|FG001|Double-blind Phase|Adverse Event|0|||
145776205|NCT00637728|525691562|FG002|Double-blind Phase|Adverse Event|0|||
145776206|NCT00637728|525691560|FG000|Double-blind Phase|Non-compliance|2|||
145776207|NCT00637728|525691561|FG001|Double-blind Phase|Non-compliance|0|||
145776208|NCT00637728|525691562|FG002|Double-blind Phase|Non-compliance|0|||
145776209|NCT00637728|525691560|FG000|Double-blind Phase|Study Discontinued|1|||
145776210|NCT00637728|525691561|FG001|Double-blind Phase|Study Discontinued|1|||
145776211|NCT00637728|525691562|FG002|Double-blind Phase|Study Discontinued|0|||
145776212|NCT01050062|525691563|FG000|Overall Study|Adverse Event|75|||
145776213|NCT01050062|525691564|FG001|Overall Study|Adverse Event|22|||
145776214|NCT01050062|525691563|FG000|Overall Study|Lost to Follow-up|83|||
145776215|NCT01050062|525691564|FG001|Overall Study|Lost to Follow-up|35|||
145776216|NCT01050062|525691563|FG000|Overall Study|Lack of Efficacy|22|||
145776217|NCT01050062|525691564|FG001|Overall Study|Lack of Efficacy|35|||
145776218|NCT01050062|525691563|FG000|Overall Study|Physician Decision|74|||
145535914|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
145535915|NCT01999868|524820857|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
145535916|NCT01999868|524820858|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
145535917|NCT01999868|524820859|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
145535918|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
145535919|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
145535920|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
145535921|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
145776219|NCT01050062|525691564|FG001|Overall Study|Physician Decision|9|||
145776220|NCT01050062|525691563|FG000|Overall Study|Others|17|||
145776221|NCT01050062|525691564|FG001|Overall Study|Others|11|||
145776222|NCT01873950|525691567|FG000|Period 5|Withdrawal by Subject|0|||
145776223|NCT01873950|525691568|FG001|Period 5|Withdrawal by Subject|0|||
145776224|NCT01873950|525691569|FG002|Period 5|Withdrawal by Subject|0|||
145776225|NCT01873950|525691570|FG003|Period 5|Withdrawal by Subject|1|||
145776226|NCT01873950|525691571|FG004|Period 5|Withdrawal by Subject|0|||
145776227|NCT03894540|525691572|FG000|Overall Study|Adverse Event|0|||
145535922|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
145776228|NCT03894540|525691573|FG001|Overall Study|Adverse Event|0|||
145776229|NCT03894540|525691574|FG002|Overall Study|Adverse Event|0|||
145776230|NCT03894540|525691575|FG003|Overall Study|Adverse Event|0|||
145776231|NCT03894540|525691576|FG004|Overall Study|Adverse Event|1|||
145776232|NCT03894540|525691577|FG005|Overall Study|Adverse Event|0|||
145776233|NCT03894540|525691572|FG000|Overall Study|Withdrawal by Subject|0|||
145776234|NCT03894540|525691573|FG001|Overall Study|Withdrawal by Subject|0|||
145776235|NCT03894540|525691574|FG002|Overall Study|Withdrawal by Subject|0|||
145776236|NCT03894540|525691575|FG003|Overall Study|Withdrawal by Subject|0|||
145776237|NCT03894540|525691576|FG004|Overall Study|Withdrawal by Subject|1|||
145776238|NCT03894540|525691577|FG005|Overall Study|Withdrawal by Subject|0|||
145776239|NCT03894540|525691572|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
145776240|NCT03894540|525691573|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
145776241|NCT03894540|525691574|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
145776242|NCT03894540|525691575|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
145776243|NCT03894540|525691576|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
145776244|NCT03894540|525691577|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
145776245|NCT03894540|525691572|FG000|Overall Study|Progressive Disease Clinical|1|||
145776246|NCT03894540|525691573|FG001|Overall Study|Progressive Disease Clinical|1|||
145776247|NCT03894540|525691574|FG002|Overall Study|Progressive Disease Clinical|0|||
145776248|NCT03894540|525691575|FG003|Overall Study|Progressive Disease Clinical|1|||
145776249|NCT03894540|525691576|FG004|Overall Study|Progressive Disease Clinical|5|||
145776250|NCT03894540|525691577|FG005|Overall Study|Progressive Disease Clinical|1|||
145776251|NCT03894540|525691572|FG000|Overall Study|Study termination by sponsor|0|||
145776252|NCT03894540|525691573|FG001|Overall Study|Study termination by sponsor|0|||
145776253|NCT03894540|525691574|FG002|Overall Study|Study termination by sponsor|0|||
145776254|NCT03894540|525691575|FG003|Overall Study|Study termination by sponsor|0|||
145776255|NCT03894540|525691576|FG004|Overall Study|Study termination by sponsor|2|||
145776256|NCT03894540|525691577|FG005|Overall Study|Study termination by sponsor|0|||
145776257|NCT03000452|525691578|FG000|Treatment Period|Death|1|||
145776258|NCT03000452|525691578|FG000|Treatment Period|Progressive Disease (PD)|14|||
145776259|NCT03000452|525691578|FG000|Treatment Period|Physician Decision|1|||
145776260|NCT03000452|525691578|FG000|Treatment Period|Miscellaneous|2|||
145776261|NCT03000452|525691578|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
145776262|NCT03000452|525691578|FG000|Follow-Up Period|Death|3|||
145776263|NCT03000452|525691578|FG000|Follow-Up Period|Withdrawal by Subject|3|||
145776264|NCT00593112|525691579|FG000|Overall Study|Scan Anxiety|3|||
145776265|NCT00593112|525691580|FG001|Overall Study|Scan Anxiety|0|||
145776266|NCT00593112|525691579|FG000|Overall Study|Abnormal Scan|1|||
145776267|NCT00593112|525691580|FG001|Overall Study|Abnormal Scan|0|||
145776268|NCT00593112|525691579|FG000|Overall Study|Unreadable Scan|1|||
145776269|NCT00593112|525691580|FG001|Overall Study|Unreadable Scan|0|||
145776270|NCT00593112|525691579|FG000|Overall Study|Withdrawal by Subject|5|||
145776271|NCT00593112|525691580|FG001|Overall Study|Withdrawal by Subject|0|||
145776272|NCT03043365|525691581|FG000|Weeks 0 to Week 8|Adverse Event|1|||
145776273|NCT03043365|525691582|FG001|Weeks 0 to Week 8|Adverse Event|3|||
145776274|NCT03043365|525691581|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
145776275|NCT03043365|525691582|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
145776276|NCT03043365|525691581|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
145776277|NCT03043365|525691582|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
145776278|NCT02723630|525691583|FG000|Intervention Period 1|Adverse Event|1|||
145776279|NCT02723630|525691584|FG001|Intervention Period 1|Adverse Event|0|||
145776280|NCT02723630|525691585|FG002|Intervention Period 1|Adverse Event|0|||
145776281|NCT02723630|525691586|FG003|Intervention Period 1|Adverse Event|0|||
145776282|NCT02723630|525691587|FG004|Intervention Period 1|Adverse Event|0|||
145776283|NCT02723630|525691588|FG005|Intervention Period 1|Adverse Event|0|||
145776284|NCT02723630|525691583|FG000|Intervention Period 3|consumption of restricted item|0|||
145776285|NCT02723630|525691584|FG001|Intervention Period 3|consumption of restricted item|1|||
145776286|NCT02723630|525691585|FG002|Intervention Period 3|consumption of restricted item|0|||
145776287|NCT02723630|525691586|FG003|Intervention Period 3|consumption of restricted item|0|||
145776288|NCT02723630|525691587|FG004|Intervention Period 3|consumption of restricted item|0|||
145776289|NCT02723630|525691588|FG005|Intervention Period 3|consumption of restricted item|0|||
145776290|NCT03455543|525691589|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
145608520|NCT03315130|525081082|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
145608521|NCT03315130|525081083|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
145608522|NCT03315130|525081084|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
145608523|NCT03315130|525081085|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
145608524|NCT03315130|525081082|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
145608525|NCT03315130|525081083|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
145608526|NCT03315130|525081084|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
145608527|NCT03315130|525081085|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
145608528|NCT03315130|525081082|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
145608529|NCT03315130|525081083|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
145608530|NCT03315130|525081084|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
145608531|NCT03315130|525081085|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
145608532|NCT03315130|525081082|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
145608533|NCT03315130|525081083|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
145608534|NCT03315130|525081084|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
145608535|NCT03315130|525081085|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
145608536|NCT03315130|525081082|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
145608537|NCT03315130|525081083|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
145608538|NCT03315130|525081084|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
145608539|NCT03315130|525081085|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
145608540|NCT02089230|525081086|FG000|Overall Study|Death|0|||
145608541|NCT02089230|525081087|FG001|Overall Study|Death|0|||
145608542|NCT02089230|525081088|FG002|Overall Study|Death|2|||
145608543|NCT02089230|525081086|FG000|Overall Study|Seeking Alternative Therapy|0|||
145776291|NCT03455543|525691590|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
145776292|NCT03455543|525691591|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
145776293|NCT03455543|525691589|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
145776294|NCT03455543|525691590|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
145776295|NCT03455543|525691591|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
145776296|NCT03455543|525691589|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
145776297|NCT03455543|525691590|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
145776298|NCT03455543|525691591|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
145776299|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
145776300|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
145776301|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
145776302|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
145776303|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
145776304|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
145776305|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
145776306|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
145776307|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
145776308|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
145776309|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
145776310|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
145776311|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
145776312|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
145776313|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
145776314|NCT03455543|525691589|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
145776315|NCT03455543|525691590|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
145776316|NCT03455543|525691591|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
145776317|NCT00852930|525691592|FG000|Overall Study|Withdrawal by Subject|1|||
145776318|NCT00852930|525691593|FG001|Overall Study|Withdrawal by Subject|1|||
145776319|NCT00852930|525691594|FG002|Overall Study|Withdrawal by Subject|1|||
145776320|NCT00852930|525691592|FG000|Overall Study|Physician Decision|0|||
145535923|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
145535924|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
145535925|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
145535926|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
145535927|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
145535928|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
145535929|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
145608544|NCT02089230|525081087|FG001|Overall Study|Seeking Alternative Therapy|0|||
145776321|NCT00852930|525691593|FG001|Overall Study|Physician Decision|0|||
145776322|NCT00852930|525691594|FG002|Overall Study|Physician Decision|1|||
145776323|NCT00779038|525691595|FG000|Overall Study|Study Prematurely Terminated|13|||
145776324|NCT05372315|525691598|FG000|Overall Study|Withdrawal by Subject|1|||
145776325|NCT05372315|525691599|FG001|Overall Study|Withdrawal by Subject|0|||
145776326|NCT00537745|525691600|FG000|Overall Study|Did not meet eligibility criteria|2|||
145776327|NCT00537745|525691600|FG000|Overall Study|Withdrawal by Subject|2|||
145776328|NCT00537745|525691600|FG000|Overall Study|Subject unable to provide Interlock info|1|||
145776329|NCT01512368|525691601|FG000|Overall Study|Protocol Violation|3|||
145776330|NCT00650585|525691604|FG000|Overall Study|Lost to Follow-up|505|||
145776331|NCT00650585|525691605|FG001|Overall Study|Lost to Follow-up|482|||
145776332|NCT00650585|525691604|FG000|Overall Study|No parental consent|935|||
145776333|NCT00650585|525691605|FG001|Overall Study|No parental consent|866|||
145776334|NCT00650585|525691604|FG000|Overall Study|Excluded/ruled ineligible|357|||
145776335|NCT00650585|525691605|FG001|Overall Study|Excluded/ruled ineligible|129|||
145776336|NCT02532543|525691606|FG000|Overall Study|Lost to Follow-up|0|||
145776337|NCT02532543|525691607|FG001|Overall Study|Lost to Follow-up|0|||
145776338|NCT02532543|525691608|FG002|Overall Study|Lost to Follow-up|1|||
145776339|NCT02532543|525691609|FG003|Overall Study|Lost to Follow-up|0|||
145776340|NCT02640612|525691610|FG000|Overall Study|Adverse Event|6|||
145776341|NCT02640612|525691611|FG001|Overall Study|Adverse Event|7|||
145776342|NCT02640612|525691612|FG002|Overall Study|Adverse Event|2|||
145776343|NCT02640612|525691610|FG000|Overall Study|Death|1|||
145776344|NCT02640612|525691611|FG001|Overall Study|Death|0|||
145776345|NCT02640612|525691612|FG002|Overall Study|Death|0|||
145776346|NCT02640612|525691610|FG000|Overall Study|Withdrawal by Subject|10|||
145776347|NCT02640612|525691611|FG001|Overall Study|Withdrawal by Subject|3|||
145776348|NCT02640612|525691612|FG002|Overall Study|Withdrawal by Subject|3|||
145776349|NCT02640612|525691610|FG000|Overall Study|Lost to Follow-up|4|||
145776350|NCT02640612|525691611|FG001|Overall Study|Lost to Follow-up|1|||
145776351|NCT02640612|525691612|FG002|Overall Study|Lost to Follow-up|1|||
145776352|NCT02640612|525691610|FG000|Overall Study|Protocol Violation|0|||
145776353|NCT02640612|525691611|FG001|Overall Study|Protocol Violation|2|||
145776354|NCT02640612|525691612|FG002|Overall Study|Protocol Violation|0|||
145776355|NCT02640612|525691610|FG000|Overall Study|Lack of Efficacy|1|||
145776356|NCT02640612|525691611|FG001|Overall Study|Lack of Efficacy|1|||
145776357|NCT02640612|525691612|FG002|Overall Study|Lack of Efficacy|0|||
145776358|NCT00923091|525691623|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
145776359|NCT00923091|525691624|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
145776360|NCT00923091|525691625|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
145776361|NCT00923091|525691626|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
145776362|NCT00923091|525691627|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
145776363|NCT00923091|525691628|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
145535930|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
145535931|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
145535932|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
145535933|NCT01999868|524820857|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
145535934|NCT01999868|524820858|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
145535935|NCT01999868|524820859|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
145535936|NCT00289016|524820864|FG000|Overall Study|Disease Progression|29|||
145535937|NCT00289016|524820864|FG000|Overall Study|Death|2|||
145535938|NCT00289016|524820864|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
145535939|NCT00289016|524820864|FG000|Overall Study|Withdrawal by Subject|2|||
145535940|NCT00289016|524820864|FG000|Overall Study|Adverse Event|1|||
145535941|NCT00289016|524820864|FG000|Overall Study|Other|1|||
145535942|NCT00319501|524820865|FG000|Double-blind Period|Withdrawal by Subject|0|||
145535943|NCT00319501|524820866|FG001|Double-blind Period|Withdrawal by Subject|3|||
145535944|NCT00319501|524820865|FG000|Double-blind Period|Sponsor Request|1|||
145535945|NCT00319501|524820866|FG001|Double-blind Period|Sponsor Request|0|||
145776364|NCT00923091|525691629|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
145776365|NCT00923091|525691630|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
145776366|NCT00923091|525691631|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
145776367|NCT00923091|525691632|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
145776368|NCT00923091|525691633|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
145776369|NCT00923091|525691634|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
145776370|NCT00923091|525691635|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
145776371|NCT00923091|525691623|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
145776372|NCT00923091|525691624|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
145776373|NCT00923091|525691625|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
145776374|NCT00923091|525691626|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
145535946|NCT00319501|524820865|FG000|Double-blind Period|Did not receive treatment|42|||
145776375|NCT00923091|525691627|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
145776376|NCT00923091|525691628|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
145776377|NCT00923091|525691629|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
145776378|NCT00923091|525691630|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
145776379|NCT00923091|525691631|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
145776380|NCT00923091|525691632|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
145776381|NCT00923091|525691633|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
145776382|NCT00923091|525691634|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
145776383|NCT00923091|525691635|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
145776384|NCT00923091|525691623|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
145776385|NCT00923091|525691624|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
145776386|NCT00923091|525691625|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
145535947|NCT00319501|524820866|FG001|Double-blind Period|Did not receive treatment|29|||
145535948|NCT00319501|524820865|FG000|Open-label Period|Adverse Event|5|||
145535949|NCT00319501|524820866|FG001|Open-label Period|Adverse Event|0|||
145535950|NCT00319501|524820865|FG000|Open-label Period|Protocol Violation|6|||
145535951|NCT00319501|524820866|FG001|Open-label Period|Protocol Violation|0|||
145535952|NCT00319501|524820865|FG000|Open-label Period|Withdrawal by Subject|38|||
145535953|NCT00319501|524820866|FG001|Open-label Period|Withdrawal by Subject|0|||
145535954|NCT00319501|524820865|FG000|Open-label Period|Principal Investigator decision|6|||
145535955|NCT00319501|524820866|FG001|Open-label Period|Principal Investigator decision|0|||
145535956|NCT00319501|524820865|FG000|Open-label Period|Sponsor request|12|||
145535957|NCT00319501|524820866|FG001|Open-label Period|Sponsor request|0|||
145535958|NCT00319501|524820865|FG000|Open-label Period|Lost to Follow-up|5|||
145535959|NCT00319501|524820866|FG001|Open-label Period|Lost to Follow-up|0|||
145535960|NCT00319501|524820865|FG000|Open-label Period|Did not receive treatment|33|||
145535961|NCT00319501|524820866|FG001|Open-label Period|Did not receive treatment|0|||
145535962|NCT00319501|524820865|FG000|Open-label Period|Other|11|||
145535963|NCT00319501|524820866|FG001|Open-label Period|Other|0|||
145535964|NCT00319501|524820865|FG000|Open-label Extension Period|Adverse Event|2|||
145535965|NCT00319501|524820866|FG001|Open-label Extension Period|Adverse Event|0|||
145776387|NCT00923091|525691626|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
145776388|NCT00923091|525691627|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
145776389|NCT00923091|525691628|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
145776390|NCT00923091|525691629|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
145776391|NCT00923091|525691630|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
145776392|NCT00923091|525691631|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
145776393|NCT00923091|525691632|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
145776394|NCT00923091|525691633|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
145776395|NCT00923091|525691634|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
145776396|NCT00923091|525691635|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
145776397|NCT00923091|525691623|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776398|NCT00923091|525691624|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776399|NCT00923091|525691625|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776400|NCT00923091|525691626|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776401|NCT00923091|525691627|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776402|NCT00923091|525691628|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
145776403|NCT00923091|525691629|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776404|NCT00923091|525691630|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776405|NCT00923091|525691631|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776406|NCT00923091|525691632|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776407|NCT00923091|525691633|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776408|NCT00923091|525691634|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776409|NCT00923091|525691635|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
145776410|NCT00923091|525691623|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145535966|NCT00319501|524820865|FG000|Open-label Extension Period|Did not receive treatment|18|||
145535967|NCT00319501|524820866|FG001|Open-label Extension Period|Did not receive treatment|0|||
145535968|NCT00319501|524820865|FG000|Open-label Extension Period|Other|1|||
145535969|NCT00319501|524820866|FG001|Open-label Extension Period|Other|0|||
145535970|NCT00319501|524820865|FG000|Open-label Extension Period|Principal investigator decision|2|||
145776411|NCT00923091|525691624|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
145776412|NCT00923091|525691625|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776413|NCT00923091|525691626|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
145535971|NCT00319501|524820866|FG001|Open-label Extension Period|Principal investigator decision|0|||
145535972|NCT00319501|524820865|FG000|Open-label Extension Period|Sponsor request|26|||
145535973|NCT00319501|524820866|FG001|Open-label Extension Period|Sponsor request|0|||
145535974|NCT00319501|524820865|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
145776414|NCT00923091|525691627|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776415|NCT00923091|525691628|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
145776416|NCT00923091|525691629|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776417|NCT00923091|525691630|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776418|NCT00923091|525691631|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776419|NCT00923091|525691632|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145535975|NCT00319501|524820866|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
145535976|NCT00667875|524820868|FG000|Overall Study|Adverse Event|0|||
145776420|NCT00923091|525691633|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145535977|NCT00667875|524820869|FG001|Overall Study|Adverse Event|2|||
145535978|NCT00667875|524820870|FG002|Overall Study|Adverse Event|6|||
145535979|NCT00667875|524820868|FG000|Overall Study|Withdrawal by Subject|10|||
145535980|NCT00667875|524820869|FG001|Overall Study|Withdrawal by Subject|9|||
145535981|NCT00667875|524820870|FG002|Overall Study|Withdrawal by Subject|7|||
145535982|NCT00450255|524820871|FG000|Overall Study|Prior RFA ablation of liver|1|||
145535983|NCT03689530|524822083|FG000|Overall Study|Withdrawal by Subject|53|||
145535984|NCT03689530|524822084|FG001|Overall Study|Withdrawal by Subject|16|||
145535985|NCT01392443|524822085|FG000|Overall Study|Disease progression|30|||
145535986|NCT01392443|524822085|FG000|Overall Study|Adverse Event|24|||
145776421|NCT00923091|525691634|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776422|NCT00923091|525691635|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
145776423|NCT00923091|525691623|FG000|Period III (Single-Blind)|Adverse Event|5|||
145776424|NCT00923091|525691624|FG001|Period III (Single-Blind)|Adverse Event|0|||
145776425|NCT00923091|525691625|FG002|Period III (Single-Blind)|Adverse Event|0|||
145776426|NCT00923091|525691626|FG003|Period III (Single-Blind)|Adverse Event|0|||
145776427|NCT00923091|525691627|FG004|Period III (Single-Blind)|Adverse Event|0|||
145776428|NCT00923091|525691628|FG005|Period III (Single-Blind)|Adverse Event|0|||
145776429|NCT00923091|525691629|FG006|Period III (Single-Blind)|Adverse Event|0|||
145776430|NCT00923091|525691630|FG007|Period III (Single-Blind)|Adverse Event|0|||
145776431|NCT00923091|525691631|FG008|Period III (Single-Blind)|Adverse Event|0|||
145776432|NCT00923091|525691632|FG009|Period III (Single-Blind)|Adverse Event|0|||
145776433|NCT00923091|525691633|FG010|Period III (Single-Blind)|Adverse Event|0|||
145776434|NCT00923091|525691634|FG011|Period III (Single-Blind)|Adverse Event|0|||
145776435|NCT00923091|525691635|FG012|Period III (Single-Blind)|Adverse Event|0|||
145776436|NCT00923091|525691623|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
145535987|NCT01392443|524822085|FG000|Overall Study|Death|7|||
145535988|NCT01392443|524822085|FG000|Overall Study|Withdrawal by Subject|5|||
145776437|NCT00923091|525691624|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776438|NCT00923091|525691625|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776439|NCT00923091|525691626|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
145535989|NCT01392443|524822085|FG000|Overall Study|Lost to Follow-up|1|||
145535990|NCT01392443|524822085|FG000|Overall Study|Protocol Violation|1|||
145535991|NCT01977794|524822088|FG000|Overall Study|Adverse Event|2|||
145535992|NCT01977794|524822089|FG001|Overall Study|Adverse Event|2|||
145535993|NCT01977794|524822088|FG000|Overall Study|Lost to Follow-up|2|||
145535994|NCT01977794|524822089|FG001|Overall Study|Lost to Follow-up|1|||
145535995|NCT01977794|524822088|FG000|Overall Study|Protocol Violation|1|||
145535996|NCT01977794|524822089|FG001|Overall Study|Protocol Violation|0|||
145535997|NCT01977794|524822088|FG000|Overall Study|Death|1|||
145535998|NCT01977794|524822089|FG001|Overall Study|Death|1|||
145535999|NCT01977794|524822088|FG000|Overall Study|Withdrew consent|2|||
145536000|NCT01977794|524822089|FG001|Overall Study|Withdrew consent|1|||
145536001|NCT01977794|524822088|FG000|Overall Study|Other|0|||
145536002|NCT01977794|524822089|FG001|Overall Study|Other|1|||
145536003|NCT01626456|524822090|FG000|Overall Study|Withdrawal by Subject|21|||
145536004|NCT01626456|524822091|FG001|Overall Study|Withdrawal by Subject|46|||
145536005|NCT01626456|524822090|FG000|Overall Study|Adverse Event|2|||
145536006|NCT01626456|524822091|FG001|Overall Study|Adverse Event|27|||
145536007|NCT01626456|524822090|FG000|Overall Study|Lost to Follow-up|2|||
145536008|NCT01626456|524822091|FG001|Overall Study|Lost to Follow-up|27|||
145536009|NCT01626456|524822090|FG000|Overall Study|Lack of Efficacy|6|||
145536010|NCT01626456|524822091|FG001|Overall Study|Lack of Efficacy|7|||
145776440|NCT00923091|525691627|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
145403670|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403671|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
145403672|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
145536011|NCT01626456|524822090|FG000|Overall Study|Physician Decision|1|||
145536012|NCT01626456|524822091|FG001|Overall Study|Physician Decision|4|||
145536013|NCT01626456|524822090|FG000|Overall Study|Protocol Violation|1|||
145536014|NCT01626456|524822091|FG001|Overall Study|Protocol Violation|1|||
145536015|NCT01626456|524822090|FG000|Overall Study|Site Closure|2|||
145536016|NCT01626456|524822091|FG001|Overall Study|Site Closure|3|||
145536017|NCT01626456|524822090|FG000|Overall Study|Incarceration|0|||
145536018|NCT01626456|524822091|FG001|Overall Study|Incarceration|2|||
145536019|NCT00246753|524822093|FG000|Overall Study|Withdrawal by Subject|2|||
145776441|NCT00923091|525691628|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776442|NCT00923091|525691629|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776443|NCT00923091|525691630|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776444|NCT00923091|525691631|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776445|NCT00923091|525691632|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776446|NCT00923091|525691633|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776447|NCT00923091|525691634|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776448|NCT00923091|525691635|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
145776449|NCT00923091|525691623|FG000|Period III (Single-Blind)|Protocol Violation|3|||
145776450|NCT00923091|525691624|FG001|Period III (Single-Blind)|Protocol Violation|0|||
145776451|NCT00923091|525691625|FG002|Period III (Single-Blind)|Protocol Violation|0|||
145776452|NCT00923091|525691626|FG003|Period III (Single-Blind)|Protocol Violation|0|||
145776453|NCT00923091|525691627|FG004|Period III (Single-Blind)|Protocol Violation|0|||
145776454|NCT00923091|525691628|FG005|Period III (Single-Blind)|Protocol Violation|0|||
145776455|NCT00923091|525691629|FG006|Period III (Single-Blind)|Protocol Violation|0|||
145776456|NCT00923091|525691630|FG007|Period III (Single-Blind)|Protocol Violation|0|||
145776457|NCT00923091|525691631|FG008|Period III (Single-Blind)|Protocol Violation|0|||
145608545|NCT02089230|525081088|FG002|Overall Study|Seeking Alternative Therapy|4|||
145608546|NCT04867785|525083123|FG000|Overall Study|Adverse Event|1|||
145608547|NCT04867785|525083124|FG001|Overall Study|Adverse Event|0|||
145608548|NCT04867785|525083125|FG002|Overall Study|Adverse Event|1|||
145608549|NCT04867785|525083126|FG003|Overall Study|Adverse Event|0|||
145608550|NCT04867785|525083127|FG004|Overall Study|Adverse Event|0|||
145608551|NCT04867785|525083128|FG005|Overall Study|Adverse Event|0|||
145608552|NCT04867785|525083129|FG006|Overall Study|Adverse Event|0|||
145608553|NCT04867785|525083130|FG007|Overall Study|Adverse Event|2|||
145608554|NCT04867785|525083123|FG000|Overall Study|Lost to Follow-up|4|||
145608555|NCT04867785|525083124|FG001|Overall Study|Lost to Follow-up|4|||
145608556|NCT04867785|525083125|FG002|Overall Study|Lost to Follow-up|3|||
145608557|NCT04867785|525083126|FG003|Overall Study|Lost to Follow-up|2|||
145608558|NCT04867785|525083127|FG004|Overall Study|Lost to Follow-up|0|||
145608559|NCT04867785|525083128|FG005|Overall Study|Lost to Follow-up|1|||
145608560|NCT04867785|525083129|FG006|Overall Study|Lost to Follow-up|0|||
145608561|NCT04867785|525083130|FG007|Overall Study|Lost to Follow-up|1|||
145608562|NCT04867785|525083123|FG000|Overall Study|Withdrawal by Subject|6|||
145608563|NCT04867785|525083124|FG001|Overall Study|Withdrawal by Subject|2|||
145608564|NCT04867785|525083125|FG002|Overall Study|Withdrawal by Subject|2|||
145608565|NCT04867785|525083126|FG003|Overall Study|Withdrawal by Subject|1|||
145608566|NCT04867785|525083127|FG004|Overall Study|Withdrawal by Subject|2|||
145608567|NCT04867785|525083128|FG005|Overall Study|Withdrawal by Subject|0|||
145608568|NCT04867785|525083129|FG006|Overall Study|Withdrawal by Subject|2|||
145608569|NCT04867785|525083130|FG007|Overall Study|Withdrawal by Subject|5|||
145608570|NCT04867785|525083123|FG000|Overall Study|Physician Decision|0|||
145608571|NCT04867785|525083124|FG001|Overall Study|Physician Decision|0|||
145608572|NCT04867785|525083125|FG002|Overall Study|Physician Decision|0|||
145608573|NCT04867785|525083126|FG003|Overall Study|Physician Decision|0|||
145608574|NCT04867785|525083127|FG004|Overall Study|Physician Decision|0|||
145608575|NCT04867785|525083128|FG005|Overall Study|Physician Decision|0|||
145608576|NCT04867785|525083129|FG006|Overall Study|Physician Decision|0|||
145608577|NCT04867785|525083130|FG007|Overall Study|Physician Decision|1|||
145608578|NCT04867785|525083123|FG000|Overall Study|Inadvertent Enrollment|0|||
145608579|NCT04867785|525083124|FG001|Overall Study|Inadvertent Enrollment|0|||
145608580|NCT04867785|525083125|FG002|Overall Study|Inadvertent Enrollment|0|||
145608581|NCT04867785|525083126|FG003|Overall Study|Inadvertent Enrollment|1|||
145608582|NCT04867785|525083127|FG004|Overall Study|Inadvertent Enrollment|1|||
145608583|NCT04867785|525083128|FG005|Overall Study|Inadvertent Enrollment|0|||
145608584|NCT04867785|525083129|FG006|Overall Study|Inadvertent Enrollment|0|||
145608585|NCT04867785|525083130|FG007|Overall Study|Inadvertent Enrollment|1|||
145608586|NCT04867785|525083123|FG000|Overall Study|Eligibility Criteria Not Met|0|||
145608587|NCT04867785|525083124|FG001|Overall Study|Eligibility Criteria Not Met|0|||
145608588|NCT04867785|525083125|FG002|Overall Study|Eligibility Criteria Not Met|0|||
145776458|NCT00923091|525691632|FG009|Period III (Single-Blind)|Protocol Violation|0|||
145776459|NCT00923091|525691633|FG010|Period III (Single-Blind)|Protocol Violation|0|||
145608589|NCT04867785|525083126|FG003|Overall Study|Eligibility Criteria Not Met|0|||
145608590|NCT04867785|525083127|FG004|Overall Study|Eligibility Criteria Not Met|0|||
145608591|NCT04867785|525083128|FG005|Overall Study|Eligibility Criteria Not Met|0|||
145776460|NCT00923091|525691634|FG011|Period III (Single-Blind)|Protocol Violation|0|||
145608592|NCT04867785|525083129|FG006|Overall Study|Eligibility Criteria Not Met|0|||
145608593|NCT04867785|525083130|FG007|Overall Study|Eligibility Criteria Not Met|1|||
145608594|NCT02494921|525083131|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
145608595|NCT02494921|525083132|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
145608596|NCT02494921|525083133|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
145608597|NCT02494921|525083134|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
145608598|NCT02494921|525083135|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
145776461|NCT00923091|525691635|FG012|Period III (Single-Blind)|Protocol Violation|0|||
145608599|NCT02494921|525083131|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
145608600|NCT02494921|525083132|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
145608601|NCT02494921|525083133|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
145608602|NCT02494921|525083134|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
145608603|NCT02494921|525083135|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
145608604|NCT02494921|525083131|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
145608605|NCT02494921|525083132|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
145608606|NCT02494921|525083133|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
145608607|NCT02494921|525083134|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
145608608|NCT02494921|525083135|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
145608609|NCT03585296|525083140|FG000|Overall Study|Adverse Event|1|||
145608610|NCT03585296|525083140|FG000|Overall Study|Lost to Follow-up|2|||
145608611|NCT03585296|525083140|FG000|Overall Study|Withdrawal by Subject|2|||
145608612|NCT00462670|525083143|FG000|Overall Study|Adverse Event|3|||
145608613|NCT00462670|525083144|FG001|Overall Study|Adverse Event|5|||
145608614|NCT00462670|525083143|FG000|Overall Study|Lack of Efficacy|1|||
145608615|NCT00462670|525083144|FG001|Overall Study|Lack of Efficacy|0|||
145608616|NCT00462670|525083143|FG000|Overall Study|Protocol Violation|1|||
145608617|NCT00462670|525083144|FG001|Overall Study|Protocol Violation|0|||
145608618|NCT00462670|525083143|FG000|Overall Study|Resolution of signs and symptoms|0|||
145608619|NCT00462670|525083144|FG001|Overall Study|Resolution of signs and symptoms|2|||
145608620|NCT02966002|525083145|FG000|Overall Study|Withdrawal by Subject|2|||
145608621|NCT02966002|525083145|FG000|Overall Study|Adverse Event|1|||
145608622|NCT02966002|525083145|FG000|Overall Study|Lost to Follow-up|1|||
145608623|NCT02291432|525083147|FG000|Overall Study|Withdrawal by Subject|2|||
145608624|NCT00584805|525083150|FG000|Overall Study|No longer at risk of exposure|39|||
145608625|NCT00584805|525083150|FG000|Overall Study|Relocation|36|||
145608626|NCT00584805|525083150|FG000|Overall Study|Withdrawal by Subject|18|||
145608627|NCT00584805|525083150|FG000|Overall Study|Non-compliance|1|||
145608628|NCT00584805|525083150|FG000|Overall Study|Lost to follow up|3|||
145608629|NCT00584805|525083150|FG000|Overall Study|Screen failures|2|||
145608630|NCT03097861|525083155|FG000|Overall Study|Adverse Event|3|||
145608631|NCT03097861|525083156|FG001|Overall Study|Adverse Event|8|||
145608632|NCT03097861|525083157|FG002|Overall Study|Adverse Event|4|||
145608633|NCT03097861|525083155|FG000|Overall Study|Investigator Decision|0|||
145608634|NCT03097861|525083156|FG001|Overall Study|Investigator Decision|1|||
145608635|NCT03097861|525083157|FG002|Overall Study|Investigator Decision|0|||
145608636|NCT03097861|525083155|FG000|Overall Study|Lost to Follow-up|0|||
145608637|NCT03097861|525083156|FG001|Overall Study|Lost to Follow-up|7|||
145608638|NCT03097861|525083157|FG002|Overall Study|Lost to Follow-up|1|||
145608639|NCT03097861|525083155|FG000|Overall Study|Withdrawal by Subject|1|||
145608640|NCT03097861|525083156|FG001|Overall Study|Withdrawal by Subject|5|||
145776462|NCT00923091|525691623|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
145776463|NCT00923091|525691624|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
145776464|NCT00923091|525691625|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
145776465|NCT00923091|525691626|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
145776466|NCT00923091|525691627|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
145776467|NCT00923091|525691628|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
145776468|NCT00923091|525691629|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
145776469|NCT00923091|525691630|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
145776470|NCT00923091|525691631|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
145776471|NCT00923091|525691632|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
145776472|NCT00923091|525691633|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
145776473|NCT00923091|525691634|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
145776474|NCT00923091|525691635|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
145776475|NCT00923091|525691623|FG000|Period IV (Double-Blind)|Adverse Event|2|||
145776476|NCT00923091|525691624|FG001|Period IV (Double-Blind)|Adverse Event|0|||
145776477|NCT00923091|525691625|FG002|Period IV (Double-Blind)|Adverse Event|0|||
145776478|NCT00923091|525691626|FG003|Period IV (Double-Blind)|Adverse Event|0|||
145776479|NCT00923091|525691627|FG004|Period IV (Double-Blind)|Adverse Event|0|||
145776480|NCT00923091|525691628|FG005|Period IV (Double-Blind)|Adverse Event|0|||
145776481|NCT00923091|525691629|FG006|Period IV (Double-Blind)|Adverse Event|0|||
145776482|NCT00923091|525691630|FG007|Period IV (Double-Blind)|Adverse Event|0|||
145776483|NCT00923091|525691631|FG008|Period IV (Double-Blind)|Adverse Event|0|||
145608641|NCT03097861|525083157|FG002|Overall Study|Withdrawal by Subject|3|||
145608642|NCT03097861|525083155|FG000|Overall Study|Reason not provided|3|||
145608643|NCT03097861|525083156|FG001|Overall Study|Reason not provided|1|||
145608644|NCT03097861|525083157|FG002|Overall Study|Reason not provided|1|||
145608645|NCT01785563|525083158|FG000|Overall Study|Physician Decision|10|||
145608646|NCT01785563|525083158|FG000|Overall Study|Withdrawal by Subject|1|||
145608647|NCT01785563|525083158|FG000|Overall Study|Protocol Violation|2|||
145608648|NCT01616771|525083161|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
145608649|NCT00744328|525083162|FG000|Overall Study|Lost to Follow-up|2|||
145608650|NCT00744328|525083163|FG001|Overall Study|Lost to Follow-up|5|||
145776484|NCT00923091|525691632|FG009|Period IV (Double-Blind)|Adverse Event|0|||
145608651|NCT00744328|525083164|FG002|Overall Study|Lost to Follow-up|3|||
145536020|NCT00246753|524822093|FG000|Overall Study|Physician Decision|2|||
145536021|NCT00246753|524822093|FG000|Overall Study|Adverse Event|2|||
145536022|NCT00246753|524822093|FG000|Overall Study|Unacceptable toxicity|2|||
145536023|NCT03019185|524822096|FG000|Overall Study|Lost to Follow-up|3|||
145536024|NCT03019185|524822097|FG001|Overall Study|Lost to Follow-up|0|||
145536025|NCT03019185|524822098|FG002|Overall Study|Lost to Follow-up|2|||
145536026|NCT03019185|524822096|FG000|Overall Study|Withdrawal by Subject|1|||
145536027|NCT03019185|524822097|FG001|Overall Study|Withdrawal by Subject|1|||
145536028|NCT03019185|524822098|FG002|Overall Study|Withdrawal by Subject|0|||
145536029|NCT03019185|524822096|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
145536030|NCT03019185|524822097|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
145536031|NCT03019185|524822098|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
145536032|NCT03019185|524822096|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
145536033|NCT03019185|524822097|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
145536034|NCT03019185|524822098|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
145536035|NCT00617851|524822099|FG000|Overall Study|Death|0|||
145536036|NCT00617851|524822100|FG001|Overall Study|Death|0|||
145536037|NCT00617851|524822101|FG002|Overall Study|Death|0|||
145536038|NCT00617851|524822102|FG003|Overall Study|Death|1|||
145536039|NCT00617851|524822099|FG000|Overall Study|Withdrawal by Subject|14|||
145536040|NCT00617851|524822100|FG001|Overall Study|Withdrawal by Subject|7|||
145536041|NCT00617851|524822101|FG002|Overall Study|Withdrawal by Subject|12|||
145536042|NCT00617851|524822102|FG003|Overall Study|Withdrawal by Subject|4|||
145536043|NCT00617851|524822099|FG000|Overall Study|Lost to Follow-up|27|||
145536044|NCT00617851|524822100|FG001|Overall Study|Lost to Follow-up|29|||
145536045|NCT00617851|524822101|FG002|Overall Study|Lost to Follow-up|31|||
145536046|NCT00617851|524822102|FG003|Overall Study|Lost to Follow-up|19|||
145536047|NCT00617851|524822099|FG000|Overall Study|Inappropriate Enrollment|5|||
145536048|NCT00617851|524822100|FG001|Overall Study|Inappropriate Enrollment|4|||
145536049|NCT00617851|524822101|FG002|Overall Study|Inappropriate Enrollment|1|||
145536050|NCT00617851|524822102|FG003|Overall Study|Inappropriate Enrollment|1|||
145536051|NCT00617851|524822099|FG000|Overall Study|Unable to classify|1|||
145536052|NCT00617851|524822100|FG001|Overall Study|Unable to classify|0|||
145776485|NCT00923091|525691633|FG010|Period IV (Double-Blind)|Adverse Event|0|||
145776486|NCT00923091|525691634|FG011|Period IV (Double-Blind)|Adverse Event|0|||
145776487|NCT00923091|525691635|FG012|Period IV (Double-Blind)|Adverse Event|0|||
145776488|NCT00923091|525691623|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776489|NCT00923091|525691624|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
145776490|NCT00923091|525691625|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776491|NCT00923091|525691626|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776492|NCT00923091|525691627|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776493|NCT00923091|525691628|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776494|NCT00923091|525691629|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776495|NCT00923091|525691630|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776496|NCT00923091|525691631|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776497|NCT00923091|525691632|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776498|NCT00923091|525691633|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776499|NCT00923091|525691634|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776500|NCT00923091|525691635|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
145776501|NCT00923091|525691623|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
145776502|NCT00923091|525691624|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
145776503|NCT00923091|525691625|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
145776504|NCT00923091|525691626|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
145776505|NCT00923091|525691627|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
145776506|NCT00923091|525691628|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
145776507|NCT00923091|525691629|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
145776508|NCT00923091|525691630|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
145776509|NCT00923091|525691631|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
145776510|NCT00923091|525691632|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
145776511|NCT00923091|525691633|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
145403673|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
145536053|NCT00617851|524822101|FG002|Overall Study|Unable to classify|1|||
145536054|NCT00617851|524822102|FG003|Overall Study|Unable to classify|0|||
145536055|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Adverse Event|3|||
145536056|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Adverse Event|0|||
145536057|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
145536058|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
145536059|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
145536060|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
145536061|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Physician Decision|0|||
145536062|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Physician Decision|2|||
145536063|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
145536064|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
145776512|NCT00923091|525691634|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
145776513|NCT00923091|525691635|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
145776514|NCT00923091|525691623|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776515|NCT00923091|525691624|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776516|NCT00923091|525691625|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776517|NCT00923091|525691626|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776518|NCT00923091|525691627|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776519|NCT00923091|525691628|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
145536065|NCT02110238|524822105|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
145536066|NCT02110238|524822106|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
145536067|NCT02110238|524822105|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
145536068|NCT02110238|524822106|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
145536069|NCT02110238|524822105|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
145536070|NCT02110238|524822106|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
145536071|NCT02110238|524822105|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
145536072|NCT02110238|524822106|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
145536073|NCT02110238|524822105|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
145536074|NCT02110238|524822106|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
145536075|NCT02110238|524822105|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
145536076|NCT02110238|524822106|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
145536077|NCT03228433|524822111|FG000|Overall Study|Lost to Follow-up|1|||
145536078|NCT03228433|524822112|FG001|Overall Study|Lost to Follow-up|0|||
145536079|NCT03228433|524822113|FG002|Overall Study|Lost to Follow-up|0|||
145536080|NCT03228433|524822114|FG003|Overall Study|Lost to Follow-up|0|||
145536081|NCT03228433|524822115|FG004|Overall Study|Lost to Follow-up|0|||
145536082|NCT03228433|524822116|FG005|Overall Study|Lost to Follow-up|0|||
145536083|NCT03228433|524822111|FG000|Overall Study|Positive alcohol test|0|||
145536084|NCT03228433|524822112|FG001|Overall Study|Positive alcohol test|0|||
145536085|NCT03228433|524822113|FG002|Overall Study|Positive alcohol test|0|||
145536086|NCT03228433|524822114|FG003|Overall Study|Positive alcohol test|1|||
145536087|NCT03228433|524822115|FG004|Overall Study|Positive alcohol test|0|||
145536088|NCT03228433|524822116|FG005|Overall Study|Positive alcohol test|0|||
145776520|NCT00923091|525691629|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776521|NCT00923091|525691630|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776522|NCT00923091|525691631|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
145776523|NCT00923091|525691632|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776524|NCT00923091|525691633|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776525|NCT00923091|525691634|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
145776526|NCT00923091|525691635|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
145776527|NCT00923091|525691623|FG000|Period V (Double -Blind)|Protocol Violation|0|||
145776528|NCT00923091|525691624|FG001|Period V (Double -Blind)|Protocol Violation|0|||
145776529|NCT00923091|525691625|FG002|Period V (Double -Blind)|Protocol Violation|0|||
145776530|NCT00923091|525691626|FG003|Period V (Double -Blind)|Protocol Violation|0|||
145776531|NCT00923091|525691627|FG004|Period V (Double -Blind)|Protocol Violation|0|||
145776532|NCT00923091|525691628|FG005|Period V (Double -Blind)|Protocol Violation|0|||
145776533|NCT00923091|525691629|FG006|Period V (Double -Blind)|Protocol Violation|0|||
145776534|NCT00923091|525691630|FG007|Period V (Double -Blind)|Protocol Violation|0|||
145776535|NCT00923091|525691631|FG008|Period V (Double -Blind)|Protocol Violation|0|||
145776536|NCT00923091|525691632|FG009|Period V (Double -Blind)|Protocol Violation|0|||
145776537|NCT00923091|525691633|FG010|Period V (Double -Blind)|Protocol Violation|0|||
145776538|NCT00923091|525691634|FG011|Period V (Double -Blind)|Protocol Violation|0|||
145776539|NCT00923091|525691635|FG012|Period V (Double -Blind)|Protocol Violation|1|||
145776540|NCT00923091|525691623|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
145776541|NCT00923091|525691624|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
145776542|NCT00923091|525691625|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
145776543|NCT00923091|525691626|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
145776544|NCT00923091|525691627|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
145776545|NCT00923091|525691628|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
145776546|NCT00923091|525691629|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
145776547|NCT00923091|525691630|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
145776548|NCT00923091|525691631|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
145536089|NCT01365052|524822124|FG000|Overall Study|Adverse Event|4|||
145536090|NCT01365052|524822125|FG001|Overall Study|Adverse Event|4|||
145536091|NCT02980783|524822126|FG000|Overall Study|Lost to Follow-up|1|||
145536092|NCT00850070|524822127|FG000|Overall Study|Lack of Efficacy|1|||
145608652|NCT00744328|525083162|FG000|Overall Study|Withdrawal by Subject|5|||
145536093|NCT00850070|524822128|FG001|Overall Study|Lack of Efficacy|1|||
145536094|NCT00850070|524822127|FG000|Overall Study|Adverse Event|2|||
145536095|NCT00850070|524822128|FG001|Overall Study|Adverse Event|0|||
145536096|NCT01522248|524822129|FG000|Overall Study|Lost to Follow-up|1|||
145776549|NCT00923091|525691632|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
145776550|NCT00923091|525691633|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
145776551|NCT00923091|525691634|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
145776552|NCT00923091|525691635|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
145776553|NCT00923091|525691623|FG000|Period VI (Open-Label)|Adverse Event|17|||
145776554|NCT00923091|525691624|FG001|Period VI (Open-Label)|Adverse Event|0|||
145776555|NCT00923091|525691625|FG002|Period VI (Open-Label)|Adverse Event|4|||
145776556|NCT00923091|525691626|FG003|Period VI (Open-Label)|Adverse Event|1|||
145776557|NCT00923091|525691627|FG004|Period VI (Open-Label)|Adverse Event|1|||
145776558|NCT00923091|525691628|FG005|Period VI (Open-Label)|Adverse Event|0|||
145776559|NCT00923091|525691629|FG006|Period VI (Open-Label)|Adverse Event|0|||
145776560|NCT00923091|525691630|FG007|Period VI (Open-Label)|Adverse Event|0|||
145776561|NCT00923091|525691631|FG008|Period VI (Open-Label)|Adverse Event|0|||
145776562|NCT00923091|525691632|FG009|Period VI (Open-Label)|Adverse Event|0|||
145776563|NCT00923091|525691633|FG010|Period VI (Open-Label)|Adverse Event|0|||
145776564|NCT00923091|525691634|FG011|Period VI (Open-Label)|Adverse Event|0|||
145776565|NCT00923091|525691635|FG012|Period VI (Open-Label)|Adverse Event|0|||
145776566|NCT00923091|525691623|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
145776567|NCT00923091|525691624|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
145776568|NCT00923091|525691625|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
145776569|NCT00923091|525691626|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776570|NCT00923091|525691627|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
145776571|NCT00923091|525691628|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776572|NCT00923091|525691629|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776573|NCT00923091|525691630|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776574|NCT00923091|525691631|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776575|NCT00923091|525691632|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776576|NCT00923091|525691633|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776577|NCT00923091|525691634|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776578|NCT00923091|525691635|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
145776579|NCT00923091|525691623|FG000|Period VI (Open-Label)|Protocol Violation|6|||
145776580|NCT00923091|525691624|FG001|Period VI (Open-Label)|Protocol Violation|1|||
145776581|NCT00923091|525691625|FG002|Period VI (Open-Label)|Protocol Violation|3|||
145776582|NCT00923091|525691626|FG003|Period VI (Open-Label)|Protocol Violation|1|||
145776583|NCT00923091|525691627|FG004|Period VI (Open-Label)|Protocol Violation|4|||
145776584|NCT00923091|525691628|FG005|Period VI (Open-Label)|Protocol Violation|0|||
145776585|NCT00923091|525691629|FG006|Period VI (Open-Label)|Protocol Violation|0|||
145776586|NCT00923091|525691630|FG007|Period VI (Open-Label)|Protocol Violation|0|||
145776587|NCT00923091|525691631|FG008|Period VI (Open-Label)|Protocol Violation|0|||
145776588|NCT00923091|525691632|FG009|Period VI (Open-Label)|Protocol Violation|0|||
145776589|NCT00923091|525691633|FG010|Period VI (Open-Label)|Protocol Violation|0|||
145776590|NCT00923091|525691634|FG011|Period VI (Open-Label)|Protocol Violation|0|||
145776591|NCT00923091|525691635|FG012|Period VI (Open-Label)|Protocol Violation|0|||
145776592|NCT00923091|525691623|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
145776593|NCT00923091|525691624|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
145776594|NCT00923091|525691625|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
145776595|NCT00923091|525691626|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
145776596|NCT00923091|525691627|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
145776597|NCT00923091|525691628|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
145776598|NCT00923091|525691629|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
145776599|NCT00923091|525691630|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
145776600|NCT00923091|525691631|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
145776601|NCT00923091|525691632|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
145776602|NCT00923091|525691633|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
145776603|NCT00923091|525691634|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
145776604|NCT00923091|525691635|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
145776605|NCT00923091|525691623|FG000|Period VI (Open-Label)|Other Reason|0|||
145776606|NCT00923091|525691624|FG001|Period VI (Open-Label)|Other Reason|0|||
145403674|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145403675|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145403676|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145403677|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145776607|NCT00923091|525691625|FG002|Period VI (Open-Label)|Other Reason|0|||
145776608|NCT00923091|525691626|FG003|Period VI (Open-Label)|Other Reason|1|||
145776609|NCT00923091|525691627|FG004|Period VI (Open-Label)|Other Reason|1|||
145776610|NCT00923091|525691628|FG005|Period VI (Open-Label)|Other Reason|0|||
145776611|NCT00923091|525691629|FG006|Period VI (Open-Label)|Other Reason|0|||
145776612|NCT00923091|525691630|FG007|Period VI (Open-Label)|Other Reason|0|||
145776613|NCT00923091|525691631|FG008|Period VI (Open-Label)|Other Reason|0|||
145403678|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145403679|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145776614|NCT00923091|525691632|FG009|Period VI (Open-Label)|Other Reason|0|||
145776615|NCT00923091|525691633|FG010|Period VI (Open-Label)|Other Reason|0|||
145536097|NCT01522248|524822130|FG001|Overall Study|Lost to Follow-up|0|||
145536098|NCT01696695|524822134|FG000|Overall Study|Disease progression|373|||
145536099|NCT01696695|524822134|FG000|Overall Study|Death|29|||
145536100|NCT01696695|524822134|FG000|Overall Study|Adverse Event|74|||
145776616|NCT00923091|525691634|FG011|Period VI (Open-Label)|Other Reason|0|||
145776617|NCT00923091|525691635|FG012|Period VI (Open-Label)|Other Reason|0|||
145776618|NCT02460822|525691638|FG000|Overall Study|Withdrawal by Subject|1|||
145776619|NCT00467649|525691639|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
145776620|NCT00467649|525691640|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
145776621|NCT00467649|525691641|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
145776622|NCT00467649|525691642|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
145776623|NCT00467649|525691643|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
145776624|NCT00467649|525691644|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
145776625|NCT00467649|525691639|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
145776626|NCT00467649|525691640|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
145776627|NCT00467649|525691641|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
145776628|NCT00467649|525691642|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
145776629|NCT00467649|525691643|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
145776630|NCT00467649|525691644|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
145776631|NCT00467649|525691639|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
145776632|NCT00467649|525691640|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
145776633|NCT00467649|525691641|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
145776634|NCT00467649|525691642|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
145776635|NCT00467649|525691643|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
145776636|NCT00467649|525691644|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
145776637|NCT00467649|525691639|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
145776638|NCT00467649|525691640|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
145776639|NCT00467649|525691641|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
145536101|NCT01696695|524822134|FG000|Overall Study|Withdrawal by Subject|92|||
145536102|NCT01696695|524822134|FG000|Overall Study|Lost to Follow-up|48|||
145776640|NCT00467649|525691642|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
145776641|NCT00467649|525691643|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
145536103|NCT01696695|524822134|FG000|Overall Study|Other|74|||
145536104|NCT01696695|524822134|FG000|Overall Study|Major Protocol Violation|192|||
145536105|NCT05224141|524822137|FG000|Overall Study|Ongoing|75|||
145536106|NCT05224141|524822138|FG001|Overall Study|Ongoing|88|||
145536107|NCT05224141|524822137|FG000|Overall Study|Withdrawal by Subject|2|||
145536108|NCT05224141|524822138|FG001|Overall Study|Withdrawal by Subject|4|||
145536109|NCT05224141|524822137|FG000|Overall Study|Death|153|||
145536110|NCT05224141|524822138|FG001|Overall Study|Death|138|||
145536111|NCT00116428|524822146|FG000|Overall Study|Withdrawal by Subject|2|||
145536112|NCT00116428|524822147|FG001|Overall Study|Withdrawal by Subject|5|||
145536113|NCT00116428|524822146|FG000|Overall Study|Did not meet inclusion criteria|1|||
145776642|NCT00467649|525691644|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
145776643|NCT00467649|525691639|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
145776644|NCT00467649|525691640|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
145776645|NCT00467649|525691641|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
145776646|NCT00467649|525691642|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
145279067|NCT00550420|523872849|FG000|Overall Study|Lack of curative effect|1|||
145279068|NCT00550420|523872849|FG000|Overall Study|Unethical stop of enrollment|2|||
145279069|NCT00550420|523872849|FG000|Overall Study|Caregiver's decision to withdraw|1|||
145279070|NCT00550420|523872849|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
145279071|NCT00550420|523872849|FG000|Overall Study|Exclusion criteria|1|||
145279072|NCT00550420|523872849|FG000|Overall Study|Prohibited medicine|1|||
145279073|NCT00782275|523872850|FG000|Overall Study|Adverse Event|11|||
145279074|NCT00782275|523872850|FG000|Overall Study|Withdrawal by Subject|1|||
145403680|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145536114|NCT00116428|524822147|FG001|Overall Study|Did not meet inclusion criteria|0|||
145776647|NCT00467649|525691643|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
145776648|NCT00467649|525691644|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
145776649|NCT00467649|525691639|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
145776650|NCT00467649|525691640|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
145279075|NCT00782275|523872850|FG000|Overall Study|Progressive Disease|21|||
145403681|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
145536115|NCT00113087|524822148|FG000|Overall Study|Death or Transplant|14|||
145536116|NCT00113087|524822149|FG001|Overall Study|Death or Transplant|16|||
145536117|NCT00113087|524822148|FG000|Overall Study|Family or MD withdrew subject|10|||
145536118|NCT00113087|524822149|FG001|Overall Study|Family or MD withdrew subject|5|||
145536119|NCT03452228|524822150|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145536120|NCT03452228|524822151|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
145536121|NCT03452228|524822152|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145776651|NCT00467649|525691641|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
145776652|NCT00467649|525691642|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
145776653|NCT00467649|525691643|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
145776654|NCT00467649|525691644|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
145776655|NCT00467649|525691639|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
145776656|NCT00467649|525691640|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
145279076|NCT00782275|523872850|FG000|Overall Study|Physician Decision|4|||
145608653|NCT00744328|525083163|FG001|Overall Study|Withdrawal by Subject|3|||
145608654|NCT00744328|525083164|FG002|Overall Study|Withdrawal by Subject|4|||
145608655|NCT00744328|525083162|FG000|Overall Study|Found ineligible after randomization|0|||
145608656|NCT00744328|525083163|FG001|Overall Study|Found ineligible after randomization|0|||
145608657|NCT00744328|525083164|FG002|Overall Study|Found ineligible after randomization|1|||
145608658|NCT00154310|525083166|FG000|Overall Study|Adverse Event|19|||
145608659|NCT00154310|525083167|FG001|Overall Study|Adverse Event|9|||
145608660|NCT00154310|525083166|FG000|Overall Study|Lack of Efficacy|5|||
145608661|NCT00154310|525083167|FG001|Overall Study|Lack of Efficacy|4|||
145608662|NCT00154310|525083166|FG000|Overall Study|Protocol Violation|4|||
145608663|NCT00154310|525083167|FG001|Overall Study|Protocol Violation|2|||
145608664|NCT00154310|525083166|FG000|Overall Study|Withdrawal by Subject|9|||
145608665|NCT00154310|525083167|FG001|Overall Study|Withdrawal by Subject|3|||
145608666|NCT00154310|525083166|FG000|Overall Study|Lost to Follow-up|0|||
145608667|NCT00154310|525083167|FG001|Overall Study|Lost to Follow-up|8|||
145608668|NCT00154310|525083166|FG000|Overall Study|Administrative problems|0|||
145608669|NCT00154310|525083167|FG001|Overall Study|Administrative problems|1|||
145608670|NCT00154310|525083166|FG000|Overall Study|Death|0|||
145608671|NCT00154310|525083167|FG001|Overall Study|Death|1|||
145608672|NCT04399356|525083168|FG000|Overall Study|Lost to Follow-up|1|||
145608673|NCT04399356|525083169|FG001|Overall Study|Lost to Follow-up|1|||
145608674|NCT04399356|525083168|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
145608675|NCT04399356|525083169|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
145608676|NCT04399356|525083168|FG000|Overall Study|Withdrawal by Subject|1|||
145608677|NCT04399356|525083169|FG001|Overall Study|Withdrawal by Subject|0|||
145608678|NCT04041440|525083170|FG000|Overall Study|Withdrawal by Subject|0|||
145608679|NCT04041440|525083171|FG001|Overall Study|Withdrawal by Subject|1|||
145608680|NCT04041440|525083170|FG000|Overall Study|Lost to Follow-up|0|||
145608681|NCT04041440|525083171|FG001|Overall Study|Lost to Follow-up|1|||
145608682|NCT02247804|525083176|FG000|Treatment Period 1|Adverse Event|9|||
145608683|NCT02247804|525083177|FG001|Treatment Period 1|Adverse Event|2|||
145608684|NCT02247804|525083178|FG002|Treatment Period 1|Adverse Event|0|||
145608685|NCT02247804|525083176|FG000|Treatment Period 1|Lack of Efficacy|0|||
145608686|NCT02247804|525083177|FG001|Treatment Period 1|Lack of Efficacy|0|||
145608687|NCT02247804|525083178|FG002|Treatment Period 1|Lack of Efficacy|2|||
145608688|NCT02247804|525083176|FG000|Treatment Period 1|Lost to Follow-up|1|||
145608689|NCT02247804|525083177|FG001|Treatment Period 1|Lost to Follow-up|0|||
145608690|NCT02247804|525083178|FG002|Treatment Period 1|Lost to Follow-up|2|||
145608691|NCT02247804|525083176|FG000|Treatment Period 1|Personal Reasons|7|||
145608692|NCT02247804|525083177|FG001|Treatment Period 1|Personal Reasons|1|||
145608693|NCT02247804|525083178|FG002|Treatment Period 1|Personal Reasons|2|||
145608694|NCT02247804|525083176|FG000|Treatment Period 1|Protocol Deviation|0|||
145608695|NCT02247804|525083177|FG001|Treatment Period 1|Protocol Deviation|0|||
145608696|NCT02247804|525083178|FG002|Treatment Period 1|Protocol Deviation|1|||
145608697|NCT02247804|525083176|FG000|Treatment Period 1|Randomized but not Treated|5|||
145608698|NCT02247804|525083177|FG001|Treatment Period 1|Randomized but not Treated|1|||
145608699|NCT02247804|525083178|FG002|Treatment Period 1|Randomized but not Treated|1|||
145608700|NCT02247804|525083176|FG000|Treatment Period 2|Adverse Event|6|||
145608701|NCT02247804|525083177|FG001|Treatment Period 2|Adverse Event|3|||
145608702|NCT02247804|525083178|FG002|Treatment Period 2|Adverse Event|3|||
145608703|NCT02247804|525083176|FG000|Treatment Period 2|Lack of Efficacy|0|||
145608704|NCT02247804|525083177|FG001|Treatment Period 2|Lack of Efficacy|0|||
145608705|NCT02247804|525083178|FG002|Treatment Period 2|Lack of Efficacy|1|||
145608706|NCT02247804|525083176|FG000|Treatment Period 2|Lost to Follow-up|0|||
145608707|NCT02247804|525083177|FG001|Treatment Period 2|Lost to Follow-up|1|||
145608708|NCT02247804|525083178|FG002|Treatment Period 2|Lost to Follow-up|1|||
145608709|NCT02247804|525083176|FG000|Treatment Period 2|Personal Reasons|2|||
145608710|NCT02247804|525083177|FG001|Treatment Period 2|Personal Reasons|1|||
145608711|NCT02247804|525083178|FG002|Treatment Period 2|Personal Reasons|1|||
145608712|NCT02247804|525083176|FG000|Treatment Period 2|Reason not Specified|0|||
145608713|NCT02247804|525083177|FG001|Treatment Period 2|Reason not Specified|0|||
145776657|NCT00467649|525691641|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
145776658|NCT00467649|525691642|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
145279077|NCT00782275|523872850|FG000|Overall Study|Not started treatment|1|||
145608714|NCT02247804|525083178|FG002|Treatment Period 2|Reason not Specified|2|||
145608715|NCT02247804|525083176|FG000|Treatment Period 3|Adverse Event|4|||
145608716|NCT02247804|525083177|FG001|Treatment Period 3|Adverse Event|3|||
145776659|NCT00467649|525691643|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
145776660|NCT00467649|525691644|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
145776661|NCT03240081|525691645|FG000|Overall Study|Withdrawal by Subject|0|||
145776662|NCT03240081|525691646|FG001|Overall Study|Withdrawal by Subject|2|||
145776663|NCT03240081|525691645|FG000|Overall Study|Lost to Follow-up|0|||
145776664|NCT03240081|525691646|FG001|Overall Study|Lost to Follow-up|1|||
145776665|NCT04925570|525691649|FG000|Overall Study|Protocol Violation|24|||
145536122|NCT03452228|524822150|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145536123|NCT03452228|524822151|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145536124|NCT03452228|524822152|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145536125|NCT03452228|524822150|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
145536126|NCT03452228|524822151|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
145536127|NCT03452228|524822152|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
145536128|NCT03452228|524822150|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145536129|NCT03452228|524822151|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145536130|NCT03452228|524822152|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
145536131|NCT00386607|524822153|FG000|Core|Adverse Event|40|||
145536132|NCT00386607|524822154|FG001|Core|Adverse Event|0|||
145536133|NCT00386607|524822153|FG000|Core|Abnormal laboratory value(s)|3|||
145536134|NCT00386607|524822154|FG001|Core|Abnormal laboratory value(s)|0|||
145536135|NCT00386607|524822153|FG000|Core|Unsatisfactory therapeutic effect|23|||
145536136|NCT00386607|524822154|FG001|Core|Unsatisfactory therapeutic effect|0|||
145536137|NCT00386607|524822153|FG000|Core|Condition no longer requires study drug|4|||
145536138|NCT00386607|524822154|FG001|Core|Condition no longer requires study drug|0|||
145536139|NCT00386607|524822153|FG000|Core|Patient withdrew consent|15|||
145536140|NCT00386607|524822154|FG001|Core|Patient withdrew consent|0|||
145536141|NCT00386607|524822153|FG000|Core|Lost to Follow-up|23|||
145536142|NCT00386607|524822154|FG001|Core|Lost to Follow-up|0|||
145536143|NCT00386607|524822153|FG000|Core|Administrative problems|1|||
145776666|NCT04925570|525691650|FG001|Overall Study|Protocol Violation|30|||
145776667|NCT04925570|525691649|FG000|Overall Study|Withdrawal by Subject|0|||
145536144|NCT00386607|524822154|FG001|Core|Administrative problems|0|||
145536145|NCT00386607|524822153|FG000|Core|Protocol Deviation|6|||
145536146|NCT00386607|524822154|FG001|Core|Protocol Deviation|0|||
145536147|NCT00386607|524822153|FG000|Extension|Adverse Event|0|||
145536148|NCT00386607|524822154|FG001|Extension|Adverse Event|6|||
145536149|NCT00386607|524822153|FG000|Extension|Abnormal laboratory value(s)|0|||
145536150|NCT00386607|524822154|FG001|Extension|Abnormal laboratory value(s)|1|||
145536151|NCT00386607|524822153|FG000|Extension|Administrative problems|0|||
145536152|NCT00386607|524822154|FG001|Extension|Administrative problems|1|||
145536153|NCT00386607|524822153|FG000|Extension|Lost to Follow-up|0|||
145776668|NCT04925570|525691650|FG001|Overall Study|Withdrawal by Subject|2|||
145776669|NCT05121103|525691653|FG000|Overall Study|Progressive disease|2|||
145776670|NCT05121103|525691654|FG001|Overall Study|Progressive disease|1|||
145776671|NCT05121103|525691655|FG002|Overall Study|Progressive disease|6|||
145776672|NCT05121103|525691653|FG000|Overall Study|Physician Decision|2|||
145776673|NCT05121103|525691654|FG001|Overall Study|Physician Decision|1|||
145776674|NCT05121103|525691655|FG002|Overall Study|Physician Decision|0|||
145776675|NCT05121103|525691653|FG000|Overall Study|Withdrawal by Subject|0|||
145776676|NCT05121103|525691654|FG001|Overall Study|Withdrawal by Subject|1|||
145776677|NCT05121103|525691655|FG002|Overall Study|Withdrawal by Subject|0|||
145776678|NCT03443024|525691656|FG000|Overall Study|Adverse Event|2|||
145776679|NCT03443024|525691657|FG001|Overall Study|Adverse Event|4|||
145776680|NCT03443024|525691658|FG002|Overall Study|Adverse Event|3|||
145776681|NCT03443024|525691659|FG003|Overall Study|Adverse Event|1|||
145776682|NCT03443024|525691656|FG000|Overall Study|Lost to Follow-up|9|||
145776683|NCT03443024|525691657|FG001|Overall Study|Lost to Follow-up|9|||
145776684|NCT03443024|525691658|FG002|Overall Study|Lost to Follow-up|7|||
145776685|NCT03443024|525691659|FG003|Overall Study|Lost to Follow-up|5|||
145776686|NCT03443024|525691656|FG000|Overall Study|Withdrawal by Subject|8|||
145776687|NCT03443024|525691657|FG001|Overall Study|Withdrawal by Subject|15|||
145776688|NCT03443024|525691658|FG002|Overall Study|Withdrawal by Subject|9|||
145776689|NCT03443024|525691659|FG003|Overall Study|Withdrawal by Subject|23|||
145776690|NCT03443024|525691656|FG000|Overall Study|Physician Decision|1|||
145776691|NCT03443024|525691657|FG001|Overall Study|Physician Decision|2|||
145776692|NCT03443024|525691658|FG002|Overall Study|Physician Decision|0|||
145776693|NCT03443024|525691659|FG003|Overall Study|Physician Decision|1|||
145536154|NCT00386607|524822154|FG001|Extension|Lost to Follow-up|3|||
145536155|NCT00386607|524822153|FG000|Extension|Patient withdrew consent|0|||
145536156|NCT00386607|524822154|FG001|Extension|Patient withdrew consent|5|||
145536157|NCT00386607|524822153|FG000|Extension|Unsatisfactory therapeutic effect|0|||
145776694|NCT03443024|525691656|FG000|Overall Study|Sponsor Decision|1|||
145776695|NCT03443024|525691657|FG001|Overall Study|Sponsor Decision|1|||
145776696|NCT03443024|525691658|FG002|Overall Study|Sponsor Decision|0|||
145776697|NCT03443024|525691659|FG003|Overall Study|Sponsor Decision|0|||
145776698|NCT03443024|525691656|FG000|Overall Study|Protocol Deviation|0|||
145536158|NCT00386607|524822154|FG001|Extension|Unsatisfactory therapeutic effect|1|||
145536159|NCT00423514|524822159|FG000|Overall Study|Ineligible|1|||
145536160|NCT00423514|524822160|FG001|Overall Study|Ineligible|0|||
145536161|NCT04729621|524822161|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
145536162|NCT04729621|524822162|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
145536163|NCT04729621|524822163|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
145536164|NCT04729621|524822164|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
145536165|NCT04729621|524822165|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
145536166|NCT04729621|524822161|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
145536167|NCT04729621|524822162|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
145536168|NCT04729621|524822163|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
145536169|NCT04729621|524822164|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
145776699|NCT03443024|525691657|FG001|Overall Study|Protocol Deviation|0|||
145776700|NCT03443024|525691658|FG002|Overall Study|Protocol Deviation|0|||
145776701|NCT03443024|525691659|FG003|Overall Study|Protocol Deviation|2|||
145776702|NCT05593432|525691660|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
145776703|NCT05593432|525691661|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
145776704|NCT05593432|525691662|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
145776705|NCT05593432|525691663|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
145776706|NCT05593432|525691660|FG000|16-Week OLE Period|Lack of Efficacy|0|||
145776707|NCT05593432|525691661|FG001|16-Week OLE Period|Lack of Efficacy|0|||
145776708|NCT05593432|525691662|FG002|16-Week OLE Period|Lack of Efficacy|0|||
145776709|NCT05593432|525691663|FG003|16-Week OLE Period|Lack of Efficacy|1|||
145776710|NCT05593432|525691660|FG000|16-Week OLE Period|Lost to Follow-up|0|||
145776711|NCT05593432|525691661|FG001|16-Week OLE Period|Lost to Follow-up|0|||
145776712|NCT05593432|525691662|FG002|16-Week OLE Period|Lost to Follow-up|1|||
145776713|NCT05593432|525691663|FG003|16-Week OLE Period|Lost to Follow-up|2|||
145776714|NCT05593432|525691660|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
145776715|NCT05593432|525691661|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
145776716|NCT05593432|525691662|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
145776717|NCT05593432|525691663|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
145776718|NCT00586690|525691672|FG000|Overall Study|Death|2|||
145776719|NCT00586690|525691673|FG001|Overall Study|Death|0|||
145776720|NCT00586690|525691672|FG000|Overall Study|Disease Progression|10|||
145776721|NCT00586690|525691673|FG001|Overall Study|Disease Progression|0|||
145776722|NCT00586690|525691672|FG000|Overall Study|Adverse Event|1|||
145776723|NCT00586690|525691673|FG001|Overall Study|Adverse Event|0|||
145776724|NCT00586690|525691672|FG000|Overall Study|Lack of Efficacy|2|||
145776725|NCT00586690|525691673|FG001|Overall Study|Lack of Efficacy|0|||
145776726|NCT00586690|525691672|FG000|Overall Study|Lab can't accommodate|1|||
145776727|NCT00586690|525691673|FG001|Overall Study|Lab can't accommodate|0|||
145776728|NCT01751646|525691674|FG000|Overall Study|Lost to Follow-up|5|||
145776729|NCT01751646|525691675|FG001|Overall Study|Lost to Follow-up|1|||
145776730|NCT01751646|525691674|FG000|Overall Study|Withdrawal by Subject|0|||
145776731|NCT01751646|525691675|FG001|Overall Study|Withdrawal by Subject|4|||
145776732|NCT01751646|525691674|FG000|Overall Study|Starting hormone therapy|1|||
145776733|NCT01751646|525691675|FG001|Overall Study|Starting hormone therapy|0|||
145776734|NCT01751646|525691674|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
145776735|NCT01751646|525691675|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
145776736|NCT01751646|525691674|FG000|Overall Study|Inadvertent enrollment|1|||
145776737|NCT01751646|525691675|FG001|Overall Study|Inadvertent enrollment|1|||
145536170|NCT04729621|524822165|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
145536171|NCT04729621|524822161|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
145536172|NCT04729621|524822162|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
145536173|NCT04729621|524822163|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
145536174|NCT04729621|524822164|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
145776738|NCT01751646|525691674|FG000|Overall Study|Moved out of the area|1|||
145776739|NCT01751646|525691675|FG001|Overall Study|Moved out of the area|5|||
145776740|NCT01751646|525691674|FG000|Overall Study|Inability to attend required visits|0|||
145536175|NCT04729621|524822165|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
145536176|NCT04729621|524822161|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145536177|NCT04729621|524822162|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
145536178|NCT04729621|524822163|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
145536179|NCT04729621|524822164|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
145776741|NCT01751646|525691675|FG001|Overall Study|Inability to attend required visits|1|||
145776742|NCT01751646|525691674|FG000|Overall Study|Off study due to multiple obligations|0|||
145776743|NCT01751646|525691675|FG001|Overall Study|Off study due to multiple obligations|1|||
145776744|NCT01751646|525691674|FG000|Overall Study|Fails to comply with study requirements|0|||
145776745|NCT01751646|525691675|FG001|Overall Study|Fails to comply with study requirements|1|||
145776746|NCT01751646|525691674|FG000|Overall Study|Childcare issues|1|||
145536180|NCT04729621|524822165|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
145776747|NCT01751646|525691675|FG001|Overall Study|Childcare issues|1|||
145776748|NCT01151137|525691678|FG000|Overall Study|Death|15|||
145776749|NCT01151137|525691679|FG001|Overall Study|Death|27|||
145776750|NCT01151137|525691678|FG000|Overall Study|Lost to Follow-up|1|||
145776751|NCT01151137|525691679|FG001|Overall Study|Lost to Follow-up|1|||
145776752|NCT01933672|525691681|FG000|Metformin Run-in Period|Adverse Event|1|||
145776753|NCT01933672|525691682|FG001|Metformin Run-in Period|Adverse Event|0|||
145536181|NCT04729621|524822161|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
145776754|NCT01933672|525691683|FG002|Metformin Run-in Period|Adverse Event|0|||
145776755|NCT01933672|525691684|FG003|Metformin Run-in Period|Adverse Event|0|||
145776756|NCT01933672|525691685|FG004|Metformin Run-in Period|Adverse Event|0|||
145776757|NCT01933672|525691686|FG005|Metformin Run-in Period|Adverse Event|0|||
145776758|NCT01933672|525691687|FG006|Metformin Run-in Period|Adverse Event|0|||
145776759|NCT01933672|525691681|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
145776760|NCT01933672|525691682|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145776761|NCT01933672|525691683|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145776762|NCT01933672|525691684|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145776763|NCT01933672|525691685|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145776764|NCT01933672|525691686|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145776765|NCT01933672|525691687|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
145536182|NCT04729621|524822162|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
145536183|NCT04729621|524822163|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
145536184|NCT04729621|524822164|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
145536185|NCT04729621|524822165|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
145536186|NCT04729621|524822161|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
145536187|NCT04729621|524822162|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
145536188|NCT04729621|524822163|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
145536189|NCT04729621|524822164|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
145536190|NCT04729621|524822165|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
145536191|NCT02004522|524822166|FG000|Overall Study|Adverse Event|55|||
145536192|NCT02004522|524822167|FG001|Overall Study|Adverse Event|6|||
145536193|NCT02004522|524822166|FG000|Overall Study|Withdrawal by Subject|13|||
145536194|NCT02004522|524822167|FG001|Overall Study|Withdrawal by Subject|7|||
145536195|NCT02004522|524822166|FG000|Overall Study|Death|12|||
145536196|NCT02004522|524822167|FG001|Overall Study|Death|3|||
145536197|NCT02004522|524822166|FG000|Overall Study|Physician Decision|3|||
145536198|NCT02004522|524822167|FG001|Overall Study|Physician Decision|4|||
145536199|NCT02004522|524822166|FG000|Overall Study|Protocol Violation|1|||
145536200|NCT02004522|524822167|FG001|Overall Study|Protocol Violation|0|||
145536201|NCT02004522|524822166|FG000|Overall Study|Other is reason listed by PI|4|||
145536202|NCT02004522|524822167|FG001|Overall Study|Other is reason listed by PI|1|||
145536203|NCT02004522|524822166|FG000|Overall Study|Never Dosed|2|||
145536204|NCT02004522|524822167|FG001|Overall Study|Never Dosed|4|||
145536205|NCT02004522|524822166|FG000|Overall Study|Disease Progression|35|||
145536206|NCT02004522|524822167|FG001|Overall Study|Disease Progression|31|||
145536207|NCT02004522|524822166|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
145536208|NCT02004522|524822167|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
145536209|NCT01787331|524822168|FG000|Overall Study|Physician Decision|1|||
145536210|NCT01787331|524822168|FG000|Overall Study|Withdrawal by Subject|1|||
145536211|NCT01441180|524822170|FG000|Overall Study|Lost to Follow-up|1|||
145536212|NCT01441180|524822171|FG001|Overall Study|Lost to Follow-up|1|||
145536213|NCT01441180|524822172|FG002|Overall Study|Lost to Follow-up|1|||
145536214|NCT01441180|524822170|FG000|Overall Study|Discontinued|0|||
145536215|NCT01441180|524822171|FG001|Overall Study|Discontinued|0|||
145536216|NCT01441180|524822172|FG002|Overall Study|Discontinued|2|||
145536217|NCT01402011|524822173|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
145536218|NCT01402011|524822174|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
145776766|NCT01933672|525691681|FG000|Metformin Run-in Period|Other|5|||
145776767|NCT01933672|525691682|FG001|Metformin Run-in Period|Other|0|||
145776768|NCT01933672|525691683|FG002|Metformin Run-in Period|Other|0|||
145776769|NCT01933672|525691684|FG003|Metformin Run-in Period|Other|0|||
145279078|NCT00782275|523872850|FG000|Overall Study|Other|3|||
145536219|NCT01402011|524822175|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
145536220|NCT01402011|524822173|FG000|Active Treatment Period|Withdrawal by Subject|1|||
145776770|NCT01933672|525691685|FG004|Metformin Run-in Period|Other|0|||
145776771|NCT01933672|525691686|FG005|Metformin Run-in Period|Other|0|||
145776772|NCT01933672|525691687|FG006|Metformin Run-in Period|Other|0|||
145776773|NCT01933672|525691681|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776774|NCT01933672|525691682|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776775|NCT01933672|525691683|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776776|NCT01933672|525691684|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776777|NCT01933672|525691685|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
145776778|NCT01933672|525691686|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776779|NCT01933672|525691687|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776780|NCT01933672|525691681|FG000|First Intervention Period (12-16 Days)|Other|0|||
145776781|NCT01933672|525691682|FG001|First Intervention Period (12-16 Days)|Other|0|||
145776782|NCT01933672|525691683|FG002|First Intervention Period (12-16 Days)|Other|1|||
145776783|NCT01933672|525691684|FG003|First Intervention Period (12-16 Days)|Other|0|||
145776784|NCT01933672|525691685|FG004|First Intervention Period (12-16 Days)|Other|0|||
145776785|NCT01933672|525691686|FG005|First Intervention Period (12-16 Days)|Other|1|||
145776786|NCT01933672|525691687|FG006|First Intervention Period (12-16 Days)|Other|0|||
145776787|NCT01933672|525691681|FG000|Second Intervention Period (12-16 Days)|Other|0|||
145776788|NCT01933672|525691682|FG001|Second Intervention Period (12-16 Days)|Other|1|||
145776789|NCT01933672|525691683|FG002|Second Intervention Period (12-16 Days)|Other|1|||
145776790|NCT01933672|525691684|FG003|Second Intervention Period (12-16 Days)|Other|0|||
145776791|NCT01933672|525691685|FG004|Second Intervention Period (12-16 Days)|Other|0|||
145776792|NCT01933672|525691686|FG005|Second Intervention Period (12-16 Days)|Other|0|||
145776793|NCT01933672|525691687|FG006|Second Intervention Period (12-16 Days)|Other|0|||
145776794|NCT01933672|525691681|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776795|NCT01933672|525691682|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776796|NCT01933672|525691683|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776797|NCT01933672|525691684|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
145776798|NCT01933672|525691685|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776799|NCT01933672|525691686|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145536221|NCT01402011|524822174|FG001|Active Treatment Period|Withdrawal by Subject|3|||
145536222|NCT01402011|524822175|FG002|Active Treatment Period|Withdrawal by Subject|0|||
145536223|NCT01402011|524822173|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
145536224|NCT01402011|524822174|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
145536225|NCT01402011|524822175|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
145536226|NCT00142298|524822176|FG000|Overall Study|Adverse Event|10|||
145536227|NCT00142298|524822177|FG001|Overall Study|Adverse Event|10|||
145536228|NCT00142298|524822178|FG002|Overall Study|Adverse Event|1|||
145536229|NCT00142298|524822179|FG003|Overall Study|Adverse Event|5|||
145536230|NCT00142298|524822180|FG004|Overall Study|Adverse Event|2|||
145536231|NCT00142298|524822181|FG005|Overall Study|Adverse Event|2|||
145536232|NCT00142298|524822182|FG006|Overall Study|Adverse Event|0|||
145536233|NCT00142298|524822183|FG007|Overall Study|Adverse Event|0|||
145536234|NCT00142298|524822184|FG008|Overall Study|Adverse Event|0|||
145536235|NCT00142298|524822185|FG009|Overall Study|Adverse Event|0|||
145536236|NCT00142298|524822176|FG000|Overall Study|Clinical disease progression|1|||
145536237|NCT00142298|524822177|FG001|Overall Study|Clinical disease progression|0|||
145536238|NCT00142298|524822178|FG002|Overall Study|Clinical disease progression|0|||
145536239|NCT00142298|524822179|FG003|Overall Study|Clinical disease progression|0|||
145536240|NCT00142298|524822180|FG004|Overall Study|Clinical disease progression|0|||
145536241|NCT00142298|524822181|FG005|Overall Study|Clinical disease progression|0|||
145536242|NCT00142298|524822182|FG006|Overall Study|Clinical disease progression|0|||
145776800|NCT01933672|525691687|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
145776801|NCT01933672|525691681|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776802|NCT01933672|525691682|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
145776803|NCT01933672|525691683|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776804|NCT01933672|525691684|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776805|NCT01933672|525691685|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776806|NCT01933672|525691686|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776807|NCT01933672|525691687|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
145776808|NCT01282814|525691688|FG000|First Intervention|Emesis During Dosing Interval|0|||
145536243|NCT00142298|524822183|FG007|Overall Study|Clinical disease progression|0|||
145536244|NCT00142298|524822184|FG008|Overall Study|Clinical disease progression|0|||
145776809|NCT01282814|525691689|FG001|First Intervention|Emesis During Dosing Interval|3|||
145536245|NCT00142298|524822185|FG009|Overall Study|Clinical disease progression|0|||
145536246|NCT00142298|524822176|FG000|Overall Study|Death|1|||
145536247|NCT00142298|524822177|FG001|Overall Study|Death|1|||
145536248|NCT00142298|524822178|FG002|Overall Study|Death|1|||
145536249|NCT00142298|524822179|FG003|Overall Study|Death|0|||
145776810|NCT01282814|525691688|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
145776811|NCT01282814|525691689|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145776812|NCT01676116|525691690|FG000|Overall Study|Withdrawal criteria|2|||
145776813|NCT01676116|525691691|FG001|Overall Study|Withdrawal criteria|14|||
145776814|NCT01676116|525691690|FG000|Overall Study|Adverse Event|1|||
145776815|NCT01676116|525691691|FG001|Overall Study|Adverse Event|2|||
145776816|NCT01676116|525691690|FG000|Overall Study|Unclassified|4|||
145776817|NCT01676116|525691691|FG001|Overall Study|Unclassified|10|||
145776818|NCT01676116|525691690|FG000|Overall Study|Protocol Violation|9|||
145776819|NCT01676116|525691691|FG001|Overall Study|Protocol Violation|3|||
145776820|NCT01287117|525691692|FG000|Overall Study|Adverse Event|2|||
145776821|NCT01287117|525691693|FG001|Overall Study|Adverse Event|1|||
145776822|NCT01287117|525691694|FG002|Overall Study|Adverse Event|1|||
145776823|NCT01287117|525691695|FG003|Overall Study|Adverse Event|1|||
145776824|NCT01287117|525691692|FG000|Overall Study|Lost to Follow-up|1|||
145776825|NCT01287117|525691693|FG001|Overall Study|Lost to Follow-up|1|||
145776826|NCT01287117|525691694|FG002|Overall Study|Lost to Follow-up|0|||
145776827|NCT01287117|525691695|FG003|Overall Study|Lost to Follow-up|0|||
145776828|NCT01287117|525691692|FG000|Overall Study|Physician Decision|0|||
145776829|NCT01287117|525691693|FG001|Overall Study|Physician Decision|1|||
145776830|NCT01287117|525691694|FG002|Overall Study|Physician Decision|1|||
145776831|NCT01287117|525691695|FG003|Overall Study|Physician Decision|1|||
145776832|NCT01287117|525691692|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
145776833|NCT01287117|525691693|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
145776834|NCT01287117|525691694|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
145776835|NCT01287117|525691695|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
145776836|NCT01287117|525691692|FG000|Overall Study|Disease Progression|10|||
145776837|NCT01287117|525691693|FG001|Overall Study|Disease Progression|5|||
145776838|NCT01287117|525691694|FG002|Overall Study|Disease Progression|6|||
145776839|NCT01287117|525691695|FG003|Overall Study|Disease Progression|5|||
145776840|NCT02031146|525693183|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
145776841|NCT02031146|525693184|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
145776842|NCT02031146|525693185|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
145776843|NCT02031146|525693186|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
145776844|NCT02031146|525693187|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
145776845|NCT02031146|525693188|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
145776846|NCT02031146|525693189|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
145776847|NCT00001259|525693192|FG000|Study 2|Adverse Event|0|||
145776848|NCT00001259|525693193|FG001|Study 2|Adverse Event|0|||
145776849|NCT00001259|525693194|FG002|Study 2|Adverse Event|0|||
145776850|NCT00001259|525693195|FG003|Study 2|Adverse Event|0|||
145776851|NCT00001259|525693196|FG004|Study 2|Adverse Event|2|||
145776852|NCT00001259|525693197|FG005|Study 2|Adverse Event|0|||
145776853|NCT00001259|525693198|FG006|Study 2|Adverse Event|0|||
145776854|NCT03705494|525693199|FG000|Overall Study|Lost to Follow-up|2|||
145776855|NCT03705494|525693200|FG001|Overall Study|Lost to Follow-up|1|||
145776856|NCT03705494|525693199|FG000|Overall Study|Withdrawal by Subject|5|||
145776857|NCT03705494|525693200|FG001|Overall Study|Withdrawal by Subject|2|||
145776858|NCT01582282|525693201|FG000|Overall Study|Adverse Event|1|||
145776859|NCT01582282|525693202|FG001|Overall Study|Adverse Event|1|||
145776860|NCT01582282|525693203|FG002|Overall Study|Adverse Event|0|||
145776861|NCT01582282|525693201|FG000|Overall Study|Lost to Follow-up|1|||
145776862|NCT01582282|525693202|FG001|Overall Study|Lost to Follow-up|0|||
145776863|NCT01582282|525693203|FG002|Overall Study|Lost to Follow-up|0|||
145776864|NCT01582282|525693201|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
145776865|NCT01582282|525693202|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
145776866|NCT01582282|525693203|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
145776867|NCT02629393|525693205|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
145776868|NCT02629393|525693205|FG000|Overall Study|Physician Decision|1|||
145776869|NCT03937986|525693206|FG000|Overall Study|COVID-19 Pandemic|1|||
145776870|NCT01853228|525693207|FG000|Phase 1|Lack of Efficacy|8|||
145776871|NCT01853228|525693208|FG001|Phase 1|Lack of Efficacy|0|||
145776872|NCT01853228|525693207|FG000|Phase 1|Other|1|||
145776873|NCT01853228|525693208|FG001|Phase 1|Other|0|||
145776874|NCT01853228|525693207|FG000|Phase 2|Physician Decision|0|||
145776875|NCT01853228|525693208|FG001|Phase 2|Physician Decision|1|||
145776876|NCT01853228|525693207|FG000|Phase 2|Proceed To Transplant|0|||
145536250|NCT00142298|524822180|FG004|Overall Study|Death|0|||
145776877|NCT01853228|525693208|FG001|Phase 2|Proceed To Transplant|3|||
145776878|NCT01853228|525693207|FG000|Phase 2|Lack of Efficacy|0|||
145776879|NCT01853228|525693208|FG001|Phase 2|Lack of Efficacy|4|||
145776880|NCT01300286|525693209|FG000|Overall Study|did not get dosed|1|||
145776881|NCT01123889|525693210|FG000|Overall Study|Lost to Follow-up|3|||
145776882|NCT01123889|525693211|FG001|Overall Study|Lost to Follow-up|1|||
145776883|NCT02786537|525693212|FG000|As Randomized|Adverse Event|0|||
145776884|NCT02786537|525693213|FG001|As Randomized|Adverse Event|11|||
145776885|NCT02786537|525693214|FG002|As Randomized|Adverse Event|0|||
145776886|NCT02786537|525693215|FG003|As Randomized|Adverse Event|4|||
145776887|NCT02786537|525693216|FG004|As Randomized|Adverse Event|6|||
145776888|NCT02786537|525693217|FG005|As Randomized|Adverse Event|2|||
145776889|NCT02786537|525693212|FG000|As Randomized|Lack of Efficacy|0|||
145776890|NCT02786537|525693213|FG001|As Randomized|Lack of Efficacy|0|||
145776891|NCT02786537|525693214|FG002|As Randomized|Lack of Efficacy|0|||
145776892|NCT02786537|525693215|FG003|As Randomized|Lack of Efficacy|1|||
145776893|NCT02786537|525693216|FG004|As Randomized|Lack of Efficacy|0|||
145776894|NCT02786537|525693217|FG005|As Randomized|Lack of Efficacy|0|||
145776895|NCT02786537|525693212|FG000|As Randomized|Withdrawal by Subject|1|||
145776896|NCT02786537|525693213|FG001|As Randomized|Withdrawal by Subject|2|||
145776897|NCT02786537|525693214|FG002|As Randomized|Withdrawal by Subject|0|||
145776898|NCT02786537|525693215|FG003|As Randomized|Withdrawal by Subject|1|||
145776899|NCT02786537|525693216|FG004|As Randomized|Withdrawal by Subject|1|||
145776900|NCT02786537|525693217|FG005|As Randomized|Withdrawal by Subject|0|||
145536251|NCT00142298|524822181|FG005|Overall Study|Death|6|||
145536252|NCT00142298|524822182|FG006|Overall Study|Death|0|||
145536253|NCT00142298|524822183|FG007|Overall Study|Death|0|||
145536254|NCT00142298|524822184|FG008|Overall Study|Death|0|||
145536255|NCT00142298|524822185|FG009|Overall Study|Death|0|||
145536256|NCT00142298|524822176|FG000|Overall Study|Lack of Efficacy|44|||
145536257|NCT00142298|524822177|FG001|Overall Study|Lack of Efficacy|62|||
145536258|NCT00142298|524822178|FG002|Overall Study|Lack of Efficacy|9|||
145536259|NCT00142298|524822179|FG003|Overall Study|Lack of Efficacy|12|||
145536260|NCT00142298|524822180|FG004|Overall Study|Lack of Efficacy|1|||
145536261|NCT00142298|524822181|FG005|Overall Study|Lack of Efficacy|0|||
145536262|NCT00142298|524822182|FG006|Overall Study|Lack of Efficacy|0|||
145536263|NCT00142298|524822183|FG007|Overall Study|Lack of Efficacy|1|||
145536264|NCT00142298|524822184|FG008|Overall Study|Lack of Efficacy|0|||
145536265|NCT00142298|524822185|FG009|Overall Study|Lack of Efficacy|0|||
145536266|NCT00142298|524822176|FG000|Overall Study|Non-compliance|15|||
145536267|NCT00142298|524822177|FG001|Overall Study|Non-compliance|13|||
145536268|NCT00142298|524822178|FG002|Overall Study|Non-compliance|0|||
145536269|NCT00142298|524822179|FG003|Overall Study|Non-compliance|6|||
145536270|NCT00142298|524822180|FG004|Overall Study|Non-compliance|1|||
145536271|NCT00142298|524822181|FG005|Overall Study|Non-compliance|0|||
145536272|NCT00142298|524822182|FG006|Overall Study|Non-compliance|0|||
145536273|NCT00142298|524822183|FG007|Overall Study|Non-compliance|3|||
145536274|NCT00142298|524822184|FG008|Overall Study|Non-compliance|3|||
145776901|NCT02786537|525693212|FG000|As Randomized|Death|0|||
145776902|NCT02786537|525693213|FG001|As Randomized|Death|2|||
145776903|NCT02786537|525693214|FG002|As Randomized|Death|0|||
145776904|NCT02786537|525693215|FG003|As Randomized|Death|3|||
145776905|NCT02786537|525693216|FG004|As Randomized|Death|1|||
145776906|NCT02786537|525693217|FG005|As Randomized|Death|0|||
145776907|NCT02786537|525693212|FG000|As Randomized|Non-compliance with study drug|1|||
145776908|NCT02786537|525693213|FG001|As Randomized|Non-compliance with study drug|11|||
145776909|NCT02786537|525693214|FG002|As Randomized|Non-compliance with study drug|0|||
145776910|NCT02786537|525693215|FG003|As Randomized|Non-compliance with study drug|1|||
145776911|NCT02786537|525693216|FG004|As Randomized|Non-compliance with study drug|0|||
145776912|NCT02786537|525693217|FG005|As Randomized|Non-compliance with study drug|1|||
145776913|NCT02786537|525693212|FG000|As Randomized|Lost to treatment follow-up|4|||
145776914|NCT02786537|525693213|FG001|As Randomized|Lost to treatment follow-up|32|||
145776915|NCT02786537|525693214|FG002|As Randomized|Lost to treatment follow-up|0|||
145776916|NCT02786537|525693215|FG003|As Randomized|Lost to treatment follow-up|24|||
145776917|NCT02786537|525693216|FG004|As Randomized|Lost to treatment follow-up|4|||
145776918|NCT02786537|525693217|FG005|As Randomized|Lost to treatment follow-up|4|||
145776919|NCT02786537|525693212|FG000|As Randomized|Incarceration|0|||
145776920|NCT02786537|525693213|FG001|As Randomized|Incarceration|1|||
145776921|NCT02786537|525693214|FG002|As Randomized|Incarceration|0|||
145776922|NCT02786537|525693215|FG003|As Randomized|Incarceration|0|||
145776923|NCT02786537|525693216|FG004|As Randomized|Incarceration|0|||
145403682|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
145536275|NCT00142298|524822185|FG009|Overall Study|Non-compliance|0|||
145536276|NCT00142298|524822176|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
145536277|NCT00142298|524822177|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
145536278|NCT00142298|524822178|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
145536279|NCT00142298|524822179|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
145536280|NCT00142298|524822180|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
145776924|NCT02786537|525693217|FG005|As Randomized|Incarceration|0|||
145776925|NCT02786537|525693212|FG000|As Randomized|Opiate Dependency Relapse|0|||
145776926|NCT02786537|525693213|FG001|As Randomized|Opiate Dependency Relapse|1|||
145776927|NCT02786537|525693214|FG002|As Randomized|Opiate Dependency Relapse|0|||
145776928|NCT02786537|525693215|FG003|As Randomized|Opiate Dependency Relapse|0|||
145776929|NCT02786537|525693216|FG004|As Randomized|Opiate Dependency Relapse|0|||
145536281|NCT00142298|524822181|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
145536282|NCT00142298|524822182|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
145776930|NCT02786537|525693217|FG005|As Randomized|Opiate Dependency Relapse|0|||
145776931|NCT02786537|525693212|FG000|As Randomized|HCV drugs stolen from pt|0|||
145776932|NCT02786537|525693213|FG001|As Randomized|HCV drugs stolen from pt|1|||
145776933|NCT02786537|525693214|FG002|As Randomized|HCV drugs stolen from pt|0|||
145776934|NCT02786537|525693215|FG003|As Randomized|HCV drugs stolen from pt|0|||
145776935|NCT02786537|525693216|FG004|As Randomized|HCV drugs stolen from pt|0|||
145279079|NCT04378010|523872851|FG000|Overall Study|Adverse Event|8|||
145279080|NCT04378010|523872852|FG001|Overall Study|Adverse Event|14|||
145279081|NCT04378010|523872853|FG002|Overall Study|Adverse Event|4|||
145279082|NCT04378010|523872851|FG000|Overall Study|Withdrawal by Subject|0|||
145536283|NCT00142298|524822183|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
145536284|NCT00142298|524822184|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
145536285|NCT00142298|524822185|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
145536286|NCT00142298|524822176|FG000|Overall Study|Pregnancy|4|||
145536287|NCT00142298|524822177|FG001|Overall Study|Pregnancy|4|||
145536288|NCT00142298|524822178|FG002|Overall Study|Pregnancy|2|||
145536289|NCT00142298|524822179|FG003|Overall Study|Pregnancy|3|||
145536290|NCT00142298|524822180|FG004|Overall Study|Pregnancy|0|||
145536291|NCT00142298|524822181|FG005|Overall Study|Pregnancy|0|||
145536292|NCT00142298|524822182|FG006|Overall Study|Pregnancy|0|||
145536293|NCT00142298|524822183|FG007|Overall Study|Pregnancy|0|||
145536294|NCT00142298|524822184|FG008|Overall Study|Pregnancy|1|||
145536295|NCT00142298|524822185|FG009|Overall Study|Pregnancy|0|||
145536296|NCT00142298|524822176|FG000|Overall Study|Virologic breakthrough|19|||
145536297|NCT00142298|524822177|FG001|Overall Study|Virologic breakthrough|23|||
145536298|NCT00142298|524822178|FG002|Overall Study|Virologic breakthrough|9|||
145536299|NCT00142298|524822179|FG003|Overall Study|Virologic breakthrough|7|||
145536300|NCT00142298|524822180|FG004|Overall Study|Virologic breakthrough|2|||
145536301|NCT00142298|524822181|FG005|Overall Study|Virologic breakthrough|3|||
145536302|NCT00142298|524822182|FG006|Overall Study|Virologic breakthrough|3|||
145536303|NCT00142298|524822183|FG007|Overall Study|Virologic breakthrough|0|||
145536304|NCT00142298|524822184|FG008|Overall Study|Virologic breakthrough|0|||
145536305|NCT00142298|524822185|FG009|Overall Study|Virologic breakthrough|0|||
145536306|NCT00142298|524822176|FG000|Overall Study|Other- not specified|0|||
145536307|NCT00142298|524822177|FG001|Overall Study|Other- not specified|3|||
145536308|NCT00142298|524822178|FG002|Overall Study|Other- not specified|0|||
145776936|NCT02786537|525693217|FG005|As Randomized|HCV drugs stolen from pt|0|||
145776937|NCT02786537|525693212|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
145279083|NCT04378010|523872852|FG001|Overall Study|Withdrawal by Subject|2|||
145279084|NCT04378010|523872853|FG002|Overall Study|Withdrawal by Subject|1|||
145279085|NCT04378010|523872851|FG000|Overall Study|Protocol Violation|2|||
145279086|NCT04378010|523872852|FG001|Overall Study|Protocol Violation|1|||
145279087|NCT04378010|523872853|FG002|Overall Study|Protocol Violation|4|||
145279088|NCT04378010|523872851|FG000|Overall Study|Study terminated by Sponsor|22|||
145279089|NCT04378010|523872852|FG001|Overall Study|Study terminated by Sponsor|16|||
145279090|NCT04378010|523872853|FG002|Overall Study|Study terminated by Sponsor|22|||
145279091|NCT04378010|523872851|FG000|Overall Study|Subject inability to complete study visit|0|||
145279092|NCT04378010|523872852|FG001|Overall Study|Subject inability to complete study visit|0|||
145279093|NCT04378010|523872853|FG002|Overall Study|Subject inability to complete study visit|1|||
145279094|NCT04378010|523872851|FG000|Overall Study|Subject never dosed|0|||
145279095|NCT04378010|523872852|FG001|Overall Study|Subject never dosed|1|||
145279096|NCT04378010|523872853|FG002|Overall Study|Subject never dosed|0|||
145279097|NCT02019979|523872854|FG000|Overall Study|study terminated|14|||
145279098|NCT02513459|523872855|FG000|Overall Study|Adverse Event|7|||
145279099|NCT02513459|523872855|FG000|Overall Study|Withdrew consent|5|||
145279100|NCT02513459|523872855|FG000|Overall Study|Loss of efficacy|2|||
145776938|NCT02786537|525693213|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
145279101|NCT02513459|523872855|FG000|Overall Study|Pregnancy|2|||
145279102|NCT02513459|523872855|FG000|Overall Study|Subject decision|2|||
145279103|NCT02513459|523872855|FG000|Overall Study|Lack of response|1|||
145279104|NCT02513459|523872855|FG000|Overall Study|Reproductive plans|1|||
145279105|NCT02513459|523872855|FG000|Overall Study|Surgery planned-- not done|1|||
145279106|NCT03237611|523872856|FG000|Overall Study|Withdrawal by Subject|1|||
145279107|NCT03237611|523872856|FG000|Overall Study|Ineligible|1|||
145279108|NCT00923195|523872860|FG000|Overall Study|Death|0|||
145279109|NCT00923195|523872861|FG001|Overall Study|Death|1|||
145279110|NCT00525031|523872862|FG000|Overall Study|Disease Progression|1|||
145279111|NCT00525031|523872863|FG001|Overall Study|Disease Progression|1|||
145536309|NCT00142298|524822179|FG003|Overall Study|Other- not specified|1|||
145536310|NCT00142298|524822180|FG004|Overall Study|Other- not specified|0|||
145536311|NCT00142298|524822181|FG005|Overall Study|Other- not specified|0|||
145536312|NCT00142298|524822182|FG006|Overall Study|Other- not specified|0|||
145536313|NCT00142298|524822183|FG007|Overall Study|Other- not specified|0|||
145536314|NCT00142298|524822184|FG008|Overall Study|Other- not specified|0|||
145536315|NCT00142298|524822185|FG009|Overall Study|Other- not specified|0|||
145536316|NCT00142298|524822176|FG000|Overall Study|Lost to Follow-up|0|||
145536317|NCT00142298|524822177|FG001|Overall Study|Lost to Follow-up|0|||
145536318|NCT00142298|524822178|FG002|Overall Study|Lost to Follow-up|0|||
145536319|NCT00142298|524822179|FG003|Overall Study|Lost to Follow-up|0|||
145776939|NCT02786537|525693214|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
145776940|NCT02786537|525693215|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
145776941|NCT02786537|525693216|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
145776942|NCT02786537|525693217|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
145776943|NCT02786537|525693212|FG000|As Randomized|Subject lost insurance|0|||
145776944|NCT02786537|525693213|FG001|As Randomized|Subject lost insurance|0|||
145776945|NCT02786537|525693214|FG002|As Randomized|Subject lost insurance|0|||
145536320|NCT00142298|524822180|FG004|Overall Study|Lost to Follow-up|0|||
145536321|NCT00142298|524822181|FG005|Overall Study|Lost to Follow-up|0|||
145776946|NCT02786537|525693215|FG003|As Randomized|Subject lost insurance|1|||
145776947|NCT02786537|525693216|FG004|As Randomized|Subject lost insurance|0|||
145776948|NCT02786537|525693217|FG005|As Randomized|Subject lost insurance|0|||
145776949|NCT02786537|525693212|FG000|As Treated|Adverse Event|0|||
145776950|NCT02786537|525693213|FG001|As Treated|Adverse Event|11|||
145776951|NCT02786537|525693214|FG002|As Treated|Adverse Event|0|||
145776952|NCT02786537|525693215|FG003|As Treated|Adverse Event|4|||
145776953|NCT02786537|525693216|FG004|As Treated|Adverse Event|6|||
145776954|NCT02786537|525693217|FG005|As Treated|Adverse Event|2|||
145776955|NCT02786537|525693212|FG000|As Treated|Death|0|||
145776956|NCT02786537|525693213|FG001|As Treated|Death|2|||
145776957|NCT02786537|525693214|FG002|As Treated|Death|0|||
145776958|NCT02786537|525693215|FG003|As Treated|Death|3|||
145776959|NCT02786537|525693216|FG004|As Treated|Death|1|||
145776960|NCT02786537|525693217|FG005|As Treated|Death|0|||
145403683|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
145403684|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403685|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403686|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403687|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403688|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403689|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403690|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403691|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
145403692|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
145403693|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
145403694|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403695|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403696|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403697|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403698|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403699|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403700|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403701|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
145403702|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
145536322|NCT00142298|524822182|FG006|Overall Study|Lost to Follow-up|2|||
145536323|NCT00142298|524822183|FG007|Overall Study|Lost to Follow-up|0|||
145536324|NCT00142298|524822184|FG008|Overall Study|Lost to Follow-up|0|||
145536325|NCT00142298|524822185|FG009|Overall Study|Lost to Follow-up|0|||
145776961|NCT02786537|525693212|FG000|As Treated|Lack of Efficacy|0|||
145776962|NCT02786537|525693213|FG001|As Treated|Lack of Efficacy|0|||
145776963|NCT02786537|525693214|FG002|As Treated|Lack of Efficacy|0|||
145776964|NCT02786537|525693215|FG003|As Treated|Lack of Efficacy|1|||
145776965|NCT02786537|525693216|FG004|As Treated|Lack of Efficacy|0|||
145776966|NCT02786537|525693217|FG005|As Treated|Lack of Efficacy|0|||
145776967|NCT02786537|525693212|FG000|As Treated|Lost to Follow-up|4|||
145776968|NCT02786537|525693213|FG001|As Treated|Lost to Follow-up|32|||
145776969|NCT02786537|525693214|FG002|As Treated|Lost to Follow-up|0|||
145776970|NCT02786537|525693215|FG003|As Treated|Lost to Follow-up|25|||
145776971|NCT02786537|525693216|FG004|As Treated|Lost to Follow-up|4|||
145776972|NCT02786537|525693217|FG005|As Treated|Lost to Follow-up|4|||
145776973|NCT02786537|525693212|FG000|As Treated|Non-compliance with study drug|1|||
145776974|NCT02786537|525693213|FG001|As Treated|Non-compliance with study drug|11|||
145536326|NCT00142298|524822176|FG000|Overall Study|Treatment Failure|0|||
145536327|NCT00142298|524822177|FG001|Overall Study|Treatment Failure|0|||
145776975|NCT02786537|525693214|FG002|As Treated|Non-compliance with study drug|0|||
145776976|NCT02786537|525693215|FG003|As Treated|Non-compliance with study drug|1|||
145776977|NCT02786537|525693216|FG004|As Treated|Non-compliance with study drug|0|||
145279112|NCT02454972|523872868|FG000|Overall Study|Progressive disease|17|||
145776978|NCT02786537|525693217|FG005|As Treated|Non-compliance with study drug|1|||
145776979|NCT02786537|525693212|FG000|As Treated|Lost insurance|0|||
145536328|NCT00142298|524822178|FG002|Overall Study|Treatment Failure|0|||
145776980|NCT02786537|525693213|FG001|As Treated|Lost insurance|0|||
145776981|NCT02786537|525693214|FG002|As Treated|Lost insurance|0|||
145776982|NCT02786537|525693215|FG003|As Treated|Lost insurance|1|||
145776983|NCT02786537|525693216|FG004|As Treated|Lost insurance|0|||
145776984|NCT02786537|525693217|FG005|As Treated|Lost insurance|0|||
145776985|NCT02786537|525693212|FG000|As Treated|Withdrawal by Subject|1|||
145776986|NCT02786537|525693213|FG001|As Treated|Withdrawal by Subject|2|||
145776987|NCT02786537|525693214|FG002|As Treated|Withdrawal by Subject|0|||
145776988|NCT02786537|525693215|FG003|As Treated|Withdrawal by Subject|0|||
145776989|NCT02786537|525693216|FG004|As Treated|Withdrawal by Subject|1|||
145776990|NCT02786537|525693217|FG005|As Treated|Withdrawal by Subject|0|||
145776991|NCT02786537|525693212|FG000|As Treated|Incarceration|0|||
145776992|NCT02786537|525693213|FG001|As Treated|Incarceration|1|||
145776993|NCT02786537|525693214|FG002|As Treated|Incarceration|0|||
145776994|NCT02786537|525693215|FG003|As Treated|Incarceration|0|||
145776995|NCT02786537|525693216|FG004|As Treated|Incarceration|0|||
145776996|NCT02786537|525693217|FG005|As Treated|Incarceration|0|||
145776997|NCT02786537|525693212|FG000|As Treated|Opiate dependency relapse|0|||
145776998|NCT02786537|525693213|FG001|As Treated|Opiate dependency relapse|1|||
145776999|NCT02786537|525693214|FG002|As Treated|Opiate dependency relapse|0|||
145777000|NCT02786537|525693215|FG003|As Treated|Opiate dependency relapse|0|||
145777001|NCT02786537|525693216|FG004|As Treated|Opiate dependency relapse|0|||
145777002|NCT02786537|525693217|FG005|As Treated|Opiate dependency relapse|0|||
145777003|NCT02786537|525693212|FG000|As Treated|Drugs stolen from patient|0|||
145777004|NCT02786537|525693213|FG001|As Treated|Drugs stolen from patient|1|||
145777005|NCT02786537|525693214|FG002|As Treated|Drugs stolen from patient|0|||
145777006|NCT02786537|525693215|FG003|As Treated|Drugs stolen from patient|0|||
145777007|NCT02786537|525693216|FG004|As Treated|Drugs stolen from patient|0|||
145777008|NCT02786537|525693217|FG005|As Treated|Drugs stolen from patient|0|||
145777009|NCT02786537|525693212|FG000|As Treated|Advised to stop tx after loss of meds|0|||
145777010|NCT02786537|525693213|FG001|As Treated|Advised to stop tx after loss of meds|1|||
145777011|NCT02786537|525693214|FG002|As Treated|Advised to stop tx after loss of meds|0|||
145777012|NCT02786537|525693215|FG003|As Treated|Advised to stop tx after loss of meds|0|||
145777013|NCT02786537|525693216|FG004|As Treated|Advised to stop tx after loss of meds|0|||
145777014|NCT02786537|525693217|FG005|As Treated|Advised to stop tx after loss of meds|0|||
145777015|NCT01272180|525693218|FG000|Overall Study|Adverse Event|0|||
145777016|NCT01272180|525693219|FG001|Overall Study|Adverse Event|0|||
145777017|NCT01272180|525693220|FG002|Overall Study|Adverse Event|1|||
145777018|NCT01272180|525693221|FG003|Overall Study|Adverse Event|0|||
145777019|NCT01272180|525693218|FG000|Overall Study|Withdrawal by Subject|2|||
145777020|NCT01272180|525693219|FG001|Overall Study|Withdrawal by Subject|6|||
145777021|NCT01272180|525693220|FG002|Overall Study|Withdrawal by Subject|3|||
145777022|NCT01272180|525693221|FG003|Overall Study|Withdrawal by Subject|2|||
145777023|NCT01272180|525693218|FG000|Overall Study|Lost to Follow-up|15|||
145777024|NCT01272180|525693219|FG001|Overall Study|Lost to Follow-up|14|||
145777025|NCT01272180|525693220|FG002|Overall Study|Lost to Follow-up|8|||
145777026|NCT01272180|525693221|FG003|Overall Study|Lost to Follow-up|10|||
145777027|NCT01272180|525693218|FG000|Overall Study|Inappropriate enrollment|0|||
145777028|NCT01272180|525693219|FG001|Overall Study|Inappropriate enrollment|0|||
145777029|NCT01272180|525693220|FG002|Overall Study|Inappropriate enrollment|1|||
145777030|NCT01272180|525693221|FG003|Overall Study|Inappropriate enrollment|1|||
145777031|NCT01272180|525693218|FG000|Overall Study|Protocol Violation|0|||
145777032|NCT01272180|525693219|FG001|Overall Study|Protocol Violation|1|||
145777033|NCT01272180|525693220|FG002|Overall Study|Protocol Violation|0|||
145777034|NCT01272180|525693221|FG003|Overall Study|Protocol Violation|1|||
145777035|NCT03472534|525693223|FG000|Overall Study|Withdrawal by Subject|9|||
145777036|NCT03472534|525693223|FG000|Overall Study|Adverse Event|2|||
145777037|NCT01221233|525693226|FG000|Overall Study|Withdrawal by Subject|3|||
145777038|NCT01221233|525693227|FG001|Overall Study|Withdrawal by Subject|1|||
145777039|NCT03865407|525693228|FG000|Overall Study|Adverse Event|1|||
145777040|NCT03865407|525693229|FG001|Overall Study|Adverse Event|0|||
145777041|NCT03865407|525693228|FG000|Overall Study|Withdrawal by Subject|1|||
145777042|NCT03865407|525693229|FG001|Overall Study|Withdrawal by Subject|0|||
145777043|NCT03865407|525693228|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
145777044|NCT03865407|525693229|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
145777045|NCT01645280|525693230|FG000|Overall Study|Death|0|||
145536329|NCT00142298|524822179|FG003|Overall Study|Treatment Failure|0|||
145536330|NCT00142298|524822180|FG004|Overall Study|Treatment Failure|0|||
145536331|NCT00142298|524822181|FG005|Overall Study|Treatment Failure|2|||
145536332|NCT00142298|524822182|FG006|Overall Study|Treatment Failure|2|||
145536333|NCT00142298|524822183|FG007|Overall Study|Treatment Failure|0|||
145536334|NCT00142298|524822184|FG008|Overall Study|Treatment Failure|0|||
145536335|NCT00142298|524822185|FG009|Overall Study|Treatment Failure|0|||
145777046|NCT01645280|525693231|FG001|Overall Study|Death|1|||
145777047|NCT01645280|525693232|FG002|Overall Study|Death|0|||
145777048|NCT01645280|525693233|FG003|Overall Study|Death|0|||
145777049|NCT01645280|525693234|FG004|Overall Study|Death|0|||
145777050|NCT01645280|525693230|FG000|Overall Study|Withdrawal by Subject|4|||
145536336|NCT03360747|524822186|FG000|Overall Study|Voluntary Withdrawal|1|||
145536337|NCT01759511|524822187|FG000|Overall Study|Adverse Event|4|||
145536338|NCT01759511|524822187|FG000|Overall Study|Death|2|||
145536339|NCT01759511|524822187|FG000|Overall Study|Lack of Efficacy|2|||
145536340|NCT01759511|524822187|FG000|Overall Study|Physician Decision|1|||
145536341|NCT01759511|524822187|FG000|Overall Study|Progressive Disease|5|||
145536342|NCT01759511|524822187|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
145536343|NCT01759511|524822187|FG000|Overall Study|Study Terminated by Sponsor|13|||
145536344|NCT01759511|524822187|FG000|Overall Study|Withdrawal by Subject|3|||
145536345|NCT02569671|524822188|FG000|Overall Study|Lost to Follow-up|2|||
145536346|NCT02569671|524822189|FG001|Overall Study|Lost to Follow-up|1|||
145536347|NCT02569671|524822188|FG000|Overall Study|Withdrawal by Subject|1|||
145536348|NCT02569671|524822189|FG001|Overall Study|Withdrawal by Subject|3|||
145536349|NCT02612129|524822190|FG000|Single Dose Treatment Period|Screening Failure|1|||
145536350|NCT02612129|524822191|FG001|Single Dose Treatment Period|Screening Failure|0|||
145536351|NCT02612129|524822192|FG002|Single Dose Treatment Period|Screening Failure|0|||
145536352|NCT02612129|524822190|FG000|Continuous Treatment Period|Early Escape|0|||
145536353|NCT02612129|524822191|FG001|Continuous Treatment Period|Early Escape|2|||
145536354|NCT02612129|524822192|FG002|Continuous Treatment Period|Early Escape|0|||
145536355|NCT02612129|524822190|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
145536356|NCT02612129|524822191|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
145536357|NCT02612129|524822192|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
145536358|NCT02612129|524822190|FG000|Continuous Treatment Period|Safety Reasons|0|||
145536359|NCT02612129|524822191|FG001|Continuous Treatment Period|Safety Reasons|3|||
145536360|NCT02612129|524822192|FG002|Continuous Treatment Period|Safety Reasons|0|||
145536361|NCT02612129|524822190|FG000|Continuous Treatment Period|Death|0|||
145536362|NCT02612129|524822191|FG001|Continuous Treatment Period|Death|1|||
145536363|NCT02612129|524822192|FG002|Continuous Treatment Period|Death|0|||
145536364|NCT02612129|524822190|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
145536365|NCT02612129|524822191|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
145536366|NCT02612129|524822192|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
145536367|NCT01757535|524822193|FG000|Overall Study|Disease Relapse|151|||
145536368|NCT01757535|524822194|FG001|Overall Study|Disease Relapse|181|||
145536369|NCT01757535|524822193|FG000|Overall Study|Other Reasons|28|||
145536370|NCT01757535|524822194|FG001|Overall Study|Other Reasons|27|||
145777051|NCT01645280|525693231|FG001|Overall Study|Withdrawal by Subject|0|||
145777052|NCT01645280|525693232|FG002|Overall Study|Withdrawal by Subject|2|||
145777053|NCT01645280|525693233|FG003|Overall Study|Withdrawal by Subject|4|||
145777054|NCT01645280|525693234|FG004|Overall Study|Withdrawal by Subject|5|||
145777055|NCT01645280|525693230|FG000|Overall Study|Lost to Follow-up|0|||
145777056|NCT01645280|525693231|FG001|Overall Study|Lost to Follow-up|0|||
145777057|NCT01645280|525693232|FG002|Overall Study|Lost to Follow-up|0|||
145777058|NCT01645280|525693233|FG003|Overall Study|Lost to Follow-up|2|||
145777059|NCT01645280|525693234|FG004|Overall Study|Lost to Follow-up|1|||
145777060|NCT01645280|525693230|FG000|Overall Study|Other|1|||
145777061|NCT01645280|525693231|FG001|Overall Study|Other|1|||
145777062|NCT01645280|525693232|FG002|Overall Study|Other|2|||
145777063|NCT01645280|525693233|FG003|Overall Study|Other|0|||
145777064|NCT01645280|525693234|FG004|Overall Study|Other|0|||
145777065|NCT01645280|525693230|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
145777066|NCT01645280|525693231|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
145777067|NCT01645280|525693232|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
145777068|NCT01645280|525693233|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
145777069|NCT01645280|525693234|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
145777070|NCT00234104|525693239|FG000|Overall Study|Adverse Event|4|||
145777071|NCT00234104|525693240|FG001|Overall Study|Adverse Event|0|||
145777072|NCT00234104|525693241|FG002|Overall Study|Adverse Event|3|||
145777073|NCT00234104|525693242|FG003|Overall Study|Adverse Event|5|||
145777074|NCT00234104|525693239|FG000|Overall Study|Protocol Violation|0|||
145777075|NCT00234104|525693240|FG001|Overall Study|Protocol Violation|0|||
145777076|NCT00234104|525693241|FG002|Overall Study|Protocol Violation|0|||
145777077|NCT00234104|525693242|FG003|Overall Study|Protocol Violation|1|||
145777078|NCT00234104|525693239|FG000|Overall Study|Physician Decision|0|||
145777079|NCT00234104|525693240|FG001|Overall Study|Physician Decision|1|||
145777080|NCT00234104|525693241|FG002|Overall Study|Physician Decision|2|||
145279113|NCT02454972|523872869|FG001|Overall Study|Progressive disease|16|||
145279114|NCT02454972|523872870|FG002|Overall Study|Progressive disease|59|||
145279115|NCT02454972|523872871|FG003|Overall Study|Progressive disease|23|||
145279116|NCT02454972|523872872|FG004|Overall Study|Progressive disease|16|||
145777081|NCT00234104|525693242|FG003|Overall Study|Physician Decision|2|||
145777082|NCT00546819|525693243|FG000|Overall Study|Adverse Event|2|||
145777083|NCT00546819|525693244|FG001|Overall Study|Adverse Event|3|||
145777084|NCT00546819|525693243|FG000|Overall Study|Lost to Follow-up|2|||
145777085|NCT00546819|525693244|FG001|Overall Study|Lost to Follow-up|1|||
145777086|NCT00546819|525693243|FG000|Overall Study|Withdrawal by Subject|4|||
145777087|NCT00546819|525693244|FG001|Overall Study|Withdrawal by Subject|2|||
145777088|NCT04045613|525693245|FG000|Overall Study|Adverse Event|2|||
145777089|NCT04045613|525693246|FG001|Overall Study|Adverse Event|2|||
145777090|NCT04045613|525693247|FG002|Overall Study|Adverse Event|1|||
145777091|NCT04045613|525693248|FG003|Overall Study|Adverse Event|1|||
145777092|NCT04045613|525693249|FG004|Overall Study|Adverse Event|0|||
145777093|NCT04045613|525693250|FG005|Overall Study|Adverse Event|0|||
145777094|NCT04045613|525693251|FG006|Overall Study|Adverse Event|1|||
145777095|NCT04045613|525693245|FG000|Overall Study|Withdrawal by Subject|0|||
145777096|NCT04045613|525693246|FG001|Overall Study|Withdrawal by Subject|5|||
145777097|NCT04045613|525693247|FG002|Overall Study|Withdrawal by Subject|0|||
145777098|NCT04045613|525693248|FG003|Overall Study|Withdrawal by Subject|0|||
145777099|NCT04045613|525693249|FG004|Overall Study|Withdrawal by Subject|0|||
145777100|NCT04045613|525693250|FG005|Overall Study|Withdrawal by Subject|1|||
145777101|NCT04045613|525693251|FG006|Overall Study|Withdrawal by Subject|0|||
145777102|NCT04045613|525693245|FG000|Overall Study|Physician Decision|2|||
145777103|NCT04045613|525693246|FG001|Overall Study|Physician Decision|0|||
145777104|NCT04045613|525693247|FG002|Overall Study|Physician Decision|0|||
145777105|NCT04045613|525693248|FG003|Overall Study|Physician Decision|0|||
145777106|NCT04045613|525693249|FG004|Overall Study|Physician Decision|1|||
145777107|NCT04045613|525693250|FG005|Overall Study|Physician Decision|0|||
145777108|NCT04045613|525693251|FG006|Overall Study|Physician Decision|0|||
145777109|NCT04045613|525693245|FG000|Overall Study|Death|3|||
145777110|NCT04045613|525693246|FG001|Overall Study|Death|0|||
145777111|NCT04045613|525693247|FG002|Overall Study|Death|0|||
145777112|NCT04045613|525693248|FG003|Overall Study|Death|0|||
145777113|NCT04045613|525693249|FG004|Overall Study|Death|0|||
145777114|NCT04045613|525693250|FG005|Overall Study|Death|0|||
145777115|NCT04045613|525693251|FG006|Overall Study|Death|1|||
145777116|NCT04045613|525693245|FG000|Overall Study|Other reasons|0|||
145777117|NCT04045613|525693246|FG001|Overall Study|Other reasons|1|||
145777118|NCT04045613|525693247|FG002|Overall Study|Other reasons|0|||
145777119|NCT04045613|525693248|FG003|Overall Study|Other reasons|0|||
145777120|NCT04045613|525693249|FG004|Overall Study|Other reasons|0|||
145777121|NCT04045613|525693250|FG005|Overall Study|Other reasons|0|||
145777122|NCT04045613|525693251|FG006|Overall Study|Other reasons|1|||
145777123|NCT04045613|525693245|FG000|Overall Study|Progressive disease: Clinical progression|1|||
145777124|NCT04045613|525693246|FG001|Overall Study|Progressive disease: Clinical progression|0|||
145777125|NCT04045613|525693247|FG002|Overall Study|Progressive disease: Clinical progression|3|||
145777126|NCT04045613|525693248|FG003|Overall Study|Progressive disease: Clinical progression|1|||
145777127|NCT04045613|525693249|FG004|Overall Study|Progressive disease: Clinical progression|1|||
145777128|NCT04045613|525693250|FG005|Overall Study|Progressive disease: Clinical progression|3|||
145777129|NCT04045613|525693251|FG006|Overall Study|Progressive disease: Clinical progression|3|||
145777130|NCT04045613|525693245|FG000|Overall Study|Progressive disease: Radiological progression|24|||
145777131|NCT04045613|525693246|FG001|Overall Study|Progressive disease: Radiological progression|6|||
145777132|NCT04045613|525693247|FG002|Overall Study|Progressive disease: Radiological progression|8|||
145777133|NCT04045613|525693248|FG003|Overall Study|Progressive disease: Radiological progression|0|||
145777134|NCT04045613|525693249|FG004|Overall Study|Progressive disease: Radiological progression|6|||
145777135|NCT04045613|525693250|FG005|Overall Study|Progressive disease: Radiological progression|6|||
145777136|NCT04045613|525693251|FG006|Overall Study|Progressive disease: Radiological progression|11|||
145777137|NCT03633331|525693256|FG000|Overall Study|Withdrawal by Subject|1|||
145777138|NCT01009294|525693257|FG000|Overall Study|Study discontinued by Sponsor|6|||
145777139|NCT00883753|525693258|FG000|Overall Study|Adverse Event|37|||
145777140|NCT00883753|525693258|FG000|Overall Study|Death|2|||
145777141|NCT00883753|525693258|FG000|Overall Study|Insufficient therapeutic response|16|||
145777142|NCT00883753|525693258|FG000|Overall Study|Lost to Follow-up|4|||
145777143|NCT00883753|525693258|FG000|Overall Study|Violation of selection criteria at entry|7|||
145777144|NCT00883753|525693258|FG000|Overall Study|Protocol Violation|2|||
145777145|NCT00883753|525693258|FG000|Overall Study|Refused treatment|4|||
145777146|NCT00883753|525693258|FG000|Overall Study|Withdrew consent|10|||
145777147|NCT00883753|525693258|FG000|Overall Study|Investigator's decision|17|||
145777148|NCT00883753|525693258|FG000|Overall Study|Administrative/Other|8|||
145777149|NCT01743027|525693263|FG000|Overall Study|Adverse Event|2|||
145777150|NCT01743027|525693264|FG001|Overall Study|Adverse Event|0|||
145777151|NCT01743027|525693265|FG002|Overall Study|Adverse Event|0|||
145777152|NCT01743027|525693266|FG003|Overall Study|Adverse Event|0|||
145777153|NCT01743027|525693263|FG000|Overall Study|Lost to Follow-up|0|||
145777154|NCT01743027|525693264|FG001|Overall Study|Lost to Follow-up|0|||
145777155|NCT01743027|525693265|FG002|Overall Study|Lost to Follow-up|2|||
145777156|NCT01743027|525693266|FG003|Overall Study|Lost to Follow-up|0|||
145777157|NCT01743027|525693263|FG000|Overall Study|Progressive Disease|1|||
145777158|NCT01743027|525693264|FG001|Overall Study|Progressive Disease|4|||
145777159|NCT01743027|525693265|FG002|Overall Study|Progressive Disease|3|||
145777160|NCT01743027|525693266|FG003|Overall Study|Progressive Disease|0|||
145777161|NCT01743027|525693263|FG000|Overall Study|Protocol Violation|1|||
145279117|NCT02454972|523872873|FG005|Overall Study|Progressive disease|12|||
145279118|NCT02454972|523872874|FG006|Overall Study|Progressive disease|19|||
145279119|NCT02454972|523872875|FG007|Overall Study|Progressive disease|27|||
145279120|NCT02454972|523872876|FG008|Overall Study|Progressive disease|0|||
145279121|NCT02454972|523872868|FG000|Overall Study|Death|0|||
145279122|NCT02454972|523872869|FG001|Overall Study|Death|0|||
145279123|NCT02454972|523872870|FG002|Overall Study|Death|5|||
145279124|NCT02454972|523872871|FG003|Overall Study|Death|1|||
145279125|NCT02454972|523872872|FG004|Overall Study|Death|0|||
145279126|NCT02454972|523872873|FG005|Overall Study|Death|0|||
145279127|NCT02454972|523872874|FG006|Overall Study|Death|0|||
145279128|NCT02454972|523872875|FG007|Overall Study|Death|0|||
145279129|NCT02454972|523872876|FG008|Overall Study|Death|95|||
145279130|NCT02454972|523872868|FG000|Overall Study|Physician Decision|0|||
145279131|NCT02454972|523872869|FG001|Overall Study|Physician Decision|1|||
145279132|NCT02454972|523872870|FG002|Overall Study|Physician Decision|2|||
145279133|NCT02454972|523872871|FG003|Overall Study|Physician Decision|1|||
145279134|NCT02454972|523872872|FG004|Overall Study|Physician Decision|2|||
145279135|NCT02454972|523872873|FG005|Overall Study|Physician Decision|0|||
145279136|NCT02454972|523872874|FG006|Overall Study|Physician Decision|0|||
145279137|NCT02454972|523872875|FG007|Overall Study|Physician Decision|1|||
145279138|NCT02454972|523872876|FG008|Overall Study|Physician Decision|0|||
145279139|NCT02454972|523872868|FG000|Overall Study|Non treatment-related adverse event|2|||
145279140|NCT02454972|523872869|FG001|Overall Study|Non treatment-related adverse event|0|||
145403703|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
145403704|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145536371|NCT01757535|524822193|FG000|Overall Study|Adverse Event|31|||
145536372|NCT01757535|524822194|FG001|Overall Study|Adverse Event|11|||
145536373|NCT01757535|524822193|FG000|Overall Study|Withdrew Consent|19|||
145777162|NCT01743027|525693264|FG001|Overall Study|Protocol Violation|1|||
145777163|NCT01743027|525693265|FG002|Overall Study|Protocol Violation|1|||
145777164|NCT01743027|525693266|FG003|Overall Study|Protocol Violation|0|||
145279141|NCT02454972|523872870|FG002|Overall Study|Non treatment-related adverse event|1|||
145777165|NCT01743027|525693263|FG000|Overall Study|Withdrawal by Subject|1|||
145777166|NCT01743027|525693264|FG001|Overall Study|Withdrawal by Subject|0|||
145777167|NCT01743027|525693265|FG002|Overall Study|Withdrawal by Subject|3|||
145777168|NCT01743027|525693266|FG003|Overall Study|Withdrawal by Subject|1|||
145777169|NCT02111811|525693267|FG000|Treatment Phase|Lost to Follow-up|22|||
145777170|NCT02111811|525693268|FG001|Treatment Phase|Lost to Follow-up|18|||
145777171|NCT02111811|525693267|FG000|Treatment Phase|Death|2|||
145777172|NCT02111811|525693268|FG001|Treatment Phase|Death|0|||
145777173|NCT02111811|525693267|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
145777174|NCT02111811|525693268|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
145777175|NCT02111811|525693267|FG000|Follow up Period (Aim 2)|Death|2|||
145777176|NCT02111811|525693268|FG001|Follow up Period (Aim 2)|Death|0|||
145777177|NCT01359982|525693272|FG000|Overall Study|Adverse Event|2|||
145777178|NCT01359982|525693273|FG001|Overall Study|Adverse Event|0|||
145777179|NCT01359982|525693274|FG002|Overall Study|Adverse Event|0|||
145536374|NCT01757535|524822194|FG001|Overall Study|Withdrew Consent|13|||
145536375|NCT01757535|524822193|FG000|Overall Study|Physician Decision|7|||
145536376|NCT01757535|524822194|FG001|Overall Study|Physician Decision|0|||
145536377|NCT01757535|524822193|FG000|Overall Study|Death|2|||
145777180|NCT01359982|525693275|FG003|Overall Study|Adverse Event|1|||
145777181|NCT01359982|525693276|FG004|Overall Study|Adverse Event|0|||
145777182|NCT01359982|525693277|FG005|Overall Study|Adverse Event|0|||
145777183|NCT01359982|525693272|FG000|Overall Study|Death|1|||
145777184|NCT01359982|525693273|FG001|Overall Study|Death|0|||
145777185|NCT01359982|525693274|FG002|Overall Study|Death|0|||
145777186|NCT01359982|525693275|FG003|Overall Study|Death|0|||
145777187|NCT01359982|525693276|FG004|Overall Study|Death|0|||
145777188|NCT01359982|525693277|FG005|Overall Study|Death|0|||
145777189|NCT01926886|525693280|FG000|Overall Study|Administrative/other|1|||
145536378|NCT01757535|524822194|FG001|Overall Study|Death|2|||
145536379|NCT06238362|524822195|FG000|Overall Study|Insufficient total sleep time|1|||
145536380|NCT06238362|524822196|FG001|Overall Study|Insufficient total sleep time|0|||
145536381|NCT06238362|524822195|FG000|Overall Study|Inadequate signal quality|1|||
145536382|NCT06238362|524822196|FG001|Overall Study|Inadequate signal quality|0|||
145536383|NCT00531934|524824105|FG000|Overall Study|Adverse Event|4|||
145777190|NCT01926886|525693281|FG001|Overall Study|Administrative/other|0|||
145777191|NCT01926886|525693280|FG000|Overall Study|Adverse event/intercurrent illness|4|||
145536384|NCT00531934|524824106|FG001|Overall Study|Adverse Event|8|||
145536385|NCT00531934|524824105|FG000|Overall Study|Progression|52|||
145536386|NCT00531934|524824106|FG001|Overall Study|Progression|42|||
145536387|NCT00531934|524824105|FG000|Overall Study|Death|7|||
145536388|NCT00531934|524824106|FG001|Overall Study|Death|10|||
145536389|NCT00531934|524824105|FG000|Overall Study|Withdrawal by Subject|1|||
145536390|NCT00531934|524824106|FG001|Overall Study|Withdrawal by Subject|1|||
145536391|NCT00531934|524824105|FG000|Overall Study|Other|2|||
145536392|NCT00531934|524824106|FG001|Overall Study|Other|2|||
145536393|NCT00150709|524824107|FG000|Overall Study|Protocol Violation|7|||
145536394|NCT00150709|524824108|FG001|Overall Study|Protocol Violation|8|||
145536395|NCT00150709|524824109|FG002|Overall Study|Protocol Violation|3|||
145536396|NCT00150709|524824110|FG003|Overall Study|Protocol Violation|1|||
145536397|NCT00150709|524824107|FG000|Overall Study|Adverse Event|8|||
145536398|NCT00150709|524824108|FG001|Overall Study|Adverse Event|2|||
145536399|NCT00150709|524824109|FG002|Overall Study|Adverse Event|2|||
145536400|NCT00150709|524824110|FG003|Overall Study|Adverse Event|3|||
145536401|NCT00150709|524824107|FG000|Overall Study|Lack of Efficacy|6|||
145536402|NCT00150709|524824108|FG001|Overall Study|Lack of Efficacy|11|||
145536403|NCT00150709|524824109|FG002|Overall Study|Lack of Efficacy|9|||
145536404|NCT00150709|524824110|FG003|Overall Study|Lack of Efficacy|0|||
145536405|NCT00150709|524824107|FG000|Overall Study|Withdrawal by Subject|7|||
145777192|NCT01926886|525693281|FG001|Overall Study|Adverse event/intercurrent illness|0|||
145777193|NCT01926886|525693280|FG000|Overall Study|Disease progression/recurrence|4|||
145536406|NCT00150709|524824108|FG001|Overall Study|Withdrawal by Subject|10|||
145777194|NCT01926886|525693281|FG001|Overall Study|Disease progression/recurrence|0|||
145777195|NCT01926886|525693280|FG000|Overall Study|Withdrawal by Subject|15|||
145279142|NCT02454972|523872871|FG003|Overall Study|Non treatment-related adverse event|0|||
145536407|NCT00150709|524824109|FG002|Overall Study|Withdrawal by Subject|5|||
145777196|NCT01926886|525693281|FG001|Overall Study|Withdrawal by Subject|0|||
145777197|NCT01926886|525693280|FG000|Overall Study|Failure to return|3|||
145777198|NCT01926886|525693281|FG001|Overall Study|Failure to return|0|||
145777199|NCT01926886|525693280|FG000|Overall Study|Recurrence of disease|1|||
145777200|NCT01926886|525693281|FG001|Overall Study|Recurrence of disease|0|||
145777201|NCT01926886|525693280|FG000|Overall Study|Progression of disease|2|||
145777202|NCT01926886|525693281|FG001|Overall Study|Progression of disease|0|||
145777203|NCT01926886|525693280|FG000|Overall Study|Death|1|||
145777204|NCT01926886|525693281|FG001|Overall Study|Death|0|||
145536408|NCT00150709|524824110|FG003|Overall Study|Withdrawal by Subject|0|||
145536409|NCT00150709|524824107|FG000|Overall Study|Lost to Follow-up|3|||
145536410|NCT00150709|524824108|FG001|Overall Study|Lost to Follow-up|2|||
145536411|NCT00150709|524824109|FG002|Overall Study|Lost to Follow-up|0|||
145536412|NCT00150709|524824110|FG003|Overall Study|Lost to Follow-up|0|||
145536413|NCT00150709|524824107|FG000|Overall Study|Sponsor decision|0|||
145777205|NCT01926886|525693280|FG000|Overall Study|Did not cooperate|1|||
145777206|NCT01926886|525693281|FG001|Overall Study|Did not cooperate|0|||
145777207|NCT02609399|525693285|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
145777208|NCT02609399|525693286|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
145777209|NCT02609399|525693285|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
145777210|NCT02609399|525693286|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
145777211|NCT02609399|525693285|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
145777212|NCT02609399|525693286|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
145777213|NCT00196937|525693288|FG000|Overall Study|Serious Adverse Event|1|||
145777214|NCT00196937|525693289|FG001|Overall Study|Serious Adverse Event|0|||
145777215|NCT00196937|525693290|FG002|Overall Study|Serious Adverse Event|0|||
145777216|NCT00196937|525693288|FG000|Overall Study|Non-serious adverse event|1|||
145777217|NCT00196937|525693289|FG001|Overall Study|Non-serious adverse event|1|||
145777218|NCT00196937|525693290|FG002|Overall Study|Non-serious adverse event|1|||
145777219|NCT00196937|525693288|FG000|Overall Study|Withdrawal by Subject|0|||
145777220|NCT00196937|525693289|FG001|Overall Study|Withdrawal by Subject|0|||
145777221|NCT00196937|525693290|FG002|Overall Study|Withdrawal by Subject|2|||
145777222|NCT00196937|525693288|FG000|Overall Study|Lost to Follow-up|4|||
145777223|NCT00196937|525693289|FG001|Overall Study|Lost to Follow-up|3|||
145777224|NCT00196937|525693290|FG002|Overall Study|Lost to Follow-up|3|||
145777225|NCT00196937|525693288|FG000|Overall Study|Other|3|||
145777226|NCT00196937|525693289|FG001|Overall Study|Other|1|||
145777227|NCT00196937|525693290|FG002|Overall Study|Other|1|||
145777228|NCT03368404|525693296|FG000|Overall Study|Adverse Event|2|||
145777229|NCT03368404|525693297|FG001|Overall Study|Adverse Event|1|||
145777230|NCT03368404|525693296|FG000|Overall Study|Withdrawal by Subject|1|||
145777231|NCT03368404|525693297|FG001|Overall Study|Withdrawal by Subject|1|||
145777232|NCT00995371|525693298|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
145777233|NCT00995371|525693299|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
145777234|NCT02983292|525693300|FG000|Overall Study|Participant unwell & cannot travel|2|||
145777235|NCT02983292|525693300|FG000|Overall Study|Lost to Follow-up|3|||
145777236|NCT02983292|525693300|FG000|Overall Study|Participant withdrew consent|2|||
145777237|NCT02983292|525693300|FG000|Overall Study|Revision|7|||
145777238|NCT02983292|525693300|FG000|Overall Study|Death|1|||
145777239|NCT02983292|525693300|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
145777240|NCT02983292|525693300|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
145777241|NCT02983292|525693300|FG000|Overall Study|Participant relocation|1|||
145777242|NCT00964795|525693301|FG000|Overall Study|Withdrawal by Subject|79|||
145777243|NCT00964795|525693301|FG000|Overall Study|Adverse Event|12|||
145777244|NCT00964795|525693301|FG000|Overall Study|Death|14|||
145777245|NCT00964795|525693301|FG000|Overall Study|Lost to Follow-up|7|||
145777246|NCT00964795|525693301|FG000|Overall Study|Termination of Study by Sponsor|169|||
145777247|NCT00964795|525693301|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
145777248|NCT00964795|525693301|FG000|Overall Study|Other|23|||
145777249|NCT02453841|525693305|FG000|Overall Study|Protocol Violation|1|||
145777250|NCT02453841|525693305|FG000|Overall Study|Unable to obtain blood samples|2|||
145777251|NCT02190591|525693306|FG000|Overall Study|Withdrawal by Subject|1|||
145777252|NCT02190591|525693307|FG001|Overall Study|Withdrawal by Subject|8|||
145777253|NCT02190591|525693306|FG000|Overall Study|Protocol Violation|1|||
145777254|NCT02190591|525693307|FG001|Overall Study|Protocol Violation|0|||
145777255|NCT02190591|525693306|FG000|Overall Study|did not use peanut ball as instructed|0|||
145777256|NCT02190591|525693307|FG001|Overall Study|did not use peanut ball as instructed|2|||
145777257|NCT02190591|525693306|FG000|Overall Study|face presentation so she was ineligible|0|||
145777258|NCT02190591|525693307|FG001|Overall Study|face presentation so she was ineligible|1|||
145777259|NCT00857246|525693308|FG000|Induction Regimen|Adverse Event|1|||
145777260|NCT00857246|525693308|FG000|Induction Regimen|disease-related complications|1|||
145777261|NCT00857246|525693308|FG000|Induction Regimen|Withdrawal by Subject|1|||
145777262|NCT00857246|525693308|FG000|Surgery (Curative)|disease progression|6|||
145777263|NCT00857246|525693308|FG000|ChemoRT|Withdrawal by Subject|1|||
145777264|NCT00857246|525693308|FG000|ChemoRT|Adverse Event|2|||
145777265|NCT03851510|525693309|FG000|Overall Study|Screen Fail|1|||
145777266|NCT03851510|525693309|FG000|Overall Study|Adverse Event|1|||
145777267|NCT03851510|525693309|FG000|Overall Study|Withdrawal by Subject|1|||
145777268|NCT00072189|525693310|FG000|Overall Study|Withdrawal by Subject|1|||
145777269|NCT02973815|525693311|FG000|Post Intervention|Death|1|||
145777270|NCT02973815|525693312|FG001|Post Intervention|Death|0|||
145777271|NCT02973815|525693311|FG000|Post Intervention|Lost to Follow-up|7|||
145777272|NCT02973815|525693312|FG001|Post Intervention|Lost to Follow-up|24|||
145777273|NCT02973815|525693311|FG000|Follow-up|Lost to Follow-up|2|||
145777274|NCT02973815|525693312|FG001|Follow-up|Lost to Follow-up|0|||
145777275|NCT04542291|525693313|FG000|Overall Study|Adverse Event|1|||
145777276|NCT04542291|525693313|FG000|Overall Study|Physician Decision|2|||
145777277|NCT04579393|525693319|FG000|Overall Study|Withdrawal by Subject|2|||
145777278|NCT04579393|525693320|FG001|Overall Study|Withdrawal by Subject|2|||
145777279|NCT04579393|525693319|FG000|Overall Study|Death|1|||
145777280|NCT04579393|525693320|FG001|Overall Study|Death|3|||
145777281|NCT01739595|525693322|FG000|Overall Study|Adverse Event|3|||
145777282|NCT01739595|525693323|FG001|Overall Study|Adverse Event|0|||
145777283|NCT01739595|525693324|FG002|Overall Study|Adverse Event|0|||
145777284|NCT01739595|525693322|FG000|Overall Study|Lost to Follow-up|2|||
145777285|NCT01739595|525693323|FG001|Overall Study|Lost to Follow-up|0|||
145777286|NCT01739595|525693324|FG002|Overall Study|Lost to Follow-up|0|||
145777287|NCT01739595|525693322|FG000|Overall Study|Withdrawal by Subject|2|||
145777288|NCT01739595|525693323|FG001|Overall Study|Withdrawal by Subject|1|||
145777289|NCT01739595|525693324|FG002|Overall Study|Withdrawal by Subject|2|||
145777290|NCT01739595|525693322|FG000|Overall Study|Eligibility issue|3|||
145777291|NCT01739595|525693323|FG001|Overall Study|Eligibility issue|0|||
145777292|NCT01739595|525693324|FG002|Overall Study|Eligibility issue|0|||
145777293|NCT01739595|525693322|FG000|Overall Study|Protocol Violation|1|||
145777294|NCT01739595|525693323|FG001|Overall Study|Protocol Violation|0|||
145777295|NCT01739595|525693324|FG002|Overall Study|Protocol Violation|0|||
145777296|NCT01739595|525693322|FG000|Overall Study|Lab assessment|1|||
145777297|NCT01739595|525693323|FG001|Overall Study|Lab assessment|0|||
145777298|NCT01739595|525693324|FG002|Overall Study|Lab assessment|0|||
145777299|NCT01739595|525693322|FG000|Overall Study|Drug discrepancy|1|||
145777300|NCT01739595|525693323|FG001|Overall Study|Drug discrepancy|0|||
145777301|NCT01739595|525693324|FG002|Overall Study|Drug discrepancy|0|||
145777302|NCT01524289|525693325|FG000|Overall Study|Lost to Follow-up|0|||
145777303|NCT01524289|525693326|FG001|Overall Study|Lost to Follow-up|1|||
145777304|NCT01524289|525693325|FG000|Overall Study|Physician Decision|1|||
145777305|NCT01524289|525693326|FG001|Overall Study|Physician Decision|0|||
145777306|NCT01524289|525693325|FG000|Overall Study|Protocol Violation|5|||
145777307|NCT01524289|525693326|FG001|Overall Study|Protocol Violation|1|||
145777308|NCT01524289|525693325|FG000|Overall Study|Withdrawal by Subject|11|||
145777309|NCT01524289|525693326|FG001|Overall Study|Withdrawal by Subject|7|||
145777310|NCT01524289|525693325|FG000|Overall Study|Adverse Event|12|||
145777311|NCT01524289|525693326|FG001|Overall Study|Adverse Event|5|||
145777312|NCT01524289|525693325|FG000|Overall Study|Did not take study medication|1|||
145777313|NCT01524289|525693326|FG001|Overall Study|Did not take study medication|0|||
145777314|NCT02104180|525693327|FG000|Overall Study|Protocol Violation|1|||
145777315|NCT02104180|525693328|FG001|Overall Study|Protocol Violation|0|||
145777316|NCT02704429|525693331|FG000|Part A: 24 Weeks|Adverse Event|3|||
145777317|NCT02704429|525693332|FG001|Part A: 24 Weeks|Adverse Event|0|||
145777318|NCT02704429|525693331|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
145777319|NCT02704429|525693332|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
145777320|NCT00104104|525693333|FG000|Overall Study|Adverse Event|8|||
145777321|NCT00104104|525693334|FG001|Overall Study|Adverse Event|8|||
145777322|NCT00104104|525693333|FG000|Overall Study|Abnormal laboratory value(s)|20|||
145777323|NCT00104104|525693334|FG001|Overall Study|Abnormal laboratory value(s)|14|||
145777324|NCT00104104|525693333|FG000|Overall Study|Lack of Efficacy|0|||
145777325|NCT00104104|525693334|FG001|Overall Study|Lack of Efficacy|3|||
145777326|NCT00104104|525693333|FG000|Overall Study|Condition no longer requires study drug|7|||
145777327|NCT00104104|525693334|FG001|Overall Study|Condition no longer requires study drug|4|||
145777328|NCT00104104|525693333|FG000|Overall Study|Protocol Violation|5|||
145777329|NCT00104104|525693334|FG001|Overall Study|Protocol Violation|2|||
145777330|NCT00104104|525693333|FG000|Overall Study|Withdrawal by Subject|11|||
145777331|NCT00104104|525693334|FG001|Overall Study|Withdrawal by Subject|15|||
145777332|NCT00104104|525693333|FG000|Overall Study|Lost to Follow-up|3|||
145777333|NCT00104104|525693334|FG001|Overall Study|Lost to Follow-up|7|||
145777334|NCT00104104|525693333|FG000|Overall Study|Administrative problems|12|||
145777335|NCT00104104|525693334|FG001|Overall Study|Administrative problems|13|||
145777336|NCT00104104|525693333|FG000|Overall Study|Death|9|||
145777337|NCT00104104|525693334|FG001|Overall Study|Death|6|||
145777338|NCT01821677|525693340|FG000|Overall Study|Adverse Event|4|||
145777339|NCT01821677|525693341|FG001|Overall Study|Adverse Event|6|||
145777340|NCT01821677|525693342|FG002|Overall Study|Adverse Event|5|||
145777341|NCT01821677|525693340|FG000|Overall Study|Physician Decision|1|||
145777342|NCT01821677|525693341|FG001|Overall Study|Physician Decision|4|||
145777343|NCT01821677|525693342|FG002|Overall Study|Physician Decision|1|||
145777344|NCT01821677|525693340|FG000|Overall Study|Non-compliance|0|||
145777345|NCT01821677|525693341|FG001|Overall Study|Non-compliance|1|||
145777346|NCT01821677|525693342|FG002|Overall Study|Non-compliance|2|||
145777347|NCT01821677|525693340|FG000|Overall Study|Lost to Follow-up|2|||
145777348|NCT01821677|525693341|FG001|Overall Study|Lost to Follow-up|1|||
145777349|NCT01821677|525693342|FG002|Overall Study|Lost to Follow-up|3|||
145777350|NCT01821677|525693340|FG000|Overall Study|Protocol Violation|0|||
145777351|NCT01821677|525693341|FG001|Overall Study|Protocol Violation|0|||
145777352|NCT01821677|525693342|FG002|Overall Study|Protocol Violation|2|||
145777353|NCT01821677|525693340|FG000|Overall Study|Withdrawal by Subject|7|||
145777354|NCT01821677|525693341|FG001|Overall Study|Withdrawal by Subject|3|||
145777355|NCT01821677|525693342|FG002|Overall Study|Withdrawal by Subject|2|||
145777356|NCT01821677|525693340|FG000|Overall Study|Other|9|||
145777357|NCT01821677|525693341|FG001|Overall Study|Other|0|||
145777358|NCT01821677|525693342|FG002|Overall Study|Other|0|||
145777359|NCT02209597|525693351|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
145777360|NCT02209597|525693351|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
145777361|NCT02209597|525693351|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
145777362|NCT02209597|525693351|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
145777363|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Adverse Event|37|||
145777364|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Adverse Event|0|||
145777365|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Adverse Event|0|||
145777366|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Adverse Event|0|||
145777367|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Death|2|||
145777368|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Death|0|||
145777369|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Death|0|||
145777370|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Death|0|||
145777371|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
145777372|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
145777373|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
145777374|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
145777375|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
145777376|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
145777377|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
145777378|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
145777379|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
145777380|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
145777381|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
145777382|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
145777383|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
145777384|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
145777385|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
145777386|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
145777387|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Physician Decision|4|||
145777388|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Physician Decision|0|||
145777389|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Physician Decision|0|||
145777390|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Physician Decision|0|||
145777391|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Pregnancy|1|||
145777392|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Pregnancy|0|||
145777393|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Pregnancy|0|||
145777394|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Pregnancy|0|||
145777395|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
145777396|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
145777397|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
145777398|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
145777399|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
145777400|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
145777401|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
145777402|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
145777403|NCT01855789|525693353|FG000|1) Baseline up to Week 24|Other|4|||
145777404|NCT01855789|525693354|FG001|1) Baseline up to Week 24|Other|0|||
145777405|NCT01855789|525693355|FG002|1) Baseline up to Week 24|Other|0|||
145777406|NCT01855789|525693356|FG003|1) Baseline up to Week 24|Other|0|||
145777407|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
145777408|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
145777409|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
145777410|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
145777411|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
145777412|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
145777413|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
145777414|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
145777415|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
145777416|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
145777417|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
145777418|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
145777419|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
145777420|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
145777421|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
145777422|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
145777423|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
145777424|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
145777425|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
145777426|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
145777427|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
145777428|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
145777429|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
145777430|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
145777431|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
145777432|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
145777433|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
145777434|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
145777435|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
145777436|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
145777437|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
145777438|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
145777439|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
145777440|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
145777441|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
145777442|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
145777443|NCT01855789|525693353|FG000|2) Week 24 up to End of Study|Other|0|||
145777444|NCT01855789|525693354|FG001|2) Week 24 up to End of Study|Other|0|||
145777445|NCT01855789|525693355|FG002|2) Week 24 up to End of Study|Other|0|||
145777446|NCT01855789|525693356|FG003|2) Week 24 up to End of Study|Other|1|||
145777447|NCT01863758|525693357|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
145777448|NCT01863758|525693357|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
145777449|NCT02606877|525693360|FG000|Overall Study|Adverse Event|3|||
145777450|NCT02606877|525693361|FG001|Overall Study|Adverse Event|0|||
145777451|NCT02606877|525693360|FG000|Overall Study|Non-compliance with protocol|0|||
145777452|NCT02606877|525693361|FG001|Overall Study|Non-compliance with protocol|1|||
145777453|NCT02606877|525693360|FG000|Overall Study|Other than listed above|1|||
145777454|NCT02606877|525693361|FG001|Overall Study|Other than listed above|0|||
145777455|NCT04952389|525693362|FG000|Overall Study|Withdrawal by Subject|8|||
145777456|NCT04952389|525693363|FG001|Overall Study|Withdrawal by Subject|4|||
145777457|NCT00778999|525693364|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
145777458|NCT00778999|525693365|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
145777459|NCT00778999|525693364|FG000|Overall Study|Did not receive recFSH|14|||
145777460|NCT00778999|525693365|FG001|Overall Study|Did not receive recFSH|20|||
145536414|NCT00150709|524824108|FG001|Overall Study|Sponsor decision|0|||
145536415|NCT00150709|524824109|FG002|Overall Study|Sponsor decision|0|||
145536416|NCT00150709|524824110|FG003|Overall Study|Sponsor decision|1|||
145536417|NCT00150709|524824107|FG000|Overall Study|Site/Investigator discontinued the study|5|||
145536418|NCT00150709|524824108|FG001|Overall Study|Site/Investigator discontinued the study|5|||
145536419|NCT00150709|524824109|FG002|Overall Study|Site/Investigator discontinued the study|2|||
145536420|NCT00150709|524824110|FG003|Overall Study|Site/Investigator discontinued the study|0|||
145536421|NCT00150709|524824107|FG000|Overall Study|Decision of parent(s)|1|||
145536422|NCT00150709|524824108|FG001|Overall Study|Decision of parent(s)|2|||
145536423|NCT00150709|524824109|FG002|Overall Study|Decision of parent(s)|0|||
145536424|NCT00150709|524824110|FG003|Overall Study|Decision of parent(s)|0|||
145536425|NCT00150709|524824107|FG000|Overall Study|Decision of parent(s) and investigator|3|||
145536426|NCT00150709|524824108|FG001|Overall Study|Decision of parent(s) and investigator|0|||
145536427|NCT00150709|524824109|FG002|Overall Study|Decision of parent(s) and investigator|0|||
145536428|NCT00150709|524824110|FG003|Overall Study|Decision of parent(s) and investigator|0|||
145536429|NCT00150709|524824107|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
145536430|NCT00150709|524824108|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
145536431|NCT00150709|524824109|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
145536432|NCT00150709|524824110|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
145536433|NCT00150709|524824107|FG000|Overall Study|Investigator decision|1|||
145536434|NCT00150709|524824108|FG001|Overall Study|Investigator decision|0|||
145536435|NCT00150709|524824109|FG002|Overall Study|Investigator decision|0|||
145536436|NCT00150709|524824110|FG003|Overall Study|Investigator decision|1|||
145536437|NCT00150709|524824107|FG000|Overall Study|Subject relocated|2|||
145608717|NCT02247804|525083178|FG002|Treatment Period 3|Adverse Event|3|||
145608718|NCT02247804|525083176|FG000|Treatment Period 3|Lack of Efficacy|0|||
145608719|NCT02247804|525083177|FG001|Treatment Period 3|Lack of Efficacy|1|||
145608720|NCT02247804|525083178|FG002|Treatment Period 3|Lack of Efficacy|0|||
145608721|NCT02247804|525083176|FG000|Treatment Period 3|Lost to Follow-up|1|||
145608722|NCT02247804|525083177|FG001|Treatment Period 3|Lost to Follow-up|2|||
145608723|NCT02247804|525083178|FG002|Treatment Period 3|Lost to Follow-up|2|||
145608724|NCT02247804|525083176|FG000|Treatment Period 3|Personal Reasons|4|||
145608725|NCT02247804|525083177|FG001|Treatment Period 3|Personal Reasons|3|||
145608726|NCT02247804|525083178|FG002|Treatment Period 3|Personal Reasons|2|||
145608727|NCT02247804|525083176|FG000|Treatment Period 3|Reason not Specified|2|||
145608728|NCT02247804|525083177|FG001|Treatment Period 3|Reason not Specified|1|||
145608729|NCT02247804|525083178|FG002|Treatment Period 3|Reason not Specified|3|||
145608730|NCT03447730|525083179|FG000|Overall Study|Adverse Event|0|||
145608731|NCT03447730|525083180|FG001|Overall Study|Adverse Event|2|||
145608732|NCT03447730|525083181|FG002|Overall Study|Adverse Event|0|||
145608733|NCT01350505|525083183|FG000|Overall Study|Lost to Follow-up|4|||
145608734|NCT04251065|525083184|FG000|Overall Study|Death|2|||
145608735|NCT04251065|525083184|FG000|Overall Study|Lack of Efficacy|3|||
145608736|NCT04251065|525083184|FG000|Overall Study|Death|1|||
145608737|NCT01054573|525083185|FG000|Overall Study|Adverse Event|1|||
145608738|NCT01054573|525083186|FG001|Overall Study|Adverse Event|0|||
145608739|NCT01054573|525083187|FG002|Overall Study|Adverse Event|1|||
145608740|NCT01054573|525083188|FG003|Overall Study|Adverse Event|1|||
145608741|NCT01054573|525083185|FG000|Overall Study|Lost to Follow-up|0|||
145608742|NCT01054573|525083186|FG001|Overall Study|Lost to Follow-up|2|||
145608743|NCT01054573|525083187|FG002|Overall Study|Lost to Follow-up|0|||
145608744|NCT01054573|525083188|FG003|Overall Study|Lost to Follow-up|0|||
145608745|NCT01054573|525083185|FG000|Overall Study|Withdrawal by Subject|0|||
145608746|NCT01054573|525083186|FG001|Overall Study|Withdrawal by Subject|2|||
145608747|NCT01054573|525083187|FG002|Overall Study|Withdrawal by Subject|2|||
145608748|NCT01054573|525083188|FG003|Overall Study|Withdrawal by Subject|1|||
145608749|NCT05266963|525083189|FG000|Drug Period A|Withdrawal by Subject|0|||
145536438|NCT00150709|524824108|FG001|Overall Study|Subject relocated|2|||
145777461|NCT00744055|525694491|FG000|Overall Study|Withdrawal by Subject|6|||
145777462|NCT00744055|525694492|FG001|Overall Study|Withdrawal by Subject|9|||
145777463|NCT00744055|525694491|FG000|Overall Study|Lack of Efficacy|0|||
145777464|NCT00744055|525694492|FG001|Overall Study|Lack of Efficacy|1|||
145777465|NCT00744055|525694491|FG000|Overall Study|Physician Decision|0|||
145777466|NCT00744055|525694492|FG001|Overall Study|Physician Decision|2|||
145777467|NCT00744055|525694491|FG000|Overall Study|Protocol Violation|1|||
145777468|NCT00744055|525694492|FG001|Overall Study|Protocol Violation|1|||
145777469|NCT00744055|525694491|FG000|Overall Study|Lost to Follow-up|0|||
145777470|NCT00744055|525694492|FG001|Overall Study|Lost to Follow-up|1|||
145777471|NCT03635190|525694493|FG000|Overall Study|Lost to Follow-up|4|||
145536439|NCT00150709|524824109|FG002|Overall Study|Subject relocated|1|||
145536440|NCT00150709|524824110|FG003|Overall Study|Subject relocated|0|||
145536441|NCT00150709|524824107|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
145536442|NCT00150709|524824108|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
145536443|NCT00150709|524824109|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
145536444|NCT00150709|524824110|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
145536445|NCT00150709|524824107|FG000|Overall Study|Convenience|0|||
145536446|NCT00150709|524824108|FG001|Overall Study|Convenience|1|||
145536447|NCT00150709|524824109|FG002|Overall Study|Convenience|0|||
145536448|NCT00150709|524824110|FG003|Overall Study|Convenience|0|||
145536449|NCT00150709|524824107|FG000|Overall Study|Subject entered new drug study|0|||
145536450|NCT00150709|524824108|FG001|Overall Study|Subject entered new drug study|1|||
145536451|NCT00150709|524824109|FG002|Overall Study|Subject entered new drug study|0|||
145608750|NCT05266963|525083190|FG001|Drug Period A|Withdrawal by Subject|1|||
145608751|NCT03812536|525083191|FG000|Overall Study|Protocol Violation|2|||
145608752|NCT03812536|525083192|FG001|Overall Study|Protocol Violation|0|||
145608753|NCT03812536|525083191|FG000|Overall Study|Withdrawal by Subject|1|||
145536452|NCT00150709|524824110|FG003|Overall Study|Subject entered new drug study|0|||
145608754|NCT03812536|525083192|FG001|Overall Study|Withdrawal by Subject|1|||
145608755|NCT00152009|525083193|FG000|Overall Study|Adverse Event|9|||
145608756|NCT00152009|525083194|FG001|Overall Study|Adverse Event|13|||
145608757|NCT00152009|525083195|FG002|Overall Study|Adverse Event|20|||
145608758|NCT00152009|525083196|FG003|Overall Study|Adverse Event|1|||
145608759|NCT00152009|525083193|FG000|Overall Study|Protocol Violation|3|||
145777472|NCT03635190|525694493|FG000|Overall Study|Death|3|||
145536453|NCT00150709|524824107|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
145608760|NCT00152009|525083194|FG001|Overall Study|Protocol Violation|0|||
145608761|NCT00152009|525083195|FG002|Overall Study|Protocol Violation|0|||
145608762|NCT00152009|525083196|FG003|Overall Study|Protocol Violation|1|||
145608763|NCT00152009|525083193|FG000|Overall Study|Withdrawal by Subject|2|||
145608764|NCT00152009|525083194|FG001|Overall Study|Withdrawal by Subject|3|||
145608765|NCT00152009|525083195|FG002|Overall Study|Withdrawal by Subject|4|||
145536454|NCT00150709|524824108|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
145536455|NCT00150709|524824109|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
145536456|NCT00150709|524824110|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
145536457|NCT00150709|524824107|FG000|Overall Study|Lack of ease of swallowing|0|||
145536458|NCT00150709|524824108|FG001|Overall Study|Lack of ease of swallowing|1|||
145536459|NCT00150709|524824109|FG002|Overall Study|Lack of ease of swallowing|0|||
145536460|NCT00150709|524824110|FG003|Overall Study|Lack of ease of swallowing|0|||
145536461|NCT02280304|524824111|FG000|Overall Study|Lost to Follow-up|7|||
145536462|NCT02280304|524824112|FG001|Overall Study|Lost to Follow-up|8|||
145536463|NCT01644565|524824113|FG000|Overall Study|Undisclosed Medical History|1|||
145536464|NCT01644565|524824114|FG001|Overall Study|Undisclosed Medical History|0|||
145536465|NCT01644565|524824115|FG002|Overall Study|Undisclosed Medical History|0|||
145536466|NCT01644565|524824116|FG003|Overall Study|Undisclosed Medical History|0|||
145536467|NCT01644565|524824117|FG004|Overall Study|Undisclosed Medical History|0|||
145536468|NCT01644565|524824118|FG005|Overall Study|Undisclosed Medical History|0|||
145536469|NCT01644565|524824119|FG006|Overall Study|Undisclosed Medical History|0|||
145536470|NCT01644565|524824120|FG007|Overall Study|Undisclosed Medical History|0|||
145536471|NCT01644565|524824121|FG008|Overall Study|Undisclosed Medical History|0|||
145536472|NCT01644565|524824113|FG000|Overall Study|Lost to Follow-up|0|||
145536473|NCT01644565|524824114|FG001|Overall Study|Lost to Follow-up|0|||
145536474|NCT01644565|524824115|FG002|Overall Study|Lost to Follow-up|0|||
145536475|NCT01644565|524824116|FG003|Overall Study|Lost to Follow-up|1|||
145536476|NCT01644565|524824117|FG004|Overall Study|Lost to Follow-up|0|||
145536477|NCT01644565|524824118|FG005|Overall Study|Lost to Follow-up|0|||
145536478|NCT01644565|524824119|FG006|Overall Study|Lost to Follow-up|0|||
145536479|NCT01644565|524824120|FG007|Overall Study|Lost to Follow-up|2|||
145536480|NCT01644565|524824121|FG008|Overall Study|Lost to Follow-up|0|||
145536481|NCT01644565|524824113|FG000|Overall Study|Family emergency|0|||
145536482|NCT01644565|524824114|FG001|Overall Study|Family emergency|0|||
145536483|NCT01644565|524824115|FG002|Overall Study|Family emergency|0|||
145536484|NCT01644565|524824116|FG003|Overall Study|Family emergency|0|||
145536485|NCT01644565|524824117|FG004|Overall Study|Family emergency|1|||
145536486|NCT01644565|524824118|FG005|Overall Study|Family emergency|0|||
145536487|NCT01644565|524824119|FG006|Overall Study|Family emergency|0|||
145536488|NCT01644565|524824120|FG007|Overall Study|Family emergency|0|||
145536489|NCT01644565|524824121|FG008|Overall Study|Family emergency|0|||
145536490|NCT01644565|524824113|FG000|Overall Study|Relocation|0|||
145536491|NCT01644565|524824114|FG001|Overall Study|Relocation|0|||
145536492|NCT01644565|524824115|FG002|Overall Study|Relocation|0|||
145536493|NCT01644565|524824116|FG003|Overall Study|Relocation|0|||
145536494|NCT01644565|524824117|FG004|Overall Study|Relocation|0|||
145536495|NCT01644565|524824118|FG005|Overall Study|Relocation|0|||
145536496|NCT01644565|524824119|FG006|Overall Study|Relocation|0|||
145536497|NCT01644565|524824120|FG007|Overall Study|Relocation|0|||
145536498|NCT01644565|524824121|FG008|Overall Study|Relocation|1|||
145536499|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
145536500|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
145536501|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
145536502|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
145536503|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
145536504|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
145536505|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
145536506|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
145536507|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
145777473|NCT03635190|525694493|FG000|Overall Study|Withdrawal by Subject|1|||
145777474|NCT03635190|525694493|FG000|Overall Study|Patient moved and did not return for follow up|1|||
145777475|NCT01306058|525694496|FG000|Overall Study|Death|1|||
145777476|NCT01306058|525694496|FG000|Overall Study|Enrolled but did not get treatment|1|||
145777477|NCT00224107|525694497|FG000|Overall Study|Adverse Event|20|||
145777478|NCT00224107|525694498|FG001|Overall Study|Adverse Event|6|||
145403705|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145403706|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145536508|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536509|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536510|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536511|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536512|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145777479|NCT00224107|525694497|FG000|Overall Study|Protocol Violation|2|||
145403707|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145536513|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536514|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
145536515|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
145536516|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536517|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536518|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536519|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145777480|NCT00224107|525694498|FG001|Overall Study|Protocol Violation|3|||
145777481|NCT00224107|525694497|FG000|Overall Study|Withdrawal by Subject|1|||
145777482|NCT00224107|525694498|FG001|Overall Study|Withdrawal by Subject|4|||
145777483|NCT00224107|525694497|FG000|Overall Study|Lack of Efficacy|2|||
145777484|NCT00224107|525694498|FG001|Overall Study|Lack of Efficacy|0|||
145777485|NCT00224107|525694497|FG000|Overall Study|Lost to Follow-up|4|||
145777486|NCT00224107|525694498|FG001|Overall Study|Lost to Follow-up|0|||
145777487|NCT00224107|525694497|FG000|Overall Study|Physician Decision|1|||
145777488|NCT00224107|525694498|FG001|Overall Study|Physician Decision|0|||
145777489|NCT00224107|525694497|FG000|Overall Study|Other|1|||
145777490|NCT00224107|525694498|FG001|Overall Study|Other|1|||
145536520|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536521|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536522|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
145536523|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
145777491|NCT03842709|525694499|FG000|Overall Study|Withdrawal by Subject|3|||
145777492|NCT03842709|525694500|FG001|Overall Study|Withdrawal by Subject|3|||
145777493|NCT03842709|525694499|FG000|Overall Study|Lost to Follow-up|1|||
145777494|NCT03842709|525694500|FG001|Overall Study|Lost to Follow-up|0|||
145777495|NCT00984659|525694501|FG000|2-week Run-in Period|Adverse Event|8|||
145777496|NCT00984659|525694502|FG001|2-week Run-in Period|Adverse Event|0|||
145777497|NCT00984659|525694503|FG002|2-week Run-in Period|Adverse Event|0|||
145777498|NCT00984659|525694504|FG003|2-week Run-in Period|Adverse Event|0|||
145777499|NCT00984659|525694501|FG000|2-week Run-in Period|Protocol Violation|5|||
145777500|NCT00984659|525694502|FG001|2-week Run-in Period|Protocol Violation|0|||
145777501|NCT00984659|525694503|FG002|2-week Run-in Period|Protocol Violation|0|||
145777502|NCT00984659|525694504|FG003|2-week Run-in Period|Protocol Violation|0|||
145777503|NCT00984659|525694501|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
145777504|NCT00984659|525694502|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
145777505|NCT00984659|525694503|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
145777506|NCT00984659|525694504|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
145777507|NCT00984659|525694501|FG000|2-week Run-in Period|Lost to Follow-up|3|||
145777508|NCT00984659|525694502|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145777509|NCT00984659|525694503|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145777510|NCT00984659|525694504|FG003|2-week Run-in Period|Lost to Follow-up|0|||
145777511|NCT00984659|525694501|FG000|2-week Run-in Period|Physician Decision|10|||
145777512|NCT00984659|525694502|FG001|2-week Run-in Period|Physician Decision|0|||
145777513|NCT00984659|525694503|FG002|2-week Run-in Period|Physician Decision|0|||
145777514|NCT00984659|525694504|FG003|2-week Run-in Period|Physician Decision|0|||
145777515|NCT00984659|525694501|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
145777516|NCT00984659|525694502|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145777517|NCT00984659|525694503|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145777518|NCT00984659|525694504|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
145777519|NCT00984659|525694501|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
145777520|NCT00984659|525694502|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145777521|NCT00984659|525694503|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145536524|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145536525|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145777522|NCT00984659|525694504|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145777523|NCT00984659|525694501|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
145777524|NCT00984659|525694502|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
145777525|NCT00984659|525694503|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
145777526|NCT00984659|525694504|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
145777527|NCT00984659|525694501|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
145777528|NCT00984659|525694502|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
145777529|NCT00984659|525694503|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
145777530|NCT00984659|525694504|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
145777531|NCT00984659|525694501|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
145777532|NCT00984659|525694502|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
145777533|NCT00984659|525694503|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
145777534|NCT00984659|525694504|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
145777535|NCT00984659|525694501|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
145777536|NCT00984659|525694502|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
145536526|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145777537|NCT00984659|525694503|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
145777538|NCT00984659|525694504|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
145777539|NCT00984659|525694501|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145777540|NCT00984659|525694502|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
145777541|NCT00984659|525694503|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
145777542|NCT00984659|525694504|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
145777543|NCT02424149|525694506|FG000|Overall Study|surgery cancelled|2|||
145777544|NCT02424149|525694507|FG001|Overall Study|surgery cancelled|0|||
145777545|NCT02424149|525694506|FG000|Overall Study|Withdrawal by Subject|0|||
145777546|NCT02424149|525694507|FG001|Overall Study|Withdrawal by Subject|1|||
145777547|NCT01357239|525694512|FG000|Stratum: All Patients|Adverse Event|0|||
145777548|NCT01357239|525694513|FG001|Stratum: All Patients|Adverse Event|0|||
145777549|NCT01357239|525694514|FG002|Stratum: All Patients|Adverse Event|1|||
145777550|NCT01357239|525694515|FG003|Stratum: All Patients|Adverse Event|1|||
145777551|NCT01357239|525694512|FG000|Stratum: All Patients|Subject withdrew consent|0|||
145777552|NCT01357239|525694513|FG001|Stratum: All Patients|Subject withdrew consent|0|||
145608766|NCT00152009|525083196|FG003|Overall Study|Withdrawal by Subject|9|||
145608767|NCT00152009|525083193|FG000|Overall Study|Lost to Follow-up|2|||
145608768|NCT00152009|525083194|FG001|Overall Study|Lost to Follow-up|4|||
145608769|NCT00152009|525083195|FG002|Overall Study|Lost to Follow-up|3|||
145608770|NCT00152009|525083196|FG003|Overall Study|Lost to Follow-up|3|||
145608771|NCT00152009|525083193|FG000|Overall Study|Lack of Efficacy|8|||
145608772|NCT00152009|525083194|FG001|Overall Study|Lack of Efficacy|6|||
145608773|NCT00152009|525083195|FG002|Overall Study|Lack of Efficacy|7|||
145608774|NCT00152009|525083196|FG003|Overall Study|Lack of Efficacy|15|||
145608775|NCT00152009|525083193|FG000|Overall Study|ECG abnormalities|2|||
145608776|NCT00152009|525083194|FG001|Overall Study|ECG abnormalities|2|||
145608777|NCT00152009|525083195|FG002|Overall Study|ECG abnormalities|2|||
145608778|NCT00152009|525083196|FG003|Overall Study|ECG abnormalities|1|||
145608779|NCT00152009|525083193|FG000|Overall Study|Sponsor's decision|3|||
145608780|NCT00152009|525083194|FG001|Overall Study|Sponsor's decision|3|||
145608781|NCT00152009|525083195|FG002|Overall Study|Sponsor's decision|1|||
145608782|NCT00152009|525083196|FG003|Overall Study|Sponsor's decision|3|||
145608783|NCT04091360|525083199|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145608784|NCT04091360|525083200|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145608785|NCT04091360|525083201|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145777553|NCT01357239|525694514|FG002|Stratum: All Patients|Subject withdrew consent|1|||
145777554|NCT01357239|525694515|FG003|Stratum: All Patients|Subject withdrew consent|1|||
145777555|NCT01357239|525694512|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
145777556|NCT01357239|525694513|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
145777557|NCT01357239|525694514|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
145777558|NCT01357239|525694515|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
145777559|NCT01357239|525694512|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
145777560|NCT01357239|525694513|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
145777561|NCT01357239|525694514|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
145777562|NCT01357239|525694515|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
145777563|NCT01357239|525694512|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
145777564|NCT01357239|525694513|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
145777565|NCT01357239|525694514|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
145777566|NCT01357239|525694515|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
145777567|NCT02614794|525694520|FG000|Overall Study|Death|258|||
145777568|NCT02614794|525694521|FG001|Overall Study|Death|151|||
145777569|NCT02614794|525694520|FG000|Overall Study|Study closure by Sponsor|119|||
145777570|NCT02614794|525694521|FG001|Overall Study|Study closure by Sponsor|45|||
145777571|NCT02614794|525694520|FG000|Overall Study|Withdrawal by Subject|24|||
145777572|NCT02614794|525694521|FG001|Overall Study|Withdrawal by Subject|5|||
145777573|NCT02614794|525694520|FG000|Overall Study|Lost to Follow-up|7|||
145777574|NCT02614794|525694521|FG001|Overall Study|Lost to Follow-up|0|||
145777575|NCT02614794|525694520|FG000|Overall Study|Physician Decision|1|||
145777576|NCT02614794|525694521|FG001|Overall Study|Physician Decision|1|||
145777577|NCT02614794|525694520|FG000|Overall Study|Hospital closure|1|||
145777578|NCT02614794|525694521|FG001|Overall Study|Hospital closure|0|||
145777579|NCT03396471|525694526|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
145777580|NCT03396471|525694526|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
145777581|NCT03396471|525694526|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
145777582|NCT03396471|525694526|FG000|Study Treatment - Up to 22 Months|Death|2|||
145777583|NCT03396471|525694526|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
145777584|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|Death|9|||
145777585|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
145608786|NCT04091360|525083202|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145608787|NCT04091360|525083203|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145777586|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
145777587|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|study terminated|1|||
145777588|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
145292776|NCT05014412|523922234|FG002|Overall Study|Death|4|||
145608788|NCT04091360|525083204|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145608789|NCT04091360|525083205|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145536527|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145536528|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145536529|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145536530|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
145536531|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
145536532|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536533|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536534|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536535|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536536|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536537|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536538|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
145536539|NCT00533897|524824129|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
145536540|NCT00533897|524824130|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536541|NCT00533897|524824131|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536542|NCT00533897|524824132|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536543|NCT00533897|524824133|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536544|NCT00533897|524824134|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536545|NCT00533897|524824135|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536546|NCT00533897|524824136|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
145536547|NCT00533897|524824129|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145536548|NCT00533897|524824130|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
145536549|NCT00533897|524824131|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
145536550|NCT00533897|524824132|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145536551|NCT00533897|524824133|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145777589|NCT03396471|525694526|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
145777590|NCT01319929|525694530|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
145777591|NCT01319929|525694531|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
145777592|NCT01319929|525694530|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
145777593|NCT01319929|525694531|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
145777594|NCT01319929|525694530|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
145777595|NCT01319929|525694531|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
145777596|NCT01319929|525694530|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
145777597|NCT01319929|525694531|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
145777598|NCT01319929|525694530|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
145777599|NCT01319929|525694531|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
145777600|NCT03237845|525694532|FG000|Overall Study|Adverse Event|0|||
145777601|NCT03237845|525694533|FG001|Overall Study|Adverse Event|1|||
145777602|NCT03237845|525694532|FG000|Overall Study|Lost to Follow-up|13|||
145777603|NCT03237845|525694533|FG001|Overall Study|Lost to Follow-up|10|||
145777604|NCT03237845|525694532|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
145777605|NCT03237845|525694533|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
145777606|NCT03237845|525694532|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
145777607|NCT03237845|525694533|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
145777608|NCT03237845|525694532|FG000|Overall Study|Physician Decision|1|||
145777609|NCT03237845|525694533|FG001|Overall Study|Physician Decision|2|||
145777610|NCT03237845|525694532|FG000|Overall Study|Pregnancy|1|||
145777611|NCT03237845|525694533|FG001|Overall Study|Pregnancy|0|||
145777612|NCT03237845|525694532|FG000|Overall Study|Protocol Deviation|0|||
145777613|NCT03237845|525694533|FG001|Overall Study|Protocol Deviation|1|||
145536552|NCT00533897|524824134|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145536553|NCT00533897|524824135|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145536554|NCT00533897|524824136|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
145536555|NCT00533897|524824129|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536556|NCT00533897|524824130|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536557|NCT00533897|524824131|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
145536558|NCT00533897|524824132|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536559|NCT00533897|524824133|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536560|NCT00533897|524824134|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536561|NCT00533897|524824135|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536562|NCT00533897|524824136|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
145536563|NCT00533897|524824129|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145777614|NCT03237845|525694532|FG000|Overall Study|Technical Problems|8|||
145777615|NCT03237845|525694533|FG001|Overall Study|Technical Problems|1|||
145777616|NCT03237845|525694532|FG000|Overall Study|Withdrawal by Subject|3|||
145777617|NCT03237845|525694533|FG001|Overall Study|Withdrawal by Subject|3|||
145777618|NCT03237845|525694532|FG000|Overall Study|Other Reasons|4|||
145777619|NCT03237845|525694533|FG001|Overall Study|Other Reasons|0|||
145777620|NCT01633060|525694542|FG000|Randomization Phase|Protocol deviation|1|||
145536564|NCT00533897|524824130|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145536565|NCT00533897|524824131|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145536566|NCT00533897|524824132|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145777621|NCT01633060|525694543|FG001|Randomization Phase|Protocol deviation|2|||
145777622|NCT01633060|525694542|FG000|Randomization Phase|Technical problem|0|||
145777623|NCT01633060|525694543|FG001|Randomization Phase|Technical problem|1|||
145777624|NCT01633060|525694542|FG000|Treatment Phase|Adverse Event|24|||
145777625|NCT01633060|525694543|FG001|Treatment Phase|Adverse Event|3|||
145777626|NCT01633060|525694542|FG000|Treatment Phase|Lost to Follow-up|1|||
145777627|NCT01633060|525694543|FG001|Treatment Phase|Lost to Follow-up|0|||
145536567|NCT00533897|524824133|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145536568|NCT00533897|524824134|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
145536569|NCT00533897|524824135|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145536570|NCT00533897|524824136|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
145536571|NCT00533897|524824129|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145777628|NCT01633060|525694542|FG000|Treatment Phase|Physician Decision|16|||
145536572|NCT00533897|524824130|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145536573|NCT00533897|524824131|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145536574|NCT00533897|524824132|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145777629|NCT01633060|525694543|FG001|Treatment Phase|Physician Decision|7|||
145777630|NCT01633060|525694542|FG000|Treatment Phase|Progressive Disease|210|||
145777631|NCT01633060|525694543|FG001|Treatment Phase|Progressive Disease|120|||
145777632|NCT01633060|525694542|FG000|Treatment Phase|Protocol Deviation|1|||
145777633|NCT01633060|525694543|FG001|Treatment Phase|Protocol Deviation|0|||
145777634|NCT01633060|525694542|FG000|Treatment Phase|Study Terminated by sponsor|7|||
145777635|NCT01633060|525694543|FG001|Treatment Phase|Study Terminated by sponsor|3|||
145777636|NCT01633060|525694542|FG000|Treatment Phase|Subject/guardian decision|25|||
145777637|NCT01633060|525694543|FG001|Treatment Phase|Subject/guardian decision|4|||
145777638|NCT01633060|525694542|FG000|Treatment Phase|Death|4|||
145777639|NCT01633060|525694543|FG001|Treatment Phase|Death|3|||
145777640|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
145777641|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145777642|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
145777643|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
145777644|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
145777645|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
145777646|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
145279143|NCT02454972|523872872|FG004|Overall Study|Non treatment-related adverse event|0|||
145279144|NCT02454972|523872873|FG005|Overall Study|Non treatment-related adverse event|1|||
145536575|NCT00533897|524824133|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145536576|NCT00533897|524824134|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
145536577|NCT00533897|524824135|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145536578|NCT00533897|524824136|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
145536579|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145536580|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145536581|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145536582|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145608790|NCT04091360|525083206|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
145777647|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
145777648|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
145777649|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
145777650|NCT01633060|525694542|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
145777651|NCT01633060|525694543|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
145279145|NCT02454972|523872874|FG006|Overall Study|Non treatment-related adverse event|0|||
145608791|NCT04091360|525083207|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
145536583|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145536584|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
145536585|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
145536586|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
145536587|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Death|0|||
145536588|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Death|0|||
145536589|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Death|0|||
145536590|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Death|0|||
145536591|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Death|0|||
145536592|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Death|0|||
145536593|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Death|1|||
145536594|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Death|3|||
145536595|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536596|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536597|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536598|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536599|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536600|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
145536601|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
145536602|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
145536603|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536604|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536605|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536606|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536607|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536608|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536609|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
145536610|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
145536611|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Adverse Event|0|||
145536612|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Adverse Event|0|||
145536613|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Adverse Event|0|||
145536614|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Adverse Event|0|||
145536615|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Adverse Event|0|||
145536616|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Adverse Event|0|||
145536617|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Adverse Event|2|||
145536618|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Adverse Event|5|||
145536619|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Pregnancy|0|||
145536620|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Pregnancy|0|||
145536621|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Pregnancy|0|||
145536622|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Pregnancy|0|||
145536623|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Pregnancy|0|||
145536624|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Pregnancy|0|||
145536625|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Pregnancy|0|||
145536626|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Pregnancy|2|||
145536627|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536628|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536629|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536630|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536631|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536632|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
145536633|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
145536634|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
145536635|NCT00533897|524824129|FG000|Long Term Extension (LTE)|Other|0|||
145608792|NCT04091360|525083208|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
145608793|NCT04091360|525083199|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608794|NCT04091360|525083200|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145777652|NCT01856673|525694549|FG000|Overall Study|Withdrawal by Subject|44|||
145777653|NCT01856673|525694550|FG001|Overall Study|Withdrawal by Subject|50|||
145777654|NCT01856673|525694551|FG002|Overall Study|Withdrawal by Subject|33|||
145777655|NCT01856673|525694549|FG000|Overall Study|Lost to Follow-up|31|||
145777656|NCT01856673|525694550|FG001|Overall Study|Lost to Follow-up|34|||
145777657|NCT01856673|525694551|FG002|Overall Study|Lost to Follow-up|0|||
145777658|NCT01856673|525694549|FG000|Overall Study|Unknown reasons|9|||
145777659|NCT01856673|525694550|FG001|Overall Study|Unknown reasons|0|||
145777660|NCT01856673|525694551|FG002|Overall Study|Unknown reasons|0|||
145777661|NCT01856673|525694549|FG000|Overall Study|Psychologist decision|1|||
145777662|NCT01856673|525694550|FG001|Overall Study|Psychologist decision|0|||
145777663|NCT01856673|525694551|FG002|Overall Study|Psychologist decision|0|||
145777664|NCT01856673|525694549|FG000|Overall Study|Paperwork errors|8|||
145777665|NCT01856673|525694550|FG001|Overall Study|Paperwork errors|0|||
145777666|NCT01856673|525694551|FG002|Overall Study|Paperwork errors|0|||
145536636|NCT00533897|524824130|FG001|Long Term Extension (LTE)|Other|0|||
145536637|NCT00533897|524824131|FG002|Long Term Extension (LTE)|Other|0|||
145536638|NCT00533897|524824132|FG003|Long Term Extension (LTE)|Other|0|||
145536639|NCT00533897|524824133|FG004|Long Term Extension (LTE)|Other|0|||
145536640|NCT00533897|524824134|FG005|Long Term Extension (LTE)|Other|0|||
145536641|NCT00533897|524824135|FG006|Long Term Extension (LTE)|Other|1|||
145536642|NCT00533897|524824136|FG007|Long Term Extension (LTE)|Other|6|||
145536643|NCT01546207|524824150|FG000|Overall Study|Death|1|||
145536644|NCT00713323|524824151|FG000|Overall Study|Adverse Event|75|||
145536645|NCT00713323|524824151|FG000|Overall Study|Withdrawal by Subject|15|||
145536646|NCT00713323|524824151|FG000|Overall Study|Lost to Follow-up|11|||
145536647|NCT00713323|524824151|FG000|Overall Study|Lack of Efficacy|36|||
145536648|NCT00713323|524824151|FG000|Overall Study|Low creatine clearance at screening|1|||
145536649|NCT00713323|524824151|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
145536650|NCT00713323|524824151|FG000|Overall Study|Surgery cured allodynic pain|1|||
145536651|NCT00713323|524824151|FG000|Overall Study|Pain free|1|||
145536652|NCT00713323|524824151|FG000|Overall Study|Non-compliance|1|||
145536653|NCT00713323|524824151|FG000|Overall Study|Pain resolved|1|||
145536654|NCT00713323|524824151|FG000|Overall Study|Subject travelling to USA|1|||
145536655|NCT00713323|524824151|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
145536656|NCT00713323|524824151|FG000|Overall Study|Treatment that may interact with Sativex|1|||
145777667|NCT01856673|525694549|FG000|Overall Study|Death|1|||
145777668|NCT01856673|525694550|FG001|Overall Study|Death|1|||
145777669|NCT01856673|525694551|FG002|Overall Study|Death|0|||
145777670|NCT01856673|525694549|FG000|Overall Study|Protocol Violation|1|||
145777671|NCT01856673|525694550|FG001|Overall Study|Protocol Violation|0|||
145777672|NCT01856673|525694551|FG002|Overall Study|Protocol Violation|1|||
145777673|NCT02859415|525694552|FG000|Overall Study|Physician Decision|1|||
145777674|NCT02859415|525694553|FG001|Overall Study|Physician Decision|0|||
145777675|NCT02859415|525694552|FG000|Overall Study|Off treatment due to cardiac event|0|||
145777676|NCT02859415|525694553|FG001|Overall Study|Off treatment due to cardiac event|1|||
145777677|NCT02168946|525694556|FG000|Overall Study|Adverse Event|8|||
145777678|NCT02168946|525694557|FG001|Overall Study|Adverse Event|5|||
145777679|NCT02168946|525694556|FG000|Overall Study|Lost to Follow-up|3|||
145777680|NCT02168946|525694557|FG001|Overall Study|Lost to Follow-up|0|||
145777681|NCT02168946|525694556|FG000|Overall Study|Subject unable to come back for visits|1|||
145777682|NCT02168946|525694557|FG001|Overall Study|Subject unable to come back for visits|0|||
145777683|NCT00450866|525694563|FG000|Overall Study|Adverse Event|0|||
145777684|NCT00450866|525694564|FG001|Overall Study|Adverse Event|1|||
145777685|NCT00450866|525694563|FG000|Overall Study|Withdrawal by Subject|5|||
145777686|NCT00450866|525694564|FG001|Overall Study|Withdrawal by Subject|2|||
145777687|NCT00450866|525694563|FG000|Overall Study|Death|1|||
145777688|NCT00450866|525694564|FG001|Overall Study|Death|0|||
145777689|NCT00450866|525694563|FG000|Overall Study|Physician Decision|1|||
145777690|NCT00450866|525694564|FG001|Overall Study|Physician Decision|0|||
145777691|NCT04725682|525694567|FG000|Overall Study|Withdrawal by Subject|7|||
145777692|NCT04725682|525694568|FG001|Overall Study|Withdrawal by Subject|5|||
145777693|NCT04725682|525694567|FG000|Overall Study|Failed to comply with the requirements|2|||
145777694|NCT04725682|525694568|FG001|Overall Study|Failed to comply with the requirements|1|||
145777695|NCT04725682|525694567|FG000|Overall Study|Adverse Event|1|||
145777696|NCT04725682|525694568|FG001|Overall Study|Adverse Event|1|||
145777697|NCT04725682|525694567|FG000|Overall Study|Death|0|||
145777698|NCT04725682|525694568|FG001|Overall Study|Death|1|||
145777699|NCT02613572|525694569|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
145777700|NCT02613572|525694570|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
145777701|NCT02613572|525694571|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
145777702|NCT02613572|525694569|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
145777703|NCT02613572|525694570|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
145777704|NCT02613572|525694571|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
145777705|NCT00970294|525694576|FG000|Overall Study|Physician Decision|4|||
145536657|NCT00506662|524824152|FG000|Overall Study|Adverse Event|0|||
145536658|NCT00506662|524824153|FG001|Overall Study|Adverse Event|2|||
145777706|NCT00970294|525694576|FG000|Overall Study|Withdrawal by Subject|1|||
145536659|NCT00506662|524824152|FG000|Overall Study|Lack of Efficacy|1|||
145536660|NCT00506662|524824153|FG001|Overall Study|Lack of Efficacy|0|||
145536661|NCT00506662|524824152|FG000|Overall Study|Protocol Violation|2|||
145777707|NCT01333189|525694579|FG000|Overall Study|Time constraints|1|||
145777708|NCT01333189|525694580|FG001|Overall Study|Time constraints|0|||
145777709|NCT01333189|525694579|FG000|Overall Study|Adverse Event|1|||
145777710|NCT01333189|525694580|FG001|Overall Study|Adverse Event|0|||
145777711|NCT01333189|525694579|FG000|Overall Study|Transportation difficulties|0|||
145536662|NCT00506662|524824153|FG001|Overall Study|Protocol Violation|4|||
145777712|NCT01333189|525694580|FG001|Overall Study|Transportation difficulties|1|||
145777713|NCT01333189|525694579|FG000|Overall Study|Moved from region|0|||
145777714|NCT01333189|525694580|FG001|Overall Study|Moved from region|1|||
145777715|NCT00393458|525694581|FG000|Overall Study|Adverse Event|35|||
145777716|NCT00393458|525694582|FG001|Overall Study|Adverse Event|24|||
145777717|NCT00393458|525694583|FG002|Overall Study|Adverse Event|40|||
145777718|NCT00393458|525694584|FG003|Overall Study|Adverse Event|35|||
145777719|NCT00393458|525694581|FG000|Overall Study|Subject withdrew consent|27|||
145777720|NCT00393458|525694582|FG001|Overall Study|Subject withdrew consent|40|||
145777721|NCT00393458|525694583|FG002|Overall Study|Subject withdrew consent|33|||
145777722|NCT00393458|525694584|FG003|Overall Study|Subject withdrew consent|50|||
145777723|NCT00393458|525694581|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
145777724|NCT00393458|525694582|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
145777725|NCT00393458|525694583|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
145777726|NCT00393458|525694584|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
145777727|NCT00393458|525694581|FG000|Overall Study|Protocol deviation|11|||
145777728|NCT00393458|525694582|FG001|Overall Study|Protocol deviation|11|||
145777729|NCT00393458|525694583|FG002|Overall Study|Protocol deviation|11|||
145777730|NCT00393458|525694584|FG003|Overall Study|Protocol deviation|10|||
145777731|NCT00393458|525694581|FG000|Overall Study|Administrative problems|7|||
145777732|NCT00393458|525694582|FG001|Overall Study|Administrative problems|8|||
145777733|NCT00393458|525694583|FG002|Overall Study|Administrative problems|5|||
145777734|NCT00393458|525694584|FG003|Overall Study|Administrative problems|2|||
145777735|NCT00393458|525694581|FG000|Overall Study|Lost to Follow-up|5|||
145777736|NCT00393458|525694582|FG001|Overall Study|Lost to Follow-up|6|||
145777737|NCT00393458|525694583|FG002|Overall Study|Lost to Follow-up|5|||
145777738|NCT00393458|525694584|FG003|Overall Study|Lost to Follow-up|3|||
145777739|NCT00393458|525694581|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145777740|NCT00393458|525694582|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145777741|NCT00393458|525694583|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145777742|NCT00393458|525694584|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145777743|NCT00393458|525694581|FG000|Overall Study|Death|1|||
145777744|NCT00393458|525694582|FG001|Overall Study|Death|1|||
145777745|NCT00393458|525694583|FG002|Overall Study|Death|5|||
145777746|NCT00393458|525694584|FG003|Overall Study|Death|5|||
145777747|NCT00393458|525694581|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145777748|NCT00393458|525694582|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145777749|NCT00393458|525694583|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145777750|NCT00393458|525694584|FG003|Overall Study|Abnormal test procedure result(s)|2|||
145777751|NCT00393458|525694581|FG000|Overall Study|Subject no longer requires study drug|0|||
145777752|NCT00393458|525694582|FG001|Overall Study|Subject no longer requires study drug|1|||
145777753|NCT00393458|525694583|FG002|Overall Study|Subject no longer requires study drug|0|||
145777754|NCT00393458|525694584|FG003|Overall Study|Subject no longer requires study drug|0|||
145777755|NCT01326962|525694592|FG000|Overall Study|Adverse Event|1|||
145777756|NCT01326962|525694592|FG000|Overall Study|Withdrawal by Subject|1|||
145777757|NCT01326962|525694592|FG000|Overall Study|Lost to Follow-up|3|||
145777758|NCT01326962|525694592|FG000|Overall Study|Other|2|||
145777759|NCT00793585|525694593|FG000|Overall Study|Adverse Event|1|||
145777760|NCT00793585|525694594|FG001|Overall Study|Adverse Event|1|||
145777761|NCT00793585|525694593|FG000|Overall Study|Protocol Violation|1|||
145777762|NCT00793585|525694594|FG001|Overall Study|Protocol Violation|2|||
145777763|NCT01056523|525694595|FG000|Overall Study|Death|1|||
145608795|NCT04091360|525083201|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608796|NCT04091360|525083202|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608797|NCT04091360|525083203|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608798|NCT04091360|525083204|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608799|NCT04091360|525083205|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
145608800|NCT04091360|525083206|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
145608801|NCT04091360|525083207|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608802|NCT04091360|525083208|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
145608803|NCT04091360|525083199|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608804|NCT04091360|525083200|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608805|NCT04091360|525083201|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145777764|NCT01056523|525694596|FG001|Overall Study|Death|0|||
145777765|NCT01056523|525694597|FG002|Overall Study|Death|2|||
145777766|NCT01056523|525694598|FG003|Overall Study|Death|3|||
145777767|NCT01056523|525694599|FG004|Overall Study|Death|0|||
145777768|NCT01056523|525694600|FG005|Overall Study|Death|0|||
145777769|NCT01056523|525694601|FG006|Overall Study|Death|1|||
145777770|NCT03067311|525694609|FG000|Overall Study|Lost to Follow-up|1|||
145777771|NCT03067311|525694610|FG001|Overall Study|Lost to Follow-up|1|||
145777772|NCT03067311|525694609|FG000|Overall Study|Moved away|1|||
145777773|NCT03067311|525694610|FG001|Overall Study|Moved away|1|||
145777774|NCT02903511|525694611|FG000|Overall Study|Withdrawal by Subject|1|||
145777775|NCT02903511|525694612|FG001|Overall Study|Withdrawal by Subject|0|||
145536663|NCT00506662|524824152|FG000|Overall Study|Trial terminated|10|||
145777776|NCT02903511|525694611|FG000|Overall Study|Lost to Follow-up|3|||
145777777|NCT02903511|525694612|FG001|Overall Study|Lost to Follow-up|2|||
145777778|NCT00907738|525694613|FG000|Overall Study|Adverse Event|2|||
145777779|NCT00907738|525694614|FG001|Overall Study|Adverse Event|0|||
145777780|NCT00907738|525694615|FG002|Overall Study|Adverse Event|1|||
145777781|NCT00907738|525694616|FG003|Overall Study|Adverse Event|0|||
145777782|NCT00907738|525694617|FG004|Overall Study|Adverse Event|0|||
145777783|NCT00907738|525694613|FG000|Overall Study|not specified or withdrew consent|3|||
145777784|NCT00907738|525694614|FG001|Overall Study|not specified or withdrew consent|0|||
145777785|NCT00907738|525694615|FG002|Overall Study|not specified or withdrew consent|0|||
145777786|NCT00907738|525694616|FG003|Overall Study|not specified or withdrew consent|0|||
145777787|NCT00907738|525694617|FG004|Overall Study|not specified or withdrew consent|0|||
145777788|NCT00907738|525694613|FG000|Overall Study|Disease progression|8|||
145777789|NCT00907738|525694614|FG001|Overall Study|Disease progression|1|||
145777790|NCT00907738|525694615|FG002|Overall Study|Disease progression|6|||
145777791|NCT00907738|525694616|FG003|Overall Study|Disease progression|4|||
145777792|NCT00907738|525694617|FG004|Overall Study|Disease progression|2|||
145777793|NCT01269125|525696064|FG000|Overall Study|Adverse Event|3|||
145777794|NCT01269125|525696065|FG001|Overall Study|Adverse Event|5|||
145777795|NCT01269125|525696066|FG002|Overall Study|Adverse Event|0|||
145777796|NCT01269125|525696064|FG000|Overall Study|Lost to Follow-up|4|||
145777797|NCT01269125|525696065|FG001|Overall Study|Lost to Follow-up|0|||
145777798|NCT01269125|525696066|FG002|Overall Study|Lost to Follow-up|0|||
145777799|NCT01040832|525696067|FG000|Overall Study|Adverse Event|4|||
145777800|NCT01040832|525696068|FG001|Overall Study|Adverse Event|5|||
145777801|NCT01040832|525696067|FG000|Overall Study|Death|4|||
145777802|NCT01040832|525696068|FG001|Overall Study|Death|6|||
145777803|NCT01040832|525696067|FG000|Overall Study|Withdrawal by Subject|2|||
145777804|NCT01040832|525696068|FG001|Overall Study|Withdrawal by Subject|3|||
145777805|NCT01040832|525696067|FG000|Overall Study|Progressive disease|32|||
145777806|NCT01040832|525696068|FG001|Overall Study|Progressive disease|17|||
145777807|NCT01040832|525696067|FG000|Overall Study|Symptomatic deterioration|2|||
145777808|NCT01040832|525696068|FG001|Overall Study|Symptomatic deterioration|5|||
145777809|NCT01040832|525696067|FG000|Overall Study|Other|2|||
145777810|NCT01040832|525696068|FG001|Overall Study|Other|1|||
145777811|NCT01518699|525696069|FG000|Period 2|Protocol Violation|1|||
145777812|NCT01518699|525696070|FG001|Period 2|Protocol Violation|1|||
145777813|NCT01518699|525696071|FG002|Period 2|Protocol Violation|0|||
145777814|NCT01518699|525696072|FG003|Period 2|Protocol Violation|0|||
145777815|NCT01518699|525696073|FG004|Period 2|Protocol Violation|0|||
145777816|NCT01518699|525696074|FG005|Period 2|Protocol Violation|0|||
145777817|NCT01518699|525696069|FG000|Period 2|Lost to Follow-up|0|||
145777818|NCT01518699|525696070|FG001|Period 2|Lost to Follow-up|1|||
145777819|NCT01518699|525696071|FG002|Period 2|Lost to Follow-up|0|||
145777820|NCT01518699|525696072|FG003|Period 2|Lost to Follow-up|0|||
145777821|NCT01518699|525696073|FG004|Period 2|Lost to Follow-up|0|||
145777822|NCT01518699|525696074|FG005|Period 2|Lost to Follow-up|0|||
145777823|NCT01518699|525696069|FG000|Period 2|Adverse Event|1|||
145777824|NCT01518699|525696070|FG001|Period 2|Adverse Event|0|||
145777825|NCT01518699|525696071|FG002|Period 2|Adverse Event|0|||
145777826|NCT01518699|525696072|FG003|Period 2|Adverse Event|0|||
145777827|NCT01518699|525696073|FG004|Period 2|Adverse Event|0|||
145777828|NCT01518699|525696074|FG005|Period 2|Adverse Event|0|||
145777829|NCT03692910|525696077|FG000|Overall Study|Lost to Follow-up|4|||
145777830|NCT03692910|525696078|FG001|Overall Study|Lost to Follow-up|0|||
145777831|NCT03692910|525696079|FG002|Overall Study|Lost to Follow-up|0|||
145777832|NCT03692910|525696077|FG000|Overall Study|Withdrawal by Subject|2|||
145777833|NCT03692910|525696078|FG001|Overall Study|Withdrawal by Subject|0|||
145777834|NCT03692910|525696079|FG002|Overall Study|Withdrawal by Subject|0|||
145777835|NCT00417612|525696080|FG000|Overall Study|Errant diagnosis|0|||
145777836|NCT00417612|525696081|FG001|Overall Study|Errant diagnosis|1|||
145777837|NCT00417612|525696080|FG000|Overall Study|Adverse Event|2|||
145777838|NCT00417612|525696081|FG001|Overall Study|Adverse Event|0|||
145777839|NCT00417612|525696080|FG000|Overall Study|Protocol Violation|0|||
145777840|NCT00417612|525696081|FG001|Overall Study|Protocol Violation|2|||
145777841|NCT00417612|525696080|FG000|Overall Study|Lost to Follow-up|1|||
145777842|NCT00417612|525696081|FG001|Overall Study|Lost to Follow-up|0|||
145777843|NCT00486226|525696082|FG000|Overall Study|Death|3|||
145777844|NCT00486226|525696082|FG000|Overall Study|Adverse Event|1|||
145777845|NCT00486226|525696082|FG000|Overall Study|Withdrawal by Subject|1|||
145777846|NCT00486226|525696082|FG000|Overall Study|Lost to Follow-up|8|||
145777847|NCT03846947|525696087|FG000|Overall Study|technical issues with imaging sequence|2|||
145777848|NCT02940886|525696088|FG000|Overall Study|Adverse Event|7|||
145777849|NCT02940886|525696089|FG001|Overall Study|Adverse Event|3|||
145777850|NCT02940886|525696088|FG000|Overall Study|Protocol Violation|0|||
145777851|NCT02940886|525696089|FG001|Overall Study|Protocol Violation|2|||
145608806|NCT04091360|525083202|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608807|NCT04091360|525083203|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608808|NCT04091360|525083204|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608809|NCT04091360|525083205|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
145608810|NCT04091360|525083206|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608811|NCT04091360|525083207|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
145608812|NCT04091360|525083208|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
145608813|NCT01735396|525083209|FG000|Overall Study|not evaluable|1|||
145608814|NCT00423852|525083212|FG000|Overall Study|Removed pior to the high-dose portion|3|||
145608815|NCT00980005|525083213|FG000|Overall Study|Withdrawal by Subject|6|||
145608816|NCT00980005|525083214|FG001|Overall Study|Withdrawal by Subject|17|||
145608817|NCT00980005|525083213|FG000|Overall Study|Lost to Follow-up|37|||
145608818|NCT00980005|525083214|FG001|Overall Study|Lost to Follow-up|43|||
145608819|NCT00980005|525083213|FG000|Overall Study|Other|4|||
145608820|NCT00980005|525083214|FG001|Overall Study|Other|3|||
145608821|NCT00572624|525083215|FG000|Overall Study|Lost to Follow-up|10|||
145608822|NCT00572624|525083216|FG001|Overall Study|Lost to Follow-up|4|||
145608823|NCT00572624|525083215|FG000|Overall Study|Wanted to do a different diet program|1|||
145608824|NCT00572624|525083216|FG001|Overall Study|Wanted to do a different diet program|0|||
145608825|NCT00572624|525083215|FG000|Overall Study|Medication change|1|||
145608826|NCT00572624|525083216|FG001|Overall Study|Medication change|0|||
145608827|NCT00572624|525083215|FG000|Overall Study|Started a new job-- no time for study|1|||
145608828|NCT00572624|525083216|FG001|Overall Study|Started a new job-- no time for study|0|||
145608829|NCT00572624|525083215|FG000|Overall Study|Admitted to being a smoker|1|||
145608830|NCT00572624|525083216|FG001|Overall Study|Admitted to being a smoker|0|||
145608831|NCT00572624|525083215|FG000|Overall Study|Refused to do the stress test|1|||
145608832|NCT00572624|525083216|FG001|Overall Study|Refused to do the stress test|0|||
145608833|NCT00572624|525083215|FG000|Overall Study|Problem with vascular access|1|||
145608834|NCT00572624|525083216|FG001|Overall Study|Problem with vascular access|0|||
145608835|NCT00572624|525083215|FG000|Overall Study|Health issues unrelated to the study|1|||
145608836|NCT00572624|525083216|FG001|Overall Study|Health issues unrelated to the study|0|||
145608837|NCT02597933|525083217|FG000|Overall Study|Withdrawal by Subject|7|||
145608838|NCT02597933|525083218|FG001|Overall Study|Withdrawal by Subject|5|||
145608839|NCT02597933|525083217|FG000|Overall Study|Protocol Violation|2|||
145608840|NCT02597933|525083218|FG001|Overall Study|Protocol Violation|2|||
145279146|NCT02454972|523872875|FG007|Overall Study|Non treatment-related adverse event|1|||
145279147|NCT02454972|523872876|FG008|Overall Study|Non treatment-related adverse event|0|||
145279148|NCT02454972|523872868|FG000|Overall Study|Treatment-related adverse events|0|||
145279149|NCT02454972|523872869|FG001|Overall Study|Treatment-related adverse events|1|||
145608841|NCT02597933|525083217|FG000|Overall Study|Adverse Event|20|||
145608842|NCT02597933|525083218|FG001|Overall Study|Adverse Event|28|||
145608843|NCT02597933|525083217|FG000|Overall Study|Not treated|2|||
145608844|NCT02597933|525083218|FG001|Overall Study|Not treated|2|||
145608845|NCT02597933|525083217|FG000|Overall Study|Other than stated above|7|||
145279150|NCT02454972|523872870|FG002|Overall Study|Treatment-related adverse events|1|||
145536664|NCT00506662|524824153|FG001|Overall Study|Trial terminated|16|||
145536665|NCT00506662|524824152|FG000|Overall Study|Not recorded|4|||
145536666|NCT00506662|524824153|FG001|Overall Study|Not recorded|6|||
145536667|NCT04015336|524824155|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
145536668|NCT00491075|524824156|FG000|Overall Study|Withdrawal by Subject|1|||
145536669|NCT00491075|524824156|FG000|Overall Study|Physician Decision|1|||
145608846|NCT02597933|525083218|FG001|Overall Study|Other than stated above|14|||
145608847|NCT00130793|525083222|FG000|Overall Study|Lost to Follow-up|1|||
145608848|NCT00130793|525083223|FG001|Overall Study|Lost to Follow-up|4|||
145608849|NCT00130793|525083222|FG000|Overall Study|Withdrew consent|2|||
145608850|NCT00130793|525083223|FG001|Overall Study|Withdrew consent|0|||
145608851|NCT02100722|525083224|FG000|Overall Study|Withdrawal pre-procedure|4|||
145608852|NCT02100722|525083225|FG001|Overall Study|Withdrawal pre-procedure|9|||
145608853|NCT02100722|525083224|FG000|Overall Study|Withdrawal post-procedure|0|||
145608854|NCT02100722|525083225|FG001|Overall Study|Withdrawal post-procedure|3|||
145608855|NCT02100722|525083224|FG000|Overall Study|Lost to Follow-up|2|||
145608856|NCT02100722|525083225|FG001|Overall Study|Lost to Follow-up|2|||
145608857|NCT02100722|525083224|FG000|Overall Study|Continuing on study|751|||
145608858|NCT02100722|525083225|FG001|Overall Study|Continuing on study|729|||
145608859|NCT03929562|525083232|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
145608860|NCT03929562|525083233|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
145608861|NCT03929562|525083232|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
145608862|NCT03929562|525083233|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
145608863|NCT03929562|525083232|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
145608864|NCT03929562|525083233|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
145608865|NCT01778556|525083235|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
145608866|NCT01778556|525083236|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
145536670|NCT01603355|524824157|FG000|Overall Study|Lack of Efficacy|2|||
145536671|NCT02764333|524824160|FG000|Overall Study|Ineligible|1|||
145536672|NCT03355365|524824161|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
145536673|NCT03355365|524824162|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
145536674|NCT03355365|524824161|FG000|Year 1, First Intervention|Protocol Violation|1|||
145536675|NCT03355365|524824162|FG001|Year 1, First Intervention|Protocol Violation|0|||
145536676|NCT03355365|524824161|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
145536677|NCT03355365|524824162|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
145536678|NCT03355365|524824161|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
145536679|NCT03355365|524824162|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
145536680|NCT03355365|524824161|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
145536681|NCT03355365|524824162|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
145536682|NCT03355365|524824161|FG000|Year 2, Crossover Intervention|severe COVID|0|||
145536683|NCT03355365|524824162|FG001|Year 2, Crossover Intervention|severe COVID|1|||
145536684|NCT03355365|524824161|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
145536685|NCT03355365|524824162|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
145536686|NCT04622306|524824163|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
145536687|NCT04622306|524824164|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
145536688|NCT04622306|524824165|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
145536689|NCT04622306|524824166|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
145536690|NCT04622306|524824167|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
145536691|NCT04622306|524824168|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
145536692|NCT04622306|524824163|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
145536693|NCT04622306|524824164|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
145608867|NCT01778556|525083235|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145608868|NCT01778556|525083236|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
145608869|NCT01778556|525083235|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
145608870|NCT01778556|525083236|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
145608871|NCT01778556|525083235|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
145608872|NCT01778556|525083236|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
145536694|NCT04622306|524824165|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
145536695|NCT04622306|524824166|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
145536696|NCT04622306|524824167|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
145536697|NCT04622306|524824168|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
145536698|NCT01200524|524824169|FG000|Overall Study|Withdrawal by Subject|1|||
145608873|NCT00265330|525083238|FG000|Overall Study|Adverse Event|41|||
145777852|NCT02940886|525696088|FG000|Overall Study|Withdrawal by Subject|28|||
145777853|NCT02940886|525696089|FG001|Overall Study|Withdrawal by Subject|20|||
145292777|NCT05014412|523922235|FG003|Overall Study|Death|7|||
145536699|NCT01200524|524824170|FG001|Overall Study|Withdrawal by Subject|1|||
145608874|NCT00265330|525083238|FG000|Overall Study|Lost to Follow-up|8|||
145777854|NCT02940886|525696088|FG000|Overall Study|Death|1|||
145777855|NCT02940886|525696089|FG001|Overall Study|Death|0|||
145608875|NCT00265330|525083238|FG000|Overall Study|Withdrawal by Subject|34|||
145608876|NCT00265330|525083238|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
145608877|NCT00265330|525083238|FG000|Overall Study|Lack of Efficacy|4|||
145608878|NCT00265330|525083238|FG000|Overall Study|Family Scheduling Conflicts|1|||
145608879|NCT00265330|525083238|FG000|Overall Study|Began Taking Formulary Geodon|1|||
145608880|NCT00265330|525083238|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
145608881|NCT00265330|525083238|FG000|Overall Study|Site Closed by Sponsor|1|||
145608882|NCT00265330|525083238|FG000|Overall Study|Principal Investigators Request|1|||
145608883|NCT00265330|525083238|FG000|Overall Study|Withdrew Consent|1|||
145608884|NCT00265330|525083238|FG000|Overall Study|Protocol Violation|1|||
145608885|NCT03403426|525083240|FG000|Overall Study|Death|1|||
145608886|NCT03403426|525083240|FG000|Overall Study|Lost to Follow-up|2|||
145608887|NCT01933880|525083241|FG000|Overall Study|Withdrawal by Subject|5|||
145608888|NCT01933880|525083242|FG001|Overall Study|Withdrawal by Subject|0|||
145608889|NCT01933880|525083241|FG000|Overall Study|Lack of Efficacy|1|||
145608890|NCT01933880|525083242|FG001|Overall Study|Lack of Efficacy|0|||
145608891|NCT01933880|525083241|FG000|Overall Study|Concomitant medication Interference|0|||
145608892|NCT01933880|525083242|FG001|Overall Study|Concomitant medication Interference|1|||
145608893|NCT01933880|525083241|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
145608894|NCT01933880|525083242|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
145608895|NCT01933880|525083241|FG000|Overall Study|Other|4|||
145608896|NCT01933880|525083242|FG001|Overall Study|Other|0|||
145608897|NCT01933880|525083241|FG000|Overall Study|Protocol Violation|1|||
145608898|NCT01933880|525083242|FG001|Overall Study|Protocol Violation|0|||
145608899|NCT00510458|525083243|FG000|Overall Study|5 year not evaluable/missed|21|||
145608900|NCT00510458|525083243|FG000|Overall Study|Death|1|||
145608901|NCT00510458|525083243|FG000|Overall Study|Terminated|14|||
145608902|NCT00510458|525083243|FG000|Overall Study|Lost to Follow-up|6|||
145608903|NCT00510458|525083243|FG000|Overall Study|Withdrawal by Subject|3|||
145608904|NCT00510458|525083243|FG000|Overall Study|Revision|2|||
145608905|NCT02569710|525083244|FG000|Overall Study|Adverse Event|1|||
145777856|NCT02940886|525696088|FG000|Overall Study|Lack of Efficacy|1|||
145777857|NCT02940886|525696089|FG001|Overall Study|Lack of Efficacy|0|||
145777858|NCT02940886|525696088|FG000|Overall Study|Lost to Follow-up|49|||
145777859|NCT02940886|525696089|FG001|Overall Study|Lost to Follow-up|21|||
145777860|NCT02940886|525696088|FG000|Overall Study|Physician Decision|9|||
145777861|NCT02940886|525696089|FG001|Overall Study|Physician Decision|4|||
145777862|NCT02940886|525696088|FG000|Overall Study|Sponsor decision|0|||
145777863|NCT02940886|525696089|FG001|Overall Study|Sponsor decision|1|||
145777864|NCT02940886|525696088|FG000|Overall Study|No treatment|7|||
145777865|NCT02940886|525696089|FG001|Overall Study|No treatment|2|||
145777866|NCT02940886|525696088|FG000|Overall Study|Enrolment error|0|||
145777867|NCT02940886|525696089|FG001|Overall Study|Enrolment error|1|||
145777868|NCT03216265|525696090|FG000|Overall Study|Adverse Event|2|||
145777869|NCT03216265|525696091|FG001|Overall Study|Adverse Event|0|||
145777870|NCT03216265|525696092|FG002|Overall Study|Adverse Event|2|||
145777871|NCT03216265|525696090|FG000|Overall Study|Lost to Follow-up|0|||
145777872|NCT03216265|525696091|FG001|Overall Study|Lost to Follow-up|1|||
145777873|NCT03216265|525696092|FG002|Overall Study|Lost to Follow-up|0|||
145777874|NCT03216265|525696090|FG000|Overall Study|Withdrawal by Subject|0|||
145777875|NCT03216265|525696091|FG001|Overall Study|Withdrawal by Subject|0|||
145777876|NCT03216265|525696092|FG002|Overall Study|Withdrawal by Subject|1|||
145777877|NCT01539837|525696094|FG000|Overall Study|reduce neutrophil level|0|||
145777878|NCT01539837|525696095|FG001|Overall Study|reduce neutrophil level|1|||
145777879|NCT01539837|525696096|FG002|Overall Study|reduce neutrophil level|1|||
145777880|NCT01539837|525696094|FG000|Overall Study|bad compliance|0|||
145777881|NCT01539837|525696095|FG001|Overall Study|bad compliance|0|||
145777882|NCT01539837|525696096|FG002|Overall Study|bad compliance|1|||
145777883|NCT00849693|525696097|FG000|Acute Treatment Phase|Adverse Event|12|||
145777884|NCT00849693|525696098|FG001|Acute Treatment Phase|Adverse Event|7|||
145608906|NCT02569710|525083245|FG001|Overall Study|Adverse Event|0|||
145608907|NCT02569710|525083246|FG002|Overall Study|Adverse Event|0|||
145608908|NCT02569710|525083247|FG003|Overall Study|Adverse Event|0|||
145608909|NCT02569710|525083248|FG004|Overall Study|Adverse Event|0|||
145608910|NCT02569710|525083249|FG005|Overall Study|Adverse Event|0|||
145608911|NCT02569710|525083250|FG006|Overall Study|Adverse Event|0|||
145608912|NCT02569710|525083251|FG007|Overall Study|Adverse Event|0|||
145608913|NCT02569710|525083252|FG008|Overall Study|Adverse Event|0|||
145608914|NCT02569710|525083253|FG009|Overall Study|Adverse Event|0|||
145608915|NCT02569710|525083244|FG000|Overall Study|Lost to Follow-up|0|||
145608916|NCT02569710|525083245|FG001|Overall Study|Lost to Follow-up|0|||
145777885|NCT00849693|525696099|FG002|Acute Treatment Phase|Adverse Event|6|||
145777886|NCT00849693|525696100|FG003|Acute Treatment Phase|Adverse Event|4|||
145777887|NCT00849693|525696097|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
145777888|NCT00849693|525696098|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
145777889|NCT00849693|525696099|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
145777890|NCT00849693|525696100|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
145777891|NCT00849693|525696097|FG000|Acute Treatment Phase|Protocol Violation|1|||
145608917|NCT02569710|525083246|FG002|Overall Study|Lost to Follow-up|0|||
145608918|NCT02569710|525083247|FG003|Overall Study|Lost to Follow-up|0|||
145608919|NCT02569710|525083248|FG004|Overall Study|Lost to Follow-up|0|||
145608920|NCT02569710|525083249|FG005|Overall Study|Lost to Follow-up|0|||
145608921|NCT02569710|525083250|FG006|Overall Study|Lost to Follow-up|1|||
145608922|NCT02569710|525083251|FG007|Overall Study|Lost to Follow-up|0|||
145608923|NCT02569710|525083252|FG008|Overall Study|Lost to Follow-up|1|||
145608924|NCT02569710|525083253|FG009|Overall Study|Lost to Follow-up|0|||
145608925|NCT02569710|525083244|FG000|Overall Study|Virologic failure|0|||
145777892|NCT00849693|525696098|FG001|Acute Treatment Phase|Protocol Violation|5|||
145777893|NCT00849693|525696099|FG002|Acute Treatment Phase|Protocol Violation|2|||
145777894|NCT00849693|525696100|FG003|Acute Treatment Phase|Protocol Violation|6|||
145777895|NCT00849693|525696097|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
145777896|NCT00849693|525696098|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
145777897|NCT00849693|525696099|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
145608926|NCT02569710|525083245|FG001|Overall Study|Virologic failure|0|||
145608927|NCT02569710|525083246|FG002|Overall Study|Virologic failure|0|||
145608928|NCT02569710|525083247|FG003|Overall Study|Virologic failure|0|||
145777898|NCT00849693|525696100|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
145777899|NCT00849693|525696097|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
145777900|NCT00849693|525696098|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
145777901|NCT00849693|525696099|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
145777902|NCT00849693|525696100|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
145777903|NCT00849693|525696097|FG000|Acute Treatment Phase|Physician Decision|2|||
145777904|NCT00849693|525696098|FG001|Acute Treatment Phase|Physician Decision|1|||
145777905|NCT00849693|525696099|FG002|Acute Treatment Phase|Physician Decision|2|||
145777906|NCT00849693|525696100|FG003|Acute Treatment Phase|Physician Decision|1|||
145777907|NCT00849693|525696097|FG000|Acute Treatment Phase|Sponsor decision|0|||
145777908|NCT00849693|525696098|FG001|Acute Treatment Phase|Sponsor decision|0|||
145777909|NCT00849693|525696099|FG002|Acute Treatment Phase|Sponsor decision|1|||
145777910|NCT00849693|525696100|FG003|Acute Treatment Phase|Sponsor decision|0|||
145777911|NCT00849693|525696097|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
145777912|NCT00849693|525696098|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
145777913|NCT00849693|525696099|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
145777914|NCT00849693|525696100|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
145777915|NCT00849693|525696097|FG000|Extension Phase|Adverse Event|4|||
145777916|NCT00849693|525696098|FG001|Extension Phase|Adverse Event|6|||
145777917|NCT00849693|525696099|FG002|Extension Phase|Adverse Event|3|||
145777918|NCT00849693|525696100|FG003|Extension Phase|Adverse Event|7|||
145777919|NCT00849693|525696097|FG000|Extension Phase|Lost to Follow-up|7|||
145777920|NCT00849693|525696098|FG001|Extension Phase|Lost to Follow-up|5|||
145777921|NCT00849693|525696099|FG002|Extension Phase|Lost to Follow-up|6|||
145777922|NCT00849693|525696100|FG003|Extension Phase|Lost to Follow-up|6|||
145777923|NCT00849693|525696097|FG000|Extension Phase|Protocol Violation|0|||
145777924|NCT00849693|525696098|FG001|Extension Phase|Protocol Violation|3|||
145777925|NCT00849693|525696099|FG002|Extension Phase|Protocol Violation|2|||
145777926|NCT00849693|525696100|FG003|Extension Phase|Protocol Violation|3|||
145777927|NCT00849693|525696097|FG000|Extension Phase|Withdrawal by Subject|6|||
145777928|NCT00849693|525696098|FG001|Extension Phase|Withdrawal by Subject|9|||
145777929|NCT00849693|525696099|FG002|Extension Phase|Withdrawal by Subject|10|||
145777930|NCT00849693|525696100|FG003|Extension Phase|Withdrawal by Subject|15|||
145608929|NCT02569710|525083248|FG004|Overall Study|Virologic failure|1|||
145608930|NCT02569710|525083249|FG005|Overall Study|Virologic failure|0|||
145608931|NCT02569710|525083250|FG006|Overall Study|Virologic failure|1|||
145608932|NCT02569710|525083251|FG007|Overall Study|Virologic failure|0|||
145608933|NCT02569710|525083252|FG008|Overall Study|Virologic failure|0|||
145608934|NCT02569710|525083253|FG009|Overall Study|Virologic failure|0|||
145608935|NCT02569710|525083244|FG000|Overall Study|Withdrawal by Subject|0|||
145608936|NCT02569710|525083245|FG001|Overall Study|Withdrawal by Subject|0|||
145777931|NCT00849693|525696097|FG000|Extension Phase|Parent or caregiver decision|9|||
145608937|NCT02569710|525083246|FG002|Overall Study|Withdrawal by Subject|0|||
145608938|NCT02569710|525083247|FG003|Overall Study|Withdrawal by Subject|0|||
145777932|NCT00849693|525696098|FG001|Extension Phase|Parent or caregiver decision|4|||
145777933|NCT00849693|525696099|FG002|Extension Phase|Parent or caregiver decision|10|||
145777934|NCT00849693|525696100|FG003|Extension Phase|Parent or caregiver decision|5|||
145777935|NCT00849693|525696097|FG000|Extension Phase|Physician Decision|1|||
145777936|NCT00849693|525696098|FG001|Extension Phase|Physician Decision|1|||
145777937|NCT00849693|525696099|FG002|Extension Phase|Physician Decision|2|||
145777938|NCT00849693|525696100|FG003|Extension Phase|Physician Decision|0|||
145777939|NCT00849693|525696097|FG000|Extension Phase|Sponsor decision|1|||
145777940|NCT00849693|525696098|FG001|Extension Phase|Sponsor decision|0|||
145777941|NCT00849693|525696099|FG002|Extension Phase|Sponsor decision|0|||
145608939|NCT02569710|525083248|FG004|Overall Study|Withdrawal by Subject|0|||
145608940|NCT02569710|525083249|FG005|Overall Study|Withdrawal by Subject|1|||
145608941|NCT02569710|525083250|FG006|Overall Study|Withdrawal by Subject|0|||
145608942|NCT02569710|525083251|FG007|Overall Study|Withdrawal by Subject|0|||
145536700|NCT01200524|524824171|FG002|Overall Study|Withdrawal by Subject|3|||
145536701|NCT01200524|524824169|FG000|Overall Study|Adverse Event|1|||
145536702|NCT01200524|524824170|FG001|Overall Study|Adverse Event|0|||
145536703|NCT01200524|524824171|FG002|Overall Study|Adverse Event|0|||
145536704|NCT01200524|524824169|FG000|Overall Study|Non availability of study nurse|0|||
145536705|NCT01200524|524824170|FG001|Overall Study|Non availability of study nurse|0|||
145536706|NCT01200524|524824171|FG002|Overall Study|Non availability of study nurse|1|||
145536707|NCT00491764|524824173|FG000|Overall Study|Adverse Event|1|||
145536708|NCT00491764|524824174|FG001|Overall Study|Adverse Event|2|||
145536709|NCT00491764|524824175|FG002|Overall Study|Adverse Event|4|||
145536710|NCT00491764|524824176|FG003|Overall Study|Adverse Event|4|||
145777942|NCT00849693|525696100|FG003|Extension Phase|Sponsor decision|1|||
145777943|NCT00849693|525696097|FG000|Extension Phase|Lack of Efficacy|2|||
145777944|NCT00849693|525696098|FG001|Extension Phase|Lack of Efficacy|2|||
145777945|NCT00849693|525696099|FG002|Extension Phase|Lack of Efficacy|2|||
145777946|NCT00849693|525696100|FG003|Extension Phase|Lack of Efficacy|1|||
145777947|NCT01736683|525696102|FG000|Overall Study|Disease Relapse|0|||
145777948|NCT01736683|525696103|FG001|Overall Study|Disease Relapse|0|||
145777949|NCT01736683|525696104|FG002|Overall Study|Disease Relapse|2|||
145777950|NCT01736683|525696105|FG003|Overall Study|Disease Relapse|1|||
145777951|NCT01736683|525696106|FG004|Overall Study|Disease Relapse|0|||
145777952|NCT01736683|525696102|FG000|Overall Study|Adverse Event|0|||
145777953|NCT01736683|525696103|FG001|Overall Study|Adverse Event|2|||
145777954|NCT01736683|525696104|FG002|Overall Study|Adverse Event|2|||
145536711|NCT00491764|524824177|FG004|Overall Study|Adverse Event|0|||
145536712|NCT00491764|524824178|FG005|Overall Study|Adverse Event|1|||
145608943|NCT02569710|525083252|FG008|Overall Study|Withdrawal by Subject|0|||
145608944|NCT02569710|525083253|FG009|Overall Study|Withdrawal by Subject|0|||
145777955|NCT01736683|525696105|FG003|Overall Study|Adverse Event|3|||
145777956|NCT01736683|525696106|FG004|Overall Study|Adverse Event|2|||
145777957|NCT01736683|525696102|FG000|Overall Study|Withdrawal by Subject|0|||
145777958|NCT01736683|525696103|FG001|Overall Study|Withdrawal by Subject|0|||
145777959|NCT01736683|525696104|FG002|Overall Study|Withdrawal by Subject|3|||
145777960|NCT01736683|525696105|FG003|Overall Study|Withdrawal by Subject|1|||
145777961|NCT01736683|525696106|FG004|Overall Study|Withdrawal by Subject|1|||
145777962|NCT01736683|525696102|FG000|Overall Study|Lack of Therapeutic Effect|7|||
145777963|NCT01736683|525696103|FG001|Overall Study|Lack of Therapeutic Effect|4|||
145777964|NCT01736683|525696104|FG002|Overall Study|Lack of Therapeutic Effect|13|||
145777965|NCT01736683|525696105|FG003|Overall Study|Lack of Therapeutic Effect|20|||
145777966|NCT01736683|525696106|FG004|Overall Study|Lack of Therapeutic Effect|1|||
145777967|NCT01736683|525696102|FG000|Overall Study|Progressive Disease|0|||
145777968|NCT01736683|525696103|FG001|Overall Study|Progressive Disease|0|||
145777969|NCT01736683|525696104|FG002|Overall Study|Progressive Disease|0|||
145777970|NCT01736683|525696105|FG003|Overall Study|Progressive Disease|1|||
145777971|NCT01736683|525696106|FG004|Overall Study|Progressive Disease|0|||
145777972|NCT01736683|525696102|FG000|Overall Study|Other|0|||
145777973|NCT01736683|525696103|FG001|Overall Study|Other|0|||
145777974|NCT01736683|525696104|FG002|Overall Study|Other|1|||
145777975|NCT01736683|525696105|FG003|Overall Study|Other|9|||
145777976|NCT01736683|525696106|FG004|Overall Study|Other|1|||
145777977|NCT02046564|525696107|FG000|Overall Study|Adverse Event|6|||
145777978|NCT02046564|525696108|FG001|Overall Study|Adverse Event|3|||
145777979|NCT02046564|525696107|FG000|Overall Study|Physician Decision|0|||
145777980|NCT02046564|525696108|FG001|Overall Study|Physician Decision|1|||
145777981|NCT02046564|525696107|FG000|Overall Study|Protocol Violation|3|||
145777982|NCT02046564|525696108|FG001|Overall Study|Protocol Violation|1|||
145777983|NCT02046564|525696107|FG000|Overall Study|Withdrawal by Subject|4|||
145777984|NCT02046564|525696108|FG001|Overall Study|Withdrawal by Subject|10|||
145777985|NCT02046564|525696107|FG000|Overall Study|Subject met withdrawal criteria|2|||
145777986|NCT02046564|525696108|FG001|Overall Study|Subject met withdrawal criteria|5|||
145777987|NCT01295905|525696111|FG000|Overall Study|Did not meet inclusion criteria|1|||
145777988|NCT01295905|525696112|FG001|Overall Study|Did not meet inclusion criteria|0|||
145777989|NCT01295905|525696111|FG000|Overall Study|Met exclusion criteria|1|||
145777990|NCT01295905|525696112|FG001|Overall Study|Met exclusion criteria|0|||
145777991|NCT00537823|525696119|FG000|Overall Study|Adverse Event|2|||
145536713|NCT00491764|524824173|FG000|Overall Study|Lost to Follow-up|0|||
145608945|NCT03474549|525083254|FG000|Overall Study|Death|31|||
145608946|NCT03474549|525083254|FG000|Overall Study|Lost to Follow-up|4|||
145777992|NCT00537823|525696120|FG001|Overall Study|Adverse Event|0|||
145777993|NCT03065530|525696121|FG000|Overall Study|Lack of Efficacy|1|||
145777994|NCT03065530|525696122|FG001|Overall Study|Lack of Efficacy|1|||
145777995|NCT03065530|525696123|FG002|Overall Study|Lack of Efficacy|0|||
145777996|NCT03065530|525696124|FG003|Overall Study|Lack of Efficacy|1|||
145777997|NCT03065530|525696121|FG000|Overall Study|Protocol Violation|1|||
145536714|NCT00491764|524824174|FG001|Overall Study|Lost to Follow-up|1|||
145777998|NCT03065530|525696122|FG001|Overall Study|Protocol Violation|0|||
145608947|NCT03474549|525083254|FG000|Overall Study|Withdrawal by Subject|2|||
145777999|NCT03065530|525696123|FG002|Overall Study|Protocol Violation|1|||
145778000|NCT03065530|525696124|FG003|Overall Study|Protocol Violation|1|||
145778001|NCT02873221|525696125|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
145778002|NCT02873221|525696126|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
145778003|NCT02873221|525696127|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
145778004|NCT02873221|525696125|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
145778005|NCT02873221|525696126|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
145778006|NCT02873221|525696127|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
145778007|NCT02873221|525696125|FG000|Treatment Period|Protocol Violation|2|||
145778008|NCT02873221|525696126|FG001|Treatment Period|Protocol Violation|5|||
145778009|NCT02873221|525696127|FG002|Treatment Period|Protocol Violation|8|||
145778010|NCT02873221|525696125|FG000|Treatment Period|Pregnancy|4|||
145778011|NCT02873221|525696126|FG001|Treatment Period|Pregnancy|6|||
145778012|NCT02873221|525696127|FG002|Treatment Period|Pregnancy|3|||
145778013|NCT02873221|525696125|FG000|Treatment Period|Lack of Qualifying Event|0|||
145778014|NCT02873221|525696126|FG001|Treatment Period|Lack of Qualifying Event|3|||
145778015|NCT02873221|525696127|FG002|Treatment Period|Lack of Qualifying Event|1|||
145778016|NCT02873221|525696125|FG000|Treatment Period|Withdrawal of Consent|52|||
145778017|NCT02873221|525696126|FG001|Treatment Period|Withdrawal of Consent|51|||
145778018|NCT02873221|525696127|FG002|Treatment Period|Withdrawal of Consent|41|||
145778019|NCT02873221|525696125|FG000|Treatment Period|Lack of Efficacy|0|||
145778020|NCT02873221|525696126|FG001|Treatment Period|Lack of Efficacy|17|||
145778021|NCT02873221|525696127|FG002|Treatment Period|Lack of Efficacy|12|||
145778022|NCT02873221|525696125|FG000|Treatment Period|Adverse Event|4|||
145778023|NCT02873221|525696126|FG001|Treatment Period|Adverse Event|9|||
145778024|NCT02873221|525696127|FG002|Treatment Period|Adverse Event|11|||
145778025|NCT02873221|525696125|FG000|Treatment Period|Lost to Follow-up|26|||
145778026|NCT02873221|525696126|FG001|Treatment Period|Lost to Follow-up|30|||
145778027|NCT02873221|525696127|FG002|Treatment Period|Lost to Follow-up|26|||
145778028|NCT02873221|525696125|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
145778029|NCT02873221|525696126|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
145778030|NCT02873221|525696127|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
145778031|NCT02873221|525696125|FG000|Safety Follow-up Period|Protocol Violation|0|||
145778032|NCT02873221|525696126|FG001|Safety Follow-up Period|Protocol Violation|0|||
145778033|NCT02873221|525696127|FG002|Safety Follow-up Period|Protocol Violation|1|||
145778034|NCT02873221|525696125|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
145778035|NCT02873221|525696126|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
145778036|NCT02873221|525696127|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
145778037|NCT02873221|525696125|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
145778038|NCT02873221|525696126|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
145778039|NCT02873221|525696127|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
145778040|NCT02717546|525696131|FG000|Overall Study|Lost to Follow-up|12|||
145778041|NCT03849560|525696135|FG000|Overall Study|Withdrawal by Subject|1|||
145778042|NCT03849560|525696136|FG001|Overall Study|Withdrawal by Subject|0|||
145778043|NCT03849560|525696137|FG002|Overall Study|Withdrawal by Subject|0|||
145778044|NCT03233048|525696140|FG000|Overall Study|Withdrawal by Subject|1|||
145778045|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Adverse Event|12|||
145778046|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Adverse Event|3|||
145778047|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Adverse Event|4|||
145778048|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Adverse Event|2|||
145778049|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
145778050|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
145778051|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
145778052|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
145778053|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
145536715|NCT00491764|524824175|FG002|Overall Study|Lost to Follow-up|0|||
145536716|NCT00491764|524824176|FG003|Overall Study|Lost to Follow-up|1|||
145536717|NCT00491764|524824177|FG004|Overall Study|Lost to Follow-up|0|||
145536718|NCT00491764|524824178|FG005|Overall Study|Lost to Follow-up|3|||
145536719|NCT00491764|524824173|FG000|Overall Study|Withdrawal by Subject|2|||
145536720|NCT00491764|524824174|FG001|Overall Study|Withdrawal by Subject|3|||
145536721|NCT00491764|524824175|FG002|Overall Study|Withdrawal by Subject|1|||
145536722|NCT00491764|524824176|FG003|Overall Study|Withdrawal by Subject|2|||
145778054|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
145778055|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
145536723|NCT00491764|524824177|FG004|Overall Study|Withdrawal by Subject|2|||
145536724|NCT00491764|524824178|FG005|Overall Study|Withdrawal by Subject|4|||
145536725|NCT00491764|524824173|FG000|Overall Study|Non Compliance with the Protocol|1|||
145536726|NCT00491764|524824174|FG001|Overall Study|Non Compliance with the Protocol|0|||
145536727|NCT00491764|524824175|FG002|Overall Study|Non Compliance with the Protocol|0|||
145778056|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
145778057|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
145778058|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
145536728|NCT00491764|524824176|FG003|Overall Study|Non Compliance with the Protocol|0|||
145536729|NCT00491764|524824177|FG004|Overall Study|Non Compliance with the Protocol|0|||
145536730|NCT00491764|524824178|FG005|Overall Study|Non Compliance with the Protocol|0|||
145536731|NCT00491764|524824173|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
145536732|NCT00491764|524824174|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
145536733|NCT00491764|524824175|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
145536734|NCT00491764|524824176|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
145536735|NCT00491764|524824177|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
145536736|NCT00491764|524824178|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
145536737|NCT00491764|524824173|FG000|Overall Study|Administrative|1|||
145536738|NCT00491764|524824174|FG001|Overall Study|Administrative|0|||
145536739|NCT00491764|524824175|FG002|Overall Study|Administrative|2|||
145536740|NCT00491764|524824176|FG003|Overall Study|Administrative|1|||
145536741|NCT00491764|524824177|FG004|Overall Study|Administrative|0|||
145536742|NCT00491764|524824178|FG005|Overall Study|Administrative|0|||
145536743|NCT01601132|524824180|FG000|Overall Study|Patient withdrew consent|1|||
145536744|NCT01601132|524824180|FG000|Overall Study|Protocol deviation|1|||
145536745|NCT00697788|524824183|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536746|NCT00697788|524824184|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
145536747|NCT00697788|524824185|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536748|NCT00697788|524824186|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536749|NCT00697788|524824187|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536750|NCT00697788|524824188|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536751|NCT00697788|524824189|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536752|NCT00697788|524824190|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
145536753|NCT00697788|524824183|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536754|NCT00697788|524824184|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536755|NCT00697788|524824185|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536756|NCT00697788|524824186|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536757|NCT00697788|524824187|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
145536758|NCT00697788|524824188|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536759|NCT00697788|524824189|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536760|NCT00697788|524824190|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
145536761|NCT00074984|524824193|FG000|Overall Study|Death|1|||
145536762|NCT00074984|524824194|FG001|Overall Study|Death|2|||
145536763|NCT00074984|524824193|FG000|Overall Study|Withdrawal by Subject|2|||
145536764|NCT00074984|524824194|FG001|Overall Study|Withdrawal by Subject|3|||
145536765|NCT00074984|524824193|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
145536766|NCT00074984|524824194|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
145608948|NCT01555164|525083261|FG000|Overall Study|Adverse Event|5|||
145608949|NCT01555164|525083262|FG001|Overall Study|Adverse Event|7|||
145778059|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
145778060|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
145778061|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
145778062|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
145778063|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
145778064|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
145778065|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
145778066|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
145778067|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
145778068|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
145778069|NCT02436239|525696143|FG000|Open-Lable Treatment Period|Other Reason|1|||
145778070|NCT02436239|525696144|FG001|Open-Lable Treatment Period|Other Reason|1|||
145778071|NCT02436239|525696145|FG002|Open-Lable Treatment Period|Other Reason|0|||
145778072|NCT02436239|525696146|FG003|Open-Lable Treatment Period|Other Reason|0|||
145778073|NCT02436239|525696143|FG000|Down-Taper Period|Withdrawal by Subject|4|||
145778074|NCT02436239|525696144|FG001|Down-Taper Period|Withdrawal by Subject|4|||
145778075|NCT02436239|525696145|FG002|Down-Taper Period|Withdrawal by Subject|1|||
145778076|NCT02436239|525696146|FG003|Down-Taper Period|Withdrawal by Subject|2|||
145778077|NCT00138151|525696147|FG000|Overall Study|Withdrawal by Subject|3|||
145778078|NCT00138151|525696147|FG000|Overall Study|Physician Decision|1|||
145279151|NCT02454972|523872871|FG003|Overall Study|Treatment-related adverse events|0|||
145279152|NCT02454972|523872872|FG004|Overall Study|Treatment-related adverse events|2|||
145279153|NCT02454972|523872873|FG005|Overall Study|Treatment-related adverse events|0|||
145536767|NCT03080454|524824195|FG000|Baseline|Adverse Event|2|||
145536768|NCT03080454|524824195|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
145536769|NCT03080454|524824195|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
145536770|NCT02202980|524824196|FG000|Overall Study|Lack of Efficacy|1|||
145536771|NCT02202980|524824197|FG001|Overall Study|Lack of Efficacy|0|||
145608950|NCT01555164|525083261|FG000|Overall Study|Hyperglycemia|0|||
145778079|NCT02498821|525696148|FG000|Overall Study|Screen failure|3|||
145279154|NCT02454972|523872874|FG006|Overall Study|Treatment-related adverse events|0|||
145778080|NCT02498821|525696149|FG001|Overall Study|Screen failure|5|||
145778081|NCT02675517|525696152|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
145778082|NCT02675517|525696152|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
145778083|NCT01716169|525696156|FG000|Overall Study|Adverse Event|1|||
145778084|NCT01716169|525696156|FG000|Overall Study|Lost to Follow-up|1|||
145778085|NCT01716169|525696156|FG000|Overall Study|Withdrawal by Subject|1|||
145778086|NCT01716169|525696156|FG000|Overall Study|inconsistent dressing application|1|||
145778087|NCT00301067|525696159|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
145778088|NCT00301067|525696160|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
145778089|NCT00301067|525696161|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
145778090|NCT00301067|525696162|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
145778091|NCT00301067|525696159|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
145778092|NCT00301067|525696160|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
145778093|NCT00301067|525696161|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
145778094|NCT00301067|525696162|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
145778095|NCT00301067|525696159|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
145778096|NCT00301067|525696160|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
145778097|NCT00301067|525696161|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
145778098|NCT00301067|525696162|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
145778099|NCT00301067|525696159|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
145778100|NCT00301067|525696160|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
145778101|NCT00301067|525696161|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
145778102|NCT00301067|525696162|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
145778103|NCT00301067|525696159|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
145778104|NCT00301067|525696160|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
145778105|NCT00301067|525696161|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
145778106|NCT00301067|525696162|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
145778107|NCT00301067|525696159|FG000|Follow up Until Death|Alive at last data cut point|1|||
145778108|NCT00301067|525696160|FG001|Follow up Until Death|Alive at last data cut point|0|||
145778109|NCT00301067|525696161|FG002|Follow up Until Death|Alive at last data cut point|0|||
145778110|NCT00301067|525696162|FG003|Follow up Until Death|Alive at last data cut point|1|||
145778111|NCT00149825|525696163|FG000|Overall Study|Intolerance to medication side effects|1|||
145778112|NCT00149825|525696164|FG001|Overall Study|Intolerance to medication side effects|2|||
145778113|NCT00149825|525696163|FG000|Overall Study|Time commitments|2|||
145778114|NCT00149825|525696164|FG001|Overall Study|Time commitments|1|||
145778115|NCT00149825|525696163|FG000|Overall Study|Not liking insomnia therapy|1|||
145778116|NCT00149825|525696164|FG001|Overall Study|Not liking insomnia therapy|0|||
145778117|NCT00149825|525696163|FG000|Overall Study|Other|1|||
145778118|NCT00149825|525696164|FG001|Overall Study|Other|0|||
145778119|NCT00069121|525696165|FG000|Overall Study|Death|286|||
145778120|NCT00069121|525696166|FG001|Overall Study|Death|242|||
145778121|NCT00069121|525696165|FG000|Overall Study|Withdrawal by Subject|18|||
145778122|NCT00069121|525696166|FG001|Overall Study|Withdrawal by Subject|20|||
145778123|NCT00069121|525696165|FG000|Overall Study|Lost to Follow-up|63|||
145778124|NCT00069121|525696166|FG001|Overall Study|Lost to Follow-up|63|||
145778125|NCT00942708|525696167|FG000|Overall Study|Withdrawal by Subject|1|||
145778126|NCT00306891|525696168|FG000|Part A|Withdrawal by Subject|1|||
145778127|NCT00306891|525696169|FG001|Part A|Withdrawal by Subject|1|||
145778128|NCT00306891|525696170|FG002|Part A|Withdrawal by Subject|0|||
145778129|NCT00306891|525696171|FG003|Part A|Withdrawal by Subject|0|||
145778130|NCT00306891|525696168|FG000|Part A|Condition under investigation worsened|2|||
145778131|NCT00306891|525696169|FG001|Part A|Condition under investigation worsened|2|||
145778132|NCT00306891|525696170|FG002|Part A|Condition under investigation worsened|0|||
145778133|NCT00306891|525696171|FG003|Part A|Condition under investigation worsened|0|||
145778134|NCT00306891|525696168|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
145778135|NCT00306891|525696169|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
145778136|NCT00306891|525696170|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
145778137|NCT00306891|525696171|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
145778138|NCT00306891|525696168|FG000|Part A|Partial bowel obstruction|1|||
145778139|NCT00306891|525696169|FG001|Part A|Partial bowel obstruction|0|||
145778140|NCT00306891|525696170|FG002|Part A|Partial bowel obstruction|0|||
145778141|NCT00306891|525696171|FG003|Part A|Partial bowel obstruction|0|||
145778142|NCT00306891|525696168|FG000|Part A|Reaccumul. of ascites following drainage|0|||
145778143|NCT00306891|525696169|FG001|Part A|Reaccumul. of ascites following drainage|1|||
145778144|NCT00306891|525696170|FG002|Part A|Reaccumul. of ascites following drainage|0|||
145778145|NCT00306891|525696171|FG003|Part A|Reaccumul. of ascites following drainage|0|||
145778146|NCT00306891|525696168|FG000|Part A|Suspicion of second malignancy|0|||
145778147|NCT00306891|525696169|FG001|Part A|Suspicion of second malignancy|1|||
145778148|NCT00306891|525696170|FG002|Part A|Suspicion of second malignancy|0|||
145778149|NCT00306891|525696171|FG003|Part A|Suspicion of second malignancy|0|||
145778150|NCT00306891|525696168|FG000|Part A|QTC interval outwith elig. criteria|1|||
145778151|NCT00306891|525696169|FG001|Part A|QTC interval outwith elig. criteria|0|||
145778152|NCT00306891|525696170|FG002|Part A|QTC interval outwith elig. criteria|0|||
145778153|NCT00306891|525696171|FG003|Part A|QTC interval outwith elig. criteria|0|||
145778154|NCT00306891|525696168|FG000|Part B|Death|0|||
145778155|NCT00306891|525696169|FG001|Part B|Death|0|||
145778156|NCT00306891|525696170|FG002|Part B|Death|1|||
145778157|NCT00306891|525696171|FG003|Part B|Death|2|||
145778158|NCT00306891|525696168|FG000|Part B|Adverse Event|0|||
145778159|NCT00306891|525696169|FG001|Part B|Adverse Event|0|||
145778160|NCT00306891|525696170|FG002|Part B|Adverse Event|5|||
145778161|NCT00306891|525696171|FG003|Part B|Adverse Event|5|||
145778162|NCT00306891|525696168|FG000|Part B|Withdrawal by Subject|0|||
145778163|NCT00306891|525696169|FG001|Part B|Withdrawal by Subject|0|||
145778164|NCT00306891|525696170|FG002|Part B|Withdrawal by Subject|3|||
145778165|NCT00306891|525696171|FG003|Part B|Withdrawal by Subject|1|||
145778166|NCT00306891|525696168|FG000|Part B|Condition under investigation worsened|0|||
145778167|NCT00306891|525696169|FG001|Part B|Condition under investigation worsened|0|||
145778168|NCT00306891|525696170|FG002|Part B|Condition under investigation worsened|2|||
145778169|NCT00306891|525696171|FG003|Part B|Condition under investigation worsened|8|||
145778170|NCT00306891|525696168|FG000|Part B|Development of study specific disc crit.|0|||
145778171|NCT00306891|525696169|FG001|Part B|Development of study specific disc crit.|0|||
145778172|NCT00306891|525696170|FG002|Part B|Development of study specific disc crit.|0|||
145778173|NCT00306891|525696171|FG003|Part B|Development of study specific disc crit.|1|||
145778174|NCT00673673|525696172|FG000|Overall Study|Progressive disease|27|||
145778175|NCT00673673|525696172|FG000|Overall Study|Adverse Event|4|||
145778176|NCT00673673|525696172|FG000|Overall Study|Withdrawal by Subject|3|||
145778177|NCT00673673|525696172|FG000|Overall Study|Investigators' discretion|2|||
145778178|NCT00231478|525696177|FG000|Overall Study|Protocol Violation|3|||
145778179|NCT00231478|525696178|FG001|Overall Study|Protocol Violation|2|||
145778180|NCT00231478|525696177|FG000|Overall Study|Refused Treatment|1|||
145778181|NCT00231478|525696178|FG001|Overall Study|Refused Treatment|1|||
145778182|NCT00231478|525696177|FG000|Overall Study|Withdrawal by Subject|1|||
145778183|NCT00231478|525696178|FG001|Overall Study|Withdrawal by Subject|0|||
145778184|NCT00231478|525696177|FG000|Overall Study|Adverse Event|0|||
145778185|NCT00231478|525696178|FG001|Overall Study|Adverse Event|1|||
145778186|NCT00231478|525696177|FG000|Overall Study|Administrative|3|||
145778187|NCT00231478|525696178|FG001|Overall Study|Administrative|2|||
145778188|NCT04538950|525696179|FG000|Overall Study|Pulmonary Issues|2|||
145778189|NCT04538950|525696179|FG000|Overall Study|illness|2|||
145778190|NCT01707147|525696180|FG000|Overall Study|Administered Trajenta prior to contract|5|||
145778191|NCT01707147|525696180|FG000|Overall Study|Patients who have not taken Trajenta|1|||
145778192|NCT01707147|525696180|FG000|Overall Study|Follow-up failure|17|||
145778193|NCT01707147|525696180|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
145778194|NCT02489630|525696182|FG000|Overall Study|Oversedation|1|||
145778195|NCT02489630|525696183|FG001|Overall Study|Oversedation|1|||
145778196|NCT02489630|525696182|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
145778197|NCT02489630|525696183|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
145778198|NCT02053246|525696186|FG000|Overall Study|Withdrawal by Subject|3|||
145778199|NCT02053246|525696186|FG000|Overall Study|Physician Decision|1|||
145778200|NCT03429556|525696187|FG000|Overall Study|Lost to Follow-up|0|||
145778201|NCT03429556|525696188|FG001|Overall Study|Lost to Follow-up|1|||
145778202|NCT03429556|525696189|FG002|Overall Study|Lost to Follow-up|0|||
145778203|NCT03429556|525696190|FG003|Overall Study|Lost to Follow-up|0|||
145778204|NCT00035815|525696191|FG000|Overall Study|Withdrawal by Subject|17|||
145778205|NCT00035815|525696192|FG001|Overall Study|Withdrawal by Subject|11|||
145778206|NCT02369510|525696193|FG000|Overall Study|Spilled Medication|1|||
145778207|NCT02369510|525696194|FG001|Overall Study|Spilled Medication|2|||
145778208|NCT02369510|525696195|FG002|Overall Study|Spilled Medication|1|||
145778209|NCT02369510|525696193|FG000|Overall Study|Epidural Activation|1|||
145778210|NCT02369510|525696194|FG001|Overall Study|Epidural Activation|1|||
145778211|NCT02369510|525696195|FG002|Overall Study|Epidural Activation|5|||
145279155|NCT02454972|523872875|FG007|Overall Study|Treatment-related adverse events|2|||
145279156|NCT02454972|523872876|FG008|Overall Study|Treatment-related adverse events|0|||
145778212|NCT04285723|525696197|FG000|Overall Study|Subject decision|1|||
145778213|NCT04285723|525696198|FG001|Overall Study|Subject decision|2|||
145778214|NCT04285723|525696197|FG000|Overall Study|Physician Decision|1|||
145778215|NCT04285723|525696198|FG001|Overall Study|Physician Decision|0|||
145778216|NCT04285723|525696197|FG000|Overall Study|No efficiency|1|||
145778217|NCT04285723|525696198|FG001|Overall Study|No efficiency|0|||
145778218|NCT05363293|525696199|FG000|Overall Study|Withdrawal by Subject|1|||
145778219|NCT05363293|525696200|FG001|Overall Study|Withdrawal by Subject|0|||
145279157|NCT02454972|523872868|FG000|Overall Study|Patient moves to compassionate use|0|||
145778220|NCT05363293|525696201|FG002|Overall Study|Withdrawal by Subject|0|||
145778221|NCT05363293|525696202|FG003|Overall Study|Withdrawal by Subject|0|||
145778222|NCT05363293|525696203|FG004|Overall Study|Withdrawal by Subject|0|||
145778223|NCT05363293|525696204|FG005|Overall Study|Withdrawal by Subject|0|||
145778224|NCT05363293|525696205|FG006|Overall Study|Withdrawal by Subject|0|||
145778225|NCT05363293|525696206|FG007|Overall Study|Withdrawal by Subject|0|||
145778226|NCT05363293|525696207|FG008|Overall Study|Withdrawal by Subject|0|||
145778227|NCT05363293|525696208|FG009|Overall Study|Withdrawal by Subject|0|||
145778228|NCT01089725|525696212|FG000|Overall Study|Adverse Event|1|||
145778229|NCT01089725|525696213|FG001|Overall Study|Adverse Event|1|||
145778230|NCT01089725|525696214|FG002|Overall Study|Adverse Event|0|||
145778231|NCT01089725|525696215|FG003|Overall Study|Adverse Event|0|||
145778232|NCT01089725|525696216|FG004|Overall Study|Adverse Event|2|||
145778233|NCT01089725|525696212|FG000|Overall Study|Lack of Efficacy|4|||
145778234|NCT01089725|525696213|FG001|Overall Study|Lack of Efficacy|3|||
145778235|NCT01089725|525696214|FG002|Overall Study|Lack of Efficacy|1|||
145778236|NCT01089725|525696215|FG003|Overall Study|Lack of Efficacy|0|||
145778237|NCT01089725|525696216|FG004|Overall Study|Lack of Efficacy|4|||
145778238|NCT01089725|525696212|FG000|Overall Study|Lost to Follow-up|2|||
145778239|NCT01089725|525696213|FG001|Overall Study|Lost to Follow-up|2|||
145778240|NCT01089725|525696214|FG002|Overall Study|Lost to Follow-up|0|||
145778241|NCT01089725|525696215|FG003|Overall Study|Lost to Follow-up|3|||
145778242|NCT01089725|525696216|FG004|Overall Study|Lost to Follow-up|0|||
145778243|NCT01089725|525696212|FG000|Overall Study|Protocol Violation|0|||
145778244|NCT01089725|525696213|FG001|Overall Study|Protocol Violation|0|||
145778245|NCT01089725|525696214|FG002|Overall Study|Protocol Violation|1|||
145778246|NCT01089725|525696215|FG003|Overall Study|Protocol Violation|1|||
145778247|NCT01089725|525696216|FG004|Overall Study|Protocol Violation|0|||
145778248|NCT01089725|525696212|FG000|Overall Study|Withdrawal by Subject|5|||
145778249|NCT01089725|525696213|FG001|Overall Study|Withdrawal by Subject|5|||
145778250|NCT01089725|525696214|FG002|Overall Study|Withdrawal by Subject|4|||
145778251|NCT01089725|525696215|FG003|Overall Study|Withdrawal by Subject|5|||
145778252|NCT01089725|525696216|FG004|Overall Study|Withdrawal by Subject|4|||
145778253|NCT01089725|525696212|FG000|Overall Study|Study Terminated by Sponsor|51|||
145778254|NCT01089725|525696213|FG001|Overall Study|Study Terminated by Sponsor|56|||
145778255|NCT01089725|525696214|FG002|Overall Study|Study Terminated by Sponsor|53|||
145778256|NCT01089725|525696215|FG003|Overall Study|Study Terminated by Sponsor|68|||
145778257|NCT01089725|525696216|FG004|Overall Study|Study Terminated by Sponsor|68|||
145778258|NCT01089725|525696212|FG000|Overall Study|Randomized, but not treated|0|||
145778259|NCT01089725|525696213|FG001|Overall Study|Randomized, but not treated|1|||
145778260|NCT01089725|525696214|FG002|Overall Study|Randomized, but not treated|2|||
145778261|NCT01089725|525696215|FG003|Overall Study|Randomized, but not treated|1|||
145778262|NCT01089725|525696216|FG004|Overall Study|Randomized, but not treated|2|||
145778263|NCT01089725|525696212|FG000|Overall Study|Other|3|||
145778264|NCT01089725|525696213|FG001|Overall Study|Other|0|||
145778265|NCT01089725|525696214|FG002|Overall Study|Other|0|||
145778266|NCT01089725|525696215|FG003|Overall Study|Other|1|||
145778267|NCT01089725|525696216|FG004|Overall Study|Other|0|||
145778268|NCT01486316|525698304|FG000|Overall Study|Device explanted with/without re-implant|3|||
145778269|NCT01486316|525698305|FG001|Overall Study|Device explanted with/without re-implant|2|||
145778270|NCT01486316|525698306|FG002|Overall Study|Device explanted with/without re-implant|0|||
145778271|NCT01486316|525698307|FG003|Overall Study|Device explanted with/without re-implant|2|||
145778272|NCT01486316|525698304|FG000|Overall Study|Not meeting eligibility criteria|0|||
145778273|NCT01486316|525698305|FG001|Overall Study|Not meeting eligibility criteria|0|||
145778274|NCT01486316|525698306|FG002|Overall Study|Not meeting eligibility criteria|1|||
145536772|NCT02202980|524824198|FG002|Overall Study|Lack of Efficacy|7|||
145536773|NCT02202980|524824199|FG003|Overall Study|Lack of Efficacy|0|||
145536774|NCT02202980|524824200|FG004|Overall Study|Lack of Efficacy|3|||
145536775|NCT02202980|524824201|FG005|Overall Study|Lack of Efficacy|1|||
145536776|NCT02202980|524824202|FG006|Overall Study|Lack of Efficacy|11|||
145536777|NCT02202980|524824203|FG007|Overall Study|Lack of Efficacy|2|||
145778275|NCT01486316|525698307|FG003|Overall Study|Not meeting eligibility criteria|0|||
145778276|NCT01486316|525698304|FG000|Overall Study|Withdrawal by Subject|1|||
145778277|NCT01486316|525698305|FG001|Overall Study|Withdrawal by Subject|0|||
145778278|NCT01486316|525698306|FG002|Overall Study|Withdrawal by Subject|3|||
145778279|NCT01486316|525698307|FG003|Overall Study|Withdrawal by Subject|0|||
145778280|NCT01486316|525698304|FG000|Overall Study|Physician Decision|0|||
145778281|NCT01486316|525698305|FG001|Overall Study|Physician Decision|0|||
145778282|NCT01486316|525698306|FG002|Overall Study|Physician Decision|1|||
145536778|NCT02202980|524824204|FG008|Overall Study|Lack of Efficacy|2|||
145536779|NCT02202980|524824205|FG009|Overall Study|Lack of Efficacy|0|||
145778283|NCT01486316|525698307|FG003|Overall Study|Physician Decision|0|||
145778284|NCT01486316|525698304|FG000|Overall Study|Death|0|||
145778285|NCT01486316|525698305|FG001|Overall Study|Death|1|||
145778286|NCT01486316|525698306|FG002|Overall Study|Death|0|||
145778287|NCT01486316|525698307|FG003|Overall Study|Death|0|||
145778288|NCT00375934|525698316|FG000|Overall Study|Adverse Event|1|||
145778289|NCT00375934|525698317|FG001|Overall Study|Adverse Event|1|||
145778290|NCT00375934|525698316|FG000|Overall Study|Withdrawal by Subject|2|||
145778291|NCT00375934|525698317|FG001|Overall Study|Withdrawal by Subject|2|||
145778292|NCT00375934|525698316|FG000|Overall Study|Lack of Efficacy|0|||
145778293|NCT00375934|525698317|FG001|Overall Study|Lack of Efficacy|2|||
145778294|NCT00375934|525698316|FG000|Overall Study|Physician Decision|0|||
145778295|NCT00375934|525698317|FG001|Overall Study|Physician Decision|1|||
145778296|NCT03191396|525698319|FG000|Overall Study|Lost to Follow-up|0|||
145778297|NCT03191396|525698320|FG001|Overall Study|Lost to Follow-up|3|||
145778298|NCT03191396|525698319|FG000|Overall Study|Withdrawal by Subject|3|||
145778299|NCT03191396|525698320|FG001|Overall Study|Withdrawal by Subject|2|||
145778300|NCT02452970|525698321|FG000|Overall Study|Adverse Event|1|||
145778301|NCT01266148|525698322|FG000|Overall Study|Adverse Event|2|||
145778302|NCT01266148|525698323|FG001|Overall Study|Adverse Event|0|||
145778303|NCT01266148|525698322|FG000|Overall Study|Ongoing rejection|1|||
145778304|NCT01266148|525698323|FG001|Overall Study|Ongoing rejection|0|||
145778305|NCT01266148|525698322|FG000|Overall Study|2 2R rejections|1|||
145778306|NCT01266148|525698323|FG001|Overall Study|2 2R rejections|0|||
145778307|NCT01266148|525698322|FG000|Overall Study|Death|2|||
145778308|NCT01266148|525698323|FG001|Overall Study|Death|3|||
145778309|NCT01266148|525698322|FG000|Overall Study|missing mGFR value + AE|1|||
145778310|NCT01266148|525698323|FG001|Overall Study|missing mGFR value + AE|0|||
145778311|NCT01712438|525698332|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
145778312|NCT01712438|525698332|FG000|Overall Study|Ongoing ITI treatment|6|||
145778313|NCT01712438|525698332|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
145778314|NCT01712438|525698332|FG000|Overall Study|Prematurely Discontinued|25|||
145778315|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
145778316|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
145778317|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
145778318|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
145778319|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
145778320|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
145778321|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
145778322|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
145778323|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
145778324|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
145778325|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
145778326|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
145778327|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
145778328|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
145778329|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
145778330|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
145778331|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
145778332|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
145778333|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
145778334|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
145778335|NCT01259492|525698333|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
145778336|NCT01259492|525698334|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
145778337|NCT01259492|525698335|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
145778338|NCT01259492|525698336|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
145778339|NCT01259492|525698333|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
145778340|NCT01259492|525698334|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
145778341|NCT01259492|525698335|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
145778342|NCT01259492|525698336|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
145778343|NCT01259492|525698333|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
145778344|NCT01259492|525698334|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
145778345|NCT01259492|525698335|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
145403708|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145778346|NCT01259492|525698336|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
145778347|NCT01259492|525698333|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
145403709|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145403710|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145403711|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145778348|NCT01259492|525698334|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
145778349|NCT01259492|525698335|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
145778350|NCT01259492|525698336|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
145778351|NCT01259492|525698333|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
145778352|NCT01259492|525698334|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
145778353|NCT01259492|525698335|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
145778354|NCT01259492|525698336|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
145778355|NCT01259492|525698333|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
145778356|NCT01259492|525698334|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
145778357|NCT01259492|525698335|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
145778358|NCT01259492|525698336|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
145536780|NCT02202980|524824206|FG010|Overall Study|Lack of Efficacy|0|||
145536781|NCT02202980|524824207|FG011|Overall Study|Lack of Efficacy|3|||
145778359|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
145778360|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
145778361|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
145778362|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
145778363|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
145778364|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
145778365|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
145778366|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
145536782|NCT02202980|524824208|FG012|Overall Study|Lack of Efficacy|10|||
145536783|NCT02202980|524824209|FG013|Overall Study|Lack of Efficacy|0|||
145536784|NCT02202980|524824196|FG000|Overall Study|Protocol Violation|0|||
145536785|NCT02202980|524824197|FG001|Overall Study|Protocol Violation|0|||
145778367|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
145778368|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
145778369|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
145778370|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
145778371|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
145778372|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
145778373|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
145778374|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
145778375|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
145778376|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
145778377|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
145778378|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
145778379|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
145778380|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
145778381|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
145778382|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
145778383|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
145778384|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
145778385|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
145778386|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
145778387|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
145778388|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
145778389|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
145778390|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
145778391|NCT01259492|525698333|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
145778392|NCT01259492|525698334|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
145778393|NCT01259492|525698335|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
145536786|NCT02202980|524824198|FG002|Overall Study|Protocol Violation|0|||
145536787|NCT02202980|524824199|FG003|Overall Study|Protocol Violation|3|||
145536788|NCT02202980|524824200|FG004|Overall Study|Protocol Violation|3|||
145778394|NCT01259492|525698336|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
145778395|NCT01981122|525698337|FG000|Overall Study|Withdrawal by Subject|0|||
145778396|NCT01981122|525698338|FG001|Overall Study|Withdrawal by Subject|2|||
145778397|NCT01981122|525698337|FG000|Overall Study|Protocol Violation|0|||
145536789|NCT02202980|524824201|FG005|Overall Study|Protocol Violation|0|||
145536790|NCT02202980|524824202|FG006|Overall Study|Protocol Violation|0|||
145536791|NCT02202980|524824203|FG007|Overall Study|Protocol Violation|0|||
145536792|NCT02202980|524824204|FG008|Overall Study|Protocol Violation|0|||
145536793|NCT02202980|524824205|FG009|Overall Study|Protocol Violation|0|||
145536794|NCT02202980|524824206|FG010|Overall Study|Protocol Violation|0|||
145536795|NCT02202980|524824207|FG011|Overall Study|Protocol Violation|0|||
145536796|NCT02202980|524824208|FG012|Overall Study|Protocol Violation|0|||
145536797|NCT02202980|524824209|FG013|Overall Study|Protocol Violation|0|||
145778398|NCT01981122|525698338|FG001|Overall Study|Protocol Violation|1|||
145778399|NCT01981122|525698337|FG000|Overall Study|Lost to Follow-up|0|||
145778400|NCT01981122|525698338|FG001|Overall Study|Lost to Follow-up|1|||
145778401|NCT01981122|525698337|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
145778402|NCT01981122|525698338|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
145778403|NCT01981122|525698337|FG000|Overall Study|Death|14|||
145778404|NCT01981122|525698338|FG001|Overall Study|Death|15|||
145778405|NCT00521339|525698339|FG000|Treatment Phase|Adverse Event|2|||
145778406|NCT00521339|525698340|FG001|Treatment Phase|Adverse Event|0|||
145778407|NCT00521339|525698341|FG002|Treatment Phase|Adverse Event|0|||
145778408|NCT00521339|525698339|FG000|Treatment Phase|Intolerability to study drug|2|||
145778409|NCT00521339|525698340|FG001|Treatment Phase|Intolerability to study drug|0|||
145778410|NCT00521339|525698341|FG002|Treatment Phase|Intolerability to study drug|0|||
145778411|NCT00521339|525698339|FG000|Treatment Phase|Lack of Efficacy|3|||
145778412|NCT00521339|525698340|FG001|Treatment Phase|Lack of Efficacy|0|||
145778413|NCT00521339|525698341|FG002|Treatment Phase|Lack of Efficacy|0|||
145778414|NCT00521339|525698339|FG000|Treatment Phase|Withdrawal by Subject|3|||
145778415|NCT00521339|525698340|FG001|Treatment Phase|Withdrawal by Subject|0|||
145778416|NCT00521339|525698341|FG002|Treatment Phase|Withdrawal by Subject|0|||
145778417|NCT00521339|525698339|FG000|Treatment Phase|Lost to Follow-up|1|||
145778418|NCT00521339|525698340|FG001|Treatment Phase|Lost to Follow-up|0|||
145778419|NCT00521339|525698341|FG002|Treatment Phase|Lost to Follow-up|0|||
145778420|NCT00521339|525698339|FG000|Treatment Phase|Protocol Violation|1|||
145778421|NCT00521339|525698340|FG001|Treatment Phase|Protocol Violation|0|||
145778422|NCT00521339|525698341|FG002|Treatment Phase|Protocol Violation|0|||
145778423|NCT00521339|525698339|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
145778424|NCT00521339|525698340|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
145778425|NCT00521339|525698341|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
145778426|NCT00521339|525698339|FG000|Treatment Extension Phase|Death|0|||
145778427|NCT00521339|525698340|FG001|Treatment Extension Phase|Death|0|||
145778428|NCT00521339|525698341|FG002|Treatment Extension Phase|Death|1|||
145778429|NCT00634543|525698344|FG000|Overall Study|Other|1|||
145778430|NCT00634543|525698345|FG001|Overall Study|Other|2|||
145778431|NCT00634543|525698344|FG000|Overall Study|Protocol Violation|3|||
145778432|NCT00634543|525698345|FG001|Overall Study|Protocol Violation|3|||
145778433|NCT00634543|525698344|FG000|Overall Study|Adverse Event|11|||
145778434|NCT00634543|525698345|FG001|Overall Study|Adverse Event|11|||
145778435|NCT00634543|525698344|FG000|Overall Study|Withdrawal by Subject|4|||
145778436|NCT00634543|525698345|FG001|Overall Study|Withdrawal by Subject|4|||
145778437|NCT00634543|525698344|FG000|Overall Study|Lost to Follow-up|0|||
145778438|NCT00634543|525698345|FG001|Overall Study|Lost to Follow-up|1|||
145778439|NCT03515538|525698346|FG000|Overall Study|Lack of Efficacy|2|||
145778440|NCT03515538|525698347|FG001|Overall Study|Lack of Efficacy|0|||
145778441|NCT03515538|525698348|FG002|Overall Study|Lack of Efficacy|2|||
145778442|NCT03515538|525698349|FG003|Overall Study|Lack of Efficacy|0|||
145778443|NCT03515538|525698346|FG000|Overall Study|Death|0|||
145778444|NCT03515538|525698347|FG001|Overall Study|Death|0|||
145778445|NCT03515538|525698348|FG002|Overall Study|Death|1|||
145778446|NCT03515538|525698349|FG003|Overall Study|Death|0|||
145778447|NCT03515538|525698346|FG000|Overall Study|Protocol Violation|0|||
145778448|NCT03515538|525698347|FG001|Overall Study|Protocol Violation|0|||
145778449|NCT03515538|525698348|FG002|Overall Study|Protocol Violation|0|||
145778450|NCT03515538|525698349|FG003|Overall Study|Protocol Violation|1|||
145778451|NCT03515538|525698346|FG000|Overall Study|Screen failure (baseline dropout)|0|||
145778452|NCT03515538|525698347|FG001|Overall Study|Screen failure (baseline dropout)|1|||
145778453|NCT03515538|525698348|FG002|Overall Study|Screen failure (baseline dropout)|0|||
145536798|NCT02202980|524824196|FG000|Overall Study|Lost to Follow-up|0|||
145536799|NCT02202980|524824197|FG001|Overall Study|Lost to Follow-up|1|||
145536800|NCT02202980|524824198|FG002|Overall Study|Lost to Follow-up|1|||
145536801|NCT02202980|524824199|FG003|Overall Study|Lost to Follow-up|1|||
145536802|NCT02202980|524824200|FG004|Overall Study|Lost to Follow-up|0|||
145536803|NCT02202980|524824201|FG005|Overall Study|Lost to Follow-up|0|||
145536804|NCT02202980|524824202|FG006|Overall Study|Lost to Follow-up|0|||
145778454|NCT03515538|525698349|FG003|Overall Study|Screen failure (baseline dropout)|0|||
145778455|NCT03515538|525698346|FG000|Overall Study|Withdrawal by Subject|2|||
145536805|NCT02202980|524824203|FG007|Overall Study|Lost to Follow-up|1|||
145778456|NCT03515538|525698347|FG001|Overall Study|Withdrawal by Subject|2|||
145778457|NCT03515538|525698348|FG002|Overall Study|Withdrawal by Subject|1|||
145778458|NCT03515538|525698349|FG003|Overall Study|Withdrawal by Subject|3|||
145778459|NCT03515538|525698346|FG000|Overall Study|Physician Decision|1|||
145778460|NCT03515538|525698347|FG001|Overall Study|Physician Decision|0|||
145778461|NCT03515538|525698348|FG002|Overall Study|Physician Decision|0|||
145778462|NCT03515538|525698349|FG003|Overall Study|Physician Decision|1|||
145778463|NCT01650779|525698358|FG000|Overall Study|Withdrawal by Subject|1|||
145778464|NCT02397655|525698364|FG000|Overall Study|data not completed|1301|||
145778465|NCT00098345|525698366|FG000|Overall Study|Adverse Event|7|||
145778466|NCT00098345|525698366|FG000|Overall Study|Withdrawal by Subject|2|||
145778467|NCT00098345|525698366|FG000|Overall Study|progression|4|||
145778468|NCT01183858|525698367|FG000|Overall Study|Death not related to Progressive Disease|5|||
145778469|NCT01183858|525698368|FG001|Overall Study|Death not related to Progressive Disease|6|||
145778470|NCT01183858|525698367|FG000|Overall Study|Adverse Event|14|||
145778471|NCT01183858|525698368|FG001|Overall Study|Adverse Event|11|||
145778472|NCT01183858|525698367|FG000|Overall Study|Investigator's Decision|0|||
145778473|NCT01183858|525698368|FG001|Overall Study|Investigator's Decision|3|||
145778474|NCT01183858|525698367|FG000|Overall Study|Insufficient Therapeutic Response|2|||
145778475|NCT01183858|525698368|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145778476|NCT01183858|525698367|FG000|Overall Study|Refused Treatment|1|||
145778477|NCT01183858|525698368|FG001|Overall Study|Refused Treatment|4|||
145778478|NCT01183858|525698367|FG000|Overall Study|Withdrew Consent|4|||
145778479|NCT01183858|525698368|FG001|Overall Study|Withdrew Consent|4|||
145778480|NCT01183858|525698367|FG000|Overall Study|Discontinued Smoking|3|||
145778481|NCT01183858|525698368|FG001|Overall Study|Discontinued Smoking|1|||
145778482|NCT01183858|525698367|FG000|Overall Study|Protocol Violation|1|||
145778483|NCT01183858|525698368|FG001|Overall Study|Protocol Violation|0|||
145778484|NCT01183858|525698367|FG000|Overall Study|Administrative/Other|6|||
145778485|NCT01183858|525698368|FG001|Overall Study|Administrative/Other|6|||
145778486|NCT01183858|525698367|FG000|Overall Study|Progressive Disease|112|||
145778487|NCT01183858|525698368|FG001|Overall Study|Progressive Disease|115|||
145778488|NCT01183858|525698367|FG000|Overall Study|Death related to Progressive Disease|4|||
145778489|NCT01183858|525698368|FG001|Overall Study|Death related to Progressive Disease|5|||
145778490|NCT01183858|525698367|FG000|Overall Study|Lost to Follow-up|1|||
145778491|NCT01183858|525698368|FG001|Overall Study|Lost to Follow-up|1|||
145778492|NCT03707977|525698371|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
145778493|NCT03707977|525698372|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
145778494|NCT03707977|525698373|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
145778495|NCT03707977|525698371|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
145778496|NCT03707977|525698372|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
145778497|NCT03707977|525698373|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
145778498|NCT00641147|525698374|FG000|Completed 4 Months.|Physician Decision|1|||
145778499|NCT00641147|525698375|FG001|Completed 4 Months.|Physician Decision|0|||
145778500|NCT00641147|525698374|FG000|Completed 4 Months.|Adverse Event|1|||
145778501|NCT00641147|525698375|FG001|Completed 4 Months.|Adverse Event|0|||
145778502|NCT00641147|525698374|FG000|Completed 8 Months.|Physician Decision|2|||
145778503|NCT00641147|525698375|FG001|Completed 8 Months.|Physician Decision|1|||
145778504|NCT00641147|525698374|FG000|Completed 8 Months.|non compliance|1|||
145778505|NCT00641147|525698375|FG001|Completed 8 Months.|non compliance|0|||
145778506|NCT00641147|525698374|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
145778507|NCT00641147|525698375|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
145778508|NCT00641147|525698374|FG000|Completed 12 Months.|Physician Decision|1|||
145778509|NCT00641147|525698375|FG001|Completed 12 Months.|Physician Decision|1|||
145778510|NCT00641147|525698374|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
145778511|NCT00641147|525698375|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
145778512|NCT00641147|525698374|FG000|Completed 16 Months.|Physician Decision|1|||
145778513|NCT00641147|525698375|FG001|Completed 16 Months.|Physician Decision|0|||
145778514|NCT00641147|525698374|FG000|Completed 16 Months.|Lost to Follow-up|1|||
145778515|NCT00641147|525698375|FG001|Completed 16 Months.|Lost to Follow-up|0|||
145778516|NCT00791128|525698376|FG000|Overall Study|Adverse Event|4|||
145778517|NCT00791128|525698376|FG000|Overall Study|Device migration|2|||
145778518|NCT00791128|525698376|FG000|Overall Study|non-compliance by subject|2|||
145778519|NCT00791128|525698376|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
145778520|NCT01629667|525698377|FG000|Overall Study|Lost to Follow-up|0|||
145778521|NCT01629667|525698378|FG001|Overall Study|Lost to Follow-up|1|||
145778522|NCT01629667|525698379|FG002|Overall Study|Lost to Follow-up|1|||
145778523|NCT01629667|525698377|FG000|Overall Study|Withdrawal by Subject|31|||
145778524|NCT01629667|525698378|FG001|Overall Study|Withdrawal by Subject|20|||
145778525|NCT01629667|525698379|FG002|Overall Study|Withdrawal by Subject|28|||
145778526|NCT01629667|525698377|FG000|Overall Study|Death|1|||
145778527|NCT01629667|525698378|FG001|Overall Study|Death|5|||
145778528|NCT01629667|525698379|FG002|Overall Study|Death|3|||
145778529|NCT01629667|525698377|FG000|Overall Study|Randomized, not treated|2|||
145778530|NCT01629667|525698378|FG001|Overall Study|Randomized, not treated|1|||
145778531|NCT01629667|525698379|FG002|Overall Study|Randomized, not treated|0|||
145778532|NCT01629667|525698377|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
145279158|NCT02454972|523872869|FG001|Overall Study|Patient moves to compassionate use|0|||
145778533|NCT01629667|525698378|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
145778534|NCT01629667|525698379|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
145778535|NCT01629667|525698377|FG000|Overall Study|Requiring lung transplant|2|||
145279159|NCT02454972|523872870|FG002|Overall Study|Patient moves to compassionate use|0|||
145778536|NCT01629667|525698378|FG001|Overall Study|Requiring lung transplant|1|||
145778537|NCT01629667|525698379|FG002|Overall Study|Requiring lung transplant|3|||
145778538|NCT01629667|525698377|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
145778539|NCT01629667|525698378|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
145778540|NCT01629667|525698379|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
145778541|NCT01629667|525698377|FG000|Overall Study|Started other medicine|1|||
145778542|NCT01629667|525698378|FG001|Overall Study|Started other medicine|0|||
145778543|NCT01629667|525698379|FG002|Overall Study|Started other medicine|1|||
145778544|NCT01629667|525698377|FG000|Overall Study|Site error in safety follow-up|0|||
145778545|NCT01629667|525698378|FG001|Overall Study|Site error in safety follow-up|0|||
145778546|NCT01629667|525698379|FG002|Overall Study|Site error in safety follow-up|1|||
145778547|NCT01629667|525698377|FG000|Overall Study|Enrolled in another clinical study|0|||
145778548|NCT01629667|525698378|FG001|Overall Study|Enrolled in another clinical study|1|||
145778549|NCT01629667|525698379|FG002|Overall Study|Enrolled in another clinical study|0|||
145778550|NCT01629667|525698377|FG000|Overall Study|Code break|1|||
145778551|NCT01629667|525698378|FG001|Overall Study|Code break|0|||
145778552|NCT01629667|525698379|FG002|Overall Study|Code break|0|||
145778553|NCT00670111|525698381|FG000|Enrollment to One Month|Testing Failure|0|||
145778554|NCT00670111|525698382|FG001|Enrollment to One Month|Testing Failure|0|||
145778555|NCT00670111|525698383|FG002|Enrollment to One Month|Testing Failure|13|||
145778556|NCT00670111|525698381|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
145778557|NCT00670111|525698382|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
145778558|NCT00670111|525698383|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
145778559|NCT00670111|525698381|FG000|Enrollment to One Month|Physician Decision|1|||
145778560|NCT00670111|525698382|FG001|Enrollment to One Month|Physician Decision|0|||
145778561|NCT00670111|525698383|FG002|Enrollment to One Month|Physician Decision|0|||
145778562|NCT02623361|525698384|FG000|Overall Study|Protocol Violation|0|||
145778563|NCT02623361|525698385|FG001|Overall Study|Protocol Violation|1|||
145778564|NCT02623361|525698384|FG000|Overall Study|Withdrawal by Subject|0|||
145778565|NCT02623361|525698385|FG001|Overall Study|Withdrawal by Subject|1|||
145778566|NCT00844883|525698386|FG000|Overall Study|Bridged to liver transplant|3|||
145778567|NCT00844883|525698386|FG000|Overall Study|Bridged to resection|1|||
145778568|NCT02441803|525698388|FG000|Overall Study|Physician Decision|0|||
145778569|NCT02441803|525698389|FG001|Overall Study|Physician Decision|2|||
145778570|NCT02441803|525698390|FG002|Overall Study|Physician Decision|2|||
145778571|NCT01325493|525698395|FG000|Overall Study|Protocol Violation|0|||
145778572|NCT01325493|525698396|FG001|Overall Study|Protocol Violation|1|||
145778573|NCT01325493|525698395|FG000|Overall Study|loss of neuromonitoring signals|0|||
145778574|NCT01325493|525698396|FG001|Overall Study|loss of neuromonitoring signals|2|||
145778575|NCT01325493|525698395|FG000|Overall Study|Allergy|1|||
145778576|NCT01325493|525698396|FG001|Overall Study|Allergy|0|||
145778577|NCT00328198|525698401|FG000|Treatment|Adverse Event|21|||
145778578|NCT00328198|525698401|FG000|Treatment|Death|1|||
145778579|NCT00328198|525698401|FG000|Treatment|Physician Decision|5|||
145778580|NCT00328198|525698401|FG000|Treatment|Withdrawal by Subject|5|||
145778581|NCT00328198|525698401|FG000|Treatment|Evidence of disease progression|2|||
145778582|NCT00328198|525698401|FG000|Treatment|Non-compliance|1|||
145778583|NCT00328198|525698401|FG000|Treatment|Confirmed complete response, MRD -|3|||
145778584|NCT00328198|525698401|FG000|Follow-up|Lost to Follow-up|4|||
145778585|NCT00328198|525698401|FG000|Follow-up|Death|31|||
145778586|NCT01720667|525698402|FG000|Overall Study|Adverse Event|1|||
145778587|NCT01720667|525698403|FG001|Overall Study|Adverse Event|1|||
145778588|NCT01720667|525698402|FG000|Overall Study|Withdrawal by Subject|3|||
145778589|NCT01720667|525698403|FG001|Overall Study|Withdrawal by Subject|0|||
145778590|NCT02117050|525698406|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
145778591|NCT02052960|525698407|FG000|Overall Study|Adverse Event|19|||
145778592|NCT02052960|525698408|FG001|Overall Study|Adverse Event|17|||
145778593|NCT02052960|525698407|FG000|Overall Study|Protocol Violation|4|||
145778594|NCT02052960|525698408|FG001|Overall Study|Protocol Violation|3|||
145778595|NCT02052960|525698407|FG000|Overall Study|Withdrawal by Subject|6|||
145778596|NCT02052960|525698408|FG001|Overall Study|Withdrawal by Subject|11|||
145778597|NCT02052960|525698407|FG000|Overall Study|Other|25|||
145778598|NCT02052960|525698408|FG001|Overall Study|Other|15|||
145778599|NCT00491530|525698409|FG000|Overall Study|Adverse Event|6|||
145778600|NCT00491530|525698410|FG001|Overall Study|Adverse Event|1|||
145778601|NCT00491530|525698411|FG002|Overall Study|Adverse Event|2|||
145279160|NCT02454972|523872871|FG003|Overall Study|Patient moves to compassionate use|0|||
145536806|NCT02202980|524824204|FG008|Overall Study|Lost to Follow-up|1|||
145778602|NCT00491530|525698409|FG000|Overall Study|Withdrawal by Subject|3|||
145778603|NCT00491530|525698410|FG001|Overall Study|Withdrawal by Subject|0|||
145778604|NCT00491530|525698411|FG002|Overall Study|Withdrawal by Subject|0|||
145778605|NCT00491530|525698409|FG000|Overall Study|Lost to Follow-up|3|||
145778606|NCT00491530|525698410|FG001|Overall Study|Lost to Follow-up|2|||
145778607|NCT00491530|525698411|FG002|Overall Study|Lost to Follow-up|2|||
145778608|NCT00491530|525698409|FG000|Overall Study|Lack of Efficacy|0|||
145778609|NCT00491530|525698410|FG001|Overall Study|Lack of Efficacy|1|||
145778610|NCT00491530|525698411|FG002|Overall Study|Lack of Efficacy|0|||
145778611|NCT00491530|525698409|FG000|Overall Study|Investigator Discretion|0|||
145778612|NCT00491530|525698410|FG001|Overall Study|Investigator Discretion|1|||
145778613|NCT00491530|525698411|FG002|Overall Study|Investigator Discretion|0|||
145778614|NCT00491530|525698409|FG000|Overall Study|Patient Request|0|||
145778615|NCT00491530|525698410|FG001|Overall Study|Patient Request|1|||
145778616|NCT00491530|525698411|FG002|Overall Study|Patient Request|0|||
145778617|NCT00491530|525698409|FG000|Overall Study|Use of Prohibited Medication|0|||
145778618|NCT00491530|525698410|FG001|Overall Study|Use of Prohibited Medication|0|||
145778619|NCT00491530|525698411|FG002|Overall Study|Use of Prohibited Medication|1|||
145778620|NCT01396525|525698412|FG000|Overall Study|Withdrawal by Subject|8|||
145778621|NCT01396525|525698412|FG000|Overall Study|Death|14|||
145778622|NCT01396525|525698412|FG000|Overall Study|Lost to Follow-up|4|||
145536807|NCT02202980|524824205|FG009|Overall Study|Lost to Follow-up|0|||
145778623|NCT00949650|525698413|FG000|Overall Study|Progressive disease|188|||
145778624|NCT00949650|525698414|FG001|Overall Study|Progressive disease|19|||
145778625|NCT00949650|525698413|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
145778626|NCT00949650|525698414|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
145778627|NCT00949650|525698413|FG000|Overall Study|Other Adverse Event (AE)|28|||
145536808|NCT02202980|524824206|FG010|Overall Study|Lost to Follow-up|0|||
145536809|NCT02202980|524824207|FG011|Overall Study|Lost to Follow-up|0|||
145536810|NCT02202980|524824208|FG012|Overall Study|Lost to Follow-up|1|||
145536811|NCT02202980|524824209|FG013|Overall Study|Lost to Follow-up|0|||
145536812|NCT02202980|524824196|FG000|Overall Study|Withdrew Consent|0|||
145536813|NCT02202980|524824197|FG001|Overall Study|Withdrew Consent|1|||
145536814|NCT02202980|524824198|FG002|Overall Study|Withdrew Consent|2|||
145536815|NCT02202980|524824199|FG003|Overall Study|Withdrew Consent|0|||
145536816|NCT02202980|524824200|FG004|Overall Study|Withdrew Consent|0|||
145536817|NCT02202980|524824201|FG005|Overall Study|Withdrew Consent|0|||
145536818|NCT02202980|524824202|FG006|Overall Study|Withdrew Consent|0|||
145536819|NCT02202980|524824203|FG007|Overall Study|Withdrew Consent|0|||
145536820|NCT02202980|524824204|FG008|Overall Study|Withdrew Consent|1|||
145536821|NCT02202980|524824205|FG009|Overall Study|Withdrew Consent|0|||
145536822|NCT02202980|524824206|FG010|Overall Study|Withdrew Consent|0|||
145536823|NCT02202980|524824207|FG011|Overall Study|Withdrew Consent|0|||
145536824|NCT02202980|524824208|FG012|Overall Study|Withdrew Consent|0|||
145536825|NCT02202980|524824209|FG013|Overall Study|Withdrew Consent|0|||
145536826|NCT04138810|524824213|FG000|Overall Study|Withdrawal by Subject|0|||
145536827|NCT04138810|524824214|FG001|Overall Study|Withdrawal by Subject|1|||
145536828|NCT04138810|524824213|FG000|Overall Study|Subject cancelled surgery|1|||
145536829|NCT04138810|524824214|FG001|Overall Study|Subject cancelled surgery|0|||
145778628|NCT00949650|525698414|FG001|Overall Study|Other Adverse Event (AE)|17|||
145778629|NCT00949650|525698413|FG000|Overall Study|Protocol Violation|1|||
145778630|NCT00949650|525698414|FG001|Overall Study|Protocol Violation|4|||
145778631|NCT00949650|525698413|FG000|Overall Study|Refusal to continue medication|7|||
145778632|NCT00949650|525698414|FG001|Overall Study|Refusal to continue medication|11|||
145778633|NCT00949650|525698413|FG000|Overall Study|Not treated|1|||
145778634|NCT00949650|525698414|FG001|Overall Study|Not treated|4|||
145778635|NCT00949650|525698413|FG000|Overall Study|Other not specified above|5|||
145778636|NCT00949650|525698414|FG001|Overall Study|Other not specified above|0|||
145778637|NCT03671369|525698416|FG000|Overall Study|Other|1|||
145778638|NCT03671369|525698416|FG000|Overall Study|Withdrawal by Subject|289|||
145778639|NCT03671369|525698416|FG000|Overall Study|Not willing to be vaccinated|1|||
145778640|NCT02612077|525698418|FG000|Overall Study|Adverse Event|3|||
145778641|NCT02612077|525698418|FG000|Overall Study|Withdrawal by Subject|9|||
145778642|NCT02612077|525698418|FG000|Overall Study|Protocol Violation|28|||
145778643|NCT02612077|525698418|FG000|Overall Study|Lost to Follow-up|20|||
145778644|NCT02612077|525698418|FG000|Overall Study|Death|377|||
145778645|NCT02612077|525698418|FG000|Overall Study|Moved or Changed Medical Team|23|||
145778646|NCT02612077|525698418|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
145778647|NCT02612077|525698418|FG000|Overall Study|Disease Progression|3|||
145778648|NCT02612077|525698418|FG000|Overall Study|Unknown reason|2|||
145778649|NCT01971476|525698419|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
145403712|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
145536830|NCT00591344|524824215|FG000|Overall Study|Transportation issues|1|||
145536831|NCT00591344|524824216|FG001|Overall Study|Transportation issues|0|||
145536832|NCT00591344|524824215|FG000|Overall Study|Moved out of state|1|||
145536833|NCT00591344|524824216|FG001|Overall Study|Moved out of state|0|||
145536834|NCT00591344|524824215|FG000|Overall Study|Medical complications|1|||
145608951|NCT01555164|525083262|FG001|Overall Study|Hyperglycemia|1|||
145778650|NCT01971476|525698420|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
145778651|NCT01971476|525698421|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
145536835|NCT00591344|524824216|FG001|Overall Study|Medical complications|3|||
145536836|NCT00591344|524824215|FG000|Overall Study|Underwent DBS|2|||
145536837|NCT00591344|524824216|FG001|Overall Study|Underwent DBS|2|||
145536838|NCT00591344|524824215|FG000|Overall Study|Death|0|||
145536839|NCT00591344|524824216|FG001|Overall Study|Death|1|||
145778652|NCT01971476|525698419|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
145778653|NCT01971476|525698420|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
145778654|NCT01971476|525698421|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
145778655|NCT01971476|525698419|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
145778656|NCT01971476|525698420|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
145608952|NCT01555164|525083261|FG000|Overall Study|Investigator's Discretion|2|||
145608953|NCT01555164|525083262|FG001|Overall Study|Investigator's Discretion|2|||
145608954|NCT01555164|525083261|FG000|Overall Study|Lost to Follow-up|4|||
145608955|NCT01555164|525083262|FG001|Overall Study|Lost to Follow-up|3|||
145608956|NCT01555164|525083261|FG000|Overall Study|Protocol Violation|9|||
145608957|NCT01555164|525083262|FG001|Overall Study|Protocol Violation|5|||
145608958|NCT01555164|525083261|FG000|Overall Study|Subject Non-compliance|14|||
145608959|NCT01555164|525083262|FG001|Overall Study|Subject Non-compliance|6|||
145608960|NCT01555164|525083261|FG000|Overall Study|Subject Withdrew Consent|6|||
145608961|NCT01555164|525083262|FG001|Overall Study|Subject Withdrew Consent|11|||
145608962|NCT01672853|525083263|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
145608963|NCT01672853|525083264|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
145608964|NCT01672853|525083265|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
145608965|NCT01672853|525083263|FG000|Overall Study|Pregnancy|0|||
145608966|NCT01672853|525083264|FG001|Overall Study|Pregnancy|1|||
145608967|NCT01672853|525083265|FG002|Overall Study|Pregnancy|0|||
145608968|NCT01672853|525083263|FG000|Overall Study|Investigator's Discretion|1|||
145608969|NCT01672853|525083264|FG001|Overall Study|Investigator's Discretion|0|||
145608970|NCT01672853|525083265|FG002|Overall Study|Investigator's Discretion|0|||
145608971|NCT01672853|525083263|FG000|Overall Study|Withdrew Consent|5|||
145608972|NCT01672853|525083264|FG001|Overall Study|Withdrew Consent|5|||
145536840|NCT00591344|524824215|FG000|Overall Study|Lost to Follow-up|0|||
145536841|NCT00591344|524824216|FG001|Overall Study|Lost to Follow-up|1|||
145536842|NCT00591344|524824215|FG000|Overall Study|Did not want to come off medication|0|||
145536843|NCT00591344|524824216|FG001|Overall Study|Did not want to come off medication|1|||
145536844|NCT01058655|524824221|FG000|Overall Study|Withdrawal by Subject|1|||
145536845|NCT01058655|524824222|FG001|Overall Study|Withdrawal by Subject|0|||
145536846|NCT01058655|524824223|FG002|Overall Study|Withdrawal by Subject|3|||
145536847|NCT01058655|524824224|FG003|Overall Study|Withdrawal by Subject|4|||
145536848|NCT01058655|524824221|FG000|Overall Study|Prolonged Treatment Delay|0|||
145536849|NCT01058655|524824222|FG001|Overall Study|Prolonged Treatment Delay|0|||
145536850|NCT01058655|524824223|FG002|Overall Study|Prolonged Treatment Delay|0|||
145536851|NCT01058655|524824224|FG003|Overall Study|Prolonged Treatment Delay|2|||
145536852|NCT01058655|524824221|FG000|Overall Study|Symptomatic Deterioration|0|||
145536853|NCT01058655|524824222|FG001|Overall Study|Symptomatic Deterioration|0|||
145536854|NCT01058655|524824223|FG002|Overall Study|Symptomatic Deterioration|0|||
145536855|NCT01058655|524824224|FG003|Overall Study|Symptomatic Deterioration|1|||
145536856|NCT01058655|524824221|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
145536857|NCT01058655|524824222|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
145536858|NCT01058655|524824223|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
145536859|NCT01058655|524824224|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
145536860|NCT01058655|524824221|FG000|Overall Study|Death|0|||
145536861|NCT01058655|524824222|FG001|Overall Study|Death|1|||
145536862|NCT01058655|524824223|FG002|Overall Study|Death|1|||
145536863|NCT01058655|524824224|FG003|Overall Study|Death|0|||
145536864|NCT01058655|524824221|FG000|Overall Study|Disease Progression|1|||
145536865|NCT01058655|524824222|FG001|Overall Study|Disease Progression|2|||
145536866|NCT01058655|524824223|FG002|Overall Study|Disease Progression|4|||
145536867|NCT01058655|524824224|FG003|Overall Study|Disease Progression|24|||
145536868|NCT01058655|524824221|FG000|Overall Study|Other|0|||
145536869|NCT01058655|524824222|FG001|Overall Study|Other|0|||
145536870|NCT01058655|524824223|FG002|Overall Study|Other|0|||
145536871|NCT01058655|524824224|FG003|Overall Study|Other|4|||
145536872|NCT00619177|524824227|FG000|Overall Study|Adverse Event|18|||
145536873|NCT00619177|524824227|FG000|Overall Study|Lost to Follow-up|2|||
145536874|NCT00619177|524824227|FG000|Overall Study|Lack of Efficacy|1|||
145536875|NCT00619177|524824227|FG000|Overall Study|Missing termination information|481|||
145608973|NCT01672853|525083265|FG002|Overall Study|Withdrew Consent|5|||
145608974|NCT01672853|525083263|FG000|Overall Study|Adverse Event|4|||
145536876|NCT00619177|524824227|FG000|Overall Study|Not specified reasons|6|||
145536877|NCT02435147|524824229|FG000|Overall Study|non-evaluable DXA scan|11|||
145536878|NCT02939079|524824230|FG000|Overall Study|Adverse Event|2|||
145536879|NCT02939079|524824231|FG001|Overall Study|Adverse Event|1|||
145536880|NCT02939079|524824230|FG000|Overall Study|Lost to Follow-up|0|||
145608975|NCT01672853|525083264|FG001|Overall Study|Adverse Event|6|||
145778657|NCT01971476|525698421|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
145778658|NCT00553787|525698422|FG000|Overall Study|Adverse Event|34|||
145778659|NCT00553787|525698423|FG001|Overall Study|Adverse Event|21|||
145778660|NCT00553787|525698424|FG002|Overall Study|Adverse Event|67|||
145536881|NCT02939079|524824231|FG001|Overall Study|Lost to Follow-up|2|||
145536882|NCT02939079|524824230|FG000|Overall Study|Protocol Violation|1|||
145536883|NCT02939079|524824231|FG001|Overall Study|Protocol Violation|0|||
145536884|NCT02939079|524824230|FG000|Overall Study|Withdrawal by Subject|0|||
145536885|NCT02939079|524824231|FG001|Overall Study|Withdrawal by Subject|1|||
145608976|NCT01672853|525083265|FG002|Overall Study|Adverse Event|8|||
145608977|NCT01672853|525083263|FG000|Overall Study|Lost to Follow-up|0|||
145608978|NCT01672853|525083264|FG001|Overall Study|Lost to Follow-up|1|||
145778661|NCT00553787|525698422|FG000|Overall Study|Lost to Follow-up|132|||
145778662|NCT00553787|525698423|FG001|Overall Study|Lost to Follow-up|44|||
145778663|NCT00553787|525698424|FG002|Overall Study|Lost to Follow-up|78|||
145778664|NCT00553787|525698422|FG000|Overall Study|Withdrawal by Subject|151|||
145778665|NCT00553787|525698423|FG001|Overall Study|Withdrawal by Subject|40|||
145778666|NCT00553787|525698424|FG002|Overall Study|Withdrawal by Subject|83|||
145778667|NCT00553787|525698422|FG000|Overall Study|Lack of Efficacy|31|||
145778668|NCT00553787|525698423|FG001|Overall Study|Lack of Efficacy|1|||
145778669|NCT00553787|525698424|FG002|Overall Study|Lack of Efficacy|3|||
145778670|NCT00553787|525698422|FG000|Overall Study|Pregnancy|0|||
145778671|NCT00553787|525698423|FG001|Overall Study|Pregnancy|1|||
145778672|NCT00553787|525698424|FG002|Overall Study|Pregnancy|2|||
145778673|NCT00553787|525698422|FG000|Overall Study|non compliance|4|||
145778674|NCT00553787|525698423|FG001|Overall Study|non compliance|0|||
145778675|NCT00553787|525698424|FG002|Overall Study|non compliance|11|||
145778676|NCT00553787|525698422|FG000|Overall Study|Requirement for restricted medication|8|||
145778677|NCT00553787|525698423|FG001|Overall Study|Requirement for restricted medication|7|||
145778678|NCT00553787|525698424|FG002|Overall Study|Requirement for restricted medication|5|||
145778679|NCT00553787|525698422|FG000|Overall Study|Other|18|||
145778680|NCT00553787|525698423|FG001|Overall Study|Other|10|||
145778681|NCT00553787|525698424|FG002|Overall Study|Other|13|||
145536886|NCT02939079|524824230|FG000|Overall Study|relapse during the study|1|||
145536887|NCT02939079|524824231|FG001|Overall Study|relapse during the study|1|||
145536888|NCT04093414|524824232|FG000|3 Month Follow up|Physician Decision|0|||
145536889|NCT04093414|524824233|FG001|3 Month Follow up|Physician Decision|1|||
145536890|NCT04093414|524824232|FG000|6month Follow up|Physician Decision|1|||
145536891|NCT04093414|524824233|FG001|6month Follow up|Physician Decision|3|||
145536892|NCT04889222|524824234|FG000|Overall Study|Did not meet eligibility criteria|8|||
145536893|NCT04889222|524824234|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
145536894|NCT04889222|524824234|FG000|Overall Study|Did not proceed due to time constraints|5|||
145536895|NCT01180647|524824235|FG000|Overall Study|Lost to Follow-up|5|||
145536896|NCT01180647|524824236|FG001|Overall Study|Lost to Follow-up|6|||
145536897|NCT03800173|524824248|FG000|Overall Study|Lost to Follow-up|0|||
145536898|NCT03800173|524824249|FG001|Overall Study|Lost to Follow-up|0|||
145536899|NCT03800173|524824250|FG002|Overall Study|Lost to Follow-up|0|||
145536900|NCT03800173|524824251|FG003|Overall Study|Lost to Follow-up|0|||
145536901|NCT03800173|524824252|FG004|Overall Study|Lost to Follow-up|1|||
145536902|NCT00338104|524824270|FG000|Overall Study|Protocol Violation|2|||
145536903|NCT00338104|524824271|FG001|Overall Study|Protocol Violation|1|||
145536904|NCT00338104|524824272|FG002|Overall Study|Protocol Violation|3|||
145536905|NCT00633750|524824273|FG000|Overall Study|Adverse Event|2|||
145536906|NCT00633750|524824273|FG000|Overall Study|Withdrawal by Subject|3|||
145536907|NCT02362269|524824276|FG000|Overall Study|Moved|1|||
145536908|NCT02362269|524824277|FG001|Overall Study|Moved|0|||
145536909|NCT02362269|524824276|FG000|Overall Study|Lost to Follow-up|0|||
145536910|NCT02362269|524824277|FG001|Overall Study|Lost to Follow-up|6|||
145536911|NCT01903031|524824278|FG000|Overall Study|Not Able to Attend Clinic|1|||
145536912|NCT01903031|524824279|FG001|Overall Study|Not Able to Attend Clinic|1|||
145536913|NCT01903031|524824280|FG002|Overall Study|Not Able to Attend Clinic|0|||
145536914|NCT01903031|524824278|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
145536915|NCT01903031|524824279|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
145536916|NCT01903031|524824280|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
145536917|NCT01903031|524824278|FG000|Overall Study|Adverse Event|0|||
145536918|NCT01903031|524824279|FG001|Overall Study|Adverse Event|1|||
145536919|NCT01903031|524824280|FG002|Overall Study|Adverse Event|0|||
145536920|NCT01903031|524824278|FG000|Overall Study|Withdrawal by Subject|0|||
145536921|NCT01903031|524824279|FG001|Overall Study|Withdrawal by Subject|1|||
145536922|NCT01903031|524824280|FG002|Overall Study|Withdrawal by Subject|1|||
145536923|NCT01903031|524824278|FG000|Overall Study|Protocol Violation|0|||
145536924|NCT01903031|524824279|FG001|Overall Study|Protocol Violation|0|||
145536925|NCT01903031|524824280|FG002|Overall Study|Protocol Violation|2|||
145536926|NCT01903031|524824278|FG000|Overall Study|Lost to Follow-up|0|||
145536927|NCT01903031|524824279|FG001|Overall Study|Lost to Follow-up|0|||
145536928|NCT01903031|524824280|FG002|Overall Study|Lost to Follow-up|1|||
145536929|NCT01903031|524824278|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
145536930|NCT01903031|524824279|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
145536931|NCT01903031|524824280|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
145536932|NCT01811225|524824281|FG000|Treatment Period 1|Adverse Event|2|||
145536933|NCT01811225|524824282|FG001|Treatment Period 1|Adverse Event|3|||
145608979|NCT01672853|525083265|FG002|Overall Study|Lost to Follow-up|0|||
145778682|NCT00793104|525698425|FG000|Overall Study|Lost to Follow-up|1|||
145778683|NCT02619253|525698426|FG000|Overall Study|Adverse Event|0|||
145778684|NCT02619253|525698427|FG001|Overall Study|Adverse Event|0|||
145778685|NCT02619253|525698428|FG002|Overall Study|Adverse Event|1|||
145778686|NCT02619253|525698429|FG003|Overall Study|Adverse Event|1|||
145778687|NCT02619253|525698430|FG004|Overall Study|Adverse Event|3|||
145778688|NCT02619253|525698426|FG000|Overall Study|Alternative Therapy|0|||
145778689|NCT02619253|525698427|FG001|Overall Study|Alternative Therapy|0|||
145778690|NCT02619253|525698428|FG002|Overall Study|Alternative Therapy|1|||
145536934|NCT01811225|524824281|FG000|Treatment Period 1|Lost to Follow-up|12|||
145536935|NCT01811225|524824282|FG001|Treatment Period 1|Lost to Follow-up|8|||
145778691|NCT02619253|525698429|FG003|Overall Study|Alternative Therapy|0|||
145778692|NCT02619253|525698430|FG004|Overall Study|Alternative Therapy|0|||
145778693|NCT02619253|525698426|FG000|Overall Study|Death|0|||
145778694|NCT02619253|525698427|FG001|Overall Study|Death|0|||
145778695|NCT02619253|525698428|FG002|Overall Study|Death|0|||
145778696|NCT02619253|525698429|FG003|Overall Study|Death|1|||
145778697|NCT02619253|525698430|FG004|Overall Study|Death|0|||
145778698|NCT02619253|525698426|FG000|Overall Study|Disease Progression|4|||
145778699|NCT02619253|525698427|FG001|Overall Study|Disease Progression|2|||
145778700|NCT02619253|525698428|FG002|Overall Study|Disease Progression|8|||
145778701|NCT02619253|525698429|FG003|Overall Study|Disease Progression|9|||
145778702|NCT02619253|525698430|FG004|Overall Study|Disease Progression|10|||
145778703|NCT02619253|525698426|FG000|Overall Study|Needed a disqualifying therapy|0|||
145778704|NCT02619253|525698427|FG001|Overall Study|Needed a disqualifying therapy|0|||
145778705|NCT02619253|525698428|FG002|Overall Study|Needed a disqualifying therapy|1|||
145778706|NCT02619253|525698429|FG003|Overall Study|Needed a disqualifying therapy|0|||
145778707|NCT02619253|525698430|FG004|Overall Study|Needed a disqualifying therapy|0|||
145778708|NCT02619253|525698426|FG000|Overall Study|Transferred to hospice|0|||
145778709|NCT02619253|525698427|FG001|Overall Study|Transferred to hospice|0|||
145778710|NCT02619253|525698428|FG002|Overall Study|Transferred to hospice|1|||
145778711|NCT02619253|525698429|FG003|Overall Study|Transferred to hospice|0|||
145778712|NCT02619253|525698430|FG004|Overall Study|Transferred to hospice|0|||
145778713|NCT02619253|525698426|FG000|Overall Study|Physician Decision|0|||
145778714|NCT02619253|525698427|FG001|Overall Study|Physician Decision|1|||
145778715|NCT02619253|525698428|FG002|Overall Study|Physician Decision|2|||
145778716|NCT02619253|525698429|FG003|Overall Study|Physician Decision|3|||
145778717|NCT02619253|525698430|FG004|Overall Study|Physician Decision|0|||
145778718|NCT02619253|525698426|FG000|Overall Study|Withdrawal by Subject|0|||
145778719|NCT02619253|525698427|FG001|Overall Study|Withdrawal by Subject|1|||
145778720|NCT02619253|525698428|FG002|Overall Study|Withdrawal by Subject|0|||
145778721|NCT02619253|525698429|FG003|Overall Study|Withdrawal by Subject|0|||
145778722|NCT02619253|525698430|FG004|Overall Study|Withdrawal by Subject|2|||
145778723|NCT00514449|525698431|FG000|Overall Study|Withdrawal by Subject|1|||
145778724|NCT00514449|525698432|FG001|Overall Study|Withdrawal by Subject|2|||
145778725|NCT00514449|525698431|FG000|Overall Study|Protocol Violation|1|||
145778726|NCT00514449|525698432|FG001|Overall Study|Protocol Violation|2|||
145778727|NCT00514449|525698431|FG000|Overall Study|Lost to Follow-up|1|||
145778728|NCT00514449|525698432|FG001|Overall Study|Lost to Follow-up|0|||
145778729|NCT01457339|525698443|FG000|Period 3 (100 mg)|Adverse Event|0|||
145778730|NCT01457339|525698444|FG001|Period 3 (100 mg)|Adverse Event|1|||
145778731|NCT01457339|525698443|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
145778732|NCT01457339|525698444|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
145778733|NCT01457339|525698443|FG000|Period 6 (250 mg)|Family Emergency|1|||
145778734|NCT01457339|525698444|FG001|Period 6 (250 mg)|Family Emergency|0|||
145778735|NCT01457339|525698443|FG000|Period 6 (250 mg)|Personal appointment|0|||
145778736|NCT01457339|525698444|FG001|Period 6 (250 mg)|Personal appointment|1|||
145778737|NCT01164501|525698448|FG000|Overall Study|Not treated|2|||
145778738|NCT01164501|525698449|FG001|Overall Study|Not treated|0|||
145778739|NCT01164501|525698450|FG002|Overall Study|Not treated|1|||
145778740|NCT01164501|525698448|FG000|Overall Study|Adverse Event|18|||
145778741|NCT01164501|525698449|FG001|Overall Study|Adverse Event|4|||
145778742|NCT01164501|525698450|FG002|Overall Study|Adverse Event|21|||
145778743|NCT01164501|525698448|FG000|Overall Study|Lack of Efficacy|0|||
145778744|NCT01164501|525698449|FG001|Overall Study|Lack of Efficacy|0|||
145778745|NCT01164501|525698450|FG002|Overall Study|Lack of Efficacy|1|||
145403713|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
145536936|NCT01811225|524824281|FG000|Treatment Period 1|transporation|1|||
145536937|NCT01811225|524824282|FG001|Treatment Period 1|transporation|0|||
145536938|NCT01811225|524824281|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
145536939|NCT01811225|524824282|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
145536940|NCT01811225|524824281|FG000|Treatment Period 2|Lost to Follow-up|1|||
145536941|NCT01811225|524824282|FG001|Treatment Period 2|Lost to Follow-up|2|||
145536942|NCT01811225|524824281|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
145778746|NCT01164501|525698448|FG000|Overall Study|Non compliant with protocol|1|||
145778747|NCT01164501|525698449|FG001|Overall Study|Non compliant with protocol|1|||
145778748|NCT01164501|525698450|FG002|Overall Study|Non compliant with protocol|4|||
145778749|NCT01164501|525698448|FG000|Overall Study|Lost to Follow-up|3|||
145778750|NCT01164501|525698449|FG001|Overall Study|Lost to Follow-up|0|||
145778751|NCT01164501|525698450|FG002|Overall Study|Lost to Follow-up|3|||
145778752|NCT01164501|525698448|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
145778753|NCT01164501|525698449|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
145778754|NCT01164501|525698450|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
145778755|NCT01164501|525698448|FG000|Overall Study|Other reason not defined above|9|||
145778756|NCT01164501|525698449|FG001|Overall Study|Other reason not defined above|1|||
145778757|NCT01164501|525698450|FG002|Overall Study|Other reason not defined above|4|||
145778758|NCT01096667|525698451|FG000|Overall Study|Lost to Follow-up|1|||
145778759|NCT01096667|525698452|FG001|Overall Study|Lost to Follow-up|1|||
145778760|NCT01096667|525698453|FG002|Overall Study|Lost to Follow-up|1|||
145778761|NCT01096667|525698454|FG003|Overall Study|Lost to Follow-up|0|||
145778762|NCT01096667|525698455|FG004|Overall Study|Lost to Follow-up|0|||
145778763|NCT01096667|525698451|FG000|Overall Study|Withdrawal by Subject|1|||
145778764|NCT01096667|525698452|FG001|Overall Study|Withdrawal by Subject|0|||
145778765|NCT01096667|525698453|FG002|Overall Study|Withdrawal by Subject|0|||
145778766|NCT01096667|525698454|FG003|Overall Study|Withdrawal by Subject|1|||
145778767|NCT01096667|525698455|FG004|Overall Study|Withdrawal by Subject|0|||
145778768|NCT01096667|525698451|FG000|Overall Study|Reason not available|0|||
145778769|NCT01096667|525698452|FG001|Overall Study|Reason not available|1|||
145778770|NCT01096667|525698453|FG002|Overall Study|Reason not available|1|||
145778771|NCT01096667|525698454|FG003|Overall Study|Reason not available|1|||
145778772|NCT01096667|525698455|FG004|Overall Study|Reason not available|0|||
145778773|NCT01096667|525698451|FG000|Overall Study|Protocol Violation|0|||
145778774|NCT01096667|525698452|FG001|Overall Study|Protocol Violation|0|||
145778775|NCT01096667|525698453|FG002|Overall Study|Protocol Violation|0|||
145778776|NCT01096667|525698454|FG003|Overall Study|Protocol Violation|1|||
145778777|NCT01096667|525698455|FG004|Overall Study|Protocol Violation|0|||
145778778|NCT01096667|525698451|FG000|Overall Study|Not treated|1|||
145778779|NCT01096667|525698452|FG001|Overall Study|Not treated|0|||
145778780|NCT01096667|525698453|FG002|Overall Study|Not treated|0|||
145778781|NCT01096667|525698454|FG003|Overall Study|Not treated|0|||
145778782|NCT01096667|525698455|FG004|Overall Study|Not treated|0|||
145778783|NCT00847561|525698458|FG000|Overall Study|Withdrawal by Subject|4|||
145778784|NCT00847561|525698459|FG001|Overall Study|Withdrawal by Subject|3|||
145778785|NCT00847561|525698458|FG000|Overall Study|Unable to schedule|9|||
145778786|NCT00847561|525698459|FG001|Overall Study|Unable to schedule|1|||
145778787|NCT00377299|525698460|FG000|Overall Study|Lost to Follow-up|14|||
145778788|NCT00377299|525698461|FG001|Overall Study|Lost to Follow-up|19|||
145778789|NCT00377299|525698460|FG000|Overall Study|Adverse Event|0|||
145778790|NCT00377299|525698461|FG001|Overall Study|Adverse Event|1|||
145778791|NCT00377299|525698460|FG000|Overall Study|Withdrawal by Subject|5|||
145778792|NCT00377299|525698461|FG001|Overall Study|Withdrawal by Subject|4|||
145778793|NCT02050048|525698464|FG000|Overall Study|Lost to Follow-up|0|||
145778794|NCT02050048|525698465|FG001|Overall Study|Lost to Follow-up|1|||
145778795|NCT02050048|525698464|FG000|Overall Study|Death|1|||
145778796|NCT02050048|525698465|FG001|Overall Study|Death|0|||
145778797|NCT02050048|525698464|FG000|Overall Study|Ineligible after ERCP|4|||
145778798|NCT02050048|525698465|FG001|Overall Study|Ineligible after ERCP|1|||
145778799|NCT01507246|525698469|FG000|Overall Study|Required different surgical procedures|2|||
145778800|NCT01507246|525698470|FG001|Overall Study|Required different surgical procedures|1|||
145778801|NCT02975349|525698471|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145778802|NCT02975349|525698472|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145778803|NCT02975349|525698473|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145536943|NCT01811225|524824282|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
145536944|NCT00287365|524824283|FG000|Overall Study|sample not acquired|13|||
145536945|NCT03000569|524824284|FG000|Overall Study|Withdrawal by Subject|1|||
145536946|NCT03000569|524824285|FG001|Overall Study|Withdrawal by Subject|0|||
145536947|NCT02298023|524824286|FG000|Overall Study|Withdrawal by Subject|1|||
145536948|NCT02298023|524824287|FG001|Overall Study|Withdrawal by Subject|0|||
145536949|NCT02298023|524824288|FG002|Overall Study|Withdrawal by Subject|0|||
145536950|NCT03308786|524824289|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
145536951|NCT03320057|524825670|FG000|Overall Study|Lost to Follow-up|4|||
145536952|NCT03320057|524825671|FG001|Overall Study|Lost to Follow-up|17|||
145536953|NCT03320057|524825670|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
145536954|NCT03320057|524825671|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
145536955|NCT04092582|524825673|FG000|Overall Study|Death|1|||
145536956|NCT04092582|524825674|FG001|Overall Study|Death|1|||
145536957|NCT04092582|524825673|FG000|Overall Study|Withdrawal by Subject|4|||
145778804|NCT02975349|525698474|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145778805|NCT02975349|525698475|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145778806|NCT02975349|525698476|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145778807|NCT02975349|525698477|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145778808|NCT02975349|525698471|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145778809|NCT02975349|525698472|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145536958|NCT04092582|524825674|FG001|Overall Study|Withdrawal by Subject|1|||
145608980|NCT01672853|525083263|FG000|Overall Study|Randomized but Never Treated|0|||
145778810|NCT02975349|525698473|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145778811|NCT02975349|525698474|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145778812|NCT02975349|525698475|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145778813|NCT02975349|525698476|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145778814|NCT02975349|525698477|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145778815|NCT02975349|525698471|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
145778816|NCT02975349|525698472|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
145778817|NCT02975349|525698473|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
145778818|NCT02975349|525698474|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
145778819|NCT02975349|525698475|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
145778820|NCT02975349|525698476|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
145778821|NCT02975349|525698477|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
145778822|NCT02975349|525698471|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
145778823|NCT02975349|525698472|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
145778824|NCT02975349|525698473|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
145778825|NCT02975349|525698474|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
145778826|NCT02975349|525698475|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
145778827|NCT02975349|525698476|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
145778828|NCT02975349|525698477|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
145778829|NCT02975349|525698471|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
145778830|NCT02975349|525698472|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
145778831|NCT02975349|525698473|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
145778832|NCT02975349|525698474|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
145778833|NCT02975349|525698475|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
145778834|NCT02975349|525698476|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
145778835|NCT02975349|525698477|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
145778836|NCT02975349|525698471|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778837|NCT02975349|525698472|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778838|NCT02975349|525698473|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778839|NCT02975349|525698474|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
145778840|NCT02975349|525698475|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778841|NCT02975349|525698476|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778842|NCT02975349|525698477|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
145778843|NCT02975349|525698471|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778844|NCT02975349|525698472|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
145778845|NCT02975349|525698473|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778846|NCT02975349|525698474|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778847|NCT02975349|525698475|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778848|NCT02975349|525698476|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778849|NCT02975349|525698477|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
145778850|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
145778851|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
145778852|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
145778853|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
145778854|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
145778855|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
145778856|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
145778857|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778858|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778859|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778860|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778861|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
145778862|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778863|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
145778864|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
145778865|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
145778866|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
145778867|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
145778868|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
145778869|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
145778870|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
145778871|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
145778872|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
145778873|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
145778874|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
145778875|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
145778876|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
145778877|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
145778878|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
145778879|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
145778880|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
145778881|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
145778882|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
145778883|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
145778884|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
145778885|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
145778886|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
145778887|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
145778888|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
145778889|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
145778890|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
145778891|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
145778892|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
145778893|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
145778894|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
145778895|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
145778896|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
145778897|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
145778898|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
145778899|NCT02975349|525698471|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
145778900|NCT02975349|525698472|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
145778901|NCT02975349|525698473|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
145778902|NCT02975349|525698474|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
145778903|NCT02975349|525698475|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
145778904|NCT02975349|525698476|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
145778905|NCT02975349|525698477|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
145778906|NCT05243550|525700220|FG000|Overall Study|Ongoing in the Study|171|||
145778907|NCT05243550|525700220|FG000|Overall Study|Withdrawal by Subject|10|||
145778908|NCT05243550|525700220|FG000|Overall Study|Lost to Follow-up|7|||
145778909|NCT05243550|525700220|FG000|Overall Study|Adverse Event|3|||
145778910|NCT05243550|525700220|FG000|Overall Study|Noncompliance|1|||
145778911|NCT05243550|525700220|FG000|Overall Study|Physician Decision|1|||
145778912|NCT05243550|525700220|FG000|Overall Study|Other Reason|4|||
145778913|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
145778914|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
145778915|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
145778916|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
145778917|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
145778918|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145778919|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145778920|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145778921|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
145778922|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
145778923|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
145778924|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
145778925|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
145778926|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
145778927|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
145778928|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
145778929|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
145778930|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
145778931|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
145778932|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
145778933|NCT01894516|525700221|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
145778934|NCT01894516|525700222|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
145778935|NCT01894516|525700223|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
145778936|NCT01894516|525700224|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
145778937|NCT01894516|525700221|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
145778938|NCT01894516|525700222|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
145778939|NCT01894516|525700223|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
145778940|NCT01894516|525700224|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
145778941|NCT01894516|525700221|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145778942|NCT01894516|525700222|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145778943|NCT01894516|525700223|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
145778944|NCT01894516|525700224|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145403714|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145403715|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145778945|NCT00893113|525700227|FG000|Overall Study|Lost to Follow-up|4|||
145778946|NCT00893113|525700228|FG001|Overall Study|Lost to Follow-up|8|||
145778947|NCT00893113|525700227|FG000|Overall Study|Early Termination|1|||
145778948|NCT00893113|525700228|FG001|Overall Study|Early Termination|1|||
145778949|NCT00893113|525700227|FG000|Overall Study|Withdrew Consent|8|||
145778950|NCT00893113|525700228|FG001|Overall Study|Withdrew Consent|7|||
145778951|NCT03270085|525700231|FG000|Overall Study|Withdrawal by Subject|1|||
145778952|NCT03270085|525700232|FG001|Overall Study|Withdrawal by Subject|0|||
145778953|NCT02114203|525700233|FG000|Overall Study|Adverse Event|0|||
145778954|NCT02114203|525700234|FG001|Overall Study|Adverse Event|1|||
145778955|NCT02114203|525700235|FG002|Overall Study|Adverse Event|0|||
145778956|NCT02114203|525700233|FG000|Overall Study|Withdrawal by Subject|0|||
145778957|NCT02114203|525700234|FG001|Overall Study|Withdrawal by Subject|1|||
145778958|NCT02114203|525700235|FG002|Overall Study|Withdrawal by Subject|0|||
145778959|NCT00151411|525700240|FG000|Overall Study|Lost to Follow-up|15|||
145778960|NCT00151411|525700241|FG001|Overall Study|Lost to Follow-up|19|||
145778961|NCT00151411|525700240|FG000|Overall Study|Withdrawal by Subject|12|||
145778962|NCT00151411|525700241|FG001|Overall Study|Withdrawal by Subject|20|||
145778963|NCT00151411|525700240|FG000|Overall Study|Adverse Event|6|||
145778964|NCT00151411|525700241|FG001|Overall Study|Adverse Event|0|||
145778965|NCT00151411|525700240|FG000|Overall Study|Pregnancy|0|||
145778966|NCT00151411|525700241|FG001|Overall Study|Pregnancy|4|||
145778967|NCT01283581|525700242|FG000|Overall Study|Lost to Follow-up|8|||
145778968|NCT01283581|525700243|FG001|Overall Study|Lost to Follow-up|6|||
145778969|NCT01283581|525700244|FG002|Overall Study|Lost to Follow-up|8|||
145778970|NCT01283581|525700242|FG000|Overall Study|Withdrawal by Subject|2|||
145778971|NCT01283581|525700243|FG001|Overall Study|Withdrawal by Subject|5|||
145778972|NCT01283581|525700244|FG002|Overall Study|Withdrawal by Subject|2|||
145778973|NCT01283581|525700242|FG000|Overall Study|Adverse Event|1|||
145778974|NCT01283581|525700243|FG001|Overall Study|Adverse Event|1|||
145778975|NCT01283581|525700244|FG002|Overall Study|Adverse Event|4|||
145778976|NCT01283581|525700242|FG000|Overall Study|Physician Decision|0|||
145778977|NCT01283581|525700243|FG001|Overall Study|Physician Decision|1|||
145778978|NCT01283581|525700244|FG002|Overall Study|Physician Decision|2|||
145536959|NCT04092582|524825673|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
145536960|NCT04092582|524825674|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
145536961|NCT00316719|524825675|FG000|Overall Study|Adverse Event|0|||
145536962|NCT00316719|524825676|FG001|Overall Study|Adverse Event|6|||
145536963|NCT00316719|524825675|FG000|Overall Study|Consent withdrawn|2|||
145536964|NCT00316719|524825676|FG001|Overall Study|Consent withdrawn|0|||
145536965|NCT02468674|524825679|FG000|Overall Study|Adverse Event|0|||
145536966|NCT02468674|524825680|FG001|Overall Study|Adverse Event|0|||
145536967|NCT02468674|524825681|FG002|Overall Study|Adverse Event|0|||
145536968|NCT02468674|524825682|FG003|Overall Study|Adverse Event|1|||
145536969|NCT02468674|524825683|FG004|Overall Study|Adverse Event|0|||
145536970|NCT02468674|524825684|FG005|Overall Study|Adverse Event|1|||
145536971|NCT02468674|524825685|FG006|Overall Study|Adverse Event|0|||
145536972|NCT02468674|524825686|FG007|Overall Study|Adverse Event|0|||
145536973|NCT02468674|524825687|FG008|Overall Study|Adverse Event|0|||
145536974|NCT02468674|524825679|FG000|Overall Study|Lost to Follow-up|1|||
145536975|NCT02468674|524825680|FG001|Overall Study|Lost to Follow-up|0|||
145536976|NCT02468674|524825681|FG002|Overall Study|Lost to Follow-up|0|||
145778979|NCT01283581|525700242|FG000|Overall Study|Protocol Violation|0|||
145778980|NCT01283581|525700243|FG001|Overall Study|Protocol Violation|1|||
145536977|NCT02468674|524825682|FG003|Overall Study|Lost to Follow-up|0|||
145778981|NCT01283581|525700244|FG002|Overall Study|Protocol Violation|2|||
145778982|NCT01283581|525700242|FG000|Overall Study|Noncompliance|1|||
145778983|NCT01283581|525700243|FG001|Overall Study|Noncompliance|0|||
145279161|NCT02454972|523872872|FG004|Overall Study|Patient moves to compassionate use|0|||
145279162|NCT02454972|523872873|FG005|Overall Study|Patient moves to compassionate use|0|||
145279163|NCT02454972|523872874|FG006|Overall Study|Patient moves to compassionate use|2|||
145279164|NCT02454972|523872875|FG007|Overall Study|Patient moves to compassionate use|0|||
145279165|NCT02454972|523872876|FG008|Overall Study|Patient moves to compassionate use|0|||
145279166|NCT02454972|523872868|FG000|Overall Study|Withdrawal by Subject|0|||
145279167|NCT02454972|523872869|FG001|Overall Study|Withdrawal by Subject|1|||
145279168|NCT02454972|523872870|FG002|Overall Study|Withdrawal by Subject|5|||
145279169|NCT02454972|523872871|FG003|Overall Study|Withdrawal by Subject|2|||
145279170|NCT02454972|523872872|FG004|Overall Study|Withdrawal by Subject|3|||
145279171|NCT02454972|523872873|FG005|Overall Study|Withdrawal by Subject|2|||
145778984|NCT01283581|525700244|FG002|Overall Study|Noncompliance|0|||
145778985|NCT01283581|525700242|FG000|Overall Study|Investigator unblinded|0|||
145778986|NCT01283581|525700243|FG001|Overall Study|Investigator unblinded|0|||
145778987|NCT01283581|525700244|FG002|Overall Study|Investigator unblinded|1|||
145778988|NCT01283581|525700242|FG000|Overall Study|"Early termination"|0|||
145778989|NCT01283581|525700243|FG001|Overall Study|"Early termination"|0|||
145778990|NCT01283581|525700244|FG002|Overall Study|"Early termination"|1|||
145778991|NCT03060577|525700252|FG000|Overall Study|Withdrawal by Subject|25|||
145778992|NCT03060577|525700253|FG001|Overall Study|Withdrawal by Subject|5|||
145778993|NCT03060577|525700252|FG000|Overall Study|Physician Decision|4|||
145778994|NCT03060577|525700253|FG001|Overall Study|Physician Decision|3|||
145778995|NCT03060577|525700252|FG000|Overall Study|Lost to Follow-up|3|||
145778996|NCT03060577|525700253|FG001|Overall Study|Lost to Follow-up|0|||
145778997|NCT03060577|525700252|FG000|Overall Study|Death|7|||
145778998|NCT03060577|525700253|FG001|Overall Study|Death|1|||
145778999|NCT03060577|525700252|FG000|Overall Study|Adverse Event|9|||
145779000|NCT03060577|525700253|FG001|Overall Study|Adverse Event|1|||
145779001|NCT03060577|525700252|FG000|Overall Study|Inclusion/Exclusion|1|||
145779002|NCT03060577|525700253|FG001|Overall Study|Inclusion/Exclusion|0|||
145779003|NCT03060577|525700252|FG000|Overall Study|Other|8|||
145779004|NCT03060577|525700253|FG001|Overall Study|Other|2|||
145779005|NCT02584634|525700255|FG000|Overall Study|Adverse Event|3|||
145779006|NCT02584634|525700256|FG001|Overall Study|Adverse Event|5|||
145779007|NCT02584634|525700255|FG000|Overall Study|Death|0|||
145779008|NCT02584634|525700256|FG001|Overall Study|Death|1|||
145779009|NCT02584634|525700255|FG000|Overall Study|Lost to Follow-up|0|||
145779010|NCT02584634|525700256|FG001|Overall Study|Lost to Follow-up|1|||
145779011|NCT02584634|525700255|FG000|Overall Study|Physician Decision|1|||
145779012|NCT02584634|525700256|FG001|Overall Study|Physician Decision|2|||
145779013|NCT02584634|525700255|FG000|Overall Study|Progressive disease|7|||
145779014|NCT02584634|525700256|FG001|Overall Study|Progressive disease|15|||
145779015|NCT02584634|525700255|FG000|Overall Study|Withdrawal by Subject|1|||
145779016|NCT02584634|525700256|FG001|Overall Study|Withdrawal by Subject|1|||
145779017|NCT02584634|525700255|FG000|Overall Study|Other|0|||
145779018|NCT02584634|525700256|FG001|Overall Study|Other|6|||
145779019|NCT00474630|525700257|FG000|Overall Study|Adverse Event|98|||
145779020|NCT00474630|525700258|FG001|Overall Study|Adverse Event|26|||
145779021|NCT00474630|525700257|FG000|Overall Study|Lost to Follow-up|22|||
145779022|NCT00474630|525700258|FG001|Overall Study|Lost to Follow-up|15|||
145779023|NCT00474630|525700257|FG000|Overall Study|Withdrawal by Subject|21|||
145779024|NCT00474630|525700258|FG001|Overall Study|Withdrawal by Subject|15|||
145779025|NCT00474630|525700257|FG000|Overall Study|Protocol Violation|3|||
145779026|NCT00474630|525700258|FG001|Overall Study|Protocol Violation|4|||
145779027|NCT00474630|525700257|FG000|Overall Study|Lack of Efficacy|5|||
145779028|NCT00474630|525700258|FG001|Overall Study|Lack of Efficacy|6|||
145779029|NCT00474630|525700257|FG000|Overall Study|Drug noncompliance, other|11|||
145779030|NCT00474630|525700258|FG001|Overall Study|Drug noncompliance, other|4|||
145779031|NCT00915005|525700259|FG000|Overall Study|Withdrawal by Subject|4|||
145779032|NCT00915005|525700260|FG001|Overall Study|Withdrawal by Subject|4|||
145779033|NCT00915005|525700259|FG000|Overall Study|Patient preferred protons therapy|6|||
145779034|NCT00915005|525700260|FG001|Overall Study|Patient preferred protons therapy|0|||
145779035|NCT00915005|525700259|FG000|Overall Study|Insurance denial|3|||
145779036|NCT00915005|525700260|FG001|Overall Study|Insurance denial|15|||
145779037|NCT03069690|525700263|FG000|Pregnancy Intervention|Pregnancy loss|9|||
145779038|NCT03069690|525700264|FG001|Pregnancy Intervention|Pregnancy loss|4|||
145279172|NCT02454972|523872874|FG006|Overall Study|Withdrawal by Subject|0|||
145779039|NCT03069690|525700265|FG002|Pregnancy Intervention|Pregnancy loss|0|||
145779040|NCT03069690|525700266|FG003|Pregnancy Intervention|Pregnancy loss|0|||
145779041|NCT03069690|525700267|FG004|Pregnancy Intervention|Pregnancy loss|0|||
145779042|NCT03069690|525700268|FG005|Pregnancy Intervention|Pregnancy loss|0|||
145779043|NCT03069690|525700263|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
145779044|NCT03069690|525700264|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
145779045|NCT03069690|525700265|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
145279173|NCT02454972|523872875|FG007|Overall Study|Withdrawal by Subject|1|||
145279174|NCT02454972|523872876|FG008|Overall Study|Withdrawal by Subject|2|||
145779046|NCT03069690|525700266|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
145779047|NCT03069690|525700267|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
145779048|NCT03069690|525700268|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
145779049|NCT03069690|525700263|FG000|Postpartum Intervention|Lost to Follow-up|0|||
145779050|NCT03069690|525700264|FG001|Postpartum Intervention|Lost to Follow-up|0|||
145779051|NCT03069690|525700265|FG002|Postpartum Intervention|Lost to Follow-up|5|||
145779052|NCT03069690|525700266|FG003|Postpartum Intervention|Lost to Follow-up|5|||
145779053|NCT03069690|525700267|FG004|Postpartum Intervention|Lost to Follow-up|2|||
145779054|NCT03069690|525700268|FG005|Postpartum Intervention|Lost to Follow-up|4|||
145779055|NCT02564120|525700269|FG000|Overall Study|Did not return release forms|160|||
145779056|NCT02564120|525700269|FG000|Overall Study|Death|58|||
145779057|NCT02564120|525700269|FG000|Overall Study|Withdrawal by Subject|204|||
145779058|NCT02564120|525700269|FG000|Overall Study|Other medical condition|24|||
145779059|NCT01966731|525700272|FG000|Overall Study|Death|2|||
145779060|NCT01966731|525700272|FG000|Overall Study|Lost to Follow-up|1|||
145779061|NCT01966731|525700272|FG000|Overall Study|Physician Decision|2|||
145779062|NCT01966731|525700272|FG000|Overall Study|Follow up is not complete|600|||
145779063|NCT01966731|525700272|FG000|Overall Study|Screening Failure|29|||
145779064|NCT01966731|525700272|FG000|Overall Study|Found to be ineligible|1|||
145779065|NCT01380093|525700273|FG000|Naloxone Challenge Phase|Screen failures|21|||
145779066|NCT01380093|525700274|FG001|Naloxone Challenge Phase|Screen failures|0|||
145779067|NCT01380093|525700275|FG002|Naloxone Challenge Phase|Screen failures|0|||
145779068|NCT01380093|525700276|FG003|Naloxone Challenge Phase|Screen failures|0|||
145779069|NCT01380093|525700277|FG004|Naloxone Challenge Phase|Screen failures|0|||
145779070|NCT01380093|525700278|FG005|Naloxone Challenge Phase|Screen failures|0|||
145779071|NCT01380093|525700279|FG006|Naloxone Challenge Phase|Screen failures|0|||
145779072|NCT01380093|525700280|FG007|Naloxone Challenge Phase|Screen failures|0|||
145779073|NCT01380093|525700281|FG008|Naloxone Challenge Phase|Screen failures|0|||
145779074|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779075|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
145779076|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779077|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779078|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779079|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779080|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779081|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779082|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
145779083|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779084|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
145779085|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
145779086|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779087|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779088|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779089|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779090|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779091|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
145779092|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779093|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
145779094|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779095|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779096|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779097|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779098|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779099|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779100|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
145779101|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779102|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
145779103|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
145779104|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779105|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145536978|NCT02468674|524825683|FG004|Overall Study|Lost to Follow-up|0|||
145279175|NCT02454972|523872868|FG000|Overall Study|Multiple delay/holds on treatment|0|||
145279176|NCT02454972|523872869|FG001|Overall Study|Multiple delay/holds on treatment|0|||
145536979|NCT02468674|524825684|FG005|Overall Study|Lost to Follow-up|0|||
145279177|NCT02454972|523872870|FG002|Overall Study|Multiple delay/holds on treatment|0|||
145279178|NCT02454972|523872871|FG003|Overall Study|Multiple delay/holds on treatment|1|||
145536980|NCT02468674|524825685|FG006|Overall Study|Lost to Follow-up|0|||
145279179|NCT02454972|523872872|FG004|Overall Study|Multiple delay/holds on treatment|0|||
145536981|NCT02468674|524825686|FG007|Overall Study|Lost to Follow-up|1|||
145536982|NCT02468674|524825687|FG008|Overall Study|Lost to Follow-up|1|||
145536983|NCT02468674|524825679|FG000|Overall Study|Physician Decision|0|||
145536984|NCT02468674|524825680|FG001|Overall Study|Physician Decision|0|||
145779106|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779107|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779108|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779109|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
145779110|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779111|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
145779112|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
145779113|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779114|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779115|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779116|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779117|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779118|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
145779119|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779120|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779121|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
145779122|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779123|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779124|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779125|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779126|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779127|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
145779128|NCT01380093|525700273|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145536985|NCT02468674|524825681|FG002|Overall Study|Physician Decision|0|||
145536986|NCT02468674|524825682|FG003|Overall Study|Physician Decision|0|||
145536987|NCT02468674|524825683|FG004|Overall Study|Physician Decision|0|||
145536988|NCT02468674|524825684|FG005|Overall Study|Physician Decision|0|||
145536989|NCT02468674|524825685|FG006|Overall Study|Physician Decision|1|||
145536990|NCT02468674|524825686|FG007|Overall Study|Physician Decision|0|||
145536991|NCT02468674|524825687|FG008|Overall Study|Physician Decision|0|||
145536992|NCT02468674|524825679|FG000|Overall Study|Patient/Guardian Decision|0|||
145536993|NCT02468674|524825680|FG001|Overall Study|Patient/Guardian Decision|0|||
145536994|NCT02468674|524825681|FG002|Overall Study|Patient/Guardian Decision|0|||
145536995|NCT02468674|524825682|FG003|Overall Study|Patient/Guardian Decision|0|||
145536996|NCT02468674|524825683|FG004|Overall Study|Patient/Guardian Decision|1|||
145536997|NCT02468674|524825684|FG005|Overall Study|Patient/Guardian Decision|0|||
145536998|NCT02468674|524825685|FG006|Overall Study|Patient/Guardian Decision|0|||
145536999|NCT02468674|524825686|FG007|Overall Study|Patient/Guardian Decision|2|||
145537000|NCT02468674|524825687|FG008|Overall Study|Patient/Guardian Decision|1|||
145537001|NCT02468674|524825679|FG000|Overall Study|Protocol Deviation|0|||
145537002|NCT02468674|524825680|FG001|Overall Study|Protocol Deviation|0|||
145537003|NCT02468674|524825681|FG002|Overall Study|Protocol Deviation|0|||
145537004|NCT02468674|524825682|FG003|Overall Study|Protocol Deviation|0|||
145537005|NCT02468674|524825683|FG004|Overall Study|Protocol Deviation|0|||
145537006|NCT02468674|524825684|FG005|Overall Study|Protocol Deviation|0|||
145537007|NCT02468674|524825685|FG006|Overall Study|Protocol Deviation|0|||
145537008|NCT02468674|524825686|FG007|Overall Study|Protocol Deviation|1|||
145537009|NCT02468674|524825687|FG008|Overall Study|Protocol Deviation|1|||
145537010|NCT01550289|524825688|FG000|Overall Study|Protocol Violation|1|||
145537011|NCT01550289|524825689|FG001|Overall Study|Protocol Violation|0|||
145537012|NCT01550289|524825688|FG000|Overall Study|Lost to Follow-up|1|||
145537013|NCT01550289|524825689|FG001|Overall Study|Lost to Follow-up|1|||
145537014|NCT01550289|524825688|FG000|Overall Study|Withdrawal by Subject|11|||
145537015|NCT01550289|524825689|FG001|Overall Study|Withdrawal by Subject|3|||
145537016|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Adverse Event|16|||
145537017|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Adverse Event|17|||
145537018|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Adverse Event|13|||
145537019|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Adverse Event|18|||
145537020|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Adverse Event|0|||
145779129|NCT01380093|525700274|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779130|NCT01380093|525700275|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
145537021|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Adverse Event|0|||
145537022|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Adverse Event|0|||
145537023|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Adverse Event|0|||
145537024|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
145537025|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
145537026|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
145537027|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
145537028|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
145537029|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
145537030|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
145537031|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
145779131|NCT01380093|525700276|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779132|NCT01380093|525700277|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779133|NCT01380093|525700278|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779134|NCT01380093|525700279|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779135|NCT01380093|525700280|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779136|NCT01380093|525700281|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
145779137|NCT01380093|525700273|FG000|Treatment Phase: Second Intervention|Other|0|||
145779138|NCT01380093|525700274|FG001|Treatment Phase: Second Intervention|Other|0|||
145779139|NCT01380093|525700275|FG002|Treatment Phase: Second Intervention|Other|0|||
145779140|NCT01380093|525700276|FG003|Treatment Phase: Second Intervention|Other|1|||
145779141|NCT01380093|525700277|FG004|Treatment Phase: Second Intervention|Other|0|||
145779142|NCT01380093|525700278|FG005|Treatment Phase: Second Intervention|Other|0|||
145537032|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
145537033|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
145779143|NCT01380093|525700279|FG006|Treatment Phase: Second Intervention|Other|0|||
145537034|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
145537035|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
145779144|NCT01380093|525700280|FG007|Treatment Phase: Second Intervention|Other|0|||
145779145|NCT01380093|525700281|FG008|Treatment Phase: Second Intervention|Other|0|||
145779146|NCT01380093|525700273|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
145779147|NCT01380093|525700274|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
145779148|NCT01380093|525700275|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
145779149|NCT01380093|525700276|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
145779150|NCT01380093|525700277|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
145779151|NCT01380093|525700278|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
145779152|NCT01380093|525700279|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
145779153|NCT01380093|525700280|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
145779154|NCT01380093|525700281|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
145779155|NCT01380093|525700273|FG000|Treatment Phase: Third Intervention|Other|0|||
145779156|NCT01380093|525700274|FG001|Treatment Phase: Third Intervention|Other|0|||
145779157|NCT01380093|525700275|FG002|Treatment Phase: Third Intervention|Other|0|||
145779158|NCT01380093|525700276|FG003|Treatment Phase: Third Intervention|Other|0|||
145779159|NCT01380093|525700277|FG004|Treatment Phase: Third Intervention|Other|0|||
145779160|NCT01380093|525700278|FG005|Treatment Phase: Third Intervention|Other|0|||
145537036|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
145537037|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
145537038|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
145537039|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
145537040|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
145537041|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
145779161|NCT01380093|525700279|FG006|Treatment Phase: Third Intervention|Other|0|||
145403716|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145537042|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
145537043|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
145537044|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
145537045|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
145537046|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
145779162|NCT01380093|525700280|FG007|Treatment Phase: Third Intervention|Other|0|||
145537047|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
145537048|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
145779163|NCT01380093|525700281|FG008|Treatment Phase: Third Intervention|Other|1|||
145779164|NCT03952650|525700282|FG000|Overall Study|TRAVEL|0|||
145779165|NCT03952650|525700283|FG001|Overall Study|TRAVEL|4|||
145779166|NCT03952650|525700284|FG002|Overall Study|TRAVEL|0|||
145779167|NCT03952650|525700285|FG003|Overall Study|TRAVEL|4|||
145779168|NCT03952650|525700286|FG004|Overall Study|TRAVEL|0|||
145779169|NCT03952650|525700287|FG005|Overall Study|TRAVEL|3|||
145779170|NCT03952650|525700288|FG006|Overall Study|TRAVEL|2|||
145779171|NCT03952650|525700282|FG000|Overall Study|Withdrawal by Subject|0|||
145779172|NCT03952650|525700283|FG001|Overall Study|Withdrawal by Subject|2|||
145779173|NCT03952650|525700284|FG002|Overall Study|Withdrawal by Subject|0|||
145779174|NCT03952650|525700285|FG003|Overall Study|Withdrawal by Subject|3|||
145779175|NCT03952650|525700286|FG004|Overall Study|Withdrawal by Subject|0|||
145779176|NCT03952650|525700287|FG005|Overall Study|Withdrawal by Subject|1|||
145779177|NCT03952650|525700288|FG006|Overall Study|Withdrawal by Subject|1|||
145779178|NCT03952650|525700282|FG000|Overall Study|Lost to Follow-up|0|||
145779179|NCT03952650|525700283|FG001|Overall Study|Lost to Follow-up|1|||
145779180|NCT03952650|525700284|FG002|Overall Study|Lost to Follow-up|0|||
145779181|NCT03952650|525700285|FG003|Overall Study|Lost to Follow-up|0|||
145779182|NCT03952650|525700286|FG004|Overall Study|Lost to Follow-up|0|||
145779183|NCT03952650|525700287|FG005|Overall Study|Lost to Follow-up|1|||
145779184|NCT03952650|525700288|FG006|Overall Study|Lost to Follow-up|1|||
145779185|NCT03952650|525700282|FG000|Overall Study|Received wrong vaccine and travelled|0|||
145779186|NCT03952650|525700283|FG001|Overall Study|Received wrong vaccine and travelled|0|||
145779187|NCT03952650|525700284|FG002|Overall Study|Received wrong vaccine and travelled|0|||
145779188|NCT03952650|525700285|FG003|Overall Study|Received wrong vaccine and travelled|0|||
145779189|NCT03952650|525700286|FG004|Overall Study|Received wrong vaccine and travelled|0|||
145779190|NCT03952650|525700287|FG005|Overall Study|Received wrong vaccine and travelled|1|||
145779191|NCT03952650|525700288|FG006|Overall Study|Received wrong vaccine and travelled|0|||
145779192|NCT03952650|525700282|FG000|Overall Study|Unable to make study visit|0|||
145779193|NCT03952650|525700283|FG001|Overall Study|Unable to make study visit|0|||
145779194|NCT03952650|525700284|FG002|Overall Study|Unable to make study visit|0|||
145779195|NCT03952650|525700285|FG003|Overall Study|Unable to make study visit|0|||
145779196|NCT03952650|525700286|FG004|Overall Study|Unable to make study visit|0|||
145779197|NCT03952650|525700287|FG005|Overall Study|Unable to make study visit|1|||
145779198|NCT03952650|525700288|FG006|Overall Study|Unable to make study visit|0|||
145779199|NCT00592683|525700289|FG000|Overall Study|Found ineligible|0|||
145779200|NCT00592683|525700290|FG001|Overall Study|Found ineligible|1|||
145779201|NCT00592683|525700289|FG000|Overall Study|Withdrawal by Subject|1|||
145779202|NCT00592683|525700290|FG001|Overall Study|Withdrawal by Subject|0|||
145779203|NCT00592683|525700289|FG000|Overall Study|Adverse Event|0|||
145779204|NCT00592683|525700290|FG001|Overall Study|Adverse Event|2|||
145779205|NCT00592683|525700289|FG000|Overall Study|Protocol Violation|1|||
145779206|NCT00592683|525700290|FG001|Overall Study|Protocol Violation|0|||
145779207|NCT00592683|525700289|FG000|Overall Study|Study drug expired|1|||
145779208|NCT00592683|525700290|FG001|Overall Study|Study drug expired|0|||
145779209|NCT00592683|525700289|FG000|Overall Study|Other|1|||
145779210|NCT00592683|525700290|FG001|Overall Study|Other|0|||
145779211|NCT00592683|525700289|FG000|Overall Study|Lost to Follow-up|0|||
145779212|NCT00592683|525700290|FG001|Overall Study|Lost to Follow-up|1|||
145779213|NCT00201201|525700291|FG000|Overall Study|Death|0|||
145779214|NCT00201201|525700292|FG001|Overall Study|Death|2|||
145779215|NCT00201201|525700291|FG000|Overall Study|Withdrawal by Subject|5|||
145779216|NCT00201201|525700292|FG001|Overall Study|Withdrawal by Subject|5|||
145779217|NCT00545818|525700296|FG000|Overall Study|Protocol Violation|1|||
145779218|NCT00545818|525700297|FG001|Overall Study|Protocol Violation|0|||
145779219|NCT00545818|525700296|FG000|Overall Study|Adverse Event|1|||
145779220|NCT00545818|525700297|FG001|Overall Study|Adverse Event|1|||
145779221|NCT00545818|525700296|FG000|Overall Study|Lost to Follow-up|1|||
145779222|NCT00545818|525700297|FG001|Overall Study|Lost to Follow-up|6|||
145779223|NCT00609609|525700298|FG000|Overall Study|Withdrawal by Subject|2|||
145779224|NCT00609609|525700299|FG001|Overall Study|Withdrawal by Subject|0|||
145779225|NCT00609609|525700298|FG000|Overall Study|Progression|4|||
145779226|NCT00609609|525700299|FG001|Overall Study|Progression|2|||
145779227|NCT03988751|525700302|FG000|Overall Study|Withdrawal by Subject|1|||
145779228|NCT03988751|525700303|FG001|Overall Study|Withdrawal by Subject|0|||
145779229|NCT03988751|525700302|FG000|Overall Study|Protocol Violation|0|||
145779230|NCT03988751|525700303|FG001|Overall Study|Protocol Violation|1|||
145537049|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
145779231|NCT01753518|525700305|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
145779232|NCT01753518|525700306|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
145779233|NCT01753518|525700305|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
145779234|NCT01753518|525700306|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
145779235|NCT01753518|525700305|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
145779236|NCT01753518|525700306|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
145779237|NCT01753518|525700305|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
145779238|NCT01753518|525700306|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
145779239|NCT00940342|525700307|FG000|Overall Study|Adverse Event|0|||
145779240|NCT00940342|525700308|FG001|Overall Study|Adverse Event|2|||
145779241|NCT00940342|525700309|FG002|Overall Study|Adverse Event|1|||
145779242|NCT01088412|525700310|FG000|Overall Study|Adverse Event|38|||
145779243|NCT01088412|525700311|FG001|Overall Study|Adverse Event|0|||
145779244|NCT01088412|525700312|FG002|Overall Study|Adverse Event|0|||
145779245|NCT01088412|525700310|FG000|Overall Study|Death|42|||
145779246|NCT01088412|525700311|FG001|Overall Study|Death|6|||
145779247|NCT01088412|525700312|FG002|Overall Study|Death|0|||
145779248|NCT01088412|525700310|FG000|Overall Study|Other Reason per Case Report Form|2089|||
145779249|NCT01088412|525700311|FG001|Overall Study|Other Reason per Case Report Form|103|||
145779250|NCT01088412|525700312|FG002|Overall Study|Other Reason per Case Report Form|9|||
145779251|NCT01088412|525700310|FG000|Overall Study|Withdrawal by Subject|1761|||
145779252|NCT01088412|525700311|FG001|Overall Study|Withdrawal by Subject|25|||
145779253|NCT01088412|525700312|FG002|Overall Study|Withdrawal by Subject|1|||
145779254|NCT01088412|525700310|FG000|Overall Study|Received Another GH Product|79|||
145779255|NCT01088412|525700311|FG001|Overall Study|Received Another GH Product|0|||
145779256|NCT01088412|525700312|FG002|Overall Study|Received Another GH Product|0|||
145779257|NCT01088412|525700310|FG000|Overall Study|Participant Moved|601|||
145779258|NCT01088412|525700311|FG001|Overall Study|Participant Moved|21|||
145779259|NCT01088412|525700312|FG002|Overall Study|Participant Moved|2|||
145779260|NCT01088412|525700310|FG000|Overall Study|Physician Decision|1041|||
145779261|NCT01088412|525700311|FG001|Overall Study|Physician Decision|8|||
145779262|NCT01088412|525700312|FG002|Overall Study|Physician Decision|4|||
145779263|NCT01088412|525700310|FG000|Overall Study|Sponsor Decision|4467|||
145779264|NCT01088412|525700311|FG001|Overall Study|Sponsor Decision|79|||
145779265|NCT01088412|525700312|FG002|Overall Study|Sponsor Decision|23|||
145779266|NCT01088412|525700310|FG000|Overall Study|Third Party Required to Change Brand|487|||
145779267|NCT01088412|525700311|FG001|Overall Study|Third Party Required to Change Brand|0|||
145537050|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
145537051|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
145537052|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
145537053|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
145537054|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
145537055|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
145537056|NCT02975336|524825690|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
145537057|NCT02975336|524825691|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
145537058|NCT02975336|524825692|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
145537059|NCT02975336|524825693|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
145537060|NCT02975336|524825694|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
145537061|NCT02975336|524825695|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
145537062|NCT02975336|524825696|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
145537063|NCT02975336|524825697|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
145537064|NCT02975336|524825690|FG000|LTE (104 Weeks)|Adverse Event|0|||
145537065|NCT02975336|524825691|FG001|LTE (104 Weeks)|Adverse Event|0|||
145537066|NCT02975336|524825692|FG002|LTE (104 Weeks)|Adverse Event|0|||
145537067|NCT02975336|524825693|FG003|LTE (104 Weeks)|Adverse Event|0|||
145537068|NCT02975336|524825694|FG004|LTE (104 Weeks)|Adverse Event|7|||
145537069|NCT02975336|524825695|FG005|LTE (104 Weeks)|Adverse Event|4|||
145537070|NCT02975336|524825696|FG006|LTE (104 Weeks)|Adverse Event|2|||
145537071|NCT02975336|524825697|FG007|LTE (104 Weeks)|Adverse Event|0|||
145537072|NCT02975336|524825690|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
145537073|NCT02975336|524825691|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
145537074|NCT02975336|524825692|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
145537075|NCT02975336|524825693|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
145537076|NCT02975336|524825694|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
145537077|NCT02975336|524825695|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
145537078|NCT02975336|524825696|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
145537079|NCT02975336|524825697|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
145537080|NCT02975336|524825690|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
145779268|NCT01088412|525700312|FG002|Overall Study|Third Party Required to Change Brand|0|||
145779269|NCT01088412|525700310|FG000|Overall Study|Lost to Follow-up|3052|||
145779270|NCT01088412|525700311|FG001|Overall Study|Lost to Follow-up|130|||
145537081|NCT02975336|524825691|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
145537082|NCT02975336|524825692|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
145537083|NCT02975336|524825693|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
145537084|NCT02975336|524825694|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
145779271|NCT01088412|525700312|FG002|Overall Study|Lost to Follow-up|11|||
145779272|NCT01088412|525700310|FG000|Overall Study|Study Summary Not Completed|4360|||
145779273|NCT01088412|525700311|FG001|Overall Study|Study Summary Not Completed|64|||
145779274|NCT01088412|525700312|FG002|Overall Study|Study Summary Not Completed|22|||
145779275|NCT03494725|525700315|FG000|Overall Study|Withdrawal by Subject|0|||
145779276|NCT03494725|525700316|FG001|Overall Study|Withdrawal by Subject|2|||
145779277|NCT03494725|525700315|FG000|Overall Study|Antibiotic use|1|||
145779278|NCT03494725|525700316|FG001|Overall Study|Antibiotic use|0|||
145779279|NCT00206518|525700325|FG000|Overall Study|Lack of Efficacy|6|||
145779280|NCT00206518|525700326|FG001|Overall Study|Lack of Efficacy|4|||
145779281|NCT00206518|525700325|FG000|Overall Study|Adverse Event|2|||
145779282|NCT00206518|525700326|FG001|Overall Study|Adverse Event|1|||
145779283|NCT00206518|525700325|FG000|Overall Study|Physician Decision|1|||
145779284|NCT00206518|525700326|FG001|Overall Study|Physician Decision|0|||
145779285|NCT00206518|525700325|FG000|Overall Study|Protocol Violation|1|||
145779286|NCT00206518|525700326|FG001|Overall Study|Protocol Violation|1|||
145779287|NCT02335450|525700327|FG000|Overall Study|Pregnancy|1|||
145779288|NCT00853905|525700330|FG000|Overall Study|Lost to Follow-up|1|||
145779289|NCT00853905|525700331|FG001|Overall Study|Lost to Follow-up|3|||
145779290|NCT00853905|525700330|FG000|Overall Study|Withdrawal by Subject|0|||
145779291|NCT00853905|525700331|FG001|Overall Study|Withdrawal by Subject|1|||
145779292|NCT00853905|525700330|FG000|Overall Study|never had surgery|1|||
145779293|NCT00853905|525700331|FG001|Overall Study|never had surgery|0|||
145779294|NCT00408681|525700345|FG000|Overall Study|Lack of Efficacy|2|||
145779295|NCT00408681|525700345|FG000|Overall Study|Adverse Event|7|||
145779296|NCT00447421|525700346|FG000|Overall Study|Lack of Efficacy|1|||
145779297|NCT00447421|525700346|FG000|Overall Study|Adverse Event|3|||
145779298|NCT00447421|525700346|FG000|Overall Study|Sponsor Decision|2|||
145779299|NCT01787591|525700347|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
145779300|NCT01787591|525700348|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
145779301|NCT01787591|525700349|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
145779302|NCT01787591|525700350|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
145779303|NCT02725177|525700353|FG000|Overall Study|Physician Decision|4|||
145779304|NCT02725177|525700353|FG000|Overall Study|Adverse Event|1|||
145779305|NCT00638846|525700354|FG000|Overall Study|Adverse Event|0|||
145779306|NCT00638846|525700355|FG001|Overall Study|Adverse Event|1|||
145779307|NCT00638846|525700354|FG000|Overall Study|Lost to Follow-up|3|||
145779308|NCT00638846|525700355|FG001|Overall Study|Lost to Follow-up|2|||
145779309|NCT00638846|525700354|FG000|Overall Study|lens issue|1|||
145779310|NCT00638846|525700355|FG001|Overall Study|lens issue|3|||
145779311|NCT04799782|525700360|FG000|Washout|Physician Decision|2|||
145779312|NCT04799782|525700361|FG001|Washout|Physician Decision|0|||
145779313|NCT04799782|525700360|FG000|Washout|Withdrawal by Subject|0|||
145779314|NCT04799782|525700361|FG001|Washout|Withdrawal by Subject|2|||
145779315|NCT04799782|525700360|FG000|Washout|Lost to Follow-up|0|||
145779316|NCT04799782|525700361|FG001|Washout|Lost to Follow-up|1|||
145779317|NCT01589094|525700368|FG000|Overall Study|Did not receive treatment|2|||
145779318|NCT00969618|525700377|FG000|Overall Study|Adverse Event|29|||
145779319|NCT00969618|525700377|FG000|Overall Study|Entry Criteria Not Met|3|||
145779320|NCT00969618|525700377|FG000|Overall Study|Lack of Efficacy|2|||
145779321|NCT00969618|525700377|FG000|Overall Study|Lost to Follow-up|7|||
145779322|NCT00969618|525700377|FG000|Overall Study|Physician Decision|1|||
145779323|NCT00969618|525700377|FG000|Overall Study|Protocol Violation|9|||
145779324|NCT00969618|525700377|FG000|Overall Study|Withdrawal by Subject|27|||
145779325|NCT02531035|525701838|FG000|Overall Study|Death|0|||
145779326|NCT02531035|525701839|FG001|Overall Study|Death|1|||
145779327|NCT02531035|525701838|FG000|Overall Study|Protocol Violation|1|||
145779328|NCT02531035|525701839|FG001|Overall Study|Protocol Violation|1|||
145779329|NCT02531035|525701838|FG000|Overall Study|Noncompliance with study drug|8|||
145779330|NCT02531035|525701839|FG001|Overall Study|Noncompliance with study drug|3|||
145779331|NCT02531035|525701838|FG000|Overall Study|Physician Decision|1|||
145779332|NCT02531035|525701839|FG001|Overall Study|Physician Decision|0|||
145779333|NCT02531035|525701838|FG000|Overall Study|Adverse Event|16|||
145779334|NCT02531035|525701839|FG001|Overall Study|Adverse Event|45|||
145779335|NCT02531035|525701838|FG000|Overall Study|Other|3|||
145779336|NCT02531035|525701839|FG001|Overall Study|Other|2|||
145779337|NCT02531035|525701838|FG000|Overall Study|Withdrawal by Subject|42|||
145779338|NCT02531035|525701839|FG001|Overall Study|Withdrawal by Subject|32|||
145779339|NCT02531035|525701838|FG000|Overall Study|Lost to Follow-up|8|||
145779340|NCT02531035|525701839|FG001|Overall Study|Lost to Follow-up|10|||
145779341|NCT02531035|525701838|FG000|Overall Study|Randomized, not treated|2|||
145779342|NCT02531035|525701839|FG001|Overall Study|Randomized, not treated|1|||
145779343|NCT01543490|525701843|FG000|Overall Study|Adverse Event|4|||
145779344|NCT01543490|525701844|FG001|Overall Study|Adverse Event|0|||
145779345|NCT01543490|525701843|FG000|Overall Study|Physician Decision|1|||
145779346|NCT01543490|525701844|FG001|Overall Study|Physician Decision|0|||
145779347|NCT01543490|525701843|FG000|Overall Study|Lack of Efficacy|3|||
145779348|NCT01543490|525701844|FG001|Overall Study|Lack of Efficacy|3|||
145779349|NCT01543490|525701843|FG000|Overall Study|Lost to Follow-up|5|||
145779350|NCT01543490|525701844|FG001|Overall Study|Lost to Follow-up|0|||
145779351|NCT01543490|525701843|FG000|Overall Study|Withdrawal by Subject|2|||
145779352|NCT01543490|525701844|FG001|Overall Study|Withdrawal by Subject|0|||
145537085|NCT02975336|524825695|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
145779353|NCT01543490|525701843|FG000|Overall Study|Other-Various Administrative Reasons|1|||
145779354|NCT01543490|525701844|FG001|Overall Study|Other-Various Administrative Reasons|2|||
145779355|NCT04168645|525701849|FG000|Overall Study|Lost to Follow-up|23|||
145779356|NCT04168645|525701850|FG001|Overall Study|Lost to Follow-up|28|||
145779357|NCT04168645|525701851|FG002|Overall Study|Lost to Follow-up|15|||
145779358|NCT04168645|525701852|FG003|Overall Study|Lost to Follow-up|12|||
145779359|NCT04168645|525701849|FG000|Overall Study|Death|1|||
145779360|NCT04168645|525701850|FG001|Overall Study|Death|1|||
145779361|NCT04168645|525701851|FG002|Overall Study|Death|0|||
145779362|NCT04168645|525701852|FG003|Overall Study|Death|0|||
145779363|NCT04168645|525701849|FG000|Overall Study|Withdrawal by Subject|5|||
145779364|NCT04168645|525701850|FG001|Overall Study|Withdrawal by Subject|2|||
145779365|NCT04168645|525701851|FG002|Overall Study|Withdrawal by Subject|2|||
145779366|NCT04168645|525701852|FG003|Overall Study|Withdrawal by Subject|2|||
145779367|NCT04168645|525701849|FG000|Overall Study|Administrative Withdrawal|3|||
145779368|NCT04168645|525701850|FG001|Overall Study|Administrative Withdrawal|1|||
145779369|NCT04168645|525701851|FG002|Overall Study|Administrative Withdrawal|1|||
145779370|NCT04168645|525701852|FG003|Overall Study|Administrative Withdrawal|3|||
145779371|NCT02400346|525701853|FG000|Overall Study|Adverse Event|24|||
145779372|NCT02400346|525701853|FG000|Overall Study|Lack of Efficacy|9|||
145779373|NCT02400346|525701853|FG000|Overall Study|Non-compliance with IMP|1|||
145779374|NCT02400346|525701853|FG000|Overall Study|Withdrawal by Subject|7|||
145779375|NCT02400346|525701853|FG000|Overall Study|Administrative or other reason(s)|2|||
145779376|NCT02400346|525701853|FG000|Overall Study|Lost to Follow-up|1|||
145779377|NCT00500149|525701854|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
145779378|NCT00500149|525701855|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
145779379|NCT00500149|525701854|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
145779380|NCT00500149|525701855|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
145779381|NCT00500149|525701854|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
145779382|NCT00500149|525701855|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
145779383|NCT00500149|525701854|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
145779384|NCT00500149|525701855|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
145779385|NCT00500149|525701854|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
145779386|NCT00500149|525701855|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
145779387|NCT00500149|525701854|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
145779388|NCT00500149|525701855|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
145779389|NCT00500149|525701854|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
145779390|NCT00500149|525701855|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
145779391|NCT01058369|525701856|FG000|Overall Study|Adverse Event|1|||
145779392|NCT01058369|525701856|FG000|Overall Study|Early termination study|1|||
145779393|NCT00089843|525701857|FG000|Overall Study|Withdrawal by Subject|1|||
145779394|NCT00089843|525701858|FG001|Overall Study|Withdrawal by Subject|4|||
145779395|NCT00089843|525701859|FG002|Overall Study|Withdrawal by Subject|5|||
145779396|NCT00089843|525701860|FG003|Overall Study|Withdrawal by Subject|6|||
145779397|NCT00089843|525701857|FG000|Overall Study|Physician Decision|1|||
145779398|NCT00089843|525701858|FG001|Overall Study|Physician Decision|0|||
145779399|NCT00089843|525701859|FG002|Overall Study|Physician Decision|0|||
145779400|NCT00089843|525701860|FG003|Overall Study|Physician Decision|1|||
145779401|NCT01157169|525701861|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
145779402|NCT01157169|525701862|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
145779403|NCT01157169|525701861|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
145779404|NCT01157169|525701862|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
145779405|NCT00663858|525701863|FG000|Overall Study|Adverse Event|9|||
145779406|NCT00663858|525701864|FG001|Overall Study|Adverse Event|1|||
145779407|NCT00663858|525701865|FG002|Overall Study|Adverse Event|6|||
145779408|NCT00663858|525701863|FG000|Overall Study|Lack of Efficacy|5|||
145779409|NCT00663858|525701864|FG001|Overall Study|Lack of Efficacy|1|||
145779410|NCT00663858|525701865|FG002|Overall Study|Lack of Efficacy|3|||
145779411|NCT00663858|525701863|FG000|Overall Study|Withdrawal by Subject|7|||
145779412|NCT00663858|525701864|FG001|Overall Study|Withdrawal by Subject|3|||
145779413|NCT00663858|525701865|FG002|Overall Study|Withdrawal by Subject|3|||
145779414|NCT00663858|525701863|FG000|Overall Study|Protocol Violation|5|||
145779415|NCT00663858|525701864|FG001|Overall Study|Protocol Violation|3|||
145779416|NCT00663858|525701865|FG002|Overall Study|Protocol Violation|4|||
145779417|NCT00663858|525701863|FG000|Overall Study|Other|8|||
145779418|NCT00663858|525701864|FG001|Overall Study|Other|2|||
145537086|NCT02975336|524825696|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
145537087|NCT02975336|524825697|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
145537088|NCT02975336|524825690|FG000|LTE (104 Weeks)|Other|0|||
145537089|NCT02975336|524825691|FG001|LTE (104 Weeks)|Other|0|||
145537090|NCT02975336|524825692|FG002|LTE (104 Weeks)|Other|0|||
145537091|NCT02975336|524825693|FG003|LTE (104 Weeks)|Other|0|||
145537092|NCT02975336|524825694|FG004|LTE (104 Weeks)|Other|55|||
145779419|NCT00663858|525701865|FG002|Overall Study|Other|4|||
145779420|NCT01277289|525701869|FG000|Overall Study|fragile vein|1|||
145779421|NCT01277289|525701870|FG001|Overall Study|fragile vein|0|||
145779422|NCT01277289|525701869|FG000|Overall Study|Physician Decision|1|||
145537093|NCT02975336|524825695|FG005|LTE (104 Weeks)|Other|63|||
145779423|NCT01277289|525701870|FG001|Overall Study|Physician Decision|0|||
145779424|NCT01277289|525701869|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
145779425|NCT01277289|525701870|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
145779426|NCT01277289|525701869|FG000|Overall Study|Protocol Violation|1|||
145779427|NCT01277289|525701870|FG001|Overall Study|Protocol Violation|1|||
145779428|NCT01277289|525701869|FG000|Overall Study|Adverse Event|2|||
145779429|NCT01277289|525701870|FG001|Overall Study|Adverse Event|1|||
145779430|NCT01277289|525701869|FG000|Overall Study|consent withdrawn|1|||
145779431|NCT01277289|525701870|FG001|Overall Study|consent withdrawn|1|||
145779432|NCT01277289|525701869|FG000|Overall Study|premature closure of the study|4|||
145779433|NCT01277289|525701870|FG001|Overall Study|premature closure of the study|2|||
145779434|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
145779435|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
145779436|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
145779437|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
145779438|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
145779439|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
145779440|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
145779441|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
145779442|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
145779443|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
145779444|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
145779445|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
145779446|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
145779447|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
145779448|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
145779449|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
145779450|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
145779451|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
145779452|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
145779453|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
145779454|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
145779455|NCT00092547|525701871|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
145779456|NCT00092547|525701872|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
145779457|NCT00092547|525701873|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
145779458|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
145779459|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
145779460|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
145779461|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
145779462|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
145779463|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
145779464|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
145779465|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
145779466|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
145779467|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
145779468|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
145779469|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
145779470|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
145779471|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
145779472|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
145779473|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
145779474|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
145779475|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
145779476|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
145279180|NCT02454972|523872873|FG005|Overall Study|Multiple delay/holds on treatment|0|||
145279181|NCT02454972|523872874|FG006|Overall Study|Multiple delay/holds on treatment|0|||
145279182|NCT02454972|523872875|FG007|Overall Study|Multiple delay/holds on treatment|0|||
145279183|NCT02454972|523872876|FG008|Overall Study|Multiple delay/holds on treatment|0|||
145279184|NCT02454972|523872868|FG000|Overall Study|Never treated|0|||
145279185|NCT02454972|523872869|FG001|Overall Study|Never treated|0|||
145279186|NCT02454972|523872870|FG002|Overall Study|Never treated|3|||
145279187|NCT02454972|523872871|FG003|Overall Study|Never treated|1|||
145779477|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
145779478|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
145779479|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
145779480|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
145279188|NCT02454972|523872872|FG004|Overall Study|Never treated|1|||
145608981|NCT01672853|525083264|FG001|Overall Study|Randomized but Never Treated|0|||
145279189|NCT02454972|523872873|FG005|Overall Study|Never treated|0|||
145779481|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
145779482|NCT00092547|525701871|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
145779483|NCT00092547|525701872|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
145779484|NCT00092547|525701873|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
145779485|NCT00092547|525701871|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
145779486|NCT00092547|525701872|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
145779487|NCT00092547|525701873|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
145779488|NCT00092547|525701871|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
145779489|NCT00092547|525701872|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
145779490|NCT00092547|525701873|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
145279190|NCT02454972|523872874|FG006|Overall Study|Never treated|0|||
145279191|NCT02454972|523872875|FG007|Overall Study|Never treated|0|||
145779491|NCT00092547|525701871|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
145779492|NCT00092547|525701872|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
145779493|NCT00092547|525701873|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
145779494|NCT00092547|525701871|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
145779495|NCT00092547|525701872|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
145779496|NCT00092547|525701873|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
145779497|NCT01371838|525701875|FG000|Overall Study|Withdrawal by Subject|27|||
145779498|NCT01371838|525701876|FG001|Overall Study|Withdrawal by Subject|33|||
145779499|NCT01371838|525701875|FG000|Overall Study|Lost to Follow-up|10|||
145779500|NCT01371838|525701876|FG001|Overall Study|Lost to Follow-up|20|||
145779501|NCT01371838|525701875|FG000|Overall Study|Death|3|||
145779502|NCT01371838|525701876|FG001|Overall Study|Death|4|||
145779503|NCT01371838|525701875|FG000|Overall Study|Protocol Violation|3|||
145779504|NCT01371838|525701876|FG001|Overall Study|Protocol Violation|0|||
145779505|NCT01371838|525701875|FG000|Overall Study|Investigator Decision|3|||
145779506|NCT01371838|525701876|FG001|Overall Study|Investigator Decision|8|||
145779507|NCT01371838|525701875|FG000|Overall Study|Last follow-up visit not conducted|2|||
145779508|NCT01371838|525701876|FG001|Overall Study|Last follow-up visit not conducted|0|||
145779509|NCT01371838|525701875|FG000|Overall Study|Lack of therapeutic response|0|||
145779510|NCT01371838|525701876|FG001|Overall Study|Lack of therapeutic response|1|||
145779511|NCT01371838|525701875|FG000|Overall Study|Surgery|1|||
145779512|NCT01371838|525701876|FG001|Overall Study|Surgery|0|||
145779513|NCT00641043|525701881|FG000|Overall Study|Adverse Event|6|||
145779514|NCT00641043|525701882|FG001|Overall Study|Adverse Event|4|||
145779515|NCT00641043|525701881|FG000|Overall Study|Protocol Violation|2|||
145779516|NCT00641043|525701882|FG001|Overall Study|Protocol Violation|3|||
145779517|NCT00641043|525701881|FG000|Overall Study|Lost to Follow-up|3|||
145779518|NCT00641043|525701882|FG001|Overall Study|Lost to Follow-up|2|||
145779519|NCT00641043|525701881|FG000|Overall Study|Withdrawal by Subject|4|||
145779520|NCT00641043|525701882|FG001|Overall Study|Withdrawal by Subject|4|||
145779521|NCT00641043|525701881|FG000|Overall Study|Other incl. lack of efficacy|4|||
145779522|NCT00641043|525701882|FG001|Overall Study|Other incl. lack of efficacy|2|||
145779523|NCT03088605|525701883|FG000|Overall Study|Withdrawal by Subject|1|||
145779524|NCT03088605|525701884|FG001|Overall Study|Withdrawal by Subject|0|||
145779525|NCT02225223|525701885|FG000|Overall Study|Death|10|||
145779526|NCT02225223|525701886|FG001|Overall Study|Death|1|||
145779527|NCT02225223|525701885|FG000|Overall Study|Lost to Follow-up|5|||
145779528|NCT02225223|525701886|FG001|Overall Study|Lost to Follow-up|0|||
145779529|NCT02225223|525701885|FG000|Overall Study|Other|1|||
145779530|NCT02225223|525701886|FG001|Overall Study|Other|2|||
145779531|NCT02225223|525701885|FG000|Overall Study|Physician Decision|1|||
145779532|NCT02225223|525701886|FG001|Overall Study|Physician Decision|0|||
145779533|NCT02225223|525701885|FG000|Overall Study|Withdrawal by Subject|2|||
145779534|NCT02225223|525701886|FG001|Overall Study|Withdrawal by Subject|2|||
145779535|NCT03567291|525701888|FG000|Period I|Adverse Event|14|||
145779536|NCT03567291|525701889|FG001|Period I|Adverse Event|0|||
145779537|NCT03567291|525701890|FG002|Period I|Adverse Event|0|||
145779538|NCT03567291|525701891|FG003|Period I|Adverse Event|0|||
145779539|NCT03567291|525701888|FG000|Period I|Protocol Violation|1|||
145779540|NCT03567291|525701889|FG001|Period I|Protocol Violation|0|||
145779541|NCT03567291|525701890|FG002|Period I|Protocol Violation|0|||
145779542|NCT03567291|525701891|FG003|Period I|Protocol Violation|0|||
145779543|NCT03567291|525701888|FG000|Period I|Withdrawal by Subject|23|||
145779544|NCT03567291|525701889|FG001|Period I|Withdrawal by Subject|0|||
145779545|NCT03567291|525701890|FG002|Period I|Withdrawal by Subject|0|||
145779546|NCT03567291|525701891|FG003|Period I|Withdrawal by Subject|0|||
145779547|NCT03567291|525701888|FG000|Period I|Lost to Follow-up|2|||
145779548|NCT03567291|525701889|FG001|Period I|Lost to Follow-up|0|||
145779549|NCT03567291|525701890|FG002|Period I|Lost to Follow-up|0|||
145779550|NCT03567291|525701891|FG003|Period I|Lost to Follow-up|0|||
145779551|NCT03567291|525701888|FG000|Period I|Terminated by sponsor|44|||
145779552|NCT03567291|525701889|FG001|Period I|Terminated by sponsor|0|||
145779553|NCT03567291|525701890|FG002|Period I|Terminated by sponsor|0|||
145779554|NCT03567291|525701891|FG003|Period I|Terminated by sponsor|0|||
145779555|NCT03567291|525701888|FG000|Period I|Missing or unknown|7|||
145779556|NCT03567291|525701889|FG001|Period I|Missing or unknown|0|||
145779557|NCT03567291|525701890|FG002|Period I|Missing or unknown|0|||
145779558|NCT03567291|525701891|FG003|Period I|Missing or unknown|0|||
145537094|NCT02975336|524825696|FG006|LTE (104 Weeks)|Other|76|||
145537095|NCT02975336|524825697|FG007|LTE (104 Weeks)|Other|72|||
145537096|NCT05154578|524825699|FG000|Overall Study|Withdrawal by Subject|2|||
145537097|NCT05154578|524825700|FG001|Overall Study|Withdrawal by Subject|3|||
145779559|NCT03567291|525701888|FG000|Period II|Adverse Event|0|||
145779560|NCT03567291|525701889|FG001|Period II|Adverse Event|1|||
145779561|NCT03567291|525701890|FG002|Period II|Adverse Event|0|||
145779562|NCT03567291|525701891|FG003|Period II|Adverse Event|0|||
145779563|NCT03567291|525701888|FG000|Period II|Missing or unknown|0|||
145779564|NCT03567291|525701889|FG001|Period II|Missing or unknown|2|||
145779565|NCT03567291|525701890|FG002|Period II|Missing or unknown|1|||
145779566|NCT03567291|525701891|FG003|Period II|Missing or unknown|0|||
145779567|NCT03567291|525701888|FG000|Period III|Adverse Event|0|||
145779568|NCT03567291|525701889|FG001|Period III|Adverse Event|0|||
145779569|NCT03567291|525701890|FG002|Period III|Adverse Event|0|||
145779570|NCT03567291|525701891|FG003|Period III|Adverse Event|4|||
145779571|NCT03567291|525701888|FG000|Period III|Withdrawal by Subject|0|||
145779572|NCT03567291|525701889|FG001|Period III|Withdrawal by Subject|0|||
145779573|NCT03567291|525701890|FG002|Period III|Withdrawal by Subject|0|||
145779574|NCT03567291|525701891|FG003|Period III|Withdrawal by Subject|4|||
145779575|NCT03567291|525701888|FG000|Period III|Lost to Follow-up|0|||
145779576|NCT03567291|525701889|FG001|Period III|Lost to Follow-up|0|||
145779577|NCT03567291|525701890|FG002|Period III|Lost to Follow-up|0|||
145779578|NCT03567291|525701891|FG003|Period III|Lost to Follow-up|1|||
145779579|NCT03567291|525701888|FG000|Period III|Terminated by sponsor|0|||
145779580|NCT03567291|525701889|FG001|Period III|Terminated by sponsor|0|||
145779581|NCT03567291|525701890|FG002|Period III|Terminated by sponsor|0|||
145779582|NCT03567291|525701891|FG003|Period III|Terminated by sponsor|68|||
145779583|NCT03567291|525701888|FG000|Period III|Missing or unknown|0|||
145779584|NCT03567291|525701889|FG001|Period III|Missing or unknown|0|||
145779585|NCT03567291|525701890|FG002|Period III|Missing or unknown|0|||
145779586|NCT03567291|525701891|FG003|Period III|Missing or unknown|8|||
145779587|NCT01103349|525701892|FG000|Overall Study|Adverse Event|8|||
145779588|NCT01103349|525701893|FG001|Overall Study|Adverse Event|5|||
145779589|NCT01103349|525701894|FG002|Overall Study|Adverse Event|3|||
145779590|NCT01103349|525701892|FG000|Overall Study|Consent withdrawn|1|||
145779591|NCT01103349|525701893|FG001|Overall Study|Consent withdrawn|0|||
145779592|NCT01103349|525701894|FG002|Overall Study|Consent withdrawn|0|||
145779593|NCT01103349|525701892|FG000|Overall Study|Incorrectly included in the trial|1|||
145779594|NCT01103349|525701893|FG001|Overall Study|Incorrectly included in the trial|0|||
145779595|NCT01103349|525701894|FG002|Overall Study|Incorrectly included in the trial|0|||
145779596|NCT01103349|525701892|FG000|Overall Study|Withdrawal by Subject|1|||
145779597|NCT01103349|525701893|FG001|Overall Study|Withdrawal by Subject|1|||
145779598|NCT01103349|525701894|FG002|Overall Study|Withdrawal by Subject|0|||
145779599|NCT01103349|525701892|FG000|Overall Study|did not want to take trial medication|0|||
145779600|NCT01103349|525701893|FG001|Overall Study|did not want to take trial medication|1|||
145779601|NCT01103349|525701894|FG002|Overall Study|did not want to take trial medication|0|||
145779602|NCT01103349|525701892|FG000|Overall Study|forgot to take medication|0|||
145779603|NCT01103349|525701893|FG001|Overall Study|forgot to take medication|0|||
145779604|NCT01103349|525701894|FG002|Overall Study|forgot to take medication|1|||
145779605|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
145779606|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
145779607|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
145779608|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
145779609|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
145779610|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
145537098|NCT05154578|524825701|FG002|Overall Study|Withdrawal by Subject|2|||
145537099|NCT05154578|524825702|FG003|Overall Study|Withdrawal by Subject|4|||
145779611|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
145779612|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
145779613|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
145779614|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
145779615|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
145779616|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
145779617|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
145779618|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
145779619|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
145779620|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
145779621|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
145779622|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
145779623|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
145779624|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
145779625|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
145779626|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
145779627|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
145779628|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
145779629|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
145779630|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
145779631|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
145779632|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
145779633|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
145779634|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
145779635|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
145779636|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
145779637|NCT00958568|525701896|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
145779638|NCT00958568|525701897|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
145779639|NCT00958568|525701898|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
145779640|NCT00958568|525701899|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
145779641|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
145779642|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
145779643|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
145779644|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
145779645|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
145779646|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
145779647|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
145779648|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
145537100|NCT05154578|524825703|FG004|Overall Study|Withdrawal by Subject|0|||
145779649|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
145779650|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
145779651|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
145779652|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
145779653|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
145779654|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
145779655|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
145779656|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
145779657|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
145537101|NCT05154578|524825699|FG000|Overall Study|Lost to Follow-up|0|||
145537102|NCT05154578|524825700|FG001|Overall Study|Lost to Follow-up|1|||
145537103|NCT05154578|524825701|FG002|Overall Study|Lost to Follow-up|0|||
145537104|NCT05154578|524825702|FG003|Overall Study|Lost to Follow-up|3|||
145537105|NCT05154578|524825703|FG004|Overall Study|Lost to Follow-up|0|||
145537106|NCT05154578|524825699|FG000|Overall Study|Adverse Event|0|||
145537107|NCT05154578|524825700|FG001|Overall Study|Adverse Event|0|||
145537108|NCT05154578|524825701|FG002|Overall Study|Adverse Event|0|||
145537109|NCT05154578|524825702|FG003|Overall Study|Adverse Event|1|||
145537110|NCT05154578|524825703|FG004|Overall Study|Adverse Event|0|||
145537111|NCT05154578|524825699|FG000|Overall Study|Relocated to another province|0|||
145537112|NCT05154578|524825700|FG001|Overall Study|Relocated to another province|0|||
145537113|NCT05154578|524825701|FG002|Overall Study|Relocated to another province|1|||
145537114|NCT05154578|524825702|FG003|Overall Study|Relocated to another province|0|||
145537115|NCT05154578|524825703|FG004|Overall Study|Relocated to another province|1|||
145537116|NCT05154578|524825699|FG000|Overall Study|Baby loss|0|||
145779658|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
145779659|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
145537117|NCT05154578|524825700|FG001|Overall Study|Baby loss|1|||
145537118|NCT05154578|524825701|FG002|Overall Study|Baby loss|0|||
145537119|NCT05154578|524825702|FG003|Overall Study|Baby loss|0|||
145537120|NCT05154578|524825703|FG004|Overall Study|Baby loss|0|||
145537121|NCT04289623|524825704|FG000|Wave 1 Emails|Email was not delivered|268|||
145537122|NCT04289623|524825705|FG001|Wave 1 Emails|Email was not delivered|257|||
145537123|NCT04289623|524825706|FG002|Wave 1 Emails|Email was not delivered|0|||
145537124|NCT04289623|524825707|FG003|Wave 1 Emails|Email was not delivered|0|||
145537125|NCT04289623|524825708|FG004|Wave 1 Emails|Email was not delivered|0|||
145537126|NCT04289623|524825709|FG005|Wave 1 Emails|Email was not delivered|0|||
145537127|NCT04515394|524825714|FG000|Overall Study|Participant did not receive treatment|1|||
145779660|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
145779661|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
145537128|NCT00413244|524825715|FG000|Overall Study|Withdrawal by Subject|10|||
145537129|NCT00413244|524825716|FG001|Overall Study|Withdrawal by Subject|1|||
145537130|NCT01609231|524825717|FG000|Overall Study|Adverse Event|1|||
145537131|NCT01609231|524825718|FG001|Overall Study|Adverse Event|3|||
145537132|NCT01609231|524825717|FG000|Overall Study|Physician Decision|1|||
145537133|NCT01609231|524825718|FG001|Overall Study|Physician Decision|0|||
145537134|NCT01609231|524825717|FG000|Overall Study|Withdrawal by Subject|1|||
145537135|NCT01609231|524825718|FG001|Overall Study|Withdrawal by Subject|0|||
145537136|NCT02761733|524825720|FG000|Overall Study|Death|3|||
145537137|NCT02761733|524825721|FG001|Overall Study|Death|5|||
145779662|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
145779663|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
145779664|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
145779665|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
145779666|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
145779667|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
145779668|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
145779669|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
145779670|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
145779671|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
145779672|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
145779673|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
145779674|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
145779675|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
145779676|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
145779677|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
145779678|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
145779679|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
145779680|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
145779681|NCT00958568|525701896|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
145779682|NCT00958568|525701897|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
145779683|NCT00958568|525701898|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
145779684|NCT00958568|525701899|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
145779685|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
145779686|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
145608982|NCT01672853|525083265|FG002|Overall Study|Randomized but Never Treated|1|||
145608983|NCT02969525|525083268|FG000|Double-Blind Period|Adverse Event|0|||
145608984|NCT02969525|525083269|FG001|Double-Blind Period|Adverse Event|0|||
145779687|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
145779688|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
145779689|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
145608985|NCT02969525|525083270|FG002|Double-Blind Period|Adverse Event|1|||
145608986|NCT02969525|525083271|FG003|Double-Blind Period|Adverse Event|1|||
145779690|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
145779691|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
145779692|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
145779693|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
145779694|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
145779695|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
145779696|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
145779697|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
145779698|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
145779699|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
145537138|NCT02761733|524825722|FG002|Overall Study|Death|1|||
145537139|NCT02761733|524825723|FG003|Overall Study|Death|1|||
145279192|NCT02454972|523872876|FG008|Overall Study|Never treated|5|||
145537140|NCT02761733|524825720|FG000|Overall Study|Lost to Follow-up|6|||
145537141|NCT02761733|524825721|FG001|Overall Study|Lost to Follow-up|7|||
145537142|NCT02761733|524825722|FG002|Overall Study|Lost to Follow-up|0|||
145608987|NCT02969525|525083272|FG004|Double-Blind Period|Adverse Event|0|||
145608988|NCT02969525|525083273|FG005|Double-Blind Period|Adverse Event|0|||
145779700|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
145537143|NCT02761733|524825723|FG003|Overall Study|Lost to Follow-up|3|||
145779701|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
145779702|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
145779703|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
145779704|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
145779705|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
145779706|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
145779707|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
145779708|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
145779709|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
145779710|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
145779711|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
145779712|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
145779713|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
145779714|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
145779715|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
145779716|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
145779717|NCT00958568|525701896|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
145779718|NCT00958568|525701897|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
145779719|NCT00958568|525701898|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
145779720|NCT00958568|525701899|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
145779721|NCT00283712|525701900|FG000|Overall Study|Death|0|||
145779722|NCT00283712|525701901|FG001|Overall Study|Death|1|||
145779723|NCT02747043|525701908|FG000|Overall Study|Other|1|||
145779724|NCT02747043|525701909|FG001|Overall Study|Other|1|||
145537144|NCT02761733|524825720|FG000|Overall Study|Physician Decision|4|||
145537145|NCT02761733|524825721|FG001|Overall Study|Physician Decision|0|||
145537146|NCT02761733|524825722|FG002|Overall Study|Physician Decision|0|||
145779725|NCT02747043|525701908|FG000|Overall Study|Adverse Event|3|||
145779726|NCT02747043|525701909|FG001|Overall Study|Adverse Event|1|||
145779727|NCT02747043|525701908|FG000|Overall Study|Withdrawal by Subject|1|||
145779728|NCT02747043|525701909|FG001|Overall Study|Withdrawal by Subject|1|||
145779729|NCT02747043|525701908|FG000|Overall Study|Physician Decision|1|||
145779730|NCT02747043|525701909|FG001|Overall Study|Physician Decision|1|||
145779731|NCT02747043|525701908|FG000|Overall Study|Protocol Violation|0|||
145779732|NCT02747043|525701909|FG001|Overall Study|Protocol Violation|1|||
145779733|NCT02747043|525701908|FG000|Overall Study|Disease progression|4|||
145779734|NCT02747043|525701909|FG001|Overall Study|Disease progression|0|||
145779735|NCT00553059|525701914|FG000|Overall Study|Deemed ineligible|1|||
145779736|NCT00553059|525701915|FG001|Overall Study|Deemed ineligible|1|||
145779737|NCT00553059|525701914|FG000|Overall Study|Drug supply not available|0|||
145779738|NCT00553059|525701915|FG001|Overall Study|Drug supply not available|1|||
145779739|NCT00891657|525701919|FG000|Overall Study|Withdrawal by Subject|1|||
145779740|NCT00891657|525701920|FG001|Overall Study|Withdrawal by Subject|1|||
145779741|NCT00909090|525701921|FG000|Overall Study|Lost to Follow-up|17|||
145779742|NCT00909090|525701922|FG001|Overall Study|Lost to Follow-up|17|||
145779743|NCT01749735|525701924|FG000|Overall Study|Withdrawal by Subject|1|||
145779744|NCT01749735|525701925|FG001|Overall Study|Withdrawal by Subject|0|||
145779745|NCT02926573|525701926|FG000|Overall Study|Nausea|1|||
145779746|NCT02926573|525701927|FG001|Overall Study|Nausea|0|||
145779747|NCT02926573|525701926|FG000|Overall Study|Remain intubated|2|||
145779748|NCT02926573|525701927|FG001|Overall Study|Remain intubated|2|||
145779749|NCT02926573|525701926|FG000|Overall Study|Change in surgery plan|3|||
145779750|NCT02926573|525701927|FG001|Overall Study|Change in surgery plan|1|||
145779751|NCT02926573|525701926|FG000|Overall Study|Change to outpatient status|5|||
145279193|NCT02454972|523872868|FG000|Overall Study|Lost to Follow-up|0|||
145279194|NCT02454972|523872869|FG001|Overall Study|Lost to Follow-up|0|||
145537147|NCT02761733|524825723|FG003|Overall Study|Physician Decision|0|||
145537148|NCT02761733|524825720|FG000|Overall Study|Withdrawal by Subject|2|||
145537149|NCT02761733|524825721|FG001|Overall Study|Withdrawal by Subject|0|||
145779752|NCT02926573|525701927|FG001|Overall Study|Change to outpatient status|1|||
145779753|NCT02926573|525701926|FG000|Overall Study|Withdrawal by Subject|0|||
145779754|NCT02926573|525701927|FG001|Overall Study|Withdrawal by Subject|2|||
145779755|NCT02926573|525701926|FG000|Overall Study|Return to operating room|0|||
145779756|NCT02926573|525701927|FG001|Overall Study|Return to operating room|2|||
145779757|NCT02926573|525701926|FG000|Overall Study|Delirium|0|||
145779758|NCT02926573|525701927|FG001|Overall Study|Delirium|1|||
145779759|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
145779760|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
145779761|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145779762|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
145779763|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145279195|NCT02454972|523872870|FG002|Overall Study|Lost to Follow-up|0|||
145779764|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145779765|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
145779766|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
145779767|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145779768|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
145779769|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145779770|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145779771|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
145779772|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
145779773|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
145779774|NCT00611455|525701930|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
145779775|NCT00611455|525701931|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
145779776|NCT00611455|525701932|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
145779777|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
145779778|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
145779779|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
145779780|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
145779781|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
145779782|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
145779783|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
145779784|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
145779785|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
145779786|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
145779787|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
145779788|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
145779789|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
145779790|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
145779791|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
145779792|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
145779793|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
145779794|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
145779795|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
145779796|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
145779797|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
145779798|NCT00611455|525701930|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
145779799|NCT00611455|525701931|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
145779800|NCT00611455|525701932|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
145779801|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
145779802|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
145779803|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
145779804|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
145779805|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
145779806|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
145779807|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
145779808|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
145779809|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
145779810|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
145779811|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
145779812|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
145779813|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
145779814|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
145779815|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
145779816|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
145779817|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
145779818|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
145779819|NCT00611455|525701930|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
145779820|NCT00611455|525701931|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
145537150|NCT02761733|524825722|FG002|Overall Study|Withdrawal by Subject|0|||
145537151|NCT02761733|524825723|FG003|Overall Study|Withdrawal by Subject|0|||
145537152|NCT02761733|524825720|FG000|Overall Study|Discharged from Study Site|10|||
145537153|NCT02761733|524825721|FG001|Overall Study|Discharged from Study Site|9|||
145537154|NCT02761733|524825722|FG002|Overall Study|Discharged from Study Site|25|||
145537155|NCT02761733|524825723|FG003|Overall Study|Discharged from Study Site|11|||
145779821|NCT00611455|525701932|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
145779822|NCT04601272|525701933|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
145779823|NCT04601272|525701934|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
145779824|NCT04601272|525701935|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
145779825|NCT00414440|525701938|FG000|Core Period|Withdrawal by Subject|70|||
145779826|NCT00414440|525701939|FG001|Core Period|Withdrawal by Subject|32|||
145779827|NCT00414440|525701938|FG000|Extension Period|Lost to Follow-up|44|||
145779828|NCT00414440|525701939|FG001|Extension Period|Lost to Follow-up|52|||
145779829|NCT00414440|525701938|FG000|Extension Period|Did not consent to continue follow up|61|||
145779830|NCT00414440|525701939|FG001|Extension Period|Did not consent to continue follow up|54|||
145779831|NCT00414440|525701938|FG000|Extension Period|Other|1|||
145779832|NCT00414440|525701939|FG001|Extension Period|Other|1|||
145779833|NCT00414440|525701938|FG000|Extension Period|Administrative|16|||
145779834|NCT00414440|525701939|FG001|Extension Period|Administrative|16|||
145779835|NCT00414440|525701938|FG000|Extension Period|Death|1|||
145779836|NCT00414440|525701939|FG001|Extension Period|Death|2|||
145779837|NCT00414440|525701938|FG000|Extension Period|Withdrawal by Subject|9|||
145779838|NCT00414440|525701939|FG001|Extension Period|Withdrawal by Subject|7|||
145779839|NCT00414440|525701938|FG000|Extension Period|Not included in follow up period|18|||
145779840|NCT00414440|525701939|FG001|Extension Period|Not included in follow up period|8|||
145779841|NCT02732912|525701940|FG000|Overall Study|Discharged before night|2|||
145779842|NCT02732912|525701941|FG001|Overall Study|Discharged before night|6|||
145779843|NCT02732912|525701940|FG000|Overall Study|Incomplete completion of questionnaire|2|||
145779844|NCT02732912|525701941|FG001|Overall Study|Incomplete completion of questionnaire|3|||
145779845|NCT02732912|525701940|FG000|Overall Study|No outcome; discharged or refused|6|||
145779846|NCT02732912|525701941|FG001|Overall Study|No outcome; discharged or refused|9|||
145779847|NCT04382651|525701942|FG000|Overall Study|Death|26|||
145779848|NCT04382651|525701943|FG001|Overall Study|Death|23|||
145779849|NCT04382651|525701942|FG000|Overall Study|Lost to Follow-up|3|||
145779850|NCT04382651|525701943|FG001|Overall Study|Lost to Follow-up|4|||
145779851|NCT04382651|525701942|FG000|Overall Study|Withdrawal by Subject|2|||
145779852|NCT04382651|525701943|FG001|Overall Study|Withdrawal by Subject|0|||
145779853|NCT04382651|525701942|FG000|Overall Study|Physician Decision|0|||
145779854|NCT04382651|525701943|FG001|Overall Study|Physician Decision|1|||
145779855|NCT01873742|525701944|FG000|Overall Study|Lost to Follow-up|68|||
145779856|NCT01873742|525701945|FG001|Overall Study|Lost to Follow-up|76|||
145779857|NCT01507545|525701946|FG000|Overall Study|Withdrawal by Subject|6|||
145779858|NCT01507545|525701947|FG001|Overall Study|Withdrawal by Subject|2|||
145779859|NCT01507545|525701946|FG000|Overall Study|Lost to Follow-up|1|||
145779860|NCT01507545|525701947|FG001|Overall Study|Lost to Follow-up|0|||
145779861|NCT01507545|525701946|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
145779862|NCT01507545|525701947|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
145779863|NCT01507545|525701946|FG000|Overall Study|Progressive disease|60|||
145779864|NCT01507545|525701947|FG001|Overall Study|Progressive disease|27|||
145779865|NCT01507545|525701946|FG000|Overall Study|Other|6|||
145403717|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145403718|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145537156|NCT02761733|524825720|FG000|Overall Study|Cognitive Impairment|5|||
145537157|NCT02761733|524825721|FG001|Overall Study|Cognitive Impairment|0|||
145537158|NCT02761733|524825722|FG002|Overall Study|Cognitive Impairment|1|||
145537159|NCT02761733|524825723|FG003|Overall Study|Cognitive Impairment|0|||
145537160|NCT00569270|524825724|FG000|Period: First Intervention|Protocol Violation|0|||
145537161|NCT00569270|524825725|FG001|Period: First Intervention|Protocol Violation|1|||
145537162|NCT00447005|524825727|FG000|Overall Study|Adverse Event|1|||
145537163|NCT00447005|524825727|FG000|Overall Study|Lack of Efficacy|11|||
145537164|NCT00492531|524825728|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
145537165|NCT00492531|524825729|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
145537166|NCT03685123|524825733|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
145537167|NCT03685123|524825734|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
145537168|NCT03685123|524825735|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
145537169|NCT03685123|524825733|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
145537170|NCT03685123|524825734|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
145537171|NCT03685123|524825735|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
145537172|NCT03685123|524825733|FG000|Weight Loss Phase|Lost to Follow-up|1|||
145537173|NCT03685123|524825734|FG001|Weight Loss Phase|Lost to Follow-up|0|||
145537174|NCT03685123|524825735|FG002|Weight Loss Phase|Lost to Follow-up|0|||
145537175|NCT03685123|524825733|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
145537176|NCT03685123|524825734|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
145537177|NCT03685123|524825735|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
145537178|NCT03685123|524825733|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
145537179|NCT03685123|524825734|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
145537180|NCT03685123|524825735|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
145779866|NCT01507545|525701947|FG001|Overall Study|Other|4|||
145403719|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145779867|NCT00790296|525701948|FG000|Overall Study|Did not meet study eligibility criteria|1|||
145779868|NCT00790296|525701949|FG001|Overall Study|Did not meet study eligibility criteria|1|||
145779869|NCT00790296|525701948|FG000|Overall Study|Adverse Event|0|||
145779870|NCT00790296|525701949|FG001|Overall Study|Adverse Event|1|||
145779871|NCT01671488|525701950|FG000|Overall Study|Withdrawal by Subject|1|||
145779872|NCT03503773|525701951|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
145779873|NCT03503773|525701952|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
145779874|NCT03503773|525701951|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
145779875|NCT03503773|525701952|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
145779876|NCT03503773|525701951|FG000|Overall Study|Not completing the primary ABPM|3|||
145779877|NCT03503773|525701952|FG001|Overall Study|Not completing the primary ABPM|1|||
145779878|NCT03503773|525701951|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
145779879|NCT03503773|525701952|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145779880|NCT02285010|525701958|FG000|Overall Study|not abdominal hysterectomy|2|||
145779881|NCT02285010|525701959|FG001|Overall Study|not abdominal hysterectomy|0|||
145779882|NCT02285010|525701958|FG000|Overall Study|Not spinal anesthesia|3|||
145779883|NCT02285010|525701959|FG001|Overall Study|Not spinal anesthesia|1|||
145779884|NCT02902809|525701960|FG000|Overall Study|Discontinuation of asthma program|28|||
145779885|NCT00532259|525701961|FG000|Overall Study|Withdrawal by Subject|2|||
145779886|NCT00532259|525701961|FG000|Overall Study|Adverse Event|1|||
145779887|NCT00532259|525701961|FG000|Overall Study|Death|1|||
145779888|NCT00532259|525701961|FG000|Overall Study|Lack of Efficacy|21|||
145779889|NCT00532259|525701961|FG000|Overall Study|Lost to Follow-up|3|||
145779890|NCT00532259|525701961|FG000|Overall Study|Physician Decision|3|||
145779891|NCT00532259|525701961|FG000|Overall Study|Protocol Violation|1|||
145779892|NCT05258058|525701964|FG000|Overall Study|Withdrawal by Subject|2|||
145779893|NCT00465738|525701969|FG000|Overall Study|Lost to Follow-up|2|||
145779894|NCT00465738|525701970|FG001|Overall Study|Lost to Follow-up|0|||
145779895|NCT00465738|525701969|FG000|Overall Study|Adverse Event|0|||
145779896|NCT00465738|525701970|FG001|Overall Study|Adverse Event|1|||
145779897|NCT00465738|525701969|FG000|Overall Study|Withdrawal by Subject|2|||
145779898|NCT00465738|525701970|FG001|Overall Study|Withdrawal by Subject|0|||
145779899|NCT00465738|525701969|FG000|Overall Study|Other|2|||
145779900|NCT00465738|525701970|FG001|Overall Study|Other|5|||
145779901|NCT02707757|525701971|FG000|Overall Study|Protocol Violation|3|||
145779902|NCT02707757|525701972|FG001|Overall Study|Protocol Violation|2|||
145779903|NCT02707757|525701971|FG000|Overall Study|Withdrawal by Subject|2|||
145779904|NCT02707757|525701972|FG001|Overall Study|Withdrawal by Subject|0|||
145779905|NCT02707757|525701971|FG000|Overall Study|Death|0|||
145779906|NCT02707757|525701972|FG001|Overall Study|Death|1|||
145779907|NCT02707757|525701971|FG000|Overall Study|Adverse Event|6|||
145779908|NCT02707757|525701972|FG001|Overall Study|Adverse Event|4|||
145779909|NCT02707757|525701971|FG000|Overall Study|Renal transplant/elective operation|1|||
145779910|NCT02707757|525701972|FG001|Overall Study|Renal transplant/elective operation|5|||
145779911|NCT00734929|525701973|FG000|Overall Study|Lost to Follow-up|1|||
145779912|NCT00734929|525701974|FG001|Overall Study|Lost to Follow-up|2|||
145779913|NCT00734929|525701973|FG000|Overall Study|No intervention/ screen fail|5|||
145779914|NCT00734929|525701974|FG001|Overall Study|No intervention/ screen fail|3|||
145537181|NCT03685123|524825733|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
145779915|NCT01318902|525701975|FG000|Overall Study|Symptomatic Deterioration|0|||
145779916|NCT01318902|525701976|FG001|Overall Study|Symptomatic Deterioration|1|||
145779917|NCT01318902|525701977|FG002|Overall Study|Symptomatic Deterioration|1|||
145779918|NCT01318902|525701978|FG003|Overall Study|Symptomatic Deterioration|2|||
145779919|NCT01318902|525701975|FG000|Overall Study|Withdrawal by Patient|0|||
145779920|NCT01318902|525701976|FG001|Overall Study|Withdrawal by Patient|1|||
145779921|NCT01318902|525701977|FG002|Overall Study|Withdrawal by Patient|0|||
145779922|NCT01318902|525701978|FG003|Overall Study|Withdrawal by Patient|3|||
145779923|NCT01318902|525701975|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
145779924|NCT01318902|525701976|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
145779925|NCT01318902|525701977|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
145779926|NCT01318902|525701978|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
145779927|NCT01318902|525701975|FG000|Overall Study|Adverse Event|0|||
145779928|NCT01318902|525701976|FG001|Overall Study|Adverse Event|1|||
145779929|NCT01318902|525701977|FG002|Overall Study|Adverse Event|0|||
145279196|NCT02454972|523872871|FG003|Overall Study|Lost to Follow-up|0|||
145537182|NCT03685123|524825734|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
145537183|NCT03685123|524825735|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
145779930|NCT01318902|525701978|FG003|Overall Study|Adverse Event|0|||
145779931|NCT01318902|525701975|FG000|Overall Study|Terminated by Sponsor|0|||
145779932|NCT01318902|525701976|FG001|Overall Study|Terminated by Sponsor|0|||
145779933|NCT01318902|525701977|FG002|Overall Study|Terminated by Sponsor|1|||
145779934|NCT01318902|525701978|FG003|Overall Study|Terminated by Sponsor|0|||
145537184|NCT00400764|524825737|FG000|Phase Ib|Adverse Event|1|||
145779935|NCT05094154|525703577|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
145537185|NCT00400764|524825738|FG001|Phase Ib|Adverse Event|0|||
145537186|NCT00400764|524825739|FG002|Phase Ib|Adverse Event|0|||
145537187|NCT00400764|524825740|FG003|Phase Ib|Adverse Event|0|||
145537188|NCT00400764|524825741|FG004|Phase Ib|Adverse Event|0|||
145537189|NCT00400764|524825737|FG000|Phase Ib|Death|1|||
145537190|NCT00400764|524825738|FG001|Phase Ib|Death|0|||
145537191|NCT00400764|524825739|FG002|Phase Ib|Death|0|||
145537192|NCT00400764|524825740|FG003|Phase Ib|Death|0|||
145537193|NCT00400764|524825741|FG004|Phase Ib|Death|0|||
145537194|NCT00400764|524825737|FG000|Phase Ib|Disease Progression|4|||
145537195|NCT00400764|524825738|FG001|Phase Ib|Disease Progression|4|||
145537196|NCT00400764|524825739|FG002|Phase Ib|Disease Progression|0|||
145537197|NCT00400764|524825740|FG003|Phase Ib|Disease Progression|0|||
145537198|NCT00400764|524825741|FG004|Phase Ib|Disease Progression|0|||
145537199|NCT00400764|524825737|FG000|Phase II|Death|0|||
145537200|NCT00400764|524825738|FG001|Phase II|Death|0|||
145537201|NCT00400764|524825739|FG002|Phase II|Death|1|||
145779936|NCT05094154|525703578|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
145779937|NCT05094154|525703577|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
145779938|NCT05094154|525703578|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
145779939|NCT02100657|525703579|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
145779940|NCT02100657|525703580|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
145779941|NCT02100657|525703581|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
145537202|NCT00400764|524825740|FG003|Phase II|Death|2|||
145779942|NCT02100657|525703579|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
145779943|NCT02100657|525703580|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
145779944|NCT02100657|525703581|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
145779945|NCT02100657|525703579|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
145779946|NCT02100657|525703580|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
145779947|NCT02100657|525703581|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
145779948|NCT02100657|525703579|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
145779949|NCT02100657|525703580|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
145779950|NCT02100657|525703581|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
145779951|NCT02100657|525703579|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
145779952|NCT02100657|525703580|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
145779953|NCT02100657|525703581|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
145779954|NCT02100657|525703579|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
145779955|NCT02100657|525703580|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
145779956|NCT02100657|525703581|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
145779957|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
145779958|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
145779959|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
145779960|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Death|0|||
145779961|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Death|0|||
145779962|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Death|1|||
145779963|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
145779964|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
145779965|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
145779966|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
145779967|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
145779968|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
145779969|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
145779970|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
145779971|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
145779972|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
145779973|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
145779974|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
145779975|NCT02100657|525703579|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
145779976|NCT02100657|525703580|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
145779977|NCT02100657|525703581|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
145537203|NCT00400764|524825741|FG004|Phase II|Death|0|||
145537204|NCT00400764|524825737|FG000|Phase II|Lost to Follow-up|0|||
145279197|NCT02454972|523872872|FG004|Overall Study|Lost to Follow-up|0|||
145403720|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145537205|NCT00400764|524825738|FG001|Phase II|Lost to Follow-up|0|||
145537206|NCT00400764|524825739|FG002|Phase II|Lost to Follow-up|1|||
145537207|NCT00400764|524825740|FG003|Phase II|Lost to Follow-up|0|||
145537208|NCT00400764|524825741|FG004|Phase II|Lost to Follow-up|0|||
145537209|NCT00400764|524825737|FG000|Phase II|Physician Decision|0|||
145537210|NCT00400764|524825738|FG001|Phase II|Physician Decision|0|||
145537211|NCT00400764|524825739|FG002|Phase II|Physician Decision|1|||
145537212|NCT00400764|524825740|FG003|Phase II|Physician Decision|1|||
145537213|NCT00400764|524825741|FG004|Phase II|Physician Decision|0|||
145537214|NCT00400764|524825737|FG000|Phase II|Sponsor's decision to terminate|0|||
145537215|NCT00400764|524825738|FG001|Phase II|Sponsor's decision to terminate|0|||
145779978|NCT03825042|525703583|FG000|Overall Study|Adverse Event|1|||
145779979|NCT03825042|525703584|FG001|Overall Study|Adverse Event|0|||
145779980|NCT03825042|525703583|FG000|Overall Study|Withdrawal by Subject|1|||
145779981|NCT03825042|525703584|FG001|Overall Study|Withdrawal by Subject|0|||
145779982|NCT01158534|525703585|FG000|Overall Study|Withdrawal by Subject|1|||
145779983|NCT01158534|525703585|FG000|Overall Study|Death|1|||
145779984|NCT01158534|525703585|FG000|Overall Study|Other|1|||
145779985|NCT04003155|525703586|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
145779986|NCT04003155|525703587|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
145779987|NCT04003155|525703588|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
145779988|NCT04003155|525703589|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
145779989|NCT04003155|525703590|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
145779990|NCT04003155|525703586|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
145779991|NCT04003155|525703587|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
145779992|NCT04003155|525703588|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
145779993|NCT04003155|525703589|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
145779994|NCT04003155|525703590|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
145779995|NCT04003155|525703586|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
145779996|NCT04003155|525703587|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
145779997|NCT04003155|525703588|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
145779998|NCT04003155|525703589|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
145779999|NCT04003155|525703590|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
145780000|NCT04003155|525703586|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
145780001|NCT04003155|525703587|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
145780002|NCT04003155|525703588|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
145780003|NCT04003155|525703589|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
145780004|NCT04003155|525703590|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
145780005|NCT04003155|525703586|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
145780006|NCT04003155|525703587|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
145780007|NCT04003155|525703588|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
145780008|NCT04003155|525703589|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
145780009|NCT04003155|525703590|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
145780010|NCT04003155|525703586|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
145780011|NCT04003155|525703587|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
145780012|NCT04003155|525703588|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
145780013|NCT04003155|525703589|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
145780014|NCT04003155|525703590|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
145780015|NCT04003155|525703586|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
145780016|NCT04003155|525703587|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
145780017|NCT04003155|525703588|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
145780018|NCT04003155|525703589|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
145780019|NCT04003155|525703590|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
145780020|NCT04003155|525703586|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
145780021|NCT04003155|525703587|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
145780022|NCT04003155|525703588|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
145780023|NCT04003155|525703589|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
145780024|NCT04003155|525703590|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
145780025|NCT04003155|525703586|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
145780026|NCT04003155|525703587|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
145780027|NCT04003155|525703588|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
145780028|NCT04003155|525703589|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
145780029|NCT04003155|525703590|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
145780030|NCT03042611|525703591|FG000|Core Phase|Withdrawal by Subject|13|||
145780031|NCT03042611|525703592|FG001|Core Phase|Withdrawal by Subject|4|||
145780032|NCT03042611|525703593|FG002|Core Phase|Withdrawal by Subject|0|||
145279198|NCT02454972|523872873|FG005|Overall Study|Lost to Follow-up|0|||
145279199|NCT02454972|523872874|FG006|Overall Study|Lost to Follow-up|0|||
145279200|NCT02454972|523872875|FG007|Overall Study|Lost to Follow-up|0|||
145279201|NCT02454972|523872876|FG008|Overall Study|Lost to Follow-up|2|||
145279202|NCT02454972|523872868|FG000|Overall Study|Study termination|0|||
145537216|NCT00400764|524825739|FG002|Phase II|Sponsor's decision to terminate|18|||
145780033|NCT03042611|525703594|FG003|Core Phase|Withdrawal by Subject|0|||
145780034|NCT03042611|525703591|FG000|Core Phase|Death|232|||
145780035|NCT03042611|525703592|FG001|Core Phase|Death|110|||
145780036|NCT03042611|525703593|FG002|Core Phase|Death|0|||
145780037|NCT03042611|525703594|FG003|Core Phase|Death|0|||
145780038|NCT03042611|525703591|FG000|Core Phase|Lost to Follow-up|4|||
145780039|NCT03042611|525703592|FG001|Core Phase|Lost to Follow-up|7|||
145780040|NCT03042611|525703593|FG002|Core Phase|Lost to Follow-up|0|||
145780041|NCT03042611|525703594|FG003|Core Phase|Lost to Follow-up|0|||
145279203|NCT02454972|523872869|FG001|Overall Study|Study termination|0|||
145537217|NCT00400764|524825740|FG003|Phase II|Sponsor's decision to terminate|22|||
145780042|NCT03042611|525703591|FG000|Core Phase|Physician Decision|7|||
145780043|NCT03042611|525703592|FG001|Core Phase|Physician Decision|2|||
145780044|NCT03042611|525703593|FG002|Core Phase|Physician Decision|0|||
145780045|NCT03042611|525703594|FG003|Core Phase|Physician Decision|0|||
145780046|NCT03042611|525703591|FG000|Core Phase|Study Closed|0|||
145780047|NCT03042611|525703592|FG001|Core Phase|Study Closed|1|||
145780048|NCT03042611|525703593|FG002|Core Phase|Study Closed|0|||
145780049|NCT03042611|525703594|FG003|Core Phase|Study Closed|0|||
145780050|NCT03042611|525703591|FG000|Extension Phase|Death|0|||
145780051|NCT03042611|525703592|FG001|Extension Phase|Death|0|||
145780052|NCT03042611|525703593|FG002|Extension Phase|Death|34|||
145780053|NCT03042611|525703594|FG003|Extension Phase|Death|16|||
145780054|NCT03042611|525703591|FG000|Extension Phase|Lost to Follow-up|0|||
145780055|NCT03042611|525703592|FG001|Extension Phase|Lost to Follow-up|0|||
145780056|NCT03042611|525703593|FG002|Extension Phase|Lost to Follow-up|1|||
145780057|NCT03042611|525703594|FG003|Extension Phase|Lost to Follow-up|1|||
145780058|NCT03042611|525703591|FG000|Extension Phase|Study Closed|0|||
145780059|NCT03042611|525703592|FG001|Extension Phase|Study Closed|0|||
145780060|NCT03042611|525703593|FG002|Extension Phase|Study Closed|17|||
145780061|NCT03042611|525703594|FG003|Extension Phase|Study Closed|11|||
145780062|NCT01666444|525703598|FG000|Overall Study|Did not initiate treatment|2|||
145780063|NCT01666444|525703599|FG001|Overall Study|Did not initiate treatment|1|||
145780064|NCT00950690|525703600|FG000|Overall Study|Death|4|||
145780065|NCT00950690|525703600|FG000|Overall Study|Adverse Event|15|||
145780066|NCT00950690|525703600|FG000|Overall Study|Lack of Efficacy|22|||
145780067|NCT00950690|525703600|FG000|Overall Study|Lost to Follow-up|40|||
145780068|NCT00950690|525703600|FG000|Overall Study|Other|163|||
145780069|NCT00084682|525703605|FG000|Overall Study|Withdrawal by Subject|1|||
145780070|NCT01013883|525703611|FG000|Overall Study|Lost to Follow-up|2|||
145780071|NCT01013883|525703612|FG001|Overall Study|Lost to Follow-up|2|||
145780072|NCT03666143|525703617|FG000|Overall Study|Death|158|||
145780073|NCT03666143|525703617|FG000|Overall Study|Sponsor Decision|31|||
145780074|NCT03666143|525703617|FG000|Overall Study|Withdrawal by Subject|11|||
145780075|NCT03666143|525703617|FG000|Overall Study|Lost to Follow-up|5|||
145780076|NCT03666143|525703617|FG000|Overall Study|Physician Decision|1|||
145780077|NCT03666143|525703617|FG000|Overall Study|Rolled into extension study|9|||
145780078|NCT03666143|525703617|FG000|Overall Study|Progressive Disease|1|||
145780079|NCT00907478|525703623|FG000|Overall Study|Ineligibility determined|0|||
145780080|NCT00907478|525703624|FG001|Overall Study|Ineligibility determined|0|||
145780081|NCT00907478|525703625|FG002|Overall Study|Ineligibility determined|1|||
145780082|NCT00907478|525703623|FG000|Overall Study|Noncompliance|0|||
145780083|NCT00907478|525703624|FG001|Overall Study|Noncompliance|0|||
145780084|NCT00907478|525703625|FG002|Overall Study|Noncompliance|1|||
145780085|NCT00907478|525703623|FG000|Overall Study|Adverse Event|3|||
145780086|NCT00907478|525703624|FG001|Overall Study|Adverse Event|1|||
145780087|NCT00907478|525703625|FG002|Overall Study|Adverse Event|2|||
145780088|NCT00907478|525703623|FG000|Overall Study|Withdrawal by Subject|8|||
145780089|NCT00907478|525703624|FG001|Overall Study|Withdrawal by Subject|9|||
145780090|NCT00907478|525703625|FG002|Overall Study|Withdrawal by Subject|6|||
145780091|NCT00907478|525703623|FG000|Overall Study|Requirement for alternative therapy|1|||
145780092|NCT00907478|525703624|FG001|Overall Study|Requirement for alternative therapy|2|||
145780093|NCT00907478|525703625|FG002|Overall Study|Requirement for alternative therapy|3|||
145780094|NCT00907478|525703623|FG000|Overall Study|Physician Decision|2|||
145780095|NCT00907478|525703624|FG001|Overall Study|Physician Decision|0|||
145780096|NCT00907478|525703625|FG002|Overall Study|Physician Decision|3|||
145780097|NCT00907478|525703623|FG000|Overall Study|Death|4|||
145780098|NCT00907478|525703624|FG001|Overall Study|Death|2|||
145537218|NCT00400764|524825741|FG004|Phase II|Sponsor's decision to terminate|11|||
145537219|NCT00400764|524825737|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
145780099|NCT00907478|525703625|FG002|Overall Study|Death|1|||
145537220|NCT00400764|524825738|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
145537221|NCT00400764|524825739|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
145537222|NCT00400764|524825740|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
145537223|NCT00400764|524825741|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
145537224|NCT00400764|524825737|FG000|Phase II|Withdrawal by Subject|0|||
145537225|NCT00400764|524825738|FG001|Phase II|Withdrawal by Subject|0|||
145537226|NCT00400764|524825739|FG002|Phase II|Withdrawal by Subject|1|||
145780100|NCT00907478|525703623|FG000|Overall Study|Protocol-specified criteria|5|||
145780101|NCT00907478|525703624|FG001|Overall Study|Protocol-specified criteria|2|||
145780102|NCT00907478|525703625|FG002|Overall Study|Protocol-specified criteria|3|||
145780103|NCT00907478|525703623|FG000|Overall Study|Pregnancy|0|||
145537227|NCT00400764|524825740|FG003|Phase II|Withdrawal by Subject|1|||
145780104|NCT00907478|525703624|FG001|Overall Study|Pregnancy|1|||
145780105|NCT00907478|525703625|FG002|Overall Study|Pregnancy|1|||
145537228|NCT00400764|524825741|FG004|Phase II|Withdrawal by Subject|0|||
145780106|NCT00907478|525703623|FG000|Overall Study|Lost to Follow-up|1|||
145780107|NCT00907478|525703624|FG001|Overall Study|Lost to Follow-up|0|||
145780108|NCT00907478|525703625|FG002|Overall Study|Lost to Follow-up|0|||
145780109|NCT00907478|525703623|FG000|Overall Study|Other|3|||
145780110|NCT00907478|525703624|FG001|Overall Study|Other|0|||
145780111|NCT00907478|525703625|FG002|Overall Study|Other|1|||
145537229|NCT00621959|524825745|FG000|Overall Study|Adverse Event|4|||
145780112|NCT01936649|525703630|FG000|Overall Study|Withdrawal by Subject|4|||
145780113|NCT01936649|525703630|FG000|Overall Study|Physician Decision|2|||
145780114|NCT01936649|525703630|FG000|Overall Study|Protocol Violation|2|||
145780115|NCT01936649|525703630|FG000|Overall Study|Other than specified above|5|||
145780116|NCT03554005|525703635|FG000|Overall Study|Not in participant's best interest|0|||
145780117|NCT03554005|525703636|FG001|Overall Study|Not in participant's best interest|0|||
145780118|NCT03554005|525703637|FG002|Overall Study|Not in participant's best interest|0|||
145780119|NCT03554005|525703638|FG003|Overall Study|Not in participant's best interest|0|||
145780120|NCT03554005|525703639|FG004|Overall Study|Not in participant's best interest|0|||
145780121|NCT03554005|525703640|FG005|Overall Study|Not in participant's best interest|1|||
145780122|NCT03554005|525703635|FG000|Overall Study|Disease Progression|1|||
145780123|NCT03554005|525703636|FG001|Overall Study|Disease Progression|1|||
145780124|NCT03554005|525703637|FG002|Overall Study|Disease Progression|1|||
145780125|NCT03554005|525703638|FG003|Overall Study|Disease Progression|1|||
145780126|NCT03554005|525703639|FG004|Overall Study|Disease Progression|5|||
145780127|NCT03554005|525703640|FG005|Overall Study|Disease Progression|6|||
145780128|NCT03554005|525703635|FG000|Overall Study|Adverse Event|0|||
145780129|NCT03554005|525703636|FG001|Overall Study|Adverse Event|0|||
145780130|NCT03554005|525703637|FG002|Overall Study|Adverse Event|0|||
145780131|NCT03554005|525703638|FG003|Overall Study|Adverse Event|0|||
145780132|NCT03554005|525703639|FG004|Overall Study|Adverse Event|0|||
145780133|NCT03554005|525703640|FG005|Overall Study|Adverse Event|3|||
145780134|NCT03554005|525703635|FG000|Overall Study|Physician Decision|0|||
145780135|NCT03554005|525703636|FG001|Overall Study|Physician Decision|0|||
145780136|NCT03554005|525703637|FG002|Overall Study|Physician Decision|0|||
145780137|NCT03554005|525703638|FG003|Overall Study|Physician Decision|0|||
145780138|NCT03554005|525703639|FG004|Overall Study|Physician Decision|1|||
145780139|NCT03554005|525703640|FG005|Overall Study|Physician Decision|0|||
145780140|NCT03554005|525703635|FG000|Overall Study|Other|0|||
145780141|NCT03554005|525703636|FG001|Overall Study|Other|0|||
145780142|NCT03554005|525703637|FG002|Overall Study|Other|0|||
145780143|NCT03554005|525703638|FG003|Overall Study|Other|0|||
145780144|NCT03554005|525703639|FG004|Overall Study|Other|0|||
145780145|NCT03554005|525703640|FG005|Overall Study|Other|1|||
145780146|NCT03648476|525703641|FG000|Overall Study|Withdrawal by Subject|2|||
145780147|NCT03648476|525703642|FG001|Overall Study|Withdrawal by Subject|1|||
145780148|NCT02639182|525703644|FG000|Overall Study|Disease Progression|50|||
145780149|NCT02639182|525703645|FG001|Overall Study|Disease Progression|49|||
145780150|NCT02639182|525703644|FG000|Overall Study|Adverse Event|7|||
145780151|NCT02639182|525703645|FG001|Overall Study|Adverse Event|5|||
145780152|NCT02639182|525703644|FG000|Overall Study|Physician Decision|3|||
145780153|NCT02639182|525703645|FG001|Overall Study|Physician Decision|3|||
145780154|NCT02639182|525703644|FG000|Overall Study|Withdrew Consent|5|||
145780155|NCT02639182|525703645|FG001|Overall Study|Withdrew Consent|4|||
145780156|NCT02639182|525703644|FG000|Overall Study|Lost to Follow-up|0|||
145780157|NCT02639182|525703645|FG001|Overall Study|Lost to Follow-up|1|||
145780158|NCT02639182|525703644|FG000|Overall Study|Study Closure|1|||
145780159|NCT02639182|525703645|FG001|Overall Study|Study Closure|2|||
145780160|NCT02639182|525703644|FG000|Overall Study|Sponsor Ended Study|0|||
145780161|NCT02639182|525703645|FG001|Overall Study|Sponsor Ended Study|1|||
145780162|NCT02639182|525703644|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
145780163|NCT02639182|525703645|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
145780164|NCT02546856|525703646|FG000|4 Months Evaluation|Death|2|||
145780165|NCT02546856|525703647|FG001|4 Months Evaluation|Death|3|||
145780166|NCT02546856|525703646|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
145780167|NCT02546856|525703647|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
145780168|NCT02546856|525703646|FG000|4 Months Evaluation|Lost to Follow-up|3|||
145780169|NCT02546856|525703647|FG001|4 Months Evaluation|Lost to Follow-up|3|||
145780170|NCT02546856|525703646|FG000|4 Months Evaluation|Physician Decision|3|||
145780171|NCT02546856|525703647|FG001|4 Months Evaluation|Physician Decision|0|||
145279204|NCT02454972|523872870|FG002|Overall Study|Study termination|0|||
145537230|NCT00621959|524825746|FG001|Overall Study|Adverse Event|2|||
145537231|NCT00621959|524825745|FG000|Overall Study|Lack of Efficacy|1|||
145537232|NCT00621959|524825746|FG001|Overall Study|Lack of Efficacy|1|||
145537233|NCT00621959|524825745|FG000|Overall Study|Lost to Follow-up|0|||
145537234|NCT00621959|524825746|FG001|Overall Study|Lost to Follow-up|2|||
145537235|NCT00621959|524825745|FG000|Overall Study|Withdrawal by Subject|1|||
145537236|NCT00621959|524825746|FG001|Overall Study|Withdrawal by Subject|1|||
145537237|NCT00621959|524825745|FG000|Overall Study|Other|1|||
145537238|NCT00621959|524825746|FG001|Overall Study|Other|3|||
145537239|NCT02130297|524825751|FG000|Overall Study|Lost to Follow-up|4|||
145537240|NCT01387789|524825752|FG000|Overall Study|Adverse Event|5|||
145537241|NCT01387789|524825752|FG000|Overall Study|Lack of Efficacy|2|||
145537242|NCT01387789|524825752|FG000|Overall Study|Lost to Follow-up|1|||
145537243|NCT00508755|524825755|FG000|Overall Study|Withdrawal by Subject|1|||
145780172|NCT02546856|525703646|FG000|4 Months Evaluation|Working or living abroad|5|||
145780173|NCT02546856|525703647|FG001|4 Months Evaluation|Working or living abroad|1|||
145780174|NCT02546856|525703646|FG000|4 Months Evaluation|reasons not due to titration|4|||
145780175|NCT02546856|525703647|FG001|4 Months Evaluation|reasons not due to titration|1|||
145780176|NCT02546856|525703646|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
145780177|NCT02546856|525703647|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
145780178|NCT02546856|525703646|FG000|6 Months Evaluation|Death|1|||
145780179|NCT02546856|525703647|FG001|6 Months Evaluation|Death|1|||
145403721|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145780180|NCT02546856|525703646|FG000|6 Months Evaluation|Lost to Follow-up|1|||
145780181|NCT02546856|525703647|FG001|6 Months Evaluation|Lost to Follow-up|1|||
145780182|NCT02546856|525703646|FG000|6 Months Evaluation|Working or living abroad|6|||
145780183|NCT02546856|525703647|FG001|6 Months Evaluation|Working or living abroad|4|||
145780184|NCT02546856|525703646|FG000|6 Months Evaluation|reasons not due to titration|0|||
145780185|NCT02546856|525703647|FG001|6 Months Evaluation|reasons not due to titration|1|||
145780186|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
145780187|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
145780188|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
145780189|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145780190|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145780191|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145780192|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145780193|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
145780194|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
145780195|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
145780196|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
145780197|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145780198|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145780199|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145780200|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145780201|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
145780202|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
145780203|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
145780204|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
145780205|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145780206|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145780207|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145780208|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145780209|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
145780210|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
145780211|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
145780212|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780213|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780214|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780215|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780216|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780217|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
145780218|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
145780219|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
145780220|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
145780221|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145780222|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145780223|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145780224|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145780225|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
145780226|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
145780227|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
145780228|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145780229|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145780230|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145403722|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
145780231|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145780232|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145780233|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
145780234|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
145780235|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
145780236|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780237|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780238|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780239|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780240|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780241|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
145780242|NCT01097616|525703649|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780243|NCT01097616|525703650|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780244|NCT01097616|525703651|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
145780245|NCT01097616|525703652|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780246|NCT01097616|525703653|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780247|NCT01097616|525703654|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780248|NCT01097616|525703655|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780249|NCT01097616|525703656|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
145780250|NCT01097616|525703649|FG000|Optional DB EXT Phase|Adverse Event|0|||
145780251|NCT01097616|525703650|FG001|Optional DB EXT Phase|Adverse Event|7|||
145780252|NCT01097616|525703651|FG002|Optional DB EXT Phase|Adverse Event|2|||
145780253|NCT01097616|525703652|FG003|Optional DB EXT Phase|Adverse Event|0|||
145780254|NCT01097616|525703653|FG004|Optional DB EXT Phase|Adverse Event|0|||
145780255|NCT01097616|525703654|FG005|Optional DB EXT Phase|Adverse Event|0|||
145780256|NCT01097616|525703655|FG006|Optional DB EXT Phase|Adverse Event|0|||
145780257|NCT01097616|525703656|FG007|Optional DB EXT Phase|Adverse Event|0|||
145780258|NCT01097616|525703649|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
145780259|NCT01097616|525703650|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
145780260|NCT01097616|525703651|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
145780261|NCT01097616|525703652|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
145780262|NCT01097616|525703653|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
145780263|NCT01097616|525703654|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
145780264|NCT01097616|525703655|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
145780265|NCT01097616|525703656|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
145780266|NCT01097616|525703649|FG000|Optional DB EXT Phase|Protocol Violation|0|||
145780267|NCT01097616|525703650|FG001|Optional DB EXT Phase|Protocol Violation|2|||
145780268|NCT01097616|525703651|FG002|Optional DB EXT Phase|Protocol Violation|3|||
145780269|NCT01097616|525703652|FG003|Optional DB EXT Phase|Protocol Violation|0|||
145780270|NCT01097616|525703653|FG004|Optional DB EXT Phase|Protocol Violation|0|||
145780271|NCT01097616|525703654|FG005|Optional DB EXT Phase|Protocol Violation|0|||
145780272|NCT01097616|525703655|FG006|Optional DB EXT Phase|Protocol Violation|0|||
145780273|NCT01097616|525703656|FG007|Optional DB EXT Phase|Protocol Violation|0|||
145780274|NCT01097616|525703649|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
145780275|NCT01097616|525703650|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
145780276|NCT01097616|525703651|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
145780277|NCT01097616|525703652|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
145780278|NCT01097616|525703653|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
145780279|NCT01097616|525703654|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
145780280|NCT01097616|525703655|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
145780281|NCT01097616|525703656|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
145780282|NCT01097616|525703649|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
145780283|NCT01097616|525703650|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
145780284|NCT01097616|525703651|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
145780285|NCT01097616|525703652|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
145780286|NCT01097616|525703653|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
145780287|NCT01097616|525703654|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
145780288|NCT01097616|525703655|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
145780289|NCT01097616|525703656|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
145780290|NCT01097616|525703649|FG000|Optional DB EXT Phase|Physician Decision|1|||
145780291|NCT01097616|525703650|FG001|Optional DB EXT Phase|Physician Decision|0|||
145780292|NCT01097616|525703651|FG002|Optional DB EXT Phase|Physician Decision|0|||
145780293|NCT01097616|525703652|FG003|Optional DB EXT Phase|Physician Decision|0|||
145780294|NCT01097616|525703653|FG004|Optional DB EXT Phase|Physician Decision|0|||
145780295|NCT01097616|525703654|FG005|Optional DB EXT Phase|Physician Decision|0|||
145780296|NCT01097616|525703655|FG006|Optional DB EXT Phase|Physician Decision|0|||
145780297|NCT01097616|525703656|FG007|Optional DB EXT Phase|Physician Decision|0|||
145279205|NCT02454972|523872871|FG003|Overall Study|Study termination|0|||
145780298|NCT01097616|525703649|FG000|DB RO Phase|Adverse Event|0|||
145780299|NCT01097616|525703650|FG001|DB RO Phase|Adverse Event|0|||
145780300|NCT01097616|525703651|FG002|DB RO Phase|Adverse Event|0|||
145780301|NCT01097616|525703652|FG003|DB RO Phase|Adverse Event|0|||
145780302|NCT01097616|525703653|FG004|DB RO Phase|Adverse Event|0|||
145780303|NCT01097616|525703654|FG005|DB RO Phase|Adverse Event|0|||
145780304|NCT01097616|525703655|FG006|DB RO Phase|Adverse Event|1|||
145780305|NCT01097616|525703656|FG007|DB RO Phase|Adverse Event|0|||
145780306|NCT01097616|525703649|FG000|DB RO Phase|Withdrawal by Subject|0|||
145780307|NCT01097616|525703650|FG001|DB RO Phase|Withdrawal by Subject|0|||
145780308|NCT01097616|525703651|FG002|DB RO Phase|Withdrawal by Subject|0|||
145780309|NCT01097616|525703652|FG003|DB RO Phase|Withdrawal by Subject|0|||
145780310|NCT01097616|525703653|FG004|DB RO Phase|Withdrawal by Subject|0|||
145780311|NCT01097616|525703654|FG005|DB RO Phase|Withdrawal by Subject|1|||
145780312|NCT01097616|525703655|FG006|DB RO Phase|Withdrawal by Subject|0|||
145780313|NCT01097616|525703656|FG007|DB RO Phase|Withdrawal by Subject|0|||
145780314|NCT01097616|525703649|FG000|DB RO Phase|Lost to Follow-up|0|||
145780315|NCT01097616|525703650|FG001|DB RO Phase|Lost to Follow-up|0|||
145780316|NCT01097616|525703651|FG002|DB RO Phase|Lost to Follow-up|0|||
145780317|NCT01097616|525703652|FG003|DB RO Phase|Lost to Follow-up|1|||
145780318|NCT01097616|525703653|FG004|DB RO Phase|Lost to Follow-up|1|||
145780319|NCT01097616|525703654|FG005|DB RO Phase|Lost to Follow-up|0|||
145780320|NCT01097616|525703655|FG006|DB RO Phase|Lost to Follow-up|0|||
145780321|NCT01097616|525703656|FG007|DB RO Phase|Lost to Follow-up|1|||
145780322|NCT01097616|525703649|FG000|DB RO Phase|Not Treated in RO|0|||
145780323|NCT01097616|525703650|FG001|DB RO Phase|Not Treated in RO|0|||
145780324|NCT01097616|525703651|FG002|DB RO Phase|Not Treated in RO|0|||
145780325|NCT01097616|525703652|FG003|DB RO Phase|Not Treated in RO|0|||
145780326|NCT01097616|525703653|FG004|DB RO Phase|Not Treated in RO|0|||
145780327|NCT01097616|525703654|FG005|DB RO Phase|Not Treated in RO|1|||
145780328|NCT01097616|525703655|FG006|DB RO Phase|Not Treated in RO|0|||
145780329|NCT01097616|525703656|FG007|DB RO Phase|Not Treated in RO|0|||
145780330|NCT00130208|525703657|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
145780331|NCT00130208|525703658|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
145780332|NCT00130208|525703657|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
145780333|NCT00130208|525703658|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
145780334|NCT00130208|525703657|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
145780335|NCT00130208|525703658|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
145780336|NCT00130208|525703657|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
145780337|NCT00130208|525703658|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
145780338|NCT00130208|525703657|FG000|Maintenance Period (26 Weeks)|Other|1|||
145780339|NCT00130208|525703658|FG001|Maintenance Period (26 Weeks)|Other|1|||
145780340|NCT00130208|525703657|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
145780341|NCT00130208|525703658|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
145780342|NCT00130208|525703657|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
145780343|NCT00130208|525703658|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
145780344|NCT00130208|525703657|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
145780345|NCT00130208|525703658|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
145780346|NCT00130208|525703657|FG000|Washout Period (8 Weeks)|Other|1|||
145780347|NCT00130208|525703658|FG001|Washout Period (8 Weeks)|Other|1|||
145780348|NCT04655586|525703661|FG000|Overall Study|Physician Decision|1|||
145780349|NCT04655586|525703662|FG001|Overall Study|Physician Decision|3|||
145780350|NCT04655586|525703663|FG002|Overall Study|Physician Decision|4|||
145780351|NCT04655586|525703661|FG000|Overall Study|Withdrawal by Subject|1|||
145780352|NCT04655586|525703662|FG001|Overall Study|Withdrawal by Subject|3|||
145780353|NCT04655586|525703663|FG002|Overall Study|Withdrawal by Subject|1|||
145780354|NCT03268746|525703671|FG000|Overall Study|Withdrawal by Subject|1|||
145780355|NCT00589472|525703672|FG000|Overall Study|Adverse Event|1|||
145780356|NCT00117338|525703673|FG000|Overall Study|Adverse Event|0|||
145780357|NCT00117338|525703674|FG001|Overall Study|Adverse Event|1|||
145780358|NCT00117338|525703673|FG000|Overall Study|Protocol Violation|3|||
145780359|NCT00117338|525703674|FG001|Overall Study|Protocol Violation|2|||
145279206|NCT02454972|523872872|FG004|Overall Study|Study termination|0|||
145780360|NCT00117338|525703673|FG000|Overall Study|Withdrawal by Subject|1|||
145780361|NCT00117338|525703674|FG001|Overall Study|Withdrawal by Subject|0|||
145780362|NCT00117338|525703673|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
145780363|NCT00117338|525703674|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
145780364|NCT00117338|525703673|FG000|Overall Study|Lack of Efficacy|0|||
145279207|NCT02454972|523872873|FG005|Overall Study|Study termination|0|||
145279208|NCT02454972|523872874|FG006|Overall Study|Study termination|0|||
145780365|NCT00117338|525703674|FG001|Overall Study|Lack of Efficacy|1|||
145780366|NCT00546351|525703675|FG000|Overall Study|Adverse Event|76|||
145608989|NCT02969525|525083274|FG006|Double-Blind Period|Adverse Event|0|||
145780367|NCT00546351|525703675|FG000|Overall Study|Lack of Efficacy|15|||
145780368|NCT00546351|525703675|FG000|Overall Study|Withdrawal by Subject|109|||
145780369|NCT00546351|525703675|FG000|Overall Study|Lost to Follow-up|9|||
145780370|NCT00546351|525703675|FG000|Overall Study|Protocol Deviation|1|||
145780371|NCT00546351|525703675|FG000|Overall Study|Unsatisfactory compliance|9|||
145279209|NCT02454972|523872875|FG007|Overall Study|Study termination|0|||
145780372|NCT00546351|525703675|FG000|Overall Study|Other reasons for premature termination|17|||
145780373|NCT04734873|525703676|FG000|Overall Study|Lost to Follow-up|1|||
145780374|NCT04734873|525703677|FG001|Overall Study|Lost to Follow-up|3|||
145780375|NCT04734873|525703678|FG002|Overall Study|Lost to Follow-up|2|||
145780376|NCT04734873|525703676|FG000|Overall Study|Randomized but not dosed|1|||
145780377|NCT04734873|525703677|FG001|Overall Study|Randomized but not dosed|0|||
145780378|NCT04734873|525703678|FG002|Overall Study|Randomized but not dosed|1|||
145780379|NCT01342640|525703679|FG000|Overall Study|Adverse Event|3|||
145780380|NCT01342640|525703679|FG000|Overall Study|Protocol Violation|16|||
145780381|NCT01342640|525703679|FG000|Overall Study|Lost to Follow-up|21|||
145780382|NCT01342640|525703679|FG000|Overall Study|Other|1|||
145780383|NCT00479466|525703682|FG000|Overall Study|Adverse Event|5|||
145780384|NCT00479466|525703683|FG001|Overall Study|Adverse Event|1|||
145780385|NCT00479466|525703684|FG002|Overall Study|Adverse Event|0|||
145780386|NCT00479466|525703685|FG003|Overall Study|Adverse Event|1|||
145780387|NCT00479466|525703686|FG004|Overall Study|Adverse Event|2|||
145780388|NCT00479466|525703687|FG005|Overall Study|Adverse Event|0|||
145780389|NCT00479466|525703682|FG000|Overall Study|Hyperglycemia|0|||
145780390|NCT00479466|525703683|FG001|Overall Study|Hyperglycemia|0|||
145780391|NCT00479466|525703684|FG002|Overall Study|Hyperglycemia|0|||
145780392|NCT00479466|525703685|FG003|Overall Study|Hyperglycemia|0|||
145780393|NCT00479466|525703686|FG004|Overall Study|Hyperglycemia|0|||
145780394|NCT00479466|525703687|FG005|Overall Study|Hyperglycemia|1|||
145780395|NCT00479466|525703682|FG000|Overall Study|Lack of Efficacy|2|||
145780396|NCT00479466|525703683|FG001|Overall Study|Lack of Efficacy|0|||
145780397|NCT00479466|525703684|FG002|Overall Study|Lack of Efficacy|1|||
145780398|NCT00479466|525703685|FG003|Overall Study|Lack of Efficacy|0|||
145780399|NCT00479466|525703686|FG004|Overall Study|Lack of Efficacy|0|||
145780400|NCT00479466|525703687|FG005|Overall Study|Lack of Efficacy|0|||
145780401|NCT00479466|525703682|FG000|Overall Study|Lost to Follow-up|0|||
145780402|NCT00479466|525703683|FG001|Overall Study|Lost to Follow-up|1|||
145780403|NCT00479466|525703684|FG002|Overall Study|Lost to Follow-up|1|||
145780404|NCT00479466|525703685|FG003|Overall Study|Lost to Follow-up|0|||
145780405|NCT00479466|525703686|FG004|Overall Study|Lost to Follow-up|2|||
145780406|NCT00479466|525703687|FG005|Overall Study|Lost to Follow-up|2|||
145780407|NCT00479466|525703682|FG000|Overall Study|Physician Decision|2|||
145780408|NCT00479466|525703683|FG001|Overall Study|Physician Decision|1|||
145780409|NCT00479466|525703684|FG002|Overall Study|Physician Decision|1|||
145780410|NCT00479466|525703685|FG003|Overall Study|Physician Decision|0|||
145780411|NCT00479466|525703686|FG004|Overall Study|Physician Decision|0|||
145780412|NCT00479466|525703687|FG005|Overall Study|Physician Decision|0|||
145780413|NCT00479466|525703682|FG000|Overall Study|Pregnancy|0|||
145780414|NCT00479466|525703683|FG001|Overall Study|Pregnancy|0|||
145780415|NCT00479466|525703684|FG002|Overall Study|Pregnancy|0|||
145780416|NCT00479466|525703685|FG003|Overall Study|Pregnancy|0|||
145780417|NCT00479466|525703686|FG004|Overall Study|Pregnancy|1|||
145780418|NCT00479466|525703687|FG005|Overall Study|Pregnancy|0|||
145780419|NCT00479466|525703682|FG000|Overall Study|Protocol Violation|1|||
145780420|NCT00479466|525703683|FG001|Overall Study|Protocol Violation|0|||
145780421|NCT00479466|525703684|FG002|Overall Study|Protocol Violation|0|||
145780422|NCT00479466|525703685|FG003|Overall Study|Protocol Violation|0|||
145780423|NCT00479466|525703686|FG004|Overall Study|Protocol Violation|0|||
145780424|NCT00479466|525703687|FG005|Overall Study|Protocol Violation|0|||
145780425|NCT00479466|525703682|FG000|Overall Study|Withdrawal by Subject|3|||
145780426|NCT00479466|525703683|FG001|Overall Study|Withdrawal by Subject|5|||
145780427|NCT00479466|525703684|FG002|Overall Study|Withdrawal by Subject|0|||
145780428|NCT00479466|525703685|FG003|Overall Study|Withdrawal by Subject|2|||
145780429|NCT00479466|525703686|FG004|Overall Study|Withdrawal by Subject|3|||
145780430|NCT00479466|525703687|FG005|Overall Study|Withdrawal by Subject|1|||
145780431|NCT02927171|525703690|FG000|Overall Study|Lost to Follow-up|0|||
145780432|NCT02927171|525703691|FG001|Overall Study|Lost to Follow-up|1|||
145780433|NCT02240628|525703694|FG000|Overall Study|Physician Decision|6|||
145780434|NCT02240628|525703695|FG001|Overall Study|Physician Decision|5|||
145780435|NCT04530825|525703698|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
145780436|NCT04530825|525703699|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
145780437|NCT04530825|525703700|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
145780438|NCT04530825|525703701|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
145780439|NCT04530825|525703698|FG000|Overall Study|Did not complete follow-up|3|||
145780440|NCT04530825|525703699|FG001|Overall Study|Did not complete follow-up|0|||
145780441|NCT04530825|525703700|FG002|Overall Study|Did not complete follow-up|0|||
145780442|NCT04530825|525703701|FG003|Overall Study|Did not complete follow-up|0|||
145780443|NCT04101422|525703703|FG000|Overall Study|Ineligible|1|||
145608990|NCT02969525|525083275|FG007|Double-Blind Period|Adverse Event|0|||
145780444|NCT04101422|525703704|FG001|Overall Study|Ineligible|0|||
145780445|NCT04101422|525703705|FG002|Overall Study|Ineligible|9|||
145780446|NCT04101422|525703706|FG003|Overall Study|Ineligible|0|||
145780447|NCT04101422|525703703|FG000|Overall Study|Withdrawal by Subject|0|||
145780448|NCT04101422|525703704|FG001|Overall Study|Withdrawal by Subject|0|||
145780449|NCT04101422|525703705|FG002|Overall Study|Withdrawal by Subject|1|||
145780450|NCT04101422|525703706|FG003|Overall Study|Withdrawal by Subject|0|||
145780451|NCT04101422|525703703|FG000|Overall Study|Not attending to the stimuli|0|||
145780452|NCT04101422|525703704|FG001|Overall Study|Not attending to the stimuli|0|||
145780453|NCT04101422|525703705|FG002|Overall Study|Not attending to the stimuli|4|||
145780454|NCT04101422|525703706|FG003|Overall Study|Not attending to the stimuli|0|||
145780455|NCT04101422|525703703|FG000|Overall Study|Did not download app|0|||
145780456|NCT04101422|525703704|FG001|Overall Study|Did not download app|0|||
145403723|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
145403724|NCT01232283|524334393|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145780457|NCT04101422|525703705|FG002|Overall Study|Did not download app|0|||
145780458|NCT04101422|525703706|FG003|Overall Study|Did not download app|17|||
145780459|NCT04101422|525703703|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
145780460|NCT04101422|525703704|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
145780461|NCT04101422|525703705|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
145780462|NCT04101422|525703706|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
145780463|NCT00850499|525703707|FG000|Overall Study|Adverse Event|3|||
145780464|NCT00850499|525703708|FG001|Overall Study|Adverse Event|1|||
145780465|NCT00850499|525703707|FG000|Overall Study|Lack of Efficacy|0|||
145780466|NCT00850499|525703708|FG001|Overall Study|Lack of Efficacy|1|||
145780467|NCT00552305|525703712|FG000|Overall Study|Adverse Event|43|||
145780468|NCT00552305|525703712|FG000|Overall Study|Lack of Efficacy|120|||
145780469|NCT00552305|525703712|FG000|Overall Study|Lost to Follow-up|4|||
145780470|NCT00552305|525703712|FG000|Overall Study|Protocol Violation|3|||
145780471|NCT00552305|525703712|FG000|Overall Study|Withdrawal by Subject|44|||
145780472|NCT00552305|525703712|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
145780473|NCT00552305|525703712|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
145780474|NCT00552305|525703712|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
145780475|NCT00552305|525703712|FG000|Overall Study|Unsatisfactory compliance|11|||
145780476|NCT00552305|525703712|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
145780477|NCT00552305|525703712|FG000|Overall Study|AE/Other: prohibited drug required|1|||
145780478|NCT00552305|525703712|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
145780479|NCT00552305|525703712|FG000|Overall Study|Other: Site closed|4|||
145780480|NCT00552305|525703712|FG000|Overall Study|Other: Personal problems|1|||
145780481|NCT00552305|525703712|FG000|Overall Study|Other: Unable to attend visits|1|||
145780482|NCT00552305|525703712|FG000|Overall Study|Other: Subject underwent surgery|4|||
145780483|NCT00552305|525703712|FG000|Overall Study|Other: Subject became pregnant|1|||
145780484|NCT00552305|525703712|FG000|Overall Study|Other: Health problems, not drug related|1|||
145780485|NCT00552305|525703712|FG000|Overall Study|Other: Subject moved from area|2|||
145780486|NCT00552305|525703712|FG000|Overall Study|Other: Subject incarcerated|1|||
145780487|NCT00552305|525703712|FG000|Overall Study|Other: Subject went to rehab|1|||
145780488|NCT04498910|525703713|FG000|Overall Study|Lost to Follow-up|0|||
145780489|NCT04498910|525703714|FG001|Overall Study|Lost to Follow-up|1|||
145780490|NCT04498910|525703713|FG000|Overall Study|Withdrawal by Subject|2|||
145780491|NCT04498910|525703714|FG001|Overall Study|Withdrawal by Subject|1|||
145780492|NCT04498910|525703713|FG000|Overall Study|Adverse Event|1|||
145780493|NCT04498910|525703714|FG001|Overall Study|Adverse Event|0|||
145780494|NCT00718861|525703719|FG000|Overall Study|Withdrawal by Subject|15|||
145780495|NCT00718861|525703720|FG001|Overall Study|Withdrawal by Subject|10|||
145780496|NCT00718861|525703719|FG000|Overall Study|Adverse Event|2|||
145780497|NCT00718861|525703720|FG001|Overall Study|Adverse Event|1|||
145780498|NCT00718861|525703719|FG000|Overall Study|Lost to Follow-up|2|||
145780499|NCT00718861|525703720|FG001|Overall Study|Lost to Follow-up|1|||
145780500|NCT00718861|525703719|FG000|Overall Study|Administrative Problems|1|||
145780501|NCT00718861|525703720|FG001|Overall Study|Administrative Problems|1|||
145780502|NCT00718861|525703719|FG000|Overall Study|Death|1|||
145780503|NCT00718861|525703720|FG001|Overall Study|Death|5|||
145780504|NCT02345434|525703721|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
145780505|NCT02345434|525703722|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
145780506|NCT01703819|525703723|FG000|Overall Study|Adverse Event|0|||
145780507|NCT01703819|525703724|FG001|Overall Study|Adverse Event|1|||
145780508|NCT01703819|525703723|FG000|Overall Study|Withdrawal by Subject|0|||
145780509|NCT01703819|525703724|FG001|Overall Study|Withdrawal by Subject|1|||
145403725|NCT01232283|524334394|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145537244|NCT01187433|524825767|FG000|Overall Study|Protocol Violation|6|||
145537245|NCT01187433|524825768|FG001|Overall Study|Protocol Violation|2|||
145537246|NCT01187433|524825767|FG000|Overall Study|Withdrawal by Subject|5|||
145780510|NCT01302041|525703731|FG000|Overall Study|Death|5|||
145780511|NCT01302041|525703731|FG000|Overall Study|Withdrawal by Subject|4|||
145780512|NCT01302041|525703731|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
145780513|NCT01302041|525703731|FG000|Overall Study|Other-Miscellaneous Reason|2|||
145780514|NCT00858702|525703734|FG000|Overall Study|Lack of Efficacy|1|||
145780515|NCT00858702|525703735|FG001|Overall Study|Lack of Efficacy|0|||
145780516|NCT00858702|525703734|FG000|Overall Study|Protocol Violation|1|||
145780517|NCT00858702|525703735|FG001|Overall Study|Protocol Violation|1|||
145780518|NCT00858702|525703734|FG000|Overall Study|Other|2|||
145780519|NCT00858702|525703735|FG001|Overall Study|Other|1|||
145780520|NCT00858702|525703734|FG000|Overall Study|Withdrawal by Subject|1|||
145780521|NCT00858702|525703735|FG001|Overall Study|Withdrawal by Subject|0|||
145780522|NCT04983901|525703740|FG000|Overall Study|Death|1|||
145780523|NCT04983901|525703741|FG001|Overall Study|Death|4|||
145780524|NCT04983901|525703740|FG000|Overall Study|Lost to Follow-up|3|||
145780525|NCT04983901|525703741|FG001|Overall Study|Lost to Follow-up|0|||
145608991|NCT02969525|525083276|FG008|Double-Blind Period|Adverse Event|0|||
145608992|NCT02969525|525083277|FG009|Double-Blind Period|Adverse Event|0|||
145780526|NCT04983901|525703740|FG000|Overall Study|Protocol Violation|1|||
145780527|NCT04983901|525703741|FG001|Overall Study|Protocol Violation|0|||
145780528|NCT04983901|525703740|FG000|Overall Study|Withdrawal by Subject|1|||
145780529|NCT04983901|525703741|FG001|Overall Study|Withdrawal by Subject|2|||
145780530|NCT01174784|525703742|FG000|Overall Study|Screen fails|4|||
145780531|NCT01214434|525703745|FG000|Overall Study|Withdrawal by Subject|1|||
145780532|NCT01214434|525703746|FG001|Overall Study|Withdrawal by Subject|0|||
145780533|NCT01214434|525703745|FG000|Overall Study|Lost to Follow-up|2|||
145780534|NCT01214434|525703746|FG001|Overall Study|Lost to Follow-up|2|||
145780535|NCT01214434|525703745|FG000|Overall Study|Site error|1|||
145780536|NCT01214434|525703746|FG001|Overall Study|Site error|0|||
145780537|NCT01651052|525703747|FG000|Overall Study|Death|21|||
145780538|NCT01651052|525703747|FG000|Overall Study|Explant|1|||
145780539|NCT01651052|525703747|FG000|Overall Study|Withdrawal by Subject|1|||
145780540|NCT01651052|525703747|FG000|Overall Study|Lost to Follow-up|3|||
145780541|NCT00425438|525703748|FG000|Overall Study|Termination by Sponsor|25|||
145780542|NCT00425438|525703749|FG001|Overall Study|Termination by Sponsor|27|||
145780543|NCT04983940|525703750|FG000|Overall Study|Lost to Follow-up|14|||
145780544|NCT04983940|525703750|FG000|Overall Study|Lack of Efficacy|2|||
145780545|NCT04156646|525703756|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
145780546|NCT04156646|525703757|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
145780547|NCT01208181|525703758|FG000|Part 1|Withdrawal by Subject|11|||
145780548|NCT01208181|525703759|FG001|Part 1|Withdrawal by Subject|10|||
145780549|NCT01208181|525703760|FG002|Part 1|Withdrawal by Subject|0|||
145780550|NCT01208181|525703761|FG003|Part 1|Withdrawal by Subject|0|||
145780551|NCT01208181|525703762|FG004|Part 1|Withdrawal by Subject|0|||
145780552|NCT01208181|525703758|FG000|Part 1|Technical problem|5|||
145780553|NCT01208181|525703759|FG001|Part 1|Technical problem|0|||
145780554|NCT01208181|525703760|FG002|Part 1|Technical problem|0|||
145780555|NCT01208181|525703761|FG003|Part 1|Technical problem|0|||
145780556|NCT01208181|525703762|FG004|Part 1|Technical problem|0|||
145780557|NCT01208181|525703758|FG000|Part 1|Protocol Violation|10|||
145780558|NCT01208181|525703759|FG001|Part 1|Protocol Violation|5|||
145780559|NCT01208181|525703760|FG002|Part 1|Protocol Violation|0|||
145780560|NCT01208181|525703761|FG003|Part 1|Protocol Violation|0|||
145780561|NCT01208181|525703762|FG004|Part 1|Protocol Violation|0|||
145780562|NCT01208181|525703758|FG000|Part 1|Physician Decision|4|||
145780563|NCT01208181|525703759|FG001|Part 1|Physician Decision|0|||
145780564|NCT01208181|525703760|FG002|Part 1|Physician Decision|0|||
145780565|NCT01208181|525703761|FG003|Part 1|Physician Decision|0|||
145780566|NCT01208181|525703762|FG004|Part 1|Physician Decision|0|||
145780567|NCT01208181|525703758|FG000|Part 1|Non-compliance with study drug|1|||
145780568|NCT01208181|525703759|FG001|Part 1|Non-compliance with study drug|1|||
145780569|NCT01208181|525703760|FG002|Part 1|Non-compliance with study drug|0|||
145780570|NCT01208181|525703761|FG003|Part 1|Non-compliance with study drug|0|||
145780571|NCT01208181|525703762|FG004|Part 1|Non-compliance with study drug|0|||
145780572|NCT01208181|525703758|FG000|Part 1|Lost to Follow-up|5|||
145780573|NCT01208181|525703759|FG001|Part 1|Lost to Follow-up|3|||
145780574|NCT01208181|525703760|FG002|Part 1|Lost to Follow-up|0|||
145780575|NCT01208181|525703761|FG003|Part 1|Lost to Follow-up|0|||
145780576|NCT01208181|525703762|FG004|Part 1|Lost to Follow-up|1|||
145780577|NCT01208181|525703758|FG000|Part 1|Lack of Efficacy|37|||
145780578|NCT01208181|525703759|FG001|Part 1|Lack of Efficacy|12|||
145780579|NCT01208181|525703760|FG002|Part 1|Lack of Efficacy|0|||
145780580|NCT01208181|525703761|FG003|Part 1|Lack of Efficacy|0|||
145279210|NCT02454972|523872876|FG008|Overall Study|Study termination|6|||
145279211|NCT00830063|523872877|FG000|Overall Study|Adverse Event|7|||
145780581|NCT01208181|525703762|FG004|Part 1|Lack of Efficacy|17|||
145780582|NCT01208181|525703758|FG000|Part 1|Adverse Event|26|||
145780583|NCT01208181|525703759|FG001|Part 1|Adverse Event|24|||
145780584|NCT01208181|525703760|FG002|Part 1|Adverse Event|0|||
145780585|NCT01208181|525703761|FG003|Part 1|Adverse Event|0|||
145279212|NCT00830063|523872878|FG001|Overall Study|Adverse Event|13|||
145780586|NCT01208181|525703762|FG004|Part 1|Adverse Event|4|||
145780587|NCT01208181|525703758|FG000|Part 2|Adverse Event|0|||
145780588|NCT01208181|525703759|FG001|Part 2|Adverse Event|0|||
145780589|NCT01208181|525703760|FG002|Part 2|Adverse Event|6|||
145780590|NCT01208181|525703761|FG003|Part 2|Adverse Event|7|||
145608993|NCT02969525|525083278|FG010|Double-Blind Period|Adverse Event|0|||
145608994|NCT02969525|525083279|FG011|Double-Blind Period|Adverse Event|0|||
145608995|NCT02969525|525083268|FG000|Double-Blind Period|LOW EGFR|0|||
145608996|NCT02969525|525083269|FG001|Double-Blind Period|LOW EGFR|0|||
145608997|NCT02969525|525083270|FG002|Double-Blind Period|LOW EGFR|0|||
145608998|NCT02969525|525083271|FG003|Double-Blind Period|LOW EGFR|1|||
145608999|NCT02969525|525083272|FG004|Double-Blind Period|LOW EGFR|0|||
145609000|NCT02969525|525083273|FG005|Double-Blind Period|LOW EGFR|0|||
145609001|NCT02969525|525083274|FG006|Double-Blind Period|LOW EGFR|0|||
145609002|NCT02969525|525083275|FG007|Double-Blind Period|LOW EGFR|0|||
145609003|NCT02969525|525083276|FG008|Double-Blind Period|LOW EGFR|0|||
145609004|NCT02969525|525083277|FG009|Double-Blind Period|LOW EGFR|0|||
145609005|NCT02969525|525083278|FG010|Double-Blind Period|LOW EGFR|0|||
145609006|NCT02969525|525083279|FG011|Double-Blind Period|LOW EGFR|0|||
145609007|NCT02969525|525083268|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
145609008|NCT02969525|525083269|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609009|NCT02969525|525083270|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609010|NCT02969525|525083271|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
145609011|NCT02969525|525083272|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609012|NCT02969525|525083273|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609013|NCT02969525|525083274|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609014|NCT02969525|525083275|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609015|NCT02969525|525083276|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609016|NCT02969525|525083277|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609017|NCT02969525|525083278|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609018|NCT02969525|525083279|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
145609019|NCT02969525|525083268|FG000|Dose-Blind Period|Adverse Event|0|||
145609020|NCT02969525|525083269|FG001|Dose-Blind Period|Adverse Event|0|||
145609021|NCT02969525|525083270|FG002|Dose-Blind Period|Adverse Event|0|||
145609022|NCT02969525|525083271|FG003|Dose-Blind Period|Adverse Event|0|||
145609023|NCT02969525|525083272|FG004|Dose-Blind Period|Adverse Event|0|||
145609024|NCT02969525|525083273|FG005|Dose-Blind Period|Adverse Event|0|||
145609025|NCT02969525|525083274|FG006|Dose-Blind Period|Adverse Event|0|||
145609026|NCT02969525|525083275|FG007|Dose-Blind Period|Adverse Event|0|||
145609027|NCT02969525|525083276|FG008|Dose-Blind Period|Adverse Event|0|||
145609028|NCT02969525|525083277|FG009|Dose-Blind Period|Adverse Event|1|||
145609029|NCT02969525|525083278|FG010|Dose-Blind Period|Adverse Event|1|||
145609030|NCT02969525|525083279|FG011|Dose-Blind Period|Adverse Event|1|||
145609031|NCT02969525|525083268|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
145609032|NCT02969525|525083269|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
145609033|NCT02969525|525083270|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
145609034|NCT02969525|525083271|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
145609035|NCT02969525|525083272|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
145609036|NCT02969525|525083273|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
145609037|NCT02969525|525083274|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
145609038|NCT02969525|525083275|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
145609039|NCT02969525|525083276|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
145780591|NCT01208181|525703762|FG004|Part 2|Adverse Event|0|||
145780592|NCT01208181|525703758|FG000|Part 2|Withdrawal by Subject|0|||
145780593|NCT01208181|525703759|FG001|Part 2|Withdrawal by Subject|0|||
145780594|NCT01208181|525703760|FG002|Part 2|Withdrawal by Subject|1|||
145780595|NCT01208181|525703761|FG003|Part 2|Withdrawal by Subject|1|||
145780596|NCT01208181|525703762|FG004|Part 2|Withdrawal by Subject|0|||
145780597|NCT01208181|525703758|FG000|Part 2|Protocol Violation|0|||
145780598|NCT01208181|525703759|FG001|Part 2|Protocol Violation|0|||
145780599|NCT01208181|525703760|FG002|Part 2|Protocol Violation|1|||
145780600|NCT01208181|525703761|FG003|Part 2|Protocol Violation|0|||
145780601|NCT01208181|525703762|FG004|Part 2|Protocol Violation|0|||
145780602|NCT01208181|525703758|FG000|Part 2|Physician Decision|0|||
145609040|NCT02969525|525083277|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
145609041|NCT02969525|525083278|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
145609042|NCT02969525|525083279|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
145780603|NCT01208181|525703759|FG001|Part 2|Physician Decision|0|||
145780604|NCT01208181|525703760|FG002|Part 2|Physician Decision|1|||
145780605|NCT01208181|525703761|FG003|Part 2|Physician Decision|2|||
145609043|NCT02969525|525083268|FG000|Dose-Blind Period|Non-cooperating patient|0|||
145609044|NCT02969525|525083269|FG001|Dose-Blind Period|Non-cooperating patient|0|||
145609045|NCT02969525|525083270|FG002|Dose-Blind Period|Non-cooperating patient|0|||
145780606|NCT01208181|525703762|FG004|Part 2|Physician Decision|0|||
145780607|NCT01208181|525703758|FG000|Part 2|Non-compliance with study drug|0|||
145780608|NCT01208181|525703759|FG001|Part 2|Non-compliance with study drug|0|||
145780609|NCT01208181|525703760|FG002|Part 2|Non-compliance with study drug|1|||
145780610|NCT01208181|525703761|FG003|Part 2|Non-compliance with study drug|1|||
145780611|NCT01208181|525703762|FG004|Part 2|Non-compliance with study drug|0|||
145780612|NCT01208181|525703758|FG000|Part 2|Lost to Follow-up|0|||
145780613|NCT01208181|525703759|FG001|Part 2|Lost to Follow-up|0|||
145780614|NCT01208181|525703760|FG002|Part 2|Lost to Follow-up|1|||
145780615|NCT01208181|525703761|FG003|Part 2|Lost to Follow-up|2|||
145780616|NCT01208181|525703762|FG004|Part 2|Lost to Follow-up|0|||
145780617|NCT01208181|525703758|FG000|Part 2|Lack of Efficacy|0|||
145780618|NCT01208181|525703759|FG001|Part 2|Lack of Efficacy|0|||
145780619|NCT01208181|525703760|FG002|Part 2|Lack of Efficacy|5|||
145279213|NCT00830063|523872879|FG002|Overall Study|Adverse Event|16|||
145279214|NCT00830063|523872880|FG003|Overall Study|Adverse Event|13|||
145279215|NCT00830063|523872877|FG000|Overall Study|Death|1|||
145279216|NCT00830063|523872878|FG001|Overall Study|Death|0|||
145279217|NCT00830063|523872879|FG002|Overall Study|Death|0|||
145279218|NCT00830063|523872880|FG003|Overall Study|Death|0|||
145279219|NCT00830063|523872877|FG000|Overall Study|Lost to Follow-up|0|||
145279220|NCT00830063|523872878|FG001|Overall Study|Lost to Follow-up|0|||
145279221|NCT00830063|523872879|FG002|Overall Study|Lost to Follow-up|3|||
145279222|NCT00830063|523872880|FG003|Overall Study|Lost to Follow-up|1|||
145279223|NCT00830063|523872877|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
145279224|NCT00830063|523872878|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
145537247|NCT01187433|524825768|FG001|Overall Study|Withdrawal by Subject|2|||
145780620|NCT01208181|525703761|FG003|Part 2|Lack of Efficacy|7|||
145780621|NCT01208181|525703762|FG004|Part 2|Lack of Efficacy|0|||
145780622|NCT04275310|525705483|FG000|Overall Study|Non-randomized due to running out of funding|4|||
145780623|NCT04275310|525705484|FG001|Overall Study|Non-randomized due to running out of funding|0|||
145780624|NCT00631488|525705485|FG000|Overall Study|Adverse Event|1|||
145780625|NCT00631488|525705486|FG001|Overall Study|Adverse Event|0|||
145780626|NCT00631488|525705487|FG002|Overall Study|Adverse Event|0|||
145780627|NCT00631488|525705485|FG000|Overall Study|Lost to Follow-up|2|||
145780628|NCT00631488|525705486|FG001|Overall Study|Lost to Follow-up|2|||
145780629|NCT00631488|525705487|FG002|Overall Study|Lost to Follow-up|0|||
145780630|NCT00631488|525705485|FG000|Overall Study|Physician Decision|1|||
145780631|NCT00631488|525705486|FG001|Overall Study|Physician Decision|0|||
145780632|NCT00631488|525705487|FG002|Overall Study|Physician Decision|1|||
145780633|NCT00631488|525705485|FG000|Overall Study|Protocol Violation|0|||
145780634|NCT00631488|525705486|FG001|Overall Study|Protocol Violation|0|||
145780635|NCT00631488|525705487|FG002|Overall Study|Protocol Violation|1|||
145780636|NCT02064439|525705489|FG000|Overall Study|Adverse Event|51|||
145780637|NCT02064439|525705490|FG001|Overall Study|Adverse Event|47|||
145780638|NCT02064439|525705491|FG002|Overall Study|Adverse Event|46|||
145780639|NCT02064439|525705489|FG000|Overall Study|Death|0|||
145780640|NCT02064439|525705490|FG001|Overall Study|Death|2|||
145780641|NCT02064439|525705491|FG002|Overall Study|Death|3|||
145780642|NCT02064439|525705489|FG000|Overall Study|Withdrawal by Subject|29|||
145780643|NCT02064439|525705490|FG001|Overall Study|Withdrawal by Subject|18|||
145780644|NCT02064439|525705491|FG002|Overall Study|Withdrawal by Subject|26|||
145780645|NCT02064439|525705489|FG000|Overall Study|Protocol Violation|3|||
145780646|NCT02064439|525705490|FG001|Overall Study|Protocol Violation|5|||
145780647|NCT02064439|525705491|FG002|Overall Study|Protocol Violation|3|||
145780648|NCT02064439|525705489|FG000|Overall Study|Lost to Follow-up|1|||
145780649|NCT02064439|525705490|FG001|Overall Study|Lost to Follow-up|3|||
145780650|NCT02064439|525705491|FG002|Overall Study|Lost to Follow-up|4|||
145780651|NCT02064439|525705489|FG000|Overall Study|Non-compliance with study medication|21|||
145780652|NCT02064439|525705490|FG001|Overall Study|Non-compliance with study medication|19|||
145279225|NCT00830063|523872879|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
145537248|NCT00302107|524825769|FG000|Overall Study|Lost to Follow-up|6|||
145780653|NCT02064439|525705491|FG002|Overall Study|Non-compliance with study medication|23|||
145780654|NCT02064439|525705489|FG000|Overall Study|Physician Decision|0|||
145780655|NCT02064439|525705490|FG001|Overall Study|Physician Decision|1|||
145780656|NCT02064439|525705491|FG002|Overall Study|Physician Decision|1|||
145780657|NCT02064439|525705489|FG000|Overall Study|Logistical difficulties|6|||
145780658|NCT02064439|525705490|FG001|Overall Study|Logistical difficulties|5|||
145780659|NCT02064439|525705491|FG002|Overall Study|Logistical difficulties|2|||
145780660|NCT02064439|525705489|FG000|Overall Study|Efficacy outcome reached|18|||
145780661|NCT02064439|525705490|FG001|Overall Study|Efficacy outcome reached|16|||
145780662|NCT02064439|525705491|FG002|Overall Study|Efficacy outcome reached|57|||
145780663|NCT02064439|525705489|FG000|Overall Study|Safety outcome reached|12|||
145780664|NCT02064439|525705490|FG001|Overall Study|Safety outcome reached|20|||
145780665|NCT02064439|525705491|FG002|Overall Study|Safety outcome reached|10|||
145780666|NCT02064439|525705489|FG000|Overall Study|Other|2|||
145780667|NCT02064439|525705490|FG001|Overall Study|Other|2|||
145780668|NCT02064439|525705491|FG002|Overall Study|Other|7|||
145780669|NCT03350750|525705492|FG000|Overall Study|Death|1|||
145780670|NCT03350750|525705493|FG001|Overall Study|Death|1|||
145780671|NCT02433288|525705494|FG000|Overall Study|Severe non-compliance to protocol|13|||
145780672|NCT02433288|525705495|FG001|Overall Study|Severe non-compliance to protocol|7|||
145780673|NCT02433288|525705494|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
145780674|NCT02433288|525705495|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
145780675|NCT02433288|525705494|FG000|Overall Study|Withdrawal by Subject|101|||
145780676|NCT02433288|525705495|FG001|Overall Study|Withdrawal by Subject|99|||
145780677|NCT02433288|525705494|FG000|Overall Study|Lost to Follow-up|2|||
145780678|NCT02433288|525705495|FG001|Overall Study|Lost to Follow-up|14|||
145780679|NCT02433288|525705494|FG000|Overall Study|Death|0|||
145780680|NCT02433288|525705495|FG001|Overall Study|Death|3|||
145780681|NCT01849250|525705496|FG000|Overall Study|Withdrawal by Subject|1|||
145780682|NCT01849250|525705497|FG001|Overall Study|Withdrawal by Subject|0|||
145780683|NCT01849250|525705496|FG000|Overall Study|Not Evaluable|5|||
145780684|NCT01849250|525705497|FG001|Overall Study|Not Evaluable|3|||
145780685|NCT01849250|525705496|FG000|Overall Study|Screen Failure|1|||
145780686|NCT01849250|525705497|FG001|Overall Study|Screen Failure|0|||
145780687|NCT00367640|525705498|FG000|Overall Study|Adverse Event|3|||
145780688|NCT00367640|525705499|FG001|Overall Study|Adverse Event|6|||
145780689|NCT00367640|525705500|FG002|Overall Study|Adverse Event|8|||
145780690|NCT00367640|525705501|FG003|Overall Study|Adverse Event|0|||
145780691|NCT00367640|525705498|FG000|Overall Study|Withdrawal by Subject|8|||
145780692|NCT00367640|525705499|FG001|Overall Study|Withdrawal by Subject|11|||
145780693|NCT00367640|525705500|FG002|Overall Study|Withdrawal by Subject|8|||
145780694|NCT00367640|525705501|FG003|Overall Study|Withdrawal by Subject|6|||
145780695|NCT00367640|525705498|FG000|Overall Study|Any other reason not above-mentioned|7|||
145780696|NCT00367640|525705499|FG001|Overall Study|Any other reason not above-mentioned|5|||
145780697|NCT00367640|525705500|FG002|Overall Study|Any other reason not above-mentioned|3|||
145780698|NCT00367640|525705501|FG003|Overall Study|Any other reason not above-mentioned|4|||
145780699|NCT04504032|525705507|FG000|Overall Study|Adverse Event|1|||
145780700|NCT04504032|525705508|FG001|Overall Study|Adverse Event|2|||
145780701|NCT04504032|525705507|FG000|Overall Study|Lost to Follow-up|6|||
145780702|NCT04504032|525705508|FG001|Overall Study|Lost to Follow-up|9|||
145780703|NCT04504032|525705507|FG000|Overall Study|Protocol Violation|2|||
145780704|NCT04504032|525705508|FG001|Overall Study|Protocol Violation|0|||
145780705|NCT04504032|525705507|FG000|Overall Study|Study terminated by sponsor|1|||
145780706|NCT04504032|525705508|FG001|Overall Study|Study terminated by sponsor|2|||
145780707|NCT04504032|525705507|FG000|Overall Study|Withdrawal by Subject|9|||
145780708|NCT04504032|525705508|FG001|Overall Study|Withdrawal by Subject|11|||
145780709|NCT04504032|525705507|FG000|Overall Study|Disease progression prior to dosing|15|||
145780710|NCT04504032|525705508|FG001|Overall Study|Disease progression prior to dosing|3|||
145780711|NCT04504032|525705507|FG000|Overall Study|Drug supply issues|1|||
145780712|NCT04504032|525705508|FG001|Overall Study|Drug supply issues|1|||
145780713|NCT04504032|525705507|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
145780714|NCT04504032|525705508|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
145780715|NCT00771030|525705509|FG000|Overall Study|Adverse Event|0|||
145780716|NCT00771030|525705510|FG001|Overall Study|Adverse Event|1|||
145780717|NCT00771030|525705511|FG002|Overall Study|Adverse Event|0|||
145780718|NCT00771030|525705512|FG003|Overall Study|Adverse Event|0|||
145780719|NCT00771030|525705513|FG004|Overall Study|Adverse Event|0|||
145780720|NCT00771030|525705514|FG005|Overall Study|Adverse Event|0|||
145780721|NCT00771030|525705515|FG006|Overall Study|Adverse Event|0|||
145780722|NCT01839188|525705516|FG000|Overall Study|Withdrawal by Subject|1|||
145780723|NCT02805907|525705517|FG000|Overall Study|Lost to Follow-up|3|||
145780724|NCT02805907|525705518|FG001|Overall Study|Lost to Follow-up|3|||
145780725|NCT01022853|525705529|FG000|Overall Study|Progressive disease|2|||
145780726|NCT01022853|525705530|FG001|Overall Study|Progressive disease|3|||
145780727|NCT01022853|525705531|FG002|Overall Study|Progressive disease|11|||
145780728|NCT01022853|525705532|FG003|Overall Study|Progressive disease|7|||
145780729|NCT01022853|525705533|FG004|Overall Study|Progressive disease|1|||
145780730|NCT01022853|525705529|FG000|Overall Study|Dose-limiting toxicity|0|||
145780731|NCT01022853|525705530|FG001|Overall Study|Dose-limiting toxicity|0|||
145780732|NCT01022853|525705531|FG002|Overall Study|Dose-limiting toxicity|0|||
145780733|NCT01022853|525705532|FG003|Overall Study|Dose-limiting toxicity|0|||
145780734|NCT01022853|525705533|FG004|Overall Study|Dose-limiting toxicity|1|||
145780735|NCT01022853|525705529|FG000|Overall Study|Withdrawal by Subject|0|||
145780736|NCT01022853|525705530|FG001|Overall Study|Withdrawal by Subject|1|||
145780737|NCT01022853|525705531|FG002|Overall Study|Withdrawal by Subject|1|||
145780738|NCT01022853|525705532|FG003|Overall Study|Withdrawal by Subject|1|||
145780739|NCT01022853|525705533|FG004|Overall Study|Withdrawal by Subject|0|||
145780740|NCT01022853|525705529|FG000|Overall Study|Other not stated above|1|||
145780741|NCT01022853|525705530|FG001|Overall Study|Other not stated above|0|||
145780742|NCT01022853|525705531|FG002|Overall Study|Other not stated above|1|||
145780743|NCT01022853|525705532|FG003|Overall Study|Other not stated above|0|||
145780744|NCT01022853|525705533|FG004|Overall Study|Other not stated above|0|||
145780745|NCT02416908|525705534|FG000|Dose Escalation Phase|Adverse Event|0|||
145780746|NCT02416908|525705535|FG001|Dose Escalation Phase|Adverse Event|0|||
145780747|NCT02416908|525705536|FG002|Dose Escalation Phase|Adverse Event|3|||
145780748|NCT02416908|525705537|FG003|Dose Escalation Phase|Adverse Event|0|||
145780749|NCT02416908|525705534|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145780750|NCT02416908|525705535|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
145780751|NCT02416908|525705536|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
145609046|NCT02969525|525083271|FG003|Dose-Blind Period|Non-cooperating patient|0|||
145609047|NCT02969525|525083272|FG004|Dose-Blind Period|Non-cooperating patient|0|||
145609048|NCT02969525|525083273|FG005|Dose-Blind Period|Non-cooperating patient|0|||
145609049|NCT02969525|525083274|FG006|Dose-Blind Period|Non-cooperating patient|0|||
145609050|NCT02969525|525083275|FG007|Dose-Blind Period|Non-cooperating patient|0|||
145609051|NCT02969525|525083276|FG008|Dose-Blind Period|Non-cooperating patient|0|||
145609052|NCT02969525|525083277|FG009|Dose-Blind Period|Non-cooperating patient|0|||
145609053|NCT02969525|525083278|FG010|Dose-Blind Period|Non-cooperating patient|0|||
145609054|NCT02969525|525083279|FG011|Dose-Blind Period|Non-cooperating patient|1|||
145609055|NCT02969525|525083268|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609056|NCT02969525|525083269|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609057|NCT02969525|525083270|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609058|NCT02969525|525083271|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609059|NCT02969525|525083272|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609060|NCT02969525|525083273|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609061|NCT02969525|525083274|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609062|NCT02969525|525083275|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145780752|NCT02416908|525705537|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145780753|NCT02075255|525705539|FG000|Overall Study|Study specific withdrawal criteria|0|||
145780754|NCT02075255|525705540|FG001|Overall Study|Study specific withdrawal criteria|1|||
145780755|NCT02075255|525705541|FG002|Overall Study|Study specific withdrawal criteria|1|||
145403726|NCT01232283|524334395|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145780756|NCT02075255|525705539|FG000|Overall Study|Withdrawal by Subject|4|||
145780757|NCT02075255|525705540|FG001|Overall Study|Withdrawal by Subject|1|||
145780758|NCT02075255|525705541|FG002|Overall Study|Withdrawal by Subject|0|||
145780759|NCT02075255|525705539|FG000|Overall Study|Lost to Follow-up|0|||
145780760|NCT02075255|525705540|FG001|Overall Study|Lost to Follow-up|0|||
145780761|NCT02075255|525705541|FG002|Overall Study|Lost to Follow-up|1|||
145780762|NCT02075255|525705539|FG000|Overall Study|Adverse Event|0|||
145780763|NCT02075255|525705540|FG001|Overall Study|Adverse Event|0|||
145780764|NCT02075255|525705541|FG002|Overall Study|Adverse Event|1|||
145403727|NCT01232283|524334396|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145403728|NCT01232283|524334397|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145780765|NCT02075255|525705539|FG000|Overall Study|Death|0|||
145780766|NCT02075255|525705540|FG001|Overall Study|Death|2|||
145780767|NCT02075255|525705541|FG002|Overall Study|Death|0|||
145780768|NCT03792750|525705542|FG000|Overall Study|Death|3|||
145780769|NCT01478347|525705544|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
145780770|NCT01478347|525705544|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
145780771|NCT01478347|525705544|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
145780772|NCT01645930|525705545|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
145780773|NCT01645930|525705545|FG000|Overall Study|Progressive Disease|12|||
145780774|NCT01645930|525705545|FG000|Overall Study|Adverse Event|4|||
145780775|NCT01645930|525705545|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
145780776|NCT01645930|525705545|FG000|Overall Study|Withdrawal by Participant|2|||
145780777|NCT01645930|525705545|FG000|Overall Study|Reason not Defined|1|||
145780778|NCT01748760|525705546|FG000|Overall Study|Withdrawal by Subject|1|||
145780779|NCT01748760|525705547|FG001|Overall Study|Withdrawal by Subject|1|||
145780780|NCT01748760|525705546|FG000|Overall Study|Lost to Follow-up|5|||
145780781|NCT01748760|525705547|FG001|Overall Study|Lost to Follow-up|1|||
145780782|NCT03245814|525705548|FG000|Overall Study|Lost to Follow-up|5|||
145780783|NCT03245814|525705549|FG001|Overall Study|Lost to Follow-up|8|||
145780784|NCT03245814|525705548|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
145780785|NCT03245814|525705549|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
145780786|NCT02263365|525705553|FG000|Overall Study|Physician Decision|22|||
145780787|NCT02263365|525705554|FG001|Overall Study|Physician Decision|18|||
145780788|NCT00510692|525705555|FG000|Overall Study|Adverse Event|1|||
145780789|NCT00510692|525705556|FG001|Overall Study|Adverse Event|3|||
145780790|NCT00510692|525705555|FG000|Overall Study|Withdrawal by Subject|1|||
145780791|NCT00510692|525705556|FG001|Overall Study|Withdrawal by Subject|0|||
145780792|NCT00945191|525705557|FG000|Overall Study|Did not achieve a complete response|18|||
145780793|NCT00945191|525705557|FG000|Overall Study|Participant relocated to another state|1|||
145780794|NCT00945191|525705557|FG000|Overall Study|Disease progression|3|||
145780795|NCT00945191|525705557|FG000|Overall Study|Serious adverse event or adverse event|1|||
145780796|NCT00945191|525705557|FG000|Overall Study|Investigator's discretion|1|||
145780797|NCT01845077|525705560|FG000|Washout Period|Lost to Follow-up|0|||
145780798|NCT01845077|525705561|FG001|Washout Period|Lost to Follow-up|1|||
145780799|NCT01845077|525705562|FG002|Washout Period|Lost to Follow-up|0|||
145780800|NCT01845077|525705563|FG003|Washout Period|Lost to Follow-up|1|||
145780801|NCT01845077|525705564|FG004|Washout Period|Lost to Follow-up|0|||
145780802|NCT01845077|525705565|FG005|Washout Period|Lost to Follow-up|1|||
145780803|NCT01845077|525705560|FG000|Washout Period|Adverse Event|1|||
145780804|NCT01845077|525705561|FG001|Washout Period|Adverse Event|0|||
145780805|NCT01845077|525705562|FG002|Washout Period|Adverse Event|0|||
145780806|NCT01845077|525705563|FG003|Washout Period|Adverse Event|0|||
145780807|NCT01845077|525705564|FG004|Washout Period|Adverse Event|0|||
145780808|NCT01845077|525705565|FG005|Washout Period|Adverse Event|0|||
145780809|NCT01845077|525705560|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
145780810|NCT01845077|525705561|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
145780811|NCT01845077|525705562|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
145780812|NCT01845077|525705563|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
145780813|NCT01845077|525705564|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
145780814|NCT01845077|525705565|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
145780815|NCT01845077|525705560|FG000|Washout Period|Protocol Violation|0|||
145780816|NCT01845077|525705561|FG001|Washout Period|Protocol Violation|0|||
145780817|NCT01845077|525705562|FG002|Washout Period|Protocol Violation|0|||
145780818|NCT01845077|525705563|FG003|Washout Period|Protocol Violation|1|||
145780819|NCT01845077|525705564|FG004|Washout Period|Protocol Violation|1|||
145780820|NCT01845077|525705565|FG005|Washout Period|Protocol Violation|0|||
145780821|NCT00394914|525705568|FG000|Treatment Period|Adverse Event|0|||
145780822|NCT00394914|525705569|FG001|Treatment Period|Adverse Event|3|||
145780823|NCT00394914|525705570|FG002|Treatment Period|Adverse Event|1|||
145780824|NCT00394914|525705568|FG000|Treatment Period|Lost to Follow-up|0|||
145780825|NCT00394914|525705569|FG001|Treatment Period|Lost to Follow-up|1|||
145780826|NCT00394914|525705570|FG002|Treatment Period|Lost to Follow-up|0|||
145780827|NCT00394914|525705568|FG000|Treatment Period|Withdrawal by Subject|0|||
145780828|NCT00394914|525705569|FG001|Treatment Period|Withdrawal by Subject|2|||
145780829|NCT00394914|525705570|FG002|Treatment Period|Withdrawal by Subject|2|||
145780830|NCT00394914|525705568|FG000|Treatment Period|Noncompliance with protocol|0|||
145780831|NCT00394914|525705569|FG001|Treatment Period|Noncompliance with protocol|3|||
145780832|NCT00394914|525705570|FG002|Treatment Period|Noncompliance with protocol|2|||
145780833|NCT00394914|525705568|FG000|Treatment Period|Did not meet protocol eligibility|0|||
145780834|NCT00394914|525705569|FG001|Treatment Period|Did not meet protocol eligibility|1|||
145609063|NCT02969525|525083276|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145780835|NCT00394914|525705570|FG002|Treatment Period|Did not meet protocol eligibility|1|||
145780836|NCT00312377|525705574|FG000|Overall Study|Death|403|||
145780837|NCT00312377|525705575|FG001|Overall Study|Death|418|||
145780838|NCT00312377|525705574|FG000|Overall Study|Withdrawal by Subject|23|||
145780839|NCT00312377|525705575|FG001|Overall Study|Withdrawal by Subject|30|||
145780840|NCT00312377|525705574|FG000|Overall Study|Lost to Follow-up|9|||
145780841|NCT00312377|525705575|FG001|Overall Study|Lost to Follow-up|12|||
145780842|NCT00312377|525705574|FG000|Overall Study|Non-compliance|0|||
145780843|NCT00312377|525705575|FG001|Overall Study|Non-compliance|2|||
145780844|NCT00312377|525705574|FG000|Overall Study|Randomised but never received treatment|6|||
145780845|NCT00312377|525705575|FG001|Overall Study|Randomised but never received treatment|6|||
145780846|NCT00312377|525705574|FG000|Overall Study|Discontinue treatment survival follow up|202|||
145780847|NCT00312377|525705575|FG001|Overall Study|Discontinue treatment survival follow up|200|||
145780848|NCT00312377|525705574|FG000|Overall Study|Site ended participation in study|1|||
145780849|NCT00312377|525705575|FG001|Overall Study|Site ended participation in study|0|||
145780850|NCT00872898|525705576|FG000|Part Two - Double Blind|Adverse Event|4|||
145780851|NCT00872898|525705577|FG001|Part Two - Double Blind|Adverse Event|3|||
145780852|NCT00872898|525705576|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
145780853|NCT00872898|525705577|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
145780854|NCT00872898|525705576|FG000|Part Two - Double Blind|Protocol Violation|1|||
145780855|NCT00872898|525705577|FG001|Part Two - Double Blind|Protocol Violation|0|||
145780856|NCT00872898|525705576|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
145780857|NCT00872898|525705577|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
145780858|NCT00872898|525705576|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
145780859|NCT00872898|525705577|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
145780860|NCT00872898|525705576|FG000|Part Two - Double Blind|Other reasons|2|||
145780861|NCT00872898|525705577|FG001|Part Two - Double Blind|Other reasons|0|||
145609064|NCT02969525|525083277|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145780862|NCT01004146|525705578|FG000|Overall Study|Withdrawal by Subject|4|||
145780863|NCT01004146|525705579|FG001|Overall Study|Withdrawal by Subject|5|||
145780864|NCT03290300|525705587|FG000|Overall Study|Lost to Follow-up|3|||
145780865|NCT01001494|525705588|FG000|Overall Study|Adverse Event|8|||
145780866|NCT01001494|525705589|FG001|Overall Study|Adverse Event|4|||
145780867|NCT01001494|525705590|FG002|Overall Study|Adverse Event|6|||
145780868|NCT01001494|525705588|FG000|Overall Study|Protocol Violation|0|||
145780869|NCT01001494|525705589|FG001|Overall Study|Protocol Violation|1|||
145780870|NCT01001494|525705590|FG002|Overall Study|Protocol Violation|1|||
145780871|NCT01001494|525705588|FG000|Overall Study|Lost to Follow-up|2|||
145780872|NCT01001494|525705589|FG001|Overall Study|Lost to Follow-up|0|||
145780873|NCT01001494|525705590|FG002|Overall Study|Lost to Follow-up|1|||
145780874|NCT01001494|525705588|FG000|Overall Study|Withdrawal by Subject|9|||
145780875|NCT01001494|525705589|FG001|Overall Study|Withdrawal by Subject|7|||
145780876|NCT01001494|525705590|FG002|Overall Study|Withdrawal by Subject|17|||
145780877|NCT01001494|525705588|FG000|Overall Study|COPD exacerbation|3|||
145780878|NCT01001494|525705589|FG001|Overall Study|COPD exacerbation|4|||
145780879|NCT01001494|525705590|FG002|Overall Study|COPD exacerbation|5|||
145780880|NCT01001494|525705588|FG000|Overall Study|Lack of Efficacy|2|||
145780881|NCT01001494|525705589|FG001|Overall Study|Lack of Efficacy|0|||
145780882|NCT01001494|525705590|FG002|Overall Study|Lack of Efficacy|8|||
145609065|NCT02969525|525083278|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
145609066|NCT02969525|525083279|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
145609067|NCT03445065|525083280|FG000|Overall Study|Withdrawal by Subject|3|||
145780883|NCT01001494|525705588|FG000|Overall Study|Other|0|||
145780884|NCT01001494|525705589|FG001|Overall Study|Other|1|||
145403729|NCT01232283|524334398|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145403730|NCT01232283|524334399|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145780885|NCT01001494|525705590|FG002|Overall Study|Other|3|||
145780886|NCT02179398|525705591|FG000|Overall Study|Lack of obligatory data|3|||
145780887|NCT02179398|525705592|FG001|Overall Study|Lack of obligatory data|3|||
145780888|NCT02179398|525705591|FG000|Overall Study|Lost to Follow-up|0|||
145780889|NCT02179398|525705592|FG001|Overall Study|Lost to Follow-up|1|||
145780890|NCT02519231|525705594|FG000|Overall Study|Lost to Follow-up|2|||
145780891|NCT02519231|525705595|FG001|Overall Study|Lost to Follow-up|5|||
145780892|NCT02519231|525705594|FG000|Overall Study|Withdrawal by Subject|0|||
145780893|NCT02519231|525705595|FG001|Overall Study|Withdrawal by Subject|1|||
145780894|NCT00815308|525705596|FG000|Overall Study|Adverse Event|4|||
145780895|NCT00815308|525705596|FG000|Overall Study|Withdrawal by Subject|0|||
145780896|NCT00815308|525705596|FG000|Overall Study|Protocol Violation|6|||
145780897|NCT03176966|525705604|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
145780898|NCT03176966|525705605|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
145780899|NCT03176966|525705604|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
145780900|NCT03176966|525705605|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
145780901|NCT03176966|525705604|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
145780902|NCT03176966|525705605|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
145780903|NCT03176966|525705604|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
145780904|NCT03176966|525705605|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
145780905|NCT03176966|525705604|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
145780906|NCT03176966|525705605|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
145780907|NCT03176966|525705604|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
145780908|NCT03176966|525705605|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
145780909|NCT03176966|525705604|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
145780910|NCT03176966|525705605|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
145780911|NCT01520922|525705606|FG000|Treatment Phase|Physician Decision|2|||
145780912|NCT01520922|525705607|FG001|Treatment Phase|Physician Decision|1|||
145780913|NCT01520922|525705606|FG000|Treatment Phase|Progression|0|||
145780914|NCT01520922|525705607|FG001|Treatment Phase|Progression|2|||
145780915|NCT01520922|525705606|FG000|Treatment Phase|Adverse Event|3|||
145780916|NCT01520922|525705607|FG001|Treatment Phase|Adverse Event|5|||
145780917|NCT01520922|525705606|FG000|Follow up|Lost to Follow-up|0|||
145780918|NCT01520922|525705607|FG001|Follow up|Lost to Follow-up|1|||
145780919|NCT01520922|525705606|FG000|Survival Follow-up|Withdrawal by Subject|1|||
145780920|NCT01520922|525705607|FG001|Survival Follow-up|Withdrawal by Subject|0|||
145780921|NCT01696877|525705610|FG000|Overall Study|Adverse Event|0|||
145780922|NCT01696877|525705611|FG001|Overall Study|Adverse Event|1|||
145780923|NCT00515463|525705612|FG000|Overall Study|Physician Decision|4|||
145780924|NCT00515463|525705613|FG001|Overall Study|Physician Decision|2|||
145780925|NCT00515463|525705612|FG000|Overall Study|Adverse Event|1|||
145780926|NCT00515463|525705613|FG001|Overall Study|Adverse Event|2|||
145780927|NCT00515463|525705612|FG000|Overall Study|Withdrawal by Subject|3|||
145780928|NCT00515463|525705613|FG001|Overall Study|Withdrawal by Subject|4|||
145780929|NCT00515463|525705612|FG000|Overall Study|Lost to Follow-up|6|||
145780930|NCT00515463|525705613|FG001|Overall Study|Lost to Follow-up|5|||
145780931|NCT00515463|525705612|FG000|Overall Study|Other|0|||
145780932|NCT00515463|525705613|FG001|Overall Study|Other|1|||
145780933|NCT00916721|525705614|FG000|Overall Study|Lost to Follow-up|0|||
145780934|NCT00916721|525705615|FG001|Overall Study|Lost to Follow-up|1|||
145780935|NCT00916721|525705614|FG000|Overall Study|Adverse Event|6|||
145780936|NCT00916721|525705615|FG001|Overall Study|Adverse Event|3|||
145780937|NCT00916721|525705614|FG000|Overall Study|Withdrawal by Subject|2|||
145780938|NCT00916721|525705615|FG001|Overall Study|Withdrawal by Subject|2|||
145780939|NCT00916721|525705614|FG000|Overall Study|Protocol Violation|2|||
145780940|NCT00916721|525705615|FG001|Overall Study|Protocol Violation|4|||
145780941|NCT01903434|525705619|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
145780942|NCT01903434|525705620|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
145780943|NCT01903434|525705619|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
145780944|NCT01903434|525705620|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
145780945|NCT01469052|525705623|FG000|Overall Study|Adverse Event|2|||
145780946|NCT01469052|525705624|FG001|Overall Study|Adverse Event|3|||
145780947|NCT01469052|525705625|FG002|Overall Study|Adverse Event|0|||
145780948|NCT01469052|525705626|FG003|Overall Study|Adverse Event|2|||
145780949|NCT01469052|525705627|FG004|Overall Study|Adverse Event|0|||
145780950|NCT01469052|525705628|FG005|Overall Study|Adverse Event|1|||
145780951|NCT01469052|525705623|FG000|Overall Study|Progressive disease|3|||
145780952|NCT01469052|525705624|FG001|Overall Study|Progressive disease|0|||
145780953|NCT01469052|525705625|FG002|Overall Study|Progressive disease|5|||
145780954|NCT01469052|525705626|FG003|Overall Study|Progressive disease|3|||
145780955|NCT01469052|525705627|FG004|Overall Study|Progressive disease|7|||
145780956|NCT01469052|525705628|FG005|Overall Study|Progressive disease|2|||
145780957|NCT01469052|525705623|FG000|Overall Study|Lack of Efficacy|0|||
145780958|NCT01469052|525705624|FG001|Overall Study|Lack of Efficacy|0|||
145780959|NCT01469052|525705625|FG002|Overall Study|Lack of Efficacy|0|||
145780960|NCT01469052|525705626|FG003|Overall Study|Lack of Efficacy|0|||
145780961|NCT01469052|525705627|FG004|Overall Study|Lack of Efficacy|0|||
145780962|NCT01469052|525705628|FG005|Overall Study|Lack of Efficacy|2|||
145780963|NCT01469052|525705623|FG000|Overall Study|Moved to rollover protocol|1|||
145780964|NCT01469052|525705624|FG001|Overall Study|Moved to rollover protocol|0|||
145780965|NCT01469052|525705625|FG002|Overall Study|Moved to rollover protocol|1|||
145780966|NCT01469052|525705626|FG003|Overall Study|Moved to rollover protocol|0|||
145780967|NCT01469052|525705627|FG004|Overall Study|Moved to rollover protocol|0|||
145780968|NCT01469052|525705628|FG005|Overall Study|Moved to rollover protocol|1|||
145780969|NCT01469052|525705623|FG000|Overall Study|Other|0|||
145780970|NCT01469052|525705624|FG001|Overall Study|Other|1|||
145780971|NCT01469052|525705625|FG002|Overall Study|Other|0|||
145780972|NCT01469052|525705626|FG003|Overall Study|Other|0|||
145780973|NCT01469052|525705627|FG004|Overall Study|Other|1|||
145780974|NCT01469052|525705628|FG005|Overall Study|Other|0|||
145780975|NCT02749370|525705629|FG000|Overall Study|Withdrawal by Subject|11|||
145780976|NCT02749370|525705629|FG000|Overall Study|Lost to Follow-up|3|||
145780977|NCT01519427|525705633|FG000|Overall Study|disease progression|2|||
145780978|NCT03894904|525705634|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
145780979|NCT03894904|525705635|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
145780980|NCT03894904|525705634|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
145780981|NCT03894904|525705635|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
145780982|NCT02190435|525705636|FG000|Overall Study|First 12 patients were lead-ins|12|||
145780983|NCT02190435|525705637|FG001|Overall Study|First 12 patients were lead-ins|0|||
145780984|NCT02190435|525705636|FG000|Overall Study|3 consented screen fails|3|||
145780985|NCT02190435|525705637|FG001|Overall Study|3 consented screen fails|0|||
145780986|NCT00336492|525705638|FG000|Overall Study|Adverse Event|4|||
145780987|NCT00336492|525705639|FG001|Overall Study|Adverse Event|3|||
145780988|NCT00336492|525705640|FG002|Overall Study|Adverse Event|6|||
145780989|NCT00336492|525705638|FG000|Overall Study|Lack of Efficacy|6|||
145780990|NCT00336492|525705639|FG001|Overall Study|Lack of Efficacy|1|||
145780991|NCT00336492|525705640|FG002|Overall Study|Lack of Efficacy|4|||
145780992|NCT00336492|525705638|FG000|Overall Study|Other|5|||
145780993|NCT00336492|525705639|FG001|Overall Study|Other|0|||
145780994|NCT00336492|525705640|FG002|Overall Study|Other|1|||
145780995|NCT01781026|525705641|FG000|Overall Study|Lack of Efficacy|2|||
145780996|NCT02269319|525705642|FG000|Overall Study|Lost to Follow-up|4|||
145780997|NCT02269319|525705643|FG001|Overall Study|Lost to Follow-up|3|||
145780998|NCT02269319|525705642|FG000|Overall Study|Adverse Event|0|||
145780999|NCT02269319|525705643|FG001|Overall Study|Adverse Event|1|||
145781000|NCT02269319|525705642|FG000|Overall Study|Instructions not followed|1|||
145781001|NCT02269319|525705643|FG001|Overall Study|Instructions not followed|0|||
145781002|NCT00404768|525705646|FG000|Part A and B|Withdrawn due to labor progression|1|||
145781003|NCT00404768|525705647|FG001|Part A and B|Withdrawn due to labor progression|0|||
145781004|NCT00404768|525705648|FG002|Part A and B|Withdrawn due to labor progression|0|||
145781005|NCT00404768|525705649|FG003|Part A and B|Withdrawn due to labor progression|0|||
145781006|NCT00404768|525705646|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
145781007|NCT00404768|525705647|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
145781008|NCT00404768|525705648|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
145781009|NCT00404768|525705649|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
145781010|NCT00404768|525705646|FG000|Part C|Adverse Event|0|||
145781011|NCT00404768|525705647|FG001|Part C|Adverse Event|0|||
145781012|NCT00404768|525705648|FG002|Part C|Adverse Event|0|||
145781013|NCT00404768|525705649|FG003|Part C|Adverse Event|3|||
145781014|NCT00404768|525705646|FG000|Part C|Lost to Follow-up|0|||
145781015|NCT00404768|525705647|FG001|Part C|Lost to Follow-up|0|||
145781016|NCT00404768|525705648|FG002|Part C|Lost to Follow-up|3|||
145781017|NCT00404768|525705649|FG003|Part C|Lost to Follow-up|1|||
145781018|NCT00404768|525705646|FG000|Part C|Withdrawal by Subject|0|||
145781019|NCT00404768|525705647|FG001|Part C|Withdrawal by Subject|0|||
145781020|NCT00404768|525705648|FG002|Part C|Withdrawal by Subject|2|||
145781021|NCT00404768|525705649|FG003|Part C|Withdrawal by Subject|1|||
145781022|NCT00404768|525705646|FG000|Part C|Early withdrawal from study medication|0|||
145781023|NCT00404768|525705647|FG001|Part C|Early withdrawal from study medication|0|||
145781024|NCT00404768|525705648|FG002|Part C|Early withdrawal from study medication|1|||
145781025|NCT00404768|525705649|FG003|Part C|Early withdrawal from study medication|0|||
145781026|NCT00404768|525705646|FG000|Part C|Participant did not respond to therapy|0|||
145781027|NCT00404768|525705647|FG001|Part C|Participant did not respond to therapy|0|||
145781028|NCT00404768|525705648|FG002|Part C|Participant did not respond to therapy|1|||
145781029|NCT00404768|525705649|FG003|Part C|Participant did not respond to therapy|1|||
145781030|NCT00404768|525705646|FG000|Part C|Physician withdrew the study medication|0|||
145781031|NCT00404768|525705647|FG001|Part C|Physician withdrew the study medication|0|||
145781032|NCT00404768|525705648|FG002|Part C|Physician withdrew the study medication|1|||
145781033|NCT00404768|525705649|FG003|Part C|Physician withdrew the study medication|0|||
145781034|NCT00404768|525705646|FG000|Part C|Participant delivered baby|0|||
145781035|NCT00404768|525705647|FG001|Part C|Participant delivered baby|0|||
145781036|NCT00404768|525705648|FG002|Part C|Participant delivered baby|0|||
145781037|NCT00404768|525705649|FG003|Part C|Participant delivered baby|1|||
145781038|NCT00404768|525705646|FG000|Part C|Unsatisfactory uterine response to IP|0|||
145781039|NCT00404768|525705647|FG001|Part C|Unsatisfactory uterine response to IP|0|||
145781040|NCT00404768|525705648|FG002|Part C|Unsatisfactory uterine response to IP|0|||
145781041|NCT00404768|525705649|FG003|Part C|Unsatisfactory uterine response to IP|1|||
145781042|NCT00404768|525705646|FG000|Part C|Active labor|0|||
145781043|NCT00404768|525705647|FG001|Part C|Active labor|0|||
145403731|NCT01232283|524334400|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
145403732|NCT01232283|524334401|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
145403733|NCT01232283|524334402|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
145781044|NCT00404768|525705648|FG002|Part C|Active labor|0|||
145781045|NCT00404768|525705649|FG003|Part C|Active labor|1|||
145781046|NCT00404768|525705646|FG000|Part C|Lack of Efficacy|0|||
145781047|NCT00404768|525705647|FG001|Part C|Lack of Efficacy|0|||
145781048|NCT00404768|525705648|FG002|Part C|Lack of Efficacy|0|||
145781049|NCT00404768|525705649|FG003|Part C|Lack of Efficacy|2|||
145781050|NCT00404768|525705646|FG000|Part C|Treatment failure|0|||
145781051|NCT00404768|525705647|FG001|Part C|Treatment failure|0|||
145781052|NCT00404768|525705648|FG002|Part C|Treatment failure|0|||
145781053|NCT00404768|525705649|FG003|Part C|Treatment failure|1|||
145781054|NCT00404768|525705646|FG000|Part C|Investigator discretion|0|||
145781055|NCT00404768|525705647|FG001|Part C|Investigator discretion|0|||
145781056|NCT00404768|525705648|FG002|Part C|Investigator discretion|0|||
145781057|NCT00404768|525705649|FG003|Part C|Investigator discretion|1|||
145781058|NCT00404768|525705646|FG000|Part C|Researcher suspended study medication|0|||
145781059|NCT00404768|525705647|FG001|Part C|Researcher suspended study medication|0|||
145781060|NCT00404768|525705648|FG002|Part C|Researcher suspended study medication|0|||
145781061|NCT00404768|525705649|FG003|Part C|Researcher suspended study medication|1|||
145781062|NCT04773041|525705652|FG000|Overall Study|Unable to data match|1|||
145781063|NCT04773041|525705653|FG001|Overall Study|Unable to data match|0|||
145781064|NCT04773041|525705654|FG002|Overall Study|Unable to data match|0|||
145781065|NCT02699515|525707166|FG000|Overall Study|Death|3|||
145781066|NCT02699515|525707167|FG001|Overall Study|Death|3|||
145781067|NCT02699515|525707168|FG002|Overall Study|Death|3|||
145781068|NCT02699515|525707169|FG003|Overall Study|Death|23|||
145781069|NCT02699515|525707170|FG004|Overall Study|Death|22|||
145781070|NCT02699515|525707171|FG005|Overall Study|Death|23|||
145781071|NCT02699515|525707172|FG006|Overall Study|Death|3|||
145781072|NCT02699515|525707173|FG007|Overall Study|Death|5|||
145781073|NCT02699515|525707166|FG000|Overall Study|Withdrawal by Subject|0|||
145781074|NCT02699515|525707167|FG001|Overall Study|Withdrawal by Subject|0|||
145781075|NCT02699515|525707168|FG002|Overall Study|Withdrawal by Subject|3|||
145781076|NCT02699515|525707169|FG003|Overall Study|Withdrawal by Subject|1|||
145781077|NCT02699515|525707170|FG004|Overall Study|Withdrawal by Subject|5|||
145781078|NCT02699515|525707171|FG005|Overall Study|Withdrawal by Subject|3|||
145781079|NCT02699515|525707172|FG006|Overall Study|Withdrawal by Subject|0|||
145781080|NCT02699515|525707173|FG007|Overall Study|Withdrawal by Subject|1|||
145781081|NCT02699515|525707166|FG000|Overall Study|Other|1|||
145781082|NCT02699515|525707167|FG001|Overall Study|Other|0|||
145781083|NCT02699515|525707168|FG002|Overall Study|Other|1|||
145781084|NCT02699515|525707169|FG003|Overall Study|Other|6|||
145781085|NCT02699515|525707170|FG004|Overall Study|Other|4|||
145781086|NCT02699515|525707171|FG005|Overall Study|Other|3|||
145781087|NCT02699515|525707172|FG006|Overall Study|Other|0|||
145781088|NCT02699515|525707173|FG007|Overall Study|Other|0|||
145781089|NCT01240811|525707178|FG000|Overall Study|Physician Decision|0|||
145781090|NCT01240811|525707179|FG001|Overall Study|Physician Decision|1|||
145781091|NCT01240811|525707180|FG002|Overall Study|Physician Decision|0|||
145781092|NCT01240811|525707178|FG000|Overall Study|Withdrawal by Subject|0|||
145781093|NCT01240811|525707179|FG001|Overall Study|Withdrawal by Subject|0|||
145781094|NCT01240811|525707180|FG002|Overall Study|Withdrawal by Subject|1|||
145781095|NCT00128206|525707189|FG000|Overall Study|Lost to Follow-up|137|||
145781096|NCT00128206|525707190|FG001|Overall Study|Lost to Follow-up|118|||
145781097|NCT00128206|525707189|FG000|Overall Study|Adverse Event|0|||
145781098|NCT00128206|525707190|FG001|Overall Study|Adverse Event|2|||
145781099|NCT03032068|525707193|FG000|Overall Study|Adverse Event|1|||
145781100|NCT01597622|525707194|FG000|Overall Study|Adverse Event|7|||
145781101|NCT01597622|525707194|FG000|Overall Study|Lack of Efficacy|3|||
145781102|NCT01597622|525707194|FG000|Overall Study|Protocol Violation|1|||
145781103|NCT01597622|525707194|FG000|Overall Study|Lost to Follow-up|1|||
145781104|NCT01597622|525707194|FG000|Overall Study|Investigator Discretion|5|||
145781105|NCT01597622|525707194|FG000|Overall Study|Withdrawal by Subject|20|||
145781106|NCT01597622|525707194|FG000|Overall Study|Death|1|||
145781107|NCT01988012|525707208|FG000|Overall Study|Adverse Event|5|||
145781108|NCT01988012|525707208|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145781109|NCT01988012|525707208|FG000|Overall Study|Patient Withdrawal of Consent|4|||
145781110|NCT01988012|525707208|FG000|Overall Study|Lost to Follow-up|1|||
145781111|NCT01988012|525707208|FG000|Overall Study|Physician Decision|1|||
145781112|NCT01988012|525707208|FG000|Overall Study|Protocol Violation|1|||
145781113|NCT01228071|525707211|FG000|Overall Study|Protocol Violation|1|||
145781114|NCT01228071|525707211|FG000|Overall Study|Withdrawal by Subject|1|||
145781115|NCT03314519|525707212|FG000|Overall Study|Protocol Violation|3|||
145781116|NCT03314519|525707213|FG001|Overall Study|Protocol Violation|2|||
145781117|NCT01912872|525707214|FG000|Overall Study|Lost to Follow-up|2|||
145781118|NCT01912872|525707215|FG001|Overall Study|Lost to Follow-up|3|||
145781119|NCT01912872|525707216|FG002|Overall Study|Lost to Follow-up|5|||
145781120|NCT01912872|525707217|FG003|Overall Study|Lost to Follow-up|5|||
145781121|NCT01912872|525707214|FG000|Overall Study|Other unspecified|3|||
145781122|NCT01912872|525707215|FG001|Overall Study|Other unspecified|1|||
145781123|NCT01912872|525707216|FG002|Overall Study|Other unspecified|3|||
145781124|NCT01912872|525707217|FG003|Overall Study|Other unspecified|0|||
145781125|NCT01912872|525707214|FG000|Overall Study|Informed consent withdrawn|0|||
145781126|NCT01912872|525707215|FG001|Overall Study|Informed consent withdrawn|0|||
145403734|NCT01981616|524334403|FG000|Overall Study|Adverse Event|0|||
145781127|NCT01912872|525707216|FG002|Overall Study|Informed consent withdrawn|1|||
145781128|NCT01912872|525707217|FG003|Overall Study|Informed consent withdrawn|1|||
145781129|NCT01912872|525707214|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
145781130|NCT01912872|525707215|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
145781131|NCT01912872|525707216|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
145781132|NCT01912872|525707217|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
145781133|NCT01912872|525707214|FG000|Overall Study|Protocol Violation|0|||
145781134|NCT01912872|525707215|FG001|Overall Study|Protocol Violation|0|||
145781135|NCT01912872|525707216|FG002|Overall Study|Protocol Violation|1|||
145781136|NCT01912872|525707217|FG003|Overall Study|Protocol Violation|0|||
145781137|NCT01912872|525707214|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145781138|NCT01912872|525707215|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145781139|NCT01912872|525707216|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145781140|NCT01912872|525707217|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
145781141|NCT01912872|525707214|FG000|Overall Study|Withdrawal of study medication|0|||
145781142|NCT01912872|525707215|FG001|Overall Study|Withdrawal of study medication|0|||
145781143|NCT01912872|525707216|FG002|Overall Study|Withdrawal of study medication|0|||
145781144|NCT01912872|525707217|FG003|Overall Study|Withdrawal of study medication|2|||
145781145|NCT01912872|525707214|FG000|Overall Study|Missing|0|||
145781146|NCT01912872|525707215|FG001|Overall Study|Missing|0|||
145781147|NCT01912872|525707216|FG002|Overall Study|Missing|0|||
145781148|NCT01912872|525707217|FG003|Overall Study|Missing|1|||
145781149|NCT01713036|525707220|FG000|Overall Study|Death|1|||
145781150|NCT00592358|525707221|FG000|Overall Study|Withdrawal by Subject|2|||
145781151|NCT00592358|525707221|FG000|Overall Study|Adverse Event|1|||
145781152|NCT00592358|525707221|FG000|Overall Study|Lack of Efficacy|2|||
145781153|NCT00592358|525707221|FG000|Overall Study|Inability to swallow pills|1|||
145781154|NCT01166659|525707222|FG000|Overall Study|Subject Decision|8|||
145781155|NCT01166659|525707222|FG000|Overall Study|Investigator Decision|2|||
145781156|NCT01166659|525707222|FG000|Overall Study|Death|1|||
145781157|NCT01166659|525707222|FG000|Overall Study|Lost to Follow-up|1|||
145537249|NCT00302107|524825770|FG001|Overall Study|Lost to Follow-up|5|||
145537250|NCT00302107|524825769|FG000|Overall Study|Protocol Violation|1|||
145537251|NCT00302107|524825770|FG001|Overall Study|Protocol Violation|0|||
145537252|NCT00302107|524825769|FG000|Overall Study|Relocation|0|||
145537253|NCT00302107|524825770|FG001|Overall Study|Relocation|1|||
145537254|NCT00302107|524825769|FG000|Overall Study|Withdrawal by Subject|0|||
145537255|NCT00302107|524825770|FG001|Overall Study|Withdrawal by Subject|3|||
145537256|NCT00302107|524825769|FG000|Overall Study|Adverse Event|1|||
145537257|NCT00302107|524825770|FG001|Overall Study|Adverse Event|0|||
145537258|NCT00437983|524825771|FG000|Overall Study|Adverse Event|6|||
145537259|NCT00437983|524825772|FG001|Overall Study|Adverse Event|6|||
145537260|NCT00437983|524825771|FG000|Overall Study|Protocol Violation|2|||
145537261|NCT00437983|524825772|FG001|Overall Study|Protocol Violation|1|||
145537262|NCT00437983|524825771|FG000|Overall Study|Withdrawal by Subject|5|||
145537263|NCT00437983|524825772|FG001|Overall Study|Withdrawal by Subject|6|||
145537264|NCT01790932|524825775|FG000|Overall Study|Disease Progression|41|||
145537265|NCT01790932|524825775|FG000|Overall Study|Adverse Event|7|||
145537266|NCT01790932|524825775|FG000|Overall Study|Physician Decision|1|||
145537267|NCT01790932|524825775|FG000|Overall Study|Withdrawal by Subject|1|||
145537268|NCT04223973|524825776|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
145537269|NCT04223973|524825777|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
145537270|NCT04223973|524825776|FG000|Overall Study|Adverse Event|4|||
145537271|NCT04223973|524825777|FG001|Overall Study|Adverse Event|0|||
145537272|NCT04223973|524825776|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
145537273|NCT04223973|524825777|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
145537274|NCT04223973|524825776|FG000|Overall Study|Physician Decision|1|||
145537275|NCT04223973|524825777|FG001|Overall Study|Physician Decision|1|||
145537276|NCT04223973|524825776|FG000|Overall Study|Withdrawal by Subject|0|||
145537277|NCT04223973|524825777|FG001|Overall Study|Withdrawal by Subject|1|||
145537278|NCT00594659|524825785|FG000|Overall Study|Lost to Follow-up|13|||
145537279|NCT00594659|524825786|FG001|Overall Study|Lost to Follow-up|9|||
145781158|NCT01166659|525707222|FG000|Overall Study|Study Closed at Site|1|||
145537280|NCT00594659|524825787|FG002|Overall Study|Lost to Follow-up|7|||
145781159|NCT04760314|525707225|FG000|Induction Period|Withdrawal by Subject|0|||
145781160|NCT04760314|525707226|FG001|Induction Period|Withdrawal by Subject|1|||
145781161|NCT04760314|525707227|FG002|Induction Period|Withdrawal by Subject|1|||
145781162|NCT04760314|525707228|FG003|Induction Period|Withdrawal by Subject|0|||
145781163|NCT04760314|525707229|FG004|Induction Period|Withdrawal by Subject|0|||
145781164|NCT04760314|525707230|FG005|Induction Period|Withdrawal by Subject|0|||
145781165|NCT04760314|525707231|FG006|Induction Period|Withdrawal by Subject|0|||
145781166|NCT04760314|525707232|FG007|Induction Period|Withdrawal by Subject|0|||
145781167|NCT04760314|525707233|FG008|Induction Period|Withdrawal by Subject|0|||
145781168|NCT04760314|525707234|FG009|Induction Period|Withdrawal by Subject|0|||
145781169|NCT04760314|525707235|FG010|Induction Period|Withdrawal by Subject|0|||
145781170|NCT04760314|525707225|FG000|Induction Period|Adverse Event|0|||
145781171|NCT04760314|525707226|FG001|Induction Period|Adverse Event|0|||
145781172|NCT04760314|525707227|FG002|Induction Period|Adverse Event|2|||
145781173|NCT04760314|525707228|FG003|Induction Period|Adverse Event|0|||
145781174|NCT04760314|525707229|FG004|Induction Period|Adverse Event|0|||
145781175|NCT04760314|525707230|FG005|Induction Period|Adverse Event|0|||
145781176|NCT04760314|525707231|FG006|Induction Period|Adverse Event|0|||
145781177|NCT04760314|525707232|FG007|Induction Period|Adverse Event|0|||
145781178|NCT04760314|525707233|FG008|Induction Period|Adverse Event|0|||
145781179|NCT04760314|525707234|FG009|Induction Period|Adverse Event|0|||
145781180|NCT04760314|525707235|FG010|Induction Period|Adverse Event|0|||
145781181|NCT04760314|525707225|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781182|NCT04760314|525707226|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781183|NCT04760314|525707227|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781184|NCT04760314|525707228|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
145781185|NCT04760314|525707229|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
145781186|NCT04760314|525707230|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
145781187|NCT04760314|525707231|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
145781188|NCT04760314|525707232|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781189|NCT04760314|525707233|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781190|NCT04760314|525707234|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781191|NCT04760314|525707235|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
145781192|NCT04760314|525707225|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781193|NCT04760314|525707226|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781194|NCT04760314|525707227|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781195|NCT04760314|525707228|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
145781196|NCT04760314|525707229|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781197|NCT04760314|525707230|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
145781198|NCT04760314|525707231|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
145781199|NCT04760314|525707232|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781200|NCT04760314|525707233|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781201|NCT04760314|525707234|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781202|NCT04760314|525707235|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
145781203|NCT04760314|525707225|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781204|NCT04760314|525707226|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781205|NCT04760314|525707227|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781206|NCT04760314|525707228|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781207|NCT04760314|525707229|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
145781208|NCT04760314|525707230|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781209|NCT04760314|525707231|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781210|NCT04760314|525707232|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781211|NCT04760314|525707233|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781212|NCT04760314|525707234|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781213|NCT04760314|525707235|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
145781214|NCT04760314|525707225|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
145781215|NCT04760314|525707226|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
145781216|NCT04760314|525707227|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
145781217|NCT04760314|525707228|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
145781218|NCT04760314|525707229|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
145781219|NCT04760314|525707230|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
145781220|NCT04760314|525707231|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
145781221|NCT04760314|525707232|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
145781222|NCT04760314|525707233|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
145781223|NCT04760314|525707234|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
145781224|NCT04760314|525707235|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
145781225|NCT04760314|525707225|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781226|NCT04760314|525707226|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781227|NCT04760314|525707227|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781228|NCT04760314|525707228|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781229|NCT04760314|525707229|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781230|NCT04760314|525707230|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781231|NCT04760314|525707231|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781232|NCT04760314|525707232|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
145781233|NCT04760314|525707233|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145781234|NCT04760314|525707234|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
145781235|NCT04760314|525707235|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
145781236|NCT04760314|525707225|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781237|NCT04760314|525707226|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781238|NCT04760314|525707227|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781239|NCT04760314|525707228|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781240|NCT04760314|525707229|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781241|NCT04760314|525707230|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781242|NCT04760314|525707231|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781243|NCT04760314|525707232|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
145781244|NCT04760314|525707233|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
145781245|NCT04760314|525707234|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
145781246|NCT04760314|525707235|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145781247|NCT04760314|525707225|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781248|NCT04760314|525707226|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781249|NCT04760314|525707227|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781250|NCT04760314|525707228|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781251|NCT04760314|525707229|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781252|NCT04760314|525707230|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781253|NCT04760314|525707231|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781254|NCT04760314|525707232|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
145781255|NCT04760314|525707233|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781256|NCT04760314|525707234|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781257|NCT04760314|525707235|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145781258|NCT04760314|525707225|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781259|NCT04760314|525707226|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781260|NCT04760314|525707227|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781261|NCT04760314|525707228|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781262|NCT04760314|525707229|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781263|NCT04760314|525707230|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781264|NCT04760314|525707231|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
145609068|NCT03445065|525083281|FG001|Overall Study|Withdrawal by Subject|6|||
145609069|NCT03445065|525083282|FG002|Overall Study|Withdrawal by Subject|2|||
145781265|NCT04760314|525707232|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781266|NCT04760314|525707233|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
145781267|NCT04760314|525707234|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
145781268|NCT04760314|525707235|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
145781269|NCT03238248|525707238|FG000|Overall Study|Death|5|||
145781270|NCT03238248|525707238|FG000|Overall Study|Withdrawal by Subject|7|||
145781271|NCT03238248|525707238|FG000|Overall Study|Participant proceeding to transplant|10|||
145781272|NCT03238248|525707238|FG000|Overall Study|Lack of Efficacy|4|||
145781273|NCT03238248|525707238|FG000|Overall Study|Physician Decision|3|||
145781274|NCT03238248|525707238|FG000|Overall Study|Transitioning to another study|1|||
145781275|NCT03238248|525707238|FG000|Overall Study|No longer benefiting|1|||
145781276|NCT03238248|525707238|FG000|Overall Study|Other complicating disease|1|||
145781277|NCT03238248|525707238|FG000|Overall Study|Adverse Event|5|||
145781278|NCT03238248|525707238|FG000|Overall Study|Disease progression|26|||
145781279|NCT03238248|525707238|FG000|Overall Study|N/A participant is still on treatment|1|||
145781280|NCT03238248|525707238|FG000|Overall Study|Decline in condition|1|||
145781281|NCT03238248|525707238|FG000|Overall Study|Alternative therapy|2|||
145781282|NCT02241512|525707245|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
145781283|NCT02241512|525707246|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
145781284|NCT02345161|525707249|FG000|Overall Study|Withdrawal by Subject|25|||
145781285|NCT02345161|525707250|FG001|Overall Study|Withdrawal by Subject|33|||
145781286|NCT02345161|525707249|FG000|Overall Study|Adverse Event|16|||
145781287|NCT02345161|525707250|FG001|Overall Study|Adverse Event|19|||
145781288|NCT02345161|525707249|FG000|Overall Study|Physician Decision|4|||
145781289|NCT02345161|525707250|FG001|Overall Study|Physician Decision|4|||
145781290|NCT02345161|525707249|FG000|Overall Study|Lost to Follow-up|0|||
145403735|NCT01981616|524334404|FG001|Overall Study|Adverse Event|1|||
145609070|NCT03445065|525083283|FG003|Overall Study|Withdrawal by Subject|2|||
145781291|NCT02345161|525707250|FG001|Overall Study|Lost to Follow-up|1|||
145781292|NCT00090285|525707251|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
145781293|NCT00090285|525707252|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
145781294|NCT00090285|525707253|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145781295|NCT00090285|525707254|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145781296|NCT00090285|525707255|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145609071|NCT03445065|525083280|FG000|Overall Study|Other|4|||
145609072|NCT03445065|525083281|FG001|Overall Study|Other|3|||
145609073|NCT03445065|525083282|FG002|Overall Study|Other|3|||
145609074|NCT03445065|525083283|FG003|Overall Study|Other|1|||
145609075|NCT00524030|525083284|FG000|Overall Study|Lack of Efficacy|10|||
145609076|NCT00524030|525083285|FG001|Overall Study|Lack of Efficacy|24|||
145609077|NCT00524030|525083284|FG000|Overall Study|Lost to Follow-up|0|||
145609078|NCT00524030|525083285|FG001|Overall Study|Lost to Follow-up|2|||
145609079|NCT00524030|525083284|FG000|Overall Study|Withdrawal by Subject|3|||
145609080|NCT00524030|525083285|FG001|Overall Study|Withdrawal by Subject|8|||
145609081|NCT00524030|525083284|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
145609082|NCT00524030|525083285|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
145609083|NCT00524030|525083284|FG000|Overall Study|Protocol Violation|0|||
145609084|NCT00524030|525083285|FG001|Overall Study|Protocol Violation|1|||
145609085|NCT00524030|525083284|FG000|Overall Study|Pregnancy|1|||
145781297|NCT00090285|525707256|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
145781298|NCT00090285|525707251|FG000|Base Study Vaccination Period|Adverse Event|2|||
145781299|NCT00090285|525707252|FG001|Base Study Vaccination Period|Adverse Event|4|||
145781300|NCT00090285|525707253|FG002|Base Study Vaccination Period|Adverse Event|0|||
145781301|NCT00090285|525707254|FG003|Base Study Vaccination Period|Adverse Event|0|||
145781302|NCT00090285|525707255|FG004|Base Study Vaccination Period|Adverse Event|0|||
145781303|NCT00090285|525707256|FG005|Base Study Vaccination Period|Adverse Event|0|||
145781304|NCT00090285|525707251|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
145781305|NCT00090285|525707252|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
145781306|NCT00090285|525707253|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
145781307|NCT00090285|525707254|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
145781308|NCT00090285|525707255|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
145781309|NCT00090285|525707256|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
145781310|NCT00090285|525707251|FG000|Base Study Vaccination Period|Protocol Violation|2|||
145781311|NCT00090285|525707252|FG001|Base Study Vaccination Period|Protocol Violation|3|||
145781312|NCT00090285|525707253|FG002|Base Study Vaccination Period|Protocol Violation|0|||
145781313|NCT00090285|525707254|FG003|Base Study Vaccination Period|Protocol Violation|0|||
145781314|NCT00090285|525707255|FG004|Base Study Vaccination Period|Protocol Violation|0|||
145781315|NCT00090285|525707256|FG005|Base Study Vaccination Period|Protocol Violation|0|||
145781316|NCT00090285|525707251|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
145781317|NCT00090285|525707252|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
145781318|NCT00090285|525707253|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
145781319|NCT00090285|525707254|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
145781320|NCT00090285|525707255|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
145781321|NCT00090285|525707256|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
145781322|NCT00090285|525707251|FG000|Base Study Vaccination Period|Uncooperative|2|||
145781323|NCT00090285|525707252|FG001|Base Study Vaccination Period|Uncooperative|2|||
145609086|NCT00524030|525083285|FG001|Overall Study|Pregnancy|0|||
145609087|NCT00524030|525083284|FG000|Overall Study|Adverse Event|3|||
145781324|NCT00090285|525707253|FG002|Base Study Vaccination Period|Uncooperative|0|||
145781325|NCT00090285|525707254|FG003|Base Study Vaccination Period|Uncooperative|0|||
145781326|NCT00090285|525707255|FG004|Base Study Vaccination Period|Uncooperative|0|||
145781327|NCT00090285|525707256|FG005|Base Study Vaccination Period|Uncooperative|0|||
145781328|NCT00090285|525707251|FG000|Base Study Vaccination Period|Moved|20|||
145781329|NCT00090285|525707252|FG001|Base Study Vaccination Period|Moved|21|||
145781330|NCT00090285|525707253|FG002|Base Study Vaccination Period|Moved|0|||
145781331|NCT00090285|525707254|FG003|Base Study Vaccination Period|Moved|0|||
145781332|NCT00090285|525707255|FG004|Base Study Vaccination Period|Moved|0|||
145781333|NCT00090285|525707256|FG005|Base Study Vaccination Period|Moved|0|||
145781334|NCT00090285|525707251|FG000|Base Study Vaccination Period|Site Terminated|1|||
145609088|NCT00524030|525083285|FG001|Overall Study|Adverse Event|21|||
145609089|NCT00524030|525083284|FG000|Overall Study|Death|0|||
145609090|NCT00524030|525083285|FG001|Overall Study|Death|1|||
145781335|NCT00090285|525707252|FG001|Base Study Vaccination Period|Site Terminated|0|||
145781336|NCT00090285|525707253|FG002|Base Study Vaccination Period|Site Terminated|0|||
145781337|NCT00090285|525707254|FG003|Base Study Vaccination Period|Site Terminated|0|||
145781338|NCT00090285|525707255|FG004|Base Study Vaccination Period|Site Terminated|0|||
145609091|NCT02944656|525083293|FG000|Overall Study|No longer eligible|3|||
145609092|NCT02944656|525083294|FG001|Overall Study|No longer eligible|0|||
145609093|NCT02944656|525083293|FG000|Overall Study|Lost to Follow-up|7|||
145609094|NCT02944656|525083294|FG001|Overall Study|Lost to Follow-up|10|||
145609095|NCT04398537|525083295|FG000|Overall Study|Physician Decision|10|||
145781339|NCT00090285|525707256|FG005|Base Study Vaccination Period|Site Terminated|0|||
145781340|NCT00090285|525707251|FG000|Base Study Vaccination Period|Other|2|||
145781341|NCT00090285|525707252|FG001|Base Study Vaccination Period|Other|2|||
145781342|NCT00090285|525707253|FG002|Base Study Vaccination Period|Other|0|||
145781343|NCT00090285|525707254|FG003|Base Study Vaccination Period|Other|0|||
145781344|NCT00090285|525707255|FG004|Base Study Vaccination Period|Other|0|||
145781345|NCT00090285|525707256|FG005|Base Study Vaccination Period|Other|0|||
145781346|NCT00090285|525707251|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
145781347|NCT00090285|525707252|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
145781348|NCT00090285|525707253|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
145781349|NCT00090285|525707254|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
145781350|NCT00090285|525707255|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
145781351|NCT00090285|525707256|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
145781352|NCT00090285|525707251|FG000|Base Study Vaccination Period|HIV positive|1|||
145781353|NCT00090285|525707252|FG001|Base Study Vaccination Period|HIV positive|1|||
145781354|NCT00090285|525707253|FG002|Base Study Vaccination Period|HIV positive|0|||
145781355|NCT00090285|525707254|FG003|Base Study Vaccination Period|HIV positive|0|||
145781356|NCT00090285|525707255|FG004|Base Study Vaccination Period|HIV positive|0|||
145781357|NCT00090285|525707256|FG005|Base Study Vaccination Period|HIV positive|0|||
145781358|NCT00090285|525707251|FG000|Base Study Follow-up Period|Adverse Event|3|||
145781359|NCT00090285|525707252|FG001|Base Study Follow-up Period|Adverse Event|10|||
145781360|NCT00090285|525707253|FG002|Base Study Follow-up Period|Adverse Event|0|||
145781361|NCT00090285|525707254|FG003|Base Study Follow-up Period|Adverse Event|0|||
145781362|NCT00090285|525707255|FG004|Base Study Follow-up Period|Adverse Event|0|||
145781363|NCT00090285|525707256|FG005|Base Study Follow-up Period|Adverse Event|0|||
145781364|NCT00090285|525707251|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
145781365|NCT00090285|525707252|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
145781366|NCT00090285|525707253|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
145781367|NCT00090285|525707254|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
145781368|NCT00090285|525707255|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
145781369|NCT00090285|525707256|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
145781370|NCT00090285|525707251|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
145537281|NCT00300274|524825788|FG000|Overall Study|Withdrawal by Subject|12|||
145537282|NCT00300274|524825789|FG001|Overall Study|Withdrawal by Subject|3|||
145537283|NCT00300274|524825790|FG002|Overall Study|Withdrawal by Subject|14|||
145537284|NCT00300274|524825788|FG000|Overall Study|Lost to Follow-up|3|||
145537285|NCT00300274|524825789|FG001|Overall Study|Lost to Follow-up|4|||
145537286|NCT00300274|524825790|FG002|Overall Study|Lost to Follow-up|5|||
145537287|NCT00300274|524825788|FG000|Overall Study|Death|31|||
145537288|NCT00300274|524825789|FG001|Overall Study|Death|20|||
145537289|NCT00300274|524825790|FG002|Overall Study|Death|25|||
145537290|NCT00300274|524825788|FG000|Overall Study|Re-transplant|0|||
145537291|NCT00300274|524825789|FG001|Overall Study|Re-transplant|0|||
145537292|NCT00300274|524825790|FG002|Overall Study|Re-transplant|1|||
145537293|NCT00242216|524825791|FG000|Overall Study|Lost to Follow-up|12|||
145537294|NCT00242216|524825792|FG001|Overall Study|Lost to Follow-up|17|||
145537295|NCT00242216|524825791|FG000|Overall Study|Death|4|||
145537296|NCT00242216|524825792|FG001|Overall Study|Death|2|||
145537297|NCT00242216|524825791|FG000|Overall Study|Lack of Efficacy|1|||
145537298|NCT00242216|524825792|FG001|Overall Study|Lack of Efficacy|2|||
145537299|NCT00242216|524825791|FG000|Overall Study|no medicaiton dispensed|1|||
145537300|NCT00242216|524825792|FG001|Overall Study|no medicaiton dispensed|1|||
145537301|NCT00678080|524825794|FG000|Overall Study|Physician Decision|2|||
145537302|NCT00678080|524825795|FG001|Overall Study|Physician Decision|0|||
145537303|NCT00678080|524825794|FG000|Overall Study|Lost to Follow-up|1|||
145537304|NCT00678080|524825795|FG001|Overall Study|Lost to Follow-up|0|||
145537305|NCT00678080|524825794|FG000|Overall Study|Withdrawal by Subject|0|||
145537306|NCT00678080|524825795|FG001|Overall Study|Withdrawal by Subject|1|||
145537307|NCT04439201|524825805|FG000|Overall Study|Ineligible|2|||
145537308|NCT04439201|524825805|FG000|Overall Study|Never start protocol therapy|1|||
145537309|NCT04439201|524825805|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
145537310|NCT04439201|524825805|FG000|Overall Study|Mutation status not confirmed|4|||
145537311|NCT04439201|524825805|FG000|Overall Study|Adverse Event|1|||
145537312|NCT04439201|524825805|FG000|Overall Study|Death|7|||
145537313|NCT04439201|524825805|FG000|Overall Study|Withdrawal by Subject|2|||
145537314|NCT04439201|524825805|FG000|Overall Study|Disease progression|20|||
145537315|NCT04439201|524825805|FG000|Overall Study|Alternative therapy|1|||
145537316|NCT04439201|524825805|FG000|Overall Study|Physician Decision|1|||
145537317|NCT05136690|524825806|FG000|Period 1|Withdrawal by Subject|0|||
145537318|NCT05136690|524825807|FG001|Period 1|Withdrawal by Subject|1|||
145781371|NCT00090285|525707252|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
145537319|NCT05136690|524825806|FG000|Period 2|Lost to Follow-up|0|||
145537320|NCT05136690|524825807|FG001|Period 2|Lost to Follow-up|3|||
145537321|NCT05136690|524825806|FG000|Period 2|Withdrawal by Subject|0|||
145537322|NCT05136690|524825807|FG001|Period 2|Withdrawal by Subject|1|||
145537323|NCT02323113|524827414|FG000|Overall Study|Adverse Event|3|||
145537324|NCT02323113|524827415|FG001|Overall Study|Adverse Event|3|||
145537325|NCT02323113|524827416|FG002|Overall Study|Adverse Event|2|||
145537326|NCT02323113|524827417|FG003|Overall Study|Adverse Event|5|||
145537327|NCT02323113|524827418|FG004|Overall Study|Adverse Event|8|||
145537328|NCT02323113|524827419|FG005|Overall Study|Adverse Event|3|||
145537329|NCT02323113|524827420|FG006|Overall Study|Adverse Event|6|||
145537330|NCT02323113|524827421|FG007|Overall Study|Adverse Event|0|||
145537331|NCT02323113|524827414|FG000|Overall Study|Progressive Disease|0|||
145537332|NCT02323113|524827415|FG001|Overall Study|Progressive Disease|1|||
145537333|NCT02323113|524827416|FG002|Overall Study|Progressive Disease|1|||
145537334|NCT02323113|524827417|FG003|Overall Study|Progressive Disease|0|||
145537335|NCT02323113|524827418|FG004|Overall Study|Progressive Disease|0|||
145537336|NCT02323113|524827419|FG005|Overall Study|Progressive Disease|3|||
145537337|NCT02323113|524827420|FG006|Overall Study|Progressive Disease|0|||
145537338|NCT02323113|524827421|FG007|Overall Study|Progressive Disease|0|||
145537339|NCT02323113|524827414|FG000|Overall Study|Symptomatic Deterioration|0|||
145537340|NCT02323113|524827415|FG001|Overall Study|Symptomatic Deterioration|0|||
145537341|NCT02323113|524827416|FG002|Overall Study|Symptomatic Deterioration|1|||
145537342|NCT02323113|524827417|FG003|Overall Study|Symptomatic Deterioration|0|||
145537343|NCT02323113|524827418|FG004|Overall Study|Symptomatic Deterioration|1|||
145537344|NCT02323113|524827419|FG005|Overall Study|Symptomatic Deterioration|0|||
145537345|NCT02323113|524827420|FG006|Overall Study|Symptomatic Deterioration|0|||
145537346|NCT02323113|524827421|FG007|Overall Study|Symptomatic Deterioration|0|||
145537347|NCT02323113|524827414|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
145537348|NCT02323113|524827415|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
145537349|NCT02323113|524827416|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
145537350|NCT02323113|524827417|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
145537351|NCT02323113|524827418|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
145537352|NCT02323113|524827419|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
145537353|NCT02323113|524827420|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
145537354|NCT02323113|524827421|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
145537355|NCT02323113|524827414|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537356|NCT02323113|524827415|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
145537357|NCT02323113|524827416|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537358|NCT02323113|524827417|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537359|NCT02323113|524827418|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537360|NCT02323113|524827419|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537361|NCT02323113|524827420|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537362|NCT02323113|524827421|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
145537363|NCT00403234|524827422|FG000|Overall Study|Withdrawal by Subject|0|||
145537364|NCT00403234|524827423|FG001|Overall Study|Withdrawal by Subject|1|||
145537365|NCT00403234|524827424|FG002|Overall Study|Withdrawal by Subject|0|||
145537366|NCT00403234|524827425|FG003|Overall Study|Withdrawal by Subject|0|||
145537367|NCT00403234|524827422|FG000|Overall Study|Adverse Event|1|||
145537368|NCT00403234|524827423|FG001|Overall Study|Adverse Event|0|||
145537369|NCT00403234|524827424|FG002|Overall Study|Adverse Event|1|||
145537370|NCT00403234|524827425|FG003|Overall Study|Adverse Event|0|||
145537371|NCT03281577|524827427|FG000|Overall Study|Adverse Event|0|||
145537372|NCT03281577|524827428|FG001|Overall Study|Adverse Event|0|||
145537373|NCT03281577|524827429|FG002|Overall Study|Adverse Event|0|||
145537374|NCT03281577|524827430|FG003|Overall Study|Adverse Event|1|||
145537375|NCT03281577|524827427|FG000|Overall Study|Withdrawal by Subject|1|||
145537376|NCT03281577|524827428|FG001|Overall Study|Withdrawal by Subject|0|||
145537377|NCT03281577|524827429|FG002|Overall Study|Withdrawal by Subject|0|||
145537378|NCT03281577|524827430|FG003|Overall Study|Withdrawal by Subject|0|||
145537379|NCT01897454|524827431|FG000|Overall Study|Withdrawal by Subject|1|||
145537380|NCT00894166|524827439|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
145537381|NCT00894166|524827440|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
145537382|NCT00894166|524827441|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
145537383|NCT00894166|524827442|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
145781372|NCT00090285|525707253|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
145537384|NCT00894166|524827443|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
145537385|NCT00894166|524827444|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
145537386|NCT00894166|524827445|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
145537387|NCT00894166|524827446|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
145781373|NCT00090285|525707254|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
145781374|NCT00090285|525707255|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
145781375|NCT00090285|525707256|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
145781376|NCT00090285|525707251|FG000|Base Study Follow-up Period|Moved|41|||
145781377|NCT00090285|525707252|FG001|Base Study Follow-up Period|Moved|36|||
145781378|NCT00090285|525707253|FG002|Base Study Follow-up Period|Moved|0|||
145781379|NCT00090285|525707254|FG003|Base Study Follow-up Period|Moved|0|||
145781380|NCT00090285|525707255|FG004|Base Study Follow-up Period|Moved|0|||
145781381|NCT00090285|525707256|FG005|Base Study Follow-up Period|Moved|0|||
145781382|NCT00090285|525707251|FG000|Base Study Follow-up Period|Other|2|||
145781383|NCT00090285|525707252|FG001|Base Study Follow-up Period|Other|0|||
145781384|NCT00090285|525707253|FG002|Base Study Follow-up Period|Other|0|||
145781385|NCT00090285|525707254|FG003|Base Study Follow-up Period|Other|0|||
145781386|NCT00090285|525707255|FG004|Base Study Follow-up Period|Other|0|||
145781387|NCT00090285|525707256|FG005|Base Study Follow-up Period|Other|0|||
145781388|NCT00090285|525707251|FG000|Base Study Follow-up Period|Protocol Violation|1|||
145781389|NCT00090285|525707252|FG001|Base Study Follow-up Period|Protocol Violation|0|||
145781390|NCT00090285|525707253|FG002|Base Study Follow-up Period|Protocol Violation|0|||
145781391|NCT00090285|525707254|FG003|Base Study Follow-up Period|Protocol Violation|0|||
145781392|NCT00090285|525707255|FG004|Base Study Follow-up Period|Protocol Violation|0|||
145781393|NCT00090285|525707256|FG005|Base Study Follow-up Period|Protocol Violation|0|||
145781394|NCT00090285|525707251|FG000|Base Study Follow-up Period|Uncooperative|3|||
145781395|NCT00090285|525707252|FG001|Base Study Follow-up Period|Uncooperative|4|||
145781396|NCT00090285|525707253|FG002|Base Study Follow-up Period|Uncooperative|0|||
145781397|NCT00090285|525707254|FG003|Base Study Follow-up Period|Uncooperative|0|||
145781398|NCT00090285|525707255|FG004|Base Study Follow-up Period|Uncooperative|0|||
145781399|NCT00090285|525707256|FG005|Base Study Follow-up Period|Uncooperative|0|||
145781400|NCT00090285|525707251|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
145781401|NCT00090285|525707252|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
145781402|NCT00090285|525707253|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
145781403|NCT00090285|525707254|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
145781404|NCT00090285|525707255|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
145781405|NCT00090285|525707256|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
145781406|NCT00090285|525707251|FG000|Extension 1|Adverse Event|0|||
145781407|NCT00090285|525707252|FG001|Extension 1|Adverse Event|0|||
145781408|NCT00090285|525707253|FG002|Extension 1|Adverse Event|2|||
145781409|NCT00090285|525707254|FG003|Extension 1|Adverse Event|0|||
145781410|NCT00090285|525707255|FG004|Extension 1|Adverse Event|0|||
145781411|NCT00090285|525707256|FG005|Extension 1|Adverse Event|0|||
145781412|NCT00090285|525707251|FG000|Extension 1|Lost to Follow-up|0|||
145781413|NCT00090285|525707252|FG001|Extension 1|Lost to Follow-up|0|||
145781414|NCT00090285|525707253|FG002|Extension 1|Lost to Follow-up|35|||
145781415|NCT00090285|525707254|FG003|Extension 1|Lost to Follow-up|0|||
145781416|NCT00090285|525707255|FG004|Extension 1|Lost to Follow-up|0|||
145781417|NCT00090285|525707256|FG005|Extension 1|Lost to Follow-up|0|||
145781418|NCT00090285|525707251|FG000|Extension 1|Withdrawal by Subject|0|||
145781419|NCT00090285|525707252|FG001|Extension 1|Withdrawal by Subject|0|||
145781420|NCT00090285|525707253|FG002|Extension 1|Withdrawal by Subject|13|||
145781421|NCT00090285|525707254|FG003|Extension 1|Withdrawal by Subject|1|||
145781422|NCT00090285|525707255|FG004|Extension 1|Withdrawal by Subject|0|||
145781423|NCT00090285|525707256|FG005|Extension 1|Withdrawal by Subject|0|||
145781424|NCT00090285|525707251|FG000|Extension 1|Other|0|||
145781425|NCT00090285|525707252|FG001|Extension 1|Other|0|||
145609096|NCT04398537|525083296|FG001|Overall Study|Physician Decision|15|||
145781426|NCT00090285|525707253|FG002|Extension 1|Other|4|||
145781427|NCT00090285|525707254|FG003|Extension 1|Other|0|||
145781428|NCT00090285|525707255|FG004|Extension 1|Other|0|||
145781429|NCT00090285|525707256|FG005|Extension 1|Other|0|||
145781430|NCT00090285|525707251|FG000|Extension 1|Moved|0|||
145781431|NCT00090285|525707252|FG001|Extension 1|Moved|0|||
145781432|NCT00090285|525707253|FG002|Extension 1|Moved|3|||
145781433|NCT00090285|525707254|FG003|Extension 1|Moved|0|||
145781434|NCT00090285|525707255|FG004|Extension 1|Moved|0|||
145781435|NCT00090285|525707256|FG005|Extension 1|Moved|0|||
145781436|NCT00090285|525707251|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
145781437|NCT00090285|525707252|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
145781438|NCT00090285|525707253|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
145781439|NCT00090285|525707254|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
145537388|NCT00894166|524827439|FG000|Overall Study|Death|0|||
145537389|NCT00894166|524827440|FG001|Overall Study|Death|0|||
145537390|NCT00894166|524827441|FG002|Overall Study|Death|0|||
145537391|NCT00894166|524827442|FG003|Overall Study|Death|1|||
145537392|NCT00894166|524827443|FG004|Overall Study|Death|0|||
145781440|NCT00090285|525707255|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
145781441|NCT00090285|525707256|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
145781442|NCT00090285|525707251|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145781443|NCT00090285|525707252|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145781444|NCT00090285|525707253|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145781445|NCT00090285|525707254|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145781446|NCT00090285|525707255|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
145781447|NCT00090285|525707256|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
145781448|NCT00090285|525707251|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145781449|NCT00090285|525707252|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145781450|NCT00090285|525707253|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145781451|NCT00090285|525707254|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145781452|NCT00090285|525707255|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
145781453|NCT00090285|525707256|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
145781454|NCT00090285|525707251|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
145781455|NCT00090285|525707252|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
145781456|NCT00090285|525707253|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
145781457|NCT00090285|525707254|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
145781458|NCT00090285|525707255|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
145781459|NCT00090285|525707256|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
145781460|NCT01372878|525707264|FG000|Overall Study|Withdrawal by Subject|63|||
145781461|NCT01372878|525707264|FG000|Overall Study|Protocol Violation|17|||
145781462|NCT01372878|525707264|FG000|Overall Study|incomplete study procedure|104|||
145781463|NCT02616029|525707265|FG000|Overall Study|Adverse Event|1|||
145781464|NCT02616029|525707266|FG001|Overall Study|Adverse Event|0|||
145781465|NCT02616029|525707265|FG000|Overall Study|Death|0|||
145781466|NCT02616029|525707266|FG001|Overall Study|Death|1|||
145781467|NCT02616029|525707265|FG000|Overall Study|Protocol Violation|1|||
145781468|NCT02616029|525707266|FG001|Overall Study|Protocol Violation|0|||
145781469|NCT02616029|525707265|FG000|Overall Study|Withdrew Consent|1|||
145781470|NCT02616029|525707266|FG001|Overall Study|Withdrew Consent|0|||
145781471|NCT02616029|525707265|FG000|Overall Study|Enrolled and Never Treated|1|||
145781472|NCT02616029|525707266|FG001|Overall Study|Enrolled and Never Treated|1|||
145781473|NCT02385123|525707267|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
145781474|NCT04230486|525707268|FG000|Overall Study|Screen Failure|1|||
145781475|NCT03215264|525707269|FG000|Dose Level 2|Adverse Event|0|||
145781476|NCT03215264|525707270|FG001|Dose Level 2|Adverse Event|1|||
145781477|NCT03215264|525707271|FG002|Dose Level 2|Adverse Event|0|||
145781478|NCT03215264|525707269|FG000|Dose Level 3|Withdrawal by Subject|0|||
145781479|NCT03215264|525707270|FG001|Dose Level 3|Withdrawal by Subject|0|||
145781480|NCT03215264|525707271|FG002|Dose Level 3|Withdrawal by Subject|1|||
145781481|NCT02145156|525707273|FG000|Overall Study|No match to vaccination records|60|||
145781482|NCT02145156|525707274|FG001|Overall Study|No match to vaccination records|52|||
145781483|NCT02145156|525707275|FG002|Overall Study|No match to vaccination records|41|||
145781484|NCT02234583|525707276|FG000|Overall Study|Adverse Event|172|||
145781485|NCT02234583|525707277|FG001|Overall Study|Adverse Event|156|||
145781486|NCT02234583|525707276|FG000|Overall Study|Withdrawal by Subject|109|||
145781487|NCT02234583|525707277|FG001|Overall Study|Withdrawal by Subject|157|||
145781488|NCT02234583|525707276|FG000|Overall Study|Lost to Follow-up|0|||
145781489|NCT02234583|525707277|FG001|Overall Study|Lost to Follow-up|1|||
145781490|NCT02234583|525707276|FG000|Overall Study|Lack of Efficacy|58|||
145781491|NCT02234583|525707277|FG001|Overall Study|Lack of Efficacy|103|||
145781492|NCT02234583|525707276|FG000|Overall Study|Protocol Violation|35|||
145781493|NCT02234583|525707277|FG001|Overall Study|Protocol Violation|42|||
145537393|NCT00894166|524827444|FG005|Overall Study|Death|0|||
145781494|NCT02234583|525707276|FG000|Overall Study|Other|39|||
145781495|NCT02234583|525707277|FG001|Overall Study|Other|97|||
145781496|NCT01264965|525707284|FG000|Overall Study|Withdrawal by Subject|10|||
145781497|NCT01327339|525707286|FG000|Overall Study|Protocol Violation|8|||
145781498|NCT00700752|525707287|FG000|First Intervention|Withdrawal by Subject|0|||
145781499|NCT00700752|525707288|FG001|First Intervention|Withdrawal by Subject|2|||
145781500|NCT00784784|525707289|FG000|Overall Study|Withdrawal by Subject|2|||
145537394|NCT00894166|524827445|FG006|Overall Study|Death|0|||
145781501|NCT00784784|525707290|FG001|Overall Study|Withdrawal by Subject|2|||
145781502|NCT02792777|525707292|FG000|Overall Study|Withdrawal by Subject|2|||
145781503|NCT02792777|525707293|FG001|Overall Study|Withdrawal by Subject|0|||
145781504|NCT02792777|525707292|FG000|Overall Study|Recording malfunction|2|||
145781505|NCT02792777|525707293|FG001|Overall Study|Recording malfunction|0|||
145537395|NCT00894166|524827446|FG007|Overall Study|Death|0|||
145537396|NCT05350410|524827447|FG000|Overall Study|Withdrawal by Subject|1|||
145537397|NCT00142935|524827451|FG000|Overall Study|Other reason|1|||
145781506|NCT02792777|525707292|FG000|Overall Study|Later determined to be ineligible|2|||
145781507|NCT02792777|525707293|FG001|Overall Study|Later determined to be ineligible|0|||
145781508|NCT02792777|525707292|FG000|Overall Study|Participant interviewed twice|1|||
145781509|NCT02792777|525707293|FG001|Overall Study|Participant interviewed twice|0|||
145781510|NCT02795156|525707294|FG000|Overall Study|Progressive Disease|22|||
145781511|NCT02795156|525707295|FG001|Overall Study|Progressive Disease|7|||
145781512|NCT02795156|525707296|FG002|Overall Study|Progressive Disease|34|||
145781513|NCT02795156|525707297|FG003|Overall Study|Progressive Disease|7|||
145781514|NCT02795156|525707294|FG000|Overall Study|Adverse Event|13|||
145781515|NCT02795156|525707295|FG001|Overall Study|Adverse Event|2|||
145781516|NCT02795156|525707296|FG002|Overall Study|Adverse Event|3|||
145781517|NCT02795156|525707297|FG003|Overall Study|Adverse Event|2|||
145781518|NCT02795156|525707294|FG000|Overall Study|Death|1|||
145781519|NCT02795156|525707295|FG001|Overall Study|Death|1|||
145781520|NCT02795156|525707296|FG002|Overall Study|Death|1|||
145781521|NCT02795156|525707297|FG003|Overall Study|Death|0|||
145781522|NCT02795156|525707294|FG000|Overall Study|Physician Decision|1|||
145781523|NCT02795156|525707295|FG001|Overall Study|Physician Decision|0|||
145781524|NCT02795156|525707296|FG002|Overall Study|Physician Decision|1|||
145781525|NCT02795156|525707297|FG003|Overall Study|Physician Decision|0|||
145781526|NCT02795156|525707294|FG000|Overall Study|Withdrawal by Subject|2|||
145781527|NCT02795156|525707295|FG001|Overall Study|Withdrawal by Subject|0|||
145781528|NCT02795156|525707296|FG002|Overall Study|Withdrawal by Subject|3|||
145781529|NCT02795156|525707297|FG003|Overall Study|Withdrawal by Subject|0|||
145781530|NCT00530712|525707299|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
145781531|NCT00530712|525707299|FG000|30 Day Follow-up Visit|Missed Visit|5|||
145781532|NCT00530712|525707299|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
145781533|NCT00530712|525707299|FG000|6 Month Follow-up Visit|Missed Visit|3|||
145781534|NCT00530712|525707299|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
145781535|NCT00530712|525707299|FG000|6 Month Follow-up Visit|Death|2|||
145781536|NCT00530712|525707299|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
145781537|NCT00530712|525707299|FG000|12 Month Follow-up Visit|Missed Visit|3|||
145781538|NCT00530712|525707299|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
145781539|NCT00530712|525707299|FG000|12 Month Follow-up Visit|Death|9|||
145781540|NCT02260193|525707307|FG000|Overall Study|Lack of Efficacy|0|||
145781541|NCT02260193|525707308|FG001|Overall Study|Lack of Efficacy|1|||
145781542|NCT02260193|525707309|FG002|Overall Study|Lack of Efficacy|6|||
145781543|NCT02260193|525707307|FG000|Overall Study|Adverse Event|3|||
145781544|NCT02260193|525707308|FG001|Overall Study|Adverse Event|4|||
145781545|NCT02260193|525707309|FG002|Overall Study|Adverse Event|1|||
145781546|NCT02260193|525707307|FG000|Overall Study|Protocol Violation|0|||
145781547|NCT02260193|525707308|FG001|Overall Study|Protocol Violation|4|||
145781548|NCT02260193|525707309|FG002|Overall Study|Protocol Violation|0|||
145781549|NCT02260193|525707307|FG000|Overall Study|Withdrawal by Subject|3|||
145781550|NCT02260193|525707308|FG001|Overall Study|Withdrawal by Subject|0|||
145781551|NCT02260193|525707309|FG002|Overall Study|Withdrawal by Subject|2|||
145781552|NCT02260193|525707307|FG000|Overall Study|Kidney Transplantation|0|||
145781553|NCT02260193|525707308|FG001|Overall Study|Kidney Transplantation|0|||
145781554|NCT02260193|525707309|FG002|Overall Study|Kidney Transplantation|1|||
145781555|NCT03575468|525707310|FG000|Overall Study|Withdrawal by Subject|3|||
145781556|NCT03575468|525707311|FG001|Overall Study|Withdrawal by Subject|0|||
145781557|NCT03575468|525707310|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
145781558|NCT03575468|525707311|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
145781559|NCT03575468|525707310|FG000|Overall Study|Lost to Follow-up|13|||
145781560|NCT03575468|525707311|FG001|Overall Study|Lost to Follow-up|17|||
145781561|NCT05270694|525708938|FG000|Overall Study|Death|1|||
145781562|NCT05270694|525708938|FG000|Overall Study|Medical issues impacted ability to participate|2|||
145781563|NCT05270694|525708938|FG000|Overall Study|Lost to Follow-up|3|||
145781564|NCT05270694|525708938|FG000|Overall Study|Withdrawal by Subject|3|||
145781565|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
145781566|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
145537398|NCT00142935|524827452|FG001|Overall Study|Other reason|1|||
145781567|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
145781568|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
145781569|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Death|8|||
145781570|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Death|3|||
145781571|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
145781572|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
145781573|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
145781574|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
145781575|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
145781576|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
145781577|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
145781578|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
145781579|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
145781580|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
145781581|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
145781582|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
145781583|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
145781584|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
145781585|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
145781586|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
145781587|NCT00494871|525708939|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
145781588|NCT00494871|525708940|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
145781589|NCT00494871|525708939|FG000|Follow-up (FU) Period|Adverse Event|1|||
145781590|NCT00494871|525708940|FG001|Follow-up (FU) Period|Adverse Event|1|||
145781591|NCT00494871|525708939|FG000|Follow-up (FU) Period|Death|13|||
145781592|NCT00494871|525708940|FG001|Follow-up (FU) Period|Death|12|||
145781593|NCT00494871|525708939|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
145781594|NCT00494871|525708940|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
145781595|NCT00494871|525708939|FG000|Follow-up (FU) Period|Physician Decision|0|||
145781596|NCT00494871|525708940|FG001|Follow-up (FU) Period|Physician Decision|1|||
145781597|NCT00494871|525708939|FG000|Follow-up (FU) Period|Protocol Violation|1|||
145781598|NCT00494871|525708940|FG001|Follow-up (FU) Period|Protocol Violation|0|||
145781599|NCT00494871|525708939|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
145781600|NCT00494871|525708940|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
145781601|NCT00494871|525708939|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
145781602|NCT00494871|525708940|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
145781603|NCT04543955|525708941|FG000|Overall Study|Company cancelled study|1|||
145781604|NCT04543955|525708942|FG001|Overall Study|Company cancelled study|0|||
145781605|NCT03918642|525708943|FG000|Overall Study|Lost to Follow-up|12|||
145781606|NCT03918642|525708944|FG001|Overall Study|Lost to Follow-up|10|||
145781607|NCT00972244|525708950|FG000|Overall Study|Incorrect Enrolment|1|||
145781608|NCT00972244|525708951|FG001|Overall Study|Incorrect Enrolment|0|||
145781609|NCT00972244|525708952|FG002|Overall Study|Incorrect Enrolment|0|||
145781610|NCT00972244|525708953|FG003|Overall Study|Incorrect Enrolment|0|||
145781611|NCT00972244|525708954|FG004|Overall Study|Incorrect Enrolment|0|||
145781612|NCT00972244|525708950|FG000|Overall Study|Adverse Event|0|||
145781613|NCT00972244|525708951|FG001|Overall Study|Adverse Event|1|||
145781614|NCT00972244|525708952|FG002|Overall Study|Adverse Event|1|||
145781615|NCT00972244|525708953|FG003|Overall Study|Adverse Event|0|||
145781616|NCT00972244|525708954|FG004|Overall Study|Adverse Event|0|||
145781617|NCT00972244|525708950|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
145781618|NCT00972244|525708951|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
145781619|NCT00972244|525708952|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
145781620|NCT00972244|525708953|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
145781621|NCT00972244|525708954|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
145781622|NCT00972244|525708950|FG000|Overall Study|Withdrawal by Subject|1|||
145781623|NCT00972244|525708951|FG001|Overall Study|Withdrawal by Subject|2|||
145781624|NCT00972244|525708952|FG002|Overall Study|Withdrawal by Subject|1|||
145781625|NCT00972244|525708953|FG003|Overall Study|Withdrawal by Subject|0|||
145781626|NCT00972244|525708954|FG004|Overall Study|Withdrawal by Subject|1|||
145781627|NCT00972244|525708950|FG000|Overall Study|Safety|0|||
145781628|NCT00972244|525708951|FG001|Overall Study|Safety|0|||
145781629|NCT00972244|525708952|FG002|Overall Study|Safety|0|||
145781630|NCT00972244|525708953|FG003|Overall Study|Safety|0|||
145781631|NCT00972244|525708954|FG004|Overall Study|Safety|1|||
145781632|NCT00972244|525708950|FG000|Overall Study|Death|1|||
145537399|NCT00142935|524827453|FG002|Overall Study|Other reason|1|||
145781633|NCT00972244|525708951|FG001|Overall Study|Death|0|||
145781634|NCT00972244|525708952|FG002|Overall Study|Death|0|||
145537400|NCT00142935|524827451|FG000|Overall Study|Lost to Follow-up|2|||
145537401|NCT00142935|524827452|FG001|Overall Study|Lost to Follow-up|5|||
145537402|NCT00142935|524827453|FG002|Overall Study|Lost to Follow-up|5|||
145537403|NCT00142935|524827451|FG000|Overall Study|Death|0|||
145537404|NCT00142935|524827452|FG001|Overall Study|Death|2|||
145781635|NCT00972244|525708953|FG003|Overall Study|Death|0|||
145781636|NCT00972244|525708954|FG004|Overall Study|Death|0|||
145781637|NCT00972244|525708950|FG000|Overall Study|Various|0|||
145781638|NCT00972244|525708951|FG001|Overall Study|Various|0|||
145781639|NCT00972244|525708952|FG002|Overall Study|Various|0|||
145537405|NCT00142935|524827453|FG002|Overall Study|Death|1|||
145781640|NCT00972244|525708953|FG003|Overall Study|Various|0|||
145781641|NCT00972244|525708954|FG004|Overall Study|Various|2|||
145781642|NCT02855411|525708957|FG000|Overall Study|Study terminated by sponsor|21|||
145781643|NCT02855411|525708957|FG000|Overall Study|Does not meet entrance criteria|14|||
145781644|NCT00907881|525708958|FG000|Overall Study|Lost to Follow-up|59|||
145781645|NCT00907881|525708958|FG000|Overall Study|Noncompliance|5|||
145781646|NCT00907881|525708958|FG000|Overall Study|Withdrawal by Subject|5|||
145781647|NCT00907881|525708958|FG000|Overall Study|Protocol Violation|1|||
145781648|NCT00907881|525708958|FG000|Overall Study|Missing discontinuation information|15|||
145781649|NCT02795767|525708968|FG000|Overall Study|Received Commercial Emicizumab|1|||
145781650|NCT02795767|525708969|FG001|Overall Study|Received Commercial Emicizumab|0|||
145781651|NCT02795767|525708970|FG002|Overall Study|Received Commercial Emicizumab|0|||
145781652|NCT03964415|525708975|FG000|Overall Study|Sponsor's decision|1563|||
145781653|NCT03964415|525708976|FG001|Overall Study|Sponsor's decision|1528|||
145781654|NCT03964415|525708975|FG000|Overall Study|Lost to Follow-up|139|||
145781655|NCT03964415|525708976|FG001|Overall Study|Lost to Follow-up|146|||
145781656|NCT03964415|525708975|FG000|Overall Study|Withdrawal by Subject|68|||
145781657|NCT03964415|525708976|FG001|Overall Study|Withdrawal by Subject|72|||
145781658|NCT03964415|525708975|FG000|Overall Study|Physician Decision|34|||
145781659|NCT03964415|525708976|FG001|Overall Study|Physician Decision|48|||
145781660|NCT03964415|525708975|FG000|Overall Study|Adverse Event|3|||
145781661|NCT03964415|525708976|FG001|Overall Study|Adverse Event|0|||
145781662|NCT03964415|525708975|FG000|Overall Study|Death|4|||
145781663|NCT03964415|525708976|FG001|Overall Study|Death|6|||
145781664|NCT03964415|525708975|FG000|Overall Study|Protocol Violation|1|||
145781665|NCT03964415|525708976|FG001|Overall Study|Protocol Violation|4|||
145781666|NCT03964415|525708975|FG000|Overall Study|Other|35|||
145781667|NCT03964415|525708976|FG001|Overall Study|Other|38|||
145781668|NCT03964415|525708975|FG000|Overall Study|Randomized but not treated|6|||
145781669|NCT03964415|525708976|FG001|Overall Study|Randomized but not treated|7|||
145781670|NCT01302769|525708981|FG000|Overall Study|Lost to Follow-up|1|||
145781671|NCT01302769|525708982|FG001|Overall Study|Lost to Follow-up|1|||
145781672|NCT01426386|525708987|FG000|Overall Study|Adverse Event|0|||
145781673|NCT01426386|525708988|FG001|Overall Study|Adverse Event|1|||
145781674|NCT01426386|525708989|FG002|Overall Study|Adverse Event|0|||
145781675|NCT01426386|525708990|FG003|Overall Study|Adverse Event|0|||
145781676|NCT01426386|525708991|FG004|Overall Study|Adverse Event|0|||
145781677|NCT01426386|525708992|FG005|Overall Study|Adverse Event|0|||
145781678|NCT01426386|525708987|FG000|Overall Study|Did not attend scheduled visit|1|||
145781679|NCT01426386|525708988|FG001|Overall Study|Did not attend scheduled visit|4|||
145781680|NCT01426386|525708989|FG002|Overall Study|Did not attend scheduled visit|0|||
145781681|NCT01426386|525708990|FG003|Overall Study|Did not attend scheduled visit|0|||
145781682|NCT01426386|525708991|FG004|Overall Study|Did not attend scheduled visit|2|||
145781683|NCT01426386|525708992|FG005|Overall Study|Did not attend scheduled visit|1|||
145537406|NCT01180985|524827454|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
145537407|NCT01180985|524827455|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
145537408|NCT00705289|524827456|FG000|Overall Study|Subject or treating physician's choice|131|||
145537409|NCT01030536|524827457|FG000|Overall Study|Withdrawal by Subject|0|||
145537410|NCT01030536|524827458|FG001|Overall Study|Withdrawal by Subject|0|||
145537411|NCT01030536|524827459|FG002|Overall Study|Withdrawal by Subject|1|||
145537412|NCT01030536|524827460|FG003|Overall Study|Withdrawal by Subject|0|||
145537413|NCT01030536|524827461|FG004|Overall Study|Withdrawal by Subject|0|||
145537414|NCT01030536|524827457|FG000|Overall Study|undefined|1|||
145537415|NCT01030536|524827458|FG001|Overall Study|undefined|0|||
145781684|NCT01426386|525708987|FG000|Overall Study|Poor response|2|||
145781685|NCT01426386|525708988|FG001|Overall Study|Poor response|1|||
145781686|NCT01426386|525708989|FG002|Overall Study|Poor response|2|||
145781687|NCT01426386|525708990|FG003|Overall Study|Poor response|0|||
145781688|NCT01426386|525708991|FG004|Overall Study|Poor response|1|||
145781689|NCT01426386|525708992|FG005|Overall Study|Poor response|0|||
145781690|NCT01426386|525708987|FG000|Overall Study|Personal reasons|0|||
145781691|NCT01426386|525708988|FG001|Overall Study|Personal reasons|0|||
145781692|NCT01426386|525708989|FG002|Overall Study|Personal reasons|0|||
145781693|NCT01426386|525708990|FG003|Overall Study|Personal reasons|0|||
145781694|NCT01426386|525708991|FG004|Overall Study|Personal reasons|1|||
145781695|NCT01426386|525708992|FG005|Overall Study|Personal reasons|0|||
145781696|NCT03694522|525708994|FG000|Overall Study|Withdrawal by Subject|8|||
145537416|NCT01030536|524827459|FG002|Overall Study|undefined|1|||
145781697|NCT03694522|525708995|FG001|Overall Study|Withdrawal by Subject|10|||
145781698|NCT03694522|525708994|FG000|Overall Study|Physician Decision|53|||
145781699|NCT03694522|525708995|FG001|Overall Study|Physician Decision|54|||
145537417|NCT01030536|524827460|FG003|Overall Study|undefined|1|||
145537418|NCT01030536|524827461|FG004|Overall Study|undefined|0|||
145781700|NCT03694522|525708994|FG000|Overall Study|Other|1|||
145781701|NCT03694522|525708995|FG001|Overall Study|Other|1|||
145781702|NCT03694522|525708994|FG000|Overall Study|Lost to Follow-up|0|||
145781703|NCT03694522|525708995|FG001|Overall Study|Lost to Follow-up|1|||
145781704|NCT02760407|525708996|FG000|Overall Study|Death|2|||
145781705|NCT02760407|525708997|FG001|Overall Study|Death|3|||
145537419|NCT01030536|524827457|FG000|Overall Study|Adverse Event|0|||
145537420|NCT01030536|524827458|FG001|Overall Study|Adverse Event|3|||
145537421|NCT01030536|524827459|FG002|Overall Study|Adverse Event|1|||
145537422|NCT01030536|524827460|FG003|Overall Study|Adverse Event|0|||
145537423|NCT01030536|524827461|FG004|Overall Study|Adverse Event|1|||
145537424|NCT01030536|524827457|FG000|Overall Study|Progressive disease|6|||
145537425|NCT01030536|524827458|FG001|Overall Study|Progressive disease|2|||
145537426|NCT01030536|524827459|FG002|Overall Study|Progressive disease|3|||
145537427|NCT01030536|524827460|FG003|Overall Study|Progressive disease|2|||
145537428|NCT01030536|524827461|FG004|Overall Study|Progressive disease|0|||
145537429|NCT01030536|524827457|FG000|Overall Study|Death|0|||
145537430|NCT01030536|524827458|FG001|Overall Study|Death|1|||
145537431|NCT01030536|524827459|FG002|Overall Study|Death|0|||
145537432|NCT01030536|524827460|FG003|Overall Study|Death|0|||
145537433|NCT01030536|524827461|FG004|Overall Study|Death|0|||
145537434|NCT00129272|524827462|FG000|Overall Study|Lost to Follow-up|12|||
145537435|NCT00129272|524827463|FG001|Overall Study|Lost to Follow-up|11|||
145537436|NCT00129272|524827462|FG000|Overall Study|Withdrawal by Subject|5|||
145537437|NCT00129272|524827463|FG001|Overall Study|Withdrawal by Subject|11|||
145537438|NCT02601027|524827467|FG000|Registration to Surgery|Withdrawal by Subject|20|||
145537439|NCT02601027|524827468|FG001|Registration to Surgery|Withdrawal by Subject|10|||
145537440|NCT01419626|524827469|FG000|Overall Study|Protocol Violation|3|||
145537441|NCT01419626|524827470|FG001|Overall Study|Protocol Violation|2|||
145537442|NCT01419626|524827471|FG002|Overall Study|Protocol Violation|2|||
145537443|NCT01419626|524827469|FG000|Overall Study|Withdrawal by Subject|1|||
145781706|NCT02760407|525708998|FG002|Overall Study|Death|1|||
145781707|NCT02760407|525708999|FG003|Overall Study|Death|1|||
145781708|NCT02760407|525708996|FG000|Overall Study|Lost to Follow-up|1|||
145781709|NCT02760407|525708997|FG001|Overall Study|Lost to Follow-up|7|||
145781710|NCT02760407|525708998|FG002|Overall Study|Lost to Follow-up|4|||
145781711|NCT02760407|525708999|FG003|Overall Study|Lost to Follow-up|6|||
145781712|NCT02760407|525708996|FG000|Overall Study|Withdrawal by Subject|25|||
145781713|NCT02760407|525708997|FG001|Overall Study|Withdrawal by Subject|31|||
145781714|NCT02760407|525708998|FG002|Overall Study|Withdrawal by Subject|37|||
145781715|NCT02760407|525708999|FG003|Overall Study|Withdrawal by Subject|25|||
145781716|NCT02760407|525708996|FG000|Overall Study|Violation of Eligibility criteria|0|||
145781717|NCT02760407|525708997|FG001|Overall Study|Violation of Eligibility criteria|0|||
145781718|NCT02760407|525708998|FG002|Overall Study|Violation of Eligibility criteria|1|||
145781719|NCT02760407|525708999|FG003|Overall Study|Violation of Eligibility criteria|1|||
145781720|NCT02760407|525708996|FG000|Overall Study|Personal reasons|0|||
145781721|NCT02760407|525708997|FG001|Overall Study|Personal reasons|0|||
145781722|NCT02760407|525708998|FG002|Overall Study|Personal reasons|0|||
145781723|NCT02760407|525708999|FG003|Overall Study|Personal reasons|1|||
145781724|NCT02760407|525708996|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
145781725|NCT02760407|525708997|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
145781726|NCT02760407|525708998|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
145781727|NCT02760407|525708999|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
145781728|NCT02760407|525708996|FG000|Overall Study|Use of prohibited Medication|0|||
145781729|NCT02760407|525708997|FG001|Overall Study|Use of prohibited Medication|0|||
145781730|NCT02760407|525708998|FG002|Overall Study|Use of prohibited Medication|1|||
145781731|NCT02760407|525708999|FG003|Overall Study|Use of prohibited Medication|0|||
145781732|NCT02760407|525708996|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
145781733|NCT02760407|525708997|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
145781734|NCT02760407|525708998|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
145781735|NCT02760407|525708999|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
145781736|NCT02760407|525708996|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
145781737|NCT02760407|525708997|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
145537444|NCT01419626|524827470|FG001|Overall Study|Withdrawal by Subject|0|||
145781738|NCT02760407|525708998|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
145537445|NCT01419626|524827471|FG002|Overall Study|Withdrawal by Subject|0|||
145537446|NCT01419626|524827469|FG000|Overall Study|Lost to Follow-up|0|||
145537447|NCT01419626|524827470|FG001|Overall Study|Lost to Follow-up|1|||
145537448|NCT01419626|524827471|FG002|Overall Study|Lost to Follow-up|1|||
145537449|NCT01146912|524827472|FG000|Overall Study|Already received influenza vaccination|817|||
145537450|NCT01146912|524827473|FG001|Overall Study|Already received influenza vaccination|822|||
145537451|NCT01146912|524827474|FG002|Overall Study|Already received influenza vaccination|13|||
145537452|NCT01146912|524827475|FG003|Overall Study|Already received influenza vaccination|15|||
145537453|NCT01146912|524827476|FG004|Overall Study|Already received influenza vaccination|41|||
145781739|NCT02760407|525708999|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
145781740|NCT02760407|525708996|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
145781741|NCT02760407|525708997|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
145781742|NCT02760407|525708998|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
145781743|NCT02760407|525708999|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
145781744|NCT02760407|525708996|FG000|Overall Study|Inadequately Enrolled|0|||
145781745|NCT02760407|525708997|FG001|Overall Study|Inadequately Enrolled|0|||
145781746|NCT02760407|525708998|FG002|Overall Study|Inadequately Enrolled|0|||
145781747|NCT02760407|525708999|FG003|Overall Study|Inadequately Enrolled|1|||
145781748|NCT02760407|525708996|FG000|Overall Study|Withdrawal By PI's Decision|0|||
145781749|NCT02760407|525708997|FG001|Overall Study|Withdrawal By PI's Decision|1|||
145781750|NCT02760407|525708998|FG002|Overall Study|Withdrawal By PI's Decision|0|||
145781751|NCT02760407|525708999|FG003|Overall Study|Withdrawal By PI's Decision|0|||
145781752|NCT02760407|525708996|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
145781753|NCT02760407|525708997|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
145781754|NCT02760407|525708998|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
145781755|NCT02760407|525708999|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
145781756|NCT02760407|525708996|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
145781757|NCT02760407|525708997|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
145781758|NCT02760407|525708998|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
145781759|NCT02760407|525708999|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
145781760|NCT02760407|525708996|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
145781761|NCT02760407|525708997|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
145781762|NCT02760407|525708998|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
145781763|NCT02760407|525708999|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
145781764|NCT02760407|525708996|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
145781765|NCT02760407|525708997|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
145781766|NCT02760407|525708998|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
145781767|NCT02760407|525708999|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
145781768|NCT02760407|525708996|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
145781769|NCT02760407|525708997|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
145781770|NCT02760407|525708998|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
145781771|NCT02760407|525708999|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
145781772|NCT02760407|525708996|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
145781773|NCT02760407|525708997|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
145781774|NCT02760407|525708998|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
145781775|NCT02760407|525708999|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
145781776|NCT02760407|525708996|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
145781777|NCT02760407|525708997|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
145781778|NCT02760407|525708998|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
145781779|NCT02760407|525708999|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
145781780|NCT02760407|525708996|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
145781781|NCT02760407|525708997|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
145781782|NCT02760407|525708998|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
145781783|NCT02760407|525708999|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
145781784|NCT02760407|525708996|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
145781785|NCT02760407|525708997|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
145781786|NCT02760407|525708998|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
145781787|NCT02760407|525708999|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
145781788|NCT02522377|525709000|FG000|Overall Study|Withdrawal by Subject|1|||
145781789|NCT02522377|525709001|FG001|Overall Study|Withdrawal by Subject|0|||
145781790|NCT02522377|525709000|FG000|Overall Study|Remission Achieved|3|||
145781791|NCT02522377|525709001|FG001|Overall Study|Remission Achieved|0|||
145781792|NCT01158950|525709002|FG000|1st Intervention (1 Day)|Physician Decision|1|||
145537454|NCT01146912|524827477|FG005|Overall Study|Already received influenza vaccination|61|||
145537455|NCT01146912|524827478|FG006|Overall Study|Already received influenza vaccination|56|||
145537456|NCT01146912|524827479|FG007|Overall Study|Already received influenza vaccination|0|||
145537457|NCT01146912|524827472|FG000|Overall Study|< 14 weeks gestational age|0|||
145537458|NCT01146912|524827473|FG001|Overall Study|< 14 weeks gestational age|0|||
145537459|NCT01146912|524827474|FG002|Overall Study|< 14 weeks gestational age|3|||
145781793|NCT01158950|525709003|FG001|1st Intervention (1 Day)|Physician Decision|2|||
145781794|NCT02116972|525709006|FG000|Overall Study|Adverse Event|4|||
145781795|NCT02116972|525709007|FG001|Overall Study|Adverse Event|4|||
145781796|NCT02116972|525709008|FG002|Overall Study|Adverse Event|1|||
145781797|NCT02116972|525709006|FG000|Overall Study|Withdrawal by Subject|1|||
145781798|NCT02116972|525709007|FG001|Overall Study|Withdrawal by Subject|1|||
145781799|NCT02116972|525709008|FG002|Overall Study|Withdrawal by Subject|5|||
145781800|NCT02116972|525709006|FG000|Overall Study|Protocol Violation|1|||
145781801|NCT02116972|525709007|FG001|Overall Study|Protocol Violation|0|||
145781802|NCT02116972|525709008|FG002|Overall Study|Protocol Violation|1|||
145781803|NCT02116972|525709006|FG000|Overall Study|Lost to Follow-up|4|||
145781804|NCT02116972|525709007|FG001|Overall Study|Lost to Follow-up|3|||
145781805|NCT02116972|525709008|FG002|Overall Study|Lost to Follow-up|1|||
145781806|NCT02116972|525709006|FG000|Overall Study|Lack of Efficacy|6|||
145781807|NCT02116972|525709007|FG001|Overall Study|Lack of Efficacy|6|||
145781808|NCT02116972|525709008|FG002|Overall Study|Lack of Efficacy|5|||
145781809|NCT02116972|525709006|FG000|Overall Study|scheduling conflicts and relocation|3|||
145781810|NCT02116972|525709007|FG001|Overall Study|scheduling conflicts and relocation|3|||
145781811|NCT02116972|525709008|FG002|Overall Study|scheduling conflicts and relocation|6|||
145781812|NCT01797432|525709009|FG000|Overall Study|Lost to Follow-up|1|||
145781813|NCT01797432|525709009|FG000|Overall Study|Adverse Event|1|||
145781814|NCT01797432|525709009|FG000|Overall Study|Withdrawal by Subject|1|||
145781815|NCT01797432|525709009|FG000|Overall Study|lived too far from study site|1|||
145781816|NCT01137435|525709010|FG000|Overall Study|Lost to Follow-up|24|||
145781817|NCT01137435|525709010|FG000|Overall Study|Off label usage|4|||
145781818|NCT00487279|525709021|FG000|Overall Study|Death|1|||
145781819|NCT00487279|525709022|FG001|Overall Study|Death|0|||
145781820|NCT00487279|525709021|FG000|Overall Study|Withdrawal by Subject|0|||
145781821|NCT00487279|525709022|FG001|Overall Study|Withdrawal by Subject|2|||
145781822|NCT02746679|525709023|FG000|Overall Study|Lost to Follow-up|4|||
145781823|NCT02746679|525709024|FG001|Overall Study|Lost to Follow-up|6|||
145781824|NCT00501852|525709025|FG000|Overall Study|Adverse Event|3|||
145781825|NCT00501852|525709025|FG000|Overall Study|Withdrawal by Subject|2|||
145781826|NCT01171521|525709028|FG000|Overall Study|Lost to Follow-up|5|||
145781827|NCT01171521|525709028|FG000|Overall Study|screen failure|1|||
145781828|NCT01416610|525709029|FG000|Overall Study|Adverse Event|4|||
145781829|NCT01416610|525709029|FG000|Overall Study|Adverse Event -Patient decision|3|||
145781830|NCT01416610|525709029|FG000|Overall Study|Lack of Efficacy|4|||
145781831|NCT01416610|525709029|FG000|Overall Study|No reason given|5|||
145781832|NCT01416610|525709029|FG000|Overall Study|Withdrawal by Subject|13|||
145781833|NCT01416610|525709029|FG000|Overall Study|Lost to Follow-up|7|||
145781834|NCT01416610|525709029|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
145781835|NCT01927562|525709030|FG000|Overall Study|Lost to Follow-up|30|||
145781836|NCT01927562|525709030|FG000|Overall Study|Withdrawal by Subject|3|||
145781837|NCT01927562|525709030|FG000|Overall Study|Physician Decision|5|||
145781838|NCT00492921|525709031|FG000|Overall Study|Death|1|||
145781839|NCT00492921|525709032|FG001|Overall Study|Death|0|||
145781840|NCT00492921|525709033|FG002|Overall Study|Death|1|||
145781841|NCT00652093|525709034|FG000|Overall Study|Withdrawal by Subject|0|||
145781842|NCT00652093|525709035|FG001|Overall Study|Withdrawal by Subject|0|||
145781843|NCT00652093|525709036|FG002|Overall Study|Withdrawal by Subject|1|||
145781844|NCT00652093|525709037|FG003|Overall Study|Withdrawal by Subject|0|||
145781845|NCT00652093|525709038|FG004|Overall Study|Withdrawal by Subject|1|||
145781846|NCT00652093|525709039|FG005|Overall Study|Withdrawal by Subject|0|||
145781847|NCT00652093|525709034|FG000|Overall Study|Physician Decision|0|||
145537460|NCT01146912|524827475|FG003|Overall Study|< 14 weeks gestational age|2|||
145537461|NCT01146912|524827476|FG004|Overall Study|< 14 weeks gestational age|0|||
145781848|NCT00652093|525709035|FG001|Overall Study|Physician Decision|0|||
145781849|NCT00652093|525709036|FG002|Overall Study|Physician Decision|0|||
145537462|NCT01146912|524827477|FG005|Overall Study|< 14 weeks gestational age|0|||
145781850|NCT00652093|525709037|FG003|Overall Study|Physician Decision|0|||
145781851|NCT00652093|525709038|FG004|Overall Study|Physician Decision|1|||
145781852|NCT00652093|525709039|FG005|Overall Study|Physician Decision|0|||
145781853|NCT01422304|525709042|FG000|Overall Study|Adverse Event|0|||
145781854|NCT01422304|525709043|FG001|Overall Study|Adverse Event|1|||
145781855|NCT01422304|525709042|FG000|Overall Study|Lost to Follow-up|14|||
145781856|NCT01422304|525709043|FG001|Overall Study|Lost to Follow-up|20|||
145781857|NCT01422304|525709042|FG000|Overall Study|Never Entered Follow-up|2|||
145781858|NCT01422304|525709043|FG001|Overall Study|Never Entered Follow-up|1|||
145781859|NCT01422304|525709042|FG000|Overall Study|Protocol Violation|1|||
145781860|NCT01422304|525709043|FG001|Overall Study|Protocol Violation|0|||
145781861|NCT01422304|525709042|FG000|Overall Study|Withdrawal by Subject|4|||
145781862|NCT01422304|525709043|FG001|Overall Study|Withdrawal by Subject|2|||
145781863|NCT01422304|525709042|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
145781864|NCT01422304|525709043|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
145781865|NCT01422304|525709042|FG000|Overall Study|Not Treated|3|||
145781866|NCT01422304|525709043|FG001|Overall Study|Not Treated|11|||
145781867|NCT02961764|525709044|FG000|Overall Study|Protocol Violation|0|||
145781868|NCT02961764|525709045|FG001|Overall Study|Protocol Violation|1|||
145781869|NCT02961764|525709044|FG000|Overall Study|Death|2|||
145781870|NCT02961764|525709045|FG001|Overall Study|Death|0|||
145781871|NCT02961764|525709044|FG000|Overall Study|Lost to Follow-up|35|||
145781872|NCT02961764|525709045|FG001|Overall Study|Lost to Follow-up|24|||
145781873|NCT02961764|525709044|FG000|Overall Study|Withdrawal by Subject|2|||
145781874|NCT02961764|525709045|FG001|Overall Study|Withdrawal by Subject|0|||
145781875|NCT00469014|525709046|FG000|Initial Phase Randomization|Disease Progression|0|||
145781876|NCT00469014|525709047|FG001|Initial Phase Randomization|Disease Progression|1|||
145781877|NCT00469014|525709048|FG002|Initial Phase Randomization|Disease Progression|1|||
145781878|NCT00469014|525709049|FG003|Initial Phase Randomization|Disease Progression|0|||
145781879|NCT00469014|525709046|FG000|Initial Phase Randomization|No Response|1|||
145781880|NCT00469014|525709047|FG001|Initial Phase Randomization|No Response|0|||
145781881|NCT00469014|525709048|FG002|Initial Phase Randomization|No Response|0|||
145781882|NCT00469014|525709049|FG003|Initial Phase Randomization|No Response|1|||
145781883|NCT00469014|525709046|FG000|Adaptive Randomization|Not Evaluable|1|||
145781884|NCT00469014|525709047|FG001|Adaptive Randomization|Not Evaluable|0|||
145781885|NCT00469014|525709048|FG002|Adaptive Randomization|Not Evaluable|0|||
145781886|NCT00469014|525709049|FG003|Adaptive Randomization|Not Evaluable|1|||
145781887|NCT00469014|525709046|FG000|Adaptive Randomization|No Response|0|||
145781888|NCT00469014|525709047|FG001|Adaptive Randomization|No Response|1|||
145781889|NCT00469014|525709048|FG002|Adaptive Randomization|No Response|0|||
145781890|NCT00469014|525709049|FG003|Adaptive Randomization|No Response|0|||
145781891|NCT00469014|525709046|FG000|Adaptive Randomization|Death|0|||
145781892|NCT00469014|525709047|FG001|Adaptive Randomization|Death|0|||
145781893|NCT00469014|525709048|FG002|Adaptive Randomization|Death|1|||
145781894|NCT00469014|525709049|FG003|Adaptive Randomization|Death|0|||
145781895|NCT03461289|525709053|FG000|Overall Study|Death|1|||
145781896|NCT00866294|525709056|FG000|Overall Study|Adverse Event|12|||
145781897|NCT00866294|525709057|FG001|Overall Study|Adverse Event|13|||
145781898|NCT00866294|525709058|FG002|Overall Study|Adverse Event|9|||
145781899|NCT00866294|525709056|FG000|Overall Study|Lack of Efficacy|7|||
145781900|NCT00866294|525709057|FG001|Overall Study|Lack of Efficacy|1|||
145781901|NCT00866294|525709058|FG002|Overall Study|Lack of Efficacy|0|||
145781902|NCT00866294|525709056|FG000|Overall Study|Protocol Violation|2|||
145781903|NCT00866294|525709057|FG001|Overall Study|Protocol Violation|0|||
145781904|NCT00866294|525709058|FG002|Overall Study|Protocol Violation|0|||
145781905|NCT00866294|525709056|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
145781906|NCT00866294|525709057|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145781907|NCT00866294|525709058|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145781908|NCT00866294|525709056|FG000|Overall Study|Lost to Follow-up|1|||
145781909|NCT00866294|525709057|FG001|Overall Study|Lost to Follow-up|3|||
145781910|NCT00866294|525709058|FG002|Overall Study|Lost to Follow-up|0|||
145781911|NCT00866294|525709056|FG000|Overall Study|Physician Decision|6|||
145781912|NCT00866294|525709057|FG001|Overall Study|Physician Decision|2|||
145781913|NCT00866294|525709058|FG002|Overall Study|Physician Decision|1|||
145781914|NCT02119104|525709060|FG000|Overall Study|Protocol Violation|16|||
145781915|NCT01632878|525709061|FG000|Screening|Physician Decision|268|||
145781916|NCT01632878|525709061|FG000|Treatment|Lost to Follow-up|41|||
145781917|NCT01632878|525709061|FG000|Treatment|Withdrawal by Subject|36|||
145781918|NCT01632878|525709061|FG000|Treatment|Physician Decision|34|||
145781919|NCT01632878|525709061|FG000|Treatment|missing information|4|||
145781920|NCT01632878|525709061|FG000|Treatment|no information on study completion|43|||
145781921|NCT02698423|525709062|FG000|Overall Study|Lost to Follow-up|19|||
145781922|NCT02698423|525709063|FG001|Overall Study|Lost to Follow-up|24|||
145781923|NCT00081289|525709066|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
145781924|NCT00081289|525709067|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
145781925|NCT00081289|525709066|FG000|Overall Study|Ineligible / no protocol treatment|3|||
145781926|NCT00081289|525709067|FG001|Overall Study|Ineligible / no protocol treatment|4|||
145781927|NCT02508701|525709070|FG000|Overall Study|Lost to Follow-up|9|||
145781928|NCT02508701|525709071|FG001|Overall Study|Lost to Follow-up|5|||
145781929|NCT02508701|525709072|FG002|Overall Study|Lost to Follow-up|5|||
145781930|NCT02508701|525709073|FG003|Overall Study|Lost to Follow-up|3|||
145781931|NCT03117049|525709076|FG000|Overall Study|Continued the follow-up period|109|||
145781932|NCT03117049|525709077|FG001|Overall Study|Continued the follow-up period|129|||
145781933|NCT03117049|525709076|FG000|Overall Study|Died|82|||
145781934|NCT03117049|525709077|FG001|Overall Study|Died|93|||
145781935|NCT03117049|525709076|FG000|Overall Study|Consent withdrawal|7|||
145781936|NCT03117049|525709077|FG001|Overall Study|Consent withdrawal|6|||
145781937|NCT03117049|525709076|FG000|Overall Study|Missing contact|3|||
145781938|NCT03117049|525709077|FG001|Overall Study|Missing contact|3|||
145781939|NCT00839098|525709078|FG000|Overall Study|Withdrawal by Subject|2|||
145781940|NCT00839098|525709079|FG001|Overall Study|Withdrawal by Subject|1|||
145781941|NCT00839098|525709080|FG002|Overall Study|Withdrawal by Subject|7|||
145781942|NCT02399475|525709085|FG000|Overall Study|Physician Decision|1|||
145609097|NCT02243631|525084794|FG000|Overall Study|no synovial fluid on second aspirate|0|||
145609098|NCT02243631|525084795|FG001|Overall Study|no synovial fluid on second aspirate|1|||
145609099|NCT01590771|525084796|FG000|Overall Study|Other Protocol Specified Criteria|5|||
145609100|NCT01590771|525084797|FG001|Overall Study|Other Protocol Specified Criteria|14|||
145609101|NCT01590771|525084796|FG000|Overall Study|Withdrawal by Subject|8|||
145609102|NCT01590771|525084797|FG001|Overall Study|Withdrawal by Subject|15|||
145609103|NCT01590771|525084796|FG000|Overall Study|Protocol Violation|1|||
145609104|NCT01590771|525084797|FG001|Overall Study|Protocol Violation|2|||
145781943|NCT02399475|525709086|FG001|Overall Study|Physician Decision|0|||
145781944|NCT00935220|525709087|FG000|Overall Study|Adverse Event|1|||
145781945|NCT00935220|525709087|FG000|Overall Study|Other reason (not specified)|1|||
145609105|NCT01590771|525084796|FG000|Overall Study|Lost to Follow-up|1|||
145781946|NCT01415440|525709090|FG000|Overall Study|Lost to Follow-up|0|||
145781947|NCT01415440|525709091|FG001|Overall Study|Lost to Follow-up|1|||
145781948|NCT01415440|525709092|FG002|Overall Study|Lost to Follow-up|2|||
145781949|NCT01415440|525709090|FG000|Overall Study|Physician Decision|3|||
145781950|NCT01415440|525709091|FG001|Overall Study|Physician Decision|0|||
145781951|NCT01415440|525709092|FG002|Overall Study|Physician Decision|0|||
145781952|NCT01415440|525709090|FG000|Overall Study|Withdrawal by Subject|1|||
145781953|NCT01415440|525709091|FG001|Overall Study|Withdrawal by Subject|0|||
145781954|NCT01415440|525709092|FG002|Overall Study|Withdrawal by Subject|0|||
145781955|NCT00633139|525709093|FG000|Overall Study|Non compliance|0|||
145781956|NCT00633139|525709094|FG001|Overall Study|Non compliance|0|||
145781957|NCT00633139|525709095|FG002|Overall Study|Non compliance|1|||
145781958|NCT00633139|525709093|FG000|Overall Study|Withdrawal by Subject|0|||
145781959|NCT00633139|525709094|FG001|Overall Study|Withdrawal by Subject|1|||
145781960|NCT00633139|525709095|FG002|Overall Study|Withdrawal by Subject|0|||
145781961|NCT02160977|525709098|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
145781962|NCT02160977|525709099|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
145781963|NCT02160977|525709098|FG000|Three Months After Surgery|Lost to Follow-up|0|||
145781964|NCT02160977|525709099|FG001|Three Months After Surgery|Lost to Follow-up|2|||
145781965|NCT02160977|525709098|FG000|Six Months After Surgery|Lost to Follow-up|2|||
145781966|NCT02160977|525709099|FG001|Six Months After Surgery|Lost to Follow-up|1|||
145781967|NCT03132805|525710132|FG000|Overall Study|Lost to Follow-up|142|||
145781968|NCT03132805|525710133|FG001|Overall Study|Lost to Follow-up|141|||
145781969|NCT03132805|525710134|FG002|Overall Study|Lost to Follow-up|113|||
145781970|NCT03009539|525710135|FG000|Overall Study|Lost to Follow-up|132|||
145781971|NCT03009539|525710136|FG001|Overall Study|Lost to Follow-up|113|||
145781972|NCT03009539|525710137|FG002|Overall Study|Lost to Follow-up|132|||
145781973|NCT03009539|525710138|FG003|Overall Study|Lost to Follow-up|113|||
145781974|NCT03151148|525710139|FG000|Overall Study|Lost to Follow-up|1|||
145781975|NCT03151148|525710140|FG001|Overall Study|Lost to Follow-up|0|||
145781976|NCT03151148|525710139|FG000|Overall Study|Withdrawal by Subject|1|||
145781977|NCT03151148|525710140|FG001|Overall Study|Withdrawal by Subject|0|||
145781978|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
145781979|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
145781980|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
145781981|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
145781982|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
145781983|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
145781984|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
145781985|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
145781986|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
145781987|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
145781988|NCT00710034|525710141|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
145781989|NCT00710034|525710142|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
145781990|NCT00710034|525710141|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
145781991|NCT00710034|525710142|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
145781992|NCT00710034|525710141|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
145781993|NCT00710034|525710142|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
145781994|NCT00710034|525710141|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
145781995|NCT00710034|525710142|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
145609106|NCT01590771|525084797|FG001|Overall Study|Lost to Follow-up|1|||
145781996|NCT00710034|525710141|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
145781997|NCT00710034|525710142|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
145781998|NCT00710034|525710141|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
145781999|NCT00710034|525710142|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
145782000|NCT01614769|525710145|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
145609107|NCT01590771|525084796|FG000|Overall Study|Lack of Efficacy|1|||
145782001|NCT01614769|525710146|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
145782002|NCT01614769|525710147|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
145782003|NCT01614769|525710148|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
145609108|NCT01590771|525084797|FG001|Overall Study|Lack of Efficacy|0|||
145403736|NCT01981616|524334403|FG000|Overall Study|Protocol Violation|1|||
145403737|NCT01981616|524334404|FG001|Overall Study|Protocol Violation|0|||
145537463|NCT01146912|524827478|FG006|Overall Study|< 14 weeks gestational age|0|||
145537464|NCT01146912|524827479|FG007|Overall Study|< 14 weeks gestational age|0|||
145782004|NCT01614769|525710149|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
145782005|NCT01614769|525710150|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
145782006|NCT01614769|525710145|FG000|Period 1|Protocol Violation|0|||
145782007|NCT01614769|525710146|FG001|Period 1|Protocol Violation|0|||
145782008|NCT01614769|525710147|FG002|Period 1|Protocol Violation|0|||
145782009|NCT01614769|525710148|FG003|Period 1|Protocol Violation|1|||
145782010|NCT01614769|525710149|FG004|Period 1|Protocol Violation|0|||
145782011|NCT01614769|525710150|FG005|Period 1|Protocol Violation|0|||
145782012|NCT01614769|525710145|FG000|Period 1|Withdrawal by Subject|1|||
145782013|NCT01614769|525710146|FG001|Period 1|Withdrawal by Subject|0|||
145782014|NCT01614769|525710147|FG002|Period 1|Withdrawal by Subject|0|||
145782015|NCT01614769|525710148|FG003|Period 1|Withdrawal by Subject|0|||
145782016|NCT01614769|525710149|FG004|Period 1|Withdrawal by Subject|0|||
145782017|NCT01614769|525710150|FG005|Period 1|Withdrawal by Subject|0|||
145782018|NCT01614769|525710145|FG000|Period 3|Withdrawal by Subject|0|||
145782019|NCT01614769|525710146|FG001|Period 3|Withdrawal by Subject|0|||
145782020|NCT01614769|525710147|FG002|Period 3|Withdrawal by Subject|1|||
145782021|NCT01614769|525710148|FG003|Period 3|Withdrawal by Subject|0|||
145782022|NCT01614769|525710149|FG004|Period 3|Withdrawal by Subject|0|||
145782023|NCT01614769|525710150|FG005|Period 3|Withdrawal by Subject|0|||
145782024|NCT04439838|525710153|FG000|Overall Study|Withdrawal by Subject|0|||
145782025|NCT04439838|525710154|FG001|Overall Study|Withdrawal by Subject|0|||
145782026|NCT04439838|525710155|FG002|Overall Study|Withdrawal by Subject|0|||
145782027|NCT04439838|525710156|FG003|Overall Study|Withdrawal by Subject|0|||
145782028|NCT04439838|525710157|FG004|Overall Study|Withdrawal by Subject|0|||
145782029|NCT04439838|525710158|FG005|Overall Study|Withdrawal by Subject|0|||
145782030|NCT04439838|525710159|FG006|Overall Study|Withdrawal by Subject|0|||
145782031|NCT04439838|525710160|FG007|Overall Study|Withdrawal by Subject|0|||
145782032|NCT04439838|525710161|FG008|Overall Study|Withdrawal by Subject|1|||
145782033|NCT01958671|525710164|FG000|Overall Study|Adverse Event|1|||
145782034|NCT01958671|525710165|FG001|Overall Study|Adverse Event|1|||
145782035|NCT01958671|525710166|FG002|Overall Study|Adverse Event|5|||
145782036|NCT01958671|525710164|FG000|Overall Study|Death|1|||
145782037|NCT01958671|525710165|FG001|Overall Study|Death|0|||
145782038|NCT01958671|525710166|FG002|Overall Study|Death|0|||
145782039|NCT01958671|525710164|FG000|Overall Study|Excluded medication|0|||
145782040|NCT01958671|525710165|FG001|Overall Study|Excluded medication|0|||
145782041|NCT01958671|525710166|FG002|Overall Study|Excluded medication|1|||
145782042|NCT01958671|525710164|FG000|Overall Study|Hyperglycemia|0|||
145782043|NCT01958671|525710165|FG001|Overall Study|Hyperglycemia|0|||
145782044|NCT01958671|525710166|FG002|Overall Study|Hyperglycemia|2|||
145782045|NCT01958671|525710164|FG000|Overall Study|Lost to Follow-up|7|||
145782046|NCT01958671|525710165|FG001|Overall Study|Lost to Follow-up|11|||
145782047|NCT01958671|525710166|FG002|Overall Study|Lost to Follow-up|7|||
145782048|NCT01958671|525710164|FG000|Overall Study|Non-compliance with study drug|1|||
145782049|NCT01958671|525710165|FG001|Overall Study|Non-compliance with study drug|1|||
145782050|NCT01958671|525710166|FG002|Overall Study|Non-compliance with study drug|1|||
145782051|NCT01958671|525710164|FG000|Overall Study|Pregnancy|0|||
145782052|NCT01958671|525710165|FG001|Overall Study|Pregnancy|0|||
145782053|NCT01958671|525710166|FG002|Overall Study|Pregnancy|1|||
145782054|NCT01958671|525710164|FG000|Overall Study|Protocol Violation|0|||
145782055|NCT01958671|525710165|FG001|Overall Study|Protocol Violation|1|||
145782056|NCT01958671|525710166|FG002|Overall Study|Protocol Violation|0|||
145782057|NCT01958671|525710164|FG000|Overall Study|Study site terminated by sponsor|1|||
145782058|NCT01958671|525710165|FG001|Overall Study|Study site terminated by sponsor|0|||
145782059|NCT01958671|525710166|FG002|Overall Study|Study site terminated by sponsor|1|||
145782060|NCT01958671|525710164|FG000|Overall Study|Participant moved|0|||
145782061|NCT01958671|525710165|FG001|Overall Study|Participant moved|0|||
145782062|NCT01958671|525710166|FG002|Overall Study|Participant moved|1|||
145782063|NCT01958671|525710164|FG000|Overall Study|Withdrawal by Subject|8|||
145782064|NCT01958671|525710165|FG001|Overall Study|Withdrawal by Subject|10|||
145782065|NCT01958671|525710166|FG002|Overall Study|Withdrawal by Subject|13|||
145782066|NCT01070303|525710167|FG000|Overall Study|Adverse Event|39|||
145782067|NCT01070303|525710167|FG000|Overall Study|Withdrawal by Subject|20|||
145782068|NCT01070303|525710167|FG000|Overall Study|Lost to Follow-up|9|||
145782069|NCT01070303|525710167|FG000|Overall Study|Protocol Violation|0|||
145782070|NCT01070303|525710167|FG000|Overall Study|Lack of Efficacy|2|||
145782071|NCT01070303|525710167|FG000|Overall Study|Administrative Reason|1|||
145403738|NCT01420536|524334405|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
145782072|NCT01070303|525710167|FG000|Overall Study|Other|18|||
145782073|NCT01849848|525710168|FG000|Overall Study|Physician Decision|1|||
145782074|NCT01849848|525710168|FG000|Overall Study|Progression of the primary disease|3|||
145782075|NCT00859898|525710170|FG000|Overall Study|Lack of Efficacy|0|||
145782076|NCT00859898|525710171|FG001|Overall Study|Lack of Efficacy|1|||
145782077|NCT00859898|525710172|FG002|Overall Study|Lack of Efficacy|1|||
145782078|NCT00859898|525710170|FG000|Overall Study|Adverse Event|4|||
145782079|NCT00859898|525710171|FG001|Overall Study|Adverse Event|9|||
145782080|NCT00859898|525710172|FG002|Overall Study|Adverse Event|8|||
145782081|NCT00859898|525710170|FG000|Overall Study|Withdrawal by Subject|11|||
145782082|NCT00859898|525710171|FG001|Overall Study|Withdrawal by Subject|8|||
145782083|NCT00859898|525710172|FG002|Overall Study|Withdrawal by Subject|11|||
145782084|NCT00859898|525710170|FG000|Overall Study|Death|0|||
145782085|NCT00859898|525710171|FG001|Overall Study|Death|0|||
145782086|NCT00859898|525710172|FG002|Overall Study|Death|1|||
145782087|NCT00859898|525710170|FG000|Overall Study|Lost to Follow-up|10|||
145782088|NCT00859898|525710171|FG001|Overall Study|Lost to Follow-up|11|||
145782089|NCT00859898|525710172|FG002|Overall Study|Lost to Follow-up|5|||
145782090|NCT00859898|525710170|FG000|Overall Study|poor/non-compliance|2|||
145782091|NCT00859898|525710171|FG001|Overall Study|poor/non-compliance|0|||
145782092|NCT00859898|525710172|FG002|Overall Study|poor/non-compliance|0|||
145782093|NCT00859898|525710170|FG000|Overall Study|No longer meets criteria|0|||
145782094|NCT00859898|525710171|FG001|Overall Study|No longer meets criteria|1|||
145782095|NCT00859898|525710172|FG002|Overall Study|No longer meets criteria|0|||
145782096|NCT00859898|525710170|FG000|Overall Study|non-specified|1|||
145782097|NCT00859898|525710171|FG001|Overall Study|non-specified|1|||
145782098|NCT00859898|525710172|FG002|Overall Study|non-specified|1|||
145782099|NCT02417233|525710175|FG000|Overall Study|Death|4|||
145782100|NCT02417233|525710176|FG001|Overall Study|Death|10|||
145782101|NCT02417233|525710177|FG002|Overall Study|Death|14|||
145782102|NCT02417233|525710175|FG000|Overall Study|Lost to Follow-up|27|||
145782103|NCT02417233|525710176|FG001|Overall Study|Lost to Follow-up|39|||
145782104|NCT02417233|525710177|FG002|Overall Study|Lost to Follow-up|34|||
145782105|NCT02417233|525710175|FG000|Overall Study|Protocol Violation|2|||
145782106|NCT02417233|525710176|FG001|Overall Study|Protocol Violation|0|||
145782107|NCT02417233|525710177|FG002|Overall Study|Protocol Violation|2|||
145782108|NCT02417233|525710175|FG000|Overall Study|Withdrawal by Subject|2|||
145782109|NCT02417233|525710176|FG001|Overall Study|Withdrawal by Subject|1|||
145782110|NCT02417233|525710177|FG002|Overall Study|Withdrawal by Subject|8|||
145782111|NCT02417233|525710175|FG000|Overall Study|Relocation out of study area|1|||
145782112|NCT02417233|525710176|FG001|Overall Study|Relocation out of study area|0|||
145782113|NCT02417233|525710177|FG002|Overall Study|Relocation out of study area|1|||
145782114|NCT02417233|525710175|FG000|Overall Study|Mentally unstable|0|||
145782115|NCT02417233|525710176|FG001|Overall Study|Mentally unstable|1|||
145782116|NCT02417233|525710177|FG002|Overall Study|Mentally unstable|0|||
145782117|NCT00532883|525710178|FG000|Overall Study|Adverse Event|1|||
145782118|NCT00532883|525710179|FG001|Overall Study|Adverse Event|0|||
145782119|NCT00532883|525710180|FG002|Overall Study|Adverse Event|0|||
145782120|NCT00532883|525710181|FG003|Overall Study|Adverse Event|1|||
145782121|NCT00532883|525710178|FG000|Overall Study|Lost to Follow-up|1|||
145782122|NCT00532883|525710179|FG001|Overall Study|Lost to Follow-up|1|||
145782123|NCT00532883|525710180|FG002|Overall Study|Lost to Follow-up|1|||
145782124|NCT00532883|525710181|FG003|Overall Study|Lost to Follow-up|0|||
145782125|NCT00532883|525710178|FG000|Overall Study|Withdrawal by Subject|0|||
145782126|NCT00532883|525710179|FG001|Overall Study|Withdrawal by Subject|1|||
145782127|NCT00532883|525710180|FG002|Overall Study|Withdrawal by Subject|1|||
145782128|NCT00532883|525710181|FG003|Overall Study|Withdrawal by Subject|0|||
145782129|NCT00532883|525710178|FG000|Overall Study|Subject was Nonadherent|0|||
145782130|NCT00532883|525710179|FG001|Overall Study|Subject was Nonadherent|1|||
145782131|NCT00532883|525710180|FG002|Overall Study|Subject was Nonadherent|1|||
145782132|NCT00532883|525710181|FG003|Overall Study|Subject was Nonadherent|0|||
145782133|NCT00532883|525710178|FG000|Overall Study|Early Study Termination|4|||
145537465|NCT01146912|524827472|FG000|Overall Study|Duplicate patient|0|||
145537466|NCT01146912|524827473|FG001|Overall Study|Duplicate patient|0|||
145537467|NCT01146912|524827474|FG002|Overall Study|Duplicate patient|1|||
145537468|NCT01146912|524827475|FG003|Overall Study|Duplicate patient|0|||
145537469|NCT01146912|524827476|FG004|Overall Study|Duplicate patient|0|||
145782134|NCT00532883|525710179|FG001|Overall Study|Early Study Termination|4|||
145782135|NCT00532883|525710180|FG002|Overall Study|Early Study Termination|1|||
145782136|NCT00532883|525710181|FG003|Overall Study|Early Study Termination|4|||
145782137|NCT03799718|525710182|FG000|Overall Study|Adverse Event|2|||
145782138|NCT02202031|525710183|FG000|Overall Study|Lost to Follow-up|1|||
145782139|NCT02202031|525710184|FG001|Overall Study|Lost to Follow-up|0|||
145782140|NCT02202031|525710183|FG000|Overall Study|Too Busy|1|||
145782141|NCT02202031|525710184|FG001|Overall Study|Too Busy|3|||
145537470|NCT01146912|524827477|FG005|Overall Study|Duplicate patient|0|||
145782142|NCT02202031|525710183|FG000|Overall Study|Illness/Medical Reason|0|||
145782143|NCT02202031|525710184|FG001|Overall Study|Illness/Medical Reason|2|||
145782144|NCT02202031|525710183|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
145537471|NCT01146912|524827478|FG006|Overall Study|Duplicate patient|0|||
145782145|NCT02202031|525710184|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
145782146|NCT02184143|525710185|FG000|Overall Study|Withdrawal by Subject|4|||
145782147|NCT02184143|525710186|FG001|Overall Study|Withdrawal by Subject|4|||
145782148|NCT02184143|525710185|FG000|Overall Study|Lost to Follow-up|5|||
145782149|NCT02184143|525710186|FG001|Overall Study|Lost to Follow-up|3|||
145782150|NCT02184143|525710185|FG000|Overall Study|Death|1|||
145782151|NCT02184143|525710186|FG001|Overall Study|Death|0|||
145782152|NCT00321984|525710187|FG000|Overall Study|Adverse Event|9|||
145782153|NCT00321984|525710188|FG001|Overall Study|Adverse Event|6|||
145782154|NCT00321984|525710189|FG002|Overall Study|Adverse Event|8|||
145782155|NCT00321984|525710187|FG000|Overall Study|Protocol Violation|0|||
145782156|NCT00321984|525710188|FG001|Overall Study|Protocol Violation|1|||
145782157|NCT00321984|525710189|FG002|Overall Study|Protocol Violation|1|||
145782158|NCT00321984|525710187|FG000|Overall Study|Lost to Follow-up|2|||
145782159|NCT00321984|525710188|FG001|Overall Study|Lost to Follow-up|4|||
145782160|NCT00321984|525710189|FG002|Overall Study|Lost to Follow-up|2|||
145782161|NCT00321984|525710187|FG000|Overall Study|Withdrawal by Subject|8|||
145782162|NCT00321984|525710188|FG001|Overall Study|Withdrawal by Subject|6|||
145782163|NCT00321984|525710189|FG002|Overall Study|Withdrawal by Subject|5|||
145782164|NCT00321984|525710187|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
145782165|NCT00321984|525710188|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
145782166|NCT00321984|525710189|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
145782167|NCT00321984|525710187|FG000|Overall Study|Lack of Efficacy|3|||
145782168|NCT00321984|525710188|FG001|Overall Study|Lack of Efficacy|1|||
145782169|NCT00321984|525710189|FG002|Overall Study|Lack of Efficacy|3|||
145782170|NCT00321984|525710187|FG000|Overall Study|Noncompliant|0|||
145782171|NCT00321984|525710188|FG001|Overall Study|Noncompliant|0|||
145782172|NCT00321984|525710189|FG002|Overall Study|Noncompliant|2|||
145782173|NCT00321984|525710187|FG000|Overall Study|Pregnancy|0|||
145782174|NCT00321984|525710188|FG001|Overall Study|Pregnancy|1|||
145782175|NCT00321984|525710189|FG002|Overall Study|Pregnancy|0|||
145782176|NCT00321984|525710187|FG000|Overall Study|Per Subject Request|1|||
145782177|NCT00321984|525710188|FG001|Overall Study|Per Subject Request|0|||
145782178|NCT00321984|525710189|FG002|Overall Study|Per Subject Request|0|||
145782179|NCT00321984|525710187|FG000|Overall Study|Per Investigator Request|1|||
145782180|NCT00321984|525710188|FG001|Overall Study|Per Investigator Request|0|||
145782181|NCT00321984|525710189|FG002|Overall Study|Per Investigator Request|0|||
145782182|NCT00321984|525710187|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
145782183|NCT00321984|525710188|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
145782184|NCT00321984|525710189|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
145782185|NCT05232097|525710190|FG000|Overall Study|Physician Decision|1|||
145782186|NCT01172288|525710191|FG000|Overall Study|Adverse Event|1|||
145782187|NCT01172288|525710192|FG001|Overall Study|Adverse Event|0|||
145782188|NCT01172288|525710191|FG000|Overall Study|Protocol Violation|0|||
145782189|NCT01172288|525710192|FG001|Overall Study|Protocol Violation|1|||
145782190|NCT00871858|525710195|FG000|Overall Study|Protocol Violation|3|||
145782191|NCT00871858|525710196|FG001|Overall Study|Protocol Violation|4|||
145782192|NCT00871858|525710195|FG000|Overall Study|Adverse Event|1|||
145782193|NCT00871858|525710196|FG001|Overall Study|Adverse Event|1|||
145782194|NCT00871858|525710195|FG000|Overall Study|Withdrawal by Subject|1|||
145782195|NCT00871858|525710196|FG001|Overall Study|Withdrawal by Subject|1|||
145782196|NCT00871858|525710195|FG000|Overall Study|Lost to Follow-up|0|||
145782197|NCT00871858|525710196|FG001|Overall Study|Lost to Follow-up|1|||
145782198|NCT01188798|525710197|FG000|Overall Study|Death|0|||
145782199|NCT01188798|525710198|FG001|Overall Study|Death|1|||
145782200|NCT01188798|525710197|FG000|Overall Study|Required additional transplant|1|||
145782201|NCT01188798|525710198|FG001|Overall Study|Required additional transplant|1|||
145782202|NCT01188798|525710197|FG000|Overall Study|Protocol closure|1|||
145782203|NCT01188798|525710198|FG001|Overall Study|Protocol closure|1|||
145782204|NCT01097330|525710202|FG000|Overall Study|Study terminated early|7|||
145782205|NCT01097330|525710203|FG001|Overall Study|Study terminated early|5|||
145782206|NCT03078608|525710208|FG000|Overall Study|Death|1|||
145782207|NCT03078608|525710209|FG001|Overall Study|Death|2|||
145782208|NCT03078608|525710210|FG002|Overall Study|Death|0|||
145782209|NCT03078608|525710211|FG003|Overall Study|Death|0|||
145782210|NCT03078608|525710208|FG000|Overall Study|Withdrawal by Subject|8|||
145782211|NCT03078608|525710209|FG001|Overall Study|Withdrawal by Subject|1|||
145782212|NCT03078608|525710210|FG002|Overall Study|Withdrawal by Subject|0|||
145782213|NCT03078608|525710211|FG003|Overall Study|Withdrawal by Subject|0|||
145782214|NCT03078608|525710208|FG000|Overall Study|Lost to Follow-up|5|||
145782215|NCT03078608|525710209|FG001|Overall Study|Lost to Follow-up|8|||
145782216|NCT03078608|525710210|FG002|Overall Study|Lost to Follow-up|4|||
145782217|NCT03078608|525710211|FG003|Overall Study|Lost to Follow-up|1|||
145782218|NCT00863928|525710217|FG000|Overall Study|Protocol Violation|26|||
145782219|NCT00863928|525710218|FG001|Overall Study|Protocol Violation|0|||
145782220|NCT00863928|525710217|FG000|Overall Study|Withdrawal by Subject|3|||
145782221|NCT00863928|525710218|FG001|Overall Study|Withdrawal by Subject|0|||
145782222|NCT00863928|525710217|FG000|Overall Study|surgery cancellation|4|||
145782223|NCT00863928|525710218|FG001|Overall Study|surgery cancellation|0|||
145782224|NCT00863928|525710217|FG000|Overall Study|medication allergy|3|||
145782225|NCT00863928|525710218|FG001|Overall Study|medication allergy|0|||
145782226|NCT02124798|525710220|FG000|Overall Study|Adverse Event|3|||
145782227|NCT02124798|525710220|FG000|Overall Study|Lost to Follow-up|1|||
145782228|NCT02144220|525710224|FG000|Overall Study|technology incompatibility|9|||
145782229|NCT02144220|525710224|FG000|Overall Study|Lack of Efficacy|4|||
145782230|NCT02144220|525710224|FG000|Overall Study|Physician Decision|3|||
145537472|NCT01146912|524827479|FG007|Overall Study|Duplicate patient|0|||
145537473|NCT02248701|524827482|FG000|Overall Study|Withdrawal by Subject|2|||
145782231|NCT02144220|525710224|FG000|Overall Study|Withdrawal by Subject|2|||
145782232|NCT02144220|525710224|FG000|Overall Study|Protocol Violation|1|||
145782233|NCT00651118|525710229|FG000|Overall Study|Adverse Event|4|||
145782234|NCT00651118|525710230|FG001|Overall Study|Adverse Event|0|||
145782235|NCT00651118|525710231|FG002|Overall Study|Adverse Event|1|||
145782236|NCT00651118|525710232|FG003|Overall Study|Adverse Event|1|||
145782237|NCT00651118|525710229|FG000|Overall Study|Protocol Violation|2|||
145782238|NCT00651118|525710230|FG001|Overall Study|Protocol Violation|2|||
145782239|NCT00651118|525710231|FG002|Overall Study|Protocol Violation|6|||
145782240|NCT00651118|525710232|FG003|Overall Study|Protocol Violation|2|||
145782241|NCT00651118|525710229|FG000|Overall Study|Lost to Follow-up|2|||
145782242|NCT00651118|525710230|FG001|Overall Study|Lost to Follow-up|0|||
145782243|NCT00651118|525710231|FG002|Overall Study|Lost to Follow-up|1|||
145782244|NCT00651118|525710232|FG003|Overall Study|Lost to Follow-up|2|||
145782245|NCT00651118|525710229|FG000|Overall Study|administrative|1|||
145782246|NCT00651118|525710230|FG001|Overall Study|administrative|4|||
145782247|NCT00651118|525710231|FG002|Overall Study|administrative|2|||
145782248|NCT00651118|525710232|FG003|Overall Study|administrative|1|||
145782249|NCT00651118|525710229|FG000|Overall Study|Withdrawal by Subject|0|||
145782250|NCT00651118|525710230|FG001|Overall Study|Withdrawal by Subject|1|||
145782251|NCT00651118|525710231|FG002|Overall Study|Withdrawal by Subject|1|||
145782252|NCT00651118|525710232|FG003|Overall Study|Withdrawal by Subject|1|||
145782253|NCT03103750|525710234|FG000|Overall Study|Adverse Event|1|||
145782254|NCT03103750|525710235|FG001|Overall Study|Adverse Event|0|||
145782255|NCT03103750|525710234|FG000|Overall Study|Lost to Follow-up|1|||
145782256|NCT03103750|525710235|FG001|Overall Study|Lost to Follow-up|0|||
145782257|NCT03103750|525710234|FG000|Overall Study|PET Equipment Related|2|||
145782258|NCT03103750|525710235|FG001|Overall Study|PET Equipment Related|2|||
145782259|NCT01522651|525710236|FG000|Overall Study|Adverse Event|3|||
145782260|NCT01522651|525710237|FG001|Overall Study|Adverse Event|4|||
145782261|NCT01522651|525710238|FG002|Overall Study|Adverse Event|4|||
145782262|NCT01522651|525710239|FG003|Overall Study|Adverse Event|5|||
145782263|NCT01522651|525710240|FG004|Overall Study|Adverse Event|4|||
145782264|NCT01522651|525710236|FG000|Overall Study|Cardioversion|1|||
145782265|NCT01522651|525710237|FG001|Overall Study|Cardioversion|0|||
145782266|NCT01522651|525710238|FG002|Overall Study|Cardioversion|0|||
145782267|NCT01522651|525710239|FG003|Overall Study|Cardioversion|0|||
145782268|NCT01522651|525710240|FG004|Overall Study|Cardioversion|0|||
145782269|NCT01522651|525710236|FG000|Overall Study|Device Malfunction|0|||
145782270|NCT01522651|525710237|FG001|Overall Study|Device Malfunction|1|||
145782271|NCT01522651|525710238|FG002|Overall Study|Device Malfunction|0|||
145782272|NCT01522651|525710239|FG003|Overall Study|Device Malfunction|0|||
145782273|NCT01522651|525710240|FG004|Overall Study|Device Malfunction|0|||
145782274|NCT01522651|525710236|FG000|Overall Study|Investigator's Discretion|0|||
145782275|NCT01522651|525710237|FG001|Overall Study|Investigator's Discretion|1|||
145537474|NCT02248701|524827483|FG001|Overall Study|Withdrawal by Subject|1|||
145782276|NCT01522651|525710238|FG002|Overall Study|Investigator's Discretion|0|||
145782277|NCT01522651|525710239|FG003|Overall Study|Investigator's Discretion|0|||
145782278|NCT01522651|525710240|FG004|Overall Study|Investigator's Discretion|0|||
145782279|NCT01522651|525710236|FG000|Overall Study|Protocol Violation|3|||
145782280|NCT01522651|525710237|FG001|Overall Study|Protocol Violation|0|||
145782281|NCT01522651|525710238|FG002|Overall Study|Protocol Violation|0|||
145782282|NCT01522651|525710239|FG003|Overall Study|Protocol Violation|0|||
145537475|NCT02248701|524827482|FG000|Overall Study|Physician Decision|0|||
145782283|NCT01522651|525710240|FG004|Overall Study|Protocol Violation|0|||
145782284|NCT01522651|525710236|FG000|Overall Study|Reason Not Specified|0|||
145782285|NCT01522651|525710237|FG001|Overall Study|Reason Not Specified|0|||
145782286|NCT01522651|525710238|FG002|Overall Study|Reason Not Specified|0|||
145782287|NCT01522651|525710239|FG003|Overall Study|Reason Not Specified|1|||
145782288|NCT01522651|525710240|FG004|Overall Study|Reason Not Specified|0|||
145782289|NCT01522651|525710236|FG000|Overall Study|Participant Non-Compliance|1|||
145782290|NCT01522651|525710237|FG001|Overall Study|Participant Non-Compliance|0|||
145782291|NCT01522651|525710238|FG002|Overall Study|Participant Non-Compliance|0|||
145782292|NCT01522651|525710239|FG003|Overall Study|Participant Non-Compliance|0|||
145782293|NCT01522651|525710240|FG004|Overall Study|Participant Non-Compliance|0|||
145782294|NCT01522651|525710236|FG000|Overall Study|Withdrew Consent|1|||
145782295|NCT01522651|525710237|FG001|Overall Study|Withdrew Consent|1|||
145782296|NCT01522651|525710238|FG002|Overall Study|Withdrew Consent|0|||
145782297|NCT01522651|525710239|FG003|Overall Study|Withdrew Consent|1|||
145782298|NCT01522651|525710240|FG004|Overall Study|Withdrew Consent|1|||
145782299|NCT01522651|525710236|FG000|Overall Study|Randomized but Never Treated|0|||
145782300|NCT01522651|525710237|FG001|Overall Study|Randomized but Never Treated|1|||
145782301|NCT01522651|525710238|FG002|Overall Study|Randomized but Never Treated|0|||
145782302|NCT01522651|525710239|FG003|Overall Study|Randomized but Never Treated|1|||
145782303|NCT01522651|525710240|FG004|Overall Study|Randomized but Never Treated|1|||
145782304|NCT02658656|525710241|FG000|Screening|Failed eligibility criteria|0|||
145782305|NCT02658656|525710242|FG001|Screening|Failed eligibility criteria|0|||
145782306|NCT02658656|525710243|FG002|Screening|Failed eligibility criteria|263|||
145782307|NCT02658656|525710241|FG000|Randomization|Withdrawal by Subject|8|||
145782308|NCT02658656|525710242|FG001|Randomization|Withdrawal by Subject|7|||
145782309|NCT02658656|525710243|FG002|Randomization|Withdrawal by Subject|0|||
145782310|NCT02658656|525710241|FG000|Randomization|Lost to Follow-up|1|||
145782311|NCT02658656|525710242|FG001|Randomization|Lost to Follow-up|3|||
145782312|NCT02658656|525710243|FG002|Randomization|Lost to Follow-up|0|||
145782313|NCT02658656|525710241|FG000|Randomization|Adverse Event|4|||
145782314|NCT02658656|525710242|FG001|Randomization|Adverse Event|0|||
145782315|NCT02658656|525710243|FG002|Randomization|Adverse Event|0|||
145782316|NCT02658656|525710241|FG000|Randomization|Administrative Termination|3|||
145782317|NCT02658656|525710242|FG001|Randomization|Administrative Termination|1|||
145782318|NCT02658656|525710243|FG002|Randomization|Administrative Termination|0|||
145782319|NCT02658656|525710241|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
145782320|NCT02658656|525710242|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
145782321|NCT02658656|525710243|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
145782322|NCT02658656|525710241|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
145782323|NCT02658656|525710242|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
145782324|NCT02658656|525710243|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
145782325|NCT02658656|525710241|FG000|Randomization|Not eligible for Randomization|1|||
145782326|NCT02658656|525710242|FG001|Randomization|Not eligible for Randomization|0|||
145782327|NCT02658656|525710243|FG002|Randomization|Not eligible for Randomization|0|||
145782328|NCT02658656|525710241|FG000|Randomization|Protocol Violation|1|||
145782329|NCT02658656|525710242|FG001|Randomization|Protocol Violation|0|||
145782330|NCT02658656|525710243|FG002|Randomization|Protocol Violation|0|||
145782331|NCT01118143|525710244|FG000|Overall Study|Withdrawal by Subject|2|||
145782332|NCT01118143|525710245|FG001|Overall Study|Withdrawal by Subject|5|||
145782333|NCT02112448|525710246|FG000|Overall Study|lab values precluding use of ketorolac|2|||
145782334|NCT02112448|525710247|FG001|Overall Study|lab values precluding use of ketorolac|2|||
145782335|NCT02112448|525710246|FG000|Overall Study|Protocol Violation|1|||
145782336|NCT02112448|525710247|FG001|Overall Study|Protocol Violation|2|||
145782337|NCT02112448|525710246|FG000|Overall Study|Physician Decision|4|||
145782338|NCT02112448|525710247|FG001|Overall Study|Physician Decision|6|||
145782339|NCT02112448|525710246|FG000|Overall Study|required heparin so could not use ketoro|1|||
145782340|NCT02112448|525710247|FG001|Overall Study|required heparin so could not use ketoro|0|||
145782341|NCT02115815|525712063|FG000|Overall Study|Withdrawal by Subject|2|||
145782342|NCT02115815|525712064|FG001|Overall Study|Withdrawal by Subject|0|||
145782343|NCT02115815|525712065|FG002|Overall Study|Withdrawal by Subject|0|||
145782344|NCT02115815|525712066|FG003|Overall Study|Withdrawal by Subject|0|||
145782345|NCT02115815|525712067|FG004|Overall Study|Withdrawal by Subject|0|||
145782346|NCT02115815|525712068|FG005|Overall Study|Withdrawal by Subject|0|||
145782347|NCT02115815|525712069|FG006|Overall Study|Withdrawal by Subject|0|||
145782348|NCT02115815|525712063|FG000|Overall Study|Not enough drug to dose participant|0|||
145782349|NCT02115815|525712064|FG001|Overall Study|Not enough drug to dose participant|0|||
145782350|NCT02115815|525712065|FG002|Overall Study|Not enough drug to dose participant|0|||
145782351|NCT02115815|525712066|FG003|Overall Study|Not enough drug to dose participant|0|||
145782352|NCT02115815|525712067|FG004|Overall Study|Not enough drug to dose participant|0|||
145782353|NCT02115815|525712068|FG005|Overall Study|Not enough drug to dose participant|1|||
145782354|NCT02115815|525712069|FG006|Overall Study|Not enough drug to dose participant|0|||
145782355|NCT02115815|525712063|FG000|Overall Study|Missed appointment, randomized in error|0|||
145782356|NCT02115815|525712064|FG001|Overall Study|Missed appointment, randomized in error|0|||
145782357|NCT02115815|525712065|FG002|Overall Study|Missed appointment, randomized in error|0|||
145537476|NCT02248701|524827483|FG001|Overall Study|Physician Decision|1|||
145537477|NCT02248701|524827482|FG000|Overall Study|Adverse Event|1|||
145782358|NCT02115815|525712066|FG003|Overall Study|Missed appointment, randomized in error|0|||
145782359|NCT02115815|525712067|FG004|Overall Study|Missed appointment, randomized in error|0|||
145782360|NCT02115815|525712068|FG005|Overall Study|Missed appointment, randomized in error|1|||
145782361|NCT02115815|525712069|FG006|Overall Study|Missed appointment, randomized in error|0|||
145782362|NCT01989546|525712070|FG000|Overall Study|Clinical Progression|1|||
145782363|NCT01989546|525712070|FG000|Overall Study|Disease progression on study|8|||
145782364|NCT02778867|525712073|FG000|Phase 1|Withdrawal by Subject|2|||
145782365|NCT02778867|525712074|FG001|Phase 1|Withdrawal by Subject|3|||
145782366|NCT02778867|525712075|FG002|Phase 1|Withdrawal by Subject|0|||
145782367|NCT02778867|525712076|FG003|Phase 1|Withdrawal by Subject|0|||
145782368|NCT02778867|525712073|FG000|Phase 2|Withdrawal by Subject|0|||
145782369|NCT02778867|525712074|FG001|Phase 2|Withdrawal by Subject|0|||
145782370|NCT02778867|525712075|FG002|Phase 2|Withdrawal by Subject|1|||
145782371|NCT02778867|525712076|FG003|Phase 2|Withdrawal by Subject|0|||
145782372|NCT02778867|525712073|FG000|Phase 2|Physician Decision|0|||
145782373|NCT02778867|525712074|FG001|Phase 2|Physician Decision|0|||
145782374|NCT02778867|525712075|FG002|Phase 2|Physician Decision|0|||
145782375|NCT02778867|525712076|FG003|Phase 2|Physician Decision|1|||
145782376|NCT02778867|525712073|FG000|Phase 2|Adverse Event|0|||
145782377|NCT02778867|525712074|FG001|Phase 2|Adverse Event|0|||
145782378|NCT02778867|525712075|FG002|Phase 2|Adverse Event|0|||
145782379|NCT02778867|525712076|FG003|Phase 2|Adverse Event|1|||
145782380|NCT00960440|525712078|FG000|Overall Study|Death|0|||
145782381|NCT00960440|525712079|FG001|Overall Study|Death|0|||
145782382|NCT00960440|525712080|FG002|Overall Study|Death|0|||
145782383|NCT00960440|525712081|FG003|Overall Study|Death|1|||
145782384|NCT00960440|525712078|FG000|Overall Study|Adverse Event|12|||
145782385|NCT00960440|525712079|FG001|Overall Study|Adverse Event|12|||
145782386|NCT00960440|525712080|FG002|Overall Study|Adverse Event|4|||
145782387|NCT00960440|525712081|FG003|Overall Study|Adverse Event|4|||
145782388|NCT00960440|525712078|FG000|Overall Study|Lack of Efficacy|2|||
145782389|NCT00960440|525712079|FG001|Overall Study|Lack of Efficacy|5|||
145782390|NCT00960440|525712080|FG002|Overall Study|Lack of Efficacy|3|||
145782391|NCT00960440|525712081|FG003|Overall Study|Lack of Efficacy|8|||
145782392|NCT00960440|525712078|FG000|Overall Study|Protocol Violation|2|||
145782393|NCT00960440|525712079|FG001|Overall Study|Protocol Violation|8|||
145782394|NCT00960440|525712080|FG002|Overall Study|Protocol Violation|3|||
145782395|NCT00960440|525712081|FG003|Overall Study|Protocol Violation|4|||
145782396|NCT00960440|525712078|FG000|Overall Study|Withdrawal by Subject|9|||
145782397|NCT00960440|525712079|FG001|Overall Study|Withdrawal by Subject|5|||
145782398|NCT00960440|525712080|FG002|Overall Study|Withdrawal by Subject|2|||
145782399|NCT00960440|525712081|FG003|Overall Study|Withdrawal by Subject|1|||
145782400|NCT00960440|525712078|FG000|Overall Study|Other|1|||
145782401|NCT00960440|525712079|FG001|Overall Study|Other|1|||
145782402|NCT00960440|525712080|FG002|Overall Study|Other|1|||
145782403|NCT00960440|525712081|FG003|Overall Study|Other|0|||
145782404|NCT03504774|525712082|FG000|Overall Study|Adverse Event|2|||
145782405|NCT03504774|525712083|FG001|Overall Study|Adverse Event|0|||
145782406|NCT03504774|525712082|FG000|Overall Study|Lost to Follow-up|0|||
145782407|NCT03504774|525712083|FG001|Overall Study|Lost to Follow-up|1|||
145782408|NCT03504774|525712082|FG000|Overall Study|Protocol Violation|11|||
145782409|NCT03504774|525712083|FG001|Overall Study|Protocol Violation|3|||
145782410|NCT03504774|525712082|FG000|Overall Study|failed wk 52 DBPCFC|1|||
145782411|NCT03504774|525712083|FG001|Overall Study|failed wk 52 DBPCFC|0|||
145782412|NCT01781429|525712084|FG000|Overall Study|Death|0|||
145782413|NCT01781429|525712085|FG001|Overall Study|Death|0|||
145782414|NCT01781429|525712086|FG002|Overall Study|Death|0|||
145782415|NCT01781429|525712087|FG003|Overall Study|Death|0|||
145782416|NCT01781429|525712088|FG004|Overall Study|Death|0|||
145782417|NCT01781429|525712089|FG005|Overall Study|Death|0|||
145782418|NCT01781429|525712090|FG006|Overall Study|Death|0|||
145537478|NCT02248701|524827483|FG001|Overall Study|Adverse Event|0|||
145782419|NCT01781429|525712091|FG007|Overall Study|Death|0|||
145782420|NCT01781429|525712092|FG008|Overall Study|Death|0|||
145782421|NCT01781429|525712093|FG009|Overall Study|Death|1|||
145782422|NCT01781429|525712094|FG010|Overall Study|Death|0|||
145782423|NCT01781429|525712095|FG011|Overall Study|Death|0|||
145782424|NCT01781429|525712096|FG012|Overall Study|Death|1|||
145782425|NCT01781429|525712097|FG013|Overall Study|Death|0|||
145782426|NCT01781429|525712098|FG014|Overall Study|Death|1|||
145782427|NCT01781429|525712099|FG015|Overall Study|Death|0|||
145609109|NCT01590771|525084796|FG000|Overall Study|Adverse Event|3|||
145782428|NCT01781429|525712084|FG000|Overall Study|Withdrawal by Subject|0|||
145782429|NCT01781429|525712085|FG001|Overall Study|Withdrawal by Subject|0|||
145782430|NCT01781429|525712086|FG002|Overall Study|Withdrawal by Subject|0|||
145782431|NCT01781429|525712087|FG003|Overall Study|Withdrawal by Subject|0|||
145782432|NCT01781429|525712088|FG004|Overall Study|Withdrawal by Subject|0|||
145782433|NCT01781429|525712089|FG005|Overall Study|Withdrawal by Subject|0|||
145782434|NCT01781429|525712090|FG006|Overall Study|Withdrawal by Subject|0|||
145782435|NCT01781429|525712091|FG007|Overall Study|Withdrawal by Subject|0|||
145782436|NCT01781429|525712092|FG008|Overall Study|Withdrawal by Subject|1|||
145782437|NCT01781429|525712093|FG009|Overall Study|Withdrawal by Subject|3|||
145782438|NCT01781429|525712094|FG010|Overall Study|Withdrawal by Subject|1|||
145782439|NCT01781429|525712095|FG011|Overall Study|Withdrawal by Subject|1|||
145782440|NCT01781429|525712096|FG012|Overall Study|Withdrawal by Subject|5|||
145782441|NCT01781429|525712097|FG013|Overall Study|Withdrawal by Subject|2|||
145782442|NCT01781429|525712098|FG014|Overall Study|Withdrawal by Subject|3|||
145782443|NCT01781429|525712099|FG015|Overall Study|Withdrawal by Subject|0|||
145782444|NCT01781429|525712084|FG000|Overall Study|Disease Progression|1|||
145782445|NCT01781429|525712085|FG001|Overall Study|Disease Progression|0|||
145782446|NCT01781429|525712086|FG002|Overall Study|Disease Progression|1|||
145782447|NCT01781429|525712087|FG003|Overall Study|Disease Progression|1|||
145782448|NCT01781429|525712088|FG004|Overall Study|Disease Progression|1|||
145782449|NCT01781429|525712089|FG005|Overall Study|Disease Progression|4|||
145782450|NCT01781429|525712090|FG006|Overall Study|Disease Progression|7|||
145782451|NCT01781429|525712091|FG007|Overall Study|Disease Progression|4|||
145782452|NCT01781429|525712092|FG008|Overall Study|Disease Progression|6|||
145782453|NCT01781429|525712093|FG009|Overall Study|Disease Progression|15|||
145782454|NCT01781429|525712094|FG010|Overall Study|Disease Progression|15|||
145782455|NCT01781429|525712095|FG011|Overall Study|Disease Progression|15|||
145782456|NCT01781429|525712096|FG012|Overall Study|Disease Progression|15|||
145782457|NCT01781429|525712097|FG013|Overall Study|Disease Progression|4|||
145782458|NCT01781429|525712098|FG014|Overall Study|Disease Progression|11|||
145782459|NCT01781429|525712099|FG015|Overall Study|Disease Progression|0|||
145782460|NCT01781429|525712084|FG000|Overall Study|Unacceptable Toxicity|0|||
145782461|NCT01781429|525712085|FG001|Overall Study|Unacceptable Toxicity|0|||
145782462|NCT01781429|525712086|FG002|Overall Study|Unacceptable Toxicity|0|||
145782463|NCT01781429|525712087|FG003|Overall Study|Unacceptable Toxicity|0|||
145782464|NCT01781429|525712088|FG004|Overall Study|Unacceptable Toxicity|0|||
145782465|NCT01781429|525712089|FG005|Overall Study|Unacceptable Toxicity|0|||
145782466|NCT01781429|525712090|FG006|Overall Study|Unacceptable Toxicity|0|||
145782467|NCT01781429|525712091|FG007|Overall Study|Unacceptable Toxicity|0|||
145782468|NCT01781429|525712092|FG008|Overall Study|Unacceptable Toxicity|0|||
145782469|NCT01781429|525712093|FG009|Overall Study|Unacceptable Toxicity|0|||
145782470|NCT01781429|525712094|FG010|Overall Study|Unacceptable Toxicity|0|||
145782471|NCT01781429|525712095|FG011|Overall Study|Unacceptable Toxicity|2|||
145782472|NCT01781429|525712096|FG012|Overall Study|Unacceptable Toxicity|0|||
145782473|NCT01781429|525712097|FG013|Overall Study|Unacceptable Toxicity|0|||
145782474|NCT01781429|525712098|FG014|Overall Study|Unacceptable Toxicity|0|||
145782475|NCT01781429|525712099|FG015|Overall Study|Unacceptable Toxicity|0|||
145782476|NCT01781429|525712084|FG000|Overall Study|Patient Condition Changed|0|||
145782477|NCT01781429|525712085|FG001|Overall Study|Patient Condition Changed|0|||
145782478|NCT01781429|525712086|FG002|Overall Study|Patient Condition Changed|0|||
145782479|NCT01781429|525712087|FG003|Overall Study|Patient Condition Changed|0|||
145782480|NCT01781429|525712088|FG004|Overall Study|Patient Condition Changed|0|||
145782481|NCT01781429|525712089|FG005|Overall Study|Patient Condition Changed|0|||
145782482|NCT01781429|525712090|FG006|Overall Study|Patient Condition Changed|0|||
145782483|NCT01781429|525712091|FG007|Overall Study|Patient Condition Changed|0|||
145782484|NCT01781429|525712092|FG008|Overall Study|Patient Condition Changed|0|||
145782485|NCT01781429|525712093|FG009|Overall Study|Patient Condition Changed|4|||
145782486|NCT01781429|525712094|FG010|Overall Study|Patient Condition Changed|0|||
145782487|NCT01781429|525712095|FG011|Overall Study|Patient Condition Changed|1|||
145782488|NCT01781429|525712096|FG012|Overall Study|Patient Condition Changed|0|||
145782489|NCT01781429|525712097|FG013|Overall Study|Patient Condition Changed|1|||
145782490|NCT01781429|525712098|FG014|Overall Study|Patient Condition Changed|0|||
145782491|NCT01781429|525712099|FG015|Overall Study|Patient Condition Changed|0|||
145782492|NCT01781429|525712084|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
145782493|NCT01781429|525712085|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
145782494|NCT01781429|525712086|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
145403739|NCT01420536|524334406|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
145403740|NCT00764790|524334407|FG000|Overall Study|Protocol Violation|0|||
145782495|NCT01781429|525712087|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
145782496|NCT01781429|525712088|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
145782497|NCT01781429|525712089|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
145782498|NCT01781429|525712090|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
145782499|NCT01781429|525712091|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
145782500|NCT01781429|525712092|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
145782501|NCT01781429|525712093|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
145782502|NCT01781429|525712094|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
145782503|NCT01781429|525712095|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
145782504|NCT01781429|525712096|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
145782505|NCT01781429|525712097|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
145782506|NCT01781429|525712098|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
145782507|NCT01781429|525712099|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
145782508|NCT01781429|525712084|FG000|Overall Study|Enrolled, but not treated|0|||
145782509|NCT01781429|525712085|FG001|Overall Study|Enrolled, but not treated|0|||
145782510|NCT01781429|525712086|FG002|Overall Study|Enrolled, but not treated|0|||
145782511|NCT01781429|525712087|FG003|Overall Study|Enrolled, but not treated|0|||
145782512|NCT01781429|525712088|FG004|Overall Study|Enrolled, but not treated|0|||
145782513|NCT01781429|525712089|FG005|Overall Study|Enrolled, but not treated|0|||
145782514|NCT01781429|525712090|FG006|Overall Study|Enrolled, but not treated|0|||
145782515|NCT01781429|525712091|FG007|Overall Study|Enrolled, but not treated|0|||
145782516|NCT01781429|525712092|FG008|Overall Study|Enrolled, but not treated|0|||
145782517|NCT01781429|525712093|FG009|Overall Study|Enrolled, but not treated|0|||
145782518|NCT01781429|525712094|FG010|Overall Study|Enrolled, but not treated|1|||
145782519|NCT01781429|525712095|FG011|Overall Study|Enrolled, but not treated|0|||
145782520|NCT01781429|525712096|FG012|Overall Study|Enrolled, but not treated|0|||
145782521|NCT01781429|525712097|FG013|Overall Study|Enrolled, but not treated|0|||
145782522|NCT01781429|525712098|FG014|Overall Study|Enrolled, but not treated|0|||
145782523|NCT01781429|525712099|FG015|Overall Study|Enrolled, but not treated|0|||
145782524|NCT01312428|525712102|FG000|Overall Study|Study Termination|3|||
145782525|NCT01312428|525712103|FG001|Overall Study|Study Termination|4|||
145782526|NCT02214186|525712110|FG000|Overall Study|Lost to Follow-up|1|||
145782527|NCT02214186|525712111|FG001|Overall Study|Lost to Follow-up|1|||
145782528|NCT02214186|525712110|FG000|Overall Study|Protocol Violation|1|||
145782529|NCT02214186|525712111|FG001|Overall Study|Protocol Violation|1|||
145782530|NCT01525849|525712112|FG000|Overall Study|Lost to Follow-up|3|||
145782531|NCT01525849|525712113|FG001|Overall Study|Lost to Follow-up|2|||
145782532|NCT01525849|525712112|FG000|Overall Study|Withdrawal by Subject|1|||
145782533|NCT01525849|525712113|FG001|Overall Study|Withdrawal by Subject|9|||
145782534|NCT01525849|525712112|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
145782535|NCT01525849|525712113|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
145782536|NCT01525849|525712112|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
145782537|NCT01525849|525712113|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
145782538|NCT01469013|525712114|FG000|Part A (Treatment Period)|Adverse Event|1|||
145782539|NCT01469013|525712115|FG001|Part A (Treatment Period)|Adverse Event|0|||
145782540|NCT01469013|525712116|FG002|Part A (Treatment Period)|Adverse Event|0|||
145782541|NCT01469013|525712117|FG003|Part A (Treatment Period)|Adverse Event|0|||
145782542|NCT01469013|525712118|FG004|Part A (Treatment Period)|Adverse Event|1|||
145782543|NCT01469013|525712119|FG005|Part A (Treatment Period)|Adverse Event|0|||
145782544|NCT01469013|525712120|FG006|Part A (Treatment Period)|Adverse Event|0|||
145782545|NCT01469013|525712121|FG007|Part A (Treatment Period)|Adverse Event|0|||
145782546|NCT01469013|525712122|FG008|Part A (Treatment Period)|Adverse Event|0|||
145782547|NCT01469013|525712123|FG009|Part A (Treatment Period)|Adverse Event|0|||
145782548|NCT01469013|525712124|FG010|Part A (Treatment Period)|Adverse Event|0|||
145782549|NCT01469013|525712125|FG011|Part A (Treatment Period)|Adverse Event|0|||
145782550|NCT01469013|525712126|FG012|Part A (Treatment Period)|Adverse Event|0|||
145782551|NCT01469013|525712114|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782552|NCT01469013|525712115|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782553|NCT01469013|525712116|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
145782554|NCT01469013|525712117|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782555|NCT01469013|525712118|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782556|NCT01469013|525712119|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782557|NCT01469013|525712120|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782558|NCT01469013|525712121|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782559|NCT01469013|525712122|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782560|NCT01469013|525712123|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782561|NCT01469013|525712124|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782562|NCT01469013|525712125|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782563|NCT01469013|525712126|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
145782564|NCT01469013|525712114|FG000|Part B (Extension Period)|Adverse Event|0|||
145782565|NCT01469013|525712115|FG001|Part B (Extension Period)|Adverse Event|0|||
145782566|NCT01469013|525712116|FG002|Part B (Extension Period)|Adverse Event|0|||
145782567|NCT01469013|525712117|FG003|Part B (Extension Period)|Adverse Event|0|||
145782568|NCT01469013|525712118|FG004|Part B (Extension Period)|Adverse Event|0|||
145782569|NCT01469013|525712119|FG005|Part B (Extension Period)|Adverse Event|2|||
145782570|NCT01469013|525712120|FG006|Part B (Extension Period)|Adverse Event|5|||
145782571|NCT01469013|525712121|FG007|Part B (Extension Period)|Adverse Event|5|||
145782572|NCT01469013|525712122|FG008|Part B (Extension Period)|Adverse Event|3|||
145609110|NCT01590771|525084797|FG001|Overall Study|Adverse Event|7|||
145609111|NCT01785628|525084798|FG000|Overall Study|Lost to Follow-up|2|||
145782573|NCT01469013|525712123|FG009|Part B (Extension Period)|Adverse Event|3|||
145782574|NCT01469013|525712124|FG010|Part B (Extension Period)|Adverse Event|1|||
145782575|NCT01469013|525712125|FG011|Part B (Extension Period)|Adverse Event|6|||
145782576|NCT01469013|525712126|FG012|Part B (Extension Period)|Adverse Event|3|||
145782577|NCT01469013|525712114|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
145782578|NCT01469013|525712115|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
145782579|NCT01469013|525712116|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
145403741|NCT00764790|524334408|FG001|Overall Study|Protocol Violation|0|||
145537479|NCT02248701|524827482|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
145537480|NCT02248701|524827483|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
145537481|NCT01145625|524827484|FG000|Overall Study|Lost to Follow-up|8|||
145782580|NCT01469013|525712117|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
145782581|NCT01469013|525712118|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
145782582|NCT01469013|525712119|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
145782583|NCT01469013|525712120|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
145782584|NCT01469013|525712121|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
145782585|NCT01469013|525712122|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
145782586|NCT01469013|525712123|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
145782587|NCT01469013|525712124|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
145782588|NCT01469013|525712125|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
145782589|NCT01469013|525712126|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
145782590|NCT00339183|525712127|FG000|Overall Study|Adverse Event|5|||
145782591|NCT00339183|525712128|FG001|Overall Study|Adverse Event|3|||
145782592|NCT00339183|525712127|FG000|Overall Study|Withdrawal by Subject|16|||
145782593|NCT00339183|525712128|FG001|Overall Study|Withdrawal by Subject|19|||
145782594|NCT00339183|525712127|FG000|Overall Study|Physician Decision|2|||
145782595|NCT00339183|525712128|FG001|Overall Study|Physician Decision|4|||
145782596|NCT00339183|525712127|FG000|Overall Study|Lost to Follow-up|17|||
145782597|NCT00339183|525712128|FG001|Overall Study|Lost to Follow-up|17|||
145782598|NCT00339183|525712127|FG000|Overall Study|Protocol-specified criteria|12|||
145782599|NCT00339183|525712128|FG001|Overall Study|Protocol-specified criteria|8|||
145782600|NCT00339183|525712127|FG000|Overall Study|Missing reason|3|||
145782601|NCT00339183|525712128|FG001|Overall Study|Missing reason|1|||
145782602|NCT00339183|525712127|FG000|Overall Study|Other|46|||
145782603|NCT00339183|525712128|FG001|Overall Study|Other|40|||
145782604|NCT00339183|525712127|FG000|Overall Study|Ongoing|20|||
145782605|NCT00339183|525712128|FG001|Overall Study|Ongoing|13|||
145782606|NCT00446446|525712131|FG000|Overall Study|Death|10|||
145782607|NCT00446446|525712131|FG000|Overall Study|Withdrawal by Subject|6|||
145782608|NCT00446446|525712131|FG000|Overall Study|Other|4|||
145782609|NCT00446446|525712131|FG000|Overall Study|Disease Progession|2|||
145782610|NCT00446446|525712131|FG000|Overall Study|Adverse Event|1|||
145782611|NCT00446446|525712131|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
145782612|NCT00611130|525712136|FG000|Overall Study|Lost to Follow-up|25|||
145782613|NCT00611130|525712137|FG001|Overall Study|Lost to Follow-up|29|||
145782614|NCT00611130|525712136|FG000|Overall Study|Protocol noncompliance|7|||
145782615|NCT00611130|525712137|FG001|Overall Study|Protocol noncompliance|6|||
145782616|NCT00611130|525712136|FG000|Overall Study|Withdrawal by Subject|6|||
145782617|NCT00611130|525712137|FG001|Overall Study|Withdrawal by Subject|5|||
145782618|NCT00611130|525712136|FG000|Overall Study|Other|5|||
145782619|NCT00611130|525712137|FG001|Overall Study|Other|4|||
145782620|NCT00611130|525712136|FG000|Overall Study|Incarceration|3|||
145782621|NCT00611130|525712137|FG001|Overall Study|Incarceration|2|||
145782622|NCT00611130|525712136|FG000|Overall Study|Administrative|1|||
145782623|NCT00611130|525712137|FG001|Overall Study|Administrative|1|||
145782624|NCT00611130|525712136|FG000|Overall Study|Adverse Event|1|||
145782625|NCT00611130|525712137|FG001|Overall Study|Adverse Event|0|||
145782626|NCT00611130|525712136|FG000|Overall Study|Death|1|||
145782627|NCT00611130|525712137|FG001|Overall Study|Death|0|||
145782628|NCT03662334|525712139|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
145782629|NCT03662334|525712140|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
145782630|NCT01024465|525712142|FG000|Overall Study|Adverse Event|2|||
145782631|NCT01024465|525712142|FG000|Overall Study|Physician Decision|1|||
145782632|NCT01734993|525712143|FG000|Overall Study|Adverse Event|1|||
145782633|NCT01734993|525712143|FG000|Overall Study|Lack of Efficacy|1|||
145782634|NCT00723840|525712147|FG000|Overall Study|Lost to Follow-up|2|||
145782635|NCT00723840|525712147|FG000|Overall Study|Failure to return|18|||
145782636|NCT00723840|525712147|FG000|Overall Study|Withdrawal by Subject|55|||
145782637|NCT00723840|525712147|FG000|Overall Study|Serious Adverse Events|3|||
145782638|NCT00723840|525712147|FG000|Overall Study|Other Medical Event|2|||
145782639|NCT00723840|525712147|FG000|Overall Study|Unspecified reason|2|||
145782640|NCT03303339|525712148|FG000|Overall Study|Death|2|||
145782641|NCT03303339|525712149|FG001|Overall Study|Death|2|||
145782642|NCT03303339|525712150|FG002|Overall Study|Death|2|||
145782643|NCT03303339|525712151|FG003|Overall Study|Death|1|||
145782644|NCT03303339|525712152|FG004|Overall Study|Death|4|||
145782645|NCT03303339|525712153|FG005|Overall Study|Death|2|||
145782646|NCT03303339|525712154|FG006|Overall Study|Death|2|||
145782647|NCT03303339|525712155|FG007|Overall Study|Death|2|||
145782648|NCT03303339|525712156|FG008|Overall Study|Death|3|||
145782649|NCT03303339|525712157|FG009|Overall Study|Death|3|||
145782650|NCT03303339|525712158|FG010|Overall Study|Death|4|||
145782651|NCT03303339|525712159|FG011|Overall Study|Death|24|||
145782652|NCT03303339|525712148|FG000|Overall Study|Study Terminated by Sponsor|0|||
145782653|NCT03303339|525712149|FG001|Overall Study|Study Terminated by Sponsor|0|||
145782654|NCT03303339|525712150|FG002|Overall Study|Study Terminated by Sponsor|0|||
145782655|NCT03303339|525712151|FG003|Overall Study|Study Terminated by Sponsor|0|||
145782656|NCT03303339|525712152|FG004|Overall Study|Study Terminated by Sponsor|0|||
145782657|NCT03303339|525712153|FG005|Overall Study|Study Terminated by Sponsor|0|||
145782658|NCT03303339|525712154|FG006|Overall Study|Study Terminated by Sponsor|0|||
145782659|NCT03303339|525712155|FG007|Overall Study|Study Terminated by Sponsor|0|||
145782660|NCT03303339|525712156|FG008|Overall Study|Study Terminated by Sponsor|1|||
145782661|NCT03303339|525712157|FG009|Overall Study|Study Terminated by Sponsor|0|||
145782662|NCT03303339|525712158|FG010|Overall Study|Study Terminated by Sponsor|1|||
145782663|NCT03303339|525712159|FG011|Overall Study|Study Terminated by Sponsor|1|||
145782664|NCT03303339|525712148|FG000|Overall Study|Withdrawal by Subject|1|||
145782665|NCT03303339|525712149|FG001|Overall Study|Withdrawal by Subject|0|||
145782666|NCT03303339|525712150|FG002|Overall Study|Withdrawal by Subject|0|||
145782667|NCT03303339|525712151|FG003|Overall Study|Withdrawal by Subject|0|||
145782668|NCT03303339|525712152|FG004|Overall Study|Withdrawal by Subject|0|||
145782669|NCT03303339|525712153|FG005|Overall Study|Withdrawal by Subject|1|||
145782670|NCT03303339|525712154|FG006|Overall Study|Withdrawal by Subject|1|||
145782671|NCT03303339|525712155|FG007|Overall Study|Withdrawal by Subject|0|||
145782672|NCT03303339|525712156|FG008|Overall Study|Withdrawal by Subject|0|||
145782673|NCT03303339|525712157|FG009|Overall Study|Withdrawal by Subject|0|||
145782674|NCT03303339|525712158|FG010|Overall Study|Withdrawal by Subject|0|||
145782675|NCT03303339|525712159|FG011|Overall Study|Withdrawal by Subject|2|||
145782676|NCT03303339|525712148|FG000|Overall Study|Physician Decision|0|||
145782677|NCT03303339|525712149|FG001|Overall Study|Physician Decision|0|||
145782678|NCT03303339|525712150|FG002|Overall Study|Physician Decision|0|||
145782679|NCT03303339|525712151|FG003|Overall Study|Physician Decision|0|||
145782680|NCT03303339|525712152|FG004|Overall Study|Physician Decision|1|||
145782681|NCT03303339|525712153|FG005|Overall Study|Physician Decision|0|||
145782682|NCT03303339|525712154|FG006|Overall Study|Physician Decision|0|||
145782683|NCT03303339|525712155|FG007|Overall Study|Physician Decision|0|||
145782684|NCT03303339|525712156|FG008|Overall Study|Physician Decision|0|||
145782685|NCT03303339|525712157|FG009|Overall Study|Physician Decision|0|||
145782686|NCT03303339|525712158|FG010|Overall Study|Physician Decision|0|||
145782687|NCT03303339|525712159|FG011|Overall Study|Physician Decision|0|||
145782688|NCT03303339|525712148|FG000|Overall Study|Safety/Non-compliance|0|||
145782689|NCT03303339|525712149|FG001|Overall Study|Safety/Non-compliance|0|||
145782690|NCT03303339|525712150|FG002|Overall Study|Safety/Non-compliance|0|||
145782691|NCT03303339|525712151|FG003|Overall Study|Safety/Non-compliance|0|||
145782692|NCT03303339|525712152|FG004|Overall Study|Safety/Non-compliance|0|||
145782693|NCT03303339|525712153|FG005|Overall Study|Safety/Non-compliance|0|||
145782694|NCT03303339|525712154|FG006|Overall Study|Safety/Non-compliance|0|||
145782695|NCT03303339|525712155|FG007|Overall Study|Safety/Non-compliance|0|||
145782696|NCT03303339|525712156|FG008|Overall Study|Safety/Non-compliance|0|||
145782697|NCT03303339|525712157|FG009|Overall Study|Safety/Non-compliance|0|||
145782698|NCT03303339|525712158|FG010|Overall Study|Safety/Non-compliance|0|||
145782699|NCT03303339|525712159|FG011|Overall Study|Safety/Non-compliance|1|||
145782700|NCT01400971|525712162|FG000|Overall Study|Death|82|||
145782701|NCT01400971|525712162|FG000|Overall Study|Lost to Follow-up|196|||
145782702|NCT01400971|525712162|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
145782703|NCT01400971|525712162|FG000|Overall Study|Physician Decision|57|||
145782704|NCT01400971|525712162|FG000|Overall Study|Withdrawal by Subject|158|||
145782705|NCT01400971|525712162|FG000|Overall Study|Other|422|||
145782706|NCT01879618|525712163|FG000|Overall Study|Does not meet entrance criteria|1|||
145782707|NCT01879618|525712163|FG000|Overall Study|Withdrawal by Subject|1|||
145782708|NCT01879618|525712163|FG000|Overall Study|Surgery;changed schedule; not available|8|||
145782709|NCT01879618|525712163|FG000|Overall Study|Protocol Violation|6|||
145782710|NCT01879618|525712163|FG000|Overall Study|Adverse Event|5|||
145782711|NCT01161524|525712172|FG000|Core Study (23 Weeks)|Adverse Event|3|||
145782712|NCT01161524|525712173|FG001|Core Study (23 Weeks)|Adverse Event|0|||
145782713|NCT01161524|525712174|FG002|Core Study (23 Weeks)|Adverse Event|0|||
145782714|NCT01161524|525712172|FG000|Core Study (23 Weeks)|Other|1|||
145782715|NCT01161524|525712173|FG001|Core Study (23 Weeks)|Other|0|||
145782716|NCT01161524|525712174|FG002|Core Study (23 Weeks)|Other|0|||
145782717|NCT01161524|525712172|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
145782718|NCT01161524|525712173|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
145782719|NCT01161524|525712174|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
145782720|NCT01161524|525712172|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
145782721|NCT01161524|525712173|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
145782722|NCT01161524|525712174|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
145782723|NCT01161524|525712172|FG000|Core Study (23 Weeks)|Subject Choice|3|||
145782724|NCT01161524|525712173|FG001|Core Study (23 Weeks)|Subject Choice|2|||
145782725|NCT01161524|525712174|FG002|Core Study (23 Weeks)|Subject Choice|0|||
145782726|NCT01161524|525712172|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
145782727|NCT01161524|525712173|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
145782728|NCT01161524|525712174|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
145782729|NCT01161524|525712172|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
145782730|NCT01161524|525712173|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
145782731|NCT01161524|525712174|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
145782732|NCT01161524|525712172|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
145782733|NCT01161524|525712173|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
145782734|NCT01161524|525712174|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
145782735|NCT01161524|525712172|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
145782736|NCT01161524|525712173|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
145782737|NCT01161524|525712174|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
145782738|NCT01161524|525712172|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
145782739|NCT01161524|525712173|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
145782740|NCT01161524|525712174|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
145782741|NCT00642616|525712175|FG000|Overall Study|Adverse Event|2|||
145782742|NCT00642616|525712176|FG001|Overall Study|Adverse Event|0|||
145782743|NCT00642616|525712177|FG002|Overall Study|Adverse Event|1|||
145782744|NCT00642616|525712178|FG003|Overall Study|Adverse Event|0|||
145782745|NCT00642616|525712175|FG000|Overall Study|Study Terminated by Sponsor|7|||
145782746|NCT00642616|525712176|FG001|Overall Study|Study Terminated by Sponsor|6|||
145782747|NCT00642616|525712177|FG002|Overall Study|Study Terminated by Sponsor|4|||
145782748|NCT00642616|525712178|FG003|Overall Study|Study Terminated by Sponsor|5|||
145782749|NCT00642616|525712175|FG000|Overall Study|Withdrawal by Subject|0|||
145782750|NCT00642616|525712176|FG001|Overall Study|Withdrawal by Subject|1|||
145782751|NCT00642616|525712177|FG002|Overall Study|Withdrawal by Subject|1|||
145782752|NCT00642616|525712178|FG003|Overall Study|Withdrawal by Subject|1|||
145782753|NCT00642616|525712175|FG000|Overall Study|Protocol Violation|0|||
145782754|NCT00642616|525712176|FG001|Overall Study|Protocol Violation|0|||
145782755|NCT00642616|525712177|FG002|Overall Study|Protocol Violation|2|||
145782756|NCT00642616|525712178|FG003|Overall Study|Protocol Violation|0|||
145782757|NCT00642616|525712175|FG000|Overall Study|Physician Decision|0|||
145782758|NCT00642616|525712176|FG001|Overall Study|Physician Decision|0|||
145782759|NCT00642616|525712177|FG002|Overall Study|Physician Decision|1|||
145782760|NCT00642616|525712178|FG003|Overall Study|Physician Decision|1|||
145782761|NCT00399802|525712179|FG000|Overall Study|Adverse Event|0|||
145782762|NCT00399802|525712180|FG001|Overall Study|Adverse Event|2|||
145782763|NCT00399802|525712179|FG000|Overall Study|Participant discontinued by mistake|0|||
145782764|NCT00399802|525712180|FG001|Overall Study|Participant discontinued by mistake|1|||
145782765|NCT00542815|525712185|FG000|Overall Study|Adverse Event|19|||
145782766|NCT00542815|525712186|FG001|Overall Study|Adverse Event|6|||
145782767|NCT00542815|525712187|FG002|Overall Study|Adverse Event|9|||
145782768|NCT00542815|525712185|FG000|Overall Study|Death|10|||
145782769|NCT00542815|525712186|FG001|Overall Study|Death|7|||
145782770|NCT00542815|525712187|FG002|Overall Study|Death|3|||
145782771|NCT00542815|525712185|FG000|Overall Study|Lack of Efficacy|9|||
145782772|NCT00542815|525712186|FG001|Overall Study|Lack of Efficacy|2|||
145782773|NCT00542815|525712187|FG002|Overall Study|Lack of Efficacy|0|||
145782774|NCT00542815|525712185|FG000|Overall Study|Physician Decision|2|||
145782775|NCT00542815|525712186|FG001|Overall Study|Physician Decision|1|||
145782776|NCT00542815|525712187|FG002|Overall Study|Physician Decision|0|||
145782777|NCT00542815|525712185|FG000|Overall Study|Protocol Violation|1|||
145782778|NCT00542815|525712186|FG001|Overall Study|Protocol Violation|1|||
145782779|NCT00542815|525712187|FG002|Overall Study|Protocol Violation|2|||
145782780|NCT00542815|525712185|FG000|Overall Study|Withdrawal by Subject|41|||
145782781|NCT00542815|525712186|FG001|Overall Study|Withdrawal by Subject|5|||
145782782|NCT00542815|525712187|FG002|Overall Study|Withdrawal by Subject|8|||
145782783|NCT00542815|525712185|FG000|Overall Study|Other reasons|24|||
145782784|NCT00542815|525712186|FG001|Overall Study|Other reasons|10|||
145782785|NCT00542815|525712187|FG002|Overall Study|Other reasons|10|||
145782786|NCT01041573|525712190|FG000|Overall Study|Withdrawal by Subject|2|||
145782787|NCT01041573|525712191|FG001|Overall Study|Withdrawal by Subject|5|||
145782788|NCT01041573|525712192|FG002|Overall Study|Withdrawal by Subject|2|||
145782789|NCT01041573|525712193|FG003|Overall Study|Withdrawal by Subject|0|||
145782790|NCT01041573|525712190|FG000|Overall Study|Death|1|||
145782791|NCT01041573|525712191|FG001|Overall Study|Death|0|||
145782792|NCT01041573|525712192|FG002|Overall Study|Death|0|||
145782793|NCT01041573|525712193|FG003|Overall Study|Death|0|||
145403742|NCT00764790|524334409|FG002|Overall Study|Protocol Violation|1|||
145782794|NCT01041573|525712190|FG000|Overall Study|Lost to Follow-up|0|||
145782795|NCT01041573|525712191|FG001|Overall Study|Lost to Follow-up|1|||
145782796|NCT01041573|525712192|FG002|Overall Study|Lost to Follow-up|2|||
145782797|NCT01041573|525712193|FG003|Overall Study|Lost to Follow-up|1|||
145782798|NCT01041573|525712190|FG000|Overall Study|Adverse Event|0|||
145782799|NCT01041573|525712191|FG001|Overall Study|Adverse Event|2|||
145782800|NCT01041573|525712192|FG002|Overall Study|Adverse Event|0|||
145782801|NCT01041573|525712193|FG003|Overall Study|Adverse Event|0|||
145782802|NCT01041573|525712190|FG000|Overall Study|relocation|1|||
145782803|NCT01041573|525712191|FG001|Overall Study|relocation|4|||
145782804|NCT01041573|525712192|FG002|Overall Study|relocation|3|||
145782805|NCT01041573|525712193|FG003|Overall Study|relocation|1|||
145782806|NCT01041573|525712190|FG000|Overall Study|further blood extraction|0|||
145782807|NCT01041573|525712191|FG001|Overall Study|further blood extraction|1|||
145782808|NCT01041573|525712192|FG002|Overall Study|further blood extraction|0|||
145782809|NCT01041573|525712193|FG003|Overall Study|further blood extraction|0|||
145782810|NCT01041573|525712190|FG000|Overall Study|positive to anti-HCV|1|||
145782811|NCT01041573|525712191|FG001|Overall Study|positive to anti-HCV|0|||
145782812|NCT01041573|525712192|FG002|Overall Study|positive to anti-HCV|0|||
145782813|NCT01041573|525712193|FG003|Overall Study|positive to anti-HCV|0|||
145782814|NCT02955186|525712194|FG000|Overall Study|Withdrawal by Subject|6|||
145782815|NCT02955186|525712195|FG001|Overall Study|Withdrawal by Subject|2|||
145782816|NCT02955186|525712194|FG000|Overall Study|Protocol Violation|1|||
145782817|NCT02955186|525712195|FG001|Overall Study|Protocol Violation|0|||
145782818|NCT01618656|525712198|FG000|Overall Study|Withdrawal by Subject|7|||
145782819|NCT01618656|525712199|FG001|Overall Study|Withdrawal by Subject|3|||
145782820|NCT01618656|525712198|FG000|Overall Study|Physician Decision|1|||
145782821|NCT01618656|525712199|FG001|Overall Study|Physician Decision|1|||
145782822|NCT01899144|525712200|FG000|Treatment Period 2|Other|1|||
145782823|NCT01899144|525712200|FG000|Treatment Period 3|Other|2|||
145782824|NCT01899144|525712200|FG000|Treatment Period 5|Other|1|||
145782825|NCT00751881|525712203|FG000|Core Treatment Period|Not treated|1|||
145782826|NCT00751881|525712204|FG001|Core Treatment Period|Not treated|1|||
145782827|NCT00751881|525712205|FG002|Core Treatment Period|Not treated|2|||
145782828|NCT00751881|525712203|FG000|Core Treatment Period|Adverse Event|26|||
145782829|NCT00751881|525712204|FG001|Core Treatment Period|Adverse Event|54|||
145782830|NCT00751881|525712205|FG002|Core Treatment Period|Adverse Event|58|||
145782831|NCT00751881|525712203|FG000|Core Treatment Period|Lack of Efficacy|37|||
145782832|NCT00751881|525712204|FG001|Core Treatment Period|Lack of Efficacy|30|||
145782833|NCT00751881|525712205|FG002|Core Treatment Period|Lack of Efficacy|20|||
145782834|NCT00751881|525712203|FG000|Core Treatment Period|Poor compliance to protocol|15|||
145782835|NCT00751881|525712204|FG001|Core Treatment Period|Poor compliance to protocol|3|||
145782836|NCT00751881|525712205|FG002|Core Treatment Period|Poor compliance to protocol|4|||
145782837|NCT00751881|525712203|FG000|Core Treatment Period|Lost to Follow-up|6|||
145782838|NCT00751881|525712204|FG001|Core Treatment Period|Lost to Follow-up|4|||
145782839|NCT00751881|525712205|FG002|Core Treatment Period|Lost to Follow-up|3|||
145782840|NCT00751881|525712203|FG000|Core Treatment Period|Other: protocol deviation|3|||
145782841|NCT00751881|525712204|FG001|Core Treatment Period|Other: protocol deviation|3|||
145782842|NCT00751881|525712205|FG002|Core Treatment Period|Other: protocol deviation|7|||
145782843|NCT00751881|525712203|FG000|Core Treatment Period|Other: wish to parent|5|||
145782844|NCT00751881|525712204|FG001|Core Treatment Period|Other: wish to parent|7|||
145782845|NCT00751881|525712205|FG002|Core Treatment Period|Other: wish to parent|4|||
145537482|NCT01145625|524827485|FG001|Overall Study|Lost to Follow-up|9|||
145537483|NCT01145625|524827484|FG000|Overall Study|Adverse Event|6|||
145782846|NCT00751881|525712203|FG000|Core Treatment Period|Other: personal/family constraints|6|||
145782847|NCT00751881|525712204|FG001|Core Treatment Period|Other: personal/family constraints|7|||
145537484|NCT01145625|524827485|FG001|Overall Study|Adverse Event|4|||
145537485|NCT01145625|524827484|FG000|Overall Study|Protocol Violation|3|||
145782848|NCT00751881|525712205|FG002|Core Treatment Period|Other: personal/family constraints|10|||
145782849|NCT00751881|525712203|FG000|Core Treatment Period|Other: MS treatment change|6|||
145782850|NCT00751881|525712204|FG001|Core Treatment Period|Other: MS treatment change|4|||
145782851|NCT00751881|525712205|FG002|Core Treatment Period|Other: MS treatment change|4|||
145782852|NCT00751881|525712203|FG000|Core Treatment Period|Other: tolerability complaints|2|||
145537486|NCT01145625|524827485|FG001|Overall Study|Protocol Violation|1|||
145537487|NCT01145625|524827484|FG000|Overall Study|Withdrawal by Subject|7|||
145537488|NCT01145625|524827485|FG001|Overall Study|Withdrawal by Subject|16|||
145537489|NCT01145625|524827484|FG000|Overall Study|Pregnancy|0|||
145782853|NCT00751881|525712204|FG001|Core Treatment Period|Other: tolerability complaints|0|||
145782854|NCT00751881|525712205|FG002|Core Treatment Period|Other: tolerability complaints|0|||
145782855|NCT00751881|525712203|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
145782856|NCT00751881|525712204|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
145782857|NCT00751881|525712205|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
145782858|NCT00751881|525712203|FG000|Extension Study Period|Adverse Event|18|||
145782859|NCT00751881|525712204|FG001|Extension Study Period|Adverse Event|20|||
145782860|NCT00751881|525712205|FG002|Extension Study Period|Adverse Event|21|||
145782861|NCT00751881|525712203|FG000|Extension Study Period|Lack of Efficacy|14|||
145782862|NCT00751881|525712204|FG001|Extension Study Period|Lack of Efficacy|10|||
145782863|NCT00751881|525712205|FG002|Extension Study Period|Lack of Efficacy|20|||
145782864|NCT00751881|525712203|FG000|Extension Study Period|Lost to Follow-up|4|||
145782865|NCT00751881|525712204|FG001|Extension Study Period|Lost to Follow-up|9|||
145782866|NCT00751881|525712205|FG002|Extension Study Period|Lost to Follow-up|6|||
145782867|NCT00751881|525712203|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
145782868|NCT00751881|525712204|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
145782869|NCT00751881|525712205|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
145782870|NCT00751881|525712203|FG000|Extension Study Period|Other than specified above|26|||
145782871|NCT00751881|525712204|FG001|Extension Study Period|Other than specified above|30|||
145782872|NCT00751881|525712205|FG002|Extension Study Period|Other than specified above|18|||
145782873|NCT04770155|525712206|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782874|NCT04770155|525712207|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782875|NCT04770155|525712208|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782876|NCT04770155|525712209|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782877|NCT04770155|525712210|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782878|NCT04770155|525712211|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782879|NCT04770155|525712212|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782880|NCT04770155|525712213|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
145782881|NCT00864227|525712214|FG000|Overall Study|Withdrawal by Subject|1|||
145782882|NCT00864227|525712214|FG000|Overall Study|Disease Relapse/Progression|3|||
145782883|NCT03241173|525712215|FG000|Overall Study|Death|3|||
145782884|NCT03241173|525712216|FG001|Overall Study|Death|2|||
145782885|NCT03241173|525712217|FG002|Overall Study|Death|4|||
145782886|NCT03241173|525712218|FG003|Overall Study|Death|4|||
145782887|NCT03241173|525712219|FG004|Overall Study|Death|2|||
145782888|NCT03241173|525712220|FG005|Overall Study|Death|2|||
145782889|NCT03241173|525712221|FG006|Overall Study|Death|3|||
145782890|NCT03241173|525712222|FG007|Overall Study|Death|1|||
145782891|NCT03241173|525712223|FG008|Overall Study|Death|0|||
145782892|NCT03241173|525712224|FG009|Overall Study|Death|5|||
145782893|NCT03241173|525712225|FG010|Overall Study|Death|4|||
145782894|NCT03241173|525712226|FG011|Overall Study|Death|3|||
145782895|NCT03241173|525712227|FG012|Overall Study|Death|0|||
145782896|NCT03241173|525712228|FG013|Overall Study|Death|0|||
145782897|NCT03241173|525712229|FG014|Overall Study|Death|0|||
145782898|NCT03241173|525712215|FG000|Overall Study|Withdrawal by Subject|0|||
145782899|NCT03241173|525712216|FG001|Overall Study|Withdrawal by Subject|0|||
145782900|NCT03241173|525712217|FG002|Overall Study|Withdrawal by Subject|1|||
145782901|NCT03241173|525712218|FG003|Overall Study|Withdrawal by Subject|0|||
145782902|NCT03241173|525712219|FG004|Overall Study|Withdrawal by Subject|0|||
145782903|NCT03241173|525712220|FG005|Overall Study|Withdrawal by Subject|1|||
145782904|NCT03241173|525712221|FG006|Overall Study|Withdrawal by Subject|0|||
145782905|NCT03241173|525712222|FG007|Overall Study|Withdrawal by Subject|0|||
145782906|NCT03241173|525712223|FG008|Overall Study|Withdrawal by Subject|0|||
145782907|NCT03241173|525712224|FG009|Overall Study|Withdrawal by Subject|0|||
145537490|NCT01145625|524827485|FG001|Overall Study|Pregnancy|1|||
145537491|NCT00885846|524827486|FG000|Overall Study|Withdrawal by Subject|2|||
145537492|NCT00885846|524827487|FG001|Overall Study|Withdrawal by Subject|5|||
145782908|NCT03241173|525712225|FG010|Overall Study|Withdrawal by Subject|0|||
145782909|NCT03241173|525712226|FG011|Overall Study|Withdrawal by Subject|0|||
145782910|NCT03241173|525712227|FG012|Overall Study|Withdrawal by Subject|0|||
145782911|NCT03241173|525712228|FG013|Overall Study|Withdrawal by Subject|0|||
145782912|NCT03241173|525712229|FG014|Overall Study|Withdrawal by Subject|0|||
145782913|NCT03241173|525712215|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
145403743|NCT00764790|524334407|FG000|Overall Study|Withdrawal by Subject|10|||
145537493|NCT00885846|524827488|FG002|Overall Study|Withdrawal by Subject|2|||
145782914|NCT03241173|525712216|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
145782915|NCT03241173|525712217|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782916|NCT03241173|525712218|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
145782917|NCT03241173|525712219|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
145782918|NCT03241173|525712220|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
145782919|NCT03241173|525712221|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
145782920|NCT03241173|525712222|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
145782921|NCT03241173|525712223|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782922|NCT03241173|525712224|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782923|NCT03241173|525712225|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
145782924|NCT03241173|525712226|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
145782925|NCT03241173|525712227|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782926|NCT03241173|525712228|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782927|NCT03241173|525712229|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
145782928|NCT03241173|525712215|FG000|Overall Study|Lost to Follow-up|0|||
145782929|NCT03241173|525712216|FG001|Overall Study|Lost to Follow-up|0|||
145782930|NCT03241173|525712217|FG002|Overall Study|Lost to Follow-up|0|||
145782931|NCT03241173|525712218|FG003|Overall Study|Lost to Follow-up|0|||
145782932|NCT03241173|525712219|FG004|Overall Study|Lost to Follow-up|1|||
145782933|NCT03241173|525712220|FG005|Overall Study|Lost to Follow-up|0|||
145782934|NCT03241173|525712221|FG006|Overall Study|Lost to Follow-up|0|||
145782935|NCT03241173|525712222|FG007|Overall Study|Lost to Follow-up|0|||
145782936|NCT03241173|525712223|FG008|Overall Study|Lost to Follow-up|0|||
145782937|NCT03241173|525712224|FG009|Overall Study|Lost to Follow-up|1|||
145782938|NCT03241173|525712225|FG010|Overall Study|Lost to Follow-up|0|||
145782939|NCT03241173|525712226|FG011|Overall Study|Lost to Follow-up|0|||
145782940|NCT03241173|525712227|FG012|Overall Study|Lost to Follow-up|0|||
145782941|NCT03241173|525712228|FG013|Overall Study|Lost to Follow-up|0|||
145782942|NCT03241173|525712229|FG014|Overall Study|Lost to Follow-up|0|||
145782943|NCT03634072|525712230|FG000|Overall Study|Early termination of overall study|1|||
145782944|NCT03634072|525712231|FG001|Overall Study|Early termination of overall study|0|||
145782945|NCT01765764|525712232|FG000|Treatment Period|Adverse Event|1|||
145782946|NCT01765764|525712233|FG001|Treatment Period|Adverse Event|2|||
145782947|NCT01765764|525712234|FG002|Treatment Period|Adverse Event|1|||
145782948|NCT01765764|525712232|FG000|Treatment Period|Lost to Follow-up|0|||
145782949|NCT01765764|525712233|FG001|Treatment Period|Lost to Follow-up|3|||
145782950|NCT01765764|525712234|FG002|Treatment Period|Lost to Follow-up|2|||
145782951|NCT01765764|525712232|FG000|Treatment Period|Personal Reasons|1|||
145782952|NCT01765764|525712233|FG001|Treatment Period|Personal Reasons|2|||
145782953|NCT01765764|525712234|FG002|Treatment Period|Personal Reasons|1|||
145782954|NCT01765764|525712232|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
145782955|NCT01765764|525712233|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
145782956|NCT01765764|525712234|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
145782957|NCT01558089|525712235|FG000|Overall Study|Adverse Event|1|||
145782958|NCT01558089|525712235|FG000|Overall Study|Lack of Efficacy|1|||
145782959|NCT01558089|525712235|FG000|Overall Study|Lost to Follow-up|5|||
145782960|NCT01558089|525712235|FG000|Overall Study|Withdrawal by Subject|6|||
145782961|NCT01952015|525712238|FG000|Induction|Protocol Violation|1|||
145782962|NCT01952015|525712238|FG000|Maintenance|Adverse Event|2|||
145782963|NCT01952015|525712238|FG000|Treatment Period 3|Physician Decision|9|||
145782964|NCT03184701|525712239|FG000|Overall Study|Death|3|||
145782965|NCT03184701|525712239|FG000|Overall Study|Physician Decision|3|||
145782966|NCT03184701|525712239|FG000|Overall Study|Withdrawal by Subject|6|||
145782967|NCT03184701|525712239|FG000|Overall Study|Lost to Follow-up|5|||
145782968|NCT03242759|525712241|FG000|Overall Study|Adverse Event|5|||
145782969|NCT03242759|525712242|FG001|Overall Study|Adverse Event|1|||
145782970|NCT03242759|525712241|FG000|Overall Study|Withdrawal by Subject|4|||
145782971|NCT03242759|525712242|FG001|Overall Study|Withdrawal by Subject|3|||
145782972|NCT03242759|525712241|FG000|Overall Study|Lost to Follow-up|3|||
145782973|NCT03242759|525712242|FG001|Overall Study|Lost to Follow-up|1|||
145537494|NCT01952145|524827489|FG000|Overall Study|Protocol Violation|2|||
145537495|NCT01952145|524827490|FG001|Overall Study|Protocol Violation|1|||
145537496|NCT01952145|524827489|FG000|Overall Study|Death|0|||
145537497|NCT01952145|524827490|FG001|Overall Study|Death|1|||
145537498|NCT01952145|524827489|FG000|Overall Study|Adverse Event|9|||
145537499|NCT01952145|524827490|FG001|Overall Study|Adverse Event|0|||
145537500|NCT01952145|524827489|FG000|Overall Study|Withdrawal Criteria|16|||
145782974|NCT03242759|525712241|FG000|Overall Study|Administrative problems|1|||
145782975|NCT03242759|525712242|FG001|Overall Study|Administrative problems|1|||
145782976|NCT03242759|525712241|FG000|Overall Study|Death|22|||
145782977|NCT03242759|525712242|FG001|Overall Study|Death|0|||
145782978|NCT03242759|525712241|FG000|Overall Study|Change visit schedule|0|||
145782979|NCT03242759|525712242|FG001|Overall Study|Change visit schedule|1|||
145782980|NCT00798967|525712249|FG000|Overall Study|Adverse Event|2|||
145782981|NCT00798967|525712250|FG001|Overall Study|Adverse Event|3|||
145782982|NCT00798967|525712249|FG000|Overall Study|Withdrawal by Subject|0|||
145782983|NCT00798967|525712250|FG001|Overall Study|Withdrawal by Subject|1|||
145782984|NCT00798967|525712249|FG000|Overall Study|Physician Decision|1|||
145782985|NCT00798967|525712250|FG001|Overall Study|Physician Decision|0|||
145782986|NCT00798967|525712249|FG000|Overall Study|Randomized in error by site|1|||
145782987|NCT00798967|525712250|FG001|Overall Study|Randomized in error by site|0|||
145782988|NCT03090737|525712253|FG000|Overall Study|Other reasons|1|||
145782989|NCT03090737|525712253|FG000|Overall Study|Completed treatment as per protocol|17|||
145782990|NCT03090737|525712253|FG000|Overall Study|Maximum clinical benefit|2|||
145782991|NCT03090737|525712253|FG000|Overall Study|Adverse event unrelated to study drug|7|||
145782992|NCT03090737|525712253|FG000|Overall Study|Study drug toxicity|4|||
145782993|NCT03090737|525712253|FG000|Overall Study|Disease progression|98|||
145782994|NCT00227877|525712254|FG000|Pre-visit Assessment|Technical difficulties|7|||
145782995|NCT00227877|525712255|FG001|Pre-visit Assessment|Technical difficulties|3|||
145782996|NCT00227877|525712256|FG002|Pre-visit Assessment|Technical difficulties|0|||
145782997|NCT00227877|525712257|FG003|Pre-visit Assessment|Technical difficulties|0|||
145782998|NCT00227877|525712254|FG000|Post-visit Checklist|Lost to Follow-up|24|||
145782999|NCT00227877|525712255|FG001|Post-visit Checklist|Lost to Follow-up|13|||
145783000|NCT00227877|525712256|FG002|Post-visit Checklist|Lost to Follow-up|1|||
145783001|NCT00227877|525712257|FG003|Post-visit Checklist|Lost to Follow-up|0|||
145783002|NCT00227877|525712254|FG000|3-months Follow-up|Completed late|135|||
145783003|NCT00227877|525712255|FG001|3-months Follow-up|Completed late|128|||
145783004|NCT00227877|525712256|FG002|3-months Follow-up|Completed late|34|||
145783005|NCT00227877|525712257|FG003|3-months Follow-up|Completed late|8|||
145783006|NCT00227877|525712254|FG000|3-months Follow-up|Lost to Follow-up|178|||
145783007|NCT00227877|525712255|FG001|3-months Follow-up|Lost to Follow-up|139|||
145783008|NCT00227877|525712256|FG002|3-months Follow-up|Lost to Follow-up|18|||
145783009|NCT00227877|525712257|FG003|3-months Follow-up|Lost to Follow-up|13|||
145783010|NCT00227877|525712254|FG000|12-months Follow-up|Completed late|78|||
145783011|NCT00227877|525712255|FG001|12-months Follow-up|Completed late|74|||
145783012|NCT00227877|525712256|FG002|12-months Follow-up|Completed late|1|||
145783013|NCT00227877|525712257|FG003|12-months Follow-up|Completed late|0|||
145783014|NCT00227877|525712254|FG000|12-months Follow-up|Lost to Follow-up|232|||
145783015|NCT00227877|525712255|FG001|12-months Follow-up|Lost to Follow-up|189|||
145783016|NCT00227877|525712256|FG002|12-months Follow-up|Lost to Follow-up|30|||
145783017|NCT00227877|525712257|FG003|12-months Follow-up|Lost to Follow-up|26|||
145783018|NCT03141307|525712258|FG000|In-Hospital|Withdrawal by Subject|0|||
145783019|NCT03141307|525712259|FG001|In-Hospital|Withdrawal by Subject|2|||
145783020|NCT03141307|525712258|FG000|In-Hospital|Protocol Violation|4|||
145783021|NCT03141307|525712259|FG001|In-Hospital|Protocol Violation|0|||
145783022|NCT03141307|525712258|FG000|Follow-Up|Lost to Follow-up|97|||
145783023|NCT03141307|525712259|FG001|Follow-Up|Lost to Follow-up|54|||
145783024|NCT01663740|525712261|FG000|Overall Study|Lost to Follow-up|1|||
145783025|NCT01663740|525712262|FG001|Overall Study|Lost to Follow-up|4|||
145783026|NCT01663740|525712261|FG000|Overall Study|Other|9|||
145783027|NCT01663740|525712262|FG001|Overall Study|Other|2|||
145783028|NCT01663740|525712261|FG000|Overall Study|Inclusion/Exclusion not met|1|||
145783029|NCT01663740|525712262|FG001|Overall Study|Inclusion/Exclusion not met|0|||
145783030|NCT01663740|525712261|FG000|Overall Study|Death|0|||
145403744|NCT00764790|524334408|FG001|Overall Study|Withdrawal by Subject|12|||
145403745|NCT00764790|524334409|FG002|Overall Study|Withdrawal by Subject|6|||
145537501|NCT01952145|524827490|FG001|Overall Study|Withdrawal Criteria|11|||
145783031|NCT01663740|525712262|FG001|Overall Study|Death|1|||
145783032|NCT01663740|525712261|FG000|Overall Study|Withdrawal by Subject|2|||
145783033|NCT01663740|525712262|FG001|Overall Study|Withdrawal by Subject|1|||
145783034|NCT01663740|525712261|FG000|Overall Study|No end of study status|3|||
145783035|NCT01663740|525712262|FG001|Overall Study|No end of study status|0|||
145783036|NCT02522481|525712263|FG000|Overall Study|discontinued|1|||
145783037|NCT02522481|525712263|FG000|Overall Study|Not dosed|2|||
145783038|NCT03123939|525712266|FG000|Overall Study|Lack of Efficacy|6|||
145783039|NCT03123939|525712266|FG000|Overall Study|Death|5|||
145783040|NCT03123939|525712266|FG000|Overall Study|Physician Decision|2|||
145783041|NCT03123939|525712266|FG000|Overall Study|Subject/guardian decision|2|||
145537502|NCT01952145|524827489|FG000|Overall Study|Unclassified|1|||
145783042|NCT03123939|525712266|FG000|Overall Study|Lost to Follow-up|1|||
145783043|NCT03123939|525712266|FG000|Overall Study|New therapy for study indication|1|||
145783044|NCT03123939|525712266|FG000|Overall Study|Protocol deviation|1|||
145783045|NCT03123939|525712266|FG000|Overall Study|Progressive disease|18|||
145783046|NCT03123939|525712266|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
145783047|NCT03123939|525712266|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
145783048|NCT04267562|525713872|FG000|Assessed for Eligibility|Screen Failure|64|||
145783049|NCT04267562|525713872|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
145783050|NCT04267562|525713872|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
145783051|NCT04267562|525713872|FG000|Assessed for Eligibility|Site closure|6|||
145783052|NCT04267562|525713872|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
145783053|NCT04267562|525713872|FG000|Assessed for Eligibility|Physician Decision|1|||
145783054|NCT04267562|525713872|FG000|Month 24|Elective hysterectomy|1|||
145783055|NCT04267562|525713872|FG000|Month 24|Lost to Follow-up|1|||
145783056|NCT04267562|525713872|FG000|Month 36|Elective hysterectomy|2|||
145783057|NCT04267562|525713872|FG000|Month 36|Lost to Follow-up|3|||
145783058|NCT01937130|525713874|FG000|Overall Study|Withdrawal by Subject|0|||
145783059|NCT01937130|525713875|FG001|Overall Study|Withdrawal by Subject|0|||
145783060|NCT01937130|525713876|FG002|Overall Study|Withdrawal by Subject|0|||
145783061|NCT01937130|525713877|FG003|Overall Study|Withdrawal by Subject|1|||
145783062|NCT01937130|525713874|FG000|Overall Study|Adverse Event|0|||
145783063|NCT01937130|525713875|FG001|Overall Study|Adverse Event|1|||
145783064|NCT01937130|525713876|FG002|Overall Study|Adverse Event|0|||
145783065|NCT01937130|525713877|FG003|Overall Study|Adverse Event|1|||
145783066|NCT01937130|525713874|FG000|Overall Study|Death|1|||
145783067|NCT01937130|525713875|FG001|Overall Study|Death|1|||
145783068|NCT01937130|525713876|FG002|Overall Study|Death|1|||
145783069|NCT01937130|525713877|FG003|Overall Study|Death|0|||
145783070|NCT01937130|525713874|FG000|Overall Study|Lost to Follow-up|2|||
145783071|NCT01937130|525713875|FG001|Overall Study|Lost to Follow-up|0|||
145783072|NCT01937130|525713876|FG002|Overall Study|Lost to Follow-up|2|||
145783073|NCT01937130|525713877|FG003|Overall Study|Lost to Follow-up|0|||
145783074|NCT01937130|525713874|FG000|Overall Study|Physician Decision|0|||
145783075|NCT01937130|525713875|FG001|Overall Study|Physician Decision|1|||
145783076|NCT01937130|525713876|FG002|Overall Study|Physician Decision|0|||
145783077|NCT01937130|525713877|FG003|Overall Study|Physician Decision|0|||
145783078|NCT01937130|525713874|FG000|Overall Study|Patients unable to swallow|0|||
145783079|NCT01937130|525713875|FG001|Overall Study|Patients unable to swallow|1|||
145783080|NCT01937130|525713876|FG002|Overall Study|Patients unable to swallow|0|||
145783081|NCT01937130|525713877|FG003|Overall Study|Patients unable to swallow|0|||
145783082|NCT01937130|525713874|FG000|Overall Study|Patient lost to FU due to death|2|||
145783083|NCT01937130|525713875|FG001|Overall Study|Patient lost to FU due to death|0|||
145783084|NCT01937130|525713876|FG002|Overall Study|Patient lost to FU due to death|0|||
145783085|NCT01937130|525713877|FG003|Overall Study|Patient lost to FU due to death|0|||
145783086|NCT01850563|525713878|FG000|Overall Study|Not eligible|3|||
145783087|NCT01850563|525713879|FG001|Overall Study|Not eligible|0|||
145783088|NCT01431144|525713880|FG000|Overall Study|Implant mobility and removal|2|||
145783089|NCT01431144|525713881|FG001|Overall Study|Implant mobility and removal|0|||
145783090|NCT00408421|525713882|FG000|Treatment Initial Randomization|Adverse Event|5|||
145783091|NCT00408421|525713883|FG001|Treatment Initial Randomization|Adverse Event|9|||
145783092|NCT00408421|525713884|FG002|Treatment Initial Randomization|Adverse Event|0|||
145783093|NCT00408421|525713882|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
145783094|NCT00408421|525713883|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
145783095|NCT00408421|525713884|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
145783096|NCT00408421|525713882|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
145783097|NCT00408421|525713883|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
145783098|NCT00408421|525713884|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
145783099|NCT00408421|525713882|FG000|Treatment Initial Randomization|Physician Decision|1|||
145783100|NCT00408421|525713883|FG001|Treatment Initial Randomization|Physician Decision|0|||
145783101|NCT00408421|525713884|FG002|Treatment Initial Randomization|Physician Decision|0|||
145783102|NCT00408421|525713882|FG000|Treatment Initial Randomization|Protocol Violation|0|||
145783103|NCT00408421|525713883|FG001|Treatment Initial Randomization|Protocol Violation|1|||
145783104|NCT00408421|525713884|FG002|Treatment Initial Randomization|Protocol Violation|0|||
145783105|NCT00408421|525713882|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
145783106|NCT00408421|525713883|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
145783107|NCT00408421|525713884|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
145783108|NCT00408421|525713882|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
145783109|NCT00408421|525713883|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
145783110|NCT00408421|525713884|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
145783111|NCT00408421|525713882|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
145783112|NCT00408421|525713883|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
145783113|NCT00408421|525713884|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
145783114|NCT00408421|525713882|FG000|Treatment Re-Randomization|Adverse Event|2|||
145783115|NCT00408421|525713883|FG001|Treatment Re-Randomization|Adverse Event|2|||
145783116|NCT00408421|525713884|FG002|Treatment Re-Randomization|Adverse Event|4|||
145783117|NCT00408421|525713882|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
145783118|NCT00408421|525713883|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
145783119|NCT00408421|525713884|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
145783120|NCT00408421|525713882|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
145783121|NCT00408421|525713883|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
145783122|NCT00408421|525713884|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
145783123|NCT00408421|525713882|FG000|Treatment Re-Randomization|Physician Decision|1|||
145783124|NCT00408421|525713883|FG001|Treatment Re-Randomization|Physician Decision|3|||
145783125|NCT00408421|525713884|FG002|Treatment Re-Randomization|Physician Decision|0|||
145783126|NCT00408421|525713882|FG000|Treatment Re-Randomization|Protocol Violation|1|||
145783127|NCT00408421|525713883|FG001|Treatment Re-Randomization|Protocol Violation|1|||
145783128|NCT00408421|525713884|FG002|Treatment Re-Randomization|Protocol Violation|0|||
145783129|NCT00408421|525713882|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
145783130|NCT00408421|525713883|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
145783131|NCT00408421|525713884|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
145783132|NCT02322892|525713885|FG000|Overall Study|Surgery cancelled|1|||
145783133|NCT02322892|525713886|FG001|Overall Study|Surgery cancelled|2|||
145783134|NCT02322892|525713885|FG000|Overall Study|Met exclusion criteria|0|||
145783135|NCT02322892|525713886|FG001|Overall Study|Met exclusion criteria|1|||
145783136|NCT02322892|525713885|FG000|Overall Study|Protocol Violation|1|||
145783137|NCT02322892|525713886|FG001|Overall Study|Protocol Violation|0|||
145783138|NCT02125331|525713889|FG000|Overall Study|Protocol Violation|1|||
145783139|NCT02125331|525713890|FG001|Overall Study|Protocol Violation|0|||
145783140|NCT02125331|525713889|FG000|Overall Study|technical problem|2|||
145783141|NCT02125331|525713890|FG001|Overall Study|technical problem|0|||
145783142|NCT02125331|525713889|FG000|Overall Study|screen failure|2|||
145783143|NCT02125331|525713890|FG001|Overall Study|screen failure|0|||
145783144|NCT02601001|525713895|FG000|Dosing Period 2|Adverse Event|0|||
145783145|NCT02601001|525713896|FG001|Dosing Period 2|Adverse Event|0|||
145783146|NCT02601001|525713897|FG002|Dosing Period 2|Adverse Event|0|||
145783147|NCT02601001|525713898|FG003|Dosing Period 2|Adverse Event|0|||
145783148|NCT02601001|525713899|FG004|Dosing Period 2|Adverse Event|0|||
145783149|NCT02601001|525713900|FG005|Dosing Period 2|Adverse Event|0|||
145783150|NCT02601001|525713901|FG006|Dosing Period 2|Adverse Event|1|||
145783151|NCT01115569|525713906|FG000|Conversion/Titration Phase|Adverse Event|59|||
145783152|NCT01115569|525713907|FG001|Conversion/Titration Phase|Adverse Event|0|||
145783153|NCT01115569|525713906|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
145783154|NCT01115569|525713907|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
145783155|NCT01115569|525713906|FG000|Conversion/Titration Phase|Physician Decision|5|||
145783156|NCT01115569|525713907|FG001|Conversion/Titration Phase|Physician Decision|0|||
145783157|NCT01115569|525713906|FG000|Conversion/Titration Phase|Protocol Violation|68|||
145783158|NCT01115569|525713907|FG001|Conversion/Titration Phase|Protocol Violation|0|||
145783159|NCT01115569|525713906|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
145783160|NCT01115569|525713907|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
145783161|NCT01115569|525713906|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
145783162|NCT01115569|525713907|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
145783163|NCT01115569|525713906|FG000|Maintenance Phase|Adverse Event|0|||
145783164|NCT01115569|525713907|FG001|Maintenance Phase|Adverse Event|43|||
145783165|NCT01115569|525713906|FG000|Maintenance Phase|Lost to Follow-up|0|||
145783166|NCT01115569|525713907|FG001|Maintenance Phase|Lost to Follow-up|8|||
145783167|NCT01115569|525713906|FG000|Maintenance Phase|Physician Decision|0|||
145783168|NCT01115569|525713907|FG001|Maintenance Phase|Physician Decision|3|||
145783169|NCT01115569|525713906|FG000|Maintenance Phase|Protocol Violation|0|||
145783170|NCT01115569|525713907|FG001|Maintenance Phase|Protocol Violation|9|||
145783171|NCT01115569|525713906|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145783172|NCT01115569|525713907|FG001|Maintenance Phase|Withdrawal by Subject|27|||
145783173|NCT01115569|525713906|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
145783174|NCT01115569|525713907|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
145783175|NCT01115569|525713906|FG000|Maintenance Phase|Administrative|0|||
145537503|NCT01952145|524827490|FG001|Overall Study|Unclassified|1|||
145537504|NCT01540838|524827492|FG000|Overall Study|Open nasogastric tube|9|||
145537505|NCT01540838|524827493|FG001|Overall Study|Open nasogastric tube|7|||
145537506|NCT01540838|524827492|FG000|Overall Study|Treatment doses missing|8|||
145783176|NCT01115569|525713907|FG001|Maintenance Phase|Administrative|1|||
145783177|NCT01254604|525713910|FG000|Overall Study|Lost to Follow-up|1|||
145783178|NCT01254604|525713911|FG001|Overall Study|Lost to Follow-up|1|||
145783179|NCT01254604|525713910|FG000|Overall Study|Protocol Violation|2|||
145783180|NCT01254604|525713911|FG001|Overall Study|Protocol Violation|2|||
145783181|NCT01254604|525713910|FG000|Overall Study|Withdrawal by Subject|2|||
145783182|NCT01254604|525713911|FG001|Overall Study|Withdrawal by Subject|4|||
145783183|NCT01254604|525713910|FG000|Overall Study|Adverse Event|3|||
145783184|NCT01254604|525713911|FG001|Overall Study|Adverse Event|2|||
145537507|NCT01540838|524827493|FG001|Overall Study|Treatment doses missing|12|||
145783185|NCT03074162|525713912|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
145783186|NCT03074162|525713913|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
145783187|NCT03074162|525713914|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
145783188|NCT03074162|525713915|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
145783189|NCT03074162|525713916|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
145783190|NCT03074162|525713917|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
145783191|NCT03074162|525713912|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
145783192|NCT03074162|525713913|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
145783193|NCT03074162|525713914|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
145783194|NCT03074162|525713915|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
145783195|NCT03074162|525713916|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
145783196|NCT03074162|525713917|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
145783197|NCT03074162|525713912|FG000|Period 3|Withdrawal by Subject|1|||
145537508|NCT01540838|524827492|FG000|Overall Study|Additional antibiotic treatment|1|||
145537509|NCT01540838|524827493|FG001|Overall Study|Additional antibiotic treatment|2|||
145783198|NCT03074162|525713913|FG001|Period 3|Withdrawal by Subject|0|||
145783199|NCT03074162|525713914|FG002|Period 3|Withdrawal by Subject|0|||
145783200|NCT03074162|525713915|FG003|Period 3|Withdrawal by Subject|0|||
145783201|NCT03074162|525713916|FG004|Period 3|Withdrawal by Subject|1|||
145783202|NCT03074162|525713917|FG005|Period 3|Withdrawal by Subject|0|||
145783203|NCT02948777|525713923|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
145783204|NCT03242928|525713924|FG000|Overall Study|Adverse Event|2|||
145783205|NCT03242928|525713925|FG001|Overall Study|Adverse Event|1|||
145783206|NCT03242928|525713924|FG000|Overall Study|Lost to Follow-up|2|||
145783207|NCT03242928|525713925|FG001|Overall Study|Lost to Follow-up|0|||
145783208|NCT03242928|525713924|FG000|Overall Study|Physician Decision|0|||
145783209|NCT03242928|525713925|FG001|Overall Study|Physician Decision|1|||
145783210|NCT03242928|525713924|FG000|Overall Study|Withdrawal by Subject|5|||
145783211|NCT03242928|525713925|FG001|Overall Study|Withdrawal by Subject|3|||
145783212|NCT00625365|525713929|FG000|Overall Study|Withdrawal by Subject|1|||
145783213|NCT00625365|525713929|FG000|Overall Study|No IV access|5|||
145783214|NCT00625365|525713929|FG000|Overall Study|VSD|1|||
145783215|NCT01703286|525713937|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
145783216|NCT01703286|525713938|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
145783217|NCT01703286|525713939|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
145783218|NCT01703286|525713940|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
145783219|NCT01703286|525713941|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
145783220|NCT01703286|525713942|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
145783221|NCT01703286|525713937|FG000|Period 2 Including Washout|Adverse Event|0|||
145783222|NCT01703286|525713938|FG001|Period 2 Including Washout|Adverse Event|0|||
145783223|NCT01703286|525713939|FG002|Period 2 Including Washout|Adverse Event|0|||
145403746|NCT00764790|524334407|FG000|Overall Study|Lost to Follow-up|28|||
145403747|NCT00764790|524334408|FG001|Overall Study|Lost to Follow-up|29|||
145403748|NCT00764790|524334409|FG002|Overall Study|Lost to Follow-up|23|||
145783224|NCT01703286|525713940|FG003|Period 2 Including Washout|Adverse Event|1|||
145783225|NCT01703286|525713941|FG004|Period 2 Including Washout|Adverse Event|0|||
145537510|NCT01540838|524827492|FG000|Overall Study|Died before treatment initiation|1|||
145537511|NCT01540838|524827493|FG001|Overall Study|Died before treatment initiation|1|||
145783226|NCT01703286|525713942|FG005|Period 2 Including Washout|Adverse Event|0|||
145783227|NCT02421120|525713943|FG000|Overall Study|Adverse Event|1|||
145783228|NCT00931892|525713944|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
145783229|NCT00931892|525713945|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
145783230|NCT01876732|525713946|FG000|Overall Study|MMA was not over 800mg/dL|75|||
145537512|NCT01540838|524827492|FG000|Overall Study|Not BM. Other treatment|3|||
145537513|NCT01540838|524827493|FG001|Overall Study|Not BM. Other treatment|1|||
145537514|NCT02130570|524827494|FG000|Overall Study|Death|3|||
145537515|NCT02130570|524827495|FG001|Overall Study|Death|5|||
145783231|NCT02207530|525713947|FG000|Overall Study|Worsening condition under investigation|78|||
145783232|NCT02207530|525713947|FG000|Overall Study|Patient decision to stop study treatment|5|||
145783233|NCT02207530|525713947|FG000|Overall Study|Adverse Event|8|||
145783234|NCT00305006|525713948|FG000|Overall Study|Withdrawal by Subject|1|||
145783235|NCT00305006|525713949|FG001|Overall Study|Withdrawal by Subject|0|||
145783236|NCT00305006|525713948|FG000|Overall Study|Failure to complete pretest|0|||
145783237|NCT00305006|525713949|FG001|Overall Study|Failure to complete pretest|1|||
145783238|NCT01996319|525713950|FG000|Overall Study|Protocol Violation|1|||
145783239|NCT01996319|525713951|FG001|Overall Study|Protocol Violation|0|||
145783240|NCT01996319|525713950|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
145783241|NCT01996319|525713951|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
145537516|NCT02130570|524827494|FG000|Overall Study|Withdrawal by Subject|6|||
145537517|NCT02130570|524827495|FG001|Overall Study|Withdrawal by Subject|3|||
145783242|NCT01996319|525713950|FG000|Overall Study|Adverse Event|2|||
145783243|NCT01996319|525713951|FG001|Overall Study|Adverse Event|2|||
145537518|NCT02130570|524827494|FG000|Overall Study|Part of practice that discontinued study|0|||
145537519|NCT02130570|524827495|FG001|Overall Study|Part of practice that discontinued study|5|||
145537520|NCT00493025|524827498|FG000|Overall Study|Physician Decision|19|||
145537521|NCT03863197|524827499|FG000|Overall Study|Lost to Follow-up|2|||
145537522|NCT03863197|524827500|FG001|Overall Study|Lost to Follow-up|3|||
145537523|NCT03863197|524827499|FG000|Overall Study|Withdrawal by Subject|4|||
145537524|NCT03863197|524827500|FG001|Overall Study|Withdrawal by Subject|0|||
145537525|NCT03863197|524827499|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
145537526|NCT03863197|524827500|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
145537527|NCT01065597|524827501|FG000|Overall Study|Adverse Event|1|||
145537528|NCT01622231|524827502|FG000|Overall Study|Physician Decision|1|||
145537529|NCT01622231|524827502|FG000|Overall Study|Withdrawal by Subject|1|||
145783244|NCT06094296|525713952|FG000|Overall Study|Progressive Disease|1|||
145783245|NCT06094296|525713953|FG001|Overall Study|Progressive Disease|0|||
145783246|NCT06094296|525713954|FG002|Overall Study|Progressive Disease|0|||
145783247|NCT06094296|525713955|FG003|Overall Study|Progressive Disease|0|||
145783248|NCT00986258|525713956|FG000|Observation Period|Not eligible to be dosed|11|||
145783249|NCT00986258|525713956|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
145783250|NCT00986258|525713956|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
145783251|NCT00986258|525713956|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
145783252|NCT00986258|525713956|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
145783253|NCT00986258|525713956|FG000|Titration and Optimal Dose Period|Other|1|||
145537530|NCT01032174|524827507|FG000|Overall Study|Adverse Event|0|||
145537531|NCT01032174|524827508|FG001|Overall Study|Adverse Event|1|||
145537532|NCT02713204|524827511|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
145537533|NCT02713204|524827512|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145783254|NCT00986258|525713956|FG000|Maintenance Period|Adverse Event|5|||
145783255|NCT00986258|525713956|FG000|Maintenance Period|Lack of Efficacy|2|||
145783256|NCT00986258|525713956|FG000|Maintenance Period|Withdrawal by Subject|2|||
145783257|NCT03332667|525713957|FG000|Overall Study|Adverse Event|0|||
145783258|NCT03332667|525713958|FG001|Overall Study|Adverse Event|0|||
145783259|NCT03332667|525713959|FG002|Overall Study|Adverse Event|2|||
145783260|NCT03332667|525713960|FG003|Overall Study|Adverse Event|1|||
145783261|NCT03332667|525713957|FG000|Overall Study|Withdrawal by Subject|2|||
145783262|NCT03332667|525713958|FG001|Overall Study|Withdrawal by Subject|1|||
145783263|NCT03332667|525713959|FG002|Overall Study|Withdrawal by Subject|5|||
145783264|NCT03332667|525713960|FG003|Overall Study|Withdrawal by Subject|1|||
145783265|NCT03332667|525713957|FG000|Overall Study|Disease Progression or Relapse|2|||
145783266|NCT03332667|525713958|FG001|Overall Study|Disease Progression or Relapse|1|||
145783267|NCT03332667|525713959|FG002|Overall Study|Disease Progression or Relapse|3|||
145783268|NCT03332667|525713960|FG003|Overall Study|Disease Progression or Relapse|0|||
145783269|NCT03332667|525713957|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
145783270|NCT03332667|525713958|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
145783271|NCT03332667|525713959|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
145783272|NCT03332667|525713960|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
145537534|NCT02713204|524827513|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
145537535|NCT02713204|524827514|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145537536|NCT02713204|524827515|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145537537|NCT02713204|524827516|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145537538|NCT02713204|524827517|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145537539|NCT02713204|524827518|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
145537540|NCT02713204|524827511|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145537541|NCT02713204|524827512|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145537542|NCT02713204|524827513|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
145537543|NCT02713204|524827514|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145783273|NCT03332667|525713957|FG000|Overall Study|No Treatment Received|0|||
145783274|NCT03332667|525713958|FG001|Overall Study|No Treatment Received|0|||
145537544|NCT02713204|524827515|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145537545|NCT02713204|524827516|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145609112|NCT01785628|525084799|FG001|Overall Study|Lost to Follow-up|3|||
145783275|NCT03332667|525713959|FG002|Overall Study|No Treatment Received|1|||
145783276|NCT03332667|525713960|FG003|Overall Study|No Treatment Received|0|||
145783277|NCT04964063|525713961|FG000|Overall Study|Adverse Event|4|||
145783278|NCT04964063|525713961|FG000|Overall Study|Lost to Follow-up|47|||
145783279|NCT04964063|525713961|FG000|Overall Study|Withdrawal by Subject|5|||
145783280|NCT04964063|525713961|FG000|Overall Study|Baseline Tasks Expired|41|||
145783281|NCT04964063|525713961|FG000|Overall Study|Participant withdrawn in error|1|||
145783282|NCT01035606|525713964|FG000|Overall Study|change in health, job demands,family|3|||
145783283|NCT01035606|525713965|FG001|Overall Study|change in health, job demands,family|3|||
145783284|NCT01035606|525713966|FG002|Overall Study|change in health, job demands,family|4|||
145783285|NCT01809262|525713967|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783286|NCT01809262|525713968|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783287|NCT01809262|525713969|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783288|NCT01809262|525713970|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783289|NCT01809262|525713971|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
145783290|NCT01809262|525713972|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783291|NCT01809262|525713973|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783292|NCT01809262|525713974|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783293|NCT01809262|525713975|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783294|NCT01809262|525713976|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
145783295|NCT01809262|525713967|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783296|NCT01809262|525713968|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
145783297|NCT01809262|525713969|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783298|NCT01809262|525713970|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783299|NCT01809262|525713971|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145537546|NCT02713204|524827517|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145537547|NCT02713204|524827518|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145537548|NCT02713204|524827511|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537549|NCT02713204|524827512|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
145537550|NCT02713204|524827513|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537551|NCT02713204|524827514|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537552|NCT02713204|524827515|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537553|NCT02713204|524827516|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537554|NCT02713204|524827517|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537555|NCT02713204|524827518|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145537556|NCT02713204|524827511|FG000|From Week 12 up to Week 36|Adverse Event|1|||
145783300|NCT01809262|525713972|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145537557|NCT02713204|524827512|FG001|From Week 12 up to Week 36|Adverse Event|0|||
145537558|NCT02713204|524827513|FG002|From Week 12 up to Week 36|Adverse Event|0|||
145537559|NCT02713204|524827514|FG003|From Week 12 up to Week 36|Adverse Event|1|||
145537560|NCT02713204|524827515|FG004|From Week 12 up to Week 36|Adverse Event|1|||
145537561|NCT02713204|524827516|FG005|From Week 12 up to Week 36|Adverse Event|0|||
145537562|NCT02713204|524827517|FG006|From Week 12 up to Week 36|Adverse Event|2|||
145537563|NCT02713204|524827518|FG007|From Week 12 up to Week 36|Adverse Event|1|||
145537564|NCT02713204|524827511|FG000|From Week 12 up to Week 36|Death|0|||
145537565|NCT02713204|524827512|FG001|From Week 12 up to Week 36|Death|0|||
145537566|NCT02713204|524827513|FG002|From Week 12 up to Week 36|Death|0|||
145537567|NCT02713204|524827514|FG003|From Week 12 up to Week 36|Death|1|||
145537568|NCT02713204|524827515|FG004|From Week 12 up to Week 36|Death|0|||
145537569|NCT02713204|524827516|FG005|From Week 12 up to Week 36|Death|1|||
145537570|NCT02713204|524827517|FG006|From Week 12 up to Week 36|Death|0|||
145537571|NCT02713204|524827518|FG007|From Week 12 up to Week 36|Death|3|||
145537572|NCT02713204|524827511|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
145783301|NCT01809262|525713973|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783302|NCT01809262|525713974|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783303|NCT01809262|525713975|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783304|NCT01809262|525713976|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
145783305|NCT01505491|525713977|FG000|Overall Study|Other reason not listed|1|||
145783306|NCT01505491|525713978|FG001|Overall Study|Other reason not listed|0|||
145783307|NCT01505491|525713979|FG002|Overall Study|Other reason not listed|0|||
145783308|NCT01505491|525713977|FG000|Overall Study|Withdrawal by Subject|1|||
145783309|NCT01505491|525713978|FG001|Overall Study|Withdrawal by Subject|1|||
145783310|NCT01505491|525713979|FG002|Overall Study|Withdrawal by Subject|4|||
145537573|NCT02713204|524827512|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
145783311|NCT01505491|525713977|FG000|Overall Study|Lost to Follow-up|0|||
145783312|NCT01505491|525713978|FG001|Overall Study|Lost to Follow-up|0|||
145783313|NCT01505491|525713979|FG002|Overall Study|Lost to Follow-up|1|||
145783314|NCT01740440|525713982|FG000|Overall Study|Lost to Follow-up|3|||
145783315|NCT01063751|525713984|FG000|Overall Study|Censored from analyses|42|||
145537574|NCT02713204|524827513|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
145537575|NCT02713204|524827514|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
145537576|NCT02713204|524827515|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
145537577|NCT02713204|524827516|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
145783316|NCT01063751|525713984|FG000|Overall Study|Withdrawal by Subject|34|||
145537578|NCT02713204|524827517|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
145537579|NCT02713204|524827518|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
145783317|NCT01063751|525713984|FG000|Overall Study|Lost to Follow-up|30|||
145783318|NCT01063751|525713984|FG000|Overall Study|Death|13|||
145783319|NCT01063751|525713984|FG000|Overall Study|Sponsored Terminated Study|60|||
145783320|NCT01063751|525713984|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
145783321|NCT01063751|525713984|FG000|Overall Study|Investigator site closed|10|||
145783322|NCT01063751|525713984|FG000|Overall Study|Revision|6|||
145783323|NCT01063751|525713984|FG000|Overall Study|Physician Decision|4|||
145783324|NCT03408873|525713990|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
145783325|NCT03408873|525713990|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
145783326|NCT03408873|525713990|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
145783327|NCT03408873|525713990|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
145783328|NCT03408873|525713990|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
145783329|NCT03408873|525713990|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
145783330|NCT00406315|525713996|FG000|Overall Study|Death|1|||
145783331|NCT00406315|525713996|FG000|Overall Study|Adverse Event|39|||
145783332|NCT00406315|525713996|FG000|Overall Study|Laboratory Abnormality|4|||
145783333|NCT00406315|525713996|FG000|Overall Study|Lack of Efficacy|13|||
145783334|NCT00406315|525713996|FG000|Overall Study|Other|33|||
145783335|NCT00406315|525713996|FG000|Overall Study|Lost to Follow-up|21|||
145783336|NCT00406315|525713996|FG000|Overall Study|Withdrawal by Subject|30|||
145783337|NCT01797783|525713998|FG000|Overall Study|Adverse Event|1|||
145783338|NCT01797783|525713999|FG001|Overall Study|Adverse Event|1|||
145783339|NCT01797783|525713998|FG000|Overall Study|Withdrawal by Subject|1|||
145783340|NCT01797783|525713999|FG001|Overall Study|Withdrawal by Subject|0|||
145783341|NCT00793819|525714002|FG000|Overall Study|Adverse Event|8|||
145783342|NCT00793819|525714003|FG001|Overall Study|Adverse Event|4|||
145783343|NCT00793819|525714002|FG000|Overall Study|Lack of Efficacy|1|||
145783344|NCT00793819|525714003|FG001|Overall Study|Lack of Efficacy|1|||
145783345|NCT00793819|525714002|FG000|Overall Study|Withdrawal by Subject|4|||
145783346|NCT00793819|525714003|FG001|Overall Study|Withdrawal by Subject|3|||
145783347|NCT00793819|525714002|FG000|Overall Study|Lost to Follow-up|1|||
145783348|NCT00793819|525714003|FG001|Overall Study|Lost to Follow-up|1|||
145537580|NCT02713204|524827511|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
145783349|NCT01276847|525714009|FG000|Overall Study|Withdrawal by Subject|1|||
145783350|NCT01276847|525714010|FG001|Overall Study|Withdrawal by Subject|0|||
145783351|NCT01276847|525714011|FG002|Overall Study|Withdrawal by Subject|0|||
145783352|NCT02021812|525714012|FG000|Overall Study|Death|8|||
145783353|NCT02021812|525714012|FG000|Overall Study|Withdrawal by Subject|3|||
145783354|NCT02021812|525714012|FG000|Overall Study|Lost to Follow-up|2|||
145783355|NCT02021812|525714012|FG000|Overall Study|Refuse to return, COVD 19|2|||
145783356|NCT00564629|525714013|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
145783357|NCT00564629|525714014|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
145783358|NCT01597193|525714017|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
145783359|NCT01597193|525714018|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
145783360|NCT01597193|525714019|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
145783361|NCT01597193|525714020|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
145783362|NCT01597193|525714021|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
145783363|NCT01597193|525714022|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
145783364|NCT01597193|525714023|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
145783365|NCT01597193|525714017|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
145783366|NCT01597193|525714018|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
145783367|NCT01597193|525714019|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
145783368|NCT01597193|525714020|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
145783369|NCT01597193|525714021|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
145783370|NCT01597193|525714022|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
145783371|NCT01597193|525714023|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
145783372|NCT01597193|525714017|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
145783373|NCT01597193|525714018|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
145783374|NCT01597193|525714019|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
145783375|NCT01597193|525714020|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
145783376|NCT01597193|525714021|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
145783377|NCT01597193|525714022|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
145783378|NCT01597193|525714023|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
145783379|NCT01597193|525714017|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783380|NCT01597193|525714018|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783381|NCT01597193|525714019|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783382|NCT01597193|525714020|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783383|NCT01597193|525714021|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783384|NCT01597193|525714022|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
145783385|NCT01597193|525714023|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
145783386|NCT01597193|525714017|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
145783387|NCT01597193|525714018|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
145783388|NCT01597193|525714019|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
145783389|NCT01597193|525714020|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
145783390|NCT01597193|525714021|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
145783391|NCT01597193|525714022|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
145783392|NCT01597193|525714023|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
145783393|NCT00064662|525714024|FG000|Overall Study|Death|1|||
145783394|NCT00064662|525714025|FG001|Overall Study|Death|1|||
145783395|NCT00064662|525714024|FG000|Overall Study|Lost to Follow-up|57|||
145783396|NCT00064662|525714025|FG001|Overall Study|Lost to Follow-up|44|||
145783397|NCT00064662|525714024|FG000|Overall Study|Withdrawal by Subject|14|||
145783398|NCT00064662|525714025|FG001|Overall Study|Withdrawal by Subject|14|||
145783399|NCT00064662|525714024|FG000|Overall Study|Administratively withdrawn|2|||
145783400|NCT00064662|525714025|FG001|Overall Study|Administratively withdrawn|2|||
145783401|NCT00365976|525714028|FG000|Overall Study|Withdrawal by Subject|1|||
145783402|NCT00365976|525714029|FG001|Overall Study|Withdrawal by Subject|5|||
145783403|NCT01000064|525714030|FG000|Overall Study|Withdrawal by Subject|1|||
145783404|NCT01000064|525714031|FG001|Overall Study|Withdrawal by Subject|1|||
145783405|NCT02518620|525714032|FG000|Overall Study|Adverse Event|23|||
145783406|NCT02518620|525714033|FG001|Overall Study|Adverse Event|11|||
145783407|NCT02518620|525714032|FG000|Overall Study|Lack of Efficacy|2|||
145783408|NCT02518620|525714033|FG001|Overall Study|Lack of Efficacy|0|||
145783409|NCT02518620|525714032|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145783410|NCT02518620|525714033|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145783411|NCT02518620|525714032|FG000|Overall Study|Physician Decision|1|||
145783412|NCT02518620|525714033|FG001|Overall Study|Physician Decision|1|||
145783413|NCT02518620|525714032|FG000|Overall Study|Sponsor's Decision|0|||
145783414|NCT02518620|525714033|FG001|Overall Study|Sponsor's Decision|3|||
145783415|NCT02518620|525714032|FG000|Overall Study|Lost to Follow-up|1|||
145783416|NCT02518620|525714033|FG001|Overall Study|Lost to Follow-up|1|||
145783417|NCT02518620|525714032|FG000|Overall Study|Withdrawal by Subject|17|||
145783418|NCT02518620|525714033|FG001|Overall Study|Withdrawal by Subject|9|||
145783419|NCT02518620|525714032|FG000|Overall Study|Death|1|||
145783420|NCT02518620|525714033|FG001|Overall Study|Death|0|||
145783421|NCT02518620|525714032|FG000|Overall Study|Pregnancy Wish|3|||
145783422|NCT02518620|525714033|FG001|Overall Study|Pregnancy Wish|0|||
145783423|NCT02518620|525714032|FG000|Overall Study|Pregnancy|1|||
145783424|NCT02518620|525714033|FG001|Overall Study|Pregnancy|0|||
145783425|NCT02518620|525714032|FG000|Overall Study|Relocation|2|||
145783426|NCT02518620|525714033|FG001|Overall Study|Relocation|1|||
145783427|NCT02078713|525716078|FG000|Overall Study|Lost to Follow-up|49|||
145783428|NCT02078713|525716079|FG001|Overall Study|Lost to Follow-up|55|||
145783429|NCT02078713|525716080|FG002|Overall Study|Lost to Follow-up|0|||
145783430|NCT02078713|525716081|FG003|Overall Study|Lost to Follow-up|0|||
145783431|NCT02078713|525716078|FG000|Overall Study|Pregnant at baseline|3|||
145783432|NCT02078713|525716079|FG001|Overall Study|Pregnant at baseline|5|||
145783433|NCT02078713|525716080|FG002|Overall Study|Pregnant at baseline|0|||
145783434|NCT02078713|525716081|FG003|Overall Study|Pregnant at baseline|0|||
145783435|NCT02078713|525716078|FG000|Overall Study|Enrolled twice|0|||
145783436|NCT02078713|525716079|FG001|Overall Study|Enrolled twice|1|||
145783437|NCT02078713|525716080|FG002|Overall Study|Enrolled twice|0|||
145783438|NCT02078713|525716081|FG003|Overall Study|Enrolled twice|0|||
145783439|NCT00696657|525716082|FG000|Overall Study|Protocol Violation|0|||
145783440|NCT00696657|525716083|FG001|Overall Study|Protocol Violation|0|||
145783441|NCT00696657|525716084|FG002|Overall Study|Protocol Violation|0|||
145783442|NCT00696657|525716085|FG003|Overall Study|Protocol Violation|0|||
145783443|NCT00696657|525716086|FG004|Overall Study|Protocol Violation|0|||
145783444|NCT00696657|525716087|FG005|Overall Study|Protocol Violation|1|||
145783445|NCT00696657|525716088|FG006|Overall Study|Protocol Violation|0|||
145537581|NCT02713204|524827512|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
145783446|NCT00696657|525716089|FG007|Overall Study|Protocol Violation|0|||
145783447|NCT00696657|525716090|FG008|Overall Study|Protocol Violation|1|||
145783448|NCT00696657|525716082|FG000|Overall Study|Lack of Efficacy|0|||
145783449|NCT00696657|525716083|FG001|Overall Study|Lack of Efficacy|1|||
145783450|NCT00696657|525716084|FG002|Overall Study|Lack of Efficacy|0|||
145783451|NCT00696657|525716085|FG003|Overall Study|Lack of Efficacy|0|||
145783452|NCT00696657|525716086|FG004|Overall Study|Lack of Efficacy|0|||
145783453|NCT00696657|525716087|FG005|Overall Study|Lack of Efficacy|0|||
145783454|NCT00696657|525716088|FG006|Overall Study|Lack of Efficacy|0|||
145783455|NCT00696657|525716089|FG007|Overall Study|Lack of Efficacy|0|||
145783456|NCT00696657|525716090|FG008|Overall Study|Lack of Efficacy|0|||
145783457|NCT00696657|525716082|FG000|Overall Study|Withdrawal criteria|1|||
145783458|NCT00696657|525716083|FG001|Overall Study|Withdrawal criteria|3|||
145783459|NCT00696657|525716084|FG002|Overall Study|Withdrawal criteria|2|||
145783460|NCT00696657|525716085|FG003|Overall Study|Withdrawal criteria|2|||
145783461|NCT00696657|525716086|FG004|Overall Study|Withdrawal criteria|0|||
145783462|NCT00696657|525716087|FG005|Overall Study|Withdrawal criteria|0|||
145783463|NCT00696657|525716088|FG006|Overall Study|Withdrawal criteria|1|||
145783464|NCT00696657|525716089|FG007|Overall Study|Withdrawal criteria|1|||
145783465|NCT00696657|525716090|FG008|Overall Study|Withdrawal criteria|2|||
145783466|NCT00696657|525716082|FG000|Overall Study|Unclassified|0|||
145783467|NCT00696657|525716083|FG001|Overall Study|Unclassified|1|||
145783468|NCT00696657|525716084|FG002|Overall Study|Unclassified|3|||
145783469|NCT00696657|525716085|FG003|Overall Study|Unclassified|2|||
145783470|NCT00696657|525716086|FG004|Overall Study|Unclassified|4|||
145783471|NCT00696657|525716087|FG005|Overall Study|Unclassified|2|||
145783472|NCT00696657|525716088|FG006|Overall Study|Unclassified|0|||
145783473|NCT00696657|525716089|FG007|Overall Study|Unclassified|0|||
145783474|NCT00696657|525716090|FG008|Overall Study|Unclassified|1|||
145783475|NCT00696657|525716082|FG000|Overall Study|Adverse Event|0|||
145783476|NCT00696657|525716083|FG001|Overall Study|Adverse Event|0|||
145783477|NCT00696657|525716084|FG002|Overall Study|Adverse Event|3|||
145783478|NCT00696657|525716085|FG003|Overall Study|Adverse Event|7|||
145783479|NCT00696657|525716086|FG004|Overall Study|Adverse Event|6|||
145783480|NCT00696657|525716087|FG005|Overall Study|Adverse Event|9|||
145783481|NCT00696657|525716088|FG006|Overall Study|Adverse Event|14|||
145783482|NCT00696657|525716089|FG007|Overall Study|Adverse Event|2|||
145783483|NCT00696657|525716090|FG008|Overall Study|Adverse Event|5|||
145783484|NCT03123354|525716091|FG000|Overall Study|Physician Decision|6|||
145783485|NCT05070429|525716092|FG000|Overall Study|Death|0|||
145783486|NCT05070429|525716093|FG001|Overall Study|Death|4|||
145783487|NCT05070429|525716092|FG000|Overall Study|Withdrawal by Subject|2|||
145537582|NCT02713204|524827513|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
145537583|NCT02713204|524827514|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
145537584|NCT02713204|524827515|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
145783488|NCT05070429|525716093|FG001|Overall Study|Withdrawal by Subject|1|||
145783489|NCT05070429|525716092|FG000|Overall Study|Other|15|||
145783490|NCT05070429|525716093|FG001|Overall Study|Other|5|||
145783491|NCT02436577|525716094|FG000|Overall Study|Protocol Deviation|0|||
145279226|NCT00830063|523872880|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
145783492|NCT02436577|525716095|FG001|Overall Study|Protocol Deviation|1|||
145783493|NCT02436577|525716096|FG002|Overall Study|Protocol Deviation|0|||
145783494|NCT02436577|525716097|FG003|Overall Study|Protocol Deviation|0|||
145279227|NCT00830063|523872877|FG000|Overall Study|Lack of Efficacy|51|||
145783495|NCT02436577|525716098|FG004|Overall Study|Protocol Deviation|0|||
145537585|NCT02713204|524827516|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
145783496|NCT02436577|525716099|FG005|Overall Study|Protocol Deviation|0|||
145783497|NCT03650452|525716100|FG000|Overall Study|Physician Decision|1|||
145783498|NCT03650452|525716101|FG001|Overall Study|Physician Decision|0|||
145783499|NCT03650452|525716100|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
145783500|NCT03650452|525716101|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145783501|NCT03650452|525716100|FG000|Overall Study|Adverse Event|3|||
145783502|NCT03650452|525716101|FG001|Overall Study|Adverse Event|4|||
145783503|NCT03650452|525716100|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
145783504|NCT03650452|525716101|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
145783505|NCT02531373|525716104|FG000|Overall Study|Lack of Efficacy|0|||
145783506|NCT02531373|525716105|FG001|Overall Study|Lack of Efficacy|0|||
145783507|NCT02531373|525716106|FG002|Overall Study|Lack of Efficacy|0|||
145783508|NCT02531373|525716107|FG003|Overall Study|Lack of Efficacy|0|||
145783509|NCT02531373|525716108|FG004|Overall Study|Lack of Efficacy|3|||
145783510|NCT02531373|525716109|FG005|Overall Study|Lack of Efficacy|2|||
145783511|NCT02531373|525716110|FG006|Overall Study|Lack of Efficacy|4|||
145783512|NCT02531373|525716111|FG007|Overall Study|Lack of Efficacy|8|||
145783513|NCT02531373|525716112|FG008|Overall Study|Lack of Efficacy|5|||
145783514|NCT02531373|525716104|FG000|Overall Study|Lost to Follow-up|0|||
145783515|NCT02531373|525716105|FG001|Overall Study|Lost to Follow-up|0|||
145783516|NCT02531373|525716106|FG002|Overall Study|Lost to Follow-up|0|||
145783517|NCT02531373|525716107|FG003|Overall Study|Lost to Follow-up|0|||
145783518|NCT02531373|525716108|FG004|Overall Study|Lost to Follow-up|0|||
145783519|NCT02531373|525716109|FG005|Overall Study|Lost to Follow-up|2|||
145783520|NCT02531373|525716110|FG006|Overall Study|Lost to Follow-up|2|||
145783521|NCT02531373|525716111|FG007|Overall Study|Lost to Follow-up|0|||
145783522|NCT02531373|525716112|FG008|Overall Study|Lost to Follow-up|0|||
145783523|NCT02531373|525716104|FG000|Overall Study|Physician Decision|0|||
145783524|NCT02531373|525716105|FG001|Overall Study|Physician Decision|0|||
145783525|NCT02531373|525716106|FG002|Overall Study|Physician Decision|0|||
145783526|NCT02531373|525716107|FG003|Overall Study|Physician Decision|0|||
145783527|NCT02531373|525716108|FG004|Overall Study|Physician Decision|2|||
145783528|NCT02531373|525716109|FG005|Overall Study|Physician Decision|1|||
145783529|NCT02531373|525716110|FG006|Overall Study|Physician Decision|0|||
145783530|NCT02531373|525716111|FG007|Overall Study|Physician Decision|0|||
145783531|NCT02531373|525716112|FG008|Overall Study|Physician Decision|0|||
145783532|NCT02531373|525716104|FG000|Overall Study|Protocol Violation|0|||
145783533|NCT02531373|525716105|FG001|Overall Study|Protocol Violation|0|||
145783534|NCT02531373|525716106|FG002|Overall Study|Protocol Violation|0|||
145783535|NCT02531373|525716107|FG003|Overall Study|Protocol Violation|0|||
145783536|NCT02531373|525716108|FG004|Overall Study|Protocol Violation|0|||
145783537|NCT02531373|525716109|FG005|Overall Study|Protocol Violation|1|||
145783538|NCT02531373|525716110|FG006|Overall Study|Protocol Violation|1|||
145783539|NCT02531373|525716111|FG007|Overall Study|Protocol Violation|0|||
145783540|NCT02531373|525716112|FG008|Overall Study|Protocol Violation|1|||
145783541|NCT02531373|525716104|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145783542|NCT02531373|525716105|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145783543|NCT02531373|525716106|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145783544|NCT02531373|525716107|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145783545|NCT02531373|525716108|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145783546|NCT02531373|525716109|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
145783547|NCT02531373|525716110|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
145783548|NCT02531373|525716111|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
145783549|NCT02531373|525716112|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
145783550|NCT02531373|525716104|FG000|Overall Study|Withdrawal by Subject|0|||
145783551|NCT02531373|525716105|FG001|Overall Study|Withdrawal by Subject|0|||
145783552|NCT02531373|525716106|FG002|Overall Study|Withdrawal by Subject|0|||
145783553|NCT02531373|525716107|FG003|Overall Study|Withdrawal by Subject|0|||
145783554|NCT02531373|525716108|FG004|Overall Study|Withdrawal by Subject|3|||
145783555|NCT02531373|525716109|FG005|Overall Study|Withdrawal by Subject|0|||
145783556|NCT02531373|525716110|FG006|Overall Study|Withdrawal by Subject|0|||
145783557|NCT02531373|525716111|FG007|Overall Study|Withdrawal by Subject|0|||
145783558|NCT02531373|525716112|FG008|Overall Study|Withdrawal by Subject|0|||
145783559|NCT00623467|525716113|FG000|Overall Study|Lost to Follow-up|1|||
145783560|NCT00623467|525716113|FG000|Overall Study|Protocol Violation|4|||
145783561|NCT00623467|525716113|FG000|Overall Study|Withdrawal by Subject|2|||
145783562|NCT02834403|525716122|FG000|Overall Study|Physician Decision|2|||
145783563|NCT02834403|525716123|FG001|Overall Study|Physician Decision|1|||
145783564|NCT02834403|525716124|FG002|Overall Study|Physician Decision|2|||
145783565|NCT02834403|525716125|FG003|Overall Study|Physician Decision|1|||
145783566|NCT02834403|525716126|FG004|Overall Study|Physician Decision|1|||
145783567|NCT02834403|525716127|FG005|Overall Study|Physician Decision|2|||
145783568|NCT02834403|525716128|FG006|Overall Study|Physician Decision|12|||
145783569|NCT02834403|525716122|FG000|Overall Study|Adverse Event|0|||
145783570|NCT02834403|525716123|FG001|Overall Study|Adverse Event|0|||
145783571|NCT02834403|525716124|FG002|Overall Study|Adverse Event|0|||
145783572|NCT02834403|525716125|FG003|Overall Study|Adverse Event|0|||
145783573|NCT02834403|525716126|FG004|Overall Study|Adverse Event|1|||
145783574|NCT02834403|525716127|FG005|Overall Study|Adverse Event|1|||
145783575|NCT02834403|525716128|FG006|Overall Study|Adverse Event|3|||
145783576|NCT02834403|525716122|FG000|Overall Study|Withdrawal by Subject|0|||
145783577|NCT02834403|525716123|FG001|Overall Study|Withdrawal by Subject|1|||
145783578|NCT02834403|525716124|FG002|Overall Study|Withdrawal by Subject|0|||
145783579|NCT02834403|525716125|FG003|Overall Study|Withdrawal by Subject|0|||
145783580|NCT02834403|525716126|FG004|Overall Study|Withdrawal by Subject|1|||
145279228|NCT00830063|523872878|FG001|Overall Study|Lack of Efficacy|23|||
145279229|NCT00830063|523872879|FG002|Overall Study|Lack of Efficacy|25|||
145279230|NCT00830063|523872880|FG003|Overall Study|Lack of Efficacy|32|||
145279231|NCT00830063|523872877|FG000|Overall Study|Other|5|||
145279232|NCT00830063|523872878|FG001|Overall Study|Other|5|||
145279233|NCT00830063|523872879|FG002|Overall Study|Other|8|||
145279234|NCT00830063|523872880|FG003|Overall Study|Other|6|||
145279235|NCT00830063|523872877|FG000|Overall Study|Withdrawal by Subject|16|||
145279236|NCT00830063|523872878|FG001|Overall Study|Withdrawal by Subject|10|||
145279237|NCT00830063|523872879|FG002|Overall Study|Withdrawal by Subject|16|||
145279238|NCT00830063|523872880|FG003|Overall Study|Withdrawal by Subject|13|||
145279239|NCT00830063|523872877|FG000|Overall Study|Protocol Violation|1|||
145279240|NCT00830063|523872878|FG001|Overall Study|Protocol Violation|0|||
145279241|NCT00830063|523872879|FG002|Overall Study|Protocol Violation|3|||
145279242|NCT00830063|523872880|FG003|Overall Study|Protocol Violation|2|||
145279243|NCT00830063|523872877|FG000|Overall Study|Randomized But Not Treated|0|||
145279244|NCT00830063|523872878|FG001|Overall Study|Randomized But Not Treated|2|||
145279245|NCT00830063|523872879|FG002|Overall Study|Randomized But Not Treated|0|||
145279246|NCT00830063|523872880|FG003|Overall Study|Randomized But Not Treated|2|||
145279247|NCT00787566|523872883|FG000|Overall Study|AE related to chemotherapy|0|||
145279248|NCT00787566|523872884|FG001|Overall Study|AE related to chemotherapy|1|||
145279249|NCT00787566|523872885|FG002|Overall Study|AE related to chemotherapy|0|||
145279250|NCT02140164|523872886|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
145279251|NCT01814761|523872891|FG000|Overall Study|Other Reasons|1|||
145279252|NCT01814761|523872892|FG001|Overall Study|Other Reasons|10|||
145279253|NCT01814761|523872891|FG000|Overall Study|Ocular Adverse Event|6|||
145279254|NCT01814761|523872892|FG001|Overall Study|Ocular Adverse Event|15|||
145783581|NCT02834403|525716127|FG005|Overall Study|Withdrawal by Subject|0|||
145783582|NCT02834403|525716128|FG006|Overall Study|Withdrawal by Subject|0|||
145783583|NCT02834403|525716122|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
145783584|NCT02834403|525716123|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
145783585|NCT02834403|525716124|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
145783586|NCT02834403|525716125|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
145783587|NCT02834403|525716126|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
145783588|NCT02834403|525716127|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
145783589|NCT02834403|525716128|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
145783590|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
145783591|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
145783592|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
145783593|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
145783594|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
145783595|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
145783596|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
145783597|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
145783598|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
145783599|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
145783600|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
145279255|NCT01814761|523872891|FG000|Overall Study|Lost to Follow-up|1|||
145279256|NCT01814761|523872892|FG001|Overall Study|Lost to Follow-up|5|||
145279257|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
145279258|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
145279259|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
145279260|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
145783601|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
145783602|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
145783603|NCT02232516|525716133|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
145783604|NCT02232516|525716133|FG000|Survival Follow-up|Death|15|||
145783605|NCT02232516|525716133|FG000|Survival Follow-up|Withdrawal by Subject|3|||
145783606|NCT02232516|525716133|FG000|Survival Follow-up|Lost to Follow-up|1|||
145783607|NCT02232516|525716133|FG000|Survival Follow-up|Still in follow-up|5|||
145783608|NCT05058664|525716134|FG000|Overall Study|No follow-up data provided|4|||
145783609|NCT05058664|525716135|FG001|Overall Study|No follow-up data provided|0|||
145783610|NCT05058664|525716136|FG002|Overall Study|No follow-up data provided|2|||
145783611|NCT05058664|525716134|FG000|Overall Study|Withdrawal by Subject|0|||
145783612|NCT05058664|525716135|FG001|Overall Study|Withdrawal by Subject|0|||
145783613|NCT05058664|525716136|FG002|Overall Study|Withdrawal by Subject|1|||
145783614|NCT02606045|525716137|FG000|Overall Study|Study closed before treament could begin|1|||
145783615|NCT02606045|525716138|FG001|Overall Study|Study closed before treament could begin|2|||
145783616|NCT01671085|525716139|FG000|Overall Study|Withdrawal by Subject|1|||
145783617|NCT01671085|525716140|FG001|Overall Study|Withdrawal by Subject|0|||
145783618|NCT00637273|525716141|FG000|Overall Study|Adverse Event|11|||
145783619|NCT00637273|525716142|FG001|Overall Study|Adverse Event|5|||
145783620|NCT00637273|525716143|FG002|Overall Study|Adverse Event|7|||
145783621|NCT00637273|525716141|FG000|Overall Study|Lost to Follow-up|8|||
145783622|NCT00637273|525716142|FG001|Overall Study|Lost to Follow-up|9|||
145783623|NCT00637273|525716143|FG002|Overall Study|Lost to Follow-up|13|||
145783624|NCT00637273|525716141|FG000|Overall Study|Protocol Violation|2|||
145783625|NCT00637273|525716142|FG001|Overall Study|Protocol Violation|4|||
145783626|NCT00637273|525716143|FG002|Overall Study|Protocol Violation|1|||
145783627|NCT00637273|525716141|FG000|Overall Study|Withdrawal of Consent|18|||
145783628|NCT00637273|525716142|FG001|Overall Study|Withdrawal of Consent|6|||
145783629|NCT00637273|525716143|FG002|Overall Study|Withdrawal of Consent|18|||
145783630|NCT00637273|525716141|FG000|Overall Study|Investigator Decision|1|||
145783631|NCT00637273|525716142|FG001|Overall Study|Investigator Decision|3|||
145783632|NCT00637273|525716143|FG002|Overall Study|Investigator Decision|1|||
145783633|NCT00637273|525716141|FG000|Overall Study|Administrative|2|||
145783634|NCT00637273|525716142|FG001|Overall Study|Administrative|0|||
145783635|NCT00637273|525716143|FG002|Overall Study|Administrative|0|||
145783636|NCT00637273|525716141|FG000|Overall Study|Loss of Glucose Control|1|||
145783637|NCT00637273|525716142|FG001|Overall Study|Loss of Glucose Control|1|||
145783638|NCT00637273|525716143|FG002|Overall Study|Loss of Glucose Control|1|||
145783639|NCT01120093|525716145|FG000|Treatment Period 1|Adverse Event|0|||
145783640|NCT01120093|525716146|FG001|Treatment Period 1|Adverse Event|0|||
145783641|NCT01120093|525716147|FG002|Treatment Period 1|Adverse Event|1|||
145783642|NCT01120093|525716148|FG003|Treatment Period 1|Adverse Event|0|||
145783643|NCT01120093|525716149|FG004|Treatment Period 1|Adverse Event|1|||
145783644|NCT01120093|525716145|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145783645|NCT01120093|525716146|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145537586|NCT02713204|524827517|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
145537587|NCT02713204|524827518|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
145537588|NCT00467857|524827521|FG000|Overall Study|Adverse Event|1|||
145783646|NCT01120093|525716147|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145783647|NCT01120093|525716148|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145783648|NCT01120093|525716149|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145783649|NCT01120093|525716145|FG000|Treatment Period 2|Adverse Event|0|||
145783650|NCT01120093|525716146|FG001|Treatment Period 2|Adverse Event|0|||
145783651|NCT01120093|525716147|FG002|Treatment Period 2|Adverse Event|0|||
145403749|NCT01773928|524334410|FG000|Overall Study|Adverse Event|0|||
145783652|NCT01120093|525716148|FG003|Treatment Period 2|Adverse Event|1|||
145783653|NCT01120093|525716149|FG004|Treatment Period 2|Adverse Event|0|||
145783654|NCT01120093|525716145|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145783655|NCT01120093|525716146|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145783656|NCT01120093|525716147|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145783657|NCT01120093|525716148|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145783658|NCT01120093|525716149|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145783659|NCT01120093|525716145|FG000|Treatment Period 3|Lack of Efficacy|0|||
145783660|NCT01120093|525716146|FG001|Treatment Period 3|Lack of Efficacy|0|||
145783661|NCT01120093|525716147|FG002|Treatment Period 3|Lack of Efficacy|0|||
145783662|NCT01120093|525716148|FG003|Treatment Period 3|Lack of Efficacy|1|||
145783663|NCT01120093|525716149|FG004|Treatment Period 3|Lack of Efficacy|0|||
145783664|NCT01120093|525716145|FG000|Treatment Period 3|Adverse Event|0|||
145783665|NCT01120093|525716146|FG001|Treatment Period 3|Adverse Event|0|||
145783666|NCT01120093|525716147|FG002|Treatment Period 3|Adverse Event|0|||
145783667|NCT01120093|525716148|FG003|Treatment Period 3|Adverse Event|0|||
145783668|NCT01120093|525716149|FG004|Treatment Period 3|Adverse Event|1|||
145783669|NCT01120093|525716145|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145783670|NCT01120093|525716146|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145783671|NCT01120093|525716147|FG002|Treatment Period 3|Withdrawal by Subject|1|||
145783672|NCT01120093|525716148|FG003|Treatment Period 3|Withdrawal by Subject|0|||
145783673|NCT01120093|525716149|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145783674|NCT01120093|525716145|FG000|Treatment Period 4|Adverse Event|1|||
145783675|NCT01120093|525716146|FG001|Treatment Period 4|Adverse Event|0|||
145783676|NCT01120093|525716147|FG002|Treatment Period 4|Adverse Event|0|||
145783677|NCT01120093|525716148|FG003|Treatment Period 4|Adverse Event|0|||
145783678|NCT01120093|525716149|FG004|Treatment Period 4|Adverse Event|0|||
145783679|NCT01120093|525716145|FG000|Treatment Period 5|Adverse Event|0|||
145783680|NCT01120093|525716146|FG001|Treatment Period 5|Adverse Event|1|||
145783681|NCT01120093|525716147|FG002|Treatment Period 5|Adverse Event|0|||
145783682|NCT01120093|525716148|FG003|Treatment Period 5|Adverse Event|1|||
145783683|NCT01120093|525716149|FG004|Treatment Period 5|Adverse Event|0|||
145783684|NCT03649321|525716150|FG000|Overall Study|Withdrawal by Subject|1|||
145783685|NCT03649321|525716151|FG001|Overall Study|Withdrawal by Subject|0|||
145783686|NCT03649321|525716150|FG000|Overall Study|Death|1|||
145783687|NCT03649321|525716151|FG001|Overall Study|Death|0|||
145783688|NCT00431847|525716157|FG000|Overall Study|completion of less than two study visits|6|||
145783689|NCT00431847|525716158|FG001|Overall Study|completion of less than two study visits|3|||
145783690|NCT00431847|525716159|FG002|Overall Study|completion of less than two study visits|4|||
145783691|NCT00431847|525716160|FG003|Overall Study|completion of less than two study visits|14|||
145783692|NCT00431847|525716161|FG004|Overall Study|completion of less than two study visits|0|||
145783693|NCT00431847|525716157|FG000|Overall Study|Protocol Violation|0|||
145783694|NCT00431847|525716158|FG001|Overall Study|Protocol Violation|0|||
145783695|NCT00431847|525716159|FG002|Overall Study|Protocol Violation|0|||
145783696|NCT00431847|525716160|FG003|Overall Study|Protocol Violation|0|||
145783697|NCT00431847|525716161|FG004|Overall Study|Protocol Violation|1|||
145783698|NCT02142894|525716162|FG000|Overall Study|Protocol Violation|8|||
145783699|NCT02853331|525716164|FG000|Overall Study|Death|59|||
145783700|NCT02853331|525716165|FG001|Overall Study|Death|95|||
145783701|NCT02853331|525716164|FG000|Overall Study|Withdrawal by Subject|5|||
145783702|NCT02853331|525716165|FG001|Overall Study|Withdrawal by Subject|9|||
145783703|NCT02853331|525716164|FG000|Overall Study|Ongoing in study|368|||
145783704|NCT02853331|525716165|FG001|Overall Study|Ongoing in study|325|||
145783705|NCT01455428|525716166|FG000|Overall Study|Protocol Violation|2|||
145783706|NCT01455428|525716167|FG001|Overall Study|Protocol Violation|1|||
145783707|NCT01455428|525716166|FG000|Overall Study|Adverse Event|6|||
145783708|NCT01455428|525716167|FG001|Overall Study|Adverse Event|2|||
145783709|NCT01455428|525716166|FG000|Overall Study|Lost to Follow-up|1|||
145783710|NCT01455428|525716167|FG001|Overall Study|Lost to Follow-up|1|||
145783711|NCT01455428|525716166|FG000|Overall Study|Withdrawal by Subject|2|||
145783712|NCT01455428|525716167|FG001|Overall Study|Withdrawal by Subject|5|||
145783713|NCT01455428|525716166|FG000|Overall Study|Did not meet entrance criteria|0|||
145783714|NCT01455428|525716167|FG001|Overall Study|Did not meet entrance criteria|2|||
145783715|NCT01455428|525716166|FG000|Overall Study|Insufficient clinical response|0|||
145783716|NCT01455428|525716167|FG001|Overall Study|Insufficient clinical response|2|||
145783717|NCT01455428|525716166|FG000|Overall Study|Did not receive treatment|1|||
145783718|NCT01455428|525716167|FG001|Overall Study|Did not receive treatment|1|||
145783719|NCT01455428|525716166|FG000|Overall Study|Other|2|||
145783720|NCT01455428|525716167|FG001|Overall Study|Other|4|||
145783721|NCT02062151|525716170|FG000|Overall Study|screen failure|1|||
145783722|NCT00257192|525716171|FG000|Overall Study|Adverse Event|21|||
145783723|NCT00257192|525716172|FG001|Overall Study|Adverse Event|10|||
145783724|NCT00257192|525716171|FG000|Overall Study|Laboratory abnormality|1|||
145783725|NCT00257192|525716172|FG001|Overall Study|Laboratory abnormality|1|||
145783726|NCT00257192|525716171|FG000|Overall Study|Lost to Follow-up|3|||
145783727|NCT00257192|525716172|FG001|Overall Study|Lost to Follow-up|3|||
145783728|NCT00257192|525716171|FG000|Overall Study|Insufficient clinical response|18|||
145783729|NCT00257192|525716172|FG001|Overall Study|Insufficient clinical response|18|||
145537589|NCT00467857|524827522|FG001|Overall Study|Adverse Event|0|||
145537590|NCT00467857|524827521|FG000|Overall Study|Withdrew consent|2|||
145537591|NCT00467857|524827522|FG001|Overall Study|Withdrew consent|0|||
145537592|NCT00467857|524827521|FG000|Overall Study|Death|0|||
145537593|NCT00467857|524827522|FG001|Overall Study|Death|1|||
145537594|NCT00467857|524827521|FG000|Overall Study|Discharged from court service|0|||
145537595|NCT00467857|524827522|FG001|Overall Study|Discharged from court service|1|||
145537596|NCT00467857|524827521|FG000|Overall Study|Emergency care required|0|||
145537597|NCT00467857|524827522|FG001|Overall Study|Emergency care required|1|||
145537598|NCT00467857|524827521|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
145537599|NCT00467857|524827522|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
145537600|NCT00467857|524827521|FG000|Overall Study|Discontinuation reason missing|0|||
145537601|NCT00467857|524827522|FG001|Overall Study|Discontinuation reason missing|3|||
145537602|NCT00660673|524827523|FG000|Overall Study|Adverse Event|84|||
145537603|NCT00660673|524827523|FG000|Overall Study|Lack of Efficacy|7|||
145537604|NCT00660673|524827523|FG000|Overall Study|Withdrawal by Subject|22|||
145537605|NCT00660673|524827523|FG000|Overall Study|Administrative|2|||
145537606|NCT00660673|524827523|FG000|Overall Study|Protocol Violation|2|||
145537607|NCT01484275|524827527|FG000|Overall Study|Study terminated by sponsor|28|||
145537608|NCT01484275|524827528|FG001|Overall Study|Study terminated by sponsor|32|||
145537609|NCT01484275|524827527|FG000|Overall Study|Other|10|||
145537610|NCT01484275|524827528|FG001|Overall Study|Other|0|||
145537611|NCT01484275|524827527|FG000|Overall Study|Death|3|||
145537612|NCT01484275|524827528|FG001|Overall Study|Death|4|||
145537613|NCT01484275|524827527|FG000|Overall Study|Withdrawal by Subject|1|||
145537614|NCT01484275|524827528|FG001|Overall Study|Withdrawal by Subject|5|||
145537615|NCT01484275|524827527|FG000|Overall Study|Lost to Follow-up|1|||
145537616|NCT01484275|524827528|FG001|Overall Study|Lost to Follow-up|1|||
145537617|NCT00657358|524827531|FG000|Overall Study|Lack of Efficacy|6|||
145537618|NCT01893203|524827536|FG000|Overall Study|Withdrawal by Subject|1|||
145537619|NCT01758523|524827537|FG000|Overall Study|Adverse Event|2|||
145537620|NCT01758523|524827538|FG001|Overall Study|Adverse Event|1|||
145537621|NCT01758523|524827537|FG000|Overall Study|Lack of Efficacy|4|||
145537622|NCT01758523|524827538|FG001|Overall Study|Lack of Efficacy|2|||
145537623|NCT01758523|524827537|FG000|Overall Study|Lost to Follow-up|3|||
145537624|NCT01758523|524827538|FG001|Overall Study|Lost to Follow-up|4|||
145537625|NCT01758523|524827537|FG000|Overall Study|Withdrawal by Subject|12|||
145537626|NCT01758523|524827538|FG001|Overall Study|Withdrawal by Subject|7|||
145537627|NCT00722800|524827539|FG000|Overall Study|Withdrawal by Subject|1|||
145537628|NCT00722800|524827540|FG001|Overall Study|Withdrawal by Subject|0|||
145537629|NCT00722800|524827539|FG000|Overall Study|Physician Decision|1|||
145537630|NCT00722800|524827540|FG001|Overall Study|Physician Decision|0|||
145537631|NCT02925117|524827544|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
145537632|NCT02925117|524827545|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
145537633|NCT02925117|524827546|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
145537634|NCT02925117|524827547|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
145537635|NCT02925117|524827548|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145783730|NCT00257192|525716171|FG000|Overall Study|Withdrawal by Subject|14|||
145783731|NCT00257192|525716172|FG001|Overall Study|Withdrawal by Subject|2|||
145783732|NCT00257192|525716171|FG000|Overall Study|Randomized but not treated|0|||
145783733|NCT00257192|525716172|FG001|Overall Study|Randomized but not treated|1|||
145783734|NCT00257192|525716171|FG000|Overall Study|Study terminated by sponsor|1|||
145783735|NCT00257192|525716172|FG001|Overall Study|Study terminated by sponsor|0|||
145783736|NCT00257192|525716171|FG000|Overall Study|Miscellaneous|0|||
145279261|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
145537636|NCT02925117|524827549|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537637|NCT02925117|524827550|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537638|NCT02925117|524827551|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537639|NCT02925117|524827552|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537640|NCT02925117|524827553|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537641|NCT02925117|524827554|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145609113|NCT02200939|525084800|FG000|Overall Study|Participant withdrew consent|0|||
145279262|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
145279263|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
145537642|NCT02925117|524827555|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
145537643|NCT02925117|524827544|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
145783737|NCT00257192|525716172|FG001|Overall Study|Miscellaneous|4|||
145403750|NCT01773928|524334411|FG001|Overall Study|Adverse Event|0|||
145537644|NCT02925117|524827545|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
145537645|NCT02925117|524827546|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
145537646|NCT02925117|524827547|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537647|NCT02925117|524827548|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537648|NCT02925117|524827549|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537649|NCT02925117|524827550|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537650|NCT02925117|524827551|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537651|NCT02925117|524827552|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537652|NCT02925117|524827553|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145279264|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
145279265|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
145279266|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
145279267|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
145279268|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
145279269|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
145279270|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
145279271|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
145279272|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
145279273|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
145279274|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
145279275|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
145279276|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
145279277|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
145279278|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
145279279|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
145279280|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
145279281|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
145279282|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
145279283|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
145279284|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
145279285|NCT01872689|523872907|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
145279286|NCT01872689|523872908|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
145279287|NCT01872689|523872909|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
145279288|NCT01872689|523872910|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
145279289|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
145279290|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
145279291|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
145279292|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
145279293|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
145279294|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
145279295|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
145279296|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
145279297|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
145279298|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
145279299|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
145279300|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
145279301|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
145279302|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
145279303|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
145279304|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
145279305|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
145279306|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
145279307|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
145537653|NCT02925117|524827554|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537654|NCT02925117|524827555|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
145537655|NCT02925117|524827544|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
145537656|NCT02925117|524827545|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
145537657|NCT02925117|524827546|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145537658|NCT02925117|524827547|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145537659|NCT02925117|524827548|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145783738|NCT00570739|525716173|FG000|Overall Study|Adverse Event|8|||
145783739|NCT00570739|525716174|FG001|Overall Study|Adverse Event|6|||
145783740|NCT00570739|525716175|FG002|Overall Study|Adverse Event|2|||
145783741|NCT00570739|525716176|FG003|Overall Study|Adverse Event|2|||
145783742|NCT00570739|525716173|FG000|Overall Study|Lost to Follow-up|4|||
145783743|NCT00570739|525716174|FG001|Overall Study|Lost to Follow-up|5|||
145783744|NCT00570739|525716175|FG002|Overall Study|Lost to Follow-up|4|||
145783745|NCT00570739|525716176|FG003|Overall Study|Lost to Follow-up|1|||
145783746|NCT00570739|525716173|FG000|Overall Study|Physician Decision|1|||
145783747|NCT00570739|525716174|FG001|Overall Study|Physician Decision|1|||
145537660|NCT02925117|524827549|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145537661|NCT02925117|524827550|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145537662|NCT02925117|524827551|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145783748|NCT00570739|525716175|FG002|Overall Study|Physician Decision|0|||
145783749|NCT00570739|525716176|FG003|Overall Study|Physician Decision|0|||
145783750|NCT00570739|525716173|FG000|Overall Study|Withdrawal by Subject|7|||
145783751|NCT00570739|525716174|FG001|Overall Study|Withdrawal by Subject|7|||
145537663|NCT02925117|524827552|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145537664|NCT02925117|524827553|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145783752|NCT00570739|525716175|FG002|Overall Study|Withdrawal by Subject|3|||
145783753|NCT00570739|525716176|FG003|Overall Study|Withdrawal by Subject|5|||
145783754|NCT00570739|525716173|FG000|Overall Study|Required restricted medication|0|||
145783755|NCT00570739|525716174|FG001|Overall Study|Required restricted medication|0|||
145783756|NCT00570739|525716175|FG002|Overall Study|Required restricted medication|1|||
145783757|NCT00570739|525716176|FG003|Overall Study|Required restricted medication|0|||
145783758|NCT00570739|525716173|FG000|Overall Study|Met discontinuation criteria|1|||
145783759|NCT00570739|525716174|FG001|Overall Study|Met discontinuation criteria|0|||
145783760|NCT00570739|525716175|FG002|Overall Study|Met discontinuation criteria|1|||
145783761|NCT00570739|525716176|FG003|Overall Study|Met discontinuation criteria|1|||
145783762|NCT00570739|525716173|FG000|Overall Study|Other|0|||
145783763|NCT00570739|525716174|FG001|Overall Study|Other|2|||
145783764|NCT00570739|525716175|FG002|Overall Study|Other|5|||
145783765|NCT00570739|525716176|FG003|Overall Study|Other|3|||
145783766|NCT00751101|525716178|FG000|Overall Study|Withdrawal by Subject|1|||
145783767|NCT00751101|525716179|FG001|Overall Study|Withdrawal by Subject|0|||
145783768|NCT00751101|525716178|FG000|Overall Study|No HFS / Never Started Patch/|0|||
145783769|NCT00751101|525716179|FG001|Overall Study|No HFS / Never Started Patch/|4|||
145783770|NCT00751101|525716178|FG000|Overall Study|Never began capecitabine|1|||
145783771|NCT00751101|525716179|FG001|Overall Study|Never began capecitabine|0|||
145783772|NCT00751101|525716178|FG000|Overall Study|Physician Decision|0|||
145783773|NCT00751101|525716179|FG001|Overall Study|Physician Decision|1|||
145783774|NCT02086565|525716180|FG000|Overall Study|Lost to Follow-up|9|||
145783775|NCT02086565|525716181|FG001|Overall Study|Lost to Follow-up|7|||
145537665|NCT02925117|524827554|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145783776|NCT02086565|525716180|FG000|Overall Study|Withdrawal by Subject|2|||
145783777|NCT02086565|525716181|FG001|Overall Study|Withdrawal by Subject|1|||
145783778|NCT02086565|525716180|FG000|Overall Study|Death|3|||
145783779|NCT02086565|525716181|FG001|Overall Study|Death|2|||
145783780|NCT02086565|525716180|FG000|Overall Study|withdrawn by research team|2|||
145783781|NCT02086565|525716181|FG001|Overall Study|withdrawn by research team|2|||
145783782|NCT00739297|525716182|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
145783783|NCT00739297|525716183|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
145783784|NCT00739297|525716184|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
145783785|NCT00739297|525716185|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
145783786|NCT00739297|525716186|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
145783787|NCT00739297|525716187|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
145783788|NCT00739297|525716188|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
145783789|NCT00739297|525716182|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
145783790|NCT00739297|525716183|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
145783791|NCT00739297|525716184|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
145783792|NCT00739297|525716185|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
145783793|NCT00739297|525716186|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
145783794|NCT00739297|525716187|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
145783795|NCT00739297|525716188|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
145783796|NCT01921270|525716191|FG000|Overall Study|Withdrawal by Subject|1|||
145783797|NCT00844428|525716192|FG000|Screening Period|Screen Failure|3|||
145783798|NCT00844428|525716192|FG000|Extension Treatment Period|Death|1|||
145783799|NCT00844428|525716192|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
145783800|NCT00789477|525716193|FG000|Overall Study|Withdrawal by Subject|2|||
145783801|NCT00789477|525716194|FG001|Overall Study|Withdrawal by Subject|1|||
145783802|NCT00789477|525716195|FG002|Overall Study|Withdrawal by Subject|3|||
145783803|NCT00789477|525716196|FG003|Overall Study|Withdrawal by Subject|2|||
145783804|NCT00789477|525716197|FG004|Overall Study|Withdrawal by Subject|3|||
145783805|NCT00789477|525716193|FG000|Overall Study|Protocol Violation|1|||
145783806|NCT00789477|525716194|FG001|Overall Study|Protocol Violation|0|||
145783807|NCT00789477|525716195|FG002|Overall Study|Protocol Violation|0|||
145783808|NCT00789477|525716196|FG003|Overall Study|Protocol Violation|1|||
145783809|NCT00789477|525716197|FG004|Overall Study|Protocol Violation|0|||
145783810|NCT00789477|525716193|FG000|Overall Study|Adverse Event|3|||
145783811|NCT00789477|525716194|FG001|Overall Study|Adverse Event|3|||
145783812|NCT00789477|525716195|FG002|Overall Study|Adverse Event|1|||
145537666|NCT02925117|524827555|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
145783813|NCT00789477|525716196|FG003|Overall Study|Adverse Event|0|||
145783814|NCT00789477|525716197|FG004|Overall Study|Adverse Event|0|||
145783815|NCT00789477|525716193|FG000|Overall Study|Death|1|||
145783816|NCT00789477|525716194|FG001|Overall Study|Death|1|||
145783817|NCT00789477|525716195|FG002|Overall Study|Death|2|||
145783818|NCT00789477|525716196|FG003|Overall Study|Death|2|||
145783819|NCT00789477|525716197|FG004|Overall Study|Death|0|||
145783820|NCT00789477|525716193|FG000|Overall Study|Lost to Follow-up|0|||
145783821|NCT00789477|525716194|FG001|Overall Study|Lost to Follow-up|1|||
145537667|NCT02925117|524827544|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
145537668|NCT02925117|524827545|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
145783822|NCT00789477|525716195|FG002|Overall Study|Lost to Follow-up|4|||
145609114|NCT02200939|525084801|FG001|Overall Study|Participant withdrew consent|1|||
145609115|NCT02200939|525084800|FG000|Overall Study|Lost to Follow-up|2|||
145609116|NCT02200939|525084801|FG001|Overall Study|Lost to Follow-up|9|||
145609117|NCT02200939|525084800|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
145609118|NCT02200939|525084801|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
145609119|NCT02746575|525084802|FG000|Overall Study|Surgery cancelled or time chaned|13|||
145609120|NCT02746575|525084802|FG000|Overall Study|Received epidural|10|||
145609121|NCT02746575|525084802|FG000|Overall Study|Withdrawal by Subject|3|||
145609122|NCT02746575|525084802|FG000|Overall Study|Bradycardia/hypotension|9|||
145609123|NCT02746575|525084802|FG000|Overall Study|Study paused|8|||
145609124|NCT02746575|525084802|FG000|Overall Study|put on beta-blocker|3|||
145609125|NCT02746575|525084802|FG000|Overall Study|type of surgery|1|||
145609126|NCT02746575|525084802|FG000|Overall Study|typ of surgery|1|||
145609127|NCT02746575|525084802|FG000|Overall Study|PI unavailable|1|||
145609128|NCT02746575|525084802|FG000|Overall Study|Unknown history of CVA|1|||
145609129|NCT04567693|525084803|FG000|Overall Study|Death|0|||
145609130|NCT04567693|525084804|FG001|Overall Study|Death|0|||
145609131|NCT04567693|525084805|FG002|Overall Study|Death|2|||
145609132|NCT04567693|525084803|FG000|Overall Study|Lost to Follow-up|1|||
145609133|NCT04567693|525084804|FG001|Overall Study|Lost to Follow-up|0|||
145609134|NCT04567693|525084805|FG002|Overall Study|Lost to Follow-up|2|||
145609135|NCT04567693|525084803|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
145609136|NCT04567693|525084804|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
145609137|NCT04567693|525084805|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
145609138|NCT00976482|525084808|FG000|Overall Study|Death|208|||
145783823|NCT00789477|525716196|FG003|Overall Study|Lost to Follow-up|2|||
145783824|NCT00789477|525716197|FG004|Overall Study|Lost to Follow-up|4|||
145783825|NCT00789477|525716193|FG000|Overall Study|Lack of Efficacy|2|||
145279308|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
145279309|NCT01872689|523872907|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
145279310|NCT01872689|523872908|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
145279311|NCT01872689|523872909|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
145279312|NCT01872689|523872910|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
145279313|NCT00660790|523872913|FG000|Baseline to 3 Months|Death|1|||
145279314|NCT00660790|523872913|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
145279315|NCT00660790|523872913|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
145279316|NCT00686374|523872921|FG000|Overall Study|Lack of Efficacy|10|||
145279317|NCT00686374|523872921|FG000|Overall Study|Adverse Event|8|||
145279318|NCT00686374|523872921|FG000|Overall Study|Withdrew consent|5|||
145279319|NCT00686374|523872921|FG000|Overall Study|Lost to Follow-up|1|||
145403751|NCT01773928|524334412|FG002|Overall Study|Adverse Event|0|||
145403752|NCT01773928|524334413|FG003|Overall Study|Adverse Event|0|||
145537669|NCT02925117|524827546|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
145537670|NCT02925117|524827547|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
145537671|NCT02925117|524827548|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
145537672|NCT02925117|524827549|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
145537673|NCT02925117|524827550|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
145537674|NCT02925117|524827551|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
145537675|NCT02925117|524827552|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
145783826|NCT00789477|525716194|FG001|Overall Study|Lack of Efficacy|0|||
145783827|NCT00789477|525716195|FG002|Overall Study|Lack of Efficacy|0|||
145783828|NCT00789477|525716196|FG003|Overall Study|Lack of Efficacy|0|||
145783829|NCT00789477|525716197|FG004|Overall Study|Lack of Efficacy|0|||
145279320|NCT00686374|523872921|FG000|Overall Study|Missing reason|33|||
145279321|NCT00686374|523872921|FG000|Overall Study|Other, not specified|4|||
145279322|NCT01070966|523872922|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
145537676|NCT02925117|524827553|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
145537677|NCT02925117|524827554|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
145537678|NCT02925117|524827555|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
145537679|NCT02925117|524827544|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145279323|NCT01070966|523872922|FG000|Participants for Safety Evaluation|Off-label use|9|||
145279324|NCT01070966|523872922|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
145279325|NCT01070966|523872922|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
145279326|NCT01070966|523872922|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
145403753|NCT01773928|524334414|FG004|Overall Study|Adverse Event|0|||
145537680|NCT02925117|524827545|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537681|NCT02925117|524827546|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537682|NCT02925117|524827547|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145609139|NCT00976482|525084808|FG000|Overall Study|Withdrawal by Subject|45|||
145609140|NCT00976482|525084808|FG000|Overall Study|Center terminated|1|||
145609141|NCT00976482|525084808|FG000|Overall Study|Protocol Violation|5|||
145783830|NCT00789477|525716193|FG000|Overall Study|Other|2|||
145279327|NCT01070966|523872922|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
145279328|NCT01070966|523872922|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
145279329|NCT01070966|523872922|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
145279330|NCT01725113|523872924|FG000|Overall Study|Kidney Transplant|1|||
145279331|NCT01725113|523872925|FG001|Overall Study|Kidney Transplant|1|||
145279332|NCT01725113|523872924|FG000|Overall Study|Withdrawal by Subject|0|||
145279333|NCT01725113|523872925|FG001|Overall Study|Withdrawal by Subject|1|||
145279334|NCT01415921|523872927|FG000|Overall Study|Adverse Event|0|||
145279335|NCT01415921|523872928|FG001|Overall Study|Adverse Event|1|||
145279336|NCT01415921|523872927|FG000|Overall Study|Physician Decision|1|||
145279337|NCT01415921|523872928|FG001|Overall Study|Physician Decision|1|||
145279338|NCT01415921|523872927|FG000|Overall Study|Withdrawal by Subject|0|||
145279339|NCT01415921|523872928|FG001|Overall Study|Withdrawal by Subject|1|||
145279340|NCT01415921|523872927|FG000|Overall Study|Other|2|||
145279341|NCT01415921|523872928|FG001|Overall Study|Other|0|||
145537683|NCT02925117|524827548|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537684|NCT02925117|524827549|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
145537685|NCT02925117|524827550|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145279342|NCT02143947|523872929|FG000|Overall Study|Lost to Follow-up|4|||
145279343|NCT02143947|523872930|FG001|Overall Study|Lost to Follow-up|2|||
145279344|NCT01244815|523872933|FG000|Overall Study|Not Treated|0|||
145279345|NCT01244815|523872934|FG001|Overall Study|Not Treated|1|||
145279346|NCT01244815|523872935|FG002|Overall Study|Not Treated|0|||
145279347|NCT01244815|523872936|FG003|Overall Study|Not Treated|0|||
145279348|NCT01244815|523872933|FG000|Overall Study|Adverse Event|4|||
145279349|NCT01244815|523872934|FG001|Overall Study|Adverse Event|7|||
145609142|NCT03722264|525084811|FG000|Overall Study|Physician Decision|3|||
145609143|NCT00720902|525084812|FG000|Overall Study|Withdrawal by Subject|1|||
145609144|NCT00720902|525084813|FG001|Overall Study|Withdrawal by Subject|0|||
145609145|NCT00720902|525084812|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
145609146|NCT00720902|525084813|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
145609147|NCT01486758|525084814|FG000|Overall Study|Lost to Follow-up|0|||
145609148|NCT01486758|525084815|FG001|Overall Study|Lost to Follow-up|1|||
145609149|NCT02959671|525084816|FG000|Overall Study|Adverse Event|2|||
145609150|NCT02959671|525084816|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
145279350|NCT01244815|523872935|FG002|Overall Study|Adverse Event|5|||
145279351|NCT01244815|523872936|FG003|Overall Study|Adverse Event|5|||
145279352|NCT01244815|523872933|FG000|Overall Study|Treatment Failure|0|||
145279353|NCT01244815|523872934|FG001|Overall Study|Treatment Failure|0|||
145279354|NCT01244815|523872935|FG002|Overall Study|Treatment Failure|0|||
145279355|NCT01244815|523872936|FG003|Overall Study|Treatment Failure|1|||
145279356|NCT01244815|523872933|FG000|Overall Study|Lost to Follow-up|3|||
145279357|NCT01244815|523872934|FG001|Overall Study|Lost to Follow-up|2|||
145279358|NCT01244815|523872935|FG002|Overall Study|Lost to Follow-up|3|||
145279359|NCT01244815|523872936|FG003|Overall Study|Lost to Follow-up|2|||
145279360|NCT01244815|523872933|FG000|Overall Study|Withdrawal by Subject|0|||
145279361|NCT01244815|523872934|FG001|Overall Study|Withdrawal by Subject|2|||
145279362|NCT01244815|523872935|FG002|Overall Study|Withdrawal by Subject|0|||
145279363|NCT01244815|523872936|FG003|Overall Study|Withdrawal by Subject|3|||
145279364|NCT01244815|523872933|FG000|Overall Study|Protocol Violation|7|||
145279365|NCT01244815|523872934|FG001|Overall Study|Protocol Violation|4|||
145279366|NCT01244815|523872935|FG002|Overall Study|Protocol Violation|3|||
145279367|NCT01244815|523872936|FG003|Overall Study|Protocol Violation|1|||
145279368|NCT01244815|523872933|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
145279369|NCT01244815|523872934|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
145279370|NCT01244815|523872935|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
145279371|NCT01244815|523872936|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
145279372|NCT01808209|523872938|FG000|Overall Study|Lost to Follow-up|0|||
145279373|NCT01808209|523872939|FG001|Overall Study|Lost to Follow-up|1|||
145279374|NCT00697112|523872940|FG000|Overall Study|Adverse Event|8|||
145279375|NCT00697112|523872940|FG000|Overall Study|Lost to Follow-up|1|||
145279376|NCT00697112|523872940|FG000|Overall Study|Did not meet inclusion criteria|1|||
145279377|NCT01427920|523872945|FG000|Overall Study|Adverse Event|1|||
145279378|NCT01427920|523872946|FG001|Overall Study|Adverse Event|2|||
145279379|NCT01427920|523872945|FG000|Overall Study|Lack of Efficacy|1|||
145279380|NCT01427920|523872946|FG001|Overall Study|Lack of Efficacy|0|||
145279381|NCT01427920|523872945|FG000|Overall Study|Protocol Violation|1|||
145279382|NCT01427920|523872946|FG001|Overall Study|Protocol Violation|3|||
145279383|NCT01427920|523872945|FG000|Overall Study|Withdrawal Criteria|4|||
145279384|NCT01427920|523872946|FG001|Overall Study|Withdrawal Criteria|4|||
145279385|NCT01427920|523872945|FG000|Overall Study|Unclassified|2|||
145279386|NCT01427920|523872946|FG001|Overall Study|Unclassified|8|||
145279387|NCT04228302|523872947|FG000|Overall Study|Adverse Event|0|||
145279388|NCT04228302|523872948|FG001|Overall Study|Adverse Event|0|||
145279389|NCT04228302|523872949|FG002|Overall Study|Adverse Event|0|||
145279390|NCT04228302|523872950|FG003|Overall Study|Adverse Event|0|||
145279391|NCT04228302|523872951|FG004|Overall Study|Adverse Event|1|||
145279392|NCT04228302|523872952|FG005|Overall Study|Adverse Event|0|||
145279393|NCT03066440|523872957|FG000|Overall Study|Physician Decision|1|||
145279394|NCT03066440|523872958|FG001|Overall Study|Physician Decision|1|||
145279395|NCT03066440|523872957|FG000|Overall Study|Protocol Violation|0|||
145279396|NCT03066440|523872958|FG001|Overall Study|Protocol Violation|2|||
145279397|NCT04991311|523872959|FG000|Overall Study|Adverse Event|1|||
145279398|NCT03876873|523872962|FG000|Overall Study|Physician Decision|0|||
145279399|NCT03876873|523872963|FG001|Overall Study|Physician Decision|1|||
145279400|NCT02117479|523872965|FG000|Overall Study|Death|13|||
145279401|NCT02117479|523872966|FG001|Overall Study|Death|8|||
145609151|NCT04105972|525084825|FG000|Overall Study|Adverse Event|2|||
145609152|NCT04105972|525084826|FG001|Overall Study|Adverse Event|1|||
145279402|NCT02117479|523872965|FG000|Overall Study|Adverse Event|8|||
145279403|NCT02117479|523872966|FG001|Overall Study|Adverse Event|16|||
145279404|NCT02117479|523872965|FG000|Overall Study|Subject decision|8|||
145279405|NCT02117479|523872966|FG001|Overall Study|Subject decision|9|||
145279406|NCT02117479|523872965|FG000|Overall Study|Disease progression|104|||
145403754|NCT01773928|524334415|FG005|Overall Study|Adverse Event|0|||
145403755|NCT01773928|524334416|FG006|Overall Study|Adverse Event|0|||
145403756|NCT01773928|524334417|FG007|Overall Study|Adverse Event|1|||
145403757|NCT01773928|524334418|FG008|Overall Study|Adverse Event|0|||
145403758|NCT01773928|524334410|FG000|Overall Study|Physician Decision|0|||
145403759|NCT01773928|524334411|FG001|Overall Study|Physician Decision|0|||
145403760|NCT01773928|524334412|FG002|Overall Study|Physician Decision|0|||
145403761|NCT01773928|524334413|FG003|Overall Study|Physician Decision|1|||
145403762|NCT01773928|524334414|FG004|Overall Study|Physician Decision|0|||
145403763|NCT01773928|524334415|FG005|Overall Study|Physician Decision|0|||
145403764|NCT01773928|524334416|FG006|Overall Study|Physician Decision|0|||
145403765|NCT01773928|524334417|FG007|Overall Study|Physician Decision|0|||
145403766|NCT01773928|524334418|FG008|Overall Study|Physician Decision|0|||
145403767|NCT01773928|524334410|FG000|Overall Study|Withdrawal by Subject|5|||
145403768|NCT01773928|524334411|FG001|Overall Study|Withdrawal by Subject|4|||
145403769|NCT01773928|524334412|FG002|Overall Study|Withdrawal by Subject|4|||
145403770|NCT01773928|524334413|FG003|Overall Study|Withdrawal by Subject|4|||
145403771|NCT01773928|524334414|FG004|Overall Study|Withdrawal by Subject|7|||
145403772|NCT01773928|524334415|FG005|Overall Study|Withdrawal by Subject|1|||
145403773|NCT01773928|524334416|FG006|Overall Study|Withdrawal by Subject|0|||
145403774|NCT01773928|524334417|FG007|Overall Study|Withdrawal by Subject|0|||
145403775|NCT01773928|524334418|FG008|Overall Study|Withdrawal by Subject|1|||
145403776|NCT01773928|524334410|FG000|Overall Study|Lost to Follow-up|0|||
145403777|NCT01773928|524334411|FG001|Overall Study|Lost to Follow-up|0|||
145403778|NCT01773928|524334412|FG002|Overall Study|Lost to Follow-up|0|||
145403779|NCT01773928|524334413|FG003|Overall Study|Lost to Follow-up|0|||
145403780|NCT01773928|524334414|FG004|Overall Study|Lost to Follow-up|0|||
145403781|NCT01773928|524334415|FG005|Overall Study|Lost to Follow-up|1|||
145403782|NCT01773928|524334416|FG006|Overall Study|Lost to Follow-up|0|||
145403783|NCT01773928|524334417|FG007|Overall Study|Lost to Follow-up|0|||
145403784|NCT01773928|524334418|FG008|Overall Study|Lost to Follow-up|0|||
145403785|NCT01773928|524334410|FG000|Overall Study|Subject misrepresented age|0|||
145403786|NCT01773928|524334411|FG001|Overall Study|Subject misrepresented age|1|||
145403787|NCT01773928|524334412|FG002|Overall Study|Subject misrepresented age|0|||
145403788|NCT01773928|524334413|FG003|Overall Study|Subject misrepresented age|0|||
145403789|NCT01773928|524334414|FG004|Overall Study|Subject misrepresented age|0|||
145403790|NCT01773928|524334415|FG005|Overall Study|Subject misrepresented age|0|||
145403791|NCT01773928|524334416|FG006|Overall Study|Subject misrepresented age|0|||
145403792|NCT01773928|524334417|FG007|Overall Study|Subject misrepresented age|0|||
145403793|NCT01773928|524334418|FG008|Overall Study|Subject misrepresented age|0|||
145403794|NCT01773928|524334410|FG000|Overall Study|Subject met exclusion criteria|0|||
145403795|NCT01773928|524334411|FG001|Overall Study|Subject met exclusion criteria|0|||
145403796|NCT01773928|524334412|FG002|Overall Study|Subject met exclusion criteria|0|||
145403797|NCT01773928|524334413|FG003|Overall Study|Subject met exclusion criteria|0|||
145783831|NCT00789477|525716194|FG001|Overall Study|Other|0|||
145783832|NCT00789477|525716195|FG002|Overall Study|Other|1|||
145783833|NCT00789477|525716196|FG003|Overall Study|Other|3|||
145783834|NCT00789477|525716197|FG004|Overall Study|Other|0|||
145783835|NCT02137772|525716198|FG000|Overall Study|Adverse Event|6|||
145783836|NCT02137772|525716199|FG001|Overall Study|Adverse Event|3|||
145783837|NCT02137772|525716198|FG000|Overall Study|Death|71|||
145783838|NCT02137772|525716199|FG001|Overall Study|Death|44|||
145783839|NCT02137772|525716198|FG000|Overall Study|Lost to Follow-up|8|||
145783840|NCT02137772|525716199|FG001|Overall Study|Lost to Follow-up|4|||
145403798|NCT01773928|524334414|FG004|Overall Study|Subject met exclusion criteria|0|||
145403799|NCT01773928|524334415|FG005|Overall Study|Subject met exclusion criteria|0|||
145403800|NCT01773928|524334416|FG006|Overall Study|Subject met exclusion criteria|0|||
145403801|NCT01773928|524334417|FG007|Overall Study|Subject met exclusion criteria|0|||
145403802|NCT01773928|524334418|FG008|Overall Study|Subject met exclusion criteria|1|||
145403803|NCT01773928|524334410|FG000|Overall Study|Randomized, had to leave, never returned|0|||
145403804|NCT01773928|524334411|FG001|Overall Study|Randomized, had to leave, never returned|0|||
145403805|NCT01773928|524334412|FG002|Overall Study|Randomized, had to leave, never returned|0|||
145537686|NCT02925117|524827551|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537687|NCT02925117|524827552|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537688|NCT02925117|524827553|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
145537689|NCT02925117|524827554|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
145537690|NCT02925117|524827555|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
145537691|NCT02925117|524827544|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
145537692|NCT02925117|524827545|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
145537693|NCT02925117|524827546|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
145537694|NCT02925117|524827547|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
145537695|NCT02925117|524827548|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
145537696|NCT02925117|524827549|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
145783841|NCT02137772|525716198|FG000|Overall Study|Physician Decision|15|||
145783842|NCT02137772|525716199|FG001|Overall Study|Physician Decision|5|||
145783843|NCT02137772|525716198|FG000|Overall Study|Withdrawal by Subject|28|||
145783844|NCT02137772|525716199|FG001|Overall Study|Withdrawal by Subject|17|||
145537697|NCT02925117|524827550|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
145537698|NCT02925117|524827551|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
145537699|NCT02925117|524827552|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
145537700|NCT02925117|524827553|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
145783845|NCT02137772|525716198|FG000|Overall Study|Non-compliance with study drug|1|||
145783846|NCT02137772|525716199|FG001|Overall Study|Non-compliance with study drug|0|||
145783847|NCT02137772|525716198|FG000|Overall Study|Not treated|3|||
145783848|NCT02137772|525716199|FG001|Overall Study|Not treated|2|||
145783849|NCT00455858|525716200|FG000|Overall Study|Lost to Follow-up|2|||
145783850|NCT00455858|525716200|FG000|Overall Study|Protocol Violation|1|||
145783851|NCT00455858|525716200|FG000|Overall Study|Lack of Efficacy|1|||
145783852|NCT00455858|525716200|FG000|Overall Study|Well controlled FPG without insulin|1|||
145783853|NCT00455858|525716200|FG000|Overall Study|Withdrawal|1|||
145783854|NCT02092389|525716201|FG000|Overall Study|Adverse Event|1|||
145783855|NCT02092389|525716201|FG000|Overall Study|Other|5|||
145783856|NCT01844700|525716202|FG000|Overall Study|Lack of Efficacy|1|||
145783857|NCT01844700|525716203|FG001|Overall Study|Lack of Efficacy|0|||
145783858|NCT01844700|525716202|FG000|Overall Study|refused medication switch|1|||
145783859|NCT01844700|525716203|FG001|Overall Study|refused medication switch|0|||
145783860|NCT01844700|525716202|FG000|Overall Study|Withdrawal by Subject|1|||
145783861|NCT01844700|525716203|FG001|Overall Study|Withdrawal by Subject|0|||
145783862|NCT01844700|525716202|FG000|Overall Study|stopped taking meds|0|||
145783863|NCT01844700|525716203|FG001|Overall Study|stopped taking meds|1|||
145783864|NCT01242020|525716204|FG000|Overall Study|Withdrawal by Subject|2|||
145783865|NCT01242020|525716205|FG001|Overall Study|Withdrawal by Subject|0|||
145783866|NCT01242020|525716204|FG000|Overall Study|Failed screening|1|||
145783867|NCT01242020|525716205|FG001|Overall Study|Failed screening|0|||
145783868|NCT02375698|525716206|FG000|Overall Study|Withdrawal by Subject|0|||
145783869|NCT02375698|525716207|FG001|Overall Study|Withdrawal by Subject|2|||
145783870|NCT02375698|525716206|FG000|Overall Study|Physician Decision|2|||
145783871|NCT02375698|525716207|FG001|Overall Study|Physician Decision|0|||
145783872|NCT02680847|525716208|FG000|Overall Study|Other|2|||
145783873|NCT02680847|525716209|FG001|Overall Study|Other|0|||
145783874|NCT02680847|525716210|FG002|Overall Study|Other|0|||
145783875|NCT02680847|525716208|FG000|Overall Study|No longer met eligibility criteria|2|||
145783876|NCT02680847|525716209|FG001|Overall Study|No longer met eligibility criteria|2|||
145783877|NCT02680847|525716210|FG002|Overall Study|No longer met eligibility criteria|0|||
145783878|NCT02680847|525716208|FG000|Overall Study|Unwilling to participate in study|1|||
145783879|NCT02680847|525716209|FG001|Overall Study|Unwilling to participate in study|1|||
145783880|NCT02680847|525716210|FG002|Overall Study|Unwilling to participate in study|0|||
145783881|NCT02680847|525716208|FG000|Overall Study|Lack of Efficacy|0|||
145783882|NCT02680847|525716209|FG001|Overall Study|Lack of Efficacy|0|||
145783883|NCT02680847|525716210|FG002|Overall Study|Lack of Efficacy|2|||
145783884|NCT02680847|525716208|FG000|Overall Study|Adverse Event|0|||
145783885|NCT02680847|525716209|FG001|Overall Study|Adverse Event|0|||
145783886|NCT02680847|525716210|FG002|Overall Study|Adverse Event|1|||
145783887|NCT00772967|525716211|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
145783888|NCT00772967|525716212|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
145783889|NCT00772967|525716213|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
145783890|NCT00772967|525716214|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
145783891|NCT00772967|525716215|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
145783892|NCT00772967|525716216|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
145783893|NCT00772967|525716211|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
145783894|NCT00772967|525716212|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
145783895|NCT00772967|525716213|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
145783896|NCT00772967|525716214|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
145783897|NCT00772967|525716215|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
145783898|NCT00772967|525716216|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
145783899|NCT00772967|525716211|FG000|Crossover Treatment 3|Adverse Event|0|||
145783900|NCT00772967|525716212|FG001|Crossover Treatment 3|Adverse Event|0|||
145783901|NCT00772967|525716213|FG002|Crossover Treatment 3|Adverse Event|0|||
145783902|NCT00772967|525716214|FG003|Crossover Treatment 3|Adverse Event|0|||
145783903|NCT00772967|525716215|FG004|Crossover Treatment 3|Adverse Event|1|||
145783904|NCT00772967|525716216|FG005|Crossover Treatment 3|Adverse Event|0|||
145783905|NCT01595646|525716217|FG000|Overall Study|Withdrawal by Subject|1|||
145783906|NCT01595646|525716218|FG001|Overall Study|Withdrawal by Subject|0|||
145783907|NCT01595646|525716219|FG002|Overall Study|Withdrawal by Subject|0|||
145783908|NCT04172831|525716221|FG000|Overall Study|Adverse Event|21|||
145783909|NCT04172831|525716222|FG001|Overall Study|Adverse Event|9|||
145783910|NCT04172831|525716221|FG000|Overall Study|Lack of Efficacy|2|||
145783911|NCT04172831|525716222|FG001|Overall Study|Lack of Efficacy|8|||
145537701|NCT02925117|524827554|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
145783912|NCT04172831|525716221|FG000|Overall Study|Physician Decision|0|||
145783913|NCT04172831|525716222|FG001|Overall Study|Physician Decision|1|||
145783914|NCT04172831|525716221|FG000|Overall Study|Withdrawal by Subject|12|||
145783915|NCT04172831|525716222|FG001|Overall Study|Withdrawal by Subject|11|||
145783916|NCT04172831|525716221|FG000|Overall Study|Lost to Follow-up|4|||
145783917|NCT04172831|525716222|FG001|Overall Study|Lost to Follow-up|9|||
145783918|NCT04172831|525716221|FG000|Overall Study|COVID-19 related crisis|3|||
145783919|NCT04172831|525716222|FG001|Overall Study|COVID-19 related crisis|3|||
145783920|NCT04172831|525716221|FG000|Overall Study|Subject non-compliance|1|||
145783921|NCT04172831|525716222|FG001|Overall Study|Subject non-compliance|1|||
145783922|NCT04172831|525716221|FG000|Overall Study|Family emergency|1|||
145783923|NCT04172831|525716222|FG001|Overall Study|Family emergency|0|||
145783924|NCT00231062|525716225|FG000|Overall Study|Physician Decision|6|||
145783925|NCT01651260|525716229|FG000|Overall Study|unable to apply product|3|||
145783926|NCT02239094|525716230|FG000|Overall Study|Withdrawal by Subject|1|||
145783927|NCT02239094|525716230|FG000|Overall Study|Remitted before started|1|||
145783928|NCT03648996|525716233|FG000|Overall Study|Withdrawal by Subject|0|||
145783929|NCT03648996|525716234|FG001|Overall Study|Withdrawal by Subject|2|||
145783930|NCT03648996|525716235|FG002|Overall Study|Withdrawal by Subject|2|||
145783931|NCT03648996|525716233|FG000|Overall Study|Physician Decision|2|||
145783932|NCT03648996|525716234|FG001|Overall Study|Physician Decision|0|||
145783933|NCT03648996|525716235|FG002|Overall Study|Physician Decision|0|||
145783934|NCT01963117|525716243|FG000|Overall Study|Death|1|||
145783935|NCT01780389|525716244|FG000|Overall Study|Adverse Event|1|||
145783936|NCT01095250|525716245|FG000|Overall Study|administrative reasons|8|||
145783937|NCT01095250|525716246|FG001|Overall Study|administrative reasons|10|||
145783938|NCT01095250|525716247|FG002|Overall Study|administrative reasons|7|||
145783939|NCT01095250|525716248|FG003|Overall Study|administrative reasons|5|||
145783940|NCT01095250|525716245|FG000|Overall Study|Withdrawal by Subject|0|||
145783941|NCT01095250|525716246|FG001|Overall Study|Withdrawal by Subject|0|||
145783942|NCT01095250|525716247|FG002|Overall Study|Withdrawal by Subject|1|||
145783943|NCT01095250|525716248|FG003|Overall Study|Withdrawal by Subject|0|||
145783944|NCT01605396|525716253|FG000|Overall Study|Adverse Event|5|||
145783945|NCT01605396|525716254|FG001|Overall Study|Adverse Event|3|||
145783946|NCT01605396|525716253|FG000|Overall Study|Lost to Follow-up|1|||
145783947|NCT01605396|525716254|FG001|Overall Study|Lost to Follow-up|0|||
145783948|NCT01605396|525716253|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145783949|NCT01605396|525716254|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145783950|NCT01605396|525716253|FG000|Overall Study|Physician Decision|2|||
145783951|NCT01605396|525716254|FG001|Overall Study|Physician Decision|2|||
145783952|NCT01605396|525716253|FG000|Overall Study|Progressive Disease|23|||
145783953|NCT01605396|525716254|FG001|Overall Study|Progressive Disease|27|||
145783954|NCT01605396|525716253|FG000|Overall Study|Withdrawal by Subject|4|||
145783955|NCT01605396|525716254|FG001|Overall Study|Withdrawal by Subject|2|||
145783956|NCT01605396|525716253|FG000|Overall Study|Transfer Off Study|4|||
145783957|NCT01605396|525716254|FG001|Overall Study|Transfer Off Study|5|||
145783958|NCT04598165|525716255|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
145783959|NCT04598165|525716256|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
145783960|NCT04598165|525716255|FG000|Completed 6-week Follow-up|Death|2|||
145783961|NCT04598165|525716256|FG001|Completed 6-week Follow-up|Death|1|||
145783962|NCT04598165|525716255|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
145783963|NCT04598165|525716256|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
145783964|NCT04598165|525716255|FG000|Completed 6-week Follow-up|Ineligible|4|||
145783965|NCT04598165|525716256|FG001|Completed 6-week Follow-up|Ineligible|3|||
145783966|NCT04598165|525716255|FG000|Completed 6-week Follow-up|Partner refusal|0|||
145783967|NCT04598165|525716256|FG001|Completed 6-week Follow-up|Partner refusal|1|||
145783968|NCT04598165|525716255|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
145783969|NCT04598165|525716256|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
145783970|NCT01323673|525716257|FG000|Overall Study|Adverse Event|0|||
145783971|NCT01323673|525716258|FG001|Overall Study|Adverse Event|1|||
145783972|NCT01323673|525716257|FG000|Overall Study|Lost to Follow-up|0|||
145783973|NCT01323673|525716258|FG001|Overall Study|Lost to Follow-up|1|||
145783974|NCT01323673|525716257|FG000|Overall Study|Protocol Violation|1|||
145783975|NCT01323673|525716258|FG001|Overall Study|Protocol Violation|0|||
145783976|NCT01323673|525716257|FG000|Overall Study|Withdrawal by Subject|2|||
145783977|NCT01323673|525716258|FG001|Overall Study|Withdrawal by Subject|3|||
145783978|NCT04430582|525716260|FG000|Overall Study|Found to meet exclusionary criteria|1|||
145783979|NCT04430582|525716261|FG001|Overall Study|Found to meet exclusionary criteria|0|||
145783980|NCT04430582|525716260|FG000|Overall Study|Withdrawal by Subject|0|||
145783981|NCT04430582|525716261|FG001|Overall Study|Withdrawal by Subject|1|||
145783982|NCT03607682|525716262|FG000|Overall Study|Withdrawal by Subject|1|||
145783983|NCT03607682|525716262|FG000|Overall Study|Disease progression|1|||
145783984|NCT03625986|525718255|FG000|Randomization Period|Lost to Follow-up|7|||
145783985|NCT03625986|525718256|FG001|Randomization Period|Lost to Follow-up|12|||
145783986|NCT03625986|525718255|FG000|Randomization Period|Withdrawal by Subject|10|||
145783987|NCT03625986|525718256|FG001|Randomization Period|Withdrawal by Subject|6|||
145783988|NCT04400318|525718257|FG000|Overall Study|Adverse Event|1|||
145783989|NCT04400318|525718258|FG001|Overall Study|Adverse Event|0|||
145783990|NCT04400318|525718257|FG000|Overall Study|Withdrawal by Subject|1|||
145279407|NCT02117479|523872966|FG001|Overall Study|Disease progression|108|||
145279408|NCT02117479|523872965|FG000|Overall Study|Noncompliance with study treatment|1|||
145279409|NCT02117479|523872966|FG001|Overall Study|Noncompliance with study treatment|0|||
145279410|NCT02117479|523872965|FG000|Overall Study|Study terminated by the sponsor|4|||
145279411|NCT02117479|523872966|FG001|Overall Study|Study terminated by the sponsor|6|||
145279412|NCT02117479|523872965|FG000|Overall Study|Physician Decision|7|||
145279413|NCT02117479|523872966|FG001|Overall Study|Physician Decision|2|||
145279414|NCT02117479|523872965|FG000|Overall Study|Other unspecified|11|||
145279415|NCT02117479|523872966|FG001|Overall Study|Other unspecified|7|||
145279416|NCT01223196|523872970|FG000|Overall Study|Lost to Follow-up|2|||
145279417|NCT01223196|523872971|FG001|Overall Study|Lost to Follow-up|0|||
145279418|NCT01223196|523872970|FG000|Overall Study|Physician Decision|1|||
145279419|NCT01223196|523872971|FG001|Overall Study|Physician Decision|0|||
145279420|NCT01223196|523872970|FG000|Overall Study|Withdrawal by Subject|1|||
145279421|NCT01223196|523872971|FG001|Overall Study|Withdrawal by Subject|0|||
145279422|NCT02629133|523872972|FG000|Overall Study|Lost to Follow-up|3|||
145279423|NCT02629133|523872973|FG001|Overall Study|Lost to Follow-up|1|||
145279424|NCT02629133|523872972|FG000|Overall Study|Withdrawal by Subject|1|||
145279425|NCT02629133|523872973|FG001|Overall Study|Withdrawal by Subject|1|||
145279426|NCT03216954|523872974|FG000|Overall Study|Adverse Event|0|||
145279427|NCT03216954|523872975|FG001|Overall Study|Adverse Event|0|||
145783991|NCT04400318|525718258|FG001|Overall Study|Withdrawal by Subject|1|||
145279428|NCT03216954|523872976|FG002|Overall Study|Adverse Event|1|||
145279429|NCT03216954|523872977|FG003|Overall Study|Adverse Event|0|||
145279430|NCT03216954|523872978|FG004|Overall Study|Adverse Event|1|||
145279431|NCT03216954|523872974|FG000|Overall Study|Withdrawal by Subject|2|||
145783992|NCT04400318|525718257|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
145783993|NCT04400318|525718258|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
145783994|NCT04359823|525718259|FG000|Overall Study|Lost to Follow-up|0|||
145279432|NCT03216954|523872975|FG001|Overall Study|Withdrawal by Subject|0|||
145279433|NCT03216954|523872976|FG002|Overall Study|Withdrawal by Subject|0|||
145279434|NCT03216954|523872977|FG003|Overall Study|Withdrawal by Subject|0|||
145783995|NCT04359823|525718260|FG001|Overall Study|Lost to Follow-up|1|||
145279435|NCT03216954|523872978|FG004|Overall Study|Withdrawal by Subject|0|||
145279436|NCT03216954|523872974|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
145279437|NCT03216954|523872975|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
145279438|NCT03216954|523872976|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
145279439|NCT03216954|523872977|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
145279440|NCT03216954|523872978|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
145279441|NCT05180630|523872979|FG000|First Intervention|Physician Decision|0|||
145279442|NCT05180630|523872980|FG001|First Intervention|Physician Decision|0|||
145279443|NCT05180630|523872981|FG002|First Intervention|Physician Decision|3|||
145279444|NCT00447694|523872984|FG000|Overall Study|Adverse Event|2|||
145279445|NCT00447694|523872984|FG000|Overall Study|Abnormal laboratory value|1|||
145279446|NCT00447694|523872984|FG000|Overall Study|Abnormal test procedure result|1|||
145279447|NCT00447694|523872984|FG000|Overall Study|Withdrawal by Subject|2|||
145279448|NCT00709735|523872985|FG000|Overall Study|Lost to Follow-up|1|||
145279449|NCT00709735|523872986|FG001|Overall Study|Lost to Follow-up|1|||
145279450|NCT00709735|523872985|FG000|Overall Study|Relapse into Opioid Abuse|0|||
145279451|NCT00709735|523872986|FG001|Overall Study|Relapse into Opioid Abuse|1|||
145279452|NCT00709735|523872985|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
145279453|NCT00709735|523872986|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
145279454|NCT01169987|523872987|FG000|Overall Study|Withdrawal by Subject|3|||
145279455|NCT01169987|523872987|FG000|Overall Study|Lost to Follow-up|24|||
145279456|NCT01169987|523872987|FG000|Overall Study|Other|4|||
145279457|NCT00829439|523872988|FG000|Overall Study|Adverse Event|0|||
145279458|NCT00829439|523872989|FG001|Overall Study|Adverse Event|0|||
145279459|NCT00829439|523872990|FG002|Overall Study|Adverse Event|1|||
145279460|NCT00829439|523872991|FG003|Overall Study|Adverse Event|0|||
145279461|NCT00386100|523872992|FG000|Overall Study|Did not receive study medication|6|||
145279462|NCT00386100|523872993|FG001|Overall Study|Did not receive study medication|4|||
145279463|NCT00386100|523872992|FG000|Overall Study|Adverse Event|15|||
145279464|NCT00386100|523872993|FG001|Overall Study|Adverse Event|25|||
145279465|NCT00386100|523872992|FG000|Overall Study|Death|0|||
145279466|NCT00386100|523872993|FG001|Overall Study|Death|1|||
145279467|NCT00386100|523872992|FG000|Overall Study|Insufficient therapeutic effect|30|||
145279468|NCT00386100|523872993|FG001|Overall Study|Insufficient therapeutic effect|6|||
145279469|NCT00386100|523872992|FG000|Overall Study|Lost to Follow-up|29|||
145279470|NCT00386100|523872993|FG001|Overall Study|Lost to Follow-up|29|||
145279471|NCT00386100|523872992|FG000|Overall Study|Non-compliance|18|||
145279472|NCT00386100|523872993|FG001|Overall Study|Non-compliance|19|||
145279473|NCT00386100|523872992|FG000|Overall Study|Protocol Violation|5|||
145279474|NCT00386100|523872993|FG001|Overall Study|Protocol Violation|3|||
145279475|NCT00386100|523872992|FG000|Overall Study|Withdrawal by Subject|32|||
145537702|NCT02925117|524827555|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
145537703|NCT02925117|524827544|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145279476|NCT00386100|523872993|FG001|Overall Study|Withdrawal by Subject|31|||
145279477|NCT00386100|523872992|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
145279478|NCT00386100|523872993|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
145279479|NCT00386100|523872992|FG000|Overall Study|BMD <2.5|1|||
145279480|NCT00386100|523872993|FG001|Overall Study|BMD <2.5|0|||
145279481|NCT00386100|523872992|FG000|Overall Study|Consecutive elevated Hba1C|1|||
145279482|NCT00386100|523872993|FG001|Overall Study|Consecutive elevated Hba1C|0|||
145279483|NCT00386100|523872992|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
145403806|NCT01773928|524334413|FG003|Overall Study|Randomized, had to leave, never returned|1|||
145403807|NCT01773928|524334414|FG004|Overall Study|Randomized, had to leave, never returned|0|||
145403808|NCT01773928|524334415|FG005|Overall Study|Randomized, had to leave, never returned|0|||
145403809|NCT01773928|524334416|FG006|Overall Study|Randomized, had to leave, never returned|0|||
145403810|NCT01773928|524334417|FG007|Overall Study|Randomized, had to leave, never returned|0|||
145403811|NCT01773928|524334418|FG008|Overall Study|Randomized, had to leave, never returned|0|||
145403812|NCT01773928|524334410|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
145403813|NCT01773928|524334411|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
145403814|NCT01773928|524334412|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
145403815|NCT01773928|524334413|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
145403816|NCT01773928|524334414|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
145403817|NCT01773928|524334415|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
145403818|NCT01773928|524334416|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
145403819|NCT01773928|524334417|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
145403820|NCT01773928|524334418|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
145403821|NCT03533751|524334419|FG000|Overall Study|Withdrawal by Subject|12|||
145403822|NCT03533751|524334420|FG001|Overall Study|Withdrawal by Subject|6|||
145403823|NCT03533751|524334421|FG002|Overall Study|Withdrawal by Subject|11|||
145403824|NCT03533751|524334422|FG003|Overall Study|Withdrawal by Subject|9|||
145403825|NCT03533751|524334423|FG004|Overall Study|Withdrawal by Subject|10|||
145403826|NCT03533751|524334419|FG000|Overall Study|Adverse Event|4|||
145403827|NCT03533751|524334420|FG001|Overall Study|Adverse Event|7|||
145403828|NCT03533751|524334421|FG002|Overall Study|Adverse Event|2|||
145403829|NCT03533751|524334422|FG003|Overall Study|Adverse Event|4|||
145403830|NCT03533751|524334423|FG004|Overall Study|Adverse Event|5|||
145403831|NCT03533751|524334419|FG000|Overall Study|Physician Decision|0|||
145403832|NCT03533751|524334420|FG001|Overall Study|Physician Decision|2|||
145403833|NCT03533751|524334421|FG002|Overall Study|Physician Decision|1|||
145403834|NCT03533751|524334422|FG003|Overall Study|Physician Decision|2|||
145403835|NCT03533751|524334423|FG004|Overall Study|Physician Decision|1|||
145403836|NCT03533751|524334419|FG000|Overall Study|Sponsor Decision|0|||
145403837|NCT03533751|524334420|FG001|Overall Study|Sponsor Decision|0|||
145403838|NCT03533751|524334421|FG002|Overall Study|Sponsor Decision|1|||
145403839|NCT03533751|524334422|FG003|Overall Study|Sponsor Decision|1|||
145783996|NCT04359823|525718259|FG000|Overall Study|Withdrawal by Subject|0|||
145783997|NCT04359823|525718260|FG001|Overall Study|Withdrawal by Subject|1|||
145783998|NCT04191967|525718261|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
145783999|NCT04191967|525718261|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
145279484|NCT00386100|523872993|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
145279485|NCT00386100|523872992|FG000|Overall Study|Laboratory findings|1|||
145279486|NCT00386100|523872993|FG001|Overall Study|Laboratory findings|0|||
145279487|NCT00386100|523872992|FG000|Overall Study|Participant's concern due to CPK levels|1|||
145279488|NCT00386100|523872993|FG001|Overall Study|Participant's concern due to CPK levels|0|||
145279489|NCT00386100|523872992|FG000|Overall Study|Participant moving out of state|2|||
145279490|NCT00386100|523872993|FG001|Overall Study|Participant moving out of state|0|||
145279491|NCT00386100|523872992|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
145279492|NCT00386100|523872993|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
145279493|NCT00386100|523872992|FG000|Overall Study|Didn't meet entry criteria|1|||
145279494|NCT00386100|523872993|FG001|Overall Study|Didn't meet entry criteria|1|||
145279495|NCT00386100|523872992|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
145279496|NCT00386100|523872993|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
145279497|NCT00386100|523872992|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
145279498|NCT00386100|523872993|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
145784000|NCT01790438|525718266|FG000|Overall Study|Adverse Event|3|||
145784001|NCT01790438|525718267|FG001|Overall Study|Adverse Event|2|||
145403840|NCT03533751|524334423|FG004|Overall Study|Sponsor Decision|0|||
145403841|NCT03533751|524334419|FG000|Overall Study|Lost to Follow-up|3|||
145403842|NCT03533751|524334420|FG001|Overall Study|Lost to Follow-up|7|||
145403843|NCT03533751|524334421|FG002|Overall Study|Lost to Follow-up|6|||
145403844|NCT03533751|524334422|FG003|Overall Study|Lost to Follow-up|4|||
145403845|NCT03533751|524334423|FG004|Overall Study|Lost to Follow-up|3|||
145403846|NCT03533751|524334419|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
145403847|NCT03533751|524334420|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
145784002|NCT01790438|525718266|FG000|Overall Study|Death|4|||
145403848|NCT03533751|524334421|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
145279499|NCT00386100|523872992|FG000|Overall Study|Bad metabolic control & patient security|1|||
145279500|NCT00386100|523872993|FG001|Overall Study|Bad metabolic control & patient security|0|||
145537704|NCT02925117|524827545|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145537705|NCT02925117|524827546|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145537706|NCT02925117|524827547|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145537707|NCT02925117|524827548|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
145537708|NCT02925117|524827549|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
145537709|NCT02925117|524827550|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
145537710|NCT02925117|524827551|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
145537711|NCT02925117|524827552|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
145537712|NCT02925117|524827553|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145784003|NCT01790438|525718267|FG001|Overall Study|Death|0|||
145784004|NCT01790438|525718266|FG000|Overall Study|Lost to Follow-up|5|||
145784005|NCT01790438|525718267|FG001|Overall Study|Lost to Follow-up|2|||
145784006|NCT01790438|525718266|FG000|Overall Study|Withdrawal by Subject|13|||
145784007|NCT01790438|525718267|FG001|Overall Study|Withdrawal by Subject|2|||
145279501|NCT00386100|523872992|FG000|Overall Study|Bone loss by DXA bone scan|1|||
145279502|NCT00386100|523872993|FG001|Overall Study|Bone loss by DXA bone scan|0|||
145279503|NCT00386100|523872992|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
145279504|NCT00386100|523872993|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
145279505|NCT00386100|523872992|FG000|Overall Study|7.6% bone loss|1|||
145279506|NCT00386100|523872993|FG001|Overall Study|7.6% bone loss|0|||
145279507|NCT00386100|523872992|FG000|Overall Study|Osteoporosis|0|||
145279508|NCT00386100|523872993|FG001|Overall Study|Osteoporosis|1|||
145279509|NCT00386100|523872992|FG000|Overall Study|Positive pregnancy test|1|||
145279510|NCT00386100|523872993|FG001|Overall Study|Positive pregnancy test|3|||
145279511|NCT00386100|523872992|FG000|Overall Study|Out of country for 5 months|1|||
145279512|NCT00386100|523872993|FG001|Overall Study|Out of country for 5 months|0|||
145279513|NCT00386100|523872992|FG000|Overall Study|Hb1Ac >8%|0|||
145279514|NCT00386100|523872993|FG001|Overall Study|Hb1Ac >8%|1|||
145279515|NCT00386100|523872992|FG000|Overall Study|Participant randomized in error|1|||
145279516|NCT00386100|523872993|FG001|Overall Study|Participant randomized in error|0|||
145279517|NCT03185949|523872999|FG000|ITT Analysis|Withdrawal by Subject|4|||
145279518|NCT03185949|523873000|FG001|ITT Analysis|Withdrawal by Subject|3|||
145279519|NCT03185949|523872999|FG000|PP Analysis|Protocol Violation|2|||
145279520|NCT03185949|523873000|FG001|PP Analysis|Protocol Violation|2|||
145279521|NCT03185949|523872999|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
145279522|NCT03185949|523873000|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
145279523|NCT05788237|523873006|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
145279524|NCT05788237|523873007|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
145279525|NCT05788237|523873008|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
145279526|NCT05788237|523873009|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
145279527|NCT05788237|523873006|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
145279528|NCT05788237|523873007|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
145279529|NCT05788237|523873008|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
145279530|NCT05788237|523873009|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
145279531|NCT05788237|523873006|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
145279532|NCT05788237|523873007|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
145279533|NCT05788237|523873008|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
145279534|NCT05788237|523873009|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
145279535|NCT05788237|523873006|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
145279536|NCT05788237|523873007|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
145279537|NCT05788237|523873008|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
145279538|NCT05788237|523873009|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
145279539|NCT05788237|523873006|FG000|SSA (Approximately 2 Months)|Death|0|||
145784008|NCT01790438|525718266|FG000|Overall Study|Physician Decision|3|||
145279540|NCT05788237|523873007|FG001|SSA (Approximately 2 Months)|Death|1|||
145279541|NCT05788237|523873008|FG002|SSA (Approximately 2 Months)|Death|0|||
145537713|NCT02925117|524827554|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
145537714|NCT02925117|524827555|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
145537715|NCT02925117|524827544|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
145537716|NCT02925117|524827545|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
145537717|NCT02925117|524827546|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
145537718|NCT02925117|524827547|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
145537719|NCT02925117|524827548|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
145537720|NCT02925117|524827549|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
145537721|NCT02925117|524827550|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
145537722|NCT02925117|524827551|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
145537723|NCT02925117|524827552|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
145537724|NCT02925117|524827553|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
145537725|NCT02925117|524827554|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
145537726|NCT02925117|524827555|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
145537727|NCT00347360|524827557|FG000|Overall Study|Adverse Event|1|||
145537728|NCT00347360|524827558|FG001|Overall Study|Adverse Event|2|||
145537729|NCT00347360|524827559|FG002|Overall Study|Adverse Event|0|||
145537730|NCT00347360|524827560|FG003|Overall Study|Adverse Event|4|||
145537731|NCT00347360|524827561|FG004|Overall Study|Adverse Event|1|||
145537732|NCT00347360|524827562|FG005|Overall Study|Adverse Event|2|||
145537733|NCT00347360|524827563|FG006|Overall Study|Adverse Event|2|||
145537734|NCT00347360|524827564|FG007|Overall Study|Adverse Event|0|||
145537735|NCT00347360|524827565|FG008|Overall Study|Adverse Event|2|||
145537736|NCT00347360|524827566|FG009|Overall Study|Adverse Event|3|||
145537737|NCT00347360|524827567|FG010|Overall Study|Adverse Event|3|||
145537738|NCT00347360|524827568|FG011|Overall Study|Adverse Event|1|||
145537739|NCT00347360|524827569|FG012|Overall Study|Adverse Event|3|||
145537740|NCT00347360|524827570|FG013|Overall Study|Adverse Event|2|||
145537741|NCT00347360|524827571|FG014|Overall Study|Adverse Event|2|||
145537742|NCT00347360|524827557|FG000|Overall Study|Lost to Follow-up|0|||
145537743|NCT00347360|524827558|FG001|Overall Study|Lost to Follow-up|0|||
145537744|NCT00347360|524827559|FG002|Overall Study|Lost to Follow-up|0|||
145537745|NCT00347360|524827560|FG003|Overall Study|Lost to Follow-up|2|||
145537746|NCT00347360|524827561|FG004|Overall Study|Lost to Follow-up|1|||
145537747|NCT00347360|524827562|FG005|Overall Study|Lost to Follow-up|1|||
145537748|NCT00347360|524827563|FG006|Overall Study|Lost to Follow-up|0|||
145537749|NCT00347360|524827564|FG007|Overall Study|Lost to Follow-up|1|||
145609153|NCT00553202|525084829|FG000|Overall Study|Death|16|||
145537750|NCT00347360|524827565|FG008|Overall Study|Lost to Follow-up|1|||
145537751|NCT00347360|524827566|FG009|Overall Study|Lost to Follow-up|2|||
145537752|NCT00347360|524827567|FG010|Overall Study|Lost to Follow-up|0|||
145784009|NCT01790438|525718267|FG001|Overall Study|Physician Decision|1|||
145784010|NCT01790438|525718266|FG000|Overall Study|Sponsor Decision|0|||
145784011|NCT01790438|525718267|FG001|Overall Study|Sponsor Decision|3|||
145784012|NCT01790438|525718266|FG000|Overall Study|Protocol Required Discontinuation|7|||
145784013|NCT01790438|525718267|FG001|Overall Study|Protocol Required Discontinuation|1|||
145784014|NCT02433210|525718271|FG000|Overall Study|Physician Decision|1|||
145784015|NCT02433210|525718272|FG001|Overall Study|Physician Decision|0|||
145784016|NCT02433210|525718273|FG002|Overall Study|Physician Decision|0|||
145784017|NCT02090114|525718274|FG000|Overall Study|Withdrawal by Subject|3|||
145784018|NCT02090114|525718275|FG001|Overall Study|Withdrawal by Subject|6|||
145784019|NCT02090114|525718276|FG002|Overall Study|Withdrawal by Subject|2|||
145784020|NCT02090114|525718277|FG003|Overall Study|Withdrawal by Subject|1|||
145784021|NCT02090114|525718274|FG000|Overall Study|Physician Decision|5|||
145784022|NCT02090114|525718275|FG001|Overall Study|Physician Decision|0|||
145784023|NCT02090114|525718276|FG002|Overall Study|Physician Decision|1|||
145784024|NCT02090114|525718277|FG003|Overall Study|Physician Decision|1|||
145784025|NCT02090114|525718274|FG000|Overall Study|Adverse Event|1|||
145784026|NCT02090114|525718275|FG001|Overall Study|Adverse Event|2|||
145784027|NCT02090114|525718276|FG002|Overall Study|Adverse Event|2|||
145784028|NCT02090114|525718277|FG003|Overall Study|Adverse Event|0|||
145784029|NCT02090114|525718274|FG000|Overall Study|Progressive Disease|20|||
145784030|NCT02090114|525718275|FG001|Overall Study|Progressive Disease|21|||
145784031|NCT02090114|525718276|FG002|Overall Study|Progressive Disease|23|||
145784032|NCT02090114|525718277|FG003|Overall Study|Progressive Disease|6|||
145784033|NCT02090114|525718274|FG000|Overall Study|Death|1|||
145784034|NCT02090114|525718275|FG001|Overall Study|Death|0|||
145784035|NCT02090114|525718276|FG002|Overall Study|Death|1|||
145784036|NCT02090114|525718277|FG003|Overall Study|Death|0|||
145784037|NCT01931462|525718278|FG000|Overall Study|Withdrawal by Subject|1|||
145784038|NCT01793051|525718283|FG000|Overall Study|Withdrawal by Subject|6|||
145784039|NCT01793051|525718284|FG001|Overall Study|Withdrawal by Subject|4|||
145784040|NCT01793051|525718283|FG000|Overall Study|Adverse Event|0|||
145784041|NCT01793051|525718284|FG001|Overall Study|Adverse Event|2|||
145784042|NCT01793051|525718283|FG000|Overall Study|Too ill to continue|1|||
145784043|NCT01793051|525718284|FG001|Overall Study|Too ill to continue|0|||
145784044|NCT01793051|525718283|FG000|Overall Study|Switched chemo|1|||
145784045|NCT01793051|525718284|FG001|Overall Study|Switched chemo|1|||
145784046|NCT01793051|525718283|FG000|Overall Study|Lack of compliance|1|||
145784047|NCT01793051|525718284|FG001|Overall Study|Lack of compliance|0|||
145784048|NCT01793051|525718283|FG000|Overall Study|Requested to be removed from the study|1|||
145784049|NCT01793051|525718284|FG001|Overall Study|Requested to be removed from the study|1|||
145784050|NCT00059215|525718286|FG000|Overall Study|Adverse Event|5|||
145784051|NCT00059215|525718287|FG001|Overall Study|Adverse Event|5|||
145784052|NCT00059215|525718288|FG002|Overall Study|Adverse Event|9|||
145784053|NCT00059215|525718289|FG003|Overall Study|Adverse Event|9|||
145784054|NCT00059215|525718286|FG000|Overall Study|Death|0|||
145784055|NCT00059215|525718287|FG001|Overall Study|Death|0|||
145784056|NCT00059215|525718288|FG002|Overall Study|Death|3|||
145784057|NCT00059215|525718289|FG003|Overall Study|Death|0|||
145784058|NCT00059215|525718286|FG000|Overall Study|Lost to Follow-up|1|||
145784059|NCT00059215|525718287|FG001|Overall Study|Lost to Follow-up|2|||
145784060|NCT00059215|525718288|FG002|Overall Study|Lost to Follow-up|0|||
145784061|NCT00059215|525718289|FG003|Overall Study|Lost to Follow-up|0|||
145784062|NCT00059215|525718286|FG000|Overall Study|Withdrawal by Subject|4|||
145784063|NCT00059215|525718287|FG001|Overall Study|Withdrawal by Subject|4|||
145784064|NCT00059215|525718288|FG002|Overall Study|Withdrawal by Subject|1|||
145784065|NCT00059215|525718289|FG003|Overall Study|Withdrawal by Subject|3|||
145784066|NCT00059215|525718286|FG000|Overall Study|Protocol Violation|1|||
145784067|NCT00059215|525718287|FG001|Overall Study|Protocol Violation|0|||
145784068|NCT00059215|525718288|FG002|Overall Study|Protocol Violation|1|||
145784069|NCT00059215|525718289|FG003|Overall Study|Protocol Violation|0|||
145784070|NCT00059215|525718286|FG000|Overall Study|Protocol entry criteria not met|1|||
145537753|NCT00347360|524827568|FG011|Overall Study|Lost to Follow-up|0|||
145537754|NCT00347360|524827569|FG012|Overall Study|Lost to Follow-up|1|||
145784071|NCT00059215|525718287|FG001|Overall Study|Protocol entry criteria not met|1|||
145784072|NCT00059215|525718288|FG002|Overall Study|Protocol entry criteria not met|0|||
145784073|NCT00059215|525718289|FG003|Overall Study|Protocol entry criteria not met|2|||
145784074|NCT00059215|525718286|FG000|Overall Study|Physician Decision|1|||
145784075|NCT00059215|525718287|FG001|Overall Study|Physician Decision|2|||
145784076|NCT00059215|525718288|FG002|Overall Study|Physician Decision|1|||
145784077|NCT00059215|525718289|FG003|Overall Study|Physician Decision|1|||
145784078|NCT04494633|525718294|FG000|Overall Study|Lost to Follow-up|5|||
145784079|NCT04494633|525718295|FG001|Overall Study|Lost to Follow-up|3|||
145784080|NCT04494633|525718294|FG000|Overall Study|Protocol Violation|1|||
145784081|NCT04494633|525718295|FG001|Overall Study|Protocol Violation|1|||
145784082|NCT04907539|525718296|FG000|Overall Study|Consent withdrawn|1|||
145784083|NCT04907539|525718297|FG001|Overall Study|Consent withdrawn|0|||
145784084|NCT04907539|525718296|FG000|Overall Study|Death|14|||
145784085|NCT04907539|525718297|FG001|Overall Study|Death|3|||
145784086|NCT01881620|525718300|FG000|Overall Study|Protocol Violation|4|||
145537755|NCT00347360|524827570|FG013|Overall Study|Lost to Follow-up|0|||
145537756|NCT00347360|524827571|FG014|Overall Study|Lost to Follow-up|0|||
145279542|NCT05788237|523873009|FG003|SSA (Approximately 2 Months)|Death|0|||
145279543|NCT05788237|523873006|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
145279544|NCT05788237|523873007|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
145279545|NCT05788237|523873008|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
145279546|NCT05788237|523873009|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
145279547|NCT05788237|523873006|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
145279548|NCT05788237|523873007|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
145279549|NCT05788237|523873008|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
145279550|NCT05788237|523873009|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
145279551|NCT05788237|523873006|FG000|SSB (Approximately 1 Month)|Other|0|||
145279552|NCT05788237|523873007|FG001|SSB (Approximately 1 Month)|Other|0|||
145279553|NCT05788237|523873008|FG002|SSB (Approximately 1 Month)|Other|0|||
145279554|NCT05788237|523873009|FG003|SSB (Approximately 1 Month)|Other|1|||
145279555|NCT01246973|523874292|FG000|Overall Study|Other|38|||
145279556|NCT01246973|523874293|FG001|Overall Study|Other|25|||
145279557|NCT01246973|523874292|FG000|Overall Study|Adverse Event|16|||
145279558|NCT01246973|523874293|FG001|Overall Study|Adverse Event|9|||
145279559|NCT01246973|523874292|FG000|Overall Study|Withdrawal by Subject|7|||
145279560|NCT01246973|523874293|FG001|Overall Study|Withdrawal by Subject|13|||
145279561|NCT01835470|523874296|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
145279562|NCT01835470|523874296|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
145279563|NCT01011907|523874297|FG000|Overall Study|Withdrawal by Subject|13|||
145279564|NCT01011907|523874298|FG001|Overall Study|Withdrawal by Subject|11|||
145279565|NCT01011907|523874297|FG000|Overall Study|Adverse Event|1|||
145279566|NCT01011907|523874298|FG001|Overall Study|Adverse Event|4|||
145279567|NCT00304954|523874299|FG000|Overall Study|Withdrawal by Subject|0|||
145279568|NCT00304954|523874300|FG001|Overall Study|Withdrawal by Subject|0|||
145279569|NCT00304954|523874301|FG002|Overall Study|Withdrawal by Subject|1|||
145279570|NCT00304954|523874302|FG003|Overall Study|Withdrawal by Subject|0|||
145279571|NCT00304954|523874299|FG000|Overall Study|Adverse Event|1|||
145279572|NCT00304954|523874300|FG001|Overall Study|Adverse Event|0|||
145279573|NCT00304954|523874301|FG002|Overall Study|Adverse Event|0|||
145279574|NCT00304954|523874302|FG003|Overall Study|Adverse Event|0|||
145279575|NCT01406873|523874307|FG000|Overall Study|Withdrawal by Subject|1|||
145279576|NCT01406873|523874308|FG001|Overall Study|Withdrawal by Subject|1|||
145279577|NCT00207714|523874309|FG000|Overall Study|Adverse Event|6|||
145279578|NCT00207714|523874310|FG001|Overall Study|Adverse Event|2|||
145279579|NCT00207714|523874311|FG002|Overall Study|Adverse Event|4|||
145279580|NCT00207714|523874312|FG003|Overall Study|Adverse Event|3|||
145279581|NCT00207714|523874313|FG004|Overall Study|Adverse Event|1|||
145279582|NCT00207714|523874309|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145279583|NCT00207714|523874310|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145279584|NCT00207714|523874311|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
145279585|NCT00207714|523874312|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
145279586|NCT00207714|523874313|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
145279587|NCT00207714|523874309|FG000|Overall Study|Other|3|||
145279588|NCT00207714|523874310|FG001|Overall Study|Other|2|||
145279589|NCT00207714|523874311|FG002|Overall Study|Other|5|||
145279590|NCT00207714|523874312|FG003|Overall Study|Other|1|||
145279591|NCT00207714|523874313|FG004|Overall Study|Other|0|||
145279592|NCT03627195|523874314|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
145279593|NCT03627195|523874315|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
145279594|NCT03627195|523874316|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
145279595|NCT03627195|523874317|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
145279596|NCT03627195|523874318|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
145279597|NCT03627195|523874319|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
145279598|NCT02290028|523874323|FG000|Overall Study|Death|217|||
145279599|NCT02290028|523874323|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
145279600|NCT02290028|523874323|FG000|Overall Study|No longer under care of study physician|76|||
145279601|NCT02290028|523874323|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
145279602|NCT02290028|523874323|FG000|Overall Study|Withdrawal by Subject|52|||
145279603|NCT02290028|523874323|FG000|Overall Study|Study site closure|44|||
145279604|NCT02290028|523874323|FG000|Overall Study|Lost to Follow-up|34|||
145279605|NCT02290028|523874323|FG000|Overall Study|Miscellaneous|10|||
145537757|NCT00347360|524827557|FG000|Overall Study|Protocol Violation|2|||
145279606|NCT02290028|523874323|FG000|Overall Study|Transition to EP PASSION|1295|||
145279607|NCT02290028|523874323|FG000|Overall Study|Planned study completion at 12 months|257|||
145537758|NCT00347360|524827558|FG001|Overall Study|Protocol Violation|3|||
145279608|NCT00054275|523874326|FG000|Overall Study|Withdrawal by Subject|4|||
145279609|NCT00054275|523874326|FG000|Overall Study|Adverse Event|5|||
145537759|NCT00347360|524827559|FG002|Overall Study|Protocol Violation|1|||
145537760|NCT00347360|524827560|FG003|Overall Study|Protocol Violation|2|||
145279610|NCT00054275|523874326|FG000|Overall Study|Progressive disease in cycle 1|1|||
145537761|NCT00347360|524827561|FG004|Overall Study|Protocol Violation|1|||
145537762|NCT00347360|524827562|FG005|Overall Study|Protocol Violation|2|||
145537763|NCT00347360|524827563|FG006|Overall Study|Protocol Violation|0|||
145537764|NCT00347360|524827564|FG007|Overall Study|Protocol Violation|0|||
145537765|NCT00347360|524827565|FG008|Overall Study|Protocol Violation|1|||
145537766|NCT00347360|524827566|FG009|Overall Study|Protocol Violation|2|||
145537767|NCT00347360|524827567|FG010|Overall Study|Protocol Violation|0|||
145537768|NCT00347360|524827568|FG011|Overall Study|Protocol Violation|0|||
145537769|NCT00347360|524827569|FG012|Overall Study|Protocol Violation|0|||
145537770|NCT00347360|524827570|FG013|Overall Study|Protocol Violation|1|||
145537771|NCT00347360|524827571|FG014|Overall Study|Protocol Violation|0|||
145537772|NCT00347360|524827557|FG000|Overall Study|Withdrawal by Subject|0|||
145537773|NCT00347360|524827558|FG001|Overall Study|Withdrawal by Subject|1|||
145537774|NCT00347360|524827559|FG002|Overall Study|Withdrawal by Subject|2|||
145537775|NCT00347360|524827560|FG003|Overall Study|Withdrawal by Subject|4|||
145537776|NCT00347360|524827561|FG004|Overall Study|Withdrawal by Subject|1|||
145537777|NCT00347360|524827562|FG005|Overall Study|Withdrawal by Subject|2|||
145537778|NCT00347360|524827563|FG006|Overall Study|Withdrawal by Subject|1|||
145537779|NCT00347360|524827564|FG007|Overall Study|Withdrawal by Subject|1|||
145537780|NCT00347360|524827565|FG008|Overall Study|Withdrawal by Subject|1|||
145537781|NCT00347360|524827566|FG009|Overall Study|Withdrawal by Subject|1|||
145537782|NCT00347360|524827567|FG010|Overall Study|Withdrawal by Subject|0|||
145537783|NCT00347360|524827568|FG011|Overall Study|Withdrawal by Subject|3|||
145537784|NCT00347360|524827569|FG012|Overall Study|Withdrawal by Subject|4|||
145537785|NCT00347360|524827570|FG013|Overall Study|Withdrawal by Subject|2|||
145537786|NCT00347360|524827571|FG014|Overall Study|Withdrawal by Subject|1|||
145537787|NCT00347360|524827557|FG000|Overall Study|Lack of Efficacy|1|||
145537788|NCT00347360|524827558|FG001|Overall Study|Lack of Efficacy|1|||
145537789|NCT00347360|524827559|FG002|Overall Study|Lack of Efficacy|3|||
145537790|NCT00347360|524827560|FG003|Overall Study|Lack of Efficacy|1|||
145537791|NCT00347360|524827561|FG004|Overall Study|Lack of Efficacy|0|||
145537792|NCT00347360|524827562|FG005|Overall Study|Lack of Efficacy|1|||
145537793|NCT00347360|524827563|FG006|Overall Study|Lack of Efficacy|0|||
145537794|NCT00347360|524827564|FG007|Overall Study|Lack of Efficacy|1|||
145537795|NCT00347360|524827565|FG008|Overall Study|Lack of Efficacy|1|||
145537796|NCT00347360|524827566|FG009|Overall Study|Lack of Efficacy|0|||
145537797|NCT00347360|524827567|FG010|Overall Study|Lack of Efficacy|0|||
145537798|NCT00347360|524827568|FG011|Overall Study|Lack of Efficacy|0|||
145537799|NCT00347360|524827569|FG012|Overall Study|Lack of Efficacy|0|||
145537800|NCT00347360|524827570|FG013|Overall Study|Lack of Efficacy|0|||
145537801|NCT00347360|524827571|FG014|Overall Study|Lack of Efficacy|0|||
145537802|NCT00347360|524827557|FG000|Overall Study|Reason not listed/blank|1|||
145537803|NCT00347360|524827558|FG001|Overall Study|Reason not listed/blank|0|||
145537804|NCT00347360|524827559|FG002|Overall Study|Reason not listed/blank|0|||
145537805|NCT00347360|524827560|FG003|Overall Study|Reason not listed/blank|0|||
145537806|NCT00347360|524827561|FG004|Overall Study|Reason not listed/blank|0|||
145537807|NCT00347360|524827562|FG005|Overall Study|Reason not listed/blank|0|||
145537808|NCT00347360|524827563|FG006|Overall Study|Reason not listed/blank|1|||
145537809|NCT00347360|524827564|FG007|Overall Study|Reason not listed/blank|0|||
145784087|NCT01808118|525718303|FG000|Period 1|Adverse Event|15|||
145784088|NCT01808118|525718304|FG001|Period 1|Adverse Event|0|||
145784089|NCT01808118|525718305|FG002|Period 1|Adverse Event|0|||
145784090|NCT01808118|525718303|FG000|Period 1|Withdrew consent|24|||
145784091|NCT01808118|525718304|FG001|Period 1|Withdrew consent|0|||
145784092|NCT01808118|525718305|FG002|Period 1|Withdrew consent|0|||
145784093|NCT01808118|525718303|FG000|Period 1|Lost to Follow-up|9|||
145784094|NCT01808118|525718304|FG001|Period 1|Lost to Follow-up|0|||
145784095|NCT01808118|525718305|FG002|Period 1|Lost to Follow-up|0|||
145784096|NCT01808118|525718303|FG000|Period 1|Did not meet criteria for remission|303|||
145784097|NCT01808118|525718304|FG001|Period 1|Did not meet criteria for remission|0|||
145784098|NCT01808118|525718305|FG002|Period 1|Did not meet criteria for remission|0|||
145784099|NCT01808118|525718303|FG000|Period 1|Enrolled in error|7|||
145784100|NCT01808118|525718304|FG001|Period 1|Enrolled in error|0|||
145784101|NCT01808118|525718305|FG002|Period 1|Enrolled in error|0|||
145784102|NCT01808118|525718303|FG000|Period 1|Did not meet inclusion criteria|3|||
145537810|NCT00347360|524827565|FG008|Overall Study|Reason not listed/blank|0|||
145537811|NCT00347360|524827566|FG009|Overall Study|Reason not listed/blank|0|||
145537812|NCT00347360|524827567|FG010|Overall Study|Reason not listed/blank|0|||
145537813|NCT00347360|524827568|FG011|Overall Study|Reason not listed/blank|0|||
145784103|NCT01808118|525718304|FG001|Period 1|Did not meet inclusion criteria|0|||
145784104|NCT01808118|525718305|FG002|Period 1|Did not meet inclusion criteria|0|||
145784105|NCT01808118|525718303|FG000|Period 1|Non-conformance with inclusion criteria|3|||
145537814|NCT00347360|524827569|FG012|Overall Study|Reason not listed/blank|0|||
145537815|NCT00347360|524827570|FG013|Overall Study|Reason not listed/blank|1|||
145537816|NCT00347360|524827571|FG014|Overall Study|Reason not listed/blank|0|||
145784106|NCT01808118|525718304|FG001|Period 1|Non-conformance with inclusion criteria|0|||
145537817|NCT00347360|524827557|FG000|Overall Study|Per sponsors instruction|0|||
145537818|NCT00347360|524827558|FG001|Overall Study|Per sponsors instruction|1|||
145537819|NCT00347360|524827559|FG002|Overall Study|Per sponsors instruction|0|||
145537820|NCT00347360|524827560|FG003|Overall Study|Per sponsors instruction|0|||
145537821|NCT00347360|524827561|FG004|Overall Study|Per sponsors instruction|0|||
145537822|NCT00347360|524827562|FG005|Overall Study|Per sponsors instruction|0|||
145537823|NCT00347360|524827563|FG006|Overall Study|Per sponsors instruction|0|||
145537824|NCT00347360|524827564|FG007|Overall Study|Per sponsors instruction|0|||
145537825|NCT00347360|524827565|FG008|Overall Study|Per sponsors instruction|0|||
145537826|NCT00347360|524827566|FG009|Overall Study|Per sponsors instruction|0|||
145537827|NCT00347360|524827567|FG010|Overall Study|Per sponsors instruction|0|||
145537828|NCT00347360|524827568|FG011|Overall Study|Per sponsors instruction|0|||
145537829|NCT00347360|524827569|FG012|Overall Study|Per sponsors instruction|0|||
145537830|NCT00347360|524827570|FG013|Overall Study|Per sponsors instruction|0|||
145537831|NCT00347360|524827571|FG014|Overall Study|Per sponsors instruction|0|||
145537832|NCT00347360|524827557|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
145537833|NCT00347360|524827558|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
145537834|NCT00347360|524827559|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
145537835|NCT00347360|524827560|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
145537836|NCT00347360|524827561|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
145537837|NCT00347360|524827562|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
145537838|NCT00347360|524827563|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
145537839|NCT00347360|524827564|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
145537840|NCT00347360|524827565|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
145537841|NCT00347360|524827566|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
145537842|NCT00347360|524827567|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
145537843|NCT00347360|524827568|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
145537844|NCT00347360|524827569|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
145537845|NCT00347360|524827570|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
145537846|NCT00347360|524827571|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
145537847|NCT00347360|524827557|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
145537848|NCT00347360|524827558|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
145537849|NCT00347360|524827559|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
145537850|NCT00347360|524827560|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
145537851|NCT00347360|524827561|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
145537852|NCT00347360|524827562|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
145537853|NCT00347360|524827563|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
145537854|NCT00347360|524827564|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
145537855|NCT00347360|524827565|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
145537856|NCT00347360|524827566|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
145537857|NCT00347360|524827567|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
145537858|NCT00347360|524827568|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
145537859|NCT00347360|524827569|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
145537860|NCT00347360|524827570|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
145537861|NCT00347360|524827571|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
145537862|NCT00347360|524827557|FG000|Overall Study|Abnormal lab values|0|||
145537863|NCT00347360|524827558|FG001|Overall Study|Abnormal lab values|0|||
145537864|NCT00347360|524827559|FG002|Overall Study|Abnormal lab values|0|||
145537865|NCT00347360|524827560|FG003|Overall Study|Abnormal lab values|0|||
145537866|NCT00347360|524827561|FG004|Overall Study|Abnormal lab values|0|||
145537867|NCT00347360|524827562|FG005|Overall Study|Abnormal lab values|0|||
145537868|NCT00347360|524827563|FG006|Overall Study|Abnormal lab values|1|||
145537869|NCT00347360|524827564|FG007|Overall Study|Abnormal lab values|0|||
145537870|NCT00347360|524827565|FG008|Overall Study|Abnormal lab values|0|||
145537871|NCT00347360|524827566|FG009|Overall Study|Abnormal lab values|0|||
145537872|NCT00347360|524827567|FG010|Overall Study|Abnormal lab values|0|||
145537873|NCT00347360|524827568|FG011|Overall Study|Abnormal lab values|0|||
145537874|NCT00347360|524827569|FG012|Overall Study|Abnormal lab values|0|||
145537875|NCT00347360|524827570|FG013|Overall Study|Abnormal lab values|0|||
145537876|NCT00347360|524827571|FG014|Overall Study|Abnormal lab values|0|||
145537877|NCT00347360|524827557|FG000|Overall Study|PI recommended early withdrawal|0|||
145537878|NCT00347360|524827558|FG001|Overall Study|PI recommended early withdrawal|0|||
145537879|NCT00347360|524827559|FG002|Overall Study|PI recommended early withdrawal|0|||
145537880|NCT00347360|524827560|FG003|Overall Study|PI recommended early withdrawal|0|||
145537881|NCT00347360|524827561|FG004|Overall Study|PI recommended early withdrawal|0|||
145609154|NCT00553202|525084829|FG000|Overall Study|Lost to Follow-up|1|||
145403849|NCT03533751|524334422|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
145537882|NCT00347360|524827562|FG005|Overall Study|PI recommended early withdrawal|0|||
145537883|NCT00347360|524827563|FG006|Overall Study|PI recommended early withdrawal|0|||
145537884|NCT00347360|524827564|FG007|Overall Study|PI recommended early withdrawal|0|||
145537885|NCT00347360|524827565|FG008|Overall Study|PI recommended early withdrawal|0|||
145537886|NCT00347360|524827566|FG009|Overall Study|PI recommended early withdrawal|1|||
145537887|NCT00347360|524827567|FG010|Overall Study|PI recommended early withdrawal|0|||
145609155|NCT00553202|525084829|FG000|Overall Study|Physician Decision|28|||
145279611|NCT00054275|523874326|FG000|Overall Study|Physician Decision|1|||
145279612|NCT00755937|523874327|FG000|Recruitment|Unknown if infliximab received|164|||
145279613|NCT00755937|523874327|FG000|Observational Follow-up|Lost to Follow-up|148|||
145279614|NCT01106352|523874328|FG000|Overall Study|Subjects untreated|0|||
145279615|NCT01106352|523874329|FG001|Overall Study|Subjects untreated|0|||
145279616|NCT01106352|523874330|FG002|Overall Study|Subjects untreated|0|||
145279617|NCT01106352|523874331|FG003|Overall Study|Subjects untreated|3|||
145279618|NCT01106352|523874332|FG004|Overall Study|Subjects untreated|4|||
145279619|NCT01106352|523874328|FG000|Overall Study|Sponsor Decision|1|||
145279620|NCT01106352|523874329|FG001|Overall Study|Sponsor Decision|0|||
145279621|NCT01106352|523874330|FG002|Overall Study|Sponsor Decision|0|||
145279622|NCT01106352|523874331|FG003|Overall Study|Sponsor Decision|0|||
145279623|NCT01106352|523874332|FG004|Overall Study|Sponsor Decision|0|||
145279624|NCT01106352|523874328|FG000|Overall Study|Too ill to come in for the visit|0|||
145279625|NCT01106352|523874329|FG001|Overall Study|Too ill to come in for the visit|0|||
145279626|NCT01106352|523874330|FG002|Overall Study|Too ill to come in for the visit|1|||
145279627|NCT01106352|523874331|FG003|Overall Study|Too ill to come in for the visit|0|||
145279628|NCT01106352|523874332|FG004|Overall Study|Too ill to come in for the visit|0|||
145279629|NCT01106352|523874328|FG000|Overall Study|Lost to Follow-up|0|||
145279630|NCT01106352|523874329|FG001|Overall Study|Lost to Follow-up|0|||
145279631|NCT01106352|523874330|FG002|Overall Study|Lost to Follow-up|0|||
145279632|NCT01106352|523874331|FG003|Overall Study|Lost to Follow-up|0|||
145279633|NCT01106352|523874332|FG004|Overall Study|Lost to Follow-up|1|||
145279634|NCT01106352|523874328|FG000|Overall Study|Death|0|||
145279635|NCT01106352|523874329|FG001|Overall Study|Death|0|||
145279636|NCT01106352|523874330|FG002|Overall Study|Death|1|||
145279637|NCT01106352|523874331|FG003|Overall Study|Death|3|||
145279638|NCT01106352|523874332|FG004|Overall Study|Death|1|||
145279639|NCT01106352|523874328|FG000|Overall Study|Disease progression|0|||
145279640|NCT01106352|523874329|FG001|Overall Study|Disease progression|0|||
145279641|NCT01106352|523874330|FG002|Overall Study|Disease progression|0|||
145279642|NCT01106352|523874331|FG003|Overall Study|Disease progression|1|||
145279643|NCT01106352|523874332|FG004|Overall Study|Disease progression|0|||
145279644|NCT01106352|523874328|FG000|Overall Study|Withdrawal by Subject|0|||
145279645|NCT01106352|523874329|FG001|Overall Study|Withdrawal by Subject|0|||
145279646|NCT01106352|523874330|FG002|Overall Study|Withdrawal by Subject|0|||
145279647|NCT01106352|523874331|FG003|Overall Study|Withdrawal by Subject|3|||
145279648|NCT01106352|523874332|FG004|Overall Study|Withdrawal by Subject|2|||
145279649|NCT01106352|523874328|FG000|Overall Study|Went on hospice|0|||
145279650|NCT01106352|523874329|FG001|Overall Study|Went on hospice|0|||
145279651|NCT01106352|523874330|FG002|Overall Study|Went on hospice|0|||
145279652|NCT01106352|523874331|FG003|Overall Study|Went on hospice|1|||
145279653|NCT01106352|523874332|FG004|Overall Study|Went on hospice|0|||
145279654|NCT01106352|523874328|FG000|Overall Study|Subject entered hospice|0|||
145279655|NCT01106352|523874329|FG001|Overall Study|Subject entered hospice|0|||
145279656|NCT01106352|523874330|FG002|Overall Study|Subject entered hospice|0|||
145279657|NCT01106352|523874331|FG003|Overall Study|Subject entered hospice|1|||
145279658|NCT01106352|523874332|FG004|Overall Study|Subject entered hospice|0|||
145279659|NCT01106352|523874328|FG000|Overall Study|Home hospice since July 2013|0|||
145279660|NCT01106352|523874329|FG001|Overall Study|Home hospice since July 2013|0|||
145279661|NCT01106352|523874330|FG002|Overall Study|Home hospice since July 2013|0|||
145279662|NCT01106352|523874331|FG003|Overall Study|Home hospice since July 2013|1|||
145279663|NCT01106352|523874332|FG004|Overall Study|Home hospice since July 2013|0|||
145279664|NCT03547531|523874333|FG000|Overall Study|not coming in data collection : sick|2|||
145279665|NCT03547531|523874334|FG001|Overall Study|not coming in data collection : sick|2|||
145279666|NCT03547531|523874333|FG000|Overall Study|having family occasion|0|||
145279667|NCT03547531|523874334|FG001|Overall Study|having family occasion|2|||
145279668|NCT03944707|523874335|FG000|Overall Study|Adverse Event|0|||
145279669|NCT03944707|523874336|FG001|Overall Study|Adverse Event|2|||
145279670|NCT03944707|523874335|FG000|Overall Study|Study terminated by sponsor|12|||
145279671|NCT03944707|523874336|FG001|Overall Study|Study terminated by sponsor|7|||
145279672|NCT03944707|523874335|FG000|Overall Study|Subject decision|0|||
145279673|NCT03944707|523874336|FG001|Overall Study|Subject decision|1|||
145279674|NCT03402126|523874344|FG000|Overall Study|Lost to Follow-up|6|||
145279675|NCT03402126|523874344|FG000|Overall Study|Protocol Violation|10|||
145403850|NCT03533751|524334423|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
145279676|NCT03402126|523874344|FG000|Overall Study|Sponsor request/Study termination|29|||
145279677|NCT03402126|523874344|FG000|Overall Study|Study product no longer in use|1|||
145279678|NCT03402126|523874344|FG000|Overall Study|Technical problems|1|||
145279679|NCT03402126|523874344|FG000|Overall Study|Withdrawal by Subject|6|||
145279680|NCT03402126|523874344|FG000|Overall Study|Physician Decision|2|||
145279681|NCT03402126|523874344|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
145279682|NCT03402126|523874344|FG000|Overall Study|Death|4|||
145279683|NCT02444182|523874345|FG000|Overall Study|non-compliance|2|||
145279684|NCT02444182|523874346|FG001|Overall Study|non-compliance|1|||
145279685|NCT02444182|523874345|FG000|Overall Study|Lost to Follow-up|0|||
145279686|NCT02444182|523874346|FG001|Overall Study|Lost to Follow-up|4|||
145784107|NCT01808118|525718305|FG002|Period 1|Non-conformance with inclusion criteria|0|||
145784108|NCT01808118|525718303|FG000|Period 1|Investigator decision: site closure|2|||
145784109|NCT01808118|525718304|FG001|Period 1|Investigator decision: site closure|0|||
145784110|NCT01808118|525718305|FG002|Period 1|Investigator decision: site closure|0|||
145784111|NCT01808118|525718303|FG000|Period 1|Non-compliance per sponsor|1|||
145784112|NCT01808118|525718304|FG001|Period 1|Non-compliance per sponsor|0|||
145537888|NCT00347360|524827568|FG011|Overall Study|PI recommended early withdrawal|0|||
145537889|NCT00347360|524827569|FG012|Overall Study|PI recommended early withdrawal|0|||
145537890|NCT00347360|524827570|FG013|Overall Study|PI recommended early withdrawal|0|||
145784113|NCT01808118|525718305|FG002|Period 1|Non-compliance per sponsor|0|||
145784114|NCT01808118|525718303|FG000|Period 1|Lack of Efficacy|1|||
145784115|NCT01808118|525718304|FG001|Period 1|Lack of Efficacy|0|||
145784116|NCT01808118|525718305|FG002|Period 1|Lack of Efficacy|0|||
145784117|NCT01808118|525718303|FG000|Period 2|Adverse Event|0|||
145784118|NCT01808118|525718304|FG001|Period 2|Adverse Event|4|||
145784119|NCT01808118|525718305|FG002|Period 2|Adverse Event|0|||
145784120|NCT01808118|525718303|FG000|Period 2|Withdrew consent|0|||
145784121|NCT01808118|525718304|FG001|Period 2|Withdrew consent|7|||
145784122|NCT01808118|525718305|FG002|Period 2|Withdrew consent|6|||
145784123|NCT01808118|525718303|FG000|Period 2|Lost to Follow-up|0|||
145784124|NCT01808118|525718304|FG001|Period 2|Lost to Follow-up|0|||
145784125|NCT01808118|525718305|FG002|Period 2|Lost to Follow-up|2|||
145784126|NCT01808118|525718303|FG000|Period 2|Investigator no longer conducting trials|0|||
145784127|NCT01808118|525718304|FG001|Period 2|Investigator no longer conducting trials|1|||
145784128|NCT01808118|525718305|FG002|Period 2|Investigator no longer conducting trials|0|||
145279687|NCT01959230|523874349|FG000|Overall Study|Failure to follow study procedures|0|||
145784129|NCT01808118|525718303|FG000|Period 2|Switched to other therapy|0|||
145784130|NCT01808118|525718304|FG001|Period 2|Switched to other therapy|1|||
145784131|NCT01808118|525718305|FG002|Period 2|Switched to other therapy|0|||
145784132|NCT00414310|525718306|FG000|Overall Study|Not treated|1|||
145784133|NCT00414310|525718307|FG001|Overall Study|Not treated|0|||
145784134|NCT01993329|525718311|FG000|Period 2|Adverse Event|0|||
145784135|NCT01993329|525718312|FG001|Period 2|Adverse Event|0|||
145403851|NCT03533751|524334419|FG000|Overall Study|Other|0|||
145403852|NCT03533751|524334420|FG001|Overall Study|Other|2|||
145537891|NCT00347360|524827571|FG014|Overall Study|PI recommended early withdrawal|0|||
145537892|NCT00347360|524827557|FG000|Overall Study|Did not meet criteria before ABPM|0|||
145537893|NCT00347360|524827558|FG001|Overall Study|Did not meet criteria before ABPM|0|||
145537894|NCT00347360|524827559|FG002|Overall Study|Did not meet criteria before ABPM|0|||
145537895|NCT00347360|524827560|FG003|Overall Study|Did not meet criteria before ABPM|0|||
145537896|NCT00347360|524827561|FG004|Overall Study|Did not meet criteria before ABPM|0|||
145537897|NCT00347360|524827562|FG005|Overall Study|Did not meet criteria before ABPM|0|||
145537898|NCT00347360|524827563|FG006|Overall Study|Did not meet criteria before ABPM|0|||
145537899|NCT00347360|524827564|FG007|Overall Study|Did not meet criteria before ABPM|0|||
145537900|NCT00347360|524827565|FG008|Overall Study|Did not meet criteria before ABPM|0|||
145537901|NCT00347360|524827566|FG009|Overall Study|Did not meet criteria before ABPM|0|||
145537902|NCT00347360|524827567|FG010|Overall Study|Did not meet criteria before ABPM|1|||
145537903|NCT00347360|524827568|FG011|Overall Study|Did not meet criteria before ABPM|0|||
145537904|NCT00347360|524827569|FG012|Overall Study|Did not meet criteria before ABPM|0|||
145537905|NCT00347360|524827570|FG013|Overall Study|Did not meet criteria before ABPM|0|||
145537906|NCT00347360|524827571|FG014|Overall Study|Did not meet criteria before ABPM|0|||
145537907|NCT00347360|524827557|FG000|Overall Study|Randomized in error|0|||
145537908|NCT00347360|524827558|FG001|Overall Study|Randomized in error|0|||
145537909|NCT00347360|524827559|FG002|Overall Study|Randomized in error|0|||
145537910|NCT00347360|524827560|FG003|Overall Study|Randomized in error|0|||
145537911|NCT00347360|524827561|FG004|Overall Study|Randomized in error|0|||
145537912|NCT00347360|524827562|FG005|Overall Study|Randomized in error|0|||
145537913|NCT00347360|524827563|FG006|Overall Study|Randomized in error|0|||
145537914|NCT00347360|524827564|FG007|Overall Study|Randomized in error|0|||
145537915|NCT00347360|524827565|FG008|Overall Study|Randomized in error|0|||
145537916|NCT00347360|524827566|FG009|Overall Study|Randomized in error|0|||
145537917|NCT00347360|524827567|FG010|Overall Study|Randomized in error|0|||
145537918|NCT00347360|524827568|FG011|Overall Study|Randomized in error|1|||
145537919|NCT00347360|524827569|FG012|Overall Study|Randomized in error|0|||
145537920|NCT00347360|524827570|FG013|Overall Study|Randomized in error|0|||
145537921|NCT00347360|524827571|FG014|Overall Study|Randomized in error|0|||
145537922|NCT00347360|524827557|FG000|Overall Study|Failed inclusion criteria #4|0|||
145537923|NCT00347360|524827558|FG001|Overall Study|Failed inclusion criteria #4|0|||
145537924|NCT00347360|524827559|FG002|Overall Study|Failed inclusion criteria #4|0|||
145537925|NCT00347360|524827560|FG003|Overall Study|Failed inclusion criteria #4|0|||
145537926|NCT00347360|524827561|FG004|Overall Study|Failed inclusion criteria #4|0|||
145537927|NCT00347360|524827562|FG005|Overall Study|Failed inclusion criteria #4|0|||
145537928|NCT00347360|524827563|FG006|Overall Study|Failed inclusion criteria #4|0|||
145537929|NCT00347360|524827564|FG007|Overall Study|Failed inclusion criteria #4|0|||
145537930|NCT00347360|524827565|FG008|Overall Study|Failed inclusion criteria #4|0|||
145537931|NCT00347360|524827566|FG009|Overall Study|Failed inclusion criteria #4|0|||
145537932|NCT00347360|524827567|FG010|Overall Study|Failed inclusion criteria #4|0|||
145537933|NCT00347360|524827568|FG011|Overall Study|Failed inclusion criteria #4|1|||
145537934|NCT00347360|524827569|FG012|Overall Study|Failed inclusion criteria #4|0|||
145537935|NCT00347360|524827570|FG013|Overall Study|Failed inclusion criteria #4|0|||
145537936|NCT00347360|524827571|FG014|Overall Study|Failed inclusion criteria #4|0|||
145537937|NCT00347360|524827557|FG000|Overall Study|Prolonged duration between visits|0|||
145537938|NCT00347360|524827558|FG001|Overall Study|Prolonged duration between visits|0|||
145537939|NCT00347360|524827559|FG002|Overall Study|Prolonged duration between visits|0|||
145537940|NCT00347360|524827560|FG003|Overall Study|Prolonged duration between visits|0|||
145537941|NCT00347360|524827561|FG004|Overall Study|Prolonged duration between visits|0|||
145537942|NCT00347360|524827562|FG005|Overall Study|Prolonged duration between visits|0|||
145537943|NCT00347360|524827563|FG006|Overall Study|Prolonged duration between visits|0|||
145537944|NCT00347360|524827564|FG007|Overall Study|Prolonged duration between visits|0|||
145537945|NCT00347360|524827565|FG008|Overall Study|Prolonged duration between visits|0|||
145609156|NCT00553202|525084829|FG000|Overall Study|Withdrawal by Subject|1|||
145609157|NCT00553202|525084829|FG000|Overall Study|No donor identified|16|||
145537946|NCT00347360|524827566|FG009|Overall Study|Prolonged duration between visits|0|||
145537947|NCT00347360|524827567|FG010|Overall Study|Prolonged duration between visits|0|||
145537948|NCT00347360|524827568|FG011|Overall Study|Prolonged duration between visits|0|||
145537949|NCT00347360|524827569|FG012|Overall Study|Prolonged duration between visits|1|||
145537950|NCT00347360|524827570|FG013|Overall Study|Prolonged duration between visits|0|||
145537951|NCT00347360|524827571|FG014|Overall Study|Prolonged duration between visits|0|||
145537952|NCT00347360|524827557|FG000|Overall Study|Subject left town, ran out of study drug|0|||
145537953|NCT00347360|524827558|FG001|Overall Study|Subject left town, ran out of study drug|0|||
145537954|NCT00347360|524827559|FG002|Overall Study|Subject left town, ran out of study drug|0|||
145537955|NCT00347360|524827560|FG003|Overall Study|Subject left town, ran out of study drug|0|||
145537956|NCT00347360|524827561|FG004|Overall Study|Subject left town, ran out of study drug|0|||
145537957|NCT00347360|524827562|FG005|Overall Study|Subject left town, ran out of study drug|0|||
145609158|NCT00553202|525084829|FG000|Overall Study|Fails to meet organ function|6|||
145784136|NCT01993329|525718313|FG002|Period 2|Adverse Event|0|||
145784137|NCT01993329|525718314|FG003|Period 2|Adverse Event|0|||
145784138|NCT01993329|525718315|FG004|Period 2|Adverse Event|0|||
145784139|NCT01993329|525718316|FG005|Period 2|Adverse Event|1|||
145784140|NCT01993329|525718311|FG000|Wash-out|Personal reasons|0|||
145784141|NCT01993329|525718312|FG001|Wash-out|Personal reasons|1|||
145784142|NCT01993329|525718313|FG002|Wash-out|Personal reasons|0|||
145784143|NCT01993329|525718314|FG003|Wash-out|Personal reasons|0|||
145784144|NCT01993329|525718315|FG004|Wash-out|Personal reasons|0|||
145784145|NCT01993329|525718316|FG005|Wash-out|Personal reasons|0|||
145784146|NCT02311478|525718317|FG000|Overall Study|Withdrawal by Subject|1|||
145784147|NCT02311478|525718317|FG000|Overall Study|Lost to Follow-up|5|||
145784148|NCT02311478|525718317|FG000|Overall Study|Failed IUD Insertion|1|||
145784149|NCT03276936|525718318|FG000|Overall Study|Adverse Event|4|||
145784150|NCT03276936|525718319|FG001|Overall Study|Adverse Event|2|||
145784151|NCT03276936|525718318|FG000|Overall Study|Lost to Follow-up|16|||
145784152|NCT03276936|525718319|FG001|Overall Study|Lost to Follow-up|13|||
145784153|NCT03276936|525718318|FG000|Overall Study|Withdrawal by Subject|30|||
145784154|NCT03276936|525718319|FG001|Overall Study|Withdrawal by Subject|20|||
145784155|NCT03276936|525718318|FG000|Overall Study|Not mentioned|6|||
145784156|NCT03276936|525718319|FG001|Overall Study|Not mentioned|3|||
145784157|NCT03041116|525718320|FG000|Double-blind|Death|0|||
145784158|NCT03041116|525718321|FG001|Double-blind|Death|2|||
145784159|NCT03041116|525718320|FG000|Double-blind|Withdrawal by Subject|0|||
145784160|NCT03041116|525718321|FG001|Double-blind|Withdrawal by Subject|4|||
145784161|NCT03041116|525718320|FG000|Open-label|Death|1|||
145784162|NCT03041116|525718321|FG001|Open-label|Death|0|||
145784163|NCT03041116|525718320|FG000|Open-label|Termination of the study by Sponsor|39|||
145784164|NCT03041116|525718321|FG001|Open-label|Termination of the study by Sponsor|37|||
145784165|NCT03041116|525718320|FG000|Open-label|Withdrawal by Subject|1|||
145784166|NCT03041116|525718321|FG001|Open-label|Withdrawal by Subject|0|||
145784167|NCT00943319|525718322|FG000|Overall Study|Death|1|||
145784168|NCT02043301|525718323|FG000|Overall Study|Discontinued|0|||
145279688|NCT01959230|523874350|FG001|Overall Study|Failure to follow study procedures|1|||
145279689|NCT01959230|523874349|FG000|Overall Study|Administrative reasons|2|||
145279690|NCT01959230|523874350|FG001|Overall Study|Administrative reasons|0|||
145279691|NCT01959230|523874349|FG000|Overall Study|Withdrawal by Subject|2|||
145279692|NCT01959230|523874350|FG001|Overall Study|Withdrawal by Subject|0|||
145279693|NCT00751998|523874351|FG000|Overall Study|Lost to Follow-up|7|||
145279694|NCT00751998|523874351|FG000|Overall Study|Death|11|||
145279695|NCT00751998|523874351|FG000|Overall Study|Withdrawal by Subject|2|||
145279696|NCT04126733|523874352|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
145279697|NCT04126733|523874352|FG000|Treatment Period|Adverse Event|8|||
145279698|NCT04126733|523874352|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
145279699|NCT04126733|523874352|FG000|Treatment Period|Physician Decision|5|||
145279700|NCT04126733|523874352|FG000|Treatment Period|Death|1|||
145279701|NCT04126733|523874352|FG000|Treatment Period|Other Reasons|2|||
145279702|NCT04126733|523874352|FG000|Active Follow-up Period|Death|13|||
145279703|NCT04126733|523874352|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
145279704|NCT04126733|523874352|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
145279705|NCT04126733|523874352|FG000|Active Follow-up Period|Other Reasons|1|||
145279706|NCT04126733|523874352|FG000|Long-term Follow-up Period|Death|22|||
145279707|NCT04126733|523874352|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
145537958|NCT00347360|524827563|FG006|Overall Study|Subject left town, ran out of study drug|0|||
145279708|NCT04126733|523874352|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
145784169|NCT02043301|525718324|FG001|Overall Study|Discontinued|1|||
145784170|NCT02043301|525718325|FG002|Overall Study|Discontinued|0|||
145784171|NCT03097328|525718326|FG000|Overall Study|Still on Therapy|2|||
145784172|NCT03097328|525718326|FG000|Overall Study|Progressive Disease|29|||
145784173|NCT03097328|525718326|FG000|Overall Study|Adverse Event|4|||
145784174|NCT03097328|525718326|FG000|Overall Study|Withdrawal by Subject|1|||
145784175|NCT03097328|525718326|FG000|Overall Study|Physician Decision|1|||
145279709|NCT02598193|523874353|FG000|Overall Study|Adverse Event|13|||
145279710|NCT02598193|523874353|FG000|Overall Study|Withdrawal by Subject|1|||
145784176|NCT03097328|525718326|FG000|Overall Study|Patient Decision|1|||
145784177|NCT03097328|525718326|FG000|Overall Study|Ineligible for Study Drug|1|||
145784178|NCT01798134|525718327|FG000|Overall Study|Lost to Follow-up|1|||
145784179|NCT01798134|525718327|FG000|Overall Study|Withdrawal by Subject|3|||
145784180|NCT01798134|525718327|FG000|Overall Study|Death|2|||
145784181|NCT01798134|525718327|FG000|Overall Study|Adverse Event|3|||
145784182|NCT01798134|525718327|FG000|Overall Study|Physician Decision|3|||
145784183|NCT01798134|525718327|FG000|Overall Study|Liver transplant/surgery|4|||
145784184|NCT02023164|525718328|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
145784185|NCT02023164|525718329|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
145784186|NCT02653976|525718330|FG000|Overall Study|Withdrawal by Subject|5|||
145784187|NCT02653976|525718330|FG000|Overall Study|Death|4|||
145784188|NCT03703375|525718331|FG000|Randomization Period|Withdrawal by Subject|0|||
145784189|NCT03703375|525718332|FG001|Randomization Period|Withdrawal by Subject|0|||
145784190|NCT03703375|525718333|FG002|Randomization Period|Withdrawal by Subject|0|||
145784191|NCT03703375|525718334|FG003|Randomization Period|Withdrawal by Subject|1|||
145784192|NCT03703375|525718331|FG000|Randomization Period|Completed safety run-in treatment|7|||
145784193|NCT03703375|525718332|FG001|Randomization Period|Completed safety run-in treatment|0|||
145784194|NCT03703375|525718333|FG002|Randomization Period|Completed safety run-in treatment|0|||
145784195|NCT03703375|525718334|FG003|Randomization Period|Completed safety run-in treatment|0|||
145784196|NCT03703375|525718331|FG000|Treatment Period|Other Reasons|0|||
145784197|NCT03703375|525718332|FG001|Treatment Period|Other Reasons|1|||
145784198|NCT03703375|525718333|FG002|Treatment Period|Other Reasons|0|||
145784199|NCT03703375|525718334|FG003|Treatment Period|Other Reasons|3|||
145784200|NCT03703375|525718331|FG000|Treatment Period|Consent Withdrawal|0|||
145784201|NCT03703375|525718332|FG001|Treatment Period|Consent Withdrawal|0|||
145784202|NCT03703375|525718333|FG002|Treatment Period|Consent Withdrawal|0|||
145784203|NCT03703375|525718334|FG003|Treatment Period|Consent Withdrawal|1|||
145784204|NCT03703375|525718331|FG000|Treatment Period|Death|1|||
145784205|NCT03703375|525718332|FG001|Treatment Period|Death|0|||
145784206|NCT03703375|525718333|FG002|Treatment Period|Death|1|||
145784207|NCT03703375|525718334|FG003|Treatment Period|Death|2|||
145784208|NCT03703375|525718331|FG000|Treatment Period|Toxicity of Study Treatment|2|||
145784209|NCT03703375|525718332|FG001|Treatment Period|Toxicity of Study Treatment|0|||
145784210|NCT03703375|525718333|FG002|Treatment Period|Toxicity of Study Treatment|4|||
145784211|NCT03703375|525718334|FG003|Treatment Period|Toxicity of Study Treatment|1|||
145784212|NCT03703375|525718331|FG000|Treatment Period|Progression|32|||
145784213|NCT03703375|525718332|FG001|Treatment Period|Progression|1|||
145784214|NCT03703375|525718333|FG002|Treatment Period|Progression|7|||
145784215|NCT03703375|525718334|FG003|Treatment Period|Progression|11|||
145784216|NCT03703375|525718331|FG000|Treatment Period|Completed treatment|7|||
145784217|NCT03703375|525718332|FG001|Treatment Period|Completed treatment|2|||
145784218|NCT03703375|525718333|FG002|Treatment Period|Completed treatment|0|||
145784219|NCT03703375|525718334|FG003|Treatment Period|Completed treatment|0|||
145784220|NCT00615290|525718335|FG000|Overall Study|Adverse Event|2|||
145784221|NCT00615290|525718335|FG000|Overall Study|Lost to Follow-up|3|||
145784222|NCT00615290|525718335|FG000|Overall Study|Withdrawal by Subject|1|||
145403853|NCT03533751|524334421|FG002|Overall Study|Other|1|||
145403854|NCT03533751|524334422|FG003|Overall Study|Other|0|||
145403855|NCT03533751|524334423|FG004|Overall Study|Other|3|||
145403856|NCT02074514|524334425|FG000|Overall Study|Lack of Efficacy|3|||
145403857|NCT02074514|524334426|FG001|Overall Study|Lack of Efficacy|2|||
145403858|NCT02074514|524334425|FG000|Overall Study|Lost to Follow-up|0|||
145403859|NCT02074514|524334426|FG001|Overall Study|Lost to Follow-up|1|||
145403860|NCT02074514|524334425|FG000|Overall Study|Withdrew Consent|0|||
145403861|NCT02074514|524334426|FG001|Overall Study|Withdrew Consent|1|||
145403862|NCT03082729|524334427|FG000|Overall Study|Lost to Follow-up|7|||
145403863|NCT03082729|524334427|FG000|Overall Study|Physician Decision|2|||
145403864|NCT03082729|524334427|FG000|Overall Study|Withdrawal by Subject|1|||
145403865|NCT03082729|524334427|FG000|Overall Study|Lack of Efficacy|9|||
145403866|NCT03082729|524334427|FG000|Overall Study|Adverse Event|4|||
145403867|NCT03082729|524334427|FG000|Overall Study|Protocol Violation|6|||
145403868|NCT03082729|524334427|FG000|Overall Study|Fear of study procedure|1|||
145403869|NCT03082729|524334427|FG000|Overall Study|Scheduling conflict|1|||
145403870|NCT01171534|524336419|FG000|Overall Study|Lost to Follow-up|0|||
145403871|NCT01171534|524336420|FG001|Overall Study|Lost to Follow-up|2|||
145403872|NCT01171534|524336419|FG000|Overall Study|screen failure|0|||
145403873|NCT01171534|524336420|FG001|Overall Study|screen failure|1|||
145403874|NCT03861039|524336421|FG000|Overall Study|Adverse Event|2|||
145403875|NCT03861039|524336422|FG001|Overall Study|Adverse Event|5|||
145403876|NCT03861039|524336423|FG002|Overall Study|Adverse Event|11|||
145403877|NCT03861039|524336421|FG000|Overall Study|Withdrawal by Subject|1|||
145537959|NCT00347360|524827564|FG007|Overall Study|Subject left town, ran out of study drug|0|||
145537960|NCT00347360|524827565|FG008|Overall Study|Subject left town, ran out of study drug|0|||
145784223|NCT00615290|525718335|FG000|Overall Study|Other|2|||
145784224|NCT00372190|525718348|FG000|Overall Study|Lost to Follow-up|3|||
145784225|NCT00372190|525718349|FG001|Overall Study|Lost to Follow-up|1|||
145784226|NCT04184622|525718353|FG000|Primary Treatment Period|Adverse Event|6|||
145784227|NCT04184622|525718354|FG001|Primary Treatment Period|Adverse Event|4|||
145784228|NCT04184622|525718355|FG002|Primary Treatment Period|Adverse Event|8|||
145784229|NCT04184622|525718356|FG003|Primary Treatment Period|Adverse Event|6|||
145784230|NCT04184622|525718353|FG000|Primary Treatment Period|Death|4|||
145537961|NCT00347360|524827566|FG009|Overall Study|Subject left town, ran out of study drug|0|||
145784231|NCT04184622|525718354|FG001|Primary Treatment Period|Death|4|||
145784232|NCT04184622|525718355|FG002|Primary Treatment Period|Death|2|||
145784233|NCT04184622|525718356|FG003|Primary Treatment Period|Death|1|||
145784234|NCT04184622|525718353|FG000|Primary Treatment Period|Lost to Follow-up|41|||
145784235|NCT04184622|525718354|FG001|Primary Treatment Period|Lost to Follow-up|17|||
145784236|NCT04184622|525718355|FG002|Primary Treatment Period|Lost to Follow-up|15|||
145784237|NCT04184622|525718356|FG003|Primary Treatment Period|Lost to Follow-up|13|||
145784238|NCT04184622|525718353|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
145784239|NCT04184622|525718354|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
145784240|NCT04184622|525718355|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
145784241|NCT04184622|525718356|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
145784242|NCT04184622|525718353|FG000|Primary Treatment Period|Physician Decision|0|||
145784243|NCT04184622|525718354|FG001|Primary Treatment Period|Physician Decision|0|||
145784244|NCT04184622|525718355|FG002|Primary Treatment Period|Physician Decision|3|||
145784245|NCT04184622|525718356|FG003|Primary Treatment Period|Physician Decision|1|||
145784246|NCT04184622|525718353|FG000|Primary Treatment Period|Pregnancy|4|||
145784247|NCT04184622|525718354|FG001|Primary Treatment Period|Pregnancy|3|||
145784248|NCT04184622|525718355|FG002|Primary Treatment Period|Pregnancy|4|||
145784249|NCT04184622|525718356|FG003|Primary Treatment Period|Pregnancy|1|||
145784250|NCT04184622|525718353|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
145784251|NCT04184622|525718354|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
145784252|NCT04184622|525718355|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
145784253|NCT04184622|525718356|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
145784254|NCT04184622|525718353|FG000|Additional Treatment Period|Adverse Event|1|||
145784255|NCT04184622|525718354|FG001|Additional Treatment Period|Adverse Event|2|||
145784256|NCT04184622|525718355|FG002|Additional Treatment Period|Adverse Event|1|||
145784257|NCT04184622|525718356|FG003|Additional Treatment Period|Adverse Event|0|||
145784258|NCT04184622|525718353|FG000|Additional Treatment Period|Death|0|||
145784259|NCT04184622|525718354|FG001|Additional Treatment Period|Death|0|||
145784260|NCT04184622|525718355|FG002|Additional Treatment Period|Death|1|||
145784261|NCT04184622|525718356|FG003|Additional Treatment Period|Death|1|||
145403878|NCT03861039|524336422|FG001|Overall Study|Withdrawal by Subject|3|||
145403879|NCT03861039|524336423|FG002|Overall Study|Withdrawal by Subject|4|||
145403880|NCT01113749|524336424|FG000|Overall Study|Lost to Follow-up|1|||
145403881|NCT01113749|524336425|FG001|Overall Study|Lost to Follow-up|2|||
145784262|NCT04184622|525718353|FG000|Additional Treatment Period|Lost to Follow-up|6|||
145403882|NCT03427892|524336427|FG000|Overall Study|Lost to Follow-up|2|||
145403883|NCT00548327|524336428|FG000|Overall Study|Adverse Event|0|||
145403884|NCT00548327|524336429|FG001|Overall Study|Adverse Event|1|||
145784263|NCT04184622|525718354|FG001|Additional Treatment Period|Lost to Follow-up|4|||
145279711|NCT02598193|523874353|FG000|Overall Study|Listed in active lung transplant list|1|||
145279712|NCT02598193|523874353|FG000|Overall Study|Does not want to take Nintedanib|1|||
145537962|NCT00347360|524827567|FG010|Overall Study|Subject left town, ran out of study drug|0|||
145784264|NCT04184622|525718355|FG002|Additional Treatment Period|Lost to Follow-up|8|||
145784265|NCT04184622|525718356|FG003|Additional Treatment Period|Lost to Follow-up|6|||
145784266|NCT04184622|525718353|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
145784267|NCT04184622|525718354|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
145784268|NCT04184622|525718355|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
145784269|NCT04184622|525718356|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
145784270|NCT04184622|525718353|FG000|Additional Treatment Period|Physician Decision|0|||
145784271|NCT04184622|525718354|FG001|Additional Treatment Period|Physician Decision|0|||
145784272|NCT04184622|525718355|FG002|Additional Treatment Period|Physician Decision|1|||
145784273|NCT04184622|525718356|FG003|Additional Treatment Period|Physician Decision|0|||
145784274|NCT04184622|525718353|FG000|Additional Treatment Period|Pregnancy|0|||
145784275|NCT04184622|525718354|FG001|Additional Treatment Period|Pregnancy|0|||
145784276|NCT04184622|525718355|FG002|Additional Treatment Period|Pregnancy|0|||
145784277|NCT04184622|525718356|FG003|Additional Treatment Period|Pregnancy|1|||
145784278|NCT04184622|525718353|FG000|Additional Treatment Period|Protocol deviation|0|||
145784279|NCT04184622|525718354|FG001|Additional Treatment Period|Protocol deviation|0|||
145784280|NCT04184622|525718355|FG002|Additional Treatment Period|Protocol deviation|1|||
145784281|NCT04184622|525718356|FG003|Additional Treatment Period|Protocol deviation|0|||
145784282|NCT04184622|525718353|FG000|Additional Treatment Period|Site closed|1|||
145784283|NCT04184622|525718354|FG001|Additional Treatment Period|Site closed|0|||
145784284|NCT04184622|525718355|FG002|Additional Treatment Period|Site closed|1|||
145784285|NCT04184622|525718356|FG003|Additional Treatment Period|Site closed|0|||
145784286|NCT04184622|525718353|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
145784287|NCT04184622|525718354|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
145784288|NCT04184622|525718355|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
145784289|NCT04184622|525718356|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
145784290|NCT04184622|525718353|FG000|Safety Follow-up Period|Adverse Event|6|||
145784291|NCT04184622|525718354|FG001|Safety Follow-up Period|Adverse Event|8|||
145784292|NCT04184622|525718355|FG002|Safety Follow-up Period|Adverse Event|9|||
145784293|NCT04184622|525718356|FG003|Safety Follow-up Period|Adverse Event|16|||
145784294|NCT04184622|525718353|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
145279713|NCT02487979|523874354|FG000|Overall Study|Physician Decision|2|||
145537963|NCT00347360|524827568|FG011|Overall Study|Subject left town, ran out of study drug|0|||
145537964|NCT00347360|524827569|FG012|Overall Study|Subject left town, ran out of study drug|0|||
145537965|NCT00347360|524827570|FG013|Overall Study|Subject left town, ran out of study drug|1|||
145537966|NCT00347360|524827571|FG014|Overall Study|Subject left town, ran out of study drug|0|||
145537967|NCT00347360|524827557|FG000|Overall Study|Subject refuse to sign updated consent|0|||
145537968|NCT00347360|524827558|FG001|Overall Study|Subject refuse to sign updated consent|0|||
145537969|NCT00347360|524827559|FG002|Overall Study|Subject refuse to sign updated consent|0|||
145537970|NCT00347360|524827560|FG003|Overall Study|Subject refuse to sign updated consent|0|||
145537971|NCT00347360|524827561|FG004|Overall Study|Subject refuse to sign updated consent|0|||
145537972|NCT00347360|524827562|FG005|Overall Study|Subject refuse to sign updated consent|0|||
145537973|NCT00347360|524827563|FG006|Overall Study|Subject refuse to sign updated consent|0|||
145537974|NCT00347360|524827564|FG007|Overall Study|Subject refuse to sign updated consent|0|||
145537975|NCT00347360|524827565|FG008|Overall Study|Subject refuse to sign updated consent|0|||
145537976|NCT00347360|524827566|FG009|Overall Study|Subject refuse to sign updated consent|0|||
145537977|NCT00347360|524827567|FG010|Overall Study|Subject refuse to sign updated consent|0|||
145537978|NCT00347360|524827568|FG011|Overall Study|Subject refuse to sign updated consent|0|||
145537979|NCT00347360|524827569|FG012|Overall Study|Subject refuse to sign updated consent|0|||
145537980|NCT00347360|524827570|FG013|Overall Study|Subject refuse to sign updated consent|0|||
145537981|NCT00347360|524827571|FG014|Overall Study|Subject refuse to sign updated consent|1|||
145537982|NCT00347360|524827557|FG000|Overall Study|Visits conflicted with new job|0|||
145537983|NCT00347360|524827558|FG001|Overall Study|Visits conflicted with new job|0|||
145537984|NCT00347360|524827559|FG002|Overall Study|Visits conflicted with new job|0|||
145537985|NCT00347360|524827560|FG003|Overall Study|Visits conflicted with new job|0|||
145537986|NCT00347360|524827561|FG004|Overall Study|Visits conflicted with new job|0|||
145537987|NCT00347360|524827562|FG005|Overall Study|Visits conflicted with new job|0|||
145537988|NCT00347360|524827563|FG006|Overall Study|Visits conflicted with new job|1|||
145537989|NCT00347360|524827564|FG007|Overall Study|Visits conflicted with new job|0|||
145537990|NCT00347360|524827565|FG008|Overall Study|Visits conflicted with new job|0|||
145537991|NCT00347360|524827566|FG009|Overall Study|Visits conflicted with new job|0|||
145537992|NCT00347360|524827567|FG010|Overall Study|Visits conflicted with new job|0|||
145537993|NCT00347360|524827568|FG011|Overall Study|Visits conflicted with new job|0|||
145537994|NCT00347360|524827569|FG012|Overall Study|Visits conflicted with new job|0|||
145537995|NCT00347360|524827570|FG013|Overall Study|Visits conflicted with new job|0|||
145784295|NCT04184622|525718354|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
145537996|NCT00347360|524827571|FG014|Overall Study|Visits conflicted with new job|0|||
145537997|NCT01788228|524827574|FG000|Overall Study|Migrated/moved from study area|1|||
145537998|NCT01788228|524827575|FG001|Overall Study|Migrated/moved from study area|0|||
145537999|NCT00945893|524827579|FG000|Overall Study|Lost to Follow-up|2|||
145784296|NCT04184622|525718355|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
145784297|NCT04184622|525718356|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
145784298|NCT04184622|525718353|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
145784299|NCT04184622|525718354|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
145784300|NCT04184622|525718355|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
145784301|NCT04184622|525718356|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
145784302|NCT04184622|525718353|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
145784303|NCT04184622|525718354|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
145784304|NCT04184622|525718355|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
145784305|NCT04184622|525718356|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
145784306|NCT04184622|525718353|FG000|Safety Follow-up Period|Physician Decision|1|||
145784307|NCT04184622|525718354|FG001|Safety Follow-up Period|Physician Decision|0|||
145784308|NCT04184622|525718355|FG002|Safety Follow-up Period|Physician Decision|0|||
145784309|NCT04184622|525718356|FG003|Safety Follow-up Period|Physician Decision|1|||
145784310|NCT04184622|525718353|FG000|Safety Follow-up Period|Pregnancy|1|||
145784311|NCT04184622|525718354|FG001|Safety Follow-up Period|Pregnancy|3|||
145784312|NCT04184622|525718355|FG002|Safety Follow-up Period|Pregnancy|0|||
145784313|NCT04184622|525718356|FG003|Safety Follow-up Period|Pregnancy|6|||
145784314|NCT04184622|525718353|FG000|Safety Follow-up Period|Protocol deviation|1|||
145784315|NCT04184622|525718354|FG001|Safety Follow-up Period|Protocol deviation|0|||
145784316|NCT04184622|525718355|FG002|Safety Follow-up Period|Protocol deviation|0|||
145784317|NCT04184622|525718356|FG003|Safety Follow-up Period|Protocol deviation|0|||
145784318|NCT04184622|525718353|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
145784319|NCT04184622|525718354|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
145784320|NCT04184622|525718355|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
145784321|NCT04184622|525718356|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
145784322|NCT02795988|525718357|FG000|Phase 1b|Withdrawal by Subject|0|||
145784323|NCT02795988|525718358|FG001|Phase 1b|Withdrawal by Subject|1|||
145784324|NCT02795988|525718359|FG002|Phase 1b|Withdrawal by Subject|0|||
145784325|NCT02795988|525718360|FG003|Phase 1b|Withdrawal by Subject|0|||
145784326|NCT02795988|525718361|FG004|Phase 1b|Withdrawal by Subject|0|||
145784327|NCT02795988|525718362|FG005|Phase 1b|Withdrawal by Subject|0|||
145784328|NCT02795988|525718363|FG006|Phase 1b|Withdrawal by Subject|0|||
145784329|NCT02795988|525718357|FG000|Phase 1b|Death|1|||
145784330|NCT02795988|525718358|FG001|Phase 1b|Death|2|||
145784331|NCT02795988|525718359|FG002|Phase 1b|Death|1|||
145784332|NCT02795988|525718360|FG003|Phase 1b|Death|0|||
145279714|NCT02487979|523874354|FG000|Overall Study|Withdrawal by Subject|2|||
145279715|NCT02487979|523874354|FG000|Overall Study|Progressive Disease|17|||
145279716|NCT01493531|523874359|FG000|Overall Study|Adverse Event|4|||
145279717|NCT01493531|523874360|FG001|Overall Study|Adverse Event|12|||
145279718|NCT01493531|523874361|FG002|Overall Study|Adverse Event|9|||
145279719|NCT01493531|523874359|FG000|Overall Study|Gout flare|3|||
145279720|NCT01493531|523874360|FG001|Overall Study|Gout flare|0|||
145279721|NCT01493531|523874361|FG002|Overall Study|Gout flare|2|||
145784333|NCT02795988|525718361|FG004|Phase 1b|Death|0|||
145784334|NCT02795988|525718362|FG005|Phase 1b|Death|0|||
145538000|NCT00945893|524827580|FG001|Overall Study|Lost to Follow-up|8|||
145538001|NCT00945893|524827579|FG000|Overall Study|Withdrawal of consent|1|||
145784335|NCT02795988|525718363|FG006|Phase 1b|Death|0|||
145784336|NCT02795988|525718357|FG000|Phase 1b|Physician Decision|0|||
145784337|NCT02795988|525718358|FG001|Phase 1b|Physician Decision|0|||
145784338|NCT02795988|525718359|FG002|Phase 1b|Physician Decision|1|||
145784339|NCT02795988|525718360|FG003|Phase 1b|Physician Decision|0|||
145784340|NCT02795988|525718361|FG004|Phase 1b|Physician Decision|0|||
145279722|NCT01493531|523874359|FG000|Overall Study|Protocol Violation|8|||
145279723|NCT01493531|523874360|FG001|Overall Study|Protocol Violation|15|||
145538002|NCT00945893|524827580|FG001|Overall Study|Withdrawal of consent|2|||
145538003|NCT03113071|524827581|FG000|Overall Study|Withdrawal by Subject|1|||
145784341|NCT02795988|525718362|FG005|Phase 1b|Physician Decision|0|||
145784342|NCT02795988|525718363|FG006|Phase 1b|Physician Decision|0|||
145784343|NCT02795988|525718357|FG000|Phase 1b|Progressive Disease|2|||
145784344|NCT02795988|525718358|FG001|Phase 1b|Progressive Disease|2|||
145784345|NCT02795988|525718359|FG002|Phase 1b|Progressive Disease|0|||
145279724|NCT01493531|523874361|FG002|Overall Study|Protocol Violation|12|||
145784346|NCT02795988|525718360|FG003|Phase 1b|Progressive Disease|0|||
145784347|NCT02795988|525718361|FG004|Phase 1b|Progressive Disease|0|||
145784348|NCT02795988|525718362|FG005|Phase 1b|Progressive Disease|0|||
145784349|NCT02795988|525718363|FG006|Phase 1b|Progressive Disease|0|||
145784350|NCT02795988|525718357|FG000|Phase 2|Withdrawal by Subject|0|||
145784351|NCT02795988|525718358|FG001|Phase 2|Withdrawal by Subject|0|||
145784352|NCT02795988|525718359|FG002|Phase 2|Withdrawal by Subject|0|||
145279725|NCT01493531|523874359|FG000|Overall Study|Sponsor terminated study|5|||
145784353|NCT02795988|525718360|FG003|Phase 2|Withdrawal by Subject|1|||
145784354|NCT02795988|525718361|FG004|Phase 2|Withdrawal by Subject|0|||
145784355|NCT02795988|525718362|FG005|Phase 2|Withdrawal by Subject|0|||
145784356|NCT02795988|525718363|FG006|Phase 2|Withdrawal by Subject|0|||
145784357|NCT02795988|525718357|FG000|Phase 2|Death|0|||
145784358|NCT02795988|525718358|FG001|Phase 2|Death|0|||
145784359|NCT02795988|525718359|FG002|Phase 2|Death|0|||
145784360|NCT02795988|525718360|FG003|Phase 2|Death|17|||
145784361|NCT02795988|525718361|FG004|Phase 2|Death|17|||
145784362|NCT02795988|525718362|FG005|Phase 2|Death|0|||
145784363|NCT02795988|525718363|FG006|Phase 2|Death|0|||
145784364|NCT02795988|525718357|FG000|Phase 2|Other|0|||
145784365|NCT02795988|525718358|FG001|Phase 2|Other|0|||
145784366|NCT02795988|525718359|FG002|Phase 2|Other|0|||
145784367|NCT02795988|525718360|FG003|Phase 2|Other|1|||
145784368|NCT02795988|525718361|FG004|Phase 2|Other|0|||
145784369|NCT02795988|525718362|FG005|Phase 2|Other|0|||
145784370|NCT02795988|525718363|FG006|Phase 2|Other|0|||
145784371|NCT02795988|525718357|FG000|Phase 2 Extension|Death|0|||
145784372|NCT02795988|525718358|FG001|Phase 2 Extension|Death|0|||
145784373|NCT02795988|525718359|FG002|Phase 2 Extension|Death|0|||
145784374|NCT02795988|525718360|FG003|Phase 2 Extension|Death|0|||
145784375|NCT02795988|525718361|FG004|Phase 2 Extension|Death|0|||
145784376|NCT02795988|525718362|FG005|Phase 2 Extension|Death|5|||
145784377|NCT02795988|525718363|FG006|Phase 2 Extension|Death|6|||
145784378|NCT02795988|525718357|FG000|Phase 2 Extension|Other reasons|0|||
145784379|NCT02795988|525718358|FG001|Phase 2 Extension|Other reasons|0|||
145784380|NCT02795988|525718359|FG002|Phase 2 Extension|Other reasons|0|||
145784381|NCT02795988|525718360|FG003|Phase 2 Extension|Other reasons|0|||
145784382|NCT02795988|525718361|FG004|Phase 2 Extension|Other reasons|0|||
145784383|NCT02795988|525718362|FG005|Phase 2 Extension|Other reasons|2|||
145784384|NCT02795988|525718363|FG006|Phase 2 Extension|Other reasons|1|||
145784385|NCT02341014|525718364|FG000|Overall Study|Adverse Event|0|||
145784386|NCT02341014|525718365|FG001|Overall Study|Adverse Event|1|||
145784387|NCT02341014|525718366|FG002|Overall Study|Adverse Event|0|||
145784388|NCT02341014|525718367|FG003|Overall Study|Adverse Event|0|||
145784389|NCT02341014|525718368|FG004|Overall Study|Adverse Event|2|||
145784390|NCT04705597|525718369|FG000|Overall Study|Death|16|||
145784391|NCT04705597|525718370|FG001|Overall Study|Death|9|||
145784392|NCT04705597|525718369|FG000|Overall Study|Lost to Follow-up|1|||
145784393|NCT04705597|525718370|FG001|Overall Study|Lost to Follow-up|0|||
145784394|NCT04705597|525718369|FG000|Overall Study|Withdrawal by Subject|1|||
145784395|NCT04705597|525718370|FG001|Overall Study|Withdrawal by Subject|2|||
145784396|NCT00273858|525718380|FG000|Overall Study|Not completed 24 month observation time|334|||
145784397|NCT00273858|525718380|FG000|Overall Study|Lost to Follow-up|101|||
145784398|NCT00273858|525718380|FG000|Overall Study|Withdrawal by Subject|21|||
145784399|NCT00273858|525718380|FG000|Overall Study|Adverse Event|81|||
145784400|NCT00390780|525718381|FG000|Overall Study|Not completed|10|||
145784401|NCT00390780|525718382|FG001|Overall Study|Not completed|4|||
145784402|NCT00390780|525718381|FG000|Overall Study|Protocol Violation|6|||
145784403|NCT00390780|525718382|FG001|Overall Study|Protocol Violation|4|||
145784404|NCT00390780|525718381|FG000|Overall Study|Lost to Follow-up|3|||
145784405|NCT00390780|525718382|FG001|Overall Study|Lost to Follow-up|6|||
145784406|NCT00390780|525718381|FG000|Overall Study|Adverse Event|2|||
145784407|NCT00390780|525718382|FG001|Overall Study|Adverse Event|3|||
145784408|NCT00390780|525718381|FG000|Overall Study|Death|1|||
145784409|NCT00390780|525718382|FG001|Overall Study|Death|3|||
145784410|NCT00390780|525718381|FG000|Overall Study|Withdrawal by Subject|1|||
145784411|NCT00390780|525718382|FG001|Overall Study|Withdrawal by Subject|2|||
145784412|NCT00390780|525718381|FG000|Overall Study|Inclusion criteria not satisfied|0|||
145784413|NCT00390780|525718382|FG001|Overall Study|Inclusion criteria not satisfied|2|||
145784414|NCT00390780|525718381|FG000|Overall Study|Lost to follow up and other reasons|0|||
145784415|NCT00390780|525718382|FG001|Overall Study|Lost to follow up and other reasons|1|||
145279726|NCT01493531|523874360|FG001|Overall Study|Sponsor terminated study|2|||
145279727|NCT01493531|523874361|FG002|Overall Study|Sponsor terminated study|3|||
145279728|NCT01493531|523874359|FG000|Overall Study|Lost to Follow-up|5|||
145538004|NCT03113071|524827582|FG001|Overall Study|Withdrawal by Subject|0|||
145784416|NCT00390780|525718381|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
145784417|NCT00390780|525718382|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
145784418|NCT00390780|525718381|FG000|Overall Study|SAE, death|0|||
145784419|NCT00390780|525718382|FG001|Overall Study|SAE, death|1|||
145784420|NCT01585961|525718384|FG000|Overall Study|Death|6|||
145784421|NCT01585961|525718384|FG000|Overall Study|Physician Decision|1|||
145784422|NCT01585961|525718384|FG000|Overall Study|Decision to use non-study catheter|1|||
145784423|NCT01585961|525718384|FG000|Overall Study|Withdrawal by Subject|1|||
145784424|NCT01585961|525718384|FG000|Overall Study|Lost to Follow-up|23|||
145784425|NCT01585961|525718384|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
145784426|NCT01258348|525718385|FG000|Overall Study|Adverse Event|1|||
145784427|NCT01258348|525718386|FG001|Overall Study|Adverse Event|1|||
145784428|NCT01258348|525718387|FG002|Overall Study|Adverse Event|3|||
145784429|NCT01258348|525718388|FG003|Overall Study|Adverse Event|2|||
145784430|NCT01258348|525718389|FG004|Overall Study|Adverse Event|4|||
145784431|NCT01258348|525718385|FG000|Overall Study|Progressive Disease|0|||
145784432|NCT01258348|525718386|FG001|Overall Study|Progressive Disease|3|||
145784433|NCT01258348|525718387|FG002|Overall Study|Progressive Disease|0|||
145784434|NCT01258348|525718388|FG003|Overall Study|Progressive Disease|2|||
145784435|NCT01258348|525718389|FG004|Overall Study|Progressive Disease|2|||
145784436|NCT01258348|525718385|FG000|Overall Study|Physician Decision|0|||
145784437|NCT01258348|525718386|FG001|Overall Study|Physician Decision|0|||
145784438|NCT01258348|525718387|FG002|Overall Study|Physician Decision|0|||
145784439|NCT01258348|525718388|FG003|Overall Study|Physician Decision|2|||
145784440|NCT01258348|525718389|FG004|Overall Study|Physician Decision|0|||
145279729|NCT01493531|523874360|FG001|Overall Study|Lost to Follow-up|7|||
145279730|NCT01493531|523874361|FG002|Overall Study|Lost to Follow-up|11|||
145279731|NCT01493531|523874359|FG000|Overall Study|Withdrawal by Subject|16|||
145279732|NCT01493531|523874360|FG001|Overall Study|Withdrawal by Subject|13|||
145279733|NCT01493531|523874361|FG002|Overall Study|Withdrawal by Subject|11|||
145279734|NCT01493531|523874359|FG000|Overall Study|Death|0|||
145279735|NCT01493531|523874360|FG001|Overall Study|Death|1|||
145279736|NCT01493531|523874361|FG002|Overall Study|Death|0|||
145279737|NCT01946282|523874362|FG000|Year 1|Did not return FIT kit|4186|||
145279738|NCT01946282|523874363|FG001|Year 1|Did not return FIT kit|608|||
145279739|NCT01946282|523874364|FG002|Year 1|Did not return FIT kit|654|||
145279740|NCT01946282|523874362|FG000|Year 2|Did not return FIT kit|803|||
145279741|NCT01946282|523874363|FG001|Year 2|Did not return FIT kit|131|||
145279742|NCT01946282|523874364|FG002|Year 2|Did not return FIT kit|115|||
145279743|NCT01946282|523874362|FG000|Year 3|Did not return FIT kit|288|||
145279744|NCT01946282|523874363|FG001|Year 3|Did not return FIT kit|43|||
145279745|NCT01946282|523874364|FG002|Year 3|Did not return FIT kit|30|||
145279746|NCT03031431|523874365|FG000|Overall Study|Infant removed by maternal request|1|||
145279747|NCT03670537|523874370|FG000|Overall Study|Protocol Violation|1|||
145279748|NCT04133519|523874371|FG000|Overall Study|Withdrawal by Subject|5|||
145279749|NCT04133519|523874372|FG001|Overall Study|Withdrawal by Subject|4|||
145279750|NCT04133519|523874371|FG000|Overall Study|Protocol Violation|0|||
145279751|NCT04133519|523874372|FG001|Overall Study|Protocol Violation|1|||
145279752|NCT04133519|523874371|FG000|Overall Study|Never started treatment|1|||
145279753|NCT04133519|523874372|FG001|Overall Study|Never started treatment|1|||
145279754|NCT02217345|523874373|FG000|Overall Study|Lost to Follow-up|2|||
145279755|NCT02217345|523874374|FG001|Overall Study|Lost to Follow-up|1|||
145279756|NCT02217345|523874373|FG000|Overall Study|Withdrawal by Subject|3|||
145279757|NCT02217345|523874374|FG001|Overall Study|Withdrawal by Subject|2|||
145279758|NCT02217345|523874373|FG000|Overall Study|Adverse Event|2|||
145279759|NCT02217345|523874374|FG001|Overall Study|Adverse Event|1|||
145279760|NCT02217345|523874373|FG000|Overall Study|Physician Decision|0|||
145279761|NCT02217345|523874374|FG001|Overall Study|Physician Decision|1|||
145784441|NCT01258348|525718385|FG000|Overall Study|Withdrawal by Subject|0|||
145784442|NCT01258348|525718386|FG001|Overall Study|Withdrawal by Subject|1|||
145784443|NCT01258348|525718387|FG002|Overall Study|Withdrawal by Subject|0|||
145784444|NCT01258348|525718388|FG003|Overall Study|Withdrawal by Subject|0|||
145784445|NCT01258348|525718389|FG004|Overall Study|Withdrawal by Subject|0|||
145784446|NCT00590681|525718401|FG000|Overall Study|Withdrawal by Subject|7|||
145784447|NCT00590681|525718401|FG000|Overall Study|Adverse Event|8|||
145784448|NCT00590681|525718401|FG000|Overall Study|Death|3|||
145784449|NCT00590681|525718401|FG000|Overall Study|Lost to Follow-up|1|||
145784450|NCT00590681|525718401|FG000|Overall Study|disease progression|1|||
145784451|NCT01259297|525718402|FG000|Double Blind Randomized Period|Death|1|||
145784452|NCT01259297|525718403|FG001|Double Blind Randomized Period|Death|1|||
145784453|NCT01259297|525718404|FG002|Double Blind Randomized Period|Death|1|||
145784454|NCT01259297|525718405|FG003|Double Blind Randomized Period|Death|2|||
145784455|NCT01259297|525718406|FG004|Double Blind Randomized Period|Death|1|||
145784456|NCT01259297|525718407|FG005|Double Blind Randomized Period|Death|5|||
145784457|NCT01259297|525718408|FG006|Double Blind Randomized Period|Death|2|||
145784458|NCT01259297|525718409|FG007|Double Blind Randomized Period|Death|1|||
145784459|NCT01259297|525718402|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
145784460|NCT01259297|525718403|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
145784461|NCT01259297|525718404|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
145784462|NCT01259297|525718405|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
145784463|NCT01259297|525718406|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
145784464|NCT01259297|525718407|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
145784465|NCT01259297|525718408|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
145279762|NCT01280981|523874381|FG000|Overall Study|Withdrawal by Subject|11|||
145279763|NCT01280981|523874381|FG000|Overall Study|Protocol Violation|2|||
145279764|NCT01280981|523874381|FG000|Overall Study|Lack of Efficacy|13|||
145279765|NCT01280981|523874381|FG000|Overall Study|Lost to Follow-up|3|||
145279766|NCT01280981|523874381|FG000|Overall Study|Adverse Event|6|||
145279767|NCT01280981|523874381|FG000|Overall Study|Irregular or discontinued menses|3|||
145279768|NCT01280981|523874381|FG000|Overall Study|Failed to return|45|||
145279769|NCT01280981|523874381|FG000|Overall Study|Non-compliance with protocol|3|||
145784466|NCT01259297|525718409|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
145279770|NCT01280981|523874381|FG000|Overall Study|Withdrawal of consent|3|||
145279771|NCT01280981|523874381|FG000|Overall Study|Elective surgery|2|||
145279772|NCT01280981|523874381|FG000|Overall Study|Study site closure|1|||
145279773|NCT01256398|523874382|FG000|Overall Study|Withdrawal by Subject|1|||
145279774|NCT01364298|523874384|FG000|Overall Study|Adverse Event|3|||
145279775|NCT01364298|523874385|FG001|Overall Study|Adverse Event|4|||
145279776|NCT01364298|523874384|FG000|Overall Study|Lack of adherence to treatment|1|||
145279777|NCT01364298|523874385|FG001|Overall Study|Lack of adherence to treatment|3|||
145279778|NCT01364298|523874384|FG000|Overall Study|Lack of Efficacy|1|||
145279779|NCT01364298|523874385|FG001|Overall Study|Lack of Efficacy|0|||
145279780|NCT01364298|523874384|FG000|Overall Study|Lost to Follow-up|5|||
145279781|NCT01364298|523874385|FG001|Overall Study|Lost to Follow-up|10|||
145279782|NCT01364298|523874384|FG000|Overall Study|Withdrawal by Subject|3|||
145279783|NCT01364298|523874385|FG001|Overall Study|Withdrawal by Subject|3|||
145279784|NCT01364298|523874384|FG000|Overall Study|Other|1|||
145279785|NCT01364298|523874385|FG001|Overall Study|Other|3|||
145279786|NCT01864525|523874388|FG000|Overall Study|Adverse Event|1|||
145279787|NCT01864525|523874389|FG001|Overall Study|Adverse Event|0|||
145279788|NCT03296553|523874390|FG000|Overall Study|Withdrawal by Subject|1|||
145279789|NCT03296553|523874391|FG001|Overall Study|Withdrawal by Subject|1|||
145279790|NCT03296553|523874390|FG000|Overall Study|Death|1|||
145279791|NCT03296553|523874391|FG001|Overall Study|Death|0|||
145279792|NCT00065065|523874392|FG000|Overall Study|Adverse Event|3|||
145279793|NCT00065065|523874393|FG001|Overall Study|Adverse Event|2|||
145279794|NCT00065065|523874392|FG000|Overall Study|Withdrawal by Subject|1|||
145279795|NCT00065065|523874393|FG001|Overall Study|Withdrawal by Subject|5|||
145279796|NCT00065065|523874392|FG000|Overall Study|Lack of Efficacy|4|||
145279797|NCT00065065|523874393|FG001|Overall Study|Lack of Efficacy|11|||
145279798|NCT00065065|523874392|FG000|Overall Study|Other|2|||
145279799|NCT00065065|523874393|FG001|Overall Study|Other|2|||
145538005|NCT01602120|524827583|FG000|Overall Study|Adverse Event|3|||
145784467|NCT01259297|525718402|FG000|Double Blind Randomized Period|Other reasons|0|||
145538006|NCT01602120|524827584|FG001|Overall Study|Adverse Event|6|||
145538007|NCT01602120|524827585|FG002|Overall Study|Adverse Event|0|||
145538008|NCT01602120|524827586|FG003|Overall Study|Adverse Event|2|||
145538009|NCT01602120|524827583|FG000|Overall Study|Death|0|||
145538010|NCT01602120|524827584|FG001|Overall Study|Death|4|||
145538011|NCT01602120|524827585|FG002|Overall Study|Death|0|||
145784468|NCT01259297|525718403|FG001|Double Blind Randomized Period|Other reasons|1|||
145784469|NCT01259297|525718404|FG002|Double Blind Randomized Period|Other reasons|0|||
145784470|NCT01259297|525718405|FG003|Double Blind Randomized Period|Other reasons|0|||
145784471|NCT01259297|525718406|FG004|Double Blind Randomized Period|Other reasons|1|||
145784472|NCT01259297|525718407|FG005|Double Blind Randomized Period|Other reasons|2|||
145784473|NCT01259297|525718408|FG006|Double Blind Randomized Period|Other reasons|3|||
145784474|NCT01259297|525718409|FG007|Double Blind Randomized Period|Other reasons|1|||
145784475|NCT02229864|525718412|FG000|Overall Study|Death|2|||
145784476|NCT02229864|525718412|FG000|Overall Study|Lost to Follow-up|1|||
145784477|NCT01345786|525718415|FG000|Overall Study|Adverse Event|0|||
145784478|NCT01345786|525718416|FG001|Overall Study|Adverse Event|1|||
145784479|NCT01345786|525718417|FG002|Overall Study|Adverse Event|3|||
145784480|NCT01345786|525718418|FG003|Overall Study|Adverse Event|1|||
145784481|NCT01345786|525718415|FG000|Overall Study|Subject withdrew consent|2|||
145784482|NCT01345786|525718416|FG001|Overall Study|Subject withdrew consent|2|||
145784483|NCT01345786|525718417|FG002|Overall Study|Subject withdrew consent|1|||
145784484|NCT01345786|525718418|FG003|Overall Study|Subject withdrew consent|0|||
145784485|NCT01345786|525718415|FG000|Overall Study|Noncompliance with protocol|1|||
145784486|NCT01345786|525718416|FG001|Overall Study|Noncompliance with protocol|0|||
145784487|NCT01345786|525718417|FG002|Overall Study|Noncompliance with protocol|1|||
145784488|NCT01345786|525718418|FG003|Overall Study|Noncompliance with protocol|0|||
145784489|NCT01345786|525718415|FG000|Overall Study|Administrative|3|||
145279800|NCT01050673|523874394|FG000|Overall Study|Physician Decision|4|||
145538012|NCT01602120|524827586|FG003|Overall Study|Death|0|||
145538013|NCT01602120|524827583|FG000|Overall Study|Lost to Follow-up|0|||
145538014|NCT01602120|524827584|FG001|Overall Study|Lost to Follow-up|1|||
145538015|NCT01602120|524827585|FG002|Overall Study|Lost to Follow-up|0|||
145538016|NCT01602120|524827586|FG003|Overall Study|Lost to Follow-up|1|||
145538017|NCT01602120|524827583|FG000|Overall Study|Protocol Violation|1|||
145784490|NCT01345786|525718416|FG001|Overall Study|Administrative|5|||
145784491|NCT01345786|525718417|FG002|Overall Study|Administrative|0|||
145784492|NCT01345786|525718418|FG003|Overall Study|Administrative|0|||
145784493|NCT01345786|525718415|FG000|Overall Study|Lost to Follow-up|0|||
145279801|NCT01050673|523874395|FG001|Overall Study|Physician Decision|5|||
145279802|NCT04363736|523874396|FG000|Overall Study|Withdrawal by Subject|1|||
145279803|NCT04363736|523874397|FG001|Overall Study|Withdrawal by Subject|0|||
145279804|NCT04363736|523874396|FG000|Overall Study|Lost to Follow-up|10|||
145279805|NCT04363736|523874397|FG001|Overall Study|Lost to Follow-up|7|||
145279806|NCT04363736|523874396|FG000|Overall Study|Death|8|||
145538018|NCT01602120|524827584|FG001|Overall Study|Protocol Violation|1|||
145784494|NCT01345786|525718416|FG001|Overall Study|Lost to Follow-up|0|||
145784495|NCT01345786|525718417|FG002|Overall Study|Lost to Follow-up|0|||
145784496|NCT01345786|525718418|FG003|Overall Study|Lost to Follow-up|2|||
145784497|NCT03844633|525718421|FG000|1 Week FU|Lost to Follow-up|0|||
145784498|NCT03844633|525718422|FG001|1 Week FU|Lost to Follow-up|1|||
145784499|NCT03844633|525718423|FG002|1 Week FU|Lost to Follow-up|4|||
145784500|NCT03844633|525718421|FG000|12-month Follow-up|Lost to Follow-up|7|||
145279807|NCT04363736|523874397|FG001|Overall Study|Death|6|||
145279808|NCT01254045|523874398|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
145279809|NCT01254045|523874399|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
145279810|NCT01254045|523874400|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
145279811|NCT01254045|523874401|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
145279812|NCT01254045|523874402|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
145279813|NCT01254045|523874403|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
145279814|NCT00520351|523874404|FG000|First Intervention|Withdrawal by Subject|1|||
145279815|NCT00520351|523874405|FG001|First Intervention|Withdrawal by Subject|1|||
145279816|NCT03797222|523874407|FG000|Overall Study|Withdrawal by Subject|1|||
145279817|NCT03439293|523874409|FG000|Overall Study|Death|22|||
145279818|NCT03439293|523874409|FG000|Overall Study|Withdrawal by Subject|8|||
145279819|NCT03439293|523874409|FG000|Overall Study|Lost to Follow-up|2|||
145279820|NCT03439293|523874409|FG000|Overall Study|Reason Not Specified|28|||
145279821|NCT03439293|523874409|FG000|Overall Study|Missing|1|||
145279822|NCT04288115|523874416|FG000|Overall Study|Withdrawal by Subject|0|||
145279823|NCT04288115|523874417|FG001|Overall Study|Withdrawal by Subject|1|||
145279824|NCT04288115|523874416|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
145279825|NCT04288115|523874417|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
145279826|NCT00729365|523874419|FG000|Overall Study|Physician Decision|33|||
145279827|NCT00729365|523874420|FG001|Overall Study|Physician Decision|6|||
145279828|NCT00729365|523874421|FG002|Overall Study|Physician Decision|7|||
145279829|NCT00869089|523874424|FG000|Overall Study|Lost to Follow-up|1|||
145279830|NCT00869089|523874424|FG000|Overall Study|Withdrawal by Subject|1|||
145279831|NCT00869089|523874424|FG000|Overall Study|Screen Fail|1|||
145279832|NCT01374906|523874425|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145279833|NCT01374906|523874426|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145279834|NCT01374906|523874425|FG000|Overall Study|Administrative problems|2|||
145279835|NCT01374906|523874426|FG001|Overall Study|Administrative problems|2|||
145279836|NCT01374906|523874425|FG000|Overall Study|Adverse Event|10|||
145279837|NCT01374906|523874426|FG001|Overall Study|Adverse Event|11|||
145279838|NCT01374906|523874425|FG000|Overall Study|Death|0|||
145279839|NCT01374906|523874426|FG001|Overall Study|Death|2|||
145279840|NCT01374906|523874425|FG000|Overall Study|Protocol Violation|2|||
145279841|NCT01374906|523874426|FG001|Overall Study|Protocol Violation|2|||
145279842|NCT01374906|523874425|FG000|Overall Study|Withdrawal by Subject|15|||
145279843|NCT01374906|523874426|FG001|Overall Study|Withdrawal by Subject|9|||
145279844|NCT01374906|523874425|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
145279845|NCT01374906|523874426|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
145279846|NCT00430638|523874431|FG000|Overall Study|Adverse Event|15|||
145279847|NCT00430638|523874432|FG001|Overall Study|Adverse Event|15|||
145279848|NCT00430638|523874431|FG000|Overall Study|Uncontrolled blood pressure|48|||
145279849|NCT00430638|523874432|FG001|Overall Study|Uncontrolled blood pressure|13|||
145279850|NCT00430638|523874431|FG000|Overall Study|Lost to Follow-up|1|||
145279851|NCT00430638|523874432|FG001|Overall Study|Lost to Follow-up|7|||
145279852|NCT00430638|523874431|FG000|Overall Study|Protocol Violation|6|||
145279853|NCT00430638|523874432|FG001|Overall Study|Protocol Violation|4|||
145279854|NCT00430638|523874431|FG000|Overall Study|Withdrawal by Subject|4|||
145279855|NCT00430638|523874432|FG001|Overall Study|Withdrawal by Subject|6|||
145279856|NCT00430638|523874431|FG000|Overall Study|Non-compliant|2|||
145279857|NCT00430638|523874432|FG001|Overall Study|Non-compliant|1|||
145279858|NCT00430638|523874431|FG000|Overall Study|Other|2|||
145538019|NCT01602120|524827585|FG002|Overall Study|Protocol Violation|0|||
145538020|NCT01602120|524827586|FG003|Overall Study|Protocol Violation|0|||
145538021|NCT01602120|524827583|FG000|Overall Study|Non-compliance|0|||
145538022|NCT01602120|524827584|FG001|Overall Study|Non-compliance|3|||
145538023|NCT01602120|524827585|FG002|Overall Study|Non-compliance|0|||
145538024|NCT01602120|524827586|FG003|Overall Study|Non-compliance|1|||
145538025|NCT01602120|524827583|FG000|Overall Study|Withdrawal by Subject|8|||
145538026|NCT01602120|524827584|FG001|Overall Study|Withdrawal by Subject|17|||
145279859|NCT00430638|523874432|FG001|Overall Study|Other|2|||
145279860|NCT02367781|523874433|FG000|Overall Study|Withdrawal by Subject|20|||
145279861|NCT02367781|523874434|FG001|Overall Study|Withdrawal by Subject|13|||
145279862|NCT02367781|523874433|FG000|Overall Study|Protocol Violation|0|||
145279863|NCT02367781|523874434|FG001|Overall Study|Protocol Violation|1|||
145279864|NCT02367781|523874433|FG000|Overall Study|Physician Decision|7|||
145403885|NCT01673386|524336430|FG000|Overall Study|Study terminated by sponsor|16|||
145538027|NCT01602120|524827585|FG002|Overall Study|Withdrawal by Subject|0|||
145784501|NCT03844633|525718422|FG001|12-month Follow-up|Lost to Follow-up|5|||
145784502|NCT03844633|525718423|FG002|12-month Follow-up|Lost to Follow-up|8|||
145279865|NCT02367781|523874434|FG001|Overall Study|Physician Decision|0|||
145279866|NCT02367781|523874433|FG000|Overall Study|Randomized in Error|5|||
145279867|NCT02367781|523874434|FG001|Overall Study|Randomized in Error|4|||
145279868|NCT02367781|523874433|FG000|Overall Study|Non-Compliance|1|||
145279869|NCT02367781|523874434|FG001|Overall Study|Non-Compliance|0|||
145279870|NCT02367781|523874433|FG000|Overall Study|Lost to Follow-up|1|||
145279871|NCT02367781|523874434|FG001|Overall Study|Lost to Follow-up|2|||
145279872|NCT02367781|523874433|FG000|Overall Study|Death|330|||
145279873|NCT02367781|523874434|FG001|Overall Study|Death|176|||
145279874|NCT02367781|523874433|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
145279875|NCT02367781|523874434|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
145279876|NCT02367781|523874433|FG000|Overall Study|Prolonged Hospitalization|1|||
145279877|NCT02367781|523874434|FG001|Overall Study|Prolonged Hospitalization|0|||
145279878|NCT02367781|523874433|FG000|Overall Study|Death Prior First Dose|1|||
145279879|NCT02367781|523874434|FG001|Overall Study|Death Prior First Dose|0|||
145279880|NCT02367781|523874433|FG000|Overall Study|Administrative-Change Facility|1|||
145279881|NCT02367781|523874434|FG001|Overall Study|Administrative-Change Facility|0|||
145279882|NCT02367781|523874433|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
145279883|NCT02367781|523874434|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
145279884|NCT02367781|523874433|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
145279885|NCT02367781|523874434|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
145279886|NCT02367781|523874433|FG000|Overall Study|Study Terminated by Sponsor|3|||
145279887|NCT02367781|523874434|FG001|Overall Study|Study Terminated by Sponsor|1|||
145279888|NCT02367781|523874433|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
145279889|NCT02367781|523874434|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
145279890|NCT02367781|523874433|FG000|Overall Study|Sponsor Decision|2|||
145279891|NCT02367781|523874434|FG001|Overall Study|Sponsor Decision|0|||
145279892|NCT02367781|523874433|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
145279893|NCT02367781|523874434|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
145279894|NCT01529749|523874435|FG000|Overall Study|Lost to Follow-up|0|||
145279895|NCT01529749|523874436|FG001|Overall Study|Lost to Follow-up|1|||
145279896|NCT01529749|523874437|FG002|Overall Study|Lost to Follow-up|1|||
145279897|NCT01529749|523874438|FG003|Overall Study|Lost to Follow-up|0|||
145279898|NCT01529749|523874435|FG000|Overall Study|Physician Decision|0|||
145279899|NCT01529749|523874436|FG001|Overall Study|Physician Decision|0|||
145279900|NCT01529749|523874437|FG002|Overall Study|Physician Decision|0|||
145279901|NCT01529749|523874438|FG003|Overall Study|Physician Decision|1|||
145279902|NCT01529749|523874435|FG000|Overall Study|Withdrawal by Subject|0|||
145538028|NCT01602120|524827586|FG003|Overall Study|Withdrawal by Subject|3|||
145538029|NCT01602120|524827583|FG000|Overall Study|Study Terminated by Sponsor|12|||
145538030|NCT01602120|524827584|FG001|Overall Study|Study Terminated by Sponsor|24|||
145538031|NCT01602120|524827585|FG002|Overall Study|Study Terminated by Sponsor|17|||
145538032|NCT01602120|524827586|FG003|Overall Study|Study Terminated by Sponsor|44|||
145538033|NCT01602120|524827583|FG000|Overall Study|Physician Decision|2|||
145538034|NCT01602120|524827584|FG001|Overall Study|Physician Decision|3|||
145538035|NCT01602120|524827585|FG002|Overall Study|Physician Decision|0|||
145538036|NCT01602120|524827586|FG003|Overall Study|Physician Decision|0|||
145538037|NCT01602120|524827583|FG000|Overall Study|Unspecified Reason|3|||
145538038|NCT01602120|524827584|FG001|Overall Study|Unspecified Reason|1|||
145538039|NCT01602120|524827585|FG002|Overall Study|Unspecified Reason|0|||
145538040|NCT01602120|524827586|FG003|Overall Study|Unspecified Reason|2|||
145538041|NCT03730012|524827589|FG000|Overall Study|Adverse Event|0|||
145538042|NCT03730012|524827590|FG001|Overall Study|Adverse Event|1|||
145538043|NCT03730012|524827589|FG000|Overall Study|Lack of Efficacy|1|||
145538044|NCT03730012|524827590|FG001|Overall Study|Lack of Efficacy|5|||
145538045|NCT03730012|524827589|FG000|Overall Study|Withdrawal by Subject|0|||
145538046|NCT03730012|524827590|FG001|Overall Study|Withdrawal by Subject|1|||
145538047|NCT03730012|524827589|FG000|Overall Study|Miscellaneous|2|||
145538048|NCT03730012|524827590|FG001|Overall Study|Miscellaneous|1|||
145279903|NCT01529749|523874436|FG001|Overall Study|Withdrawal by Subject|1|||
145279904|NCT01529749|523874437|FG002|Overall Study|Withdrawal by Subject|1|||
145538049|NCT04680052|524829415|FG000|Overall Study|Ongoing|244|||
145538050|NCT04680052|524829416|FG001|Overall Study|Ongoing|229|||
145538051|NCT04680052|524829417|FG002|Overall Study|Ongoing|39|||
145538052|NCT04680052|524829418|FG003|Overall Study|Ongoing|46|||
145538053|NCT04680052|524829415|FG000|Overall Study|Death|15|||
145538054|NCT04680052|524829416|FG001|Overall Study|Death|22|||
145538055|NCT04680052|524829417|FG002|Overall Study|Death|7|||
145538056|NCT04680052|524829418|FG003|Overall Study|Death|1|||
145538057|NCT04680052|524829415|FG000|Overall Study|Lost to Follow-up|3|||
145538058|NCT04680052|524829416|FG001|Overall Study|Lost to Follow-up|2|||
145538059|NCT04680052|524829417|FG002|Overall Study|Lost to Follow-up|0|||
145538060|NCT04680052|524829418|FG003|Overall Study|Lost to Follow-up|1|||
145538061|NCT04680052|524829415|FG000|Overall Study|Withdrawal by Subject|11|||
145538062|NCT04680052|524829416|FG001|Overall Study|Withdrawal by Subject|19|||
145538063|NCT04680052|524829417|FG002|Overall Study|Withdrawal by Subject|7|||
145609159|NCT03239873|525084830|FG000|Overall Study|Lost to Follow-up|15|||
145609160|NCT03239873|525084831|FG001|Overall Study|Lost to Follow-up|16|||
145609161|NCT03239873|525084830|FG000|Overall Study|Physician Decision|1|||
145609162|NCT03239873|525084831|FG001|Overall Study|Physician Decision|0|||
145609163|NCT03239873|525084830|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
145609164|NCT03239873|525084831|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
145609165|NCT03239873|525084830|FG000|Overall Study|Withdrawal by Subject|2|||
145609166|NCT03239873|525084831|FG001|Overall Study|Withdrawal by Subject|0|||
145609167|NCT03239873|525084830|FG000|Overall Study|Contraindication to study medication|1|||
145609168|NCT03239873|525084831|FG001|Overall Study|Contraindication to study medication|0|||
145609169|NCT03239873|525084830|FG000|Overall Study|Protocol Violation|1|||
145609170|NCT03239873|525084831|FG001|Overall Study|Protocol Violation|0|||
145609171|NCT01161472|525084833|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
145609172|NCT01161472|525084834|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
145784503|NCT02588248|525718426|FG000|Overall Study|Physician Decision|4|||
145784504|NCT02588248|525718427|FG001|Overall Study|Physician Decision|3|||
145784505|NCT04229446|525718430|FG000|Overall Study|Death|12|||
145784506|NCT04229446|525718431|FG001|Overall Study|Death|10|||
145784507|NCT04229446|525718430|FG000|Overall Study|Lost to Follow-up|5|||
145784508|NCT04229446|525718431|FG001|Overall Study|Lost to Follow-up|8|||
145609173|NCT01161472|525084835|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
145609174|NCT01161472|525084836|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
145609175|NCT00798174|525084839|FG000|Overall Study|inability to implant azygos coil|3|||
145609176|NCT00798174|525084840|FG001|Overall Study|inability to implant azygos coil|3|||
145609177|NCT00798174|525084839|FG000|Overall Study|Inability to sedate for DFT testing|1|||
145609178|NCT00798174|525084840|FG001|Overall Study|Inability to sedate for DFT testing|0|||
145609179|NCT01478113|525084845|FG000|Overall Study|Withdrawal by Subject|0|||
145609180|NCT01478113|525084846|FG001|Overall Study|Withdrawal by Subject|1|||
145609181|NCT01478113|525084845|FG000|Overall Study|Physician Decision|1|||
145609182|NCT01478113|525084846|FG001|Overall Study|Physician Decision|0|||
145609183|NCT03093428|525084849|FG000|Overall Study|Not eligible for treatment|2|||
145609184|NCT03093428|525084850|FG001|Overall Study|Not eligible for treatment|1|||
145609185|NCT03093428|525084849|FG000|Overall Study|Progression|14|||
145609186|NCT03093428|525084850|FG001|Overall Study|Progression|4|||
145609187|NCT03093428|525084849|FG000|Overall Study|Death|1|||
145609188|NCT03093428|525084850|FG001|Overall Study|Death|0|||
145609189|NCT03093428|525084849|FG000|Overall Study|Adverse Event|1|||
145609190|NCT03093428|525084850|FG001|Overall Study|Adverse Event|0|||
145609191|NCT03093428|525084849|FG000|Overall Study|Withdrawal by Subject|1|||
145609192|NCT03093428|525084850|FG001|Overall Study|Withdrawal by Subject|1|||
145609193|NCT03980184|525084851|FG000|Overall Study|Dropped out before treatment|2|||
145609194|NCT03980184|525084852|FG001|Overall Study|Dropped out before treatment|2|||
145609195|NCT03980184|525084851|FG000|Overall Study|Lost to Follow-up|11|||
145609196|NCT03980184|525084852|FG001|Overall Study|Lost to Follow-up|13|||
145609197|NCT02002884|525084853|FG000|Main Period (MP)|Other|0|||
145609198|NCT02002884|525084854|FG001|Main Period (MP)|Other|3|||
145609199|NCT02002884|525084855|FG002|Main Period (MP)|Other|3|||
145609200|NCT02002884|525084856|FG003|Main Period (MP)|Other|0|||
145609201|NCT02002884|525084853|FG000|Main Period (MP)|Adverse Event|0|||
145609202|NCT02002884|525084854|FG001|Main Period (MP)|Adverse Event|1|||
145609203|NCT02002884|525084855|FG002|Main Period (MP)|Adverse Event|1|||
145609204|NCT02002884|525084856|FG003|Main Period (MP)|Adverse Event|0|||
145609205|NCT02002884|525084853|FG000|Main Period (MP)|Withdrawal by Subject|6|||
145609206|NCT02002884|525084854|FG001|Main Period (MP)|Withdrawal by Subject|2|||
145609207|NCT02002884|525084855|FG002|Main Period (MP)|Withdrawal by Subject|2|||
145609208|NCT02002884|525084856|FG003|Main Period (MP)|Withdrawal by Subject|0|||
145609209|NCT02002884|525084853|FG000|Main Period (MP)|Lost to Follow-up|0|||
145609210|NCT02002884|525084854|FG001|Main Period (MP)|Lost to Follow-up|0|||
145609211|NCT02002884|525084855|FG002|Main Period (MP)|Lost to Follow-up|2|||
145609212|NCT02002884|525084856|FG003|Main Period (MP)|Lost to Follow-up|0|||
145609213|NCT02002884|525084853|FG000|Open-Label Extension Period (OLEX)|Other|0|||
145609214|NCT02002884|525084854|FG001|Open-Label Extension Period (OLEX)|Other|0|||
145609215|NCT02002884|525084855|FG002|Open-Label Extension Period (OLEX)|Other|0|||
145609216|NCT02002884|525084856|FG003|Open-Label Extension Period (OLEX)|Other|24|||
145609217|NCT02002884|525084853|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
145609218|NCT02002884|525084854|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
145609219|NCT02002884|525084855|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
145784509|NCT00705224|525718432|FG000|Overall Study|Adverse Event|1|||
145609220|NCT02002884|525084856|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
145609221|NCT02002884|525084853|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
145609222|NCT02002884|525084854|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
145784510|NCT00705224|525718432|FG000|Overall Study|Lack of Efficacy|2|||
145609223|NCT02002884|525084855|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
145609224|NCT02002884|525084856|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
145784511|NCT00705224|525718432|FG000|Overall Study|Withdrawal by Subject|3|||
145784512|NCT00705224|525718432|FG000|Overall Study|Lost to Follow-up|5|||
145279905|NCT01529749|523874438|FG003|Overall Study|Withdrawal by Subject|0|||
145279906|NCT01529749|523874435|FG000|Overall Study|Protocol Violation|0|||
145538064|NCT04680052|524829418|FG003|Overall Study|Withdrawal by Subject|5|||
145538065|NCT04680052|524829415|FG000|Overall Study|Missing|0|||
145538066|NCT04680052|524829416|FG001|Overall Study|Missing|1|||
145538067|NCT04680052|524829417|FG002|Overall Study|Missing|0|||
145538068|NCT04680052|524829418|FG003|Overall Study|Missing|0|||
145538069|NCT04680052|524829415|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
145538070|NCT04680052|524829416|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
145538071|NCT04680052|524829417|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
145538072|NCT04680052|524829418|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
145538073|NCT04680052|524829415|FG000|Overall Study|Physician Decision|0|||
145538074|NCT04680052|524829416|FG001|Overall Study|Physician Decision|1|||
145538075|NCT04680052|524829417|FG002|Overall Study|Physician Decision|0|||
145538076|NCT04680052|524829418|FG003|Overall Study|Physician Decision|0|||
145538077|NCT06956170|524829419|FG000|Overall Study|Death|2|||
145538078|NCT06956170|524829420|FG001|Overall Study|Death|1|||
145538079|NCT06956170|524829419|FG000|Overall Study|Withdrawal by Subject|1|||
145538080|NCT06956170|524829420|FG001|Overall Study|Withdrawal by Subject|0|||
145538081|NCT06956170|524829419|FG000|Overall Study|Ongoing|7|||
145538082|NCT06956170|524829420|FG001|Overall Study|Ongoing|10|||
145538083|NCT00825682|524829421|FG000|Overall Study|personal reasons/ inconvenience|13|||
145538084|NCT00825682|524829422|FG001|Overall Study|personal reasons/ inconvenience|5|||
145538085|NCT02478632|524829428|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
145538086|NCT02478632|524829429|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
145538087|NCT02478632|524829428|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
145538088|NCT02478632|524829429|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
145538089|NCT02478632|524829428|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
145538090|NCT02478632|524829429|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
145538091|NCT00002651|524829430|FG000|Induction|Adverse Event|44|||
145538092|NCT00002651|524829431|FG001|Induction|Adverse Event|0|||
145538093|NCT00002651|524829432|FG002|Induction|Adverse Event|0|||
145538094|NCT00002651|524829430|FG000|Induction|Refusal unrelated to adverse event|50|||
145538095|NCT00002651|524829431|FG001|Induction|Refusal unrelated to adverse event|0|||
145538096|NCT00002651|524829432|FG002|Induction|Refusal unrelated to adverse event|0|||
145538097|NCT00002651|524829430|FG000|Induction|Progression/relapse|274|||
145538098|NCT00002651|524829431|FG001|Induction|Progression/relapse|0|||
145538099|NCT00002651|524829432|FG002|Induction|Progression/relapse|0|||
145538100|NCT00002651|524829430|FG000|Induction|Death|62|||
145538101|NCT00002651|524829431|FG001|Induction|Death|0|||
145538102|NCT00002651|524829432|FG002|Induction|Death|0|||
145538103|NCT00002651|524829430|FG000|Induction|Other|823|||
145538104|NCT00002651|524829431|FG001|Induction|Other|0|||
145538105|NCT00002651|524829432|FG002|Induction|Other|0|||
145538106|NCT00002651|524829430|FG000|Induction|not eligible|90|||
145538107|NCT00002651|524829431|FG001|Induction|not eligible|0|||
145538108|NCT00002651|524829432|FG002|Induction|not eligible|0|||
145538109|NCT00002651|524829430|FG000|Consolidation and Randomization|Adverse Event|0|||
145538110|NCT00002651|524829431|FG001|Consolidation and Randomization|Adverse Event|36|||
145538111|NCT00002651|524829432|FG002|Consolidation and Randomization|Adverse Event|14|||
145538112|NCT00002651|524829430|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
145538113|NCT00002651|524829431|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
145538114|NCT00002651|524829432|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
145279907|NCT01529749|523874436|FG001|Overall Study|Protocol Violation|0|||
145538115|NCT00002651|524829430|FG000|Consolidation and Randomization|Progression/relapse|0|||
145538116|NCT00002651|524829431|FG001|Consolidation and Randomization|Progression/relapse|295|||
145538117|NCT00002651|524829432|FG002|Consolidation and Randomization|Progression/relapse|298|||
145538118|NCT00002651|524829430|FG000|Consolidation and Randomization|Death|0|||
145538119|NCT00002651|524829431|FG001|Consolidation and Randomization|Death|38|||
145538120|NCT00002651|524829432|FG002|Consolidation and Randomization|Death|48|||
145538121|NCT00002651|524829430|FG000|Consolidation and Randomization|Other|0|||
145538122|NCT00002651|524829431|FG001|Consolidation and Randomization|Other|314|||
145538123|NCT00002651|524829432|FG002|Consolidation and Randomization|Other|313|||
145609225|NCT02002884|525084853|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
145609226|NCT02002884|525084854|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
145609227|NCT02002884|525084855|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
145609228|NCT02002884|525084856|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
145609229|NCT02002884|525084853|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
145609230|NCT02002884|525084854|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
145609231|NCT02002884|525084855|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
145609232|NCT02002884|525084856|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
145609233|NCT02176421|525084857|FG000|Overall Study|Lost to Follow-up|4|||
145609234|NCT02176421|525084857|FG000|Overall Study|Adverse Event|1|||
145784513|NCT03596177|525718433|FG000|Single Blind Period|Withdrawal by Subject|1|||
145784514|NCT03596177|525718434|FG001|Single Blind Period|Withdrawal by Subject|1|||
145784515|NCT03596177|525718433|FG000|Single Blind Period|Other|1|||
145784516|NCT03596177|525718434|FG001|Single Blind Period|Other|0|||
145784517|NCT03596177|525718433|FG000|Double Blind Period|Withdrawal by Subject|0|||
145784518|NCT03596177|525718434|FG001|Double Blind Period|Withdrawal by Subject|1|||
145784519|NCT03596177|525718433|FG000|Double Blind Period|Other|0|||
145279908|NCT01529749|523874437|FG002|Overall Study|Protocol Violation|0|||
145279909|NCT01529749|523874438|FG003|Overall Study|Protocol Violation|1|||
145279910|NCT00789828|523874439|FG000|Core Period (48 Weeks)|Administrative problems|0|||
145279911|NCT00789828|523874440|FG001|Core Period (48 Weeks)|Administrative problems|1|||
145279912|NCT00789828|523874439|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
145279913|NCT00789828|523874440|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
145279914|NCT00789828|523874439|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
145279915|NCT00789828|523874440|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
145279916|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
145279917|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
145279918|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
145279919|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
145279920|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
145609235|NCT02145078|525084858|FG000|Overall Study|Death|1|||
145609236|NCT02145078|525084858|FG000|Overall Study|Reason not given|3|||
145609237|NCT03327402|525084861|FG000|Overall Study|Withdrawal by Subject|1|||
145609238|NCT03327402|525084861|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
145609239|NCT01454830|525084864|FG000|Overall Study|Withdrawal by Subject|4|||
145609240|NCT01454830|525084865|FG001|Overall Study|Withdrawal by Subject|4|||
145609241|NCT01454830|525084864|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
145784520|NCT03596177|525718434|FG001|Double Blind Period|Other|4|||
145609242|NCT01454830|525084865|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
145609243|NCT01454830|525084864|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
145609244|NCT01454830|525084865|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
145609245|NCT01454830|525084864|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
145609246|NCT01454830|525084865|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
145609247|NCT01454830|525084864|FG000|Overall Study|Withdrawal - no polysomnography|3|||
145609248|NCT01454830|525084865|FG001|Overall Study|Withdrawal - no polysomnography|2|||
145609249|NCT01872910|525084872|FG000|Overall Study|Lost to Follow-up|2|||
145784521|NCT03596177|525718433|FG000|Double Blind Period|Death during safety follow-up|0|||
145784522|NCT03596177|525718434|FG001|Double Blind Period|Death during safety follow-up|1|||
145784523|NCT02566525|525718436|FG000|Overall Study|Protocol Violation|3|||
145279921|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
145609250|NCT01872910|525084873|FG001|Overall Study|Lost to Follow-up|0|||
145609251|NCT01872910|525084874|FG002|Overall Study|Lost to Follow-up|2|||
145609252|NCT01872910|525084875|FG003|Overall Study|Lost to Follow-up|0|||
145609253|NCT01872910|525084876|FG004|Overall Study|Lost to Follow-up|0|||
145609254|NCT01872910|525084877|FG005|Overall Study|Lost to Follow-up|0|||
145609255|NCT03469349|525084878|FG000|Overall Study|Withdrawal by Subject|1|||
145609256|NCT03469349|525084879|FG001|Overall Study|Withdrawal by Subject|3|||
145609257|NCT03469349|525084878|FG000|Overall Study|Progressive Disease|0|||
145609258|NCT03469349|525084879|FG001|Overall Study|Progressive Disease|1|||
145609259|NCT03469349|525084878|FG000|Overall Study|Lost to Follow-up|2|||
145609260|NCT03469349|525084879|FG001|Overall Study|Lost to Follow-up|2|||
145609261|NCT03469349|525084878|FG000|Overall Study|Adverse Event|2|||
145609262|NCT03469349|525084879|FG001|Overall Study|Adverse Event|4|||
145609263|NCT01306201|525084882|FG000|Overall Study|Arrhythmia|4|||
145609264|NCT01306201|525084882|FG000|Overall Study|Files could not be processed|3|||
145609265|NCT01306201|525084882|FG000|Overall Study|Files unreadable|3|||
145609266|NCT04702568|525084883|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
145609267|NCT04702568|525084884|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
145609268|NCT04702568|525084883|FG000|Overall Study|Pregnancy|1|||
145609269|NCT04702568|525084884|FG001|Overall Study|Pregnancy|0|||
145784524|NCT02566525|525718437|FG001|Overall Study|Protocol Violation|5|||
145784525|NCT00337467|525718440|FG000|Overall Study|Adverse Event|3|||
145784526|NCT00337467|525718440|FG000|Overall Study|Subject Withdrew Consent|2|||
145784527|NCT00337467|525718440|FG000|Overall Study|Pregnancy|1|||
145538124|NCT00002651|524829430|FG000|Consolidation and Randomization|not eligible|0|||
145538125|NCT00002651|524829431|FG001|Consolidation and Randomization|not eligible|102|||
145609270|NCT04702568|525084883|FG000|Overall Study|Bone marrow transplant|1|||
145609271|NCT04702568|525084884|FG001|Overall Study|Bone marrow transplant|0|||
145609272|NCT04702568|525084883|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
145609273|NCT04702568|525084884|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
145609274|NCT04702568|525084883|FG000|Overall Study|Withdrawal by Subject|0|||
145609275|NCT04702568|525084884|FG001|Overall Study|Withdrawal by Subject|2|||
145609276|NCT00393523|525084885|FG000|Overall Study|Lost to Follow-up|0|||
145609277|NCT00393523|525084886|FG001|Overall Study|Lost to Follow-up|0|||
145609278|NCT00393523|525084887|FG002|Overall Study|Lost to Follow-up|0|||
145609279|NCT00393523|525084888|FG003|Overall Study|Lost to Follow-up|2|||
145784528|NCT00337467|525718440|FG000|Overall Study|Lost to Follow-up|2|||
145784529|NCT00337467|525718440|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
145784530|NCT03141086|525718441|FG000|Overall Study|Study Terminated By Sponsor|1|||
145784531|NCT03141086|525718442|FG001|Overall Study|Study Terminated By Sponsor|1|||
145784532|NCT03141086|525718441|FG000|Overall Study|Withdrawal by Subject|0|||
145784533|NCT03141086|525718442|FG001|Overall Study|Withdrawal by Subject|1|||
145784534|NCT03141086|525718441|FG000|Overall Study|Protocol Violation|0|||
145784535|NCT03141086|525718442|FG001|Overall Study|Protocol Violation|1|||
145784536|NCT03141086|525718441|FG000|Overall Study|Adverse Event|0|||
145784537|NCT03141086|525718442|FG001|Overall Study|Adverse Event|2|||
145784538|NCT04083222|525718444|FG000|Overall Study|Voluntary Withdrawal|0|||
145784539|NCT04083222|525718445|FG001|Overall Study|Voluntary Withdrawal|1|||
145784540|NCT04083222|525718444|FG000|Overall Study|Reason not Specified|0|||
145784541|NCT04083222|525718445|FG001|Overall Study|Reason not Specified|1|||
145784542|NCT02410902|525720274|FG000|Overall Study|Adverse Event|2|||
145784543|NCT02410902|525720275|FG001|Overall Study|Adverse Event|3|||
145784544|NCT02410902|525720274|FG000|Overall Study|Lost to Follow-up|4|||
145784545|NCT02410902|525720275|FG001|Overall Study|Lost to Follow-up|1|||
145784546|NCT02410902|525720274|FG000|Overall Study|Protocol Violation|1|||
145784547|NCT02410902|525720275|FG001|Overall Study|Protocol Violation|4|||
145784548|NCT02410902|525720274|FG000|Overall Study|Withdrawal by Subject|6|||
145784549|NCT02410902|525720275|FG001|Overall Study|Withdrawal by Subject|8|||
145784550|NCT02410902|525720274|FG000|Overall Study|Non-Compliance|8|||
145784551|NCT02410902|525720275|FG001|Overall Study|Non-Compliance|2|||
145538126|NCT00002651|524829432|FG002|Consolidation and Randomization|not eligible|112|||
145538127|NCT03750955|524829433|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
145538128|NCT03750955|524829434|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
145538129|NCT03750955|524829433|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
145538130|NCT03750955|524829434|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
145538131|NCT01705730|524829435|FG000|Overall Study|Lack of Efficacy|1|||
145538132|NCT01705730|524829435|FG000|Overall Study|Adverse Event|3|||
145538133|NCT01705730|524829435|FG000|Overall Study|Lost to Follow-up|1|||
145538134|NCT01705730|524829435|FG000|Overall Study|Reason not Specified|4|||
145538135|NCT01773733|524829436|FG000|Overall Study|Adverse Event|3286|||
145538136|NCT01773733|524829437|FG001|Overall Study|Adverse Event|540|||
145538137|NCT01773733|524829436|FG000|Overall Study|Pregnancy|28|||
145538138|NCT01773733|524829437|FG001|Overall Study|Pregnancy|0|||
145538139|NCT01773733|524829436|FG000|Overall Study|Other different categories of not compl|55415|||
145538140|NCT01773733|524829437|FG001|Overall Study|Other different categories of not compl|7781|||
145538141|NCT00880542|524829442|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
145538142|NCT00880542|524829442|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
145538143|NCT00880542|524829442|FG000|REP: Surgical Resection|progressive disease|1|||
145538144|NCT00762385|524829443|FG000|First Intervention|Lens Issue|1|||
145538145|NCT00762385|524829444|FG001|First Intervention|Lens Issue|1|||
145538146|NCT00762385|524829443|FG000|First Intervention|Lost to Follow-up|0|||
145538147|NCT00762385|524829444|FG001|First Intervention|Lost to Follow-up|2|||
145538148|NCT00762385|524829443|FG000|First Intervention|Ineligible|1|||
145538149|NCT00762385|524829444|FG001|First Intervention|Ineligible|0|||
145538150|NCT00762385|524829443|FG000|First Intervention|Protocol Violation|0|||
145538151|NCT00762385|524829444|FG001|First Intervention|Protocol Violation|1|||
145538152|NCT00762385|524829443|FG000|Second Intervention|Protocol Violation|3|||
145538153|NCT00762385|524829444|FG001|Second Intervention|Protocol Violation|3|||
145538154|NCT01781975|524829445|FG000|Overall Study|Death|1|||
145609280|NCT00393523|525084889|FG004|Overall Study|Lost to Follow-up|1|||
145609281|NCT00393523|525084885|FG000|Overall Study|Protocol Violation|6|||
145538155|NCT01781975|524829446|FG001|Overall Study|Death|0|||
145538156|NCT01781975|524829445|FG000|Overall Study|Withdrawal by Subject|1|||
145538157|NCT01781975|524829446|FG001|Overall Study|Withdrawal by Subject|1|||
145784552|NCT00953043|525720276|FG000|Overall Study|Withdrawal by Subject|4|||
145784553|NCT00953043|525720277|FG001|Overall Study|Withdrawal by Subject|0|||
145784554|NCT00953043|525720276|FG000|Overall Study|Physician Decision|0|||
145784555|NCT00953043|525720277|FG001|Overall Study|Physician Decision|2|||
145784556|NCT00747617|525720279|FG000|Overall Study|Lost to Follow-up|3|||
145784557|NCT00747617|525720280|FG001|Overall Study|Lost to Follow-up|1|||
145538158|NCT02329080|524829447|FG000|Overall Study|Adverse Event|1|||
145538159|NCT02329080|524829447|FG000|Overall Study|Death|4|||
145538160|NCT02329080|524829447|FG000|Overall Study|Lack of Efficacy|22|||
145538161|NCT02329080|524829447|FG000|Overall Study|Lost to Follow-up|1|||
145538162|NCT02329080|524829447|FG000|Overall Study|Physician Decision|2|||
145538163|NCT02329080|524829447|FG000|Overall Study|Partial response|4|||
145538164|NCT02329080|524829447|FG000|Overall Study|Complete response|4|||
145538165|NCT04545060|524829448|FG000|Overall Study|Adverse Event|0|||
145538166|NCT04545060|524829449|FG001|Overall Study|Adverse Event|1|||
145538167|NCT04545060|524829448|FG000|Overall Study|Death|0|||
145538168|NCT04545060|524829449|FG001|Overall Study|Death|5|||
145538169|NCT04545060|524829448|FG000|Overall Study|Lost to Follow-up|10|||
145538170|NCT04545060|524829449|FG001|Overall Study|Lost to Follow-up|13|||
145609282|NCT00393523|525084886|FG001|Overall Study|Protocol Violation|2|||
145609283|NCT00393523|525084887|FG002|Overall Study|Protocol Violation|0|||
145609284|NCT00393523|525084888|FG003|Overall Study|Protocol Violation|1|||
145609285|NCT00393523|525084889|FG004|Overall Study|Protocol Violation|0|||
145609286|NCT00393523|525084885|FG000|Overall Study|Withdrawal by Subject|6|||
145609287|NCT00393523|525084886|FG001|Overall Study|Withdrawal by Subject|7|||
145609288|NCT00393523|525084887|FG002|Overall Study|Withdrawal by Subject|2|||
145609289|NCT00393523|525084888|FG003|Overall Study|Withdrawal by Subject|3|||
145609290|NCT00393523|525084889|FG004|Overall Study|Withdrawal by Subject|0|||
145538171|NCT04545060|524829448|FG000|Overall Study|Physician Decision|3|||
145538172|NCT04545060|524829449|FG001|Overall Study|Physician Decision|0|||
145538173|NCT04545060|524829448|FG000|Overall Study|Withdrawal by Subject|17|||
145538174|NCT04545060|524829449|FG001|Overall Study|Withdrawal by Subject|22|||
145538175|NCT00973674|524829450|FG000|Overall Study|Protocol Violation|2|||
145538176|NCT00973674|524829451|FG001|Overall Study|Protocol Violation|0|||
145538177|NCT00071396|524829456|FG000|Overall Study|Withdrawal by Subject|1|||
145538178|NCT00071396|524829456|FG000|Overall Study|Physician Decision|2|||
145538179|NCT00839852|524829457|FG000|Overall Study|Adverse Event|10|||
145538180|NCT00839852|524829457|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145538181|NCT00839852|524829457|FG000|Overall Study|Protocol Violation|9|||
145538182|NCT00839852|524829457|FG000|Overall Study|Withdrawal of Consent|16|||
145538183|NCT00839852|524829457|FG000|Overall Study|Lost to Follow-up|7|||
145538184|NCT00839852|524829457|FG000|Overall Study|Lack of Compliance While in Jail|1|||
145538185|NCT00839852|524829457|FG000|Overall Study|Pregnancy|1|||
145609291|NCT00393523|525084885|FG000|Overall Study|Difficulties in specimen collection|0|||
145609292|NCT00393523|525084886|FG001|Overall Study|Difficulties in specimen collection|0|||
145609293|NCT00393523|525084887|FG002|Overall Study|Difficulties in specimen collection|1|||
145609294|NCT00393523|525084888|FG003|Overall Study|Difficulties in specimen collection|0|||
145609295|NCT00393523|525084889|FG004|Overall Study|Difficulties in specimen collection|0|||
145538186|NCT03082261|524829458|FG000|Overall Study|Death|4|||
145609296|NCT00393523|525084885|FG000|Overall Study|Vaccine supply issue|0|||
145538187|NCT03082261|524829458|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
145538188|NCT03082261|524829458|FG000|Overall Study|Insurance denial|1|||
145538189|NCT03082261|524829458|FG000|Overall Study|Peripheral lead added|1|||
145609297|NCT00393523|525084886|FG001|Overall Study|Vaccine supply issue|0|||
145609298|NCT00393523|525084887|FG002|Overall Study|Vaccine supply issue|1|||
145538190|NCT03082261|524829458|FG000|Overall Study|Withdrawal by Subject|40|||
145538191|NCT03082261|524829458|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
145784558|NCT01746732|525720281|FG000|Lead-In Period|Withdrawal by Subject|1|||
145784559|NCT01746732|525720282|FG001|Lead-In Period|Withdrawal by Subject|0|||
145609299|NCT00393523|525084888|FG003|Overall Study|Vaccine supply issue|0|||
145609300|NCT00393523|525084889|FG004|Overall Study|Vaccine supply issue|0|||
145784560|NCT01746732|525720283|FG002|Lead-In Period|Withdrawal by Subject|0|||
145784561|NCT01746732|525720281|FG000|Period 1|Physician Decision|0|||
145784562|NCT01746732|525720282|FG001|Period 1|Physician Decision|1|||
145784563|NCT01746732|525720283|FG002|Period 1|Physician Decision|0|||
145784564|NCT01746732|525720281|FG000|Period 2|Withdrawal by Subject|0|||
145784565|NCT01746732|525720282|FG001|Period 2|Withdrawal by Subject|0|||
145784566|NCT01746732|525720283|FG002|Period 2|Withdrawal by Subject|2|||
145609301|NCT02912468|525084890|FG000|Overall Study|Adverse Event|3|||
145609302|NCT02912468|525084891|FG001|Overall Study|Adverse Event|2|||
145609303|NCT02912468|525084890|FG000|Overall Study|Withdrawal by Subject|6|||
145609304|NCT02912468|525084891|FG001|Overall Study|Withdrawal by Subject|2|||
145784567|NCT01746732|525720281|FG000|Period 2|Adverse Event|0|||
145784568|NCT01746732|525720282|FG001|Period 2|Adverse Event|0|||
145784569|NCT01746732|525720283|FG002|Period 2|Adverse Event|1|||
145784570|NCT01746732|525720281|FG000|Period 2|Lost to Follow-up|0|||
145784571|NCT01746732|525720282|FG001|Period 2|Lost to Follow-up|0|||
145538192|NCT03082261|524829458|FG000|Overall Study|Subject implanted with device other than study device|1|||
145538193|NCT03082261|524829458|FG000|Overall Study|Lost to Follow-up|14|||
145538194|NCT03082261|524829458|FG000|Overall Study|Subject moved to a different state|1|||
145538195|NCT03082261|524829458|FG000|Overall Study|Subject non-compliance|2|||
145538196|NCT03082261|524829458|FG000|Overall Study|Subject participation terminated by investigator|9|||
145538197|NCT03082261|524829458|FG000|Overall Study|Subject participation terminated by sponsor|4|||
145538198|NCT03082261|524829458|FG000|Overall Study|System explant|19|||
145538199|NCT03082261|524829458|FG000|Overall Study|Unable to place lead(s)|2|||
145538200|NCT03082261|524829458|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
145538201|NCT04545554|524829459|FG000|Overall Study|Withdrawal by Subject|0|||
145538202|NCT04545554|524829460|FG001|Overall Study|Withdrawal by Subject|0|||
145538203|NCT04545554|524829461|FG002|Overall Study|Withdrawal by Subject|0|||
145538204|NCT04545554|524829462|FG003|Overall Study|Withdrawal by Subject|1|||
145538205|NCT04545554|524829463|FG004|Overall Study|Withdrawal by Subject|0|||
145538206|NCT04545554|524829464|FG005|Overall Study|Withdrawal by Subject|0|||
145538207|NCT00494299|524829465|FG000|Overall Study|Adverse Event|93|||
145538208|NCT00494299|524829466|FG001|Overall Study|Adverse Event|13|||
145538209|NCT00494299|524829465|FG000|Overall Study|Lost to Follow-up|1|||
145538210|NCT00494299|524829466|FG001|Overall Study|Lost to Follow-up|0|||
145538211|NCT00494299|524829465|FG000|Overall Study|Physician Decision|0|||
145538212|NCT00494299|524829466|FG001|Overall Study|Physician Decision|2|||
145538213|NCT00494299|524829465|FG000|Overall Study|Protocol Violation|1|||
145538214|NCT00494299|524829466|FG001|Overall Study|Protocol Violation|2|||
145538215|NCT00494299|524829465|FG000|Overall Study|Withdrawal by Subject|8|||
145538216|NCT00494299|524829466|FG001|Overall Study|Withdrawal by Subject|3|||
145538217|NCT00494299|524829465|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
145538218|NCT00494299|524829466|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
145538219|NCT00494299|524829465|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
145538220|NCT00494299|524829466|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
145538221|NCT00494299|524829465|FG000|Overall Study|Site Closed by Sponsor|6|||
145538222|NCT00494299|524829466|FG001|Overall Study|Site Closed by Sponsor|0|||
145538223|NCT00494299|524829465|FG000|Overall Study|Protocol Driven Decision Point|11|||
145538224|NCT00494299|524829466|FG001|Overall Study|Protocol Driven Decision Point|22|||
145538225|NCT01986907|524829467|FG000|Overall Study|Adverse Event|11|||
145538226|NCT01986907|524829467|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
145538227|NCT01986907|524829467|FG000|Overall Study|Protocol Violation|4|||
145538228|NCT01986907|524829467|FG000|Overall Study|Withdrawal by Subject|76|||
145538229|NCT01986907|524829467|FG000|Overall Study|Lost to Follow-up|38|||
145538230|NCT01986907|524829467|FG000|Overall Study|Death|9|||
145538231|NCT02846324|524829469|FG000|Overall Study|Other|1|||
145538232|NCT02846324|524829470|FG001|Overall Study|Other|0|||
145538233|NCT02846324|524829471|FG002|Overall Study|Other|0|||
145609305|NCT02912468|525084890|FG000|Overall Study|Randomized and not treated|0|||
145609306|NCT02912468|525084891|FG001|Overall Study|Randomized and not treated|1|||
145538234|NCT02846324|524829472|FG003|Overall Study|Other|0|||
145538235|NCT02846324|524829469|FG000|Overall Study|Withdrawal by Subject|1|||
145538236|NCT02846324|524829470|FG001|Overall Study|Withdrawal by Subject|0|||
145538237|NCT02846324|524829471|FG002|Overall Study|Withdrawal by Subject|4|||
145538238|NCT02846324|524829472|FG003|Overall Study|Withdrawal by Subject|0|||
145538239|NCT03576495|524829479|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
145538240|NCT03576495|524829480|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
145609307|NCT00692406|525084894|FG000|Overall Study|PI dropped, bad data|57|||
145609308|NCT04599101|525084895|FG000|Overall Study|Lost to Follow-up|5|||
145784572|NCT01746732|525720283|FG002|Period 2|Lost to Follow-up|1|||
145784573|NCT02279524|525720284|FG000|Overall Study|Withdrawal by Subject|3|||
145784574|NCT02279524|525720285|FG001|Overall Study|Withdrawal by Subject|6|||
145784575|NCT02279524|525720286|FG002|Overall Study|Withdrawal by Subject|3|||
145538241|NCT02635776|524829482|FG000|Overall Study|Physician Decision|1|||
145538242|NCT02635776|524829483|FG001|Overall Study|Physician Decision|0|||
145538243|NCT02635776|524829482|FG000|Overall Study|Adverse Event|51|||
145538244|NCT02635776|524829483|FG001|Overall Study|Adverse Event|3|||
145538245|NCT02635776|524829482|FG000|Overall Study|Withdrawal by Subject|41|||
145538246|NCT02635776|524829483|FG001|Overall Study|Withdrawal by Subject|7|||
145538247|NCT02635776|524829482|FG000|Overall Study|Lost to Follow-up|4|||
145538248|NCT02635776|524829483|FG001|Overall Study|Lost to Follow-up|0|||
145538249|NCT02635776|524829482|FG000|Overall Study|Other reasons|5|||
145538250|NCT02635776|524829483|FG001|Overall Study|Other reasons|1|||
145538251|NCT00788073|524829484|FG000|STX209 Then Placebo|Adverse Event|1|||
145538252|NCT00788073|524829485|FG001|STX209 Then Placebo|Adverse Event|0|||
145538253|NCT00788073|524829484|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
145538254|NCT00788073|524829485|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
145538255|NCT00788073|524829484|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
145538256|NCT00788073|524829485|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
145538257|NCT00788073|524829484|FG000|STX209 Then Placebo|unable to return due to travel|0|||
145538258|NCT00788073|524829485|FG001|STX209 Then Placebo|unable to return due to travel|1|||
145538259|NCT00788073|524829484|FG000|Placebo Then STX209|Adverse Event|2|||
145538260|NCT00788073|524829485|FG001|Placebo Then STX209|Adverse Event|0|||
145538261|NCT00788073|524829484|FG000|Placebo Then STX209|Protocol Violation|0|||
145538262|NCT00788073|524829485|FG001|Placebo Then STX209|Protocol Violation|1|||
145538263|NCT03608254|524829486|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
145538264|NCT03608254|524829486|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
145538265|NCT03208127|524829487|FG000|Overall Study|Death|1|||
145538266|NCT00516074|524829488|FG000|Overall Study|Adverse Event|0|||
145538267|NCT00516074|524829489|FG001|Overall Study|Adverse Event|1|||
145538268|NCT00516074|524829488|FG000|Overall Study|Subject Decision|4|||
145538269|NCT00516074|524829489|FG001|Overall Study|Subject Decision|2|||
145538270|NCT00516074|524829488|FG000|Overall Study|Loss of Glucose Control|2|||
145538271|NCT00516074|524829489|FG001|Overall Study|Loss of Glucose Control|0|||
145538272|NCT05213481|524829491|FG000|Overall Study|Adverse Event|3|||
145538273|NCT05213481|524829491|FG000|Overall Study|Lost to Follow-up|1|||
145538274|NCT03822182|524829494|FG000|Overall Study|Protocol Violation|0|||
145538275|NCT03822182|524829495|FG001|Overall Study|Protocol Violation|1|||
145538276|NCT03822182|524829496|FG002|Overall Study|Protocol Violation|1|||
145538277|NCT00810355|524829497|FG000|Overall Study|Lost to Follow-up|13|||
145538278|NCT00810355|524829498|FG001|Overall Study|Lost to Follow-up|17|||
145538279|NCT00810355|524829499|FG002|Overall Study|Lost to Follow-up|11|||
145538280|NCT00810355|524829497|FG000|Overall Study|Withdrawal by Subject|1|||
145538281|NCT00810355|524829498|FG001|Overall Study|Withdrawal by Subject|0|||
145538282|NCT00810355|524829499|FG002|Overall Study|Withdrawal by Subject|0|||
145538283|NCT01612858|524829501|FG000|Overall Study|Withdrawal by Subject|5|||
145538284|NCT01612858|524829502|FG001|Overall Study|Withdrawal by Subject|1|||
145538285|NCT00003487|524829503|FG000|Overall Study|Not evaluable|2|||
145538286|NCT04154930|524829506|FG000|Overall Study|Withdrawal by Subject|15|||
145538287|NCT04154930|524829507|FG001|Overall Study|Withdrawal by Subject|6|||
145538288|NCT04154930|524829506|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
145538289|NCT04154930|524829507|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
145538290|NCT04154930|524829506|FG000|Overall Study|Lost to Follow-up|14|||
145538291|NCT04154930|524829507|FG001|Overall Study|Lost to Follow-up|6|||
145538292|NCT04154930|524829506|FG000|Overall Study|Other|6|||
145538293|NCT04154930|524829507|FG001|Overall Study|Other|0|||
145538294|NCT02628938|524829508|FG000|Overall Study|Did not attend the follow up recall|2|||
145538295|NCT02628938|524829509|FG001|Overall Study|Did not attend the follow up recall|2|||
145538296|NCT02628938|524829510|FG002|Overall Study|Did not attend the follow up recall|1|||
145538297|NCT02628938|524829508|FG000|Overall Study|Failure to comply with the instructions|3|||
145538298|NCT02628938|524829509|FG001|Overall Study|Failure to comply with the instructions|0|||
145538299|NCT02628938|524829510|FG002|Overall Study|Failure to comply with the instructions|3|||
145538300|NCT02058693|524829511|FG000|Phase 1|Withdrawal by Subject|3|||
145538301|NCT02058693|524829512|FG001|Phase 1|Withdrawal by Subject|2|||
145538302|NCT02058693|524829511|FG000|Phase 1|Adverse Event|0|||
145538303|NCT02058693|524829512|FG001|Phase 1|Adverse Event|1|||
145538304|NCT02058693|524829511|FG000|Phase 1|Lack of Efficacy|1|||
145538305|NCT02058693|524829512|FG001|Phase 1|Lack of Efficacy|0|||
145538306|NCT02058693|524829511|FG000|Phase 1|Physician Decision|1|||
145538307|NCT02058693|524829512|FG001|Phase 1|Physician Decision|1|||
145538308|NCT02058693|524829511|FG000|Phase 2|Withdrawal by Subject|0|||
145538309|NCT02058693|524829512|FG001|Phase 2|Withdrawal by Subject|2|||
145538310|NCT00241358|524829513|FG000|Overall Study|Determined to be not ineligible|0|||
145538311|NCT00241358|524829514|FG001|Overall Study|Determined to be not ineligible|1|||
145538312|NCT00241358|524829515|FG002|Overall Study|Determined to be not ineligible|1|||
145609309|NCT04599101|525084896|FG001|Overall Study|Lost to Follow-up|5|||
145538313|NCT03855228|524829516|FG000|Overall Study|Adverse Event|2|||
145538314|NCT03855228|524829517|FG001|Overall Study|Adverse Event|4|||
145538315|NCT03855228|524829518|FG002|Overall Study|Adverse Event|4|||
145538316|NCT03855228|524829519|FG003|Overall Study|Adverse Event|8|||
145538317|NCT03855228|524829516|FG000|Overall Study|Treatment Failure|1|||
145538318|NCT03855228|524829517|FG001|Overall Study|Treatment Failure|2|||
145538319|NCT03855228|524829518|FG002|Overall Study|Treatment Failure|1|||
145538320|NCT03855228|524829519|FG003|Overall Study|Treatment Failure|8|||
145538321|NCT03855228|524829516|FG000|Overall Study|Lost to Follow-up|0|||
145538322|NCT03855228|524829517|FG001|Overall Study|Lost to Follow-up|0|||
145609310|NCT00525265|525084901|FG000|Overall Study|Protocol Violation|1|||
145609311|NCT00525265|525084902|FG001|Overall Study|Protocol Violation|0|||
145609312|NCT01913639|525084903|FG000|Overall Study|Not Eligible|3|||
145609313|NCT01515189|525084915|FG000|Induction|Disease Progression|109|||
145609314|NCT01515189|525084916|FG001|Induction|Disease Progression|155|||
145609315|NCT01515189|525084915|FG000|Induction|Study drug toxicity|86|||
145609316|NCT01515189|525084916|FG001|Induction|Study drug toxicity|36|||
145609317|NCT01515189|525084915|FG000|Induction|Death|24|||
145538323|NCT03855228|524829518|FG002|Overall Study|Lost to Follow-up|0|||
145538324|NCT03855228|524829519|FG003|Overall Study|Lost to Follow-up|1|||
145609318|NCT01515189|525084916|FG001|Induction|Death|17|||
145609319|NCT01515189|525084915|FG000|Induction|Adverse Event|14|||
145538325|NCT03855228|524829516|FG000|Overall Study|Protocol Violation|0|||
145538326|NCT03855228|524829517|FG001|Overall Study|Protocol Violation|1|||
145538327|NCT03855228|524829518|FG002|Overall Study|Protocol Violation|2|||
145538328|NCT03855228|524829519|FG003|Overall Study|Protocol Violation|1|||
145609320|NCT01515189|525084916|FG001|Induction|Adverse Event|9|||
145609321|NCT01515189|525084915|FG000|Induction|Withdrawal by Subject|3|||
145279922|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
145279923|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
145279924|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Death|1|||
145279925|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Death|0|||
145279926|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
145279927|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
145279928|NCT00789828|523874439|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
145279929|NCT00789828|523874440|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
145279930|NCT01133392|523874441|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
145279931|NCT01133392|523874442|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
145279932|NCT01133392|523874441|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
145279933|NCT01133392|523874442|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
145279934|NCT00378482|523874443|FG000|Overall Study|Lost to Follow-up|1|||
145279935|NCT00378482|523874443|FG000|Overall Study|Lack of Efficacy|8|||
145279936|NCT00378482|523874443|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
145279937|NCT00378482|523874443|FG000|Overall Study|Withdrawal by Subject|4|||
145279938|NCT00378482|523874443|FG000|Overall Study|Adverse Event|9|||
145279939|NCT05166421|523874446|FG000|Overall Study|Other|3|||
145279940|NCT05166421|523874447|FG001|Overall Study|Other|1|||
145279941|NCT05166421|523874448|FG002|Overall Study|Other|1|||
145279942|NCT05166421|523874446|FG000|Overall Study|Withdrawal by Subject|5|||
145279943|NCT05166421|523874447|FG001|Overall Study|Withdrawal by Subject|3|||
145279944|NCT05166421|523874448|FG002|Overall Study|Withdrawal by Subject|6|||
145279945|NCT05166421|523874446|FG000|Overall Study|Lost to Follow-up|4|||
145279946|NCT05166421|523874447|FG001|Overall Study|Lost to Follow-up|1|||
145279947|NCT05166421|523874448|FG002|Overall Study|Lost to Follow-up|7|||
145279948|NCT01335399|523875676|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
145279949|NCT01335399|523875677|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
145279950|NCT01335399|523875676|FG000|Pre-treatment Period|Participant request to discontinue|0|||
145279951|NCT01335399|523875677|FG001|Pre-treatment Period|Participant request to discontinue|1|||
145279952|NCT01335399|523875676|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
145279953|NCT01335399|523875677|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
145279954|NCT01335399|523875676|FG000|Pre-treatment Period|Consent withdrawal|3|||
145279955|NCT01335399|523875677|FG001|Pre-treatment Period|Consent withdrawal|0|||
145279956|NCT01335399|523875676|FG000|Treatment Period|Disease progression|117|||
145279957|NCT01335399|523875677|FG001|Treatment Period|Disease progression|145|||
145279958|NCT01335399|523875676|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
145279959|NCT01335399|523875677|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
145279960|NCT01335399|523875676|FG000|Treatment Period|Study drug toxicity|52|||
145279961|NCT01335399|523875677|FG001|Treatment Period|Study drug toxicity|64|||
145279962|NCT01335399|523875676|FG000|Treatment Period|Participant request to discontinue|30|||
145279963|NCT01335399|523875677|FG001|Treatment Period|Participant request to discontinue|22|||
145279964|NCT01335399|523875676|FG000|Treatment Period|Other reasons|30|||
145279965|NCT01335399|523875677|FG001|Treatment Period|Other reasons|30|||
145279966|NCT01335399|523875676|FG000|Treatment Period|Consent withdrawal|10|||
145279967|NCT01335399|523875677|FG001|Treatment Period|Consent withdrawal|7|||
145279968|NCT01335399|523875676|FG000|Treatment Period|Death|7|||
145279969|NCT01335399|523875677|FG001|Treatment Period|Death|6|||
145279970|NCT01335399|523875676|FG000|Treatment Period|Poor/Non-compliance|3|||
145279971|NCT01335399|523875677|FG001|Treatment Period|Poor/Non-compliance|4|||
145279972|NCT01335399|523875676|FG000|Treatment Period|Lost to Follow-up|2|||
145538329|NCT03855228|524829516|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
145538330|NCT03855228|524829517|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
145538331|NCT03855228|524829518|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
145279973|NCT01335399|523875677|FG001|Treatment Period|Lost to Follow-up|2|||
145279974|NCT01335399|523875676|FG000|Treatment Period|Maximum clinical benefit|1|||
145279975|NCT01335399|523875677|FG001|Treatment Period|Maximum clinical benefit|1|||
145279976|NCT01335399|523875676|FG000|Treatment Period|No longer meet study criteria|1|||
145279977|NCT01335399|523875677|FG001|Treatment Period|No longer meet study criteria|1|||
145279978|NCT01335399|523875676|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
145403886|NCT01673386|524336431|FG001|Overall Study|Study terminated by sponsor|22|||
145609322|NCT01515189|525084916|FG001|Induction|Withdrawal by Subject|9|||
145279979|NCT01335399|523875677|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
145538332|NCT03855228|524829519|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
145538333|NCT00843856|524829520|FG000|Overall Study|Lost to Follow-up|1|||
145538334|NCT00843856|524829521|FG001|Overall Study|Lost to Follow-up|2|||
145279980|NCT03202511|523875681|FG000|Overall Study|Withdrawal by Subject|1|||
145279981|NCT03202511|523875682|FG001|Overall Study|Withdrawal by Subject|0|||
145279982|NCT00096382|523875683|FG000|Overall Study|Not treated|1|||
145279983|NCT00096382|523875684|FG001|Overall Study|Not treated|0|||
145279984|NCT00096382|523875683|FG000|Overall Study|Death during treatment|1|||
145279985|NCT00096382|523875684|FG001|Overall Study|Death during treatment|0|||
145279986|NCT01270841|523875685|FG000|Overall Study|Adverse Event|0|||
145279987|NCT01270841|523875686|FG001|Overall Study|Adverse Event|1|||
145279988|NCT01270841|523875687|FG002|Overall Study|Adverse Event|0|||
145279989|NCT01270841|523875688|FG003|Overall Study|Adverse Event|3|||
145279990|NCT01270841|523875685|FG000|Overall Study|Withdrawal by Subject|3|||
145403887|NCT01673386|524336430|FG000|Overall Study|Adverse Event|5|||
145403888|NCT01673386|524336431|FG001|Overall Study|Adverse Event|2|||
145403889|NCT01673386|524336430|FG000|Overall Study|Progressive disease|4|||
145403890|NCT01673386|524336431|FG001|Overall Study|Progressive disease|1|||
145403891|NCT01673386|524336430|FG000|Overall Study|Withdrawal by Subject|0|||
145403892|NCT01673386|524336431|FG001|Overall Study|Withdrawal by Subject|2|||
145403893|NCT00109343|524336432|FG000|Overall Study|Adverse Event|1|||
145403894|NCT00109343|524336433|FG001|Overall Study|Adverse Event|0|||
145403895|NCT00109343|524336434|FG002|Overall Study|Adverse Event|2|||
145403896|NCT00109343|524336432|FG000|Overall Study|Lack of Efficacy|1|||
145403897|NCT00109343|524336433|FG001|Overall Study|Lack of Efficacy|0|||
145403898|NCT00109343|524336434|FG002|Overall Study|Lack of Efficacy|0|||
145403899|NCT00109343|524336432|FG000|Overall Study|Lost to Follow-up|35|||
145403900|NCT00109343|524336433|FG001|Overall Study|Lost to Follow-up|20|||
145403901|NCT00109343|524336434|FG002|Overall Study|Lost to Follow-up|14|||
145403902|NCT00109343|524336432|FG000|Overall Study|Protocol Violation|1|||
145538335|NCT00590135|524829522|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
145538336|NCT01449539|524829535|FG000|Overall Study|Withdrawal by Subject|3|||
145538337|NCT01449539|524829535|FG000|Overall Study|Toxicity not study related|1|||
145538338|NCT00806351|524829539|FG000|Overall Study|Death|5|||
145538339|NCT00806351|524829540|FG001|Overall Study|Death|4|||
145538340|NCT00913380|524829543|FG000|Clinical Outcomes|Lost to Follow-up|6|||
145538341|NCT00913380|524829544|FG001|Clinical Outcomes|Lost to Follow-up|6|||
145538342|NCT02187744|524829545|FG000|Study|Participant refused further follow-up|1|||
145538343|NCT02187744|524829546|FG001|Study|Participant refused further follow-up|0|||
145538344|NCT02187744|524829545|FG000|Study|Other|2|||
145538345|NCT02187744|524829546|FG001|Study|Other|1|||
145538346|NCT02187744|524829545|FG000|Study|Lost to Follow-up|0|||
145538347|NCT02187744|524829546|FG001|Study|Lost to Follow-up|2|||
145538348|NCT02187744|524829545|FG000|Study|Related adverse event, not serious|0|||
145538349|NCT02187744|524829546|FG001|Study|Related adverse event, not serious|2|||
145538350|NCT02187744|524829545|FG000|Study|Death|1|||
145538351|NCT02187744|524829546|FG001|Study|Death|0|||
145538352|NCT02187744|524829545|FG000|Study|Related adverse event, serious non-fatal|0|||
145538353|NCT02187744|524829546|FG001|Study|Related adverse event, serious non-fatal|1|||
145538354|NCT02187744|524829545|FG000|Treatment|Death|1|||
145538355|NCT02187744|524829546|FG001|Treatment|Death|0|||
145538356|NCT02187744|524829545|FG000|Treatment|Related adverse event, serious non-fatal|0|||
145538357|NCT02187744|524829546|FG001|Treatment|Related adverse event, serious non-fatal|1|||
145538358|NCT02187744|524829545|FG000|Treatment|Related adverse event, not serious|0|||
145538359|NCT02187744|524829546|FG001|Treatment|Related adverse event, not serious|2|||
145538360|NCT02187744|524829545|FG000|Treatment|Lost to Follow-up|0|||
145538361|NCT02187744|524829546|FG001|Treatment|Lost to Follow-up|1|||
145538362|NCT02187744|524829545|FG000|Treatment|Other|2|||
145538363|NCT02187744|524829546|FG001|Treatment|Other|0|||
145538364|NCT02187744|524829545|FG000|Treatment|Participant refused continued treatment|1|||
145538365|NCT02187744|524829546|FG001|Treatment|Participant refused continued treatment|1|||
145538366|NCT01972568|524829551|FG000|Overall Study|Other events|3|||
145538367|NCT01972568|524829552|FG001|Overall Study|Other events|0|||
145538368|NCT01972568|524829553|FG002|Overall Study|Other events|0|||
145538369|NCT01972568|524829551|FG000|Overall Study|Lack of Efficacy|0|||
145538370|NCT01972568|524829552|FG001|Overall Study|Lack of Efficacy|1|||
145538371|NCT01972568|524829553|FG002|Overall Study|Lack of Efficacy|2|||
145538372|NCT01972568|524829551|FG000|Overall Study|Protocol Violation|1|||
145538373|NCT01972568|524829552|FG001|Overall Study|Protocol Violation|2|||
145538374|NCT01972568|524829553|FG002|Overall Study|Protocol Violation|2|||
145538375|NCT01972568|524829551|FG000|Overall Study|Withdrawal by Subject|6|||
145538376|NCT01972568|524829552|FG001|Overall Study|Withdrawal by Subject|3|||
145538377|NCT01972568|524829553|FG002|Overall Study|Withdrawal by Subject|7|||
145538378|NCT01972568|524829551|FG000|Overall Study|Lost to Follow-up|1|||
145538379|NCT01972568|524829552|FG001|Overall Study|Lost to Follow-up|0|||
145538380|NCT01972568|524829553|FG002|Overall Study|Lost to Follow-up|0|||
145538381|NCT01972568|524829551|FG000|Overall Study|Adverse Event|5|||
145538382|NCT01972568|524829552|FG001|Overall Study|Adverse Event|6|||
145279991|NCT01270841|523875686|FG001|Overall Study|Withdrawal by Subject|2|||
145403903|NCT00109343|524336433|FG001|Overall Study|Protocol Violation|2|||
145403904|NCT00109343|524336434|FG002|Overall Study|Protocol Violation|2|||
145403905|NCT00109343|524336432|FG000|Overall Study|Withdrawal by Subject|15|||
145538383|NCT01972568|524829553|FG002|Overall Study|Adverse Event|5|||
145538384|NCT00957580|524829554|FG000|Overall Study|Ongoing at data cut-off|0|||
145538385|NCT00957580|524829555|FG001|Overall Study|Ongoing at data cut-off|1|||
145538386|NCT00957580|524829556|FG002|Overall Study|Ongoing at data cut-off|0|||
145538387|NCT00957580|524829554|FG000|Overall Study|Enrolled but not treated|0|||
145538388|NCT00957580|524829555|FG001|Overall Study|Enrolled but not treated|1|||
145538389|NCT00957580|524829556|FG002|Overall Study|Enrolled but not treated|0|||
145538390|NCT02699593|524829562|FG000|Period 1|Unsatisfactory Visual Response|0|||
145538391|NCT02699593|524829563|FG001|Period 1|Unsatisfactory Visual Response|1|||
145538392|NCT02699593|524829562|FG000|Period 1|Torn Contact Len|4|||
145538393|NCT02699593|524829563|FG001|Period 1|Torn Contact Len|3|||
145538394|NCT02699593|524829562|FG000|Period 1|Protocol Violation|0|||
145609323|NCT01515189|525084915|FG000|Induction|No longer meets study criteria|0|||
145609324|NCT01515189|525084916|FG001|Induction|No longer meets study criteria|2|||
145609325|NCT01515189|525084915|FG000|Induction|Lost to Follow-up|1|||
145609326|NCT01515189|525084916|FG001|Induction|Lost to Follow-up|0|||
145609327|NCT01515189|525084915|FG000|Induction|Other|0|||
145609328|NCT01515189|525084916|FG001|Induction|Other|4|||
145609329|NCT01515189|525084915|FG000|First Re-Induction Phase|Disease progression|6|||
145609330|NCT01515189|525084916|FG001|First Re-Induction Phase|Disease progression|14|||
145609331|NCT01515189|525084915|FG000|First Re-Induction Phase|Study drug toxicity|5|||
145609332|NCT01515189|525084916|FG001|First Re-Induction Phase|Study drug toxicity|0|||
145609333|NCT01515189|525084915|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
145609334|NCT01515189|525084916|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
145609335|NCT01515189|525084915|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
145609336|NCT01515189|525084916|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
145609337|NCT01515189|525084915|FG000|First Re-Induction Phase|Other|1|||
145609338|NCT01515189|525084916|FG001|First Re-Induction Phase|Other|0|||
145609339|NCT01013792|525084917|FG000|Overall Study|Study suspended|2|||
145609340|NCT01013792|525084918|FG001|Overall Study|Study suspended|1|||
145609341|NCT01013792|525084917|FG000|Overall Study|Adverse Event|0|||
145609342|NCT01013792|525084918|FG001|Overall Study|Adverse Event|3|||
145609343|NCT01013792|525084917|FG000|Overall Study|Lost to Follow-up|0|||
145609344|NCT01013792|525084918|FG001|Overall Study|Lost to Follow-up|1|||
145609345|NCT05644353|525084919|FG000|Overall Study|Physician Decision|1|||
145609346|NCT05644353|525084920|FG001|Overall Study|Physician Decision|0|||
145609347|NCT05644353|525084921|FG002|Overall Study|Physician Decision|0|||
145609348|NCT05644353|525084922|FG003|Overall Study|Physician Decision|0|||
145609349|NCT05644353|525084923|FG004|Overall Study|Physician Decision|0|||
145609350|NCT05644353|525084924|FG005|Overall Study|Physician Decision|0|||
145609351|NCT05644353|525084919|FG000|Overall Study|Protocol Violation|1|||
145609352|NCT05644353|525084920|FG001|Overall Study|Protocol Violation|0|||
145609353|NCT05644353|525084921|FG002|Overall Study|Protocol Violation|0|||
145609354|NCT05644353|525084922|FG003|Overall Study|Protocol Violation|0|||
145609355|NCT05644353|525084923|FG004|Overall Study|Protocol Violation|0|||
145609356|NCT05644353|525084924|FG005|Overall Study|Protocol Violation|0|||
145609357|NCT05644353|525084919|FG000|Overall Study|Withdrawal by Subject|0|||
145609358|NCT05644353|525084920|FG001|Overall Study|Withdrawal by Subject|2|||
145609359|NCT05644353|525084921|FG002|Overall Study|Withdrawal by Subject|0|||
145609360|NCT05644353|525084922|FG003|Overall Study|Withdrawal by Subject|0|||
145609361|NCT05644353|525084923|FG004|Overall Study|Withdrawal by Subject|1|||
145609362|NCT05644353|525084924|FG005|Overall Study|Withdrawal by Subject|0|||
145609363|NCT05644353|525084919|FG000|Overall Study|Lost to Follow-up|0|||
145609364|NCT05644353|525084920|FG001|Overall Study|Lost to Follow-up|0|||
145609365|NCT05644353|525084921|FG002|Overall Study|Lost to Follow-up|1|||
145609366|NCT05644353|525084922|FG003|Overall Study|Lost to Follow-up|0|||
145279992|NCT01270841|523875687|FG002|Overall Study|Withdrawal by Subject|3|||
145279993|NCT01270841|523875688|FG003|Overall Study|Withdrawal by Subject|3|||
145279994|NCT01270841|523875685|FG000|Overall Study|Lost to Follow-up|3|||
145279995|NCT01270841|523875686|FG001|Overall Study|Lost to Follow-up|1|||
145279996|NCT01270841|523875687|FG002|Overall Study|Lost to Follow-up|4|||
145279997|NCT01270841|523875688|FG003|Overall Study|Lost to Follow-up|2|||
145279998|NCT01270841|523875685|FG000|Overall Study|Physician Decision|0|||
145279999|NCT01270841|523875686|FG001|Overall Study|Physician Decision|1|||
145280000|NCT01270841|523875687|FG002|Overall Study|Physician Decision|0|||
145280001|NCT01270841|523875688|FG003|Overall Study|Physician Decision|0|||
145280002|NCT01270841|523875685|FG000|Overall Study|Did not qualify|6|||
145280003|NCT01270841|523875686|FG001|Overall Study|Did not qualify|3|||
145280004|NCT01270841|523875687|FG002|Overall Study|Did not qualify|4|||
145280005|NCT01270841|523875688|FG003|Overall Study|Did not qualify|5|||
145280006|NCT01270841|523875685|FG000|Overall Study|Protocol Violation|1|||
145280007|NCT01270841|523875686|FG001|Overall Study|Protocol Violation|5|||
145280008|NCT01270841|523875687|FG002|Overall Study|Protocol Violation|0|||
145280009|NCT01270841|523875688|FG003|Overall Study|Protocol Violation|0|||
145280010|NCT01270841|523875685|FG000|Overall Study|Enrolled in error|0|||
145280011|NCT01270841|523875686|FG001|Overall Study|Enrolled in error|1|||
145280012|NCT01270841|523875687|FG002|Overall Study|Enrolled in error|0|||
145280013|NCT01270841|523875688|FG003|Overall Study|Enrolled in error|0|||
145280014|NCT01375010|523875689|FG000|Overall Study|Lost to Follow-up|8|||
145280015|NCT01375010|523875690|FG001|Overall Study|Lost to Follow-up|2|||
145280016|NCT01375010|523875689|FG000|Overall Study|Withdrawal by Subject|4|||
145280017|NCT01375010|523875690|FG001|Overall Study|Withdrawal by Subject|2|||
145280018|NCT02614703|523875691|FG000|Overall Study|Withdrawal by Subject|7|||
145280019|NCT02614703|523875692|FG001|Overall Study|Withdrawal by Subject|1|||
145280020|NCT01681771|523875701|FG000|Overall Study|Lost to Follow-up|4|||
145280021|NCT01681771|523875702|FG001|Overall Study|Lost to Follow-up|2|||
145280022|NCT04242186|523875705|FG000|Overall Study|Death|5|||
145280023|NCT00331773|523875706|FG000|Overall Study|Withdrawal by Subject|6|||
145280024|NCT00331773|523875707|FG001|Overall Study|Withdrawal by Subject|4|||
145280025|NCT00331773|523875706|FG000|Overall Study|Protocol Violation|10|||
145280026|NCT00331773|523875707|FG001|Overall Study|Protocol Violation|3|||
145280027|NCT01792284|523875708|FG000|Lead-in Period|Adverse Event|15|||
145280028|NCT01792284|523875709|FG001|Lead-in Period|Adverse Event|0|||
145280029|NCT01792284|523875710|FG002|Lead-in Period|Adverse Event|0|||
145280030|NCT01792284|523875708|FG000|Lead-in Period|Lost to Follow-up|2|||
145280031|NCT01792284|523875709|FG001|Lead-in Period|Lost to Follow-up|0|||
145280032|NCT01792284|523875710|FG002|Lead-in Period|Lost to Follow-up|0|||
145280033|NCT01792284|523875708|FG000|Lead-in Period|Protocol Violation|1|||
145280034|NCT01792284|523875709|FG001|Lead-in Period|Protocol Violation|0|||
145280035|NCT01792284|523875710|FG002|Lead-in Period|Protocol Violation|0|||
145280036|NCT01792284|523875708|FG000|Lead-in Period|Withdrawal by Subject|10|||
145280037|NCT01792284|523875709|FG001|Lead-in Period|Withdrawal by Subject|0|||
145280038|NCT01792284|523875710|FG002|Lead-in Period|Withdrawal by Subject|0|||
145280039|NCT01792284|523875708|FG000|Lead-in Period|Physician Decision|1|||
145280040|NCT01792284|523875709|FG001|Lead-in Period|Physician Decision|0|||
145280041|NCT01792284|523875710|FG002|Lead-in Period|Physician Decision|0|||
145280042|NCT01792284|523875708|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
145280043|NCT01792284|523875709|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
145280044|NCT01792284|523875710|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
145280045|NCT01792284|523875708|FG000|Randomization Period 1|Withdrawal by Subject|0|||
145280046|NCT01792284|523875709|FG001|Randomization Period 1|Withdrawal by Subject|1|||
145280047|NCT01792284|523875710|FG002|Randomization Period 1|Withdrawal by Subject|1|||
145280048|NCT01792284|523875708|FG000|Randomization Period 1|Physician Decision|0|||
145280049|NCT01792284|523875709|FG001|Randomization Period 1|Physician Decision|1|||
145280050|NCT01792284|523875710|FG002|Randomization Period 1|Physician Decision|1|||
145538395|NCT02699593|524829563|FG001|Period 1|Protocol Violation|1|||
145538396|NCT02699593|524829562|FG000|Period 1|Withdrawal by Subject|0|||
145538397|NCT02699593|524829563|FG001|Period 1|Withdrawal by Subject|1|||
145538398|NCT02699593|524829562|FG000|Period 1|Adverse Event|1|||
145538399|NCT02699593|524829563|FG001|Period 1|Adverse Event|1|||
145538400|NCT02699593|524829562|FG000|Period 2|Adverse Event|1|||
145538401|NCT02699593|524829563|FG001|Period 2|Adverse Event|1|||
145280051|NCT01792284|523875708|FG000|Randomization Period 1|Adverse Event|0|||
145280052|NCT01792284|523875709|FG001|Randomization Period 1|Adverse Event|0|||
145280053|NCT01792284|523875710|FG002|Randomization Period 1|Adverse Event|2|||
145280054|NCT01792284|523875708|FG000|Randomization Period 1|Lost to Follow-up|0|||
145280055|NCT01792284|523875709|FG001|Randomization Period 1|Lost to Follow-up|0|||
145280056|NCT01792284|523875710|FG002|Randomization Period 1|Lost to Follow-up|1|||
145280057|NCT01792284|523875708|FG000|Randomization Period 2|Protocol Violation|0|||
145280058|NCT01792284|523875709|FG001|Randomization Period 2|Protocol Violation|1|||
145280059|NCT01792284|523875710|FG002|Randomization Period 2|Protocol Violation|0|||
145280060|NCT01792284|523875708|FG000|Randomization Period 2|Withdrawal by Subject|0|||
145280061|NCT01792284|523875709|FG001|Randomization Period 2|Withdrawal by Subject|2|||
145280062|NCT01792284|523875710|FG002|Randomization Period 2|Withdrawal by Subject|0|||
145538402|NCT02699593|524829562|FG000|Period 2|Lost Contact Lens|0|||
145538403|NCT02699593|524829563|FG001|Period 2|Lost Contact Lens|1|||
145609367|NCT05644353|525084923|FG004|Overall Study|Lost to Follow-up|0|||
145609368|NCT05644353|525084924|FG005|Overall Study|Lost to Follow-up|0|||
145609369|NCT03500640|525084925|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
145538404|NCT02699593|524829562|FG000|Period 2|Torn Contact Lens|1|||
145538405|NCT02699593|524829563|FG001|Period 2|Torn Contact Lens|0|||
145538406|NCT01681472|524829564|FG000|Overall Study|Adverse Event|0|||
145538407|NCT01681472|524829565|FG001|Overall Study|Adverse Event|1|||
145538408|NCT01681472|524829566|FG002|Overall Study|Adverse Event|0|||
145538409|NCT01681472|524829567|FG003|Overall Study|Adverse Event|0|||
145538410|NCT01696071|524829580|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
145538411|NCT01696071|524829581|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
145538412|NCT02764697|524829582|FG000|Overall Study|Lack of Efficacy|3|||
145538413|NCT01999179|524829583|FG000|Overall Study|Adverse Event|1|||
145538414|NCT01999179|524829583|FG000|Overall Study|Lost to Follow-up|1|||
145538415|NCT01999179|524829583|FG000|Overall Study|Change in Therapy|3|||
145538416|NCT01999179|524829583|FG000|Overall Study|New catheter|2|||
145538417|NCT03298867|524829591|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
145538418|NCT03298867|524829592|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
145538419|NCT03298867|524829591|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
145538420|NCT03298867|524829592|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
145538421|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
145538422|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
145538423|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
145538424|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
145538425|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
145538426|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
145538427|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
145538428|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
145609370|NCT03500640|525084926|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
145609371|NCT03500640|525084927|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
145609372|NCT03500640|525084925|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
145609373|NCT03500640|525084926|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
145538429|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
145538430|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
145538431|NCT03298867|524829591|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
145609374|NCT03500640|525084927|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
145609375|NCT03500640|525084925|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
145538432|NCT03298867|524829592|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
145538433|NCT03298867|524829591|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
145538434|NCT03298867|524829592|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
145538435|NCT01752985|524829593|FG000|Treatment Period|Subject request to discontinue treatment|1|||
145538436|NCT01752985|524829594|FG001|Treatment Period|Subject request to discontinue treatment|0|||
145538437|NCT01752985|524829595|FG002|Treatment Period|Subject request to discontinue treatment|1|||
145538438|NCT01752985|524829593|FG000|Treatment Period|Subject no longer meets study criteria|0|||
145538439|NCT01752985|524829594|FG001|Treatment Period|Subject no longer meets study criteria|1|||
145538440|NCT01752985|524829595|FG002|Treatment Period|Subject no longer meets study criteria|1|||
145538441|NCT01752985|524829593|FG000|Treatment Period|Adverse Event|2|||
145538442|NCT01752985|524829594|FG001|Treatment Period|Adverse Event|1|||
145538443|NCT01752985|524829595|FG002|Treatment Period|Adverse Event|2|||
145538444|NCT01752985|524829593|FG000|Treatment Period|Withdrawal by Subject|1|||
145538445|NCT01752985|524829594|FG001|Treatment Period|Withdrawal by Subject|1|||
145538446|NCT01752985|524829595|FG002|Treatment Period|Withdrawal by Subject|0|||
145538447|NCT01752985|524829593|FG000|Treatment Period|Lost to Follow-up|0|||
145538448|NCT01752985|524829594|FG001|Treatment Period|Lost to Follow-up|0|||
145538449|NCT01752985|524829595|FG002|Treatment Period|Lost to Follow-up|1|||
145538450|NCT05147428|524829596|FG000|Overall Study|Removed prior to mailing|289|||
145538451|NCT05147428|524829597|FG001|Overall Study|Removed prior to mailing|306|||
145538452|NCT05147428|524829598|FG002|Overall Study|Removed prior to mailing|270|||
145538453|NCT05147428|524829596|FG000|Overall Study|Died or disenrolled during blackout period|239|||
145538454|NCT05147428|524829597|FG001|Overall Study|Died or disenrolled during blackout period|278|||
145538455|NCT05147428|524829598|FG002|Overall Study|Died or disenrolled during blackout period|273|||
145538456|NCT01995825|524831547|FG000|Overall Study|Withdrawal by Subject|1|||
145538457|NCT01995825|524831548|FG001|Overall Study|Withdrawal by Subject|0|||
145538458|NCT01798004|524831549|FG000|Overall Study|Death|2|||
145538459|NCT01798004|524831549|FG000|Overall Study|Lack of Efficacy|8|||
145538460|NCT01798004|524831549|FG000|Overall Study|Physician Decision|25|||
145538461|NCT01798004|524831549|FG000|Overall Study|Withdrawal by Subject|4|||
145538462|NCT01798004|524831549|FG000|Overall Study|Ineligible|4|||
145538463|NCT01798004|524831549|FG000|Overall Study|Patient/parent refusal|7|||
145538464|NCT01798004|524831549|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
145538465|NCT01798004|524831549|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
145538466|NCT01367002|524831550|FG000|Overall Study|Withdrawal by Subject|1|||
145538467|NCT01367002|524831551|FG001|Overall Study|Withdrawal by Subject|0|||
145538468|NCT01367002|524831550|FG000|Overall Study|Physician Decision|0|||
145538469|NCT01367002|524831551|FG001|Overall Study|Physician Decision|2|||
145538470|NCT01516437|524831552|FG000|Overall Study|Reason not specified|0|||
145538471|NCT01516437|524831553|FG001|Overall Study|Reason not specified|0|||
145538472|NCT01516437|524831554|FG002|Overall Study|Reason not specified|1|||
145538473|NCT01516437|524831555|FG003|Overall Study|Reason not specified|1|||
145538474|NCT01385566|524831559|FG000|Overall Study|Lost to Follow-up|1|||
145538475|NCT01385566|524831560|FG001|Overall Study|Lost to Follow-up|0|||
145538476|NCT01385566|524831561|FG002|Overall Study|Lost to Follow-up|0|||
145538477|NCT01385566|524831562|FG003|Overall Study|Lost to Follow-up|0|||
145538478|NCT01385566|524831563|FG004|Overall Study|Lost to Follow-up|0|||
145538479|NCT01385566|524831564|FG005|Overall Study|Lost to Follow-up|0|||
145538480|NCT01385566|524831559|FG000|Overall Study|Withdrawal by Subject|0|||
145538481|NCT01385566|524831560|FG001|Overall Study|Withdrawal by Subject|0|||
145538482|NCT01385566|524831561|FG002|Overall Study|Withdrawal by Subject|0|||
145538483|NCT01385566|524831562|FG003|Overall Study|Withdrawal by Subject|1|||
145538484|NCT01385566|524831563|FG004|Overall Study|Withdrawal by Subject|0|||
145538485|NCT01385566|524831564|FG005|Overall Study|Withdrawal by Subject|0|||
145538486|NCT00560105|524831571|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
145538487|NCT00560105|524831572|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
145538488|NCT02400333|524831573|FG000|Overall Study|Withdrawal by Subject|0|||
145538489|NCT02400333|524831574|FG001|Overall Study|Withdrawal by Subject|1|||
145538490|NCT02400333|524831575|FG002|Overall Study|Withdrawal by Subject|0|||
145538491|NCT02400333|524831576|FG003|Overall Study|Withdrawal by Subject|1|||
145538492|NCT02400333|524831573|FG000|Overall Study|Protocol Violation|1|||
145538493|NCT02400333|524831574|FG001|Overall Study|Protocol Violation|0|||
145538494|NCT02400333|524831575|FG002|Overall Study|Protocol Violation|2|||
145538495|NCT02400333|524831576|FG003|Overall Study|Protocol Violation|1|||
145538496|NCT00094172|524831586|FG000|Overall Study|Adverse Event|0|||
145538497|NCT00094172|524831587|FG001|Overall Study|Adverse Event|1|||
145538498|NCT00094172|524831586|FG000|Overall Study|Lost to Follow-up|2|||
145538499|NCT00094172|524831587|FG001|Overall Study|Lost to Follow-up|0|||
145538500|NCT00094172|524831586|FG000|Overall Study|Protocol Violation|0|||
145538501|NCT00094172|524831587|FG001|Overall Study|Protocol Violation|1|||
145403906|NCT00109343|524336433|FG001|Overall Study|Withdrawal by Subject|11|||
145403907|NCT00109343|524336434|FG002|Overall Study|Withdrawal by Subject|10|||
145538502|NCT00094172|524831586|FG000|Overall Study|Withdrawal by Subject|10|||
145538503|NCT00094172|524831587|FG001|Overall Study|Withdrawal by Subject|5|||
145784576|NCT02279524|525720284|FG000|Overall Study|Adverse Event|4|||
145538504|NCT00094172|524831586|FG000|Overall Study|Primary endpoint met.|1|||
145784577|NCT02279524|525720285|FG001|Overall Study|Adverse Event|3|||
145784578|NCT02279524|525720286|FG002|Overall Study|Adverse Event|2|||
145784579|NCT02279524|525720284|FG000|Overall Study|Lost to Follow-up|1|||
145784580|NCT02279524|525720285|FG001|Overall Study|Lost to Follow-up|1|||
145784581|NCT02279524|525720286|FG002|Overall Study|Lost to Follow-up|0|||
145784582|NCT02279524|525720284|FG000|Overall Study|Disallowed medication|1|||
145784583|NCT02279524|525720285|FG001|Overall Study|Disallowed medication|1|||
145784584|NCT02279524|525720286|FG002|Overall Study|Disallowed medication|2|||
145784585|NCT02279524|525720284|FG000|Overall Study|Bariatric surgery|1|||
145784586|NCT02279524|525720285|FG001|Overall Study|Bariatric surgery|0|||
145784587|NCT02279524|525720286|FG002|Overall Study|Bariatric surgery|0|||
145784588|NCT03509207|525720287|FG000|Overall Study|Death|2|||
145784589|NCT02817555|525720288|FG000|Overall Study|Death|1|||
145784590|NCT02817555|525720289|FG001|Overall Study|Death|3|||
145784591|NCT02817555|525720288|FG000|Overall Study|moved away|1|||
145784592|NCT02817555|525720289|FG001|Overall Study|moved away|0|||
145784593|NCT02817555|525720288|FG000|Overall Study|transplant|1|||
145784594|NCT02817555|525720289|FG001|Overall Study|transplant|1|||
145784595|NCT02817555|525720288|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
145784596|NCT02817555|525720289|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
145784597|NCT01043185|525720290|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
145280063|NCT00379587|523875716|FG000|Overall Study|Lost to Follow-up|2|||
145538505|NCT00094172|524831587|FG001|Overall Study|Primary endpoint met.|0|||
145280064|NCT00775983|523875721|FG000|Overall Study|Protocol Violation|1|||
145280065|NCT00775983|523875722|FG001|Overall Study|Protocol Violation|2|||
145280066|NCT01059071|523875723|FG000|Overall Study|Lack of Efficacy|1|||
145280067|NCT01059071|523875724|FG001|Overall Study|Lack of Efficacy|4|||
145280068|NCT01059071|523875725|FG002|Overall Study|Lack of Efficacy|2|||
145280069|NCT01059071|523875726|FG003|Overall Study|Lack of Efficacy|3|||
145280070|NCT01059071|523875723|FG000|Overall Study|Withdrawal by Subject|1|||
145280071|NCT01059071|523875724|FG001|Overall Study|Withdrawal by Subject|0|||
145280072|NCT01059071|523875725|FG002|Overall Study|Withdrawal by Subject|0|||
145280073|NCT01059071|523875726|FG003|Overall Study|Withdrawal by Subject|2|||
145280074|NCT01059071|523875723|FG000|Overall Study|Physician Decision|0|||
145538506|NCT00094172|524831586|FG000|Overall Study|Started other MS therapy due to disease|1|||
145538507|NCT00094172|524831587|FG001|Overall Study|Started other MS therapy due to disease|0|||
145538508|NCT00289133|524831592|FG000|Overall Study|Non-study device implanted|12|||
145538509|NCT00289133|524831593|FG001|Overall Study|Non-study device implanted|0|||
145538510|NCT00289133|524831592|FG000|Overall Study|Protocol Violation|32|||
145538511|NCT00289133|524831593|FG001|Overall Study|Protocol Violation|38|||
145538512|NCT00289133|524831592|FG000|Overall Study|Withdrawal by Subject|9|||
145280075|NCT01059071|523875724|FG001|Overall Study|Physician Decision|0|||
145280076|NCT01059071|523875725|FG002|Overall Study|Physician Decision|0|||
145280077|NCT01059071|523875726|FG003|Overall Study|Physician Decision|1|||
145280078|NCT01314703|523875727|FG000|Overall Study|screen failure and closed enrollment|8|||
145280079|NCT00597584|523875728|FG000|Overall Study|Adverse Event|4|||
145280080|NCT00597584|523875729|FG001|Overall Study|Adverse Event|2|||
145280081|NCT00597584|523875728|FG000|Overall Study|Death|53|||
145280082|NCT00597584|523875729|FG001|Overall Study|Death|30|||
145280083|NCT00597584|523875728|FG000|Overall Study|Lack of Efficacy|1|||
145538513|NCT00289133|524831593|FG001|Overall Study|Withdrawal by Subject|10|||
145538514|NCT00289133|524831592|FG000|Overall Study|Death|5|||
145538515|NCT00289133|524831593|FG001|Overall Study|Death|10|||
145538516|NCT00289133|524831592|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
145538517|NCT00289133|524831593|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
145538518|NCT00289133|524831592|FG000|Overall Study|Physician Decision|41|||
145609376|NCT03500640|525084926|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
145784598|NCT01043185|525720291|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
145280084|NCT00597584|523875729|FG001|Overall Study|Lack of Efficacy|0|||
145280085|NCT00597584|523875728|FG000|Overall Study|Lost to Follow-up|2|||
145784599|NCT01043185|525720292|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
145784600|NCT01043185|525720293|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
145784601|NCT01043185|525720294|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
145784602|NCT01043185|525720295|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
145784603|NCT01043185|525720296|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
145784604|NCT01043185|525720297|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
145280086|NCT00597584|523875729|FG001|Overall Study|Lost to Follow-up|4|||
145280087|NCT00597584|523875728|FG000|Overall Study|Physician Decision|3|||
145280088|NCT00597584|523875729|FG001|Overall Study|Physician Decision|0|||
145280089|NCT00597584|523875728|FG000|Overall Study|Pregnancy|2|||
145280090|NCT00597584|523875729|FG001|Overall Study|Pregnancy|0|||
145784605|NCT01043185|525720298|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
145538519|NCT00289133|524831593|FG001|Overall Study|Physician Decision|45|||
145538520|NCT00289133|524831592|FG000|Overall Study|Revision|8|||
145538521|NCT00289133|524831593|FG001|Overall Study|Revision|6|||
145538522|NCT00289133|524831592|FG000|Overall Study|Lost to Follow-up|92|||
145784606|NCT01043185|525720299|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
145784607|NCT00137436|525720300|FG000|Overall Study|Adverse Event|13|||
145784608|NCT00137436|525720300|FG000|Overall Study|Death|2|||
145784609|NCT00137436|525720300|FG000|Overall Study|Lack of Efficacy|17|||
145784610|NCT00137436|525720300|FG000|Overall Study|Withdrawal by Subject|6|||
145784611|NCT00137436|525720300|FG000|Overall Study|Other|5|||
145784612|NCT01432262|525720301|FG000|Overall Study|Withdrawal by Subject|2|||
145784613|NCT01432262|525720302|FG001|Overall Study|Withdrawal by Subject|1|||
145538523|NCT00289133|524831593|FG001|Overall Study|Lost to Follow-up|115|||
145538524|NCT00541931|524831598|FG000|Overall Study|Adverse Event|1|||
145538525|NCT00541931|524831599|FG001|Overall Study|Adverse Event|0|||
145538526|NCT00541931|524831598|FG000|Overall Study|Lost to Follow-up|3|||
145538527|NCT00541931|524831599|FG001|Overall Study|Lost to Follow-up|3|||
145538528|NCT00541931|524831598|FG000|Overall Study|Withdrawal by Subject|1|||
145538529|NCT00541931|524831599|FG001|Overall Study|Withdrawal by Subject|0|||
145538530|NCT00541931|524831598|FG000|Overall Study|Transportation Issue|0|||
145538531|NCT00541931|524831599|FG001|Overall Study|Transportation Issue|1|||
145538532|NCT01947582|524831600|FG000|Overall Study|Withdrawal by Subject|1|||
145538533|NCT00064337|524831601|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
145538534|NCT00064337|524831601|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
145538535|NCT00064337|524831601|FG000|PBSCC or Induction/PBSCC|Progression|3|||
145538536|NCT00064337|524831601|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
145538537|NCT00064337|524831601|FG000|PBSCC or Induction/PBSCC|Death|2|||
145538538|NCT00064337|524831601|FG000|Transplant|Adverse Event|9|||
145538539|NCT00064337|524831601|FG000|Transplant|Not protocol-specified|5|||
145538540|NCT00064337|524831601|FG000|Transplant|Death|3|||
145538541|NCT00064337|524831601|FG000|Transplant|Patient Refusal|2|||
145538542|NCT00064337|524831601|FG000|Transplant|Progression|2|||
145538543|NCT00064337|524831601|FG000|Maintenance|Adverse Event|3|||
145538544|NCT00064337|524831601|FG000|Maintenance|Progression|2|||
145538545|NCT00064337|524831601|FG000|Maintenance|On treatment at time of analysis|2|||
145538546|NCT00064337|524831601|FG000|Maintenance|Not protocol-specified|2|||
145538547|NCT00064337|524831601|FG000|Maintenance|Death|1|||
145784614|NCT00165646|525720303|FG000|Overall Study|Adverse Event|1|||
145280091|NCT00597584|523875728|FG000|Overall Study|Withdrawal by Subject|44|||
145280092|NCT00597584|523875729|FG001|Overall Study|Withdrawal by Subject|12|||
145280093|NCT00597584|523875728|FG000|Overall Study|Discontinued Dialysis|0|||
145280094|NCT00597584|523875729|FG001|Overall Study|Discontinued Dialysis|1|||
145280095|NCT00597584|523875728|FG000|Overall Study|Lost ability to consent|1|||
145280096|NCT00597584|523875729|FG001|Overall Study|Lost ability to consent|1|||
145280097|NCT00597584|523875728|FG000|Overall Study|Never dosed|1|||
145280098|NCT00597584|523875729|FG001|Overall Study|Never dosed|0|||
145280099|NCT00597584|523875728|FG000|Overall Study|Relocation|8|||
145280100|NCT00597584|523875729|FG001|Overall Study|Relocation|6|||
145280101|NCT00597584|523875728|FG000|Overall Study|Renal transplant|9|||
145280102|NCT00597584|523875729|FG001|Overall Study|Renal transplant|7|||
145280103|NCT00515073|523875736|FG000|Overall Study|Withdrawal by Subject|1|||
145280104|NCT00515073|523875736|FG000|Overall Study|Physician Decision|1|||
145280105|NCT00881959|523875737|FG000|Overall Study|Lost to Follow-up|2|||
145280106|NCT00881959|523875738|FG001|Overall Study|Lost to Follow-up|4|||
145280107|NCT02791659|523875739|FG000|Overall Study|Protocol Violation|0|||
145280108|NCT02791659|523875740|FG001|Overall Study|Protocol Violation|1|||
145280109|NCT01456052|523875741|FG000|Overall Study|Adverse Event|1|||
145280110|NCT01456052|523875742|FG001|Overall Study|Adverse Event|1|||
145784615|NCT00165646|525720304|FG001|Overall Study|Adverse Event|1|||
145280111|NCT01456052|523875743|FG002|Overall Study|Adverse Event|2|||
145280112|NCT01456052|523875741|FG000|Overall Study|Consent withdrawn|0|||
145280113|NCT01456052|523875742|FG001|Overall Study|Consent withdrawn|2|||
145538548|NCT00612040|524831602|FG000|Overall Study|Adverse Event|0|||
145280114|NCT01456052|523875743|FG002|Overall Study|Consent withdrawn|1|||
145280115|NCT01456052|523875741|FG000|Overall Study|Protocol Violation|0|||
145280116|NCT01456052|523875742|FG001|Overall Study|Protocol Violation|1|||
145280117|NCT01456052|523875743|FG002|Overall Study|Protocol Violation|0|||
145280118|NCT01456052|523875741|FG000|Overall Study|Physician Decision|1|||
145280119|NCT01456052|523875742|FG001|Overall Study|Physician Decision|0|||
145280120|NCT01456052|523875743|FG002|Overall Study|Physician Decision|1|||
145538549|NCT00612040|524831603|FG001|Overall Study|Adverse Event|2|||
145784616|NCT00165646|525720305|FG002|Overall Study|Adverse Event|1|||
145280121|NCT01456052|523875741|FG000|Overall Study|Treatment Failure|0|||
145280122|NCT01456052|523875742|FG001|Overall Study|Treatment Failure|1|||
145280123|NCT01456052|523875743|FG002|Overall Study|Treatment Failure|1|||
145280124|NCT04356573|523875745|FG000|Overall Study|Didn't Qualify|1|||
145280125|NCT04356573|523875746|FG001|Overall Study|Didn't Qualify|0|||
145280126|NCT03650400|523875747|FG000|Overall Study|Study terminated by sponsor|0|||
145280127|NCT03650400|523875748|FG001|Overall Study|Study terminated by sponsor|5|||
145280128|NCT02410837|523875755|FG000|Overall Study|Death|387|||
145280129|NCT02410837|523875755|FG000|Overall Study|Lost to Follow-up|50|||
145280130|NCT02410837|523875755|FG000|Overall Study|Withdrawal by Subject|44|||
145280131|NCT02410837|523875755|FG000|Overall Study|Physician Decision|6|||
145280132|NCT02410837|523875755|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
145280133|NCT01965535|523875756|FG000|Overall Study|Lack of Efficacy|2|||
145280134|NCT01965535|523875757|FG001|Overall Study|Lack of Efficacy|1|||
145280135|NCT01825876|523875758|FG000|Period 2|Withdrawal by Subject|0|||
145280136|NCT01825876|523875759|FG001|Period 2|Withdrawal by Subject|1|||
145280137|NCT03751020|523875762|FG000|Overall Study|Withdrawal by Subject|2|||
145280138|NCT03751020|523875763|FG001|Overall Study|Withdrawal by Subject|0|||
145280139|NCT03751020|523875764|FG002|Overall Study|Withdrawal by Subject|0|||
145280140|NCT03751020|523875762|FG000|Overall Study|Lost to Follow-up|7|||
145280141|NCT03751020|523875763|FG001|Overall Study|Lost to Follow-up|4|||
145280142|NCT03751020|523875764|FG002|Overall Study|Lost to Follow-up|10|||
145280143|NCT01889862|523875765|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
145280144|NCT01889862|523875766|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
145280145|NCT01889862|523875767|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
145280146|NCT01889862|523875768|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
145280147|NCT01889862|523875769|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
145280148|NCT01889862|523875765|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
145280149|NCT01889862|523875766|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
145280150|NCT01889862|523875767|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
145280151|NCT01889862|523875768|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
145280152|NCT01889862|523875769|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
145280153|NCT01889862|523875765|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
145280154|NCT01889862|523875766|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
145280155|NCT01889862|523875767|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
145280156|NCT01889862|523875768|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
145280157|NCT01889862|523875769|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
145280158|NCT01889862|523875765|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
145280159|NCT01889862|523875766|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
145280160|NCT01889862|523875767|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
145280161|NCT01889862|523875768|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
145280162|NCT01889862|523875769|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
145280163|NCT01889862|523875765|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
145280164|NCT01889862|523875766|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
145280165|NCT01889862|523875767|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
145280166|NCT01889862|523875768|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
145280167|NCT01889862|523875769|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
145280168|NCT01889862|523875765|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
145280169|NCT01889862|523875766|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
145280170|NCT01889862|523875767|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
145280171|NCT01889862|523875768|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
145280172|NCT01889862|523875769|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
145280173|NCT01889862|523875765|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
145280174|NCT01889862|523875766|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
145280175|NCT01889862|523875767|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
145280176|NCT01889862|523875768|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
145280177|NCT01889862|523875769|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
145280178|NCT01889862|523875765|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
145280179|NCT01889862|523875766|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
145280180|NCT01889862|523875767|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
145280181|NCT01889862|523875768|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
145280182|NCT01889862|523875769|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
145280183|NCT01889862|523875765|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
145280184|NCT01889862|523875766|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
145280185|NCT01889862|523875767|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
145280186|NCT01889862|523875768|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
145280187|NCT01889862|523875769|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
145280188|NCT01889862|523875765|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
145280189|NCT01889862|523875766|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
145280190|NCT01889862|523875767|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
145280191|NCT01889862|523875768|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
145280192|NCT01889862|523875769|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
145280193|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
145280194|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
145280195|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
145280196|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
145280197|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
145280198|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
145280199|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
145403908|NCT00109343|524336432|FG000|Overall Study|Subject Moved|6|||
145609377|NCT03500640|525084927|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
145609378|NCT03500640|525084925|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
145609379|NCT03500640|525084926|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
145609380|NCT03500640|525084927|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
145609381|NCT03500640|525084925|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
145609382|NCT03500640|525084926|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
145609383|NCT03500640|525084927|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
145609384|NCT03500640|525084925|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
145609385|NCT03500640|525084926|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
145609386|NCT03500640|525084927|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
145609387|NCT03500640|525084925|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
145609388|NCT03500640|525084926|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
145609389|NCT03500640|525084927|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
145609390|NCT03500640|525084925|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
145609391|NCT03500640|525084926|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
145609392|NCT03500640|525084927|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
145609393|NCT03500640|525084925|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
145609394|NCT03500640|525084926|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
145609395|NCT03500640|525084927|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
145609396|NCT03500640|525084925|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
145609397|NCT03500640|525084926|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
145609398|NCT03500640|525084927|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
145609399|NCT01125722|525084932|FG000|Overall Study|Withdrawal by Subject|2|||
145609400|NCT01125722|525084933|FG001|Overall Study|Withdrawal by Subject|1|||
145280200|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
145280201|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
145280202|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
145280203|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
145280204|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
145280205|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
145280206|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
145280207|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
145280208|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
145280209|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
145280210|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
145280211|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
145280212|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
145280213|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
145280214|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
145280215|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
145280216|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
145280217|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
145280218|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
145280219|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
145280220|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
145280221|NCT00528879|523875770|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
145280222|NCT00528879|523875771|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
145280223|NCT00528879|523875772|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
145280224|NCT00528879|523875773|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
145280225|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
145280226|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
145280227|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
145280228|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
145280229|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
145280230|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
145280231|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
145280232|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
145280233|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
145609401|NCT01125722|525084932|FG000|Overall Study|Lost to Follow-up|1|||
145609402|NCT01125722|525084933|FG001|Overall Study|Lost to Follow-up|0|||
145609403|NCT03573908|525084934|FG000|Treatment Period|Adverse Event|4|||
145609404|NCT03573908|525084935|FG001|Treatment Period|Adverse Event|9|||
145609405|NCT03573908|525084936|FG002|Treatment Period|Adverse Event|0|||
145609406|NCT03573908|525084937|FG003|Treatment Period|Adverse Event|0|||
145609407|NCT03573908|525084938|FG004|Treatment Period|Adverse Event|0|||
145609408|NCT03573908|525084934|FG000|Treatment Period|Protocol Violation|1|||
145609409|NCT03573908|525084935|FG001|Treatment Period|Protocol Violation|0|||
145609410|NCT03573908|525084936|FG002|Treatment Period|Protocol Violation|0|||
145609411|NCT03573908|525084937|FG003|Treatment Period|Protocol Violation|0|||
145609412|NCT03573908|525084938|FG004|Treatment Period|Protocol Violation|0|||
145609413|NCT03573908|525084934|FG000|Treatment Period|Withdrawal by Subject|7|||
145609414|NCT03573908|525084935|FG001|Treatment Period|Withdrawal by Subject|5|||
145609415|NCT03573908|525084936|FG002|Treatment Period|Withdrawal by Subject|0|||
145609416|NCT03573908|525084937|FG003|Treatment Period|Withdrawal by Subject|0|||
145609417|NCT03573908|525084938|FG004|Treatment Period|Withdrawal by Subject|0|||
145609418|NCT03573908|525084934|FG000|Treatment Period|Lost to Follow-up|7|||
145609419|NCT03573908|525084935|FG001|Treatment Period|Lost to Follow-up|6|||
145609420|NCT03573908|525084936|FG002|Treatment Period|Lost to Follow-up|0|||
145609421|NCT03573908|525084937|FG003|Treatment Period|Lost to Follow-up|0|||
145609422|NCT03573908|525084938|FG004|Treatment Period|Lost to Follow-up|0|||
145609423|NCT03573908|525084934|FG000|Treatment Period|Pregnancy|1|||
145609424|NCT03573908|525084935|FG001|Treatment Period|Pregnancy|0|||
145609425|NCT03573908|525084936|FG002|Treatment Period|Pregnancy|0|||
145609426|NCT03573908|525084937|FG003|Treatment Period|Pregnancy|0|||
145609427|NCT03573908|525084938|FG004|Treatment Period|Pregnancy|0|||
145609428|NCT03573908|525084934|FG000|Treatment Period|Other, Not Specified|4|||
145609429|NCT03573908|525084935|FG001|Treatment Period|Other, Not Specified|6|||
145609430|NCT03573908|525084936|FG002|Treatment Period|Other, Not Specified|0|||
145609431|NCT03573908|525084937|FG003|Treatment Period|Other, Not Specified|0|||
145609432|NCT03573908|525084938|FG004|Treatment Period|Other, Not Specified|0|||
145609433|NCT03573908|525084934|FG000|Randomized Withdrawal Period|Adverse Event|0|||
145609434|NCT03573908|525084935|FG001|Randomized Withdrawal Period|Adverse Event|0|||
145609435|NCT03573908|525084936|FG002|Randomized Withdrawal Period|Adverse Event|3|||
145609436|NCT03573908|525084937|FG003|Randomized Withdrawal Period|Adverse Event|0|||
145609437|NCT03573908|525084938|FG004|Randomized Withdrawal Period|Adverse Event|0|||
145609438|NCT03573908|525084934|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145609439|NCT03573908|525084935|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145609440|NCT03573908|525084936|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145609441|NCT03573908|525084937|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145609442|NCT03573908|525084938|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
145609443|NCT03573908|525084934|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
145609444|NCT03573908|525084935|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
145609445|NCT03573908|525084936|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
145609446|NCT03573908|525084937|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
145609447|NCT03573908|525084938|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
145609448|NCT03573908|525084934|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
145609449|NCT03573908|525084935|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
145609450|NCT03573908|525084936|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
145609451|NCT03573908|525084937|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
145609452|NCT03573908|525084938|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
145609453|NCT04006925|525084939|FG000|Overall Study|Side effects|2|||
145609454|NCT04006925|525084940|FG001|Overall Study|Side effects|0|||
145609455|NCT03443713|525084943|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
145609456|NCT03443713|525084944|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
145609457|NCT03443713|525084945|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
145609458|NCT01598298|525084950|FG000|Overall Study|Not eligible|5|||
145609459|NCT01598298|525084951|FG001|Overall Study|Not eligible|5|||
145609460|NCT01598298|525084950|FG000|Overall Study|Adverse Event|21|||
145609461|NCT01598298|525084951|FG001|Overall Study|Adverse Event|19|||
145609462|NCT01598298|525084950|FG000|Overall Study|Progression/relapse|0|||
145609463|NCT01598298|525084951|FG001|Overall Study|Progression/relapse|2|||
145609464|NCT01598298|525084950|FG000|Overall Study|Withdrawal by Subject|10|||
145609465|NCT01598298|525084951|FG001|Overall Study|Withdrawal by Subject|15|||
145609466|NCT01598298|525084950|FG000|Overall Study|Other reason (not protocol specified)|4|||
145609467|NCT01598298|525084951|FG001|Overall Study|Other reason (not protocol specified)|0|||
145609468|NCT03462706|525086345|FG000|Overall Study|Polyp was pedunculated|1|||
145609469|NCT03462706|525086346|FG001|Overall Study|Polyp was pedunculated|0|||
145609470|NCT03462706|525086347|FG002|Overall Study|Polyp was pedunculated|1|||
145609471|NCT03462706|525086348|FG003|Overall Study|Polyp was pedunculated|0|||
145784617|NCT00165646|525720303|FG000|Overall Study|Lack of Efficacy|1|||
145784618|NCT00165646|525720304|FG001|Overall Study|Lack of Efficacy|2|||
145784619|NCT00165646|525720305|FG002|Overall Study|Lack of Efficacy|0|||
145609472|NCT03462706|525086345|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
145609473|NCT03462706|525086346|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
145609474|NCT03462706|525086347|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
145609475|NCT03462706|525086348|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
145609476|NCT02091739|525086357|FG000|MP: 16 Weeks|Adverse Event|1|||
145609477|NCT02091739|525086358|FG001|MP: 16 Weeks|Adverse Event|1|||
145784620|NCT00165646|525720303|FG000|Overall Study|Withdrawal by Subject|0|||
145609478|NCT02091739|525086359|FG002|MP: 16 Weeks|Adverse Event|1|||
145609479|NCT02091739|525086360|FG003|MP: 16 Weeks|Adverse Event|0|||
145609480|NCT02091739|525086361|FG004|MP: 16 Weeks|Adverse Event|0|||
145609481|NCT02091739|525086357|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
145609482|NCT02091739|525086358|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
145609483|NCT02091739|525086359|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
145609484|NCT02091739|525086360|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
145609485|NCT02091739|525086361|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
145609486|NCT02091739|525086357|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
145609487|NCT02091739|525086358|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
145609488|NCT02091739|525086359|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
145609489|NCT02091739|525086360|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
145609490|NCT02091739|525086361|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
145609491|NCT02091739|525086357|FG000|EP: 48 Weeks|Other|0|||
145609492|NCT02091739|525086358|FG001|EP: 48 Weeks|Other|0|||
145609493|NCT02091739|525086359|FG002|EP: 48 Weeks|Other|0|||
145609494|NCT02091739|525086360|FG003|EP: 48 Weeks|Other|1|||
145609495|NCT02091739|525086361|FG004|EP: 48 Weeks|Other|0|||
145609496|NCT02091739|525086357|FG000|EP: 48 Weeks|Death|0|||
145609497|NCT02091739|525086358|FG001|EP: 48 Weeks|Death|0|||
145609498|NCT02091739|525086359|FG002|EP: 48 Weeks|Death|0|||
145609499|NCT02091739|525086360|FG003|EP: 48 Weeks|Death|3|||
145609500|NCT02091739|525086361|FG004|EP: 48 Weeks|Death|2|||
145609501|NCT02091739|525086357|FG000|EP: 48 Weeks|Adverse Event|0|||
145784621|NCT00165646|525720304|FG001|Overall Study|Withdrawal by Subject|2|||
145784622|NCT00165646|525720305|FG002|Overall Study|Withdrawal by Subject|1|||
145280234|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
145280235|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
145280236|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
145280237|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
145280238|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
145609502|NCT02091739|525086358|FG001|EP: 48 Weeks|Adverse Event|0|||
145609503|NCT02091739|525086359|FG002|EP: 48 Weeks|Adverse Event|0|||
145609504|NCT02091739|525086360|FG003|EP: 48 Weeks|Adverse Event|2|||
145609505|NCT02091739|525086361|FG004|EP: 48 Weeks|Adverse Event|6|||
145609506|NCT02091739|525086357|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
145784623|NCT00165646|525720303|FG000|Overall Study|Physician Decision|2|||
145784624|NCT00165646|525720304|FG001|Overall Study|Physician Decision|0|||
145784625|NCT00165646|525720305|FG002|Overall Study|Physician Decision|2|||
145784626|NCT00165646|525720303|FG000|Overall Study|Protocol Violation|1|||
145784627|NCT00165646|525720304|FG001|Overall Study|Protocol Violation|0|||
145784628|NCT00165646|525720305|FG002|Overall Study|Protocol Violation|0|||
145784629|NCT04657016|525720306|FG000|Overall Study|Adverse Event|2|||
145784630|NCT04657016|525720307|FG001|Overall Study|Adverse Event|4|||
145784631|NCT04657016|525720306|FG000|Overall Study|Death|1|||
145784632|NCT04657016|525720307|FG001|Overall Study|Death|1|||
145784633|NCT04657016|525720306|FG000|Overall Study|Lost to Follow-up|24|||
145784634|NCT04657016|525720307|FG001|Overall Study|Lost to Follow-up|12|||
145784635|NCT04657016|525720306|FG000|Overall Study|Physician Decision|1|||
145784636|NCT04657016|525720307|FG001|Overall Study|Physician Decision|2|||
145784637|NCT04657016|525720306|FG000|Overall Study|Pregnancy|2|||
145784638|NCT04657016|525720307|FG001|Overall Study|Pregnancy|2|||
145784639|NCT04657016|525720306|FG000|Overall Study|Protocol Deviation|1|||
145784640|NCT04657016|525720307|FG001|Overall Study|Protocol Deviation|0|||
145784641|NCT04657016|525720306|FG000|Overall Study|Withdrawal by Subject|28|||
145280239|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
145609507|NCT02091739|525086358|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
145609508|NCT02091739|525086359|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
145784642|NCT04657016|525720307|FG001|Overall Study|Withdrawal by Subject|14|||
145609509|NCT02091739|525086360|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
145609510|NCT02091739|525086361|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
145609511|NCT01617005|525086367|FG000|Overall Study|Pregnancy|1|||
145609512|NCT01617005|525086367|FG000|Overall Study|Lack of motivation for treatment|1|||
145784643|NCT04657016|525720306|FG000|Overall Study|Other - as reported by the investigator|6|||
145280240|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
145609513|NCT01320735|525086368|FG000|Overall Study|Adverse Event|3|||
145609514|NCT01320735|525086368|FG000|Overall Study|Withdrawal by Subject|3|||
145784644|NCT04657016|525720307|FG001|Overall Study|Other - as reported by the investigator|0|||
145280241|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
145280242|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
145280243|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
145280244|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
145280245|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
145280246|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
145280247|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
145280248|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
145280249|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
145280250|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
145280251|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
145280252|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
145280253|NCT00528879|523875770|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
145280254|NCT00528879|523875771|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
145280255|NCT00528879|523875772|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
145280256|NCT00528879|523875773|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
145280257|NCT00078819|523875776|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
145280258|NCT00078819|523875777|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
145280259|NCT00078819|523875778|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
145280260|NCT00078819|523875779|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
145280261|NCT00078819|523875776|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
145280262|NCT00078819|523875777|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
145280263|NCT00078819|523875778|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
145280264|NCT00078819|523875779|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
145280265|NCT00078819|523875776|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
145280266|NCT00078819|523875777|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
145280267|NCT00078819|523875778|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
145280268|NCT00078819|523875779|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
145280269|NCT00078819|523875776|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
145280270|NCT00078819|523875777|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
145280271|NCT00078819|523875778|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
145280272|NCT00078819|523875779|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
145280273|NCT00078819|523875776|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
145280274|NCT00078819|523875777|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
145280275|NCT00078819|523875778|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
145280276|NCT00078819|523875779|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
145280277|NCT00078819|523875776|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
145280278|NCT00078819|523875777|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
145280279|NCT00078819|523875778|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
145280280|NCT00078819|523875779|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
145280281|NCT00078819|523875776|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
145280282|NCT00078819|523875777|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
145280283|NCT00078819|523875778|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
145280284|NCT00078819|523875779|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
145280285|NCT00078819|523875776|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
145280286|NCT00078819|523875777|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
145280287|NCT00078819|523875778|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
145280288|NCT00078819|523875779|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
145280289|NCT02555618|523875780|FG000|Overall Study|Sponsor's Circumstances|1|||
145280290|NCT02555618|523875781|FG001|Overall Study|Sponsor's Circumstances|0|||
145280291|NCT01325532|523875782|FG000|Overall Study|Withdrawal by Subject|2|||
145280292|NCT01325532|523875783|FG001|Overall Study|Withdrawal by Subject|0|||
145280293|NCT01749033|523875788|FG000|Overall Study|Did not receive allocated intervention|3|||
145280294|NCT01749033|523875789|FG001|Overall Study|Did not receive allocated intervention|3|||
145280295|NCT01749033|523875790|FG002|Overall Study|Did not receive allocated intervention|0|||
145280296|NCT01749033|523875788|FG000|Overall Study|Lost to Follow-up|0|||
145280297|NCT01749033|523875789|FG001|Overall Study|Lost to Follow-up|2|||
145280298|NCT01749033|523875790|FG002|Overall Study|Lost to Follow-up|1|||
145280299|NCT03056001|523875791|FG000|Overall Study|Death|24|||
145280300|NCT03550794|523875794|FG000|Overall Study|No longer met inclusion criteria|1|||
145280301|NCT03550794|523875795|FG001|Overall Study|No longer met inclusion criteria|2|||
145280302|NCT03550794|523875794|FG000|Overall Study|Goals of care changed|1|||
145784645|NCT00701727|525720308|FG000|First Treatment Period|Adverse Event|0|||
145784646|NCT00701727|525720309|FG001|First Treatment Period|Adverse Event|0|||
145280303|NCT03550794|523875795|FG001|Overall Study|Goals of care changed|0|||
145280304|NCT03550794|523875794|FG000|Overall Study|Withdrawal by Subject|2|||
145280305|NCT03550794|523875795|FG001|Overall Study|Withdrawal by Subject|0|||
145280306|NCT03550794|523875794|FG000|Overall Study|Death|0|||
145280307|NCT03550794|523875795|FG001|Overall Study|Death|1|||
145280308|NCT01890785|523875796|FG000|Third Intervention|Withdrawal by Subject|0|||
145280309|NCT01890785|523875797|FG001|Third Intervention|Withdrawal by Subject|1|||
145280310|NCT01890785|523875798|FG002|Third Intervention|Withdrawal by Subject|0|||
145280311|NCT01890785|523875799|FG003|Third Intervention|Withdrawal by Subject|0|||
145280312|NCT01890785|523875800|FG004|Third Intervention|Withdrawal by Subject|0|||
145280313|NCT01890785|523875801|FG005|Third Intervention|Withdrawal by Subject|0|||
145280314|NCT02295280|523875803|FG000|Overall Study|Adverse Event|0|||
145280315|NCT02295280|523875804|FG001|Overall Study|Adverse Event|1|||
145280316|NCT02875067|523875805|FG000|Overall Study|Withdrawal by Subject|1|||
145280317|NCT02875067|523875805|FG000|Overall Study|Withdrawal by Termination of Study|5|||
145280318|NCT02713243|523875807|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
145280319|NCT02713243|523875808|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
145280320|NCT02713243|523875807|FG000|Overall Study|Administrative problems|0|||
145280321|NCT02713243|523875808|FG001|Overall Study|Administrative problems|1|||
145280322|NCT02713243|523875807|FG000|Overall Study|Protocol deviation|0|||
145280323|NCT02713243|523875808|FG001|Overall Study|Protocol deviation|1|||
145280324|NCT03056352|523875809|FG000|Overall Study|Lost to Follow-up|1|||
145280325|NCT02971605|523875810|FG000|Overall Study|Withdrawal by Subject|1|||
145280326|NCT00597207|523875811|FG000|Overall Study|Lost to Follow-up|5|||
145280327|NCT00597207|523875812|FG001|Overall Study|Lost to Follow-up|7|||
145280328|NCT03077828|523875815|FG000|Treatment Cycles|Death|1|||
145280329|NCT03077828|523875815|FG000|Treatment Cycles|Withdrawal by Subject|1|||
145280330|NCT03077828|523875815|FG000|Treatment Cycles|Screen Fail|2|||
145280331|NCT03077828|523875815|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
145280332|NCT03077828|523875815|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
145280333|NCT03077828|523875815|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
145280334|NCT03077828|523875815|FG000|Follow-up|Patients still in follow-up|15|||
145280335|NCT02766400|523875817|FG000|Overall Study|Death|1|||
145280336|NCT02766400|523875818|FG001|Overall Study|Death|2|||
145280337|NCT02766400|523875817|FG000|Overall Study|Withdrawal by Subject|1|||
145280338|NCT02766400|523875818|FG001|Overall Study|Withdrawal by Subject|0|||
145280339|NCT05037409|523875819|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
145280340|NCT05037409|523875820|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
145280341|NCT05037409|523875821|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
145280342|NCT03499249|523875822|FG000|Overall Study|Physician Decision|1|||
145538550|NCT00612040|524831604|FG002|Overall Study|Adverse Event|1|||
145538551|NCT00612040|524831602|FG000|Overall Study|Protocol Violation|1|||
145538552|NCT00612040|524831603|FG001|Overall Study|Protocol Violation|2|||
145538553|NCT00612040|524831604|FG002|Overall Study|Protocol Violation|1|||
145538554|NCT00612040|524831602|FG000|Overall Study|Lack of Efficacy|2|||
145538555|NCT00612040|524831603|FG001|Overall Study|Lack of Efficacy|1|||
145538556|NCT00612040|524831604|FG002|Overall Study|Lack of Efficacy|0|||
145538557|NCT00612040|524831602|FG000|Overall Study|Unclassified|2|||
145538558|NCT00612040|524831603|FG001|Overall Study|Unclassified|2|||
145538559|NCT00612040|524831604|FG002|Overall Study|Unclassified|5|||
145538560|NCT00827502|524831605|FG000|Overall Study|randomized but not treated|11|||
145538561|NCT00827502|524831605|FG000|Overall Study|Adverse Event|1|||
145538562|NCT00827502|524831605|FG000|Overall Study|Lost to Follow-up|4|||
145538563|NCT00827502|524831605|FG000|Overall Study|Withdrawal by Subject|5|||
145538564|NCT01397890|524831610|FG000|Overall Study|Withdrawal by Subject|7|||
145538565|NCT01397890|524831611|FG001|Overall Study|Withdrawal by Subject|11|||
145538566|NCT01397890|524831610|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
145538567|NCT01397890|524831611|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
145538568|NCT01397890|524831610|FG000|Overall Study|Death|2|||
145538569|NCT01397890|524831611|FG001|Overall Study|Death|3|||
145538570|NCT01397890|524831610|FG000|Overall Study|Lost to Follow-up|1|||
145538571|NCT01397890|524831611|FG001|Overall Study|Lost to Follow-up|4|||
145538572|NCT01397890|524831610|FG000|Overall Study|Condition under Investigation Worsened|1|||
145538573|NCT01397890|524831611|FG001|Overall Study|Condition under Investigation Worsened|3|||
145538574|NCT01397890|524831610|FG000|Overall Study|Adverse Event|1|||
145538575|NCT01397890|524831611|FG001|Overall Study|Adverse Event|2|||
145538576|NCT01397890|524831610|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
145609515|NCT01320735|525086368|FG000|Overall Study|Lost to Follow-up|13|||
145280343|NCT00435825|523875827|FG000|Overall Study|Abnormality of Laboratory Test|0|||
145784647|NCT00701727|525720308|FG000|First Treatment Period|Withdrawal by Subject|1|||
145784648|NCT00701727|525720309|FG001|First Treatment Period|Withdrawal by Subject|0|||
145784649|NCT00701727|525720308|FG000|First Treatment Period|sponsor decision|0|||
145784650|NCT00701727|525720309|FG001|First Treatment Period|sponsor decision|1|||
145784651|NCT00701727|525720308|FG000|First Treatment Period|Lost to Follow-up|0|||
145784652|NCT00701727|525720309|FG001|First Treatment Period|Lost to Follow-up|1|||
145784653|NCT00701727|525720308|FG000|Second Treatment Period|Withdrawal by Subject|2|||
145784654|NCT00701727|525720309|FG001|Second Treatment Period|Withdrawal by Subject|0|||
145784655|NCT01104558|525720312|FG000|Overall Study|Protocol Violation|6|||
145784656|NCT01104558|525720312|FG000|Overall Study|Missing of primary efficacy assessment|10|||
145784657|NCT01104558|525720312|FG000|Overall Study|Missing of genetic analysis results|1|||
145784658|NCT00523341|525720316|FG000|Overall Study|Withdrawal by Subject|399|||
145784659|NCT00523341|525720317|FG001|Overall Study|Withdrawal by Subject|427|||
145784660|NCT00523341|525720316|FG000|Overall Study|Other|181|||
145784661|NCT00523341|525720317|FG001|Overall Study|Other|198|||
145784662|NCT00523341|525720316|FG000|Overall Study|Adverse Event|122|||
145784663|NCT00523341|525720317|FG001|Overall Study|Adverse Event|155|||
145609516|NCT01320735|525086368|FG000|Overall Study|Administrative Reason|6|||
145609517|NCT01320735|525086368|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
145609518|NCT01320735|525086368|FG000|Overall Study|Protocol Violation|1|||
145609519|NCT01320735|525086368|FG000|Overall Study|Other|1|||
145609520|NCT01320735|525086368|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
145609521|NCT01320735|525086368|FG000|Overall Study|Investigator Unable to be Contacted|17|||
145609522|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
145609523|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
145609524|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
145609525|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
145609526|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
145609527|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
145609528|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
145609529|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
145609530|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
145609531|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
145609532|NCT02307513|525086369|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
145609533|NCT02307513|525086370|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
145609534|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
145609535|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
145609536|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
145609537|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
145609538|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
145609539|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
145609540|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
145609541|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
145609542|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
145609543|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
145609544|NCT02307513|525086369|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
145609545|NCT02307513|525086370|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
145609546|NCT02307513|525086369|FG000|Long-term Extension|Physician Decision|1|||
145609547|NCT02307513|525086370|FG001|Long-term Extension|Physician Decision|0|||
145609548|NCT05952297|525086372|FG000|Overall Study|Withdrawal by Subject|1|||
145609549|NCT05952297|525086373|FG001|Overall Study|Withdrawal by Subject|0|||
145609550|NCT01225822|525086374|FG000|Overall Study|Adverse Event|13|||
145609551|NCT01225822|525086375|FG001|Overall Study|Adverse Event|31|||
145609552|NCT01225822|525086376|FG002|Overall Study|Adverse Event|18|||
145609553|NCT01225822|525086377|FG003|Overall Study|Adverse Event|23|||
145609554|NCT01225822|525086378|FG004|Overall Study|Adverse Event|14|||
145609555|NCT01225822|525086374|FG000|Overall Study|Protocol Violation|6|||
145784664|NCT00523341|525720316|FG000|Overall Study|Death|101|||
145784665|NCT00523341|525720317|FG001|Overall Study|Death|110|||
145784666|NCT00523341|525720316|FG000|Overall Study|Lost to Follow-up|73|||
145609556|NCT01225822|525086375|FG001|Overall Study|Protocol Violation|8|||
145609557|NCT01225822|525086376|FG002|Overall Study|Protocol Violation|6|||
145609558|NCT01225822|525086377|FG003|Overall Study|Protocol Violation|7|||
145609559|NCT01225822|525086378|FG004|Overall Study|Protocol Violation|4|||
145609560|NCT01225822|525086374|FG000|Overall Study|Lost to Follow-up|0|||
145609561|NCT01225822|525086375|FG001|Overall Study|Lost to Follow-up|0|||
145784667|NCT00523341|525720317|FG001|Overall Study|Lost to Follow-up|61|||
145784668|NCT00523341|525720316|FG000|Overall Study|Non-compliance|20|||
145784669|NCT00523341|525720317|FG001|Overall Study|Non-compliance|13|||
145784670|NCT00523341|525720316|FG000|Overall Study|Physician Decision|14|||
145784671|NCT00523341|525720317|FG001|Overall Study|Physician Decision|13|||
145784672|NCT00523341|525720316|FG000|Overall Study|Requirement for Alternative Therapy|4|||
145784673|NCT00523341|525720317|FG001|Overall Study|Requirement for Alternative Therapy|14|||
145784674|NCT00523341|525720316|FG000|Overall Study|Protocol Deviation|6|||
145784675|NCT00523341|525720317|FG001|Overall Study|Protocol Deviation|5|||
145784676|NCT00523341|525720316|FG000|Overall Study|Ineligibility Determined|3|||
145784677|NCT00523341|525720317|FG001|Overall Study|Ineligibility Determined|4|||
145784678|NCT00523341|525720316|FG000|Overall Study|Disease Progression|1|||
145784679|NCT00523341|525720317|FG001|Overall Study|Disease Progression|0|||
145784680|NCT00912015|525720320|FG000|Overall Study|Lack of Efficacy|1|||
145784681|NCT00912015|525720321|FG001|Overall Study|Lack of Efficacy|0|||
145784682|NCT00912015|525720322|FG002|Overall Study|Lack of Efficacy|0|||
145784683|NCT00912015|525720323|FG003|Overall Study|Lack of Efficacy|0|||
145784684|NCT00912015|525720320|FG000|Overall Study|Withdrawal by Subject|8|||
145784685|NCT00912015|525720321|FG001|Overall Study|Withdrawal by Subject|8|||
145784686|NCT00912015|525720322|FG002|Overall Study|Withdrawal by Subject|3|||
145538577|NCT01397890|524831611|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
145538578|NCT01397890|524831610|FG000|Overall Study|Others|2|||
145538579|NCT01397890|524831611|FG001|Overall Study|Others|1|||
145538580|NCT02924571|524831612|FG000|Overall Study|Lost to Follow-up|1|||
145538581|NCT02924571|524831613|FG001|Overall Study|Lost to Follow-up|1|||
145538582|NCT02924571|524831614|FG002|Overall Study|Lost to Follow-up|0|||
145538583|NCT00434954|524831618|FG000|Overall Study|Adverse Event|17|||
145538584|NCT00434954|524831619|FG001|Overall Study|Adverse Event|2|||
145538585|NCT00434954|524831618|FG000|Overall Study|Entry criteria not met|14|||
145538586|NCT00434954|524831619|FG001|Overall Study|Entry criteria not met|16|||
145538587|NCT00434954|524831618|FG000|Overall Study|Lost to Follow-up|0|||
145538588|NCT00434954|524831619|FG001|Overall Study|Lost to Follow-up|1|||
145538589|NCT00434954|524831618|FG000|Overall Study|Physician Decision|6|||
145538590|NCT00434954|524831619|FG001|Overall Study|Physician Decision|3|||
145538591|NCT00434954|524831618|FG000|Overall Study|Protocol Violation|36|||
145538592|NCT00434954|524831619|FG001|Overall Study|Protocol Violation|27|||
145538593|NCT00434954|524831618|FG000|Overall Study|Sponsor decision|1|||
145538594|NCT00434954|524831619|FG001|Overall Study|Sponsor decision|0|||
145538595|NCT00434954|524831618|FG000|Overall Study|Subject decision|8|||
145538596|NCT00434954|524831619|FG001|Overall Study|Subject decision|22|||
145538597|NCT03417219|524831628|FG000|Overall Study|Lost to Follow-up|0|||
145538598|NCT03417219|524831629|FG001|Overall Study|Lost to Follow-up|3|||
145538599|NCT03345914|524831630|FG000|Overall Study|Transition to another study at week 16|80|||
145538600|NCT03345914|524831631|FG001|Overall Study|Transition to another study at week 16|86|||
145538601|NCT03345914|524831632|FG002|Overall Study|Transition to another study at week 16|78|||
145538602|NCT03345914|524831630|FG000|Overall Study|Transition to OLE during follow-up|37|||
145538603|NCT03345914|524831631|FG001|Overall Study|Transition to OLE during follow-up|33|||
145538604|NCT03345914|524831632|FG002|Overall Study|Transition to OLE during follow-up|39|||
145538605|NCT03345914|524831630|FG000|Overall Study|Physician Decision|0|||
145538606|NCT03345914|524831631|FG001|Overall Study|Physician Decision|1|||
145538607|NCT03345914|524831632|FG002|Overall Study|Physician Decision|1|||
145538608|NCT03345914|524831630|FG000|Overall Study|Withdrawal by Subject|5|||
145784687|NCT00912015|525720323|FG003|Overall Study|Withdrawal by Subject|0|||
145784688|NCT00912015|525720320|FG000|Overall Study|Protocol Violation|1|||
145784689|NCT00912015|525720321|FG001|Overall Study|Protocol Violation|0|||
145784690|NCT00912015|525720322|FG002|Overall Study|Protocol Violation|0|||
145784691|NCT00912015|525720323|FG003|Overall Study|Protocol Violation|1|||
145538609|NCT03345914|524831631|FG001|Overall Study|Withdrawal by Subject|1|||
145538610|NCT03345914|524831632|FG002|Overall Study|Withdrawal by Subject|2|||
145538611|NCT03345914|524831630|FG000|Overall Study|Other|1|||
145538612|NCT03345914|524831631|FG001|Overall Study|Other|1|||
145784692|NCT00912015|525720320|FG000|Overall Study|Adverse Event|6|||
145784693|NCT00912015|525720321|FG001|Overall Study|Adverse Event|0|||
145784694|NCT00912015|525720322|FG002|Overall Study|Adverse Event|0|||
145784695|NCT00912015|525720323|FG003|Overall Study|Adverse Event|1|||
145784696|NCT05137041|525720324|FG000|Overall Study|Lost to Follow-up|1|||
145784697|NCT05137041|525720325|FG001|Overall Study|Lost to Follow-up|1|||
145784698|NCT05137041|525720324|FG000|Overall Study|Withdrawal by Subject|0|||
145784699|NCT05137041|525720325|FG001|Overall Study|Withdrawal by Subject|2|||
145784700|NCT05137041|525720324|FG000|Overall Study|Reason not Specified|0|||
145538613|NCT03345914|524831632|FG002|Overall Study|Other|1|||
145538614|NCT03345914|524831630|FG000|Overall Study|Ongoing|0|||
145538615|NCT03345914|524831631|FG001|Overall Study|Ongoing|0|||
145538616|NCT03345914|524831632|FG002|Overall Study|Ongoing|1|||
145538617|NCT02609828|524831633|FG000|Overall Study|Adverse Event|8|||
145538618|NCT02609828|524831634|FG001|Overall Study|Adverse Event|1|||
145538619|NCT02609828|524831635|FG002|Overall Study|Adverse Event|0|||
145538620|NCT02609828|524831636|FG003|Overall Study|Adverse Event|6|||
145538621|NCT02609828|524831633|FG000|Overall Study|Death|15|||
145538622|NCT02609828|524831634|FG001|Overall Study|Death|1|||
145538623|NCT02609828|524831635|FG002|Overall Study|Death|1|||
145538624|NCT02609828|524831636|FG003|Overall Study|Death|19|||
145538625|NCT02609828|524831633|FG000|Overall Study|Insufficient clinical response|2|||
145538626|NCT02609828|524831634|FG001|Overall Study|Insufficient clinical response|1|||
145538627|NCT02609828|524831635|FG002|Overall Study|Insufficient clinical response|0|||
145538628|NCT02609828|524831636|FG003|Overall Study|Insufficient clinical response|0|||
145538629|NCT02609828|524831633|FG000|Overall Study|Lost to Follow-up|0|||
145538630|NCT02609828|524831634|FG001|Overall Study|Lost to Follow-up|0|||
145538631|NCT02609828|524831635|FG002|Overall Study|Lost to Follow-up|0|||
145538632|NCT02609828|524831636|FG003|Overall Study|Lost to Follow-up|1|||
145538633|NCT02609828|524831633|FG000|Overall Study|Protocol Violation|2|||
145538634|NCT02609828|524831634|FG001|Overall Study|Protocol Violation|0|||
145538635|NCT02609828|524831635|FG002|Overall Study|Protocol Violation|0|||
145538636|NCT02609828|524831636|FG003|Overall Study|Protocol Violation|1|||
145538637|NCT02609828|524831633|FG000|Overall Study|Withdrawal by Subject|12|||
145538638|NCT02609828|524831634|FG001|Overall Study|Withdrawal by Subject|1|||
145538639|NCT02609828|524831635|FG002|Overall Study|Withdrawal by Subject|0|||
145538640|NCT02609828|524831636|FG003|Overall Study|Withdrawal by Subject|10|||
145538641|NCT02609828|524831633|FG000|Overall Study|Other|3|||
145538642|NCT02609828|524831634|FG001|Overall Study|Other|0|||
145538643|NCT02609828|524831635|FG002|Overall Study|Other|0|||
145538644|NCT02609828|524831636|FG003|Overall Study|Other|6|||
145538645|NCT02609828|524831633|FG000|Overall Study|Randomized but not treated|1|||
145538646|NCT02609828|524831634|FG001|Overall Study|Randomized but not treated|0|||
145538647|NCT02609828|524831635|FG002|Overall Study|Randomized but not treated|0|||
145538648|NCT02609828|524831636|FG003|Overall Study|Randomized but not treated|0|||
145280344|NCT00435825|523875828|FG001|Overall Study|Abnormality of Laboratory Test|1|||
145280345|NCT00435825|523875829|FG002|Overall Study|Abnormality of Laboratory Test|0|||
145280346|NCT00435825|523875830|FG003|Overall Study|Abnormality of Laboratory Test|0|||
145280347|NCT00435825|523875827|FG000|Overall Study|Insufficient Therapeutic Response|3|||
145280348|NCT00435825|523875828|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145280349|NCT00435825|523875829|FG002|Overall Study|Insufficient Therapeutic Response|0|||
145280350|NCT00435825|523875830|FG003|Overall Study|Insufficient Therapeutic Response|3|||
145280351|NCT00435825|523875827|FG000|Overall Study|Other Protocol Violation|1|||
145280352|NCT00435825|523875828|FG001|Overall Study|Other Protocol Violation|0|||
145280353|NCT00435825|523875829|FG002|Overall Study|Other Protocol Violation|0|||
145280354|NCT00435825|523875830|FG003|Overall Study|Other Protocol Violation|0|||
145280355|NCT00435825|523875827|FG000|Overall Study|Refused treatment|2|||
145280356|NCT00435825|523875828|FG001|Overall Study|Refused treatment|0|||
145280357|NCT00435825|523875829|FG002|Overall Study|Refused treatment|0|||
145280358|NCT00435825|523875830|FG003|Overall Study|Refused treatment|5|||
145280359|NCT00435825|523875827|FG000|Overall Study|Failure to return|5|||
145784701|NCT05137041|525720325|FG001|Overall Study|Reason not Specified|1|||
145784702|NCT01356602|525720326|FG000|Overall Study|Protocol Deviation|0|||
145784703|NCT01356602|525720327|FG001|Overall Study|Protocol Deviation|1|||
145280360|NCT00435825|523875828|FG001|Overall Study|Failure to return|0|||
145280361|NCT00435825|523875829|FG002|Overall Study|Failure to return|4|||
145280362|NCT00435825|523875830|FG003|Overall Study|Failure to return|0|||
145538649|NCT00319553|524831637|FG000|Overall Study|Protocol Violation|1|||
145538650|NCT00319553|524831638|FG001|Overall Study|Protocol Violation|2|||
145538651|NCT00319553|524831637|FG000|Overall Study|Lost to Follow-up|2|||
145538652|NCT00319553|524831638|FG001|Overall Study|Lost to Follow-up|1|||
145538653|NCT00319553|524831637|FG000|Overall Study|Withdrawal by Subject|1|||
145538654|NCT00319553|524831638|FG001|Overall Study|Withdrawal by Subject|1|||
145538655|NCT00753766|524831641|FG000|Overall Study|Physician Decision|1|||
145538656|NCT00753766|524831642|FG001|Overall Study|Physician Decision|0|||
145538657|NCT01281137|524831645|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
145538658|NCT01281137|524831646|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
145538659|NCT01281137|524831645|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
145784704|NCT01356602|525720328|FG002|Overall Study|Protocol Deviation|1|||
145280363|NCT00435825|523875827|FG000|Overall Study|Did not receive study drug|1|||
145280364|NCT00435825|523875828|FG001|Overall Study|Did not receive study drug|0|||
145280365|NCT00435825|523875829|FG002|Overall Study|Did not receive study drug|2|||
145280366|NCT00435825|523875830|FG003|Overall Study|Did not receive study drug|0|||
145280367|NCT00435825|523875827|FG000|Overall Study|Did not enter follow-up|0|||
145280368|NCT00435825|523875828|FG001|Overall Study|Did not enter follow-up|4|||
145280369|NCT00435825|523875829|FG002|Overall Study|Did not enter follow-up|1|||
145280370|NCT00435825|523875830|FG003|Overall Study|Did not enter follow-up|3|||
145280371|NCT00435825|523875827|FG000|Overall Study|Did not complete full follow-up period|6|||
145280372|NCT00435825|523875828|FG001|Overall Study|Did not complete full follow-up period|6|||
145280373|NCT00435825|523875829|FG002|Overall Study|Did not complete full follow-up period|4|||
145280374|NCT00435825|523875830|FG003|Overall Study|Did not complete full follow-up period|5|||
145280375|NCT00686790|523877567|FG000|Overall Study|Adverse Event|2|||
145280376|NCT00686790|523877567|FG000|Overall Study|Withdrawal by Subject|1|||
145280377|NCT00686790|523877567|FG000|Overall Study|Death|1|||
145280378|NCT00686790|523877567|FG000|Overall Study|Lost to Follow-up|12|||
145280379|NCT00382291|523877568|FG000|Overall Study|Adverse Event|1|||
145280380|NCT00382291|523877569|FG001|Overall Study|Adverse Event|2|||
145280381|NCT00382291|523877570|FG002|Overall Study|Adverse Event|2|||
145280382|NCT00382291|523877568|FG000|Overall Study|Protocol Violation|1|||
145280383|NCT00382291|523877569|FG001|Overall Study|Protocol Violation|0|||
145280384|NCT00382291|523877570|FG002|Overall Study|Protocol Violation|0|||
145280385|NCT00382291|523877568|FG000|Overall Study|Temporary study suspension|2|||
145280386|NCT00382291|523877569|FG001|Overall Study|Temporary study suspension|2|||
145280387|NCT00382291|523877570|FG002|Overall Study|Temporary study suspension|5|||
145280388|NCT00382291|523877568|FG000|Overall Study|Withdrawal by Subject|0|||
145280389|NCT00382291|523877569|FG001|Overall Study|Withdrawal by Subject|2|||
145280390|NCT00382291|523877570|FG002|Overall Study|Withdrawal by Subject|0|||
145280391|NCT00382291|523877568|FG000|Overall Study|Physician Decision|0|||
145280392|NCT00382291|523877569|FG001|Overall Study|Physician Decision|1|||
145280393|NCT00382291|523877570|FG002|Overall Study|Physician Decision|0|||
145280394|NCT00382291|523877568|FG000|Overall Study|Lack of Efficacy|0|||
145280395|NCT00382291|523877569|FG001|Overall Study|Lack of Efficacy|0|||
145280396|NCT00382291|523877570|FG002|Overall Study|Lack of Efficacy|1|||
145280397|NCT02266706|523877571|FG000|Overall Study|Withdrawal by Subject|0|||
145280398|NCT02266706|523877572|FG001|Overall Study|Withdrawal by Subject|1|||
145280399|NCT02266706|523877573|FG002|Overall Study|Withdrawal by Subject|1|||
145280400|NCT02266706|523877574|FG003|Overall Study|Withdrawal by Subject|0|||
145280401|NCT02266706|523877575|FG004|Overall Study|Withdrawal by Subject|0|||
145280402|NCT02266706|523877576|FG005|Overall Study|Withdrawal by Subject|1|||
145280403|NCT02266706|523877577|FG006|Overall Study|Withdrawal by Subject|0|||
145280404|NCT02266706|523877578|FG007|Overall Study|Withdrawal by Subject|0|||
145280405|NCT02266706|523877579|FG008|Overall Study|Withdrawal by Subject|0|||
145280406|NCT02266706|523877571|FG000|Overall Study|Screen failure|0|||
145280407|NCT02266706|523877572|FG001|Overall Study|Screen failure|0|||
145280408|NCT02266706|523877573|FG002|Overall Study|Screen failure|0|||
145280409|NCT02266706|523877574|FG003|Overall Study|Screen failure|0|||
145280410|NCT02266706|523877575|FG004|Overall Study|Screen failure|0|||
145280411|NCT02266706|523877576|FG005|Overall Study|Screen failure|1|||
145280412|NCT02266706|523877577|FG006|Overall Study|Screen failure|1|||
145280413|NCT02266706|523877578|FG007|Overall Study|Screen failure|0|||
145280414|NCT02266706|523877579|FG008|Overall Study|Screen failure|0|||
145280415|NCT02266706|523877571|FG000|Overall Study|Enrollment in another study|0|||
145280416|NCT02266706|523877572|FG001|Overall Study|Enrollment in another study|0|||
145280417|NCT02266706|523877573|FG002|Overall Study|Enrollment in another study|0|||
145280418|NCT02266706|523877574|FG003|Overall Study|Enrollment in another study|1|||
145280419|NCT02266706|523877575|FG004|Overall Study|Enrollment in another study|0|||
145280420|NCT02266706|523877576|FG005|Overall Study|Enrollment in another study|0|||
145280421|NCT02266706|523877577|FG006|Overall Study|Enrollment in another study|0|||
145280422|NCT02266706|523877578|FG007|Overall Study|Enrollment in another study|0|||
145280423|NCT02266706|523877579|FG008|Overall Study|Enrollment in another study|0|||
145280424|NCT02402933|523877580|FG000|Overall Study|Withdrawal by Subject|4|||
145280425|NCT02402933|523877580|FG000|Overall Study|Discontinued; Site Termination|10|||
145280426|NCT01977352|523877581|FG000|Overall Study|Lost to Follow-up|1|||
145280427|NCT01977352|523877582|FG001|Overall Study|Lost to Follow-up|2|||
145280428|NCT00409188|523877583|FG000|Overall Study|Ongoing at data cut-off|383|||
145280429|NCT00409188|523877584|FG001|Overall Study|Ongoing at data cut-off|175|||
145280430|NCT00854620|523877591|FG000|Overall Study|Adverse Event|1|||
145403909|NCT00109343|524336433|FG001|Overall Study|Subject Moved|2|||
145280431|NCT01169649|523877597|FG000|Overall Study|Patient Not Treated|3|||
145280432|NCT00534092|523877598|FG000|Overall Study|Lost to Follow-up|1|||
145280433|NCT00534092|523877599|FG001|Overall Study|Lost to Follow-up|0|||
145280434|NCT00534092|523877598|FG000|Overall Study|personal reasons/family concerns|1|||
145280435|NCT00534092|523877599|FG001|Overall Study|personal reasons/family concerns|0|||
145280436|NCT02919475|523877600|FG000|Overall Study|Adverse Event|3|||
145280437|NCT02919475|523877601|FG001|Overall Study|Adverse Event|3|||
145280438|NCT02919475|523877602|FG002|Overall Study|Adverse Event|3|||
145280439|NCT02919475|523877603|FG003|Overall Study|Adverse Event|9|||
145280440|NCT02919475|523877604|FG004|Overall Study|Adverse Event|2|||
145280441|NCT02919475|523877600|FG000|Overall Study|Death|0|||
145280442|NCT02919475|523877601|FG001|Overall Study|Death|1|||
145280443|NCT02919475|523877602|FG002|Overall Study|Death|0|||
145280444|NCT02919475|523877603|FG003|Overall Study|Death|0|||
145280445|NCT02919475|523877604|FG004|Overall Study|Death|0|||
145280446|NCT02919475|523877600|FG000|Overall Study|Lost to Follow-up|0|||
145538660|NCT01281137|524831646|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
145538661|NCT01281137|524831645|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
145538662|NCT01281137|524831646|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
145538663|NCT01281137|524831645|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
145280447|NCT02919475|523877601|FG001|Overall Study|Lost to Follow-up|0|||
145280448|NCT02919475|523877602|FG002|Overall Study|Lost to Follow-up|0|||
145280449|NCT02919475|523877603|FG003|Overall Study|Lost to Follow-up|1|||
145280450|NCT02919475|523877604|FG004|Overall Study|Lost to Follow-up|0|||
145280451|NCT02919475|523877600|FG000|Overall Study|Withdrawal by Subject|2|||
145280452|NCT02919475|523877601|FG001|Overall Study|Withdrawal by Subject|3|||
145280453|NCT02919475|523877602|FG002|Overall Study|Withdrawal by Subject|1|||
145280454|NCT02919475|523877603|FG003|Overall Study|Withdrawal by Subject|2|||
145280455|NCT02919475|523877604|FG004|Overall Study|Withdrawal by Subject|2|||
145280456|NCT02919475|523877600|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145280457|NCT02919475|523877601|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145280458|NCT02919475|523877602|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145280459|NCT02919475|523877603|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145280460|NCT02919475|523877604|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145280461|NCT02323295|523877608|FG000|Overall Study|Adverse Event|0|||
145280462|NCT02323295|523877609|FG001|Overall Study|Adverse Event|1|||
145280463|NCT02323295|523877608|FG000|Overall Study|Withdrawal by Subject|0|||
145280464|NCT02323295|523877609|FG001|Overall Study|Withdrawal by Subject|1|||
145280465|NCT02323295|523877608|FG000|Overall Study|Patient did not have surgery as planned.|0|||
145280466|NCT02323295|523877609|FG001|Overall Study|Patient did not have surgery as planned.|1|||
145280467|NCT02370784|523877610|FG000|Overall Study|Patient started prohibited medication|0|||
145280468|NCT02370784|523877611|FG001|Overall Study|Patient started prohibited medication|1|||
145280469|NCT02962882|523877613|FG000|Overall Study|Adverse Event|2|||
145280470|NCT02962882|523877613|FG000|Overall Study|Withdrawal by Subject|2|||
145280471|NCT02962882|523877613|FG000|Overall Study|Transfer from ICU|32|||
145280472|NCT03763331|523877614|FG000|Overall Study|Lost to Follow-up|1|||
145280473|NCT03763331|523877615|FG001|Overall Study|Lost to Follow-up|0|||
145280474|NCT03763331|523877614|FG000|Overall Study|Withdrawal by Subject|1|||
145280475|NCT03763331|523877615|FG001|Overall Study|Withdrawal by Subject|0|||
145280476|NCT03763331|523877614|FG000|Overall Study|Non-compliance|0|||
145280477|NCT03763331|523877615|FG001|Overall Study|Non-compliance|3|||
145280478|NCT01155063|523877616|FG000|Overall Study|Adverse Event|1|||
145280479|NCT01155063|523877616|FG000|Overall Study|Withdrawal by Subject|1|||
145280480|NCT01155063|523877616|FG000|Overall Study|Study terminated by sponsor|87|||
145280481|NCT04741503|523877617|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
145280482|NCT04741503|523877618|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
145280483|NCT04741503|523877619|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
145280484|NCT04741503|523877617|FG000|Initial Enrollment|Overquotas removed|0|||
145280485|NCT04741503|523877618|FG001|Initial Enrollment|Overquotas removed|0|||
145538664|NCT01281137|524831646|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
145280486|NCT04741503|523877619|FG002|Initial Enrollment|Overquotas removed|186|||
145280487|NCT04741503|523877617|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
145280488|NCT04741503|523877618|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
145280489|NCT04741503|523877619|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
145280490|NCT01663714|523877620|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
145280491|NCT01663714|523877620|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
145280492|NCT01663714|523877620|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
145280493|NCT01663714|523877620|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
145280494|NCT01663714|523877620|FG000|Long-Term Follow-Up|Death|4|||
145280495|NCT01663714|523877620|FG000|Long-Term Follow-Up|Non-compliance|1|||
145280496|NCT03840811|523877621|FG000|Overall Study|Lost to Follow-up|0|||
145280497|NCT03840811|523877622|FG001|Overall Study|Lost to Follow-up|0|||
145280498|NCT03840811|523877623|FG002|Overall Study|Lost to Follow-up|1|||
145280499|NCT01904383|523877624|FG000|Overall Study|CRF not collected|117|||
145280500|NCT01904383|523877624|FG000|Overall Study|Reason not listed|147|||
145538665|NCT01281137|524831645|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
145280501|NCT01904383|523877624|FG000|Overall Study|Lost to Follow-up|674|||
145280502|NCT01904383|523877624|FG000|Overall Study|Lack of Efficacy|370|||
145280503|NCT01904383|523877624|FG000|Overall Study|Improvement|141|||
145280504|NCT01904383|523877624|FG000|Overall Study|Adverse Event|271|||
145280505|NCT01904383|523877624|FG000|Overall Study|No patient visit after entry|54|||
145280506|NCT00623623|523877625|FG000|Overall Study|Previous enrolment into this study|1|||
145280507|NCT00623623|523877626|FG001|Overall Study|Previous enrolment into this study|1|||
145280508|NCT00693784|523877627|FG000|Overall Study|Lost to Follow-up|2|||
145280509|NCT00693784|523877627|FG000|Overall Study|Withdrawal by Subject|2|||
145280510|NCT02265952|523877628|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
145280511|NCT02265952|523877629|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
145280512|NCT02265952|523877628|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
145280513|NCT02265952|523877629|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
145280514|NCT00326885|523877633|FG000|Overall Study|Adverse Event|1|||
145280515|NCT00326885|523877633|FG000|Overall Study|Withdrawal by Subject|3|||
145280516|NCT00326885|523877633|FG000|Overall Study|Physician Decision|1|||
145280517|NCT00326885|523877633|FG000|Overall Study|Hospice withdrew consent|2|||
145280518|NCT01042977|523877634|FG000|Overall Study|Adverse Event|4|||
145280519|NCT01042977|523877635|FG001|Overall Study|Adverse Event|12|||
145280520|NCT01042977|523877634|FG000|Overall Study|Death|2|||
145280521|NCT01042977|523877635|FG001|Overall Study|Death|1|||
145280522|NCT01042977|523877634|FG000|Overall Study|Withdrawal by Subject|8|||
145280523|NCT01042977|523877635|FG001|Overall Study|Withdrawal by Subject|16|||
145280524|NCT01042977|523877634|FG000|Overall Study|Lost to Follow-up|0|||
145538666|NCT01281137|524831646|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
145538667|NCT01313312|524831647|FG000|Overall Study|Adverse Event|5|||
145538668|NCT01313312|524831647|FG000|Overall Study|Withdrawal by Subject|18|||
145538669|NCT01313312|524831647|FG000|Overall Study|Lack of Efficacy|3|||
145280525|NCT01042977|523877635|FG001|Overall Study|Lost to Follow-up|2|||
145280526|NCT01042977|523877634|FG000|Overall Study|Poor/non-compliance|3|||
145280527|NCT01042977|523877635|FG001|Overall Study|Poor/non-compliance|4|||
145280528|NCT01042977|523877634|FG000|Overall Study|Subject no longer meets study criteria|15|||
145280529|NCT01042977|523877635|FG001|Overall Study|Subject no longer meets study criteria|13|||
145280530|NCT01042977|523877634|FG000|Overall Study|Incorrect enrollment|6|||
145280531|NCT01042977|523877635|FG001|Overall Study|Incorrect enrollment|4|||
145280532|NCT01042977|523877634|FG000|Overall Study|Safety|0|||
145280533|NCT01042977|523877635|FG001|Overall Study|Safety|2|||
145280534|NCT01042977|523877634|FG000|Overall Study|Administrative reason by sponsor|0|||
145280535|NCT01042977|523877635|FG001|Overall Study|Administrative reason by sponsor|1|||
145280536|NCT01042977|523877634|FG000|Overall Study|Various|3|||
145280537|NCT01042977|523877635|FG001|Overall Study|Various|0|||
145280538|NCT02499354|523877636|FG000|Overall Study|Withdrawal by Subject|1|||
145280539|NCT02499354|523877637|FG001|Overall Study|Withdrawal by Subject|0|||
145280540|NCT02424565|523877639|FG000|Period 1 (D0)|Protocol Violation|0|||
145280541|NCT02424565|523877640|FG001|Period 1 (D0)|Protocol Violation|1|||
145280542|NCT01677910|523877641|FG000|Double-Blind Treatment Period|Adverse Event|6|||
145280543|NCT01677910|523877642|FG001|Double-Blind Treatment Period|Adverse Event|2|||
145280544|NCT01677910|523877643|FG002|Double-Blind Treatment Period|Adverse Event|3|||
145280545|NCT01677910|523877644|FG003|Double-Blind Treatment Period|Adverse Event|0|||
145280546|NCT01677910|523877641|FG000|Double-Blind Treatment Period|Physician Decision|0|||
145280547|NCT01677910|523877642|FG001|Double-Blind Treatment Period|Physician Decision|0|||
145280548|NCT01677910|523877643|FG002|Double-Blind Treatment Period|Physician Decision|1|||
145280549|NCT01677910|523877644|FG003|Double-Blind Treatment Period|Physician Decision|0|||
145280550|NCT01677910|523877641|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
145280551|NCT01677910|523877642|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
145280552|NCT01677910|523877643|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
145280553|NCT01677910|523877644|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
145538670|NCT01313312|524831647|FG000|Overall Study|Investigator Decision|1|||
145280554|NCT01677910|523877641|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
145280555|NCT01677910|523877642|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
145784705|NCT01356602|525720326|FG000|Overall Study|Administrative Problems|1|||
145784706|NCT01356602|525720327|FG001|Overall Study|Administrative Problems|4|||
145784707|NCT01356602|525720328|FG002|Overall Study|Administrative Problems|5|||
145784708|NCT01356602|525720326|FG000|Overall Study|Lost to Follow-up|4|||
145784709|NCT01356602|525720327|FG001|Overall Study|Lost to Follow-up|5|||
145784710|NCT01356602|525720328|FG002|Overall Study|Lost to Follow-up|6|||
145784711|NCT01356602|525720326|FG000|Overall Study|Withdrawal by Subject|4|||
145784712|NCT01356602|525720327|FG001|Overall Study|Withdrawal by Subject|3|||
145784713|NCT01356602|525720328|FG002|Overall Study|Withdrawal by Subject|7|||
145784714|NCT01356602|525720326|FG000|Overall Study|Lack of Efficacy|0|||
145784715|NCT01356602|525720327|FG001|Overall Study|Lack of Efficacy|1|||
145784716|NCT01356602|525720328|FG002|Overall Study|Lack of Efficacy|4|||
145784717|NCT01356602|525720326|FG000|Overall Study|Adverse Event|0|||
145280556|NCT01677910|523877643|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
145280557|NCT01677910|523877644|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
145280558|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
145280559|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
145538671|NCT01313312|524831647|FG000|Overall Study|Observational Phase|1|||
145538672|NCT01313312|524831647|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
145538673|NCT01313312|524831647|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
145538674|NCT04295772|524831648|FG000|Overall Study|Protocol Violation|1|||
145538675|NCT04295772|524831649|FG001|Overall Study|Protocol Violation|0|||
145538676|NCT04295772|524831648|FG000|Overall Study|Ongoing for safety monitoring|14|||
145538677|NCT04295772|524831649|FG001|Overall Study|Ongoing for safety monitoring|1|||
145538678|NCT04295772|524831648|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
145538679|NCT04295772|524831649|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
145538680|NCT01206166|524831656|FG000|Overall Study|No evaluable data|2|||
145538681|NCT01206166|524831657|FG001|Overall Study|No evaluable data|3|||
145538682|NCT00932126|524831658|FG000|Overall Study|Adverse Event|0|||
145538683|NCT00932126|524831659|FG001|Overall Study|Adverse Event|0|||
145538684|NCT00932126|524831660|FG002|Overall Study|Adverse Event|0|||
145538685|NCT00932126|524831661|FG003|Overall Study|Adverse Event|0|||
145538686|NCT00932126|524831662|FG004|Overall Study|Adverse Event|0|||
145538687|NCT00932126|524831663|FG005|Overall Study|Adverse Event|0|||
145538688|NCT00932126|524831664|FG006|Overall Study|Adverse Event|1|||
145538689|NCT00932126|524831665|FG007|Overall Study|Adverse Event|2|||
145538690|NCT00932126|524831658|FG000|Overall Study|Protocol Violation|0|||
145538691|NCT00932126|524831659|FG001|Overall Study|Protocol Violation|0|||
145538692|NCT00932126|524831660|FG002|Overall Study|Protocol Violation|0|||
145538693|NCT00932126|524831661|FG003|Overall Study|Protocol Violation|0|||
145538694|NCT00932126|524831662|FG004|Overall Study|Protocol Violation|1|||
145538695|NCT00932126|524831663|FG005|Overall Study|Protocol Violation|0|||
145538696|NCT00932126|524831664|FG006|Overall Study|Protocol Violation|0|||
145538697|NCT00932126|524831665|FG007|Overall Study|Protocol Violation|0|||
145538698|NCT00932126|524831658|FG000|Overall Study|Withdrawal by Subject|0|||
145538699|NCT00932126|524831659|FG001|Overall Study|Withdrawal by Subject|0|||
145538700|NCT00932126|524831660|FG002|Overall Study|Withdrawal by Subject|1|||
145538701|NCT00932126|524831661|FG003|Overall Study|Withdrawal by Subject|0|||
145538702|NCT00932126|524831662|FG004|Overall Study|Withdrawal by Subject|0|||
145538703|NCT00932126|524831663|FG005|Overall Study|Withdrawal by Subject|0|||
145538704|NCT00932126|524831664|FG006|Overall Study|Withdrawal by Subject|0|||
145538705|NCT00932126|524831665|FG007|Overall Study|Withdrawal by Subject|1|||
145538706|NCT00932126|524831658|FG000|Overall Study|Objective progression or relapse|3|||
145538707|NCT00932126|524831659|FG001|Overall Study|Objective progression or relapse|3|||
145538708|NCT00932126|524831660|FG002|Overall Study|Objective progression or relapse|2|||
145784718|NCT01356602|525720327|FG001|Overall Study|Adverse Event|1|||
145280560|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
145280561|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
145280562|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145280563|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145280564|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145538709|NCT00932126|524831661|FG003|Overall Study|Objective progression or relapse|3|||
145538710|NCT00932126|524831662|FG004|Overall Study|Objective progression or relapse|3|||
145538711|NCT00932126|524831663|FG005|Overall Study|Objective progression or relapse|3|||
145538712|NCT00932126|524831664|FG006|Overall Study|Objective progression or relapse|3|||
145538713|NCT00932126|524831665|FG007|Overall Study|Objective progression or relapse|5|||
145538714|NCT00932126|524831658|FG000|Overall Study|Other|0|||
145280565|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
145280566|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145280567|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145280568|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145280569|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
145280570|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145280571|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145280572|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145280573|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
145538715|NCT00932126|524831659|FG001|Overall Study|Other|0|||
145280574|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
145280575|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
145280576|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
145280577|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
145280578|NCT01677910|523877641|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
145280579|NCT01677910|523877642|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
145280580|NCT01677910|523877643|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
145280581|NCT01677910|523877644|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
145280582|NCT03568500|523877645|FG000|Overall Study|Lost to Follow-up|1|||
145784719|NCT01356602|525720328|FG002|Overall Study|Adverse Event|1|||
145784720|NCT00392171|525720329|FG000|Overall Study|Did not meet inclusion criteria|4|||
145784721|NCT00392171|525720329|FG000|Overall Study|Disease progression|101|||
145784722|NCT01605071|525720330|FG000|Overall Study|Withdrawal by Subject|3|||
145784723|NCT01605071|525720331|FG001|Overall Study|Withdrawal by Subject|2|||
145784724|NCT03470922|525720333|FG000|Overall Study|Death|107|||
145538716|NCT00932126|524831660|FG002|Overall Study|Other|0|||
145538717|NCT00932126|524831661|FG003|Overall Study|Other|0|||
145538718|NCT00932126|524831662|FG004|Overall Study|Other|1|||
145538719|NCT00932126|524831663|FG005|Overall Study|Other|0|||
145538720|NCT00932126|524831664|FG006|Overall Study|Other|1|||
145538721|NCT00932126|524831665|FG007|Overall Study|Other|2|||
145538722|NCT02716805|524831666|FG000|Overall Study|Progressive disease|2|||
145538723|NCT02716805|524831667|FG001|Overall Study|Progressive disease|0|||
145538724|NCT02716805|524831668|FG002|Overall Study|Progressive disease|0|||
145538725|NCT02716805|524831669|FG003|Overall Study|Progressive disease|0|||
145538726|NCT00066365|524831670|FG000|Overall Study|Adverse Event|1|||
145538727|NCT00066365|524831671|FG001|Overall Study|Adverse Event|0|||
145538728|NCT00066365|524831670|FG000|Overall Study|Lack of Efficacy|15|||
145538729|NCT00066365|524831671|FG001|Overall Study|Lack of Efficacy|12|||
145538730|NCT00066365|524831670|FG000|Overall Study|Physician Decision|1|||
145538731|NCT00066365|524831671|FG001|Overall Study|Physician Decision|0|||
145280583|NCT03568500|523877646|FG001|Overall Study|Lost to Follow-up|1|||
145538732|NCT00066365|524831670|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
145538733|NCT00066365|524831671|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
145538734|NCT00066365|524831670|FG000|Overall Study|Ineligible|4|||
145280584|NCT03568500|523877647|FG002|Overall Study|Lost to Follow-up|2|||
145280585|NCT03568500|523877645|FG000|Overall Study|Adverse Event|1|||
145280586|NCT03568500|523877646|FG001|Overall Study|Adverse Event|1|||
145280587|NCT03568500|523877647|FG002|Overall Study|Adverse Event|2|||
145280588|NCT03568500|523877645|FG000|Overall Study|Physician Decision|1|||
145538735|NCT00066365|524831671|FG001|Overall Study|Ineligible|2|||
145538736|NCT04203797|524831677|FG000|Overall Study|Adverse Event|1|||
145538737|NCT04203797|524831678|FG001|Overall Study|Adverse Event|0|||
145538738|NCT04203797|524831677|FG000|Overall Study|Did not complete End of Study follow-up|1|||
145538739|NCT04203797|524831678|FG001|Overall Study|Did not complete End of Study follow-up|0|||
145538740|NCT00579098|524831680|FG000|Overall Study|Lost to Follow-up|2|||
145280589|NCT03568500|523877646|FG001|Overall Study|Physician Decision|0|||
145280590|NCT03568500|523877647|FG002|Overall Study|Physician Decision|0|||
145280591|NCT03568500|523877645|FG000|Overall Study|Withdrawal by Subject|4|||
145538741|NCT00579098|524831681|FG001|Overall Study|Lost to Follow-up|0|||
145538742|NCT00579098|524831680|FG000|Overall Study|Adverse Event|2|||
145784725|NCT03470922|525720334|FG001|Overall Study|Death|118|||
145784726|NCT03470922|525720333|FG000|Overall Study|Lost to Follow-up|5|||
145784727|NCT03470922|525720334|FG001|Overall Study|Lost to Follow-up|5|||
145280592|NCT03568500|523877646|FG001|Overall Study|Withdrawal by Subject|2|||
145280593|NCT03568500|523877647|FG002|Overall Study|Withdrawal by Subject|0|||
145280594|NCT03568500|523877645|FG000|Overall Study|Technical Problems|2|||
145280595|NCT03568500|523877646|FG001|Overall Study|Technical Problems|1|||
145280596|NCT03568500|523877647|FG002|Overall Study|Technical Problems|0|||
145280597|NCT03568500|523877645|FG000|Overall Study|Participant Noncompliance|1|||
145280598|NCT03568500|523877646|FG001|Overall Study|Participant Noncompliance|1|||
145280599|NCT03568500|523877647|FG002|Overall Study|Participant Noncompliance|0|||
145280600|NCT01703741|523877653|FG000|Overall Study|Withdrawal by Subject|6|||
145280601|NCT01703741|523877653|FG000|Overall Study|Adverse Event|2|||
145280602|NCT01703741|523877653|FG000|Overall Study|Physician Decision|2|||
145280603|NCT01703741|523877653|FG000|Overall Study|Protocol Violation|1|||
145280604|NCT01703741|523877653|FG000|Overall Study|Lost to Follow-up|3|||
145280605|NCT01703741|523877653|FG000|Overall Study|Subject did not want to continue|2|||
145280606|NCT01703741|523877653|FG000|Overall Study|Subject cannot comply with study visits|1|||
145280607|NCT01703741|523877653|FG000|Overall Study|Subject started testosterone injections|1|||
145280608|NCT01368276|523877654|FG000|Overall Study|Death|1|||
145280609|NCT01368276|523877655|FG001|Overall Study|Death|10|||
145280610|NCT03341273|523877656|FG000|Overall Study|Lost to Follow-up|7|||
145280611|NCT03341273|523877657|FG001|Overall Study|Lost to Follow-up|7|||
145280612|NCT03341273|523877656|FG000|Overall Study|Withdrawal by Subject|4|||
145280613|NCT03341273|523877657|FG001|Overall Study|Withdrawal by Subject|2|||
145280614|NCT03341273|523877656|FG000|Overall Study|Physician Decision|1|||
145280615|NCT03341273|523877657|FG001|Overall Study|Physician Decision|0|||
145280616|NCT03341273|523877656|FG000|Overall Study|Protocol Violation|0|||
145280617|NCT03341273|523877657|FG001|Overall Study|Protocol Violation|1|||
145280618|NCT03341273|523877656|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
145280619|NCT03341273|523877657|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
145280620|NCT03341273|523877656|FG000|Overall Study|Became ineligible after enrollment|1|||
145280621|NCT03341273|523877657|FG001|Overall Study|Became ineligible after enrollment|0|||
145280622|NCT03341273|523877656|FG000|Overall Study|Not Eligible at Enrollment|0|||
145280623|NCT03341273|523877657|FG001|Overall Study|Not Eligible at Enrollment|1|||
145280624|NCT03341273|523877656|FG000|Overall Study|Participant incarcerated|1|||
145280625|NCT03341273|523877657|FG001|Overall Study|Participant incarcerated|0|||
145280626|NCT02041494|523877658|FG000|Overall Study|Death|1|||
145280627|NCT02041494|523877659|FG001|Overall Study|Death|3|||
145280628|NCT02041494|523877658|FG000|Overall Study|Lost to Follow-up|2|||
145280629|NCT02041494|523877659|FG001|Overall Study|Lost to Follow-up|6|||
145280630|NCT02041494|523877658|FG000|Overall Study|study terminated|16|||
145280631|NCT02041494|523877659|FG001|Overall Study|study terminated|11|||
145280632|NCT00685919|523877660|FG000|Overall Study|Withdrawal by Subject|0|||
145280633|NCT00685919|523877661|FG001|Overall Study|Withdrawal by Subject|0|||
145280634|NCT00685919|523877662|FG002|Overall Study|Withdrawal by Subject|1|||
145280635|NCT00685919|523877663|FG003|Overall Study|Withdrawal by Subject|0|||
145280636|NCT00685919|523877660|FG000|Overall Study|Physician Decision|1|||
145280637|NCT00685919|523877661|FG001|Overall Study|Physician Decision|0|||
145280638|NCT00685919|523877662|FG002|Overall Study|Physician Decision|0|||
145280639|NCT00685919|523877663|FG003|Overall Study|Physician Decision|0|||
145280640|NCT01717456|523877664|FG000|End of Treatment|Physician Decision|0|||
145280641|NCT01717456|523877665|FG001|End of Treatment|Physician Decision|1|||
145280642|NCT01717456|523877664|FG000|End of Treatment|Lost to Follow-up|0|||
145280643|NCT01717456|523877665|FG001|End of Treatment|Lost to Follow-up|1|||
145280644|NCT01717456|523877664|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
145280645|NCT01717456|523877665|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
145280646|NCT00837577|523877666|FG000|Double-blind Period|Clinical Adverse Event|1|||
145280647|NCT00837577|523877667|FG001|Double-blind Period|Clinical Adverse Event|0|||
145280648|NCT00837577|523877666|FG000|Double-blind Period|Withdrawal by Subject|1|||
145280649|NCT00837577|523877667|FG001|Double-blind Period|Withdrawal by Subject|0|||
145280650|NCT00837577|523877666|FG000|Open-label Period|Clinical Adverse Event|2|||
145280651|NCT00837577|523877667|FG001|Open-label Period|Clinical Adverse Event|2|||
145280652|NCT00837577|523877666|FG000|Open-label Period|Laboratory Adverse Event|0|||
145280653|NCT00837577|523877667|FG001|Open-label Period|Laboratory Adverse Event|1|||
145280654|NCT00837577|523877666|FG000|Open-label Period|Lack of Efficacy|4|||
145403910|NCT00109343|524336434|FG002|Overall Study|Subject Moved|1|||
145280655|NCT00837577|523877667|FG001|Open-label Period|Lack of Efficacy|3|||
145280656|NCT00837577|523877666|FG000|Open-label Period|Withdrawal by Subject|1|||
145280657|NCT00837577|523877667|FG001|Open-label Period|Withdrawal by Subject|2|||
145280658|NCT00837577|523877666|FG000|Open-label Period|Other Reason|1|||
145280659|NCT00837577|523877667|FG001|Open-label Period|Other Reason|1|||
145403911|NCT00109343|524336432|FG000|Overall Study|Other|5|||
145280660|NCT00986154|523877668|FG000|Overall Study|Death|136|||
145280661|NCT00986154|523877669|FG001|Overall Study|Death|127|||
145280662|NCT00986154|523877668|FG000|Overall Study|Lost to Follow-up|7|||
145280663|NCT00986154|523877669|FG001|Overall Study|Lost to Follow-up|4|||
145280664|NCT00986154|523877668|FG000|Overall Study|Withdrawal by Subject|32|||
145280665|NCT00986154|523877669|FG001|Overall Study|Withdrawal by Subject|33|||
145403912|NCT00109343|524336433|FG001|Overall Study|Other|2|||
145784728|NCT03470922|525720333|FG000|Overall Study|Participant Withdrew Consent|4|||
145784729|NCT03470922|525720334|FG001|Overall Study|Participant Withdrew Consent|9|||
145280666|NCT00986154|523877668|FG000|Overall Study|investigator/subject decide not continue|6|||
145280667|NCT00986154|523877669|FG001|Overall Study|investigator/subject decide not continue|3|||
145280668|NCT00986154|523877668|FG000|Overall Study|never received study drug|25|||
145280669|NCT00986154|523877669|FG001|Overall Study|never received study drug|27|||
145609562|NCT01225822|525086376|FG002|Overall Study|Lost to Follow-up|0|||
145609563|NCT01225822|525086377|FG003|Overall Study|Lost to Follow-up|1|||
145609564|NCT01225822|525086378|FG004|Overall Study|Lost to Follow-up|0|||
145609565|NCT01225822|525086374|FG000|Overall Study|Withdrawal by Subject|6|||
145609566|NCT01225822|525086375|FG001|Overall Study|Withdrawal by Subject|7|||
145609567|NCT01225822|525086376|FG002|Overall Study|Withdrawal by Subject|7|||
145609568|NCT01225822|525086377|FG003|Overall Study|Withdrawal by Subject|11|||
145609569|NCT01225822|525086378|FG004|Overall Study|Withdrawal by Subject|6|||
145609570|NCT01225822|525086374|FG000|Overall Study|Other|13|||
145609571|NCT01225822|525086375|FG001|Overall Study|Other|10|||
145609572|NCT01225822|525086376|FG002|Overall Study|Other|7|||
145609573|NCT01225822|525086377|FG003|Overall Study|Other|10|||
145609574|NCT01225822|525086378|FG004|Overall Study|Other|7|||
145609575|NCT01290822|525086379|FG000|Overall Study|Withdrawal by Subject|1|||
145280670|NCT00033631|523877676|FG000|Overall Study|Protocol Violation|14|||
145280671|NCT00033631|523877677|FG001|Overall Study|Protocol Violation|11|||
145280672|NCT00033631|523877676|FG000|Overall Study|Withdrawal by Subject|4|||
145280673|NCT00033631|523877677|FG001|Overall Study|Withdrawal by Subject|4|||
145280674|NCT00971204|523877678|FG000|Overall Study|Did not meet all criteria-not treated|14|||
145280675|NCT00971204|523877678|FG000|Overall Study|Lost to Follow-up|10|||
145280676|NCT01252238|523877683|FG000|Overall Study|Sponsor terminated study|4|||
145280677|NCT01252238|523877684|FG001|Overall Study|Sponsor terminated study|4|||
145280678|NCT01252238|523877685|FG002|Overall Study|Sponsor terminated study|4|||
145280679|NCT00272961|523877686|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
145280680|NCT00272961|523877687|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
145280681|NCT00272961|523877688|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
145280682|NCT00272961|523877689|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
145280683|NCT00272961|523877690|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
145280684|NCT00272961|523877686|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
145280685|NCT00272961|523877687|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
145280686|NCT00272961|523877688|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
145280687|NCT00272961|523877689|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
145280688|NCT00272961|523877690|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
145280689|NCT00272961|523877686|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
145280690|NCT00272961|523877687|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
145280691|NCT00272961|523877688|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
145280692|NCT00272961|523877689|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
145280693|NCT00272961|523877690|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
145280694|NCT00272961|523877686|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
145280695|NCT00272961|523877687|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
145280696|NCT00272961|523877688|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
145280697|NCT00272961|523877689|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
145280698|NCT00272961|523877690|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
145280699|NCT00272961|523877686|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
145280700|NCT00272961|523877687|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
145403913|NCT00109343|524336434|FG002|Overall Study|Other|1|||
145403914|NCT02100631|524336435|FG000|Overall Study|Withdrawal by Subject|1|||
145403915|NCT02100631|524336436|FG001|Overall Study|Withdrawal by Subject|0|||
145538743|NCT00579098|524831681|FG001|Overall Study|Adverse Event|3|||
145538744|NCT00579098|524831680|FG000|Overall Study|Withdrawal by Subject|2|||
145538745|NCT00579098|524831681|FG001|Overall Study|Withdrawal by Subject|3|||
145538746|NCT00579098|524831680|FG000|Overall Study|AF returned after ablation|3|||
145538747|NCT00579098|524831681|FG001|Overall Study|AF returned after ablation|2|||
145538748|NCT01254331|524831683|FG000|Initial Phase|Adverse Event|3|||
145538749|NCT01254331|524831683|FG000|Initial Phase|Withdrawal by Subject|1|||
145538750|NCT01254331|524831683|FG000|Initial Phase|Pregnancy|1|||
145538751|NCT01254331|524831683|FG000|Extension Phase|Lack of Efficacy|1|||
145538752|NCT01254331|524831683|FG000|Extension Phase|Lost to Follow-up|3|||
145538753|NCT00306189|524831687|FG000|Overall Study|Physician Decision|0|||
145538754|NCT00306189|524831688|FG001|Overall Study|Physician Decision|0|||
145538755|NCT00306189|524831689|FG002|Overall Study|Physician Decision|0|||
145538756|NCT00306189|524831690|FG003|Overall Study|Physician Decision|1|||
145538757|NCT00306189|524831687|FG000|Overall Study|Adverse Event|3|||
145538758|NCT00306189|524831688|FG001|Overall Study|Adverse Event|3|||
145538759|NCT00306189|524831689|FG002|Overall Study|Adverse Event|2|||
145538760|NCT00306189|524831690|FG003|Overall Study|Adverse Event|2|||
145538761|NCT00306189|524831687|FG000|Overall Study|Withdrawal by Subject|4|||
145784730|NCT03470922|525720333|FG000|Overall Study|Other reasons|1|||
145784731|NCT03470922|525720334|FG001|Overall Study|Other reasons|0|||
145784732|NCT03470922|525720333|FG000|Overall Study|Not reported|1|||
145784733|NCT03470922|525720334|FG001|Overall Study|Not reported|0|||
145784734|NCT02819310|525720335|FG000|Overall Study|Withdrawal by Subject|37|||
145784735|NCT02819310|525720335|FG000|Overall Study|Lost to Follow-up|16|||
145784736|NCT02819310|525720335|FG000|Overall Study|Adverse Event|13|||
145280701|NCT00272961|523877688|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
145280702|NCT00272961|523877689|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
145280703|NCT00272961|523877690|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
145280704|NCT00272961|523877686|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
145280705|NCT00272961|523877687|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
145280706|NCT00272961|523877688|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
145280707|NCT00272961|523877689|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
145280708|NCT00272961|523877690|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
145280709|NCT00272961|523877686|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
145280710|NCT00272961|523877687|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
145280711|NCT00272961|523877688|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
145280712|NCT00272961|523877689|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
145280713|NCT00272961|523877690|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
145280714|NCT00272961|523877686|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
145280715|NCT00272961|523877687|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
145280716|NCT00272961|523877688|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
145280717|NCT00272961|523877689|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
145280718|NCT00272961|523877690|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
145280719|NCT01507831|523877691|FG000|Overall Study|Randomized but not treated|0|||
145280720|NCT01507831|523877692|FG001|Overall Study|Randomized but not treated|3|||
145280721|NCT01507831|523877691|FG000|Overall Study|Adverse Event|48|||
145280722|NCT01507831|523877692|FG001|Overall Study|Adverse Event|113|||
145280723|NCT01507831|523877691|FG000|Overall Study|Death|6|||
145280724|NCT01507831|523877692|FG001|Overall Study|Death|2|||
145280725|NCT01507831|523877691|FG000|Overall Study|Poor compliance to protocol|38|||
145280726|NCT01507831|523877692|FG001|Overall Study|Poor compliance to protocol|60|||
145280727|NCT01507831|523877691|FG000|Overall Study|Physician Decision|0|||
145280728|NCT01507831|523877692|FG001|Overall Study|Physician Decision|4|||
145280729|NCT01507831|523877691|FG000|Overall Study|Participant moved|5|||
145280730|NCT01507831|523877692|FG001|Overall Study|Participant moved|19|||
145280731|NCT01507831|523877691|FG000|Overall Study|Consent withdrawn by participant|34|||
145280732|NCT01507831|523877692|FG001|Overall Study|Consent withdrawn by participant|72|||
145280733|NCT01507831|523877691|FG000|Overall Study|Related to study drug administration|5|||
145280734|NCT01507831|523877692|FG001|Overall Study|Related to study drug administration|14|||
145280735|NCT01507831|523877691|FG000|Overall Study|Last visit outside protocol visit window|51|||
145280736|NCT01507831|523877692|FG001|Overall Study|Last visit outside protocol visit window|143|||
145280737|NCT01507831|523877691|FG000|Overall Study|Selection criteria finally not met|0|||
145280738|NCT01507831|523877692|FG001|Overall Study|Selection criteria finally not met|1|||
145280739|NCT01507831|523877691|FG000|Overall Study|Site closure|0|||
145280740|NCT01507831|523877692|FG001|Overall Study|Site closure|3|||
145784737|NCT02819310|525720335|FG000|Overall Study|Lack of Efficacy|5|||
145784738|NCT02819310|525720335|FG000|Overall Study|Physician Decision|8|||
145784739|NCT02819310|525720335|FG000|Overall Study|Protocol Violation|30|||
145280741|NCT01507831|523877691|FG000|Overall Study|Potential lost to follow-up|3|||
145280742|NCT01507831|523877692|FG001|Overall Study|Potential lost to follow-up|0|||
145280743|NCT01507831|523877691|FG000|Overall Study|Other|3|||
145280744|NCT01507831|523877692|FG001|Overall Study|Other|6|||
145280745|NCT03196791|523877693|FG000|Overall Study|Protocol Violation|7|||
145280746|NCT03196791|523877694|FG001|Overall Study|Protocol Violation|3|||
145280747|NCT03196791|523877693|FG000|Overall Study|Withdrawal by Subject|3|||
145784740|NCT01675011|525720336|FG000|Overall Study|Trial terminated by Sponsor|3|||
145280748|NCT03196791|523877694|FG001|Overall Study|Withdrawal by Subject|2|||
145280749|NCT00068237|523877697|FG000|Overall Study|Ineligible|3|||
145280750|NCT00068237|523877697|FG000|Overall Study|No protocol treatment received|2|||
145280751|NCT03276962|523877703|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
145280752|NCT03276962|523877704|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
145280753|NCT03276962|523877705|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
145280754|NCT03276962|523877706|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
145280755|NCT03276962|523877707|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
145280756|NCT03276962|523877703|FG000|Overall Study|Protocol Deviation|2|||
145280757|NCT03276962|523877704|FG001|Overall Study|Protocol Deviation|0|||
145280758|NCT03276962|523877705|FG002|Overall Study|Protocol Deviation|1|||
145280759|NCT03276962|523877706|FG003|Overall Study|Protocol Deviation|2|||
145280760|NCT03276962|523877707|FG004|Overall Study|Protocol Deviation|1|||
145280761|NCT03276962|523877703|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
145280762|NCT03276962|523877704|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
145280763|NCT03276962|523877705|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
145280764|NCT03276962|523877706|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
145280765|NCT03276962|523877707|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
145280766|NCT03276962|523877703|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
145280767|NCT03276962|523877704|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
145280768|NCT03276962|523877705|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
145280769|NCT03276962|523877706|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
145280770|NCT03276962|523877707|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
145280771|NCT03276962|523877703|FG000|Overall Study|Lost to Follow-up|10|||
145280772|NCT03276962|523877704|FG001|Overall Study|Lost to Follow-up|10|||
145280773|NCT03276962|523877705|FG002|Overall Study|Lost to Follow-up|4|||
145280774|NCT03276962|523877706|FG003|Overall Study|Lost to Follow-up|6|||
145280775|NCT03276962|523877707|FG004|Overall Study|Lost to Follow-up|10|||
145280776|NCT03276962|523877703|FG000|Overall Study|Other|0|||
145280777|NCT03276962|523877704|FG001|Overall Study|Other|2|||
145280778|NCT03276962|523877705|FG002|Overall Study|Other|0|||
145280779|NCT03276962|523877706|FG003|Overall Study|Other|2|||
145280780|NCT03276962|523877707|FG004|Overall Study|Other|1|||
145280781|NCT01238211|523877708|FG000|Overall Study|Continues active treatment|31|||
145280782|NCT01238211|523877708|FG000|Overall Study|Adverse Event|7|||
145280783|NCT01238211|523877708|FG000|Overall Study|Death|4|||
145280784|NCT01238211|523877708|FG000|Overall Study|Relapse/Progression|2|||
145280785|NCT01238211|523877708|FG000|Overall Study|Withdrawal by Subject|7|||
145280786|NCT01238211|523877708|FG000|Overall Study|Non-protocol treatment|4|||
145280787|NCT01238211|523877708|FG000|Overall Study|Investigator/Patient Decision|3|||
145280788|NCT01358708|523877709|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
145280789|NCT01358708|523877710|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145280790|NCT01358708|523877709|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
145280791|NCT01358708|523877710|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
145280792|NCT02475980|523877715|FG000|Overall Study|Lost to Follow-up|4|||
145280793|NCT02475980|523877715|FG000|Overall Study|Withdrawal by Subject|1|||
145280794|NCT00990093|523877716|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
145280795|NCT00990093|523877717|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
145280796|NCT00990093|523877716|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
145280797|NCT00990093|523877717|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
145280798|NCT00990093|523877716|FG000|Test Period 1 (1-14 Days)|Other|1|||
145280799|NCT00990093|523877717|FG001|Test Period 1 (1-14 Days)|Other|0|||
145280800|NCT00990093|523877716|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
145784741|NCT01675011|525720337|FG001|Overall Study|Trial terminated by Sponsor|1|||
145784742|NCT02849990|525720338|FG000|Overall Study|Adverse Event|1|||
145784743|NCT02849990|525720338|FG000|Overall Study|Withdrawal by Subject|1|||
145784744|NCT02678741|525720339|FG000|Overall Study|Death|4|||
145784745|NCT02678741|525720339|FG000|Overall Study|Withdrawal by Subject|1|||
145784746|NCT02678741|525720339|FG000|Overall Study|ineligible|3|||
145784747|NCT02678741|525720339|FG000|Overall Study|Not RECIST Measurable|2|||
145784748|NCT02678741|525720339|FG000|Overall Study|Lack of Efficacy|10|||
145784749|NCT01795898|525720340|FG000|Overall Study|Adverse Event|27|||
145784750|NCT01795898|525720340|FG000|Overall Study|Lost to Follow-up|20|||
145280801|NCT00990093|523877717|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
145280802|NCT00990093|523877716|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
145280803|NCT00990093|523877717|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
145280804|NCT00990093|523877716|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
145784751|NCT01795898|525720340|FG000|Overall Study|Withdrawal of consent|6|||
145280805|NCT00990093|523877717|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
145280806|NCT00990093|523877716|FG000|Test Period 2 (15-28 Days)|Other|0|||
145280807|NCT00990093|523877717|FG001|Test Period 2 (15-28 Days)|Other|1|||
145280808|NCT00343642|523878949|FG000|Overall Study|Lost to Follow-up|0|||
145280809|NCT00343642|523878950|FG001|Overall Study|Lost to Follow-up|1|||
145784752|NCT01795898|525720340|FG000|Overall Study|Diagnosed with metastasis|1|||
145280810|NCT00343642|523878951|FG002|Overall Study|Lost to Follow-up|0|||
145784753|NCT01795898|525720340|FG000|Overall Study|No pain|1|||
145784754|NCT01795898|525720340|FG000|Overall Study|Death|1|||
145784755|NCT01795898|525720340|FG000|Overall Study|Withdrew consent & had adverse events|3|||
145784756|NCT01795898|525720340|FG000|Overall Study|Physician Decision|1|||
145784757|NCT01984346|525720341|FG000|Overall Study|Physician Decision|4|||
145784758|NCT01984346|525720342|FG001|Overall Study|Physician Decision|2|||
145784759|NCT01984346|525720341|FG000|Overall Study|Withdrawal by Subject|2|||
145784760|NCT01984346|525720342|FG001|Overall Study|Withdrawal by Subject|2|||
145784761|NCT01984346|525720341|FG000|Overall Study|Enrollment Closed|8|||
145784762|NCT01984346|525720342|FG001|Overall Study|Enrollment Closed|1|||
145784763|NCT01984346|525720341|FG000|Overall Study|Insurance Coverage|1|||
145784764|NCT01984346|525720342|FG001|Overall Study|Insurance Coverage|0|||
145784765|NCT01984346|525720341|FG000|Overall Study|Intra-operative Exclusion|2|||
145784766|NCT01984346|525720342|FG001|Overall Study|Intra-operative Exclusion|0|||
145784767|NCT00536731|525720343|FG000|Overall Study|Adverse Event|3|||
145784768|NCT00536731|525720344|FG001|Overall Study|Adverse Event|2|||
145784769|NCT00536731|525720345|FG002|Overall Study|Adverse Event|3|||
145784770|NCT00536731|525720343|FG000|Overall Study|Withdrawal by Subject|0|||
145784771|NCT00536731|525720344|FG001|Overall Study|Withdrawal by Subject|2|||
145784772|NCT00536731|525720345|FG002|Overall Study|Withdrawal by Subject|0|||
145784773|NCT00536731|525720343|FG000|Overall Study|Intake of prohibited conc. medication|0|||
145784774|NCT00536731|525720344|FG001|Overall Study|Intake of prohibited conc. medication|0|||
145784775|NCT00536731|525720345|FG002|Overall Study|Intake of prohibited conc. medication|1|||
145784776|NCT00536731|525720343|FG000|Overall Study|Safety reasons|0|||
145784777|NCT00536731|525720344|FG001|Overall Study|Safety reasons|0|||
145784778|NCT00536731|525720345|FG002|Overall Study|Safety reasons|1|||
145784779|NCT00536731|525720343|FG000|Overall Study|Other|1|||
145784780|NCT00536731|525720344|FG001|Overall Study|Other|1|||
145784781|NCT00536731|525720345|FG002|Overall Study|Other|0|||
145784782|NCT01623531|525720346|FG000|Overall Study|Death|1|||
145784783|NCT01623531|525720347|FG001|Overall Study|Death|0|||
145784784|NCT01623531|525720346|FG000|Overall Study|Protocol Violation|2|||
145784785|NCT01623531|525720347|FG001|Overall Study|Protocol Violation|1|||
145280811|NCT00343642|523878949|FG000|Overall Study|Pregnancy|1|||
145280812|NCT00343642|523878950|FG001|Overall Study|Pregnancy|0|||
145280813|NCT00343642|523878951|FG002|Overall Study|Pregnancy|2|||
145280814|NCT00343642|523878949|FG000|Overall Study|Withdrawal by Subject|2|||
145280815|NCT00343642|523878950|FG001|Overall Study|Withdrawal by Subject|3|||
145280816|NCT00343642|523878951|FG002|Overall Study|Withdrawal by Subject|4|||
145280817|NCT00343642|523878949|FG000|Overall Study|Adverse Event|0|||
145280818|NCT00343642|523878950|FG001|Overall Study|Adverse Event|0|||
145280819|NCT00343642|523878951|FG002|Overall Study|Adverse Event|1|||
145280820|NCT00343642|523878949|FG000|Overall Study|Flare up|6|||
145280821|NCT00343642|523878950|FG001|Overall Study|Flare up|4|||
145280822|NCT00343642|523878951|FG002|Overall Study|Flare up|0|||
145280823|NCT01963676|523878952|FG000|Overall Study|Withdrawal by Subject|1|||
145280824|NCT01963676|523878953|FG001|Overall Study|Withdrawal by Subject|0|||
145784786|NCT01623531|525720346|FG000|Overall Study|Missing data at primary outcome time poi|1|||
145280825|NCT00766506|523878954|FG000|Overall Study|Use rescue medication after 3 hours|3|||
145784787|NCT01623531|525720347|FG001|Overall Study|Missing data at primary outcome time poi|1|||
145784788|NCT01070550|525720348|FG000|Overall Study|Adverse Event|43|||
145280826|NCT00766506|523878955|FG001|Overall Study|Use rescue medication after 3 hours|0|||
145280827|NCT00766506|523878954|FG000|Overall Study|Other|2|||
145280828|NCT00766506|523878955|FG001|Overall Study|Other|2|||
145280829|NCT00860574|523878956|FG000|Overall Study|Death|2|||
145280830|NCT00860574|523878956|FG000|Overall Study|Relapse|1|||
145280831|NCT01246986|523878957|FG000|Overall Study|Lost to Follow-up|0|||
145280832|NCT01246986|523878958|FG001|Overall Study|Lost to Follow-up|1|||
145280833|NCT01246986|523878959|FG002|Overall Study|Lost to Follow-up|3|||
145280834|NCT01246986|523878960|FG003|Overall Study|Lost to Follow-up|0|||
145280835|NCT01246986|523878961|FG004|Overall Study|Lost to Follow-up|0|||
145280836|NCT01246986|523878962|FG005|Overall Study|Lost to Follow-up|1|||
145280837|NCT01246986|523878963|FG006|Overall Study|Lost to Follow-up|0|||
145280838|NCT01246986|523878957|FG000|Overall Study|Withdrawal by Subject|3|||
145280839|NCT01246986|523878958|FG001|Overall Study|Withdrawal by Subject|4|||
145280840|NCT01246986|523878959|FG002|Overall Study|Withdrawal by Subject|3|||
145280841|NCT01246986|523878960|FG003|Overall Study|Withdrawal by Subject|0|||
145280842|NCT01246986|523878961|FG004|Overall Study|Withdrawal by Subject|4|||
145280843|NCT01246986|523878962|FG005|Overall Study|Withdrawal by Subject|0|||
145280844|NCT01246986|523878963|FG006|Overall Study|Withdrawal by Subject|0|||
145280845|NCT02496221|523878965|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
145280846|NCT02496221|523878966|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
145280847|NCT02496221|523878965|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
145280848|NCT02496221|523878966|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
145280849|NCT02496221|523878965|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
145280850|NCT02496221|523878966|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
145280851|NCT03262233|523878967|FG000|Overall Study|Withdrawal by Subject|12|||
145784789|NCT01070550|525720349|FG001|Overall Study|Adverse Event|1|||
145784790|NCT01070550|525720350|FG002|Overall Study|Adverse Event|3|||
145784791|NCT01070550|525720351|FG003|Overall Study|Adverse Event|0|||
145784792|NCT01070550|525720352|FG004|Overall Study|Adverse Event|0|||
145784793|NCT01070550|525720353|FG005|Overall Study|Adverse Event|0|||
145784794|NCT01070550|525720348|FG000|Overall Study|Death|20|||
145784795|NCT01070550|525720349|FG001|Overall Study|Death|4|||
145784796|NCT01070550|525720350|FG002|Overall Study|Death|3|||
145784797|NCT01070550|525720351|FG003|Overall Study|Death|0|||
145784798|NCT01070550|525720352|FG004|Overall Study|Death|0|||
145784799|NCT01070550|525720353|FG005|Overall Study|Death|0|||
145784800|NCT01070550|525720348|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
145784801|NCT01070550|525720349|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
145784802|NCT01070550|525720350|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
145784803|NCT01070550|525720351|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145784804|NCT01070550|525720352|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145784805|NCT01070550|525720353|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145784806|NCT01070550|525720348|FG000|Overall Study|Early termination|3|||
145784807|NCT01070550|525720349|FG001|Overall Study|Early termination|0|||
145784808|NCT01070550|525720350|FG002|Overall Study|Early termination|0|||
145784809|NCT01070550|525720351|FG003|Overall Study|Early termination|0|||
145784810|NCT01070550|525720352|FG004|Overall Study|Early termination|0|||
145784811|NCT01070550|525720353|FG005|Overall Study|Early termination|0|||
145784812|NCT01070550|525720348|FG000|Overall Study|Failed to return|450|||
145784813|NCT01070550|525720349|FG001|Overall Study|Failed to return|33|||
145784814|NCT01070550|525720350|FG002|Overall Study|Failed to return|144|||
145784815|NCT01070550|525720351|FG003|Overall Study|Failed to return|40|||
145784816|NCT01070550|525720352|FG004|Overall Study|Failed to return|1|||
145784817|NCT01070550|525720353|FG005|Overall Study|Failed to return|2|||
145784818|NCT01070550|525720348|FG000|Overall Study|Incomplete treatment|2|||
145784819|NCT01070550|525720349|FG001|Overall Study|Incomplete treatment|0|||
145784820|NCT01070550|525720350|FG002|Overall Study|Incomplete treatment|0|||
145784821|NCT01070550|525720351|FG003|Overall Study|Incomplete treatment|0|||
145784822|NCT01070550|525720352|FG004|Overall Study|Incomplete treatment|0|||
145784823|NCT01070550|525720353|FG005|Overall Study|Incomplete treatment|0|||
145784824|NCT01070550|525720348|FG000|Overall Study|Lab test not done|22|||
145784825|NCT01070550|525720349|FG001|Overall Study|Lab test not done|3|||
145784826|NCT01070550|525720350|FG002|Overall Study|Lab test not done|4|||
145280852|NCT03262233|523878968|FG001|Overall Study|Withdrawal by Subject|8|||
145280853|NCT03262233|523878969|FG002|Overall Study|Withdrawal by Subject|21|||
145280854|NCT03262233|523878970|FG003|Overall Study|Withdrawal by Subject|13|||
145280855|NCT03262233|523878967|FG000|Overall Study|Declined due to shock|1|||
145538762|NCT00306189|524831688|FG001|Overall Study|Withdrawal by Subject|2|||
145280856|NCT03262233|523878968|FG001|Overall Study|Declined due to shock|2|||
145280857|NCT03262233|523878969|FG002|Overall Study|Declined due to shock|2|||
145280858|NCT03262233|523878970|FG003|Overall Study|Declined due to shock|3|||
145280859|NCT03262233|523878967|FG000|Overall Study|Protocol Violation|5|||
145280860|NCT03262233|523878968|FG001|Overall Study|Protocol Violation|10|||
145784827|NCT01070550|525720351|FG003|Overall Study|Lab test not done|1|||
145784828|NCT01070550|525720352|FG004|Overall Study|Lab test not done|0|||
145784829|NCT01070550|525720353|FG005|Overall Study|Lab test not done|1|||
145784830|NCT01070550|525720348|FG000|Overall Study|Lack of Efficacy|65|||
145784831|NCT01070550|525720349|FG001|Overall Study|Lack of Efficacy|1|||
145784832|NCT01070550|525720350|FG002|Overall Study|Lack of Efficacy|5|||
145784833|NCT01070550|525720351|FG003|Overall Study|Lack of Efficacy|5|||
145784834|NCT01070550|525720352|FG004|Overall Study|Lack of Efficacy|0|||
145784835|NCT01070550|525720353|FG005|Overall Study|Lack of Efficacy|1|||
145784836|NCT01070550|525720348|FG000|Overall Study|Miscellaneous|12|||
145784837|NCT01070550|525720349|FG001|Overall Study|Miscellaneous|2|||
145784838|NCT01070550|525720350|FG002|Overall Study|Miscellaneous|3|||
145784839|NCT01070550|525720351|FG003|Overall Study|Miscellaneous|1|||
145784840|NCT01070550|525720352|FG004|Overall Study|Miscellaneous|0|||
145784841|NCT01070550|525720353|FG005|Overall Study|Miscellaneous|0|||
145784842|NCT01070550|525720348|FG000|Overall Study|New treatment started|3|||
145784843|NCT01070550|525720349|FG001|Overall Study|New treatment started|1|||
145784844|NCT01070550|525720350|FG002|Overall Study|New treatment started|0|||
145784845|NCT01070550|525720351|FG003|Overall Study|New treatment started|2|||
145784846|NCT01070550|525720352|FG004|Overall Study|New treatment started|0|||
145784847|NCT01070550|525720353|FG005|Overall Study|New treatment started|0|||
145784848|NCT01070550|525720348|FG000|Overall Study|Non-responders|493|||
145784849|NCT01070550|525720349|FG001|Overall Study|Non-responders|4|||
145784850|NCT01070550|525720350|FG002|Overall Study|Non-responders|21|||
145784851|NCT01070550|525720351|FG003|Overall Study|Non-responders|20|||
145784852|NCT01070550|525720352|FG004|Overall Study|Non-responders|0|||
145784853|NCT01070550|525720353|FG005|Overall Study|Non-responders|2|||
145784854|NCT01070550|525720348|FG000|Overall Study|Not categorized|33|||
145784855|NCT01070550|525720349|FG001|Overall Study|Not categorized|2|||
145784856|NCT01070550|525720350|FG002|Overall Study|Not categorized|6|||
145784857|NCT01070550|525720351|FG003|Overall Study|Not categorized|1|||
145784858|NCT01070550|525720352|FG004|Overall Study|Not categorized|0|||
145784859|NCT01070550|525720353|FG005|Overall Study|Not categorized|1|||
145784860|NCT01070550|525720348|FG000|Overall Study|Protocol Violation|15|||
145784861|NCT01070550|525720349|FG001|Overall Study|Protocol Violation|1|||
145784862|NCT01070550|525720350|FG002|Overall Study|Protocol Violation|1|||
145784863|NCT01070550|525720351|FG003|Overall Study|Protocol Violation|1|||
145784864|NCT01070550|525720352|FG004|Overall Study|Protocol Violation|0|||
145784865|NCT01070550|525720353|FG005|Overall Study|Protocol Violation|0|||
145784866|NCT01070550|525720348|FG000|Overall Study|Relapse|44|||
145784867|NCT01070550|525720349|FG001|Overall Study|Relapse|5|||
145784868|NCT01070550|525720350|FG002|Overall Study|Relapse|14|||
145784869|NCT01070550|525720351|FG003|Overall Study|Relapse|4|||
145784870|NCT01070550|525720352|FG004|Overall Study|Relapse|0|||
145784871|NCT01070550|525720353|FG005|Overall Study|Relapse|0|||
145784872|NCT01070550|525720348|FG000|Overall Study|Result not available|3|||
145784873|NCT01070550|525720349|FG001|Overall Study|Result not available|1|||
145784874|NCT01070550|525720350|FG002|Overall Study|Result not available|3|||
145784875|NCT01070550|525720351|FG003|Overall Study|Result not available|0|||
145784876|NCT01070550|525720352|FG004|Overall Study|Result not available|0|||
145784877|NCT01070550|525720353|FG005|Overall Study|Result not available|0|||
145784878|NCT01070550|525720348|FG000|Overall Study|Screen failure|1|||
145784879|NCT01070550|525720349|FG001|Overall Study|Screen failure|0|||
145784880|NCT01070550|525720350|FG002|Overall Study|Screen failure|0|||
145784881|NCT01070550|525720351|FG003|Overall Study|Screen failure|0|||
145784882|NCT01070550|525720352|FG004|Overall Study|Screen failure|0|||
145784883|NCT01070550|525720353|FG005|Overall Study|Screen failure|0|||
145784884|NCT01070550|525720348|FG000|Overall Study|Sponsor decision|1|||
145784885|NCT01070550|525720349|FG001|Overall Study|Sponsor decision|0|||
145784886|NCT01070550|525720350|FG002|Overall Study|Sponsor decision|0|||
145784887|NCT01070550|525720351|FG003|Overall Study|Sponsor decision|0|||
145784888|NCT01070550|525720352|FG004|Overall Study|Sponsor decision|0|||
145784889|NCT01070550|525720353|FG005|Overall Study|Sponsor decision|0|||
145784890|NCT01070550|525720348|FG000|Overall Study|Treatment duration shortened|1|||
145784891|NCT01070550|525720349|FG001|Overall Study|Treatment duration shortened|0|||
145784892|NCT01070550|525720350|FG002|Overall Study|Treatment duration shortened|0|||
145784893|NCT01070550|525720351|FG003|Overall Study|Treatment duration shortened|0|||
145784894|NCT01070550|525720352|FG004|Overall Study|Treatment duration shortened|0|||
145784895|NCT01070550|525720353|FG005|Overall Study|Treatment duration shortened|0|||
145784896|NCT01070550|525720348|FG000|Overall Study|Treatment interrupted|7|||
145784897|NCT01070550|525720349|FG001|Overall Study|Treatment interrupted|0|||
145784898|NCT01070550|525720350|FG002|Overall Study|Treatment interrupted|1|||
145784899|NCT01070550|525720351|FG003|Overall Study|Treatment interrupted|1|||
145784900|NCT01070550|525720352|FG004|Overall Study|Treatment interrupted|0|||
145784901|NCT01070550|525720353|FG005|Overall Study|Treatment interrupted|0|||
145784902|NCT01070550|525720348|FG000|Overall Study|Treatment not started|14|||
145784903|NCT01070550|525720349|FG001|Overall Study|Treatment not started|2|||
145784904|NCT01070550|525720350|FG002|Overall Study|Treatment not started|4|||
145784905|NCT01070550|525720351|FG003|Overall Study|Treatment not started|0|||
145784906|NCT01070550|525720352|FG004|Overall Study|Treatment not started|0|||
145784907|NCT01070550|525720353|FG005|Overall Study|Treatment not started|0|||
145784908|NCT01070550|525720348|FG000|Overall Study|Treatment restarted|0|||
145784909|NCT01070550|525720349|FG001|Overall Study|Treatment restarted|1|||
145784910|NCT01070550|525720350|FG002|Overall Study|Treatment restarted|0|||
145784911|NCT01070550|525720351|FG003|Overall Study|Treatment restarted|0|||
145784912|NCT01070550|525720352|FG004|Overall Study|Treatment restarted|0|||
145784913|NCT01070550|525720353|FG005|Overall Study|Treatment restarted|0|||
145784914|NCT01070550|525720348|FG000|Overall Study|Treatment stopped|3|||
145784915|NCT01070550|525720349|FG001|Overall Study|Treatment stopped|0|||
145784916|NCT01070550|525720350|FG002|Overall Study|Treatment stopped|0|||
145784917|NCT01070550|525720351|FG003|Overall Study|Treatment stopped|0|||
145784918|NCT01070550|525720352|FG004|Overall Study|Treatment stopped|0|||
145784919|NCT01070550|525720353|FG005|Overall Study|Treatment stopped|0|||
145784920|NCT01070550|525720348|FG000|Overall Study|Treatment unavailable|1|||
145784921|NCT01070550|525720349|FG001|Overall Study|Treatment unavailable|0|||
145784922|NCT01070550|525720350|FG002|Overall Study|Treatment unavailable|0|||
145784923|NCT01070550|525720351|FG003|Overall Study|Treatment unavailable|0|||
145784924|NCT01070550|525720352|FG004|Overall Study|Treatment unavailable|0|||
145784925|NCT01070550|525720353|FG005|Overall Study|Treatment unavailable|0|||
145784926|NCT01070550|525720348|FG000|Overall Study|Treatment was stopped early|7|||
145784927|NCT01070550|525720349|FG001|Overall Study|Treatment was stopped early|0|||
145784928|NCT01070550|525720350|FG002|Overall Study|Treatment was stopped early|0|||
145784929|NCT01070550|525720351|FG003|Overall Study|Treatment was stopped early|0|||
145784930|NCT01070550|525720352|FG004|Overall Study|Treatment was stopped early|0|||
145784931|NCT01070550|525720353|FG005|Overall Study|Treatment was stopped early|0|||
145784932|NCT01070550|525720348|FG000|Overall Study|Other|5|||
145784933|NCT01070550|525720349|FG001|Overall Study|Other|0|||
145784934|NCT01070550|525720350|FG002|Overall Study|Other|0|||
145784935|NCT01070550|525720351|FG003|Overall Study|Other|1|||
145784936|NCT01070550|525720352|FG004|Overall Study|Other|0|||
145784937|NCT01070550|525720353|FG005|Overall Study|Other|0|||
145784938|NCT01070550|525720348|FG000|Overall Study|Withdrawal by Subject|35|||
145784939|NCT01070550|525720349|FG001|Overall Study|Withdrawal by Subject|0|||
145784940|NCT01070550|525720350|FG002|Overall Study|Withdrawal by Subject|3|||
145784941|NCT01070550|525720351|FG003|Overall Study|Withdrawal by Subject|0|||
145784942|NCT01070550|525720352|FG004|Overall Study|Withdrawal by Subject|0|||
145784943|NCT01070550|525720353|FG005|Overall Study|Withdrawal by Subject|0|||
145784944|NCT00109733|525720357|FG000|Overall Study|Protocol Violation|0|||
145784945|NCT00109733|525720358|FG001|Overall Study|Protocol Violation|1|||
145784946|NCT00109733|525720357|FG000|Overall Study|Stopped taking study drug|1|||
145784947|NCT00109733|525720358|FG001|Overall Study|Stopped taking study drug|1|||
145784948|NCT00109733|525720357|FG000|Overall Study|Non-compliant|0|||
145784949|NCT00109733|525720358|FG001|Overall Study|Non-compliant|1|||
145784950|NCT00109733|525720357|FG000|Overall Study|Could not commit time for study|1|||
145784951|NCT00109733|525720358|FG001|Overall Study|Could not commit time for study|1|||
145784952|NCT01702363|525720359|FG000|Overall Study|Adverse Event|14|||
145784953|NCT01702363|525720359|FG000|Overall Study|Lack of Efficacy|4|||
145784954|NCT01702363|525720359|FG000|Overall Study|Withdrawal by Subject|2|||
145784955|NCT02985450|525720367|FG000|Overall Study|Lost to Follow-up|7|||
145784956|NCT00002663|525720368|FG000|Overall Study|Death|4|||
145784957|NCT00002663|525720369|FG001|Overall Study|Death|1|||
145784958|NCT00002663|525720370|FG002|Overall Study|Death|1|||
145784959|NCT00002663|525720371|FG003|Overall Study|Death|0|||
145784960|NCT00002663|525720372|FG004|Overall Study|Death|0|||
145784961|NCT00002663|525720373|FG005|Overall Study|Death|13|||
145784962|NCT00002663|525720374|FG006|Overall Study|Death|0|||
145784963|NCT00002663|525720375|FG007|Overall Study|Death|1|||
145784964|NCT00002663|525720376|FG008|Overall Study|Death|1|||
145784965|NCT00002663|525720377|FG009|Overall Study|Death|1|||
145784966|NCT00002663|525720368|FG000|Overall Study|Lost to Follow-up|3|||
145784967|NCT00002663|525720369|FG001|Overall Study|Lost to Follow-up|0|||
145784968|NCT00002663|525720370|FG002|Overall Study|Lost to Follow-up|0|||
145784969|NCT00002663|525720371|FG003|Overall Study|Lost to Follow-up|1|||
145784970|NCT00002663|525720372|FG004|Overall Study|Lost to Follow-up|0|||
145784971|NCT00002663|525720373|FG005|Overall Study|Lost to Follow-up|1|||
145784972|NCT00002663|525720374|FG006|Overall Study|Lost to Follow-up|0|||
145280861|NCT03262233|523878969|FG002|Overall Study|Protocol Violation|2|||
145280862|NCT03262233|523878970|FG003|Overall Study|Protocol Violation|13|||
145280863|NCT03262233|523878967|FG000|Overall Study|data collection artifact|0|||
145784973|NCT00002663|525720375|FG007|Overall Study|Lost to Follow-up|0|||
145784974|NCT00002663|525720376|FG008|Overall Study|Lost to Follow-up|0|||
145784975|NCT00002663|525720377|FG009|Overall Study|Lost to Follow-up|0|||
145784976|NCT00002663|525720368|FG000|Overall Study|Other|0|||
145784977|NCT00002663|525720369|FG001|Overall Study|Other|1|||
145784978|NCT00002663|525720370|FG002|Overall Study|Other|0|||
145784979|NCT00002663|525720371|FG003|Overall Study|Other|0|||
145784980|NCT00002663|525720372|FG004|Overall Study|Other|0|||
145784981|NCT00002663|525720373|FG005|Overall Study|Other|1|||
145784982|NCT00002663|525720374|FG006|Overall Study|Other|1|||
145784983|NCT00002663|525720375|FG007|Overall Study|Other|0|||
145609576|NCT01290822|525086379|FG000|Overall Study|Physician Decision|10|||
145609577|NCT02541383|525086380|FG000|Overall Study|Death|50|||
145784984|NCT00002663|525720376|FG008|Overall Study|Other|0|||
145784985|NCT00002663|525720377|FG009|Overall Study|Other|0|||
145784986|NCT00002663|525720368|FG000|Overall Study|Physician Decision|0|||
145784987|NCT00002663|525720369|FG001|Overall Study|Physician Decision|0|||
145784988|NCT00002663|525720370|FG002|Overall Study|Physician Decision|0|||
145784989|NCT00002663|525720371|FG003|Overall Study|Physician Decision|0|||
145784990|NCT00002663|525720372|FG004|Overall Study|Physician Decision|1|||
145784991|NCT00002663|525720373|FG005|Overall Study|Physician Decision|0|||
145784992|NCT00002663|525720374|FG006|Overall Study|Physician Decision|0|||
145784993|NCT00002663|525720375|FG007|Overall Study|Physician Decision|0|||
145784994|NCT00002663|525720376|FG008|Overall Study|Physician Decision|1|||
145784995|NCT00002663|525720377|FG009|Overall Study|Physician Decision|1|||
145784996|NCT00002663|525720368|FG000|Overall Study|Adverse Event|0|||
145784997|NCT00002663|525720369|FG001|Overall Study|Adverse Event|0|||
145784998|NCT00002663|525720370|FG002|Overall Study|Adverse Event|0|||
145784999|NCT00002663|525720371|FG003|Overall Study|Adverse Event|1|||
145785000|NCT00002663|525720372|FG004|Overall Study|Adverse Event|0|||
145785001|NCT00002663|525720373|FG005|Overall Study|Adverse Event|0|||
145785002|NCT00002663|525720374|FG006|Overall Study|Adverse Event|0|||
145785003|NCT00002663|525720375|FG007|Overall Study|Adverse Event|1|||
145785004|NCT00002663|525720376|FG008|Overall Study|Adverse Event|0|||
145785005|NCT00002663|525720377|FG009|Overall Study|Adverse Event|0|||
145785006|NCT00069576|525720378|FG000|Original Trial|Lost to Follow-up|25|||
145785007|NCT00069576|525720379|FG001|Original Trial|Lost to Follow-up|33|||
145785008|NCT00069576|525720378|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
145785009|NCT00069576|525720379|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
145280864|NCT03262233|523878968|FG001|Overall Study|data collection artifact|1|||
145785010|NCT00905307|525720381|FG000|Overall Study|Switched to Open Label Rescue|7|||
145785011|NCT00905307|525720382|FG001|Overall Study|Switched to Open Label Rescue|17|||
145609578|NCT02541383|525086381|FG001|Overall Study|Death|37|||
145280865|NCT03262233|523878969|FG002|Overall Study|data collection artifact|0|||
145280866|NCT03262233|523878970|FG003|Overall Study|data collection artifact|0|||
145280867|NCT01120600|523878973|FG000|Overall Study|Adverse Event|7|||
145280868|NCT01120600|523878974|FG001|Overall Study|Adverse Event|7|||
145280869|NCT01120600|523878973|FG000|Overall Study|Excessive Bone Loss|0|||
145280870|NCT01120600|523878974|FG001|Overall Study|Excessive Bone Loss|4|||
145280871|NCT01120600|523878973|FG000|Overall Study|Lost to Follow-up|1|||
145280872|NCT01120600|523878974|FG001|Overall Study|Lost to Follow-up|3|||
145280873|NCT01120600|523878973|FG000|Overall Study|Physician Decision|1|||
145280874|NCT01120600|523878974|FG001|Overall Study|Physician Decision|3|||
145280875|NCT01120600|523878973|FG000|Overall Study|Protocol Violation|0|||
145280876|NCT01120600|523878974|FG001|Overall Study|Protocol Violation|4|||
145280877|NCT01120600|523878973|FG000|Overall Study|Withdrawal by Subject|10|||
145280878|NCT01120600|523878974|FG001|Overall Study|Withdrawal by Subject|11|||
145280879|NCT03990389|523878975|FG000|Overall Study|Lost to Follow-up|3|||
145280880|NCT03990389|523878976|FG001|Overall Study|Lost to Follow-up|0|||
145280881|NCT03770000|523878977|FG000|Overall Study|Premature discontinuation due to PD|0|||
145280882|NCT03770000|523878978|FG001|Overall Study|Premature discontinuation due to PD|0|||
145280883|NCT03770000|523878979|FG002|Overall Study|Premature discontinuation due to PD|1|||
145280884|NCT03770000|523878980|FG003|Overall Study|Premature discontinuation due to PD|3|||
145280885|NCT03770000|523878981|FG004|Overall Study|Premature discontinuation due to PD|2|||
145280886|NCT02595528|523878983|FG000|Overall Study|Withdrawal by Subject|1|||
145280887|NCT02595528|523878984|FG001|Overall Study|Withdrawal by Subject|2|||
145280888|NCT02595528|523878985|FG002|Overall Study|Withdrawal by Subject|1|||
145280889|NCT02595528|523878986|FG003|Overall Study|Withdrawal by Subject|3|||
145280890|NCT02595528|523878983|FG000|Overall Study|Lost to Follow-up|1|||
145280891|NCT02595528|523878984|FG001|Overall Study|Lost to Follow-up|1|||
145280892|NCT02595528|523878985|FG002|Overall Study|Lost to Follow-up|0|||
145280893|NCT02595528|523878986|FG003|Overall Study|Lost to Follow-up|1|||
145280894|NCT00833547|523878987|FG000|Overall Study|Withdrawal by Subject|2|||
145280895|NCT00833547|523878988|FG001|Overall Study|Withdrawal by Subject|2|||
145280896|NCT00566098|523878990|FG000|Collection of MILs|Withdrawal by Subject|1|||
145280897|NCT00566098|523878990|FG000|Collection of MILs|Relapsed|1|||
145280898|NCT00566098|523878990|FG000|Generation of MILs Product|Relapsed|1|||
145280899|NCT00566098|523878990|FG000|Administration of ASCT+MILs|Death|10|||
145280900|NCT00566098|523878990|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
145280901|NCT01690520|523878993|FG000|Overall Study|Death|25|||
145280902|NCT01690520|523878994|FG001|Overall Study|Death|21|||
145280903|NCT01690520|523878993|FG000|Overall Study|Lost to Follow-up|2|||
145280904|NCT01690520|523878994|FG001|Overall Study|Lost to Follow-up|3|||
145280905|NCT01690520|523878993|FG000|Overall Study|Withdrawal by Subject|2|||
145280906|NCT01690520|523878994|FG001|Overall Study|Withdrawal by Subject|0|||
145280907|NCT01690520|523878993|FG000|Overall Study|Relapse|0|||
145280908|NCT01690520|523878994|FG001|Overall Study|Relapse|1|||
145280909|NCT01690520|523878993|FG000|Overall Study|Other|0|||
145280910|NCT01690520|523878994|FG001|Overall Study|Other|1|||
145280911|NCT01690520|523878993|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
145280912|NCT01690520|523878994|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
145280913|NCT00275028|523878995|FG000|Overall Study|Withdrew consent before treatment began|1|||
145785012|NCT00905307|525720383|FG002|Overall Study|Switched to Open Label Rescue|11|||
145785013|NCT00905307|525720384|FG003|Overall Study|Switched to Open Label Rescue|11|||
145785014|NCT00905307|525720385|FG004|Overall Study|Switched to Open Label Rescue|4|||
145785015|NCT00905307|525720386|FG005|Overall Study|Switched to Open Label Rescue|15|||
145785016|NCT00905307|525720381|FG000|Overall Study|Lost to Follow-up|0|||
145785017|NCT00905307|525720382|FG001|Overall Study|Lost to Follow-up|0|||
145785018|NCT00905307|525720383|FG002|Overall Study|Lost to Follow-up|0|||
145785019|NCT00905307|525720384|FG003|Overall Study|Lost to Follow-up|0|||
145785020|NCT00905307|525720385|FG004|Overall Study|Lost to Follow-up|1|||
145785021|NCT00905307|525720386|FG005|Overall Study|Lost to Follow-up|1|||
145785022|NCT00905307|525720381|FG000|Overall Study|Adverse Event|3|||
145785023|NCT00905307|525720382|FG001|Overall Study|Adverse Event|4|||
145785024|NCT00905307|525720383|FG002|Overall Study|Adverse Event|5|||
145785025|NCT00905307|525720384|FG003|Overall Study|Adverse Event|11|||
145785026|NCT00905307|525720385|FG004|Overall Study|Adverse Event|3|||
145785027|NCT00905307|525720386|FG005|Overall Study|Adverse Event|5|||
145785028|NCT00905307|525720381|FG000|Overall Study|Withdrawal by Subject|5|||
145785029|NCT00905307|525720382|FG001|Overall Study|Withdrawal by Subject|13|||
145785030|NCT00905307|525720383|FG002|Overall Study|Withdrawal by Subject|15|||
145785031|NCT00905307|525720384|FG003|Overall Study|Withdrawal by Subject|11|||
145785032|NCT00905307|525720385|FG004|Overall Study|Withdrawal by Subject|4|||
145785033|NCT00905307|525720386|FG005|Overall Study|Withdrawal by Subject|13|||
145280914|NCT00275028|523878995|FG000|Overall Study|Withdrawal by Subject|5|||
145280915|NCT00275028|523878995|FG000|Overall Study|Adverse Event|9|||
145280916|NCT00275028|523878995|FG000|Overall Study|Progressive Disease|30|||
145280917|NCT00275028|523878995|FG000|Overall Study|Physician Decision|2|||
145280918|NCT01847313|523878998|FG000|Overall Study|Death|0|||
145280919|NCT01847313|523878999|FG001|Overall Study|Death|1|||
145785034|NCT00905307|525720381|FG000|Overall Study|Protocol Violation|1|||
145785035|NCT00905307|525720382|FG001|Overall Study|Protocol Violation|0|||
145785036|NCT00905307|525720383|FG002|Overall Study|Protocol Violation|1|||
145785037|NCT00905307|525720384|FG003|Overall Study|Protocol Violation|0|||
145785038|NCT00905307|525720385|FG004|Overall Study|Protocol Violation|0|||
145785039|NCT00905307|525720386|FG005|Overall Study|Protocol Violation|0|||
145785040|NCT00905307|525720381|FG000|Overall Study|Lack of Efficacy|6|||
145785041|NCT00905307|525720382|FG001|Overall Study|Lack of Efficacy|3|||
145785042|NCT00905307|525720383|FG002|Overall Study|Lack of Efficacy|5|||
145785043|NCT00905307|525720384|FG003|Overall Study|Lack of Efficacy|4|||
145785044|NCT00905307|525720385|FG004|Overall Study|Lack of Efficacy|4|||
145785045|NCT00905307|525720386|FG005|Overall Study|Lack of Efficacy|8|||
145785046|NCT03838367|525720387|FG000|Overall Study|Early termination of study|3|||
145785047|NCT03838367|525720388|FG001|Overall Study|Early termination of study|4|||
145785048|NCT03838367|525720389|FG002|Overall Study|Early termination of study|3|||
145785049|NCT03838367|525720390|FG003|Overall Study|Early termination of study|0|||
145785050|NCT03406104|525720391|FG000|Overall Study|Lost to Follow-up|2|||
145785051|NCT03406104|525720391|FG000|Overall Study|Withdrawal by Subject|2|||
145785052|NCT03406104|525720391|FG000|Overall Study|due to Covid patient did not want to travel|1|||
145785053|NCT03406104|525720391|FG000|Overall Study|Death|2|||
145785054|NCT00525148|525720394|FG000|Overall Study|Other Adverse Event|3|||
145785055|NCT00525148|525720395|FG001|Overall Study|Other Adverse Event|5|||
145785056|NCT00525148|525720396|FG002|Overall Study|Other Adverse Event|1|||
145785057|NCT00525148|525720397|FG003|Overall Study|Other Adverse Event|8|||
145785058|NCT00525148|525720394|FG000|Overall Study|Progressive disease|18|||
145785059|NCT00525148|525720395|FG001|Overall Study|Progressive disease|30|||
145785060|NCT00525148|525720396|FG002|Overall Study|Progressive disease|6|||
145785061|NCT00525148|525720397|FG003|Overall Study|Progressive disease|49|||
145785062|NCT00525148|525720394|FG000|Overall Study|Refused continuation of study medication|0|||
145785063|NCT00525148|525720395|FG001|Overall Study|Refused continuation of study medication|2|||
145785064|NCT00525148|525720396|FG002|Overall Study|Refused continuation of study medication|0|||
145785065|NCT00525148|525720397|FG003|Overall Study|Refused continuation of study medication|1|||
145785066|NCT00525148|525720394|FG000|Overall Study|Other than stated|2|||
145785067|NCT00525148|525720395|FG001|Overall Study|Other than stated|1|||
145785068|NCT00525148|525720396|FG002|Overall Study|Other than stated|0|||
145785069|NCT00525148|525720397|FG003|Overall Study|Other than stated|3|||
145785070|NCT03015610|525720398|FG000|Overall Study|Lost to Follow-up|1|||
145785071|NCT03015610|525720399|FG001|Overall Study|Lost to Follow-up|5|||
145785072|NCT01603641|525720400|FG000|Overall Study|Did not Receive Treatment|3|||
145785073|NCT01603641|525720400|FG000|Overall Study|Adverse Event|1|||
145785074|NCT01603641|525720400|FG000|Overall Study|Lack of Efficacy|1|||
145785075|NCT01603641|525720400|FG000|Overall Study|Lost to Follow-up|6|||
145785076|NCT01603641|525720400|FG000|Overall Study|Personal Reasons|18|||
145785077|NCT01603641|525720400|FG000|Overall Study|Other Miscellaneous Reasons|6|||
145785078|NCT05100199|525720407|FG000|Overall Study|Lost to Follow-up|5|||
145785079|NCT05100199|525720408|FG001|Overall Study|Lost to Follow-up|8|||
145785080|NCT05100199|525720409|FG002|Overall Study|Lost to Follow-up|3|||
145785081|NCT05100199|525720410|FG003|Overall Study|Lost to Follow-up|6|||
145785082|NCT05100199|525720407|FG000|Overall Study|Withdrawal by Subject|3|||
145785083|NCT05100199|525720408|FG001|Overall Study|Withdrawal by Subject|3|||
145785084|NCT05100199|525720409|FG002|Overall Study|Withdrawal by Subject|9|||
145785085|NCT05100199|525720410|FG003|Overall Study|Withdrawal by Subject|7|||
145785086|NCT05100199|525720407|FG000|Overall Study|Other|0|||
145785087|NCT05100199|525720408|FG001|Overall Study|Other|0|||
145785088|NCT05100199|525720409|FG002|Overall Study|Other|1|||
145785089|NCT05100199|525720410|FG003|Overall Study|Other|1|||
145785090|NCT01905397|525720411|FG000|Overall Study|Death|0|||
145785091|NCT01905397|525720412|FG001|Overall Study|Death|1|||
145785092|NCT01905397|525720411|FG000|Overall Study|Withdrawal by Subject|2|||
145785093|NCT01905397|525720412|FG001|Overall Study|Withdrawal by Subject|0|||
145403916|NCT02100631|524336437|FG002|Overall Study|Withdrawal by Subject|0|||
145403917|NCT02100631|524336435|FG000|Overall Study|Lost to Follow-up|3|||
145785094|NCT01905397|525720411|FG000|Overall Study|Surgery canceled/aborted|9|||
145785095|NCT01905397|525720412|FG001|Overall Study|Surgery canceled/aborted|5|||
145785096|NCT01905397|525720411|FG000|Overall Study|Incision < 7 cm|2|||
145785097|NCT01905397|525720412|FG001|Overall Study|Incision < 7 cm|0|||
145785098|NCT01905397|525720411|FG000|Overall Study|Wrong treatment|1|||
145785099|NCT01905397|525720412|FG001|Overall Study|Wrong treatment|1|||
145785100|NCT01905397|525720411|FG000|Overall Study|Device not applied|3|||
145403918|NCT02100631|524336436|FG001|Overall Study|Lost to Follow-up|4|||
145403919|NCT02100631|524336437|FG002|Overall Study|Lost to Follow-up|0|||
145403920|NCT02100631|524336435|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
145785101|NCT01905397|525720412|FG001|Overall Study|Device not applied|0|||
145403921|NCT02100631|524336436|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
145785102|NCT01905397|525720411|FG000|Overall Study|Dressing not applied in operating room|1|||
145785103|NCT01905397|525720412|FG001|Overall Study|Dressing not applied in operating room|0|||
145785104|NCT01905397|525720411|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
145785105|NCT01905397|525720412|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
145785106|NCT00443430|525720420|FG000|Overall Study|Lack of Efficacy|3|||
145785107|NCT00443430|525720421|FG001|Overall Study|Lack of Efficacy|3|||
145785108|NCT00443430|525720420|FG000|Overall Study|Adverse Event|1|||
145785109|NCT00443430|525720421|FG001|Overall Study|Adverse Event|1|||
145785110|NCT00592501|525720422|FG000|Overall Study|Withdrawal by Subject|1|||
145785111|NCT00592501|525720422|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
145785112|NCT00053846|525720423|FG000|Overall Study|Changed mind|8|||
145785113|NCT00053846|525720424|FG001|Overall Study|Changed mind|13|||
145785114|NCT00053846|525720423|FG000|Overall Study|Became too ill|8|||
145785115|NCT00053846|525720424|FG001|Overall Study|Became too ill|7|||
145785116|NCT00053846|525720423|FG000|Overall Study|Expired|5|||
145785117|NCT00053846|525720424|FG001|Overall Study|Expired|0|||
145280920|NCT01847313|523878998|FG000|Overall Study|Withdrawal by Subject|0|||
145538763|NCT00306189|524831689|FG002|Overall Study|Withdrawal by Subject|8|||
145538764|NCT00306189|524831690|FG003|Overall Study|Withdrawal by Subject|1|||
145538765|NCT00306189|524831687|FG000|Overall Study|Ineligibility determined|1|||
145538766|NCT00306189|524831688|FG001|Overall Study|Ineligibility determined|1|||
145785118|NCT00053846|525720423|FG000|Overall Study|Became ineligible|3|||
145785119|NCT00053846|525720424|FG001|Overall Study|Became ineligible|1|||
145785120|NCT00053846|525720423|FG000|Overall Study|Did not return data|1|||
145785121|NCT00053846|525720424|FG001|Overall Study|Did not return data|2|||
145785122|NCT00053846|525720423|FG000|Overall Study|Quit due to side effects|1|||
145785123|NCT00053846|525720424|FG001|Overall Study|Quit due to side effects|3|||
145785124|NCT00053846|525720423|FG000|Overall Study|Pills too large|0|||
145785125|NCT00053846|525720424|FG001|Overall Study|Pills too large|1|||
145785126|NCT00933335|525720426|FG000|Overall Study|Lost to Follow-up|1|||
145280921|NCT01847313|523878999|FG001|Overall Study|Withdrawal by Subject|1|||
145280922|NCT00598559|523879001|FG000|Overall Study|Adverse Event|11|||
145280923|NCT00598559|523879002|FG001|Overall Study|Adverse Event|7|||
145280924|NCT00598559|523879003|FG002|Overall Study|Adverse Event|0|||
145280925|NCT00598559|523879001|FG000|Overall Study|Withdrawal by Subject|2|||
145280926|NCT00598559|523879002|FG001|Overall Study|Withdrawal by Subject|2|||
145280927|NCT00598559|523879003|FG002|Overall Study|Withdrawal by Subject|0|||
145280928|NCT00598559|523879001|FG000|Overall Study|Protocol Non-compliance|1|||
145280929|NCT00598559|523879002|FG001|Overall Study|Protocol Non-compliance|0|||
145280930|NCT00598559|523879003|FG002|Overall Study|Protocol Non-compliance|0|||
145280931|NCT00598559|523879001|FG000|Overall Study|Early discharge from hospital|9|||
145280932|NCT00598559|523879002|FG001|Overall Study|Early discharge from hospital|12|||
145280933|NCT00598559|523879003|FG002|Overall Study|Early discharge from hospital|3|||
145785127|NCT00933335|525720427|FG001|Overall Study|Lost to Follow-up|3|||
145785128|NCT00933335|525720426|FG000|Overall Study|Withdrawal by Subject|0|||
145785129|NCT00933335|525720427|FG001|Overall Study|Withdrawal by Subject|1|||
145785130|NCT00933335|525720426|FG000|Overall Study|Progressive Disease|0|||
145785131|NCT00933335|525720427|FG001|Overall Study|Progressive Disease|11|||
145785132|NCT00933335|525720426|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
145785133|NCT00933335|525720427|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
145785134|NCT00933335|525720426|FG000|Overall Study|Co-morbid Illness|1|||
145785135|NCT00933335|525720427|FG001|Overall Study|Co-morbid Illness|0|||
145785136|NCT03880227|525720428|FG000|First Visit|Withdrawal by Subject|1|||
145785137|NCT03880227|525720429|FG001|First Visit|Withdrawal by Subject|0|||
145785138|NCT03880227|525720430|FG002|First Visit|Withdrawal by Subject|0|||
145785139|NCT03880227|525720431|FG003|First Visit|Withdrawal by Subject|0|||
145785140|NCT03880227|525720428|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
145785141|NCT03880227|525720429|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
145785142|NCT03880227|525720430|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
145785143|NCT03880227|525720431|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
145785144|NCT03880227|525720428|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
145785145|NCT03880227|525720429|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
145785146|NCT03880227|525720430|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
145785147|NCT03880227|525720431|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
145785148|NCT03880227|525720428|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
145785149|NCT03880227|525720429|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
145785150|NCT03880227|525720430|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
145785151|NCT03880227|525720431|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
145785152|NCT00504166|525720432|FG000|Overall Study|Adverse Event|1|||
145785153|NCT00504166|525720433|FG001|Overall Study|Adverse Event|4|||
145785154|NCT00504166|525720432|FG000|Overall Study|Withdrawal by Subject|3|||
145785155|NCT00504166|525720433|FG001|Overall Study|Withdrawal by Subject|6|||
145785156|NCT00504166|525720432|FG000|Overall Study|Physician Decision|1|||
145785157|NCT00504166|525720433|FG001|Overall Study|Physician Decision|1|||
145785158|NCT00504166|525720432|FG000|Overall Study|Lost to Follow-up|1|||
145785159|NCT00504166|525720433|FG001|Overall Study|Lost to Follow-up|3|||
145785160|NCT01096550|525720434|FG000|Overall Study|discontinued site|10|||
145785161|NCT01096550|525720435|FG001|Overall Study|discontinued site|11|||
145785162|NCT01096550|525720434|FG000|Overall Study|non-regular treatment track at clinic|1|||
145785163|NCT01096550|525720435|FG001|Overall Study|non-regular treatment track at clinic|1|||
145785164|NCT01096550|525720434|FG000|Overall Study|clinic readmission|1|||
145785165|NCT01096550|525720435|FG001|Overall Study|clinic readmission|1|||
145785166|NCT01096550|525720434|FG000|Overall Study|Withdrawal by Subject|0|||
145785167|NCT01096550|525720435|FG001|Overall Study|Withdrawal by Subject|1|||
145785168|NCT01096550|525720434|FG000|Overall Study|non-African American participant|13|||
145785169|NCT01096550|525720435|FG001|Overall Study|non-African American participant|6|||
145785170|NCT01096550|525720434|FG000|Overall Study|Lost to Follow-up|12|||
145785171|NCT01096550|525720435|FG001|Overall Study|Lost to Follow-up|9|||
145785172|NCT02650284|525720440|FG000|Overall Study|Lost to Follow-up|3|||
145785173|NCT02650284|525720441|FG001|Overall Study|Lost to Follow-up|3|||
145785174|NCT02650284|525720440|FG000|Overall Study|Consent incorrectly taken|0|||
145785175|NCT02650284|525720441|FG001|Overall Study|Consent incorrectly taken|1|||
145785176|NCT00783705|525720442|FG000|Overall Study|Adverse Event|2|||
145785177|NCT00783705|525720443|FG001|Overall Study|Adverse Event|0|||
145280934|NCT00598559|523879001|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
145280935|NCT00598559|523879002|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
145785178|NCT00783705|525720442|FG000|Overall Study|Withdrawal by Subject|3|||
145785179|NCT00783705|525720443|FG001|Overall Study|Withdrawal by Subject|2|||
145785180|NCT00783705|525720442|FG000|Overall Study|Lost to Follow-up|1|||
145785181|NCT00783705|525720443|FG001|Overall Study|Lost to Follow-up|3|||
145785182|NCT01770353|525720444|FG000|Overall Study|Progressive disease|2|||
145785183|NCT01770353|525720445|FG001|Overall Study|Progressive disease|1|||
145785184|NCT01770353|525720444|FG000|Overall Study|Adverse Event|0|||
145785185|NCT01770353|525720445|FG001|Overall Study|Adverse Event|1|||
145785186|NCT01770353|525720444|FG000|Overall Study|Protocol Violation|1|||
145785187|NCT01770353|525720445|FG001|Overall Study|Protocol Violation|0|||
145785188|NCT01770353|525720444|FG000|Overall Study|Physician Decision|0|||
145785189|NCT01770353|525720445|FG001|Overall Study|Physician Decision|3|||
145785190|NCT01770353|525720444|FG000|Overall Study|Clinical deterioration|3|||
145785191|NCT01770353|525720445|FG001|Overall Study|Clinical deterioration|6|||
145785192|NCT01770353|525720444|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
145785193|NCT01770353|525720445|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
145785194|NCT00376688|525720446|FG000|Overall Study|Adverse Event|3|||
145785195|NCT00376688|525720446|FG000|Overall Study|Death|1|||
145785196|NCT02574312|525720447|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
145785197|NCT02574312|525720448|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
145785198|NCT05128162|525720449|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
145785199|NCT05128162|525720449|FG000|Overall Study|Physician Decision|1|||
145785200|NCT04920084|525721764|FG000|Overall Study|Adverse Event|1|||
145785201|NCT04920084|525721764|FG000|Overall Study|Lost to Follow-up|2|||
145785202|NCT04920084|525721764|FG000|Overall Study|Withdrawal by Subject|2|||
145785203|NCT01755195|525721765|FG000|Overall Study|Participant noncompliance|2|||
145785204|NCT01755195|525721765|FG000|Overall Study|Switched to alternative treatment|4|||
145785205|NCT01755195|525721765|FG000|Overall Study|Withdrawal by Subject|1|||
145785206|NCT01755195|525721765|FG000|Overall Study|Participant refused to start treatment|1|||
145785207|NCT01755195|525721765|FG000|Overall Study|Participant has been consented for another trial|1|||
145785208|NCT01755195|525721765|FG000|Overall Study|Refused further treatment|3|||
145785209|NCT01755195|525721765|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
145785210|NCT00366548|525721766|FG000|Infant Series|Adverse Event|1|||
145785211|NCT00366548|525721767|FG001|Infant Series|Adverse Event|3|||
145785212|NCT00366548|525721766|FG000|Infant Series|Protocol Violation|0|||
145785213|NCT00366548|525721767|FG001|Infant Series|Protocol Violation|1|||
145785214|NCT00366548|525721766|FG000|Infant Series|Withdrawal by Subject|3|||
145785215|NCT00366548|525721767|FG001|Infant Series|Withdrawal by Subject|1|||
145785216|NCT00366548|525721766|FG000|After Infant Series|Withdrawal by Subject|3|||
145785217|NCT00366548|525721767|FG001|After Infant Series|Withdrawal by Subject|1|||
145785218|NCT00366548|525721766|FG000|After Infant Series|Adverse Event|2|||
145785219|NCT00366548|525721767|FG001|After Infant Series|Adverse Event|0|||
145785220|NCT00366548|525721766|FG000|After Infant Series|Lost to Follow-up|1|||
145785221|NCT00366548|525721767|FG001|After Infant Series|Lost to Follow-up|0|||
145785222|NCT03539458|525721768|FG000|Overall Study|Death|1|||
145785223|NCT00718419|525721769|FG000|Overall Study|Adverse Event|2|||
145785224|NCT00718419|525721770|FG001|Overall Study|Adverse Event|1|||
145785225|NCT00718419|525721769|FG000|Overall Study|Physician Decision|1|||
145785226|NCT00718419|525721770|FG001|Overall Study|Physician Decision|6|||
145785227|NCT00718419|525721769|FG000|Overall Study|Sponsor decision|0|||
145785228|NCT00718419|525721770|FG001|Overall Study|Sponsor decision|1|||
145785229|NCT00718419|525721769|FG000|Overall Study|Withdrawal by Subject|0|||
145785230|NCT00718419|525721770|FG001|Overall Study|Withdrawal by Subject|5|||
145785231|NCT00718419|525721769|FG000|Overall Study|Progressive Disease|7|||
145785232|NCT00718419|525721770|FG001|Overall Study|Progressive Disease|25|||
145785233|NCT00718419|525721769|FG000|Overall Study|Death Due to Progressive Disease|2|||
145785234|NCT00718419|525721770|FG001|Overall Study|Death Due to Progressive Disease|0|||
145785235|NCT00718419|525721769|FG000|Overall Study|Death Due to Study Drug Related|0|||
145785236|NCT00718419|525721770|FG001|Overall Study|Death Due to Study Drug Related|1|||
145785237|NCT00718419|525721769|FG000|Overall Study|Death Due to Adverse Events|1|||
145785238|NCT00718419|525721770|FG001|Overall Study|Death Due to Adverse Events|0|||
145785239|NCT00972478|525721778|FG000|Overall Study|Adverse Event|3|||
145785240|NCT00972478|525721779|FG001|Overall Study|Adverse Event|16|||
145785241|NCT00972478|525721778|FG000|Overall Study|Withdrawal by Subject|1|||
145785242|NCT00972478|525721779|FG001|Overall Study|Withdrawal by Subject|8|||
145785243|NCT00972478|525721778|FG000|Overall Study|Progression/Relapse|0|||
145785244|NCT00972478|525721779|FG001|Overall Study|Progression/Relapse|2|||
145785245|NCT00972478|525721778|FG000|Overall Study|Death|0|||
145785246|NCT00972478|525721779|FG001|Overall Study|Death|2|||
145785247|NCT00972478|525721778|FG000|Overall Study|Not protocol specified|1|||
145785248|NCT00972478|525721779|FG001|Overall Study|Not protocol specified|1|||
145785249|NCT00972478|525721778|FG000|Overall Study|Ineligible|1|||
145785250|NCT00972478|525721779|FG001|Overall Study|Ineligible|7|||
145785251|NCT00972478|525721778|FG000|Overall Study|Not start protocol treatment|1|||
145785252|NCT00972478|525721779|FG001|Overall Study|Not start protocol treatment|2|||
145785253|NCT02561000|525721780|FG000|Overall Study|Withdrawal by Subject|2|||
145609579|NCT02541383|525086382|FG002|Overall Study|Death|48|||
145280936|NCT00598559|523879003|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
145280937|NCT00936884|523879008|FG000|Double-blind|Withdrawal by Subject|6|||
145280938|NCT00936884|523879009|FG001|Double-blind|Withdrawal by Subject|4|||
145280939|NCT00936884|523879010|FG002|Double-blind|Withdrawal by Subject|0|||
145280940|NCT00936884|523879008|FG000|Double-blind|Death|2|||
145280941|NCT00936884|523879009|FG001|Double-blind|Death|1|||
145280942|NCT00936884|523879010|FG002|Double-blind|Death|0|||
145280943|NCT00936884|523879008|FG000|Double-blind|Lack of Efficacy|1|||
145280944|NCT00936884|523879009|FG001|Double-blind|Lack of Efficacy|1|||
145280945|NCT00936884|523879010|FG002|Double-blind|Lack of Efficacy|0|||
145785254|NCT02561000|525721781|FG001|Overall Study|Withdrawal by Subject|3|||
145785255|NCT02561000|525721782|FG002|Overall Study|Withdrawal by Subject|0|||
145785256|NCT02561000|525721780|FG000|Overall Study|Adverse Event|0|||
145785257|NCT02561000|525721781|FG001|Overall Study|Adverse Event|1|||
145785258|NCT02561000|525721782|FG002|Overall Study|Adverse Event|0|||
145785259|NCT03952468|525721783|FG000|Overall Study|Death|0|||
145785260|NCT03952468|525721784|FG001|Overall Study|Death|1|||
145785261|NCT03952468|525721783|FG000|Overall Study|Adverse Event|0|||
145785262|NCT03952468|525721784|FG001|Overall Study|Adverse Event|1|||
145785263|NCT03952468|525721783|FG000|Overall Study|Physician Decision|1|||
145785264|NCT03952468|525721784|FG001|Overall Study|Physician Decision|0|||
145785265|NCT03952468|525721783|FG000|Overall Study|Lost to Follow-up|3|||
145785266|NCT03952468|525721784|FG001|Overall Study|Lost to Follow-up|4|||
145785267|NCT03952468|525721783|FG000|Overall Study|Withdrawal by Subject|2|||
145785268|NCT03952468|525721784|FG001|Overall Study|Withdrawal by Subject|1|||
145785269|NCT01234402|525721785|FG000|Overall Study|Lost to Follow-up|0|||
145785270|NCT01234402|525721786|FG001|Overall Study|Lost to Follow-up|1|||
145785271|NCT01234402|525721787|FG002|Overall Study|Lost to Follow-up|3|||
145785272|NCT01234402|525721785|FG000|Overall Study|Withdrawal by Subject|1|||
145785273|NCT01234402|525721786|FG001|Overall Study|Withdrawal by Subject|3|||
145785274|NCT01234402|525721787|FG002|Overall Study|Withdrawal by Subject|4|||
145785275|NCT01234402|525721785|FG000|Overall Study|Never treated: Death|0|||
145785276|NCT01234402|525721786|FG001|Overall Study|Never treated: Death|0|||
145785277|NCT01234402|525721787|FG002|Overall Study|Never treated: Death|1|||
145785278|NCT01234402|525721785|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
145785279|NCT01234402|525721786|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
145785280|NCT01234402|525721787|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
145785281|NCT01234402|525721785|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
145785282|NCT01234402|525721786|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
145785283|NCT01234402|525721787|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
145785284|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
145785285|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
145785286|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145785287|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145785288|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145785289|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145785290|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145785291|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
145785292|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
145785293|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
145785294|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
145785295|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
145785296|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
145785297|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
145785298|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
145785299|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
145785300|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
145785301|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
145785302|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
145785303|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
145280946|NCT00936884|523879008|FG000|Double-blind|Adverse Event|1|||
145280947|NCT00936884|523879009|FG001|Double-blind|Adverse Event|0|||
145280948|NCT00936884|523879010|FG002|Double-blind|Adverse Event|0|||
145280949|NCT00936884|523879008|FG000|Double-blind|Physician Decision|1|||
145280950|NCT00936884|523879009|FG001|Double-blind|Physician Decision|0|||
145280951|NCT00936884|523879010|FG002|Double-blind|Physician Decision|0|||
145280952|NCT00936884|523879008|FG000|Double-blind|No post baseline diary entry|1|||
145280953|NCT00936884|523879009|FG001|Double-blind|No post baseline diary entry|0|||
145403922|NCT02100631|524336437|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
145785304|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
145785305|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Other|0|||
145785306|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Other|1|||
145785307|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Other|0|||
145280954|NCT00936884|523879010|FG002|Double-blind|No post baseline diary entry|0|||
145280955|NCT00936884|523879008|FG000|Double-blind|Did not receive study drug|0|||
145280956|NCT00936884|523879009|FG001|Double-blind|Did not receive study drug|1|||
145280957|NCT00936884|523879010|FG002|Double-blind|Did not receive study drug|0|||
145280958|NCT02280421|523879013|FG000|Washout (2 Weeks)|Adverse Event|0|||
145280959|NCT02280421|523879014|FG001|Washout (2 Weeks)|Adverse Event|1|||
145280960|NCT02280421|523879013|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
145280961|NCT02280421|523879014|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
145280962|NCT02764489|523879015|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
145280963|NCT02764489|523879016|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
145280964|NCT02764489|523879015|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
145280965|NCT02764489|523879016|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
145280966|NCT02764489|523879015|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
145280967|NCT02764489|523879016|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
145280968|NCT02764489|523879015|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
145280969|NCT02764489|523879016|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
145280970|NCT01625845|523879017|FG000|Overall Study|Adverse Event|1|||
145280971|NCT01625845|523879018|FG001|Overall Study|Adverse Event|2|||
145538767|NCT00306189|524831689|FG002|Overall Study|Ineligibility determined|1|||
145538768|NCT00306189|524831690|FG003|Overall Study|Ineligibility determined|1|||
145538769|NCT00306189|524831687|FG000|Overall Study|Other|1|||
145538770|NCT00306189|524831688|FG001|Overall Study|Other|0|||
145538771|NCT00306189|524831689|FG002|Overall Study|Other|0|||
145538772|NCT00306189|524831690|FG003|Overall Study|Other|0|||
145785308|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Other|0|||
145280972|NCT01625845|523879017|FG000|Overall Study|Lost to Follow-up|2|||
145280973|NCT01625845|523879018|FG001|Overall Study|Lost to Follow-up|1|||
145280974|NCT01625845|523879017|FG000|Overall Study|Withdrawal by Subject|2|||
145280975|NCT01625845|523879018|FG001|Overall Study|Withdrawal by Subject|0|||
145280976|NCT01294592|523879019|FG000|Overall Study|Adverse Event|28|||
145280977|NCT01294592|523879020|FG001|Overall Study|Adverse Event|13|||
145280978|NCT01294592|523879019|FG000|Overall Study|Lack of Efficacy|7|||
145280979|NCT01294592|523879020|FG001|Overall Study|Lack of Efficacy|5|||
145280980|NCT01294592|523879019|FG000|Overall Study|Protocol Violation|1|||
145280981|NCT01294592|523879020|FG001|Overall Study|Protocol Violation|7|||
145280982|NCT01294592|523879019|FG000|Overall Study|Lost to Follow-up|7|||
145280983|NCT01294592|523879020|FG001|Overall Study|Lost to Follow-up|9|||
145280984|NCT01294592|523879019|FG000|Overall Study|Physician Decision|6|||
145280985|NCT01294592|523879020|FG001|Overall Study|Physician Decision|11|||
145280986|NCT01294592|523879019|FG000|Overall Study|Withdrawal by Subject|28|||
145280987|NCT01294592|523879020|FG001|Overall Study|Withdrawal by Subject|28|||
145280988|NCT02853929|523879021|FG000|Overall Study|Lost to Follow-up|3|||
145280989|NCT02853929|523879022|FG001|Overall Study|Lost to Follow-up|0|||
145280990|NCT02853929|523879021|FG000|Overall Study|Withdrawal by Subject|1|||
145280991|NCT02853929|523879022|FG001|Overall Study|Withdrawal by Subject|0|||
145785309|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Other|0|||
145785310|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Other|0|||
145785311|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Other|0|||
145785312|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
145785313|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
145785314|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
145785315|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
145785316|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
145785317|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
145785318|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
145785319|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
145785320|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
145280992|NCT02853929|523879021|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
145280993|NCT02853929|523879022|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
145280994|NCT02762565|523879023|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
145280995|NCT03549130|523879024|FG000|Overall Study|Adverse Event|0|||
145280996|NCT03549130|523879025|FG001|Overall Study|Adverse Event|1|||
145280997|NCT03549130|523879024|FG000|Overall Study|Lost to Follow-up|0|||
145280998|NCT03549130|523879025|FG001|Overall Study|Lost to Follow-up|1|||
145280999|NCT01113710|523879026|FG000|Overall Study|Adverse Event|64|||
145281000|NCT01113710|523879026|FG000|Overall Study|Lack of Efficacy|41|||
145281001|NCT01113710|523879026|FG000|Overall Study|No Information Available|40|||
145281002|NCT01113710|523879026|FG000|Overall Study|Withdrawal by Subject|28|||
145281003|NCT01113710|523879026|FG000|Overall Study|Lost to Follow-up|20|||
145281004|NCT01113710|523879026|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
145281005|NCT01113710|523879026|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
145281006|NCT01113710|523879026|FG000|Overall Study|Lack of Patient's Compliance|8|||
145281007|NCT01113710|523879026|FG000|Overall Study|Other|7|||
145538773|NCT02059408|524831691|FG000|Overall Study|Did not get tested|0|||
145538774|NCT02059408|524831692|FG001|Overall Study|Did not get tested|330|||
145785321|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
145785322|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
145785323|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
145785324|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
145785325|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
145785326|NCT00365716|525721788|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
145785327|NCT00365716|525721789|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
145785328|NCT00365716|525721790|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
145785329|NCT00365716|525721791|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
145785330|NCT00365716|525721792|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
145785331|NCT00365716|525721793|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
145785332|NCT00365716|525721794|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
145785333|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
145785334|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
145785335|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
145785336|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
145785337|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
145785338|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
145785339|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
145785340|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
145785341|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
145785342|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
145785343|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
145785344|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
145281008|NCT01113710|523879026|FG000|Overall Study|Adverse Event/Other|5|||
145281009|NCT01113710|523879026|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
145281010|NCT01113710|523879026|FG000|Overall Study|Lack of Efficacy/Other|4|||
145281011|NCT01113710|523879026|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
145281012|NCT01113710|523879026|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
145281013|NCT01113710|523879026|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
145281014|NCT01113710|523879026|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
145281015|NCT01113710|523879026|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
145281016|NCT01113710|523879026|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
145281017|NCT01113710|523879026|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
145281018|NCT01113710|523879026|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
145281019|NCT01113710|523879026|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
145281020|NCT01113710|523879026|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
145538775|NCT02059408|524831693|FG002|Overall Study|Did not get tested|358|||
145538776|NCT02993757|524831694|FG000|Overall Study|Non compliance with the protocol|155|||
145538777|NCT02993757|524831695|FG001|Overall Study|Non compliance with the protocol|170|||
145538778|NCT02993757|524831694|FG000|Overall Study|Lost to Follow-up|1|||
145538779|NCT02993757|524831695|FG001|Overall Study|Lost to Follow-up|0|||
145538780|NCT02993757|524831694|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
145538781|NCT02993757|524831695|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
145538782|NCT00672646|524831698|FG000|Overall Study|Lost to Follow-up|0|||
145538783|NCT00672646|524831699|FG001|Overall Study|Lost to Follow-up|1|||
145538784|NCT00672646|524831700|FG002|Overall Study|Lost to Follow-up|2|||
145538785|NCT00672646|524831698|FG000|Overall Study|Withdrawal by Subject|0|||
145538786|NCT00672646|524831699|FG001|Overall Study|Withdrawal by Subject|0|||
145538787|NCT00672646|524831700|FG002|Overall Study|Withdrawal by Subject|1|||
145538788|NCT00289783|524831701|FG000|Primary Phase|Adverse Event|10|||
145538789|NCT00289783|524831702|FG001|Primary Phase|Adverse Event|1|||
145538790|NCT00289783|524831701|FG000|Primary Phase|Protocol Violation|27|||
145538791|NCT00289783|524831702|FG001|Primary Phase|Protocol Violation|6|||
145538792|NCT00289783|524831701|FG000|Primary Phase|Withdrawal by Subject|93|||
145538793|NCT00289783|524831702|FG001|Primary Phase|Withdrawal by Subject|40|||
145538794|NCT00289783|524831701|FG000|Primary Phase|Lost to Follow-up|60|||
145281021|NCT01113710|523879026|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
145281022|NCT01113710|523879026|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
145538795|NCT00289783|524831702|FG001|Primary Phase|Lost to Follow-up|14|||
145538796|NCT00289783|524831701|FG000|Primary Phase|Migration from the study area|26|||
145538797|NCT00289783|524831702|FG001|Primary Phase|Migration from the study area|10|||
145785345|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
145785346|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
145281023|NCT01113710|523879026|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
145538798|NCT00289783|524831701|FG000|Primary Phase|Other|32|||
145538799|NCT00289783|524831702|FG001|Primary Phase|Other|12|||
145538800|NCT00289783|524831701|FG000|Fourth Dose Phase|Adverse Event|1|||
145538801|NCT00289783|524831702|FG001|Fourth Dose Phase|Adverse Event|0|||
145538802|NCT00289783|524831701|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
145538803|NCT00289783|524831702|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
145281024|NCT01078623|523879028|FG000|Treatment Period 1|Adverse Event|1|||
145538804|NCT00289783|524831701|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
145538805|NCT00289783|524831702|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
145538806|NCT00289783|524831701|FG000|Fourth Dose Phase|Migration from the study area|1|||
145538807|NCT00289783|524831702|FG001|Fourth Dose Phase|Migration from the study area|1|||
145538808|NCT00289783|524831701|FG000|Fourth Dose Phase|Other|22|||
145538809|NCT00289783|524831702|FG001|Fourth Dose Phase|Other|10|||
145538810|NCT00443261|524832862|FG000|Overall Study|Death|1|||
145785347|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
145281025|NCT01078623|523879029|FG001|Treatment Period 1|Adverse Event|1|||
145281026|NCT01078623|523879030|FG002|Treatment Period 1|Adverse Event|1|||
145281027|NCT01078623|523879031|FG003|Treatment Period 1|Adverse Event|0|||
145281028|NCT01078623|523879032|FG004|Treatment Period 1|Adverse Event|0|||
145281029|NCT01078623|523879033|FG005|Treatment Period 1|Adverse Event|0|||
145281030|NCT01078623|523879034|FG006|Treatment Period 1|Adverse Event|1|||
145281031|NCT01078623|523879035|FG007|Treatment Period 1|Adverse Event|0|||
145281032|NCT01078623|523879036|FG008|Treatment Period 1|Adverse Event|1|||
145281033|NCT01078623|523879037|FG009|Treatment Period 1|Adverse Event|1|||
145281034|NCT01078623|523879038|FG010|Treatment Period 1|Adverse Event|0|||
145281035|NCT01078623|523879039|FG011|Treatment Period 1|Adverse Event|0|||
145281036|NCT01078623|523879040|FG012|Treatment Period 1|Adverse Event|0|||
145281037|NCT01078623|523879041|FG013|Treatment Period 1|Adverse Event|0|||
145281038|NCT01078623|523879042|FG014|Treatment Period 1|Adverse Event|0|||
145281039|NCT01078623|523879043|FG015|Treatment Period 1|Adverse Event|0|||
145281040|NCT01078623|523879044|FG016|Treatment Period 1|Adverse Event|0|||
145281041|NCT01078623|523879045|FG017|Treatment Period 1|Adverse Event|0|||
145281042|NCT01078623|523879046|FG018|Treatment Period 1|Adverse Event|0|||
145281043|NCT01078623|523879047|FG019|Treatment Period 1|Adverse Event|0|||
145281044|NCT01078623|523879028|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145281045|NCT01078623|523879029|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145281046|NCT01078623|523879030|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145281047|NCT01078623|523879031|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145281048|NCT01078623|523879032|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145281049|NCT01078623|523879033|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145281050|NCT01078623|523879034|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145281051|NCT01078623|523879035|FG007|Treatment Period 1|Withdrawal by Subject|1|||
145281052|NCT01078623|523879036|FG008|Treatment Period 1|Withdrawal by Subject|0|||
145281053|NCT01078623|523879037|FG009|Treatment Period 1|Withdrawal by Subject|0|||
145281054|NCT01078623|523879038|FG010|Treatment Period 1|Withdrawal by Subject|1|||
145281055|NCT01078623|523879039|FG011|Treatment Period 1|Withdrawal by Subject|0|||
145281056|NCT01078623|523879040|FG012|Treatment Period 1|Withdrawal by Subject|0|||
145281057|NCT01078623|523879041|FG013|Treatment Period 1|Withdrawal by Subject|0|||
145281058|NCT01078623|523879042|FG014|Treatment Period 1|Withdrawal by Subject|0|||
145281059|NCT01078623|523879043|FG015|Treatment Period 1|Withdrawal by Subject|0|||
145281060|NCT01078623|523879044|FG016|Treatment Period 1|Withdrawal by Subject|0|||
145281061|NCT01078623|523879045|FG017|Treatment Period 1|Withdrawal by Subject|0|||
145281062|NCT01078623|523879046|FG018|Treatment Period 1|Withdrawal by Subject|0|||
145281063|NCT01078623|523879047|FG019|Treatment Period 1|Withdrawal by Subject|0|||
145281064|NCT01078623|523879028|FG000|Treatment Period 1|Protocol Violation|0|||
145281065|NCT01078623|523879029|FG001|Treatment Period 1|Protocol Violation|0|||
145281066|NCT01078623|523879030|FG002|Treatment Period 1|Protocol Violation|0|||
145281067|NCT01078623|523879031|FG003|Treatment Period 1|Protocol Violation|0|||
145281068|NCT01078623|523879032|FG004|Treatment Period 1|Protocol Violation|0|||
145281069|NCT01078623|523879033|FG005|Treatment Period 1|Protocol Violation|1|||
145281070|NCT01078623|523879034|FG006|Treatment Period 1|Protocol Violation|0|||
145281071|NCT01078623|523879035|FG007|Treatment Period 1|Protocol Violation|0|||
145281072|NCT01078623|523879036|FG008|Treatment Period 1|Protocol Violation|0|||
145785348|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
145785349|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
145785350|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
145785351|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
145785352|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
145281073|NCT01078623|523879037|FG009|Treatment Period 1|Protocol Violation|0|||
145281074|NCT01078623|523879038|FG010|Treatment Period 1|Protocol Violation|0|||
145281075|NCT01078623|523879039|FG011|Treatment Period 1|Protocol Violation|0|||
145281076|NCT01078623|523879040|FG012|Treatment Period 1|Protocol Violation|0|||
145281077|NCT01078623|523879041|FG013|Treatment Period 1|Protocol Violation|0|||
145281078|NCT01078623|523879042|FG014|Treatment Period 1|Protocol Violation|0|||
145281079|NCT01078623|523879043|FG015|Treatment Period 1|Protocol Violation|0|||
145281080|NCT01078623|523879044|FG016|Treatment Period 1|Protocol Violation|0|||
145281081|NCT01078623|523879045|FG017|Treatment Period 1|Protocol Violation|0|||
145281082|NCT01078623|523879046|FG018|Treatment Period 1|Protocol Violation|0|||
145281083|NCT01078623|523879047|FG019|Treatment Period 1|Protocol Violation|0|||
145281084|NCT01078623|523879028|FG000|Treatment Period 2|Adverse Event|0|||
145538811|NCT01663532|524832863|FG000|Overall Study|Lost to Follow-up|9|||
145538812|NCT01663532|524832864|FG001|Overall Study|Lost to Follow-up|10|||
145785353|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
145281085|NCT01078623|523879029|FG001|Treatment Period 2|Adverse Event|0|||
145281086|NCT01078623|523879030|FG002|Treatment Period 2|Adverse Event|0|||
145281087|NCT01078623|523879031|FG003|Treatment Period 2|Adverse Event|0|||
145281088|NCT01078623|523879032|FG004|Treatment Period 2|Adverse Event|0|||
145281089|NCT01078623|523879033|FG005|Treatment Period 2|Adverse Event|0|||
145281090|NCT01078623|523879034|FG006|Treatment Period 2|Adverse Event|1|||
145281091|NCT01078623|523879035|FG007|Treatment Period 2|Adverse Event|0|||
145281092|NCT01078623|523879036|FG008|Treatment Period 2|Adverse Event|0|||
145281093|NCT01078623|523879037|FG009|Treatment Period 2|Adverse Event|0|||
145281094|NCT01078623|523879038|FG010|Treatment Period 2|Adverse Event|0|||
145281095|NCT01078623|523879039|FG011|Treatment Period 2|Adverse Event|0|||
145538813|NCT01663532|524832863|FG000|Overall Study|Adverse Event|7|||
145538814|NCT01663532|524832864|FG001|Overall Study|Adverse Event|13|||
145538815|NCT01663532|524832863|FG000|Overall Study|Met Withdrawal Criteria|7|||
145538816|NCT01663532|524832864|FG001|Overall Study|Met Withdrawal Criteria|6|||
145538817|NCT01663532|524832863|FG000|Overall Study|Physician Decision|1|||
145538818|NCT01663532|524832864|FG001|Overall Study|Physician Decision|1|||
145538819|NCT01663532|524832863|FG000|Overall Study|Withdrawal by Subject|35|||
145538820|NCT01663532|524832864|FG001|Overall Study|Withdrawal by Subject|17|||
145281096|NCT01078623|523879040|FG012|Treatment Period 2|Adverse Event|0|||
145281097|NCT01078623|523879041|FG013|Treatment Period 2|Adverse Event|0|||
145281098|NCT01078623|523879042|FG014|Treatment Period 2|Adverse Event|0|||
145281099|NCT01078623|523879043|FG015|Treatment Period 2|Adverse Event|0|||
145538821|NCT01663532|524832863|FG000|Overall Study|Lack of Efficacy|15|||
145538822|NCT01663532|524832864|FG001|Overall Study|Lack of Efficacy|60|||
145538823|NCT03539081|524832866|FG000|Overall Study|Withdrawal by Subject|2|||
145538824|NCT03539081|524832867|FG001|Overall Study|Withdrawal by Subject|3|||
145785354|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
145281100|NCT01078623|523879044|FG016|Treatment Period 2|Adverse Event|0|||
145281101|NCT01078623|523879045|FG017|Treatment Period 2|Adverse Event|0|||
145281102|NCT01078623|523879046|FG018|Treatment Period 2|Adverse Event|1|||
145281103|NCT01078623|523879047|FG019|Treatment Period 2|Adverse Event|0|||
145281104|NCT01078623|523879028|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145281105|NCT01078623|523879029|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145403923|NCT03944616|524336438|FG000|Overall Study|Lost to Follow-up|0|||
145403924|NCT03944616|524336439|FG001|Overall Study|Lost to Follow-up|2|||
145785355|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
145785356|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
145403925|NCT01287936|524336440|FG000|Overall Study|Lost to Follow-up|0|||
145403926|NCT01287936|524336441|FG001|Overall Study|Lost to Follow-up|1|||
145785357|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
145785358|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
145785359|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
145785360|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
145785361|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
145785362|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
145785363|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
145785364|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
145785365|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
145785366|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
145785367|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
145785368|NCT00365716|525721788|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
145785369|NCT00365716|525721789|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
145785370|NCT00365716|525721790|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
145785371|NCT00365716|525721791|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
145785372|NCT00365716|525721792|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
145785373|NCT00365716|525721793|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
145785374|NCT00365716|525721794|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
145785375|NCT00365716|525721788|FG000|Extension 1|Lost to Follow-up|0|||
145785376|NCT00365716|525721789|FG001|Extension 1|Lost to Follow-up|0|||
145785377|NCT00365716|525721790|FG002|Extension 1|Lost to Follow-up|0|||
145785378|NCT00365716|525721791|FG003|Extension 1|Lost to Follow-up|0|||
145281106|NCT01078623|523879030|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145281107|NCT01078623|523879031|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145281108|NCT01078623|523879032|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145281109|NCT01078623|523879033|FG005|Treatment Period 2|Withdrawal by Subject|1|||
145281110|NCT01078623|523879034|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145281111|NCT01078623|523879035|FG007|Treatment Period 2|Withdrawal by Subject|0|||
145281112|NCT01078623|523879036|FG008|Treatment Period 2|Withdrawal by Subject|0|||
145281113|NCT01078623|523879037|FG009|Treatment Period 2|Withdrawal by Subject|0|||
145403927|NCT01287936|524336442|FG002|Overall Study|Lost to Follow-up|1|||
145403928|NCT01721798|524336443|FG000|Overall Study|Death|0|||
145538825|NCT03539081|524832868|FG002|Overall Study|Withdrawal by Subject|0|||
145609580|NCT02541383|525086383|FG003|Overall Study|Death|41|||
145281114|NCT01078623|523879038|FG010|Treatment Period 2|Withdrawal by Subject|0|||
145281115|NCT01078623|523879039|FG011|Treatment Period 2|Withdrawal by Subject|0|||
145281116|NCT01078623|523879040|FG012|Treatment Period 2|Withdrawal by Subject|0|||
145281117|NCT01078623|523879041|FG013|Treatment Period 2|Withdrawal by Subject|0|||
145281118|NCT01078623|523879042|FG014|Treatment Period 2|Withdrawal by Subject|0|||
145281119|NCT01078623|523879043|FG015|Treatment Period 2|Withdrawal by Subject|0|||
145281120|NCT01078623|523879044|FG016|Treatment Period 2|Withdrawal by Subject|0|||
145281121|NCT01078623|523879045|FG017|Treatment Period 2|Withdrawal by Subject|0|||
145281122|NCT01078623|523879046|FG018|Treatment Period 2|Withdrawal by Subject|0|||
145281123|NCT01078623|523879047|FG019|Treatment Period 2|Withdrawal by Subject|0|||
145281124|NCT01078623|523879028|FG000|Treatment Period 3|Adverse Event|0|||
145281125|NCT01078623|523879029|FG001|Treatment Period 3|Adverse Event|0|||
145281126|NCT01078623|523879030|FG002|Treatment Period 3|Adverse Event|0|||
145281127|NCT01078623|523879031|FG003|Treatment Period 3|Adverse Event|0|||
145281128|NCT01078623|523879032|FG004|Treatment Period 3|Adverse Event|1|||
145281129|NCT01078623|523879033|FG005|Treatment Period 3|Adverse Event|0|||
145281130|NCT01078623|523879034|FG006|Treatment Period 3|Adverse Event|0|||
145281131|NCT01078623|523879035|FG007|Treatment Period 3|Adverse Event|0|||
145281132|NCT01078623|523879036|FG008|Treatment Period 3|Adverse Event|0|||
145281133|NCT01078623|523879037|FG009|Treatment Period 3|Adverse Event|0|||
145281134|NCT01078623|523879038|FG010|Treatment Period 3|Adverse Event|0|||
145281135|NCT01078623|523879039|FG011|Treatment Period 3|Adverse Event|0|||
145281136|NCT01078623|523879040|FG012|Treatment Period 3|Adverse Event|0|||
145281137|NCT01078623|523879041|FG013|Treatment Period 3|Adverse Event|1|||
145785379|NCT00365716|525721792|FG004|Extension 1|Lost to Follow-up|0|||
145785380|NCT00365716|525721793|FG005|Extension 1|Lost to Follow-up|1|||
145785381|NCT00365716|525721794|FG006|Extension 1|Lost to Follow-up|0|||
145281138|NCT01078623|523879042|FG014|Treatment Period 3|Adverse Event|0|||
145281139|NCT01078623|523879043|FG015|Treatment Period 3|Adverse Event|0|||
145281140|NCT01078623|523879044|FG016|Treatment Period 3|Adverse Event|0|||
145281141|NCT01078623|523879045|FG017|Treatment Period 3|Adverse Event|0|||
145281142|NCT01078623|523879046|FG018|Treatment Period 3|Adverse Event|0|||
145281143|NCT01078623|523879047|FG019|Treatment Period 3|Adverse Event|0|||
145785382|NCT00365716|525721788|FG000|Extension 1|Other|0|||
145785383|NCT00365716|525721789|FG001|Extension 1|Other|0|||
145785384|NCT00365716|525721790|FG002|Extension 1|Other|0|||
145281144|NCT01078623|523879028|FG000|Treatment Period 4|Adverse Event|0|||
145281145|NCT01078623|523879029|FG001|Treatment Period 4|Adverse Event|0|||
145281146|NCT01078623|523879030|FG002|Treatment Period 4|Adverse Event|1|||
145281147|NCT01078623|523879031|FG003|Treatment Period 4|Adverse Event|0|||
145281148|NCT01078623|523879032|FG004|Treatment Period 4|Adverse Event|0|||
145281149|NCT01078623|523879033|FG005|Treatment Period 4|Adverse Event|0|||
145281150|NCT01078623|523879034|FG006|Treatment Period 4|Adverse Event|0|||
145281151|NCT01078623|523879035|FG007|Treatment Period 4|Adverse Event|0|||
145281152|NCT01078623|523879036|FG008|Treatment Period 4|Adverse Event|0|||
145281153|NCT01078623|523879037|FG009|Treatment Period 4|Adverse Event|0|||
145281154|NCT01078623|523879038|FG010|Treatment Period 4|Adverse Event|0|||
145281155|NCT01078623|523879039|FG011|Treatment Period 4|Adverse Event|0|||
145281156|NCT01078623|523879040|FG012|Treatment Period 4|Adverse Event|0|||
145281157|NCT01078623|523879041|FG013|Treatment Period 4|Adverse Event|0|||
145281158|NCT01078623|523879042|FG014|Treatment Period 4|Adverse Event|0|||
145281159|NCT01078623|523879043|FG015|Treatment Period 4|Adverse Event|0|||
145281160|NCT01078623|523879044|FG016|Treatment Period 4|Adverse Event|0|||
145281161|NCT01078623|523879045|FG017|Treatment Period 4|Adverse Event|0|||
145281162|NCT01078623|523879046|FG018|Treatment Period 4|Adverse Event|0|||
145281163|NCT01078623|523879047|FG019|Treatment Period 4|Adverse Event|0|||
145281164|NCT01078623|523879028|FG000|Treatment Period 4|Withdrawal by Subject|0|||
145785385|NCT00365716|525721791|FG003|Extension 1|Other|0|||
145785386|NCT00365716|525721792|FG004|Extension 1|Other|0|||
145785387|NCT00365716|525721793|FG005|Extension 1|Other|9|||
145785388|NCT00365716|525721794|FG006|Extension 1|Other|0|||
145785389|NCT00365716|525721788|FG000|Extension 1|Moved|0|||
145785390|NCT00365716|525721789|FG001|Extension 1|Moved|0|||
145785391|NCT00365716|525721790|FG002|Extension 1|Moved|0|||
145403929|NCT01721798|524336444|FG001|Overall Study|Death|0|||
145281165|NCT01078623|523879029|FG001|Treatment Period 4|Withdrawal by Subject|0|||
145281166|NCT01078623|523879030|FG002|Treatment Period 4|Withdrawal by Subject|0|||
145281167|NCT01078623|523879031|FG003|Treatment Period 4|Withdrawal by Subject|0|||
145281168|NCT01078623|523879032|FG004|Treatment Period 4|Withdrawal by Subject|0|||
145281169|NCT01078623|523879033|FG005|Treatment Period 4|Withdrawal by Subject|0|||
145785392|NCT00365716|525721791|FG003|Extension 1|Moved|0|||
145281170|NCT01078623|523879034|FG006|Treatment Period 4|Withdrawal by Subject|0|||
145281171|NCT01078623|523879035|FG007|Treatment Period 4|Withdrawal by Subject|0|||
145403930|NCT01721798|524336445|FG002|Overall Study|Death|1|||
145281172|NCT01078623|523879036|FG008|Treatment Period 4|Withdrawal by Subject|0|||
145281173|NCT01078623|523879037|FG009|Treatment Period 4|Withdrawal by Subject|0|||
145785393|NCT00365716|525721792|FG004|Extension 1|Moved|0|||
145785394|NCT00365716|525721793|FG005|Extension 1|Moved|4|||
145785395|NCT00365716|525721794|FG006|Extension 1|Moved|0|||
145785396|NCT00365716|525721788|FG000|Extension 1|Withdrawal by Subject|0|||
145785397|NCT00365716|525721789|FG001|Extension 1|Withdrawal by Subject|0|||
145785398|NCT00365716|525721790|FG002|Extension 1|Withdrawal by Subject|0|||
145403931|NCT01721798|524336446|FG003|Overall Study|Death|1|||
145785399|NCT00365716|525721791|FG003|Extension 1|Withdrawal by Subject|0|||
145785400|NCT00365716|525721792|FG004|Extension 1|Withdrawal by Subject|0|||
145785401|NCT00365716|525721793|FG005|Extension 1|Withdrawal by Subject|3|||
145785402|NCT00365716|525721794|FG006|Extension 1|Withdrawal by Subject|0|||
145785403|NCT00365716|525721788|FG000|Extension 1|Pregnancy|0|||
145785404|NCT00365716|525721789|FG001|Extension 1|Pregnancy|0|||
145785405|NCT00365716|525721790|FG002|Extension 1|Pregnancy|0|||
145785406|NCT00365716|525721791|FG003|Extension 1|Pregnancy|0|||
145785407|NCT00365716|525721792|FG004|Extension 1|Pregnancy|0|||
145785408|NCT00365716|525721793|FG005|Extension 1|Pregnancy|4|||
145785409|NCT00365716|525721794|FG006|Extension 1|Pregnancy|0|||
145785410|NCT00365716|525721788|FG000|Extension 1|Protocol Violation|0|||
145785411|NCT00365716|525721789|FG001|Extension 1|Protocol Violation|0|||
145785412|NCT00365716|525721790|FG002|Extension 1|Protocol Violation|0|||
145785413|NCT00365716|525721791|FG003|Extension 1|Protocol Violation|0|||
145785414|NCT00365716|525721792|FG004|Extension 1|Protocol Violation|0|||
145785415|NCT00365716|525721793|FG005|Extension 1|Protocol Violation|1|||
145785416|NCT00365716|525721794|FG006|Extension 1|Protocol Violation|0|||
145785417|NCT00365716|525721788|FG000|Extension 2|Lost to Follow-up|0|||
145785418|NCT00365716|525721789|FG001|Extension 2|Lost to Follow-up|0|||
145785419|NCT00365716|525721790|FG002|Extension 2|Lost to Follow-up|0|||
145785420|NCT00365716|525721791|FG003|Extension 2|Lost to Follow-up|0|||
145785421|NCT00365716|525721792|FG004|Extension 2|Lost to Follow-up|0|||
145785422|NCT00365716|525721793|FG005|Extension 2|Lost to Follow-up|0|||
145785423|NCT00365716|525721794|FG006|Extension 2|Lost to Follow-up|2|||
145785424|NCT00365716|525721788|FG000|Extension 2|Other|0|||
145785425|NCT00365716|525721789|FG001|Extension 2|Other|0|||
145785426|NCT00365716|525721790|FG002|Extension 2|Other|0|||
145785427|NCT00365716|525721791|FG003|Extension 2|Other|0|||
145785428|NCT00365716|525721792|FG004|Extension 2|Other|0|||
145785429|NCT00365716|525721793|FG005|Extension 2|Other|0|||
145785430|NCT00365716|525721794|FG006|Extension 2|Other|3|||
145785431|NCT00365716|525721788|FG000|Extension 2|Withdrawal by Subject|0|||
145785432|NCT00365716|525721789|FG001|Extension 2|Withdrawal by Subject|0|||
145785433|NCT00365716|525721790|FG002|Extension 2|Withdrawal by Subject|0|||
145785434|NCT00365716|525721791|FG003|Extension 2|Withdrawal by Subject|0|||
145785435|NCT00365716|525721792|FG004|Extension 2|Withdrawal by Subject|0|||
145785436|NCT00365716|525721793|FG005|Extension 2|Withdrawal by Subject|0|||
145785437|NCT00365716|525721794|FG006|Extension 2|Withdrawal by Subject|5|||
145785438|NCT02280291|525721795|FG000|Overall Study|Lost to Follow-up|2|||
145785439|NCT02280291|525721796|FG001|Overall Study|Lost to Follow-up|1|||
145785440|NCT02280291|525721797|FG002|Overall Study|Lost to Follow-up|3|||
145785441|NCT02280291|525721798|FG003|Overall Study|Lost to Follow-up|8|||
145785442|NCT02280291|525721795|FG000|Overall Study|Protocol Violation|1|||
145785443|NCT02280291|525721796|FG001|Overall Study|Protocol Violation|0|||
145785444|NCT02280291|525721797|FG002|Overall Study|Protocol Violation|0|||
145785445|NCT02280291|525721798|FG003|Overall Study|Protocol Violation|0|||
145785446|NCT02280291|525721795|FG000|Overall Study|Other|1|||
145785447|NCT02280291|525721796|FG001|Overall Study|Other|1|||
145785448|NCT02280291|525721797|FG002|Overall Study|Other|0|||
145785449|NCT02280291|525721798|FG003|Overall Study|Other|0|||
145785450|NCT00316303|525721800|FG000|Overall Study|Lost to Follow-up|11|||
145785451|NCT00316303|525721801|FG001|Overall Study|Lost to Follow-up|16|||
145785452|NCT01106534|525721806|FG000|Overall Study|Withdrawal by Subject|18|||
145785453|NCT01106534|525721806|FG000|Overall Study|Lost to Follow-up|2|||
145785454|NCT01106534|525721806|FG000|Overall Study|Death|16|||
145785455|NCT01106534|525721806|FG000|Overall Study|Physician Decision|1|||
145785456|NCT05590793|525721809|FG000|Overall Study|Withdrawal by Subject|6|||
145785457|NCT05590793|525721809|FG000|Overall Study|Physician Decision|1|||
145785458|NCT04060667|525721810|FG000|Overall Study|Lost to Follow-up|75|||
145785459|NCT04060667|525721811|FG001|Overall Study|Lost to Follow-up|10|||
145403932|NCT01721798|524336443|FG000|Overall Study|Lost to Follow-up|2|||
145785460|NCT04488822|525721812|FG000|Overall Study|Adverse Event|8|||
145785461|NCT04488822|525721812|FG000|Overall Study|Withdrawal by Subject|1|||
145785462|NCT00114972|525721818|FG000|Overall Study|Withdrawal by Subject|40|||
145785463|NCT00114972|525721819|FG001|Overall Study|Withdrawal by Subject|7|||
145785464|NCT00114972|525721818|FG000|Overall Study|Lost to Follow-up|8|||
145785465|NCT00114972|525721819|FG001|Overall Study|Lost to Follow-up|5|||
145785466|NCT02890329|525721820|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
145785467|NCT02890329|525721821|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
145785468|NCT02890329|525721822|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
145785469|NCT02890329|525721823|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
145785470|NCT02890329|525721824|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
145785471|NCT02890329|525721825|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
145785472|NCT02890329|525721820|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
145785473|NCT02890329|525721821|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
145785474|NCT02890329|525721822|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
145281174|NCT01078623|523879038|FG010|Treatment Period 4|Withdrawal by Subject|0|||
145281175|NCT01078623|523879039|FG011|Treatment Period 4|Withdrawal by Subject|0|||
145281176|NCT01078623|523879040|FG012|Treatment Period 4|Withdrawal by Subject|0|||
145281177|NCT01078623|523879041|FG013|Treatment Period 4|Withdrawal by Subject|0|||
145281178|NCT01078623|523879042|FG014|Treatment Period 4|Withdrawal by Subject|0|||
145281179|NCT01078623|523879043|FG015|Treatment Period 4|Withdrawal by Subject|1|||
145281180|NCT01078623|523879044|FG016|Treatment Period 4|Withdrawal by Subject|0|||
145281181|NCT01078623|523879045|FG017|Treatment Period 4|Withdrawal by Subject|0|||
145281182|NCT01078623|523879046|FG018|Treatment Period 4|Withdrawal by Subject|0|||
145281183|NCT01078623|523879047|FG019|Treatment Period 4|Withdrawal by Subject|0|||
145281184|NCT00463866|523879048|FG000|Overall Study|Adverse Event|70|||
145281185|NCT00463866|523879049|FG001|Overall Study|Adverse Event|93|||
145281186|NCT00463866|523879048|FG000|Overall Study|Withdrawal by Subject|81|||
145281187|NCT00463866|523879049|FG001|Overall Study|Withdrawal by Subject|79|||
145281188|NCT00463866|523879048|FG000|Overall Study|Lost to Follow-up|46|||
145281189|NCT00463866|523879049|FG001|Overall Study|Lost to Follow-up|55|||
145281190|NCT00463866|523879048|FG000|Overall Study|Incorrect Enrolment|64|||
145281191|NCT00463866|523879049|FG001|Overall Study|Incorrect Enrolment|66|||
145281192|NCT00463866|523879048|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
145281193|NCT00463866|523879049|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
145281194|NCT00463866|523879048|FG000|Overall Study|Safety Reason|1|||
145281195|NCT00463866|523879049|FG001|Overall Study|Safety Reason|3|||
145281196|NCT00463866|523879048|FG000|Overall Study|Mis-Randomization of subject|0|||
145281197|NCT00463866|523879049|FG001|Overall Study|Mis-Randomization of subject|1|||
145281198|NCT00463866|523879048|FG000|Overall Study|Other|22|||
145281199|NCT00463866|523879049|FG001|Overall Study|Other|22|||
145281200|NCT01170364|523879064|FG000|Overall Study|Protocol Violation|4|||
145281201|NCT01170364|523879065|FG001|Overall Study|Protocol Violation|1|||
145281202|NCT03870997|523879070|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
145281203|NCT03870997|523879071|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
145281204|NCT03870997|523879072|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
145281205|NCT03870997|523879073|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
145281206|NCT03870997|523879074|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
145281207|NCT03870997|523879075|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
145281208|NCT01361607|523879077|FG000|Overall Study|Adverse Event|38|||
145281209|NCT01361607|523879078|FG001|Overall Study|Adverse Event|29|||
145281210|NCT01361607|523879077|FG000|Overall Study|Withdrawal by Subject|19|||
145281211|NCT01361607|523879078|FG001|Overall Study|Withdrawal by Subject|8|||
145281212|NCT01361607|523879077|FG000|Overall Study|Withdrawal by Investigator|5|||
145281213|NCT01361607|523879078|FG001|Overall Study|Withdrawal by Investigator|3|||
145281214|NCT01361607|523879077|FG000|Overall Study|Lost to Follow-up|1|||
145281215|NCT01361607|523879078|FG001|Overall Study|Lost to Follow-up|0|||
145785475|NCT02890329|525721823|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
145785476|NCT02890329|525721824|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
145785477|NCT02890329|525721825|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
145785478|NCT02890329|525721820|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
145403933|NCT01721798|524336444|FG001|Overall Study|Lost to Follow-up|2|||
145403934|NCT01721798|524336445|FG002|Overall Study|Lost to Follow-up|9|||
145403935|NCT01721798|524336446|FG003|Overall Study|Lost to Follow-up|9|||
145403936|NCT01721798|524336443|FG000|Overall Study|Pregnancy|0|||
145403937|NCT01721798|524336444|FG001|Overall Study|Pregnancy|0|||
145785479|NCT02890329|525721821|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
145785480|NCT02890329|525721822|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
145785481|NCT02890329|525721823|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
145785482|NCT02890329|525721824|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
145785483|NCT02890329|525721825|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
145281216|NCT01361607|523879077|FG000|Overall Study|Met Withdrawal Criteria|1|||
145281217|NCT01361607|523879078|FG001|Overall Study|Met Withdrawal Criteria|1|||
145281218|NCT00373685|523879079|FG000|Overall Study|Death|2|||
145403938|NCT01721798|524336445|FG002|Overall Study|Pregnancy|1|||
145403939|NCT01721798|524336446|FG003|Overall Study|Pregnancy|1|||
145403940|NCT01721798|524336443|FG000|Overall Study|Withdrawal by Subject|1|||
145403941|NCT01721798|524336444|FG001|Overall Study|Withdrawal by Subject|0|||
145281219|NCT00373685|523879080|FG001|Overall Study|Death|1|||
145281220|NCT00373685|523879079|FG000|Overall Study|Adverse Event|278|||
145281221|NCT00373685|523879080|FG001|Overall Study|Adverse Event|253|||
145281222|NCT00373685|523879079|FG000|Overall Study|Insufficient clinical response|169|||
145281223|NCT00373685|523879080|FG001|Overall Study|Insufficient clinical response|119|||
145281224|NCT00373685|523879079|FG000|Overall Study|Did not meet entrance criteria|167|||
145281225|NCT00373685|523879080|FG001|Overall Study|Did not meet entrance criteria|184|||
145281226|NCT00373685|523879079|FG000|Overall Study|Lost to follow up|83|||
145281227|NCT00373685|523879080|FG001|Overall Study|Lost to follow up|103|||
145403942|NCT01721798|524336445|FG002|Overall Study|Withdrawal by Subject|2|||
145403943|NCT01721798|524336446|FG003|Overall Study|Withdrawal by Subject|1|||
145281228|NCT00373685|523879079|FG000|Overall Study|No longer willing to participate|337|||
145281229|NCT00373685|523879080|FG001|Overall Study|No longer willing to participate|352|||
145281230|NCT00373685|523879079|FG000|Overall Study|Other|149|||
145785484|NCT02890329|525721820|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
145785485|NCT02890329|525721821|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
145785486|NCT02890329|525721822|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
145785487|NCT02890329|525721823|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
145785488|NCT02890329|525721824|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
145785489|NCT02890329|525721825|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
145785490|NCT02691247|525721829|FG000|Overall Study|Withdrawal by Subject|1|||
145785491|NCT02691247|525721830|FG001|Overall Study|Withdrawal by Subject|2|||
145785492|NCT02691247|525721831|FG002|Overall Study|Withdrawal by Subject|2|||
145785493|NCT02691247|525721829|FG000|Overall Study|Lost to Follow-up|2|||
145785494|NCT02691247|525721830|FG001|Overall Study|Lost to Follow-up|0|||
145785495|NCT02691247|525721831|FG002|Overall Study|Lost to Follow-up|1|||
145785496|NCT02552355|525721832|FG000|Overall Study|Adverse Event|0|||
145785497|NCT02552355|525721833|FG001|Overall Study|Adverse Event|2|||
145785498|NCT02552355|525721834|FG002|Overall Study|Adverse Event|2|||
145785499|NCT02552355|525721835|FG003|Overall Study|Adverse Event|0|||
145785500|NCT02552355|525721832|FG000|Overall Study|Withdrawal by Subject|0|||
145785501|NCT02552355|525721833|FG001|Overall Study|Withdrawal by Subject|0|||
145785502|NCT02552355|525721834|FG002|Overall Study|Withdrawal by Subject|0|||
145785503|NCT02552355|525721835|FG003|Overall Study|Withdrawal by Subject|1|||
145281231|NCT00373685|523879080|FG001|Overall Study|Other|146|||
145281232|NCT00373685|523879079|FG000|Overall Study|Protocol Violation|191|||
145281233|NCT00373685|523879080|FG001|Overall Study|Protocol Violation|182|||
145403944|NCT01721798|524336443|FG000|Overall Study|Not eligible for 24 month visit|1|||
145403945|NCT01721798|524336444|FG001|Overall Study|Not eligible for 24 month visit|0|||
145785504|NCT01519245|525721836|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
145785505|NCT01519245|525721837|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
145785506|NCT00803244|525721840|FG000|Overall Study|Adverse Event|1|||
145281234|NCT00373685|523879079|FG000|Overall Study|Final Status Unknown|12|||
145281235|NCT00373685|523879080|FG001|Overall Study|Final Status Unknown|4|||
145281236|NCT00373685|523879079|FG000|Overall Study|Randomized, not treated|51|||
145281237|NCT00373685|523879080|FG001|Overall Study|Randomized, not treated|77|||
145281238|NCT02570165|523879081|FG000|Overall Study|Adverse Event|1|||
145281239|NCT02570165|523879082|FG001|Overall Study|Adverse Event|0|||
145281240|NCT02570165|523879083|FG002|Overall Study|Adverse Event|2|||
145281241|NCT02570165|523879084|FG003|Overall Study|Adverse Event|0|||
145281242|NCT02570165|523879085|FG004|Overall Study|Adverse Event|0|||
145281243|NCT02570165|523879086|FG005|Overall Study|Adverse Event|0|||
145281244|NCT02570165|523879087|FG006|Overall Study|Adverse Event|0|||
145281245|NCT02570165|523879081|FG000|Overall Study|Lack of Efficacy|0|||
145281246|NCT02570165|523879082|FG001|Overall Study|Lack of Efficacy|1|||
145281247|NCT02570165|523879083|FG002|Overall Study|Lack of Efficacy|0|||
145281248|NCT02570165|523879084|FG003|Overall Study|Lack of Efficacy|0|||
145281249|NCT02570165|523879085|FG004|Overall Study|Lack of Efficacy|4|||
145281250|NCT02570165|523879086|FG005|Overall Study|Lack of Efficacy|0|||
145281251|NCT02570165|523879087|FG006|Overall Study|Lack of Efficacy|0|||
145281252|NCT02570165|523879081|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
145281253|NCT02570165|523879082|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
145281254|NCT02570165|523879083|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
145281255|NCT02570165|523879084|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
145281256|NCT02570165|523879085|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
145281257|NCT02570165|523879086|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
145281258|NCT02570165|523879087|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
145281259|NCT02570165|523879081|FG000|Overall Study|Lost to Follow-up|0|||
145281260|NCT02570165|523879082|FG001|Overall Study|Lost to Follow-up|0|||
145281261|NCT02570165|523879083|FG002|Overall Study|Lost to Follow-up|1|||
145281262|NCT02570165|523879084|FG003|Overall Study|Lost to Follow-up|1|||
145281263|NCT02570165|523879085|FG004|Overall Study|Lost to Follow-up|0|||
145281264|NCT02570165|523879086|FG005|Overall Study|Lost to Follow-up|0|||
145281265|NCT02570165|523879087|FG006|Overall Study|Lost to Follow-up|0|||
145281266|NCT02570165|523879081|FG000|Overall Study|Physician Decision|0|||
145538826|NCT03539081|524832866|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
145538827|NCT03539081|524832867|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
145538828|NCT03539081|524832868|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
145538829|NCT02025621|524832869|FG000|Overall Study|Withdrawal by Subject|1|||
145538830|NCT02025621|524832870|FG001|Overall Study|Withdrawal by Subject|0|||
145538831|NCT02025621|524832869|FG000|Overall Study|Death|0|||
145538832|NCT02025621|524832870|FG001|Overall Study|Death|1|||
145785507|NCT00803244|525721841|FG001|Overall Study|Adverse Event|2|||
145785508|NCT00803244|525721840|FG000|Overall Study|Withdrawal by Subject|2|||
145281267|NCT02570165|523879082|FG001|Overall Study|Physician Decision|1|||
145281268|NCT02570165|523879083|FG002|Overall Study|Physician Decision|0|||
145281269|NCT02570165|523879084|FG003|Overall Study|Physician Decision|0|||
145281270|NCT02570165|523879085|FG004|Overall Study|Physician Decision|0|||
145281271|NCT02570165|523879086|FG005|Overall Study|Physician Decision|0|||
145281272|NCT02570165|523879087|FG006|Overall Study|Physician Decision|0|||
145281273|NCT02570165|523879081|FG000|Overall Study|Withdrawal by Subject|0|||
145281274|NCT02570165|523879082|FG001|Overall Study|Withdrawal by Subject|0|||
145281275|NCT02570165|523879083|FG002|Overall Study|Withdrawal by Subject|0|||
145281276|NCT02570165|523879084|FG003|Overall Study|Withdrawal by Subject|2|||
145281277|NCT02570165|523879085|FG004|Overall Study|Withdrawal by Subject|1|||
145281278|NCT02570165|523879086|FG005|Overall Study|Withdrawal by Subject|0|||
145785509|NCT00803244|525721841|FG001|Overall Study|Withdrawal by Subject|3|||
145785510|NCT00803244|525721840|FG000|Overall Study|Any other reason not above-mentioned|4|||
145785511|NCT00803244|525721841|FG001|Overall Study|Any other reason not above-mentioned|10|||
145281279|NCT02570165|523879087|FG006|Overall Study|Withdrawal by Subject|0|||
145281280|NCT02570165|523879081|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281281|NCT02570165|523879082|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281282|NCT02570165|523879083|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281283|NCT02570165|523879084|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281284|NCT02570165|523879085|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281285|NCT02570165|523879086|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
145281286|NCT02570165|523879087|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
145281287|NCT02570165|523879081|FG000|Overall Study|Withdrawal Request by GSK|0|||
145281288|NCT02570165|523879082|FG001|Overall Study|Withdrawal Request by GSK|0|||
145281289|NCT02570165|523879083|FG002|Overall Study|Withdrawal Request by GSK|2|||
145281290|NCT02570165|523879084|FG003|Overall Study|Withdrawal Request by GSK|0|||
145281291|NCT02570165|523879085|FG004|Overall Study|Withdrawal Request by GSK|0|||
145281292|NCT02570165|523879086|FG005|Overall Study|Withdrawal Request by GSK|0|||
145281293|NCT02570165|523879087|FG006|Overall Study|Withdrawal Request by GSK|0|||
145281294|NCT04428502|523879088|FG000|Overall Study|Did not meet entrance criteria|14|||
145281295|NCT05288673|523879089|FG000|Overall Study|Consent withdrawn by subject|0|||
145785512|NCT03321929|525721842|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
145785513|NCT00616239|525721844|FG000|Overall Study|Withdrawal by Subject|2|||
145785514|NCT01052012|525721845|FG000|Overall Study|Not treated|2|||
145785515|NCT01052012|525721846|FG001|Overall Study|Not treated|5|||
145785516|NCT01052012|525721847|FG002|Overall Study|Not treated|0|||
145785517|NCT01052012|525721848|FG003|Overall Study|Not treated|0|||
145785518|NCT01052012|525721849|FG004|Overall Study|Not treated|11|||
145785519|NCT01052012|525721850|FG005|Overall Study|Not treated|8|||
145785520|NCT01052012|525721845|FG000|Overall Study|Adverse Event|1|||
145785521|NCT01052012|525721846|FG001|Overall Study|Adverse Event|0|||
145785522|NCT01052012|525721847|FG002|Overall Study|Adverse Event|0|||
145785523|NCT01052012|525721848|FG003|Overall Study|Adverse Event|1|||
145785524|NCT01052012|525721849|FG004|Overall Study|Adverse Event|0|||
145785525|NCT01052012|525721850|FG005|Overall Study|Adverse Event|0|||
145785526|NCT01052012|525721845|FG000|Overall Study|Lost to Follow-up|0|||
145785527|NCT01052012|525721846|FG001|Overall Study|Lost to Follow-up|0|||
145785528|NCT01052012|525721847|FG002|Overall Study|Lost to Follow-up|0|||
145785529|NCT01052012|525721848|FG003|Overall Study|Lost to Follow-up|0|||
145785530|NCT01052012|525721849|FG004|Overall Study|Lost to Follow-up|1|||
145785531|NCT01052012|525721850|FG005|Overall Study|Lost to Follow-up|0|||
145785532|NCT01052012|525721845|FG000|Overall Study|Withdrawal by Subject|1|||
145785533|NCT01052012|525721846|FG001|Overall Study|Withdrawal by Subject|1|||
145785534|NCT01052012|525721847|FG002|Overall Study|Withdrawal by Subject|0|||
145785535|NCT01052012|525721848|FG003|Overall Study|Withdrawal by Subject|0|||
145785536|NCT01052012|525721849|FG004|Overall Study|Withdrawal by Subject|3|||
145785537|NCT01052012|525721850|FG005|Overall Study|Withdrawal by Subject|1|||
145785538|NCT01052012|525721845|FG000|Overall Study|Physician Decision|0|||
145785539|NCT01052012|525721846|FG001|Overall Study|Physician Decision|0|||
145785540|NCT01052012|525721847|FG002|Overall Study|Physician Decision|0|||
145785541|NCT01052012|525721848|FG003|Overall Study|Physician Decision|0|||
145785542|NCT01052012|525721849|FG004|Overall Study|Physician Decision|0|||
145785543|NCT01052012|525721850|FG005|Overall Study|Physician Decision|1|||
145785544|NCT01052012|525721845|FG000|Overall Study|Other|0|||
145785545|NCT01052012|525721846|FG001|Overall Study|Other|0|||
145785546|NCT01052012|525721847|FG002|Overall Study|Other|0|||
145785547|NCT01052012|525721848|FG003|Overall Study|Other|0|||
145785548|NCT01052012|525721849|FG004|Overall Study|Other|1|||
145785549|NCT01052012|525721850|FG005|Overall Study|Other|0|||
145785550|NCT02873715|525721851|FG000|Overall Study|Lost to Follow-up|84|||
145785551|NCT02873715|525721852|FG001|Overall Study|Lost to Follow-up|94|||
145785552|NCT02873715|525721851|FG000|Overall Study|Withdrawal by Subject|7|||
145785553|NCT02873715|525721852|FG001|Overall Study|Withdrawal by Subject|26|||
145785554|NCT04590937|525721853|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
145785555|NCT02084134|525721861|FG000|Overall Study|Protocol Violation|4|||
145785556|NCT02084134|525721862|FG001|Overall Study|Protocol Violation|2|||
145785557|NCT02084134|525721861|FG000|Overall Study|Death|0|||
145785558|NCT02084134|525721862|FG001|Overall Study|Death|1|||
145785559|NCT02807454|525721863|FG000|Overall Study|Adverse Event|1|||
145785560|NCT02807454|525721864|FG001|Overall Study|Adverse Event|0|||
145785561|NCT02807454|525721863|FG000|Overall Study|Withdrawal by Subject|0|||
145785562|NCT02807454|525721864|FG001|Overall Study|Withdrawal by Subject|1|||
145785563|NCT02807454|525721863|FG000|Overall Study|Progressive Disease|30|||
145785564|NCT02807454|525721864|FG001|Overall Study|Progressive Disease|3|||
145785565|NCT02807454|525721863|FG000|Overall Study|Other Reasons|1|||
145785566|NCT02807454|525721864|FG001|Overall Study|Other Reasons|1|||
145785567|NCT05468086|525721865|FG000|Overall Study|Withdrawal by Subject|3|||
145785568|NCT05468086|525721865|FG000|Overall Study|Subject was found ineligible after consent|1|||
145785569|NCT01165203|525721866|FG000|Active Phase|Serious Adverse Event|1|||
145785570|NCT01165203|525721867|FG001|Active Phase|Serious Adverse Event|0|||
145785571|NCT01165203|525721866|FG000|Active Phase|Withdrawal by Subject|2|||
145785572|NCT01165203|525721867|FG001|Active Phase|Withdrawal by Subject|1|||
145785573|NCT01165203|525721866|FG000|Active Phase|Migrated/moved from study area|0|||
145403946|NCT01721798|524336445|FG002|Overall Study|Not eligible for 24 month visit|8|||
145403947|NCT01721798|524336446|FG003|Overall Study|Not eligible for 24 month visit|7|||
145785574|NCT01165203|525721867|FG001|Active Phase|Migrated/moved from study area|1|||
145785575|NCT01165203|525721866|FG000|Active Phase|Lost to Follow-up|2|||
145785576|NCT01165203|525721867|FG001|Active Phase|Lost to Follow-up|0|||
145785577|NCT01165203|525721866|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
145785578|NCT01165203|525721867|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
145785579|NCT01165203|525721866|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
145785580|NCT01165203|525721867|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
145785581|NCT01165203|525721866|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
145785582|NCT01165203|525721867|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
145785583|NCT01165203|525721866|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
145785584|NCT01165203|525721867|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
145785585|NCT01165203|525721866|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
145785586|NCT01165203|525721867|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
145281296|NCT05288673|523879090|FG001|Overall Study|Consent withdrawn by subject|0|||
145281297|NCT05288673|523879091|FG002|Overall Study|Consent withdrawn by subject|1|||
145785587|NCT01070784|525721871|FG000|Overall Study|Withdrawal by Subject|6|||
145785588|NCT01070784|525721872|FG001|Overall Study|Withdrawal by Subject|9|||
145281298|NCT04147611|523879098|FG000|Overall Study|Physician Decision|0|||
145281299|NCT04147611|523879099|FG001|Overall Study|Physician Decision|1|||
145281300|NCT05003167|523879100|FG000|Overall Study|Withdrawal by Subject|1|||
145281301|NCT01010230|523879101|FG000|Overall Study|Withdrawal by Subject|6|||
145281302|NCT01010230|523879102|FG001|Overall Study|Withdrawal by Subject|5|||
145281303|NCT01010230|523879101|FG000|Overall Study|Lost to Follow-up|4|||
145281304|NCT01010230|523879102|FG001|Overall Study|Lost to Follow-up|2|||
145281305|NCT01585831|523879103|FG000|Overall Study|Physician Decision|0|||
145281306|NCT01585831|523879104|FG001|Overall Study|Physician Decision|1|||
145281307|NCT01585831|523879103|FG000|Overall Study|Withdrawal by Subject|2|||
145538833|NCT02025621|524832869|FG000|Overall Study|No longer eligible|10|||
145538834|NCT02025621|524832870|FG001|Overall Study|No longer eligible|15|||
145538835|NCT02025621|524832869|FG000|Overall Study|Surgery initiated before infusion|3|||
145538836|NCT02025621|524832870|FG001|Overall Study|Surgery initiated before infusion|3|||
145538837|NCT00739674|524832871|FG000|Overall Study|Screening failures|19|||
145785589|NCT01070784|525721871|FG000|Overall Study|Adverse Event|14|||
145785590|NCT01070784|525721872|FG001|Overall Study|Adverse Event|9|||
145785591|NCT02815397|525721874|FG000|Overall Study|Physician Decision|2|||
145785592|NCT00085540|525721875|FG000|Overall Study|Withdrawal by Subject|0|||
145785593|NCT00085540|525721876|FG001|Overall Study|Withdrawal by Subject|1|||
145785594|NCT00085540|525721875|FG000|Overall Study|Protocol Violation|0|||
145785595|NCT00085540|525721876|FG001|Overall Study|Protocol Violation|1|||
145785596|NCT01518192|525721877|FG000|Overall Study|Lost to Follow-up|29|||
145785597|NCT01518192|525721878|FG001|Overall Study|Lost to Follow-up|26|||
145785598|NCT01518192|525721879|FG002|Overall Study|Lost to Follow-up|35|||
145785599|NCT00426751|525721880|FG000|Overall Study|Adverse Event|8|||
145785600|NCT00426751|525721881|FG001|Overall Study|Adverse Event|1|||
145785601|NCT00426751|525721880|FG000|Overall Study|Lost to Follow-up|7|||
145785602|NCT00426751|525721881|FG001|Overall Study|Lost to Follow-up|6|||
145785603|NCT00426751|525721880|FG000|Overall Study|Consent Withdrawn|0|||
145785604|NCT00426751|525721881|FG001|Overall Study|Consent Withdrawn|1|||
145785605|NCT00426751|525721880|FG000|Overall Study|Other Reasons|7|||
145785606|NCT00426751|525721881|FG001|Overall Study|Other Reasons|12|||
145785607|NCT01200511|525721886|FG000|Overall Study|Lost to Follow-up|3|||
145785608|NCT01200511|525721886|FG000|Overall Study|Withdrawal by Subject|1|||
145785609|NCT01200511|525721886|FG000|Overall Study|Adverse Event|1|||
145785610|NCT03288779|525721887|FG000|Overall Study|Withdrawal by Subject|3|||
145785611|NCT01355068|525721891|FG000|First Intervention Period|Adverse Event|0|||
145785612|NCT01355068|525721892|FG001|First Intervention Period|Adverse Event|1|||
145785613|NCT01355068|525721891|FG000|First Intervention Period|Withdrawal by Subject|0|||
145785614|NCT01355068|525721892|FG001|First Intervention Period|Withdrawal by Subject|1|||
145785615|NCT02504892|525721893|FG000|Overall Study|Adverse event-pneumonitis|2|||
145785616|NCT00524745|525721894|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
145785617|NCT00524745|525721895|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
145785618|NCT00524745|525721896|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
145538838|NCT00739674|524832872|FG001|Overall Study|Screening failures|17|||
145538839|NCT00739674|524832871|FG000|Overall Study|Site 212 removal|19|||
145538840|NCT00739674|524832872|FG001|Overall Study|Site 212 removal|13|||
145538841|NCT00739674|524832871|FG000|Overall Study|No follow-up data|33|||
145538842|NCT00739674|524832872|FG001|Overall Study|No follow-up data|18|||
145785619|NCT00524745|525721897|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
145785620|NCT00237796|525721898|FG000|Overall Study|Baseline and one other ILSS required|10|||
145281308|NCT01585831|523879104|FG001|Overall Study|Withdrawal by Subject|1|||
145281309|NCT01123980|523879105|FG000|Overall Study|Adverse Event|1|||
145281310|NCT01123980|523879106|FG001|Overall Study|Adverse Event|1|||
145281311|NCT01123980|523879105|FG000|Overall Study|Lack of Efficacy|1|||
145281312|NCT01123980|523879106|FG001|Overall Study|Lack of Efficacy|0|||
145281313|NCT01123980|523879105|FG000|Overall Study|Physician Decision|0|||
145281314|NCT01123980|523879106|FG001|Overall Study|Physician Decision|1|||
145281315|NCT01123980|523879105|FG000|Overall Study|Lost to Follow-up|0|||
145281316|NCT01123980|523879106|FG001|Overall Study|Lost to Follow-up|6|||
145538843|NCT00739674|524832871|FG000|Overall Study|Dietician consultation >30 days|1|||
145538844|NCT00739674|524832872|FG001|Overall Study|Dietician consultation >30 days|9|||
145538845|NCT00739674|524832871|FG000|Overall Study|Adverse Event|22|||
145538846|NCT00739674|524832872|FG001|Overall Study|Adverse Event|13|||
145609581|NCT02541383|525086384|FG004|Overall Study|Death|21|||
145609582|NCT02541383|525086385|FG005|Overall Study|Death|25|||
145785621|NCT00237796|525721899|FG001|Overall Study|Baseline and one other ILSS required|5|||
145785622|NCT00370149|525721900|FG000|Overall Study|Physician Decision|16|||
145785623|NCT00370149|525721901|FG001|Overall Study|Physician Decision|16|||
145785624|NCT00370149|525721900|FG000|Overall Study|Protocol Violation|1|||
145785625|NCT00370149|525721901|FG001|Overall Study|Protocol Violation|0|||
145785626|NCT00370149|525721900|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
145403948|NCT00427934|524336447|FG000|Overall Study|Adverse Event|1|||
145403949|NCT00427934|524336448|FG001|Overall Study|Adverse Event|0|||
145403950|NCT00427934|524336449|FG002|Overall Study|Adverse Event|5|||
145403951|NCT00427934|524336450|FG003|Overall Study|Adverse Event|4|||
145403952|NCT00427934|524336447|FG000|Overall Study|Lack of Efficacy|0|||
145403953|NCT00427934|524336448|FG001|Overall Study|Lack of Efficacy|0|||
145403954|NCT00427934|524336449|FG002|Overall Study|Lack of Efficacy|5|||
145403955|NCT00427934|524336450|FG003|Overall Study|Lack of Efficacy|2|||
145403956|NCT00427934|524336447|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
145403957|NCT00427934|524336448|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
145403958|NCT00427934|524336449|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
145403959|NCT00427934|524336450|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
145403960|NCT00427934|524336447|FG000|Overall Study|Other|0|||
145403961|NCT00427934|524336448|FG001|Overall Study|Other|0|||
145403962|NCT00427934|524336449|FG002|Overall Study|Other|11|||
145403963|NCT00427934|524336450|FG003|Overall Study|Other|5|||
145403964|NCT00427934|524336447|FG000|Overall Study|Withdrawal by Subject|0|||
145403965|NCT00427934|524336448|FG001|Overall Study|Withdrawal by Subject|0|||
145403966|NCT00427934|524336449|FG002|Overall Study|Withdrawal by Subject|1|||
145403967|NCT00427934|524336450|FG003|Overall Study|Withdrawal by Subject|3|||
145403968|NCT02194465|524336451|FG000|Overall Study|Adverse Event|6|||
145403969|NCT02194465|524336452|FG001|Overall Study|Adverse Event|1|||
145403970|NCT02194465|524336453|FG002|Overall Study|Adverse Event|4|||
145538847|NCT00739674|524832871|FG000|Overall Study|Death|1|||
145538848|NCT00739674|524832872|FG001|Overall Study|Death|0|||
145538849|NCT00739674|524832871|FG000|Overall Study|Lack of Efficacy|1|||
145538850|NCT00739674|524832872|FG001|Overall Study|Lack of Efficacy|0|||
145538851|NCT00739674|524832871|FG000|Overall Study|Lost to Follow-up|52|||
145281317|NCT01123980|523879105|FG000|Overall Study|Protocol Violation|6|||
145281318|NCT01123980|523879106|FG001|Overall Study|Protocol Violation|6|||
145281319|NCT01123980|523879105|FG000|Overall Study|Withdrawal by Subject|5|||
145281320|NCT01123980|523879106|FG001|Overall Study|Withdrawal by Subject|3|||
145281321|NCT01123980|523879105|FG000|Overall Study|Unclassified|6|||
145281322|NCT01123980|523879106|FG001|Overall Study|Unclassified|7|||
145281323|NCT01225991|523879107|FG000|Overall Study|Withdrawal by Subject|6|||
145281324|NCT04444752|523879108|FG000|Overall Study|Adverse Event|1|||
145281325|NCT04444752|523879109|FG001|Overall Study|Adverse Event|0|||
145281326|NCT04444752|523879110|FG002|Overall Study|Adverse Event|0|||
145281327|NCT04444752|523879111|FG003|Overall Study|Adverse Event|2|||
145281328|NCT04444752|523879108|FG000|Overall Study|Lost to Follow-up|2|||
145281329|NCT04444752|523879109|FG001|Overall Study|Lost to Follow-up|6|||
145281330|NCT04444752|523879110|FG002|Overall Study|Lost to Follow-up|2|||
145281331|NCT04444752|523879111|FG003|Overall Study|Lost to Follow-up|5|||
145281332|NCT04444752|523879108|FG000|Overall Study|Physician Decision|0|||
145281333|NCT04444752|523879109|FG001|Overall Study|Physician Decision|0|||
145281334|NCT04444752|523879110|FG002|Overall Study|Physician Decision|0|||
145281335|NCT04444752|523879111|FG003|Overall Study|Physician Decision|2|||
145281336|NCT04444752|523879108|FG000|Overall Study|Pregnancy|0|||
145281337|NCT04444752|523879109|FG001|Overall Study|Pregnancy|0|||
145281338|NCT04444752|523879110|FG002|Overall Study|Pregnancy|0|||
145281339|NCT04444752|523879111|FG003|Overall Study|Pregnancy|1|||
145281340|NCT04444752|523879108|FG000|Overall Study|Withdrawal by Subject|6|||
145281341|NCT04444752|523879109|FG001|Overall Study|Withdrawal by Subject|5|||
145281342|NCT04444752|523879110|FG002|Overall Study|Withdrawal by Subject|3|||
145281343|NCT04444752|523879111|FG003|Overall Study|Withdrawal by Subject|4|||
145403971|NCT02194465|524336454|FG003|Overall Study|Adverse Event|4|||
145403972|NCT02194465|524336455|FG004|Overall Study|Adverse Event|4|||
145403973|NCT02194465|524336456|FG005|Overall Study|Adverse Event|2|||
145403974|NCT02194465|524336457|FG006|Overall Study|Adverse Event|0|||
145403975|NCT02194465|524336451|FG000|Overall Study|Lost to Follow-up|0|||
145403976|NCT02194465|524336452|FG001|Overall Study|Lost to Follow-up|0|||
145403977|NCT02194465|524336453|FG002|Overall Study|Lost to Follow-up|0|||
145403978|NCT02194465|524336454|FG003|Overall Study|Lost to Follow-up|1|||
145403979|NCT02194465|524336455|FG004|Overall Study|Lost to Follow-up|0|||
145403980|NCT02194465|524336456|FG005|Overall Study|Lost to Follow-up|1|||
145403981|NCT02194465|524336457|FG006|Overall Study|Lost to Follow-up|0|||
145403982|NCT02194465|524336451|FG000|Overall Study|Physician Decision|1|||
145403983|NCT02194465|524336452|FG001|Overall Study|Physician Decision|0|||
145403984|NCT02194465|524336453|FG002|Overall Study|Physician Decision|0|||
145403985|NCT02194465|524336454|FG003|Overall Study|Physician Decision|0|||
145281344|NCT04444752|523879108|FG000|Overall Study|Protocol Violation|1|||
145281345|NCT04444752|523879109|FG001|Overall Study|Protocol Violation|1|||
145281346|NCT04444752|523879110|FG002|Overall Study|Protocol Violation|0|||
145281347|NCT04444752|523879111|FG003|Overall Study|Protocol Violation|0|||
145281348|NCT04444752|523879108|FG000|Overall Study|Patient moving out of town|1|||
145538852|NCT00739674|524832872|FG001|Overall Study|Lost to Follow-up|30|||
145281349|NCT04444752|523879109|FG001|Overall Study|Patient moving out of town|0|||
145281350|NCT04444752|523879110|FG002|Overall Study|Patient moving out of town|0|||
145403986|NCT02194465|524336455|FG004|Overall Study|Physician Decision|0|||
145403987|NCT02194465|524336456|FG005|Overall Study|Physician Decision|0|||
145609583|NCT02541383|525086380|FG000|Overall Study|Lost to Follow-up|5|||
145609584|NCT02541383|525086381|FG001|Overall Study|Lost to Follow-up|3|||
145609585|NCT02541383|525086382|FG002|Overall Study|Lost to Follow-up|1|||
145609586|NCT02541383|525086383|FG003|Overall Study|Lost to Follow-up|1|||
145609587|NCT02541383|525086384|FG004|Overall Study|Lost to Follow-up|3|||
145609588|NCT02541383|525086385|FG005|Overall Study|Lost to Follow-up|0|||
145403988|NCT02194465|524336457|FG006|Overall Study|Physician Decision|0|||
145403989|NCT02194465|524336451|FG000|Overall Study|Protocol Violation|1|||
145785627|NCT00370149|525721901|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
145785628|NCT00370149|525721900|FG000|Overall Study|Pre-existing infection|0|||
145785629|NCT00370149|525721901|FG001|Overall Study|Pre-existing infection|1|||
145785630|NCT00370149|525721900|FG000|Overall Study|Antibiotic coated dressing placed|0|||
145785631|NCT00370149|525721901|FG001|Overall Study|Antibiotic coated dressing placed|1|||
145785632|NCT00620321|525722982|FG000|Overall Study|Adverse Event|1|||
145785633|NCT00620321|525722983|FG001|Overall Study|Adverse Event|1|||
145785634|NCT00620321|525722982|FG000|Overall Study|Death|1|||
145785635|NCT00620321|525722983|FG001|Overall Study|Death|1|||
145785636|NCT00620321|525722982|FG000|Overall Study|Physician Decision|0|||
145785637|NCT00620321|525722983|FG001|Overall Study|Physician Decision|7|||
145785638|NCT00620321|525722982|FG000|Overall Study|Progressive Disease|5|||
145785639|NCT00620321|525722983|FG001|Overall Study|Progressive Disease|5|||
145785640|NCT00620321|525722982|FG000|Overall Study|Sponsor Decision|0|||
145785641|NCT00620321|525722983|FG001|Overall Study|Sponsor Decision|1|||
145785642|NCT00620321|525722982|FG000|Overall Study|Withdrawal by Subject|1|||
145785643|NCT00620321|525722983|FG001|Overall Study|Withdrawal by Subject|1|||
145785644|NCT02340819|525722984|FG000|Overall Study|Adverse Event|1|||
145785645|NCT02340819|525722984|FG000|Overall Study|Withdrawal by Subject|2|||
145785646|NCT02340819|525722984|FG000|Overall Study|Discontinued with other reason|1|||
145785647|NCT00051558|525722985|FG000|Overall Study|Adverse Event|30|||
145785648|NCT00051558|525722986|FG001|Overall Study|Adverse Event|18|||
145785649|NCT00051558|525722985|FG000|Overall Study|Withdrawal by Subject|29|||
145785650|NCT00051558|525722986|FG001|Overall Study|Withdrawal by Subject|42|||
145785651|NCT00051558|525722985|FG000|Overall Study|Death|9|||
145785652|NCT00051558|525722986|FG001|Overall Study|Death|15|||
145785653|NCT00051558|525722985|FG000|Overall Study|Lost to Follow-up|4|||
145785654|NCT00051558|525722986|FG001|Overall Study|Lost to Follow-up|13|||
145785655|NCT00051558|525722985|FG000|Overall Study|Protocol Violation|3|||
145785656|NCT00051558|525722986|FG001|Overall Study|Protocol Violation|4|||
145785657|NCT00051558|525722985|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
145785658|NCT00051558|525722986|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
145785659|NCT00051558|525722985|FG000|Overall Study|Sponsor Decision|6|||
145785660|NCT00051558|525722986|FG001|Overall Study|Sponsor Decision|1|||
145785661|NCT00051558|525722985|FG000|Overall Study|Other|2|||
145785662|NCT00051558|525722986|FG001|Overall Study|Other|1|||
145403990|NCT02194465|524336452|FG001|Overall Study|Protocol Violation|1|||
145609589|NCT02541383|525086380|FG000|Overall Study|Consent withdrawn|5|||
145609590|NCT02541383|525086381|FG001|Overall Study|Consent withdrawn|6|||
145609591|NCT02541383|525086382|FG002|Overall Study|Consent withdrawn|1|||
145609592|NCT02541383|525086383|FG003|Overall Study|Consent withdrawn|1|||
145609593|NCT02541383|525086384|FG004|Overall Study|Consent withdrawn|0|||
145785663|NCT00051558|525722985|FG000|Overall Study|Significant Lab Value|2|||
145785664|NCT00051558|525722986|FG001|Overall Study|Significant Lab Value|0|||
145785665|NCT00051558|525722985|FG000|Overall Study|Physician Decision|5|||
145403991|NCT02194465|524336453|FG002|Overall Study|Protocol Violation|2|||
145403992|NCT02194465|524336454|FG003|Overall Study|Protocol Violation|1|||
145785666|NCT00051558|525722986|FG001|Overall Study|Physician Decision|0|||
145785667|NCT01701583|525722990|FG000|Overall Study|Withdrawal by Subject|2|||
145785668|NCT01701583|525722991|FG001|Overall Study|Withdrawal by Subject|0|||
145785669|NCT01441440|525722992|FG000|Overall Study|Death|1|||
145785670|NCT01441440|525722993|FG001|Overall Study|Death|0|||
145609594|NCT02541383|525086385|FG005|Overall Study|Consent withdrawn|0|||
145785671|NCT01441440|525722994|FG002|Overall Study|Death|1|||
145785672|NCT01441440|525722992|FG000|Overall Study|Adverse Event|2|||
145785673|NCT01441440|525722993|FG001|Overall Study|Adverse Event|9|||
145785674|NCT01441440|525722994|FG002|Overall Study|Adverse Event|9|||
145785675|NCT01441440|525722992|FG000|Overall Study|Lost to Follow-up|0|||
145785676|NCT01441440|525722993|FG001|Overall Study|Lost to Follow-up|2|||
145785677|NCT01441440|525722994|FG002|Overall Study|Lost to Follow-up|1|||
145785678|NCT01441440|525722992|FG000|Overall Study|Withdrawal by Subject|11|||
145785679|NCT01441440|525722993|FG001|Overall Study|Withdrawal by Subject|9|||
145785680|NCT01441440|525722994|FG002|Overall Study|Withdrawal by Subject|9|||
145785681|NCT01441440|525722992|FG000|Overall Study|Pregnancy|1|||
145785682|NCT01441440|525722993|FG001|Overall Study|Pregnancy|0|||
145785683|NCT01441440|525722994|FG002|Overall Study|Pregnancy|0|||
145785684|NCT01441440|525722992|FG000|Overall Study|Lack of Efficacy|1|||
145785685|NCT01441440|525722993|FG001|Overall Study|Lack of Efficacy|0|||
145785686|NCT01441440|525722994|FG002|Overall Study|Lack of Efficacy|1|||
145785687|NCT01441440|525722992|FG000|Overall Study|Moving|0|||
145785688|NCT01441440|525722993|FG001|Overall Study|Moving|1|||
145785689|NCT01441440|525722994|FG002|Overall Study|Moving|1|||
145785690|NCT01441440|525722992|FG000|Overall Study|Work-related matter|0|||
145785691|NCT01441440|525722993|FG001|Overall Study|Work-related matter|1|||
145785692|NCT01441440|525722994|FG002|Overall Study|Work-related matter|0|||
145785693|NCT01441440|525722992|FG000|Overall Study|Difficllty in keeping the schedule|1|||
145785694|NCT01441440|525722993|FG001|Overall Study|Difficllty in keeping the schedule|1|||
145785695|NCT01441440|525722994|FG002|Overall Study|Difficllty in keeping the schedule|0|||
145785696|NCT01345123|525722995|FG000|Overall Study|participants no longer with health plan|79|||
145785697|NCT01345123|525722996|FG001|Overall Study|participants no longer with health plan|85|||
145785698|NCT01345123|525722997|FG002|Overall Study|participants no longer with health plan|88|||
145785699|NCT00883558|525722998|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
145785700|NCT00883558|525722999|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
145785701|NCT00883558|525723000|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
145785702|NCT00883558|525722998|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
145281351|NCT04444752|523879111|FG003|Overall Study|Patient moving out of town|1|||
145281352|NCT04444752|523879108|FG000|Overall Study|Lack of Efficacy|0|||
145281353|NCT04444752|523879109|FG001|Overall Study|Lack of Efficacy|0|||
145281354|NCT04444752|523879110|FG002|Overall Study|Lack of Efficacy|0|||
145281355|NCT04444752|523879111|FG003|Overall Study|Lack of Efficacy|1|||
145281356|NCT04444752|523879108|FG000|Overall Study|Death|0|||
145281357|NCT04444752|523879109|FG001|Overall Study|Death|0|||
145281358|NCT04444752|523879110|FG002|Overall Study|Death|1|||
145281359|NCT04444752|523879111|FG003|Overall Study|Death|0|||
145281360|NCT00579254|523879112|FG000|Overall Study|Lost to Follow-up|39|||
145281361|NCT00579254|523879112|FG000|Overall Study|Discontinued when study terminated|73|||
145281362|NCT02557672|523879113|FG000|Overall Study|Withdrawal by Subject|4|||
145281363|NCT02557672|523879114|FG001|Overall Study|Withdrawal by Subject|2|||
145281364|NCT01165242|523880511|FG000|Overall Study|Unreachable Subjects|1|||
145281365|NCT01165242|523880512|FG001|Overall Study|Unreachable Subjects|0|||
145281366|NCT01165242|523880513|FG002|Overall Study|Unreachable Subjects|0|||
145281367|NCT01165242|523880511|FG000|Overall Study|Incarcerated Subjects|0|||
145281368|NCT01165242|523880512|FG001|Overall Study|Incarcerated Subjects|1|||
145281369|NCT01165242|523880513|FG002|Overall Study|Incarcerated Subjects|0|||
145281370|NCT01165242|523880511|FG000|Overall Study|Visit 2 Declined by Subject|0|||
145281371|NCT01165242|523880512|FG001|Overall Study|Visit 2 Declined by Subject|0|||
145281372|NCT01165242|523880513|FG002|Overall Study|Visit 2 Declined by Subject|1|||
145281373|NCT01165242|523880511|FG000|Overall Study|Withdrawal by Subject|0|||
145281374|NCT01165242|523880512|FG001|Overall Study|Withdrawal by Subject|2|||
145281375|NCT01165242|523880513|FG002|Overall Study|Withdrawal by Subject|2|||
145281376|NCT01165242|523880511|FG000|Overall Study|Extended Holiday|0|||
145281377|NCT01165242|523880512|FG001|Overall Study|Extended Holiday|0|||
145281378|NCT01165242|523880513|FG002|Overall Study|Extended Holiday|1|||
145281379|NCT01165242|523880511|FG000|Overall Study|Lost to Follow-up|9|||
145281380|NCT01165242|523880512|FG001|Overall Study|Lost to Follow-up|7|||
145281381|NCT01165242|523880513|FG002|Overall Study|Lost to Follow-up|10|||
145281382|NCT03877237|523880514|FG000|Overall Study|Adverse Event|1|||
145281383|NCT03877237|523880515|FG001|Overall Study|Adverse Event|2|||
145281384|NCT03877237|523880514|FG000|Overall Study|Death|3|||
145281385|NCT03877237|523880515|FG001|Overall Study|Death|2|||
145281386|NCT03877237|523880514|FG000|Overall Study|Physician Decision|1|||
145281387|NCT03877237|523880515|FG001|Overall Study|Physician Decision|0|||
145281388|NCT03877237|523880514|FG000|Overall Study|Withdrawal by Subject|0|||
145281389|NCT03877237|523880515|FG001|Overall Study|Withdrawal by Subject|2|||
145281390|NCT03372083|523880516|FG000|Overall Study|Adverse Event|3|||
145281391|NCT03372083|523880516|FG000|Overall Study|Physician Decision|1|||
145281392|NCT03372083|523880516|FG000|Overall Study|Withdrawal by Subject|1|||
145281393|NCT02236754|523880517|FG000|Overall Study|Withdrawal by Subject|1|||
145281394|NCT02236754|523880518|FG001|Overall Study|Withdrawal by Subject|0|||
145281395|NCT02544633|523880519|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
145281396|NCT02544633|523880520|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
145281397|NCT02544633|523880521|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
145785703|NCT00883558|525722999|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
145785704|NCT00883558|525723000|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
145281398|NCT02544633|523880522|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
145281399|NCT02544633|523880519|FG000|Treatment Period|Adverse Event|7|||
145281400|NCT02544633|523880520|FG001|Treatment Period|Adverse Event|4|||
145281401|NCT02544633|523880521|FG002|Treatment Period|Adverse Event|0|||
145281402|NCT02544633|523880522|FG003|Treatment Period|Adverse Event|5|||
145281403|NCT02544633|523880519|FG000|Treatment Period|Lack of Efficacy|17|||
145281404|NCT02544633|523880520|FG001|Treatment Period|Lack of Efficacy|11|||
145281405|NCT02544633|523880521|FG002|Treatment Period|Lack of Efficacy|5|||
145281406|NCT02544633|523880522|FG003|Treatment Period|Lack of Efficacy|5|||
145281407|NCT02544633|523880519|FG000|Treatment Period|Global Deterioration of Health|3|||
145281408|NCT02544633|523880520|FG001|Treatment Period|Global Deterioration of Health|3|||
145281409|NCT02544633|523880521|FG002|Treatment Period|Global Deterioration of Health|0|||
145281410|NCT02544633|523880522|FG003|Treatment Period|Global Deterioration of Health|1|||
145281411|NCT02544633|523880519|FG000|Treatment Period|Withdrawal by Subject|1|||
145281412|NCT02544633|523880520|FG001|Treatment Period|Withdrawal by Subject|0|||
145281413|NCT02544633|523880521|FG002|Treatment Period|Withdrawal by Subject|0|||
145281414|NCT02544633|523880522|FG003|Treatment Period|Withdrawal by Subject|0|||
145281415|NCT02544633|523880519|FG000|Treatment Period|Lost to Follow-up|0|||
145281416|NCT02544633|523880520|FG001|Treatment Period|Lost to Follow-up|1|||
145281417|NCT02544633|523880521|FG002|Treatment Period|Lost to Follow-up|0|||
145281418|NCT02544633|523880522|FG003|Treatment Period|Lost to Follow-up|0|||
145785705|NCT00883558|525722998|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
145785706|NCT00883558|525722999|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
145785707|NCT00883558|525723000|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
145785708|NCT00883558|525722998|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
145785709|NCT00883558|525722999|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
145785710|NCT00883558|525723000|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
145785711|NCT00883558|525722998|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
145785712|NCT00883558|525722999|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
145785713|NCT00883558|525723000|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
145785714|NCT01252134|525723002|FG000|Period 1, 8 Hours|Personal Reasons|0|||
145785715|NCT01252134|525723003|FG001|Period 1, 8 Hours|Personal Reasons|1|||
145785716|NCT01252134|525723004|FG002|Period 1, 8 Hours|Personal Reasons|1|||
145785717|NCT01252134|525723005|FG003|Period 1, 8 Hours|Personal Reasons|0|||
145785718|NCT01252134|525723006|FG004|Period 1, 8 Hours|Personal Reasons|0|||
145785719|NCT01252134|525723007|FG005|Period 1, 8 Hours|Personal Reasons|0|||
145785720|NCT02273050|525723009|FG000|Overall Study|Adverse Event|4|||
145785721|NCT02273050|525723010|FG001|Overall Study|Adverse Event|3|||
145785722|NCT02273050|525723011|FG002|Overall Study|Adverse Event|3|||
145785723|NCT02273050|525723009|FG000|Overall Study|Death|0|||
145785724|NCT02273050|525723010|FG001|Overall Study|Death|0|||
145785725|NCT02273050|525723011|FG002|Overall Study|Death|1|||
145785726|NCT02273050|525723009|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
145785727|NCT02273050|525723010|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
145785728|NCT02273050|525723011|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
145785729|NCT02273050|525723009|FG000|Overall Study|Lack of Efficacy|0|||
145785730|NCT02273050|525723010|FG001|Overall Study|Lack of Efficacy|1|||
145785731|NCT02273050|525723011|FG002|Overall Study|Lack of Efficacy|1|||
145785732|NCT02273050|525723009|FG000|Overall Study|Withdrawal by Subject|17|||
145785733|NCT02273050|525723010|FG001|Overall Study|Withdrawal by Subject|14|||
145785734|NCT02273050|525723011|FG002|Overall Study|Withdrawal by Subject|16|||
145785735|NCT02273050|525723009|FG000|Overall Study|Lost to Follow-up|0|||
145785736|NCT02273050|525723010|FG001|Overall Study|Lost to Follow-up|2|||
145785737|NCT02273050|525723011|FG002|Overall Study|Lost to Follow-up|3|||
145785738|NCT02273050|525723009|FG000|Overall Study|Protocol Violation|3|||
145785739|NCT02273050|525723010|FG001|Overall Study|Protocol Violation|1|||
145785740|NCT02273050|525723011|FG002|Overall Study|Protocol Violation|4|||
145785741|NCT00903032|525723012|FG000|Overall Study|Withdrawal by Subject|5|||
145785742|NCT00903032|525723013|FG001|Overall Study|Withdrawal by Subject|3|||
145785743|NCT00903032|525723012|FG000|Overall Study|Lost to Follow-up|2|||
145281419|NCT02544633|523880519|FG000|Treatment Period|Death|0|||
145281420|NCT02544633|523880520|FG001|Treatment Period|Death|0|||
145281421|NCT02544633|523880521|FG002|Treatment Period|Death|1|||
145281422|NCT02544633|523880522|FG003|Treatment Period|Death|0|||
145281423|NCT02544633|523880519|FG000|Treatment Period|Non-compliance|0|||
145281424|NCT02544633|523880520|FG001|Treatment Period|Non-compliance|0|||
145281425|NCT02544633|523880521|FG002|Treatment Period|Non-compliance|1|||
145281426|NCT02544633|523880522|FG003|Treatment Period|Non-compliance|0|||
145281427|NCT02544633|523880519|FG000|Treatment Period|Clinical Disease Progression|0|||
145281428|NCT02544633|523880520|FG001|Treatment Period|Clinical Disease Progression|0|||
145281429|NCT02544633|523880521|FG002|Treatment Period|Clinical Disease Progression|0|||
145785744|NCT00903032|525723013|FG001|Overall Study|Lost to Follow-up|2|||
145785745|NCT01675531|525723015|FG000|Overall Study|Adverse Event|9|||
145281430|NCT02544633|523880522|FG003|Treatment Period|Clinical Disease Progression|1|||
145281431|NCT02544633|523880519|FG000|Survival Follow-up Period|Death|12|||
145785746|NCT01675531|525723015|FG000|Overall Study|Withdrawal by Subject|7|||
145785747|NCT01675531|525723015|FG000|Overall Study|Lack of Efficacy|1|||
145785748|NCT01675531|525723015|FG000|Overall Study|Protocol Violation|8|||
145281432|NCT02544633|523880520|FG001|Survival Follow-up Period|Death|14|||
145281433|NCT02544633|523880521|FG002|Survival Follow-up Period|Death|3|||
145281434|NCT02544633|523880522|FG003|Survival Follow-up Period|Death|9|||
145281435|NCT02544633|523880519|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
145281436|NCT02544633|523880520|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
145281437|NCT02544633|523880521|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
145281438|NCT02544633|523880522|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
145281439|NCT02544633|523880519|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
145281440|NCT02544633|523880520|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
145281441|NCT02544633|523880521|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
145281442|NCT02544633|523880522|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
145281443|NCT02544633|523880519|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
145281444|NCT02544633|523880520|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
145281445|NCT02544633|523880521|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
145281446|NCT02544633|523880522|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
145281447|NCT02092961|523880523|FG000|Overall Study|Not reported|1|||
145281448|NCT02092961|523880524|FG001|Overall Study|Not reported|0|||
145281449|NCT02092961|523880525|FG002|Overall Study|Not reported|1|||
145281450|NCT02092961|523880523|FG000|Overall Study|Study stopped|13|||
145785749|NCT00506077|525723021|FG000|Treatment Period 1|Adverse Event|2|||
145785750|NCT00506077|525723022|FG001|Treatment Period 1|Adverse Event|1|||
145785751|NCT00506077|525723021|FG000|Treatment Period 1|Lost to Follow-up|0|||
145785752|NCT00506077|525723022|FG001|Treatment Period 1|Lost to Follow-up|2|||
145785753|NCT00506077|525723021|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145785754|NCT00506077|525723022|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145785755|NCT00506077|525723021|FG000|Treatment Period 2|Adverse Event|0|||
145785756|NCT00506077|525723022|FG001|Treatment Period 2|Adverse Event|1|||
145785757|NCT00506077|525723021|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145281451|NCT02092961|523880524|FG001|Overall Study|Study stopped|9|||
145281452|NCT02092961|523880525|FG002|Overall Study|Study stopped|12|||
145281453|NCT02092961|523880523|FG000|Overall Study|Lack of therapeutic response|2|||
145281454|NCT02092961|523880524|FG001|Overall Study|Lack of therapeutic response|1|||
145281455|NCT02092961|523880525|FG002|Overall Study|Lack of therapeutic response|3|||
145281456|NCT02092961|523880523|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
145281457|NCT02092961|523880524|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
145281458|NCT02092961|523880525|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
145281459|NCT02092961|523880523|FG000|Overall Study|Adverse Event|2|||
145281460|NCT02092961|523880524|FG001|Overall Study|Adverse Event|4|||
145281461|NCT02092961|523880525|FG002|Overall Study|Adverse Event|0|||
145281462|NCT02270983|523880526|FG000|Overall Study|Adverse Event|3|||
145281463|NCT02270983|523880527|FG001|Overall Study|Adverse Event|2|||
145281464|NCT02270983|523880528|FG002|Overall Study|Adverse Event|6|||
145281465|NCT02270983|523880526|FG000|Overall Study|Lack of Efficacy|2|||
145281466|NCT02270983|523880527|FG001|Overall Study|Lack of Efficacy|1|||
145281467|NCT02270983|523880528|FG002|Overall Study|Lack of Efficacy|1|||
145281468|NCT02270983|523880526|FG000|Overall Study|Withdrawal by Subject|1|||
145281469|NCT02270983|523880527|FG001|Overall Study|Withdrawal by Subject|0|||
145281470|NCT02270983|523880528|FG002|Overall Study|Withdrawal by Subject|2|||
145281471|NCT02270983|523880526|FG000|Overall Study|Lost to Follow-up|1|||
145281472|NCT02270983|523880527|FG001|Overall Study|Lost to Follow-up|1|||
145785758|NCT00506077|525723022|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145785759|NCT01293032|525723024|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
145785760|NCT01293032|525723025|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
145281473|NCT02270983|523880528|FG002|Overall Study|Lost to Follow-up|2|||
145785761|NCT01293032|525723026|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
145785762|NCT01293032|525723027|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
145785763|NCT01293032|525723024|FG000|Treatment|Adverse Event|0|||
145785764|NCT01293032|525723025|FG001|Treatment|Adverse Event|0|||
145785765|NCT01293032|525723026|FG002|Treatment|Adverse Event|1|||
145785766|NCT01293032|525723027|FG003|Treatment|Adverse Event|1|||
145785767|NCT01293032|525723024|FG000|Treatment|Withdrawal by Subject|2|||
145785768|NCT01293032|525723025|FG001|Treatment|Withdrawal by Subject|4|||
145281474|NCT02270983|523880526|FG000|Overall Study|Protocol Violation|1|||
145281475|NCT02270983|523880527|FG001|Overall Study|Protocol Violation|1|||
145281476|NCT02270983|523880528|FG002|Overall Study|Protocol Violation|1|||
145281477|NCT02270983|523880526|FG000|Overall Study|family emergency|0|||
145785769|NCT01293032|525723026|FG002|Treatment|Withdrawal by Subject|0|||
145281478|NCT02270983|523880527|FG001|Overall Study|family emergency|1|||
145281479|NCT02270983|523880528|FG002|Overall Study|family emergency|0|||
145281480|NCT02270983|523880526|FG000|Overall Study|study procedure non-compliance|1|||
145281481|NCT02270983|523880527|FG001|Overall Study|study procedure non-compliance|0|||
145785770|NCT01293032|525723027|FG003|Treatment|Withdrawal by Subject|0|||
145785771|NCT01293032|525723024|FG000|Treatment|Disease Progression, relapse|0|||
145281482|NCT02270983|523880528|FG002|Overall Study|study procedure non-compliance|0|||
145785772|NCT01293032|525723025|FG001|Treatment|Disease Progression, relapse|1|||
145281483|NCT02270983|523880526|FG000|Overall Study|moved away from study site|0|||
145281484|NCT02270983|523880527|FG001|Overall Study|moved away from study site|1|||
145281485|NCT02270983|523880528|FG002|Overall Study|moved away from study site|0|||
145281486|NCT00928252|523880531|FG000|Overall Study|Physician Decision|3|||
145281487|NCT01605461|523880532|FG000|Overall Study|Lost to Follow-up|3|||
145281488|NCT01605461|523880532|FG000|Overall Study|Withdrawal by Subject|1|||
145281489|NCT02024698|523880533|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
145281490|NCT02024698|523880534|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
145281491|NCT04132232|523880535|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
145281492|NCT04132232|523880536|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
145281493|NCT04132232|523880535|FG000|Overall Study|Lost to Follow-up|6|||
145281494|NCT04132232|523880536|FG001|Overall Study|Lost to Follow-up|7|||
145281495|NCT00368537|523880538|FG000|Randomization|No study drug dosed|13|||
145281496|NCT00368537|523880539|FG001|Randomization|No study drug dosed|6|||
145281497|NCT00368537|523880538|FG000|Baseline Participants|Lost to Follow-up|16|||
145281498|NCT00368537|523880539|FG001|Baseline Participants|Lost to Follow-up|17|||
145281499|NCT00368537|523880538|FG000|Baseline Participants|Withdrawal by Subject|6|||
145281500|NCT00368537|523880539|FG001|Baseline Participants|Withdrawal by Subject|4|||
145281501|NCT00368537|523880538|FG000|Baseline Participants|Death|1|||
145281502|NCT00368537|523880539|FG001|Baseline Participants|Death|2|||
145281503|NCT00368537|523880538|FG000|Baseline Participants|No susceptibility|1|||
145281504|NCT00368537|523880539|FG001|Baseline Participants|No susceptibility|0|||
145281505|NCT00368537|523880538|FG000|Baseline Participants|Patient uncompliant|0|||
145281506|NCT00368537|523880539|FG001|Baseline Participants|Patient uncompliant|1|||
145281507|NCT02732561|523880555|FG000|Overall Study|Lost to Follow-up|1|||
145281508|NCT02732561|523880556|FG001|Overall Study|Lost to Follow-up|1|||
145281509|NCT02732561|523880555|FG000|Overall Study|Withdrawal by Subject|1|||
145281510|NCT02732561|523880556|FG001|Overall Study|Withdrawal by Subject|0|||
145281511|NCT01886300|523880557|FG000|Overall Study|Trial terminated by sponsor|16|||
145281512|NCT01797120|523880558|FG000|Overall Study|Disesae progression|37|||
145281513|NCT01797120|523880559|FG001|Overall Study|Disesae progression|49|||
145281514|NCT01797120|523880558|FG000|Overall Study|Adverse Event|13|||
145281515|NCT01797120|523880559|FG001|Overall Study|Adverse Event|5|||
145281516|NCT01797120|523880558|FG000|Overall Study|Withdrawal by Subject|6|||
145281517|NCT01797120|523880559|FG001|Overall Study|Withdrawal by Subject|6|||
145281518|NCT01797120|523880558|FG000|Overall Study|Symptomatic progression|2|||
145281519|NCT01797120|523880559|FG001|Overall Study|Symptomatic progression|1|||
145281520|NCT01797120|523880558|FG000|Overall Study|Non-compliance|1|||
145281521|NCT01797120|523880559|FG001|Overall Study|Non-compliance|0|||
145281522|NCT01797120|523880558|FG000|Overall Study|Physician Decision|3|||
145281523|NCT01797120|523880559|FG001|Overall Study|Physician Decision|0|||
145281524|NCT01797120|523880558|FG000|Overall Study|still on treatment|2|||
145281525|NCT01797120|523880559|FG001|Overall Study|still on treatment|4|||
145281526|NCT01797120|523880558|FG000|Overall Study|never start protocol therapy|2|||
145281527|NCT01797120|523880559|FG001|Overall Study|never start protocol therapy|0|||
145281528|NCT02622074|523880560|FG000|Overall Study|Death|4|||
145281529|NCT02622074|523880561|FG001|Overall Study|Death|0|||
145281530|NCT02622074|523880562|FG002|Overall Study|Death|0|||
145281531|NCT02622074|523880563|FG003|Overall Study|Death|1|||
145281532|NCT02622074|523880564|FG004|Overall Study|Death|1|||
145281533|NCT02622074|523880565|FG005|Overall Study|Death|0|||
145785773|NCT01293032|525723026|FG002|Treatment|Disease Progression, relapse|0|||
145785774|NCT01293032|525723027|FG003|Treatment|Disease Progression, relapse|0|||
145785775|NCT01757704|525723030|FG000|Overall Study|Protocol Violation|1|||
145785776|NCT01757704|525723031|FG001|Overall Study|Protocol Violation|3|||
145785777|NCT02749721|525723034|FG000|Screening|Withdrawal by Subject|1|||
145785778|NCT02749721|525723034|FG000|Screening|Lost to Follow-up|2|||
145785779|NCT02749721|525723034|FG000|Screening|Protocol Violation|3|||
145785780|NCT02749721|525723034|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
145785781|NCT02749721|525723034|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
145785782|NCT01929044|525723039|FG000|Overall Study|Adverse Event|1|||
145785783|NCT01929044|525723040|FG001|Overall Study|Adverse Event|0|||
145281534|NCT02622074|523880560|FG000|Overall Study|Withdrawal by Subject|0|||
145281535|NCT02622074|523880561|FG001|Overall Study|Withdrawal by Subject|1|||
145281536|NCT02622074|523880562|FG002|Overall Study|Withdrawal by Subject|0|||
145281537|NCT02622074|523880563|FG003|Overall Study|Withdrawal by Subject|0|||
145281538|NCT02622074|523880564|FG004|Overall Study|Withdrawal by Subject|0|||
145281539|NCT02622074|523880565|FG005|Overall Study|Withdrawal by Subject|0|||
145281540|NCT02114931|523880566|FG000|Overall Study|Withdrawal by Subject|15|||
145281541|NCT02114931|523880567|FG001|Overall Study|Withdrawal by Subject|18|||
145403993|NCT02194465|524336455|FG004|Overall Study|Protocol Violation|1|||
145281542|NCT02114931|523880566|FG000|Overall Study|Adverse Event|4|||
145281543|NCT02114931|523880567|FG001|Overall Study|Adverse Event|6|||
145785784|NCT01929044|525723039|FG000|Overall Study|Protocol Violation|9|||
145785785|NCT01929044|525723040|FG001|Overall Study|Protocol Violation|14|||
145281544|NCT02114931|523880566|FG000|Overall Study|Lost to Follow-up|3|||
145281545|NCT02114931|523880567|FG001|Overall Study|Lost to Follow-up|3|||
145281546|NCT02114931|523880566|FG000|Overall Study|Physician Decision|1|||
145785786|NCT01929044|525723039|FG000|Overall Study|Not Treated|1|||
145785787|NCT01929044|525723040|FG001|Overall Study|Not Treated|3|||
145785788|NCT01555463|525723043|FG000|Treatment|Adverse Event|6|||
145785789|NCT01555463|525723044|FG001|Treatment|Adverse Event|12|||
145785790|NCT01555463|525723043|FG000|Treatment|Withdrawal by Subject|24|||
145785791|NCT01555463|525723044|FG001|Treatment|Withdrawal by Subject|36|||
145785792|NCT01555463|525723043|FG000|Treatment|Lost to Follow-up|28|||
145785793|NCT01555463|525723044|FG001|Treatment|Lost to Follow-up|23|||
145785794|NCT01555463|525723043|FG000|Treatment|Protocol Violation|4|||
145785795|NCT01555463|525723044|FG001|Treatment|Protocol Violation|5|||
145785796|NCT01555463|525723043|FG000|Treatment|Other reason|2|||
145785797|NCT01555463|525723044|FG001|Treatment|Other reason|3|||
145785798|NCT01555463|525723043|FG000|Follow up|Adverse Event|2|||
145785799|NCT01555463|525723044|FG001|Follow up|Adverse Event|5|||
145785800|NCT01555463|525723043|FG000|Follow up|Death|0|||
145785801|NCT01555463|525723044|FG001|Follow up|Death|1|||
145785802|NCT01555463|525723043|FG000|Follow up|Withdrawal by Subject|22|||
145785803|NCT01555463|525723044|FG001|Follow up|Withdrawal by Subject|22|||
145785804|NCT01555463|525723043|FG000|Follow up|Lost to Follow-up|9|||
145785805|NCT01555463|525723044|FG001|Follow up|Lost to Follow-up|10|||
145785806|NCT01555463|525723043|FG000|Follow up|Protocol Violation|2|||
145785807|NCT01555463|525723044|FG001|Follow up|Protocol Violation|4|||
145785808|NCT01555463|525723043|FG000|Follow up|Other reason|3|||
145785809|NCT01555463|525723044|FG001|Follow up|Other reason|3|||
145785810|NCT04333433|525723045|FG000|Overall Study|Withdrawal by Subject|6|||
145785811|NCT04333433|525723046|FG001|Overall Study|Withdrawal by Subject|3|||
145785812|NCT04333433|525723045|FG000|Overall Study|Death|3|||
145785813|NCT04333433|525723046|FG001|Overall Study|Death|0|||
145785814|NCT04333433|525723045|FG000|Overall Study|Lost to Follow-up|6|||
145785815|NCT04333433|525723046|FG001|Overall Study|Lost to Follow-up|1|||
145785816|NCT04333433|525723045|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
145785817|NCT04333433|525723046|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
145785818|NCT02026271|525723047|FG000|Overall Study|Adverse Event|2|||
145785819|NCT02026271|525723048|FG001|Overall Study|Adverse Event|3|||
145785820|NCT02026271|525723049|FG002|Overall Study|Adverse Event|2|||
145785821|NCT02026271|525723050|FG003|Overall Study|Adverse Event|3|||
145785822|NCT02026271|525723051|FG004|Overall Study|Adverse Event|0|||
145785823|NCT02026271|525723047|FG000|Overall Study|Withdrawal by Subject|0|||
145785824|NCT02026271|525723048|FG001|Overall Study|Withdrawal by Subject|0|||
145785825|NCT02026271|525723049|FG002|Overall Study|Withdrawal by Subject|0|||
145785826|NCT02026271|525723050|FG003|Overall Study|Withdrawal by Subject|0|||
145785827|NCT02026271|525723051|FG004|Overall Study|Withdrawal by Subject|1|||
145785828|NCT02275026|525723054|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
145785829|NCT02275026|525723054|FG000|Overall Study|Withdrawal by Subject|4|||
145785830|NCT02275026|525723054|FG000|Overall Study|Ineligible due to medical history|13|||
145785831|NCT02275026|525723054|FG000|Overall Study|MRI malfunction precluded testing|1|||
145785832|NCT02275026|525723054|FG000|Overall Study|Ineligible after MRI findings|1|||
145785833|NCT02275026|525723054|FG000|Overall Study|Lost to Follow-up|2|||
145785834|NCT02275026|525723054|FG000|Overall Study|Scanner failure|1|||
145785835|NCT00374907|525723055|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
145785836|NCT00374907|525723056|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
145785837|NCT00374907|525723055|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
145785838|NCT00374907|525723056|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
145281547|NCT02114931|523880567|FG001|Overall Study|Physician Decision|2|||
145281548|NCT02114931|523880566|FG000|Overall Study|Other|2|||
145281549|NCT02114931|523880567|FG001|Overall Study|Other|1|||
145785839|NCT00374907|525723055|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
145785840|NCT00374907|525723056|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
145785841|NCT00374907|525723055|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
145281550|NCT03726437|523880568|FG000|Overall Study|Lost to Follow-up|85|||
145281551|NCT03726437|523880569|FG001|Overall Study|Lost to Follow-up|76|||
145785842|NCT00374907|525723056|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
145785843|NCT00374907|525723055|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
145785844|NCT00374907|525723056|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
145785845|NCT01108809|525723057|FG000|Overall Study|Adverse Event|3|||
145785846|NCT01108809|525723057|FG000|Overall Study|Lost to Follow-up|1|||
145785847|NCT02582749|525723059|FG000|Overall Study|Study terminated by funder|5|||
145785848|NCT02582749|525723060|FG001|Overall Study|Study terminated by funder|10|||
145785849|NCT02582749|525723059|FG000|Overall Study|Withdrawal by Subject|0|||
145785850|NCT02582749|525723060|FG001|Overall Study|Withdrawal by Subject|1|||
145785851|NCT00001262|525723061|FG000|Overall Study|Death|10|||
145785852|NCT00001262|525723062|FG001|Overall Study|Death|11|||
145785853|NCT00001262|525723063|FG002|Overall Study|Death|0|||
145785854|NCT00001262|525723061|FG000|Overall Study|Withdrawal by Subject|0|||
145785855|NCT00001262|525723062|FG001|Overall Study|Withdrawal by Subject|3|||
145281552|NCT00267007|523880570|FG000|Overall Study|Withdrawal by Subject|6|||
145281553|NCT00267007|523880571|FG001|Overall Study|Withdrawal by Subject|0|||
145281554|NCT00267007|523880570|FG000|Overall Study|Lost to Follow-up|1|||
145281555|NCT00267007|523880571|FG001|Overall Study|Lost to Follow-up|0|||
145281556|NCT00267007|523880570|FG000|Overall Study|Non-compliance|0|||
145281557|NCT00267007|523880571|FG001|Overall Study|Non-compliance|1|||
145785856|NCT00001262|525723063|FG002|Overall Study|Withdrawal by Subject|0|||
145785857|NCT02379923|525723064|FG000|Overall Study|Death|5|||
145785858|NCT00576693|525723068|FG000|Overall Study|Lost to Follow-up|7|||
145785859|NCT00576693|525723069|FG001|Overall Study|Lost to Follow-up|11|||
145785860|NCT00576693|525723068|FG000|Overall Study|Withdrawal by Subject|3|||
145785861|NCT00576693|525723069|FG001|Overall Study|Withdrawal by Subject|13|||
145785862|NCT01413178|525723070|FG000|Overall Study|Toxicity|1|||
145785863|NCT01413178|525723071|FG001|Overall Study|Toxicity|0|||
145785864|NCT01413178|525723070|FG000|Overall Study|Ineligible|0|||
145785865|NCT01413178|525723071|FG001|Overall Study|Ineligible|2|||
145785866|NCT00540449|525723072|FG000|Overall Study|Adverse Event|12|||
145785867|NCT00540449|525723073|FG001|Overall Study|Adverse Event|32|||
145785868|NCT00540449|525723072|FG000|Overall Study|Sponsor's Decision|1|||
145785869|NCT00540449|525723073|FG001|Overall Study|Sponsor's Decision|1|||
145785870|NCT00540449|525723072|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
145785871|NCT00540449|525723073|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
145785872|NCT00540449|525723072|FG000|Overall Study|Lost to Follow-up|19|||
145785873|NCT00540449|525723073|FG001|Overall Study|Lost to Follow-up|17|||
145785874|NCT00540449|525723072|FG000|Overall Study|Subject Non-Compliant|7|||
145785875|NCT00540449|525723073|FG001|Overall Study|Subject Non-Compliant|5|||
145785876|NCT00540449|525723072|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
145785877|NCT00540449|525723073|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
145785878|NCT00540449|525723072|FG000|Overall Study|Withdrawal by Subject|10|||
145785879|NCT00540449|525723073|FG001|Overall Study|Withdrawal by Subject|10|||
145785880|NCT00540449|525723072|FG000|Overall Study|Other|1|||
145785881|NCT00540449|525723073|FG001|Overall Study|Other|4|||
145785882|NCT00601523|525723074|FG000|Overall Study|Adverse Event|42|||
145785883|NCT00601523|525723075|FG001|Overall Study|Adverse Event|14|||
145785884|NCT00601523|525723074|FG000|Overall Study|Lack of Efficacy|3|||
145785885|NCT00601523|525723075|FG001|Overall Study|Lack of Efficacy|0|||
145785886|NCT00601523|525723074|FG000|Overall Study|Protocol Violation|5|||
145785887|NCT00601523|525723075|FG001|Overall Study|Protocol Violation|1|||
145785888|NCT00601523|525723074|FG000|Overall Study|Lost to Follow-up|0|||
145785889|NCT00601523|525723075|FG001|Overall Study|Lost to Follow-up|1|||
145785890|NCT00601523|525723074|FG000|Overall Study|Withdrawal by Subject|18|||
145785891|NCT00601523|525723075|FG001|Overall Study|Withdrawal by Subject|9|||
145785892|NCT00601523|525723074|FG000|Overall Study|Other|9|||
145785893|NCT00601523|525723075|FG001|Overall Study|Other|1|||
145785894|NCT03643432|525723076|FG000|Overall Study|Lost to Follow-up|1|||
145785895|NCT03643432|525723077|FG001|Overall Study|Lost to Follow-up|0|||
145785896|NCT00804193|525723078|FG000|Overall Study|Lack of baseline fungus|32|||
145403994|NCT02194465|524336456|FG005|Overall Study|Protocol Violation|0|||
145403995|NCT02194465|524336457|FG006|Overall Study|Protocol Violation|0|||
145403996|NCT02194465|524336451|FG000|Overall Study|Withdrawal by Subject|1|||
145403997|NCT02194465|524336452|FG001|Overall Study|Withdrawal by Subject|3|||
145403998|NCT02194465|524336453|FG002|Overall Study|Withdrawal by Subject|1|||
145403999|NCT02194465|524336454|FG003|Overall Study|Withdrawal by Subject|2|||
145404000|NCT02194465|524336455|FG004|Overall Study|Withdrawal by Subject|2|||
145404001|NCT02194465|524336456|FG005|Overall Study|Withdrawal by Subject|1|||
145404002|NCT02194465|524336457|FG006|Overall Study|Withdrawal by Subject|2|||
145281558|NCT00267007|523880570|FG000|Overall Study|Adverse Event|1|||
145785897|NCT00804193|525723079|FG001|Overall Study|Lack of baseline fungus|31|||
145785898|NCT00804193|525723080|FG002|Overall Study|Lack of baseline fungus|19|||
145785899|NCT00804193|525723078|FG000|Overall Study|Adverse Event|0|||
145785900|NCT00804193|525723079|FG001|Overall Study|Adverse Event|0|||
145785901|NCT00804193|525723080|FG002|Overall Study|Adverse Event|2|||
145785902|NCT00804193|525723078|FG000|Overall Study|Lack of Efficacy|1|||
145281559|NCT00267007|523880571|FG001|Overall Study|Adverse Event|0|||
145281560|NCT01205529|523880575|FG000|Overall Study|Procedure Cancelled|4|||
145785903|NCT00804193|525723079|FG001|Overall Study|Lack of Efficacy|1|||
145785904|NCT00804193|525723080|FG002|Overall Study|Lack of Efficacy|3|||
145785905|NCT00804193|525723078|FG000|Overall Study|Protocol Violation|0|||
145785906|NCT00804193|525723079|FG001|Overall Study|Protocol Violation|8|||
145785907|NCT00804193|525723080|FG002|Overall Study|Protocol Violation|2|||
145785908|NCT00804193|525723078|FG000|Overall Study|Lost to Follow-up|3|||
145785909|NCT00804193|525723079|FG001|Overall Study|Lost to Follow-up|3|||
145785910|NCT00804193|525723080|FG002|Overall Study|Lost to Follow-up|4|||
145785911|NCT00804193|525723078|FG000|Overall Study|Withdrawal by Subject|3|||
145785912|NCT00804193|525723079|FG001|Overall Study|Withdrawal by Subject|1|||
145281561|NCT01205529|523880575|FG000|Overall Study|Withdrawal by Subject|2|||
145281562|NCT01205529|523880575|FG000|Overall Study|Physician Decision|4|||
145404003|NCT02194465|524336451|FG000|Overall Study|Discontinued follow-up period|0|||
145404004|NCT02194465|524336452|FG001|Overall Study|Discontinued follow-up period|2|||
145785913|NCT00804193|525723080|FG002|Overall Study|Withdrawal by Subject|2|||
145785914|NCT04072146|525723083|FG000|Overall Study|Adverse Event|0|||
145281563|NCT01205529|523880575|FG000|Overall Study|Unstable post op|15|||
145785915|NCT04072146|525723084|FG001|Overall Study|Adverse Event|1|||
145785916|NCT01617434|525723085|FG000|Overall Study|Adverse Event|12|||
145785917|NCT01617434|525723086|FG001|Overall Study|Adverse Event|3|||
145785918|NCT01617434|525723085|FG000|Overall Study|Protocol Violation|8|||
145785919|NCT01617434|525723086|FG001|Overall Study|Protocol Violation|7|||
145785920|NCT01617434|525723085|FG000|Overall Study|Withdrawal Criteria|12|||
145785921|NCT01617434|525723086|FG001|Overall Study|Withdrawal Criteria|37|||
145785922|NCT01617434|525723085|FG000|Overall Study|Unclassified|3|||
145785923|NCT01617434|525723086|FG001|Overall Study|Unclassified|4|||
145785924|NCT03283163|525723087|FG000|Overall Study|Lost to Follow-up|1|||
145785925|NCT03283163|525723087|FG000|Overall Study|other life commitments|6|||
145785926|NCT03283163|525723087|FG000|Overall Study|COVID-19 institution wide halting|1|||
145785927|NCT03283163|525723087|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
145785928|NCT03283163|525723087|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
145785929|NCT04238663|525723088|FG000|Overall Study|Lost to Follow-up|0|||
145785930|NCT04238663|525723089|FG001|Overall Study|Lost to Follow-up|1|||
145785931|NCT04238663|525723090|FG002|Overall Study|Lost to Follow-up|0|||
145785932|NCT01193348|525723091|FG000|Screening Period|Screen Failure|5|||
145785933|NCT01193348|525723091|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
145785934|NCT01193348|525723091|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
145785935|NCT01193348|525723091|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
145785936|NCT01193348|525723091|FG000|Extension Treatment Period|Physician Decision|1|||
145785937|NCT01193348|525723091|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
145785938|NCT00968253|525723092|FG000|Overall Study|Death|0|||
145785939|NCT00968253|525723093|FG001|Overall Study|Death|0|||
145785940|NCT00968253|525723094|FG002|Overall Study|Death|2|||
145785941|NCT00968253|525723092|FG000|Overall Study|Withdrawal by Subject|0|||
145785942|NCT00968253|525723093|FG001|Overall Study|Withdrawal by Subject|0|||
145785943|NCT00968253|525723094|FG002|Overall Study|Withdrawal by Subject|1|||
145785944|NCT00968253|525723092|FG000|Overall Study|Disease Progression|0|||
145785945|NCT00968253|525723093|FG001|Overall Study|Disease Progression|3|||
145785946|NCT00968253|525723094|FG002|Overall Study|Disease Progression|3|||
145785947|NCT00968253|525723092|FG000|Overall Study|Adverse Event|0|||
145785948|NCT00968253|525723093|FG001|Overall Study|Adverse Event|0|||
145785949|NCT00968253|525723094|FG002|Overall Study|Adverse Event|1|||
145785950|NCT01721408|525723095|FG000|Overall Study|Adverse Event|6|||
145785951|NCT01721408|525723096|FG001|Overall Study|Adverse Event|1|||
145785952|NCT01721408|525723095|FG000|Overall Study|Death|1|||
145785953|NCT01721408|525723096|FG001|Overall Study|Death|0|||
145785954|NCT01721408|525723095|FG000|Overall Study|Insufficient clinical response|15|||
145785955|NCT01721408|525723096|FG001|Overall Study|Insufficient clinical response|6|||
145785956|NCT01721408|525723095|FG000|Overall Study|No longer willing to participate study|9|||
145785957|NCT01721408|525723096|FG001|Overall Study|No longer willing to participate study|10|||
145785958|NCT01721408|525723095|FG000|Overall Study|Protocol Violation|0|||
145785959|NCT01721408|525723096|FG001|Overall Study|Protocol Violation|2|||
145785960|NCT01721408|525723095|FG000|Overall Study|Other|3|||
145785961|NCT01721408|525723096|FG001|Overall Study|Other|3|||
145785962|NCT01721408|525723095|FG000|Overall Study|Lost to Follow-up|1|||
145785963|NCT01721408|525723096|FG001|Overall Study|Lost to Follow-up|2|||
145785964|NCT01721408|525723095|FG000|Overall Study|Does not meet entrance criteria|1|||
145785965|NCT01721408|525723096|FG001|Overall Study|Does not meet entrance criteria|0|||
145785966|NCT02928406|525723099|FG000|Overall Study|Death|780|||
145785967|NCT02928406|525723099|FG000|Overall Study|Progressive disease|3|||
145785968|NCT02928406|525723099|FG000|Overall Study|Lost to Follow-up|49|||
145785969|NCT02928406|525723099|FG000|Overall Study|Non-compliance|2|||
145785970|NCT02928406|525723099|FG000|Overall Study|Withdrawal by Subject|40|||
145785971|NCT02928406|525723099|FG000|Overall Study|Study terminated by sponsor|57|||
145785972|NCT02928406|525723099|FG000|Overall Study|Physician Decision|1|||
145281564|NCT01205529|523880575|FG000|Overall Study|No longer met criteria|30|||
145281565|NCT00667719|523880576|FG000|Overall Study|Adverse Event|39|||
145281566|NCT00667719|523880576|FG000|Overall Study|Abnormal Test Procedure|1|||
145785973|NCT02928406|525723099|FG000|Overall Study|Various reasons|72|||
145785974|NCT03987620|525723100|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
145785975|NCT03987620|525723101|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
145785976|NCT03987620|525723100|FG000|Overall Study|Adverse Event|3|||
145281567|NCT00667719|523880576|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145281568|NCT00667719|523880576|FG000|Overall Study|Protocol Violation|3|||
145281569|NCT00667719|523880576|FG000|Overall Study|Withdrawal by Subject|17|||
145281570|NCT00667719|523880576|FG000|Overall Study|Lost to Follow-up|8|||
145785977|NCT03987620|525723101|FG001|Overall Study|Adverse Event|0|||
145785978|NCT03987620|525723100|FG000|Overall Study|Lost to Follow-up|1|||
145785979|NCT03987620|525723101|FG001|Overall Study|Lost to Follow-up|2|||
145785980|NCT03987620|525723100|FG000|Overall Study|Physician Decision|0|||
145785981|NCT03987620|525723101|FG001|Overall Study|Physician Decision|1|||
145281571|NCT03840135|523880577|FG000|Overall Study|Protocol Violation|6|||
145281572|NCT03840135|523880578|FG001|Overall Study|Protocol Violation|1|||
145281573|NCT03840135|523880577|FG000|Overall Study|Withdrawal by Subject|1|||
145281574|NCT03840135|523880578|FG001|Overall Study|Withdrawal by Subject|0|||
145281575|NCT01159769|523880579|FG000|Overall Study|Adverse Event|1|||
145281576|NCT01827371|523880580|FG000|Overall Study|Adverse Event|0|||
145281577|NCT01827371|523880581|FG001|Overall Study|Adverse Event|0|||
145281578|NCT01827371|523880582|FG002|Overall Study|Adverse Event|4|||
145281579|NCT01827371|523880583|FG003|Overall Study|Adverse Event|2|||
145281580|NCT01827371|523880580|FG000|Overall Study|Lost to Follow-up|0|||
145281581|NCT01827371|523880581|FG001|Overall Study|Lost to Follow-up|2|||
145281582|NCT01827371|523880582|FG002|Overall Study|Lost to Follow-up|0|||
145281583|NCT01827371|523880583|FG003|Overall Study|Lost to Follow-up|4|||
145281584|NCT01827371|523880580|FG000|Overall Study|Protocol Violation|1|||
145281585|NCT01827371|523880581|FG001|Overall Study|Protocol Violation|0|||
145281586|NCT01827371|523880582|FG002|Overall Study|Protocol Violation|0|||
145281587|NCT01827371|523880583|FG003|Overall Study|Protocol Violation|0|||
145281588|NCT01827371|523880580|FG000|Overall Study|Withdrawal by Subject|1|||
145281589|NCT01827371|523880581|FG001|Overall Study|Withdrawal by Subject|2|||
145281590|NCT01827371|523880582|FG002|Overall Study|Withdrawal by Subject|2|||
145281591|NCT01827371|523880583|FG003|Overall Study|Withdrawal by Subject|3|||
145281592|NCT01827371|523880580|FG000|Overall Study|Physician Decision|0|||
145281593|NCT01827371|523880581|FG001|Overall Study|Physician Decision|1|||
145281594|NCT01827371|523880582|FG002|Overall Study|Physician Decision|0|||
145281595|NCT01827371|523880583|FG003|Overall Study|Physician Decision|1|||
145281596|NCT01827371|523880580|FG000|Overall Study|Temporary study halt to vaccinations|11|||
145281597|NCT01827371|523880581|FG001|Overall Study|Temporary study halt to vaccinations|2|||
145281598|NCT01827371|523880582|FG002|Overall Study|Temporary study halt to vaccinations|5|||
145281599|NCT01827371|523880583|FG003|Overall Study|Temporary study halt to vaccinations|13|||
145281600|NCT03063632|523880584|FG000|Overall Study|Death|4|||
145281601|NCT03063632|523880585|FG001|Overall Study|Death|6|||
145281602|NCT03063632|523880584|FG000|Overall Study|Lost to Follow-up|0|||
145785982|NCT03987620|525723100|FG000|Overall Study|Pregnancy|1|||
145785983|NCT03987620|525723101|FG001|Overall Study|Pregnancy|0|||
145785984|NCT03987620|525723100|FG000|Overall Study|Withdrawal by Subject|7|||
145785985|NCT03987620|525723101|FG001|Overall Study|Withdrawal by Subject|1|||
145785986|NCT03987620|525723100|FG000|Overall Study|Other|2|||
145785987|NCT03987620|525723101|FG001|Overall Study|Other|5|||
145785988|NCT02149836|525723103|FG000|Overall Study|Withdrawal by Subject|1|||
145785989|NCT01745393|525723104|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
145785990|NCT01745393|525723105|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
145785991|NCT01745393|525723104|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
145785992|NCT01745393|525723105|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
145785993|NCT01745393|525723104|FG000|12-month Follow-up|Lost to Follow-up|6|||
145785994|NCT01745393|525723105|FG001|12-month Follow-up|Lost to Follow-up|5|||
145785995|NCT00786838|525723106|FG000|Overall Study|Physician Decision|4|||
145785996|NCT00786838|525723106|FG000|Overall Study|Death|4|||
145785997|NCT00786838|525723106|FG000|Overall Study|Adverse Event|6|||
145785998|NCT00786838|525723106|FG000|Overall Study|Progressive disease|31|||
145785999|NCT00786838|525723106|FG000|Overall Study|Withdrawal by Subject|4|||
145786000|NCT02488759|525723108|FG000|Overall Study|Disease progression|73|||
145786001|NCT02488759|525723109|FG001|Overall Study|Disease progression|111|||
145786002|NCT02488759|525723110|FG002|Overall Study|Disease progression|62|||
145786003|NCT02488759|525723111|FG003|Overall Study|Disease progression|7|||
145786004|NCT02488759|525723112|FG004|Overall Study|Disease progression|4|||
145786005|NCT02488759|525723113|FG005|Overall Study|Disease progression|2|||
145786006|NCT02488759|525723108|FG000|Overall Study|Study drug toxicity|11|||
145281603|NCT03063632|523880585|FG001|Overall Study|Lost to Follow-up|1|||
145281604|NCT03063632|523880584|FG000|Overall Study|Withdrawal by Subject|0|||
145281605|NCT03063632|523880585|FG001|Overall Study|Withdrawal by Subject|2|||
145281606|NCT03063632|523880584|FG000|Overall Study|Physician Decision|2|||
145281607|NCT03063632|523880585|FG001|Overall Study|Physician Decision|0|||
145281608|NCT03063632|523880584|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
145281609|NCT03063632|523880585|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
145281610|NCT00106028|523880588|FG000|Overall Study|Adverse Event|3|||
145281611|NCT00106028|523880589|FG001|Overall Study|Adverse Event|2|||
145281612|NCT00106028|523880588|FG000|Overall Study|Protocol Violation|1|||
145281613|NCT00106028|523880589|FG001|Overall Study|Protocol Violation|1|||
145281614|NCT00106028|523880588|FG000|Overall Study|Withdrawal by Subject|2|||
145281615|NCT00106028|523880589|FG001|Overall Study|Withdrawal by Subject|8|||
145281616|NCT00106028|523880588|FG000|Overall Study|Lost to Follow-up|0|||
145786007|NCT02488759|525723109|FG001|Overall Study|Study drug toxicity|33|||
145786008|NCT02488759|525723110|FG002|Overall Study|Study drug toxicity|31|||
145281617|NCT00106028|523880589|FG001|Overall Study|Lost to Follow-up|1|||
145281618|NCT00947011|523880591|FG000|Overall Study|Study was terminated,PI left institution|12|||
145786009|NCT02488759|525723111|FG003|Overall Study|Study drug toxicity|0|||
145786010|NCT02488759|525723112|FG004|Overall Study|Study drug toxicity|0|||
145786011|NCT02488759|525723113|FG005|Overall Study|Study drug toxicity|2|||
145786012|NCT02488759|525723108|FG000|Overall Study|Adverse event unrelated to study drug|9|||
145786013|NCT02488759|525723109|FG001|Overall Study|Adverse event unrelated to study drug|11|||
145786014|NCT02488759|525723110|FG002|Overall Study|Adverse event unrelated to study drug|7|||
145281619|NCT00814658|523880592|FG000|Overall Study|Lost to Follow-up|0|||
145281620|NCT00814658|523880593|FG001|Overall Study|Lost to Follow-up|1|||
145281621|NCT00814658|523880592|FG000|Overall Study|Physician Decision|1|||
145786015|NCT02488759|525723111|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145786016|NCT02488759|525723112|FG004|Overall Study|Adverse event unrelated to study drug|1|||
145786017|NCT02488759|525723113|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145786018|NCT02488759|525723108|FG000|Overall Study|Participant request to discontinue study treatment|6|||
145786019|NCT02488759|525723109|FG001|Overall Study|Participant request to discontinue study treatment|8|||
145786020|NCT02488759|525723110|FG002|Overall Study|Participant request to discontinue study treatment|4|||
145786021|NCT02488759|525723111|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145786022|NCT02488759|525723112|FG004|Overall Study|Participant request to discontinue study treatment|0|||
145786023|NCT02488759|525723113|FG005|Overall Study|Participant request to discontinue study treatment|0|||
145786024|NCT02488759|525723108|FG000|Overall Study|Withdrawal by Subject|4|||
145786025|NCT02488759|525723109|FG001|Overall Study|Withdrawal by Subject|0|||
145786026|NCT02488759|525723110|FG002|Overall Study|Withdrawal by Subject|3|||
145786027|NCT02488759|525723111|FG003|Overall Study|Withdrawal by Subject|0|||
145786028|NCT02488759|525723112|FG004|Overall Study|Withdrawal by Subject|0|||
145786029|NCT02488759|525723113|FG005|Overall Study|Withdrawal by Subject|2|||
145786030|NCT02488759|525723108|FG000|Overall Study|Lost to Follow-up|0|||
145786031|NCT02488759|525723109|FG001|Overall Study|Lost to Follow-up|0|||
145786032|NCT02488759|525723110|FG002|Overall Study|Lost to Follow-up|2|||
145786033|NCT02488759|525723111|FG003|Overall Study|Lost to Follow-up|0|||
145281622|NCT00814658|523880593|FG001|Overall Study|Physician Decision|0|||
145281623|NCT00814658|523880592|FG000|Overall Study|Adverse Event|3|||
145281624|NCT00814658|523880593|FG001|Overall Study|Adverse Event|3|||
145281625|NCT05266456|523880594|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
145281626|NCT05266456|523880595|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
145281627|NCT05266456|523880596|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
145281628|NCT05266456|523880597|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
145281629|NCT05266456|523880594|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
145281630|NCT05266456|523880595|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
145281631|NCT05266456|523880596|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
145281632|NCT05266456|523880597|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
145281633|NCT05266456|523880594|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
145281634|NCT05266456|523880595|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
145786034|NCT02488759|525723112|FG004|Overall Study|Lost to Follow-up|0|||
145786035|NCT02488759|525723113|FG005|Overall Study|Lost to Follow-up|0|||
145786036|NCT02488759|525723108|FG000|Overall Study|Maximum clinical benefit|3|||
145786037|NCT02488759|525723109|FG001|Overall Study|Maximum clinical benefit|0|||
145786038|NCT02488759|525723110|FG002|Overall Study|Maximum clinical benefit|1|||
145786039|NCT02488759|525723111|FG003|Overall Study|Maximum clinical benefit|0|||
145786040|NCT02488759|525723112|FG004|Overall Study|Maximum clinical benefit|0|||
145786041|NCT02488759|525723113|FG005|Overall Study|Maximum clinical benefit|0|||
145786042|NCT02488759|525723108|FG000|Overall Study|Other reasons|7|||
145786043|NCT02488759|525723109|FG001|Overall Study|Other reasons|32|||
145786044|NCT02488759|525723110|FG002|Overall Study|Other reasons|23|||
145786045|NCT02488759|525723111|FG003|Overall Study|Other reasons|1|||
145786046|NCT02488759|525723112|FG004|Overall Study|Other reasons|1|||
145786047|NCT02488759|525723113|FG005|Overall Study|Other reasons|1|||
145786048|NCT05306873|525724349|FG000|Stage 2|Study stopped|1|||
145786049|NCT05306873|525724350|FG001|Stage 2|Study stopped|1|||
145786050|NCT05306873|525724351|FG002|Stage 2|Study stopped|0|||
145786051|NCT05306873|525724352|FG003|Stage 2|Study stopped|0|||
145786052|NCT05306873|525724349|FG000|Stage 2|Stage 2 Treatment Failure|2|||
145786053|NCT05306873|525724350|FG001|Stage 2|Stage 2 Treatment Failure|3|||
145786054|NCT05306873|525724351|FG002|Stage 2|Stage 2 Treatment Failure|0|||
145786055|NCT05306873|525724352|FG003|Stage 2|Stage 2 Treatment Failure|0|||
145786056|NCT05306873|525724349|FG000|Stage 2|Logistical issues due to participant moving|1|||
145281635|NCT05266456|523880596|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
145281636|NCT05266456|523880597|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
145281637|NCT05266456|523880594|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
145281638|NCT05266456|523880595|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
145786057|NCT05306873|525724350|FG001|Stage 2|Logistical issues due to participant moving|0|||
145786058|NCT05306873|525724351|FG002|Stage 2|Logistical issues due to participant moving|0|||
145786059|NCT05306873|525724352|FG003|Stage 2|Logistical issues due to participant moving|0|||
145786060|NCT05306873|525724349|FG000|Stage 3|Stage 3 Treatment Failure|0|||
145786061|NCT05306873|525724350|FG001|Stage 3|Stage 3 Treatment Failure|0|||
145281639|NCT05266456|523880596|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
145281640|NCT05266456|523880597|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
145281641|NCT05266456|523880594|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
145281642|NCT05266456|523880595|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
145281643|NCT05266456|523880596|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
145786062|NCT05306873|525724351|FG002|Stage 3|Stage 3 Treatment Failure|0|||
145786063|NCT05306873|525724352|FG003|Stage 3|Stage 3 Treatment Failure|1|||
145786064|NCT05306873|525724349|FG000|Stage 3|Study Stopped|0|||
145786065|NCT05306873|525724350|FG001|Stage 3|Study Stopped|0|||
145786066|NCT05306873|525724351|FG002|Stage 3|Study Stopped|1|||
145786067|NCT05306873|525724352|FG003|Stage 3|Study Stopped|0|||
145786068|NCT00074412|525724353|FG000|Overall Study|Death|30|||
145786069|NCT00074412|525724354|FG001|Overall Study|Death|26|||
145786070|NCT00074412|525724353|FG000|Overall Study|Lost to Follow-up|52|||
145786071|NCT00074412|525724354|FG001|Overall Study|Lost to Follow-up|58|||
145281644|NCT05266456|523880597|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
145281645|NCT01610167|523880599|FG000|Overall Study|Scheduling conflict.|0|||
145281646|NCT01610167|523880600|FG001|Overall Study|Scheduling conflict.|0|||
145281647|NCT01610167|523880601|FG002|Overall Study|Scheduling conflict.|2|||
145281648|NCT06371079|523880603|FG000|Overall Study|Missing data|88|||
145281649|NCT06371079|523880604|FG001|Overall Study|Missing data|247|||
145281650|NCT00411762|523880605|FG000|Overall Study|Withdrawal by Subject|5|||
145281651|NCT03712228|523880609|FG000|Treatment Period 1|Lack of Efficacy|0|||
145281652|NCT03712228|523880610|FG001|Treatment Period 1|Lack of Efficacy|0|||
145281653|NCT03712228|523880611|FG002|Treatment Period 1|Lack of Efficacy|0|||
145786072|NCT02361762|525724355|FG000|Overall Study|Withdrawal by Subject|0|||
145786073|NCT02361762|525724356|FG001|Overall Study|Withdrawal by Subject|1|||
145786074|NCT02361762|525724355|FG000|Overall Study|Lost to Follow-up|0|||
145786075|NCT02361762|525724356|FG001|Overall Study|Lost to Follow-up|1|||
145786076|NCT00028002|525724359|FG000|Overall Study|Withdrawal by Subject|3|||
145786077|NCT00028002|525724359|FG000|Overall Study|Ineligible|8|||
145786078|NCT02163993|525724363|FG000|Treatment Period|Adverse Event|0|||
145786079|NCT02163993|525724364|FG001|Treatment Period|Adverse Event|1|||
145786080|NCT02163993|525724365|FG002|Treatment Period|Adverse Event|0|||
145786081|NCT02163993|525724366|FG003|Treatment Period|Adverse Event|0|||
145786082|NCT02163993|525724367|FG004|Treatment Period|Adverse Event|1|||
145786083|NCT02163993|525724363|FG000|Treatment Period|Lost to Follow-up|2|||
145786084|NCT02163993|525724364|FG001|Treatment Period|Lost to Follow-up|3|||
145786085|NCT02163993|525724365|FG002|Treatment Period|Lost to Follow-up|1|||
145786086|NCT02163993|525724366|FG003|Treatment Period|Lost to Follow-up|3|||
145786087|NCT02163993|525724367|FG004|Treatment Period|Lost to Follow-up|1|||
145786088|NCT02163993|525724363|FG000|Treatment Period|Physician Decision|1|||
145786089|NCT02163993|525724364|FG001|Treatment Period|Physician Decision|0|||
145786090|NCT02163993|525724365|FG002|Treatment Period|Physician Decision|0|||
145786091|NCT02163993|525724366|FG003|Treatment Period|Physician Decision|0|||
145786092|NCT02163993|525724367|FG004|Treatment Period|Physician Decision|0|||
145786093|NCT02163993|525724363|FG000|Treatment Period|Protocol Violation|2|||
145786094|NCT02163993|525724364|FG001|Treatment Period|Protocol Violation|1|||
145281654|NCT03712228|523880612|FG003|Treatment Period 1|Lack of Efficacy|0|||
145281655|NCT03712228|523880613|FG004|Treatment Period 1|Lack of Efficacy|0|||
145281656|NCT03712228|523880614|FG005|Treatment Period 1|Lack of Efficacy|1|||
145281657|NCT03712228|523880609|FG000|Treatment Period 2|Pregnancy|0|||
145281658|NCT03712228|523880610|FG001|Treatment Period 2|Pregnancy|0|||
145281659|NCT03712228|523880611|FG002|Treatment Period 2|Pregnancy|0|||
145281660|NCT03712228|523880612|FG003|Treatment Period 2|Pregnancy|1|||
145281661|NCT03712228|523880613|FG004|Treatment Period 2|Pregnancy|0|||
145281662|NCT03712228|523880614|FG005|Treatment Period 2|Pregnancy|0|||
145281663|NCT03712228|523880609|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145281664|NCT03712228|523880610|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145281665|NCT03712228|523880611|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145281666|NCT03712228|523880612|FG003|Treatment Period 2|Withdrawal by Subject|1|||
145281667|NCT03712228|523880613|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145281668|NCT03712228|523880614|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145281669|NCT02746705|523880615|FG000|Overall Study|Physician Decision|1|||
145786095|NCT02163993|525724365|FG002|Treatment Period|Protocol Violation|0|||
145786096|NCT02163993|525724366|FG003|Treatment Period|Protocol Violation|1|||
145786097|NCT02163993|525724367|FG004|Treatment Period|Protocol Violation|2|||
145786098|NCT02163993|525724363|FG000|Treatment Period|Withdrawal by Subject|6|||
145786099|NCT02163993|525724364|FG001|Treatment Period|Withdrawal by Subject|4|||
145786100|NCT02163993|525724365|FG002|Treatment Period|Withdrawal by Subject|1|||
145786101|NCT02163993|525724366|FG003|Treatment Period|Withdrawal by Subject|4|||
145786102|NCT02163993|525724367|FG004|Treatment Period|Withdrawal by Subject|1|||
145786103|NCT02163993|525724363|FG000|Treatment Period|Not treated|1|||
145786104|NCT02163993|525724364|FG001|Treatment Period|Not treated|0|||
145281670|NCT02746705|523880616|FG001|Overall Study|Physician Decision|1|||
145281671|NCT02746705|523880615|FG000|Overall Study|Lost to Follow-up|1|||
145281672|NCT02746705|523880616|FG001|Overall Study|Lost to Follow-up|0|||
145281673|NCT02746705|523880615|FG000|Overall Study|outlier scores deemed not valid|0|||
145281674|NCT02746705|523880616|FG001|Overall Study|outlier scores deemed not valid|1|||
145281675|NCT01964105|523880617|FG000|Overall Study|Lost to Follow-up|2|||
145786105|NCT02163993|525724365|FG002|Treatment Period|Not treated|0|||
145786106|NCT02163993|525724366|FG003|Treatment Period|Not treated|1|||
145786107|NCT02163993|525724367|FG004|Treatment Period|Not treated|2|||
145786108|NCT02163993|525724363|FG000|Post-treatment Period|Adverse Event|0|||
145786109|NCT02163993|525724364|FG001|Post-treatment Period|Adverse Event|0|||
145786110|NCT02163993|525724365|FG002|Post-treatment Period|Adverse Event|1|||
145786111|NCT02163993|525724366|FG003|Post-treatment Period|Adverse Event|0|||
145786112|NCT02163993|525724367|FG004|Post-treatment Period|Adverse Event|0|||
145786113|NCT02163993|525724363|FG000|Post-treatment Period|Lost to Follow-up|2|||
145786114|NCT02163993|525724364|FG001|Post-treatment Period|Lost to Follow-up|2|||
145786115|NCT02163993|525724365|FG002|Post-treatment Period|Lost to Follow-up|3|||
145786116|NCT02163993|525724366|FG003|Post-treatment Period|Lost to Follow-up|1|||
145786117|NCT02163993|525724367|FG004|Post-treatment Period|Lost to Follow-up|0|||
145786118|NCT02163993|525724363|FG000|Post-treatment Period|Protocol Violation|0|||
145786119|NCT02163993|525724364|FG001|Post-treatment Period|Protocol Violation|0|||
145786120|NCT02163993|525724365|FG002|Post-treatment Period|Protocol Violation|0|||
145786121|NCT02163993|525724366|FG003|Post-treatment Period|Protocol Violation|0|||
145786122|NCT02163993|525724367|FG004|Post-treatment Period|Protocol Violation|1|||
145786123|NCT02163993|525724363|FG000|Post-treatment Period|Withdrawal by Subject|2|||
145786124|NCT02163993|525724364|FG001|Post-treatment Period|Withdrawal by Subject|4|||
145786125|NCT02163993|525724365|FG002|Post-treatment Period|Withdrawal by Subject|0|||
145786126|NCT02163993|525724366|FG003|Post-treatment Period|Withdrawal by Subject|1|||
145786127|NCT02163993|525724367|FG004|Post-treatment Period|Withdrawal by Subject|2|||
145786128|NCT04467164|525724368|FG000|Washout (1 Week)|Lost to Follow-up|2|||
145786129|NCT04467164|525724369|FG001|Washout (1 Week)|Lost to Follow-up|0|||
145786130|NCT02750813|525724370|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
145786131|NCT02750813|525724371|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
145786132|NCT02750813|525724370|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
145786133|NCT02750813|525724371|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
145786134|NCT02273752|525724372|FG000|Overall Study|Trial was terminated early|2|||
145786135|NCT02042404|525724375|FG000|Overall Study|Death|1|||
145786136|NCT02042404|525724376|FG001|Overall Study|Death|0|||
145786137|NCT02042404|525724375|FG000|Overall Study|Unrelated Adverse Event|3|||
145786138|NCT02042404|525724376|FG001|Overall Study|Unrelated Adverse Event|0|||
145786139|NCT02042404|525724375|FG000|Overall Study|Inability to meet time requirements|1|||
145786140|NCT02042404|525724376|FG001|Overall Study|Inability to meet time requirements|0|||
145786141|NCT03100942|525724377|FG000|Randomized Treatment Period|Withdrew Consent|4|||
145786142|NCT03100942|525724378|FG001|Randomized Treatment Period|Withdrew Consent|5|||
145786143|NCT03100942|525724379|FG002|Randomized Treatment Period|Withdrew Consent|3|||
145786144|NCT03100942|525724380|FG003|Randomized Treatment Period|Withdrew Consent|3|||
145786145|NCT03100942|525724381|FG004|Randomized Treatment Period|Withdrew Consent|0|||
145786146|NCT03100942|525724382|FG005|Randomized Treatment Period|Withdrew Consent|0|||
145786147|NCT03100942|525724383|FG006|Randomized Treatment Period|Withdrew Consent|0|||
145786148|NCT03100942|525724377|FG000|Randomized Treatment Period|Adverse Event|5|||
145786149|NCT03100942|525724378|FG001|Randomized Treatment Period|Adverse Event|2|||
145786150|NCT03100942|525724379|FG002|Randomized Treatment Period|Adverse Event|1|||
145786151|NCT03100942|525724380|FG003|Randomized Treatment Period|Adverse Event|0|||
145786152|NCT03100942|525724381|FG004|Randomized Treatment Period|Adverse Event|0|||
145786153|NCT03100942|525724382|FG005|Randomized Treatment Period|Adverse Event|0|||
145786154|NCT03100942|525724383|FG006|Randomized Treatment Period|Adverse Event|0|||
145786155|NCT03100942|525724377|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
145786156|NCT03100942|525724378|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
145786157|NCT03100942|525724379|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
145786158|NCT03100942|525724380|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
145786159|NCT03100942|525724381|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
145786160|NCT03100942|525724382|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
145786161|NCT03100942|525724383|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
145786162|NCT03100942|525724377|FG000|Randomized Treatment Period|Protocol Violation|0|||
145786163|NCT03100942|525724378|FG001|Randomized Treatment Period|Protocol Violation|1|||
145281676|NCT01964105|523880618|FG001|Overall Study|Lost to Follow-up|13|||
145281677|NCT01964105|523880619|FG002|Overall Study|Lost to Follow-up|0|||
145281678|NCT00575328|523880620|FG000|Overall Study|Adverse Event|1|||
145786164|NCT03100942|525724379|FG002|Randomized Treatment Period|Protocol Violation|1|||
145786165|NCT03100942|525724380|FG003|Randomized Treatment Period|Protocol Violation|1|||
145786166|NCT03100942|525724381|FG004|Randomized Treatment Period|Protocol Violation|0|||
145786167|NCT03100942|525724382|FG005|Randomized Treatment Period|Protocol Violation|0|||
145786168|NCT03100942|525724383|FG006|Randomized Treatment Period|Protocol Violation|0|||
145786169|NCT03100942|525724377|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
145786170|NCT03100942|525724378|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
145786171|NCT03100942|525724379|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
145786172|NCT03100942|525724380|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
145281679|NCT00575328|523880621|FG001|Overall Study|Adverse Event|1|||
145281680|NCT00575328|523880620|FG000|Overall Study|Lost to Follow-up|2|||
145281681|NCT00575328|523880621|FG001|Overall Study|Lost to Follow-up|1|||
145609595|NCT02541383|525086380|FG000|Overall Study|Sponsor's decision|1|||
145609596|NCT02541383|525086381|FG001|Overall Study|Sponsor's decision|1|||
145609597|NCT02541383|525086382|FG002|Overall Study|Sponsor's decision|0|||
145609598|NCT02541383|525086383|FG003|Overall Study|Sponsor's decision|0|||
145609599|NCT02541383|525086384|FG004|Overall Study|Sponsor's decision|0|||
145609600|NCT02541383|525086385|FG005|Overall Study|Sponsor's decision|0|||
145609601|NCT02487095|525086391|FG000|Dose Expansion|Unable to scan/restage participant|0|||
145609602|NCT02487095|525086392|FG001|Dose Expansion|Unable to scan/restage participant|0|||
145609603|NCT02487095|525086393|FG002|Dose Expansion|Unable to scan/restage participant|0|||
145609604|NCT02487095|525086394|FG003|Dose Expansion|Unable to scan/restage participant|0|||
145609605|NCT02487095|525086395|FG004|Dose Expansion|Unable to scan/restage participant|1|||
145609606|NCT03108157|525086398|FG000|Overall Study|Protocol Violation|15|||
145281682|NCT01430104|523880622|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
145281683|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
145281684|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
145609607|NCT03108157|525086399|FG001|Overall Study|Protocol Violation|4|||
145609608|NCT01279343|525086402|FG000|Overall Study|Did not receive treatment|2|||
145609609|NCT01279343|525086403|FG001|Overall Study|Did not receive treatment|6|||
145609610|NCT04534114|525086404|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
145609611|NCT04534114|525086405|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
145609612|NCT04534114|525086406|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
145609613|NCT04534114|525086407|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
145786173|NCT03100942|525724381|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
145281685|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
145281686|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
145281687|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
145281688|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
145281689|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
145281690|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281691|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
145281692|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
145538853|NCT00739674|524832871|FG000|Overall Study|Protocol Violation|5|||
145538854|NCT00739674|524832872|FG001|Overall Study|Protocol Violation|5|||
145538855|NCT00739674|524832871|FG000|Overall Study|Withdrawal by Subject|9|||
145538856|NCT00739674|524832872|FG001|Overall Study|Withdrawal by Subject|9|||
145538857|NCT00739674|524832871|FG000|Overall Study|Reason missing|2|||
145538858|NCT00739674|524832872|FG001|Overall Study|Reason missing|0|||
145538859|NCT00739674|524832871|FG000|Overall Study|Clinic closed|6|||
145538860|NCT00739674|524832872|FG001|Overall Study|Clinic closed|4|||
145538861|NCT00739674|524832871|FG000|Overall Study|Patient moved|3|||
145538862|NCT00739674|524832872|FG001|Overall Study|Patient moved|2|||
145538863|NCT00739674|524832871|FG000|Overall Study|Non compliant|4|||
145538864|NCT00739674|524832872|FG001|Overall Study|Non compliant|0|||
145538865|NCT00739674|524832871|FG000|Overall Study|Unable to attend visit|3|||
145538866|NCT00739674|524832872|FG001|Overall Study|Unable to attend visit|1|||
145538867|NCT00739674|524832871|FG000|Overall Study|Home monitoring off meds|1|||
145538868|NCT00739674|524832872|FG001|Overall Study|Home monitoring off meds|0|||
145538869|NCT00739674|524832871|FG000|Overall Study|Erectile dysfunction|0|||
145538870|NCT00739674|524832872|FG001|Overall Study|Erectile dysfunction|1|||
145538871|NCT04805541|524832874|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
145538872|NCT00283400|524832877|FG000|Overall Study|Withdrawal by Subject|1|||
145538873|NCT00283400|524832878|FG001|Overall Study|Withdrawal by Subject|1|||
145538874|NCT00283400|524832879|FG002|Overall Study|Withdrawal by Subject|0|||
145786174|NCT03100942|525724382|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
145786175|NCT03100942|525724383|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
145786176|NCT03100942|525724377|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
145786177|NCT03100942|525724378|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
145786178|NCT03100942|525724379|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
145786179|NCT03100942|525724380|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
145609614|NCT04534114|525086404|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
145609615|NCT04534114|525086405|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
145538875|NCT00283400|524832880|FG003|Overall Study|Withdrawal by Subject|0|||
145538876|NCT00283400|524832877|FG000|Overall Study|Death|1|||
145538877|NCT00283400|524832878|FG001|Overall Study|Death|0|||
145538878|NCT00283400|524832879|FG002|Overall Study|Death|1|||
145538879|NCT00283400|524832880|FG003|Overall Study|Death|0|||
145538880|NCT00983437|524832882|FG000|Overall Study|Adverse Event|9|||
145538881|NCT00983437|524832882|FG000|Overall Study|Lack of Efficacy|1|||
145538882|NCT00983437|524832882|FG000|Overall Study|Withdrawal by Subject|8|||
145609616|NCT04534114|525086406|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
145786180|NCT03100942|525724381|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
145786181|NCT03100942|525724382|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
145786182|NCT03100942|525724383|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
145786183|NCT03100942|525724377|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786184|NCT03100942|525724378|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786185|NCT03100942|525724379|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786186|NCT03100942|525724380|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786187|NCT03100942|525724381|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786188|NCT03100942|525724382|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
145786189|NCT03100942|525724383|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
145786190|NCT01429792|525724384|FG000|Overall Study|Other Reasons|67|||
145786191|NCT01429792|525724384|FG000|Overall Study|Unknown Disposition|94|||
145786192|NCT01429792|525724384|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
145786193|NCT01429792|525724384|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
145786194|NCT01429792|525724384|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
145786195|NCT01429792|525724384|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
145786196|NCT01429792|525724384|FG000|Overall Study|Withdrawal by Subject|70|||
145786197|NCT01429792|525724384|FG000|Overall Study|Lost to Follow-up|88|||
145786198|NCT00726323|525724385|FG000|Overall Study|Withdrawal by Subject|3|||
145786199|NCT00726323|525724386|FG001|Overall Study|Withdrawal by Subject|1|||
145786200|NCT00726323|525724385|FG000|Overall Study|Physician Decision|1|||
145786201|NCT00726323|525724386|FG001|Overall Study|Physician Decision|0|||
145786202|NCT00726323|525724385|FG000|Overall Study|Progressive disease|23|||
145786203|NCT00726323|525724386|FG001|Overall Study|Progressive disease|16|||
145786204|NCT00726323|525724385|FG000|Overall Study|Clinical progression|0|||
145786205|NCT00726323|525724386|FG001|Overall Study|Clinical progression|3|||
145786206|NCT00726323|525724385|FG000|Overall Study|Adverse Event|9|||
145786207|NCT00726323|525724386|FG001|Overall Study|Adverse Event|9|||
145786208|NCT00726323|525724385|FG000|Overall Study|Death|1|||
145786209|NCT00726323|525724386|FG001|Overall Study|Death|0|||
145786210|NCT00726323|525724385|FG000|Overall Study|Participant wished to discontinue|0|||
145786211|NCT00726323|525724386|FG001|Overall Study|Participant wished to discontinue|1|||
145786212|NCT00726323|525724385|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
145786213|NCT00726323|525724386|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
145786214|NCT05761444|525724388|FG000|Overall Study|Protocol Violation|2|||
145786215|NCT05761444|525724389|FG001|Overall Study|Protocol Violation|1|||
145786216|NCT05761444|525724388|FG000|Overall Study|Adverse Event|2|||
145786217|NCT05761444|525724389|FG001|Overall Study|Adverse Event|2|||
145786218|NCT05761444|525724388|FG000|Overall Study|Withdrawal by Subject|3|||
145786219|NCT05761444|525724389|FG001|Overall Study|Withdrawal by Subject|2|||
145786220|NCT05761444|525724388|FG000|Overall Study|Other|1|||
145786221|NCT05761444|525724389|FG001|Overall Study|Other|0|||
145786222|NCT03508622|525724390|FG000|Overall Study|Protocol Violation|1|||
145786223|NCT03508622|525724391|FG001|Overall Study|Protocol Violation|0|||
145786224|NCT03508622|525724390|FG000|Overall Study|Withdrawal by Subject|1|||
145786225|NCT03508622|525724391|FG001|Overall Study|Withdrawal by Subject|0|||
145786226|NCT03508622|525724390|FG000|Overall Study|Lost to Follow-up|16|||
145786227|NCT03508622|525724391|FG001|Overall Study|Lost to Follow-up|0|||
145786228|NCT03508622|525724390|FG000|Overall Study|Incomplete data|0|||
145786229|NCT03508622|525724391|FG001|Overall Study|Incomplete data|24|||
145786230|NCT01005719|525724392|FG000|Period 1|Adverse Event|0|||
145786231|NCT01005719|525724393|FG001|Period 1|Adverse Event|0|||
145786232|NCT01005719|525724394|FG002|Period 1|Adverse Event|0|||
145786233|NCT01005719|525724395|FG003|Period 1|Adverse Event|1|||
145786234|NCT01005719|525724396|FG004|Period 1|Adverse Event|0|||
145786235|NCT01005719|525724397|FG005|Period 1|Adverse Event|0|||
145538883|NCT00983437|524832882|FG000|Overall Study|Noncompliance to Study Procedures|1|||
145538884|NCT00983437|524832882|FG000|Overall Study|Lost to Follow-up|2|||
145538885|NCT00983437|524832882|FG000|Overall Study|Other Reason|26|||
145786236|NCT01005719|525724392|FG000|Period 1|Delay in completing study procedures|0|||
145786237|NCT01005719|525724393|FG001|Period 1|Delay in completing study procedures|0|||
145786238|NCT01005719|525724394|FG002|Period 1|Delay in completing study procedures|0|||
145786239|NCT01005719|525724395|FG003|Period 1|Delay in completing study procedures|0|||
145786240|NCT01005719|525724396|FG004|Period 1|Delay in completing study procedures|0|||
145786241|NCT01005719|525724397|FG005|Period 1|Delay in completing study procedures|1|||
145538886|NCT01020981|524832883|FG000|Overall Study|Did not return mailed survey|74|||
145538887|NCT01020981|524832884|FG001|Overall Study|Did not return mailed survey|58|||
145786242|NCT01005719|525724392|FG000|Period 2|Adverse Event|0|||
145786243|NCT01005719|525724393|FG001|Period 2|Adverse Event|0|||
145786244|NCT01005719|525724394|FG002|Period 2|Adverse Event|0|||
145786245|NCT01005719|525724395|FG003|Period 2|Adverse Event|0|||
145786246|NCT01005719|525724396|FG004|Period 2|Adverse Event|1|||
145786247|NCT01005719|525724397|FG005|Period 2|Adverse Event|1|||
145786248|NCT02389816|525724398|FG000|Overall Study|Randomized but Not Treated|1|||
145786249|NCT02389816|525724399|FG001|Overall Study|Randomized but Not Treated|0|||
145786250|NCT02389816|525724400|FG002|Overall Study|Randomized but Not Treated|0|||
145786251|NCT02389816|525724398|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
145786252|NCT02389816|525724399|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
145786253|NCT02389816|525724400|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
145786254|NCT02389816|525724398|FG000|Overall Study|Major Protocol Deviation|1|||
145786255|NCT02389816|525724399|FG001|Overall Study|Major Protocol Deviation|0|||
145786256|NCT02389816|525724400|FG002|Overall Study|Major Protocol Deviation|0|||
145538888|NCT01020981|524832883|FG000|Overall Study|Survey returned undeliverable|8|||
145538889|NCT01020981|524832884|FG001|Overall Study|Survey returned undeliverable|32|||
145538890|NCT01020981|524832883|FG000|Overall Study|Participant declined to complete survey|2|||
145538891|NCT01020981|524832884|FG001|Overall Study|Participant declined to complete survey|0|||
145786257|NCT02389816|525724398|FG000|Overall Study|Lost to Follow-up|1|||
145786258|NCT02389816|525724399|FG001|Overall Study|Lost to Follow-up|0|||
145786259|NCT02389816|525724400|FG002|Overall Study|Lost to Follow-up|0|||
145786260|NCT02389816|525724398|FG000|Overall Study|Withdrawal of Consent|6|||
145786261|NCT02389816|525724399|FG001|Overall Study|Withdrawal of Consent|4|||
145786262|NCT02389816|525724400|FG002|Overall Study|Withdrawal of Consent|4|||
145538892|NCT03372096|524832885|FG000|Overall Study|Study Closed|8|||
145538893|NCT05096221|524832889|FG000|Part 2|Physician Decision|0|||
145538894|NCT05096221|524832890|FG001|Part 2|Physician Decision|1|||
145538895|NCT04678661|524832893|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
145538896|NCT04678661|524832894|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
145538897|NCT04678661|524832893|FG000|Overall Study|Protocol Violation|2|||
145538898|NCT04678661|524832894|FG001|Overall Study|Protocol Violation|0|||
145538899|NCT04678661|524832893|FG000|Overall Study|Withdrawal by Subject|1|||
145538900|NCT04678661|524832894|FG001|Overall Study|Withdrawal by Subject|0|||
145538901|NCT04678661|524832893|FG000|Overall Study|Lost to Follow-up|2|||
145538902|NCT04678661|524832894|FG001|Overall Study|Lost to Follow-up|0|||
145786263|NCT02389816|525724398|FG000|Overall Study|Lack of Efficacy|1|||
145786264|NCT02389816|525724399|FG001|Overall Study|Lack of Efficacy|0|||
145786265|NCT02389816|525724400|FG002|Overall Study|Lack of Efficacy|0|||
145786266|NCT02389816|525724398|FG000|Overall Study|Non Compliance with Study Drug|1|||
145786267|NCT02389816|525724399|FG001|Overall Study|Non Compliance with Study Drug|1|||
145786268|NCT02389816|525724400|FG002|Overall Study|Non Compliance with Study Drug|1|||
145786269|NCT02389816|525724398|FG000|Overall Study|Reason not Specified|0|||
145786270|NCT02389816|525724399|FG001|Overall Study|Reason not Specified|2|||
145786271|NCT02389816|525724400|FG002|Overall Study|Reason not Specified|0|||
145786272|NCT02918266|525724401|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
145786273|NCT02918266|525724402|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786274|NCT02918266|525724403|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786275|NCT02918266|525724404|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786276|NCT02918266|525724405|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786277|NCT02918266|525724406|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786278|NCT02918266|525724407|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
145786279|NCT02918266|525724408|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786280|NCT02918266|525724409|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
145538903|NCT04678661|524832893|FG000|Overall Study|Death|2|||
145538904|NCT04678661|524832894|FG001|Overall Study|Death|0|||
145281693|NCT00124449|523880627|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
145281694|NCT00124449|523880628|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
145538905|NCT01086033|524832895|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
145538906|NCT01086033|524832895|FG000|Overall Study|Lost to Follow-up|86|||
145538907|NCT01086033|524832895|FG000|Overall Study|Adverse Event|42|||
145538908|NCT01086033|524832895|FG000|Overall Study|Withdrawal by Subject|41|||
145538909|NCT01086033|524832895|FG000|Overall Study|Other|14|||
145538910|NCT01086033|524832895|FG000|Overall Study|Other|13|||
145538911|NCT01086033|524832895|FG000|Overall Study|AE and Withdrew Consent|5|||
145538912|NCT01086033|524832895|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
145538913|NCT01086033|524832895|FG000|Overall Study|Withdrew consent and Other Reason|4|||
145538914|NCT01086033|524832895|FG000|Overall Study|AE and Lack of Efficacy|4|||
145538915|NCT01086033|524832895|FG000|Overall Study|Death|1|||
145786281|NCT02918266|525724410|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145281695|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
145281696|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
145281697|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
145538916|NCT01086033|524832895|FG000|Overall Study|AE and Lost to Follow-up|1|||
145538917|NCT01086033|524832895|FG000|Overall Study|AE and Other Reason|1|||
145538918|NCT01086033|524832895|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
145538919|NCT03094169|524832896|FG000|Overall Study|Lack of Efficacy|0|||
145786282|NCT02918266|525724411|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
145786283|NCT01259856|525724418|FG000|Overall Study|Adverse Event|12|||
145786284|NCT01259856|525724419|FG001|Overall Study|Adverse Event|9|||
145786285|NCT01259856|525724418|FG000|Overall Study|Death|0|||
145281698|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
145281699|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
145281700|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
145786286|NCT01259856|525724419|FG001|Overall Study|Death|1|||
145786287|NCT01259856|525724418|FG000|Overall Study|Lack of Efficacy|3|||
145786288|NCT01259856|525724419|FG001|Overall Study|Lack of Efficacy|1|||
145786289|NCT01259856|525724418|FG000|Overall Study|Lost to Follow-up|1|||
145786290|NCT01259856|525724419|FG001|Overall Study|Lost to Follow-up|1|||
145786291|NCT01259856|525724418|FG000|Overall Study|Physician Decision|2|||
145786292|NCT01259856|525724419|FG001|Overall Study|Physician Decision|1|||
145786293|NCT01259856|525724418|FG000|Overall Study|Withdrawal by Subject|9|||
145786294|NCT01259856|525724419|FG001|Overall Study|Withdrawal by Subject|10|||
145786295|NCT01259856|525724418|FG000|Overall Study|Treatment never started|0|||
145786296|NCT01259856|525724419|FG001|Overall Study|Treatment never started|6|||
145786297|NCT01259856|525724418|FG000|Overall Study|Study closure by sponsor|40|||
145786298|NCT01259856|525724419|FG001|Overall Study|Study closure by sponsor|41|||
145786299|NCT01259856|525724418|FG000|Overall Study|Patient developed other disease|0|||
145786300|NCT01259856|525724419|FG001|Overall Study|Patient developed other disease|1|||
145786301|NCT01259856|525724418|FG000|Overall Study|Transfer to another study|0|||
145786302|NCT01259856|525724419|FG001|Overall Study|Transfer to another study|1|||
145786303|NCT01259856|525724418|FG000|Overall Study|Unknown/missing|2|||
145786304|NCT01259856|525724419|FG001|Overall Study|Unknown/missing|2|||
145786305|NCT02499146|525724420|FG000|Overall Study|Lost to Follow-up|1|||
145786306|NCT02499146|525724420|FG000|Overall Study|Withdrawal by Subject|1|||
145786307|NCT02499146|525724420|FG000|Overall Study|Other|2|||
145786308|NCT02499146|525724420|FG000|Overall Study|Ongoing at date of cut-off|9|||
145786309|NCT02499146|525724420|FG000|Overall Study|Began other treatment/therapy|13|||
145786310|NCT03161678|525724421|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
145786311|NCT03161678|525724422|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
145786312|NCT03161678|525724423|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145786313|NCT03161678|525724424|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
145786314|NCT03161678|525724425|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
145786315|NCT03161678|525724426|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145786316|NCT03161678|525724421|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
145786317|NCT03161678|525724422|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
145786318|NCT03161678|525724423|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
145786319|NCT03161678|525724424|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
145786320|NCT03161678|525724425|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
145786321|NCT03161678|525724426|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
145786322|NCT03161678|525724421|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
145786323|NCT03161678|525724422|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
145786324|NCT03161678|525724423|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
145281701|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
145281702|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
145281703|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
145281704|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
145281705|NCT00124449|523880627|FG000|18-Month Untreated Observation Period|Relocated|1|||
145281706|NCT00124449|523880628|FG001|18-Month Untreated Observation Period|Relocated|0|||
145281707|NCT00811070|523880633|FG000|Overall Study|Death|0|||
145281708|NCT00811070|523880634|FG001|Overall Study|Death|0|||
145281709|NCT00811070|523880635|FG002|Overall Study|Death|0|||
145281710|NCT00811070|523880636|FG003|Overall Study|Death|2|||
145281711|NCT00811070|523880637|FG004|Overall Study|Death|5|||
145281712|NCT00811070|523880638|FG005|Overall Study|Death|0|||
145281713|NCT00811070|523880633|FG000|Overall Study|Other|1|||
145281714|NCT00811070|523880634|FG001|Overall Study|Other|0|||
145281715|NCT00811070|523880635|FG002|Overall Study|Other|0|||
145281716|NCT00811070|523880636|FG003|Overall Study|Other|0|||
145281717|NCT00811070|523880637|FG004|Overall Study|Other|0|||
145281718|NCT00811070|523880638|FG005|Overall Study|Other|0|||
145281719|NCT00811070|523880633|FG000|Overall Study|Withdrawal by Subject|0|||
145281720|NCT00811070|523880634|FG001|Overall Study|Withdrawal by Subject|1|||
145281721|NCT00811070|523880635|FG002|Overall Study|Withdrawal by Subject|0|||
145281722|NCT00811070|523880636|FG003|Overall Study|Withdrawal by Subject|0|||
145281723|NCT00811070|523880637|FG004|Overall Study|Withdrawal by Subject|0|||
145281724|NCT00811070|523880638|FG005|Overall Study|Withdrawal by Subject|0|||
145404005|NCT02194465|524336453|FG002|Overall Study|Discontinued follow-up period|1|||
145786325|NCT03161678|525724424|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
145786326|NCT03161678|525724425|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
145786327|NCT03161678|525724426|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
145786328|NCT03161678|525724421|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
145786329|NCT03161678|525724422|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
145786330|NCT03161678|525724423|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
145786331|NCT03161678|525724424|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
145786332|NCT03161678|525724425|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
145786333|NCT03161678|525724426|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
145786334|NCT00752609|525724427|FG000|Overall Study|Adverse Event|2|||
145786335|NCT00752609|525724428|FG001|Overall Study|Adverse Event|2|||
145538920|NCT03094169|524832897|FG001|Overall Study|Lack of Efficacy|0|||
145538921|NCT03094169|524832898|FG002|Overall Study|Lack of Efficacy|0|||
145538922|NCT03094169|524832899|FG003|Overall Study|Lack of Efficacy|0|||
145538923|NCT03094169|524832900|FG004|Overall Study|Lack of Efficacy|0|||
145786336|NCT00752609|525724427|FG000|Overall Study|Withdrawal by Subject|3|||
145786337|NCT00752609|525724428|FG001|Overall Study|Withdrawal by Subject|0|||
145786338|NCT00752609|525724427|FG000|Overall Study|Physician Decision|1|||
145786339|NCT00752609|525724428|FG001|Overall Study|Physician Decision|0|||
145786340|NCT00752609|525724427|FG000|Overall Study|Death|1|||
145786341|NCT00752609|525724428|FG001|Overall Study|Death|0|||
145786342|NCT00752609|525724427|FG000|Overall Study|Met exclusion criteria|1|||
145786343|NCT00752609|525724428|FG001|Overall Study|Met exclusion criteria|0|||
145786344|NCT00752609|525724427|FG000|Overall Study|Received Aranesp in error|1|||
145786345|NCT00752609|525724428|FG001|Overall Study|Received Aranesp in error|0|||
145786346|NCT05114590|525724429|FG000|Overall Study|Adverse Event|1|||
145786347|NCT05114590|525724429|FG000|Overall Study|Investigator decision|1|||
145786348|NCT05114590|525724429|FG000|Overall Study|Lost to Follow-up|5|||
145786349|NCT05114590|525724429|FG000|Overall Study|Withdrawal by Subject|5|||
145786350|NCT05114590|525724429|FG000|Overall Study|Other|2|||
145786351|NCT00358917|525724430|FG000|Overall Study|Adverse Event|14|||
145786352|NCT00358917|525724431|FG001|Overall Study|Adverse Event|21|||
145786353|NCT00358917|525724430|FG000|Overall Study|Withdrawal by Subject|5|||
145786354|NCT00358917|525724431|FG001|Overall Study|Withdrawal by Subject|7|||
145786355|NCT00358917|525724430|FG000|Overall Study|Lost to Follow-up|20|||
145786356|NCT00358917|525724431|FG001|Overall Study|Lost to Follow-up|17|||
145786357|NCT00358917|525724430|FG000|Overall Study|Noncompliance|12|||
145786358|NCT00358917|525724431|FG001|Overall Study|Noncompliance|11|||
145786359|NCT00358917|525724430|FG000|Overall Study|Death|2|||
145786360|NCT00358917|525724431|FG001|Overall Study|Death|3|||
145786361|NCT00358917|525724430|FG000|Overall Study|Virologic failure|11|||
145786362|NCT00358917|525724431|FG001|Overall Study|Virologic failure|8|||
145786363|NCT00358917|525724430|FG000|Overall Study|Unable to Continue Participation|2|||
145786364|NCT00358917|525724431|FG001|Overall Study|Unable to Continue Participation|2|||
145786365|NCT00938327|525724438|FG000|Overall Study|Adverse Event|2|||
145538924|NCT03094169|524832901|FG005|Overall Study|Lack of Efficacy|0|||
145538925|NCT03094169|524832902|FG006|Overall Study|Lack of Efficacy|0|||
145538926|NCT03094169|524832903|FG007|Overall Study|Lack of Efficacy|21|||
145786366|NCT00938327|525724438|FG000|Overall Study|Protocol Violation|1|||
145786367|NCT00938327|525724438|FG000|Overall Study|Withdrawal by Subject|4|||
145786368|NCT00938327|525724438|FG000|Overall Study|Lost to Follow-up|37|||
145786369|NCT00938327|525724438|FG000|Overall Study|2nd dose received outside of the study|7|||
145786370|NCT00938327|525724438|FG000|Overall Study|Vaccine not received as out of stock|9|||
145786371|NCT02213198|525724441|FG000|Baseline|No show for intake|7|||
145538927|NCT03094169|524832896|FG000|Overall Study|Adverse Event|0|||
145786372|NCT02213198|525724442|FG001|Baseline|No show for intake|9|||
145786373|NCT02213198|525724441|FG000|Baseline|Withdrawal by Subject|34|||
145786374|NCT02213198|525724442|FG001|Baseline|Withdrawal by Subject|11|||
145609617|NCT04534114|525086407|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
145609618|NCT04534114|525086404|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
145609619|NCT04534114|525086405|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
145609620|NCT04534114|525086406|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
145609621|NCT04534114|525086407|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
145609622|NCT04534114|525086404|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
145609623|NCT04534114|525086405|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
145609624|NCT04534114|525086406|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
145609625|NCT04534114|525086407|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
145609626|NCT04534114|525086404|FG000|Main Treatment Period|Physician Decision|0|||
145609627|NCT04534114|525086405|FG001|Main Treatment Period|Physician Decision|0|||
145609628|NCT04534114|525086406|FG002|Main Treatment Period|Physician Decision|0|||
145786375|NCT02213198|525724441|FG000|Baseline|transferred out of clinic|7|||
145786376|NCT02213198|525724442|FG001|Baseline|transferred out of clinic|9|||
145786377|NCT02213198|525724441|FG000|Baseline|Lost to Follow-up|40|||
145786378|NCT02213198|525724442|FG001|Baseline|Lost to Follow-up|21|||
145786379|NCT02213198|525724441|FG000|Baseline|incarcerated,violent|0|||
145281725|NCT00811070|523880633|FG000|Overall Study|Physician Decision|0|||
145538928|NCT03094169|524832897|FG001|Overall Study|Adverse Event|0|||
145538929|NCT03094169|524832898|FG002|Overall Study|Adverse Event|0|||
145538930|NCT03094169|524832899|FG003|Overall Study|Adverse Event|0|||
145538931|NCT03094169|524832900|FG004|Overall Study|Adverse Event|0|||
145538932|NCT03094169|524832901|FG005|Overall Study|Adverse Event|0|||
145538933|NCT03094169|524832902|FG006|Overall Study|Adverse Event|0|||
145538934|NCT03094169|524832903|FG007|Overall Study|Adverse Event|2|||
145538935|NCT03094169|524832896|FG000|Overall Study|Withdrawal by Subject|0|||
145538936|NCT03094169|524832897|FG001|Overall Study|Withdrawal by Subject|0|||
145538937|NCT03094169|524832898|FG002|Overall Study|Withdrawal by Subject|0|||
145538938|NCT03094169|524832899|FG003|Overall Study|Withdrawal by Subject|0|||
145538939|NCT03094169|524832900|FG004|Overall Study|Withdrawal by Subject|0|||
145538940|NCT03094169|524832901|FG005|Overall Study|Withdrawal by Subject|0|||
145538941|NCT03094169|524832902|FG006|Overall Study|Withdrawal by Subject|1|||
145786380|NCT02213198|525724442|FG001|Baseline|incarcerated,violent|1|||
145786381|NCT02213198|525724441|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
145786382|NCT02213198|525724442|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
145786383|NCT02213198|525724441|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
145786384|NCT02213198|525724442|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
145786385|NCT02213198|525724441|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
145786386|NCT02213198|525724442|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
145786387|NCT02213198|525724441|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
145786388|NCT02213198|525724442|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
145786389|NCT02213198|525724441|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
145786390|NCT02213198|525724442|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
145786391|NCT02213198|525724441|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
145786392|NCT02213198|525724442|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
145786393|NCT03860844|525724443|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
145786394|NCT03860844|525724444|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
145786395|NCT03860844|525724445|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
145786396|NCT03860844|525724443|FG000|Overall Study|Progressive disease|5|||
145786397|NCT03860844|525724444|FG001|Overall Study|Progressive disease|3|||
145786398|NCT03860844|525724445|FG002|Overall Study|Progressive disease|4|||
145786399|NCT03860844|525724443|FG000|Overall Study|Other, Not related to COVID-19|0|||
145786400|NCT03860844|525724444|FG001|Overall Study|Other, Not related to COVID-19|1|||
145786401|NCT03860844|525724445|FG002|Overall Study|Other, Not related to COVID-19|0|||
145786402|NCT01678807|525724453|FG000|Overall Study|Adverse Event|4|||
145786403|NCT01678807|525724454|FG001|Overall Study|Adverse Event|4|||
145786404|NCT01678807|525724455|FG002|Overall Study|Adverse Event|0|||
145786405|NCT01678807|525724453|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
145786406|NCT01678807|525724454|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
145786407|NCT01678807|525724455|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
145786408|NCT05281523|525724456|FG000|Overall Study|Adverse Event|1|||
145786409|NCT05281523|525724457|FG001|Overall Study|Adverse Event|1|||
145786410|NCT05281523|525724456|FG000|Overall Study|Physician Decision|1|||
145786411|NCT05281523|525724457|FG001|Overall Study|Physician Decision|1|||
145786412|NCT05281523|525724456|FG000|Overall Study|Withdrawal by Subject|5|||
145281726|NCT00811070|523880634|FG001|Overall Study|Physician Decision|0|||
145538942|NCT03094169|524832903|FG007|Overall Study|Withdrawal by Subject|1|||
145538943|NCT03094169|524832896|FG000|Overall Study|Trial Termination|0|||
145609629|NCT04534114|525086407|FG003|Main Treatment Period|Physician Decision|1|||
145609630|NCT04534114|525086404|FG000|Main Treatment Period|Death|1|||
145609631|NCT04534114|525086405|FG001|Main Treatment Period|Death|0|||
145281727|NCT00811070|523880635|FG002|Overall Study|Physician Decision|0|||
145281728|NCT00811070|523880636|FG003|Overall Study|Physician Decision|0|||
145281729|NCT00811070|523880637|FG004|Overall Study|Physician Decision|0|||
145281730|NCT00811070|523880638|FG005|Overall Study|Physician Decision|1|||
145281731|NCT00585039|523880640|FG000|Overall Study|medication spilled|2|||
145281732|NCT00585039|523880641|FG001|Overall Study|medication spilled|0|||
145281733|NCT00185211|523880648|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
145281734|NCT00185211|523880649|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
145281735|NCT00185211|523880648|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
145281736|NCT00185211|523880649|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
145281737|NCT00185211|523880648|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
145281738|NCT00185211|523880649|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
145281739|NCT00185211|523880648|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
145281740|NCT00185211|523880649|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
145281741|NCT00185211|523880648|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
145281742|NCT00185211|523880649|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
145281743|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
145281744|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
145281745|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
145281746|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
145281747|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
145281748|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
145281749|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
145281750|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
145281751|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
145281752|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
145281753|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
145609632|NCT04534114|525086406|FG002|Main Treatment Period|Death|0|||
145609633|NCT04534114|525086407|FG003|Main Treatment Period|Death|1|||
145609634|NCT04534114|525086404|FG000|Main Treatment Period|Other reason|1|||
145786413|NCT05281523|525724457|FG001|Overall Study|Withdrawal by Subject|15|||
145786414|NCT05281523|525724456|FG000|Overall Study|GCP violations|3|||
145786415|NCT05281523|525724457|FG001|Overall Study|GCP violations|4|||
145786416|NCT02429427|525724458|FG000|Overall Study|Adverse Event|220|||
145786417|NCT02429427|525724459|FG001|Overall Study|Adverse Event|92|||
145786418|NCT02429427|525724458|FG000|Overall Study|Protocol Violation|10|||
145786419|NCT02429427|525724459|FG001|Overall Study|Protocol Violation|6|||
145786420|NCT02429427|525724458|FG000|Overall Study|Lost to Follow-up|15|||
145786421|NCT02429427|525724459|FG001|Overall Study|Lost to Follow-up|6|||
145786422|NCT02429427|525724458|FG000|Overall Study|Withdrawal by Subject|64|||
145786423|NCT02429427|525724459|FG001|Overall Study|Withdrawal by Subject|34|||
145786424|NCT02429427|525724458|FG000|Overall Study|Other|62|||
145786425|NCT02429427|525724459|FG001|Overall Study|Other|41|||
145786426|NCT00719732|525724460|FG000|Overall Study|Lost to Follow-up|20|||
145786427|NCT00719732|525724460|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
145786428|NCT00719732|525724460|FG000|Overall Study|Illness not associated with device|1|||
145786429|NCT02626819|525726077|FG000|Overall Study|Lost to Follow-up|3|||
145786430|NCT02626819|525726078|FG001|Overall Study|Lost to Follow-up|2|||
145786431|NCT02626819|525726077|FG000|Overall Study|Withdrawal by Subject|1|||
145786432|NCT02626819|525726078|FG001|Overall Study|Withdrawal by Subject|0|||
145786433|NCT02626819|525726077|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
145786434|NCT02626819|525726078|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
145786435|NCT03488472|525726079|FG000|Overall Study|disease progression additional mets|1|||
145786436|NCT01617681|525726080|FG000|Period 1 Double Blind|Adverse Event|2|||
145786437|NCT01617681|525726081|FG001|Period 1 Double Blind|Adverse Event|0|||
145786438|NCT01617681|525726082|FG002|Period 1 Double Blind|Adverse Event|0|||
145786439|NCT01617681|525726083|FG003|Period 1 Double Blind|Adverse Event|2|||
145786440|NCT01617681|525726084|FG004|Period 1 Double Blind|Adverse Event|0|||
145786441|NCT01617681|525726080|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
145786442|NCT01617681|525726081|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
145786443|NCT01617681|525726082|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
145786444|NCT01617681|525726083|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
145786445|NCT01617681|525726084|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
145786446|NCT01617681|525726080|FG000|Period 2 Open Label|Adverse Event|0|||
145786447|NCT01617681|525726081|FG001|Period 2 Open Label|Adverse Event|0|||
145786448|NCT01617681|525726082|FG002|Period 2 Open Label|Adverse Event|0|||
145786449|NCT01617681|525726083|FG003|Period 2 Open Label|Adverse Event|0|||
145786450|NCT01617681|525726084|FG004|Period 2 Open Label|Adverse Event|3|||
145786451|NCT01617681|525726080|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
145786452|NCT01617681|525726081|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
145786453|NCT01617681|525726082|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
145786454|NCT01617681|525726083|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
145786455|NCT01617681|525726084|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
145786456|NCT04426825|525726087|FG000|Overall Study|Death|17|||
145786457|NCT04426825|525726087|FG000|Overall Study|Lost to Follow-up|1|||
145786458|NCT04426825|525726087|FG000|Overall Study|Study terminated by sponsor|5|||
145786459|NCT01597557|525726088|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
145786460|NCT01597557|525726089|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
145786461|NCT01263691|525726090|FG000|Overall Study|Lost to Follow-up|1|||
145786462|NCT01263691|525726091|FG001|Overall Study|Lost to Follow-up|0|||
145404006|NCT02194465|524336454|FG003|Overall Study|Discontinued follow-up period|0|||
145404007|NCT02194465|524336455|FG004|Overall Study|Discontinued follow-up period|2|||
145786463|NCT01263691|525726092|FG002|Overall Study|Lost to Follow-up|1|||
145786464|NCT01263691|525726093|FG003|Overall Study|Lost to Follow-up|1|||
145786465|NCT01263691|525726094|FG004|Overall Study|Lost to Follow-up|0|||
145786466|NCT01263691|525726095|FG005|Overall Study|Lost to Follow-up|0|||
145786467|NCT01263691|525726090|FG000|Overall Study|Withdrawal by Subject|1|||
145786468|NCT01263691|525726091|FG001|Overall Study|Withdrawal by Subject|0|||
145786469|NCT01263691|525726092|FG002|Overall Study|Withdrawal by Subject|0|||
145786470|NCT01263691|525726093|FG003|Overall Study|Withdrawal by Subject|0|||
145786471|NCT01263691|525726094|FG004|Overall Study|Withdrawal by Subject|0|||
145786472|NCT01263691|525726095|FG005|Overall Study|Withdrawal by Subject|0|||
145786473|NCT01263691|525726090|FG000|Overall Study|Adverse Event|1|||
145786474|NCT01263691|525726091|FG001|Overall Study|Adverse Event|0|||
145786475|NCT01263691|525726092|FG002|Overall Study|Adverse Event|0|||
145786476|NCT01263691|525726093|FG003|Overall Study|Adverse Event|0|||
145786477|NCT01263691|525726094|FG004|Overall Study|Adverse Event|0|||
145786478|NCT01263691|525726095|FG005|Overall Study|Adverse Event|0|||
145786479|NCT00879814|525726098|FG000|Overall Study|Adverse Event|0|||
145786480|NCT00879814|525726099|FG001|Overall Study|Adverse Event|1|||
145786481|NCT00879814|525726100|FG002|Overall Study|Adverse Event|0|||
145786482|NCT00879814|525726101|FG003|Overall Study|Adverse Event|0|||
145786483|NCT00879814|525726098|FG000|Overall Study|Lost to Follow-up|1|||
145786484|NCT00879814|525726099|FG001|Overall Study|Lost to Follow-up|0|||
145786485|NCT00879814|525726100|FG002|Overall Study|Lost to Follow-up|0|||
145786486|NCT00879814|525726101|FG003|Overall Study|Lost to Follow-up|2|||
145786487|NCT00879814|525726098|FG000|Overall Study|Participant Failed to Return|0|||
145786488|NCT00879814|525726099|FG001|Overall Study|Participant Failed to Return|0|||
145786489|NCT00879814|525726100|FG002|Overall Study|Participant Failed to Return|0|||
145786490|NCT00879814|525726101|FG003|Overall Study|Participant Failed to Return|1|||
145786491|NCT00879814|525726098|FG000|Overall Study|Withdrawal by Subject|3|||
145786492|NCT00879814|525726099|FG001|Overall Study|Withdrawal by Subject|1|||
145786493|NCT00879814|525726100|FG002|Overall Study|Withdrawal by Subject|1|||
145786494|NCT00879814|525726101|FG003|Overall Study|Withdrawal by Subject|2|||
145786495|NCT00879814|525726098|FG000|Overall Study|Physician Decision|0|||
145786496|NCT00879814|525726099|FG001|Overall Study|Physician Decision|0|||
145786497|NCT00879814|525726100|FG002|Overall Study|Physician Decision|1|||
145786498|NCT00879814|525726101|FG003|Overall Study|Physician Decision|0|||
145786499|NCT00879814|525726098|FG000|Overall Study|Other|0|||
145786500|NCT00879814|525726099|FG001|Overall Study|Other|0|||
145786501|NCT00879814|525726100|FG002|Overall Study|Other|1|||
145786502|NCT00879814|525726101|FG003|Overall Study|Other|0|||
145786503|NCT00630812|525726112|FG000|Randomisation to First Dose|Adverse Event|1|||
145786504|NCT00630812|525726113|FG001|Randomisation to First Dose|Adverse Event|1|||
145786505|NCT00630812|525726112|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
145786506|NCT00630812|525726113|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
145786507|NCT00630812|525726112|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
145786508|NCT00630812|525726113|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
145786509|NCT00630812|525726112|FG000|Randomisation to First Dose|Protocol Violation|4|||
145786510|NCT00630812|525726113|FG001|Randomisation to First Dose|Protocol Violation|1|||
145786511|NCT00630812|525726112|FG000|Double Blind Treatment Period|Adverse Event|13|||
145786512|NCT00630812|525726113|FG001|Double Blind Treatment Period|Adverse Event|5|||
145786513|NCT00630812|525726112|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
145786514|NCT00630812|525726113|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
145786515|NCT00630812|525726112|FG000|Double Blind Treatment Period|Physician Decision|2|||
145786516|NCT00630812|525726113|FG001|Double Blind Treatment Period|Physician Decision|1|||
145786517|NCT00630812|525726112|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145786518|NCT00630812|525726113|FG001|Double Blind Treatment Period|Protocol Violation|0|||
145786519|NCT00630812|525726112|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
145786520|NCT00630812|525726113|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
145786521|NCT00630812|525726112|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
145786522|NCT00630812|525726113|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
145786523|NCT00630812|525726112|FG000|Double Blind Treatment Period|Non-compliance|0|||
145404008|NCT02194465|524336456|FG005|Overall Study|Discontinued follow-up period|0|||
145538944|NCT03094169|524832897|FG001|Overall Study|Trial Termination|0|||
145786524|NCT00630812|525726113|FG001|Double Blind Treatment Period|Non-compliance|1|||
145786525|NCT03430245|525726116|FG000|Overall Study|Withdrawal by Subject|6|||
145786526|NCT03430245|525726116|FG000|Overall Study|Lost to Follow-up|1|||
145786527|NCT05628181|525726117|FG000|Overall Study|Death|2|||
145786528|NCT05628181|525726118|FG001|Overall Study|Death|4|||
145786529|NCT05628181|525726119|FG002|Overall Study|Death|0|||
145786530|NCT04102098|525726120|FG000|Main Study Period|Ongoing in study|302|||
145786531|NCT04102098|525726121|FG001|Main Study Period|Ongoing in study|291|||
145786532|NCT04102098|525726120|FG000|Main Study Period|Death|20|||
145786533|NCT04102098|525726121|FG001|Main Study Period|Death|27|||
145786534|NCT04102098|525726120|FG000|Main Study Period|Lost to Follow-up|1|||
145786535|NCT04102098|525726121|FG001|Main Study Period|Lost to Follow-up|1|||
145786536|NCT04102098|525726120|FG000|Main Study Period|Physician Decision|0|||
145786537|NCT04102098|525726121|FG001|Main Study Period|Physician Decision|1|||
145786538|NCT04102098|525726120|FG000|Main Study Period|Withdrawal by Subject|11|||
145786539|NCT04102098|525726121|FG001|Main Study Period|Withdrawal by Subject|14|||
145786540|NCT04102098|525726120|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
145786541|NCT04102098|525726121|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
145786542|NCT04102098|525726120|FG000|Crossover: AS Who Crossed Over|Death|11|||
145786543|NCT04102098|525726121|FG001|Crossover: AS Who Crossed Over|Death|0|||
145786544|NCT04102098|525726120|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
145786545|NCT04102098|525726121|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
145786546|NCT04742907|525726128|FG000|Overall Study|Adverse Event|1|||
145786547|NCT04742907|525726129|FG001|Overall Study|Adverse Event|0|||
145786548|NCT04742907|525726130|FG002|Overall Study|Adverse Event|1|||
145786549|NCT04742907|525726128|FG000|Overall Study|Lost to Follow-up|3|||
145786550|NCT04742907|525726129|FG001|Overall Study|Lost to Follow-up|3|||
145786551|NCT04742907|525726130|FG002|Overall Study|Lost to Follow-up|2|||
145786552|NCT04742907|525726128|FG000|Overall Study|Physician Decision|0|||
145786553|NCT04742907|525726129|FG001|Overall Study|Physician Decision|1|||
145786554|NCT04742907|525726130|FG002|Overall Study|Physician Decision|0|||
145786555|NCT04742907|525726128|FG000|Overall Study|Protocol Violation|1|||
145786556|NCT04742907|525726129|FG001|Overall Study|Protocol Violation|1|||
145786557|NCT04742907|525726130|FG002|Overall Study|Protocol Violation|1|||
145786558|NCT04742907|525726128|FG000|Overall Study|Withdrawal by Subject|5|||
145786559|NCT04742907|525726129|FG001|Overall Study|Withdrawal by Subject|6|||
145786560|NCT04742907|525726130|FG002|Overall Study|Withdrawal by Subject|4|||
145786561|NCT04742907|525726128|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
145786562|NCT04742907|525726129|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
145786563|NCT04742907|525726130|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
145786564|NCT04742907|525726128|FG000|Overall Study|Did Not Receive the Study Drug|2|||
145786565|NCT04742907|525726129|FG001|Overall Study|Did Not Receive the Study Drug|4|||
145786566|NCT04742907|525726130|FG002|Overall Study|Did Not Receive the Study Drug|4|||
145786567|NCT01428063|525726132|FG000|Overall Study|Lack of Efficacy|8|||
145786568|NCT01428063|525726133|FG001|Overall Study|Lack of Efficacy|4|||
145786569|NCT01428063|525726134|FG002|Overall Study|Lack of Efficacy|1|||
145786570|NCT01428063|525726132|FG000|Overall Study|Adverse Event|2|||
145786571|NCT01428063|525726133|FG001|Overall Study|Adverse Event|3|||
145786572|NCT01428063|525726134|FG002|Overall Study|Adverse Event|0|||
145786573|NCT01428063|525726132|FG000|Overall Study|Lost to Follow-up|0|||
145786574|NCT01428063|525726133|FG001|Overall Study|Lost to Follow-up|2|||
145786575|NCT01428063|525726134|FG002|Overall Study|Lost to Follow-up|0|||
145786576|NCT01428063|525726132|FG000|Overall Study|No longer meets study criteria|0|||
145786577|NCT01428063|525726133|FG001|Overall Study|No longer meets study criteria|1|||
145786578|NCT01428063|525726134|FG002|Overall Study|No longer meets study criteria|0|||
145786579|NCT00850759|525726136|FG000|Overall Study|Lost to Follow-up|7|||
145786580|NCT00850759|525726137|FG001|Overall Study|Lost to Follow-up|5|||
145786581|NCT00850759|525726138|FG002|Overall Study|Lost to Follow-up|5|||
145786582|NCT00850759|525726139|FG003|Overall Study|Lost to Follow-up|3|||
145786583|NCT03196505|525726140|FG000|Overall Study|Physician Decision|26|||
145786584|NCT03196505|525726141|FG001|Overall Study|Physician Decision|26|||
145786585|NCT00788775|525726142|FG000|Overall Study|Progressive Disease|8|||
145786586|NCT00788775|525726143|FG001|Overall Study|Progressive Disease|6|||
145786587|NCT00788775|525726142|FG000|Overall Study|Withdrawal by Subject|0|||
145786588|NCT00788775|525726143|FG001|Overall Study|Withdrawal by Subject|2|||
145786589|NCT00788775|525726142|FG000|Overall Study|Patient Non-Compliance|1|||
145786590|NCT00788775|525726143|FG001|Overall Study|Patient Non-Compliance|0|||
145786591|NCT00788775|525726142|FG000|Overall Study|Patient's measurable disease resected.|1|||
145786592|NCT00788775|525726143|FG001|Overall Study|Patient's measurable disease resected.|0|||
145786593|NCT00578864|525726144|FG000|Overall Study|Death|1|||
145786594|NCT00578864|525726145|FG001|Overall Study|Death|0|||
145786595|NCT01217190|525726149|FG000|Second Dosing|Withdrawal by Subject|0|||
145786596|NCT01217190|525726150|FG001|Second Dosing|Withdrawal by Subject|2|||
145786597|NCT01594476|525726151|FG000|Overall Study|Protocol Violation|1|||
145786598|NCT01594476|525726152|FG001|Overall Study|Protocol Violation|3|||
145786599|NCT03116399|525726153|FG000|Overall Study|Death|8|||
145786600|NCT03116399|525726154|FG001|Overall Study|Death|3|||
145786601|NCT03116399|525726153|FG000|Overall Study|Lost to Follow-up|7|||
145538945|NCT03094169|524832898|FG002|Overall Study|Trial Termination|0|||
145538946|NCT03094169|524832899|FG003|Overall Study|Trial Termination|0|||
145538947|NCT03094169|524832900|FG004|Overall Study|Trial Termination|0|||
145538948|NCT03094169|524832901|FG005|Overall Study|Trial Termination|0|||
145538949|NCT03094169|524832902|FG006|Overall Study|Trial Termination|0|||
145538950|NCT03094169|524832903|FG007|Overall Study|Trial Termination|1|||
145538951|NCT04645953|524832904|FG000|Overall Study|Lost to Follow-up|2|||
145538952|NCT04645953|524832905|FG001|Overall Study|Lost to Follow-up|1|||
145538953|NCT04645953|524832906|FG002|Overall Study|Lost to Follow-up|1|||
145538954|NCT04645953|524832904|FG000|Overall Study|Withdrawal by Subject|0|||
145538955|NCT04645953|524832905|FG001|Overall Study|Withdrawal by Subject|1|||
145538956|NCT04645953|524832906|FG002|Overall Study|Withdrawal by Subject|0|||
145538957|NCT04645953|524832904|FG000|Overall Study|Physician Decision|0|||
145538958|NCT04645953|524832905|FG001|Overall Study|Physician Decision|1|||
145538959|NCT04645953|524832906|FG002|Overall Study|Physician Decision|0|||
145538960|NCT04645953|524832904|FG000|Overall Study|Discontinued Prior to Dosing|0|||
145786602|NCT03116399|525726154|FG001|Overall Study|Lost to Follow-up|11|||
145786603|NCT03116399|525726153|FG000|Overall Study|Investigator Decision|1|||
145786604|NCT03116399|525726154|FG001|Overall Study|Investigator Decision|1|||
145786605|NCT03116399|525726153|FG000|Overall Study|Withdrawal by Subject|24|||
145786606|NCT03116399|525726154|FG001|Overall Study|Withdrawal by Subject|9|||
145786607|NCT01425190|525726156|FG000|Overall Study|Full dose not consumed.|1|||
145538961|NCT04645953|524832905|FG001|Overall Study|Discontinued Prior to Dosing|0|||
145538962|NCT04645953|524832906|FG002|Overall Study|Discontinued Prior to Dosing|2|||
145538963|NCT00864721|524832907|FG000|Overall Study|Patient request|11|||
145538964|NCT00864721|524832907|FG000|Overall Study|Hospitalized|1|||
145538965|NCT00864721|524832907|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
145538966|NCT00864721|524832907|FG000|Overall Study|Adverse Event|21|||
145786608|NCT01425190|525726157|FG001|Overall Study|Full dose not consumed.|0|||
145786609|NCT01425190|525726158|FG002|Overall Study|Full dose not consumed.|0|||
145786610|NCT01035255|525726160|FG000|Overall Study|Death|724|||
145786611|NCT01035255|525726161|FG001|Overall Study|Death|844|||
145786612|NCT01035255|525726160|FG000|Overall Study|Lost to Follow-up|2|||
145786613|NCT01035255|525726161|FG001|Overall Study|Lost to Follow-up|5|||
145786614|NCT01035255|525726160|FG000|Overall Study|patient's request|15|||
145786615|NCT01035255|525726161|FG001|Overall Study|patient's request|13|||
145786616|NCT00195260|525726164|FG000|Part 1: Dose Escalation|Adverse Event|0|||
145786617|NCT00195260|525726165|FG001|Part 1: Dose Escalation|Adverse Event|1|||
145786618|NCT00195260|525726166|FG002|Part 1: Dose Escalation|Adverse Event|0|||
145786619|NCT00195260|525726167|FG003|Part 1: Dose Escalation|Adverse Event|1|||
145786620|NCT00195260|525726168|FG004|Part 1: Dose Escalation|Adverse Event|1|||
145786621|NCT00195260|525726169|FG005|Part 1: Dose Escalation|Adverse Event|0|||
145786622|NCT00195260|525726170|FG006|Part 1: Dose Escalation|Adverse Event|3|||
145786623|NCT00195260|525726171|FG007|Part 1: Dose Escalation|Adverse Event|0|||
145786624|NCT00195260|525726172|FG008|Part 1: Dose Escalation|Adverse Event|0|||
145786625|NCT00195260|525726173|FG009|Part 1: Dose Escalation|Adverse Event|0|||
145786626|NCT00195260|525726174|FG010|Part 1: Dose Escalation|Adverse Event|0|||
145786627|NCT00195260|525726164|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786628|NCT00195260|525726165|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786629|NCT00195260|525726166|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786630|NCT00195260|525726167|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786631|NCT00195260|525726168|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
145786632|NCT00195260|525726169|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786633|NCT00195260|525726170|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786634|NCT00195260|525726171|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
145786635|NCT00195260|525726172|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786636|NCT00195260|525726173|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786637|NCT00195260|525726174|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145786638|NCT00195260|525726164|FG000|Part 1: Dose Escalation|Death|0|||
145786639|NCT00195260|525726165|FG001|Part 1: Dose Escalation|Death|0|||
145786640|NCT00195260|525726166|FG002|Part 1: Dose Escalation|Death|0|||
145786641|NCT00195260|525726167|FG003|Part 1: Dose Escalation|Death|0|||
145786642|NCT00195260|525726168|FG004|Part 1: Dose Escalation|Death|0|||
145786643|NCT00195260|525726169|FG005|Part 1: Dose Escalation|Death|0|||
145786644|NCT00195260|525726170|FG006|Part 1: Dose Escalation|Death|0|||
145786645|NCT00195260|525726171|FG007|Part 1: Dose Escalation|Death|1|||
145786646|NCT00195260|525726172|FG008|Part 1: Dose Escalation|Death|0|||
145786647|NCT00195260|525726173|FG009|Part 1: Dose Escalation|Death|0|||
145786648|NCT00195260|525726174|FG010|Part 1: Dose Escalation|Death|0|||
145786649|NCT00195260|525726164|FG000|Part 1: Dose Escalation|Disease Progression|3|||
145786650|NCT00195260|525726165|FG001|Part 1: Dose Escalation|Disease Progression|2|||
145538967|NCT01896102|524832910|FG000|Overall Study|Death|1|||
145538968|NCT01896102|524832910|FG000|Overall Study|Participant to receive allogenic transplant|2|||
145538969|NCT01751178|524832911|FG000|Overall Study|Adverse Event|2|||
145786651|NCT00195260|525726166|FG002|Part 1: Dose Escalation|Disease Progression|5|||
145786652|NCT00195260|525726167|FG003|Part 1: Dose Escalation|Disease Progression|6|||
145786653|NCT00195260|525726168|FG004|Part 1: Dose Escalation|Disease Progression|4|||
145786654|NCT00195260|525726169|FG005|Part 1: Dose Escalation|Disease Progression|6|||
145786655|NCT00195260|525726170|FG006|Part 1: Dose Escalation|Disease Progression|7|||
145786656|NCT00195260|525726171|FG007|Part 1: Dose Escalation|Disease Progression|4|||
145786657|NCT00195260|525726172|FG008|Part 1: Dose Escalation|Disease Progression|0|||
145786658|NCT00195260|525726173|FG009|Part 1: Dose Escalation|Disease Progression|0|||
145786659|NCT00195260|525726174|FG010|Part 1: Dose Escalation|Disease Progression|0|||
145786660|NCT00195260|525726164|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
145786661|NCT00195260|525726165|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
145786662|NCT00195260|525726166|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
145786663|NCT00195260|525726167|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786664|NCT00195260|525726168|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786665|NCT00195260|525726169|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
145786666|NCT00195260|525726170|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786667|NCT00195260|525726171|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786668|NCT00195260|525726172|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786669|NCT00195260|525726173|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786670|NCT00195260|525726174|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
145786671|NCT00195260|525726164|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786672|NCT00195260|525726165|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786673|NCT00195260|525726166|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786674|NCT00195260|525726167|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786675|NCT00195260|525726168|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786676|NCT00195260|525726169|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786677|NCT00195260|525726170|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786678|NCT00195260|525726171|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
145786679|NCT00195260|525726172|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
145786680|NCT00195260|525726173|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
145786681|NCT00195260|525726174|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
145786682|NCT00195260|525726164|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786683|NCT00195260|525726165|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786684|NCT00195260|525726166|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786685|NCT00195260|525726167|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786686|NCT00195260|525726168|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786687|NCT00195260|525726169|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786688|NCT00195260|525726170|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786689|NCT00195260|525726171|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
145786690|NCT00195260|525726172|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
145786691|NCT00195260|525726173|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
145786692|NCT00195260|525726174|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
145786693|NCT00195260|525726164|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786694|NCT00195260|525726165|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786695|NCT00195260|525726166|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786696|NCT00195260|525726167|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786697|NCT00195260|525726168|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786698|NCT00195260|525726169|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786699|NCT00195260|525726170|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145538970|NCT01751178|524832912|FG001|Overall Study|Adverse Event|0|||
145538971|NCT01751178|524832913|FG002|Overall Study|Adverse Event|0|||
145538972|NCT01751178|524832911|FG000|Overall Study|Other Reason (unknown)|1|||
145538973|NCT01751178|524832912|FG001|Overall Study|Other Reason (unknown)|0|||
145538974|NCT01751178|524832913|FG002|Overall Study|Other Reason (unknown)|2|||
145538975|NCT04891978|524832919|FG000|Baseline|Protocol Violation|2|||
145538976|NCT04891978|524832920|FG001|Baseline|Protocol Violation|1|||
145538977|NCT04891978|524832921|FG002|Baseline|Protocol Violation|0|||
145538978|NCT04891978|524832919|FG000|Baseline|Missing AIRQ|1|||
145538979|NCT04891978|524832920|FG001|Baseline|Missing AIRQ|0|||
145538980|NCT04891978|524832921|FG002|Baseline|Missing AIRQ|0|||
145538981|NCT04891978|524832919|FG000|Baseline|Did not attend a baseline visit|0|||
145538982|NCT04891978|524832920|FG001|Baseline|Did not attend a baseline visit|0|||
145786700|NCT00195260|525726171|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
145786701|NCT00195260|525726172|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
145786702|NCT00195260|525726173|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
145538983|NCT04891978|524832921|FG002|Baseline|Did not attend a baseline visit|9|||
145538984|NCT01776840|524832922|FG000|Overall Study|Lost to Follow-up|12|||
145538985|NCT01776840|524832923|FG001|Overall Study|Lost to Follow-up|7|||
145538986|NCT01776840|524832922|FG000|Overall Study|Withdrawal by Subject|32|||
145538987|NCT01776840|524832923|FG001|Overall Study|Withdrawal by Subject|48|||
145538988|NCT01776840|524832922|FG000|Overall Study|Sponsor decision|89|||
145538989|NCT01776840|524832923|FG001|Overall Study|Sponsor decision|87|||
145538990|NCT03641339|524832926|FG000|Overall Study|Physician Decision|1|||
145538991|NCT03641339|524832927|FG001|Overall Study|Physician Decision|0|||
145538992|NCT03641339|524832928|FG002|Overall Study|Physician Decision|0|||
145538993|NCT03641339|524832929|FG003|Overall Study|Physician Decision|0|||
145538994|NCT03641339|524832930|FG004|Overall Study|Physician Decision|0|||
145538995|NCT03641339|524832931|FG005|Overall Study|Physician Decision|0|||
145538996|NCT03641339|524832926|FG000|Overall Study|Withdrawal by Subject|0|||
145538997|NCT03641339|524832927|FG001|Overall Study|Withdrawal by Subject|2|||
145538998|NCT03641339|524832928|FG002|Overall Study|Withdrawal by Subject|0|||
145538999|NCT03641339|524832929|FG003|Overall Study|Withdrawal by Subject|2|||
145539000|NCT03641339|524832930|FG004|Overall Study|Withdrawal by Subject|0|||
145539001|NCT03641339|524832931|FG005|Overall Study|Withdrawal by Subject|1|||
145539002|NCT02589405|524832932|FG000|Overall Study|Adverse Event|3|||
145539003|NCT02589405|524832932|FG000|Overall Study|Withdrawal by Subject|1|||
145539004|NCT00446251|524832936|FG000|Overall Study|On-study Transplants|2|||
145539005|NCT00446251|524832936|FG000|Overall Study|Rituximab Infusion Reaction|2|||
145539006|NCT00446251|524832936|FG000|Overall Study|Lost to Follow-up|1|||
145539007|NCT02693119|524832944|FG000|Open-Label Period|Withdrawal by Subject|0|||
145539008|NCT02693119|524832945|FG001|Open-Label Period|Withdrawal by Subject|1|||
145539009|NCT02319837|524832946|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
145539010|NCT02319837|524832947|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
145539011|NCT02319837|524832948|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
145539012|NCT02319837|524832946|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
145539013|NCT02319837|524832947|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
145539014|NCT02319837|524832948|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
145539015|NCT02319837|524832946|FG000|Study Treatment Phase|Adverse Event|73|||
145539016|NCT02319837|524832947|FG001|Study Treatment Phase|Adverse Event|36|||
145539017|NCT02319837|524832948|FG002|Study Treatment Phase|Adverse Event|63|||
145539018|NCT02319837|524832946|FG000|Study Treatment Phase|Development of castration resistance|0|||
145539019|NCT02319837|524832947|FG001|Study Treatment Phase|Development of castration resistance|2|||
145539020|NCT02319837|524832948|FG002|Study Treatment Phase|Development of castration resistance|0|||
145539021|NCT02319837|524832946|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
145539022|NCT02319837|524832947|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
145539023|NCT02319837|524832948|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
145539024|NCT02319837|524832946|FG000|Study Treatment Phase|Protocol Violation|2|||
145539025|NCT02319837|524832947|FG001|Study Treatment Phase|Protocol Violation|2|||
145539026|NCT02319837|524832948|FG002|Study Treatment Phase|Protocol Violation|1|||
145539027|NCT02319837|524832946|FG000|Study Treatment Phase|Lost to Follow-up|0|||
145539028|NCT02319837|524832947|FG001|Study Treatment Phase|Lost to Follow-up|1|||
145539029|NCT02319837|524832948|FG002|Study Treatment Phase|Lost to Follow-up|0|||
145539030|NCT02319837|524832946|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
145539031|NCT02319837|524832947|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
145539032|NCT02319837|524832948|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
145539033|NCT02319837|524832946|FG000|Study Treatment Phase|Other|0|||
145539034|NCT02319837|524832947|FG001|Study Treatment Phase|Other|1|||
145539035|NCT02319837|524832948|FG002|Study Treatment Phase|Other|0|||
145539036|NCT02319837|524832946|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
145539037|NCT02319837|524832947|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
145786703|NCT00195260|525726174|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
145786704|NCT00195260|525726164|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786705|NCT00195260|525726165|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786706|NCT00195260|525726166|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145539038|NCT02319837|524832948|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
145539039|NCT02319837|524832946|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
145539040|NCT02319837|524832947|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
145786707|NCT00195260|525726167|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786708|NCT00195260|525726168|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786709|NCT00195260|525726169|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145539041|NCT02319837|524832948|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
145786710|NCT00195260|525726170|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786711|NCT00195260|525726171|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
145786712|NCT00195260|525726172|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
145786713|NCT00195260|525726173|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
145558237|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
145786714|NCT00195260|525726174|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
145786715|NCT01379534|525726175|FG000|Treatment Phase|Withdrawal by Subject|2|||
145786716|NCT01379534|525726176|FG001|Treatment Phase|Withdrawal by Subject|2|||
145786717|NCT01379534|525726175|FG000|Treatment Phase|Progressive disease|13|||
145786718|NCT01379534|525726176|FG001|Treatment Phase|Progressive disease|22|||
145786719|NCT01379534|525726175|FG000|Treatment Phase|Adverse Event|7|||
145786720|NCT01379534|525726176|FG001|Treatment Phase|Adverse Event|7|||
145786721|NCT01379534|525726175|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
145786722|NCT01379534|525726176|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
145786723|NCT01379534|525726175|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
145786724|NCT01379534|525726176|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
145786725|NCT01379534|525726175|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
145786726|NCT01379534|525726176|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
145786727|NCT01379534|525726175|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
145786728|NCT01379534|525726176|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
145786729|NCT03007953|525726179|FG000|Overall Study|Withdrawal by Subject|5|||
145786730|NCT03007953|525726180|FG001|Overall Study|Withdrawal by Subject|2|||
145786731|NCT03007953|525726179|FG000|Overall Study|Death|5|||
145786732|NCT03007953|525726180|FG001|Overall Study|Death|7|||
145786733|NCT03007953|525726179|FG000|Overall Study|Lost to Follow-up|3|||
145786734|NCT03007953|525726180|FG001|Overall Study|Lost to Follow-up|2|||
145786735|NCT03007953|525726179|FG000|Overall Study|Enrolled in Hospice|3|||
145786736|NCT03007953|525726180|FG001|Overall Study|Enrolled in Hospice|2|||
145786737|NCT00829166|525726184|FG000|Overall Study|Death|305|||
145786738|NCT00829166|525726185|FG001|Overall Study|Death|333|||
145786739|NCT00829166|525726184|FG000|Overall Study|Lost to Follow-up|5|||
145786740|NCT00829166|525726185|FG001|Overall Study|Lost to Follow-up|4|||
145786741|NCT00829166|525726184|FG000|Overall Study|Physician's Decision|4|||
145786742|NCT00829166|525726185|FG001|Overall Study|Physician's Decision|3|||
145786743|NCT00829166|525726184|FG000|Overall Study|Subject's Decision|41|||
145786744|NCT00829166|525726185|FG001|Overall Study|Subject's Decision|55|||
145786745|NCT00829166|525726184|FG000|Overall Study|Sponsor's Decision|137|||
145786746|NCT00829166|525726185|FG001|Overall Study|Sponsor's Decision|98|||
145786747|NCT00829166|525726184|FG000|Overall Study|Reason Not Specified|3|||
145786748|NCT00829166|525726185|FG001|Overall Study|Reason Not Specified|3|||
145786749|NCT02538666|525726186|FG000|Pre-Treatment|Disease progression|1|||
145786750|NCT02538666|525726187|FG001|Pre-Treatment|Disease progression|0|||
145786751|NCT02538666|525726188|FG002|Pre-Treatment|Disease progression|0|||
145786752|NCT02538666|525726186|FG000|Pre-Treatment|no longer meets study criteria|1|||
145786753|NCT02538666|525726187|FG001|Pre-Treatment|no longer meets study criteria|0|||
145786754|NCT02538666|525726188|FG002|Pre-Treatment|no longer meets study criteria|0|||
145786755|NCT02538666|525726186|FG000|Pre-Treatment|Withdrew Consent|0|||
145786756|NCT02538666|525726187|FG001|Pre-Treatment|Withdrew Consent|1|||
145786757|NCT02538666|525726188|FG002|Pre-Treatment|Withdrew Consent|1|||
145786758|NCT02538666|525726186|FG000|Treatment|Disease progression|270|||
145786759|NCT02538666|525726187|FG001|Treatment|Disease progression|227|||
145539042|NCT02319837|524832946|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
145539043|NCT02319837|524832947|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
145539044|NCT02319837|524832948|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
145539045|NCT02319837|524832946|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
145539046|NCT02319837|524832947|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
145786760|NCT02538666|525726188|FG002|Treatment|Disease progression|165|||
145786761|NCT02538666|525726186|FG000|Treatment|Study drug toxicity|1|||
145786762|NCT02538666|525726187|FG001|Treatment|Study drug toxicity|29|||
145786763|NCT02538666|525726188|FG002|Treatment|Study drug toxicity|92|||
145786764|NCT02538666|525726186|FG000|Treatment|Death|0|||
145786765|NCT02538666|525726187|FG001|Treatment|Death|2|||
145786766|NCT02538666|525726188|FG002|Treatment|Death|3|||
145786767|NCT02538666|525726186|FG000|Treatment|Adverse event unrelated to study drug|8|||
145539047|NCT02319837|524832948|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
145786768|NCT02538666|525726187|FG001|Treatment|Adverse event unrelated to study drug|10|||
145786769|NCT02538666|525726188|FG002|Treatment|Adverse event unrelated to study drug|15|||
145786770|NCT02538666|525726186|FG000|Treatment|Participant request to discontinue study treatment|3|||
145786771|NCT02538666|525726187|FG001|Treatment|Participant request to discontinue study treatment|6|||
145786772|NCT02538666|525726188|FG002|Treatment|Participant request to discontinue study treatment|11|||
145786773|NCT02538666|525726186|FG000|Treatment|Participant withdrew consent|2|||
145786774|NCT02538666|525726187|FG001|Treatment|Participant withdrew consent|5|||
145786775|NCT02538666|525726188|FG002|Treatment|Participant withdrew consent|3|||
145786776|NCT02538666|525726186|FG000|Treatment|Lost to Follow-up|0|||
145786777|NCT02538666|525726187|FG001|Treatment|Lost to Follow-up|1|||
145786778|NCT02538666|525726188|FG002|Treatment|Lost to Follow-up|1|||
145786779|NCT02538666|525726186|FG000|Treatment|Maximum clinical benefit|4|||
145786780|NCT02538666|525726187|FG001|Treatment|Maximum clinical benefit|3|||
145786781|NCT02538666|525726188|FG002|Treatment|Maximum clinical benefit|4|||
145786782|NCT02538666|525726186|FG000|Treatment|Poor/non-compliance|0|||
145786783|NCT02538666|525726187|FG001|Treatment|Poor/non-compliance|1|||
145786784|NCT02538666|525726188|FG002|Treatment|Poor/non-compliance|0|||
145786785|NCT02538666|525726186|FG000|Treatment|Participant no longer meets study criteria|0|||
145786786|NCT02538666|525726187|FG001|Treatment|Participant no longer meets study criteria|2|||
145786787|NCT02538666|525726188|FG002|Treatment|Participant no longer meets study criteria|0|||
145786788|NCT02538666|525726186|FG000|Treatment|Administrative reason by sponsor|0|||
145786789|NCT02538666|525726187|FG001|Treatment|Administrative reason by sponsor|0|||
145786790|NCT02538666|525726188|FG002|Treatment|Administrative reason by sponsor|1|||
145786791|NCT02538666|525726186|FG000|Treatment|Other reasons|8|||
145786792|NCT02538666|525726187|FG001|Treatment|Other reasons|15|||
145786793|NCT02538666|525726188|FG002|Treatment|Other reasons|5|||
145786794|NCT02538666|525726186|FG000|Treatment|Not reported|2|||
145786795|NCT02538666|525726187|FG001|Treatment|Not reported|2|||
145786796|NCT02538666|525726188|FG002|Treatment|Not reported|2|||
145786797|NCT01635933|525726189|FG000|Overall Study|Adverse Event|1|||
145786798|NCT01635933|525726190|FG001|Overall Study|Adverse Event|0|||
145786799|NCT01635933|525726189|FG000|Overall Study|Lost to Follow-up|0|||
145786800|NCT01635933|525726190|FG001|Overall Study|Lost to Follow-up|5|||
145786801|NCT01635933|525726189|FG000|Overall Study|Subject decision|1|||
145786802|NCT01635933|525726190|FG001|Overall Study|Subject decision|1|||
145786803|NCT01635933|525726189|FG000|Overall Study|Noncompliance|0|||
145786804|NCT01635933|525726190|FG001|Overall Study|Noncompliance|1|||
145786805|NCT01635933|525726189|FG000|Overall Study|No longer had transportation|0|||
145786806|NCT01635933|525726190|FG001|Overall Study|No longer had transportation|1|||
145786807|NCT01544595|525726193|FG000|Status at Week 68|Adverse Event|3|||
145786808|NCT01544595|525726194|FG001|Status at Week 68|Adverse Event|2|||
145786809|NCT01544595|525726195|FG002|Status at Week 68|Adverse Event|1|||
145786810|NCT01544595|525726196|FG003|Status at Week 68|Adverse Event|0|||
145786811|NCT01544595|525726197|FG004|Status at Week 68|Adverse Event|0|||
145786812|NCT01544595|525726198|FG005|Status at Week 68|Adverse Event|0|||
145786813|NCT01544595|525726193|FG000|Status at Week 68|Lack of Efficacy|1|||
145786814|NCT01544595|525726194|FG001|Status at Week 68|Lack of Efficacy|0|||
145786815|NCT01544595|525726195|FG002|Status at Week 68|Lack of Efficacy|0|||
145786816|NCT01544595|525726196|FG003|Status at Week 68|Lack of Efficacy|0|||
145786817|NCT01544595|525726197|FG004|Status at Week 68|Lack of Efficacy|0|||
145786818|NCT01544595|525726198|FG005|Status at Week 68|Lack of Efficacy|0|||
145786819|NCT01544595|525726193|FG000|Status at Week 68|Lost to Follow-up|1|||
145786820|NCT01544595|525726194|FG001|Status at Week 68|Lost to Follow-up|1|||
145786821|NCT01544595|525726195|FG002|Status at Week 68|Lost to Follow-up|0|||
145786822|NCT01544595|525726196|FG003|Status at Week 68|Lost to Follow-up|0|||
145404009|NCT02194465|524336457|FG006|Overall Study|Discontinued follow-up period|0|||
145539048|NCT02319837|524832946|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
145539049|NCT02319837|524832947|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
145786823|NCT01544595|525726197|FG004|Status at Week 68|Lost to Follow-up|0|||
145786824|NCT01544595|525726198|FG005|Status at Week 68|Lost to Follow-up|0|||
145786825|NCT01544595|525726193|FG000|Status at Week 68|Non-compliance with study treatment|1|||
145786826|NCT01544595|525726194|FG001|Status at Week 68|Non-compliance with study treatment|0|||
145786827|NCT01544595|525726195|FG002|Status at Week 68|Non-compliance with study treatment|0|||
145786828|NCT01544595|525726196|FG003|Status at Week 68|Non-compliance with study treatment|1|||
145786829|NCT01544595|525726197|FG004|Status at Week 68|Non-compliance with study treatment|0|||
145786830|NCT01544595|525726198|FG005|Status at Week 68|Non-compliance with study treatment|0|||
145404010|NCT01648764|524336458|FG000|Overall Study|Progressive Disease|0|||
145404011|NCT01648764|524336459|FG001|Overall Study|Progressive Disease|1|||
145404012|NCT01648764|524336460|FG002|Overall Study|Progressive Disease|0|||
145786831|NCT01544595|525726193|FG000|Status at Week 68|Protocol Violation|2|||
145786832|NCT01544595|525726194|FG001|Status at Week 68|Protocol Violation|0|||
145786833|NCT01544595|525726195|FG002|Status at Week 68|Protocol Violation|1|||
145786834|NCT01544595|525726196|FG003|Status at Week 68|Protocol Violation|1|||
145786835|NCT01544595|525726197|FG004|Status at Week 68|Protocol Violation|0|||
145786836|NCT01544595|525726198|FG005|Status at Week 68|Protocol Violation|0|||
145609635|NCT04534114|525086405|FG001|Main Treatment Period|Other reason|1|||
145609636|NCT04534114|525086406|FG002|Main Treatment Period|Other reason|0|||
145609637|NCT04534114|525086407|FG003|Main Treatment Period|Other reason|0|||
145609638|NCT04534114|525086404|FG000|Main Treatment Period|Participant decision|1|||
145609639|NCT04534114|525086405|FG001|Main Treatment Period|Participant decision|3|||
145609640|NCT04534114|525086406|FG002|Main Treatment Period|Participant decision|3|||
145609641|NCT04534114|525086407|FG003|Main Treatment Period|Participant decision|1|||
145609642|NCT04534114|525086404|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
145609643|NCT04534114|525086405|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
145609644|NCT04534114|525086406|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
145609645|NCT04534114|525086407|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
145609646|NCT04534114|525086404|FG000|Main Treatment Period|Adverse Event|4|||
145609647|NCT04534114|525086405|FG001|Main Treatment Period|Adverse Event|2|||
145609648|NCT04534114|525086406|FG002|Main Treatment Period|Adverse Event|1|||
145609649|NCT04534114|525086407|FG003|Main Treatment Period|Adverse Event|2|||
145609650|NCT04534114|525086404|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
145609651|NCT04534114|525086405|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
145609652|NCT04534114|525086406|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
145609653|NCT04534114|525086407|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
145786837|NCT01544595|525726193|FG000|Status at Week 68|Technical problems|1|||
145786838|NCT01544595|525726194|FG001|Status at Week 68|Technical problems|0|||
145786839|NCT01544595|525726195|FG002|Status at Week 68|Technical problems|0|||
145786840|NCT01544595|525726196|FG003|Status at Week 68|Technical problems|1|||
145786841|NCT01544595|525726197|FG004|Status at Week 68|Technical problems|0|||
145786842|NCT01544595|525726198|FG005|Status at Week 68|Technical problems|0|||
145786843|NCT01544595|525726193|FG000|Status at Week 68|Withdrawal by Subject|0|||
145786844|NCT01544595|525726194|FG001|Status at Week 68|Withdrawal by Subject|1|||
145786845|NCT01544595|525726195|FG002|Status at Week 68|Withdrawal by Subject|1|||
145786846|NCT01544595|525726196|FG003|Status at Week 68|Withdrawal by Subject|2|||
145786847|NCT01544595|525726197|FG004|Status at Week 68|Withdrawal by Subject|0|||
145786848|NCT01544595|525726198|FG005|Status at Week 68|Withdrawal by Subject|0|||
145786849|NCT01544595|525726193|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
145786850|NCT01544595|525726194|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
145786851|NCT01544595|525726195|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
145786852|NCT01544595|525726196|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
145786853|NCT01544595|525726197|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
145786854|NCT01544595|525726198|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
145786855|NCT01544595|525726193|FG000|Status at Week 156|Withdrawal by Subject|9|||
145786856|NCT01544595|525726194|FG001|Status at Week 156|Withdrawal by Subject|10|||
145786857|NCT01544595|525726195|FG002|Status at Week 156|Withdrawal by Subject|4|||
145786858|NCT01544595|525726196|FG003|Status at Week 156|Withdrawal by Subject|9|||
145786859|NCT01544595|525726197|FG004|Status at Week 156|Withdrawal by Subject|20|||
145786860|NCT01544595|525726198|FG005|Status at Week 156|Withdrawal by Subject|6|||
145786861|NCT01544595|525726193|FG000|Status at Week 156|Adverse Event|9|||
145786862|NCT01544595|525726194|FG001|Status at Week 156|Adverse Event|11|||
145786863|NCT01544595|525726195|FG002|Status at Week 156|Adverse Event|1|||
145786864|NCT01544595|525726196|FG003|Status at Week 156|Adverse Event|3|||
145786865|NCT01544595|525726197|FG004|Status at Week 156|Adverse Event|4|||
145786866|NCT01544595|525726198|FG005|Status at Week 156|Adverse Event|2|||
145786867|NCT01544595|525726193|FG000|Status at Week 156|Lost to Follow-up|4|||
145786868|NCT01544595|525726194|FG001|Status at Week 156|Lost to Follow-up|4|||
145786869|NCT01544595|525726195|FG002|Status at Week 156|Lost to Follow-up|0|||
145786870|NCT01544595|525726196|FG003|Status at Week 156|Lost to Follow-up|1|||
145609654|NCT04534114|525086404|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
145786871|NCT01544595|525726197|FG004|Status at Week 156|Lost to Follow-up|4|||
145786872|NCT01544595|525726198|FG005|Status at Week 156|Lost to Follow-up|1|||
145786873|NCT01544595|525726193|FG000|Status at Week 156|Non-compliance with study treatement|0|||
145786874|NCT01544595|525726194|FG001|Status at Week 156|Non-compliance with study treatement|1|||
145609655|NCT04534114|525086405|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
145539050|NCT02319837|524832948|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
145539051|NCT02319837|524832946|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
145539052|NCT02319837|524832947|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
145539053|NCT02319837|524832948|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
145539054|NCT02319837|524832946|FG000|Long-Term Follow-Up Phase|Death|33|||
145539055|NCT02319837|524832947|FG001|Long-Term Follow-Up Phase|Death|54|||
145539056|NCT02319837|524832948|FG002|Long-Term Follow-Up Phase|Death|42|||
145539057|NCT00939640|524832958|FG000|Overall Study|Physician Decision|1|||
145539058|NCT00239590|524832959|FG000|Randomized|Lost to Follow-up|0|||
145539059|NCT00239590|524832960|FG001|Randomized|Lost to Follow-up|1|||
145539060|NCT00239590|524832959|FG000|Randomized|Withdrawal by Subject|0|||
145539061|NCT00239590|524832960|FG001|Randomized|Withdrawal by Subject|1|||
145539062|NCT00239590|524832959|FG000|Completed Study Protocol|Adverse Event|1|||
145539063|NCT00239590|524832960|FG001|Completed Study Protocol|Adverse Event|1|||
145539064|NCT00239590|524832959|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
145539065|NCT00239590|524832960|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
145539066|NCT02121522|524832961|FG000|Overall Study|Adverse Event|1|||
145539067|NCT00892047|524832966|FG000|Overall Study|Adverse Event|2|||
145539068|NCT00892047|524832967|FG001|Overall Study|Adverse Event|2|||
145539069|NCT00892047|524832966|FG000|Overall Study|subject burden|2|||
145539070|NCT00892047|524832967|FG001|Overall Study|subject burden|3|||
145539071|NCT00892047|524832966|FG000|Overall Study|Lack of Efficacy|0|||
145539072|NCT00892047|524832967|FG001|Overall Study|Lack of Efficacy|2|||
145539073|NCT05306977|524832968|FG000|Overall Study|Withdrawal by Subject|1|||
145539074|NCT00190671|524832969|FG000|Overall Study|Satisfactory Response|4|||
145539075|NCT00190671|524832970|FG001|Overall Study|Satisfactory Response|7|||
145539076|NCT00190671|524832969|FG000|Overall Study|Lack of Efficacy|19|||
145539077|NCT00190671|524832970|FG001|Overall Study|Lack of Efficacy|24|||
145539078|NCT00190671|524832969|FG000|Overall Study|Death from Study Disease|1|||
145539079|NCT00190671|524832970|FG001|Overall Study|Death from Study Disease|1|||
145539080|NCT00190671|524832969|FG000|Overall Study|Adverse Event|3|||
145539081|NCT00190671|524832970|FG001|Overall Study|Adverse Event|2|||
145539082|NCT00190671|524832969|FG000|Overall Study|Clinical Relapse|0|||
145539083|NCT00190671|524832970|FG001|Overall Study|Clinical Relapse|1|||
145539084|NCT00190671|524832969|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
145539085|NCT00190671|524832970|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
145539086|NCT00190671|524832969|FG000|Overall Study|Death from Other Causes|0|||
145539087|NCT00190671|524832970|FG001|Overall Study|Death from Other Causes|2|||
145539088|NCT00190671|524832969|FG000|Overall Study|Protocol Violation|0|||
145539089|NCT00190671|524832970|FG001|Overall Study|Protocol Violation|1|||
145539090|NCT00190671|524832969|FG000|Overall Study|Withdrawal by Subject|0|||
145539091|NCT00190671|524832970|FG001|Overall Study|Withdrawal by Subject|2|||
145539092|NCT04502433|524832971|FG000|Overall Study|Death|2|||
145539093|NCT04502433|524832972|FG001|Overall Study|Death|4|||
145539094|NCT04502433|524832971|FG000|Overall Study|Lost to Follow-up|1|||
145539095|NCT04502433|524832972|FG001|Overall Study|Lost to Follow-up|0|||
145539096|NCT04502433|524832971|FG000|Overall Study|Physician Decision|0|||
145539097|NCT04502433|524832972|FG001|Overall Study|Physician Decision|1|||
145539098|NCT00660699|524832973|FG000|Overall Study|Withdrawal by Subject|2|||
145539099|NCT01453361|524832974|FG000|Overall Study|Disease Progression|6|||
145539100|NCT01453361|524832974|FG000|Overall Study|Screen-Failures|10|||
145539101|NCT06934993|524832975|FG000|Overall Study|Withdrawal by Subject|29|||
145539102|NCT06934993|524832975|FG000|Overall Study|elevated postoperative creatinine level|11|||
145539103|NCT06934993|524832975|FG000|Overall Study|Death|3|||
145539104|NCT03128047|524832976|FG000|Overall Study|Withdrawal by Subject|1|||
145539105|NCT02195583|524834189|FG000|Overall Study|Lost to Follow-up|1|||
145539106|NCT02195583|524834189|FG000|Overall Study|Withdrawal by Subject|4|||
145539107|NCT02195583|524834189|FG000|Overall Study|Adverse Event|2|||
145539108|NCT02195583|524834189|FG000|Overall Study|Other Reason|2|||
145539109|NCT01560403|524834190|FG000|Overall Study|Lost to Follow-up|0|||
145539110|NCT01560403|524834191|FG001|Overall Study|Lost to Follow-up|1|||
145539111|NCT00040365|524834197|FG000|Overall Study|Death|1|||
145539112|NCT00040365|524834197|FG000|Overall Study|Progressive disease|7|||
145609656|NCT04534114|525086406|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
145609657|NCT04534114|525086407|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
145539113|NCT00040365|524834197|FG000|Overall Study|Lost to Follow-up|3|||
145539114|NCT00680017|524834198|FG000|Overall Study|Adverse Event|13|||
145539115|NCT00680017|524834199|FG001|Overall Study|Adverse Event|7|||
145539116|NCT00680017|524834198|FG000|Overall Study|Withdrawal by Subject|2|||
145609658|NCT04534114|525086404|FG000|Extension Treatment Period|Other reason|0|||
145539117|NCT00680017|524834199|FG001|Overall Study|Withdrawal by Subject|5|||
145539118|NCT00680017|524834198|FG000|Overall Study|Lost to Follow-up|2|||
145539119|NCT00680017|524834199|FG001|Overall Study|Lost to Follow-up|0|||
145609659|NCT04534114|525086405|FG001|Extension Treatment Period|Other reason|1|||
145539120|NCT02555683|524834200|FG000|Overall Study|Physician Decision|1|||
145539121|NCT02555683|524834201|FG001|Overall Study|Physician Decision|0|||
145539122|NCT02555683|524834202|FG002|Overall Study|Physician Decision|2|||
145539123|NCT02555683|524834200|FG000|Overall Study|Lost to Follow-up|2|||
145539124|NCT02555683|524834201|FG001|Overall Study|Lost to Follow-up|1|||
145539125|NCT02555683|524834202|FG002|Overall Study|Lost to Follow-up|2|||
145539126|NCT02555683|524834200|FG000|Overall Study|Technical Problems|1|||
145539127|NCT02555683|524834201|FG001|Overall Study|Technical Problems|1|||
145539128|NCT02555683|524834202|FG002|Overall Study|Technical Problems|0|||
145539129|NCT02555683|524834200|FG000|Overall Study|Protocol deviation|0|||
145539130|NCT02555683|524834201|FG001|Overall Study|Protocol deviation|1|||
145539131|NCT02555683|524834202|FG002|Overall Study|Protocol deviation|0|||
145539132|NCT02555683|524834200|FG000|Overall Study|Lack of Efficacy|2|||
145539133|NCT02555683|524834201|FG001|Overall Study|Lack of Efficacy|0|||
145539134|NCT02555683|524834202|FG002|Overall Study|Lack of Efficacy|0|||
145539135|NCT02555683|524834200|FG000|Overall Study|Death|0|||
145539136|NCT02555683|524834201|FG001|Overall Study|Death|1|||
145539137|NCT02555683|524834202|FG002|Overall Study|Death|2|||
145539138|NCT02555683|524834200|FG000|Overall Study|Adverse Event|1|||
145539139|NCT02555683|524834201|FG001|Overall Study|Adverse Event|0|||
145539140|NCT02555683|524834202|FG002|Overall Study|Adverse Event|1|||
145539141|NCT02555683|524834200|FG000|Overall Study|Subject/guardian decision|12|||
145539142|NCT02555683|524834201|FG001|Overall Study|Subject/guardian decision|12|||
145539143|NCT02555683|524834202|FG002|Overall Study|Subject/guardian decision|22|||
145539144|NCT02555683|524834200|FG000|Overall Study|Death post Treatment/safety period|0|||
145539145|NCT02555683|524834201|FG001|Overall Study|Death post Treatment/safety period|1|||
145539146|NCT02555683|524834202|FG002|Overall Study|Death post Treatment/safety period|0|||
145539147|NCT01153347|524834203|FG000|Overall Study|Withdrawal by Subject|7|||
145539148|NCT01153347|524834204|FG001|Overall Study|Withdrawal by Subject|7|||
145539149|NCT01153347|524834205|FG002|Overall Study|Withdrawal by Subject|7|||
145539150|NCT01153347|524834206|FG003|Overall Study|Withdrawal by Subject|7|||
145539151|NCT01153347|524834203|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145539152|NCT01153347|524834204|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145539153|NCT01153347|524834205|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
145539154|NCT01153347|524834206|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145539155|NCT01153347|524834203|FG000|Overall Study|Adverse Event|3|||
145539156|NCT01153347|524834204|FG001|Overall Study|Adverse Event|9|||
145539157|NCT01153347|524834205|FG002|Overall Study|Adverse Event|21|||
145539158|NCT01153347|524834206|FG003|Overall Study|Adverse Event|7|||
145539159|NCT01153347|524834203|FG000|Overall Study|Severe non-compliance to protocol|6|||
145539160|NCT01153347|524834204|FG001|Overall Study|Severe non-compliance to protocol|7|||
145539161|NCT01153347|524834205|FG002|Overall Study|Severe non-compliance to protocol|4|||
145539162|NCT01153347|524834206|FG003|Overall Study|Severe non-compliance to protocol|3|||
145539163|NCT01153347|524834203|FG000|Overall Study|Condition under investigation worsened|1|||
145539164|NCT01153347|524834204|FG001|Overall Study|Condition under investigation worsened|1|||
145539165|NCT01153347|524834205|FG002|Overall Study|Condition under investigation worsened|0|||
145539166|NCT01153347|524834206|FG003|Overall Study|Condition under investigation worsened|0|||
145539167|NCT01153347|524834203|FG000|Overall Study|Lack of Efficacy|2|||
145539168|NCT01153347|524834204|FG001|Overall Study|Lack of Efficacy|2|||
145539169|NCT01153347|524834205|FG002|Overall Study|Lack of Efficacy|0|||
145539170|NCT01153347|524834206|FG003|Overall Study|Lack of Efficacy|4|||
145539171|NCT01153347|524834203|FG000|Overall Study|Study-specific withdrawal criteria|4|||
145539172|NCT01153347|524834204|FG001|Overall Study|Study-specific withdrawal criteria|3|||
145539173|NCT01153347|524834205|FG002|Overall Study|Study-specific withdrawal criteria|1|||
145539174|NCT01153347|524834206|FG003|Overall Study|Study-specific withdrawal criteria|2|||
145539175|NCT01153347|524834203|FG000|Overall Study|Lost to Follow-up|4|||
145539176|NCT01153347|524834204|FG001|Overall Study|Lost to Follow-up|9|||
145786875|NCT01544595|525726195|FG002|Status at Week 156|Non-compliance with study treatement|0|||
145786876|NCT01544595|525726196|FG003|Status at Week 156|Non-compliance with study treatement|1|||
145539177|NCT01153347|524834205|FG002|Overall Study|Lost to Follow-up|11|||
145539178|NCT01153347|524834206|FG003|Overall Study|Lost to Follow-up|8|||
145539179|NCT01153347|524834203|FG000|Overall Study|Other|5|||
145539180|NCT01153347|524834204|FG001|Overall Study|Other|5|||
145539181|NCT01153347|524834205|FG002|Overall Study|Other|4|||
145786877|NCT01544595|525726197|FG004|Status at Week 156|Non-compliance with study treatement|0|||
145539182|NCT01153347|524834206|FG003|Overall Study|Other|0|||
145539183|NCT01153347|524834203|FG000|Overall Study|Death|1|||
145539184|NCT01153347|524834204|FG001|Overall Study|Death|0|||
145539185|NCT01153347|524834205|FG002|Overall Study|Death|0|||
145539186|NCT01153347|524834206|FG003|Overall Study|Death|0|||
145539187|NCT01921387|524834209|FG000|Overall Study|Adverse Event|1|||
145539188|NCT03741062|524834210|FG000|Overall Study|Protocol Violation|1|||
145539189|NCT03741062|524834211|FG001|Overall Study|Protocol Violation|0|||
145539190|NCT02763462|524834214|FG000|Overall Study|Protocol Violation|6|||
145539191|NCT00261807|524834215|FG000|Overall Study|Lost to Follow-up|2|||
145539192|NCT00261807|524834215|FG000|Overall Study|Adverse Event|2|||
145539193|NCT00261807|524834215|FG000|Overall Study|Death|1|||
145539194|NCT00261807|524834215|FG000|Overall Study|Protocol Violation|2|||
145786878|NCT01544595|525726198|FG005|Status at Week 156|Non-compliance with study treatement|1|||
145786879|NCT01544595|525726193|FG000|Status at Week 156|Physician Decision|0|||
145786880|NCT01544595|525726194|FG001|Status at Week 156|Physician Decision|3|||
145786881|NCT01544595|525726195|FG002|Status at Week 156|Physician Decision|1|||
145786882|NCT01544595|525726196|FG003|Status at Week 156|Physician Decision|0|||
145786883|NCT01544595|525726197|FG004|Status at Week 156|Physician Decision|0|||
145786884|NCT01544595|525726198|FG005|Status at Week 156|Physician Decision|0|||
145786885|NCT01544595|525726193|FG000|Status at Week 156|Pregnancy|2|||
145786886|NCT01544595|525726194|FG001|Status at Week 156|Pregnancy|3|||
145786887|NCT01544595|525726195|FG002|Status at Week 156|Pregnancy|0|||
145786888|NCT01544595|525726196|FG003|Status at Week 156|Pregnancy|0|||
145786889|NCT01544595|525726197|FG004|Status at Week 156|Pregnancy|0|||
145786890|NCT01544595|525726198|FG005|Status at Week 156|Pregnancy|0|||
145786891|NCT01544595|525726193|FG000|Status at Week 156|Protocol Violation|3|||
145786892|NCT01544595|525726194|FG001|Status at Week 156|Protocol Violation|1|||
145786893|NCT01544595|525726195|FG002|Status at Week 156|Protocol Violation|2|||
145786894|NCT01544595|525726196|FG003|Status at Week 156|Protocol Violation|2|||
145786895|NCT01544595|525726197|FG004|Status at Week 156|Protocol Violation|0|||
145786896|NCT01544595|525726198|FG005|Status at Week 156|Protocol Violation|0|||
145786897|NCT01544595|525726193|FG000|Status at Week 156|Technical problems|3|||
145786898|NCT01544595|525726194|FG001|Status at Week 156|Technical problems|1|||
145786899|NCT01544595|525726195|FG002|Status at Week 156|Technical problems|0|||
145786900|NCT01544595|525726196|FG003|Status at Week 156|Technical problems|1|||
145786901|NCT01544595|525726197|FG004|Status at Week 156|Technical problems|0|||
145786902|NCT01544595|525726198|FG005|Status at Week 156|Technical problems|0|||
145786903|NCT01544595|525726193|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
145786904|NCT01544595|525726194|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
145786905|NCT01544595|525726195|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
145786906|NCT01544595|525726196|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
145786907|NCT01544595|525726197|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
145786908|NCT01544595|525726198|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
145786909|NCT01544595|525726193|FG000|Status at Week 156|Lack of Efficacy|1|||
145786910|NCT01544595|525726194|FG001|Status at Week 156|Lack of Efficacy|0|||
145786911|NCT01544595|525726195|FG002|Status at Week 156|Lack of Efficacy|1|||
145786912|NCT01544595|525726196|FG003|Status at Week 156|Lack of Efficacy|4|||
145786913|NCT01544595|525726197|FG004|Status at Week 156|Lack of Efficacy|10|||
145786914|NCT01544595|525726198|FG005|Status at Week 156|Lack of Efficacy|5|||
145786915|NCT00878072|525726199|FG000|Overall Study|Withdrew consent|2|||
145786916|NCT03382899|525726205|FG000|Overall Study|Ineligibility Determined|0|||
145786917|NCT03382899|525726206|FG001|Overall Study|Ineligibility Determined|1|||
145786918|NCT03382899|525726205|FG000|Overall Study|Lost to Follow-up|0|||
145786919|NCT03382899|525726206|FG001|Overall Study|Lost to Follow-up|1|||
145786920|NCT03382899|525726205|FG000|Overall Study|Sponsor's decision|31|||
145786921|NCT03382899|525726206|FG001|Overall Study|Sponsor's decision|28|||
145786922|NCT03382899|525726205|FG000|Overall Study|Withdrawal by Subject|0|||
145786923|NCT03382899|525726206|FG001|Overall Study|Withdrawal by Subject|5|||
145786924|NCT00872170|525726207|FG000|Overall Study|Adverse Event|1|||
145786925|NCT00872170|525726208|FG001|Overall Study|Adverse Event|0|||
145786926|NCT01987986|525726209|FG000|Overall Study|Lost to Follow-up|1|||
145786927|NCT01987986|525726210|FG001|Overall Study|Lost to Follow-up|0|||
145786928|NCT01987986|525726211|FG002|Overall Study|Lost to Follow-up|0|||
145786929|NCT01987986|525726212|FG003|Overall Study|Lost to Follow-up|0|||
145786930|NCT01987986|525726209|FG000|Overall Study|Adverse Event|1|||
145786931|NCT01987986|525726210|FG001|Overall Study|Adverse Event|0|||
145786932|NCT01987986|525726211|FG002|Overall Study|Adverse Event|2|||
145786933|NCT01987986|525726212|FG003|Overall Study|Adverse Event|0|||
145786934|NCT03259334|525726213|FG000|Overall Study|Adverse Event|3|||
145786935|NCT03259334|525726214|FG001|Overall Study|Adverse Event|8|||
145786936|NCT03259334|525726215|FG002|Overall Study|Adverse Event|5|||
145786937|NCT03259334|525726213|FG000|Overall Study|Withdrawal by Subject|4|||
145786938|NCT03259334|525726214|FG001|Overall Study|Withdrawal by Subject|2|||
145786939|NCT03259334|525726215|FG002|Overall Study|Withdrawal by Subject|4|||
145786940|NCT03259334|525726213|FG000|Overall Study|Physician Decision|1|||
145786941|NCT03259334|525726214|FG001|Overall Study|Physician Decision|0|||
145786942|NCT03259334|525726215|FG002|Overall Study|Physician Decision|0|||
145786943|NCT03259334|525726213|FG000|Overall Study|Lost to Follow-up|0|||
145786944|NCT03259334|525726214|FG001|Overall Study|Lost to Follow-up|2|||
145786945|NCT03259334|525726215|FG002|Overall Study|Lost to Follow-up|1|||
145786946|NCT03259334|525726213|FG000|Overall Study|Protocol Deviation|0|||
145786947|NCT03259334|525726214|FG001|Overall Study|Protocol Deviation|3|||
145786948|NCT03259334|525726215|FG002|Overall Study|Protocol Deviation|2|||
145786949|NCT03259334|525726213|FG000|Overall Study|Lack of Efficacy|2|||
145404013|NCT01648764|524336461|FG003|Overall Study|Progressive Disease|0|||
145786950|NCT03259334|525726214|FG001|Overall Study|Lack of Efficacy|0|||
145786951|NCT03259334|525726215|FG002|Overall Study|Lack of Efficacy|1|||
145786952|NCT03259334|525726213|FG000|Overall Study|Randomized but never treated|0|||
145786953|NCT03259334|525726214|FG001|Overall Study|Randomized but never treated|2|||
145786954|NCT03259334|525726215|FG002|Overall Study|Randomized but never treated|0|||
145786955|NCT04160468|525726218|FG000|Overall Study|Lost to Follow-up|19|||
145786956|NCT04160468|525726219|FG001|Overall Study|Lost to Follow-up|4|||
145786957|NCT04160468|525726218|FG000|Overall Study|Randomized but not dosed|6|||
145786958|NCT04160468|525726219|FG001|Overall Study|Randomized but not dosed|0|||
145786959|NCT04160468|525726218|FG000|Overall Study|Withdrawal by Subject|4|||
145786960|NCT04160468|525726219|FG001|Overall Study|Withdrawal by Subject|1|||
145786961|NCT04160468|525726218|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
145786962|NCT04160468|525726219|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
145786963|NCT04160468|525726218|FG000|Overall Study|Participant incarcerated|1|||
145786964|NCT04160468|525726219|FG001|Overall Study|Participant incarcerated|0|||
145786965|NCT01187901|525726220|FG000|Overall Study|Protocol Violation|1|||
145786966|NCT01187901|525726221|FG001|Overall Study|Protocol Violation|0|||
145786967|NCT01187901|525726220|FG000|Overall Study|Lost to Follow-up|1|||
145786968|NCT01187901|525726221|FG001|Overall Study|Lost to Follow-up|2|||
145786969|NCT01187901|525726220|FG000|Overall Study|Unrelated Health Reasons|1|||
145786970|NCT01187901|525726221|FG001|Overall Study|Unrelated Health Reasons|2|||
145786971|NCT01187901|525726220|FG000|Overall Study|Suspected Allergic Reaction|1|||
145786972|NCT01187901|525726221|FG001|Overall Study|Suspected Allergic Reaction|1|||
145786973|NCT01187901|525726220|FG000|Overall Study|Adverse Event|3|||
145786974|NCT01187901|525726221|FG001|Overall Study|Adverse Event|0|||
145786975|NCT01187901|525726220|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
145786976|NCT01187901|525726221|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
145786977|NCT01187901|525726220|FG000|Overall Study|Pregnancy|0|||
145786978|NCT01187901|525726221|FG001|Overall Study|Pregnancy|2|||
145786979|NCT01402284|525726222|FG000|Overall Study|Withdrawal consent|2|||
145786980|NCT01402284|525726222|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
145786981|NCT01402284|525726222|FG000|Overall Study|Physician Decision|1|||
145786982|NCT01402284|525726222|FG000|Overall Study|Disease progression on study|10|||
145786983|NCT00540436|525726223|FG000|First 12-Week Treatment Period|Adverse Event|1|||
145786984|NCT00540436|525726223|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
145786985|NCT00540436|525726223|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
145786986|NCT00540436|525726223|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
145786987|NCT00905021|525726228|FG000|Overall Study|Adverse Event|2|||
145786988|NCT04038255|525727739|FG000|Overall Study|Lost to Follow-up|0|||
145786989|NCT04038255|525727740|FG001|Overall Study|Lost to Follow-up|9|||
145786990|NCT04038255|525727741|FG002|Overall Study|Lost to Follow-up|5|||
145786991|NCT04038255|525727739|FG000|Overall Study|Withdrawal by Subject|0|||
145786992|NCT04038255|525727740|FG001|Overall Study|Withdrawal by Subject|0|||
145786993|NCT04038255|525727741|FG002|Overall Study|Withdrawal by Subject|1|||
145786994|NCT04491877|525727742|FG000|Overall Study|Protocol Deviation|1|||
145786995|NCT04491877|525727743|FG001|Overall Study|Protocol Deviation|0|||
145786996|NCT04491877|525727744|FG002|Overall Study|Protocol Deviation|2|||
145786997|NCT04491877|525727745|FG003|Overall Study|Protocol Deviation|0|||
145786998|NCT04491877|525727746|FG004|Overall Study|Protocol Deviation|0|||
145786999|NCT04491877|525727747|FG005|Overall Study|Protocol Deviation|0|||
145787000|NCT04491877|525727748|FG006|Overall Study|Protocol Deviation|1|||
145787001|NCT04491877|525727749|FG007|Overall Study|Protocol Deviation|1|||
145787002|NCT04491877|525727750|FG008|Overall Study|Protocol Deviation|0|||
145787003|NCT04491877|525727742|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145787004|NCT04491877|525727743|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145787005|NCT04491877|525727744|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145787006|NCT04491877|525727745|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
145787007|NCT04491877|525727746|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145787008|NCT04491877|525727747|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
145787009|NCT04491877|525727748|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
145787010|NCT04491877|525727749|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
145787011|NCT04491877|525727750|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
145787012|NCT04491877|525727742|FG000|Overall Study|Lost to Follow-up|0|||
145787013|NCT04491877|525727743|FG001|Overall Study|Lost to Follow-up|2|||
145787014|NCT04491877|525727744|FG002|Overall Study|Lost to Follow-up|0|||
145787015|NCT04491877|525727745|FG003|Overall Study|Lost to Follow-up|0|||
145787016|NCT04491877|525727746|FG004|Overall Study|Lost to Follow-up|0|||
145787017|NCT04491877|525727747|FG005|Overall Study|Lost to Follow-up|0|||
145787018|NCT04491877|525727748|FG006|Overall Study|Lost to Follow-up|2|||
145787019|NCT04491877|525727749|FG007|Overall Study|Lost to Follow-up|1|||
145787020|NCT04491877|525727750|FG008|Overall Study|Lost to Follow-up|1|||
145539195|NCT01706146|524834216|FG000|Overall Study|Withdrawal by Subject|1|||
145787021|NCT01096446|525727756|FG000|Overall Study|Death|1|||
145787022|NCT01096446|525727757|FG001|Overall Study|Death|0|||
145787023|NCT01096446|525727756|FG000|Overall Study|Protocol Violation|2|||
145787024|NCT01096446|525727757|FG001|Overall Study|Protocol Violation|0|||
145787025|NCT00418834|525727760|FG000|Overall Study|Adverse Event|16|||
145787026|NCT00418834|525727761|FG001|Overall Study|Adverse Event|9|||
145787027|NCT00418834|525727760|FG000|Overall Study|Lost to Follow-up|0|||
145787028|NCT00418834|525727761|FG001|Overall Study|Lost to Follow-up|1|||
145787029|NCT00418834|525727760|FG000|Overall Study|Protocol Violation|4|||
145787030|NCT00418834|525727761|FG001|Overall Study|Protocol Violation|3|||
145787031|NCT00418834|525727760|FG000|Overall Study|Withdrawal by Subject|3|||
145787032|NCT00418834|525727761|FG001|Overall Study|Withdrawal by Subject|7|||
145787033|NCT01953328|525727762|FG000|Overall Study|Withdrawal by Subject|0|||
145787034|NCT01953328|525727763|FG001|Overall Study|Withdrawal by Subject|0|||
145787035|NCT01953328|525727764|FG002|Overall Study|Withdrawal by Subject|0|||
145787036|NCT01953328|525727765|FG003|Overall Study|Withdrawal by Subject|0|||
145787037|NCT01953328|525727766|FG004|Overall Study|Withdrawal by Subject|1|||
145787038|NCT01953328|525727767|FG005|Overall Study|Withdrawal by Subject|0|||
145787039|NCT01953328|525727768|FG006|Overall Study|Withdrawal by Subject|0|||
145787040|NCT01953328|525727769|FG007|Overall Study|Withdrawal by Subject|0|||
145787041|NCT01953328|525727762|FG000|Overall Study|Lost to Follow-up|0|||
145787042|NCT01953328|525727763|FG001|Overall Study|Lost to Follow-up|0|||
145787043|NCT01953328|525727764|FG002|Overall Study|Lost to Follow-up|0|||
145787044|NCT01953328|525727765|FG003|Overall Study|Lost to Follow-up|0|||
145787045|NCT01953328|525727766|FG004|Overall Study|Lost to Follow-up|1|||
145787046|NCT01953328|525727767|FG005|Overall Study|Lost to Follow-up|0|||
145787047|NCT01953328|525727768|FG006|Overall Study|Lost to Follow-up|0|||
145787048|NCT01953328|525727769|FG007|Overall Study|Lost to Follow-up|0|||
145787049|NCT05113953|525727775|FG000|Overall Study|Adverse Event|5|||
145787050|NCT05113953|525727776|FG001|Overall Study|Adverse Event|0|||
145787051|NCT05113953|525727777|FG002|Overall Study|Adverse Event|3|||
145787052|NCT05113953|525727775|FG000|Overall Study|Lost to Follow-up|3|||
145787053|NCT05113953|525727776|FG001|Overall Study|Lost to Follow-up|4|||
145787054|NCT05113953|525727777|FG002|Overall Study|Lost to Follow-up|2|||
145787055|NCT05113953|525727775|FG000|Overall Study|Non-compliance with Study Drug|1|||
145787056|NCT05113953|525727776|FG001|Overall Study|Non-compliance with Study Drug|0|||
145787057|NCT05113953|525727777|FG002|Overall Study|Non-compliance with Study Drug|0|||
145787058|NCT05113953|525727775|FG000|Overall Study|Withdrawal by Subject|2|||
145787059|NCT05113953|525727776|FG001|Overall Study|Withdrawal by Subject|6|||
145787060|NCT05113953|525727777|FG002|Overall Study|Withdrawal by Subject|4|||
145787061|NCT05113953|525727775|FG000|Overall Study|Reason not Specified|2|||
145787062|NCT05113953|525727776|FG001|Overall Study|Reason not Specified|0|||
145787063|NCT05113953|525727777|FG002|Overall Study|Reason not Specified|0|||
145787064|NCT00502307|525727778|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
145787065|NCT00502307|525727779|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
145787066|NCT00502307|525727780|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
145787067|NCT00502307|525727778|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
145787068|NCT00502307|525727779|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
145787069|NCT00502307|525727780|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
145787070|NCT00502307|525727778|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
145787071|NCT00502307|525727779|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
145787072|NCT00502307|525727780|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
145787073|NCT00502307|525727778|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
145787074|NCT00502307|525727779|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
145787075|NCT00502307|525727780|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
145787076|NCT00502307|525727778|FG000|Maintenance Period|Progressive disease|80|||
145787077|NCT00502307|525727779|FG001|Maintenance Period|Progressive disease|0|||
145787078|NCT00502307|525727780|FG002|Maintenance Period|Progressive disease|0|||
145787079|NCT00502307|525727778|FG000|Maintenance Period|Discontinued due to other reasons|68|||
145787080|NCT00502307|525727779|FG001|Maintenance Period|Discontinued due to other reasons|0|||
145787081|NCT00502307|525727780|FG002|Maintenance Period|Discontinued due to other reasons|0|||
145787082|NCT00748553|525727781|FG000|Overall Study|Adverse Event|0|||
145787083|NCT00748553|525727782|FG001|Overall Study|Adverse Event|1|||
145787084|NCT00748553|525727781|FG000|Overall Study|disease progression|2|||
145787085|NCT00748553|525727782|FG001|Overall Study|disease progression|0|||
145787086|NCT00748553|525727781|FG000|Overall Study|noncompliance|1|||
145787087|NCT00748553|525727782|FG001|Overall Study|noncompliance|0|||
145787088|NCT01998581|525727786|FG000|Overall Study|Refused repeat treatment|20|||
145787089|NCT01998581|525727787|FG001|Overall Study|Refused repeat treatment|4|||
145787090|NCT01998581|525727786|FG000|Overall Study|Protocol Violation|1|||
145787091|NCT01998581|525727787|FG001|Overall Study|Protocol Violation|0|||
145281754|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
145281755|NCT00185211|523880648|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
145539196|NCT01706146|524834216|FG000|Overall Study|Adverse Event|3|||
145539197|NCT01706146|524834216|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
145787092|NCT01998581|525727786|FG000|Overall Study|Withdrawal by Subject|8|||
145787093|NCT01998581|525727787|FG001|Overall Study|Withdrawal by Subject|1|||
145787094|NCT01998581|525727786|FG000|Overall Study|Lost to Follow-up|12|||
145787095|NCT01998581|525727787|FG001|Overall Study|Lost to Follow-up|4|||
145787096|NCT01998581|525727786|FG000|Overall Study|Adverse Event|1|||
145787097|NCT01998581|525727787|FG001|Overall Study|Adverse Event|1|||
145787098|NCT01998581|525727786|FG000|Overall Study|Other reasons|3|||
145787099|NCT01998581|525727787|FG001|Overall Study|Other reasons|2|||
145787100|NCT01998581|525727786|FG000|Overall Study|Randomized but withdrew before treatment|1|||
145787101|NCT01998581|525727787|FG001|Overall Study|Randomized but withdrew before treatment|0|||
145787102|NCT01251276|525727788|FG000|Overall Study|Protocol Violation|1|||
145787103|NCT01251276|525727789|FG001|Overall Study|Protocol Violation|0|||
145787104|NCT01251276|525727788|FG000|Overall Study|Lost to Follow-up|0|||
145787105|NCT01251276|525727789|FG001|Overall Study|Lost to Follow-up|1|||
145787106|NCT02245568|525727793|FG000|Overall Study|Study terminated by Sponsor|346|||
145787107|NCT02245568|525727793|FG000|Overall Study|Adverse Event|144|||
145787108|NCT02245568|525727793|FG000|Overall Study|Lack of Efficacy|98|||
145787109|NCT02245568|525727793|FG000|Overall Study|Withdrawal by Caregiver|85|||
145787110|NCT02245568|525727793|FG000|Overall Study|Withdrawal by Subject|77|||
145787111|NCT02245568|525727793|FG000|Overall Study|Withdrawal by Legal Representative|31|||
145787112|NCT02245568|525727793|FG000|Overall Study|Missing (Site closure)|16|||
145787113|NCT02245568|525727793|FG000|Overall Study|Physician Decision|14|||
145787114|NCT02245568|525727793|FG000|Overall Study|Non-compliance with study drug|11|||
145787115|NCT02245568|525727793|FG000|Overall Study|Death|9|||
145787116|NCT02245568|525727793|FG000|Overall Study|Blue staining|6|||
145787117|NCT02245568|525727793|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
145787118|NCT02245568|525727793|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
145787119|NCT02245568|525727793|FG000|Overall Study|Lost to Follow-up|5|||
145787120|NCT04346628|525727801|FG000|Overall Study|Lost to Follow-up|4|||
145787121|NCT04346628|525727802|FG001|Overall Study|Lost to Follow-up|4|||
145787122|NCT04346628|525727801|FG000|Overall Study|Withdrew (had personal reasons)|2|||
145787123|NCT04346628|525727802|FG001|Overall Study|Withdrew (had personal reasons)|5|||
145787124|NCT04346628|525727801|FG000|Overall Study|Withdrew (medication intolerant)|0|||
145787125|NCT04346628|525727802|FG001|Overall Study|Withdrew (medication intolerant)|3|||
145787126|NCT04346628|525727801|FG000|Overall Study|Withdrew (declined intervention)|0|||
145787127|NCT04346628|525727802|FG001|Overall Study|Withdrew (declined intervention)|1|||
145787128|NCT01763905|525727803|FG000|Overall Study|Withdrawal by Subject|1|||
145787129|NCT01763905|525727804|FG001|Overall Study|Withdrawal by Subject|1|||
145787130|NCT01763905|525727805|FG002|Overall Study|Withdrawal by Subject|0|||
145787131|NCT01763905|525727806|FG003|Overall Study|Withdrawal by Subject|1|||
145787132|NCT01763905|525727803|FG000|Overall Study|Decision by sponsor|5|||
145787133|NCT01763905|525727804|FG001|Overall Study|Decision by sponsor|0|||
145787134|NCT01763905|525727805|FG002|Overall Study|Decision by sponsor|8|||
145787135|NCT01763905|525727806|FG003|Overall Study|Decision by sponsor|0|||
145787136|NCT01763905|525727803|FG000|Overall Study|Lost to Follow-up|0|||
145787137|NCT01763905|525727804|FG001|Overall Study|Lost to Follow-up|0|||
145787138|NCT01763905|525727805|FG002|Overall Study|Lost to Follow-up|1|||
145787139|NCT01763905|525727806|FG003|Overall Study|Lost to Follow-up|0|||
145787140|NCT03165721|525727815|FG000|Overall Study|Refused further treatment|3|||
145787141|NCT03165721|525727816|FG001|Overall Study|Refused further treatment|0|||
145787142|NCT03165721|525727817|FG002|Overall Study|Refused further treatment|0|||
145787143|NCT03165721|525727815|FG000|Overall Study|Physician Decision|1|||
145787144|NCT03165721|525727816|FG001|Overall Study|Physician Decision|0|||
145787145|NCT03165721|525727817|FG002|Overall Study|Physician Decision|0|||
145787146|NCT01863849|525727819|FG000|Overall Study|Lost to Follow-up|1|||
145787147|NCT01863849|525727820|FG001|Overall Study|Lost to Follow-up|0|||
145787148|NCT01457118|525727821|FG000|Overall Study|Adverse Event|1|||
145787149|NCT01457118|525727822|FG001|Overall Study|Adverse Event|0|||
145787150|NCT01457118|525727823|FG002|Overall Study|Adverse Event|0|||
145787151|NCT01457118|525727824|FG003|Overall Study|Adverse Event|1|||
145787152|NCT01457118|525727821|FG000|Overall Study|Clinical Progression|0|||
145787153|NCT01457118|525727822|FG001|Overall Study|Clinical Progression|1|||
145787154|NCT01457118|525727823|FG002|Overall Study|Clinical Progression|0|||
145787155|NCT01457118|525727824|FG003|Overall Study|Clinical Progression|1|||
145787156|NCT01457118|525727821|FG000|Overall Study|Physician Decision|2|||
145787157|NCT01457118|525727822|FG001|Overall Study|Physician Decision|0|||
145787158|NCT01457118|525727823|FG002|Overall Study|Physician Decision|0|||
145539198|NCT00675948|524834217|FG000|Overall Study|Adverse Event|23|||
145787159|NCT01457118|525727824|FG003|Overall Study|Physician Decision|0|||
145787160|NCT01457118|525727821|FG000|Overall Study|Progressive Disease by RECIST|12|||
145787161|NCT01457118|525727822|FG001|Overall Study|Progressive Disease by RECIST|3|||
145787162|NCT01457118|525727823|FG002|Overall Study|Progressive Disease by RECIST|1|||
145787163|NCT01457118|525727824|FG003|Overall Study|Progressive Disease by RECIST|0|||
145787164|NCT01457118|525727821|FG000|Overall Study|Withdrawal by Subject|5|||
145787165|NCT01457118|525727822|FG001|Overall Study|Withdrawal by Subject|0|||
145787166|NCT01457118|525727823|FG002|Overall Study|Withdrawal by Subject|0|||
145787167|NCT01457118|525727824|FG003|Overall Study|Withdrawal by Subject|0|||
145787168|NCT02324842|525727825|FG000|Overall Study|Lost to Follow-up|1|||
145787169|NCT02324842|525727826|FG001|Overall Study|Lost to Follow-up|1|||
145539199|NCT00675948|524834218|FG001|Overall Study|Adverse Event|1|||
145539200|NCT00675948|524834217|FG000|Overall Study|Lack of Efficacy|3|||
145539201|NCT00675948|524834218|FG001|Overall Study|Lack of Efficacy|0|||
145539202|NCT00675948|524834217|FG000|Overall Study|Withdrawal by Subject|7|||
145539203|NCT00675948|524834218|FG001|Overall Study|Withdrawal by Subject|0|||
145539204|NCT00675948|524834217|FG000|Overall Study|Lost to Follow-up|2|||
145539205|NCT00675948|524834218|FG001|Overall Study|Lost to Follow-up|0|||
145539206|NCT00675948|524834217|FG000|Overall Study|Protocol Violation|1|||
145539207|NCT00675948|524834218|FG001|Overall Study|Protocol Violation|0|||
145539208|NCT00675948|524834217|FG000|Overall Study|Pain under control|1|||
145539209|NCT00675948|524834218|FG001|Overall Study|Pain under control|0|||
145539210|NCT00675948|524834217|FG000|Overall Study|Sponsor decision|0|||
145539211|NCT00675948|524834218|FG001|Overall Study|Sponsor decision|1|||
145539212|NCT00675948|524834217|FG000|Overall Study|Patient died|1|||
145539213|NCT00675948|524834218|FG001|Overall Study|Patient died|0|||
145539214|NCT00675948|524834217|FG000|Overall Study|Patient unable to comply with diaries|1|||
145539215|NCT00675948|524834218|FG001|Overall Study|Patient unable to comply with diaries|0|||
145539216|NCT00675948|524834217|FG000|Overall Study|Patient feels unable to take medication|0|||
145539217|NCT00675948|524834218|FG001|Overall Study|Patient feels unable to take medication|1|||
145539218|NCT02527161|524834219|FG000|Overall Study|Failed MRI|52|||
145539219|NCT02527161|524834219|FG000|Overall Study|Withdrawal by Subject|19|||
145539220|NCT02527161|524834219|FG000|Overall Study|Delay in or unfit for surgery|16|||
145539221|NCT02527161|524834219|FG000|Overall Study|MRI contraindication|6|||
145539222|NCT02527161|524834219|FG000|Overall Study|Consent violation|4|||
145539223|NCT02527161|524834219|FG000|Overall Study|Only Recruited to Part A|27|||
145539224|NCT02527161|524834219|FG000|Overall Study|Physician Decision|1|||
145539225|NCT02527161|524834219|FG000|Overall Study|Adverse Event|1|||
145539226|NCT02527161|524834219|FG000|Overall Study|Lost to Follow-up|6|||
145539227|NCT02100514|524834220|FG000|Treatment Period|Adverse Event|0|||
145539228|NCT02100514|524834221|FG001|Treatment Period|Adverse Event|5|||
145539229|NCT02100514|524834222|FG002|Treatment Period|Adverse Event|0|||
145539230|NCT02100514|524834223|FG003|Treatment Period|Adverse Event|0|||
145539231|NCT02100514|524834224|FG004|Treatment Period|Adverse Event|0|||
145539232|NCT02100514|524834220|FG000|Treatment Period|Death|2|||
145539233|NCT02100514|524834221|FG001|Treatment Period|Death|2|||
145539234|NCT02100514|524834222|FG002|Treatment Period|Death|0|||
145539235|NCT02100514|524834223|FG003|Treatment Period|Death|0|||
145539236|NCT02100514|524834224|FG004|Treatment Period|Death|0|||
145539237|NCT02100514|524834220|FG000|Treatment Period|Lost to Follow-up|5|||
145539238|NCT02100514|524834221|FG001|Treatment Period|Lost to Follow-up|17|||
145539239|NCT02100514|524834222|FG002|Treatment Period|Lost to Follow-up|0|||
145539240|NCT02100514|524834223|FG003|Treatment Period|Lost to Follow-up|0|||
145539241|NCT02100514|524834224|FG004|Treatment Period|Lost to Follow-up|0|||
145539242|NCT02100514|524834220|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
145539243|NCT02100514|524834221|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
145539244|NCT02100514|524834222|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
145539245|NCT02100514|524834223|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
145539246|NCT02100514|524834224|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
145539247|NCT02100514|524834220|FG000|Treatment Period|Protocol Violation|1|||
145539248|NCT02100514|524834221|FG001|Treatment Period|Protocol Violation|1|||
145539249|NCT02100514|524834222|FG002|Treatment Period|Protocol Violation|0|||
145539250|NCT02100514|524834223|FG003|Treatment Period|Protocol Violation|0|||
145539251|NCT02100514|524834224|FG004|Treatment Period|Protocol Violation|0|||
145539252|NCT02100514|524834220|FG000|Treatment Period|Withdrawal by Subject|12|||
145539253|NCT02100514|524834221|FG001|Treatment Period|Withdrawal by Subject|37|||
145539254|NCT02100514|524834222|FG002|Treatment Period|Withdrawal by Subject|0|||
145539255|NCT02100514|524834223|FG003|Treatment Period|Withdrawal by Subject|0|||
145539256|NCT02100514|524834224|FG004|Treatment Period|Withdrawal by Subject|0|||
145539257|NCT02100514|524834220|FG000|Treatment Period|Other|9|||
145787170|NCT02324842|525727827|FG002|Overall Study|Lost to Follow-up|2|||
145787171|NCT02750800|525727831|FG000|Overall Study|Adverse Event|18|||
145539258|NCT02100514|524834221|FG001|Treatment Period|Other|11|||
145539259|NCT02100514|524834222|FG002|Treatment Period|Other|0|||
145539260|NCT02100514|524834223|FG003|Treatment Period|Other|0|||
145539261|NCT02100514|524834224|FG004|Treatment Period|Other|0|||
145539262|NCT02100514|524834220|FG000|Extension Period|Withdrew consent|0|||
145539263|NCT02100514|524834221|FG001|Extension Period|Withdrew consent|0|||
145539264|NCT02100514|524834222|FG002|Extension Period|Withdrew consent|2|||
145539265|NCT02100514|524834223|FG003|Extension Period|Withdrew consent|0|||
145539266|NCT02100514|524834224|FG004|Extension Period|Withdrew consent|0|||
145539267|NCT00762229|524834225|FG000|Overall Study|Lost to Follow-up|1|||
145539268|NCT00762229|524834226|FG001|Overall Study|Lost to Follow-up|1|||
145539269|NCT00762229|524834225|FG000|Overall Study|did not recveive intervention|0|||
145539270|NCT00762229|524834226|FG001|Overall Study|did not recveive intervention|1|||
145539271|NCT02747875|524834239|FG000|Overall Study|Physician Decision|1|||
145787172|NCT02750800|525727831|FG000|Overall Study|Lost to Follow-up|12|||
145609660|NCT04534114|525086406|FG002|Extension Treatment Period|Other reason|0|||
145609661|NCT04534114|525086407|FG003|Extension Treatment Period|Other reason|0|||
145609662|NCT04534114|525086404|FG000|Extension Treatment Period|Death|0|||
145609663|NCT04534114|525086405|FG001|Extension Treatment Period|Death|0|||
145609664|NCT04534114|525086406|FG002|Extension Treatment Period|Death|1|||
145609665|NCT04534114|525086407|FG003|Extension Treatment Period|Death|2|||
145609666|NCT04534114|525086404|FG000|Extension Treatment Period|Adverse Event|0|||
145609667|NCT04534114|525086405|FG001|Extension Treatment Period|Adverse Event|1|||
145609668|NCT04534114|525086406|FG002|Extension Treatment Period|Adverse Event|0|||
145609669|NCT04534114|525086407|FG003|Extension Treatment Period|Adverse Event|1|||
145609670|NCT04534114|525086404|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
145609671|NCT04534114|525086405|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
145787173|NCT02750800|525727831|FG000|Overall Study|Investigator decision|53|||
145787174|NCT02750800|525727831|FG000|Overall Study|Patient request|12|||
145787175|NCT02750800|525727831|FG000|Overall Study|Other, not specified|3|||
145787176|NCT03456713|525727834|FG000|Overall Study|Lost to Follow-up|1|||
145787177|NCT03456713|525727835|FG001|Overall Study|Lost to Follow-up|0|||
145787178|NCT03456713|525727836|FG002|Overall Study|Lost to Follow-up|0|||
145787179|NCT03456713|525727837|FG003|Overall Study|Lost to Follow-up|0|||
145787180|NCT01202227|525727843|FG000|Overall Study|Adverse Event|16|||
145787181|NCT01202227|525727843|FG000|Overall Study|Withdrawal by Subject|2|||
145787182|NCT01202227|525727843|FG000|Overall Study|Lack of Efficacy|1|||
145787183|NCT00643487|525727844|FG000|Overall Study|Technical difficulty|3|||
145787184|NCT06150573|525727845|FG000|Overall Study|Did not meet study criteria|1|||
145787185|NCT06150573|525727846|FG001|Overall Study|Did not meet study criteria|0|||
145787186|NCT06150573|525727845|FG000|Overall Study|Adverse Event|1|||
145787187|NCT06150573|525727846|FG001|Overall Study|Adverse Event|0|||
145787188|NCT06150573|525727845|FG000|Overall Study|Lost to Follow-up|0|||
145787189|NCT06150573|525727846|FG001|Overall Study|Lost to Follow-up|1|||
145787190|NCT06150573|525727845|FG000|Overall Study|Protocol Violation|0|||
145787191|NCT06150573|525727846|FG001|Overall Study|Protocol Violation|1|||
145281756|NCT00185211|523880649|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
145281757|NCT01759537|523880650|FG000|Overall Study|Death|1|||
145539272|NCT02747875|524834240|FG001|Overall Study|Physician Decision|0|||
145539273|NCT02747875|524834239|FG000|Overall Study|Adverse Event|0|||
145539274|NCT02747875|524834240|FG001|Overall Study|Adverse Event|1|||
145539275|NCT03570697|524834241|FG000|Overall Study|Lost to Follow-up|0|||
145539276|NCT03570697|524834242|FG001|Overall Study|Lost to Follow-up|1|||
145539277|NCT03570697|524834241|FG000|Overall Study|Death|2|||
145539278|NCT03570697|524834242|FG001|Overall Study|Death|0|||
145539279|NCT03570697|524834241|FG000|Overall Study|Withdrawal by Subject|4|||
145539280|NCT03570697|524834242|FG001|Overall Study|Withdrawal by Subject|2|||
145539281|NCT01876420|524834244|FG000|Overall Study|Missed 30 day visit|1|||
145539282|NCT03173313|524834245|FG000|Overall Study|Lost to Follow-up|2|||
145539283|NCT03173313|524834246|FG001|Overall Study|Lost to Follow-up|3|||
145539284|NCT03173313|524834245|FG000|Overall Study|Withdrawal by Subject|0|||
145539285|NCT03173313|524834246|FG001|Overall Study|Withdrawal by Subject|1|||
145539286|NCT03173313|524834245|FG000|Overall Study|Death|5|||
145787192|NCT06150573|525727845|FG000|Overall Study|Withdrawal by Subject|2|||
145787193|NCT06150573|525727846|FG001|Overall Study|Withdrawal by Subject|0|||
145787194|NCT02284906|525727847|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145787195|NCT02284906|525727848|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
145787196|NCT02284906|525727849|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145787197|NCT02284906|525727847|FG000|Overall Study|Major Protocol Deviation|0|||
145787198|NCT02284906|525727848|FG001|Overall Study|Major Protocol Deviation|1|||
145787199|NCT02284906|525727849|FG002|Overall Study|Major Protocol Deviation|0|||
145787200|NCT02284906|525727847|FG000|Overall Study|Voluntary Withdrawal|2|||
145787201|NCT02284906|525727848|FG001|Overall Study|Voluntary Withdrawal|4|||
145787202|NCT02284906|525727849|FG002|Overall Study|Voluntary Withdrawal|5|||
145787203|NCT02284906|525727847|FG000|Overall Study|Study Termination|0|||
145787204|NCT02284906|525727848|FG001|Overall Study|Study Termination|11|||
145281758|NCT01759537|523880651|FG001|Overall Study|Death|1|||
145539287|NCT03173313|524834246|FG001|Overall Study|Death|0|||
145539288|NCT03173313|524834245|FG000|Overall Study|Physician Decision|1|||
145539289|NCT03173313|524834246|FG001|Overall Study|Physician Decision|0|||
145787205|NCT02284906|525727849|FG002|Overall Study|Study Termination|14|||
145787206|NCT02284906|525727847|FG000|Overall Study|Reason not Specified|1|||
145787207|NCT02284906|525727848|FG001|Overall Study|Reason not Specified|1|||
145787208|NCT02284906|525727849|FG002|Overall Study|Reason not Specified|0|||
145787209|NCT01753076|525727850|FG000|Overall Study|Adverse Event|17|||
145539290|NCT03173313|524834245|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
145609672|NCT04534114|525086406|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
145539291|NCT03173313|524834246|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
145787210|NCT01753076|525727851|FG001|Overall Study|Adverse Event|18|||
145787211|NCT01753076|525727850|FG000|Overall Study|Lack of Efficacy|3|||
145787212|NCT01753076|525727851|FG001|Overall Study|Lack of Efficacy|1|||
145787213|NCT01753076|525727850|FG000|Overall Study|Lost to Follow-up|2|||
145787214|NCT01753076|525727851|FG001|Overall Study|Lost to Follow-up|1|||
145787215|NCT01753076|525727850|FG000|Overall Study|Physician Decision|4|||
145787216|NCT01753076|525727851|FG001|Overall Study|Physician Decision|2|||
145787217|NCT01753076|525727850|FG000|Overall Study|Withdrawal by Subject|14|||
145787218|NCT01753076|525727851|FG001|Overall Study|Withdrawal by Subject|24|||
145787219|NCT01753076|525727850|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
145787220|NCT01753076|525727851|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
145787221|NCT02575079|525727852|FG000|Overall Study|Death|3|||
145787222|NCT02575079|525727853|FG001|Overall Study|Death|0|||
145787223|NCT02575079|525727852|FG000|Overall Study|Withdrawal by Subject|3|||
145787224|NCT02575079|525727853|FG001|Overall Study|Withdrawal by Subject|0|||
145787225|NCT05692154|525727854|FG000|Overall Study|Adverse Event|0|||
145787226|NCT05692154|525727855|FG001|Overall Study|Adverse Event|1|||
145787227|NCT03510663|525727859|FG000|Overall Study|Withdrawal by Subject|0|||
145787228|NCT03510663|525727860|FG001|Overall Study|Withdrawal by Subject|1|||
145787229|NCT03510663|525727861|FG002|Overall Study|Withdrawal by Subject|0|||
145787230|NCT03510663|525727862|FG003|Overall Study|Withdrawal by Subject|0|||
145787231|NCT03510663|525727863|FG004|Overall Study|Withdrawal by Subject|0|||
145787232|NCT03510663|525727864|FG005|Overall Study|Withdrawal by Subject|0|||
145787233|NCT03510663|525727865|FG006|Overall Study|Withdrawal by Subject|0|||
145787234|NCT03510663|525727866|FG007|Overall Study|Withdrawal by Subject|0|||
145787235|NCT04370028|525727869|FG000|Overall Study|Withdrawal by Subject|695|||
145787236|NCT04370028|525727869|FG000|Overall Study|Protocol Violation|9|||
145787237|NCT04370028|525727869|FG000|Overall Study|Adverse Event|3|||
145787238|NCT04743635|525727872|FG000|Overall Study|Lost to Follow-up|2|||
145787239|NCT04743635|525727873|FG001|Overall Study|Lost to Follow-up|0|||
145787240|NCT01954121|525727874|FG000|Overall Study|Lack of Efficacy|94|||
145787241|NCT01954121|525727875|FG001|Overall Study|Lack of Efficacy|41|||
145787242|NCT01954121|525727874|FG000|Overall Study|Protocol Violation|0|||
145787243|NCT01954121|525727875|FG001|Overall Study|Protocol Violation|2|||
145787244|NCT01954121|525727874|FG000|Overall Study|Lost to Follow-up|5|||
145787245|NCT01954121|525727875|FG001|Overall Study|Lost to Follow-up|6|||
145787246|NCT01954121|525727874|FG000|Overall Study|Withdrawal by Subject|18|||
145787247|NCT01954121|525727875|FG001|Overall Study|Withdrawal by Subject|12|||
145787248|NCT01954121|525727874|FG000|Overall Study|Pregnancy|1|||
145787249|NCT01954121|525727875|FG001|Overall Study|Pregnancy|1|||
145539292|NCT03173313|524834245|FG000|Overall Study|Bone Fracture|1|||
145539293|NCT03173313|524834246|FG001|Overall Study|Bone Fracture|0|||
145539294|NCT05338216|524834247|FG000|Overall Study|Withdrawal by Subject|1|||
145539295|NCT05338216|524834248|FG001|Overall Study|Withdrawal by Subject|1|||
145539296|NCT03330288|524834255|FG000|Overall Study|Other reason|1|||
145539297|NCT03330288|524834256|FG001|Overall Study|Other reason|1|||
145539298|NCT03330288|524834255|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
145539299|NCT03330288|524834256|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
145539300|NCT03330288|524834255|FG000|Overall Study|Adverse Event|1|||
145539301|NCT03330288|524834256|FG001|Overall Study|Adverse Event|0|||
145539302|NCT03330288|524834255|FG000|Overall Study|Withdrawal by Subject|1|||
145539303|NCT03330288|524834256|FG001|Overall Study|Withdrawal by Subject|0|||
145539304|NCT03330288|524834255|FG000|Overall Study|Lost to Follow-up|26|||
145539305|NCT03330288|524834256|FG001|Overall Study|Lost to Follow-up|7|||
145539306|NCT02264639|524834257|FG000|Overall Study|Death (after completing single-dose phase)|1|||
145539307|NCT02264639|524834258|FG001|Overall Study|Death (after completing single-dose phase)|0|||
145539308|NCT02264639|524834259|FG002|Overall Study|Death (after completing single-dose phase)|0|||
145539309|NCT02264639|524834260|FG003|Overall Study|Death (after completing single-dose phase)|0|||
145539310|NCT02264639|524834261|FG004|Overall Study|Death (after completing single-dose phase)|0|||
145539311|NCT02264639|524834257|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
145539312|NCT02264639|524834258|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
145539313|NCT02264639|524834259|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
145539314|NCT02264639|524834260|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
145539315|NCT02264639|524834261|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
145539316|NCT02264639|524834257|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
145539317|NCT02264639|524834258|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
145539318|NCT02264639|524834259|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
145787250|NCT01954121|525727874|FG000|Overall Study|AE, serious fatal|1|||
145787251|NCT01954121|525727875|FG001|Overall Study|AE, serious fatal|0|||
145787252|NCT01954121|525727874|FG000|Overall Study|AE, non-serious non-fatal|5|||
145787253|NCT01954121|525727875|FG001|Overall Study|AE, non-serious non-fatal|22|||
145787254|NCT01954121|525727874|FG000|Overall Study|SAE, non-fatal|1|||
145787255|NCT01954121|525727875|FG001|Overall Study|SAE, non-fatal|4|||
145787256|NCT01954121|525727874|FG000|Overall Study|Non-compliant with study procedures|1|||
145787257|NCT01954121|525727875|FG001|Overall Study|Non-compliant with study procedures|0|||
145787258|NCT01954121|525727874|FG000|Overall Study|Non-compliant patient|1|||
145787259|NCT01954121|525727875|FG001|Overall Study|Non-compliant patient|1|||
145787260|NCT01954121|525727874|FG000|Overall Study|Subject did not follow instructions|0|||
145787261|NCT01954121|525727875|FG001|Overall Study|Subject did not follow instructions|2|||
145787262|NCT01064648|525727880|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
145787263|NCT01064648|525727881|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
145787264|NCT01064648|525727882|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
145787265|NCT01064648|525727883|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
145787266|NCT01064648|525727880|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
145787267|NCT01064648|525727881|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
145787268|NCT01064648|525727882|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
145787269|NCT01064648|525727883|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
145787270|NCT01064648|525727880|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
145787271|NCT01064648|525727881|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
145787272|NCT01064648|525727882|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
145787273|NCT01064648|525727883|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
145787274|NCT01064648|525727880|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
145787275|NCT01064648|525727881|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
145787276|NCT01064648|525727882|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
145787277|NCT01064648|525727883|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
145787278|NCT01064648|525727880|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
145787279|NCT01064648|525727881|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
145787280|NCT01064648|525727882|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
145787281|NCT01064648|525727883|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
145787282|NCT01064648|525727880|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
145787283|NCT01064648|525727881|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
145787284|NCT01064648|525727882|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
145787285|NCT01064648|525727883|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
145787286|NCT01064648|525727880|FG000|Phase II|Adverse Event|0|||
145787287|NCT01064648|525727881|FG001|Phase II|Adverse Event|0|||
145787288|NCT01064648|525727882|FG002|Phase II|Adverse Event|15|||
145787289|NCT01064648|525727883|FG003|Phase II|Adverse Event|8|||
145787290|NCT01064648|525727880|FG000|Phase II|Death|0|||
145787291|NCT01064648|525727881|FG001|Phase II|Death|0|||
145787292|NCT01064648|525727882|FG002|Phase II|Death|4|||
145787293|NCT01064648|525727883|FG003|Phase II|Death|5|||
145787294|NCT01064648|525727880|FG000|Phase II|Withdrawal by Subject|0|||
145787295|NCT01064648|525727881|FG001|Phase II|Withdrawal by Subject|0|||
145787296|NCT01064648|525727882|FG002|Phase II|Withdrawal by Subject|2|||
145787297|NCT01064648|525727883|FG003|Phase II|Withdrawal by Subject|5|||
145787298|NCT01064648|525727880|FG000|Phase II|Progression|0|||
145787299|NCT01064648|525727881|FG001|Phase II|Progression|0|||
145787300|NCT01064648|525727882|FG002|Phase II|Progression|21|||
145787301|NCT01064648|525727883|FG003|Phase II|Progression|27|||
145787302|NCT01064648|525727880|FG000|Phase II|Non-protocol specified|0|||
145787303|NCT01064648|525727881|FG001|Phase II|Non-protocol specified|0|||
145787304|NCT01064648|525727882|FG002|Phase II|Non-protocol specified|5|||
145787305|NCT01064648|525727883|FG003|Phase II|Non-protocol specified|3|||
145787306|NCT01064648|525727880|FG000|Phase II|Under Review|0|||
145787307|NCT01064648|525727881|FG001|Phase II|Under Review|0|||
145787308|NCT01064648|525727882|FG002|Phase II|Under Review|2|||
145787309|NCT01064648|525727883|FG003|Phase II|Under Review|0|||
145787310|NCT05513391|525727884|FG000|Overall Study|Adverse Event|1|||
145787311|NCT05513391|525727885|FG001|Overall Study|Adverse Event|0|||
145787312|NCT05513391|525727884|FG000|Overall Study|Protocol Deviation|0|||
145787313|NCT05513391|525727885|FG001|Overall Study|Protocol Deviation|1|||
145787314|NCT05513391|525727884|FG000|Overall Study|Withdrawal by Subject|3|||
145787315|NCT05513391|525727885|FG001|Overall Study|Withdrawal by Subject|1|||
145787316|NCT05513391|525727884|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145787317|NCT05513391|525727885|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145787318|NCT05513391|525727884|FG000|Overall Study|Lost to Follow-up|0|||
145787319|NCT05513391|525727885|FG001|Overall Study|Lost to Follow-up|2|||
145787320|NCT05183867|525730170|FG000|Overall Study|Withdrawal by Subject|3|||
145787321|NCT05183867|525730171|FG001|Overall Study|Withdrawal by Subject|2|||
145787322|NCT05183867|525730172|FG002|Overall Study|Withdrawal by Subject|0|||
145787323|NCT00492856|525730173|FG000|Induction|Adverse Event|2|||
145787324|NCT00492856|525730174|FG001|Induction|Adverse Event|0|||
145787325|NCT00492856|525730175|FG002|Induction|Adverse Event|0|||
145787326|NCT00492856|525730176|FG003|Induction|Adverse Event|0|||
145787327|NCT00492856|525730173|FG000|Induction|Withdrawal by Subject|1|||
145787328|NCT00492856|525730174|FG001|Induction|Withdrawal by Subject|0|||
145787329|NCT00492856|525730175|FG002|Induction|Withdrawal by Subject|0|||
145787330|NCT00492856|525730176|FG003|Induction|Withdrawal by Subject|0|||
145787331|NCT00492856|525730173|FG000|Induction|Death|3|||
145787332|NCT00492856|525730174|FG001|Induction|Death|0|||
145787333|NCT00492856|525730175|FG002|Induction|Death|0|||
145787334|NCT00492856|525730176|FG003|Induction|Death|0|||
145787335|NCT00492856|525730173|FG000|Consolidation|Adverse Event|6|||
145787336|NCT00492856|525730174|FG001|Consolidation|Adverse Event|0|||
145787337|NCT00492856|525730175|FG002|Consolidation|Adverse Event|0|||
145787338|NCT00492856|525730176|FG003|Consolidation|Adverse Event|0|||
145787339|NCT00492856|525730173|FG000|Consolidation|Not protocol specified|2|||
145787340|NCT00492856|525730174|FG001|Consolidation|Not protocol specified|0|||
145787341|NCT00492856|525730175|FG002|Consolidation|Not protocol specified|0|||
145787342|NCT00492856|525730176|FG003|Consolidation|Not protocol specified|0|||
145787343|NCT00492856|525730173|FG000|Consolidation|Lost to Follow-up|1|||
145787344|NCT00492856|525730174|FG001|Consolidation|Lost to Follow-up|0|||
145787345|NCT00492856|525730175|FG002|Consolidation|Lost to Follow-up|0|||
145787346|NCT00492856|525730176|FG003|Consolidation|Lost to Follow-up|0|||
145787347|NCT00492856|525730173|FG000|Post-consolidation|Adverse Event|0|||
145787348|NCT00492856|525730174|FG001|Post-consolidation|Adverse Event|4|||
145787349|NCT00492856|525730175|FG002|Post-consolidation|Adverse Event|0|||
145787350|NCT00492856|525730176|FG003|Post-consolidation|Adverse Event|1|||
145787351|NCT00492856|525730173|FG000|Post-consolidation|Withdrawal by Subject|0|||
145787352|NCT00492856|525730174|FG001|Post-consolidation|Withdrawal by Subject|4|||
145787353|NCT00492856|525730175|FG002|Post-consolidation|Withdrawal by Subject|0|||
145787354|NCT00492856|525730176|FG003|Post-consolidation|Withdrawal by Subject|0|||
145787355|NCT00492856|525730173|FG000|Post-consolidation|Death|0|||
145787356|NCT00492856|525730174|FG001|Post-consolidation|Death|1|||
145787357|NCT00492856|525730175|FG002|Post-consolidation|Death|0|||
145787358|NCT00492856|525730176|FG003|Post-consolidation|Death|0|||
145787359|NCT00492856|525730173|FG000|Post-consolidation|Not protocol specified|0|||
145787360|NCT00492856|525730174|FG001|Post-consolidation|Not protocol specified|1|||
145787361|NCT00492856|525730175|FG002|Post-consolidation|Not protocol specified|0|||
145787362|NCT00492856|525730176|FG003|Post-consolidation|Not protocol specified|0|||
145787363|NCT00492856|525730173|FG000|Post-consolidation|Lost to Follow-up|0|||
145787364|NCT00492856|525730174|FG001|Post-consolidation|Lost to Follow-up|2|||
145787365|NCT00492856|525730175|FG002|Post-consolidation|Lost to Follow-up|0|||
145787366|NCT00492856|525730176|FG003|Post-consolidation|Lost to Follow-up|0|||
145787367|NCT00492856|525730173|FG000|Post-consolidation|Observation Arm|0|||
145787368|NCT00492856|525730174|FG001|Post-consolidation|Observation Arm|0|||
145787369|NCT00492856|525730175|FG002|Post-consolidation|Observation Arm|27|||
145787370|NCT00492856|525730176|FG003|Post-consolidation|Observation Arm|0|||
145787371|NCT01520324|525730183|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
145787372|NCT00948818|525730184|FG000|Overall Study|Adverse Event|10|||
145787373|NCT00948818|525730185|FG001|Overall Study|Adverse Event|32|||
145787374|NCT00948818|525730184|FG000|Overall Study|Protocol Violation|9|||
145787375|NCT00948818|525730185|FG001|Overall Study|Protocol Violation|10|||
145787376|NCT00948818|525730184|FG000|Overall Study|Withdrawal by Subject|25|||
145787377|NCT00948818|525730185|FG001|Overall Study|Withdrawal by Subject|25|||
145787378|NCT00948818|525730184|FG000|Overall Study|Lost to Follow-up|10|||
145787379|NCT00948818|525730185|FG001|Overall Study|Lost to Follow-up|17|||
145539319|NCT02264639|524834260|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
145539320|NCT02264639|524834261|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
145787380|NCT00948818|525730184|FG000|Overall Study|Lack of Efficacy|4|||
145787381|NCT00948818|525730185|FG001|Overall Study|Lack of Efficacy|5|||
145787382|NCT00948818|525730184|FG000|Overall Study|Other Reason|4|||
145787383|NCT00948818|525730185|FG001|Overall Study|Other Reason|5|||
145787384|NCT02330549|525730186|FG000|Overall Study|Adverse Event|1|||
145787385|NCT02330549|525730187|FG001|Overall Study|Adverse Event|0|||
145787386|NCT02330549|525730186|FG000|Overall Study|Subject withdrew consent|2|||
145787387|NCT02330549|525730187|FG001|Overall Study|Subject withdrew consent|1|||
145787388|NCT02330549|525730186|FG000|Overall Study|Failure to meet randomization criteria|1|||
145787389|NCT02330549|525730187|FG001|Overall Study|Failure to meet randomization criteria|0|||
145787390|NCT00745368|525730188|FG000|Overall Study|Unable to provide sample|3|||
145787391|NCT02364947|525730189|FG000|Overall Study|Withdrawal by Subject|10|||
145787392|NCT02364947|525730190|FG001|Overall Study|Withdrawal by Subject|8|||
145539321|NCT02264639|524834257|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
145787393|NCT02364947|525730191|FG002|Overall Study|Withdrawal by Subject|9|||
145787394|NCT02364947|525730189|FG000|Overall Study|Adverse Event|45|||
145609673|NCT04534114|525086407|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
145609674|NCT03287414|525086408|FG000|Treatment Epoch|Adverse Event|0|||
145609675|NCT03287414|525086409|FG001|Treatment Epoch|Adverse Event|1|||
145609676|NCT03287414|525086408|FG000|Treatment Epoch|Study terminated by sponsor|2|||
145609677|NCT03287414|525086409|FG001|Treatment Epoch|Study terminated by sponsor|2|||
145609678|NCT03287414|525086408|FG000|Treatment Epoch|Subject/Guardian decision|4|||
145609679|NCT03287414|525086409|FG001|Treatment Epoch|Subject/Guardian decision|0|||
145609680|NCT03287414|525086408|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
145609681|NCT03287414|525086409|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
145609682|NCT03287414|525086408|FG000|Treatment Epoch|Withdrawal by Subject|1|||
145609683|NCT03287414|525086409|FG001|Treatment Epoch|Withdrawal by Subject|0|||
145609684|NCT03287414|525086408|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
145609685|NCT03287414|525086409|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
145609686|NCT03287414|525086408|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
145609687|NCT03287414|525086409|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
145609688|NCT02759185|525086410|FG000|Stage 1|Adverse Event|0|||
145609689|NCT02759185|525086411|FG001|Stage 1|Adverse Event|1|||
145609690|NCT02759185|525086412|FG002|Stage 1|Adverse Event|3|||
145609691|NCT02759185|525086413|FG003|Stage 1|Adverse Event|0|||
145609692|NCT02759185|525086414|FG004|Stage 1|Adverse Event|0|||
145609693|NCT02759185|525086415|FG005|Stage 1|Adverse Event|0|||
145609694|NCT02759185|525086416|FG006|Stage 1|Adverse Event|0|||
145609695|NCT02759185|525086410|FG000|Stage 1|Withdrawal by Subject|1|||
145609696|NCT02759185|525086411|FG001|Stage 1|Withdrawal by Subject|0|||
145609697|NCT02759185|525086412|FG002|Stage 1|Withdrawal by Subject|0|||
145609698|NCT02759185|525086413|FG003|Stage 1|Withdrawal by Subject|0|||
145609699|NCT02759185|525086414|FG004|Stage 1|Withdrawal by Subject|0|||
145609700|NCT02759185|525086415|FG005|Stage 1|Withdrawal by Subject|0|||
145609701|NCT02759185|525086416|FG006|Stage 1|Withdrawal by Subject|0|||
145609702|NCT02759185|525086410|FG000|Stage 2|Adverse Event|0|||
145609703|NCT02759185|525086411|FG001|Stage 2|Adverse Event|0|||
145609704|NCT02759185|525086412|FG002|Stage 2|Adverse Event|0|||
145609705|NCT02759185|525086413|FG003|Stage 2|Adverse Event|0|||
145609706|NCT02759185|525086414|FG004|Stage 2|Adverse Event|1|||
145609707|NCT02759185|525086415|FG005|Stage 2|Adverse Event|2|||
145609708|NCT02759185|525086416|FG006|Stage 2|Adverse Event|0|||
145609709|NCT02759185|525086410|FG000|Stage 2|Withdrawal by Subject|0|||
145609710|NCT02759185|525086411|FG001|Stage 2|Withdrawal by Subject|0|||
145609711|NCT02759185|525086412|FG002|Stage 2|Withdrawal by Subject|0|||
145609712|NCT02759185|525086413|FG003|Stage 2|Withdrawal by Subject|0|||
145609713|NCT02759185|525086414|FG004|Stage 2|Withdrawal by Subject|1|||
145609714|NCT02759185|525086415|FG005|Stage 2|Withdrawal by Subject|1|||
145609715|NCT02759185|525086416|FG006|Stage 2|Withdrawal by Subject|1|||
145787395|NCT02364947|525730190|FG001|Overall Study|Adverse Event|33|||
145787396|NCT02364947|525730191|FG002|Overall Study|Adverse Event|11|||
145787397|NCT02364947|525730189|FG000|Overall Study|Protocol Violation|1|||
145787398|NCT02364947|525730190|FG001|Overall Study|Protocol Violation|1|||
145787399|NCT02364947|525730191|FG002|Overall Study|Protocol Violation|1|||
145787400|NCT02364947|525730189|FG000|Overall Study|Physician Decision|3|||
145787401|NCT02364947|525730190|FG001|Overall Study|Physician Decision|2|||
145787402|NCT02364947|525730191|FG002|Overall Study|Physician Decision|5|||
145787403|NCT02364947|525730189|FG000|Overall Study|Death|0|||
145787404|NCT02364947|525730190|FG001|Overall Study|Death|1|||
145787405|NCT02364947|525730191|FG002|Overall Study|Death|0|||
145787406|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
145787407|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
145787408|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
145787409|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
145787410|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
145787411|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
145787412|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
145787413|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145787414|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
145787415|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
145787416|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
145787417|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
145609716|NCT04395183|525086423|FG000|Overall Study|Withdrawal by Subject|1|||
145609717|NCT04395183|525086424|FG001|Overall Study|Withdrawal by Subject|0|||
145609718|NCT04395183|525086425|FG002|Overall Study|Withdrawal by Subject|2|||
145609719|NCT04395183|525086426|FG003|Overall Study|Withdrawal by Subject|2|||
145787418|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
145787419|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
145609720|NCT01008475|525086427|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
145609721|NCT01008475|525086428|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
145609722|NCT01008475|525086429|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
145539322|NCT02264639|524834258|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
145787420|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
145787421|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
145787422|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
145787423|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
145787424|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
145787425|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
145787426|NCT00423085|525730192|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
145787427|NCT00423085|525730193|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
145787428|NCT00423085|525730194|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
145787429|NCT00423085|525730195|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
145787430|NCT00423085|525730192|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
145787431|NCT00423085|525730193|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
145787432|NCT00423085|525730194|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
145787433|NCT00423085|525730195|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
145787434|NCT00423085|525730192|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
145787435|NCT00423085|525730193|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
145787436|NCT00423085|525730194|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
145787437|NCT00423085|525730195|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
145787438|NCT00423085|525730192|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
145787439|NCT00423085|525730193|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
145787440|NCT00423085|525730194|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
145787441|NCT00423085|525730195|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
145787442|NCT00423085|525730192|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
145787443|NCT00423085|525730193|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
145787444|NCT00423085|525730194|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
145787445|NCT00423085|525730195|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
145787446|NCT00423085|525730192|FG000|52-Week Open-Label Extension Phase|Death|0|||
145787447|NCT00423085|525730193|FG001|52-Week Open-Label Extension Phase|Death|0|||
145787448|NCT00423085|525730194|FG002|52-Week Open-Label Extension Phase|Death|0|||
145787449|NCT00423085|525730195|FG003|52-Week Open-Label Extension Phase|Death|2|||
145787450|NCT00853489|525730196|FG000|Overall Study|Lost to Follow-up|5|||
145787451|NCT00853489|525730197|FG001|Overall Study|Lost to Follow-up|2|||
145787452|NCT05525975|525730198|FG000|Overall Study|Surgery cancellation|4|||
145787453|NCT05525975|525730199|FG001|Overall Study|Surgery cancellation|5|||
145787454|NCT05525975|525730198|FG000|Overall Study|didn't fill prescription|1|||
145787455|NCT05525975|525730199|FG001|Overall Study|didn't fill prescription|0|||
145787456|NCT05525975|525730198|FG000|Overall Study|Withdrawal by Subject|0|||
145787457|NCT05525975|525730199|FG001|Overall Study|Withdrawal by Subject|3|||
145787458|NCT02326467|525730200|FG000|Overall Study|Withdrawal by Subject|1|||
145787459|NCT00441441|525730201|FG000|Overall Study|Adverse Event|2|||
145787460|NCT00441441|525730202|FG001|Overall Study|Adverse Event|1|||
145787461|NCT00441441|525730201|FG000|Overall Study|Protocol Violation|4|||
145787462|NCT00441441|525730202|FG001|Overall Study|Protocol Violation|6|||
145787463|NCT00441441|525730201|FG000|Overall Study|Exacerbation of asthma|1|||
145787464|NCT00441441|525730202|FG001|Overall Study|Exacerbation of asthma|2|||
145787465|NCT00441441|525730201|FG000|Overall Study|Withdrawal by Subject|1|||
145787466|NCT00441441|525730202|FG001|Overall Study|Withdrawal by Subject|2|||
145787467|NCT00441441|525730201|FG000|Overall Study|Other|3|||
145787468|NCT00441441|525730202|FG001|Overall Study|Other|3|||
145787469|NCT01051986|525730203|FG000|Overall Study|Death|1|||
145787470|NCT01051986|525730204|FG001|Overall Study|Death|0|||
145787471|NCT01051986|525730203|FG000|Overall Study|Withdrawal by Subject|2|||
145539323|NCT02264639|524834259|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
145787472|NCT01051986|525730204|FG001|Overall Study|Withdrawal by Subject|1|||
145787473|NCT01051986|525730203|FG000|Overall Study|Protocol Violation|2|||
145539324|NCT02264639|524834260|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
145539325|NCT02264639|524834261|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
145539326|NCT01416272|524834266|FG000|Overall Study|Unacceptable distance visual acuity|2|||
145787474|NCT01051986|525730204|FG001|Overall Study|Protocol Violation|3|||
145787475|NCT01725152|525730206|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
145787476|NCT01725152|525730207|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
145787477|NCT01725152|525730206|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
145787478|NCT01725152|525730207|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
145787479|NCT01725152|525730206|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
145787480|NCT01725152|525730207|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
145787481|NCT01725152|525730206|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
145787482|NCT01725152|525730207|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
145787483|NCT02044159|525730208|FG000|Overall Study|Consent declined (deferred consent)|2|||
145787484|NCT02044159|525730209|FG001|Overall Study|Consent declined (deferred consent)|4|||
145539327|NCT01416272|524834266|FG000|Overall Study|Lost to Follow-up|1|||
145539328|NCT01416272|524834266|FG000|Overall Study|Study related complaints|1|||
145539329|NCT01350492|524834269|FG000|Intervention|Lost to Follow-up|2|||
145539330|NCT01350492|524834270|FG001|Intervention|Lost to Follow-up|5|||
145539331|NCT01350492|524834269|FG000|Intervention|Withdrawal by Subject|3|||
145539332|NCT01350492|524834270|FG001|Intervention|Withdrawal by Subject|1|||
145539333|NCT01350492|524834269|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
145539334|NCT01350492|524834270|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
145539335|NCT01350492|524834269|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
145539336|NCT01350492|524834270|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
145539337|NCT00205881|524834271|FG000|Overall Study|Withdrawal by Subject|16|||
145539338|NCT00702689|524834272|FG000|Overall Study|Withdrawal by Subject|4|||
145539339|NCT00702689|524834272|FG000|Overall Study|Recurrent malignancy|1|||
145539340|NCT00702689|524834272|FG000|Overall Study|Adverse Event|1|||
145539341|NCT02805972|524834277|FG000|Washout Period|Lost to Follow-up|3|||
145539342|NCT02805972|524834278|FG001|Washout Period|Lost to Follow-up|0|||
145539343|NCT00369824|524834280|FG000|Overall Study|Adverse Event|0|||
145539344|NCT00369824|524834281|FG001|Overall Study|Adverse Event|2|||
145539345|NCT00369824|524834282|FG002|Overall Study|Adverse Event|0|||
145539346|NCT00369824|524834283|FG003|Overall Study|Adverse Event|0|||
145539347|NCT00369824|524834284|FG004|Overall Study|Adverse Event|1|||
145539348|NCT00369824|524834285|FG005|Overall Study|Adverse Event|0|||
145539349|NCT00369824|524834280|FG000|Overall Study|Protocol Violation|0|||
145539350|NCT00369824|524834281|FG001|Overall Study|Protocol Violation|1|||
145539351|NCT00369824|524834282|FG002|Overall Study|Protocol Violation|0|||
145539352|NCT00369824|524834283|FG003|Overall Study|Protocol Violation|1|||
145539353|NCT00369824|524834284|FG004|Overall Study|Protocol Violation|1|||
145539354|NCT00369824|524834285|FG005|Overall Study|Protocol Violation|0|||
145539355|NCT00369824|524834280|FG000|Overall Study|Withdrawal by Subject|9|||
145539356|NCT00369824|524834281|FG001|Overall Study|Withdrawal by Subject|5|||
145539357|NCT00369824|524834282|FG002|Overall Study|Withdrawal by Subject|5|||
145539358|NCT00369824|524834283|FG003|Overall Study|Withdrawal by Subject|4|||
145539359|NCT00369824|524834284|FG004|Overall Study|Withdrawal by Subject|6|||
145539360|NCT00369824|524834285|FG005|Overall Study|Withdrawal by Subject|2|||
145539361|NCT00369824|524834280|FG000|Overall Study|Lost to Follow-up|6|||
145539362|NCT00369824|524834281|FG001|Overall Study|Lost to Follow-up|11|||
145539363|NCT00369824|524834282|FG002|Overall Study|Lost to Follow-up|7|||
145539364|NCT00369824|524834283|FG003|Overall Study|Lost to Follow-up|8|||
145539365|NCT00369824|524834284|FG004|Overall Study|Lost to Follow-up|9|||
145539366|NCT00369824|524834285|FG005|Overall Study|Lost to Follow-up|6|||
145539367|NCT00369824|524834280|FG000|Overall Study|Other|0|||
145539368|NCT00369824|524834281|FG001|Overall Study|Other|0|||
145539369|NCT00369824|524834282|FG002|Overall Study|Other|0|||
145539370|NCT00369824|524834283|FG003|Overall Study|Other|2|||
145539371|NCT00369824|524834284|FG004|Overall Study|Other|1|||
145539372|NCT00369824|524834285|FG005|Overall Study|Other|3|||
145539373|NCT01443078|524834286|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
145539374|NCT01443078|524834286|FG000|Overall Study|Withdrawal by Subject|1|||
145539375|NCT01443078|524834286|FG000|Overall Study|Patient had brain mets|1|||
145539376|NCT01611155|524834287|FG000|Overall Study|Adverse Event|1|||
145539377|NCT01611155|524834288|FG001|Overall Study|Adverse Event|1|||
145539378|NCT01611155|524834287|FG000|Overall Study|Refused further treatment|6|||
145539379|NCT01611155|524834288|FG001|Overall Study|Refused further treatment|4|||
145539380|NCT01611155|524834287|FG000|Overall Study|Disease progression|1|||
145539381|NCT01611155|524834288|FG001|Overall Study|Disease progression|0|||
145539382|NCT01611155|524834287|FG000|Overall Study|Withdrawal by Subject|1|||
145539383|NCT01611155|524834288|FG001|Overall Study|Withdrawal by Subject|0|||
145539384|NCT01611155|524834287|FG000|Overall Study|Alternative treatment|0|||
145539385|NCT01611155|524834288|FG001|Overall Study|Alternative treatment|1|||
145539386|NCT01611155|524834287|FG000|Overall Study|Ineligible patient|0|||
145539387|NCT01611155|524834288|FG001|Overall Study|Ineligible patient|1|||
145539388|NCT00087607|524834290|FG000|Overall Study|Adverse Event|14|||
145539389|NCT00087607|524834291|FG001|Overall Study|Adverse Event|24|||
145539390|NCT00087607|524834290|FG000|Overall Study|Death|0|||
145539391|NCT00087607|524834291|FG001|Overall Study|Death|1|||
145539392|NCT00087607|524834290|FG000|Overall Study|Insufficient Therapeutic Response|53|||
145539393|NCT00087607|524834291|FG001|Overall Study|Insufficient Therapeutic Response|42|||
145539394|NCT00087607|524834290|FG000|Overall Study|Failure to return|21|||
145539395|NCT00087607|524834291|FG001|Overall Study|Failure to return|17|||
145539396|NCT00087607|524834290|FG000|Overall Study|Withdrew Consent|12|||
145539397|NCT00087607|524834291|FG001|Overall Study|Withdrew Consent|16|||
145539398|NCT00087607|524834290|FG000|Overall Study|Administrative|12|||
145539399|NCT00087607|524834291|FG001|Overall Study|Administrative|12|||
145787485|NCT02044159|525730208|FG000|Overall Study|No longer eligible, drug not given|1|||
145787486|NCT02044159|525730209|FG001|Overall Study|No longer eligible, drug not given|0|||
145787487|NCT02044159|525730208|FG000|Overall Study|Nurse declined to give study drug|1|||
145787488|NCT02044159|525730209|FG001|Overall Study|Nurse declined to give study drug|0|||
145787489|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
145787490|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145787491|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145787492|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145787493|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145787494|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
145787495|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145787496|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145787497|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145787498|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145787499|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
145787500|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145787501|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145787502|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145787503|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145787504|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
145787505|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
145787506|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
145787507|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
145787508|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
145787509|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
145787510|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
145787511|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
145787512|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
145787513|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
145787514|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
145787515|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145787516|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145787517|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145787518|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145787519|NCT01111539|525730210|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
145787520|NCT01111539|525730211|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
145787521|NCT01111539|525730212|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
145787522|NCT01111539|525730213|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
145787523|NCT01111539|525730214|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
145787524|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145787525|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145787526|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
145787527|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
145787528|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
145787529|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145787530|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145539400|NCT00087607|524834290|FG000|Overall Study|Refused Treatment|5|||
145281759|NCT01759537|523880650|FG000|Overall Study|Pregnancy|1|||
145281760|NCT01759537|523880651|FG001|Overall Study|Pregnancy|1|||
145539401|NCT00087607|524834291|FG001|Overall Study|Refused Treatment|7|||
145281761|NCT01759537|523880650|FG000|Overall Study|Lost to Follow-up|9|||
145539402|NCT00087607|524834290|FG000|Overall Study|Other Protocol Violation|5|||
145539403|NCT00087607|524834291|FG001|Overall Study|Other Protocol Violation|2|||
145539404|NCT00087607|524834290|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
145539405|NCT00087607|524834291|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145787531|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
145787532|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145787533|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
145787534|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
145787535|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
145787536|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
145281762|NCT01759537|523880651|FG001|Overall Study|Lost to Follow-up|9|||
145281763|NCT01759537|523880650|FG000|Overall Study|Accident involving jaw fracture|1|||
145281764|NCT01759537|523880651|FG001|Overall Study|Accident involving jaw fracture|1|||
145281765|NCT01759537|523880650|FG000|Overall Study|Subcrestal implant too coronal|1|||
145281766|NCT01759537|523880651|FG001|Overall Study|Subcrestal implant too coronal|1|||
145281767|NCT00420290|523880652|FG000|Overall Study|Adverse Event|3|||
145281768|NCT00420290|523880653|FG001|Overall Study|Adverse Event|1|||
145539406|NCT02229383|524834292|FG000|Overall Study|Adverse Event|7|||
145539407|NCT02229383|524834293|FG001|Overall Study|Adverse Event|4|||
145787537|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145787538|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145787539|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
145787540|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
145787541|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
145787542|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
145787543|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
145787544|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
145787545|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
145787546|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
145787547|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
145787548|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
145787549|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
145787550|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
145787551|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
145539408|NCT02229383|524834292|FG000|Overall Study|Death|0|||
145539409|NCT02229383|524834293|FG001|Overall Study|Death|1|||
145281769|NCT00420290|523880652|FG000|Overall Study|Withdrawal by Subject|0|||
145281770|NCT00420290|523880653|FG001|Overall Study|Withdrawal by Subject|2|||
145281771|NCT00420290|523880652|FG000|Overall Study|did not meet inclusion/exclusion|1|||
145281772|NCT00420290|523880653|FG001|Overall Study|did not meet inclusion/exclusion|1|||
145539410|NCT02229383|524834292|FG000|Overall Study|Lost to Follow-up|5|||
145539411|NCT02229383|524834293|FG001|Overall Study|Lost to Follow-up|3|||
145539412|NCT02229383|524834292|FG000|Overall Study|Withdrawal by Subject|4|||
145539413|NCT02229383|524834293|FG001|Overall Study|Withdrawal by Subject|6|||
145539414|NCT02229383|524834292|FG000|Overall Study|Did not receive treatment|1|||
145539415|NCT02229383|524834293|FG001|Overall Study|Did not receive treatment|0|||
145539416|NCT02229383|524834292|FG000|Overall Study|Other|3|||
145539417|NCT02229383|524834293|FG001|Overall Study|Other|8|||
145539418|NCT00873015|524834298|FG000|Overall Study|Withdrawal by Subject|0|||
145539419|NCT00873015|524834299|FG001|Overall Study|Withdrawal by Subject|1|||
145539420|NCT00873015|524834300|FG002|Overall Study|Withdrawal by Subject|0|||
145787552|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
145787553|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
145787554|NCT01111539|525730210|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145787555|NCT01111539|525730211|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145787556|NCT01111539|525730212|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145787557|NCT01111539|525730213|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145787558|NCT01111539|525730214|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
145787559|NCT03580382|525730215|FG000|Overall Study|Early Termination of Study|0|||
145787560|NCT03580382|525730216|FG001|Overall Study|Early Termination of Study|3|||
145787561|NCT02808312|525730217|FG000|Overall Study|Enrolled but Never Treated|0|||
145787562|NCT02808312|525730218|FG001|Overall Study|Enrolled but Never Treated|0|||
145787563|NCT02808312|525730219|FG002|Overall Study|Enrolled but Never Treated|1|||
145787564|NCT02808312|525730220|FG003|Overall Study|Enrolled but Never Treated|0|||
145787565|NCT02808312|525730221|FG004|Overall Study|Enrolled but Never Treated|0|||
145787566|NCT03628417|525730222|FG000|Overall Study|Death|1|||
145787567|NCT03628417|525730223|FG001|Overall Study|Death|1|||
145787568|NCT05619172|525730227|FG000|Safety Cohort 1|Death|7|||
145787569|NCT05619172|525730228|FG001|Safety Cohort 1|Death|0|||
145787570|NCT05619172|525730227|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
145787571|NCT05619172|525730228|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
145787572|NCT05619172|525730227|FG000|Safety Cohort 2|Death|0|||
145787573|NCT05619172|525730228|FG001|Safety Cohort 2|Death|1|||
145787574|NCT05619172|525730227|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
145787575|NCT05619172|525730228|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
145787576|NCT04263142|525730229|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
145787577|NCT04263142|525730230|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
145787578|NCT04263142|525730231|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
145787579|NCT04263142|525730232|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
145787580|NCT04263142|525730233|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
145787581|NCT04263142|525730229|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
145787582|NCT04263142|525730230|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
145787583|NCT04263142|525730231|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
145787584|NCT04263142|525730232|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
145787585|NCT04263142|525730233|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
145787586|NCT00450372|525730235|FG000|Overall Study|Physician Decision|1|||
145539421|NCT00873015|524834301|FG003|Overall Study|Withdrawal by Subject|0|||
145539422|NCT00345839|524834302|FG000|Overall Study|Withdrawal by Subject|91|||
145539423|NCT00345839|524834303|FG001|Overall Study|Withdrawal by Subject|98|||
145539424|NCT00345839|524834302|FG000|Overall Study|Lost to Follow-up|58|||
145539425|NCT00345839|524834303|FG001|Overall Study|Lost to Follow-up|61|||
145539426|NCT01687998|524836607|FG000|Overall Study|Withdrawal by Subject|49|||
145539427|NCT01687998|524836608|FG001|Overall Study|Withdrawal by Subject|51|||
145539428|NCT01687998|524836607|FG000|Overall Study|Known to be Alive at Study End|54|||
145539429|NCT01687998|524836608|FG001|Overall Study|Known to be Alive at Study End|62|||
145539430|NCT01687998|524836607|FG000|Overall Study|Lost to Follow-up|9|||
145539431|NCT01687998|524836608|FG001|Overall Study|Lost to Follow-up|7|||
145539432|NCT01594281|524836610|FG000|Interventional Core Phase|Protocol Deviation|1|||
145539433|NCT01594281|524836611|FG001|Interventional Core Phase|Protocol Deviation|0|||
145539434|NCT01594281|524836612|FG002|Interventional Core Phase|Protocol Deviation|0|||
145539435|NCT01594281|524836610|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
145539436|NCT01594281|524836611|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
145539437|NCT01594281|524836612|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
145539438|NCT01594281|524836610|FG000|Interventional Core Phase|Death|1|||
145787587|NCT00769704|525730236|FG000|Overall Study|Lost to Follow-up|3|||
145787588|NCT00769704|525730237|FG001|Overall Study|Lost to Follow-up|2|||
145787589|NCT00769704|525730236|FG000|Overall Study|Death|95|||
145787590|NCT00769704|525730237|FG001|Overall Study|Death|190|||
145539439|NCT01594281|524836611|FG001|Interventional Core Phase|Death|1|||
145787591|NCT00769704|525730236|FG000|Overall Study|Withdrawal by Subject|12|||
145787592|NCT00769704|525730237|FG001|Overall Study|Withdrawal by Subject|5|||
145787593|NCT00769704|525730236|FG000|Overall Study|Other|1|||
145787594|NCT00769704|525730237|FG001|Overall Study|Other|2|||
145787595|NCT00520676|525730241|FG000|Overall Study|Death|84|||
145539440|NCT01594281|524836612|FG002|Interventional Core Phase|Death|2|||
145539441|NCT01594281|524836610|FG000|Interventional Core Phase|Lost to Follow-up|1|||
145539442|NCT01594281|524836611|FG001|Interventional Core Phase|Lost to Follow-up|4|||
145539443|NCT01594281|524836612|FG002|Interventional Core Phase|Lost to Follow-up|1|||
145539444|NCT01594281|524836610|FG000|Interventional Core Phase|Adverse Event|4|||
145787596|NCT00520676|525730242|FG001|Overall Study|Death|81|||
145281773|NCT01623830|523882966|FG000|Overall Study|Withdrawal by Subject|6|||
145281774|NCT01623830|523882967|FG001|Overall Study|Withdrawal by Subject|7|||
145281775|NCT01623830|523882966|FG000|Overall Study|Exclusion from Study|1|||
145281776|NCT01623830|523882967|FG001|Overall Study|Exclusion from Study|2|||
145281777|NCT01859390|523882970|FG000|Overall Study|Insufficient Sputum Collected|1|||
145281778|NCT01859390|523882971|FG001|Overall Study|Insufficient Sputum Collected|3|||
145281779|NCT01859390|523882970|FG000|Overall Study|Sample Missing Collection Date|0|||
145281780|NCT01859390|523882971|FG001|Overall Study|Sample Missing Collection Date|1|||
145281781|NCT01859390|523882970|FG000|Overall Study|Tube Cracked|0|||
145281782|NCT01859390|523882971|FG001|Overall Study|Tube Cracked|2|||
145281783|NCT01859390|523882970|FG000|Overall Study|Shipment Error|0|||
145787597|NCT00520676|525730241|FG000|Overall Study|Lost to Follow-up|6|||
145787598|NCT00520676|525730242|FG001|Overall Study|Lost to Follow-up|10|||
145787599|NCT00520676|525730241|FG000|Overall Study|Physician Decision|4|||
145787600|NCT00520676|525730242|FG001|Overall Study|Physician Decision|1|||
145787601|NCT00520676|525730241|FG000|Overall Study|Withdrawal by Subject|7|||
145787602|NCT00520676|525730242|FG001|Overall Study|Withdrawal by Subject|11|||
145787603|NCT05131451|525730245|FG000|Overall Study|Protocol Violation|1|||
145787604|NCT05131451|525730246|FG001|Overall Study|Protocol Violation|0|||
145787605|NCT01856595|525730251|FG000|Overall Study|Withdrawal by Subject|0|||
145787606|NCT01856595|525730252|FG001|Overall Study|Withdrawal by Subject|1|||
145787607|NCT01856595|525730253|FG002|Overall Study|Withdrawal by Subject|0|||
145787608|NCT01856595|525730254|FG003|Overall Study|Withdrawal by Subject|0|||
145787609|NCT01856595|525730255|FG004|Overall Study|Withdrawal by Subject|0|||
145787610|NCT01856595|525730256|FG005|Overall Study|Withdrawal by Subject|0|||
145787611|NCT01856595|525730257|FG006|Overall Study|Withdrawal by Subject|1|||
145787612|NCT01856595|525730258|FG007|Overall Study|Withdrawal by Subject|0|||
145787613|NCT01856595|525730259|FG008|Overall Study|Withdrawal by Subject|0|||
145787614|NCT04402008|525730263|FG000|Overall Study|Adverse Event|0|||
145787615|NCT04402008|525730264|FG001|Overall Study|Adverse Event|0|||
145787616|NCT04402008|525730265|FG002|Overall Study|Adverse Event|0|||
145787617|NCT04402008|525730266|FG003|Overall Study|Adverse Event|1|||
145787618|NCT04402008|525730267|FG004|Overall Study|Adverse Event|0|||
145787619|NCT04402008|525730268|FG005|Overall Study|Adverse Event|0|||
145787620|NCT04402008|525730269|FG006|Overall Study|Adverse Event|0|||
145787621|NCT04402008|525730263|FG000|Overall Study|Disease Progression|3|||
145787622|NCT04402008|525730264|FG001|Overall Study|Disease Progression|2|||
145787623|NCT04402008|525730265|FG002|Overall Study|Disease Progression|3|||
145787624|NCT04402008|525730266|FG003|Overall Study|Disease Progression|3|||
145787625|NCT04402008|525730267|FG004|Overall Study|Disease Progression|4|||
145787626|NCT04402008|525730268|FG005|Overall Study|Disease Progression|3|||
145787627|NCT04402008|525730269|FG006|Overall Study|Disease Progression|10|||
145787628|NCT04402008|525730263|FG000|Overall Study|Withdrawal by Subject|0|||
145787629|NCT04402008|525730264|FG001|Overall Study|Withdrawal by Subject|1|||
145787630|NCT04402008|525730265|FG002|Overall Study|Withdrawal by Subject|0|||
145787631|NCT04402008|525730266|FG003|Overall Study|Withdrawal by Subject|0|||
145787632|NCT04402008|525730267|FG004|Overall Study|Withdrawal by Subject|1|||
145787633|NCT04402008|525730268|FG005|Overall Study|Withdrawal by Subject|0|||
145787634|NCT04402008|525730269|FG006|Overall Study|Withdrawal by Subject|0|||
145787635|NCT04402008|525730263|FG000|Overall Study|Sponsor Decision|0|||
145787636|NCT04402008|525730264|FG001|Overall Study|Sponsor Decision|0|||
145787637|NCT04402008|525730265|FG002|Overall Study|Sponsor Decision|0|||
145787638|NCT04402008|525730266|FG003|Overall Study|Sponsor Decision|0|||
145787639|NCT04402008|525730267|FG004|Overall Study|Sponsor Decision|0|||
145787640|NCT04402008|525730268|FG005|Overall Study|Sponsor Decision|0|||
145281784|NCT01859390|523882971|FG001|Overall Study|Shipment Error|1|||
145281785|NCT01706198|523882973|FG000|Overall Study|Adverse Event|12|||
145281786|NCT01706198|523882974|FG001|Overall Study|Adverse Event|15|||
145281787|NCT01706198|523882973|FG000|Overall Study|Protocol Violation|7|||
145281788|NCT01706198|523882974|FG001|Overall Study|Protocol Violation|5|||
145281789|NCT01706198|523882973|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
145281790|NCT01706198|523882974|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
145281791|NCT01706198|523882973|FG000|Overall Study|Lost to Follow-up|97|||
145787641|NCT04402008|525730269|FG006|Overall Study|Sponsor Decision|3|||
145787642|NCT04402008|525730263|FG000|Overall Study|Death|0|||
145787643|NCT04402008|525730264|FG001|Overall Study|Death|0|||
145787644|NCT04402008|525730265|FG002|Overall Study|Death|0|||
145787645|NCT04402008|525730266|FG003|Overall Study|Death|0|||
145787646|NCT04402008|525730267|FG004|Overall Study|Death|1|||
145787647|NCT04402008|525730268|FG005|Overall Study|Death|0|||
145787648|NCT04402008|525730269|FG006|Overall Study|Death|2|||
145787649|NCT04402008|525730263|FG000|Overall Study|Other|0|||
145787650|NCT04402008|525730264|FG001|Overall Study|Other|0|||
145281792|NCT01706198|523882974|FG001|Overall Study|Lost to Follow-up|93|||
145281793|NCT01706198|523882973|FG000|Overall Study|Physician Decision|23|||
145281794|NCT01706198|523882974|FG001|Overall Study|Physician Decision|37|||
145787651|NCT04402008|525730265|FG002|Overall Study|Other|0|||
145787652|NCT04402008|525730266|FG003|Overall Study|Other|0|||
145539445|NCT01594281|524836611|FG001|Interventional Core Phase|Adverse Event|4|||
145539446|NCT01594281|524836612|FG002|Interventional Core Phase|Adverse Event|4|||
145539447|NCT01594281|524836610|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
145539448|NCT01594281|524836611|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
145539449|NCT01594281|524836612|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
145539450|NCT01594281|524836610|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
145539451|NCT01594281|524836611|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
145539452|NCT01594281|524836612|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
145539453|NCT01594281|524836610|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
145539454|NCT01594281|524836611|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
145539455|NCT01594281|524836612|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
145539456|NCT01871532|524836613|FG000|Overall Study|Withdrawal by Subject|1|||
145539457|NCT01871532|524836614|FG001|Overall Study|Withdrawal by Subject|2|||
145539458|NCT02550106|524836616|FG000|Overall Study|Adverse Event|1|||
145539459|NCT02550106|524836616|FG000|Overall Study|Lack of Efficacy|3|||
145539460|NCT02550106|524836616|FG000|Overall Study|Protocol Violation|6|||
145539461|NCT02550106|524836616|FG000|Overall Study|Withdrawal by Subject|2|||
145539462|NCT01709513|524836617|FG000|Overall Study|Randomized but not treated|0|||
145539463|NCT01709513|524836618|FG001|Overall Study|Randomized but not treated|1|||
145539464|NCT01709513|524836619|FG002|Overall Study|Randomized but not treated|0|||
145539465|NCT01709513|524836617|FG000|Overall Study|Adverse Event|16|||
145539466|NCT01709513|524836618|FG001|Overall Study|Adverse Event|31|||
145539467|NCT01709513|524836619|FG002|Overall Study|Adverse Event|23|||
145539468|NCT01709513|524836617|FG000|Overall Study|Poor compliance to protocol|2|||
145539469|NCT01709513|524836618|FG001|Overall Study|Poor compliance to protocol|0|||
145539470|NCT01709513|524836619|FG002|Overall Study|Poor compliance to protocol|0|||
145539471|NCT01709513|524836617|FG000|Overall Study|Other|3|||
145539472|NCT01709513|524836618|FG001|Overall Study|Other|11|||
145539473|NCT01709513|524836619|FG002|Overall Study|Other|7|||
145539474|NCT01034631|524836620|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
145539475|NCT01034631|524836621|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
145539476|NCT01034631|524836622|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
145539477|NCT01034631|524836620|FG000|Phase II|Not Evaluable per protocol|0|||
145539478|NCT01034631|524836621|FG001|Phase II|Not Evaluable per protocol|0|||
145539479|NCT01034631|524836622|FG002|Phase II|Not Evaluable per protocol|2|||
145539480|NCT01034631|524836620|FG000|Phase II|Determined Ineligible per protocol|0|||
145539481|NCT01034631|524836621|FG001|Phase II|Determined Ineligible per protocol|1|||
145539482|NCT01034631|524836622|FG002|Phase II|Determined Ineligible per protocol|0|||
145539483|NCT00354744|524836623|FG000|Overall Study|Adverse Event|2|||
145539484|NCT00354744|524836623|FG000|Overall Study|Death|2|||
145539485|NCT00354744|524836623|FG000|Overall Study|Lack of Efficacy|11|||
145539486|NCT00354744|524836623|FG000|Overall Study|Lost to Follow-up|2|||
145539487|NCT00354744|524836623|FG000|Overall Study|Physician Decision|11|||
145539488|NCT00354744|524836623|FG000|Overall Study|Withdrawal by Subject|14|||
145539489|NCT01193530|524836626|FG000|Overall Study|Withdrawal by Subject|2|||
145539490|NCT01193530|524836627|FG001|Overall Study|Withdrawal by Subject|2|||
145539491|NCT01193530|524836626|FG000|Overall Study|Began Contraindicated Therapy|1|||
145539492|NCT01193530|524836627|FG001|Overall Study|Began Contraindicated Therapy|0|||
145539493|NCT01193530|524836626|FG000|Overall Study|Lost Light Box|0|||
145539494|NCT01193530|524836627|FG001|Overall Study|Lost Light Box|1|||
145539495|NCT01193530|524836626|FG000|Overall Study|Returned home - out of state|0|||
145539496|NCT01193530|524836627|FG001|Overall Study|Returned home - out of state|1|||
145539497|NCT01193530|524836626|FG000|Overall Study|Non-Compliance|0|||
145539498|NCT01193530|524836627|FG001|Overall Study|Non-Compliance|1|||
145539499|NCT04218695|524836628|FG000|Overall Study|Adverse Event|1|||
145539500|NCT04218695|524836629|FG001|Overall Study|Adverse Event|0|||
145539501|NCT01890473|524836630|FG000|Overall Study|Lost to Follow-up|1|||
145539502|NCT01890473|524836631|FG001|Overall Study|Lost to Follow-up|0|||
145539503|NCT01890473|524836630|FG000|Overall Study|Poor/non-compliance|1|||
145539504|NCT01890473|524836631|FG001|Overall Study|Poor/non-compliance|0|||
145539505|NCT04019288|524836632|FG000|Overall Study|Death|1|||
145539506|NCT04019288|524836633|FG001|Overall Study|Death|0|||
145539507|NCT04019288|524836634|FG002|Overall Study|Death|0|||
145539508|NCT01543958|524836635|FG000|Overall Study|Loss to follow-up|3|||
145539509|NCT01543958|524836635|FG000|Overall Study|ART initiation|1|||
145539510|NCT03166735|524836636|FG000|Overall Study|Not Treated|1|||
145539511|NCT03166735|524836637|FG001|Overall Study|Not Treated|0|||
145787653|NCT04402008|525730267|FG004|Overall Study|Other|0|||
145787654|NCT04402008|525730268|FG005|Overall Study|Other|0|||
145787655|NCT04402008|525730269|FG006|Overall Study|Other|5|||
145787656|NCT00069095|525730272|FG000|Primary Treatment Phase|Ongoing|0|||
145539512|NCT03166735|524836638|FG002|Overall Study|Not Treated|0|||
145539513|NCT03166735|524836639|FG003|Overall Study|Not Treated|0|||
145539514|NCT03166735|524836640|FG004|Overall Study|Not Treated|0|||
145539515|NCT03166735|524836636|FG000|Overall Study|follow-up not completed as planned|0|||
145539516|NCT03166735|524836637|FG001|Overall Study|follow-up not completed as planned|1|||
145539517|NCT03166735|524836638|FG002|Overall Study|follow-up not completed as planned|1|||
145787657|NCT00069095|525730273|FG001|Primary Treatment Phase|Ongoing|0|||
145787658|NCT00069095|525730274|FG002|Primary Treatment Phase|Ongoing|5|||
145787659|NCT00069095|525730275|FG003|Primary Treatment Phase|Ongoing|7|||
145787660|NCT00069095|525730276|FG004|Primary Treatment Phase|Ongoing|7|||
145787661|NCT00069095|525730277|FG005|Primary Treatment Phase|Ongoing|4|||
145787662|NCT00069095|525730272|FG000|Primary Treatment Phase|Admin/Other|29|||
145787663|NCT00069095|525730273|FG001|Primary Treatment Phase|Admin/Other|38|||
145787664|NCT00069095|525730274|FG002|Primary Treatment Phase|Admin/Other|31|||
145787665|NCT00069095|525730275|FG003|Primary Treatment Phase|Admin/Other|45|||
145787666|NCT00069095|525730276|FG004|Primary Treatment Phase|Admin/Other|48|||
145787667|NCT00069095|525730277|FG005|Primary Treatment Phase|Admin/Other|42|||
145787668|NCT00069095|525730272|FG000|Primary Treatment Phase|Adverse Event|99|||
145787669|NCT00069095|525730273|FG001|Primary Treatment Phase|Adverse Event|92|||
145787670|NCT00069095|525730274|FG002|Primary Treatment Phase|Adverse Event|71|||
145787671|NCT00069095|525730275|FG003|Primary Treatment Phase|Adverse Event|72|||
145787672|NCT00069095|525730276|FG004|Primary Treatment Phase|Adverse Event|109|||
145787673|NCT00069095|525730277|FG005|Primary Treatment Phase|Adverse Event|101|||
145787674|NCT00069095|525730272|FG000|Primary Treatment Phase|Death|14|||
145787675|NCT00069095|525730273|FG001|Primary Treatment Phase|Death|8|||
145787676|NCT00069095|525730274|FG002|Primary Treatment Phase|Death|2|||
145787677|NCT00069095|525730275|FG003|Primary Treatment Phase|Death|5|||
145787678|NCT00069095|525730276|FG004|Primary Treatment Phase|Death|8|||
145787679|NCT00069095|525730277|FG005|Primary Treatment Phase|Death|8|||
145787680|NCT00069095|525730272|FG000|Primary Treatment Phase|Failure to return|5|||
145787681|NCT00069095|525730273|FG001|Primary Treatment Phase|Failure to return|5|||
145787682|NCT00069095|525730274|FG002|Primary Treatment Phase|Failure to return|0|||
145787683|NCT00069095|525730275|FG003|Primary Treatment Phase|Failure to return|0|||
145787684|NCT00069095|525730276|FG004|Primary Treatment Phase|Failure to return|0|||
145787685|NCT00069095|525730277|FG005|Primary Treatment Phase|Failure to return|2|||
145787686|NCT00069095|525730272|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
145787687|NCT00069095|525730273|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
145787688|NCT00069095|525730274|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
145787689|NCT00069095|525730275|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
145787690|NCT00069095|525730276|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
145787691|NCT00069095|525730277|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
145787692|NCT00069095|525730272|FG000|Primary Treatment Phase|Refused treatment|15|||
145787693|NCT00069095|525730273|FG001|Primary Treatment Phase|Refused treatment|26|||
145787694|NCT00069095|525730274|FG002|Primary Treatment Phase|Refused treatment|17|||
145787695|NCT00069095|525730275|FG003|Primary Treatment Phase|Refused treatment|31|||
145787696|NCT00069095|525730276|FG004|Primary Treatment Phase|Refused treatment|24|||
145787697|NCT00069095|525730277|FG005|Primary Treatment Phase|Refused treatment|27|||
145787698|NCT00069095|525730272|FG000|Primary Treatment Phase|Withdrew|2|||
145787699|NCT00069095|525730273|FG001|Primary Treatment Phase|Withdrew|3|||
145787700|NCT00069095|525730274|FG002|Primary Treatment Phase|Withdrew|8|||
145787701|NCT00069095|525730275|FG003|Primary Treatment Phase|Withdrew|2|||
145787702|NCT00069095|525730276|FG004|Primary Treatment Phase|Withdrew|4|||
145787703|NCT00069095|525730277|FG005|Primary Treatment Phase|Withdrew|9|||
145787704|NCT00069095|525730272|FG000|Primary Treatment Phase|Other Violation|0|||
145787705|NCT00069095|525730273|FG001|Primary Treatment Phase|Other Violation|1|||
145787706|NCT00069095|525730274|FG002|Primary Treatment Phase|Other Violation|1|||
145787707|NCT00069095|525730275|FG003|Primary Treatment Phase|Other Violation|1|||
145787708|NCT00069095|525730276|FG004|Primary Treatment Phase|Other Violation|0|||
145787709|NCT00069095|525730277|FG005|Primary Treatment Phase|Other Violation|1|||
145787710|NCT00069095|525730272|FG000|Primary Treatment Phase|Violation criteria|0|||
145787711|NCT00069095|525730273|FG001|Primary Treatment Phase|Violation criteria|2|||
145787712|NCT00069095|525730274|FG002|Primary Treatment Phase|Violation criteria|4|||
145787713|NCT00069095|525730275|FG003|Primary Treatment Phase|Violation criteria|3|||
145787714|NCT00069095|525730276|FG004|Primary Treatment Phase|Violation criteria|1|||
145787715|NCT00069095|525730277|FG005|Primary Treatment Phase|Violation criteria|5|||
145787716|NCT00069095|525730272|FG000|Post-study Treatment Phase|Missing reason|1|||
145787717|NCT00069095|525730273|FG001|Post-study Treatment Phase|Missing reason|3|||
145787718|NCT00069095|525730274|FG002|Post-study Treatment Phase|Missing reason|12|||
145787719|NCT00069095|525730275|FG003|Post-study Treatment Phase|Missing reason|8|||
145787720|NCT00069095|525730276|FG004|Post-study Treatment Phase|Missing reason|18|||
145787721|NCT00069095|525730277|FG005|Post-study Treatment Phase|Missing reason|17|||
145787722|NCT00069095|525730272|FG000|Post-study Treatment Phase|Adverse Event|2|||
145787723|NCT00069095|525730273|FG001|Post-study Treatment Phase|Adverse Event|3|||
145787724|NCT00069095|525730274|FG002|Post-study Treatment Phase|Adverse Event|1|||
145787725|NCT00069095|525730275|FG003|Post-study Treatment Phase|Adverse Event|0|||
145787726|NCT00069095|525730276|FG004|Post-study Treatment Phase|Adverse Event|5|||
145787727|NCT00069095|525730277|FG005|Post-study Treatment Phase|Adverse Event|1|||
145787728|NCT00069095|525730272|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
145787729|NCT00069095|525730273|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
145787730|NCT00069095|525730274|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
145787731|NCT00069095|525730275|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
145787732|NCT00069095|525730276|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
145787733|NCT00069095|525730277|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
145787734|NCT00069095|525730272|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
145787735|NCT00069095|525730273|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
145787736|NCT00069095|525730274|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
145787737|NCT00069095|525730275|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
145787738|NCT00069095|525730276|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
145787739|NCT00069095|525730277|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
145787740|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
145787741|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
145787742|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
145787743|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
145787744|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
145787745|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
145787746|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant had complete response|1|||
145787747|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant had complete response|1|||
145787748|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant had complete response|0|||
145787749|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant had complete response|0|||
145787750|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant had complete response|0|||
145787751|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant had complete response|0|||
145787752|NCT00069095|525730272|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
145787753|NCT00069095|525730273|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
145787754|NCT00069095|525730274|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
145787755|NCT00069095|525730275|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
145787756|NCT00069095|525730276|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
145787757|NCT00069095|525730277|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
145787758|NCT00069095|525730272|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
145787759|NCT00069095|525730273|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
145787760|NCT00069095|525730274|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
145787761|NCT00069095|525730275|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
145787762|NCT00069095|525730276|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
145787763|NCT00069095|525730277|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
145787764|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
145787765|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
145787766|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
145787767|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
145787768|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
145787769|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
145787770|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
145787771|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
145787772|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
145787773|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
145787774|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
145787775|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
145787776|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
145787777|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
145787778|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
145787779|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
145787780|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
145787781|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
145787782|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
145787783|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
145787784|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
145787785|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
145787786|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
145787787|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
145787788|NCT00069095|525730272|FG000|Post-study Treatment Phase|Surgery|0|||
145787789|NCT00069095|525730273|FG001|Post-study Treatment Phase|Surgery|0|||
145787790|NCT00069095|525730274|FG002|Post-study Treatment Phase|Surgery|0|||
145787791|NCT00069095|525730275|FG003|Post-study Treatment Phase|Surgery|1|||
145787792|NCT00069095|525730276|FG004|Post-study Treatment Phase|Surgery|1|||
145787793|NCT00069095|525730277|FG005|Post-study Treatment Phase|Surgery|0|||
145787794|NCT00069095|525730272|FG000|Post-study Treatment Phase|Death|0|||
145787795|NCT00069095|525730273|FG001|Post-study Treatment Phase|Death|0|||
145787796|NCT00069095|525730274|FG002|Post-study Treatment Phase|Death|0|||
145787797|NCT00069095|525730275|FG003|Post-study Treatment Phase|Death|0|||
145787798|NCT00069095|525730276|FG004|Post-study Treatment Phase|Death|1|||
145281795|NCT01706198|523882973|FG000|Overall Study|Withdrawal by Subject|23|||
145281796|NCT01706198|523882974|FG001|Overall Study|Withdrawal by Subject|31|||
145281797|NCT04313283|523882975|FG000|Overall Study|did not complete intervention|4|||
145281798|NCT01084005|523882976|FG000|Overall Study|Adverse Event|1|||
145281799|NCT01084005|523882977|FG001|Overall Study|Adverse Event|8|||
145787799|NCT00069095|525730277|FG005|Post-study Treatment Phase|Death|0|||
145787800|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
145787801|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
145787802|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
145787803|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
145787804|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
145787805|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
145787806|NCT00069095|525730272|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
145787807|NCT00069095|525730273|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
145787808|NCT00069095|525730274|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
145787809|NCT00069095|525730275|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
145787810|NCT00069095|525730276|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
145787811|NCT00069095|525730277|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
145787812|NCT00069095|525730272|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
145787813|NCT00069095|525730273|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
145787814|NCT00069095|525730274|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
145787815|NCT00069095|525730275|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
145787816|NCT00069095|525730276|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
145787817|NCT00069095|525730277|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
145787818|NCT00069095|525730272|FG000|Post-study Treatment Phase|Investigator decision|0|||
145787819|NCT00069095|525730273|FG001|Post-study Treatment Phase|Investigator decision|0|||
145787820|NCT00069095|525730274|FG002|Post-study Treatment Phase|Investigator decision|0|||
145787821|NCT00069095|525730275|FG003|Post-study Treatment Phase|Investigator decision|0|||
145787822|NCT00069095|525730276|FG004|Post-study Treatment Phase|Investigator decision|0|||
145787823|NCT00069095|525730277|FG005|Post-study Treatment Phase|Investigator decision|1|||
145787824|NCT00069095|525730272|FG000|Follow-up Phase|Death|174|||
145787825|NCT00069095|525730273|FG001|Follow-up Phase|Death|206|||
145787826|NCT00069095|525730274|FG002|Follow-up Phase|Death|120|||
145787827|NCT00069095|525730275|FG003|Follow-up Phase|Death|112|||
145787828|NCT00069095|525730276|FG004|Follow-up Phase|Death|92|||
145281800|NCT01084005|523882976|FG000|Overall Study|Protocol Violation|3|||
145281801|NCT01084005|523882977|FG001|Overall Study|Protocol Violation|7|||
145281802|NCT01084005|523882976|FG000|Overall Study|Withdrawal by Subject|1|||
145787829|NCT00069095|525730277|FG005|Follow-up Phase|Death|101|||
145787830|NCT00210158|525730281|FG000|Overall Study|Protocol Violation|0|||
145787831|NCT00210158|525730282|FG001|Overall Study|Protocol Violation|2|||
145787832|NCT04716933|525730283|FG000|Overall Study|Sponsor Decision|36|||
145787833|NCT04716933|525730284|FG001|Overall Study|Sponsor Decision|33|||
145281803|NCT01084005|523882977|FG001|Overall Study|Withdrawal by Subject|1|||
145787834|NCT04716933|525730283|FG000|Overall Study|Death|65|||
145787835|NCT04716933|525730284|FG001|Overall Study|Death|67|||
145787836|NCT03249792|525730289|FG000|Arms 1, 2, and 4|Death|1|||
145787837|NCT03249792|525730290|FG001|Arms 1, 2, and 4|Death|1|||
145787838|NCT03249792|525730291|FG002|Arms 1, 2, and 4|Death|0|||
145787839|NCT03249792|525730292|FG003|Arms 1, 2, and 4|Death|2|||
145787840|NCT03249792|525730293|FG004|Arms 1, 2, and 4|Death|3|||
145787841|NCT03249792|525730294|FG005|Arms 1, 2, and 4|Death|2|||
145787842|NCT03249792|525730295|FG006|Arms 1, 2, and 4|Death|2|||
145787843|NCT03249792|525730296|FG007|Arms 1, 2, and 4|Death|4|||
145787844|NCT03249792|525730297|FG008|Arms 1, 2, and 4|Death|2|||
145787845|NCT03249792|525730298|FG009|Arms 1, 2, and 4|Death|1|||
145787846|NCT03249792|525730299|FG010|Arms 1, 2, and 4|Death|7|||
145787847|NCT03249792|525730300|FG011|Arms 1, 2, and 4|Death|7|||
145787848|NCT03249792|525730301|FG012|Arms 1, 2, and 4|Death|12|||
145787849|NCT03249792|525730302|FG013|Arms 1, 2, and 4|Death|7|||
145787850|NCT03249792|525730303|FG014|Arms 1, 2, and 4|Death|0|||
145787851|NCT03249792|525730304|FG015|Arms 1, 2, and 4|Death|4|||
145787852|NCT03249792|525730305|FG016|Arms 1, 2, and 4|Death|4|||
145787853|NCT03249792|525730306|FG017|Arms 1, 2, and 4|Death|12|||
145787854|NCT03249792|525730307|FG018|Arms 1, 2, and 4|Death|6|||
145787855|NCT03249792|525730308|FG019|Arms 1, 2, and 4|Death|4|||
145787856|NCT03249792|525730309|FG020|Arms 1, 2, and 4|Death|2|||
145787857|NCT03249792|525730310|FG021|Arms 1, 2, and 4|Death|3|||
145787858|NCT03249792|525730311|FG022|Arms 1, 2, and 4|Death|1|||
145787859|NCT03249792|525730312|FG023|Arms 1, 2, and 4|Death|1|||
145787860|NCT03249792|525730313|FG024|Arms 1, 2, and 4|Death|4|||
145787861|NCT03249792|525730314|FG025|Arms 1, 2, and 4|Death|0|||
145787862|NCT03249792|525730315|FG026|Arms 1, 2, and 4|Death|0|||
145787863|NCT03249792|525730316|FG027|Arms 1, 2, and 4|Death|0|||
145787864|NCT03249792|525730317|FG028|Arms 1, 2, and 4|Death|0|||
145787865|NCT03249792|525730318|FG029|Arms 1, 2, and 4|Death|0|||
145787866|NCT03249792|525730319|FG030|Arms 1, 2, and 4|Death|0|||
145787867|NCT03249792|525730320|FG031|Arms 1, 2, and 4|Death|0|||
145787868|NCT03249792|525730321|FG032|Arms 1, 2, and 4|Death|0|||
145787869|NCT03249792|525730289|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787870|NCT03249792|525730290|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787871|NCT03249792|525730291|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787872|NCT03249792|525730292|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787873|NCT03249792|525730293|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787874|NCT03249792|525730294|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787875|NCT03249792|525730295|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
145787876|NCT03249792|525730296|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787877|NCT03249792|525730297|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
145787878|NCT03249792|525730298|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787879|NCT03249792|525730299|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
145787880|NCT03249792|525730300|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
145787881|NCT03249792|525730301|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
145787882|NCT03249792|525730302|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
145787883|NCT03249792|525730303|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787884|NCT03249792|525730304|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787885|NCT03249792|525730305|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
145787886|NCT03249792|525730306|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787887|NCT03249792|525730307|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787888|NCT03249792|525730308|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787889|NCT03249792|525730309|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787890|NCT03249792|525730310|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787891|NCT03249792|525730311|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787892|NCT03249792|525730312|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
145787893|NCT03249792|525730313|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787894|NCT03249792|525730314|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787895|NCT03249792|525730315|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787896|NCT03249792|525730316|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787897|NCT03249792|525730317|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787898|NCT03249792|525730318|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787899|NCT03249792|525730319|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787900|NCT03249792|525730320|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145787901|NCT03249792|525730321|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
145539518|NCT03166735|524836639|FG003|Overall Study|follow-up not completed as planned|0|||
145787902|NCT03249792|525730289|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
145539519|NCT03166735|524836640|FG004|Overall Study|follow-up not completed as planned|1|||
145539520|NCT03166735|524836636|FG000|Overall Study|Withdrawal by Subject|0|||
145787903|NCT03249792|525730290|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
145787904|NCT03249792|525730291|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
145787905|NCT03249792|525730292|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
145787906|NCT03249792|525730293|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
145787907|NCT03249792|525730294|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
145787908|NCT03249792|525730295|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
145787909|NCT03249792|525730296|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
145787910|NCT03249792|525730297|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
145787911|NCT03249792|525730298|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
145404014|NCT01648764|524336462|FG004|Overall Study|Progressive Disease|0|||
145404015|NCT01648764|524336463|FG005|Overall Study|Progressive Disease|1|||
145609723|NCT01008475|525086430|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
145609724|NCT01008475|525086431|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
145609725|NCT01008475|525086432|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
145609726|NCT01008475|525086433|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
145609727|NCT02668016|525086434|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
145609728|NCT02668016|525086434|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
145609729|NCT02668016|525086434|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
145609730|NCT02668016|525086434|FG000|Month 4|Withdrawal due to severe symptoms|1|||
145609731|NCT02668016|525086434|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
145609732|NCT02668016|525086434|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
145609733|NCT02668016|525086434|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
145609734|NCT02668016|525086434|FG000|Month 6|Withdrawal due to severe symptoms|2|||
145609735|NCT02668016|525086434|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
145609736|NCT02668016|525086434|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
145609737|NCT02668016|525086434|FG000|Month 8|Withdrawal due to severe symptoms|1|||
145609738|NCT02668016|525086434|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
145609739|NCT02668016|525086434|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
145609740|NCT02668016|525086434|FG000|Month 10|Withdrawal due to severe symptoms|1|||
145609741|NCT02668016|525086434|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
145609742|NCT01657266|525086440|FG000|Overall Study|Lost to Follow-up|2|||
145609743|NCT01657266|525086441|FG001|Overall Study|Lost to Follow-up|2|||
145609744|NCT01657266|525086440|FG000|Overall Study|Adverse Event|2|||
145609745|NCT01657266|525086441|FG001|Overall Study|Adverse Event|3|||
145609746|NCT01122381|525086448|FG000|Overall Study|study terminated early|0|||
145609747|NCT01122381|525086449|FG001|Overall Study|study terminated early|1|||
145609748|NCT00736489|525086450|FG000|Period 1|Lost to Follow-up|1|||
145281804|NCT03377556|523882983|FG000|Overall Study|Adverse Event|5|||
145281805|NCT03377556|523882983|FG000|Overall Study|Refusal unrelated to adverse events|1|||
145609749|NCT00736489|525086451|FG001|Period 1|Lost to Follow-up|0|||
145609750|NCT00736489|525086452|FG002|Period 1|Lost to Follow-up|0|||
145609751|NCT00736489|525086453|FG003|Period 1|Lost to Follow-up|0|||
145281806|NCT03377556|523882983|FG000|Overall Study|Progression/relapse|38|||
145281807|NCT03377556|523882983|FG000|Overall Study|Death|3|||
145281808|NCT00472446|523882984|FG000|Overall Study|Protocol Violation|0|||
145281809|NCT00472446|523882985|FG001|Overall Study|Protocol Violation|0|||
145281810|NCT00472446|523882986|FG002|Overall Study|Protocol Violation|0|||
145281811|NCT00472446|523882987|FG003|Overall Study|Protocol Violation|1|||
145281812|NCT00472446|523882984|FG000|Overall Study|Reintervention|0|||
145281813|NCT00472446|523882985|FG001|Overall Study|Reintervention|0|||
145281814|NCT00472446|523882986|FG002|Overall Study|Reintervention|1|||
145281815|NCT00472446|523882987|FG003|Overall Study|Reintervention|1|||
145281816|NCT00472446|523882984|FG000|Overall Study|Questionnaires not returned|5|||
145404016|NCT01648764|524336464|FG006|Overall Study|Progressive Disease|1|||
145404017|NCT01648764|524336465|FG007|Overall Study|Progressive Disease|0|||
145404018|NCT01648764|524336466|FG008|Overall Study|Progressive Disease|0|||
145404019|NCT01648764|524336467|FG009|Overall Study|Progressive Disease|2|||
145404020|NCT01648764|524336468|FG010|Overall Study|Progressive Disease|0|||
145404021|NCT01648764|524336469|FG011|Overall Study|Progressive Disease|1|||
145609752|NCT00736489|525086454|FG004|Period 1|Lost to Follow-up|0|||
145609753|NCT00736489|525086455|FG005|Period 1|Lost to Follow-up|0|||
145609754|NCT00736489|525086450|FG000|Period 1|Withdrawal by Subject|0|||
145609755|NCT00736489|525086451|FG001|Period 1|Withdrawal by Subject|0|||
145609756|NCT00736489|525086452|FG002|Period 1|Withdrawal by Subject|0|||
145787912|NCT03249792|525730299|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
145787913|NCT03249792|525730300|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
145787914|NCT03249792|525730301|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
145787915|NCT03249792|525730302|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
145787916|NCT03249792|525730303|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
145787917|NCT03249792|525730304|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
145787918|NCT03249792|525730305|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
145787919|NCT03249792|525730306|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
145787920|NCT03249792|525730307|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
145787921|NCT03249792|525730308|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
145787922|NCT03249792|525730309|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
145787923|NCT03249792|525730310|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
145787924|NCT03249792|525730311|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
145787925|NCT03249792|525730312|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
145787926|NCT03249792|525730313|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
145787927|NCT03249792|525730314|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
145787928|NCT03249792|525730315|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
145787929|NCT03249792|525730316|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
145787930|NCT03249792|525730317|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
145787931|NCT03249792|525730318|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
145787932|NCT03249792|525730319|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
145787933|NCT03249792|525730320|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
145787934|NCT03249792|525730321|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
145787935|NCT03249792|525730289|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787936|NCT03249792|525730290|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787937|NCT03249792|525730291|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787938|NCT03249792|525730292|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787939|NCT03249792|525730293|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787940|NCT03249792|525730294|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787941|NCT03249792|525730295|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787942|NCT03249792|525730296|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787943|NCT03249792|525730297|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
145787944|NCT03249792|525730298|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787945|NCT03249792|525730299|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787946|NCT03249792|525730300|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787947|NCT03249792|525730301|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787948|NCT03249792|525730302|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787949|NCT03249792|525730303|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787950|NCT03249792|525730304|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787951|NCT03249792|525730305|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
145787952|NCT03249792|525730306|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
145787953|NCT03249792|525730307|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787954|NCT03249792|525730308|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
145787955|NCT03249792|525730309|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787956|NCT03249792|525730310|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787957|NCT03249792|525730311|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787958|NCT03249792|525730312|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787959|NCT03249792|525730313|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787960|NCT03249792|525730314|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787961|NCT03249792|525730315|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787962|NCT03249792|525730316|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787963|NCT03249792|525730317|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787964|NCT03249792|525730318|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787965|NCT03249792|525730319|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787966|NCT03249792|525730320|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787967|NCT03249792|525730321|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
145787968|NCT03249792|525730289|FG000|Switch Over Period|Withdrawal by Subject|0|||
145787969|NCT03249792|525730290|FG001|Switch Over Period|Withdrawal by Subject|0|||
145787970|NCT03249792|525730291|FG002|Switch Over Period|Withdrawal by Subject|0|||
145787971|NCT03249792|525730292|FG003|Switch Over Period|Withdrawal by Subject|0|||
145787972|NCT03249792|525730293|FG004|Switch Over Period|Withdrawal by Subject|0|||
145787973|NCT03249792|525730294|FG005|Switch Over Period|Withdrawal by Subject|0|||
145787974|NCT03249792|525730295|FG006|Switch Over Period|Withdrawal by Subject|0|||
145787975|NCT03249792|525730296|FG007|Switch Over Period|Withdrawal by Subject|0|||
145539521|NCT03166735|524836637|FG001|Overall Study|Withdrawal by Subject|0|||
145539522|NCT03166735|524836638|FG002|Overall Study|Withdrawal by Subject|1|||
145539523|NCT03166735|524836639|FG003|Overall Study|Withdrawal by Subject|1|||
145539524|NCT03166735|524836640|FG004|Overall Study|Withdrawal by Subject|2|||
145539525|NCT03166735|524836636|FG000|Overall Study|Lost to Follow-up|0|||
145539526|NCT03166735|524836637|FG001|Overall Study|Lost to Follow-up|2|||
145787976|NCT03249792|525730297|FG008|Switch Over Period|Withdrawal by Subject|0|||
145281817|NCT00472446|523882985|FG001|Overall Study|Questionnaires not returned|6|||
145404022|NCT01648764|524336470|FG012|Overall Study|Progressive Disease|2|||
145539527|NCT03166735|524836638|FG002|Overall Study|Lost to Follow-up|1|||
145539528|NCT03166735|524836639|FG003|Overall Study|Lost to Follow-up|0|||
145539529|NCT03166735|524836640|FG004|Overall Study|Lost to Follow-up|1|||
145539530|NCT01945281|524836642|FG000|Overall Study|Adverse Event|1|||
145539531|NCT01945281|524836643|FG001|Overall Study|Adverse Event|0|||
145539532|NCT01945281|524836642|FG000|Overall Study|Death|3|||
145609757|NCT00736489|525086453|FG003|Period 1|Withdrawal by Subject|0|||
145609758|NCT00736489|525086454|FG004|Period 1|Withdrawal by Subject|0|||
145787977|NCT03249792|525730298|FG009|Switch Over Period|Withdrawal by Subject|0|||
145787978|NCT03249792|525730299|FG010|Switch Over Period|Withdrawal by Subject|0|||
145787979|NCT03249792|525730300|FG011|Switch Over Period|Withdrawal by Subject|0|||
145787980|NCT03249792|525730301|FG012|Switch Over Period|Withdrawal by Subject|0|||
145787981|NCT03249792|525730302|FG013|Switch Over Period|Withdrawal by Subject|0|||
145787982|NCT03249792|525730303|FG014|Switch Over Period|Withdrawal by Subject|0|||
145787983|NCT03249792|525730304|FG015|Switch Over Period|Withdrawal by Subject|0|||
145787984|NCT03249792|525730305|FG016|Switch Over Period|Withdrawal by Subject|0|||
145787985|NCT03249792|525730306|FG017|Switch Over Period|Withdrawal by Subject|0|||
145787986|NCT03249792|525730307|FG018|Switch Over Period|Withdrawal by Subject|0|||
145787987|NCT03249792|525730308|FG019|Switch Over Period|Withdrawal by Subject|0|||
145787988|NCT03249792|525730309|FG020|Switch Over Period|Withdrawal by Subject|0|||
145787989|NCT03249792|525730310|FG021|Switch Over Period|Withdrawal by Subject|0|||
145787990|NCT03249792|525730311|FG022|Switch Over Period|Withdrawal by Subject|0|||
145539533|NCT01945281|524836643|FG001|Overall Study|Death|3|||
145539534|NCT01945281|524836642|FG000|Overall Study|Physician Decision|1|||
145787991|NCT03249792|525730312|FG023|Switch Over Period|Withdrawal by Subject|0|||
145787992|NCT03249792|525730313|FG024|Switch Over Period|Withdrawal by Subject|0|||
145787993|NCT03249792|525730314|FG025|Switch Over Period|Withdrawal by Subject|0|||
145787994|NCT03249792|525730315|FG026|Switch Over Period|Withdrawal by Subject|0|||
145787995|NCT03249792|525730316|FG027|Switch Over Period|Withdrawal by Subject|0|||
145787996|NCT03249792|525730317|FG028|Switch Over Period|Withdrawal by Subject|0|||
145787997|NCT03249792|525730318|FG029|Switch Over Period|Withdrawal by Subject|0|||
145787998|NCT03249792|525730319|FG030|Switch Over Period|Withdrawal by Subject|0|||
145787999|NCT03249792|525730320|FG031|Switch Over Period|Withdrawal by Subject|1|||
145788000|NCT03249792|525730321|FG032|Switch Over Period|Withdrawal by Subject|0|||
145788001|NCT03249792|525730289|FG000|Switch Over Period|Progressive Disease|0|||
145788002|NCT03249792|525730290|FG001|Switch Over Period|Progressive Disease|0|||
145539535|NCT01945281|524836643|FG001|Overall Study|Physician Decision|1|||
145539536|NCT01945281|524836642|FG000|Overall Study|Technical Problems|1|||
145539537|NCT01945281|524836643|FG001|Overall Study|Technical Problems|0|||
145539538|NCT00934089|524836644|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
145539539|NCT00934089|524836645|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
145539540|NCT00934089|524836644|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
145539541|NCT00934089|524836645|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
145539542|NCT00003473|524836646|FG000|Overall Study|Three patients were not evaluable.|3|||
145539543|NCT04401423|524836647|FG000|Overall Study|Withdrawal by Subject|3|||
145539544|NCT04401423|524836648|FG001|Overall Study|Withdrawal by Subject|1|||
145539545|NCT04401423|524836647|FG000|Overall Study|Physician Decision|2|||
145539546|NCT04401423|524836648|FG001|Overall Study|Physician Decision|1|||
145539547|NCT00799383|524836651|FG000|Overall Study|Protocol Violation|1|||
145539548|NCT00799383|524836652|FG001|Overall Study|Protocol Violation|1|||
145788003|NCT03249792|525730291|FG002|Switch Over Period|Progressive Disease|0|||
145788004|NCT03249792|525730292|FG003|Switch Over Period|Progressive Disease|0|||
145788005|NCT03249792|525730293|FG004|Switch Over Period|Progressive Disease|0|||
145788006|NCT03249792|525730294|FG005|Switch Over Period|Progressive Disease|0|||
145788007|NCT03249792|525730295|FG006|Switch Over Period|Progressive Disease|0|||
145539549|NCT00799383|524836651|FG000|Overall Study|Adverse Event|0|||
145539550|NCT00799383|524836652|FG001|Overall Study|Adverse Event|1|||
145539551|NCT00799383|524836651|FG000|Overall Study|Lost to Follow-up|1|||
145539552|NCT00799383|524836652|FG001|Overall Study|Lost to Follow-up|2|||
145539553|NCT00799383|524836651|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
145539554|NCT00799383|524836652|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
145539555|NCT00799383|524836651|FG000|Overall Study|Withdrawal by Subject|0|||
145539556|NCT00799383|524836652|FG001|Overall Study|Withdrawal by Subject|1|||
145539557|NCT00926328|524836653|FG000|Overall Study|Lost to Follow-up|12|||
145539558|NCT00926328|524836654|FG001|Overall Study|Lost to Follow-up|14|||
145539559|NCT00726986|524836655|FG000|Induction Phase|Adverse Event|4|||
145539560|NCT00726986|524836655|FG000|Induction Phase|Withdrawal by Subject|2|||
145539561|NCT00726986|524836655|FG000|Induction Phase|Death|2|||
145539562|NCT00726986|524836655|FG000|Induction Phase|Lack of Efficacy|5|||
145539563|NCT00726986|524836655|FG000|Induction Phase|Secondary Disease|2|||
145539564|NCT00726986|524836655|FG000|Maintenance Phase|Adverse Event|1|||
145539565|NCT00726986|524836655|FG000|Maintenance Phase|Lack of Efficacy|2|||
145539566|NCT01434667|524836661|FG000|Overall Study|Lost to Follow-up|5|||
145539567|NCT01434667|524836662|FG001|Overall Study|Lost to Follow-up|10|||
145539568|NCT02165215|524836663|FG000|Induction Phase|Adverse Event|1|||
145539569|NCT02165215|524836664|FG001|Induction Phase|Adverse Event|0|||
145539570|NCT02165215|524836665|FG002|Induction Phase|Adverse Event|0|||
145539571|NCT02165215|524836663|FG000|Induction Phase|Withdrawal by Subject|10|||
145539572|NCT02165215|524836664|FG001|Induction Phase|Withdrawal by Subject|0|||
145539573|NCT02165215|524836665|FG002|Induction Phase|Withdrawal by Subject|0|||
145788008|NCT03249792|525730296|FG007|Switch Over Period|Progressive Disease|0|||
145788009|NCT03249792|525730297|FG008|Switch Over Period|Progressive Disease|0|||
145788010|NCT03249792|525730298|FG009|Switch Over Period|Progressive Disease|0|||
145539574|NCT02165215|524836663|FG000|Induction Phase|Protocol Violation|1|||
145539575|NCT02165215|524836664|FG001|Induction Phase|Protocol Violation|0|||
145539576|NCT02165215|524836665|FG002|Induction Phase|Protocol Violation|0|||
145539577|NCT02165215|524836663|FG000|Induction Phase|Physician Decision|1|||
145539578|NCT02165215|524836664|FG001|Induction Phase|Physician Decision|0|||
145539579|NCT02165215|524836665|FG002|Induction Phase|Physician Decision|0|||
145539580|NCT02165215|524836663|FG000|Induction Phase|Lack of Efficacy|2|||
145539581|NCT02165215|524836664|FG001|Induction Phase|Lack of Efficacy|0|||
145539582|NCT02165215|524836665|FG002|Induction Phase|Lack of Efficacy|0|||
145539583|NCT02165215|524836663|FG000|Induction Phase|Non-Compliance|2|||
145539584|NCT02165215|524836664|FG001|Induction Phase|Non-Compliance|0|||
145539585|NCT02165215|524836665|FG002|Induction Phase|Non-Compliance|0|||
145788011|NCT03249792|525730299|FG010|Switch Over Period|Progressive Disease|0|||
145788012|NCT03249792|525730300|FG011|Switch Over Period|Progressive Disease|0|||
145788013|NCT03249792|525730301|FG012|Switch Over Period|Progressive Disease|0|||
145788014|NCT03249792|525730302|FG013|Switch Over Period|Progressive Disease|0|||
145609759|NCT00736489|525086455|FG005|Period 1|Withdrawal by Subject|1|||
145609760|NCT02395133|525086460|FG000|Overall Study|Adverse Event|4|||
145788015|NCT03249792|525730303|FG014|Switch Over Period|Progressive Disease|0|||
145788016|NCT03249792|525730304|FG015|Switch Over Period|Progressive Disease|0|||
145788017|NCT03249792|525730305|FG016|Switch Over Period|Progressive Disease|0|||
145788018|NCT03249792|525730306|FG017|Switch Over Period|Progressive Disease|0|||
145788019|NCT03249792|525730307|FG018|Switch Over Period|Progressive Disease|0|||
145788020|NCT03249792|525730308|FG019|Switch Over Period|Progressive Disease|0|||
145788021|NCT03249792|525730309|FG020|Switch Over Period|Progressive Disease|0|||
145788022|NCT03249792|525730310|FG021|Switch Over Period|Progressive Disease|0|||
145788023|NCT03249792|525730311|FG022|Switch Over Period|Progressive Disease|0|||
145788024|NCT03249792|525730312|FG023|Switch Over Period|Progressive Disease|0|||
145788025|NCT03249792|525730313|FG024|Switch Over Period|Progressive Disease|0|||
145788026|NCT03249792|525730314|FG025|Switch Over Period|Progressive Disease|0|||
145788027|NCT03249792|525730315|FG026|Switch Over Period|Progressive Disease|1|||
145788028|NCT03249792|525730316|FG027|Switch Over Period|Progressive Disease|0|||
145788029|NCT03249792|525730317|FG028|Switch Over Period|Progressive Disease|1|||
145788030|NCT03249792|525730318|FG029|Switch Over Period|Progressive Disease|2|||
145788031|NCT03249792|525730319|FG030|Switch Over Period|Progressive Disease|1|||
145788032|NCT03249792|525730320|FG031|Switch Over Period|Progressive Disease|0|||
145788033|NCT03249792|525730321|FG032|Switch Over Period|Progressive Disease|1|||
145788034|NCT03249792|525730289|FG000|Switch Over Period|Adverse Event|0|||
145788035|NCT03249792|525730290|FG001|Switch Over Period|Adverse Event|0|||
145788036|NCT03249792|525730291|FG002|Switch Over Period|Adverse Event|0|||
145788037|NCT03249792|525730292|FG003|Switch Over Period|Adverse Event|0|||
145788038|NCT03249792|525730293|FG004|Switch Over Period|Adverse Event|0|||
145788039|NCT03249792|525730294|FG005|Switch Over Period|Adverse Event|0|||
145788040|NCT03249792|525730295|FG006|Switch Over Period|Adverse Event|0|||
145788041|NCT03249792|525730296|FG007|Switch Over Period|Adverse Event|0|||
145788042|NCT03249792|525730297|FG008|Switch Over Period|Adverse Event|0|||
145788043|NCT03249792|525730298|FG009|Switch Over Period|Adverse Event|0|||
145788044|NCT03249792|525730299|FG010|Switch Over Period|Adverse Event|0|||
145788045|NCT03249792|525730300|FG011|Switch Over Period|Adverse Event|0|||
145788046|NCT03249792|525730301|FG012|Switch Over Period|Adverse Event|0|||
145788047|NCT03249792|525730302|FG013|Switch Over Period|Adverse Event|0|||
145788048|NCT03249792|525730303|FG014|Switch Over Period|Adverse Event|0|||
145788049|NCT03249792|525730304|FG015|Switch Over Period|Adverse Event|0|||
145788050|NCT03249792|525730305|FG016|Switch Over Period|Adverse Event|0|||
145788051|NCT03249792|525730306|FG017|Switch Over Period|Adverse Event|0|||
145788052|NCT03249792|525730307|FG018|Switch Over Period|Adverse Event|0|||
145788053|NCT03249792|525730308|FG019|Switch Over Period|Adverse Event|0|||
145788054|NCT03249792|525730309|FG020|Switch Over Period|Adverse Event|0|||
145788055|NCT03249792|525730310|FG021|Switch Over Period|Adverse Event|0|||
145609761|NCT02395133|525086461|FG001|Overall Study|Adverse Event|1|||
145609762|NCT02395133|525086462|FG002|Overall Study|Adverse Event|3|||
145609763|NCT02395133|525086463|FG003|Overall Study|Adverse Event|0|||
145609764|NCT02395133|525086460|FG000|Overall Study|Lack of Efficacy|1|||
145788056|NCT03249792|525730311|FG022|Switch Over Period|Adverse Event|0|||
145788057|NCT03249792|525730312|FG023|Switch Over Period|Adverse Event|0|||
145788058|NCT03249792|525730313|FG024|Switch Over Period|Adverse Event|0|||
145788059|NCT03249792|525730314|FG025|Switch Over Period|Adverse Event|1|||
145788060|NCT03249792|525730315|FG026|Switch Over Period|Adverse Event|0|||
145788061|NCT03249792|525730316|FG027|Switch Over Period|Adverse Event|1|||
145788062|NCT03249792|525730317|FG028|Switch Over Period|Adverse Event|0|||
145788063|NCT03249792|525730318|FG029|Switch Over Period|Adverse Event|0|||
145788064|NCT03249792|525730319|FG030|Switch Over Period|Adverse Event|0|||
145788065|NCT03249792|525730320|FG031|Switch Over Period|Adverse Event|0|||
145788066|NCT03249792|525730321|FG032|Switch Over Period|Adverse Event|0|||
145788067|NCT01087528|525730326|FG000|Overall Study|Withdrawal by Subject|1|||
145788068|NCT01087528|525730326|FG000|Overall Study|Incomplete CE procedure|6|||
145788069|NCT03609359|525730331|FG000|Overall Study|Progression of primary disease (PD)|25|||
145609765|NCT02395133|525086461|FG001|Overall Study|Lack of Efficacy|0|||
145788070|NCT03609359|525730331|FG000|Overall Study|Patient's refusal|1|||
145788071|NCT03609359|525730331|FG000|Overall Study|Physician Decision|1|||
145788072|NCT03609359|525730331|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
145788073|NCT01912729|525730333|FG000|Overall Study|Withdrawal by Subject|0|||
145788074|NCT01912729|525730334|FG001|Overall Study|Withdrawal by Subject|1|||
145788075|NCT04285346|525730342|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
145788076|NCT04285346|525730343|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
145788077|NCT04285346|525730342|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
145788078|NCT04285346|525730343|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145788079|NCT04285346|525730342|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
145539586|NCT02165215|524836663|FG000|Induction Phase|Lost to Follow-up|6|||
145539587|NCT02165215|524836664|FG001|Induction Phase|Lost to Follow-up|0|||
145539588|NCT02165215|524836665|FG002|Induction Phase|Lost to Follow-up|0|||
145539589|NCT02165215|524836663|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145539590|NCT02165215|524836664|FG001|Maintenance Phase|Withdrawal by Subject|7|||
145539591|NCT02165215|524836665|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145539592|NCT02165215|524836663|FG000|Maintenance Phase|Multiple reasons|0|||
145539593|NCT02165215|524836664|FG001|Maintenance Phase|Multiple reasons|2|||
145539594|NCT02165215|524836665|FG002|Maintenance Phase|Multiple reasons|1|||
145539595|NCT02165215|524836663|FG000|Maintenance Phase|Lost to Follow-up|0|||
145539596|NCT02165215|524836664|FG001|Maintenance Phase|Lost to Follow-up|2|||
145539597|NCT02165215|524836665|FG002|Maintenance Phase|Lost to Follow-up|0|||
145539598|NCT02165215|524836663|FG000|Maintenance Phase|Adverse Event|0|||
145539599|NCT02165215|524836664|FG001|Maintenance Phase|Adverse Event|1|||
145539600|NCT02165215|524836665|FG002|Maintenance Phase|Adverse Event|1|||
145539601|NCT05074667|524836666|FG000|Overall Study|Death|1|||
145539602|NCT05074667|524836666|FG000|Overall Study|Withdrawal by Subject|4|||
145539603|NCT05074667|524836666|FG000|Overall Study|Lost to Follow-up|10|||
145539604|NCT02279420|524836667|FG000|Overall Study|Lost to Follow-up|23|||
145539605|NCT03535844|524836670|FG000|Overall Study|Withdrawal by Subject|0|||
145539606|NCT03535844|524836671|FG001|Overall Study|Withdrawal by Subject|1|||
145539607|NCT00297830|524836674|FG000|6 Month Visit|Death|1|||
145539608|NCT00297830|524836675|FG001|6 Month Visit|Death|0|||
145539609|NCT00297830|524836676|FG002|6 Month Visit|Death|2|||
145539610|NCT00297830|524836674|FG000|6 Month Visit|Withdrawal by Subject|2|||
145539611|NCT00297830|524836675|FG001|6 Month Visit|Withdrawal by Subject|1|||
145539612|NCT00297830|524836676|FG002|6 Month Visit|Withdrawal by Subject|1|||
145539613|NCT00297830|524836674|FG000|6 Month Visit|Adverse Event|0|||
145539614|NCT00297830|524836675|FG001|6 Month Visit|Adverse Event|1|||
145539615|NCT00297830|524836676|FG002|6 Month Visit|Adverse Event|0|||
145539616|NCT00297830|524836674|FG000|12 Month Visit|Lost to Follow-up|1|||
145539617|NCT00297830|524836675|FG001|12 Month Visit|Lost to Follow-up|0|||
145539618|NCT00297830|524836676|FG002|12 Month Visit|Lost to Follow-up|0|||
145281818|NCT00472446|523882986|FG002|Overall Study|Questionnaires not returned|6|||
145539619|NCT00297830|524836674|FG000|12 Month Visit|Adverse Event|0|||
145539620|NCT00297830|524836675|FG001|12 Month Visit|Adverse Event|3|||
145539621|NCT00297830|524836676|FG002|12 Month Visit|Adverse Event|0|||
145539622|NCT00297830|524836674|FG000|12 Month Visit|Withdrawal by Subject|0|||
145539623|NCT00297830|524836675|FG001|12 Month Visit|Withdrawal by Subject|3|||
145539624|NCT00297830|524836676|FG002|12 Month Visit|Withdrawal by Subject|0|||
145539625|NCT02835820|524836677|FG000|Overall Study|Baseline Screen Failure|0|||
145539626|NCT02835820|524836678|FG001|Overall Study|Baseline Screen Failure|3|||
145539627|NCT01867424|524836682|FG000|Overall Study|Patient noncompliance|2|||
145539628|NCT01867424|524836683|FG001|Overall Study|Patient noncompliance|1|||
145539629|NCT04613375|524836684|FG000|Overall Study|Death|198|||
145404023|NCT01648764|524336471|FG013|Overall Study|Progressive Disease|1|||
145404024|NCT01648764|524336458|FG000|Overall Study|Adverse Event|0|||
145404025|NCT01648764|524336459|FG001|Overall Study|Adverse Event|0|||
145404026|NCT01648764|524336460|FG002|Overall Study|Adverse Event|0|||
145404027|NCT01648764|524336461|FG003|Overall Study|Adverse Event|0|||
145404028|NCT01648764|524336462|FG004|Overall Study|Adverse Event|0|||
145404029|NCT01648764|524336463|FG005|Overall Study|Adverse Event|1|||
145404030|NCT01648764|524336464|FG006|Overall Study|Adverse Event|0|||
145404031|NCT01648764|524336465|FG007|Overall Study|Adverse Event|0|||
145404032|NCT01648764|524336466|FG008|Overall Study|Adverse Event|0|||
145404033|NCT01648764|524336467|FG009|Overall Study|Adverse Event|1|||
145404034|NCT01648764|524336468|FG010|Overall Study|Adverse Event|0|||
145404035|NCT01648764|524336469|FG011|Overall Study|Adverse Event|3|||
145404036|NCT01648764|524336470|FG012|Overall Study|Adverse Event|1|||
145404037|NCT01648764|524336471|FG013|Overall Study|Adverse Event|1|||
145404038|NCT01648764|524336458|FG000|Overall Study|Death|0|||
145404039|NCT01648764|524336459|FG001|Overall Study|Death|0|||
145404040|NCT01648764|524336460|FG002|Overall Study|Death|0|||
145404041|NCT01648764|524336461|FG003|Overall Study|Death|0|||
145404042|NCT01648764|524336462|FG004|Overall Study|Death|0|||
145404043|NCT01648764|524336463|FG005|Overall Study|Death|0|||
145404044|NCT01648764|524336464|FG006|Overall Study|Death|1|||
145404045|NCT01648764|524336465|FG007|Overall Study|Death|0|||
145404046|NCT01648764|524336466|FG008|Overall Study|Death|0|||
145404047|NCT01648764|524336467|FG009|Overall Study|Death|0|||
145404048|NCT01648764|524336468|FG010|Overall Study|Death|0|||
145404049|NCT01648764|524336469|FG011|Overall Study|Death|0|||
145404050|NCT01648764|524336470|FG012|Overall Study|Death|0|||
145404051|NCT01648764|524336471|FG013|Overall Study|Death|1|||
145404052|NCT01648764|524336458|FG000|Overall Study|Withdrawal by Subject|0|||
145404053|NCT01648764|524336459|FG001|Overall Study|Withdrawal by Subject|0|||
145404054|NCT01648764|524336460|FG002|Overall Study|Withdrawal by Subject|0|||
145404055|NCT01648764|524336461|FG003|Overall Study|Withdrawal by Subject|0|||
145404056|NCT01648764|524336462|FG004|Overall Study|Withdrawal by Subject|0|||
145404057|NCT01648764|524336463|FG005|Overall Study|Withdrawal by Subject|0|||
145539630|NCT04613375|524836684|FG000|Overall Study|Withdrawal by Subject|3|||
145539631|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
145404058|NCT01648764|524336464|FG006|Overall Study|Withdrawal by Subject|2|||
145404059|NCT01648764|524336465|FG007|Overall Study|Withdrawal by Subject|0|||
145404060|NCT01648764|524336466|FG008|Overall Study|Withdrawal by Subject|0|||
145788080|NCT04285346|525730343|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145788081|NCT01975272|525730344|FG000|Overall Study|Excluded after protocol amendment|1|||
145788082|NCT01975272|525730345|FG001|Overall Study|Excluded after protocol amendment|1|||
145788083|NCT01975272|525730346|FG002|Overall Study|Excluded after protocol amendment|2|||
145788084|NCT00850460|525730347|FG000|Overall Study|Lost to Follow-up|4|||
145788085|NCT00850460|525730348|FG001|Overall Study|Lost to Follow-up|4|||
145788086|NCT05372575|525730349|FG000|Overall Study|Protocol Violation|7|||
145788087|NCT05372575|525730350|FG001|Overall Study|Protocol Violation|16|||
145788088|NCT03196297|525730351|FG000|Main Period|Withdrawal by Subject|4|||
145788089|NCT03196297|525730351|FG000|Extension Period|Withdrawal by Subject|1|||
145788090|NCT03196297|525730351|FG000|Extension Period|Lack of Efficacy|2|||
145788091|NCT01465178|525730357|FG000|Overall Study|Withdrawal by Subject|1|||
145788092|NCT01465178|525730358|FG001|Overall Study|Withdrawal by Subject|0|||
145788093|NCT04937816|525730362|FG000|Overall Study|Study drug stopped, reason missing|5|||
145788094|NCT04937816|525730363|FG001|Overall Study|Study drug stopped, reason missing|3|||
145788095|NCT04937816|525730364|FG002|Overall Study|Study drug stopped, reason missing|4|||
145404061|NCT01648764|524336467|FG009|Overall Study|Withdrawal by Subject|0|||
145404062|NCT01648764|524336468|FG010|Overall Study|Withdrawal by Subject|0|||
145404063|NCT01648764|524336469|FG011|Overall Study|Withdrawal by Subject|0|||
145539632|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
145539633|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
145539634|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
145539635|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145539636|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145539637|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145788096|NCT04937816|525730365|FG003|Overall Study|Study drug stopped, reason missing|6|||
145404064|NCT01648764|524336470|FG012|Overall Study|Withdrawal by Subject|1|||
145404065|NCT01648764|524336471|FG013|Overall Study|Withdrawal by Subject|0|||
145539638|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145404066|NCT01648764|524336458|FG000|Overall Study|Investigator Decision|0|||
145788097|NCT04937816|525730366|FG004|Overall Study|Study drug stopped, reason missing|1|||
145404067|NCT01648764|524336459|FG001|Overall Study|Investigator Decision|0|||
145404068|NCT01648764|524336460|FG002|Overall Study|Investigator Decision|0|||
145404069|NCT01648764|524336461|FG003|Overall Study|Investigator Decision|0|||
145404070|NCT01648764|524336462|FG004|Overall Study|Investigator Decision|0|||
145404071|NCT01648764|524336463|FG005|Overall Study|Investigator Decision|0|||
145539639|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145788098|NCT04937816|525730367|FG005|Overall Study|Study drug stopped, reason missing|0|||
145788099|NCT04937816|525730368|FG006|Overall Study|Study drug stopped, reason missing|0|||
145788100|NCT04937816|525730362|FG000|Overall Study|Other than stated below|173|||
145788101|NCT04937816|525730363|FG001|Overall Study|Other than stated below|143|||
145788102|NCT04937816|525730364|FG002|Overall Study|Other than stated below|125|||
145788103|NCT04937816|525730365|FG003|Overall Study|Other than stated below|44|||
145788104|NCT04937816|525730366|FG004|Overall Study|Other than stated below|45|||
145788105|NCT04937816|525730367|FG005|Overall Study|Other than stated below|28|||
145788106|NCT04937816|525730368|FG006|Overall Study|Other than stated below|31|||
145788107|NCT04937816|525730362|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
145788108|NCT04937816|525730363|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
145788109|NCT04937816|525730364|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
145788110|NCT04937816|525730365|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
145788111|NCT04937816|525730366|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
145788112|NCT04937816|525730367|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
145788113|NCT04937816|525730368|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
145788114|NCT04937816|525730362|FG000|Overall Study|Lost to Follow-up|15|||
145788115|NCT04937816|525730363|FG001|Overall Study|Lost to Follow-up|9|||
145788116|NCT04937816|525730364|FG002|Overall Study|Lost to Follow-up|6|||
145788117|NCT04937816|525730365|FG003|Overall Study|Lost to Follow-up|6|||
145788118|NCT04937816|525730366|FG004|Overall Study|Lost to Follow-up|16|||
145788119|NCT04937816|525730367|FG005|Overall Study|Lost to Follow-up|11|||
145788120|NCT04937816|525730368|FG006|Overall Study|Lost to Follow-up|17|||
145788121|NCT04937816|525730362|FG000|Overall Study|Protocol Violation|15|||
145788122|NCT04937816|525730363|FG001|Overall Study|Protocol Violation|15|||
145788123|NCT04937816|525730364|FG002|Overall Study|Protocol Violation|12|||
145788124|NCT04937816|525730365|FG003|Overall Study|Protocol Violation|30|||
145788125|NCT04937816|525730366|FG004|Overall Study|Protocol Violation|24|||
145788126|NCT04937816|525730367|FG005|Overall Study|Protocol Violation|5|||
145788127|NCT04937816|525730368|FG006|Overall Study|Protocol Violation|5|||
145788128|NCT04937816|525730362|FG000|Overall Study|Adverse Event|303|||
145788129|NCT04937816|525730363|FG001|Overall Study|Adverse Event|267|||
145539640|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145539641|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
145539642|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
145788130|NCT04937816|525730364|FG002|Overall Study|Adverse Event|273|||
145788131|NCT04937816|525730365|FG003|Overall Study|Adverse Event|553|||
145788132|NCT04937816|525730366|FG004|Overall Study|Adverse Event|575|||
145788133|NCT04937816|525730367|FG005|Overall Study|Adverse Event|343|||
145788134|NCT04937816|525730368|FG006|Overall Study|Adverse Event|337|||
145788135|NCT04937816|525730362|FG000|Overall Study|Not treated|4|||
145788136|NCT04937816|525730363|FG001|Overall Study|Not treated|2|||
145788137|NCT04937816|525730364|FG002|Overall Study|Not treated|2|||
145788138|NCT04937816|525730365|FG003|Overall Study|Not treated|2|||
145788139|NCT04937816|525730366|FG004|Overall Study|Not treated|1|||
145788140|NCT04937816|525730367|FG005|Overall Study|Not treated|4|||
145788141|NCT04937816|525730368|FG006|Overall Study|Not treated|0|||
145788142|NCT00436215|525730369|FG000|Overall Study|Refused further treatment|3|||
145788143|NCT00436215|525730369|FG000|Overall Study|Small bowel obstruction|1|||
145788144|NCT00309777|525730370|FG000|Overall Study|Adverse Event|13|||
145788145|NCT00309777|525730371|FG001|Overall Study|Adverse Event|2|||
145788146|NCT00309777|525730372|FG002|Overall Study|Adverse Event|8|||
145788147|NCT00309777|525730373|FG003|Overall Study|Adverse Event|1|||
145788148|NCT00309777|525730370|FG000|Overall Study|Protocol Violation|4|||
145788149|NCT00309777|525730371|FG001|Overall Study|Protocol Violation|1|||
145788150|NCT00309777|525730372|FG002|Overall Study|Protocol Violation|3|||
145788151|NCT00309777|525730373|FG003|Overall Study|Protocol Violation|1|||
145788152|NCT00309777|525730370|FG000|Overall Study|Withdrawal by Subject|6|||
145788153|NCT00309777|525730371|FG001|Overall Study|Withdrawal by Subject|5|||
145788154|NCT00309777|525730372|FG002|Overall Study|Withdrawal by Subject|7|||
145788155|NCT00309777|525730373|FG003|Overall Study|Withdrawal by Subject|2|||
145788156|NCT00309777|525730370|FG000|Overall Study|Lost to Follow-up|0|||
145788157|NCT00309777|525730371|FG001|Overall Study|Lost to Follow-up|0|||
145788158|NCT00309777|525730372|FG002|Overall Study|Lost to Follow-up|1|||
145788159|NCT00309777|525730373|FG003|Overall Study|Lost to Follow-up|0|||
145788160|NCT00309777|525730370|FG000|Overall Study|Death|0|||
145539643|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
145539644|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
145539645|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
145539646|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539647|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539648|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539649|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539650|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539651|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539652|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
145539653|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
145539654|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
145539655|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
145539656|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
145539657|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539658|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539659|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539660|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539661|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539662|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539663|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
145539664|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539665|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539666|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539667|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
145539668|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539669|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539670|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539671|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539672|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539673|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539674|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
145539675|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
145539676|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
145539677|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
145539678|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
145539679|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539680|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539681|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539682|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539683|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145788161|NCT00309777|525730371|FG001|Overall Study|Death|1|||
145788162|NCT00309777|525730372|FG002|Overall Study|Death|0|||
145788163|NCT00309777|525730373|FG003|Overall Study|Death|0|||
145788164|NCT05513053|525730374|FG000|Overall Study|Lost to Follow-up|9|||
145788165|NCT05513053|525730375|FG001|Overall Study|Lost to Follow-up|11|||
145788166|NCT05513053|525730374|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145788167|NCT05513053|525730375|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145788168|NCT05513053|525730374|FG000|Overall Study|Withdrawal by Subject|2|||
145788169|NCT05513053|525730375|FG001|Overall Study|Withdrawal by Subject|9|||
145788170|NCT05513053|525730374|FG000|Overall Study|Protocol Violation|6|||
145539684|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539685|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
145539686|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
145539687|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
145539688|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
145788171|NCT05513053|525730375|FG001|Overall Study|Protocol Violation|3|||
145788172|NCT05513053|525730374|FG000|Overall Study|Adverse Event|0|||
145788173|NCT05513053|525730375|FG001|Overall Study|Adverse Event|2|||
145788174|NCT03050359|525731689|FG000|Overall Study|Randomized But Not Treated|2|||
145788175|NCT03050359|525731690|FG001|Overall Study|Randomized But Not Treated|0|||
145788176|NCT03050359|525731689|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
145788177|NCT03050359|525731690|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
145788178|NCT03050359|525731689|FG000|Overall Study|Significant Protocol Deviation|2|||
145788179|NCT03050359|525731690|FG001|Overall Study|Significant Protocol Deviation|3|||
145788180|NCT03050359|525731689|FG000|Overall Study|Lost to Follow-up|2|||
145788181|NCT03050359|525731690|FG001|Overall Study|Lost to Follow-up|1|||
145788182|NCT03050359|525731689|FG000|Overall Study|Voluntary Withdrawal|4|||
145788183|NCT03050359|525731690|FG001|Overall Study|Voluntary Withdrawal|6|||
145788184|NCT03050359|525731689|FG000|Overall Study|Pregnancy|1|||
145788185|NCT03050359|525731690|FG001|Overall Study|Pregnancy|0|||
145788186|NCT03050359|525731689|FG000|Overall Study|Reason Not Specified|1|||
145788187|NCT03050359|525731690|FG001|Overall Study|Reason Not Specified|0|||
145788188|NCT02614287|525731693|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
145788189|NCT02614287|525731694|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
145788190|NCT02614287|525731693|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
145788191|NCT02614287|525731694|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
145788192|NCT02614287|525731693|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
145788193|NCT02614287|525731694|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
145788194|NCT02614287|525731693|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
145788195|NCT02614287|525731694|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
145788196|NCT02614287|525731693|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
145788197|NCT02614287|525731694|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
145788198|NCT02614287|525731693|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
145788199|NCT02614287|525731694|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
145788200|NCT02614287|525731693|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
145788201|NCT02614287|525731694|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
145788202|NCT02614287|525731693|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
145788203|NCT02614287|525731694|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
145788204|NCT01328249|525731696|FG000|Overall Study|Adverse Event|3|||
145788205|NCT01328249|525731697|FG001|Overall Study|Adverse Event|0|||
145788206|NCT01328249|525731696|FG000|Overall Study|Disease progression|1|||
145788207|NCT01328249|525731697|FG001|Overall Study|Disease progression|0|||
145788208|NCT01328249|525731696|FG000|Overall Study|Withdrawal by Subject|1|||
145788209|NCT01328249|525731697|FG001|Overall Study|Withdrawal by Subject|1|||
145788210|NCT01328249|525731696|FG000|Overall Study|Moved before end of treatment visit|1|||
145788211|NCT01328249|525731697|FG001|Overall Study|Moved before end of treatment visit|0|||
145788212|NCT01328249|525731696|FG000|Overall Study|Subject choice|1|||
145788213|NCT01328249|525731697|FG001|Overall Study|Subject choice|1|||
145788214|NCT01328249|525731696|FG000|Overall Study|Protocol Violation|0|||
145788215|NCT01328249|525731697|FG001|Overall Study|Protocol Violation|1|||
145788216|NCT03439748|525731700|FG000|Overall Study|Withdrawal by Subject|11|||
145788217|NCT03439748|525731701|FG001|Overall Study|Withdrawal by Subject|17|||
145788218|NCT03298412|525731702|FG000|Run-in Period|Other, Not Specified|1|||
145788219|NCT03298412|525731702|FG000|Run-in Period|Disease Progression|1|||
145788220|NCT03298412|525731702|FG000|Run-in Period|Ineligibility Determined|1|||
145788221|NCT03298412|525731702|FG000|Run-in Period|Decision by Sponsor|6|||
145788222|NCT01894477|525731703|FG000|Overall Study|Protocol Violation|0|||
145539689|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
145539690|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145539691|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145609766|NCT02395133|525086462|FG002|Overall Study|Lack of Efficacy|1|||
145788223|NCT01894477|525731704|FG001|Overall Study|Protocol Violation|1|||
145788224|NCT01894477|525731703|FG000|Overall Study|protocol changed due SC changed to cord|0|||
145788225|NCT01894477|525731704|FG001|Overall Study|protocol changed due SC changed to cord|1|||
145788226|NCT01028651|525731706|FG000|Overall Study|Death|2|||
145539692|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145788227|NCT01028651|525731706|FG000|Overall Study|Adverse Event|1|||
145788228|NCT01533935|525731707|FG000|Overall Study|Adverse Event|5|||
145788229|NCT01533935|525731708|FG001|Overall Study|Adverse Event|7|||
145788230|NCT01533935|525731709|FG002|Overall Study|Adverse Event|1|||
145788231|NCT01533935|525731710|FG003|Overall Study|Adverse Event|5|||
145788232|NCT01533935|525731711|FG004|Overall Study|Adverse Event|3|||
145788233|NCT01533935|525731707|FG000|Overall Study|Protocol Violation|0|||
145788234|NCT01533935|525731708|FG001|Overall Study|Protocol Violation|2|||
145539693|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145539694|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145539695|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145539696|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
145539697|NCT01847274|524836685|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
145539698|NCT01847274|524836686|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
145539699|NCT01847274|524836687|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
145539700|NCT01847274|524836688|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
145539701|NCT01847274|524836689|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539702|NCT01847274|524836690|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539703|NCT01847274|524836691|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539704|NCT01847274|524836692|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539705|NCT01847274|524836693|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539706|NCT01847274|524836694|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539707|NCT01847274|524836695|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
145539708|NCT01847274|524836685|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539709|NCT01847274|524836686|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145788235|NCT01533935|525731709|FG002|Overall Study|Protocol Violation|0|||
145788236|NCT01533935|525731710|FG003|Overall Study|Protocol Violation|0|||
145788237|NCT01533935|525731711|FG004|Overall Study|Protocol Violation|0|||
145788238|NCT01533935|525731707|FG000|Overall Study|Lost to Follow-up|0|||
145788239|NCT01533935|525731708|FG001|Overall Study|Lost to Follow-up|0|||
145788240|NCT01533935|525731709|FG002|Overall Study|Lost to Follow-up|1|||
145788241|NCT01533935|525731710|FG003|Overall Study|Lost to Follow-up|0|||
145788242|NCT01533935|525731711|FG004|Overall Study|Lost to Follow-up|0|||
145788243|NCT01533935|525731707|FG000|Overall Study|Withdrawal by Subject|0|||
145788244|NCT01533935|525731708|FG001|Overall Study|Withdrawal by Subject|4|||
145788245|NCT01533935|525731709|FG002|Overall Study|Withdrawal by Subject|5|||
145788246|NCT01533935|525731710|FG003|Overall Study|Withdrawal by Subject|2|||
145788247|NCT01533935|525731711|FG004|Overall Study|Withdrawal by Subject|4|||
145788248|NCT01533935|525731707|FG000|Overall Study|Other reason not defined above|1|||
145788249|NCT01533935|525731708|FG001|Overall Study|Other reason not defined above|0|||
145788250|NCT01533935|525731709|FG002|Overall Study|Other reason not defined above|1|||
145788251|NCT01533935|525731710|FG003|Overall Study|Other reason not defined above|0|||
145788252|NCT01533935|525731711|FG004|Overall Study|Other reason not defined above|1|||
145788253|NCT05631548|525731712|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
145788254|NCT05631548|525731713|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
145788255|NCT04075266|525731716|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
145788256|NCT04075266|525731717|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
145788257|NCT04075266|525731716|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
145788258|NCT04075266|525731717|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
145788259|NCT05132569|525731718|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
145788260|NCT05132569|525731719|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
145788261|NCT05132569|525731718|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
145788262|NCT05132569|525731719|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
145788263|NCT05132569|525731718|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
145788264|NCT05132569|525731719|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
145788265|NCT01554956|525731720|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
145788266|NCT01554956|525731721|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
145788267|NCT01554956|525731722|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
145788268|NCT01554956|525731720|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
145788269|NCT01554956|525731721|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
145788270|NCT01554956|525731722|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
145788271|NCT01554956|525731720|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
145788272|NCT01554956|525731721|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
145788273|NCT01554956|525731722|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
145788274|NCT03656926|525731723|FG000|Overall Study|Adverse Event|5|||
145788275|NCT03656926|525731724|FG001|Overall Study|Adverse Event|4|||
145788276|NCT03656926|525731723|FG000|Overall Study|Withdrawal by Subject|7|||
145788277|NCT03656926|525731724|FG001|Overall Study|Withdrawal by Subject|2|||
145788278|NCT03656926|525731723|FG000|Overall Study|Screen fail after randomization|1|||
145788279|NCT03656926|525731724|FG001|Overall Study|Screen fail after randomization|0|||
145788280|NCT03656926|525731723|FG000|Overall Study|PI decision due to patient condition|1|||
145788281|NCT03656926|525731724|FG001|Overall Study|PI decision due to patient condition|0|||
145788282|NCT03656926|525731723|FG000|Overall Study|Patient unresponsiveness|1|||
145788283|NCT03656926|525731724|FG001|Overall Study|Patient unresponsiveness|0|||
145788284|NCT00913978|525731725|FG000|Overall Study|Surgeon choice|1|||
145788285|NCT00913978|525731726|FG001|Overall Study|Surgeon choice|3|||
145788286|NCT05610176|525731727|FG000|Overall Study|Death|6|||
145788287|NCT01327651|525731728|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
145788288|NCT01327651|525731729|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
145788289|NCT01327651|525731730|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
145788290|NCT01327651|525731731|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
145788291|NCT01327651|525731732|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
145788292|NCT01327651|525731733|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
145788293|NCT01327651|525731734|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
145788294|NCT01327651|525731735|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
145788295|NCT01327651|525731736|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
145788296|NCT01327651|525731728|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
145788297|NCT01327651|525731729|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788298|NCT01327651|525731730|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788299|NCT01327651|525731731|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788300|NCT01327651|525731732|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788301|NCT01327651|525731733|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788302|NCT01327651|525731734|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788303|NCT01327651|525731735|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788304|NCT01327651|525731736|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
145788305|NCT01327651|525731728|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
145788306|NCT01327651|525731729|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
145788307|NCT01327651|525731730|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
145788308|NCT01327651|525731731|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
145788309|NCT01327651|525731732|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
145788310|NCT01327651|525731733|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
145788311|NCT01327651|525731734|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
145788312|NCT01327651|525731735|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
145788313|NCT01327651|525731736|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
145788314|NCT01327651|525731728|FG000|Post Study Follow-up|Lost to Follow-up|0|||
145788315|NCT01327651|525731729|FG001|Post Study Follow-up|Lost to Follow-up|1|||
145788316|NCT01327651|525731730|FG002|Post Study Follow-up|Lost to Follow-up|1|||
145788317|NCT01327651|525731731|FG003|Post Study Follow-up|Lost to Follow-up|0|||
145788318|NCT01327651|525731732|FG004|Post Study Follow-up|Lost to Follow-up|0|||
145788319|NCT01327651|525731733|FG005|Post Study Follow-up|Lost to Follow-up|0|||
145788320|NCT01327651|525731734|FG006|Post Study Follow-up|Lost to Follow-up|4|||
145788321|NCT01327651|525731735|FG007|Post Study Follow-up|Lost to Follow-up|1|||
145788322|NCT01327651|525731736|FG008|Post Study Follow-up|Lost to Follow-up|2|||
145788323|NCT01727713|525731744|FG000|Overall Study|Lost to Follow-up|5|||
145788324|NCT01727713|525731744|FG000|Overall Study|Adverse Event|10|||
145788325|NCT01727713|525731744|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
145788326|NCT01727713|525731744|FG000|Overall Study|Withdrawal by Subject|13|||
145788327|NCT01727713|525731744|FG000|Overall Study|Protocol Deviation|2|||
145788328|NCT00532948|525731745|FG000|Overall Study|Protocol Violation|1|||
145788329|NCT00532948|525731746|FG001|Overall Study|Protocol Violation|0|||
145788330|NCT00532948|525731747|FG002|Overall Study|Protocol Violation|0|||
145788331|NCT00532948|525731745|FG000|Overall Study|Death|3|||
145788332|NCT00532948|525731746|FG001|Overall Study|Death|3|||
145788333|NCT00532948|525731747|FG002|Overall Study|Death|4|||
145788334|NCT00532948|525731745|FG000|Overall Study|Violation of selection criteria at entry|0|||
145788335|NCT00532948|525731746|FG001|Overall Study|Violation of selection criteria at entry|1|||
145609767|NCT02395133|525086463|FG003|Overall Study|Lack of Efficacy|1|||
145609768|NCT02395133|525086460|FG000|Overall Study|Protocol Violation|1|||
145609769|NCT02395133|525086461|FG001|Overall Study|Protocol Violation|1|||
145609770|NCT02395133|525086462|FG002|Overall Study|Protocol Violation|0|||
145609771|NCT02395133|525086463|FG003|Overall Study|Protocol Violation|3|||
145609772|NCT02395133|525086460|FG000|Overall Study|Lost to Follow-up|0|||
145609773|NCT02395133|525086461|FG001|Overall Study|Lost to Follow-up|1|||
145609774|NCT02395133|525086462|FG002|Overall Study|Lost to Follow-up|1|||
145539710|NCT01847274|524836687|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539711|NCT01847274|524836688|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539712|NCT01847274|524836689|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539713|NCT01847274|524836690|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
145539714|NCT01847274|524836691|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539715|NCT01847274|524836692|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145609775|NCT02395133|525086463|FG003|Overall Study|Lost to Follow-up|0|||
145609776|NCT02395133|525086460|FG000|Overall Study|Pregnancy|0|||
145609777|NCT02395133|525086461|FG001|Overall Study|Pregnancy|0|||
145609778|NCT02395133|525086462|FG002|Overall Study|Pregnancy|3|||
145609779|NCT02395133|525086463|FG003|Overall Study|Pregnancy|0|||
145609780|NCT02395133|525086460|FG000|Overall Study|Consent withdrawn with no reason given|1|||
145609781|NCT02395133|525086461|FG001|Overall Study|Consent withdrawn with no reason given|3|||
145609782|NCT02395133|525086462|FG002|Overall Study|Consent withdrawn with no reason given|0|||
145609783|NCT02395133|525086463|FG003|Overall Study|Consent withdrawn with no reason given|2|||
145609784|NCT02395133|525086460|FG000|Overall Study|Consent withdrawn with personal reason|0|||
145609785|NCT02395133|525086461|FG001|Overall Study|Consent withdrawn with personal reason|1|||
145609786|NCT02395133|525086462|FG002|Overall Study|Consent withdrawn with personal reason|0|||
145609787|NCT02395133|525086463|FG003|Overall Study|Consent withdrawn with personal reason|3|||
145609788|NCT02395133|525086460|FG000|Overall Study|Sponsor decision|2|||
145609789|NCT02395133|525086461|FG001|Overall Study|Sponsor decision|0|||
145609790|NCT02395133|525086462|FG002|Overall Study|Sponsor decision|0|||
145609791|NCT02395133|525086463|FG003|Overall Study|Sponsor decision|1|||
145609792|NCT02395133|525086460|FG000|Overall Study|Other than specified above|5|||
145609793|NCT02395133|525086461|FG001|Overall Study|Other than specified above|2|||
145609794|NCT02395133|525086462|FG002|Overall Study|Other than specified above|2|||
145281819|NCT00472446|523882987|FG003|Overall Study|Questionnaires not returned|4|||
145281820|NCT02008721|523882992|FG000|Overall Study|Withdrawal by Subject|5|||
145281821|NCT02008721|523882993|FG001|Overall Study|Withdrawal by Subject|1|||
145281822|NCT02008721|523882992|FG000|Overall Study|Death|4|||
145539716|NCT01847274|524836693|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539717|NCT01847274|524836694|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539718|NCT01847274|524836695|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
145539719|NCT01847274|524836685|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539720|NCT01847274|524836686|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539721|NCT01847274|524836687|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539722|NCT01847274|524836688|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539723|NCT01847274|524836689|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
145539724|NCT01847274|524836690|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539725|NCT01847274|524836691|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539726|NCT01847274|524836692|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539727|NCT01847274|524836693|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539728|NCT01847274|524836694|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539729|NCT01847274|524836695|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
145539730|NCT01847274|524836685|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539731|NCT01847274|524836686|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145609795|NCT02395133|525086463|FG003|Overall Study|Other than specified above|4|||
145281823|NCT02008721|523882993|FG001|Overall Study|Death|2|||
145281824|NCT02008721|523882992|FG000|Overall Study|Adverse Event|3|||
145281825|NCT02008721|523882993|FG001|Overall Study|Adverse Event|5|||
145281826|NCT02008721|523882992|FG000|Overall Study|Protocol Violation|3|||
145281827|NCT02008721|523882993|FG001|Overall Study|Protocol Violation|2|||
145281828|NCT00295854|523882999|FG000|Overall Study|Adverse Event|7|||
145281829|NCT00295854|523883000|FG001|Overall Study|Adverse Event|7|||
145609796|NCT00962247|525086466|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
145609797|NCT00962247|525086466|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
145788336|NCT00532948|525731747|FG002|Overall Study|Violation of selection criteria at entry|0|||
145281830|NCT00295854|523883001|FG002|Overall Study|Adverse Event|6|||
145281831|NCT00295854|523882999|FG000|Overall Study|Protocol Violation|1|||
145281832|NCT00295854|523883000|FG001|Overall Study|Protocol Violation|1|||
145609798|NCT02234063|525086469|FG000|Overall Study|Lost to Follow-up|235|||
145609799|NCT02234063|525086470|FG001|Overall Study|Lost to Follow-up|42|||
145281833|NCT00295854|523883001|FG002|Overall Study|Protocol Violation|1|||
145281834|NCT00295854|523882999|FG000|Overall Study|Lost to Follow-up|2|||
145788337|NCT00532948|525731745|FG000|Overall Study|Failure to return|0|||
145788338|NCT00532948|525731746|FG001|Overall Study|Failure to return|1|||
145788339|NCT00532948|525731747|FG002|Overall Study|Failure to return|0|||
145788340|NCT01253044|525731752|FG000|Overall Study|Lost to Follow-up|38|||
145788341|NCT01253044|525731753|FG001|Overall Study|Lost to Follow-up|29|||
145788342|NCT03885726|525731754|FG000|Overall Study|Staffing issues/lost interest|1|||
145788343|NCT03885726|525731754|FG000|Overall Study|Early discharge from hospital|3|||
145788344|NCT02868216|525731757|FG000|Overall Study|Death|0|||
145788345|NCT02868216|525731758|FG001|Overall Study|Death|1|||
145788346|NCT02868216|525731757|FG000|Overall Study|coronary artery bypass|1|||
145788347|NCT02868216|525731758|FG001|Overall Study|coronary artery bypass|0|||
145788348|NCT02868216|525731757|FG000|Overall Study|Withdrawal by Subject|7|||
145788349|NCT02868216|525731758|FG001|Overall Study|Withdrawal by Subject|5|||
145788350|NCT00987623|525731759|FG000|Overall Study|Lost to Follow-up|2|||
145788351|NCT00987623|525731760|FG001|Overall Study|Lost to Follow-up|1|||
145788352|NCT00987623|525731759|FG000|Overall Study|Time/job conflict|2|||
145788353|NCT00987623|525731760|FG001|Overall Study|Time/job conflict|0|||
145788354|NCT00987623|525731759|FG000|Overall Study|Discomfort|1|||
145788355|NCT00987623|525731760|FG001|Overall Study|Discomfort|0|||
145788356|NCT00987623|525731759|FG000|Overall Study|Biomicroscopy|0|||
145788357|NCT00987623|525731760|FG001|Overall Study|Biomicroscopy|1|||
145788358|NCT00987623|525731759|FG000|Overall Study|Influenza|0|||
145788359|NCT00987623|525731760|FG001|Overall Study|Influenza|1|||
145788360|NCT02702193|525731763|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
145788361|NCT02702193|525731764|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
145788362|NCT02702193|525731763|FG000|4 Month Follow up|Withdrawal by Subject|1|||
145788363|NCT02702193|525731764|FG001|4 Month Follow up|Withdrawal by Subject|0|||
145788364|NCT02702193|525731763|FG000|4 Month Follow up|Lost to Follow-up|17|||
145788365|NCT02702193|525731764|FG001|4 Month Follow up|Lost to Follow-up|18|||
145788366|NCT02702193|525731763|FG000|8 Month Follow up|Withdrawal by Subject|1|||
145788367|NCT02702193|525731764|FG001|8 Month Follow up|Withdrawal by Subject|0|||
145788368|NCT02702193|525731763|FG000|8 Month Follow up|Lost to Follow-up|14|||
145788369|NCT02702193|525731764|FG001|8 Month Follow up|Lost to Follow-up|18|||
145788370|NCT02702193|525731763|FG000|12 Month Follow up|Withdrawal by Subject|1|||
145788371|NCT02702193|525731764|FG001|12 Month Follow up|Withdrawal by Subject|0|||
145788372|NCT02702193|525731763|FG000|12 Month Follow up|Lost to Follow-up|16|||
145788373|NCT02702193|525731764|FG001|12 Month Follow up|Lost to Follow-up|18|||
145788374|NCT01201798|525731765|FG000|Overall Study|Adverse Event|2|||
145788375|NCT01201798|525731766|FG001|Overall Study|Adverse Event|0|||
145788376|NCT01201798|525731765|FG000|Overall Study|Lost to Follow-up|3|||
145788377|NCT01201798|525731766|FG001|Overall Study|Lost to Follow-up|5|||
145788378|NCT01201798|525731765|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
145788379|NCT01201798|525731766|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
145788380|NCT01201798|525731765|FG000|Overall Study|Noncompliance|1|||
145788381|NCT01201798|525731766|FG001|Overall Study|Noncompliance|0|||
145788382|NCT01201798|525731765|FG000|Overall Study|Protocol Violation|1|||
145788383|NCT01201798|525731766|FG001|Overall Study|Protocol Violation|1|||
145788384|NCT01201798|525731765|FG000|Overall Study|Treatment Failure|1|||
145788385|NCT01201798|525731766|FG001|Overall Study|Treatment Failure|8|||
145788386|NCT00610935|525731779|FG000|Overall Study|Lost to Follow-up|0|||
145788387|NCT00610935|525731780|FG001|Overall Study|Lost to Follow-up|1|||
145788388|NCT00610935|525731779|FG000|Overall Study|Withdrawal by Subject|0|||
145788389|NCT00610935|525731780|FG001|Overall Study|Withdrawal by Subject|2|||
145788390|NCT00610935|525731779|FG000|Overall Study|Sponsor Discontinuation|1|||
145788391|NCT00610935|525731780|FG001|Overall Study|Sponsor Discontinuation|0|||
145788392|NCT02399813|525731786|FG000|Overall Study|Progressive Disease-Radiographic|2|||
145788393|NCT02399813|525731786|FG000|Overall Study|Death|20|||
145788394|NCT02399813|525731786|FG000|Overall Study|Withdrawal by Subject|3|||
145788395|NCT02399813|525731786|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
145788396|NCT02399813|525731786|FG000|Overall Study|Lost to Follow-up|2|||
145788397|NCT02399813|525731786|FG000|Overall Study|Other than specified|5|||
145788398|NCT00988559|525731787|FG000|Overall Study|Withdrawal by Subject|1|||
145788399|NCT00988559|525731788|FG001|Overall Study|Withdrawal by Subject|1|||
145788400|NCT00988559|525731789|FG002|Overall Study|Withdrawal by Subject|0|||
145788401|NCT00988559|525731790|FG003|Overall Study|Withdrawal by Subject|1|||
145788402|NCT00988559|525731787|FG000|Overall Study|Pregnancy|0|||
145788403|NCT00988559|525731788|FG001|Overall Study|Pregnancy|1|||
145788404|NCT00988559|525731789|FG002|Overall Study|Pregnancy|1|||
145788405|NCT00988559|525731790|FG003|Overall Study|Pregnancy|0|||
145788406|NCT00988559|525731787|FG000|Overall Study|Lost to Follow-up|0|||
145788407|NCT00988559|525731788|FG001|Overall Study|Lost to Follow-up|0|||
145788408|NCT00988559|525731789|FG002|Overall Study|Lost to Follow-up|1|||
145788409|NCT00988559|525731790|FG003|Overall Study|Lost to Follow-up|0|||
145788410|NCT02224846|525731791|FG000|Period 1 (Month 3)|Adverse Event|2|||
145788411|NCT02224846|525731792|FG001|Period 1 (Month 3)|Adverse Event|1|||
145788412|NCT02224846|525731791|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
145788413|NCT02224846|525731792|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
145788414|NCT02224846|525731791|FG000|Period 1 (Month 3)|Protocol Violation|4|||
145788415|NCT02224846|525731792|FG001|Period 1 (Month 3)|Protocol Violation|8|||
145539732|NCT01847274|524836687|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539733|NCT01847274|524836688|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539734|NCT01847274|524836689|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539735|NCT01847274|524836690|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539736|NCT01847274|524836691|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
145539737|NCT01847274|524836692|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539738|NCT01847274|524836693|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539739|NCT01847274|524836694|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539740|NCT01847274|524836695|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
145539741|NCT01847274|524836685|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539742|NCT01847274|524836686|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539743|NCT01847274|524836687|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539744|NCT01847274|524836688|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539745|NCT01847274|524836689|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539746|NCT01847274|524836690|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539747|NCT01847274|524836691|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
145539748|NCT01847274|524836692|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539749|NCT01847274|524836693|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539750|NCT01847274|524836694|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145788416|NCT02224846|525731791|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
145788417|NCT02224846|525731792|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
145788418|NCT02224846|525731791|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
145788419|NCT02224846|525731792|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
145788420|NCT02224846|525731791|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
145788421|NCT02224846|525731792|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
145788422|NCT02224846|525731791|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
145788423|NCT02224846|525731792|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
145788424|NCT02224846|525731791|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
145788425|NCT02224846|525731792|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
145788426|NCT02224846|525731791|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
145788427|NCT02224846|525731792|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
145788428|NCT02224846|525731791|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
145788429|NCT02224846|525731792|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
145788430|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
145788431|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
145788432|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
145788433|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
145788434|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
145788435|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
145788436|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
145788437|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
145788438|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
145788439|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
145788440|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
145539751|NCT01847274|524836695|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
145539752|NCT01847274|524836685|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539753|NCT01847274|524836686|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539754|NCT01847274|524836687|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539755|NCT01847274|524836688|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539756|NCT01847274|524836689|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539757|NCT01847274|524836690|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539758|NCT01847274|524836691|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
145539759|NCT01847274|524836692|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145788441|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
145788442|NCT02224846|525731791|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
145788443|NCT02224846|525731792|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
145788444|NCT03280550|525731793|FG000|Overall Study|Withdrawal by Subject|2|||
145788445|NCT03280550|525731794|FG001|Overall Study|Withdrawal by Subject|2|||
145788446|NCT03280550|525731793|FG000|Overall Study|Physician Decision|0|||
145788447|NCT03280550|525731794|FG001|Overall Study|Physician Decision|1|||
145788448|NCT00256867|525731795|FG000|Overall Study|Adverse Event|0|||
145788449|NCT00256867|525731796|FG001|Overall Study|Adverse Event|1|||
145788450|NCT00256867|525731797|FG002|Overall Study|Adverse Event|1|||
145788451|NCT00256867|525731798|FG003|Overall Study|Adverse Event|1|||
145788452|NCT00256867|525731799|FG004|Overall Study|Adverse Event|2|||
145788453|NCT00256867|525731800|FG005|Overall Study|Adverse Event|2|||
145788454|NCT00256867|525731801|FG006|Overall Study|Adverse Event|1|||
145788455|NCT00256867|525731802|FG007|Overall Study|Adverse Event|4|||
145788456|NCT00256867|525731795|FG000|Overall Study|Lost to Follow-up|2|||
145788457|NCT00256867|525731796|FG001|Overall Study|Lost to Follow-up|2|||
145788458|NCT00256867|525731797|FG002|Overall Study|Lost to Follow-up|2|||
145788459|NCT00256867|525731798|FG003|Overall Study|Lost to Follow-up|3|||
145788460|NCT00256867|525731799|FG004|Overall Study|Lost to Follow-up|2|||
145788461|NCT00256867|525731800|FG005|Overall Study|Lost to Follow-up|0|||
145788462|NCT00256867|525731801|FG006|Overall Study|Lost to Follow-up|1|||
145788463|NCT00256867|525731802|FG007|Overall Study|Lost to Follow-up|2|||
145788464|NCT00256867|525731795|FG000|Overall Study|Protocol Violation|0|||
145788465|NCT00256867|525731796|FG001|Overall Study|Protocol Violation|0|||
145281835|NCT00295854|523883000|FG001|Overall Study|Lost to Follow-up|0|||
145281836|NCT00295854|523883001|FG002|Overall Study|Lost to Follow-up|1|||
145281837|NCT00295854|523882999|FG000|Overall Study|Withdrawal by Subject|3|||
145281838|NCT00295854|523883000|FG001|Overall Study|Withdrawal by Subject|7|||
145281839|NCT00295854|523883001|FG002|Overall Study|Withdrawal by Subject|4|||
145281840|NCT00295854|523882999|FG000|Overall Study|did not continue to meet criteria|1|||
145281841|NCT00295854|523883000|FG001|Overall Study|did not continue to meet criteria|1|||
145281842|NCT00295854|523883001|FG002|Overall Study|did not continue to meet criteria|2|||
145281843|NCT00295854|523882999|FG000|Overall Study|required a prohibited medication|1|||
145281844|NCT00295854|523883000|FG001|Overall Study|required a prohibited medication|0|||
145281845|NCT00295854|523883001|FG002|Overall Study|required a prohibited medication|0|||
145281846|NCT00295854|523882999|FG000|Overall Study|Other|3|||
145281847|NCT00295854|523883000|FG001|Overall Study|Other|5|||
145281848|NCT00295854|523883001|FG002|Overall Study|Other|1|||
145281849|NCT00772577|523883002|FG000|Overall Study|Adverse Event|6|||
145281850|NCT00772577|523883003|FG001|Overall Study|Adverse Event|3|||
145281851|NCT00772577|523883002|FG000|Overall Study|Abnormal laboratory values|0|||
145281852|NCT00772577|523883003|FG001|Overall Study|Abnormal laboratory values|1|||
145281853|NCT00772577|523883002|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145281854|NCT00772577|523883003|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
145281855|NCT00772577|523883002|FG000|Overall Study|Patient withdrew consent|8|||
145281856|NCT00772577|523883003|FG001|Overall Study|Patient withdrew consent|5|||
145281857|NCT00772577|523883002|FG000|Overall Study|Lost to Follow-up|4|||
145281858|NCT00772577|523883003|FG001|Overall Study|Lost to Follow-up|3|||
145281859|NCT00772577|523883002|FG000|Overall Study|Administrative problems|2|||
145281860|NCT00772577|523883003|FG001|Overall Study|Administrative problems|1|||
145281861|NCT00772577|523883002|FG000|Overall Study|Protocol Deviation|3|||
145281862|NCT00772577|523883003|FG001|Overall Study|Protocol Deviation|2|||
145281863|NCT00672620|523883004|FG000|Overall Study|Adverse Event|7|||
145281864|NCT00672620|523883005|FG001|Overall Study|Adverse Event|7|||
145281865|NCT00672620|523883006|FG002|Overall Study|Adverse Event|12|||
145281866|NCT00672620|523883007|FG003|Overall Study|Adverse Event|17|||
145281867|NCT00672620|523883004|FG000|Overall Study|Lack of Efficacy|1|||
145539760|NCT01847274|524836693|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539761|NCT01847274|524836694|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539762|NCT01847274|524836695|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
145539763|NCT01847274|524836685|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539764|NCT01847274|524836686|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539765|NCT01847274|524836687|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539766|NCT01847274|524836688|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539767|NCT01847274|524836689|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539768|NCT01847274|524836690|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539769|NCT01847274|524836691|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
145539770|NCT01847274|524836692|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
145539771|NCT01847274|524836693|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
145539772|NCT01847274|524836694|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
145539773|NCT01847274|524836695|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
145539774|NCT01847274|524836685|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539775|NCT01847274|524836686|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145788466|NCT00256867|525731797|FG002|Overall Study|Protocol Violation|0|||
145788467|NCT00256867|525731798|FG003|Overall Study|Protocol Violation|1|||
145788468|NCT00256867|525731799|FG004|Overall Study|Protocol Violation|0|||
145788469|NCT00256867|525731800|FG005|Overall Study|Protocol Violation|1|||
145788470|NCT00256867|525731801|FG006|Overall Study|Protocol Violation|0|||
145788471|NCT00256867|525731802|FG007|Overall Study|Protocol Violation|1|||
145788472|NCT00256867|525731795|FG000|Overall Study|Withdrawal by Subject|0|||
145788473|NCT00256867|525731796|FG001|Overall Study|Withdrawal by Subject|0|||
145788474|NCT00256867|525731797|FG002|Overall Study|Withdrawal by Subject|1|||
145788475|NCT00256867|525731798|FG003|Overall Study|Withdrawal by Subject|1|||
145788476|NCT00256867|525731799|FG004|Overall Study|Withdrawal by Subject|2|||
145788477|NCT00256867|525731800|FG005|Overall Study|Withdrawal by Subject|2|||
145788478|NCT00256867|525731801|FG006|Overall Study|Withdrawal by Subject|3|||
145788479|NCT00256867|525731802|FG007|Overall Study|Withdrawal by Subject|2|||
145788480|NCT00256867|525731795|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788481|NCT00256867|525731796|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
145788482|NCT00256867|525731797|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788483|NCT00256867|525731798|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788484|NCT00256867|525731799|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788485|NCT00256867|525731800|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788486|NCT00256867|525731801|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788487|NCT00256867|525731802|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
145788488|NCT00256867|525731795|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788489|NCT00256867|525731796|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788490|NCT00256867|525731797|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788491|NCT00256867|525731798|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788492|NCT00256867|525731799|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788493|NCT00256867|525731800|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788494|NCT00256867|525731801|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
145788495|NCT00256867|525731802|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
145788496|NCT00256867|525731795|FG000|Overall Study|Investigator's Decision|0|||
145788497|NCT00256867|525731796|FG001|Overall Study|Investigator's Decision|0|||
145788498|NCT00256867|525731797|FG002|Overall Study|Investigator's Decision|0|||
145788499|NCT00256867|525731798|FG003|Overall Study|Investigator's Decision|0|||
145788500|NCT00256867|525731799|FG004|Overall Study|Investigator's Decision|1|||
145788501|NCT00256867|525731800|FG005|Overall Study|Investigator's Decision|0|||
145788502|NCT00256867|525731801|FG006|Overall Study|Investigator's Decision|0|||
145788503|NCT00256867|525731802|FG007|Overall Study|Investigator's Decision|0|||
145788504|NCT00256867|525731795|FG000|Overall Study|Non-compliance with study medication|0|||
145788505|NCT00256867|525731796|FG001|Overall Study|Non-compliance with study medication|0|||
145788506|NCT00256867|525731797|FG002|Overall Study|Non-compliance with study medication|0|||
145788507|NCT00256867|525731798|FG003|Overall Study|Non-compliance with study medication|0|||
145788508|NCT00256867|525731799|FG004|Overall Study|Non-compliance with study medication|0|||
145788509|NCT00256867|525731800|FG005|Overall Study|Non-compliance with study medication|0|||
145788510|NCT00256867|525731801|FG006|Overall Study|Non-compliance with study medication|0|||
145788511|NCT00256867|525731802|FG007|Overall Study|Non-compliance with study medication|1|||
145788512|NCT00256867|525731795|FG000|Overall Study|Participant travelled Overseas|0|||
145788513|NCT00256867|525731796|FG001|Overall Study|Participant travelled Overseas|1|||
145788514|NCT00256867|525731797|FG002|Overall Study|Participant travelled Overseas|0|||
145788515|NCT00256867|525731798|FG003|Overall Study|Participant travelled Overseas|0|||
145788516|NCT00256867|525731799|FG004|Overall Study|Participant travelled Overseas|0|||
145788517|NCT00256867|525731800|FG005|Overall Study|Participant travelled Overseas|0|||
145788518|NCT00256867|525731801|FG006|Overall Study|Participant travelled Overseas|0|||
145788519|NCT00256867|525731802|FG007|Overall Study|Participant travelled Overseas|0|||
145788520|NCT00256867|525731795|FG000|Overall Study|Participant out of assessment window|0|||
145788521|NCT00256867|525731796|FG001|Overall Study|Participant out of assessment window|0|||
145788522|NCT00256867|525731797|FG002|Overall Study|Participant out of assessment window|1|||
145788523|NCT00256867|525731798|FG003|Overall Study|Participant out of assessment window|0|||
145788524|NCT00256867|525731799|FG004|Overall Study|Participant out of assessment window|0|||
145788525|NCT00256867|525731800|FG005|Overall Study|Participant out of assessment window|0|||
145539776|NCT01847274|524836687|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539777|NCT01847274|524836688|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539778|NCT01847274|524836689|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145788526|NCT00256867|525731801|FG006|Overall Study|Participant out of assessment window|0|||
145788527|NCT00256867|525731802|FG007|Overall Study|Participant out of assessment window|0|||
145788528|NCT00256867|525731795|FG000|Overall Study|Withdrawal by participant|0|||
145404072|NCT01648764|524336464|FG006|Overall Study|Investigator Decision|1|||
145788529|NCT00256867|525731796|FG001|Overall Study|Withdrawal by participant|0|||
145788530|NCT00256867|525731797|FG002|Overall Study|Withdrawal by participant|0|||
145788531|NCT00256867|525731798|FG003|Overall Study|Withdrawal by participant|0|||
145788532|NCT00256867|525731799|FG004|Overall Study|Withdrawal by participant|0|||
145788533|NCT00256867|525731800|FG005|Overall Study|Withdrawal by participant|1|||
145788534|NCT00256867|525731801|FG006|Overall Study|Withdrawal by participant|0|||
145539779|NCT01847274|524836690|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539780|NCT01847274|524836691|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539781|NCT01847274|524836692|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
145539782|NCT01847274|524836693|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539783|NCT01847274|524836694|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
145539784|NCT01847274|524836695|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
145539785|NCT01847274|524836685|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145539786|NCT01847274|524836686|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145788535|NCT00256867|525731802|FG007|Overall Study|Withdrawal by participant|0|||
145788536|NCT00875017|525731805|FG000|First Intervention|Withdrawal by Subject|1|||
145788537|NCT00875017|525731806|FG001|First Intervention|Withdrawal by Subject|0|||
145788538|NCT00875017|525731807|FG002|First Intervention|Withdrawal by Subject|1|||
145788539|NCT00875017|525731808|FG003|First Intervention|Withdrawal by Subject|0|||
145788540|NCT00875017|525731809|FG004|First Intervention|Withdrawal by Subject|0|||
145788541|NCT00875017|525731810|FG005|First Intervention|Withdrawal by Subject|0|||
145788542|NCT00875017|525731805|FG000|First Intervention|Adverse Event|0|||
145788543|NCT00875017|525731806|FG001|First Intervention|Adverse Event|0|||
145788544|NCT00875017|525731807|FG002|First Intervention|Adverse Event|0|||
145788545|NCT00875017|525731808|FG003|First Intervention|Adverse Event|1|||
145788546|NCT00875017|525731809|FG004|First Intervention|Adverse Event|0|||
145788547|NCT00875017|525731810|FG005|First Intervention|Adverse Event|0|||
145788548|NCT00875017|525731805|FG000|First Intervention|Problems collecting rectal effluent|1|||
145788549|NCT00875017|525731806|FG001|First Intervention|Problems collecting rectal effluent|0|||
145788550|NCT00875017|525731807|FG002|First Intervention|Problems collecting rectal effluent|0|||
145788551|NCT00875017|525731808|FG003|First Intervention|Problems collecting rectal effluent|0|||
145788552|NCT00875017|525731809|FG004|First Intervention|Problems collecting rectal effluent|0|||
145788553|NCT00875017|525731810|FG005|First Intervention|Problems collecting rectal effluent|0|||
145788554|NCT00875017|525731805|FG000|First Intervention|Intolerance to nasogastric tube|0|||
145788555|NCT00875017|525731806|FG001|First Intervention|Intolerance to nasogastric tube|0|||
145788556|NCT00875017|525731807|FG002|First Intervention|Intolerance to nasogastric tube|0|||
145788557|NCT00875017|525731808|FG003|First Intervention|Intolerance to nasogastric tube|0|||
145788558|NCT00875017|525731809|FG004|First Intervention|Intolerance to nasogastric tube|1|||
145788559|NCT00875017|525731810|FG005|First Intervention|Intolerance to nasogastric tube|0|||
145788560|NCT00875017|525731805|FG000|Washout|Problem collecting rectal effluent|0|||
145788561|NCT00875017|525731806|FG001|Washout|Problem collecting rectal effluent|0|||
145788562|NCT00875017|525731807|FG002|Washout|Problem collecting rectal effluent|1|||
145788563|NCT00875017|525731808|FG003|Washout|Problem collecting rectal effluent|0|||
145788564|NCT00875017|525731809|FG004|Washout|Problem collecting rectal effluent|0|||
145788565|NCT00875017|525731810|FG005|Washout|Problem collecting rectal effluent|0|||
145788566|NCT00875017|525731805|FG000|Second Intervention|Adverse Event|0|||
145788567|NCT00875017|525731806|FG001|Second Intervention|Adverse Event|0|||
145788568|NCT00875017|525731807|FG002|Second Intervention|Adverse Event|0|||
145404073|NCT01648764|524336465|FG007|Overall Study|Investigator Decision|0|||
145609800|NCT02234063|525086469|FG000|Overall Study|Withdrawal by Subject|20|||
145609801|NCT02234063|525086470|FG001|Overall Study|Withdrawal by Subject|1|||
145609802|NCT01861522|525086473|FG000|Overall Study|Adverse Event|1|||
145788569|NCT00875017|525731808|FG003|Second Intervention|Adverse Event|1|||
145788570|NCT00875017|525731809|FG004|Second Intervention|Adverse Event|0|||
145788571|NCT00875017|525731810|FG005|Second Intervention|Adverse Event|0|||
145788572|NCT00875017|525731805|FG000|Washout|Problems collecting rectal effluent|0|||
145788573|NCT00875017|525731806|FG001|Washout|Problems collecting rectal effluent|1|||
145788574|NCT00875017|525731807|FG002|Washout|Problems collecting rectal effluent|0|||
145788575|NCT00875017|525731808|FG003|Washout|Problems collecting rectal effluent|0|||
145788576|NCT00875017|525731809|FG004|Washout|Problems collecting rectal effluent|0|||
145788577|NCT00875017|525731810|FG005|Washout|Problems collecting rectal effluent|0|||
145788578|NCT00875017|525731805|FG000|Third Intervention|Adverse Event|0|||
145788579|NCT00875017|525731806|FG001|Third Intervention|Adverse Event|1|||
145788580|NCT00875017|525731807|FG002|Third Intervention|Adverse Event|1|||
145788581|NCT00875017|525731808|FG003|Third Intervention|Adverse Event|0|||
145788582|NCT00875017|525731809|FG004|Third Intervention|Adverse Event|0|||
145788583|NCT00875017|525731810|FG005|Third Intervention|Adverse Event|0|||
145788584|NCT00875017|525731805|FG000|Washout|Withdrawal by Subject|0|||
145788585|NCT00875017|525731806|FG001|Washout|Withdrawal by Subject|0|||
145788586|NCT00875017|525731807|FG002|Washout|Withdrawal by Subject|0|||
145788587|NCT00875017|525731808|FG003|Washout|Withdrawal by Subject|0|||
145788588|NCT00875017|525731809|FG004|Washout|Withdrawal by Subject|1|||
145788589|NCT00875017|525731810|FG005|Washout|Withdrawal by Subject|0|||
145788590|NCT00875017|525731805|FG000|Fourth Intervention|Inability to comply with fasting|0|||
145788591|NCT00875017|525731806|FG001|Fourth Intervention|Inability to comply with fasting|0|||
145788592|NCT00875017|525731807|FG002|Fourth Intervention|Inability to comply with fasting|0|||
145788593|NCT00875017|525731808|FG003|Fourth Intervention|Inability to comply with fasting|0|||
145788594|NCT00875017|525731809|FG004|Fourth Intervention|Inability to comply with fasting|0|||
145788595|NCT00875017|525731810|FG005|Fourth Intervention|Inability to comply with fasting|1|||
145788596|NCT03342469|525731811|FG000|Overall Study|Withdrawal by Subject|0|||
145788597|NCT03342469|525731812|FG001|Overall Study|Withdrawal by Subject|1|||
145788598|NCT03342469|525731813|FG002|Overall Study|Withdrawal by Subject|0|||
145788599|NCT03342469|525731814|FG003|Overall Study|Withdrawal by Subject|0|||
145788600|NCT01477892|525731815|FG000|Overall Study|Withdrawal by Subject|0|||
145788601|NCT01477892|525731816|FG001|Overall Study|Withdrawal by Subject|2|||
145788602|NCT01575197|525733227|FG000|Overall Study|Migration out of study area|1|||
145788603|NCT01575197|525733228|FG001|Overall Study|Migration out of study area|5|||
145788604|NCT01575197|525733229|FG002|Overall Study|Migration out of study area|4|||
145788605|NCT01575197|525733227|FG000|Overall Study|SAE|0|||
145788606|NCT01575197|525733228|FG001|Overall Study|SAE|1|||
145788607|NCT01575197|525733229|FG002|Overall Study|SAE|0|||
145788608|NCT01575197|525733227|FG000|Overall Study|Lost to Follow-up|0|||
145788609|NCT01575197|525733228|FG001|Overall Study|Lost to Follow-up|1|||
145788610|NCT01575197|525733229|FG002|Overall Study|Lost to Follow-up|0|||
145788611|NCT01575197|525733227|FG000|Overall Study|Withdrawal by Subject|0|||
145788612|NCT01575197|525733228|FG001|Overall Study|Withdrawal by Subject|1|||
145788613|NCT01575197|525733229|FG002|Overall Study|Withdrawal by Subject|1|||
145788614|NCT01575197|525733227|FG000|Overall Study|Protocol Violation|2|||
145788615|NCT01575197|525733228|FG001|Overall Study|Protocol Violation|1|||
145788616|NCT01575197|525733229|FG002|Overall Study|Protocol Violation|1|||
145788617|NCT00833248|525733233|FG000|Overall Study|Adverse Event|3|||
145788618|NCT00833248|525733234|FG001|Overall Study|Adverse Event|0|||
145788619|NCT00833248|525733233|FG000|Overall Study|Protocol Violation|1|||
145788620|NCT00833248|525733234|FG001|Overall Study|Protocol Violation|2|||
145788621|NCT00833248|525733233|FG000|Overall Study|Withdrawal by Subject|0|||
145788622|NCT00833248|525733234|FG001|Overall Study|Withdrawal by Subject|1|||
145788623|NCT01826422|525733237|FG000|Overall Study|Withdrawal by Subject|1|||
145788624|NCT01826422|525733238|FG001|Overall Study|Withdrawal by Subject|3|||
145788625|NCT04009096|525733239|FG000|Overall Study|Withdrawal by Subject|0|||
145788626|NCT04009096|525733240|FG001|Overall Study|Withdrawal by Subject|7|||
145788627|NCT04009096|525733241|FG002|Overall Study|Withdrawal by Subject|0|||
145788628|NCT04009096|525733239|FG000|Overall Study|Physician Decision|0|||
145788629|NCT04009096|525733240|FG001|Overall Study|Physician Decision|1|||
145788630|NCT04009096|525733241|FG002|Overall Study|Physician Decision|0|||
145788631|NCT05151471|525733242|FG000|Overall Study|Adverse Event|21|||
145788632|NCT05151471|525733243|FG001|Overall Study|Adverse Event|16|||
145788633|NCT05151471|525733242|FG000|Overall Study|Death|1|||
145788634|NCT05151471|525733243|FG001|Overall Study|Death|0|||
145788635|NCT05151471|525733242|FG000|Overall Study|Lost to Follow-up|0|||
145788636|NCT05151471|525733243|FG001|Overall Study|Lost to Follow-up|1|||
145788637|NCT05151471|525733242|FG000|Overall Study|Withdrawal by Subject|7|||
145788638|NCT05151471|525733243|FG001|Overall Study|Withdrawal by Subject|9|||
145788639|NCT05151471|525733242|FG000|Overall Study|Study terminated by sponsor|49|||
145788640|NCT05151471|525733243|FG001|Overall Study|Study terminated by sponsor|47|||
145788641|NCT05151471|525733242|FG000|Overall Study|Other|2|||
145788642|NCT05151471|525733243|FG001|Overall Study|Other|1|||
145788643|NCT03010423|525733244|FG000|Overall Study|Study termination|8|||
145788644|NCT03484923|525733247|FG000|Overall Study|Adverse Event|3|||
145788645|NCT03484923|525733248|FG001|Overall Study|Adverse Event|3|||
145788646|NCT03484923|525733249|FG002|Overall Study|Adverse Event|5|||
145788647|NCT03484923|525733250|FG003|Overall Study|Adverse Event|11|||
145788648|NCT03484923|525733251|FG004|Overall Study|Adverse Event|1|||
145788649|NCT03484923|525733247|FG000|Overall Study|Death|2|||
145788650|NCT03484923|525733248|FG001|Overall Study|Death|2|||
145788651|NCT03484923|525733249|FG002|Overall Study|Death|3|||
145788652|NCT03484923|525733250|FG003|Overall Study|Death|0|||
145788653|NCT03484923|525733251|FG004|Overall Study|Death|1|||
145788654|NCT03484923|525733247|FG000|Overall Study|Physician Decision|6|||
145788655|NCT03484923|525733248|FG001|Overall Study|Physician Decision|7|||
145788656|NCT03484923|525733249|FG002|Overall Study|Physician Decision|6|||
145788657|NCT03484923|525733250|FG003|Overall Study|Physician Decision|3|||
145788658|NCT03484923|525733251|FG004|Overall Study|Physician Decision|2|||
145788659|NCT03484923|525733247|FG000|Overall Study|Progressive disease|33|||
145788660|NCT03484923|525733248|FG001|Overall Study|Progressive disease|28|||
145788661|NCT03484923|525733249|FG002|Overall Study|Progressive disease|26|||
145788662|NCT03484923|525733250|FG003|Overall Study|Progressive disease|30|||
145788663|NCT03484923|525733251|FG004|Overall Study|Progressive disease|16|||
145788664|NCT03484923|525733247|FG000|Overall Study|Subject Decision|1|||
145788665|NCT03484923|525733248|FG001|Overall Study|Subject Decision|3|||
145788666|NCT03484923|525733249|FG002|Overall Study|Subject Decision|3|||
145788667|NCT03484923|525733250|FG003|Overall Study|Subject Decision|0|||
145788668|NCT03484923|525733251|FG004|Overall Study|Subject Decision|1|||
145788669|NCT00115349|525733254|FG000|Overall Study|Study closed due to low enrollment.|11|||
145788670|NCT00115349|525733255|FG001|Overall Study|Study closed due to low enrollment.|9|||
145788671|NCT02935634|525733256|FG000|Randomization|Participant withdrew consent|0|||
145788672|NCT02935634|525733257|FG001|Randomization|Participant withdrew consent|1|||
145788673|NCT02935634|525733258|FG002|Randomization|Participant withdrew consent|0|||
145788674|NCT02935634|525733259|FG003|Randomization|Participant withdrew consent|0|||
145788675|NCT02935634|525733260|FG004|Randomization|Participant withdrew consent|0|||
145788676|NCT02935634|525733261|FG005|Randomization|Participant withdrew consent|0|||
145788677|NCT02935634|525733256|FG000|Randomization|Death|2|||
145788678|NCT02935634|525733257|FG001|Randomization|Death|1|||
145788679|NCT02935634|525733258|FG002|Randomization|Death|1|||
145788680|NCT02935634|525733259|FG003|Randomization|Death|0|||
145788681|NCT02935634|525733260|FG004|Randomization|Death|0|||
145788682|NCT02935634|525733261|FG005|Randomization|Death|0|||
145788683|NCT02935634|525733256|FG000|Randomization|Other reasons|0|||
145788684|NCT02935634|525733257|FG001|Randomization|Other reasons|2|||
145788685|NCT02935634|525733258|FG002|Randomization|Other reasons|2|||
145788686|NCT02935634|525733259|FG003|Randomization|Other reasons|0|||
145788687|NCT02935634|525733260|FG004|Randomization|Other reasons|0|||
145788688|NCT02935634|525733261|FG005|Randomization|Other reasons|0|||
145788689|NCT02935634|525733256|FG000|Treatment: Track 1|Disease progression|15|||
145788690|NCT02935634|525733257|FG001|Treatment: Track 1|Disease progression|17|||
145788691|NCT02935634|525733258|FG002|Treatment: Track 1|Disease progression|28|||
145788692|NCT02935634|525733259|FG003|Treatment: Track 1|Disease progression|4|||
145788693|NCT02935634|525733260|FG004|Treatment: Track 1|Disease progression|6|||
145788694|NCT02935634|525733261|FG005|Treatment: Track 1|Disease progression|2|||
145788695|NCT02935634|525733256|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
145788696|NCT02935634|525733257|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
145788697|NCT02935634|525733258|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
145788698|NCT02935634|525733259|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
145788699|NCT02935634|525733260|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
145788700|NCT02935634|525733261|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
145788701|NCT02935634|525733256|FG000|Treatment: Track 1|Lost to Follow-up|1|||
145788702|NCT02935634|525733257|FG001|Treatment: Track 1|Lost to Follow-up|0|||
145788703|NCT02935634|525733258|FG002|Treatment: Track 1|Lost to Follow-up|0|||
145788704|NCT02935634|525733259|FG003|Treatment: Track 1|Lost to Follow-up|0|||
145788705|NCT02935634|525733260|FG004|Treatment: Track 1|Lost to Follow-up|0|||
145788706|NCT02935634|525733261|FG005|Treatment: Track 1|Lost to Follow-up|0|||
145788707|NCT02935634|525733256|FG000|Treatment: Track 1|Study drug toxicity|2|||
145788708|NCT02935634|525733257|FG001|Treatment: Track 1|Study drug toxicity|1|||
145788709|NCT02935634|525733258|FG002|Treatment: Track 1|Study drug toxicity|3|||
145788710|NCT02935634|525733259|FG003|Treatment: Track 1|Study drug toxicity|0|||
145788711|NCT02935634|525733260|FG004|Treatment: Track 1|Study drug toxicity|0|||
145281868|NCT00672620|523883005|FG001|Overall Study|Lack of Efficacy|2|||
145281869|NCT00672620|523883006|FG002|Overall Study|Lack of Efficacy|2|||
145281870|NCT00672620|523883007|FG003|Overall Study|Lack of Efficacy|0|||
145281871|NCT00672620|523883004|FG000|Overall Study|Noncompliance with Study Drug|3|||
145281872|NCT00672620|523883005|FG001|Overall Study|Noncompliance with Study Drug|4|||
145281873|NCT00672620|523883006|FG002|Overall Study|Noncompliance with Study Drug|0|||
145788712|NCT02935634|525733261|FG005|Treatment: Track 1|Study drug toxicity|1|||
145788713|NCT02935634|525733256|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
145788714|NCT02935634|525733257|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
145788715|NCT02935634|525733258|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
145788716|NCT02935634|525733259|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
145788717|NCT02935634|525733260|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
145788718|NCT02935634|525733261|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
145788719|NCT02935634|525733256|FG000|Treatment: Track 1|Participant withdrew consent|2|||
145788720|NCT02935634|525733257|FG001|Treatment: Track 1|Participant withdrew consent|0|||
145788721|NCT02935634|525733258|FG002|Treatment: Track 1|Participant withdrew consent|1|||
145788722|NCT02935634|525733259|FG003|Treatment: Track 1|Participant withdrew consent|0|||
145788723|NCT02935634|525733260|FG004|Treatment: Track 1|Participant withdrew consent|1|||
145788724|NCT02935634|525733261|FG005|Treatment: Track 1|Participant withdrew consent|0|||
145788725|NCT02935634|525733256|FG000|Treatment: Track 1|Other reasons|0|||
145788726|NCT02935634|525733257|FG001|Treatment: Track 1|Other reasons|0|||
145788727|NCT02935634|525733258|FG002|Treatment: Track 1|Other reasons|2|||
145788728|NCT02935634|525733259|FG003|Treatment: Track 1|Other reasons|0|||
145788729|NCT02935634|525733260|FG004|Treatment: Track 1|Other reasons|0|||
145788730|NCT02935634|525733261|FG005|Treatment: Track 1|Other reasons|0|||
145788731|NCT02935634|525733256|FG000|Treatment: Track 2|Disease progression|13|||
145788732|NCT02935634|525733257|FG001|Treatment: Track 2|Disease progression|26|||
145788733|NCT02935634|525733258|FG002|Treatment: Track 2|Disease progression|20|||
145788734|NCT02935634|525733259|FG003|Treatment: Track 2|Disease progression|5|||
145788735|NCT02935634|525733260|FG004|Treatment: Track 2|Disease progression|1|||
145788736|NCT02935634|525733261|FG005|Treatment: Track 2|Disease progression|4|||
145788737|NCT02935634|525733256|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
145788738|NCT02935634|525733257|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
145788739|NCT02935634|525733258|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
145788740|NCT02935634|525733259|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
145788741|NCT02935634|525733260|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
145788742|NCT02935634|525733261|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
145788743|NCT02935634|525733256|FG000|Treatment: Track 2|Study drug toxicity|7|||
145788744|NCT02935634|525733257|FG001|Treatment: Track 2|Study drug toxicity|3|||
145788745|NCT02935634|525733258|FG002|Treatment: Track 2|Study drug toxicity|0|||
145788746|NCT02935634|525733259|FG003|Treatment: Track 2|Study drug toxicity|0|||
145788747|NCT02935634|525733260|FG004|Treatment: Track 2|Study drug toxicity|0|||
145788748|NCT02935634|525733261|FG005|Treatment: Track 2|Study drug toxicity|0|||
145788749|NCT02935634|525733256|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
145788750|NCT02935634|525733257|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
145788751|NCT02935634|525733258|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
145788752|NCT02935634|525733259|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
145788753|NCT02935634|525733260|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
145788754|NCT02935634|525733261|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
145788755|NCT02935634|525733256|FG000|Treatment: Track 2|Participant withdrew consent|0|||
145788756|NCT02935634|525733257|FG001|Treatment: Track 2|Participant withdrew consent|1|||
145788757|NCT02935634|525733258|FG002|Treatment: Track 2|Participant withdrew consent|1|||
145788758|NCT02935634|525733259|FG003|Treatment: Track 2|Participant withdrew consent|0|||
145788759|NCT02935634|525733260|FG004|Treatment: Track 2|Participant withdrew consent|1|||
145788760|NCT02935634|525733261|FG005|Treatment: Track 2|Participant withdrew consent|0|||
145788761|NCT00995345|525733262|FG000|Overall Study|Withdrawal by Subject|4|||
145788762|NCT00995345|525733263|FG001|Overall Study|Withdrawal by Subject|2|||
145788763|NCT00995345|525733264|FG002|Overall Study|Withdrawal by Subject|1|||
145788764|NCT00995345|525733265|FG003|Overall Study|Withdrawal by Subject|3|||
145788765|NCT00995345|525733266|FG004|Overall Study|Withdrawal by Subject|1|||
145788766|NCT00995345|525733262|FG000|Overall Study|Adverse Event|3|||
145788767|NCT00995345|525733263|FG001|Overall Study|Adverse Event|1|||
145788768|NCT00995345|525733264|FG002|Overall Study|Adverse Event|2|||
145788769|NCT00995345|525733265|FG003|Overall Study|Adverse Event|0|||
145788770|NCT00995345|525733266|FG004|Overall Study|Adverse Event|1|||
145788771|NCT00995345|525733262|FG000|Overall Study|Lost to Follow-up|2|||
145281874|NCT00672620|523883007|FG003|Overall Study|Noncompliance with Study Drug|2|||
145281875|NCT00672620|523883004|FG000|Overall Study|Protocol Deviations|5|||
145281876|NCT00672620|523883005|FG001|Overall Study|Protocol Deviations|7|||
145281877|NCT00672620|523883006|FG002|Overall Study|Protocol Deviations|2|||
145281878|NCT00672620|523883007|FG003|Overall Study|Protocol Deviations|5|||
145281879|NCT00672620|523883004|FG000|Overall Study|Withdrawal of Consent|6|||
145281880|NCT00672620|523883005|FG001|Overall Study|Withdrawal of Consent|12|||
145788772|NCT00995345|525733263|FG001|Overall Study|Lost to Follow-up|2|||
145788773|NCT00995345|525733264|FG002|Overall Study|Lost to Follow-up|2|||
145788774|NCT00995345|525733265|FG003|Overall Study|Lost to Follow-up|1|||
145788775|NCT00995345|525733266|FG004|Overall Study|Lost to Follow-up|0|||
145788776|NCT00995345|525733262|FG000|Overall Study|all other reasons combined|2|||
145788777|NCT00995345|525733263|FG001|Overall Study|all other reasons combined|2|||
145788778|NCT00995345|525733264|FG002|Overall Study|all other reasons combined|2|||
145788779|NCT00995345|525733265|FG003|Overall Study|all other reasons combined|1|||
145788780|NCT00995345|525733266|FG004|Overall Study|all other reasons combined|3|||
145788781|NCT02651194|525733267|FG000|Overall Study|Lost to Follow-up|3|||
145788782|NCT02651194|525733267|FG000|Overall Study|Other|2|||
145788783|NCT01842308|525733268|FG000|Overall Study|Withdrawal by Subject|0|||
145788784|NCT01842308|525733269|FG001|Overall Study|Withdrawal by Subject|0|||
145788785|NCT01842308|525733270|FG002|Overall Study|Withdrawal by Subject|0|||
145539787|NCT01847274|524836687|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145539788|NCT01847274|524836688|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145788786|NCT01842308|525733271|FG003|Overall Study|Withdrawal by Subject|0|||
145788787|NCT01842308|525733272|FG004|Overall Study|Withdrawal by Subject|1|||
145788788|NCT03345836|525733285|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
145788789|NCT03345836|525733286|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
145788790|NCT03345836|525733287|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
145788791|NCT03345836|525733288|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
145788792|NCT03345836|525733289|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
145788793|NCT03345836|525733290|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
145788794|NCT03345836|525733285|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
145788795|NCT03345836|525733286|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
145788796|NCT03345836|525733287|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
145788797|NCT03345836|525733288|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
145788798|NCT03345836|525733289|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
145788799|NCT03345836|525733290|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
145788800|NCT03345836|525733285|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
145788801|NCT03345836|525733286|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
145788802|NCT03345836|525733287|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
145788803|NCT03345836|525733288|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
145788804|NCT03345836|525733289|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
145788805|NCT03345836|525733290|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
145788806|NCT03345836|525733285|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
145788807|NCT03345836|525733286|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
145788808|NCT03345836|525733287|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
145788809|NCT03345836|525733288|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
145788810|NCT03345836|525733289|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
145788811|NCT03345836|525733290|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
145788812|NCT03345836|525733285|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
145788813|NCT03345836|525733286|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
145788814|NCT03345836|525733287|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
145788815|NCT03345836|525733288|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
145788816|NCT03345836|525733289|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
145788817|NCT03345836|525733290|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
145788818|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
145788819|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
145788820|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
145788821|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
145788822|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
145788823|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
145788824|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
145788825|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
145788826|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
145788827|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
145788828|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
145788829|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
145788830|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
145788831|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
145788832|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
145788833|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
145788834|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
145788835|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
145788836|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
145788837|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
145788838|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
145788839|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
145788840|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
145404074|NCT01648764|524336466|FG008|Overall Study|Investigator Decision|0|||
145404075|NCT01648764|524336467|FG009|Overall Study|Investigator Decision|0|||
145609803|NCT01861522|525086474|FG001|Overall Study|Adverse Event|0|||
145788841|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
145404076|NCT01648764|524336468|FG010|Overall Study|Investigator Decision|0|||
145788842|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
145788843|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
145788844|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
145788845|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
145788846|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
145788847|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
145788848|NCT03345836|525733285|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
145788849|NCT03345836|525733286|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
145788850|NCT03345836|525733287|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
145788851|NCT03345836|525733288|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
145788852|NCT03345836|525733289|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
145788853|NCT03345836|525733290|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
145788854|NCT00320385|525733293|FG000|Overall Study|Lost to Follow-up|7|||
145788855|NCT00320385|525733294|FG001|Overall Study|Lost to Follow-up|10|||
145788856|NCT00320385|525733293|FG000|Overall Study|Withdrawal by Subject|6|||
145788857|NCT00320385|525733294|FG001|Overall Study|Withdrawal by Subject|7|||
145788858|NCT00320385|525733293|FG000|Overall Study|Sponsor Terminated Study|2|||
145788859|NCT00320385|525733294|FG001|Overall Study|Sponsor Terminated Study|1|||
145788860|NCT00320385|525733293|FG000|Overall Study|Investigator Decision|0|||
145788861|NCT00320385|525733294|FG001|Overall Study|Investigator Decision|1|||
145788862|NCT00320385|525733293|FG000|Overall Study|Death|1|||
145788863|NCT00320385|525733294|FG001|Overall Study|Death|2|||
145788864|NCT00320385|525733293|FG000|Overall Study|Serious Adverse Event|1|||
145788865|NCT00320385|525733294|FG001|Overall Study|Serious Adverse Event|0|||
145788866|NCT00320385|525733293|FG000|Overall Study|Withdrew Consent|1|||
145788867|NCT00320385|525733294|FG001|Overall Study|Withdrew Consent|0|||
145788868|NCT00320385|525733293|FG000|Overall Study|Adverse Event|0|||
145788869|NCT00320385|525733294|FG001|Overall Study|Adverse Event|1|||
145788870|NCT00222729|525733295|FG000|Overall Study|Adverse Event|3|||
145788871|NCT01915849|525733303|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
145788872|NCT01915849|525733304|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
145788873|NCT01915849|525733305|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
145788874|NCT01915849|525733306|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
145788875|NCT01915849|525733303|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
145788876|NCT01915849|525733304|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145788877|NCT01915849|525733305|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145788878|NCT01915849|525733306|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145788879|NCT01798706|525733307|FG000|Overall Study|Adverse Event|15|||
145788880|NCT01798706|525733308|FG001|Overall Study|Adverse Event|10|||
145788881|NCT01798706|525733307|FG000|Overall Study|Lack of Efficacy|0|||
145788882|NCT01798706|525733308|FG001|Overall Study|Lack of Efficacy|2|||
145788883|NCT01798706|525733307|FG000|Overall Study|Poor compliance to protocol|1|||
145788884|NCT01798706|525733308|FG001|Overall Study|Poor compliance to protocol|0|||
145788885|NCT01798706|525733307|FG000|Overall Study|Other than specified above|5|||
145788886|NCT01798706|525733308|FG001|Overall Study|Other than specified above|9|||
145788887|NCT00496873|525733309|FG000|Overall Study|Ineligible|2|||
145788888|NCT00496873|525733309|FG000|Overall Study|Death|2|||
145788889|NCT00496873|525733309|FG000|Overall Study|Withdrawal by Subject|3|||
145788890|NCT00748540|525733310|FG000|Overall Study|Physician Decision|1|||
145788891|NCT02775864|525733311|FG000|Overall Study|Data ended end of 2010|1764|||
145788892|NCT02775864|525733312|FG001|Overall Study|Data ended end of 2010|2880|||
145788893|NCT02775864|525733313|FG002|Overall Study|Data ended end of 2010|1140|||
145788894|NCT02775864|525733314|FG003|Overall Study|Data ended end of 2010|1194|||
145788895|NCT02775864|525733311|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
145788896|NCT02775864|525733312|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
145788897|NCT02775864|525733313|FG002|Overall Study|Medicaid eligibility discontinued|720|||
145788898|NCT02775864|525733314|FG003|Overall Study|Medicaid eligibility discontinued|890|||
145788899|NCT02028338|525733316|FG000|Overall Study|Withdrawal by Subject|3|||
145788900|NCT02028338|525733317|FG001|Overall Study|Withdrawal by Subject|1|||
145788901|NCT02028338|525733316|FG000|Overall Study|Unable to contact participant|1|||
145788902|NCT02028338|525733317|FG001|Overall Study|Unable to contact participant|0|||
145788903|NCT03552549|525733318|FG000|Overall Study|Disease progression|25|||
145788904|NCT03552549|525733319|FG001|Overall Study|Disease progression|17|||
145788905|NCT03552549|525733318|FG000|Overall Study|Adverse event in first 12 months|12|||
145788906|NCT03552549|525733319|FG001|Overall Study|Adverse event in first 12 months|8|||
145788907|NCT03552549|525733318|FG000|Overall Study|Withdrawal by Subject|7|||
145788908|NCT03552549|525733319|FG001|Overall Study|Withdrawal by Subject|7|||
145788909|NCT03552549|525733318|FG000|Overall Study|Unknown (no reason provided)|4|||
145788910|NCT03552549|525733319|FG001|Overall Study|Unknown (no reason provided)|2|||
145788911|NCT03552549|525733318|FG000|Overall Study|Not in participant's best interest|2|||
145788912|NCT03552549|525733319|FG001|Overall Study|Not in participant's best interest|1|||
145788913|NCT03552549|525733318|FG000|Overall Study|Did not complete study treatment|2|||
145788914|NCT03552549|525733319|FG001|Overall Study|Did not complete study treatment|3|||
145788915|NCT03552549|525733318|FG000|Overall Study|Did not meet eligibility criteria|1|||
145788916|NCT03552549|525733319|FG001|Overall Study|Did not meet eligibility criteria|0|||
145788917|NCT03552549|525733318|FG000|Overall Study|Administrative|0|||
145788918|NCT03552549|525733319|FG001|Overall Study|Administrative|14|||
145788919|NCT02761993|525733328|FG000|Overall Study|Adverse Event|0|||
145788920|NCT02761993|525733329|FG001|Overall Study|Adverse Event|2|||
145788921|NCT02761993|525733330|FG002|Overall Study|Adverse Event|0|||
145788922|NCT02761993|525733328|FG000|Overall Study|Lost to Follow-up|1|||
145788923|NCT02761993|525733329|FG001|Overall Study|Lost to Follow-up|3|||
145788924|NCT02761993|525733330|FG002|Overall Study|Lost to Follow-up|2|||
145788925|NCT02761993|525733328|FG000|Overall Study|Withdrawal by Subject|1|||
145788926|NCT02761993|525733329|FG001|Overall Study|Withdrawal by Subject|1|||
145788927|NCT02761993|525733330|FG002|Overall Study|Withdrawal by Subject|2|||
145788928|NCT01842620|525733331|FG000|Period 1|Withdrawal by Subject|1|||
145788929|NCT01842620|525733332|FG001|Period 1|Withdrawal by Subject|0|||
145788930|NCT01930799|525733337|FG000|Overall Study|Withdrawal by Subject|3|||
145788931|NCT01930799|525733337|FG000|Overall Study|Lost to Follow-up|5|||
145788932|NCT02689219|525733340|FG000|Overall Study|Death|1|||
145788933|NCT02689219|525733341|FG001|Overall Study|Death|1|||
145788934|NCT02689219|525733340|FG000|Overall Study|Disease Progression|10|||
145788935|NCT02689219|525733341|FG001|Overall Study|Disease Progression|6|||
145788936|NCT01921257|525733342|FG000|Overall Study|Adverse Event|1|||
145788937|NCT01921257|525733342|FG000|Overall Study|Protocol Violation|1|||
145788938|NCT01921257|525733342|FG000|Overall Study|Withdrawal by Subject|1|||
145788939|NCT05515601|525733347|FG000|Overall Study|Withdrawal by Subject|1|||
145788940|NCT05515601|525733348|FG001|Overall Study|Withdrawal by Subject|3|||
145788941|NCT05515601|525733349|FG002|Overall Study|Withdrawal by Subject|2|||
145788942|NCT05515601|525733350|FG003|Overall Study|Withdrawal by Subject|1|||
145788943|NCT05515601|525733351|FG004|Overall Study|Withdrawal by Subject|1|||
145788944|NCT05515601|525733352|FG005|Overall Study|Withdrawal by Subject|1|||
145788945|NCT05515601|525733347|FG000|Overall Study|Lost to Follow-up|0|||
145788946|NCT05515601|525733348|FG001|Overall Study|Lost to Follow-up|0|||
145788947|NCT05515601|525733349|FG002|Overall Study|Lost to Follow-up|0|||
145788948|NCT05515601|525733350|FG003|Overall Study|Lost to Follow-up|0|||
145788949|NCT05515601|525733351|FG004|Overall Study|Lost to Follow-up|1|||
145788950|NCT05515601|525733352|FG005|Overall Study|Lost to Follow-up|0|||
145788951|NCT00777491|525733353|FG000|Overall Study|Protocol Violation|0|||
145788952|NCT00777491|525733354|FG001|Overall Study|Protocol Violation|2|||
145788953|NCT00777491|525733353|FG000|Overall Study|Did not receive any protocol treatment|2|||
145788954|NCT00777491|525733354|FG001|Overall Study|Did not receive any protocol treatment|0|||
145788955|NCT01689207|525733355|FG000|Overall Study|Adverse Event|0|||
145788956|NCT01689207|525733356|FG001|Overall Study|Adverse Event|1|||
145788957|NCT01689207|525733357|FG002|Overall Study|Adverse Event|0|||
145788958|NCT01689207|525733358|FG003|Overall Study|Adverse Event|0|||
145788959|NCT01689207|525733359|FG004|Overall Study|Adverse Event|2|||
145788960|NCT01689207|525733360|FG005|Overall Study|Adverse Event|1|||
145788961|NCT01689207|525733361|FG006|Overall Study|Adverse Event|0|||
145788962|NCT01689207|525733362|FG007|Overall Study|Adverse Event|0|||
145788963|NCT01689207|525733363|FG008|Overall Study|Adverse Event|1|||
145788964|NCT01689207|525733364|FG009|Overall Study|Adverse Event|0|||
145788965|NCT01689207|525733365|FG010|Overall Study|Adverse Event|0|||
145788966|NCT00364845|525733366|FG000|Overall Study|Adverse Event|1|||
145788967|NCT00364845|525733367|FG001|Overall Study|Adverse Event|0|||
145788968|NCT00364845|525733366|FG000|Overall Study|Withdrawal by Subject|2|||
145788969|NCT00364845|525733367|FG001|Overall Study|Withdrawal by Subject|1|||
145788970|NCT00364845|525733366|FG000|Overall Study|Physician Decision|8|||
145788971|NCT00364845|525733367|FG001|Overall Study|Physician Decision|8|||
145788972|NCT00364845|525733366|FG000|Overall Study|Lost to Follow-up|0|||
145788973|NCT00364845|525733367|FG001|Overall Study|Lost to Follow-up|1|||
145788974|NCT00364845|525733366|FG000|Overall Study|Death|0|||
145788975|NCT00364845|525733367|FG001|Overall Study|Death|1|||
145788976|NCT01912768|525733368|FG000|Overall Study|Adverse Event|2|||
145788977|NCT01912768|525733369|FG001|Overall Study|Adverse Event|0|||
145788978|NCT01912768|525733368|FG000|Overall Study|Lost to Follow-up|2|||
145788979|NCT01912768|525733369|FG001|Overall Study|Lost to Follow-up|1|||
145788980|NCT01912768|525733368|FG000|Overall Study|Withdrawal by Subject|5|||
145788981|NCT01912768|525733369|FG001|Overall Study|Withdrawal by Subject|3|||
145788982|NCT01912768|525733368|FG000|Overall Study|Randomized in error|1|||
145788983|NCT01912768|525733369|FG001|Overall Study|Randomized in error|0|||
145788984|NCT00524316|525733370|FG000|Overall Study|Withdrawal by Subject|2|||
145788985|NCT00524316|525733370|FG000|Overall Study|Adverse Event|7|||
145788986|NCT00524316|525733370|FG000|Overall Study|Disease Progression|7|||
145788987|NCT02426658|525733373|FG000|Overall Study|Withdrawal by Subject|1|||
145788988|NCT02426658|525733373|FG000|Overall Study|Patient expired before treatment|2|||
145788989|NCT01199263|525733374|FG000|Overall Study|Ineligible|0|||
145788990|NCT01199263|525733375|FG001|Overall Study|Ineligible|2|||
145788991|NCT01199263|525733374|FG000|Overall Study|Never Treated|6|||
145788992|NCT01199263|525733375|FG001|Overall Study|Never Treated|0|||
145788993|NCT00488033|525733376|FG000|Overall Study|Withdrawal by Subject|1|||
145788994|NCT00488033|525733377|FG001|Overall Study|Withdrawal by Subject|0|||
145788995|NCT01515306|525733378|FG000|Overall Study|Adverse Event|3|||
145788996|NCT01515306|525733379|FG001|Overall Study|Adverse Event|2|||
145788997|NCT01515306|525733378|FG000|Overall Study|Progressive Disease|19|||
145788998|NCT01515306|525733379|FG001|Overall Study|Progressive Disease|9|||
145788999|NCT01515306|525733378|FG000|Overall Study|Withdrawal by Subject|1|||
145789000|NCT01515306|525733379|FG001|Overall Study|Withdrawal by Subject|2|||
145789001|NCT01515306|525733378|FG000|Overall Study|Physician Decision|1|||
145789002|NCT01515306|525733379|FG001|Overall Study|Physician Decision|1|||
145789003|NCT03591146|525733385|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
145789004|NCT03591146|525733386|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
145789005|NCT03591146|525733387|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
145789006|NCT03591146|525733388|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
145789007|NCT03591146|525733389|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
145789008|NCT03591146|525733385|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
145789009|NCT03591146|525733386|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
145789010|NCT03591146|525733387|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
145789011|NCT03591146|525733388|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
145789012|NCT03591146|525733389|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
145789013|NCT03591146|525733385|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
145789014|NCT03591146|525733386|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
145789015|NCT03591146|525733387|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
145789016|NCT03591146|525733388|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
145789017|NCT03591146|525733389|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
145789018|NCT03591146|525733385|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
145789019|NCT03591146|525733386|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
145789020|NCT03591146|525733387|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
145789021|NCT03591146|525733388|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
145789022|NCT03591146|525733389|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
145789023|NCT04737031|525733390|FG000|Overall Study|Patients who did not have a treatment visit|0|||
145789024|NCT04737031|525733391|FG001|Overall Study|Patients who did not have a treatment visit|31|||
145789025|NCT04737031|525733392|FG002|Overall Study|Patients who did not have a treatment visit|93|||
145789026|NCT04737031|525733393|FG003|Overall Study|Patients who did not have a treatment visit|227|||
145789027|NCT03453151|525733394|FG000|Overall Study|Withdrawal by Subject|1|||
145789028|NCT03453151|525733394|FG000|Overall Study|Physician Decision|3|||
145789029|NCT01204658|525733395|FG000|Primary Phase|Adverse Event|0|||
145789030|NCT01204658|525733396|FG001|Primary Phase|Adverse Event|0|||
145789031|NCT01204658|525733397|FG002|Primary Phase|Adverse Event|1|||
145789032|NCT01204658|525733398|FG003|Primary Phase|Adverse Event|0|||
145789033|NCT03364335|525734660|FG000|Overall Study|Adverse Event|3|||
145789034|NCT03364335|525734661|FG001|Overall Study|Adverse Event|4|||
145789035|NCT03364335|525734662|FG002|Overall Study|Adverse Event|1|||
145789036|NCT03364335|525734663|FG003|Overall Study|Adverse Event|2|||
145789037|NCT03364335|525734664|FG004|Overall Study|Adverse Event|0|||
145789038|NCT03364335|525734660|FG000|Overall Study|Lost to Follow-up|7|||
145789039|NCT03364335|525734661|FG001|Overall Study|Lost to Follow-up|7|||
145789040|NCT03364335|525734662|FG002|Overall Study|Lost to Follow-up|10|||
145789041|NCT03364335|525734663|FG003|Overall Study|Lost to Follow-up|11|||
145789042|NCT03364335|525734664|FG004|Overall Study|Lost to Follow-up|11|||
145789043|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
145789044|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
145789045|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
145789046|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
145789047|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
145789048|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
145789049|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
145789050|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
145789051|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
145789052|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
145789053|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
145789054|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
145789055|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
145789056|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
145789057|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
145789058|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
145789059|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
145789060|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789061|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789062|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789063|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789064|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789065|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789066|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
145789067|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
145789068|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789069|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789070|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789071|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789072|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789073|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789074|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
145789075|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
145789076|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
145789077|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
145789078|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
145789079|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
145789080|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
145789081|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
145789082|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
145789083|NCT03725202|525734665|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789084|NCT03725202|525734666|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789085|NCT03725202|525734667|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
145789086|NCT03725202|525734668|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789087|NCT03725202|525734669|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789088|NCT03725202|525734670|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789089|NCT03725202|525734671|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789090|NCT03725202|525734672|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
145789091|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
145789092|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
145789093|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
145789094|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
145789095|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
145789096|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
145789097|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
145789098|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
145609804|NCT01861522|525086473|FG000|Overall Study|Withdrawal by Subject|2|||
145609805|NCT01861522|525086474|FG001|Overall Study|Withdrawal by Subject|0|||
145609806|NCT00926003|525086476|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
145609807|NCT00926003|525086477|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
145609808|NCT00926003|525086478|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
145609809|NCT00926003|525086476|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
145609810|NCT00926003|525086477|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
145609811|NCT00926003|525086478|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
145609812|NCT01103960|525086479|FG000|Overall Study|Adverse Event|2|||
145609813|NCT01103960|525086480|FG001|Overall Study|Adverse Event|1|||
145609814|NCT01103960|525086479|FG000|Overall Study|Withdrawal by Subject|2|||
145609815|NCT01103960|525086480|FG001|Overall Study|Withdrawal by Subject|1|||
145609816|NCT01103960|525086479|FG000|Overall Study|Other|1|||
145609817|NCT01103960|525086480|FG001|Overall Study|Other|0|||
145609818|NCT00118898|525086484|FG000|Overall Study|Death|6|||
145609819|NCT00118898|525086485|FG001|Overall Study|Death|11|||
145609820|NCT00118898|525086486|FG002|Overall Study|Death|6|||
145609821|NCT00118898|525086487|FG003|Overall Study|Death|8|||
145609822|NCT00118898|525086484|FG000|Overall Study|Lost to Follow-up|26|||
145609823|NCT00118898|525086485|FG001|Overall Study|Lost to Follow-up|34|||
145609824|NCT00118898|525086486|FG002|Overall Study|Lost to Follow-up|33|||
145609825|NCT00118898|525086487|FG003|Overall Study|Lost to Follow-up|33|||
145609826|NCT00118898|525086484|FG000|Overall Study|Withdrawal by Subject|10|||
145609827|NCT00118898|525086485|FG001|Overall Study|Withdrawal by Subject|5|||
145609828|NCT00118898|525086486|FG002|Overall Study|Withdrawal by Subject|8|||
145609829|NCT00118898|525086487|FG003|Overall Study|Withdrawal by Subject|8|||
145609830|NCT00118898|525086484|FG000|Overall Study|Site Closure|33|||
145609831|NCT00118898|525086485|FG001|Overall Study|Site Closure|31|||
145609832|NCT00118898|525086486|FG002|Overall Study|Site Closure|28|||
145609833|NCT00118898|525086487|FG003|Overall Study|Site Closure|37|||
145609834|NCT00118898|525086484|FG000|Overall Study|Severe debilitation|1|||
145281881|NCT00672620|523883006|FG002|Overall Study|Withdrawal of Consent|5|||
145281882|NCT00672620|523883007|FG003|Overall Study|Withdrawal of Consent|6|||
145281883|NCT00672620|523883004|FG000|Overall Study|Lost to Follow-up|8|||
145281884|NCT00672620|523883005|FG001|Overall Study|Lost to Follow-up|19|||
145281885|NCT00672620|523883006|FG002|Overall Study|Lost to Follow-up|8|||
145281886|NCT00672620|523883007|FG003|Overall Study|Lost to Follow-up|11|||
145281887|NCT00672620|523883004|FG000|Overall Study|Reason not Specified|3|||
145281888|NCT00672620|523883005|FG001|Overall Study|Reason not Specified|3|||
145281889|NCT00672620|523883006|FG002|Overall Study|Reason not Specified|2|||
145281890|NCT00672620|523883007|FG003|Overall Study|Reason not Specified|1|||
145281891|NCT03211156|523883008|FG000|Overall Study|Withdrawal by Subject|0|||
145281892|NCT03211156|523883009|FG001|Overall Study|Withdrawal by Subject|2|||
145281893|NCT03211156|523883008|FG000|Overall Study|Lost to Follow-up|1|||
145281894|NCT03211156|523883009|FG001|Overall Study|Lost to Follow-up|1|||
145281895|NCT03211156|523883008|FG000|Overall Study|Adverse Event|1|||
145281896|NCT03211156|523883009|FG001|Overall Study|Adverse Event|0|||
145281897|NCT02736227|523883015|FG000|Overall Study|Withdrawal by Subject|0|||
145281898|NCT02736227|523883016|FG001|Overall Study|Withdrawal by Subject|0|||
145281899|NCT02736227|523883017|FG002|Overall Study|Withdrawal by Subject|1|||
145281900|NCT02736227|523883015|FG000|Overall Study|Physician Decision|0|||
145281901|NCT02736227|523883016|FG001|Overall Study|Physician Decision|0|||
145539789|NCT01847274|524836689|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145539790|NCT01847274|524836690|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145539791|NCT01847274|524836691|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145281902|NCT02736227|523883017|FG002|Overall Study|Physician Decision|5|||
145281903|NCT02736227|523883015|FG000|Overall Study|Non Compliant|0|||
145281904|NCT02736227|523883016|FG001|Overall Study|Non Compliant|0|||
145281905|NCT02736227|523883017|FG002|Overall Study|Non Compliant|2|||
145281906|NCT04120194|523883026|FG000|Overall Study|Lost to Follow-up|11|||
145281907|NCT04120194|523883027|FG001|Overall Study|Lost to Follow-up|8|||
145281908|NCT04120194|523883026|FG000|Overall Study|Adverse Event|4|||
145281909|NCT04120194|523883027|FG001|Overall Study|Adverse Event|5|||
145281910|NCT04120194|523883026|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
145281911|NCT04120194|523883027|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
145281912|NCT04120194|523883026|FG000|Overall Study|Miscellaneous|4|||
145281913|NCT04120194|523883027|FG001|Overall Study|Miscellaneous|5|||
145281914|NCT00553540|523883028|FG000|Overall Study|discharged after first visit|2|||
145281915|NCT00553540|523883029|FG001|Overall Study|discharged after first visit|5|||
145281916|NCT03565211|523883042|FG000|Overall Study|Withdrawal by Subject|2|||
145281917|NCT03565211|523883042|FG000|Overall Study|Lost to Follow-up|1|||
145281918|NCT03565211|523883042|FG000|Overall Study|Adverse Event|44|||
145281919|NCT03565211|523883042|FG000|Overall Study|Personal issues|1|||
145281920|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281921|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281922|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281923|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
145281924|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281925|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281926|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281927|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281928|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281929|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
145281930|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145539792|NCT01847274|524836692|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
145539793|NCT01847274|524836693|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
145539794|NCT01847274|524836694|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
145539795|NCT01847274|524836695|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
145539796|NCT01847274|524836685|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539797|NCT01847274|524836686|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539798|NCT01847274|524836687|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539799|NCT01847274|524836688|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539800|NCT01847274|524836689|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539801|NCT01847274|524836690|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539802|NCT01847274|524836691|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539803|NCT01847274|524836692|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539804|NCT01847274|524836693|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145539805|NCT01847274|524836694|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
145281931|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145281932|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Adverse Event|1|||
145281933|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Adverse Event|1|||
145281934|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Adverse Event|1|||
145281935|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Adverse Event|1|||
145281936|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Adverse Event|0|||
145281937|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Adverse Event|0|||
145281938|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Adverse Event|0|||
145281939|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Adverse Event|0|||
145281940|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
145609835|NCT00118898|525086485|FG001|Overall Study|Severe debilitation|4|||
145609836|NCT00118898|525086486|FG002|Overall Study|Severe debilitation|6|||
145609837|NCT00118898|525086487|FG003|Overall Study|Severe debilitation|4|||
145609838|NCT00118898|525086484|FG000|Overall Study|Not compliant with requirements|11|||
145609839|NCT00118898|525086485|FG001|Overall Study|Not compliant with requirements|13|||
145609840|NCT00118898|525086486|FG002|Overall Study|Not compliant with requirements|11|||
145609841|NCT00118898|525086487|FG003|Overall Study|Not compliant with requirements|11|||
145609842|NCT00118898|525086484|FG000|Overall Study|Not able to get to clinic|34|||
145609843|NCT00118898|525086485|FG001|Overall Study|Not able to get to clinic|43|||
145609844|NCT00118898|525086486|FG002|Overall Study|Not able to get to clinic|31|||
145609845|NCT00118898|525086487|FG003|Overall Study|Not able to get to clinic|40|||
145609846|NCT02073097|525086488|FG000|Overall Study|Adverse Event|0|||
145609847|NCT02073097|525086489|FG001|Overall Study|Adverse Event|0|||
145609848|NCT02073097|525086490|FG002|Overall Study|Adverse Event|0|||
145609849|NCT02073097|525086491|FG003|Overall Study|Adverse Event|0|||
145609850|NCT02073097|525086492|FG004|Overall Study|Adverse Event|0|||
145609851|NCT02073097|525086493|FG005|Overall Study|Adverse Event|0|||
145609852|NCT02073097|525086494|FG006|Overall Study|Adverse Event|0|||
145609853|NCT02073097|525086495|FG007|Overall Study|Adverse Event|2|||
145609854|NCT02073097|525086488|FG000|Overall Study|Withdrawal by Subject|0|||
145609855|NCT02073097|525086489|FG001|Overall Study|Withdrawal by Subject|0|||
145609856|NCT02073097|525086490|FG002|Overall Study|Withdrawal by Subject|0|||
145609857|NCT02073097|525086491|FG003|Overall Study|Withdrawal by Subject|0|||
145609858|NCT02073097|525086492|FG004|Overall Study|Withdrawal by Subject|0|||
145609859|NCT02073097|525086493|FG005|Overall Study|Withdrawal by Subject|0|||
145609860|NCT02073097|525086494|FG006|Overall Study|Withdrawal by Subject|0|||
145609861|NCT02073097|525086495|FG007|Overall Study|Withdrawal by Subject|2|||
145609862|NCT02073097|525086488|FG000|Overall Study|Death|0|||
145609863|NCT02073097|525086489|FG001|Overall Study|Death|0|||
145609864|NCT02073097|525086490|FG002|Overall Study|Death|0|||
145609865|NCT02073097|525086491|FG003|Overall Study|Death|0|||
145609866|NCT02073097|525086492|FG004|Overall Study|Death|0|||
145609867|NCT02073097|525086493|FG005|Overall Study|Death|0|||
145609868|NCT02073097|525086494|FG006|Overall Study|Death|0|||
145609869|NCT02073097|525086495|FG007|Overall Study|Death|1|||
145609870|NCT02073097|525086488|FG000|Overall Study|Physician Decision|0|||
145609871|NCT02073097|525086489|FG001|Overall Study|Physician Decision|0|||
145609872|NCT02073097|525086490|FG002|Overall Study|Physician Decision|0|||
145609873|NCT02073097|525086491|FG003|Overall Study|Physician Decision|0|||
145609874|NCT02073097|525086492|FG004|Overall Study|Physician Decision|0|||
145609875|NCT02073097|525086493|FG005|Overall Study|Physician Decision|0|||
145609876|NCT02073097|525086494|FG006|Overall Study|Physician Decision|0|||
145609877|NCT02073097|525086495|FG007|Overall Study|Physician Decision|1|||
145609878|NCT02254408|525088038|FG000|Overall Study|Randomized But Not Treated|1|||
145609879|NCT02254408|525088039|FG001|Overall Study|Randomized But Not Treated|3|||
145609880|NCT02254408|525088038|FG000|Overall Study|Adverse Event|1|||
145609881|NCT02254408|525088039|FG001|Overall Study|Adverse Event|0|||
145609882|NCT02254408|525088038|FG000|Overall Study|Death|2|||
145609883|NCT02254408|525088039|FG001|Overall Study|Death|3|||
145609884|NCT02254408|525088038|FG000|Overall Study|Investigator's Discretion|0|||
145609885|NCT02254408|525088039|FG001|Overall Study|Investigator's Discretion|1|||
145609886|NCT02254408|525088038|FG000|Overall Study|Withdrawal by Subject|3|||
145609887|NCT02254408|525088039|FG001|Overall Study|Withdrawal by Subject|3|||
145281941|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
145404077|NCT01648764|524336469|FG011|Overall Study|Investigator Decision|1|||
145404078|NCT01648764|524336470|FG012|Overall Study|Investigator Decision|0|||
145609888|NCT02254408|525088038|FG000|Overall Study|Lost to Follow-up|1|||
145609889|NCT02254408|525088039|FG001|Overall Study|Lost to Follow-up|0|||
145609890|NCT02914184|525088043|FG000|Overall Study|Lost to Follow-up|7|||
145609891|NCT02914184|525088044|FG001|Overall Study|Lost to Follow-up|10|||
145609892|NCT02914184|525088045|FG002|Overall Study|Lost to Follow-up|8|||
145609893|NCT02914184|525088046|FG003|Overall Study|Lost to Follow-up|7|||
145609894|NCT02914184|525088043|FG000|Overall Study|Withdrawal by Subject|4|||
145609895|NCT02914184|525088044|FG001|Overall Study|Withdrawal by Subject|2|||
145609896|NCT02914184|525088045|FG002|Overall Study|Withdrawal by Subject|7|||
145281942|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
145281943|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
145609897|NCT02914184|525088046|FG003|Overall Study|Withdrawal by Subject|3|||
145609898|NCT02914184|525088043|FG000|Overall Study|Other|1|||
145609899|NCT02914184|525088044|FG001|Overall Study|Other|0|||
145609900|NCT02914184|525088045|FG002|Overall Study|Other|0|||
145609901|NCT02914184|525088046|FG003|Overall Study|Other|0|||
145609902|NCT02914184|525088043|FG000|Overall Study|Migrated/moved from the study area|2|||
145609903|NCT02914184|525088044|FG001|Overall Study|Migrated/moved from the study area|1|||
145609904|NCT02914184|525088045|FG002|Overall Study|Migrated/moved from the study area|2|||
145609905|NCT02914184|525088046|FG003|Overall Study|Migrated/moved from the study area|1|||
145609906|NCT00768430|525088047|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
145609907|NCT00768430|525088048|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
145609908|NCT00802659|525088049|FG000|Overall Study|Physician Decision|0|||
145609909|NCT00802659|525088050|FG001|Overall Study|Physician Decision|1|||
145609910|NCT00802659|525088051|FG002|Overall Study|Physician Decision|0|||
145609911|NCT00802659|525088052|FG003|Overall Study|Physician Decision|0|||
145609912|NCT00041756|525088053|FG000|Overall Study|Adverse Event|4|||
145609913|NCT00041756|525088054|FG001|Overall Study|Adverse Event|10|||
145609914|NCT00041756|525088055|FG002|Overall Study|Adverse Event|6|||
145609915|NCT00041756|525088056|FG003|Overall Study|Adverse Event|11|||
145609916|NCT00041756|525088057|FG004|Overall Study|Adverse Event|34|||
145609917|NCT00041756|525088053|FG000|Overall Study|Protocol Violation|1|||
145609918|NCT00041756|525088054|FG001|Overall Study|Protocol Violation|1|||
145609919|NCT00041756|525088055|FG002|Overall Study|Protocol Violation|2|||
145609920|NCT00041756|525088056|FG003|Overall Study|Protocol Violation|2|||
145609921|NCT00041756|525088057|FG004|Overall Study|Protocol Violation|1|||
145609922|NCT00041756|525088053|FG000|Overall Study|Withdrawal by Subject|3|||
145609923|NCT00041756|525088054|FG001|Overall Study|Withdrawal by Subject|3|||
145609924|NCT00041756|525088055|FG002|Overall Study|Withdrawal by Subject|4|||
145609925|NCT00041756|525088056|FG003|Overall Study|Withdrawal by Subject|2|||
145609926|NCT00041756|525088057|FG004|Overall Study|Withdrawal by Subject|3|||
145609927|NCT00041756|525088053|FG000|Overall Study|Lost to Follow-up|0|||
145609928|NCT00041756|525088054|FG001|Overall Study|Lost to Follow-up|1|||
145609929|NCT00041756|525088055|FG002|Overall Study|Lost to Follow-up|0|||
145609930|NCT00041756|525088056|FG003|Overall Study|Lost to Follow-up|1|||
145789099|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
145789100|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
145789101|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
145789102|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
145789103|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
145789104|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
145789105|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
145789106|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
145789107|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
145789108|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
145789109|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
145789110|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
145789111|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
145789112|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
145789113|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
145789114|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
145789115|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789116|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789117|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789118|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789119|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789120|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789121|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
145789122|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
145789123|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789124|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789125|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789126|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789127|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789128|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
145789129|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789130|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
145789131|NCT03725202|525734665|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
145789132|NCT03725202|525734666|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
145609931|NCT00041756|525088057|FG004|Overall Study|Lost to Follow-up|0|||
145609932|NCT00041756|525088053|FG000|Overall Study|Unable to meet protocol criteria|0|||
145609933|NCT00041756|525088054|FG001|Overall Study|Unable to meet protocol criteria|0|||
145609934|NCT00041756|525088055|FG002|Overall Study|Unable to meet protocol criteria|1|||
145609935|NCT00041756|525088056|FG003|Overall Study|Unable to meet protocol criteria|0|||
145609936|NCT00041756|525088057|FG004|Overall Study|Unable to meet protocol criteria|1|||
145609937|NCT00041756|525088053|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
145789133|NCT03725202|525734667|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
145789134|NCT03725202|525734668|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
145789135|NCT03725202|525734669|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
145789136|NCT03725202|525734670|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
145789137|NCT03725202|525734671|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
145789138|NCT03725202|525734672|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
145789139|NCT00262080|525734679|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
145789140|NCT00262080|525734680|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
145789141|NCT00262080|525734681|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
145789142|NCT00262080|525734679|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
145789143|NCT00262080|525734680|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
145789144|NCT00262080|525734681|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
145789145|NCT00262080|525734679|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
145789146|NCT00262080|525734680|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
145789147|NCT00262080|525734681|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
145789148|NCT00262080|525734679|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
145789149|NCT00262080|525734680|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
145789150|NCT00262080|525734681|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
145789151|NCT00262080|525734679|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
145789152|NCT00262080|525734680|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
145789153|NCT00262080|525734681|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
145789154|NCT00262080|525734679|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
145789155|NCT00262080|525734680|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
145789156|NCT00262080|525734681|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
145789157|NCT01030458|525734686|FG000|Overall Study|Lost to Follow-up|9|||
145789158|NCT01030458|525734687|FG001|Overall Study|Lost to Follow-up|10|||
145789159|NCT01030458|525734686|FG000|Overall Study|Withdrawal by Subject|2|||
145789160|NCT01030458|525734687|FG001|Overall Study|Withdrawal by Subject|3|||
145789161|NCT01030458|525734686|FG000|Overall Study|Logistical reasons|9|||
145789162|NCT01030458|525734687|FG001|Overall Study|Logistical reasons|5|||
145789163|NCT01030458|525734686|FG000|Overall Study|Moved or changed job|6|||
145789164|NCT01030458|525734687|FG001|Overall Study|Moved or changed job|13|||
145789165|NCT01030458|525734686|FG000|Overall Study|Side effect of medication|1|||
145789166|NCT01030458|525734687|FG001|Overall Study|Side effect of medication|1|||
145789167|NCT02420223|525734688|FG000|Overall Study|Adverse Event|1|||
145789168|NCT02420223|525734689|FG001|Overall Study|Adverse Event|0|||
145789169|NCT02420223|525734688|FG000|Overall Study|Physician Decision|0|||
145789170|NCT02420223|525734689|FG001|Overall Study|Physician Decision|2|||
145789171|NCT01361009|525734690|FG000|Overall Study|Protocol Violation|116|||
145789172|NCT02345252|525734694|FG000|Double-Blind Phase|Adverse Event|2|||
145789173|NCT02345252|525734695|FG001|Double-Blind Phase|Adverse Event|3|||
145789174|NCT02345252|525734694|FG000|Double-Blind Phase|Death|1|||
145789175|NCT02345252|525734695|FG001|Double-Blind Phase|Death|2|||
145789176|NCT02345252|525734694|FG000|Double-Blind Phase|Lack of Efficacy|1|||
145789177|NCT02345252|525734695|FG001|Double-Blind Phase|Lack of Efficacy|0|||
145789178|NCT02345252|525734694|FG000|Double-Blind Phase|Investigator's Discretion|4|||
145789179|NCT02345252|525734695|FG001|Double-Blind Phase|Investigator's Discretion|6|||
145789180|NCT02345252|525734694|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
145789181|NCT02345252|525734695|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
145789182|NCT02345252|525734694|FG000|Double-Blind Phase|Protocol Violation|2|||
145789183|NCT02345252|525734695|FG001|Double-Blind Phase|Protocol Violation|1|||
145789184|NCT02345252|525734694|FG000|Double-Blind Phase|Withdrew Consent|21|||
145789185|NCT02345252|525734695|FG001|Double-Blind Phase|Withdrew Consent|23|||
145789186|NCT02345252|525734694|FG000|Double-Blind Phase|Lost to Follow-up|8|||
145789187|NCT02345252|525734695|FG001|Double-Blind Phase|Lost to Follow-up|10|||
145789188|NCT02345252|525734694|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
145789189|NCT02345252|525734695|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
145789190|NCT00471536|525734700|FG000|Overall Study|Withdrawal by Subject|1|||
145789191|NCT01980706|525734701|FG000|Overall Study|Withdrawal by Subject|9|||
145789192|NCT01980706|525734702|FG001|Overall Study|Withdrawal by Subject|6|||
145789193|NCT01980706|525734703|FG002|Overall Study|Withdrawal by Subject|2|||
145789194|NCT01980706|525734701|FG000|Overall Study|Adverse Event|1|||
145789195|NCT01980706|525734702|FG001|Overall Study|Adverse Event|2|||
145789196|NCT01980706|525734703|FG002|Overall Study|Adverse Event|5|||
145789197|NCT01980706|525734701|FG000|Overall Study|Lost to Follow-up|3|||
145789198|NCT01980706|525734702|FG001|Overall Study|Lost to Follow-up|4|||
145789199|NCT01980706|525734703|FG002|Overall Study|Lost to Follow-up|3|||
145789200|NCT01980706|525734701|FG000|Overall Study|miscellaneous|4|||
145789201|NCT01980706|525734702|FG001|Overall Study|miscellaneous|5|||
145789202|NCT01980706|525734703|FG002|Overall Study|miscellaneous|3|||
145789203|NCT02546674|525734706|FG000|Overall Study|Adverse Event|19|||
145789204|NCT02546674|525734706|FG000|Overall Study|Death|1|||
145789205|NCT02546674|525734706|FG000|Overall Study|Lost to Follow-up|1|||
145789206|NCT02546674|525734706|FG000|Overall Study|Physician Decision|13|||
145789207|NCT02546674|525734706|FG000|Overall Study|Pregnancy|1|||
145789208|NCT02546674|525734706|FG000|Overall Study|Progressive Disease|2|||
145789209|NCT02546674|525734706|FG000|Overall Study|Protocol Deviation|2|||
145789210|NCT02546674|525734706|FG000|Overall Study|Subject/Guardian Decision|6|||
145789211|NCT02546674|525734706|FG000|Overall Study|Withdrawal of Informed Consent|3|||
145789212|NCT01864018|525734707|FG000|Overall Study|Ineligible|3|||
145789213|NCT01864018|525734708|FG001|Overall Study|Ineligible|1|||
145789214|NCT04056455|525734709|FG000|Overall Study|Adverse Event|1|||
145789215|NCT04056455|525734710|FG001|Overall Study|Adverse Event|0|||
145789216|NCT03521687|525734712|FG000|Overall Study|Adverse Event|4|||
145789217|NCT03521687|525734712|FG000|Overall Study|Physician Decision|1|||
145789218|NCT04891770|525734718|FG000|Overall Study|Withdrew consent|1|||
145789219|NCT04891770|525734719|FG001|Overall Study|Withdrew consent|3|||
145789220|NCT04891770|525734720|FG002|Overall Study|Withdrew consent|0|||
145789221|NCT04891770|525734718|FG000|Overall Study|Enrolled but never treated|0|||
145789222|NCT04891770|525734719|FG001|Overall Study|Enrolled but never treated|0|||
145789223|NCT04891770|525734720|FG002|Overall Study|Enrolled but never treated|1|||
145789224|NCT04891770|525734718|FG000|Overall Study|Investigator's discretion|0|||
145789225|NCT04891770|525734719|FG001|Overall Study|Investigator's discretion|1|||
145789226|NCT04891770|525734720|FG002|Overall Study|Investigator's discretion|0|||
145789227|NCT05122650|525734721|FG000|Overall Study|Adverse Event|4|||
145789228|NCT05122650|525734722|FG001|Overall Study|Adverse Event|16|||
145789229|NCT05122650|525734723|FG002|Overall Study|Adverse Event|11|||
145789230|NCT05122650|525734724|FG003|Overall Study|Adverse Event|12|||
145789231|NCT05122650|525734721|FG000|Overall Study|Lack of Efficacy|0|||
145789232|NCT05122650|525734722|FG001|Overall Study|Lack of Efficacy|1|||
145789233|NCT05122650|525734723|FG002|Overall Study|Lack of Efficacy|1|||
145789234|NCT05122650|525734724|FG003|Overall Study|Lack of Efficacy|2|||
145789235|NCT05122650|525734721|FG000|Overall Study|Lost to Follow-up|1|||
145789236|NCT05122650|525734722|FG001|Overall Study|Lost to Follow-up|1|||
145789237|NCT05122650|525734723|FG002|Overall Study|Lost to Follow-up|3|||
145789238|NCT05122650|525734724|FG003|Overall Study|Lost to Follow-up|0|||
145789239|NCT05122650|525734721|FG000|Overall Study|Non-compliance with study intervention|0|||
145789240|NCT05122650|525734722|FG001|Overall Study|Non-compliance with study intervention|0|||
145789241|NCT05122650|525734723|FG002|Overall Study|Non-compliance with study intervention|0|||
145789242|NCT05122650|525734724|FG003|Overall Study|Non-compliance with study intervention|2|||
145789243|NCT05122650|525734721|FG000|Overall Study|Protocol Violation|0|||
145789244|NCT05122650|525734722|FG001|Overall Study|Protocol Violation|1|||
145789245|NCT05122650|525734723|FG002|Overall Study|Protocol Violation|0|||
145789246|NCT05122650|525734724|FG003|Overall Study|Protocol Violation|1|||
145789247|NCT05122650|525734721|FG000|Overall Study|Randomized by mistake|0|||
145789248|NCT05122650|525734722|FG001|Overall Study|Randomized by mistake|0|||
145789249|NCT05122650|525734723|FG002|Overall Study|Randomized by mistake|3|||
145789250|NCT05122650|525734724|FG003|Overall Study|Randomized by mistake|2|||
145539806|NCT01847274|524836695|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
145789251|NCT05122650|525734721|FG000|Overall Study|Sponsor request|0|||
145539807|NCT02582983|524836697|FG000|Overall Study|Death|3|||
145539808|NCT02582983|524836697|FG000|Overall Study|Withdrawal by Subject|2|||
145539809|NCT02582983|524836697|FG000|Overall Study|Adverse Event|1|||
145789252|NCT05122650|525734722|FG001|Overall Study|Sponsor request|1|||
145789253|NCT05122650|525734723|FG002|Overall Study|Sponsor request|1|||
145789254|NCT05122650|525734724|FG003|Overall Study|Sponsor request|2|||
145789255|NCT05122650|525734721|FG000|Overall Study|Withdrawal by Subject|3|||
145789256|NCT05122650|525734722|FG001|Overall Study|Withdrawal by Subject|7|||
145789257|NCT05122650|525734723|FG002|Overall Study|Withdrawal by Subject|4|||
145789258|NCT05122650|525734724|FG003|Overall Study|Withdrawal by Subject|8|||
145789259|NCT05122650|525734721|FG000|Overall Study|Other|5|||
145789260|NCT05122650|525734722|FG001|Overall Study|Other|0|||
145789261|NCT05122650|525734723|FG002|Overall Study|Other|0|||
145789262|NCT05122650|525734724|FG003|Overall Study|Other|0|||
145789263|NCT00830037|525734725|FG000|Overall Study|Withdrawal by Subject|2|||
145789264|NCT00830037|525734726|FG001|Overall Study|Withdrawal by Subject|3|||
145789265|NCT00830037|525734725|FG000|Overall Study|Lost to Follow-up|1|||
145789266|NCT00830037|525734726|FG001|Overall Study|Lost to Follow-up|2|||
145789267|NCT00830037|525734725|FG000|Overall Study|Active when terminated by DSMB|15|||
145789268|NCT00830037|525734726|FG001|Overall Study|Active when terminated by DSMB|14|||
145789269|NCT01952834|525734727|FG000|Overall Study|Adverse Event|1|||
145789270|NCT00740779|525734728|FG000|Overall Study|Adverse Event|4|||
145789271|NCT00740779|525734729|FG001|Overall Study|Adverse Event|6|||
145789272|NCT00740779|525734730|FG002|Overall Study|Adverse Event|3|||
145789273|NCT00740779|525734728|FG000|Overall Study|Protocol Violation|1|||
145789274|NCT00740779|525734729|FG001|Overall Study|Protocol Violation|1|||
145789275|NCT00740779|525734730|FG002|Overall Study|Protocol Violation|1|||
145789276|NCT00740779|525734728|FG000|Overall Study|Lack of Efficacy|0|||
145789277|NCT00740779|525734729|FG001|Overall Study|Lack of Efficacy|0|||
145789278|NCT00740779|525734730|FG002|Overall Study|Lack of Efficacy|2|||
145789279|NCT00740779|525734728|FG000|Overall Study|Withdrawal by Subject|2|||
145789280|NCT00740779|525734729|FG001|Overall Study|Withdrawal by Subject|4|||
145789281|NCT00740779|525734730|FG002|Overall Study|Withdrawal by Subject|2|||
145789282|NCT00740779|525734728|FG000|Overall Study|Lost to Follow-up|2|||
145789283|NCT00740779|525734729|FG001|Overall Study|Lost to Follow-up|3|||
145789284|NCT00740779|525734730|FG002|Overall Study|Lost to Follow-up|5|||
145789285|NCT03255291|525734732|FG000|Overall Study|Determined to be ineligible|10|||
145789286|NCT03255291|525734733|FG001|Overall Study|Determined to be ineligible|12|||
145789287|NCT03255291|525734734|FG002|Overall Study|Determined to be ineligible|6|||
145789288|NCT03255291|525734735|FG003|Overall Study|Determined to be ineligible|6|||
145789289|NCT03255291|525734736|FG004|Overall Study|Determined to be ineligible|5|||
145789290|NCT03255291|525734737|FG005|Overall Study|Determined to be ineligible|10|||
145789291|NCT03255291|525734732|FG000|Overall Study|Baseline data collection issues|3|||
145789292|NCT03255291|525734733|FG001|Overall Study|Baseline data collection issues|0|||
145789293|NCT03255291|525734734|FG002|Overall Study|Baseline data collection issues|0|||
145789294|NCT03255291|525734735|FG003|Overall Study|Baseline data collection issues|0|||
145789295|NCT03255291|525734736|FG004|Overall Study|Baseline data collection issues|2|||
145789296|NCT03255291|525734737|FG005|Overall Study|Baseline data collection issues|0|||
145789297|NCT00634244|525734738|FG000|Overall Study|Never started treatment|0|||
145789298|NCT00634244|525734739|FG001|Overall Study|Never started treatment|1|||
145789299|NCT00634244|525734740|FG002|Overall Study|Never started treatment|0|||
145789300|NCT00634244|525734738|FG000|Overall Study|Death|1|||
145789301|NCT00634244|525734739|FG001|Overall Study|Death|6|||
145789302|NCT00634244|525734740|FG002|Overall Study|Death|0|||
145789303|NCT00634244|525734738|FG000|Overall Study|Adverse Event|0|||
145789304|NCT00634244|525734739|FG001|Overall Study|Adverse Event|2|||
145789305|NCT00634244|525734740|FG002|Overall Study|Adverse Event|0|||
145789306|NCT00634244|525734738|FG000|Overall Study|Withdrawal by Subject|0|||
145789307|NCT00634244|525734739|FG001|Overall Study|Withdrawal by Subject|1|||
145789308|NCT00634244|525734740|FG002|Overall Study|Withdrawal by Subject|0|||
145789309|NCT00634244|525734738|FG000|Overall Study|Physician Decision|0|||
145789310|NCT00634244|525734739|FG001|Overall Study|Physician Decision|1|||
145789311|NCT00634244|525734740|FG002|Overall Study|Physician Decision|0|||
145789312|NCT00634244|525734738|FG000|Overall Study|Disease progression/relapse|0|||
145789313|NCT00634244|525734739|FG001|Overall Study|Disease progression/relapse|1|||
145789314|NCT00634244|525734740|FG002|Overall Study|Disease progression/relapse|0|||
145789315|NCT00634244|525734738|FG000|Overall Study|Other complicating disease|0|||
145789316|NCT00634244|525734739|FG001|Overall Study|Other complicating disease|1|||
145789317|NCT00634244|525734740|FG002|Overall Study|Other complicating disease|0|||
145789318|NCT04369430|525734748|FG000|Overall Study|Adverse Event|2|||
145789319|NCT04369430|525734749|FG001|Overall Study|Adverse Event|3|||
145789320|NCT04369430|525734748|FG000|Overall Study|Death|1|||
145789321|NCT04369430|525734749|FG001|Overall Study|Death|0|||
145789322|NCT04369430|525734748|FG000|Overall Study|Withdrawal by Subject|4|||
145789323|NCT04369430|525734749|FG001|Overall Study|Withdrawal by Subject|3|||
145789324|NCT04369430|525734748|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
145789325|NCT04369430|525734749|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
145789326|NCT04369430|525734748|FG000|Overall Study|Lost to Follow-up|0|||
145789327|NCT04369430|525734749|FG001|Overall Study|Lost to Follow-up|1|||
145789328|NCT00444626|525734752|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
145789329|NCT00444626|525734752|FG000|Initial Treatment Period|Adverse Event|1|||
145789330|NCT00444626|525734752|FG000|Initial Treatment Period|Lost to Follow-up|9|||
145789331|NCT00008138|525734755|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
145789332|NCT00008138|525734755|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
145789333|NCT00008138|525734755|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
145789334|NCT00008138|525734755|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
145789335|NCT00008138|525734755|FG000|Interval Debulking|Withdrawal by Subject|2|||
145789336|NCT00008138|525734755|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
145789337|NCT00008138|525734755|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
145789338|NCT00008138|525734755|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
145789339|NCT04594239|525734761|FG000|Overall Study|Withdrawal by Subject|3|||
145789340|NCT04594239|525734762|FG001|Overall Study|Withdrawal by Subject|4|||
145789341|NCT04594239|525734763|FG002|Overall Study|Withdrawal by Subject|2|||
145789342|NCT04594239|525734764|FG003|Overall Study|Withdrawal by Subject|4|||
145789343|NCT04594239|525734761|FG000|Overall Study|Lost to Follow-up|8|||
145789344|NCT04594239|525734762|FG001|Overall Study|Lost to Follow-up|5|||
145789345|NCT04594239|525734763|FG002|Overall Study|Lost to Follow-up|4|||
145789346|NCT04594239|525734764|FG003|Overall Study|Lost to Follow-up|6|||
145789347|NCT04594239|525734761|FG000|Overall Study|Subject relocated|0|||
145789348|NCT04594239|525734762|FG001|Overall Study|Subject relocated|0|||
145789349|NCT04594239|525734763|FG002|Overall Study|Subject relocated|0|||
145789350|NCT04594239|525734764|FG003|Overall Study|Subject relocated|1|||
145789351|NCT04973228|525734765|FG000|Overall Study|Adverse Event|2|||
145789352|NCT04973228|525734766|FG001|Overall Study|Adverse Event|3|||
145789353|NCT04973228|525734765|FG000|Overall Study|Lack of Efficacy|1|||
145789354|NCT04973228|525734766|FG001|Overall Study|Lack of Efficacy|3|||
145789355|NCT04973228|525734765|FG000|Overall Study|Lost to Follow-up|12|||
145789356|NCT04973228|525734766|FG001|Overall Study|Lost to Follow-up|4|||
145789357|NCT04973228|525734765|FG000|Overall Study|Withdrawal by Subject|11|||
145789358|NCT04973228|525734766|FG001|Overall Study|Withdrawal by Subject|4|||
145789359|NCT04973228|525734765|FG000|Overall Study|Did not tolerate application|1|||
145789360|NCT04973228|525734766|FG001|Overall Study|Did not tolerate application|0|||
145789361|NCT04973228|525734765|FG000|Overall Study|Wanted to early terminate and use own product|0|||
145789362|NCT04973228|525734766|FG001|Overall Study|Wanted to early terminate and use own product|1|||
145789363|NCT04973228|525734765|FG000|Overall Study|Missed visits due to new work schedule|1|||
145789364|NCT04973228|525734766|FG001|Overall Study|Missed visits due to new work schedule|0|||
145789365|NCT02678780|525734767|FG000|Overall Study|Adverse Event|11|||
145789366|NCT02678780|525734768|FG001|Overall Study|Adverse Event|14|||
145789367|NCT02678780|525734767|FG000|Overall Study|Withdrawal by Subject|2|||
145789368|NCT02678780|525734768|FG001|Overall Study|Withdrawal by Subject|1|||
145789369|NCT02678780|525734767|FG000|Overall Study|Sponsor discontinuation|7|||
145789370|NCT02678780|525734768|FG001|Overall Study|Sponsor discontinuation|4|||
145789371|NCT02678780|525734767|FG000|Overall Study|Death|1|||
145789372|NCT02678780|525734768|FG001|Overall Study|Death|1|||
145789373|NCT02678780|525734767|FG000|Overall Study|Other|6|||
145789374|NCT02678780|525734768|FG001|Overall Study|Other|8|||
145789375|NCT00091390|525734782|FG000|Overall Study|Protocol Violation|1|||
145789376|NCT00091390|525734782|FG000|Overall Study|No protocol treatment|3|||
145789377|NCT00406640|525734789|FG000|Acute Phase|Adverse Event|18|||
145789378|NCT00406640|525734790|FG001|Acute Phase|Adverse Event|13|||
145789379|NCT00406640|525734789|FG000|Acute Phase|Failed to Return|5|||
145789380|NCT00406640|525734790|FG001|Acute Phase|Failed to Return|1|||
145789381|NCT00406640|525734789|FG000|Acute Phase|Physician Decision|0|||
145789382|NCT00406640|525734790|FG001|Acute Phase|Physician Decision|1|||
145789383|NCT00406640|525734789|FG000|Acute Phase|Lost to Follow-up|7|||
145789384|NCT00406640|525734790|FG001|Acute Phase|Lost to Follow-up|4|||
145789385|NCT00406640|525734789|FG000|Acute Phase|Protocol deviation|4|||
145789386|NCT00406640|525734790|FG001|Acute Phase|Protocol deviation|10|||
145789387|NCT00406640|525734789|FG000|Acute Phase|Protocol Violation|3|||
145789388|NCT00406640|525734790|FG001|Acute Phase|Protocol Violation|2|||
145789389|NCT00406640|525734789|FG000|Acute Phase|Withdrawal by Subject|11|||
145789390|NCT00406640|525734790|FG001|Acute Phase|Withdrawal by Subject|9|||
145789391|NCT00406640|525734789|FG000|Acute Phase|Lack of Efficacy|3|||
145789392|NCT00406640|525734790|FG001|Acute Phase|Lack of Efficacy|3|||
145789393|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
145789394|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
145789395|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Death|1|||
145789396|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Death|0|||
145789397|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
145789398|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
145789399|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
145789400|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
145789401|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
145789402|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
145789403|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|non-compliance|7|||
145789404|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|non-compliance|5|||
145789405|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
145789406|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
145789407|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
145789408|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
145789409|NCT00406640|525734789|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
145789410|NCT00406640|525734790|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
145789411|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
145789412|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
145789413|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
145789414|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
145789415|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
145789416|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
145789417|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
145789418|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
145789419|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
145789420|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
145789421|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
145789422|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
145789423|NCT00406640|525734789|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
145789424|NCT00406640|525734790|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
145789425|NCT03229759|525734796|FG000|Overall Study|Screen Failure|30|||
145789426|NCT02020031|525736581|FG000|Overall Study|Physician Decision|1|||
145789427|NCT02020031|525736582|FG001|Overall Study|Physician Decision|1|||
145789428|NCT00683475|525736585|FG000|Overall Study|Withdrawal by Subject|1|||
145789429|NCT00683475|525736586|FG001|Overall Study|Withdrawal by Subject|0|||
145789430|NCT00683475|525736585|FG000|Overall Study|Never Treated: Adverse Event|2|||
145789431|NCT00683475|525736586|FG001|Overall Study|Never Treated: Adverse Event|3|||
145789432|NCT00683475|525736585|FG000|Overall Study|Never Treated: Progressive Disease|1|||
145789433|NCT00683475|525736586|FG001|Overall Study|Never Treated: Progressive Disease|0|||
145789434|NCT02669862|525736587|FG000|Overall Study|Lost to Follow-up|0|||
145789435|NCT02669862|525736588|FG001|Overall Study|Lost to Follow-up|2|||
145789436|NCT02669862|525736589|FG002|Overall Study|Lost to Follow-up|1|||
145789437|NCT02669862|525736587|FG000|Overall Study|Withdrawal by Subject|2|||
145789438|NCT02669862|525736588|FG001|Overall Study|Withdrawal by Subject|2|||
145789439|NCT02669862|525736589|FG002|Overall Study|Withdrawal by Subject|3|||
145789440|NCT02669862|525736587|FG000|Overall Study|moved|0|||
145789441|NCT02669862|525736588|FG001|Overall Study|moved|1|||
145789442|NCT02669862|525736589|FG002|Overall Study|moved|0|||
145789443|NCT02669862|525736587|FG000|Overall Study|Protocol Violation|0|||
145789444|NCT02669862|525736588|FG001|Overall Study|Protocol Violation|0|||
145789445|NCT02669862|525736589|FG002|Overall Study|Protocol Violation|1|||
145789446|NCT02429258|525736590|FG000|Overall Study|Withdrawal by Subject|2|||
145789447|NCT02429258|525736591|FG001|Overall Study|Withdrawal by Subject|0|||
145789448|NCT02429258|525736590|FG000|Overall Study|Protocol Violation|0|||
145789449|NCT02429258|525736591|FG001|Overall Study|Protocol Violation|1|||
145789450|NCT01694420|525736592|FG000|Overall Study|Lost to Follow-up|3|||
145789451|NCT03987919|525736594|FG000|Overall Study|Adverse Event|1|||
145789452|NCT03987919|525736595|FG001|Overall Study|Adverse Event|4|||
145789453|NCT03987919|525736596|FG002|Overall Study|Adverse Event|1|||
145539810|NCT05209360|524836698|FG000|Overall Study|Withdrawal by Subject|0|||
145789454|NCT03987919|525736597|FG003|Overall Study|Adverse Event|3|||
145789455|NCT03987919|525736594|FG000|Overall Study|Death|4|||
145789456|NCT03987919|525736595|FG001|Overall Study|Death|4|||
145789457|NCT03987919|525736596|FG002|Overall Study|Death|4|||
145789458|NCT03987919|525736597|FG003|Overall Study|Death|1|||
145789459|NCT03987919|525736594|FG000|Overall Study|Lost to Follow-up|5|||
145789460|NCT03987919|525736595|FG001|Overall Study|Lost to Follow-up|6|||
145789461|NCT03987919|525736596|FG002|Overall Study|Lost to Follow-up|8|||
145789462|NCT03987919|525736597|FG003|Overall Study|Lost to Follow-up|12|||
145789463|NCT03987919|525736594|FG000|Overall Study|Physician Decision|0|||
145789464|NCT03987919|525736595|FG001|Overall Study|Physician Decision|2|||
145789465|NCT03987919|525736596|FG002|Overall Study|Physician Decision|0|||
145789466|NCT03987919|525736597|FG003|Overall Study|Physician Decision|4|||
145789467|NCT03987919|525736594|FG000|Overall Study|Pregnancy|1|||
145789468|NCT03987919|525736595|FG001|Overall Study|Pregnancy|0|||
145789469|NCT03987919|525736596|FG002|Overall Study|Pregnancy|1|||
145789470|NCT03987919|525736597|FG003|Overall Study|Pregnancy|1|||
145539811|NCT05209360|524836699|FG001|Overall Study|Withdrawal by Subject|0|||
145539812|NCT05209360|524836700|FG002|Overall Study|Withdrawal by Subject|1|||
145789471|NCT03987919|525736594|FG000|Overall Study|Protocol Violation|0|||
145789472|NCT03987919|525736595|FG001|Overall Study|Protocol Violation|1|||
145789473|NCT03987919|525736596|FG002|Overall Study|Protocol Violation|0|||
145789474|NCT03987919|525736597|FG003|Overall Study|Protocol Violation|0|||
145789475|NCT03987919|525736594|FG000|Overall Study|Site terminated by Sponsor|0|||
145789476|NCT03987919|525736595|FG001|Overall Study|Site terminated by Sponsor|0|||
145789477|NCT03987919|525736596|FG002|Overall Study|Site terminated by Sponsor|0|||
145789478|NCT03987919|525736597|FG003|Overall Study|Site terminated by Sponsor|1|||
145789479|NCT03987919|525736594|FG000|Overall Study|Withdrawal by Subject|7|||
145789480|NCT03987919|525736595|FG001|Overall Study|Withdrawal by Subject|7|||
145789481|NCT03987919|525736596|FG002|Overall Study|Withdrawal by Subject|8|||
145789482|NCT03987919|525736597|FG003|Overall Study|Withdrawal by Subject|4|||
145789483|NCT03987919|525736594|FG000|Overall Study|Other - as reported by the investigator|1|||
145789484|NCT03987919|525736595|FG001|Overall Study|Other - as reported by the investigator|3|||
145789485|NCT03987919|525736596|FG002|Overall Study|Other - as reported by the investigator|2|||
145789486|NCT03987919|525736597|FG003|Overall Study|Other - as reported by the investigator|0|||
145789487|NCT00434512|525736601|FG000|Overall Study|Migrated/moved from study area|0|||
145789488|NCT00434512|525736602|FG001|Overall Study|Migrated/moved from study area|0|||
145789489|NCT00434512|525736603|FG002|Overall Study|Migrated/moved from study area|0|||
145789490|NCT00434512|525736604|FG003|Overall Study|Migrated/moved from study area|1|||
145789491|NCT00434512|525736605|FG004|Overall Study|Migrated/moved from study area|1|||
145789492|NCT00434512|525736606|FG005|Overall Study|Migrated/moved from study area|1|||
145789493|NCT00434512|525736601|FG000|Overall Study|Other|0|||
145789494|NCT00434512|525736602|FG001|Overall Study|Other|1|||
145789495|NCT00434512|525736603|FG002|Overall Study|Other|0|||
145789496|NCT00434512|525736604|FG003|Overall Study|Other|0|||
145789497|NCT00434512|525736605|FG004|Overall Study|Other|0|||
145789498|NCT00434512|525736606|FG005|Overall Study|Other|0|||
145789499|NCT03303092|525736607|FG000|Overall Study|Adverse Event|1|||
145789500|NCT03303092|525736608|FG001|Overall Study|Adverse Event|0|||
145789501|NCT03303092|525736609|FG002|Overall Study|Adverse Event|1|||
145789502|NCT03303092|525736607|FG000|Overall Study|Protocol Violation|1|||
145789503|NCT03303092|525736608|FG001|Overall Study|Protocol Violation|5|||
145789504|NCT03303092|525736609|FG002|Overall Study|Protocol Violation|1|||
145789505|NCT03303092|525736607|FG000|Overall Study|Withdrawal by Subject|1|||
145789506|NCT03303092|525736608|FG001|Overall Study|Withdrawal by Subject|1|||
145789507|NCT03303092|525736609|FG002|Overall Study|Withdrawal by Subject|3|||
145789508|NCT05142332|525736615|FG000|Overall Study|Withdrawal by Subject|0|||
145789509|NCT05142332|525736616|FG001|Overall Study|Withdrawal by Subject|1|||
145789510|NCT05142332|525736617|FG002|Overall Study|Withdrawal by Subject|2|||
145789511|NCT05142332|525736618|FG003|Overall Study|Withdrawal by Subject|0|||
145789512|NCT05142332|525736619|FG004|Overall Study|Withdrawal by Subject|0|||
145789513|NCT05142332|525736620|FG005|Overall Study|Withdrawal by Subject|2|||
145789514|NCT05142332|525736621|FG006|Overall Study|Withdrawal by Subject|6|||
145789515|NCT05142332|525736615|FG000|Overall Study|Left ED|3|||
145789516|NCT05142332|525736616|FG001|Overall Study|Left ED|0|||
145789517|NCT05142332|525736617|FG002|Overall Study|Left ED|4|||
145789518|NCT05142332|525736618|FG003|Overall Study|Left ED|6|||
145789519|NCT05142332|525736619|FG004|Overall Study|Left ED|1|||
145789520|NCT05142332|525736620|FG005|Overall Study|Left ED|2|||
145789521|NCT05142332|525736621|FG006|Overall Study|Left ED|6|||
145789522|NCT05142332|525736615|FG000|Overall Study|Physician Decision|0|||
145789523|NCT05142332|525736616|FG001|Overall Study|Physician Decision|0|||
145789524|NCT05142332|525736617|FG002|Overall Study|Physician Decision|2|||
145789525|NCT05142332|525736618|FG003|Overall Study|Physician Decision|1|||
145789526|NCT05142332|525736619|FG004|Overall Study|Physician Decision|0|||
145789527|NCT05142332|525736620|FG005|Overall Study|Physician Decision|0|||
145789528|NCT05142332|525736621|FG006|Overall Study|Physician Decision|3|||
145789529|NCT05142332|525736615|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
145789530|NCT05142332|525736616|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
145789531|NCT05142332|525736617|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
145539813|NCT05209360|524836701|FG003|Overall Study|Withdrawal by Subject|0|||
145789532|NCT05142332|525736618|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
145789533|NCT05142332|525736619|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
145789534|NCT05142332|525736620|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
145539814|NCT05209360|524836702|FG004|Overall Study|Withdrawal by Subject|0|||
145539815|NCT05209360|524836703|FG005|Overall Study|Withdrawal by Subject|0|||
145539816|NCT02021331|524836706|FG000|Overall Study|Adverse Event|0|||
145789535|NCT05142332|525736621|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
145789536|NCT00411788|525736626|FG000|Overall Study|Protocol Violation|1|||
145789537|NCT00411788|525736626|FG000|Overall Study|Adverse Event|1|||
145789538|NCT00390416|525736628|FG000|Overall Study|Withdrawal by Subject|1|||
145789539|NCT00390416|525736628|FG000|Overall Study|Not treated|3|||
145789540|NCT01592409|525736629|FG000|Overall Study|Withdrawal by Subject|0|||
145789541|NCT01592409|525736630|FG001|Overall Study|Withdrawal by Subject|1|||
145789542|NCT01219959|525736631|FG000|Overall Study|Adverse Event|6|||
145789543|NCT01219959|525736632|FG001|Overall Study|Adverse Event|14|||
145789544|NCT01219959|525736631|FG000|Overall Study|Physician Decision|0|||
145789545|NCT01219959|525736632|FG001|Overall Study|Physician Decision|4|||
145789546|NCT01219959|525736631|FG000|Overall Study|Withdrawal by Subject|0|||
145789547|NCT01219959|525736632|FG001|Overall Study|Withdrawal by Subject|2|||
145789548|NCT01219959|525736631|FG000|Overall Study|Renal Transplantation|0|||
145789549|NCT01219959|525736632|FG001|Overall Study|Renal Transplantation|3|||
145789550|NCT01219959|525736631|FG000|Overall Study|Other|1|||
145789551|NCT01219959|525736632|FG001|Overall Study|Other|0|||
145789552|NCT01728584|525736633|FG000|Overall Study|Adverse Event|1|||
145789553|NCT01728584|525736634|FG001|Overall Study|Adverse Event|0|||
145789554|NCT01728584|525736635|FG002|Overall Study|Adverse Event|0|||
145789555|NCT01728584|525736636|FG003|Overall Study|Adverse Event|0|||
145789556|NCT01728584|525736633|FG000|Overall Study|Physician Decision|4|||
145789557|NCT01728584|525736634|FG001|Overall Study|Physician Decision|0|||
145789558|NCT01728584|525736635|FG002|Overall Study|Physician Decision|1|||
145789559|NCT01728584|525736636|FG003|Overall Study|Physician Decision|0|||
145789560|NCT01728584|525736633|FG000|Overall Study|Withdrawal by Subject|1|||
145789561|NCT01728584|525736634|FG001|Overall Study|Withdrawal by Subject|0|||
145789562|NCT01728584|525736635|FG002|Overall Study|Withdrawal by Subject|0|||
145789563|NCT01728584|525736636|FG003|Overall Study|Withdrawal by Subject|0|||
145789564|NCT01728584|525736633|FG000|Overall Study|Screen failure|1|||
145789565|NCT01728584|525736634|FG001|Overall Study|Screen failure|0|||
145789566|NCT01728584|525736635|FG002|Overall Study|Screen failure|0|||
145789567|NCT01728584|525736636|FG003|Overall Study|Screen failure|0|||
145789568|NCT01728584|525736633|FG000|Overall Study|Other reason (not specified)|1|||
145789569|NCT01728584|525736634|FG001|Overall Study|Other reason (not specified)|0|||
145789570|NCT01728584|525736635|FG002|Overall Study|Other reason (not specified)|0|||
145789571|NCT01728584|525736636|FG003|Overall Study|Other reason (not specified)|1|||
145789572|NCT05906732|525736638|FG000|Overall Study|Withdrawal by Subject|1|||
145789573|NCT05906732|525736639|FG001|Overall Study|Withdrawal by Subject|0|||
145789574|NCT05906732|525736640|FG002|Overall Study|Withdrawal by Subject|0|||
145789575|NCT05906732|525736641|FG003|Overall Study|Withdrawal by Subject|0|||
145789576|NCT05906732|525736638|FG000|Overall Study|Physician Decision|2|||
145789577|NCT05906732|525736639|FG001|Overall Study|Physician Decision|4|||
145789578|NCT05906732|525736640|FG002|Overall Study|Physician Decision|0|||
145789579|NCT05906732|525736641|FG003|Overall Study|Physician Decision|0|||
145789580|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
145789581|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
145789582|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
145789583|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
145789584|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
145789585|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
145789586|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789587|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
145789588|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
145789589|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
145789590|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
145789591|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
145789592|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
145789593|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
145789594|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789595|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789596|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789597|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789598|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789599|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789600|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789601|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789602|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
145789603|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
145789604|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
145789605|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
145789606|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
145789607|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
145789608|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
145789609|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
145789610|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
145789611|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
145789612|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789613|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789614|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
145789615|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
145789616|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
145789617|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789618|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789619|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789620|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789621|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789622|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789623|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789624|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789625|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
145789626|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789627|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789628|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789629|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789630|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789631|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789632|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789633|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789634|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789635|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789636|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789637|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789638|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789639|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
145789640|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789641|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789642|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789643|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789644|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789645|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789646|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789647|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789648|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
145789649|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
145789650|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
145789651|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
145789652|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
145789653|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
145789654|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
145789655|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
145789656|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
145789657|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
145789658|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
145789659|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
145789660|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
145789661|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
145789662|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
145789663|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
145789664|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
145789665|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
145789666|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
145789667|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
145789668|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
145789669|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
145281944|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
145281945|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
145281946|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
145281947|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
145281948|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
145281949|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
145281950|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145609938|NCT00041756|525088054|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
145609939|NCT00041756|525088055|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
145789670|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
145789671|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
145789672|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789673|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789674|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789675|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789676|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789677|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789678|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789679|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789680|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
145789681|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789682|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789683|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789684|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789685|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
145789686|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789687|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789688|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789689|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789690|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789691|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789692|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789693|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789694|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
145789695|NCT02052778|525736642|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789696|NCT02052778|525736643|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789697|NCT02052778|525736644|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789698|NCT02052778|525736645|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789699|NCT02052778|525736646|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789700|NCT02052778|525736647|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
145789701|NCT02052778|525736648|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789702|NCT02052778|525736649|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789703|NCT02052778|525736650|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789704|NCT02052778|525736651|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789705|NCT02052778|525736652|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789706|NCT02052778|525736653|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789707|NCT02052778|525736654|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
145789708|NCT02052778|525736655|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789709|NCT02052778|525736656|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789710|NCT02052778|525736657|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789711|NCT02052778|525736658|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789712|NCT02052778|525736659|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789713|NCT02052778|525736660|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789714|NCT02052778|525736661|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789715|NCT02052778|525736662|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789716|NCT02052778|525736663|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789717|NCT02052778|525736664|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
145789718|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789719|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789720|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789721|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789722|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789723|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789724|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789725|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789726|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789727|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789728|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789729|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789730|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789731|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789732|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
145789733|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
145789734|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
145789735|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
145789736|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
145789737|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
145789738|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
145789739|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
145789740|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
145789741|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789742|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789743|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789744|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789745|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789746|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789747|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145539817|NCT02021331|524836707|FG001|Overall Study|Adverse Event|2|||
145539818|NCT01081678|524836710|FG000|Overall Study|Ineligibility Determined|0|||
145539819|NCT01081678|524836711|FG001|Overall Study|Ineligibility Determined|0|||
145539820|NCT01081678|524836712|FG002|Overall Study|Ineligibility Determined|1|||
145539821|NCT01081678|524836713|FG003|Overall Study|Ineligibility Determined|1|||
145539822|NCT01081678|524836710|FG000|Overall Study|Noncompliance|3|||
145539823|NCT01081678|524836711|FG001|Overall Study|Noncompliance|4|||
145539824|NCT01081678|524836712|FG002|Overall Study|Noncompliance|5|||
145539825|NCT01081678|524836713|FG003|Overall Study|Noncompliance|2|||
145539826|NCT01081678|524836710|FG000|Overall Study|Adverse Event|2|||
145539827|NCT01081678|524836711|FG001|Overall Study|Adverse Event|1|||
145539828|NCT01081678|524836712|FG002|Overall Study|Adverse Event|2|||
145539829|NCT01081678|524836713|FG003|Overall Study|Adverse Event|2|||
145539830|NCT01081678|524836710|FG000|Overall Study|Withdrawal by Subject|15|||
145539831|NCT01081678|524836711|FG001|Overall Study|Withdrawal by Subject|7|||
145539832|NCT01081678|524836712|FG002|Overall Study|Withdrawal by Subject|17|||
145539833|NCT01081678|524836713|FG003|Overall Study|Withdrawal by Subject|14|||
145539834|NCT01081678|524836710|FG000|Overall Study|Administrative Decision|1|||
145539835|NCT01081678|524836711|FG001|Overall Study|Administrative Decision|0|||
145539836|NCT01081678|524836712|FG002|Overall Study|Administrative Decision|0|||
145539837|NCT01081678|524836713|FG003|Overall Study|Administrative Decision|1|||
145539838|NCT01081678|524836710|FG000|Overall Study|Lost to Follow-up|4|||
145539839|NCT01081678|524836711|FG001|Overall Study|Lost to Follow-up|1|||
145539840|NCT01081678|524836712|FG002|Overall Study|Lost to Follow-up|4|||
145539841|NCT01081678|524836713|FG003|Overall Study|Lost to Follow-up|3|||
145539842|NCT01081678|524836710|FG000|Overall Study|Death|2|||
145539843|NCT01081678|524836711|FG001|Overall Study|Death|2|||
145539844|NCT01081678|524836712|FG002|Overall Study|Death|2|||
145539845|NCT01081678|524836713|FG003|Overall Study|Death|6|||
145539846|NCT01081678|524836710|FG000|Overall Study|Other|0|||
145539847|NCT01081678|524836711|FG001|Overall Study|Other|1|||
145539848|NCT01081678|524836712|FG002|Overall Study|Other|0|||
145539849|NCT01081678|524836713|FG003|Overall Study|Other|0|||
145539850|NCT01619423|524836716|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
145539851|NCT01619423|524836717|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
145539852|NCT01619423|524836718|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
145539853|NCT01619423|524836719|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
145539854|NCT01281865|524836720|FG000|Overall Study|Adverse Event|1|||
145539855|NCT01281865|524836721|FG001|Overall Study|Adverse Event|1|||
145539856|NCT01281865|524836720|FG000|Overall Study|Withdrawal by Subject|1|||
145539857|NCT01281865|524836721|FG001|Overall Study|Withdrawal by Subject|0|||
145539858|NCT01281865|524836720|FG000|Overall Study|Lack of Efficacy|1|||
145539859|NCT01281865|524836721|FG001|Overall Study|Lack of Efficacy|0|||
145609940|NCT00041756|525088056|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
145539860|NCT03478657|524836722|FG000|Overall Study|Withdrawal by Subject|0|||
145539861|NCT03478657|524836723|FG001|Overall Study|Withdrawal by Subject|1|||
145539862|NCT01786668|524836724|FG000|Overall Study|Adverse Event|0|||
145539863|NCT01786668|524836725|FG001|Overall Study|Adverse Event|1|||
145539864|NCT01786668|524836726|FG002|Overall Study|Adverse Event|1|||
145539865|NCT01786668|524836727|FG003|Overall Study|Adverse Event|2|||
145539866|NCT01786668|524836724|FG000|Overall Study|Withdrawal by Subject|0|||
145539867|NCT01786668|524836725|FG001|Overall Study|Withdrawal by Subject|0|||
145539868|NCT01786668|524836726|FG002|Overall Study|Withdrawal by Subject|3|||
145539869|NCT01786668|524836727|FG003|Overall Study|Withdrawal by Subject|1|||
145539870|NCT01786668|524836724|FG000|Overall Study|Pregnancy|0|||
145539871|NCT01786668|524836725|FG001|Overall Study|Pregnancy|0|||
145539872|NCT01786668|524836726|FG002|Overall Study|Pregnancy|0|||
145539873|NCT01786668|524836727|FG003|Overall Study|Pregnancy|1|||
145539874|NCT01786668|524836724|FG000|Overall Study|Lost to Follow-up|1|||
145539875|NCT01786668|524836725|FG001|Overall Study|Lost to Follow-up|0|||
145539876|NCT01786668|524836726|FG002|Overall Study|Lost to Follow-up|1|||
145539877|NCT01786668|524836727|FG003|Overall Study|Lost to Follow-up|0|||
145539878|NCT04457336|524836730|FG000|Period 2: Part A|Withdrawal by Subject|0|||
145539879|NCT04457336|524836731|FG001|Period 2: Part A|Withdrawal by Subject|1|||
145539880|NCT04457336|524836732|FG002|Period 2: Part A|Withdrawal by Subject|1|||
145539881|NCT04457336|524836733|FG003|Period 2: Part A|Withdrawal by Subject|1|||
145539882|NCT04457336|524836734|FG004|Period 2: Part A|Withdrawal by Subject|0|||
145539883|NCT04457336|524836735|FG005|Period 2: Part A|Withdrawal by Subject|0|||
145539884|NCT04457336|524836736|FG006|Period 2: Part A|Withdrawal by Subject|0|||
145539885|NCT04457336|524836737|FG007|Period 2: Part A|Withdrawal by Subject|0|||
145539886|NCT04457336|524836730|FG000|Period 2: Part A|Adverse Event|0|||
145539887|NCT04457336|524836731|FG001|Period 2: Part A|Adverse Event|0|||
145539888|NCT04457336|524836732|FG002|Period 2: Part A|Adverse Event|1|||
145539889|NCT04457336|524836733|FG003|Period 2: Part A|Adverse Event|1|||
145539890|NCT04457336|524836734|FG004|Period 2: Part A|Adverse Event|0|||
145539891|NCT04457336|524836735|FG005|Period 2: Part A|Adverse Event|0|||
145539892|NCT04457336|524836736|FG006|Period 2: Part A|Adverse Event|0|||
145539893|NCT04457336|524836737|FG007|Period 2: Part A|Adverse Event|0|||
145539894|NCT04457336|524836730|FG000|Period 2: Part A|Study Terminated|0|||
145539895|NCT04457336|524836731|FG001|Period 2: Part A|Study Terminated|0|||
145539896|NCT04457336|524836732|FG002|Period 2: Part A|Study Terminated|1|||
145539897|NCT04457336|524836733|FG003|Period 2: Part A|Study Terminated|0|||
145539898|NCT04457336|524836734|FG004|Period 2: Part A|Study Terminated|0|||
145539899|NCT04457336|524836735|FG005|Period 2: Part A|Study Terminated|0|||
145539900|NCT04457336|524836736|FG006|Period 2: Part A|Study Terminated|0|||
145539901|NCT04457336|524836737|FG007|Period 2: Part A|Study Terminated|0|||
145539902|NCT04457336|524836730|FG000|Period 2: Part A|Protocol Violation|0|||
145539903|NCT04457336|524836731|FG001|Period 2: Part A|Protocol Violation|1|||
145539904|NCT04457336|524836732|FG002|Period 2: Part A|Protocol Violation|0|||
145539905|NCT04457336|524836733|FG003|Period 2: Part A|Protocol Violation|0|||
145539906|NCT04457336|524836734|FG004|Period 2: Part A|Protocol Violation|0|||
145539907|NCT04457336|524836735|FG005|Period 2: Part A|Protocol Violation|0|||
145539908|NCT04457336|524836736|FG006|Period 2: Part A|Protocol Violation|0|||
145539909|NCT04457336|524836737|FG007|Period 2: Part A|Protocol Violation|0|||
145539910|NCT04457336|524836730|FG000|Period 2: Part A|Lost to Follow-up|0|||
145539911|NCT04457336|524836731|FG001|Period 2: Part A|Lost to Follow-up|1|||
145539912|NCT04457336|524836732|FG002|Period 2: Part A|Lost to Follow-up|0|||
145539913|NCT04457336|524836733|FG003|Period 2: Part A|Lost to Follow-up|0|||
145539914|NCT04457336|524836734|FG004|Period 2: Part A|Lost to Follow-up|0|||
145539915|NCT04457336|524836735|FG005|Period 2: Part A|Lost to Follow-up|0|||
145539916|NCT04457336|524836736|FG006|Period 2: Part A|Lost to Follow-up|0|||
145539917|NCT04457336|524836737|FG007|Period 2: Part A|Lost to Follow-up|0|||
145539918|NCT04457336|524836730|FG000|Period 2: Part A|Other|0|||
145539919|NCT04457336|524836731|FG001|Period 2: Part A|Other|1|||
145539920|NCT04457336|524836732|FG002|Period 2: Part A|Other|0|||
145539921|NCT04457336|524836733|FG003|Period 2: Part A|Other|0|||
145281951|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
145539922|NCT04457336|524836734|FG004|Period 2: Part A|Other|0|||
145539923|NCT04457336|524836735|FG005|Period 2: Part A|Other|0|||
145539924|NCT04457336|524836736|FG006|Period 2: Part A|Other|0|||
145539925|NCT04457336|524836737|FG007|Period 2: Part A|Other|0|||
145281952|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
145539926|NCT04457336|524836730|FG000|Period 2: Part A|Physician Decision|0|||
145539927|NCT04457336|524836731|FG001|Period 2: Part A|Physician Decision|0|||
145539928|NCT04457336|524836732|FG002|Period 2: Part A|Physician Decision|0|||
145539929|NCT04457336|524836733|FG003|Period 2: Part A|Physician Decision|1|||
145539930|NCT04457336|524836734|FG004|Period 2: Part A|Physician Decision|0|||
145539931|NCT04457336|524836735|FG005|Period 2: Part A|Physician Decision|0|||
145539932|NCT04457336|524836736|FG006|Period 2: Part A|Physician Decision|0|||
145539933|NCT04457336|524836737|FG007|Period 2: Part A|Physician Decision|0|||
145539934|NCT04457336|524836730|FG000|Period 3: Part B|Study Terminated|0|||
145539935|NCT04457336|524836731|FG001|Period 3: Part B|Study Terminated|0|||
145539936|NCT04457336|524836732|FG002|Period 3: Part B|Study Terminated|0|||
145539937|NCT04457336|524836733|FG003|Period 3: Part B|Study Terminated|0|||
145539938|NCT04457336|524836734|FG004|Period 3: Part B|Study Terminated|1|||
145539939|NCT04457336|524836735|FG005|Period 3: Part B|Study Terminated|10|||
145539940|NCT04457336|524836736|FG006|Period 3: Part B|Study Terminated|13|||
145539941|NCT04457336|524836737|FG007|Period 3: Part B|Study Terminated|0|||
145539942|NCT04457336|524836730|FG000|Period 3: Part B|Withdrawal by Subject|0|||
145539943|NCT04457336|524836731|FG001|Period 3: Part B|Withdrawal by Subject|0|||
145539944|NCT04457336|524836732|FG002|Period 3: Part B|Withdrawal by Subject|0|||
145539945|NCT04457336|524836733|FG003|Period 3: Part B|Withdrawal by Subject|0|||
145539946|NCT04457336|524836734|FG004|Period 3: Part B|Withdrawal by Subject|0|||
145539947|NCT04457336|524836735|FG005|Period 3: Part B|Withdrawal by Subject|1|||
145539948|NCT04457336|524836736|FG006|Period 3: Part B|Withdrawal by Subject|2|||
145539949|NCT04457336|524836737|FG007|Period 3: Part B|Withdrawal by Subject|0|||
145539950|NCT04457336|524836730|FG000|Period 4: Part C|Study Terminated|0|||
145539951|NCT04457336|524836731|FG001|Period 4: Part C|Study Terminated|0|||
145539952|NCT04457336|524836732|FG002|Period 4: Part C|Study Terminated|0|||
145539953|NCT04457336|524836733|FG003|Period 4: Part C|Study Terminated|0|||
145539954|NCT04457336|524836734|FG004|Period 4: Part C|Study Terminated|0|||
145539955|NCT04457336|524836735|FG005|Period 4: Part C|Study Terminated|0|||
145539956|NCT04457336|524836736|FG006|Period 4: Part C|Study Terminated|0|||
145539957|NCT04457336|524836737|FG007|Period 4: Part C|Study Terminated|30|||
145539958|NCT04457336|524836730|FG000|Period 4: Part C|Adverse Event|0|||
145539959|NCT04457336|524836731|FG001|Period 4: Part C|Adverse Event|0|||
145539960|NCT04457336|524836732|FG002|Period 4: Part C|Adverse Event|0|||
145539961|NCT04457336|524836733|FG003|Period 4: Part C|Adverse Event|0|||
145539962|NCT04457336|524836734|FG004|Period 4: Part C|Adverse Event|0|||
145539963|NCT04457336|524836735|FG005|Period 4: Part C|Adverse Event|0|||
145539964|NCT04457336|524836736|FG006|Period 4: Part C|Adverse Event|0|||
145539965|NCT04457336|524836737|FG007|Period 4: Part C|Adverse Event|2|||
145539966|NCT04457336|524836730|FG000|Period 4: Part C|Site Terminated|0|||
145539967|NCT04457336|524836731|FG001|Period 4: Part C|Site Terminated|0|||
145539968|NCT04457336|524836732|FG002|Period 4: Part C|Site Terminated|0|||
145539969|NCT04457336|524836733|FG003|Period 4: Part C|Site Terminated|0|||
145539970|NCT04457336|524836734|FG004|Period 4: Part C|Site Terminated|0|||
145539971|NCT04457336|524836735|FG005|Period 4: Part C|Site Terminated|0|||
145539972|NCT04457336|524836736|FG006|Period 4: Part C|Site Terminated|0|||
145539973|NCT04457336|524836737|FG007|Period 4: Part C|Site Terminated|1|||
145539974|NCT04457336|524836730|FG000|Period 4: Part C|Other|0|||
145539975|NCT04457336|524836731|FG001|Period 4: Part C|Other|0|||
145539976|NCT04457336|524836732|FG002|Period 4: Part C|Other|0|||
145539977|NCT04457336|524836733|FG003|Period 4: Part C|Other|0|||
145539978|NCT04457336|524836734|FG004|Period 4: Part C|Other|0|||
145539979|NCT04457336|524836735|FG005|Period 4: Part C|Other|0|||
145539980|NCT04457336|524836736|FG006|Period 4: Part C|Other|0|||
145539981|NCT04457336|524836737|FG007|Period 4: Part C|Other|2|||
145539982|NCT04457336|524836730|FG000|Period 4: Part C|Withdrawal by Subject|0|||
145539983|NCT04457336|524836731|FG001|Period 4: Part C|Withdrawal by Subject|0|||
145539984|NCT04457336|524836732|FG002|Period 4: Part C|Withdrawal by Subject|0|||
145539985|NCT04457336|524836733|FG003|Period 4: Part C|Withdrawal by Subject|0|||
145539986|NCT04457336|524836734|FG004|Period 4: Part C|Withdrawal by Subject|0|||
145539987|NCT04457336|524836735|FG005|Period 4: Part C|Withdrawal by Subject|0|||
145539988|NCT04457336|524836736|FG006|Period 4: Part C|Withdrawal by Subject|0|||
145539989|NCT04457336|524836737|FG007|Period 4: Part C|Withdrawal by Subject|3|||
145539990|NCT01042678|524836738|FG000|Overall Study|Physician Decision|1|||
145539991|NCT01042678|524836739|FG001|Overall Study|Physician Decision|0|||
145539992|NCT01042678|524836740|FG002|Overall Study|Physician Decision|0|||
145539993|NCT01042678|524836741|FG003|Overall Study|Physician Decision|0|||
145539994|NCT01042678|524836742|FG004|Overall Study|Physician Decision|0|||
145539995|NCT01042678|524836743|FG005|Overall Study|Physician Decision|0|||
145539996|NCT01719783|524836744|FG000|Dose 2|Physician Decision|1|||
145789748|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789749|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789750|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789751|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789752|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789753|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145539997|NCT01719783|524836745|FG001|Dose 2|Physician Decision|0|||
145539998|NCT02217878|524836751|FG000|Overall Study|required morphine due to chest pain|1|||
145539999|NCT02217878|524836752|FG001|Overall Study|required morphine due to chest pain|2|||
145540000|NCT02217878|524836751|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
145540001|NCT02217878|524836752|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
145540002|NCT00415168|524836753|FG000|Overall Study|Death|26|||
145540003|NCT00415168|524836753|FG000|Overall Study|Lost to Follow-up|3|||
145540004|NCT00415168|524836753|FG000|Overall Study|Physician Decision|13|||
145540005|NCT00415168|524836753|FG000|Overall Study|Sponsor Decision|4|||
145540006|NCT00415168|524836753|FG000|Overall Study|Withdrawal by Subject|6|||
145540007|NCT02106975|524836756|FG000|Overall Study|Death|25|||
145540008|NCT02106975|524836757|FG001|Overall Study|Death|39|||
145540009|NCT00005044|524836758|FG000|Overall Study|Protocol Violation|37|||
145540010|NCT00005044|524836759|FG001|Overall Study|Protocol Violation|46|||
145540011|NCT00005044|524836758|FG000|Overall Study|Withdrawal by Subject|1|||
145540012|NCT00005044|524836759|FG001|Overall Study|Withdrawal by Subject|5|||
145540013|NCT00005044|524836758|FG000|Overall Study|No protocol treatment|0|||
145540014|NCT00005044|524836759|FG001|Overall Study|No protocol treatment|1|||
145540015|NCT02572401|524836760|FG000|Overall Study|Lost to Follow-up|5|||
145540016|NCT02572401|524836761|FG001|Overall Study|Lost to Follow-up|8|||
145540017|NCT02572401|524836762|FG002|Overall Study|Lost to Follow-up|9|||
145540018|NCT02572401|524836763|FG003|Overall Study|Lost to Follow-up|9|||
145540019|NCT02572401|524836760|FG000|Overall Study|Death|0|||
145540020|NCT02572401|524836761|FG001|Overall Study|Death|0|||
145540021|NCT02572401|524836762|FG002|Overall Study|Death|0|||
145540022|NCT02572401|524836763|FG003|Overall Study|Death|1|||
145540023|NCT01548287|524836764|FG000|Screening|No reason provided|0|||
145540024|NCT01548287|524836765|FG001|Screening|No reason provided|0|||
145540025|NCT01548287|524836766|FG002|Screening|No reason provided|0|||
145540026|NCT01548287|524836767|FG003|Screening|No reason provided|0|||
145540027|NCT01548287|524836768|FG004|Screening|No reason provided|9|||
145540028|NCT01548287|524836764|FG000|Screening|Did not meet eligibility criteria|0|||
145540029|NCT01548287|524836765|FG001|Screening|Did not meet eligibility criteria|0|||
145540030|NCT01548287|524836766|FG002|Screening|Did not meet eligibility criteria|0|||
145540031|NCT01548287|524836767|FG003|Screening|Did not meet eligibility criteria|0|||
145540032|NCT01548287|524836768|FG004|Screening|Did not meet eligibility criteria|74|||
145540033|NCT01548287|524836764|FG000|Randomized Period|Did not meet inclusion criteria|0|||
145540034|NCT01548287|524836765|FG001|Randomized Period|Did not meet inclusion criteria|0|||
145540035|NCT01548287|524836766|FG002|Randomized Period|Did not meet inclusion criteria|2|||
145540036|NCT01548287|524836767|FG003|Randomized Period|Did not meet inclusion criteria|0|||
145540037|NCT01548287|524836768|FG004|Randomized Period|Did not meet inclusion criteria|0|||
145540038|NCT01548287|524836764|FG000|Randomized Period|Adverse Event|0|||
145540039|NCT01548287|524836765|FG001|Randomized Period|Adverse Event|2|||
145540040|NCT01548287|524836766|FG002|Randomized Period|Adverse Event|5|||
145540041|NCT01548287|524836767|FG003|Randomized Period|Adverse Event|0|||
145540042|NCT01548287|524836768|FG004|Randomized Period|Adverse Event|0|||
145540043|NCT02762578|524836770|FG000|Overall Study|Adverse Event|1|||
145540044|NCT02762578|524836771|FG001|Overall Study|Adverse Event|6|||
145540045|NCT02762578|524836770|FG000|Overall Study|Protocol Violation|4|||
145540046|NCT02762578|524836771|FG001|Overall Study|Protocol Violation|2|||
145540047|NCT02762578|524836770|FG000|Overall Study|Withdrawal by Subject|4|||
145404079|NCT01648764|524336471|FG013|Overall Study|Investigator Decision|0|||
145404080|NCT00076570|524336472|FG000|Overall Study|Drug intolerance|8|||
145404081|NCT00076570|524336473|FG001|Overall Study|Drug intolerance|8|||
145404082|NCT00420745|524336474|FG000|Overall Study|Adverse Event|2|||
145404083|NCT00420745|524336475|FG001|Overall Study|Adverse Event|2|||
145404084|NCT00420745|524336474|FG000|Overall Study|Lost to Follow-up|10|||
145404085|NCT00420745|524336475|FG001|Overall Study|Lost to Follow-up|2|||
145404086|NCT00420745|524336474|FG000|Overall Study|Protocol Violation|1|||
145404087|NCT00420745|524336475|FG001|Overall Study|Protocol Violation|0|||
145404088|NCT00420745|524336474|FG000|Overall Study|Physician Decision|1|||
145404089|NCT00420745|524336475|FG001|Overall Study|Physician Decision|1|||
145404090|NCT00420745|524336474|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
145404091|NCT00420745|524336475|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
145404092|NCT00420745|524336474|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
145404093|NCT00420745|524336475|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
145540048|NCT02762578|524836771|FG001|Overall Study|Withdrawal by Subject|2|||
145540049|NCT02762578|524836770|FG000|Overall Study|Unclassified|6|||
145540050|NCT02762578|524836771|FG001|Overall Study|Unclassified|0|||
145540051|NCT00259610|524836772|FG000|Overall Study|Withdrawal by Subject|33|||
145540052|NCT00259610|524836773|FG001|Overall Study|Withdrawal by Subject|25|||
145789754|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789755|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
145789756|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
145789757|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145789758|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
145789759|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
145404094|NCT01499511|524336478|FG000|Overall Study|Death|1|||
145404095|NCT01499511|524336479|FG001|Overall Study|Death|0|||
145404096|NCT00998946|524336480|FG000|Overall Study|Lost to Follow-up|1|||
145540053|NCT00259610|524836774|FG002|Overall Study|Withdrawal by Subject|29|||
145540054|NCT00259610|524836775|FG003|Overall Study|Withdrawal by Subject|19|||
145540055|NCT00259610|524836772|FG000|Overall Study|Lost to Follow-up|19|||
145540056|NCT00259610|524836773|FG001|Overall Study|Lost to Follow-up|8|||
145540057|NCT00259610|524836774|FG002|Overall Study|Lost to Follow-up|18|||
145540058|NCT00259610|524836775|FG003|Overall Study|Lost to Follow-up|15|||
145540059|NCT00259610|524836772|FG000|Overall Study|Physician Decision|6|||
145540060|NCT00259610|524836773|FG001|Overall Study|Physician Decision|4|||
145540061|NCT00259610|524836774|FG002|Overall Study|Physician Decision|7|||
145540062|NCT00259610|524836775|FG003|Overall Study|Physician Decision|2|||
145540063|NCT00259610|524836772|FG000|Overall Study|Death|1|||
145540064|NCT00259610|524836773|FG001|Overall Study|Death|1|||
145540065|NCT00259610|524836774|FG002|Overall Study|Death|2|||
145281953|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
145281954|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
145281955|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
145281956|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
145281957|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
145281958|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
145281959|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
145281960|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
145281961|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
145281962|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281963|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281964|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281965|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281966|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281967|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
145281968|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281969|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
145281970|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281971|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281972|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281973|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281974|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
145281975|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
145281976|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281977|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281978|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281979|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
145281980|NCT00950599|523883047|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
145281981|NCT00950599|523883048|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
145281982|NCT00950599|523883049|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
145281983|NCT00950599|523883050|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
145281984|NCT00950599|523883051|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
145281985|NCT00950599|523883052|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
145281986|NCT00950599|523883053|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
145281987|NCT00950599|523883054|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
145281988|NCT00950599|523883055|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
145281989|NCT00950599|523883056|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
145281990|NCT00950599|523883047|FG000|Follow-Up Period|Adverse Event|0|||
145281991|NCT00950599|523883048|FG001|Follow-Up Period|Adverse Event|0|||
145281992|NCT00950599|523883049|FG002|Follow-Up Period|Adverse Event|0|||
145281993|NCT00950599|523883050|FG003|Follow-Up Period|Adverse Event|0|||
145281994|NCT00950599|523883051|FG004|Follow-Up Period|Adverse Event|0|||
145281995|NCT00950599|523883052|FG005|Follow-Up Period|Adverse Event|0|||
145281996|NCT00950599|523883053|FG006|Follow-Up Period|Adverse Event|0|||
145281997|NCT00950599|523883054|FG007|Follow-Up Period|Adverse Event|0|||
145281998|NCT00950599|523883055|FG008|Follow-Up Period|Adverse Event|1|||
145281999|NCT00950599|523883056|FG009|Follow-Up Period|Adverse Event|0|||
145282000|NCT00950599|523883047|FG000|Follow-Up Period|Lack of Efficacy|0|||
145282001|NCT00950599|523883048|FG001|Follow-Up Period|Lack of Efficacy|0|||
145540066|NCT00259610|524836775|FG003|Overall Study|Death|0|||
145540067|NCT00259610|524836772|FG000|Overall Study|non medical reason|6|||
145540068|NCT00259610|524836773|FG001|Overall Study|non medical reason|2|||
145540069|NCT00259610|524836774|FG002|Overall Study|non medical reason|10|||
145540070|NCT00259610|524836775|FG003|Overall Study|non medical reason|3|||
145540071|NCT00259610|524836772|FG000|Overall Study|Adverse Event|3|||
145540072|NCT00259610|524836773|FG001|Overall Study|Adverse Event|4|||
145789760|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
145789761|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
145789762|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
145282002|NCT00950599|523883049|FG002|Follow-Up Period|Lack of Efficacy|0|||
145282003|NCT00950599|523883050|FG003|Follow-Up Period|Lack of Efficacy|0|||
145540073|NCT00259610|524836774|FG002|Overall Study|Adverse Event|5|||
145789763|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
145540074|NCT00259610|524836775|FG003|Overall Study|Adverse Event|2|||
145540075|NCT00259610|524836772|FG000|Overall Study|Serious Adverse Event|8|||
145540076|NCT00259610|524836773|FG001|Overall Study|Serious Adverse Event|2|||
145540077|NCT00259610|524836774|FG002|Overall Study|Serious Adverse Event|2|||
145540078|NCT00259610|524836775|FG003|Overall Study|Serious Adverse Event|2|||
145540079|NCT01768286|524836778|FG000|Overall Study|Randomized But Not Treated|0|||
145540080|NCT01768286|524836779|FG001|Overall Study|Randomized But Not Treated|0|||
145540081|NCT01768286|524836780|FG002|Overall Study|Randomized But Not Treated|1|||
145540082|NCT01768286|524836781|FG003|Overall Study|Randomized But Not Treated|0|||
145540083|NCT01768286|524836778|FG000|Overall Study|Lack of Efficacy|7|||
145540084|NCT01768286|524836779|FG001|Overall Study|Lack of Efficacy|4|||
145540085|NCT01768286|524836780|FG002|Overall Study|Lack of Efficacy|0|||
145540086|NCT01768286|524836781|FG003|Overall Study|Lack of Efficacy|1|||
145540087|NCT01768286|524836778|FG000|Overall Study|Withdrew Consent|0|||
145540088|NCT01768286|524836779|FG001|Overall Study|Withdrew Consent|0|||
145540089|NCT01768286|524836780|FG002|Overall Study|Withdrew Consent|1|||
145540090|NCT01768286|524836781|FG003|Overall Study|Withdrew Consent|0|||
145540091|NCT01201785|524836783|FG000|Overall Study|Lost to Follow-up|16|||
145540092|NCT02151110|524836784|FG000|Overall Study|Withdrawal by Subject|0|||
145540093|NCT02151110|524836785|FG001|Overall Study|Withdrawal by Subject|0|||
145540094|NCT02151110|524836786|FG002|Overall Study|Withdrawal by Subject|0|||
145540095|NCT02151110|524836787|FG003|Overall Study|Withdrawal by Subject|0|||
145540096|NCT02151110|524836788|FG004|Overall Study|Withdrawal by Subject|0|||
145540097|NCT02151110|524836789|FG005|Overall Study|Withdrawal by Subject|0|||
145540098|NCT02151110|524836790|FG006|Overall Study|Withdrawal by Subject|0|||
145540099|NCT02151110|524836791|FG007|Overall Study|Withdrawal by Subject|1|||
145540100|NCT02151110|524836784|FG000|Overall Study|Lost to Follow-up|0|||
145540101|NCT02151110|524836785|FG001|Overall Study|Lost to Follow-up|0|||
145540102|NCT02151110|524836786|FG002|Overall Study|Lost to Follow-up|0|||
145540103|NCT02151110|524836787|FG003|Overall Study|Lost to Follow-up|0|||
145540104|NCT02151110|524836788|FG004|Overall Study|Lost to Follow-up|0|||
145540105|NCT02151110|524836789|FG005|Overall Study|Lost to Follow-up|0|||
145540106|NCT02151110|524836790|FG006|Overall Study|Lost to Follow-up|0|||
145540107|NCT02151110|524836791|FG007|Overall Study|Lost to Follow-up|2|||
145540108|NCT02015754|524836792|FG000|Overall Study|Disease progression|5|||
145282004|NCT00950599|523883051|FG004|Follow-Up Period|Lack of Efficacy|0|||
145282005|NCT00950599|523883052|FG005|Follow-Up Period|Lack of Efficacy|0|||
145282006|NCT00950599|523883053|FG006|Follow-Up Period|Lack of Efficacy|0|||
145282007|NCT00950599|523883054|FG007|Follow-Up Period|Lack of Efficacy|0|||
145282008|NCT00950599|523883055|FG008|Follow-Up Period|Lack of Efficacy|3|||
145282009|NCT00950599|523883056|FG009|Follow-Up Period|Lack of Efficacy|0|||
145282010|NCT00950599|523883047|FG000|Follow-Up Period|Lost to Follow-up|0|||
145540109|NCT02015754|524836792|FG000|Overall Study|Change in treatment modality|5|||
145540110|NCT02015754|524836792|FG000|Overall Study|Lost to Follow-up|1|||
145540111|NCT02369016|524836793|FG000|Overall Study|AE associated with clinical disease progression|2|||
145540112|NCT02369016|524836794|FG001|Overall Study|AE associated with clinical disease progression|1|||
145540113|NCT02369016|524836793|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
145540114|NCT02369016|524836794|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
145540115|NCT02369016|524836793|FG000|Overall Study|Progressive disease - clinical progression|1|||
145540116|NCT02369016|524836794|FG001|Overall Study|Progressive disease - clinical progression|4|||
145540117|NCT02369016|524836793|FG000|Overall Study|withdrawal by patient|4|||
145540118|NCT02369016|524836794|FG001|Overall Study|withdrawal by patient|0|||
145540119|NCT02369016|524836793|FG000|Overall Study|Progressive disease - radiological progression|6|||
145540120|NCT02369016|524836794|FG001|Overall Study|Progressive disease - radiological progression|2|||
145540121|NCT00939770|524836797|FG000|Overall Study|Adverse Event|1|||
145540122|NCT00939770|524836798|FG001|Overall Study|Adverse Event|1|||
145540123|NCT00939770|524836799|FG002|Overall Study|Adverse Event|0|||
145540124|NCT00939770|524836800|FG003|Overall Study|Adverse Event|0|||
145540125|NCT00939770|524836801|FG004|Overall Study|Adverse Event|6|||
145540126|NCT00939770|524836802|FG005|Overall Study|Adverse Event|2|||
145540127|NCT00939770|524836803|FG006|Overall Study|Adverse Event|1|||
145540128|NCT00939770|524836804|FG007|Overall Study|Adverse Event|1|||
145540129|NCT00939770|524836797|FG000|Overall Study|Lack of Efficacy|4|||
145540130|NCT00939770|524836798|FG001|Overall Study|Lack of Efficacy|6|||
145540131|NCT00939770|524836799|FG002|Overall Study|Lack of Efficacy|13|||
145540132|NCT00939770|524836800|FG003|Overall Study|Lack of Efficacy|9|||
145540133|NCT00939770|524836801|FG004|Overall Study|Lack of Efficacy|16|||
145540134|NCT00939770|524836802|FG005|Overall Study|Lack of Efficacy|8|||
145540135|NCT00939770|524836803|FG006|Overall Study|Lack of Efficacy|11|||
145540136|NCT00939770|524836804|FG007|Overall Study|Lack of Efficacy|1|||
145540137|NCT00939770|524836797|FG000|Overall Study|Lost to Follow-up|0|||
145540138|NCT00939770|524836798|FG001|Overall Study|Lost to Follow-up|0|||
145540139|NCT00939770|524836799|FG002|Overall Study|Lost to Follow-up|0|||
145540140|NCT00939770|524836800|FG003|Overall Study|Lost to Follow-up|0|||
145282011|NCT00950599|523883048|FG001|Follow-Up Period|Lost to Follow-up|0|||
145540141|NCT00939770|524836801|FG004|Overall Study|Lost to Follow-up|1|||
145540142|NCT00939770|524836802|FG005|Overall Study|Lost to Follow-up|0|||
145540143|NCT00939770|524836803|FG006|Overall Study|Lost to Follow-up|0|||
145540144|NCT00939770|524836804|FG007|Overall Study|Lost to Follow-up|0|||
145540145|NCT00939770|524836797|FG000|Overall Study|Physician Decision|0|||
145540146|NCT00939770|524836798|FG001|Overall Study|Physician Decision|0|||
145540147|NCT00939770|524836799|FG002|Overall Study|Physician Decision|2|||
145540148|NCT00939770|524836800|FG003|Overall Study|Physician Decision|0|||
145540149|NCT00939770|524836801|FG004|Overall Study|Physician Decision|7|||
145540150|NCT00939770|524836802|FG005|Overall Study|Physician Decision|1|||
145540151|NCT00939770|524836803|FG006|Overall Study|Physician Decision|0|||
145540152|NCT00939770|524836804|FG007|Overall Study|Physician Decision|6|||
145540153|NCT00939770|524836797|FG000|Overall Study|Protocol Violation|0|||
145540154|NCT00939770|524836798|FG001|Overall Study|Protocol Violation|0|||
145540155|NCT00939770|524836799|FG002|Overall Study|Protocol Violation|0|||
145540156|NCT00939770|524836800|FG003|Overall Study|Protocol Violation|0|||
145540157|NCT00939770|524836801|FG004|Overall Study|Protocol Violation|1|||
145540158|NCT00939770|524836802|FG005|Overall Study|Protocol Violation|0|||
145540159|NCT00939770|524836803|FG006|Overall Study|Protocol Violation|0|||
145540160|NCT00939770|524836804|FG007|Overall Study|Protocol Violation|0|||
145540161|NCT00939770|524836797|FG000|Overall Study|Withdrawal by Subject|0|||
145540162|NCT00939770|524836798|FG001|Overall Study|Withdrawal by Subject|1|||
145540163|NCT00939770|524836799|FG002|Overall Study|Withdrawal by Subject|5|||
145540164|NCT00939770|524836800|FG003|Overall Study|Withdrawal by Subject|2|||
145540165|NCT00939770|524836801|FG004|Overall Study|Withdrawal by Subject|6|||
145540166|NCT00939770|524836802|FG005|Overall Study|Withdrawal by Subject|0|||
145609941|NCT00041756|525088057|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
145609942|NCT00067990|525088058|FG000|Overall Study|Death|5|||
145609943|NCT00067990|525088059|FG001|Overall Study|Death|7|||
145609944|NCT00067990|525088058|FG000|Overall Study|ESRD, Non IF/TA|1|||
145609945|NCT00067990|525088059|FG001|Overall Study|ESRD, Non IF/TA|3|||
145609946|NCT00067990|525088058|FG000|Overall Study|Withdrawal by Subject|4|||
145609947|NCT00067990|525088059|FG001|Overall Study|Withdrawal by Subject|12|||
145609948|NCT03810313|525088062|FG000|Overall Study|Study terminated by sponsor|164|||
145609949|NCT03810313|525088063|FG001|Overall Study|Study terminated by sponsor|159|||
145609950|NCT03810313|525088062|FG000|Overall Study|Subject decision|10|||
145609951|NCT03810313|525088063|FG001|Overall Study|Subject decision|11|||
145609952|NCT03810313|525088062|FG000|Overall Study|Lost to Follow-up|3|||
145609953|NCT03810313|525088063|FG001|Overall Study|Lost to Follow-up|3|||
145609954|NCT03810313|525088062|FG000|Overall Study|Adverse Event|2|||
145789764|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789765|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789766|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789767|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789768|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789769|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789770|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789771|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789772|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789773|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789774|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789775|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789776|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789777|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789778|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
145789779|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
145789780|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
145789781|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789782|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
145789783|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
145789784|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789785|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789786|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
145789787|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789788|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789789|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789790|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789791|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789792|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789793|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789794|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145540167|NCT00939770|524836803|FG006|Overall Study|Withdrawal by Subject|2|||
145540168|NCT00939770|524836804|FG007|Overall Study|Withdrawal by Subject|2|||
145609955|NCT03810313|525088063|FG001|Overall Study|Adverse Event|1|||
145540169|NCT01146665|524836805|FG000|Overall Study|Withdrawal by Subject|10|||
145540170|NCT01146665|524836806|FG001|Overall Study|Withdrawal by Subject|16|||
145609956|NCT03810313|525088062|FG000|Overall Study|Death|2|||
145282012|NCT00950599|523883049|FG002|Follow-Up Period|Lost to Follow-up|0|||
145282013|NCT00950599|523883050|FG003|Follow-Up Period|Lost to Follow-up|0|||
145282014|NCT00950599|523883051|FG004|Follow-Up Period|Lost to Follow-up|0|||
145282015|NCT00950599|523883052|FG005|Follow-Up Period|Lost to Follow-up|0|||
145282016|NCT00950599|523883053|FG006|Follow-Up Period|Lost to Follow-up|0|||
145282017|NCT00950599|523883054|FG007|Follow-Up Period|Lost to Follow-up|0|||
145282018|NCT00950599|523883055|FG008|Follow-Up Period|Lost to Follow-up|5|||
145282019|NCT00950599|523883056|FG009|Follow-Up Period|Lost to Follow-up|1|||
145282020|NCT00950599|523883047|FG000|Follow-Up Period|Physician Decision|0|||
145282021|NCT00950599|523883048|FG001|Follow-Up Period|Physician Decision|0|||
145282022|NCT00950599|523883049|FG002|Follow-Up Period|Physician Decision|0|||
145540171|NCT05248867|524836807|FG000|Double-blind Period|Lost to Follow-up|0|||
145540172|NCT05248867|524836808|FG001|Double-blind Period|Lost to Follow-up|3|||
145540173|NCT05248867|524836809|FG002|Double-blind Period|Lost to Follow-up|0|||
145540174|NCT05248867|524836810|FG003|Double-blind Period|Lost to Follow-up|0|||
145540175|NCT05248867|524836811|FG004|Double-blind Period|Lost to Follow-up|0|||
145540176|NCT05248867|524836812|FG005|Double-blind Period|Lost to Follow-up|0|||
145540177|NCT05248867|524836807|FG000|Double-blind Period|Withdrawal by Subject|5|||
145540178|NCT05248867|524836808|FG001|Double-blind Period|Withdrawal by Subject|14|||
145540179|NCT05248867|524836809|FG002|Double-blind Period|Withdrawal by Subject|0|||
145540180|NCT05248867|524836810|FG003|Double-blind Period|Withdrawal by Subject|0|||
145540181|NCT05248867|524836811|FG004|Double-blind Period|Withdrawal by Subject|0|||
145540182|NCT05248867|524836812|FG005|Double-blind Period|Withdrawal by Subject|0|||
145540183|NCT05248867|524836807|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
145540184|NCT05248867|524836808|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
145540185|NCT05248867|524836809|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
145540186|NCT05248867|524836810|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
145540187|NCT05248867|524836811|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
145540188|NCT05248867|524836812|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
145540189|NCT05248867|524836807|FG000|Double-blind Period|Other, not specified|3|||
145540190|NCT05248867|524836808|FG001|Double-blind Period|Other, not specified|8|||
145540191|NCT05248867|524836809|FG002|Double-blind Period|Other, not specified|0|||
145540192|NCT05248867|524836810|FG003|Double-blind Period|Other, not specified|0|||
145540193|NCT05248867|524836811|FG004|Double-blind Period|Other, not specified|0|||
145540194|NCT05248867|524836812|FG005|Double-blind Period|Other, not specified|0|||
145540195|NCT05248867|524836807|FG000|Open-label Period|Withdrawal by Subject|0|||
145540196|NCT05248867|524836808|FG001|Open-label Period|Withdrawal by Subject|0|||
145540197|NCT05248867|524836809|FG002|Open-label Period|Withdrawal by Subject|3|||
145540198|NCT05248867|524836810|FG003|Open-label Period|Withdrawal by Subject|1|||
145540199|NCT05248867|524836811|FG004|Open-label Period|Withdrawal by Subject|7|||
145540200|NCT05248867|524836812|FG005|Open-label Period|Withdrawal by Subject|9|||
145540201|NCT05248867|524836807|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
145540202|NCT05248867|524836808|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
145540203|NCT05248867|524836809|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
145540204|NCT05248867|524836810|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
145540205|NCT05248867|524836811|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
145540206|NCT05248867|524836812|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
145540207|NCT05248867|524836807|FG000|Open-label Period|Lost to Follow-up|0|||
145540208|NCT05248867|524836808|FG001|Open-label Period|Lost to Follow-up|0|||
145540209|NCT05248867|524836809|FG002|Open-label Period|Lost to Follow-up|0|||
145540210|NCT05248867|524836810|FG003|Open-label Period|Lost to Follow-up|0|||
145540211|NCT05248867|524836811|FG004|Open-label Period|Lost to Follow-up|5|||
145540212|NCT05248867|524836812|FG005|Open-label Period|Lost to Follow-up|2|||
145540213|NCT05248867|524836807|FG000|Open-label Period|COVID-19 Infection|0|||
145540214|NCT05248867|524836808|FG001|Open-label Period|COVID-19 Infection|0|||
145540215|NCT05248867|524836809|FG002|Open-label Period|COVID-19 Infection|0|||
145540216|NCT05248867|524836810|FG003|Open-label Period|COVID-19 Infection|0|||
145540217|NCT05248867|524836811|FG004|Open-label Period|COVID-19 Infection|1|||
145540218|NCT05248867|524836812|FG005|Open-label Period|COVID-19 Infection|0|||
145540219|NCT05248867|524836807|FG000|Open-label Period|Other, not specified|0|||
145282023|NCT00950599|523883050|FG003|Follow-Up Period|Physician Decision|0|||
145282024|NCT00950599|523883051|FG004|Follow-Up Period|Physician Decision|0|||
145282025|NCT00950599|523883052|FG005|Follow-Up Period|Physician Decision|0|||
145282026|NCT00950599|523883053|FG006|Follow-Up Period|Physician Decision|0|||
145282027|NCT00950599|523883054|FG007|Follow-Up Period|Physician Decision|0|||
145282028|NCT00950599|523883055|FG008|Follow-Up Period|Physician Decision|1|||
145282029|NCT00950599|523883056|FG009|Follow-Up Period|Physician Decision|0|||
145282030|NCT00950599|523883047|FG000|Follow-Up Period|Poor/Noncompliance|0|||
145540220|NCT05248867|524836808|FG001|Open-label Period|Other, not specified|0|||
145540221|NCT05248867|524836809|FG002|Open-label Period|Other, not specified|0|||
145540222|NCT05248867|524836810|FG003|Open-label Period|Other, not specified|0|||
145540223|NCT05248867|524836811|FG004|Open-label Period|Other, not specified|4|||
145609957|NCT03810313|525088063|FG001|Overall Study|Death|1|||
145540224|NCT05248867|524836812|FG005|Open-label Period|Other, not specified|0|||
145540225|NCT03128411|524836814|FG000|Treatment Phase|Adverse Event|21|||
145540226|NCT03128411|524836814|FG000|Treatment Phase|Physician Decision|1|||
145540227|NCT03128411|524836814|FG000|Treatment Phase|Other|2|||
145540228|NCT03128411|524836814|FG000|Long Term Follow-up Phase|Death|2|||
145540229|NCT01218113|524838223|FG000|Overall Study|Withdrawal by Subject|1|||
145540230|NCT01218113|524838224|FG001|Overall Study|Withdrawal by Subject|0|||
145540231|NCT01218113|524838225|FG002|Overall Study|Withdrawal by Subject|1|||
145540232|NCT01218113|524838223|FG000|Overall Study|Lost to Follow-up|4|||
145540233|NCT01218113|524838224|FG001|Overall Study|Lost to Follow-up|1|||
145540234|NCT01218113|524838225|FG002|Overall Study|Lost to Follow-up|4|||
145540235|NCT01218113|524838223|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
145540236|NCT01218113|524838224|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
145540237|NCT01218113|524838225|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
145540238|NCT01433991|524838228|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
145540239|NCT01433991|524838229|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
145540240|NCT01433991|524838230|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
145540241|NCT01433991|524838231|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
145540242|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
145540243|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
145540244|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
145540245|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
145540246|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
145540247|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
145540248|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
145540249|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
145540250|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
145540251|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
145540252|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
145540253|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
145540254|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
145540255|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
145540256|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
145540257|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
145540258|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
145540259|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
145540260|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
145540261|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
145540262|NCT01433991|524838228|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
145540263|NCT01433991|524838229|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
145540264|NCT01433991|524838230|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
145540265|NCT01433991|524838231|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
145540266|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
145540267|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
145540268|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
145540269|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
145540270|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
145540271|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
145540272|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
145540273|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
145540274|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
145540275|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
145540276|NCT00787891|524838234|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
145540277|NCT00787891|524838235|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
145540278|NCT00787891|524838234|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
145540279|NCT00787891|524838235|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
145540280|NCT00787891|524838234|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
145540281|NCT00787891|524838235|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
145540282|NCT00787891|524838234|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
145540283|NCT00787891|524838235|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
145540284|NCT00787891|524838234|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
145540285|NCT00787891|524838235|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
145558238|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
145540286|NCT03486223|524838243|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
145540287|NCT03486223|524838244|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
145540288|NCT01513343|524838247|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
145540289|NCT01513343|524838248|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
145540290|NCT01513343|524838247|FG000|Post Data Collection|Dropped/withdrew from study|7|||
145540291|NCT01513343|524838248|FG001|Post Data Collection|Dropped/withdrew from study|1|||
145540292|NCT01513343|524838247|FG000|Post Data Collection|Lost to Follow-up|10|||
145540293|NCT01513343|524838248|FG001|Post Data Collection|Lost to Follow-up|23|||
145540294|NCT01513343|524838247|FG000|6-month Follow-up|Lost to Follow-up|28|||
145540295|NCT01513343|524838248|FG001|6-month Follow-up|Lost to Follow-up|17|||
145540296|NCT01513343|524838247|FG000|12-month Follow-up|Lost to Follow-up|10|||
145540297|NCT01513343|524838248|FG001|12-month Follow-up|Lost to Follow-up|3|||
145540298|NCT01877265|524838261|FG000|Treatment Period 1|Sponsor Decision|0|||
145540299|NCT01877265|524838262|FG001|Treatment Period 1|Sponsor Decision|0|||
145540300|NCT01877265|524838263|FG002|Treatment Period 1|Sponsor Decision|1|||
145540301|NCT01877265|524838264|FG003|Treatment Period 1|Sponsor Decision|0|||
145540302|NCT01877265|524838265|FG004|Treatment Period 1|Sponsor Decision|0|||
145540303|NCT01877265|524838266|FG005|Treatment Period 1|Sponsor Decision|0|||
145540304|NCT01877265|524838261|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
145540305|NCT01877265|524838262|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
145540306|NCT01877265|524838263|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
145540307|NCT01877265|524838264|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
145540308|NCT01877265|524838265|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
145540309|NCT01877265|524838266|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
145540310|NCT01877265|524838261|FG000|Treatment Period 3|Lost to Follow-up|1|||
145540311|NCT01877265|524838262|FG001|Treatment Period 3|Lost to Follow-up|0|||
145540312|NCT01877265|524838263|FG002|Treatment Period 3|Lost to Follow-up|0|||
145540313|NCT01877265|524838264|FG003|Treatment Period 3|Lost to Follow-up|0|||
145540314|NCT01877265|524838265|FG004|Treatment Period 3|Lost to Follow-up|0|||
145540315|NCT01877265|524838266|FG005|Treatment Period 3|Lost to Follow-up|0|||
145540316|NCT02193867|524838272|FG000|Overall Study|Death|2|||
145540317|NCT02193867|524838272|FG000|Overall Study|Sponsor Study Termination|2|||
145540318|NCT00724932|524838273|FG000|Overall Study|Lost to Follow-up|1|||
145540319|NCT00724932|524838274|FG001|Overall Study|Lost to Follow-up|0|||
145540320|NCT00724932|524838273|FG000|Overall Study|Not treated|4|||
145540321|NCT00724932|524838274|FG001|Overall Study|Not treated|3|||
145540322|NCT03758066|524838276|FG000|Overall Study|Lost to Follow-up|14|||
145540323|NCT02590003|524838277|FG000|Overall Study|Death|1|||
145540324|NCT02590003|524838278|FG001|Overall Study|Death|2|||
145540325|NCT03733470|524838279|FG000|Overall Study|PI Decision|1|||
145540326|NCT03733470|524838280|FG001|Overall Study|PI Decision|1|||
145540327|NCT01849783|524838283|FG000|Overall Study|Adverse Event|5|||
145540328|NCT01849783|524838283|FG000|Overall Study|Death|2|||
145540329|NCT01849783|524838283|FG000|Overall Study|Physician Decision|1|||
145540330|NCT01849783|524838283|FG000|Overall Study|Withdrawal by Subject|1|||
145540331|NCT01849783|524838283|FG000|Overall Study|Unable to comply|2|||
145540332|NCT01849783|524838283|FG000|Overall Study|Disease progression|11|||
145540333|NCT03948581|524838284|FG000|Overall Study|Lost to Follow-up|0|||
145540334|NCT03948581|524838285|FG001|Overall Study|Lost to Follow-up|1|||
145540335|NCT03068455|524838286|FG000|Pre-treatment Period|Disease progression|0|||
145540336|NCT03068455|524838287|FG001|Pre-treatment Period|Disease progression|1|||
145540337|NCT03068455|524838286|FG000|Pre-treatment Period|Participant withdrew consent|1|||
145540338|NCT03068455|524838287|FG001|Pre-treatment Period|Participant withdrew consent|1|||
145540339|NCT03068455|524838286|FG000|Pre-treatment Period|Poor/non-compliance|0|||
145540340|NCT03068455|524838287|FG001|Pre-treatment Period|Poor/non-compliance|1|||
145540341|NCT03068455|524838286|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
145540342|NCT03068455|524838287|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
145540343|NCT03068455|524838286|FG000|Pre-treatment Period|Not reported|2|||
145540344|NCT03068455|524838287|FG001|Pre-treatment Period|Not reported|1|||
145540345|NCT03068455|524838286|FG000|Treatment Period|Disease progression|166|||
145540346|NCT03068455|524838287|FG001|Treatment Period|Disease progression|208|||
145540347|NCT03068455|524838286|FG000|Treatment Period|Study drug toxicity|317|||
145540348|NCT03068455|524838287|FG001|Treatment Period|Study drug toxicity|104|||
145540349|NCT03068455|524838286|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
145609958|NCT03810313|525088062|FG000|Overall Study|Physician Decision|0|||
145609959|NCT03810313|525088063|FG001|Overall Study|Physician Decision|1|||
145540350|NCT03068455|524838287|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
145540351|NCT03068455|524838286|FG000|Treatment Period|Participant request to stop therapy|33|||
145609960|NCT01111838|525088064|FG000|Overall Study|Patient Ineligible|2|||
145540352|NCT03068455|524838287|FG001|Treatment Period|Participant request to stop therapy|20|||
145540353|NCT03068455|524838286|FG000|Treatment Period|Participant withdrew consent|5|||
145540354|NCT03068455|524838287|FG001|Treatment Period|Participant withdrew consent|10|||
145540355|NCT03068455|524838286|FG000|Treatment Period|Poor/non-compliance|3|||
145540356|NCT03068455|524838287|FG001|Treatment Period|Poor/non-compliance|0|||
145540357|NCT03068455|524838286|FG000|Treatment Period|Participant no longer meets study criteria|1|||
145540358|NCT03068455|524838287|FG001|Treatment Period|Participant no longer meets study criteria|3|||
145540359|NCT03068455|524838286|FG000|Treatment Period|Other reasons|12|||
145540360|NCT03068455|524838287|FG001|Treatment Period|Other reasons|4|||
145540361|NCT04203498|524838295|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
145540362|NCT04203498|524838296|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
145540363|NCT04203498|524838295|FG000|Overall Study|Withdrawal of patient consent|7|||
145540364|NCT04203498|524838296|FG001|Overall Study|Withdrawal of patient consent|2|||
145540365|NCT04203498|524838295|FG000|Overall Study|Adverse Event|4|||
145540366|NCT04203498|524838296|FG001|Overall Study|Adverse Event|1|||
145540367|NCT04203498|524838295|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
145540368|NCT04203498|524838296|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
145540369|NCT04203498|524838295|FG000|Overall Study|Did not receive IMP|2|||
145540370|NCT04203498|524838296|FG001|Overall Study|Did not receive IMP|0|||
145540371|NCT03546062|524838298|FG000|Overall Study|Adverse Event|6|||
145540372|NCT03546062|524838299|FG001|Overall Study|Adverse Event|5|||
145540373|NCT03546062|524838300|FG002|Overall Study|Adverse Event|8|||
145540374|NCT00781274|524838301|FG000|Overall Study|Withdrawal by Subject|2|||
145540375|NCT00181155|524838302|FG000|Overall Study|Physician Decision|1|||
145540376|NCT00181155|524838303|FG001|Overall Study|Physician Decision|0|||
145540377|NCT00181155|524838302|FG000|Overall Study|Withdrawal by Subject|1|||
145540378|NCT00181155|524838303|FG001|Overall Study|Withdrawal by Subject|0|||
145540379|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
145540380|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
145540381|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
145540382|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
145540383|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
145540384|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
145540385|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
145540386|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
145540387|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540388|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
145540389|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540390|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540391|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540392|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540393|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
145540394|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
145540395|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540396|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540397|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
145540398|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540399|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540400|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540401|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540402|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540403|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Other|0|||
145540404|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Other|0|||
145540405|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Other|1|||
145540406|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Other|1|||
145540407|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Other|2|||
145540408|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Other|0|||
145540409|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Other|0|||
145540410|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Other|0|||
145540411|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540412|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540413|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
145609961|NCT01111838|525088064|FG000|Overall Study|Not Treated|3|||
145540414|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540415|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
145540416|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540417|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540418|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
145540419|NCT01090492|524838307|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
145540420|NCT01090492|524838308|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
145540421|NCT01090492|524838309|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
145540422|NCT01090492|524838310|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
145540423|NCT01090492|524838311|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
145540424|NCT01090492|524838312|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
145540425|NCT01090492|524838313|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
145540426|NCT01090492|524838314|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
145540427|NCT01090492|524838307|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
145540428|NCT01090492|524838308|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
145540429|NCT01090492|524838309|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
145540430|NCT01090492|524838310|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
145540431|NCT01090492|524838311|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
145540432|NCT01090492|524838312|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
145540433|NCT01090492|524838313|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
145540434|NCT01090492|524838314|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
145540435|NCT01090492|524838307|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540436|NCT01090492|524838308|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
145540437|NCT01090492|524838309|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540438|NCT01090492|524838310|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540439|NCT01090492|524838311|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540440|NCT01090492|524838312|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540441|NCT01090492|524838313|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540442|NCT01090492|524838314|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
145540443|NCT01090492|524838307|FG000|Second Intervention Period (4 Weeks)|Other|0|||
145540444|NCT01090492|524838308|FG001|Second Intervention Period (4 Weeks)|Other|1|||
145540445|NCT01090492|524838309|FG002|Second Intervention Period (4 Weeks)|Other|1|||
145540446|NCT01090492|524838310|FG003|Second Intervention Period (4 Weeks)|Other|0|||
145540447|NCT01090492|524838311|FG004|Second Intervention Period (4 Weeks)|Other|0|||
145540448|NCT01090492|524838312|FG005|Second Intervention Period (4 Weeks)|Other|0|||
145540449|NCT01090492|524838313|FG006|Second Intervention Period (4 Weeks)|Other|0|||
145540450|NCT01090492|524838314|FG007|Second Intervention Period (4 Weeks)|Other|0|||
145540451|NCT01090492|524838307|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
145540452|NCT01090492|524838308|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
145540453|NCT01090492|524838309|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
145540454|NCT01090492|524838310|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
145540455|NCT01090492|524838311|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
145540456|NCT01090492|524838312|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
145540457|NCT01090492|524838313|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
145540458|NCT01090492|524838314|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
145540459|NCT01090492|524838307|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540460|NCT01090492|524838308|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540461|NCT01090492|524838309|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540462|NCT01090492|524838310|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540463|NCT01090492|524838311|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540464|NCT01090492|524838312|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540465|NCT01090492|524838313|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
145540466|NCT01090492|524838314|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
145540467|NCT02083965|524838315|FG000|Treatment Period|Other|1|||
145540468|NCT02083965|524838316|FG001|Treatment Period|Other|0|||
145540469|NCT00868608|524838317|FG000|Overall Study|Withdrawal by Subject|3|||
145540470|NCT00868608|524838318|FG001|Overall Study|Withdrawal by Subject|1|||
145540471|NCT00868608|524838319|FG002|Overall Study|Withdrawal by Subject|0|||
145540472|NCT00868608|524838317|FG000|Overall Study|Lost to Follow-up|3|||
145540473|NCT00868608|524838318|FG001|Overall Study|Lost to Follow-up|0|||
145540474|NCT00868608|524838319|FG002|Overall Study|Lost to Follow-up|1|||
145540475|NCT00868608|524838317|FG000|Overall Study|Death|16|||
145540476|NCT00868608|524838318|FG001|Overall Study|Death|2|||
145540477|NCT00868608|524838319|FG002|Overall Study|Death|4|||
145540478|NCT00868608|524838317|FG000|Overall Study|Other - Unspecified|1|||
145540479|NCT00868608|524838318|FG001|Overall Study|Other - Unspecified|0|||
145540480|NCT00868608|524838319|FG002|Overall Study|Other - Unspecified|0|||
145540481|NCT02935842|524838320|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
145540482|NCT02935842|524838321|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
145540483|NCT02935842|524838322|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
145540484|NCT02935842|524838323|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
145540485|NCT02935842|524838320|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
145540486|NCT02935842|524838321|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
145540487|NCT02935842|524838322|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
145540488|NCT02935842|524838323|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
145540489|NCT02935842|524838320|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
145540490|NCT02935842|524838321|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
145540491|NCT02935842|524838322|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
145540492|NCT02935842|524838323|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
145540493|NCT02935842|524838320|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
145540494|NCT02935842|524838321|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
145540495|NCT02935842|524838322|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
145540496|NCT02935842|524838323|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
145540497|NCT02935842|524838320|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
145540498|NCT02935842|524838321|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
145540499|NCT02935842|524838322|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
145540500|NCT02935842|524838323|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
145540501|NCT00911547|524838324|FG000|Overall Study|Adverse Event|8|||
145540502|NCT00911547|524838325|FG001|Overall Study|Adverse Event|27|||
145540503|NCT00911547|524838326|FG002|Overall Study|Adverse Event|11|||
145540504|NCT00911547|524838327|FG003|Overall Study|Adverse Event|6|||
145540505|NCT00911547|524838324|FG000|Overall Study|Lost to Follow-up|0|||
145540506|NCT00911547|524838325|FG001|Overall Study|Lost to Follow-up|0|||
145540507|NCT00911547|524838326|FG002|Overall Study|Lost to Follow-up|2|||
145540508|NCT00911547|524838327|FG003|Overall Study|Lost to Follow-up|1|||
145540509|NCT00911547|524838324|FG000|Overall Study|Protocol Violation|0|||
145540510|NCT00911547|524838325|FG001|Overall Study|Protocol Violation|5|||
145540511|NCT00911547|524838326|FG002|Overall Study|Protocol Violation|5|||
145540512|NCT00911547|524838327|FG003|Overall Study|Protocol Violation|1|||
145540513|NCT00911547|524838324|FG000|Overall Study|Withdrawal by Subject|3|||
145540514|NCT00911547|524838325|FG001|Overall Study|Withdrawal by Subject|10|||
145540515|NCT00911547|524838326|FG002|Overall Study|Withdrawal by Subject|4|||
145540516|NCT00911547|524838327|FG003|Overall Study|Withdrawal by Subject|8|||
145540517|NCT03344796|524838328|FG000|Overall Study|Lost to Follow-up|0|||
145540518|NCT03344796|524838329|FG001|Overall Study|Lost to Follow-up|0|||
145540519|NCT03344796|524838330|FG002|Overall Study|Lost to Follow-up|0|||
145540520|NCT03344796|524838331|FG003|Overall Study|Lost to Follow-up|0|||
145540521|NCT03344796|524838332|FG004|Overall Study|Lost to Follow-up|0|||
145540522|NCT03344796|524838333|FG005|Overall Study|Lost to Follow-up|2|||
145540523|NCT01064310|524838340|FG000|Period 1|Adverse Event|7|||
145540524|NCT01064310|524838341|FG001|Period 1|Adverse Event|10|||
145540525|NCT01064310|524838342|FG002|Period 1|Adverse Event|0|||
145540526|NCT01064310|524838340|FG000|Period 1|Physician Decision|1|||
145540527|NCT01064310|524838341|FG001|Period 1|Physician Decision|0|||
145540528|NCT01064310|524838342|FG002|Period 1|Physician Decision|0|||
145540529|NCT01064310|524838340|FG000|Period 1|Withdrawal by Subject|2|||
145540530|NCT01064310|524838341|FG001|Period 1|Withdrawal by Subject|2|||
145540531|NCT01064310|524838342|FG002|Period 1|Withdrawal by Subject|0|||
145540532|NCT01064310|524838340|FG000|Period 1|Lack of Efficacy|3|||
145540533|NCT01064310|524838341|FG001|Period 1|Lack of Efficacy|5|||
145540534|NCT01064310|524838342|FG002|Period 1|Lack of Efficacy|0|||
145540535|NCT01064310|524838340|FG000|Period 1|Entered Open-label Period|1|||
145540536|NCT01064310|524838341|FG001|Period 1|Entered Open-label Period|1|||
145540537|NCT01064310|524838342|FG002|Period 1|Entered Open-label Period|0|||
145540538|NCT01064310|524838340|FG000|Period 2|Adverse Event|2|||
145540539|NCT01064310|524838341|FG001|Period 2|Adverse Event|1|||
145540540|NCT01064310|524838342|FG002|Period 2|Adverse Event|0|||
145540541|NCT01064310|524838340|FG000|Period 2|Physician Decision|0|||
145540542|NCT01064310|524838341|FG001|Period 2|Physician Decision|1|||
145540543|NCT01064310|524838342|FG002|Period 2|Physician Decision|0|||
145540544|NCT01064310|524838340|FG000|Period 2|Entered Open-label Period|1|||
145540545|NCT01064310|524838341|FG001|Period 2|Entered Open-label Period|0|||
145540546|NCT01064310|524838342|FG002|Period 2|Entered Open-label Period|0|||
145540547|NCT01064310|524838340|FG000|Period 2|Lack of Efficacy|1|||
145540548|NCT01064310|524838341|FG001|Period 2|Lack of Efficacy|4|||
145540549|NCT01064310|524838342|FG002|Period 2|Lack of Efficacy|0|||
145540550|NCT01064310|524838340|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
145540551|NCT01064310|524838341|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
145540552|NCT01064310|524838342|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
145540553|NCT01064310|524838340|FG000|Open Label Pazopinib|Adverse Event|0|||
145540554|NCT01064310|524838341|FG001|Open Label Pazopinib|Adverse Event|0|||
145540555|NCT01064310|524838342|FG002|Open Label Pazopinib|Adverse Event|12|||
145540556|NCT01064310|524838340|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
145540557|NCT01064310|524838341|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
145540558|NCT01064310|524838342|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
145540559|NCT01064310|524838340|FG000|Open Label Pazopinib|Physician Decision|0|||
145540560|NCT01064310|524838341|FG001|Open Label Pazopinib|Physician Decision|0|||
145540561|NCT01064310|524838342|FG002|Open Label Pazopinib|Physician Decision|20|||
145540562|NCT02639065|524838343|FG000|Study Treatment|Disease Progression|13|||
145540563|NCT02639065|524838343|FG000|Study Treatment|Adverse Event|9|||
145540564|NCT02639065|524838343|FG000|Study Treatment|Withdrawal by Subject|1|||
145540565|NCT02639065|524838343|FG000|Follow up|Subject refused to follow up|1|||
145540566|NCT02639065|524838343|FG000|Follow up|Symptomatic Deterioration|2|||
145540567|NCT02639065|524838343|FG000|Follow up|Death|2|||
145540568|NCT02639065|524838343|FG000|Follow up|Study Terminated|1|||
145540569|NCT02639065|524838343|FG000|Follow up|Disease Progression|3|||
145540570|NCT05695209|524838348|FG000|3-months|Withdrawal by Subject|2|||
145540571|NCT05695209|524838349|FG001|3-months|Withdrawal by Subject|0|||
145540572|NCT05695209|524838348|FG000|3-months|Unable to contact for 3-month data collection|0|||
145540573|NCT05695209|524838349|FG001|3-months|Unable to contact for 3-month data collection|1|||
145540574|NCT05695209|524838348|FG000|6-months|Lost to Follow-up|1|||
145540575|NCT05695209|524838349|FG001|6-months|Lost to Follow-up|1|||
145540576|NCT05372419|524838350|FG000|Overall Study|Protocol Deviation|1|||
145540577|NCT05372419|524838350|FG000|Overall Study|Withdrawal by Subject|5|||
145540578|NCT05372419|524838350|FG000|Overall Study|Lost to Follow-up|7|||
145540579|NCT04362072|524838353|FG000|Treatment|Adverse Event|1|||
145540580|NCT04362072|524838353|FG000|Treatment|Death|9|||
145540581|NCT04362072|524838353|FG000|Treatment|Physician Decision|2|||
145540582|NCT04362072|524838353|FG000|Treatment|Progressive disease|27|||
145540583|NCT04362072|524838353|FG000|Treatment|Withdrawal by Subject|4|||
145540584|NCT04362072|524838353|FG000|Treatment|Global deterioration of health status|1|||
145540585|NCT04362072|524838353|FG000|Treatment|Switched to commercial Lorlatinib|13|||
145540586|NCT04362072|524838353|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
145540587|NCT04362072|524838353|FG000|Treatment|Other|3|||
145540588|NCT04362072|524838353|FG000|Follow up|Death|2|||
145540589|NCT04362072|524838353|FG000|Follow up|Other|2|||
145540590|NCT04731363|524838354|FG000|Overall Study|Could not obtain samples|0|||
145540591|NCT04731363|524838355|FG001|Overall Study|Could not obtain samples|1|||
145540592|NCT04731363|524838356|FG002|Overall Study|Could not obtain samples|0|||
145540593|NCT04731363|524838357|FG003|Overall Study|Could not obtain samples|0|||
145540594|NCT04731363|524838354|FG000|Overall Study|Physician Decision|0|||
145540595|NCT04731363|524838355|FG001|Overall Study|Physician Decision|1|||
145540596|NCT04731363|524838356|FG002|Overall Study|Physician Decision|0|||
145540597|NCT04731363|524838357|FG003|Overall Study|Physician Decision|0|||
145540598|NCT03749447|524839757|FG000|Overall Study|Adverse Event|11|||
145540599|NCT03749447|524839758|FG001|Overall Study|Adverse Event|3|||
145540600|NCT03749447|524839757|FG000|Overall Study|Death|1|||
145540601|NCT03749447|524839758|FG001|Overall Study|Death|1|||
145540602|NCT03749447|524839757|FG000|Overall Study|Lost to Follow-up|2|||
145540603|NCT03749447|524839758|FG001|Overall Study|Lost to Follow-up|2|||
145540604|NCT03749447|524839757|FG000|Overall Study|Reason Not Specified|0|||
145540605|NCT03749447|524839758|FG001|Overall Study|Reason Not Specified|3|||
145540606|NCT03749447|524839757|FG000|Overall Study|Physician Decision|4|||
145540607|NCT03749447|524839758|FG001|Overall Study|Physician Decision|3|||
145540608|NCT03749447|524839757|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
145540609|NCT03749447|524839758|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
145540610|NCT03749447|524839757|FG000|Overall Study|Study Terminated By Sponsor|112|||
145540611|NCT03749447|524839758|FG001|Overall Study|Study Terminated By Sponsor|105|||
145540612|NCT03749447|524839757|FG000|Overall Study|Withdrawal by Subject|12|||
145540613|NCT03749447|524839758|FG001|Overall Study|Withdrawal by Subject|6|||
145540614|NCT03749447|524839757|FG000|Overall Study|Non-compliance With Study Drug|0|||
145540615|NCT03749447|524839758|FG001|Overall Study|Non-compliance With Study Drug|1|||
145540616|NCT00967668|524839759|FG000|Overall Study|Withdrawal by Subject|13|||
145540617|NCT00967668|524839760|FG001|Overall Study|Withdrawal by Subject|8|||
145540618|NCT00967668|524839761|FG002|Overall Study|Withdrawal by Subject|8|||
145540619|NCT00967668|524839759|FG000|Overall Study|Death|0|||
145540620|NCT00967668|524839760|FG001|Overall Study|Death|2|||
145540621|NCT00967668|524839761|FG002|Overall Study|Death|4|||
145540622|NCT00967668|524839759|FG000|Overall Study|Removed due to behavior|1|||
145540623|NCT00967668|524839760|FG001|Overall Study|Removed due to behavior|1|||
145540624|NCT00967668|524839761|FG002|Overall Study|Removed due to behavior|2|||
145540625|NCT00967668|524839759|FG000|Overall Study|Refused Year 2|11|||
145540626|NCT00967668|524839760|FG001|Overall Study|Refused Year 2|6|||
145540627|NCT00967668|524839761|FG002|Overall Study|Refused Year 2|4|||
145540628|NCT00967668|524839759|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
145540629|NCT00967668|524839760|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
145540630|NCT00967668|524839761|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
145540631|NCT00967668|524839759|FG000|Overall Study|Lost to Follow-up|15|||
145540632|NCT00967668|524839760|FG001|Overall Study|Lost to Follow-up|9|||
145540633|NCT00967668|524839761|FG002|Overall Study|Lost to Follow-up|16|||
145540634|NCT00967668|524839759|FG000|Overall Study|Refused 12-mo assessment|3|||
145404097|NCT00998946|524336480|FG000|Overall Study|Withdrawal by Subject|1|||
145540635|NCT00967668|524839760|FG001|Overall Study|Refused 12-mo assessment|1|||
145540636|NCT00967668|524839761|FG002|Overall Study|Refused 12-mo assessment|9|||
145540637|NCT00967668|524839759|FG000|Overall Study|Pregnancy|1|||
145540638|NCT00967668|524839760|FG001|Overall Study|Pregnancy|0|||
145540639|NCT00967668|524839761|FG002|Overall Study|Pregnancy|0|||
145404098|NCT00998946|524336480|FG000|Overall Study|Death|2|||
145404099|NCT00998946|524336480|FG000|Overall Study|Reason Unspecified|3|||
145404100|NCT00998946|524336480|FG000|Overall Study|Enrolled but not Dosed|2|||
145404101|NCT01454284|524336482|FG000|Overall Study|Adverse Event|20|||
145404102|NCT01454284|524336483|FG001|Overall Study|Adverse Event|7|||
145404103|NCT01454284|524336482|FG000|Overall Study|Death|0|||
145404104|NCT01454284|524336483|FG001|Overall Study|Death|3|||
145404105|NCT01454284|524336482|FG000|Overall Study|Lost to Follow-up|13|||
145404106|NCT01454284|524336483|FG001|Overall Study|Lost to Follow-up|8|||
145404107|NCT01454284|524336482|FG000|Overall Study|Protocol Violation|9|||
145404108|NCT01454284|524336483|FG001|Overall Study|Protocol Violation|6|||
145404109|NCT01454284|524336482|FG000|Overall Study|Withdrawal by Subject|58|||
145404110|NCT01454284|524336483|FG001|Overall Study|Withdrawal by Subject|36|||
145404111|NCT01454284|524336482|FG000|Overall Study|Physician Decision|16|||
145404112|NCT01454284|524336483|FG001|Overall Study|Physician Decision|11|||
145404113|NCT01454284|524336482|FG000|Overall Study|Sponsor Decision|0|||
145404114|NCT01454284|524336483|FG001|Overall Study|Sponsor Decision|2|||
145404115|NCT02842866|524336484|FG000|Overall Study|Serious Adverse Event|0|||
145404116|NCT02842866|524336485|FG001|Overall Study|Serious Adverse Event|1|||
145404117|NCT02842866|524336484|FG000|Overall Study|Protocol Violation|4|||
145404118|NCT02842866|524336485|FG001|Overall Study|Protocol Violation|2|||
145404119|NCT02842866|524336484|FG000|Overall Study|Lost to Follow-up|2|||
145404120|NCT02842866|524336485|FG001|Overall Study|Lost to Follow-up|0|||
145404121|NCT02842866|524336484|FG000|Overall Study|Withdrawal by Subject|1|||
145404122|NCT02842866|524336485|FG001|Overall Study|Withdrawal by Subject|0|||
145404123|NCT01432327|524336486|FG000|Posttest 3 Months|depression|3|||
145404124|NCT01432327|524336487|FG001|Posttest 3 Months|depression|0|||
145404125|NCT01432327|524336488|FG002|Posttest 3 Months|depression|0|||
145404126|NCT01432327|524336489|FG003|Posttest 3 Months|depression|0|||
145540640|NCT00115739|524839763|FG000|Overall Study|Lost to Follow-up|3|||
145540641|NCT00259649|524839764|FG000|Overall Study|Lost to Follow-up|7|||
145540642|NCT00259649|524839764|FG000|Overall Study|irregular menses|3|||
145540643|NCT00745823|524839767|FG000|Overall Study|Adverse Event|5|||
145540644|NCT00745823|524839768|FG001|Overall Study|Adverse Event|3|||
145540645|NCT00745823|524839767|FG000|Overall Study|Lack of Efficacy|20|||
145540646|NCT00745823|524839768|FG001|Overall Study|Lack of Efficacy|6|||
145540647|NCT00745823|524839767|FG000|Overall Study|Lost to Follow-up|10|||
145540648|NCT00745823|524839768|FG001|Overall Study|Lost to Follow-up|11|||
145540649|NCT00745823|524839767|FG000|Overall Study|Physician Decision|10|||
145540650|NCT00745823|524839768|FG001|Overall Study|Physician Decision|5|||
145540651|NCT00745823|524839767|FG000|Overall Study|Pregnancy|0|||
145540652|NCT00745823|524839768|FG001|Overall Study|Pregnancy|4|||
145540653|NCT00745823|524839767|FG000|Overall Study|Withdrawal by Subject|14|||
145540654|NCT00745823|524839768|FG001|Overall Study|Withdrawal by Subject|8|||
145404127|NCT01432327|524336486|FG000|Posttest 3 Months|Lost to Follow-up|1|||
145404128|NCT01432327|524336487|FG001|Posttest 3 Months|Lost to Follow-up|0|||
145404129|NCT01432327|524336488|FG002|Posttest 3 Months|Lost to Follow-up|2|||
145404130|NCT01432327|524336489|FG003|Posttest 3 Months|Lost to Follow-up|1|||
145404131|NCT01432327|524336486|FG000|Posttest 3 Months|Allergic reaction|0|||
145540655|NCT00745823|524839767|FG000|Overall Study|Study Terminated by Sponsor|326|||
145540656|NCT00745823|524839768|FG001|Overall Study|Study Terminated by Sponsor|349|||
145540657|NCT01673867|524839776|FG000|Randomization|Adverse event unrelated to study drug|1|||
145404132|NCT01432327|524336487|FG001|Posttest 3 Months|Allergic reaction|2|||
145404133|NCT01432327|524336488|FG002|Posttest 3 Months|Allergic reaction|0|||
145404134|NCT01432327|524336489|FG003|Posttest 3 Months|Allergic reaction|0|||
145540658|NCT01673867|524839777|FG001|Randomization|Adverse event unrelated to study drug|0|||
145540659|NCT01673867|524839776|FG000|Randomization|Participant request to discontinue study treatment|0|||
145540660|NCT01673867|524839777|FG001|Randomization|Participant request to discontinue study treatment|4|||
145540661|NCT01673867|524839776|FG000|Randomization|Withdrawal by participant|0|||
145404135|NCT01432327|524336486|FG000|Posttest 6 Months|Lost to Follow-up|0|||
145404136|NCT01432327|524336487|FG001|Posttest 6 Months|Lost to Follow-up|0|||
145404137|NCT01432327|524336488|FG002|Posttest 6 Months|Lost to Follow-up|3|||
145540662|NCT01673867|524839777|FG001|Randomization|Withdrawal by participant|12|||
145540663|NCT01673867|524839776|FG000|Randomization|Lost to Follow-up|0|||
145540664|NCT01673867|524839777|FG001|Randomization|Lost to Follow-up|1|||
145540665|NCT01673867|524839776|FG000|Randomization|Participant no longer meets study criteria|4|||
145540666|NCT01673867|524839777|FG001|Randomization|Participant no longer meets study criteria|5|||
145540667|NCT01673867|524839776|FG000|Treatment|Disease Progression|208|||
145540668|NCT01673867|524839777|FG001|Treatment|Disease Progression|178|||
145540669|NCT01673867|524839776|FG000|Treatment|Study Drug Toxicity|23|||
145540670|NCT01673867|524839777|FG001|Treatment|Study Drug Toxicity|43|||
145540671|NCT01673867|524839776|FG000|Treatment|Death|2|||
145540672|NCT01673867|524839777|FG001|Treatment|Death|3|||
145540673|NCT01673867|524839776|FG000|Treatment|Adverse event unrelated to study drug|23|||
145540674|NCT01673867|524839777|FG001|Treatment|Adverse event unrelated to study drug|10|||
145540675|NCT01673867|524839776|FG000|Treatment|Participant request to discontinue study treatment|7|||
145540676|NCT01673867|524839777|FG001|Treatment|Participant request to discontinue study treatment|17|||
145540677|NCT01673867|524839776|FG000|Treatment|Withdrawal by participant|5|||
145540678|NCT01673867|524839777|FG001|Treatment|Withdrawal by participant|5|||
145540679|NCT01673867|524839776|FG000|Treatment|Maximum clinical benefit|1|||
145540680|NCT01673867|524839777|FG001|Treatment|Maximum clinical benefit|10|||
145540681|NCT01673867|524839776|FG000|Treatment|Participant no longer meets study criteria|2|||
145540682|NCT01673867|524839777|FG001|Treatment|Participant no longer meets study criteria|0|||
145540683|NCT01673867|524839776|FG000|Treatment|Administrative reason by sponsor|3|||
145540684|NCT01673867|524839777|FG001|Treatment|Administrative reason by sponsor|0|||
145540685|NCT01673867|524839776|FG000|Treatment|Other reason|11|||
145540686|NCT01673867|524839777|FG001|Treatment|Other reason|2|||
145540687|NCT01819831|524839782|FG000|Overall Study|Withdrawal by Subject|1|||
145540688|NCT02034110|524839783|FG000|Overall Study|Physician Decision|0|||
145540689|NCT02034110|524839784|FG001|Overall Study|Physician Decision|0|||
145540690|NCT02034110|524839785|FG002|Overall Study|Physician Decision|0|||
145540691|NCT02034110|524839786|FG003|Overall Study|Physician Decision|0|||
145540692|NCT02034110|524839787|FG004|Overall Study|Physician Decision|2|||
145540693|NCT02034110|524839788|FG005|Overall Study|Physician Decision|0|||
145540694|NCT02034110|524839789|FG006|Overall Study|Physician Decision|1|||
145540695|NCT02034110|524839790|FG007|Overall Study|Physician Decision|0|||
145540696|NCT02034110|524839783|FG000|Overall Study|Lost to Follow-up|1|||
145540697|NCT02034110|524839784|FG001|Overall Study|Lost to Follow-up|0|||
145540698|NCT02034110|524839785|FG002|Overall Study|Lost to Follow-up|0|||
145540699|NCT02034110|524839786|FG003|Overall Study|Lost to Follow-up|0|||
145540700|NCT02034110|524839787|FG004|Overall Study|Lost to Follow-up|1|||
145540701|NCT02034110|524839788|FG005|Overall Study|Lost to Follow-up|0|||
145540702|NCT02034110|524839789|FG006|Overall Study|Lost to Follow-up|1|||
145540703|NCT02034110|524839790|FG007|Overall Study|Lost to Follow-up|0|||
145540704|NCT02034110|524839783|FG000|Overall Study|Withdrawal by Subject|5|||
145540705|NCT02034110|524839784|FG001|Overall Study|Withdrawal by Subject|7|||
145540706|NCT02034110|524839785|FG002|Overall Study|Withdrawal by Subject|0|||
145540707|NCT02034110|524839786|FG003|Overall Study|Withdrawal by Subject|3|||
145540708|NCT02034110|524839787|FG004|Overall Study|Withdrawal by Subject|7|||
145540709|NCT02034110|524839788|FG005|Overall Study|Withdrawal by Subject|0|||
145540710|NCT02034110|524839789|FG006|Overall Study|Withdrawal by Subject|3|||
145540711|NCT02034110|524839790|FG007|Overall Study|Withdrawal by Subject|1|||
145540712|NCT02034110|524839783|FG000|Overall Study|Study closed by sponsor|6|||
145540713|NCT02034110|524839784|FG001|Overall Study|Study closed by sponsor|2|||
145540714|NCT02034110|524839785|FG002|Overall Study|Study closed by sponsor|0|||
145540715|NCT02034110|524839786|FG003|Overall Study|Study closed by sponsor|6|||
145540716|NCT02034110|524839787|FG004|Overall Study|Study closed by sponsor|7|||
145540717|NCT02034110|524839788|FG005|Overall Study|Study closed by sponsor|0|||
145540718|NCT02034110|524839789|FG006|Overall Study|Study closed by sponsor|42|||
145540719|NCT02034110|524839790|FG007|Overall Study|Study closed by sponsor|0|||
145540720|NCT02587234|524839791|FG000|Overall Study|Withdrawal by Subject|1|||
145540721|NCT02587234|524839792|FG001|Overall Study|Withdrawal by Subject|1|||
145540722|NCT02587234|524839791|FG000|Overall Study|Lost to Follow-up|0|||
145540723|NCT02587234|524839792|FG001|Overall Study|Lost to Follow-up|2|||
145540724|NCT00590720|524839793|FG000|Overall Study|Lost to Follow-up|1|||
145540725|NCT00590720|524839794|FG001|Overall Study|Lost to Follow-up|0|||
145540726|NCT00590720|524839793|FG000|Overall Study|Withdrawal by Subject|0|||
145540727|NCT00590720|524839794|FG001|Overall Study|Withdrawal by Subject|1|||
145540728|NCT01001377|524839796|FG000|Overall Study|Ineligibility determined|2|||
145540729|NCT01001377|524839797|FG001|Overall Study|Ineligibility determined|0|||
145540730|NCT01001377|524839796|FG000|Overall Study|Withdrawal by Subject|19|||
145540731|NCT01001377|524839797|FG001|Overall Study|Withdrawal by Subject|20|||
145540732|NCT01001377|524839796|FG000|Overall Study|Lost to Follow-up|14|||
145540733|NCT01001377|524839797|FG001|Overall Study|Lost to Follow-up|17|||
145540734|NCT01001377|524839796|FG000|Overall Study|Death|391|||
145540735|NCT01001377|524839797|FG001|Overall Study|Death|384|||
145540736|NCT02732119|524839801|FG000|Phase I|Adverse Event|1|||
145540737|NCT02732119|524839802|FG001|Phase I|Adverse Event|3|||
145540738|NCT02732119|524839803|FG002|Phase I|Adverse Event|1|||
145540739|NCT02732119|524839804|FG003|Phase I|Adverse Event|0|||
145540740|NCT02732119|524839805|FG004|Phase I|Adverse Event|0|||
145540741|NCT02732119|524839801|FG000|Phase I|Progressive disease|7|||
145540742|NCT02732119|524839802|FG001|Phase I|Progressive disease|3|||
145540743|NCT02732119|524839803|FG002|Phase I|Progressive disease|2|||
145540744|NCT02732119|524839804|FG003|Phase I|Progressive disease|0|||
145540745|NCT02732119|524839805|FG004|Phase I|Progressive disease|0|||
145540746|NCT02732119|524839801|FG000|Phase I|Protocol deviation|0|||
145540747|NCT02732119|524839802|FG001|Phase I|Protocol deviation|1|||
145540748|NCT02732119|524839803|FG002|Phase I|Protocol deviation|0|||
145540749|NCT02732119|524839804|FG003|Phase I|Protocol deviation|0|||
145540750|NCT02732119|524839805|FG004|Phase I|Protocol deviation|0|||
145540751|NCT02732119|524839801|FG000|Phase I|Physician Decision|0|||
145540752|NCT02732119|524839802|FG001|Phase I|Physician Decision|3|||
145540753|NCT02732119|524839803|FG002|Phase I|Physician Decision|4|||
145540754|NCT02732119|524839804|FG003|Phase I|Physician Decision|0|||
145540755|NCT02732119|524839805|FG004|Phase I|Physician Decision|0|||
145540756|NCT02732119|524839801|FG000|Phase II|Adverse Event|0|||
145540757|NCT02732119|524839802|FG001|Phase II|Adverse Event|0|||
145540758|NCT02732119|524839803|FG002|Phase II|Adverse Event|0|||
145540759|NCT02732119|524839804|FG003|Phase II|Adverse Event|3|||
145540760|NCT02732119|524839805|FG004|Phase II|Adverse Event|3|||
145540761|NCT02732119|524839801|FG000|Phase II|Death|0|||
145540762|NCT02732119|524839802|FG001|Phase II|Death|0|||
145540763|NCT02732119|524839803|FG002|Phase II|Death|0|||
145540764|NCT02732119|524839804|FG003|Phase II|Death|1|||
145540765|NCT02732119|524839805|FG004|Phase II|Death|0|||
145540766|NCT02732119|524839801|FG000|Phase II|Progressive dissease|0|||
145540767|NCT02732119|524839802|FG001|Phase II|Progressive dissease|0|||
145540768|NCT02732119|524839803|FG002|Phase II|Progressive dissease|0|||
145540769|NCT02732119|524839804|FG003|Phase II|Progressive dissease|30|||
145540770|NCT02732119|524839805|FG004|Phase II|Progressive dissease|23|||
145540771|NCT02732119|524839801|FG000|Phase II|Study terminated by sponsor|0|||
145540772|NCT02732119|524839802|FG001|Phase II|Study terminated by sponsor|0|||
145540773|NCT02732119|524839803|FG002|Phase II|Study terminated by sponsor|0|||
145540774|NCT02732119|524839804|FG003|Phase II|Study terminated by sponsor|2|||
145540775|NCT02732119|524839805|FG004|Phase II|Study terminated by sponsor|2|||
145540776|NCT02732119|524839801|FG000|Phase II|Other|0|||
145540777|NCT02732119|524839802|FG001|Phase II|Other|0|||
145540778|NCT02732119|524839803|FG002|Phase II|Other|0|||
145540779|NCT02732119|524839804|FG003|Phase II|Other|2|||
145540780|NCT02732119|524839805|FG004|Phase II|Other|0|||
145540781|NCT02732119|524839801|FG000|Phase II|Physician Decision|0|||
145540782|NCT02732119|524839802|FG001|Phase II|Physician Decision|0|||
145540783|NCT02732119|524839803|FG002|Phase II|Physician Decision|0|||
145540784|NCT02732119|524839804|FG003|Phase II|Physician Decision|8|||
145540785|NCT02732119|524839805|FG004|Phase II|Physician Decision|5|||
145540786|NCT00867568|524839806|FG000|Overall Study|Lack of Efficacy|10|||
145540787|NCT00867568|524839806|FG000|Overall Study|Adverse Event|4|||
145540788|NCT00867568|524839806|FG000|Overall Study|Withdrawal by Subject|1|||
145540789|NCT01056653|524839807|FG000|Overall Study|Lost to Follow-up|0|||
145540790|NCT01056653|524839808|FG001|Overall Study|Lost to Follow-up|0|||
145540791|NCT01056653|524839809|FG002|Overall Study|Lost to Follow-up|2|||
145540792|NCT03639935|524839810|FG000|Overall Study|Death|3|||
145540793|NCT03639935|524839810|FG000|Overall Study|Adverse Event|1|||
145540794|NCT03727230|524839812|FG000|Overall Study|Lost to Follow-up|12|||
145540795|NCT02059395|524839814|FG000|Overall Study|Lost to Follow-up|2|||
145540796|NCT02059395|524839815|FG001|Overall Study|Lost to Follow-up|4|||
145540797|NCT04377620|524839816|FG000|Overall Study|Death|42|||
145540798|NCT04377620|524839817|FG001|Overall Study|Death|48|||
145540799|NCT04377620|524839818|FG002|Overall Study|Death|36|||
145540800|NCT04377620|524839816|FG000|Overall Study|Withdrawal by Subject|0|||
145540801|NCT04377620|524839817|FG001|Overall Study|Withdrawal by Subject|2|||
145540802|NCT04377620|524839818|FG002|Overall Study|Withdrawal by Subject|0|||
145540803|NCT00134082|524839819|FG000|Overall Study|Adverse Event|2|||
145540804|NCT00134082|524839819|FG000|Overall Study|Death|1|||
145540805|NCT01606007|524839822|FG000|Overall Study|Reason 'Other' in the protocol|0|||
145540806|NCT01606007|524839823|FG001|Overall Study|Reason 'Other' in the protocol|1|||
145540807|NCT01606007|524839824|FG002|Overall Study|Reason 'Other' in the protocol|1|||
145540808|NCT01606007|524839822|FG000|Overall Study|Pregnancy|0|||
145540809|NCT01606007|524839823|FG001|Overall Study|Pregnancy|1|||
145540810|NCT01606007|524839824|FG002|Overall Study|Pregnancy|1|||
145540811|NCT01606007|524839822|FG000|Overall Study|Withdrawal by Subject|8|||
145540812|NCT01606007|524839823|FG001|Overall Study|Withdrawal by Subject|6|||
145540813|NCT01606007|524839824|FG002|Overall Study|Withdrawal by Subject|1|||
145540814|NCT01606007|524839822|FG000|Overall Study|Adverse Event|0|||
145540815|NCT01606007|524839823|FG001|Overall Study|Adverse Event|1|||
145540816|NCT01606007|524839824|FG002|Overall Study|Adverse Event|1|||
145540817|NCT01606007|524839822|FG000|Overall Study|discontinue study treatment|0|||
145540818|NCT01606007|524839823|FG001|Overall Study|discontinue study treatment|2|||
145540819|NCT01606007|524839824|FG002|Overall Study|discontinue study treatment|1|||
145540820|NCT01606007|524839822|FG000|Overall Study|Lost to Follow-up|6|||
145540821|NCT01606007|524839823|FG001|Overall Study|Lost to Follow-up|8|||
145789795|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145540822|NCT01606007|524839824|FG002|Overall Study|Lost to Follow-up|5|||
145540823|NCT01606007|524839822|FG000|Overall Study|Poor/Non-compliance|1|||
145540824|NCT01606007|524839823|FG001|Overall Study|Poor/Non-compliance|0|||
145540825|NCT01606007|524839824|FG002|Overall Study|Poor/Non-compliance|0|||
145540826|NCT03095612|524839828|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540827|NCT03095612|524839829|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
145540828|NCT03095612|524839830|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540829|NCT03095612|524839831|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540830|NCT03095612|524839832|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540831|NCT03095612|524839833|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540832|NCT03095612|524839834|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
145540833|NCT04447794|524839835|FG000|Overall Study|Lost to Follow-up|2|||
145540834|NCT04447794|524839836|FG001|Overall Study|Lost to Follow-up|3|||
145540835|NCT04447794|524839837|FG002|Overall Study|Lost to Follow-up|8|||
145540836|NCT04447794|524839835|FG000|Overall Study|Withdrawal by Subject|1|||
145540837|NCT04447794|524839836|FG001|Overall Study|Withdrawal by Subject|1|||
145540838|NCT04447794|524839837|FG002|Overall Study|Withdrawal by Subject|0|||
145540839|NCT01235689|524839838|FG000|Overall Study|Adverse Event|12|||
145540840|NCT01235689|524839839|FG001|Overall Study|Adverse Event|16|||
145540841|NCT01235689|524839838|FG000|Overall Study|Lack of Efficacy|12|||
145540842|NCT01235689|524839839|FG001|Overall Study|Lack of Efficacy|5|||
145540843|NCT01235689|524839838|FG000|Overall Study|Withdrawal by Subject|3|||
145540844|NCT01235689|524839839|FG001|Overall Study|Withdrawal by Subject|4|||
145540845|NCT01235689|524839838|FG000|Overall Study|Lost to Follow-up|1|||
145540846|NCT01235689|524839839|FG001|Overall Study|Lost to Follow-up|2|||
145540847|NCT01235689|524839838|FG000|Overall Study|Miscellaneous|1|||
145540848|NCT01235689|524839839|FG001|Overall Study|Miscellaneous|5|||
145540849|NCT01390649|524839840|FG000|Overall Study|Physician Decision|1|||
145540850|NCT00389597|524839845|FG000|Overall Study|Lost to Follow-up|8|||
145540851|NCT00389597|524839846|FG001|Overall Study|Lost to Follow-up|6|||
145540852|NCT00389597|524839847|FG002|Overall Study|Lost to Follow-up|4|||
145540853|NCT00389597|524839848|FG003|Overall Study|Lost to Follow-up|6|||
145540854|NCT03988088|524839849|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
145540855|NCT03988088|524839850|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
145540856|NCT03988088|524839851|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
145540857|NCT03988088|524839852|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
145540858|NCT03988088|524839849|FG000|Open-Label Addendum|Lost to Follow-up|0|||
145540859|NCT03988088|524839850|FG001|Open-Label Addendum|Lost to Follow-up|0|||
145540860|NCT03988088|524839851|FG002|Open-Label Addendum|Lost to Follow-up|1|||
145540861|NCT03988088|524839852|FG003|Open-Label Addendum|Lost to Follow-up|0|||
145540862|NCT04431453|524839853|FG000|Overall Study|Withdrew Consent|0|||
145540863|NCT04431453|524839854|FG001|Overall Study|Withdrew Consent|1|||
145540864|NCT04431453|524839855|FG002|Overall Study|Withdrew Consent|0|||
145540865|NCT04431453|524839856|FG003|Overall Study|Withdrew Consent|2|||
145540866|NCT04431453|524839857|FG004|Overall Study|Withdrew Consent|0|||
145540867|NCT04431453|524839858|FG005|Overall Study|Withdrew Consent|0|||
145540868|NCT04431453|524839859|FG006|Overall Study|Withdrew Consent|0|||
145540869|NCT04431453|524839860|FG007|Overall Study|Withdrew Consent|0|||
145540870|NCT04431453|524839853|FG000|Overall Study|Death|1|||
145540871|NCT04431453|524839854|FG001|Overall Study|Death|0|||
145540872|NCT04431453|524839855|FG002|Overall Study|Death|0|||
145540873|NCT04431453|524839856|FG003|Overall Study|Death|0|||
145540874|NCT04431453|524839857|FG004|Overall Study|Death|0|||
145540875|NCT04431453|524839858|FG005|Overall Study|Death|0|||
145540876|NCT04431453|524839859|FG006|Overall Study|Death|0|||
145540877|NCT04431453|524839860|FG007|Overall Study|Death|1|||
145540878|NCT04431453|524839853|FG000|Overall Study|Lost to Follow-up|0|||
145540879|NCT04431453|524839854|FG001|Overall Study|Lost to Follow-up|0|||
145540880|NCT04431453|524839855|FG002|Overall Study|Lost to Follow-up|1|||
145540881|NCT04431453|524839856|FG003|Overall Study|Lost to Follow-up|1|||
145540882|NCT04431453|524839857|FG004|Overall Study|Lost to Follow-up|0|||
145540883|NCT04431453|524839858|FG005|Overall Study|Lost to Follow-up|0|||
145540884|NCT04431453|524839859|FG006|Overall Study|Lost to Follow-up|0|||
145540885|NCT04431453|524839860|FG007|Overall Study|Lost to Follow-up|0|||
145540886|NCT04431453|524839853|FG000|Overall Study|Enrolled but Never Treated|0|||
145540887|NCT04431453|524839854|FG001|Overall Study|Enrolled but Never Treated|0|||
145540888|NCT04431453|524839855|FG002|Overall Study|Enrolled but Never Treated|0|||
145540889|NCT04431453|524839856|FG003|Overall Study|Enrolled but Never Treated|0|||
145540890|NCT04431453|524839857|FG004|Overall Study|Enrolled but Never Treated|1|||
145540891|NCT04431453|524839858|FG005|Overall Study|Enrolled but Never Treated|0|||
145540892|NCT04431453|524839859|FG006|Overall Study|Enrolled but Never Treated|0|||
145540893|NCT04431453|524839860|FG007|Overall Study|Enrolled but Never Treated|0|||
145540894|NCT00622401|524839861|FG000|Overall Study|Disease progression prior to treatment|3|||
145540895|NCT00622401|524839862|FG001|Overall Study|Disease progression prior to treatment|2|||
145540896|NCT00622401|524839863|FG002|Overall Study|Disease progression prior to treatment|0|||
145540897|NCT01201850|524839867|FG000|Overall Study|Tumor progression|4|||
145540898|NCT00816595|524839868|FG000|Overall Study|Withdrawal by Subject|2|||
145540899|NCT00816595|524839869|FG001|Overall Study|Withdrawal by Subject|0|||
145540900|NCT00453063|524839870|FG000|Overall Study|Adverse Event|1|||
145540901|NCT00453063|524839871|FG001|Overall Study|Adverse Event|2|||
145540902|NCT00453063|524839870|FG000|Overall Study|Withdrawal by Subject|1|||
145540903|NCT00453063|524839871|FG001|Overall Study|Withdrawal by Subject|1|||
145540904|NCT00453063|524839870|FG000|Overall Study|Protocol Violation|1|||
145540905|NCT00453063|524839871|FG001|Overall Study|Protocol Violation|0|||
145540906|NCT00365508|524839872|FG000|Overall Study|Lost to Follow-up|139|||
145540907|NCT00365508|524839873|FG001|Overall Study|Lost to Follow-up|154|||
145540908|NCT02538029|524839877|FG000|Overall Study|unable to complete cognitive assessments|1|||
145540909|NCT02538029|524839878|FG001|Overall Study|unable to complete cognitive assessments|0|||
145540910|NCT02538029|524839879|FG002|Overall Study|unable to complete cognitive assessments|1|||
145540911|NCT00404235|524839883|FG000|Overall Study|Withdrawal by Subject|1|||
145540912|NCT00404235|524839884|FG001|Overall Study|Withdrawal by Subject|2|||
145540913|NCT00566995|524839885|FG000|Overall Study|Toxicity|4|||
145540914|NCT00566995|524839885|FG000|Overall Study|Withdrew consent|3|||
145540915|NCT00001880|524839886|FG000|Overall Study|Death|14|||
145789796|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789797|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145540916|NCT00481078|524839887|FG000|Overall Study|Progression of disease|11|||
145789798|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145540917|NCT00481078|524839888|FG001|Overall Study|Progression of disease|11|||
145789799|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789800|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789801|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
145789802|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
145789803|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789804|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789805|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789806|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789807|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789808|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789809|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
145789810|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789811|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789812|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789813|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789814|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789815|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789816|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789817|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789818|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789819|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789820|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789821|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789822|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789823|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789824|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
145789825|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
145789826|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789827|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789828|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789829|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
145789830|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789831|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789832|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
145789833|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
145789834|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
145789835|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
145540918|NCT00481078|524839887|FG000|Overall Study|Adverse Event|15|||
145540919|NCT00481078|524839888|FG001|Overall Study|Adverse Event|3|||
145540920|NCT00481078|524839887|FG000|Overall Study|Death|5|||
145540921|NCT00481078|524839888|FG001|Overall Study|Death|3|||
145540922|NCT00481078|524839887|FG000|Overall Study|Intercurrent illness|1|||
145540923|NCT00481078|524839888|FG001|Overall Study|Intercurrent illness|0|||
145540924|NCT00481078|524839887|FG000|Overall Study|Withdrawal by Subject|7|||
145540925|NCT00481078|524839888|FG001|Overall Study|Withdrawal by Subject|1|||
145540926|NCT00481078|524839887|FG000|Overall Study|Information not available|1|||
145540927|NCT00481078|524839888|FG001|Overall Study|Information not available|0|||
145540928|NCT00481078|524839887|FG000|Overall Study|Received other treatment|2|||
145540929|NCT00481078|524839888|FG001|Overall Study|Received other treatment|1|||
145540930|NCT00481078|524839887|FG000|Overall Study|Brain metastasis|0|||
145540931|NCT00481078|524839888|FG001|Overall Study|Brain metastasis|1|||
145540932|NCT01558271|524839889|FG000|Overall Study|Adverse Event|6|||
145540933|NCT01558271|524839890|FG001|Overall Study|Adverse Event|3|||
145540934|NCT01558271|524839891|FG002|Overall Study|Adverse Event|4|||
145540935|NCT01558271|524839889|FG000|Overall Study|Lost to Follow-up|1|||
145540936|NCT01558271|524839890|FG001|Overall Study|Lost to Follow-up|0|||
145540937|NCT01558271|524839891|FG002|Overall Study|Lost to Follow-up|0|||
145540938|NCT01558271|524839889|FG000|Overall Study|Protocol Violation|1|||
145540939|NCT01558271|524839890|FG001|Overall Study|Protocol Violation|0|||
145540940|NCT01558271|524839891|FG002|Overall Study|Protocol Violation|0|||
145540941|NCT01558271|524839889|FG000|Overall Study|Withdrawal by Subject|10|||
145540942|NCT01558271|524839890|FG001|Overall Study|Withdrawal by Subject|6|||
145540943|NCT01558271|524839891|FG002|Overall Study|Withdrawal by Subject|12|||
145540944|NCT01558271|524839889|FG000|Overall Study|Physician Decision|0|||
145540945|NCT01558271|524839890|FG001|Overall Study|Physician Decision|2|||
145540946|NCT01558271|524839891|FG002|Overall Study|Physician Decision|1|||
145540947|NCT00228384|524839892|FG000|Overall Study|Death|9|||
145540948|NCT00228384|524839893|FG001|Overall Study|Death|3|||
145540949|NCT00228384|524839892|FG000|Overall Study|Lost to Follow-up|6|||
145540950|NCT00228384|524839893|FG001|Overall Study|Lost to Follow-up|10|||
145540951|NCT00228384|524839892|FG000|Overall Study|Surgical Intervention (bypass)|5|||
145540952|NCT00228384|524839893|FG001|Overall Study|Surgical Intervention (bypass)|5|||
145540953|NCT00228384|524839892|FG000|Overall Study|Withdrawal by Subject|9|||
145540954|NCT00228384|524839893|FG001|Overall Study|Withdrawal by Subject|10|||
145540955|NCT00228384|524839892|FG000|Overall Study|Physician Decision|0|||
145540956|NCT00228384|524839893|FG001|Overall Study|Physician Decision|1|||
145540957|NCT00873912|524839894|FG000|Overall Study|Withdrawal by Subject|1|||
145540958|NCT00873912|524839895|FG001|Overall Study|Withdrawal by Subject|0|||
145540959|NCT00873912|524839894|FG000|Overall Study|Lost to Follow-up|2|||
145540960|NCT00873912|524839895|FG001|Overall Study|Lost to Follow-up|0|||
145540961|NCT01980940|524839899|FG000|Overall Study|Protocol Violation|0|||
145540962|NCT01980940|524839900|FG001|Overall Study|Protocol Violation|0|||
145540963|NCT01980940|524839901|FG002|Overall Study|Protocol Violation|0|||
145540964|NCT01980940|524839902|FG003|Overall Study|Protocol Violation|0|||
145540965|NCT01980940|524839903|FG004|Overall Study|Protocol Violation|0|||
145540966|NCT01980940|524839904|FG005|Overall Study|Protocol Violation|2|||
145540967|NCT01980940|524839905|FG006|Overall Study|Protocol Violation|0|||
145540968|NCT01980940|524839906|FG007|Overall Study|Protocol Violation|0|||
145540969|NCT05358444|524839910|FG000|Overall Study|Withdrawal by Subject|0|||
145540970|NCT05358444|524839911|FG001|Overall Study|Withdrawal by Subject|1|||
145540971|NCT05358444|524839910|FG000|Overall Study|Lost to Follow-up|0|||
145540972|NCT05358444|524839911|FG001|Overall Study|Lost to Follow-up|3|||
145540973|NCT04560998|524839915|FG000|Overall Study|Withdrawal by Subject|18|||
145540974|NCT04560998|524839916|FG001|Overall Study|Withdrawal by Subject|12|||
145540975|NCT04560998|524839915|FG000|Overall Study|Lost to Follow-up|8|||
145540976|NCT04560998|524839916|FG001|Overall Study|Lost to Follow-up|5|||
145540977|NCT04560998|524839915|FG000|Overall Study|Physician Decision|4|||
145540978|NCT04560998|524839916|FG001|Overall Study|Physician Decision|0|||
145540979|NCT02955602|524841777|FG000|Overall Study|Adverse Event|0|||
145540980|NCT02955602|524841778|FG001|Overall Study|Adverse Event|3|||
145540981|NCT02955602|524841779|FG002|Overall Study|Adverse Event|0|||
145540982|NCT02955602|524841777|FG000|Overall Study|Withdrawal of informed consent|1|||
145540983|NCT02955602|524841778|FG001|Overall Study|Withdrawal of informed consent|3|||
145540984|NCT02955602|524841779|FG002|Overall Study|Withdrawal of informed consent|2|||
145540985|NCT02955602|524841777|FG000|Overall Study|Lost to Follow-up|0|||
145540986|NCT02955602|524841778|FG001|Overall Study|Lost to Follow-up|0|||
145789836|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
145789837|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
145540987|NCT02955602|524841779|FG002|Overall Study|Lost to Follow-up|1|||
145540988|NCT02955602|524841777|FG000|Overall Study|Other|0|||
145540989|NCT02955602|524841778|FG001|Overall Study|Other|1|||
145540990|NCT02955602|524841779|FG002|Overall Study|Other|3|||
145540991|NCT00290888|524841780|FG000|Overall Study|Physician Decision|3|||
145540992|NCT00290888|524841781|FG001|Overall Study|Physician Decision|1|||
145540993|NCT04160195|524841786|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
145540994|NCT04160195|524841787|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
145540995|NCT03068130|524841788|FG000|Overall Study|Adverse Event|19|||
145540996|NCT03068130|524841788|FG000|Overall Study|Death|14|||
145540997|NCT03068130|524841788|FG000|Overall Study|Lost to Follow-up|4|||
145540998|NCT03068130|524841788|FG000|Overall Study|Withdrawal by Subject|26|||
145540999|NCT03068130|524841788|FG000|Overall Study|Administrative Reasons|3|||
145541000|NCT03068130|524841788|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
145541001|NCT03068130|524841788|FG000|Overall Study|Study terminated by sponsor|194|||
145541002|NCT03039283|524841795|FG000|Overall Study|Protocol Violation|2|||
145541003|NCT00964860|524841796|FG000|Overall Study|Withdrawal by Subject|0|||
145541004|NCT00964860|524841797|FG001|Overall Study|Withdrawal by Subject|1|||
145541005|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Physician Decision|0|||
145541006|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Physician Decision|1|||
145541007|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Physician Decision|0|||
145541008|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
145541009|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
145541010|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
145541011|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
145541012|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
145541013|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
145541014|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Other|4|||
145541015|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Other|4|||
145541016|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Other|0|||
145541017|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
145541018|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
145541019|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
145541020|NCT02585960|524841798|FG000|PK/Safety Assessment Period|Screen Failure|0|||
145541021|NCT02585960|524841799|FG001|PK/Safety Assessment Period|Screen Failure|0|||
145541022|NCT02585960|524841800|FG002|PK/Safety Assessment Period|Screen Failure|1|||
145541023|NCT02585960|524841798|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
145541024|NCT02585960|524841799|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
145541025|NCT02585960|524841800|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
145541026|NCT02585960|524841798|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
145541027|NCT02585960|524841799|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
145541028|NCT02585960|524841800|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
145541029|NCT04930965|524841802|FG000|Overall Study|Lost to Follow-up|7|||
145541030|NCT04930965|524841803|FG001|Overall Study|Lost to Follow-up|5|||
145541031|NCT02849678|524841804|FG000|Overall Study|Protocol Violation|3|||
145541032|NCT02849678|524841805|FG001|Overall Study|Protocol Violation|6|||
145541033|NCT00444912|524841806|FG000|Overall Study|Death|1|||
145541034|NCT00444912|524841807|FG001|Overall Study|Death|2|||
145541035|NCT00444912|524841806|FG000|Overall Study|Lost to Follow-up|1|||
145541036|NCT00444912|524841807|FG001|Overall Study|Lost to Follow-up|0|||
145541037|NCT00444912|524841806|FG000|Overall Study|Participant Failed Mobilization|1|||
145541038|NCT00444912|524841807|FG001|Overall Study|Participant Failed Mobilization|0|||
145541039|NCT02499783|524841808|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
145541040|NCT02499783|524841809|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
145541041|NCT02499783|524841810|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
145541042|NCT02499783|524841808|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
145541043|NCT02499783|524841809|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
145541044|NCT02499783|524841810|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
145541045|NCT02499783|524841808|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
145541046|NCT02499783|524841809|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
145541047|NCT02499783|524841810|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
145541048|NCT02499783|524841808|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
145541049|NCT02499783|524841809|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
145541050|NCT02499783|524841810|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
145541051|NCT02499783|524841808|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
145541052|NCT02499783|524841809|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
145541053|NCT02499783|524841810|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
145541054|NCT02499783|524841808|FG000|DB Period: Weeks 0-8|Other|1|||
145541055|NCT02499783|524841809|FG001|DB Period: Weeks 0-8|Other|1|||
145541056|NCT02499783|524841810|FG002|DB Period: Weeks 0-8|Other|0|||
145541057|NCT02499783|524841808|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
145541058|NCT02499783|524841809|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
145541059|NCT02499783|524841810|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
145541060|NCT02499783|524841808|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
145282031|NCT00950599|523883048|FG001|Follow-Up Period|Poor/Noncompliance|0|||
145541061|NCT02499783|524841809|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
145541062|NCT02499783|524841810|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
145541063|NCT02499783|524841808|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
145282032|NCT00950599|523883049|FG002|Follow-Up Period|Poor/Noncompliance|0|||
145541064|NCT02499783|524841809|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
145541065|NCT02499783|524841810|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
145541066|NCT02499783|524841808|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
145541067|NCT02499783|524841809|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
145541068|NCT02499783|524841810|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
145541069|NCT02228460|524841811|FG000|Overall Study|Adverse Event|1|||
145541070|NCT02228460|524841811|FG000|Overall Study|Lost to Follow-up|1|||
145541071|NCT00329238|524841816|FG000|Overall Study|Adverse Event|147|||
145541072|NCT00329238|524841817|FG001|Overall Study|Adverse Event|129|||
145541073|NCT00329238|524841816|FG000|Overall Study|Protocol Violation|23|||
145541074|NCT00329238|524841817|FG001|Overall Study|Protocol Violation|34|||
145541075|NCT00329238|524841816|FG000|Overall Study|Lost to Follow-up|2|||
145541076|NCT00329238|524841817|FG001|Overall Study|Lost to Follow-up|6|||
145541077|NCT00329238|524841816|FG000|Overall Study|Withdrawal by Subject|64|||
145541078|NCT00329238|524841817|FG001|Overall Study|Withdrawal by Subject|58|||
145541079|NCT00329238|524841816|FG000|Overall Study|Other reason (not specified)|40|||
145541080|NCT00329238|524841817|FG001|Overall Study|Other reason (not specified)|54|||
145541081|NCT00801632|524841818|FG000|Overall Study|Re-transplant|1|||
145541082|NCT05379231|524841819|FG000|Home Visit|Withdrawal by Subject|2|||
145541083|NCT05379231|524841819|FG000|In-lab Visit|Withdrawal by Subject|2|||
145541084|NCT00334958|524841827|FG000|Overall Study|Medication Noncompliance|0|||
145541085|NCT00334958|524841828|FG001|Overall Study|Medication Noncompliance|3|||
145541086|NCT00334958|524841827|FG000|Overall Study|Protocol Violation|2|||
145541087|NCT00334958|524841828|FG001|Overall Study|Protocol Violation|2|||
145541088|NCT00334958|524841827|FG000|Overall Study|Request of the investigator or sponsor|0|||
145541089|NCT00334958|524841828|FG001|Overall Study|Request of the investigator or sponsor|1|||
145541090|NCT00334958|524841827|FG000|Overall Study|Withdrawal by Subject|7|||
145541091|NCT00334958|524841828|FG001|Overall Study|Withdrawal by Subject|4|||
145541092|NCT00334958|524841827|FG000|Overall Study|Adverse Event|27|||
145541093|NCT00334958|524841828|FG001|Overall Study|Adverse Event|12|||
145541094|NCT00334958|524841827|FG000|Overall Study|Other|1|||
145541095|NCT00334958|524841828|FG001|Overall Study|Other|2|||
145541096|NCT02021773|524841832|FG000|Overall Study|Adverse Event|1|||
145541097|NCT02021773|524841833|FG001|Overall Study|Adverse Event|4|||
145541098|NCT02021773|524841834|FG002|Overall Study|Adverse Event|3|||
145541099|NCT02021773|524841832|FG000|Overall Study|Lack of Efficacy|2|||
145541100|NCT02021773|524841833|FG001|Overall Study|Lack of Efficacy|2|||
145541101|NCT02021773|524841834|FG002|Overall Study|Lack of Efficacy|2|||
145541102|NCT02021773|524841832|FG000|Overall Study|Protocol Violation|2|||
145541103|NCT02021773|524841833|FG001|Overall Study|Protocol Violation|3|||
145541104|NCT02021773|524841834|FG002|Overall Study|Protocol Violation|1|||
145541105|NCT02021773|524841832|FG000|Overall Study|Withdrawal by Subject|3|||
145541106|NCT02021773|524841833|FG001|Overall Study|Withdrawal by Subject|4|||
145541107|NCT02021773|524841834|FG002|Overall Study|Withdrawal by Subject|5|||
145541108|NCT02021773|524841832|FG000|Overall Study|Lost to Follow-up|1|||
145541109|NCT02021773|524841833|FG001|Overall Study|Lost to Follow-up|3|||
145541110|NCT02021773|524841834|FG002|Overall Study|Lost to Follow-up|0|||
145541111|NCT02021773|524841832|FG000|Overall Study|Reason not specified|3|||
145541112|NCT02021773|524841833|FG001|Overall Study|Reason not specified|0|||
145541113|NCT02021773|524841834|FG002|Overall Study|Reason not specified|0|||
145541114|NCT00282984|524841835|FG000|Overall Study|Death|2|||
145541115|NCT00282984|524841836|FG001|Overall Study|Death|5|||
145541116|NCT00282984|524841835|FG000|Overall Study|Adverse Event|8|||
145541117|NCT00282984|524841836|FG001|Overall Study|Adverse Event|5|||
145541118|NCT00282984|524841835|FG000|Overall Study|Lack of Efficacy|0|||
145541119|NCT00282984|524841836|FG001|Overall Study|Lack of Efficacy|2|||
145541120|NCT00282984|524841835|FG000|Overall Study|Lost to Follow-up|14|||
145541121|NCT00282984|524841836|FG001|Overall Study|Lost to Follow-up|10|||
145541122|NCT00282984|524841835|FG000|Overall Study|Withdrawal by Participant|22|||
145541123|NCT00282984|524841836|FG001|Overall Study|Withdrawal by Participant|34|||
145541124|NCT00282984|524841835|FG000|Overall Study|Participant stopped study medication|2|||
145541125|NCT00282984|524841836|FG001|Overall Study|Participant stopped study medication|2|||
145541126|NCT00282984|524841835|FG000|Overall Study|Participant only allowed phone follow-up|0|||
145541127|NCT00282984|524841836|FG001|Overall Study|Participant only allowed phone follow-up|1|||
145541128|NCT00282984|524841835|FG000|Overall Study|Participant used antipsychosis meds|0|||
145541129|NCT00282984|524841836|FG001|Overall Study|Participant used antipsychosis meds|1|||
145541130|NCT00282984|524841835|FG000|Overall Study|lack of motivation|1|||
145789838|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
145789839|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
145789840|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
145541131|NCT00282984|524841836|FG001|Overall Study|lack of motivation|0|||
145541132|NCT00282984|524841835|FG000|Overall Study|in prison|0|||
145541133|NCT00282984|524841836|FG001|Overall Study|in prison|1|||
145541134|NCT00282984|524841835|FG000|Overall Study|Protocol Violation|2|||
145541135|NCT00282984|524841836|FG001|Overall Study|Protocol Violation|0|||
145541136|NCT00191269|524841837|FG000|Overall Study|Protocol Violation|0|||
145541137|NCT00191269|524841838|FG001|Overall Study|Protocol Violation|2|||
145541138|NCT00191269|524841837|FG000|Overall Study|Adverse Event|1|||
145541139|NCT00191269|524841838|FG001|Overall Study|Adverse Event|4|||
145541140|NCT00191269|524841837|FG000|Overall Study|Progression of Disease|4|||
145541141|NCT00191269|524841838|FG001|Overall Study|Progression of Disease|42|||
145541142|NCT00191269|524841837|FG000|Overall Study|Lack of Efficacy|1|||
145541143|NCT00191269|524841838|FG001|Overall Study|Lack of Efficacy|5|||
145541144|NCT00191269|524841837|FG000|Overall Study|Withdrawal by Subject|0|||
145541145|NCT00191269|524841838|FG001|Overall Study|Withdrawal by Subject|1|||
145541146|NCT00191269|524841837|FG000|Overall Study|Pathologic Aggrevation|0|||
145541147|NCT00191269|524841838|FG001|Overall Study|Pathologic Aggrevation|1|||
145541148|NCT00191269|524841837|FG000|Overall Study|Physician Decision|0|||
145541149|NCT00191269|524841838|FG001|Overall Study|Physician Decision|3|||
145541150|NCT00915278|524841846|FG000|Overall Study|Death|1|||
145541151|NCT00915278|524841847|FG001|Overall Study|Death|0|||
145541152|NCT00915278|524841848|FG002|Overall Study|Death|0|||
145541153|NCT00915278|524841849|FG003|Overall Study|Death|0|||
145541154|NCT00915278|524841850|FG004|Overall Study|Death|0|||
145541155|NCT00915278|524841851|FG005|Overall Study|Death|0|||
145541156|NCT00915278|524841846|FG000|Overall Study|Lost to Follow-up|0|||
145541157|NCT00915278|524841847|FG001|Overall Study|Lost to Follow-up|1|||
145541158|NCT00915278|524841848|FG002|Overall Study|Lost to Follow-up|0|||
145541159|NCT00915278|524841849|FG003|Overall Study|Lost to Follow-up|0|||
145541160|NCT00915278|524841850|FG004|Overall Study|Lost to Follow-up|0|||
145541161|NCT00915278|524841851|FG005|Overall Study|Lost to Follow-up|0|||
145541162|NCT00915278|524841846|FG000|Overall Study|Withdrawal by Subject|0|||
145541163|NCT00915278|524841847|FG001|Overall Study|Withdrawal by Subject|1|||
145541164|NCT00915278|524841848|FG002|Overall Study|Withdrawal by Subject|0|||
145541165|NCT00915278|524841849|FG003|Overall Study|Withdrawal by Subject|0|||
145541166|NCT00915278|524841850|FG004|Overall Study|Withdrawal by Subject|1|||
145541167|NCT00915278|524841851|FG005|Overall Study|Withdrawal by Subject|4|||
145541168|NCT00915278|524841846|FG000|Overall Study|Adverse Event|4|||
145541169|NCT00915278|524841847|FG001|Overall Study|Adverse Event|1|||
145541170|NCT00915278|524841848|FG002|Overall Study|Adverse Event|0|||
145541171|NCT00915278|524841849|FG003|Overall Study|Adverse Event|0|||
145541172|NCT00915278|524841850|FG004|Overall Study|Adverse Event|0|||
145541173|NCT00915278|524841851|FG005|Overall Study|Adverse Event|0|||
145541174|NCT00915278|524841846|FG000|Overall Study|Progressive disease/clinical progression|0|||
145541175|NCT00915278|524841847|FG001|Overall Study|Progressive disease/clinical progression|0|||
145541176|NCT00915278|524841848|FG002|Overall Study|Progressive disease/clinical progression|0|||
145541177|NCT00915278|524841849|FG003|Overall Study|Progressive disease/clinical progression|3|||
145541178|NCT00915278|524841850|FG004|Overall Study|Progressive disease/clinical progression|1|||
145541179|NCT00915278|524841851|FG005|Overall Study|Progressive disease/clinical progression|2|||
145541180|NCT00915278|524841846|FG000|Overall Study|Infusion related AEs|0|||
145541181|NCT00915278|524841847|FG001|Overall Study|Infusion related AEs|0|||
145541182|NCT00915278|524841848|FG002|Overall Study|Infusion related AEs|0|||
145541183|NCT00915278|524841849|FG003|Overall Study|Infusion related AEs|0|||
145541184|NCT00915278|524841850|FG004|Overall Study|Infusion related AEs|0|||
145541185|NCT00915278|524841851|FG005|Overall Study|Infusion related AEs|2|||
145541186|NCT00915278|524841846|FG000|Overall Study|Admission to hospice|0|||
145541187|NCT00915278|524841847|FG001|Overall Study|Admission to hospice|0|||
145541188|NCT00915278|524841848|FG002|Overall Study|Admission to hospice|1|||
145541189|NCT00915278|524841849|FG003|Overall Study|Admission to hospice|0|||
145541190|NCT00915278|524841850|FG004|Overall Study|Admission to hospice|0|||
145541191|NCT00915278|524841851|FG005|Overall Study|Admission to hospice|0|||
145541192|NCT00674362|524841859|FG000|Double Blind|Adverse Event|6|||
145541193|NCT00674362|524841860|FG001|Double Blind|Adverse Event|6|||
145404138|NCT01432327|524336489|FG003|Posttest 6 Months|Lost to Follow-up|2|||
145541194|NCT00674362|524841859|FG000|Double Blind|Lack of Efficacy|2|||
145541195|NCT00674362|524841860|FG001|Double Blind|Lack of Efficacy|6|||
145541196|NCT00674362|524841859|FG000|Double Blind|Loss of efficacy|0|||
145541197|NCT00674362|524841860|FG001|Double Blind|Loss of efficacy|1|||
145541198|NCT00674362|524841859|FG000|Double Blind|Withdrawal by Subject|4|||
145541199|NCT00674362|524841860|FG001|Double Blind|Withdrawal by Subject|3|||
145541200|NCT00674362|524841859|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
145541201|NCT00674362|524841860|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
145541202|NCT00674362|524841859|FG000|Double Blind|Other: Surgery|0|||
145541203|NCT00674362|524841860|FG001|Double Blind|Other: Surgery|1|||
145541204|NCT00674362|524841859|FG000|Open Label|Adverse Event|1|||
145541205|NCT00674362|524841860|FG001|Open Label|Adverse Event|0|||
145541206|NCT00674362|524841859|FG000|Open Label|Other: Subject moved to extension study|1|||
145541207|NCT00674362|524841860|FG001|Open Label|Other: Subject moved to extension study|0|||
145541208|NCT03137537|524841863|FG000|Overall Study|Adverse Event|0|||
145541209|NCT03137537|524841864|FG001|Overall Study|Adverse Event|1|||
145789841|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
145789842|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
145404139|NCT01432327|524336486|FG000|Posttest 6 Months|Allergic reaction|0|||
145541210|NCT04066023|524841865|FG000|Overall Study|Adverse Event|0|||
145541211|NCT04066023|524841866|FG001|Overall Study|Adverse Event|0|||
145541212|NCT04066023|524841867|FG002|Overall Study|Adverse Event|1|||
145541213|NCT04066023|524841865|FG000|Overall Study|Sponsor decision|3|||
145541214|NCT04066023|524841866|FG001|Overall Study|Sponsor decision|6|||
145541215|NCT04066023|524841867|FG002|Overall Study|Sponsor decision|2|||
145541216|NCT04066023|524841865|FG000|Overall Study|Physician Decision|0|||
145541217|NCT04066023|524841866|FG001|Overall Study|Physician Decision|0|||
145541218|NCT04066023|524841867|FG002|Overall Study|Physician Decision|1|||
145541219|NCT04066023|524841865|FG000|Overall Study|Lost to Follow-up|0|||
145541220|NCT04066023|524841866|FG001|Overall Study|Lost to Follow-up|1|||
145541221|NCT04066023|524841867|FG002|Overall Study|Lost to Follow-up|1|||
145541222|NCT04066023|524841865|FG000|Overall Study|Noncompliance|0|||
145541223|NCT04066023|524841866|FG001|Overall Study|Noncompliance|1|||
145541224|NCT04066023|524841867|FG002|Overall Study|Noncompliance|1|||
145541225|NCT01552694|524841868|FG000|Overall Study|Lost to Follow-up|0|||
145541226|NCT01552694|524841869|FG001|Overall Study|Lost to Follow-up|1|||
145541227|NCT01552694|524841868|FG000|Overall Study|Protocol Violation|0|||
145541228|NCT01552694|524841869|FG001|Overall Study|Protocol Violation|1|||
145541229|NCT04665856|524841870|FG000|Overall Study|Site Terminated by Sponsor|1|||
145541230|NCT04665856|524841871|FG001|Overall Study|Site Terminated by Sponsor|0|||
145541231|NCT04665856|524841870|FG000|Overall Study|Withdrawal by Subject|2|||
145541232|NCT04665856|524841871|FG001|Overall Study|Withdrawal by Subject|0|||
145541233|NCT04665856|524841870|FG000|Overall Study|Lost to Follow-up|3|||
145541234|NCT04665856|524841871|FG001|Overall Study|Lost to Follow-up|2|||
145541235|NCT04665856|524841870|FG000|Overall Study|Death|39|||
145541236|NCT04665856|524841871|FG001|Overall Study|Death|44|||
145541237|NCT04665856|524841870|FG000|Overall Study|Ongoing in study|17|||
145541238|NCT04665856|524841871|FG001|Overall Study|Ongoing in study|15|||
145541239|NCT00191139|524841873|FG000|Overall Study|Adverse Event|2|||
145541240|NCT00191139|524841874|FG001|Overall Study|Adverse Event|6|||
145541241|NCT00191139|524841873|FG000|Overall Study|Death|2|||
145541242|NCT00191139|524841874|FG001|Overall Study|Death|0|||
145541243|NCT00191139|524841873|FG000|Overall Study|Withdrawal by Subject|0|||
145541244|NCT00191139|524841874|FG001|Overall Study|Withdrawal by Subject|3|||
145541245|NCT00191139|524841873|FG000|Overall Study|Disease Progression|0|||
145541246|NCT00191139|524841874|FG001|Overall Study|Disease Progression|1|||
145541247|NCT00191139|524841873|FG000|Overall Study|Other|1|||
145541248|NCT00191139|524841874|FG001|Overall Study|Other|2|||
145541249|NCT02465515|524841877|FG000|Overall Study|Investigator site closed|4|||
145541250|NCT02465515|524841878|FG001|Overall Study|Investigator site closed|5|||
145541251|NCT02465515|524841877|FG000|Overall Study|Withdrawal by Subject|74|||
145541252|NCT02465515|524841878|FG001|Overall Study|Withdrawal by Subject|43|||
145541253|NCT02465515|524841877|FG000|Overall Study|Physician Decision|8|||
145541254|NCT02465515|524841878|FG001|Overall Study|Physician Decision|12|||
145541255|NCT02465515|524841877|FG000|Overall Study|Lost to Follow-up|68|||
145541256|NCT02465515|524841878|FG001|Overall Study|Lost to Follow-up|51|||
145541257|NCT02564796|524841879|FG000|Overall Study|Physician Decision|2|||
145541258|NCT02564796|524841880|FG001|Overall Study|Physician Decision|2|||
145541259|NCT00293033|524841881|FG000|Open-label Titration Period|Adverse Event|10|||
145541260|NCT00293033|524841881|FG000|Open-label Titration Period|Death|3|||
145541261|NCT00293033|524841881|FG000|Open-label Titration Period|Lack of Efficacy|5|||
145541262|NCT00293033|524841881|FG000|Open-label Titration Period|Protocol Violation|2|||
145541263|NCT00293033|524841881|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
145541264|NCT00293033|524841881|FG000|Open-label Titration Period|Noncompliance and other|27|||
145789843|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
145789844|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
145789845|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
145789846|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
145789847|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
145789848|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
145789849|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
145789850|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
145789851|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
145789852|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
145789853|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
145789854|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
145789855|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
145541265|NCT00293033|524841881|FG000|Double-blind Treatment Period|Adverse Event|3|||
145541266|NCT00293033|524841881|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
145541267|NCT00293033|524841881|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
145541268|NCT00293033|524841881|FG000|Double-blind Treatment Period|Noncompliance|4|||
145541269|NCT00114530|524841883|FG000|Overall Study|Death|3|||
145541270|NCT00114530|524841884|FG001|Overall Study|Death|11|||
145541271|NCT00114530|524841883|FG000|Overall Study|Lost to Follow-up|1|||
145541272|NCT00114530|524841884|FG001|Overall Study|Lost to Follow-up|1|||
145541273|NCT00114530|524841883|FG000|Overall Study|Physician Decision|1|||
145541274|NCT00114530|524841884|FG001|Overall Study|Physician Decision|1|||
145541275|NCT00114530|524841883|FG000|Overall Study|Withdrawal by Subject|2|||
145541276|NCT00114530|524841884|FG001|Overall Study|Withdrawal by Subject|6|||
145541277|NCT00114530|524841883|FG000|Overall Study|Breast Cancer|1|||
145541278|NCT00114530|524841884|FG001|Overall Study|Breast Cancer|0|||
145282033|NCT00950599|523883050|FG003|Follow-Up Period|Poor/Noncompliance|0|||
145282034|NCT00950599|523883051|FG004|Follow-Up Period|Poor/Noncompliance|0|||
145541279|NCT00114530|524841883|FG000|Overall Study|Subject decision after endpoint failure|0|||
145541280|NCT00114530|524841884|FG001|Overall Study|Subject decision after endpoint failure|1|||
145541281|NCT00114530|524841883|FG000|Overall Study|Ineligible|1|||
145541282|NCT00114530|524841884|FG001|Overall Study|Ineligible|0|||
145541283|NCT00751933|524841885|FG000|Overall Study|Withdrawal by Subject|0|||
145541284|NCT00751933|524841886|FG001|Overall Study|Withdrawal by Subject|1|||
145541285|NCT00751933|524841887|FG002|Overall Study|Withdrawal by Subject|0|||
145541286|NCT00751933|524841888|FG003|Overall Study|Withdrawal by Subject|0|||
145541287|NCT00751933|524841885|FG000|Overall Study|Physician Decision|0|||
145541288|NCT00751933|524841886|FG001|Overall Study|Physician Decision|0|||
145541289|NCT00751933|524841887|FG002|Overall Study|Physician Decision|1|||
145541290|NCT00751933|524841888|FG003|Overall Study|Physician Decision|1|||
145541291|NCT01817530|524841890|FG000|Overall Study|Exclusionary Medication Received|0|||
145541292|NCT01817530|524841891|FG001|Overall Study|Exclusionary Medication Received|0|||
145541293|NCT01817530|524841892|FG002|Overall Study|Exclusionary Medication Received|0|||
145541294|NCT01817530|524841893|FG003|Overall Study|Exclusionary Medication Received|0|||
145541295|NCT01817530|524841894|FG004|Overall Study|Exclusionary Medication Received|1|||
145541296|NCT01817530|524841895|FG005|Overall Study|Exclusionary Medication Received|0|||
145541297|NCT01817530|524841896|FG006|Overall Study|Exclusionary Medication Received|0|||
145541298|NCT01817530|524841897|FG007|Overall Study|Exclusionary Medication Received|0|||
145541299|NCT01817530|524841890|FG000|Overall Study|Adverse Event|6|||
145541300|NCT01817530|524841891|FG001|Overall Study|Adverse Event|3|||
145541301|NCT01817530|524841892|FG002|Overall Study|Adverse Event|2|||
145541302|NCT01817530|524841893|FG003|Overall Study|Adverse Event|5|||
145541303|NCT01817530|524841894|FG004|Overall Study|Adverse Event|0|||
145541304|NCT01817530|524841895|FG005|Overall Study|Adverse Event|10|||
145541305|NCT01817530|524841896|FG006|Overall Study|Adverse Event|5|||
145541306|NCT01817530|524841897|FG007|Overall Study|Adverse Event|8|||
145541307|NCT01817530|524841890|FG000|Overall Study|Subject Noncompliant|3|||
145541308|NCT01817530|524841891|FG001|Overall Study|Subject Noncompliant|1|||
145541309|NCT01817530|524841892|FG002|Overall Study|Subject Noncompliant|0|||
145541310|NCT01817530|524841893|FG003|Overall Study|Subject Noncompliant|4|||
145541311|NCT01817530|524841894|FG004|Overall Study|Subject Noncompliant|0|||
145541312|NCT01817530|524841895|FG005|Overall Study|Subject Noncompliant|1|||
145541313|NCT01817530|524841896|FG006|Overall Study|Subject Noncompliant|1|||
145541314|NCT01817530|524841897|FG007|Overall Study|Subject Noncompliant|1|||
145541315|NCT01817530|524841890|FG000|Overall Study|Lack of Efficacy|1|||
145541316|NCT01817530|524841891|FG001|Overall Study|Lack of Efficacy|0|||
145541317|NCT01817530|524841892|FG002|Overall Study|Lack of Efficacy|0|||
145541318|NCT01817530|524841893|FG003|Overall Study|Lack of Efficacy|0|||
145541319|NCT01817530|524841894|FG004|Overall Study|Lack of Efficacy|0|||
145541320|NCT01817530|524841895|FG005|Overall Study|Lack of Efficacy|1|||
145541321|NCT01817530|524841896|FG006|Overall Study|Lack of Efficacy|0|||
145541322|NCT01817530|524841897|FG007|Overall Study|Lack of Efficacy|1|||
145541323|NCT01817530|524841890|FG000|Overall Study|Pregnancy|0|||
145541324|NCT01817530|524841891|FG001|Overall Study|Pregnancy|0|||
145541325|NCT01817530|524841892|FG002|Overall Study|Pregnancy|0|||
145541326|NCT01817530|524841893|FG003|Overall Study|Pregnancy|0|||
145541327|NCT01817530|524841894|FG004|Overall Study|Pregnancy|0|||
145541328|NCT01817530|524841895|FG005|Overall Study|Pregnancy|1|||
145282035|NCT00950599|523883052|FG005|Follow-Up Period|Poor/Noncompliance|0|||
145282036|NCT00950599|523883053|FG006|Follow-Up Period|Poor/Noncompliance|0|||
145282037|NCT00950599|523883054|FG007|Follow-Up Period|Poor/Noncompliance|0|||
145282038|NCT00950599|523883055|FG008|Follow-Up Period|Poor/Noncompliance|1|||
145282039|NCT00950599|523883056|FG009|Follow-Up Period|Poor/Noncompliance|0|||
145282040|NCT00950599|523883047|FG000|Follow-Up Period|Subject withdrew Consent|0|||
145282041|NCT00950599|523883048|FG001|Follow-Up Period|Subject withdrew Consent|0|||
145282042|NCT00950599|523883049|FG002|Follow-Up Period|Subject withdrew Consent|0|||
145282043|NCT00950599|523883050|FG003|Follow-Up Period|Subject withdrew Consent|0|||
145541329|NCT01817530|524841896|FG006|Overall Study|Pregnancy|0|||
145541330|NCT01817530|524841897|FG007|Overall Study|Pregnancy|0|||
145541331|NCT01817530|524841890|FG000|Overall Study|Other|0|||
145541332|NCT01817530|524841891|FG001|Overall Study|Other|1|||
145282044|NCT00950599|523883051|FG004|Follow-Up Period|Subject withdrew Consent|0|||
145282045|NCT00950599|523883052|FG005|Follow-Up Period|Subject withdrew Consent|0|||
145282046|NCT00950599|523883053|FG006|Follow-Up Period|Subject withdrew Consent|0|||
145282047|NCT00950599|523883054|FG007|Follow-Up Period|Subject withdrew Consent|0|||
145541333|NCT01817530|524841892|FG002|Overall Study|Other|0|||
145541334|NCT01817530|524841893|FG003|Overall Study|Other|0|||
145541335|NCT01817530|524841894|FG004|Overall Study|Other|1|||
145541336|NCT01817530|524841895|FG005|Overall Study|Other|0|||
145541337|NCT01817530|524841896|FG006|Overall Study|Other|5|||
145541338|NCT01817530|524841897|FG007|Overall Study|Other|0|||
145541339|NCT01817530|524841890|FG000|Overall Study|Surgery or Invasive Intervention|1|||
145541340|NCT01817530|524841891|FG001|Overall Study|Surgery or Invasive Intervention|0|||
145541341|NCT01817530|524841892|FG002|Overall Study|Surgery or Invasive Intervention|0|||
145404140|NCT01432327|524336487|FG001|Posttest 6 Months|Allergic reaction|0|||
145404141|NCT01432327|524336488|FG002|Posttest 6 Months|Allergic reaction|1|||
145404142|NCT01432327|524336489|FG003|Posttest 6 Months|Allergic reaction|0|||
145404143|NCT01432327|524336486|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
145404144|NCT01432327|524336487|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
145404145|NCT01432327|524336488|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
145404146|NCT01432327|524336489|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
145404147|NCT01432327|524336486|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
145404148|NCT01432327|524336487|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
145404149|NCT01432327|524336488|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
145404150|NCT01432327|524336489|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
145404151|NCT01432327|524336486|FG000|Posttest 1 Year|Lost to Follow-up|0|||
145404152|NCT01432327|524336487|FG001|Posttest 1 Year|Lost to Follow-up|0|||
145404153|NCT01432327|524336488|FG002|Posttest 1 Year|Lost to Follow-up|4|||
145404154|NCT01432327|524336489|FG003|Posttest 1 Year|Lost to Follow-up|2|||
145404155|NCT01432327|524336486|FG000|Posttest 1 Year|Allergic reaction|0|||
145404156|NCT01432327|524336487|FG001|Posttest 1 Year|Allergic reaction|0|||
145404157|NCT01432327|524336488|FG002|Posttest 1 Year|Allergic reaction|1|||
145404158|NCT01432327|524336489|FG003|Posttest 1 Year|Allergic reaction|1|||
145404159|NCT00577408|524336490|FG000|Overall Study|Stopped attending study visits|9|||
145404160|NCT00577408|524336491|FG001|Overall Study|Stopped attending study visits|11|||
145404161|NCT00577408|524336490|FG000|Overall Study|Continued opioid use|3|||
145404162|NCT00577408|524336491|FG001|Overall Study|Continued opioid use|2|||
145404163|NCT00577408|524336490|FG000|Overall Study|Non-compliance with study meds|0|||
145404164|NCT00577408|524336491|FG001|Overall Study|Non-compliance with study meds|3|||
145404165|NCT00577408|524336490|FG000|Overall Study|Refused Oral Naltrexone|0|||
145404166|NCT00577408|524336491|FG001|Overall Study|Refused Oral Naltrexone|1|||
145404167|NCT00577408|524336490|FG000|Overall Study|Moved out of state|0|||
145404168|NCT00577408|524336491|FG001|Overall Study|Moved out of state|1|||
145404169|NCT00577408|524336490|FG000|Overall Study|Scheduling Issues|0|||
145404170|NCT00577408|524336491|FG001|Overall Study|Scheduling Issues|3|||
145404171|NCT00577408|524336490|FG000|Overall Study|Death|0|||
145404172|NCT00577408|524336491|FG001|Overall Study|Death|1|||
145404173|NCT00577408|524336490|FG000|Overall Study|Psychiatric hospitalization|0|||
145404174|NCT00577408|524336491|FG001|Overall Study|Psychiatric hospitalization|1|||
145404175|NCT00827567|524336500|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
145404176|NCT03482024|524336505|FG000|Overall Study|Physician Decision|1|||
145404177|NCT03482024|524336506|FG001|Overall Study|Physician Decision|0|||
145404178|NCT03482024|524336507|FG002|Overall Study|Physician Decision|0|||
145404179|NCT03482024|524336508|FG003|Overall Study|Physician Decision|0|||
145404180|NCT03482024|524336509|FG004|Overall Study|Physician Decision|0|||
145404181|NCT00676143|524336512|FG000|Overall Study|Adverse Event|34|||
145404182|NCT00676143|524336513|FG001|Overall Study|Adverse Event|60|||
145404183|NCT00676143|524336512|FG000|Overall Study|Death|4|||
145404184|NCT00676143|524336513|FG001|Overall Study|Death|4|||
145404185|NCT00676143|524336512|FG000|Overall Study|Lack of Efficacy|0|||
145404186|NCT00676143|524336513|FG001|Overall Study|Lack of Efficacy|6|||
145404187|NCT00676143|524336512|FG000|Overall Study|Lost to Follow-up|0|||
145404188|NCT00676143|524336513|FG001|Overall Study|Lost to Follow-up|13|||
145404189|NCT00676143|524336512|FG000|Overall Study|Physician Decision|5|||
145404190|NCT00676143|524336513|FG001|Overall Study|Physician Decision|8|||
145404191|NCT00676143|524336512|FG000|Overall Study|Protocol Violation|4|||
145404192|NCT00676143|524336513|FG001|Overall Study|Protocol Violation|8|||
145404193|NCT00676143|524336512|FG000|Overall Study|Withdrawal by Subject|24|||
145404194|NCT00676143|524336513|FG001|Overall Study|Withdrawal by Subject|42|||
145404195|NCT00676143|524336512|FG000|Overall Study|Discontinuation of study by sponsor|65|||
145404196|NCT00676143|524336513|FG001|Overall Study|Discontinuation of study by sponsor|88|||
145404197|NCT00676143|524336512|FG000|Overall Study|Failed to return|2|||
145404198|NCT00676143|524336513|FG001|Overall Study|Failed to return|1|||
145404199|NCT00676143|524336512|FG000|Overall Study|Loss of caregiver|5|||
145404200|NCT00676143|524336513|FG001|Overall Study|Loss of caregiver|3|||
145404201|NCT00676143|524336512|FG000|Overall Study|Other|11|||
145404202|NCT00676143|524336513|FG001|Overall Study|Other|20|||
145404203|NCT00676143|524336512|FG000|Overall Study|Participant participation unknown|1|||
145404204|NCT00676143|524336513|FG001|Overall Study|Participant participation unknown|4|||
145404205|NCT00676143|524336512|FG000|Overall Study|Vasogenic edema recurrence|1|||
145404206|NCT00676143|524336513|FG001|Overall Study|Vasogenic edema recurrence|3|||
145404207|NCT02412657|524336521|FG000|Overall Study|Lost to Follow-up|1|||
145404208|NCT02412657|524336522|FG001|Overall Study|Lost to Follow-up|0|||
145404209|NCT02412657|524336523|FG002|Overall Study|Lost to Follow-up|0|||
145404210|NCT02412657|524336521|FG000|Overall Study|Protocol Violation|0|||
145404211|NCT02412657|524336522|FG001|Overall Study|Protocol Violation|2|||
145404212|NCT02412657|524336523|FG002|Overall Study|Protocol Violation|3|||
145404213|NCT01281306|524336527|FG000|Overall Study|Lack of Efficacy|0|||
145404214|NCT01281306|524336528|FG001|Overall Study|Lack of Efficacy|1|||
145404215|NCT01281306|524336529|FG002|Overall Study|Lack of Efficacy|3|||
145404216|NCT01281306|524336530|FG003|Overall Study|Lack of Efficacy|0|||
145404217|NCT01281306|524336531|FG004|Overall Study|Lack of Efficacy|2|||
145541342|NCT01817530|524841893|FG003|Overall Study|Surgery or Invasive Intervention|0|||
145541343|NCT01817530|524841894|FG004|Overall Study|Surgery or Invasive Intervention|1|||
145541344|NCT01817530|524841895|FG005|Overall Study|Surgery or Invasive Intervention|1|||
145541345|NCT01817530|524841896|FG006|Overall Study|Surgery or Invasive Intervention|1|||
145541346|NCT01817530|524841897|FG007|Overall Study|Surgery or Invasive Intervention|0|||
145541347|NCT01817530|524841890|FG000|Overall Study|Consent Withdrawn by Subject|3|||
145541348|NCT01817530|524841891|FG001|Overall Study|Consent Withdrawn by Subject|4|||
145541349|NCT01817530|524841892|FG002|Overall Study|Consent Withdrawn by Subject|7|||
145541350|NCT01817530|524841893|FG003|Overall Study|Consent Withdrawn by Subject|3|||
145541351|NCT01817530|524841894|FG004|Overall Study|Consent Withdrawn by Subject|5|||
145541352|NCT01817530|524841895|FG005|Overall Study|Consent Withdrawn by Subject|3|||
145541353|NCT01817530|524841896|FG006|Overall Study|Consent Withdrawn by Subject|3|||
145541354|NCT01817530|524841897|FG007|Overall Study|Consent Withdrawn by Subject|10|||
145541355|NCT01817530|524841890|FG000|Overall Study|Lost to Follow-up|1|||
145541356|NCT01817530|524841891|FG001|Overall Study|Lost to Follow-up|4|||
145541357|NCT01817530|524841892|FG002|Overall Study|Lost to Follow-up|2|||
145541358|NCT01817530|524841893|FG003|Overall Study|Lost to Follow-up|1|||
145541359|NCT01817530|524841894|FG004|Overall Study|Lost to Follow-up|3|||
145541360|NCT01817530|524841895|FG005|Overall Study|Lost to Follow-up|2|||
145541361|NCT01817530|524841896|FG006|Overall Study|Lost to Follow-up|8|||
145541362|NCT01817530|524841897|FG007|Overall Study|Lost to Follow-up|4|||
145541363|NCT03846804|524841898|FG000|Overall Study|Refused blood draw|1|||
145541364|NCT03846804|524841898|FG000|Overall Study|Protocol Violation|1|||
145541365|NCT00679432|524841899|FG000|Overall Study|Adverse Event|5|||
145541366|NCT00679432|524841900|FG001|Overall Study|Adverse Event|6|||
145541367|NCT00679432|524841901|FG002|Overall Study|Adverse Event|10|||
145541368|NCT00679432|524841902|FG003|Overall Study|Adverse Event|7|||
145541369|NCT00679432|524841899|FG000|Overall Study|Protocol Violation|1|||
145541370|NCT00679432|524841900|FG001|Overall Study|Protocol Violation|1|||
145541371|NCT00679432|524841901|FG002|Overall Study|Protocol Violation|2|||
145541372|NCT00679432|524841902|FG003|Overall Study|Protocol Violation|1|||
145541373|NCT00679432|524841899|FG000|Overall Study|Withdrawal by Subject|8|||
145541374|NCT00679432|524841900|FG001|Overall Study|Withdrawal by Subject|11|||
145541375|NCT00679432|524841901|FG002|Overall Study|Withdrawal by Subject|10|||
145541376|NCT00679432|524841902|FG003|Overall Study|Withdrawal by Subject|9|||
145541377|NCT00679432|524841899|FG000|Overall Study|Lost to Follow-up|1|||
145541378|NCT00679432|524841900|FG001|Overall Study|Lost to Follow-up|5|||
145541379|NCT00679432|524841901|FG002|Overall Study|Lost to Follow-up|4|||
145541380|NCT00679432|524841902|FG003|Overall Study|Lost to Follow-up|2|||
145541381|NCT00679432|524841899|FG000|Overall Study|Physician Decision|3|||
145541382|NCT00679432|524841900|FG001|Overall Study|Physician Decision|2|||
145541383|NCT00679432|524841901|FG002|Overall Study|Physician Decision|2|||
145541384|NCT00679432|524841902|FG003|Overall Study|Physician Decision|2|||
145541385|NCT00679432|524841899|FG000|Overall Study|Sponsor decision|1|||
145541386|NCT00679432|524841900|FG001|Overall Study|Sponsor decision|0|||
145541387|NCT00679432|524841901|FG002|Overall Study|Sponsor decision|0|||
145541388|NCT00679432|524841902|FG003|Overall Study|Sponsor decision|0|||
145541389|NCT00679432|524841899|FG000|Overall Study|Lack of Efficacy|13|||
145541390|NCT00679432|524841900|FG001|Overall Study|Lack of Efficacy|9|||
145541391|NCT00679432|524841901|FG002|Overall Study|Lack of Efficacy|14|||
145282048|NCT00950599|523883055|FG008|Follow-Up Period|Subject withdrew Consent|2|||
145282049|NCT00950599|523883056|FG009|Follow-Up Period|Subject withdrew Consent|1|||
145282050|NCT01684722|523883057|FG000|Overall Study|Lost to Follow-up|78|||
145282051|NCT01684722|523883058|FG001|Overall Study|Lost to Follow-up|56|||
145282052|NCT01684722|523883059|FG002|Overall Study|Lost to Follow-up|75|||
145282053|NCT01684722|523883060|FG003|Overall Study|Lost to Follow-up|89|||
145282054|NCT01684722|523883057|FG000|Overall Study|Death|19|||
145282055|NCT01684722|523883058|FG001|Overall Study|Death|21|||
145282056|NCT01684722|523883059|FG002|Overall Study|Death|19|||
145282057|NCT01684722|523883060|FG003|Overall Study|Death|21|||
145282058|NCT00219557|523883061|FG000|Phase 1|Lack of Efficacy|3|||
145282059|NCT00219557|523883062|FG001|Phase 1|Lack of Efficacy|0|||
145282060|NCT00219557|523883063|FG002|Phase 1|Lack of Efficacy|0|||
145541392|NCT00679432|524841902|FG003|Overall Study|Lack of Efficacy|8|||
145541393|NCT00679432|524841899|FG000|Overall Study|Infectious colitis, normal histology|5|||
145541394|NCT00679432|524841900|FG001|Overall Study|Infectious colitis, normal histology|4|||
145282061|NCT00219557|523883061|FG000|Phase 1|Adverse Event|2|||
145541395|NCT00679432|524841901|FG002|Overall Study|Infectious colitis, normal histology|8|||
145541396|NCT00679432|524841902|FG003|Overall Study|Infectious colitis, normal histology|3|||
145541397|NCT00679432|524841899|FG000|Overall Study|Randomization error, return to prior Rx|0|||
145541398|NCT00679432|524841900|FG001|Overall Study|Randomization error, return to prior Rx|0|||
145541399|NCT00679432|524841901|FG002|Overall Study|Randomization error, return to prior Rx|3|||
145541400|NCT00679432|524841902|FG003|Overall Study|Randomization error, return to prior Rx|0|||
145541401|NCT00824720|524841903|FG000|Overall Study|failed plug insertion|3|||
145282062|NCT00219557|523883062|FG001|Phase 1|Adverse Event|0|||
145282063|NCT00219557|523883063|FG002|Phase 1|Adverse Event|0|||
145541402|NCT00824720|524841904|FG001|Overall Study|failed plug insertion|1|||
145541403|NCT00824720|524841905|FG002|Overall Study|failed plug insertion|0|||
145541404|NCT00824720|524841903|FG000|Overall Study|Protocol Violation|0|||
145541405|NCT00824720|524841904|FG001|Overall Study|Protocol Violation|0|||
145541406|NCT00824720|524841905|FG002|Overall Study|Protocol Violation|1|||
145541407|NCT00743483|524841906|FG000|Baseline Period|Physician Decision|1|||
145541408|NCT00743483|524841906|FG000|Treatment Period|Adverse Event|1|||
145541409|NCT01084083|524841907|FG000|Overall Study|Adverse Event|5|||
145541410|NCT01084083|524841907|FG000|Overall Study|Death|1|||
145541411|NCT01084083|524841907|FG000|Overall Study|Withdrawal by Subject|2|||
145541412|NCT01084083|524841907|FG000|Overall Study|Complicating disease|1|||
145541413|NCT01084083|524841907|FG000|Overall Study|Other|2|||
145541414|NCT01084083|524841907|FG000|Overall Study|Never started assigned therapy|1|||
145541415|NCT01273597|524841908|FG000|Overall Study|Adverse Event|5|||
145541416|NCT01273597|524841908|FG000|Overall Study|Underwent Kidney Transplantation|2|||
145541417|NCT01273597|524841908|FG000|Overall Study|Reason Not Reported|1|||
145541418|NCT01466153|524841911|FG000|Overall Study|Disease Progression|2|||
145541419|NCT01466153|524841912|FG001|Overall Study|Disease Progression|2|||
145541420|NCT01466153|524841913|FG002|Overall Study|Disease Progression|0|||
145541421|NCT01466153|524841911|FG000|Overall Study|Adverse Event|14|||
145541422|NCT01466153|524841912|FG001|Overall Study|Adverse Event|13|||
145541423|NCT01466153|524841913|FG002|Overall Study|Adverse Event|17|||
145541424|NCT01466153|524841911|FG000|Overall Study|Withdrawal of Consent|2|||
145541425|NCT01466153|524841912|FG001|Overall Study|Withdrawal of Consent|0|||
145541426|NCT01466153|524841913|FG002|Overall Study|Withdrawal of Consent|0|||
145541427|NCT01466153|524841911|FG000|Overall Study|Investigator Discretion|3|||
145541428|NCT01466153|524841912|FG001|Overall Study|Investigator Discretion|2|||
145541429|NCT01466153|524841913|FG002|Overall Study|Investigator Discretion|2|||
145541430|NCT01466153|524841911|FG000|Overall Study|Randomized-Not Treated|2|||
145541431|NCT01466153|524841912|FG001|Overall Study|Randomized-Not Treated|3|||
145541432|NCT01466153|524841913|FG002|Overall Study|Randomized-Not Treated|4|||
145541433|NCT01466153|524841911|FG000|Overall Study|Other-Unspecified|6|||
145541434|NCT01466153|524841912|FG001|Overall Study|Other-Unspecified|4|||
145541435|NCT01466153|524841913|FG002|Overall Study|Other-Unspecified|2|||
145541436|NCT01785069|524841917|FG000|Overall Study|Implanted with nonstudy device|1|||
145541437|NCT01785069|524841918|FG001|Overall Study|Implanted with nonstudy device|2|||
145541438|NCT01785069|524841919|FG002|Overall Study|Implanted with nonstudy device|1|||
145541439|NCT01785069|524841920|FG003|Overall Study|Implanted with nonstudy device|0|||
145541440|NCT01785069|524841917|FG000|Overall Study|Death|0|||
145541441|NCT01785069|524841918|FG001|Overall Study|Death|0|||
145541442|NCT01785069|524841919|FG002|Overall Study|Death|2|||
145541443|NCT01785069|524841920|FG003|Overall Study|Death|0|||
145541444|NCT01785069|524841917|FG000|Overall Study|Subject choice|2|||
145541445|NCT01785069|524841918|FG001|Overall Study|Subject choice|2|||
145541446|NCT01785069|524841919|FG002|Overall Study|Subject choice|0|||
145541447|NCT01785069|524841920|FG003|Overall Study|Subject choice|1|||
145541448|NCT01785069|524841917|FG000|Overall Study|Lost to Follow-up|1|||
145541449|NCT01785069|524841918|FG001|Overall Study|Lost to Follow-up|2|||
145541450|NCT01785069|524841919|FG002|Overall Study|Lost to Follow-up|4|||
145541451|NCT01785069|524841920|FG003|Overall Study|Lost to Follow-up|1|||
145541452|NCT01785069|524841917|FG000|Overall Study|Reason not Specified|1|||
145541453|NCT01785069|524841918|FG001|Overall Study|Reason not Specified|2|||
145541454|NCT01785069|524841919|FG002|Overall Study|Reason not Specified|1|||
145541455|NCT01785069|524841920|FG003|Overall Study|Reason not Specified|4|||
145541456|NCT01785069|524841917|FG000|Overall Study|Not evaluable|7|||
145541457|NCT01785069|524841918|FG001|Overall Study|Not evaluable|4|||
145541458|NCT01785069|524841919|FG002|Overall Study|Not evaluable|5|||
145541459|NCT01785069|524841920|FG003|Overall Study|Not evaluable|8|||
145541460|NCT01088997|524841923|FG000|Overall Study|Physician Decision|1|||
145541461|NCT01088997|524841924|FG001|Overall Study|Physician Decision|1|||
145541462|NCT01088997|524841923|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
145541463|NCT01088997|524841924|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
145541464|NCT01088997|524841923|FG000|Overall Study|Excluded prior to receiving drug|1|||
145541465|NCT01088997|524841924|FG001|Overall Study|Excluded prior to receiving drug|1|||
145404218|NCT01281306|524336532|FG005|Overall Study|Lack of Efficacy|0|||
145404219|NCT01281306|524336533|FG006|Overall Study|Lack of Efficacy|1|||
145404220|NCT01281306|524336527|FG000|Overall Study|Withdrawal by Subject|1|||
145404221|NCT01281306|524336528|FG001|Overall Study|Withdrawal by Subject|0|||
145541466|NCT05570500|524841929|FG000|Overall Study|Lost to Follow-up|7|||
145541467|NCT05570500|524841930|FG001|Overall Study|Lost to Follow-up|5|||
145541468|NCT04997304|524841931|FG000|Overall Study|Lost to Follow-up|11|||
145541469|NCT04997304|524841931|FG000|Overall Study|Death|1|||
145541470|NCT04997304|524841931|FG000|Overall Study|Withdrawal by Subject|14|||
145541471|NCT00709761|524843997|FG000|Overall Study|Withdrawal by Subject|8|||
145541472|NCT00709761|524843997|FG000|Overall Study|study closed/terminated|17|||
145541473|NCT00709761|524843997|FG000|Overall Study|Lost to Follow-up|2|||
145541474|NCT00126191|524844001|FG000|Overall Study|Physician Decision|0|||
145541475|NCT00126191|524844002|FG001|Overall Study|Physician Decision|1|||
145541476|NCT00126191|524844001|FG000|Overall Study|Death|0|||
145541477|NCT00126191|524844002|FG001|Overall Study|Death|1|||
145541478|NCT03000439|524844003|FG000|Open Label Part 1|Adverse Event|6|||
145541479|NCT03000439|524844004|FG001|Open Label Part 1|Adverse Event|0|||
145541480|NCT03000439|524844005|FG002|Open Label Part 1|Adverse Event|0|||
145541481|NCT03000439|524844006|FG003|Open Label Part 1|Adverse Event|0|||
145541482|NCT03000439|524844003|FG000|Open Label Part 1|Other|2|||
145541483|NCT03000439|524844004|FG001|Open Label Part 1|Other|0|||
145541484|NCT03000439|524844005|FG002|Open Label Part 1|Other|0|||
145541485|NCT03000439|524844006|FG003|Open Label Part 1|Other|0|||
145541486|NCT03000439|524844003|FG000|Open Label Part 1|Insufficient clinical response|16|||
145541487|NCT03000439|524844004|FG001|Open Label Part 1|Insufficient clinical response|0|||
145541488|NCT03000439|524844005|FG002|Open Label Part 1|Insufficient clinical response|0|||
145541489|NCT03000439|524844006|FG003|Open Label Part 1|Insufficient clinical response|0|||
145541490|NCT03000439|524844003|FG000|Open Label Part 2|Other|0|||
145541491|NCT03000439|524844004|FG001|Open Label Part 2|Other|5|||
145541492|NCT03000439|524844005|FG002|Open Label Part 2|Other|0|||
145541493|NCT03000439|524844006|FG003|Open Label Part 2|Other|0|||
145541494|NCT03000439|524844003|FG000|Open Label Part 2|Insufficient clinical response|0|||
145541495|NCT03000439|524844004|FG001|Open Label Part 2|Insufficient clinical response|12|||
145541496|NCT03000439|524844005|FG002|Open Label Part 2|Insufficient clinical response|0|||
145541497|NCT03000439|524844006|FG003|Open Label Part 2|Insufficient clinical response|0|||
145541498|NCT03000439|524844003|FG000|Double Blind Phase|Adverse Event|0|||
145541499|NCT03000439|524844004|FG001|Double Blind Phase|Adverse Event|0|||
145541500|NCT03000439|524844005|FG002|Double Blind Phase|Adverse Event|2|||
145541501|NCT03000439|524844006|FG003|Double Blind Phase|Adverse Event|1|||
145541502|NCT03000439|524844003|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
145541503|NCT03000439|524844004|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
145541504|NCT03000439|524844005|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
145541505|NCT03000439|524844006|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
145541506|NCT03000439|524844003|FG000|Double Blind Phase|Other|0|||
145541507|NCT03000439|524844004|FG001|Double Blind Phase|Other|0|||
145541508|NCT03000439|524844005|FG002|Double Blind Phase|Other|10|||
145541509|NCT03000439|524844006|FG003|Double Blind Phase|Other|11|||
145541510|NCT03000439|524844003|FG000|Double Blind Phase|Insufficient clinical response|0|||
145541511|NCT03000439|524844004|FG001|Double Blind Phase|Insufficient clinical response|0|||
145541512|NCT03000439|524844005|FG002|Double Blind Phase|Insufficient clinical response|0|||
145541513|NCT03000439|524844006|FG003|Double Blind Phase|Insufficient clinical response|2|||
145541514|NCT02370160|524844009|FG000|Overall Study|Death|3|||
145541515|NCT02370160|524844010|FG001|Overall Study|Death|4|||
145541516|NCT02370160|524844011|FG002|Overall Study|Death|1|||
145541517|NCT02501473|524844016|FG000|Overall Study|Study Terminated|2|||
145541518|NCT02501473|524844017|FG001|Overall Study|Study Terminated|3|||
145541519|NCT02501473|524844018|FG002|Overall Study|Study Terminated|7|||
145541520|NCT02501473|524844019|FG003|Overall Study|Study Terminated|9|||
145541521|NCT02501473|524844020|FG004|Overall Study|Study Terminated|2|||
145541522|NCT02501473|524844021|FG005|Overall Study|Study Terminated|10|||
145541523|NCT02501473|524844022|FG006|Overall Study|Study Terminated|1|||
145541524|NCT02501473|524844023|FG007|Overall Study|Study Terminated|0|||
145541525|NCT02501473|524844016|FG000|Overall Study|Withdrawal by Subject|0|||
145541526|NCT02501473|524844017|FG001|Overall Study|Withdrawal by Subject|0|||
145541527|NCT02501473|524844018|FG002|Overall Study|Withdrawal by Subject|3|||
145541528|NCT02501473|524844019|FG003|Overall Study|Withdrawal by Subject|3|||
145541529|NCT02501473|524844020|FG004|Overall Study|Withdrawal by Subject|2|||
145541530|NCT02501473|524844021|FG005|Overall Study|Withdrawal by Subject|2|||
145541531|NCT02501473|524844022|FG006|Overall Study|Withdrawal by Subject|0|||
145541532|NCT02501473|524844023|FG007|Overall Study|Withdrawal by Subject|0|||
145541533|NCT02501473|524844016|FG000|Overall Study|Death|0|||
145541534|NCT02501473|524844017|FG001|Overall Study|Death|0|||
145541535|NCT02501473|524844018|FG002|Overall Study|Death|1|||
145541536|NCT02501473|524844019|FG003|Overall Study|Death|1|||
145541537|NCT02501473|524844020|FG004|Overall Study|Death|0|||
145282064|NCT00219557|523883061|FG000|Phase 1|Withdrawal by Subject|1|||
145282065|NCT00219557|523883062|FG001|Phase 1|Withdrawal by Subject|0|||
145282066|NCT00219557|523883063|FG002|Phase 1|Withdrawal by Subject|0|||
145789856|NCT02052778|525736642|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789857|NCT02052778|525736643|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789858|NCT02052778|525736644|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145282067|NCT00219557|523883061|FG000|Phase 1|Started chemotherapy at other institute|1|||
145541538|NCT02501473|524844021|FG005|Overall Study|Death|1|||
145541539|NCT02501473|524844022|FG006|Overall Study|Death|0|||
145541540|NCT02501473|524844023|FG007|Overall Study|Death|0|||
145541541|NCT02501473|524844016|FG000|Overall Study|Lost to Follow-up|1|||
145541542|NCT02501473|524844017|FG001|Overall Study|Lost to Follow-up|0|||
145541543|NCT02501473|524844018|FG002|Overall Study|Lost to Follow-up|1|||
145541544|NCT02501473|524844019|FG003|Overall Study|Lost to Follow-up|0|||
145541545|NCT02501473|524844020|FG004|Overall Study|Lost to Follow-up|0|||
145541546|NCT02501473|524844021|FG005|Overall Study|Lost to Follow-up|1|||
145541547|NCT02501473|524844022|FG006|Overall Study|Lost to Follow-up|0|||
145541548|NCT02501473|524844023|FG007|Overall Study|Lost to Follow-up|0|||
145541549|NCT02501473|524844016|FG000|Overall Study|Reason not specified|0|||
145541550|NCT02501473|524844017|FG001|Overall Study|Reason not specified|0|||
145541551|NCT02501473|524844018|FG002|Overall Study|Reason not specified|1|||
145541552|NCT02501473|524844019|FG003|Overall Study|Reason not specified|1|||
145541553|NCT02501473|524844020|FG004|Overall Study|Reason not specified|0|||
145541554|NCT02501473|524844021|FG005|Overall Study|Reason not specified|0|||
145541555|NCT02501473|524844022|FG006|Overall Study|Reason not specified|0|||
145541556|NCT02501473|524844023|FG007|Overall Study|Reason not specified|0|||
145541557|NCT01581931|524844024|FG000|Washout|Adverse Event|0|||
145541558|NCT01581931|524844025|FG001|Washout|Adverse Event|1|||
145541559|NCT05275400|524844030|FG000|Treatment Period|Adverse Event|7|||
145541560|NCT05275400|524844031|FG001|Treatment Period|Adverse Event|1|||
145541561|NCT05275400|524844030|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
145541562|NCT05275400|524844031|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
145541563|NCT05275400|524844030|FG000|Treatment Period|Death|5|||
145541564|NCT05275400|524844031|FG001|Treatment Period|Death|2|||
145541565|NCT05275400|524844030|FG000|Treatment Period|Protocol Violation|1|||
145541566|NCT05275400|524844031|FG001|Treatment Period|Protocol Violation|0|||
145541567|NCT05275400|524844030|FG000|Treatment Period|Physician Decision|5|||
145541568|NCT05275400|524844031|FG001|Treatment Period|Physician Decision|4|||
145541569|NCT05275400|524844030|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
145541570|NCT05275400|524844031|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
145541571|NCT05275400|524844030|FG000|Treatment Period|Withdrawal by Subject|30|||
145541572|NCT05275400|524844031|FG001|Treatment Period|Withdrawal by Subject|12|||
145541573|NCT05275400|524844030|FG000|Treatment Period|Lost to Follow-up|1|||
145541574|NCT05275400|524844031|FG001|Treatment Period|Lost to Follow-up|5|||
145541575|NCT05275400|524844030|FG000|Treatment Period|Lack of Efficacy|1|||
145541576|NCT05275400|524844031|FG001|Treatment Period|Lack of Efficacy|0|||
145541577|NCT05275400|524844030|FG000|Treatment Period|Sponsor Decision|1|||
145541578|NCT05275400|524844031|FG001|Treatment Period|Sponsor Decision|0|||
145541579|NCT05275400|524844030|FG000|Follow-Up Period|Death|2|||
145541580|NCT05275400|524844031|FG001|Follow-Up Period|Death|0|||
145541581|NCT05275400|524844030|FG000|Follow-Up Period|Protocol Violation|1|||
145541582|NCT05275400|524844031|FG001|Follow-Up Period|Protocol Violation|0|||
145541583|NCT05275400|524844030|FG000|Follow-Up Period|Withdrawal by Subject|3|||
145541584|NCT05275400|524844031|FG001|Follow-Up Period|Withdrawal by Subject|0|||
145541585|NCT06333613|524844032|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
145541586|NCT05587296|524844036|FG000|Overall Study|Adverse Event|15|||
145541587|NCT05587296|524844037|FG001|Overall Study|Adverse Event|7|||
145541588|NCT05587296|524844036|FG000|Overall Study|Lack of Efficacy|2|||
145541589|NCT05587296|524844037|FG001|Overall Study|Lack of Efficacy|0|||
145541590|NCT05587296|524844036|FG000|Overall Study|Lost to Follow-up|1|||
145541591|NCT05587296|524844037|FG001|Overall Study|Lost to Follow-up|0|||
145541592|NCT05587296|524844036|FG000|Overall Study|Withdrawal by Subject|14|||
145541593|NCT05587296|524844037|FG001|Overall Study|Withdrawal by Subject|4|||
145541594|NCT05587296|524844036|FG000|Overall Study|miscellaneous|3|||
145541595|NCT05587296|524844037|FG001|Overall Study|miscellaneous|6|||
145541596|NCT05587296|524844036|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
145541597|NCT05587296|524844037|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
145541598|NCT03478930|524844039|FG000|Overall Study|Adverse Event|0|||
145541599|NCT03478930|524844040|FG001|Overall Study|Adverse Event|1|||
145541600|NCT03478930|524844039|FG000|Overall Study|Lack of Efficacy|3|||
145541601|NCT03478930|524844040|FG001|Overall Study|Lack of Efficacy|3|||
145541602|NCT03478930|524844039|FG000|Overall Study|Withdrawal by Subject|6|||
145541603|NCT03478930|524844040|FG001|Overall Study|Withdrawal by Subject|5|||
145541604|NCT04189081|524844041|FG000|Overall Study|Lost to Follow-up|1|||
145541605|NCT04189081|524844042|FG001|Overall Study|Lost to Follow-up|0|||
145789859|NCT02052778|525736645|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789860|NCT02052778|525736646|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145541606|NCT04189081|524844043|FG002|Overall Study|Lost to Follow-up|0|||
145541607|NCT04189081|524844041|FG000|Overall Study|Withdrawal by Subject|0|||
145541608|NCT04189081|524844042|FG001|Overall Study|Withdrawal by Subject|0|||
145541609|NCT04189081|524844043|FG002|Overall Study|Withdrawal by Subject|1|||
145541610|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
145541611|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
145541612|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
145541613|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
145541614|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
145541615|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
145541616|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
145541617|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
145541618|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
145541619|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
145541620|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
145541621|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
145541622|NCT00044083|524844044|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
145541623|NCT00044083|524844045|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
145541624|NCT00044083|524844044|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
145541625|NCT00044083|524844045|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
145541626|NCT00044083|524844044|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
145541627|NCT00044083|524844045|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
145541628|NCT00044083|524844044|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
145541629|NCT00044083|524844045|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
145541630|NCT00288054|524844046|FG000|Overall Study|Protocol Violation|2|||
145541631|NCT00288054|524844046|FG000|Overall Study|Lack of Efficacy|16|||
145541632|NCT00288054|524844046|FG000|Overall Study|Adverse Event|3|||
145541633|NCT00288054|524844046|FG000|Overall Study|Withdrawal by Subject|1|||
145541634|NCT00288054|524844046|FG000|Overall Study|Not protocol specified|2|||
145541635|NCT00289991|524844047|FG000|Overall Study|Death|35|||
145541636|NCT00289991|524844048|FG001|Overall Study|Death|38|||
145541637|NCT00289991|524844047|FG000|Overall Study|Adverse Event|15|||
145541638|NCT00289991|524844048|FG001|Overall Study|Adverse Event|13|||
145541639|NCT00289991|524844047|FG000|Overall Study|Failure of prophylaxis|1|||
145541640|NCT00289991|524844048|FG001|Overall Study|Failure of prophylaxis|1|||
145541641|NCT00289991|524844047|FG000|Overall Study|Fungal breakthrough infection|0|||
145541642|NCT00289991|524844048|FG001|Overall Study|Fungal breakthrough infection|1|||
145541643|NCT00289991|524844047|FG000|Overall Study|Lost to Follow-up|0|||
145541644|NCT00289991|524844048|FG001|Overall Study|Lost to Follow-up|1|||
145541645|NCT00289991|524844047|FG000|Overall Study|Withdrawal by Subject|2|||
145541646|NCT00289991|524844048|FG001|Overall Study|Withdrawal by Subject|12|||
145541647|NCT00289991|524844047|FG000|Overall Study|Other|5|||
145541648|NCT00289991|524844048|FG001|Overall Study|Other|14|||
145541649|NCT00851747|524844070|FG000|Overall Study|Physician Decision|6|||
145541650|NCT00851747|524844071|FG001|Overall Study|Physician Decision|6|||
145541651|NCT00851747|524844072|FG002|Overall Study|Physician Decision|6|||
145541652|NCT02340975|524844073|FG000|Overall Study|Death|6|||
145541653|NCT02340975|524844074|FG001|Overall Study|Death|23|||
145541654|NCT02340975|524844075|FG002|Overall Study|Death|21|||
145541655|NCT02340975|524844076|FG003|Overall Study|Death|7|||
145541656|NCT02340975|524844077|FG004|Overall Study|Death|21|||
145541657|NCT02340975|524844078|FG005|Overall Study|Death|13|||
145541658|NCT02340975|524844073|FG000|Overall Study|Lost to Follow-up|0|||
145541659|NCT02340975|524844074|FG001|Overall Study|Lost to Follow-up|0|||
145541660|NCT02340975|524844075|FG002|Overall Study|Lost to Follow-up|0|||
145541661|NCT02340975|524844076|FG003|Overall Study|Lost to Follow-up|0|||
145541662|NCT02340975|524844077|FG004|Overall Study|Lost to Follow-up|2|||
145541663|NCT02340975|524844078|FG005|Overall Study|Lost to Follow-up|0|||
145541664|NCT02340975|524844073|FG000|Overall Study|Withdrawal by Subject|0|||
145541665|NCT02340975|524844074|FG001|Overall Study|Withdrawal by Subject|0|||
145282068|NCT00219557|523883062|FG001|Phase 1|Started chemotherapy at other institute|0|||
145282069|NCT00219557|523883063|FG002|Phase 1|Started chemotherapy at other institute|0|||
145282070|NCT00219557|523883061|FG000|Phase 2|Lack of Efficacy|0|||
145282071|NCT00219557|523883062|FG001|Phase 2|Lack of Efficacy|21|||
145282072|NCT00219557|523883063|FG002|Phase 2|Lack of Efficacy|15|||
145282073|NCT00219557|523883061|FG000|Phase 2|Adverse Event|0|||
145282074|NCT00219557|523883062|FG001|Phase 2|Adverse Event|22|||
145282075|NCT00219557|523883063|FG002|Phase 2|Adverse Event|2|||
145282076|NCT00219557|523883061|FG000|Phase 2|Death|0|||
145282077|NCT00219557|523883062|FG001|Phase 2|Death|8|||
145282078|NCT00219557|523883063|FG002|Phase 2|Death|2|||
145282079|NCT00219557|523883061|FG000|Phase 2|Other|0|||
145282080|NCT00219557|523883062|FG001|Phase 2|Other|8|||
145282081|NCT00219557|523883063|FG002|Phase 2|Other|6|||
145282082|NCT00219557|523883061|FG000|Phase 2|Withdrawal by Subject|0|||
145282083|NCT00219557|523883062|FG001|Phase 2|Withdrawal by Subject|9|||
145282084|NCT00219557|523883063|FG002|Phase 2|Withdrawal by Subject|5|||
145541666|NCT02340975|524844075|FG002|Overall Study|Withdrawal by Subject|3|||
145541667|NCT02340975|524844076|FG003|Overall Study|Withdrawal by Subject|3|||
145282085|NCT00219557|523883061|FG000|Phase 2|Treatment not received|0|||
145282086|NCT00219557|523883062|FG001|Phase 2|Treatment not received|1|||
145404222|NCT01281306|524336529|FG002|Overall Study|Withdrawal by Subject|2|||
145541668|NCT02340975|524844077|FG004|Overall Study|Withdrawal by Subject|2|||
145541669|NCT02340975|524844078|FG005|Overall Study|Withdrawal by Subject|0|||
145541670|NCT02340975|524844073|FG000|Overall Study|Other|0|||
145541671|NCT02340975|524844074|FG001|Overall Study|Other|4|||
145541672|NCT02340975|524844075|FG002|Overall Study|Other|0|||
145541673|NCT02340975|524844076|FG003|Overall Study|Other|2|||
145541674|NCT02340975|524844077|FG004|Overall Study|Other|0|||
145282087|NCT00219557|523883063|FG002|Phase 2|Treatment not received|3|||
145282088|NCT02741271|523883074|FG000|Overall Study|Lost to Follow-up|2|||
145282089|NCT02741271|523883075|FG001|Overall Study|Lost to Follow-up|0|||
145541675|NCT02340975|524844078|FG005|Overall Study|Other|6|||
145541676|NCT01007812|524844081|FG000|Period 1, One Week|Lost to Follow-up|0|||
145541677|NCT01007812|524844082|FG001|Period 1, One Week|Lost to Follow-up|1|||
145404223|NCT01281306|524336530|FG003|Overall Study|Withdrawal by Subject|4|||
145404224|NCT01281306|524336531|FG004|Overall Study|Withdrawal by Subject|1|||
145404225|NCT01281306|524336532|FG005|Overall Study|Withdrawal by Subject|3|||
145404226|NCT01281306|524336533|FG006|Overall Study|Withdrawal by Subject|1|||
145404227|NCT01281306|524336527|FG000|Overall Study|Protocol deviation|0|||
145404228|NCT01281306|524336528|FG001|Overall Study|Protocol deviation|1|||
145404229|NCT01281306|524336529|FG002|Overall Study|Protocol deviation|1|||
145404230|NCT01281306|524336530|FG003|Overall Study|Protocol deviation|1|||
145404231|NCT01281306|524336531|FG004|Overall Study|Protocol deviation|1|||
145404232|NCT01281306|524336532|FG005|Overall Study|Protocol deviation|0|||
145541678|NCT01007812|524844081|FG000|Period 1, One Week|Discomfort|1|||
145541679|NCT01007812|524844082|FG001|Period 1, One Week|Discomfort|0|||
145541680|NCT01091974|524844085|FG000|Overall Study|Did not start intervention|3|||
145541681|NCT01091974|524844086|FG001|Overall Study|Did not start intervention|1|||
145541682|NCT01091974|524844087|FG002|Overall Study|Did not start intervention|3|||
145541683|NCT01091974|524844088|FG003|Overall Study|Did not start intervention|1|||
145541684|NCT01091974|524844085|FG000|Overall Study|resumed sleep medication|0|||
145541685|NCT01091974|524844086|FG001|Overall Study|resumed sleep medication|0|||
145541686|NCT01091974|524844087|FG002|Overall Study|resumed sleep medication|1|||
145541687|NCT01091974|524844088|FG003|Overall Study|resumed sleep medication|2|||
145541688|NCT01091974|524844085|FG000|Overall Study|Withdrawal by Subject|1|||
145541689|NCT01091974|524844086|FG001|Overall Study|Withdrawal by Subject|3|||
145541690|NCT01091974|524844087|FG002|Overall Study|Withdrawal by Subject|2|||
145541691|NCT01091974|524844088|FG003|Overall Study|Withdrawal by Subject|2|||
145541692|NCT01091974|524844085|FG000|Overall Study|side-effects|1|||
145541693|NCT01091974|524844086|FG001|Overall Study|side-effects|1|||
145541694|NCT01091974|524844087|FG002|Overall Study|side-effects|0|||
145541695|NCT01091974|524844088|FG003|Overall Study|side-effects|2|||
145541696|NCT01243892|524844089|FG000|Overall Study|Did not meet eligibility criteria|2|||
145541697|NCT01243892|524844090|FG001|Overall Study|Did not meet eligibility criteria|0|||
145541698|NCT01866293|524844095|FG000|Overall Study|Adverse Event|2|||
145541699|NCT03066804|524844096|FG000|Overall Study|Physician Decision|0|||
145541700|NCT03066804|524844097|FG001|Overall Study|Physician Decision|4|||
145541701|NCT03066804|524844096|FG000|Overall Study|Death|23|||
145541702|NCT03066804|524844097|FG001|Overall Study|Death|17|||
145541703|NCT03066804|524844096|FG000|Overall Study|Withdrawal by Subject|19|||
145541704|NCT03066804|524844097|FG001|Overall Study|Withdrawal by Subject|25|||
145541705|NCT03066804|524844096|FG000|Overall Study|Lost to Follow-up|2|||
145541706|NCT03066804|524844097|FG001|Overall Study|Lost to Follow-up|0|||
145541707|NCT03066804|524844096|FG000|Overall Study|Adverse Event|2|||
145541708|NCT03066804|524844097|FG001|Overall Study|Adverse Event|3|||
145541709|NCT03066804|524844096|FG000|Overall Study|Technical problems|5|||
145541710|NCT03066804|524844097|FG001|Overall Study|Technical problems|1|||
145541711|NCT00555971|524844099|FG000|Overall Study|Adverse Event|1|||
145541712|NCT00555971|524844100|FG001|Overall Study|Adverse Event|1|||
145541713|NCT03982368|524844101|FG000|Overall Study|Adverse Event|6|||
145541714|NCT03982368|524844102|FG001|Overall Study|Adverse Event|4|||
145541715|NCT03982368|524844103|FG002|Overall Study|Adverse Event|3|||
145541716|NCT03982368|524844101|FG000|Overall Study|Lost to Follow-up|2|||
145541717|NCT03982368|524844102|FG001|Overall Study|Lost to Follow-up|1|||
145541718|NCT03982368|524844103|FG002|Overall Study|Lost to Follow-up|0|||
145609962|NCT01111838|525088064|FG000|Overall Study|Clinical deterioration|1|||
145609963|NCT01111838|525088064|FG000|Overall Study|Other Complicating Disease|1|||
145609964|NCT01540565|525088065|FG000|Overall Study|Ineligible|2|||
145609965|NCT02086162|525088067|FG000|Overall Study|Withdrawal by Subject|4|||
145609966|NCT02086162|525088068|FG001|Overall Study|Withdrawal by Subject|4|||
145282090|NCT02741271|523883074|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145282091|NCT02741271|523883075|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145282092|NCT03652961|523883076|FG000|Overall Study|Lost to Follow-up|3|||
145282093|NCT03652961|523883076|FG000|Overall Study|Screen Failure|1|||
145282094|NCT00410410|523883077|FG000|Induction Period (IP)|Death|1|||
145282095|NCT00410410|523883078|FG001|Induction Period (IP)|Death|0|||
145282096|NCT00410410|523883079|FG002|Induction Period (IP)|Death|0|||
145282097|NCT00410410|523883080|FG003|Induction Period (IP)|Death|0|||
145541719|NCT03982368|524844101|FG000|Overall Study|Withdrawal by Subject|1|||
145541720|NCT03982368|524844102|FG001|Overall Study|Withdrawal by Subject|2|||
145541721|NCT03982368|524844103|FG002|Overall Study|Withdrawal by Subject|0|||
145541722|NCT03982368|524844101|FG000|Overall Study|unknow|4|||
145541723|NCT03982368|524844102|FG001|Overall Study|unknow|0|||
145541724|NCT03982368|524844103|FG002|Overall Study|unknow|2|||
145541725|NCT00518284|524844104|FG000|Overall Study|Adverse Event|0|||
145541726|NCT00518284|524844105|FG001|Overall Study|Adverse Event|1|||
145541727|NCT00518284|524844106|FG002|Overall Study|Adverse Event|0|||
145541728|NCT00518284|524844107|FG003|Overall Study|Adverse Event|0|||
145282098|NCT00410410|523883081|FG004|Induction Period (IP)|Death|0|||
145282099|NCT00410410|523883082|FG005|Induction Period (IP)|Death|0|||
145282100|NCT00410410|523883083|FG006|Induction Period (IP)|Death|0|||
145541729|NCT00518284|524844104|FG000|Overall Study|Study Termination|0|||
145541730|NCT00518284|524844105|FG001|Overall Study|Study Termination|2|||
145541731|NCT00518284|524844106|FG002|Overall Study|Study Termination|1|||
145541732|NCT00518284|524844107|FG003|Overall Study|Study Termination|2|||
145541733|NCT03768414|524844108|FG000|Overall Study|Adverse Event or side effects|72|||
145541734|NCT03768414|524844109|FG001|Overall Study|Adverse Event or side effects|28|||
145541735|NCT03768414|524844108|FG000|Overall Study|Refusal unrelated to adverse event|33|||
145541736|NCT03768414|524844109|FG001|Overall Study|Refusal unrelated to adverse event|33|||
145541737|NCT03768414|524844108|FG000|Overall Study|Progression/relapse|132|||
145541738|NCT03768414|524844109|FG001|Overall Study|Progression/relapse|60|||
145541739|NCT03768414|524844108|FG000|Overall Study|Death|9|||
145541740|NCT03768414|524844109|FG001|Overall Study|Death|6|||
145541741|NCT03768414|524844108|FG000|Overall Study|Other - not protocol specified|45|||
145541742|NCT03768414|524844109|FG001|Overall Study|Other - not protocol specified|18|||
145541743|NCT03768414|524844108|FG000|Overall Study|Reason under review|3|||
145541744|NCT03768414|524844109|FG001|Overall Study|Reason under review|2|||
145541745|NCT02571777|524844111|FG000|Overall Study|Subject/guardian decision|34|||
145541746|NCT02571777|524844112|FG001|Overall Study|Subject/guardian decision|26|||
145541747|NCT02571777|524844113|FG002|Overall Study|Subject/guardian decision|26|||
145541748|NCT02571777|524844114|FG003|Overall Study|Subject/guardian decision|25|||
145541749|NCT02571777|524844115|FG004|Overall Study|Subject/guardian decision|27|||
145541750|NCT02571777|524844111|FG000|Overall Study|Protocol Deviation|2|||
145541751|NCT02571777|524844112|FG001|Overall Study|Protocol Deviation|3|||
145541752|NCT02571777|524844113|FG002|Overall Study|Protocol Deviation|4|||
145541753|NCT02571777|524844114|FG003|Overall Study|Protocol Deviation|8|||
145541754|NCT02571777|524844115|FG004|Overall Study|Protocol Deviation|4|||
145541755|NCT02571777|524844111|FG000|Overall Study|Death|1|||
145541756|NCT02571777|524844112|FG001|Overall Study|Death|1|||
145541757|NCT02571777|524844113|FG002|Overall Study|Death|4|||
145541758|NCT02571777|524844114|FG003|Overall Study|Death|0|||
145541759|NCT02571777|524844115|FG004|Overall Study|Death|0|||
145541760|NCT02571777|524844111|FG000|Overall Study|Lost to Follow-up|1|||
145541761|NCT02571777|524844112|FG001|Overall Study|Lost to Follow-up|1|||
145541762|NCT02571777|524844113|FG002|Overall Study|Lost to Follow-up|2|||
145541763|NCT02571777|524844114|FG003|Overall Study|Lost to Follow-up|0|||
145541764|NCT02571777|524844115|FG004|Overall Study|Lost to Follow-up|1|||
145541765|NCT02571777|524844111|FG000|Overall Study|Physician Decision|1|||
145541766|NCT02571777|524844112|FG001|Overall Study|Physician Decision|7|||
145541767|NCT02571777|524844113|FG002|Overall Study|Physician Decision|5|||
145541768|NCT02571777|524844114|FG003|Overall Study|Physician Decision|2|||
145541769|NCT02571777|524844115|FG004|Overall Study|Physician Decision|4|||
145541770|NCT02571777|524844111|FG000|Overall Study|Pregnancy|0|||
145541771|NCT02571777|524844112|FG001|Overall Study|Pregnancy|0|||
145541772|NCT02571777|524844113|FG002|Overall Study|Pregnancy|0|||
145541773|NCT02571777|524844114|FG003|Overall Study|Pregnancy|2|||
145541774|NCT02571777|524844115|FG004|Overall Study|Pregnancy|0|||
145541775|NCT03706079|524844116|FG000|Predecessor Study|Death|0|||
145541776|NCT03706079|524844117|FG001|Predecessor Study|Death|2|||
145541777|NCT03706079|524844118|FG002|Predecessor Study|Death|0|||
145541778|NCT03706079|524844119|FG003|Predecessor Study|Death|1|||
145541779|NCT03706079|524844120|FG004|Predecessor Study|Death|0|||
145541780|NCT03706079|524844121|FG005|Predecessor Study|Death|0|||
145541781|NCT03706079|524844116|FG000|Predecessor Study|Lost to Follow-up|5|||
145541782|NCT03706079|524844117|FG001|Predecessor Study|Lost to Follow-up|2|||
145541783|NCT03706079|524844118|FG002|Predecessor Study|Lost to Follow-up|0|||
145541784|NCT03706079|524844119|FG003|Predecessor Study|Lost to Follow-up|0|||
145541785|NCT03706079|524844120|FG004|Predecessor Study|Lost to Follow-up|1|||
145541786|NCT03706079|524844121|FG005|Predecessor Study|Lost to Follow-up|0|||
145541787|NCT03706079|524844116|FG000|Predecessor Study|Withdrawal by Subject|8|||
145541788|NCT03706079|524844117|FG001|Predecessor Study|Withdrawal by Subject|15|||
145541789|NCT03706079|524844118|FG002|Predecessor Study|Withdrawal by Subject|0|||
145541790|NCT03706079|524844119|FG003|Predecessor Study|Withdrawal by Subject|5|||
145541791|NCT03706079|524844120|FG004|Predecessor Study|Withdrawal by Subject|2|||
145541792|NCT03706079|524844121|FG005|Predecessor Study|Withdrawal by Subject|0|||
145541793|NCT03706079|524844116|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
145541794|NCT03706079|524844117|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
145541795|NCT03706079|524844118|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
145541796|NCT03706079|524844119|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
145541797|NCT03706079|524844120|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
145541798|NCT03706079|524844121|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
145541799|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
145404233|NCT01281306|524336533|FG006|Overall Study|Protocol deviation|0|||
145404234|NCT01281306|524336527|FG000|Overall Study|Condition no longer requires study drug|1|||
145404235|NCT01281306|524336528|FG001|Overall Study|Condition no longer requires study drug|0|||
145404236|NCT01281306|524336529|FG002|Overall Study|Condition no longer requires study drug|0|||
145404237|NCT01281306|524336530|FG003|Overall Study|Condition no longer requires study drug|0|||
145404238|NCT01281306|524336531|FG004|Overall Study|Condition no longer requires study drug|0|||
145404239|NCT01281306|524336532|FG005|Overall Study|Condition no longer requires study drug|1|||
145404240|NCT01281306|524336533|FG006|Overall Study|Condition no longer requires study drug|1|||
145404241|NCT01281306|524336527|FG000|Overall Study|Lost to Follow-up|1|||
145404242|NCT01281306|524336528|FG001|Overall Study|Lost to Follow-up|0|||
145404243|NCT01281306|524336529|FG002|Overall Study|Lost to Follow-up|0|||
145404244|NCT01281306|524336530|FG003|Overall Study|Lost to Follow-up|2|||
145404245|NCT01281306|524336531|FG004|Overall Study|Lost to Follow-up|0|||
145404246|NCT01281306|524336532|FG005|Overall Study|Lost to Follow-up|0|||
145404247|NCT01281306|524336533|FG006|Overall Study|Lost to Follow-up|1|||
145404248|NCT01281306|524336527|FG000|Overall Study|Death|1|||
145404249|NCT01281306|524336528|FG001|Overall Study|Death|0|||
145404250|NCT01281306|524336529|FG002|Overall Study|Death|0|||
145404251|NCT01281306|524336530|FG003|Overall Study|Death|0|||
145404252|NCT01281306|524336531|FG004|Overall Study|Death|0|||
145404253|NCT01281306|524336532|FG005|Overall Study|Death|0|||
145404254|NCT01281306|524336533|FG006|Overall Study|Death|0|||
145404255|NCT01281306|524336527|FG000|Overall Study|Adverse Event|3|||
145404256|NCT01281306|524336528|FG001|Overall Study|Adverse Event|2|||
145404257|NCT01281306|524336529|FG002|Overall Study|Adverse Event|2|||
145404258|NCT01281306|524336530|FG003|Overall Study|Adverse Event|3|||
145404259|NCT01281306|524336531|FG004|Overall Study|Adverse Event|5|||
145404260|NCT01281306|524336532|FG005|Overall Study|Adverse Event|3|||
145404261|NCT01281306|524336533|FG006|Overall Study|Adverse Event|3|||
145404262|NCT01281306|524336527|FG000|Overall Study|Randomized in error|1|||
145404263|NCT01281306|524336528|FG001|Overall Study|Randomized in error|0|||
145404264|NCT01281306|524336529|FG002|Overall Study|Randomized in error|0|||
145404265|NCT01281306|524336530|FG003|Overall Study|Randomized in error|1|||
145404266|NCT01281306|524336531|FG004|Overall Study|Randomized in error|0|||
145404267|NCT01281306|524336532|FG005|Overall Study|Randomized in error|0|||
145404268|NCT01281306|524336533|FG006|Overall Study|Randomized in error|0|||
145282101|NCT00410410|523883084|FG007|Induction Period (IP)|Death|0|||
145282102|NCT00410410|523883085|FG008|Induction Period (IP)|Death|0|||
145282103|NCT00410410|523883077|FG000|Induction Period (IP)|Adverse Event|3|||
145282104|NCT00410410|523883078|FG001|Induction Period (IP)|Adverse Event|4|||
145282105|NCT00410410|523883079|FG002|Induction Period (IP)|Adverse Event|2|||
145282106|NCT00410410|523883080|FG003|Induction Period (IP)|Adverse Event|4|||
145282107|NCT00410410|523883081|FG004|Induction Period (IP)|Adverse Event|1|||
145282108|NCT00410410|523883082|FG005|Induction Period (IP)|Adverse Event|0|||
145282109|NCT00410410|523883083|FG006|Induction Period (IP)|Adverse Event|0|||
145282110|NCT00410410|523883084|FG007|Induction Period (IP)|Adverse Event|0|||
145282111|NCT00410410|523883085|FG008|Induction Period (IP)|Adverse Event|0|||
145282112|NCT00410410|523883077|FG000|Induction Period (IP)|Lack of Efficacy|26|||
145282113|NCT00410410|523883078|FG001|Induction Period (IP)|Lack of Efficacy|24|||
145282114|NCT00410410|523883079|FG002|Induction Period (IP)|Lack of Efficacy|8|||
145282115|NCT00410410|523883080|FG003|Induction Period (IP)|Lack of Efficacy|8|||
145282116|NCT00410410|523883081|FG004|Induction Period (IP)|Lack of Efficacy|7|||
145282117|NCT00410410|523883082|FG005|Induction Period (IP)|Lack of Efficacy|7|||
145282118|NCT00410410|523883083|FG006|Induction Period (IP)|Lack of Efficacy|0|||
145282119|NCT00410410|523883084|FG007|Induction Period (IP)|Lack of Efficacy|0|||
145404269|NCT03185208|524336534|FG000|Overall Study|Did not start study medication|0|||
145541800|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
145541801|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
145541802|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
145541803|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
145541804|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
145541805|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
145282120|NCT00410410|523883085|FG008|Induction Period (IP)|Lack of Efficacy|0|||
145282121|NCT00410410|523883077|FG000|Induction Period (IP)|Lost to Follow-up|2|||
145404270|NCT03185208|524336535|FG001|Overall Study|Did not start study medication|3|||
145282122|NCT00410410|523883078|FG001|Induction Period (IP)|Lost to Follow-up|2|||
145541806|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
145541807|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
145282123|NCT00410410|523883079|FG002|Induction Period (IP)|Lost to Follow-up|2|||
145282124|NCT00410410|523883080|FG003|Induction Period (IP)|Lost to Follow-up|3|||
145404271|NCT03834350|524336536|FG000|Overall Study|Withdrawal by Subject|1|||
145404272|NCT02701634|524336537|FG000|Overall Study|Adverse Event|2|||
145404273|NCT02701634|524336538|FG001|Overall Study|Adverse Event|3|||
145404274|NCT02701634|524336537|FG000|Overall Study|Death|1|||
145404275|NCT02701634|524336538|FG001|Overall Study|Death|0|||
145541808|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
145541809|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
145541810|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
145541811|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
145541812|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
145541813|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
145541814|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
145541815|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
145541816|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
145541817|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
145541818|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
145541819|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
145541820|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
145541821|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
145541822|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
145541823|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
145541824|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
145541825|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
145541826|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
145541827|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
145541828|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
145541829|NCT03706079|524844116|FG000|Long Term Extension (DESTINATION)|Death|8|||
145541830|NCT03706079|524844117|FG001|Long Term Extension (DESTINATION)|Death|2|||
145541831|NCT03706079|524844118|FG002|Long Term Extension (DESTINATION)|Death|2|||
145541832|NCT03706079|524844119|FG003|Long Term Extension (DESTINATION)|Death|1|||
145541833|NCT03706079|524844120|FG004|Long Term Extension (DESTINATION)|Death|0|||
145541834|NCT03706079|524844121|FG005|Long Term Extension (DESTINATION)|Death|0|||
145541835|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
145541836|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
145541837|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
145541838|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
145541839|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
145541840|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
145541841|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
145541842|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
145541843|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
145541844|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
145541845|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
145541846|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
145541847|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
145282125|NCT00410410|523883081|FG004|Induction Period (IP)|Lost to Follow-up|0|||
145282126|NCT00410410|523883082|FG005|Induction Period (IP)|Lost to Follow-up|1|||
145282127|NCT00410410|523883083|FG006|Induction Period (IP)|Lost to Follow-up|0|||
145282128|NCT00410410|523883084|FG007|Induction Period (IP)|Lost to Follow-up|0|||
145282129|NCT00410410|523883085|FG008|Induction Period (IP)|Lost to Follow-up|0|||
145282130|NCT00410410|523883077|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
145282131|NCT00410410|523883078|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
145282132|NCT00410410|523883079|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
145282133|NCT00410410|523883080|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
145282134|NCT00410410|523883081|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
145282135|NCT00410410|523883082|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
145282136|NCT00410410|523883083|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
145282137|NCT00410410|523883084|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
145282138|NCT00410410|523883085|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
145282139|NCT00410410|523883077|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145282140|NCT00410410|523883078|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145282141|NCT00410410|523883079|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
145282142|NCT00410410|523883080|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145282143|NCT00410410|523883081|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145541848|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
145282144|NCT00410410|523883082|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145541849|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
145282145|NCT00410410|523883083|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145282146|NCT00410410|523883084|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145282147|NCT00410410|523883085|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
145541850|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
145541851|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
145282148|NCT00410410|523883077|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282149|NCT00410410|523883078|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282150|NCT00410410|523883079|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282151|NCT00410410|523883080|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282152|NCT00410410|523883081|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
145282153|NCT00410410|523883082|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
145282154|NCT00410410|523883083|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282155|NCT00410410|523883084|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282156|NCT00410410|523883085|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
145282157|NCT00410410|523883077|FG000|Induction Period (IP)|Other|0|||
145282158|NCT00410410|523883078|FG001|Induction Period (IP)|Other|0|||
145282159|NCT00410410|523883079|FG002|Induction Period (IP)|Other|1|||
145282160|NCT00410410|523883080|FG003|Induction Period (IP)|Other|0|||
145282161|NCT00410410|523883081|FG004|Induction Period (IP)|Other|0|||
145282162|NCT00410410|523883082|FG005|Induction Period (IP)|Other|0|||
145282163|NCT00410410|523883083|FG006|Induction Period (IP)|Other|0|||
145282164|NCT00410410|523883084|FG007|Induction Period (IP)|Other|0|||
145282165|NCT00410410|523883085|FG008|Induction Period (IP)|Other|0|||
145282166|NCT00410410|523883077|FG000|Maintenance Period (MP)|Death|0|||
145282167|NCT00410410|523883078|FG001|Maintenance Period (MP)|Death|0|||
145282168|NCT00410410|523883079|FG002|Maintenance Period (MP)|Death|0|||
145282169|NCT00410410|523883080|FG003|Maintenance Period (MP)|Death|0|||
145282170|NCT00410410|523883081|FG004|Maintenance Period (MP)|Death|0|||
145282171|NCT00410410|523883082|FG005|Maintenance Period (MP)|Death|0|||
145282172|NCT00410410|523883083|FG006|Maintenance Period (MP)|Death|1|||
145282173|NCT00410410|523883084|FG007|Maintenance Period (MP)|Death|0|||
145282174|NCT00410410|523883085|FG008|Maintenance Period (MP)|Death|0|||
145282175|NCT00410410|523883077|FG000|Maintenance Period (MP)|Adverse Event|0|||
145282176|NCT00410410|523883078|FG001|Maintenance Period (MP)|Adverse Event|0|||
145282177|NCT00410410|523883079|FG002|Maintenance Period (MP)|Adverse Event|0|||
145282178|NCT00410410|523883080|FG003|Maintenance Period (MP)|Adverse Event|0|||
145282179|NCT00410410|523883081|FG004|Maintenance Period (MP)|Adverse Event|0|||
145282180|NCT00410410|523883082|FG005|Maintenance Period (MP)|Adverse Event|0|||
145282181|NCT00410410|523883083|FG006|Maintenance Period (MP)|Adverse Event|1|||
145282182|NCT00410410|523883084|FG007|Maintenance Period (MP)|Adverse Event|3|||
145282183|NCT00410410|523883085|FG008|Maintenance Period (MP)|Adverse Event|0|||
145282184|NCT00410410|523883077|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
145282185|NCT00410410|523883078|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
145282186|NCT00410410|523883079|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
145282187|NCT00410410|523883080|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
145282188|NCT00410410|523883081|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
145282189|NCT00410410|523883082|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
145282190|NCT00410410|523883083|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
145282191|NCT00410410|523883084|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
145282192|NCT00410410|523883085|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
145282193|NCT00410410|523883077|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
145282194|NCT00410410|523883078|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
145282195|NCT00410410|523883079|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
145282196|NCT00410410|523883080|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
145282197|NCT00410410|523883081|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
145282198|NCT00410410|523883082|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
145282199|NCT00410410|523883083|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
145282200|NCT00410410|523883084|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
145282201|NCT00410410|523883085|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
145282202|NCT00410410|523883077|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282203|NCT00410410|523883078|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282204|NCT00410410|523883079|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282205|NCT00410410|523883080|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282206|NCT00410410|523883081|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282207|NCT00410410|523883082|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
145541852|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
145282208|NCT00410410|523883083|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
145282209|NCT00410410|523883084|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
145282210|NCT00410410|523883085|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
145282211|NCT00410410|523883077|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282212|NCT00410410|523883078|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282213|NCT00410410|523883079|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145541853|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
145282214|NCT00410410|523883080|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282215|NCT00410410|523883081|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282216|NCT00410410|523883082|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282217|NCT00410410|523883083|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
145282218|NCT00410410|523883084|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
145541854|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
145282219|NCT00410410|523883085|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
145282220|NCT00410410|523883077|FG000|Open-Label Period (OL)|Death|0|||
145282221|NCT00410410|523883078|FG001|Open-Label Period (OL)|Death|0|||
145282222|NCT00410410|523883079|FG002|Open-Label Period (OL)|Death|0|||
145282223|NCT00410410|523883080|FG003|Open-Label Period (OL)|Death|0|||
145282224|NCT00410410|523883081|FG004|Open-Label Period (OL)|Death|0|||
145282225|NCT00410410|523883082|FG005|Open-Label Period (OL)|Death|0|||
145282226|NCT00410410|523883083|FG006|Open-Label Period (OL)|Death|0|||
145282227|NCT00410410|523883084|FG007|Open-Label Period (OL)|Death|0|||
145282228|NCT00410410|523883085|FG008|Open-Label Period (OL)|Death|1|||
145282229|NCT00410410|523883077|FG000|Open-Label Period (OL)|Adverse Event|0|||
145282230|NCT00410410|523883078|FG001|Open-Label Period (OL)|Adverse Event|0|||
145282231|NCT00410410|523883079|FG002|Open-Label Period (OL)|Adverse Event|0|||
145282232|NCT00410410|523883080|FG003|Open-Label Period (OL)|Adverse Event|0|||
145282233|NCT00410410|523883081|FG004|Open-Label Period (OL)|Adverse Event|0|||
145282234|NCT00410410|523883082|FG005|Open-Label Period (OL)|Adverse Event|0|||
145282235|NCT00410410|523883083|FG006|Open-Label Period (OL)|Adverse Event|0|||
145282236|NCT00410410|523883084|FG007|Open-Label Period (OL)|Adverse Event|0|||
145282237|NCT00410410|523883085|FG008|Open-Label Period (OL)|Adverse Event|10|||
145282238|NCT00410410|523883077|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
145282239|NCT00410410|523883078|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
145541855|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
145541856|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
145282240|NCT00410410|523883079|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
145282241|NCT00410410|523883080|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
145282242|NCT00410410|523883081|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
145282243|NCT00410410|523883082|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
145282244|NCT00410410|523883083|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
145282245|NCT00410410|523883084|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
145282246|NCT00410410|523883085|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
145282247|NCT00410410|523883077|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
145282248|NCT00410410|523883078|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
145282249|NCT00410410|523883079|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
145282250|NCT00410410|523883080|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
145282251|NCT00410410|523883081|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
145282252|NCT00410410|523883082|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
145282253|NCT00410410|523883083|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
145282254|NCT00410410|523883084|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
145282255|NCT00410410|523883085|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
145282256|NCT00410410|523883077|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282257|NCT00410410|523883078|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282258|NCT00410410|523883079|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282259|NCT00410410|523883080|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282260|NCT00410410|523883081|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282261|NCT00410410|523883082|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282262|NCT00410410|523883083|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282263|NCT00410410|523883084|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
145282264|NCT00410410|523883085|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
145282265|NCT00410410|523883077|FG000|Open-Label Period (OL)|Pregnancy|0|||
145282266|NCT00410410|523883078|FG001|Open-Label Period (OL)|Pregnancy|0|||
145282267|NCT00410410|523883079|FG002|Open-Label Period (OL)|Pregnancy|0|||
145282268|NCT00410410|523883080|FG003|Open-Label Period (OL)|Pregnancy|0|||
145282269|NCT00410410|523883081|FG004|Open-Label Period (OL)|Pregnancy|0|||
145282270|NCT00410410|523883082|FG005|Open-Label Period (OL)|Pregnancy|0|||
145282271|NCT00410410|523883083|FG006|Open-Label Period (OL)|Pregnancy|0|||
145282272|NCT00410410|523883084|FG007|Open-Label Period (OL)|Pregnancy|0|||
145282273|NCT00410410|523883085|FG008|Open-Label Period (OL)|Pregnancy|1|||
145404276|NCT02701634|524336537|FG000|Overall Study|Investigator's Discretion|7|||
145541857|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
145541858|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
145541859|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
145282274|NCT00410410|523883077|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145404277|NCT02701634|524336538|FG001|Overall Study|Investigator's Discretion|4|||
145282275|NCT00410410|523883078|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282276|NCT00410410|523883079|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282277|NCT00410410|523883080|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282278|NCT00410410|523883081|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282279|NCT00410410|523883082|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282280|NCT00410410|523883083|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282281|NCT00410410|523883084|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
145282282|NCT00410410|523883085|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
145282283|NCT00410410|523883077|FG000|Open-Label Period (OL)|Other|0|||
145282284|NCT00410410|523883078|FG001|Open-Label Period (OL)|Other|0|||
145541860|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
145541861|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
145541862|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
145541863|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
145541864|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
145541865|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
145541866|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
145541867|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
145541868|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
145541869|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
145541870|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
145541871|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
145541872|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
145541873|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
145541874|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
145541875|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
145541876|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
145541877|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
145541878|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
145541879|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
145541880|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
145541881|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
145541882|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
145541883|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
145541884|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
145541885|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
145541886|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
145541887|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
145541888|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
145541889|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
145541890|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
145541891|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
145541892|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
145541893|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
145541894|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
145541895|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
145541896|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
145541897|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
145541898|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
145541899|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
145541900|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
145541901|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
145541902|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
145541903|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
145541904|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
145541905|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Change of location|0|||
145541906|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Change of location|0|||
145541907|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Change of location|0|||
145541908|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Change of location|1|||
145541909|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Change of location|0|||
145541910|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
145541911|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
145541912|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
145541913|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
145541914|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
145541915|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
145541916|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
145541917|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
145541918|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
145541919|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
145609967|NCT02086162|525088067|FG000|Overall Study|moved|1|||
145789861|NCT02052778|525736647|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789862|NCT02052778|525736648|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789863|NCT02052778|525736649|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789864|NCT02052778|525736650|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789865|NCT02052778|525736651|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789866|NCT02052778|525736652|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789867|NCT02052778|525736653|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789868|NCT02052778|525736654|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789869|NCT02052778|525736655|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145541920|NCT00730405|524844124|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
145541921|NCT00730405|524844125|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
145541922|NCT00730405|524844126|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
145541923|NCT00730405|524844127|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
145541924|NCT00730405|524844128|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
145541925|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
145541926|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
145541927|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
145541928|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
145541929|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
145541930|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
145541931|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
145541932|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
145541933|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
145541934|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
145541935|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
145541936|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
145541937|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
145541938|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
145541939|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
145541940|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Death|0|||
145541941|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Death|1|||
145541942|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Death|0|||
145541943|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Death|1|||
145541944|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Death|0|||
145541945|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Change of location|1|||
145541946|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Change of location|1|||
145541947|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Change of location|0|||
145541948|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Change of location|1|||
145541949|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Change of location|0|||
145541950|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
145541951|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
145541952|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
145541953|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
145541954|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
145541955|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
145541956|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
145541957|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
145541958|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
145541959|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
145541960|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
145541961|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
145541962|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
145541963|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
145541964|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
145541965|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
145541966|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
145541967|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
145541968|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
145541969|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
145541970|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
145541971|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
145541972|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
145541973|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
145541974|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
145541975|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
145541976|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
145541977|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
145609968|NCT02086162|525088068|FG001|Overall Study|moved|1|||
145404278|NCT02701634|524336537|FG000|Overall Study|Study terminated by Sponsor|15|||
145404279|NCT02701634|524336538|FG001|Overall Study|Study terminated by Sponsor|17|||
145404280|NCT02701634|524336537|FG000|Overall Study|Withdrew Consent|6|||
145404281|NCT02701634|524336538|FG001|Overall Study|Withdrew Consent|7|||
145404282|NCT02701634|524336537|FG000|Overall Study|Randomized but not treated|1|||
145404283|NCT02701634|524336538|FG001|Overall Study|Randomized but not treated|0|||
145404284|NCT00961415|524336543|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
145404285|NCT00961415|524336544|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
145541978|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
145541979|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
145541980|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
145541981|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
145541982|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
145541983|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
145541984|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
145541985|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
145541986|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
145541987|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
145541988|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
145541989|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
145541990|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
145541991|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
145541992|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
145541993|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
145541994|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
145541995|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
145541996|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
145541997|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
145541998|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
145541999|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
145542000|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Missing|0|||
145542001|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Missing|0|||
145542002|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Missing|2|||
145542003|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Missing|0|||
145542004|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Missing|0|||
145542005|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
145542006|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
145542007|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
145542008|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
145542009|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
145542010|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
145542011|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
145542012|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
145542013|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
145542014|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
145542015|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
145542016|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
145542017|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
145542018|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
145542019|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
145542020|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
145542021|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
145542022|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
145542023|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
145542024|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
145542025|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
145542026|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
145542027|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
145542028|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
145542029|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
145542030|NCT00730405|524844124|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
145789870|NCT02052778|525736656|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
145789871|NCT02052778|525736657|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
145404286|NCT00961415|524336545|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
145404287|NCT00961415|524336543|FG000|Induction Treatment Phase|Death|77|||
145404288|NCT00961415|524336544|FG001|Induction Treatment Phase|Death|0|||
145404289|NCT00961415|524336545|FG002|Induction Treatment Phase|Death|0|||
145404290|NCT00961415|524336543|FG000|Induction Treatment Phase|Protocol Violation|1|||
145404291|NCT00961415|524336544|FG001|Induction Treatment Phase|Protocol Violation|0|||
145404292|NCT00961415|524336545|FG002|Induction Treatment Phase|Protocol Violation|0|||
145404293|NCT00961415|524336543|FG000|Induction Treatment Phase|Physician Decision|2|||
145404294|NCT00961415|524336544|FG001|Induction Treatment Phase|Physician Decision|0|||
145404295|NCT00961415|524336545|FG002|Induction Treatment Phase|Physician Decision|0|||
145404296|NCT00961415|524336543|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
145404297|NCT00961415|524336544|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
145404298|NCT00961415|524336545|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
145404299|NCT00961415|524336543|FG000|Induction Treatment Phase|Other Reason|5|||
145404300|NCT00961415|524336544|FG001|Induction Treatment Phase|Other Reason|0|||
145404301|NCT00961415|524336545|FG002|Induction Treatment Phase|Other Reason|0|||
145404302|NCT00961415|524336543|FG000|Maintenance Treatment Phase|Death|0|||
145404303|NCT00961415|524336544|FG001|Maintenance Treatment Phase|Death|42|||
145404304|NCT00961415|524336545|FG002|Maintenance Treatment Phase|Death|34|||
145404305|NCT00961415|524336543|FG000|Maintenance Treatment Phase|Investigators decision|0|||
145542031|NCT00730405|524844125|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
145542032|NCT00730405|524844126|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
145542033|NCT00730405|524844127|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
145542034|NCT00730405|524844128|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
145542035|NCT01496807|524844132|FG000|Overall Study|Progressive Disease|21|||
145542036|NCT01496807|524844132|FG000|Overall Study|Participant preference/toxicity|8|||
145542037|NCT01496807|524844132|FG000|Overall Study|Change in diagnosis|1|||
145542038|NCT00963937|524844138|FG000|Overall Study|Protocol Violation|1|||
145542039|NCT00963937|524844139|FG001|Overall Study|Protocol Violation|1|||
145542040|NCT00963937|524844140|FG002|Overall Study|Protocol Violation|0|||
145542041|NCT00963937|524844138|FG000|Overall Study|Physician Decision|18|||
145542042|NCT00963937|524844139|FG001|Overall Study|Physician Decision|10|||
145542043|NCT00963937|524844140|FG002|Overall Study|Physician Decision|4|||
145542044|NCT02197520|524844141|FG000|Period 1|Withdrawal by Subject|1|||
145542045|NCT02197520|524844142|FG001|Period 1|Withdrawal by Subject|0|||
145542046|NCT02197520|524844141|FG000|Period 2|Adverse Event|0|||
145542047|NCT02197520|524844142|FG001|Period 2|Adverse Event|2|||
145542048|NCT02197520|524844141|FG000|Period 2|Withdrawal by Subject|1|||
145542049|NCT02197520|524844142|FG001|Period 2|Withdrawal by Subject|0|||
145542050|NCT00913497|524844143|FG000|Overall Study|Adverse Event|1|||
145542051|NCT00913497|524844143|FG000|Overall Study|Withdrawal by Subject|2|||
145542052|NCT03087643|524844148|FG000|Overall Study|Withdrawal by Subject|2|||
145542053|NCT03087643|524844149|FG001|Overall Study|Withdrawal by Subject|4|||
145542054|NCT03087643|524844148|FG000|Overall Study|Death|2|||
145542055|NCT03087643|524844149|FG001|Overall Study|Death|2|||
145542056|NCT01427972|524844150|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542057|NCT01427972|524844151|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542058|NCT01427972|524844152|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542059|NCT01427972|524844153|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542060|NCT01427972|524844154|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542061|NCT01427972|524844155|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542062|NCT01427972|524844156|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542063|NCT01427972|524844157|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
145542064|NCT01427972|524844158|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542065|NCT01427972|524844159|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542066|NCT01427972|524844160|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542067|NCT01427972|524844161|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
145542068|NCT01427972|524844150|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542069|NCT01427972|524844151|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542070|NCT01427972|524844152|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542071|NCT01427972|524844153|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542072|NCT01427972|524844154|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542073|NCT01427972|524844155|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
145542074|NCT01427972|524844156|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542075|NCT01427972|524844157|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542076|NCT01427972|524844158|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542077|NCT01427972|524844159|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145542078|NCT01427972|524844160|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145789872|NCT02052778|525736658|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
145542079|NCT01427972|524844161|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
145789873|NCT02052778|525736659|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789874|NCT02052778|525736660|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
145282285|NCT00410410|523883079|FG002|Open-Label Period (OL)|Other|0|||
145404306|NCT00961415|524336544|FG001|Maintenance Treatment Phase|Investigators decision|2|||
145542080|NCT01427972|524844150|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542081|NCT01427972|524844151|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
145542082|NCT01427972|524844152|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542083|NCT01427972|524844153|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542084|NCT01427972|524844154|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542085|NCT01427972|524844155|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542086|NCT01427972|524844156|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542087|NCT01427972|524844157|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542088|NCT01427972|524844158|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542089|NCT01427972|524844159|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542090|NCT01427972|524844160|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542091|NCT01427972|524844161|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
145542092|NCT00530946|524844163|FG000|Overall Study|Adverse Event|1|||
145542093|NCT00530946|524844164|FG001|Overall Study|Adverse Event|2|||
145542094|NCT00530946|524844165|FG002|Overall Study|Adverse Event|1|||
145542095|NCT00530946|524844166|FG003|Overall Study|Adverse Event|1|||
145542096|NCT00530946|524844163|FG000|Overall Study|Protocol Violation|0|||
145542097|NCT00530946|524844164|FG001|Overall Study|Protocol Violation|0|||
145542098|NCT00530946|524844165|FG002|Overall Study|Protocol Violation|0|||
145542099|NCT00530946|524844166|FG003|Overall Study|Protocol Violation|1|||
145542100|NCT00530946|524844163|FG000|Overall Study|Noncompliance|1|||
145542101|NCT00530946|524844164|FG001|Overall Study|Noncompliance|0|||
145542102|NCT00530946|524844165|FG002|Overall Study|Noncompliance|0|||
145542103|NCT00530946|524844166|FG003|Overall Study|Noncompliance|0|||
145542104|NCT02243696|524844167|FG000|Overall Study|Death|282|||
145542105|NCT02243696|524844167|FG000|Overall Study|Withdrawal by Subject|79|||
145542106|NCT02243696|524844167|FG000|Overall Study|Lost to Follow-up|57|||
145542107|NCT02243696|524844167|FG000|Overall Study|Subject No Longer has Study System|42|||
145542108|NCT02243696|524844167|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
145789875|NCT02052778|525736661|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789876|NCT02052778|525736662|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789877|NCT02052778|525736663|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789878|NCT02052778|525736664|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
145789879|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789880|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789881|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789882|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789883|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789884|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789885|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789886|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789887|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789888|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789889|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789890|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789891|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789892|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789893|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789894|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789895|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789896|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145542109|NCT02243696|524844167|FG000|Overall Study|Study Terminated for EP PASSION|961|||
145542110|NCT01534962|524844168|FG000|Overall Study|Randomized but did not start treatment|2|||
145542111|NCT01534962|524844169|FG001|Overall Study|Randomized but did not start treatment|0|||
145542112|NCT01534962|524844170|FG002|Overall Study|Randomized but did not start treatment|0|||
145542113|NCT01534962|524844171|FG003|Overall Study|Randomized but did not start treatment|1|||
145542114|NCT01534962|524844168|FG000|Overall Study|Discontinued at AF recurrence|35|||
145542115|NCT01534962|524844169|FG001|Overall Study|Discontinued at AF recurrence|26|||
145542116|NCT01534962|524844170|FG002|Overall Study|Discontinued at AF recurrence|24|||
145542117|NCT01534962|524844171|FG003|Overall Study|Discontinued at AF recurrence|31|||
145542118|NCT00457301|524844172|FG000|Overall Study|Withdrawal by Subject|3|||
145542119|NCT00457301|524844173|FG001|Overall Study|Withdrawal by Subject|3|||
145542120|NCT00457301|524844172|FG000|Overall Study|Censored out of the study|15|||
145789897|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789898|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789899|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145282286|NCT00410410|523883080|FG003|Open-Label Period (OL)|Other|0|||
145282287|NCT00410410|523883081|FG004|Open-Label Period (OL)|Other|0|||
145282288|NCT00410410|523883082|FG005|Open-Label Period (OL)|Other|0|||
145282289|NCT00410410|523883083|FG006|Open-Label Period (OL)|Other|0|||
145282290|NCT00410410|523883084|FG007|Open-Label Period (OL)|Other|0|||
145542121|NCT00457301|524844173|FG001|Overall Study|Censored out of the study|14|||
145542122|NCT00457301|524844172|FG000|Overall Study|Death|5|||
145542123|NCT00457301|524844173|FG001|Overall Study|Death|7|||
145542124|NCT05399641|524844176|FG000|Overall Study|Adverse Event|0|||
145542125|NCT05399641|524844177|FG001|Overall Study|Adverse Event|1|||
145542126|NCT05399641|524844178|FG002|Overall Study|Adverse Event|1|||
145542127|NCT05399641|524844176|FG000|Overall Study|Lost to Follow-up|1|||
145542128|NCT05399641|524844177|FG001|Overall Study|Lost to Follow-up|2|||
145542129|NCT05399641|524844178|FG002|Overall Study|Lost to Follow-up|2|||
145542130|NCT05399641|524844176|FG000|Overall Study|Physician Decision|1|||
145542131|NCT05399641|524844177|FG001|Overall Study|Physician Decision|3|||
145542132|NCT05399641|524844178|FG002|Overall Study|Physician Decision|3|||
145542133|NCT05399641|524844176|FG000|Overall Study|Withdrawal by Subject|4|||
145542134|NCT05399641|524844177|FG001|Overall Study|Withdrawal by Subject|11|||
145542135|NCT05399641|524844178|FG002|Overall Study|Withdrawal by Subject|7|||
145542136|NCT05399641|524844176|FG000|Overall Study|Reason not defined|3|||
145542137|NCT05399641|524844177|FG001|Overall Study|Reason not defined|5|||
145542138|NCT05399641|524844178|FG002|Overall Study|Reason not defined|6|||
145542139|NCT03408483|524844179|FG000|Overall Study|Physician Decision|3|||
145542140|NCT03408483|524844180|FG001|Overall Study|Physician Decision|3|||
145542141|NCT03408483|524844179|FG000|Overall Study|Lost to Follow-up|3|||
145542142|NCT03408483|524844180|FG001|Overall Study|Lost to Follow-up|0|||
145542143|NCT02094677|524844181|FG000|Overall Study|Screening|3|||
145542144|NCT02094677|524844182|FG001|Overall Study|Screening|1|||
145542145|NCT00478231|524844183|FG000|Overall Study|Death|7|||
145542146|NCT00478231|524844183|FG000|Overall Study|Lack of Efficacy|47|||
145542147|NCT00478231|524844183|FG000|Overall Study|Lost to Follow-up|7|||
145542148|NCT00478231|524844183|FG000|Overall Study|Withdrawal by Subject|6|||
145542149|NCT00478231|524844183|FG000|Overall Study|Other|9|||
145542150|NCT00478231|524844183|FG000|Overall Study|Adverse Event|5|||
145542151|NCT00478231|524844183|FG000|Overall Study|Randomized, not treated|3|||
145542152|NCT01300650|524844184|FG000|Overall Study|Adverse Event|1|||
145542153|NCT01702961|524844185|FG000|Overall Study|Additional treatment|3|||
145542154|NCT01702961|524844185|FG000|Overall Study|Progressive disease|5|||
145542155|NCT01702961|524844185|FG000|Overall Study|Relapse|20|||
145542156|NCT01702961|524844185|FG000|Overall Study|Death|6|||
145542157|NCT01702961|524844185|FG000|Overall Study|Lost to Follow-up|2|||
145542158|NCT01702961|524844185|FG000|Overall Study|Ongoing|11|||
145542159|NCT00923156|524844188|FG000|Overall Study|Adverse Event|0|||
145542160|NCT00923156|524844189|FG001|Overall Study|Adverse Event|2|||
145542161|NCT00923156|524844190|FG002|Overall Study|Adverse Event|1|||
145542162|NCT00923156|524844188|FG000|Overall Study|Abnormal laboratory values|0|||
145542163|NCT00923156|524844189|FG001|Overall Study|Abnormal laboratory values|0|||
145542164|NCT00923156|524844190|FG002|Overall Study|Abnormal laboratory values|1|||
145542165|NCT00923156|524844188|FG000|Overall Study|Withdrawal by Subject|0|||
145542166|NCT00923156|524844189|FG001|Overall Study|Withdrawal by Subject|1|||
145542167|NCT00923156|524844190|FG002|Overall Study|Withdrawal by Subject|0|||
145542168|NCT00923156|524844188|FG000|Overall Study|Death|0|||
145542169|NCT00923156|524844189|FG001|Overall Study|Death|1|||
145542170|NCT00923156|524844190|FG002|Overall Study|Death|0|||
145542171|NCT00923156|524844188|FG000|Overall Study|Lack of Efficacy|0|||
145542172|NCT00923156|524844189|FG001|Overall Study|Lack of Efficacy|0|||
145542173|NCT00923156|524844190|FG002|Overall Study|Lack of Efficacy|1|||
145542174|NCT03386448|524844191|FG000|Overall Study|Adverse Event|0|||
145542175|NCT03386448|524844192|FG001|Overall Study|Adverse Event|2|||
145542176|NCT03338010|524844193|FG000|Overall Study|Withdrawal by Subject|14|||
145542177|NCT03338010|524844194|FG001|Overall Study|Withdrawal by Subject|8|||
145542178|NCT03338010|524844193|FG000|Overall Study|Lost to Follow-up|4|||
145542179|NCT03338010|524844194|FG001|Overall Study|Lost to Follow-up|2|||
145542180|NCT03338010|524844193|FG000|Overall Study|Adverse Event|3|||
145542181|NCT03338010|524844194|FG001|Overall Study|Adverse Event|2|||
145542182|NCT03338010|524844193|FG000|Overall Study|Physician Decision|2|||
145542183|NCT03338010|524844194|FG001|Overall Study|Physician Decision|2|||
145542184|NCT03338010|524844193|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145542185|NCT03338010|524844194|FG001|Overall Study|Non-Compliance with Study Drug|3|||
145542186|NCT03338010|524844193|FG000|Overall Study|Protocol Violation|0|||
145789900|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
145789901|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
145282291|NCT00410410|523883085|FG008|Open-Label Period (OL)|Other|7|||
145542187|NCT03338010|524844194|FG001|Overall Study|Protocol Violation|1|||
145542188|NCT03583697|524844195|FG000|Overall Study|Withdrawal by Subject|0|||
145542189|NCT03583697|524844196|FG001|Overall Study|Withdrawal by Subject|0|||
145542190|NCT03583697|524844197|FG002|Overall Study|Withdrawal by Subject|1|||
145542191|NCT03583697|524844195|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
145609969|NCT02086162|525088067|FG000|Overall Study|Lost to Follow-up|4|||
145609970|NCT02086162|525088068|FG001|Overall Study|Lost to Follow-up|2|||
145609971|NCT02086162|525088067|FG000|Overall Study|Death|1|||
145609972|NCT02086162|525088068|FG001|Overall Study|Death|0|||
145609973|NCT01827254|525088072|FG000|Overall Study|Death|10|||
145609974|NCT01827254|525088072|FG000|Overall Study|Case report form not completed|4|||
145609975|NCT01827254|525088072|FG000|Overall Study|Invalidated centre|3|||
145609976|NCT01827254|525088072|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
145609977|NCT01827254|525088072|FG000|Overall Study|Did not complete re-challenge|1|||
145609978|NCT01827254|525088072|FG000|Overall Study|Disease progression|36|||
145609979|NCT01827254|525088072|FG000|Overall Study|Intolerance to treatment|4|||
145609980|NCT01834222|525088073|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
145609981|NCT01107743|525088079|FG000|Overall Study|Protocol Violation|46|||
145789902|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789903|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789904|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789905|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789906|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789907|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789908|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789909|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789910|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789911|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789912|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789913|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789914|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789915|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789916|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789917|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789918|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789919|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789920|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789921|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789922|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789923|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
145789924|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
145789925|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789926|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789927|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789928|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789929|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789930|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789931|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789932|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789933|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789934|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789935|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789936|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789937|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789938|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789939|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789940|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789941|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789942|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789943|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789944|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789945|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789946|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
145789947|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
145282292|NCT01783496|523883086|FG000|Overall Study|Lost to Follow-up|0|||
145282293|NCT01783496|523883087|FG001|Overall Study|Lost to Follow-up|0|||
145609982|NCT00308737|525088080|FG000|Overall Study|Adverse Event|104|||
145282294|NCT01783496|523883088|FG002|Overall Study|Lost to Follow-up|0|||
145609983|NCT00308737|525088081|FG001|Overall Study|Adverse Event|9|||
145609984|NCT00308737|525088082|FG002|Overall Study|Adverse Event|0|||
145609985|NCT00308737|525088080|FG000|Overall Study|Death|4|||
145609986|NCT00308737|525088081|FG001|Overall Study|Death|3|||
145282295|NCT01783496|523883089|FG003|Overall Study|Lost to Follow-up|2|||
145789948|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789949|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789950|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789951|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789952|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789953|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789954|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789955|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789956|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789957|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789958|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789959|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789960|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789961|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789962|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789963|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789964|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789965|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789966|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789967|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789968|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789969|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
145789970|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
145789971|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789972|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789973|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789974|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789975|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789976|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789977|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789978|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789979|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789980|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789981|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789982|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789983|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789984|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789985|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789986|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789987|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789988|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789989|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789990|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789991|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789992|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
145789993|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
145789994|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
145789995|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
145789996|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
145789997|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
145789998|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
145789999|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
145790000|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
145790001|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
145790002|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
145790003|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
145790004|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
145790005|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
145790006|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
145790007|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
145790008|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
145790009|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
145790010|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
145790011|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
145790012|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
145790013|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
145790014|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
145790015|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
145790016|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
145790017|NCT02052778|525736642|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790018|NCT02052778|525736643|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790019|NCT02052778|525736644|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790020|NCT02052778|525736645|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790021|NCT02052778|525736646|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790022|NCT02052778|525736647|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790023|NCT02052778|525736648|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790024|NCT02052778|525736649|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790025|NCT02052778|525736650|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790026|NCT02052778|525736651|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790027|NCT02052778|525736652|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790028|NCT02052778|525736653|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790029|NCT02052778|525736654|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790030|NCT02052778|525736655|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790031|NCT02052778|525736656|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790032|NCT02052778|525736657|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790033|NCT02052778|525736658|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790034|NCT02052778|525736659|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790035|NCT02052778|525736660|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790036|NCT02052778|525736661|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790037|NCT02052778|525736662|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790038|NCT02052778|525736663|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
145790039|NCT02052778|525736664|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
145790040|NCT01994226|525736673|FG000|Overall Study|Protocol Violation|13|||
145790041|NCT01994226|525736674|FG001|Overall Study|Protocol Violation|10|||
145790042|NCT01994226|525736673|FG000|Overall Study|Early Cessation of treatment|6|||
145790043|NCT01994226|525736674|FG001|Overall Study|Early Cessation of treatment|11|||
145790044|NCT01409031|525736675|FG000|Overall Study|transferred to other hosp|1|||
145790045|NCT01409031|525736676|FG001|Overall Study|transferred to other hosp|0|||
145790046|NCT04171037|525736681|FG000|Overall Study|Lost to Follow-up|1|||
145790047|NCT04171037|525736682|FG001|Overall Study|Lost to Follow-up|0|||
145790048|NCT04171037|525736681|FG000|Overall Study|Physician Decision|3|||
145790049|NCT04171037|525736682|FG001|Overall Study|Physician Decision|3|||
145790050|NCT02232087|525736683|FG000|Overall Study|Withdrawal by Subject|2|||
145790051|NCT02232087|525736684|FG001|Overall Study|Withdrawal by Subject|0|||
145790052|NCT02232087|525736685|FG002|Overall Study|Withdrawal by Subject|0|||
145790053|NCT02232087|525736686|FG003|Overall Study|Withdrawal by Subject|0|||
145790054|NCT02232087|525736687|FG004|Overall Study|Withdrawal by Subject|0|||
145790055|NCT02232087|525736688|FG005|Overall Study|Withdrawal by Subject|1|||
145790056|NCT02232087|525736683|FG000|Overall Study|poor inhalation technique|0|||
145790057|NCT02232087|525736684|FG001|Overall Study|poor inhalation technique|1|||
145790058|NCT02232087|525736685|FG002|Overall Study|poor inhalation technique|0|||
145790059|NCT02232087|525736686|FG003|Overall Study|poor inhalation technique|0|||
145790060|NCT02232087|525736687|FG004|Overall Study|poor inhalation technique|0|||
145790061|NCT02232087|525736688|FG005|Overall Study|poor inhalation technique|2|||
145790062|NCT02232087|525736683|FG000|Overall Study|protocol stop criteria|0|||
145790063|NCT02232087|525736684|FG001|Overall Study|protocol stop criteria|1|||
145790064|NCT02232087|525736685|FG002|Overall Study|protocol stop criteria|0|||
145790065|NCT02232087|525736686|FG003|Overall Study|protocol stop criteria|1|||
145790066|NCT02232087|525736687|FG004|Overall Study|protocol stop criteria|0|||
145790067|NCT02232087|525736688|FG005|Overall Study|protocol stop criteria|0|||
145790068|NCT02232087|525736683|FG000|Overall Study|Adverse Event|0|||
145790069|NCT02232087|525736684|FG001|Overall Study|Adverse Event|0|||
145790070|NCT02232087|525736685|FG002|Overall Study|Adverse Event|0|||
145790071|NCT02232087|525736686|FG003|Overall Study|Adverse Event|0|||
145790072|NCT02232087|525736687|FG004|Overall Study|Adverse Event|1|||
145790073|NCT02232087|525736688|FG005|Overall Study|Adverse Event|0|||
145790074|NCT01958125|525736689|FG000|Overall Study|Missing diary data|2|||
145790075|NCT01958125|525736690|FG001|Overall Study|Missing diary data|6|||
145790076|NCT01958125|525736689|FG000|Overall Study|No headache attacks|0|||
145790077|NCT01958125|525736690|FG001|Overall Study|No headache attacks|2|||
145790078|NCT02512068|525736691|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
145790079|NCT02512068|525736692|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
145790080|NCT02512068|525736691|FG000|Overall Study|Major Protocol Deviation|1|||
145790081|NCT02512068|525736692|FG001|Overall Study|Major Protocol Deviation|0|||
145790082|NCT02512068|525736691|FG000|Overall Study|Voluntary Withdrawal|0|||
145790083|NCT02512068|525736692|FG001|Overall Study|Voluntary Withdrawal|1|||
145790084|NCT02512068|525736691|FG000|Overall Study|Lack of Efficacy|0|||
145790085|NCT02512068|525736692|FG001|Overall Study|Lack of Efficacy|1|||
145790086|NCT02512068|525736691|FG000|Overall Study|Reason Not Specified|3|||
145790087|NCT02512068|525736692|FG001|Overall Study|Reason Not Specified|5|||
145790088|NCT01401010|525736699|FG000|Overall Study|Could not interpret assay results|1|||
145790089|NCT01401010|525736700|FG001|Overall Study|Could not interpret assay results|0|||
145790090|NCT04360187|525736708|FG000|Double-Blind Treatment|Adverse Event|9|||
145790091|NCT04360187|525736709|FG001|Double-Blind Treatment|Adverse Event|11|||
145790092|NCT04360187|525736708|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
145790093|NCT04360187|525736709|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
145790094|NCT04360187|525736708|FG000|Double-Blind Treatment|Physician Decision|1|||
145790095|NCT04360187|525736709|FG001|Double-Blind Treatment|Physician Decision|0|||
145609987|NCT00308737|525088082|FG002|Overall Study|Death|0|||
145609988|NCT00308737|525088080|FG000|Overall Study|Lost to Follow-up|56|||
145609989|NCT00308737|525088081|FG001|Overall Study|Lost to Follow-up|80|||
145609990|NCT00308737|525088082|FG002|Overall Study|Lost to Follow-up|5|||
145609991|NCT00308737|525088080|FG000|Overall Study|Physician Decision|15|||
145609992|NCT00308737|525088081|FG001|Overall Study|Physician Decision|2|||
145609993|NCT00308737|525088082|FG002|Overall Study|Physician Decision|1|||
145609994|NCT00308737|525088080|FG000|Overall Study|Protocol Violation|34|||
145609995|NCT00308737|525088081|FG001|Overall Study|Protocol Violation|9|||
145609996|NCT00308737|525088082|FG002|Overall Study|Protocol Violation|5|||
145609997|NCT00308737|525088080|FG000|Overall Study|Withdrawal by Subject|218|||
145609998|NCT00308737|525088081|FG001|Overall Study|Withdrawal by Subject|166|||
145609999|NCT00308737|525088082|FG002|Overall Study|Withdrawal by Subject|18|||
145610000|NCT00308737|525088080|FG000|Overall Study|Various|32|||
145610001|NCT00308737|525088081|FG001|Overall Study|Various|20|||
145610002|NCT00308737|525088082|FG002|Overall Study|Various|8|||
145610003|NCT00089895|525088083|FG000|Overall Study|Consent Withdrawn|11|||
145610004|NCT00089895|525088084|FG001|Overall Study|Consent Withdrawn|14|||
145610005|NCT00089895|525088083|FG000|Overall Study|Technical reason|7|||
145610006|NCT00089895|525088084|FG001|Overall Study|Technical reason|2|||
145610007|NCT00089895|525088083|FG000|Overall Study|Surgery|0|||
145610008|NCT00089895|525088084|FG001|Overall Study|Surgery|1|||
145610009|NCT00089895|525088083|FG000|Overall Study|Bleeding|0|||
145610010|NCT00089895|525088084|FG001|Overall Study|Bleeding|2|||
145610011|NCT00089895|525088083|FG000|Overall Study|Physician Decision|3|||
145610012|NCT00089895|525088084|FG001|Overall Study|Physician Decision|7|||
145610013|NCT00089895|525088083|FG000|Overall Study|Exclusion criteria met|6|||
145610014|NCT00089895|525088084|FG001|Overall Study|Exclusion criteria met|6|||
145610015|NCT00089895|525088083|FG000|Overall Study|Not otherwise specified|4|||
145610016|NCT00089895|525088084|FG001|Overall Study|Not otherwise specified|8|||
145610017|NCT00089895|525088083|FG000|Overall Study|Missing|4|||
145610018|NCT00089895|525088084|FG001|Overall Study|Missing|2|||
145790096|NCT04360187|525736708|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
145790097|NCT04360187|525736709|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
145790098|NCT04360187|525736708|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
145790099|NCT04360187|525736709|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
145790100|NCT04360187|525736708|FG000|Follow-Up|Lost to Follow-up|1|||
145790101|NCT04360187|525736709|FG001|Follow-Up|Lost to Follow-up|0|||
145790102|NCT02203838|525736710|FG000|Overall Study|Lack of Efficacy|7|||
145790103|NCT02203838|525736711|FG001|Overall Study|Lack of Efficacy|0|||
145790104|NCT02203838|525736712|FG002|Overall Study|Lack of Efficacy|1|||
145610019|NCT02494206|525088098|FG000|Overall Study|Adverse Event|1|||
145610020|NCT02494206|525088098|FG000|Overall Study|Disease Progression|1|||
145610021|NCT05796518|525088101|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
145610022|NCT01535274|525088102|FG000|Overall Study|Determined to be ineligible|0|||
145610023|NCT01535274|525088103|FG001|Overall Study|Determined to be ineligible|1|||
145610024|NCT01535274|525088102|FG000|Overall Study|Misallocated to propofol intervention|0|||
145610025|NCT01535274|525088103|FG001|Overall Study|Misallocated to propofol intervention|1|||
145790105|NCT02203838|525736713|FG003|Overall Study|Lack of Efficacy|1|||
145790106|NCT02203838|525736710|FG000|Overall Study|Adverse Event|46|||
145790107|NCT02203838|525736711|FG001|Overall Study|Adverse Event|6|||
145790108|NCT02203838|525736712|FG002|Overall Study|Adverse Event|3|||
145790109|NCT02203838|525736713|FG003|Overall Study|Adverse Event|2|||
145282296|NCT01783496|523883090|FG004|Overall Study|Lost to Follow-up|0|||
145610026|NCT03679767|525088104|FG000|Overall Study|Death|16|||
145790110|NCT02203838|525736710|FG000|Overall Study|Lost to Follow-up|39|||
145790111|NCT02203838|525736711|FG001|Overall Study|Lost to Follow-up|3|||
145790112|NCT02203838|525736712|FG002|Overall Study|Lost to Follow-up|2|||
145790113|NCT02203838|525736713|FG003|Overall Study|Lost to Follow-up|1|||
145790114|NCT02203838|525736710|FG000|Overall Study|Protocol Violation|7|||
145790115|NCT02203838|525736711|FG001|Overall Study|Protocol Violation|3|||
145790116|NCT02203838|525736712|FG002|Overall Study|Protocol Violation|0|||
145790117|NCT02203838|525736713|FG003|Overall Study|Protocol Violation|0|||
145790118|NCT02203838|525736710|FG000|Overall Study|Withdrawal by Subject|83|||
145790119|NCT02203838|525736711|FG001|Overall Study|Withdrawal by Subject|10|||
145790120|NCT02203838|525736712|FG002|Overall Study|Withdrawal by Subject|8|||
145790121|NCT02203838|525736713|FG003|Overall Study|Withdrawal by Subject|11|||
145790122|NCT02203838|525736710|FG000|Overall Study|Physician Decision|27|||
145790123|NCT02203838|525736711|FG001|Overall Study|Physician Decision|0|||
145790124|NCT02203838|525736712|FG002|Overall Study|Physician Decision|2|||
145790125|NCT02203838|525736713|FG003|Overall Study|Physician Decision|3|||
145790126|NCT02203838|525736710|FG000|Overall Study|Other|1|||
145790127|NCT02203838|525736711|FG001|Overall Study|Other|0|||
145790128|NCT02203838|525736712|FG002|Overall Study|Other|0|||
145790129|NCT02203838|525736713|FG003|Overall Study|Other|0|||
145790130|NCT05091060|525736714|FG000|Overall Study|Lost to Follow-up|1|||
145790131|NCT05896761|525736715|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
145790132|NCT05896761|525736716|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
145790133|NCT05896761|525736715|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
145790134|NCT05896761|525736716|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
145790135|NCT01318083|525736717|FG000|Overall Study|Adverse Event|4|||
145790136|NCT01318083|525736718|FG001|Overall Study|Adverse Event|1|||
145790137|NCT01318083|525736719|FG002|Overall Study|Adverse Event|2|||
145790138|NCT01318083|525736717|FG000|Overall Study|Withdrawal by Subject|1|||
145790139|NCT01318083|525736718|FG001|Overall Study|Withdrawal by Subject|0|||
145790140|NCT01318083|525736719|FG002|Overall Study|Withdrawal by Subject|2|||
145790141|NCT01318083|525736717|FG000|Overall Study|Lack of Efficacy|0|||
145542192|NCT03583697|524844196|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
145790142|NCT01318083|525736718|FG001|Overall Study|Lack of Efficacy|0|||
145790143|NCT01318083|525736719|FG002|Overall Study|Lack of Efficacy|1|||
145790144|NCT01318083|525736717|FG000|Overall Study|Treatment Complications|1|||
145790145|NCT01318083|525736718|FG001|Overall Study|Treatment Complications|0|||
145790146|NCT01318083|525736719|FG002|Overall Study|Treatment Complications|0|||
145790147|NCT01318083|525736717|FG000|Overall Study|Lack of Study Medication Compliance|0|||
145790148|NCT01318083|525736718|FG001|Overall Study|Lack of Study Medication Compliance|1|||
145790149|NCT01318083|525736719|FG002|Overall Study|Lack of Study Medication Compliance|0|||
145790150|NCT02065869|525736721|FG000|Overall Study|Death|7|||
145790151|NCT02065869|525736721|FG000|Overall Study|Disease relapse|16|||
145790152|NCT02065869|525736721|FG000|Overall Study|Lost to Follow-up|4|||
145790153|NCT02065869|525736721|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
145790154|NCT02065869|525736721|FG000|Overall Study|Withdrawal by Subject|1|||
145790155|NCT02739594|525736722|FG000|Overall Study|Undesired Event|3|||
145790156|NCT02739594|525736723|FG001|Overall Study|Undesired Event|4|||
145790157|NCT02739594|525736722|FG000|Overall Study|Violation of Eligibility Criteria|1|||
145790158|NCT02739594|525736723|FG001|Overall Study|Violation of Eligibility Criteria|2|||
145790159|NCT02739594|525736722|FG000|Overall Study|Protocol Violation|5|||
145790160|NCT02739594|525736723|FG001|Overall Study|Protocol Violation|6|||
145790161|NCT02739594|525736722|FG000|Overall Study|Death|4|||
145790162|NCT02739594|525736723|FG001|Overall Study|Death|2|||
145790163|NCT02739594|525736722|FG000|Overall Study|Renal Insufficiency|4|||
145790164|NCT02739594|525736723|FG001|Overall Study|Renal Insufficiency|6|||
145790165|NCT02739594|525736722|FG000|Overall Study|Administrative Reasons|1|||
145790166|NCT02739594|525736723|FG001|Overall Study|Administrative Reasons|3|||
145790167|NCT02739594|525736722|FG000|Overall Study|Withdrawal by Subject|1|||
145790168|NCT02739594|525736723|FG001|Overall Study|Withdrawal by Subject|1|||
145790169|NCT02739594|525736722|FG000|Overall Study|Lost to Follow-up|0|||
145790170|NCT02739594|525736723|FG001|Overall Study|Lost to Follow-up|1|||
145790171|NCT02739594|525736722|FG000|Overall Study|Elevated Serum Creatinine|0|||
145790172|NCT02739594|525736723|FG001|Overall Study|Elevated Serum Creatinine|1|||
145790173|NCT02739594|525736722|FG000|Overall Study|Other|6|||
145790174|NCT02739594|525736723|FG001|Overall Study|Other|2|||
145790175|NCT00527111|525736726|FG000|Overall Study|Adverse Event|14|||
145790176|NCT00527111|525736727|FG001|Overall Study|Adverse Event|13|||
145790177|NCT00527111|525736726|FG000|Overall Study|Death|0|||
145790178|NCT00527111|525736727|FG001|Overall Study|Death|1|||
145790179|NCT00527111|525736726|FG000|Overall Study|Investigator Request|2|||
145790180|NCT00527111|525736727|FG001|Overall Study|Investigator Request|1|||
145790181|NCT00527111|525736726|FG000|Overall Study|Patient Request|2|||
145790182|NCT00527111|525736727|FG001|Overall Study|Patient Request|5|||
145790183|NCT00527111|525736726|FG000|Overall Study|Other|2|||
145790184|NCT00527111|525736727|FG001|Overall Study|Other|2|||
145790185|NCT00952289|525736730|FG000|All Participants|Death|9|||
145790186|NCT00952289|525736731|FG001|All Participants|Death|9|||
145790187|NCT00952289|525736730|FG000|All Participants|Adverse Event|8|||
145790188|NCT00952289|525736731|FG001|All Participants|Adverse Event|8|||
145790189|NCT00952289|525736730|FG000|All Participants|Disease progression|3|||
145790190|NCT00952289|525736731|FG001|All Participants|Disease progression|12|||
145790191|NCT00952289|525736730|FG000|All Participants|Withdrawal by Subject|1|||
145790192|NCT00952289|525736731|FG001|All Participants|Withdrawal by Subject|10|||
145790193|NCT00952289|525736730|FG000|All Participants|Data lost during site relocation|0|||
145790194|NCT00952289|525736731|FG001|All Participants|Data lost during site relocation|1|||
145790195|NCT00952289|525736730|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
145790196|NCT00952289|525736731|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
145542193|NCT03583697|524844197|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
145790197|NCT00952289|525736730|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
145542194|NCT03724032|524844198|FG000|Overall Study|Physician Decision|1|||
145542195|NCT03724032|524844199|FG001|Overall Study|Physician Decision|0|||
145542196|NCT03724032|524844200|FG002|Overall Study|Physician Decision|0|||
145542197|NCT03724032|524844198|FG000|Overall Study|Protocol Violation|2|||
145790198|NCT00952289|525736731|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
145790199|NCT00952289|525736730|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
145790200|NCT00952289|525736731|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
145790201|NCT00952289|525736730|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
145790202|NCT00952289|525736731|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
145790203|NCT00952289|525736730|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
145790204|NCT00952289|525736731|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
145790205|NCT03827473|525736732|FG000|Overall Study|Withdrawal by Subject|1|||
145790206|NCT03827473|525736733|FG001|Overall Study|Withdrawal by Subject|0|||
145790207|NCT00142519|525736738|FG000|Overall Study|Not Treated|7|||
145790208|NCT00142519|525736739|FG001|Overall Study|Not Treated|9|||
145790209|NCT00142519|525736738|FG000|Overall Study|Protocol Violation|1|||
145790210|NCT00142519|525736739|FG001|Overall Study|Protocol Violation|0|||
145790211|NCT00142519|525736738|FG000|Overall Study|Withdrawal by Subject|10|||
145790212|NCT00142519|525736739|FG001|Overall Study|Withdrawal by Subject|7|||
145790213|NCT01468909|525736740|FG000|Overall Study|Never Treated|2|||
145790214|NCT01468909|525736741|FG001|Overall Study|Never Treated|2|||
145790215|NCT02635737|525736746|FG000|Overall Study|Protocol Violation|1|||
145790216|NCT01511419|525736747|FG000|Dose 2|Physician Decision|1|||
145790217|NCT01511419|525736748|FG001|Dose 2|Physician Decision|0|||
145790218|NCT00937768|525736749|FG000|Overall Study|Refused Further Treatment|3|||
145790219|NCT00937768|525736750|FG001|Overall Study|Refused Further Treatment|2|||
145790220|NCT00937768|525736749|FG000|Overall Study|Disease Progression|1|||
145790221|NCT00937768|525736750|FG001|Overall Study|Disease Progression|1|||
145790222|NCT00937768|525736749|FG000|Overall Study|Alternate Treatment|0|||
145790223|NCT00937768|525736750|FG001|Overall Study|Alternate Treatment|1|||
145790224|NCT00937768|525736749|FG000|Overall Study|No Further Funding|4|||
145790225|NCT00937768|525736750|FG001|Overall Study|No Further Funding|4|||
145790226|NCT02065622|525736751|FG000|Induction Study|Adverse Event|13|||
145790227|NCT02065622|525736752|FG001|Induction Study|Adverse Event|19|||
145790228|NCT02065622|525736753|FG002|Induction Study|Adverse Event|0|||
145790229|NCT02065622|525736754|FG003|Induction Study|Adverse Event|0|||
145790230|NCT02065622|525736755|FG004|Induction Study|Adverse Event|0|||
145790231|NCT02065622|525736751|FG000|Induction Study|Withdrawal by Subject|3|||
145790232|NCT02065622|525736752|FG001|Induction Study|Withdrawal by Subject|5|||
145790233|NCT02065622|525736753|FG002|Induction Study|Withdrawal by Subject|0|||
145790234|NCT02065622|525736754|FG003|Induction Study|Withdrawal by Subject|0|||
145790235|NCT02065622|525736755|FG004|Induction Study|Withdrawal by Subject|0|||
145790236|NCT02065622|525736751|FG000|Induction Study|Lost to Follow-up|1|||
145790237|NCT02065622|525736752|FG001|Induction Study|Lost to Follow-up|0|||
145790238|NCT02065622|525736753|FG002|Induction Study|Lost to Follow-up|0|||
145790239|NCT02065622|525736754|FG003|Induction Study|Lost to Follow-up|0|||
145790240|NCT02065622|525736755|FG004|Induction Study|Lost to Follow-up|0|||
145790241|NCT02065622|525736751|FG000|Induction Study|Lack of Efficacy|22|||
145790242|NCT02065622|525736752|FG001|Induction Study|Lack of Efficacy|27|||
145790243|NCT02065622|525736753|FG002|Induction Study|Lack of Efficacy|0|||
145790244|NCT02065622|525736754|FG003|Induction Study|Lack of Efficacy|0|||
145790245|NCT02065622|525736755|FG004|Induction Study|Lack of Efficacy|0|||
145790246|NCT02065622|525736751|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
145790247|NCT02065622|525736752|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
145790248|NCT02065622|525736753|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
145790249|NCT02065622|525736754|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
145790250|NCT02065622|525736755|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
145790251|NCT02065622|525736751|FG000|Induction Study|Subject Noncompliance|1|||
145790252|NCT02065622|525736752|FG001|Induction Study|Subject Noncompliance|1|||
145790253|NCT02065622|525736753|FG002|Induction Study|Subject Noncompliance|0|||
145790254|NCT02065622|525736754|FG003|Induction Study|Subject Noncompliance|0|||
145790255|NCT02065622|525736755|FG004|Induction Study|Subject Noncompliance|0|||
145790256|NCT02065622|525736751|FG000|Induction Study|Other, Not Specified|3|||
145790257|NCT02065622|525736752|FG001|Induction Study|Other, Not Specified|2|||
145790258|NCT02065622|525736753|FG002|Induction Study|Other, Not Specified|0|||
145790259|NCT02065622|525736754|FG003|Induction Study|Other, Not Specified|0|||
145282297|NCT01783496|523883091|FG005|Overall Study|Lost to Follow-up|1|||
145542198|NCT03724032|524844199|FG001|Overall Study|Protocol Violation|2|||
145542199|NCT03724032|524844200|FG002|Overall Study|Protocol Violation|1|||
145542200|NCT02339584|524844201|FG000|Overall Study|Adverse Event|11|||
145790260|NCT02065622|525736755|FG004|Induction Study|Other, Not Specified|0|||
145790261|NCT02065622|525736751|FG000|Maintenance Study|Adverse Event|0|||
145790262|NCT02065622|525736752|FG001|Maintenance Study|Adverse Event|0|||
145790263|NCT02065622|525736753|FG002|Maintenance Study|Adverse Event|25|||
145790264|NCT02065622|525736754|FG003|Maintenance Study|Adverse Event|22|||
145790265|NCT02065622|525736755|FG004|Maintenance Study|Adverse Event|11|||
145790266|NCT02065622|525736751|FG000|Maintenance Study|Withdrawal by Subject|0|||
145790267|NCT02065622|525736752|FG001|Maintenance Study|Withdrawal by Subject|0|||
145790268|NCT02065622|525736753|FG002|Maintenance Study|Withdrawal by Subject|11|||
145790269|NCT02065622|525736754|FG003|Maintenance Study|Withdrawal by Subject|5|||
145790270|NCT02065622|525736755|FG004|Maintenance Study|Withdrawal by Subject|7|||
145790271|NCT02065622|525736751|FG000|Maintenance Study|Lost to Follow-up|0|||
145790272|NCT02065622|525736752|FG001|Maintenance Study|Lost to Follow-up|0|||
145790273|NCT02065622|525736753|FG002|Maintenance Study|Lost to Follow-up|4|||
145790274|NCT02065622|525736754|FG003|Maintenance Study|Lost to Follow-up|1|||
145790275|NCT02065622|525736755|FG004|Maintenance Study|Lost to Follow-up|1|||
145790276|NCT02065622|525736751|FG000|Maintenance Study|Lack of Efficacy|0|||
145790277|NCT02065622|525736752|FG001|Maintenance Study|Lack of Efficacy|0|||
145790278|NCT02065622|525736753|FG002|Maintenance Study|Lack of Efficacy|70|||
145790279|NCT02065622|525736754|FG003|Maintenance Study|Lack of Efficacy|55|||
145790280|NCT02065622|525736755|FG004|Maintenance Study|Lack of Efficacy|19|||
145790281|NCT02065622|525736751|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
145790282|NCT02065622|525736752|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
145790283|NCT02065622|525736753|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
145790284|NCT02065622|525736754|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
145790285|NCT02065622|525736755|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
145790286|NCT02065622|525736751|FG000|Maintenance Study|Subject Non-Compliance|0|||
145790287|NCT02065622|525736752|FG001|Maintenance Study|Subject Non-Compliance|0|||
145790288|NCT02065622|525736753|FG002|Maintenance Study|Subject Non-Compliance|1|||
145790289|NCT02065622|525736754|FG003|Maintenance Study|Subject Non-Compliance|3|||
145790290|NCT02065622|525736755|FG004|Maintenance Study|Subject Non-Compliance|2|||
145790291|NCT02065622|525736751|FG000|Maintenance Study|Other, Not Specified|0|||
145790292|NCT02065622|525736752|FG001|Maintenance Study|Other, Not Specified|0|||
145790293|NCT02065622|525736753|FG002|Maintenance Study|Other, Not Specified|6|||
145790294|NCT02065622|525736754|FG003|Maintenance Study|Other, Not Specified|14|||
145790295|NCT02065622|525736755|FG004|Maintenance Study|Other, Not Specified|2|||
145790296|NCT02065622|525736751|FG000|Maintenance Study|Unknown Reason|0|||
145790297|NCT02065622|525736752|FG001|Maintenance Study|Unknown Reason|0|||
145790298|NCT02065622|525736753|FG002|Maintenance Study|Unknown Reason|0|||
145790299|NCT02065622|525736754|FG003|Maintenance Study|Unknown Reason|1|||
145790300|NCT02065622|525736755|FG004|Maintenance Study|Unknown Reason|0|||
145790301|NCT00786032|525738858|FG000|Overall Study|Death|4|||
145790302|NCT00786032|525738858|FG000|Overall Study|Withdrawal by Subject|14|||
145790303|NCT00786032|525738858|FG000|Overall Study|Did not complete in the timeframe|6|||
145790304|NCT02922634|525738859|FG000|Overall Study|Withdrawal by Subject|5|||
145790305|NCT02922634|525738859|FG000|Overall Study|Did not have their surgery|5|||
145790306|NCT02294318|525738860|FG000|Overall Study|Worsening of drinking|3|||
145790307|NCT02294318|525738861|FG001|Overall Study|Worsening of drinking|0|||
145790308|NCT02294318|525738860|FG000|Overall Study|Not exposed to intervention|0|||
145282298|NCT01783496|523883086|FG000|Overall Study|Withdrawal by Subject|1|||
145282299|NCT01783496|523883087|FG001|Overall Study|Withdrawal by Subject|0|||
145282300|NCT01783496|523883088|FG002|Overall Study|Withdrawal by Subject|0|||
145282301|NCT01783496|523883089|FG003|Overall Study|Withdrawal by Subject|0|||
145282302|NCT01783496|523883090|FG004|Overall Study|Withdrawal by Subject|0|||
145282303|NCT01783496|523883091|FG005|Overall Study|Withdrawal by Subject|0|||
145282304|NCT01789281|523883092|FG000|Overall Study|Disease progression|15|||
145282305|NCT01789281|523883093|FG001|Overall Study|Disease progression|4|||
145282306|NCT01789281|523883092|FG000|Overall Study|Adverse Event|5|||
145282307|NCT01789281|523883093|FG001|Overall Study|Adverse Event|5|||
145282308|NCT01789281|523883092|FG000|Overall Study|Withdrawal by Subject|1|||
145282309|NCT01789281|523883093|FG001|Overall Study|Withdrawal by Subject|0|||
145282310|NCT01789281|523883092|FG000|Overall Study|Lost to Follow-up|1|||
145282311|NCT01789281|523883093|FG001|Overall Study|Lost to Follow-up|0|||
145542201|NCT02339584|524844202|FG001|Overall Study|Adverse Event|7|||
145542202|NCT02339584|524844201|FG000|Overall Study|Lack of Efficacy|0|||
145542203|NCT02339584|524844202|FG001|Overall Study|Lack of Efficacy|1|||
145542204|NCT02339584|524844201|FG000|Overall Study|Physician Decision|1|||
145542205|NCT02339584|524844202|FG001|Overall Study|Physician Decision|2|||
145790309|NCT02294318|525738861|FG001|Overall Study|Not exposed to intervention|2|||
145790310|NCT00762372|525738864|FG000|Overall Study|Adverse Event|1|||
145790311|NCT00762372|525738865|FG001|Overall Study|Adverse Event|0|||
145790312|NCT00762372|525738866|FG002|Overall Study|Adverse Event|0|||
145790313|NCT01194804|525738867|FG000|Overall Study|Withdrawal by Subject|1|||
145790314|NCT02670915|525738868|FG000|Overall Study|Withdrawal by Subject|0|||
145790315|NCT02670915|525738869|FG001|Overall Study|Withdrawal by Subject|1|||
145790316|NCT02670915|525738870|FG002|Overall Study|Withdrawal by Subject|4|||
145790317|NCT02670915|525738868|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145790318|NCT02670915|525738869|FG001|Overall Study|Withdrawal by parent/guardian|4|||
145282312|NCT01789281|523883092|FG000|Overall Study|Administrative problems|0|||
145282313|NCT01789281|523883093|FG001|Overall Study|Administrative problems|1|||
145282314|NCT00686920|523883094|FG000|Overall Study|Death|45|||
145282315|NCT00686920|523883095|FG001|Overall Study|Death|14|||
145790319|NCT02670915|525738870|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145790320|NCT02670915|525738868|FG000|Overall Study|Unclassified|0|||
145790321|NCT02670915|525738869|FG001|Overall Study|Unclassified|3|||
145790322|NCT02670915|525738870|FG002|Overall Study|Unclassified|0|||
145790323|NCT00818207|525738871|FG000|Overall Study|Adverse Event|6|||
145790324|NCT00818207|525738872|FG001|Overall Study|Adverse Event|0|||
145790325|NCT00818207|525738871|FG000|Overall Study|Lost to Follow-up|160|||
145790326|NCT00818207|525738872|FG001|Overall Study|Lost to Follow-up|146|||
145790327|NCT00818207|525738871|FG000|Overall Study|Multiple reasons|11|||
145790328|NCT00818207|525738872|FG001|Overall Study|Multiple reasons|12|||
145790329|NCT00818207|525738871|FG000|Overall Study|Withdrawal by Subject|42|||
145790330|NCT00818207|525738872|FG001|Overall Study|Withdrawal by Subject|104|||
145790331|NCT00818207|525738871|FG000|Overall Study|Death|3|||
145790332|NCT00818207|525738872|FG001|Overall Study|Death|5|||
145790333|NCT02616185|525738873|FG000|Overall Study|Death|0|||
145790334|NCT02616185|525738874|FG001|Overall Study|Death|0|||
145790335|NCT02616185|525738875|FG002|Overall Study|Death|0|||
145790336|NCT02616185|525738876|FG003|Overall Study|Death|1|||
145790337|NCT02616185|525738877|FG004|Overall Study|Death|2|||
145790338|NCT02616185|525738878|FG005|Overall Study|Death|0|||
145790339|NCT02616185|525738879|FG006|Overall Study|Death|0|||
145790340|NCT02616185|525738880|FG007|Overall Study|Death|2|||
145790341|NCT02616185|525738881|FG008|Overall Study|Death|1|||
145790342|NCT02616185|525738873|FG000|Overall Study|Study terminated by sponsor|0|||
145790343|NCT02616185|525738874|FG001|Overall Study|Study terminated by sponsor|0|||
145790344|NCT02616185|525738875|FG002|Overall Study|Study terminated by sponsor|1|||
145790345|NCT02616185|525738876|FG003|Overall Study|Study terminated by sponsor|0|||
145790346|NCT02616185|525738877|FG004|Overall Study|Study terminated by sponsor|0|||
145790347|NCT02616185|525738878|FG005|Overall Study|Study terminated by sponsor|0|||
145790348|NCT02616185|525738879|FG006|Overall Study|Study terminated by sponsor|5|||
145790349|NCT02616185|525738880|FG007|Overall Study|Study terminated by sponsor|2|||
145790350|NCT02616185|525738881|FG008|Overall Study|Study terminated by sponsor|0|||
145790351|NCT02616185|525738873|FG000|Overall Study|Participant refused further follow-up|1|||
145790352|NCT02616185|525738874|FG001|Overall Study|Participant refused further follow-up|1|||
145790353|NCT02616185|525738875|FG002|Overall Study|Participant refused further follow-up|2|||
145790354|NCT02616185|525738876|FG003|Overall Study|Participant refused further follow-up|3|||
145790355|NCT02616185|525738877|FG004|Overall Study|Participant refused further follow-up|4|||
145790356|NCT02616185|525738878|FG005|Overall Study|Participant refused further follow-up|0|||
145790357|NCT02616185|525738879|FG006|Overall Study|Participant refused further follow-up|3|||
145790358|NCT02616185|525738880|FG007|Overall Study|Participant refused further follow-up|4|||
145790359|NCT02616185|525738881|FG008|Overall Study|Participant refused further follow-up|3|||
145790360|NCT02616185|525738873|FG000|Overall Study|Not reported|0|||
145790361|NCT02616185|525738874|FG001|Overall Study|Not reported|0|||
145790362|NCT02616185|525738875|FG002|Overall Study|Not reported|0|||
145790363|NCT02616185|525738876|FG003|Overall Study|Not reported|1|||
145790364|NCT02616185|525738877|FG004|Overall Study|Not reported|3|||
145790365|NCT02616185|525738878|FG005|Overall Study|Not reported|1|||
145790366|NCT02616185|525738879|FG006|Overall Study|Not reported|0|||
145790367|NCT02616185|525738880|FG007|Overall Study|Not reported|5|||
145790368|NCT02616185|525738881|FG008|Overall Study|Not reported|2|||
145790369|NCT03621943|525738882|FG000|First Randomized Intervention|Lost to Follow-up|51|||
145790370|NCT03621943|525738883|FG001|First Randomized Intervention|Lost to Follow-up|54|||
145790371|NCT03621943|525738882|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
145790372|NCT03621943|525738883|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
145790373|NCT03621943|525738882|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
145790374|NCT03621943|525738883|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
145790375|NCT03621943|525738882|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
145790376|NCT03621943|525738883|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
145790377|NCT02174861|525738884|FG000|Overall Study|Decision by sponsor|8|||
145790378|NCT02174861|525738884|FG000|Overall Study|Withdrawal by Subject|124|||
145790379|NCT02174861|525738884|FG000|Overall Study|Lost to Follow-up|26|||
145790380|NCT01215734|525738885|FG000|Overall Study|Death|0|||
145790381|NCT01215734|525738886|FG001|Overall Study|Death|1|||
145790382|NCT00315705|525738887|FG000|Phase 1|Refused further treatment|1|||
145790383|NCT00315705|525738887|FG000|Phase 1|Failure to achieve response|8|||
145790384|NCT00315705|525738887|FG000|Phase 1|Disease relapse|4|||
145790385|NCT00315705|525738887|FG000|Phase 1|Scheduled for transplant|9|||
145790386|NCT00315705|525738887|FG000|Phase 1|Death|3|||
145790387|NCT00315705|525738887|FG000|Phase 2|Physician Decision|4|||
145790388|NCT00315705|525738887|FG000|Phase 2|Adverse Event|1|||
145790389|NCT00315705|525738887|FG000|Phase 2|Failure to achieve response|3|||
145790390|NCT00315705|525738887|FG000|Phase 2|Disease relapse|1|||
145790391|NCT00315705|525738887|FG000|Phase 2|Scheduled for transplant|8|||
145790392|NCT00315705|525738887|FG000|Phase 2|Other|1|||
145790393|NCT00315705|525738887|FG000|Phase 2|Death|7|||
145790394|NCT01346371|525738888|FG000|Overall Study|Lost to Follow-up|2|||
145790395|NCT01346371|525738889|FG001|Overall Study|Lost to Follow-up|0|||
145790396|NCT01716533|525738890|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
145790397|NCT01716533|525738891|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
145790398|NCT01716533|525738892|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
145790399|NCT01716533|525738893|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
145790400|NCT01716533|525738890|FG000|Overall Study|Withdrawal by Subject|0|||
145790401|NCT01716533|525738891|FG001|Overall Study|Withdrawal by Subject|0|||
145790402|NCT01716533|525738892|FG002|Overall Study|Withdrawal by Subject|0|||
145790403|NCT01716533|525738893|FG003|Overall Study|Withdrawal by Subject|5|||
145790404|NCT01716533|525738890|FG000|Overall Study|Death|0|||
145610027|NCT03679767|525088105|FG001|Overall Study|Death|11|||
145610028|NCT03679767|525088106|FG002|Overall Study|Death|17|||
145610029|NCT03679767|525088107|FG003|Overall Study|Death|10|||
145610030|NCT03679767|525088104|FG000|Overall Study|Lost to Follow-up|1|||
145790405|NCT01716533|525738891|FG001|Overall Study|Death|0|||
145790406|NCT01716533|525738892|FG002|Overall Study|Death|0|||
145790407|NCT01716533|525738893|FG003|Overall Study|Death|2|||
145790408|NCT01716533|525738890|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
145790409|NCT01716533|525738891|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
145790410|NCT01716533|525738892|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
145790411|NCT01716533|525738893|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
145790412|NCT00495495|525738897|FG000|Overall Study|Protocol Violation|99|||
145790413|NCT01670656|525738898|FG000|Overall Study|Non-compliance with study drug|0|||
145790414|NCT01670656|525738899|FG001|Overall Study|Non-compliance with study drug|0|||
145790415|NCT01670656|525738900|FG002|Overall Study|Non-compliance with study drug|3|||
145790416|NCT01670656|525738901|FG003|Overall Study|Non-compliance with study drug|0|||
145790417|NCT01670656|525738902|FG004|Overall Study|Non-compliance with study drug|1|||
145790418|NCT01670656|525738898|FG000|Overall Study|Pregnancy|0|||
145790419|NCT01670656|525738899|FG001|Overall Study|Pregnancy|0|||
145790420|NCT01670656|525738900|FG002|Overall Study|Pregnancy|0|||
145790421|NCT01670656|525738901|FG003|Overall Study|Pregnancy|0|||
145790422|NCT01670656|525738902|FG004|Overall Study|Pregnancy|1|||
145790423|NCT01670656|525738898|FG000|Overall Study|Withdrawal by Subject|1|||
145790424|NCT01670656|525738899|FG001|Overall Study|Withdrawal by Subject|1|||
145790425|NCT01670656|525738900|FG002|Overall Study|Withdrawal by Subject|0|||
145790426|NCT01670656|525738901|FG003|Overall Study|Withdrawal by Subject|0|||
145790427|NCT01670656|525738902|FG004|Overall Study|Withdrawal by Subject|0|||
145790428|NCT01670656|525738898|FG000|Overall Study|Non-compliance with protocol|0|||
145790429|NCT01670656|525738899|FG001|Overall Study|Non-compliance with protocol|3|||
145790430|NCT01670656|525738900|FG002|Overall Study|Non-compliance with protocol|1|||
145790431|NCT01670656|525738901|FG003|Overall Study|Non-compliance with protocol|1|||
145790432|NCT01670656|525738902|FG004|Overall Study|Non-compliance with protocol|2|||
145790433|NCT01670656|525738898|FG000|Overall Study|Adverse Event|2|||
145790434|NCT01670656|525738899|FG001|Overall Study|Adverse Event|2|||
145790435|NCT01670656|525738900|FG002|Overall Study|Adverse Event|2|||
145790436|NCT01670656|525738901|FG003|Overall Study|Adverse Event|3|||
145790437|NCT01670656|525738902|FG004|Overall Study|Adverse Event|3|||
145790438|NCT01670656|525738898|FG000|Overall Study|Subject withdrew consent|0|||
145790439|NCT01670656|525738899|FG001|Overall Study|Subject withdrew consent|1|||
145790440|NCT01670656|525738900|FG002|Overall Study|Subject withdrew consent|2|||
145790441|NCT01670656|525738901|FG003|Overall Study|Subject withdrew consent|1|||
145790442|NCT01670656|525738902|FG004|Overall Study|Subject withdrew consent|1|||
145790443|NCT01670656|525738898|FG000|Overall Study|Lost to Follow-up|0|||
145790444|NCT01670656|525738899|FG001|Overall Study|Lost to Follow-up|0|||
145790445|NCT01670656|525738900|FG002|Overall Study|Lost to Follow-up|0|||
145790446|NCT01670656|525738901|FG003|Overall Study|Lost to Follow-up|0|||
145790447|NCT01670656|525738902|FG004|Overall Study|Lost to Follow-up|3|||
145790448|NCT01670656|525738898|FG000|Overall Study|Subject moved|0|||
145790449|NCT01670656|525738899|FG001|Overall Study|Subject moved|0|||
145790450|NCT01670656|525738900|FG002|Overall Study|Subject moved|0|||
145790451|NCT01670656|525738901|FG003|Overall Study|Subject moved|1|||
145610031|NCT03679767|525088105|FG001|Overall Study|Lost to Follow-up|1|||
145610032|NCT03679767|525088106|FG002|Overall Study|Lost to Follow-up|1|||
145610033|NCT03679767|525088107|FG003|Overall Study|Lost to Follow-up|1|||
145790452|NCT01670656|525738902|FG004|Overall Study|Subject moved|0|||
145790453|NCT02702518|525738903|FG000|Overall Study|Lost to Follow-up|3|||
145790454|NCT02702518|525738904|FG001|Overall Study|Lost to Follow-up|4|||
145790455|NCT03331666|525738905|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
145790456|NCT03331666|525738906|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
145790457|NCT00111475|525738907|FG000|Overall Study|Lost to Follow-up|0|||
145790458|NCT00111475|525738908|FG001|Overall Study|Lost to Follow-up|0|||
145790459|NCT00111475|525738909|FG002|Overall Study|Lost to Follow-up|0|||
145790460|NCT00111475|525738910|FG003|Overall Study|Lost to Follow-up|0|||
145790461|NCT00111475|525738911|FG004|Overall Study|Lost to Follow-up|0|||
145790462|NCT00111475|525738912|FG005|Overall Study|Lost to Follow-up|1|||
145790463|NCT00111475|525738913|FG006|Overall Study|Lost to Follow-up|0|||
145790464|NCT00111475|525738914|FG007|Overall Study|Lost to Follow-up|0|||
145790465|NCT00111475|525738915|FG008|Overall Study|Lost to Follow-up|0|||
145790466|NCT00111475|525738916|FG009|Overall Study|Lost to Follow-up|0|||
145790467|NCT01026389|525738921|FG000|Overall Study|Withdrawal by Subject|1|||
145790468|NCT01026389|525738922|FG001|Overall Study|Withdrawal by Subject|3|||
145790469|NCT01026389|525738921|FG000|Overall Study|change of treatment, patient moved|4|||
145790470|NCT01026389|525738922|FG001|Overall Study|change of treatment, patient moved|2|||
145790471|NCT01995136|525738923|FG000|Overall Study|Change in residence|1|||
145790472|NCT03544268|525738924|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
145790473|NCT03544268|525738925|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
145790474|NCT01830543|525738929|FG000|Overall Study|Subject Decision|19|||
145790475|NCT01830543|525738930|FG001|Overall Study|Subject Decision|21|||
145790476|NCT01830543|525738931|FG002|Overall Study|Subject Decision|57|||
145790477|NCT01830543|525738929|FG000|Overall Study|Adverse Event|91|||
145790478|NCT01830543|525738930|FG001|Overall Study|Adverse Event|77|||
145790479|NCT01830543|525738931|FG002|Overall Study|Adverse Event|76|||
145790480|NCT01830543|525738929|FG000|Overall Study|Death|20|||
145790481|NCT01830543|525738930|FG001|Overall Study|Death|22|||
145790482|NCT01830543|525738931|FG002|Overall Study|Death|22|||
145790483|NCT01830543|525738929|FG000|Overall Study|Protocol Violation|3|||
145790484|NCT01830543|525738930|FG001|Overall Study|Protocol Violation|7|||
145790485|NCT01830543|525738931|FG002|Overall Study|Protocol Violation|7|||
145790486|NCT01830543|525738929|FG000|Overall Study|Physician Decision|11|||
145790487|NCT01830543|525738930|FG001|Overall Study|Physician Decision|5|||
145790488|NCT01830543|525738931|FG002|Overall Study|Physician Decision|12|||
145790489|NCT01830543|525738929|FG000|Overall Study|Withdrawal by consent|3|||
145790490|NCT01830543|525738930|FG001|Overall Study|Withdrawal by consent|3|||
145790491|NCT01830543|525738931|FG002|Overall Study|Withdrawal by consent|3|||
145790492|NCT01830543|525738929|FG000|Overall Study|Other|12|||
145790493|NCT01830543|525738930|FG001|Overall Study|Other|17|||
145790494|NCT01830543|525738931|FG002|Overall Study|Other|37|||
145790495|NCT02695524|525738936|FG000|Overall Study|Lost to Follow-up|3|||
145790496|NCT02695524|525738937|FG001|Overall Study|Lost to Follow-up|2|||
145790497|NCT02695524|525738936|FG000|Overall Study|Death|0|||
145790498|NCT02695524|525738937|FG001|Overall Study|Death|1|||
145790499|NCT04281030|525738949|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
145790500|NCT04281030|525738950|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
145790501|NCT04281030|525738949|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
145790502|NCT04281030|525738950|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
145790503|NCT01395368|525738951|FG000|Overall Study|Physician Decision|14|||
145790504|NCT01395368|525738951|FG000|Overall Study|Withdrawal by Subject|2|||
145790505|NCT00288860|525738956|FG000|Overall Study|Did not complete intake|4|||
145790506|NCT00288860|525738957|FG001|Overall Study|Did not complete intake|8|||
145790507|NCT00288860|525738956|FG000|Overall Study|Death|4|||
145542206|NCT02339584|524844201|FG000|Overall Study|Protocol Violation|1|||
145542207|NCT02339584|524844202|FG001|Overall Study|Protocol Violation|1|||
145542208|NCT02339584|524844201|FG000|Overall Study|Withdrawal by Subject|2|||
145542209|NCT02339584|524844202|FG001|Overall Study|Withdrawal by Subject|4|||
145542210|NCT02610725|524844203|FG000|Overall Study|Lost to Follow-up|197|||
145542211|NCT02610725|524844203|FG000|Overall Study|self-reported contraindication|9|||
145542212|NCT04094883|524844204|FG000|Overall Study|Withdrawal by Subject|1|||
145542213|NCT05996718|524846357|FG000|Overall Study|Lost to Follow-up|3|||
145542214|NCT03945773|524846358|FG000|Overall Study|Consent Withdrawn|1|||
145542215|NCT03945773|524846359|FG001|Overall Study|Consent Withdrawn|1|||
145542216|NCT03945773|524846358|FG000|Overall Study|Lost to Follow-up|1|||
145790508|NCT00288860|525738957|FG001|Overall Study|Death|3|||
145542217|NCT03945773|524846359|FG001|Overall Study|Lost to Follow-up|0|||
145542218|NCT03945773|524846358|FG000|Overall Study|Death|46|||
145790509|NCT00288860|525738956|FG000|Overall Study|Withdrawal by Subject|20|||
145790510|NCT00288860|525738957|FG001|Overall Study|Withdrawal by Subject|15|||
145790511|NCT00288860|525738956|FG000|Overall Study|Lost to Follow-up|74|||
145790512|NCT00288860|525738957|FG001|Overall Study|Lost to Follow-up|71|||
145790513|NCT02179515|525738960|FG000|Overall Study|switched to alternative treatment|0|||
145790514|NCT02179515|525738961|FG001|Overall Study|switched to alternative treatment|1|||
145542219|NCT03945773|524846359|FG001|Overall Study|Death|22|||
145790515|NCT02179515|525738962|FG002|Overall Study|switched to alternative treatment|1|||
145790516|NCT02179515|525738960|FG000|Overall Study|Death|0|||
145790517|NCT02179515|525738961|FG001|Overall Study|Death|1|||
145790518|NCT02179515|525738962|FG002|Overall Study|Death|1|||
145790519|NCT02179515|525738960|FG000|Overall Study|refused further treatment|0|||
145790520|NCT02179515|525738961|FG001|Overall Study|refused further treatment|3|||
145790521|NCT02179515|525738962|FG002|Overall Study|refused further treatment|4|||
145790522|NCT02179515|525738960|FG000|Overall Study|Disease progression on study|2|||
145790523|NCT02179515|525738961|FG001|Overall Study|Disease progression on study|11|||
145790524|NCT02179515|525738962|FG002|Overall Study|Disease progression on study|8|||
145790525|NCT00782418|525738963|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
145790526|NCT00782418|525738964|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790527|NCT00782418|525738965|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790528|NCT00782418|525738966|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790529|NCT00782418|525738967|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790530|NCT00782418|525738968|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790531|NCT00782418|525738969|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
145790532|NCT00782418|525738963|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
145790533|NCT00782418|525738964|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
145790534|NCT00782418|525738965|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
145790535|NCT00782418|525738966|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
145790536|NCT00782418|525738967|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
145790537|NCT00782418|525738968|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
145790538|NCT00782418|525738969|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
145790539|NCT02116660|525738970|FG000|Overall Study|Deteriorating renal function|0|||
145790540|NCT02116660|525738971|FG001|Overall Study|Deteriorating renal function|1|||
145790541|NCT02116660|525738970|FG000|Overall Study|Adverse Event|1|||
145790542|NCT02116660|525738971|FG001|Overall Study|Adverse Event|1|||
145790543|NCT02116660|525738970|FG000|Overall Study|Withdrawal by Subject|0|||
145790544|NCT02116660|525738971|FG001|Overall Study|Withdrawal by Subject|2|||
145790545|NCT02116660|525738970|FG000|Overall Study|Organization reason|1|||
145790546|NCT02116660|525738971|FG001|Overall Study|Organization reason|0|||
145790547|NCT01718509|525738972|FG000|Overall Study|Lost to Follow-up|18|||
145790548|NCT01718509|525738973|FG001|Overall Study|Lost to Follow-up|15|||
145790549|NCT01718509|525738972|FG000|Overall Study|Withdrawal by Subject|7|||
145790550|NCT01718509|525738973|FG001|Overall Study|Withdrawal by Subject|13|||
145790551|NCT01718509|525738972|FG000|Overall Study|Adverse Event|5|||
145790552|NCT01718509|525738973|FG001|Overall Study|Adverse Event|7|||
145790553|NCT01718509|525738972|FG000|Overall Study|Other|13|||
145790554|NCT01718509|525738973|FG001|Overall Study|Other|11|||
145790555|NCT01718509|525738972|FG000|Overall Study|Protocol Violation|4|||
145790556|NCT01718509|525738973|FG001|Overall Study|Protocol Violation|2|||
145790557|NCT01718509|525738972|FG000|Overall Study|Lack of Efficacy|1|||
145790558|NCT01718509|525738973|FG001|Overall Study|Lack of Efficacy|0|||
145790559|NCT02488551|525738974|FG000|Overall Study|Lost to Follow-up|4|||
145790560|NCT02488551|525738975|FG001|Overall Study|Lost to Follow-up|7|||
145790561|NCT02488551|525738976|FG002|Overall Study|Lost to Follow-up|0|||
145790562|NCT02488551|525738977|FG003|Overall Study|Lost to Follow-up|0|||
145790563|NCT02488551|525738974|FG000|Overall Study|Military Deployment|1|||
145790564|NCT02488551|525738975|FG001|Overall Study|Military Deployment|1|||
145790565|NCT02488551|525738976|FG002|Overall Study|Military Deployment|0|||
145790566|NCT02488551|525738977|FG003|Overall Study|Military Deployment|0|||
145790567|NCT01094730|525738984|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
145790568|NCT01094730|525738985|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
145790569|NCT01094730|525738984|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
145790570|NCT01094730|525738985|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
145790571|NCT01094730|525738984|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
145790572|NCT01094730|525738985|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
145790573|NCT01094730|525738984|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
145790574|NCT01094730|525738985|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
145790575|NCT01094730|525738984|FG000|Period 2 (14 Days)|Protocol Violation|2|||
145790576|NCT01094730|525738985|FG001|Period 2 (14 Days)|Protocol Violation|0|||
145790577|NCT01094730|525738984|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
145790578|NCT01094730|525738985|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
145790579|NCT01094730|525738984|FG000|Period 2 (14 Days)|Adverse Event|0|||
145610034|NCT03679767|525088104|FG000|Overall Study|Withdrawal by Subject|0|||
145610035|NCT03679767|525088105|FG001|Overall Study|Withdrawal by Subject|0|||
145610036|NCT03679767|525088106|FG002|Overall Study|Withdrawal by Subject|0|||
145610037|NCT03679767|525088107|FG003|Overall Study|Withdrawal by Subject|1|||
145610038|NCT03679767|525088104|FG000|Overall Study|Follow-up Completed|18|||
145610039|NCT03679767|525088105|FG001|Overall Study|Follow-up Completed|11|||
145610040|NCT03679767|525088106|FG002|Overall Study|Follow-up Completed|11|||
145610041|NCT03679767|525088107|FG003|Overall Study|Follow-up Completed|20|||
145610042|NCT03679767|525088104|FG000|Overall Study|Entered Hospice Care|0|||
145610043|NCT03679767|525088105|FG001|Overall Study|Entered Hospice Care|0|||
145610044|NCT03679767|525088106|FG002|Overall Study|Entered Hospice Care|0|||
145610045|NCT03679767|525088107|FG003|Overall Study|Entered Hospice Care|1|||
145610046|NCT03679767|525088104|FG000|Overall Study|Progressive Disease|0|||
145610047|NCT03679767|525088105|FG001|Overall Study|Progressive Disease|0|||
145610048|NCT03679767|525088106|FG002|Overall Study|Progressive Disease|0|||
145610049|NCT03679767|525088107|FG003|Overall Study|Progressive Disease|1|||
145610050|NCT02690077|525088108|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
145610051|NCT02690077|525088109|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
145610052|NCT02690077|525088108|FG000|Overall Study|Withdrawal by Subject|0|||
145610053|NCT02690077|525088109|FG001|Overall Study|Withdrawal by Subject|5|||
145610054|NCT02690077|525088108|FG000|Overall Study|Excluded by IRB|0|||
145610055|NCT02690077|525088109|FG001|Overall Study|Excluded by IRB|2|||
145610056|NCT05229653|525088110|FG000|Overall Study|Lost to Follow-up|1|||
145610057|NCT05229653|525088111|FG001|Overall Study|Lost to Follow-up|0|||
145610058|NCT01845974|525088112|FG000|Overall Study|screen failure|1|||
145610059|NCT01845974|525088113|FG001|Overall Study|screen failure|0|||
145610060|NCT02667886|525088114|FG000|Dose Escalation (Part A)|Adverse Event|1|||
145610061|NCT02667886|525088115|FG001|Dose Escalation (Part A)|Adverse Event|3|||
145610062|NCT02667886|525088116|FG002|Dose Escalation (Part A)|Adverse Event|1|||
145610063|NCT02667886|525088117|FG003|Dose Escalation (Part A)|Adverse Event|0|||
145610064|NCT02667886|525088118|FG004|Dose Escalation (Part A)|Adverse Event|0|||
145610065|NCT02667886|525088114|FG000|Dose Escalation (Part A)|Disease Progression|1|||
145610066|NCT02667886|525088115|FG001|Dose Escalation (Part A)|Disease Progression|4|||
145610067|NCT02667886|525088116|FG002|Dose Escalation (Part A)|Disease Progression|3|||
145610068|NCT02667886|525088117|FG003|Dose Escalation (Part A)|Disease Progression|0|||
145610069|NCT02667886|525088118|FG004|Dose Escalation (Part A)|Disease Progression|0|||
145610070|NCT02667886|525088114|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
145610071|NCT02667886|525088115|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
145610072|NCT02667886|525088116|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
145610073|NCT02667886|525088117|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
145610074|NCT02667886|525088118|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
145610075|NCT02667886|525088114|FG000|Dose Expansion (Part B)|Adverse Event|0|||
145610076|NCT02667886|525088115|FG001|Dose Expansion (Part B)|Adverse Event|0|||
145610077|NCT02667886|525088116|FG002|Dose Expansion (Part B)|Adverse Event|0|||
145610078|NCT02667886|525088117|FG003|Dose Expansion (Part B)|Adverse Event|9|||
145790580|NCT01094730|525738985|FG001|Period 2 (14 Days)|Adverse Event|1|||
145790581|NCT01094730|525738984|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
145790582|NCT01094730|525738985|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
145790583|NCT01934894|525738986|FG000|Overall Study|Adverse Event|1|||
145790584|NCT01934894|525738987|FG001|Overall Study|Adverse Event|2|||
145790585|NCT01934894|525738986|FG000|Overall Study|Death|2|||
145790586|NCT01934894|525738987|FG001|Overall Study|Death|0|||
145790587|NCT01934894|525738986|FG000|Overall Study|Withdrawal by Subject|0|||
145790588|NCT01934894|525738987|FG001|Overall Study|Withdrawal by Subject|1|||
145790589|NCT01934894|525738986|FG000|Overall Study|Progressive Disease|3|||
145790590|NCT01934894|525738987|FG001|Overall Study|Progressive Disease|2|||
145790591|NCT04096326|525738988|FG000|Overall Study|Withdrawal by Subject|0|||
145790592|NCT04096326|525738989|FG001|Overall Study|Withdrawal by Subject|0|||
145790593|NCT04096326|525738990|FG002|Overall Study|Withdrawal by Subject|0|||
145790594|NCT04096326|525738991|FG003|Overall Study|Withdrawal by Subject|0|||
145610079|NCT02667886|525088118|FG004|Dose Expansion (Part B)|Adverse Event|0|||
145610080|NCT02667886|525088114|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
145610081|NCT02667886|525088115|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
145610082|NCT02667886|525088116|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
145610083|NCT02667886|525088117|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
145610084|NCT02667886|525088118|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
145790595|NCT04096326|525738992|FG004|Overall Study|Withdrawal by Subject|0|||
145790596|NCT04096326|525738993|FG005|Overall Study|Withdrawal by Subject|0|||
145542220|NCT03945773|524846358|FG000|Overall Study|Physician Decision|1|||
145542221|NCT03945773|524846359|FG001|Overall Study|Physician Decision|0|||
145542222|NCT03945773|524846358|FG000|Overall Study|Other|1|||
145542223|NCT03945773|524846359|FG001|Overall Study|Other|0|||
145542224|NCT03945773|524846358|FG000|Overall Study|Ongoing at the time of DCO|4|||
145542225|NCT03945773|524846359|FG001|Overall Study|Ongoing at the time of DCO|3|||
145542226|NCT01713686|524846360|FG000|Overall Study|Lost to Follow-up|9|||
145542227|NCT01713686|524846360|FG000|Overall Study|Withdrawal by Subject|6|||
145542228|NCT02200211|524846365|FG000|Overall Study|Lost to Follow-up|7|||
145542229|NCT02200211|524846366|FG001|Overall Study|Lost to Follow-up|7|||
145542230|NCT02200211|524846367|FG002|Overall Study|Lost to Follow-up|1|||
145542231|NCT02200211|524846368|FG003|Overall Study|Lost to Follow-up|2|||
145542232|NCT02200211|524846365|FG000|Overall Study|Withdrawal by Subject|1|||
145542233|NCT02200211|524846366|FG001|Overall Study|Withdrawal by Subject|0|||
145542234|NCT02200211|524846367|FG002|Overall Study|Withdrawal by Subject|0|||
145542235|NCT02200211|524846368|FG003|Overall Study|Withdrawal by Subject|0|||
145542236|NCT00381485|524846369|FG000|Open-Label Run-In Period|Adverse Event|9|||
145542237|NCT00381485|524846370|FG001|Open-Label Run-In Period|Adverse Event|0|||
145542238|NCT00381485|524846371|FG002|Open-Label Run-In Period|Adverse Event|0|||
145542239|NCT00381485|524846372|FG003|Open-Label Run-In Period|Adverse Event|0|||
145542240|NCT00381485|524846369|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
145542241|NCT00381485|524846370|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
145542242|NCT00381485|524846371|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
145542243|NCT00381485|524846372|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
145542244|NCT00381485|524846369|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
145542245|NCT00381485|524846370|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
145542246|NCT00381485|524846371|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
145542247|NCT00381485|524846372|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
145542248|NCT00381485|524846369|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
145790597|NCT04096326|525738994|FG006|Overall Study|Withdrawal by Subject|1|||
145790598|NCT04096326|525738995|FG007|Overall Study|Withdrawal by Subject|0|||
145790599|NCT04096326|525738996|FG008|Overall Study|Withdrawal by Subject|0|||
145790600|NCT04096326|525738997|FG009|Overall Study|Withdrawal by Subject|0|||
145790601|NCT04096326|525738988|FG000|Overall Study|Lost to Follow-up|0|||
145790602|NCT04096326|525738989|FG001|Overall Study|Lost to Follow-up|1|||
145790603|NCT04096326|525738990|FG002|Overall Study|Lost to Follow-up|0|||
145790604|NCT04096326|525738991|FG003|Overall Study|Lost to Follow-up|0|||
145790605|NCT04096326|525738992|FG004|Overall Study|Lost to Follow-up|0|||
145790606|NCT04096326|525738993|FG005|Overall Study|Lost to Follow-up|0|||
145542249|NCT00381485|524846370|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
145790607|NCT04096326|525738994|FG006|Overall Study|Lost to Follow-up|0|||
145542250|NCT00381485|524846371|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
145790608|NCT04096326|525738995|FG007|Overall Study|Lost to Follow-up|0|||
145542251|NCT00381485|524846372|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
145542252|NCT00381485|524846369|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
145790609|NCT04096326|525738996|FG008|Overall Study|Lost to Follow-up|0|||
145790610|NCT04096326|525738997|FG009|Overall Study|Lost to Follow-up|0|||
145790611|NCT04096326|525738988|FG000|Overall Study|COVID-19-related reasons|0|||
145790612|NCT04096326|525738989|FG001|Overall Study|COVID-19-related reasons|0|||
145790613|NCT04096326|525738990|FG002|Overall Study|COVID-19-related reasons|0|||
145790614|NCT04096326|525738991|FG003|Overall Study|COVID-19-related reasons|0|||
145790615|NCT04096326|525738992|FG004|Overall Study|COVID-19-related reasons|1|||
145790616|NCT04096326|525738993|FG005|Overall Study|COVID-19-related reasons|5|||
145790617|NCT04096326|525738994|FG006|Overall Study|COVID-19-related reasons|0|||
145790618|NCT04096326|525738995|FG007|Overall Study|COVID-19-related reasons|0|||
145790619|NCT04096326|525738996|FG008|Overall Study|COVID-19-related reasons|0|||
145790620|NCT04096326|525738997|FG009|Overall Study|COVID-19-related reasons|0|||
145790621|NCT04804033|525738999|FG000|Period 1: DBT Phase|Adverse Event|1|||
145790622|NCT04804033|525739000|FG001|Period 1: DBT Phase|Adverse Event|5|||
145790623|NCT04804033|525739001|FG002|Period 1: DBT Phase|Adverse Event|3|||
145790624|NCT04804033|525739002|FG003|Period 1: DBT Phase|Adverse Event|4|||
145790625|NCT04804033|525738999|FG000|Period 1: DBT Phase|Death|1|||
145790626|NCT04804033|525739000|FG001|Period 1: DBT Phase|Death|0|||
145790627|NCT04804033|525739001|FG002|Period 1: DBT Phase|Death|0|||
145790628|NCT04804033|525739002|FG003|Period 1: DBT Phase|Death|0|||
145790629|NCT04804033|525738999|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
145790630|NCT04804033|525739000|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
145790631|NCT04804033|525739001|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
145790632|NCT04804033|525739002|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
145790633|NCT04804033|525738999|FG000|Period 1: DBT Phase|Non-compliance|1|||
145790634|NCT04804033|525739000|FG001|Period 1: DBT Phase|Non-compliance|0|||
145790635|NCT04804033|525739001|FG002|Period 1: DBT Phase|Non-compliance|1|||
145790636|NCT04804033|525739002|FG003|Period 1: DBT Phase|Non-compliance|2|||
145542253|NCT00381485|524846370|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
145542254|NCT00381485|524846371|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
145790637|NCT04804033|525738999|FG000|Period 1: DBT Phase|Other|0|||
145790638|NCT04804033|525739000|FG001|Period 1: DBT Phase|Other|1|||
145790639|NCT04804033|525739001|FG002|Period 1: DBT Phase|Other|0|||
145790640|NCT04804033|525739002|FG003|Period 1: DBT Phase|Other|0|||
145790641|NCT04804033|525738999|FG000|Period 1: DBT Phase|Pregnancy|2|||
145790642|NCT04804033|525739000|FG001|Period 1: DBT Phase|Pregnancy|0|||
145790643|NCT04804033|525739001|FG002|Period 1: DBT Phase|Pregnancy|0|||
145790644|NCT04804033|525739002|FG003|Period 1: DBT Phase|Pregnancy|0|||
145790645|NCT04804033|525738999|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
145790646|NCT04804033|525739000|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
145790647|NCT04804033|525739001|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
145790648|NCT04804033|525739002|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
145790649|NCT04804033|525738999|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
145790650|NCT04804033|525739000|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
145790651|NCT04804033|525739001|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
145790652|NCT04804033|525739002|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
145790653|NCT04804033|525738999|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
145790654|NCT04804033|525739000|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
145790655|NCT04804033|525739001|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
145790656|NCT04804033|525739002|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
145790657|NCT04804033|525738999|FG000|Period 2: OLE Phase|Adverse Event|3|||
145542255|NCT00381485|524846372|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
145542256|NCT00381485|524846369|FG000|Open-Label Run-In Period|Treatment failure|1|||
145542257|NCT00381485|524846370|FG001|Open-Label Run-In Period|Treatment failure|0|||
145790658|NCT04804033|525739000|FG001|Period 2: OLE Phase|Adverse Event|4|||
145790659|NCT04804033|525739001|FG002|Period 2: OLE Phase|Adverse Event|2|||
145790660|NCT04804033|525739002|FG003|Period 2: OLE Phase|Adverse Event|0|||
145790661|NCT04804033|525738999|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
145790662|NCT04804033|525739000|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
145790663|NCT04804033|525739001|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
145790664|NCT04804033|525739002|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
145790665|NCT04804033|525738999|FG000|Period 2: OLE Phase|Non-compliance|2|||
145790666|NCT04804033|525739000|FG001|Period 2: OLE Phase|Non-compliance|2|||
145790667|NCT04804033|525739001|FG002|Period 2: OLE Phase|Non-compliance|0|||
145282316|NCT00686920|523883094|FG000|Overall Study|Liver Transplant|23|||
145542258|NCT00381485|524846371|FG002|Open-Label Run-In Period|Treatment failure|0|||
145542259|NCT00381485|524846372|FG003|Open-Label Run-In Period|Treatment failure|0|||
145542260|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145542261|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Adverse Event|2|||
145542262|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Adverse Event|2|||
145542263|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Adverse Event|5|||
145542264|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145542265|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
145542266|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
145542267|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
145542268|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145542269|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
145542270|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
145542271|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
145542272|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
145542273|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
145542274|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
145542275|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
145542276|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
145542277|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
145542278|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
145542279|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
145542280|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
145542281|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
145542282|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
145542283|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
145542284|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
145542285|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
145542286|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
145790668|NCT04804033|525739002|FG003|Period 2: OLE Phase|Non-compliance|1|||
145790669|NCT04804033|525738999|FG000|Period 2: OLE Phase|Other|0|||
145790670|NCT04804033|525739000|FG001|Period 2: OLE Phase|Other|2|||
145790671|NCT04804033|525739001|FG002|Period 2: OLE Phase|Other|0|||
145790672|NCT04804033|525739002|FG003|Period 2: OLE Phase|Other|0|||
145790673|NCT04804033|525738999|FG000|Period 2: OLE Phase|Physician Decision|1|||
145790674|NCT04804033|525739000|FG001|Period 2: OLE Phase|Physician Decision|1|||
145790675|NCT04804033|525739001|FG002|Period 2: OLE Phase|Physician Decision|0|||
145790676|NCT04804033|525739002|FG003|Period 2: OLE Phase|Physician Decision|0|||
145790677|NCT04804033|525738999|FG000|Period 2: OLE Phase|Pregnancy|0|||
145790678|NCT04804033|525739000|FG001|Period 2: OLE Phase|Pregnancy|0|||
145790679|NCT04804033|525739001|FG002|Period 2: OLE Phase|Pregnancy|2|||
145790680|NCT04804033|525739002|FG003|Period 2: OLE Phase|Pregnancy|0|||
145790681|NCT04804033|525738999|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
145790682|NCT04804033|525739000|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
145790683|NCT04804033|525739001|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
145790684|NCT04804033|525739002|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
145790685|NCT04804033|525738999|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
145790686|NCT04804033|525739000|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
145790687|NCT04804033|525739001|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
145790688|NCT04804033|525739002|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
145790689|NCT04804033|525738999|FG000|Period 2: OLE Phase|Not reported|0|||
145790690|NCT04804033|525739000|FG001|Period 2: OLE Phase|Not reported|2|||
145790691|NCT04804033|525739001|FG002|Period 2: OLE Phase|Not reported|0|||
145790692|NCT04804033|525739002|FG003|Period 2: OLE Phase|Not reported|0|||
145790693|NCT04804033|525738999|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
145790694|NCT04804033|525739000|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
145790695|NCT04804033|525739001|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
145542287|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
145610085|NCT02667886|525088114|FG000|Dose Expansion (Part B)|Disease Progression|0|||
145610086|NCT02667886|525088115|FG001|Dose Expansion (Part B)|Disease Progression|0|||
145610087|NCT02667886|525088116|FG002|Dose Expansion (Part B)|Disease Progression|0|||
145610088|NCT02667886|525088117|FG003|Dose Expansion (Part B)|Disease Progression|38|||
145790696|NCT04804033|525739002|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
145790697|NCT04804033|525738999|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
145790698|NCT04804033|525739000|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
145790699|NCT04804033|525739001|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
145790700|NCT04804033|525739002|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
145790701|NCT04804033|525738999|FG000|Period 3: Follow-up Phase|Other|0|||
145790702|NCT04804033|525739000|FG001|Period 3: Follow-up Phase|Other|1|||
145790703|NCT04804033|525739001|FG002|Period 3: Follow-up Phase|Other|2|||
145542288|NCT00381485|524846369|FG000|Double-Blind Treatment Period|Administrative|0|||
145790704|NCT04804033|525739002|FG003|Period 3: Follow-up Phase|Other|1|||
145790705|NCT04804033|525738999|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
145790706|NCT04804033|525739000|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
145790707|NCT04804033|525739001|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
145790708|NCT04804033|525739002|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
145790709|NCT04804033|525738999|FG000|Period 3: Follow-up Phase|Not reported|18|||
145790710|NCT04804033|525739000|FG001|Period 3: Follow-up Phase|Not reported|15|||
145790711|NCT04804033|525739001|FG002|Period 3: Follow-up Phase|Not reported|1|||
145790712|NCT04804033|525739002|FG003|Period 3: Follow-up Phase|Not reported|4|||
145790713|NCT01100307|525739003|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
145790714|NCT01100307|525739004|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
145790715|NCT01100307|525739003|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
145790716|NCT01100307|525739004|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
145790717|NCT01100307|525739003|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
145790718|NCT01100307|525739004|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
145790719|NCT01100307|525739003|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
145790720|NCT01100307|525739004|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
145790721|NCT01100307|525739003|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
145790722|NCT01100307|525739004|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
145790723|NCT01100307|525739003|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
145790724|NCT01100307|525739004|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
145790725|NCT02509598|525739005|FG000|Overall Study|Withdrawal by Subject|1|||
145790726|NCT02993224|525739006|FG000|Core Phase - Period 1|Adverse Event|4|||
145790727|NCT02993224|525739006|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
145790728|NCT02993224|525739006|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
145790729|NCT02993224|525739006|FG000|Core Phase- Period 2|Adverse Event|1|||
145790730|NCT02993224|525739006|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
145790731|NCT02993224|525739006|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
145790732|NCT02993224|525739006|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
145542289|NCT00381485|524846370|FG001|Double-Blind Treatment Period|Administrative|1|||
145542290|NCT00381485|524846371|FG002|Double-Blind Treatment Period|Administrative|0|||
145542291|NCT00381485|524846372|FG003|Double-Blind Treatment Period|Administrative|1|||
145542292|NCT01235351|524846373|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
145542293|NCT01235351|524846374|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
145542294|NCT01918774|524846375|FG000|Overall Study|Lost prior to first CBTw session|4|||
145542295|NCT01918774|524846375|FG000|Overall Study|Lost to Follow-up|1|||
145542296|NCT01606800|524846376|FG000|Overall Study|Adverse Event|3|||
145542297|NCT01606800|524846377|FG001|Overall Study|Adverse Event|1|||
145542298|NCT01606800|524846376|FG000|Overall Study|Participant withdrew consent|0|||
145542299|NCT01606800|524846377|FG001|Overall Study|Participant withdrew consent|1|||
145610089|NCT02667886|525088118|FG004|Dose Expansion (Part B)|Disease Progression|0|||
145610090|NCT02667886|525088114|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
145790733|NCT02993224|525739006|FG000|Extension Phase|Adverse Event|3|||
145790734|NCT02993224|525739006|FG000|Extension Phase|Withdrawal by Subject|3|||
145790735|NCT02993224|525739006|FG000|Extension Phase|Lost to Follow-up|2|||
145790736|NCT02993224|525739006|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
145790737|NCT01423617|525739010|FG000|Overall Study|Lost to Follow-up|0|||
145790738|NCT01423617|525739011|FG001|Overall Study|Lost to Follow-up|1|||
145790739|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
145790740|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
145790741|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
145790742|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
145790743|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
145790744|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
145790745|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
145790746|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
145790747|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
145790748|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
145790749|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
145790750|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
145790751|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
145790752|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
145790753|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
145790754|NCT03855137|525739014|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
145542300|NCT01606800|524846376|FG000|Overall Study|Missing completion status|2|||
145542301|NCT01606800|524846377|FG001|Overall Study|Missing completion status|0|||
145542302|NCT00042289|524846378|FG000|Overall Study|Lost to Follow-up|3|||
145282317|NCT00686920|523883095|FG001|Overall Study|Liver Transplant|8|||
145542303|NCT00042289|524846379|FG001|Overall Study|Lost to Follow-up|0|||
145542304|NCT00042289|524846380|FG002|Overall Study|Lost to Follow-up|0|||
145542305|NCT00042289|524846381|FG003|Overall Study|Lost to Follow-up|1|||
145542306|NCT00042289|524846382|FG004|Overall Study|Lost to Follow-up|3|||
145542307|NCT00042289|524846383|FG005|Overall Study|Lost to Follow-up|3|||
145542308|NCT00042289|524846384|FG006|Overall Study|Lost to Follow-up|6|||
145542309|NCT00042289|524846385|FG007|Overall Study|Lost to Follow-up|1|||
145542310|NCT00042289|524846386|FG008|Overall Study|Lost to Follow-up|1|||
145542311|NCT00042289|524846387|FG009|Overall Study|Lost to Follow-up|0|||
145542312|NCT00042289|524846388|FG010|Overall Study|Lost to Follow-up|0|||
145542313|NCT00042289|524846389|FG011|Overall Study|Lost to Follow-up|0|||
145542314|NCT00042289|524846390|FG012|Overall Study|Lost to Follow-up|0|||
145542315|NCT00042289|524846391|FG013|Overall Study|Lost to Follow-up|0|||
145790755|NCT03855137|525739015|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
145790756|NCT03855137|525739016|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
145542316|NCT00042289|524846392|FG014|Overall Study|Lost to Follow-up|0|||
145542317|NCT00042289|524846393|FG015|Overall Study|Lost to Follow-up|1|||
145542318|NCT00042289|524846394|FG016|Overall Study|Lost to Follow-up|1|||
145542319|NCT00042289|524846395|FG017|Overall Study|Lost to Follow-up|0|||
145542320|NCT00042289|524846396|FG018|Overall Study|Lost to Follow-up|3|||
145542321|NCT00042289|524846397|FG019|Overall Study|Lost to Follow-up|2|||
145542322|NCT00042289|524846398|FG020|Overall Study|Lost to Follow-up|0|||
145790757|NCT03855137|525739014|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
145790758|NCT03855137|525739015|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
145790759|NCT03855137|525739016|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
145790760|NCT03855137|525739014|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
145790761|NCT03855137|525739015|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
145790762|NCT03855137|525739016|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
145790763|NCT03855137|525739014|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
145790764|NCT03855137|525739015|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
145542323|NCT00042289|524846399|FG021|Overall Study|Lost to Follow-up|0|||
145542324|NCT00042289|524846400|FG022|Overall Study|Lost to Follow-up|0|||
145542325|NCT00042289|524846401|FG023|Overall Study|Lost to Follow-up|0|||
145542326|NCT00042289|524846402|FG024|Overall Study|Lost to Follow-up|0|||
145542327|NCT00042289|524846403|FG025|Overall Study|Lost to Follow-up|0|||
145542328|NCT00042289|524846404|FG026|Overall Study|Lost to Follow-up|2|||
145542329|NCT00042289|524846405|FG027|Overall Study|Lost to Follow-up|2|||
145542330|NCT00042289|524846406|FG028|Overall Study|Lost to Follow-up|2|||
145542331|NCT00042289|524846407|FG029|Overall Study|Lost to Follow-up|0|||
145542332|NCT00042289|524846408|FG030|Overall Study|Lost to Follow-up|0|||
145542333|NCT00042289|524846409|FG031|Overall Study|Lost to Follow-up|2|||
145542334|NCT00042289|524846410|FG032|Overall Study|Lost to Follow-up|1|||
145542335|NCT00042289|524846411|FG033|Overall Study|Lost to Follow-up|1|||
145542336|NCT00042289|524846412|FG034|Overall Study|Lost to Follow-up|1|||
145790765|NCT03855137|525739016|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
145790766|NCT03855137|525739014|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
145542337|NCT00042289|524846413|FG035|Overall Study|Lost to Follow-up|2|||
145542338|NCT00042289|524846414|FG036|Overall Study|Lost to Follow-up|1|||
145542339|NCT00042289|524846415|FG037|Overall Study|Lost to Follow-up|1|||
145542340|NCT00042289|524846416|FG038|Overall Study|Lost to Follow-up|0|||
145542341|NCT00042289|524846417|FG039|Overall Study|Lost to Follow-up|5|||
145542342|NCT00042289|524846418|FG040|Overall Study|Lost to Follow-up|0|||
145542343|NCT00042289|524846419|FG041|Overall Study|Lost to Follow-up|2|||
145542344|NCT00042289|524846420|FG042|Overall Study|Lost to Follow-up|2|||
145542345|NCT00042289|524846421|FG043|Overall Study|Lost to Follow-up|0|||
145542346|NCT00042289|524846422|FG044|Overall Study|Lost to Follow-up|0|||
145610091|NCT02667886|525088115|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
145542347|NCT00042289|524846423|FG045|Overall Study|Lost to Follow-up|1|||
145542348|NCT00042289|524846424|FG046|Overall Study|Lost to Follow-up|0|||
145542349|NCT00042289|524846378|FG000|Overall Study|Other reason|0|||
145542350|NCT00042289|524846379|FG001|Overall Study|Other reason|0|||
145542351|NCT00042289|524846380|FG002|Overall Study|Other reason|0|||
145610092|NCT02667886|525088116|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
145610093|NCT02667886|525088117|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
145610094|NCT02667886|525088118|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
145610095|NCT02667886|525088114|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
145610096|NCT02667886|525088115|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
145610097|NCT02667886|525088116|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
145610098|NCT02667886|525088117|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
145610099|NCT02667886|525088118|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
145790767|NCT03855137|525739015|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
145790768|NCT03855137|525739016|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
145790769|NCT02435277|525739017|FG000|Overall Study|Adverse Event|1|||
145790770|NCT02435277|525739018|FG001|Overall Study|Adverse Event|1|||
145790771|NCT02435277|525739019|FG002|Overall Study|Adverse Event|0|||
145790772|NCT02435277|525739020|FG003|Overall Study|Adverse Event|0|||
145790773|NCT02435277|525739017|FG000|Overall Study|Withdrawal by Subject|1|||
145790774|NCT02435277|525739018|FG001|Overall Study|Withdrawal by Subject|0|||
145790775|NCT02435277|525739019|FG002|Overall Study|Withdrawal by Subject|0|||
145790776|NCT02435277|525739020|FG003|Overall Study|Withdrawal by Subject|0|||
145790777|NCT01067508|525739021|FG000|Overall Study|Physician Decision|0|||
145790778|NCT01067508|525739022|FG001|Overall Study|Physician Decision|1|||
145790779|NCT01067508|525739021|FG000|Overall Study|Withdrawal by Subject|0|||
145790780|NCT01067508|525739022|FG001|Overall Study|Withdrawal by Subject|1|||
145790781|NCT04715230|525739023|FG000|Overall Study|Withdrawal by Subject|1|||
145790782|NCT04715230|525739024|FG001|Overall Study|Withdrawal by Subject|0|||
145790783|NCT04715230|525739025|FG002|Overall Study|Withdrawal by Subject|0|||
145790784|NCT04715230|525739023|FG000|Overall Study|Lost to Follow-up|0|||
145790785|NCT04715230|525739024|FG001|Overall Study|Lost to Follow-up|5|||
145790786|NCT04715230|525739025|FG002|Overall Study|Lost to Follow-up|1|||
145790787|NCT01687413|525739039|FG000|Overall Study|Withdrawal by Subject|0|||
145790788|NCT01687413|525739040|FG001|Overall Study|Withdrawal by Subject|2|||
145790789|NCT01687413|525739039|FG000|Overall Study|Not eligible|0|||
145790790|NCT01687413|525739040|FG001|Overall Study|Not eligible|2|||
145790791|NCT01687413|525739039|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
145790792|NCT01687413|525739040|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
145790793|NCT00488618|525739048|FG000|Overall Study|Adverse Event|13|||
145790794|NCT00488618|525739049|FG001|Overall Study|Adverse Event|17|||
145790795|NCT00488618|525739048|FG000|Overall Study|Insufficient Therapeutic Response|18|||
145790796|NCT00488618|525739049|FG001|Overall Study|Insufficient Therapeutic Response|11|||
145610100|NCT02667886|525088114|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
145790797|NCT00488618|525739048|FG000|Overall Study|Protocol Violation|0|||
145790798|NCT00488618|525739049|FG001|Overall Study|Protocol Violation|2|||
145790799|NCT00488618|525739048|FG000|Overall Study|Withdrawal of Consent|15|||
145790800|NCT00488618|525739049|FG001|Overall Study|Withdrawal of Consent|13|||
145542352|NCT00042289|524846381|FG003|Overall Study|Other reason|2|||
145542353|NCT00042289|524846382|FG004|Overall Study|Other reason|0|||
145542354|NCT00042289|524846383|FG005|Overall Study|Other reason|0|||
145542355|NCT00042289|524846384|FG006|Overall Study|Other reason|0|||
145542356|NCT00042289|524846385|FG007|Overall Study|Other reason|0|||
145542357|NCT00042289|524846386|FG008|Overall Study|Other reason|0|||
145542358|NCT00042289|524846387|FG009|Overall Study|Other reason|0|||
145542359|NCT00042289|524846388|FG010|Overall Study|Other reason|0|||
145542360|NCT00042289|524846389|FG011|Overall Study|Other reason|0|||
145542361|NCT00042289|524846390|FG012|Overall Study|Other reason|0|||
145542362|NCT00042289|524846391|FG013|Overall Study|Other reason|0|||
145542363|NCT00042289|524846392|FG014|Overall Study|Other reason|0|||
145542364|NCT00042289|524846393|FG015|Overall Study|Other reason|0|||
145542365|NCT00042289|524846394|FG016|Overall Study|Other reason|0|||
145542366|NCT00042289|524846395|FG017|Overall Study|Other reason|0|||
145542367|NCT00042289|524846396|FG018|Overall Study|Other reason|1|||
145542368|NCT00042289|524846397|FG019|Overall Study|Other reason|0|||
145542369|NCT00042289|524846398|FG020|Overall Study|Other reason|0|||
145542370|NCT00042289|524846399|FG021|Overall Study|Other reason|0|||
145542371|NCT00042289|524846400|FG022|Overall Study|Other reason|0|||
145542372|NCT00042289|524846401|FG023|Overall Study|Other reason|1|||
145542373|NCT00042289|524846402|FG024|Overall Study|Other reason|0|||
145542374|NCT00042289|524846403|FG025|Overall Study|Other reason|0|||
145542375|NCT00042289|524846404|FG026|Overall Study|Other reason|1|||
145542376|NCT00042289|524846405|FG027|Overall Study|Other reason|0|||
145542377|NCT00042289|524846406|FG028|Overall Study|Other reason|3|||
145542378|NCT00042289|524846407|FG029|Overall Study|Other reason|0|||
145542379|NCT00042289|524846408|FG030|Overall Study|Other reason|0|||
145542380|NCT00042289|524846409|FG031|Overall Study|Other reason|1|||
145542381|NCT00042289|524846410|FG032|Overall Study|Other reason|0|||
145542382|NCT00042289|524846411|FG033|Overall Study|Other reason|1|||
145542383|NCT00042289|524846412|FG034|Overall Study|Other reason|0|||
145610101|NCT02667886|525088115|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
145790801|NCT00488618|525739048|FG000|Overall Study|Lost to Follow-up|1|||
145790802|NCT00488618|525739049|FG001|Overall Study|Lost to Follow-up|0|||
145790803|NCT00992446|525739050|FG000|Overall Study|Disease Progression|1|||
145790804|NCT00992446|525739050|FG000|Overall Study|Withdrawal by Subject|2|||
145790805|NCT00992446|525739050|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
145790806|NCT00755846|525740953|FG000|Overall Study|Adverse Event|0|||
145790807|NCT00755846|525740954|FG001|Overall Study|Adverse Event|0|||
145790808|NCT00755846|525740955|FG002|Overall Study|Adverse Event|0|||
145790809|NCT00755846|525740956|FG003|Overall Study|Adverse Event|1|||
145790810|NCT00755846|525740957|FG004|Overall Study|Adverse Event|3|||
145790811|NCT00755846|525740958|FG005|Overall Study|Adverse Event|2|||
145282318|NCT00686920|523883094|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
145282319|NCT00686920|523883095|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
145790812|NCT00755846|525740953|FG000|Overall Study|Protocol Violation|1|||
145790813|NCT00755846|525740954|FG001|Overall Study|Protocol Violation|1|||
145790814|NCT00755846|525740955|FG002|Overall Study|Protocol Violation|1|||
145790815|NCT00755846|525740956|FG003|Overall Study|Protocol Violation|1|||
145790816|NCT00755846|525740957|FG004|Overall Study|Protocol Violation|1|||
145790817|NCT00755846|525740958|FG005|Overall Study|Protocol Violation|1|||
145282320|NCT00686920|523883094|FG000|Overall Study|Withdrawal by Subject|23|||
145542384|NCT00042289|524846413|FG035|Overall Study|Other reason|2|||
145790818|NCT00755846|525740953|FG000|Overall Study|Lost to Follow-up|0|||
145790819|NCT00755846|525740954|FG001|Overall Study|Lost to Follow-up|2|||
145790820|NCT00755846|525740955|FG002|Overall Study|Lost to Follow-up|1|||
145790821|NCT00755846|525740956|FG003|Overall Study|Lost to Follow-up|0|||
145790822|NCT00755846|525740957|FG004|Overall Study|Lost to Follow-up|4|||
145790823|NCT00755846|525740958|FG005|Overall Study|Lost to Follow-up|2|||
145790824|NCT00755846|525740953|FG000|Overall Study|Withdrawal by Subject|2|||
145790825|NCT00755846|525740954|FG001|Overall Study|Withdrawal by Subject|3|||
145790826|NCT00755846|525740955|FG002|Overall Study|Withdrawal by Subject|5|||
145790827|NCT00755846|525740956|FG003|Overall Study|Withdrawal by Subject|2|||
145790828|NCT00755846|525740957|FG004|Overall Study|Withdrawal by Subject|0|||
145790829|NCT00755846|525740958|FG005|Overall Study|Withdrawal by Subject|1|||
145790830|NCT00755846|525740953|FG000|Overall Study|Hyperglycemic Rescue|21|||
145790831|NCT00755846|525740954|FG001|Overall Study|Hyperglycemic Rescue|7|||
145790832|NCT00755846|525740955|FG002|Overall Study|Hyperglycemic Rescue|5|||
145542385|NCT00042289|524846414|FG036|Overall Study|Other reason|0|||
145542386|NCT00042289|524846415|FG037|Overall Study|Other reason|0|||
145542387|NCT00042289|524846416|FG038|Overall Study|Other reason|0|||
145542388|NCT00042289|524846417|FG039|Overall Study|Other reason|0|||
145542389|NCT00042289|524846418|FG040|Overall Study|Other reason|0|||
145610102|NCT02667886|525088116|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
145542390|NCT00042289|524846419|FG041|Overall Study|Other reason|0|||
145542391|NCT00042289|524846420|FG042|Overall Study|Other reason|0|||
145790833|NCT00755846|525740956|FG003|Overall Study|Hyperglycemic Rescue|8|||
145790834|NCT00755846|525740957|FG004|Overall Study|Hyperglycemic Rescue|8|||
145542392|NCT00042289|524846421|FG043|Overall Study|Other reason|1|||
145542393|NCT00042289|524846422|FG044|Overall Study|Other reason|0|||
145542394|NCT00042289|524846423|FG045|Overall Study|Other reason|0|||
145542395|NCT00042289|524846424|FG046|Overall Study|Other reason|0|||
145542396|NCT00042289|524846378|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145542397|NCT00042289|524846379|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145542398|NCT00042289|524846380|FG002|Overall Study|Severe debilitation, unable to continue|0|||
145542399|NCT00042289|524846381|FG003|Overall Study|Severe debilitation, unable to continue|0|||
145542400|NCT00042289|524846382|FG004|Overall Study|Severe debilitation, unable to continue|0|||
145542401|NCT00042289|524846383|FG005|Overall Study|Severe debilitation, unable to continue|0|||
145542402|NCT00042289|524846384|FG006|Overall Study|Severe debilitation, unable to continue|0|||
145542403|NCT00042289|524846385|FG007|Overall Study|Severe debilitation, unable to continue|0|||
145542404|NCT00042289|524846386|FG008|Overall Study|Severe debilitation, unable to continue|0|||
145542405|NCT00042289|524846387|FG009|Overall Study|Severe debilitation, unable to continue|0|||
145542406|NCT00042289|524846388|FG010|Overall Study|Severe debilitation, unable to continue|0|||
145542407|NCT00042289|524846389|FG011|Overall Study|Severe debilitation, unable to continue|0|||
145542408|NCT00042289|524846390|FG012|Overall Study|Severe debilitation, unable to continue|0|||
145542409|NCT00042289|524846391|FG013|Overall Study|Severe debilitation, unable to continue|0|||
145542410|NCT00042289|524846392|FG014|Overall Study|Severe debilitation, unable to continue|0|||
145542411|NCT00042289|524846393|FG015|Overall Study|Severe debilitation, unable to continue|0|||
145542412|NCT00042289|524846394|FG016|Overall Study|Severe debilitation, unable to continue|0|||
145542413|NCT00042289|524846395|FG017|Overall Study|Severe debilitation, unable to continue|0|||
145542414|NCT00042289|524846396|FG018|Overall Study|Severe debilitation, unable to continue|0|||
145542415|NCT00042289|524846397|FG019|Overall Study|Severe debilitation, unable to continue|0|||
145542416|NCT00042289|524846398|FG020|Overall Study|Severe debilitation, unable to continue|0|||
145542417|NCT00042289|524846399|FG021|Overall Study|Severe debilitation, unable to continue|1|||
145542418|NCT00042289|524846400|FG022|Overall Study|Severe debilitation, unable to continue|0|||
145542419|NCT00042289|524846401|FG023|Overall Study|Severe debilitation, unable to continue|1|||
145542420|NCT00042289|524846402|FG024|Overall Study|Severe debilitation, unable to continue|0|||
145542421|NCT00042289|524846403|FG025|Overall Study|Severe debilitation, unable to continue|0|||
145542422|NCT00042289|524846404|FG026|Overall Study|Severe debilitation, unable to continue|0|||
145542423|NCT00042289|524846405|FG027|Overall Study|Severe debilitation, unable to continue|1|||
145542424|NCT00042289|524846406|FG028|Overall Study|Severe debilitation, unable to continue|0|||
145542425|NCT00042289|524846407|FG029|Overall Study|Severe debilitation, unable to continue|0|||
145542426|NCT00042289|524846408|FG030|Overall Study|Severe debilitation, unable to continue|0|||
145542427|NCT00042289|524846409|FG031|Overall Study|Severe debilitation, unable to continue|1|||
145542428|NCT00042289|524846410|FG032|Overall Study|Severe debilitation, unable to continue|1|||
145542429|NCT00042289|524846411|FG033|Overall Study|Severe debilitation, unable to continue|0|||
145542430|NCT00042289|524846412|FG034|Overall Study|Severe debilitation, unable to continue|0|||
145542431|NCT00042289|524846413|FG035|Overall Study|Severe debilitation, unable to continue|0|||
145542432|NCT00042289|524846414|FG036|Overall Study|Severe debilitation, unable to continue|0|||
145542433|NCT00042289|524846415|FG037|Overall Study|Severe debilitation, unable to continue|0|||
145542434|NCT00042289|524846416|FG038|Overall Study|Severe debilitation, unable to continue|0|||
145542435|NCT00042289|524846417|FG039|Overall Study|Severe debilitation, unable to continue|0|||
145542436|NCT00042289|524846418|FG040|Overall Study|Severe debilitation, unable to continue|0|||
145542437|NCT00042289|524846419|FG041|Overall Study|Severe debilitation, unable to continue|0|||
145542438|NCT00042289|524846420|FG042|Overall Study|Severe debilitation, unable to continue|0|||
145542439|NCT00042289|524846421|FG043|Overall Study|Severe debilitation, unable to continue|0|||
145542440|NCT00042289|524846422|FG044|Overall Study|Severe debilitation, unable to continue|0|||
145542441|NCT00042289|524846423|FG045|Overall Study|Severe debilitation, unable to continue|0|||
145542442|NCT00042289|524846424|FG046|Overall Study|Severe debilitation, unable to continue|0|||
145542443|NCT00042289|524846378|FG000|Overall Study|Site closed|0|||
145542444|NCT00042289|524846379|FG001|Overall Study|Site closed|0|||
145542445|NCT00042289|524846380|FG002|Overall Study|Site closed|0|||
145542446|NCT00042289|524846381|FG003|Overall Study|Site closed|0|||
145542447|NCT00042289|524846382|FG004|Overall Study|Site closed|0|||
145542448|NCT00042289|524846383|FG005|Overall Study|Site closed|0|||
145542449|NCT00042289|524846384|FG006|Overall Study|Site closed|0|||
145790835|NCT00755846|525740958|FG005|Overall Study|Hyperglycemic Rescue|7|||
145282321|NCT00686920|523883095|FG001|Overall Study|Withdrawal by Subject|5|||
145282322|NCT00686920|523883094|FG000|Overall Study|Protocol Violation|2|||
145282323|NCT00686920|523883095|FG001|Overall Study|Protocol Violation|1|||
145790836|NCT00755846|525740953|FG000|Overall Study|Physician Decision|1|||
145790837|NCT00755846|525740954|FG001|Overall Study|Physician Decision|3|||
145542450|NCT00042289|524846385|FG007|Overall Study|Site closed|0|||
145542451|NCT00042289|524846386|FG008|Overall Study|Site closed|0|||
145542452|NCT00042289|524846387|FG009|Overall Study|Site closed|0|||
145542453|NCT00042289|524846388|FG010|Overall Study|Site closed|0|||
145542454|NCT00042289|524846389|FG011|Overall Study|Site closed|0|||
145282324|NCT00686920|523883094|FG000|Overall Study|Adverse Event|10|||
145542455|NCT00042289|524846390|FG012|Overall Study|Site closed|0|||
145404307|NCT00961415|524336545|FG002|Maintenance Treatment Phase|Investigators decision|0|||
145404308|NCT00961415|524336543|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145404309|NCT00961415|524336544|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
145404310|NCT00961415|524336545|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
145404311|NCT00961415|524336543|FG000|Maintenance Treatment Phase|Other reason|0|||
145404312|NCT00961415|524336544|FG001|Maintenance Treatment Phase|Other reason|1|||
145404313|NCT00961415|524336545|FG002|Maintenance Treatment Phase|Other reason|3|||
145404314|NCT00226655|524336546|FG000|Overall Study|Death|13|||
145404315|NCT00226655|524336546|FG000|Overall Study|Withdrawal by Subject|15|||
145404316|NCT00226655|524336546|FG000|Overall Study|Adverse Event|35|||
145404317|NCT00226655|524336546|FG000|Overall Study|Physician Decision|6|||
145790838|NCT00755846|525740955|FG002|Overall Study|Physician Decision|0|||
145790839|NCT00755846|525740956|FG003|Overall Study|Physician Decision|1|||
145790840|NCT00755846|525740957|FG004|Overall Study|Physician Decision|0|||
145790841|NCT00755846|525740958|FG005|Overall Study|Physician Decision|1|||
145790842|NCT00755846|525740953|FG000|Overall Study|Administrative Error|0|||
145790843|NCT00755846|525740954|FG001|Overall Study|Administrative Error|1|||
145790844|NCT00755846|525740955|FG002|Overall Study|Administrative Error|0|||
145790845|NCT00755846|525740956|FG003|Overall Study|Administrative Error|0|||
145790846|NCT00755846|525740957|FG004|Overall Study|Administrative Error|0|||
145790847|NCT00755846|525740958|FG005|Overall Study|Administrative Error|0|||
145790848|NCT00755846|525740953|FG000|Overall Study|Participant Non-compliance|0|||
145790849|NCT00755846|525740954|FG001|Overall Study|Participant Non-compliance|0|||
145790850|NCT00755846|525740955|FG002|Overall Study|Participant Non-compliance|0|||
145404318|NCT00226655|524336546|FG000|Overall Study|Clinical deterioration|10|||
145404319|NCT00284856|524336549|FG000|Overall Study|Adverse Event|3|||
145404320|NCT00284856|524336550|FG001|Overall Study|Adverse Event|3|||
145404321|NCT00284856|524336551|FG002|Overall Study|Adverse Event|3|||
145404322|NCT00284856|524336549|FG000|Overall Study|Lack of Efficacy|2|||
145404323|NCT00284856|524336550|FG001|Overall Study|Lack of Efficacy|1|||
145404324|NCT00284856|524336551|FG002|Overall Study|Lack of Efficacy|8|||
145404325|NCT00284856|524336549|FG000|Overall Study|Lost to Follow-up|25|||
145542456|NCT00042289|524846391|FG013|Overall Study|Site closed|0|||
145542457|NCT00042289|524846392|FG014|Overall Study|Site closed|0|||
145542458|NCT00042289|524846393|FG015|Overall Study|Site closed|0|||
145542459|NCT00042289|524846394|FG016|Overall Study|Site closed|0|||
145542460|NCT00042289|524846395|FG017|Overall Study|Site closed|0|||
145542461|NCT00042289|524846396|FG018|Overall Study|Site closed|0|||
145542462|NCT00042289|524846397|FG019|Overall Study|Site closed|0|||
145542463|NCT00042289|524846398|FG020|Overall Study|Site closed|0|||
145542464|NCT00042289|524846399|FG021|Overall Study|Site closed|0|||
145542465|NCT00042289|524846400|FG022|Overall Study|Site closed|0|||
145542466|NCT00042289|524846401|FG023|Overall Study|Site closed|0|||
145542467|NCT00042289|524846402|FG024|Overall Study|Site closed|0|||
145542468|NCT00042289|524846403|FG025|Overall Study|Site closed|0|||
145542469|NCT00042289|524846404|FG026|Overall Study|Site closed|0|||
145542470|NCT00042289|524846405|FG027|Overall Study|Site closed|0|||
145542471|NCT00042289|524846406|FG028|Overall Study|Site closed|0|||
145542472|NCT00042289|524846407|FG029|Overall Study|Site closed|0|||
145542473|NCT00042289|524846408|FG030|Overall Study|Site closed|0|||
145542474|NCT00042289|524846409|FG031|Overall Study|Site closed|3|||
145542475|NCT00042289|524846410|FG032|Overall Study|Site closed|0|||
145542476|NCT00042289|524846411|FG033|Overall Study|Site closed|0|||
145542477|NCT00042289|524846412|FG034|Overall Study|Site closed|0|||
145542478|NCT00042289|524846413|FG035|Overall Study|Site closed|0|||
145542479|NCT00042289|524846414|FG036|Overall Study|Site closed|1|||
145404326|NCT00284856|524336550|FG001|Overall Study|Lost to Follow-up|21|||
145404327|NCT00284856|524336551|FG002|Overall Study|Lost to Follow-up|22|||
145404328|NCT00284856|524336549|FG000|Overall Study|Protocol Violation|5|||
145542480|NCT00042289|524846415|FG037|Overall Study|Site closed|0|||
145404329|NCT00284856|524336550|FG001|Overall Study|Protocol Violation|4|||
145404330|NCT00284856|524336551|FG002|Overall Study|Protocol Violation|5|||
145542481|NCT00042289|524846416|FG038|Overall Study|Site closed|0|||
145542482|NCT00042289|524846417|FG039|Overall Study|Site closed|0|||
145542483|NCT00042289|524846418|FG040|Overall Study|Site closed|0|||
145542484|NCT00042289|524846419|FG041|Overall Study|Site closed|0|||
145542485|NCT00042289|524846420|FG042|Overall Study|Site closed|1|||
145790851|NCT00755846|525740956|FG003|Overall Study|Participant Non-compliance|0|||
145790852|NCT00755846|525740957|FG004|Overall Study|Participant Non-compliance|1|||
145542486|NCT00042289|524846421|FG043|Overall Study|Site closed|0|||
145404331|NCT00284856|524336549|FG000|Overall Study|Withdrawal by Subject|12|||
145542487|NCT00042289|524846422|FG044|Overall Study|Site closed|0|||
145542488|NCT00042289|524846423|FG045|Overall Study|Site closed|0|||
145542489|NCT00042289|524846424|FG046|Overall Study|Site closed|0|||
145790853|NCT00755846|525740958|FG005|Overall Study|Participant Non-compliance|0|||
145790854|NCT02494778|525740967|FG000|Overall Study|Death|3|||
145790855|NCT02494778|525740967|FG000|Overall Study|Other|173|||
145790856|NCT02494778|525740967|FG000|Overall Study|Lack of Efficacy|4|||
145790857|NCT02494778|525740967|FG000|Overall Study|Adverse Event|18|||
145790858|NCT02494778|525740967|FG000|Overall Study|Withdrawal by Subject|20|||
145790859|NCT02494778|525740967|FG000|Overall Study|Lost to Follow-up|2|||
145790860|NCT02494778|525740967|FG000|Overall Study|Noncompliant with study drug admin.|1|||
145790861|NCT01303380|525740968|FG000|Overall Study|Lack of compliance to study procedures|1|||
145790862|NCT00165841|525740977|FG000|Overall Study|Adverse Event|2|||
145790863|NCT00165841|525740978|FG001|Overall Study|Adverse Event|3|||
145790864|NCT00165841|525740977|FG000|Overall Study|Lack of Efficacy|6|||
145790865|NCT00165841|525740978|FG001|Overall Study|Lack of Efficacy|33|||
145790866|NCT00165841|525740977|FG000|Overall Study|Lost to Follow-up|4|||
145790867|NCT00165841|525740978|FG001|Overall Study|Lost to Follow-up|4|||
145790868|NCT00165841|525740977|FG000|Overall Study|Withdrawal by Subject|7|||
145790869|NCT00165841|525740978|FG001|Overall Study|Withdrawal by Subject|8|||
145790870|NCT00165841|525740977|FG000|Overall Study|Physician Decision|1|||
145790871|NCT00165841|525740978|FG001|Overall Study|Physician Decision|0|||
145790872|NCT00165841|525740977|FG000|Overall Study|Protocol Violation|6|||
145790873|NCT00165841|525740978|FG001|Overall Study|Protocol Violation|8|||
145790874|NCT00165841|525740977|FG000|Overall Study|Other|3|||
145790875|NCT00165841|525740978|FG001|Overall Study|Other|5|||
145790876|NCT00165841|525740977|FG000|Overall Study|Medication Noncompliance|1|||
145790877|NCT00165841|525740978|FG001|Overall Study|Medication Noncompliance|1|||
145790878|NCT00789958|525740979|FG000|Overall Study|Adverse Event|3|||
145790879|NCT00789958|525740979|FG000|Overall Study|Withdrawal by Subject|4|||
145790880|NCT00789958|525740979|FG000|Overall Study|Progression|3|||
145790881|NCT00789958|525740979|FG000|Overall Study|not protocol specified|1|||
145790882|NCT00789958|525740979|FG000|Overall Study|Not eligible/not analyzable|26|||
145790883|NCT00254293|525740982|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
145790884|NCT00254293|525740983|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
145790885|NCT00254293|525740984|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
145790886|NCT00254293|525740985|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
145790887|NCT00254293|525740986|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
145790888|NCT00254293|525740987|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
145790889|NCT00254293|525740988|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
145282325|NCT00686920|523883095|FG001|Overall Study|Adverse Event|2|||
145282326|NCT00686920|523883094|FG000|Overall Study|Personal Reason|0|||
145282327|NCT00686920|523883095|FG001|Overall Study|Personal Reason|1|||
145282328|NCT00686920|523883094|FG000|Overall Study|Lost to Follow-up|15|||
145282329|NCT00686920|523883095|FG001|Overall Study|Lost to Follow-up|3|||
145282330|NCT00686920|523883094|FG000|Overall Study|Moved to Another State|1|||
145282331|NCT00686920|523883095|FG001|Overall Study|Moved to Another State|0|||
145542490|NCT00042289|524846378|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
145542491|NCT00042289|524846379|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
145542492|NCT00042289|524846380|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
145542493|NCT00042289|524846381|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
145542494|NCT00042289|524846382|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
145542495|NCT00042289|524846383|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
145542496|NCT00042289|524846384|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
145542497|NCT00042289|524846385|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
145542498|NCT00042289|524846386|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
145542499|NCT00042289|524846387|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
145542500|NCT00042289|524846388|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
145542501|NCT00042289|524846389|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
145542502|NCT00042289|524846390|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
145542503|NCT00042289|524846391|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
145542504|NCT00042289|524846392|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
145542505|NCT00042289|524846393|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
145542506|NCT00042289|524846394|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
145790890|NCT00254293|525740982|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790891|NCT00254293|525740983|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790892|NCT00254293|525740984|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
145790893|NCT00254293|525740985|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790894|NCT00254293|525740986|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790895|NCT00254293|525740987|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790896|NCT00254293|525740988|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
145790897|NCT00254293|525740982|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145790898|NCT00254293|525740983|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145282332|NCT00686920|523883094|FG000|Overall Study|Transferred to Nursing Home|1|||
145282333|NCT00686920|523883095|FG001|Overall Study|Transferred to Nursing Home|0|||
145282334|NCT00686920|523883094|FG000|Overall Study|Noncompliance|9|||
145610103|NCT02667886|525088117|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
145610104|NCT02667886|525088118|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
145610105|NCT00594217|525088119|FG000|Overall Study|Withdrawal by Subject|1|||
145610106|NCT00594217|525088120|FG001|Overall Study|Withdrawal by Subject|3|||
145610107|NCT05408468|525088121|FG000|Overall Study|Lost to Follow-up|3|||
145610108|NCT05408468|525088122|FG001|Overall Study|Lost to Follow-up|1|||
145610109|NCT05408468|525088121|FG000|Overall Study|Physician Decision|1|||
145610110|NCT05408468|525088122|FG001|Overall Study|Physician Decision|0|||
145610111|NCT05408468|525088121|FG000|Overall Study|Overwhelmed by clinical situation|3|||
145610112|NCT05408468|525088122|FG001|Overall Study|Overwhelmed by clinical situation|0|||
145610113|NCT05408468|525088121|FG000|Overall Study|Personal illness precluding participation|1|||
145610114|NCT05408468|525088122|FG001|Overall Study|Personal illness precluding participation|0|||
145610115|NCT05408468|525088121|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
145610116|NCT05408468|525088122|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
145610117|NCT00405639|525088126|FG000|Overall Study|Withdrawal by Subject|1|||
145610118|NCT00405639|525088127|FG001|Overall Study|Withdrawal by Subject|0|||
145610119|NCT00405639|525088126|FG000|Overall Study|Adverse Event|1|||
145610120|NCT00405639|525088127|FG001|Overall Study|Adverse Event|0|||
145610121|NCT00405639|525088126|FG000|Overall Study|Seizure prior to receiving BNP|1|||
145610122|NCT00405639|525088127|FG001|Overall Study|Seizure prior to receiving BNP|0|||
145610123|NCT00612534|525088128|FG000|Overall Study|Adverse Event|0|||
145610124|NCT00612534|525088129|FG001|Overall Study|Adverse Event|4|||
145610125|NCT00612534|525088130|FG002|Overall Study|Adverse Event|2|||
145610126|NCT00612534|525088131|FG003|Overall Study|Adverse Event|1|||
145610127|NCT00612534|525088128|FG000|Overall Study|Lack of Efficacy|13|||
145610128|NCT00612534|525088129|FG001|Overall Study|Lack of Efficacy|12|||
145610129|NCT00612534|525088130|FG002|Overall Study|Lack of Efficacy|5|||
145610130|NCT00612534|525088131|FG003|Overall Study|Lack of Efficacy|16|||
145610131|NCT00612534|525088128|FG000|Overall Study|Other Reason|0|||
145610132|NCT00612534|525088129|FG001|Overall Study|Other Reason|1|||
145610133|NCT00612534|525088130|FG002|Overall Study|Other Reason|0|||
145610134|NCT00612534|525088131|FG003|Overall Study|Other Reason|0|||
145610135|NCT02223754|525088132|FG000|Period 1|Adverse Event|1|||
145610136|NCT02223754|525088133|FG001|Period 1|Adverse Event|0|||
145610137|NCT02223754|525088132|FG000|Period 1|Lost to Follow-up|0|||
145610138|NCT02223754|525088133|FG001|Period 1|Lost to Follow-up|1|||
145610139|NCT02223754|525088132|FG000|Period 1|Protocol Violation|2|||
145610140|NCT02223754|525088133|FG001|Period 1|Protocol Violation|4|||
145610141|NCT02223754|525088132|FG000|Period 1|Withdrawal by Subject|0|||
145610142|NCT02223754|525088133|FG001|Period 1|Withdrawal by Subject|4|||
145610143|NCT02223754|525088132|FG000|Period 1|Test Article No Longer Available|1|||
145610144|NCT02223754|525088133|FG001|Period 1|Test Article No Longer Available|5|||
145610145|NCT02223754|525088132|FG000|Period 1|Unsatisfactory Visual Response|0|||
145282335|NCT00686920|523883095|FG001|Overall Study|Noncompliance|0|||
145282336|NCT00686920|523883094|FG000|Overall Study|Principal Investigator Decision|2|||
145282337|NCT00686920|523883095|FG001|Overall Study|Principal Investigator Decision|0|||
145282338|NCT03124381|523883101|FG000|Overall Study|Lost to Follow-up|1|||
145610146|NCT02223754|525088133|FG001|Period 1|Unsatisfactory Visual Response|1|||
145282339|NCT03124381|523883102|FG001|Overall Study|Lost to Follow-up|1|||
145282340|NCT03124381|523883101|FG000|Overall Study|Withdrawal by Subject|6|||
145282341|NCT03124381|523883102|FG001|Overall Study|Withdrawal by Subject|3|||
145282342|NCT03124381|523883101|FG000|Overall Study|Protocol Violation|0|||
145282343|NCT03124381|523883102|FG001|Overall Study|Protocol Violation|1|||
145610147|NCT02223754|525088132|FG000|Period 2|Adverse Event|0|||
145610148|NCT02223754|525088133|FG001|Period 2|Adverse Event|1|||
145610149|NCT02223754|525088132|FG000|Period 2|Protocol Violation|1|||
145610150|NCT02223754|525088133|FG001|Period 2|Protocol Violation|0|||
145610151|NCT02223754|525088132|FG000|Period 2|Lens Discomfort|1|||
145610152|NCT02223754|525088133|FG001|Period 2|Lens Discomfort|1|||
145282344|NCT03124381|523883101|FG000|Overall Study|Adverse Event|1|||
145610153|NCT02223754|525088132|FG000|Period 2|Lost to Follow-up|1|||
145610154|NCT02223754|525088133|FG001|Period 2|Lost to Follow-up|0|||
145610155|NCT02223754|525088132|FG000|Period 2|Test Article No Longer Available|0|||
145790899|NCT00254293|525740984|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
145790900|NCT00254293|525740985|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145790901|NCT00254293|525740986|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145790902|NCT00254293|525740987|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145790903|NCT00254293|525740988|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
145790904|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Death|0|||
145790905|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Death|0|||
145790906|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Death|1|||
145790907|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Death|0|||
145790908|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Death|0|||
145790909|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Death|0|||
145790910|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Death|0|||
145790911|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
145790912|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
145790913|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
145790914|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
145790915|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
145790916|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
145790917|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
145790918|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
145790919|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
145790920|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
145790921|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
145790922|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
145790923|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
145790924|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
145790925|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790926|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790927|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
145790928|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790929|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790930|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790931|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
145790932|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790933|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790934|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
145790935|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790936|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790937|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790938|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
145790939|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790940|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790941|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
145790942|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790943|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790944|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790945|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
145790946|NCT00254293|525740982|FG000|LTE Open Label Variable SC Dosing|Other|0|||
145790947|NCT00254293|525740983|FG001|LTE Open Label Variable SC Dosing|Other|0|||
145790948|NCT00254293|525740984|FG002|LTE Open Label Variable SC Dosing|Other|2|||
145790949|NCT00254293|525740985|FG003|LTE Open Label Variable SC Dosing|Other|0|||
145790950|NCT00254293|525740986|FG004|LTE Open Label Variable SC Dosing|Other|0|||
145790951|NCT00254293|525740987|FG005|LTE Open Label Variable SC Dosing|Other|0|||
145790952|NCT00254293|525740988|FG006|LTE Open Label Variable SC Dosing|Other|0|||
145790953|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Death|0|||
145790954|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Death|0|||
145790955|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Death|0|||
145790956|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Death|0|||
145790957|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Death|0|||
145790958|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Death|0|||
145790959|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Death|3|||
145790960|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
145790961|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
145790962|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
145282345|NCT03124381|523883102|FG001|Overall Study|Adverse Event|1|||
145282346|NCT03124381|523883101|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
145282347|NCT03124381|523883102|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
145282348|NCT03940586|523883106|FG000|Overall Study|Death|3|||
145542507|NCT00042289|524846395|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
145542508|NCT00042289|524846396|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
145542509|NCT00042289|524846397|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
145542510|NCT00042289|524846398|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
145542511|NCT00042289|524846399|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
145542512|NCT00042289|524846400|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
145542513|NCT00042289|524846401|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
145542514|NCT00042289|524846402|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
145542515|NCT00042289|524846403|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
145542516|NCT00042289|524846404|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
145542517|NCT00042289|524846405|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
145542518|NCT00042289|524846406|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
145542519|NCT00042289|524846407|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
145542520|NCT00042289|524846408|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
145542521|NCT00042289|524846409|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
145542522|NCT00042289|524846410|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
145542523|NCT00042289|524846411|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
145542524|NCT00042289|524846412|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
145542525|NCT00042289|524846413|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
145542526|NCT00042289|524846414|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
145542527|NCT00042289|524846415|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
145542528|NCT00042289|524846416|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
145542529|NCT00042289|524846417|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
145542530|NCT00042289|524846418|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
145542531|NCT00042289|524846419|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
145542532|NCT00042289|524846420|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
145542533|NCT00042289|524846421|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
145542534|NCT00042289|524846422|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
145542535|NCT00042289|524846423|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
145542536|NCT00042289|524846424|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
145542537|NCT00042289|524846378|FG000|Overall Study|Protocol Violation|0|||
145542538|NCT00042289|524846379|FG001|Overall Study|Protocol Violation|0|||
145542539|NCT00042289|524846380|FG002|Overall Study|Protocol Violation|0|||
145542540|NCT00042289|524846381|FG003|Overall Study|Protocol Violation|0|||
145542541|NCT00042289|524846382|FG004|Overall Study|Protocol Violation|0|||
145542542|NCT00042289|524846383|FG005|Overall Study|Protocol Violation|1|||
145790963|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
145542543|NCT00042289|524846384|FG006|Overall Study|Protocol Violation|0|||
145542544|NCT00042289|524846385|FG007|Overall Study|Protocol Violation|1|||
145790964|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
145790965|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
145790966|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
145790967|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145790968|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145542545|NCT00042289|524846386|FG008|Overall Study|Protocol Violation|0|||
145542546|NCT00042289|524846387|FG009|Overall Study|Protocol Violation|0|||
145542547|NCT00042289|524846388|FG010|Overall Study|Protocol Violation|0|||
145542548|NCT00042289|524846389|FG011|Overall Study|Protocol Violation|0|||
145542549|NCT00042289|524846390|FG012|Overall Study|Protocol Violation|0|||
145542550|NCT00042289|524846391|FG013|Overall Study|Protocol Violation|0|||
145542551|NCT00042289|524846392|FG014|Overall Study|Protocol Violation|0|||
145542552|NCT00042289|524846393|FG015|Overall Study|Protocol Violation|0|||
145542553|NCT00042289|524846394|FG016|Overall Study|Protocol Violation|0|||
145542554|NCT00042289|524846395|FG017|Overall Study|Protocol Violation|0|||
145542555|NCT00042289|524846396|FG018|Overall Study|Protocol Violation|0|||
145542556|NCT00042289|524846397|FG019|Overall Study|Protocol Violation|0|||
145542557|NCT00042289|524846398|FG020|Overall Study|Protocol Violation|0|||
145542558|NCT00042289|524846399|FG021|Overall Study|Protocol Violation|0|||
145542559|NCT00042289|524846400|FG022|Overall Study|Protocol Violation|0|||
145542560|NCT00042289|524846401|FG023|Overall Study|Protocol Violation|1|||
145542561|NCT00042289|524846402|FG024|Overall Study|Protocol Violation|1|||
145542562|NCT00042289|524846403|FG025|Overall Study|Protocol Violation|0|||
145542563|NCT00042289|524846404|FG026|Overall Study|Protocol Violation|2|||
145542564|NCT00042289|524846405|FG027|Overall Study|Protocol Violation|0|||
145542565|NCT00042289|524846406|FG028|Overall Study|Protocol Violation|0|||
145542566|NCT00042289|524846407|FG029|Overall Study|Protocol Violation|0|||
145542567|NCT00042289|524846408|FG030|Overall Study|Protocol Violation|1|||
145542568|NCT00042289|524846409|FG031|Overall Study|Protocol Violation|0|||
145542569|NCT00042289|524846410|FG032|Overall Study|Protocol Violation|0|||
145542570|NCT00042289|524846411|FG033|Overall Study|Protocol Violation|0|||
145542571|NCT00042289|524846412|FG034|Overall Study|Protocol Violation|0|||
145542572|NCT00042289|524846413|FG035|Overall Study|Protocol Violation|0|||
145542573|NCT00042289|524846414|FG036|Overall Study|Protocol Violation|0|||
145542574|NCT00042289|524846415|FG037|Overall Study|Protocol Violation|0|||
145542575|NCT00042289|524846416|FG038|Overall Study|Protocol Violation|0|||
145542576|NCT00042289|524846417|FG039|Overall Study|Protocol Violation|0|||
145542577|NCT00042289|524846418|FG040|Overall Study|Protocol Violation|0|||
145542578|NCT00042289|524846419|FG041|Overall Study|Protocol Violation|1|||
145542579|NCT00042289|524846420|FG042|Overall Study|Protocol Violation|1|||
145542580|NCT00042289|524846421|FG043|Overall Study|Protocol Violation|1|||
145542581|NCT00042289|524846422|FG044|Overall Study|Protocol Violation|0|||
145542582|NCT00042289|524846423|FG045|Overall Study|Protocol Violation|0|||
145542583|NCT00042289|524846424|FG046|Overall Study|Protocol Violation|0|||
145542584|NCT00042289|524846378|FG000|Overall Study|Withdrawal by Subject|4|||
145542585|NCT00042289|524846379|FG001|Overall Study|Withdrawal by Subject|1|||
145542586|NCT00042289|524846380|FG002|Overall Study|Withdrawal by Subject|0|||
145542587|NCT00042289|524846381|FG003|Overall Study|Withdrawal by Subject|2|||
145542588|NCT00042289|524846382|FG004|Overall Study|Withdrawal by Subject|0|||
145542589|NCT00042289|524846383|FG005|Overall Study|Withdrawal by Subject|2|||
145542590|NCT00042289|524846384|FG006|Overall Study|Withdrawal by Subject|0|||
145542591|NCT00042289|524846385|FG007|Overall Study|Withdrawal by Subject|0|||
145542592|NCT00042289|524846386|FG008|Overall Study|Withdrawal by Subject|0|||
145542593|NCT00042289|524846387|FG009|Overall Study|Withdrawal by Subject|1|||
145542594|NCT00042289|524846388|FG010|Overall Study|Withdrawal by Subject|0|||
145542595|NCT00042289|524846389|FG011|Overall Study|Withdrawal by Subject|0|||
145542596|NCT00042289|524846390|FG012|Overall Study|Withdrawal by Subject|2|||
145542597|NCT00042289|524846391|FG013|Overall Study|Withdrawal by Subject|0|||
145542598|NCT00042289|524846392|FG014|Overall Study|Withdrawal by Subject|0|||
145542599|NCT00042289|524846393|FG015|Overall Study|Withdrawal by Subject|0|||
145542600|NCT00042289|524846394|FG016|Overall Study|Withdrawal by Subject|0|||
145542601|NCT00042289|524846395|FG017|Overall Study|Withdrawal by Subject|0|||
145542602|NCT00042289|524846396|FG018|Overall Study|Withdrawal by Subject|0|||
145542603|NCT00042289|524846397|FG019|Overall Study|Withdrawal by Subject|0|||
145542604|NCT00042289|524846398|FG020|Overall Study|Withdrawal by Subject|0|||
145542605|NCT00042289|524846399|FG021|Overall Study|Withdrawal by Subject|1|||
145542606|NCT00042289|524846400|FG022|Overall Study|Withdrawal by Subject|1|||
145542607|NCT00042289|524846401|FG023|Overall Study|Withdrawal by Subject|1|||
145542608|NCT00042289|524846402|FG024|Overall Study|Withdrawal by Subject|0|||
145542609|NCT00042289|524846403|FG025|Overall Study|Withdrawal by Subject|0|||
145542610|NCT00042289|524846404|FG026|Overall Study|Withdrawal by Subject|1|||
145542611|NCT00042289|524846405|FG027|Overall Study|Withdrawal by Subject|0|||
145542612|NCT00042289|524846406|FG028|Overall Study|Withdrawal by Subject|2|||
145542613|NCT00042289|524846407|FG029|Overall Study|Withdrawal by Subject|0|||
145542614|NCT00042289|524846408|FG030|Overall Study|Withdrawal by Subject|0|||
145542615|NCT00042289|524846409|FG031|Overall Study|Withdrawal by Subject|1|||
145542616|NCT00042289|524846410|FG032|Overall Study|Withdrawal by Subject|2|||
145542617|NCT00042289|524846411|FG033|Overall Study|Withdrawal by Subject|1|||
145542618|NCT00042289|524846412|FG034|Overall Study|Withdrawal by Subject|0|||
145542619|NCT00042289|524846413|FG035|Overall Study|Withdrawal by Subject|0|||
145542620|NCT00042289|524846414|FG036|Overall Study|Withdrawal by Subject|0|||
145542621|NCT00042289|524846415|FG037|Overall Study|Withdrawal by Subject|1|||
145542622|NCT00042289|524846416|FG038|Overall Study|Withdrawal by Subject|0|||
145542623|NCT00042289|524846417|FG039|Overall Study|Withdrawal by Subject|0|||
145542624|NCT00042289|524846418|FG040|Overall Study|Withdrawal by Subject|0|||
145542625|NCT00042289|524846419|FG041|Overall Study|Withdrawal by Subject|0|||
145542626|NCT00042289|524846420|FG042|Overall Study|Withdrawal by Subject|1|||
145542627|NCT00042289|524846421|FG043|Overall Study|Withdrawal by Subject|0|||
145542628|NCT00042289|524846422|FG044|Overall Study|Withdrawal by Subject|0|||
145542629|NCT00042289|524846423|FG045|Overall Study|Withdrawal by Subject|0|||
145542630|NCT00042289|524846424|FG046|Overall Study|Withdrawal by Subject|0|||
145542631|NCT00717197|524846429|FG000|Overall Study|Unable to purchase study drug|5|||
145542632|NCT00717197|524846429|FG000|Overall Study|Tumor Progression|1|||
145542633|NCT00717197|524846429|FG000|Overall Study|Physician Decision|1|||
145542634|NCT00982137|524846430|FG000|Overall Study|Lost to Follow-up|0|||
145542635|NCT00982137|524846431|FG001|Overall Study|Lost to Follow-up|0|||
145542636|NCT00982137|524846432|FG002|Overall Study|Lost to Follow-up|0|||
145542637|NCT00982137|524846433|FG003|Overall Study|Lost to Follow-up|1|||
145542638|NCT00982137|524846430|FG000|Overall Study|Withdrawal by Subject|0|||
145542639|NCT00982137|524846431|FG001|Overall Study|Withdrawal by Subject|1|||
145542640|NCT00982137|524846432|FG002|Overall Study|Withdrawal by Subject|0|||
145542641|NCT00982137|524846433|FG003|Overall Study|Withdrawal by Subject|0|||
145542642|NCT01648101|524846436|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
145542643|NCT01648101|524846437|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
145542644|NCT01648101|524846438|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
145542645|NCT01648101|524846436|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
145542646|NCT01648101|524846437|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
145542647|NCT01648101|524846438|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
145542648|NCT01648101|524846436|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
145542649|NCT01648101|524846437|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
145542650|NCT01648101|524846438|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
145542651|NCT01648101|524846436|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
145542652|NCT01648101|524846437|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
145542653|NCT01648101|524846438|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
145542654|NCT01648101|524846436|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
145542655|NCT01648101|524846437|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
145542656|NCT01648101|524846438|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
145542657|NCT01648101|524846436|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
145542658|NCT01648101|524846437|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
145542659|NCT01648101|524846438|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
145542660|NCT01648101|524846436|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
145542661|NCT01648101|524846437|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
145542662|NCT01648101|524846438|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
145542663|NCT01648101|524846436|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
145542664|NCT01648101|524846437|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
145542665|NCT01648101|524846438|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
145542666|NCT01648101|524846436|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
145542667|NCT01648101|524846437|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
145542668|NCT01648101|524846438|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
145542669|NCT01648101|524846436|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
145542670|NCT01648101|524846437|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
145542671|NCT01648101|524846438|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
145542672|NCT01648101|524846436|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
145542673|NCT01648101|524846437|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
145542674|NCT01648101|524846438|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
145542675|NCT02469298|524846454|FG000|Overall Study|Protocol Violation|0|||
145542676|NCT02469298|524846455|FG001|Overall Study|Protocol Violation|1|||
145542677|NCT02469298|524846456|FG002|Overall Study|Protocol Violation|1|||
145542678|NCT02469298|524846457|FG003|Overall Study|Protocol Violation|0|||
145542679|NCT02469298|524846454|FG000|Overall Study|Lost to Follow-up|1|||
145542680|NCT02469298|524846455|FG001|Overall Study|Lost to Follow-up|0|||
145610156|NCT02223754|525088133|FG001|Period 2|Test Article No Longer Available|1|||
145610157|NCT01807650|525088141|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
145610158|NCT01807650|525088141|FG000|Overall Study|Adverse Event|5|||
145610159|NCT01807650|525088141|FG000|Overall Study|Other|2|||
145610160|NCT02946918|525088148|FG000|Overall Study|Patient unblinded himself|1|||
145790969|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145790970|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145790971|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145790972|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
145790973|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
145790974|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790975|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790976|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790977|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790978|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790979|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
145790980|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
145790981|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790982|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790983|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790984|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790985|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790986|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
145790987|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
145790988|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790989|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790990|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790991|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790992|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790993|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
145790994|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
145790995|NCT00254293|525740982|FG000|LTE Open Label Fixed Dosing|Other|0|||
145790996|NCT00254293|525740983|FG001|LTE Open Label Fixed Dosing|Other|0|||
145790997|NCT00254293|525740984|FG002|LTE Open Label Fixed Dosing|Other|0|||
145790998|NCT00254293|525740985|FG003|LTE Open Label Fixed Dosing|Other|0|||
145790999|NCT00254293|525740986|FG004|LTE Open Label Fixed Dosing|Other|0|||
145791000|NCT00254293|525740987|FG005|LTE Open Label Fixed Dosing|Other|0|||
145791001|NCT00254293|525740988|FG006|LTE Open Label Fixed Dosing|Other|1|||
145791002|NCT01000727|525740996|FG000|Overall Study|Lost to Follow-up|41|||
145791003|NCT01000727|525740997|FG001|Overall Study|Lost to Follow-up|43|||
145791004|NCT01000727|525740996|FG000|Overall Study|Withdrawal by Subject|111|||
145791005|NCT01000727|525740997|FG001|Overall Study|Withdrawal by Subject|109|||
145791006|NCT01000727|525740996|FG000|Overall Study|Study closed/terminated|23|||
145791007|NCT01000727|525740997|FG001|Overall Study|Study closed/terminated|24|||
145791008|NCT03196193|525741000|FG000|Overall Study|Adverse Event|1|||
145791009|NCT03196193|525741001|FG001|Overall Study|Adverse Event|0|||
145791010|NCT03196193|525741000|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
145791011|NCT03196193|525741001|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
145791012|NCT02709083|525741005|FG000|Overall Study|Original PI left institution|7|||
145791013|NCT04410198|525741007|FG000|Overall Study|Death|10|||
145791014|NCT04410198|525741007|FG000|Overall Study|Withdrawal by Subject|7|||
145791015|NCT04410198|525741007|FG000|Overall Study|Transferred/Relocation|4|||
145791016|NCT04410198|525741007|FG000|Overall Study|Kidney Transplant|9|||
145791017|NCT04410198|525741007|FG000|Overall Study|Adverse Event|4|||
145791018|NCT04410198|525741007|FG000|Overall Study|Physician Decision|2|||
145791019|NCT04410198|525741007|FG000|Overall Study|Other than specified|1|||
145791020|NCT02006667|525741008|FG000|Overall Study|Adverse Event|3|||
145791021|NCT02006667|525741008|FG000|Overall Study|Death|2|||
145791022|NCT02006667|525741008|FG000|Overall Study|Withdrawal by Subject|1|||
145791023|NCT01626352|525741009|FG000|Overall Study|Disease Progression|3|||
145791024|NCT01626352|525741009|FG000|Overall Study|Intercurrent Illness|2|||
145282349|NCT03940586|523883107|FG001|Overall Study|Death|2|||
145791025|NCT01626352|525741009|FG000|Overall Study|Death|2|||
145791026|NCT01626352|525741009|FG000|Overall Study|Withdrawal by Subject|1|||
145791027|NCT01626352|525741009|FG000|Overall Study|Non-Compliance|1|||
145791028|NCT01626352|525741009|FG000|Overall Study|Never Treated|1|||
145791029|NCT02939937|525741010|FG000|Overall Study|Adverse Event|5|||
145791030|NCT02939937|525741011|FG001|Overall Study|Adverse Event|0|||
145791031|NCT02939937|525741010|FG000|Overall Study|Lost to Follow-up|1|||
145791032|NCT02939937|525741011|FG001|Overall Study|Lost to Follow-up|3|||
145282350|NCT03940586|523883108|FG002|Overall Study|Death|0|||
145791033|NCT02681055|525741014|FG000|Weeks 5-12|Adverse Event|1|||
145791034|NCT03446651|525741017|FG000|Overall Study|Lost to Follow-up|4|||
145282351|NCT03940586|523883106|FG000|Overall Study|Physician Decision|1|||
145610161|NCT02946918|525088149|FG001|Overall Study|Patient unblinded himself|0|||
145542681|NCT02469298|524846456|FG002|Overall Study|Lost to Follow-up|1|||
145542682|NCT02469298|524846457|FG003|Overall Study|Lost to Follow-up|0|||
145542683|NCT02469298|524846454|FG000|Overall Study|Physician Decision|0|||
145542684|NCT02469298|524846455|FG001|Overall Study|Physician Decision|0|||
145542685|NCT02469298|524846456|FG002|Overall Study|Physician Decision|0|||
145542686|NCT02469298|524846457|FG003|Overall Study|Physician Decision|1|||
145542687|NCT02469298|524846454|FG000|Overall Study|Withdrawal by Subject|0|||
145542688|NCT02469298|524846455|FG001|Overall Study|Withdrawal by Subject|0|||
145542689|NCT02469298|524846456|FG002|Overall Study|Withdrawal by Subject|0|||
145542690|NCT02469298|524846457|FG003|Overall Study|Withdrawal by Subject|1|||
145542691|NCT00307294|524846458|FG000|Overall Study|Withdrawal by Subject|1|||
145542692|NCT03311724|524846461|FG000|Overall Study|Physician Decision|0|||
145542693|NCT03311724|524846462|FG001|Overall Study|Physician Decision|0|||
145542694|NCT03311724|524846463|FG002|Overall Study|Physician Decision|0|||
145542695|NCT03311724|524846464|FG003|Overall Study|Physician Decision|1|||
145542696|NCT03311724|524846461|FG000|Overall Study|Protocol Violation|1|||
145542697|NCT03311724|524846462|FG001|Overall Study|Protocol Violation|0|||
145542698|NCT03311724|524846463|FG002|Overall Study|Protocol Violation|1|||
145542699|NCT03311724|524846464|FG003|Overall Study|Protocol Violation|0|||
145542700|NCT03311724|524846461|FG000|Overall Study|Withdrawal by Subject|1|||
145542701|NCT03311724|524846462|FG001|Overall Study|Withdrawal by Subject|1|||
145542702|NCT03311724|524846463|FG002|Overall Study|Withdrawal by Subject|0|||
145542703|NCT03311724|524846464|FG003|Overall Study|Withdrawal by Subject|0|||
145542704|NCT03311724|524846461|FG000|Overall Study|Lost to Follow-up|1|||
145542705|NCT03311724|524846462|FG001|Overall Study|Lost to Follow-up|0|||
145542706|NCT03311724|524846463|FG002|Overall Study|Lost to Follow-up|0|||
145542707|NCT03311724|524846464|FG003|Overall Study|Lost to Follow-up|0|||
145542708|NCT03311724|524846461|FG000|Overall Study|Sponsor Decision|0|||
145542709|NCT03311724|524846462|FG001|Overall Study|Sponsor Decision|0|||
145610162|NCT02946918|525088148|FG000|Overall Study|Physician Decision|0|||
145542710|NCT03311724|524846463|FG002|Overall Study|Sponsor Decision|1|||
145542711|NCT03311724|524846464|FG003|Overall Study|Sponsor Decision|0|||
145542712|NCT02980601|524846471|FG000|Overall Study|Lost to Follow-up|2|||
145610163|NCT02946918|525088149|FG001|Overall Study|Physician Decision|2|||
145610164|NCT02946918|525088148|FG000|Overall Study|Ran out of study medication|0|||
145542713|NCT02980601|524846472|FG001|Overall Study|Lost to Follow-up|2|||
145610165|NCT02946918|525088149|FG001|Overall Study|Ran out of study medication|1|||
145542714|NCT02980601|524846471|FG000|Overall Study|Death|0|||
145610166|NCT00069784|525088150|FG000|Overall Study|Adverse Event|105|||
145610167|NCT00069784|525088151|FG001|Overall Study|Adverse Event|0|||
145610168|NCT00069784|525088150|FG000|Overall Study|Withdrawal by Subject|1090|||
145610169|NCT00069784|525088151|FG001|Overall Study|Withdrawal by Subject|0|||
145610170|NCT00069784|525088150|FG000|Overall Study|Other|17|||
145610171|NCT00069784|525088151|FG001|Overall Study|Other|0|||
145610172|NCT02716038|525088152|FG000|Overall Study|Not evaluable|1|||
145610173|NCT02716038|525088152|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
145610174|NCT02716038|525088152|FG000|Overall Study|Unresectable|3|||
145610175|NCT02669095|525088158|FG000|Overall Study|Adverse Event|1|||
145610176|NCT02669095|525088159|FG001|Overall Study|Adverse Event|0|||
145610177|NCT02669095|525088158|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
145610178|NCT02669095|525088159|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
145610179|NCT02669095|525088158|FG000|Overall Study|Torn Lens|0|||
145610180|NCT02669095|525088159|FG001|Overall Study|Torn Lens|1|||
145610181|NCT02669095|525088158|FG000|Overall Study|Visit 5 assessments not completed|0|||
145610182|NCT02669095|525088159|FG001|Overall Study|Visit 5 assessments not completed|1|||
145610183|NCT00886639|525088162|FG000|Overall Study|acute exacerbation|14|||
145610184|NCT00886639|525088162|FG000|Overall Study|non-compliance|2|||
145610185|NCT01871558|525088165|FG000|Overall Study|Other reason|0|||
145610186|NCT01871558|525088166|FG001|Overall Study|Other reason|1|||
145610187|NCT01871558|525088165|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
145610188|NCT01871558|525088166|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
145610189|NCT01871558|525088165|FG000|Overall Study|Withdrawal by Subject|2|||
145610190|NCT01871558|525088166|FG001|Overall Study|Withdrawal by Subject|0|||
145610191|NCT03203694|525088167|FG000|Overall Study|Withdrawal by Subject|2|||
145610192|NCT03203694|525088168|FG001|Overall Study|Withdrawal by Subject|0|||
145610193|NCT03203694|525088169|FG002|Overall Study|Withdrawal by Subject|0|||
145610194|NCT03203694|525088170|FG003|Overall Study|Withdrawal by Subject|0|||
145610195|NCT03203694|525088171|FG004|Overall Study|Withdrawal by Subject|0|||
145610196|NCT03203694|525088172|FG005|Overall Study|Withdrawal by Subject|0|||
145610197|NCT01709305|525088173|FG000|Phase 1|Clinical Adverse Event|80|||
145610198|NCT01709305|525088174|FG001|Phase 1|Clinical Adverse Event|0|||
145610199|NCT01709305|525088175|FG002|Phase 1|Clinical Adverse Event|0|||
145610200|NCT01709305|525088176|FG003|Phase 1|Clinical Adverse Event|0|||
145610201|NCT01709305|525088177|FG004|Phase 1|Clinical Adverse Event|0|||
145610202|NCT01709305|525088173|FG000|Phase 1|Death|2|||
145610203|NCT01709305|525088174|FG001|Phase 1|Death|0|||
145610204|NCT01709305|525088175|FG002|Phase 1|Death|0|||
145610205|NCT01709305|525088176|FG003|Phase 1|Death|0|||
145610206|NCT01709305|525088177|FG004|Phase 1|Death|0|||
145610207|NCT01709305|525088173|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
145610208|NCT01709305|525088174|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
145610209|NCT01709305|525088175|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
145610210|NCT01709305|525088176|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
145610211|NCT01709305|525088177|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
145610212|NCT01709305|525088173|FG000|Phase 1|Laboratory Adverse Event|16|||
145610213|NCT01709305|525088174|FG001|Phase 1|Laboratory Adverse Event|0|||
145610214|NCT01709305|525088175|FG002|Phase 1|Laboratory Adverse Event|0|||
145610215|NCT01709305|525088176|FG003|Phase 1|Laboratory Adverse Event|0|||
145610216|NCT01709305|525088177|FG004|Phase 1|Laboratory Adverse Event|0|||
145610217|NCT01709305|525088173|FG000|Phase 1|Lost to Follow-up|147|||
145610218|NCT01709305|525088174|FG001|Phase 1|Lost to Follow-up|0|||
145791035|NCT03446651|525741018|FG001|Overall Study|Lost to Follow-up|0|||
145791036|NCT03446651|525741017|FG000|Overall Study|Open Label Participants|5|||
145791037|NCT03446651|525741018|FG001|Overall Study|Open Label Participants|0|||
145791038|NCT00798655|525741019|FG000|Overall Study|Did not receive at least one dose of pan|2|||
145791039|NCT00343291|525741020|FG000|Overall Study|Adverse Event|13|||
145791040|NCT00343291|525741021|FG001|Overall Study|Adverse Event|13|||
145791041|NCT00343291|525741020|FG000|Overall Study|Death|3|||
145282352|NCT03940586|523883107|FG001|Overall Study|Physician Decision|0|||
145282353|NCT03940586|523883108|FG002|Overall Study|Physician Decision|1|||
145610219|NCT01709305|525088175|FG002|Phase 1|Lost to Follow-up|0|||
145610220|NCT01709305|525088176|FG003|Phase 1|Lost to Follow-up|0|||
145610221|NCT01709305|525088177|FG004|Phase 1|Lost to Follow-up|0|||
145610222|NCT01709305|525088173|FG000|Phase 1|Travel, moving, etc.|30|||
145610223|NCT01709305|525088174|FG001|Phase 1|Travel, moving, etc.|0|||
145791042|NCT00343291|525741021|FG001|Overall Study|Death|2|||
145791043|NCT00343291|525741020|FG000|Overall Study|Progressive disease|33|||
145791044|NCT00343291|525741021|FG001|Overall Study|Progressive disease|34|||
145791045|NCT00343291|525741020|FG000|Overall Study|Withdrawal by Subject|0|||
145282354|NCT03940586|523883106|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
145610224|NCT01709305|525088175|FG002|Phase 1|Travel, moving, etc.|0|||
145610225|NCT01709305|525088176|FG003|Phase 1|Travel, moving, etc.|0|||
145610226|NCT01709305|525088177|FG004|Phase 1|Travel, moving, etc.|0|||
145610227|NCT01709305|525088173|FG000|Phase 1|Physician Decision|13|||
145610228|NCT01709305|525088174|FG001|Phase 1|Physician Decision|0|||
145610229|NCT01709305|525088175|FG002|Phase 1|Physician Decision|0|||
145610230|NCT01709305|525088176|FG003|Phase 1|Physician Decision|0|||
145791046|NCT00343291|525741021|FG001|Overall Study|Withdrawal by Subject|2|||
145542715|NCT02980601|524846472|FG001|Overall Study|Death|1|||
145542716|NCT02980601|524846471|FG000|Overall Study|Graft loss|1|||
145542717|NCT02980601|524846472|FG001|Overall Study|Graft loss|0|||
145542718|NCT02980601|524846471|FG000|Overall Study|Failed to sign consent|2|||
145542719|NCT02980601|524846472|FG001|Overall Study|Failed to sign consent|0|||
145542720|NCT01575769|524846473|FG000|Overall Study|Adverse Event|1|||
145542721|NCT01575769|524846473|FG000|Overall Study|Study terminated by sponsor|40|||
145542722|NCT01473836|524846476|FG000|Overall Study|Adverse Event|4|||
145542723|NCT01473836|524846476|FG000|Overall Study|Lack of Efficacy|1|||
145542724|NCT01473836|524846476|FG000|Overall Study|Does not meet entrance criteria|1|||
145542725|NCT02954237|524846482|FG000|Overall Study|Withdrawal by Subject|25|||
145542726|NCT02954237|524846482|FG000|Overall Study|Missed visit|16|||
145542727|NCT02954237|524846482|FG000|Overall Study|Death|2|||
145542728|NCT00980057|524846484|FG000|Overall Study|Death|13|||
145542729|NCT00980057|524846485|FG001|Overall Study|Death|3|||
145542730|NCT00980057|524846484|FG000|Overall Study|Adverse Event|0|||
145542731|NCT00980057|524846485|FG001|Overall Study|Adverse Event|1|||
145542732|NCT00980057|524846484|FG000|Overall Study|Physician Decision|4|||
145542733|NCT00980057|524846485|FG001|Overall Study|Physician Decision|0|||
145542734|NCT00980057|524846484|FG000|Overall Study|Lost to Follow-up|1|||
145542735|NCT00980057|524846485|FG001|Overall Study|Lost to Follow-up|0|||
145542736|NCT00980057|524846484|FG000|Overall Study|Withdrawal by Subject|1|||
145542737|NCT00980057|524846485|FG001|Overall Study|Withdrawal by Subject|1|||
145542738|NCT00592384|524846493|FG000|Overall Study|Withdrawal by Subject|5|||
145542739|NCT00592384|524846494|FG001|Overall Study|Withdrawal by Subject|6|||
145542740|NCT00705484|524846495|FG000|Overall Study|Adverse Event|28|||
145542741|NCT00705484|524846496|FG001|Overall Study|Adverse Event|27|||
145542742|NCT00705484|524846495|FG000|Overall Study|Lost to Follow-up|169|||
145542743|NCT00705484|524846496|FG001|Overall Study|Lost to Follow-up|250|||
145542744|NCT00705484|524846495|FG000|Overall Study|Withdrawal by Subject|96|||
145542745|NCT00705484|524846496|FG001|Overall Study|Withdrawal by Subject|72|||
145542746|NCT00705484|524846495|FG000|Overall Study|Administrative|89|||
145542747|NCT00705484|524846496|FG001|Overall Study|Administrative|59|||
145542748|NCT00119106|524846497|FG000|Overall Study|HIV infected at baseline|179|||
145542749|NCT00119106|524846498|FG001|Overall Study|HIV infected at baseline|178|||
145542750|NCT01010061|524846499|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
145542751|NCT01010061|524846500|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
145542752|NCT01010061|524846499|FG000|Overall Study|Disease Progression|2|||
145542753|NCT01010061|524846500|FG001|Overall Study|Disease Progression|8|||
145542754|NCT01010061|524846499|FG000|Overall Study|Withdrew Consent|5|||
145542755|NCT01010061|524846500|FG001|Overall Study|Withdrew Consent|1|||
145542756|NCT01010061|524846499|FG000|Overall Study|Death|3|||
145542757|NCT01010061|524846500|FG001|Overall Study|Death|6|||
145542758|NCT01010061|524846499|FG000|Overall Study|Administrative/Other|0|||
145542759|NCT01010061|524846500|FG001|Overall Study|Administrative/Other|1|||
145542760|NCT01010061|524846499|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
145542761|NCT01010061|524846500|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
145542762|NCT01010061|524846499|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145542763|NCT01010061|524846500|FG001|Overall Study|Insufficient Therapeutic Response|5|||
145542764|NCT01010061|524846499|FG000|Overall Study|Violation of Selection Criteria|0|||
145542765|NCT01010061|524846500|FG001|Overall Study|Violation of Selection Criteria|1|||
145542766|NCT01010061|524846499|FG000|Overall Study|Did Not Receive Treatment|2|||
145542767|NCT01010061|524846500|FG001|Overall Study|Did Not Receive Treatment|2|||
145542768|NCT01203098|524846503|FG000|Overall Study|Adverse Event|3|||
145542769|NCT01203098|524846504|FG001|Overall Study|Adverse Event|1|||
145542770|NCT01203098|524846505|FG002|Overall Study|Adverse Event|7|||
145542771|NCT01203098|524846503|FG000|Overall Study|Lost to Follow-up|0|||
145542772|NCT01203098|524846504|FG001|Overall Study|Lost to Follow-up|0|||
145542773|NCT01203098|524846505|FG002|Overall Study|Lost to Follow-up|1|||
145542774|NCT01203098|524846503|FG000|Overall Study|Physician Decision|2|||
145542775|NCT01203098|524846504|FG001|Overall Study|Physician Decision|2|||
145542776|NCT01203098|524846505|FG002|Overall Study|Physician Decision|0|||
145542777|NCT01203098|524846503|FG000|Overall Study|Withdrawal by Subject|1|||
145542778|NCT01203098|524846504|FG001|Overall Study|Withdrawal by Subject|1|||
145542779|NCT01203098|524846505|FG002|Overall Study|Withdrawal by Subject|3|||
145542780|NCT03851705|524846513|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
145542781|NCT03851705|524846514|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145542782|NCT03851705|524846515|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145542783|NCT03851705|524846516|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145542784|NCT03851705|524846513|FG000|Part 1: Double-Blind Period|Other reason|1|||
145542785|NCT03851705|524846514|FG001|Part 1: Double-Blind Period|Other reason|0|||
145542786|NCT03851705|524846515|FG002|Part 1: Double-Blind Period|Other reason|0|||
145542787|NCT03851705|524846516|FG003|Part 1: Double-Blind Period|Other reason|0|||
145542788|NCT03851705|524846513|FG000|Part 2: Open-Label Period|Other reason|0|||
145542789|NCT03851705|524846514|FG001|Part 2: Open-Label Period|Other reason|0|||
145282355|NCT03940586|523883107|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
145542790|NCT03851705|524846515|FG002|Part 2: Open-Label Period|Other reason|0|||
145542791|NCT03851705|524846516|FG003|Part 2: Open-Label Period|Other reason|1|||
145542792|NCT03851705|524846513|FG000|Part 2: Open-Label Period|Death|0|||
145542793|NCT03851705|524846514|FG001|Part 2: Open-Label Period|Death|0|||
145542794|NCT03851705|524846515|FG002|Part 2: Open-Label Period|Death|3|||
145542795|NCT03851705|524846516|FG003|Part 2: Open-Label Period|Death|0|||
145542796|NCT03851705|524846513|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
145542797|NCT03851705|524846514|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
145542798|NCT03851705|524846515|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
145542799|NCT03851705|524846516|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
145542800|NCT00621582|524846517|FG000|Overall Study|Adverse Event|7|||
145542801|NCT00621582|524846517|FG000|Overall Study|Protocol Violation|57|||
145542802|NCT00621582|524846517|FG000|Overall Study|Lost to Follow-up|24|||
145542803|NCT00621582|524846517|FG000|Overall Study|issues not identified by investigators|18|||
145542804|NCT01387932|524846519|FG000|Randomized and Treated|Physician Decision|3|||
145542805|NCT01387932|524846520|FG001|Randomized and Treated|Physician Decision|2|||
145542806|NCT01387932|524846519|FG000|Randomized and Treated|Withdrawal by Subject|4|||
145542807|NCT01387932|524846520|FG001|Randomized and Treated|Withdrawal by Subject|2|||
145542808|NCT01387932|524846519|FG000|Survival Follow-up|Liver Transplant|24|||
145542809|NCT01387932|524846520|FG001|Survival Follow-up|Liver Transplant|28|||
145542810|NCT01387932|524846519|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
145542811|NCT01387932|524846520|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
145542812|NCT01387932|524846519|FG000|Survival Follow-up|Withdrawal by Subject|2|||
145542813|NCT01387932|524846520|FG001|Survival Follow-up|Withdrawal by Subject|4|||
145542814|NCT01387932|524846519|FG000|Survival Follow-up|Lost to Follow-up|6|||
145542815|NCT01387932|524846520|FG001|Survival Follow-up|Lost to Follow-up|5|||
145542816|NCT02591290|524846521|FG000|Overall Study|Withdrawal by Subject|2|||
145542817|NCT02571075|524846522|FG000|Overall Study|Lost to Follow-up|20|||
145542818|NCT02571075|524846523|FG001|Overall Study|Lost to Follow-up|24|||
145542819|NCT01306942|524846529|FG000|Phase I|Adverse Event|2|||
145542820|NCT01306942|524846530|FG001|Phase I|Adverse Event|2|||
145542821|NCT01306942|524846531|FG002|Phase I|Adverse Event|0|||
145542822|NCT01306942|524846532|FG003|Phase I|Adverse Event|0|||
145542823|NCT01306942|524846529|FG000|Phase I|Physician Decision|3|||
145542824|NCT01306942|524846530|FG001|Phase I|Physician Decision|1|||
145542825|NCT01306942|524846531|FG002|Phase I|Physician Decision|0|||
145542826|NCT01306942|524846532|FG003|Phase I|Physician Decision|0|||
145542827|NCT01306942|524846529|FG000|Phase II|Adverse Event|0|||
145542828|NCT01306942|524846530|FG001|Phase II|Adverse Event|0|||
145542829|NCT01306942|524846531|FG002|Phase II|Adverse Event|0|||
145542830|NCT01306942|524846532|FG003|Phase II|Adverse Event|6|||
145542831|NCT01306942|524846529|FG000|Phase II|Physician Decision|2|||
145542832|NCT01306942|524846530|FG001|Phase II|Physician Decision|0|||
145542833|NCT01306942|524846531|FG002|Phase II|Physician Decision|0|||
145542834|NCT01306942|524846532|FG003|Phase II|Physician Decision|5|||
145542835|NCT01306942|524846529|FG000|Phase II|Withdrawal by Subject|0|||
145542836|NCT01306942|524846530|FG001|Phase II|Withdrawal by Subject|0|||
145542837|NCT01306942|524846531|FG002|Phase II|Withdrawal by Subject|0|||
145542838|NCT01306942|524846532|FG003|Phase II|Withdrawal by Subject|2|||
145542839|NCT01306942|524846529|FG000|Phase II|Death|0|||
145542840|NCT01306942|524846530|FG001|Phase II|Death|0|||
145542841|NCT01306942|524846531|FG002|Phase II|Death|0|||
145542842|NCT01306942|524846532|FG003|Phase II|Death|1|||
145542843|NCT01306942|524846529|FG000|Phase II|Not finished treatment|0|||
145542844|NCT01306942|524846530|FG001|Phase II|Not finished treatment|0|||
145542845|NCT01306942|524846531|FG002|Phase II|Not finished treatment|0|||
145542846|NCT01306942|524846532|FG003|Phase II|Not finished treatment|1|||
145542847|NCT01306942|524846529|FG000|Phase II|Protocol Violation|0|||
145542848|NCT01306942|524846530|FG001|Phase II|Protocol Violation|0|||
145542849|NCT01306942|524846531|FG002|Phase II|Protocol Violation|0|||
145542850|NCT01306942|524846532|FG003|Phase II|Protocol Violation|1|||
145282356|NCT03940586|523883108|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
145542851|NCT03190915|524846539|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
145542852|NCT03190915|524846539|FG000|Overall Study|Progressive Disease|3|||
145542853|NCT03385564|524846540|FG000|Overall Study|Adverse Event|0|||
145542854|NCT03385564|524846541|FG001|Overall Study|Adverse Event|0|||
145542855|NCT03385564|524846542|FG002|Overall Study|Adverse Event|3|||
145542856|NCT03385564|524846543|FG003|Overall Study|Adverse Event|3|||
145542857|NCT03385564|524846540|FG000|Overall Study|Other than listed|0|||
145282357|NCT03940586|523883106|FG000|Overall Study|Not Treated|0|||
145282358|NCT03940586|523883107|FG001|Overall Study|Not Treated|2|||
145282359|NCT03940586|523883108|FG002|Overall Study|Not Treated|0|||
145282360|NCT00964223|523883109|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
145282361|NCT01559818|523883110|FG000|Overall Study|Physician Decision|1|||
145282362|NCT01559818|523883110|FG000|Overall Study|Pregnancy|1|||
145282363|NCT01559818|523883110|FG000|Overall Study|Study terminated by Sponsor|4|||
145282364|NCT01559818|523883110|FG000|Overall Study|Withdrawal by Subject|1|||
145282365|NCT04071626|523883111|FG000|Overall Study|Withdrawal by Subject|1|||
145282366|NCT04071626|523883112|FG001|Overall Study|Withdrawal by Subject|1|||
145282367|NCT04071626|523883111|FG000|Overall Study|Protocol Violation|0|||
145282368|NCT04071626|523883112|FG001|Overall Study|Protocol Violation|1|||
145282369|NCT00931385|523883113|FG000|Overall Study|Adverse Event|2|||
145282370|NCT00931385|523883114|FG001|Overall Study|Adverse Event|1|||
145282371|NCT00931385|523883115|FG002|Overall Study|Adverse Event|0|||
145282372|NCT00931385|523883116|FG003|Overall Study|Adverse Event|3|||
145542858|NCT03385564|524846541|FG001|Overall Study|Other than listed|0|||
145542859|NCT03385564|524846542|FG002|Overall Study|Other than listed|0|||
145542860|NCT03385564|524846543|FG003|Overall Study|Other than listed|5|||
145542861|NCT03385564|524846540|FG000|Overall Study|Withdrawal by Subject|0|||
145542862|NCT03385564|524846541|FG001|Overall Study|Withdrawal by Subject|1|||
145542863|NCT03385564|524846542|FG002|Overall Study|Withdrawal by Subject|1|||
145542864|NCT03385564|524846543|FG003|Overall Study|Withdrawal by Subject|0|||
145542865|NCT03385564|524846540|FG000|Overall Study|Lack of Efficacy|0|||
145542866|NCT03385564|524846541|FG001|Overall Study|Lack of Efficacy|0|||
145542867|NCT03385564|524846542|FG002|Overall Study|Lack of Efficacy|0|||
145542868|NCT03385564|524846543|FG003|Overall Study|Lack of Efficacy|1|||
145542869|NCT03385564|524846540|FG000|Overall Study|Death|0|||
145542870|NCT03385564|524846541|FG001|Overall Study|Death|0|||
145542871|NCT03385564|524846542|FG002|Overall Study|Death|1|||
145542872|NCT03385564|524846543|FG003|Overall Study|Death|0|||
145542873|NCT01546883|524846547|FG000|Overall Study|Withdrawal by Subject|3|||
145542874|NCT01546883|524846547|FG000|Overall Study|Adverse Event|4|||
145542875|NCT01546883|524846547|FG000|Overall Study|Lost to Follow-up|2|||
145542876|NCT01546883|524846547|FG000|Overall Study|early closure of study|2|||
145542877|NCT01546883|524846547|FG000|Overall Study|other unrelated illness|1|||
145542878|NCT02256631|524846552|FG000|Overall Study|Lost to Follow-up|1|||
145542879|NCT02256631|524846553|FG001|Overall Study|Lost to Follow-up|1|||
145542880|NCT02256631|524846554|FG002|Overall Study|Lost to Follow-up|0|||
145542881|NCT02256631|524846555|FG003|Overall Study|Lost to Follow-up|2|||
145542882|NCT02256631|524846556|FG004|Overall Study|Lost to Follow-up|0|||
145542883|NCT02256631|524846557|FG005|Overall Study|Lost to Follow-up|4|||
145542884|NCT02256631|524846558|FG006|Overall Study|Lost to Follow-up|1|||
145542885|NCT02256631|524846552|FG000|Overall Study|Withdrawal by Subject|0|||
145542886|NCT02256631|524846553|FG001|Overall Study|Withdrawal by Subject|0|||
145542887|NCT02256631|524846554|FG002|Overall Study|Withdrawal by Subject|0|||
145542888|NCT02256631|524846555|FG003|Overall Study|Withdrawal by Subject|1|||
145542889|NCT02256631|524846556|FG004|Overall Study|Withdrawal by Subject|1|||
145542890|NCT02256631|524846557|FG005|Overall Study|Withdrawal by Subject|0|||
145542891|NCT02256631|524846558|FG006|Overall Study|Withdrawal by Subject|1|||
145542892|NCT02256631|524846552|FG000|Overall Study|Unable to get to clinic|0|||
145542893|NCT02256631|524846553|FG001|Overall Study|Unable to get to clinic|2|||
145542894|NCT02256631|524846554|FG002|Overall Study|Unable to get to clinic|0|||
145542895|NCT02256631|524846555|FG003|Overall Study|Unable to get to clinic|1|||
145282373|NCT00931385|523883113|FG000|Overall Study|Protocol Violation|0|||
145282374|NCT00931385|523883114|FG001|Overall Study|Protocol Violation|0|||
145282375|NCT00931385|523883115|FG002|Overall Study|Protocol Violation|1|||
145542896|NCT02256631|524846556|FG004|Overall Study|Unable to get to clinic|0|||
145542897|NCT02256631|524846557|FG005|Overall Study|Unable to get to clinic|1|||
145542898|NCT02256631|524846558|FG006|Overall Study|Unable to get to clinic|2|||
145282376|NCT00931385|523883116|FG003|Overall Study|Protocol Violation|0|||
145282377|NCT00931385|523883113|FG000|Overall Study|Withdrawal by Subject|0|||
145282378|NCT00931385|523883114|FG001|Overall Study|Withdrawal by Subject|1|||
145542899|NCT00622284|524846559|FG000|Overall Study|Lack of Efficacy|45|||
145542900|NCT00622284|524846560|FG001|Overall Study|Lack of Efficacy|15|||
145542901|NCT00622284|524846559|FG000|Overall Study|Adverse Event|61|||
145542902|NCT00622284|524846560|FG001|Overall Study|Adverse Event|90|||
145542903|NCT00622284|524846559|FG000|Overall Study|Protocol Violation|12|||
145542904|NCT00622284|524846560|FG001|Overall Study|Protocol Violation|5|||
145542905|NCT00622284|524846559|FG000|Overall Study|Lost to Follow-up|11|||
145542906|NCT00622284|524846560|FG001|Overall Study|Lost to Follow-up|13|||
145542907|NCT00622284|524846559|FG000|Overall Study|Withdrawal by Subject|27|||
145542908|NCT00622284|524846560|FG001|Overall Study|Withdrawal by Subject|24|||
145542909|NCT00622284|524846559|FG000|Overall Study|Other reason (not specified)|33|||
145542910|NCT00622284|524846560|FG001|Overall Study|Other reason (not specified)|24|||
145542911|NCT04545385|524846561|FG000|Overall Study|Withdrawal by Subject|2|||
145542912|NCT04545385|524846562|FG001|Overall Study|Withdrawal by Subject|0|||
145542913|NCT04545385|524846561|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
145542914|NCT04545385|524846562|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
145542915|NCT04545385|524846561|FG000|Overall Study|Study termination|10|||
145542916|NCT04545385|524846562|FG001|Overall Study|Study termination|10|||
145542917|NCT04545385|524846561|FG000|Overall Study|Sponsor decision|2|||
145542918|NCT04545385|524846562|FG001|Overall Study|Sponsor decision|2|||
145542919|NCT04545385|524846561|FG000|Overall Study|Other than specified|1|||
145542920|NCT04545385|524846562|FG001|Overall Study|Other than specified|0|||
145542921|NCT01128842|524846563|FG000|Overall Study|Adverse Event|1|||
145542922|NCT01128842|524846563|FG000|Overall Study|Disease Progression|6|||
145542923|NCT04528732|524846564|FG000|Overall Study|Death|1|||
145542924|NCT04528732|524846565|FG001|Overall Study|Death|0|||
145542925|NCT04528732|524846566|FG002|Overall Study|Death|1|||
145542926|NCT04528732|524846564|FG000|Overall Study|Lost to Follow-up|0|||
145542927|NCT04528732|524846565|FG001|Overall Study|Lost to Follow-up|1|||
145542928|NCT04528732|524846566|FG002|Overall Study|Lost to Follow-up|2|||
145542929|NCT00668707|524846573|FG000|Overall Study|Cancer Recurrence|58|||
145542930|NCT00668707|524846574|FG001|Overall Study|Cancer Recurrence|58|||
145542931|NCT00668707|524846573|FG000|Overall Study|Withdrawal by Subject|117|||
145542932|NCT00668707|524846574|FG001|Overall Study|Withdrawal by Subject|100|||
145542933|NCT00668707|524846573|FG000|Overall Study|Lost to Follow-up|3|||
145542934|NCT00668707|524846574|FG001|Overall Study|Lost to Follow-up|6|||
145542935|NCT00668707|524846573|FG000|Overall Study|Protocol Violation|10|||
145542936|NCT00668707|524846574|FG001|Overall Study|Protocol Violation|12|||
145542937|NCT00668707|524846573|FG000|Overall Study|Death|11|||
145542938|NCT00668707|524846574|FG001|Overall Study|Death|4|||
145542939|NCT00826943|524846575|FG000|Overall Study|Withdrawal by Subject|0|||
145542940|NCT00826943|524846576|FG001|Overall Study|Withdrawal by Subject|0|||
145542941|NCT00826943|524846577|FG002|Overall Study|Withdrawal by Subject|0|||
145542942|NCT00826943|524846578|FG003|Overall Study|Withdrawal by Subject|0|||
145542943|NCT00826943|524846579|FG004|Overall Study|Withdrawal by Subject|1|||
145542944|NCT00826943|524846580|FG005|Overall Study|Withdrawal by Subject|0|||
145542945|NCT01382212|524846581|FG000|Overall Study|Kidney transplant|1|||
145542946|NCT01382212|524846581|FG000|Overall Study|Withdrew consent|1|||
145542947|NCT02302807|524846584|FG000|Overall Study|Withdrawal by Subject|28|||
145542948|NCT02302807|524846585|FG001|Overall Study|Withdrawal by Subject|11|||
145542949|NCT02302807|524846584|FG000|Overall Study|Lost to Follow-up|4|||
145542950|NCT02302807|524846585|FG001|Overall Study|Lost to Follow-up|6|||
145542951|NCT02302807|524846584|FG000|Overall Study|Death|397|||
145542952|NCT02302807|524846585|FG001|Overall Study|Death|385|||
145542953|NCT02302807|524846584|FG000|Overall Study|Study Terminated By Sponsor|35|||
145542954|NCT02302807|524846585|FG001|Overall Study|Study Terminated By Sponsor|64|||
145542955|NCT02302807|524846584|FG000|Overall Study|Physician Decision|0|||
145542956|NCT02302807|524846585|FG001|Overall Study|Physician Decision|1|||
145542957|NCT01133522|524846589|FG000|Overall Study|Withdrawal by Subject|0|||
145542958|NCT01133522|524846590|FG001|Overall Study|Withdrawal by Subject|1|||
145542959|NCT01133522|524846591|FG002|Overall Study|Withdrawal by Subject|0|||
145542960|NCT01133522|524846592|FG003|Overall Study|Withdrawal by Subject|1|||
145542961|NCT01133522|524846593|FG004|Overall Study|Withdrawal by Subject|0|||
145542962|NCT01133522|524846594|FG005|Overall Study|Withdrawal by Subject|0|||
145542963|NCT01133522|524846595|FG006|Overall Study|Withdrawal by Subject|0|||
145542964|NCT01133522|524846596|FG007|Overall Study|Withdrawal by Subject|0|||
145542965|NCT01133522|524846597|FG008|Overall Study|Withdrawal by Subject|0|||
145542966|NCT01133522|524846598|FG009|Overall Study|Withdrawal by Subject|0|||
145542967|NCT01133522|524846589|FG000|Overall Study|Physician Decision|0|||
145542968|NCT01133522|524846590|FG001|Overall Study|Physician Decision|0|||
145542969|NCT01133522|524846591|FG002|Overall Study|Physician Decision|0|||
145542970|NCT01133522|524846592|FG003|Overall Study|Physician Decision|0|||
145542971|NCT01133522|524846593|FG004|Overall Study|Physician Decision|1|||
145542972|NCT01133522|524846594|FG005|Overall Study|Physician Decision|0|||
145542973|NCT01133522|524846595|FG006|Overall Study|Physician Decision|0|||
145542974|NCT01133522|524846596|FG007|Overall Study|Physician Decision|0|||
145542975|NCT01133522|524846597|FG008|Overall Study|Physician Decision|0|||
145542976|NCT01133522|524846598|FG009|Overall Study|Physician Decision|0|||
145542977|NCT00688753|524848296|FG000|Overall Study|Disease progression|55|||
145542978|NCT00688753|524848296|FG000|Overall Study|Missing|1|||
145542979|NCT00688753|524848296|FG000|Overall Study|Death|9|||
145542980|NCT00688753|524848296|FG000|Overall Study|Withdrawal by Subject|3|||
145542981|NCT00688753|524848296|FG000|Overall Study|Adverse Event|20|||
145542982|NCT00688753|524848296|FG000|Overall Study|Protocol Violation|1|||
145542983|NCT00688753|524848296|FG000|Overall Study|Lost to Follow-up|3|||
145542984|NCT03192462|524848297|FG000|Overall Study|Death|13|||
145542985|NCT03192462|524848298|FG001|Overall Study|Death|11|||
145542986|NCT03192462|524848299|FG002|Overall Study|Death|10|||
145542987|NCT03192462|524848297|FG000|Overall Study|Lost to Follow-up|0|||
145791047|NCT00343291|525741020|FG000|Overall Study|Other|8|||
145791048|NCT00343291|525741021|FG001|Overall Study|Other|5|||
145791049|NCT03712345|525741022|FG000|Overall Study|Failure to meet randomization criteria|0|||
145791050|NCT03712345|525741023|FG001|Overall Study|Failure to meet randomization criteria|0|||
145791051|NCT03712345|525741024|FG002|Overall Study|Failure to meet randomization criteria|1|||
145791052|NCT00960934|525741027|FG000|Overall Study|Adverse Event|2|||
145791053|NCT00960934|525741028|FG001|Overall Study|Adverse Event|3|||
145791054|NCT00960934|525741029|FG002|Overall Study|Adverse Event|3|||
145791055|NCT00960934|525741030|FG003|Overall Study|Adverse Event|2|||
145791056|NCT00960934|525741031|FG004|Overall Study|Adverse Event|4|||
145791057|NCT00960934|525741032|FG005|Overall Study|Adverse Event|3|||
145791058|NCT00960934|525741027|FG000|Overall Study|Lack of Efficacy|1|||
145791059|NCT00960934|525741028|FG001|Overall Study|Lack of Efficacy|0|||
145791060|NCT00960934|525741029|FG002|Overall Study|Lack of Efficacy|0|||
145791061|NCT00960934|525741030|FG003|Overall Study|Lack of Efficacy|0|||
145791062|NCT00960934|525741031|FG004|Overall Study|Lack of Efficacy|0|||
145791063|NCT00960934|525741032|FG005|Overall Study|Lack of Efficacy|0|||
145791064|NCT00960934|525741027|FG000|Overall Study|Lost to Follow-up|0|||
145791065|NCT00960934|525741028|FG001|Overall Study|Lost to Follow-up|1|||
145791066|NCT00960934|525741029|FG002|Overall Study|Lost to Follow-up|0|||
145791067|NCT00960934|525741030|FG003|Overall Study|Lost to Follow-up|0|||
145791068|NCT00960934|525741031|FG004|Overall Study|Lost to Follow-up|0|||
145791069|NCT00960934|525741032|FG005|Overall Study|Lost to Follow-up|0|||
145791070|NCT00960934|525741027|FG000|Overall Study|Other|2|||
145791071|NCT00960934|525741028|FG001|Overall Study|Other|1|||
145791072|NCT00960934|525741029|FG002|Overall Study|Other|5|||
145542988|NCT03192462|524848298|FG001|Overall Study|Lost to Follow-up|1|||
145542989|NCT03192462|524848299|FG002|Overall Study|Lost to Follow-up|0|||
145542990|NCT03187197|524848301|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
145542991|NCT03187197|524848302|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
145542992|NCT03187197|524848303|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
145542993|NCT03187197|524848301|FG000|Overall Study|Withdrawal by Subject|8|||
145542994|NCT03187197|524848302|FG001|Overall Study|Withdrawal by Subject|63|||
145791073|NCT00960934|525741030|FG003|Overall Study|Other|4|||
145791074|NCT00960934|525741031|FG004|Overall Study|Other|2|||
145542995|NCT03187197|524848303|FG002|Overall Study|Withdrawal by Subject|4|||
145542996|NCT03187197|524848301|FG000|Overall Study|Lost to Follow-up|1|||
145542997|NCT03187197|524848302|FG001|Overall Study|Lost to Follow-up|60|||
145542998|NCT03187197|524848303|FG002|Overall Study|Lost to Follow-up|7|||
145542999|NCT03187197|524848301|FG000|Overall Study|Adverse Event|6|||
145543000|NCT03187197|524848302|FG001|Overall Study|Adverse Event|29|||
145791075|NCT00960934|525741032|FG005|Overall Study|Other|2|||
145791076|NCT00960934|525741027|FG000|Overall Study|Physician Decision|0|||
145791077|NCT00960934|525741028|FG001|Overall Study|Physician Decision|1|||
145543001|NCT03187197|524848303|FG002|Overall Study|Adverse Event|0|||
145282379|NCT00931385|523883115|FG002|Overall Study|Withdrawal by Subject|0|||
145282380|NCT00931385|523883116|FG003|Overall Study|Withdrawal by Subject|1|||
145282381|NCT00931385|523883113|FG000|Overall Study|Lost to Follow-up|0|||
145282382|NCT00931385|523883114|FG001|Overall Study|Lost to Follow-up|0|||
145543002|NCT03187197|524848301|FG000|Overall Study|Death|0|||
145543003|NCT03187197|524848302|FG001|Overall Study|Death|11|||
145543004|NCT03187197|524848303|FG002|Overall Study|Death|0|||
145543005|NCT03187197|524848301|FG000|Overall Study|Administrative problem|1|||
145543006|NCT03187197|524848302|FG001|Overall Study|Administrative problem|1|||
145543007|NCT03187197|524848303|FG002|Overall Study|Administrative problem|0|||
145543008|NCT03187197|524848301|FG000|Overall Study|Reason not listed|2|||
145543009|NCT03187197|524848302|FG001|Overall Study|Reason not listed|54|||
145543010|NCT03187197|524848303|FG002|Overall Study|Reason not listed|1|||
145543011|NCT03187197|524848301|FG000|Overall Study|Missing|1|||
145543012|NCT03187197|524848302|FG001|Overall Study|Missing|32|||
145543013|NCT03187197|524848303|FG002|Overall Study|Missing|3|||
145543014|NCT03187197|524848301|FG000|Overall Study|Status missing|2|||
145543015|NCT03187197|524848302|FG001|Overall Study|Status missing|33|||
145543016|NCT03187197|524848303|FG002|Overall Study|Status missing|3|||
145543017|NCT03187197|524848301|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
145543018|NCT03187197|524848302|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
145543019|NCT03187197|524848303|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
145543020|NCT02385045|524848304|FG000|Overall Study|Endoscopy could not be completed|4|||
145543021|NCT04840615|524848305|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
145543022|NCT04840615|524848306|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
145543023|NCT04840615|524848307|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
145543024|NCT01898806|524848309|FG000|Overall Study|Withdrawal by Subject|2|||
145543025|NCT01898806|524848309|FG000|Overall Study|Physician Decision|1|||
145543026|NCT03003390|524848310|FG000|Overall Study|Physician Decision|2|||
145543027|NCT03003390|524848311|FG001|Overall Study|Physician Decision|0|||
145543028|NCT03003390|524848310|FG000|Overall Study|Parent refused intervention|2|||
145543029|NCT03003390|524848311|FG001|Overall Study|Parent refused intervention|0|||
145543030|NCT03156543|524848314|FG000|Overall Study|Withdrawal by Subject|1|||
145543031|NCT03156543|524848315|FG001|Overall Study|Withdrawal by Subject|0|||
145543032|NCT00674700|524848318|FG000|Year 1|Adverse Event|17|||
145543033|NCT00674700|524848319|FG001|Year 1|Adverse Event|20|||
145543034|NCT00674700|524848320|FG002|Year 1|Adverse Event|5|||
145543035|NCT00674700|524848318|FG000|Year 1|Withdrawal by Subject|7|||
145543036|NCT00674700|524848319|FG001|Year 1|Withdrawal by Subject|7|||
145543037|NCT00674700|524848320|FG002|Year 1|Withdrawal by Subject|6|||
145543038|NCT00674700|524848318|FG000|Year 1|Any other reason not above-mentioned|7|||
145543039|NCT00674700|524848319|FG001|Year 1|Any other reason not above-mentioned|7|||
145543040|NCT00674700|524848320|FG002|Year 1|Any other reason not above-mentioned|6|||
145543041|NCT00674700|524848318|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
145543042|NCT00674700|524848319|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
145543043|NCT00674700|524848320|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
145543044|NCT00674700|524848318|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
145543045|NCT00674700|524848319|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
145543046|NCT00674700|524848320|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
145543047|NCT00674700|524848318|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
145543048|NCT00674700|524848319|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
145543049|NCT00674700|524848320|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
145543050|NCT00395304|524848321|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145543051|NCT00395304|524848322|FG001|Treatment Period 1|Withdrawal by Subject|3|||
145543052|NCT00395304|524848323|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145543053|NCT00395304|524848324|FG003|Treatment Period 1|Withdrawal by Subject|2|||
145282383|NCT00931385|523883115|FG002|Overall Study|Lost to Follow-up|0|||
145543054|NCT00395304|524848325|FG004|Treatment Period 1|Withdrawal by Subject|1|||
145543055|NCT00395304|524848326|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145543056|NCT00395304|524848321|FG000|Treatment Period 1|Lost to Follow-up|1|||
145543057|NCT00395304|524848322|FG001|Treatment Period 1|Lost to Follow-up|0|||
145543058|NCT00395304|524848323|FG002|Treatment Period 1|Lost to Follow-up|0|||
145543059|NCT00395304|524848324|FG003|Treatment Period 1|Lost to Follow-up|1|||
145543060|NCT00395304|524848325|FG004|Treatment Period 1|Lost to Follow-up|0|||
145543061|NCT00395304|524848326|FG005|Treatment Period 1|Lost to Follow-up|1|||
145543062|NCT00395304|524848321|FG000|Treatment Period 1|Physician Decision|0|||
145543063|NCT00395304|524848322|FG001|Treatment Period 1|Physician Decision|1|||
145543064|NCT00395304|524848323|FG002|Treatment Period 1|Physician Decision|0|||
145543065|NCT00395304|524848324|FG003|Treatment Period 1|Physician Decision|0|||
145543066|NCT00395304|524848325|FG004|Treatment Period 1|Physician Decision|0|||
145543067|NCT00395304|524848326|FG005|Treatment Period 1|Physician Decision|0|||
145543068|NCT00395304|524848321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145543069|NCT00395304|524848322|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145543070|NCT00395304|524848323|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145543071|NCT00395304|524848324|FG003|Treatment Period 2|Withdrawal by Subject|1|||
145543072|NCT00395304|524848325|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145543073|NCT00395304|524848326|FG005|Treatment Period 2|Withdrawal by Subject|2|||
145543074|NCT00395304|524848321|FG000|Treatment Period 2|Lost to Follow-up|0|||
145543075|NCT00395304|524848322|FG001|Treatment Period 2|Lost to Follow-up|3|||
145543076|NCT00395304|524848323|FG002|Treatment Period 2|Lost to Follow-up|0|||
145543077|NCT00395304|524848324|FG003|Treatment Period 2|Lost to Follow-up|0|||
145543078|NCT00395304|524848325|FG004|Treatment Period 2|Lost to Follow-up|0|||
145543079|NCT00395304|524848326|FG005|Treatment Period 2|Lost to Follow-up|0|||
145543080|NCT00395304|524848321|FG000|Treatment Period 2|Physician Decision|0|||
145543081|NCT00395304|524848322|FG001|Treatment Period 2|Physician Decision|0|||
145791078|NCT00960934|525741029|FG002|Overall Study|Physician Decision|0|||
145791079|NCT00960934|525741030|FG003|Overall Study|Physician Decision|0|||
145543082|NCT00395304|524848323|FG002|Treatment Period 2|Physician Decision|1|||
145543083|NCT00395304|524848324|FG003|Treatment Period 2|Physician Decision|0|||
145543084|NCT00395304|524848325|FG004|Treatment Period 2|Physician Decision|0|||
145543085|NCT00395304|524848326|FG005|Treatment Period 2|Physician Decision|0|||
145543086|NCT00395304|524848321|FG000|Treatment Period 2|Other|0|||
145543087|NCT00395304|524848322|FG001|Treatment Period 2|Other|1|||
145543088|NCT00395304|524848323|FG002|Treatment Period 2|Other|0|||
145543089|NCT00395304|524848324|FG003|Treatment Period 2|Other|0|||
145543090|NCT00395304|524848325|FG004|Treatment Period 2|Other|0|||
145543091|NCT00395304|524848326|FG005|Treatment Period 2|Other|0|||
145543092|NCT00395304|524848321|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145543093|NCT00395304|524848322|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145543094|NCT00395304|524848323|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145543095|NCT00395304|524848324|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145543096|NCT00395304|524848325|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145543097|NCT00395304|524848326|FG005|Treatment Period 3|Withdrawal by Subject|1|||
145543098|NCT00395304|524848321|FG000|Treatment Period 3|Lost to Follow-up|1|||
145543099|NCT00395304|524848322|FG001|Treatment Period 3|Lost to Follow-up|1|||
145543100|NCT00395304|524848323|FG002|Treatment Period 3|Lost to Follow-up|0|||
145543101|NCT00395304|524848324|FG003|Treatment Period 3|Lost to Follow-up|0|||
145543102|NCT00395304|524848325|FG004|Treatment Period 3|Lost to Follow-up|0|||
145543103|NCT00395304|524848326|FG005|Treatment Period 3|Lost to Follow-up|0|||
145543104|NCT00395304|524848321|FG000|Treatment Period 3|Physician Decision|0|||
145543105|NCT00395304|524848322|FG001|Treatment Period 3|Physician Decision|1|||
145543106|NCT00395304|524848323|FG002|Treatment Period 3|Physician Decision|0|||
145543107|NCT00395304|524848324|FG003|Treatment Period 3|Physician Decision|0|||
145543108|NCT00395304|524848325|FG004|Treatment Period 3|Physician Decision|0|||
145543109|NCT00395304|524848326|FG005|Treatment Period 3|Physician Decision|0|||
145543110|NCT00395304|524848321|FG000|Treatment Period 3|Other|0|||
145543111|NCT00395304|524848322|FG001|Treatment Period 3|Other|0|||
145543112|NCT00395304|524848323|FG002|Treatment Period 3|Other|0|||
145543113|NCT00395304|524848324|FG003|Treatment Period 3|Other|1|||
145543114|NCT00395304|524848325|FG004|Treatment Period 3|Other|0|||
145543115|NCT00395304|524848326|FG005|Treatment Period 3|Other|0|||
145543116|NCT01389817|524848327|FG000|Overall Study|Physician Decision|1|||
145791080|NCT00960934|525741031|FG004|Overall Study|Physician Decision|0|||
145791081|NCT00960934|525741032|FG005|Overall Study|Physician Decision|0|||
145791082|NCT00960934|525741027|FG000|Overall Study|Progressive Disease|1|||
145791083|NCT00960934|525741028|FG001|Overall Study|Progressive Disease|1|||
145791084|NCT00960934|525741029|FG002|Overall Study|Progressive Disease|0|||
145791085|NCT00960934|525741030|FG003|Overall Study|Progressive Disease|0|||
145791086|NCT00960934|525741031|FG004|Overall Study|Progressive Disease|1|||
145543117|NCT01389817|524848328|FG001|Overall Study|Physician Decision|0|||
145791087|NCT00960934|525741032|FG005|Overall Study|Progressive Disease|1|||
145791088|NCT00960934|525741027|FG000|Overall Study|Protocol Violation|3|||
145543118|NCT01389817|524848327|FG000|Overall Study|Lost to Follow-up|1|||
145543119|NCT01389817|524848328|FG001|Overall Study|Lost to Follow-up|0|||
145543120|NCT01389817|524848327|FG000|Overall Study|Withdrawal by Subject|2|||
145543121|NCT01389817|524848328|FG001|Overall Study|Withdrawal by Subject|0|||
145543122|NCT02871297|524848329|FG000|Overall Study|Adverse Event|34|||
145791089|NCT00960934|525741028|FG001|Overall Study|Protocol Violation|4|||
145791090|NCT00960934|525741029|FG002|Overall Study|Protocol Violation|0|||
145791091|NCT00960934|525741030|FG003|Overall Study|Protocol Violation|3|||
145404332|NCT00284856|524336550|FG001|Overall Study|Withdrawal by Subject|16|||
145543123|NCT02871297|524848329|FG000|Overall Study|Lack of Efficacy|10|||
145543124|NCT02871297|524848329|FG000|Overall Study|Non-compliance with study drug|15|||
145543125|NCT02871297|524848329|FG000|Overall Study|Protocol Violation|3|||
145543126|NCT02871297|524848329|FG000|Overall Study|Withdrawal by Subject|20|||
145543127|NCT02871297|524848329|FG000|Overall Study|Lost to Follow-up|13|||
145543128|NCT02871297|524848329|FG000|Overall Study|Rolled over to 13546A|2|||
145543129|NCT02871297|524848329|FG000|Overall Study|Other than specified|39|||
145543130|NCT02966028|524848330|FG000|Overall Study|Adverse Event|7|||
145543131|NCT02966028|524848331|FG001|Overall Study|Adverse Event|13|||
145543132|NCT02966028|524848332|FG002|Overall Study|Adverse Event|10|||
145543133|NCT02966028|524848330|FG000|Overall Study|Physician Decision|1|||
145543134|NCT02966028|524848331|FG001|Overall Study|Physician Decision|0|||
145543135|NCT02966028|524848332|FG002|Overall Study|Physician Decision|2|||
145543136|NCT02966028|524848330|FG000|Overall Study|Withdrawal by Subject|7|||
145543137|NCT02966028|524848331|FG001|Overall Study|Withdrawal by Subject|5|||
145543138|NCT02966028|524848332|FG002|Overall Study|Withdrawal by Subject|5|||
145543139|NCT02966028|524848330|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
145543140|NCT02966028|524848331|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
145543141|NCT02966028|524848332|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
145543142|NCT00599924|524848333|FG000|Overall Study|Lack of Efficacy|3|||
145543143|NCT00599924|524848334|FG001|Overall Study|Lack of Efficacy|5|||
145543144|NCT00599924|524848335|FG002|Overall Study|Lack of Efficacy|1|||
145543145|NCT00599924|524848336|FG003|Overall Study|Lack of Efficacy|2|||
145543146|NCT00599924|524848337|FG004|Overall Study|Lack of Efficacy|3|||
145543147|NCT00599924|524848338|FG005|Overall Study|Lack of Efficacy|2|||
145543148|NCT00599924|524848339|FG006|Overall Study|Lack of Efficacy|0|||
145543149|NCT00599924|524848333|FG000|Overall Study|Adverse Event|0|||
145543150|NCT00599924|524848334|FG001|Overall Study|Adverse Event|0|||
145543151|NCT00599924|524848335|FG002|Overall Study|Adverse Event|0|||
145543152|NCT00599924|524848336|FG003|Overall Study|Adverse Event|2|||
145543153|NCT00599924|524848337|FG004|Overall Study|Adverse Event|0|||
145543154|NCT00599924|524848338|FG005|Overall Study|Adverse Event|0|||
145543155|NCT00599924|524848339|FG006|Overall Study|Adverse Event|2|||
145543156|NCT00599924|524848333|FG000|Overall Study|Death|0|||
145543157|NCT00599924|524848334|FG001|Overall Study|Death|0|||
145543158|NCT00599924|524848335|FG002|Overall Study|Death|0|||
145543159|NCT00599924|524848336|FG003|Overall Study|Death|2|||
145543160|NCT00599924|524848337|FG004|Overall Study|Death|0|||
145543161|NCT00599924|524848338|FG005|Overall Study|Death|2|||
145543162|NCT00599924|524848339|FG006|Overall Study|Death|1|||
145543163|NCT00599924|524848333|FG000|Overall Study|Protocol Violation|0|||
145543164|NCT00599924|524848334|FG001|Overall Study|Protocol Violation|0|||
145543165|NCT00599924|524848335|FG002|Overall Study|Protocol Violation|0|||
145543166|NCT00599924|524848336|FG003|Overall Study|Protocol Violation|1|||
145543167|NCT00599924|524848337|FG004|Overall Study|Protocol Violation|0|||
145543168|NCT00599924|524848338|FG005|Overall Study|Protocol Violation|0|||
145543169|NCT00599924|524848339|FG006|Overall Study|Protocol Violation|0|||
145543170|NCT00599924|524848333|FG000|Overall Study|Withdrawal by Subject|0|||
145543171|NCT00599924|524848334|FG001|Overall Study|Withdrawal by Subject|0|||
145543172|NCT00599924|524848335|FG002|Overall Study|Withdrawal by Subject|1|||
145543173|NCT00599924|524848336|FG003|Overall Study|Withdrawal by Subject|0|||
145543174|NCT00599924|524848337|FG004|Overall Study|Withdrawal by Subject|1|||
145543175|NCT00599924|524848338|FG005|Overall Study|Withdrawal by Subject|0|||
145543176|NCT00599924|524848339|FG006|Overall Study|Withdrawal by Subject|0|||
145543177|NCT00599924|524848333|FG000|Overall Study|Other|0|||
145543178|NCT00599924|524848334|FG001|Overall Study|Other|0|||
145543179|NCT00599924|524848335|FG002|Overall Study|Other|0|||
145543180|NCT00599924|524848336|FG003|Overall Study|Other|1|||
145543181|NCT00599924|524848337|FG004|Overall Study|Other|2|||
145543182|NCT00599924|524848338|FG005|Overall Study|Other|0|||
145610231|NCT01709305|525088177|FG004|Phase 1|Physician Decision|0|||
145543183|NCT00599924|524848339|FG006|Overall Study|Other|2|||
145543184|NCT01806298|524848340|FG000|Overall Study|Adverse Event|3|||
145543185|NCT01806298|524848340|FG000|Overall Study|Protocol Non-compliance|1|||
145543186|NCT01806298|524848340|FG000|Overall Study|Withdrawal by Subject|1|||
145543187|NCT01806298|524848340|FG000|Overall Study|Other|5|||
145610232|NCT01709305|525088173|FG000|Phase 1|Protocol Violation|118|||
145543188|NCT04980040|524848345|FG000|Overall Study|Violated the Inclusion Criteria|260|||
145543189|NCT04980040|524848345|FG000|Overall Study|Violated the Administration & Dosage|225|||
145543190|NCT04980040|524848345|FG000|Overall Study|Lost to Safety-Follow-up|4|||
145543191|NCT04980040|524848345|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
145543192|NCT00691015|524848346|FG000|Overall Study|Refused further treatment|1|||
145543193|NCT01397084|524848347|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
145543194|NCT01397084|524848347|FG000|Overall Study|Protocol Violation|2|||
145543195|NCT01397084|524848347|FG000|Overall Study|Adverse Event|2|||
145543196|NCT01397084|524848347|FG000|Overall Study|Withdrawal by Subject|1|||
145543197|NCT01397084|524848347|FG000|Overall Study|Lost to Follow-up|1|||
145543198|NCT01397084|524848347|FG000|Overall Study|Used other proton pump inhibitor|1|||
145543199|NCT01976338|524848348|FG000|Overall Study|Physician Decision|0|||
145543200|NCT01976338|524848349|FG001|Overall Study|Physician Decision|1|||
145610233|NCT01709305|525088174|FG001|Phase 1|Protocol Violation|0|||
145610234|NCT01709305|525088175|FG002|Phase 1|Protocol Violation|0|||
145610235|NCT01709305|525088176|FG003|Phase 1|Protocol Violation|0|||
145610236|NCT01709305|525088177|FG004|Phase 1|Protocol Violation|0|||
145610237|NCT01709305|525088173|FG000|Phase 1|Withdrawal by Subject|218|||
145610238|NCT01709305|525088174|FG001|Phase 1|Withdrawal by Subject|0|||
145610239|NCT01709305|525088175|FG002|Phase 1|Withdrawal by Subject|0|||
145610240|NCT01709305|525088176|FG003|Phase 1|Withdrawal by Subject|0|||
145791092|NCT00960934|525741031|FG004|Overall Study|Protocol Violation|3|||
145791093|NCT00960934|525741032|FG005|Overall Study|Protocol Violation|2|||
145791094|NCT00960934|525741027|FG000|Overall Study|Withdrawal by Subject|5|||
145791095|NCT00960934|525741028|FG001|Overall Study|Withdrawal by Subject|6|||
145791096|NCT00960934|525741029|FG002|Overall Study|Withdrawal by Subject|4|||
145791097|NCT00960934|525741030|FG003|Overall Study|Withdrawal by Subject|5|||
145791098|NCT00960934|525741031|FG004|Overall Study|Withdrawal by Subject|5|||
145791099|NCT00960934|525741032|FG005|Overall Study|Withdrawal by Subject|7|||
145791100|NCT00960934|525741027|FG000|Overall Study|Study Terminated by Sponsor|50|||
145791101|NCT00960934|525741028|FG001|Overall Study|Study Terminated by Sponsor|46|||
145791102|NCT00960934|525741029|FG002|Overall Study|Study Terminated by Sponsor|52|||
145791103|NCT00960934|525741030|FG003|Overall Study|Study Terminated by Sponsor|50|||
145791104|NCT00960934|525741031|FG004|Overall Study|Study Terminated by Sponsor|49|||
145791105|NCT00960934|525741032|FG005|Overall Study|Study Terminated by Sponsor|49|||
145791106|NCT01071096|525741035|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
145791107|NCT01071096|525741036|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
145791108|NCT02561299|525741037|FG000|Overall Study|Death|2|||
145791109|NCT02561299|525741038|FG001|Overall Study|Death|4|||
145791110|NCT02561299|525741037|FG000|Overall Study|Lost to Follow-up|1|||
145791111|NCT02561299|525741038|FG001|Overall Study|Lost to Follow-up|0|||
145791112|NCT02561299|525741037|FG000|Overall Study|Withdrawal by Subject|2|||
145791113|NCT02561299|525741038|FG001|Overall Study|Withdrawal by Subject|2|||
145791114|NCT01911845|525741041|FG000|Overall Study|Adverse Event|2|||
145791115|NCT01911845|525741041|FG000|Overall Study|Lost to Follow-up|1|||
145791116|NCT01911845|525741041|FG000|Overall Study|Other (not specified)|3|||
145543201|NCT01976338|524848348|FG000|Overall Study|Lost to Follow-up|3|||
145791117|NCT01860534|525741047|FG000|ROP #1|Needed treatment for ROP|0|||
145791118|NCT01860534|525741048|FG001|ROP #1|Needed treatment for ROP|1|||
145791119|NCT01860534|525741047|FG000|ROP #2|discharged prior to ROP #2|1|||
145791120|NCT01860534|525741048|FG001|ROP #2|discharged prior to ROP #2|0|||
145791121|NCT01188564|525741049|FG000|Double-blind Phase|randomized not treated|1|||
145791122|NCT01188564|525741050|FG001|Double-blind Phase|randomized not treated|0|||
145610241|NCT01709305|525088177|FG004|Phase 1|Withdrawal by Subject|0|||
145610242|NCT01709305|525088173|FG000|Phase 2|Clinical Adverse Event|0|||
145610243|NCT01709305|525088174|FG001|Phase 2|Clinical Adverse Event|10|||
145610244|NCT01709305|525088175|FG002|Phase 2|Clinical Adverse Event|10|||
145610245|NCT01709305|525088176|FG003|Phase 2|Clinical Adverse Event|6|||
145610246|NCT01709305|525088177|FG004|Phase 2|Clinical Adverse Event|11|||
145610247|NCT01709305|525088173|FG000|Phase 2|Death|0|||
145610248|NCT01709305|525088174|FG001|Phase 2|Death|0|||
145610249|NCT01709305|525088175|FG002|Phase 2|Death|1|||
145610250|NCT01709305|525088176|FG003|Phase 2|Death|0|||
145610251|NCT01709305|525088177|FG004|Phase 2|Death|0|||
145610252|NCT01709305|525088173|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
145610253|NCT01709305|525088174|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
145610254|NCT01709305|525088175|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
145610255|NCT01709305|525088176|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
145610256|NCT01709305|525088177|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
145610257|NCT01709305|525088173|FG000|Phase 2|Laboratory Adverse Event|0|||
145610258|NCT01709305|525088174|FG001|Phase 2|Laboratory Adverse Event|1|||
145610259|NCT01709305|525088175|FG002|Phase 2|Laboratory Adverse Event|0|||
145610260|NCT01709305|525088176|FG003|Phase 2|Laboratory Adverse Event|1|||
145610261|NCT01709305|525088177|FG004|Phase 2|Laboratory Adverse Event|1|||
145610262|NCT01709305|525088173|FG000|Phase 2|Lost to Follow-up|0|||
145610263|NCT01709305|525088174|FG001|Phase 2|Lost to Follow-up|10|||
145610264|NCT01709305|525088175|FG002|Phase 2|Lost to Follow-up|6|||
145610265|NCT01709305|525088176|FG003|Phase 2|Lost to Follow-up|9|||
145610266|NCT01709305|525088177|FG004|Phase 2|Lost to Follow-up|5|||
145610267|NCT01709305|525088173|FG000|Phase 2|Travel, moving, etc.|0|||
145610268|NCT01709305|525088174|FG001|Phase 2|Travel, moving, etc.|2|||
145610269|NCT01709305|525088175|FG002|Phase 2|Travel, moving, etc.|3|||
145610270|NCT01709305|525088176|FG003|Phase 2|Travel, moving, etc.|3|||
145610271|NCT01709305|525088177|FG004|Phase 2|Travel, moving, etc.|5|||
145610272|NCT01709305|525088173|FG000|Phase 2|Physician Decision|0|||
145610273|NCT01709305|525088174|FG001|Phase 2|Physician Decision|2|||
145610274|NCT01709305|525088175|FG002|Phase 2|Physician Decision|0|||
145610275|NCT01709305|525088176|FG003|Phase 2|Physician Decision|1|||
145610276|NCT01709305|525088177|FG004|Phase 2|Physician Decision|2|||
145610277|NCT01709305|525088173|FG000|Phase 2|Protocol Violation|0|||
145610278|NCT01709305|525088174|FG001|Phase 2|Protocol Violation|19|||
145610279|NCT01709305|525088175|FG002|Phase 2|Protocol Violation|19|||
145610280|NCT01709305|525088176|FG003|Phase 2|Protocol Violation|13|||
145282384|NCT00931385|523883116|FG003|Overall Study|Lost to Follow-up|1|||
145610281|NCT01709305|525088177|FG004|Phase 2|Protocol Violation|9|||
145282385|NCT00665626|523883121|FG000|Overall Study|Lack of Efficacy|8|||
145282386|NCT00665626|523883122|FG001|Overall Study|Lack of Efficacy|5|||
145282387|NCT00665626|523883121|FG000|Overall Study|Lost to Follow-up|0|||
145282388|NCT00665626|523883122|FG001|Overall Study|Lost to Follow-up|2|||
145282389|NCT00665626|523883121|FG000|Overall Study|Withdrawal by Subject|0|||
145282390|NCT00665626|523883122|FG001|Overall Study|Withdrawal by Subject|1|||
145282391|NCT00665626|523883121|FG000|Overall Study|Protocol Violation|0|||
145282392|NCT00665626|523883122|FG001|Overall Study|Protocol Violation|2|||
145282393|NCT00665626|523883121|FG000|Overall Study|Adverse Event|1|||
145282394|NCT00665626|523883122|FG001|Overall Study|Adverse Event|9|||
145282395|NCT00665626|523883121|FG000|Overall Study|Due to exclusion criteria|0|||
145610282|NCT01709305|525088173|FG000|Phase 2|Withdrawal by Subject|0|||
145610283|NCT01709305|525088174|FG001|Phase 2|Withdrawal by Subject|8|||
145610284|NCT01709305|525088175|FG002|Phase 2|Withdrawal by Subject|6|||
145610285|NCT01709305|525088176|FG003|Phase 2|Withdrawal by Subject|15|||
145610286|NCT01709305|525088177|FG004|Phase 2|Withdrawal by Subject|12|||
145610287|NCT02294474|525088180|FG000|Overall Study|Adverse Event|7|||
145610288|NCT02294474|525088181|FG001|Overall Study|Adverse Event|7|||
145610289|NCT02294474|525088180|FG000|Overall Study|Lack of Efficacy|2|||
145610290|NCT02294474|525088181|FG001|Overall Study|Lack of Efficacy|1|||
145282396|NCT00665626|523883122|FG001|Overall Study|Due to exclusion criteria|1|||
145282397|NCT00665626|523883121|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
145282398|NCT00665626|523883122|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
145282399|NCT00665626|523883121|FG000|Overall Study|Unably to comply with dosing regimen|0|||
145282400|NCT00665626|523883122|FG001|Overall Study|Unably to comply with dosing regimen|1|||
145282401|NCT00665626|523883121|FG000|Overall Study|Death|1|||
145282402|NCT00665626|523883122|FG001|Overall Study|Death|0|||
145282403|NCT00530439|523883123|FG000|Overall Study|GDM|9|||
145610291|NCT02294474|525088180|FG000|Overall Study|Protocol Violation|4|||
145610292|NCT02294474|525088181|FG001|Overall Study|Protocol Violation|2|||
145610293|NCT02294474|525088180|FG000|Overall Study|Other than specified above|12|||
145610294|NCT02294474|525088181|FG001|Overall Study|Other than specified above|12|||
145610295|NCT01338012|525088186|FG000|Overall Study|Death|4|||
145610296|NCT01338012|525088186|FG000|Overall Study|Study terminated|4|||
145610297|NCT02714205|525088187|FG000|Overall Study|Cannot tolerate medication|1|||
145610298|NCT02714205|525088188|FG001|Overall Study|Cannot tolerate medication|0|||
145610299|NCT02714205|525088187|FG000|Overall Study|Adverse Event|2|||
145610300|NCT02714205|525088188|FG001|Overall Study|Adverse Event|0|||
145610301|NCT02714205|525088187|FG000|Overall Study|Too busy|1|||
145610302|NCT02714205|525088188|FG001|Overall Study|Too busy|0|||
145610303|NCT02714205|525088187|FG000|Overall Study|Incomplete outcome data|0|||
145543202|NCT01976338|524848349|FG001|Overall Study|Lost to Follow-up|0|||
145543203|NCT01976338|524848348|FG000|Overall Study|Withdrawal by Subject|5|||
145543204|NCT01976338|524848349|FG001|Overall Study|Withdrawal by Subject|2|||
145543205|NCT01976338|524848348|FG000|Overall Study|Adverse Event|5|||
145543206|NCT01976338|524848349|FG001|Overall Study|Adverse Event|1|||
145543207|NCT02853604|524848350|FG000|Overall Study|Withdrawal by Subject|12|||
145543208|NCT02853604|524848351|FG001|Overall Study|Withdrawal by Subject|35|||
145543209|NCT02853604|524848350|FG000|Overall Study|Lost to Follow-up|4|||
145543210|NCT02853604|524848351|FG001|Overall Study|Lost to Follow-up|8|||
145543211|NCT02853604|524848350|FG000|Overall Study|Death|1|||
145543212|NCT02853604|524848351|FG001|Overall Study|Death|5|||
145543213|NCT02853604|524848350|FG000|Overall Study|Miscellaneous|11|||
145543214|NCT02853604|524848351|FG001|Overall Study|Miscellaneous|2|||
145543215|NCT02853604|524848350|FG000|Overall Study|Progressive Disease|0|||
145543216|NCT02853604|524848351|FG001|Overall Study|Progressive Disease|2|||
145543217|NCT03766581|524848352|FG000|Randomization|Other reasons|2|||
145543218|NCT03766581|524848353|FG001|Randomization|Other reasons|1|||
145543219|NCT03766581|524848354|FG002|Randomization|Other reasons|0|||
145543220|NCT03766581|524848355|FG003|Randomization|Other reasons|1|||
145543221|NCT03766581|524848356|FG004|Randomization|Other reasons|0|||
145543222|NCT03766581|524848357|FG005|Randomization|Other reasons|0|||
145543223|NCT03766581|524848358|FG006|Randomization|Other reasons|0|||
145543224|NCT03766581|524848359|FG007|Randomization|Other reasons|0|||
145543225|NCT03766581|524848352|FG000|Randomization|Participant no longer meets study criteria|5|||
145543226|NCT03766581|524848353|FG001|Randomization|Participant no longer meets study criteria|3|||
145543227|NCT03766581|524848354|FG002|Randomization|Participant no longer meets study criteria|4|||
145543228|NCT03766581|524848355|FG003|Randomization|Participant no longer meets study criteria|0|||
145543229|NCT03766581|524848356|FG004|Randomization|Participant no longer meets study criteria|2|||
145543230|NCT03766581|524848357|FG005|Randomization|Participant no longer meets study criteria|3|||
145543231|NCT03766581|524848358|FG006|Randomization|Participant no longer meets study criteria|0|||
145543232|NCT03766581|524848359|FG007|Randomization|Participant no longer meets study criteria|1|||
145543233|NCT03766581|524848352|FG000|Randomization|Participant request to discontinue study treatment|1|||
145543234|NCT03766581|524848353|FG001|Randomization|Participant request to discontinue study treatment|0|||
145543235|NCT03766581|524848354|FG002|Randomization|Participant request to discontinue study treatment|0|||
145543236|NCT03766581|524848355|FG003|Randomization|Participant request to discontinue study treatment|0|||
145543237|NCT03766581|524848356|FG004|Randomization|Participant request to discontinue study treatment|1|||
145543238|NCT03766581|524848357|FG005|Randomization|Participant request to discontinue study treatment|2|||
145543239|NCT03766581|524848358|FG006|Randomization|Participant request to discontinue study treatment|0|||
145543240|NCT03766581|524848359|FG007|Randomization|Participant request to discontinue study treatment|0|||
145543241|NCT03766581|524848352|FG000|Randomization|Participant withdrew consent|1|||
145543242|NCT03766581|524848353|FG001|Randomization|Participant withdrew consent|0|||
145543243|NCT03766581|524848354|FG002|Randomization|Participant withdrew consent|1|||
145543244|NCT03766581|524848355|FG003|Randomization|Participant withdrew consent|2|||
145543245|NCT03766581|524848356|FG004|Randomization|Participant withdrew consent|1|||
145791123|NCT02864940|525741051|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
145543246|NCT03766581|524848357|FG005|Randomization|Participant withdrew consent|1|||
145543247|NCT03766581|524848358|FG006|Randomization|Participant withdrew consent|0|||
145543248|NCT03766581|524848359|FG007|Randomization|Participant withdrew consent|0|||
145543249|NCT03766581|524848352|FG000|Treatment|Adverse Event|82|||
145543250|NCT03766581|524848353|FG001|Treatment|Adverse Event|44|||
145543251|NCT03766581|524848354|FG002|Treatment|Adverse Event|47|||
145543252|NCT03766581|524848355|FG003|Treatment|Adverse Event|46|||
145543253|NCT03766581|524848356|FG004|Treatment|Adverse Event|50|||
145543254|NCT03766581|524848357|FG005|Treatment|Adverse Event|77|||
145543255|NCT03766581|524848358|FG006|Treatment|Adverse Event|5|||
145543256|NCT03766581|524848359|FG007|Treatment|Adverse Event|2|||
145543257|NCT03766581|524848352|FG000|Treatment|Participant request to discontinue treatment|34|||
145543258|NCT03766581|524848353|FG001|Treatment|Participant request to discontinue treatment|6|||
145543259|NCT03766581|524848354|FG002|Treatment|Participant request to discontinue treatment|10|||
145543260|NCT03766581|524848355|FG003|Treatment|Participant request to discontinue treatment|10|||
145543261|NCT03766581|524848356|FG004|Treatment|Participant request to discontinue treatment|14|||
145543262|NCT03766581|524848357|FG005|Treatment|Participant request to discontinue treatment|15|||
145543263|NCT03766581|524848358|FG006|Treatment|Participant request to discontinue treatment|0|||
145543264|NCT03766581|524848359|FG007|Treatment|Participant request to discontinue treatment|1|||
145543265|NCT03766581|524848352|FG000|Treatment|Participant withdrew consent|11|||
145543266|NCT03766581|524848353|FG001|Treatment|Participant withdrew consent|4|||
145543267|NCT03766581|524848354|FG002|Treatment|Participant withdrew consent|5|||
145543268|NCT03766581|524848355|FG003|Treatment|Participant withdrew consent|5|||
145543269|NCT03766581|524848356|FG004|Treatment|Participant withdrew consent|4|||
145543270|NCT03766581|524848357|FG005|Treatment|Participant withdrew consent|4|||
145282404|NCT00530439|523883124|FG001|Overall Study|GDM|3|||
145282405|NCT00530439|523883123|FG000|Overall Study|Withdraw|18|||
145791124|NCT02864940|525741052|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
145791125|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
145791126|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
145791127|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
145791128|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
145791129|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
145791130|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
145791131|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
145791132|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
145791133|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
145791134|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
145791135|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
145791136|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
145791137|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
145791138|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
145791139|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
145791140|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
145791141|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
145791142|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145791143|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
145791144|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
145791145|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
145791146|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145791147|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145791148|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145543271|NCT03766581|524848358|FG006|Treatment|Participant withdrew consent|0|||
145543272|NCT03766581|524848359|FG007|Treatment|Participant withdrew consent|0|||
145543273|NCT03766581|524848352|FG000|Treatment|Death|1|||
145543274|NCT03766581|524848353|FG001|Treatment|Death|0|||
145543275|NCT03766581|524848354|FG002|Treatment|Death|0|||
145543276|NCT03766581|524848355|FG003|Treatment|Death|0|||
145543277|NCT03766581|524848356|FG004|Treatment|Death|0|||
145543278|NCT03766581|524848357|FG005|Treatment|Death|0|||
145543279|NCT03766581|524848358|FG006|Treatment|Death|0|||
145543280|NCT03766581|524848359|FG007|Treatment|Death|0|||
145543281|NCT03766581|524848352|FG000|Treatment|Lost to Follow-up|1|||
145543282|NCT03766581|524848353|FG001|Treatment|Lost to Follow-up|0|||
145543283|NCT03766581|524848354|FG002|Treatment|Lost to Follow-up|0|||
145543284|NCT03766581|524848355|FG003|Treatment|Lost to Follow-up|1|||
145543285|NCT03766581|524848356|FG004|Treatment|Lost to Follow-up|0|||
145543286|NCT03766581|524848357|FG005|Treatment|Lost to Follow-up|0|||
145543287|NCT03766581|524848358|FG006|Treatment|Lost to Follow-up|0|||
145543288|NCT03766581|524848359|FG007|Treatment|Lost to Follow-up|0|||
145543289|NCT03766581|524848352|FG000|Treatment|Poor/Non compliance|2|||
145543290|NCT03766581|524848353|FG001|Treatment|Poor/Non compliance|2|||
145543291|NCT03766581|524848354|FG002|Treatment|Poor/Non compliance|1|||
145543292|NCT03766581|524848355|FG003|Treatment|Poor/Non compliance|1|||
145543293|NCT03766581|524848356|FG004|Treatment|Poor/Non compliance|1|||
145543294|NCT03766581|524848357|FG005|Treatment|Poor/Non compliance|1|||
145791149|NCT01106625|525741063|FG000|Core Period: Baseline to Week 26|Other|8|||
145791150|NCT01106625|525741064|FG001|Core Period: Baseline to Week 26|Other|7|||
145791151|NCT01106625|525741065|FG002|Core Period: Baseline to Week 26|Other|4|||
145791152|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145791153|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
145791154|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
145791155|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
145791156|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
145791157|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145791158|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145791159|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145791160|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
145791161|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145404333|NCT00284856|524336551|FG002|Overall Study|Withdrawal by Subject|18|||
145791162|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145791163|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145282406|NCT00530439|523883124|FG001|Overall Study|Withdraw|14|||
145543295|NCT03766581|524848358|FG006|Treatment|Poor/Non compliance|0|||
145543296|NCT03766581|524848359|FG007|Treatment|Poor/Non compliance|0|||
145543297|NCT03766581|524848352|FG000|Treatment|Participant no longer meets study criteria|9|||
145543298|NCT03766581|524848353|FG001|Treatment|Participant no longer meets study criteria|1|||
145543299|NCT03766581|524848354|FG002|Treatment|Participant no longer meets study criteria|5|||
145543300|NCT03766581|524848355|FG003|Treatment|Participant no longer meets study criteria|4|||
145543301|NCT03766581|524848356|FG004|Treatment|Participant no longer meets study criteria|4|||
145543302|NCT03766581|524848357|FG005|Treatment|Participant no longer meets study criteria|4|||
145543303|NCT03766581|524848358|FG006|Treatment|Participant no longer meets study criteria|2|||
145543304|NCT03766581|524848359|FG007|Treatment|Participant no longer meets study criteria|0|||
145543305|NCT03766581|524848352|FG000|Treatment|Other reasons|13|||
145543306|NCT03766581|524848353|FG001|Treatment|Other reasons|8|||
145543307|NCT03766581|524848354|FG002|Treatment|Other reasons|3|||
145543308|NCT03766581|524848355|FG003|Treatment|Other reasons|7|||
145543309|NCT03766581|524848356|FG004|Treatment|Other reasons|3|||
145543310|NCT03766581|524848357|FG005|Treatment|Other reasons|3|||
145543311|NCT03766581|524848358|FG006|Treatment|Other reasons|0|||
145543312|NCT03766581|524848359|FG007|Treatment|Other reasons|0|||
145543313|NCT03716024|524848360|FG000|Overall Study|Randomized, not Treated|7|||
145543314|NCT03716024|524848361|FG001|Overall Study|Randomized, not Treated|8|||
145543315|NCT03716024|524848360|FG000|Overall Study|Adverse Event|1|||
145543316|NCT03716024|524848361|FG001|Overall Study|Adverse Event|2|||
145543317|NCT03716024|524848360|FG000|Overall Study|Treatment Failure|1|||
145543318|NCT03716024|524848361|FG001|Overall Study|Treatment Failure|0|||
145543319|NCT03716024|524848360|FG000|Overall Study|Lost to Follow-up|2|||
145543320|NCT03716024|524848361|FG001|Overall Study|Lost to Follow-up|6|||
145791164|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
145791165|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145791166|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145791167|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
145791168|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
145791169|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
145791170|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
145791171|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
145791172|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
145791173|NCT01106625|525741063|FG000|Extension Period: Week 26 to Week 52|Other|5|||
145791174|NCT01106625|525741064|FG001|Extension Period: Week 26 to Week 52|Other|5|||
145791175|NCT01106625|525741065|FG002|Extension Period: Week 26 to Week 52|Other|4|||
145791176|NCT02496585|525741066|FG000|Overall Study|Death|3|||
145791177|NCT02496585|525741067|FG001|Overall Study|Death|0|||
145791178|NCT02496585|525741066|FG000|Overall Study|Lost to Follow-up|2|||
145791179|NCT02496585|525741067|FG001|Overall Study|Lost to Follow-up|0|||
145791180|NCT02496585|525741066|FG000|Overall Study|Withdrawal by Subject|1|||
145791181|NCT02496585|525741067|FG001|Overall Study|Withdrawal by Subject|2|||
145543321|NCT03716024|524848360|FG000|Overall Study|Withdrawal by Subject|0|||
145543322|NCT03716024|524848361|FG001|Overall Study|Withdrawal by Subject|1|||
145543323|NCT03716024|524848360|FG000|Overall Study|Missing Reason|0|||
145543324|NCT03716024|524848361|FG001|Overall Study|Missing Reason|1|||
145543325|NCT04182763|524848368|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
145543326|NCT04182763|524848369|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
145543327|NCT04182763|524848370|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
145543328|NCT04182763|524848371|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
145543329|NCT04182763|524848372|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
145543330|NCT04182763|524848368|FG000|Double-Blind Period, initial 6 months|Death|0|||
145543331|NCT04182763|524848369|FG001|Double-Blind Period, initial 6 months|Death|1|||
145543332|NCT04182763|524848370|FG002|Double-Blind Period, initial 6 months|Death|0|||
145543333|NCT04182763|524848371|FG003|Double-Blind Period, initial 6 months|Death|0|||
145543334|NCT04182763|524848372|FG004|Double-Blind Period, initial 6 months|Death|0|||
145543335|NCT04182763|524848368|FG000|Open-Label Period, subsequent 18 months|Death|3|||
145543336|NCT04182763|524848369|FG001|Open-Label Period, subsequent 18 months|Death|2|||
145543337|NCT04182763|524848370|FG002|Open-Label Period, subsequent 18 months|Death|2|||
145543338|NCT04182763|524848371|FG003|Open-Label Period, subsequent 18 months|Death|0|||
145543339|NCT04182763|524848372|FG004|Open-Label Period, subsequent 18 months|Death|1|||
145610304|NCT02714205|525088188|FG001|Overall Study|Incomplete outcome data|1|||
145543340|NCT04182763|524848368|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
145543341|NCT04182763|524848369|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
145543342|NCT04182763|524848370|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
145543343|NCT04182763|524848371|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
145543344|NCT04182763|524848372|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
145543345|NCT04182763|524848368|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
145543346|NCT04182763|524848369|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
145543347|NCT04182763|524848370|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
145791182|NCT02496585|525741066|FG000|Overall Study|Progression of Malignancy|4|||
145791183|NCT02496585|525741067|FG001|Overall Study|Progression of Malignancy|1|||
145543348|NCT04182763|524848371|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
145543349|NCT04182763|524848372|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
145543350|NCT05988619|524848374|FG000|Overall Study|Lost to Follow-up|1|||
145543351|NCT05988619|524848375|FG001|Overall Study|Lost to Follow-up|4|||
145543352|NCT05988619|524848374|FG000|Overall Study|Withdrawal by Subject|2|||
145543353|NCT05988619|524848375|FG001|Overall Study|Withdrawal by Subject|9|||
145543354|NCT00587054|524848378|FG000|Overall Study|Patient not treated|9|||
145543355|NCT03010176|524848380|FG000|Overall Study|Death|21|||
145543356|NCT03010176|524848381|FG001|Overall Study|Death|35|||
145543357|NCT03010176|524848382|FG002|Overall Study|Death|19|||
145543358|NCT03010176|524848383|FG003|Overall Study|Death|19|||
145543359|NCT03010176|524848384|FG004|Overall Study|Death|14|||
145543360|NCT03010176|524848385|FG005|Overall Study|Death|0|||
145543361|NCT03010176|524848380|FG000|Overall Study|Lost to Follow-up|0|||
145543362|NCT03010176|524848381|FG001|Overall Study|Lost to Follow-up|0|||
145543363|NCT03010176|524848382|FG002|Overall Study|Lost to Follow-up|0|||
145543364|NCT03010176|524848383|FG003|Overall Study|Lost to Follow-up|0|||
145543365|NCT03010176|524848384|FG004|Overall Study|Lost to Follow-up|1|||
145543366|NCT03010176|524848385|FG005|Overall Study|Lost to Follow-up|0|||
145543367|NCT03010176|524848380|FG000|Overall Study|Physician Decision|0|||
145543368|NCT03010176|524848381|FG001|Overall Study|Physician Decision|4|||
145543369|NCT03010176|524848382|FG002|Overall Study|Physician Decision|0|||
145543370|NCT03010176|524848383|FG003|Overall Study|Physician Decision|1|||
145543371|NCT03010176|524848384|FG004|Overall Study|Physician Decision|0|||
145543372|NCT03010176|524848385|FG005|Overall Study|Physician Decision|0|||
145543373|NCT03010176|524848380|FG000|Overall Study|Sponsor Decision|0|||
145543374|NCT03010176|524848381|FG001|Overall Study|Sponsor Decision|4|||
145543375|NCT03010176|524848382|FG002|Overall Study|Sponsor Decision|4|||
145543376|NCT03010176|524848383|FG003|Overall Study|Sponsor Decision|1|||
145543377|NCT03010176|524848384|FG004|Overall Study|Sponsor Decision|6|||
145543378|NCT03010176|524848385|FG005|Overall Study|Sponsor Decision|0|||
145543379|NCT03010176|524848380|FG000|Overall Study|Withdrawal by Subject|11|||
145543380|NCT03010176|524848381|FG001|Overall Study|Withdrawal by Subject|9|||
145543381|NCT03010176|524848382|FG002|Overall Study|Withdrawal by Subject|3|||
145543382|NCT03010176|524848383|FG003|Overall Study|Withdrawal by Subject|0|||
145543383|NCT03010176|524848384|FG004|Overall Study|Withdrawal by Subject|4|||
145543384|NCT03010176|524848385|FG005|Overall Study|Withdrawal by Subject|0|||
145543385|NCT01651039|524848388|FG000|Overall Study|Non-evaluables|5|||
145543386|NCT01651039|524848388|FG000|Overall Study|Physician Decision|2|||
145543387|NCT01651039|524848388|FG000|Overall Study|Withdrawal by Subject|1|||
145543388|NCT01651039|524848388|FG000|Overall Study|Progressive Disease|22|||
145543389|NCT03600818|524848389|FG000|Overall Study|Adverse Event|4|||
145543390|NCT03600818|524848390|FG001|Overall Study|Adverse Event|7|||
145543391|NCT03600818|524848389|FG000|Overall Study|Lack of Efficacy|9|||
145543392|NCT03600818|524848390|FG001|Overall Study|Lack of Efficacy|4|||
145543393|NCT03600818|524848389|FG000|Overall Study|Withdrawal by Subject|4|||
145543394|NCT03600818|524848390|FG001|Overall Study|Withdrawal by Subject|3|||
145543395|NCT03600818|524848389|FG000|Overall Study|Other-unspecified|5|||
145543396|NCT03600818|524848390|FG001|Overall Study|Other-unspecified|3|||
145543397|NCT03600818|524848389|FG000|Overall Study|Randomized and not treated|0|||
145282407|NCT00530439|523883123|FG000|Overall Study|Missed abortion|1|||
145543398|NCT03600818|524848390|FG001|Overall Study|Randomized and not treated|1|||
145543399|NCT01488370|524848391|FG000|Overall Study|Protocol Violation|0|||
145543400|NCT01488370|524848392|FG001|Overall Study|Protocol Violation|1|||
145543401|NCT01488370|524848393|FG002|Overall Study|Protocol Violation|1|||
145543402|NCT01471171|524848394|FG000|Treatment Period 1|Adverse Event|4|||
145543403|NCT01471171|524848395|FG001|Treatment Period 1|Adverse Event|1|||
145543404|NCT01471171|524848394|FG000|Treatment Period 2|Adverse Event|1|||
145543405|NCT01471171|524848395|FG001|Treatment Period 2|Adverse Event|0|||
145543406|NCT00553644|524848398|FG000|Overall Study|Adverse Event|17|||
145543407|NCT00553644|524848398|FG000|Overall Study|Withdrawal by Subject|4|||
145543408|NCT00553644|524848398|FG000|Overall Study|Physician Decision|1|||
145543409|NCT00553644|524848398|FG000|Overall Study|Alternative therapy|6|||
145543410|NCT03470441|524848403|FG000|Overall Study|Death|0|||
145543411|NCT03470441|524848404|FG001|Overall Study|Death|1|||
145543412|NCT03470441|524848405|FG002|Overall Study|Death|1|||
145543413|NCT03470441|524848406|FG003|Overall Study|Death|0|||
145543414|NCT03470441|524848403|FG000|Overall Study|Adverse Event|0|||
145543415|NCT03470441|524848404|FG001|Overall Study|Adverse Event|0|||
145543416|NCT03470441|524848405|FG002|Overall Study|Adverse Event|0|||
145543417|NCT03470441|524848406|FG003|Overall Study|Adverse Event|1|||
145543418|NCT03470441|524848403|FG000|Overall Study|Withdrawal by Subject|1|||
145543419|NCT03470441|524848404|FG001|Overall Study|Withdrawal by Subject|4|||
145543420|NCT03470441|524848405|FG002|Overall Study|Withdrawal by Subject|1|||
145543421|NCT03470441|524848406|FG003|Overall Study|Withdrawal by Subject|3|||
145543422|NCT05393895|524848408|FG000|Overall Study|Adverse Event|2|||
145543423|NCT05393895|524848409|FG001|Overall Study|Adverse Event|3|||
145543424|NCT05393895|524848408|FG000|Overall Study|Lost to Follow-up|4|||
145543425|NCT05393895|524848409|FG001|Overall Study|Lost to Follow-up|3|||
145543426|NCT05393895|524848408|FG000|Overall Study|Protocol Violation|1|||
145543427|NCT05393895|524848409|FG001|Overall Study|Protocol Violation|0|||
145543428|NCT05393895|524848408|FG000|Overall Study|Withdrawal by Subject|1|||
145543429|NCT05393895|524848409|FG001|Overall Study|Withdrawal by Subject|4|||
145543430|NCT00968513|524848410|FG000|Overall Study|Death|4|||
145543431|NCT00968513|524848411|FG001|Overall Study|Death|10|||
145543432|NCT00968513|524848412|FG002|Overall Study|Death|15|||
145543433|NCT02002091|524848417|FG000|Screening|Lost to Follow-up|10|||
145543434|NCT02002091|524848418|FG001|Screening|Lost to Follow-up|12|||
145543435|NCT02002091|524848417|FG000|Screening|Death|3|||
145543436|NCT02002091|524848418|FG001|Screening|Death|2|||
145543437|NCT02083783|524848427|FG000|Overall Study|Withdrawal by Subject|1|||
145543438|NCT02083783|524848428|FG001|Overall Study|Withdrawal by Subject|0|||
145543439|NCT04967443|524848429|FG000|Open Label Treatment|Death|1|||
145543440|NCT04967443|524848430|FG001|Open Label Treatment|Death|0|||
145543441|NCT04967443|524848431|FG002|Open Label Treatment|Death|0|||
145543442|NCT04967443|524848432|FG003|Open Label Treatment|Death|0|||
145543443|NCT04967443|524848433|FG004|Open Label Treatment|Death|0|||
145543444|NCT04967443|524848434|FG005|Open Label Treatment|Death|0|||
145543445|NCT04967443|524848435|FG006|Open Label Treatment|Death|0|||
145543446|NCT04967443|524848436|FG007|Open Label Treatment|Death|0|||
145543447|NCT04967443|524848429|FG000|Open Label Treatment|Lost to Follow-up|0|||
145543448|NCT04967443|524848430|FG001|Open Label Treatment|Lost to Follow-up|0|||
145543449|NCT04967443|524848431|FG002|Open Label Treatment|Lost to Follow-up|1|||
145543450|NCT04967443|524848432|FG003|Open Label Treatment|Lost to Follow-up|0|||
145543451|NCT04967443|524848433|FG004|Open Label Treatment|Lost to Follow-up|0|||
145543452|NCT04967443|524848434|FG005|Open Label Treatment|Lost to Follow-up|0|||
145543453|NCT04967443|524848435|FG006|Open Label Treatment|Lost to Follow-up|0|||
145543454|NCT04967443|524848436|FG007|Open Label Treatment|Lost to Follow-up|0|||
145543455|NCT04967443|524848429|FG000|Open Label Treatment|Withdrawal by Subject|0|||
145543456|NCT04967443|524848430|FG001|Open Label Treatment|Withdrawal by Subject|1|||
145543457|NCT04967443|524848431|FG002|Open Label Treatment|Withdrawal by Subject|0|||
145543458|NCT04967443|524848432|FG003|Open Label Treatment|Withdrawal by Subject|1|||
145543459|NCT04967443|524848433|FG004|Open Label Treatment|Withdrawal by Subject|0|||
145543460|NCT04967443|524848434|FG005|Open Label Treatment|Withdrawal by Subject|1|||
145543461|NCT04967443|524848435|FG006|Open Label Treatment|Withdrawal by Subject|2|||
145543462|NCT04967443|524848436|FG007|Open Label Treatment|Withdrawal by Subject|3|||
145543463|NCT04967443|524848429|FG000|Follow-Up|Death|1|||
145543464|NCT04967443|524848430|FG001|Follow-Up|Death|0|||
145543465|NCT04967443|524848431|FG002|Follow-Up|Death|0|||
145543466|NCT04967443|524848432|FG003|Follow-Up|Death|0|||
145543467|NCT04967443|524848433|FG004|Follow-Up|Death|0|||
145543468|NCT04967443|524848434|FG005|Follow-Up|Death|0|||
145543469|NCT04967443|524848435|FG006|Follow-Up|Death|0|||
145543470|NCT04967443|524848436|FG007|Follow-Up|Death|0|||
145543471|NCT04967443|524848429|FG000|Follow-Up|Lost to Follow-up|0|||
145543472|NCT04967443|524848430|FG001|Follow-Up|Lost to Follow-up|0|||
145404334|NCT00284856|524336549|FG000|Overall Study|Other|4|||
145543473|NCT04967443|524848431|FG002|Follow-Up|Lost to Follow-up|1|||
145543474|NCT04967443|524848432|FG003|Follow-Up|Lost to Follow-up|1|||
145543475|NCT04967443|524848433|FG004|Follow-Up|Lost to Follow-up|0|||
145543476|NCT04967443|524848434|FG005|Follow-Up|Lost to Follow-up|0|||
145543477|NCT04967443|524848435|FG006|Follow-Up|Lost to Follow-up|0|||
145543478|NCT04967443|524848436|FG007|Follow-Up|Lost to Follow-up|0|||
145543479|NCT04967443|524848429|FG000|Follow-Up|Withdrawal by Subject|0|||
145543480|NCT04967443|524848430|FG001|Follow-Up|Withdrawal by Subject|1|||
145543481|NCT04967443|524848431|FG002|Follow-Up|Withdrawal by Subject|0|||
145543482|NCT04967443|524848432|FG003|Follow-Up|Withdrawal by Subject|1|||
145543483|NCT04967443|524848433|FG004|Follow-Up|Withdrawal by Subject|0|||
145543484|NCT04967443|524848434|FG005|Follow-Up|Withdrawal by Subject|1|||
145543485|NCT04967443|524848435|FG006|Follow-Up|Withdrawal by Subject|2|||
145543486|NCT04967443|524848436|FG007|Follow-Up|Withdrawal by Subject|3|||
145543487|NCT01654536|524848437|FG000|Overall Study|Lost to Follow-up|5|||
145543488|NCT01654536|524848438|FG001|Overall Study|Lost to Follow-up|5|||
145610305|NCT05879198|525088189|FG000|Overall Study|Lost to Follow-up|1|||
145610306|NCT03813147|525088190|FG000|Overall Study|Lack of Efficacy|4|||
145610307|NCT03813147|525088191|FG001|Overall Study|Lack of Efficacy|4|||
145610308|NCT03813147|525088190|FG000|Overall Study|Physician Decision|2|||
145610309|NCT03813147|525088191|FG001|Overall Study|Physician Decision|1|||
145610310|NCT01693692|525088192|FG000|Overall Study|Withdrawal by Subject|12|||
145610311|NCT01693692|525088193|FG001|Overall Study|Withdrawal by Subject|10|||
145610312|NCT01693692|525088194|FG002|Overall Study|Withdrawal by Subject|11|||
145610313|NCT01693692|525088192|FG000|Overall Study|Adverse Event|7|||
145610314|NCT01693692|525088193|FG001|Overall Study|Adverse Event|14|||
145610315|NCT01693692|525088194|FG002|Overall Study|Adverse Event|9|||
145610316|NCT01693692|525088192|FG000|Overall Study|Physician Decision|0|||
145610317|NCT01693692|525088193|FG001|Overall Study|Physician Decision|0|||
145610318|NCT01693692|525088194|FG002|Overall Study|Physician Decision|1|||
145610319|NCT01693692|525088192|FG000|Overall Study|Protocol Violation|5|||
145610320|NCT01693692|525088193|FG001|Overall Study|Protocol Violation|4|||
145610321|NCT01693692|525088194|FG002|Overall Study|Protocol Violation|6|||
145610322|NCT01693692|525088192|FG000|Overall Study|Lost to Follow-up|2|||
145610323|NCT01693692|525088193|FG001|Overall Study|Lost to Follow-up|2|||
145610324|NCT01693692|525088194|FG002|Overall Study|Lost to Follow-up|3|||
145610325|NCT01693692|525088192|FG000|Overall Study|Other|4|||
145610326|NCT01693692|525088193|FG001|Overall Study|Other|4|||
145610327|NCT01693692|525088194|FG002|Overall Study|Other|6|||
145610328|NCT01683994|525089776|FG000|Overall Study|Withdrawal by Subject|1|||
145610329|NCT01683994|525089777|FG001|Overall Study|Withdrawal by Subject|0|||
145610330|NCT01683994|525089778|FG002|Overall Study|Withdrawal by Subject|0|||
145610331|NCT01683994|525089779|FG003|Overall Study|Withdrawal by Subject|1|||
145610332|NCT01683994|525089780|FG004|Overall Study|Withdrawal by Subject|0|||
145610333|NCT01683994|525089776|FG000|Overall Study|Intercurrent illness|0|||
145610334|NCT01683994|525089777|FG001|Overall Study|Intercurrent illness|0|||
145610335|NCT01683994|525089778|FG002|Overall Study|Intercurrent illness|0|||
145610336|NCT01683994|525089779|FG003|Overall Study|Intercurrent illness|2|||
145610337|NCT01683994|525089780|FG004|Overall Study|Intercurrent illness|1|||
145610338|NCT00999661|525089781|FG000|Overall Study|Lost to Follow-up|59|||
145610339|NCT00999661|525089781|FG000|Overall Study|Adverse Event|1|||
145610340|NCT00999661|525089781|FG000|Overall Study|Withdrawal by Subject|1|||
145610341|NCT00999661|525089781|FG000|Overall Study|Not meeting eligibility criteria|9|||
145610342|NCT00917267|525089782|FG000|Overall Study|Adverse Event|15|||
145610343|NCT00917267|525089783|FG001|Overall Study|Adverse Event|36|||
145610344|NCT00917267|525089782|FG000|Overall Study|Physician Decision|2|||
145610345|NCT00917267|525089783|FG001|Overall Study|Physician Decision|4|||
145610346|NCT00917267|525089782|FG000|Overall Study|Protocol Violation|9|||
145610347|NCT00917267|525089783|FG001|Overall Study|Protocol Violation|18|||
145610348|NCT00917267|525089782|FG000|Overall Study|Withdrawal by Subject|5|||
145610349|NCT00917267|525089783|FG001|Overall Study|Withdrawal by Subject|12|||
145610350|NCT00917267|525089782|FG000|Overall Study|Lost to follow up|0|||
145610351|NCT00917267|525089783|FG001|Overall Study|Lost to follow up|2|||
145543489|NCT01654536|524848437|FG000|Overall Study|Physician Decision|12|||
145543490|NCT01654536|524848438|FG001|Overall Study|Physician Decision|8|||
145543491|NCT01654536|524848437|FG000|Overall Study|Withdrawal by Subject|27|||
145543492|NCT01654536|524848438|FG001|Overall Study|Withdrawal by Subject|25|||
145543493|NCT03943147|524848439|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
145543494|NCT03943147|524848440|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
145543495|NCT03943147|524848439|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
145543496|NCT03943147|524848440|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
145543497|NCT03943147|524848439|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
145543498|NCT03943147|524848440|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
145543499|NCT03943147|524848439|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
145543500|NCT03943147|524848440|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
145543501|NCT03943147|524848439|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
145610352|NCT00917267|525089782|FG000|Overall Study|Entry Criteria Not Met|1|||
145610353|NCT00917267|525089783|FG001|Overall Study|Entry Criteria Not Met|0|||
145610354|NCT00917267|525089782|FG000|Overall Study|Sponsor Decision|5|||
145610355|NCT00917267|525089783|FG001|Overall Study|Sponsor Decision|5|||
145610356|NCT00917267|525089782|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
145610357|NCT00917267|525089783|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
145610358|NCT02960763|525089785|FG000|Step 1|Withdrawal by Subject|10|||
145610359|NCT02960763|525089786|FG001|Step 1|Withdrawal by Subject|8|||
145610360|NCT02960763|525089787|FG002|Step 1|Withdrawal by Subject|13|||
145610361|NCT02960763|525089788|FG003|Step 1|Withdrawal by Subject|0|||
145610362|NCT02960763|525089789|FG004|Step 1|Withdrawal by Subject|0|||
145610363|NCT02960763|525089785|FG000|Step 1|Lost to Follow-up|7|||
145610364|NCT02960763|525089786|FG001|Step 1|Lost to Follow-up|9|||
145610365|NCT02960763|525089787|FG002|Step 1|Lost to Follow-up|12|||
145543502|NCT03943147|524848440|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
145543503|NCT03943147|524848439|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
145543504|NCT03943147|524848440|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
145543505|NCT00629707|524848441|FG000|Overall Study|Withdrawal by Subject|0|||
145543506|NCT00629707|524848442|FG001|Overall Study|Withdrawal by Subject|1|||
145543507|NCT00629707|524848441|FG000|Overall Study|Physician Decision|0|||
145543508|NCT00629707|524848442|FG001|Overall Study|Physician Decision|1|||
145543509|NCT00968201|524848446|FG000|Base Study - (Period II)|Adverse Event|8|||
145543510|NCT00968201|524848447|FG001|Base Study - (Period II)|Adverse Event|0|||
145543511|NCT00968201|524848448|FG002|Base Study - (Period II)|Adverse Event|16|||
145543512|NCT00968201|524848446|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
145543513|NCT00968201|524848447|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
145543514|NCT00968201|524848448|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
145543515|NCT00968201|524848446|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
145543516|NCT00968201|524848447|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
145543517|NCT00968201|524848448|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
145543518|NCT00968201|524848446|FG000|Base Study - (Period II)|Protocol Violation|12|||
145543519|NCT00968201|524848447|FG001|Base Study - (Period II)|Protocol Violation|0|||
145543520|NCT00968201|524848448|FG002|Base Study - (Period II)|Protocol Violation|12|||
145543521|NCT00968201|524848446|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
145543522|NCT00968201|524848447|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
145543523|NCT00968201|524848448|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
145543524|NCT00968201|524848446|FG000|Base Study - (Period II)|Site Error|0|||
145543525|NCT00968201|524848447|FG001|Base Study - (Period II)|Site Error|0|||
145543526|NCT00968201|524848448|FG002|Base Study - (Period II)|Site Error|1|||
145543527|NCT00968201|524848446|FG000|Extension Study - (Period III)|Adverse Event|0|||
145543528|NCT00968201|524848447|FG001|Extension Study - (Period III)|Adverse Event|5|||
145543529|NCT00968201|524848448|FG002|Extension Study - (Period III)|Adverse Event|22|||
145543530|NCT00968201|524848446|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
145543531|NCT00968201|524848447|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
145543532|NCT00968201|524848448|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
145543533|NCT00968201|524848446|FG000|Extension Study - (Period III)|Protocol Violation|0|||
145543534|NCT00968201|524848447|FG001|Extension Study - (Period III)|Protocol Violation|17|||
145543535|NCT00968201|524848448|FG002|Extension Study - (Period III)|Protocol Violation|14|||
145543536|NCT00968201|524848446|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
145543537|NCT00968201|524848447|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
145543538|NCT00968201|524848448|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
145543539|NCT00968201|524848446|FG000|Extension Study - (Period III)|Patient Relocated|0|||
145543540|NCT00968201|524848447|FG001|Extension Study - (Period III)|Patient Relocated|1|||
145543541|NCT00968201|524848448|FG002|Extension Study - (Period III)|Patient Relocated|1|||
145543542|NCT00968201|524848446|FG000|Extension Study - (Period III)|Noncompliance|0|||
145543543|NCT00968201|524848447|FG001|Extension Study - (Period III)|Noncompliance|0|||
145543544|NCT00968201|524848448|FG002|Extension Study - (Period III)|Noncompliance|3|||
145543545|NCT00968201|524848446|FG000|Extension Study - (Period III)|Other|0|||
145543546|NCT00968201|524848447|FG001|Extension Study - (Period III)|Other|0|||
145543547|NCT00968201|524848448|FG002|Extension Study - (Period III)|Other|2|||
145543548|NCT00968201|524848446|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
145543549|NCT00968201|524848447|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
145543550|NCT00968201|524848448|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
145543551|NCT02619175|524848450|FG000|Overall Study|Withdrawal by Subject|1|||
145543552|NCT02619175|524848451|FG001|Overall Study|Withdrawal by Subject|0|||
145543553|NCT02619175|524848450|FG000|Overall Study|foot pain|1|||
145543554|NCT02619175|524848451|FG001|Overall Study|foot pain|0|||
145543555|NCT02657369|524848452|FG000|Overall Study|Death|27|||
145543556|NCT02657369|524848452|FG000|Overall Study|Study terminated by sponsor|7|||
145543557|NCT00361569|524848453|FG000|Overall Study|Protocol Violation|3|||
145543558|NCT00361569|524848454|FG001|Overall Study|Protocol Violation|2|||
145543559|NCT00361569|524848455|FG002|Overall Study|Protocol Violation|4|||
145282408|NCT00530439|523883124|FG001|Overall Study|Missed abortion|4|||
145282409|NCT00530439|523883123|FG000|Overall Study|Misclassification|2|||
145282410|NCT00530439|523883124|FG001|Overall Study|Misclassification|0|||
145282411|NCT00530439|523883123|FG000|Overall Study|Twin pregnancy|0|||
145282412|NCT00530439|523883124|FG001|Overall Study|Twin pregnancy|2|||
145282413|NCT00530439|523883123|FG000|Overall Study|Severe malformation/abortion|0|||
145282414|NCT00530439|523883124|FG001|Overall Study|Severe malformation/abortion|3|||
145282415|NCT01629693|523883127|FG000|Overall Study|Lost to Follow-up|2|||
145282416|NCT01629693|523883128|FG001|Overall Study|Lost to Follow-up|4|||
145282417|NCT01629693|523883127|FG000|Overall Study|Withdrawal by Subject|2|||
145282418|NCT01629693|523883128|FG001|Overall Study|Withdrawal by Subject|2|||
145282419|NCT01629693|523883127|FG000|Overall Study|Adverse Event|1|||
145282420|NCT01629693|523883128|FG001|Overall Study|Adverse Event|0|||
145282421|NCT01629693|523883127|FG000|Overall Study|Investigator decision|0|||
145282422|NCT01629693|523883128|FG001|Overall Study|Investigator decision|1|||
145282423|NCT01629693|523883127|FG000|Overall Study|Poor comfort of study lenses|0|||
145282424|NCT01629693|523883128|FG001|Overall Study|Poor comfort of study lenses|2|||
145282425|NCT01629693|523883127|FG000|Overall Study|Subject decision unrelated to AE|0|||
145282426|NCT01629693|523883128|FG001|Overall Study|Subject decision unrelated to AE|1|||
145282427|NCT04385199|523883129|FG000|Overall Study|Withdrawal by Subject|1|||
145282428|NCT04385199|523883130|FG001|Overall Study|Withdrawal by Subject|0|||
145282429|NCT01025193|523883132|FG000|Overall Study|Protocol Violation|1|||
145282430|NCT01025193|523883132|FG000|Overall Study|Adverse Event|3|||
145282431|NCT04079842|523883133|FG000|Overall Study|Request of subject|2|||
145282432|NCT04079842|523883133|FG000|Overall Study|Unable to draw Arterial samples|1|||
145543560|NCT00361569|524848456|FG003|Overall Study|Protocol Violation|2|||
145543561|NCT00361569|524848453|FG000|Overall Study|Withdrawal by Subject|2|||
145543562|NCT00361569|524848454|FG001|Overall Study|Withdrawal by Subject|1|||
145543563|NCT00361569|524848455|FG002|Overall Study|Withdrawal by Subject|9|||
145543564|NCT00361569|524848456|FG003|Overall Study|Withdrawal by Subject|14|||
145543565|NCT00361569|524848453|FG000|Overall Study|Adverse Event|3|||
145543566|NCT00361569|524848454|FG001|Overall Study|Adverse Event|5|||
145543567|NCT00361569|524848455|FG002|Overall Study|Adverse Event|2|||
145543568|NCT00361569|524848456|FG003|Overall Study|Adverse Event|2|||
145543569|NCT00361569|524848453|FG000|Overall Study|Lost to Follow-up|2|||
145543570|NCT00361569|524848454|FG001|Overall Study|Lost to Follow-up|3|||
145543571|NCT00361569|524848455|FG002|Overall Study|Lost to Follow-up|3|||
145543572|NCT00361569|524848456|FG003|Overall Study|Lost to Follow-up|2|||
145543573|NCT00361569|524848453|FG000|Overall Study|Not specified by investigator|2|||
145543574|NCT00361569|524848454|FG001|Overall Study|Not specified by investigator|0|||
145543575|NCT00361569|524848455|FG002|Overall Study|Not specified by investigator|0|||
145543576|NCT00361569|524848456|FG003|Overall Study|Not specified by investigator|1|||
145543577|NCT03307967|524848459|FG000|Overall Study|Lost to Follow-up|4|||
145543578|NCT03268954|524848460|FG000|Overall Study|Withdrawal by Subject|27|||
145543579|NCT03268954|524848461|FG001|Overall Study|Withdrawal by Subject|17|||
145543580|NCT03268954|524848460|FG000|Overall Study|Lost to Follow-up|2|||
145543581|NCT03268954|524848461|FG001|Overall Study|Lost to Follow-up|3|||
145543582|NCT03268954|524848460|FG000|Overall Study|Reason Not Specified|3|||
145543583|NCT03268954|524848461|FG001|Overall Study|Reason Not Specified|8|||
145543584|NCT02513394|524848464|FG000|Overall Study|Withdrawal by Subject|11|||
145543585|NCT02513394|524848465|FG001|Overall Study|Withdrawal by Subject|23|||
145543586|NCT02513394|524848464|FG000|Overall Study|Ineligible|1|||
145543587|NCT02513394|524848465|FG001|Overall Study|Ineligible|0|||
145282433|NCT02904200|523883134|FG000|Overall Study|Withdrawal by Subject|1|||
145282434|NCT02904200|523883135|FG001|Overall Study|Withdrawal by Subject|0|||
145282435|NCT02133352|523883138|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
145543588|NCT00612690|524850440|FG000|Overall Study|Lost to Follow-up|72|||
145543589|NCT00612690|524850441|FG001|Overall Study|Lost to Follow-up|98|||
145543590|NCT00612690|524850440|FG000|Overall Study|Withdrawal by Subject|32|||
145543591|NCT00612690|524850441|FG001|Overall Study|Withdrawal by Subject|20|||
145543592|NCT00612690|524850440|FG000|Overall Study|Withdrawal by Site|11|||
145543593|NCT00612690|524850441|FG001|Overall Study|Withdrawal by Site|0|||
145543594|NCT03797014|524850443|FG000|Overall Study|Withdrawal by Subject|1|||
145543595|NCT03797014|524850443|FG000|Overall Study|Lost to Follow-up|1|||
145282436|NCT03705169|523883139|FG000|Overall Study|Lost to Follow-up|0|||
145282437|NCT03705169|523883140|FG001|Overall Study|Lost to Follow-up|0|||
145543596|NCT03797014|524850443|FG000|Overall Study|Protocol Violation|1|||
145543597|NCT01970397|524850444|FG000|Overall Study|Adverse Event|0|||
145543598|NCT01970397|524850445|FG001|Overall Study|Adverse Event|1|||
145543599|NCT01970397|524850444|FG000|Overall Study|Lost to Follow-up|0|||
145543600|NCT01970397|524850445|FG001|Overall Study|Lost to Follow-up|1|||
145543601|NCT01970397|524850444|FG000|Overall Study|Personal Reasons|1|||
145543602|NCT01970397|524850445|FG001|Overall Study|Personal Reasons|2|||
145543603|NCT01970397|524850444|FG000|Overall Study|Protocol Violation|1|||
145404335|NCT00284856|524336550|FG001|Overall Study|Other|5|||
145282438|NCT03705169|523883141|FG002|Overall Study|Lost to Follow-up|0|||
145543604|NCT01970397|524850445|FG001|Overall Study|Protocol Violation|1|||
145282439|NCT03705169|523883142|FG003|Overall Study|Lost to Follow-up|2|||
145282440|NCT03705169|523883143|FG004|Overall Study|Lost to Follow-up|0|||
145282441|NCT03705169|523883144|FG005|Overall Study|Lost to Follow-up|2|||
145282442|NCT03705169|523883145|FG006|Overall Study|Lost to Follow-up|1|||
145282443|NCT03705169|523883146|FG007|Overall Study|Lost to Follow-up|0|||
145282444|NCT03705169|523883147|FG008|Overall Study|Lost to Follow-up|0|||
145282445|NCT03705169|523883148|FG009|Overall Study|Lost to Follow-up|1|||
145282446|NCT03705169|523883139|FG000|Overall Study|Adverse Event|0|||
145282447|NCT03705169|523883140|FG001|Overall Study|Adverse Event|0|||
145282448|NCT03705169|523883141|FG002|Overall Study|Adverse Event|0|||
145282449|NCT03705169|523883142|FG003|Overall Study|Adverse Event|1|||
145282450|NCT03705169|523883143|FG004|Overall Study|Adverse Event|0|||
145282451|NCT03705169|523883144|FG005|Overall Study|Adverse Event|0|||
145282452|NCT03705169|523883145|FG006|Overall Study|Adverse Event|0|||
145543605|NCT03305575|524850454|FG000|Overall Study|Physician Decision|1|||
145543606|NCT03305575|524850455|FG001|Overall Study|Physician Decision|0|||
145543607|NCT00105469|524850456|FG000|Overall Study|Adverse Event|9|||
145543608|NCT00105469|524850457|FG001|Overall Study|Adverse Event|8|||
145543609|NCT00105469|524850456|FG000|Overall Study|Protocol Violation|4|||
145543610|NCT00105469|524850457|FG001|Overall Study|Protocol Violation|0|||
145543611|NCT00105469|524850456|FG000|Overall Study|Withdrawal by Subject|2|||
145543612|NCT00105469|524850457|FG001|Overall Study|Withdrawal by Subject|3|||
145543613|NCT00105469|524850456|FG000|Overall Study|Lost to Follow-up|1|||
145543614|NCT00105469|524850457|FG001|Overall Study|Lost to Follow-up|0|||
145543615|NCT00105469|524850456|FG000|Overall Study|Lack of Efficacy|2|||
145543616|NCT00105469|524850457|FG001|Overall Study|Lack of Efficacy|0|||
145543617|NCT00105469|524850456|FG000|Overall Study|Other Reason|4|||
145543618|NCT00105469|524850457|FG001|Overall Study|Other Reason|0|||
145543619|NCT01749137|524850458|FG000|Overall Study|Adverse Event|4|||
145543620|NCT01749137|524850459|FG001|Overall Study|Adverse Event|4|||
145543621|NCT01749137|524850458|FG000|Overall Study|Lost to Follow-up|2|||
145543622|NCT01749137|524850459|FG001|Overall Study|Lost to Follow-up|3|||
145543623|NCT01749137|524850458|FG000|Overall Study|Physician Decision|1|||
145543624|NCT01749137|524850459|FG001|Overall Study|Physician Decision|0|||
145543625|NCT01749137|524850458|FG000|Overall Study|Withdrawal by Subject|8|||
145543626|NCT01749137|524850459|FG001|Overall Study|Withdrawal by Subject|4|||
145543627|NCT01338792|524850468|FG000|Overall Study|Adverse Event|2|||
145543628|NCT01338792|524850468|FG000|Overall Study|Death|1|||
145543629|NCT01338792|524850468|FG000|Overall Study|Withdrawal by Subject|1|||
145543630|NCT00573469|524850469|FG000|Overall Study|Adverse Event|1|||
145543631|NCT00573469|524850470|FG001|Overall Study|Adverse Event|1|||
145543632|NCT00573469|524850471|FG002|Overall Study|Adverse Event|1|||
145543633|NCT00573469|524850469|FG000|Overall Study|Withdrawal by Subject|0|||
145543634|NCT00573469|524850470|FG001|Overall Study|Withdrawal by Subject|2|||
145543635|NCT00573469|524850471|FG002|Overall Study|Withdrawal by Subject|0|||
145543636|NCT00573469|524850469|FG000|Overall Study|Other|5|||
145543637|NCT00573469|524850470|FG001|Overall Study|Other|1|||
145543638|NCT00573469|524850471|FG002|Overall Study|Other|3|||
145543639|NCT00684593|524850473|FG000|Overall Study|Adverse Event|0|||
145543640|NCT00684593|524850474|FG001|Overall Study|Adverse Event|2|||
145543641|NCT00617773|524850475|FG000|Overall Study|Physician Decision|1|||
145543642|NCT00617773|524850475|FG000|Overall Study|Lack of compliance with the protocol|1|||
145543643|NCT00617773|524850475|FG000|Overall Study|Withdrawal by Subject|1|||
145543644|NCT00617773|524850475|FG000|Overall Study|Death|1|||
145543645|NCT00617773|524850475|FG000|Overall Study|Progressive disease|19|||
145543646|NCT00617773|524850475|FG000|Overall Study|Protocol Violation|1|||
145543647|NCT05526716|524850477|FG000|Overall Study|Death|1|||
145543648|NCT05526716|524850478|FG001|Overall Study|Death|2|||
145543649|NCT05526716|524850477|FG000|Overall Study|Lost to Follow-up|17|||
145543650|NCT05526716|524850478|FG001|Overall Study|Lost to Follow-up|15|||
145543651|NCT05526716|524850477|FG000|Overall Study|Physician Decision|0|||
145543652|NCT05526716|524850478|FG001|Overall Study|Physician Decision|1|||
145543653|NCT05526716|524850477|FG000|Overall Study|Randomized by mistake without study treatment|0|||
145543654|NCT05526716|524850478|FG001|Overall Study|Randomized by mistake without study treatment|1|||
145543655|NCT05526716|524850477|FG000|Overall Study|Withdrawal by Subject|12|||
145543656|NCT05526716|524850478|FG001|Overall Study|Withdrawal by Subject|12|||
145543657|NCT05526716|524850477|FG000|Overall Study|Not reported|0|||
145543658|NCT05526716|524850478|FG001|Overall Study|Not reported|2|||
145543659|NCT01751867|524850479|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
145543660|NCT01751867|524850480|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
145543661|NCT01751867|524850479|FG000|Overall Study|Diease Progression|4|||
145543662|NCT01751867|524850480|FG001|Overall Study|Diease Progression|18|||
145543663|NCT01751867|524850479|FG000|Overall Study|Adverse Event|8|||
145543664|NCT01751867|524850480|FG001|Overall Study|Adverse Event|15|||
145543665|NCT01751867|524850479|FG000|Overall Study|Poor Compliance|0|||
145543666|NCT01751867|524850480|FG001|Overall Study|Poor Compliance|5|||
145543667|NCT01751867|524850479|FG000|Overall Study|Withdrawal by Subject|3|||
145543668|NCT01751867|524850480|FG001|Overall Study|Withdrawal by Subject|1|||
145543669|NCT01751867|524850479|FG000|Overall Study|Physician Decision|4|||
145543670|NCT01751867|524850480|FG001|Overall Study|Physician Decision|7|||
145543671|NCT01751867|524850479|FG000|Overall Study|Protocol Violation|0|||
145543672|NCT01751867|524850480|FG001|Overall Study|Protocol Violation|2|||
145543673|NCT01751867|524850479|FG000|Overall Study|Death|0|||
145543674|NCT01751867|524850480|FG001|Overall Study|Death|5|||
145543675|NCT01751867|524850479|FG000|Overall Study|Other|11|||
145543676|NCT01751867|524850480|FG001|Overall Study|Other|37|||
145543677|NCT01751867|524850479|FG000|Overall Study|Randomized but not treated.|2|||
145543678|NCT01751867|524850480|FG001|Overall Study|Randomized but not treated.|1|||
145543679|NCT04932096|524850481|FG000|Overall Study|Withdrawal by Subject|1|||
145543680|NCT04932096|524850482|FG001|Overall Study|Withdrawal by Subject|1|||
145543681|NCT04932096|524850481|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
145543682|NCT04932096|524850482|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
145543683|NCT01508650|524850483|FG000|Overall Study|Lost to Follow-up|0|||
145543684|NCT01508650|524850484|FG001|Overall Study|Lost to Follow-up|3|||
145543685|NCT02064894|524850485|FG000|Overall Study|Withdrawal by Subject|43|||
145543686|NCT02064894|524850486|FG001|Overall Study|Withdrawal by Subject|102|||
145543687|NCT02064894|524850487|FG002|Overall Study|Withdrawal by Subject|115|||
145543688|NCT01396148|524850488|FG000|Overall Study|Patient Decision|1|||
145543689|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
145543690|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
145543691|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543692|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543693|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543694|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543695|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543696|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
145543697|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
145543698|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
145543699|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543700|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543701|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543702|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543703|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543704|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
145543705|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
145543706|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
145543707|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543708|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543709|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543710|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543711|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543712|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
145543713|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543714|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
145543715|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543716|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543717|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543718|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543719|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543720|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
145543721|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
145543722|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
145543723|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543724|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543725|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543726|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543727|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543728|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
145543729|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
145543730|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543731|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543732|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543733|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543734|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543735|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543736|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
145543737|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
145543738|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
145543739|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543740|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543741|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543742|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543743|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543744|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
145543745|NCT03095066|524850497|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
145543746|NCT03095066|524850498|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
145543747|NCT03095066|524850499|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543748|NCT03095066|524850500|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543749|NCT03095066|524850501|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543750|NCT03095066|524850502|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543751|NCT03095066|524850503|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543752|NCT03095066|524850504|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
145543753|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543754|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543755|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
145543756|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543757|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543758|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543759|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
145543760|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
145543761|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543762|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543763|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
145543764|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543765|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543766|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543767|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
145543768|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
145543769|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543770|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543771|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
145543772|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543773|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543774|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543775|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
145543776|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
145543777|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543778|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543779|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
145543780|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543781|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543782|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543783|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
145543784|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
145543785|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543786|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543787|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
145543788|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543789|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543790|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543791|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543792|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
145543793|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543794|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543795|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
145543796|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543797|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543798|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543799|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
145543800|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
145543801|NCT03095066|524850497|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543802|NCT03095066|524850498|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543803|NCT03095066|524850499|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543804|NCT03095066|524850500|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543805|NCT03095066|524850501|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543806|NCT03095066|524850502|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543807|NCT03095066|524850503|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
145543808|NCT03095066|524850504|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
145543809|NCT03095066|524850497|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543810|NCT03095066|524850498|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543811|NCT03095066|524850499|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543812|NCT03095066|524850500|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543813|NCT03095066|524850501|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543814|NCT03095066|524850502|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
145543815|NCT03095066|524850503|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543816|NCT03095066|524850504|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
145543817|NCT03095066|524850497|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543818|NCT03095066|524850498|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543819|NCT03095066|524850499|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543820|NCT03095066|524850500|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543821|NCT03095066|524850501|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
145543822|NCT03095066|524850502|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543823|NCT03095066|524850503|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
145543824|NCT03095066|524850504|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
145543825|NCT03095066|524850497|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145543826|NCT03095066|524850498|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145543827|NCT03095066|524850499|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145543828|NCT03095066|524850500|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145543829|NCT03095066|524850501|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
145543830|NCT03095066|524850502|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145282453|NCT03705169|523883146|FG007|Overall Study|Adverse Event|0|||
145282454|NCT03705169|523883147|FG008|Overall Study|Adverse Event|0|||
145543831|NCT03095066|524850503|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
145543832|NCT03095066|524850504|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
145610366|NCT02960763|525089788|FG003|Step 1|Lost to Follow-up|0|||
145610367|NCT02960763|525089789|FG004|Step 1|Lost to Follow-up|0|||
145610368|NCT02960763|525089785|FG000|Step 1|Death|1|||
145610369|NCT02960763|525089786|FG001|Step 1|Death|1|||
145610370|NCT02960763|525089787|FG002|Step 1|Death|1|||
145610371|NCT02960763|525089788|FG003|Step 1|Death|0|||
145610372|NCT02960763|525089789|FG004|Step 1|Death|0|||
145610373|NCT02960763|525089785|FG000|Step 1|Investigator discretion|1|||
145610374|NCT02960763|525089786|FG001|Step 1|Investigator discretion|0|||
145610375|NCT02960763|525089787|FG002|Step 1|Investigator discretion|1|||
145610376|NCT02960763|525089788|FG003|Step 1|Investigator discretion|0|||
145610377|NCT02960763|525089789|FG004|Step 1|Investigator discretion|0|||
145610378|NCT02960763|525089785|FG000|Step 1|Other|0|||
145610379|NCT02960763|525089786|FG001|Step 1|Other|0|||
145610380|NCT02960763|525089787|FG002|Step 1|Other|1|||
145610381|NCT02960763|525089788|FG003|Step 1|Other|0|||
145610382|NCT02960763|525089789|FG004|Step 1|Other|0|||
145610383|NCT02960763|525089785|FG000|Step 2|Withdrawal by Subject|0|||
145610384|NCT02960763|525089786|FG001|Step 2|Withdrawal by Subject|0|||
145610385|NCT02960763|525089787|FG002|Step 2|Withdrawal by Subject|0|||
145610386|NCT02960763|525089788|FG003|Step 2|Withdrawal by Subject|7|||
145610387|NCT02960763|525089789|FG004|Step 2|Withdrawal by Subject|3|||
145610388|NCT02960763|525089785|FG000|Step 2|Lost to Follow-up|0|||
145610389|NCT02960763|525089786|FG001|Step 2|Lost to Follow-up|0|||
145610390|NCT02960763|525089787|FG002|Step 2|Lost to Follow-up|0|||
145610391|NCT02960763|525089788|FG003|Step 2|Lost to Follow-up|4|||
145610392|NCT02960763|525089789|FG004|Step 2|Lost to Follow-up|1|||
145610393|NCT02960763|525089785|FG000|Step 2|Investigator discretion|0|||
145610394|NCT02960763|525089786|FG001|Step 2|Investigator discretion|0|||
145610395|NCT02960763|525089787|FG002|Step 2|Investigator discretion|0|||
145610396|NCT02960763|525089788|FG003|Step 2|Investigator discretion|0|||
145610397|NCT02960763|525089789|FG004|Step 2|Investigator discretion|1|||
145610398|NCT00312858|525089791|FG000|Overall Study|Adverse Event|0|||
145610399|NCT00312858|525089792|FG001|Overall Study|Adverse Event|1|||
145610400|NCT00312858|525089791|FG000|Overall Study|Lost to Follow-up|25|||
145610401|NCT00312858|525089792|FG001|Overall Study|Lost to Follow-up|42|||
145610402|NCT00312858|525089791|FG000|Overall Study|Protocol Violation|3|||
145610403|NCT00312858|525089792|FG001|Overall Study|Protocol Violation|8|||
145610404|NCT00312858|525089791|FG000|Overall Study|Withdraw by Participant|20|||
145610405|NCT00312858|525089792|FG001|Overall Study|Withdraw by Participant|20|||
145610406|NCT00312858|525089791|FG000|Overall Study|Participant Moved|11|||
145610407|NCT00312858|525089792|FG001|Overall Study|Participant Moved|10|||
145610408|NCT00312858|525089791|FG000|Overall Study|Other|9|||
145610409|NCT00312858|525089792|FG001|Overall Study|Other|12|||
145610410|NCT03638635|525089793|FG000|Initial Hospitalization|Study terminated prematurely|0|||
145610411|NCT03638635|525089794|FG001|Initial Hospitalization|Study terminated prematurely|1|||
145610412|NCT03638635|525089793|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
145610413|NCT03638635|525089794|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
145610414|NCT03638635|525089793|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
145543833|NCT03095066|524850497|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543834|NCT03095066|524850498|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543835|NCT03095066|524850499|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543836|NCT03095066|524850500|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543837|NCT03095066|524850501|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
145543838|NCT03095066|524850502|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543839|NCT03095066|524850503|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
145543840|NCT03095066|524850504|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
145543841|NCT03095066|524850497|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145543842|NCT03095066|524850498|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145543843|NCT03095066|524850499|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145543844|NCT03095066|524850500|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
145543845|NCT03095066|524850501|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145543846|NCT03095066|524850502|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
145543847|NCT03095066|524850503|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145543848|NCT03095066|524850504|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
145610415|NCT03638635|525089794|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
145610416|NCT02318719|525089797|FG000|Double-blind Phase|Adverse Event|7|||
145610417|NCT02318719|525089798|FG001|Double-blind Phase|Adverse Event|6|||
145610418|NCT02318719|525089799|FG002|Double-blind Phase|Adverse Event|12|||
145610419|NCT02318719|525089800|FG003|Double-blind Phase|Adverse Event|4|||
145610420|NCT02318719|525089801|FG004|Double-blind Phase|Adverse Event|0|||
145610421|NCT02318719|525089797|FG000|Double-blind Phase|Lack of Efficacy|5|||
145610422|NCT02318719|525089798|FG001|Double-blind Phase|Lack of Efficacy|0|||
145543849|NCT00160693|524850505|FG000|Overall Study|Adverse Event|97|||
145543850|NCT00160693|524850505|FG000|Overall Study|Lack of Efficacy|30|||
145610423|NCT02318719|525089799|FG002|Double-blind Phase|Lack of Efficacy|1|||
145610424|NCT02318719|525089800|FG003|Double-blind Phase|Lack of Efficacy|1|||
145610425|NCT02318719|525089801|FG004|Double-blind Phase|Lack of Efficacy|0|||
145543851|NCT00160693|524850505|FG000|Overall Study|Protocol Violation|24|||
145543852|NCT00160693|524850505|FG000|Overall Study|Lost to Follow-up|15|||
145543853|NCT00160693|524850505|FG000|Overall Study|Withdrawal by Subject|54|||
145543854|NCT00160693|524850505|FG000|Overall Study|Study terminated by sponsor|15|||
145543855|NCT02170298|524850510|FG000|Overall Study|Withdrawal by Subject|0|||
145404336|NCT00284856|524336551|FG002|Overall Study|Other|4|||
145404337|NCT03692949|524336552|FG000|Overall Study|Lost to Follow-up|0|||
145543856|NCT02170298|524850511|FG001|Overall Study|Withdrawal by Subject|1|||
145543857|NCT02170298|524850510|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
145543858|NCT02170298|524850511|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
145543859|NCT00777608|524850513|FG000|Overall Study|Lost to Follow-up|1|||
145543860|NCT00777608|524850514|FG001|Overall Study|Lost to Follow-up|1|||
145543861|NCT00777608|524850513|FG000|Overall Study|Withdrawal by Subject|1|||
145543862|NCT00777608|524850514|FG001|Overall Study|Withdrawal by Subject|3|||
145543863|NCT00777608|524850513|FG000|Overall Study|Protocol Violation|1|||
145543864|NCT00777608|524850514|FG001|Overall Study|Protocol Violation|0|||
145543865|NCT00777608|524850513|FG000|Overall Study|Investigator Decision|1|||
145543866|NCT00777608|524850514|FG001|Overall Study|Investigator Decision|2|||
145543867|NCT04213079|524850515|FG000|Overall Study|Lost to Follow-up|0|||
145543868|NCT04213079|524850516|FG001|Overall Study|Lost to Follow-up|2|||
145543869|NCT00520936|524850518|FG000|Overall Study|Physician Decision|0|||
145543870|NCT00520936|524850519|FG001|Overall Study|Physician Decision|2|||
145404338|NCT03692949|524336553|FG001|Overall Study|Lost to Follow-up|0|||
145404339|NCT03692949|524336554|FG002|Overall Study|Lost to Follow-up|0|||
145404340|NCT03692949|524336555|FG003|Overall Study|Lost to Follow-up|0|||
145404341|NCT03692949|524336556|FG004|Overall Study|Lost to Follow-up|0|||
145404342|NCT03692949|524336557|FG005|Overall Study|Lost to Follow-up|0|||
145404343|NCT03692949|524336558|FG006|Overall Study|Lost to Follow-up|0|||
145404344|NCT03692949|524336559|FG007|Overall Study|Lost to Follow-up|1|||
145404345|NCT03426878|524336567|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
145404346|NCT03426878|524336567|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
145404347|NCT03426878|524336567|FG000|Overall Study|Declined to receive results|3|||
145404348|NCT03426878|524336567|FG000|Overall Study|Received negative results by mailed letter|65|||
145404349|NCT03426878|524336567|FG000|Overall Study|Lost to Follow-up|177|||
145404350|NCT00402831|524336572|FG000|Overall Study|Lost to Follow-up|1|||
145404351|NCT00402831|524336573|FG001|Overall Study|Lost to Follow-up|2|||
145404352|NCT00402831|524336572|FG000|Overall Study|Non-compliance with protocol|0|||
145404353|NCT00402831|524336573|FG001|Overall Study|Non-compliance with protocol|1|||
145404354|NCT00671788|524336576|FG000|Overall Study|Adverse Event|8|||
145404355|NCT00671788|524336576|FG000|Overall Study|Refused further treatment|3|||
145404356|NCT00671788|524336576|FG000|Overall Study|Ineligible|1|||
145404357|NCT00671788|524336576|FG000|Overall Study|MD Decision|1|||
145404358|NCT00671788|524336576|FG000|Overall Study|Other|1|||
145404359|NCT02792504|524336579|FG000|Overall Study|Lost to Follow-up|24|||
145404360|NCT02792504|524336579|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
145404361|NCT01035138|524336580|FG000|Overall Study|Adverse Event|4|||
145404362|NCT01035138|524336581|FG001|Overall Study|Adverse Event|0|||
145404363|NCT01035138|524336582|FG002|Overall Study|Adverse Event|2|||
145404364|NCT01035138|524336580|FG000|Overall Study|Caregiver Decision|2|||
145404365|NCT01035138|524336581|FG001|Overall Study|Caregiver Decision|0|||
145404366|NCT01035138|524336582|FG002|Overall Study|Caregiver Decision|1|||
145404367|NCT01035138|524336580|FG000|Overall Study|Withdrawal by Subject|1|||
145404368|NCT01035138|524336581|FG001|Overall Study|Withdrawal by Subject|0|||
145404369|NCT01035138|524336582|FG002|Overall Study|Withdrawal by Subject|0|||
145404370|NCT01035138|524336580|FG000|Overall Study|Physician Decision|0|||
145404371|NCT01035138|524336581|FG001|Overall Study|Physician Decision|0|||
145404372|NCT01035138|524336582|FG002|Overall Study|Physician Decision|1|||
145543871|NCT00520936|524850520|FG002|Overall Study|Physician Decision|1|||
145543872|NCT00520936|524850521|FG003|Overall Study|Physician Decision|0|||
145543873|NCT00520936|524850522|FG004|Overall Study|Physician Decision|0|||
145404373|NCT01035138|524336580|FG000|Overall Study|Sponsor Decision|66|||
145404374|NCT01035138|524336581|FG001|Overall Study|Sponsor Decision|60|||
145404375|NCT01035138|524336582|FG002|Overall Study|Sponsor Decision|42|||
145404376|NCT01035138|524336580|FG000|Overall Study|Lost to Follow-up|0|||
145404377|NCT01035138|524336581|FG001|Overall Study|Lost to Follow-up|0|||
145404378|NCT01035138|524336582|FG002|Overall Study|Lost to Follow-up|1|||
145543874|NCT00520936|524850523|FG005|Overall Study|Physician Decision|0|||
145543875|NCT00520936|524850524|FG006|Overall Study|Physician Decision|0|||
145543876|NCT00520936|524850525|FG007|Overall Study|Physician Decision|0|||
145543877|NCT00520936|524850518|FG000|Overall Study|Withdrawal by Subject|0|||
145543878|NCT00520936|524850519|FG001|Overall Study|Withdrawal by Subject|0|||
145543879|NCT00520936|524850520|FG002|Overall Study|Withdrawal by Subject|0|||
145543880|NCT00520936|524850521|FG003|Overall Study|Withdrawal by Subject|0|||
145404379|NCT00848497|524336589|FG000|Overall Study|Screen failure|2|||
145404380|NCT00848497|524336590|FG001|Overall Study|Screen failure|0|||
145404381|NCT00848497|524336589|FG000|Overall Study|Withdrawal by Subject|0|||
145404382|NCT00848497|524336590|FG001|Overall Study|Withdrawal by Subject|1|||
145543881|NCT00520936|524850522|FG004|Overall Study|Withdrawal by Subject|0|||
145282455|NCT03705169|523883148|FG009|Overall Study|Adverse Event|0|||
145282456|NCT03705169|523883139|FG000|Overall Study|Site Closure|0|||
145282457|NCT03705169|523883140|FG001|Overall Study|Site Closure|0|||
145282458|NCT03705169|523883141|FG002|Overall Study|Site Closure|0|||
145282459|NCT03705169|523883142|FG003|Overall Study|Site Closure|1|||
145282460|NCT03705169|523883143|FG004|Overall Study|Site Closure|0|||
145282461|NCT03705169|523883144|FG005|Overall Study|Site Closure|0|||
145282462|NCT03705169|523883145|FG006|Overall Study|Site Closure|0|||
145282463|NCT03705169|523883146|FG007|Overall Study|Site Closure|0|||
145282464|NCT03705169|523883147|FG008|Overall Study|Site Closure|0|||
145282465|NCT03705169|523883148|FG009|Overall Study|Site Closure|0|||
145282466|NCT03705169|523883139|FG000|Overall Study|Did not receive study treatment|0|||
145543882|NCT00520936|524850523|FG005|Overall Study|Withdrawal by Subject|0|||
145543883|NCT00520936|524850524|FG006|Overall Study|Withdrawal by Subject|0|||
145543884|NCT00520936|524850525|FG007|Overall Study|Withdrawal by Subject|1|||
145543885|NCT00520936|524850518|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
145543886|NCT00520936|524850519|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
145543887|NCT00520936|524850520|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
145543888|NCT00520936|524850521|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
145543889|NCT00520936|524850522|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
145543890|NCT00520936|524850523|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
145543891|NCT00520936|524850524|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
145543892|NCT00520936|524850525|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
145543893|NCT00520936|524850518|FG000|Overall Study|Death|0|||
145543894|NCT00520936|524850519|FG001|Overall Study|Death|0|||
145543895|NCT00520936|524850520|FG002|Overall Study|Death|0|||
145543896|NCT00520936|524850521|FG003|Overall Study|Death|0|||
145543897|NCT00520936|524850522|FG004|Overall Study|Death|0|||
145543898|NCT00520936|524850523|FG005|Overall Study|Death|0|||
145543899|NCT00520936|524850524|FG006|Overall Study|Death|1|||
145543900|NCT00520936|524850525|FG007|Overall Study|Death|0|||
145543901|NCT00520936|524850518|FG000|Overall Study|Protocol Violation|0|||
145543902|NCT00520936|524850519|FG001|Overall Study|Protocol Violation|1|||
145543903|NCT00520936|524850520|FG002|Overall Study|Protocol Violation|1|||
145543904|NCT00520936|524850521|FG003|Overall Study|Protocol Violation|0|||
145543905|NCT00520936|524850522|FG004|Overall Study|Protocol Violation|1|||
145543906|NCT00520936|524850523|FG005|Overall Study|Protocol Violation|0|||
145543907|NCT00520936|524850524|FG006|Overall Study|Protocol Violation|1|||
145543908|NCT00520936|524850525|FG007|Overall Study|Protocol Violation|0|||
145543909|NCT04343261|524850526|FG000|Overall Study|Adverse Event|1|||
145543910|NCT04343261|524850526|FG000|Overall Study|received inadequate amount of antibodies|7|||
145543911|NCT03616600|524850531|FG000|Overall Study|Withdrawal by Subject|1|||
145543912|NCT03616600|524850532|FG001|Overall Study|Withdrawal by Subject|0|||
145543913|NCT03984994|524850533|FG000|Overall Study|Withdrawal by Subject|2|||
145543914|NCT03984994|524850534|FG001|Overall Study|Withdrawal by Subject|1|||
145543915|NCT04220866|524850535|FG000|Overall Study|Death|4|||
145543916|NCT04220866|524850536|FG001|Overall Study|Death|5|||
145282467|NCT03705169|523883140|FG001|Overall Study|Did not receive study treatment|0|||
145282468|NCT03705169|523883141|FG002|Overall Study|Did not receive study treatment|0|||
145282469|NCT03705169|523883142|FG003|Overall Study|Did not receive study treatment|1|||
145282470|NCT03705169|523883143|FG004|Overall Study|Did not receive study treatment|0|||
145282471|NCT03705169|523883144|FG005|Overall Study|Did not receive study treatment|0|||
145282472|NCT03705169|523883145|FG006|Overall Study|Did not receive study treatment|0|||
145282473|NCT03705169|523883146|FG007|Overall Study|Did not receive study treatment|0|||
145282474|NCT03705169|523883147|FG008|Overall Study|Did not receive study treatment|0|||
145282475|NCT03705169|523883148|FG009|Overall Study|Did not receive study treatment|0|||
145282476|NCT03705169|523883139|FG000|Overall Study|Concerns about study visit compliance|0|||
145282477|NCT03705169|523883140|FG001|Overall Study|Concerns about study visit compliance|0|||
145282478|NCT03705169|523883141|FG002|Overall Study|Concerns about study visit compliance|0|||
145282479|NCT03705169|523883142|FG003|Overall Study|Concerns about study visit compliance|1|||
145282480|NCT03705169|523883143|FG004|Overall Study|Concerns about study visit compliance|0|||
145404383|NCT01832766|524336591|FG000|Washout|Lost to Follow-up|0|||
145404384|NCT01832766|524336592|FG001|Washout|Lost to Follow-up|1|||
145543917|NCT04220866|524850535|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
145543918|NCT04220866|524850536|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
145543919|NCT04220866|524850535|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
145543920|NCT04220866|524850536|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
145543921|NCT04220866|524850535|FG000|Overall Study|Withdrawal by Subject|0|||
145543922|NCT04220866|524850536|FG001|Overall Study|Withdrawal by Subject|1|||
145282481|NCT03705169|523883144|FG005|Overall Study|Concerns about study visit compliance|0|||
145282482|NCT03705169|523883145|FG006|Overall Study|Concerns about study visit compliance|0|||
145282483|NCT03705169|523883146|FG007|Overall Study|Concerns about study visit compliance|0|||
145282484|NCT03705169|523883147|FG008|Overall Study|Concerns about study visit compliance|0|||
145543923|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Death|0|||
145404385|NCT01114724|524336595|FG000|Overall Study|Death|8|||
145404386|NCT01114724|524336595|FG000|Overall Study|Lost to Follow-up|1|||
145404387|NCT01114724|524336595|FG000|Overall Study|Withdrawal by Subject|1|||
145404388|NCT04711005|524336605|FG000|Overall Study|Withdrawal by Subject|0|||
145404389|NCT04711005|524336606|FG001|Overall Study|Withdrawal by Subject|0|||
145404390|NCT04711005|524336607|FG002|Overall Study|Withdrawal by Subject|0|||
145404391|NCT04711005|524336608|FG003|Overall Study|Withdrawal by Subject|0|||
145404392|NCT04711005|524336609|FG004|Overall Study|Withdrawal by Subject|0|||
145404393|NCT04711005|524336610|FG005|Overall Study|Withdrawal by Subject|0|||
145404394|NCT04711005|524336611|FG006|Overall Study|Withdrawal by Subject|0|||
145404395|NCT04711005|524336612|FG007|Overall Study|Withdrawal by Subject|1|||
145404396|NCT04711005|524336613|FG008|Overall Study|Withdrawal by Subject|0|||
145404397|NCT04711005|524336614|FG009|Overall Study|Withdrawal by Subject|0|||
145404398|NCT04711005|524336605|FG000|Overall Study|Physician Decision|0|||
145404399|NCT04711005|524336606|FG001|Overall Study|Physician Decision|0|||
145404400|NCT04711005|524336607|FG002|Overall Study|Physician Decision|0|||
145404401|NCT04711005|524336608|FG003|Overall Study|Physician Decision|0|||
145404402|NCT04711005|524336609|FG004|Overall Study|Physician Decision|0|||
145404403|NCT04711005|524336610|FG005|Overall Study|Physician Decision|0|||
145404404|NCT04711005|524336611|FG006|Overall Study|Physician Decision|0|||
145404405|NCT04711005|524336612|FG007|Overall Study|Physician Decision|2|||
145404406|NCT04711005|524336613|FG008|Overall Study|Physician Decision|1|||
145404407|NCT04711005|524336614|FG009|Overall Study|Physician Decision|0|||
145404408|NCT03415178|524336622|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
145404409|NCT03415178|524336623|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
145404410|NCT03415178|524336622|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
145404411|NCT03415178|524336623|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
145404412|NCT02781324|524336624|FG000|Overall Study|Withdrawal by Subject|1|||
145404413|NCT02781324|524336625|FG001|Overall Study|Withdrawal by Subject|0|||
145404414|NCT02781324|524336624|FG000|Overall Study|Physician Decision|1|||
145404415|NCT02781324|524336625|FG001|Overall Study|Physician Decision|2|||
145404416|NCT00834041|524336626|FG000|Overall Study|Withdrawal by Subject|1|||
145404417|NCT00834041|524336627|FG001|Overall Study|Withdrawal by Subject|0|||
145404418|NCT00834041|524336626|FG000|Overall Study|Lost to Follow-up|0|||
145404419|NCT00834041|524336627|FG001|Overall Study|Lost to Follow-up|1|||
145404420|NCT04530630|524338601|FG000|Overall Study|Physician Decision|1|||
145404421|NCT03675308|524338604|FG000|Overall Study|Adverse Event|3|||
145404422|NCT03675308|524338605|FG001|Overall Study|Adverse Event|2|||
145404423|NCT03675308|524338604|FG000|Overall Study|Withdrawal by Subject|6|||
145404424|NCT03675308|524338605|FG001|Overall Study|Withdrawal by Subject|4|||
145404425|NCT03675308|524338604|FG000|Overall Study|Lost to Follow-up|3|||
145404426|NCT03675308|524338605|FG001|Overall Study|Lost to Follow-up|0|||
145404427|NCT03675308|524338604|FG000|Overall Study|Lack of Efficacy|1|||
145404428|NCT03675308|524338605|FG001|Overall Study|Lack of Efficacy|1|||
145404429|NCT03675308|524338604|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
145404430|NCT03675308|524338605|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
145404431|NCT03675308|524338604|FG000|Overall Study|Other|0|||
145404432|NCT03675308|524338605|FG001|Overall Study|Other|1|||
145404433|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
145404434|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
145404435|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
145404436|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Death|1|||
145543924|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Death|0|||
145543925|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Death|0|||
145543926|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Death|0|||
145543927|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Death|1|||
145543928|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Death|0|||
145543929|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Death|0|||
145543930|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Death|0|||
145543931|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
145543932|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
145543933|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
145404437|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Death|1|||
145404438|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Death|0|||
145404439|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
145404440|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
145543934|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
145404441|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
145543935|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
145543936|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
145404442|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
145404443|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
145404444|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
145543937|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
145543938|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
145404445|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
145543939|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
145404446|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
145543940|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
145543941|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
145543942|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
145543943|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
145543944|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
145543945|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
145543946|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
145543947|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
145543948|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
145543949|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
145543950|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
145543951|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
145543952|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
145543953|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
145543954|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
145543955|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
145543956|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
145543957|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
145543958|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
145543959|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
145543960|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
145543961|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
145543962|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
145543963|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
145543964|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
145543965|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
145543966|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
145543967|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
145543968|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
145543969|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
145543970|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
145543971|NCT00726232|524850537|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
145543972|NCT00726232|524850538|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543973|NCT00726232|524850539|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543974|NCT00726232|524850540|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543975|NCT00726232|524850541|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543976|NCT00726232|524850542|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543977|NCT00726232|524850543|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543978|NCT00726232|524850544|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
145543979|NCT00726232|524850537|FG000|Expansion Phase|Death|0|||
145543980|NCT00726232|524850538|FG001|Expansion Phase|Death|0|||
145543981|NCT00726232|524850539|FG002|Expansion Phase|Death|0|||
145543982|NCT00726232|524850540|FG003|Expansion Phase|Death|0|||
145543983|NCT00726232|524850541|FG004|Expansion Phase|Death|0|||
145543984|NCT00726232|524850542|FG005|Expansion Phase|Death|0|||
145543985|NCT00726232|524850543|FG006|Expansion Phase|Death|0|||
145543986|NCT00726232|524850544|FG007|Expansion Phase|Death|1|||
145543987|NCT00726232|524850537|FG000|Expansion Phase|Adverse Event|0|||
145543988|NCT00726232|524850538|FG001|Expansion Phase|Adverse Event|0|||
145543989|NCT00726232|524850539|FG002|Expansion Phase|Adverse Event|0|||
145543990|NCT00726232|524850540|FG003|Expansion Phase|Adverse Event|0|||
145404447|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
145404448|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
145404449|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
145404450|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
145404451|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
145404452|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
145404453|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
145543991|NCT00726232|524850541|FG004|Expansion Phase|Adverse Event|0|||
145543992|NCT00726232|524850542|FG005|Expansion Phase|Adverse Event|0|||
145543993|NCT00726232|524850543|FG006|Expansion Phase|Adverse Event|6|||
145543994|NCT00726232|524850544|FG007|Expansion Phase|Adverse Event|11|||
145543995|NCT00726232|524850537|FG000|Expansion Phase|Withdrawal by Subject|0|||
145543996|NCT00726232|524850538|FG001|Expansion Phase|Withdrawal by Subject|0|||
145404454|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
145543997|NCT00726232|524850539|FG002|Expansion Phase|Withdrawal by Subject|0|||
145543998|NCT00726232|524850540|FG003|Expansion Phase|Withdrawal by Subject|0|||
145404455|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
145404456|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
145404457|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
145404458|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
145404459|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
145404460|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
145404461|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
145404462|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
145543999|NCT00726232|524850541|FG004|Expansion Phase|Withdrawal by Subject|0|||
145544000|NCT00726232|524850542|FG005|Expansion Phase|Withdrawal by Subject|0|||
145544001|NCT00726232|524850543|FG006|Expansion Phase|Withdrawal by Subject|2|||
145544002|NCT00726232|524850544|FG007|Expansion Phase|Withdrawal by Subject|3|||
145544003|NCT00726232|524850537|FG000|Expansion Phase|Disease progression|0|||
145544004|NCT00726232|524850538|FG001|Expansion Phase|Disease progression|0|||
145544005|NCT00726232|524850539|FG002|Expansion Phase|Disease progression|0|||
145544006|NCT00726232|524850540|FG003|Expansion Phase|Disease progression|0|||
145544007|NCT00726232|524850541|FG004|Expansion Phase|Disease progression|0|||
145544008|NCT00726232|524850542|FG005|Expansion Phase|Disease progression|0|||
145544009|NCT00726232|524850543|FG006|Expansion Phase|Disease progression|4|||
145544010|NCT00726232|524850544|FG007|Expansion Phase|Disease progression|0|||
145544011|NCT00726232|524850537|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
145544012|NCT00726232|524850538|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
145544013|NCT00726232|524850539|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
145544014|NCT00726232|524850540|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
145544015|NCT00726232|524850541|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
145544016|NCT00726232|524850542|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
145544017|NCT00726232|524850543|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
145544018|NCT00726232|524850544|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
145544019|NCT00726232|524850537|FG000|Expansion Phase|Per Investigator: lack of response|0|||
145544020|NCT00726232|524850538|FG001|Expansion Phase|Per Investigator: lack of response|0|||
145544021|NCT00726232|524850539|FG002|Expansion Phase|Per Investigator: lack of response|0|||
145544022|NCT00726232|524850540|FG003|Expansion Phase|Per Investigator: lack of response|0|||
145544023|NCT00726232|524850541|FG004|Expansion Phase|Per Investigator: lack of response|0|||
145544024|NCT00726232|524850542|FG005|Expansion Phase|Per Investigator: lack of response|0|||
145544025|NCT00726232|524850543|FG006|Expansion Phase|Per Investigator: lack of response|1|||
145544026|NCT00726232|524850544|FG007|Expansion Phase|Per Investigator: lack of response|7|||
145544027|NCT00726232|524850537|FG000|Expansion Phase|Unspecified reason|0|||
145544028|NCT00726232|524850538|FG001|Expansion Phase|Unspecified reason|0|||
145544029|NCT00726232|524850539|FG002|Expansion Phase|Unspecified reason|0|||
145544030|NCT00726232|524850540|FG003|Expansion Phase|Unspecified reason|0|||
145544031|NCT00726232|524850541|FG004|Expansion Phase|Unspecified reason|0|||
145544032|NCT00726232|524850542|FG005|Expansion Phase|Unspecified reason|0|||
145544033|NCT00726232|524850543|FG006|Expansion Phase|Unspecified reason|1|||
145544034|NCT00726232|524850544|FG007|Expansion Phase|Unspecified reason|0|||
145544035|NCT03858309|524850545|FG000|Overall Study|Withdrawal by Subject|2|||
145544036|NCT03858309|524850546|FG001|Overall Study|Withdrawal by Subject|3|||
145544037|NCT03897465|524850555|FG000|Overall Study|Lost to Follow-up|2|||
145544038|NCT03897465|524850556|FG001|Overall Study|Lost to Follow-up|1|||
145544039|NCT03897465|524850555|FG000|Overall Study|Adverse Event|2|||
145544040|NCT03897465|524850556|FG001|Overall Study|Adverse Event|0|||
145544041|NCT03897465|524850555|FG000|Overall Study|complete healing by V2|1|||
145544042|NCT03897465|524850556|FG001|Overall Study|complete healing by V2|0|||
145544043|NCT03897465|524850555|FG000|Overall Study|occurence of exclusion criterion|1|||
145544044|NCT03897465|524850556|FG001|Overall Study|occurence of exclusion criterion|1|||
145544045|NCT03897465|524850555|FG000|Overall Study|Other|1|||
145544046|NCT03897465|524850556|FG001|Overall Study|Other|0|||
145544047|NCT02197247|524850559|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
145544048|NCT02197247|524850559|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
145544049|NCT02197247|524850559|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
145544050|NCT02197247|524850559|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
145544051|NCT02197247|524850559|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
145544052|NCT02197247|524850559|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
145544053|NCT02197247|524850559|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
145544054|NCT02197247|524850559|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
145544055|NCT00370032|524850563|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
145544056|NCT00370032|524850564|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
145544057|NCT00370032|524850563|FG000|Washout Period|Withdrawal by Subject|0|||
145544058|NCT00370032|524850564|FG001|Washout Period|Withdrawal by Subject|1|||
145544059|NCT00370032|524850563|FG000|Washout Period|Lost to Follow-up|0|||
145404463|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Other|10|||
145544060|NCT00370032|524850564|FG001|Washout Period|Lost to Follow-up|1|||
145544061|NCT00370032|524850563|FG000|Washout Period|Adverse Event|1|||
145544062|NCT00370032|524850564|FG001|Washout Period|Adverse Event|0|||
145544063|NCT00370032|524850563|FG000|Follow-up Period|Withdrawal by Subject|1|||
145544064|NCT00370032|524850564|FG001|Follow-up Period|Withdrawal by Subject|0|||
145544065|NCT02405780|524850572|FG000|Period I|Adverse Event|8|||
145544066|NCT02405780|524850573|FG001|Period I|Adverse Event|0|||
145544067|NCT02405780|524850574|FG002|Period I|Adverse Event|3|||
145544068|NCT02405780|524850575|FG003|Period I|Adverse Event|7|||
145544069|NCT02405780|524850572|FG000|Period I|Medical reasons|1|||
145544070|NCT02405780|524850573|FG001|Period I|Medical reasons|1|||
145544071|NCT02405780|524850574|FG002|Period I|Medical reasons|0|||
145544072|NCT02405780|524850575|FG003|Period I|Medical reasons|1|||
145544073|NCT02405780|524850572|FG000|Period I|Screening Failure|1|||
145544074|NCT02405780|524850573|FG001|Period I|Screening Failure|0|||
145404464|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Other|4|||
145404465|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Other|0|||
145404466|NCT04006457|524338610|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
145404467|NCT04006457|524338611|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
145404468|NCT04006457|524338612|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
145404469|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
145404470|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
145404471|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
145404472|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
145404473|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
145404474|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
145404475|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
145404476|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
145404477|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
145404478|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
145404479|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
145404480|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
145404481|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
145404482|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
145404483|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
145404484|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Other|2|||
145404485|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Other|3|||
145404486|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Other|0|||
145404487|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
145404488|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
145404489|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
145404490|NCT04006457|524338610|FG000|Main Study: Treatment Period 2|Ongoing|86|||
145404491|NCT04006457|524338611|FG001|Main Study: Treatment Period 2|Ongoing|96|||
145404492|NCT04006457|524338612|FG002|Main Study: Treatment Period 2|Ongoing|0|||
145404493|NCT04006457|524338610|FG000|Main Study Observation Period|Adverse Event|1|||
145404494|NCT04006457|524338611|FG001|Main Study Observation Period|Adverse Event|1|||
145404495|NCT04006457|524338612|FG002|Main Study Observation Period|Adverse Event|0|||
145404496|NCT04006457|524338610|FG000|Main Study Observation Period|Lost to Follow-up|0|||
145404497|NCT04006457|524338611|FG001|Main Study Observation Period|Lost to Follow-up|1|||
145404498|NCT04006457|524338612|FG002|Main Study Observation Period|Lost to Follow-up|0|||
145404499|NCT04006457|524338610|FG000|Main Study Observation Period|Pregnancy|1|||
145404500|NCT04006457|524338611|FG001|Main Study Observation Period|Pregnancy|0|||
145404501|NCT04006457|524338612|FG002|Main Study Observation Period|Pregnancy|0|||
145404502|NCT04006457|524338610|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
145404503|NCT04006457|524338611|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
145404504|NCT04006457|524338612|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
145404505|NCT04006457|524338610|FG000|Main Study Observation Period|Other|8|||
145404506|NCT04006457|524338611|FG001|Main Study Observation Period|Other|16|||
145404507|NCT04006457|524338612|FG002|Main Study Observation Period|Other|0|||
145404508|NCT04006457|524338610|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
145404509|NCT04006457|524338611|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
145404510|NCT04006457|524338612|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
145544075|NCT02405780|524850574|FG002|Period I|Screening Failure|1|||
145544076|NCT02405780|524850575|FG003|Period I|Screening Failure|0|||
145544077|NCT02405780|524850572|FG000|Period I|Withdrawal by Subject|9|||
145544078|NCT02405780|524850573|FG001|Period I|Withdrawal by Subject|1|||
145544079|NCT02405780|524850574|FG002|Period I|Withdrawal by Subject|3|||
145544080|NCT02405780|524850575|FG003|Period I|Withdrawal by Subject|4|||
145544081|NCT02405780|524850572|FG000|Period I|Non-compliance with study procedures|8|||
145544082|NCT02405780|524850573|FG001|Period I|Non-compliance with study procedures|6|||
145544083|NCT02405780|524850574|FG002|Period I|Non-compliance with study procedures|8|||
145544084|NCT02405780|524850575|FG003|Period I|Non-compliance with study procedures|11|||
145544085|NCT02405780|524850572|FG000|Period II|Adverse Event|3|||
145544086|NCT02405780|524850573|FG001|Period II|Adverse Event|5|||
145544087|NCT02405780|524850574|FG002|Period II|Adverse Event|4|||
145544088|NCT02405780|524850575|FG003|Period II|Adverse Event|11|||
145544089|NCT02405780|524850572|FG000|Period II|Medical reason|0|||
145544090|NCT02405780|524850573|FG001|Period II|Medical reason|1|||
145544091|NCT02405780|524850574|FG002|Period II|Medical reason|0|||
145544092|NCT02405780|524850575|FG003|Period II|Medical reason|0|||
145544093|NCT02405780|524850572|FG000|Period II|Pregnancy|0|||
145544094|NCT02405780|524850573|FG001|Period II|Pregnancy|0|||
145544095|NCT02405780|524850574|FG002|Period II|Pregnancy|1|||
145544096|NCT02405780|524850575|FG003|Period II|Pregnancy|0|||
145544097|NCT02405780|524850572|FG000|Period II|Withdrawal by Subject|7|||
145544098|NCT02405780|524850573|FG001|Period II|Withdrawal by Subject|4|||
145544099|NCT02405780|524850574|FG002|Period II|Withdrawal by Subject|0|||
145544100|NCT02405780|524850575|FG003|Period II|Withdrawal by Subject|3|||
145544101|NCT02405780|524850572|FG000|Period II|Non-compliance with study procedures|5|||
145544102|NCT02405780|524850573|FG001|Period II|Non-compliance with study procedures|2|||
145544103|NCT02405780|524850574|FG002|Period II|Non-compliance with study procedures|7|||
145544104|NCT02405780|524850575|FG003|Period II|Non-compliance with study procedures|4|||
145544105|NCT04502693|524850577|FG000|Overall Study|Adverse Event|7|||
145544106|NCT04502693|524850578|FG001|Overall Study|Adverse Event|6|||
145544107|NCT04502693|524850579|FG002|Overall Study|Adverse Event|11|||
145544108|NCT04502693|524850580|FG003|Overall Study|Adverse Event|1|||
145544109|NCT04502693|524850577|FG000|Overall Study|Lost to Follow-up|32|||
145544110|NCT04502693|524850578|FG001|Overall Study|Lost to Follow-up|36|||
145544111|NCT04502693|524850579|FG002|Overall Study|Lost to Follow-up|69|||
145544112|NCT04502693|524850580|FG003|Overall Study|Lost to Follow-up|4|||
145544113|NCT04502693|524850577|FG000|Overall Study|Protocol Violation|8|||
145544114|NCT04502693|524850578|FG001|Overall Study|Protocol Violation|8|||
145544115|NCT04502693|524850579|FG002|Overall Study|Protocol Violation|16|||
145544116|NCT04502693|524850580|FG003|Overall Study|Protocol Violation|1|||
145544117|NCT04502693|524850577|FG000|Overall Study|Withdrawal by Subject|46|||
145544118|NCT04502693|524850578|FG001|Overall Study|Withdrawal by Subject|38|||
145544119|NCT04502693|524850579|FG002|Overall Study|Withdrawal by Subject|54|||
145544120|NCT04502693|524850580|FG003|Overall Study|Withdrawal by Subject|7|||
145544121|NCT04502693|524850577|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
145544122|NCT04502693|524850578|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
145544123|NCT04502693|524850579|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
145544124|NCT04502693|524850580|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145544125|NCT04502693|524850577|FG000|Overall Study|Other|1|||
145544126|NCT04502693|524850578|FG001|Overall Study|Other|0|||
145544127|NCT04502693|524850579|FG002|Overall Study|Other|1|||
145544128|NCT04502693|524850580|FG003|Overall Study|Other|1|||
145544129|NCT00602797|524850581|FG000|Overall Study|Adverse Event|1|||
145544130|NCT03736447|524850584|FG000|Overall Study|Adverse Event|5|||
145544131|NCT03736447|524850585|FG001|Overall Study|Adverse Event|1|||
145544132|NCT03736447|524850584|FG000|Overall Study|Withdrawal by Subject|5|||
145544133|NCT03736447|524850585|FG001|Overall Study|Withdrawal by Subject|1|||
145544134|NCT03736447|524850584|FG000|Overall Study|Lost to Follow-up|1|||
145544135|NCT03736447|524850585|FG001|Overall Study|Lost to Follow-up|0|||
145544136|NCT03736447|524850584|FG000|Overall Study|Physician Decision|1|||
145544137|NCT03736447|524850585|FG001|Overall Study|Physician Decision|0|||
145544138|NCT03736447|524850584|FG000|Overall Study|Continued commitment to study treatment|3|||
145544139|NCT03736447|524850585|FG001|Overall Study|Continued commitment to study treatment|0|||
145544140|NCT03736447|524850584|FG000|Overall Study|Taste aversion to study product|0|||
145544141|NCT03736447|524850585|FG001|Overall Study|Taste aversion to study product|1|||
145544142|NCT02784431|524850586|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
145544143|NCT02784431|524850586|FG000|Overall Study|Early Study Termination|19|||
145544144|NCT02605824|524850587|FG000|Overall Study|Physician Decision|1|||
145544145|NCT02605824|524850588|FG001|Overall Study|Physician Decision|0|||
145544146|NCT04875195|524850589|FG000|Overall Study|Death|9|||
145544147|NCT04875195|524850590|FG001|Overall Study|Death|3|||
145544148|NCT04875195|524850589|FG000|Overall Study|Withdrawal by Subject|2|||
145544149|NCT04875195|524850590|FG001|Overall Study|Withdrawal by Subject|1|||
145544150|NCT04875195|524850589|FG000|Overall Study|Ongoing in study|49|||
145544151|NCT04875195|524850590|FG001|Overall Study|Ongoing in study|2|||
145544152|NCT00074152|524850591|FG000|Overall Study|Death|21|||
145544153|NCT00074152|524850592|FG001|Overall Study|Death|9|||
145544154|NCT00074152|524850591|FG000|Overall Study|Lack of Efficacy|34|||
145544155|NCT00074152|524850592|FG001|Overall Study|Lack of Efficacy|24|||
145544156|NCT01594762|524850596|FG000|Overall Study|Withdrawal by Subject|1|||
145544157|NCT01594762|524850597|FG001|Overall Study|Withdrawal by Subject|0|||
145544158|NCT01594762|524850596|FG000|Overall Study|Lost to Follow-up|10|||
145544159|NCT01594762|524850597|FG001|Overall Study|Lost to Follow-up|10|||
145544160|NCT00382252|524850598|FG000|Overall Study|Death|4|||
145544161|NCT00382252|524850598|FG000|Overall Study|Protocol Violation|8|||
145544162|NCT00382252|524850598|FG000|Overall Study|Not treated by RFA|1|||
145544163|NCT02612727|524850599|FG000|Overall Study|Parent request|4|||
145544164|NCT02612727|524850600|FG001|Overall Study|Parent request|1|||
145544165|NCT02612727|524850599|FG000|Overall Study|Needed treatment incompatible with PT|1|||
145544166|NCT02612727|524850600|FG001|Overall Study|Needed treatment incompatible with PT|1|||
145544167|NCT02612727|524850599|FG000|Overall Study|Direct hyperbilirubinemia|0|||
145544168|NCT02612727|524850600|FG001|Overall Study|Direct hyperbilirubinemia|2|||
145544169|NCT01095731|524850601|FG000|Overall Study|Protocol Violation|1|||
145544170|NCT01095731|524850602|FG001|Overall Study|Protocol Violation|1|||
145544171|NCT01095731|524850601|FG000|Overall Study|Withdrawal by Subject|0|||
145544172|NCT01095731|524850602|FG001|Overall Study|Withdrawal by Subject|1|||
145544173|NCT01446289|524850603|FG000|Overall Study|Withdrawal by Subject|1|||
145544174|NCT01446289|524850604|FG001|Overall Study|Withdrawal by Subject|0|||
145544175|NCT01446289|524850605|FG002|Overall Study|Withdrawal by Subject|1|||
145544176|NCT01446289|524850606|FG003|Overall Study|Withdrawal by Subject|0|||
145544177|NCT03329573|524850607|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
145544178|NCT03329573|524850608|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
145544179|NCT03329573|524850609|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
145544180|NCT03329573|524850610|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
145544181|NCT03329573|524850607|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
145544182|NCT03329573|524850608|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
145544183|NCT03329573|524850609|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145544184|NCT03329573|524850610|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145544185|NCT03329573|524850607|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
145544186|NCT03329573|524850608|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
145544187|NCT03329573|524850609|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
145544188|NCT03329573|524850610|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
145544189|NCT03329573|524850607|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
145544190|NCT03329573|524850608|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
145544191|NCT03329573|524850609|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
145544192|NCT03329573|524850610|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
145544193|NCT02777333|524850611|FG000|Overall Study|Withdrawal by Subject|0|||
145544194|NCT02777333|524850612|FG001|Overall Study|Withdrawal by Subject|1|||
145544195|NCT02777333|524850611|FG000|Overall Study|Lost to Follow-up|0|||
145544196|NCT02777333|524850612|FG001|Overall Study|Lost to Follow-up|1|||
145544197|NCT00837811|524850613|FG000|Overall Study|Adverse Event|4|||
145544198|NCT00837811|524850614|FG001|Overall Study|Adverse Event|6|||
145544199|NCT00837811|524850615|FG002|Overall Study|Adverse Event|0|||
145544200|NCT00837811|524850613|FG000|Overall Study|Death|1|||
145544201|NCT00837811|524850614|FG001|Overall Study|Death|1|||
145544202|NCT00837811|524850615|FG002|Overall Study|Death|0|||
145544203|NCT00837811|524850613|FG000|Overall Study|Lack of Efficacy|0|||
145544204|NCT00837811|524850614|FG001|Overall Study|Lack of Efficacy|11|||
145544205|NCT00837811|524850615|FG002|Overall Study|Lack of Efficacy|0|||
145544206|NCT00837811|524850613|FG000|Overall Study|Lost to Follow-up|1|||
145544207|NCT00837811|524850614|FG001|Overall Study|Lost to Follow-up|3|||
145544208|NCT00837811|524850615|FG002|Overall Study|Lost to Follow-up|0|||
145544209|NCT00837811|524850613|FG000|Overall Study|Physician Decision|0|||
145544210|NCT00837811|524850614|FG001|Overall Study|Physician Decision|2|||
145544211|NCT00837811|524850615|FG002|Overall Study|Physician Decision|1|||
145544212|NCT00837811|524850613|FG000|Overall Study|Withdrawal by Subject|1|||
145544213|NCT00837811|524850614|FG001|Overall Study|Withdrawal by Subject|9|||
145544214|NCT00837811|524850615|FG002|Overall Study|Withdrawal by Subject|0|||
145544215|NCT00837811|524850613|FG000|Overall Study|Sponsor Decision|0|||
145544216|NCT00837811|524850614|FG001|Overall Study|Sponsor Decision|2|||
145544217|NCT00837811|524850615|FG002|Overall Study|Sponsor Decision|0|||
145544218|NCT02578316|524850616|FG000|Extension Phase|Progression of disease|6|||
145544219|NCT05243641|524850620|FG000|Overall Study|Adverse Event|3|||
145544220|NCT05243641|524850621|FG001|Overall Study|Adverse Event|0|||
145544221|NCT05243641|524850622|FG002|Overall Study|Adverse Event|0|||
145544222|NCT05243641|524850623|FG003|Overall Study|Adverse Event|1|||
145544223|NCT05243641|524850624|FG004|Overall Study|Adverse Event|0|||
145544224|NCT05243641|524850625|FG005|Overall Study|Adverse Event|0|||
145544225|NCT05243641|524850620|FG000|Overall Study|Disease progression|4|||
145544226|NCT05243641|524850621|FG001|Overall Study|Disease progression|0|||
145544227|NCT05243641|524850622|FG002|Overall Study|Disease progression|0|||
145544228|NCT05243641|524850623|FG003|Overall Study|Disease progression|2|||
145544229|NCT05243641|524850624|FG004|Overall Study|Disease progression|0|||
145544230|NCT05243641|524850625|FG005|Overall Study|Disease progression|0|||
145544231|NCT04698187|524850629|FG000|Overall Study|Withdrawal by Subject|7|||
145610426|NCT02318719|525089797|FG000|Double-blind Phase|Protocol Violation|0|||
145610427|NCT02318719|525089798|FG001|Double-blind Phase|Protocol Violation|1|||
145610428|NCT02318719|525089799|FG002|Double-blind Phase|Protocol Violation|3|||
145610429|NCT02318719|525089800|FG003|Double-blind Phase|Protocol Violation|0|||
145610430|NCT02318719|525089801|FG004|Double-blind Phase|Protocol Violation|0|||
145610431|NCT02318719|525089797|FG000|Double-blind Phase|Withdrawal by Subject|25|||
145610432|NCT02318719|525089798|FG001|Double-blind Phase|Withdrawal by Subject|7|||
145610433|NCT02318719|525089799|FG002|Double-blind Phase|Withdrawal by Subject|9|||
145610434|NCT02318719|525089800|FG003|Double-blind Phase|Withdrawal by Subject|10|||
145610435|NCT02318719|525089801|FG004|Double-blind Phase|Withdrawal by Subject|0|||
145610436|NCT02318719|525089797|FG000|Double-blind Phase|Other|1|||
145610437|NCT02318719|525089798|FG001|Double-blind Phase|Other|2|||
145610438|NCT02318719|525089799|FG002|Double-blind Phase|Other|0|||
145610439|NCT02318719|525089800|FG003|Double-blind Phase|Other|0|||
145610440|NCT02318719|525089801|FG004|Double-blind Phase|Other|0|||
145610441|NCT02318719|525089797|FG000|Open-label Extension Phase|Adverse Event|0|||
145610442|NCT02318719|525089798|FG001|Open-label Extension Phase|Adverse Event|0|||
145610443|NCT02318719|525089799|FG002|Open-label Extension Phase|Adverse Event|0|||
145610444|NCT02318719|525089800|FG003|Open-label Extension Phase|Adverse Event|0|||
145610445|NCT02318719|525089801|FG004|Open-label Extension Phase|Adverse Event|15|||
145404511|NCT04006457|524338610|FG000|Main Study Observation Period|Ongoing|2|||
145404512|NCT04006457|524338611|FG001|Main Study Observation Period|Ongoing|1|||
145404513|NCT04006457|524338612|FG002|Main Study Observation Period|Ongoing|0|||
145610446|NCT02318719|525089797|FG000|Open-label Extension Phase|Death|0|||
145610447|NCT02318719|525089798|FG001|Open-label Extension Phase|Death|0|||
145610448|NCT02318719|525089799|FG002|Open-label Extension Phase|Death|0|||
145610449|NCT02318719|525089800|FG003|Open-label Extension Phase|Death|0|||
145610450|NCT02318719|525089801|FG004|Open-label Extension Phase|Death|1|||
145610451|NCT02318719|525089797|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
145610452|NCT02318719|525089798|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
145610453|NCT02318719|525089799|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
145610454|NCT02318719|525089800|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
145610455|NCT02318719|525089801|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
145610456|NCT02318719|525089797|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
145544232|NCT04698187|524850629|FG000|Overall Study|Death|21|||
145544233|NCT04698187|524850629|FG000|Overall Study|Sponsor Decision|15|||
145544234|NCT04698187|524850629|FG000|Overall Study|In-transit Disease|1|||
145544235|NCT03820986|524850630|FG000|Overall Study|Death|201|||
145544236|NCT03820986|524850631|FG001|Overall Study|Death|175|||
145544237|NCT03820986|524850630|FG000|Overall Study|Lost to Follow-up|1|||
145544238|NCT03820986|524850631|FG001|Overall Study|Lost to Follow-up|1|||
145544239|NCT03820986|524850630|FG000|Overall Study|Physician Decision|1|||
145544240|NCT03820986|524850631|FG001|Overall Study|Physician Decision|0|||
145544241|NCT03820986|524850630|FG000|Overall Study|Sponsor Decision|122|||
145544242|NCT03820986|524850631|FG001|Overall Study|Sponsor Decision|160|||
145544243|NCT03820986|524850630|FG000|Overall Study|Withdrawal by Subject|9|||
145544244|NCT03820986|524850631|FG001|Overall Study|Withdrawal by Subject|4|||
145544245|NCT02993146|524850632|FG000|Overall Study|Withdrawal by Subject|0|||
145544246|NCT02993146|524850633|FG001|Overall Study|Withdrawal by Subject|0|||
145544247|NCT02993146|524850634|FG002|Overall Study|Withdrawal by Subject|1|||
145544248|NCT02993146|524850635|FG003|Overall Study|Withdrawal by Subject|1|||
145544249|NCT04526665|524850638|FG000|Overall Study|Withdrawal by Subject|6|||
145544250|NCT04526665|524850639|FG001|Overall Study|Withdrawal by Subject|3|||
145544251|NCT04526665|524850638|FG000|Overall Study|Adverse Event|4|||
145544252|NCT04526665|524850639|FG001|Overall Study|Adverse Event|1|||
145544253|NCT04526665|524850638|FG000|Overall Study|Physician Decision|2|||
145544254|NCT04526665|524850639|FG001|Overall Study|Physician Decision|2|||
145544255|NCT04526665|524850638|FG000|Overall Study|Death|2|||
145544256|NCT04526665|524850639|FG001|Overall Study|Death|0|||
145544257|NCT04526665|524850638|FG000|Overall Study|Other|0|||
145544258|NCT04526665|524850639|FG001|Overall Study|Other|1|||
145544259|NCT04524689|524850640|FG000|Overall Study|Withdrawal by Subject|1|||
145544260|NCT04524689|524850641|FG001|Overall Study|Withdrawal by Subject|1|||
145544261|NCT04524689|524850642|FG002|Overall Study|Withdrawal by Subject|0|||
145544262|NCT04524689|524850643|FG003|Overall Study|Withdrawal by Subject|0|||
145404514|NCT04006457|524338610|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
145404515|NCT04006457|524338611|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
145610457|NCT02318719|525089798|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
145610458|NCT02318719|525089799|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
145610459|NCT02318719|525089800|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
145610460|NCT02318719|525089801|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
145544263|NCT04524689|524850644|FG004|Overall Study|Withdrawal by Subject|2|||
145544264|NCT04524689|524850645|FG005|Overall Study|Withdrawal by Subject|0|||
145544265|NCT04524689|524850640|FG000|Overall Study|Study terminated by Sponsor|6|||
145610461|NCT02318719|525089797|FG000|Open-label Extension Phase|Other|0|||
145404516|NCT04006457|524338612|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
145544266|NCT04524689|524850641|FG001|Overall Study|Study terminated by Sponsor|0|||
145610462|NCT02318719|525089798|FG001|Open-label Extension Phase|Other|0|||
145544267|NCT04524689|524850642|FG002|Overall Study|Study terminated by Sponsor|1|||
145544268|NCT04524689|524850643|FG003|Overall Study|Study terminated by Sponsor|0|||
145544269|NCT04524689|524850644|FG004|Overall Study|Study terminated by Sponsor|4|||
145544270|NCT04524689|524850645|FG005|Overall Study|Study terminated by Sponsor|0|||
145544271|NCT04524689|524850640|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
145544272|NCT04524689|524850641|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
145544273|NCT04524689|524850642|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
145544274|NCT04524689|524850643|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
145544275|NCT04524689|524850644|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
145544276|NCT04524689|524850645|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
145544277|NCT04292743|524850646|FG000|Overall Study|Physician Decision|1|||
145544278|NCT04292743|524850647|FG001|Overall Study|Physician Decision|3|||
145544279|NCT04292743|524850648|FG002|Overall Study|Physician Decision|0|||
145544280|NCT04292743|524850649|FG003|Overall Study|Physician Decision|0|||
145544281|NCT04292743|524850646|FG000|Overall Study|Withdrawal by Subject|0|||
145544282|NCT04292743|524850647|FG001|Overall Study|Withdrawal by Subject|5|||
145544283|NCT04292743|524850648|FG002|Overall Study|Withdrawal by Subject|0|||
145544284|NCT04292743|524850649|FG003|Overall Study|Withdrawal by Subject|0|||
145544285|NCT04292743|524850646|FG000|Overall Study|Death|0|||
145544286|NCT04292743|524850647|FG001|Overall Study|Death|1|||
145544287|NCT04292743|524850648|FG002|Overall Study|Death|0|||
145544288|NCT04292743|524850649|FG003|Overall Study|Death|0|||
145544289|NCT04292743|524850646|FG000|Overall Study|Progression of Disease|2|||
145544290|NCT04292743|524850647|FG001|Overall Study|Progression of Disease|5|||
145544291|NCT04292743|524850648|FG002|Overall Study|Progression of Disease|0|||
145544292|NCT04292743|524850649|FG003|Overall Study|Progression of Disease|0|||
145544293|NCT04292743|524850646|FG000|Overall Study|No Treatment per protocol|0|||
145544294|NCT04292743|524850647|FG001|Overall Study|No Treatment per protocol|2|||
145544295|NCT04292743|524850648|FG002|Overall Study|No Treatment per protocol|0|||
145544296|NCT04292743|524850649|FG003|Overall Study|No Treatment per protocol|0|||
145544297|NCT05766423|524850650|FG000|Overall Study|Withdrawal by Subject|1|||
145544298|NCT05766423|524850651|FG001|Overall Study|Withdrawal by Subject|0|||
145544299|NCT05766423|524850650|FG000|Overall Study|Consented, not scheduled|3|||
145544300|NCT05766423|524850651|FG001|Overall Study|Consented, not scheduled|5|||
145544301|NCT00844831|524853010|FG000|Overall Study|Withdrawal by Subject|4|||
145544302|NCT00844831|524853010|FG000|Overall Study|Adverse Event|1|||
145544303|NCT00844831|524853010|FG000|Overall Study|Physician Decision|1|||
145544304|NCT05255068|524853011|FG000|Overall Study|Lost to Follow-up|0|||
145544305|NCT05255068|524853012|FG001|Overall Study|Lost to Follow-up|1|||
145544306|NCT00540514|524853014|FG000|Overall Study|Still on treatment|3|||
145544307|NCT00540514|524853015|FG001|Overall Study|Still on treatment|0|||
145544308|NCT00540514|524853014|FG000|Overall Study|Unacceptable Toxicity|61|||
145544309|NCT00540514|524853015|FG001|Overall Study|Unacceptable Toxicity|62|||
145544310|NCT00540514|524853014|FG000|Overall Study|Adverse Event|20|||
145544311|NCT00540514|524853015|FG001|Overall Study|Adverse Event|24|||
145544312|NCT00540514|524853014|FG000|Overall Study|Physician Decision|86|||
145544313|NCT00540514|524853015|FG001|Overall Study|Physician Decision|99|||
145544314|NCT00540514|524853014|FG000|Overall Study|Protocol Deviation|3|||
145544315|NCT00540514|524853015|FG001|Overall Study|Protocol Deviation|4|||
145544316|NCT00540514|524853014|FG000|Overall Study|Lost to Follow-up|1|||
145544317|NCT00540514|524853015|FG001|Overall Study|Lost to Follow-up|1|||
145544318|NCT00540514|524853014|FG000|Overall Study|Withdrawal by Subject|65|||
145544319|NCT00540514|524853015|FG001|Overall Study|Withdrawal by Subject|67|||
145544320|NCT00540514|524853014|FG000|Overall Study|Excluded prior to treatment|7|||
145544321|NCT00540514|524853015|FG001|Overall Study|Excluded prior to treatment|7|||
145544322|NCT00540514|524853014|FG000|Overall Study|Paclitaxel not available|0|||
145544323|NCT00540514|524853015|FG001|Overall Study|Paclitaxel not available|2|||
145544324|NCT04487730|524853016|FG000|Overall Study|Withdrawal by Subject|3|||
145544325|NCT04487730|524853017|FG001|Overall Study|Withdrawal by Subject|1|||
145544326|NCT04487730|524853016|FG000|Overall Study|Lost to Follow-up|0|||
145544327|NCT04487730|524853017|FG001|Overall Study|Lost to Follow-up|1|||
145544328|NCT04487730|524853016|FG000|Overall Study|Physician Decision|0|||
145544329|NCT04487730|524853017|FG001|Overall Study|Physician Decision|1|||
145544330|NCT00907777|524853018|FG000|Overall Study|Withdrawal by Subject|0|||
145544331|NCT00907777|524853019|FG001|Overall Study|Withdrawal by Subject|1|||
145544332|NCT03364023|524853022|FG000|Overall Study|Lost to Follow-up|3|||
145544333|NCT03364023|524853022|FG000|Overall Study|Death|14|||
145544334|NCT04115839|524853028|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
145544335|NCT04115839|524853029|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
145544336|NCT04115839|524853030|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
145544337|NCT04115839|524853031|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
145544338|NCT04115839|524853032|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
145544339|NCT04115839|524853033|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
145544340|NCT04115839|524853034|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
145610463|NCT02318719|525089799|FG002|Open-label Extension Phase|Other|0|||
145544341|NCT04115839|524853028|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
145544342|NCT04115839|524853029|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
145544343|NCT04115839|524853030|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
145544344|NCT04115839|524853031|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
145544345|NCT04115839|524853032|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
145544346|NCT04115839|524853033|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
145544347|NCT04115839|524853034|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
145544348|NCT04115839|524853028|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
145544349|NCT04115839|524853029|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544350|NCT04115839|524853030|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544351|NCT04115839|524853031|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544352|NCT04115839|524853032|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544353|NCT04115839|524853033|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544354|NCT04115839|524853034|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
145544355|NCT04115839|524853028|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544356|NCT04115839|524853029|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544357|NCT04115839|524853030|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
145544358|NCT04115839|524853031|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544359|NCT04115839|524853032|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544360|NCT04115839|524853033|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544361|NCT04115839|524853034|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
145544362|NCT04115839|524853028|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
145544363|NCT04115839|524853029|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
145544364|NCT04115839|524853030|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
145544365|NCT04115839|524853031|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
145544366|NCT04115839|524853032|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
145544367|NCT04115839|524853033|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
145544368|NCT04115839|524853034|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
145544369|NCT04115839|524853028|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
145544370|NCT04115839|524853029|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
145544371|NCT04115839|524853030|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
145544372|NCT04115839|524853031|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
145544373|NCT04115839|524853032|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
145544374|NCT04115839|524853033|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
145544375|NCT04115839|524853034|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
145544376|NCT00621985|524853035|FG000|Dexamethasone Admission|Adverse Event|1|||
145544377|NCT03808545|524853038|FG000|Overall Study|Withdrawal by Subject|1|||
145610464|NCT02318719|525089800|FG003|Open-label Extension Phase|Other|0|||
145610465|NCT02318719|525089801|FG004|Open-label Extension Phase|Other|7|||
145610466|NCT00432835|525089805|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
145610467|NCT00432835|525089806|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
145610468|NCT00289770|525089807|FG000|Year 15|Withdrawal by Subject|1|||
145610469|NCT00423293|525089808|FG000|Overall Study|Ineligible / No protocol treatment|11|||
145610470|NCT05340751|525089817|FG000|Overall Study|Physician Decision|3|||
145610471|NCT04399551|525089818|FG000|Overall Study|Adverse Event|15|||
145610472|NCT04399551|525089818|FG000|Overall Study|Withdrawal by Subject|6|||
145610473|NCT04399551|525089818|FG000|Overall Study|Physician Decision|3|||
145610474|NCT04399551|525089818|FG000|Overall Study|Lost to Follow-up|2|||
145610475|NCT04399551|525089818|FG000|Overall Study|Protocol Deviation|2|||
145610476|NCT01014975|525089820|FG000|Overall Study|Withdrawal by Subject|1|||
145610477|NCT01014975|525089821|FG001|Overall Study|Withdrawal by Subject|0|||
145610478|NCT01014975|525089822|FG002|Overall Study|Withdrawal by Subject|1|||
145610479|NCT01014975|525089820|FG000|Overall Study|Death|3|||
145282485|NCT03705169|523883148|FG009|Overall Study|Concerns about study visit compliance|0|||
145610480|NCT01014975|525089821|FG001|Overall Study|Death|3|||
145610481|NCT01014975|525089822|FG002|Overall Study|Death|4|||
145610482|NCT01014975|525089820|FG000|Overall Study|Lost to Follow-up|0|||
145282486|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
145610483|NCT01014975|525089821|FG001|Overall Study|Lost to Follow-up|0|||
145610484|NCT01014975|525089822|FG002|Overall Study|Lost to Follow-up|1|||
145610485|NCT01336634|525089825|FG000|Overall Study|Study closed/terminated|5|||
145404517|NCT03729362|524338613|FG000|Overall Study|Withdrawal by Subject|2|||
145404518|NCT03729362|524338614|FG001|Overall Study|Withdrawal by Subject|0|||
145610486|NCT01336634|525089826|FG001|Overall Study|Study closed/terminated|6|||
145544378|NCT03808545|524853039|FG001|Overall Study|Withdrawal by Subject|1|||
145610487|NCT01336634|525089827|FG002|Overall Study|Study closed/terminated|6|||
145610488|NCT01336634|525089825|FG000|Overall Study|Lost to Follow-up|2|||
145610489|NCT01336634|525089826|FG001|Overall Study|Lost to Follow-up|1|||
145610490|NCT01336634|525089827|FG002|Overall Study|Lost to Follow-up|1|||
145610491|NCT01336634|525089825|FG000|Overall Study|Physician Decision|1|||
145610492|NCT01336634|525089826|FG001|Overall Study|Physician Decision|1|||
145610493|NCT01336634|525089827|FG002|Overall Study|Physician Decision|0|||
145610494|NCT01336634|525089825|FG000|Overall Study|Withdrawal by Subject|6|||
145610495|NCT01336634|525089826|FG001|Overall Study|Withdrawal by Subject|0|||
145610496|NCT01336634|525089827|FG002|Overall Study|Withdrawal by Subject|2|||
145610497|NCT01112514|525089828|FG000|Overall Study|Lost to Follow-up|1|||
145610498|NCT03321006|525089839|FG000|Overall Study|Death|1|||
145610499|NCT03321006|525089840|FG001|Overall Study|Death|0|||
145610500|NCT03321006|525089839|FG000|Overall Study|Lack of Efficacy|1|||
145610501|NCT03321006|525089840|FG001|Overall Study|Lack of Efficacy|0|||
145610502|NCT02567825|525089843|FG000|Overall Study|No follow-up post-randomization|5|||
145610503|NCT02567825|525089844|FG001|Overall Study|No follow-up post-randomization|1|||
145544379|NCT01408485|524853040|FG000|Overall Study|Withdrawal by Subject|21|||
145544380|NCT00618072|524853041|FG000|Overall Study|Lost to Follow-up|2|||
145544381|NCT00618072|524853042|FG001|Overall Study|Lost to Follow-up|0|||
145544382|NCT00618072|524853043|FG002|Overall Study|Lost to Follow-up|3|||
145544383|NCT00618072|524853041|FG000|Overall Study|Physician Decision|0|||
145544384|NCT00618072|524853042|FG001|Overall Study|Physician Decision|1|||
145544385|NCT00618072|524853043|FG002|Overall Study|Physician Decision|1|||
145544386|NCT02151591|524853044|FG000|Overall Study|Lost to Follow-up|6|||
145544387|NCT02151591|524853045|FG001|Overall Study|Lost to Follow-up|3|||
145544388|NCT03555591|524853048|FG000|Overall Study|Protocol Violation|77|||
145544389|NCT03633695|524853049|FG000|Overall Study|Lost to Follow-up|4|||
145544390|NCT03633695|524853050|FG001|Overall Study|Lost to Follow-up|5|||
145544391|NCT03633695|524853049|FG000|Overall Study|Discontinued|8|||
145544392|NCT03633695|524853050|FG001|Overall Study|Discontinued|4|||
145544393|NCT03130257|524853060|FG000|Overall Study|Withdrawal by Subject|1|||
145610504|NCT02567825|525089843|FG000|Overall Study|Follow-up less than 23 months|16|||
145610505|NCT02567825|525089844|FG001|Overall Study|Follow-up less than 23 months|20|||
145610506|NCT04741802|525089845|FG000|Overall Study|Death|1|||
145610507|NCT04741802|525089845|FG000|Overall Study|Lost to Follow-up|11|||
145610508|NCT03101241|525089847|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
145610509|NCT03101241|525089848|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
145610510|NCT03101241|525089847|FG000|Overall Study|Participant withdrew consent|3|||
145610511|NCT03101241|525089848|FG001|Overall Study|Participant withdrew consent|1|||
145610512|NCT03101241|525089847|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
145610513|NCT03101241|525089848|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
145610514|NCT03101241|525089847|FG000|Overall Study|Lost to Follow-up|2|||
145610515|NCT03101241|525089848|FG001|Overall Study|Lost to Follow-up|0|||
145610516|NCT03101241|525089847|FG000|Overall Study|Lack of Efficacy|0|||
145610517|NCT03101241|525089848|FG001|Overall Study|Lack of Efficacy|1|||
145610518|NCT03101241|525089847|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
145544394|NCT03130257|524853061|FG001|Overall Study|Withdrawal by Subject|0|||
145544395|NCT03130257|524853062|FG002|Overall Study|Withdrawal by Subject|2|||
145544396|NCT01438957|524853066|FG000|Overall Study|Physician Decision|1|||
145404519|NCT03729362|524338613|FG000|Overall Study|Physician Decision|1|||
145610519|NCT03101241|525089848|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
145610520|NCT04498247|525089849|FG000|Overall Study|Lost to Follow-up|0|||
145610521|NCT04498247|525089850|FG001|Overall Study|Lost to Follow-up|0|||
145610522|NCT04498247|525089851|FG002|Overall Study|Lost to Follow-up|0|||
145610523|NCT04498247|525089852|FG003|Overall Study|Lost to Follow-up|1|||
145544397|NCT01438957|524853067|FG001|Overall Study|Physician Decision|1|||
145544398|NCT01438957|524853068|FG002|Overall Study|Physician Decision|0|||
145610524|NCT04498247|525089853|FG004|Overall Study|Lost to Follow-up|0|||
145610525|NCT04498247|525089854|FG005|Overall Study|Lost to Follow-up|0|||
145610526|NCT04498247|525089855|FG006|Overall Study|Lost to Follow-up|0|||
145610527|NCT04498247|525089856|FG007|Overall Study|Lost to Follow-up|0|||
145404520|NCT03729362|524338614|FG001|Overall Study|Physician Decision|0|||
145404521|NCT03729362|524338613|FG000|Overall Study|COVID-19 Pandemic|1|||
145404522|NCT03729362|524338614|FG001|Overall Study|COVID-19 Pandemic|0|||
145404523|NCT03729362|524338613|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
145404524|NCT03729362|524338614|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
145404525|NCT03729362|524338613|FG000|Overall Study|Adverse Event|0|||
145404526|NCT03729362|524338614|FG001|Overall Study|Adverse Event|1|||
145544399|NCT01438957|524853069|FG003|Overall Study|Physician Decision|1|||
145544400|NCT01438957|524853070|FG004|Overall Study|Physician Decision|0|||
145544401|NCT00601458|524853073|FG000|Overall Study|Dosing Error|1|||
145544402|NCT00601458|524853074|FG001|Overall Study|Dosing Error|0|||
145544403|NCT00601458|524853075|FG002|Overall Study|Dosing Error|0|||
145544404|NCT00601458|524853073|FG000|Overall Study|Incomplete Data|0|||
145544405|NCT00601458|524853074|FG001|Overall Study|Incomplete Data|2|||
145544406|NCT00601458|524853075|FG002|Overall Study|Incomplete Data|0|||
145544407|NCT00601458|524853073|FG000|Overall Study|Protocol Violation|3|||
145544408|NCT00601458|524853074|FG001|Overall Study|Protocol Violation|2|||
145544409|NCT00601458|524853075|FG002|Overall Study|Protocol Violation|1|||
145544410|NCT00601458|524853073|FG000|Overall Study|Early Termination|0|||
145544411|NCT00601458|524853074|FG001|Overall Study|Early Termination|1|||
145544412|NCT00601458|524853075|FG002|Overall Study|Early Termination|1|||
145544413|NCT00518986|524853076|FG000|Overall Study|Adverse Event|12|||
145544414|NCT00518986|524853077|FG001|Overall Study|Adverse Event|7|||
145544415|NCT00518986|524853076|FG000|Overall Study|Lack of Efficacy|0|||
145544416|NCT00518986|524853077|FG001|Overall Study|Lack of Efficacy|2|||
145544417|NCT00518986|524853076|FG000|Overall Study|Lost to Follow-up|3|||
145404527|NCT03729362|524338613|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
145404528|NCT03729362|524338614|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
145404529|NCT02807259|524338616|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
145404530|NCT02807259|524338617|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
145404531|NCT02807259|524338616|FG000|Midline (3 Months)|migration, refusal, not available|30|||
145404532|NCT02807259|524338617|FG001|Midline (3 Months)|migration, refusal, not available|34|||
145404533|NCT02807259|524338616|FG000|Endline (3 Months)|migration, refusal, not available|35|||
145404534|NCT02807259|524338617|FG001|Endline (3 Months)|migration, refusal, not available|87|||
145404535|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
145404536|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
145404537|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
145404538|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
145404539|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
145404540|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
145404541|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
145404542|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
145404543|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
145404544|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
145404545|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
145544418|NCT00518986|524853077|FG001|Overall Study|Lost to Follow-up|2|||
145544419|NCT00518986|524853076|FG000|Overall Study|Physician Decision|0|||
145544420|NCT00518986|524853077|FG001|Overall Study|Physician Decision|3|||
145544421|NCT00518986|524853076|FG000|Overall Study|Protocol Violation|5|||
145544422|NCT00518986|524853077|FG001|Overall Study|Protocol Violation|7|||
145544423|NCT00518986|524853076|FG000|Overall Study|Withdrawal by Subject|4|||
145544424|NCT00518986|524853077|FG001|Overall Study|Withdrawal by Subject|4|||
145544425|NCT00518986|524853076|FG000|Overall Study|Non-Specific|2|||
145544426|NCT00518986|524853077|FG001|Overall Study|Non-Specific|1|||
145544427|NCT02166463|524853078|FG000|Overall Study|Lost to Follow-up|0|||
145544428|NCT02166463|524853079|FG001|Overall Study|Lost to Follow-up|1|||
145544429|NCT02166463|524853078|FG000|Overall Study|Physician Decision|10|||
145544430|NCT02166463|524853079|FG001|Overall Study|Physician Decision|10|||
145544431|NCT02166463|524853078|FG000|Overall Study|Ineligible|11|||
145544432|NCT02166463|524853079|FG001|Overall Study|Ineligible|2|||
145544433|NCT02166463|524853078|FG000|Overall Study|Progressive Disease|9|||
145544434|NCT02166463|524853079|FG001|Overall Study|Progressive Disease|6|||
145544435|NCT02166463|524853078|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
145544436|NCT02166463|524853079|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
145544437|NCT02166463|524853078|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
145544438|NCT02166463|524853079|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
145544439|NCT02166463|524853078|FG000|Overall Study|Refusal of further protocol therapy|5|||
145544440|NCT02166463|524853079|FG001|Overall Study|Refusal of further protocol therapy|6|||
145544441|NCT05683249|524853080|FG000|Overall Study|Adverse Event|3|||
145544442|NCT05683249|524853081|FG001|Overall Study|Adverse Event|1|||
145544443|NCT05683249|524853080|FG000|Overall Study|Lack of Efficacy|0|||
145544444|NCT05683249|524853081|FG001|Overall Study|Lack of Efficacy|2|||
145544445|NCT05683249|524853080|FG000|Overall Study|Lost to Follow-up|6|||
145610528|NCT04498247|525089849|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
145610529|NCT04498247|525089850|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
145610530|NCT04498247|525089851|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
145610531|NCT04498247|525089852|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
145610532|NCT04498247|525089853|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
145544446|NCT05683249|524853081|FG001|Overall Study|Lost to Follow-up|5|||
145544447|NCT05683249|524853080|FG000|Overall Study|Non-compliance with Study Drug|2|||
145544448|NCT05683249|524853081|FG001|Overall Study|Non-compliance with Study Drug|0|||
145544449|NCT05683249|524853080|FG000|Overall Study|Protocol Violation|6|||
145544450|NCT05683249|524853081|FG001|Overall Study|Protocol Violation|3|||
145544451|NCT05683249|524853080|FG000|Overall Study|Withdrawal by Subject|9|||
145544452|NCT05683249|524853081|FG001|Overall Study|Withdrawal by Subject|8|||
145544453|NCT05683249|524853080|FG000|Overall Study|Other|0|||
145544454|NCT05683249|524853081|FG001|Overall Study|Other|2|||
145544455|NCT05469178|524853082|FG000|Overall Study|Death|1|||
145544456|NCT05469178|524853083|FG001|Overall Study|Death|1|||
145544457|NCT05469178|524853084|FG002|Overall Study|Death|3|||
145544458|NCT05469178|524853085|FG003|Overall Study|Death|6|||
145544459|NCT05469178|524853082|FG000|Overall Study|Lack of Efficacy|2|||
145544460|NCT05469178|524853083|FG001|Overall Study|Lack of Efficacy|2|||
145544461|NCT05469178|524853084|FG002|Overall Study|Lack of Efficacy|1|||
145544462|NCT05469178|524853085|FG003|Overall Study|Lack of Efficacy|10|||
145544463|NCT01328431|524853086|FG000|Baseline|Protocol Violation|0|||
145544464|NCT01328431|524853087|FG001|Baseline|Protocol Violation|2|||
145544465|NCT01328431|524853086|FG000|1 Month (1M)|Lost to Follow-up|55|||
145544466|NCT01328431|524853087|FG001|1 Month (1M)|Lost to Follow-up|58|||
145544467|NCT01328431|524853086|FG000|3 Month (3M)|Death|2|||
145544468|NCT01328431|524853087|FG001|3 Month (3M)|Death|2|||
145544469|NCT01328431|524853086|FG000|3 Month (3M)|Lost to Follow-up|75|||
145544470|NCT01328431|524853087|FG001|3 Month (3M)|Lost to Follow-up|70|||
145544471|NCT01328431|524853086|FG000|12 Month (12M)|Death|2|||
145544472|NCT01328431|524853087|FG001|12 Month (12M)|Death|6|||
145544473|NCT01328431|524853086|FG000|12 Month (12M)|Lost to Follow-up|82|||
145544474|NCT01328431|524853087|FG001|12 Month (12M)|Lost to Follow-up|91|||
145544475|NCT03617185|524853093|FG000|Baseline|Lost to Follow-up|0|||
145544476|NCT03617185|524853094|FG001|Baseline|Lost to Follow-up|2|||
145544477|NCT03617185|524853095|FG002|Baseline|Lost to Follow-up|1|||
145544478|NCT03617185|524853096|FG003|Baseline|Lost to Follow-up|1|||
145544479|NCT03617185|524853093|FG000|Baseline|Withdrawal by Subject|0|||
145544480|NCT03617185|524853094|FG001|Baseline|Withdrawal by Subject|1|||
145544481|NCT03617185|524853095|FG002|Baseline|Withdrawal by Subject|0|||
145544482|NCT03617185|524853096|FG003|Baseline|Withdrawal by Subject|1|||
145544483|NCT03617185|524853093|FG000|Baseline|Driving Distance/Travel|0|||
145544484|NCT03617185|524853094|FG001|Baseline|Driving Distance/Travel|0|||
145544485|NCT03617185|524853095|FG002|Baseline|Driving Distance/Travel|2|||
145544486|NCT03617185|524853096|FG003|Baseline|Driving Distance/Travel|0|||
145544487|NCT03617185|524853093|FG000|Baseline|Family Obligations|0|||
145544488|NCT03617185|524853094|FG001|Baseline|Family Obligations|0|||
145544489|NCT03617185|524853095|FG002|Baseline|Family Obligations|0|||
145544490|NCT03617185|524853096|FG003|Baseline|Family Obligations|1|||
145544491|NCT03617185|524853093|FG000|3 Months|Lost to Follow-up|4|||
145544492|NCT03617185|524853094|FG001|3 Months|Lost to Follow-up|1|||
145544493|NCT03617185|524853095|FG002|3 Months|Lost to Follow-up|0|||
145544494|NCT03617185|524853096|FG003|3 Months|Lost to Follow-up|2|||
145544495|NCT03617185|524853093|FG000|3 Months|Withdrawal by Subject|1|||
145544496|NCT03617185|524853094|FG001|3 Months|Withdrawal by Subject|3|||
145544497|NCT03617185|524853095|FG002|3 Months|Withdrawal by Subject|0|||
145544498|NCT03617185|524853096|FG003|3 Months|Withdrawal by Subject|0|||
145544499|NCT03617185|524853093|FG000|3 Months|Driving Distance/Travel|1|||
145544500|NCT03617185|524853094|FG001|3 Months|Driving Distance/Travel|0|||
145610533|NCT04498247|525089854|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
145610534|NCT04498247|525089855|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
145544501|NCT03617185|524853095|FG002|3 Months|Driving Distance/Travel|0|||
145610535|NCT04498247|525089856|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
145610536|NCT04498247|525089849|FG000|Overall Study|Withdrawal by Subject|0|||
145544502|NCT03617185|524853096|FG003|3 Months|Driving Distance/Travel|0|||
145544503|NCT03617185|524853093|FG000|3 Months|Family Obligations|0|||
145544504|NCT03617185|524853094|FG001|3 Months|Family Obligations|0|||
145544505|NCT03617185|524853095|FG002|3 Months|Family Obligations|0|||
145544506|NCT03617185|524853096|FG003|3 Months|Family Obligations|1|||
145544507|NCT03617185|524853093|FG000|12 Months|Lost to Follow-up|3|||
145544508|NCT03617185|524853094|FG001|12 Months|Lost to Follow-up|1|||
145544509|NCT03617185|524853095|FG002|12 Months|Lost to Follow-up|3|||
145544510|NCT03617185|524853096|FG003|12 Months|Lost to Follow-up|0|||
145544511|NCT03617185|524853093|FG000|12 Months|Withdrawal by Subject|0|||
145544512|NCT03617185|524853094|FG001|12 Months|Withdrawal by Subject|0|||
145544513|NCT03617185|524853095|FG002|12 Months|Withdrawal by Subject|0|||
145544514|NCT03617185|524853096|FG003|12 Months|Withdrawal by Subject|1|||
145544515|NCT03617185|524853093|FG000|12 Months|Driving Distance/Travel|0|||
145610537|NCT04498247|525089850|FG001|Overall Study|Withdrawal by Subject|8|||
145544516|NCT03617185|524853094|FG001|12 Months|Driving Distance/Travel|0|||
145544517|NCT03617185|524853095|FG002|12 Months|Driving Distance/Travel|1|||
145544518|NCT03617185|524853096|FG003|12 Months|Driving Distance/Travel|0|||
145544519|NCT01964430|524853097|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
145544520|NCT01964430|524853098|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
145544521|NCT01964430|524853097|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
145404546|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
145404547|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
145404548|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
145404549|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
145404550|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
145404551|NCT00849056|524338618|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145404552|NCT00849056|524338619|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
145404553|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145404554|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
145404555|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
145404556|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
145404557|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
145404558|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
145404559|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
145404560|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
145404561|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145404562|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145404563|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
145404564|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
145404565|NCT00849056|524338618|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
145404566|NCT00849056|524338619|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
145404567|NCT00274456|524338620|FG000|Overall Study|Still on treatment|2|||
145404568|NCT00274456|524338621|FG001|Overall Study|Still on treatment|3|||
145404569|NCT00274456|524338622|FG002|Overall Study|Still on treatment|5|||
145404570|NCT00274456|524338623|FG003|Overall Study|Still on treatment|1|||
145404571|NCT00274456|524338620|FG000|Overall Study|Unacceptable toxicity|10|||
145404572|NCT00274456|524338621|FG001|Overall Study|Unacceptable toxicity|5|||
145404573|NCT00274456|524338622|FG002|Overall Study|Unacceptable toxicity|12|||
145404574|NCT00274456|524338623|FG003|Overall Study|Unacceptable toxicity|16|||
145404575|NCT00274456|524338620|FG000|Overall Study|Adverse Event|0|||
145404576|NCT00274456|524338621|FG001|Overall Study|Adverse Event|1|||
145404577|NCT00274456|524338622|FG002|Overall Study|Adverse Event|2|||
145404578|NCT00274456|524338623|FG003|Overall Study|Adverse Event|2|||
145404579|NCT00274456|524338620|FG000|Overall Study|Physician Decision|7|||
145404580|NCT00274456|524338621|FG001|Overall Study|Physician Decision|5|||
145404581|NCT00274456|524338622|FG002|Overall Study|Physician Decision|6|||
145404582|NCT00274456|524338623|FG003|Overall Study|Physician Decision|13|||
145404583|NCT00274456|524338620|FG000|Overall Study|Lost to Follow-up|0|||
145404584|NCT00274456|524338621|FG001|Overall Study|Lost to Follow-up|0|||
145404585|NCT00274456|524338622|FG002|Overall Study|Lost to Follow-up|1|||
145404586|NCT00274456|524338623|FG003|Overall Study|Lost to Follow-up|0|||
145404587|NCT00274456|524338620|FG000|Overall Study|Withdrawal by Subject|18|||
145404588|NCT00274456|524338621|FG001|Overall Study|Withdrawal by Subject|13|||
145404589|NCT00274456|524338622|FG002|Overall Study|Withdrawal by Subject|9|||
145404590|NCT00274456|524338623|FG003|Overall Study|Withdrawal by Subject|13|||
145404591|NCT00375752|524338627|FG000|Overall Study|Lack of Efficacy|4|||
145404592|NCT00375752|524338628|FG001|Overall Study|Lack of Efficacy|4|||
145404593|NCT00375752|524338627|FG000|Overall Study|Adverse Event|1|||
145404594|NCT00375752|524338628|FG001|Overall Study|Adverse Event|6|||
145404595|NCT00375752|524338627|FG000|Overall Study|Withdrawal by Subject|6|||
145404596|NCT00375752|524338628|FG001|Overall Study|Withdrawal by Subject|1|||
145404597|NCT00375752|524338627|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
145404598|NCT00375752|524338628|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
145404599|NCT00375752|524338627|FG000|Overall Study|Protocol Violation|0|||
145404600|NCT00375752|524338628|FG001|Overall Study|Protocol Violation|2|||
145404601|NCT00375752|524338627|FG000|Overall Study|Administrative Problems|0|||
145404602|NCT00375752|524338628|FG001|Overall Study|Administrative Problems|1|||
145404603|NCT01140906|524338635|FG000|Overall Study|Adverse Event|7|||
145544522|NCT01964430|524853098|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
145544523|NCT01964430|524853097|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
145544524|NCT01964430|524853098|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
145404604|NCT01140906|524338636|FG001|Overall Study|Adverse Event|10|||
145404605|NCT01140906|524338637|FG002|Overall Study|Adverse Event|17|||
145404606|NCT01140906|524338638|FG003|Overall Study|Adverse Event|7|||
145404607|NCT01140906|524338635|FG000|Overall Study|Lack of Efficacy|6|||
145404608|NCT01140906|524338636|FG001|Overall Study|Lack of Efficacy|8|||
145404609|NCT01140906|524338637|FG002|Overall Study|Lack of Efficacy|2|||
145610538|NCT04498247|525089851|FG002|Overall Study|Withdrawal by Subject|0|||
145610539|NCT04498247|525089852|FG003|Overall Study|Withdrawal by Subject|7|||
145610540|NCT04498247|525089853|FG004|Overall Study|Withdrawal by Subject|0|||
145610541|NCT04498247|525089854|FG005|Overall Study|Withdrawal by Subject|0|||
145610542|NCT04498247|525089855|FG006|Overall Study|Withdrawal by Subject|1|||
145610543|NCT04498247|525089856|FG007|Overall Study|Withdrawal by Subject|0|||
145610544|NCT04498247|525089849|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
145610545|NCT04498247|525089850|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
145610546|NCT04498247|525089851|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
145610547|NCT04498247|525089852|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
145610548|NCT04498247|525089853|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
145610549|NCT04498247|525089854|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
145610550|NCT04498247|525089855|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
145610551|NCT04498247|525089856|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
145610552|NCT01381874|525089857|FG000|Overall Study|Lost to Follow-up|1|||
145610553|NCT01381874|525089858|FG001|Overall Study|Lost to Follow-up|1|||
145610554|NCT01381874|525089859|FG002|Overall Study|Lost to Follow-up|0|||
145610555|NCT01381874|525089857|FG000|Overall Study|Withdrawal by Subject|9|||
145610556|NCT01381874|525089858|FG001|Overall Study|Withdrawal by Subject|10|||
145610557|NCT01381874|525089859|FG002|Overall Study|Withdrawal by Subject|9|||
145610558|NCT01381874|525089857|FG000|Overall Study|Other|67|||
145610559|NCT01381874|525089858|FG001|Overall Study|Other|52|||
145610560|NCT01381874|525089859|FG002|Overall Study|Other|67|||
145610561|NCT04488003|525089860|FG000|Assessed for Eligibility|Screen Failure|24|||
145610562|NCT04488003|525089861|FG001|Assessed for Eligibility|Screen Failure|0|||
145610563|NCT04488003|525089862|FG002|Assessed for Eligibility|Screen Failure|0|||
145610564|NCT04488003|525089860|FG000|Assessed for Eligibility|Adverse Event|1|||
145610565|NCT04488003|525089861|FG001|Assessed for Eligibility|Adverse Event|0|||
145610566|NCT04488003|525089862|FG002|Assessed for Eligibility|Adverse Event|0|||
145610567|NCT04488003|525089860|FG000|Assessed for Eligibility|Death|1|||
145610568|NCT04488003|525089861|FG001|Assessed for Eligibility|Death|0|||
145610569|NCT04488003|525089862|FG002|Assessed for Eligibility|Death|0|||
145610570|NCT04488003|525089860|FG000|Assessed for Eligibility|Physician Decision|1|||
145610571|NCT04488003|525089861|FG001|Assessed for Eligibility|Physician Decision|0|||
145610572|NCT04488003|525089862|FG002|Assessed for Eligibility|Physician Decision|0|||
145610573|NCT04488003|525089860|FG000|Allocated to Treatment|Progressive Disease|51|||
145610574|NCT04488003|525089861|FG001|Allocated to Treatment|Progressive Disease|0|||
145610575|NCT04488003|525089862|FG002|Allocated to Treatment|Progressive Disease|0|||
145610576|NCT04488003|525089860|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
145610577|NCT04488003|525089861|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
145610578|NCT04488003|525089862|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
145610579|NCT04488003|525089860|FG000|Allocated to Treatment|Adverse Event|6|||
145610580|NCT04488003|525089861|FG001|Allocated to Treatment|Adverse Event|0|||
145610581|NCT04488003|525089862|FG002|Allocated to Treatment|Adverse Event|0|||
145610582|NCT04488003|525089860|FG000|Allocated to Treatment|Other|5|||
145610583|NCT04488003|525089861|FG001|Allocated to Treatment|Other|0|||
145610584|NCT04488003|525089862|FG002|Allocated to Treatment|Other|0|||
145610585|NCT04488003|525089860|FG000|Allocated to Treatment|Physician Decision|4|||
145610586|NCT04488003|525089861|FG001|Allocated to Treatment|Physician Decision|0|||
145610587|NCT04488003|525089862|FG002|Allocated to Treatment|Physician Decision|0|||
145610588|NCT04488003|525089860|FG000|Allocated to Treatment|Death|4|||
145610589|NCT04488003|525089861|FG001|Allocated to Treatment|Death|0|||
145610590|NCT04488003|525089862|FG002|Allocated to Treatment|Death|0|||
145610591|NCT01248962|525089863|FG000|Overall Study|Withdrawal by Subject|1|||
145610592|NCT01248962|525089864|FG001|Overall Study|Withdrawal by Subject|1|||
145610593|NCT01248962|525089863|FG000|Overall Study|Adverse Event|2|||
145610594|NCT01248962|525089864|FG001|Overall Study|Adverse Event|1|||
145610595|NCT01248962|525089863|FG000|Overall Study|Complete Response after 4 Cycles|1|||
145610596|NCT01248962|525089864|FG001|Overall Study|Complete Response after 4 Cycles|0|||
145610597|NCT01248962|525089863|FG000|Overall Study|Complete Response after 3 Cycles|0|||
145610598|NCT01248962|525089864|FG001|Overall Study|Complete Response after 3 Cycles|1|||
145610599|NCT01248962|525089863|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
145544525|NCT01964430|524853097|FG000|Treatment Period|Adverse Event|71|||
145544526|NCT01964430|524853098|FG001|Treatment Period|Adverse Event|37|||
145544527|NCT01964430|524853097|FG000|Treatment Period|Withdrawal by Subject|36|||
145404610|NCT01140906|524338638|FG003|Overall Study|Lack of Efficacy|1|||
145404611|NCT01140906|524338635|FG000|Overall Study|Non-compliance|0|||
145404612|NCT01140906|524338636|FG001|Overall Study|Non-compliance|1|||
145404613|NCT01140906|524338637|FG002|Overall Study|Non-compliance|0|||
145544528|NCT01964430|524853098|FG001|Treatment Period|Withdrawal by Subject|27|||
145544529|NCT01964430|524853097|FG000|Treatment Period|Death|1|||
145544530|NCT01964430|524853098|FG001|Treatment Period|Death|3|||
145544531|NCT01964430|524853097|FG000|Treatment Period|Protocol Deviation|0|||
145544532|NCT01964430|524853098|FG001|Treatment Period|Protocol Deviation|1|||
145544533|NCT01964430|524853097|FG000|Treatment Period|Physician Decision|5|||
145544534|NCT01964430|524853098|FG001|Treatment Period|Physician Decision|4|||
145544535|NCT01964430|524853097|FG000|Treatment Period|Disease Relapse|28|||
145544536|NCT01964430|524853098|FG001|Treatment Period|Disease Relapse|38|||
145544537|NCT01964430|524853097|FG000|Treatment Period|Other reasons|1|||
145544538|NCT01964430|524853098|FG001|Treatment Period|Other reasons|3|||
145544539|NCT02801396|524853099|FG000|Period 1|Withdrawal by Subject|0|||
145544540|NCT02801396|524853100|FG001|Period 1|Withdrawal by Subject|0|||
145544541|NCT02801396|524853101|FG002|Period 1|Withdrawal by Subject|0|||
145544542|NCT02801396|524853102|FG003|Period 1|Withdrawal by Subject|0|||
145544543|NCT02801396|524853103|FG004|Period 1|Withdrawal by Subject|1|||
145544544|NCT02801396|524853104|FG005|Period 1|Withdrawal by Subject|0|||
145544545|NCT03310021|524853109|FG000|Overall Study|Withdrawal by Subject|0|||
145544546|NCT03310021|524853110|FG001|Overall Study|Withdrawal by Subject|0|||
145544547|NCT03310021|524853111|FG002|Overall Study|Withdrawal by Subject|0|||
145544548|NCT03310021|524853112|FG003|Overall Study|Withdrawal by Subject|0|||
145544549|NCT03310021|524853113|FG004|Overall Study|Withdrawal by Subject|0|||
145544550|NCT03310021|524853114|FG005|Overall Study|Withdrawal by Subject|0|||
145544551|NCT03310021|524853115|FG006|Overall Study|Withdrawal by Subject|1|||
145544552|NCT03310021|524853116|FG007|Overall Study|Withdrawal by Subject|0|||
145544553|NCT03310021|524853117|FG008|Overall Study|Withdrawal by Subject|0|||
145544554|NCT03310021|524853118|FG009|Overall Study|Withdrawal by Subject|0|||
145544555|NCT03310021|524853119|FG010|Overall Study|Withdrawal by Subject|0|||
145544556|NCT03310021|524853120|FG011|Overall Study|Withdrawal by Subject|0|||
145544557|NCT03310021|524853121|FG012|Overall Study|Withdrawal by Subject|0|||
145544558|NCT03310021|524853122|FG013|Overall Study|Withdrawal by Subject|0|||
145544559|NCT03310021|524853123|FG014|Overall Study|Withdrawal by Subject|0|||
145544560|NCT03310021|524853124|FG015|Overall Study|Withdrawal by Subject|0|||
145544561|NCT03310021|524853125|FG016|Overall Study|Withdrawal by Subject|0|||
145544562|NCT03310021|524853126|FG017|Overall Study|Withdrawal by Subject|0|||
145544563|NCT03310021|524853127|FG018|Overall Study|Withdrawal by Subject|0|||
145544564|NCT03310021|524853128|FG019|Overall Study|Withdrawal by Subject|0|||
145544565|NCT03310021|524853109|FG000|Overall Study|Lost to Follow-up|0|||
145544566|NCT03310021|524853110|FG001|Overall Study|Lost to Follow-up|0|||
145544567|NCT03310021|524853111|FG002|Overall Study|Lost to Follow-up|0|||
145544568|NCT03310021|524853112|FG003|Overall Study|Lost to Follow-up|0|||
145544569|NCT03310021|524853113|FG004|Overall Study|Lost to Follow-up|0|||
145404614|NCT01140906|524338638|FG003|Overall Study|Non-compliance|1|||
145404615|NCT01140906|524338635|FG000|Overall Study|Protocol Violation|5|||
145404616|NCT01140906|524338636|FG001|Overall Study|Protocol Violation|3|||
145404617|NCT01140906|524338637|FG002|Overall Study|Protocol Violation|2|||
145404618|NCT01140906|524338638|FG003|Overall Study|Protocol Violation|1|||
145404619|NCT01140906|524338635|FG000|Overall Study|Withdrawal of consent|6|||
145404620|NCT01140906|524338636|FG001|Overall Study|Withdrawal of consent|6|||
145404621|NCT01140906|524338637|FG002|Overall Study|Withdrawal of consent|2|||
145404622|NCT01140906|524338638|FG003|Overall Study|Withdrawal of consent|2|||
145404623|NCT01140906|524338635|FG000|Overall Study|Lost to Follow-up|1|||
145404624|NCT01140906|524338636|FG001|Overall Study|Lost to Follow-up|1|||
145404625|NCT01140906|524338637|FG002|Overall Study|Lost to Follow-up|0|||
145404626|NCT01140906|524338638|FG003|Overall Study|Lost to Follow-up|2|||
145544570|NCT03310021|524853114|FG005|Overall Study|Lost to Follow-up|0|||
145544571|NCT03310021|524853115|FG006|Overall Study|Lost to Follow-up|0|||
145544572|NCT03310021|524853116|FG007|Overall Study|Lost to Follow-up|0|||
145544573|NCT03310021|524853117|FG008|Overall Study|Lost to Follow-up|0|||
145544574|NCT03310021|524853118|FG009|Overall Study|Lost to Follow-up|0|||
145404627|NCT01140906|524338635|FG000|Overall Study|Administrative or other reason|0|||
145404628|NCT01140906|524338636|FG001|Overall Study|Administrative or other reason|5|||
145404629|NCT01140906|524338637|FG002|Overall Study|Administrative or other reason|3|||
145404630|NCT01140906|524338638|FG003|Overall Study|Administrative or other reason|2|||
145404631|NCT00336544|524338639|FG000|Overall Study|Lack of Efficacy|8|||
145544575|NCT03310021|524853119|FG010|Overall Study|Lost to Follow-up|1|||
145544576|NCT03310021|524853120|FG011|Overall Study|Lost to Follow-up|0|||
145544577|NCT03310021|524853121|FG012|Overall Study|Lost to Follow-up|0|||
145544578|NCT03310021|524853122|FG013|Overall Study|Lost to Follow-up|0|||
145544579|NCT03310021|524853123|FG014|Overall Study|Lost to Follow-up|0|||
145544580|NCT03310021|524853124|FG015|Overall Study|Lost to Follow-up|0|||
145404632|NCT00336544|524338640|FG001|Overall Study|Lack of Efficacy|5|||
145544581|NCT03310021|524853125|FG016|Overall Study|Lost to Follow-up|0|||
145544582|NCT03310021|524853126|FG017|Overall Study|Lost to Follow-up|0|||
145544583|NCT03310021|524853127|FG018|Overall Study|Lost to Follow-up|0|||
145544584|NCT03310021|524853128|FG019|Overall Study|Lost to Follow-up|0|||
145544585|NCT00702923|524853131|FG000|Overall Study|Adverse Event|1|||
145544586|NCT03322631|524853137|FG000|Overall Study|Withdrawal by Subject|0|||
145544587|NCT03322631|524853138|FG001|Overall Study|Withdrawal by Subject|1|||
145544588|NCT03322631|524853139|FG002|Overall Study|Withdrawal by Subject|0|||
145544589|NCT03322631|524853140|FG003|Overall Study|Withdrawal by Subject|0|||
145544590|NCT03322631|524853137|FG000|Overall Study|Adverse Event|0|||
145544591|NCT03322631|524853138|FG001|Overall Study|Adverse Event|0|||
145544592|NCT03322631|524853139|FG002|Overall Study|Adverse Event|1|||
145544593|NCT03322631|524853140|FG003|Overall Study|Adverse Event|0|||
145544594|NCT02412618|524853141|FG000|Overall Study|Withdrawal by Subject|1|||
145544595|NCT02412618|524853142|FG001|Overall Study|Withdrawal by Subject|1|||
145544596|NCT02412618|524853141|FG000|Overall Study|Expulsion|1|||
145544597|NCT02412618|524853142|FG001|Overall Study|Expulsion|1|||
145544598|NCT02378961|524853143|FG000|Overall Study|Lack of Efficacy|4|||
145544599|NCT02378961|524853144|FG001|Overall Study|Lack of Efficacy|2|||
145544600|NCT02378961|524853145|FG002|Overall Study|Lack of Efficacy|0|||
145544601|NCT02378961|524853146|FG003|Overall Study|Lack of Efficacy|1|||
145544602|NCT02378961|524853143|FG000|Overall Study|Death|0|||
145544603|NCT02378961|524853144|FG001|Overall Study|Death|0|||
145544604|NCT02378961|524853145|FG002|Overall Study|Death|1|||
145544605|NCT02378961|524853146|FG003|Overall Study|Death|0|||
145544606|NCT01253408|524853148|FG000|Overall Study|Adverse Event|0|||
145544607|NCT01253408|524853149|FG001|Overall Study|Adverse Event|1|||
145544608|NCT01253408|524853150|FG002|Overall Study|Adverse Event|0|||
145544609|NCT00393029|524853157|FG000|Overall Study|Not treated|0|||
145544610|NCT00393029|524853158|FG001|Overall Study|Not treated|1|||
145544611|NCT03715530|524853159|FG000|Overall Study|Lost to Follow-up|3|||
145544612|NCT03715530|524853160|FG001|Overall Study|Lost to Follow-up|1|||
145544613|NCT03715530|524853161|FG002|Overall Study|Lost to Follow-up|2|||
145544614|NCT03338998|524853163|FG000|Treatment Period|Withdrawal by Subject|1|||
145544615|NCT03338998|524853164|FG001|Treatment Period|Withdrawal by Subject|1|||
145544616|NCT03338998|524853163|FG000|Treatment Period|Adverse Event|0|||
145544617|NCT03338998|524853164|FG001|Treatment Period|Adverse Event|2|||
145544618|NCT03338998|524853163|FG000|Treatment Period|Protocol deviation|1|||
145544619|NCT03338998|524853164|FG001|Treatment Period|Protocol deviation|0|||
145544620|NCT03338998|524853163|FG000|Treatment Period|Physician Decision|2|||
145544621|NCT03338998|524853164|FG001|Treatment Period|Physician Decision|0|||
145544622|NCT03338998|524853163|FG000|Treatment Period|Subject failed swallow test|4|||
145544623|NCT03338998|524853164|FG001|Treatment Period|Subject failed swallow test|0|||
145544624|NCT03338998|524853163|FG000|Safety Follow-Up Period|Adverse Event|0|||
145544625|NCT03338998|524853164|FG001|Safety Follow-Up Period|Adverse Event|1|||
145544626|NCT03338998|524853163|FG000|Safety Follow-Up Period|Protocol deviation|1|||
145544627|NCT03338998|524853164|FG001|Safety Follow-Up Period|Protocol deviation|0|||
145544628|NCT03338998|524853163|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
145544629|NCT03338998|524853164|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
145544630|NCT00039130|524853165|FG000|Overall Study|Adverse Event|11|||
145544631|NCT00039130|524853165|FG000|Overall Study|Death|9|||
145544632|NCT00039130|524853165|FG000|Overall Study|Withdrawal by Subject|3|||
145544633|NCT00039130|524853165|FG000|Overall Study|Progression|2|||
145544634|NCT00039130|524853165|FG000|Overall Study|Subsequent treatment|2|||
145544635|NCT00039130|524853165|FG000|Overall Study|Physician Decision|3|||
145544636|NCT03288129|524853166|FG000|Overall Study|Adverse Event|10|||
145544637|NCT03288129|524853166|FG000|Overall Study|Lost to Follow-up|3|||
145544638|NCT03288129|524853166|FG000|Overall Study|Withdrawal by Subject|3|||
145544639|NCT03288129|524853166|FG000|Overall Study|Withdrawal of consent/assent|1|||
145544640|NCT03288129|524853166|FG000|Overall Study|Other|5|||
145544641|NCT01744197|524853172|FG000|Overall Study|Received 1 patch|2|||
145544642|NCT01744197|524853173|FG001|Overall Study|Received 1 patch|1|||
145544643|NCT01744197|524853172|FG000|Overall Study|No patch received|2|||
145544644|NCT01744197|524853173|FG001|Overall Study|No patch received|2|||
145544645|NCT01949506|524853174|FG000|Overall Study|Physician Decision|1|||
145544646|NCT02915016|524853175|FG000|Overall Study|Lost to Follow-up|4|||
145544647|NCT02915016|524853176|FG001|Overall Study|Lost to Follow-up|2|||
145544648|NCT02915016|524853177|FG002|Overall Study|Lost to Follow-up|5|||
145544649|NCT02915016|524853178|FG003|Overall Study|Lost to Follow-up|3|||
145544650|NCT02915016|524853179|FG004|Overall Study|Lost to Follow-up|5|||
145544651|NCT02915016|524853180|FG005|Overall Study|Lost to Follow-up|2|||
145544652|NCT02915016|524853181|FG006|Overall Study|Lost to Follow-up|8|||
145544653|NCT02915016|524853182|FG007|Overall Study|Lost to Follow-up|2|||
145544654|NCT02915016|524853175|FG000|Overall Study|Physician Decision|0|||
145544655|NCT02915016|524853176|FG001|Overall Study|Physician Decision|0|||
145544656|NCT02915016|524853177|FG002|Overall Study|Physician Decision|1|||
145544657|NCT02915016|524853178|FG003|Overall Study|Physician Decision|0|||
145544658|NCT02915016|524853179|FG004|Overall Study|Physician Decision|0|||
145544659|NCT02915016|524853180|FG005|Overall Study|Physician Decision|1|||
145544660|NCT02915016|524853181|FG006|Overall Study|Physician Decision|2|||
145544661|NCT02915016|524853182|FG007|Overall Study|Physician Decision|0|||
145544662|NCT02915016|524853175|FG000|Overall Study|Withdrawal by Subject|2|||
145544663|NCT02915016|524853176|FG001|Overall Study|Withdrawal by Subject|0|||
145404633|NCT00336544|524338639|FG000|Overall Study|Adverse Event|4|||
145404634|NCT00336544|524338640|FG001|Overall Study|Adverse Event|9|||
145404635|NCT00336544|524338639|FG000|Overall Study|Withdrawal by Subject|4|||
145404636|NCT00336544|524338640|FG001|Overall Study|Withdrawal by Subject|3|||
145404637|NCT00336544|524338639|FG000|Overall Study|Other|3|||
145404638|NCT00336544|524338640|FG001|Overall Study|Other|5|||
145404639|NCT00576758|524338641|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
145404640|NCT00576758|524338642|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
145404641|NCT00576758|524338641|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
145404642|NCT00576758|524338642|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
145404643|NCT00576758|524338641|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
145404644|NCT00576758|524338642|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
145404645|NCT00576758|524338641|FG000|Induction Treatment Period|Death|1|||
145404646|NCT00576758|524338642|FG001|Induction Treatment Period|Death|0|||
145404647|NCT00576758|524338641|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
145544664|NCT02915016|524853177|FG002|Overall Study|Withdrawal by Subject|1|||
145544665|NCT02915016|524853178|FG003|Overall Study|Withdrawal by Subject|0|||
145544666|NCT02915016|524853179|FG004|Overall Study|Withdrawal by Subject|1|||
145404648|NCT00576758|524338642|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
145404649|NCT00576758|524338641|FG000|Induction Treatment Period|Withdrew consent|1|||
145404650|NCT00576758|524338642|FG001|Induction Treatment Period|Withdrew consent|0|||
145404651|NCT00576758|524338641|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
145404652|NCT00576758|524338642|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
145404653|NCT00576758|524338641|FG000|Extension Treatment Period|Death|1|||
145404654|NCT00576758|524338642|FG001|Extension Treatment Period|Death|1|||
145404655|NCT00576758|524338641|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
145404656|NCT00576758|524338642|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
145404657|NCT00576758|524338641|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
145404658|NCT00576758|524338642|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
145404659|NCT00576758|524338641|FG000|Extension Treatment Period|Administrative/Other|3|||
145404660|NCT00576758|524338642|FG001|Extension Treatment Period|Administrative/Other|1|||
145404661|NCT00576758|524338641|FG000|Follow-up Period|Administrative/Other|6|||
145404662|NCT00576758|524338642|FG001|Follow-up Period|Administrative/Other|8|||
145404663|NCT00576758|524338641|FG000|Follow-up Period|Death|3|||
145404664|NCT00576758|524338642|FG001|Follow-up Period|Death|3|||
145404665|NCT00576758|524338641|FG000|Follow-up Period|Insufficient therapeutic response|16|||
145404666|NCT00576758|524338642|FG001|Follow-up Period|Insufficient therapeutic response|5|||
145404667|NCT00576758|524338641|FG000|Follow-up Period|Withdrew consent|2|||
145404668|NCT00576758|524338642|FG001|Follow-up Period|Withdrew consent|1|||
145404669|NCT01316614|524338643|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
145404670|NCT01316614|524338643|FG000|Overall Study|Cytology slides not available for review|4|||
145404671|NCT01316614|524338643|FG000|Overall Study|Cystic lesion|5|||
145404672|NCT01316614|524338643|FG000|Overall Study|Inadequate number of passes|2|||
145404673|NCT01316614|524338643|FG000|Overall Study|Medically unstable|1|||
145404674|NCT03427411|524338644|FG000|Overall Study|Screen failure - platelets too low|0|||
145404675|NCT03427411|524338645|FG001|Overall Study|Screen failure - platelets too low|1|||
145404676|NCT00903968|524338646|FG000|Overall Study|Adverse Event|0|||
145404677|NCT00903968|524338647|FG001|Overall Study|Adverse Event|0|||
145404678|NCT00903968|524338648|FG002|Overall Study|Adverse Event|0|||
145404679|NCT00903968|524338649|FG003|Overall Study|Adverse Event|0|||
145404680|NCT00903968|524338650|FG004|Overall Study|Adverse Event|0|||
145404681|NCT00903968|524338651|FG005|Overall Study|Adverse Event|0|||
145404682|NCT00903968|524338652|FG006|Overall Study|Adverse Event|1|||
145404683|NCT00903968|524338653|FG007|Overall Study|Adverse Event|8|||
145404684|NCT00903968|524338646|FG000|Overall Study|DLT|0|||
145404685|NCT00903968|524338647|FG001|Overall Study|DLT|0|||
145404686|NCT00903968|524338648|FG002|Overall Study|DLT|0|||
145404687|NCT00903968|524338649|FG003|Overall Study|DLT|0|||
145404688|NCT00903968|524338650|FG004|Overall Study|DLT|0|||
145404689|NCT00903968|524338651|FG005|Overall Study|DLT|0|||
145404690|NCT00903968|524338652|FG006|Overall Study|DLT|2|||
145404691|NCT00903968|524338653|FG007|Overall Study|DLT|0|||
145404692|NCT00903968|524338646|FG000|Overall Study|Withdrawal by Subject|1|||
145404693|NCT00903968|524338647|FG001|Overall Study|Withdrawal by Subject|0|||
145544667|NCT02915016|524853180|FG005|Overall Study|Withdrawal by Subject|3|||
145544668|NCT02915016|524853181|FG006|Overall Study|Withdrawal by Subject|1|||
145544669|NCT02915016|524853182|FG007|Overall Study|Withdrawal by Subject|1|||
145544670|NCT02915016|524853175|FG000|Overall Study|Elected not to continue|0|||
145544671|NCT02915016|524853176|FG001|Overall Study|Elected not to continue|0|||
145610600|NCT01248962|525089864|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
145610601|NCT00245856|525089865|FG000|Period Two|Withdrawal by Subject|0|||
145610602|NCT00245856|525089866|FG001|Period Two|Withdrawal by Subject|1|||
145610603|NCT01003184|525089867|FG000|Overall Study|Adverse Event|12|||
145610604|NCT01003184|525089868|FG001|Overall Study|Adverse Event|5|||
145610605|NCT01003184|525089867|FG000|Overall Study|Lost to Follow-up|1|||
145610606|NCT01003184|525089868|FG001|Overall Study|Lost to Follow-up|0|||
145610607|NCT01003184|525089867|FG000|Overall Study|Loss of glucose control|1|||
145610608|NCT01003184|525089868|FG001|Overall Study|Loss of glucose control|1|||
145610609|NCT01003184|525089867|FG000|Overall Study|Protocol Violation|3|||
145610610|NCT01003184|525089868|FG001|Overall Study|Protocol Violation|0|||
145610611|NCT01003184|525089867|FG000|Overall Study|Withdrawal by Subject|1|||
145610612|NCT01003184|525089868|FG001|Overall Study|Withdrawal by Subject|6|||
145610613|NCT01003184|525089867|FG000|Overall Study|Physician Decision|1|||
145610614|NCT01003184|525089868|FG001|Overall Study|Physician Decision|0|||
145610615|NCT01539863|525089869|FG000|Overall Study|Lost to Follow-up|5|||
145610616|NCT01539863|525089870|FG001|Overall Study|Lost to Follow-up|4|||
145610617|NCT00557622|525089871|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
145610618|NCT00557622|525089872|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
145610619|NCT00557622|525089871|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
145610620|NCT00557622|525089872|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
145610621|NCT00557622|525089871|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
145610622|NCT00557622|525089872|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
145610623|NCT04848662|525089873|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
145610624|NCT04848662|525089874|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
145610625|NCT03662997|525089881|FG000|Overall Study|Adverse Event|0|||
145610626|NCT03662997|525089882|FG001|Overall Study|Adverse Event|2|||
145610627|NCT03662997|525089883|FG002|Overall Study|Adverse Event|0|||
145610628|NCT03662997|525089884|FG003|Overall Study|Adverse Event|0|||
145610629|NCT00007475|525089885|FG000|Overall Study|Withdrawal by Subject|1|||
145610630|NCT00007475|525089886|FG001|Overall Study|Withdrawal by Subject|0|||
145610631|NCT00007475|525089887|FG002|Overall Study|Withdrawal by Subject|0|||
145610632|NCT00007475|525089888|FG003|Overall Study|Withdrawal by Subject|0|||
145610633|NCT00007475|525089885|FG000|Overall Study|Adverse Event|3|||
145610634|NCT00007475|525089886|FG001|Overall Study|Adverse Event|0|||
145610635|NCT00007475|525089887|FG002|Overall Study|Adverse Event|0|||
145610636|NCT00007475|525089888|FG003|Overall Study|Adverse Event|0|||
145610637|NCT01719224|525089889|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
145610638|NCT01719224|525089890|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
145610639|NCT03000673|525089891|FG000|Overall Study|Withdrawal by Subject|1|||
145610640|NCT03000673|525089892|FG001|Overall Study|Withdrawal by Subject|0|||
145610641|NCT03000673|525089893|FG002|Overall Study|Withdrawal by Subject|0|||
145610642|NCT03000673|525089894|FG003|Overall Study|Withdrawal by Subject|0|||
145610643|NCT01121484|525089895|FG000|Overall Study|Adverse Event|12|||
145610644|NCT01121484|525089896|FG001|Overall Study|Adverse Event|5|||
145610645|NCT01121484|525089895|FG000|Overall Study|Lack of Efficacy|3|||
145610646|NCT01121484|525089896|FG001|Overall Study|Lack of Efficacy|11|||
145610647|NCT01121484|525089895|FG000|Overall Study|Lost to Follow-up|5|||
145610648|NCT01121484|525089896|FG001|Overall Study|Lost to Follow-up|9|||
145610649|NCT01121484|525089895|FG000|Overall Study|Physician Decision|0|||
145610650|NCT01121484|525089896|FG001|Overall Study|Physician Decision|3|||
145610651|NCT01121484|525089895|FG000|Overall Study|Protocol Violation|1|||
145610652|NCT01121484|525089896|FG001|Overall Study|Protocol Violation|0|||
145544672|NCT02915016|524853177|FG002|Overall Study|Elected not to continue|0|||
145544673|NCT02915016|524853178|FG003|Overall Study|Elected not to continue|1|||
145544674|NCT02915016|524853179|FG004|Overall Study|Elected not to continue|0|||
145544675|NCT02915016|524853180|FG005|Overall Study|Elected not to continue|0|||
145610653|NCT01121484|525089895|FG000|Overall Study|Withdrawal by Subject|8|||
145610654|NCT01121484|525089896|FG001|Overall Study|Withdrawal by Subject|7|||
145544676|NCT02915016|524853181|FG006|Overall Study|Elected not to continue|1|||
145544677|NCT02915016|524853182|FG007|Overall Study|Elected not to continue|0|||
145544678|NCT02915016|524853175|FG000|Overall Study|HIV infection|1|||
145544679|NCT02915016|524853176|FG001|Overall Study|HIV infection|1|||
145610655|NCT01121484|525089895|FG000|Overall Study|Discontinuation of study by sponsor|0|||
145610656|NCT01121484|525089896|FG001|Overall Study|Discontinuation of study by sponsor|1|||
145610657|NCT01121484|525089895|FG000|Overall Study|Other|3|||
145610658|NCT01121484|525089896|FG001|Overall Study|Other|3|||
145610659|NCT01121484|525089895|FG000|Overall Study|Randomized, not treated|1|||
145610660|NCT01121484|525089896|FG001|Overall Study|Randomized, not treated|4|||
145610661|NCT01512745|525089898|FG000|Overall Study|Adverse Event|22|||
145610662|NCT01512745|525089899|FG001|Overall Study|Adverse Event|3|||
145544680|NCT02915016|524853177|FG002|Overall Study|HIV infection|1|||
145610663|NCT01512745|525089898|FG000|Overall Study|Death|9|||
145610664|NCT01512745|525089899|FG001|Overall Study|Death|13|||
145544681|NCT02915016|524853178|FG003|Overall Study|HIV infection|0|||
145544682|NCT02915016|524853179|FG004|Overall Study|HIV infection|1|||
145544683|NCT02915016|524853180|FG005|Overall Study|HIV infection|0|||
145544684|NCT02915016|524853181|FG006|Overall Study|HIV infection|0|||
145544685|NCT02915016|524853182|FG007|Overall Study|HIV infection|0|||
145544686|NCT02915016|524853175|FG000|Overall Study|Participant unable to adhere|0|||
145544687|NCT02915016|524853176|FG001|Overall Study|Participant unable to adhere|0|||
145544688|NCT02915016|524853177|FG002|Overall Study|Participant unable to adhere|0|||
145544689|NCT02915016|524853178|FG003|Overall Study|Participant unable to adhere|0|||
145544690|NCT02915016|524853179|FG004|Overall Study|Participant unable to adhere|0|||
145544691|NCT02915016|524853180|FG005|Overall Study|Participant unable to adhere|0|||
145544692|NCT02915016|524853181|FG006|Overall Study|Participant unable to adhere|0|||
145544693|NCT02915016|524853182|FG007|Overall Study|Participant unable to adhere|1|||
145544694|NCT02166905|524853183|FG000|Overall Study|Withdrawal by Subject|1|||
145544695|NCT02166905|524853184|FG001|Overall Study|Withdrawal by Subject|0|||
145544696|NCT02166905|524853185|FG002|Overall Study|Withdrawal by Subject|0|||
145544697|NCT02166905|524853186|FG003|Overall Study|Withdrawal by Subject|0|||
145544698|NCT02617628|524853187|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
145544699|NCT02617628|524853188|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
145544700|NCT03278873|524853189|FG000|Overall Study|Withdrawal by Subject|0|||
145544701|NCT03278873|524853190|FG001|Overall Study|Withdrawal by Subject|1|||
145544702|NCT03278873|524853191|FG002|Overall Study|Withdrawal by Subject|0|||
145544703|NCT03278873|524853192|FG003|Overall Study|Withdrawal by Subject|0|||
145544704|NCT03278873|524853189|FG000|Overall Study|Sponsor's decision|0|||
145544705|NCT03278873|524853190|FG001|Overall Study|Sponsor's decision|1|||
145544706|NCT03278873|524853191|FG002|Overall Study|Sponsor's decision|0|||
145544707|NCT03278873|524853192|FG003|Overall Study|Sponsor's decision|0|||
145544708|NCT03278873|524853189|FG000|Overall Study|Early Termination|2|||
145544709|NCT03278873|524853190|FG001|Overall Study|Early Termination|6|||
145544710|NCT03278873|524853191|FG002|Overall Study|Early Termination|0|||
145544711|NCT03278873|524853192|FG003|Overall Study|Early Termination|4|||
145544712|NCT03278873|524853189|FG000|Overall Study|Lost to Follow-up|0|||
145544713|NCT03278873|524853190|FG001|Overall Study|Lost to Follow-up|0|||
145544714|NCT03278873|524853191|FG002|Overall Study|Lost to Follow-up|2|||
145544715|NCT03278873|524853192|FG003|Overall Study|Lost to Follow-up|0|||
145544716|NCT03278873|524853189|FG000|Overall Study|The patient decided to withdraw via email|1|||
145544717|NCT03278873|524853190|FG001|Overall Study|The patient decided to withdraw via email|0|||
145544718|NCT03278873|524853191|FG002|Overall Study|The patient decided to withdraw via email|0|||
145544719|NCT03278873|524853192|FG003|Overall Study|The patient decided to withdraw via email|0|||
145544720|NCT03278873|524853189|FG000|Overall Study|The patient was unresponsive to contact|0|||
145544721|NCT03278873|524853190|FG001|Overall Study|The patient was unresponsive to contact|0|||
145544722|NCT03278873|524853191|FG002|Overall Study|The patient was unresponsive to contact|0|||
145544723|NCT03278873|524853192|FG003|Overall Study|The patient was unresponsive to contact|4|||
145544724|NCT03278873|524853189|FG000|Overall Study|The patient wished to participate no longer|0|||
145544725|NCT03278873|524853190|FG001|Overall Study|The patient wished to participate no longer|1|||
145544726|NCT03278873|524853191|FG002|Overall Study|The patient wished to participate no longer|0|||
145544727|NCT03278873|524853192|FG003|Overall Study|The patient wished to participate no longer|0|||
145544728|NCT03278873|524853189|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
145544729|NCT03278873|524853190|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
145404694|NCT00903968|524338648|FG002|Overall Study|Withdrawal by Subject|1|||
145404695|NCT00903968|524338649|FG003|Overall Study|Withdrawal by Subject|0|||
145404696|NCT00903968|524338650|FG004|Overall Study|Withdrawal by Subject|1|||
145404697|NCT00903968|524338651|FG005|Overall Study|Withdrawal by Subject|1|||
145404698|NCT00903968|524338652|FG006|Overall Study|Withdrawal by Subject|0|||
145404699|NCT00903968|524338653|FG007|Overall Study|Withdrawal by Subject|4|||
145404700|NCT00903968|524338646|FG000|Overall Study|Non-Compliance|0|||
145404701|NCT00903968|524338647|FG001|Overall Study|Non-Compliance|0|||
145404702|NCT00903968|524338648|FG002|Overall Study|Non-Compliance|0|||
145404703|NCT00903968|524338649|FG003|Overall Study|Non-Compliance|0|||
145404704|NCT00903968|524338650|FG004|Overall Study|Non-Compliance|0|||
145544730|NCT03278873|524853191|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
145544731|NCT03278873|524853192|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
145544732|NCT02801331|524853205|FG000|Overall Study|Transferred to another hospital|8|||
145544733|NCT02801331|524853206|FG001|Overall Study|Transferred to another hospital|7|||
145544734|NCT02801331|524853205|FG000|Overall Study|Withdrawal by Subject|0|||
145544735|NCT02801331|524853206|FG001|Overall Study|Withdrawal by Subject|4|||
145544736|NCT02801331|524853205|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
145404705|NCT00903968|524338651|FG005|Overall Study|Non-Compliance|1|||
145404706|NCT00903968|524338652|FG006|Overall Study|Non-Compliance|0|||
145404707|NCT00903968|524338653|FG007|Overall Study|Non-Compliance|0|||
145404708|NCT00903968|524338646|FG000|Overall Study|Physician Decision|0|||
145404709|NCT00903968|524338647|FG001|Overall Study|Physician Decision|0|||
145404710|NCT00903968|524338648|FG002|Overall Study|Physician Decision|0|||
145404711|NCT00903968|524338649|FG003|Overall Study|Physician Decision|0|||
145544737|NCT02801331|524853206|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
145544738|NCT02443987|524853207|FG000|Overall Study|Bladder injury|1|||
145404712|NCT00903968|524338650|FG004|Overall Study|Physician Decision|0|||
145404713|NCT00903968|524338651|FG005|Overall Study|Physician Decision|1|||
145544739|NCT02443987|524853208|FG001|Overall Study|Bladder injury|1|||
145544740|NCT02443987|524853207|FG000|Overall Study|Other|0|||
145544741|NCT02443987|524853208|FG001|Overall Study|Other|1|||
145404714|NCT00903968|524338652|FG006|Overall Study|Physician Decision|0|||
145404715|NCT00903968|524338653|FG007|Overall Study|Physician Decision|0|||
145404716|NCT00903968|524338646|FG000|Overall Study|Progressive Disease|2|||
145404717|NCT00903968|524338647|FG001|Overall Study|Progressive Disease|3|||
145544742|NCT01397708|524853209|FG000|Overall Study|Withdrawal by Subject|0|||
145544743|NCT01397708|524853210|FG001|Overall Study|Withdrawal by Subject|0|||
145544744|NCT01397708|524853211|FG002|Overall Study|Withdrawal by Subject|1|||
145544745|NCT01397708|524853212|FG003|Overall Study|Withdrawal by Subject|0|||
145544746|NCT01397708|524853213|FG004|Overall Study|Withdrawal by Subject|0|||
145544747|NCT01397708|524853214|FG005|Overall Study|Withdrawal by Subject|0|||
145544748|NCT01397708|524853215|FG006|Overall Study|Withdrawal by Subject|0|||
145544749|NCT01397708|524853216|FG007|Overall Study|Withdrawal by Subject|1|||
145544750|NCT01397708|524853209|FG000|Overall Study|Death|0|||
145544751|NCT01397708|524853210|FG001|Overall Study|Death|0|||
145610665|NCT01512745|525089898|FG000|Overall Study|Withdrawal by Subject|2|||
145610666|NCT01512745|525089899|FG001|Overall Study|Withdrawal by Subject|2|||
145610667|NCT01512745|525089898|FG000|Overall Study|Lost to Follow-up|4|||
145610668|NCT01512745|525089899|FG001|Overall Study|Lost to Follow-up|0|||
145610669|NCT01512745|525089898|FG000|Overall Study|Lack of Efficacy|2|||
145610670|NCT01512745|525089899|FG001|Overall Study|Lack of Efficacy|2|||
145610671|NCT01512745|525089898|FG000|Overall Study|Protocol Violation|1|||
145610672|NCT01512745|525089899|FG001|Overall Study|Protocol Violation|0|||
145610673|NCT02357810|525089900|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
145610674|NCT02357810|525089900|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
145610675|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Adverse Event|5|||
145610676|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
145610677|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
145610678|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
145610679|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Death|1|||
145610680|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Physician Decision|1|||
145610681|NCT02357810|525089900|FG000|Reached 12 Weeks Response|Other|1|||
145610682|NCT02357810|525089900|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
145610683|NCT02357810|525089900|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
145610684|NCT02357810|525089900|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
145610685|NCT02357810|525089900|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
145610686|NCT02357810|525089900|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
145610687|NCT02357810|525089900|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
145610688|NCT00562978|525089901|FG000|Overall Study|Patient had imaging dose only|1|||
145610689|NCT00562978|525089902|FG001|Overall Study|Patient had imaging dose only|11|||
145610690|NCT00152971|525089904|FG000|Overall Study|Adverse Event|12|||
145610691|NCT00152971|525089905|FG001|Overall Study|Adverse Event|10|||
145610692|NCT00152971|525089906|FG002|Overall Study|Adverse Event|9|||
145610693|NCT00152971|525089904|FG000|Overall Study|Protocol Violation|10|||
145610694|NCT00152971|525089905|FG001|Overall Study|Protocol Violation|11|||
145610695|NCT00152971|525089906|FG002|Overall Study|Protocol Violation|8|||
145610696|NCT00152971|525089904|FG000|Overall Study|Lost to Follow-up|17|||
145610697|NCT00152971|525089905|FG001|Overall Study|Lost to Follow-up|14|||
145610698|NCT00152971|525089906|FG002|Overall Study|Lost to Follow-up|13|||
145544752|NCT01397708|524853211|FG002|Overall Study|Death|1|||
145544753|NCT01397708|524853212|FG003|Overall Study|Death|1|||
145544754|NCT01397708|524853213|FG004|Overall Study|Death|0|||
145544755|NCT01397708|524853214|FG005|Overall Study|Death|0|||
145544756|NCT01397708|524853215|FG006|Overall Study|Death|0|||
145544757|NCT01397708|524853216|FG007|Overall Study|Death|0|||
145544758|NCT01397708|524853209|FG000|Overall Study|Lost to Follow-up|0|||
145544759|NCT01397708|524853210|FG001|Overall Study|Lost to Follow-up|0|||
145610699|NCT00152971|525089904|FG000|Overall Study|Withdrawal by Subject|9|||
145610700|NCT00152971|525089905|FG001|Overall Study|Withdrawal by Subject|8|||
145610701|NCT00152971|525089906|FG002|Overall Study|Withdrawal by Subject|14|||
145610702|NCT00152971|525089904|FG000|Overall Study|Other|3|||
145610703|NCT00152971|525089905|FG001|Overall Study|Other|5|||
145610704|NCT00152971|525089906|FG002|Overall Study|Other|5|||
145610705|NCT00152971|525089904|FG000|Treatment|Adverse Event|49|||
145610706|NCT00152971|525089905|FG001|Treatment|Adverse Event|40|||
145404718|NCT00903968|524338648|FG002|Overall Study|Progressive Disease|2|||
145404719|NCT00903968|524338649|FG003|Overall Study|Progressive Disease|3|||
145610707|NCT00152971|525089906|FG002|Treatment|Adverse Event|54|||
145610708|NCT00152971|525089904|FG000|Treatment|Protocol Violation|8|||
145610709|NCT00152971|525089905|FG001|Treatment|Protocol Violation|6|||
145610710|NCT00152971|525089906|FG002|Treatment|Protocol Violation|10|||
145610711|NCT00152971|525089904|FG000|Treatment|Lost to Follow-up|1|||
145610712|NCT00152971|525089905|FG001|Treatment|Lost to Follow-up|2|||
145610713|NCT00152971|525089906|FG002|Treatment|Lost to Follow-up|1|||
145610714|NCT00152971|525089904|FG000|Treatment|Withdrawal by Subject|4|||
145610715|NCT00152971|525089905|FG001|Treatment|Withdrawal by Subject|4|||
145610716|NCT00152971|525089906|FG002|Treatment|Withdrawal by Subject|5|||
145544760|NCT01397708|524853211|FG002|Overall Study|Lost to Follow-up|0|||
145544761|NCT01397708|524853212|FG003|Overall Study|Lost to Follow-up|0|||
145544762|NCT01397708|524853213|FG004|Overall Study|Lost to Follow-up|1|||
145544763|NCT01397708|524853214|FG005|Overall Study|Lost to Follow-up|0|||
145544764|NCT01397708|524853215|FG006|Overall Study|Lost to Follow-up|0|||
145544765|NCT01397708|524853216|FG007|Overall Study|Lost to Follow-up|0|||
145544766|NCT01397708|524853209|FG000|Overall Study|Other|0|||
145544767|NCT01397708|524853210|FG001|Overall Study|Other|0|||
145544768|NCT01397708|524853211|FG002|Overall Study|Other|0|||
145544769|NCT01397708|524853212|FG003|Overall Study|Other|0|||
145544770|NCT01397708|524853213|FG004|Overall Study|Other|0|||
145544771|NCT01397708|524853214|FG005|Overall Study|Other|0|||
145544772|NCT01397708|524853215|FG006|Overall Study|Other|1|||
145544773|NCT01397708|524853216|FG007|Overall Study|Other|0|||
145544774|NCT01638546|524853219|FG000|Overall Study|Adverse Event|1|||
145544775|NCT01638546|524853220|FG001|Overall Study|Adverse Event|3|||
145544776|NCT05330702|524853221|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
145544777|NCT05330702|524853222|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
145544778|NCT05330702|524853223|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
145544779|NCT01664533|524854503|FG000|Overall Study|Death|42|||
145544780|NCT01664533|524854503|FG000|Overall Study|Lost to Follow-up|3|||
145544781|NCT01664533|524854503|FG000|Overall Study|Study termination|9|||
145544782|NCT01664533|524854503|FG000|Overall Study|Protocol Violation|3|||
145544783|NCT03291808|524854504|FG000|Overall Study|Lost to Follow-up|6|||
145544784|NCT03291808|524854504|FG000|Overall Study|Research burden|4|||
145544785|NCT02891850|524854505|FG000|Overall Study|Adverse Event|3|||
145544786|NCT02891850|524854506|FG001|Overall Study|Adverse Event|0|||
145544787|NCT02891850|524854505|FG000|Overall Study|Death|0|||
145544788|NCT02891850|524854506|FG001|Overall Study|Death|4|||
145544789|NCT02891850|524854505|FG000|Overall Study|Physician Decision|1|||
145544790|NCT02891850|524854506|FG001|Overall Study|Physician Decision|0|||
145544791|NCT02891850|524854505|FG000|Overall Study|Pregnancy|1|||
145544792|NCT02891850|524854506|FG001|Overall Study|Pregnancy|0|||
145544793|NCT02891850|524854505|FG000|Overall Study|Withdrawal by Subject|2|||
145544794|NCT02891850|524854506|FG001|Overall Study|Withdrawal by Subject|3|||
145544795|NCT02674529|524854507|FG000|Overall Study|Lost to Follow-up|1|||
145544796|NCT02674529|524854508|FG001|Overall Study|Lost to Follow-up|2|||
145544797|NCT02674529|524854507|FG000|Overall Study|Withdrawal by Subject|2|||
145544798|NCT02674529|524854508|FG001|Overall Study|Withdrawal by Subject|1|||
145544799|NCT02674529|524854507|FG000|Overall Study|Physician Decision|0|||
145544800|NCT02674529|524854508|FG001|Overall Study|Physician Decision|1|||
145544801|NCT02674529|524854507|FG000|Overall Study|Protocol Violation|0|||
145544802|NCT02674529|524854508|FG001|Overall Study|Protocol Violation|1|||
145544803|NCT00790023|524854509|FG000|Overall Study|Adverse Event|2|||
145544804|NCT00790023|524854510|FG001|Overall Study|Adverse Event|1|||
145544805|NCT00790023|524854511|FG002|Overall Study|Adverse Event|4|||
145544806|NCT00790023|524854509|FG000|Overall Study|Protocol Violation|2|||
145544807|NCT00790023|524854510|FG001|Overall Study|Protocol Violation|4|||
145544808|NCT00790023|524854511|FG002|Overall Study|Protocol Violation|2|||
145544809|NCT00790023|524854509|FG000|Overall Study|Withdrawal by Subject|2|||
145544810|NCT00790023|524854510|FG001|Overall Study|Withdrawal by Subject|0|||
145544811|NCT00790023|524854511|FG002|Overall Study|Withdrawal by Subject|6|||
145544812|NCT00790023|524854509|FG000|Overall Study|Lost to Follow-up|0|||
145544813|NCT00790023|524854510|FG001|Overall Study|Lost to Follow-up|0|||
145544814|NCT00790023|524854511|FG002|Overall Study|Lost to Follow-up|1|||
145544815|NCT00790023|524854509|FG000|Overall Study|Other|5|||
145544816|NCT00790023|524854510|FG001|Overall Study|Other|5|||
145544817|NCT00790023|524854511|FG002|Overall Study|Other|8|||
145544818|NCT02468414|524854512|FG000|Overall Study|Early Study Termination by Sponsor|1|||
145544819|NCT02468414|524854513|FG001|Overall Study|Early Study Termination by Sponsor|0|||
145544820|NCT02468414|524854512|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
145544821|NCT02468414|524854513|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
145544822|NCT02468414|524854512|FG000|Overall Study|Screen Failure|1|||
145544823|NCT02468414|524854513|FG001|Overall Study|Screen Failure|0|||
145544824|NCT00187486|524854514|FG000|Overall Study|Protocol Violation|1|||
145544825|NCT02599129|524854517|FG000|Overall Study|Lack of Efficacy|2|||
145544826|NCT02599129|524854518|FG001|Overall Study|Lack of Efficacy|2|||
145544827|NCT02599129|524854517|FG000|Overall Study|Lost to Follow-up|1|||
145544828|NCT02599129|524854518|FG001|Overall Study|Lost to Follow-up|0|||
145544829|NCT02599129|524854517|FG000|Overall Study|Withdrawal by Subject|2|||
145544830|NCT02599129|524854518|FG001|Overall Study|Withdrawal by Subject|1|||
145544831|NCT01029795|524854523|FG000|Overall Study|Entry Criteria Not Met|2|||
145544832|NCT01029795|524854524|FG001|Overall Study|Entry Criteria Not Met|1|||
145544833|NCT01029795|524854523|FG000|Overall Study|Physician Decision|2|||
145544834|NCT01029795|524854524|FG001|Overall Study|Physician Decision|1|||
145544835|NCT01029795|524854523|FG000|Overall Study|Sponsor Decision|11|||
145544836|NCT01029795|524854524|FG001|Overall Study|Sponsor Decision|17|||
145544837|NCT01029795|524854523|FG000|Overall Study|Withdrawal by Subject|1|||
145544838|NCT01029795|524854524|FG001|Overall Study|Withdrawal by Subject|3|||
145544839|NCT03217175|524854525|FG000|Overall Study|Physician Decision|4|||
145544840|NCT03217175|524854526|FG001|Overall Study|Physician Decision|1|||
145544841|NCT05035550|524854534|FG000|Overall Study|Withdrawal by Subject|3|||
145544842|NCT05035550|524854535|FG001|Overall Study|Withdrawal by Subject|0|||
145544843|NCT00407797|524854536|FG000|Overall Study|Lost to Follow-up|2|||
145544844|NCT00407797|524854536|FG000|Overall Study|Adverse Event|6|||
145544845|NCT00407797|524854536|FG000|Overall Study|Other|7|||
145544846|NCT00407797|524854536|FG000|Overall Study|Withdrawal by Subject|3|||
145544847|NCT01812174|524854537|FG000|Overall Study|Death|1|||
145544848|NCT01812174|524854538|FG001|Overall Study|Death|0|||
145544849|NCT01812174|524854537|FG000|Overall Study|Protocol Violation|2|||
145544850|NCT01812174|524854538|FG001|Overall Study|Protocol Violation|0|||
145544851|NCT01854710|524854549|FG000|Overall Study|Withdrawal by Subject|2|||
145544852|NCT01854710|524854550|FG001|Overall Study|Withdrawal by Subject|1|||
145544853|NCT01854710|524854551|FG002|Overall Study|Withdrawal by Subject|0|||
145544854|NCT01854710|524854552|FG003|Overall Study|Withdrawal by Subject|0|||
145544855|NCT01854710|524854553|FG004|Overall Study|Withdrawal by Subject|0|||
145544856|NCT01854710|524854554|FG005|Overall Study|Withdrawal by Subject|0|||
145544857|NCT01854710|524854549|FG000|Overall Study|CRI procedural error|2|||
145544858|NCT01854710|524854550|FG001|Overall Study|CRI procedural error|2|||
145544859|NCT01854710|524854551|FG002|Overall Study|CRI procedural error|2|||
145544860|NCT01854710|524854552|FG003|Overall Study|CRI procedural error|2|||
145404720|NCT00903968|524338650|FG004|Overall Study|Progressive Disease|3|||
145404721|NCT00903968|524338651|FG005|Overall Study|Progressive Disease|3|||
145404722|NCT00903968|524338652|FG006|Overall Study|Progressive Disease|0|||
145404723|NCT00903968|524338653|FG007|Overall Study|Progressive Disease|18|||
145404724|NCT00903968|524338646|FG000|Overall Study|Lack of Efficacy|0|||
145404725|NCT00903968|524338647|FG001|Overall Study|Lack of Efficacy|0|||
145404726|NCT00903968|524338648|FG002|Overall Study|Lack of Efficacy|0|||
145404727|NCT00903968|524338649|FG003|Overall Study|Lack of Efficacy|0|||
145404728|NCT00903968|524338650|FG004|Overall Study|Lack of Efficacy|0|||
145404729|NCT00903968|524338651|FG005|Overall Study|Lack of Efficacy|0|||
145404730|NCT00903968|524338652|FG006|Overall Study|Lack of Efficacy|0|||
145404731|NCT00903968|524338653|FG007|Overall Study|Lack of Efficacy|3|||
145404732|NCT00089648|524338654|FG000|Overall Study|Adverse Event|7|||
145404733|NCT00089648|524338654|FG000|Overall Study|Withdrawal by Subject|1|||
145404734|NCT00089648|524338654|FG000|Overall Study|Lack of Efficacy|33|||
145404735|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
145404736|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
145404737|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
145404738|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
145404739|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
145404740|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
145404741|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
145404742|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
145404743|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
145404744|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
145404745|NCT03979313|524338655|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
145404746|NCT03979313|524338656|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
145404747|NCT03979313|524338655|FG000|All Subjects|Any Other Reason|16|||
145404748|NCT03979313|524338656|FG001|All Subjects|Any Other Reason|23|||
145404749|NCT03979313|524338655|FG000|All Subjects|Covid-19|1|||
145404750|NCT03979313|524338656|FG001|All Subjects|Covid-19|3|||
145404751|NCT03979313|524338655|FG000|All Subjects|Withdrawal by Subject|35|||
145404752|NCT03979313|524338656|FG001|All Subjects|Withdrawal by Subject|44|||
145404753|NCT03979313|524338655|FG000|All Subjects|Death|0|||
145404754|NCT03979313|524338656|FG001|All Subjects|Death|5|||
145404755|NCT03979313|524338655|FG000|All Subjects|Lost to Follow-up|28|||
145404756|NCT03979313|524338656|FG001|All Subjects|Lost to Follow-up|61|||
145404757|NCT00423605|524338657|FG000|Overall Study|Adverse Event|129|||
145404758|NCT00423605|524338657|FG000|Overall Study|Withdrawal by Subject|36|||
145404759|NCT00423605|524338657|FG000|Overall Study|Lost to Follow-up|15|||
145404760|NCT00423605|524338657|FG000|Overall Study|Lack of Efficacy|38|||
145404761|NCT00423605|524338657|FG000|Overall Study|Sponsor Decision|3|||
145404762|NCT00423605|524338657|FG000|Overall Study|Physician Decision|8|||
145404763|NCT00423605|524338657|FG000|Overall Study|Protocol Violation|7|||
145404764|NCT00423605|524338657|FG000|Overall Study|Not one of the pre-specified options|5|||
145404765|NCT03183908|524338658|FG000|Overall Study|Missing Symptom Diary Data|0|||
145404766|NCT03183908|524338659|FG001|Overall Study|Missing Symptom Diary Data|2|||
145404767|NCT04889040|524338663|FG000|Overall Study|Withdrawal by Subject|3|||
145404768|NCT04889040|524338664|FG001|Overall Study|Withdrawal by Subject|3|||
145404769|NCT04889040|524338663|FG000|Overall Study|Lost to Follow-up|0|||
145404770|NCT04889040|524338664|FG001|Overall Study|Lost to Follow-up|1|||
145404771|NCT04889040|524338663|FG000|Overall Study|Adverse Event|2|||
145404772|NCT04889040|524338664|FG001|Overall Study|Adverse Event|1|||
145404773|NCT03738696|524338665|FG000|Overall Study|Withdrawal by Subject|0|||
145404774|NCT03738696|524338666|FG001|Overall Study|Withdrawal by Subject|1|||
145404775|NCT03738696|524338665|FG000|Overall Study|Lost to Follow-up|8|||
145404776|NCT03738696|524338666|FG001|Overall Study|Lost to Follow-up|14|||
145404777|NCT02058095|524338672|FG000|Overall Study|Adverse Event|1|||
145404778|NCT02058095|524338673|FG001|Overall Study|Adverse Event|0|||
145404779|NCT00726453|524338674|FG000|Primary Enrollment Group|Death|18|||
145544861|NCT01854710|524854553|FG004|Overall Study|CRI procedural error|2|||
145544862|NCT01854710|524854554|FG005|Overall Study|CRI procedural error|2|||
145544863|NCT03132220|524854555|FG000|Overall Study|Lost to Follow-up|17|||
145544864|NCT03132220|524854556|FG001|Overall Study|Lost to Follow-up|8|||
145544865|NCT03132220|524854555|FG000|Overall Study|Withdrawal by Subject|1|||
145404780|NCT00726453|524338675|FG001|Primary Enrollment Group|Death|0|||
145404781|NCT00726453|524338674|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
145404782|NCT00726453|524338675|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
145404783|NCT00726453|524338674|FG000|38 mm Length Group|Death|0|||
145404784|NCT00726453|524338675|FG001|38 mm Length Group|Death|3|||
145404785|NCT02690727|524338678|FG000|Overall Study|Adverse Event|2|||
145404786|NCT02690727|524338679|FG001|Overall Study|Adverse Event|2|||
145404787|NCT01588509|524338680|FG000|Overall Study|Lost to Follow-up|1|||
145404788|NCT01588509|524338681|FG001|Overall Study|Lost to Follow-up|0|||
145404789|NCT01983930|524338682|FG000|Overall Study|Withdrawal by Subject|9|||
145404790|NCT01983930|524338683|FG001|Overall Study|Withdrawal by Subject|8|||
145544866|NCT03132220|524854556|FG001|Overall Study|Withdrawal by Subject|4|||
145544867|NCT00730132|524854557|FG000|Overall Study|Protocol Violation|154|||
145544868|NCT00730132|524854557|FG000|Overall Study|Death|1|||
145544869|NCT02296320|524854558|FG000|Overall Study|Withdrawal by Subject|4|||
145610717|NCT00152971|525089904|FG000|Treatment|Other|9|||
145610718|NCT00152971|525089905|FG001|Treatment|Other|11|||
145610719|NCT00152971|525089906|FG002|Treatment|Other|10|||
145610720|NCT00675506|525089907|FG000|Overall Study|Lost to Follow-up|1|||
145610721|NCT00675506|525089908|FG001|Overall Study|Lost to Follow-up|5|||
145610722|NCT00675506|525089907|FG000|Overall Study|Lost interest|3|||
145610723|NCT00675506|525089908|FG001|Overall Study|Lost interest|5|||
145610724|NCT00675506|525089907|FG000|Overall Study|Elevated fasting glucose|2|||
145610725|NCT00675506|525089908|FG001|Overall Study|Elevated fasting glucose|1|||
145610726|NCT00675506|525089907|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
145610727|NCT00675506|525089908|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
145610728|NCT00675506|525089907|FG000|Overall Study|Elevated IGF-1|2|||
145544870|NCT02296320|524854559|FG001|Overall Study|Withdrawal by Subject|0|||
145544871|NCT02296320|524854560|FG002|Overall Study|Withdrawal by Subject|2|||
145544872|NCT02296320|524854558|FG000|Overall Study|Death|24|||
145544873|NCT02296320|524854559|FG001|Overall Study|Death|3|||
145544874|NCT02296320|524854560|FG002|Overall Study|Death|27|||
145610729|NCT00675506|525089908|FG001|Overall Study|Elevated IGF-1|0|||
145610730|NCT00675506|525089907|FG000|Overall Study|Hypersensitivity Reaction|1|||
145610731|NCT00675506|525089908|FG001|Overall Study|Hypersensitivity Reaction|0|||
145610732|NCT00675506|525089907|FG000|Overall Study|Disclosed history of cancer|1|||
145610733|NCT00675506|525089908|FG001|Overall Study|Disclosed history of cancer|0|||
145610734|NCT00675506|525089907|FG000|Overall Study|Declined participation|1|||
145610735|NCT00675506|525089908|FG001|Overall Study|Declined participation|0|||
145610736|NCT00675506|525089907|FG000|Overall Study|Schedule conflict|0|||
145610737|NCT00675506|525089908|FG001|Overall Study|Schedule conflict|1|||
145610738|NCT03820323|525089909|FG000|Overall Study|Lost to Follow-up|2|||
145610739|NCT03820323|525089910|FG001|Overall Study|Lost to Follow-up|1|||
145610740|NCT03820323|525089909|FG000|Overall Study|Missed 12-month visit|22|||
145610741|NCT03820323|525089910|FG001|Overall Study|Missed 12-month visit|14|||
145610742|NCT03820323|525089909|FG000|Overall Study|Death|2|||
145610743|NCT03820323|525089910|FG001|Overall Study|Death|1|||
145610744|NCT03820323|525089909|FG000|Overall Study|Transferred out|13|||
145610745|NCT03820323|525089910|FG001|Overall Study|Transferred out|11|||
145610746|NCT03820323|525089909|FG000|Overall Study|Terminated|0|||
145610747|NCT03820323|525089910|FG001|Overall Study|Terminated|3|||
145610748|NCT03820323|525089909|FG000|Overall Study|Withdrawal by Subject|1|||
145610749|NCT03820323|525089910|FG001|Overall Study|Withdrawal by Subject|6|||
145610750|NCT03151395|525089911|FG000|Overall Study|Adverse Event|2|||
145610751|NCT03151395|525089911|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
145610752|NCT03151395|525089911|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
145610753|NCT03151395|525089911|FG000|Overall Study|Unspecified reason|4|||
145610754|NCT01003639|525089914|FG000|Overall Study|Lost to Follow-up|6|||
145610755|NCT01003639|525089915|FG001|Overall Study|Lost to Follow-up|9|||
145610756|NCT01003639|525089914|FG000|Overall Study|Withdrawal by Subject|9|||
145544875|NCT02296320|524854558|FG000|Overall Study|Lost to Follow-up|5|||
145544876|NCT02296320|524854559|FG001|Overall Study|Lost to Follow-up|2|||
145544877|NCT02296320|524854560|FG002|Overall Study|Lost to Follow-up|7|||
145544878|NCT02296320|524854558|FG000|Overall Study|Not treated|2|||
145544879|NCT02296320|524854559|FG001|Overall Study|Not treated|0|||
145544880|NCT02296320|524854560|FG002|Overall Study|Not treated|0|||
145544881|NCT02296320|524854558|FG000|Overall Study|Not - specified|0|||
145544882|NCT02296320|524854559|FG001|Overall Study|Not - specified|0|||
145544883|NCT02296320|524854560|FG002|Overall Study|Not - specified|1|||
145544884|NCT05466682|524854564|FG000|Overall Study|Withdrawal by Subject|0|||
145544885|NCT05466682|524854565|FG001|Overall Study|Withdrawal by Subject|2|||
145544886|NCT05466682|524854564|FG000|Overall Study|Lost to Follow-up|2|||
145544887|NCT05466682|524854565|FG001|Overall Study|Lost to Follow-up|1|||
145544888|NCT01930123|524854566|FG000|Overall Study|Adverse Event|1|||
145544889|NCT01930123|524854567|FG001|Overall Study|Adverse Event|0|||
145610757|NCT01003639|525089915|FG001|Overall Study|Withdrawal by Subject|5|||
145610758|NCT01003639|525089914|FG000|Overall Study|Lack of Efficacy|1|||
145610759|NCT01003639|525089915|FG001|Overall Study|Lack of Efficacy|6|||
145610760|NCT01003639|525089914|FG000|Overall Study|Adverse Event|0|||
145610761|NCT01003639|525089915|FG001|Overall Study|Adverse Event|1|||
145610762|NCT01003639|525089914|FG000|Overall Study|Protocol Violation|0|||
145610763|NCT01003639|525089915|FG001|Overall Study|Protocol Violation|1|||
145610764|NCT01003639|525089914|FG000|Overall Study|Physician Decision|1|||
145544890|NCT01930123|524854566|FG000|Overall Study|Physician Decision|21|||
145544891|NCT01930123|524854567|FG001|Overall Study|Physician Decision|8|||
145544892|NCT01930123|524854566|FG000|Overall Study|Withdrawal by Subject|1|||
145544893|NCT01930123|524854567|FG001|Overall Study|Withdrawal by Subject|0|||
145544894|NCT03208244|524854568|FG000|Overall Study|Death|1|||
145544895|NCT03953820|524854570|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
145544896|NCT03953820|524854571|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
145610765|NCT01003639|525089915|FG001|Overall Study|Physician Decision|0|||
145544897|NCT03953820|524854572|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
145544898|NCT03953820|524854570|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
145544899|NCT03953820|524854571|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
145544900|NCT03953820|524854572|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
145544901|NCT03334539|524854577|FG000|Overall Study|Adverse Event|3|||
145544902|NCT03334539|524854578|FG001|Overall Study|Adverse Event|5|||
145544903|NCT03334539|524854579|FG002|Overall Study|Adverse Event|0|||
145544904|NCT03334539|524854577|FG000|Overall Study|Withdrawal by Subject|0|||
145544905|NCT03334539|524854578|FG001|Overall Study|Withdrawal by Subject|1|||
145544906|NCT03334539|524854579|FG002|Overall Study|Withdrawal by Subject|1|||
145544907|NCT03334539|524854577|FG000|Overall Study|Administrative Reasons|1|||
145544908|NCT03334539|524854578|FG001|Overall Study|Administrative Reasons|0|||
145544909|NCT03334539|524854579|FG002|Overall Study|Administrative Reasons|0|||
145544910|NCT03334539|524854577|FG000|Overall Study|Hypertension Not Controlled|0|||
145544911|NCT03334539|524854578|FG001|Overall Study|Hypertension Not Controlled|1|||
145544912|NCT03334539|524854579|FG002|Overall Study|Hypertension Not Controlled|0|||
145544913|NCT03547583|524854584|FG000|Overall Study|Adverse Event|16|||
145544914|NCT03547583|524854585|FG001|Overall Study|Adverse Event|11|||
145544915|NCT03547583|524854586|FG002|Overall Study|Adverse Event|10|||
145544916|NCT03547583|524854584|FG000|Overall Study|Death|11|||
145544917|NCT03547583|524854585|FG001|Overall Study|Death|7|||
145544918|NCT03547583|524854586|FG002|Overall Study|Death|4|||
145544919|NCT03547583|524854584|FG000|Overall Study|Lost to Follow-up|1|||
145544920|NCT03547583|524854585|FG001|Overall Study|Lost to Follow-up|0|||
145544921|NCT03547583|524854586|FG002|Overall Study|Lost to Follow-up|0|||
145544922|NCT03547583|524854584|FG000|Overall Study|Non-compliance with study drug|0|||
145544923|NCT03547583|524854585|FG001|Overall Study|Non-compliance with study drug|0|||
145544924|NCT03547583|524854586|FG002|Overall Study|Non-compliance with study drug|1|||
145544925|NCT03547583|524854584|FG000|Overall Study|Physician Decision|1|||
145544926|NCT03547583|524854585|FG001|Overall Study|Physician Decision|0|||
145544927|NCT03547583|524854586|FG002|Overall Study|Physician Decision|3|||
145544928|NCT03547583|524854584|FG000|Overall Study|Protocol Violation|2|||
145544929|NCT03547583|524854585|FG001|Overall Study|Protocol Violation|1|||
145544930|NCT03547583|524854586|FG002|Overall Study|Protocol Violation|1|||
145544931|NCT03547583|524854584|FG000|Overall Study|Withdrawal by Subject|12|||
145544932|NCT03547583|524854585|FG001|Overall Study|Withdrawal by Subject|19|||
145544933|NCT03547583|524854586|FG002|Overall Study|Withdrawal by Subject|10|||
145544934|NCT03547583|524854584|FG000|Overall Study|Other|2|||
145544935|NCT03547583|524854585|FG001|Overall Study|Other|2|||
145544936|NCT03547583|524854586|FG002|Overall Study|Other|3|||
145544937|NCT04706091|524854589|FG000|Treatment 2|Withdrawal by Subject|1|||
145544938|NCT04706091|524854590|FG001|Treatment 2|Withdrawal by Subject|0|||
145544939|NCT01063868|524854591|FG000|Overall Study|Adverse Event|9|||
145544940|NCT01063868|524854592|FG001|Overall Study|Adverse Event|7|||
145544941|NCT01063868|524854591|FG000|Overall Study|Withdrawal by Subject|3|||
145544942|NCT01063868|524854592|FG001|Overall Study|Withdrawal by Subject|1|||
145544943|NCT01063868|524854591|FG000|Overall Study|Study Terminated By Sponsor|23|||
145544944|NCT01063868|524854592|FG001|Overall Study|Study Terminated By Sponsor|4|||
145544945|NCT04518306|524854595|FG000|Double-Blind Period|Run in failure|0|||
145544946|NCT04518306|524854596|FG001|Double-Blind Period|Run in failure|0|||
145544947|NCT04518306|524854597|FG002|Double-Blind Period|Run in failure|1|||
145544948|NCT04518306|524854595|FG000|Double-Blind Period|Adverse Event|0|||
145544949|NCT04518306|524854596|FG001|Double-Blind Period|Adverse Event|2|||
145544950|NCT04518306|524854597|FG002|Double-Blind Period|Adverse Event|2|||
145544951|NCT04518306|524854595|FG000|Double-Blind Period|Lost to Follow-up|1|||
145544952|NCT04518306|524854596|FG001|Double-Blind Period|Lost to Follow-up|2|||
145544953|NCT04518306|524854597|FG002|Double-Blind Period|Lost to Follow-up|2|||
145544954|NCT04518306|524854595|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
145544955|NCT04518306|524854596|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
145544956|NCT04518306|524854597|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
145544957|NCT04518306|524854595|FG000|Double-Blind Period|Other|0|||
145544958|NCT04518306|524854596|FG001|Double-Blind Period|Other|2|||
145544959|NCT04518306|524854597|FG002|Double-Blind Period|Other|0|||
145544960|NCT04518306|524854595|FG000|Double-Blind Period|Missing|0|||
145544961|NCT04518306|524854596|FG001|Double-Blind Period|Missing|1|||
145544962|NCT04518306|524854597|FG002|Double-Blind Period|Missing|0|||
145544963|NCT03069378|524854601|FG000|Overall Study|Withdrawal by Subject|1|||
145544964|NCT02881554|524854612|FG000|Overall Study|Withdrawal by Subject|2|||
145544965|NCT02881554|524854613|FG001|Overall Study|Withdrawal by Subject|0|||
145544966|NCT02397278|524856107|FG000|Overall Study|Withdrawal by Subject|0|||
145544967|NCT02397278|524856108|FG001|Overall Study|Withdrawal by Subject|2|||
145544968|NCT02397278|524856107|FG000|Overall Study|Deemed ineligible following surgery|1|||
145544969|NCT02397278|524856108|FG001|Overall Study|Deemed ineligible following surgery|1|||
145544970|NCT00331682|524856113|FG000|Overall Study|Adverse Event|1|||
145544971|NCT03292588|524856114|FG000|Overall Study|Death|1|||
145544972|NCT03292588|524856115|FG001|Overall Study|Death|0|||
145544973|NCT03292588|524856114|FG000|Overall Study|Lost to Follow-up|12|||
145544974|NCT03292588|524856115|FG001|Overall Study|Lost to Follow-up|16|||
145544975|NCT03292588|524856114|FG000|Overall Study|Physician Decision|0|||
145544976|NCT03292588|524856115|FG001|Overall Study|Physician Decision|1|||
145544977|NCT03292588|524856114|FG000|Overall Study|Withdrawal by Subject|4|||
145544978|NCT03292588|524856115|FG001|Overall Study|Withdrawal by Subject|4|||
145544979|NCT03292588|524856114|FG000|Overall Study|Move out of town|1|||
145544980|NCT03292588|524856115|FG001|Overall Study|Move out of town|0|||
145544981|NCT03292588|524856114|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
145544982|NCT03292588|524856115|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
145544983|NCT00004978|524856116|FG000|Overall Study|Death|107|||
145544984|NCT00004978|524856117|FG001|Overall Study|Death|116|||
145544985|NCT00004978|524856116|FG000|Overall Study|Lost to Follow-up|101|||
145544986|NCT00004978|524856117|FG001|Overall Study|Lost to Follow-up|108|||
145544987|NCT00004978|524856116|FG000|Overall Study|Withdrawal by Subject|17|||
145544988|NCT00004978|524856117|FG001|Overall Study|Withdrawal by Subject|26|||
145544989|NCT00004978|524856116|FG000|Overall Study|site closure - not in analysis cohort|19|||
145544990|NCT00004978|524856117|FG001|Overall Study|site closure - not in analysis cohort|20|||
145544991|NCT01652703|524856118|FG000|Overall Study|Withdrawal by Subject|0|||
145544992|NCT01652703|524856119|FG001|Overall Study|Withdrawal by Subject|1|||
145610766|NCT00284089|525089918|FG000|Multiple Dose Phase|Adverse Event|1|||
145610767|NCT00284089|525089919|FG001|Multiple Dose Phase|Adverse Event|0|||
145610768|NCT00284089|525089920|FG002|Multiple Dose Phase|Adverse Event|1|||
145610769|NCT00284089|525089921|FG003|Multiple Dose Phase|Adverse Event|1|||
145610770|NCT00284089|525089918|FG000|Multiple Dose Phase|Protocol Violation|0|||
145610771|NCT00284089|525089919|FG001|Multiple Dose Phase|Protocol Violation|0|||
145610772|NCT00284089|525089920|FG002|Multiple Dose Phase|Protocol Violation|1|||
145610773|NCT00284089|525089921|FG003|Multiple Dose Phase|Protocol Violation|0|||
145610774|NCT00284089|525089918|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
145610775|NCT00284089|525089919|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
145610776|NCT00284089|525089920|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
145610777|NCT00284089|525089921|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
145610778|NCT00284089|525089918|FG000|Multiple Dose Phase|Death|0|||
145610779|NCT00284089|525089919|FG001|Multiple Dose Phase|Death|0|||
145610780|NCT00284089|525089920|FG002|Multiple Dose Phase|Death|1|||
145610781|NCT00284089|525089921|FG003|Multiple Dose Phase|Death|1|||
145610782|NCT00284089|525089918|FG000|Extension Phase|Adverse Event|0|||
145610783|NCT00284089|525089919|FG001|Extension Phase|Adverse Event|0|||
145610784|NCT00284089|525089920|FG002|Extension Phase|Adverse Event|2|||
145610785|NCT00284089|525089921|FG003|Extension Phase|Adverse Event|2|||
145610786|NCT00284089|525089918|FG000|Extension Phase|condition no longer requires study drug|2|||
145610787|NCT00284089|525089919|FG001|Extension Phase|condition no longer requires study drug|0|||
145610788|NCT00284089|525089920|FG002|Extension Phase|condition no longer requires study drug|2|||
145610789|NCT00284089|525089921|FG003|Extension Phase|condition no longer requires study drug|7|||
145610790|NCT00284089|525089918|FG000|Extension Phase|Protocol Violation|0|||
145610791|NCT00284089|525089919|FG001|Extension Phase|Protocol Violation|0|||
145610792|NCT00284089|525089920|FG002|Extension Phase|Protocol Violation|1|||
145610793|NCT00284089|525089921|FG003|Extension Phase|Protocol Violation|0|||
145610794|NCT00284089|525089918|FG000|Extension Phase|Withdrawal by Subject|0|||
145610795|NCT00284089|525089919|FG001|Extension Phase|Withdrawal by Subject|0|||
145610796|NCT00284089|525089920|FG002|Extension Phase|Withdrawal by Subject|1|||
145610797|NCT00284089|525089921|FG003|Extension Phase|Withdrawal by Subject|3|||
145610798|NCT04986982|525089925|FG000|Overall Study|Withdrawal by Subject|3|||
145610799|NCT04986982|525089926|FG001|Overall Study|Withdrawal by Subject|1|||
145610800|NCT04986982|525089925|FG000|Overall Study|Lack of Efficacy|0|||
145610801|NCT04986982|525089926|FG001|Overall Study|Lack of Efficacy|2|||
145610802|NCT04986982|525089925|FG000|Overall Study|Ineligibility|3|||
145610803|NCT04986982|525089926|FG001|Overall Study|Ineligibility|0|||
145610804|NCT04986982|525089925|FG000|Overall Study|Adverse Event|4|||
145610805|NCT04986982|525089926|FG001|Overall Study|Adverse Event|4|||
145610806|NCT04986982|525089925|FG000|Overall Study|Lost to Follow-up|0|||
145610807|NCT04986982|525089926|FG001|Overall Study|Lost to Follow-up|1|||
145610808|NCT04986982|525089925|FG000|Overall Study|Sponsor's discretion|1|||
145610809|NCT04986982|525089926|FG001|Overall Study|Sponsor's discretion|0|||
145610810|NCT04186403|525089927|FG000|Overall Study|Adverse Event|1|||
145610811|NCT04186403|525089928|FG001|Overall Study|Adverse Event|8|||
145610812|NCT04186403|525089927|FG000|Overall Study|Lost to Follow-up|7|||
145610813|NCT04186403|525089928|FG001|Overall Study|Lost to Follow-up|3|||
145610814|NCT04186403|525089927|FG000|Overall Study|Physician Decision|1|||
145610815|NCT04186403|525089928|FG001|Overall Study|Physician Decision|0|||
145610816|NCT04186403|525089927|FG000|Overall Study|Withdrawal by Subject|7|||
145610817|NCT04186403|525089928|FG001|Overall Study|Withdrawal by Subject|8|||
145610818|NCT04186403|525089927|FG000|Overall Study|Other: Not Related to Covid-19|3|||
145610819|NCT04186403|525089928|FG001|Overall Study|Other: Not Related to Covid-19|0|||
145610820|NCT01407354|525089929|FG000|First Intervention|Withdrawal by Subject|0|||
145610821|NCT01407354|525089930|FG001|First Intervention|Withdrawal by Subject|2|||
145610822|NCT01407354|525089929|FG000|First Intervention|Adverse Event|1|||
145610823|NCT01407354|525089930|FG001|First Intervention|Adverse Event|0|||
145610824|NCT01407354|525089929|FG000|First Intervention|Physician Decision|1|||
145610825|NCT01407354|525089930|FG001|First Intervention|Physician Decision|0|||
145610826|NCT02778399|525089931|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
145610827|NCT02778399|525089932|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
145610828|NCT02778399|525089933|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
145610829|NCT02778399|525089934|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
145610830|NCT02778399|525089935|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
145610831|NCT02778399|525089936|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
145610832|NCT02778399|525089931|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
145610833|NCT02778399|525089932|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
145610834|NCT02778399|525089933|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
145610835|NCT02778399|525089934|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
145610836|NCT02778399|525089935|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
145610837|NCT02778399|525089936|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
145610838|NCT02778399|525089931|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
145610839|NCT02778399|525089932|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
145610840|NCT02778399|525089933|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
145610841|NCT02778399|525089934|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
145610842|NCT02778399|525089935|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
145610843|NCT02778399|525089936|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
145610844|NCT02778399|525089931|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
145610845|NCT02778399|525089932|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
145610846|NCT02778399|525089933|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
145610847|NCT02778399|525089934|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
145610848|NCT02778399|525089935|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
145610849|NCT02778399|525089936|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
145610850|NCT02778399|525089931|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
145610851|NCT02778399|525089932|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
145610852|NCT02778399|525089933|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
145610853|NCT02778399|525089934|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
145610854|NCT02778399|525089935|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
145610855|NCT02778399|525089936|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
145544993|NCT01652703|524856120|FG002|Overall Study|Withdrawal by Subject|3|||
145544994|NCT01652703|524856121|FG003|Overall Study|Withdrawal by Subject|1|||
145544995|NCT01652703|524856122|FG004|Overall Study|Withdrawal by Subject|0|||
145544996|NCT01652703|524856123|FG005|Overall Study|Withdrawal by Subject|1|||
145544997|NCT01652703|524856118|FG000|Overall Study|Other|0|||
145544998|NCT01652703|524856119|FG001|Overall Study|Other|0|||
145282487|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282488|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282489|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282490|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282491|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282492|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
145282493|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
145282494|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145282495|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145282496|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145544999|NCT01652703|524856120|FG002|Overall Study|Other|0|||
145545000|NCT01652703|524856121|FG003|Overall Study|Other|1|||
145545001|NCT01652703|524856122|FG004|Overall Study|Other|1|||
145545002|NCT01652703|524856123|FG005|Overall Study|Other|1|||
145545003|NCT00062374|524856127|FG000|Overall Study|Not treated|12|||
145545004|NCT02155608|524856128|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
145545005|NCT02155608|524856129|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
145545006|NCT02155608|524856128|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
145545007|NCT02155608|524856129|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
145282497|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145545008|NCT01532414|524856130|FG000|Overall Study|Lost to Follow-up|3|||
145545009|NCT01532414|524856131|FG001|Overall Study|Lost to Follow-up|0|||
145545010|NCT01532414|524856132|FG002|Overall Study|Lost to Follow-up|1|||
145545011|NCT01532414|524856130|FG000|Overall Study|Withdrawal by Subject|3|||
145610856|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
145282498|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145282499|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
145282500|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
145282501|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282502|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282503|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282504|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282505|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282506|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
145282507|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
145282508|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282509|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282510|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282511|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282512|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282513|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
145282514|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
145282515|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145282516|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145282517|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145545012|NCT01532414|524856131|FG001|Overall Study|Withdrawal by Subject|0|||
145545013|NCT01532414|524856132|FG002|Overall Study|Withdrawal by Subject|0|||
145282518|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145545014|NCT01532414|524856130|FG000|Overall Study|No V6 semen sample|0|||
145545015|NCT01532414|524856131|FG001|Overall Study|No V6 semen sample|1|||
145545016|NCT01532414|524856132|FG002|Overall Study|No V6 semen sample|0|||
145545017|NCT01532414|524856130|FG000|Overall Study|Adverse Event|0|||
145545018|NCT01532414|524856131|FG001|Overall Study|Adverse Event|1|||
145545019|NCT01532414|524856132|FG002|Overall Study|Adverse Event|1|||
145545020|NCT01532414|524856130|FG000|Overall Study|Unable to complete 24 hour PK|0|||
145545021|NCT01532414|524856131|FG001|Overall Study|Unable to complete 24 hour PK|0|||
145545022|NCT01532414|524856132|FG002|Overall Study|Unable to complete 24 hour PK|1|||
145545023|NCT01532414|524856130|FG000|Overall Study|Withdrawn by sponsor|1|||
145545024|NCT01532414|524856131|FG001|Overall Study|Withdrawn by sponsor|0|||
145545025|NCT01532414|524856132|FG002|Overall Study|Withdrawn by sponsor|0|||
145545026|NCT02380677|524856135|FG000|Overall Study|Adverse Event|0|||
145545027|NCT02380677|524856136|FG001|Overall Study|Adverse Event|0|||
145545028|NCT02380677|524856137|FG002|Overall Study|Adverse Event|0|||
145545029|NCT02380677|524856138|FG003|Overall Study|Adverse Event|1|||
145545030|NCT02380677|524856139|FG004|Overall Study|Adverse Event|1|||
145545031|NCT02380677|524856140|FG005|Overall Study|Adverse Event|4|||
145545032|NCT02380677|524856141|FG006|Overall Study|Adverse Event|2|||
145545033|NCT02380677|524856142|FG007|Overall Study|Adverse Event|2|||
145545034|NCT02380677|524856143|FG008|Overall Study|Adverse Event|2|||
145545035|NCT02380677|524856144|FG009|Overall Study|Adverse Event|1|||
145545036|NCT02380677|524856145|FG010|Overall Study|Adverse Event|2|||
145545037|NCT02380677|524856146|FG011|Overall Study|Adverse Event|1|||
145545038|NCT02380677|524856135|FG000|Overall Study|Physician Decision|1|||
145545039|NCT02380677|524856136|FG001|Overall Study|Physician Decision|0|||
145545040|NCT02380677|524856137|FG002|Overall Study|Physician Decision|1|||
145545041|NCT02380677|524856138|FG003|Overall Study|Physician Decision|1|||
145545042|NCT02380677|524856139|FG004|Overall Study|Physician Decision|0|||
145545043|NCT02380677|524856140|FG005|Overall Study|Physician Decision|0|||
145545044|NCT02380677|524856141|FG006|Overall Study|Physician Decision|0|||
145545045|NCT02380677|524856142|FG007|Overall Study|Physician Decision|0|||
145545046|NCT02380677|524856143|FG008|Overall Study|Physician Decision|0|||
145545047|NCT02380677|524856144|FG009|Overall Study|Physician Decision|0|||
145545048|NCT02380677|524856145|FG010|Overall Study|Physician Decision|0|||
145545049|NCT02380677|524856146|FG011|Overall Study|Physician Decision|0|||
145545050|NCT02380677|524856135|FG000|Overall Study|Lack of Efficacy|0|||
145545051|NCT02380677|524856136|FG001|Overall Study|Lack of Efficacy|1|||
145545052|NCT02380677|524856137|FG002|Overall Study|Lack of Efficacy|2|||
145545053|NCT02380677|524856138|FG003|Overall Study|Lack of Efficacy|0|||
145545054|NCT02380677|524856139|FG004|Overall Study|Lack of Efficacy|4|||
145545055|NCT02380677|524856140|FG005|Overall Study|Lack of Efficacy|1|||
145545056|NCT02380677|524856141|FG006|Overall Study|Lack of Efficacy|1|||
145545057|NCT02380677|524856142|FG007|Overall Study|Lack of Efficacy|2|||
145545058|NCT02380677|524856143|FG008|Overall Study|Lack of Efficacy|2|||
145545059|NCT02380677|524856144|FG009|Overall Study|Lack of Efficacy|0|||
145545060|NCT02380677|524856145|FG010|Overall Study|Lack of Efficacy|2|||
145545061|NCT02380677|524856146|FG011|Overall Study|Lack of Efficacy|1|||
145545062|NCT02380677|524856135|FG000|Overall Study|Withdrawal by Subject|0|||
145545063|NCT02380677|524856136|FG001|Overall Study|Withdrawal by Subject|0|||
145545064|NCT02380677|524856137|FG002|Overall Study|Withdrawal by Subject|0|||
145545065|NCT02380677|524856138|FG003|Overall Study|Withdrawal by Subject|0|||
145545066|NCT02380677|524856139|FG004|Overall Study|Withdrawal by Subject|0|||
145545067|NCT02380677|524856140|FG005|Overall Study|Withdrawal by Subject|0|||
145545068|NCT02380677|524856141|FG006|Overall Study|Withdrawal by Subject|0|||
145545069|NCT02380677|524856142|FG007|Overall Study|Withdrawal by Subject|0|||
145545070|NCT02380677|524856143|FG008|Overall Study|Withdrawal by Subject|0|||
145545071|NCT02380677|524856144|FG009|Overall Study|Withdrawal by Subject|1|||
145545072|NCT02380677|524856145|FG010|Overall Study|Withdrawal by Subject|0|||
145545073|NCT02380677|524856146|FG011|Overall Study|Withdrawal by Subject|3|||
145545074|NCT02380677|524856135|FG000|Overall Study|Other|0|||
145545075|NCT02380677|524856136|FG001|Overall Study|Other|0|||
145545076|NCT02380677|524856137|FG002|Overall Study|Other|0|||
145545077|NCT02380677|524856138|FG003|Overall Study|Other|1|||
145545078|NCT02380677|524856139|FG004|Overall Study|Other|1|||
145545079|NCT02380677|524856140|FG005|Overall Study|Other|1|||
145545080|NCT02380677|524856141|FG006|Overall Study|Other|0|||
145545081|NCT02380677|524856142|FG007|Overall Study|Other|0|||
145545082|NCT02380677|524856143|FG008|Overall Study|Other|0|||
145545083|NCT02380677|524856144|FG009|Overall Study|Other|0|||
145545084|NCT02380677|524856145|FG010|Overall Study|Other|0|||
145545085|NCT02380677|524856146|FG011|Overall Study|Other|0|||
145545086|NCT01806545|524856150|FG000|Overall Study|Adverse Event|2|||
145545087|NCT01806545|524856151|FG001|Overall Study|Adverse Event|3|||
145545088|NCT01806545|524856150|FG000|Overall Study|Lost to Follow-up|1|||
145545089|NCT01806545|524856151|FG001|Overall Study|Lost to Follow-up|0|||
145545090|NCT01806545|524856150|FG000|Overall Study|Withdrawal by Subject|3|||
145545091|NCT01806545|524856151|FG001|Overall Study|Withdrawal by Subject|2|||
145282519|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145282520|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
145282521|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
145282522|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282523|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282524|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282525|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282526|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282527|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
145282528|NCT00606684|523884271|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
145282529|NCT00606684|523884272|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282530|NCT00606684|523884273|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282531|NCT00606684|523884274|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282532|NCT00606684|523884275|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282533|NCT00606684|523884276|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282534|NCT00606684|523884277|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
145282535|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145282536|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Adverse Event|3|||
145282537|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Adverse Event|2|||
145282538|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Adverse Event|4|||
145282539|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Adverse Event|2|||
145282540|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Adverse Event|0|||
145282541|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Adverse Event|1|||
145282542|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145282543|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
145282544|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
145282545|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
145282546|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
145282547|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
145282548|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
145282549|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145282550|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
145282551|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
145282552|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
145282553|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
145282554|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
145282555|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
145282556|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
145282557|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
145282558|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
145282559|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
145545092|NCT00429273|524856152|FG000|Overall Study|Lost to Follow-up|1|||
145545093|NCT00429273|524856153|FG001|Overall Study|Lost to Follow-up|2|||
145545094|NCT00429273|524856154|FG002|Overall Study|Lost to Follow-up|2|||
145545095|NCT00429273|524856152|FG000|Overall Study|Physician Decision|6|||
145545096|NCT00429273|524856153|FG001|Overall Study|Physician Decision|5|||
145545097|NCT00429273|524856154|FG002|Overall Study|Physician Decision|5|||
145545098|NCT00429273|524856152|FG000|Overall Study|Adverse Event|1|||
145545099|NCT00429273|524856153|FG001|Overall Study|Adverse Event|1|||
145545100|NCT00429273|524856154|FG002|Overall Study|Adverse Event|2|||
145545101|NCT00884312|524856156|FG000|Overall Study|Non-fatal Progressive Disease|0|||
145545102|NCT00884312|524856157|FG001|Overall Study|Non-fatal Progressive Disease|8|||
145545103|NCT00884312|524856156|FG000|Overall Study|Fatal Progressive Disease|0|||
145610857|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
145282560|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
145282561|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
145282562|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
145282563|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Physician Decision|0|||
145282564|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Physician Decision|5|||
145545104|NCT00884312|524856157|FG001|Overall Study|Fatal Progressive Disease|1|||
145545105|NCT00884312|524856156|FG000|Overall Study|Non-fatal Adverse Event|1|||
145282565|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Physician Decision|1|||
145282566|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Physician Decision|0|||
145282567|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Physician Decision|3|||
145282568|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Physician Decision|1|||
145282569|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Physician Decision|2|||
145282570|NCT00606684|523884271|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145282571|NCT00606684|523884272|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145545106|NCT00884312|524856157|FG001|Overall Study|Non-fatal Adverse Event|0|||
145545107|NCT00884312|524856156|FG000|Overall Study|Fatal Adverse Event|1|||
145545108|NCT00884312|524856157|FG001|Overall Study|Fatal Adverse Event|4|||
145545109|NCT00884312|524856156|FG000|Overall Study|Withdrawal by Subject|0|||
145545110|NCT00884312|524856157|FG001|Overall Study|Withdrawal by Subject|6|||
145545111|NCT00884312|524856156|FG000|Overall Study|Physician Decision|0|||
145545112|NCT00884312|524856157|FG001|Overall Study|Physician Decision|1|||
145545113|NCT00884312|524856156|FG000|Overall Study|Other|0|||
145545114|NCT00884312|524856157|FG001|Overall Study|Other|4|||
145545115|NCT00884312|524856156|FG000|Overall Study|Did Not Receive Study Drug|0|||
145545116|NCT00884312|524856157|FG001|Overall Study|Did Not Receive Study Drug|1|||
145545117|NCT00224042|524856158|FG000|Overall Study|Adverse Event|2|||
145545118|NCT00224042|524856159|FG001|Overall Study|Adverse Event|1|||
145545119|NCT00224042|524856158|FG000|Overall Study|Protocol Violation|0|||
145545120|NCT00224042|524856159|FG001|Overall Study|Protocol Violation|1|||
145545121|NCT00224042|524856158|FG000|Overall Study|Physician Decision|0|||
145545122|NCT00224042|524856159|FG001|Overall Study|Physician Decision|1|||
145545123|NCT00224042|524856158|FG000|Overall Study|Did not meet lab incusion criteria|2|||
145545124|NCT00224042|524856159|FG001|Overall Study|Did not meet lab incusion criteria|3|||
145545125|NCT00224042|524856158|FG000|Overall Study|Other|2|||
145545126|NCT00224042|524856159|FG001|Overall Study|Other|0|||
145545127|NCT00840450|524856160|FG000|Overall Study|Adverse Event|1|||
145545128|NCT00840450|524856160|FG000|Overall Study|Lack of Efficacy|2|||
145545129|NCT00617123|524856161|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
145545130|NCT00617123|524856162|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
145545131|NCT00617123|524856161|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
145545132|NCT00617123|524856162|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
145545133|NCT00617123|524856161|FG000|Referral Screening Period|Adverse Event|0|||
145545134|NCT00617123|524856162|FG001|Referral Screening Period|Adverse Event|1|||
145545135|NCT00617123|524856161|FG000|Study Treatment Period|Withdrawal by Subject|8|||
145545136|NCT00617123|524856162|FG001|Study Treatment Period|Withdrawal by Subject|12|||
145545137|NCT00617123|524856161|FG000|Study Treatment Period|Adverse Event|7|||
145545138|NCT00617123|524856162|FG001|Study Treatment Period|Adverse Event|3|||
145545139|NCT00617123|524856161|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
145545140|NCT00617123|524856162|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
145545141|NCT00617123|524856161|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
145545142|NCT00617123|524856162|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
145545143|NCT00133952|524856164|FG000|Overall Study|Adverse Event|1|||
145545144|NCT00133952|524856165|FG001|Overall Study|Adverse Event|2|||
145282572|NCT00606684|523884273|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145282573|NCT00606684|523884274|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145282574|NCT00606684|523884275|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145545145|NCT00133952|524856164|FG000|Overall Study|Death|3|||
145545146|NCT00133952|524856165|FG001|Overall Study|Death|2|||
145545147|NCT00133952|524856164|FG000|Overall Study|Lost to Follow-up|9|||
145545148|NCT00133952|524856165|FG001|Overall Study|Lost to Follow-up|14|||
145545149|NCT00133952|524856164|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
145545150|NCT00133952|524856165|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
145545151|NCT00133952|524856164|FG000|Overall Study|Protocol Violation|1|||
145545152|NCT00133952|524856165|FG001|Overall Study|Protocol Violation|1|||
145545153|NCT00133952|524856164|FG000|Overall Study|Withdrawal by Subject|20|||
145545154|NCT00133952|524856165|FG001|Overall Study|Withdrawal by Subject|4|||
145545155|NCT00133952|524856164|FG000|Overall Study|Physician Decision|4|||
145545156|NCT00133952|524856165|FG001|Overall Study|Physician Decision|3|||
145545157|NCT00133952|524856164|FG000|Overall Study|Sponsor Decision|0|||
145545158|NCT00133952|524856165|FG001|Overall Study|Sponsor Decision|1|||
145545159|NCT03052725|524856166|FG000|Overall Study|Adverse Event|2|||
145545160|NCT03052725|524856167|FG001|Overall Study|Adverse Event|0|||
145545161|NCT03052725|524856166|FG000|Overall Study|Withdrawal by Subject|3|||
145545162|NCT03052725|524856167|FG001|Overall Study|Withdrawal by Subject|4|||
145545163|NCT03052725|524856166|FG000|Overall Study|Pregnancy|0|||
145545164|NCT03052725|524856167|FG001|Overall Study|Pregnancy|1|||
145545165|NCT03052725|524856166|FG000|Overall Study|Site closure|0|||
145545166|NCT03052725|524856167|FG001|Overall Study|Site closure|1|||
145545167|NCT03052725|524856166|FG000|Overall Study|Study terminated by sponsor|143|||
145545168|NCT03052725|524856167|FG001|Overall Study|Study terminated by sponsor|144|||
145545169|NCT03462082|524856171|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145545170|NCT03462082|524856172|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145545171|NCT03462082|524856173|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145545172|NCT03462082|524856174|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145545173|NCT03462082|524856175|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145610858|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
145545174|NCT03462082|524856176|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
145545175|NCT03462082|524856177|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
145545176|NCT03462082|524856178|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
145545177|NCT02548650|524856191|FG000|Triple Therapy|Adverse Event|1|||
145545178|NCT02548650|524856192|FG001|Triple Therapy|Adverse Event|0|||
145545179|NCT02548650|524856191|FG000|Triple Therapy|Withdrawal by Subject|0|||
145545180|NCT02548650|524856192|FG001|Triple Therapy|Withdrawal by Subject|4|||
145545181|NCT02548650|524856191|FG000|Double Therapy|Adverse Event|1|||
145545182|NCT02548650|524856192|FG001|Double Therapy|Adverse Event|1|||
145610859|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
145610860|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
145610861|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
145610862|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
145610863|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
145610864|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
145610865|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
145610866|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
145610867|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
145610868|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
145610869|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
145610870|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
145610871|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
145610872|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
145610873|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
145610874|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
145610875|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
145610876|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
145610877|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
145404791|NCT01983930|524338682|FG000|Overall Study|Adverse Event|0|||
145404792|NCT01983930|524338683|FG001|Overall Study|Adverse Event|1|||
145404793|NCT00393367|524338686|FG000|Overall Study|Protocol Violation|2|||
145404794|NCT00393367|524338687|FG001|Overall Study|Protocol Violation|5|||
145404795|NCT00393367|524338686|FG000|Overall Study|Withdrawal by Subject|0|||
145404796|NCT00393367|524338687|FG001|Overall Study|Withdrawal by Subject|2|||
145404797|NCT00915525|524338688|FG000|Overall Study|Protocol Violation|9|||
145404798|NCT00915525|524338689|FG001|Overall Study|Protocol Violation|4|||
145545183|NCT02548650|524856191|FG000|Double Therapy|Withdrawal by Subject|0|||
145545184|NCT02548650|524856192|FG001|Double Therapy|Withdrawal by Subject|1|||
145545185|NCT02128113|524856194|FG000|Overall Study|Withdrawal by Subject|3|||
145545186|NCT02128113|524856195|FG001|Overall Study|Withdrawal by Subject|1|||
145610878|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
145610879|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
145610880|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
145610881|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
145610882|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
145610883|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
145610884|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
145610885|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
145610886|NCT02778399|525089931|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
145610887|NCT02778399|525089932|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
145610888|NCT02778399|525089933|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
145545187|NCT02128113|524856196|FG002|Overall Study|Withdrawal by Subject|0|||
145610889|NCT02778399|525089934|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
145610890|NCT02778399|525089935|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
145610891|NCT02778399|525089936|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
145610892|NCT00386308|525092515|FG000|Overall Study|Adverse Event|3|||
145610893|NCT00386308|525092516|FG001|Overall Study|Adverse Event|3|||
145610894|NCT00386308|525092515|FG000|Overall Study|Protocol Violation|2|||
145610895|NCT00386308|525092516|FG001|Overall Study|Protocol Violation|5|||
145610896|NCT00386308|525092515|FG000|Overall Study|Lack of Efficacy|0|||
145610897|NCT00386308|525092516|FG001|Overall Study|Lack of Efficacy|2|||
145610898|NCT00386308|525092515|FG000|Overall Study|Lost to Follow-up|10|||
145545188|NCT02128113|524856194|FG000|Overall Study|Protocol Violation|0|||
145545189|NCT02128113|524856195|FG001|Overall Study|Protocol Violation|1|||
145404799|NCT00915525|524338688|FG000|Overall Study|Withdrawal by Subject|59|||
145404800|NCT00915525|524338689|FG001|Overall Study|Withdrawal by Subject|21|||
145545190|NCT02128113|524856196|FG002|Overall Study|Protocol Violation|0|||
145404801|NCT00915525|524338688|FG000|Overall Study|Lost to Follow-up|27|||
145545191|NCT02128113|524856194|FG000|Overall Study|Surgery cancelled|0|||
145545192|NCT02128113|524856195|FG001|Overall Study|Surgery cancelled|1|||
145545193|NCT02128113|524856196|FG002|Overall Study|Surgery cancelled|0|||
145545194|NCT02128113|524856194|FG000|Overall Study|Adverse Event|0|||
145545195|NCT02128113|524856195|FG001|Overall Study|Adverse Event|0|||
145545196|NCT02128113|524856196|FG002|Overall Study|Adverse Event|1|||
145545197|NCT01061177|524856197|FG000|Overall Study|Adverse Event|117|||
145545198|NCT01061177|524856197|FG000|Overall Study|Withdrawal by Subject|27|||
145545199|NCT01061177|524856197|FG000|Overall Study|Disease progression|17|||
145545200|NCT01061177|524856197|FG000|Overall Study|Protocol Violation|11|||
145545201|NCT01061177|524856197|FG000|Overall Study|Lost to Follow-up|9|||
145545202|NCT01061177|524856197|FG000|Overall Study|New cancer therapy|9|||
145545203|NCT01061177|524856197|FG000|Overall Study|Abnormal laboratory values|6|||
145545204|NCT01061177|524856197|FG000|Overall Study|Abnormal test procedure results|4|||
145545205|NCT01061177|524856197|FG000|Overall Study|Administratie problems|4|||
145545206|NCT01061177|524856197|FG000|Overall Study|Death|4|||
145545207|NCT05147350|524856201|FG000|Overall Study|Death|2|||
145545208|NCT05147350|524856202|FG001|Overall Study|Death|3|||
145545209|NCT05147350|524856203|FG002|Overall Study|Death|3|||
145545210|NCT05147350|524856204|FG003|Overall Study|Death|2|||
145545211|NCT05147350|524856205|FG004|Overall Study|Death|2|||
145545212|NCT05147350|524856206|FG005|Overall Study|Death|1|||
145545213|NCT05147350|524856207|FG006|Overall Study|Death|1|||
145545214|NCT05147350|524856208|FG007|Overall Study|Death|3|||
145545215|NCT05147350|524856201|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
145545216|NCT05147350|524856202|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
145545217|NCT05147350|524856203|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
145545218|NCT05147350|524856204|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
145545219|NCT05147350|524856205|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
145545220|NCT05147350|524856206|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
145545221|NCT05147350|524856207|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
145545222|NCT05147350|524856208|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
145545223|NCT05147350|524856201|FG000|Overall Study|Withdrawal by Subject|0|||
145545224|NCT05147350|524856202|FG001|Overall Study|Withdrawal by Subject|0|||
145545225|NCT05147350|524856203|FG002|Overall Study|Withdrawal by Subject|3|||
145545226|NCT05147350|524856204|FG003|Overall Study|Withdrawal by Subject|1|||
145545227|NCT05147350|524856205|FG004|Overall Study|Withdrawal by Subject|1|||
145545228|NCT05147350|524856206|FG005|Overall Study|Withdrawal by Subject|0|||
145545229|NCT05147350|524856207|FG006|Overall Study|Withdrawal by Subject|1|||
145545230|NCT05147350|524856208|FG007|Overall Study|Withdrawal by Subject|0|||
145545231|NCT05147350|524856201|FG000|Overall Study|Other Reasons|0|||
145545232|NCT05147350|524856202|FG001|Overall Study|Other Reasons|0|||
145545233|NCT05147350|524856203|FG002|Overall Study|Other Reasons|2|||
145545234|NCT05147350|524856204|FG003|Overall Study|Other Reasons|0|||
145545235|NCT05147350|524856205|FG004|Overall Study|Other Reasons|0|||
145545236|NCT05147350|524856206|FG005|Overall Study|Other Reasons|2|||
145545237|NCT05147350|524856207|FG006|Overall Study|Other Reasons|1|||
145545238|NCT05147350|524856208|FG007|Overall Study|Other Reasons|1|||
145545239|NCT01539538|524856209|FG000|Overall Study|Adverse Event|13|||
145545240|NCT01539538|524856210|FG001|Overall Study|Adverse Event|18|||
145545241|NCT01539538|524856209|FG000|Overall Study|Lack of Efficacy|13|||
145545242|NCT01539538|524856210|FG001|Overall Study|Lack of Efficacy|16|||
145545243|NCT01539538|524856209|FG000|Overall Study|Withdrawal by Subject|2|||
145545244|NCT01539538|524856210|FG001|Overall Study|Withdrawal by Subject|3|||
145545245|NCT01539538|524856209|FG000|Overall Study|PCA no longer required or PCA problem|3|||
145545246|NCT01539538|524856210|FG001|Overall Study|PCA no longer required or PCA problem|7|||
145545247|NCT00847379|524856211|FG000|Overall Study|Study terminated by Sponsor|59|||
145545248|NCT00847379|524856212|FG001|Overall Study|Study terminated by Sponsor|57|||
145545249|NCT00847379|524856213|FG002|Overall Study|Study terminated by Sponsor|57|||
145545250|NCT00521014|524856214|FG000|Overall Study|Inevaluable, not treated|1|||
145545251|NCT03978832|524856215|FG000|Overall Study|Adverse Event|1|||
145545252|NCT03978832|524856215|FG000|Overall Study|Lost to Follow-up|1|||
145545253|NCT03978832|524856215|FG000|Overall Study|Withdrawal by Subject|6|||
145545254|NCT03978832|524856215|FG000|Overall Study|Physician Decision|2|||
145545255|NCT03978832|524856215|FG000|Overall Study|did not pass screening criteria|44|||
145545256|NCT02864498|524856220|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
145545257|NCT02864498|524856221|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
145545258|NCT02864498|524856222|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
145545259|NCT02864498|524856220|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
145545260|NCT02864498|524856221|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
145545261|NCT02864498|524856222|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
145545262|NCT02864498|524856220|FG000|Overall Study|Investigator Discretion|0|||
145545263|NCT02864498|524856221|FG001|Overall Study|Investigator Discretion|2|||
145545264|NCT02864498|524856222|FG002|Overall Study|Investigator Discretion|1|||
145545265|NCT02864498|524856220|FG000|Overall Study|Lost to Follow-up|8|||
145545266|NCT02864498|524856221|FG001|Overall Study|Lost to Follow-up|6|||
145545267|NCT02864498|524856222|FG002|Overall Study|Lost to Follow-up|3|||
145545268|NCT02864498|524856220|FG000|Overall Study|Lack of Efficacy|5|||
145545269|NCT02864498|524856221|FG001|Overall Study|Lack of Efficacy|3|||
145545270|NCT02864498|524856222|FG002|Overall Study|Lack of Efficacy|3|||
145545271|NCT02864498|524856220|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
145545272|NCT02864498|524856221|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
145610899|NCT00386308|525092516|FG001|Overall Study|Lost to Follow-up|6|||
145545273|NCT02864498|524856222|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
145545274|NCT02864498|524856220|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
145545275|NCT02864498|524856221|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
145545276|NCT02864498|524856222|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
145545277|NCT02864498|524856220|FG000|Overall Study|Subject moved out of the country.|0|||
145545278|NCT02864498|524856221|FG001|Overall Study|Subject moved out of the country.|0|||
145545279|NCT02864498|524856222|FG002|Overall Study|Subject moved out of the country.|1|||
145545280|NCT01256008|524856223|FG000|Overall Study|Lost to Follow-up|6|||
145545281|NCT01256008|524856224|FG001|Overall Study|Lost to Follow-up|4|||
145545282|NCT01256008|524856225|FG002|Overall Study|Lost to Follow-up|11|||
145545283|NCT01256008|524856223|FG000|Overall Study|Withdrawal by Subject|2|||
145545284|NCT01256008|524856224|FG001|Overall Study|Withdrawal by Subject|3|||
145545285|NCT01256008|524856225|FG002|Overall Study|Withdrawal by Subject|10|||
145545286|NCT02244606|524856226|FG000|Overall Study|Adverse Event|0|||
145545287|NCT02244606|524856227|FG001|Overall Study|Adverse Event|1|||
145545288|NCT02244606|524856228|FG002|Overall Study|Adverse Event|1|||
145545289|NCT02244606|524856229|FG003|Overall Study|Adverse Event|0|||
145545290|NCT02244606|524856226|FG000|Overall Study|Lost to Follow-up|2|||
145545291|NCT02244606|524856227|FG001|Overall Study|Lost to Follow-up|2|||
145545292|NCT02244606|524856228|FG002|Overall Study|Lost to Follow-up|1|||
145545293|NCT02244606|524856229|FG003|Overall Study|Lost to Follow-up|0|||
145545294|NCT02244606|524856226|FG000|Overall Study|Protocol Violation|0|||
145545295|NCT02244606|524856227|FG001|Overall Study|Protocol Violation|0|||
145545296|NCT02244606|524856228|FG002|Overall Study|Protocol Violation|0|||
145545297|NCT02244606|524856229|FG003|Overall Study|Protocol Violation|1|||
145545298|NCT02244606|524856226|FG000|Overall Study|Withdrawal by Subject|1|||
145545299|NCT02244606|524856227|FG001|Overall Study|Withdrawal by Subject|1|||
145545300|NCT02244606|524856228|FG002|Overall Study|Withdrawal by Subject|0|||
145545301|NCT02244606|524856229|FG003|Overall Study|Withdrawal by Subject|0|||
145545302|NCT02244606|524856226|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
145545303|NCT02244606|524856227|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
145545304|NCT02244606|524856228|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
145545305|NCT02244606|524856229|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
145545306|NCT00378378|524856232|FG000|Overall Study|Withdrawal by Subject|0|||
145545307|NCT00378378|524856233|FG001|Overall Study|Withdrawal by Subject|1|||
145545308|NCT00378378|524856234|FG002|Overall Study|Withdrawal by Subject|0|||
145545309|NCT00378378|524856232|FG000|Overall Study|Treatment Failure|0|||
145545310|NCT00378378|524856233|FG001|Overall Study|Treatment Failure|0|||
145545311|NCT00378378|524856234|FG002|Overall Study|Treatment Failure|1|||
145545312|NCT00378378|524856232|FG000|Overall Study|Non-compliance with protocol|0|||
145545313|NCT00378378|524856233|FG001|Overall Study|Non-compliance with protocol|0|||
145545314|NCT00378378|524856234|FG002|Overall Study|Non-compliance with protocol|1|||
145545315|NCT01402492|524856235|FG000|Overall Study|Withdrawal by Subject|17|||
145545316|NCT01402492|524856236|FG001|Overall Study|Withdrawal by Subject|11|||
145545317|NCT01402492|524856237|FG002|Overall Study|Withdrawal by Subject|11|||
145545318|NCT01402492|524856235|FG000|Overall Study|Adverse Event|2|||
145545319|NCT01402492|524856236|FG001|Overall Study|Adverse Event|3|||
145545320|NCT01402492|524856237|FG002|Overall Study|Adverse Event|4|||
145545321|NCT01402492|524856235|FG000|Overall Study|Physician Decision|0|||
145545322|NCT01402492|524856236|FG001|Overall Study|Physician Decision|3|||
145545323|NCT01402492|524856237|FG002|Overall Study|Physician Decision|0|||
145545324|NCT01402492|524856235|FG000|Overall Study|Incarcerated (N=3)|2|||
145545325|NCT01402492|524856236|FG001|Overall Study|Incarcerated (N=3)|0|||
145545326|NCT01402492|524856237|FG002|Overall Study|Incarcerated (N=3)|1|||
145545327|NCT01336764|524856239|FG000|Overall Study|Withdrawal by Subject|5|||
145545328|NCT01336764|524856240|FG001|Overall Study|Withdrawal by Subject|5|||
145545329|NCT05537883|524856242|FG000|Overall Study|revisional surgery|4|||
145545330|NCT05537883|524856243|FG001|Overall Study|revisional surgery|2|||
145404802|NCT00915525|524338689|FG001|Overall Study|Lost to Follow-up|16|||
145404803|NCT00915525|524338688|FG000|Overall Study|Pregnancy|2|||
145404804|NCT00915525|524338689|FG001|Overall Study|Pregnancy|0|||
145404805|NCT00915525|524338688|FG000|Overall Study|Lack of Efficacy|15|||
145404806|NCT00915525|524338689|FG001|Overall Study|Lack of Efficacy|32|||
145404807|NCT00915525|524338688|FG000|Overall Study|Adverse Event|29|||
145404808|NCT00915525|524338689|FG001|Overall Study|Adverse Event|13|||
145404809|NCT00915525|524338688|FG000|Overall Study|Missing|12|||
145545331|NCT05537883|524856242|FG000|Overall Study|surgeries were cancelled|0|||
145545332|NCT05537883|524856243|FG001|Overall Study|surgeries were cancelled|2|||
145282575|NCT00606684|523884276|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145282576|NCT00606684|523884277|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145545333|NCT05537883|524856242|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
145545334|NCT05537883|524856243|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
145404810|NCT00915525|524338689|FG001|Overall Study|Missing|1|||
145404811|NCT00915525|524338688|FG000|Overall Study|Other Reason|35|||
145545335|NCT02099708|524856244|FG000|Overall Study|Data Not Available|30|||
145545336|NCT02099708|524856244|FG000|Overall Study|Lost to Follow-up|141|||
145545337|NCT02099708|524856244|FG000|Overall Study|Other|29|||
145545338|NCT01049308|524856245|FG000|Pill Counts|Withdrawal by Subject|83|||
145545339|NCT03845985|524856246|FG000|Overall Study|Lost to Follow-up|2|||
145545340|NCT03845985|524856247|FG001|Overall Study|Lost to Follow-up|1|||
145545341|NCT03845985|524856246|FG000|Overall Study|Physician Decision|1|||
145545342|NCT03845985|524856247|FG001|Overall Study|Physician Decision|0|||
145545343|NCT03845985|524856246|FG000|Overall Study|Withdrawal by Subject|4|||
145545344|NCT03845985|524856247|FG001|Overall Study|Withdrawal by Subject|1|||
145545345|NCT01318993|524856248|FG000|Overall Study|Adverse Event|53|||
145545346|NCT01318993|524856248|FG000|Overall Study|Lack of Efficacy|121|||
145545347|NCT01318993|524856248|FG000|Overall Study|Protocol Violation|3|||
145545348|NCT01318993|524856248|FG000|Overall Study|Protocol based stopping criteria|6|||
145545349|NCT01318993|524856248|FG000|Overall Study|Study closed or terminated|174|||
145545350|NCT01318993|524856248|FG000|Overall Study|Lost to Follow-up|4|||
145545351|NCT01318993|524856248|FG000|Overall Study|Physician Decision|13|||
145545352|NCT01318993|524856248|FG000|Overall Study|Withdrawal by Subject|24|||
145545353|NCT04974697|524856249|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
145545354|NCT04974697|524856249|FG000|Overall Study|Lens discomfort|1|||
145545355|NCT03706456|524856250|FG000|Overall Study|Adverse Event|1|||
145545356|NCT03706456|524856250|FG000|Overall Study|Lack of Efficacy|2|||
145545357|NCT03302234|524856251|FG000|Overall Study|Death|191|||
145545358|NCT03302234|524856252|FG001|Overall Study|Death|192|||
145545359|NCT03302234|524856251|FG000|Overall Study|Withdrawal by Subject|2|||
145545360|NCT03302234|524856252|FG001|Overall Study|Withdrawal by Subject|2|||
145545361|NCT03302234|524856251|FG000|Overall Study|Sponsor Decision|90|||
145545362|NCT03302234|524856252|FG001|Overall Study|Sponsor Decision|89|||
145545363|NCT03302234|524856251|FG000|Overall Study|Laryngeal carcinoma|0|||
145545364|NCT03302234|524856252|FG001|Overall Study|Laryngeal carcinoma|1|||
145545365|NCT03302234|524856251|FG000|Overall Study|Not Reported|1|||
145545366|NCT03302234|524856252|FG001|Overall Study|Not Reported|0|||
145545367|NCT02795832|524856255|FG000|Overall Study|Adverse Event|0|||
145545368|NCT02795832|524856256|FG001|Overall Study|Adverse Event|0|||
145545369|NCT02795832|524856257|FG002|Overall Study|Adverse Event|0|||
145545370|NCT02795832|524856258|FG003|Overall Study|Adverse Event|0|||
145545371|NCT02795832|524856259|FG004|Overall Study|Adverse Event|0|||
145545372|NCT02795832|524856260|FG005|Overall Study|Adverse Event|3|||
145545373|NCT01845831|524856261|FG000|Inpatient Phase|Withdrawal by Subject|1|||
145545374|NCT01845831|524856262|FG001|Inpatient Phase|Withdrawal by Subject|1|||
145545375|NCT01845831|524856263|FG002|Inpatient Phase|Withdrawal by Subject|0|||
145545376|NCT01845831|524856264|FG003|Inpatient Phase|Withdrawal by Subject|0|||
145545377|NCT01845831|524856265|FG004|Inpatient Phase|Withdrawal by Subject|0|||
145545378|NCT00221403|524856266|FG000|Overall Study|Protocol Violation|1|||
145545379|NCT00221403|524856267|FG001|Overall Study|Protocol Violation|0|||
145545380|NCT00221403|524856268|FG002|Overall Study|Protocol Violation|0|||
145545381|NCT00221403|524856266|FG000|Overall Study|Physician Decision|1|||
145545382|NCT00221403|524856267|FG001|Overall Study|Physician Decision|0|||
145545383|NCT00221403|524856268|FG002|Overall Study|Physician Decision|0|||
145545384|NCT00221403|524856266|FG000|Overall Study|Withdrawal by Subject|0|||
145545385|NCT00221403|524856267|FG001|Overall Study|Withdrawal by Subject|3|||
145545386|NCT00221403|524856268|FG002|Overall Study|Withdrawal by Subject|0|||
145545387|NCT00221403|524856266|FG000|Overall Study|Lack of Efficacy|0|||
145545388|NCT00221403|524856267|FG001|Overall Study|Lack of Efficacy|1|||
145545389|NCT00221403|524856268|FG002|Overall Study|Lack of Efficacy|0|||
145545390|NCT00221403|524856266|FG000|Overall Study|Adverse Event|0|||
145545391|NCT00221403|524856267|FG001|Overall Study|Adverse Event|1|||
145545392|NCT00221403|524856268|FG002|Overall Study|Adverse Event|0|||
145545393|NCT02695329|524856269|FG000|Overall Study|Adverse Event|1|||
145545394|NCT02695329|524856270|FG001|Overall Study|Adverse Event|0|||
145545395|NCT02695329|524856269|FG000|Overall Study|Poor X-ray quality for measurement|4|||
145545396|NCT02695329|524856270|FG001|Overall Study|Poor X-ray quality for measurement|5|||
145545397|NCT01348165|524856271|FG000|Overall Study|Adverse Event|0|||
145545398|NCT01348165|524856272|FG001|Overall Study|Adverse Event|0|||
145545399|NCT01348165|524856273|FG002|Overall Study|Adverse Event|0|||
145545400|NCT01348165|524856274|FG003|Overall Study|Adverse Event|0|||
145545401|NCT01348165|524856275|FG004|Overall Study|Adverse Event|0|||
145545402|NCT01348165|524856276|FG005|Overall Study|Adverse Event|0|||
145545403|NCT01348165|524856277|FG006|Overall Study|Adverse Event|1|||
145545404|NCT01929343|524856278|FG000|Overall Study|Physician Decision|0|||
145545405|NCT01929343|524856279|FG001|Overall Study|Physician Decision|2|||
145545406|NCT01929343|524856280|FG002|Overall Study|Physician Decision|0|||
145545407|NCT01929343|524856278|FG000|Overall Study|Withdrawal by Subject|1|||
145545408|NCT01929343|524856279|FG001|Overall Study|Withdrawal by Subject|0|||
145545409|NCT01929343|524856280|FG002|Overall Study|Withdrawal by Subject|0|||
145545410|NCT01892293|524857656|FG000|Overall Study|Apheresed but not treated|4|||
145545411|NCT03602482|524857657|FG000|Overall Study|Withdrawal by Subject|6|||
145545412|NCT03602482|524857658|FG001|Overall Study|Withdrawal by Subject|7|||
145545413|NCT03602482|524857659|FG002|Overall Study|Withdrawal by Subject|0|||
145545414|NCT03602482|524857660|FG003|Overall Study|Withdrawal by Subject|0|||
145545415|NCT02601469|524857663|FG000|Overall Study|Enrolled in Error|1|||
145545416|NCT02601469|524857664|FG001|Overall Study|Enrolled in Error|0|||
145545417|NCT01411774|524857669|FG000|Overall Study|Withdrawal by Subject|0|||
145545418|NCT01411774|524857670|FG001|Overall Study|Withdrawal by Subject|3|||
145545419|NCT00056316|524857671|FG000|Overall Study|Withdrawal by Subject|2|||
145545420|NCT00056316|524857672|FG001|Overall Study|Withdrawal by Subject|2|||
145545421|NCT00056316|524857671|FG000|Overall Study|Death/NH placement of pt|1|||
145545422|NCT00056316|524857672|FG001|Overall Study|Death/NH placement of pt|1|||
145545423|NCT02820753|524857673|FG000|2 Month|Withdrawal by Subject|3|||
145545424|NCT02820753|524857674|FG001|2 Month|Withdrawal by Subject|3|||
145545425|NCT02820753|524857673|FG000|2 Month|Lost to Follow-up|24|||
145545426|NCT02820753|524857674|FG001|2 Month|Lost to Follow-up|26|||
145545427|NCT02820753|524857673|FG000|2 Month|Stopped per NIH Hold|51|||
145545428|NCT02820753|524857674|FG001|2 Month|Stopped per NIH Hold|13|||
145545429|NCT02820753|524857673|FG000|6 Month|Withdrawal by Subject|2|||
145545430|NCT02820753|524857674|FG001|6 Month|Withdrawal by Subject|2|||
145545431|NCT02820753|524857673|FG000|6 Month|Lost to Follow-up|20|||
145545432|NCT02820753|524857674|FG001|6 Month|Lost to Follow-up|27|||
145545433|NCT02820753|524857673|FG000|6 Month|Stopped per NIH Hold|81|||
145545434|NCT02820753|524857674|FG001|6 Month|Stopped per NIH Hold|81|||
145545435|NCT02820753|524857673|FG000|6 Month|Death|0|||
145545436|NCT02820753|524857674|FG001|6 Month|Death|1|||
145545437|NCT02161731|524857675|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
145545438|NCT02161731|524857676|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
145545439|NCT02161731|524857675|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
145545440|NCT02161731|524857676|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
145545441|NCT01315678|524857681|FG000|Overall Study|Withdrawal by Subject|7|||
145545442|NCT01315678|524857682|FG001|Overall Study|Withdrawal by Subject|3|||
145545443|NCT01315678|524857681|FG000|Overall Study|Adverse Event|3|||
145545444|NCT01315678|524857682|FG001|Overall Study|Adverse Event|1|||
145545445|NCT01315678|524857681|FG000|Overall Study|Lost to Follow-up|1|||
145545446|NCT01315678|524857682|FG001|Overall Study|Lost to Follow-up|0|||
145545447|NCT01315678|524857681|FG000|Overall Study|similar reason to those listed above|3|||
145545448|NCT01315678|524857682|FG001|Overall Study|similar reason to those listed above|2|||
145545449|NCT05048784|524857690|FG000|Period 1|Adverse Event|3|||
145545450|NCT05048784|524857691|FG001|Period 1|Adverse Event|1|||
145545451|NCT05048784|524857692|FG002|Period 1|Adverse Event|0|||
145545452|NCT05048784|524857693|FG003|Period 1|Adverse Event|0|||
145545453|NCT05048784|524857690|FG000|Period 2|Lost to Follow-up|0|||
145545454|NCT05048784|524857691|FG001|Period 2|Lost to Follow-up|1|||
145545455|NCT05048784|524857692|FG002|Period 2|Lost to Follow-up|0|||
145545456|NCT05048784|524857693|FG003|Period 2|Lost to Follow-up|0|||
145545457|NCT02269241|524857696|FG000|Overall Study|Lost to Follow-up|269|||
145545458|NCT02269241|524857696|FG000|Overall Study|Withdrawal by Subject|155|||
145545459|NCT02269241|524857696|FG000|Overall Study|Protocol Violation|1|||
145545460|NCT02269241|524857696|FG000|Overall Study|Physician Decision|7|||
145545461|NCT02269241|524857696|FG000|Overall Study|Pregnancy|15|||
145545462|NCT02269241|524857696|FG000|Overall Study|Wish for pregnancy|5|||
145545463|NCT02269241|524857696|FG000|Overall Study|Development of an exclusion criteria|16|||
145545464|NCT02269241|524857696|FG000|Overall Study|Adverse Event|113|||
145545465|NCT02269241|524857696|FG000|Overall Study|At the specific request of the sponsor|20|||
145610900|NCT00386308|525092515|FG000|Overall Study|Withdrawal by Subject|6|||
145610901|NCT00386308|525092516|FG001|Overall Study|Withdrawal by Subject|2|||
145610902|NCT00386308|525092515|FG000|Overall Study|Other Event|8|||
145610903|NCT00386308|525092516|FG001|Overall Study|Other Event|1|||
145610904|NCT01167179|525092517|FG000|Overall Study|disease recurrence|4|||
145610905|NCT01167179|525092518|FG001|Overall Study|disease recurrence|4|||
145610906|NCT01167179|525092517|FG000|Overall Study|Death|4|||
145610907|NCT01167179|525092518|FG001|Overall Study|Death|10|||
145545466|NCT02269241|524857696|FG000|Overall Study|Several reasons not classified|53|||
145545467|NCT02269241|524857696|FG000|Overall Study|Screening failures|546|||
145545468|NCT03020160|524857697|FG000|Overall Study|Withdrawal by Subject|1|||
145545469|NCT03020160|524857698|FG001|Overall Study|Withdrawal by Subject|0|||
145545470|NCT02270957|524857699|FG000|Overall Study|Lack of Efficacy|2|||
145545471|NCT02270957|524857700|FG001|Overall Study|Lack of Efficacy|4|||
145545472|NCT02270957|524857699|FG000|Overall Study|Adverse Event|2|||
145545473|NCT02270957|524857700|FG001|Overall Study|Adverse Event|0|||
145610908|NCT01167179|525092517|FG000|Overall Study|Withdrawal by Subject|1|||
145610909|NCT01167179|525092518|FG001|Overall Study|Withdrawal by Subject|2|||
145545474|NCT01513473|524857701|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
145545475|NCT01513473|524857702|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
145545476|NCT01513473|524857701|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
145545477|NCT01513473|524857702|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
145545478|NCT01513473|524857701|FG000|Main Trial (26 Weeks)|Unclassified|0|||
145545479|NCT01513473|524857702|FG001|Main Trial (26 Weeks)|Unclassified|2|||
145545480|NCT01513473|524857701|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
145545481|NCT01513473|524857702|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
145610910|NCT01167179|525092517|FG000|Overall Study|diverse|6|||
145545482|NCT01513473|524857701|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
145545483|NCT01513473|524857702|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
145545484|NCT00166114|524857706|FG000|Overall Study|Protocol Violation|2|||
145545485|NCT00166114|524857707|FG001|Overall Study|Protocol Violation|1|||
145545486|NCT00166114|524857706|FG000|Overall Study|Withdrawal by Subject|10|||
145545487|NCT00166114|524857707|FG001|Overall Study|Withdrawal by Subject|4|||
145404812|NCT00915525|524338689|FG001|Overall Study|Other Reason|12|||
145404813|NCT00915525|524338688|FG000|Overall Study|Site Closed|27|||
145545488|NCT00166114|524857706|FG000|Overall Study|Adverse Event|2|||
145545489|NCT00166114|524857707|FG001|Overall Study|Adverse Event|1|||
145545490|NCT00545168|524857714|FG000|Overall Study|Lost to Follow-up|5|||
145545491|NCT00545168|524857715|FG001|Overall Study|Lost to Follow-up|5|||
145545492|NCT00545168|524857716|FG002|Overall Study|Lost to Follow-up|5|||
145545493|NCT00545168|524857714|FG000|Overall Study|Withdrawal by Subject|9|||
145545494|NCT00545168|524857715|FG001|Overall Study|Withdrawal by Subject|0|||
145545495|NCT00545168|524857716|FG002|Overall Study|Withdrawal by Subject|13|||
145545496|NCT00545168|524857714|FG000|Overall Study|Protocol Violation|1|||
145545497|NCT00545168|524857715|FG001|Overall Study|Protocol Violation|0|||
145545498|NCT00545168|524857716|FG002|Overall Study|Protocol Violation|1|||
145545499|NCT00545168|524857714|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
145545500|NCT00545168|524857715|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
145545501|NCT00545168|524857716|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
145545502|NCT00299104|524857719|FG000|Treatment Period|Adverse Event|14|||
145545503|NCT00299104|524857720|FG001|Treatment Period|Adverse Event|9|||
145545504|NCT00299104|524857721|FG002|Treatment Period|Adverse Event|7|||
145545505|NCT00299104|524857719|FG000|Treatment Period|Death|1|||
145545506|NCT00299104|524857720|FG001|Treatment Period|Death|1|||
145545507|NCT00299104|524857721|FG002|Treatment Period|Death|1|||
145545508|NCT00299104|524857719|FG000|Treatment Period|Insufficient therapeutic response|34|||
145545509|NCT00299104|524857720|FG001|Treatment Period|Insufficient therapeutic response|13|||
145545510|NCT00299104|524857721|FG002|Treatment Period|Insufficient therapeutic response|8|||
145545511|NCT00299104|524857719|FG000|Treatment Period|Failure to return|9|||
145545512|NCT00299104|524857720|FG001|Treatment Period|Failure to return|8|||
145545513|NCT00299104|524857721|FG002|Treatment Period|Failure to return|8|||
145545514|NCT00299104|524857719|FG000|Treatment Period|Violation of selection criteria|1|||
145545515|NCT00299104|524857720|FG001|Treatment Period|Violation of selection criteria|2|||
145545516|NCT00299104|524857721|FG002|Treatment Period|Violation of selection criteria|0|||
145545517|NCT00299104|524857719|FG000|Treatment Period|Protocol Violation|1|||
145545518|NCT00299104|524857720|FG001|Treatment Period|Protocol Violation|1|||
145545519|NCT00299104|524857721|FG002|Treatment Period|Protocol Violation|0|||
145545520|NCT00299104|524857719|FG000|Treatment Period|Refused treatment|9|||
145545521|NCT00299104|524857720|FG001|Treatment Period|Refused treatment|2|||
145545522|NCT00299104|524857721|FG002|Treatment Period|Refused treatment|2|||
145545523|NCT00299104|524857719|FG000|Treatment Period|Withdrew consent|14|||
145404814|NCT00915525|524338689|FG001|Overall Study|Site Closed|9|||
145545524|NCT00299104|524857720|FG001|Treatment Period|Withdrew consent|19|||
145545525|NCT00299104|524857721|FG002|Treatment Period|Withdrew consent|9|||
145545526|NCT00299104|524857719|FG000|Treatment Period|Administrative reasons|106|||
145545527|NCT00299104|524857720|FG001|Treatment Period|Administrative reasons|120|||
145545528|NCT00299104|524857721|FG002|Treatment Period|Administrative reasons|137|||
145545529|NCT00299104|524857719|FG000|Safety Follow-Up (SFU) Period|Death|3|||
145545530|NCT00299104|524857720|FG001|Safety Follow-Up (SFU) Period|Death|2|||
145404815|NCT00915525|524338688|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
145545531|NCT00299104|524857721|FG002|Safety Follow-Up (SFU) Period|Death|1|||
145545532|NCT00299104|524857719|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
145545533|NCT00299104|524857720|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
145545534|NCT00299104|524857721|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
145545535|NCT00299104|524857719|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
145545536|NCT00299104|524857720|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
145545537|NCT00299104|524857721|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
145545538|NCT00299104|524857719|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
145545539|NCT00299104|524857720|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
145545540|NCT00299104|524857721|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
145545541|NCT00299104|524857719|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
145545542|NCT00299104|524857720|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
145545543|NCT00299104|524857721|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
145545544|NCT00299104|524857719|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
145545545|NCT00299104|524857720|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
145545546|NCT00299104|524857721|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
145545547|NCT00299104|524857719|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
145545548|NCT00299104|524857720|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
145545549|NCT00299104|524857721|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
145545550|NCT00299104|524857719|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
145545551|NCT00299104|524857720|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
145545552|NCT00299104|524857721|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
145545553|NCT04390191|524857731|FG000|Overall Study|Withdrawal by Subject|1|||
145545554|NCT04390191|524857732|FG001|Overall Study|Withdrawal by Subject|0|||
145545555|NCT00003499|524857733|FG000|Overall Study|Not evaluable|8|||
145545556|NCT02321800|524857736|FG000|Overall Study|Withdrawal by Subject|3|||
145545557|NCT02321800|524857737|FG001|Overall Study|Withdrawal by Subject|3|||
145545558|NCT02321800|524857736|FG000|Overall Study|Death|1|||
145545559|NCT02321800|524857737|FG001|Overall Study|Death|0|||
145545560|NCT02321800|524857736|FG000|Overall Study|Protocol Violation|1|||
145545561|NCT02321800|524857737|FG001|Overall Study|Protocol Violation|0|||
145545562|NCT02321800|524857736|FG000|Overall Study|Lost to Follow-up|10|||
145545563|NCT02321800|524857737|FG001|Overall Study|Lost to Follow-up|4|||
145545564|NCT02321800|524857736|FG000|Overall Study|Adverse Event|2|||
145545565|NCT02321800|524857737|FG001|Overall Study|Adverse Event|3|||
145545566|NCT02321800|524857736|FG000|Overall Study|Other, Miscellaneous|3|||
145545567|NCT02321800|524857737|FG001|Overall Study|Other, Miscellaneous|1|||
145545568|NCT02573311|524857742|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
145545569|NCT02573311|524857743|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
145545570|NCT02573311|524857742|FG000|Disposition for Part 2|Physician Decision|25|||
145545571|NCT02573311|524857743|FG001|Disposition for Part 2|Physician Decision|7|||
145545572|NCT02573311|524857742|FG000|Disposition for Part 2|Adverse Event|36|||
145545573|NCT02573311|524857743|FG001|Disposition for Part 2|Adverse Event|5|||
145545574|NCT02573311|524857742|FG000|Disposition for Part 2|Lost to Follow-up|76|||
145545575|NCT02573311|524857743|FG001|Disposition for Part 2|Lost to Follow-up|7|||
145545576|NCT02573311|524857742|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
145545577|NCT02573311|524857743|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
145545578|NCT02573311|524857742|FG000|Disposition for Part 2|Investigator decision|0|||
145545579|NCT02573311|524857743|FG001|Disposition for Part 2|Investigator decision|1|||
145545580|NCT02573311|524857742|FG000|Disposition for Part 2|Other than specified above|13|||
145545581|NCT02573311|524857743|FG001|Disposition for Part 2|Other than specified above|3|||
145545582|NCT05229406|524857745|FG000|Overall Study|Withdrawal by Subject|1|||
145545583|NCT05229406|524857746|FG001|Overall Study|Withdrawal by Subject|2|||
145545584|NCT00036270|524857747|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
145545585|NCT00036270|524857748|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
145545586|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
145545587|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
145545588|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
145545589|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
145545590|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
145545591|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
145545592|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Other|277|||
145545593|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Other|288|||
145545594|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
145545595|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
145545596|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
145545597|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
145545598|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
145545599|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
145545600|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
145545601|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
145545602|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
145404816|NCT00915525|524338689|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
145404817|NCT00915525|524338688|FG000|Overall Study|Study Burden|28|||
145404818|NCT00915525|524338689|FG001|Overall Study|Study Burden|12|||
145404819|NCT00915525|524338688|FG000|Overall Study|Non-Compliance|3|||
145545603|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
145545604|NCT00036270|524857747|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
145545605|NCT00036270|524857748|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
145282577|NCT01759381|523884280|FG000|Overall Study|Death|1|||
145282578|NCT01759381|523884281|FG001|Overall Study|Death|0|||
145282579|NCT01907737|523884286|FG000|Overall Study|Withdrawal by Subject|1|||
145282580|NCT02965820|523884289|FG000|Period 2, Second 30 Days|Adverse Event|1|||
145282581|NCT02965820|523884290|FG001|Period 2, Second 30 Days|Adverse Event|1|||
145282582|NCT01967888|523884291|FG000|Overall Study|Lost to Follow-up|6|||
145545606|NCT01370356|524857749|FG000|Overall Study|Death|1|||
145545607|NCT01370356|524857750|FG001|Overall Study|Death|0|||
145545608|NCT01370356|524857749|FG000|Overall Study|Lack of Efficacy|6|||
145545609|NCT01370356|524857750|FG001|Overall Study|Lack of Efficacy|28|||
145545610|NCT01370356|524857749|FG000|Overall Study|Lost to Follow-up|76|||
145545611|NCT01370356|524857750|FG001|Overall Study|Lost to Follow-up|81|||
145545612|NCT01370356|524857749|FG000|Overall Study|Withdrawal by Subject|54|||
145545613|NCT01370356|524857750|FG001|Overall Study|Withdrawal by Subject|59|||
145545614|NCT01370356|524857749|FG000|Overall Study|Reason not specified|39|||
145545615|NCT01370356|524857750|FG001|Overall Study|Reason not specified|43|||
145545616|NCT01370356|524857749|FG000|Overall Study|Protocol Violation|3|||
145545617|NCT01370356|524857750|FG001|Overall Study|Protocol Violation|3|||
145545618|NCT01370356|524857749|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
145545619|NCT01370356|524857750|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
145545620|NCT01370356|524857749|FG000|Overall Study|AE Not Related to Study Drug|1|||
145545621|NCT01370356|524857750|FG001|Overall Study|AE Not Related to Study Drug|4|||
145545622|NCT01874054|524857751|FG000|Overall Study|Withdrawal by Subject|3|||
145545623|NCT01874054|524857751|FG000|Overall Study|Study Termination by Sponsor|42|||
145545624|NCT01874054|524857751|FG000|Overall Study|Lost to Follow-up|5|||
145545625|NCT01874054|524857751|FG000|Overall Study|Death|5|||
145545626|NCT01233258|524857754|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
145545627|NCT01233258|524857755|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
145545628|NCT01233258|524857756|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
145545629|NCT01233258|524857757|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
145545630|NCT01233258|524857758|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
145545631|NCT01233258|524857759|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
145545632|NCT01233258|524857754|FG000|First Intervention (6 Months)|Protocol Violation|0|||
145545633|NCT01233258|524857755|FG001|First Intervention (6 Months)|Protocol Violation|0|||
145545634|NCT01233258|524857756|FG002|First Intervention (6 Months)|Protocol Violation|1|||
145545635|NCT01233258|524857757|FG003|First Intervention (6 Months)|Protocol Violation|0|||
145545636|NCT01233258|524857758|FG004|First Intervention (6 Months)|Protocol Violation|0|||
145545637|NCT01233258|524857759|FG005|First Intervention (6 Months)|Protocol Violation|0|||
145545638|NCT01233258|524857754|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
145545639|NCT01233258|524857755|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
145545640|NCT01233258|524857756|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
145545641|NCT01233258|524857757|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
145545642|NCT01233258|524857758|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
145545643|NCT01233258|524857759|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
145545644|NCT00799422|524857763|FG000|First Week of Wear|Lost to Follow-up|0|||
145545645|NCT00799422|524857764|FG001|First Week of Wear|Lost to Follow-up|0|||
145545646|NCT00799422|524857765|FG002|First Week of Wear|Lost to Follow-up|1|||
145545647|NCT00799422|524857766|FG003|First Week of Wear|Lost to Follow-up|0|||
145545648|NCT00799422|524857767|FG004|First Week of Wear|Lost to Follow-up|0|||
145545649|NCT00799422|524857768|FG005|First Week of Wear|Lost to Follow-up|0|||
145545650|NCT00799422|524857763|FG000|First Week of Wear|Adverse Event|0|||
145545651|NCT00799422|524857764|FG001|First Week of Wear|Adverse Event|0|||
145545652|NCT00799422|524857765|FG002|First Week of Wear|Adverse Event|0|||
145545653|NCT00799422|524857766|FG003|First Week of Wear|Adverse Event|1|||
145545654|NCT00799422|524857767|FG004|First Week of Wear|Adverse Event|0|||
145545655|NCT00799422|524857768|FG005|First Week of Wear|Adverse Event|0|||
145545656|NCT00880009|524857769|FG000|Overall Study|Study terminated by sponsor|14|||
145282583|NCT01967888|523884292|FG001|Overall Study|Lost to Follow-up|4|||
145282584|NCT01967888|523884291|FG000|Overall Study|Withdrawal by Subject|1|||
145282585|NCT01967888|523884292|FG001|Overall Study|Withdrawal by Subject|1|||
145282586|NCT01967888|523884291|FG000|Overall Study|Did Not Have Transplant|1|||
145545657|NCT00880009|524857769|FG000|Overall Study|Withdrawal by Subject|1|||
145545658|NCT00880009|524857769|FG000|Overall Study|Protocol Violation|1|||
145545659|NCT02010775|524857774|FG000|Overall Study|Adverse Event|0|||
145545660|NCT02010775|524857775|FG001|Overall Study|Adverse Event|0|||
145545661|NCT02010775|524857776|FG002|Overall Study|Adverse Event|0|||
145545662|NCT02010775|524857777|FG003|Overall Study|Adverse Event|0|||
145545663|NCT02010775|524857778|FG004|Overall Study|Adverse Event|1|||
145545664|NCT02010775|524857774|FG000|Overall Study|Pregnancy|0|||
145282587|NCT01967888|523884292|FG001|Overall Study|Did Not Have Transplant|0|||
145282588|NCT01967888|523884291|FG000|Overall Study|Research visit not done, data recorded|1|||
145545665|NCT02010775|524857775|FG001|Overall Study|Pregnancy|0|||
145545666|NCT02010775|524857776|FG002|Overall Study|Pregnancy|2|||
145545667|NCT02010775|524857777|FG003|Overall Study|Pregnancy|0|||
145545668|NCT02010775|524857778|FG004|Overall Study|Pregnancy|0|||
145545669|NCT02010775|524857774|FG000|Overall Study|Lost to Follow-up|2|||
145545670|NCT02010775|524857775|FG001|Overall Study|Lost to Follow-up|0|||
145545671|NCT02010775|524857776|FG002|Overall Study|Lost to Follow-up|0|||
145545672|NCT02010775|524857777|FG003|Overall Study|Lost to Follow-up|1|||
145545673|NCT02010775|524857778|FG004|Overall Study|Lost to Follow-up|1|||
145545674|NCT02010775|524857774|FG000|Overall Study|Personal Reasons|3|||
145545675|NCT02010775|524857775|FG001|Overall Study|Personal Reasons|3|||
145545676|NCT02010775|524857776|FG002|Overall Study|Personal Reasons|1|||
145545677|NCT02010775|524857777|FG003|Overall Study|Personal Reasons|2|||
145545678|NCT02010775|524857778|FG004|Overall Study|Personal Reasons|4|||
145545679|NCT04659161|524857779|FG000|Overall Study|Adverse Event|10|||
145545680|NCT04659161|524857780|FG001|Overall Study|Adverse Event|6|||
145545681|NCT04659161|524857779|FG000|Overall Study|Withdrawal by Subject|13|||
145545682|NCT04659161|524857780|FG001|Overall Study|Withdrawal by Subject|12|||
145545683|NCT04659161|524857779|FG000|Overall Study|Other|9|||
145545684|NCT04659161|524857780|FG001|Overall Study|Other|8|||
145545685|NCT02197130|524857784|FG000|Overall Study|Adverse Event|13|||
145545686|NCT02197130|524857785|FG001|Overall Study|Adverse Event|4|||
145545687|NCT02197130|524857786|FG002|Overall Study|Adverse Event|23|||
145545688|NCT02197130|524857784|FG000|Overall Study|Death|0|||
145545689|NCT02197130|524857785|FG001|Overall Study|Death|1|||
145545690|NCT02197130|524857786|FG002|Overall Study|Death|0|||
145545691|NCT02197130|524857784|FG000|Overall Study|Lost to Follow-up|2|||
145545692|NCT02197130|524857785|FG001|Overall Study|Lost to Follow-up|0|||
145545693|NCT02197130|524857786|FG002|Overall Study|Lost to Follow-up|1|||
145545694|NCT02197130|524857784|FG000|Overall Study|Does not meet entrance criteria|0|||
145545695|NCT02197130|524857785|FG001|Overall Study|Does not meet entrance criteria|0|||
145545696|NCT02197130|524857786|FG002|Overall Study|Does not meet entrance criteria|1|||
145545697|NCT02197130|524857784|FG000|Overall Study|Withdrawal by Subject|0|||
145545698|NCT02197130|524857785|FG001|Overall Study|Withdrawal by Subject|3|||
145545699|NCT02197130|524857786|FG002|Overall Study|Withdrawal by Subject|4|||
145545700|NCT02197130|524857784|FG000|Overall Study|Other|1|||
145545701|NCT02197130|524857785|FG001|Overall Study|Other|0|||
145545702|NCT02197130|524857786|FG002|Overall Study|Other|3|||
145545703|NCT01269463|524857795|FG000|First Intervention|Withdrawal by Subject|1|||
145545704|NCT01269463|524857796|FG001|First Intervention|Withdrawal by Subject|0|||
145545705|NCT01269463|524857795|FG000|First Intervention|Adverse Event|1|||
145545706|NCT01269463|524857796|FG001|First Intervention|Adverse Event|0|||
145545707|NCT01269463|524857795|FG000|First Intervention|Lack of Efficacy|0|||
145545708|NCT01269463|524857796|FG001|First Intervention|Lack of Efficacy|1|||
145545709|NCT01269463|524857795|FG000|First Intervention|Physician Decision|0|||
145545710|NCT01269463|524857796|FG001|First Intervention|Physician Decision|1|||
145545711|NCT02549937|524857798|FG000|Overall Study|Death|0|||
145545712|NCT02549937|524857799|FG001|Overall Study|Death|1|||
145545713|NCT02549937|524857800|FG002|Overall Study|Death|0|||
145545714|NCT02549937|524857801|FG003|Overall Study|Death|1|||
145545715|NCT02549937|524857802|FG004|Overall Study|Death|0|||
145545716|NCT02549937|524857803|FG005|Overall Study|Death|8|||
145545717|NCT02549937|524857804|FG006|Overall Study|Death|0|||
145545718|NCT02549937|524857805|FG007|Overall Study|Death|0|||
145545719|NCT02549937|524857806|FG008|Overall Study|Death|19|||
145545720|NCT02549937|524857798|FG000|Overall Study|No follow up required|3|||
145545721|NCT02549937|524857799|FG001|Overall Study|No follow up required|6|||
145545722|NCT02549937|524857800|FG002|Overall Study|No follow up required|3|||
145545723|NCT02549937|524857801|FG003|Overall Study|No follow up required|8|||
145545724|NCT02549937|524857802|FG004|Overall Study|No follow up required|12|||
145545725|NCT02549937|524857803|FG005|Overall Study|No follow up required|21|||
145545726|NCT02549937|524857804|FG006|Overall Study|No follow up required|9|||
145545727|NCT02549937|524857805|FG007|Overall Study|No follow up required|11|||
145545728|NCT02549937|524857806|FG008|Overall Study|No follow up required|0|||
145545729|NCT02549937|524857798|FG000|Overall Study|Other|0|||
145545730|NCT02549937|524857799|FG001|Overall Study|Other|0|||
145545731|NCT02549937|524857800|FG002|Overall Study|Other|0|||
145545732|NCT02549937|524857801|FG003|Overall Study|Other|0|||
145545733|NCT02549937|524857802|FG004|Overall Study|Other|1|||
145545734|NCT02549937|524857803|FG005|Overall Study|Other|0|||
145545735|NCT02549937|524857804|FG006|Overall Study|Other|3|||
145545736|NCT02549937|524857805|FG007|Overall Study|Other|2|||
145545737|NCT02549937|524857806|FG008|Overall Study|Other|3|||
145545738|NCT02549937|524857798|FG000|Overall Study|Lost to Follow-up|0|||
145545739|NCT02549937|524857799|FG001|Overall Study|Lost to Follow-up|0|||
145545740|NCT02549937|524857800|FG002|Overall Study|Lost to Follow-up|0|||
145545741|NCT02549937|524857801|FG003|Overall Study|Lost to Follow-up|0|||
145545742|NCT02549937|524857802|FG004|Overall Study|Lost to Follow-up|0|||
145545743|NCT02549937|524857803|FG005|Overall Study|Lost to Follow-up|0|||
145545744|NCT02549937|524857804|FG006|Overall Study|Lost to Follow-up|0|||
145545745|NCT02549937|524857805|FG007|Overall Study|Lost to Follow-up|0|||
145545746|NCT02549937|524857806|FG008|Overall Study|Lost to Follow-up|3|||
145545747|NCT02549937|524857798|FG000|Overall Study|Withdrawal by Subject|0|||
145545748|NCT02549937|524857799|FG001|Overall Study|Withdrawal by Subject|0|||
145545749|NCT02549937|524857800|FG002|Overall Study|Withdrawal by Subject|0|||
145545750|NCT02549937|524857801|FG003|Overall Study|Withdrawal by Subject|0|||
145545751|NCT02549937|524857802|FG004|Overall Study|Withdrawal by Subject|0|||
145545752|NCT02549937|524857803|FG005|Overall Study|Withdrawal by Subject|1|||
145545753|NCT02549937|524857804|FG006|Overall Study|Withdrawal by Subject|4|||
145545754|NCT02549937|524857805|FG007|Overall Study|Withdrawal by Subject|3|||
145545755|NCT02549937|524857806|FG008|Overall Study|Withdrawal by Subject|2|||
145545756|NCT02549937|524857798|FG000|Overall Study|Sponsor Decision|0|||
145545757|NCT02549937|524857799|FG001|Overall Study|Sponsor Decision|0|||
145545758|NCT02549937|524857800|FG002|Overall Study|Sponsor Decision|0|||
145545759|NCT02549937|524857801|FG003|Overall Study|Sponsor Decision|0|||
145545760|NCT02549937|524857802|FG004|Overall Study|Sponsor Decision|0|||
145545761|NCT02549937|524857803|FG005|Overall Study|Sponsor Decision|0|||
145545762|NCT02549937|524857804|FG006|Overall Study|Sponsor Decision|0|||
145545763|NCT02549937|524857805|FG007|Overall Study|Sponsor Decision|0|||
145545764|NCT02549937|524857806|FG008|Overall Study|Sponsor Decision|6|||
145545765|NCT00317356|524857807|FG000|Overall Study|Adverse Event|0|||
145545766|NCT00317356|524857808|FG001|Overall Study|Adverse Event|0|||
145545767|NCT00317356|524857809|FG002|Overall Study|Adverse Event|1|||
145545768|NCT00317356|524857810|FG003|Overall Study|Adverse Event|0|||
145545769|NCT00317356|524857807|FG000|Overall Study|Lack of Efficacy|1|||
145545770|NCT00317356|524857808|FG001|Overall Study|Lack of Efficacy|1|||
145545771|NCT00317356|524857809|FG002|Overall Study|Lack of Efficacy|0|||
145545772|NCT00317356|524857810|FG003|Overall Study|Lack of Efficacy|3|||
145545773|NCT00317356|524857807|FG000|Overall Study|Physician Decision|0|||
145545774|NCT00317356|524857808|FG001|Overall Study|Physician Decision|1|||
145545775|NCT00317356|524857809|FG002|Overall Study|Physician Decision|0|||
145545776|NCT00317356|524857810|FG003|Overall Study|Physician Decision|0|||
145545777|NCT03199274|524857811|FG000|Overall Study|Withdrawal by Subject|4|||
145545778|NCT03199274|524857812|FG001|Overall Study|Withdrawal by Subject|0|||
145545779|NCT03199274|524857811|FG000|Overall Study|Lost to Follow-up|0|||
145545780|NCT03199274|524857812|FG001|Overall Study|Lost to Follow-up|1|||
145545781|NCT03199274|524857811|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
145545782|NCT03199274|524857812|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
145545783|NCT05980182|524857813|FG000|Overall Study|Lost to Follow-up|10|||
145545784|NCT03761277|524860037|FG000|Enrollment to Implant|Screen Failure|17|||
145545785|NCT03761277|524860037|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
145545786|NCT03761277|524860037|FG000|Enrollment to Implant|Physician Decision|2|||
145545787|NCT03761277|524860037|FG000|Enrollment to Implant|Site Closure|3|||
145545788|NCT03761277|524860037|FG000|Enrollment to Implant|Sponsor Request|2|||
145545789|NCT03761277|524860037|FG000|Post-Implant to 6 Months|Adverse Event|2|||
145545790|NCT03761277|524860037|FG000|Post-Implant to 6 Months|Death|1|||
145545791|NCT03761277|524860037|FG000|Post-Implant to 6 Months|Site Closure|2|||
145545792|NCT03761277|524860037|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
145545793|NCT03761277|524860037|FG000|6 Months to 12 Months|Physician Decision|2|||
145545794|NCT03761277|524860037|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
145545795|NCT00684307|524860038|FG000|Overall Study|Adverse Event|11|||
145545796|NCT00684307|524860039|FG001|Overall Study|Adverse Event|6|||
145545797|NCT00684307|524860040|FG002|Overall Study|Adverse Event|15|||
145545798|NCT00684307|524860041|FG003|Overall Study|Adverse Event|16|||
145545799|NCT00684307|524860042|FG004|Overall Study|Adverse Event|8|||
145545800|NCT00684307|524860038|FG000|Overall Study|Development of increasing Liver Function|0|||
145545801|NCT00684307|524860039|FG001|Overall Study|Development of increasing Liver Function|2|||
145545802|NCT00684307|524860040|FG002|Overall Study|Development of increasing Liver Function|0|||
145545803|NCT00684307|524860041|FG003|Overall Study|Development of increasing Liver Function|1|||
145545804|NCT00684307|524860042|FG004|Overall Study|Development of increasing Liver Function|0|||
145545805|NCT00684307|524860038|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
145545806|NCT00684307|524860039|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
145545807|NCT00684307|524860040|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
145545808|NCT00684307|524860041|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
145545809|NCT00684307|524860042|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
145545810|NCT00684307|524860038|FG000|Overall Study|Incorrect enrolment or randomization|4|||
145545811|NCT00684307|524860039|FG001|Overall Study|Incorrect enrolment or randomization|0|||
145545812|NCT00684307|524860040|FG002|Overall Study|Incorrect enrolment or randomization|0|||
145545813|NCT00684307|524860041|FG003|Overall Study|Incorrect enrolment or randomization|0|||
145545814|NCT00684307|524860042|FG004|Overall Study|Incorrect enrolment or randomization|0|||
145545815|NCT00684307|524860038|FG000|Overall Study|Interupted IP for more than 7 days|0|||
145545816|NCT00684307|524860039|FG001|Overall Study|Interupted IP for more than 7 days|4|||
145545817|NCT00684307|524860040|FG002|Overall Study|Interupted IP for more than 7 days|1|||
145545818|NCT00684307|524860041|FG003|Overall Study|Interupted IP for more than 7 days|3|||
145545819|NCT00684307|524860042|FG004|Overall Study|Interupted IP for more than 7 days|3|||
145545820|NCT00684307|524860038|FG000|Overall Study|Severe non compliance to protocol|1|||
145545821|NCT00684307|524860039|FG001|Overall Study|Severe non compliance to protocol|0|||
145545822|NCT00684307|524860040|FG002|Overall Study|Severe non compliance to protocol|0|||
145545823|NCT00684307|524860041|FG003|Overall Study|Severe non compliance to protocol|1|||
145545824|NCT00684307|524860042|FG004|Overall Study|Severe non compliance to protocol|2|||
145545825|NCT00684307|524860038|FG000|Overall Study|Participant not willing to continue|7|||
145545826|NCT00684307|524860039|FG001|Overall Study|Participant not willing to continue|10|||
145545827|NCT00684307|524860040|FG002|Overall Study|Participant not willing to continue|11|||
145545828|NCT00684307|524860041|FG003|Overall Study|Participant not willing to continue|5|||
145545829|NCT00684307|524860042|FG004|Overall Study|Participant not willing to continue|8|||
145545830|NCT00684307|524860038|FG000|Overall Study|Criteria from the CSR|0|||
145545831|NCT00684307|524860039|FG001|Overall Study|Criteria from the CSR|0|||
145545832|NCT00684307|524860040|FG002|Overall Study|Criteria from the CSR|1|||
145545833|NCT00684307|524860041|FG003|Overall Study|Criteria from the CSR|3|||
145545834|NCT00684307|524860042|FG004|Overall Study|Criteria from the CSR|3|||
145545835|NCT00543140|524860043|FG000|Overall Study|Lost to Follow-up|33|||
145545836|NCT00543140|524860043|FG000|Overall Study|Withdrawal by Subject|13|||
145545837|NCT00543140|524860043|FG000|Overall Study|Protocol Violation|10|||
145545838|NCT00543140|524860043|FG000|Overall Study|Insufficient weight loss|10|||
145545839|NCT00543140|524860043|FG000|Overall Study|SAE leading to explant of SAGB|3|||
145545840|NCT00543140|524860043|FG000|Overall Study|Death|1|||
145545841|NCT00543140|524860043|FG000|Overall Study|Subject moved|1|||
145545842|NCT00543140|524860043|FG000|Overall Study|Conversion to different procedure|1|||
145545843|NCT02483520|524860044|FG000|Overall Study|Lost to Follow-up|3|||
145545844|NCT02483520|524860045|FG001|Overall Study|Lost to Follow-up|4|||
145545845|NCT02483520|524860044|FG000|Overall Study|Withdrawal by Subject|4|||
145545846|NCT02483520|524860045|FG001|Overall Study|Withdrawal by Subject|14|||
145545847|NCT02483520|524860044|FG000|Overall Study|Hospitalized|2|||
145545848|NCT02483520|524860045|FG001|Overall Study|Hospitalized|3|||
145545849|NCT02483520|524860044|FG000|Overall Study|Moved to LTC|2|||
145545850|NCT02483520|524860045|FG001|Overall Study|Moved to LTC|3|||
145545851|NCT01218204|524860047|FG000|Part B Washout|Adverse Event|0|||
145545852|NCT01218204|524860048|FG001|Part B Washout|Adverse Event|1|||
145545853|NCT01218204|524860049|FG002|Part B Washout|Adverse Event|0|||
145545854|NCT01218204|524860050|FG003|Part B Washout|Adverse Event|0|||
145545855|NCT01218204|524860047|FG000|Part B Washout|Lost to Follow-up|0|||
145545856|NCT01218204|524860048|FG001|Part B Washout|Lost to Follow-up|2|||
145545857|NCT01218204|524860049|FG002|Part B Washout|Lost to Follow-up|0|||
145545858|NCT01218204|524860050|FG003|Part B Washout|Lost to Follow-up|0|||
145545859|NCT01218204|524860047|FG000|Part B Washout|Physician Decision|0|||
145545860|NCT01218204|524860048|FG001|Part B Washout|Physician Decision|14|||
145545861|NCT01218204|524860049|FG002|Part B Washout|Physician Decision|0|||
145545862|NCT01218204|524860050|FG003|Part B Washout|Physician Decision|0|||
145545863|NCT01218204|524860047|FG000|Part B Washout|Withdrawal by Subject|0|||
145545864|NCT01218204|524860048|FG001|Part B Washout|Withdrawal by Subject|14|||
145545865|NCT01218204|524860049|FG002|Part B Washout|Withdrawal by Subject|0|||
145545866|NCT01218204|524860050|FG003|Part B Washout|Withdrawal by Subject|0|||
145545867|NCT01218204|524860047|FG000|Part B Washout|Reached defined stopping criteria|0|||
145545868|NCT01218204|524860048|FG001|Part B Washout|Reached defined stopping criteria|2|||
145545869|NCT01218204|524860049|FG002|Part B Washout|Reached defined stopping criteria|0|||
145545870|NCT01218204|524860050|FG003|Part B Washout|Reached defined stopping criteria|0|||
145545871|NCT01218204|524860047|FG000|Part B Washout|Did not meet continuation criteria|0|||
145545872|NCT01218204|524860048|FG001|Part B Washout|Did not meet continuation criteria|112|||
145545873|NCT01218204|524860049|FG002|Part B Washout|Did not meet continuation criteria|0|||
145545874|NCT01218204|524860050|FG003|Part B Washout|Did not meet continuation criteria|0|||
145545875|NCT01218204|524860047|FG000|Part B Run-in|Adverse Event|0|||
145545876|NCT01218204|524860048|FG001|Part B Run-in|Adverse Event|0|||
145545877|NCT01218204|524860049|FG002|Part B Run-in|Adverse Event|1|||
145545878|NCT01218204|524860050|FG003|Part B Run-in|Adverse Event|0|||
145545879|NCT01218204|524860047|FG000|Part B Run-in|Protocol Violation|0|||
145545880|NCT01218204|524860048|FG001|Part B Run-in|Protocol Violation|0|||
145545881|NCT01218204|524860049|FG002|Part B Run-in|Protocol Violation|2|||
145545882|NCT01218204|524860050|FG003|Part B Run-in|Protocol Violation|0|||
145545883|NCT01218204|524860047|FG000|Part B Run-in|Withdrawal by Subject|0|||
145545884|NCT01218204|524860048|FG001|Part B Run-in|Withdrawal by Subject|0|||
145545885|NCT01218204|524860049|FG002|Part B Run-in|Withdrawal by Subject|3|||
145545886|NCT01218204|524860050|FG003|Part B Run-in|Withdrawal by Subject|0|||
145545887|NCT01218204|524860047|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
145545888|NCT01218204|524860048|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
145545889|NCT01218204|524860049|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
145545890|NCT01218204|524860050|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
145545891|NCT01218204|524860047|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
145545892|NCT01218204|524860048|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
145545893|NCT01218204|524860049|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
145545894|NCT01218204|524860050|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
145545895|NCT00743340|524860051|FG000|Overall Study|Study medication non-compliance|1|||
145545896|NCT00743340|524860051|FG000|Overall Study|Lost to Follow-up|1|||
145545897|NCT00743340|524860051|FG000|Overall Study|Withdrawal from the Study|5|||
145545898|NCT00743340|524860051|FG000|Overall Study|Protocol Violation|1|||
145545899|NCT00743340|524860051|FG000|Overall Study|Virologic failure|8|||
145545900|NCT00743340|524860051|FG000|Overall Study|Pregnancy|1|||
145545901|NCT00743340|524860051|FG000|Overall Study|Rolled over to other Gilead Study|23|||
145545902|NCT00743340|524860051|FG000|Overall Study|Participant Relocated|1|||
145545903|NCT00489541|524860052|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
145545904|NCT00489541|524860053|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
145545905|NCT00489541|524860052|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
145545906|NCT00489541|524860053|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
145545907|NCT00489541|524860052|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
145545908|NCT00489541|524860053|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
145545909|NCT00489541|524860052|FG000|12-Month Clinical Follow-up|Death|3|||
145545910|NCT00489541|524860053|FG001|12-Month Clinical Follow-up|Death|2|||
145545911|NCT00489541|524860052|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
145545912|NCT00489541|524860053|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
145545913|NCT00489541|524860052|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
145545914|NCT00489541|524860053|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
145545915|NCT00003479|524860054|FG000|Overall Study|Not evaluable|3|||
145545916|NCT02042183|524860057|FG000|Overall Study|Physician Decision|7|||
145545917|NCT02042183|524860058|FG001|Overall Study|Physician Decision|2|||
145545918|NCT02042183|524860057|FG000|Overall Study|Lack of Efficacy|4|||
145545919|NCT02042183|524860058|FG001|Overall Study|Lack of Efficacy|3|||
145545920|NCT02042183|524860057|FG000|Overall Study|Non-compliance with Study Drug|2|||
145545921|NCT02042183|524860058|FG001|Overall Study|Non-compliance with Study Drug|3|||
145545922|NCT02042183|524860057|FG000|Overall Study|Adverse Event|17|||
145545923|NCT02042183|524860058|FG001|Overall Study|Adverse Event|6|||
145545924|NCT02042183|524860057|FG000|Overall Study|Other|3|||
145545925|NCT02042183|524860058|FG001|Overall Study|Other|3|||
145545926|NCT02042183|524860057|FG000|Overall Study|Withdrawal by Subject|21|||
145545927|NCT02042183|524860058|FG001|Overall Study|Withdrawal by Subject|16|||
145545928|NCT02042183|524860057|FG000|Overall Study|Site Terminated by Sponsor|2|||
145545929|NCT02042183|524860058|FG001|Overall Study|Site Terminated by Sponsor|1|||
145545930|NCT02042183|524860057|FG000|Overall Study|Lost to Follow-up|9|||
145545931|NCT02042183|524860058|FG001|Overall Study|Lost to Follow-up|2|||
145545932|NCT01192516|524860059|FG000|Overall Study|Lost to Follow-up|7|||
145545933|NCT01192516|524860060|FG001|Overall Study|Lost to Follow-up|10|||
145545934|NCT01192516|524860061|FG002|Overall Study|Lost to Follow-up|7|||
145545935|NCT01192516|524860059|FG000|Overall Study|Withdrawal by Subject|4|||
145545936|NCT01192516|524860060|FG001|Overall Study|Withdrawal by Subject|4|||
145545937|NCT01192516|524860061|FG002|Overall Study|Withdrawal by Subject|1|||
145545938|NCT01192516|524860059|FG000|Overall Study|started new treatment|5|||
145545939|NCT01192516|524860060|FG001|Overall Study|started new treatment|1|||
145545940|NCT01192516|524860061|FG002|Overall Study|started new treatment|0|||
145545941|NCT01192516|524860059|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
145545942|NCT01192516|524860060|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
145545943|NCT01192516|524860061|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
145545944|NCT00982878|524860064|FG000|Overall Study|Physician Decision|1|||
145545945|NCT01051323|524860065|FG000|Overall Study|Discontinuation of treatment|103|||
145545946|NCT01051323|524860065|FG000|Overall Study|Transplantation|28|||
145545947|NCT01051323|524860065|FG000|Overall Study|Dialysis dependency|22|||
145545948|NCT01051323|524860065|FG000|Overall Study|Withdrawal by Subject|13|||
145545949|NCT01051323|524860065|FG000|Overall Study|Lost to Follow-up|31|||
145545950|NCT01051323|524860065|FG000|Overall Study|Death|129|||
145545951|NCT01051323|524860065|FG000|Overall Study|Hospitalization|28|||
145545952|NCT01051323|524860065|FG000|Overall Study|Other|148|||
145282589|NCT01967888|523884292|FG001|Overall Study|Research visit not done, data recorded|0|||
145282590|NCT01967888|523884291|FG000|Overall Study|Subject excluded after randomization|1|||
145282591|NCT01967888|523884292|FG001|Overall Study|Subject excluded after randomization|0|||
145282592|NCT01967888|523884291|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
145282593|NCT01967888|523884292|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
145282594|NCT01967888|523884291|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
145282595|NCT01967888|523884292|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
145282596|NCT01894984|523884295|FG000|Overall Study|Other|314|||
145282597|NCT01894984|523884296|FG001|Overall Study|Other|175|||
145282598|NCT00827359|523884297|FG000|Overall Study|Progressive Diseas|19|||
145282599|NCT00827359|523884297|FG000|Overall Study|Unacceptable Toxicity|5|||
145282600|NCT00827359|523884297|FG000|Overall Study|Ineligible|1|||
145282601|NCT00323609|523884298|FG000|Overall Study|Death|16|||
145282602|NCT00323609|523884299|FG001|Overall Study|Death|21|||
145282603|NCT00323609|523884300|FG002|Overall Study|Death|0|||
145282604|NCT00323609|523884301|FG003|Overall Study|Death|0|||
145282605|NCT00323609|523884298|FG000|Overall Study|Lost to Follow-up|9|||
145282606|NCT00323609|523884299|FG001|Overall Study|Lost to Follow-up|10|||
145282607|NCT00323609|523884300|FG002|Overall Study|Lost to Follow-up|0|||
145282608|NCT00323609|523884301|FG003|Overall Study|Lost to Follow-up|0|||
145282609|NCT00323609|523884298|FG000|Overall Study|Physician Decision|2|||
145282610|NCT00323609|523884299|FG001|Overall Study|Physician Decision|0|||
145282611|NCT00323609|523884300|FG002|Overall Study|Physician Decision|0|||
145282612|NCT00323609|523884301|FG003|Overall Study|Physician Decision|1|||
145282613|NCT00323609|523884298|FG000|Overall Study|Withdrawal by Subject|11|||
145282614|NCT00323609|523884299|FG001|Overall Study|Withdrawal by Subject|23|||
145282615|NCT00323609|523884300|FG002|Overall Study|Withdrawal by Subject|4|||
145282616|NCT00323609|523884301|FG003|Overall Study|Withdrawal by Subject|4|||
145282617|NCT00323609|523884298|FG000|Overall Study|Other non-VCF-related medical condition|3|||
145282618|NCT00323609|523884299|FG001|Overall Study|Other non-VCF-related medical condition|2|||
145282619|NCT00323609|523884300|FG002|Overall Study|Other non-VCF-related medical condition|0|||
145282620|NCT00323609|523884301|FG003|Overall Study|Other non-VCF-related medical condition|0|||
145282621|NCT00323609|523884298|FG000|Overall Study|Sponsor discontinued trial|29|||
145282622|NCT00323609|523884299|FG001|Overall Study|Sponsor discontinued trial|29|||
145282623|NCT00323609|523884300|FG002|Overall Study|Sponsor discontinued trial|0|||
145282624|NCT00323609|523884301|FG003|Overall Study|Sponsor discontinued trial|0|||
145282625|NCT00323609|523884298|FG000|Overall Study|Unrelenting or severe back pain|1|||
145282626|NCT00323609|523884299|FG001|Overall Study|Unrelenting or severe back pain|1|||
145282627|NCT00323609|523884300|FG002|Overall Study|Unrelenting or severe back pain|0|||
145282628|NCT00323609|523884301|FG003|Overall Study|Unrelenting or severe back pain|0|||
145282629|NCT00323609|523884298|FG000|Overall Study|Logistical withdrawal|9|||
145545953|NCT01051323|524860065|FG000|Overall Study|Missing|37|||
145545954|NCT01626391|524860066|FG000|Overall Study|Physician Decision|1|||
145545955|NCT01626391|524860067|FG001|Overall Study|Physician Decision|0|||
145545956|NCT01626391|524860066|FG000|Overall Study|Withdrawal by Subject|1|||
145545957|NCT01626391|524860067|FG001|Overall Study|Withdrawal by Subject|0|||
145545958|NCT04171531|524860069|FG000|Overall Study|Lost to Follow-up|4|||
145545959|NCT04171531|524860070|FG001|Overall Study|Lost to Follow-up|5|||
145545960|NCT04171531|524860069|FG000|Overall Study|Consent only through 6 months|1|||
145545961|NCT04171531|524860070|FG001|Overall Study|Consent only through 6 months|1|||
145545962|NCT04171531|524860069|FG000|Overall Study|Insurance did not cover procedure|0|||
145545963|NCT04171531|524860070|FG001|Overall Study|Insurance did not cover procedure|1|||
145545964|NCT04171531|524860069|FG000|Overall Study|Physician Decision|0|||
145545965|NCT04171531|524860070|FG001|Overall Study|Physician Decision|3|||
145545966|NCT04171531|524860069|FG000|Overall Study|Withdrawal by Subject|1|||
145545967|NCT04171531|524860070|FG001|Overall Study|Withdrawal by Subject|5|||
145545968|NCT04862585|524860074|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
145545969|NCT04862585|524860075|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
145545970|NCT04862585|524860074|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
145545971|NCT04862585|524860075|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
145545972|NCT04862585|524860074|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
145282630|NCT00323609|523884299|FG001|Overall Study|Logistical withdrawal|5|||
145282631|NCT00323609|523884300|FG002|Overall Study|Logistical withdrawal|0|||
145282632|NCT00323609|523884301|FG003|Overall Study|Logistical withdrawal|1|||
145282633|NCT00323609|523884298|FG000|Overall Study|Other reason|11|||
145282634|NCT00323609|523884299|FG001|Overall Study|Other reason|8|||
145282635|NCT00323609|523884300|FG002|Overall Study|Other reason|4|||
145282636|NCT00323609|523884301|FG003|Overall Study|Other reason|9|||
145282637|NCT01141283|523884303|FG000|Overall Study|Adverse Event|56|||
145282638|NCT01141283|523884303|FG000|Overall Study|Lost to Follow-up|4|||
145282639|NCT01141283|523884303|FG000|Overall Study|Withdrawal by Subject|14|||
145282640|NCT01141283|523884303|FG000|Overall Study|Administrative|4|||
145282641|NCT01141283|523884303|FG000|Overall Study|Lack of Efficacy|10|||
145282642|NCT00449930|523884306|FG000|Overall Study|Adverse Event|9|||
145282643|NCT00449930|523884307|FG001|Overall Study|Adverse Event|19|||
145282644|NCT00449930|523884306|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
145282645|NCT00449930|523884307|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
145282646|NCT00449930|523884306|FG000|Overall Study|Lack of Efficacy|10|||
145545973|NCT04862585|524860075|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
145545974|NCT04862585|524860074|FG000|Overall Study|one withdrew without providing a reason|0|||
145545975|NCT04862585|524860075|FG001|Overall Study|one withdrew without providing a reason|1|||
145545976|NCT03366337|524860078|FG000|Overall Study|Lost to Follow-up|1|||
145545977|NCT03366337|524860079|FG001|Overall Study|Lost to Follow-up|0|||
145545978|NCT03366337|524860080|FG002|Overall Study|Lost to Follow-up|1|||
145282647|NCT00449930|523884307|FG001|Overall Study|Lack of Efficacy|1|||
145282648|NCT00449930|523884306|FG000|Overall Study|Lost to Follow-up|9|||
145545979|NCT03366337|524860081|FG003|Overall Study|Lost to Follow-up|0|||
145545980|NCT03366337|524860078|FG000|Overall Study|Withdrawal by Subject|2|||
145545981|NCT03366337|524860079|FG001|Overall Study|Withdrawal by Subject|0|||
145545982|NCT03366337|524860080|FG002|Overall Study|Withdrawal by Subject|1|||
145545983|NCT03366337|524860081|FG003|Overall Study|Withdrawal by Subject|1|||
145545984|NCT05288062|524860082|FG000|Overall Study|Ineligible|0|||
145545985|NCT05288062|524860083|FG001|Overall Study|Ineligible|0|||
145545986|NCT05288062|524860084|FG002|Overall Study|Ineligible|1|||
145545987|NCT05288062|524860085|FG003|Overall Study|Ineligible|0|||
145545988|NCT05288062|524860082|FG000|Overall Study|Withdrawal by Subject|0|||
145545989|NCT05288062|524860083|FG001|Overall Study|Withdrawal by Subject|0|||
145545990|NCT05288062|524860084|FG002|Overall Study|Withdrawal by Subject|1|||
145610911|NCT01167179|525092518|FG001|Overall Study|diverse|5|||
145282649|NCT00449930|523884307|FG001|Overall Study|Lost to Follow-up|14|||
145282650|NCT00449930|523884306|FG000|Overall Study|Physician Decision|1|||
145282651|NCT00449930|523884307|FG001|Overall Study|Physician Decision|2|||
145545991|NCT05288062|524860085|FG003|Overall Study|Withdrawal by Subject|0|||
145545992|NCT01025752|524860089|FG000|Overall Study|Lost to Follow-up|7|||
145545993|NCT01025752|524860090|FG001|Overall Study|Lost to Follow-up|10|||
145545994|NCT01025752|524860089|FG000|Overall Study|Physician Decision|1|||
145545995|NCT01025752|524860090|FG001|Overall Study|Physician Decision|3|||
145545996|NCT01537393|524860093|FG000|Overall Study|Exclude prior to study|32|||
145545997|NCT01537393|524860094|FG001|Overall Study|Exclude prior to study|44|||
145545998|NCT01537393|524860093|FG000|Overall Study|Death|20|||
145545999|NCT01537393|524860094|FG001|Overall Study|Death|32|||
145546000|NCT01537393|524860093|FG000|Overall Study|Withdrawal by Subject|18|||
145546001|NCT01537393|524860094|FG001|Overall Study|Withdrawal by Subject|17|||
145546002|NCT01537393|524860093|FG000|Overall Study|Lost to Follow-up|53|||
145546003|NCT01537393|524860094|FG001|Overall Study|Lost to Follow-up|48|||
145546004|NCT01537393|524860093|FG000|Overall Study|Failure - Regrafted|28|||
145546005|NCT01537393|524860094|FG001|Overall Study|Failure - Regrafted|43|||
145546006|NCT01537393|524860093|FG000|Overall Study|Failure - Not regrafted|2|||
145546007|NCT01537393|524860094|FG001|Overall Study|Failure - Not regrafted|6|||
145546008|NCT01537393|524860093|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
145546009|NCT01537393|524860094|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
145546010|NCT01697566|524860095|FG000|Overall Study|Withdrawal by Subject|0|||
145546011|NCT01697566|524860096|FG001|Overall Study|Withdrawal by Subject|0|||
145546012|NCT01697566|524860097|FG002|Overall Study|Withdrawal by Subject|1|||
145546013|NCT01697566|524860098|FG003|Overall Study|Withdrawal by Subject|1|||
145546014|NCT01697566|524860095|FG000|Overall Study|Final biopsy not obtained|0|||
145546015|NCT01697566|524860096|FG001|Overall Study|Final biopsy not obtained|0|||
145546016|NCT01697566|524860097|FG002|Overall Study|Final biopsy not obtained|1|||
145546017|NCT01697566|524860098|FG003|Overall Study|Final biopsy not obtained|0|||
145546018|NCT00459953|524860099|FG000|Overall Study|not analyzed-household member in study|1|||
145546019|NCT00459953|524860100|FG001|Overall Study|not analyzed-household member in study|1|||
145546020|NCT01447433|524860103|FG000|Overall Study|Lost to Follow-up|0|||
145546021|NCT01447433|524860104|FG001|Overall Study|Lost to Follow-up|2|||
145546022|NCT01447433|524860103|FG000|Overall Study|Withdrawal by Subject|3|||
145546023|NCT01447433|524860104|FG001|Overall Study|Withdrawal by Subject|3|||
145546024|NCT01447433|524860103|FG000|Overall Study|Protocol Violation|1|||
145546025|NCT01447433|524860104|FG001|Overall Study|Protocol Violation|1|||
145546026|NCT01578187|524860105|FG000|Usability Phase|Withdrawal by Subject|1|||
145546027|NCT02516163|524860110|FG000|Overall Study|Withdrawal by Subject|1|||
145546028|NCT02516163|524860110|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
145546029|NCT02516163|524860110|FG000|Overall Study|Unfit/delay in surgery|3|||
145546030|NCT02516163|524860110|FG000|Overall Study|Use of incorrect measurement technique|5|||
145546031|NCT02516163|524860110|FG000|Overall Study|Data not recorded|2|||
145546032|NCT02516163|524860110|FG000|Overall Study|MRI contraindication exclusion|6|||
145546033|NCT01658072|524860111|FG000|Overall Study|Protocol Violation|4|||
145546034|NCT01658072|524860112|FG001|Overall Study|Protocol Violation|2|||
145546035|NCT00040664|524860115|FG000|Overall Study|Adverse Event|12|||
145546036|NCT00040664|524860116|FG001|Overall Study|Adverse Event|3|||
145546037|NCT00040664|524860117|FG002|Overall Study|Adverse Event|2|||
145546038|NCT00040664|524860118|FG003|Overall Study|Adverse Event|7|||
145546039|NCT00040664|524860115|FG000|Overall Study|Lack of Efficacy|9|||
145546040|NCT00040664|524860116|FG001|Overall Study|Lack of Efficacy|2|||
145546041|NCT00040664|524860117|FG002|Overall Study|Lack of Efficacy|3|||
145546042|NCT00040664|524860118|FG003|Overall Study|Lack of Efficacy|4|||
145546043|NCT00040664|524860115|FG000|Overall Study|Insufficient CD4 response|1|||
145546044|NCT00040664|524860116|FG001|Overall Study|Insufficient CD4 response|0|||
145546045|NCT00040664|524860117|FG002|Overall Study|Insufficient CD4 response|1|||
145546046|NCT00040664|524860118|FG003|Overall Study|Insufficient CD4 response|0|||
145546047|NCT00040664|524860115|FG000|Overall Study|Lost to Follow-up|4|||
145546048|NCT00040664|524860116|FG001|Overall Study|Lost to Follow-up|2|||
145546049|NCT00040664|524860117|FG002|Overall Study|Lost to Follow-up|0|||
145546050|NCT00040664|524860118|FG003|Overall Study|Lost to Follow-up|2|||
145546051|NCT00040664|524860115|FG000|Overall Study|Protocol Violation|2|||
145546052|NCT00040664|524860116|FG001|Overall Study|Protocol Violation|1|||
145546053|NCT00040664|524860117|FG002|Overall Study|Protocol Violation|0|||
145546054|NCT00040664|524860118|FG003|Overall Study|Protocol Violation|1|||
145546055|NCT00040664|524860115|FG000|Overall Study|Withdrawal by Subject|7|||
145546056|NCT00040664|524860116|FG001|Overall Study|Withdrawal by Subject|0|||
145546057|NCT00040664|524860117|FG002|Overall Study|Withdrawal by Subject|3|||
145546058|NCT00040664|524860118|FG003|Overall Study|Withdrawal by Subject|4|||
145546059|NCT00040664|524860115|FG000|Overall Study|Pregnancy|3|||
145546060|NCT00040664|524860116|FG001|Overall Study|Pregnancy|0|||
145546061|NCT00040664|524860117|FG002|Overall Study|Pregnancy|0|||
145546062|NCT00040664|524860118|FG003|Overall Study|Pregnancy|3|||
145546063|NCT00040664|524860115|FG000|Overall Study|Medication adherence/compliance problems|8|||
145546064|NCT00040664|524860116|FG001|Overall Study|Medication adherence/compliance problems|2|||
145546065|NCT00040664|524860117|FG002|Overall Study|Medication adherence/compliance problems|1|||
145546066|NCT00040664|524860118|FG003|Overall Study|Medication adherence/compliance problems|5|||
145546067|NCT00040664|524860115|FG000|Overall Study|Poor taste|2|||
145546068|NCT00040664|524860116|FG001|Overall Study|Poor taste|0|||
145546069|NCT00040664|524860117|FG002|Overall Study|Poor taste|2|||
145546070|NCT00040664|524860118|FG003|Overall Study|Poor taste|0|||
145546071|NCT00040664|524860115|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
145546072|NCT00040664|524860116|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
145546073|NCT00040664|524860117|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
145546074|NCT00040664|524860118|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
145546075|NCT00040664|524860115|FG000|Overall Study|Change of formulation|2|||
145546076|NCT00040664|524860116|FG001|Overall Study|Change of formulation|2|||
145546077|NCT00040664|524860117|FG002|Overall Study|Change of formulation|0|||
145546078|NCT00040664|524860118|FG003|Overall Study|Change of formulation|0|||
145546079|NCT00040664|524860115|FG000|Overall Study|Non-viability of oral suspension|1|||
145546080|NCT00040664|524860116|FG001|Overall Study|Non-viability of oral suspension|0|||
145546081|NCT00040664|524860117|FG002|Overall Study|Non-viability of oral suspension|1|||
145546082|NCT00040664|524860118|FG003|Overall Study|Non-viability of oral suspension|0|||
145546083|NCT01709162|524860119|FG000|Overall Study|Disease progression|3|||
145546084|NCT01709162|524860120|FG001|Overall Study|Disease progression|3|||
145546085|NCT01709162|524860119|FG000|Overall Study|Study drug toxicity|2|||
145546086|NCT01709162|524860120|FG001|Overall Study|Study drug toxicity|0|||
145546087|NCT01709162|524860119|FG000|Overall Study|Administrative reason by sponsor|0|||
145546088|NCT01709162|524860120|FG001|Overall Study|Administrative reason by sponsor|1|||
145546089|NCT01709162|524860119|FG000|Overall Study|Other|1|||
145546090|NCT01709162|524860120|FG001|Overall Study|Other|0|||
145546091|NCT01709162|524860119|FG000|Overall Study|Withdrawal by Subject|0|||
145546092|NCT01709162|524860120|FG001|Overall Study|Withdrawal by Subject|1|||
145546093|NCT04584645|524860121|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
145546094|NCT04584645|524860122|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
145546095|NCT00390468|524860123|FG000|Overall Study|Protocol Violation|2|||
145546096|NCT00390468|524860123|FG000|Overall Study|Lack of Efficacy|1|||
145546097|NCT03926169|524860130|FG000|Period A|Adverse Event|2|||
145546098|NCT03926169|524860131|FG001|Period A|Adverse Event|2|||
145546099|NCT03926169|524860132|FG002|Period A|Adverse Event|1|||
145546100|NCT03926169|524860130|FG000|Period A|Withdrawal by Subject|2|||
145546101|NCT03926169|524860131|FG001|Period A|Withdrawal by Subject|2|||
145546102|NCT03926169|524860132|FG002|Period A|Withdrawal by Subject|2|||
145546103|NCT03926169|524860130|FG000|Period A|Lost to Follow-up|3|||
145546104|NCT03926169|524860131|FG001|Period A|Lost to Follow-up|1|||
145282652|NCT00449930|523884306|FG000|Overall Study|Protocol Violation|14|||
145546105|NCT03926169|524860132|FG002|Period A|Lost to Follow-up|0|||
145546106|NCT03926169|524860130|FG000|Period A|Lack of Efficacy|0|||
145546107|NCT03926169|524860131|FG001|Period A|Lack of Efficacy|2|||
145546108|NCT03926169|524860132|FG002|Period A|Lack of Efficacy|2|||
145546109|NCT03926169|524860130|FG000|Period A|COVID-19 Infection|0|||
145546110|NCT03926169|524860131|FG001|Period A|COVID-19 Infection|1|||
145546111|NCT03926169|524860132|FG002|Period A|COVID-19 Infection|0|||
145546112|NCT03926169|524860130|FG000|Period A|COVID-19 Logistical Restrictions|0|||
145546113|NCT03926169|524860131|FG001|Period A|COVID-19 Logistical Restrictions|2|||
145282653|NCT00449930|523884307|FG001|Overall Study|Protocol Violation|15|||
145282654|NCT00449930|523884306|FG000|Overall Study|Withdrawal by Subject|16|||
145546114|NCT03926169|524860132|FG002|Period A|COVID-19 Logistical Restrictions|1|||
145546115|NCT03926169|524860130|FG000|Period A|Other, Not Specified|1|||
145546116|NCT03926169|524860131|FG001|Period A|Other, Not Specified|0|||
145546117|NCT03926169|524860132|FG002|Period A|Other, Not Specified|0|||
145546118|NCT03926169|524860130|FG000|Period B|Adverse Event|3|||
145546119|NCT03926169|524860131|FG001|Period B|Adverse Event|1|||
145546120|NCT03926169|524860132|FG002|Period B|Adverse Event|1|||
145546121|NCT03926169|524860130|FG000|Period B|Withdrawal by Subject|1|||
145282655|NCT00449930|523884307|FG001|Overall Study|Withdrawal by Subject|23|||
145546122|NCT03926169|524860131|FG001|Period B|Withdrawal by Subject|3|||
145546123|NCT03926169|524860132|FG002|Period B|Withdrawal by Subject|0|||
145546124|NCT03926169|524860130|FG000|Period B|Lack of Efficacy|3|||
145546125|NCT03926169|524860131|FG001|Period B|Lack of Efficacy|1|||
145546126|NCT03926169|524860132|FG002|Period B|Lack of Efficacy|1|||
145546127|NCT03926169|524860130|FG000|Period B|Lost to Follow-up|1|||
145546128|NCT03926169|524860131|FG001|Period B|Lost to Follow-up|1|||
145546129|NCT03926169|524860132|FG002|Period B|Lost to Follow-up|4|||
145546130|NCT03926169|524860130|FG000|Period B|Other, Not Specified|62|||
145546131|NCT03926169|524860131|FG001|Period B|Other, Not Specified|57|||
145546132|NCT03926169|524860132|FG002|Period B|Other, Not Specified|65|||
145546133|NCT03708328|524860135|FG000|Overall Study|Death|3|||
145546134|NCT03708328|524860136|FG001|Overall Study|Death|3|||
145546135|NCT03708328|524860137|FG002|Overall Study|Death|4|||
145546136|NCT03708328|524860138|FG003|Overall Study|Death|2|||
145546137|NCT03708328|524860139|FG004|Overall Study|Death|2|||
145546138|NCT03708328|524860140|FG005|Overall Study|Death|13|||
145546139|NCT03708328|524860141|FG006|Overall Study|Death|26|||
145546140|NCT03708328|524860142|FG007|Overall Study|Death|18|||
145546141|NCT03708328|524860143|FG008|Overall Study|Death|13|||
145546142|NCT03708328|524860144|FG009|Overall Study|Death|8|||
145546143|NCT03708328|524860135|FG000|Overall Study|Lost to Follow-up|0|||
145546144|NCT03708328|524860136|FG001|Overall Study|Lost to Follow-up|1|||
145546145|NCT03708328|524860137|FG002|Overall Study|Lost to Follow-up|0|||
145546146|NCT03708328|524860138|FG003|Overall Study|Lost to Follow-up|1|||
145546147|NCT03708328|524860139|FG004|Overall Study|Lost to Follow-up|0|||
145546148|NCT03708328|524860140|FG005|Overall Study|Lost to Follow-up|3|||
145546149|NCT03708328|524860141|FG006|Overall Study|Lost to Follow-up|3|||
145546150|NCT03708328|524860142|FG007|Overall Study|Lost to Follow-up|0|||
145546151|NCT03708328|524860143|FG008|Overall Study|Lost to Follow-up|0|||
145546152|NCT03708328|524860144|FG009|Overall Study|Lost to Follow-up|1|||
145546153|NCT03708328|524860135|FG000|Overall Study|Physician Decision|0|||
145546154|NCT03708328|524860136|FG001|Overall Study|Physician Decision|0|||
145546155|NCT03708328|524860137|FG002|Overall Study|Physician Decision|0|||
145546156|NCT03708328|524860138|FG003|Overall Study|Physician Decision|0|||
145546157|NCT03708328|524860139|FG004|Overall Study|Physician Decision|0|||
145546158|NCT03708328|524860140|FG005|Overall Study|Physician Decision|1|||
145546159|NCT03708328|524860141|FG006|Overall Study|Physician Decision|0|||
145546160|NCT03708328|524860142|FG007|Overall Study|Physician Decision|0|||
145546161|NCT03708328|524860143|FG008|Overall Study|Physician Decision|0|||
145546162|NCT03708328|524860144|FG009|Overall Study|Physician Decision|0|||
145546163|NCT03708328|524860135|FG000|Overall Study|Withdrawal by Subject|0|||
145546164|NCT03708328|524860136|FG001|Overall Study|Withdrawal by Subject|0|||
145546165|NCT03708328|524860137|FG002|Overall Study|Withdrawal by Subject|0|||
145546166|NCT03708328|524860138|FG003|Overall Study|Withdrawal by Subject|0|||
145546167|NCT03708328|524860139|FG004|Overall Study|Withdrawal by Subject|1|||
145546168|NCT03708328|524860140|FG005|Overall Study|Withdrawal by Subject|0|||
145546169|NCT03708328|524860141|FG006|Overall Study|Withdrawal by Subject|2|||
145546170|NCT03708328|524860142|FG007|Overall Study|Withdrawal by Subject|4|||
145546171|NCT03708328|524860143|FG008|Overall Study|Withdrawal by Subject|1|||
145546172|NCT03708328|524860144|FG009|Overall Study|Withdrawal by Subject|5|||
145546173|NCT03708328|524860135|FG000|Overall Study|Study Closed Locally|0|||
145546174|NCT03708328|524860136|FG001|Overall Study|Study Closed Locally|0|||
145546175|NCT03708328|524860137|FG002|Overall Study|Study Closed Locally|0|||
145546176|NCT03708328|524860138|FG003|Overall Study|Study Closed Locally|0|||
145546177|NCT03708328|524860139|FG004|Overall Study|Study Closed Locally|0|||
145546178|NCT03708328|524860140|FG005|Overall Study|Study Closed Locally|0|||
145282656|NCT00449930|523884306|FG000|Overall Study|Glycemic discontinuation criteria|1|||
145282657|NCT00449930|523884307|FG001|Overall Study|Glycemic discontinuation criteria|1|||
145282658|NCT02124746|523884308|FG000|Overall Study|Adverse Event|2|||
145546179|NCT03708328|524860141|FG006|Overall Study|Study Closed Locally|0|||
145546180|NCT03708328|524860142|FG007|Overall Study|Study Closed Locally|1|||
145282659|NCT02124746|523884309|FG001|Overall Study|Adverse Event|1|||
145282660|NCT02124746|523884310|FG002|Overall Study|Adverse Event|2|||
145282661|NCT02124746|523884308|FG000|Overall Study|Death|2|||
145546181|NCT03708328|524860143|FG008|Overall Study|Study Closed Locally|0|||
145546182|NCT03708328|524860144|FG009|Overall Study|Study Closed Locally|0|||
145546183|NCT03708328|524860135|FG000|Overall Study|Study Ended By Sponsor|0|||
145546184|NCT03708328|524860136|FG001|Overall Study|Study Ended By Sponsor|0|||
145546185|NCT03708328|524860137|FG002|Overall Study|Study Ended By Sponsor|0|||
145546186|NCT03708328|524860138|FG003|Overall Study|Study Ended By Sponsor|0|||
145546187|NCT03708328|524860139|FG004|Overall Study|Study Ended By Sponsor|0|||
145546188|NCT03708328|524860140|FG005|Overall Study|Study Ended By Sponsor|1|||
145546189|NCT03708328|524860141|FG006|Overall Study|Study Ended By Sponsor|0|||
145546190|NCT03708328|524860142|FG007|Overall Study|Study Ended By Sponsor|1|||
145546191|NCT03708328|524860143|FG008|Overall Study|Study Ended By Sponsor|0|||
145546192|NCT03708328|524860144|FG009|Overall Study|Study Ended By Sponsor|0|||
145546193|NCT03708328|524860135|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546194|NCT03708328|524860136|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546195|NCT03708328|524860137|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546196|NCT03708328|524860138|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546197|NCT03708328|524860139|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546198|NCT03708328|524860140|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546199|NCT03708328|524860141|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546200|NCT03708328|524860142|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546201|NCT03708328|524860143|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
145546202|NCT03708328|524860144|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
145546203|NCT04523220|524860145|FG000|Main Treatment Period|Physician Decision|1|||
145546204|NCT04523220|524860146|FG001|Main Treatment Period|Physician Decision|1|||
145546205|NCT04523220|524860147|FG002|Main Treatment Period|Physician Decision|0|||
145546206|NCT04523220|524860145|FG000|Main Treatment Period|Other|5|||
145546207|NCT04523220|524860146|FG001|Main Treatment Period|Other|2|||
145546208|NCT04523220|524860147|FG002|Main Treatment Period|Other|4|||
145546209|NCT04523220|524860145|FG000|Main Treatment Period|Subject Decision|5|||
145546210|NCT04523220|524860146|FG001|Main Treatment Period|Subject Decision|7|||
145546211|NCT04523220|524860147|FG002|Main Treatment Period|Subject Decision|3|||
145546212|NCT04523220|524860145|FG000|Main Treatment Period|Death|5|||
145546213|NCT04523220|524860146|FG001|Main Treatment Period|Death|11|||
145546214|NCT04523220|524860147|FG002|Main Treatment Period|Death|4|||
145546215|NCT04523220|524860145|FG000|Main Treatment Period|Adverse Event|11|||
145546216|NCT04523220|524860146|FG001|Main Treatment Period|Adverse Event|9|||
145546217|NCT04523220|524860147|FG002|Main Treatment Period|Adverse Event|9|||
145546218|NCT04523220|524860145|FG000|Main Treatment Period|Withdrawal by Subject|3|||
145546219|NCT04523220|524860146|FG001|Main Treatment Period|Withdrawal by Subject|3|||
145546220|NCT04523220|524860147|FG002|Main Treatment Period|Withdrawal by Subject|4|||
145546221|NCT04523220|524860145|FG000|Main Treatment Period|Study drug never adminstered|10|||
145546222|NCT04523220|524860146|FG001|Main Treatment Period|Study drug never adminstered|3|||
145546223|NCT04523220|524860147|FG002|Main Treatment Period|Study drug never adminstered|5|||
145546224|NCT04523220|524860145|FG000|Extension Treatment Period|Physician Decision|1|||
145546225|NCT04523220|524860146|FG001|Extension Treatment Period|Physician Decision|0|||
145546226|NCT04523220|524860147|FG002|Extension Treatment Period|Physician Decision|3|||
145546227|NCT04523220|524860145|FG000|Extension Treatment Period|Other|2|||
145546228|NCT04523220|524860146|FG001|Extension Treatment Period|Other|6|||
145546229|NCT04523220|524860147|FG002|Extension Treatment Period|Other|6|||
145546230|NCT04523220|524860145|FG000|Extension Treatment Period|Subject Decision|5|||
145546231|NCT04523220|524860146|FG001|Extension Treatment Period|Subject Decision|2|||
145546232|NCT04523220|524860147|FG002|Extension Treatment Period|Subject Decision|4|||
145546233|NCT04523220|524860145|FG000|Extension Treatment Period|Death|6|||
145546234|NCT04523220|524860146|FG001|Extension Treatment Period|Death|4|||
145546235|NCT04523220|524860147|FG002|Extension Treatment Period|Death|7|||
145546236|NCT04523220|524860145|FG000|Extension Treatment Period|Adverse Event|6|||
145546237|NCT04523220|524860146|FG001|Extension Treatment Period|Adverse Event|7|||
145546238|NCT04523220|524860147|FG002|Extension Treatment Period|Adverse Event|9|||
145546239|NCT04523220|524860145|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
145546240|NCT04523220|524860146|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
145546241|NCT04523220|524860147|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
145546242|NCT04523220|524860145|FG000|Extension Treatment Period|Study drug never administered|0|||
145546243|NCT04523220|524860146|FG001|Extension Treatment Period|Study drug never administered|1|||
145546244|NCT04523220|524860147|FG002|Extension Treatment Period|Study drug never administered|0|||
145546245|NCT00571948|524860148|FG000|Overall Study|Lost to Follow-up|2|||
145546246|NCT00571948|524860149|FG001|Overall Study|Lost to Follow-up|0|||
145546247|NCT00571948|524860148|FG000|Overall Study|Withdrawal by Subject|1|||
145546248|NCT00571948|524860149|FG001|Overall Study|Withdrawal by Subject|2|||
145546249|NCT00571948|524860148|FG000|Overall Study|Protocol Violation|3|||
145282662|NCT02124746|523884309|FG001|Overall Study|Death|1|||
145282663|NCT02124746|523884310|FG002|Overall Study|Death|3|||
145282664|NCT02124746|523884308|FG000|Overall Study|Lack of Efficacy|3|||
145546250|NCT00571948|524860149|FG001|Overall Study|Protocol Violation|3|||
145546251|NCT00571948|524860148|FG000|Overall Study|infant refused study meal|3|||
145546252|NCT00571948|524860149|FG001|Overall Study|infant refused study meal|4|||
145546253|NCT00571948|524860148|FG000|Overall Study|Parent were afraid of blood colection|2|||
145546254|NCT00571948|524860149|FG001|Overall Study|Parent were afraid of blood colection|5|||
145546255|NCT04112784|524860150|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
145546256|NCT04112784|524860150|FG000|Overall Study|Screen Failures|4|||
145546257|NCT00256750|524860151|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
145546258|NCT00256750|524860152|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
145546259|NCT00256750|524860153|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
145546260|NCT00256750|524860151|FG000|Transplanted Pre-Treatment|Other|2|||
145546261|NCT00256750|524860152|FG001|Transplanted Pre-Treatment|Other|0|||
145282665|NCT02124746|523884309|FG001|Overall Study|Lack of Efficacy|2|||
145546262|NCT00256750|524860153|FG002|Transplanted Pre-Treatment|Other|0|||
145546263|NCT00256750|524860151|FG000|Transplanted Pre-Treatment|Death|1|||
145546264|NCT00256750|524860152|FG001|Transplanted Pre-Treatment|Death|0|||
145546265|NCT00256750|524860153|FG002|Transplanted Pre-Treatment|Death|0|||
145546266|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
145546267|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
145546268|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
145546269|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Death|3|||
145546270|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Death|2|||
145546271|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Death|4|||
145546272|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
145610912|NCT00663117|525092519|FG000|Overall Study|Lack of Efficacy|1|||
145610913|NCT00663117|525092520|FG001|Overall Study|Lack of Efficacy|0|||
145610914|NCT01158378|525092521|FG000|Overall Study|Death|4|||
145546273|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
145546274|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
145546275|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
145546276|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
145546277|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
145546278|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Other|5|||
145546279|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Other|4|||
145546280|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Other|2|||
145546281|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
145546282|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
145546283|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
145546284|NCT00256750|524860151|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
145546285|NCT00256750|524860152|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
145546286|NCT00256750|524860153|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
145546287|NCT00256750|524860151|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
145546288|NCT00256750|524860152|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
145282666|NCT02124746|523884310|FG002|Overall Study|Lack of Efficacy|2|||
145282667|NCT02124746|523884308|FG000|Overall Study|Physician Decision|6|||
145282668|NCT02124746|523884309|FG001|Overall Study|Physician Decision|4|||
145282669|NCT02124746|523884310|FG002|Overall Study|Physician Decision|5|||
145282670|NCT02124746|523884308|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145282671|NCT02124746|523884309|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145282672|NCT02124746|523884310|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145282673|NCT02124746|523884308|FG000|Overall Study|Withdrawal by Subject|3|||
145282674|NCT02124746|523884309|FG001|Overall Study|Withdrawal by Subject|3|||
145282675|NCT02124746|523884310|FG002|Overall Study|Withdrawal by Subject|0|||
145282676|NCT02124746|523884308|FG000|Overall Study|Study Terminated by Sponsor|0|||
145282677|NCT02124746|523884309|FG001|Overall Study|Study Terminated by Sponsor|0|||
145282678|NCT02124746|523884310|FG002|Overall Study|Study Terminated by Sponsor|6|||
145282679|NCT02124746|523884308|FG000|Overall Study|Disease Progression|3|||
145282680|NCT02124746|523884309|FG001|Overall Study|Disease Progression|6|||
145282681|NCT02124746|523884310|FG002|Overall Study|Disease Progression|4|||
145282682|NCT02868281|523884313|FG000|Overall Study|Adverse Event|2|||
145282683|NCT02868281|523884314|FG001|Overall Study|Adverse Event|2|||
145282684|NCT02868281|523884313|FG000|Overall Study|Protocol Violation|13|||
145282685|NCT02868281|523884314|FG001|Overall Study|Protocol Violation|10|||
145282686|NCT02868281|523884313|FG000|Overall Study|Lost to Follow-up|3|||
145282687|NCT02868281|523884314|FG001|Overall Study|Lost to Follow-up|6|||
145610915|NCT01158378|525092522|FG001|Overall Study|Death|5|||
145610916|NCT01158378|525092521|FG000|Overall Study|Lost to Follow-up|2|||
145546289|NCT00256750|524860153|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
145546290|NCT00256750|524860151|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
145546291|NCT00256750|524860152|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
145546292|NCT00256750|524860153|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
145546293|NCT00256750|524860151|FG000|Post-Transplant Treated (24 Months)|Death|3|||
145546294|NCT00256750|524860152|FG001|Post-Transplant Treated (24 Months)|Death|0|||
145546295|NCT00256750|524860153|FG002|Post-Transplant Treated (24 Months)|Death|0|||
145610917|NCT01158378|525092522|FG001|Overall Study|Lost to Follow-up|4|||
145546296|NCT00256750|524860151|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
145546297|NCT00256750|524860152|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
145546298|NCT00256750|524860153|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
145546299|NCT00256750|524860151|FG000|Post-Transplant Treated (24 Months)|Other|2|||
145546300|NCT00256750|524860152|FG001|Post-Transplant Treated (24 Months)|Other|0|||
145546301|NCT00256750|524860153|FG002|Post-Transplant Treated (24 Months)|Other|1|||
145546302|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
145546303|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
145546304|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
145610918|NCT01158378|525092521|FG000|Overall Study|Withdrawal by Subject|4|||
145610919|NCT01158378|525092522|FG001|Overall Study|Withdrawal by Subject|0|||
145546305|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
145546306|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
145546307|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
145546308|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Death|0|||
145546309|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Death|2|||
145546310|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Death|1|||
145546311|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
145546312|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
145546313|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
145546314|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
145546315|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
145546316|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
145546317|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
145546318|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
145546319|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
145546320|NCT00256750|524860151|FG000|Post-Transplant Treated (36 Months)|Other|0|||
145546321|NCT00256750|524860152|FG001|Post-Transplant Treated (36 Months)|Other|1|||
145546322|NCT00256750|524860153|FG002|Post-Transplant Treated (36 Months)|Other|1|||
145546323|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
145546324|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
145546325|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
145546326|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
145546327|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
145546328|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
145546329|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
145546330|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
145546331|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
145546332|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
145546333|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
145546334|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
145546335|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
145546336|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
145546337|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
145546338|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
145546339|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
145546340|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
145546341|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
145546342|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
145546343|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
145546344|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
145546345|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
145546346|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
145546347|NCT00256750|524860151|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
145546348|NCT00256750|524860152|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
145546349|NCT00256750|524860153|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
145546350|NCT02030041|524860155|FG000|Overall Study|Withdrawal by Subject|2|||
145546351|NCT02030041|524860156|FG001|Overall Study|Withdrawal by Subject|2|||
145546352|NCT02030041|524860157|FG002|Overall Study|Withdrawal by Subject|1|||
145546353|NCT01032837|524860158|FG000|Overall Study|Adverse event/internal illness|0|||
145546354|NCT01032837|524860159|FG001|Overall Study|Adverse event/internal illness|1|||
145546355|NCT01032837|524860160|FG002|Overall Study|Adverse event/internal illness|0|||
145546356|NCT01032837|524860161|FG003|Overall Study|Adverse event/internal illness|1|||
145546357|NCT01032837|524860158|FG000|Overall Study|Withdrew consent|0|||
145546358|NCT01032837|524860159|FG001|Overall Study|Withdrew consent|2|||
145546359|NCT01032837|524860160|FG002|Overall Study|Withdrew consent|0|||
145546360|NCT01032837|524860161|FG003|Overall Study|Withdrew consent|1|||
145546361|NCT01032837|524860158|FG000|Overall Study|Failed to return|0|||
145546362|NCT01032837|524860159|FG001|Overall Study|Failed to return|0|||
145546363|NCT01032837|524860160|FG002|Overall Study|Failed to return|1|||
145546364|NCT01032837|524860161|FG003|Overall Study|Failed to return|0|||
145546365|NCT01032837|524860158|FG000|Overall Study|Refused treatment|0|||
145546366|NCT01032837|524860159|FG001|Overall Study|Refused treatment|0|||
145546367|NCT01032837|524860160|FG002|Overall Study|Refused treatment|0|||
145546368|NCT01032837|524860161|FG003|Overall Study|Refused treatment|1|||
145546369|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
145546370|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
145546371|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
145546372|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
145546373|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
145546374|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
145546375|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
145546376|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
145546377|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
145546378|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
145546379|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
145546380|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
145546381|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
145546382|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
145546383|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
145546384|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
145546385|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
145546386|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
145546387|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
145546388|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
145546389|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
145546390|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
145546391|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
145546392|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
145546393|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
145546394|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
145546395|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
145546396|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
145546397|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
145546398|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
145546399|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
145546400|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
145546401|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
145546402|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
145546403|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
145546404|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
145546405|NCT00843024|524860162|FG000|Single-blind Placebo Run-In Phase|Other|0|||
145546406|NCT00843024|524860163|FG001|Single-blind Placebo Run-In Phase|Other|1|||
145546407|NCT00843024|524860164|FG002|Single-blind Placebo Run-In Phase|Other|0|||
145546408|NCT00843024|524860165|FG003|Single-blind Placebo Run-In Phase|Other|0|||
145546409|NCT00843024|524860166|FG004|Single-blind Placebo Run-In Phase|Other|0|||
145546410|NCT00843024|524860167|FG005|Single-blind Placebo Run-In Phase|Other|0|||
145546411|NCT00843024|524860162|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
145546412|NCT00843024|524860163|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
145546413|NCT00843024|524860164|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
145546414|NCT00843024|524860165|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
145546415|NCT00843024|524860166|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
145546416|NCT00843024|524860167|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
145546417|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145546418|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
145546419|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
145546420|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
145546421|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
145546422|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
145546423|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145546424|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145546425|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145546426|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
145546427|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145546428|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
145546429|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
145546430|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
145546431|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
145546432|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
145546433|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
145546434|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
145546435|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Physician Decision|0|||
145546436|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Physician Decision|0|||
145546437|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Physician Decision|0|||
145546438|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Physician Decision|3|||
145546439|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Physician Decision|1|||
145546440|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Physician Decision|1|||
145546441|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145546442|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Adverse Event|0|||
145546443|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Adverse Event|0|||
145546444|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Adverse Event|0|||
145546445|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Adverse Event|1|||
145546446|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Adverse Event|1|||
145546447|NCT00843024|524860162|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
145546448|NCT00843024|524860163|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
145546449|NCT00843024|524860164|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
145546450|NCT00843024|524860165|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
145546451|NCT00843024|524860166|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
145546452|NCT00843024|524860167|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
145546453|NCT05201703|524860168|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
145546454|NCT05201703|524860169|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
145546455|NCT05201703|524860168|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
145546456|NCT05201703|524860169|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
145546457|NCT02006719|524860170|FG000|Overall Study|Withdrawal by Subject|10|||
145546458|NCT02006719|524860171|FG001|Overall Study|Withdrawal by Subject|2|||
145546459|NCT02006719|524860170|FG000|Overall Study|Lost to Follow-up|5|||
145546460|NCT02006719|524860171|FG001|Overall Study|Lost to Follow-up|1|||
145546461|NCT02006719|524860170|FG000|Overall Study|Protocol Violation|2|||
145546462|NCT02006719|524860171|FG001|Overall Study|Protocol Violation|0|||
145546463|NCT02006719|524860170|FG000|Overall Study|Adverse Event|1|||
145546464|NCT02006719|524860171|FG001|Overall Study|Adverse Event|1|||
145546465|NCT02006719|524860170|FG000|Overall Study|Other/Unknown|0|||
145546466|NCT02006719|524860171|FG001|Overall Study|Other/Unknown|1|||
145546467|NCT02439138|524860177|FG000|Overall Study|Adverse Event|1|||
145546468|NCT02439138|524860177|FG000|Overall Study|PI decision to terminate the study|2|||
145546469|NCT02615145|524860178|FG000|Overall Study|Did Not Start Treatment|0|||
145546470|NCT02615145|524860179|FG001|Overall Study|Did Not Start Treatment|0|||
145546471|NCT02615145|524860180|FG002|Overall Study|Did Not Start Treatment|1|||
145546472|NCT02615145|524860181|FG003|Overall Study|Did Not Start Treatment|1|||
145546473|NCT02615145|524860178|FG000|Overall Study|Failure to Return|20|||
145546474|NCT02615145|524860179|FG001|Overall Study|Failure to Return|10|||
145546475|NCT02615145|524860180|FG002|Overall Study|Failure to Return|7|||
145546476|NCT02615145|524860181|FG003|Overall Study|Failure to Return|0|||
145546477|NCT02615145|524860178|FG000|Overall Study|Death|2|||
145546478|NCT02615145|524860179|FG001|Overall Study|Death|3|||
145546479|NCT02615145|524860180|FG002|Overall Study|Death|0|||
145546480|NCT02615145|524860181|FG003|Overall Study|Death|0|||
145546481|NCT02615145|524860178|FG000|Overall Study|Other, Not Specified|5|||
145546482|NCT02615145|524860179|FG001|Overall Study|Other, Not Specified|2|||
145546483|NCT02615145|524860180|FG002|Overall Study|Other, Not Specified|0|||
145546484|NCT02615145|524860181|FG003|Overall Study|Other, Not Specified|0|||
145546485|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546486|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
145546487|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546488|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
145546489|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
145546490|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546491|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546492|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546493|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546494|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546495|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546496|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546497|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546498|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546499|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
145546500|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
145546501|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
145546502|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
145546503|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546504|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546505|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546506|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546507|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546508|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546509|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546510|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546511|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546512|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546513|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546514|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
145546515|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546516|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546517|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546518|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
145546519|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546520|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546521|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546522|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546523|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546524|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546525|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546526|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546527|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546528|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546529|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
145546530|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546531|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
145546532|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546533|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546534|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546535|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546536|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546537|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546538|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546539|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546540|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546541|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546542|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546543|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546544|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
145546545|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546546|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546547|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546548|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546549|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
145546550|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145791184|NCT00668200|525741068|FG000|Overall Study|Withdrawal by Subject|2|||
145791185|NCT00668200|525741068|FG000|Overall Study|Lost to Follow-up|1|||
145791186|NCT01496430|525741069|FG000|Overall Study|Adverse Event|0|||
145791187|NCT01496430|525741070|FG001|Overall Study|Adverse Event|0|||
145791188|NCT01496430|525741071|FG002|Overall Study|Adverse Event|1|||
145791189|NCT01496430|525741069|FG000|Overall Study|Major Protocol Deviation|0|||
145791190|NCT01496430|525741070|FG001|Overall Study|Major Protocol Deviation|0|||
145791191|NCT01496430|525741071|FG002|Overall Study|Major Protocol Deviation|1|||
145791192|NCT01496430|525741069|FG000|Overall Study|Lost to Follow-up|2|||
145791193|NCT01496430|525741070|FG001|Overall Study|Lost to Follow-up|3|||
145791194|NCT01496430|525741071|FG002|Overall Study|Lost to Follow-up|1|||
145791195|NCT01496430|525741069|FG000|Overall Study|Voluntary Withdrawal|2|||
145791196|NCT01496430|525741070|FG001|Overall Study|Voluntary Withdrawal|1|||
145791197|NCT01496430|525741071|FG002|Overall Study|Voluntary Withdrawal|6|||
145791198|NCT01496430|525741069|FG000|Overall Study|Principal Investigator Discretion|0|||
145791199|NCT01496430|525741070|FG001|Overall Study|Principal Investigator Discretion|1|||
145791200|NCT01496430|525741071|FG002|Overall Study|Principal Investigator Discretion|1|||
145791201|NCT01496430|525741069|FG000|Overall Study|Other|2|||
145791202|NCT01496430|525741070|FG001|Overall Study|Other|0|||
145791203|NCT01496430|525741071|FG002|Overall Study|Other|0|||
145791204|NCT00997321|525741072|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
145791205|NCT00997321|525741073|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
145791206|NCT01151579|525741076|FG000|Overall Study|Physician Decision|3|||
145791207|NCT01151579|525741077|FG001|Overall Study|Physician Decision|1|||
145791208|NCT01151579|525741076|FG000|Overall Study|Withdrawal by Subject|3|||
145791209|NCT01151579|525741077|FG001|Overall Study|Withdrawal by Subject|2|||
145791210|NCT01151579|525741076|FG000|Overall Study|Not meet inclusion criteria|6|||
145791211|NCT01151579|525741077|FG001|Overall Study|Not meet inclusion criteria|4|||
145791212|NCT01276457|525741078|FG000|Core Study|Adverse Event|6|||
145791213|NCT01276457|525741079|FG001|Core Study|Adverse Event|3|||
145791214|NCT01276457|525741078|FG000|Core Study|Lost to Follow-up|1|||
145791215|NCT01276457|525741079|FG001|Core Study|Lost to Follow-up|2|||
145791216|NCT01276457|525741078|FG000|Core Study|Administrative problems|1|||
145791217|NCT01276457|525741079|FG001|Core Study|Administrative problems|1|||
145791218|NCT01276457|525741078|FG000|Core Study|Death|2|||
145791219|NCT01276457|525741079|FG001|Core Study|Death|2|||
145791220|NCT01276457|525741078|FG000|Core Study|Lack of Efficacy|3|||
145791221|NCT01276457|525741079|FG001|Core Study|Lack of Efficacy|12|||
145791222|NCT01276457|525741078|FG000|Extension Study|Lost to Follow-up|3|||
145791223|NCT01276457|525741079|FG001|Extension Study|Lost to Follow-up|0|||
145404820|NCT00915525|524338689|FG001|Overall Study|Non-Compliance|1|||
145404821|NCT00915525|524338688|FG000|Overall Study|Patient Moved|15|||
145791224|NCT01276457|525741078|FG000|Extension Study|Death|0|||
145791225|NCT01276457|525741079|FG001|Extension Study|Death|1|||
145791226|NCT01276457|525741078|FG000|Extension Study|Lack of Efficacy|3|||
145791227|NCT01276457|525741079|FG001|Extension Study|Lack of Efficacy|1|||
145791228|NCT01153763|525741082|FG000|Overall Study|Study Closed|16|||
145404822|NCT00915525|524338689|FG001|Overall Study|Patient Moved|9|||
145791229|NCT01153763|525741082|FG000|Overall Study|Lost to Follow-up|1|||
145791230|NCT01153763|525741082|FG000|Overall Study|Physician Decision|2|||
145791231|NCT01153763|525741082|FG000|Overall Study|Withdrawal by Subject|2|||
145791232|NCT04544709|525741086|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
145791233|NCT03238235|525741087|FG000|Overall Study|Adverse Event|2|||
145791234|NCT03238235|525741088|FG001|Overall Study|Adverse Event|0|||
145791235|NCT03238235|525741087|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
145791236|NCT03238235|525741088|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
145791237|NCT04436822|525741089|FG000|Overall Study|Physician Decision|2|||
145791238|NCT04436822|525741090|FG001|Overall Study|Physician Decision|0|||
145791239|NCT04436822|525741089|FG000|Overall Study|Sponsor request|1|||
145791240|NCT04436822|525741090|FG001|Overall Study|Sponsor request|0|||
145791241|NCT04436822|525741089|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145791242|NCT04436822|525741090|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145791243|NCT04436822|525741089|FG000|Overall Study|Unsuccessful procedure|0|||
145791244|NCT04436822|525741090|FG001|Overall Study|Unsuccessful procedure|1|||
145791245|NCT04436822|525741089|FG000|Overall Study|Withdrawal due to Covid-19|8|||
145791246|NCT04436822|525741090|FG001|Overall Study|Withdrawal due to Covid-19|1|||
145791247|NCT04436822|525741089|FG000|Overall Study|Withdrawal by Subject|1|||
145791248|NCT04436822|525741090|FG001|Overall Study|Withdrawal by Subject|0|||
145791249|NCT04436822|525741089|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
145791250|NCT04436822|525741090|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
145791251|NCT03807739|525741091|FG000|Overall Study|Adverse Event|1|||
145791252|NCT03807739|525741092|FG001|Overall Study|Adverse Event|0|||
145791253|NCT03807739|525741093|FG002|Overall Study|Adverse Event|0|||
145791254|NCT03807739|525741094|FG003|Overall Study|Adverse Event|0|||
145791255|NCT03807739|525741091|FG000|Overall Study|Withdrawal by Subject|1|||
145791256|NCT03807739|525741092|FG001|Overall Study|Withdrawal by Subject|0|||
145791257|NCT03807739|525741093|FG002|Overall Study|Withdrawal by Subject|0|||
145791258|NCT03807739|525741094|FG003|Overall Study|Withdrawal by Subject|0|||
145791259|NCT05118386|525741100|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
145791260|NCT05118386|525741101|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
145791261|NCT05118386|525741102|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
145791262|NCT05118386|525741103|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
145791263|NCT05118386|525741104|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
145791264|NCT05118386|525741105|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
145791265|NCT05118386|525741100|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
145791266|NCT05118386|525741101|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
145791267|NCT05118386|525741102|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
145791268|NCT05118386|525741103|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
145791269|NCT05118386|525741104|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
145791270|NCT05118386|525741105|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
145791271|NCT00369668|525741109|FG000|Overall Study|Lack of Efficacy|4|||
145791272|NCT00369668|525741110|FG001|Overall Study|Lack of Efficacy|5|||
145791273|NCT00369668|525741111|FG002|Overall Study|Lack of Efficacy|7|||
145791274|NCT00303108|525741114|FG000|Overall Study|Adverse Event|5|||
145791275|NCT00303108|525741115|FG001|Overall Study|Adverse Event|6|||
145791276|NCT00303108|525741116|FG002|Overall Study|Adverse Event|7|||
145791277|NCT00303108|525741114|FG000|Overall Study|Patient Request|4|||
145791278|NCT00303108|525741115|FG001|Overall Study|Patient Request|2|||
145791279|NCT00303108|525741116|FG002|Overall Study|Patient Request|8|||
145791280|NCT00303108|525741114|FG000|Overall Study|Failed Entry|1|||
145791281|NCT00303108|525741115|FG001|Overall Study|Failed Entry|0|||
145791282|NCT00303108|525741116|FG002|Overall Study|Failed Entry|1|||
145791283|NCT00303108|525741114|FG000|Overall Study|ineligible|2|||
145546551|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546552|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546553|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145791284|NCT00303108|525741115|FG001|Overall Study|ineligible|1|||
145791285|NCT00303108|525741116|FG002|Overall Study|ineligible|0|||
145791286|NCT00894413|525741117|FG000|Overall Study|Physician Decision|0|||
145791287|NCT00894413|525741118|FG001|Overall Study|Physician Decision|2|||
145791288|NCT00894413|525741117|FG000|Overall Study|Adverse Event|0|||
145791289|NCT00894413|525741118|FG001|Overall Study|Adverse Event|2|||
145791290|NCT00894413|525741117|FG000|Overall Study|Withdrawal by Subject|0|||
145791291|NCT00894413|525741118|FG001|Overall Study|Withdrawal by Subject|4|||
145791292|NCT02427477|525741122|FG000|Period 1|Adverse Event|1|||
145791293|NCT02427477|525741123|FG001|Period 1|Adverse Event|0|||
145791294|NCT00471445|525741124|FG000|Overall Study|Withdrawal by Subject|1|||
145791295|NCT00471445|525741125|FG001|Overall Study|Withdrawal by Subject|1|||
145791296|NCT00471445|525741124|FG000|Overall Study|Ineligible|1|||
145791297|NCT00471445|525741125|FG001|Overall Study|Ineligible|0|||
145791298|NCT00471445|525741124|FG000|Overall Study|Protocol Violation|0|||
145791299|NCT00471445|525741125|FG001|Overall Study|Protocol Violation|1|||
145791300|NCT01552928|525741126|FG000|Period 3|Adverse Event|0|||
145791301|NCT01552928|525741127|FG001|Period 3|Adverse Event|0|||
145791302|NCT01552928|525741128|FG002|Period 3|Adverse Event|1|||
145791303|NCT01552928|525741129|FG003|Period 3|Adverse Event|0|||
145791304|NCT01767194|525741130|FG000|Overall Study|Adverse Event|1|||
145791305|NCT01767194|525741131|FG001|Overall Study|Adverse Event|1|||
145791306|NCT01767194|525741130|FG000|Overall Study|Death|0|||
145791307|NCT01767194|525741131|FG001|Overall Study|Death|1|||
145791308|NCT01767194|525741130|FG000|Overall Study|Lack of Efficacy|12|||
145791309|NCT01767194|525741131|FG001|Overall Study|Lack of Efficacy|11|||
145791310|NCT01767194|525741130|FG000|Overall Study|Physician Decision|2|||
145791311|NCT01767194|525741131|FG001|Overall Study|Physician Decision|23|||
145791312|NCT01767194|525741130|FG000|Overall Study|Withdrawal by Subject|0|||
145791313|NCT01767194|525741131|FG001|Overall Study|Withdrawal by Subject|1|||
145791314|NCT01767194|525741130|FG000|Overall Study|Ineligible|1|||
145791315|NCT01767194|525741131|FG001|Overall Study|Ineligible|1|||
145791316|NCT01767194|525741130|FG000|Overall Study|Refusal by patient/parent|2|||
145791317|NCT01767194|525741131|FG001|Overall Study|Refusal by patient/parent|4|||
145791318|NCT01767194|525741130|FG000|Overall Study|Criteria not met on time for next cycle|0|||
145791319|NCT01767194|525741131|FG001|Overall Study|Criteria not met on time for next cycle|1|||
145791320|NCT02723604|525742927|FG000|Overall Study|ineligible|1|||
145791321|NCT02723604|525742927|FG000|Overall Study|never received treatment|1|||
145791322|NCT00311181|525742930|FG000|Overall Study|Final DFTs were not obtained|96|||
145791323|NCT00506948|525742936|FG000|Overall Study|Death|4|||
145791324|NCT00506948|525742936|FG000|Overall Study|Adverse Event|5|||
145791325|NCT00506948|525742936|FG000|Overall Study|Physician Decision|1|||
145791326|NCT02395653|525742937|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
145791327|NCT02395653|525742937|FG000|Overall Study|Consent Withdrawn at Screening|1|||
145791328|NCT02395653|525742937|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
145791329|NCT02395653|525742937|FG000|Overall Study|Investigator Decision at Screening|1|||
145791330|NCT02395653|525742937|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
145791331|NCT02395653|525742937|FG000|Overall Study|Withdrawal by Subject|1|||
145791332|NCT02395653|525742937|FG000|Overall Study|Lost to Follow-up|1|||
145791333|NCT00296725|525742938|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
145791334|NCT00296725|525742938|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
145791335|NCT00296725|525742938|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
145791336|NCT03137121|525742939|FG000|Overall Study|Withdrawal by Subject|0|||
145791337|NCT03137121|525742940|FG001|Overall Study|Withdrawal by Subject|1|||
145791338|NCT00839423|525742946|FG000|Overall Study|Adverse Event|4|||
145791339|NCT00839423|525742947|FG001|Overall Study|Adverse Event|3|||
145791340|NCT00839423|525742948|FG002|Overall Study|Adverse Event|7|||
145791341|NCT00839423|525742949|FG003|Overall Study|Adverse Event|16|||
145791342|NCT00839423|525742946|FG000|Overall Study|Lack of Efficacy|6|||
145791343|NCT00839423|525742947|FG001|Overall Study|Lack of Efficacy|6|||
145791344|NCT00839423|525742948|FG002|Overall Study|Lack of Efficacy|3|||
145791345|NCT00839423|525742949|FG003|Overall Study|Lack of Efficacy|2|||
145791346|NCT00839423|525742946|FG000|Overall Study|Non-compliance|0|||
145791347|NCT00839423|525742947|FG001|Overall Study|Non-compliance|0|||
145791348|NCT00839423|525742948|FG002|Overall Study|Non-compliance|0|||
145791349|NCT00839423|525742949|FG003|Overall Study|Non-compliance|1|||
145791350|NCT00839423|525742946|FG000|Overall Study|Protocol Violation|0|||
145610920|NCT02769065|525092523|FG000|Overall Study|Voluntary Withdrawal|1|||
145610921|NCT02769065|525092524|FG001|Overall Study|Voluntary Withdrawal|0|||
145610922|NCT02769065|525092525|FG002|Overall Study|Voluntary Withdrawal|0|||
145610923|NCT02769065|525092526|FG003|Overall Study|Voluntary Withdrawal|0|||
145610924|NCT02769065|525092527|FG004|Overall Study|Voluntary Withdrawal|0|||
145610925|NCT02769065|525092528|FG005|Overall Study|Voluntary Withdrawal|0|||
145610926|NCT02769065|525092529|FG006|Overall Study|Voluntary Withdrawal|0|||
145610927|NCT02769065|525092530|FG007|Overall Study|Voluntary Withdrawal|0|||
145610928|NCT02769065|525092531|FG008|Overall Study|Voluntary Withdrawal|0|||
145610929|NCT02769065|525092532|FG009|Overall Study|Voluntary Withdrawal|0|||
145610930|NCT02769065|525092533|FG010|Overall Study|Voluntary Withdrawal|0|||
145610931|NCT02769065|525092534|FG011|Overall Study|Voluntary Withdrawal|0|||
145610932|NCT02769065|525092535|FG012|Overall Study|Voluntary Withdrawal|0|||
145610933|NCT02769065|525092536|FG013|Overall Study|Voluntary Withdrawal|0|||
145610934|NCT02769065|525092537|FG014|Overall Study|Voluntary Withdrawal|0|||
145610935|NCT02769065|525092538|FG015|Overall Study|Voluntary Withdrawal|0|||
145610936|NCT02769065|525092539|FG016|Overall Study|Voluntary Withdrawal|0|||
145610937|NCT02769065|525092540|FG017|Overall Study|Voluntary Withdrawal|0|||
145610938|NCT02769065|525092541|FG018|Overall Study|Voluntary Withdrawal|0|||
145610939|NCT02769065|525092542|FG019|Overall Study|Voluntary Withdrawal|0|||
145610940|NCT02769065|525092543|FG020|Overall Study|Voluntary Withdrawal|0|||
145791351|NCT00839423|525742947|FG001|Overall Study|Protocol Violation|1|||
145791352|NCT00839423|525742948|FG002|Overall Study|Protocol Violation|2|||
145791353|NCT00839423|525742949|FG003|Overall Study|Protocol Violation|0|||
145791354|NCT00839423|525742946|FG000|Overall Study|Withdrawal of consent|4|||
145791355|NCT00839423|525742947|FG001|Overall Study|Withdrawal of consent|0|||
145791356|NCT00839423|525742948|FG002|Overall Study|Withdrawal of consent|4|||
145791357|NCT00839423|525742949|FG003|Overall Study|Withdrawal of consent|1|||
145791358|NCT00839423|525742946|FG000|Overall Study|Lost to Follow-up|1|||
145791359|NCT00839423|525742947|FG001|Overall Study|Lost to Follow-up|0|||
145791360|NCT00839423|525742948|FG002|Overall Study|Lost to Follow-up|1|||
145791361|NCT00839423|525742949|FG003|Overall Study|Lost to Follow-up|0|||
145791362|NCT00839423|525742946|FG000|Overall Study|Administrative or other reasons|3|||
145791363|NCT00839423|525742947|FG001|Overall Study|Administrative or other reasons|0|||
145791364|NCT00839423|525742948|FG002|Overall Study|Administrative or other reasons|1|||
145791365|NCT00839423|525742949|FG003|Overall Study|Administrative or other reasons|0|||
145791366|NCT02585999|525742950|FG000|Overall Study|Lost to Follow-up|1|||
145791367|NCT02585999|525742950|FG000|Overall Study|Protocol Violation|1|||
145791368|NCT01332019|525742951|FG000|Overall Study|Was Not Dosed|1|||
145791369|NCT01332019|525742952|FG001|Overall Study|Was Not Dosed|0|||
145791370|NCT01332019|525742951|FG000|Overall Study|Other|16|||
145791371|NCT01332019|525742952|FG001|Overall Study|Other|18|||
145791372|NCT01332019|525742951|FG000|Overall Study|Death|2|||
145791373|NCT01332019|525742952|FG001|Overall Study|Death|1|||
145791374|NCT01332019|525742951|FG000|Overall Study|Physician Decision|4|||
145791375|NCT01332019|525742952|FG001|Overall Study|Physician Decision|3|||
145791376|NCT01332019|525742951|FG000|Overall Study|Withdrawal by Subject|73|||
145791377|NCT01332019|525742952|FG001|Overall Study|Withdrawal by Subject|71|||
145791378|NCT01332019|525742951|FG000|Overall Study|Lost to Follow-up|4|||
145791379|NCT01332019|525742952|FG001|Overall Study|Lost to Follow-up|7|||
145791380|NCT01332019|525742951|FG000|Overall Study|Adverse Event|13|||
145791381|NCT01332019|525742952|FG001|Overall Study|Adverse Event|22|||
145791382|NCT01369849|525742953|FG000|Overall Study|Ineligible prior to treatment|0|||
145791383|NCT01369849|525742954|FG001|Overall Study|Ineligible prior to treatment|0|||
145791384|NCT01369849|525742955|FG002|Overall Study|Ineligible prior to treatment|1|||
145791385|NCT01369849|525742953|FG000|Overall Study|Ineligible after receiving treatment|0|||
145791386|NCT01369849|525742954|FG001|Overall Study|Ineligible after receiving treatment|1|||
145791387|NCT01369849|525742955|FG002|Overall Study|Ineligible after receiving treatment|0|||
145791388|NCT00871377|525742956|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145791389|NCT00871377|525742957|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145791390|NCT00871377|525742958|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
145791391|NCT00871377|525742959|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145791392|NCT00871377|525742960|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145791393|NCT00871377|525742961|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145282688|NCT02868281|523884313|FG000|Overall Study|Withdrawal by Subject|11|||
145791394|NCT00871377|525742956|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
145791395|NCT00871377|525742957|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
145791396|NCT00871377|525742958|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
145791397|NCT00871377|525742959|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
145791398|NCT00871377|525742960|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
145791399|NCT00871377|525742961|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
145610941|NCT02769065|525092544|FG021|Overall Study|Voluntary Withdrawal|0|||
145610942|NCT02769065|525092545|FG022|Overall Study|Voluntary Withdrawal|0|||
145610943|NCT02769065|525092546|FG023|Overall Study|Voluntary Withdrawal|0|||
145610944|NCT02769065|525092547|FG024|Overall Study|Voluntary Withdrawal|0|||
145791400|NCT00871377|525742956|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
145791401|NCT00871377|525742957|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791402|NCT00871377|525742958|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791403|NCT00871377|525742959|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791404|NCT00871377|525742960|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791405|NCT00871377|525742961|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791406|NCT00871377|525742956|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791407|NCT00871377|525742957|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791408|NCT00871377|525742958|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791409|NCT00871377|525742959|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791410|NCT00871377|525742960|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
145791411|NCT00871377|525742961|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
145791412|NCT00871377|525742956|FG000|Third Intervention (10 Weeks)|Death|0|||
145791413|NCT00871377|525742957|FG001|Third Intervention (10 Weeks)|Death|0|||
145791414|NCT00871377|525742958|FG002|Third Intervention (10 Weeks)|Death|0|||
145791415|NCT00871377|525742959|FG003|Third Intervention (10 Weeks)|Death|1|||
145791416|NCT00871377|525742960|FG004|Third Intervention (10 Weeks)|Death|0|||
145791417|NCT00871377|525742961|FG005|Third Intervention (10 Weeks)|Death|0|||
145791418|NCT00120289|525742962|FG000|Overall Study|Death|96|||
145791419|NCT00120289|525742963|FG001|Overall Study|Death|82|||
145791420|NCT00120289|525742962|FG000|Overall Study|Lost to Follow-up|11|||
145791421|NCT00120289|525742963|FG001|Overall Study|Lost to Follow-up|14|||
145791422|NCT00120289|525742962|FG000|Overall Study|Withdrawal by Subject|14|||
145791423|NCT00120289|525742963|FG001|Overall Study|Withdrawal by Subject|13|||
145791424|NCT00882999|525742965|FG000|Overall Study|Adverse Event|0|||
145791425|NCT00882999|525742966|FG001|Overall Study|Adverse Event|0|||
145791426|NCT00882999|525742967|FG002|Overall Study|Adverse Event|0|||
145791427|NCT00882999|525742968|FG003|Overall Study|Adverse Event|0|||
145791428|NCT00882999|525742969|FG004|Overall Study|Adverse Event|1|||
145791429|NCT00882999|525742970|FG005|Overall Study|Adverse Event|0|||
145791430|NCT00882999|525742971|FG006|Overall Study|Adverse Event|0|||
145791431|NCT00882999|525742965|FG000|Overall Study|Death|0|||
145791432|NCT00882999|525742966|FG001|Overall Study|Death|1|||
145791433|NCT00882999|525742967|FG002|Overall Study|Death|0|||
145791434|NCT00882999|525742968|FG003|Overall Study|Death|0|||
145791435|NCT00882999|525742969|FG004|Overall Study|Death|0|||
145791436|NCT00882999|525742970|FG005|Overall Study|Death|0|||
145791437|NCT00882999|525742971|FG006|Overall Study|Death|0|||
145791438|NCT00882999|525742965|FG000|Overall Study|Withdrawal by Subject|7|||
145791439|NCT00882999|525742966|FG001|Overall Study|Withdrawal by Subject|6|||
145791440|NCT00882999|525742967|FG002|Overall Study|Withdrawal by Subject|3|||
145791441|NCT00882999|525742968|FG003|Overall Study|Withdrawal by Subject|3|||
145791442|NCT00882999|525742969|FG004|Overall Study|Withdrawal by Subject|6|||
145791443|NCT00882999|525742970|FG005|Overall Study|Withdrawal by Subject|5|||
145791444|NCT00882999|525742971|FG006|Overall Study|Withdrawal by Subject|5|||
145791445|NCT00882999|525742965|FG000|Overall Study|Lost to Follow-up|0|||
145791446|NCT00882999|525742966|FG001|Overall Study|Lost to Follow-up|1|||
145791447|NCT00882999|525742967|FG002|Overall Study|Lost to Follow-up|1|||
145791448|NCT00882999|525742968|FG003|Overall Study|Lost to Follow-up|2|||
145791449|NCT00882999|525742969|FG004|Overall Study|Lost to Follow-up|1|||
145791450|NCT00882999|525742970|FG005|Overall Study|Lost to Follow-up|1|||
145791451|NCT00882999|525742971|FG006|Overall Study|Lost to Follow-up|2|||
145791452|NCT00882999|525742965|FG000|Overall Study|Physician Decision|1|||
145791453|NCT00882999|525742966|FG001|Overall Study|Physician Decision|0|||
145791454|NCT00882999|525742967|FG002|Overall Study|Physician Decision|0|||
145791455|NCT00882999|525742968|FG003|Overall Study|Physician Decision|0|||
145791456|NCT00882999|525742969|FG004|Overall Study|Physician Decision|0|||
145791457|NCT00882999|525742970|FG005|Overall Study|Physician Decision|1|||
145791458|NCT00882999|525742971|FG006|Overall Study|Physician Decision|1|||
145791459|NCT01757405|525742972|FG000|Overall Study|Lost to Follow-up|1|||
145791460|NCT01757405|525742973|FG001|Overall Study|Lost to Follow-up|1|||
145791461|NCT01757405|525742972|FG000|Overall Study|Withdrawal by Subject|0|||
145791462|NCT01757405|525742973|FG001|Overall Study|Withdrawal by Subject|1|||
145791463|NCT00238303|525742974|FG000|Overall Study|Withdrawal by Subject|11|||
145791464|NCT00238303|525742975|FG001|Overall Study|Withdrawal by Subject|1|||
145791465|NCT00238303|525742976|FG002|Overall Study|Withdrawal by Subject|2|||
145791466|NCT00238303|525742974|FG000|Overall Study|Death|1|||
145791467|NCT00238303|525742975|FG001|Overall Study|Death|0|||
145791468|NCT00238303|525742976|FG002|Overall Study|Death|1|||
145791469|NCT00238303|525742974|FG000|Overall Study|Other Medical Problems|2|||
145791470|NCT00238303|525742975|FG001|Overall Study|Other Medical Problems|0|||
145791471|NCT00238303|525742976|FG002|Overall Study|Other Medical Problems|2|||
145791472|NCT00238303|525742974|FG000|Overall Study|Poor tolerance of study treatment|1|||
145791473|NCT00238303|525742975|FG001|Overall Study|Poor tolerance of study treatment|0|||
145791474|NCT00238303|525742976|FG002|Overall Study|Poor tolerance of study treatment|1|||
145791475|NCT00238303|525742974|FG000|Overall Study|Adverse Event|0|||
145791476|NCT00238303|525742975|FG001|Overall Study|Adverse Event|1|||
145791477|NCT00238303|525742976|FG002|Overall Study|Adverse Event|3|||
145791478|NCT00937560|525742977|FG000|Initial Treatment|Death|6|||
145791479|NCT00937560|525742977|FG000|Initial Treatment|Withdraw consent|3|||
145791480|NCT00937560|525742977|FG000|Initial Treatment|Adverse Event|1|||
145791481|NCT00937560|525742977|FG000|Initial Treatment|Lost to Follow-up|1|||
145791482|NCT00937560|525742977|FG000|Initial Treatment|No end of study page|10|||
145791483|NCT00937560|525742977|FG000|Maintenance Treatment|Death|12|||
145791484|NCT00937560|525742977|FG000|Maintenance Treatment|Withdraw consent|5|||
145791485|NCT00937560|525742977|FG000|Maintenance Treatment|According to protocol|1|||
145791486|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
145791487|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
145791488|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
145791489|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
145791490|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
145791491|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
145791492|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
145791493|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
145791494|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
145791495|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
145791496|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
145282689|NCT02868281|523884314|FG001|Overall Study|Withdrawal by Subject|15|||
145282690|NCT02868281|523884313|FG000|Overall Study|Physician Decision|2|||
145282691|NCT02868281|523884314|FG001|Overall Study|Physician Decision|0|||
145791497|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
145791498|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
145791499|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
145791500|NCT00848549|525742978|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
145791501|NCT00848549|525742979|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
145791502|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
145791503|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
145791504|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
145791505|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
145791506|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
145791507|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
145791508|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
145791509|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
145791510|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
145791511|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
145791512|NCT00848549|525742978|FG000|E2090-E044-314 (Extension Study)|Other|5|||
145791513|NCT00848549|525742979|FG001|E2090-E044-314 (Extension Study)|Other|6|||
145791514|NCT01248130|525742980|FG000|Overall Study|Protocol Violation|1|||
145791515|NCT01248130|525742981|FG001|Overall Study|Protocol Violation|0|||
145791516|NCT01248130|525742980|FG000|Overall Study|Ineligible|1|||
145791517|NCT01248130|525742981|FG001|Overall Study|Ineligible|0|||
145791518|NCT00501046|525742984|FG000|Overall Study|Adverse Event|21|||
145791519|NCT00501046|525742985|FG001|Overall Study|Adverse Event|25|||
145791520|NCT00501046|525742984|FG000|Overall Study|Death|23|||
145791521|NCT00501046|525742985|FG001|Overall Study|Death|30|||
145791522|NCT00501046|525742984|FG000|Overall Study|Lost to Follow-up|14|||
145791523|NCT00501046|525742985|FG001|Overall Study|Lost to Follow-up|13|||
145791524|NCT00501046|525742984|FG000|Overall Study|Physician Decision|7|||
145791525|NCT00501046|525742985|FG001|Overall Study|Physician Decision|2|||
145791526|NCT00501046|525742984|FG000|Overall Study|Pregnancy|0|||
145791527|NCT00501046|525742985|FG001|Overall Study|Pregnancy|3|||
145791528|NCT00501046|525742984|FG000|Overall Study|Protocol Violation|2|||
145791529|NCT00501046|525742985|FG001|Overall Study|Protocol Violation|1|||
145791530|NCT00501046|525742984|FG000|Overall Study|Withdrawal by Subject|84|||
145791531|NCT00501046|525742985|FG001|Overall Study|Withdrawal by Subject|83|||
145791532|NCT00501046|525742984|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
145791533|NCT00501046|525742985|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
145791534|NCT01576016|525742986|FG000|Lead Safety|Death|132|||
145791535|NCT01576016|525742987|FG001|Lead Safety|Death|0|||
145791536|NCT01576016|525742986|FG000|Lead Safety|Withdrawal by Subject|81|||
145791537|NCT01576016|525742987|FG001|Lead Safety|Withdrawal by Subject|0|||
145282692|NCT02868281|523884313|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
145546554|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145282693|NCT02868281|523884314|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
145546555|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145791538|NCT01576016|525742986|FG000|Lead Safety|System Explanted without Replacement|24|||
145791539|NCT01576016|525742987|FG001|Lead Safety|System Explanted without Replacement|0|||
145791540|NCT01576016|525742986|FG000|Lead Safety|Physician Decision|14|||
145791541|NCT01576016|525742987|FG001|Lead Safety|Physician Decision|0|||
145791542|NCT01576016|525742986|FG000|Lead Safety|Lost to Follow-up|13|||
145791543|NCT01576016|525742987|FG001|Lead Safety|Lost to Follow-up|0|||
145791544|NCT01576016|525742986|FG000|Lead Safety|Unsuccessful implant|2|||
145546556|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546557|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145546558|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145791545|NCT01576016|525742987|FG001|Lead Safety|Unsuccessful implant|0|||
145791546|NCT01576016|525742986|FG000|Lead Safety|Sponsor request|1|||
145791547|NCT01576016|525742987|FG001|Lead Safety|Sponsor request|0|||
145791548|NCT01576016|525742986|FG000|Lead Safety|Device replaced with CRT-D|1|||
145791549|NCT01576016|525742987|FG001|Lead Safety|Device replaced with CRT-D|0|||
145791550|NCT01576016|525742986|FG000|Lead Safety|Patient on Palliative Care|1|||
145791551|NCT01576016|525742987|FG001|Lead Safety|Patient on Palliative Care|0|||
145791552|NCT01576016|525742986|FG000|Lead Safety|Patient noncompliance|1|||
145791553|NCT01576016|525742987|FG001|Lead Safety|Patient noncompliance|0|||
145791554|NCT01576016|525742986|FG000|Lead Safety|Too far from study site|1|||
145791555|NCT01576016|525742987|FG001|Lead Safety|Too far from study site|0|||
145791556|NCT01576016|525742986|FG000|Lead Safety|System deactivated|1|||
145791557|NCT01576016|525742987|FG001|Lead Safety|System deactivated|0|||
145791558|NCT01576016|525742986|FG000|Lead Safety|Patient no longer followed by study PI|1|||
145791559|NCT01576016|525742987|FG001|Lead Safety|Patient no longer followed by study PI|0|||
145791560|NCT01576016|525742986|FG000|MRI Safety|Withdrawal by Subject|0|||
145791561|NCT01576016|525742987|FG001|MRI Safety|Withdrawal by Subject|10|||
145791562|NCT01576016|525742986|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
145791563|NCT01576016|525742987|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
145791564|NCT01576016|525742986|FG000|MRI Safety|Has not yet completed MRI scan|0|||
145791565|NCT01576016|525742987|FG001|MRI Safety|Has not yet completed MRI scan|56|||
145791566|NCT01576016|525742986|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
145791567|NCT01576016|525742987|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
145791568|NCT04507867|525742991|FG000|Overall Study|Death|7|||
145791569|NCT04507867|525742992|FG001|Overall Study|Death|1|||
145791570|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
145791571|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791572|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791573|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791574|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791575|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791576|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791577|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791578|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145791579|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
145791580|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791581|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791582|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791583|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791584|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791585|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791586|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791587|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145791588|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
145791589|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791590|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791591|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791592|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791593|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791594|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791595|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791596|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145791597|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
145791598|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791599|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791600|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791601|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791602|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
145546559|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
145791603|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791604|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791605|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
145791606|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
145791607|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791608|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791609|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791610|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791611|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791612|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791613|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791614|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145791615|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
145791616|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791617|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791618|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791619|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791620|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791621|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791622|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791623|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145791624|NCT02175771|525742998|FG000|Run-In Period (Pre-assignment)|Other|8|||
145791625|NCT02175771|525742999|FG001|Run-In Period (Pre-assignment)|Other|0|||
145791626|NCT02175771|525743000|FG002|Run-In Period (Pre-assignment)|Other|0|||
145791627|NCT02175771|525743001|FG003|Run-In Period (Pre-assignment)|Other|0|||
145546560|NCT01737697|524860182|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546561|NCT01737697|524860183|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
145791628|NCT02175771|525743002|FG004|Run-In Period (Pre-assignment)|Other|0|||
145791629|NCT02175771|525743003|FG005|Run-In Period (Pre-assignment)|Other|0|||
145791630|NCT02175771|525743004|FG006|Run-In Period (Pre-assignment)|Other|0|||
145791631|NCT02175771|525743005|FG007|Run-In Period (Pre-assignment)|Other|0|||
145791632|NCT02175771|525743006|FG008|Run-In Period (Pre-assignment)|Other|0|||
145791633|NCT02175771|525742998|FG000|Treatment Period|Adverse Event|0|||
145791634|NCT02175771|525742999|FG001|Treatment Period|Adverse Event|2|||
145791635|NCT02175771|525743000|FG002|Treatment Period|Adverse Event|1|||
145791636|NCT02175771|525743001|FG003|Treatment Period|Adverse Event|1|||
145791637|NCT02175771|525743002|FG004|Treatment Period|Adverse Event|1|||
145791638|NCT02175771|525743003|FG005|Treatment Period|Adverse Event|3|||
145791639|NCT02175771|525743004|FG006|Treatment Period|Adverse Event|2|||
145791640|NCT02175771|525743005|FG007|Treatment Period|Adverse Event|0|||
145791641|NCT02175771|525743006|FG008|Treatment Period|Adverse Event|1|||
145791642|NCT02175771|525742998|FG000|Treatment Period|Withdrawal by Subject|0|||
145791643|NCT02175771|525742999|FG001|Treatment Period|Withdrawal by Subject|9|||
145791644|NCT02175771|525743000|FG002|Treatment Period|Withdrawal by Subject|3|||
145791645|NCT02175771|525743001|FG003|Treatment Period|Withdrawal by Subject|6|||
145791646|NCT02175771|525743002|FG004|Treatment Period|Withdrawal by Subject|2|||
145791647|NCT02175771|525743003|FG005|Treatment Period|Withdrawal by Subject|4|||
145791648|NCT02175771|525743004|FG006|Treatment Period|Withdrawal by Subject|2|||
145791649|NCT02175771|525743005|FG007|Treatment Period|Withdrawal by Subject|9|||
145791650|NCT02175771|525743006|FG008|Treatment Period|Withdrawal by Subject|2|||
145791651|NCT02175771|525742998|FG000|Treatment Period|Noncompliance|0|||
145791652|NCT02175771|525742999|FG001|Treatment Period|Noncompliance|1|||
145791653|NCT02175771|525743000|FG002|Treatment Period|Noncompliance|2|||
145791654|NCT02175771|525743001|FG003|Treatment Period|Noncompliance|0|||
145791655|NCT02175771|525743002|FG004|Treatment Period|Noncompliance|0|||
145791656|NCT02175771|525743003|FG005|Treatment Period|Noncompliance|0|||
145791657|NCT02175771|525743004|FG006|Treatment Period|Noncompliance|0|||
145791658|NCT02175771|525743005|FG007|Treatment Period|Noncompliance|0|||
145546562|NCT01737697|524860184|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
145546563|NCT01737697|524860185|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
145546564|NCT01737697|524860186|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
145546565|NCT01737697|524860187|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546566|NCT01737697|524860188|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546567|NCT01737697|524860189|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546568|NCT01737697|524860190|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546569|NCT01737697|524860191|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546570|NCT01737697|524860192|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546571|NCT01737697|524860193|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546572|NCT01737697|524860194|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145791659|NCT02175771|525743006|FG008|Treatment Period|Noncompliance|1|||
145791660|NCT02175771|525742998|FG000|Treatment Period|Protocol Violation|0|||
145791661|NCT02175771|525742999|FG001|Treatment Period|Protocol Violation|0|||
145791662|NCT02175771|525743000|FG002|Treatment Period|Protocol Violation|0|||
145791663|NCT02175771|525743001|FG003|Treatment Period|Protocol Violation|0|||
145791664|NCT02175771|525743002|FG004|Treatment Period|Protocol Violation|0|||
145791665|NCT02175771|525743003|FG005|Treatment Period|Protocol Violation|0|||
145791666|NCT02175771|525743004|FG006|Treatment Period|Protocol Violation|0|||
145791667|NCT02175771|525743005|FG007|Treatment Period|Protocol Violation|1|||
145791668|NCT02175771|525743006|FG008|Treatment Period|Protocol Violation|0|||
145282694|NCT02868281|523884313|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
145282695|NCT02868281|523884314|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
145282696|NCT02868281|523884313|FG000|Overall Study|Long journey/moving away|1|||
145282697|NCT02868281|523884314|FG001|Overall Study|Long journey/moving away|1|||
145282698|NCT01722266|523884315|FG000|Overall Study|Withdrawal by Subject|1|||
145282699|NCT01722266|523884316|FG001|Overall Study|Withdrawal by Subject|2|||
145282700|NCT01722266|523884317|FG002|Overall Study|Withdrawal by Subject|0|||
145282701|NCT01722266|523884318|FG003|Overall Study|Withdrawal by Subject|0|||
145282702|NCT01722266|523884315|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
145791669|NCT02175771|525742998|FG000|Treatment Period|Disease progression|0|||
145791670|NCT02175771|525742999|FG001|Treatment Period|Disease progression|0|||
145791671|NCT02175771|525743000|FG002|Treatment Period|Disease progression|0|||
145791672|NCT02175771|525743001|FG003|Treatment Period|Disease progression|0|||
145791673|NCT02175771|525743002|FG004|Treatment Period|Disease progression|0|||
145791674|NCT02175771|525743003|FG005|Treatment Period|Disease progression|0|||
145791675|NCT02175771|525743004|FG006|Treatment Period|Disease progression|0|||
145791676|NCT02175771|525743005|FG007|Treatment Period|Disease progression|2|||
145791677|NCT02175771|525743006|FG008|Treatment Period|Disease progression|0|||
145791678|NCT02175771|525742998|FG000|Treatment Period|Lost to Follow-up|0|||
145791679|NCT02175771|525742999|FG001|Treatment Period|Lost to Follow-up|3|||
145791680|NCT02175771|525743000|FG002|Treatment Period|Lost to Follow-up|1|||
145791681|NCT02175771|525743001|FG003|Treatment Period|Lost to Follow-up|3|||
145791682|NCT02175771|525743002|FG004|Treatment Period|Lost to Follow-up|1|||
145791683|NCT02175771|525743003|FG005|Treatment Period|Lost to Follow-up|2|||
145791684|NCT02175771|525743004|FG006|Treatment Period|Lost to Follow-up|1|||
145791685|NCT02175771|525743005|FG007|Treatment Period|Lost to Follow-up|2|||
145791686|NCT02175771|525743006|FG008|Treatment Period|Lost to Follow-up|2|||
145791687|NCT02175771|525742998|FG000|Treatment Period|Lack of Efficacy|0|||
145791688|NCT02175771|525742999|FG001|Treatment Period|Lack of Efficacy|0|||
145791689|NCT02175771|525743000|FG002|Treatment Period|Lack of Efficacy|0|||
145791690|NCT02175771|525743001|FG003|Treatment Period|Lack of Efficacy|0|||
145282703|NCT01722266|523884316|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
145282704|NCT01722266|523884317|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
145282705|NCT01722266|523884318|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
145282706|NCT01722266|523884315|FG000|Overall Study|Dropped out due to Nausea|0|||
145282707|NCT01722266|523884316|FG001|Overall Study|Dropped out due to Nausea|0|||
145282708|NCT01722266|523884317|FG002|Overall Study|Dropped out due to Nausea|2|||
145282709|NCT01722266|523884318|FG003|Overall Study|Dropped out due to Nausea|0|||
145282710|NCT03811249|523884319|FG000|Overall Study|Withdrawal by Subject|44|||
145282711|NCT03811249|523884319|FG000|Overall Study|Missed Visit|24|||
145282712|NCT01504867|523884323|FG000|Overall Study|Inclusion criteria not met|2|||
145282713|NCT01504867|523884324|FG001|Overall Study|Inclusion criteria not met|2|||
145282714|NCT01504867|523884323|FG000|Overall Study|Consent revoked|5|||
145282715|NCT01504867|523884324|FG001|Overall Study|Consent revoked|1|||
145546573|NCT01737697|524860195|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546574|NCT01737697|524860196|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
145546575|NCT01737697|524860182|FG000|Subacute Phase|Adverse Event|0|||
145546576|NCT01737697|524860183|FG001|Subacute Phase|Adverse Event|0|||
145546577|NCT01737697|524860184|FG002|Subacute Phase|Adverse Event|0|||
145791691|NCT02175771|525743002|FG004|Treatment Period|Lack of Efficacy|0|||
145791692|NCT02175771|525743003|FG005|Treatment Period|Lack of Efficacy|1|||
145282716|NCT00571922|523884325|FG000|Overall Study|Completion unknown|36|||
145282717|NCT00571922|523884326|FG001|Overall Study|Completion unknown|36|||
145282718|NCT03210259|523884335|FG000|12-Week Run-in Period|Adverse Event|1|||
145546578|NCT01737697|524860185|FG003|Subacute Phase|Adverse Event|0|||
145791693|NCT02175771|525743004|FG006|Treatment Period|Lack of Efficacy|0|||
145791694|NCT02175771|525743005|FG007|Treatment Period|Lack of Efficacy|1|||
145791695|NCT02175771|525743006|FG008|Treatment Period|Lack of Efficacy|0|||
145791696|NCT02175771|525742998|FG000|Treatment Period|Other|0|||
145791697|NCT02175771|525742999|FG001|Treatment Period|Other|1|||
145791698|NCT02175771|525743000|FG002|Treatment Period|Other|0|||
145791699|NCT02175771|525743001|FG003|Treatment Period|Other|3|||
145282719|NCT03210259|523884336|FG001|12-Week Run-in Period|Adverse Event|0|||
145282720|NCT03210259|523884337|FG002|12-Week Run-in Period|Adverse Event|0|||
145282721|NCT03210259|523884335|FG000|12-Week Run-in Period|Death|1|||
145282722|NCT03210259|523884336|FG001|12-Week Run-in Period|Death|0|||
145282723|NCT03210259|523884337|FG002|12-Week Run-in Period|Death|0|||
145282724|NCT03210259|523884335|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
145282725|NCT03210259|523884336|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
145282726|NCT03210259|523884337|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
145791700|NCT02175771|525743002|FG004|Treatment Period|Other|1|||
145791701|NCT02175771|525743003|FG005|Treatment Period|Other|0|||
145791702|NCT02175771|525743004|FG006|Treatment Period|Other|0|||
145791703|NCT02175771|525743005|FG007|Treatment Period|Other|2|||
145791704|NCT02175771|525743006|FG008|Treatment Period|Other|0|||
145791705|NCT03364673|525743007|FG000|Overall Study|Withdrawal by Subject|2|||
145791706|NCT03364673|525743007|FG000|Overall Study|Injury unrelated to study|3|||
145791707|NCT02207556|525743008|FG000|Overall Study|Physician Decision|1|||
145791708|NCT02207556|525743009|FG001|Overall Study|Physician Decision|0|||
145791709|NCT02207556|525743008|FG000|Overall Study|Withdrawal by Subject|1|||
145791710|NCT02207556|525743009|FG001|Overall Study|Withdrawal by Subject|0|||
145791711|NCT02207556|525743008|FG000|Overall Study|Death|0|||
145791712|NCT02207556|525743009|FG001|Overall Study|Death|5|||
145791713|NCT03558555|525743010|FG000|Overall Study|Lost to Follow-up|2|||
145791714|NCT03558555|525743011|FG001|Overall Study|Lost to Follow-up|1|||
145791715|NCT00194025|525743012|FG000|Overall Study|Adverse Event|1|||
145791716|NCT00194025|525743012|FG000|Overall Study|non-adherence with study medication|4|||
145791717|NCT00617409|525743013|FG000|Overall Study|Withdrawal by Subject|4|||
145791718|NCT00617409|525743014|FG001|Overall Study|Withdrawal by Subject|1|||
145791719|NCT00617409|525743015|FG002|Overall Study|Withdrawal by Subject|2|||
145791720|NCT00617409|525743013|FG000|Overall Study|Adverse Event|0|||
145791721|NCT00617409|525743014|FG001|Overall Study|Adverse Event|2|||
145791722|NCT00617409|525743015|FG002|Overall Study|Adverse Event|3|||
145791723|NCT00617409|525743013|FG000|Overall Study|Disease Progression|8|||
145791724|NCT00617409|525743014|FG001|Overall Study|Disease Progression|8|||
145791725|NCT00617409|525743015|FG002|Overall Study|Disease Progression|18|||
145791726|NCT00617409|525743013|FG000|Overall Study|Death|3|||
145791727|NCT00617409|525743014|FG001|Overall Study|Death|5|||
145791728|NCT00617409|525743015|FG002|Overall Study|Death|4|||
145791729|NCT00617409|525743013|FG000|Overall Study|Alternative Therapy|1|||
145791730|NCT00617409|525743014|FG001|Overall Study|Alternative Therapy|2|||
145791731|NCT00617409|525743015|FG002|Overall Study|Alternative Therapy|0|||
145791732|NCT01474746|525743025|FG000|Overall Study|Lost to Follow-up|1|||
145791733|NCT01474746|525743026|FG001|Overall Study|Lost to Follow-up|1|||
145791734|NCT01474746|525743025|FG000|Overall Study|Withdrawal by Subject|2|||
145791735|NCT01474746|525743026|FG001|Overall Study|Withdrawal by Subject|1|||
145791736|NCT01766336|525743030|FG000|Overall Study|Adverse Event|11|||
145791737|NCT01766336|525743031|FG001|Overall Study|Adverse Event|8|||
145791738|NCT01766336|525743030|FG000|Overall Study|Death|4|||
145791739|NCT01766336|525743031|FG001|Overall Study|Death|3|||
145791740|NCT01766336|525743030|FG000|Overall Study|Lost to Follow-up|1|||
145791741|NCT01766336|525743031|FG001|Overall Study|Lost to Follow-up|3|||
145791742|NCT01766336|525743030|FG000|Overall Study|Physician Decision|4|||
145791743|NCT01766336|525743031|FG001|Overall Study|Physician Decision|2|||
145791744|NCT01766336|525743030|FG000|Overall Study|Protocol Violation|0|||
145791745|NCT01766336|525743031|FG001|Overall Study|Protocol Violation|1|||
145791746|NCT01766336|525743030|FG000|Overall Study|Sponsor Decision|52|||
145791747|NCT01766336|525743031|FG001|Overall Study|Sponsor Decision|43|||
145791748|NCT01766336|525743030|FG000|Overall Study|Withdrawal by Subject|18|||
145791749|NCT01766336|525743031|FG001|Overall Study|Withdrawal by Subject|15|||
145791750|NCT02605447|525743032|FG000|Overall Study|Death|66|||
145791751|NCT02605447|525743032|FG000|Overall Study|Physician Decision|1|||
145791752|NCT02605447|525743032|FG000|Overall Study|Lost to Follow-up|24|||
145791753|NCT02605447|525743032|FG000|Overall Study|Withdrawal by Subject|10|||
145791754|NCT02605447|525743032|FG000|Overall Study|Not disclosed|1|||
145791755|NCT01479374|525743033|FG000|Overall Study|Adverse Event|2|||
145791756|NCT01479374|525743034|FG001|Overall Study|Adverse Event|1|||
145791757|NCT01479374|525743035|FG002|Overall Study|Adverse Event|0|||
145791758|NCT01479374|525743033|FG000|Overall Study|Lost to Follow-up|1|||
145791759|NCT01479374|525743034|FG001|Overall Study|Lost to Follow-up|2|||
145791760|NCT01479374|525743035|FG002|Overall Study|Lost to Follow-up|0|||
145791761|NCT01479374|525743033|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
145791762|NCT01479374|525743034|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
145791763|NCT01479374|525743035|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
145791764|NCT01479374|525743033|FG000|Overall Study|Other|0|||
145791765|NCT01479374|525743034|FG001|Overall Study|Other|4|||
145791766|NCT01479374|525743035|FG002|Overall Study|Other|5|||
145791767|NCT01606761|525743036|FG000|Prior to Week 24|Lost to Follow-up|0|||
145791768|NCT01606761|525743037|FG001|Prior to Week 24|Lost to Follow-up|3|||
145791769|NCT01606761|525743038|FG002|Prior to Week 24|Lost to Follow-up|2|||
145791770|NCT01606761|525743039|FG003|Prior to Week 24|Lost to Follow-up|0|||
145282727|NCT03210259|523884335|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
145546579|NCT01737697|524860186|FG004|Subacute Phase|Adverse Event|0|||
145546580|NCT01737697|524860187|FG005|Subacute Phase|Adverse Event|1|||
145546581|NCT01737697|524860188|FG006|Subacute Phase|Adverse Event|1|||
145546582|NCT01737697|524860189|FG007|Subacute Phase|Adverse Event|1|||
145546583|NCT01737697|524860190|FG008|Subacute Phase|Adverse Event|1|||
145546584|NCT01737697|524860191|FG009|Subacute Phase|Adverse Event|1|||
145791771|NCT01606761|525743040|FG004|Prior to Week 24|Lost to Follow-up|0|||
145791772|NCT01606761|525743036|FG000|Prior to Week 24|Withdrawal by Subject|12|||
145791773|NCT01606761|525743037|FG001|Prior to Week 24|Withdrawal by Subject|10|||
145791774|NCT01606761|525743038|FG002|Prior to Week 24|Withdrawal by Subject|9|||
145791775|NCT01606761|525743039|FG003|Prior to Week 24|Withdrawal by Subject|0|||
145791776|NCT01606761|525743040|FG004|Prior to Week 24|Withdrawal by Subject|0|||
145791777|NCT01606761|525743036|FG000|Prior to Week 24|Adverse Event|11|||
145791778|NCT01606761|525743037|FG001|Prior to Week 24|Adverse Event|18|||
145791779|NCT01606761|525743038|FG002|Prior to Week 24|Adverse Event|22|||
145791780|NCT01606761|525743039|FG003|Prior to Week 24|Adverse Event|0|||
145791781|NCT01606761|525743040|FG004|Prior to Week 24|Adverse Event|0|||
145791782|NCT01606761|525743036|FG000|Prior to Week 24|Lack of Efficacy|15|||
145791783|NCT01606761|525743037|FG001|Prior to Week 24|Lack of Efficacy|14|||
145791784|NCT01606761|525743038|FG002|Prior to Week 24|Lack of Efficacy|8|||
145791785|NCT01606761|525743039|FG003|Prior to Week 24|Lack of Efficacy|0|||
145791786|NCT01606761|525743040|FG004|Prior to Week 24|Lack of Efficacy|0|||
145791787|NCT01606761|525743036|FG000|Prior to Week 24|Physician Decision|0|||
145791788|NCT01606761|525743037|FG001|Prior to Week 24|Physician Decision|3|||
145791789|NCT01606761|525743038|FG002|Prior to Week 24|Physician Decision|1|||
145791790|NCT01606761|525743039|FG003|Prior to Week 24|Physician Decision|0|||
145791791|NCT01606761|525743040|FG004|Prior to Week 24|Physician Decision|0|||
145546585|NCT01737697|524860192|FG010|Subacute Phase|Adverse Event|4|||
145791792|NCT01606761|525743036|FG000|Prior to Week 24|Other|4|||
145791793|NCT01606761|525743037|FG001|Prior to Week 24|Other|7|||
145791794|NCT01606761|525743038|FG002|Prior to Week 24|Other|5|||
145791795|NCT01606761|525743039|FG003|Prior to Week 24|Other|0|||
145791796|NCT01606761|525743040|FG004|Prior to Week 24|Other|0|||
145791797|NCT01606761|525743036|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
145791798|NCT01606761|525743037|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
145791799|NCT01606761|525743038|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
145791800|NCT01606761|525743039|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
145791801|NCT01606761|525743040|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
145791802|NCT01606761|525743036|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
145791803|NCT01606761|525743037|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
145791804|NCT01606761|525743038|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
145791805|NCT01606761|525743039|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
145791806|NCT01606761|525743040|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
145791807|NCT01606761|525743036|FG000|Week 24 to Week 52|Adverse Event|0|||
145791808|NCT01606761|525743037|FG001|Week 24 to Week 52|Adverse Event|11|||
145791809|NCT01606761|525743038|FG002|Week 24 to Week 52|Adverse Event|14|||
145791810|NCT01606761|525743039|FG003|Week 24 to Week 52|Adverse Event|3|||
145791811|NCT01606761|525743040|FG004|Week 24 to Week 52|Adverse Event|15|||
145791812|NCT01606761|525743036|FG000|Week 24 to Week 52|Death|0|||
145791813|NCT01606761|525743037|FG001|Week 24 to Week 52|Death|0|||
145791814|NCT01606761|525743038|FG002|Week 24 to Week 52|Death|2|||
145791815|NCT01606761|525743039|FG003|Week 24 to Week 52|Death|1|||
145791816|NCT01606761|525743040|FG004|Week 24 to Week 52|Death|0|||
145791817|NCT01606761|525743036|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
145791818|NCT01606761|525743037|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
145791819|NCT01606761|525743038|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
145791820|NCT01606761|525743039|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
145791821|NCT01606761|525743040|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
145791822|NCT01606761|525743036|FG000|Week 24 to Week 52|Physician Decision|0|||
145791823|NCT01606761|525743037|FG001|Week 24 to Week 52|Physician Decision|1|||
145791824|NCT01606761|525743038|FG002|Week 24 to Week 52|Physician Decision|1|||
145791825|NCT01606761|525743039|FG003|Week 24 to Week 52|Physician Decision|0|||
145791826|NCT01606761|525743040|FG004|Week 24 to Week 52|Physician Decision|0|||
145791827|NCT01606761|525743036|FG000|Week 24 to Week 52|Other|0|||
145791828|NCT01606761|525743037|FG001|Week 24 to Week 52|Other|1|||
145791829|NCT01606761|525743038|FG002|Week 24 to Week 52|Other|5|||
145791830|NCT01606761|525743039|FG003|Week 24 to Week 52|Other|2|||
145791831|NCT01606761|525743040|FG004|Week 24 to Week 52|Other|2|||
145791832|NCT01606761|525743036|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
145791833|NCT01606761|525743037|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
145791834|NCT01606761|525743038|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
145791835|NCT01606761|525743039|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
145791836|NCT01606761|525743040|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
145791837|NCT01606761|525743036|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
145791838|NCT01606761|525743037|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
145404823|NCT01712178|524338690|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
145546586|NCT01737697|524860193|FG011|Subacute Phase|Adverse Event|1|||
145546587|NCT01737697|524860194|FG012|Subacute Phase|Adverse Event|1|||
145546588|NCT01737697|524860195|FG013|Subacute Phase|Adverse Event|0|||
145791839|NCT01606761|525743038|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
145791840|NCT01606761|525743039|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
145791841|NCT01606761|525743040|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
145791842|NCT01606761|525743036|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
145791843|NCT01606761|525743037|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
145791844|NCT01606761|525743038|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
145791845|NCT01606761|525743039|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
145791846|NCT01606761|525743040|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
145791847|NCT01606761|525743036|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
145791848|NCT01606761|525743037|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
145791849|NCT01606761|525743038|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
145791850|NCT01606761|525743039|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
145791851|NCT01606761|525743040|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
145791852|NCT05086289|525743041|FG000|Overall Study|Adverse Event|4|||
145791853|NCT05086289|525743042|FG001|Overall Study|Adverse Event|2|||
145791854|NCT05086289|525743041|FG000|Overall Study|Lost to Follow-up|2|||
145791855|NCT05086289|525743042|FG001|Overall Study|Lost to Follow-up|0|||
145791856|NCT05086289|525743041|FG000|Overall Study|Non-compliance with study drug|2|||
145791857|NCT05086289|525743042|FG001|Overall Study|Non-compliance with study drug|1|||
145791858|NCT05086289|525743041|FG000|Overall Study|Physician Decision|2|||
145791859|NCT05086289|525743042|FG001|Overall Study|Physician Decision|0|||
145791860|NCT05086289|525743041|FG000|Overall Study|Withdrawal by Subject|5|||
145791861|NCT05086289|525743042|FG001|Overall Study|Withdrawal by Subject|2|||
145791862|NCT01814800|525743046|FG000|Overall Study|Adverse Event|2|||
145791863|NCT01814800|525743046|FG000|Overall Study|Pregnancy|1|||
145791864|NCT01814800|525743046|FG000|Overall Study|Sponsor decision|1|||
145791865|NCT01814800|525743046|FG000|Overall Study|Subject relocation|1|||
145791866|NCT02371759|525743047|FG000|Overall Study|Protocol Violation|3|||
145546589|NCT01737697|524860196|FG014|Subacute Phase|Adverse Event|0|||
145546590|NCT01737697|524860182|FG000|Subacute Phase|Withdrawal by Subject|0|||
145791867|NCT02371759|525743048|FG001|Overall Study|Protocol Violation|1|||
145791868|NCT02371759|525743049|FG002|Overall Study|Protocol Violation|1|||
145791869|NCT02371759|525743050|FG003|Overall Study|Protocol Violation|0|||
145791870|NCT02371759|525743051|FG004|Overall Study|Protocol Violation|3|||
145791871|NCT02371759|525743052|FG005|Overall Study|Protocol Violation|1|||
145791872|NCT02371759|525743053|FG006|Overall Study|Protocol Violation|0|||
145791873|NCT02371759|525743054|FG007|Overall Study|Protocol Violation|3|||
145791874|NCT02371759|525743047|FG000|Overall Study|Withdrawal by Subject|0|||
145791875|NCT02371759|525743048|FG001|Overall Study|Withdrawal by Subject|0|||
145791876|NCT02371759|525743049|FG002|Overall Study|Withdrawal by Subject|0|||
145791877|NCT02371759|525743050|FG003|Overall Study|Withdrawal by Subject|0|||
145791878|NCT02371759|525743051|FG004|Overall Study|Withdrawal by Subject|0|||
145791879|NCT02371759|525743052|FG005|Overall Study|Withdrawal by Subject|0|||
145791880|NCT02371759|525743053|FG006|Overall Study|Withdrawal by Subject|0|||
145791881|NCT02371759|525743054|FG007|Overall Study|Withdrawal by Subject|1|||
145791882|NCT03375112|525743058|FG000|Overall Study|Withdrawal by Subject|3|||
145791883|NCT03375112|525743059|FG001|Overall Study|Withdrawal by Subject|0|||
145791884|NCT00243230|525743060|FG000|Double-Blind Period|Adverse Event|0|||
145546591|NCT01737697|524860183|FG001|Subacute Phase|Withdrawal by Subject|0|||
145791885|NCT00243230|525743061|FG001|Double-Blind Period|Adverse Event|2|||
145791886|NCT00243230|525743062|FG002|Double-Blind Period|Adverse Event|2|||
145791887|NCT00243230|525743063|FG003|Double-Blind Period|Adverse Event|0|||
145791888|NCT00243230|525743060|FG000|Double-Blind Period|Withdrawal by Subject|1|||
145791889|NCT00243230|525743061|FG001|Double-Blind Period|Withdrawal by Subject|0|||
145791890|NCT00243230|525743062|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145791891|NCT00243230|525743063|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145791892|NCT00243230|525743060|FG000|Double-Blind Period|Protocol Violation|0|||
145791893|NCT00243230|525743061|FG001|Double-Blind Period|Protocol Violation|0|||
145546592|NCT01737697|524860184|FG002|Subacute Phase|Withdrawal by Subject|0|||
145546593|NCT01737697|524860185|FG003|Subacute Phase|Withdrawal by Subject|0|||
145791894|NCT00243230|525743062|FG002|Double-Blind Period|Protocol Violation|1|||
145791895|NCT00243230|525743063|FG003|Double-Blind Period|Protocol Violation|0|||
145791896|NCT00243230|525743060|FG000|Double-Blind Period|Randomized but Not Treated|0|||
145791897|NCT00243230|525743061|FG001|Double-Blind Period|Randomized but Not Treated|0|||
145791898|NCT00243230|525743062|FG002|Double-Blind Period|Randomized but Not Treated|2|||
145791899|NCT00243230|525743063|FG003|Double-Blind Period|Randomized but Not Treated|0|||
145791900|NCT00243230|525743060|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
145791901|NCT00243230|525743061|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
145791902|NCT00243230|525743062|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
145791903|NCT00243230|525743063|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
145791904|NCT00243230|525743060|FG000|Open Label Period|Adverse Event|0|||
145791905|NCT00243230|525743061|FG001|Open Label Period|Adverse Event|0|||
145791906|NCT00243230|525743062|FG002|Open Label Period|Adverse Event|0|||
145791907|NCT00243230|525743063|FG003|Open Label Period|Adverse Event|2|||
145791908|NCT00243230|525743060|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
145791909|NCT00243230|525743061|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
145791910|NCT00243230|525743062|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
145791911|NCT00243230|525743063|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
145791912|NCT00243230|525743060|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
145791913|NCT00243230|525743061|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
145791914|NCT00243230|525743062|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
145791915|NCT00243230|525743063|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
145791916|NCT00243230|525743060|FG000|Open Label Period|Lost to Follow-up|0|||
145791917|NCT00243230|525743061|FG001|Open Label Period|Lost to Follow-up|0|||
145791918|NCT00243230|525743062|FG002|Open Label Period|Lost to Follow-up|0|||
145791919|NCT00243230|525743063|FG003|Open Label Period|Lost to Follow-up|2|||
145791920|NCT00243230|525743060|FG000|Open Label Period|Withdrawal by Subject|0|||
145791921|NCT00243230|525743061|FG001|Open Label Period|Withdrawal by Subject|0|||
145791922|NCT00243230|525743062|FG002|Open Label Period|Withdrawal by Subject|0|||
145791923|NCT00243230|525743063|FG003|Open Label Period|Withdrawal by Subject|2|||
145791924|NCT00243230|525743060|FG000|Open Label Period|Protocol Violation|0|||
145791925|NCT00243230|525743061|FG001|Open Label Period|Protocol Violation|0|||
145791926|NCT00243230|525743062|FG002|Open Label Period|Protocol Violation|0|||
145791927|NCT00243230|525743063|FG003|Open Label Period|Protocol Violation|2|||
145791928|NCT00243230|525743060|FG000|Open Label Period|Administrative Reason|0|||
145791929|NCT00243230|525743061|FG001|Open Label Period|Administrative Reason|0|||
145791930|NCT00243230|525743062|FG002|Open Label Period|Administrative Reason|0|||
145791931|NCT00243230|525743063|FG003|Open Label Period|Administrative Reason|63|||
145791932|NCT03136185|525743066|FG000|Overall Study|Adverse Event|0|||
145791933|NCT03136185|525743067|FG001|Overall Study|Adverse Event|1|||
145791934|NCT03136185|525743068|FG002|Overall Study|Adverse Event|3|||
145791935|NCT03136185|525743069|FG003|Overall Study|Adverse Event|1|||
145791936|NCT03136185|525743070|FG004|Overall Study|Adverse Event|2|||
145791937|NCT03136185|525743071|FG005|Overall Study|Adverse Event|2|||
145791938|NCT03136185|525743072|FG006|Overall Study|Adverse Event|5|||
145791939|NCT03136185|525743073|FG007|Overall Study|Adverse Event|1|||
145791940|NCT03136185|525743074|FG008|Overall Study|Adverse Event|1|||
145791941|NCT03136185|525743066|FG000|Overall Study|Death|0|||
145791942|NCT03136185|525743067|FG001|Overall Study|Death|0|||
145791943|NCT03136185|525743068|FG002|Overall Study|Death|0|||
145791944|NCT03136185|525743069|FG003|Overall Study|Death|1|||
145791945|NCT03136185|525743070|FG004|Overall Study|Death|1|||
145791946|NCT03136185|525743071|FG005|Overall Study|Death|0|||
145791947|NCT03136185|525743072|FG006|Overall Study|Death|1|||
145791948|NCT03136185|525743073|FG007|Overall Study|Death|0|||
145791949|NCT03136185|525743074|FG008|Overall Study|Death|0|||
145791950|NCT03136185|525743066|FG000|Overall Study|Physician Decision|3|||
145791951|NCT03136185|525743067|FG001|Overall Study|Physician Decision|1|||
145791952|NCT03136185|525743068|FG002|Overall Study|Physician Decision|1|||
145791953|NCT03136185|525743069|FG003|Overall Study|Physician Decision|2|||
145791954|NCT03136185|525743070|FG004|Overall Study|Physician Decision|1|||
145791955|NCT03136185|525743071|FG005|Overall Study|Physician Decision|2|||
145791956|NCT03136185|525743072|FG006|Overall Study|Physician Decision|1|||
145791957|NCT03136185|525743073|FG007|Overall Study|Physician Decision|0|||
145791958|NCT03136185|525743074|FG008|Overall Study|Physician Decision|1|||
145791959|NCT03136185|525743066|FG000|Overall Study|Protocol Defined Disease Progression|0|||
145791960|NCT03136185|525743067|FG001|Overall Study|Protocol Defined Disease Progression|0|||
145791961|NCT03136185|525743068|FG002|Overall Study|Protocol Defined Disease Progression|1|||
145791962|NCT03136185|525743069|FG003|Overall Study|Protocol Defined Disease Progression|0|||
145791963|NCT03136185|525743070|FG004|Overall Study|Protocol Defined Disease Progression|0|||
145791964|NCT03136185|525743071|FG005|Overall Study|Protocol Defined Disease Progression|1|||
145546594|NCT01737697|524860186|FG004|Subacute Phase|Withdrawal by Subject|0|||
145546595|NCT01737697|524860187|FG005|Subacute Phase|Withdrawal by Subject|1|||
145546596|NCT01737697|524860188|FG006|Subacute Phase|Withdrawal by Subject|0|||
145546597|NCT01737697|524860189|FG007|Subacute Phase|Withdrawal by Subject|2|||
145546598|NCT01737697|524860190|FG008|Subacute Phase|Withdrawal by Subject|0|||
145791965|NCT03136185|525743072|FG006|Overall Study|Protocol Defined Disease Progression|0|||
145791966|NCT03136185|525743073|FG007|Overall Study|Protocol Defined Disease Progression|1|||
145791967|NCT03136185|525743074|FG008|Overall Study|Protocol Defined Disease Progression|1|||
145791968|NCT03136185|525743066|FG000|Overall Study|Withdrawal by Subject|1|||
145791969|NCT03136185|525743067|FG001|Overall Study|Withdrawal by Subject|0|||
145791970|NCT03136185|525743068|FG002|Overall Study|Withdrawal by Subject|1|||
145791971|NCT03136185|525743069|FG003|Overall Study|Withdrawal by Subject|1|||
145791972|NCT03136185|525743070|FG004|Overall Study|Withdrawal by Subject|1|||
145791973|NCT03136185|525743071|FG005|Overall Study|Withdrawal by Subject|1|||
145791974|NCT03136185|525743072|FG006|Overall Study|Withdrawal by Subject|2|||
145791975|NCT03136185|525743073|FG007|Overall Study|Withdrawal by Subject|3|||
145791976|NCT03136185|525743074|FG008|Overall Study|Withdrawal by Subject|3|||
145791977|NCT03136185|525743066|FG000|Overall Study|Not Reported|4|||
145791978|NCT03136185|525743067|FG001|Overall Study|Not Reported|1|||
145791979|NCT03136185|525743068|FG002|Overall Study|Not Reported|0|||
145791980|NCT03136185|525743069|FG003|Overall Study|Not Reported|1|||
145791981|NCT03136185|525743070|FG004|Overall Study|Not Reported|0|||
145791982|NCT03136185|525743071|FG005|Overall Study|Not Reported|2|||
145791983|NCT03136185|525743072|FG006|Overall Study|Not Reported|1|||
145791984|NCT03136185|525743073|FG007|Overall Study|Not Reported|1|||
145791985|NCT03136185|525743074|FG008|Overall Study|Not Reported|0|||
145791986|NCT03201198|525743077|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
145791987|NCT03201198|525743078|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
145791988|NCT03201198|525743077|FG000|Overall Study|Withdrawal by Subject|2|||
145791989|NCT03201198|525743078|FG001|Overall Study|Withdrawal by Subject|3|||
145791990|NCT03213626|525743079|FG000|Overall Study|Adverse Event|1|||
145791991|NCT03213626|525743079|FG000|Overall Study|Progressive Disease|6|||
145791992|NCT02998554|525743081|FG000|Overall Study|Adverse Event|8|||
145791993|NCT02998554|525743082|FG001|Overall Study|Adverse Event|3|||
145791994|NCT02998554|525743081|FG000|Overall Study|Protocol deviation|1|||
145791995|NCT02998554|525743082|FG001|Overall Study|Protocol deviation|0|||
145791996|NCT02998554|525743081|FG000|Overall Study|Withdrawal by Subject|2|||
145791997|NCT02998554|525743082|FG001|Overall Study|Withdrawal by Subject|6|||
145791998|NCT02998554|525743081|FG000|Overall Study|Lost to Follow-up|0|||
145791999|NCT02998554|525743082|FG001|Overall Study|Lost to Follow-up|1|||
145792000|NCT02998554|525743081|FG000|Overall Study|Lack of Efficacy|0|||
145792001|NCT02998554|525743082|FG001|Overall Study|Lack of Efficacy|1|||
145792002|NCT00352755|525744987|FG000|Overall Study|Physician Decision|1|||
145792003|NCT00352755|525744987|FG000|Overall Study|Adverse Event|1|||
145792004|NCT02397694|525744988|FG000|Double-Blinded Phase|Adverse Event|1|||
145792005|NCT02397694|525744989|FG001|Double-Blinded Phase|Adverse Event|0|||
145792006|NCT02397694|525744988|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
145792007|NCT02397694|525744989|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
145792008|NCT02397694|525744988|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
145792009|NCT02397694|525744989|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
145792010|NCT02397694|525744988|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
145792011|NCT02397694|525744989|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
145792012|NCT02397694|525744988|FG000|Open Label Extension Phase|Protocol Violation|1|||
145792013|NCT02397694|525744989|FG001|Open Label Extension Phase|Protocol Violation|0|||
145792014|NCT02397694|525744988|FG000|Open Label Extension Phase|Withdrew Consent|3|||
145792015|NCT02397694|525744989|FG001|Open Label Extension Phase|Withdrew Consent|1|||
145792016|NCT02397694|525744988|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
145792017|NCT02397694|525744989|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
145792018|NCT02622724|525744991|FG000|Overall Study|Death|51|||
145792019|NCT02622724|525744992|FG001|Overall Study|Death|53|||
145792020|NCT02622724|525744991|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
145792021|NCT02622724|525744992|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
145792022|NCT02622724|525744991|FG000|Overall Study|Early termination of study|38|||
145792023|NCT02622724|525744992|FG001|Overall Study|Early termination of study|43|||
145792024|NCT00487084|525744993|FG000|Overall Study|Did not receive intervention|4|||
145792025|NCT00487084|525744994|FG001|Overall Study|Did not receive intervention|3|||
145792026|NCT00487084|525744995|FG002|Overall Study|Did not receive intervention|5|||
145546599|NCT01737697|524860191|FG009|Subacute Phase|Withdrawal by Subject|1|||
145792027|NCT01697267|525744996|FG000|Overall Study|Death|3|||
145792028|NCT01697267|525744997|FG001|Overall Study|Death|1|||
145792029|NCT01697267|525744996|FG000|Overall Study|Withdrawal by Subject|5|||
145792030|NCT01697267|525744997|FG001|Overall Study|Withdrawal by Subject|5|||
145792031|NCT01697267|525744996|FG000|Overall Study|Adverse Event|2|||
145792032|NCT01697267|525744997|FG001|Overall Study|Adverse Event|1|||
145792033|NCT01697267|525744996|FG000|Overall Study|Lost to Follow-up|2|||
145792034|NCT01697267|525744997|FG001|Overall Study|Lost to Follow-up|4|||
145792035|NCT01697267|525744996|FG000|Overall Study|Physician Decision|2|||
145792036|NCT01697267|525744997|FG001|Overall Study|Physician Decision|4|||
145792037|NCT05254613|525745007|FG000|Overall Study|Lost to Follow-up|0|||
145792038|NCT05254613|525745008|FG001|Overall Study|Lost to Follow-up|0|||
145792039|NCT05254613|525745009|FG002|Overall Study|Lost to Follow-up|1|||
145792040|NCT02338492|525745010|FG000|Overall Study|Death|32|||
145792041|NCT02338492|525745010|FG000|Overall Study|Adverse Event|3|||
145792042|NCT02338492|525745010|FG000|Overall Study|Lost to Follow-up|4|||
145792043|NCT02338492|525745010|FG000|Overall Study|Reason not captured above|6|||
145792044|NCT00756886|525745014|FG000|Overall Study|Lost to Follow-up|1|||
145792045|NCT00756886|525745015|FG001|Overall Study|Lost to Follow-up|0|||
145792046|NCT00756886|525745014|FG000|Overall Study|Adverse Event|0|||
145792047|NCT00756886|525745015|FG001|Overall Study|Adverse Event|3|||
145792048|NCT00756886|525745014|FG000|Overall Study|Lack of Efficacy|1|||
145792049|NCT00756886|525745015|FG001|Overall Study|Lack of Efficacy|0|||
145792050|NCT00756886|525745014|FG000|Overall Study|Ineligible|9|||
145792051|NCT00756886|525745015|FG001|Overall Study|Ineligible|4|||
145792052|NCT00174785|525745016|FG000|Overall Study|Adverse Event|293|||
145792053|NCT00174785|525745017|FG001|Overall Study|Adverse Event|191|||
145792054|NCT00174785|525745016|FG000|Overall Study|Protocol Violation|14|||
145792055|NCT00174785|525745017|FG001|Overall Study|Protocol Violation|14|||
145792056|NCT00174785|525745016|FG000|Overall Study|Withdrawal by Subject|173|||
145792057|NCT00174785|525745017|FG001|Overall Study|Withdrawal by Subject|175|||
145792058|NCT00174785|525745016|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
145792059|NCT00174785|525745017|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
145792060|NCT00174785|525745016|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
145792061|NCT00174785|525745017|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
145792062|NCT00174785|525745016|FG000|Overall Study|Other prohibited medication|5|||
145792063|NCT00174785|525745017|FG001|Overall Study|Other prohibited medication|3|||
145792064|NCT00174785|525745016|FG000|Overall Study|Family request|6|||
145792065|NCT00174785|525745017|FG001|Overall Study|Family request|8|||
145792066|NCT00174785|525745016|FG000|Overall Study|Not pre-specified/Not coded|56|||
145792067|NCT00174785|525745017|FG001|Overall Study|Not pre-specified/Not coded|70|||
145792068|NCT00310388|525745019|FG000|Primary Reporting Phase|Adverse Event|101|||
145792069|NCT00310388|525745020|FG001|Primary Reporting Phase|Adverse Event|0|||
145792070|NCT00310388|525745019|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
145792071|NCT00310388|525745020|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
145792072|NCT00310388|525745019|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
145792073|NCT00310388|525745020|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
145792074|NCT00310388|525745019|FG000|Primary Reporting Phase|Protocol Violation|10|||
145792075|NCT00310388|525745020|FG001|Primary Reporting Phase|Protocol Violation|0|||
145792076|NCT00310388|525745019|FG000|Primary Reporting Phase|Pregnancy|3|||
145792077|NCT00310388|525745020|FG001|Primary Reporting Phase|Pregnancy|0|||
145792078|NCT00310388|525745019|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
145792079|NCT00310388|525745020|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
145792080|NCT00310388|525745019|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
145792081|NCT00310388|525745020|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
145792082|NCT00310388|525745019|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
145792083|NCT00310388|525745020|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
145792084|NCT00310388|525745019|FG000|Primary Reporting Phase|Physician Decision|2|||
145792085|NCT00310388|525745020|FG001|Primary Reporting Phase|Physician Decision|0|||
145792086|NCT00310388|525745019|FG000|Primary Reporting Phase|Request of the sponsor|19|||
145792087|NCT00310388|525745020|FG001|Primary Reporting Phase|Request of the sponsor|0|||
145792088|NCT00310388|525745019|FG000|Primary Reporting Phase|Failed to return|8|||
145792089|NCT00310388|525745020|FG001|Primary Reporting Phase|Failed to return|0|||
145792090|NCT00310388|525745019|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
145792091|NCT00310388|525745020|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
145792092|NCT00310388|525745019|FG000|Primary Reporting Phase|Participant request|2|||
145792093|NCT00310388|525745020|FG001|Primary Reporting Phase|Participant request|0|||
145792094|NCT00310388|525745019|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
145792095|NCT00310388|525745020|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
145792096|NCT00310388|525745019|FG000|Primary Reporting Phase|Discontinuation of study|1|||
145792097|NCT00310388|525745020|FG001|Primary Reporting Phase|Discontinuation of study|0|||
145792098|NCT00310388|525745019|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
145792099|NCT00310388|525745020|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
145792100|NCT00310388|525745019|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
145792101|NCT00310388|525745020|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
145792102|NCT00310388|525745019|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
145792103|NCT00310388|525745020|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
145792104|NCT00310388|525745019|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
145792105|NCT00310388|525745020|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
145792106|NCT00310388|525745019|FG000|Primary Reporting Phase|Participant passed away|1|||
145792107|NCT00310388|525745020|FG001|Primary Reporting Phase|Participant passed away|0|||
145792108|NCT00310388|525745019|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
145792109|NCT00310388|525745020|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
145610945|NCT02769065|525092548|FG025|Overall Study|Voluntary Withdrawal|0|||
145610946|NCT02769065|525092549|FG026|Overall Study|Voluntary Withdrawal|0|||
145610947|NCT02769065|525092550|FG027|Overall Study|Voluntary Withdrawal|0|||
145610948|NCT02769065|525092551|FG028|Overall Study|Voluntary Withdrawal|0|||
145610949|NCT02769065|525092552|FG029|Overall Study|Voluntary Withdrawal|0|||
145610950|NCT02769065|525092523|FG000|Overall Study|Reason Not Specified|0|||
145610951|NCT02769065|525092524|FG001|Overall Study|Reason Not Specified|0|||
145610952|NCT02769065|525092525|FG002|Overall Study|Reason Not Specified|0|||
145610953|NCT02769065|525092526|FG003|Overall Study|Reason Not Specified|0|||
145610954|NCT02769065|525092527|FG004|Overall Study|Reason Not Specified|0|||
145610955|NCT02769065|525092528|FG005|Overall Study|Reason Not Specified|0|||
145610956|NCT02769065|525092529|FG006|Overall Study|Reason Not Specified|1|||
145610957|NCT02769065|525092530|FG007|Overall Study|Reason Not Specified|0|||
145610958|NCT02769065|525092531|FG008|Overall Study|Reason Not Specified|0|||
145610959|NCT02769065|525092532|FG009|Overall Study|Reason Not Specified|0|||
145610960|NCT02769065|525092533|FG010|Overall Study|Reason Not Specified|0|||
145610961|NCT02769065|525092534|FG011|Overall Study|Reason Not Specified|0|||
145610962|NCT02769065|525092535|FG012|Overall Study|Reason Not Specified|0|||
145610963|NCT02769065|525092536|FG013|Overall Study|Reason Not Specified|0|||
145610964|NCT02769065|525092537|FG014|Overall Study|Reason Not Specified|0|||
145610965|NCT02769065|525092538|FG015|Overall Study|Reason Not Specified|0|||
145610966|NCT02769065|525092539|FG016|Overall Study|Reason Not Specified|0|||
145792110|NCT00310388|525745019|FG000|Primary Reporting Phase|Missing|1|||
145792111|NCT00310388|525745020|FG001|Primary Reporting Phase|Missing|0|||
145792112|NCT00310388|525745019|FG000|Primary Reporting Phase|Other|1|||
145792113|NCT00310388|525745020|FG001|Primary Reporting Phase|Other|0|||
145792114|NCT00310388|525745019|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
145792115|NCT00310388|525745020|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
145792116|NCT00310388|525745019|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
145792117|NCT00310388|525745020|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
145792118|NCT00310388|525745019|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
145792119|NCT00310388|525745020|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
145792120|NCT00310388|525745019|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
145792121|NCT00310388|525745020|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
145792122|NCT02387372|525745027|FG000|Overall Study|Not Treated|1|||
145792123|NCT02387372|525745028|FG001|Overall Study|Not Treated|0|||
145792124|NCT00082758|525745030|FG000|Overall Study|Adverse Event|0|||
145792125|NCT00082758|525745031|FG001|Overall Study|Adverse Event|2|||
145792126|NCT00082758|525745032|FG002|Overall Study|Adverse Event|0|||
145792127|NCT00082758|525745030|FG000|Overall Study|Lack of Efficacy|12|||
145792128|NCT00082758|525745031|FG001|Overall Study|Lack of Efficacy|13|||
145792129|NCT00082758|525745032|FG002|Overall Study|Lack of Efficacy|0|||
145792130|NCT00082758|525745030|FG000|Overall Study|Physician Decision|0|||
145792131|NCT00082758|525745031|FG001|Overall Study|Physician Decision|1|||
145792132|NCT00082758|525745032|FG002|Overall Study|Physician Decision|0|||
145610967|NCT02769065|525092540|FG017|Overall Study|Reason Not Specified|0|||
145610968|NCT02769065|525092541|FG018|Overall Study|Reason Not Specified|0|||
145610969|NCT02769065|525092542|FG019|Overall Study|Reason Not Specified|0|||
145610970|NCT02769065|525092543|FG020|Overall Study|Reason Not Specified|0|||
145546600|NCT01737697|524860192|FG010|Subacute Phase|Withdrawal by Subject|0|||
145546601|NCT01737697|524860193|FG011|Subacute Phase|Withdrawal by Subject|1|||
145546602|NCT01737697|524860194|FG012|Subacute Phase|Withdrawal by Subject|1|||
145546603|NCT01737697|524860195|FG013|Subacute Phase|Withdrawal by Subject|1|||
145546604|NCT01737697|524860196|FG014|Subacute Phase|Withdrawal by Subject|0|||
145546605|NCT01737697|524860182|FG000|Subacute Phase|Lost to Follow-up|0|||
145546606|NCT01737697|524860183|FG001|Subacute Phase|Lost to Follow-up|0|||
145546607|NCT01737697|524860184|FG002|Subacute Phase|Lost to Follow-up|0|||
145546608|NCT01737697|524860185|FG003|Subacute Phase|Lost to Follow-up|0|||
145792133|NCT00082758|525745030|FG000|Overall Study|Withdrawal by Subject|3|||
145792134|NCT00082758|525745031|FG001|Overall Study|Withdrawal by Subject|0|||
145792135|NCT00082758|525745032|FG002|Overall Study|Withdrawal by Subject|0|||
145792136|NCT00082758|525745030|FG000|Overall Study|Protocol Violation|0|||
145792137|NCT00082758|525745031|FG001|Overall Study|Protocol Violation|1|||
145792138|NCT00082758|525745032|FG002|Overall Study|Protocol Violation|0|||
145546609|NCT01737697|524860186|FG004|Subacute Phase|Lost to Follow-up|0|||
145792139|NCT02208024|525745036|FG000|Overall Study|Withdrawal by Subject|1|||
145792140|NCT00779324|525745037|FG000|Overall Study|Lost to Follow-up|2|||
145792141|NCT00779324|525745038|FG001|Overall Study|Lost to Follow-up|1|||
145792142|NCT00779324|525745037|FG000|Overall Study|Withdrawal by Subject|4|||
145792143|NCT00779324|525745038|FG001|Overall Study|Withdrawal by Subject|2|||
145792144|NCT00779324|525745037|FG000|Overall Study|Missed visit|1|||
145792145|NCT00779324|525745038|FG001|Overall Study|Missed visit|1|||
145792146|NCT00543569|525745039|FG000|Overall Study|Death|2|||
145792147|NCT00543569|525745040|FG001|Overall Study|Death|2|||
145792148|NCT00543569|525745041|FG002|Overall Study|Death|3|||
145792149|NCT00543569|525745042|FG003|Overall Study|Death|1|||
145792150|NCT00543569|525745039|FG000|Overall Study|Lost to Follow-up|0|||
145792151|NCT00543569|525745040|FG001|Overall Study|Lost to Follow-up|0|||
145792152|NCT00543569|525745041|FG002|Overall Study|Lost to Follow-up|1|||
145546610|NCT01737697|524860187|FG005|Subacute Phase|Lost to Follow-up|0|||
145546611|NCT01737697|524860188|FG006|Subacute Phase|Lost to Follow-up|0|||
145546612|NCT01737697|524860189|FG007|Subacute Phase|Lost to Follow-up|0|||
145546613|NCT01737697|524860190|FG008|Subacute Phase|Lost to Follow-up|0|||
145546614|NCT01737697|524860191|FG009|Subacute Phase|Lost to Follow-up|0|||
145546615|NCT01737697|524860192|FG010|Subacute Phase|Lost to Follow-up|0|||
145546616|NCT01737697|524860193|FG011|Subacute Phase|Lost to Follow-up|0|||
145546617|NCT01737697|524860194|FG012|Subacute Phase|Lost to Follow-up|0|||
145546618|NCT01737697|524860195|FG013|Subacute Phase|Lost to Follow-up|0|||
145546619|NCT01737697|524860196|FG014|Subacute Phase|Lost to Follow-up|1|||
145546620|NCT01737697|524860182|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
145546621|NCT01737697|524860183|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
145546622|NCT01737697|524860184|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
145546623|NCT01737697|524860185|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
145546624|NCT01737697|524860186|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
145546625|NCT01737697|524860187|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
145546626|NCT01737697|524860188|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
145546627|NCT01737697|524860189|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
145546628|NCT01737697|524860190|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
145546629|NCT01737697|524860191|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
145546630|NCT01737697|524860192|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
145546631|NCT01737697|524860193|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
145546632|NCT01737697|524860194|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
145546633|NCT01737697|524860195|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
145546634|NCT01737697|524860196|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
145546635|NCT01737697|524860182|FG000|Subacute Phase|Protocol Violation|0|||
145546636|NCT01737697|524860183|FG001|Subacute Phase|Protocol Violation|0|||
145546637|NCT01737697|524860184|FG002|Subacute Phase|Protocol Violation|0|||
145546638|NCT01737697|524860185|FG003|Subacute Phase|Protocol Violation|0|||
145546639|NCT01737697|524860186|FG004|Subacute Phase|Protocol Violation|0|||
145546640|NCT01737697|524860187|FG005|Subacute Phase|Protocol Violation|1|||
145546641|NCT01737697|524860188|FG006|Subacute Phase|Protocol Violation|0|||
145546642|NCT01737697|524860189|FG007|Subacute Phase|Protocol Violation|0|||
145546643|NCT01737697|524860190|FG008|Subacute Phase|Protocol Violation|0|||
145546644|NCT01737697|524860191|FG009|Subacute Phase|Protocol Violation|0|||
145546645|NCT01737697|524860192|FG010|Subacute Phase|Protocol Violation|1|||
145792153|NCT00543569|525745042|FG003|Overall Study|Lost to Follow-up|1|||
145546646|NCT01737697|524860193|FG011|Subacute Phase|Protocol Violation|0|||
145546647|NCT01737697|524860194|FG012|Subacute Phase|Protocol Violation|0|||
145546648|NCT01737697|524860195|FG013|Subacute Phase|Protocol Violation|0|||
145546649|NCT01737697|524860196|FG014|Subacute Phase|Protocol Violation|0|||
145546650|NCT01737697|524860182|FG000|Subacute Phase|Physician Decision|0|||
145546651|NCT01737697|524860183|FG001|Subacute Phase|Physician Decision|0|||
145792154|NCT00543569|525745039|FG000|Overall Study|Miscellaneous Reasons|7|||
145792155|NCT00543569|525745040|FG001|Overall Study|Miscellaneous Reasons|3|||
145792156|NCT00543569|525745041|FG002|Overall Study|Miscellaneous Reasons|11|||
145792157|NCT00543569|525745042|FG003|Overall Study|Miscellaneous Reasons|4|||
145792158|NCT00543569|525745039|FG000|Overall Study|Randomized but never received study drug|3|||
145792159|NCT00543569|525745040|FG001|Overall Study|Randomized but never received study drug|3|||
145792160|NCT00543569|525745041|FG002|Overall Study|Randomized but never received study drug|5|||
145792161|NCT00543569|525745042|FG003|Overall Study|Randomized but never received study drug|3|||
145792162|NCT00862849|525745043|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
145792163|NCT00862849|525745044|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
145792164|NCT00862849|525745045|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
145792165|NCT00862849|525745046|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
145792166|NCT00862849|525745047|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
145792167|NCT00862849|525745048|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
145792168|NCT00862849|525745043|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
145792169|NCT00862849|525745044|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
145792170|NCT00862849|525745045|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
145792171|NCT00862849|525745046|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
145792172|NCT00862849|525745047|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
145792173|NCT00862849|525745048|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
145792174|NCT02108951|525745049|FG000|Overall Study|Lost to Follow-up|1|||
145792175|NCT02108951|525745049|FG000|Overall Study|Patient's/guardian's decision|1|||
145792176|NCT02108951|525745049|FG000|Overall Study|Study Terminated by Sponsor|14|||
145792177|NCT00718666|525745050|FG000|Booster Phase Year 5|No active participation request|0|||
145792178|NCT00718666|525745051|FG001|Booster Phase Year 5|No active participation request|0|||
145792179|NCT00718666|525745052|FG002|Booster Phase Year 5|No active participation request|1|||
145792180|NCT00718666|525745050|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
145792181|NCT00718666|525745051|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
145792182|NCT00718666|525745052|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
145546652|NCT01737697|524860184|FG002|Subacute Phase|Physician Decision|0|||
145546653|NCT01737697|524860185|FG003|Subacute Phase|Physician Decision|0|||
145546654|NCT01737697|524860186|FG004|Subacute Phase|Physician Decision|0|||
145546655|NCT01737697|524860187|FG005|Subacute Phase|Physician Decision|0|||
145546656|NCT01737697|524860188|FG006|Subacute Phase|Physician Decision|0|||
145546657|NCT01737697|524860189|FG007|Subacute Phase|Physician Decision|0|||
145546658|NCT01737697|524860190|FG008|Subacute Phase|Physician Decision|1|||
145546659|NCT01737697|524860191|FG009|Subacute Phase|Physician Decision|0|||
145546660|NCT01737697|524860192|FG010|Subacute Phase|Physician Decision|0|||
145546661|NCT01737697|524860193|FG011|Subacute Phase|Physician Decision|0|||
145546662|NCT01737697|524860194|FG012|Subacute Phase|Physician Decision|0|||
145546663|NCT01737697|524860195|FG013|Subacute Phase|Physician Decision|0|||
145546664|NCT01737697|524860196|FG014|Subacute Phase|Physician Decision|0|||
145546665|NCT01737697|524860182|FG000|Subacute Phase|Death|0|||
145546666|NCT01737697|524860183|FG001|Subacute Phase|Death|0|||
145546667|NCT01737697|524860184|FG002|Subacute Phase|Death|0|||
145546668|NCT01737697|524860185|FG003|Subacute Phase|Death|0|||
145546669|NCT01737697|524860186|FG004|Subacute Phase|Death|0|||
145546670|NCT01737697|524860187|FG005|Subacute Phase|Death|0|||
145546671|NCT01737697|524860188|FG006|Subacute Phase|Death|0|||
145546672|NCT01737697|524860189|FG007|Subacute Phase|Death|0|||
145546673|NCT01737697|524860190|FG008|Subacute Phase|Death|0|||
145546674|NCT01737697|524860191|FG009|Subacute Phase|Death|0|||
145546675|NCT01737697|524860192|FG010|Subacute Phase|Death|1|||
145546676|NCT01737697|524860193|FG011|Subacute Phase|Death|0|||
145546677|NCT01737697|524860194|FG012|Subacute Phase|Death|0|||
145546678|NCT01737697|524860195|FG013|Subacute Phase|Death|0|||
145546679|NCT01737697|524860196|FG014|Subacute Phase|Death|0|||
145546680|NCT03648983|524860198|FG000|Overall Study|Study was terminated due to PI departure|95|||
145546681|NCT01866930|524860199|FG000|Treatment Period|Other|1|||
145546682|NCT01866930|524860200|FG001|Treatment Period|Other|0|||
145546683|NCT01866930|524860199|FG000|Treatment Period|Death|0|||
145546684|NCT01866930|524860200|FG001|Treatment Period|Death|2|||
145546685|NCT01866930|524860199|FG000|Treatment Period|Poor/non compliance|0|||
145546686|NCT01866930|524860200|FG001|Treatment Period|Poor/non compliance|2|||
145546687|NCT01866930|524860199|FG000|Treatment Period|No longer meets study criteria|0|||
145546688|NCT01866930|524860200|FG001|Treatment Period|No longer meets study criteria|1|||
145546689|NCT01866930|524860199|FG000|Treatment Period|Withdrawal by Subject|2|||
145792183|NCT00718666|525745050|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
145792184|NCT00718666|525745051|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
145792185|NCT00718666|525745052|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
145546690|NCT01866930|524860200|FG001|Treatment Period|Withdrawal by Subject|8|||
145546691|NCT01866930|524860199|FG000|Treatment Period|Lack of Efficacy|1|||
145792186|NCT00718666|525745050|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
145546692|NCT01866930|524860200|FG001|Treatment Period|Lack of Efficacy|9|||
145546693|NCT01866930|524860199|FG000|Treatment Period|Adverse Event|4|||
145546694|NCT01866930|524860200|FG001|Treatment Period|Adverse Event|12|||
145546695|NCT01866930|524860199|FG000|Treatment Period|Lost to Follow-up|1|||
145546696|NCT01866930|524860200|FG001|Treatment Period|Lost to Follow-up|1|||
145546697|NCT01866930|524860199|FG000|Follow-up Period|Lost to Follow-up|1|||
145546698|NCT01866930|524860200|FG001|Follow-up Period|Lost to Follow-up|1|||
145792187|NCT00718666|525745051|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
145792188|NCT00718666|525745052|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
145792189|NCT02196038|525745055|FG000|Overall Study|Death|16|||
145792190|NCT02196038|525745056|FG001|Overall Study|Death|21|||
145792191|NCT02196038|525745055|FG000|Overall Study|Withdrawal by Subject|0|||
145546699|NCT01866930|524860199|FG000|Follow-up Period|Other|1|||
145546700|NCT01866930|524860200|FG001|Follow-up Period|Other|5|||
145546701|NCT01866930|524860199|FG000|Follow-up Period|No longer required per protocol|1|||
145546702|NCT01866930|524860200|FG001|Follow-up Period|No longer required per protocol|0|||
145546703|NCT01866930|524860199|FG000|Follow-up Period|Withdrawal by Subject|3|||
145546704|NCT01866930|524860200|FG001|Follow-up Period|Withdrawal by Subject|3|||
145546705|NCT00279305|524860205|FG000|Overall Study|Pregnancy|1|||
145546706|NCT00279305|524860206|FG001|Overall Study|Pregnancy|0|||
145546707|NCT00279305|524860205|FG000|Overall Study|Withdrawal by Subject|2|||
145546708|NCT00279305|524860206|FG001|Overall Study|Withdrawal by Subject|0|||
145546709|NCT00279305|524860205|FG000|Overall Study|Dificulting establishing IV|1|||
145546710|NCT00279305|524860206|FG001|Overall Study|Dificulting establishing IV|0|||
145546711|NCT00279305|524860205|FG000|Overall Study|FDA Safety Alert|4|||
145546712|NCT00279305|524860206|FG001|Overall Study|FDA Safety Alert|1|||
145546713|NCT02521870|524860207|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546714|NCT02521870|524860208|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
145546715|NCT02521870|524860209|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546716|NCT02521870|524860210|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546717|NCT02521870|524860211|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546718|NCT02521870|524860212|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546719|NCT02521870|524860213|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546720|NCT02521870|524860214|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546721|NCT02521870|524860215|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546722|NCT02521870|524860216|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546723|NCT02521870|524860217|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546724|NCT02521870|524860218|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145546725|NCT02521870|524860207|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
145546726|NCT02521870|524860208|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
145546727|NCT02521870|524860209|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
145546728|NCT02521870|524860210|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
145546729|NCT02521870|524860211|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
145546730|NCT02521870|524860212|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
145546731|NCT02521870|524860213|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
145546732|NCT02521870|524860214|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
145546733|NCT02521870|524860215|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
145546734|NCT02521870|524860216|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
145546735|NCT02521870|524860217|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
145546736|NCT02521870|524860218|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
145546737|NCT02521870|524860207|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
145546738|NCT02521870|524860208|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
145546739|NCT02521870|524860209|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
145546740|NCT02521870|524860210|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
145546741|NCT02521870|524860211|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
145546742|NCT02521870|524860212|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
145546743|NCT02521870|524860213|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
145546744|NCT02521870|524860214|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
145546745|NCT02521870|524860215|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
145546746|NCT02521870|524860216|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
145546747|NCT02521870|524860217|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
145546748|NCT02521870|524860218|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
145546749|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546750|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546751|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546752|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546753|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
145546754|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
145546755|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
145546756|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546757|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
145792192|NCT02196038|525745056|FG001|Overall Study|Withdrawal by Subject|1|||
145792193|NCT02196038|525745055|FG000|Overall Study|Lost to Follow-up|1|||
145546758|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
145546759|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
145610971|NCT02769065|525092544|FG021|Overall Study|Reason Not Specified|0|||
145610972|NCT02769065|525092545|FG022|Overall Study|Reason Not Specified|0|||
145546760|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145546761|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
145546762|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
145792194|NCT02196038|525745056|FG001|Overall Study|Lost to Follow-up|0|||
145792195|NCT00608530|525745063|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
145792196|NCT00608530|525745064|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
145792197|NCT00608530|525745065|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
145792198|NCT00608530|525745066|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
145792199|NCT00608530|525745063|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
145792200|NCT00608530|525745064|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
145792201|NCT00608530|525745065|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
145792202|NCT00608530|525745066|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
145792203|NCT00608530|525745063|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
145792204|NCT00608530|525745064|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
145792205|NCT00608530|525745065|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
145792206|NCT00608530|525745066|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
145792207|NCT00608530|525745063|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
145792208|NCT00608530|525745064|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
145792209|NCT00608530|525745065|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
145792210|NCT00608530|525745066|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
145792211|NCT00608530|525745063|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
145792212|NCT00608530|525745064|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
145792213|NCT00608530|525745065|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
145792214|NCT00608530|525745066|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
145792215|NCT00608530|525745063|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
145792216|NCT00608530|525745064|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
145792217|NCT00608530|525745065|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
145792218|NCT00608530|525745066|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
145792219|NCT01952730|525745067|FG000|Overall Study|FDA shut down core lab used by study|1|||
145792220|NCT01098461|525745068|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
145792221|NCT01098461|525745069|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
145792222|NCT01098461|525745070|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
145792223|NCT01098461|525745071|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
145792224|NCT01098461|525745068|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
145792225|NCT01098461|525745069|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
145792226|NCT01098461|525745070|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
145546763|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
145546764|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
145546765|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
145546766|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
145546767|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
145546768|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
145546769|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
145546770|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
145546771|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
145546772|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
145546773|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
145546774|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
145546775|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
145546776|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
145546777|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
145546778|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
145546779|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
145546780|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
145546781|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
145546782|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
145546783|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
145546784|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
145546785|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Death|0|||
145546786|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Death|0|||
145546787|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Death|0|||
145546788|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Death|0|||
145546789|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Death|1|||
145546790|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Death|1|||
145792227|NCT01098461|525745071|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
145546791|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Death|3|||
145546792|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Death|1|||
145610973|NCT02769065|525092546|FG023|Overall Study|Reason Not Specified|0|||
145610974|NCT02769065|525092547|FG024|Overall Study|Reason Not Specified|0|||
145610975|NCT02769065|525092548|FG025|Overall Study|Reason Not Specified|0|||
145610976|NCT02769065|525092549|FG026|Overall Study|Reason Not Specified|0|||
145610977|NCT02769065|525092550|FG027|Overall Study|Reason Not Specified|0|||
145610978|NCT02769065|525092551|FG028|Overall Study|Reason Not Specified|0|||
145610979|NCT02769065|525092552|FG029|Overall Study|Reason Not Specified|0|||
145610980|NCT02769065|525092523|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610981|NCT02769065|525092524|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610982|NCT02769065|525092525|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610983|NCT02769065|525092526|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610984|NCT02769065|525092527|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610985|NCT02769065|525092528|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610986|NCT02769065|525092529|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610987|NCT02769065|525092530|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
145792228|NCT01098461|525745068|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
145792229|NCT01098461|525745069|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
145792230|NCT01098461|525745070|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
145792231|NCT01098461|525745071|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
145792232|NCT01098461|525745068|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
145792233|NCT01098461|525745069|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
145792234|NCT01098461|525745070|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
145792235|NCT01098461|525745071|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
145792236|NCT01098461|525745068|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
145792237|NCT01098461|525745069|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
145792238|NCT01098461|525745070|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
145792239|NCT01098461|525745071|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
145792240|NCT01098461|525745068|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
145792241|NCT01098461|525745069|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
145792242|NCT01098461|525745070|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
145792243|NCT01098461|525745071|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
145792244|NCT01098461|525745068|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
145792245|NCT01098461|525745069|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
145792246|NCT01098461|525745070|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
145792247|NCT01098461|525745071|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
145792248|NCT01514188|525745072|FG000|Overall Study|Adverse Event|3|||
145792249|NCT01514188|525745073|FG001|Overall Study|Adverse Event|5|||
145792250|NCT01514188|525745072|FG000|Overall Study|Withdrawal by Subject|2|||
145792251|NCT01514188|525745073|FG001|Overall Study|Withdrawal by Subject|4|||
145792252|NCT01514188|525745072|FG000|Overall Study|Protocol Violation|2|||
145792253|NCT01514188|525745073|FG001|Overall Study|Protocol Violation|4|||
145792254|NCT01514188|525745072|FG000|Overall Study|Physician Decision|0|||
145792255|NCT01514188|525745073|FG001|Overall Study|Physician Decision|2|||
145792256|NCT01514188|525745072|FG000|Overall Study|Disease Progression|13|||
145792257|NCT01514188|525745073|FG001|Overall Study|Disease Progression|14|||
145792258|NCT01514188|525745072|FG000|Overall Study|Death|1|||
145792259|NCT01514188|525745073|FG001|Overall Study|Death|3|||
145792260|NCT01514188|525745072|FG000|Overall Study|Other|2|||
145792261|NCT01514188|525745073|FG001|Overall Study|Other|1|||
145792262|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
145610988|NCT02769065|525092531|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610989|NCT02769065|525092532|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
145546793|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Death|1|||
145546794|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Death|5|||
145546795|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Death|2|||
145546796|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Death|2|||
145546797|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Other|0|||
145546798|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Other|0|||
145546799|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Other|0|||
145792263|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
145792264|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Death|2|||
145792265|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Death|1|||
145792266|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
145792267|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
145792268|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
145792269|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
145792270|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
145792271|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
145792272|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
145792273|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
145792274|NCT03633227|525745078|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
145792275|NCT03633227|525745079|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
145792276|NCT03633227|525745078|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
145792277|NCT03633227|525745079|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
145792278|NCT03633227|525745078|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
145792279|NCT03633227|525745079|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
145792280|NCT03633227|525745078|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
145792281|NCT03633227|525745079|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
145792282|NCT03633227|525745078|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
145546800|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Other|0|||
145546801|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Other|10|||
145546802|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Other|3|||
145546803|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Other|2|||
145546804|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Other|0|||
145546805|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Other|10|||
145546806|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Other|5|||
145546807|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Other|1|||
145792283|NCT03633227|525745079|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
145792284|NCT03633227|525745078|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
145792285|NCT03633227|525745079|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
145792286|NCT02045212|525745086|FG000|Overall Study|Adverse Event|0|||
145792287|NCT02045212|525745087|FG001|Overall Study|Adverse Event|1|||
145792288|NCT02045212|525745086|FG000|Overall Study|Withdrawal by Subject|1|||
145792289|NCT02045212|525745087|FG001|Overall Study|Withdrawal by Subject|0|||
145792290|NCT02045212|525745086|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
145792291|NCT02045212|525745087|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
145792292|NCT00515008|525745091|FG000|Overall Study|Lost to Follow-up|1|||
145792293|NCT00515008|525745092|FG001|Overall Study|Lost to Follow-up|0|||
145792294|NCT00515008|525745091|FG000|Overall Study|Declined|0|||
145792295|NCT00515008|525745092|FG001|Overall Study|Declined|3|||
145792296|NCT00515008|525745091|FG000|Overall Study|Left the Boston Area|1|||
145792297|NCT00515008|525745092|FG001|Overall Study|Left the Boston Area|1|||
145792298|NCT00515008|525745091|FG000|Overall Study|Scheduling conflict|1|||
145792299|NCT00515008|525745092|FG001|Overall Study|Scheduling conflict|0|||
145792300|NCT03135028|525745093|FG000|Overall Study|Death|6|||
145792301|NCT03135028|525745093|FG000|Overall Study|Study Terminated by Sponsor|2|||
145792302|NCT03135028|525745093|FG000|Overall Study|Withdrew Consent|1|||
145792303|NCT03599141|525745099|FG000|Overall Study|Lost to Follow-up|3|||
145792304|NCT03599141|525745100|FG001|Overall Study|Lost to Follow-up|1|||
145792305|NCT03126539|525745108|FG000|Overall Study|Lost to Follow-up|1|||
145792306|NCT03126539|525745109|FG001|Overall Study|Lost to Follow-up|1|||
145792307|NCT03126539|525745110|FG002|Overall Study|Lost to Follow-up|1|||
145792308|NCT03126539|525745111|FG003|Overall Study|Lost to Follow-up|0|||
145792309|NCT03126539|525745112|FG004|Overall Study|Lost to Follow-up|0|||
145792310|NCT02596711|525745115|FG000|Overall Study|Lost to Follow-up|1|||
145792311|NCT02596711|525745116|FG001|Overall Study|Lost to Follow-up|2|||
145792312|NCT02596711|525745117|FG002|Overall Study|Lost to Follow-up|3|||
145792313|NCT01005732|525745118|FG000|Overall Study|Lost to Follow-up|10|||
145792314|NCT01005732|525745118|FG000|Overall Study|Death|1|||
145792315|NCT00632463|525745119|FG000|Overall Study|Adverse Event|0|||
145792316|NCT00632463|525745120|FG001|Overall Study|Adverse Event|1|||
145792317|NCT00632463|525745121|FG002|Overall Study|Adverse Event|0|||
145792318|NCT02112994|525745125|FG000|Overall Study|Progressive Disease|0|||
145792319|NCT02112994|525745126|FG001|Overall Study|Progressive Disease|0|||
145792320|NCT02112994|525745127|FG002|Overall Study|Progressive Disease|1|||
145792321|NCT02112994|525745125|FG000|Overall Study|Pregnancy|0|||
145792322|NCT02112994|525745126|FG001|Overall Study|Pregnancy|1|||
145792323|NCT02112994|525745127|FG002|Overall Study|Pregnancy|1|||
145792324|NCT02112994|525745125|FG000|Overall Study|Liver Transplant|0|||
145792325|NCT02112994|525745126|FG001|Overall Study|Liver Transplant|1|||
145792326|NCT02112994|525745127|FG002|Overall Study|Liver Transplant|0|||
145792327|NCT02112994|525745125|FG000|Overall Study|Withdrawal by Subject|0|||
145792328|NCT02112994|525745126|FG001|Overall Study|Withdrawal by Subject|0|||
145792329|NCT02112994|525745127|FG002|Overall Study|Withdrawal by Subject|1|||
145792330|NCT01683071|525745131|FG000|Part 1|Lack of Efficacy|1|||
145792331|NCT01683071|525745132|FG001|Part 1|Lack of Efficacy|0|||
145792332|NCT01683071|525745133|FG002|Part 1|Lack of Efficacy|0|||
145792333|NCT01683071|525745134|FG003|Part 1|Lack of Efficacy|3|||
145792334|NCT01683071|525745135|FG004|Part 1|Lack of Efficacy|0|||
145792335|NCT01683071|525745136|FG005|Part 1|Lack of Efficacy|0|||
145792336|NCT01683071|525745131|FG000|Part 1|Withdrawal by Subject|1|||
145792337|NCT01683071|525745132|FG001|Part 1|Withdrawal by Subject|2|||
145792338|NCT01683071|525745133|FG002|Part 1|Withdrawal by Subject|2|||
145792339|NCT01683071|525745134|FG003|Part 1|Withdrawal by Subject|1|||
145792340|NCT01683071|525745135|FG004|Part 1|Withdrawal by Subject|0|||
145792341|NCT01683071|525745136|FG005|Part 1|Withdrawal by Subject|0|||
145546808|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Other|7|||
145546809|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145792342|NCT01683071|525745131|FG000|Part 1|Surgery Cancelled|1|||
145792343|NCT01683071|525745132|FG001|Part 1|Surgery Cancelled|0|||
145792344|NCT01683071|525745133|FG002|Part 1|Surgery Cancelled|0|||
145792345|NCT01683071|525745134|FG003|Part 1|Surgery Cancelled|0|||
145792346|NCT01683071|525745135|FG004|Part 1|Surgery Cancelled|0|||
145792347|NCT01683071|525745136|FG005|Part 1|Surgery Cancelled|0|||
145792348|NCT01683071|525745131|FG000|Part 1|Did not receive study drug|1|||
145792349|NCT01683071|525745132|FG001|Part 1|Did not receive study drug|0|||
145792350|NCT01683071|525745133|FG002|Part 1|Did not receive study drug|0|||
145792351|NCT01683071|525745134|FG003|Part 1|Did not receive study drug|1|||
145792352|NCT01683071|525745135|FG004|Part 1|Did not receive study drug|0|||
145792353|NCT01683071|525745136|FG005|Part 1|Did not receive study drug|0|||
145792354|NCT01683071|525745131|FG000|Part 1|Early termination; met exclusion criteria|0|||
145792355|NCT01683071|525745132|FG001|Part 1|Early termination; met exclusion criteria|2|||
145792356|NCT01683071|525745133|FG002|Part 1|Early termination; met exclusion criteria|1|||
145792357|NCT01683071|525745134|FG003|Part 1|Early termination; met exclusion criteria|0|||
145792358|NCT01683071|525745135|FG004|Part 1|Early termination; met exclusion criteria|0|||
145792359|NCT01683071|525745136|FG005|Part 1|Early termination; met exclusion criteria|0|||
145792360|NCT01683071|525745131|FG000|Part 2|Lack of Efficacy|0|||
145792361|NCT01683071|525745132|FG001|Part 2|Lack of Efficacy|0|||
145792362|NCT01683071|525745133|FG002|Part 2|Lack of Efficacy|0|||
145792363|NCT01683071|525745134|FG003|Part 2|Lack of Efficacy|0|||
145792364|NCT01683071|525745135|FG004|Part 2|Lack of Efficacy|3|||
145792365|NCT01683071|525745136|FG005|Part 2|Lack of Efficacy|4|||
145792366|NCT01683071|525745131|FG000|Part 2|Lost to Follow-up|0|||
145792367|NCT01683071|525745132|FG001|Part 2|Lost to Follow-up|0|||
145792368|NCT01683071|525745133|FG002|Part 2|Lost to Follow-up|0|||
145792369|NCT01683071|525745134|FG003|Part 2|Lost to Follow-up|0|||
145792370|NCT01683071|525745135|FG004|Part 2|Lost to Follow-up|2|||
145792371|NCT01683071|525745136|FG005|Part 2|Lost to Follow-up|0|||
145792372|NCT01683071|525745131|FG000|Part 2|Withdrawal by Subject|0|||
145792373|NCT01683071|525745132|FG001|Part 2|Withdrawal by Subject|0|||
145792374|NCT01683071|525745133|FG002|Part 2|Withdrawal by Subject|0|||
145792375|NCT01683071|525745134|FG003|Part 2|Withdrawal by Subject|0|||
145610990|NCT02769065|525092533|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
145610991|NCT02769065|525092534|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610992|NCT02769065|525092535|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610993|NCT02769065|525092536|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610994|NCT02769065|525092537|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610995|NCT02769065|525092538|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610996|NCT02769065|525092539|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610997|NCT02769065|525092540|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610998|NCT02769065|525092541|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
145610999|NCT02769065|525092542|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611000|NCT02769065|525092543|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611001|NCT02769065|525092544|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611002|NCT02769065|525092545|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
145792376|NCT01683071|525745135|FG004|Part 2|Withdrawal by Subject|3|||
145792377|NCT01683071|525745136|FG005|Part 2|Withdrawal by Subject|3|||
145792378|NCT01683071|525745131|FG000|Part 2|Surgery cancelled|0|||
145792379|NCT01683071|525745132|FG001|Part 2|Surgery cancelled|0|||
145792380|NCT01683071|525745133|FG002|Part 2|Surgery cancelled|0|||
145792381|NCT01683071|525745134|FG003|Part 2|Surgery cancelled|0|||
145792382|NCT01683071|525745135|FG004|Part 2|Surgery cancelled|4|||
145792383|NCT01683071|525745136|FG005|Part 2|Surgery cancelled|2|||
145792384|NCT01683071|525745131|FG000|Part 2|Did not receive study drug|0|||
145792385|NCT01683071|525745132|FG001|Part 2|Did not receive study drug|0|||
145792386|NCT01683071|525745133|FG002|Part 2|Did not receive study drug|0|||
145792387|NCT01683071|525745134|FG003|Part 2|Did not receive study drug|0|||
145792388|NCT01683071|525745135|FG004|Part 2|Did not receive study drug|2|||
145792389|NCT01683071|525745136|FG005|Part 2|Did not receive study drug|1|||
145792390|NCT01683071|525745131|FG000|Part 2|Met exclusion criterion|0|||
145792391|NCT01683071|525745132|FG001|Part 2|Met exclusion criterion|0|||
145611003|NCT02769065|525092546|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
145792392|NCT01683071|525745133|FG002|Part 2|Met exclusion criterion|0|||
145792393|NCT01683071|525745134|FG003|Part 2|Met exclusion criterion|0|||
145611004|NCT02769065|525092547|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611005|NCT02769065|525092548|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
145792394|NCT01683071|525745135|FG004|Part 2|Met exclusion criterion|1|||
145792395|NCT01683071|525745136|FG005|Part 2|Met exclusion criterion|1|||
145792396|NCT01683071|525745131|FG000|Part 2|Protocol deviation|0|||
145792397|NCT01683071|525745132|FG001|Part 2|Protocol deviation|0|||
145792398|NCT01683071|525745133|FG002|Part 2|Protocol deviation|0|||
145792399|NCT01683071|525745134|FG003|Part 2|Protocol deviation|0|||
145792400|NCT01683071|525745135|FG004|Part 2|Protocol deviation|1|||
145792401|NCT01683071|525745136|FG005|Part 2|Protocol deviation|2|||
145792402|NCT01683071|525745131|FG000|Part 2|Withdrawal by investigator decision|0|||
145792403|NCT01683071|525745132|FG001|Part 2|Withdrawal by investigator decision|0|||
145792404|NCT01683071|525745133|FG002|Part 2|Withdrawal by investigator decision|0|||
145792405|NCT01683071|525745134|FG003|Part 2|Withdrawal by investigator decision|0|||
145792406|NCT01683071|525745135|FG004|Part 2|Withdrawal by investigator decision|1|||
145792407|NCT01683071|525745136|FG005|Part 2|Withdrawal by investigator decision|2|||
145792408|NCT01454401|525745139|FG000|Overall Study|Death|1|||
145792409|NCT01454401|525745139|FG000|Overall Study|hospitalised|1|||
145792410|NCT01454401|525745139|FG000|Overall Study|osteomyelitis|2|||
145792411|NCT01454401|525745139|FG000|Overall Study|non-adherence|1|||
145792412|NCT03675737|525745143|FG000|Overall Study|Death|593|||
145792413|NCT03675737|525745144|FG001|Overall Study|Death|660|||
145792414|NCT03675737|525745143|FG000|Overall Study|Lost to Follow-up|1|||
145792415|NCT03675737|525745144|FG001|Overall Study|Lost to Follow-up|5|||
145792416|NCT03675737|525745143|FG000|Overall Study|Physician Decision|1|||
145792417|NCT03675737|525745144|FG001|Overall Study|Physician Decision|0|||
145792418|NCT03675737|525745143|FG000|Overall Study|Withdrawal by Subject|14|||
145792419|NCT03675737|525745144|FG001|Overall Study|Withdrawal by Subject|12|||
145792420|NCT03675737|525745143|FG000|Overall Study|Ongoing in Study|181|||
145792421|NCT03675737|525745144|FG001|Overall Study|Ongoing in Study|112|||
145792422|NCT02349789|525746321|FG000|Overall Study|Withdrawal by Subject|2|||
145792423|NCT02625324|525746324|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
145792424|NCT02625324|525746324|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
145792425|NCT02625324|525746324|FG000|6-Month Follow-up Subject Accountability|Death|5|||
145792426|NCT02625324|525746324|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
145546810|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546811|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546812|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546813|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
145546814|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546815|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546816|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546817|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546818|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145546819|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145792427|NCT02625324|525746324|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
145792428|NCT02625324|525746324|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
145792429|NCT02625324|525746324|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
145792430|NCT02625324|525746324|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
145792431|NCT02625324|525746324|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
145792432|NCT02625324|525746324|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
145792433|NCT02625324|525746324|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
145792434|NCT02625324|525746324|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
145792435|NCT02625324|525746324|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
145792436|NCT02625324|525746324|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
145792437|NCT02625324|525746324|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145792438|NCT02625324|525746324|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
145792439|NCT02625324|525746324|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145792440|NCT02457182|525746325|FG000|Overall Study|Lost to Follow-up|1|||
145792441|NCT02457182|525746326|FG001|Overall Study|Lost to Follow-up|0|||
145792442|NCT01116687|525746327|FG000|Overall Study|Withdrawal by Subject|4|||
145792443|NCT00424528|525746328|FG000|Overall Study|Adverse Event|2|||
145792444|NCT00424528|525746329|FG001|Overall Study|Adverse Event|1|||
145792445|NCT00424528|525746330|FG002|Overall Study|Adverse Event|2|||
145792446|NCT00424528|525746328|FG000|Overall Study|Protocol Violation|1|||
145792447|NCT00424528|525746329|FG001|Overall Study|Protocol Violation|1|||
145792448|NCT00424528|525746330|FG002|Overall Study|Protocol Violation|0|||
145546820|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145792449|NCT00424528|525746328|FG000|Overall Study|Lost to Follow-up|0|||
145546821|NCT02521870|524860207|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145792450|NCT00424528|525746329|FG001|Overall Study|Lost to Follow-up|1|||
145792451|NCT00424528|525746330|FG002|Overall Study|Lost to Follow-up|0|||
145792452|NCT00424528|525746328|FG000|Overall Study|noncompliance with study requirements|2|||
145792453|NCT00424528|525746329|FG001|Overall Study|noncompliance with study requirements|1|||
145792454|NCT00424528|525746330|FG002|Overall Study|noncompliance with study requirements|2|||
145792455|NCT02115113|525746331|FG000|Participants in Run-in Period|Death|0|||
145792456|NCT02115113|525746332|FG001|Participants in Run-in Period|Death|0|||
145792457|NCT02115113|525746333|FG002|Participants in Run-in Period|Death|1|||
145792458|NCT02115113|525746331|FG000|Participants in Run-in Period|Administrative problems|0|||
145792459|NCT02115113|525746332|FG001|Participants in Run-in Period|Administrative problems|0|||
145792460|NCT02115113|525746333|FG002|Participants in Run-in Period|Administrative problems|1|||
145792461|NCT02115113|525746331|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
145792462|NCT02115113|525746332|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
145792463|NCT02115113|525746333|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
145792464|NCT02115113|525746331|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
145792465|NCT02115113|525746332|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
145792466|NCT02115113|525746333|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
145792467|NCT02115113|525746331|FG000|Participants Randomized|Lost to Follow-up|1|||
145792468|NCT02115113|525746332|FG001|Participants Randomized|Lost to Follow-up|0|||
145792469|NCT02115113|525746333|FG002|Participants Randomized|Lost to Follow-up|0|||
145792470|NCT02115113|525746331|FG000|Participants Randomized|Death|1|||
145792471|NCT02115113|525746332|FG001|Participants Randomized|Death|0|||
145792472|NCT02115113|525746333|FG002|Participants Randomized|Death|0|||
145792473|NCT00789191|525746335|FG000|Overall Study|Adverse Event|2|||
145792474|NCT00789191|525746336|FG001|Overall Study|Adverse Event|4|||
145792475|NCT00789191|525746335|FG000|Overall Study|Lack of Efficacy|0|||
145792476|NCT00789191|525746336|FG001|Overall Study|Lack of Efficacy|5|||
145792477|NCT00789191|525746335|FG000|Overall Study|Protocol Violation|5|||
145792478|NCT00789191|525746336|FG001|Overall Study|Protocol Violation|3|||
145792479|NCT00789191|525746335|FG000|Overall Study|Withdrawal Criteria|2|||
145792480|NCT00789191|525746336|FG001|Overall Study|Withdrawal Criteria|4|||
145792481|NCT00789191|525746335|FG000|Overall Study|Unclassified|5|||
145792482|NCT00789191|525746336|FG001|Overall Study|Unclassified|3|||
145792483|NCT03497429|525746337|FG000|Overall Study|Progressive disease|3|||
145792484|NCT03497429|525746338|FG001|Overall Study|Progressive disease|4|||
145792485|NCT03497429|525746337|FG000|Overall Study|Adverse Event|0|||
145792486|NCT03497429|525746338|FG001|Overall Study|Adverse Event|2|||
145792487|NCT01009983|525746339|FG000|Overall Study|necessary scans not completed|1|||
145792488|NCT00967226|525746343|FG000|Overall Study|Adverse Event|0|||
145792489|NCT00967226|525746344|FG001|Overall Study|Adverse Event|5|||
145792490|NCT00967226|525746343|FG000|Overall Study|Protocol Violation|2|||
145792491|NCT00967226|525746344|FG001|Overall Study|Protocol Violation|0|||
145792492|NCT00967226|525746343|FG000|Overall Study|Physician Decision|0|||
145792493|NCT00967226|525746344|FG001|Overall Study|Physician Decision|1|||
145792494|NCT00356863|525746345|FG000|Overall Study|Death|16|||
145792495|NCT00356863|525746346|FG001|Overall Study|Death|32|||
145792496|NCT00356863|525746345|FG000|Overall Study|Lost to Follow-up|76|||
145792497|NCT00356863|525746346|FG001|Overall Study|Lost to Follow-up|43|||
145792498|NCT00836277|525746347|FG000|Overall Study|Not evaluable for response|6|||
145792499|NCT00280150|525746348|FG000|Overall Study|Adverse Event|0|||
145792500|NCT00280150|525746349|FG001|Overall Study|Adverse Event|1|||
145792501|NCT00280150|525746350|FG002|Overall Study|Adverse Event|2|||
145792502|NCT00280150|525746351|FG003|Overall Study|Adverse Event|3|||
145792503|NCT00280150|525746348|FG000|Overall Study|Lack of Efficacy|0|||
145792504|NCT00280150|525746349|FG001|Overall Study|Lack of Efficacy|0|||
145792505|NCT00280150|525746350|FG002|Overall Study|Lack of Efficacy|0|||
145792506|NCT00280150|525746351|FG003|Overall Study|Lack of Efficacy|3|||
145792507|NCT00280150|525746348|FG000|Overall Study|Physician Decision|0|||
145792508|NCT00280150|525746349|FG001|Overall Study|Physician Decision|0|||
145792509|NCT00280150|525746350|FG002|Overall Study|Physician Decision|0|||
145792510|NCT00280150|525746351|FG003|Overall Study|Physician Decision|1|||
145792511|NCT00280150|525746348|FG000|Overall Study|Protocol Violation|0|||
145792512|NCT00280150|525746349|FG001|Overall Study|Protocol Violation|0|||
145792513|NCT00280150|525746350|FG002|Overall Study|Protocol Violation|0|||
145792514|NCT00280150|525746351|FG003|Overall Study|Protocol Violation|1|||
145792515|NCT00280150|525746348|FG000|Overall Study|Withdrawal by Subject|0|||
145792516|NCT00280150|525746349|FG001|Overall Study|Withdrawal by Subject|0|||
145792517|NCT00280150|525746350|FG002|Overall Study|Withdrawal by Subject|0|||
145792518|NCT00280150|525746351|FG003|Overall Study|Withdrawal by Subject|1|||
145792519|NCT00280150|525746348|FG000|Overall Study|Did not get consolidation therapy|3|||
145792520|NCT00280150|525746349|FG001|Overall Study|Did not get consolidation therapy|0|||
145792521|NCT00280150|525746350|FG002|Overall Study|Did not get consolidation therapy|3|||
145792522|NCT00280150|525746351|FG003|Overall Study|Did not get consolidation therapy|0|||
145792523|NCT00280150|525746348|FG000|Overall Study|Declining Performance Status|0|||
145792524|NCT00280150|525746349|FG001|Overall Study|Declining Performance Status|0|||
145792525|NCT00280150|525746350|FG002|Overall Study|Declining Performance Status|0|||
145792526|NCT00280150|525746351|FG003|Overall Study|Declining Performance Status|1|||
145792527|NCT02871401|525746354|FG000|Overall Study|Adverse Event|1|||
145792528|NCT02871401|525746355|FG001|Overall Study|Adverse Event|0|||
145792529|NCT04031404|525746356|FG000|Baseline|Lost to Follow-up|0|||
145792530|NCT04031404|525746357|FG001|Baseline|Lost to Follow-up|1|||
145792531|NCT04031404|525746356|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
145792532|NCT04031404|525746357|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
145792533|NCT04031404|525746356|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
145792534|NCT04031404|525746357|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
145792535|NCT04031404|525746356|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
145792536|NCT04031404|525746357|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
145792537|NCT04031404|525746356|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
145792538|NCT04031404|525746357|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
145792539|NCT03583372|525746361|FG000|Overall Study|Withdrawal by Subject|6|||
145792540|NCT03583372|525746362|FG001|Overall Study|Withdrawal by Subject|11|||
145792541|NCT03583372|525746363|FG002|Overall Study|Withdrawal by Subject|7|||
145792542|NCT03583372|525746364|FG003|Overall Study|Withdrawal by Subject|8|||
145792543|NCT03583372|525746361|FG000|Overall Study|Lost to Follow-up|4|||
145792544|NCT03583372|525746362|FG001|Overall Study|Lost to Follow-up|6|||
145792545|NCT03583372|525746363|FG002|Overall Study|Lost to Follow-up|3|||
145792546|NCT03583372|525746364|FG003|Overall Study|Lost to Follow-up|2|||
145792547|NCT03583372|525746361|FG000|Overall Study|Adverse Event|1|||
145792548|NCT03583372|525746362|FG001|Overall Study|Adverse Event|3|||
145792549|NCT03583372|525746363|FG002|Overall Study|Adverse Event|4|||
145792550|NCT03583372|525746364|FG003|Overall Study|Adverse Event|4|||
145792551|NCT03583372|525746361|FG000|Overall Study|Physician Decision|0|||
145792552|NCT03583372|525746362|FG001|Overall Study|Physician Decision|1|||
145792553|NCT03583372|525746363|FG002|Overall Study|Physician Decision|1|||
145792554|NCT03583372|525746364|FG003|Overall Study|Physician Decision|1|||
145792555|NCT03583372|525746361|FG000|Overall Study|Lack of Efficacy|0|||
145792556|NCT03583372|525746362|FG001|Overall Study|Lack of Efficacy|1|||
145792557|NCT03583372|525746363|FG002|Overall Study|Lack of Efficacy|0|||
145792558|NCT03583372|525746364|FG003|Overall Study|Lack of Efficacy|1|||
145792559|NCT03583372|525746361|FG000|Overall Study|Death|1|||
145792560|NCT03583372|525746362|FG001|Overall Study|Death|0|||
145792561|NCT03583372|525746363|FG002|Overall Study|Death|0|||
145792562|NCT03583372|525746364|FG003|Overall Study|Death|0|||
145792563|NCT03583372|525746361|FG000|Overall Study|Protocol Violation|0|||
145546822|NCT02521870|524860208|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546823|NCT02521870|524860209|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546824|NCT02521870|524860210|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546825|NCT02521870|524860211|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
145546826|NCT02521870|524860212|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546827|NCT02521870|524860213|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546828|NCT02521870|524860214|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546829|NCT02521870|524860215|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546830|NCT02521870|524860216|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546831|NCT02521870|524860217|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546832|NCT02521870|524860218|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
145546833|NCT04404361|524860222|FG000|Overall Study|Death|12|||
145546834|NCT04404361|524860223|FG001|Overall Study|Death|12|||
145546835|NCT04404361|524860222|FG000|Overall Study|Withdrawal by Subject|13|||
145546836|NCT04404361|524860223|FG001|Overall Study|Withdrawal by Subject|5|||
145546837|NCT04404361|524860222|FG000|Overall Study|Lost to Follow-up|6|||
145546838|NCT04404361|524860223|FG001|Overall Study|Lost to Follow-up|3|||
145546839|NCT04404361|524860222|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
145546840|NCT04404361|524860223|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
145546841|NCT02862171|524860224|FG000|Overall Study|Death|1|||
145546842|NCT02862171|524860224|FG000|Overall Study|Lost to Follow-up|13|||
145546843|NCT02862171|524860224|FG000|Overall Study|Withdrawal by Subject|57|||
145546844|NCT02862171|524860224|FG000|Overall Study|Non-compliance|4|||
145546845|NCT02862171|524860224|FG000|Overall Study|HIV-1 seroconversion|18|||
145546846|NCT00558558|524860225|FG000|Overall Study|Unable to swallow|1|||
145546847|NCT00558558|524860225|FG000|Overall Study|Withdrawal by Subject|1|||
145546848|NCT00558558|524860225|FG000|Overall Study|Lack of Efficacy|4|||
145546849|NCT04023526|524861645|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
145546850|NCT04023526|524861646|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
145546851|NCT04023526|524861645|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
145546852|NCT04023526|524861646|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
145546853|NCT02324569|524861651|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145546854|NCT02324569|524861652|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
145546855|NCT02324569|524861651|FG000|Overall Study|Voluntary Withdrawal|3|||
145546856|NCT02324569|524861652|FG001|Overall Study|Voluntary Withdrawal|6|||
145546857|NCT02324569|524861651|FG000|Overall Study|Lack of Efficacy|2|||
145546858|NCT02324569|524861652|FG001|Overall Study|Lack of Efficacy|3|||
145792564|NCT03583372|525746362|FG001|Overall Study|Protocol Violation|1|||
145792565|NCT03583372|525746363|FG002|Overall Study|Protocol Violation|0|||
145792566|NCT03583372|525746364|FG003|Overall Study|Protocol Violation|0|||
145792567|NCT03583372|525746361|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
145546859|NCT02324569|524861651|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
145546860|NCT02324569|524861652|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
145546861|NCT02324569|524861651|FG000|Overall Study|Inconvenient Schedule|2|||
145546862|NCT02324569|524861652|FG001|Overall Study|Inconvenient Schedule|0|||
145546863|NCT01943292|524861653|FG000|Overall Study|Withdrawal by Subject|1|||
145546864|NCT01943292|524861654|FG001|Overall Study|Withdrawal by Subject|0|||
145546865|NCT01943292|524861655|FG002|Overall Study|Withdrawal by Subject|0|||
145546866|NCT00638378|524861656|FG000|Overall Study|Death|2|||
145546867|NCT00638378|524861656|FG000|Overall Study|Adverse Event|1|||
145546868|NCT00638378|524861656|FG000|Overall Study|Disease progression|15|||
145546869|NCT00638378|524861656|FG000|Overall Study|Physician Decision|4|||
145546870|NCT00996216|524861657|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
145546871|NCT00996216|524861657|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
145546872|NCT00996216|524861657|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
145792568|NCT03583372|525746362|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
145792569|NCT03583372|525746363|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
145792570|NCT03583372|525746364|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
145792571|NCT03583372|525746361|FG000|Overall Study|Did Not Receive Study Drug|0|||
145792572|NCT03583372|525746362|FG001|Overall Study|Did Not Receive Study Drug|1|||
145792573|NCT03583372|525746363|FG002|Overall Study|Did Not Receive Study Drug|0|||
145792574|NCT03583372|525746364|FG003|Overall Study|Did Not Receive Study Drug|0|||
145792575|NCT03583372|525746361|FG000|Overall Study|Captured as Other in the Database|1|||
145792576|NCT03583372|525746362|FG001|Overall Study|Captured as Other in the Database|2|||
145792577|NCT03583372|525746363|FG002|Overall Study|Captured as Other in the Database|4|||
145792578|NCT03583372|525746364|FG003|Overall Study|Captured as Other in the Database|1|||
145792579|NCT02796391|525746365|FG000|Overall Study|Lost to Follow-up|2|||
145792580|NCT02796391|525746366|FG001|Overall Study|Lost to Follow-up|2|||
145792581|NCT02796391|525746367|FG002|Overall Study|Lost to Follow-up|13|||
145792582|NCT02796391|525746368|FG003|Overall Study|Lost to Follow-up|8|||
145792583|NCT02796391|525746369|FG004|Overall Study|Lost to Follow-up|14|||
145792584|NCT02796391|525746370|FG005|Overall Study|Lost to Follow-up|13|||
145792585|NCT02796391|525746365|FG000|Overall Study|COVID|0|||
145792586|NCT02796391|525746366|FG001|Overall Study|COVID|0|||
145792587|NCT02796391|525746367|FG002|Overall Study|COVID|5|||
145792588|NCT02796391|525746368|FG003|Overall Study|COVID|5|||
145792589|NCT02796391|525746369|FG004|Overall Study|COVID|2|||
145792590|NCT02796391|525746370|FG005|Overall Study|COVID|4|||
145792591|NCT02796391|525746365|FG000|Overall Study|Participant did not like study cigarettes|0|||
145792592|NCT02796391|525746366|FG001|Overall Study|Participant did not like study cigarettes|0|||
145792593|NCT02796391|525746367|FG002|Overall Study|Participant did not like study cigarettes|3|||
145792594|NCT02796391|525746368|FG003|Overall Study|Participant did not like study cigarettes|0|||
145792595|NCT02796391|525746369|FG004|Overall Study|Participant did not like study cigarettes|0|||
145792596|NCT02796391|525746370|FG005|Overall Study|Participant did not like study cigarettes|0|||
145792597|NCT02796391|525746365|FG000|Overall Study|Withdrawal by Subject|1|||
145792598|NCT02796391|525746366|FG001|Overall Study|Withdrawal by Subject|1|||
145792599|NCT02796391|525746367|FG002|Overall Study|Withdrawal by Subject|4|||
145792600|NCT02796391|525746368|FG003|Overall Study|Withdrawal by Subject|3|||
145792601|NCT02796391|525746369|FG004|Overall Study|Withdrawal by Subject|4|||
145792602|NCT02796391|525746370|FG005|Overall Study|Withdrawal by Subject|3|||
145792603|NCT02796391|525746365|FG000|Overall Study|Adverse Event|0|||
145792604|NCT02796391|525746366|FG001|Overall Study|Adverse Event|0|||
145792605|NCT02796391|525746367|FG002|Overall Study|Adverse Event|0|||
145792606|NCT02796391|525746368|FG003|Overall Study|Adverse Event|1|||
145792607|NCT02796391|525746369|FG004|Overall Study|Adverse Event|0|||
145792608|NCT02796391|525746370|FG005|Overall Study|Adverse Event|0|||
145792609|NCT02796391|525746365|FG000|Overall Study|Protocol Violation|0|||
145792610|NCT02796391|525746366|FG001|Overall Study|Protocol Violation|0|||
145792611|NCT02796391|525746367|FG002|Overall Study|Protocol Violation|0|||
145792612|NCT02796391|525746368|FG003|Overall Study|Protocol Violation|1|||
145792613|NCT02796391|525746369|FG004|Overall Study|Protocol Violation|0|||
145792614|NCT02796391|525746370|FG005|Overall Study|Protocol Violation|0|||
145792615|NCT00377611|525746371|FG000|Overall Study|Adverse Event|2|||
145792616|NCT00377611|525746372|FG001|Overall Study|Adverse Event|9|||
145792617|NCT00377611|525746371|FG000|Overall Study|Protocol Violation|2|||
145792618|NCT00377611|525746372|FG001|Overall Study|Protocol Violation|0|||
145792619|NCT00377611|525746371|FG000|Overall Study|Withdrawal by Subject|0|||
145792620|NCT00377611|525746372|FG001|Overall Study|Withdrawal by Subject|5|||
145792621|NCT00377611|525746371|FG000|Overall Study|Lost to Follow-up|18|||
145792622|NCT00377611|525746372|FG001|Overall Study|Lost to Follow-up|16|||
145792623|NCT00377611|525746371|FG000|Overall Study|Other|0|||
145792624|NCT00377611|525746372|FG001|Overall Study|Other|3|||
145792625|NCT00831441|525746373|FG000|Randomized|Death|82|||
145546873|NCT00903695|524861665|FG000|Overall Study|medical exclusion after 1st testing|1|||
145546874|NCT00903695|524861666|FG001|Overall Study|medical exclusion after 1st testing|0|||
145792626|NCT00831441|525746374|FG001|Randomized|Death|81|||
145792627|NCT00831441|525746373|FG000|Randomized|Adverse Event|248|||
145792628|NCT00831441|525746374|FG001|Randomized|Adverse Event|321|||
145546875|NCT00903695|524861665|FG000|Overall Study|lung cancer|1|||
145546876|NCT00903695|524861666|FG001|Overall Study|lung cancer|0|||
145546877|NCT00578812|524861668|FG000|Overall Study|Not treated|6|||
145546878|NCT00578812|524861669|FG001|Overall Study|Not treated|7|||
145546879|NCT04532164|524861671|FG000|Overall Study|Adverse Event|1|||
145546880|NCT04532164|524861671|FG000|Overall Study|Protocol Violation|5|||
145546881|NCT04532164|524861671|FG000|Overall Study|Lost to Follow-up|1|||
145611006|NCT02769065|525092549|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611007|NCT02769065|525092550|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611008|NCT02769065|525092551|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611009|NCT02769065|525092552|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
145611010|NCT03017235|525092553|FG000|Overall Study|Withdrawal by Subject|4|||
145611011|NCT03017235|525092554|FG001|Overall Study|Withdrawal by Subject|3|||
145611012|NCT03017235|525092553|FG000|Overall Study|Lost to Follow-up|2|||
145611013|NCT03017235|525092554|FG001|Overall Study|Lost to Follow-up|7|||
145611014|NCT03017235|525092553|FG000|Overall Study|Adverse Event|0|||
145611015|NCT03017235|525092554|FG001|Overall Study|Adverse Event|1|||
145611016|NCT03017235|525092553|FG000|Overall Study|Protocol Violation|2|||
145611017|NCT03017235|525092554|FG001|Overall Study|Protocol Violation|1|||
145611018|NCT03017235|525092553|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
145611019|NCT03017235|525092554|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
145611020|NCT00437125|525092558|FG000|Overall Study|Adverse Event|12|||
145611021|NCT00437125|525092558|FG000|Overall Study|Death|1|||
145611022|NCT00437125|525092558|FG000|Overall Study|Clinical Relapse|1|||
145611023|NCT00437125|525092558|FG000|Overall Study|Lack of Efficacy|1|||
145611024|NCT00437125|525092558|FG000|Overall Study|Lost to Follow-up|1|||
145611025|NCT00437125|525092558|FG000|Overall Study|Withdrawal by Subject|13|||
145611026|NCT00437125|525092558|FG000|Overall Study|Withdrawal by Caregiver|2|||
145611027|NCT00437125|525092558|FG000|Overall Study|Physician Decision|1|||
145611028|NCT02248961|525092559|FG000|Overall Study|Adverse Event|1|||
145611029|NCT02248961|525092560|FG001|Overall Study|Adverse Event|0|||
145611030|NCT02248961|525092559|FG000|Overall Study|Withdrawal by Subject|1|||
145611031|NCT02248961|525092560|FG001|Overall Study|Withdrawal by Subject|2|||
145611032|NCT02248961|525092559|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
145611033|NCT02248961|525092560|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
145611034|NCT03518658|525092561|FG000|Overall Study|Other|51|||
145611035|NCT03518658|525092562|FG001|Overall Study|Other|0|||
145611036|NCT02531295|525092563|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
145611037|NCT02531295|525092564|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
145611038|NCT02531295|525092565|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
145611039|NCT02531295|525092566|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
145611040|NCT02531295|525092567|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
145611041|NCT02531295|525092568|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
145611042|NCT00649389|525092569|FG000|Overall Study|Adverse Event|22|||
145611043|NCT00649389|525092570|FG001|Overall Study|Adverse Event|46|||
145611044|NCT00649389|525092571|FG002|Overall Study|Adverse Event|38|||
145611045|NCT00649389|525092572|FG003|Overall Study|Adverse Event|48|||
145611046|NCT00649389|525092569|FG000|Overall Study|Lost to Follow-up|15|||
145611047|NCT00649389|525092570|FG001|Overall Study|Lost to Follow-up|17|||
145611048|NCT00649389|525092571|FG002|Overall Study|Lost to Follow-up|21|||
145611049|NCT00649389|525092572|FG003|Overall Study|Lost to Follow-up|26|||
145611050|NCT00649389|525092569|FG000|Overall Study|Protocol Violation|11|||
145611051|NCT00649389|525092570|FG001|Overall Study|Protocol Violation|13|||
145611052|NCT00649389|525092571|FG002|Overall Study|Protocol Violation|9|||
145611053|NCT00649389|525092572|FG003|Overall Study|Protocol Violation|8|||
145611054|NCT00649389|525092569|FG000|Overall Study|Withdrawal by Subject|20|||
145611055|NCT00649389|525092570|FG001|Overall Study|Withdrawal by Subject|21|||
145611056|NCT00649389|525092571|FG002|Overall Study|Withdrawal by Subject|19|||
145611057|NCT00649389|525092572|FG003|Overall Study|Withdrawal by Subject|23|||
145611058|NCT00649389|525092569|FG000|Overall Study|Other|3|||
145792629|NCT00831441|525746373|FG000|Randomized|Emergency procedure|2|||
145546882|NCT04532164|524861671|FG000|Overall Study|Found to be Ineligible|3|||
145546883|NCT04532164|524861671|FG000|Overall Study|Withdrawal by Subject|14|||
145546884|NCT01104493|524861672|FG000|Overall Study|Lost to Follow-up|0|||
145611059|NCT00649389|525092570|FG001|Overall Study|Other|9|||
145611060|NCT00649389|525092571|FG002|Overall Study|Other|1|||
145611061|NCT00649389|525092572|FG003|Overall Study|Other|6|||
145611062|NCT00453310|525092575|FG000|Overall Study|Progression of Disease|10|||
145546885|NCT01104493|524861673|FG001|Overall Study|Lost to Follow-up|2|||
145611063|NCT01806740|525092576|FG000|Overall Study|Withdrawal by Subject|4|||
145611064|NCT01806740|525092576|FG000|Overall Study|Physician Decision|1|||
145611065|NCT01806740|525092576|FG000|Overall Study|Patient's refusal of treatment|1|||
145611066|NCT04666922|525092577|FG000|Overall Study|Withdrawal by Subject|1|||
145611067|NCT04666922|525092578|FG001|Overall Study|Withdrawal by Subject|0|||
145611068|NCT04666922|525092579|FG002|Overall Study|Withdrawal by Subject|0|||
145611069|NCT04666922|525092580|FG003|Overall Study|Withdrawal by Subject|0|||
145611070|NCT04666922|525092581|FG004|Overall Study|Withdrawal by Subject|0|||
145611071|NCT04666922|525092582|FG005|Overall Study|Withdrawal by Subject|0|||
145611072|NCT04666922|525092583|FG006|Overall Study|Withdrawal by Subject|0|||
145611073|NCT01382940|525092584|FG000|Overall Study|Adverse Event|19|||
145611074|NCT01382940|525092584|FG000|Overall Study|Lost to Follow-up|4|||
145611075|NCT01382940|525092584|FG000|Overall Study|Physician Decision|7|||
145611076|NCT01382940|525092584|FG000|Overall Study|Withdrawal by Subject|23|||
145792630|NCT00831441|525746374|FG001|Randomized|Emergency procedure|2|||
145792631|NCT00831441|525746373|FG000|Randomized|Elective procedure|26|||
145792632|NCT00831441|525746374|FG001|Randomized|Elective procedure|25|||
145792633|NCT00831441|525746373|FG000|Randomized|Physician Decision|26|||
145792634|NCT00831441|525746374|FG001|Randomized|Physician Decision|35|||
145792635|NCT00831441|525746373|FG000|Randomized|No longer met criteria|13|||
145792636|NCT00831441|525746374|FG001|Randomized|No longer met criteria|19|||
145792637|NCT00831441|525746373|FG000|Randomized|Withdrawal by Subject|178|||
145792638|NCT00831441|525746374|FG001|Randomized|Withdrawal by Subject|212|||
145792639|NCT00831441|525746373|FG000|Randomized|Lost to Follow-up|26|||
145792640|NCT00831441|525746374|FG001|Randomized|Lost to Follow-up|35|||
145792641|NCT00831441|525746373|FG000|Randomized|Administrative reason by sponsor|2780|||
145792642|NCT00831441|525746374|FG001|Randomized|Administrative reason by sponsor|2671|||
145792643|NCT00831441|525746373|FG000|Randomized|poor/non-compliance|30|||
145792644|NCT00831441|525746374|FG001|Randomized|poor/non-compliance|38|||
145792645|NCT00831441|525746373|FG000|Randomized|non-specified|276|||
145792646|NCT00831441|525746374|FG001|Randomized|non-specified|266|||
145792647|NCT00831441|525746373|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
145792648|NCT00831441|525746374|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
145792649|NCT00831441|525746373|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
145792650|NCT00831441|525746374|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
145611077|NCT01382940|525092584|FG000|Overall Study|Protocol Violation|20|||
145611078|NCT00244374|525092587|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
145611079|NCT00244374|525092588|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
145611080|NCT00244374|525092589|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
145611081|NCT00244374|525092590|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
145611082|NCT00244374|525092591|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
145611083|NCT00244374|525092587|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
145611084|NCT00244374|525092588|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
145611085|NCT00244374|525092589|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
145611086|NCT00244374|525092590|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
145611087|NCT00244374|525092591|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
145611088|NCT00244374|525092587|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
145611089|NCT00244374|525092588|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
145611090|NCT00244374|525092589|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
145611091|NCT00244374|525092590|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
145611092|NCT00244374|525092591|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
145611093|NCT00244374|525092587|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
145611094|NCT00244374|525092588|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
145611095|NCT00244374|525092589|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
145611096|NCT00244374|525092590|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
145611097|NCT00244374|525092591|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
145611098|NCT00244374|525092587|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
145611099|NCT00244374|525092588|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
145611100|NCT00244374|525092589|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
145611101|NCT00244374|525092590|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
145611102|NCT00244374|525092591|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
145611103|NCT00244374|525092587|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
145792651|NCT00831441|525746373|FG000|Follow Up (30 Days)|Death|63|||
145792652|NCT00831441|525746374|FG001|Follow Up (30 Days)|Death|86|||
145792653|NCT00831441|525746373|FG000|Follow Up (30 Days)|non-specified|16|||
145792654|NCT00831441|525746374|FG001|Follow Up (30 Days)|non-specified|26|||
145792655|NCT00831441|525746373|FG000|Follow Up (30 Days)|missing end of study status|0|||
145792656|NCT00831441|525746374|FG001|Follow Up (30 Days)|missing end of study status|1|||
145792657|NCT05674344|525746375|FG000|Overall Study|Screen Fail|21|||
145792658|NCT05674344|525746375|FG000|Overall Study|Incomplete study procedures|3|||
145792659|NCT00111917|525746376|FG000|Overall Study|Withdrawal by Subject|1|||
145792660|NCT00111917|525746377|FG001|Overall Study|Withdrawal by Subject|1|||
145792661|NCT04831515|525746378|FG000|First Intervention|Adverse Event|0|||
145792662|NCT04831515|525746379|FG001|First Intervention|Adverse Event|1|||
145792663|NCT01640925|525746380|FG000|Overall Study|Withdrawal by Subject|1|||
145792664|NCT01640925|525746381|FG001|Overall Study|Withdrawal by Subject|0|||
145792665|NCT01640925|525746380|FG000|Overall Study|Previously enrolled in this trial|13|||
145792666|NCT01640925|525746381|FG001|Overall Study|Previously enrolled in this trial|11|||
145792667|NCT02156492|525746382|FG000|Period 1|No Reason Given|0|||
145792668|NCT02156492|525746383|FG001|Period 1|No Reason Given|1|||
145792669|NCT02156492|525746384|FG002|Period 1|No Reason Given|0|||
145792670|NCT02156492|525746382|FG000|Period 3|Adverse Event|0|||
145792671|NCT02156492|525746383|FG001|Period 3|Adverse Event|1|||
145792672|NCT02156492|525746384|FG002|Period 3|Adverse Event|0|||
145792673|NCT04348656|525746401|FG000|Overall Study|Withdrawal by Subject|2|||
145792674|NCT04348656|525746402|FG001|Overall Study|Withdrawal by Subject|0|||
145792675|NCT04348656|525746401|FG000|Overall Study|Lost to Follow-up|11|||
145792676|NCT04348656|525746402|FG001|Overall Study|Lost to Follow-up|6|||
145792677|NCT03072719|525746403|FG000|Overall Study|Adverse Event|1|||
145792678|NCT03072719|525746404|FG001|Overall Study|Adverse Event|1|||
145792679|NCT02106455|525746408|FG000|Overall Study|Case Report Form Uncollected|6|||
145792680|NCT02106455|525746408|FG000|Overall Study|Protocol Deviation|2|||
145792681|NCT01260467|525746409|FG000|Overall Study|Withdrawal by Subject|2|||
145792682|NCT00436566|525746416|FG000|Overall Study|Withdrawal by Subject|2|||
145792683|NCT00436566|525746416|FG000|Overall Study|Protocol Violation|1|||
145792684|NCT01954251|525746417|FG000|Overall Study|Adverse Event|5|||
145792685|NCT01954251|525746418|FG001|Overall Study|Adverse Event|7|||
145792686|NCT01954251|525746417|FG000|Overall Study|Lost to Follow-up|6|||
145792687|NCT01954251|525746418|FG001|Overall Study|Lost to Follow-up|6|||
145792688|NCT01954251|525746417|FG000|Overall Study|Withdrawal by Subject|2|||
145792689|NCT01954251|525746418|FG001|Overall Study|Withdrawal by Subject|6|||
145792690|NCT02504268|525746421|FG000|Overall Study|Adverse Event|18|||
145792691|NCT02504268|525746422|FG001|Overall Study|Adverse Event|8|||
145792692|NCT02504268|525746423|FG002|Overall Study|Adverse Event|14|||
145792693|NCT02504268|525746424|FG003|Overall Study|Adverse Event|0|||
145792694|NCT02504268|525746425|FG004|Overall Study|Adverse Event|0|||
145792695|NCT02504268|525746426|FG005|Overall Study|Adverse Event|0|||
145546886|NCT02495168|524861686|FG000|Overall Study|Other than Specified|18|||
145792696|NCT02504268|525746427|FG006|Overall Study|Adverse Event|0|||
145792697|NCT02504268|525746428|FG007|Overall Study|Adverse Event|0|||
145792698|NCT02504268|525746429|FG008|Overall Study|Adverse Event|0|||
145792699|NCT02504268|525746421|FG000|Overall Study|Withdrawal of Consent|11|||
145546887|NCT02495168|524861687|FG001|Overall Study|Other than Specified|22|||
145546888|NCT02495168|524861688|FG002|Overall Study|Other than Specified|5|||
145546889|NCT02495168|524861686|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
145546890|NCT02495168|524861687|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
145546891|NCT02495168|524861688|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
145546892|NCT02495168|524861686|FG000|Overall Study|Physician Decision|1|||
145546893|NCT02495168|524861687|FG001|Overall Study|Physician Decision|1|||
145546894|NCT02495168|524861688|FG002|Overall Study|Physician Decision|0|||
145546895|NCT02495168|524861686|FG000|Overall Study|Lost to Follow-up|10|||
145546896|NCT02495168|524861687|FG001|Overall Study|Lost to Follow-up|6|||
145546897|NCT02495168|524861688|FG002|Overall Study|Lost to Follow-up|1|||
145546898|NCT02495168|524861686|FG000|Overall Study|Withdrawal by Subject|1|||
145546899|NCT02495168|524861687|FG001|Overall Study|Withdrawal by Subject|4|||
145546900|NCT02495168|524861688|FG002|Overall Study|Withdrawal by Subject|2|||
145546901|NCT02495168|524861686|FG000|Overall Study|Protocol Violation|0|||
145546902|NCT02495168|524861687|FG001|Overall Study|Protocol Violation|10|||
145546903|NCT02495168|524861688|FG002|Overall Study|Protocol Violation|1|||
145546904|NCT02495168|524861686|FG000|Overall Study|Adverse Event|4|||
145546905|NCT02495168|524861687|FG001|Overall Study|Adverse Event|8|||
145546906|NCT02495168|524861688|FG002|Overall Study|Adverse Event|3|||
145546907|NCT02495168|524861686|FG000|Overall Study|Lack of Efficacy|0|||
145546908|NCT02495168|524861687|FG001|Overall Study|Lack of Efficacy|0|||
145792700|NCT02504268|525746422|FG001|Overall Study|Withdrawal of Consent|10|||
145792701|NCT02504268|525746423|FG002|Overall Study|Withdrawal of Consent|3|||
145792702|NCT02504268|525746424|FG003|Overall Study|Withdrawal of Consent|0|||
145546909|NCT02495168|524861688|FG002|Overall Study|Lack of Efficacy|3|||
145546910|NCT03521934|524861697|FG000|Overall Study|Death|65|||
145546911|NCT03521934|524861698|FG001|Overall Study|Death|73|||
145546912|NCT03521934|524861697|FG000|Overall Study|Withdrawal by Subject|18|||
145546913|NCT03521934|524861698|FG001|Overall Study|Withdrawal by Subject|23|||
145546914|NCT03521934|524861697|FG000|Overall Study|Site Terminated by Sponsor|39|||
145546915|NCT03521934|524861698|FG001|Overall Study|Site Terminated by Sponsor|35|||
145546916|NCT03521934|524861697|FG000|Overall Study|Study Terminated by Sponsor|483|||
145546917|NCT03521934|524861698|FG001|Overall Study|Study Terminated by Sponsor|477|||
145546918|NCT03521934|524861697|FG000|Overall Study|Reason not Specified|3|||
145546919|NCT03521934|524861698|FG001|Overall Study|Reason not Specified|6|||
145546920|NCT00727025|524861699|FG000|Overall Study|Physician Decision|23|||
145546921|NCT02101060|524861700|FG000|Overall Study|Adverse Event|1|||
145546922|NCT02101060|524861701|FG001|Overall Study|Adverse Event|0|||
145546923|NCT02101060|524861700|FG000|Overall Study|Withdrawal by Subject|1|||
145546924|NCT02101060|524861701|FG001|Overall Study|Withdrawal by Subject|1|||
145546925|NCT02101060|524861700|FG000|Overall Study|Lost to Follow-up|3|||
145546926|NCT02101060|524861701|FG001|Overall Study|Lost to Follow-up|3|||
145546927|NCT04166435|524861702|FG000|Overall Study|2 patients ineligible for response|2|||
145546928|NCT00127660|524861706|FG000|Overall Study|Protocol Violation|3|||
145546929|NCT00127660|524861707|FG001|Overall Study|Protocol Violation|3|||
145546930|NCT00127660|524861708|FG002|Overall Study|Protocol Violation|5|||
145546931|NCT00127660|524861709|FG003|Overall Study|Protocol Violation|0|||
145546932|NCT05131646|524861710|FG000|Overall Study|Withdrawal by Subject|1|||
145546933|NCT05131646|524861711|FG001|Overall Study|Withdrawal by Subject|0|||
145546934|NCT05131646|524861712|FG002|Overall Study|Withdrawal by Subject|0|||
145546935|NCT03454997|524861713|FG000|Overall Study|Staff Coach - Left Oranization|1|||
145546936|NCT03454997|524861714|FG001|Overall Study|Staff Coach - Left Oranization|1|||
145546937|NCT03454997|524861713|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
145546938|NCT03454997|524861714|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
145546939|NCT03454997|524861713|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
145546940|NCT03454997|524861714|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
145546941|NCT03454997|524861713|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
145404824|NCT01712178|524338691|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
145546942|NCT03454997|524861714|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
145546943|NCT03454997|524861713|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
145546944|NCT03454997|524861714|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
145546945|NCT03454997|524861713|FG000|Overall Study|Client with SMI - Left organization|0|||
145546946|NCT03454997|524861714|FG001|Overall Study|Client with SMI - Left organization|1|||
145546947|NCT03454997|524861713|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
145546948|NCT03454997|524861714|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
145546949|NCT01191801|524861717|FG000|Overall Study|Death|36|||
145792703|NCT02504268|525746425|FG004|Overall Study|Withdrawal of Consent|0|||
145792704|NCT02504268|525746426|FG005|Overall Study|Withdrawal of Consent|0|||
145546950|NCT01191801|524861718|FG001|Overall Study|Death|12|||
145546951|NCT01191801|524861717|FG000|Overall Study|Lack of Efficacy|176|||
145546952|NCT01191801|524861718|FG001|Overall Study|Lack of Efficacy|258|||
145546953|NCT01191801|524861717|FG000|Overall Study|Adverse Event|9|||
145546954|NCT01191801|524861718|FG001|Overall Study|Adverse Event|8|||
145546955|NCT01191801|524861717|FG000|Overall Study|Protocol Violation|2|||
145546956|NCT01191801|524861718|FG001|Overall Study|Protocol Violation|4|||
145546957|NCT01191801|524861717|FG000|Overall Study|Physician Decision|47|||
145546958|NCT01191801|524861718|FG001|Overall Study|Physician Decision|24|||
145546959|NCT01191801|524861717|FG000|Overall Study|Withdrawal by Subject|1|||
145546960|NCT01191801|524861718|FG001|Overall Study|Withdrawal by Subject|4|||
145611104|NCT00244374|525092588|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
145611105|NCT00244374|525092589|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
145611106|NCT00244374|525092590|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
145611107|NCT00244374|525092591|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
145611108|NCT00244374|525092587|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
145611109|NCT00244374|525092588|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
145611110|NCT00244374|525092589|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
145611111|NCT00244374|525092590|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
145611112|NCT00244374|525092591|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
145611113|NCT00244374|525092587|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
145611114|NCT00244374|525092588|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
145611115|NCT00244374|525092589|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
145611116|NCT00244374|525092590|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
145611117|NCT00244374|525092591|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
145611118|NCT00244374|525092587|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
145611119|NCT00244374|525092588|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
145611120|NCT00244374|525092589|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
145611121|NCT00244374|525092590|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
145611122|NCT00244374|525092591|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
145611123|NCT02105636|525092596|FG000|Pre-Treatment|Disease Progression|1|||
145611124|NCT02105636|525092597|FG001|Pre-Treatment|Disease Progression|0|||
145611125|NCT02105636|525092596|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
145611126|NCT02105636|525092597|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
145611127|NCT02105636|525092596|FG000|Pre-Treatment|Participant withdrew consent|0|||
145611128|NCT02105636|525092597|FG001|Pre-Treatment|Participant withdrew consent|6|||
145611129|NCT02105636|525092596|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
145611130|NCT02105636|525092597|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
145611131|NCT02105636|525092596|FG000|Treatment|Study Drug Toxicity|14|||
145611132|NCT02105636|525092597|FG001|Treatment|Study Drug Toxicity|10|||
145611133|NCT02105636|525092596|FG000|Treatment|Adverse event unrelated to study drug|19|||
145611134|NCT02105636|525092597|FG001|Treatment|Adverse event unrelated to study drug|3|||
145611135|NCT02105636|525092596|FG000|Treatment|Participant request to discontinue study treatment|8|||
145611136|NCT02105636|525092597|FG001|Treatment|Participant request to discontinue study treatment|6|||
145611137|NCT02105636|525092596|FG000|Treatment|Participant withdrew consent|5|||
145611138|NCT02105636|525092597|FG001|Treatment|Participant withdrew consent|1|||
145611139|NCT02105636|525092596|FG000|Treatment|Lost to Follow-up|1|||
145611140|NCT02105636|525092597|FG001|Treatment|Lost to Follow-up|0|||
145611141|NCT02105636|525092596|FG000|Treatment|Maximum Clinical Benefit|1|||
145611142|NCT02105636|525092597|FG001|Treatment|Maximum Clinical Benefit|3|||
145611143|NCT02105636|525092596|FG000|Treatment|Poor/Non-compliance|0|||
145611144|NCT02105636|525092597|FG001|Treatment|Poor/Non-compliance|1|||
145611145|NCT02105636|525092596|FG000|Treatment|Participant no longer meets study criteria|1|||
145611146|NCT02105636|525092597|FG001|Treatment|Participant no longer meets study criteria|0|||
145611147|NCT02105636|525092596|FG000|Treatment|Other reasons|1|||
145611148|NCT02105636|525092597|FG001|Treatment|Other reasons|0|||
145611149|NCT02105636|525092596|FG000|Treatment|Disease Progression|185|||
145611150|NCT02105636|525092597|FG001|Treatment|Disease Progression|87|||
145611151|NCT02802319|525092601|FG000|Overall Study|Physician Decision|2|||
145611152|NCT02802319|525092602|FG001|Overall Study|Physician Decision|1|||
145611153|NCT02802319|525092601|FG000|Overall Study|Lost to Follow-up|0|||
145611154|NCT02802319|525092602|FG001|Overall Study|Lost to Follow-up|4|||
145611155|NCT04651114|525092603|FG000|Overall Study|Withdrawal by Subject|8|||
145611156|NCT01923896|525092608|FG000|Overall Study|Adverse Event|1|||
145611157|NCT01923896|525092609|FG001|Overall Study|Adverse Event|0|||
145611158|NCT03545113|525092612|FG000|Overall Study|Surgery Cancelled|1|||
145611159|NCT03545113|525092613|FG001|Overall Study|Surgery Cancelled|0|||
145611160|NCT03545113|525092612|FG000|Overall Study|Death|1|||
145611161|NCT03545113|525092613|FG001|Overall Study|Death|0|||
145611162|NCT03545113|525092612|FG000|Overall Study|Adverse Event|2|||
145611163|NCT03545113|525092613|FG001|Overall Study|Adverse Event|0|||
145792705|NCT02504268|525746427|FG006|Overall Study|Withdrawal of Consent|0|||
145792706|NCT02504268|525746428|FG007|Overall Study|Withdrawal of Consent|0|||
145792707|NCT02504268|525746429|FG008|Overall Study|Withdrawal of Consent|0|||
145792708|NCT02504268|525746421|FG000|Overall Study|Pregnancy|2|||
145792709|NCT02504268|525746422|FG001|Overall Study|Pregnancy|0|||
145792710|NCT02504268|525746423|FG002|Overall Study|Pregnancy|0|||
145611164|NCT03545113|525092612|FG000|Overall Study|Received different surgery|1|||
145792711|NCT02504268|525746424|FG003|Overall Study|Pregnancy|0|||
145792712|NCT02504268|525746425|FG004|Overall Study|Pregnancy|0|||
145792713|NCT02504268|525746426|FG005|Overall Study|Pregnancy|0|||
145546961|NCT01191801|524861717|FG000|Overall Study|Not Provided|45|||
145546962|NCT01191801|524861718|FG001|Overall Study|Not Provided|27|||
145792714|NCT02504268|525746427|FG006|Overall Study|Pregnancy|0|||
145792715|NCT02504268|525746428|FG007|Overall Study|Pregnancy|0|||
145792716|NCT02504268|525746429|FG008|Overall Study|Pregnancy|0|||
145792717|NCT02504268|525746421|FG000|Overall Study|Lost to Follow-up|3|||
145792718|NCT02504268|525746422|FG001|Overall Study|Lost to Follow-up|6|||
145792719|NCT02504268|525746423|FG002|Overall Study|Lost to Follow-up|4|||
145792720|NCT02504268|525746424|FG003|Overall Study|Lost to Follow-up|0|||
145792721|NCT02504268|525746425|FG004|Overall Study|Lost to Follow-up|0|||
145792722|NCT02504268|525746426|FG005|Overall Study|Lost to Follow-up|0|||
145792723|NCT02504268|525746427|FG006|Overall Study|Lost to Follow-up|0|||
145792724|NCT02504268|525746428|FG007|Overall Study|Lost to Follow-up|0|||
145792725|NCT02504268|525746429|FG008|Overall Study|Lost to Follow-up|0|||
145792726|NCT02504268|525746421|FG000|Overall Study|Death|1|||
145792727|NCT02504268|525746422|FG001|Overall Study|Death|1|||
145792728|NCT02504268|525746423|FG002|Overall Study|Death|0|||
145792729|NCT02504268|525746424|FG003|Overall Study|Death|0|||
145792730|NCT02504268|525746425|FG004|Overall Study|Death|0|||
145792731|NCT02504268|525746426|FG005|Overall Study|Death|0|||
145792732|NCT02504268|525746427|FG006|Overall Study|Death|0|||
145404825|NCT01712178|524338690|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
145404826|NCT01712178|524338691|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
145404827|NCT01712178|524338690|FG000|Overall Study|Lost to Follow-up|0|||
145546963|NCT02794883|524861721|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
145546964|NCT02794883|524861722|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
145546965|NCT02794883|524861723|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
145546966|NCT02794883|524861721|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
145546967|NCT02794883|524861722|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
145546968|NCT02794883|524861723|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
145546969|NCT02794883|524861721|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
145546970|NCT02794883|524861722|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
145546971|NCT02794883|524861723|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
145546972|NCT02794883|524861721|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
145546973|NCT02794883|524861722|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
145546974|NCT02794883|524861723|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
145546975|NCT02794883|524861721|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
145546976|NCT02794883|524861722|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
145546977|NCT02794883|524861723|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
145546978|NCT02794883|524861721|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
145546979|NCT02794883|524861722|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
145546980|NCT02794883|524861723|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
145546981|NCT02794883|524861721|FG000|Follow-up Period (up to 2 Years)|Death|12|||
145546982|NCT02794883|524861722|FG001|Follow-up Period (up to 2 Years)|Death|10|||
145546983|NCT02794883|524861723|FG002|Follow-up Period (up to 2 Years)|Death|10|||
145546984|NCT01727297|524861724|FG000|Overall Study|Death|13|||
145546985|NCT01727297|524861725|FG001|Overall Study|Death|0|||
145546986|NCT01727297|524861724|FG000|Overall Study|Protocol Violation|1|||
145546987|NCT01727297|524861725|FG001|Overall Study|Protocol Violation|10|||
145546988|NCT01727297|524861724|FG000|Overall Study|Adverse Event|3|||
145546989|NCT01727297|524861725|FG001|Overall Study|Adverse Event|1|||
145546990|NCT01727297|524861724|FG000|Overall Study|Lost to Follow-up|11|||
145546991|NCT01727297|524861725|FG001|Overall Study|Lost to Follow-up|0|||
145546992|NCT01727297|524861724|FG000|Overall Study|Withdrawal by Subject|26|||
145546993|NCT01727297|524861725|FG001|Overall Study|Withdrawal by Subject|27|||
145546994|NCT01727297|524861724|FG000|Overall Study|Physician Decision|19|||
145546995|NCT01727297|524861725|FG001|Overall Study|Physician Decision|5|||
145546996|NCT01727297|524861724|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
145546997|NCT01727297|524861725|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
145546998|NCT03018704|524861738|FG000|Overall Study|Lost to Follow-up|1|||
145792733|NCT02504268|525746428|FG007|Overall Study|Death|0|||
145404828|NCT01712178|524338691|FG001|Overall Study|Lost to Follow-up|1|||
145404829|NCT00091819|524338692|FG000|Overall Study|Adverse Event|1|||
145546999|NCT03018704|524861739|FG001|Overall Study|Lost to Follow-up|1|||
145547000|NCT04448171|524861740|FG000|Overall Study|Procedure Cancelled|1|||
145547001|NCT04448171|524861741|FG001|Overall Study|Procedure Cancelled|0|||
145404830|NCT00091819|524338693|FG001|Overall Study|Adverse Event|1|||
145547002|NCT04448171|524861740|FG000|Overall Study|Protocol Violation|1|||
145547003|NCT04448171|524861741|FG001|Overall Study|Protocol Violation|0|||
145547004|NCT04605484|524861742|FG000|Overall Study|Lost to Follow-up|0|||
145547005|NCT04605484|524861743|FG001|Overall Study|Lost to Follow-up|1|||
145547006|NCT04605484|524861744|FG002|Overall Study|Lost to Follow-up|1|||
145792734|NCT02504268|525746429|FG008|Overall Study|Death|0|||
145792735|NCT02504268|525746421|FG000|Overall Study|Subject Request to Discontinue|11|||
145792736|NCT02504268|525746422|FG001|Overall Study|Subject Request to Discontinue|3|||
145792737|NCT02504268|525746423|FG002|Overall Study|Subject Request to Discontinue|6|||
145792738|NCT02504268|525746424|FG003|Overall Study|Subject Request to Discontinue|0|||
145792739|NCT02504268|525746425|FG004|Overall Study|Subject Request to Discontinue|0|||
145792740|NCT02504268|525746426|FG005|Overall Study|Subject Request to Discontinue|0|||
145792741|NCT02504268|525746427|FG006|Overall Study|Subject Request to Discontinue|0|||
145792742|NCT02504268|525746428|FG007|Overall Study|Subject Request to Discontinue|0|||
145792743|NCT02504268|525746429|FG008|Overall Study|Subject Request to Discontinue|0|||
145792744|NCT02504268|525746421|FG000|Overall Study|No Longer Meets Study Criteria|2|||
145792745|NCT02504268|525746422|FG001|Overall Study|No Longer Meets Study Criteria|3|||
145792746|NCT02504268|525746423|FG002|Overall Study|No Longer Meets Study Criteria|0|||
145792747|NCT02504268|525746424|FG003|Overall Study|No Longer Meets Study Criteria|0|||
145792748|NCT02504268|525746425|FG004|Overall Study|No Longer Meets Study Criteria|0|||
145792749|NCT02504268|525746426|FG005|Overall Study|No Longer Meets Study Criteria|0|||
145792750|NCT02504268|525746427|FG006|Overall Study|No Longer Meets Study Criteria|0|||
145792751|NCT02504268|525746428|FG007|Overall Study|No Longer Meets Study Criteria|0|||
145792752|NCT02504268|525746429|FG008|Overall Study|No Longer Meets Study Criteria|0|||
145792753|NCT02504268|525746421|FG000|Overall Study|Lack of Efficacy|11|||
145792754|NCT02504268|525746422|FG001|Overall Study|Lack of Efficacy|35|||
145792755|NCT02504268|525746423|FG002|Overall Study|Lack of Efficacy|9|||
145547007|NCT04605484|524861742|FG000|Overall Study|Other|0|||
145547008|NCT04605484|524861743|FG001|Overall Study|Other|1|||
145547009|NCT04605484|524861744|FG002|Overall Study|Other|0|||
145547010|NCT01217801|524861748|FG000|Period 1|Protocol Violation|1|||
145547011|NCT01217801|524861749|FG001|Period 1|Protocol Violation|1|||
145547012|NCT01217801|524861748|FG000|Period 1|Withdrawal by Subject|0|||
145547013|NCT01217801|524861749|FG001|Period 1|Withdrawal by Subject|1|||
145547014|NCT03727347|524861750|FG000|Overall Study|Withdrawal by Subject|2|||
145547015|NCT03727347|524861750|FG000|Overall Study|Lost to Follow-up|1|||
145547016|NCT00006237|524861751|FG000|Overall Study|Adverse Event|39|||
145547017|NCT00006237|524861752|FG001|Overall Study|Adverse Event|29|||
145547018|NCT00006237|524861751|FG000|Overall Study|Death|1|||
145547019|NCT00006237|524861752|FG001|Overall Study|Death|0|||
145547020|NCT00006237|524861751|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
145547021|NCT00006237|524861752|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
145547022|NCT00006237|524861751|FG000|Overall Study|Progression/relapse|54|||
145547023|NCT00006237|524861752|FG001|Overall Study|Progression/relapse|2|||
145547024|NCT00006237|524861751|FG000|Overall Study|Not eligible|9|||
145547025|NCT00006237|524861752|FG001|Overall Study|Not eligible|20|||
145547026|NCT00006237|524861751|FG000|Overall Study|Withdrawal by Subject|0|||
145547027|NCT00006237|524861752|FG001|Overall Study|Withdrawal by Subject|1|||
145547028|NCT00006237|524861751|FG000|Overall Study|Not protocol specified|14|||
145547029|NCT00006237|524861752|FG001|Overall Study|Not protocol specified|5|||
145547030|NCT01846416|524861755|FG000|Treatment Phase|Death|2|||
145547031|NCT01846416|524861756|FG001|Treatment Phase|Death|9|||
145547032|NCT01846416|524861757|FG002|Treatment Phase|Death|1|||
145547033|NCT01846416|524861755|FG000|Treatment Phase|Withdrawal by Subject|2|||
145547034|NCT01846416|524861756|FG001|Treatment Phase|Withdrawal by Subject|4|||
145547035|NCT01846416|524861757|FG002|Treatment Phase|Withdrawal by Subject|2|||
145547036|NCT01846416|524861755|FG000|Treatment Phase|Other|1|||
145547037|NCT01846416|524861756|FG001|Treatment Phase|Other|5|||
145547038|NCT01846416|524861757|FG002|Treatment Phase|Other|1|||
145547039|NCT01846416|524861755|FG000|Treatment Phase|Physician Decision|1|||
145547040|NCT01846416|524861756|FG001|Treatment Phase|Physician Decision|2|||
145547041|NCT01846416|524861757|FG002|Treatment Phase|Physician Decision|0|||
145547042|NCT01846416|524861755|FG000|Treatment Phase|Adverse Event|3|||
145547043|NCT01846416|524861756|FG001|Treatment Phase|Adverse Event|4|||
145547044|NCT01846416|524861757|FG002|Treatment Phase|Adverse Event|0|||
145547045|NCT01846416|524861755|FG000|Treatment Phase|Non-compliance|0|||
145547046|NCT01846416|524861756|FG001|Treatment Phase|Non-compliance|2|||
145547047|NCT01846416|524861757|FG002|Treatment Phase|Non-compliance|0|||
145547048|NCT01846416|524861755|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
145547049|NCT01846416|524861756|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
145547050|NCT01846416|524861757|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
145792756|NCT02504268|525746424|FG003|Overall Study|Lack of Efficacy|0|||
145792757|NCT02504268|525746425|FG004|Overall Study|Lack of Efficacy|0|||
145792758|NCT02504268|525746426|FG005|Overall Study|Lack of Efficacy|0|||
145792759|NCT02504268|525746427|FG006|Overall Study|Lack of Efficacy|0|||
145547051|NCT01846416|524861755|FG000|Treatment Phase|Progressive Disease|21|||
145547052|NCT01846416|524861756|FG001|Treatment Phase|Progressive Disease|63|||
145547053|NCT01846416|524861757|FG002|Treatment Phase|Progressive Disease|9|||
145547054|NCT01846416|524861755|FG000|Survival Follow-up|Death|21|||
145547055|NCT01846416|524861756|FG001|Survival Follow-up|Death|62|||
145547056|NCT01846416|524861757|FG002|Survival Follow-up|Death|9|||
145792760|NCT02504268|525746428|FG007|Overall Study|Lack of Efficacy|0|||
145792761|NCT02504268|525746429|FG008|Overall Study|Lack of Efficacy|0|||
145792762|NCT02504268|525746421|FG000|Overall Study|Poor/Non-Compliance|3|||
145792763|NCT02504268|525746422|FG001|Overall Study|Poor/Non-Compliance|2|||
145792764|NCT02504268|525746423|FG002|Overall Study|Poor/Non-Compliance|3|||
145792765|NCT02504268|525746424|FG003|Overall Study|Poor/Non-Compliance|0|||
145792766|NCT02504268|525746425|FG004|Overall Study|Poor/Non-Compliance|0|||
145792767|NCT02504268|525746426|FG005|Overall Study|Poor/Non-Compliance|0|||
145792768|NCT02504268|525746427|FG006|Overall Study|Poor/Non-Compliance|0|||
145792769|NCT02504268|525746428|FG007|Overall Study|Poor/Non-Compliance|0|||
145792770|NCT02504268|525746429|FG008|Overall Study|Poor/Non-Compliance|0|||
145792771|NCT02504268|525746421|FG000|Overall Study|Not Disclosed|1|||
145792772|NCT02504268|525746422|FG001|Overall Study|Not Disclosed|0|||
145792773|NCT02504268|525746423|FG002|Overall Study|Not Disclosed|2|||
145792774|NCT02504268|525746424|FG003|Overall Study|Not Disclosed|0|||
145792775|NCT02504268|525746425|FG004|Overall Study|Not Disclosed|0|||
145792776|NCT02504268|525746426|FG005|Overall Study|Not Disclosed|0|||
145792777|NCT02504268|525746427|FG006|Overall Study|Not Disclosed|0|||
145792778|NCT02504268|525746428|FG007|Overall Study|Not Disclosed|0|||
145792779|NCT02504268|525746429|FG008|Overall Study|Not Disclosed|0|||
145792780|NCT03025217|525746430|FG000|Overall Study|Pregnancy|1|||
145792781|NCT03025217|525746430|FG000|Overall Study|Lost to Follow-up|1|||
145792782|NCT03025217|525746430|FG000|Overall Study|Not eligible, poor English|2|||
145792783|NCT02124707|525746437|FG000|Overall Study|Adverse Event|5|||
145792784|NCT02124707|525746437|FG000|Overall Study|Physician Decision|1|||
145792785|NCT02124707|525746437|FG000|Overall Study|Death|1|||
145792786|NCT00781599|525746438|FG000|Overall Study|Lost to Follow-up|7|||
145792787|NCT00781599|525746439|FG001|Overall Study|Lost to Follow-up|4|||
145792788|NCT01088438|525746440|FG000|Overall Study|Withdrawal by Subject|11|||
145792789|NCT01088438|525746441|FG001|Overall Study|Withdrawal by Subject|6|||
145792790|NCT01088438|525746440|FG000|Overall Study|Lost to Follow-up|18|||
145792791|NCT01088438|525746441|FG001|Overall Study|Lost to Follow-up|30|||
145792792|NCT01363713|525746442|FG000|Overall Study|Adverse Event|1|||
145792793|NCT01363713|525746442|FG000|Overall Study|Protocol Violation|3|||
145792794|NCT01363713|525746442|FG000|Overall Study|Withdrawal by Subject|2|||
145792795|NCT01199055|525746445|FG000|Overall Study|Death|0|||
145792796|NCT01199055|525746446|FG001|Overall Study|Death|1|||
145792797|NCT01199055|525746447|FG002|Overall Study|Death|0|||
145792798|NCT01199055|525746445|FG000|Overall Study|Physician Decision|0|||
145792799|NCT01199055|525746446|FG001|Overall Study|Physician Decision|1|||
145792800|NCT01199055|525746447|FG002|Overall Study|Physician Decision|1|||
145792801|NCT01199055|525746445|FG000|Overall Study|Progressive disease|2|||
145792802|NCT01199055|525746446|FG001|Overall Study|Progressive disease|1|||
145792803|NCT01199055|525746447|FG002|Overall Study|Progressive disease|2|||
145792804|NCT01199055|525746445|FG000|Overall Study|Withdrawal by Subject|0|||
145792805|NCT01199055|525746446|FG001|Overall Study|Withdrawal by Subject|0|||
145792806|NCT01199055|525746447|FG002|Overall Study|Withdrawal by Subject|1|||
145792807|NCT00511342|525746448|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
145792808|NCT00511342|525746449|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
145792809|NCT00511342|525746448|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
145792810|NCT00511342|525746449|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
145792811|NCT00511342|525746448|FG000|Overall Study|Pregnancy|0|||
145792812|NCT00511342|525746449|FG001|Overall Study|Pregnancy|1|||
145792813|NCT00511342|525746448|FG000|Overall Study|Pregnancy wish|0|||
145792814|NCT00511342|525746449|FG001|Overall Study|Pregnancy wish|1|||
145792815|NCT00511342|525746448|FG000|Overall Study|Lost to Follow-up|1|||
145792816|NCT00511342|525746449|FG001|Overall Study|Lost to Follow-up|5|||
145792817|NCT00511342|525746448|FG000|Overall Study|Other Reason|2|||
145792818|NCT00511342|525746449|FG001|Overall Study|Other Reason|2|||
145792819|NCT02432040|525746450|FG000|Overall Study|Lack of Efficacy|3|||
145792820|NCT02432040|525746451|FG001|Overall Study|Lack of Efficacy|0|||
145547057|NCT01846416|524861755|FG000|Survival Follow-up|Lost to Follow-up|0|||
145547058|NCT01846416|524861756|FG001|Survival Follow-up|Lost to Follow-up|2|||
145547059|NCT01846416|524861757|FG002|Survival Follow-up|Lost to Follow-up|2|||
145547060|NCT01846416|524861755|FG000|Survival Follow-up|Withdrawal by Subject|2|||
145547061|NCT01846416|524861756|FG001|Survival Follow-up|Withdrawal by Subject|7|||
145792821|NCT02432040|525746450|FG000|Overall Study|Lost to Follow-up|4|||
145792822|NCT02432040|525746451|FG001|Overall Study|Lost to Follow-up|5|||
145792823|NCT02432040|525746450|FG000|Overall Study|Physician Decision|1|||
145792824|NCT02432040|525746451|FG001|Overall Study|Physician Decision|1|||
145792825|NCT03198754|525746453|FG000|Overall Study|Withdrawal by Subject|5|||
145792826|NCT03198754|525746454|FG001|Overall Study|Withdrawal by Subject|4|||
145792827|NCT03198754|525746453|FG000|Overall Study|Lost to Follow-up|4|||
145792828|NCT03198754|525746454|FG001|Overall Study|Lost to Follow-up|3|||
145547062|NCT01846416|524861757|FG002|Survival Follow-up|Withdrawal by Subject|0|||
145792829|NCT03198754|525746453|FG000|Overall Study|Ineligible|2|||
145792830|NCT03198754|525746454|FG001|Overall Study|Ineligible|1|||
145547063|NCT01846416|524861755|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
145792831|NCT00421343|525746463|FG000|Overall Study|Death|1|||
145792832|NCT00421343|525746463|FG000|Overall Study|Withdrawal by Subject|2|||
145792833|NCT00421343|525746463|FG000|Overall Study|Lost to Follow-up|3|||
145792834|NCT03471767|525746471|FG000|Overall Study|Withdrawal by Subject|3|||
145792835|NCT03471767|525746472|FG001|Overall Study|Withdrawal by Subject|1|||
145792836|NCT03471767|525746471|FG000|Overall Study|Adverse Event|1|||
145792837|NCT03471767|525746472|FG001|Overall Study|Adverse Event|0|||
145792838|NCT03471767|525746471|FG000|Overall Study|Lost to Follow-up|1|||
145792839|NCT03471767|525746472|FG001|Overall Study|Lost to Follow-up|0|||
145792840|NCT03471767|525746471|FG000|Overall Study|PI Withdrawal|1|||
145792841|NCT03471767|525746472|FG001|Overall Study|PI Withdrawal|3|||
145792842|NCT05373706|525746474|FG000|Overall Study|Lost to Follow-up|2|||
145792843|NCT05373706|525746475|FG001|Overall Study|Lost to Follow-up|2|||
145792844|NCT00605722|525748016|FG000|Overall Study|Adverse Event|6|||
145792845|NCT00605722|525748016|FG000|Overall Study|Insufficient therapeutic response|44|||
145792846|NCT00605722|525748016|FG000|Overall Study|Failure to return|1|||
145792847|NCT00333619|525748024|FG000|Overall Study|Death|12|||
145792848|NCT00333619|525748025|FG001|Overall Study|Death|6|||
145792849|NCT00333619|525748024|FG000|Overall Study|Withdrawal by Subject|6|||
145792850|NCT00333619|525748025|FG001|Overall Study|Withdrawal by Subject|1|||
145792851|NCT00333619|525748024|FG000|Overall Study|Lost to Follow-up|3|||
145792852|NCT00333619|525748025|FG001|Overall Study|Lost to Follow-up|3|||
145792853|NCT01120379|525748032|FG000|One Year Timepoint|Withdrawal by Subject|41|||
145792854|NCT01120379|525748032|FG000|One Year Timepoint|Lost to Follow-up|115|||
145792855|NCT01120379|525748032|FG000|One Year Timepoint|Death|108|||
145792856|NCT01120379|525748032|FG000|One Year Timepoint|Physician Decision|9|||
145792857|NCT01120379|525748032|FG000|One Year Timepoint|Any other reason for early termination|5|||
145792858|NCT01120379|525748032|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
145792859|NCT01120379|525748032|FG000|Two Year Timepoint|Lost to Follow-up|87|||
145792860|NCT01120379|525748032|FG000|Two Year Timepoint|Death|123|||
145792861|NCT01120379|525748032|FG000|Two Year Timepoint|Physician Decision|12|||
145792862|NCT01120379|525748032|FG000|Two Year Timepoint|Any other reason for early termination|4|||
145792863|NCT01120379|525748032|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
145792864|NCT01120379|525748032|FG000|Three Year Timepoint|Lost to Follow-up|43|||
145792865|NCT01120379|525748032|FG000|Three Year Timepoint|Death|120|||
145792866|NCT01120379|525748032|FG000|Three Year Timepoint|Physician Decision|9|||
145792867|NCT01120379|525748032|FG000|Three Year Timepoint|Any other reason for early termination|17|||
145792868|NCT01120379|525748032|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
145792869|NCT01120379|525748032|FG000|Four Year Timepoint|Lost to Follow-up|10|||
145792870|NCT01120379|525748032|FG000|Four Year Timepoint|Death|131|||
145792871|NCT01120379|525748032|FG000|Four Year Timepoint|Physician Decision|5|||
145792872|NCT01120379|525748032|FG000|Four Year Timepoint|Any other reason for early termination|217|||
145792873|NCT00568958|525748033|FG000|Allocation|Withdrawal by Subject|7|||
145792874|NCT00568958|525748034|FG001|Allocation|Withdrawal by Subject|3|||
145792875|NCT00568958|525748033|FG000|Allocation|Physician Decision|2|||
145792876|NCT00568958|525748034|FG001|Allocation|Physician Decision|0|||
145792877|NCT00568958|525748033|FG000|Follow-Up|Withdrawal by Subject|6|||
145792878|NCT00568958|525748034|FG001|Follow-Up|Withdrawal by Subject|6|||
145792879|NCT00568958|525748033|FG000|Follow-Up|Physician Decision|1|||
145792880|NCT00568958|525748034|FG001|Follow-Up|Physician Decision|1|||
145792881|NCT00568958|525748033|FG000|Follow-Up|Family Emergency|1|||
145792882|NCT00568958|525748034|FG001|Follow-Up|Family Emergency|0|||
145792883|NCT00568958|525748033|FG000|Follow-Up|Adverse Event|1|||
145792884|NCT00568958|525748034|FG001|Follow-Up|Adverse Event|0|||
145792885|NCT00485589|525748036|FG000|Overall Study|Death|2|||
145792886|NCT00485589|525748037|FG001|Overall Study|Death|2|||
145792887|NCT00485589|525748038|FG002|Overall Study|Death|0|||
145792888|NCT00485589|525748036|FG000|Overall Study|Failure to return|6|||
145792889|NCT00485589|525748037|FG001|Overall Study|Failure to return|5|||
145792890|NCT00485589|525748038|FG002|Overall Study|Failure to return|1|||
145792891|NCT00485589|525748036|FG000|Overall Study|Protocol Violation|1|||
145792892|NCT00485589|525748037|FG001|Overall Study|Protocol Violation|0|||
145792893|NCT00485589|525748038|FG002|Overall Study|Protocol Violation|0|||
145792894|NCT00485589|525748036|FG000|Overall Study|Violation of selection criteria at entry|0|||
145792895|NCT00485589|525748037|FG001|Overall Study|Violation of selection criteria at entry|3|||
145792896|NCT00485589|525748038|FG002|Overall Study|Violation of selection criteria at entry|1|||
145792897|NCT00485589|525748036|FG000|Overall Study|Administrative/Other|1|||
145792898|NCT00485589|525748037|FG001|Overall Study|Administrative/Other|2|||
145792899|NCT00485589|525748038|FG002|Overall Study|Administrative/Other|1|||
145792900|NCT00485589|525748036|FG000|Overall Study|Insufficient therapeutic response|10|||
145792901|NCT00485589|525748037|FG001|Overall Study|Insufficient therapeutic response|3|||
145792902|NCT00485589|525748038|FG002|Overall Study|Insufficient therapeutic response|1|||
145792903|NCT00485589|525748036|FG000|Overall Study|Refused treatment/did not cooperate|1|||
145792904|NCT00485589|525748037|FG001|Overall Study|Refused treatment/did not cooperate|0|||
145282728|NCT03210259|523884336|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
145547064|NCT01846416|524861756|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
145792905|NCT00485589|525748038|FG002|Overall Study|Refused treatment/did not cooperate|2|||
145792906|NCT00485589|525748036|FG000|Overall Study|Withdrawal by Subject|3|||
145792907|NCT00485589|525748037|FG001|Overall Study|Withdrawal by Subject|2|||
145792908|NCT00485589|525748038|FG002|Overall Study|Withdrawal by Subject|2|||
145792909|NCT00485589|525748036|FG000|Overall Study|Adverse Event|3|||
145792910|NCT00485589|525748037|FG001|Overall Study|Adverse Event|3|||
145792911|NCT00485589|525748038|FG002|Overall Study|Adverse Event|10|||
145792912|NCT01944969|525748039|FG000|Overall Study|Adverse Event|1|||
145792913|NCT01944969|525748039|FG000|Overall Study|Lack of Efficacy|1|||
145792914|NCT01944969|525748039|FG000|Overall Study|Non-compliance with IMP|1|||
145547065|NCT01846416|524861757|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
145547066|NCT01846416|524861755|FG000|Survival Follow-up|Other|3|||
145547067|NCT01846416|524861756|FG001|Survival Follow-up|Other|1|||
145547068|NCT01846416|524861757|FG002|Survival Follow-up|Other|1|||
145547069|NCT00211510|524861760|FG000|Overall Study|Physician Decision|3|||
145547070|NCT00211510|524861761|FG001|Overall Study|Physician Decision|1|||
145547071|NCT00211510|524861760|FG000|Overall Study|Withdrawal by Subject|3|||
145792915|NCT01944969|525748039|FG000|Overall Study|Administrative or other reasons|23|||
145792916|NCT01104584|525748040|FG000|Overall Study|Study drug never administered|21|||
145792917|NCT01104584|525748040|FG000|Overall Study|Study prematurely discontinued|2|||
145792918|NCT04017442|525748041|FG000|Overall Study|Withdrawal by Subject|0|||
145792919|NCT04017442|525748042|FG001|Overall Study|Withdrawal by Subject|3|||
145792920|NCT04017442|525748041|FG000|Overall Study|Lost to Follow-up|21|||
145792921|NCT04017442|525748042|FG001|Overall Study|Lost to Follow-up|19|||
145792922|NCT02586233|525748043|FG000|Overall Study|Randomized but did not receive treatment|0|||
145792923|NCT02586233|525748044|FG001|Overall Study|Randomized but did not receive treatment|1|||
145792924|NCT02586233|525748045|FG002|Overall Study|Randomized but did not receive treatment|0|||
145792925|NCT02586233|525748046|FG003|Overall Study|Randomized but did not receive treatment|0|||
145792926|NCT02586233|525748047|FG004|Overall Study|Randomized but did not receive treatment|0|||
145792927|NCT02586233|525748048|FG005|Overall Study|Randomized but did not receive treatment|2|||
145792928|NCT02586233|525748049|FG006|Overall Study|Randomized but did not receive treatment|2|||
145792929|NCT02586233|525748043|FG000|Overall Study|Death|0|||
145792930|NCT02586233|525748044|FG001|Overall Study|Death|1|||
145792931|NCT02586233|525748045|FG002|Overall Study|Death|0|||
145792932|NCT02586233|525748046|FG003|Overall Study|Death|0|||
145792933|NCT02586233|525748047|FG004|Overall Study|Death|2|||
145792934|NCT02586233|525748048|FG005|Overall Study|Death|0|||
145792935|NCT02586233|525748049|FG006|Overall Study|Death|0|||
145792936|NCT00848250|525748050|FG000|Overall Study|surgery was completed without cardiopulm|0|||
145792937|NCT00848250|525748051|FG001|Overall Study|surgery was completed without cardiopulm|1|||
145792938|NCT03421964|525748057|FG000|Overall Study|Lost to Follow-up|11|||
145792939|NCT03421964|525748058|FG001|Overall Study|Lost to Follow-up|21|||
145792940|NCT03421964|525748057|FG000|Overall Study|Withdrawal by Subject|9|||
145792941|NCT03421964|525748058|FG001|Overall Study|Withdrawal by Subject|3|||
145792942|NCT03421964|525748057|FG000|Overall Study|Incarcerated|1|||
145792943|NCT03421964|525748058|FG001|Overall Study|Incarcerated|0|||
145792944|NCT03421964|525748057|FG000|Overall Study|Inpt Treatment Facility|1|||
145792945|NCT03421964|525748058|FG001|Overall Study|Inpt Treatment Facility|1|||
145792946|NCT03421964|525748057|FG000|Overall Study|Virtual Platform Issues|1|||
145792947|NCT03421964|525748058|FG001|Overall Study|Virtual Platform Issues|1|||
145792948|NCT02938585|525748059|FG000|Overall Study|Withdrawal by parent or guardian|0|||
145792949|NCT02938585|525748060|FG001|Overall Study|Withdrawal by parent or guardian|1|||
145792950|NCT02938585|525748061|FG002|Overall Study|Withdrawal by parent or guardian|0|||
145792951|NCT02938585|525748062|FG003|Overall Study|Withdrawal by parent or guardian|0|||
145792952|NCT02938585|525748059|FG000|Overall Study|Withdrawal by Subject|0|||
145792953|NCT02938585|525748060|FG001|Overall Study|Withdrawal by Subject|0|||
145792954|NCT02938585|525748061|FG002|Overall Study|Withdrawal by Subject|0|||
145792955|NCT02938585|525748062|FG003|Overall Study|Withdrawal by Subject|5|||
145547072|NCT00211510|524861761|FG001|Overall Study|Withdrawal by Subject|1|||
145547073|NCT01962896|524861762|FG000|Overall Study|Lack of Efficacy|4|||
145611165|NCT03545113|525092613|FG001|Overall Study|Received different surgery|0|||
145792956|NCT00213980|525748067|FG000|Overall Study|Withdrawal by Subject|3|||
145792957|NCT00213980|525748068|FG001|Overall Study|Withdrawal by Subject|1|||
145792958|NCT00213980|525748067|FG000|Overall Study|Adverse Event|1|||
145792959|NCT00213980|525748068|FG001|Overall Study|Adverse Event|1|||
145792960|NCT00213980|525748067|FG000|Overall Study|Disease progression|0|||
145547074|NCT02837783|524861763|FG000|Overall Study|Adverse Event|1|||
145547075|NCT02837783|524861764|FG001|Overall Study|Adverse Event|0|||
145547076|NCT02837783|524861763|FG000|Overall Study|Other, Not Specified|1|||
145792961|NCT00213980|525748068|FG001|Overall Study|Disease progression|2|||
145792962|NCT00213980|525748067|FG000|Overall Study|Developed ovarian cancer|1|||
145792963|NCT00213980|525748068|FG001|Overall Study|Developed ovarian cancer|0|||
145792964|NCT00213980|525748067|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
145792965|NCT00213980|525748068|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
145792966|NCT03607838|525748069|FG000|Overall Study|Lack of Efficacy|14|||
145792967|NCT03607838|525748070|FG001|Overall Study|Lack of Efficacy|20|||
145792968|NCT03607838|525748069|FG000|Overall Study|Withdrawal by Subject|13|||
145792969|NCT03607838|525748070|FG001|Overall Study|Withdrawal by Subject|8|||
145792970|NCT03607838|525748069|FG000|Overall Study|Lost to Follow-up|6|||
145792971|NCT03607838|525748070|FG001|Overall Study|Lost to Follow-up|11|||
145792972|NCT03607838|525748069|FG000|Overall Study|Adverse Event|2|||
145792973|NCT03607838|525748070|FG001|Overall Study|Adverse Event|2|||
145792974|NCT03607838|525748069|FG000|Overall Study|Physician Decision|2|||
145792975|NCT03607838|525748070|FG001|Overall Study|Physician Decision|0|||
145792976|NCT03607838|525748069|FG000|Overall Study|Failure to meet randomization criteria|1|||
145792977|NCT03607838|525748070|FG001|Overall Study|Failure to meet randomization criteria|2|||
145792978|NCT03607838|525748069|FG000|Overall Study|Pregnancy|1|||
145792979|NCT03607838|525748070|FG001|Overall Study|Pregnancy|0|||
145792980|NCT03607838|525748069|FG000|Overall Study|Protocol Violation|1|||
145792981|NCT03607838|525748070|FG001|Overall Study|Protocol Violation|0|||
145792982|NCT03607838|525748069|FG000|Overall Study|Due to work|1|||
145792983|NCT03607838|525748070|FG001|Overall Study|Due to work|0|||
145792984|NCT03607838|525748069|FG000|Overall Study|Litigation|0|||
145792985|NCT03607838|525748070|FG001|Overall Study|Litigation|1|||
145792986|NCT03607838|525748069|FG000|Overall Study|Temperature excursion for study drug|0|||
145792987|NCT03607838|525748070|FG001|Overall Study|Temperature excursion for study drug|1|||
145792988|NCT03607838|525748069|FG000|Overall Study|Change of mind|0|||
145792989|NCT03607838|525748070|FG001|Overall Study|Change of mind|1|||
145792990|NCT03888391|525748073|FG000|Overall Study|Lost to Follow-up|15|||
145792991|NCT00423735|525748074|FG000|Overall Study|Ineligible / No protocol treatment|8|||
145792992|NCT00423735|525748075|FG001|Overall Study|Ineligible / No protocol treatment|6|||
145792993|NCT00423735|525748076|FG002|Overall Study|Ineligible / No protocol treatment|0|||
145792994|NCT00502320|525748077|FG000|Overall Study|Lost to Follow-up|1|||
145792995|NCT00502320|525748078|FG001|Overall Study|Lost to Follow-up|1|||
145792996|NCT00502320|525748077|FG000|Overall Study|Withdrew Consent|1|||
145792997|NCT00502320|525748078|FG001|Overall Study|Withdrew Consent|0|||
145792998|NCT00502320|525748077|FG000|Overall Study|No longer met criteria|1|||
145792999|NCT00502320|525748078|FG001|Overall Study|No longer met criteria|0|||
145793000|NCT00502320|525748077|FG000|Overall Study|Screen Failure|0|||
145793001|NCT00502320|525748078|FG001|Overall Study|Screen Failure|1|||
145793002|NCT00502320|525748077|FG000|Overall Study|Adverse Event|3|||
145793003|NCT00502320|525748078|FG001|Overall Study|Adverse Event|5|||
145793004|NCT03654755|525748084|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
145793005|NCT03654755|525748085|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
145793006|NCT03654755|525748086|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
145793007|NCT03654755|525748084|FG000|Overall Study|Withdrawal by Subject|2|||
145793008|NCT03654755|525748085|FG001|Overall Study|Withdrawal by Subject|4|||
145793009|NCT03654755|525748086|FG002|Overall Study|Withdrawal by Subject|8|||
145793010|NCT03654755|525748084|FG000|Overall Study|Lost to Follow-up|1|||
145793011|NCT03654755|525748085|FG001|Overall Study|Lost to Follow-up|3|||
145793012|NCT03654755|525748086|FG002|Overall Study|Lost to Follow-up|7|||
145793013|NCT03654755|525748084|FG000|Overall Study|Physician Decision|0|||
145793014|NCT03654755|525748085|FG001|Overall Study|Physician Decision|1|||
145793015|NCT03654755|525748086|FG002|Overall Study|Physician Decision|0|||
145793016|NCT03654755|525748084|FG000|Overall Study|Adverse Event|0|||
145793017|NCT03654755|525748085|FG001|Overall Study|Adverse Event|0|||
145793018|NCT03654755|525748086|FG002|Overall Study|Adverse Event|4|||
145793019|NCT03654755|525748084|FG000|Overall Study|Lack of Efficacy|0|||
145793020|NCT03654755|525748085|FG001|Overall Study|Lack of Efficacy|0|||
145793021|NCT03654755|525748086|FG002|Overall Study|Lack of Efficacy|1|||
145793022|NCT00678587|525748096|FG000|Overall Study|Adverse Event|3|||
145793023|NCT00678587|525748097|FG001|Overall Study|Adverse Event|3|||
145793024|NCT00678587|525748096|FG000|Overall Study|Lack of Efficacy|1|||
145793025|NCT00678587|525748097|FG001|Overall Study|Lack of Efficacy|0|||
145793026|NCT00678587|525748096|FG000|Overall Study|Protocol Violation|2|||
145793027|NCT00678587|525748097|FG001|Overall Study|Protocol Violation|1|||
145793028|NCT00678587|525748096|FG000|Overall Study|Study Closed/Terminated|1|||
145793029|NCT00678587|525748097|FG001|Overall Study|Study Closed/Terminated|0|||
145282729|NCT03210259|523884337|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
145282730|NCT03210259|523884335|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
145793030|NCT00678587|525748096|FG000|Overall Study|Lost to Follow-up|3|||
145793031|NCT00678587|525748097|FG001|Overall Study|Lost to Follow-up|5|||
145793032|NCT00678587|525748096|FG000|Overall Study|Investigator Discretion|2|||
145793033|NCT00678587|525748097|FG001|Overall Study|Investigator Discretion|6|||
145793034|NCT00678587|525748096|FG000|Overall Study|Withdrew Consent|8|||
145793035|NCT00678587|525748097|FG001|Overall Study|Withdrew Consent|3|||
145793036|NCT00077610|525748098|FG000|Overall Study|Adverse Event|9|||
145793037|NCT00077610|525748099|FG001|Overall Study|Adverse Event|7|||
145793038|NCT00077610|525748100|FG002|Overall Study|Adverse Event|1|||
145793039|NCT00077610|525748098|FG000|Overall Study|Lost to Follow-up|0|||
145793040|NCT00077610|525748099|FG001|Overall Study|Lost to Follow-up|1|||
145547077|NCT02837783|524861764|FG001|Overall Study|Other, Not Specified|2|||
145547078|NCT03930797|524861767|FG000|Overall Study|Lost to Follow-up|3|||
145547079|NCT03930797|524861768|FG001|Overall Study|Lost to Follow-up|10|||
145547080|NCT00662012|524861769|FG000|Overall Study|Lost to Follow-up|85|||
145547081|NCT00662012|524861769|FG000|Overall Study|Death|1|||
145793041|NCT00077610|525748100|FG002|Overall Study|Lost to Follow-up|2|||
145793042|NCT00077610|525748098|FG000|Overall Study|Withdrawal by Subject|4|||
145793043|NCT00077610|525748099|FG001|Overall Study|Withdrawal by Subject|10|||
145793044|NCT00077610|525748100|FG002|Overall Study|Withdrawal by Subject|6|||
145793045|NCT00077610|525748098|FG000|Overall Study|Death|17|||
145793046|NCT00077610|525748099|FG001|Overall Study|Death|13|||
145793047|NCT00077610|525748100|FG002|Overall Study|Death|13|||
145793048|NCT00077610|525748098|FG000|Overall Study|Renal transplant|12|||
145793049|NCT00077610|525748099|FG001|Overall Study|Renal transplant|15|||
145793050|NCT00077610|525748100|FG002|Overall Study|Renal transplant|11|||
145793051|NCT00077610|525748098|FG000|Overall Study|Withdrew from dialysis care|5|||
145793052|NCT00077610|525748099|FG001|Overall Study|Withdrew from dialysis care|0|||
145793053|NCT00077610|525748100|FG002|Overall Study|Withdrew from dialysis care|3|||
145793054|NCT00077610|525748098|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145793055|NCT00077610|525748099|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145793056|NCT00077610|525748100|FG002|Overall Study|Insufficient Therapeutic Response|0|||
145793057|NCT00077610|525748098|FG000|Overall Study|Multiple blood transfusions|0|||
145793058|NCT00077610|525748099|FG001|Overall Study|Multiple blood transfusions|0|||
145793059|NCT00077610|525748100|FG002|Overall Study|Multiple blood transfusions|1|||
145793060|NCT00077610|525748098|FG000|Overall Study|Principal Investigator's decision|1|||
145793061|NCT00077610|525748099|FG001|Overall Study|Principal Investigator's decision|0|||
145793062|NCT00077610|525748100|FG002|Overall Study|Principal Investigator's decision|1|||
145793063|NCT00077610|525748098|FG000|Overall Study|Worsening of health condition|1|||
145793064|NCT00077610|525748099|FG001|Overall Study|Worsening of health condition|1|||
145793065|NCT00077610|525748100|FG002|Overall Study|Worsening of health condition|0|||
145793066|NCT00077610|525748098|FG000|Overall Study|Given Epogen in hospital|1|||
145793067|NCT00077610|525748099|FG001|Overall Study|Given Epogen in hospital|0|||
145793068|NCT00077610|525748100|FG002|Overall Study|Given Epogen in hospital|0|||
145793069|NCT00077610|525748098|FG000|Overall Study|Transferred to other unit|0|||
145793070|NCT00077610|525748099|FG001|Overall Study|Transferred to other unit|0|||
145793071|NCT00077610|525748100|FG002|Overall Study|Transferred to other unit|1|||
145793072|NCT00077610|525748098|FG000|Overall Study|Transferred to nursing home|0|||
145793073|NCT00077610|525748099|FG001|Overall Study|Transferred to nursing home|0|||
145793074|NCT00077610|525748100|FG002|Overall Study|Transferred to nursing home|1|||
145793075|NCT00077610|525748098|FG000|Overall Study|Transfer to satellite unit|1|||
145793076|NCT00077610|525748099|FG001|Overall Study|Transfer to satellite unit|0|||
145793077|NCT00077610|525748100|FG002|Overall Study|Transfer to satellite unit|0|||
145793078|NCT00077610|525748098|FG000|Overall Study|Transfer to other center for surgery|1|||
145793079|NCT00077610|525748099|FG001|Overall Study|Transfer to other center for surgery|0|||
145793080|NCT00077610|525748100|FG002|Overall Study|Transfer to other center for surgery|0|||
145793081|NCT00077610|525748098|FG000|Overall Study|Change in dialysis modality|1|||
145793082|NCT00077610|525748099|FG001|Overall Study|Change in dialysis modality|0|||
145793083|NCT00077610|525748100|FG002|Overall Study|Change in dialysis modality|0|||
145793084|NCT00077610|525748098|FG000|Overall Study|Relocation|0|||
145793085|NCT00077610|525748099|FG001|Overall Study|Relocation|8|||
145793086|NCT00077610|525748100|FG002|Overall Study|Relocation|5|||
145793087|NCT00077610|525748098|FG000|Overall Study|Financial issues|0|||
145793088|NCT00077610|525748099|FG001|Overall Study|Financial issues|1|||
145793089|NCT00077610|525748100|FG002|Overall Study|Financial issues|0|||
145793090|NCT00077610|525748098|FG000|Overall Study|Sponsors decision to withdraw|0|||
145793091|NCT00077610|525748099|FG001|Overall Study|Sponsors decision to withdraw|0|||
145793092|NCT00077610|525748100|FG002|Overall Study|Sponsors decision to withdraw|1|||
145793093|NCT00305253|525748105|FG000|Overall Study|Withdrawal by Subject|0|||
145793094|NCT00305253|525748106|FG001|Overall Study|Withdrawal by Subject|1|||
145793095|NCT01357915|525748107|FG000|Overall Study|Lost to Follow-up|3|||
145793096|NCT01357915|525748108|FG001|Overall Study|Lost to Follow-up|0|||
145793097|NCT01019486|525748110|FG000|Overall Study|Withdrawal by Subject|1|||
145793098|NCT01019486|525748111|FG001|Overall Study|Withdrawal by Subject|1|||
145404831|NCT00091819|524338692|FG000|Overall Study|Death|4|||
145547082|NCT00662012|524861769|FG000|Overall Study|Withdrawal by Subject|1|||
145793099|NCT01019486|525748112|FG002|Overall Study|Withdrawal by Subject|1|||
145547083|NCT02144012|524861773|FG000|Overall Study|Adverse Event|1|||
145793100|NCT03442829|525748113|FG000|Overall Study|Scheduling clash|3|||
145793101|NCT03442829|525748114|FG001|Overall Study|Scheduling clash|1|||
145793102|NCT03442829|525748113|FG000|Overall Study|Illness unrelated to study|1|||
145793103|NCT03442829|525748114|FG001|Overall Study|Illness unrelated to study|1|||
145793104|NCT01486784|525748115|FG000|Overall Study|Withdrawal by Subject|0|||
145793105|NCT01486784|525748116|FG001|Overall Study|Withdrawal by Subject|0|||
145793106|NCT01486784|525748117|FG002|Overall Study|Withdrawal by Subject|1|||
145793107|NCT01486784|525748118|FG003|Overall Study|Withdrawal by Subject|0|||
145793108|NCT01486784|525748119|FG004|Overall Study|Withdrawal by Subject|1|||
145793109|NCT01486784|525748120|FG005|Overall Study|Withdrawal by Subject|2|||
145793110|NCT01486784|525748115|FG000|Overall Study|Subject did not meet entry criteria|0|||
145793111|NCT01486784|525748116|FG001|Overall Study|Subject did not meet entry criteria|0|||
145793112|NCT01486784|525748117|FG002|Overall Study|Subject did not meet entry criteria|0|||
145793113|NCT01486784|525748118|FG003|Overall Study|Subject did not meet entry criteria|0|||
145793114|NCT01486784|525748119|FG004|Overall Study|Subject did not meet entry criteria|1|||
145793115|NCT01486784|525748120|FG005|Overall Study|Subject did not meet entry criteria|0|||
145793116|NCT01486784|525748115|FG000|Overall Study|Death|0|||
145793117|NCT01486784|525748116|FG001|Overall Study|Death|0|||
145793118|NCT01486784|525748117|FG002|Overall Study|Death|0|||
145793119|NCT01486784|525748118|FG003|Overall Study|Death|0|||
145793120|NCT01486784|525748119|FG004|Overall Study|Death|0|||
145793121|NCT01486784|525748120|FG005|Overall Study|Death|1|||
145793122|NCT02841787|525748121|FG000|Overall Study|Lost to Follow-up|1|||
145793123|NCT02841787|525748122|FG001|Overall Study|Lost to Follow-up|0|||
145793124|NCT02841787|525748123|FG002|Overall Study|Lost to Follow-up|0|||
145793125|NCT02841787|525748121|FG000|Overall Study|Symptoms dropped below threshold|1|||
145793126|NCT02841787|525748122|FG001|Overall Study|Symptoms dropped below threshold|0|||
145793127|NCT02841787|525748123|FG002|Overall Study|Symptoms dropped below threshold|0|||
145793128|NCT02841787|525748121|FG000|Overall Study|Withdrawal by Subject|1|||
145793129|NCT02841787|525748122|FG001|Overall Study|Withdrawal by Subject|4|||
145793130|NCT02841787|525748123|FG002|Overall Study|Withdrawal by Subject|0|||
145793131|NCT01996748|525748124|FG000|Overall Study|Personal reason|1|||
145793132|NCT01996748|525748125|FG001|Overall Study|Personal reason|0|||
145793133|NCT01996748|525748124|FG000|Overall Study|Physician Decision|2|||
145793134|NCT01996748|525748125|FG001|Overall Study|Physician Decision|0|||
145611166|NCT00235443|525092614|FG000|Overall Study|Adverse Event|4|||
145611167|NCT00235443|525092615|FG001|Overall Study|Adverse Event|12|||
145611168|NCT00235443|525092616|FG002|Overall Study|Adverse Event|17|||
145611169|NCT00235443|525092617|FG003|Overall Study|Adverse Event|44|||
145611170|NCT00235443|525092618|FG004|Overall Study|Adverse Event|10|||
145611171|NCT00235443|525092619|FG005|Overall Study|Adverse Event|15|||
145611172|NCT00235443|525092614|FG000|Overall Study|Lack of Efficacy|0|||
145793135|NCT01996748|525748124|FG000|Overall Study|Adverse Event|1|||
145793136|NCT01996748|525748125|FG001|Overall Study|Adverse Event|4|||
145793137|NCT01996748|525748124|FG000|Overall Study|Withdrawal by Subject|0|||
145793138|NCT01996748|525748125|FG001|Overall Study|Withdrawal by Subject|1|||
145793139|NCT01996748|525748124|FG000|Overall Study|Lost to Follow-up|4|||
145793140|NCT01996748|525748125|FG001|Overall Study|Lost to Follow-up|1|||
145793141|NCT02402218|525748128|FG000|Overall Study|Did not pickup study medication|12|||
145793142|NCT02402218|525748129|FG001|Overall Study|Did not pickup study medication|9|||
145793143|NCT02402218|525748130|FG002|Overall Study|Did not pickup study medication|13|||
145793144|NCT02402218|525748128|FG000|Overall Study|Lack of Efficacy|0|||
145793145|NCT02402218|525748129|FG001|Overall Study|Lack of Efficacy|1|||
145793146|NCT02402218|525748130|FG002|Overall Study|Lack of Efficacy|1|||
145793147|NCT02402218|525748128|FG000|Overall Study|Death|1|||
145793148|NCT02402218|525748129|FG001|Overall Study|Death|0|||
145793149|NCT02402218|525748130|FG002|Overall Study|Death|0|||
145793150|NCT02402218|525748128|FG000|Overall Study|Reinfection|0|||
145793151|NCT02402218|525748129|FG001|Overall Study|Reinfection|0|||
145793152|NCT02402218|525748130|FG002|Overall Study|Reinfection|1|||
145793153|NCT02402218|525748128|FG000|Overall Study|Adverse Event|0|||
145793154|NCT02402218|525748129|FG001|Overall Study|Adverse Event|2|||
145793155|NCT02402218|525748130|FG002|Overall Study|Adverse Event|1|||
145793156|NCT02402218|525748128|FG000|Overall Study|Withdrawal by Subject|1|||
145793157|NCT02402218|525748129|FG001|Overall Study|Withdrawal by Subject|1|||
145793158|NCT02402218|525748130|FG002|Overall Study|Withdrawal by Subject|1|||
145404832|NCT00091819|524338693|FG001|Overall Study|Death|5|||
145611173|NCT00235443|525092615|FG001|Overall Study|Lack of Efficacy|1|||
145793159|NCT03011840|525748131|FG000|Overall Study|Not received PIL in post PIL phase|0|||
145793160|NCT03011840|525748132|FG001|Overall Study|Not received PIL in post PIL phase|21|||
145793161|NCT03738566|525748133|FG000|Initial Study Phase|Withdrawal by Subject|1|||
145793162|NCT03738566|525748134|FG001|Initial Study Phase|Withdrawal by Subject|1|||
145793163|NCT03738566|525748135|FG002|Initial Study Phase|Withdrawal by Subject|2|||
145793164|NCT03738566|525748136|FG003|Initial Study Phase|Withdrawal by Subject|0|||
145793165|NCT03738566|525748133|FG000|Initial Study Phase|Death|0|||
145793166|NCT03738566|525748134|FG001|Initial Study Phase|Death|1|||
145793167|NCT03738566|525748135|FG002|Initial Study Phase|Death|0|||
145611174|NCT00235443|525092616|FG002|Overall Study|Lack of Efficacy|5|||
145793168|NCT03738566|525748136|FG003|Initial Study Phase|Death|0|||
145547084|NCT02144012|524861774|FG001|Overall Study|Adverse Event|0|||
145793169|NCT03738566|525748133|FG000|Initial Study Phase|Treatment failure|5|||
145793170|NCT03738566|525748134|FG001|Initial Study Phase|Treatment failure|0|||
145793171|NCT03738566|525748135|FG002|Initial Study Phase|Treatment failure|0|||
145793172|NCT03738566|525748136|FG003|Initial Study Phase|Treatment failure|0|||
145793173|NCT03738566|525748133|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
145793174|NCT03738566|525748134|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
145793175|NCT03738566|525748135|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
145793176|NCT03738566|525748136|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
145793177|NCT00946530|525748137|FG000|Overall Study|Withdrawal by Subject|0|||
145793178|NCT00946530|525748138|FG001|Overall Study|Withdrawal by Subject|3|||
145793179|NCT00946530|525748139|FG002|Overall Study|Withdrawal by Subject|0|||
145793180|NCT00946530|525748140|FG003|Overall Study|Withdrawal by Subject|3|||
145793181|NCT00946530|525748137|FG000|Overall Study|Physician Decision|1|||
145793182|NCT00946530|525748138|FG001|Overall Study|Physician Decision|1|||
145793183|NCT00946530|525748139|FG002|Overall Study|Physician Decision|1|||
145793184|NCT00946530|525748140|FG003|Overall Study|Physician Decision|1|||
145793185|NCT03105700|525748141|FG000|Overall Study|screen fail|3|||
145793186|NCT03105700|525748141|FG000|Overall Study|Lost to Follow-up|4|||
145793187|NCT02768194|525748142|FG000|Period 1|Adverse Event|0|||
145793188|NCT02768194|525748143|FG001|Period 1|Adverse Event|0|||
145793189|NCT02768194|525748144|FG002|Period 1|Adverse Event|0|||
145793190|NCT02768194|525748145|FG003|Period 1|Adverse Event|1|||
145793191|NCT02768194|525748146|FG004|Period 1|Adverse Event|0|||
145793192|NCT02768194|525748147|FG005|Period 1|Adverse Event|0|||
145793193|NCT02768194|525748142|FG000|Period 2|Other (Reason not specified)|1|||
145793194|NCT02768194|525748143|FG001|Period 2|Other (Reason not specified)|0|||
145793195|NCT02768194|525748144|FG002|Period 2|Other (Reason not specified)|0|||
145793196|NCT02768194|525748145|FG003|Period 2|Other (Reason not specified)|0|||
145793197|NCT02768194|525748146|FG004|Period 2|Other (Reason not specified)|0|||
145793198|NCT02768194|525748147|FG005|Period 2|Other (Reason not specified)|0|||
145793199|NCT02768194|525748142|FG000|Period 3|Other (Reason not specified)|0|||
145793200|NCT02768194|525748143|FG001|Period 3|Other (Reason not specified)|1|||
145793201|NCT02768194|525748144|FG002|Period 3|Other (Reason not specified)|0|||
145793202|NCT02768194|525748145|FG003|Period 3|Other (Reason not specified)|0|||
145793203|NCT02768194|525748146|FG004|Period 3|Other (Reason not specified)|0|||
145793204|NCT02768194|525748147|FG005|Period 3|Other (Reason not specified)|0|||
145793205|NCT01982773|525748148|FG000|Overall Study|Withdrawal by Subject|1|||
145793206|NCT01982773|525748149|FG001|Overall Study|Withdrawal by Subject|3|||
145793207|NCT01982773|525748148|FG000|Overall Study|Lost to Follow-up|7|||
145793208|NCT01982773|525748149|FG001|Overall Study|Lost to Follow-up|1|||
145793209|NCT01029886|525748150|FG000|Overall Study|Adverse Event|12|||
145793210|NCT01029886|525748151|FG001|Overall Study|Adverse Event|25|||
145793211|NCT01029886|525748150|FG000|Overall Study|Lost to Follow-up|1|||
145793212|NCT01029886|525748151|FG001|Overall Study|Lost to Follow-up|0|||
145793213|NCT01029886|525748150|FG000|Overall Study|Physician Decision|2|||
145793214|NCT01029886|525748151|FG001|Overall Study|Physician Decision|6|||
145793215|NCT01029886|525748150|FG000|Overall Study|Protocol Violation|17|||
145793216|NCT01029886|525748151|FG001|Overall Study|Protocol Violation|5|||
145793217|NCT01029886|525748150|FG000|Overall Study|Withdrawal by Subject|8|||
145793218|NCT01029886|525748151|FG001|Overall Study|Withdrawal by Subject|18|||
145793219|NCT01029886|525748150|FG000|Overall Study|Entry Criteria Not Met|13|||
145793220|NCT01029886|525748151|FG001|Overall Study|Entry Criteria Not Met|5|||
145793221|NCT01029886|525748150|FG000|Overall Study|Sponsor Decision|1|||
145793222|NCT01029886|525748151|FG001|Overall Study|Sponsor Decision|0|||
145793223|NCT01029886|525748150|FG000|Overall Study|Loss Glucose Control|7|||
145793224|NCT01029886|525748151|FG001|Overall Study|Loss Glucose Control|1|||
145793225|NCT01778127|525748154|FG000|Overall Study|Lost to Follow-up|5|||
145793226|NCT01778127|525748155|FG001|Overall Study|Lost to Follow-up|1|||
145793227|NCT01778127|525748156|FG002|Overall Study|Lost to Follow-up|2|||
145793228|NCT01778127|525748154|FG000|Overall Study|Withdrawal by Subject|3|||
145793229|NCT01778127|525748155|FG001|Overall Study|Withdrawal by Subject|1|||
145793230|NCT01778127|525748156|FG002|Overall Study|Withdrawal by Subject|4|||
145793231|NCT02720016|525748162|FG000|Overall Study|Separation of couple|6|||
145793232|NCT02720016|525748163|FG001|Overall Study|Separation of couple|8|||
145793233|NCT02720016|525748164|FG002|Overall Study|Separation of couple|2|||
145793234|NCT02720016|525748162|FG000|Overall Study|Withdrawal by Subject|6|||
145793235|NCT02720016|525748163|FG001|Overall Study|Withdrawal by Subject|6|||
145793236|NCT02720016|525748164|FG002|Overall Study|Withdrawal by Subject|4|||
145793237|NCT02720016|525748162|FG000|Overall Study|Scheduling issues|2|||
145793238|NCT02720016|525748163|FG001|Overall Study|Scheduling issues|4|||
145793239|NCT02720016|525748164|FG002|Overall Study|Scheduling issues|7|||
145793240|NCT02720016|525748162|FG000|Overall Study|Childcare|2|||
145547085|NCT02144012|524861773|FG000|Overall Study|Death|1|||
145793241|NCT02720016|525748163|FG001|Overall Study|Childcare|0|||
145793242|NCT02720016|525748164|FG002|Overall Study|Childcare|2|||
145547086|NCT02144012|524861774|FG001|Overall Study|Death|0|||
145547087|NCT02144012|524861773|FG000|Overall Study|Withdrawal by Subject|11|||
145793243|NCT02720016|525748162|FG000|Overall Study|Withdrawal by PI|2|||
145793244|NCT02720016|525748163|FG001|Overall Study|Withdrawal by PI|2|||
145793245|NCT02720016|525748164|FG002|Overall Study|Withdrawal by PI|0|||
145793246|NCT02720016|525748162|FG000|Overall Study|Moved away|2|||
145793247|NCT02720016|525748163|FG001|Overall Study|Moved away|0|||
145793248|NCT02720016|525748164|FG002|Overall Study|Moved away|0|||
145793249|NCT02720016|525748162|FG000|Overall Study|Not Primary Health Concern|0|||
145793250|NCT02720016|525748163|FG001|Overall Study|Not Primary Health Concern|0|||
145793251|NCT02720016|525748164|FG002|Overall Study|Not Primary Health Concern|2|||
145793252|NCT02720016|525748162|FG000|Overall Study|Transportation issues|0|||
145793253|NCT02720016|525748163|FG001|Overall Study|Transportation issues|0|||
145793254|NCT02720016|525748164|FG002|Overall Study|Transportation issues|1|||
145793255|NCT02720016|525748162|FG000|Overall Study|Other|0|||
145793256|NCT02720016|525748163|FG001|Overall Study|Other|0|||
145793257|NCT02720016|525748164|FG002|Overall Study|Other|2|||
145793258|NCT05319080|525748167|FG000|Overall Study|Withdrawal by Subject|2|||
145793259|NCT05319080|525748167|FG000|Overall Study|Physician Decision|4|||
145793260|NCT00751114|525748168|FG000|Overall Study|Adverse Event|2|||
145793261|NCT00751114|525748169|FG001|Overall Study|Adverse Event|4|||
145793262|NCT00751114|525748168|FG000|Overall Study|Protocol Violation|8|||
145793263|NCT00751114|525748169|FG001|Overall Study|Protocol Violation|9|||
145793264|NCT00751114|525748168|FG000|Overall Study|Withdrawal by Subject|9|||
145793265|NCT00751114|525748169|FG001|Overall Study|Withdrawal by Subject|4|||
145793266|NCT00751114|525748168|FG000|Overall Study|Lost to Follow-up|4|||
145793267|NCT00751114|525748169|FG001|Overall Study|Lost to Follow-up|7|||
145793268|NCT00751114|525748168|FG000|Overall Study|Lack of Efficacy|0|||
145793269|NCT00751114|525748169|FG001|Overall Study|Lack of Efficacy|7|||
145793270|NCT00751114|525748168|FG000|Overall Study|Not Treated|13|||
145793271|NCT00751114|525748169|FG001|Overall Study|Not Treated|1|||
145793272|NCT00751114|525748168|FG000|Overall Study|Out of country for 2 months|1|||
145793273|NCT00751114|525748169|FG001|Overall Study|Out of country for 2 months|0|||
145793274|NCT00751114|525748168|FG000|Overall Study|Move to another city|1|||
145793275|NCT00751114|525748169|FG001|Overall Study|Move to another city|0|||
145793276|NCT02358369|525748170|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
145793277|NCT02358369|525748171|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
145793278|NCT02358369|525748172|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
145793279|NCT02358369|525748173|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
145793280|NCT02358369|525748174|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
145793281|NCT02358369|525748170|FG000|Treatment Period A/B|Adverse Event|0|||
145793282|NCT02358369|525748171|FG001|Treatment Period A/B|Adverse Event|0|||
145793283|NCT02358369|525748172|FG002|Treatment Period A/B|Adverse Event|1|||
145793284|NCT02358369|525748173|FG003|Treatment Period A/B|Adverse Event|2|||
145793285|NCT02358369|525748174|FG004|Treatment Period A/B|Adverse Event|0|||
145793286|NCT02358369|525748170|FG000|Treatment Period A/B|Death|0|||
145793287|NCT02358369|525748171|FG001|Treatment Period A/B|Death|0|||
145793288|NCT02358369|525748172|FG002|Treatment Period A/B|Death|1|||
145793289|NCT02358369|525748173|FG003|Treatment Period A/B|Death|0|||
145793290|NCT02358369|525748174|FG004|Treatment Period A/B|Death|0|||
145793291|NCT02358369|525748170|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
145793292|NCT02358369|525748171|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
145793293|NCT02358369|525748172|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
145793294|NCT02358369|525748173|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
145793295|NCT02358369|525748174|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
145793296|NCT02358369|525748170|FG000|Treatment Period C|Adverse Event|0|||
145793297|NCT02358369|525748171|FG001|Treatment Period C|Adverse Event|0|||
145793298|NCT02358369|525748172|FG002|Treatment Period C|Adverse Event|0|||
145793299|NCT02358369|525748173|FG003|Treatment Period C|Adverse Event|0|||
145793300|NCT02358369|525748174|FG004|Treatment Period C|Adverse Event|7|||
145793301|NCT03095521|525748175|FG000|Overall Study|Withdrawal by Subject|0|||
145793302|NCT03095521|525748176|FG001|Overall Study|Withdrawal by Subject|1|||
145793303|NCT03095521|525748175|FG000|Overall Study|Lost to Follow-up|0|||
145793304|NCT03095521|525748176|FG001|Overall Study|Lost to Follow-up|1|||
145793305|NCT01536119|525748177|FG000|Overall Study|Lost to Follow-up|17|||
145793306|NCT01536119|525748178|FG001|Overall Study|Lost to Follow-up|14|||
145793307|NCT00448916|525748179|FG000|Overall Study|Adverse Event|2|||
145793308|NCT00448916|525748180|FG001|Overall Study|Adverse Event|2|||
145793309|NCT00448916|525748181|FG002|Overall Study|Adverse Event|3|||
145404833|NCT00091819|524338692|FG000|Overall Study|Lost to Follow-up|26|||
145793310|NCT00448916|525748182|FG003|Overall Study|Adverse Event|2|||
145793311|NCT00448916|525748179|FG000|Overall Study|Lack of Efficacy|1|||
145547088|NCT02144012|524861774|FG001|Overall Study|Withdrawal by Subject|3|||
145547089|NCT02144012|524861773|FG000|Overall Study|Study Terminated by Sponsor|18|||
145547090|NCT02144012|524861774|FG001|Overall Study|Study Terminated by Sponsor|12|||
145547091|NCT02144012|524861773|FG000|Overall Study|Other|3|||
145547092|NCT02144012|524861774|FG001|Overall Study|Other|0|||
145547093|NCT04656691|524861777|FG000|Overall Study|Adverse Event|1|||
145793312|NCT00448916|525748180|FG001|Overall Study|Lack of Efficacy|0|||
145793313|NCT00448916|525748181|FG002|Overall Study|Lack of Efficacy|2|||
145793314|NCT00448916|525748182|FG003|Overall Study|Lack of Efficacy|1|||
145793315|NCT00448916|525748179|FG000|Overall Study|Withdrawal by Subject|3|||
145793316|NCT00448916|525748180|FG001|Overall Study|Withdrawal by Subject|3|||
145793317|NCT00448916|525748181|FG002|Overall Study|Withdrawal by Subject|1|||
145793318|NCT00448916|525748182|FG003|Overall Study|Withdrawal by Subject|1|||
145793319|NCT00448916|525748179|FG000|Overall Study|Other|1|||
145793320|NCT00448916|525748180|FG001|Overall Study|Other|0|||
145793321|NCT00448916|525748181|FG002|Overall Study|Other|0|||
145793322|NCT00448916|525748182|FG003|Overall Study|Other|0|||
145793323|NCT00448916|525748179|FG000|Overall Study|Lost to Follow-up|0|||
145793324|NCT00448916|525748180|FG001|Overall Study|Lost to Follow-up|1|||
145793325|NCT00448916|525748181|FG002|Overall Study|Lost to Follow-up|0|||
145793326|NCT00448916|525748182|FG003|Overall Study|Lost to Follow-up|1|||
145793327|NCT00448916|525748179|FG000|Overall Study|Protocol Violation|0|||
145793328|NCT00448916|525748180|FG001|Overall Study|Protocol Violation|0|||
145793329|NCT00448916|525748181|FG002|Overall Study|Protocol Violation|0|||
145793330|NCT00448916|525748182|FG003|Overall Study|Protocol Violation|1|||
145793331|NCT03655717|525748183|FG000|Overall Study|Withdrawal by Subject|4|||
145793332|NCT03655717|525748184|FG001|Overall Study|Withdrawal by Subject|8|||
145793333|NCT03655717|525748185|FG002|Overall Study|Withdrawal by Subject|1|||
145793334|NCT03655717|525748186|FG003|Overall Study|Withdrawal by Subject|0|||
145793335|NCT03655717|525748187|FG004|Overall Study|Withdrawal by Subject|0|||
145793336|NCT03655717|525748188|FG005|Overall Study|Withdrawal by Subject|1|||
145793337|NCT03655717|525748189|FG006|Overall Study|Withdrawal by Subject|3|||
145793338|NCT03655717|525748190|FG007|Overall Study|Withdrawal by Subject|1|||
145793339|NCT03655717|525748191|FG008|Overall Study|Withdrawal by Subject|2|||
145793340|NCT03655717|525748192|FG009|Overall Study|Withdrawal by Subject|0|||
145793341|NCT03655717|525748193|FG010|Overall Study|Withdrawal by Subject|0|||
145793342|NCT03655717|525748194|FG011|Overall Study|Withdrawal by Subject|1|||
145793343|NCT03655717|525748195|FG012|Overall Study|Withdrawal by Subject|0|||
145793344|NCT03655717|525748196|FG013|Overall Study|Withdrawal by Subject|3|||
145793345|NCT03655717|525748197|FG014|Overall Study|Withdrawal by Subject|0|||
145793346|NCT03655717|525748198|FG015|Overall Study|Withdrawal by Subject|1|||
145793347|NCT03655717|525748199|FG016|Overall Study|Withdrawal by Subject|0|||
145793348|NCT03655717|525748200|FG017|Overall Study|Withdrawal by Subject|0|||
145793349|NCT03655717|525748201|FG018|Overall Study|Withdrawal by Subject|1|||
145793350|NCT03655717|525748202|FG019|Overall Study|Withdrawal by Subject|0|||
145793351|NCT03655717|525748203|FG020|Overall Study|Withdrawal by Subject|0|||
145793352|NCT03655717|525748204|FG021|Overall Study|Withdrawal by Subject|1|||
145547094|NCT02846779|524861780|FG000|Overall Study|Lost Enrollment|83|||
145793353|NCT03655717|525748205|FG022|Overall Study|Withdrawal by Subject|2|||
145793354|NCT03655717|525748206|FG023|Overall Study|Withdrawal by Subject|1|||
145793355|NCT03655717|525748207|FG024|Overall Study|Withdrawal by Subject|1|||
145793356|NCT03655717|525748208|FG025|Overall Study|Withdrawal by Subject|0|||
145793357|NCT03655717|525748183|FG000|Overall Study|Physician Decision|3|||
145793358|NCT03655717|525748184|FG001|Overall Study|Physician Decision|3|||
145793359|NCT03655717|525748185|FG002|Overall Study|Physician Decision|0|||
145793360|NCT03655717|525748186|FG003|Overall Study|Physician Decision|0|||
145793361|NCT03655717|525748187|FG004|Overall Study|Physician Decision|0|||
145793362|NCT03655717|525748188|FG005|Overall Study|Physician Decision|0|||
145793363|NCT03655717|525748189|FG006|Overall Study|Physician Decision|0|||
145793364|NCT03655717|525748190|FG007|Overall Study|Physician Decision|0|||
145793365|NCT03655717|525748191|FG008|Overall Study|Physician Decision|0|||
145793366|NCT03655717|525748192|FG009|Overall Study|Physician Decision|1|||
145793367|NCT03655717|525748193|FG010|Overall Study|Physician Decision|0|||
145793368|NCT03655717|525748194|FG011|Overall Study|Physician Decision|0|||
145793369|NCT03655717|525748195|FG012|Overall Study|Physician Decision|0|||
145793370|NCT03655717|525748196|FG013|Overall Study|Physician Decision|0|||
145793371|NCT03655717|525748197|FG014|Overall Study|Physician Decision|0|||
145793372|NCT03655717|525748198|FG015|Overall Study|Physician Decision|0|||
145793373|NCT03655717|525748199|FG016|Overall Study|Physician Decision|0|||
145793374|NCT03655717|525748200|FG017|Overall Study|Physician Decision|0|||
145793375|NCT03655717|525748201|FG018|Overall Study|Physician Decision|0|||
145793376|NCT03655717|525748202|FG019|Overall Study|Physician Decision|1|||
145793377|NCT03655717|525748203|FG020|Overall Study|Physician Decision|0|||
145793378|NCT03655717|525748204|FG021|Overall Study|Physician Decision|0|||
145793379|NCT03655717|525748205|FG022|Overall Study|Physician Decision|0|||
145793380|NCT03655717|525748206|FG023|Overall Study|Physician Decision|1|||
145793381|NCT03655717|525748207|FG024|Overall Study|Physician Decision|0|||
145793382|NCT03655717|525748208|FG025|Overall Study|Physician Decision|0|||
145793383|NCT03655717|525748183|FG000|Overall Study|Lost to Follow-up|3|||
145793384|NCT03655717|525748184|FG001|Overall Study|Lost to Follow-up|1|||
145793385|NCT03655717|525748185|FG002|Overall Study|Lost to Follow-up|0|||
145793386|NCT03655717|525748186|FG003|Overall Study|Lost to Follow-up|1|||
145793387|NCT03655717|525748187|FG004|Overall Study|Lost to Follow-up|0|||
145793388|NCT03655717|525748188|FG005|Overall Study|Lost to Follow-up|1|||
145793389|NCT03655717|525748189|FG006|Overall Study|Lost to Follow-up|0|||
145793390|NCT03655717|525748190|FG007|Overall Study|Lost to Follow-up|0|||
145793391|NCT03655717|525748191|FG008|Overall Study|Lost to Follow-up|0|||
145793392|NCT03655717|525748192|FG009|Overall Study|Lost to Follow-up|0|||
145793393|NCT03655717|525748193|FG010|Overall Study|Lost to Follow-up|0|||
145793394|NCT03655717|525748194|FG011|Overall Study|Lost to Follow-up|1|||
145793395|NCT03655717|525748195|FG012|Overall Study|Lost to Follow-up|0|||
145793396|NCT03655717|525748196|FG013|Overall Study|Lost to Follow-up|0|||
145793397|NCT03655717|525748197|FG014|Overall Study|Lost to Follow-up|0|||
145793398|NCT03655717|525748198|FG015|Overall Study|Lost to Follow-up|0|||
145793399|NCT03655717|525748199|FG016|Overall Study|Lost to Follow-up|0|||
145793400|NCT03655717|525748200|FG017|Overall Study|Lost to Follow-up|0|||
145793401|NCT03655717|525748201|FG018|Overall Study|Lost to Follow-up|0|||
145793402|NCT03655717|525748202|FG019|Overall Study|Lost to Follow-up|0|||
145793403|NCT03655717|525748203|FG020|Overall Study|Lost to Follow-up|0|||
145282731|NCT03210259|523884336|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
145793404|NCT03655717|525748204|FG021|Overall Study|Lost to Follow-up|0|||
145282732|NCT03210259|523884337|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
145404834|NCT00091819|524338693|FG001|Overall Study|Lost to Follow-up|23|||
145793405|NCT03655717|525748205|FG022|Overall Study|Lost to Follow-up|0|||
145793406|NCT03655717|525748206|FG023|Overall Study|Lost to Follow-up|0|||
145793407|NCT03655717|525748207|FG024|Overall Study|Lost to Follow-up|0|||
145793408|NCT03655717|525748208|FG025|Overall Study|Lost to Follow-up|0|||
145793409|NCT03521193|525748209|FG000|Overall Study|Withdrawal by Subject|8|||
145793410|NCT03521193|525748210|FG001|Overall Study|Withdrawal by Subject|0|||
145793411|NCT03521193|525748209|FG000|Overall Study|non compliant to ASA treatment|8|||
145793412|NCT03521193|525748210|FG001|Overall Study|non compliant to ASA treatment|0|||
145793413|NCT01810042|525748211|FG000|Overall Study|Lost to Follow-up|10|||
145793414|NCT01354353|525750800|FG000|Overall Study|Adverse Event|1|||
145793415|NCT01354353|525750801|FG001|Overall Study|Adverse Event|0|||
145793416|NCT01354353|525750802|FG002|Overall Study|Adverse Event|0|||
145793417|NCT01354353|525750803|FG003|Overall Study|Adverse Event|4|||
145793418|NCT01354353|525750804|FG004|Overall Study|Adverse Event|0|||
145793419|NCT01354353|525750805|FG005|Overall Study|Adverse Event|5|||
145793420|NCT01354353|525750800|FG000|Overall Study|Entry Criteria Not Met|0|||
145793421|NCT01354353|525750801|FG001|Overall Study|Entry Criteria Not Met|0|||
145793422|NCT01354353|525750802|FG002|Overall Study|Entry Criteria Not Met|0|||
145793423|NCT01354353|525750803|FG003|Overall Study|Entry Criteria Not Met|1|||
145793424|NCT01354353|525750804|FG004|Overall Study|Entry Criteria Not Met|1|||
145793425|NCT01354353|525750805|FG005|Overall Study|Entry Criteria Not Met|0|||
145793426|NCT01354353|525750800|FG000|Overall Study|Physician Decision|0|||
145793427|NCT01354353|525750801|FG001|Overall Study|Physician Decision|1|||
145793428|NCT01354353|525750802|FG002|Overall Study|Physician Decision|1|||
145793429|NCT01354353|525750803|FG003|Overall Study|Physician Decision|0|||
145793430|NCT01354353|525750804|FG004|Overall Study|Physician Decision|0|||
145793431|NCT01354353|525750805|FG005|Overall Study|Physician Decision|0|||
145793432|NCT01354353|525750800|FG000|Overall Study|Withdrawal by Subject|2|||
145793433|NCT01354353|525750801|FG001|Overall Study|Withdrawal by Subject|0|||
145793434|NCT01354353|525750802|FG002|Overall Study|Withdrawal by Subject|1|||
145793435|NCT01354353|525750803|FG003|Overall Study|Withdrawal by Subject|0|||
145793436|NCT01354353|525750804|FG004|Overall Study|Withdrawal by Subject|0|||
145793437|NCT01354353|525750805|FG005|Overall Study|Withdrawal by Subject|1|||
145793438|NCT03806179|525750807|FG000|Overall Study|Progressive disease|0|||
145793439|NCT03806179|525750808|FG001|Overall Study|Progressive disease|2|||
145793440|NCT02662985|525750810|FG000|Treatment Period 1|Adverse Event|0|||
145793441|NCT02662985|525750811|FG001|Treatment Period 1|Adverse Event|2|||
145793442|NCT02662985|525750810|FG000|Treatment Period 1|Protocol Violation|0|||
145793443|NCT02662985|525750811|FG001|Treatment Period 1|Protocol Violation|1|||
145793444|NCT02662985|525750810|FG000|Treatment Period 1|Physician Decision|1|||
145793445|NCT02662985|525750811|FG001|Treatment Period 1|Physician Decision|0|||
145793446|NCT02662985|525750810|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145793447|NCT02662985|525750811|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145793448|NCT02662985|525750810|FG000|Treatment Period 2|Lack of Efficacy|0|||
145793449|NCT02662985|525750811|FG001|Treatment Period 2|Lack of Efficacy|1|||
145793450|NCT02662985|525750810|FG000|Treatment Period 2|Lost to Follow-up|1|||
145793451|NCT02662985|525750811|FG001|Treatment Period 2|Lost to Follow-up|0|||
145793452|NCT02662985|525750810|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
145793453|NCT02662985|525750811|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
145793454|NCT02662985|525750810|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
145793455|NCT02662985|525750811|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
145793456|NCT02662985|525750810|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
145793457|NCT02662985|525750811|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
145793458|NCT02662985|525750810|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
145793459|NCT02662985|525750811|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
145793460|NCT02662985|525750810|FG000|Treatment Period 3 (Extension Period)|Death|0|||
145793461|NCT02662985|525750811|FG001|Treatment Period 3 (Extension Period)|Death|1|||
145793462|NCT03491553|525750812|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
145793463|NCT03491553|525750813|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
145793464|NCT03491553|525750814|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
145793465|NCT03491553|525750815|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
145793466|NCT03491553|525750816|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
145793467|NCT03491553|525750817|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
145793468|NCT03491553|525750812|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
145793469|NCT03491553|525750813|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
145793470|NCT03491553|525750814|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
145793471|NCT03491553|525750815|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
145793472|NCT03491553|525750816|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
145793473|NCT03491553|525750817|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
145793474|NCT03029650|525750820|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
145793475|NCT03029650|525750821|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
145793476|NCT03029650|525750820|FG000|Washout (1 Week)|Physician Decision|0|||
145793477|NCT03029650|525750821|FG001|Washout (1 Week)|Physician Decision|1|||
145793478|NCT01875367|525750822|FG000|Overall Study|Not complete at least 2 questionaries|4|||
145793479|NCT01875367|525750823|FG001|Overall Study|Not complete at least 2 questionaries|2|||
145793480|NCT01875367|525750822|FG000|Overall Study|Not receive study treatment|1|||
145793481|NCT01875367|525750823|FG001|Overall Study|Not receive study treatment|0|||
145793482|NCT02237157|525750824|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
145793483|NCT02237157|525750825|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
145793484|NCT02237157|525750826|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
145793485|NCT02237157|525750827|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
145793486|NCT02237157|525750824|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
145793487|NCT02237157|525750825|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
145793488|NCT02237157|525750826|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
145793489|NCT02237157|525750827|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
145793490|NCT03628508|525750828|FG000|Overall Study|Lost to Follow-up|1|||
145793491|NCT02951988|525750829|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
145793492|NCT02951988|525750830|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
145793493|NCT02951988|525750831|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
145793494|NCT02951988|525750832|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
145793495|NCT02951988|525750829|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
145793496|NCT02951988|525750830|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
145793497|NCT02951988|525750831|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
145793498|NCT02951988|525750832|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
145793499|NCT02951988|525750829|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
145793500|NCT02951988|525750830|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
145793501|NCT02951988|525750831|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
145793502|NCT02951988|525750832|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
145282733|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
145282734|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
145282735|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
145282736|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
145282737|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
145282738|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
145282739|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
145282740|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
145282741|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
145282742|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
145282743|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
145282744|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
145282745|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
145282746|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
145282747|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
145282748|NCT03210259|523884335|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
145282749|NCT03210259|523884336|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
145282750|NCT03210259|523884337|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
145282751|NCT02533999|523884338|FG000|Overall Study|Lost to Follow-up|3|||
145282752|NCT02533999|523884339|FG001|Overall Study|Lost to Follow-up|5|||
145282753|NCT02533999|523884338|FG000|Overall Study|Protocol Violation|3|||
145282754|NCT02533999|523884339|FG001|Overall Study|Protocol Violation|0|||
145282755|NCT02533999|523884338|FG000|Overall Study|Adverse Event|0|||
145282756|NCT02533999|523884339|FG001|Overall Study|Adverse Event|1|||
145282757|NCT02533999|523884338|FG000|Overall Study|Randomized but intervention not received|0|||
145282758|NCT02533999|523884339|FG001|Overall Study|Randomized but intervention not received|1|||
145282759|NCT05017493|523884342|FG000|Overall Study|Withdrawal by Subject|26|||
145282760|NCT05017493|523884343|FG001|Overall Study|Withdrawal by Subject|0|||
145282761|NCT05017493|523884342|FG000|Overall Study|Physician Decision|15|||
145282762|NCT05017493|523884343|FG001|Overall Study|Physician Decision|0|||
145282763|NCT05017493|523884342|FG000|Overall Study|Protocol Violation|81|||
145793503|NCT02951988|525750829|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
145793504|NCT02951988|525750830|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
145793505|NCT02951988|525750831|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
145793506|NCT02951988|525750832|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
145793507|NCT02951988|525750829|FG000|Open-Label Treatment Period|Protocol Violation|22|||
145793508|NCT02951988|525750830|FG001|Open-Label Treatment Period|Protocol Violation|0|||
145793509|NCT02951988|525750831|FG002|Open-Label Treatment Period|Protocol Violation|0|||
145793510|NCT02951988|525750832|FG003|Open-Label Treatment Period|Protocol Violation|0|||
145793511|NCT02951988|525750829|FG000|Open-Label Treatment Period|Pregnancy|2|||
145793512|NCT02951988|525750830|FG001|Open-Label Treatment Period|Pregnancy|0|||
145793513|NCT02951988|525750831|FG002|Open-Label Treatment Period|Pregnancy|0|||
145793514|NCT02951988|525750832|FG003|Open-Label Treatment Period|Pregnancy|0|||
145793515|NCT02951988|525750829|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
145793516|NCT02951988|525750830|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
145793517|NCT02951988|525750831|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
145793518|NCT02951988|525750832|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
145793519|NCT02951988|525750829|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
145793520|NCT02951988|525750830|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
145793521|NCT02951988|525750831|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
145793522|NCT02951988|525750832|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
145793523|NCT02951988|525750829|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
145793524|NCT02951988|525750830|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
145793525|NCT02951988|525750831|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
145793526|NCT02951988|525750832|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
145793527|NCT02951988|525750829|FG000|Open-Label Treatment Period|Adverse Event|45|||
145793528|NCT02951988|525750830|FG001|Open-Label Treatment Period|Adverse Event|0|||
145793529|NCT02951988|525750831|FG002|Open-Label Treatment Period|Adverse Event|0|||
145793530|NCT02951988|525750832|FG003|Open-Label Treatment Period|Adverse Event|0|||
145793531|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
145793532|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
145793533|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
145793534|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
145793535|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
145793536|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
145793537|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
145793538|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
145793539|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
145793540|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
145793541|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
145793542|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
145793543|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145793544|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
145793545|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
145793546|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
145793547|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Pregnancy|0|||
145793548|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Pregnancy|1|||
145793549|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Pregnancy|1|||
145793550|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Pregnancy|0|||
145793551|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145793552|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
145793553|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
145793554|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
145793555|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145793556|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
145793557|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
145793558|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
145793559|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145793560|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Adverse Event|8|||
145793561|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Adverse Event|3|||
145793562|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Adverse Event|6|||
145793563|NCT02951988|525750829|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
145793564|NCT02951988|525750830|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
145793565|NCT02951988|525750831|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
145793566|NCT02951988|525750832|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
145793567|NCT05836818|525750833|FG000|Overall Study|Physician Decision|1|||
145793568|NCT05836818|525750834|FG001|Overall Study|Physician Decision|1|||
145793569|NCT05836818|525750835|FG002|Overall Study|Physician Decision|0|||
145793570|NCT05836818|525750833|FG000|Overall Study|Withdrawal by Subject|0|||
145793571|NCT05836818|525750834|FG001|Overall Study|Withdrawal by Subject|0|||
145793572|NCT05836818|525750835|FG002|Overall Study|Withdrawal by Subject|1|||
145793573|NCT05836818|525750833|FG000|Overall Study|Later found to be previously vaccinated|0|||
145793574|NCT05836818|525750834|FG001|Overall Study|Later found to be previously vaccinated|1|||
145793575|NCT05836818|525750835|FG002|Overall Study|Later found to be previously vaccinated|3|||
145793576|NCT05836818|525750833|FG000|Overall Study|Pregnancy|0|||
145793577|NCT05836818|525750834|FG001|Overall Study|Pregnancy|1|||
145793578|NCT05836818|525750835|FG002|Overall Study|Pregnancy|0|||
145793579|NCT05836818|525750833|FG000|Overall Study|Allergic to vaccines|0|||
145793580|NCT05836818|525750834|FG001|Overall Study|Allergic to vaccines|1|||
145793581|NCT05836818|525750835|FG002|Overall Study|Allergic to vaccines|0|||
145793582|NCT01165021|525750836|FG000|Overall Study|Death|1|||
145793583|NCT02491073|525750837|FG000|Overall Study|screen failure|1|||
145793584|NCT02491073|525750838|FG001|Overall Study|screen failure|0|||
145793585|NCT03977727|525750839|FG000|Second Treatment|Lost to Follow-up|0|||
145793586|NCT03977727|525750840|FG001|Second Treatment|Lost to Follow-up|3|||
145793587|NCT01419665|525750841|FG000|Combination Treatment|Adverse Event|7|||
145793588|NCT01419665|525750842|FG001|Combination Treatment|Adverse Event|10|||
145793589|NCT01419665|525750841|FG000|Combination Treatment|Physician Decision|5|||
145793590|NCT01419665|525750842|FG001|Combination Treatment|Physician Decision|8|||
145793591|NCT01419665|525750841|FG000|Combination Treatment|Protocol Violation|6|||
145793592|NCT01419665|525750842|FG001|Combination Treatment|Protocol Violation|2|||
145793593|NCT01419665|525750841|FG000|Combination Treatment|disease progression|10|||
145793594|NCT01419665|525750842|FG001|Combination Treatment|disease progression|9|||
145793595|NCT01419665|525750841|FG000|Combination Treatment|Death|5|||
145793596|NCT01419665|525750842|FG001|Combination Treatment|Death|7|||
145793597|NCT01419665|525750841|FG000|Combination Treatment|administrative problems|0|||
145793598|NCT01419665|525750842|FG001|Combination Treatment|administrative problems|1|||
145793599|NCT01419665|525750841|FG000|Combination Treatment|Withdrawal by Subject|5|||
145793600|NCT01419665|525750842|FG001|Combination Treatment|Withdrawal by Subject|4|||
145793601|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
145793602|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
145793603|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
145793604|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
145793605|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
145793606|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
145793607|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
145793608|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
145793609|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
145793610|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
145793611|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
145793612|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
145793613|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Death|1|||
145793614|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Death|2|||
145793615|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
145793616|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
145793617|NCT01419665|525750841|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
145793618|NCT01419665|525750842|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
145793619|NCT01419665|525750841|FG000|Open Label Phase|Death|1|||
145793620|NCT01419665|525750842|FG001|Open Label Phase|Death|0|||
145793621|NCT01419665|525750841|FG000|Open Label Phase|disease progression|0|||
145793622|NCT01419665|525750842|FG001|Open Label Phase|disease progression|1|||
145793623|NCT01655823|525750844|FG000|Overall Study|Lost to Follow-up|0|||
145793624|NCT01655823|525750845|FG001|Overall Study|Lost to Follow-up|1|||
145793625|NCT01655823|525750846|FG002|Overall Study|Lost to Follow-up|0|||
145793626|NCT01655823|525750847|FG003|Overall Study|Lost to Follow-up|0|||
145793627|NCT01655823|525750848|FG004|Overall Study|Lost to Follow-up|1|||
145793628|NCT01655823|525750844|FG000|Overall Study|Withdrawal by Subject|0|||
145793629|NCT01655823|525750845|FG001|Overall Study|Withdrawal by Subject|1|||
145793630|NCT01655823|525750846|FG002|Overall Study|Withdrawal by Subject|0|||
145793631|NCT01655823|525750847|FG003|Overall Study|Withdrawal by Subject|1|||
145793632|NCT01655823|525750848|FG004|Overall Study|Withdrawal by Subject|0|||
145793633|NCT01627067|525750851|FG000|Overall Study|Screen Failure|1|||
145793634|NCT02632110|525750855|FG000|Overall Study|Withdrawal by Subject|1|||
145793635|NCT02632110|525750856|FG001|Overall Study|Withdrawal by Subject|1|||
145793636|NCT02632110|525750857|FG002|Overall Study|Withdrawal by Subject|0|||
145793637|NCT02632110|525750858|FG003|Overall Study|Withdrawal by Subject|0|||
145793638|NCT02632110|525750859|FG004|Overall Study|Withdrawal by Subject|1|||
145793639|NCT02632110|525750860|FG005|Overall Study|Withdrawal by Subject|1|||
145793640|NCT02632110|525750861|FG006|Overall Study|Withdrawal by Subject|3|||
145793641|NCT02632110|525750862|FG007|Overall Study|Withdrawal by Subject|3|||
145793642|NCT02632110|525750863|FG008|Overall Study|Withdrawal by Subject|1|||
145793643|NCT02632110|525750864|FG009|Overall Study|Withdrawal by Subject|1|||
145793644|NCT03352414|525750865|FG000|Overall Study|Ineligible by operative criteria|12|||
145793645|NCT03352414|525750866|FG001|Overall Study|Ineligible by operative criteria|10|||
145793646|NCT00516269|525750867|FG000|Overall Study|Adverse Event|2|||
145793647|NCT00516269|525750868|FG001|Overall Study|Adverse Event|1|||
145793648|NCT00516269|525750867|FG000|Overall Study|Lost to Follow-up|0|||
145793649|NCT00516269|525750868|FG001|Overall Study|Lost to Follow-up|1|||
145793650|NCT00516269|525750867|FG000|Overall Study|Protocol Violation|0|||
145793651|NCT00516269|525750868|FG001|Overall Study|Protocol Violation|1|||
145793652|NCT00926796|525750869|FG000|Overall Study|Did not receive randomized treatment|4|||
145793653|NCT00926796|525750870|FG001|Overall Study|Did not receive randomized treatment|7|||
145793654|NCT00926796|525750869|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
145793655|NCT00926796|525750870|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
145793656|NCT00926796|525750869|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
145793657|NCT00926796|525750870|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
145793658|NCT00926796|525750869|FG000|Overall Study|Adverse Event|7|||
145793659|NCT00926796|525750870|FG001|Overall Study|Adverse Event|14|||
145793660|NCT00926796|525750869|FG000|Overall Study|Lost to Follow-up|22|||
145793661|NCT00926796|525750870|FG001|Overall Study|Lost to Follow-up|13|||
145793662|NCT00926796|525750869|FG000|Overall Study|Protocol Violation|15|||
145793663|NCT00926796|525750870|FG001|Overall Study|Protocol Violation|11|||
145793664|NCT00926796|525750869|FG000|Overall Study|Withdrawal by Subject|1|||
145793665|NCT00926796|525750870|FG001|Overall Study|Withdrawal by Subject|0|||
145404835|NCT00091819|524338692|FG000|Overall Study|Withdrawal by Subject|5|||
145547095|NCT02846779|524861781|FG001|Overall Study|Lost Enrollment|82|||
145547096|NCT02846779|524861782|FG002|Overall Study|Lost Enrollment|86|||
145547097|NCT02846779|524861780|FG000|Overall Study|Less than 31 days of follow-up|56|||
145547098|NCT02846779|524861781|FG001|Overall Study|Less than 31 days of follow-up|45|||
145547099|NCT02846779|524861782|FG002|Overall Study|Less than 31 days of follow-up|52|||
145547100|NCT00911820|524863175|FG000|Overall Study|RECIST progression|12|||
145547101|NCT00911820|524863176|FG001|Overall Study|RECIST progression|8|||
145793666|NCT01341652|525750871|FG000|Overall Study|Incorrect Random Assignment|0|||
145793667|NCT01341652|525750872|FG001|Overall Study|Incorrect Random Assignment|1|||
145793668|NCT01341652|525750871|FG000|Overall Study|ineligible; presence metastatic disease|0|||
145793669|NCT01341652|525750872|FG001|Overall Study|ineligible; presence metastatic disease|1|||
145793670|NCT00586924|525750877|FG000|Overall Study|Adverse event/serious adverse event|0|||
145793671|NCT00586924|525750878|FG001|Overall Study|Adverse event/serious adverse event|0|||
145793672|NCT00586924|525750879|FG002|Overall Study|Adverse event/serious adverse event|0|||
145793673|NCT00586924|525750880|FG003|Overall Study|Adverse event/serious adverse event|1|||
145793674|NCT00586924|525750881|FG004|Overall Study|Adverse event/serious adverse event|0|||
145793675|NCT00586924|525750882|FG005|Overall Study|Adverse event/serious adverse event|2|||
145793676|NCT00586924|525750877|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
145793677|NCT00586924|525750878|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
145793678|NCT00586924|525750879|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
145793679|NCT00586924|525750880|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
145793680|NCT00586924|525750881|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
145793681|NCT00586924|525750882|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
145793682|NCT00586924|525750877|FG000|Overall Study|Disease progression|0|||
145793683|NCT00586924|525750878|FG001|Overall Study|Disease progression|0|||
145793684|NCT00586924|525750879|FG002|Overall Study|Disease progression|0|||
145793685|NCT00586924|525750880|FG003|Overall Study|Disease progression|1|||
145793686|NCT00586924|525750881|FG004|Overall Study|Disease progression|1|||
145793687|NCT00586924|525750882|FG005|Overall Study|Disease progression|0|||
145793688|NCT00586924|525750877|FG000|Overall Study|Development of neutralizing antibodies|2|||
145793689|NCT00586924|525750878|FG001|Overall Study|Development of neutralizing antibodies|2|||
145793690|NCT00586924|525750879|FG002|Overall Study|Development of neutralizing antibodies|2|||
145793691|NCT00586924|525750880|FG003|Overall Study|Development of neutralizing antibodies|0|||
145793692|NCT00586924|525750881|FG004|Overall Study|Development of neutralizing antibodies|0|||
145793693|NCT00586924|525750882|FG005|Overall Study|Development of neutralizing antibodies|22|||
145793694|NCT00586924|525750877|FG000|Overall Study|Complete response|0|||
145793695|NCT00586924|525750878|FG001|Overall Study|Complete response|1|||
145793696|NCT00586924|525750879|FG002|Overall Study|Complete response|0|||
145793697|NCT00586924|525750880|FG003|Overall Study|Complete response|0|||
145793698|NCT00586924|525750881|FG004|Overall Study|Complete response|2|||
145793699|NCT00586924|525750882|FG005|Overall Study|Complete response|2|||
145793700|NCT00586924|525750877|FG000|Overall Study|Other|1|||
145793701|NCT00586924|525750878|FG001|Overall Study|Other|0|||
145793702|NCT00586924|525750879|FG002|Overall Study|Other|1|||
145793703|NCT00586924|525750880|FG003|Overall Study|Other|1|||
145793704|NCT00586924|525750881|FG004|Overall Study|Other|1|||
145793705|NCT00586924|525750882|FG005|Overall Study|Other|6|||
145793706|NCT04570657|525750885|FG000|Overall Study|Adverse Event|0|||
145793707|NCT04570657|525750886|FG001|Overall Study|Adverse Event|0|||
145793708|NCT04570657|525750887|FG002|Overall Study|Adverse Event|1|||
145793709|NCT04570657|525750885|FG000|Overall Study|Lost to Follow-up|0|||
145793710|NCT04570657|525750886|FG001|Overall Study|Lost to Follow-up|0|||
145793711|NCT04570657|525750887|FG002|Overall Study|Lost to Follow-up|1|||
145793712|NCT04570657|525750885|FG000|Overall Study|Physician Decision|0|||
145793713|NCT04570657|525750886|FG001|Overall Study|Physician Decision|1|||
145793714|NCT04570657|525750887|FG002|Overall Study|Physician Decision|0|||
145793715|NCT04570657|525750885|FG000|Overall Study|Withdrawal by Subject|1|||
145793716|NCT04570657|525750886|FG001|Overall Study|Withdrawal by Subject|2|||
145793717|NCT04570657|525750887|FG002|Overall Study|Withdrawal by Subject|2|||
145793718|NCT01079962|525750888|FG000|Overall Study|Adverse Event|2|||
145793719|NCT01079962|525750889|FG001|Overall Study|Adverse Event|2|||
145793720|NCT01079962|525750888|FG000|Overall Study|Withdrawal by Subject|5|||
145793721|NCT01079962|525750889|FG001|Overall Study|Withdrawal by Subject|7|||
145793722|NCT01079962|525750888|FG000|Overall Study|Protocol Violation|2|||
145793723|NCT01079962|525750889|FG001|Overall Study|Protocol Violation|2|||
145793724|NCT01079962|525750888|FG000|Overall Study|No blood pressure (BP) control|3|||
145793725|NCT01079962|525750889|FG001|Overall Study|No blood pressure (BP) control|0|||
145793726|NCT01079962|525750888|FG000|Overall Study|Inclusion/exclusion criteria|1|||
145793727|NCT01079962|525750889|FG001|Overall Study|Inclusion/exclusion criteria|3|||
145793728|NCT01079962|525750888|FG000|Overall Study|Participant not returning for next visit|1|||
145793729|NCT01079962|525750889|FG001|Overall Study|Participant not returning for next visit|0|||
145793730|NCT01079962|525750888|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
145793731|NCT01079962|525750889|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
145793732|NCT01331239|525750890|FG000|Part II: Core Study|Adverse Event|0|||
145547102|NCT00911820|524863175|FG000|Overall Study|Adverse Event|8|||
145611175|NCT00235443|525092617|FG003|Overall Study|Lack of Efficacy|12|||
145611176|NCT00235443|525092618|FG004|Overall Study|Lack of Efficacy|2|||
145793733|NCT01331239|525750891|FG001|Part II: Core Study|Adverse Event|3|||
145793734|NCT01331239|525750892|FG002|Part II: Core Study|Adverse Event|0|||
145793735|NCT01331239|525750890|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
145793736|NCT01331239|525750891|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
145793737|NCT01331239|525750892|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
145793738|NCT01331239|525750890|FG000|Part II: Core Study|Withdrawal by Subject|0|||
145793739|NCT01331239|525750891|FG001|Part II: Core Study|Withdrawal by Subject|2|||
145793740|NCT01331239|525750892|FG002|Part II: Core Study|Withdrawal by Subject|0|||
145793741|NCT01331239|525750890|FG000|Part II: Core Study|Administrative problems|0|||
145793742|NCT01331239|525750891|FG001|Part II: Core Study|Administrative problems|1|||
145793743|NCT01331239|525750892|FG002|Part II: Core Study|Administrative problems|0|||
145793744|NCT01072539|525750893|FG000|Overall Study|Treated prior to the Site Initiation|1|||
145793745|NCT01072539|525750893|FG000|Overall Study|Protocol Violation|2|||
145793746|NCT01008995|525750895|FG000|Controlled Period|Adverse Event|1|||
145793747|NCT01008995|525750896|FG001|Controlled Period|Adverse Event|2|||
145793748|NCT01008995|525750897|FG002|Controlled Period|Adverse Event|0|||
145793749|NCT01008995|525750898|FG003|Controlled Period|Adverse Event|0|||
145793750|NCT01008995|525750895|FG000|Controlled Period|Other|2|||
145793751|NCT01008995|525750896|FG001|Controlled Period|Other|1|||
145793752|NCT01008995|525750897|FG002|Controlled Period|Other|0|||
145793753|NCT01008995|525750898|FG003|Controlled Period|Other|0|||
145793754|NCT01008995|525750895|FG000|After Controlled Period|Adverse Event|0|||
145793755|NCT01008995|525750896|FG001|After Controlled Period|Adverse Event|0|||
145793756|NCT01008995|525750897|FG002|After Controlled Period|Adverse Event|1|||
145793757|NCT01008995|525750898|FG003|After Controlled Period|Adverse Event|1|||
145793758|NCT01008995|525750895|FG000|After Controlled Period|Other|0|||
145793759|NCT01008995|525750896|FG001|After Controlled Period|Other|0|||
145793760|NCT01008995|525750897|FG002|After Controlled Period|Other|1|||
145793761|NCT01008995|525750898|FG003|After Controlled Period|Other|0|||
145793762|NCT00115804|525750899|FG000|Overall Study|Adverse Event|2|||
145793763|NCT00621855|525750902|FG000|Overall Study|Adverse Event|32|||
145793764|NCT00621855|525750903|FG001|Overall Study|Adverse Event|31|||
145793765|NCT00621855|525750904|FG002|Overall Study|Adverse Event|48|||
145793766|NCT00621855|525750905|FG003|Overall Study|Adverse Event|34|||
145793767|NCT00621855|525750906|FG004|Overall Study|Adverse Event|31|||
145793768|NCT00621855|525750902|FG000|Overall Study|Lost to Follow-up|0|||
145793769|NCT00621855|525750903|FG001|Overall Study|Lost to Follow-up|1|||
145793770|NCT00621855|525750904|FG002|Overall Study|Lost to Follow-up|3|||
145793771|NCT00621855|525750905|FG003|Overall Study|Lost to Follow-up|4|||
145793772|NCT00621855|525750906|FG004|Overall Study|Lost to Follow-up|1|||
145793773|NCT00621855|525750902|FG000|Overall Study|Protocol Violation|16|||
145793774|NCT00621855|525750903|FG001|Overall Study|Protocol Violation|8|||
145793775|NCT00621855|525750904|FG002|Overall Study|Protocol Violation|6|||
145793776|NCT00621855|525750905|FG003|Overall Study|Protocol Violation|7|||
145793777|NCT00621855|525750906|FG004|Overall Study|Protocol Violation|8|||
145793778|NCT00621855|525750902|FG000|Overall Study|Withdrawal by Subject|16|||
145793779|NCT00621855|525750903|FG001|Overall Study|Withdrawal by Subject|11|||
145793780|NCT00621855|525750904|FG002|Overall Study|Withdrawal by Subject|13|||
145793781|NCT00621855|525750905|FG003|Overall Study|Withdrawal by Subject|13|||
145793782|NCT00621855|525750906|FG004|Overall Study|Withdrawal by Subject|9|||
145793783|NCT00621855|525750902|FG000|Overall Study|Other|9|||
145793784|NCT00621855|525750903|FG001|Overall Study|Other|7|||
145793785|NCT00621855|525750904|FG002|Overall Study|Other|6|||
145793786|NCT00621855|525750905|FG003|Overall Study|Other|5|||
145793787|NCT00621855|525750906|FG004|Overall Study|Other|4|||
145793788|NCT00621855|525750902|FG000|Overall Study|Patients did not receive study drug|3|||
145793789|NCT00621855|525750903|FG001|Overall Study|Patients did not receive study drug|3|||
145611177|NCT00235443|525092619|FG005|Overall Study|Lack of Efficacy|9|||
145611178|NCT00235443|525092614|FG000|Overall Study|Withdrawal by Subject|3|||
145793790|NCT00621855|525750904|FG002|Overall Study|Patients did not receive study drug|5|||
145793791|NCT00621855|525750905|FG003|Overall Study|Patients did not receive study drug|4|||
145793792|NCT00621855|525750906|FG004|Overall Study|Patients did not receive study drug|2|||
145611179|NCT00235443|525092615|FG001|Overall Study|Withdrawal by Subject|9|||
145793793|NCT03731364|525750907|FG000|Overall Study|Adverse Event|0|||
145793794|NCT03731364|525750908|FG001|Overall Study|Adverse Event|0|||
145793795|NCT03731364|525750909|FG002|Overall Study|Adverse Event|1|||
145793796|NCT03731364|525750910|FG003|Overall Study|Adverse Event|2|||
145793797|NCT03731364|525750911|FG004|Overall Study|Adverse Event|1|||
145793798|NCT02953782|525750912|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
145793799|NCT02953782|525750913|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
145793800|NCT02953782|525750914|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
145793801|NCT02953782|525750915|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
145611180|NCT00235443|525092616|FG002|Overall Study|Withdrawal by Subject|25|||
145793802|NCT02953782|525750916|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
145793803|NCT02953782|525750917|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
145793804|NCT02953782|525750918|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
145793805|NCT02953782|525750919|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
145793806|NCT02953782|525750912|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
145793807|NCT02953782|525750913|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
145793808|NCT02953782|525750914|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
145793809|NCT02953782|525750915|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
145793810|NCT02953782|525750916|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
145793811|NCT02953782|525750917|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
145793812|NCT02953782|525750918|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
145793813|NCT02953782|525750919|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
145793814|NCT02953782|525750912|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
145793815|NCT02953782|525750913|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
145793816|NCT02953782|525750914|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
145793817|NCT02953782|525750915|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
145793818|NCT02953782|525750916|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
145793819|NCT02953782|525750917|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
145793820|NCT02953782|525750918|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
145793821|NCT02953782|525750919|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
145793822|NCT02953782|525750912|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793823|NCT02953782|525750913|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793824|NCT02953782|525750914|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
145793825|NCT02953782|525750915|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
145793826|NCT02953782|525750916|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793827|NCT02953782|525750917|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793828|NCT02953782|525750918|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793829|NCT02953782|525750919|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
145793830|NCT02953782|525750912|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
145793831|NCT02953782|525750913|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
145793832|NCT02953782|525750914|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
145793833|NCT02953782|525750915|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
145793834|NCT02953782|525750916|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
145793835|NCT02953782|525750917|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
145793836|NCT02953782|525750918|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
145793837|NCT02953782|525750919|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
145793838|NCT02953782|525750912|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
145793839|NCT02953782|525750913|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
145793840|NCT02953782|525750914|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
145793841|NCT02953782|525750915|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
145793842|NCT02953782|525750916|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
145793843|NCT02953782|525750917|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
145793844|NCT02953782|525750918|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
145793845|NCT02953782|525750919|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
145793846|NCT02953782|525750912|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
145793847|NCT02953782|525750913|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
145793848|NCT02953782|525750914|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
145793849|NCT02953782|525750915|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
145793850|NCT02953782|525750916|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
145793851|NCT02953782|525750917|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
145793852|NCT02953782|525750918|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
145793853|NCT02953782|525750919|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
145793854|NCT02953782|525750912|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793855|NCT02953782|525750913|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793856|NCT02953782|525750914|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793857|NCT02953782|525750915|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793858|NCT02953782|525750916|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793859|NCT02953782|525750917|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793860|NCT02953782|525750918|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
145793861|NCT02953782|525750919|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
145793862|NCT01934192|525750922|FG000|Overall Study|Protocol Violation|0|||
145793863|NCT01934192|525750923|FG001|Overall Study|Protocol Violation|0|||
145793864|NCT01934192|525750924|FG002|Overall Study|Protocol Violation|0|||
145793865|NCT01934192|525750925|FG003|Overall Study|Protocol Violation|1|||
145793866|NCT01934192|525750922|FG000|Overall Study|Other: reached stopping criteria|6|||
145793867|NCT01934192|525750923|FG001|Overall Study|Other: reached stopping criteria|5|||
145793868|NCT01934192|525750924|FG002|Overall Study|Other: reached stopping criteria|1|||
145793869|NCT01934192|525750925|FG003|Overall Study|Other: reached stopping criteria|0|||
145793870|NCT01934192|525750922|FG000|Overall Study|Physician Decision|3|||
145793871|NCT01934192|525750923|FG001|Overall Study|Physician Decision|2|||
145793872|NCT01934192|525750924|FG002|Overall Study|Physician Decision|0|||
145793873|NCT01934192|525750925|FG003|Overall Study|Physician Decision|0|||
145793874|NCT01737840|525750926|FG000|Overall Study|Diagnosed with an other pathology|2|||
145793875|NCT01737840|525750927|FG001|Overall Study|Diagnosed with an other pathology|2|||
145793876|NCT02357849|525750930|FG000|Overall Study|Withdrawal by Subject|2|||
145793877|NCT02357849|525750931|FG001|Overall Study|Withdrawal by Subject|3|||
145793878|NCT00403559|525750932|FG000|Overall Study|Adverse Event|0|||
145793879|NCT00403559|525750933|FG001|Overall Study|Adverse Event|1|||
145793880|NCT00403559|525750932|FG000|Overall Study|Lost to Follow-up|3|||
145793881|NCT00403559|525750933|FG001|Overall Study|Lost to Follow-up|3|||
145793882|NCT00403559|525750932|FG000|Overall Study|Withdrawal by Subject|1|||
145793883|NCT00403559|525750933|FG001|Overall Study|Withdrawal by Subject|0|||
145793884|NCT04105244|525750936|FG000|Overall Study|Withdrawal by Subject|10|||
145793885|NCT04105244|525750937|FG001|Overall Study|Withdrawal by Subject|12|||
145793886|NCT04105244|525750936|FG000|Overall Study|Lost to Follow-up|20|||
145793887|NCT04105244|525750937|FG001|Overall Study|Lost to Follow-up|15|||
145793888|NCT04105244|525750936|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
145793889|NCT04105244|525750937|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
145793890|NCT04105244|525750936|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
145793891|NCT04105244|525750937|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
145793892|NCT04633473|525750938|FG000|Overall Study|Withdrawal by Subject|6|||
145793893|NCT04387136|525750939|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
145793894|NCT04387136|525750940|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
145793895|NCT03294681|525750943|FG000|Overall Study|Withdrawal by Subject|1|||
145793896|NCT03089216|525750944|FG000|Overall Study|Adverse Event|0|||
145793897|NCT03089216|525750945|FG001|Overall Study|Adverse Event|0|||
145793898|NCT03089216|525750946|FG002|Overall Study|Adverse Event|0|||
145793899|NCT03089216|525750947|FG003|Overall Study|Adverse Event|1|||
145793900|NCT01348425|525750950|FG000|Overall Study|Imaging was not taken.|1|||
145793901|NCT01348425|525750951|FG001|Overall Study|Imaging was not taken.|1|||
145793902|NCT01968954|525750954|FG000|Overall Study|Adverse Event|6|||
145793903|NCT01968954|525750955|FG001|Overall Study|Adverse Event|3|||
145793904|NCT01968954|525750954|FG000|Overall Study|Death|1|||
145793905|NCT01968954|525750955|FG001|Overall Study|Death|2|||
145793906|NCT01968954|525750954|FG000|Overall Study|Lost to Follow-up|6|||
145793907|NCT01968954|525750955|FG001|Overall Study|Lost to Follow-up|4|||
145793908|NCT01968954|525750954|FG000|Overall Study|Withdrawal by Subject|20|||
145793909|NCT01968954|525750955|FG001|Overall Study|Withdrawal by Subject|23|||
145793910|NCT01968954|525750954|FG000|Overall Study|Other|7|||
145793911|NCT01968954|525750955|FG001|Overall Study|Other|8|||
145793912|NCT01968954|525750954|FG000|Overall Study|Protocol Violation|0|||
145793913|NCT01968954|525750955|FG001|Overall Study|Protocol Violation|1|||
145793914|NCT01968954|525750954|FG000|Overall Study|Did not met inclusion criteria|0|||
145793915|NCT01968954|525750955|FG001|Overall Study|Did not met inclusion criteria|2|||
145793916|NCT00064350|525750956|FG000|Induction Treatment|Disease Progression|5|||
145793917|NCT00064350|525750957|FG001|Induction Treatment|Disease Progression|1|||
145793918|NCT00064350|525750958|FG002|Induction Treatment|Disease Progression|110|||
145793919|NCT00064350|525750956|FG000|Induction Treatment|Adverse Event|0|||
145793920|NCT00064350|525750957|FG001|Induction Treatment|Adverse Event|2|||
145793921|NCT00064350|525750958|FG002|Induction Treatment|Adverse Event|49|||
145793922|NCT00064350|525750956|FG000|Induction Treatment|Death|0|||
145793923|NCT00064350|525750957|FG001|Induction Treatment|Death|0|||
145793924|NCT00064350|525750958|FG002|Induction Treatment|Death|9|||
145793925|NCT00064350|525750956|FG000|Induction Treatment|Withdrawal by Subject|0|||
145793926|NCT00064350|525750957|FG001|Induction Treatment|Withdrawal by Subject|0|||
145793927|NCT00064350|525750958|FG002|Induction Treatment|Withdrawal by Subject|21|||
145793928|NCT00064350|525750956|FG000|Induction Treatment|Ineligible or never started treatment|3|||
145793929|NCT00064350|525750957|FG001|Induction Treatment|Ineligible or never started treatment|6|||
145793930|NCT00064350|525750958|FG002|Induction Treatment|Ineligible or never started treatment|34|||
145793931|NCT00064350|525750956|FG000|Induction Treatment|Other|0|||
145793932|NCT00064350|525750957|FG001|Induction Treatment|Other|0|||
145793933|NCT00064350|525750958|FG002|Induction Treatment|Other|13|||
145793934|NCT00064350|525750956|FG000|Randomization|Adverse Event|8|||
145793935|NCT00064350|525750957|FG001|Randomization|Adverse Event|3|||
145793936|NCT00064350|525750958|FG002|Randomization|Adverse Event|0|||
145793937|NCT00064350|525750956|FG000|Randomization|Death|3|||
145793938|NCT00064350|525750957|FG001|Randomization|Death|0|||
145793939|NCT00064350|525750958|FG002|Randomization|Death|0|||
145793940|NCT00064350|525750956|FG000|Randomization|Withdrawal by Subject|1|||
145793941|NCT00064350|525750957|FG001|Randomization|Withdrawal by Subject|0|||
145793942|NCT00064350|525750958|FG002|Randomization|Withdrawal by Subject|0|||
145793943|NCT00064350|525750956|FG000|Randomization|Ineligible or never started treatment|9|||
145793944|NCT00064350|525750957|FG001|Randomization|Ineligible or never started treatment|15|||
145793945|NCT00064350|525750958|FG002|Randomization|Ineligible or never started treatment|0|||
145793946|NCT00064350|525750956|FG000|Randomization|Other|5|||
145793947|NCT00064350|525750957|FG001|Randomization|Other|0|||
145793948|NCT00064350|525750958|FG002|Randomization|Other|0|||
145793949|NCT00064350|525750956|FG000|Cross-Over|Adverse Event|0|||
145793950|NCT00064350|525750957|FG001|Cross-Over|Adverse Event|1|||
145793951|NCT00064350|525750958|FG002|Cross-Over|Adverse Event|0|||
145793952|NCT00064350|525750956|FG000|Cross-Over|Death|1|||
145793953|NCT00064350|525750957|FG001|Cross-Over|Death|3|||
145793954|NCT00064350|525750958|FG002|Cross-Over|Death|0|||
145793955|NCT00064350|525750956|FG000|Cross-Over|Withdrawal by Subject|2|||
145793956|NCT00064350|525750957|FG001|Cross-Over|Withdrawal by Subject|2|||
145793957|NCT00064350|525750958|FG002|Cross-Over|Withdrawal by Subject|0|||
145793958|NCT00064350|525750956|FG000|Cross-Over|Ineligible or never started treatment|3|||
145793959|NCT00064350|525750957|FG001|Cross-Over|Ineligible or never started treatment|6|||
145793960|NCT00064350|525750958|FG002|Cross-Over|Ineligible or never started treatment|0|||
145793961|NCT00064350|525750956|FG000|Cross-Over|Other|0|||
145793962|NCT00064350|525750957|FG001|Cross-Over|Other|2|||
145793963|NCT00064350|525750958|FG002|Cross-Over|Other|0|||
145793964|NCT03600714|525750959|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
145793965|NCT01935336|525750962|FG000|Overall Study|Adverse Event|1|||
145793966|NCT01935336|525750963|FG001|Overall Study|Adverse Event|0|||
145793967|NCT01935336|525750964|FG002|Overall Study|Adverse Event|0|||
145793968|NCT01935336|525750965|FG003|Overall Study|Adverse Event|0|||
145793969|NCT01935336|525750962|FG000|Overall Study|Progressive disease|5|||
145793970|NCT01935336|525750963|FG001|Overall Study|Progressive disease|3|||
145793971|NCT01935336|525750964|FG002|Overall Study|Progressive disease|47|||
145793972|NCT01935336|525750965|FG003|Overall Study|Progressive disease|66|||
145793973|NCT00592553|525750966|FG000|Overall Study|Protocol Noncompliance|1|||
145793974|NCT00592553|525750967|FG001|Overall Study|Protocol Noncompliance|0|||
145793975|NCT00592553|525750968|FG002|Overall Study|Protocol Noncompliance|0|||
145793976|NCT01208038|525750972|FG000|Overall Study|Withdrawal by Subject|1|||
145793977|NCT01877382|525750975|FG000|Dose Escalation|Progressive disease|2|||
145793978|NCT01877382|525750976|FG001|Dose Escalation|Progressive disease|0|||
145793979|NCT01877382|525750977|FG002|Dose Escalation|Progressive disease|1|||
145793980|NCT01877382|525750978|FG003|Dose Escalation|Progressive disease|6|||
145793981|NCT01877382|525750979|FG004|Dose Escalation|Progressive disease|1|||
145793982|NCT01877382|525750980|FG005|Dose Escalation|Progressive disease|0|||
145793983|NCT01877382|525750981|FG006|Dose Escalation|Progressive disease|3|||
145793984|NCT01877382|525750982|FG007|Dose Escalation|Progressive disease|10|||
145793985|NCT01877382|525750983|FG008|Dose Escalation|Progressive disease|4|||
145793986|NCT01877382|525750984|FG009|Dose Escalation|Progressive disease|2|||
145793987|NCT01877382|525750985|FG010|Dose Escalation|Progressive disease|3|||
145793988|NCT01877382|525750986|FG011|Dose Escalation|Progressive disease|3|||
145793989|NCT01877382|525750987|FG012|Dose Escalation|Progressive disease|13|||
145793990|NCT01877382|525750988|FG013|Dose Escalation|Progressive disease|1|||
145793991|NCT01877382|525750989|FG014|Dose Escalation|Progressive disease|0|||
145793992|NCT01877382|525750975|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
145793993|NCT01877382|525750976|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145793994|NCT01877382|525750977|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145793995|NCT01877382|525750978|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
145793996|NCT01877382|525750979|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145793997|NCT01877382|525750980|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145793998|NCT01877382|525750981|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
145793999|NCT01877382|525750982|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794000|NCT01877382|525750983|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794001|NCT01877382|525750984|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794002|NCT01877382|525750985|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794003|NCT01877382|525750986|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794004|NCT01877382|525750987|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794005|NCT01877382|525750988|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794006|NCT01877382|525750989|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794007|NCT01877382|525750975|FG000|Dose Escalation|Clinical progression|0|||
145547103|NCT00911820|524863176|FG001|Overall Study|Adverse Event|8|||
145794008|NCT01877382|525750976|FG001|Dose Escalation|Clinical progression|1|||
145794009|NCT01877382|525750977|FG002|Dose Escalation|Clinical progression|0|||
145794010|NCT01877382|525750978|FG003|Dose Escalation|Clinical progression|2|||
145794011|NCT01877382|525750979|FG004|Dose Escalation|Clinical progression|0|||
145794012|NCT01877382|525750980|FG005|Dose Escalation|Clinical progression|0|||
145794013|NCT01877382|525750981|FG006|Dose Escalation|Clinical progression|1|||
145794014|NCT01877382|525750982|FG007|Dose Escalation|Clinical progression|0|||
145794015|NCT01877382|525750983|FG008|Dose Escalation|Clinical progression|0|||
145794016|NCT01877382|525750984|FG009|Dose Escalation|Clinical progression|1|||
145794017|NCT01877382|525750985|FG010|Dose Escalation|Clinical progression|0|||
145794018|NCT01877382|525750986|FG011|Dose Escalation|Clinical progression|0|||
145794019|NCT01877382|525750987|FG012|Dose Escalation|Clinical progression|2|||
145794020|NCT01877382|525750988|FG013|Dose Escalation|Clinical progression|1|||
145794021|NCT01877382|525750989|FG014|Dose Escalation|Clinical progression|0|||
145794022|NCT01877382|525750975|FG000|Dose Escalation|Adverse Event|0|||
145794023|NCT01877382|525750976|FG001|Dose Escalation|Adverse Event|0|||
145794024|NCT01877382|525750977|FG002|Dose Escalation|Adverse Event|0|||
145794025|NCT01877382|525750978|FG003|Dose Escalation|Adverse Event|4|||
145794026|NCT01877382|525750979|FG004|Dose Escalation|Adverse Event|1|||
145794027|NCT01877382|525750980|FG005|Dose Escalation|Adverse Event|2|||
145794028|NCT01877382|525750981|FG006|Dose Escalation|Adverse Event|1|||
145794029|NCT01877382|525750982|FG007|Dose Escalation|Adverse Event|2|||
145794030|NCT01877382|525750983|FG008|Dose Escalation|Adverse Event|0|||
145794031|NCT01877382|525750984|FG009|Dose Escalation|Adverse Event|0|||
145794032|NCT01877382|525750985|FG010|Dose Escalation|Adverse Event|0|||
145794033|NCT01877382|525750986|FG011|Dose Escalation|Adverse Event|0|||
145794034|NCT01877382|525750987|FG012|Dose Escalation|Adverse Event|1|||
145794035|NCT01877382|525750988|FG013|Dose Escalation|Adverse Event|0|||
145794036|NCT01877382|525750989|FG014|Dose Escalation|Adverse Event|0|||
145794037|NCT01877382|525750975|FG000|Dose Escalation|Withdrawal by Subject|0|||
145794038|NCT01877382|525750976|FG001|Dose Escalation|Withdrawal by Subject|0|||
145794039|NCT01877382|525750977|FG002|Dose Escalation|Withdrawal by Subject|0|||
145794040|NCT01877382|525750978|FG003|Dose Escalation|Withdrawal by Subject|0|||
145794041|NCT01877382|525750979|FG004|Dose Escalation|Withdrawal by Subject|0|||
145794042|NCT01877382|525750980|FG005|Dose Escalation|Withdrawal by Subject|3|||
145794043|NCT01877382|525750981|FG006|Dose Escalation|Withdrawal by Subject|2|||
145794044|NCT01877382|525750982|FG007|Dose Escalation|Withdrawal by Subject|1|||
145794045|NCT01877382|525750983|FG008|Dose Escalation|Withdrawal by Subject|1|||
145794046|NCT01877382|525750984|FG009|Dose Escalation|Withdrawal by Subject|0|||
145794047|NCT01877382|525750985|FG010|Dose Escalation|Withdrawal by Subject|0|||
145794048|NCT01877382|525750986|FG011|Dose Escalation|Withdrawal by Subject|0|||
145794049|NCT01877382|525750987|FG012|Dose Escalation|Withdrawal by Subject|0|||
145794050|NCT01877382|525750988|FG013|Dose Escalation|Withdrawal by Subject|0|||
145794051|NCT01877382|525750989|FG014|Dose Escalation|Withdrawal by Subject|0|||
145794052|NCT01877382|525750975|FG000|Dose Escalation|Protocol Violation|0|||
145794053|NCT01877382|525750976|FG001|Dose Escalation|Protocol Violation|0|||
145794054|NCT01877382|525750977|FG002|Dose Escalation|Protocol Violation|0|||
145794055|NCT01877382|525750978|FG003|Dose Escalation|Protocol Violation|0|||
145794056|NCT01877382|525750979|FG004|Dose Escalation|Protocol Violation|0|||
145794057|NCT01877382|525750980|FG005|Dose Escalation|Protocol Violation|0|||
145794058|NCT01877382|525750981|FG006|Dose Escalation|Protocol Violation|1|||
145794059|NCT01877382|525750982|FG007|Dose Escalation|Protocol Violation|0|||
145794060|NCT01877382|525750983|FG008|Dose Escalation|Protocol Violation|0|||
145794061|NCT01877382|525750984|FG009|Dose Escalation|Protocol Violation|0|||
145794062|NCT01877382|525750985|FG010|Dose Escalation|Protocol Violation|0|||
145794063|NCT01877382|525750986|FG011|Dose Escalation|Protocol Violation|0|||
145794064|NCT01877382|525750987|FG012|Dose Escalation|Protocol Violation|0|||
145794065|NCT01877382|525750988|FG013|Dose Escalation|Protocol Violation|0|||
145794066|NCT01877382|525750989|FG014|Dose Escalation|Protocol Violation|0|||
145794067|NCT01877382|525750975|FG000|Dose Escalation|Study terminated by sponsor|0|||
145794068|NCT01877382|525750976|FG001|Dose Escalation|Study terminated by sponsor|0|||
145794069|NCT01877382|525750977|FG002|Dose Escalation|Study terminated by sponsor|0|||
145794070|NCT01877382|525750978|FG003|Dose Escalation|Study terminated by sponsor|0|||
145794071|NCT01877382|525750979|FG004|Dose Escalation|Study terminated by sponsor|0|||
145547104|NCT00911820|524863175|FG000|Overall Study|Clinical Progression|7|||
145794072|NCT01877382|525750980|FG005|Dose Escalation|Study terminated by sponsor|0|||
145547105|NCT00911820|524863176|FG001|Overall Study|Clinical Progression|5|||
145794073|NCT01877382|525750981|FG006|Dose Escalation|Study terminated by sponsor|0|||
145794074|NCT01877382|525750982|FG007|Dose Escalation|Study terminated by sponsor|1|||
145794075|NCT01877382|525750983|FG008|Dose Escalation|Study terminated by sponsor|1|||
145794076|NCT01877382|525750984|FG009|Dose Escalation|Study terminated by sponsor|0|||
145794077|NCT01877382|525750985|FG010|Dose Escalation|Study terminated by sponsor|0|||
145794078|NCT01877382|525750986|FG011|Dose Escalation|Study terminated by sponsor|0|||
145794079|NCT01877382|525750987|FG012|Dose Escalation|Study terminated by sponsor|3|||
145794080|NCT01877382|525750988|FG013|Dose Escalation|Study terminated by sponsor|0|||
145794081|NCT01877382|525750989|FG014|Dose Escalation|Study terminated by sponsor|0|||
145794082|NCT01877382|525750975|FG000|Dose Escalation|Death|0|||
145794083|NCT01877382|525750976|FG001|Dose Escalation|Death|0|||
145794084|NCT01877382|525750977|FG002|Dose Escalation|Death|0|||
145794085|NCT01877382|525750978|FG003|Dose Escalation|Death|0|||
145794086|NCT01877382|525750979|FG004|Dose Escalation|Death|0|||
145794087|NCT01877382|525750980|FG005|Dose Escalation|Death|0|||
145794088|NCT01877382|525750981|FG006|Dose Escalation|Death|0|||
145794089|NCT01877382|525750982|FG007|Dose Escalation|Death|1|||
145794090|NCT01877382|525750983|FG008|Dose Escalation|Death|0|||
145794091|NCT01877382|525750984|FG009|Dose Escalation|Death|0|||
145794092|NCT01877382|525750985|FG010|Dose Escalation|Death|0|||
145794093|NCT01877382|525750986|FG011|Dose Escalation|Death|0|||
145794094|NCT01877382|525750987|FG012|Dose Escalation|Death|1|||
145794095|NCT01877382|525750988|FG013|Dose Escalation|Death|1|||
145794096|NCT01877382|525750989|FG014|Dose Escalation|Death|0|||
145794097|NCT01877382|525750975|FG000|Dose Expansion|Progressive disease|0|||
145794098|NCT01877382|525750976|FG001|Dose Expansion|Progressive disease|0|||
145794099|NCT01877382|525750977|FG002|Dose Expansion|Progressive disease|0|||
145794100|NCT01877382|525750978|FG003|Dose Expansion|Progressive disease|0|||
145794101|NCT01877382|525750979|FG004|Dose Expansion|Progressive disease|0|||
145794102|NCT01877382|525750980|FG005|Dose Expansion|Progressive disease|0|||
145794103|NCT01877382|525750981|FG006|Dose Expansion|Progressive disease|0|||
145794104|NCT01877382|525750982|FG007|Dose Expansion|Progressive disease|0|||
145794105|NCT01877382|525750983|FG008|Dose Expansion|Progressive disease|0|||
145794106|NCT01877382|525750984|FG009|Dose Expansion|Progressive disease|0|||
145794107|NCT01877382|525750985|FG010|Dose Expansion|Progressive disease|0|||
145794108|NCT01877382|525750986|FG011|Dose Expansion|Progressive disease|0|||
145794109|NCT01877382|525750987|FG012|Dose Expansion|Progressive disease|0|||
145794110|NCT01877382|525750988|FG013|Dose Expansion|Progressive disease|0|||
145794111|NCT01877382|525750989|FG014|Dose Expansion|Progressive disease|11|||
145794112|NCT01877382|525750975|FG000|Dose Expansion|Clinical progression|0|||
145794113|NCT01877382|525750976|FG001|Dose Expansion|Clinical progression|0|||
145794114|NCT01877382|525750977|FG002|Dose Expansion|Clinical progression|0|||
145794115|NCT01877382|525750978|FG003|Dose Expansion|Clinical progression|0|||
145794116|NCT01877382|525750979|FG004|Dose Expansion|Clinical progression|0|||
145794117|NCT01877382|525750980|FG005|Dose Expansion|Clinical progression|0|||
145794118|NCT01877382|525750981|FG006|Dose Expansion|Clinical progression|0|||
145794119|NCT01877382|525750982|FG007|Dose Expansion|Clinical progression|0|||
145794120|NCT01877382|525750983|FG008|Dose Expansion|Clinical progression|0|||
145794121|NCT01877382|525750984|FG009|Dose Expansion|Clinical progression|0|||
145794122|NCT01877382|525750985|FG010|Dose Expansion|Clinical progression|0|||
145794123|NCT01877382|525750986|FG011|Dose Expansion|Clinical progression|0|||
145794124|NCT01877382|525750987|FG012|Dose Expansion|Clinical progression|0|||
145794125|NCT01877382|525750988|FG013|Dose Expansion|Clinical progression|0|||
145794126|NCT01877382|525750989|FG014|Dose Expansion|Clinical progression|6|||
145794127|NCT01877382|525750975|FG000|Dose Expansion|Adverse Event|0|||
145794128|NCT01877382|525750976|FG001|Dose Expansion|Adverse Event|0|||
145794129|NCT01877382|525750977|FG002|Dose Expansion|Adverse Event|0|||
145794130|NCT01877382|525750978|FG003|Dose Expansion|Adverse Event|0|||
145794131|NCT01877382|525750979|FG004|Dose Expansion|Adverse Event|0|||
145794132|NCT01877382|525750980|FG005|Dose Expansion|Adverse Event|0|||
145794133|NCT01877382|525750981|FG006|Dose Expansion|Adverse Event|0|||
145794134|NCT01877382|525750982|FG007|Dose Expansion|Adverse Event|0|||
145794135|NCT01877382|525750983|FG008|Dose Expansion|Adverse Event|0|||
145794136|NCT01877382|525750984|FG009|Dose Expansion|Adverse Event|0|||
145794137|NCT01877382|525750985|FG010|Dose Expansion|Adverse Event|0|||
145794138|NCT01877382|525750986|FG011|Dose Expansion|Adverse Event|0|||
145794139|NCT01877382|525750987|FG012|Dose Expansion|Adverse Event|0|||
145794140|NCT01877382|525750988|FG013|Dose Expansion|Adverse Event|0|||
145794141|NCT01877382|525750989|FG014|Dose Expansion|Adverse Event|1|||
145794142|NCT01877382|525750975|FG000|Dose Expansion|Death|0|||
145794143|NCT01877382|525750976|FG001|Dose Expansion|Death|0|||
145794144|NCT01877382|525750977|FG002|Dose Expansion|Death|0|||
145794145|NCT01877382|525750978|FG003|Dose Expansion|Death|0|||
145794146|NCT01877382|525750979|FG004|Dose Expansion|Death|0|||
145794147|NCT01877382|525750980|FG005|Dose Expansion|Death|0|||
145794148|NCT01877382|525750981|FG006|Dose Expansion|Death|0|||
145794149|NCT01877382|525750982|FG007|Dose Expansion|Death|0|||
145794150|NCT01877382|525750983|FG008|Dose Expansion|Death|0|||
145794151|NCT01877382|525750984|FG009|Dose Expansion|Death|0|||
145794152|NCT01877382|525750985|FG010|Dose Expansion|Death|0|||
145794153|NCT01877382|525750986|FG011|Dose Expansion|Death|0|||
145794154|NCT01877382|525750987|FG012|Dose Expansion|Death|0|||
145794155|NCT01877382|525750988|FG013|Dose Expansion|Death|0|||
145794156|NCT01877382|525750989|FG014|Dose Expansion|Death|1|||
145794157|NCT01877382|525750975|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794158|NCT01877382|525750976|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794159|NCT01877382|525750977|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794160|NCT01877382|525750978|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794161|NCT01877382|525750979|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794162|NCT01877382|525750980|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794163|NCT01877382|525750981|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145282764|NCT05017493|523884343|FG001|Overall Study|Protocol Violation|0|||
145282765|NCT01154153|523884344|FG000|Overall Study|Poor compliance to protocol|2|||
145547106|NCT00911820|524863175|FG000|Overall Study|Physician Decision|5|||
145547107|NCT00911820|524863176|FG001|Overall Study|Physician Decision|9|||
145547108|NCT00911820|524863175|FG000|Overall Study|Decline in Performance Status|4|||
145547109|NCT00911820|524863176|FG001|Overall Study|Decline in Performance Status|2|||
145547110|NCT00911820|524863175|FG000|Overall Study|Withdrawal by Subject|3|||
145547111|NCT00911820|524863176|FG001|Overall Study|Withdrawal by Subject|4|||
145794164|NCT01877382|525750982|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794165|NCT01877382|525750983|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794166|NCT01877382|525750984|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794167|NCT01877382|525750985|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794168|NCT01877382|525750986|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794169|NCT01877382|525750987|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794170|NCT01877382|525750988|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
145794171|NCT01877382|525750989|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
145794172|NCT00430521|525750990|FG000|Overall Study|Adverse Event|0|||
145794173|NCT00430521|525750991|FG001|Overall Study|Adverse Event|0|||
145794174|NCT00430521|525750992|FG002|Overall Study|Adverse Event|0|||
145794175|NCT00430521|525750993|FG003|Overall Study|Adverse Event|0|||
145794176|NCT00430521|525750994|FG004|Overall Study|Adverse Event|0|||
145794177|NCT00430521|525750995|FG005|Overall Study|Adverse Event|2|||
145794178|NCT00430521|525750996|FG006|Overall Study|Adverse Event|1|||
145794179|NCT00430521|525750997|FG007|Overall Study|Adverse Event|0|||
145794180|NCT00430521|525750990|FG000|Overall Study|Lost to Follow-up|7|||
145794181|NCT00430521|525750991|FG001|Overall Study|Lost to Follow-up|8|||
145794182|NCT00430521|525750992|FG002|Overall Study|Lost to Follow-up|3|||
145794183|NCT00430521|525750993|FG003|Overall Study|Lost to Follow-up|5|||
145794184|NCT00430521|525750994|FG004|Overall Study|Lost to Follow-up|5|||
145794185|NCT00430521|525750995|FG005|Overall Study|Lost to Follow-up|2|||
145794186|NCT00430521|525750996|FG006|Overall Study|Lost to Follow-up|8|||
145794187|NCT00430521|525750997|FG007|Overall Study|Lost to Follow-up|10|||
145794188|NCT00430521|525750990|FG000|Overall Study|Pregnancy|0|||
145794189|NCT00430521|525750991|FG001|Overall Study|Pregnancy|0|||
145794190|NCT00430521|525750992|FG002|Overall Study|Pregnancy|0|||
145794191|NCT00430521|525750993|FG003|Overall Study|Pregnancy|0|||
145794192|NCT00430521|525750994|FG004|Overall Study|Pregnancy|0|||
145794193|NCT00430521|525750995|FG005|Overall Study|Pregnancy|0|||
145794194|NCT00430521|525750996|FG006|Overall Study|Pregnancy|1|||
145794195|NCT00430521|525750997|FG007|Overall Study|Pregnancy|0|||
145794196|NCT00430521|525750990|FG000|Overall Study|Vaccine Expired|0|||
145794197|NCT00430521|525750991|FG001|Overall Study|Vaccine Expired|0|||
145794198|NCT00430521|525750992|FG002|Overall Study|Vaccine Expired|0|||
145794199|NCT00430521|525750993|FG003|Overall Study|Vaccine Expired|0|||
145794200|NCT00430521|525750994|FG004|Overall Study|Vaccine Expired|0|||
145794201|NCT00430521|525750995|FG005|Overall Study|Vaccine Expired|1|||
145794202|NCT00430521|525750996|FG006|Overall Study|Vaccine Expired|0|||
145794203|NCT00430521|525750997|FG007|Overall Study|Vaccine Expired|0|||
145794204|NCT00430521|525750990|FG000|Overall Study|Protocol Violation|1|||
145794205|NCT00430521|525750991|FG001|Overall Study|Protocol Violation|0|||
145794206|NCT00430521|525750992|FG002|Overall Study|Protocol Violation|0|||
145794207|NCT00430521|525750993|FG003|Overall Study|Protocol Violation|0|||
145794208|NCT00430521|525750994|FG004|Overall Study|Protocol Violation|0|||
145794209|NCT00430521|525750995|FG005|Overall Study|Protocol Violation|0|||
145794210|NCT00430521|525750996|FG006|Overall Study|Protocol Violation|0|||
145794211|NCT00430521|525750997|FG007|Overall Study|Protocol Violation|0|||
145794212|NCT00430521|525750990|FG000|Overall Study|Withdrawal by Subject|3|||
145794213|NCT00430521|525750991|FG001|Overall Study|Withdrawal by Subject|1|||
145794214|NCT00430521|525750992|FG002|Overall Study|Withdrawal by Subject|0|||
145794215|NCT00430521|525750993|FG003|Overall Study|Withdrawal by Subject|3|||
145794216|NCT00430521|525750994|FG004|Overall Study|Withdrawal by Subject|0|||
145794217|NCT00430521|525750995|FG005|Overall Study|Withdrawal by Subject|0|||
145794218|NCT00430521|525750996|FG006|Overall Study|Withdrawal by Subject|0|||
145794219|NCT00430521|525750997|FG007|Overall Study|Withdrawal by Subject|2|||
145794220|NCT04092816|525752849|FG000|Overall Study|Lost to Follow-up|1|||
145794221|NCT04092816|525752850|FG001|Overall Study|Lost to Follow-up|2|||
145794222|NCT00369967|525752852|FG000|Overall Study|Lost to Follow-up|23|||
145794223|NCT00369967|525752853|FG001|Overall Study|Lost to Follow-up|12|||
145794224|NCT03073213|525752858|FG000|Multiple Dose Period|Protocol Violation|0|||
145794225|NCT03073213|525752859|FG001|Multiple Dose Period|Protocol Violation|0|||
145794226|NCT03073213|525752860|FG002|Multiple Dose Period|Protocol Violation|1|||
145794227|NCT02690207|525752866|FG000|Overall Study|Lost to Follow-up|48|||
145794228|NCT02690207|525752866|FG000|Overall Study|Withdrawal by Subject|46|||
145794229|NCT02690207|525752866|FG000|Overall Study|Protocol Violation|2|||
145794230|NCT02690207|525752866|FG000|Overall Study|Serious adverse event|110|||
145547112|NCT00911820|524863175|FG000|Overall Study|Death|1|||
145794231|NCT02690207|525752866|FG000|Overall Study|Non-serious Adverse Event|18|||
145794232|NCT02690207|525752866|FG000|Overall Study|Migrated/moved from study area|5|||
145794233|NCT02690207|525752866|FG000|Overall Study|Suspected HZ Episode|1|||
145794234|NCT02690207|525752866|FG000|Overall Study|Other reasons for withdrawal|23|||
145794235|NCT03162055|525752869|FG000|Overall Study|Adverse Event|6|||
145794236|NCT03162055|525752870|FG001|Overall Study|Adverse Event|5|||
145794237|NCT03162055|525752869|FG000|Overall Study|Death|3|||
145794238|NCT03162055|525752870|FG001|Overall Study|Death|3|||
145794239|NCT03162055|525752869|FG000|Overall Study|Lost to Follow-up|0|||
145794240|NCT03162055|525752870|FG001|Overall Study|Lost to Follow-up|1|||
145794241|NCT03162055|525752869|FG000|Overall Study|Study-specific withdrawal criteria|22|||
145794242|NCT03162055|525752870|FG001|Overall Study|Study-specific withdrawal criteria|14|||
145794243|NCT03162055|525752869|FG000|Overall Study|Withdrawal by Subject|17|||
145794244|NCT03162055|525752870|FG001|Overall Study|Withdrawal by Subject|2|||
145794245|NCT03162055|525752869|FG000|Overall Study|Did not receive treatment|2|||
145794246|NCT03162055|525752870|FG001|Overall Study|Did not receive treatment|0|||
145794247|NCT03162055|525752869|FG000|Overall Study|Incorrect randomization|4|||
145794248|NCT03162055|525752870|FG001|Overall Study|Incorrect randomization|3|||
145794249|NCT03162055|525752869|FG000|Overall Study|Other|8|||
145794250|NCT03162055|525752870|FG001|Overall Study|Other|15|||
145794251|NCT01993615|525752871|FG000|Overall Study|Death|1|||
145794252|NCT01993615|525752872|FG001|Overall Study|Death|0|||
145794253|NCT02282982|525752878|FG000|Overall Study|Lost to Follow-up|15|||
145794254|NCT02282982|525752878|FG000|Overall Study|Withdrew consent|2|||
145794255|NCT02282982|525752878|FG000|Overall Study|Death|4|||
145794256|NCT02282982|525752878|FG000|Overall Study|Lack of product|156|||
145794257|NCT02282982|525752878|FG000|Overall Study|Palivizumab is ended|11|||
145794258|NCT02282982|525752878|FG000|Overall Study|Other, not specified|18|||
145794259|NCT02924688|525752881|FG000|Overall Study|Adverse Event|9|||
145794260|NCT02924688|525752882|FG001|Overall Study|Adverse Event|3|||
145794261|NCT02924688|525752883|FG002|Overall Study|Adverse Event|2|||
145794262|NCT02924688|525752884|FG003|Overall Study|Adverse Event|2|||
145794263|NCT02924688|525752885|FG004|Overall Study|Adverse Event|3|||
145794264|NCT02924688|525752886|FG005|Overall Study|Adverse Event|2|||
145794265|NCT02924688|525752881|FG000|Overall Study|Lack of Efficacy|2|||
145794266|NCT02924688|525752882|FG001|Overall Study|Lack of Efficacy|3|||
145794267|NCT02924688|525752883|FG002|Overall Study|Lack of Efficacy|4|||
145794268|NCT02924688|525752884|FG003|Overall Study|Lack of Efficacy|2|||
145794269|NCT02924688|525752885|FG004|Overall Study|Lack of Efficacy|1|||
145794270|NCT02924688|525752886|FG005|Overall Study|Lack of Efficacy|1|||
145794271|NCT02924688|525752881|FG000|Overall Study|Protocol Violation|3|||
145794272|NCT02924688|525752882|FG001|Overall Study|Protocol Violation|7|||
145794273|NCT02924688|525752883|FG002|Overall Study|Protocol Violation|5|||
145794274|NCT02924688|525752884|FG003|Overall Study|Protocol Violation|6|||
145794275|NCT02924688|525752885|FG004|Overall Study|Protocol Violation|2|||
145794276|NCT02924688|525752886|FG005|Overall Study|Protocol Violation|2|||
145794277|NCT02924688|525752881|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
145794278|NCT02924688|525752882|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
145794279|NCT02924688|525752883|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
145794280|NCT02924688|525752884|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
145794281|NCT02924688|525752885|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
145794282|NCT02924688|525752886|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
145794283|NCT02924688|525752881|FG000|Overall Study|Lost to Follow-up|2|||
145794284|NCT02924688|525752882|FG001|Overall Study|Lost to Follow-up|4|||
145794285|NCT02924688|525752883|FG002|Overall Study|Lost to Follow-up|2|||
145794286|NCT02924688|525752884|FG003|Overall Study|Lost to Follow-up|4|||
145794287|NCT02924688|525752885|FG004|Overall Study|Lost to Follow-up|2|||
145794288|NCT02924688|525752886|FG005|Overall Study|Lost to Follow-up|4|||
145794289|NCT02924688|525752881|FG000|Overall Study|Physician Decision|2|||
145794290|NCT02924688|525752882|FG001|Overall Study|Physician Decision|1|||
145794291|NCT02924688|525752883|FG002|Overall Study|Physician Decision|0|||
145794292|NCT02924688|525752884|FG003|Overall Study|Physician Decision|1|||
145794293|NCT02924688|525752885|FG004|Overall Study|Physician Decision|1|||
145794294|NCT02924688|525752886|FG005|Overall Study|Physician Decision|1|||
145794295|NCT02924688|525752881|FG000|Overall Study|Withdrawal by Subject|14|||
145794296|NCT02924688|525752882|FG001|Overall Study|Withdrawal by Subject|13|||
145794297|NCT02924688|525752883|FG002|Overall Study|Withdrawal by Subject|9|||
145282766|NCT01154153|523884345|FG001|Overall Study|Poor compliance to protocol|0|||
145794298|NCT02924688|525752884|FG003|Overall Study|Withdrawal by Subject|12|||
145794299|NCT02924688|525752885|FG004|Overall Study|Withdrawal by Subject|13|||
145794300|NCT02924688|525752886|FG005|Overall Study|Withdrawal by Subject|14|||
145794301|NCT02370498|525752892|FG000|Overall Study|Adverse Event|10|||
145794302|NCT02370498|525752893|FG001|Overall Study|Adverse Event|8|||
145794303|NCT02370498|525752892|FG000|Overall Study|Death|263|||
145794304|NCT02370498|525752893|FG001|Overall Study|Death|265|||
145794305|NCT02370498|525752892|FG000|Overall Study|Protocol Violation|1|||
145794306|NCT02370498|525752893|FG001|Overall Study|Protocol Violation|2|||
145794307|NCT02370498|525752892|FG000|Overall Study|Withdrawal by Subject|7|||
145794308|NCT02370498|525752893|FG001|Overall Study|Withdrawal by Subject|12|||
145794309|NCT02370498|525752892|FG000|Overall Study|Sponsor's decision|15|||
145794310|NCT02370498|525752893|FG001|Overall Study|Sponsor's decision|9|||
145794311|NCT03225716|525752897|FG000|Overall Study|Withdrawal by Subject|2|||
145794312|NCT03225716|525752898|FG001|Overall Study|Withdrawal by Subject|2|||
145794313|NCT03225716|525752899|FG002|Overall Study|Withdrawal by Subject|0|||
145794314|NCT03225716|525752897|FG000|Overall Study|Lack of Efficacy|1|||
145794315|NCT03225716|525752898|FG001|Overall Study|Lack of Efficacy|0|||
145794316|NCT03225716|525752899|FG002|Overall Study|Lack of Efficacy|0|||
145794317|NCT03225716|525752897|FG000|Overall Study|Adverse Event|2|||
145794318|NCT03225716|525752898|FG001|Overall Study|Adverse Event|0|||
145794319|NCT03225716|525752899|FG002|Overall Study|Adverse Event|1|||
145794320|NCT03225716|525752897|FG000|Overall Study|Study early termination by Sponsor|0|||
145794321|NCT03225716|525752898|FG001|Overall Study|Study early termination by Sponsor|0|||
145794322|NCT03225716|525752899|FG002|Overall Study|Study early termination by Sponsor|2|||
145794323|NCT01205451|525752910|FG000|Overall Study|Lost to Follow-up|1|||
145794324|NCT01205451|525752911|FG001|Overall Study|Lost to Follow-up|1|||
145794325|NCT01205451|525752910|FG000|Overall Study|Withdrawal by Subject|5|||
145794326|NCT01205451|525752911|FG001|Overall Study|Withdrawal by Subject|9|||
145794327|NCT00229203|525752915|FG000|Overall Study|Progressive disease|18|||
145794328|NCT00229203|525752916|FG001|Overall Study|Progressive disease|9|||
145794329|NCT00229203|525752915|FG000|Overall Study|Toxicity|6|||
145794330|NCT00229203|525752916|FG001|Overall Study|Toxicity|1|||
145794331|NCT00229203|525752915|FG000|Overall Study|Death|4|||
145794332|NCT00229203|525752916|FG001|Overall Study|Death|2|||
145794333|NCT00229203|525752915|FG000|Overall Study|Other|3|||
145794334|NCT00229203|525752916|FG001|Overall Study|Other|3|||
145794335|NCT00229203|525752915|FG000|Overall Study|Withdrawal by Subject|1|||
145794336|NCT00229203|525752916|FG001|Overall Study|Withdrawal by Subject|4|||
145794337|NCT03457103|525752917|FG000|Overall Study|illness/hospitalization|4|||
145794338|NCT03457103|525752918|FG001|Overall Study|illness/hospitalization|2|||
145794339|NCT03457103|525752917|FG000|Overall Study|Lost to Follow-up|2|||
145794340|NCT03457103|525752918|FG001|Overall Study|Lost to Follow-up|1|||
145794341|NCT03457103|525752917|FG000|Overall Study|Withdrawal by Subject|1|||
145794342|NCT03457103|525752918|FG001|Overall Study|Withdrawal by Subject|2|||
145794343|NCT03457103|525752917|FG000|Overall Study|financial/ insurance issues|1|||
145794344|NCT03457103|525752918|FG001|Overall Study|financial/ insurance issues|1|||
145794345|NCT02411201|525752919|FG000|Overall Study|Adverse Event|2|||
145794346|NCT02411201|525752919|FG000|Overall Study|Withdrawal by Subject|2|||
145794347|NCT02411201|525752919|FG000|Overall Study|Age group completed|2|||
145794348|NCT00798694|525752920|FG000|Overall Study|Lost to Follow-up|1|||
145794349|NCT00798694|525752921|FG001|Overall Study|Lost to Follow-up|1|||
145794350|NCT00798694|525752920|FG000|Overall Study|Physician Decision|1|||
145794351|NCT00798694|525752921|FG001|Overall Study|Physician Decision|0|||
145794352|NCT01774344|525752923|FG000|Overall Study|Withdrawal by Subject|3|||
145794353|NCT01774344|525752924|FG001|Overall Study|Withdrawal by Subject|10|||
145794354|NCT01774344|525752923|FG000|Overall Study|Protocol Violation|0|||
145794355|NCT01774344|525752924|FG001|Overall Study|Protocol Violation|1|||
145794356|NCT01774344|525752923|FG000|Overall Study|Lost to Follow-up|4|||
145794357|NCT01774344|525752924|FG001|Overall Study|Lost to Follow-up|10|||
145794358|NCT01774344|525752923|FG000|Overall Study|End of survival follow-up not available|2|||
145794359|NCT01774344|525752924|FG001|Overall Study|End of survival follow-up not available|2|||
145794360|NCT01774344|525752923|FG000|Overall Study|Data collection finished|4|||
145794361|NCT01774344|525752924|FG001|Overall Study|Data collection finished|14|||
145794362|NCT01774344|525752923|FG000|Overall Study|Other|0|||
145794363|NCT01774344|525752924|FG001|Overall Study|Other|1|||
145794364|NCT01774344|525752923|FG000|Overall Study|Did not enter Survival Follow up|49|||
145794365|NCT01774344|525752924|FG001|Overall Study|Did not enter Survival Follow up|83|||
145794366|NCT03364608|525752933|FG000|Overall Study|Withdrawal by Subject|4|||
145794367|NCT03364608|525752933|FG000|Overall Study|Protocol Violation|2|||
145794368|NCT03364608|525752933|FG000|Overall Study|Lost to Follow-up|2|||
145794369|NCT03004469|525752936|FG000|Overall Study|Adverse Event|6|||
145794370|NCT03004469|525752937|FG001|Overall Study|Adverse Event|4|||
145794371|NCT03004469|525752938|FG002|Overall Study|Adverse Event|6|||
145794372|NCT03004469|525752936|FG000|Overall Study|Lack of Efficacy|1|||
145794373|NCT03004469|525752937|FG001|Overall Study|Lack of Efficacy|0|||
145794374|NCT03004469|525752938|FG002|Overall Study|Lack of Efficacy|1|||
145794375|NCT03004469|525752936|FG000|Overall Study|Lost to Follow-up|23|||
145794376|NCT03004469|525752937|FG001|Overall Study|Lost to Follow-up|14|||
145794377|NCT03004469|525752938|FG002|Overall Study|Lost to Follow-up|6|||
145794378|NCT03004469|525752936|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145794379|NCT03004469|525752937|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145794380|NCT03004469|525752938|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145794381|NCT03004469|525752936|FG000|Overall Study|Protocol Violation|0|||
145794382|NCT03004469|525752937|FG001|Overall Study|Protocol Violation|0|||
145794383|NCT03004469|525752938|FG002|Overall Study|Protocol Violation|1|||
145794384|NCT03004469|525752936|FG000|Overall Study|Withdrawal by Subject|29|||
145794385|NCT03004469|525752937|FG001|Overall Study|Withdrawal by Subject|27|||
145794386|NCT03004469|525752938|FG002|Overall Study|Withdrawal by Subject|10|||
145794387|NCT03004469|525752936|FG000|Overall Study|Other unspecified reason|0|||
145794388|NCT03004469|525752937|FG001|Overall Study|Other unspecified reason|4|||
145794389|NCT03004469|525752938|FG002|Overall Study|Other unspecified reason|1|||
145794390|NCT01163253|525752939|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
145794391|NCT01163253|525752940|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
145794392|NCT01163253|525752939|FG000|Overall Study|Study Terminated by Sponsor|978|||
145794393|NCT01163253|525752940|FG001|Overall Study|Study Terminated by Sponsor|349|||
145794394|NCT01163253|525752939|FG000|Overall Study|Protocol Violation|43|||
145794395|NCT01163253|525752940|FG001|Overall Study|Protocol Violation|12|||
145794396|NCT01163253|525752939|FG000|Overall Study|Withdrawal by Subject|199|||
145794397|NCT01163253|525752940|FG001|Overall Study|Withdrawal by Subject|50|||
145794398|NCT01163253|525752939|FG000|Overall Study|Medication Error|1|||
145794399|NCT01163253|525752940|FG001|Overall Study|Medication Error|0|||
145794400|NCT01163253|525752939|FG000|Overall Study|Lost to Follow-up|125|||
145794401|NCT01163253|525752940|FG001|Overall Study|Lost to Follow-up|23|||
145794402|NCT01163253|525752939|FG000|Overall Study|Insufficient Clinical Response|423|||
145794403|NCT01163253|525752940|FG001|Overall Study|Insufficient Clinical Response|29|||
145794404|NCT01163253|525752939|FG000|Overall Study|Adverse Event|300|||
145794405|NCT01163253|525752940|FG001|Overall Study|Adverse Event|78|||
145794406|NCT01163253|525752939|FG000|Overall Study|Death|17|||
145794407|NCT01163253|525752940|FG001|Overall Study|Death|5|||
145794408|NCT01163253|525752939|FG000|Overall Study|Ongoing|13|||
145794409|NCT01163253|525752940|FG001|Overall Study|Ongoing|4|||
145794410|NCT01163253|525752939|FG000|Overall Study|Other Unspecified|170|||
145794411|NCT01163253|525752940|FG001|Overall Study|Other Unspecified|34|||
145794412|NCT02492997|525752941|FG000|Overall Study|Withdrawal by Subject|1|||
145794413|NCT02492997|525752942|FG001|Overall Study|Withdrawal by Subject|0|||
145794414|NCT02492997|525752941|FG000|Overall Study|Gained Weight|1|||
145794415|NCT02492997|525752942|FG001|Overall Study|Gained Weight|0|||
145794416|NCT02492997|525752941|FG000|Overall Study|Lost to Follow-up|0|||
145794417|NCT02492997|525752942|FG001|Overall Study|Lost to Follow-up|1|||
145794418|NCT00579501|525752948|FG000|Overall Study|Death|1|||
145794419|NCT00579501|525752948|FG000|Overall Study|End of neoadjuvant therapy|25|||
145794420|NCT00579501|525752948|FG000|Overall Study|toxicity|1|||
145794421|NCT00579501|525752948|FG000|Overall Study|Secondary lesion|1|||
145794422|NCT00579501|525752948|FG000|Overall Study|Radiation therapy before surgery|1|||
145794423|NCT01089582|525752949|FG000|Overall Study|Death|2|||
145794424|NCT01089582|525752949|FG000|Overall Study|Adverse Event|15|||
145794425|NCT01089582|525752949|FG000|Overall Study|Lost to Follow-up|8|||
145794426|NCT01089582|525752949|FG000|Overall Study|Other|4|||
145794427|NCT01089582|525752949|FG000|Overall Study|Withdrawal by Subject|1|||
145794428|NCT04069156|525752950|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
145794429|NCT04069156|525752951|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
145794430|NCT04069156|525752950|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
145794431|NCT04069156|525752951|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
145794432|NCT04069156|525752950|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
145794433|NCT04069156|525752951|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
145794434|NCT04069156|525752950|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
145794435|NCT04069156|525752951|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
145794436|NCT02394808|525752952|FG000|Period 1|Unsatisfactory lens fitting|0|||
145794437|NCT02394808|525752953|FG001|Period 1|Unsatisfactory lens fitting|1|||
145794438|NCT02394808|525752952|FG000|Period 2|Lost to Follow-up|1|||
145794439|NCT02394808|525752953|FG001|Period 2|Lost to Follow-up|0|||
145794440|NCT02130427|525752954|FG000|Overall Study|Imaging results not interpretable|30|||
145794441|NCT04032171|525752956|FG000|Overall Study|Study Termination|1|||
145794442|NCT04032171|525752957|FG001|Overall Study|Study Termination|0|||
145794443|NCT00089479|525752966|FG000|Overall Study|Death|108|||
145794444|NCT00089479|525752967|FG001|Overall Study|Death|75|||
145794445|NCT00089479|525752966|FG000|Overall Study|Withdrawal by Subject|86|||
145794446|NCT00089479|525752967|FG001|Overall Study|Withdrawal by Subject|107|||
145794447|NCT00089479|525752966|FG000|Overall Study|Lost to Follow-up|137|||
145794448|NCT00089479|525752967|FG001|Overall Study|Lost to Follow-up|107|||
145794449|NCT00289185|525752968|FG000|Overall Study|Withdrawal by Subject|4|||
145794450|NCT00289185|525752969|FG001|Overall Study|Withdrawal by Subject|8|||
145547113|NCT00911820|524863176|FG001|Overall Study|Death|2|||
145794451|NCT00289185|525752968|FG000|Overall Study|Lost to Follow-up|23|||
145794452|NCT00289185|525752969|FG001|Overall Study|Lost to Follow-up|17|||
145794453|NCT00289185|525752968|FG000|Overall Study|Death|1|||
145794454|NCT00289185|525752969|FG001|Overall Study|Death|1|||
145547114|NCT00911820|524863175|FG000|Overall Study|Pursue surgery|1|||
145794455|NCT01124448|525752974|FG000|Overall Study|Lost to Follow-up|0|||
145794456|NCT01124448|525752975|FG001|Overall Study|Lost to Follow-up|3|||
145794457|NCT01124448|525752974|FG000|Overall Study|Protocol Violation|2|||
145794458|NCT01124448|525752975|FG001|Overall Study|Protocol Violation|0|||
145794459|NCT03247413|525752978|FG000|Overall Study|Lost to Follow-up|28|||
145794460|NCT03337152|525752981|FG000|Overall Study|Physician Decision|1|||
145794461|NCT03337152|525752982|FG001|Overall Study|Physician Decision|0|||
145794462|NCT03337152|525752981|FG000|Overall Study|Lost to Follow-up|1|||
145794463|NCT03337152|525752982|FG001|Overall Study|Lost to Follow-up|3|||
145794464|NCT03337152|525752981|FG000|Overall Study|Adverse Event|3|||
145794465|NCT03337152|525752982|FG001|Overall Study|Adverse Event|1|||
145794466|NCT03337152|525752981|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
145794467|NCT03337152|525752982|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
145794468|NCT04863014|525752983|FG000|Overall Study|Lost to Follow-up|3|||
145794469|NCT04863014|525752984|FG001|Overall Study|Lost to Follow-up|2|||
145794470|NCT04863014|525752983|FG000|Overall Study|Subject Decision|0|||
145794471|NCT04863014|525752984|FG001|Overall Study|Subject Decision|4|||
145794472|NCT00417976|525752985|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
145794473|NCT00417976|525752985|FG000|Overall Study|Treatment -related toxicity|2|||
145794474|NCT01752842|525752986|FG000|Overall Study|Adverse Event|3|||
145794475|NCT01752842|525752987|FG001|Overall Study|Adverse Event|0|||
145794476|NCT01752842|525752986|FG000|Overall Study|Withdrawal by Subject|0|||
145794477|NCT01752842|525752987|FG001|Overall Study|Withdrawal by Subject|2|||
145794478|NCT03707158|525752988|FG000|Midtreatment|Lost to Follow-up|16|||
145794479|NCT03707158|525752989|FG001|Midtreatment|Lost to Follow-up|7|||
145794480|NCT03707158|525752988|FG000|Midtreatment|Withdrawal by Subject|28|||
145794481|NCT03707158|525752989|FG001|Midtreatment|Withdrawal by Subject|19|||
145794482|NCT03707158|525752988|FG000|Posttreatment|Lost to Follow-up|0|||
145794483|NCT03707158|525752989|FG001|Posttreatment|Lost to Follow-up|5|||
145794484|NCT03707158|525752988|FG000|Follow-up|Lost to Follow-up|19|||
145794485|NCT03707158|525752989|FG001|Follow-up|Lost to Follow-up|18|||
145794486|NCT03707158|525752988|FG000|Follow-up|Withdrawal by Subject|13|||
145794487|NCT03707158|525752989|FG001|Follow-up|Withdrawal by Subject|6|||
145794488|NCT03260205|525752990|FG000|Overall Study|Adverse Event|2|||
145794489|NCT03260205|525752991|FG001|Overall Study|Adverse Event|0|||
145794490|NCT03260205|525752992|FG002|Overall Study|Adverse Event|2|||
145794491|NCT03260205|525752993|FG003|Overall Study|Adverse Event|2|||
145794492|NCT03260205|525752994|FG004|Overall Study|Adverse Event|4|||
145794493|NCT03260205|525752990|FG000|Overall Study|Lost to Follow-up|2|||
145794494|NCT03260205|525752991|FG001|Overall Study|Lost to Follow-up|2|||
145794495|NCT03260205|525752992|FG002|Overall Study|Lost to Follow-up|1|||
145794496|NCT03260205|525752993|FG003|Overall Study|Lost to Follow-up|1|||
145794497|NCT03260205|525752994|FG004|Overall Study|Lost to Follow-up|5|||
145794498|NCT03260205|525752990|FG000|Overall Study|Protocol Violation|0|||
145794499|NCT03260205|525752991|FG001|Overall Study|Protocol Violation|0|||
145794500|NCT03260205|525752992|FG002|Overall Study|Protocol Violation|2|||
145794501|NCT03260205|525752993|FG003|Overall Study|Protocol Violation|0|||
145794502|NCT03260205|525752994|FG004|Overall Study|Protocol Violation|1|||
145794503|NCT03260205|525752990|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
145794504|NCT03260205|525752991|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
145794505|NCT03260205|525752992|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
145794506|NCT03260205|525752993|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
145794507|NCT03260205|525752994|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
145794508|NCT03260205|525752990|FG000|Overall Study|Other: Unspecified|0|||
145794509|NCT03260205|525752991|FG001|Overall Study|Other: Unspecified|0|||
145794510|NCT03260205|525752992|FG002|Overall Study|Other: Unspecified|3|||
145794511|NCT03260205|525752993|FG003|Overall Study|Other: Unspecified|1|||
145794512|NCT03260205|525752994|FG004|Overall Study|Other: Unspecified|1|||
145794513|NCT03260205|525752990|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
145794514|NCT03260205|525752991|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
145794515|NCT03260205|525752992|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
145794516|NCT03260205|525752993|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
145794517|NCT03260205|525752994|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
145794518|NCT01968187|525752995|FG000|Overall Study|Adverse Event|0|||
145794519|NCT01968187|525752996|FG001|Overall Study|Adverse Event|1|||
145794520|NCT01968187|525752995|FG000|Overall Study|Randomized but not treated|1|||
145794521|NCT01968187|525752996|FG001|Overall Study|Randomized but not treated|0|||
145794522|NCT05108805|525753001|FG000|Overall Study|T-cell expansion was not successful.|5|||
145794523|NCT01617655|525754852|FG000|Overall Study|Adverse Event|2|||
145794524|NCT01617655|525754853|FG001|Overall Study|Adverse Event|3|||
145794525|NCT01617655|525754852|FG000|Overall Study|Poor compliance to protocol|1|||
145794526|NCT01617655|525754853|FG001|Overall Study|Poor compliance to protocol|4|||
145794527|NCT01617655|525754852|FG000|Overall Study|Participants moved|0|||
145794528|NCT01617655|525754853|FG001|Overall Study|Participants moved|4|||
145794529|NCT01617655|525754852|FG000|Overall Study|Consent withdrawn by participant|1|||
145794530|NCT01617655|525754853|FG001|Overall Study|Consent withdrawn by participant|1|||
145794531|NCT01617655|525754852|FG000|Overall Study|Last visit outside protocol visit window|1|||
145794532|NCT01617655|525754853|FG001|Overall Study|Last visit outside protocol visit window|10|||
145794533|NCT01617655|525754852|FG000|Overall Study|Site closure|3|||
145794534|NCT01617655|525754853|FG001|Overall Study|Site closure|5|||
145794535|NCT01617655|525754852|FG000|Overall Study|Other than specified above|1|||
145794536|NCT01617655|525754853|FG001|Overall Study|Other than specified above|2|||
145794537|NCT01397552|525754854|FG000|Overall Study|Adverse Event|1|||
145794538|NCT01397552|525754855|FG001|Overall Study|Adverse Event|0|||
145794539|NCT01397552|525754854|FG000|Overall Study|Withdrawal by Subject|2|||
145794540|NCT01397552|525754855|FG001|Overall Study|Withdrawal by Subject|1|||
145794541|NCT00190983|525754856|FG000|Overall Study|Inevaluable (never treated)|2|||
145794542|NCT02287402|525754857|FG000|Treatment Period|Adverse Event|17|||
145794543|NCT02287402|525754857|FG000|Treatment Period|Voluntary Withdrawal|10|||
145794544|NCT02287402|525754857|FG000|Follow-up|Lost to Follow-up|1|||
145794545|NCT02287402|525754857|FG000|Follow-up|Voluntary Withdrawal|2|||
145794546|NCT04247815|525754858|FG000|Overall Study|Adverse Event|1|||
145794547|NCT04247815|525754859|FG001|Overall Study|Adverse Event|0|||
145794548|NCT04247815|525754858|FG000|Overall Study|Withdrawal by Subject|1|||
145794549|NCT04247815|525754859|FG001|Overall Study|Withdrawal by Subject|0|||
145794550|NCT04247815|525754858|FG000|Overall Study|Protocol Violation|0|||
145794551|NCT04247815|525754859|FG001|Overall Study|Protocol Violation|1|||
145794552|NCT00209170|525754860|FG000|Overall Study|Adverse Event|0|||
145794553|NCT00209170|525754861|FG001|Overall Study|Adverse Event|1|||
145794554|NCT00209170|525754860|FG000|Overall Study|Withdrawal by Subject|2|||
145794555|NCT00209170|525754861|FG001|Overall Study|Withdrawal by Subject|1|||
145794556|NCT00209170|525754860|FG000|Overall Study|Lack of Efficacy|0|||
145794557|NCT00209170|525754861|FG001|Overall Study|Lack of Efficacy|1|||
145794558|NCT02108600|525754866|FG000|Overall Study|Withdrawal by Subject|2|||
145794559|NCT02108600|525754867|FG001|Overall Study|Withdrawal by Subject|0|||
145794560|NCT02108600|525754866|FG000|Overall Study|Lost to Follow-up|1|||
145794561|NCT02108600|525754867|FG001|Overall Study|Lost to Follow-up|1|||
145794562|NCT01295580|525754868|FG000|Overall Study|Protocol Violation|4|||
145794563|NCT01295580|525754869|FG001|Overall Study|Protocol Violation|2|||
145794564|NCT01295580|525754868|FG000|Overall Study|Withdrawal by Subject|1|||
145794565|NCT01295580|525754869|FG001|Overall Study|Withdrawal by Subject|4|||
145794566|NCT01295580|525754868|FG000|Overall Study|Adverse Event|2|||
145794567|NCT01295580|525754869|FG001|Overall Study|Adverse Event|1|||
145794568|NCT01295580|525754868|FG000|Overall Study|Lost to Follow-up|1|||
145794569|NCT01295580|525754869|FG001|Overall Study|Lost to Follow-up|0|||
145794570|NCT01295580|525754868|FG000|Overall Study|Lack of Efficacy|1|||
145794571|NCT01295580|525754869|FG001|Overall Study|Lack of Efficacy|0|||
145794572|NCT01295580|525754868|FG000|Overall Study|Other: inconvenience|1|||
145794573|NCT01295580|525754869|FG001|Overall Study|Other: inconvenience|0|||
145794574|NCT01295580|525754868|FG000|Overall Study|Other: family objection|0|||
145794575|NCT01295580|525754869|FG001|Overall Study|Other: family objection|1|||
145794576|NCT00992784|525754870|FG000|Overall Study|Adverse Event|2|||
145794577|NCT00992784|525754871|FG001|Overall Study|Adverse Event|1|||
145794578|NCT00992784|525754872|FG002|Overall Study|Adverse Event|0|||
145794579|NCT00992784|525754870|FG000|Overall Study|Withdrawal by Subject|1|||
145794580|NCT00992784|525754871|FG001|Overall Study|Withdrawal by Subject|1|||
145794581|NCT00992784|525754872|FG002|Overall Study|Withdrawal by Subject|1|||
145794582|NCT03943953|525754873|FG000|Trial of ITG 1|Lost to Follow-up|19|||
145794583|NCT03943953|525754874|FG001|Trial of ITG 1|Lost to Follow-up|1|||
145794584|NCT03943953|525754873|FG000|Trial of ITG 2|Lost to Follow-up|8|||
145794585|NCT03943953|525754874|FG001|Trial of ITG 2|Lost to Follow-up|0|||
145794586|NCT03943953|525754873|FG000|Trial of ITG 3|Lost to Follow-up|2|||
145794587|NCT03943953|525754874|FG001|Trial of ITG 3|Lost to Follow-up|0|||
145794588|NCT03943953|525754873|FG000|Trial of ITG 4|Lost to Follow-up|2|||
145794589|NCT03943953|525754874|FG001|Trial of ITG 4|Lost to Follow-up|0|||
145794590|NCT01742078|525754877|FG000|Overall Study|Withdrawal by Subject|0|||
145794591|NCT01742078|525754878|FG001|Overall Study|Withdrawal by Subject|0|||
145794592|NCT01742078|525754879|FG002|Overall Study|Withdrawal by Subject|0|||
145794593|NCT01742078|525754880|FG003|Overall Study|Withdrawal by Subject|1|||
145794594|NCT01742078|525754881|FG004|Overall Study|Withdrawal by Subject|0|||
145794595|NCT01742078|525754882|FG005|Overall Study|Withdrawal by Subject|0|||
145794596|NCT01742078|525754883|FG006|Overall Study|Withdrawal by Subject|0|||
145794597|NCT01742078|525754884|FG007|Overall Study|Withdrawal by Subject|0|||
145794598|NCT01742078|525754885|FG008|Overall Study|Withdrawal by Subject|0|||
145794599|NCT00642746|525754887|FG000|Overall Study|Patient unevaluable|1|||
145794600|NCT00642746|525754888|FG001|Overall Study|Patient unevaluable|0|||
145794601|NCT00424294|525754889|FG000|Overall Study|Adverse Event|4|||
145794602|NCT00424294|525754890|FG001|Overall Study|Adverse Event|10|||
145794603|NCT00424294|525754889|FG000|Overall Study|Lack of Efficacy|2|||
145794604|NCT00424294|525754890|FG001|Overall Study|Lack of Efficacy|1|||
145794605|NCT00424294|525754889|FG000|Overall Study|Withdrawal by Subject|1|||
145794606|NCT00424294|525754890|FG001|Overall Study|Withdrawal by Subject|2|||
145794607|NCT00424294|525754889|FG000|Overall Study|Other|0|||
145794608|NCT00424294|525754890|FG001|Overall Study|Other|2|||
145794609|NCT00424294|525754889|FG000|Overall Study|Randomized but not Treated|1|||
145794610|NCT00424294|525754890|FG001|Overall Study|Randomized but not Treated|0|||
145794611|NCT00976950|525754892|FG000|Overall Study|Adverse Event|3|||
145794612|NCT00976950|525754892|FG000|Overall Study|Events with no relationship to Aptivus|3|||
145794613|NCT02932332|525754901|FG000|Overall Study|Withdrawal by Subject|1|||
145794614|NCT02932332|525754902|FG001|Overall Study|Withdrawal by Subject|1|||
145794615|NCT02932332|525754903|FG002|Overall Study|Withdrawal by Subject|0|||
145794616|NCT02932332|525754904|FG003|Overall Study|Withdrawal by Subject|1|||
145794617|NCT02932332|525754901|FG000|Overall Study|Chest pain|0|||
145794618|NCT02932332|525754902|FG001|Overall Study|Chest pain|0|||
145794619|NCT02932332|525754903|FG002|Overall Study|Chest pain|0|||
145794620|NCT02932332|525754904|FG003|Overall Study|Chest pain|1|||
145794621|NCT02932332|525754901|FG000|Overall Study|Not Dyspneic cough|1|||
145794622|NCT02932332|525754902|FG001|Overall Study|Not Dyspneic cough|2|||
145794623|NCT02932332|525754903|FG002|Overall Study|Not Dyspneic cough|1|||
145794624|NCT02932332|525754904|FG003|Overall Study|Not Dyspneic cough|0|||
145794625|NCT01021852|525754905|FG000|Treatment Period 1|Adverse Event|3|||
145794626|NCT01021852|525754906|FG001|Treatment Period 1|Adverse Event|1|||
145794627|NCT01021852|525754907|FG002|Treatment Period 1|Adverse Event|1|||
145794628|NCT01021852|525754908|FG003|Treatment Period 1|Adverse Event|0|||
145794629|NCT01021852|525754909|FG004|Treatment Period 1|Adverse Event|2|||
145794630|NCT01021852|525754910|FG005|Treatment Period 1|Adverse Event|2|||
145794631|NCT01021852|525754911|FG006|Treatment Period 1|Adverse Event|0|||
145794632|NCT01021852|525754912|FG007|Treatment Period 1|Adverse Event|0|||
145794633|NCT01021852|525754905|FG000|Treatment Period 1|Pregnancy|0|||
145282767|NCT01154153|523884344|FG000|Overall Study|Unable to use labs|2|||
145611181|NCT00235443|525092617|FG003|Overall Study|Withdrawal by Subject|24|||
145794634|NCT01021852|525754906|FG001|Treatment Period 1|Pregnancy|0|||
145794635|NCT01021852|525754907|FG002|Treatment Period 1|Pregnancy|1|||
145794636|NCT01021852|525754908|FG003|Treatment Period 1|Pregnancy|0|||
145794637|NCT01021852|525754909|FG004|Treatment Period 1|Pregnancy|0|||
145794638|NCT01021852|525754910|FG005|Treatment Period 1|Pregnancy|0|||
145794639|NCT01021852|525754911|FG006|Treatment Period 1|Pregnancy|0|||
145794640|NCT01021852|525754912|FG007|Treatment Period 1|Pregnancy|0|||
145794641|NCT01021852|525754905|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145794642|NCT01021852|525754906|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145794643|NCT01021852|525754907|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145794644|NCT01021852|525754908|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145794645|NCT01021852|525754909|FG004|Treatment Period 1|Withdrawal by Subject|1|||
145794646|NCT01021852|525754910|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145794647|NCT01021852|525754911|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145794648|NCT01021852|525754912|FG007|Treatment Period 1|Withdrawal by Subject|1|||
145794649|NCT01021852|525754905|FG000|Treatment Period 1|Not Treated|0|||
145794650|NCT01021852|525754906|FG001|Treatment Period 1|Not Treated|0|||
145794651|NCT01021852|525754907|FG002|Treatment Period 1|Not Treated|0|||
145794652|NCT01021852|525754908|FG003|Treatment Period 1|Not Treated|2|||
145794653|NCT01021852|525754909|FG004|Treatment Period 1|Not Treated|0|||
145794654|NCT01021852|525754910|FG005|Treatment Period 1|Not Treated|0|||
145794655|NCT01021852|525754911|FG006|Treatment Period 1|Not Treated|0|||
145794656|NCT01021852|525754912|FG007|Treatment Period 1|Not Treated|0|||
145794657|NCT01021852|525754905|FG000|Washout Period-Placebo|Adverse Event|0|||
145794658|NCT01021852|525754906|FG001|Washout Period-Placebo|Adverse Event|0|||
145794659|NCT01021852|525754907|FG002|Washout Period-Placebo|Adverse Event|0|||
145794660|NCT01021852|525754908|FG003|Washout Period-Placebo|Adverse Event|1|||
145794661|NCT01021852|525754909|FG004|Washout Period-Placebo|Adverse Event|0|||
145794662|NCT01021852|525754910|FG005|Washout Period-Placebo|Adverse Event|1|||
145794663|NCT01021852|525754911|FG006|Washout Period-Placebo|Adverse Event|0|||
145794664|NCT01021852|525754912|FG007|Washout Period-Placebo|Adverse Event|0|||
145794665|NCT01021852|525754905|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
145794666|NCT01021852|525754906|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
145794667|NCT01021852|525754907|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
145794668|NCT01021852|525754908|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
145794669|NCT01021852|525754909|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
145794670|NCT01021852|525754910|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
145794671|NCT01021852|525754911|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
145794672|NCT01021852|525754912|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
145794673|NCT01021852|525754905|FG000|Washout Period-Placebo|Protocol Violation|0|||
145794674|NCT01021852|525754906|FG001|Washout Period-Placebo|Protocol Violation|0|||
145794675|NCT01021852|525754907|FG002|Washout Period-Placebo|Protocol Violation|0|||
145794676|NCT01021852|525754908|FG003|Washout Period-Placebo|Protocol Violation|0|||
145794677|NCT01021852|525754909|FG004|Washout Period-Placebo|Protocol Violation|0|||
145794678|NCT01021852|525754910|FG005|Washout Period-Placebo|Protocol Violation|0|||
145794679|NCT01021852|525754911|FG006|Washout Period-Placebo|Protocol Violation|1|||
145794680|NCT01021852|525754912|FG007|Washout Period-Placebo|Protocol Violation|0|||
145794681|NCT01021852|525754905|FG000|Washout Period-No Drug|Adverse Event|1|||
145794682|NCT01021852|525754906|FG001|Washout Period-No Drug|Adverse Event|0|||
145794683|NCT01021852|525754907|FG002|Washout Period-No Drug|Adverse Event|0|||
145794684|NCT01021852|525754908|FG003|Washout Period-No Drug|Adverse Event|0|||
145794685|NCT01021852|525754909|FG004|Washout Period-No Drug|Adverse Event|0|||
145794686|NCT01021852|525754910|FG005|Washout Period-No Drug|Adverse Event|1|||
145794687|NCT01021852|525754911|FG006|Washout Period-No Drug|Adverse Event|0|||
145794688|NCT01021852|525754912|FG007|Washout Period-No Drug|Adverse Event|0|||
145794689|NCT01021852|525754905|FG000|Treatment Period 2|Adverse Event|0|||
145794690|NCT01021852|525754906|FG001|Treatment Period 2|Adverse Event|1|||
145794691|NCT01021852|525754907|FG002|Treatment Period 2|Adverse Event|0|||
145794692|NCT01021852|525754908|FG003|Treatment Period 2|Adverse Event|0|||
145794693|NCT01021852|525754909|FG004|Treatment Period 2|Adverse Event|1|||
145794694|NCT01021852|525754910|FG005|Treatment Period 2|Adverse Event|0|||
145794695|NCT01021852|525754911|FG006|Treatment Period 2|Adverse Event|1|||
145794696|NCT01021852|525754912|FG007|Treatment Period 2|Adverse Event|0|||
145794697|NCT01021852|525754905|FG000|Treatment Period 2|Lack of Efficacy|0|||
145794698|NCT01021852|525754906|FG001|Treatment Period 2|Lack of Efficacy|0|||
145794699|NCT01021852|525754907|FG002|Treatment Period 2|Lack of Efficacy|0|||
145794700|NCT01021852|525754908|FG003|Treatment Period 2|Lack of Efficacy|0|||
145794701|NCT01021852|525754909|FG004|Treatment Period 2|Lack of Efficacy|0|||
145794702|NCT01021852|525754910|FG005|Treatment Period 2|Lack of Efficacy|1|||
145794703|NCT01021852|525754911|FG006|Treatment Period 2|Lack of Efficacy|0|||
145794704|NCT01021852|525754912|FG007|Treatment Period 2|Lack of Efficacy|0|||
145794705|NCT01021852|525754905|FG000|Treatment Period 2|Physician Decision|0|||
145794706|NCT01021852|525754906|FG001|Treatment Period 2|Physician Decision|0|||
145794707|NCT01021852|525754907|FG002|Treatment Period 2|Physician Decision|1|||
145794708|NCT01021852|525754908|FG003|Treatment Period 2|Physician Decision|0|||
145282768|NCT01154153|523884345|FG001|Overall Study|Unable to use labs|3|||
145282769|NCT01154153|523884344|FG000|Overall Study|Withdrew consent|1|||
145282770|NCT01154153|523884345|FG001|Overall Study|Withdrew consent|0|||
145282771|NCT02473510|523884346|FG000|Overall Study|Lost to Follow-up|1|||
145282772|NCT02473510|523884347|FG001|Overall Study|Lost to Follow-up|2|||
145282773|NCT04304950|523884357|FG000|Overall Study|Lost to Follow-up|1|||
145282774|NCT04304950|523884358|FG001|Overall Study|Lost to Follow-up|1|||
145282775|NCT02006147|523884359|FG000|Overall Study|Protocol Violation|1|||
145282776|NCT02006147|523884360|FG001|Overall Study|Protocol Violation|1|||
145282777|NCT02006147|523884361|FG002|Overall Study|Protocol Violation|0|||
145794709|NCT01021852|525754909|FG004|Treatment Period 2|Physician Decision|0|||
145794710|NCT01021852|525754910|FG005|Treatment Period 2|Physician Decision|0|||
145794711|NCT01021852|525754911|FG006|Treatment Period 2|Physician Decision|0|||
145794712|NCT01021852|525754912|FG007|Treatment Period 2|Physician Decision|0|||
145794713|NCT01021852|525754905|FG000|Treatment Period 2|Protocol Violation|0|||
145794714|NCT01021852|525754906|FG001|Treatment Period 2|Protocol Violation|0|||
145794715|NCT01021852|525754907|FG002|Treatment Period 2|Protocol Violation|0|||
145794716|NCT01021852|525754908|FG003|Treatment Period 2|Protocol Violation|0|||
145794717|NCT01021852|525754909|FG004|Treatment Period 2|Protocol Violation|1|||
145794718|NCT01021852|525754910|FG005|Treatment Period 2|Protocol Violation|0|||
145794719|NCT01021852|525754911|FG006|Treatment Period 2|Protocol Violation|1|||
145794720|NCT01021852|525754912|FG007|Treatment Period 2|Protocol Violation|0|||
145794721|NCT01021852|525754905|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145794722|NCT01021852|525754906|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145794723|NCT01021852|525754907|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145794724|NCT01021852|525754908|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145794725|NCT01021852|525754909|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145794726|NCT01021852|525754910|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145794727|NCT01021852|525754911|FG006|Treatment Period 2|Withdrawal by Subject|1|||
145794728|NCT01021852|525754912|FG007|Treatment Period 2|Withdrawal by Subject|2|||
145794729|NCT02493426|525754913|FG000|Overall Study|Withdrawal by Subject|0|||
145794730|NCT02493426|525754914|FG001|Overall Study|Withdrawal by Subject|1|||
145794731|NCT01069523|525754915|FG000|Overall Study|Withdrawal by Subject|4|||
145794732|NCT01069523|525754916|FG001|Overall Study|Withdrawal by Subject|7|||
145794733|NCT01025817|525754920|FG000|Completed Study Medication|Adverse Event|66|||
145794734|NCT01025817|525754921|FG001|Completed Study Medication|Adverse Event|39|||
145794735|NCT01025817|525754920|FG000|Completed Study Medication|Protocol Deviation|9|||
145794736|NCT01025817|525754921|FG001|Completed Study Medication|Protocol Deviation|8|||
145794737|NCT01025817|525754920|FG000|Completed Study Medication|Withdrawal by Subject|8|||
145794738|NCT01025817|525754921|FG001|Completed Study Medication|Withdrawal by Subject|9|||
145794739|NCT01025817|525754920|FG000|Completed Study Medication|Administrative problems|7|||
145794740|NCT01025817|525754921|FG001|Completed Study Medication|Administrative problems|5|||
145794741|NCT01025817|525754920|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
145794742|NCT01025817|525754921|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
145794743|NCT01025817|525754920|FG000|Completed Study Medication|Abnormal test procedure|4|||
145794744|NCT01025817|525754921|FG001|Completed Study Medication|Abnormal test procedure|0|||
145794745|NCT01025817|525754920|FG000|Completed Study Medication|Graft loss|2|||
145794746|NCT01025817|525754921|FG001|Completed Study Medication|Graft loss|5|||
145794747|NCT01025817|525754920|FG000|Completed Study Medication|Death|2|||
145794748|NCT01025817|525754921|FG001|Completed Study Medication|Death|2|||
145794749|NCT01025817|525754920|FG000|Completed Study Medication|Abnormal lab values|0|||
145794750|NCT01025817|525754921|FG001|Completed Study Medication|Abnormal lab values|2|||
145794751|NCT01025817|525754920|FG000|Completed Study Medication|Subject no longer required study drug|0|||
145794752|NCT01025817|525754921|FG001|Completed Study Medication|Subject no longer required study drug|1|||
145794753|NCT01025817|525754920|FG000|Completed Study Medication|Lost to Follow-up|0|||
145794754|NCT01025817|525754921|FG001|Completed Study Medication|Lost to Follow-up|1|||
145794755|NCT01025817|525754920|FG000|Completed Study|Withdrawal by Subject|8|||
145794756|NCT01025817|525754921|FG001|Completed Study|Withdrawal by Subject|16|||
145794757|NCT01025817|525754920|FG000|Completed Study|Death|6|||
145794758|NCT01025817|525754921|FG001|Completed Study|Death|5|||
145794759|NCT01025817|525754920|FG000|Completed Study|Missing|2|||
145794760|NCT01025817|525754921|FG001|Completed Study|Missing|0|||
145794761|NCT01025817|525754920|FG000|Completed Study|Lost to Follow-up|0|||
145794762|NCT01025817|525754921|FG001|Completed Study|Lost to Follow-up|1|||
145794763|NCT04533815|525754925|FG000|Overall Study|Adverse Event|2|||
145794764|NCT04533815|525754925|FG000|Overall Study|Site withdrew|5|||
145794765|NCT00488592|525754928|FG000|Overall Study|Withdrawal by Subject|1|||
145794766|NCT00488592|525754928|FG000|Overall Study|Disease progression|1|||
145794767|NCT00488592|525754928|FG000|Overall Study|Enrolled but not treated|1|||
145794768|NCT00441103|525754929|FG000|Overall Study|Adverse Event|2|||
145794769|NCT00441103|525754930|FG001|Overall Study|Adverse Event|1|||
145794770|NCT00441103|525754929|FG000|Overall Study|Death|1|||
145794771|NCT00441103|525754930|FG001|Overall Study|Death|0|||
145282778|NCT02006147|523884362|FG003|Overall Study|Protocol Violation|0|||
145794772|NCT00441103|525754929|FG000|Overall Study|Disease Progression|2|||
145794773|NCT00441103|525754930|FG001|Overall Study|Disease Progression|0|||
145794774|NCT00441103|525754929|FG000|Overall Study|Lost to Follow-up|1|||
145794775|NCT00441103|525754930|FG001|Overall Study|Lost to Follow-up|0|||
145794776|NCT00441103|525754929|FG000|Overall Study|Protocol Violation|1|||
145794777|NCT00441103|525754930|FG001|Overall Study|Protocol Violation|0|||
145794778|NCT00441103|525754929|FG000|Overall Study|Participant unable to use Rebiject II|1|||
145794779|NCT00441103|525754930|FG001|Overall Study|Participant unable to use Rebiject II|0|||
145794780|NCT00441103|525754929|FG000|Overall Study|Participant refused MRI|1|||
145794781|NCT00441103|525754930|FG001|Overall Study|Participant refused MRI|0|||
145794782|NCT00441103|525754929|FG000|Overall Study|Inclusion criteria absent|1|||
145794783|NCT00441103|525754930|FG001|Overall Study|Inclusion criteria absent|0|||
145794784|NCT00441103|525754929|FG000|Overall Study|Non-compliant|0|||
145794785|NCT00441103|525754930|FG001|Overall Study|Non-compliant|1|||
145794786|NCT00441103|525754929|FG000|Overall Study|Participant decided to withdraw|1|||
145794787|NCT00441103|525754930|FG001|Overall Study|Participant decided to withdraw|0|||
145794788|NCT00441103|525754929|FG000|Overall Study|Participant's reason|0|||
145794789|NCT00441103|525754930|FG001|Overall Study|Participant's reason|1|||
145794790|NCT00441103|525754929|FG000|Overall Study|Participant decided to stop|0|||
145794791|NCT00441103|525754930|FG001|Overall Study|Participant decided to stop|1|||
145794792|NCT00807846|525754931|FG000|Overall Study|Adverse Event|5|||
145794793|NCT00807846|525754932|FG001|Overall Study|Adverse Event|0|||
145794794|NCT00807846|525754931|FG000|Overall Study|Lack of Efficacy|2|||
145794795|NCT00807846|525754932|FG001|Overall Study|Lack of Efficacy|0|||
145794796|NCT00807846|525754931|FG000|Overall Study|Protocol Violation|2|||
145794797|NCT00807846|525754932|FG001|Overall Study|Protocol Violation|1|||
145794798|NCT00807846|525754931|FG000|Overall Study|Withdrawal by Subject|2|||
145794799|NCT00807846|525754932|FG001|Overall Study|Withdrawal by Subject|1|||
145794800|NCT00807846|525754931|FG000|Overall Study|Other|1|||
145794801|NCT00807846|525754932|FG001|Overall Study|Other|2|||
145794802|NCT01081873|525754933|FG000|Overall Study|Death|86|||
145794803|NCT01081873|525754933|FG000|Overall Study|Withdrawal by Subject|10|||
145794804|NCT01081873|525754933|FG000|Overall Study|Lost to Follow-up|142|||
145794805|NCT01081873|525754933|FG000|Overall Study|Progression of prostate cancer|13|||
145794806|NCT01081873|525754933|FG000|Overall Study|Other|47|||
145794807|NCT04799405|525754935|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
145794808|NCT00603980|525754936|FG000|Study Qualification|Protocol Violation|3|||
145794809|NCT00603980|525754936|FG000|Study Qualification|Inconsistent data reporting|13|||
145794810|NCT00603980|525754936|FG000|Main Study|14th subject completed trial|1|||
145794811|NCT01029002|525754937|FG000|Overall Study|Lost to Follow-up|2|||
145794812|NCT01029002|525754938|FG001|Overall Study|Lost to Follow-up|4|||
145794813|NCT02683525|525754939|FG000|Overall Study|Lost to Follow-up|1|||
145794814|NCT02683525|525754939|FG000|Overall Study|Physician Decision|1|||
145794815|NCT02683525|525754939|FG000|Overall Study|Disease Progression|6|||
145794816|NCT02618928|525754946|FG000|Overall Study|Failure to Return|28|||
145794817|NCT02618928|525754946|FG000|Overall Study|Insufficient Virological Response|1|||
145794818|NCT02618928|525754946|FG000|Overall Study|Withdrawal by Subject|2|||
145794819|NCT02618928|525754946|FG000|Overall Study|Death|3|||
145794820|NCT02618928|525754946|FG000|Overall Study|Other|11|||
145794821|NCT02618928|525754946|FG000|Overall Study|Missing|6|||
145794822|NCT02618928|525754946|FG000|Overall Study|Treatment Never Started|7|||
145794823|NCT01096849|525754951|FG000|Overall Study|Consent Withdrawn|1|||
145794824|NCT01096849|525754952|FG001|Overall Study|Consent Withdrawn|4|||
145794825|NCT01096849|525754953|FG002|Overall Study|Consent Withdrawn|2|||
145794826|NCT01096849|525754951|FG000|Overall Study|Lack of Efficacy|0|||
145794827|NCT01096849|525754952|FG001|Overall Study|Lack of Efficacy|2|||
145794828|NCT01096849|525754953|FG002|Overall Study|Lack of Efficacy|0|||
145794829|NCT01096849|525754951|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
145794830|NCT01096849|525754952|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
145794831|NCT01096849|525754953|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
145794832|NCT01096849|525754951|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
145794833|NCT01096849|525754952|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
145794834|NCT01096849|525754953|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
145794835|NCT01096849|525754951|FG000|Overall Study|Administrative Reasons|0|||
145794836|NCT01096849|525754952|FG001|Overall Study|Administrative Reasons|1|||
145794837|NCT01096849|525754953|FG002|Overall Study|Administrative Reasons|2|||
145794838|NCT01096849|525754951|FG000|Overall Study|Lost to Follow-up|1|||
145794839|NCT01096849|525754952|FG001|Overall Study|Lost to Follow-up|3|||
145794840|NCT01096849|525754953|FG002|Overall Study|Lost to Follow-up|1|||
145794841|NCT04167306|525754955|FG000|Overall Study|Lost to Follow-up|2|||
145794842|NCT04167306|525754956|FG001|Overall Study|Lost to Follow-up|2|||
145794843|NCT04167306|525754957|FG002|Overall Study|Lost to Follow-up|5|||
145794844|NCT04167306|525754958|FG003|Overall Study|Lost to Follow-up|5|||
145794845|NCT04167306|525754955|FG000|Overall Study|Adverse Event|13|||
145794846|NCT04167306|525754956|FG001|Overall Study|Adverse Event|14|||
145794847|NCT04167306|525754957|FG002|Overall Study|Adverse Event|5|||
145794848|NCT04167306|525754958|FG003|Overall Study|Adverse Event|4|||
145794849|NCT04167306|525754955|FG000|Overall Study|Withdrawal by Subject|4|||
145794850|NCT04167306|525754956|FG001|Overall Study|Withdrawal by Subject|6|||
145794851|NCT04167306|525754957|FG002|Overall Study|Withdrawal by Subject|8|||
145794852|NCT04167306|525754958|FG003|Overall Study|Withdrawal by Subject|3|||
145794853|NCT04167306|525754955|FG000|Overall Study|covid|1|||
145794854|NCT04167306|525754956|FG001|Overall Study|covid|1|||
145794855|NCT04167306|525754957|FG002|Overall Study|covid|2|||
145794856|NCT04167306|525754958|FG003|Overall Study|covid|1|||
145794857|NCT04167306|525754955|FG000|Overall Study|concomitant medication|0|||
145794858|NCT04167306|525754956|FG001|Overall Study|concomitant medication|0|||
145794859|NCT04167306|525754957|FG002|Overall Study|concomitant medication|0|||
145794860|NCT04167306|525754958|FG003|Overall Study|concomitant medication|1|||
145794861|NCT04167306|525754955|FG000|Overall Study|Alcohol treatment|0|||
145794862|NCT04167306|525754956|FG001|Overall Study|Alcohol treatment|4|||
145794863|NCT04167306|525754957|FG002|Overall Study|Alcohol treatment|3|||
145794864|NCT04167306|525754958|FG003|Overall Study|Alcohol treatment|2|||
145794865|NCT04167306|525754955|FG000|Overall Study|non-compliance|0|||
145794866|NCT04167306|525754956|FG001|Overall Study|non-compliance|0|||
145794867|NCT04167306|525754957|FG002|Overall Study|non-compliance|1|||
145794868|NCT04167306|525754958|FG003|Overall Study|non-compliance|0|||
145794869|NCT04167306|525754955|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
145794870|NCT04167306|525754956|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
145794871|NCT04167306|525754957|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
145794872|NCT04167306|525754958|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
145794873|NCT04146467|525754963|FG000|Overall Study|Adverse Event|0|||
145794874|NCT04146467|525754964|FG001|Overall Study|Adverse Event|1|||
145794875|NCT04146467|525754963|FG000|Overall Study|Lost to Follow-up|0|||
145794876|NCT04146467|525754964|FG001|Overall Study|Lost to Follow-up|2|||
145794877|NCT01189435|525754967|FG000|Overall Study|Withdrawal by Subject|1|||
145794878|NCT01189435|525754967|FG000|Overall Study|Physician Decision|1|||
145794879|NCT01253421|525754968|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
145794880|NCT01253421|525754969|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
145794881|NCT01253421|525754970|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
145794882|NCT01253421|525754971|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
145794883|NCT01253421|525754972|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
145794884|NCT01253421|525754968|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
145794885|NCT01253421|525754969|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
145794886|NCT01253421|525754970|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
145794887|NCT01253421|525754971|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
145794888|NCT01253421|525754972|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
145794889|NCT01253421|525754968|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
145794890|NCT01253421|525754969|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
145794891|NCT01253421|525754970|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
145794892|NCT01253421|525754971|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
145794893|NCT01253421|525754972|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
145794894|NCT01253421|525754968|FG000|Assessment and Scheduling|Physician Decision|1|||
145794895|NCT01253421|525754969|FG001|Assessment and Scheduling|Physician Decision|0|||
145794896|NCT01253421|525754970|FG002|Assessment and Scheduling|Physician Decision|0|||
145794897|NCT01253421|525754971|FG003|Assessment and Scheduling|Physician Decision|0|||
145794898|NCT01253421|525754972|FG004|Assessment and Scheduling|Physician Decision|0|||
145794899|NCT01253421|525754968|FG000|Drug+Scanning Visit|Physician Decision|0|||
145794900|NCT01253421|525754969|FG001|Drug+Scanning Visit|Physician Decision|0|||
145404836|NCT00091819|524338693|FG001|Overall Study|Withdrawal by Subject|8|||
145794901|NCT01253421|525754970|FG002|Drug+Scanning Visit|Physician Decision|0|||
145794902|NCT01253421|525754971|FG003|Drug+Scanning Visit|Physician Decision|0|||
145794903|NCT01253421|525754972|FG004|Drug+Scanning Visit|Physician Decision|1|||
145794904|NCT00547378|525754973|FG000|Randomized Cohort|Withdrawal by Subject|7|||
145794905|NCT00547378|525754974|FG001|Randomized Cohort|Withdrawal by Subject|5|||
145794906|NCT00547378|525754975|FG002|Randomized Cohort|Withdrawal by Subject|0|||
145794907|NCT00547378|525754973|FG000|Randomized Cohort|Death|0|||
145794908|NCT00547378|525754974|FG001|Randomized Cohort|Death|1|||
145794909|NCT00547378|525754975|FG002|Randomized Cohort|Death|0|||
145794910|NCT00547378|525754973|FG000|Randomized Cohort|Lost to Follow-up|1|||
145794911|NCT00547378|525754974|FG001|Randomized Cohort|Lost to Follow-up|0|||
145794912|NCT00547378|525754975|FG002|Randomized Cohort|Lost to Follow-up|0|||
145794913|NCT00547378|525754973|FG000|Randomized Cohort|Adverse Event|1|||
145794914|NCT00547378|525754974|FG001|Randomized Cohort|Adverse Event|0|||
145794915|NCT00547378|525754975|FG002|Randomized Cohort|Adverse Event|0|||
145794916|NCT00547378|525754973|FG000|Randomized Cohort|Other reasons|2|||
145794917|NCT00547378|525754974|FG001|Randomized Cohort|Other reasons|0|||
145794918|NCT00547378|525754975|FG002|Randomized Cohort|Other reasons|0|||
145794919|NCT00547378|525754973|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
145794920|NCT00547378|525754974|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
145794921|NCT00547378|525754975|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
145794922|NCT00547378|525754973|FG000|All Implanted Cohort|Adverse Event|4|||
145794923|NCT00547378|525754974|FG001|All Implanted Cohort|Adverse Event|10|||
145794924|NCT00547378|525754975|FG002|All Implanted Cohort|Adverse Event|17|||
145794925|NCT00547378|525754973|FG000|All Implanted Cohort|Lost to Follow-up|0|||
145794926|NCT00547378|525754974|FG001|All Implanted Cohort|Lost to Follow-up|1|||
145794927|NCT00547378|525754975|FG002|All Implanted Cohort|Lost to Follow-up|14|||
145794928|NCT00547378|525754973|FG000|All Implanted Cohort|Death|3|||
145794929|NCT00547378|525754974|FG001|All Implanted Cohort|Death|1|||
145794930|NCT00547378|525754975|FG002|All Implanted Cohort|Death|4|||
145794931|NCT00547378|525754973|FG000|All Implanted Cohort|Physician Decision|0|||
145794932|NCT00547378|525754974|FG001|All Implanted Cohort|Physician Decision|2|||
145794933|NCT00547378|525754975|FG002|All Implanted Cohort|Physician Decision|6|||
145794934|NCT00547378|525754973|FG000|All Implanted Cohort|Site closure|2|||
145794935|NCT00547378|525754974|FG001|All Implanted Cohort|Site closure|0|||
145794936|NCT00547378|525754975|FG002|All Implanted Cohort|Site closure|1|||
145794937|NCT00547378|525754973|FG000|All Implanted Cohort|Other reasons|1|||
145794938|NCT00547378|525754974|FG001|All Implanted Cohort|Other reasons|0|||
145794939|NCT00547378|525754975|FG002|All Implanted Cohort|Other reasons|1|||
145794940|NCT00099359|525754977|FG000|Overall Study|Death|11|||
145794941|NCT00099359|525754978|FG001|Overall Study|Death|15|||
145794942|NCT00099359|525754979|FG002|Overall Study|Death|17|||
145794943|NCT00099359|525754977|FG000|Overall Study|Withdrawal by Subject|19|||
145794944|NCT00099359|525754978|FG001|Overall Study|Withdrawal by Subject|19|||
145794945|NCT00099359|525754979|FG002|Overall Study|Withdrawal by Subject|23|||
145794946|NCT00099359|525754977|FG000|Overall Study|Lost to Follow-up|15|||
145794947|NCT00099359|525754978|FG001|Overall Study|Lost to Follow-up|24|||
145794948|NCT00099359|525754979|FG002|Overall Study|Lost to Follow-up|24|||
145794949|NCT00099359|525754977|FG000|Overall Study|moved out of area|9|||
145794950|NCT00099359|525754978|FG001|Overall Study|moved out of area|7|||
145547115|NCT00911820|524863176|FG001|Overall Study|Pursue surgery|1|||
145547116|NCT00911820|524863175|FG000|Overall Study|Pursue Radiation|1|||
145547117|NCT00911820|524863176|FG001|Overall Study|Pursue Radiation|0|||
145547118|NCT00911820|524863175|FG000|Overall Study|Still on Therapy|2|||
145547119|NCT00911820|524863176|FG001|Overall Study|Still on Therapy|2|||
145547120|NCT00911820|524863175|FG000|Overall Study|Pathology Not Confirmed|1|||
145547121|NCT00911820|524863176|FG001|Overall Study|Pathology Not Confirmed|0|||
145547122|NCT00911820|524863175|FG000|Overall Study|Withdraw before Receive Treatment|0|||
145547123|NCT00911820|524863176|FG001|Overall Study|Withdraw before Receive Treatment|2|||
145547124|NCT00309387|524863177|FG000|Overall Study|Death|72|||
145547125|NCT00309387|524863178|FG001|Overall Study|Death|73|||
145547126|NCT00309387|524863177|FG000|Overall Study|Lost to Follow-up|70|||
145547127|NCT00309387|524863178|FG001|Overall Study|Lost to Follow-up|86|||
145547128|NCT01342796|524863179|FG000|Overall Study|Withdrawal by Subject|2|||
145547129|NCT01342796|524863180|FG001|Overall Study|Withdrawal by Subject|0|||
145794951|NCT00099359|525754979|FG002|Overall Study|moved out of area|4|||
145794952|NCT01185249|525754986|FG000|Overall Study|Patients discharged or change in status|42|||
145794953|NCT05294211|525754989|FG000|Overall Study|Withdrawal by Subject|3|||
145794954|NCT05294211|525754989|FG000|Overall Study|Physician Decision|2|||
145794955|NCT05294211|525754989|FG000|Overall Study|Progressed to active labor|1|||
145794956|NCT05294211|525754989|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
145794957|NCT05294211|525754989|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
145794958|NCT00406783|525754990|FG000|Overall Study|Adverse Event|4|||
145794959|NCT00406783|525754991|FG001|Overall Study|Adverse Event|4|||
145794960|NCT00406783|525754990|FG000|Overall Study|Treatment Failure|2|||
145794961|NCT00406783|525754991|FG001|Overall Study|Treatment Failure|3|||
145547130|NCT01342796|524863179|FG000|Overall Study|Lost to Follow-up|0|||
145547131|NCT01342796|524863180|FG001|Overall Study|Lost to Follow-up|3|||
145547132|NCT01342796|524863179|FG000|Overall Study|Inappropriate enrollment|1|||
145547133|NCT01342796|524863180|FG001|Overall Study|Inappropriate enrollment|0|||
145794962|NCT00406783|525754990|FG000|Overall Study|Lost to Follow-up|3|||
145547134|NCT01599234|524863181|FG000|Overall Study|Adverse Event|9|||
145547135|NCT01599234|524863182|FG001|Overall Study|Adverse Event|5|||
145547136|NCT01599234|524863181|FG000|Overall Study|Withdrawal by Subject|2|||
145794963|NCT00406783|525754991|FG001|Overall Study|Lost to Follow-up|0|||
145794964|NCT00406783|525754990|FG000|Overall Study|Withdrawal by Subject|1|||
145794965|NCT00406783|525754991|FG001|Overall Study|Withdrawal by Subject|4|||
145794966|NCT00406783|525754990|FG000|Overall Study|Protocol Violation|4|||
145794967|NCT00406783|525754991|FG001|Overall Study|Protocol Violation|4|||
145794968|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
145794969|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
145794970|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
145794971|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
145794972|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
145794973|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
145794974|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
145794975|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145794976|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
145794977|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
145794978|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
145794979|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
145794980|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
145794981|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
145794982|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
145794983|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
145794984|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Missing|3|||
145794985|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Missing|1|||
145794986|NCT00838916|525754992|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
145794987|NCT00838916|525754993|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
145794988|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
145794989|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
145794990|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
145794991|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
145794992|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
145794993|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
145794994|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
145794995|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
145794996|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
145794997|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
145794998|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
145794999|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
145795000|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
145795001|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
145795002|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
145795003|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
145795004|NCT00838916|525754992|FG000|Follow-up Period (8 Weeks)|Missing|3|||
145795005|NCT00838916|525754993|FG001|Follow-up Period (8 Weeks)|Missing|0|||
145795006|NCT00012012|525754994|FG000|Overall Study|Protocol Violation|1|||
145795007|NCT00012012|525754995|FG001|Overall Study|Protocol Violation|1|||
145795008|NCT00012012|525754994|FG000|Overall Study|Withdrawal by Subject|0|||
145795009|NCT00012012|525754995|FG001|Overall Study|Withdrawal by Subject|2|||
145795010|NCT02034474|525754996|FG000|Overall Study|Adverse Event|3|||
145795011|NCT02034474|525754997|FG001|Overall Study|Adverse Event|2|||
145795012|NCT02034474|525754996|FG000|Overall Study|Withdrawal by Subject|1|||
145795013|NCT02034474|525754997|FG001|Overall Study|Withdrawal by Subject|2|||
145795014|NCT01391819|525754998|FG000|Overall Study|Withdrawal by Subject|56|||
145795015|NCT01391819|525754998|FG000|Overall Study|Migrated/moved from study area|82|||
145795016|NCT01391819|525754998|FG000|Overall Study|Lost to Follow-up|252|||
145795017|NCT01391819|525754998|FG000|Overall Study|Death|3|||
145795018|NCT01391819|525754998|FG000|Overall Study|Other|9|||
145547137|NCT01599234|524863182|FG001|Overall Study|Withdrawal by Subject|1|||
145547138|NCT01599234|524863181|FG000|Overall Study|Lost to Follow-up|1|||
145547139|NCT01599234|524863182|FG001|Overall Study|Lost to Follow-up|2|||
145795019|NCT01927419|525754999|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145795020|NCT01927419|525755000|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
145795021|NCT01927419|525754999|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
145795022|NCT01927419|525755000|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
145795023|NCT01927419|525754999|FG000|Treatment Period|Disease progression|17|||
145795024|NCT01927419|525755000|FG001|Treatment Period|Disease progression|20|||
145795025|NCT01927419|525754999|FG000|Treatment Period|Study drug toxicity|48|||
145547140|NCT01599234|524863181|FG000|Overall Study|Lack of Efficacy|2|||
145547141|NCT01599234|524863182|FG001|Overall Study|Lack of Efficacy|4|||
145795026|NCT01927419|525755000|FG001|Treatment Period|Study drug toxicity|10|||
145795027|NCT01927419|525754999|FG000|Treatment Period|Death|0|||
145795028|NCT01927419|525755000|FG001|Treatment Period|Death|1|||
145795029|NCT01927419|525754999|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
145795030|NCT01927419|525755000|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
145795031|NCT01927419|525754999|FG000|Treatment Period|Participant request to discontinue|12|||
145795032|NCT01927419|525755000|FG001|Treatment Period|Participant request to discontinue|4|||
145795033|NCT01927419|525754999|FG000|Treatment Period|Withdrawal by Subject|1|||
145795034|NCT01927419|525755000|FG001|Treatment Period|Withdrawal by Subject|1|||
145795035|NCT01927419|525754999|FG000|Treatment Period|Maximum Clinical Benefit|6|||
145795036|NCT01927419|525755000|FG001|Treatment Period|Maximum Clinical Benefit|2|||
145795037|NCT01927419|525754999|FG000|Treatment Period|Other reasons|3|||
145795038|NCT01927419|525755000|FG001|Treatment Period|Other reasons|4|||
145795039|NCT01927419|525754999|FG000|Treatment Period|Not Reported|1|||
145795040|NCT01927419|525755000|FG001|Treatment Period|Not Reported|1|||
145795041|NCT00995670|525755001|FG000|Overall Study|Failed arterial cannulation|1|||
145795042|NCT00995670|525755002|FG001|Overall Study|Failed arterial cannulation|0|||
145795043|NCT00995670|525755003|FG002|Overall Study|Failed arterial cannulation|3|||
145795044|NCT02164513|525755004|FG000|Overall Study|Adverse Event|162|||
145795045|NCT02164513|525755005|FG001|Overall Study|Adverse Event|180|||
145795046|NCT02164513|525755006|FG002|Overall Study|Adverse Event|111|||
145795047|NCT02164513|525755004|FG000|Overall Study|Other: Study Closed or terminated|5|||
145795048|NCT02164513|525755005|FG001|Overall Study|Other: Study Closed or terminated|2|||
145795049|NCT02164513|525755006|FG002|Overall Study|Other: Study Closed or terminated|4|||
145795050|NCT02164513|525755004|FG000|Overall Study|Lost to Follow-up|30|||
145795051|NCT02164513|525755005|FG001|Overall Study|Lost to Follow-up|36|||
145795052|NCT02164513|525755006|FG002|Overall Study|Lost to Follow-up|22|||
145795053|NCT02164513|525755004|FG000|Overall Study|Physician Decision|47|||
145795054|NCT02164513|525755005|FG001|Overall Study|Physician Decision|57|||
145795055|NCT02164513|525755006|FG002|Overall Study|Physician Decision|28|||
145795056|NCT02164513|525755004|FG000|Overall Study|Withdrawal by Subject|192|||
145795057|NCT02164513|525755005|FG001|Overall Study|Withdrawal by Subject|261|||
145795058|NCT02164513|525755006|FG002|Overall Study|Withdrawal by Subject|130|||
145795059|NCT02164513|525755004|FG000|Overall Study|Other: Reason not provided by site|1|||
145795060|NCT02164513|525755005|FG001|Overall Study|Other: Reason not provided by site|0|||
145795061|NCT02164513|525755006|FG002|Overall Study|Other: Reason not provided by site|0|||
145795062|NCT02773238|525755008|FG000|Overall Study|Lack of Efficacy|4|||
145795063|NCT02509494|525755009|FG000|Overall Study|Lost to Follow-up|8|||
145795064|NCT02509494|525755010|FG001|Overall Study|Lost to Follow-up|47|||
145795065|NCT02509494|525755011|FG002|Overall Study|Lost to Follow-up|19|||
145795066|NCT02509494|525755012|FG003|Overall Study|Lost to Follow-up|6|||
145795067|NCT02509494|525755013|FG004|Overall Study|Lost to Follow-up|3|||
145795068|NCT02509494|525755014|FG005|Overall Study|Lost to Follow-up|3|||
145795069|NCT02509494|525755015|FG006|Overall Study|Lost to Follow-up|1|||
145795070|NCT02509494|525755016|FG007|Overall Study|Lost to Follow-up|3|||
145795071|NCT02509494|525755017|FG008|Overall Study|Lost to Follow-up|1|||
145795072|NCT02509494|525755009|FG000|Overall Study|Physician Decision|2|||
145795073|NCT02509494|525755010|FG001|Overall Study|Physician Decision|1|||
145795074|NCT02509494|525755011|FG002|Overall Study|Physician Decision|0|||
145795075|NCT02509494|525755012|FG003|Overall Study|Physician Decision|0|||
145795076|NCT02509494|525755013|FG004|Overall Study|Physician Decision|0|||
145795077|NCT02509494|525755014|FG005|Overall Study|Physician Decision|0|||
145795078|NCT02509494|525755015|FG006|Overall Study|Physician Decision|0|||
145795079|NCT02509494|525755016|FG007|Overall Study|Physician Decision|0|||
145795080|NCT02509494|525755017|FG008|Overall Study|Physician Decision|0|||
145795081|NCT02509494|525755009|FG000|Overall Study|Withdrawal by Subject|4|||
145795082|NCT02509494|525755010|FG001|Overall Study|Withdrawal by Subject|17|||
145795083|NCT02509494|525755011|FG002|Overall Study|Withdrawal by Subject|7|||
145795084|NCT02509494|525755012|FG003|Overall Study|Withdrawal by Subject|5|||
145795085|NCT02509494|525755013|FG004|Overall Study|Withdrawal by Subject|0|||
145795086|NCT02509494|525755014|FG005|Overall Study|Withdrawal by Subject|6|||
145795087|NCT02509494|525755015|FG006|Overall Study|Withdrawal by Subject|1|||
145795088|NCT02509494|525755016|FG007|Overall Study|Withdrawal by Subject|2|||
145795089|NCT02509494|525755017|FG008|Overall Study|Withdrawal by Subject|1|||
145795090|NCT02509494|525755009|FG000|Overall Study|Death|0|||
145795091|NCT02509494|525755010|FG001|Overall Study|Death|1|||
145795092|NCT02509494|525755011|FG002|Overall Study|Death|0|||
145795093|NCT02509494|525755012|FG003|Overall Study|Death|0|||
145795094|NCT02509494|525755013|FG004|Overall Study|Death|1|||
145795095|NCT02509494|525755014|FG005|Overall Study|Death|0|||
145795096|NCT02509494|525755015|FG006|Overall Study|Death|0|||
145795097|NCT02509494|525755016|FG007|Overall Study|Death|1|||
145795098|NCT02509494|525755017|FG008|Overall Study|Death|0|||
145795099|NCT02509494|525755009|FG000|Overall Study|Other|0|||
145795100|NCT02509494|525755010|FG001|Overall Study|Other|4|||
145795101|NCT02509494|525755011|FG002|Overall Study|Other|5|||
145795102|NCT02509494|525755012|FG003|Overall Study|Other|0|||
145795103|NCT02509494|525755013|FG004|Overall Study|Other|0|||
145795104|NCT02509494|525755014|FG005|Overall Study|Other|0|||
145795105|NCT02509494|525755015|FG006|Overall Study|Other|0|||
145795106|NCT02509494|525755016|FG007|Overall Study|Other|0|||
145795107|NCT02509494|525755017|FG008|Overall Study|Other|0|||
145795108|NCT02509494|525755009|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145795109|NCT02509494|525755010|FG001|Overall Study|Non-Compliance With Study Drug|11|||
145795110|NCT02509494|525755011|FG002|Overall Study|Non-Compliance With Study Drug|7|||
145795111|NCT02509494|525755012|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145795112|NCT02509494|525755013|FG004|Overall Study|Non-Compliance With Study Drug|1|||
145795113|NCT02509494|525755014|FG005|Overall Study|Non-Compliance With Study Drug|2|||
145795114|NCT02509494|525755015|FG006|Overall Study|Non-Compliance With Study Drug|1|||
145795115|NCT02509494|525755016|FG007|Overall Study|Non-Compliance With Study Drug|1|||
145795116|NCT02509494|525755017|FG008|Overall Study|Non-Compliance With Study Drug|0|||
145795117|NCT04752189|525755018|FG000|Overall Study|Withdrawal by Subject|0|||
145795118|NCT04752189|525755019|FG001|Overall Study|Withdrawal by Subject|150|||
145795119|NCT04752189|525755018|FG000|Overall Study|Lost to Follow-up|261|||
145795120|NCT04752189|525755019|FG001|Overall Study|Lost to Follow-up|126|||
145795121|NCT00975195|525755020|FG000|Overall Study|Adverse Event|108|||
145795122|NCT00975195|525755021|FG001|Overall Study|Adverse Event|101|||
145795123|NCT00975195|525755020|FG000|Overall Study|Lack of Efficacy|6|||
145795124|NCT00975195|525755021|FG001|Overall Study|Lack of Efficacy|6|||
145795125|NCT00975195|525755020|FG000|Overall Study|Protocol Violation|27|||
145795126|NCT00975195|525755021|FG001|Overall Study|Protocol Violation|23|||
145795127|NCT00975195|525755020|FG000|Overall Study|Lost to Follow-up|9|||
145795128|NCT00975195|525755021|FG001|Overall Study|Lost to Follow-up|7|||
145795129|NCT00975195|525755020|FG000|Overall Study|Withdrawal by Subject|48|||
145795130|NCT00975195|525755021|FG001|Overall Study|Withdrawal by Subject|61|||
145795131|NCT00975195|525755020|FG000|Overall Study|Other reason not defined above|29|||
145795132|NCT00975195|525755021|FG001|Overall Study|Other reason not defined above|33|||
145795133|NCT00975195|525755020|FG000|Overall Study|Not treated|1|||
145795134|NCT00975195|525755021|FG001|Overall Study|Not treated|2|||
145795135|NCT03422133|525755022|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
145795136|NCT03422133|525755023|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
145795137|NCT03003403|525755024|FG000|Overall Study|Ineligible|8|||
145795138|NCT03003403|525755025|FG001|Overall Study|Ineligible|7|||
145795139|NCT03003403|525755024|FG000|Overall Study|Withdrawal by Subject|3|||
145795140|NCT03003403|525755025|FG001|Overall Study|Withdrawal by Subject|1|||
145795141|NCT01146951|525756442|FG000|Overall Study|Adverse Event|4|||
145795142|NCT01146951|525756443|FG001|Overall Study|Adverse Event|1|||
145795143|NCT02198651|525756444|FG000|Lead-in Period|Withdrew consent|13|||
145795144|NCT02198651|525756445|FG001|Lead-in Period|Withdrew consent|0|||
145795145|NCT02198651|525756446|FG002|Lead-in Period|Withdrew consent|0|||
145795146|NCT02198651|525756447|FG003|Lead-in Period|Withdrew consent|0|||
145795147|NCT02198651|525756448|FG004|Lead-in Period|Withdrew consent|0|||
145795148|NCT02198651|525756444|FG000|Lead-in Period|Adverse Event|2|||
145795149|NCT02198651|525756445|FG001|Lead-in Period|Adverse Event|0|||
145795150|NCT02198651|525756446|FG002|Lead-in Period|Adverse Event|0|||
145795151|NCT02198651|525756447|FG003|Lead-in Period|Adverse Event|0|||
145795152|NCT02198651|525756448|FG004|Lead-in Period|Adverse Event|0|||
145795153|NCT02198651|525756444|FG000|Lead-in Period|Other, not specified|22|||
145795154|NCT02198651|525756445|FG001|Lead-in Period|Other, not specified|0|||
145795155|NCT02198651|525756446|FG002|Lead-in Period|Other, not specified|0|||
145795156|NCT02198651|525756447|FG003|Lead-in Period|Other, not specified|0|||
145795157|NCT02198651|525756448|FG004|Lead-in Period|Other, not specified|0|||
145795158|NCT02198651|525756444|FG000|Double-blind Period|Withdrew consent|0|||
145795159|NCT02198651|525756445|FG001|Double-blind Period|Withdrew consent|4|||
145795160|NCT02198651|525756446|FG002|Double-blind Period|Withdrew consent|0|||
145795161|NCT02198651|525756447|FG003|Double-blind Period|Withdrew consent|0|||
145795162|NCT02198651|525756448|FG004|Double-blind Period|Withdrew consent|0|||
145795163|NCT02198651|525756444|FG000|Double-blind Period|Adverse Event|0|||
145795164|NCT02198651|525756445|FG001|Double-blind Period|Adverse Event|1|||
145795165|NCT02198651|525756446|FG002|Double-blind Period|Adverse Event|0|||
145795166|NCT02198651|525756447|FG003|Double-blind Period|Adverse Event|0|||
145795167|NCT02198651|525756448|FG004|Double-blind Period|Adverse Event|0|||
145795168|NCT02198651|525756444|FG000|Double-blind Period|Other, not specified|0|||
145795169|NCT02198651|525756445|FG001|Double-blind Period|Other, not specified|4|||
145795170|NCT02198651|525756446|FG002|Double-blind Period|Other, not specified|1|||
145795171|NCT02198651|525756447|FG003|Double-blind Period|Other, not specified|0|||
145795172|NCT02198651|525756448|FG004|Double-blind Period|Other, not specified|0|||
145795173|NCT02198651|525756444|FG000|Open-label Rescue Period|Withdrew consent|0|||
145795174|NCT02198651|525756445|FG001|Open-label Rescue Period|Withdrew consent|0|||
145795175|NCT02198651|525756446|FG002|Open-label Rescue Period|Withdrew consent|0|||
145795176|NCT02198651|525756447|FG003|Open-label Rescue Period|Withdrew consent|2|||
145795177|NCT02198651|525756448|FG004|Open-label Rescue Period|Withdrew consent|0|||
145795178|NCT02198651|525756444|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
145795179|NCT02198651|525756445|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
145795180|NCT02198651|525756446|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
145795181|NCT02198651|525756447|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
145795182|NCT02198651|525756448|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
145795183|NCT01747811|525756449|FG000|Overall Study|Lack of Efficacy|2|||
145795184|NCT01747811|525756450|FG001|Overall Study|Lack of Efficacy|4|||
145795185|NCT01175213|525756455|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
145795186|NCT01175213|525756456|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
145795187|NCT01175213|525756455|FG000|IGSC, 10%/rHuPH20|Death|1|||
145795188|NCT01175213|525756456|FG001|IGSC, 10%/rHuPH20|Death|0|||
145795189|NCT01175213|525756455|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
145795190|NCT01175213|525756456|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
145795191|NCT01175213|525756455|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
145795192|NCT01175213|525756456|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
145795193|NCT01175213|525756455|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
145795194|NCT01175213|525756456|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
145795195|NCT01175213|525756455|FG000|Safety Follow-up|Adverse Event|1|||
145795196|NCT01175213|525756456|FG001|Safety Follow-up|Adverse Event|0|||
145795197|NCT03057951|525756458|FG000|Overall Study|Adverse Event|553|||
145795198|NCT03057951|525756459|FG001|Overall Study|Adverse Event|575|||
145795199|NCT03057951|525756458|FG000|Overall Study|Protocol Violation|30|||
145795200|NCT03057951|525756459|FG001|Overall Study|Protocol Violation|24|||
145795201|NCT03057951|525756458|FG000|Overall Study|Lost to Follow-up|6|||
145795202|NCT03057951|525756459|FG001|Overall Study|Lost to Follow-up|16|||
145795203|NCT03057951|525756458|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
145795204|NCT03057951|525756459|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
145795205|NCT03057951|525756458|FG000|Overall Study|Study drug stopped, reason missing|6|||
145795206|NCT03057951|525756459|FG001|Overall Study|Study drug stopped, reason missing|1|||
145795207|NCT03057951|525756458|FG000|Overall Study|Medical advice|6|||
145795208|NCT03057951|525756459|FG001|Overall Study|Medical advice|2|||
145795209|NCT03057951|525756458|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
145795210|NCT03057951|525756459|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
145795211|NCT03057951|525756458|FG000|Overall Study|Investigator decision|2|||
145795212|NCT03057951|525756459|FG001|Overall Study|Investigator decision|0|||
145795213|NCT03057951|525756458|FG000|Overall Study|Patient decision|5|||
145795214|NCT03057951|525756459|FG001|Overall Study|Patient decision|2|||
145795215|NCT03057951|525756458|FG000|Overall Study|Not attending study visits|3|||
145795216|NCT03057951|525756459|FG001|Overall Study|Not attending study visits|0|||
145795217|NCT03057951|525756458|FG000|Overall Study|Patient moved away|3|||
145795218|NCT03057951|525756459|FG001|Overall Study|Patient moved away|4|||
145795219|NCT03057951|525756458|FG000|Overall Study|Other reason than stated above|23|||
145795220|NCT03057951|525756459|FG001|Overall Study|Other reason than stated above|29|||
145795221|NCT03057951|525756458|FG000|Overall Study|Not treated|2|||
145795222|NCT03057951|525756459|FG001|Overall Study|Not treated|1|||
145795223|NCT02064205|525756460|FG000|Overall Study|Withdrawal by Subject|1|||
145795224|NCT02700919|525756461|FG000|Overall Study|Physician Decision|1|||
145795225|NCT02700919|525756462|FG001|Overall Study|Physician Decision|0|||
145795226|NCT02700919|525756463|FG002|Overall Study|Physician Decision|0|||
145795227|NCT02700919|525756461|FG000|Overall Study|Protocol Violation|1|||
145795228|NCT02700919|525756462|FG001|Overall Study|Protocol Violation|0|||
145795229|NCT02700919|525756463|FG002|Overall Study|Protocol Violation|0|||
145795230|NCT02700919|525756461|FG000|Overall Study|Adverse Event|1|||
145795231|NCT02700919|525756462|FG001|Overall Study|Adverse Event|3|||
145547142|NCT01599234|524863181|FG000|Overall Study|Unable to operate spray|1|||
145547143|NCT01599234|524863182|FG001|Overall Study|Unable to operate spray|0|||
145547144|NCT01599234|524863181|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
145795232|NCT02700919|525756463|FG002|Overall Study|Adverse Event|1|||
145795233|NCT02700919|525756461|FG000|Overall Study|Withdrawal by Subject|5|||
145795234|NCT02700919|525756462|FG001|Overall Study|Withdrawal by Subject|8|||
145795235|NCT02700919|525756463|FG002|Overall Study|Withdrawal by Subject|2|||
145795236|NCT02700919|525756461|FG000|Overall Study|Lost to Follow-up|2|||
145795237|NCT02700919|525756462|FG001|Overall Study|Lost to Follow-up|0|||
145795238|NCT02700919|525756463|FG002|Overall Study|Lost to Follow-up|0|||
145795239|NCT02700919|525756461|FG000|Overall Study|Other|2|||
145795240|NCT02700919|525756462|FG001|Overall Study|Other|1|||
145795241|NCT02700919|525756463|FG002|Overall Study|Other|1|||
145795242|NCT02680587|525756464|FG000|Overall Study|Withdrawal by Subject|1|||
145795243|NCT02680587|525756465|FG001|Overall Study|Withdrawal by Subject|0|||
145547145|NCT01599234|524863182|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
145795244|NCT00571688|525756472|FG000|Overall Study|Lost to Follow-up|3|||
145795245|NCT00571688|525756473|FG001|Overall Study|Lost to Follow-up|6|||
145795246|NCT00571688|525756472|FG000|Overall Study|subject did not tolerate Consta|1|||
145795247|NCT00571688|525756473|FG001|Overall Study|subject did not tolerate Consta|0|||
145795248|NCT00571688|525756472|FG000|Overall Study|subject moved out of the area|1|||
145795249|NCT00571688|525756473|FG001|Overall Study|subject moved out of the area|0|||
145795250|NCT01194869|525756474|FG000|Overall Study|Disease Progression|2|||
145795251|NCT01194869|525756474|FG000|Overall Study|Toxicity|2|||
145795252|NCT00118482|525756478|FG000|Overall Study|Lost to Follow-up|7|||
145795253|NCT00118482|525756479|FG001|Overall Study|Lost to Follow-up|7|||
145795254|NCT00118482|525756478|FG000|Overall Study|Withdrawal by Subject|23|||
145795255|NCT00118482|525756479|FG001|Overall Study|Withdrawal by Subject|22|||
145795256|NCT00125190|525756480|FG000|Overall Study|Subject/Parent Decision|7|||
145795257|NCT00125190|525756480|FG000|Overall Study|Non-compliance|2|||
145795258|NCT00125190|525756480|FG000|Overall Study|Adverse Event|1|||
145795259|NCT00125190|525756480|FG000|Overall Study|Other|1|||
145795260|NCT00125190|525756480|FG000|Overall Study|Lost to Follow-up|4|||
145795261|NCT01586156|525756481|FG000|Overall Study|Pregnancy|0|||
145795262|NCT01586156|525756482|FG001|Overall Study|Pregnancy|1|||
145795263|NCT01586156|525756483|FG002|Overall Study|Pregnancy|0|||
145795264|NCT00414960|525756484|FG000|Overall Study|Adverse Event|4|||
145795265|NCT00414960|525756485|FG001|Overall Study|Adverse Event|0|||
145795266|NCT00414960|525756484|FG000|Overall Study|Withdrawal by Subject|3|||
145795267|NCT00414960|525756485|FG001|Overall Study|Withdrawal by Subject|0|||
145795268|NCT00414960|525756484|FG000|Overall Study|Physician Decision|0|||
145795269|NCT00414960|525756485|FG001|Overall Study|Physician Decision|1|||
145795270|NCT01449682|525756487|FG000|Overall Study|Death|0|||
145795271|NCT01449682|525756488|FG001|Overall Study|Death|1|||
145795272|NCT01449682|525756487|FG000|Overall Study|Adverse Event|1|||
145795273|NCT01449682|525756488|FG001|Overall Study|Adverse Event|0|||
145795274|NCT00264849|525756493|FG000|Overall Study|Adverse Event|7|||
145795275|NCT00264849|525756494|FG001|Overall Study|Adverse Event|2|||
145795276|NCT00264849|525756493|FG000|Overall Study|Withdrawal by Subject|7|||
145795277|NCT00264849|525756494|FG001|Overall Study|Withdrawal by Subject|11|||
145795278|NCT00264849|525756493|FG000|Overall Study|Protocol Violation|5|||
145795279|NCT00264849|525756494|FG001|Overall Study|Protocol Violation|3|||
145795280|NCT00264849|525756493|FG000|Overall Study|Lack of Efficacy|1|||
145795281|NCT00264849|525756494|FG001|Overall Study|Lack of Efficacy|6|||
145795282|NCT00264849|525756493|FG000|Overall Study|Lost to Follow-up|0|||
145795283|NCT00264849|525756494|FG001|Overall Study|Lost to Follow-up|2|||
145795284|NCT00264849|525756493|FG000|Overall Study|Death|0|||
145795285|NCT00264849|525756494|FG001|Overall Study|Death|1|||
145795286|NCT00264849|525756493|FG000|Overall Study|Administrative Problems|2|||
145795287|NCT00264849|525756494|FG001|Overall Study|Administrative Problems|0|||
145795288|NCT00717366|525756495|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
145795289|NCT00717366|525756496|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
145795290|NCT00717366|525756495|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
145795291|NCT00717366|525756496|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
145795292|NCT00717366|525756495|FG000|Core Study Period (20 Weeks)|Death|0|||
145795293|NCT00717366|525756496|FG001|Core Study Period (20 Weeks)|Death|1|||
145795294|NCT00717366|525756495|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
145795295|NCT00717366|525756496|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
145795296|NCT00717366|525756495|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
145795297|NCT00717366|525756496|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
145795298|NCT00717366|525756495|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
145404837|NCT00091819|524338692|FG000|Overall Study|Protocol Violation|1|||
145404838|NCT00091819|524338693|FG001|Overall Study|Protocol Violation|2|||
145795299|NCT00717366|525756496|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
145795300|NCT00717366|525756495|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
145795301|NCT00717366|525756496|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
145795302|NCT02104804|525756497|FG000|Overall Study|Did not take study medication|0|||
145795303|NCT02104804|525756498|FG001|Overall Study|Did not take study medication|1|||
145795304|NCT02104804|525756497|FG000|Overall Study|Study specific discontinuation criteria|6|||
145795305|NCT02104804|525756498|FG001|Overall Study|Study specific discontinuation criteria|1|||
145795306|NCT02104804|525756497|FG000|Overall Study|Other listed|2|||
145795307|NCT02104804|525756498|FG001|Overall Study|Other listed|1|||
145795308|NCT02104804|525756497|FG000|Overall Study|Protocol Violation|0|||
145795309|NCT02104804|525756498|FG001|Overall Study|Protocol Violation|1|||
145795310|NCT02104804|525756497|FG000|Overall Study|Adverse Event|4|||
145795311|NCT02104804|525756498|FG001|Overall Study|Adverse Event|3|||
145795312|NCT02104804|525756497|FG000|Overall Study|Withdrawal by Subject|4|||
145795313|NCT02104804|525756498|FG001|Overall Study|Withdrawal by Subject|12|||
145795314|NCT04501679|525756499|FG000|Overall Study|Pregnancy|0|||
145795315|NCT04501679|525756500|FG001|Overall Study|Pregnancy|1|||
145795316|NCT04501679|525756499|FG000|Overall Study|Adverse Event|4|||
145795317|NCT04501679|525756500|FG001|Overall Study|Adverse Event|2|||
145795318|NCT04501679|525756499|FG000|Overall Study|Withdrawal by Subject|2|||
145795319|NCT04501679|525756500|FG001|Overall Study|Withdrawal by Subject|0|||
145795320|NCT04501679|525756499|FG000|Overall Study|Physician Decision|1|||
145547146|NCT01599234|524863181|FG000|Overall Study|Death|1|||
145547147|NCT01599234|524863182|FG001|Overall Study|Death|0|||
145547148|NCT01599234|524863181|FG000|Overall Study|Patient would not stop driving|1|||
145547149|NCT01599234|524863182|FG001|Overall Study|Patient would not stop driving|0|||
145547150|NCT01599234|524863181|FG000|Overall Study|Contra-indication discovered|0|||
145547151|NCT01599234|524863182|FG001|Overall Study|Contra-indication discovered|1|||
145547152|NCT01599234|524863181|FG000|Overall Study|Pregnancy|0|||
145547153|NCT01599234|524863182|FG001|Overall Study|Pregnancy|1|||
145547154|NCT03902574|524863191|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
145547155|NCT03902574|524863192|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
145547156|NCT03902574|524863193|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
145547157|NCT04492618|524863196|FG000|Overall Study|Withdrawal by Subject|1|||
145547158|NCT03489720|524863197|FG000|Overall Study|Withdrawal by Subject|2|||
145547159|NCT03489720|524863198|FG001|Overall Study|Withdrawal by Subject|0|||
145547160|NCT00085631|524863205|FG000|Overall Study|Missing Data|4|||
145547161|NCT00085631|524863206|FG001|Overall Study|Missing Data|11|||
145547162|NCT00085631|524863207|FG002|Overall Study|Missing Data|7|||
145547163|NCT01987505|524863212|FG000|Overall Study|Other|9|||
145547164|NCT01987505|524863212|FG000|Overall Study|Withdrawal by Subject|2|||
145547165|NCT01987505|524863212|FG000|Overall Study|Other Reason|2|||
145547166|NCT01987505|524863212|FG000|Overall Study|Lost to Follow-up|15|||
145547167|NCT01987505|524863212|FG000|Overall Study|Investigator Decision|2|||
145547168|NCT01987505|524863212|FG000|Overall Study|Death|4|||
145547169|NCT01425281|524863213|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
145795321|NCT04501679|525756500|FG001|Overall Study|Physician Decision|0|||
145795322|NCT04501679|525756499|FG000|Overall Study|Lost to Follow-up|2|||
145795323|NCT04501679|525756500|FG001|Overall Study|Lost to Follow-up|0|||
145795324|NCT02121756|525756505|FG000|Overall Study|Adverse Event|3|||
145795325|NCT02121756|525756506|FG001|Overall Study|Adverse Event|0|||
145795326|NCT02121756|525756505|FG000|Overall Study|Protocol Violation|1|||
145795327|NCT02121756|525756506|FG001|Overall Study|Protocol Violation|1|||
145795328|NCT02121756|525756505|FG000|Overall Study|Physician Decision|2|||
145795329|NCT02121756|525756506|FG001|Overall Study|Physician Decision|1|||
145795330|NCT03259490|525756508|FG000|Period 1|Withdrawal by Subject|0|||
145795331|NCT03259490|525756509|FG001|Period 1|Withdrawal by Subject|1|||
145795332|NCT03259490|525756508|FG000|Period 2|Protocol Violation|1|||
145795333|NCT03259490|525756509|FG001|Period 2|Protocol Violation|0|||
145795334|NCT00255086|525756511|FG000|Overall Study|Adverse Event|1|||
145795335|NCT00255086|525756512|FG001|Overall Study|Adverse Event|1|||
145795336|NCT00255086|525756511|FG000|Overall Study|Protocol Violation|1|||
145795337|NCT00255086|525756512|FG001|Overall Study|Protocol Violation|1|||
145795338|NCT00434122|525756513|FG000|Overall Study|Non-compliance with protocol|0|||
145795339|NCT00434122|525756514|FG001|Overall Study|Non-compliance with protocol|1|||
145795340|NCT00434122|525756513|FG000|Overall Study|loss of subject contact|1|||
145795341|NCT00434122|525756514|FG001|Overall Study|loss of subject contact|1|||
145795342|NCT00434122|525756513|FG000|Overall Study|Personal reasons|1|||
145795343|NCT00434122|525756514|FG001|Overall Study|Personal reasons|1|||
145795344|NCT00434122|525756513|FG000|Overall Study|Large follicle size|2|||
145795345|NCT00434122|525756514|FG001|Overall Study|Large follicle size|2|||
145795346|NCT00434122|525756513|FG000|Overall Study|Low follicular response.|1|||
145795347|NCT00434122|525756514|FG001|Overall Study|Low follicular response.|2|||
145795348|NCT00434122|525756513|FG000|Overall Study|Travelling of subject.|1|||
145795349|NCT00434122|525756514|FG001|Overall Study|Travelling of subject.|0|||
145795350|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
145547170|NCT01425281|524863214|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
145547171|NCT01425281|524863213|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
145547172|NCT01425281|524863214|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
145547173|NCT01425281|524863213|FG000|At 180-day Clinical Follow-up|Death|0|||
145547174|NCT01425281|524863214|FG001|At 180-day Clinical Follow-up|Death|1|||
145547175|NCT01425281|524863213|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
145547176|NCT01425281|524863214|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
145611182|NCT00235443|525092618|FG004|Overall Study|Withdrawal by Subject|10|||
145795351|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
145795352|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
145547177|NCT01425281|524863213|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
145547178|NCT01425281|524863214|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
145547179|NCT01425281|524863213|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
145547180|NCT01425281|524863214|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
145795353|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
145795354|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
145795355|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
145795356|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
145795357|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
145795358|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
145795359|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
145547181|NCT01425281|524863213|FG000|At 2-year Clinical Follow-up|Death|2|||
145547182|NCT01425281|524863214|FG001|At 2-year Clinical Follow-up|Death|0|||
145547183|NCT01425281|524863213|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
145547184|NCT01425281|524863214|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
145547185|NCT01425281|524863213|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
145547186|NCT01425281|524863214|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
145547187|NCT01425281|524863213|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
145795360|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
145795361|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
145795362|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
145795363|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
145795364|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
145795365|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
145795366|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
145795367|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
145795368|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
145795369|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
145795370|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
145795371|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
145795372|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
145795373|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
145795374|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
145795375|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
145547188|NCT01425281|524863214|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
145547189|NCT01425281|524863213|FG000|At 3-year Clinical Follow-up|Death|2|||
145611183|NCT00235443|525092619|FG005|Overall Study|Withdrawal by Subject|12|||
145611184|NCT00235443|525092614|FG000|Overall Study|Lost to Follow-up|0|||
145611185|NCT00235443|525092615|FG001|Overall Study|Lost to Follow-up|8|||
145611186|NCT00235443|525092616|FG002|Overall Study|Lost to Follow-up|6|||
145611187|NCT00235443|525092617|FG003|Overall Study|Lost to Follow-up|6|||
145611188|NCT00235443|525092618|FG004|Overall Study|Lost to Follow-up|4|||
145611189|NCT00235443|525092619|FG005|Overall Study|Lost to Follow-up|3|||
145611190|NCT00235443|525092614|FG000|Overall Study|Unsatisfactory compliance|0|||
145611191|NCT00235443|525092615|FG001|Overall Study|Unsatisfactory compliance|2|||
145611192|NCT00235443|525092616|FG002|Overall Study|Unsatisfactory compliance|3|||
145795376|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
145795377|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
145795378|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
145795379|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
145795380|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
145795381|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
145795382|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
145795383|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
145795384|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
145795385|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
145795386|NCT01963208|525756515|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
145795387|NCT01963208|525756516|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
145795388|NCT01963208|525756517|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
145795389|NCT01963208|525756518|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
145795390|NCT01963208|525756519|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
145795391|NCT01963208|525756520|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
145795392|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
145795393|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
145795394|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
145795395|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
145611193|NCT00235443|525092617|FG003|Overall Study|Unsatisfactory compliance|4|||
145611194|NCT00235443|525092618|FG004|Overall Study|Unsatisfactory compliance|1|||
145611195|NCT00235443|525092619|FG005|Overall Study|Unsatisfactory compliance|0|||
145611196|NCT00235443|525092614|FG000|Overall Study|Other reasons for premature termination|1|||
145611197|NCT00235443|525092615|FG001|Overall Study|Other reasons for premature termination|6|||
145611198|NCT00235443|525092616|FG002|Overall Study|Other reasons for premature termination|6|||
145611199|NCT00235443|525092617|FG003|Overall Study|Other reasons for premature termination|7|||
145795396|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
145795397|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
145547190|NCT01425281|524863214|FG001|At 3-year Clinical Follow-up|Death|3|||
145547191|NCT01425281|524863213|FG000|At 4-year Clinical Follow-up|Death|7|||
145611200|NCT00235443|525092618|FG004|Overall Study|Other reasons for premature termination|3|||
145547192|NCT01425281|524863214|FG001|At 4-year Clinical Follow-up|Death|3|||
145547193|NCT01425281|524863213|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
145547194|NCT01425281|524863214|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
145547195|NCT01425281|524863213|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
145547196|NCT01425281|524863214|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
145547197|NCT01425281|524863213|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
145547198|NCT01425281|524863214|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
145547199|NCT01425281|524863213|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
145547200|NCT01425281|524863214|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
145547201|NCT01425281|524863213|FG000|At 5-year Clinical Follow-up|Death|2|||
145547202|NCT01425281|524863214|FG001|At 5-year Clinical Follow-up|Death|0|||
145547203|NCT01425281|524863213|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
145547204|NCT01425281|524863214|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
145547205|NCT01425281|524863213|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
145547206|NCT01425281|524863214|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
145547207|NCT01425281|524863213|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
145547208|NCT01425281|524863214|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
145795398|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
145795399|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
145795400|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
145795401|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
145795402|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
145795403|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
145795404|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
145795405|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
145795406|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
145795407|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
145795408|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
145795409|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
145795410|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
145795411|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
145795412|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
145795413|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
145795414|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
145795415|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
145795416|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
145795417|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
145795418|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
145795419|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
145795420|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
145795421|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
145795422|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
145795423|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
145795424|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
145795425|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
145795426|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
145795427|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
145795428|NCT01963208|525756515|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
145795429|NCT01963208|525756516|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
145795430|NCT01963208|525756517|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
145795431|NCT01963208|525756518|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
145795432|NCT01963208|525756519|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
145795433|NCT01963208|525756520|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
145795434|NCT04191577|525756521|FG000|Overall Study|Withdrawal by Subject|2|||
145795435|NCT04191577|525756522|FG001|Overall Study|Withdrawal by Subject|2|||
145795436|NCT04191577|525756523|FG002|Overall Study|Withdrawal by Subject|1|||
145795437|NCT04191577|525756521|FG000|Overall Study|Physician Decision|1|||
145795438|NCT04191577|525756522|FG001|Overall Study|Physician Decision|1|||
145547209|NCT01833520|524863215|FG000|Overall Study|Lack of Efficacy|3|||
145547210|NCT01833520|524863216|FG001|Overall Study|Lack of Efficacy|3|||
145795439|NCT04191577|525756523|FG002|Overall Study|Physician Decision|0|||
145795440|NCT04191577|525756521|FG000|Overall Study|Adverse Event|0|||
145795441|NCT04191577|525756522|FG001|Overall Study|Adverse Event|0|||
145795442|NCT04191577|525756523|FG002|Overall Study|Adverse Event|1|||
145611201|NCT00235443|525092619|FG005|Overall Study|Other reasons for premature termination|6|||
145795443|NCT04191577|525756521|FG000|Overall Study|Death|0|||
145795444|NCT04191577|525756522|FG001|Overall Study|Death|0|||
145795445|NCT04191577|525756523|FG002|Overall Study|Death|1|||
145547211|NCT01833520|524863217|FG002|Overall Study|Lack of Efficacy|8|||
145611202|NCT02032173|525092620|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
145547212|NCT01833520|524863218|FG003|Overall Study|Lack of Efficacy|3|||
145547213|NCT03266107|524863219|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
145547214|NCT03266107|524863219|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
145547215|NCT03266107|524863219|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
145547216|NCT03266107|524863219|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
145547217|NCT02266225|524863224|FG000|Overall Study|Lost to Follow-up|2|||
145547218|NCT02266225|524863224|FG000|Overall Study|Death|1|||
145547219|NCT02266225|524863224|FG000|Overall Study|Withdrawal by Subject|13|||
145547220|NCT00320411|524863225|FG000|Overall Study|No investigational product admin.|4|||
145547221|NCT00660309|524863228|FG000|Overall Study|Adverse Event|2|||
145547222|NCT00660309|524863229|FG001|Overall Study|Adverse Event|0|||
145547223|NCT00660309|524863228|FG000|Overall Study|Withdrawal by Subject|0|||
145547224|NCT00660309|524863229|FG001|Overall Study|Withdrawal by Subject|3|||
145547225|NCT00211809|524863232|FG000|Overall Study|Lack of Efficacy|1|||
145547226|NCT00211809|524863232|FG000|Overall Study|Lost to Follow-up|2|||
145547227|NCT00211809|524863232|FG000|Overall Study|Pregnancy|1|||
145547228|NCT00211809|524863232|FG000|Overall Study|side effects|2|||
145547229|NCT01417234|524863233|FG000|Overall Study|Subject non-compliant|3|||
145547230|NCT00023764|524863234|FG000|Overall Study|Other|1|||
145547231|NCT00023764|524863234|FG000|Overall Study|Adverse Event|4|||
145547232|NCT00023764|524863234|FG000|Overall Study|Withdrawal by Subject|1|||
145547233|NCT00023764|524863234|FG000|Overall Study|Progression of disease|6|||
145547234|NCT00023764|524863234|FG000|Overall Study|patient received other treatment|1|||
145547235|NCT00023764|524863234|FG000|Overall Study|delay in obtaining staging images|1|||
145547236|NCT03129100|524863241|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
145547237|NCT03129100|524863242|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
145547238|NCT03129100|524863243|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
145547239|NCT03129100|524863244|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
145547240|NCT03129100|524863245|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
145547241|NCT03129100|524863246|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
145547242|NCT03129100|524863247|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
145547243|NCT03129100|524863248|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
145547244|NCT03129100|524863249|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
145547245|NCT03129100|524863250|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
145547246|NCT03129100|524863251|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
145547247|NCT03129100|524863252|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
145547248|NCT03129100|524863253|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
145547249|NCT03129100|524863254|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
145547250|NCT03129100|524863255|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
145547251|NCT03129100|524863256|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
145547252|NCT03129100|524863257|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
145547253|NCT03129100|524863258|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
145547254|NCT03129100|524863259|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
145547255|NCT03129100|524863260|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
145547256|NCT03129100|524863261|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
145547257|NCT03129100|524863262|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
145547258|NCT03129100|524863263|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
145547259|NCT03129100|524863264|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
145795446|NCT02365584|525756524|FG000|Overall Study|Adverse Event|2|||
145795447|NCT02365584|525756525|FG001|Overall Study|Adverse Event|2|||
145795448|NCT02365584|525756524|FG000|Overall Study|Withdrawal by Subject|1|||
145795449|NCT02365584|525756525|FG001|Overall Study|Withdrawal by Subject|0|||
145795450|NCT02365584|525756524|FG000|Overall Study|Disease Progression|9|||
145795451|NCT02365584|525756525|FG001|Overall Study|Disease Progression|12|||
145795452|NCT01973452|525756526|FG000|Overall Study|Lack of Efficacy|0|||
145795453|NCT01973452|525756527|FG001|Overall Study|Lack of Efficacy|1|||
145795454|NCT01973452|525756526|FG000|Overall Study|Lost to Follow-up|1|||
145795455|NCT01973452|525756527|FG001|Overall Study|Lost to Follow-up|0|||
145795456|NCT01973452|525756526|FG000|Overall Study|Withdrawal by Subject|10|||
145795457|NCT01973452|525756527|FG001|Overall Study|Withdrawal by Subject|9|||
145795458|NCT01973452|525756526|FG000|Overall Study|Ineligible|1|||
145547260|NCT03129100|524863265|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
145611203|NCT00474929|525092626|FG000|Overall Study|Withdrawal by Subject|0|||
145795459|NCT01973452|525756527|FG001|Overall Study|Ineligible|1|||
145795460|NCT01973452|525756526|FG000|Overall Study|Surgery canceled by participant|5|||
145547261|NCT03129100|524863266|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
145547262|NCT03129100|524863241|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
145547263|NCT03129100|524863242|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547264|NCT03129100|524863243|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547265|NCT03129100|524863244|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547266|NCT03129100|524863245|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547267|NCT03129100|524863246|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547268|NCT03129100|524863247|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145795461|NCT01973452|525756527|FG001|Overall Study|Surgery canceled by participant|3|||
145404839|NCT00091819|524338692|FG000|Overall Study|Other|2|||
145547269|NCT03129100|524863248|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547270|NCT03129100|524863249|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547271|NCT03129100|524863250|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547272|NCT03129100|524863251|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547273|NCT03129100|524863252|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547274|NCT03129100|524863253|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547275|NCT03129100|524863254|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547276|NCT03129100|524863255|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547277|NCT03129100|524863256|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547278|NCT03129100|524863257|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547279|NCT03129100|524863258|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547280|NCT03129100|524863259|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547281|NCT03129100|524863260|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547282|NCT03129100|524863261|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547283|NCT03129100|524863262|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547284|NCT03129100|524863263|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547285|NCT03129100|524863264|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547286|NCT03129100|524863265|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547287|NCT03129100|524863266|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
145547288|NCT03129100|524863241|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
145547289|NCT03129100|524863242|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
145547290|NCT03129100|524863243|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547291|NCT03129100|524863244|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547292|NCT03129100|524863245|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547293|NCT03129100|524863246|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547294|NCT03129100|524863247|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547295|NCT03129100|524863248|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547296|NCT03129100|524863249|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547297|NCT03129100|524863250|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547298|NCT03129100|524863251|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547299|NCT03129100|524863252|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547300|NCT03129100|524863253|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547301|NCT03129100|524863254|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547302|NCT03129100|524863255|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547303|NCT03129100|524863256|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547304|NCT03129100|524863257|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547305|NCT03129100|524863258|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547306|NCT03129100|524863259|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547307|NCT03129100|524863260|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547308|NCT03129100|524863261|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547309|NCT03129100|524863262|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547310|NCT03129100|524863263|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547311|NCT03129100|524863264|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547312|NCT03129100|524863265|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547313|NCT03129100|524863266|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
145547314|NCT03129100|524863241|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
145795462|NCT01842607|525756529|FG000|Overall Study|Adverse Event|11|||
145795463|NCT01842607|525756529|FG000|Overall Study|Lack of Efficacy|19|||
145795464|NCT01842607|525756529|FG000|Overall Study|Protocol Violation|8|||
145795465|NCT01842607|525756529|FG000|Overall Study|Protocol defined stopping criteria|2|||
145795466|NCT01842607|525756529|FG000|Overall Study|Lost to Follow-up|3|||
145795467|NCT01842607|525756529|FG000|Overall Study|Physician Decision|9|||
145795468|NCT01842607|525756529|FG000|Overall Study|Withdrawal by Subject|14|||
145795469|NCT02159469|525756530|FG000|Overall Study|Missing Completion status|1|||
145795470|NCT02159469|525756530|FG000|Overall Study|Adverse Event|5|||
145795471|NCT02159469|525756530|FG000|Overall Study|Non-compliance|2|||
145795472|NCT02159469|525756530|FG000|Overall Study|Withdrawal by Subject|9|||
145795473|NCT02159469|525756530|FG000|Overall Study|Lost to Follow-up|1|||
145795474|NCT02159469|525756530|FG000|Overall Study|Sponsor's request|2|||
145795475|NCT02159469|525756530|FG000|Overall Study|Met Stopping Criteria|3|||
145795476|NCT02159469|525756530|FG000|Overall Study|Other|1|||
145795477|NCT02159469|525756530|FG000|Overall Study|Multiple|29|||
145795478|NCT03629041|525756531|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
145795479|NCT03629041|525756532|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
145795480|NCT03629041|525756533|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
145547315|NCT03129100|524863242|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
145547316|NCT03129100|524863243|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547317|NCT03129100|524863244|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547318|NCT03129100|524863245|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547319|NCT03129100|524863246|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547320|NCT03129100|524863247|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547321|NCT03129100|524863248|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547322|NCT03129100|524863249|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547323|NCT03129100|524863250|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547324|NCT03129100|524863251|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547325|NCT03129100|524863252|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547326|NCT03129100|524863253|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547327|NCT03129100|524863254|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145795481|NCT03629041|525756534|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
145795482|NCT03488251|525756541|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
145795483|NCT03488251|525756542|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
145795484|NCT03488251|525756543|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
145795485|NCT03488251|525756544|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
145795486|NCT03488251|525756541|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
145795487|NCT03488251|525756542|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
145795488|NCT03488251|525756543|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
145795489|NCT03488251|525756544|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
145795490|NCT03488251|525756541|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
145795491|NCT03488251|525756542|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
145795492|NCT03488251|525756543|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
145795493|NCT03488251|525756544|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
145795494|NCT03488251|525756541|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
145795495|NCT03488251|525756542|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
145795496|NCT03488251|525756543|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
145795497|NCT03488251|525756544|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
145795498|NCT03488251|525756541|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
145795499|NCT03488251|525756542|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
145795500|NCT03488251|525756543|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
145795501|NCT03488251|525756544|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
145795502|NCT00115765|525756547|FG000|Overall Study|Withdrawal by Subject|22|||
145795503|NCT00115765|525756548|FG001|Overall Study|Withdrawal by Subject|53|||
145795504|NCT00115765|525756549|FG002|Overall Study|Withdrawal by Subject|76|||
145795505|NCT00115765|525756550|FG003|Overall Study|Withdrawal by Subject|15|||
145795506|NCT00115765|525756547|FG000|Overall Study|Physician Decision|4|||
145795507|NCT00115765|525756548|FG001|Overall Study|Physician Decision|15|||
145795508|NCT00115765|525756549|FG002|Overall Study|Physician Decision|18|||
145795509|NCT00115765|525756550|FG003|Overall Study|Physician Decision|13|||
145795510|NCT00115765|525756547|FG000|Overall Study|Lost to Follow-up|3|||
145795511|NCT00115765|525756548|FG001|Overall Study|Lost to Follow-up|20|||
145795512|NCT00115765|525756549|FG002|Overall Study|Lost to Follow-up|18|||
145795513|NCT00115765|525756550|FG003|Overall Study|Lost to Follow-up|1|||
145795514|NCT00115765|525756547|FG000|Overall Study|Other|6|||
145795515|NCT00115765|525756548|FG001|Overall Study|Other|12|||
145795516|NCT00115765|525756549|FG002|Overall Study|Other|9|||
145795517|NCT00115765|525756550|FG003|Overall Study|Other|2|||
145795518|NCT00675103|525756551|FG000|Overall Study|Lack of Efficacy|2|||
145795519|NCT00675103|525756551|FG000|Overall Study|Adverse Event|1|||
145795520|NCT01244191|525756555|FG000|Overall Study|Progressive disease|295|||
145795521|NCT01244191|525756556|FG001|Overall Study|Progressive disease|350|||
145795522|NCT01244191|525756555|FG000|Overall Study|Clinical disease progression|54|||
145795523|NCT01244191|525756556|FG001|Overall Study|Clinical disease progression|36|||
145795524|NCT01244191|525756555|FG000|Overall Study|Adverse Event|65|||
145795525|NCT01244191|525756556|FG001|Overall Study|Adverse Event|48|||
145795526|NCT01244191|525756555|FG000|Overall Study|Death|22|||
145547328|NCT03129100|524863255|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547329|NCT03129100|524863256|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547330|NCT03129100|524863257|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547331|NCT03129100|524863258|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547332|NCT03129100|524863259|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547333|NCT03129100|524863260|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547334|NCT03129100|524863261|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547335|NCT03129100|524863262|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547336|NCT03129100|524863263|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145795527|NCT01244191|525756556|FG001|Overall Study|Death|29|||
145795528|NCT01244191|525756555|FG000|Overall Study|Lost to Follow-up|0|||
145795529|NCT01244191|525756556|FG001|Overall Study|Lost to Follow-up|2|||
145795530|NCT01244191|525756555|FG000|Overall Study|Protocol Violation|1|||
145547337|NCT03129100|524863264|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547338|NCT03129100|524863265|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547339|NCT03129100|524863266|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
145547340|NCT03129100|524863241|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547341|NCT03129100|524863242|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
145547342|NCT03129100|524863243|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547343|NCT03129100|524863244|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547344|NCT03129100|524863245|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547345|NCT03129100|524863246|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547346|NCT03129100|524863247|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547347|NCT03129100|524863248|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547348|NCT03129100|524863249|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547349|NCT03129100|524863250|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547350|NCT03129100|524863251|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547351|NCT03129100|524863252|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547352|NCT03129100|524863253|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547353|NCT03129100|524863254|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547354|NCT03129100|524863255|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547355|NCT03129100|524863256|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547356|NCT03129100|524863257|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547357|NCT03129100|524863258|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547358|NCT03129100|524863259|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547359|NCT03129100|524863260|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547360|NCT03129100|524863261|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547361|NCT03129100|524863262|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547362|NCT03129100|524863263|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547363|NCT03129100|524863264|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547364|NCT03129100|524863265|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547365|NCT03129100|524863266|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
145547366|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547367|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547368|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
145547369|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
145547370|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547371|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
145547372|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547373|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547374|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547375|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547376|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547377|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547378|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547379|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547380|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547381|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547382|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547383|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547384|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547385|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145795531|NCT01244191|525756556|FG001|Overall Study|Protocol Violation|2|||
145795532|NCT01244191|525756555|FG000|Overall Study|Withdrawal by Subject|31|||
145795533|NCT01244191|525756556|FG001|Overall Study|Withdrawal by Subject|23|||
145795534|NCT01244191|525756555|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
145795535|NCT01244191|525756556|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
145795536|NCT05301322|525756557|FG000|Overall Study|Adverse Event|7|||
145795537|NCT05301322|525756558|FG001|Overall Study|Adverse Event|3|||
145547386|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145795538|NCT05301322|525756557|FG000|Overall Study|Death|0|||
145795539|NCT05301322|525756558|FG001|Overall Study|Death|1|||
145547387|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145795540|NCT05301322|525756557|FG000|Overall Study|Lost to Follow-up|2|||
145795541|NCT05301322|525756558|FG001|Overall Study|Lost to Follow-up|1|||
145795542|NCT05301322|525756557|FG000|Overall Study|Protocol Violation|3|||
145795543|NCT05301322|525756558|FG001|Overall Study|Protocol Violation|1|||
145795544|NCT05301322|525756557|FG000|Overall Study|Withdrawal by Subject|3|||
145547388|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547389|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547390|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547391|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
145547392|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Death|0|||
145547393|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Death|0|||
145547394|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Death|1|||
145547395|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Death|0|||
145547396|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Death|0|||
145547397|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Death|0|||
145547398|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Death|0|||
145547399|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Death|0|||
145547400|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Death|0|||
145547401|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Death|0|||
145547402|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Death|0|||
145547403|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Death|0|||
145547404|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Death|0|||
145547405|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Death|0|||
145547406|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Death|0|||
145547407|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Death|0|||
145547408|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Death|0|||
145547409|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Death|0|||
145547410|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Death|0|||
145547411|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Death|0|||
145547412|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Death|0|||
145547413|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Death|0|||
145547414|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Death|0|||
145547415|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Death|0|||
145547416|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Death|0|||
145547417|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Death|0|||
145547418|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547419|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547420|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
145547421|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
145547422|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
145547423|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
145547424|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
145547425|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547426|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547427|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547428|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547429|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547430|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547431|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547432|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547433|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547434|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547435|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547436|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547437|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547438|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547439|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547440|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547441|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547442|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547443|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
145547444|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547445|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547446|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
145795545|NCT05301322|525756558|FG001|Overall Study|Withdrawal by Subject|0|||
145547447|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547448|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547449|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547450|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547451|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547452|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547453|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547454|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547455|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547456|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547457|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547458|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547459|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547460|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547461|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547462|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547463|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547464|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547465|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547466|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547467|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547468|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547469|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
145547470|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547471|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547472|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
145547473|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547474|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547475|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547476|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547477|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547478|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547479|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547480|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547481|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547482|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547483|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547484|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547485|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547486|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547487|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547488|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547489|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547490|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547491|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547492|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547493|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547494|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547495|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
145547496|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547497|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547498|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
145547499|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547500|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547501|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547502|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547503|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547504|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547505|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547506|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547507|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547508|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547509|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547510|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547511|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547512|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547513|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547514|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547515|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547516|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547517|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547518|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547519|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547520|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547521|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
145547522|NCT03129100|524863241|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547523|NCT03129100|524863242|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547524|NCT03129100|524863243|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547525|NCT03129100|524863244|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547526|NCT03129100|524863245|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
145547527|NCT03129100|524863246|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
145547528|NCT03129100|524863247|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
145547529|NCT03129100|524863248|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547530|NCT03129100|524863249|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547531|NCT03129100|524863250|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547532|NCT03129100|524863251|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547533|NCT03129100|524863252|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547534|NCT03129100|524863253|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547535|NCT03129100|524863254|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547536|NCT03129100|524863255|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547537|NCT03129100|524863256|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547538|NCT03129100|524863257|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547539|NCT03129100|524863258|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547540|NCT03129100|524863259|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547541|NCT03129100|524863260|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547542|NCT03129100|524863261|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547543|NCT03129100|524863262|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547544|NCT03129100|524863263|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547545|NCT03129100|524863264|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547546|NCT03129100|524863265|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547547|NCT03129100|524863266|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
145547548|NCT03129100|524863241|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547549|NCT03129100|524863242|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547550|NCT03129100|524863243|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547551|NCT03129100|524863244|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547552|NCT03129100|524863245|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547553|NCT03129100|524863246|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547554|NCT03129100|524863247|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547555|NCT03129100|524863248|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547556|NCT03129100|524863249|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547557|NCT03129100|524863250|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
145547558|NCT03129100|524863251|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547559|NCT03129100|524863252|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547560|NCT03129100|524863253|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547561|NCT03129100|524863254|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547562|NCT03129100|524863255|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547563|NCT03129100|524863256|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547564|NCT03129100|524863257|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547565|NCT03129100|524863258|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547566|NCT03129100|524863259|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547567|NCT03129100|524863260|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547568|NCT03129100|524863261|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547569|NCT03129100|524863262|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547570|NCT03129100|524863263|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145795546|NCT05301322|525756557|FG000|Overall Study|Other|4|||
145547571|NCT03129100|524863264|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547572|NCT03129100|524863265|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547573|NCT03129100|524863266|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
145547574|NCT03129100|524863241|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547575|NCT03129100|524863242|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547576|NCT03129100|524863243|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547577|NCT03129100|524863244|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547578|NCT03129100|524863245|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547579|NCT03129100|524863246|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547580|NCT03129100|524863247|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547581|NCT03129100|524863248|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547582|NCT03129100|524863249|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547583|NCT03129100|524863250|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547584|NCT03129100|524863251|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547585|NCT03129100|524863252|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
145547586|NCT03129100|524863253|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547587|NCT03129100|524863254|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547588|NCT03129100|524863255|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547589|NCT03129100|524863256|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547590|NCT03129100|524863257|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547591|NCT03129100|524863258|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547592|NCT03129100|524863259|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547593|NCT03129100|524863260|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547594|NCT03129100|524863261|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547595|NCT03129100|524863262|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547596|NCT03129100|524863263|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547597|NCT03129100|524863264|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547598|NCT03129100|524863265|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547599|NCT03129100|524863266|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
145547600|NCT03129100|524863241|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547601|NCT03129100|524863242|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547602|NCT03129100|524863243|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547603|NCT03129100|524863244|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547604|NCT03129100|524863245|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547605|NCT03129100|524863246|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547606|NCT03129100|524863247|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547607|NCT03129100|524863248|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547608|NCT03129100|524863249|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547609|NCT03129100|524863250|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547610|NCT03129100|524863251|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547611|NCT03129100|524863252|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
145547612|NCT03129100|524863253|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
145547613|NCT03129100|524863254|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
145547614|NCT03129100|524863255|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
145547615|NCT03129100|524863256|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547616|NCT03129100|524863257|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547617|NCT03129100|524863258|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547618|NCT03129100|524863259|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547619|NCT03129100|524863260|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547620|NCT03129100|524863261|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547621|NCT03129100|524863262|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547622|NCT03129100|524863263|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547623|NCT03129100|524863264|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547624|NCT03129100|524863265|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547625|NCT03129100|524863266|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
145547626|NCT03129100|524863241|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547627|NCT03129100|524863242|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547628|NCT03129100|524863243|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547629|NCT03129100|524863244|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547630|NCT03129100|524863245|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547631|NCT03129100|524863246|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547632|NCT03129100|524863247|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145404840|NCT00091819|524338693|FG001|Overall Study|Other|3|||
145547633|NCT03129100|524863248|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547634|NCT03129100|524863249|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547635|NCT03129100|524863250|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547636|NCT03129100|524863251|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547637|NCT03129100|524863252|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
145547638|NCT03129100|524863253|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547639|NCT03129100|524863254|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
145547640|NCT03129100|524863255|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
145547641|NCT03129100|524863256|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547642|NCT03129100|524863257|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547643|NCT03129100|524863258|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547644|NCT03129100|524863259|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547645|NCT03129100|524863260|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547646|NCT03129100|524863261|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547647|NCT03129100|524863262|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547648|NCT03129100|524863263|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547649|NCT03129100|524863264|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547650|NCT03129100|524863265|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547651|NCT03129100|524863266|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
145547652|NCT03129100|524863241|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547653|NCT03129100|524863242|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547654|NCT03129100|524863243|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547655|NCT03129100|524863244|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547656|NCT03129100|524863245|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547657|NCT03129100|524863246|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547658|NCT03129100|524863247|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547659|NCT03129100|524863248|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547660|NCT03129100|524863249|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547661|NCT03129100|524863250|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547662|NCT03129100|524863251|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547663|NCT03129100|524863252|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547664|NCT03129100|524863253|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547665|NCT03129100|524863254|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547666|NCT03129100|524863255|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547667|NCT03129100|524863256|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
145547668|NCT03129100|524863257|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547669|NCT03129100|524863258|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547670|NCT03129100|524863259|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145282779|NCT02006147|523884359|FG000|Overall Study|Withdrawal by Subject|0|||
145282780|NCT02006147|523884360|FG001|Overall Study|Withdrawal by Subject|1|||
145282781|NCT02006147|523884361|FG002|Overall Study|Withdrawal by Subject|0|||
145282782|NCT02006147|523884362|FG003|Overall Study|Withdrawal by Subject|0|||
145282783|NCT02006147|523884359|FG000|Overall Study|Withdrawal by Sponsor|1|||
145282784|NCT02006147|523884360|FG001|Overall Study|Withdrawal by Sponsor|0|||
145282785|NCT02006147|523884361|FG002|Overall Study|Withdrawal by Sponsor|0|||
145282786|NCT02006147|523884362|FG003|Overall Study|Withdrawal by Sponsor|0|||
145282787|NCT00345683|523884369|FG000|Overall Study|Lost to Follow-up|19|||
145282788|NCT00345683|523884370|FG001|Overall Study|Lost to Follow-up|7|||
145282789|NCT00345683|523884369|FG000|Overall Study|Other|6|||
145282790|NCT00345683|523884370|FG001|Overall Study|Other|2|||
145282791|NCT03634488|523884373|FG000|Overall Study|Death|1|||
145282792|NCT03634488|523884374|FG001|Overall Study|Death|0|||
145282793|NCT03634488|523884375|FG002|Overall Study|Death|0|||
145282794|NCT03634488|523884373|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
145404841|NCT00091819|524338692|FG000|Overall Study|Never received study treatment|3|||
145404842|NCT00091819|524338693|FG001|Overall Study|Never received study treatment|4|||
145547671|NCT03129100|524863260|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547672|NCT03129100|524863261|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547673|NCT03129100|524863262|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547674|NCT03129100|524863263|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547675|NCT03129100|524863264|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547676|NCT03129100|524863265|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547677|NCT03129100|524863266|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
145547678|NCT03129100|524863241|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145282795|NCT03634488|523884374|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
145547679|NCT03129100|524863242|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547680|NCT03129100|524863243|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547681|NCT03129100|524863244|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547682|NCT03129100|524863245|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547683|NCT03129100|524863246|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547684|NCT03129100|524863247|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547685|NCT03129100|524863248|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547686|NCT03129100|524863249|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547687|NCT03129100|524863250|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547688|NCT03129100|524863251|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547689|NCT03129100|524863252|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547690|NCT03129100|524863253|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
145547691|NCT03129100|524863254|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547692|NCT03129100|524863255|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
145547693|NCT03129100|524863256|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
145547694|NCT03129100|524863257|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547695|NCT03129100|524863258|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547696|NCT03129100|524863259|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547697|NCT03129100|524863260|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547698|NCT03129100|524863261|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547699|NCT03129100|524863262|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547700|NCT03129100|524863263|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547701|NCT03129100|524863264|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547702|NCT03129100|524863265|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547703|NCT03129100|524863266|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
145547704|NCT03129100|524863241|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547705|NCT03129100|524863242|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547706|NCT03129100|524863243|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547707|NCT03129100|524863244|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547708|NCT03129100|524863245|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547709|NCT03129100|524863246|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547710|NCT03129100|524863247|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547711|NCT03129100|524863248|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547712|NCT03129100|524863249|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547713|NCT03129100|524863250|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547714|NCT03129100|524863251|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547715|NCT03129100|524863252|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547716|NCT03129100|524863253|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547717|NCT03129100|524863254|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547718|NCT03129100|524863255|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547719|NCT03129100|524863256|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547720|NCT03129100|524863257|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547721|NCT03129100|524863258|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
145547722|NCT03129100|524863259|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547723|NCT03129100|524863260|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
145547724|NCT03129100|524863261|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547725|NCT03129100|524863262|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547726|NCT03129100|524863263|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547727|NCT03129100|524863264|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547728|NCT03129100|524863265|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547729|NCT03129100|524863266|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
145547730|NCT03129100|524863241|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547731|NCT03129100|524863242|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547732|NCT03129100|524863243|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547733|NCT03129100|524863244|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547734|NCT03129100|524863245|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145292778|NCT05014412|523922232|FG000|Overall Study|Withdrawal by Subject|1|||
145547735|NCT03129100|524863246|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547736|NCT03129100|524863247|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547737|NCT03129100|524863248|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547738|NCT03129100|524863249|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547739|NCT03129100|524863250|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547740|NCT03129100|524863251|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547741|NCT03129100|524863252|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547742|NCT03129100|524863253|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547743|NCT03129100|524863254|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547744|NCT03129100|524863255|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145292779|NCT05014412|523922233|FG001|Overall Study|Withdrawal by Subject|1|||
145547745|NCT03129100|524863256|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547746|NCT03129100|524863257|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547747|NCT03129100|524863258|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547748|NCT03129100|524863259|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547749|NCT03129100|524863260|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547750|NCT03129100|524863261|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
145547751|NCT03129100|524863262|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547752|NCT03129100|524863263|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547753|NCT03129100|524863264|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547754|NCT03129100|524863265|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547755|NCT03129100|524863266|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
145547756|NCT03129100|524863241|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
145547757|NCT03129100|524863242|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
145547758|NCT03129100|524863243|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
145547759|NCT03129100|524863244|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
145547760|NCT03129100|524863245|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
145547761|NCT03129100|524863246|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
145547762|NCT03129100|524863247|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
145547763|NCT03129100|524863248|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
145547764|NCT03129100|524863249|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
145547765|NCT03129100|524863250|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
145547766|NCT03129100|524863251|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
145547767|NCT03129100|524863252|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
145547768|NCT03129100|524863253|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
145547769|NCT03129100|524863254|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
145547770|NCT03129100|524863255|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
145547771|NCT03129100|524863256|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
145547772|NCT03129100|524863257|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
145547773|NCT03129100|524863258|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
145547774|NCT03129100|524863259|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
145547775|NCT03129100|524863260|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
145547776|NCT03129100|524863261|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
145547777|NCT03129100|524863262|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
145547778|NCT03129100|524863263|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
145547779|NCT03129100|524863264|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
145547780|NCT03129100|524863265|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
145547781|NCT03129100|524863266|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
145547782|NCT03129100|524863241|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547783|NCT03129100|524863242|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547784|NCT03129100|524863243|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547785|NCT03129100|524863244|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547786|NCT03129100|524863245|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547787|NCT03129100|524863246|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547788|NCT03129100|524863247|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547789|NCT03129100|524863248|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547790|NCT03129100|524863249|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547791|NCT03129100|524863250|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547792|NCT03129100|524863251|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547793|NCT03129100|524863252|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547794|NCT03129100|524863253|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547795|NCT03129100|524863254|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145795547|NCT05301322|525756558|FG001|Overall Study|Other|0|||
145795548|NCT00808249|525756559|FG000|Overall Study|Adverse Event|4|||
145795549|NCT00808249|525756560|FG001|Overall Study|Adverse Event|7|||
145795550|NCT00808249|525756561|FG002|Overall Study|Adverse Event|10|||
145795551|NCT00808249|525756562|FG003|Overall Study|Adverse Event|6|||
145795552|NCT00808249|525756559|FG000|Overall Study|Lost to Follow-up|2|||
145795553|NCT00808249|525756560|FG001|Overall Study|Lost to Follow-up|3|||
145795554|NCT00808249|525756561|FG002|Overall Study|Lost to Follow-up|3|||
145795555|NCT00808249|525756562|FG003|Overall Study|Lost to Follow-up|5|||
145795556|NCT00808249|525756559|FG000|Overall Study|Withdrawal by Subject|4|||
145795557|NCT00808249|525756560|FG001|Overall Study|Withdrawal by Subject|0|||
145795558|NCT00808249|525756561|FG002|Overall Study|Withdrawal by Subject|2|||
145795559|NCT00808249|525756562|FG003|Overall Study|Withdrawal by Subject|4|||
145795560|NCT00808249|525756559|FG000|Overall Study|Protocol Violation|3|||
145795561|NCT00808249|525756560|FG001|Overall Study|Protocol Violation|3|||
145547796|NCT03129100|524863255|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547797|NCT03129100|524863256|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547798|NCT03129100|524863257|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547799|NCT03129100|524863258|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547800|NCT03129100|524863259|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145795562|NCT00808249|525756561|FG002|Overall Study|Protocol Violation|3|||
145547801|NCT03129100|524863260|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547802|NCT03129100|524863261|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
145547803|NCT03129100|524863262|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547804|NCT03129100|524863263|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547805|NCT03129100|524863264|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547806|NCT03129100|524863265|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547807|NCT03129100|524863266|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
145547808|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
145547809|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
145547810|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
145547811|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
145547812|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
145547813|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
145547814|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
145547815|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
145795563|NCT00808249|525756562|FG003|Overall Study|Protocol Violation|0|||
145795564|NCT00808249|525756559|FG000|Overall Study|Lack of Efficacy|1|||
145795565|NCT00808249|525756560|FG001|Overall Study|Lack of Efficacy|1|||
145795566|NCT00808249|525756561|FG002|Overall Study|Lack of Efficacy|0|||
145795567|NCT00808249|525756562|FG003|Overall Study|Lack of Efficacy|0|||
145795568|NCT00808249|525756559|FG000|Overall Study|study specific discontinuation criteria|1|||
145795569|NCT00808249|525756560|FG001|Overall Study|study specific discontinuation criteria|0|||
145795570|NCT00808249|525756561|FG002|Overall Study|study specific discontinuation criteria|1|||
145795571|NCT00808249|525756562|FG003|Overall Study|study specific discontinuation criteria|0|||
145795572|NCT00808249|525756559|FG000|Overall Study|All other reasons|2|||
145795573|NCT00808249|525756560|FG001|Overall Study|All other reasons|1|||
145795574|NCT00808249|525756561|FG002|Overall Study|All other reasons|3|||
145795575|NCT00808249|525756562|FG003|Overall Study|All other reasons|1|||
145795576|NCT03829332|525756563|FG000|Overall Study|Death|225|||
145795577|NCT03829332|525756564|FG001|Overall Study|Death|230|||
145795578|NCT03829332|525756563|FG000|Overall Study|Lost to Follow-up|1|||
145795579|NCT03829332|525756564|FG001|Overall Study|Lost to Follow-up|3|||
145795580|NCT03829332|525756563|FG000|Overall Study|Physician Decision|1|||
145795581|NCT03829332|525756564|FG001|Overall Study|Physician Decision|0|||
145795582|NCT03829332|525756563|FG000|Overall Study|Sponsor Decision|71|||
145795583|NCT03829332|525756564|FG001|Overall Study|Sponsor Decision|72|||
145547816|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
145547817|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
145547818|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
145547819|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
145547820|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
145547821|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
145547822|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
145547823|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
145547824|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
145547825|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
145547826|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
145547827|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
145547828|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
145547829|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
145547830|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
145547831|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
145547832|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
145547833|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
145547834|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547835|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547836|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547837|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547838|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547839|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547840|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547841|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547842|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547843|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547844|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145795584|NCT03829332|525756563|FG000|Overall Study|Withdrawal by Subject|11|||
145795585|NCT03829332|525756564|FG001|Overall Study|Withdrawal by Subject|9|||
145795586|NCT04095286|525756565|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795587|NCT04095286|525756566|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
145547845|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547846|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547847|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547848|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547849|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547850|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547851|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547852|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547853|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547854|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547855|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547856|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547857|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
145547858|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
145547859|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
145547860|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547861|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547862|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547863|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547864|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547865|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547866|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547867|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547868|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547869|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547870|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547871|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547872|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547873|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547874|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547875|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547876|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547877|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547878|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547879|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145795588|NCT04095286|525756567|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795589|NCT04095286|525756568|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795590|NCT04095286|525756569|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795591|NCT04095286|525756570|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795592|NCT04095286|525756565|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
145795593|NCT04095286|525756566|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
145795594|NCT04095286|525756567|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
145547880|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547881|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547882|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
145547883|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
145547884|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
145547885|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
145547886|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547887|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547888|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547889|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145795595|NCT04095286|525756568|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
145547890|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547891|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547892|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547893|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547894|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547895|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547896|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547897|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547898|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145795596|NCT04095286|525756569|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
145547899|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547900|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547901|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547902|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547903|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547904|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547905|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547906|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145282796|NCT03634488|523884375|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
145547907|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547908|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547909|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547910|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
145547911|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
145547912|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795597|NCT04095286|525756570|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
145795598|NCT04095286|525756565|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
145795599|NCT04095286|525756566|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
145795600|NCT04095286|525756567|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
145795601|NCT04095286|525756568|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
145795602|NCT04095286|525756569|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
145795603|NCT04095286|525756570|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
145795604|NCT04095286|525756565|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795605|NCT04095286|525756566|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795606|NCT04095286|525756567|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
145795607|NCT04095286|525756568|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795608|NCT04095286|525756569|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795609|NCT04095286|525756570|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
145795610|NCT04095286|525756565|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
145795611|NCT04095286|525756566|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
145795612|NCT04095286|525756567|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
145795613|NCT04095286|525756568|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
145795614|NCT04095286|525756569|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
145795615|NCT04095286|525756570|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
145795616|NCT00479557|525756571|FG000|Overall Study|Death|0|||
145795617|NCT00479557|525756572|FG001|Overall Study|Death|0|||
145795618|NCT00479557|525756573|FG002|Overall Study|Death|0|||
145795619|NCT00479557|525756574|FG003|Overall Study|Death|0|||
145795620|NCT00479557|525756575|FG004|Overall Study|Death|0|||
145795621|NCT00479557|525756576|FG005|Overall Study|Death|1|||
145795622|NCT00479557|525756577|FG006|Overall Study|Death|0|||
145795623|NCT00479557|525756571|FG000|Overall Study|Lack of Efficacy|1|||
145282797|NCT03182686|523884376|FG000|Overall Study|Lost to Follow-up|2|||
145282798|NCT03182686|523884377|FG001|Overall Study|Lost to Follow-up|0|||
145282799|NCT03182686|523884376|FG000|Overall Study|Adverse Event|2|||
145282800|NCT03182686|523884377|FG001|Overall Study|Adverse Event|0|||
145282801|NCT03182686|523884376|FG000|Overall Study|Withdrawal by Subject|3|||
145282802|NCT03182686|523884377|FG001|Overall Study|Withdrawal by Subject|0|||
145282803|NCT01154127|523884378|FG000|Period 1 (21 Days)|Adverse Event|3|||
145282804|NCT01154127|523884379|FG001|Period 1 (21 Days)|Adverse Event|4|||
145282805|NCT01154127|523884378|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
145282806|NCT01154127|523884379|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
145282807|NCT01154127|523884378|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
145282808|NCT01154127|523884379|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
145282809|NCT01154127|523884378|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
145282810|NCT01154127|523884379|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
145282811|NCT01154127|523884378|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
145282812|NCT01154127|523884379|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
145404843|NCT01311661|524338694|FG000|Overall Study|Adverse Event|2|||
145404844|NCT01311661|524338694|FG000|Overall Study|Protocol Violation|3|||
145404845|NCT01311661|524338694|FG000|Overall Study|Withdrawal by Subject|2|||
145404846|NCT02855268|524338695|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
145547913|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547914|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547915|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547916|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795624|NCT00479557|525756572|FG001|Overall Study|Lack of Efficacy|0|||
145795625|NCT00479557|525756573|FG002|Overall Study|Lack of Efficacy|0|||
145795626|NCT00479557|525756574|FG003|Overall Study|Lack of Efficacy|0|||
145795627|NCT00479557|525756575|FG004|Overall Study|Lack of Efficacy|0|||
145795628|NCT00479557|525756576|FG005|Overall Study|Lack of Efficacy|0|||
145547917|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547918|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795629|NCT00479557|525756577|FG006|Overall Study|Lack of Efficacy|0|||
145795630|NCT00479557|525756571|FG000|Overall Study|Lost to Follow-up|0|||
145795631|NCT00479557|525756572|FG001|Overall Study|Lost to Follow-up|2|||
145795632|NCT00479557|525756573|FG002|Overall Study|Lost to Follow-up|0|||
145795633|NCT00479557|525756574|FG003|Overall Study|Lost to Follow-up|2|||
145795634|NCT00479557|525756575|FG004|Overall Study|Lost to Follow-up|0|||
145795635|NCT00479557|525756576|FG005|Overall Study|Lost to Follow-up|0|||
145795636|NCT00479557|525756577|FG006|Overall Study|Lost to Follow-up|0|||
145795637|NCT00479557|525756571|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
145795638|NCT00479557|525756572|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145795639|NCT00479557|525756573|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
145795640|NCT00479557|525756574|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
145795641|NCT00479557|525756575|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145795642|NCT00479557|525756576|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
145795643|NCT00479557|525756577|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145795644|NCT00479557|525756571|FG000|Overall Study|AE not related to Study Drug|1|||
145795645|NCT00479557|525756572|FG001|Overall Study|AE not related to Study Drug|3|||
145795646|NCT00479557|525756573|FG002|Overall Study|AE not related to Study Drug|0|||
145795647|NCT00479557|525756574|FG003|Overall Study|AE not related to Study Drug|0|||
145795648|NCT00479557|525756575|FG004|Overall Study|AE not related to Study Drug|2|||
145795649|NCT00479557|525756576|FG005|Overall Study|AE not related to Study Drug|2|||
145795650|NCT00479557|525756577|FG006|Overall Study|AE not related to Study Drug|1|||
145795651|NCT00479557|525756571|FG000|Overall Study|Caregiver Request|2|||
145795652|NCT00479557|525756572|FG001|Overall Study|Caregiver Request|2|||
145795653|NCT00479557|525756573|FG002|Overall Study|Caregiver Request|2|||
145795654|NCT00479557|525756574|FG003|Overall Study|Caregiver Request|0|||
145795655|NCT00479557|525756575|FG004|Overall Study|Caregiver Request|1|||
145795656|NCT00479557|525756576|FG005|Overall Study|Caregiver Request|2|||
145795657|NCT00479557|525756577|FG006|Overall Study|Caregiver Request|0|||
145795658|NCT00479557|525756571|FG000|Overall Study|Investigator Request|0|||
145795659|NCT00479557|525756572|FG001|Overall Study|Investigator Request|0|||
145795660|NCT00479557|525756573|FG002|Overall Study|Investigator Request|1|||
145795661|NCT00479557|525756574|FG003|Overall Study|Investigator Request|0|||
145795662|NCT00479557|525756575|FG004|Overall Study|Investigator Request|0|||
145795663|NCT00479557|525756576|FG005|Overall Study|Investigator Request|0|||
145795664|NCT00479557|525756577|FG006|Overall Study|Investigator Request|0|||
145795665|NCT00479557|525756571|FG000|Overall Study|Subject Request|3|||
145795666|NCT00479557|525756572|FG001|Overall Study|Subject Request|0|||
145795667|NCT00479557|525756573|FG002|Overall Study|Subject Request|1|||
145795668|NCT00479557|525756574|FG003|Overall Study|Subject Request|1|||
145795669|NCT00479557|525756575|FG004|Overall Study|Subject Request|1|||
145795670|NCT00479557|525756576|FG005|Overall Study|Subject Request|4|||
145795671|NCT00479557|525756577|FG006|Overall Study|Subject Request|1|||
145795672|NCT00479557|525756571|FG000|Overall Study|Other|2|||
145795673|NCT00479557|525756572|FG001|Overall Study|Other|3|||
145795674|NCT00479557|525756573|FG002|Overall Study|Other|1|||
145795675|NCT00479557|525756574|FG003|Overall Study|Other|0|||
145547919|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547920|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547921|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547922|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547923|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547924|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547925|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547926|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547927|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547928|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547929|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795676|NCT00479557|525756575|FG004|Overall Study|Other|0|||
145795677|NCT00479557|525756576|FG005|Overall Study|Other|3|||
145795678|NCT00479557|525756577|FG006|Overall Study|Other|0|||
145547930|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795679|NCT01511107|525756580|FG000|Overall Study|Ineligible|3|||
145795680|NCT01511107|525756581|FG001|Overall Study|Ineligible|2|||
145795681|NCT01511107|525756580|FG000|Overall Study|Lost to Follow-up|10|||
145795682|NCT01511107|525756581|FG001|Overall Study|Lost to Follow-up|19|||
145795683|NCT01511107|525756580|FG000|Overall Study|Withdrawal by Subject|9|||
145547931|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145795684|NCT01511107|525756581|FG001|Overall Study|Withdrawal by Subject|20|||
145795685|NCT01274338|525758805|FG000|Overall Study|Lack of Efficacy|72|||
145795686|NCT01274338|525758806|FG001|Overall Study|Lack of Efficacy|108|||
145795687|NCT01274338|525758807|FG002|Overall Study|Lack of Efficacy|116|||
145795688|NCT01274338|525758808|FG003|Overall Study|Lack of Efficacy|0|||
145404847|NCT02855268|524338696|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
145404848|NCT02855268|524338695|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
145404849|NCT02855268|524338696|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
145282813|NCT01697449|523884386|FG000|Overall Study|Disease progression|47|||
145547932|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547933|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547934|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547935|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547936|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
145547937|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
145547938|NCT03129100|524863241|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
145547939|NCT03129100|524863242|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
145547940|NCT03129100|524863243|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
145547941|NCT03129100|524863244|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
145547942|NCT03129100|524863245|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
145547943|NCT03129100|524863246|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
145547944|NCT03129100|524863247|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
145547945|NCT03129100|524863248|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
145547946|NCT03129100|524863249|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
145547947|NCT03129100|524863250|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
145547948|NCT03129100|524863251|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
145547949|NCT03129100|524863252|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
145547950|NCT03129100|524863253|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
145547951|NCT03129100|524863254|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
145547952|NCT03129100|524863255|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
145547953|NCT03129100|524863256|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
145547954|NCT03129100|524863257|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
145547955|NCT03129100|524863258|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
145547956|NCT03129100|524863259|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
145547957|NCT03129100|524863260|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
145547958|NCT03129100|524863261|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
145547959|NCT03129100|524863262|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
145547960|NCT03129100|524863263|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
145547961|NCT03129100|524863264|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
145547962|NCT03129100|524863265|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
145547963|NCT03129100|524863266|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
145547964|NCT01587001|524863267|FG000|Overall Study|Lost to Follow-up|2|||
145547965|NCT01587001|524863268|FG001|Overall Study|Lost to Follow-up|0|||
145547966|NCT01587001|524863267|FG000|Overall Study|Insufficient samples to complete testing|4|||
145547967|NCT01587001|524863268|FG001|Overall Study|Insufficient samples to complete testing|1|||
145547968|NCT02756013|524863269|FG000|Overall Study|Adverse Event|1|||
145795689|NCT01274338|525758809|FG004|Overall Study|Lack of Efficacy|0|||
145795690|NCT01274338|525758810|FG005|Overall Study|Lack of Efficacy|0|||
145795691|NCT01274338|525758805|FG000|Overall Study|Adverse Event|272|||
145795692|NCT01274338|525758806|FG001|Overall Study|Adverse Event|105|||
145795693|NCT01274338|525758807|FG002|Overall Study|Adverse Event|180|||
145795694|NCT01274338|525758808|FG003|Overall Study|Adverse Event|1|||
145795695|NCT01274338|525758809|FG004|Overall Study|Adverse Event|0|||
145795696|NCT01274338|525758810|FG005|Overall Study|Adverse Event|0|||
145795697|NCT01274338|525758805|FG000|Overall Study|Death|8|||
145795698|NCT01274338|525758806|FG001|Overall Study|Death|1|||
145795699|NCT01274338|525758807|FG002|Overall Study|Death|0|||
145795700|NCT01274338|525758808|FG003|Overall Study|Death|0|||
145795701|NCT01274338|525758809|FG004|Overall Study|Death|0|||
145795702|NCT01274338|525758810|FG005|Overall Study|Death|0|||
145795703|NCT01274338|525758805|FG000|Overall Study|Withdrawal by Subject|27|||
145795704|NCT01274338|525758806|FG001|Overall Study|Withdrawal by Subject|99|||
145795705|NCT01274338|525758807|FG002|Overall Study|Withdrawal by Subject|17|||
145795706|NCT01274338|525758808|FG003|Overall Study|Withdrawal by Subject|0|||
145795707|NCT01274338|525758809|FG004|Overall Study|Withdrawal by Subject|0|||
145795708|NCT01274338|525758810|FG005|Overall Study|Withdrawal by Subject|0|||
145795709|NCT01274338|525758805|FG000|Overall Study|Did not start treatment|8|||
145795710|NCT01274338|525758806|FG001|Overall Study|Did not start treatment|116|||
145795711|NCT01274338|525758807|FG002|Overall Study|Did not start treatment|7|||
145795712|NCT01274338|525758808|FG003|Overall Study|Did not start treatment|0|||
145795713|NCT01274338|525758809|FG004|Overall Study|Did not start treatment|0|||
145795714|NCT01274338|525758810|FG005|Overall Study|Did not start treatment|0|||
145795715|NCT01274338|525758805|FG000|Overall Study|Alternative therapy|0|||
145795716|NCT01274338|525758806|FG001|Overall Study|Alternative therapy|1|||
145795717|NCT01274338|525758807|FG002|Overall Study|Alternative therapy|0|||
145795718|NCT01274338|525758808|FG003|Overall Study|Alternative therapy|0|||
145547969|NCT02756013|524863269|FG000|Overall Study|Hypersensitivity|1|||
145547970|NCT01197560|524863270|FG000|Overall Study|Adverse Event|6|||
145547971|NCT01197560|524863271|FG001|Overall Study|Adverse Event|8|||
145547972|NCT01197560|524863270|FG000|Overall Study|Death|3|||
145547973|NCT01197560|524863271|FG001|Overall Study|Death|5|||
145547974|NCT01197560|524863270|FG000|Overall Study|Withdrawal by Subject|1|||
145547975|NCT01197560|524863271|FG001|Overall Study|Withdrawal by Subject|1|||
145547976|NCT01197560|524863270|FG000|Overall Study|Disease progression|40|||
145547977|NCT01197560|524863271|FG001|Overall Study|Disease progression|35|||
145547978|NCT01197560|524863270|FG000|Overall Study|Miscellaneous|4|||
145795719|NCT01274338|525758809|FG004|Overall Study|Alternative therapy|0|||
145795720|NCT01274338|525758810|FG005|Overall Study|Alternative therapy|0|||
145795721|NCT01274338|525758805|FG000|Overall Study|Other complicating diseases|0|||
145795722|NCT01274338|525758806|FG001|Overall Study|Other complicating diseases|3|||
145795723|NCT01274338|525758807|FG002|Overall Study|Other complicating diseases|1|||
145795724|NCT01274338|525758808|FG003|Overall Study|Other complicating diseases|0|||
145795725|NCT01274338|525758809|FG004|Overall Study|Other complicating diseases|0|||
145795726|NCT01274338|525758810|FG005|Overall Study|Other complicating diseases|0|||
145547979|NCT01197560|524863271|FG001|Overall Study|Miscellaneous|3|||
145547980|NCT01197560|524863270|FG000|Overall Study|Missing|0|||
145547981|NCT01197560|524863271|FG001|Overall Study|Missing|1|||
145547982|NCT01487200|524863272|FG000|Overall Study|Withdrawal by Subject|0|||
145795727|NCT01274338|525758805|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
145795728|NCT01274338|525758806|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
145795729|NCT01274338|525758807|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
145795730|NCT01274338|525758808|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
145795731|NCT01274338|525758809|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
145795732|NCT01274338|525758810|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
145795733|NCT01274338|525758805|FG000|Overall Study|Pregnancy|0|||
145795734|NCT01274338|525758806|FG001|Overall Study|Pregnancy|0|||
145795735|NCT01274338|525758807|FG002|Overall Study|Pregnancy|1|||
145795736|NCT01274338|525758808|FG003|Overall Study|Pregnancy|0|||
145795737|NCT01274338|525758809|FG004|Overall Study|Pregnancy|0|||
145795738|NCT01274338|525758810|FG005|Overall Study|Pregnancy|0|||
145795739|NCT01274338|525758805|FG000|Overall Study|Reason not reported|12|||
145795740|NCT01274338|525758806|FG001|Overall Study|Reason not reported|21|||
145795741|NCT01274338|525758807|FG002|Overall Study|Reason not reported|3|||
145795742|NCT01274338|525758808|FG003|Overall Study|Reason not reported|0|||
145795743|NCT01274338|525758809|FG004|Overall Study|Reason not reported|1|||
145795744|NCT01274338|525758810|FG005|Overall Study|Reason not reported|0|||
145795745|NCT05084053|525758812|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
145795746|NCT05084053|525758813|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
145547983|NCT01487200|524863273|FG001|Overall Study|Withdrawal by Subject|1|||
145547984|NCT01487200|524863274|FG002|Overall Study|Withdrawal by Subject|0|||
145547985|NCT01487200|524863275|FG003|Overall Study|Withdrawal by Subject|0|||
145547986|NCT00496054|524863278|FG000|Overall Study|Adverse Event|1|||
145547987|NCT00496054|524863278|FG000|Overall Study|Lost to Follow-up|7|||
145547988|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
145547989|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
145547990|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
145547991|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547992|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547993|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547994|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547995|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547996|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547997|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547998|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
145547999|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
145548000|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548001|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
145548002|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548003|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548004|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548005|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548006|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548007|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548008|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548009|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
145548010|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
145795747|NCT05084053|525758814|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
145404850|NCT02855268|524338695|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
145548011|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
145548012|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
145548013|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548014|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145795748|NCT05084053|525758815|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
145795749|NCT05084053|525758812|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
145795750|NCT05084053|525758813|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
145548015|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548016|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548017|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548018|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145282814|NCT01697449|523884386|FG000|Overall Study|Adverse Event|7|||
145795751|NCT05084053|525758814|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
145795752|NCT05084053|525758815|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
145795753|NCT05084053|525758812|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
145795754|NCT05084053|525758813|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
145795755|NCT05084053|525758814|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
145795756|NCT05084053|525758815|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
145795757|NCT02180724|525758816|FG000|Overall Study|Death|26|||
145795758|NCT02180724|525758817|FG001|Overall Study|Death|1|||
145795759|NCT02180724|525758816|FG000|Overall Study|Lost to Follow-up|3|||
145795760|NCT02180724|525758817|FG001|Overall Study|Lost to Follow-up|1|||
145795761|NCT02180724|525758816|FG000|Overall Study|Withdrawal by Subject|4|||
145795762|NCT02180724|525758817|FG001|Overall Study|Withdrawal by Subject|2|||
145795763|NCT02180724|525758816|FG000|Overall Study|PI Decision|5|||
145795764|NCT02180724|525758817|FG001|Overall Study|PI Decision|2|||
145795765|NCT02180724|525758816|FG000|Overall Study|Study terminated by sponsor|54|||
145795766|NCT02180724|525758817|FG001|Overall Study|Study terminated by sponsor|8|||
145548019|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548020|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
145548021|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
145548022|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
145548023|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548024|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548025|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548026|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548027|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548028|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548029|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548030|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548031|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
145548032|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
145548033|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
145548034|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
145548035|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548036|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548037|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548038|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548039|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548040|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548041|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548042|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
145548043|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548044|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
145548045|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
145548046|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548047|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548048|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548049|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548050|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548051|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548052|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548053|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
145548054|NCT02207244|524863279|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548055|NCT02207244|524863280|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
145548056|NCT02207244|524863281|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548057|NCT02207244|524863282|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548058|NCT02207244|524863283|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548059|NCT02207244|524863284|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548060|NCT02207244|524863285|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548061|NCT02207244|524863286|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
145795767|NCT04662710|525758819|FG000|Overall Study|Death|14|||
145795768|NCT04662710|525758820|FG001|Overall Study|Death|331|||
145795769|NCT04662710|525758821|FG002|Overall Study|Death|367|||
145795770|NCT04662710|525758819|FG000|Overall Study|Ongoing|1|||
145795771|NCT04662710|525758820|FG001|Overall Study|Ongoing|109|||
145795772|NCT04662710|525758821|FG002|Overall Study|Ongoing|56|||
145795773|NCT04662710|525758819|FG000|Overall Study|Withdrawal by Subject|0|||
145795774|NCT04662710|525758820|FG001|Overall Study|Withdrawal by Subject|3|||
145795775|NCT04662710|525758821|FG002|Overall Study|Withdrawal by Subject|14|||
145795776|NCT01927744|525758822|FG000|Overall Study|Death|2|||
145795777|NCT01927744|525758823|FG001|Overall Study|Death|9|||
145548062|NCT02207244|524863287|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548063|NCT02207244|524863288|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548064|NCT02207244|524863289|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
145548065|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548066|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548067|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548068|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548069|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
145548070|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
145548071|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548072|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548073|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548074|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145795778|NCT05195359|525758832|FG000|Overall Study|Lost to Follow-up|124|||
145795779|NCT05195359|525758833|FG001|Overall Study|Lost to Follow-up|34|||
145795780|NCT05480800|525758834|FG000|Overall Study|Withdrawal by Subject|0|||
145795781|NCT05480800|525758835|FG001|Overall Study|Withdrawal by Subject|0|||
145795782|NCT05480800|525758836|FG002|Overall Study|Withdrawal by Subject|2|||
145795783|NCT05480800|525758837|FG003|Overall Study|Withdrawal by Subject|1|||
145795784|NCT05480800|525758838|FG004|Overall Study|Withdrawal by Subject|0|||
145795785|NCT05480800|525758839|FG005|Overall Study|Withdrawal by Subject|0|||
145795786|NCT05480800|525758840|FG006|Overall Study|Withdrawal by Subject|1|||
145795787|NCT05480800|525758841|FG007|Overall Study|Withdrawal by Subject|0|||
145795788|NCT05480800|525758834|FG000|Overall Study|Other|0|||
145795789|NCT05480800|525758835|FG001|Overall Study|Other|0|||
145795790|NCT05480800|525758836|FG002|Overall Study|Other|0|||
145795791|NCT05480800|525758837|FG003|Overall Study|Other|0|||
145795792|NCT05480800|525758838|FG004|Overall Study|Other|0|||
145795793|NCT05480800|525758839|FG005|Overall Study|Other|0|||
145795794|NCT05480800|525758840|FG006|Overall Study|Other|1|||
145795795|NCT05480800|525758841|FG007|Overall Study|Other|0|||
145795796|NCT05458011|525758843|FG000|DB Period (12 Weeks)|Adverse Event|2|||
145795797|NCT05458011|525758844|FG001|DB Period (12 Weeks)|Adverse Event|1|||
145795798|NCT05458011|525758845|FG002|DB Period (12 Weeks)|Adverse Event|1|||
145795799|NCT05458011|525758843|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
145795800|NCT05458011|525758844|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
145795801|NCT05458011|525758845|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
145795802|NCT05458011|525758843|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
145795803|NCT05458011|525758844|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
145795804|NCT05458011|525758845|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
145795805|NCT05458011|525758843|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
145795806|NCT05458011|525758844|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
145795807|NCT05458011|525758845|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
145795808|NCT05458011|525758843|FG000|OL Period (12 Weeks)|Adverse Event|1|||
145795809|NCT05458011|525758844|FG001|OL Period (12 Weeks)|Adverse Event|2|||
145795810|NCT05458011|525758845|FG002|OL Period (12 Weeks)|Adverse Event|1|||
145795811|NCT05458011|525758843|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
145795812|NCT05458011|525758844|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
145795813|NCT05458011|525758845|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
145795814|NCT05693805|525758849|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
145795815|NCT05693805|525758850|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
145795816|NCT03569449|525758852|FG000|Overall Study|Lost to Follow-up|0|||
145795817|NCT03569449|525758853|FG001|Overall Study|Lost to Follow-up|1|||
145795818|NCT03569449|525758854|FG002|Overall Study|Lost to Follow-up|0|||
145795819|NCT03569449|525758855|FG003|Overall Study|Lost to Follow-up|2|||
145795820|NCT03569449|525758856|FG004|Overall Study|Lost to Follow-up|0|||
145795821|NCT03569449|525758857|FG005|Overall Study|Lost to Follow-up|0|||
145795822|NCT03569449|525758858|FG006|Overall Study|Lost to Follow-up|0|||
145282815|NCT01697449|523884386|FG000|Overall Study|Lost to Follow-up|5|||
145548075|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
145548076|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145282816|NCT01697449|523884386|FG000|Overall Study|Withdrawal by Subject|2|||
145548077|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145795823|NCT03569449|525758859|FG007|Overall Study|Lost to Follow-up|0|||
145795824|NCT03569449|525758860|FG008|Overall Study|Lost to Follow-up|0|||
145795825|NCT03569449|525758861|FG009|Overall Study|Lost to Follow-up|0|||
145795826|NCT03569449|525758862|FG010|Overall Study|Lost to Follow-up|0|||
145795827|NCT03569449|525758863|FG011|Overall Study|Lost to Follow-up|0|||
145795828|NCT03569449|525758864|FG012|Overall Study|Lost to Follow-up|0|||
145795829|NCT03569449|525758865|FG013|Overall Study|Lost to Follow-up|0|||
145795830|NCT03569449|525758866|FG014|Overall Study|Lost to Follow-up|1|||
145795831|NCT03569449|525758867|FG015|Overall Study|Lost to Follow-up|0|||
145795832|NCT03569449|525758852|FG000|Overall Study|Withdrawal by Subject|0|||
145795833|NCT03569449|525758853|FG001|Overall Study|Withdrawal by Subject|1|||
145795834|NCT03569449|525758854|FG002|Overall Study|Withdrawal by Subject|0|||
145795835|NCT03569449|525758855|FG003|Overall Study|Withdrawal by Subject|0|||
145795836|NCT03569449|525758856|FG004|Overall Study|Withdrawal by Subject|1|||
145795837|NCT03569449|525758857|FG005|Overall Study|Withdrawal by Subject|0|||
145795838|NCT03569449|525758858|FG006|Overall Study|Withdrawal by Subject|0|||
145795839|NCT03569449|525758859|FG007|Overall Study|Withdrawal by Subject|0|||
145795840|NCT03569449|525758860|FG008|Overall Study|Withdrawal by Subject|0|||
145795841|NCT03569449|525758861|FG009|Overall Study|Withdrawal by Subject|0|||
145795842|NCT03569449|525758862|FG010|Overall Study|Withdrawal by Subject|0|||
145795843|NCT03569449|525758863|FG011|Overall Study|Withdrawal by Subject|0|||
145795844|NCT03569449|525758864|FG012|Overall Study|Withdrawal by Subject|0|||
145795845|NCT03569449|525758865|FG013|Overall Study|Withdrawal by Subject|0|||
145795846|NCT03569449|525758866|FG014|Overall Study|Withdrawal by Subject|0|||
145795847|NCT03569449|525758867|FG015|Overall Study|Withdrawal by Subject|0|||
145795848|NCT05279898|525758871|FG000|Overall Study|Withdrawal by Subject|1|||
145795849|NCT05279898|525758872|FG001|Overall Study|Withdrawal by Subject|0|||
145795850|NCT05279898|525758871|FG000|Overall Study|Physician Decision|1|||
145795851|NCT05279898|525758872|FG001|Overall Study|Physician Decision|1|||
145795852|NCT05136170|525758874|FG000|Overall Study|Withdrawal by Subject|2|||
145795853|NCT05136170|525758875|FG001|Overall Study|Withdrawal by Subject|2|||
145795854|NCT05136170|525758874|FG000|Overall Study|Can no longer make office visits|1|||
145795855|NCT05136170|525758875|FG001|Overall Study|Can no longer make office visits|0|||
145795856|NCT04393038|525758876|FG000|Overall Study|Adverse Event|11|||
145795857|NCT04393038|525758877|FG001|Overall Study|Adverse Event|2|||
145795858|NCT04393038|525758876|FG000|Overall Study|Protocol Violation|1|||
145795859|NCT04393038|525758877|FG001|Overall Study|Protocol Violation|0|||
145795860|NCT04393038|525758876|FG000|Overall Study|Death|6|||
145795861|NCT04393038|525758877|FG001|Overall Study|Death|4|||
145795862|NCT04393038|525758876|FG000|Overall Study|Withdrawal by Subject|24|||
145795863|NCT04393038|525758877|FG001|Overall Study|Withdrawal by Subject|8|||
145795864|NCT04393038|525758876|FG000|Overall Study|Lost to Follow-up|5|||
145795865|NCT04393038|525758877|FG001|Overall Study|Lost to Follow-up|4|||
145795866|NCT04393038|525758876|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
145795867|NCT04393038|525758877|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
145795868|NCT04393038|525758876|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
145795869|NCT04393038|525758877|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
145404851|NCT02855268|524338696|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
145404852|NCT02855268|524338695|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
145404853|NCT02855268|524338696|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
145404854|NCT02855268|524338695|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
145404855|NCT02855268|524338696|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
145404856|NCT02855268|524338695|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
145404857|NCT02855268|524338696|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
145404858|NCT00071981|524338698|FG000|Overall Study|Lack of Efficacy|37|||
145404859|NCT00071981|524338699|FG001|Overall Study|Lack of Efficacy|29|||
145404860|NCT00071981|524338700|FG002|Overall Study|Lack of Efficacy|30|||
145404861|NCT00071981|524338701|FG003|Overall Study|Lack of Efficacy|43|||
145404862|NCT00071981|524338698|FG000|Overall Study|Adverse Event|4|||
145404863|NCT00071981|524338699|FG001|Overall Study|Adverse Event|4|||
145404864|NCT00071981|524338700|FG002|Overall Study|Adverse Event|3|||
145404865|NCT00071981|524338701|FG003|Overall Study|Adverse Event|1|||
145404866|NCT00071981|524338698|FG000|Overall Study|Death|0|||
145404867|NCT00071981|524338699|FG001|Overall Study|Death|0|||
145404868|NCT00071981|524338700|FG002|Overall Study|Death|1|||
145404869|NCT00071981|524338701|FG003|Overall Study|Death|1|||
145404870|NCT00071981|524338698|FG000|Overall Study|Withdrawal by Subject|3|||
145404871|NCT00071981|524338699|FG001|Overall Study|Withdrawal by Subject|1|||
145404872|NCT00071981|524338700|FG002|Overall Study|Withdrawal by Subject|0|||
145404873|NCT00071981|524338701|FG003|Overall Study|Withdrawal by Subject|0|||
145404874|NCT00071981|524338698|FG000|Overall Study|No protocol therapy|2|||
145795870|NCT05168813|525758878|FG000|Part A (Open-label)|Lost to Follow-up|21|||
145795871|NCT05168813|525758879|FG001|Part A (Open-label)|Lost to Follow-up|39|||
145795872|NCT05168813|525758880|FG002|Part A (Open-label)|Lost to Follow-up|8|||
145795873|NCT05168813|525758881|FG003|Part A (Open-label)|Lost to Follow-up|26|||
145404875|NCT00071981|524338699|FG001|Overall Study|No protocol therapy|5|||
145404876|NCT00071981|524338700|FG002|Overall Study|No protocol therapy|1|||
145404877|NCT00071981|524338701|FG003|Overall Study|No protocol therapy|0|||
145404878|NCT00071981|524338698|FG000|Overall Study|others (not specified in the study)|0|||
145404879|NCT00071981|524338699|FG001|Overall Study|others (not specified in the study)|2|||
145795874|NCT05168813|525758882|FG004|Part A (Open-label)|Lost to Follow-up|0|||
145404880|NCT00071981|524338700|FG002|Overall Study|others (not specified in the study)|2|||
145404881|NCT00071981|524338701|FG003|Overall Study|others (not specified in the study)|0|||
145404882|NCT01933594|524338702|FG000|Overall Study|Lost to Follow-up|1|||
145404883|NCT01933594|524338703|FG001|Overall Study|Lost to Follow-up|0|||
145404884|NCT01933594|524338704|FG002|Overall Study|Lost to Follow-up|0|||
145404885|NCT01933594|524338705|FG003|Overall Study|Lost to Follow-up|0|||
145404886|NCT01933594|524338706|FG004|Overall Study|Lost to Follow-up|1|||
145404887|NCT01933594|524338707|FG005|Overall Study|Lost to Follow-up|0|||
145404888|NCT01933594|524338702|FG000|Overall Study|Ineligible for subsequent study step|0|||
145404889|NCT01933594|524338703|FG001|Overall Study|Ineligible for subsequent study step|0|||
145404890|NCT01933594|524338704|FG002|Overall Study|Ineligible for subsequent study step|0|||
145404891|NCT01933594|524338705|FG003|Overall Study|Ineligible for subsequent study step|0|||
145404892|NCT01933594|524338706|FG004|Overall Study|Ineligible for subsequent study step|1|||
145404893|NCT01933594|524338707|FG005|Overall Study|Ineligible for subsequent study step|0|||
145404894|NCT04513366|524338708|FG000|Treatment Phase|Withdrawal by Subject|6|||
145404895|NCT04513366|524338709|FG001|Treatment Phase|Withdrawal by Subject|8|||
145404896|NCT04513366|524338710|FG002|Treatment Phase|Withdrawal by Subject|3|||
145404897|NCT04513366|524338708|FG000|Treatment Phase|Lost to Follow-up|1|||
145404898|NCT04513366|524338709|FG001|Treatment Phase|Lost to Follow-up|2|||
145404899|NCT04513366|524338710|FG002|Treatment Phase|Lost to Follow-up|5|||
145404900|NCT04513366|524338708|FG000|Treatment Phase|Other than Specified|1|||
145404901|NCT04513366|524338709|FG001|Treatment Phase|Other than Specified|0|||
145404902|NCT04513366|524338710|FG002|Treatment Phase|Other than Specified|2|||
145404903|NCT04513366|524338708|FG000|Treatment Phase|Physician Decision|2|||
145404904|NCT04513366|524338709|FG001|Treatment Phase|Physician Decision|0|||
145404905|NCT04513366|524338710|FG002|Treatment Phase|Physician Decision|0|||
145404906|NCT04513366|524338708|FG000|Treatment Phase|Adverse Event|0|||
145404907|NCT04513366|524338709|FG001|Treatment Phase|Adverse Event|1|||
145404908|NCT04513366|524338710|FG002|Treatment Phase|Adverse Event|1|||
145404909|NCT04513366|524338708|FG000|Extension Phase|Withdrawal by Subject|3|||
145404910|NCT04513366|524338709|FG001|Extension Phase|Withdrawal by Subject|1|||
145404911|NCT04513366|524338710|FG002|Extension Phase|Withdrawal by Subject|1|||
145404912|NCT04513366|524338708|FG000|Extension Phase|Other than Specified|4|||
145404913|NCT04513366|524338709|FG001|Extension Phase|Other than Specified|0|||
145404914|NCT04513366|524338710|FG002|Extension Phase|Other than Specified|1|||
145404915|NCT04513366|524338708|FG000|Extension Phase|Lost to Follow-up|1|||
145404916|NCT04513366|524338709|FG001|Extension Phase|Lost to Follow-up|1|||
145404917|NCT04513366|524338710|FG002|Extension Phase|Lost to Follow-up|1|||
145404918|NCT04513366|524338708|FG000|Extension Phase|Sponsor Decision|0|||
145404919|NCT04513366|524338709|FG001|Extension Phase|Sponsor Decision|1|||
145404920|NCT04513366|524338710|FG002|Extension Phase|Sponsor Decision|0|||
145404921|NCT04513366|524338708|FG000|Extension Phase|Death|0|||
145404922|NCT04513366|524338709|FG001|Extension Phase|Death|1|||
145404923|NCT04513366|524338710|FG002|Extension Phase|Death|0|||
145404924|NCT04513366|524338708|FG000|Extension Phase|Adverse Event|0|||
145404925|NCT04513366|524338709|FG001|Extension Phase|Adverse Event|0|||
145404926|NCT04513366|524338710|FG002|Extension Phase|Adverse Event|1|||
145404927|NCT01316575|524338714|FG000|Overall Study|Withdrawal by Subject|2|||
145404928|NCT01316575|524338715|FG001|Overall Study|Withdrawal by Subject|0|||
145404929|NCT01316575|524338714|FG000|Overall Study|Required alternate treatment|0|||
145404930|NCT01316575|524338715|FG001|Overall Study|Required alternate treatment|1|||
145404931|NCT02966834|524338716|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145404932|NCT02966834|524338717|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145404933|NCT02966834|524338718|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145404934|NCT02966834|524338719|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145404935|NCT02966834|524338720|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
145404936|NCT02966834|524338721|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
145404937|NCT02966834|524338716|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
145404938|NCT02966834|524338717|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145404939|NCT02966834|524338718|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145404940|NCT02966834|524338719|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145404941|NCT02966834|524338720|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145404942|NCT02966834|524338721|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145404943|NCT02966834|524338716|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145404944|NCT02966834|524338717|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145404945|NCT02966834|524338718|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
145404946|NCT02966834|524338719|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
145404947|NCT02966834|524338720|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
145404948|NCT02966834|524338721|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
145404949|NCT02966834|524338716|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145404950|NCT02966834|524338717|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145404951|NCT02966834|524338718|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
145404952|NCT02966834|524338719|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
145404953|NCT02966834|524338720|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
145404954|NCT02966834|524338721|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
145404955|NCT02966834|524338716|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145404956|NCT02966834|524338717|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145404957|NCT02966834|524338718|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145404958|NCT02966834|524338719|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
145404959|NCT02966834|524338720|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145404960|NCT02966834|524338721|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145404961|NCT02966834|524338716|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145404962|NCT02966834|524338717|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145404963|NCT02966834|524338718|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145404964|NCT02966834|524338719|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
145404965|NCT02966834|524338720|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145404966|NCT02966834|524338721|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
145404967|NCT02814526|524338722|FG000|Overall Study|Adverse Event|4|||
145404968|NCT02814526|524338723|FG001|Overall Study|Adverse Event|3|||
145404969|NCT02814526|524338722|FG000|Overall Study|Death|1|||
145404970|NCT02814526|524338723|FG001|Overall Study|Death|1|||
145404971|NCT02814526|524338722|FG000|Overall Study|Lost to Follow-up|3|||
145404972|NCT02814526|524338723|FG001|Overall Study|Lost to Follow-up|4|||
145404973|NCT02814526|524338722|FG000|Overall Study|non site physician decision|1|||
145404974|NCT02814526|524338723|FG001|Overall Study|non site physician decision|0|||
145404975|NCT02814526|524338722|FG000|Overall Study|participant noncompliance|1|||
145404976|NCT02814526|524338723|FG001|Overall Study|participant noncompliance|1|||
145404977|NCT02814526|524338722|FG000|Overall Study|Withdrawal by Subject|20|||
145404978|NCT02814526|524338723|FG001|Overall Study|Withdrawal by Subject|14|||
145404979|NCT02814526|524338722|FG000|Overall Study|safety risk|2|||
145404980|NCT02814526|524338723|FG001|Overall Study|safety risk|1|||
145404981|NCT02814526|524338722|FG000|Overall Study|early termination-study terminated|1|||
145404982|NCT02814526|524338723|FG001|Overall Study|early termination-study terminated|2|||
145404983|NCT02814526|524338722|FG000|Overall Study|Other|0|||
145404984|NCT02814526|524338723|FG001|Overall Study|Other|4|||
145404985|NCT03074500|524338724|FG000|Overall Study|Lost to Follow-up|1|||
145404986|NCT03074500|524338725|FG001|Overall Study|Lost to Follow-up|0|||
145404987|NCT03074500|524338726|FG002|Overall Study|Lost to Follow-up|0|||
145404988|NCT03074500|524338724|FG000|Overall Study|Lack of Efficacy|0|||
145404989|NCT03074500|524338725|FG001|Overall Study|Lack of Efficacy|1|||
145404990|NCT03074500|524338726|FG002|Overall Study|Lack of Efficacy|0|||
145404991|NCT03074500|524338724|FG000|Overall Study|Adverse Event|0|||
145404992|NCT03074500|524338725|FG001|Overall Study|Adverse Event|0|||
145404993|NCT03074500|524338726|FG002|Overall Study|Adverse Event|1|||
145404994|NCT03321721|524338727|FG000|Overall Study|Lost to Follow-up|4|||
145404995|NCT03321721|524338728|FG001|Overall Study|Lost to Follow-up|8|||
145404996|NCT03321721|524338729|FG002|Overall Study|Lost to Follow-up|11|||
145404997|NCT01416571|524338732|FG000|Overall Study|Lost to Follow-up|2|||
145404998|NCT03608163|524338733|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
145404999|NCT03608163|524338734|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
145405000|NCT03353220|524338735|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
145405001|NCT03353220|524338736|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
145405002|NCT00661388|524338739|FG000|Overall Study|Adverse Event|14|||
145405003|NCT00661388|524338739|FG000|Overall Study|Protocol Violation|7|||
145405004|NCT00661388|524338739|FG000|Overall Study|Renal transplantation|1|||
145405005|NCT00661388|524338739|FG000|Overall Study|Dialysis initiation|1|||
145405006|NCT00661388|524338739|FG000|Overall Study|Administrative reasons|1|||
145405007|NCT03454555|524340078|FG000|Overall Study|Death|6|||
145405008|NCT03454555|524340079|FG001|Overall Study|Death|6|||
145405009|NCT03454555|524340078|FG000|Overall Study|Lost to Follow-up|31|||
145405010|NCT03454555|524340079|FG001|Overall Study|Lost to Follow-up|12|||
145795875|NCT05168813|525758883|FG005|Part A (Open-label)|Lost to Follow-up|0|||
145795876|NCT05168813|525758878|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
145795877|NCT05168813|525758879|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
145795878|NCT05168813|525758880|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
145795879|NCT05168813|525758881|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
145795880|NCT05168813|525758882|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
145795881|NCT05168813|525758883|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
145795882|NCT05168813|525758878|FG000|Part A (Open-label)|Death|23|||
145795883|NCT05168813|525758879|FG001|Part A (Open-label)|Death|28|||
145795884|NCT05168813|525758880|FG002|Part A (Open-label)|Death|1|||
145795885|NCT05168813|525758881|FG003|Part A (Open-label)|Death|9|||
145795886|NCT05168813|525758882|FG004|Part A (Open-label)|Death|0|||
145795887|NCT05168813|525758883|FG005|Part A (Open-label)|Death|0|||
145795888|NCT05168813|525758878|FG000|Part A (Open-label)|Physician Decision|0|||
145795889|NCT05168813|525758879|FG001|Part A (Open-label)|Physician Decision|1|||
145795890|NCT05168813|525758880|FG002|Part A (Open-label)|Physician Decision|0|||
145795891|NCT05168813|525758881|FG003|Part A (Open-label)|Physician Decision|2|||
145795892|NCT05168813|525758882|FG004|Part A (Open-label)|Physician Decision|0|||
145795893|NCT05168813|525758883|FG005|Part A (Open-label)|Physician Decision|0|||
145795894|NCT05168813|525758878|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
145795895|NCT05168813|525758879|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
145795896|NCT05168813|525758880|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
145795897|NCT05168813|525758881|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
145795898|NCT05168813|525758882|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
145795899|NCT05168813|525758883|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
145795900|NCT05168813|525758878|FG000|Part A (Open-label)|Protocol Violation|0|||
145795901|NCT05168813|525758879|FG001|Part A (Open-label)|Protocol Violation|1|||
145795902|NCT05168813|525758880|FG002|Part A (Open-label)|Protocol Violation|0|||
145795903|NCT05168813|525758881|FG003|Part A (Open-label)|Protocol Violation|0|||
145795904|NCT05168813|525758882|FG004|Part A (Open-label)|Protocol Violation|0|||
145795905|NCT05168813|525758883|FG005|Part A (Open-label)|Protocol Violation|0|||
145795906|NCT05168813|525758878|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
145795907|NCT05168813|525758879|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
145795908|NCT05168813|525758880|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
145795909|NCT05168813|525758881|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
145795910|NCT05168813|525758882|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
145795911|NCT05168813|525758883|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
145795912|NCT05168813|525758878|FG000|Part A (Open-label)|Other|0|||
145795913|NCT05168813|525758879|FG001|Part A (Open-label)|Other|1|||
145795914|NCT05168813|525758880|FG002|Part A (Open-label)|Other|0|||
145795915|NCT05168813|525758881|FG003|Part A (Open-label)|Other|0|||
145795916|NCT05168813|525758882|FG004|Part A (Open-label)|Other|0|||
145795917|NCT05168813|525758883|FG005|Part A (Open-label)|Other|0|||
145282817|NCT01697449|523884386|FG000|Overall Study|Physician Decision|1|||
145282818|NCT01697449|523884386|FG000|Overall Study|Death|2|||
145282819|NCT01697449|523884386|FG000|Overall Study|Other|1|||
145282820|NCT01697449|523884386|FG000|Overall Study|Missing|25|||
145282821|NCT01169844|523884387|FG000|Overall Study|Adverse Event|0|||
145282822|NCT01169844|523884388|FG001|Overall Study|Adverse Event|1|||
145282823|NCT01169844|523884387|FG000|Overall Study|Patient withdrew consent|4|||
145282824|NCT01169844|523884388|FG001|Overall Study|Patient withdrew consent|0|||
145282825|NCT01169844|523884387|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145282826|NCT01169844|523884388|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145282827|NCT01337050|523884392|FG000|Overall Study|Death|0|||
145282828|NCT01337050|523884393|FG001|Overall Study|Death|0|||
145282829|NCT01337050|523884394|FG002|Overall Study|Death|4|||
145282830|NCT01337050|523884392|FG000|Overall Study|Other|4|||
145282831|NCT01337050|523884393|FG001|Overall Study|Other|6|||
145282832|NCT01337050|523884394|FG002|Overall Study|Other|8|||
145282833|NCT01337050|523884392|FG000|Overall Study|Participants refused further follow-up|0|||
145282834|NCT01337050|523884393|FG001|Overall Study|Participants refused further follow-up|7|||
145282835|NCT01337050|523884394|FG002|Overall Study|Participants refused further follow-up|7|||
145282836|NCT00003102|523884395|FG000|Overall Study|Physician Decision|1|||
145795918|NCT05168813|525758878|FG000|Part B (Blinded)|Lost to Follow-up|0|||
145795919|NCT05168813|525758879|FG001|Part B (Blinded)|Lost to Follow-up|0|||
145282837|NCT00003102|523884396|FG001|Overall Study|Physician Decision|1|||
145282838|NCT00003102|523884397|FG002|Overall Study|Physician Decision|0|||
145282839|NCT00003102|523884395|FG000|Overall Study|Progressive Disease|0|||
145282840|NCT00003102|523884396|FG001|Overall Study|Progressive Disease|1|||
145282841|NCT00003102|523884397|FG002|Overall Study|Progressive Disease|0|||
145405011|NCT03454555|524340078|FG000|Overall Study|Physician Decision|2|||
145795920|NCT05168813|525758880|FG002|Part B (Blinded)|Lost to Follow-up|0|||
145795921|NCT05168813|525758881|FG003|Part B (Blinded)|Lost to Follow-up|0|||
145795922|NCT05168813|525758882|FG004|Part B (Blinded)|Lost to Follow-up|219|||
145795923|NCT05168813|525758883|FG005|Part B (Blinded)|Lost to Follow-up|88|||
145795924|NCT05168813|525758878|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
145548078|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145548079|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145548080|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145548081|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
145548082|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145795925|NCT05168813|525758879|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
145795926|NCT05168813|525758880|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
145795927|NCT05168813|525758881|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
145795928|NCT05168813|525758882|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
145795929|NCT05168813|525758883|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
145795930|NCT05168813|525758878|FG000|Part B (Blinded)|Death|0|||
145795931|NCT05168813|525758879|FG001|Part B (Blinded)|Death|0|||
145795932|NCT05168813|525758880|FG002|Part B (Blinded)|Death|0|||
145795933|NCT05168813|525758881|FG003|Part B (Blinded)|Death|0|||
145795934|NCT05168813|525758882|FG004|Part B (Blinded)|Death|63|||
145795935|NCT05168813|525758883|FG005|Part B (Blinded)|Death|19|||
145795936|NCT05168813|525758878|FG000|Part B (Blinded)|Physician Decision|0|||
145795937|NCT05168813|525758879|FG001|Part B (Blinded)|Physician Decision|0|||
145795938|NCT05168813|525758880|FG002|Part B (Blinded)|Physician Decision|0|||
145795939|NCT05168813|525758881|FG003|Part B (Blinded)|Physician Decision|0|||
145795940|NCT05168813|525758882|FG004|Part B (Blinded)|Physician Decision|6|||
145795941|NCT05168813|525758883|FG005|Part B (Blinded)|Physician Decision|1|||
145795942|NCT05168813|525758878|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
145795943|NCT05168813|525758879|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
145795944|NCT05168813|525758880|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
145795945|NCT05168813|525758881|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
145795946|NCT05168813|525758882|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
145795947|NCT05168813|525758883|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
145795948|NCT05168813|525758878|FG000|Part B (Blinded)|Pregnancy|0|||
145795949|NCT05168813|525758879|FG001|Part B (Blinded)|Pregnancy|0|||
145795950|NCT05168813|525758880|FG002|Part B (Blinded)|Pregnancy|0|||
145795951|NCT05168813|525758881|FG003|Part B (Blinded)|Pregnancy|0|||
145795952|NCT05168813|525758882|FG004|Part B (Blinded)|Pregnancy|1|||
145795953|NCT05168813|525758883|FG005|Part B (Blinded)|Pregnancy|0|||
145795954|NCT05168813|525758878|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
145795955|NCT05168813|525758879|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
145795956|NCT05168813|525758880|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
145795957|NCT05168813|525758881|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
145795958|NCT05168813|525758882|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
145795959|NCT05168813|525758883|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
145548083|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145795960|NCT05168813|525758878|FG000|Part B (Blinded)|Other|0|||
145795961|NCT05168813|525758879|FG001|Part B (Blinded)|Other|0|||
145795962|NCT05168813|525758880|FG002|Part B (Blinded)|Other|0|||
145795963|NCT05168813|525758881|FG003|Part B (Blinded)|Other|0|||
145795964|NCT05168813|525758882|FG004|Part B (Blinded)|Other|41|||
145795965|NCT05168813|525758883|FG005|Part B (Blinded)|Other|27|||
145795966|NCT02152982|525758887|FG000|Overall Study|Withdrawal by Subject|17|||
145795967|NCT02152982|525758888|FG001|Overall Study|Withdrawal by Subject|16|||
145795968|NCT02152982|525758887|FG000|Overall Study|Did not start treatment|11|||
145795969|NCT02152982|525758888|FG001|Overall Study|Did not start treatment|5|||
145795970|NCT02152982|525758887|FG000|Overall Study|Disease progression|41|||
145795971|NCT02152982|525758888|FG001|Overall Study|Disease progression|52|||
145795972|NCT02152982|525758887|FG000|Overall Study|Adverse Event|7|||
145795973|NCT02152982|525758888|FG001|Overall Study|Adverse Event|12|||
145795974|NCT02152982|525758887|FG000|Overall Study|Complicating disease|1|||
145795975|NCT02152982|525758888|FG001|Overall Study|Complicating disease|1|||
145795976|NCT02152982|525758887|FG000|Overall Study|Death|0|||
145795977|NCT02152982|525758888|FG001|Overall Study|Death|3|||
145795978|NCT02152982|525758887|FG000|Overall Study|Physician Decision|3|||
145795979|NCT02152982|525758888|FG001|Overall Study|Physician Decision|0|||
145548084|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145548085|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145795980|NCT03230487|525758894|FG000|Overall Study|Adverse Event|0|||
145795981|NCT03230487|525758895|FG001|Overall Study|Adverse Event|0|||
145405012|NCT03454555|524340079|FG001|Overall Study|Physician Decision|6|||
145405013|NCT03454555|524340078|FG000|Overall Study|Withdrawal by Subject|34|||
145405014|NCT03454555|524340079|FG001|Overall Study|Withdrawal by Subject|5|||
145795982|NCT03230487|525758896|FG002|Overall Study|Adverse Event|0|||
145795983|NCT03230487|525758897|FG003|Overall Study|Adverse Event|1|||
145795984|NCT03230487|525758898|FG004|Overall Study|Adverse Event|0|||
145795985|NCT03230487|525758899|FG005|Overall Study|Adverse Event|0|||
145795986|NCT05212948|525758900|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
145795987|NCT05212948|525758901|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
145282842|NCT00003102|523884395|FG000|Overall Study|Adverse Event|0|||
145282843|NCT00003102|523884396|FG001|Overall Study|Adverse Event|1|||
145282844|NCT00003102|523884397|FG002|Overall Study|Adverse Event|1|||
145282845|NCT00003102|523884395|FG000|Overall Study|Death|0|||
145282846|NCT00003102|523884396|FG001|Overall Study|Death|0|||
145282847|NCT00003102|523884397|FG002|Overall Study|Death|1|||
145282848|NCT00096486|523884398|FG000|Overall Study|Withdrawal by Subject|0|||
145795988|NCT05212948|525758900|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
145795989|NCT05212948|525758901|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
145795990|NCT05212948|525758900|FG000|Initial Vaccination Period|Pregnancy|20|||
145795991|NCT05212948|525758901|FG001|Initial Vaccination Period|Pregnancy|14|||
145795992|NCT05212948|525758900|FG000|Initial Vaccination Period|Physician Decision|686|||
145795993|NCT05212948|525758901|FG001|Initial Vaccination Period|Physician Decision|401|||
145795994|NCT05212948|525758900|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
145795995|NCT05212948|525758901|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
145795996|NCT05212948|525758900|FG000|Initial Vaccination Period|Death|23|||
145795997|NCT05212948|525758901|FG001|Initial Vaccination Period|Death|18|||
145795998|NCT05212948|525758900|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
145795999|NCT05212948|525758901|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
145796000|NCT05212948|525758900|FG000|Initial Vaccination Period|Adverse Event|36|||
145796001|NCT05212948|525758901|FG001|Initial Vaccination Period|Adverse Event|23|||
145796002|NCT05212948|525758900|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
145796003|NCT05212948|525758901|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
145796004|NCT05212948|525758900|FG000|Crossover Vaccination Period|Pregnancy|6|||
145796005|NCT05212948|525758901|FG001|Crossover Vaccination Period|Pregnancy|1|||
145796006|NCT05212948|525758900|FG000|Crossover Vaccination Period|Physician Decision|49|||
145796007|NCT05212948|525758901|FG001|Crossover Vaccination Period|Physician Decision|24|||
145796008|NCT05212948|525758900|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
145796009|NCT05212948|525758901|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
145796010|NCT05212948|525758900|FG000|Crossover Vaccination Period|Death|10|||
145796011|NCT05212948|525758901|FG001|Crossover Vaccination Period|Death|5|||
145796012|NCT05212948|525758900|FG000|Crossover Vaccination Period|Adverse Event|9|||
145796013|NCT05212948|525758901|FG001|Crossover Vaccination Period|Adverse Event|4|||
145796014|NCT01708941|525758902|FG000|Overall Study|Adverse Event|4|||
145796015|NCT01708941|525758903|FG001|Overall Study|Adverse Event|6|||
145796016|NCT01708941|525758904|FG002|Overall Study|Adverse Event|1|||
145796017|NCT01708941|525758905|FG003|Overall Study|Adverse Event|0|||
145796018|NCT01708941|525758902|FG000|Overall Study|Death|1|||
145796019|NCT01708941|525758903|FG001|Overall Study|Death|1|||
145796020|NCT01708941|525758904|FG002|Overall Study|Death|2|||
145796021|NCT01708941|525758905|FG003|Overall Study|Death|14|||
145796022|NCT01708941|525758902|FG000|Overall Study|Withdrawal by Subject|1|||
145796023|NCT01708941|525758903|FG001|Overall Study|Withdrawal by Subject|0|||
145796024|NCT01708941|525758904|FG002|Overall Study|Withdrawal by Subject|3|||
145796025|NCT01708941|525758905|FG003|Overall Study|Withdrawal by Subject|4|||
145796026|NCT01708941|525758902|FG000|Overall Study|Disease progression|9|||
145796027|NCT01708941|525758903|FG001|Overall Study|Disease progression|10|||
145796028|NCT01708941|525758904|FG002|Overall Study|Disease progression|8|||
145796029|NCT01708941|525758905|FG003|Overall Study|Disease progression|0|||
145796030|NCT01708941|525758902|FG000|Overall Study|Alternative therapy|0|||
145796031|NCT01708941|525758903|FG001|Overall Study|Alternative therapy|0|||
145796032|NCT01708941|525758904|FG002|Overall Study|Alternative therapy|2|||
145796033|NCT01708941|525758905|FG003|Overall Study|Alternative therapy|0|||
145796034|NCT01708941|525758902|FG000|Overall Study|Ineligible and never started treatment|1|||
145796035|NCT01708941|525758903|FG001|Overall Study|Ineligible and never started treatment|0|||
145796036|NCT01708941|525758904|FG002|Overall Study|Ineligible and never started treatment|1|||
145796037|NCT01708941|525758905|FG003|Overall Study|Ineligible and never started treatment|0|||
145796038|NCT01708941|525758902|FG000|Overall Study|Never started treatment|2|||
145796039|NCT01708941|525758903|FG001|Overall Study|Never started treatment|1|||
145796040|NCT01708941|525758904|FG002|Overall Study|Never started treatment|0|||
145796041|NCT01708941|525758905|FG003|Overall Study|Never started treatment|0|||
145796042|NCT01708941|525758902|FG000|Overall Study|Ineligible|0|||
145796043|NCT01708941|525758903|FG001|Overall Study|Ineligible|0|||
145796044|NCT01708941|525758904|FG002|Overall Study|Ineligible|2|||
145796045|NCT01708941|525758905|FG003|Overall Study|Ineligible|0|||
145796046|NCT05347693|525758906|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
145796047|NCT05347693|525758907|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
145796048|NCT05347693|525758908|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
145796049|NCT05347693|525758906|FG000|Inpatient Period|Withdrawal of consent|10|||
145796050|NCT05347693|525758907|FG001|Inpatient Period|Withdrawal of consent|0|||
145796051|NCT05347693|525758908|FG002|Inpatient Period|Withdrawal of consent|0|||
145796052|NCT05347693|525758906|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
145796053|NCT05347693|525758907|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
145282849|NCT00096486|523884399|FG001|Overall Study|Withdrawal by Subject|0|||
145548086|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
145548087|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548088|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548089|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548090|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
145548091|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
145548092|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
145548093|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548094|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548095|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548096|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548097|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
145548098|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548099|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548100|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548101|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
145548102|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
145548103|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
145548104|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548105|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548106|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548107|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548108|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
145548109|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548110|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548111|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548112|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
145548113|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548114|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
145548115|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548116|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548117|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548118|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548119|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
145548120|NCT02207244|524863279|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548121|NCT02207244|524863280|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548122|NCT02207244|524863281|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548123|NCT02207244|524863282|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
145548124|NCT02207244|524863283|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548125|NCT02207244|524863284|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548126|NCT02207244|524863285|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548127|NCT02207244|524863286|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548128|NCT02207244|524863287|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548129|NCT02207244|524863288|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548130|NCT02207244|524863289|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
145548131|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548132|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548133|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548134|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548135|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548136|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145548137|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
145548138|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
145548139|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
145548140|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
145796054|NCT05347693|525758908|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
145548141|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
145796055|NCT05347693|525758906|FG000|Inpatient Period|Screening Failure|8|||
145796056|NCT05347693|525758907|FG001|Inpatient Period|Screening Failure|0|||
145796057|NCT05347693|525758908|FG002|Inpatient Period|Screening Failure|0|||
145796058|NCT05347693|525758906|FG000|Inpatient Period|Death|2|||
145796059|NCT05347693|525758907|FG001|Inpatient Period|Death|0|||
145796060|NCT05347693|525758908|FG002|Inpatient Period|Death|0|||
145282850|NCT00096486|523884400|FG002|Overall Study|Withdrawal by Subject|1|||
145282851|NCT00096486|523884401|FG003|Overall Study|Withdrawal by Subject|1|||
145796061|NCT05347693|525758906|FG000|Inpatient Period|Physician Decision|5|||
145796062|NCT05347693|525758907|FG001|Inpatient Period|Physician Decision|0|||
145548142|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548143|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548144|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548145|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548146|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548147|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548148|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548149|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
145548150|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548151|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548152|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
145548153|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548154|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548155|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548156|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548157|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548158|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548159|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
145548160|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
145548161|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
145548162|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
145548163|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
145548164|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548165|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145796063|NCT05347693|525758908|FG002|Inpatient Period|Physician Decision|0|||
145796064|NCT05347693|525758906|FG000|Inpatient Period|Adverse Event|3|||
145796065|NCT05347693|525758907|FG001|Inpatient Period|Adverse Event|0|||
145796066|NCT05347693|525758908|FG002|Inpatient Period|Adverse Event|0|||
145796067|NCT05347693|525758906|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
145796068|NCT05347693|525758907|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
145796069|NCT05347693|525758908|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
145796070|NCT05347693|525758906|FG000|Outpatient Period|Adverse Event|0|||
145796071|NCT05347693|525758907|FG001|Outpatient Period|Adverse Event|9|||
145796072|NCT05347693|525758908|FG002|Outpatient Period|Adverse Event|0|||
145796073|NCT05347693|525758906|FG000|Outpatient Period|Death|0|||
145796074|NCT05347693|525758907|FG001|Outpatient Period|Death|6|||
145796075|NCT05347693|525758908|FG002|Outpatient Period|Death|2|||
145796076|NCT05347693|525758906|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
145796077|NCT05347693|525758907|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
145796078|NCT05347693|525758908|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
145796079|NCT05347693|525758906|FG000|Outpatient Period|Lost to Follow-up|0|||
145796080|NCT05347693|525758907|FG001|Outpatient Period|Lost to Follow-up|0|||
145796081|NCT05347693|525758908|FG002|Outpatient Period|Lost to Follow-up|1|||
145796082|NCT05347693|525758906|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
145796083|NCT05347693|525758907|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
145796084|NCT05347693|525758908|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
145796085|NCT05347693|525758906|FG000|Outpatient Period|Scheduled hemodialysis|0|||
145796086|NCT05347693|525758907|FG001|Outpatient Period|Scheduled hemodialysis|1|||
145796087|NCT05347693|525758908|FG002|Outpatient Period|Scheduled hemodialysis|0|||
145796088|NCT05347693|525758906|FG000|Outpatient Period|Severe HK|0|||
145796089|NCT05347693|525758907|FG001|Outpatient Period|Severe HK|0|||
145796090|NCT05347693|525758908|FG002|Outpatient Period|Severe HK|1|||
145796091|NCT05347693|525758906|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
145796092|NCT05347693|525758907|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
145796093|NCT05347693|525758908|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
145796094|NCT05347693|525758906|FG000|Outpatient Period|Start of dialysis|0|||
145796095|NCT05347693|525758907|FG001|Outpatient Period|Start of dialysis|0|||
145796096|NCT05347693|525758908|FG002|Outpatient Period|Start of dialysis|1|||
145796097|NCT05347693|525758906|FG000|Outpatient Period|The participant entered hemodialysis|0|||
145796098|NCT05347693|525758907|FG001|Outpatient Period|The participant entered hemodialysis|0|||
145796099|NCT05347693|525758908|FG002|Outpatient Period|The participant entered hemodialysis|1|||
145796100|NCT05347693|525758906|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
145796101|NCT05347693|525758907|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
145796102|NCT05347693|525758908|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
145548166|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548167|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548168|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548169|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548170|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
145548171|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
145548172|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548173|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
145548174|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
145548175|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548176|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548177|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548178|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548179|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548180|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548181|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
145548182|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
145548183|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
145548184|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
145548185|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
145548186|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548187|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548188|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548189|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548190|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548191|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548192|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548193|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
145548194|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
145548195|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548196|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
145548197|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548198|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548199|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548200|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548201|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548202|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548203|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548204|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548205|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
145548206|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548207|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
145548208|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548209|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548210|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548211|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548212|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548213|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548214|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548215|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
145548216|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548217|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548218|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
145548219|NCT02207244|524863279|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548220|NCT02207244|524863280|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145558239|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
145548221|NCT02207244|524863281|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548222|NCT02207244|524863282|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548223|NCT02207244|524863283|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548224|NCT02207244|524863284|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548225|NCT02207244|524863285|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
145548226|NCT02207244|524863286|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548227|NCT02207244|524863287|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548228|NCT02207244|524863288|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548229|NCT02207244|524863289|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
145548230|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548231|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548232|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548233|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548234|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548235|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548236|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548237|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548238|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
145548239|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
145548240|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
145548241|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548242|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548243|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548244|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548245|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548246|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548247|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548248|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548249|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
145548250|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
145548251|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
145548252|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548253|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548254|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548255|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548256|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548257|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548258|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548259|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548260|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
145548261|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
145548262|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
145548263|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145796103|NCT05347693|525758906|FG000|Outpatient Period|Withdrawal by Subject|0|||
145796104|NCT05347693|525758907|FG001|Outpatient Period|Withdrawal by Subject|8|||
145796105|NCT05347693|525758908|FG002|Outpatient Period|Withdrawal by Subject|5|||
145796106|NCT02048813|525758909|FG000|Overall Study|Still on treatment|279|||
145796107|NCT02048813|525758910|FG001|Overall Study|Still on treatment|0|||
145796108|NCT02048813|525758909|FG000|Overall Study|Adverse Event|40|||
145796109|NCT02048813|525758910|FG001|Overall Study|Adverse Event|38|||
145796110|NCT02048813|525758909|FG000|Overall Study|Disease progression|13|||
145796111|NCT02048813|525758910|FG001|Overall Study|Disease progression|3|||
145796112|NCT02048813|525758909|FG000|Overall Study|Withdrawal by Subject|7|||
145796113|NCT02048813|525758910|FG001|Overall Study|Withdrawal by Subject|8|||
145796114|NCT02048813|525758909|FG000|Overall Study|Death|2|||
145796115|NCT02048813|525758910|FG001|Overall Study|Death|1|||
145796116|NCT02048813|525758909|FG000|Overall Study|Complication|2|||
145796117|NCT02048813|525758910|FG001|Overall Study|Complication|2|||
145282852|NCT00096486|523884398|FG000|Overall Study|Not Treated|0|||
145282853|NCT00096486|523884399|FG001|Overall Study|Not Treated|0|||
145282854|NCT00096486|523884400|FG002|Overall Study|Not Treated|1|||
145282855|NCT00096486|523884401|FG003|Overall Study|Not Treated|1|||
145282856|NCT01512979|523884402|FG000|Overall Study|Adverse Event|2|||
145796118|NCT02048813|525758909|FG000|Overall Study|Non-protocol therapy|0|||
145796119|NCT02048813|525758910|FG001|Overall Study|Non-protocol therapy|1|||
145796120|NCT02048813|525758909|FG000|Overall Study|Second primary cancer|2|||
145796121|NCT02048813|525758910|FG001|Overall Study|Second primary cancer|0|||
145282857|NCT01512979|523884403|FG001|Overall Study|Adverse Event|2|||
145282858|NCT01512979|523884402|FG000|Overall Study|Protocol Violation|1|||
145282859|NCT01512979|523884403|FG001|Overall Study|Protocol Violation|4|||
145282860|NCT01512979|523884402|FG000|Overall Study|Lost to Follow-up|2|||
145282861|NCT01512979|523884403|FG001|Overall Study|Lost to Follow-up|5|||
145405015|NCT03454555|524340078|FG000|Overall Study|Ineligible|1|||
145796122|NCT02048813|525758909|FG000|Overall Study|Insurance|2|||
145796123|NCT02048813|525758910|FG001|Overall Study|Insurance|0|||
145796124|NCT02048813|525758909|FG000|Overall Study|Wound infection/healing|2|||
145796125|NCT02048813|525758910|FG001|Overall Study|Wound infection/healing|0|||
145796126|NCT02048813|525758909|FG000|Overall Study|Missed appointment|3|||
145796127|NCT02048813|525758910|FG001|Overall Study|Missed appointment|0|||
145796128|NCT02048813|525758909|FG000|Overall Study|Never started treatment|2|||
145796129|NCT02048813|525758910|FG001|Overall Study|Never started treatment|17|||
145796130|NCT01708954|525758911|FG000|Step 1|Disease progression|26|||
145796131|NCT01708954|525758912|FG001|Step 1|Disease progression|17|||
145796132|NCT01708954|525758913|FG002|Step 1|Disease progression|14|||
145796133|NCT01708954|525758911|FG000|Step 1|Adverse Event|3|||
145796134|NCT01708954|525758912|FG001|Step 1|Adverse Event|11|||
145796135|NCT01708954|525758913|FG002|Step 1|Adverse Event|13|||
145796136|NCT01708954|525758911|FG000|Step 1|Death|3|||
145796137|NCT01708954|525758912|FG001|Step 1|Death|2|||
145796138|NCT01708954|525758913|FG002|Step 1|Death|3|||
145796139|NCT01708954|525758911|FG000|Step 1|Withdrawal by Subject|2|||
145796140|NCT01708954|525758912|FG001|Step 1|Withdrawal by Subject|5|||
145796141|NCT01708954|525758913|FG002|Step 1|Withdrawal by Subject|3|||
145796142|NCT01708954|525758911|FG000|Step 1|Other complicating disease|0|||
145796143|NCT01708954|525758912|FG001|Step 1|Other complicating disease|2|||
145796144|NCT01708954|525758913|FG002|Step 1|Other complicating disease|0|||
145796145|NCT01708954|525758911|FG000|Step 1|Crossed over to Step 2|2|||
145796146|NCT01708954|525758912|FG001|Step 1|Crossed over to Step 2|0|||
145796147|NCT01708954|525758913|FG002|Step 1|Crossed over to Step 2|0|||
145796148|NCT01708954|525758911|FG000|Step 1|Symptomatic deterioration|1|||
145796149|NCT01708954|525758912|FG001|Step 1|Symptomatic deterioration|0|||
145796150|NCT01708954|525758913|FG002|Step 1|Symptomatic deterioration|1|||
145796151|NCT01708954|525758911|FG000|Step 1|Off-treatment reason not submitted|1|||
145796152|NCT01708954|525758912|FG001|Step 1|Off-treatment reason not submitted|1|||
145796153|NCT01708954|525758913|FG002|Step 1|Off-treatment reason not submitted|1|||
145796154|NCT01708954|525758911|FG000|Step 1|Ineligible or never received treatment|4|||
145796155|NCT01708954|525758912|FG001|Step 1|Ineligible or never received treatment|2|||
145796156|NCT01708954|525758913|FG002|Step 1|Ineligible or never received treatment|8|||
145405016|NCT03454555|524340079|FG001|Overall Study|Ineligible|5|||
145796157|NCT01708954|525758911|FG000|Step 2|Disease progression|9|||
145796158|NCT01708954|525758912|FG001|Step 2|Disease progression|4|||
145548264|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548265|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548266|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548267|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548268|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548269|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548270|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548271|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
145548272|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
145548273|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
145548274|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
145548275|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
145548276|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
145548277|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
145548278|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
145548279|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
145548280|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
145548281|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
145548282|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
145548283|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
145548284|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
145548285|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
145548286|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
145548287|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
145611204|NCT00474929|525092627|FG001|Overall Study|Withdrawal by Subject|1|||
145611205|NCT00474929|525092628|FG002|Overall Study|Withdrawal by Subject|0|||
145611206|NCT00474929|525092629|FG003|Overall Study|Withdrawal by Subject|0|||
145611207|NCT00474929|525092630|FG004|Overall Study|Withdrawal by Subject|0|||
145611208|NCT00474929|525092626|FG000|Overall Study|Unrelated medical condition|0|||
145796159|NCT01708954|525758913|FG002|Step 2|Disease progression|0|||
145796160|NCT01708954|525758911|FG000|Step 2|Adverse Event|3|||
145796161|NCT01708954|525758912|FG001|Step 2|Adverse Event|2|||
145796162|NCT01708954|525758913|FG002|Step 2|Adverse Event|0|||
145796163|NCT01708954|525758911|FG000|Step 2|Withdrawal by Subject|1|||
145796164|NCT01708954|525758912|FG001|Step 2|Withdrawal by Subject|1|||
145796165|NCT01708954|525758913|FG002|Step 2|Withdrawal by Subject|0|||
145796166|NCT02226146|525758914|FG000|Overall Study|Received rescue therapy|1|||
145796167|NCT02226146|525758914|FG000|Overall Study|Withdrawal by Subject|2|||
145548288|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
145548289|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
145548290|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
145548291|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
145548292|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
145548293|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
145548294|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
145548295|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
145548296|NCT02207244|524863279|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548297|NCT02207244|524863280|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548298|NCT02207244|524863281|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548299|NCT02207244|524863282|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548300|NCT02207244|524863283|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548301|NCT02207244|524863284|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548302|NCT02207244|524863285|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145796168|NCT01192776|525758915|FG000|Overall Study|Death|8|||
145796169|NCT01192776|525758916|FG001|Overall Study|Death|15|||
145796170|NCT01192776|525758917|FG002|Overall Study|Death|18|||
145796171|NCT01192776|525758918|FG003|Overall Study|Death|15|||
145796172|NCT01192776|525758915|FG000|Overall Study|Lost to Follow-up|3|||
145796173|NCT01192776|525758916|FG001|Overall Study|Lost to Follow-up|6|||
145796174|NCT01192776|525758917|FG002|Overall Study|Lost to Follow-up|3|||
145796175|NCT01192776|525758918|FG003|Overall Study|Lost to Follow-up|5|||
145796176|NCT05464836|525758919|FG000|Overall Study|Progression of Disease|1|||
145796177|NCT05464836|525758919|FG000|Overall Study|Physician Decision|1|||
145548303|NCT02207244|524863286|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548304|NCT02207244|524863287|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145796178|NCT01522976|525758920|FG000|Overall Study|Ineligible|4|||
145796179|NCT01522976|525758921|FG001|Overall Study|Ineligible|0|||
145548305|NCT02207244|524863288|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
145548306|NCT02207244|524863289|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
145548307|NCT02216591|524863290|FG000|Overall Study|Lost to Follow-up|0|||
145796180|NCT01522976|525758922|FG002|Overall Study|Ineligible|1|||
145796181|NCT01522976|525758920|FG000|Overall Study|Death|7|||
145796182|NCT01522976|525758921|FG001|Overall Study|Death|6|||
145548308|NCT02216591|524863291|FG001|Overall Study|Lost to Follow-up|1|||
145796183|NCT01522976|525758922|FG002|Overall Study|Death|2|||
145796184|NCT01522976|525758920|FG000|Overall Study|Still on treatment|9|||
145548309|NCT01950741|524863294|FG000|Overall Study|Lost to Follow-up|1|||
145548310|NCT01950741|524863294|FG000|Overall Study|Death|1|||
145548311|NCT01950741|524863294|FG000|Overall Study|Withdrawal by Subject|1|||
145548312|NCT02854631|524863297|FG000|Overall Study|Adverse Event|1|||
145548313|NCT02854631|524863298|FG001|Overall Study|Adverse Event|2|||
145548314|NCT02854631|524863297|FG000|Overall Study|Withdrew Consent|3|||
145548315|NCT02854631|524863298|FG001|Overall Study|Withdrew Consent|2|||
145796185|NCT01522976|525758921|FG001|Overall Study|Still on treatment|9|||
145796186|NCT01522976|525758922|FG002|Overall Study|Still on treatment|6|||
145796187|NCT01522976|525758920|FG000|Overall Study|Disease progression|28|||
145796188|NCT01522976|525758921|FG001|Overall Study|Disease progression|30|||
145548316|NCT02854631|524863297|FG000|Overall Study|Investigator's Discretion|2|||
145796189|NCT01522976|525758922|FG002|Overall Study|Disease progression|25|||
145796190|NCT01522976|525758920|FG000|Overall Study|Adverse Event|17|||
145796191|NCT01522976|525758921|FG001|Overall Study|Adverse Event|7|||
145796192|NCT01522976|525758922|FG002|Overall Study|Adverse Event|18|||
145796193|NCT01522976|525758920|FG000|Overall Study|Refusal unrelated to adverse event|10|||
145796194|NCT01522976|525758921|FG001|Overall Study|Refusal unrelated to adverse event|13|||
145796195|NCT01522976|525758922|FG002|Overall Study|Refusal unrelated to adverse event|14|||
145796196|NCT01522976|525758920|FG000|Overall Study|Not protocol specified|22|||
145796197|NCT01522976|525758921|FG001|Overall Study|Not protocol specified|27|||
145796198|NCT01522976|525758922|FG002|Overall Study|Not protocol specified|27|||
145796199|NCT02883049|525758926|FG000|Induction|Adverse Event|52|||
145796200|NCT02883049|525758927|FG001|Induction|Adverse Event|2|||
145796201|NCT02883049|525758928|FG002|Induction|Adverse Event|0|||
145796202|NCT02883049|525758929|FG003|Induction|Adverse Event|0|||
145796203|NCT02883049|525758930|FG004|Induction|Adverse Event|0|||
145796204|NCT02883049|525758931|FG005|Induction|Adverse Event|0|||
145796205|NCT02883049|525758932|FG006|Induction|Adverse Event|0|||
145796206|NCT02883049|525758933|FG007|Induction|Adverse Event|0|||
145796207|NCT02883049|525758934|FG008|Induction|Adverse Event|0|||
145796208|NCT02883049|525758935|FG009|Induction|Adverse Event|0|||
145796209|NCT02883049|525758936|FG010|Induction|Adverse Event|0|||
145796210|NCT02883049|525758937|FG011|Induction|Adverse Event|0|||
145796211|NCT02883049|525758938|FG012|Induction|Adverse Event|0|||
145796212|NCT02883049|525758939|FG013|Induction|Adverse Event|0|||
145796213|NCT02883049|525758940|FG014|Induction|Adverse Event|0|||
145796214|NCT02883049|525758941|FG015|Induction|Adverse Event|0|||
145796215|NCT02883049|525758926|FG000|Induction|Death|76|||
145796216|NCT02883049|525758927|FG001|Induction|Death|8|||
145796217|NCT02883049|525758928|FG002|Induction|Death|0|||
145796218|NCT02883049|525758929|FG003|Induction|Death|0|||
145796219|NCT02883049|525758930|FG004|Induction|Death|0|||
145796220|NCT02883049|525758931|FG005|Induction|Death|0|||
145796221|NCT02883049|525758932|FG006|Induction|Death|0|||
145796222|NCT02883049|525758933|FG007|Induction|Death|0|||
145796223|NCT02883049|525758934|FG008|Induction|Death|0|||
145796224|NCT02883049|525758935|FG009|Induction|Death|0|||
145796225|NCT02883049|525758936|FG010|Induction|Death|0|||
145796226|NCT02883049|525758937|FG011|Induction|Death|0|||
145796227|NCT02883049|525758938|FG012|Induction|Death|0|||
145796228|NCT02883049|525758939|FG013|Induction|Death|0|||
145796229|NCT02883049|525758940|FG014|Induction|Death|0|||
145796230|NCT02883049|525758941|FG015|Induction|Death|0|||
145796231|NCT02883049|525758926|FG000|Induction|Lost to Follow-up|2|||
145796232|NCT02883049|525758927|FG001|Induction|Lost to Follow-up|0|||
145796233|NCT02883049|525758928|FG002|Induction|Lost to Follow-up|0|||
145796234|NCT02883049|525758929|FG003|Induction|Lost to Follow-up|0|||
145796235|NCT02883049|525758930|FG004|Induction|Lost to Follow-up|0|||
145796236|NCT02883049|525758931|FG005|Induction|Lost to Follow-up|0|||
145796237|NCT02883049|525758932|FG006|Induction|Lost to Follow-up|0|||
145548317|NCT02854631|524863298|FG001|Overall Study|Investigator's Discretion|0|||
145548318|NCT02854631|524863297|FG000|Overall Study|Death|12|||
145796238|NCT02883049|525758933|FG007|Induction|Lost to Follow-up|0|||
145796239|NCT02883049|525758934|FG008|Induction|Lost to Follow-up|0|||
145796240|NCT02883049|525758935|FG009|Induction|Lost to Follow-up|0|||
145796241|NCT02883049|525758936|FG010|Induction|Lost to Follow-up|0|||
145796242|NCT02883049|525758937|FG011|Induction|Lost to Follow-up|0|||
145796243|NCT02883049|525758938|FG012|Induction|Lost to Follow-up|0|||
145796244|NCT02883049|525758939|FG013|Induction|Lost to Follow-up|0|||
145796245|NCT02883049|525758940|FG014|Induction|Lost to Follow-up|0|||
145796246|NCT02883049|525758941|FG015|Induction|Lost to Follow-up|0|||
145796247|NCT02883049|525758926|FG000|Induction|Physician Decision|1407|||
145796248|NCT02883049|525758927|FG001|Induction|Physician Decision|8|||
145796249|NCT02883049|525758928|FG002|Induction|Physician Decision|0|||
145796250|NCT02883049|525758929|FG003|Induction|Physician Decision|0|||
145548319|NCT02854631|524863298|FG001|Overall Study|Death|8|||
145796251|NCT02883049|525758930|FG004|Induction|Physician Decision|0|||
145796252|NCT02883049|525758931|FG005|Induction|Physician Decision|0|||
145796253|NCT02883049|525758932|FG006|Induction|Physician Decision|0|||
145796254|NCT02883049|525758933|FG007|Induction|Physician Decision|0|||
145796255|NCT02883049|525758934|FG008|Induction|Physician Decision|0|||
145796256|NCT02883049|525758935|FG009|Induction|Physician Decision|0|||
145796257|NCT02883049|525758936|FG010|Induction|Physician Decision|0|||
145548320|NCT02854631|524863297|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
145548321|NCT02854631|524863298|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
145548322|NCT02854631|524863297|FG000|Overall Study|Protocol Violation|0|||
145548323|NCT02854631|524863298|FG001|Overall Study|Protocol Violation|1|||
145548324|NCT02854631|524863297|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
145548325|NCT02854631|524863298|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
145548326|NCT02854631|524863297|FG000|Overall Study|Lost to Follow-up|4|||
145548327|NCT02854631|524863298|FG001|Overall Study|Lost to Follow-up|2|||
145548328|NCT02233647|524863299|FG000|Overall Study|Adverse Event|1|||
145548329|NCT00621153|524863301|FG000|Overall Study|Safety Reason|8|||
145548330|NCT00621153|524863302|FG001|Overall Study|Safety Reason|7|||
145548331|NCT00621153|524863301|FG000|Overall Study|Adverse Event|3|||
145548332|NCT00621153|524863302|FG001|Overall Study|Adverse Event|2|||
145548333|NCT00621153|524863301|FG000|Overall Study|Lost to Follow-up|5|||
145548334|NCT00621153|524863302|FG001|Overall Study|Lost to Follow-up|1|||
145548335|NCT00621153|524863301|FG000|Overall Study|Withdrawal by Subject|4|||
145548336|NCT00621153|524863302|FG001|Overall Study|Withdrawal by Subject|5|||
145548337|NCT00753415|524863303|FG000|Part A|Disease progression|1|||
145548338|NCT00753415|524863304|FG001|Part A|Disease progression|0|||
145796258|NCT02883049|525758937|FG011|Induction|Physician Decision|0|||
145796259|NCT02883049|525758938|FG012|Induction|Physician Decision|0|||
145796260|NCT02883049|525758939|FG013|Induction|Physician Decision|0|||
145796261|NCT02883049|525758940|FG014|Induction|Physician Decision|0|||
145796262|NCT02883049|525758941|FG015|Induction|Physician Decision|0|||
145796263|NCT02883049|525758926|FG000|Induction|Protocol Violation|6|||
145796264|NCT02883049|525758927|FG001|Induction|Protocol Violation|0|||
145796265|NCT02883049|525758928|FG002|Induction|Protocol Violation|0|||
145796266|NCT02883049|525758929|FG003|Induction|Protocol Violation|0|||
145796267|NCT02883049|525758930|FG004|Induction|Protocol Violation|0|||
145796268|NCT02883049|525758931|FG005|Induction|Protocol Violation|0|||
145796269|NCT02883049|525758932|FG006|Induction|Protocol Violation|0|||
145796270|NCT02883049|525758933|FG007|Induction|Protocol Violation|0|||
145796271|NCT02883049|525758934|FG008|Induction|Protocol Violation|0|||
145796272|NCT02883049|525758935|FG009|Induction|Protocol Violation|0|||
145796273|NCT02883049|525758936|FG010|Induction|Protocol Violation|0|||
145796274|NCT02883049|525758937|FG011|Induction|Protocol Violation|0|||
145796275|NCT02883049|525758938|FG012|Induction|Protocol Violation|0|||
145796276|NCT02883049|525758939|FG013|Induction|Protocol Violation|0|||
145796277|NCT02883049|525758940|FG014|Induction|Protocol Violation|0|||
145796278|NCT02883049|525758941|FG015|Induction|Protocol Violation|0|||
145796279|NCT02883049|525758926|FG000|Induction|Withdrawal by Subject|6|||
145796280|NCT02883049|525758927|FG001|Induction|Withdrawal by Subject|0|||
145796281|NCT02883049|525758928|FG002|Induction|Withdrawal by Subject|0|||
145796282|NCT02883049|525758929|FG003|Induction|Withdrawal by Subject|0|||
145796283|NCT02883049|525758930|FG004|Induction|Withdrawal by Subject|0|||
145796284|NCT02883049|525758931|FG005|Induction|Withdrawal by Subject|0|||
145796285|NCT02883049|525758932|FG006|Induction|Withdrawal by Subject|0|||
145796286|NCT02883049|525758933|FG007|Induction|Withdrawal by Subject|0|||
145796287|NCT02883049|525758934|FG008|Induction|Withdrawal by Subject|0|||
145796288|NCT02883049|525758935|FG009|Induction|Withdrawal by Subject|0|||
145796289|NCT02883049|525758936|FG010|Induction|Withdrawal by Subject|0|||
145796290|NCT02883049|525758937|FG011|Induction|Withdrawal by Subject|0|||
145796291|NCT02883049|525758938|FG012|Induction|Withdrawal by Subject|0|||
145796292|NCT02883049|525758939|FG013|Induction|Withdrawal by Subject|0|||
145796293|NCT02883049|525758940|FG014|Induction|Withdrawal by Subject|0|||
145796294|NCT02883049|525758941|FG015|Induction|Withdrawal by Subject|0|||
145796295|NCT02883049|525758926|FG000|Induction|Ineligible|35|||
145796296|NCT02883049|525758927|FG001|Induction|Ineligible|1|||
145796297|NCT02883049|525758928|FG002|Induction|Ineligible|0|||
145796298|NCT02883049|525758929|FG003|Induction|Ineligible|0|||
145796299|NCT02883049|525758930|FG004|Induction|Ineligible|0|||
145796300|NCT02883049|525758931|FG005|Induction|Ineligible|0|||
145796301|NCT02883049|525758932|FG006|Induction|Ineligible|0|||
145796302|NCT02883049|525758933|FG007|Induction|Ineligible|0|||
145796303|NCT02883049|525758934|FG008|Induction|Ineligible|0|||
145796304|NCT02883049|525758935|FG009|Induction|Ineligible|0|||
145796305|NCT02883049|525758936|FG010|Induction|Ineligible|0|||
145796306|NCT02883049|525758937|FG011|Induction|Ineligible|0|||
145796307|NCT02883049|525758938|FG012|Induction|Ineligible|0|||
145548339|NCT00753415|524863305|FG002|Part A|Disease progression|1|||
145548340|NCT00753415|524863306|FG003|Part A|Disease progression|2|||
145796308|NCT02883049|525758939|FG013|Induction|Ineligible|0|||
145796309|NCT02883049|525758940|FG014|Induction|Ineligible|0|||
145796310|NCT02883049|525758941|FG015|Induction|Ineligible|0|||
145796311|NCT02883049|525758926|FG000|Induction|Refusal of further protocol therapy|466|||
145796312|NCT02883049|525758927|FG001|Induction|Refusal of further protocol therapy|2|||
145796313|NCT02883049|525758928|FG002|Induction|Refusal of further protocol therapy|0|||
145796314|NCT02883049|525758929|FG003|Induction|Refusal of further protocol therapy|0|||
145796315|NCT02883049|525758930|FG004|Induction|Refusal of further protocol therapy|0|||
145796316|NCT02883049|525758931|FG005|Induction|Refusal of further protocol therapy|0|||
145548341|NCT00753415|524863307|FG004|Part A|Disease progression|0|||
145548342|NCT00753415|524863308|FG005|Part A|Disease progression|0|||
145548343|NCT00753415|524863309|FG006|Part A|Disease progression|0|||
145548344|NCT00753415|524863310|FG007|Part A|Disease progression|0|||
145548345|NCT00753415|524863311|FG008|Part A|Disease progression|0|||
145548346|NCT00753415|524863312|FG009|Part A|Disease progression|0|||
145548347|NCT00753415|524863303|FG000|Part A|Withdrawal by Subject|0|||
145548348|NCT00753415|524863304|FG001|Part A|Withdrawal by Subject|0|||
145548349|NCT00753415|524863305|FG002|Part A|Withdrawal by Subject|1|||
145548350|NCT00753415|524863306|FG003|Part A|Withdrawal by Subject|0|||
145548351|NCT00753415|524863307|FG004|Part A|Withdrawal by Subject|0|||
145548352|NCT00753415|524863308|FG005|Part A|Withdrawal by Subject|0|||
145548353|NCT00753415|524863309|FG006|Part A|Withdrawal by Subject|0|||
145548354|NCT00753415|524863310|FG007|Part A|Withdrawal by Subject|0|||
145548355|NCT00753415|524863311|FG008|Part A|Withdrawal by Subject|0|||
145548356|NCT00753415|524863312|FG009|Part A|Withdrawal by Subject|0|||
145548357|NCT00753415|524863303|FG000|Part B|Lost to Follow-up|0|||
145548358|NCT00753415|524863304|FG001|Part B|Lost to Follow-up|0|||
145548359|NCT00753415|524863305|FG002|Part B|Lost to Follow-up|0|||
145548360|NCT00753415|524863306|FG003|Part B|Lost to Follow-up|0|||
145548361|NCT00753415|524863307|FG004|Part B|Lost to Follow-up|0|||
145548362|NCT00753415|524863308|FG005|Part B|Lost to Follow-up|0|||
145548363|NCT00753415|524863309|FG006|Part B|Lost to Follow-up|0|||
145548364|NCT00753415|524863310|FG007|Part B|Lost to Follow-up|1|||
145548365|NCT00753415|524863311|FG008|Part B|Lost to Follow-up|1|||
145548366|NCT00753415|524863312|FG009|Part B|Lost to Follow-up|0|||
145548367|NCT00753415|524863303|FG000|Part B|Disease progression|0|||
145548368|NCT00753415|524863304|FG001|Part B|Disease progression|0|||
145548369|NCT00753415|524863305|FG002|Part B|Disease progression|0|||
145548370|NCT00753415|524863306|FG003|Part B|Disease progression|0|||
145548371|NCT00753415|524863307|FG004|Part B|Disease progression|0|||
145548372|NCT00753415|524863308|FG005|Part B|Disease progression|0|||
145548373|NCT00753415|524863309|FG006|Part B|Disease progression|0|||
145548374|NCT00753415|524863310|FG007|Part B|Disease progression|0|||
145548375|NCT00753415|524863311|FG008|Part B|Disease progression|2|||
145548376|NCT00753415|524863312|FG009|Part B|Disease progression|1|||
145548377|NCT04212650|524863313|FG000|Overall Study|Withdrawal by Subject|1|||
145548378|NCT04212650|524863314|FG001|Overall Study|Withdrawal by Subject|0|||
145548379|NCT00887978|524863316|FG000|Overall Study|Adverse Event|18|||
145548380|NCT00887978|524863317|FG001|Overall Study|Adverse Event|5|||
145548381|NCT00887978|524863316|FG000|Overall Study|Clinical Worsening|4|||
145548382|NCT00887978|524863317|FG001|Overall Study|Clinical Worsening|4|||
145548383|NCT00887978|524863316|FG000|Overall Study|Death|2|||
145548384|NCT00887978|524863317|FG001|Overall Study|Death|3|||
145548385|NCT00887978|524863316|FG000|Overall Study|Withdrawal by Subject|1|||
145548386|NCT00887978|524863317|FG001|Overall Study|Withdrawal by Subject|2|||
145548387|NCT00887978|524863316|FG000|Overall Study|Lost to Follow-up|0|||
145548388|NCT00887978|524863317|FG001|Overall Study|Lost to Follow-up|1|||
145548389|NCT01852110|524865354|FG000|Overall Study|Adverse Event|12|||
145548390|NCT01852110|524865355|FG001|Overall Study|Adverse Event|5|||
145548391|NCT01852110|524865356|FG002|Overall Study|Adverse Event|0|||
145548392|NCT01852110|524865357|FG003|Overall Study|Adverse Event|0|||
145548393|NCT01852110|524865358|FG004|Overall Study|Adverse Event|0|||
145548394|NCT01852110|524865359|FG005|Overall Study|Adverse Event|0|||
145548395|NCT01852110|524865354|FG000|Overall Study|Lost to Follow-up|1|||
145548396|NCT01852110|524865355|FG001|Overall Study|Lost to Follow-up|3|||
145548397|NCT01852110|524865356|FG002|Overall Study|Lost to Follow-up|0|||
145548398|NCT01852110|524865357|FG003|Overall Study|Lost to Follow-up|0|||
145548399|NCT01852110|524865358|FG004|Overall Study|Lost to Follow-up|0|||
145548400|NCT01852110|524865359|FG005|Overall Study|Lost to Follow-up|0|||
145548401|NCT01852110|524865354|FG000|Overall Study|Non-compliance with Study Drug|2|||
145548402|NCT01852110|524865355|FG001|Overall Study|Non-compliance with Study Drug|1|||
145548403|NCT01852110|524865356|FG002|Overall Study|Non-compliance with Study Drug|0|||
145548404|NCT01852110|524865357|FG003|Overall Study|Non-compliance with Study Drug|0|||
145548405|NCT01852110|524865358|FG004|Overall Study|Non-compliance with Study Drug|0|||
145548406|NCT01852110|524865359|FG005|Overall Study|Non-compliance with Study Drug|0|||
145548407|NCT01852110|524865354|FG000|Overall Study|Physician Decision|1|||
145548408|NCT01852110|524865355|FG001|Overall Study|Physician Decision|0|||
145548409|NCT01852110|524865356|FG002|Overall Study|Physician Decision|0|||
145548410|NCT01852110|524865357|FG003|Overall Study|Physician Decision|0|||
145548411|NCT01852110|524865358|FG004|Overall Study|Physician Decision|0|||
145548412|NCT01852110|524865359|FG005|Overall Study|Physician Decision|0|||
145548413|NCT01852110|524865354|FG000|Overall Study|Protocol Violation|0|||
145548414|NCT01852110|524865355|FG001|Overall Study|Protocol Violation|1|||
145548415|NCT01852110|524865356|FG002|Overall Study|Protocol Violation|0|||
145548416|NCT01852110|524865357|FG003|Overall Study|Protocol Violation|0|||
145548417|NCT01852110|524865358|FG004|Overall Study|Protocol Violation|0|||
145548418|NCT01852110|524865359|FG005|Overall Study|Protocol Violation|0|||
145548419|NCT01852110|524865354|FG000|Overall Study|Study Terminated by Sponsor|30|||
145548420|NCT01852110|524865355|FG001|Overall Study|Study Terminated by Sponsor|32|||
145548421|NCT01852110|524865356|FG002|Overall Study|Study Terminated by Sponsor|0|||
145548422|NCT01852110|524865357|FG003|Overall Study|Study Terminated by Sponsor|0|||
145548423|NCT01852110|524865358|FG004|Overall Study|Study Terminated by Sponsor|0|||
145548424|NCT01852110|524865359|FG005|Overall Study|Study Terminated by Sponsor|0|||
145548425|NCT01852110|524865354|FG000|Overall Study|Withdrawal by Subject|4|||
145548426|NCT01852110|524865355|FG001|Overall Study|Withdrawal by Subject|4|||
145548427|NCT01852110|524865356|FG002|Overall Study|Withdrawal by Subject|0|||
145548428|NCT01852110|524865357|FG003|Overall Study|Withdrawal by Subject|0|||
145548429|NCT01852110|524865358|FG004|Overall Study|Withdrawal by Subject|0|||
145548430|NCT01852110|524865359|FG005|Overall Study|Withdrawal by Subject|0|||
145548431|NCT02141282|524865360|FG000|Overall Study|Adverse event, not related to progression|8|||
145548432|NCT02141282|524865361|FG001|Overall Study|Adverse event, not related to progression|1|||
145548433|NCT02141282|524865362|FG002|Overall Study|Adverse event, not related to progression|3|||
145548434|NCT02141282|524865363|FG003|Overall Study|Adverse event, not related to progression|1|||
145548435|NCT02141282|524865360|FG000|Overall Study|Adverse event, related to progression|1|||
145548436|NCT02141282|524865361|FG001|Overall Study|Adverse event, related to progression|0|||
145548437|NCT02141282|524865362|FG002|Overall Study|Adverse event, related to progression|2|||
145548438|NCT02141282|524865363|FG003|Overall Study|Adverse event, related to progression|0|||
145548439|NCT02141282|524865360|FG000|Overall Study|COVID-19 infection|1|||
145548440|NCT02141282|524865361|FG001|Overall Study|COVID-19 infection|0|||
145548441|NCT02141282|524865362|FG002|Overall Study|COVID-19 infection|0|||
145548442|NCT02141282|524865363|FG003|Overall Study|COVID-19 infection|0|||
145796317|NCT02883049|525758932|FG006|Induction|Refusal of further protocol therapy|0|||
145796318|NCT02883049|525758933|FG007|Induction|Refusal of further protocol therapy|0|||
145796319|NCT02883049|525758934|FG008|Induction|Refusal of further protocol therapy|0|||
145796320|NCT02883049|525758935|FG009|Induction|Refusal of further protocol therapy|0|||
145796321|NCT02883049|525758936|FG010|Induction|Refusal of further protocol therapy|0|||
145796322|NCT02883049|525758937|FG011|Induction|Refusal of further protocol therapy|0|||
145796323|NCT02883049|525758938|FG012|Induction|Refusal of further protocol therapy|0|||
145796324|NCT02883049|525758939|FG013|Induction|Refusal of further protocol therapy|0|||
145796325|NCT02883049|525758940|FG014|Induction|Refusal of further protocol therapy|0|||
145548443|NCT02141282|524865360|FG000|Overall Study|Lost to Follow-up|0|||
145548444|NCT02141282|524865361|FG001|Overall Study|Lost to Follow-up|0|||
145548445|NCT02141282|524865362|FG002|Overall Study|Lost to Follow-up|4|||
145548446|NCT02141282|524865363|FG003|Overall Study|Lost to Follow-up|2|||
145548447|NCT02141282|524865360|FG000|Overall Study|Other, not specified|14|||
145548448|NCT02141282|524865361|FG001|Overall Study|Other, not specified|11|||
145548449|NCT02141282|524865362|FG002|Overall Study|Other, not specified|23|||
145548450|NCT02141282|524865363|FG003|Overall Study|Other, not specified|9|||
145548451|NCT02141282|524865360|FG000|Overall Study|Progressive disease, Richter's|4|||
145548452|NCT02141282|524865361|FG001|Overall Study|Progressive disease, Richter's|1|||
145548453|NCT02141282|524865362|FG002|Overall Study|Progressive disease, Richter's|1|||
145548454|NCT02141282|524865363|FG003|Overall Study|Progressive disease, Richter's|1|||
145548455|NCT02141282|524865360|FG000|Overall Study|Progressive disease per protocol|12|||
145548456|NCT02141282|524865361|FG001|Overall Study|Progressive disease per protocol|7|||
145548457|NCT02141282|524865362|FG002|Overall Study|Progressive disease per protocol|9|||
145548458|NCT02141282|524865363|FG003|Overall Study|Progressive disease per protocol|2|||
145548459|NCT02141282|524865360|FG000|Overall Study|Stem cell transplant|1|||
145548460|NCT02141282|524865361|FG001|Overall Study|Stem cell transplant|0|||
145548461|NCT02141282|524865362|FG002|Overall Study|Stem cell transplant|1|||
145548462|NCT02141282|524865363|FG003|Overall Study|Stem cell transplant|0|||
145548463|NCT02141282|524865360|FG000|Overall Study|Study terminated by Sponsor|0|||
145548464|NCT02141282|524865361|FG001|Overall Study|Study terminated by Sponsor|1|||
145548465|NCT02141282|524865362|FG002|Overall Study|Study terminated by Sponsor|0|||
145548466|NCT02141282|524865363|FG003|Overall Study|Study terminated by Sponsor|0|||
145548467|NCT02141282|524865360|FG000|Overall Study|Subject non-compliance|0|||
145548468|NCT02141282|524865361|FG001|Overall Study|Subject non-compliance|0|||
145548469|NCT02141282|524865362|FG002|Overall Study|Subject non-compliance|1|||
145548470|NCT02141282|524865363|FG003|Overall Study|Subject non-compliance|0|||
145796326|NCT02883049|525758941|FG015|Induction|Refusal of further protocol therapy|0|||
145796327|NCT02883049|525758926|FG000|Induction|Identified as Ph+ patients|279|||
145548471|NCT02141282|524865360|FG000|Overall Study|Withdrew consent|2|||
145548472|NCT02141282|524865361|FG001|Overall Study|Withdrew consent|0|||
145548473|NCT02141282|524865362|FG002|Overall Study|Withdrew consent|4|||
145548474|NCT02141282|524865363|FG003|Overall Study|Withdrew consent|0|||
145548475|NCT00630396|524865372|FG000|Overall Study|Death|4|||
145796328|NCT02883049|525758927|FG001|Induction|Identified as Ph+ patients|1|||
145796329|NCT02883049|525758928|FG002|Induction|Identified as Ph+ patients|0|||
145796330|NCT02883049|525758929|FG003|Induction|Identified as Ph+ patients|0|||
145796331|NCT02883049|525758930|FG004|Induction|Identified as Ph+ patients|0|||
145796332|NCT02883049|525758931|FG005|Induction|Identified as Ph+ patients|0|||
145796333|NCT02883049|525758932|FG006|Induction|Identified as Ph+ patients|0|||
145796334|NCT02883049|525758933|FG007|Induction|Identified as Ph+ patients|0|||
145796335|NCT02883049|525758934|FG008|Induction|Identified as Ph+ patients|0|||
145796336|NCT02883049|525758935|FG009|Induction|Identified as Ph+ patients|0|||
145796337|NCT02883049|525758936|FG010|Induction|Identified as Ph+ patients|0|||
145796338|NCT02883049|525758937|FG011|Induction|Identified as Ph+ patients|0|||
145796339|NCT02883049|525758938|FG012|Induction|Identified as Ph+ patients|0|||
145796340|NCT02883049|525758939|FG013|Induction|Identified as Ph+ patients|0|||
145796341|NCT02883049|525758940|FG014|Induction|Identified as Ph+ patients|0|||
145796342|NCT02883049|525758941|FG015|Induction|Identified as Ph+ patients|0|||
145796343|NCT02883049|525758926|FG000|Induction|M3 Marrow at Day29|8|||
145796344|NCT02883049|525758927|FG001|Induction|M3 Marrow at Day29|1|||
145796345|NCT02883049|525758928|FG002|Induction|M3 Marrow at Day29|0|||
145796346|NCT02883049|525758929|FG003|Induction|M3 Marrow at Day29|0|||
145796347|NCT02883049|525758930|FG004|Induction|M3 Marrow at Day29|0|||
145796348|NCT02883049|525758931|FG005|Induction|M3 Marrow at Day29|0|||
145796349|NCT02883049|525758932|FG006|Induction|M3 Marrow at Day29|0|||
145796350|NCT02883049|525758933|FG007|Induction|M3 Marrow at Day29|0|||
145796351|NCT02883049|525758934|FG008|Induction|M3 Marrow at Day29|0|||
145796352|NCT02883049|525758935|FG009|Induction|M3 Marrow at Day29|0|||
145796353|NCT02883049|525758936|FG010|Induction|M3 Marrow at Day29|0|||
145796354|NCT02883049|525758937|FG011|Induction|M3 Marrow at Day29|0|||
145796355|NCT02883049|525758938|FG012|Induction|M3 Marrow at Day29|0|||
145796356|NCT02883049|525758939|FG013|Induction|M3 Marrow at Day29|0|||
145796357|NCT02883049|525758940|FG014|Induction|M3 Marrow at Day29|0|||
145796358|NCT02883049|525758941|FG015|Induction|M3 Marrow at Day29|0|||
145796359|NCT02883049|525758926|FG000|Induction|Inevaluable|33|||
145796360|NCT02883049|525758927|FG001|Induction|Inevaluable|1|||
145796361|NCT02883049|525758928|FG002|Induction|Inevaluable|0|||
145796362|NCT02883049|525758929|FG003|Induction|Inevaluable|0|||
145796363|NCT02883049|525758930|FG004|Induction|Inevaluable|0|||
145796364|NCT02883049|525758931|FG005|Induction|Inevaluable|0|||
145796365|NCT02883049|525758932|FG006|Induction|Inevaluable|0|||
145796366|NCT02883049|525758933|FG007|Induction|Inevaluable|0|||
145796367|NCT02883049|525758934|FG008|Induction|Inevaluable|0|||
145796368|NCT02883049|525758935|FG009|Induction|Inevaluable|0|||
145796369|NCT02883049|525758936|FG010|Induction|Inevaluable|0|||
145796370|NCT02883049|525758937|FG011|Induction|Inevaluable|0|||
145796371|NCT02883049|525758938|FG012|Induction|Inevaluable|0|||
145796372|NCT02883049|525758939|FG013|Induction|Inevaluable|0|||
145796373|NCT02883049|525758940|FG014|Induction|Inevaluable|0|||
145796374|NCT02883049|525758941|FG015|Induction|Inevaluable|0|||
145796375|NCT02883049|525758926|FG000|Induction|Identified as VHR at end of Induction|244|||
145796376|NCT02883049|525758927|FG001|Induction|Identified as VHR at end of Induction|0|||
145796377|NCT02883049|525758928|FG002|Induction|Identified as VHR at end of Induction|0|||
145796378|NCT02883049|525758929|FG003|Induction|Identified as VHR at end of Induction|0|||
145796379|NCT02883049|525758930|FG004|Induction|Identified as VHR at end of Induction|0|||
145548476|NCT00630396|524865372|FG000|Overall Study|Lost to Follow-up|3|||
145548477|NCT00963547|524865373|FG000|Overall Study|Adverse Event|0|||
145548478|NCT00963547|524865374|FG001|Overall Study|Adverse Event|1|||
145548479|NCT00963547|524865375|FG002|Overall Study|Adverse Event|0|||
145796380|NCT02883049|525758931|FG005|Induction|Identified as VHR at end of Induction|0|||
145796381|NCT02883049|525758932|FG006|Induction|Identified as VHR at end of Induction|0|||
145796382|NCT02883049|525758933|FG007|Induction|Identified as VHR at end of Induction|0|||
145796383|NCT02883049|525758934|FG008|Induction|Identified as VHR at end of Induction|0|||
145796384|NCT02883049|525758935|FG009|Induction|Identified as VHR at end of Induction|0|||
145796385|NCT02883049|525758936|FG010|Induction|Identified as VHR at end of Induction|0|||
145548480|NCT00963547|524865376|FG003|Overall Study|Adverse Event|1|||
145548481|NCT00963547|524865377|FG004|Overall Study|Adverse Event|0|||
145796386|NCT02883049|525758937|FG011|Induction|Identified as VHR at end of Induction|0|||
145796387|NCT02883049|525758938|FG012|Induction|Identified as VHR at end of Induction|0|||
145796388|NCT02883049|525758939|FG013|Induction|Identified as VHR at end of Induction|0|||
145796389|NCT02883049|525758940|FG014|Induction|Identified as VHR at end of Induction|0|||
145796390|NCT02883049|525758941|FG015|Induction|Identified as VHR at end of Induction|0|||
145796391|NCT02883049|525758926|FG000|Induction|Moved to another non-COG institution|3|||
145796392|NCT02883049|525758927|FG001|Induction|Moved to another non-COG institution|0|||
145796393|NCT02883049|525758928|FG002|Induction|Moved to another non-COG institution|0|||
145796394|NCT02883049|525758929|FG003|Induction|Moved to another non-COG institution|0|||
145548482|NCT00963547|524865378|FG005|Overall Study|Adverse Event|0|||
145796395|NCT02883049|525758930|FG004|Induction|Moved to another non-COG institution|0|||
145796396|NCT02883049|525758931|FG005|Induction|Moved to another non-COG institution|0|||
145796397|NCT02883049|525758932|FG006|Induction|Moved to another non-COG institution|0|||
145796398|NCT02883049|525758933|FG007|Induction|Moved to another non-COG institution|0|||
145796399|NCT02883049|525758934|FG008|Induction|Moved to another non-COG institution|0|||
145796400|NCT02883049|525758935|FG009|Induction|Moved to another non-COG institution|0|||
145796401|NCT02883049|525758936|FG010|Induction|Moved to another non-COG institution|0|||
145796402|NCT02883049|525758937|FG011|Induction|Moved to another non-COG institution|0|||
145796403|NCT02883049|525758938|FG012|Induction|Moved to another non-COG institution|0|||
145796404|NCT02883049|525758939|FG013|Induction|Moved to another non-COG institution|0|||
145796405|NCT02883049|525758940|FG014|Induction|Moved to another non-COG institution|0|||
145796406|NCT02883049|525758941|FG015|Induction|Moved to another non-COG institution|0|||
145796407|NCT02883049|525758926|FG000|Induction|Randomization closed|41|||
145796408|NCT02883049|525758927|FG001|Induction|Randomization closed|0|||
145796409|NCT02883049|525758928|FG002|Induction|Randomization closed|0|||
145796410|NCT02883049|525758929|FG003|Induction|Randomization closed|0|||
145796411|NCT02883049|525758930|FG004|Induction|Randomization closed|0|||
145796412|NCT02883049|525758931|FG005|Induction|Randomization closed|0|||
145796413|NCT02883049|525758932|FG006|Induction|Randomization closed|0|||
145796414|NCT02883049|525758933|FG007|Induction|Randomization closed|0|||
145796415|NCT02883049|525758934|FG008|Induction|Randomization closed|0|||
145796416|NCT02883049|525758935|FG009|Induction|Randomization closed|0|||
145796417|NCT02883049|525758936|FG010|Induction|Randomization closed|0|||
145796418|NCT02883049|525758937|FG011|Induction|Randomization closed|0|||
145796419|NCT02883049|525758938|FG012|Induction|Randomization closed|0|||
145796420|NCT02883049|525758939|FG013|Induction|Randomization closed|0|||
145796421|NCT02883049|525758940|FG014|Induction|Randomization closed|0|||
145796422|NCT02883049|525758941|FG015|Induction|Randomization closed|0|||
145796423|NCT02883049|525758926|FG000|Induction|MRD negative|36|||
145796424|NCT02883049|525758927|FG001|Induction|MRD negative|0|||
145796425|NCT02883049|525758928|FG002|Induction|MRD negative|0|||
145796426|NCT02883049|525758929|FG003|Induction|MRD negative|0|||
145796427|NCT02883049|525758930|FG004|Induction|MRD negative|0|||
145796428|NCT02883049|525758931|FG005|Induction|MRD negative|0|||
145796429|NCT02883049|525758932|FG006|Induction|MRD negative|0|||
145796430|NCT02883049|525758933|FG007|Induction|MRD negative|0|||
145796431|NCT02883049|525758934|FG008|Induction|MRD negative|0|||
145796432|NCT02883049|525758935|FG009|Induction|MRD negative|0|||
145796433|NCT02883049|525758936|FG010|Induction|MRD negative|0|||
145796434|NCT02883049|525758937|FG011|Induction|MRD negative|0|||
145796435|NCT02883049|525758938|FG012|Induction|MRD negative|0|||
145796436|NCT02883049|525758939|FG013|Induction|MRD negative|0|||
145796437|NCT02883049|525758940|FG014|Induction|MRD negative|0|||
145796438|NCT02883049|525758941|FG015|Induction|MRD negative|0|||
145796439|NCT02883049|525758926|FG000|Induction|Identified as HR patients|165|||
145796440|NCT02883049|525758927|FG001|Induction|Identified as HR patients|0|||
145796441|NCT02883049|525758928|FG002|Induction|Identified as HR patients|0|||
145796442|NCT02883049|525758929|FG003|Induction|Identified as HR patients|0|||
145548483|NCT00963547|524865379|FG006|Overall Study|Adverse Event|0|||
145548484|NCT00963547|524865373|FG000|Overall Study|Physician Decision|1|||
145548485|NCT00963547|524865374|FG001|Overall Study|Physician Decision|1|||
145548486|NCT00963547|524865375|FG002|Overall Study|Physician Decision|0|||
145548487|NCT00963547|524865376|FG003|Overall Study|Physician Decision|0|||
145548488|NCT00963547|524865377|FG004|Overall Study|Physician Decision|0|||
145796443|NCT02883049|525758930|FG004|Induction|Identified as HR patients|0|||
145796444|NCT02883049|525758931|FG005|Induction|Identified as HR patients|0|||
145796445|NCT02883049|525758932|FG006|Induction|Identified as HR patients|0|||
145796446|NCT02883049|525758933|FG007|Induction|Identified as HR patients|0|||
145796447|NCT02883049|525758934|FG008|Induction|Identified as HR patients|0|||
145796448|NCT02883049|525758935|FG009|Induction|Identified as HR patients|0|||
145796449|NCT02883049|525758936|FG010|Induction|Identified as HR patients|0|||
145796450|NCT02883049|525758937|FG011|Induction|Identified as HR patients|0|||
145796451|NCT02883049|525758938|FG012|Induction|Identified as HR patients|0|||
145796452|NCT02883049|525758939|FG013|Induction|Identified as HR patients|0|||
145796453|NCT02883049|525758940|FG014|Induction|Identified as HR patients|0|||
145796454|NCT02883049|525758941|FG015|Induction|Identified as HR patients|0|||
145796455|NCT02883049|525758926|FG000|Induction|Developed SMN|0|||
145796456|NCT02883049|525758927|FG001|Induction|Developed SMN|1|||
145548489|NCT00963547|524865378|FG005|Overall Study|Physician Decision|0|||
145796457|NCT02883049|525758928|FG002|Induction|Developed SMN|0|||
145796458|NCT02883049|525758929|FG003|Induction|Developed SMN|0|||
145796459|NCT02883049|525758930|FG004|Induction|Developed SMN|0|||
145796460|NCT02883049|525758931|FG005|Induction|Developed SMN|0|||
145796461|NCT02883049|525758932|FG006|Induction|Developed SMN|0|||
145548490|NCT00963547|524865379|FG006|Overall Study|Physician Decision|0|||
145796462|NCT02883049|525758933|FG007|Induction|Developed SMN|0|||
145796463|NCT02883049|525758934|FG008|Induction|Developed SMN|0|||
145796464|NCT02883049|525758935|FG009|Induction|Developed SMN|0|||
145796465|NCT02883049|525758936|FG010|Induction|Developed SMN|0|||
145796466|NCT02883049|525758937|FG011|Induction|Developed SMN|0|||
145796467|NCT02883049|525758938|FG012|Induction|Developed SMN|0|||
145796468|NCT02883049|525758939|FG013|Induction|Developed SMN|0|||
145796469|NCT02883049|525758940|FG014|Induction|Developed SMN|0|||
145796470|NCT02883049|525758941|FG015|Induction|Developed SMN|0|||
145548491|NCT00963547|524865373|FG000|Overall Study|Progressive Disease|3|||
145548492|NCT00963547|524865374|FG001|Overall Study|Progressive Disease|8|||
145548493|NCT00963547|524865375|FG002|Overall Study|Progressive Disease|9|||
145548494|NCT00963547|524865376|FG003|Overall Study|Progressive Disease|5|||
145548495|NCT00963547|524865377|FG004|Overall Study|Progressive Disease|0|||
145548496|NCT00963547|524865378|FG005|Overall Study|Progressive Disease|0|||
145548497|NCT00963547|524865379|FG006|Overall Study|Progressive Disease|0|||
145548498|NCT00963547|524865373|FG000|Overall Study|Withdrawal by Subject|0|||
145548499|NCT00963547|524865374|FG001|Overall Study|Withdrawal by Subject|0|||
145548500|NCT00963547|524865375|FG002|Overall Study|Withdrawal by Subject|3|||
145548501|NCT00963547|524865376|FG003|Overall Study|Withdrawal by Subject|0|||
145548502|NCT00963547|524865377|FG004|Overall Study|Withdrawal by Subject|0|||
145548503|NCT00963547|524865378|FG005|Overall Study|Withdrawal by Subject|0|||
145548504|NCT00963547|524865379|FG006|Overall Study|Withdrawal by Subject|0|||
145548505|NCT00963547|524865373|FG000|Overall Study|Reason Unknown|0|||
145548506|NCT00963547|524865374|FG001|Overall Study|Reason Unknown|1|||
145548507|NCT00963547|524865375|FG002|Overall Study|Reason Unknown|0|||
145796471|NCT02883049|525758926|FG000|Induction|Enrolled onto another COG study|72|||
145796472|NCT02883049|525758927|FG001|Induction|Enrolled onto another COG study|0|||
145796473|NCT02883049|525758928|FG002|Induction|Enrolled onto another COG study|0|||
145796474|NCT02883049|525758929|FG003|Induction|Enrolled onto another COG study|0|||
145796475|NCT02883049|525758930|FG004|Induction|Enrolled onto another COG study|0|||
145796476|NCT02883049|525758931|FG005|Induction|Enrolled onto another COG study|0|||
145796477|NCT02883049|525758932|FG006|Induction|Enrolled onto another COG study|0|||
145796478|NCT02883049|525758933|FG007|Induction|Enrolled onto another COG study|0|||
145796479|NCT02883049|525758934|FG008|Induction|Enrolled onto another COG study|0|||
145796480|NCT02883049|525758935|FG009|Induction|Enrolled onto another COG study|0|||
145796481|NCT02883049|525758936|FG010|Induction|Enrolled onto another COG study|0|||
145548508|NCT00963547|524865376|FG003|Overall Study|Reason Unknown|0|||
145548509|NCT00963547|524865377|FG004|Overall Study|Reason Unknown|0|||
145548510|NCT00963547|524865378|FG005|Overall Study|Reason Unknown|0|||
145548511|NCT00963547|524865379|FG006|Overall Study|Reason Unknown|0|||
145548512|NCT00759031|524865382|FG000|First Intervention (1 Day)|Physician Decision|1|||
145548513|NCT00759031|524865383|FG001|First Intervention (1 Day)|Physician Decision|0|||
145548514|NCT00759031|524865382|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
145548515|NCT00759031|524865383|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
145548516|NCT00759031|524865382|FG000|First Intervention (1 Day)|Screening failure|1|||
145548517|NCT00759031|524865383|FG001|First Intervention (1 Day)|Screening failure|0|||
145548518|NCT02430311|524865384|FG000|Part A|Adverse Event|0|||
145548519|NCT02430311|524865385|FG001|Part A|Adverse Event|1|||
145548520|NCT02430311|524865384|FG000|Part A|Withdrawal by Subject|1|||
145548521|NCT02430311|524865385|FG001|Part A|Withdrawal by Subject|0|||
145548522|NCT02430311|524865384|FG000|Part B|Meet study-specific withdrawal criteria|6|||
145548523|NCT02430311|524865385|FG001|Part B|Meet study-specific withdrawal criteria|6|||
145548524|NCT02430311|524865384|FG000|Part B|Withdrawal by Subject|2|||
145548525|NCT02430311|524865385|FG001|Part B|Withdrawal by Subject|2|||
145548526|NCT02430311|524865384|FG000|Part B|Adverse Event|1|||
145548527|NCT02430311|524865385|FG001|Part B|Adverse Event|0|||
145548528|NCT02430311|524865384|FG000|Part B|Death|1|||
145548529|NCT02430311|524865385|FG001|Part B|Death|0|||
145548530|NCT04160091|524865388|FG000|Overall Study|Terminated by Sponsor|7|||
145548531|NCT04160091|524865389|FG001|Overall Study|Terminated by Sponsor|3|||
145548532|NCT04160091|524865390|FG002|Overall Study|Terminated by Sponsor|5|||
145548533|NCT04160091|524865391|FG003|Overall Study|Terminated by Sponsor|2|||
145548534|NCT04160091|524865388|FG000|Overall Study|Noncompliance|0|||
145548535|NCT04160091|524865389|FG001|Overall Study|Noncompliance|0|||
145548536|NCT04160091|524865390|FG002|Overall Study|Noncompliance|0|||
145548537|NCT04160091|524865391|FG003|Overall Study|Noncompliance|1|||
145548538|NCT04160091|524865388|FG000|Overall Study|Withdrawal by Subject|0|||
145548539|NCT04160091|524865389|FG001|Overall Study|Withdrawal by Subject|0|||
145548540|NCT04160091|524865390|FG002|Overall Study|Withdrawal by Subject|0|||
145548541|NCT04160091|524865391|FG003|Overall Study|Withdrawal by Subject|1|||
145548542|NCT00381095|524865393|FG000|Overall Study|Death|3|||
145548543|NCT00381095|524865394|FG001|Overall Study|Death|4|||
145796482|NCT02883049|525758937|FG011|Induction|Enrolled onto another COG study|0|||
145796483|NCT02883049|525758938|FG012|Induction|Enrolled onto another COG study|0|||
145796484|NCT02883049|525758939|FG013|Induction|Enrolled onto another COG study|0|||
145796485|NCT02883049|525758940|FG014|Induction|Enrolled onto another COG study|0|||
145548544|NCT00381095|524865393|FG000|Overall Study|Lack of Efficacy|2|||
145796486|NCT02883049|525758941|FG015|Induction|Enrolled onto another COG study|0|||
145548545|NCT00381095|524865394|FG001|Overall Study|Lack of Efficacy|4|||
145548546|NCT00381095|524865393|FG000|Overall Study|Other|2|||
145548547|NCT00381095|524865394|FG001|Overall Study|Other|2|||
145548548|NCT00381095|524865393|FG000|Overall Study|Protocol Violation|1|||
145548549|NCT00381095|524865394|FG001|Overall Study|Protocol Violation|1|||
145548550|NCT00381095|524865393|FG000|Overall Study|Withdrawal by Subject|3|||
145548551|NCT00381095|524865394|FG001|Overall Study|Withdrawal by Subject|3|||
145548552|NCT00381095|524865393|FG000|Overall Study|Adverse Event|2|||
145548553|NCT00381095|524865394|FG001|Overall Study|Adverse Event|7|||
145548554|NCT02485301|524865396|FG000|Overall Study|Serious Adverse Events|2|||
145548555|NCT02485301|524865397|FG001|Overall Study|Serious Adverse Events|1|||
145548556|NCT02485301|524865396|FG000|Overall Study|Protocol Violation|0|||
145548557|NCT02485301|524865397|FG001|Overall Study|Protocol Violation|1|||
145548558|NCT02485301|524865396|FG000|Overall Study|Withdrawal by Subject|6|||
145548559|NCT02485301|524865397|FG001|Overall Study|Withdrawal by Subject|7|||
145548560|NCT02485301|524865396|FG000|Overall Study|Migrated/moved from study area|10|||
145548561|NCT02485301|524865397|FG001|Overall Study|Migrated/moved from study area|19|||
145548562|NCT02485301|524865396|FG000|Overall Study|Lost to Follow-up|17|||
145548563|NCT02485301|524865397|FG001|Overall Study|Lost to Follow-up|17|||
145548564|NCT02485301|524865396|FG000|Overall Study|Other|3|||
145548565|NCT02485301|524865397|FG001|Overall Study|Other|4|||
145548566|NCT00411645|524865398|FG000|Overall Study|Consent Withdrawn|13|||
145548567|NCT00411645|524865399|FG001|Overall Study|Consent Withdrawn|22|||
145548568|NCT00411645|524865398|FG000|Overall Study|Death|56|||
145548569|NCT00411645|524865399|FG001|Overall Study|Death|135|||
145548570|NCT00411645|524865398|FG000|Overall Study|Investigator/Sponsor Decision|10|||
145548571|NCT00411645|524865399|FG001|Overall Study|Investigator/Sponsor Decision|7|||
145548572|NCT00411645|524865398|FG000|Overall Study|Lost to Follow-up|2|||
145548573|NCT00411645|524865399|FG001|Overall Study|Lost to Follow-up|0|||
145548574|NCT02573350|524865402|FG000|Overall Study|Lost to Follow-up|2|||
145548575|NCT02573350|524865403|FG001|Overall Study|Lost to Follow-up|1|||
145548576|NCT02573350|524865402|FG000|Overall Study|Adverse Event|3|||
145548577|NCT02573350|524865403|FG001|Overall Study|Adverse Event|4|||
145548578|NCT02573350|524865402|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
145548579|NCT02573350|524865403|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
145548580|NCT02573350|524865402|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
145548581|NCT02573350|524865403|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
145548582|NCT02573350|524865402|FG000|Overall Study|Subject withdrew consent to participate|6|||
145548583|NCT02573350|524865403|FG001|Overall Study|Subject withdrew consent to participate|1|||
145548584|NCT02573350|524865402|FG000|Overall Study|Protocol Deviation|1|||
145548585|NCT02573350|524865403|FG001|Overall Study|Protocol Deviation|1|||
145548586|NCT02708121|524865404|FG000|Overall Study|Withdrawn by Study Team|1|||
145548587|NCT02708121|524865405|FG001|Overall Study|Withdrawn by Study Team|1|||
145548588|NCT02708121|524865404|FG000|Overall Study|Withdrawal by Subject|0|||
145548589|NCT02708121|524865405|FG001|Overall Study|Withdrawal by Subject|4|||
145548590|NCT01111149|524865406|FG000|Overall Study|Protocol Violation|1|||
145548591|NCT01111149|524865407|FG001|Overall Study|Protocol Violation|1|||
145548592|NCT01111149|524865408|FG002|Overall Study|Protocol Violation|2|||
145548593|NCT01111149|524865406|FG000|Overall Study|Withdrawal by Subject|1|||
145548594|NCT01111149|524865407|FG001|Overall Study|Withdrawal by Subject|0|||
145548595|NCT01111149|524865408|FG002|Overall Study|Withdrawal by Subject|2|||
145548596|NCT01484197|524865414|FG000|Treatment Period 1|Adverse Event|1|||
145548597|NCT01484197|524865415|FG001|Treatment Period 1|Adverse Event|0|||
145548598|NCT01484197|524865416|FG002|Treatment Period 1|Adverse Event|0|||
145548599|NCT01484197|524865417|FG003|Treatment Period 1|Adverse Event|0|||
145548600|NCT01484197|524865414|FG000|Treatment Period 2|Subject withdrew consent|0|||
145548601|NCT01484197|524865415|FG001|Treatment Period 2|Subject withdrew consent|0|||
145548602|NCT01484197|524865416|FG002|Treatment Period 2|Subject withdrew consent|0|||
145548603|NCT01484197|524865417|FG003|Treatment Period 2|Subject withdrew consent|1|||
145548604|NCT00814164|524865418|FG000|Overall Study|Progression|7|||
145548605|NCT00814164|524865418|FG000|Overall Study|not stated|7|||
145548606|NCT00814164|524865418|FG000|Overall Study|Death|5|||
145548607|NCT01980992|524865419|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
145548608|NCT01980992|524865420|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
145548609|NCT01980992|524865419|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
145548610|NCT01980992|524865420|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
145548611|NCT01980992|524865419|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
145548612|NCT01980992|524865420|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
145548613|NCT01980992|524865419|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
145548614|NCT01980992|524865420|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
145548615|NCT01980992|524865419|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
145548616|NCT01980992|524865420|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
145548617|NCT01980992|524865419|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
145548618|NCT01980992|524865420|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
145548619|NCT00299975|524865421|FG000|Overall Study|Adverse Event|1|||
145548620|NCT00299975|524865422|FG001|Overall Study|Adverse Event|0|||
145548621|NCT00299975|524865423|FG002|Overall Study|Adverse Event|2|||
145548622|NCT00299975|524865421|FG000|Overall Study|Pregnancy|0|||
145548623|NCT00299975|524865422|FG001|Overall Study|Pregnancy|0|||
145548624|NCT00299975|524865423|FG002|Overall Study|Pregnancy|1|||
145548625|NCT00299975|524865421|FG000|Overall Study|Lack of Efficacy|1|||
145548626|NCT00299975|524865422|FG001|Overall Study|Lack of Efficacy|0|||
145548627|NCT00299975|524865423|FG002|Overall Study|Lack of Efficacy|1|||
145548628|NCT00299975|524865421|FG000|Overall Study|Lost to Follow-up|1|||
145548629|NCT00299975|524865422|FG001|Overall Study|Lost to Follow-up|0|||
145548630|NCT00299975|524865423|FG002|Overall Study|Lost to Follow-up|0|||
145548631|NCT00299975|524865421|FG000|Overall Study|Withdrawal by Subject|0|||
145548632|NCT00299975|524865422|FG001|Overall Study|Withdrawal by Subject|1|||
145548633|NCT00299975|524865423|FG002|Overall Study|Withdrawal by Subject|3|||
145548634|NCT00299975|524865421|FG000|Overall Study|Physician Decision|0|||
145548635|NCT00299975|524865422|FG001|Overall Study|Physician Decision|0|||
145548636|NCT00299975|524865423|FG002|Overall Study|Physician Decision|1|||
145548637|NCT05228132|524865426|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
145548638|NCT05228132|524865426|FG000|Overall Study|Adverse Event|3|||
145548639|NCT05228132|524865426|FG000|Overall Study|Lost to Follow-up|1|||
145548640|NCT05228132|524865426|FG000|Overall Study|Arteriovenous-fistula mature|1|||
145796487|NCT02883049|525758926|FG000|Induction|Incomplete induction data|17|||
145796488|NCT02883049|525758927|FG001|Induction|Incomplete induction data|0|||
145796489|NCT02883049|525758928|FG002|Induction|Incomplete induction data|0|||
145796490|NCT02883049|525758929|FG003|Induction|Incomplete induction data|0|||
145796491|NCT02883049|525758930|FG004|Induction|Incomplete induction data|0|||
145796492|NCT02883049|525758931|FG005|Induction|Incomplete induction data|0|||
145796493|NCT02883049|525758932|FG006|Induction|Incomplete induction data|0|||
145796494|NCT02883049|525758933|FG007|Induction|Incomplete induction data|0|||
145548641|NCT02627144|524865427|FG000|Overall Study|Serious adverse event|32|||
145548642|NCT02627144|524865427|FG000|Overall Study|Cancer progression|171|||
145548643|NCT02627144|524865427|FG000|Overall Study|Death from cancer|20|||
145548644|NCT02627144|524865427|FG000|Overall Study|Death from other cause|8|||
145548645|NCT02627144|524865427|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
145548646|NCT02627144|524865427|FG000|Overall Study|Administrative reasons|65|||
145548647|NCT02627144|524865427|FG000|Overall Study|Lost to Follow-up|8|||
145548648|NCT02627144|524865427|FG000|Overall Study|Enrolled, not treated|6|||
145548649|NCT02627144|524865427|FG000|Overall Study|Other|17|||
145548650|NCT00420927|524865428|FG000|Period 1|Adverse Event|19|||
145548651|NCT00420927|524865429|FG001|Period 1|Adverse Event|15|||
145548652|NCT00420927|524865430|FG002|Period 1|Adverse Event|0|||
145548653|NCT00420927|524865431|FG003|Period 1|Adverse Event|0|||
145548654|NCT00420927|524865432|FG004|Period 1|Adverse Event|0|||
145548655|NCT00420927|524865433|FG005|Period 1|Adverse Event|0|||
145796495|NCT02883049|525758934|FG008|Induction|Incomplete induction data|0|||
145796496|NCT02883049|525758935|FG009|Induction|Incomplete induction data|0|||
145548656|NCT00420927|524865434|FG006|Period 1|Adverse Event|0|||
145548657|NCT00420927|524865428|FG000|Period 1|Withdrawal by Subject|7|||
145548658|NCT00420927|524865429|FG001|Period 1|Withdrawal by Subject|12|||
145548659|NCT00420927|524865430|FG002|Period 1|Withdrawal by Subject|0|||
145548660|NCT00420927|524865431|FG003|Period 1|Withdrawal by Subject|0|||
145548661|NCT00420927|524865432|FG004|Period 1|Withdrawal by Subject|0|||
145548662|NCT00420927|524865433|FG005|Period 1|Withdrawal by Subject|0|||
145548663|NCT00420927|524865434|FG006|Period 1|Withdrawal by Subject|0|||
145548664|NCT00420927|524865428|FG000|Period 1|Lost to Follow-up|8|||
145548665|NCT00420927|524865429|FG001|Period 1|Lost to Follow-up|6|||
145548666|NCT00420927|524865430|FG002|Period 1|Lost to Follow-up|0|||
145548667|NCT00420927|524865431|FG003|Period 1|Lost to Follow-up|0|||
145548668|NCT00420927|524865432|FG004|Period 1|Lost to Follow-up|0|||
145548669|NCT00420927|524865433|FG005|Period 1|Lost to Follow-up|0|||
145796497|NCT02883049|525758936|FG010|Induction|Incomplete induction data|0|||
145796498|NCT02883049|525758937|FG011|Induction|Incomplete induction data|0|||
145796499|NCT02883049|525758938|FG012|Induction|Incomplete induction data|0|||
145548670|NCT00420927|524865434|FG006|Period 1|Lost to Follow-up|0|||
145548671|NCT00420927|524865428|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
145548672|NCT00420927|524865429|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
145548673|NCT00420927|524865430|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
145548674|NCT00420927|524865431|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
145548675|NCT00420927|524865432|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
145611209|NCT00474929|525092627|FG001|Overall Study|Unrelated medical condition|0|||
145611210|NCT00474929|525092628|FG002|Overall Study|Unrelated medical condition|1|||
145796500|NCT02883049|525758939|FG013|Induction|Incomplete induction data|0|||
145548676|NCT00420927|524865433|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
145548677|NCT00420927|524865434|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
145548678|NCT00420927|524865428|FG000|Period 1|Death|2|||
145548679|NCT00420927|524865429|FG001|Period 1|Death|0|||
145548680|NCT00420927|524865430|FG002|Period 1|Death|0|||
145548681|NCT00420927|524865431|FG003|Period 1|Death|0|||
145548682|NCT00420927|524865432|FG004|Period 1|Death|0|||
145548683|NCT00420927|524865433|FG005|Period 1|Death|0|||
145548684|NCT00420927|524865434|FG006|Period 1|Death|0|||
145548685|NCT00420927|524865428|FG000|Period 1|Subject moved/relocated|0|||
145796501|NCT02883049|525758940|FG014|Induction|Incomplete induction data|0|||
145796502|NCT02883049|525758941|FG015|Induction|Incomplete induction data|0|||
145796503|NCT02883049|525758926|FG000|Post Induction|Adverse Event|0|||
145796504|NCT02883049|525758927|FG001|Post Induction|Adverse Event|0|||
145548686|NCT00420927|524865429|FG001|Period 1|Subject moved/relocated|2|||
145548687|NCT00420927|524865430|FG002|Period 1|Subject moved/relocated|0|||
145548688|NCT00420927|524865431|FG003|Period 1|Subject moved/relocated|0|||
145548689|NCT00420927|524865432|FG004|Period 1|Subject moved/relocated|0|||
145548690|NCT00420927|524865433|FG005|Period 1|Subject moved/relocated|0|||
145548691|NCT00420927|524865434|FG006|Period 1|Subject moved/relocated|0|||
145548692|NCT00420927|524865428|FG000|Period 1|Noncompliant with study drug|1|||
145548693|NCT00420927|524865429|FG001|Period 1|Noncompliant with study drug|1|||
145548694|NCT00420927|524865430|FG002|Period 1|Noncompliant with study drug|0|||
145548695|NCT00420927|524865431|FG003|Period 1|Noncompliant with study drug|0|||
145548696|NCT00420927|524865432|FG004|Period 1|Noncompliant with study drug|0|||
145548697|NCT00420927|524865433|FG005|Period 1|Noncompliant with study drug|0|||
145548698|NCT00420927|524865434|FG006|Period 1|Noncompliant with study drug|0|||
145548699|NCT00420927|524865428|FG000|Period 1|Randomization error|1|||
145548700|NCT00420927|524865429|FG001|Period 1|Randomization error|0|||
145548701|NCT00420927|524865430|FG002|Period 1|Randomization error|0|||
145548702|NCT00420927|524865431|FG003|Period 1|Randomization error|0|||
145548703|NCT00420927|524865432|FG004|Period 1|Randomization error|0|||
145548704|NCT00420927|524865433|FG005|Period 1|Randomization error|0|||
145548705|NCT00420927|524865434|FG006|Period 1|Randomization error|0|||
145548706|NCT00420927|524865428|FG000|Period 1|Suspected tuberculosis/positive test|1|||
145548707|NCT00420927|524865429|FG001|Period 1|Suspected tuberculosis/positive test|1|||
145548708|NCT00420927|524865430|FG002|Period 1|Suspected tuberculosis/positive test|0|||
145548709|NCT00420927|524865431|FG003|Period 1|Suspected tuberculosis/positive test|0|||
145548710|NCT00420927|524865432|FG004|Period 1|Suspected tuberculosis/positive test|0|||
145548711|NCT00420927|524865433|FG005|Period 1|Suspected tuberculosis/positive test|0|||
145548712|NCT00420927|524865434|FG006|Period 1|Suspected tuberculosis/positive test|0|||
145548713|NCT00420927|524865428|FG000|Period 1|Study site closure|0|||
145548714|NCT00420927|524865429|FG001|Period 1|Study site closure|1|||
145548715|NCT00420927|524865430|FG002|Period 1|Study site closure|0|||
145548716|NCT00420927|524865431|FG003|Period 1|Study site closure|0|||
145548717|NCT00420927|524865432|FG004|Period 1|Study site closure|0|||
145548718|NCT00420927|524865433|FG005|Period 1|Study site closure|0|||
145548719|NCT00420927|524865434|FG006|Period 1|Study site closure|0|||
145548720|NCT00420927|524865428|FG000|Period 1|Subject received new diagnosis|0|||
145548721|NCT00420927|524865429|FG001|Period 1|Subject received new diagnosis|2|||
145548722|NCT00420927|524865430|FG002|Period 1|Subject received new diagnosis|0|||
145548723|NCT00420927|524865431|FG003|Period 1|Subject received new diagnosis|0|||
145548724|NCT00420927|524865432|FG004|Period 1|Subject received new diagnosis|0|||
145548725|NCT00420927|524865433|FG005|Period 1|Subject received new diagnosis|0|||
145548726|NCT00420927|524865434|FG006|Period 1|Subject received new diagnosis|0|||
145548727|NCT00420927|524865428|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
145548728|NCT00420927|524865429|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
145548729|NCT00420927|524865430|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
145548730|NCT00420927|524865431|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
145548731|NCT00420927|524865432|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
145548732|NCT00420927|524865433|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
145548733|NCT00420927|524865434|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
145548734|NCT00420927|524865428|FG000|Period 1|Failed to meet entry criteria|8|||
145548735|NCT00420927|524865429|FG001|Period 1|Failed to meet entry criteria|7|||
145548736|NCT00420927|524865430|FG002|Period 1|Failed to meet entry criteria|0|||
145548737|NCT00420927|524865431|FG003|Period 1|Failed to meet entry criteria|0|||
145548738|NCT00420927|524865432|FG004|Period 1|Failed to meet entry criteria|0|||
145548739|NCT00420927|524865433|FG005|Period 1|Failed to meet entry criteria|0|||
145548740|NCT00420927|524865434|FG006|Period 1|Failed to meet entry criteria|0|||
145548741|NCT00420927|524865428|FG000|Period 1|Took prohibited medication|1|||
145548742|NCT00420927|524865429|FG001|Period 1|Took prohibited medication|3|||
145548743|NCT00420927|524865430|FG002|Period 1|Took prohibited medication|0|||
145548744|NCT00420927|524865431|FG003|Period 1|Took prohibited medication|0|||
145548745|NCT00420927|524865432|FG004|Period 1|Took prohibited medication|0|||
145548746|NCT00420927|524865433|FG005|Period 1|Took prohibited medication|0|||
145548747|NCT00420927|524865434|FG006|Period 1|Took prohibited medication|0|||
145548748|NCT00420927|524865428|FG000|Period 2|Adverse Event|0|||
145796505|NCT02883049|525758928|FG002|Post Induction|Adverse Event|0|||
145796506|NCT02883049|525758929|FG003|Post Induction|Adverse Event|7|||
145796507|NCT02883049|525758930|FG004|Post Induction|Adverse Event|8|||
145796508|NCT02883049|525758931|FG005|Post Induction|Adverse Event|3|||
145796509|NCT02883049|525758932|FG006|Post Induction|Adverse Event|4|||
145796510|NCT02883049|525758933|FG007|Post Induction|Adverse Event|5|||
145282862|NCT01512979|523884402|FG000|Overall Study|Withdrawal by Subject|1|||
145282863|NCT01512979|523884403|FG001|Overall Study|Withdrawal by Subject|2|||
145548749|NCT00420927|524865429|FG001|Period 2|Adverse Event|0|||
145548750|NCT00420927|524865430|FG002|Period 2|Adverse Event|7|||
145548751|NCT00420927|524865431|FG003|Period 2|Adverse Event|3|||
145282864|NCT01512979|523884402|FG000|Overall Study|Reason other than stated above|13|||
145548752|NCT00420927|524865432|FG004|Period 2|Adverse Event|17|||
145548753|NCT00420927|524865433|FG005|Period 2|Adverse Event|6|||
145548754|NCT00420927|524865434|FG006|Period 2|Adverse Event|20|||
145548755|NCT00420927|524865428|FG000|Period 2|Withdrawal by Subject|0|||
145548756|NCT00420927|524865429|FG001|Period 2|Withdrawal by Subject|0|||
145548757|NCT00420927|524865430|FG002|Period 2|Withdrawal by Subject|1|||
145548758|NCT00420927|524865431|FG003|Period 2|Withdrawal by Subject|3|||
145548759|NCT00420927|524865432|FG004|Period 2|Withdrawal by Subject|11|||
145796511|NCT02883049|525758934|FG008|Post Induction|Adverse Event|6|||
145548760|NCT00420927|524865433|FG005|Period 2|Withdrawal by Subject|2|||
145548761|NCT00420927|524865434|FG006|Period 2|Withdrawal by Subject|12|||
145548762|NCT00420927|524865428|FG000|Period 2|Lost to Follow-up|0|||
145548763|NCT00420927|524865429|FG001|Period 2|Lost to Follow-up|0|||
145548764|NCT00420927|524865430|FG002|Period 2|Lost to Follow-up|2|||
145548765|NCT00420927|524865431|FG003|Period 2|Lost to Follow-up|2|||
145548766|NCT00420927|524865432|FG004|Period 2|Lost to Follow-up|6|||
145548767|NCT00420927|524865433|FG005|Period 2|Lost to Follow-up|3|||
145548768|NCT00420927|524865434|FG006|Period 2|Lost to Follow-up|9|||
145548769|NCT00420927|524865428|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
145548770|NCT00420927|524865429|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
145548771|NCT00420927|524865430|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
145548772|NCT00420927|524865431|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
145548773|NCT00420927|524865432|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
145548774|NCT00420927|524865433|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
145548775|NCT00420927|524865434|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
145548776|NCT00420927|524865428|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
145548777|NCT00420927|524865429|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
145796512|NCT02883049|525758935|FG009|Post Induction|Adverse Event|7|||
145796513|NCT02883049|525758936|FG010|Post Induction|Adverse Event|2|||
145796514|NCT02883049|525758937|FG011|Post Induction|Adverse Event|2|||
145796515|NCT02883049|525758938|FG012|Post Induction|Adverse Event|0|||
145796516|NCT02883049|525758939|FG013|Post Induction|Adverse Event|0|||
145796517|NCT02883049|525758940|FG014|Post Induction|Adverse Event|5|||
145796518|NCT02883049|525758941|FG015|Post Induction|Adverse Event|2|||
145796519|NCT02883049|525758926|FG000|Post Induction|Death|0|||
145796520|NCT02883049|525758927|FG001|Post Induction|Death|0|||
145796521|NCT02883049|525758928|FG002|Post Induction|Death|0|||
145796522|NCT02883049|525758929|FG003|Post Induction|Death|9|||
145796523|NCT02883049|525758930|FG004|Post Induction|Death|9|||
145796524|NCT02883049|525758931|FG005|Post Induction|Death|0|||
145796525|NCT02883049|525758932|FG006|Post Induction|Death|1|||
145796526|NCT02883049|525758933|FG007|Post Induction|Death|6|||
145796527|NCT02883049|525758934|FG008|Post Induction|Death|5|||
145796528|NCT02883049|525758935|FG009|Post Induction|Death|3|||
145796529|NCT02883049|525758936|FG010|Post Induction|Death|1|||
145548778|NCT00420927|524865430|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
145796530|NCT02883049|525758937|FG011|Post Induction|Death|0|||
145548779|NCT00420927|524865431|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
145548780|NCT00420927|524865432|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
145548781|NCT00420927|524865433|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
145548782|NCT00420927|524865434|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
145548783|NCT00420927|524865428|FG000|Period 2|Subject unable to find transportation|0|||
145611211|NCT00474929|525092629|FG003|Overall Study|Unrelated medical condition|0|||
145796531|NCT02883049|525758938|FG012|Post Induction|Death|1|||
145796532|NCT02883049|525758939|FG013|Post Induction|Death|1|||
145796533|NCT02883049|525758940|FG014|Post Induction|Death|10|||
145548784|NCT00420927|524865429|FG001|Period 2|Subject unable to find transportation|0|||
145548785|NCT00420927|524865430|FG002|Period 2|Subject unable to find transportation|0|||
145548786|NCT00420927|524865431|FG003|Period 2|Subject unable to find transportation|0|||
145548787|NCT00420927|524865432|FG004|Period 2|Subject unable to find transportation|0|||
145548788|NCT00420927|524865433|FG005|Period 2|Subject unable to find transportation|0|||
145796534|NCT02883049|525758941|FG015|Post Induction|Death|2|||
145796535|NCT02883049|525758926|FG000|Post Induction|Lost to Follow-up|0|||
145796536|NCT02883049|525758927|FG001|Post Induction|Lost to Follow-up|0|||
145796537|NCT02883049|525758928|FG002|Post Induction|Lost to Follow-up|0|||
145548789|NCT00420927|524865434|FG006|Period 2|Subject unable to find transportation|1|||
145548790|NCT00420927|524865428|FG000|Period 2|Physician Decision|0|||
145548791|NCT00420927|524865429|FG001|Period 2|Physician Decision|0|||
145548792|NCT00420927|524865430|FG002|Period 2|Physician Decision|0|||
145548793|NCT00420927|524865431|FG003|Period 2|Physician Decision|0|||
145548794|NCT00420927|524865432|FG004|Period 2|Physician Decision|1|||
145548795|NCT00420927|524865433|FG005|Period 2|Physician Decision|1|||
145548796|NCT00420927|524865434|FG006|Period 2|Physician Decision|0|||
145796538|NCT02883049|525758929|FG003|Post Induction|Lost to Follow-up|0|||
145796539|NCT02883049|525758930|FG004|Post Induction|Lost to Follow-up|1|||
145796540|NCT02883049|525758931|FG005|Post Induction|Lost to Follow-up|1|||
145796541|NCT02883049|525758932|FG006|Post Induction|Lost to Follow-up|0|||
145796542|NCT02883049|525758933|FG007|Post Induction|Lost to Follow-up|0|||
145796543|NCT02883049|525758934|FG008|Post Induction|Lost to Follow-up|3|||
145796544|NCT02883049|525758935|FG009|Post Induction|Lost to Follow-up|0|||
145796545|NCT02883049|525758936|FG010|Post Induction|Lost to Follow-up|1|||
145796546|NCT02883049|525758937|FG011|Post Induction|Lost to Follow-up|0|||
145796547|NCT02883049|525758938|FG012|Post Induction|Lost to Follow-up|0|||
145796548|NCT02883049|525758939|FG013|Post Induction|Lost to Follow-up|0|||
145796549|NCT02883049|525758940|FG014|Post Induction|Lost to Follow-up|0|||
145796550|NCT02883049|525758941|FG015|Post Induction|Lost to Follow-up|0|||
145796551|NCT02883049|525758926|FG000|Post Induction|Physician Decision|0|||
145796552|NCT02883049|525758927|FG001|Post Induction|Physician Decision|0|||
145796553|NCT02883049|525758928|FG002|Post Induction|Physician Decision|0|||
145796554|NCT02883049|525758929|FG003|Post Induction|Physician Decision|27|||
145796555|NCT02883049|525758930|FG004|Post Induction|Physician Decision|27|||
145796556|NCT02883049|525758931|FG005|Post Induction|Physician Decision|23|||
145796557|NCT02883049|525758932|FG006|Post Induction|Physician Decision|30|||
145796558|NCT02883049|525758933|FG007|Post Induction|Physician Decision|56|||
145796559|NCT02883049|525758934|FG008|Post Induction|Physician Decision|85|||
145796560|NCT02883049|525758935|FG009|Post Induction|Physician Decision|12|||
145796561|NCT02883049|525758936|FG010|Post Induction|Physician Decision|5|||
145796562|NCT02883049|525758937|FG011|Post Induction|Physician Decision|14|||
145796563|NCT02883049|525758938|FG012|Post Induction|Physician Decision|1|||
145796564|NCT02883049|525758939|FG013|Post Induction|Physician Decision|11|||
145796565|NCT02883049|525758940|FG014|Post Induction|Physician Decision|19|||
145796566|NCT02883049|525758941|FG015|Post Induction|Physician Decision|5|||
145796567|NCT02883049|525758926|FG000|Post Induction|Protocol Violation|0|||
145796568|NCT02883049|525758927|FG001|Post Induction|Protocol Violation|0|||
145796569|NCT02883049|525758928|FG002|Post Induction|Protocol Violation|0|||
145796570|NCT02883049|525758929|FG003|Post Induction|Protocol Violation|0|||
145796571|NCT02883049|525758930|FG004|Post Induction|Protocol Violation|0|||
145796572|NCT02883049|525758931|FG005|Post Induction|Protocol Violation|0|||
145796573|NCT02883049|525758932|FG006|Post Induction|Protocol Violation|0|||
145796574|NCT02883049|525758933|FG007|Post Induction|Protocol Violation|1|||
145796575|NCT02883049|525758934|FG008|Post Induction|Protocol Violation|0|||
145796576|NCT02883049|525758935|FG009|Post Induction|Protocol Violation|0|||
145796577|NCT02883049|525758936|FG010|Post Induction|Protocol Violation|0|||
145796578|NCT02883049|525758937|FG011|Post Induction|Protocol Violation|0|||
145796579|NCT02883049|525758938|FG012|Post Induction|Protocol Violation|0|||
145796580|NCT02883049|525758939|FG013|Post Induction|Protocol Violation|0|||
145796581|NCT02883049|525758940|FG014|Post Induction|Protocol Violation|0|||
145796582|NCT02883049|525758941|FG015|Post Induction|Protocol Violation|0|||
145796583|NCT02883049|525758926|FG000|Post Induction|Withdrawal by Subject|0|||
145796584|NCT02883049|525758927|FG001|Post Induction|Withdrawal by Subject|0|||
145796585|NCT02883049|525758928|FG002|Post Induction|Withdrawal by Subject|0|||
145796586|NCT02883049|525758929|FG003|Post Induction|Withdrawal by Subject|5|||
145796587|NCT02883049|525758930|FG004|Post Induction|Withdrawal by Subject|2|||
145796588|NCT02883049|525758931|FG005|Post Induction|Withdrawal by Subject|1|||
145796589|NCT02883049|525758932|FG006|Post Induction|Withdrawal by Subject|0|||
145796590|NCT02883049|525758933|FG007|Post Induction|Withdrawal by Subject|0|||
145796591|NCT02883049|525758934|FG008|Post Induction|Withdrawal by Subject|2|||
145796592|NCT02883049|525758935|FG009|Post Induction|Withdrawal by Subject|0|||
145796593|NCT02883049|525758936|FG010|Post Induction|Withdrawal by Subject|1|||
145796594|NCT02883049|525758937|FG011|Post Induction|Withdrawal by Subject|1|||
145796595|NCT02883049|525758938|FG012|Post Induction|Withdrawal by Subject|0|||
145796596|NCT02883049|525758939|FG013|Post Induction|Withdrawal by Subject|0|||
145796597|NCT02883049|525758940|FG014|Post Induction|Withdrawal by Subject|1|||
145796598|NCT02883049|525758941|FG015|Post Induction|Withdrawal by Subject|0|||
145796599|NCT02883049|525758926|FG000|Post Induction|Ineligible|0|||
145796600|NCT02883049|525758927|FG001|Post Induction|Ineligible|0|||
145796601|NCT02883049|525758928|FG002|Post Induction|Ineligible|2|||
145796602|NCT02883049|525758929|FG003|Post Induction|Ineligible|0|||
145796603|NCT02883049|525758930|FG004|Post Induction|Ineligible|0|||
145796604|NCT02883049|525758931|FG005|Post Induction|Ineligible|0|||
145796605|NCT02883049|525758932|FG006|Post Induction|Ineligible|1|||
145796606|NCT02883049|525758933|FG007|Post Induction|Ineligible|0|||
145796607|NCT02883049|525758934|FG008|Post Induction|Ineligible|0|||
145796608|NCT02883049|525758935|FG009|Post Induction|Ineligible|0|||
145796609|NCT02883049|525758936|FG010|Post Induction|Ineligible|1|||
145796610|NCT02883049|525758937|FG011|Post Induction|Ineligible|0|||
145796611|NCT02883049|525758938|FG012|Post Induction|Ineligible|0|||
145796612|NCT02883049|525758939|FG013|Post Induction|Ineligible|0|||
145796613|NCT02883049|525758940|FG014|Post Induction|Ineligible|0|||
145796614|NCT02883049|525758941|FG015|Post Induction|Ineligible|1|||
145796615|NCT02883049|525758926|FG000|Post Induction|Refusal of further protocol therapy|0|||
145796616|NCT02883049|525758927|FG001|Post Induction|Refusal of further protocol therapy|0|||
145796617|NCT02883049|525758928|FG002|Post Induction|Refusal of further protocol therapy|0|||
145548797|NCT00420927|524865428|FG000|Period 2|Sponsor decision|0|||
145548798|NCT00420927|524865429|FG001|Period 2|Sponsor decision|0|||
145548799|NCT00420927|524865430|FG002|Period 2|Sponsor decision|1|||
145548800|NCT00420927|524865431|FG003|Period 2|Sponsor decision|0|||
145548801|NCT00420927|524865432|FG004|Period 2|Sponsor decision|0|||
145548802|NCT00420927|524865433|FG005|Period 2|Sponsor decision|0|||
145548803|NCT00420927|524865434|FG006|Period 2|Sponsor decision|1|||
145548804|NCT00420927|524865428|FG000|Period 2|Randomization error|0|||
145548805|NCT00420927|524865429|FG001|Period 2|Randomization error|0|||
145548806|NCT00420927|524865430|FG002|Period 2|Randomization error|0|||
145548807|NCT00420927|524865431|FG003|Period 2|Randomization error|0|||
145548808|NCT00420927|524865432|FG004|Period 2|Randomization error|1|||
145548809|NCT00420927|524865433|FG005|Period 2|Randomization error|1|||
145548810|NCT00420927|524865434|FG006|Period 2|Randomization error|0|||
145548811|NCT00420927|524865428|FG000|Period 2|Noncompliant with study drug|0|||
145548812|NCT00420927|524865429|FG001|Period 2|Noncompliant with study drug|0|||
145548813|NCT00420927|524865430|FG002|Period 2|Noncompliant with study drug|0|||
145548814|NCT00420927|524865431|FG003|Period 2|Noncompliant with study drug|1|||
145548815|NCT00420927|524865432|FG004|Period 2|Noncompliant with study drug|0|||
145548816|NCT00420927|524865433|FG005|Period 2|Noncompliant with study drug|0|||
145548817|NCT00420927|524865434|FG006|Period 2|Noncompliant with study drug|2|||
145548818|NCT00420927|524865428|FG000|Period 2|Methotrexate intolerance|0|||
145796618|NCT02883049|525758929|FG003|Post Induction|Refusal of further protocol therapy|11|||
145796619|NCT02883049|525758930|FG004|Post Induction|Refusal of further protocol therapy|15|||
145796620|NCT02883049|525758931|FG005|Post Induction|Refusal of further protocol therapy|9|||
145796621|NCT02883049|525758932|FG006|Post Induction|Refusal of further protocol therapy|13|||
145796622|NCT02883049|525758933|FG007|Post Induction|Refusal of further protocol therapy|5|||
145796623|NCT02883049|525758934|FG008|Post Induction|Refusal of further protocol therapy|21|||
145548819|NCT00420927|524865429|FG001|Period 2|Methotrexate intolerance|0|||
145796624|NCT02883049|525758935|FG009|Post Induction|Refusal of further protocol therapy|7|||
145548820|NCT00420927|524865430|FG002|Period 2|Methotrexate intolerance|0|||
145548821|NCT00420927|524865431|FG003|Period 2|Methotrexate intolerance|0|||
145796625|NCT02883049|525758936|FG010|Post Induction|Refusal of further protocol therapy|0|||
145796626|NCT02883049|525758937|FG011|Post Induction|Refusal of further protocol therapy|7|||
145796627|NCT02883049|525758938|FG012|Post Induction|Refusal of further protocol therapy|3|||
145796628|NCT02883049|525758939|FG013|Post Induction|Refusal of further protocol therapy|0|||
145796629|NCT02883049|525758940|FG014|Post Induction|Refusal of further protocol therapy|4|||
145796630|NCT02883049|525758941|FG015|Post Induction|Refusal of further protocol therapy|1|||
145796631|NCT02883049|525758926|FG000|Post Induction|Inevaluable|0|||
145796632|NCT02883049|525758927|FG001|Post Induction|Inevaluable|0|||
145796633|NCT02883049|525758928|FG002|Post Induction|Inevaluable|0|||
145796634|NCT02883049|525758929|FG003|Post Induction|Inevaluable|1|||
145796635|NCT02883049|525758930|FG004|Post Induction|Inevaluable|1|||
145796636|NCT02883049|525758931|FG005|Post Induction|Inevaluable|2|||
145405017|NCT01288430|524340083|FG000|Part 1|Progressive disease|2|||
145548822|NCT00420927|524865432|FG004|Period 2|Methotrexate intolerance|0|||
145548823|NCT00420927|524865433|FG005|Period 2|Methotrexate intolerance|0|||
145548824|NCT00420927|524865434|FG006|Period 2|Methotrexate intolerance|1|||
145548825|NCT00420927|524865428|FG000|Period 2|Took prohibited medication|0|||
145548826|NCT00420927|524865429|FG001|Period 2|Took prohibited medication|0|||
145548827|NCT00420927|524865430|FG002|Period 2|Took prohibited medication|0|||
145548828|NCT00420927|524865431|FG003|Period 2|Took prohibited medication|0|||
145548829|NCT00420927|524865432|FG004|Period 2|Took prohibited medication|1|||
145548830|NCT00420927|524865433|FG005|Period 2|Took prohibited medication|0|||
145548831|NCT00420927|524865434|FG006|Period 2|Took prohibited medication|0|||
145548832|NCT00642460|524865435|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
145548833|NCT00642460|524865436|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
145548834|NCT00642460|524865437|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
145405018|NCT01288430|524340084|FG001|Part 1|Progressive disease|1|||
145548835|NCT00642460|524865438|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
145548836|NCT00642460|524865439|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
145548837|NCT00642460|524865440|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
145548838|NCT00642460|524865435|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
145548839|NCT00642460|524865436|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
145548840|NCT00642460|524865437|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
145405019|NCT01288430|524340085|FG002|Part 1|Progressive disease|1|||
145405020|NCT01288430|524340086|FG003|Part 1|Progressive disease|6|||
145405021|NCT01288430|524340087|FG004|Part 1|Progressive disease|2|||
145405022|NCT01288430|524340088|FG005|Part 1|Progressive disease|4|||
145548841|NCT00642460|524865438|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
145611212|NCT00474929|525092630|FG004|Overall Study|Unrelated medical condition|0|||
145611213|NCT00474929|525092626|FG000|Overall Study|Physician Decision|0|||
145611214|NCT00474929|525092627|FG001|Overall Study|Physician Decision|0|||
145611215|NCT00474929|525092628|FG002|Overall Study|Physician Decision|1|||
145611216|NCT00474929|525092629|FG003|Overall Study|Physician Decision|2|||
145611217|NCT00474929|525092630|FG004|Overall Study|Physician Decision|0|||
145611218|NCT03661996|525092633|FG000|Overall Study|Adverse Event|0|||
145548842|NCT00642460|524865439|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
145548843|NCT00642460|524865440|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
145548844|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
145611219|NCT03661996|525092634|FG001|Overall Study|Adverse Event|0|||
145611220|NCT03661996|525092635|FG002|Overall Study|Adverse Event|1|||
145796637|NCT02883049|525758932|FG006|Post Induction|Inevaluable|7|||
145796638|NCT02883049|525758933|FG007|Post Induction|Inevaluable|6|||
145796639|NCT02883049|525758934|FG008|Post Induction|Inevaluable|4|||
145796640|NCT02883049|525758935|FG009|Post Induction|Inevaluable|4|||
145796641|NCT02883049|525758936|FG010|Post Induction|Inevaluable|1|||
145796642|NCT02883049|525758937|FG011|Post Induction|Inevaluable|1|||
145796643|NCT02883049|525758938|FG012|Post Induction|Inevaluable|2|||
145796644|NCT02883049|525758939|FG013|Post Induction|Inevaluable|0|||
145796645|NCT02883049|525758940|FG014|Post Induction|Inevaluable|0|||
145796646|NCT02883049|525758941|FG015|Post Induction|Inevaluable|1|||
145796647|NCT02883049|525758926|FG000|Post Induction|Moved to another non-COG institution|0|||
145796648|NCT02883049|525758927|FG001|Post Induction|Moved to another non-COG institution|0|||
145796649|NCT02883049|525758928|FG002|Post Induction|Moved to another non-COG institution|0|||
145796650|NCT02883049|525758929|FG003|Post Induction|Moved to another non-COG institution|0|||
145796651|NCT02883049|525758930|FG004|Post Induction|Moved to another non-COG institution|0|||
145796652|NCT02883049|525758931|FG005|Post Induction|Moved to another non-COG institution|0|||
145796653|NCT02883049|525758932|FG006|Post Induction|Moved to another non-COG institution|0|||
145796654|NCT02883049|525758933|FG007|Post Induction|Moved to another non-COG institution|2|||
145796655|NCT02883049|525758934|FG008|Post Induction|Moved to another non-COG institution|2|||
145796656|NCT02883049|525758935|FG009|Post Induction|Moved to another non-COG institution|0|||
145796657|NCT02883049|525758936|FG010|Post Induction|Moved to another non-COG institution|0|||
145796658|NCT02883049|525758937|FG011|Post Induction|Moved to another non-COG institution|1|||
145796659|NCT02883049|525758938|FG012|Post Induction|Moved to another non-COG institution|0|||
145611221|NCT03661996|525092636|FG003|Overall Study|Adverse Event|1|||
145796660|NCT02883049|525758939|FG013|Post Induction|Moved to another non-COG institution|0|||
145796661|NCT02883049|525758940|FG014|Post Induction|Moved to another non-COG institution|0|||
145796662|NCT02883049|525758941|FG015|Post Induction|Moved to another non-COG institution|0|||
145796663|NCT02883049|525758926|FG000|Post Induction|Randomization closed|0|||
145796664|NCT02883049|525758927|FG001|Post Induction|Randomization closed|0|||
145796665|NCT02883049|525758928|FG002|Post Induction|Randomization closed|0|||
145796666|NCT02883049|525758929|FG003|Post Induction|Randomization closed|0|||
145796667|NCT02883049|525758930|FG004|Post Induction|Randomization closed|0|||
145796668|NCT02883049|525758931|FG005|Post Induction|Randomization closed|0|||
145796669|NCT02883049|525758932|FG006|Post Induction|Randomization closed|0|||
145796670|NCT02883049|525758933|FG007|Post Induction|Randomization closed|20|||
145796671|NCT02883049|525758934|FG008|Post Induction|Randomization closed|0|||
145796672|NCT02883049|525758935|FG009|Post Induction|Randomization closed|0|||
145796673|NCT02883049|525758936|FG010|Post Induction|Randomization closed|0|||
145796674|NCT02883049|525758937|FG011|Post Induction|Randomization closed|0|||
145796675|NCT02883049|525758938|FG012|Post Induction|Randomization closed|0|||
145796676|NCT02883049|525758939|FG013|Post Induction|Randomization closed|0|||
145796677|NCT02883049|525758940|FG014|Post Induction|Randomization closed|0|||
145796678|NCT02883049|525758941|FG015|Post Induction|Randomization closed|0|||
145796679|NCT02883049|525758926|FG000|Post Induction|MRD negative|0|||
145796680|NCT02883049|525758927|FG001|Post Induction|MRD negative|0|||
145796681|NCT02883049|525758928|FG002|Post Induction|MRD negative|0|||
145796682|NCT02883049|525758929|FG003|Post Induction|MRD negative|0|||
145796683|NCT02883049|525758930|FG004|Post Induction|MRD negative|0|||
145796684|NCT02883049|525758931|FG005|Post Induction|MRD negative|0|||
145796685|NCT02883049|525758932|FG006|Post Induction|MRD negative|0|||
145796686|NCT02883049|525758933|FG007|Post Induction|MRD negative|11|||
145796687|NCT02883049|525758934|FG008|Post Induction|MRD negative|0|||
145796688|NCT02883049|525758935|FG009|Post Induction|MRD negative|0|||
145796689|NCT02883049|525758936|FG010|Post Induction|MRD negative|0|||
145796690|NCT02883049|525758937|FG011|Post Induction|MRD negative|0|||
145796691|NCT02883049|525758938|FG012|Post Induction|MRD negative|0|||
145796692|NCT02883049|525758939|FG013|Post Induction|MRD negative|0|||
145796693|NCT02883049|525758940|FG014|Post Induction|MRD negative|0|||
145796694|NCT02883049|525758941|FG015|Post Induction|MRD negative|0|||
145796695|NCT02883049|525758926|FG000|Post Induction|Developed SMN|0|||
145796696|NCT02883049|525758927|FG001|Post Induction|Developed SMN|0|||
145796697|NCT02883049|525758928|FG002|Post Induction|Developed SMN|0|||
145796698|NCT02883049|525758929|FG003|Post Induction|Developed SMN|0|||
145796699|NCT02883049|525758930|FG004|Post Induction|Developed SMN|1|||
145796700|NCT02883049|525758931|FG005|Post Induction|Developed SMN|0|||
145796701|NCT02883049|525758932|FG006|Post Induction|Developed SMN|1|||
145796702|NCT02883049|525758933|FG007|Post Induction|Developed SMN|0|||
145548845|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
145548846|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
145548847|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
145548848|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
145548849|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
145548850|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Death|0|||
145548851|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Death|1|||
145548852|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Death|0|||
145548853|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Death|2|||
145548854|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Death|0|||
145548855|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Death|0|||
145548856|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
145548857|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
145548858|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
145796703|NCT02883049|525758934|FG008|Post Induction|Developed SMN|0|||
145796704|NCT02883049|525758935|FG009|Post Induction|Developed SMN|0|||
145796705|NCT02883049|525758936|FG010|Post Induction|Developed SMN|1|||
145796706|NCT02883049|525758937|FG011|Post Induction|Developed SMN|1|||
145796707|NCT02883049|525758938|FG012|Post Induction|Developed SMN|0|||
145796708|NCT02883049|525758939|FG013|Post Induction|Developed SMN|0|||
145796709|NCT02883049|525758940|FG014|Post Induction|Developed SMN|1|||
145796710|NCT02883049|525758941|FG015|Post Induction|Developed SMN|0|||
145796711|NCT02883049|525758926|FG000|Post Induction|Enrolled onto another COG study|0|||
145796712|NCT02883049|525758927|FG001|Post Induction|Enrolled onto another COG study|0|||
145548859|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
145548860|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
145548861|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
145548862|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
145548863|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
145796713|NCT02883049|525758928|FG002|Post Induction|Enrolled onto another COG study|0|||
145796714|NCT02883049|525758929|FG003|Post Induction|Enrolled onto another COG study|1|||
145548864|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
145548865|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
145548866|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
145548867|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
145548868|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
145548869|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
145548870|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
145548871|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
145548872|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
145548873|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
145548874|NCT00642460|524865435|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
145548875|NCT00642460|524865436|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
145548876|NCT00642460|524865437|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
145548877|NCT00642460|524865438|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
145548878|NCT00642460|524865439|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
145548879|NCT00642460|524865440|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
145548880|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
145548881|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
145548882|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
145548883|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
145548884|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
145548885|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
145548886|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
145548887|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
145548888|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
145548889|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
145548890|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
145548891|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
145548892|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
145548893|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
145548894|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
145548895|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
145548896|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
145548897|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
145548898|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
145548899|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
145548900|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
145548901|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
145548902|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
145548903|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
145548904|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Other|0|||
145548905|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Other|0|||
145548906|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Other|0|||
145548907|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Other|0|||
145548908|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Other|2|||
145548909|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Other|2|||
145548910|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Death|0|||
145548911|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Death|0|||
145548912|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Death|0|||
145548913|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Death|0|||
145548914|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Death|0|||
145548915|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Death|3|||
145548916|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
145548917|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
145548918|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
145548919|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
145548920|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
145548921|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
145548922|NCT00642460|524865435|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
145548923|NCT00642460|524865436|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
145548924|NCT00642460|524865437|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
145548925|NCT00642460|524865438|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
145548926|NCT00642460|524865439|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
145548927|NCT00642460|524865440|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
145548928|NCT02088047|524865443|FG000|Overall Study|Withdrawal by Subject|1|||
145548929|NCT02088047|524865444|FG001|Overall Study|Withdrawal by Subject|0|||
145548930|NCT00496470|524865446|FG000|Overall Study|Adverse Event|8|||
145548931|NCT00496470|524865447|FG001|Overall Study|Adverse Event|10|||
145548932|NCT00496470|524865446|FG000|Overall Study|Withdrawal by Subject|5|||
145548933|NCT00496470|524865447|FG001|Overall Study|Withdrawal by Subject|12|||
145548934|NCT00496470|524865446|FG000|Overall Study|Incorrectly enrolled|13|||
145548935|NCT00496470|524865447|FG001|Overall Study|Incorrectly enrolled|5|||
145548936|NCT00496470|524865446|FG000|Overall Study|Other reason|0|||
145548937|NCT00496470|524865447|FG001|Overall Study|Other reason|2|||
145548938|NCT01217814|524865448|FG000|Overall Study|Adverse Event|1|||
145548939|NCT01217814|524865449|FG001|Overall Study|Adverse Event|1|||
145548940|NCT01217814|524865450|FG002|Overall Study|Adverse Event|0|||
145548941|NCT01217814|524865448|FG000|Overall Study|Lack of Efficacy|0|||
145548942|NCT01217814|524865449|FG001|Overall Study|Lack of Efficacy|0|||
145548943|NCT01217814|524865450|FG002|Overall Study|Lack of Efficacy|1|||
145548944|NCT00729651|524865452|FG000|Overall Study|Withdrawal by Subject|5|||
145548945|NCT00729651|524865453|FG001|Overall Study|Withdrawal by Subject|6|||
145548946|NCT00729651|524865452|FG000|Overall Study|Lost to Follow-up|5|||
145548947|NCT00729651|524865453|FG001|Overall Study|Lost to Follow-up|4|||
145548948|NCT00729651|524865452|FG000|Overall Study|Protocol Violation|0|||
145548949|NCT00729651|524865453|FG001|Overall Study|Protocol Violation|1|||
145548950|NCT00729651|524865452|FG000|Overall Study|Adverse Event|7|||
145548951|NCT00729651|524865453|FG001|Overall Study|Adverse Event|3|||
145548952|NCT00729651|524865452|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
145548953|NCT00729651|524865453|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
145548954|NCT00729651|524865452|FG000|Overall Study|Subject's private reason|2|||
145548955|NCT00729651|524865453|FG001|Overall Study|Subject's private reason|0|||
145548956|NCT01218243|524865454|FG000|Overall Study|Lack of Efficacy|1|||
145548957|NCT01218243|524865455|FG001|Overall Study|Lack of Efficacy|1|||
145548958|NCT01218243|524865454|FG000|Overall Study|Lost to Follow-up|3|||
145548959|NCT01218243|524865455|FG001|Overall Study|Lost to Follow-up|3|||
145548960|NCT01218243|524865454|FG000|Overall Study|Protocol Violation|5|||
145548961|NCT01218243|524865455|FG001|Overall Study|Protocol Violation|10|||
145548962|NCT01844518|524865456|FG000|Overall Study|Adverse Event|7|||
145548963|NCT01844518|524865457|FG001|Overall Study|Adverse Event|1|||
145548964|NCT01844518|524865456|FG000|Overall Study|Lack of Efficacy|17|||
145548965|NCT01844518|524865457|FG001|Overall Study|Lack of Efficacy|5|||
145548966|NCT01844518|524865456|FG000|Overall Study|Participant's request to discontinue|4|||
145548967|NCT01844518|524865457|FG001|Overall Study|Participant's request to discontinue|1|||
145548968|NCT01844518|524865456|FG000|Overall Study|Poor/Non-compliance|1|||
145548969|NCT01844518|524865457|FG001|Overall Study|Poor/Non-compliance|0|||
145548970|NCT01844518|524865456|FG000|Overall Study|No Longer Met Study Criteria|2|||
145548971|NCT01844518|524865457|FG001|Overall Study|No Longer Met Study Criteria|0|||
145548972|NCT01844518|524865456|FG000|Overall Study|Withdrawal by Subject|9|||
145548973|NCT01844518|524865457|FG001|Overall Study|Withdrawal by Subject|0|||
145796715|NCT02883049|525758930|FG004|Post Induction|Enrolled onto another COG study|1|||
145796716|NCT02883049|525758931|FG005|Post Induction|Enrolled onto another COG study|0|||
145796717|NCT02883049|525758932|FG006|Post Induction|Enrolled onto another COG study|0|||
145796718|NCT02883049|525758933|FG007|Post Induction|Enrolled onto another COG study|4|||
145796719|NCT02883049|525758934|FG008|Post Induction|Enrolled onto another COG study|0|||
145796720|NCT02883049|525758935|FG009|Post Induction|Enrolled onto another COG study|0|||
145796721|NCT02883049|525758936|FG010|Post Induction|Enrolled onto another COG study|0|||
145796722|NCT02883049|525758937|FG011|Post Induction|Enrolled onto another COG study|2|||
145796723|NCT02883049|525758938|FG012|Post Induction|Enrolled onto another COG study|0|||
145796724|NCT02883049|525758939|FG013|Post Induction|Enrolled onto another COG study|1|||
145796725|NCT02883049|525758940|FG014|Post Induction|Enrolled onto another COG study|0|||
145796726|NCT02883049|525758941|FG015|Post Induction|Enrolled onto another COG study|0|||
145796727|NCT02883049|525758926|FG000|Post Induction|Recurrent leukemia|0|||
145796728|NCT02883049|525758927|FG001|Post Induction|Recurrent leukemia|0|||
145796729|NCT02883049|525758928|FG002|Post Induction|Recurrent leukemia|0|||
145796730|NCT02883049|525758929|FG003|Post Induction|Recurrent leukemia|17|||
145796731|NCT02883049|525758930|FG004|Post Induction|Recurrent leukemia|12|||
145796732|NCT02883049|525758931|FG005|Post Induction|Recurrent leukemia|4|||
145796733|NCT02883049|525758932|FG006|Post Induction|Recurrent leukemia|1|||
145796734|NCT02883049|525758933|FG007|Post Induction|Recurrent leukemia|13|||
145796735|NCT02883049|525758934|FG008|Post Induction|Recurrent leukemia|27|||
145796736|NCT02883049|525758935|FG009|Post Induction|Recurrent leukemia|5|||
145796737|NCT02883049|525758936|FG010|Post Induction|Recurrent leukemia|3|||
145796738|NCT02883049|525758937|FG011|Post Induction|Recurrent leukemia|12|||
145548974|NCT01844518|524865456|FG000|Overall Study|Pregnancy|1|||
145548975|NCT01844518|524865457|FG001|Overall Study|Pregnancy|0|||
145548976|NCT00291577|524865458|FG000|Overall Study|Adverse Event|1|||
145796739|NCT02883049|525758938|FG012|Post Induction|Recurrent leukemia|1|||
145796740|NCT02883049|525758939|FG013|Post Induction|Recurrent leukemia|1|||
145796741|NCT02883049|525758940|FG014|Post Induction|Recurrent leukemia|9|||
145548977|NCT00291577|524865458|FG000|Overall Study|Other|4|||
145548978|NCT00291577|524865458|FG000|Overall Study|Withdrawal by Subject|2|||
145548979|NCT00291577|524865458|FG000|Overall Study|Lack of Efficacy|14|||
145548980|NCT00833794|524865465|FG000|Open-label Phase|Adverse Event|225|||
145796742|NCT02883049|525758941|FG015|Post Induction|Recurrent leukemia|3|||
145548981|NCT00833794|524865466|FG001|Open-label Phase|Adverse Event|0|||
145548982|NCT00833794|524865465|FG000|Open-label Phase|Lack of Efficacy|28|||
145548983|NCT00833794|524865466|FG001|Open-label Phase|Lack of Efficacy|0|||
145548984|NCT00833794|524865465|FG000|Open-label Phase|Withdrawal by Subject|48|||
145548985|NCT00833794|524865466|FG001|Open-label Phase|Withdrawal by Subject|0|||
145548986|NCT00833794|524865465|FG000|Open-label Phase|Physician Decision|20|||
145548987|NCT00833794|524865466|FG001|Open-label Phase|Physician Decision|0|||
145548988|NCT00833794|524865465|FG000|Open-label Phase|Administrative reason|1|||
145548989|NCT00833794|524865466|FG001|Open-label Phase|Administrative reason|0|||
145548990|NCT00833794|524865465|FG000|Open-label Phase|Protocol Violation|47|||
145548991|NCT00833794|524865466|FG001|Open-label Phase|Protocol Violation|0|||
145548992|NCT00833794|524865465|FG000|Open-label Phase|Did not complete wash-out period|12|||
145548993|NCT00833794|524865466|FG001|Open-label Phase|Did not complete wash-out period|0|||
145548994|NCT00833794|524865465|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
145548995|NCT00833794|524865466|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
145548996|NCT00833794|524865465|FG000|Double-blind Phase|Adverse Event|44|||
145548997|NCT00833794|524865466|FG001|Double-blind Phase|Adverse Event|11|||
145548998|NCT00833794|524865465|FG000|Double-blind Phase|Lack of Efficacy|34|||
145548999|NCT00833794|524865466|FG001|Double-blind Phase|Lack of Efficacy|22|||
145549000|NCT00833794|524865465|FG000|Double-blind Phase|Withdrawal by Subject|23|||
145549001|NCT00833794|524865466|FG001|Double-blind Phase|Withdrawal by Subject|6|||
145549002|NCT00833794|524865465|FG000|Double-blind Phase|Physician Decision|4|||
145549003|NCT00833794|524865466|FG001|Double-blind Phase|Physician Decision|7|||
145549004|NCT00833794|524865465|FG000|Double-blind Phase|Administrative reason|1|||
145549005|NCT00833794|524865466|FG001|Double-blind Phase|Administrative reason|3|||
145549006|NCT00519831|524865469|FG000|Overall Study|Adverse Event|3|||
145549007|NCT00471328|524865470|FG000|Core Phase|Adverse Event|18|||
145549008|NCT00471328|524865471|FG001|Core Phase|Adverse Event|6|||
145549009|NCT00471328|524865470|FG000|Core Phase|Death|8|||
145549010|NCT00471328|524865471|FG001|Core Phase|Death|4|||
145549011|NCT00471328|524865470|FG000|Core Phase|Withdrawal by Subject|2|||
145549012|NCT00471328|524865471|FG001|Core Phase|Withdrawal by Subject|2|||
145549013|NCT00471328|524865470|FG000|Core Phase|Abnormal laboratory value|1|||
145549014|NCT00471328|524865471|FG001|Core Phase|Abnormal laboratory value|0|||
145549015|NCT00471328|524865470|FG000|Core Phase|Disease Progression|78|||
145549016|NCT00471328|524865471|FG001|Core Phase|Disease Progression|53|||
145549017|NCT00471328|524865470|FG000|Core Phase|Administrative Problem|0|||
145549018|NCT00471328|524865471|FG001|Core Phase|Administrative Problem|1|||
145549019|NCT00471328|524865470|FG000|Core Phase|Protocol Deviation|0|||
145549020|NCT00471328|524865471|FG001|Core Phase|Protocol Deviation|1|||
145549021|NCT00471328|524865470|FG000|Extension Phase|Adverse Event|3|||
145549022|NCT00471328|524865471|FG001|Extension Phase|Adverse Event|12|||
145796743|NCT02883049|525758926|FG000|Post Induction|Induction Failure|0|||
145796744|NCT02883049|525758927|FG001|Post Induction|Induction Failure|0|||
145796745|NCT02883049|525758928|FG002|Post Induction|Induction Failure|0|||
145796746|NCT02883049|525758929|FG003|Post Induction|Induction Failure|0|||
145796747|NCT02883049|525758930|FG004|Post Induction|Induction Failure|0|||
145796748|NCT02883049|525758931|FG005|Post Induction|Induction Failure|0|||
145796749|NCT02883049|525758932|FG006|Post Induction|Induction Failure|0|||
145796750|NCT02883049|525758933|FG007|Post Induction|Induction Failure|2|||
145796751|NCT02883049|525758934|FG008|Post Induction|Induction Failure|2|||
145796752|NCT02883049|525758935|FG009|Post Induction|Induction Failure|0|||
145796753|NCT02883049|525758936|FG010|Post Induction|Induction Failure|0|||
145796754|NCT02883049|525758937|FG011|Post Induction|Induction Failure|0|||
145796755|NCT02883049|525758938|FG012|Post Induction|Induction Failure|0|||
145796756|NCT02883049|525758939|FG013|Post Induction|Induction Failure|2|||
145549023|NCT00471328|524865470|FG000|Extension Phase|Withdrawal by Subject|0|||
145549024|NCT00471328|524865471|FG001|Extension Phase|Withdrawal by Subject|2|||
145796757|NCT02883049|525758940|FG014|Post Induction|Induction Failure|0|||
145796758|NCT02883049|525758941|FG015|Post Induction|Induction Failure|0|||
145549025|NCT00471328|524865470|FG000|Extension Phase|Death|1|||
145549026|NCT00471328|524865471|FG001|Extension Phase|Death|7|||
145796759|NCT01358877|525758942|FG000|Overall Study|Withdrawal by Subject|475|||
145549027|NCT00471328|524865470|FG000|Extension Phase|Protocol Deviation|3|||
145549028|NCT00471328|524865471|FG001|Extension Phase|Protocol Deviation|1|||
145549029|NCT00471328|524865470|FG000|Extension Phase|Treatment duration as per protocol|0|||
145549030|NCT00471328|524865471|FG001|Extension Phase|Treatment duration as per protocol|1|||
145549031|NCT00471328|524865470|FG000|Extension Phase|Disease Progression|32|||
145549032|NCT00471328|524865471|FG001|Extension Phase|Disease Progression|44|||
145796760|NCT01358877|525758943|FG001|Overall Study|Withdrawal by Subject|466|||
145796761|NCT01358877|525758942|FG000|Overall Study|Recurrence of disease|181|||
145796762|NCT01358877|525758943|FG001|Overall Study|Recurrence of disease|269|||
145796763|NCT01358877|525758942|FG000|Overall Study|Lost to Follow-up|181|||
145796764|NCT01358877|525758943|FG001|Overall Study|Lost to Follow-up|176|||
145549033|NCT00471328|524865470|FG000|Extension Phase|New cancer Therapy|1|||
145549034|NCT00471328|524865471|FG001|Extension Phase|New cancer Therapy|0|||
145549035|NCT00471328|524865470|FG000|Extension Phase|Administrative Problem|1|||
145549036|NCT00471328|524865471|FG001|Extension Phase|Administrative Problem|0|||
145549037|NCT04051008|524865472|FG000|Overall Study|Withdrawal by Subject|2|||
145549038|NCT04051008|524865473|FG001|Overall Study|Withdrawal by Subject|0|||
145549039|NCT04051008|524865474|FG002|Overall Study|Withdrawal by Subject|1|||
145549040|NCT03200860|524865475|FG000|Overall Study|Withdrawal by Subject|1|||
145549041|NCT03200860|524865476|FG001|Overall Study|Withdrawal by Subject|0|||
145549042|NCT00844896|524865477|FG000|Overall Study|Lost to Follow-up|12|||
145549043|NCT00844896|524865478|FG001|Overall Study|Lost to Follow-up|16|||
145549044|NCT00844896|524865477|FG000|Overall Study|Parents did not have time to complete|0|||
145549045|NCT00844896|524865478|FG001|Overall Study|Parents did not have time to complete|1|||
145549046|NCT00458211|524865482|FG000|Overall Study|Lack of Efficacy|12|||
145549047|NCT00458211|524865482|FG000|Overall Study|Withdrawal by Subject|2|||
145549048|NCT00458211|524865482|FG000|Overall Study|Protocol Violation|2|||
145549049|NCT04342897|524865483|FG000|Overall Study|Death|7|||
145549050|NCT04342897|524865484|FG001|Overall Study|Death|4|||
145549051|NCT04342897|524865483|FG000|Overall Study|Lost to Follow-up|6|||
145549052|NCT04342897|524865484|FG001|Overall Study|Lost to Follow-up|6|||
145549053|NCT04342897|524865483|FG000|Overall Study|Withdrawal by Subject|1|||
145549054|NCT04342897|524865484|FG001|Overall Study|Withdrawal by Subject|2|||
145549055|NCT02634320|524865491|FG000|Overall Study|Adverse Event|2|||
145549056|NCT02634320|524865491|FG000|Overall Study|Lost to Follow-up|3|||
145549057|NCT02634320|524865491|FG000|Overall Study|Moved out of area|2|||
145549058|NCT02634320|524865491|FG000|Overall Study|Out of window for study visits|1|||
145549059|NCT02634320|524865491|FG000|Overall Study|Protocol Violation|1|||
145549060|NCT02634320|524865491|FG000|Overall Study|Withdrawal by Subject|5|||
145549061|NCT02634320|524865491|FG000|Overall Study|Lack of Efficacy|2|||
145549062|NCT00838578|524865496|FG000|Overall Study|Protocol Violation|2|||
145549063|NCT00598832|524865497|FG000|Overall Study|Lack of Efficacy|3|||
145549064|NCT00598832|524865498|FG001|Overall Study|Lack of Efficacy|7|||
145549065|NCT00598832|524865497|FG000|Overall Study|Adverse Event|6|||
145549066|NCT00598832|524865498|FG001|Overall Study|Adverse Event|2|||
145549067|NCT00598832|524865497|FG000|Overall Study|Withdrawal by Subject|25|||
145549068|NCT00598832|524865498|FG001|Overall Study|Withdrawal by Subject|36|||
145549069|NCT00598832|524865497|FG000|Overall Study|Protocol Violation|0|||
145549070|NCT00598832|524865498|FG001|Overall Study|Protocol Violation|2|||
145549071|NCT00598832|524865497|FG000|Overall Study|Lost to Follow-up|24|||
145549072|NCT00598832|524865498|FG001|Overall Study|Lost to Follow-up|29|||
145549073|NCT00598832|524865497|FG000|Overall Study|Pregnancy|2|||
145549074|NCT00598832|524865498|FG001|Overall Study|Pregnancy|2|||
145549075|NCT00598832|524865497|FG000|Overall Study|Physician Decision|1|||
145549076|NCT00598832|524865498|FG001|Overall Study|Physician Decision|4|||
145549077|NCT00598832|524865497|FG000|Overall Study|Non compliance|1|||
145549078|NCT00598832|524865498|FG001|Overall Study|Non compliance|0|||
145549079|NCT00357968|524865502|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
145549080|NCT00357968|524865503|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
145549081|NCT00357968|524865502|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
145549082|NCT00357968|524865503|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
145549083|NCT03919799|524865508|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
145549084|NCT03919799|524865509|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
145549085|NCT03919799|524865510|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
145549086|NCT03919799|524865511|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
145282865|NCT01512979|523884403|FG001|Overall Study|Reason other than stated above|9|||
145282866|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
145282867|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
145282868|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
145282869|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
145282870|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
145282871|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
145549087|NCT03919799|524865512|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
145549088|NCT03919799|524865508|FG000|DB Period (28 Weeks)|Adverse Event|1|||
145549089|NCT03919799|524865509|FG001|DB Period (28 Weeks)|Adverse Event|1|||
145549090|NCT03919799|524865510|FG002|DB Period (28 Weeks)|Adverse Event|1|||
145549091|NCT03919799|524865511|FG003|DB Period (28 Weeks)|Adverse Event|0|||
145549092|NCT03919799|524865512|FG004|DB Period (28 Weeks)|Adverse Event|0|||
145549093|NCT03919799|524865508|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
145549094|NCT03919799|524865509|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
145549095|NCT03919799|524865510|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
145549096|NCT03919799|524865511|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
145549097|NCT03919799|524865512|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
145549098|NCT03919799|524865508|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
145549099|NCT03919799|524865509|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
145549100|NCT03919799|524865510|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
145549101|NCT03919799|524865511|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
145549102|NCT03919799|524865512|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
145549103|NCT03919799|524865508|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
145549104|NCT03919799|524865509|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
145549105|NCT03919799|524865510|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
145549106|NCT03919799|524865511|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
145549107|NCT03919799|524865512|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
145549108|NCT02142959|524865514|FG000|Overall Study|Adverse Event|1|||
145549109|NCT02142959|524865515|FG001|Overall Study|Adverse Event|0|||
145549110|NCT02142959|524865516|FG002|Overall Study|Adverse Event|0|||
145549111|NCT02142959|524865514|FG000|Overall Study|Death|0|||
145549112|NCT02142959|524865515|FG001|Overall Study|Death|1|||
145549113|NCT02142959|524865516|FG002|Overall Study|Death|0|||
145549114|NCT02142959|524865514|FG000|Overall Study|Withdrawal by Subject|3|||
145549115|NCT02142959|524865515|FG001|Overall Study|Withdrawal by Subject|1|||
145549116|NCT02142959|524865516|FG002|Overall Study|Withdrawal by Subject|3|||
145549117|NCT02142959|524865514|FG000|Overall Study|Administrative Reasons|1|||
145549118|NCT02142959|524865515|FG001|Overall Study|Administrative Reasons|0|||
145549119|NCT02142959|524865516|FG002|Overall Study|Administrative Reasons|1|||
145549120|NCT02142959|524865514|FG000|Overall Study|Missing|0|||
145549121|NCT02142959|524865515|FG001|Overall Study|Missing|1|||
145549122|NCT02142959|524865516|FG002|Overall Study|Missing|0|||
145549123|NCT02142959|524865514|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
145549124|NCT02142959|524865515|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
145611222|NCT03661996|525092637|FG004|Overall Study|Adverse Event|0|||
145611223|NCT03661996|525092633|FG000|Overall Study|Lost to Follow-up|5|||
145796765|NCT01358877|525758942|FG000|Overall Study|Death|41|||
145796766|NCT01358877|525758943|FG001|Overall Study|Death|46|||
145796767|NCT01358877|525758942|FG000|Overall Study|Adverse Event|39|||
145796768|NCT01358877|525758943|FG001|Overall Study|Adverse Event|42|||
145796769|NCT01358877|525758942|FG000|Overall Study|Physician Decision|43|||
145796770|NCT01358877|525758943|FG001|Overall Study|Physician Decision|32|||
145796771|NCT01358877|525758942|FG000|Overall Study|Contralateral breast cancer|42|||
145796772|NCT01358877|525758943|FG001|Overall Study|Contralateral breast cancer|28|||
145796773|NCT01358877|525758942|FG000|Overall Study|Reason not specified|37|||
145796774|NCT01358877|525758943|FG001|Overall Study|Reason not specified|29|||
145796775|NCT01048853|525758944|FG000|Overall Study|Death|1|||
145796776|NCT01048853|525758945|FG001|Overall Study|Death|0|||
145796777|NCT01048853|525758946|FG002|Overall Study|Death|0|||
145796778|NCT01048853|525758944|FG000|Overall Study|Lost to Follow-up|1|||
145796779|NCT01048853|525758945|FG001|Overall Study|Lost to Follow-up|4|||
145796780|NCT01048853|525758946|FG002|Overall Study|Lost to Follow-up|0|||
145796781|NCT05552261|525758947|FG000|Overall Study|Withdrawal by Subject|1|||
145796782|NCT05552261|525758947|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
145796783|NCT02003222|525758948|FG000|Induction|Never started treatment|0|||
145796784|NCT02003222|525758949|FG001|Induction|Never started treatment|0|||
145796785|NCT02003222|525758950|FG002|Induction|Never started treatment|0|||
145796786|NCT02003222|525758951|FG003|Induction|Never started treatment|0|||
145796787|NCT02003222|525758952|FG004|Induction|Never started treatment|8|||
145796788|NCT02003222|525758948|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
145796789|NCT02003222|525758949|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
145796790|NCT02003222|525758950|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
145796791|NCT02003222|525758951|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
145796792|NCT02003222|525758952|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
145796793|NCT02003222|525758948|FG000|Induction|Adverse Event|0|||
145796794|NCT02003222|525758949|FG001|Induction|Adverse Event|0|||
145796795|NCT02003222|525758950|FG002|Induction|Adverse Event|0|||
145796796|NCT02003222|525758951|FG003|Induction|Adverse Event|0|||
145796797|NCT02003222|525758952|FG004|Induction|Adverse Event|13|||
145549125|NCT02142959|524865516|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
145549126|NCT02142959|524865514|FG000|Overall Study|Patient didn't complete end of study visit|0|||
145549127|NCT02142959|524865515|FG001|Overall Study|Patient didn't complete end of study visit|0|||
145549128|NCT02142959|524865516|FG002|Overall Study|Patient didn't complete end of study visit|1|||
145549129|NCT03547687|524865517|FG000|Overall Study|Withdrawal by Subject|1|||
145549130|NCT03547687|524865517|FG000|Overall Study|Death|1|||
145549131|NCT00679302|524865518|FG000|Overall Study|Lost to Follow-up|8|||
145549132|NCT00679302|524865519|FG001|Overall Study|Lost to Follow-up|4|||
145549133|NCT01753856|524865520|FG000|Overall Study|Adverse Event|1|||
145611224|NCT03661996|525092634|FG001|Overall Study|Lost to Follow-up|1|||
145796798|NCT02003222|525758948|FG000|Induction|Alternative therapy|0|||
145796799|NCT02003222|525758949|FG001|Induction|Alternative therapy|0|||
145796800|NCT02003222|525758950|FG002|Induction|Alternative therapy|0|||
145796801|NCT02003222|525758951|FG003|Induction|Alternative therapy|0|||
145796802|NCT02003222|525758952|FG004|Induction|Alternative therapy|12|||
145796803|NCT02003222|525758948|FG000|Induction|Disease progression|0|||
145796804|NCT02003222|525758949|FG001|Induction|Disease progression|0|||
145611225|NCT03661996|525092635|FG002|Overall Study|Lost to Follow-up|2|||
145611226|NCT03661996|525092636|FG003|Overall Study|Lost to Follow-up|2|||
145611227|NCT03661996|525092637|FG004|Overall Study|Lost to Follow-up|6|||
145796805|NCT02003222|525758950|FG002|Induction|Disease progression|0|||
145796806|NCT02003222|525758951|FG003|Induction|Disease progression|0|||
145796807|NCT02003222|525758952|FG004|Induction|Disease progression|22|||
145796808|NCT02003222|525758948|FG000|Induction|Death|0|||
145796809|NCT02003222|525758949|FG001|Induction|Death|0|||
145796810|NCT02003222|525758950|FG002|Induction|Death|0|||
145796811|NCT02003222|525758951|FG003|Induction|Death|0|||
145796812|NCT02003222|525758952|FG004|Induction|Death|3|||
145796813|NCT02003222|525758948|FG000|Induction|Withdrawal by Subject|0|||
145796814|NCT02003222|525758949|FG001|Induction|Withdrawal by Subject|0|||
145796815|NCT02003222|525758950|FG002|Induction|Withdrawal by Subject|0|||
145796816|NCT02003222|525758951|FG003|Induction|Withdrawal by Subject|0|||
145796817|NCT02003222|525758952|FG004|Induction|Withdrawal by Subject|8|||
145796818|NCT02003222|525758948|FG000|Induction|Other reasons|0|||
145796819|NCT02003222|525758949|FG001|Induction|Other reasons|0|||
145796820|NCT02003222|525758950|FG002|Induction|Other reasons|0|||
145796821|NCT02003222|525758951|FG003|Induction|Other reasons|0|||
145796822|NCT02003222|525758952|FG004|Induction|Other reasons|22|||
145796823|NCT02003222|525758948|FG000|Intensification|Never started treatment|0|||
145796824|NCT02003222|525758949|FG001|Intensification|Never started treatment|0|||
145796825|NCT02003222|525758950|FG002|Intensification|Never started treatment|0|||
145796826|NCT02003222|525758951|FG003|Intensification|Never started treatment|0|||
145796827|NCT02003222|525758952|FG004|Intensification|Never started treatment|2|||
145796828|NCT02003222|525758948|FG000|Intensification|Adverse Event|0|||
145796829|NCT02003222|525758949|FG001|Intensification|Adverse Event|0|||
145796830|NCT02003222|525758950|FG002|Intensification|Adverse Event|0|||
145796831|NCT02003222|525758951|FG003|Intensification|Adverse Event|0|||
145796832|NCT02003222|525758952|FG004|Intensification|Adverse Event|6|||
145796833|NCT02003222|525758948|FG000|Intensification|Alternative therapy|0|||
145796834|NCT02003222|525758949|FG001|Intensification|Alternative therapy|0|||
145796835|NCT02003222|525758950|FG002|Intensification|Alternative therapy|0|||
145796836|NCT02003222|525758951|FG003|Intensification|Alternative therapy|0|||
145796837|NCT02003222|525758952|FG004|Intensification|Alternative therapy|8|||
145796838|NCT02003222|525758948|FG000|Intensification|Disease progression|0|||
145549134|NCT01753856|524865521|FG001|Overall Study|Adverse Event|0|||
145549135|NCT01753856|524865520|FG000|Overall Study|Withdrawal by Subject|0|||
145549136|NCT01753856|524865521|FG001|Overall Study|Withdrawal by Subject|2|||
145549137|NCT01753856|524865520|FG000|Overall Study|Sponsor Decision|2|||
145549138|NCT01753856|524865521|FG001|Overall Study|Sponsor Decision|0|||
145549139|NCT05425745|524865524|FG000|Overall Study|Withdrawal of Consent|3|||
145549140|NCT05425745|524865525|FG001|Overall Study|Withdrawal of Consent|3|||
145549141|NCT05425745|524865524|FG000|Overall Study|Death|2|||
145549142|NCT05425745|524865525|FG001|Overall Study|Death|3|||
145796839|NCT02003222|525758949|FG001|Intensification|Disease progression|0|||
145796840|NCT02003222|525758950|FG002|Intensification|Disease progression|0|||
145549143|NCT05425745|524865524|FG000|Overall Study|Lost to Follow-up|1|||
145549144|NCT05425745|524865525|FG001|Overall Study|Lost to Follow-up|2|||
145611228|NCT03661996|525092633|FG000|Overall Study|Physician Decision|1|||
145611229|NCT03661996|525092634|FG001|Overall Study|Physician Decision|1|||
145611230|NCT03661996|525092635|FG002|Overall Study|Physician Decision|1|||
145611231|NCT03661996|525092636|FG003|Overall Study|Physician Decision|2|||
145611232|NCT03661996|525092637|FG004|Overall Study|Physician Decision|0|||
145611233|NCT03661996|525092633|FG000|Overall Study|Protocol Violation|0|||
145611234|NCT03661996|525092634|FG001|Overall Study|Protocol Violation|0|||
145611235|NCT03661996|525092635|FG002|Overall Study|Protocol Violation|0|||
145611236|NCT03661996|525092636|FG003|Overall Study|Protocol Violation|0|||
145611237|NCT03661996|525092637|FG004|Overall Study|Protocol Violation|1|||
145796841|NCT02003222|525758951|FG003|Intensification|Disease progression|0|||
145611238|NCT03661996|525092633|FG000|Overall Study|Withdrawal by Subject|3|||
145549145|NCT05425745|524865524|FG000|Overall Study|Adverse Event|0|||
145549146|NCT05425745|524865525|FG001|Overall Study|Adverse Event|1|||
145549147|NCT05425745|524865524|FG000|Overall Study|Did not return for end of study visit|0|||
145611239|NCT03661996|525092634|FG001|Overall Study|Withdrawal by Subject|5|||
145611240|NCT03661996|525092635|FG002|Overall Study|Withdrawal by Subject|1|||
145611241|NCT03661996|525092636|FG003|Overall Study|Withdrawal by Subject|7|||
145796842|NCT02003222|525758952|FG004|Intensification|Disease progression|18|||
145796843|NCT02003222|525758948|FG000|Intensification|Withdrawal by Subject|0|||
145796844|NCT02003222|525758949|FG001|Intensification|Withdrawal by Subject|0|||
145796845|NCT02003222|525758950|FG002|Intensification|Withdrawal by Subject|0|||
145796846|NCT02003222|525758951|FG003|Intensification|Withdrawal by Subject|0|||
145796847|NCT02003222|525758952|FG004|Intensification|Withdrawal by Subject|5|||
145796848|NCT02003222|525758948|FG000|Intensification|Other reasons|0|||
145796849|NCT02003222|525758949|FG001|Intensification|Other reasons|0|||
145796850|NCT02003222|525758950|FG002|Intensification|Other reasons|0|||
145796851|NCT02003222|525758951|FG003|Intensification|Other reasons|0|||
145796852|NCT02003222|525758952|FG004|Intensification|Other reasons|8|||
145796853|NCT04941768|525758957|FG000|Overall Study|Lost to Follow-up|10|||
145796854|NCT04941768|525758957|FG000|Overall Study|Death|24|||
145796855|NCT04941768|525758957|FG000|Overall Study|Progressive Disease|4|||
145796856|NCT04941768|525758957|FG000|Overall Study|Withdrawal by Subject|4|||
145796857|NCT04941768|525758957|FG000|Overall Study|Other|3|||
145796858|NCT04941768|525758957|FG000|Overall Study|Treatment ongoing|21|||
145796859|NCT04941768|525758957|FG000|Overall Study|Off treatment and in follow-up|21|||
145796860|NCT03302078|525758959|FG000|Washout Period|Adverse Event|0|||
145796861|NCT03302078|525758960|FG001|Washout Period|Adverse Event|1|||
145796862|NCT01886872|525758961|FG000|Overall Study|Ineligible|7|||
145796863|NCT01886872|525758962|FG001|Overall Study|Ineligible|4|||
145796864|NCT01886872|525758963|FG002|Overall Study|Ineligible|12|||
145796865|NCT04999969|525758964|FG000|Overall Study|Death|76|||
145796866|NCT04999969|525758964|FG000|Overall Study|Progressive Disease|1|||
145796867|NCT04999969|525758964|FG000|Overall Study|Withdrawal by Subject|8|||
145796868|NCT03779334|525758969|FG000|Overall Study|Withdrawal by Subject|3|||
145796869|NCT03779334|525758970|FG001|Overall Study|Withdrawal by Subject|0|||
145796870|NCT03779334|525758971|FG002|Overall Study|Withdrawal by Subject|0|||
145796871|NCT03779334|525758969|FG000|Overall Study|Ongoing in Study|5|||
145796872|NCT03779334|525758970|FG001|Overall Study|Ongoing in Study|13|||
145796873|NCT03779334|525758971|FG002|Overall Study|Ongoing in Study|5|||
145796874|NCT05148299|525758972|FG000|Treatment Period|Adverse Event|1|||
145796875|NCT05148299|525758972|FG000|Treatment Period|Physician Decision|1|||
145796876|NCT05148299|525758972|FG000|Treatment Period|Death|1|||
145796877|NCT05148299|525758972|FG000|Follow-up Period|Death|3|||
145796878|NCT01856192|525758982|FG000|Overall Study|Adverse Event|12|||
145796879|NCT01856192|525758983|FG001|Overall Study|Adverse Event|4|||
145796880|NCT01856192|525758982|FG000|Overall Study|Alternative therapy|0|||
145796881|NCT01856192|525758983|FG001|Overall Study|Alternative therapy|3|||
145796882|NCT01856192|525758982|FG000|Overall Study|Death|3|||
145796883|NCT01856192|525758983|FG001|Overall Study|Death|5|||
145796884|NCT01856192|525758982|FG000|Overall Study|Lack of Efficacy|0|||
145796885|NCT01856192|525758983|FG001|Overall Study|Lack of Efficacy|5|||
145796886|NCT01856192|525758982|FG000|Overall Study|Withdrawal by Subject|1|||
145796887|NCT01856192|525758983|FG001|Overall Study|Withdrawal by Subject|1|||
145796888|NCT01856192|525758982|FG000|Overall Study|Other diseases|1|||
145796889|NCT01856192|525758983|FG001|Overall Study|Other diseases|0|||
145796890|NCT01856192|525758982|FG000|Overall Study|Never started treatment|7|||
145796891|NCT01856192|525758983|FG001|Overall Study|Never started treatment|5|||
145796892|NCT01856192|525758982|FG000|Overall Study|Path ineligible|20|||
145796893|NCT01856192|525758983|FG001|Overall Study|Path ineligible|34|||
145796894|NCT01856192|525758982|FG000|Overall Study|Non-path ineligible|2|||
145796895|NCT01856192|525758983|FG001|Overall Study|Non-path ineligible|2|||
145796896|NCT01856192|525758982|FG000|Overall Study|Physician Decision|1|||
145796897|NCT01856192|525758983|FG001|Overall Study|Physician Decision|1|||
145796898|NCT01856192|525758982|FG000|Overall Study|Suspicion of progressive disease|1|||
145796899|NCT01856192|525758983|FG001|Overall Study|Suspicion of progressive disease|0|||
145796900|NCT01856192|525758982|FG000|Overall Study|Non-compliance|1|||
145796901|NCT01856192|525758983|FG001|Overall Study|Non-compliance|0|||
145796902|NCT00098475|525758984|FG000|Step 1|Progressive disease|33|||
145796903|NCT00098475|525758985|FG001|Step 1|Progressive disease|35|||
145796904|NCT00098475|525758986|FG002|Step 1|Progressive disease|2|||
145796905|NCT00098475|525758987|FG003|Step 1|Progressive disease|1|||
145796906|NCT00098475|525758984|FG000|Step 1|Adverse Event|56|||
145796907|NCT00098475|525758985|FG001|Step 1|Adverse Event|37|||
145796908|NCT00098475|525758986|FG002|Step 1|Adverse Event|0|||
145796909|NCT00098475|525758987|FG003|Step 1|Adverse Event|1|||
145796910|NCT00098475|525758984|FG000|Step 1|Death|8|||
145796911|NCT00098475|525758985|FG001|Step 1|Death|5|||
145796912|NCT00098475|525758986|FG002|Step 1|Death|0|||
145796913|NCT00098475|525758987|FG003|Step 1|Death|1|||
145796914|NCT00098475|525758984|FG000|Step 1|Withdrawal by Subject|14|||
145796915|NCT00098475|525758985|FG001|Step 1|Withdrawal by Subject|11|||
145796916|NCT00098475|525758986|FG002|Step 1|Withdrawal by Subject|0|||
145796917|NCT00098475|525758987|FG003|Step 1|Withdrawal by Subject|0|||
145796918|NCT00098475|525758984|FG000|Step 1|Physician Decision|5|||
145796919|NCT00098475|525758985|FG001|Step 1|Physician Decision|2|||
145796920|NCT00098475|525758986|FG002|Step 1|Physician Decision|0|||
145796921|NCT00098475|525758987|FG003|Step 1|Physician Decision|0|||
145796922|NCT00098475|525758984|FG000|Step 1|Alternative therapy|31|||
145796923|NCT00098475|525758985|FG001|Step 1|Alternative therapy|43|||
145796924|NCT00098475|525758986|FG002|Step 1|Alternative therapy|1|||
145796925|NCT00098475|525758987|FG003|Step 1|Alternative therapy|0|||
145796926|NCT00098475|525758984|FG000|Step 1|Other disease|2|||
145796927|NCT00098475|525758985|FG001|Step 1|Other disease|1|||
145796928|NCT00098475|525758986|FG002|Step 1|Other disease|1|||
145796929|NCT00098475|525758987|FG003|Step 1|Other disease|0|||
145796930|NCT00098475|525758984|FG000|Step 1|Never started treatment|0|||
145796931|NCT00098475|525758985|FG001|Step 1|Never started treatment|2|||
145796932|NCT00098475|525758986|FG002|Step 1|Never started treatment|0|||
145796933|NCT00098475|525758987|FG003|Step 1|Never started treatment|0|||
145796934|NCT00098475|525758984|FG000|Step 1|Still on treatment as of this analysis|14|||
145796935|NCT00098475|525758985|FG001|Step 1|Still on treatment as of this analysis|27|||
145796936|NCT00098475|525758986|FG002|Step 1|Still on treatment as of this analysis|0|||
145796937|NCT00098475|525758987|FG003|Step 1|Still on treatment as of this analysis|0|||
145796938|NCT00098475|525758984|FG000|Step 1|Knee surgery|1|||
145796939|NCT00098475|525758985|FG001|Step 1|Knee surgery|0|||
145796940|NCT00098475|525758986|FG002|Step 1|Knee surgery|0|||
145796941|NCT00098475|525758987|FG003|Step 1|Knee surgery|0|||
145796942|NCT00098475|525758984|FG000|Step 1|Complications|1|||
145796943|NCT00098475|525758985|FG001|Step 1|Complications|0|||
145796944|NCT00098475|525758986|FG002|Step 1|Complications|0|||
145796945|NCT00098475|525758987|FG003|Step 1|Complications|0|||
145549148|NCT05425745|524865525|FG001|Overall Study|Did not return for end of study visit|1|||
145549149|NCT05425745|524865524|FG000|Overall Study|End of study visit completed by phone|1|||
145549150|NCT05425745|524865525|FG001|Overall Study|End of study visit completed by phone|0|||
145549151|NCT05425745|524865524|FG000|Overall Study|Subject decision|1|||
145549152|NCT05425745|524865525|FG001|Overall Study|Subject decision|0|||
145549153|NCT02700815|524866969|FG000|Overall Study|Adverse Event|0|||
145549154|NCT02700815|524866970|FG001|Overall Study|Adverse Event|6|||
145549155|NCT02700815|524866971|FG002|Overall Study|Adverse Event|2|||
145549156|NCT02700815|524866972|FG003|Overall Study|Adverse Event|3|||
145549157|NCT02700815|524866969|FG000|Overall Study|Lack of Efficacy|0|||
145549158|NCT02700815|524866970|FG001|Overall Study|Lack of Efficacy|0|||
145549159|NCT02700815|524866971|FG002|Overall Study|Lack of Efficacy|1|||
145549160|NCT02700815|524866972|FG003|Overall Study|Lack of Efficacy|2|||
145549161|NCT02700815|524866969|FG000|Overall Study|Lost to Follow-up|1|||
145549162|NCT02700815|524866970|FG001|Overall Study|Lost to Follow-up|0|||
145549163|NCT02700815|524866971|FG002|Overall Study|Lost to Follow-up|0|||
145796946|NCT00098475|525758984|FG000|Step 1|Cannot comply due to other tx|0|||
145796947|NCT00098475|525758985|FG001|Step 1|Cannot comply due to other tx|1|||
145549164|NCT02700815|524866972|FG003|Overall Study|Lost to Follow-up|1|||
145549165|NCT02700815|524866969|FG000|Overall Study|Refusal to continue medication|0|||
145549166|NCT02700815|524866970|FG001|Overall Study|Refusal to continue medication|1|||
145549167|NCT02700815|524866971|FG002|Overall Study|Refusal to continue medication|0|||
145549168|NCT02700815|524866972|FG003|Overall Study|Refusal to continue medication|1|||
145549169|NCT02700815|524866969|FG000|Overall Study|Withdrawal by Subject|0|||
145549170|NCT02700815|524866970|FG001|Overall Study|Withdrawal by Subject|0|||
145549171|NCT02700815|524866971|FG002|Overall Study|Withdrawal by Subject|1|||
145549172|NCT02700815|524866972|FG003|Overall Study|Withdrawal by Subject|0|||
145549173|NCT02239978|524866974|FG000|Overall Study|Withdrawal by Subject|2|||
145549174|NCT02239978|524866975|FG001|Overall Study|Withdrawal by Subject|0|||
145549175|NCT00793403|524866981|FG000|Overall Study|Other|73|||
145549176|NCT01752907|524866984|FG000|Overall Study|Withdrawal by Subject|4|||
145549177|NCT01752907|524866985|FG001|Overall Study|Withdrawal by Subject|10|||
145549178|NCT01752907|524866984|FG000|Overall Study|Lost to Follow-up|2|||
145549179|NCT01752907|524866985|FG001|Overall Study|Lost to Follow-up|1|||
145549180|NCT01752907|524866984|FG000|Overall Study|Decision by Sponsor|6|||
145549181|NCT01752907|524866985|FG001|Overall Study|Decision by Sponsor|9|||
145549182|NCT03098550|524866986|FG000|Overall Study|Disease Progression|30|||
145549183|NCT03098550|524866987|FG001|Overall Study|Disease Progression|19|||
145549184|NCT03098550|524866988|FG002|Overall Study|Disease Progression|41|||
145549185|NCT03098550|524866986|FG000|Overall Study|Study Drug Toxicity|2|||
145549186|NCT03098550|524866987|FG001|Overall Study|Study Drug Toxicity|1|||
145549187|NCT03098550|524866988|FG002|Overall Study|Study Drug Toxicity|0|||
145549188|NCT03098550|524866986|FG000|Overall Study|Death|1|||
145549189|NCT03098550|524866987|FG001|Overall Study|Death|0|||
145549190|NCT03098550|524866988|FG002|Overall Study|Death|0|||
145549191|NCT03098550|524866986|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
145549192|NCT03098550|524866987|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
145549193|NCT03098550|524866988|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
145549194|NCT03098550|524866986|FG000|Overall Study|Administrative reason by sponsor|0|||
145549195|NCT03098550|524866987|FG001|Overall Study|Administrative reason by sponsor|0|||
145549196|NCT03098550|524866988|FG002|Overall Study|Administrative reason by sponsor|1|||
145549197|NCT03098550|524866986|FG000|Overall Study|Other reasons|2|||
145549198|NCT03098550|524866987|FG001|Overall Study|Other reasons|0|||
145549199|NCT03098550|524866988|FG002|Overall Study|Other reasons|0|||
145549200|NCT01384760|524866989|FG000|Overall Study|Lost to Follow-up|0|||
145549201|NCT01384760|524866990|FG001|Overall Study|Lost to Follow-up|6|||
145549202|NCT01384760|524866989|FG000|Overall Study|Protocol Violation|16|||
145549203|NCT01384760|524866990|FG001|Overall Study|Protocol Violation|0|||
145796948|NCT00098475|525758986|FG002|Step 1|Cannot comply due to other tx|0|||
145796949|NCT00098475|525758987|FG003|Step 1|Cannot comply due to other tx|0|||
145549204|NCT02989194|524866997|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
145549205|NCT02989194|524866998|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
145549206|NCT02989194|524866999|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
145549207|NCT02989194|524866997|FG000|Overall Study|Lost to Follow-up|0|||
145796950|NCT00098475|525758984|FG000|Step 1|Both patient and physician's decision|2|||
145549208|NCT02989194|524866998|FG001|Overall Study|Lost to Follow-up|1|||
145549209|NCT02989194|524866999|FG002|Overall Study|Lost to Follow-up|0|||
145549210|NCT02989194|524866997|FG000|Overall Study|Withdrawal by Subject|0|||
145549211|NCT02989194|524866998|FG001|Overall Study|Withdrawal by Subject|1|||
145549212|NCT02989194|524866999|FG002|Overall Study|Withdrawal by Subject|0|||
145549213|NCT02692716|524867003|FG000|Overall Study|Lost to Follow-up|2|||
145549214|NCT02692716|524867004|FG001|Overall Study|Lost to Follow-up|5|||
145549215|NCT02692716|524867003|FG000|Overall Study|Withdrawal by Subject|3|||
145549216|NCT02692716|524867004|FG001|Overall Study|Withdrawal by Subject|1|||
145549217|NCT02511184|524867008|FG000|Overall Study|Death|1|||
145549218|NCT02511184|524867009|FG001|Overall Study|Death|0|||
145549219|NCT02511184|524867008|FG000|Overall Study|Lost to Follow-up|0|||
145796951|NCT00098475|525758985|FG001|Step 1|Both patient and physician's decision|1|||
145549220|NCT02511184|524867009|FG001|Overall Study|Lost to Follow-up|1|||
145549221|NCT02511184|524867008|FG000|Overall Study|Study terminated by sponsor|1|||
145549222|NCT02511184|524867009|FG001|Overall Study|Study terminated by sponsor|5|||
145549223|NCT02511184|524867008|FG000|Overall Study|Withdrawal by Subject|0|||
145549224|NCT02511184|524867009|FG001|Overall Study|Withdrawal by Subject|1|||
145549225|NCT04271605|524867010|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
145549226|NCT02041286|524867011|FG000|Overall Study|Adverse Event|1|||
145549227|NCT03138889|524867016|FG000|Overall Study|Withdrawal by Subject|5|||
145549228|NCT03138889|524867017|FG001|Overall Study|Withdrawal by Subject|5|||
145549229|NCT03138889|524867018|FG002|Overall Study|Withdrawal by Subject|0|||
145549230|NCT03138889|524867019|FG003|Overall Study|Withdrawal by Subject|2|||
145549231|NCT03138889|524867020|FG004|Overall Study|Withdrawal by Subject|1|||
145549232|NCT03138889|524867021|FG005|Overall Study|Withdrawal by Subject|3|||
145549233|NCT03138889|524867022|FG006|Overall Study|Withdrawal by Subject|0|||
145549234|NCT03138889|524867023|FG007|Overall Study|Withdrawal by Subject|1|||
145549235|NCT00105482|524867024|FG000|Overall Study|Adverse Event|1|||
145549236|NCT00105482|524867025|FG001|Overall Study|Adverse Event|1|||
145549237|NCT00105482|524867024|FG000|Overall Study|Lost to Follow-up|26|||
145549238|NCT00105482|524867025|FG001|Overall Study|Lost to Follow-up|17|||
145549239|NCT00105482|524867024|FG000|Overall Study|Withdrawal by Subject|0|||
145549240|NCT00105482|524867025|FG001|Overall Study|Withdrawal by Subject|1|||
145549241|NCT00105482|524867024|FG000|Overall Study|Lost Interest|29|||
145549242|NCT00105482|524867025|FG001|Overall Study|Lost Interest|32|||
145549243|NCT00105482|524867024|FG000|Overall Study|Scheduling Conflict|2|||
145549244|NCT00105482|524867025|FG001|Overall Study|Scheduling Conflict|3|||
145549245|NCT00105482|524867024|FG000|Overall Study|Withdrawn by PI|1|||
145549246|NCT00105482|524867025|FG001|Overall Study|Withdrawn by PI|1|||
145549247|NCT01349790|524867026|FG000|Overall Study|Investigator Judgement|3|||
145549248|NCT01349790|524867026|FG000|Overall Study|Death|2|||
145549249|NCT01349790|524867026|FG000|Overall Study|Withdrawal by Patient|2|||
145549250|NCT01349790|524867026|FG000|Overall Study|Adverse Event|1|||
145549251|NCT01349790|524867026|FG000|Overall Study|Lost to Follow-up|1|||
145549252|NCT04016285|524867027|FG000|Overall Study|Did not progress to surgery|2|||
145549253|NCT04016285|524867028|FG001|Overall Study|Did not progress to surgery|5|||
145549254|NCT04016285|524867027|FG000|Overall Study|Failed to collect outcome data|5|||
145549255|NCT04016285|524867028|FG001|Overall Study|Failed to collect outcome data|3|||
145549256|NCT00284050|524867029|FG000|Overall Study|Adverse Event|1|||
145549257|NCT00284050|524867030|FG001|Overall Study|Adverse Event|1|||
145549258|NCT00284050|524867031|FG002|Overall Study|Adverse Event|1|||
145549259|NCT00284050|524867029|FG000|Overall Study|Lack of Efficacy|0|||
145549260|NCT00284050|524867030|FG001|Overall Study|Lack of Efficacy|1|||
145549261|NCT00284050|524867031|FG002|Overall Study|Lack of Efficacy|3|||
145549262|NCT00284050|524867029|FG000|Overall Study|Protocol Violation|0|||
145549263|NCT00284050|524867030|FG001|Overall Study|Protocol Violation|1|||
145549264|NCT00284050|524867031|FG002|Overall Study|Protocol Violation|2|||
145549265|NCT00284050|524867029|FG000|Overall Study|Withdrawal by Subject|2|||
145796952|NCT00098475|525758986|FG002|Step 1|Both patient and physician's decision|0|||
145796953|NCT00098475|525758987|FG003|Step 1|Both patient and physician's decision|0|||
145796954|NCT00098475|525758984|FG000|Step 1|Incorrect disease assessment|2|||
145796955|NCT00098475|525758985|FG001|Step 1|Incorrect disease assessment|0|||
145796956|NCT00098475|525758986|FG002|Step 1|Incorrect disease assessment|0|||
145796957|NCT00098475|525758987|FG003|Step 1|Incorrect disease assessment|0|||
145796958|NCT00098475|525758984|FG000|Step 1|Off treatment for > specified timeframe|1|||
145549266|NCT00284050|524867030|FG001|Overall Study|Withdrawal by Subject|2|||
145549267|NCT00284050|524867031|FG002|Overall Study|Withdrawal by Subject|2|||
145796959|NCT00098475|525758985|FG001|Step 1|Off treatment for > specified timeframe|1|||
145549268|NCT00284050|524867029|FG000|Overall Study|Lost to Follow-up|1|||
145549269|NCT00284050|524867030|FG001|Overall Study|Lost to Follow-up|0|||
145549270|NCT00284050|524867031|FG002|Overall Study|Lost to Follow-up|1|||
145549271|NCT00284050|524867029|FG000|Overall Study|Death|1|||
145549272|NCT00284050|524867030|FG001|Overall Study|Death|0|||
145549273|NCT00284050|524867031|FG002|Overall Study|Death|0|||
145549274|NCT01750242|524867034|FG000|Overall Study|Unreadable Images|3|||
145549275|NCT03765918|524867035|FG000|Overall Study|Death|109|||
145549276|NCT03765918|524867036|FG001|Overall Study|Death|127|||
145549277|NCT03765918|524867035|FG000|Overall Study|Lost to Follow-up|2|||
145549278|NCT03765918|524867036|FG001|Overall Study|Lost to Follow-up|3|||
145549279|NCT03765918|524867035|FG000|Overall Study|Withdrawal by Subject|12|||
145549280|NCT03765918|524867036|FG001|Overall Study|Withdrawal by Subject|16|||
145549281|NCT03765918|524867035|FG000|Overall Study|Participants Ongoing|240|||
145549282|NCT03765918|524867036|FG001|Overall Study|Participants Ongoing|205|||
145549283|NCT04202965|524867037|FG000|Overall Study|Adverse Event|3|||
145549284|NCT04202965|524867037|FG000|Overall Study|Did not meet inclusion criteria|1|||
145549285|NCT00006903|524867038|FG000|Overall Study|Still receiving treatment|0|||
145549286|NCT00006903|524867039|FG001|Overall Study|Still receiving treatment|0|||
145549287|NCT00006903|524867040|FG002|Overall Study|Still receiving treatment|1|||
145549288|NCT00006903|524867038|FG000|Overall Study|Refused further treatment|0|||
145549289|NCT00006903|524867039|FG001|Overall Study|Refused further treatment|2|||
145549290|NCT00006903|524867040|FG002|Overall Study|Refused further treatment|1|||
145796960|NCT00098475|525758986|FG002|Step 1|Off treatment for > specified timeframe|0|||
145796961|NCT00098475|525758987|FG003|Step 1|Off treatment for > specified timeframe|0|||
145796962|NCT00098475|525758984|FG000|Step 1|Declining performance status|0|||
145796963|NCT00098475|525758985|FG001|Step 1|Declining performance status|1|||
145796964|NCT00098475|525758986|FG002|Step 1|Declining performance status|0|||
145796965|NCT00098475|525758987|FG003|Step 1|Declining performance status|0|||
145796966|NCT00098475|525758984|FG000|Step 1|Insurance issue|0|||
145796967|NCT00098475|525758985|FG001|Step 1|Insurance issue|1|||
145796968|NCT00098475|525758986|FG002|Step 1|Insurance issue|0|||
145796969|NCT00098475|525758987|FG003|Step 1|Insurance issue|0|||
145796970|NCT00098475|525758984|FG000|Step 1|Rising paraprotein|0|||
145796971|NCT00098475|525758985|FG001|Step 1|Rising paraprotein|1|||
145796972|NCT00098475|525758986|FG002|Step 1|Rising paraprotein|0|||
145796973|NCT00098475|525758987|FG003|Step 1|Rising paraprotein|0|||
145796974|NCT00098475|525758984|FG000|Step 1|Referred to other physicians|0|||
145796975|NCT00098475|525758985|FG001|Step 1|Referred to other physicians|1|||
145796976|NCT00098475|525758986|FG002|Step 1|Referred to other physicians|0|||
145796977|NCT00098475|525758987|FG003|Step 1|Referred to other physicians|0|||
145796978|NCT00098475|525758984|FG000|Step 1|Criteria to continue treatment not met|0|||
145796979|NCT00098475|525758985|FG001|Step 1|Criteria to continue treatment not met|1|||
145796980|NCT00098475|525758986|FG002|Step 1|Criteria to continue treatment not met|0|||
145796981|NCT00098475|525758987|FG003|Step 1|Criteria to continue treatment not met|0|||
145796982|NCT00098475|525758984|FG000|Step 1|Misinterpretation of lab data|0|||
145796983|NCT00098475|525758985|FG001|Step 1|Misinterpretation of lab data|1|||
145796984|NCT00098475|525758986|FG002|Step 1|Misinterpretation of lab data|0|||
145796985|NCT00098475|525758987|FG003|Step 1|Misinterpretation of lab data|0|||
145796986|NCT00098475|525758984|FG000|Step 1|Patient fell with fracture|1|||
145796987|NCT00098475|525758985|FG001|Step 1|Patient fell with fracture|0|||
145796988|NCT00098475|525758986|FG002|Step 1|Patient fell with fracture|0|||
145796989|NCT00098475|525758987|FG003|Step 1|Patient fell with fracture|0|||
145796990|NCT00098475|525758984|FG000|Step 1|Not documented|0|||
145796991|NCT00098475|525758985|FG001|Step 1|Not documented|1|||
145796992|NCT00098475|525758986|FG002|Step 1|Not documented|0|||
145796993|NCT00098475|525758987|FG003|Step 1|Not documented|0|||
145796994|NCT00098475|525758984|FG000|Step 2|Disease progression|1|||
145796995|NCT00098475|525758985|FG001|Step 2|Disease progression|4|||
145796996|NCT00098475|525758986|FG002|Step 2|Disease progression|0|||
145796997|NCT00098475|525758987|FG003|Step 2|Disease progression|0|||
145549291|NCT00006903|524867038|FG000|Overall Study|Adverse Event|0|||
145549292|NCT00006903|524867039|FG001|Overall Study|Adverse Event|0|||
145549293|NCT00006903|524867040|FG002|Overall Study|Adverse Event|1|||
145549294|NCT00006903|524867038|FG000|Overall Study|Death|0|||
145549295|NCT00006903|524867039|FG001|Overall Study|Death|1|||
145549296|NCT00006903|524867040|FG002|Overall Study|Death|0|||
145549297|NCT00006903|524867038|FG000|Overall Study|Patient never treated|0|||
145549298|NCT00006903|524867039|FG001|Overall Study|Patient never treated|0|||
145549299|NCT00006903|524867040|FG002|Overall Study|Patient never treated|1|||
145549300|NCT00006903|524867038|FG000|Overall Study|Ineligible|10|||
145549301|NCT00006903|524867039|FG001|Overall Study|Ineligible|1|||
145549302|NCT00006903|524867040|FG002|Overall Study|Ineligible|2|||
145796998|NCT00098475|525758984|FG000|Step 2|Adverse Event|2|||
145796999|NCT00098475|525758985|FG001|Step 2|Adverse Event|0|||
145549303|NCT01909674|524867041|FG000|Overall Study|Withdrawal by Subject|5|||
145611242|NCT03661996|525092637|FG004|Overall Study|Withdrawal by Subject|7|||
145797000|NCT00098475|525758986|FG002|Step 2|Adverse Event|0|||
145282872|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
145282873|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
145282874|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
145549304|NCT01909674|524867042|FG001|Overall Study|Withdrawal by Subject|2|||
145549305|NCT02969369|524867043|FG000|Study|Adverse Event|1|||
145797001|NCT00098475|525758987|FG003|Step 2|Adverse Event|0|||
145797002|NCT00098475|525758984|FG000|Step 2|Withdrawal by Subject|0|||
145797003|NCT00098475|525758985|FG001|Step 2|Withdrawal by Subject|2|||
145797004|NCT00098475|525758986|FG002|Step 2|Withdrawal by Subject|0|||
145549306|NCT02969369|524867044|FG001|Study|Adverse Event|6|||
145549307|NCT02969369|524867043|FG000|Study|Lack of Efficacy|0|||
145549308|NCT02969369|524867044|FG001|Study|Lack of Efficacy|1|||
145549309|NCT02969369|524867043|FG000|Study|Lost to Follow-up|0|||
145549310|NCT02969369|524867044|FG001|Study|Lost to Follow-up|1|||
145549311|NCT02969369|524867043|FG000|Study|Withdrawal by Subject|3|||
145549312|NCT02969369|524867044|FG001|Study|Withdrawal by Subject|5|||
145549313|NCT02969369|524867043|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
145797005|NCT00098475|525758987|FG003|Step 2|Withdrawal by Subject|0|||
145797006|NCT00098475|525758984|FG000|Step 2|Physician Decision|0|||
145797007|NCT00098475|525758985|FG001|Step 2|Physician Decision|1|||
145797008|NCT00098475|525758986|FG002|Step 2|Physician Decision|0|||
145797009|NCT00098475|525758987|FG003|Step 2|Physician Decision|0|||
145797010|NCT00098475|525758984|FG000|Step 2|Alternative therapy|1|||
145797011|NCT00098475|525758985|FG001|Step 2|Alternative therapy|2|||
145797012|NCT00098475|525758986|FG002|Step 2|Alternative therapy|0|||
145797013|NCT00098475|525758987|FG003|Step 2|Alternative therapy|0|||
145797014|NCT00098475|525758984|FG000|Step 2|Never started treatment|1|||
145797015|NCT00098475|525758985|FG001|Step 2|Never started treatment|1|||
145797016|NCT00098475|525758986|FG002|Step 2|Never started treatment|0|||
145797017|NCT00098475|525758987|FG003|Step 2|Never started treatment|0|||
145797018|NCT06964165|525758988|FG000|Overall Study|Death|4|||
145797019|NCT06964165|525758989|FG001|Overall Study|Death|4|||
145797020|NCT06964165|525758988|FG000|Overall Study|Physician Decision|1|||
145797021|NCT06964165|525758989|FG001|Overall Study|Physician Decision|1|||
145797022|NCT06964165|525758988|FG000|Overall Study|Withdrawal by Subject|0|||
145797023|NCT06964165|525758989|FG001|Overall Study|Withdrawal by Subject|2|||
145797024|NCT06964165|525758988|FG000|Overall Study|Study terminated by sponsor|12|||
145797025|NCT06964165|525758989|FG001|Overall Study|Study terminated by sponsor|10|||
145797026|NCT06964165|525758988|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
145797027|NCT06964165|525758989|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
145797028|NCT06964165|525758988|FG000|Overall Study|Participant removed due to non-compliance|0|||
145797029|NCT06964165|525758989|FG001|Overall Study|Participant removed due to non-compliance|1|||
145797030|NCT06245044|525758990|FG000|No MI help|Technical issues|18|||
145797031|NCT04735393|525758994|FG000|Overall Study|Lost to Follow-up|46|||
145797032|NCT04735393|525758995|FG001|Overall Study|Lost to Follow-up|24|||
145797033|NCT04735393|525758994|FG000|Overall Study|Physician Decision|2|||
145797034|NCT04735393|525758995|FG001|Overall Study|Physician Decision|1|||
145797035|NCT04735393|525758994|FG000|Overall Study|Not Detailed|1|||
145797036|NCT04735393|525758995|FG001|Overall Study|Not Detailed|2|||
145797037|NCT04735393|525758994|FG000|Overall Study|Withdrawal by Subject|71|||
145797038|NCT04735393|525758995|FG001|Overall Study|Withdrawal by Subject|28|||
145797039|NCT04735393|525758994|FG000|Overall Study|Adverse Event|56|||
145797040|NCT04735393|525758995|FG001|Overall Study|Adverse Event|7|||
145797041|NCT04735393|525758994|FG000|Overall Study|Protocol Violation|6|||
145797042|NCT04735393|525758995|FG001|Overall Study|Protocol Violation|1|||
145797043|NCT04735393|525758994|FG000|Overall Study|Trial terminated by Sponsor|49|||
145549314|NCT02969369|524867044|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
145549315|NCT02969369|524867043|FG000|Double-blind Period|Adverse Event|1|||
145549316|NCT02969369|524867044|FG001|Double-blind Period|Adverse Event|5|||
145549317|NCT02969369|524867043|FG000|Double-blind Period|Lost to Follow-up|0|||
145549318|NCT02969369|524867044|FG001|Double-blind Period|Lost to Follow-up|1|||
145549319|NCT02969369|524867043|FG000|Double-blind Period|Withdrawal by Subject|2|||
145549320|NCT02969369|524867044|FG001|Double-blind Period|Withdrawal by Subject|3|||
145549321|NCT02969369|524867043|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
145549322|NCT02969369|524867044|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
145549323|NCT02969369|524867043|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
145549324|NCT02969369|524867044|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
145549325|NCT02969369|524867043|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
145797044|NCT04735393|525758995|FG001|Overall Study|Trial terminated by Sponsor|29|||
145797045|NCT03224104|525758997|FG000|Overall Study|Lack of Efficacy|2|||
145797046|NCT03224104|525758998|FG001|Overall Study|Lack of Efficacy|6|||
145797047|NCT03224104|525758999|FG002|Overall Study|Lack of Efficacy|3|||
145797048|NCT03224104|525759000|FG003|Overall Study|Lack of Efficacy|4|||
145797049|NCT03224104|525759001|FG004|Overall Study|Lack of Efficacy|42|||
145282875|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
145282876|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
145282877|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
145405023|NCT01288430|524340089|FG006|Part 1|Progressive disease|2|||
145549326|NCT02969369|524867044|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
145549327|NCT02969369|524867043|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
145549328|NCT02969369|524867044|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
145797050|NCT03224104|525758997|FG000|Overall Study|Withdrawal by Subject|0|||
145797051|NCT03224104|525758998|FG001|Overall Study|Withdrawal by Subject|2|||
145797052|NCT03224104|525758999|FG002|Overall Study|Withdrawal by Subject|0|||
145797053|NCT03224104|525759000|FG003|Overall Study|Withdrawal by Subject|1|||
145797054|NCT03224104|525759001|FG004|Overall Study|Withdrawal by Subject|3|||
145797055|NCT03224104|525758997|FG000|Overall Study|Death|0|||
145797056|NCT03224104|525758998|FG001|Overall Study|Death|1|||
145797057|NCT03224104|525758999|FG002|Overall Study|Death|0|||
145797058|NCT03224104|525759000|FG003|Overall Study|Death|0|||
145797059|NCT03224104|525759001|FG004|Overall Study|Death|0|||
145797060|NCT03224104|525758997|FG000|Overall Study|Adverse Event|1|||
145797061|NCT03224104|525758998|FG001|Overall Study|Adverse Event|0|||
145797062|NCT03224104|525758999|FG002|Overall Study|Adverse Event|0|||
145797063|NCT03224104|525759000|FG003|Overall Study|Adverse Event|1|||
145797064|NCT03224104|525759001|FG004|Overall Study|Adverse Event|3|||
145797065|NCT03224104|525758997|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
145797066|NCT03224104|525758998|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
145797067|NCT03224104|525758999|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
145797068|NCT03224104|525759000|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
145797069|NCT03224104|525759001|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
145797070|NCT03224104|525758997|FG000|Overall Study|Treatment ongoing|0|||
145797071|NCT03224104|525758998|FG001|Overall Study|Treatment ongoing|0|||
145797072|NCT03224104|525758999|FG002|Overall Study|Treatment ongoing|0|||
145797073|NCT03224104|525759000|FG003|Overall Study|Treatment ongoing|0|||
145797074|NCT03224104|525759001|FG004|Overall Study|Treatment ongoing|1|||
145797075|NCT03422068|525759002|FG000|Overall Study|Adverse Event|0|||
145797076|NCT03422068|525759003|FG001|Overall Study|Adverse Event|1|||
145797077|NCT03422068|525759002|FG000|Overall Study|Inconvenience to frequent study visits|0|||
145797078|NCT03422068|525759003|FG001|Overall Study|Inconvenience to frequent study visits|1|||
145797079|NCT05025787|525759004|FG000|Overall Study|Lack of Efficacy|0|||
145797080|NCT05025787|525759005|FG001|Overall Study|Lack of Efficacy|1|||
145797081|NCT05025787|525759004|FG000|Overall Study|Adverse Event|2|||
145797082|NCT05025787|525759005|FG001|Overall Study|Adverse Event|4|||
145797083|NCT05025787|525759004|FG000|Overall Study|Non compliance|0|||
145797084|NCT05025787|525759005|FG001|Overall Study|Non compliance|1|||
145797085|NCT05025787|525759004|FG000|Overall Study|Protocol Violation|3|||
145797086|NCT05025787|525759005|FG001|Overall Study|Protocol Violation|1|||
145797087|NCT05025787|525759004|FG000|Overall Study|Stopping criteria met|1|||
145797088|NCT05025787|525759005|FG001|Overall Study|Stopping criteria met|1|||
145797089|NCT05025787|525759004|FG000|Overall Study|Withdrawal by Subject|3|||
145797090|NCT05025787|525759005|FG001|Overall Study|Withdrawal by Subject|1|||
145797091|NCT05600309|525759009|FG000|Overall Study|Death|41|||
145797092|NCT05600309|525759010|FG001|Overall Study|Death|38|||
145797093|NCT05600309|525759009|FG000|Overall Study|Sponsor Decision|9|||
145797094|NCT05600309|525759010|FG001|Overall Study|Sponsor Decision|6|||
145797095|NCT06087328|525759013|FG000|28-Day Treatment|Lost to Follow-up|7|||
145797096|NCT06087328|525759014|FG001|28-Day Treatment|Lost to Follow-up|3|||
145797097|NCT06087328|525759015|FG002|28-Day Treatment|Lost to Follow-up|4|||
145797098|NCT06087328|525759013|FG000|1-month Follow-up|Lost to Follow-up|0|||
145797099|NCT06087328|525759014|FG001|1-month Follow-up|Lost to Follow-up|1|||
145797100|NCT06087328|525759015|FG002|1-month Follow-up|Lost to Follow-up|1|||
145797101|NCT06128525|525759018|FG000|Overall Study|Patient withdrew consent|1|||
145797102|NCT05822830|525759019|FG000|Overall Study|Adverse Event|6|||
145797103|NCT05822830|525759020|FG001|Overall Study|Adverse Event|6|||
145797104|NCT05822830|525759019|FG000|Overall Study|Assigned Treatment by Mistake|5|||
145797105|NCT05822830|525759020|FG001|Overall Study|Assigned Treatment by Mistake|3|||
145549329|NCT01169493|524867052|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
145549330|NCT01169493|524867053|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
145549331|NCT01169493|524867054|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
145549332|NCT01169493|524867055|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
145549333|NCT01169493|524867056|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
145549334|NCT01169493|524867057|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
145549335|NCT01169493|524867052|FG000|Period 3 (6 Months)|Adverse Event|0|||
145549336|NCT01169493|524867053|FG001|Period 3 (6 Months)|Adverse Event|1|||
145797106|NCT05822830|525759019|FG000|Overall Study|Lost to Follow-up|16|||
145797107|NCT05822830|525759020|FG001|Overall Study|Lost to Follow-up|18|||
145797108|NCT05822830|525759019|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145549337|NCT01169493|524867054|FG002|Period 3 (6 Months)|Adverse Event|0|||
145797109|NCT05822830|525759020|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145797110|NCT05822830|525759019|FG000|Overall Study|Participant was Out of the Country|0|||
145549338|NCT01169493|524867055|FG003|Period 3 (6 Months)|Adverse Event|0|||
145549339|NCT01169493|524867056|FG004|Period 3 (6 Months)|Adverse Event|0|||
145549340|NCT01169493|524867057|FG005|Period 3 (6 Months)|Adverse Event|0|||
145549341|NCT01169493|524867052|FG000|Period 3 (6 Months)|Physician Decision|0|||
145797111|NCT05822830|525759020|FG001|Overall Study|Participant was Out of the Country|1|||
145797112|NCT05822830|525759019|FG000|Overall Study|Pregnancy|1|||
145797113|NCT05822830|525759020|FG001|Overall Study|Pregnancy|2|||
145797114|NCT05822830|525759019|FG000|Overall Study|Withdrawal by Subject|27|||
145797115|NCT05822830|525759020|FG001|Overall Study|Withdrawal by Subject|26|||
145797116|NCT03201965|525759713|FG000|Overall Study|Death|5|||
145797117|NCT03201965|525759714|FG001|Overall Study|Death|65|||
145797118|NCT03201965|525759715|FG002|Overall Study|Death|47|||
145797119|NCT03201965|525759713|FG000|Overall Study|Lost to Follow-up|0|||
145797120|NCT03201965|525759714|FG001|Overall Study|Lost to Follow-up|6|||
145797121|NCT03201965|525759715|FG002|Overall Study|Lost to Follow-up|0|||
145282878|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
145282879|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
145282880|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
145282881|NCT00529568|523884404|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
145282882|NCT00529568|523884405|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
145282883|NCT00529568|523884406|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
145282884|NCT00529568|523884404|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
145282885|NCT00529568|523884405|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
145282886|NCT00529568|523884406|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
145282887|NCT00529568|523884404|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
145282888|NCT00529568|523884405|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
145282889|NCT00529568|523884406|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
145282890|NCT00529568|523884404|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
145405024|NCT01288430|524340090|FG007|Part 1|Progressive disease|0|||
145405025|NCT01288430|524340091|FG008|Part 1|Progressive disease|0|||
145405026|NCT01288430|524340092|FG009|Part 1|Progressive disease|0|||
145549342|NCT01169493|524867053|FG001|Period 3 (6 Months)|Physician Decision|1|||
145549343|NCT01169493|524867054|FG002|Period 3 (6 Months)|Physician Decision|1|||
145549344|NCT01169493|524867055|FG003|Period 3 (6 Months)|Physician Decision|0|||
145549345|NCT01169493|524867056|FG004|Period 3 (6 Months)|Physician Decision|0|||
145549346|NCT01169493|524867057|FG005|Period 3 (6 Months)|Physician Decision|0|||
145549347|NCT03167411|524867058|FG000|Overall Study|Adverse Event|0|||
145549348|NCT03167411|524867059|FG001|Overall Study|Adverse Event|1|||
145549349|NCT02651922|524867066|FG000|Overall Study|due to exclusion criteria|2|||
145549350|NCT01366209|524867067|FG000|Overall Study|Adverse Event|6|||
145549351|NCT01366209|524867068|FG001|Overall Study|Adverse Event|7|||
145549352|NCT01366209|524867067|FG000|Overall Study|Withdrawal by Subject|4|||
145549353|NCT01366209|524867068|FG001|Overall Study|Withdrawal by Subject|4|||
145549354|NCT01366209|524867067|FG000|Overall Study|Death|12|||
145549355|NCT01366209|524867068|FG001|Overall Study|Death|19|||
145549356|NCT01366209|524867067|FG000|Overall Study|Lung transplantation|6|||
145549357|NCT01366209|524867068|FG001|Overall Study|Lung transplantation|1|||
145549358|NCT01366209|524867067|FG000|Overall Study|Lost to Follow-up|2|||
145549359|NCT01366209|524867068|FG001|Overall Study|Lost to Follow-up|1|||
145549360|NCT01366209|524867067|FG000|Overall Study|Physician Decision|1|||
145549361|NCT01366209|524867068|FG001|Overall Study|Physician Decision|0|||
145549362|NCT01366209|524867067|FG000|Overall Study|Sponsors decision|0|||
145549363|NCT01366209|524867068|FG001|Overall Study|Sponsors decision|1|||
145549364|NCT01366209|524867067|FG000|Overall Study|Withdrew consent|4|||
145549365|NCT01366209|524867068|FG001|Overall Study|Withdrew consent|3|||
145549366|NCT01053221|524867069|FG000|Overall Study|The study was closed prematurely|5|||
145549367|NCT01053221|524867070|FG001|Overall Study|The study was closed prematurely|9|||
145549368|NCT02246660|524867071|FG000|Overall Study|Withdrawal by Subject|0|||
145549369|NCT02246660|524867072|FG001|Overall Study|Withdrawal by Subject|1|||
145549370|NCT02246660|524867073|FG002|Overall Study|Withdrawal by Subject|0|||
145549371|NCT02246660|524867071|FG000|Overall Study|Death|0|||
145549372|NCT02246660|524867072|FG001|Overall Study|Death|0|||
145549373|NCT02246660|524867073|FG002|Overall Study|Death|1|||
145549374|NCT02557646|524867076|FG000|Overall Study|Adverse Event|40|||
145549375|NCT02557646|524867076|FG000|Overall Study|Death|1|||
145549376|NCT02557646|524867076|FG000|Overall Study|Lack of Efficacy|186|||
145549377|NCT02557646|524867076|FG000|Overall Study|Withdrawal by Subject|18|||
145549378|NCT02557646|524867076|FG000|Overall Study|Lost to Follow-up|17|||
145549379|NCT02557646|524867076|FG000|Overall Study|Other|14|||
145549380|NCT01637272|524867080|FG000|Overall Study|Adverse Event|6|||
145549381|NCT01637272|524867080|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145797122|NCT03201965|525759713|FG000|Overall Study|Withdrawal by Subject|3|||
145797123|NCT03201965|525759714|FG001|Overall Study|Withdrawal by Subject|23|||
145797124|NCT03201965|525759715|FG002|Overall Study|Withdrawal by Subject|8|||
145282891|NCT00529568|523884405|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
145405027|NCT01288430|524340083|FG000|Part 1|Clinical disease progression|0|||
145549382|NCT01637272|524867080|FG000|Overall Study|Withdrawal by Subject|3|||
145549383|NCT01637272|524867080|FG000|Overall Study|Lost to Follow-up|2|||
145549384|NCT01637272|524867080|FG000|Overall Study|completed core, did not enter ext. phase|4|||
145549385|NCT01637272|524867080|FG000|Overall Study|Administrative problems|1|||
145549386|NCT01637272|524867080|FG000|Overall Study|Protocol Violation|2|||
145549387|NCT01496612|524867081|FG000|1st Intervention|Adverse Event|1|||
145797125|NCT03201965|525759713|FG000|Overall Study|Sponsor's Decision|20|||
145797126|NCT03201965|525759714|FG001|Overall Study|Sponsor's Decision|99|||
145797127|NCT03201965|525759715|FG002|Overall Study|Sponsor's Decision|140|||
145797128|NCT03368664|525759716|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
145797129|NCT03368664|525759716|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
145797130|NCT03368664|525759716|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
145797131|NCT03368664|525759716|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
145797132|NCT03589326|525759724|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
145797133|NCT03589326|525759725|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
145797134|NCT03589326|525759724|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
145797135|NCT03589326|525759725|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
145797136|NCT03589326|525759724|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
145797137|NCT03589326|525759725|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
145797138|NCT03589326|525759724|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
145797139|NCT03589326|525759725|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
145797140|NCT03589326|525759724|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
145797141|NCT03589326|525759725|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
145797142|NCT03566238|525759726|FG000|Overall Study|Adverse Event|0|||
145797143|NCT03566238|525759727|FG001|Overall Study|Adverse Event|0|||
145797144|NCT03566238|525759728|FG002|Overall Study|Adverse Event|1|||
145797145|NCT03566238|525759726|FG000|Overall Study|Lack of Efficacy|5|||
145797146|NCT03566238|525759727|FG001|Overall Study|Lack of Efficacy|4|||
145797147|NCT03566238|525759728|FG002|Overall Study|Lack of Efficacy|2|||
145797148|NCT03566238|525759726|FG000|Overall Study|Other|0|||
145797149|NCT03566238|525759727|FG001|Overall Study|Other|1|||
145797150|NCT03566238|525759728|FG002|Overall Study|Other|0|||
145797151|NCT05441592|525759729|FG000|Overall Study|Lost to Follow-up|1|||
145797152|NCT05441592|525759730|FG001|Overall Study|Lost to Follow-up|5|||
145797153|NCT01371981|525759731|FG000|Overall Study|Adverse Event|12|||
145797154|NCT01371981|525759732|FG001|Overall Study|Adverse Event|17|||
145797155|NCT01371981|525759733|FG002|Overall Study|Adverse Event|0|||
145797156|NCT01371981|525759734|FG003|Overall Study|Adverse Event|4|||
145797157|NCT01371981|525759735|FG004|Overall Study|Adverse Event|1|||
145797158|NCT01371981|525759736|FG005|Overall Study|Adverse Event|0|||
145797159|NCT01371981|525759731|FG000|Overall Study|Death|22|||
145797160|NCT01371981|525759732|FG001|Overall Study|Death|16|||
145797161|NCT01371981|525759733|FG002|Overall Study|Death|0|||
145797162|NCT01371981|525759734|FG003|Overall Study|Death|0|||
145797163|NCT01371981|525759735|FG004|Overall Study|Death|2|||
145797164|NCT01371981|525759736|FG005|Overall Study|Death|2|||
145797165|NCT01371981|525759731|FG000|Overall Study|Lack of Efficacy|69|||
145797166|NCT01371981|525759732|FG001|Overall Study|Lack of Efficacy|61|||
145797167|NCT01371981|525759733|FG002|Overall Study|Lack of Efficacy|4|||
145797168|NCT01371981|525759734|FG003|Overall Study|Lack of Efficacy|8|||
145797169|NCT01371981|525759735|FG004|Overall Study|Lack of Efficacy|5|||
145797170|NCT01371981|525759736|FG005|Overall Study|Lack of Efficacy|0|||
145797171|NCT01371981|525759731|FG000|Overall Study|Physician Decision|48|||
145797172|NCT01371981|525759732|FG001|Overall Study|Physician Decision|63|||
145797173|NCT01371981|525759733|FG002|Overall Study|Physician Decision|1|||
145797174|NCT01371981|525759734|FG003|Overall Study|Physician Decision|7|||
145797175|NCT01371981|525759735|FG004|Overall Study|Physician Decision|14|||
145797176|NCT01371981|525759736|FG005|Overall Study|Physician Decision|3|||
145797177|NCT01371981|525759731|FG000|Overall Study|Withdrawal by Subject|12|||
145549388|NCT01496612|524867082|FG001|1st Intervention|Adverse Event|0|||
145549389|NCT01496612|524867081|FG000|1st Intervention|Withdrawal by Subject|1|||
145549390|NCT01496612|524867082|FG001|1st Intervention|Withdrawal by Subject|0|||
145549391|NCT01666782|524867083|FG000|Overall Study|Received 2 doses of vaccine|0|||
145549392|NCT01666782|524867084|FG001|Overall Study|Received 2 doses of vaccine|1|||
145549393|NCT01666782|524867083|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
145549394|NCT01666782|524867084|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
145549395|NCT01482884|524867106|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
145549396|NCT01482884|524867107|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
145549397|NCT01482884|524867106|FG000|Overall Study|Protocol Violation|1|||
145549398|NCT01482884|524867107|FG001|Overall Study|Protocol Violation|0|||
145549399|NCT01482884|524867106|FG000|Overall Study|Lost to Follow-up|2|||
145549400|NCT01482884|524867107|FG001|Overall Study|Lost to Follow-up|2|||
145549401|NCT01482884|524867106|FG000|Overall Study|Lack of Efficacy|0|||
145549402|NCT01482884|524867107|FG001|Overall Study|Lack of Efficacy|1|||
145549403|NCT01482884|524867106|FG000|Overall Study|Adverse Event|2|||
145549404|NCT01482884|524867107|FG001|Overall Study|Adverse Event|1|||
145797178|NCT01371981|525759732|FG001|Overall Study|Withdrawal by Subject|19|||
145797179|NCT01371981|525759733|FG002|Overall Study|Withdrawal by Subject|1|||
145797180|NCT01371981|525759734|FG003|Overall Study|Withdrawal by Subject|2|||
145549405|NCT01482884|524867106|FG000|Overall Study|Withdrawal by Subject|8|||
145549406|NCT01482884|524867107|FG001|Overall Study|Withdrawal by Subject|13|||
145549407|NCT00439244|524867110|FG000|Overall Study|Adverse Event|5|||
145549408|NCT00439244|524867111|FG001|Overall Study|Adverse Event|2|||
145797181|NCT01371981|525759735|FG004|Overall Study|Withdrawal by Subject|10|||
145797182|NCT01371981|525759736|FG005|Overall Study|Withdrawal by Subject|3|||
145797183|NCT01371981|525759731|FG000|Overall Study|Ineligible|19|||
145797184|NCT01371981|525759732|FG001|Overall Study|Ineligible|13|||
145797185|NCT01371981|525759733|FG002|Overall Study|Ineligible|0|||
145797186|NCT01371981|525759734|FG003|Overall Study|Ineligible|0|||
145797187|NCT01371981|525759735|FG004|Overall Study|Ineligible|0|||
145797188|NCT01371981|525759736|FG005|Overall Study|Ineligible|4|||
145797189|NCT01371981|525759731|FG000|Overall Study|Did not start treatment|2|||
145797190|NCT01371981|525759732|FG001|Overall Study|Did not start treatment|3|||
145797191|NCT01371981|525759733|FG002|Overall Study|Did not start treatment|0|||
145797192|NCT01371981|525759734|FG003|Overall Study|Did not start treatment|0|||
145797193|NCT01371981|525759735|FG004|Overall Study|Did not start treatment|0|||
145797194|NCT01371981|525759736|FG005|Overall Study|Did not start treatment|2|||
145797195|NCT05467540|525759737|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
145797196|NCT05467540|525759737|FG000|3-Month Follow-up|Lost to Follow-up|4|||
145797197|NCT05467540|525759737|FG000|3-Month Follow-up|Death|5|||
145797198|NCT05467540|525759737|FG000|12-Month Follow-up|Lost to Follow-up|6|||
145797199|NCT05467540|525759737|FG000|12-Month Follow-up|Death|8|||
145797200|NCT05467540|525759737|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
145797201|NCT05584202|525759753|FG000|Overall Study|Withdrawal of Consent|3|||
145797202|NCT05584202|525759754|FG001|Overall Study|Withdrawal of Consent|2|||
145797203|NCT05584202|525759753|FG000|Overall Study|Lost to Follow-up|2|||
145797204|NCT05584202|525759754|FG001|Overall Study|Lost to Follow-up|1|||
145797205|NCT05584202|525759753|FG000|Overall Study|Death|0|||
145797206|NCT05584202|525759754|FG001|Overall Study|Death|1|||
145797207|NCT04490057|525759755|FG000|Stage 1|Death|1|||
145797208|NCT04490057|525759756|FG001|Stage 1|Death|2|||
145797209|NCT04490057|525759757|FG002|Stage 1|Death|0|||
145797210|NCT04490057|525759758|FG003|Stage 1|Death|0|||
145797211|NCT04490057|525759759|FG004|Stage 1|Death|0|||
145797212|NCT04490057|525759760|FG005|Stage 1|Death|0|||
145797213|NCT04490057|525759761|FG006|Stage 1|Death|0|||
145797214|NCT04490057|525759762|FG007|Stage 1|Death|0|||
145797215|NCT04490057|525759755|FG000|Stage 1|Withdrawal by Subject|2|||
145797216|NCT04490057|525759756|FG001|Stage 1|Withdrawal by Subject|0|||
145797217|NCT04490057|525759757|FG002|Stage 1|Withdrawal by Subject|0|||
145797218|NCT04490057|525759758|FG003|Stage 1|Withdrawal by Subject|0|||
145797219|NCT04490057|525759759|FG004|Stage 1|Withdrawal by Subject|0|||
145797220|NCT04490057|525759760|FG005|Stage 1|Withdrawal by Subject|0|||
145797221|NCT04490057|525759761|FG006|Stage 1|Withdrawal by Subject|0|||
145797222|NCT04490057|525759762|FG007|Stage 1|Withdrawal by Subject|0|||
145797223|NCT04490057|525759755|FG000|Stage 2|Death|0|||
145797224|NCT04490057|525759756|FG001|Stage 2|Death|0|||
145797225|NCT04490057|525759757|FG002|Stage 2|Death|0|||
145797226|NCT04490057|525759758|FG003|Stage 2|Death|0|||
145549409|NCT00439244|524867112|FG002|Overall Study|Adverse Event|3|||
145549410|NCT00439244|524867110|FG000|Overall Study|Withdrawal by Subject|3|||
145549411|NCT00439244|524867111|FG001|Overall Study|Withdrawal by Subject|1|||
145549412|NCT00439244|524867112|FG002|Overall Study|Withdrawal by Subject|2|||
145549413|NCT00439244|524867110|FG000|Overall Study|Lost to Follow-up|2|||
145549414|NCT00439244|524867111|FG001|Overall Study|Lost to Follow-up|1|||
145549415|NCT00439244|524867112|FG002|Overall Study|Lost to Follow-up|2|||
145549416|NCT00439244|524867110|FG000|Overall Study|Death|0|||
145549417|NCT00439244|524867111|FG001|Overall Study|Death|1|||
145797227|NCT04490057|525759759|FG004|Stage 2|Death|1|||
145797228|NCT04490057|525759760|FG005|Stage 2|Death|0|||
145797229|NCT04490057|525759761|FG006|Stage 2|Death|0|||
145797230|NCT04490057|525759762|FG007|Stage 2|Death|0|||
145797231|NCT04490057|525759755|FG000|Stage 2|Lost to Follow-up|0|||
145797232|NCT04490057|525759756|FG001|Stage 2|Lost to Follow-up|0|||
145797233|NCT04490057|525759757|FG002|Stage 2|Lost to Follow-up|0|||
145797234|NCT04490057|525759758|FG003|Stage 2|Lost to Follow-up|11|||
145797235|NCT04490057|525759759|FG004|Stage 2|Lost to Follow-up|17|||
145797236|NCT04490057|525759760|FG005|Stage 2|Lost to Follow-up|4|||
145797237|NCT04490057|525759761|FG006|Stage 2|Lost to Follow-up|21|||
145797238|NCT04490057|525759762|FG007|Stage 2|Lost to Follow-up|14|||
145797239|NCT05757427|525759765|FG000|Overall Study|Adverse Event|1|||
145797240|NCT05757427|525759765|FG000|Overall Study|Device deficiency|1|||
145797241|NCT05757427|525759765|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
145797242|NCT05757427|525759765|FG000|Overall Study|MWBI scan of only 1 breast|3|||
145797243|NCT05757427|525759765|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
145797244|NCT04584983|525759766|FG000|Overall Study|Parental request for withdraw|2|||
145797245|NCT04584983|525759767|FG001|Overall Study|Parental request for withdraw|0|||
145797246|NCT05377489|525759768|FG000|Overall Study|Withdrawal by Subject|122|||
145797247|NCT05377489|525759768|FG000|Overall Study|Lost to Follow-up|21|||
145797248|NCT05377489|525759768|FG000|Overall Study|Lack of Efficacy|10|||
145797249|NCT05377489|525759768|FG000|Overall Study|Adverse Event|5|||
145797250|NCT05377489|525759768|FG000|Overall Study|Death|4|||
145549418|NCT00439244|524867112|FG002|Overall Study|Death|0|||
145797251|NCT05377489|525759768|FG000|Overall Study|Physician Decision|3|||
145797252|NCT05377489|525759768|FG000|Overall Study|Protocol Violation|1|||
145797253|NCT05377489|525759768|FG000|Overall Study|Other|9|||
145797254|NCT03423979|525759769|FG000|Overall Study|Death|5|||
145797255|NCT03423979|525759769|FG000|Overall Study|Adverse Event|4|||
145797256|NCT03423979|525759769|FG000|Overall Study|Withdrawal by Subject|3|||
145797257|NCT03423979|525759769|FG000|Overall Study|Lost to Follow-up|16|||
145797258|NCT04971785|525759770|FG000|Overall Study|Withdrew Consent|5|||
145797259|NCT04971785|525759771|FG001|Overall Study|Withdrew Consent|5|||
145797260|NCT04971785|525759772|FG002|Overall Study|Withdrew Consent|17|||
145797261|NCT04971785|525759773|FG003|Overall Study|Withdrew Consent|7|||
145797262|NCT04971785|525759770|FG000|Overall Study|Adverse Event|7|||
145797263|NCT04971785|525759771|FG001|Overall Study|Adverse Event|8|||
145797264|NCT04971785|525759772|FG002|Overall Study|Adverse Event|6|||
145797265|NCT04971785|525759773|FG003|Overall Study|Adverse Event|3|||
145797266|NCT04971785|525759770|FG000|Overall Study|Lost to Follow-up|2|||
145797267|NCT04971785|525759771|FG001|Overall Study|Lost to Follow-up|1|||
145797268|NCT04971785|525759772|FG002|Overall Study|Lost to Follow-up|6|||
145797269|NCT04971785|525759773|FG003|Overall Study|Lost to Follow-up|7|||
145797270|NCT04971785|525759770|FG000|Overall Study|Protocol Violation|3|||
145797271|NCT04971785|525759771|FG001|Overall Study|Protocol Violation|1|||
145797272|NCT04971785|525759772|FG002|Overall Study|Protocol Violation|1|||
145797273|NCT04971785|525759773|FG003|Overall Study|Protocol Violation|2|||
145797274|NCT04971785|525759770|FG000|Overall Study|Investigator's Discretion|3|||
145797275|NCT04971785|525759771|FG001|Overall Study|Investigator's Discretion|1|||
145797276|NCT04971785|525759772|FG002|Overall Study|Investigator's Discretion|1|||
145797277|NCT04971785|525759773|FG003|Overall Study|Investigator's Discretion|0|||
145797278|NCT04971785|525759770|FG000|Overall Study|Randomized but Never Treated|1|||
145797279|NCT04971785|525759771|FG001|Overall Study|Randomized but Never Treated|2|||
145797280|NCT04971785|525759772|FG002|Overall Study|Randomized but Never Treated|0|||
145797281|NCT04971785|525759773|FG003|Overall Study|Randomized but Never Treated|1|||
145797282|NCT04971785|525759770|FG000|Overall Study|Death|0|||
145797283|NCT04971785|525759771|FG001|Overall Study|Death|1|||
145797284|NCT04971785|525759772|FG002|Overall Study|Death|1|||
145797285|NCT04971785|525759773|FG003|Overall Study|Death|0|||
145797286|NCT04971785|525759770|FG000|Overall Study|Site Terminated by Sponsor|1|||
145797287|NCT04971785|525759771|FG001|Overall Study|Site Terminated by Sponsor|1|||
145797288|NCT04971785|525759772|FG002|Overall Study|Site Terminated by Sponsor|0|||
145797289|NCT04971785|525759773|FG003|Overall Study|Site Terminated by Sponsor|0|||
145797290|NCT01251861|525759774|FG000|Overall Study|Disease progression|6|||
145797291|NCT01251861|525759775|FG001|Overall Study|Disease progression|6|||
145797292|NCT01251861|525759774|FG000|Overall Study|Adverse Event|2|||
145797293|NCT01251861|525759775|FG001|Overall Study|Adverse Event|17|||
145797294|NCT01251861|525759774|FG000|Overall Study|Withdrawal by Subject|2|||
145797295|NCT01251861|525759775|FG001|Overall Study|Withdrawal by Subject|2|||
145797296|NCT01251861|525759774|FG000|Overall Study|Alternative therapy|1|||
145797297|NCT01251861|525759775|FG001|Overall Study|Alternative therapy|0|||
145797298|NCT01251861|525759774|FG000|Overall Study|Other complicating disease|0|||
145797299|NCT01251861|525759775|FG001|Overall Study|Other complicating disease|1|||
145797300|NCT01251861|525759774|FG000|Overall Study|Physician Decision|1|||
145797301|NCT01251861|525759775|FG001|Overall Study|Physician Decision|0|||
145797302|NCT01251861|525759774|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
145797303|NCT01251861|525759775|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
145797304|NCT01251861|525759774|FG000|Overall Study|Other|1|||
145797305|NCT01251861|525759775|FG001|Overall Study|Other|0|||
145797306|NCT01251861|525759774|FG000|Overall Study|Never started therapy|4|||
145797307|NCT01251861|525759775|FG001|Overall Study|Never started therapy|1|||
145549419|NCT00439244|524867110|FG000|Overall Study|Protocol Violation|0|||
145549420|NCT00439244|524867111|FG001|Overall Study|Protocol Violation|1|||
145549421|NCT00439244|524867112|FG002|Overall Study|Protocol Violation|0|||
145549422|NCT00439244|524867110|FG000|Overall Study|Administrative problems|1|||
145549423|NCT00439244|524867111|FG001|Overall Study|Administrative problems|0|||
145549424|NCT00439244|524867112|FG002|Overall Study|Administrative problems|0|||
145549425|NCT01774968|524867115|FG000|Overall Study|Adverse Event|4|||
145797308|NCT01251861|525759774|FG000|Overall Study|Potential interaction of drugs|0|||
145549426|NCT01774968|524867116|FG001|Overall Study|Adverse Event|4|||
145549427|NCT01774968|524867115|FG000|Overall Study|Death|0|||
145797309|NCT01251861|525759775|FG001|Overall Study|Potential interaction of drugs|1|||
145797310|NCT05371912|525759779|FG000|Overall Study|Lost to Follow-up|3|||
145797311|NCT05371912|525759780|FG001|Overall Study|Lost to Follow-up|2|||
145282892|NCT00529568|523884406|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
145549428|NCT01774968|524867116|FG001|Overall Study|Death|1|||
145797312|NCT02598661|525759781|FG000|Overall Study|Death|27|||
145797313|NCT02598661|525759782|FG001|Overall Study|Death|34|||
145549429|NCT01774968|524867115|FG000|Overall Study|Lost to Follow-up|1|||
145797314|NCT02598661|525759783|FG002|Overall Study|Death|14|||
145797315|NCT02598661|525759784|FG003|Overall Study|Death|1|||
145797316|NCT02598661|525759785|FG004|Overall Study|Death|0|||
145797317|NCT02598661|525759781|FG000|Overall Study|Lost to Follow-up|2|||
145549430|NCT01774968|524867116|FG001|Overall Study|Lost to Follow-up|3|||
145797318|NCT02598661|525759782|FG001|Overall Study|Lost to Follow-up|3|||
145797319|NCT02598661|525759783|FG002|Overall Study|Lost to Follow-up|2|||
145797320|NCT02598661|525759784|FG003|Overall Study|Lost to Follow-up|0|||
145797321|NCT02598661|525759785|FG004|Overall Study|Lost to Follow-up|0|||
145797322|NCT02598661|525759781|FG000|Overall Study|Withdrawal by Subject|13|||
145797323|NCT02598661|525759782|FG001|Overall Study|Withdrawal by Subject|24|||
145797324|NCT02598661|525759783|FG002|Overall Study|Withdrawal by Subject|14|||
145797325|NCT02598661|525759784|FG003|Overall Study|Withdrawal by Subject|1|||
145797326|NCT02598661|525759785|FG004|Overall Study|Withdrawal by Subject|1|||
145797327|NCT02598661|525759781|FG000|Overall Study|Adverse Event|0|||
145797328|NCT02598661|525759782|FG001|Overall Study|Adverse Event|0|||
145797329|NCT02598661|525759783|FG002|Overall Study|Adverse Event|1|||
145797330|NCT02598661|525759784|FG003|Overall Study|Adverse Event|0|||
145797331|NCT02598661|525759785|FG004|Overall Study|Adverse Event|0|||
145797332|NCT02598661|525759781|FG000|Overall Study|Randomized, Never Treated|0|||
145797333|NCT02598661|525759782|FG001|Overall Study|Randomized, Never Treated|0|||
145797334|NCT02598661|525759783|FG002|Overall Study|Randomized, Never Treated|0|||
145797335|NCT02598661|525759784|FG003|Overall Study|Randomized, Never Treated|0|||
145797336|NCT02598661|525759785|FG004|Overall Study|Randomized, Never Treated|1|||
145549431|NCT01774968|524867115|FG000|Overall Study|Physician Decision|5|||
145549432|NCT01774968|524867116|FG001|Overall Study|Physician Decision|1|||
145549433|NCT01774968|524867115|FG000|Overall Study|Protocol Violation|14|||
145549434|NCT01774968|524867116|FG001|Overall Study|Protocol Violation|13|||
145549435|NCT01774968|524867115|FG000|Overall Study|Sponsor Decision|0|||
145549436|NCT01774968|524867116|FG001|Overall Study|Sponsor Decision|2|||
145549437|NCT01774968|524867115|FG000|Overall Study|Withdrawal by Subject|6|||
145549438|NCT01774968|524867116|FG001|Overall Study|Withdrawal by Subject|11|||
145549439|NCT04600921|524867119|FG000|Overall Study|Withdrawal by Subject|3|||
145549440|NCT04600921|524867120|FG001|Overall Study|Withdrawal by Subject|5|||
145549441|NCT04600921|524867119|FG000|Overall Study|Death|0|||
145549442|NCT04600921|524867120|FG001|Overall Study|Death|1|||
145549443|NCT04847557|524867121|FG000|Overall Study|Adverse Event|1|||
145549444|NCT04847557|524867122|FG001|Overall Study|Adverse Event|0|||
145549445|NCT04847557|524867121|FG000|Overall Study|Death|19|||
145549446|NCT04847557|524867122|FG001|Overall Study|Death|15|||
145549447|NCT04847557|524867121|FG000|Overall Study|Lost to Follow-up|3|||
145611243|NCT03661996|525092633|FG000|Overall Study|Sponsors Decision|2|||
145549448|NCT04847557|524867122|FG001|Overall Study|Lost to Follow-up|6|||
145549449|NCT04847557|524867121|FG000|Overall Study|Physician Decision|1|||
145549450|NCT04847557|524867122|FG001|Overall Study|Physician Decision|0|||
145549451|NCT04847557|524867121|FG000|Overall Study|Protocol Violation|0|||
145549452|NCT04847557|524867122|FG001|Overall Study|Protocol Violation|1|||
145549453|NCT04847557|524867121|FG000|Overall Study|Withdrawal by Subject|8|||
145549454|NCT04847557|524867122|FG001|Overall Study|Withdrawal by Subject|14|||
145549455|NCT00793598|524869164|FG000|Overall Study|Patient Request|0|||
145549456|NCT00793598|524869165|FG001|Overall Study|Patient Request|1|||
145549457|NCT00793598|524869166|FG002|Overall Study|Patient Request|0|||
145549458|NCT00793598|524869167|FG003|Overall Study|Patient Request|0|||
145549459|NCT00793598|524869168|FG004|Overall Study|Patient Request|0|||
145549460|NCT00793598|524869169|FG005|Overall Study|Patient Request|0|||
145549461|NCT00793598|524869170|FG006|Overall Study|Patient Request|0|||
145549462|NCT00793598|524869171|FG007|Overall Study|Patient Request|0|||
145549463|NCT00793598|524869164|FG000|Overall Study|Protocol Violation|0|||
145549464|NCT00793598|524869165|FG001|Overall Study|Protocol Violation|0|||
145549465|NCT00793598|524869166|FG002|Overall Study|Protocol Violation|0|||
145405028|NCT01288430|524340084|FG001|Part 1|Clinical disease progression|0|||
145405029|NCT01288430|524340085|FG002|Part 1|Clinical disease progression|1|||
145405030|NCT01288430|524340086|FG003|Part 1|Clinical disease progression|0|||
145549466|NCT00793598|524869167|FG003|Overall Study|Protocol Violation|0|||
145549467|NCT00793598|524869168|FG004|Overall Study|Protocol Violation|0|||
145549468|NCT00793598|524869169|FG005|Overall Study|Protocol Violation|0|||
145549469|NCT00793598|524869170|FG006|Overall Study|Protocol Violation|0|||
145549470|NCT00793598|524869171|FG007|Overall Study|Protocol Violation|1|||
145549471|NCT00793598|524869164|FG000|Overall Study|Subject not dosed|0|||
145549472|NCT00793598|524869165|FG001|Overall Study|Subject not dosed|0|||
145282893|NCT00529568|523884404|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
145282894|NCT00529568|523884405|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
145282895|NCT00529568|523884406|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
145282896|NCT00529568|523884404|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
145282897|NCT00529568|523884405|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
145282898|NCT00529568|523884406|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
145282899|NCT04049552|523884407|FG000|Overall Study|Lost to Follow-up|1|||
145282900|NCT01201356|523884408|FG000|Overall Study|Adverse Event|170|||
145405031|NCT01288430|524340087|FG004|Part 1|Clinical disease progression|0|||
145405032|NCT01288430|524340088|FG005|Part 1|Clinical disease progression|2|||
145549473|NCT00793598|524869166|FG002|Overall Study|Subject not dosed|0|||
145405033|NCT01288430|524340089|FG006|Part 1|Clinical disease progression|2|||
145549474|NCT00793598|524869167|FG003|Overall Study|Subject not dosed|0|||
145549475|NCT00793598|524869168|FG004|Overall Study|Subject not dosed|0|||
145549476|NCT00793598|524869169|FG005|Overall Study|Subject not dosed|1|||
145282901|NCT01201356|523884408|FG000|Overall Study|Abnormal laboratory value(s)|51|||
145282902|NCT01201356|523884408|FG000|Overall Study|Abnormal test procedure result(s)|3|||
145282903|NCT01201356|523884408|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
145282904|NCT01201356|523884408|FG000|Overall Study|Condition no longer requires study drug|12|||
145282905|NCT01201356|523884408|FG000|Overall Study|Withdrawal by Subject|144|||
145282906|NCT01201356|523884408|FG000|Overall Study|Lost to Follow-up|50|||
145282907|NCT01201356|523884408|FG000|Overall Study|administrative problems|74|||
145282908|NCT01201356|523884408|FG000|Overall Study|Death|16|||
145282909|NCT01201356|523884408|FG000|Overall Study|Protocol Violation|12|||
145282910|NCT00738920|523884411|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
145282911|NCT00738920|523884412|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
145282912|NCT00738920|523884413|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
145282913|NCT00738920|523884411|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
145282914|NCT00738920|523884412|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
145282915|NCT00738920|523884413|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
145282916|NCT00738920|523884411|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
145282917|NCT00738920|523884412|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
145282918|NCT00738920|523884413|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
145282919|NCT00738920|523884411|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
145282920|NCT00738920|523884412|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
145282921|NCT00738920|523884413|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
145282922|NCT00738920|523884411|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
145282923|NCT00738920|523884412|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
145282924|NCT00738920|523884413|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
145282925|NCT00738920|523884411|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
145282926|NCT00738920|523884412|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
145282927|NCT00738920|523884413|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
145282928|NCT00738920|523884411|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
145282929|NCT00738920|523884412|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
145282930|NCT00738920|523884413|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
145282931|NCT00738920|523884411|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
145282932|NCT00738920|523884412|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
145282933|NCT00738920|523884413|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
145282934|NCT00738920|523884411|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
145282935|NCT00738920|523884412|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
145282936|NCT00738920|523884413|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
145282937|NCT00738920|523884411|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
145282938|NCT00738920|523884412|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
145282939|NCT00738920|523884413|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
145282940|NCT02046369|523884414|FG000|Overall Study|Adverse Event|3|||
145282941|NCT02046369|523884415|FG001|Overall Study|Adverse Event|3|||
145282942|NCT02046369|523884414|FG000|Overall Study|Lack of Efficacy|3|||
145282943|NCT02046369|523884415|FG001|Overall Study|Lack of Efficacy|3|||
145282944|NCT02046369|523884414|FG000|Overall Study|Lost to Follow-up|3|||
145282945|NCT02046369|523884415|FG001|Overall Study|Lost to Follow-up|3|||
145282946|NCT02046369|523884414|FG000|Overall Study|Protocol Violation|1|||
145549477|NCT00793598|524869170|FG006|Overall Study|Subject not dosed|0|||
145282947|NCT02046369|523884415|FG001|Overall Study|Protocol Violation|2|||
145282948|NCT02046369|523884414|FG000|Overall Study|Withdrawal by Subject|3|||
145282949|NCT02046369|523884415|FG001|Overall Study|Withdrawal by Subject|6|||
145282950|NCT02046369|523884414|FG000|Overall Study|never received study drug|0|||
145549478|NCT00793598|524869171|FG007|Overall Study|Subject not dosed|0|||
145282951|NCT02046369|523884415|FG001|Overall Study|never received study drug|1|||
145282952|NCT02046369|523884414|FG000|Overall Study|non compliance|1|||
145282953|NCT02046369|523884415|FG001|Overall Study|non compliance|0|||
145282954|NCT02196506|523884416|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
145282955|NCT02196506|523884417|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
145282956|NCT02196506|523884418|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
145282957|NCT02196506|523884419|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
145282958|NCT02196506|523884416|FG000|Phase A|Withdrawal by Subject|34|||
145282959|NCT02196506|523884417|FG001|Phase A|Withdrawal by Subject|0|||
145282960|NCT02196506|523884418|FG002|Phase A|Withdrawal by Subject|0|||
145282961|NCT02196506|523884419|FG003|Phase A|Withdrawal by Subject|0|||
145282962|NCT02196506|523884416|FG000|Phase A|Adverse Event|22|||
145282963|NCT02196506|523884417|FG001|Phase A|Adverse Event|0|||
145282964|NCT02196506|523884418|FG002|Phase A|Adverse Event|0|||
145282965|NCT02196506|523884419|FG003|Phase A|Adverse Event|0|||
145282966|NCT02196506|523884416|FG000|Phase A|Lost to Follow-up|9|||
145282967|NCT02196506|523884417|FG001|Phase A|Lost to Follow-up|0|||
145282968|NCT02196506|523884418|FG002|Phase A|Lost to Follow-up|0|||
145282969|NCT02196506|523884419|FG003|Phase A|Lost to Follow-up|0|||
145282970|NCT02196506|523884416|FG000|Phase A|Protocol deviation|12|||
145282971|NCT02196506|523884417|FG001|Phase A|Protocol deviation|0|||
145282972|NCT02196506|523884418|FG002|Phase A|Protocol deviation|0|||
145282973|NCT02196506|523884419|FG003|Phase A|Protocol deviation|0|||
145405034|NCT01288430|524340090|FG007|Part 1|Clinical disease progression|0|||
145282974|NCT02196506|523884416|FG000|Phase A|Participant withdrawn by investigator|10|||
145282975|NCT02196506|523884417|FG001|Phase A|Participant withdrawn by investigator|0|||
145282976|NCT02196506|523884418|FG002|Phase A|Participant withdrawn by investigator|0|||
145282977|NCT02196506|523884419|FG003|Phase A|Participant withdrawn by investigator|0|||
145282978|NCT02196506|523884416|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
145282979|NCT02196506|523884417|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
145282980|NCT02196506|523884418|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
145282981|NCT02196506|523884419|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
145282982|NCT02196506|523884416|FG000|Phase B|Lack of Efficacy|0|||
145282983|NCT02196506|523884417|FG001|Phase B|Lack of Efficacy|1|||
145549479|NCT02762266|524869172|FG000|Overall Study|Physician Decision|2|||
145549480|NCT02762266|524869173|FG001|Overall Study|Physician Decision|0|||
145549481|NCT02961751|524869180|FG000|Overall Study|Lost to Follow-up|11|||
145549482|NCT02961751|524869180|FG000|Overall Study|Physician Decision|2|||
145549483|NCT02961751|524869180|FG000|Overall Study|Not Eligible at Enrollment|1|||
145549484|NCT02961751|524869180|FG000|Overall Study|Protocol Violation|1|||
145549485|NCT00842712|524869181|FG000|Safety Run-in Part|Adverse Event|0|||
145549486|NCT00842712|524869182|FG001|Safety Run-in Part|Adverse Event|1|||
145549487|NCT00842712|524869183|FG002|Safety Run-in Part|Adverse Event|0|||
145549488|NCT00842712|524869184|FG003|Safety Run-in Part|Adverse Event|0|||
145549489|NCT00842712|524869185|FG004|Safety Run-in Part|Adverse Event|0|||
145549490|NCT00842712|524869186|FG005|Safety Run-in Part|Adverse Event|0|||
145549491|NCT00842712|524869187|FG006|Safety Run-in Part|Adverse Event|0|||
145549492|NCT00842712|524869181|FG000|Safety Run-in Part|Progressive disease|3|||
145549493|NCT00842712|524869182|FG001|Safety Run-in Part|Progressive disease|1|||
145549494|NCT00842712|524869183|FG002|Safety Run-in Part|Progressive disease|0|||
145549495|NCT00842712|524869184|FG003|Safety Run-in Part|Progressive disease|1|||
145549496|NCT00842712|524869185|FG004|Safety Run-in Part|Progressive disease|0|||
145549497|NCT00842712|524869186|FG005|Safety Run-in Part|Progressive disease|0|||
145549498|NCT00842712|524869187|FG006|Safety Run-in Part|Progressive disease|0|||
145549499|NCT00842712|524869181|FG000|Randomized Part|Randomized but not treated|0|||
145549500|NCT00842712|524869182|FG001|Randomized Part|Randomized but not treated|0|||
145549501|NCT00842712|524869183|FG002|Randomized Part|Randomized but not treated|0|||
145549502|NCT00842712|524869184|FG003|Randomized Part|Randomized but not treated|0|||
145549503|NCT00842712|524869185|FG004|Randomized Part|Randomized but not treated|0|||
145549504|NCT00842712|524869186|FG005|Randomized Part|Randomized but not treated|1|||
145549505|NCT00842712|524869187|FG006|Randomized Part|Randomized but not treated|4|||
145549506|NCT00842712|524869181|FG000|Randomized Part|Ongoing at cut-off date|0|||
145549507|NCT00842712|524869182|FG001|Randomized Part|Ongoing at cut-off date|0|||
145549508|NCT00842712|524869183|FG002|Randomized Part|Ongoing at cut-off date|0|||
145549509|NCT00842712|524869184|FG003|Randomized Part|Ongoing at cut-off date|0|||
145549510|NCT00842712|524869185|FG004|Randomized Part|Ongoing at cut-off date|0|||
145549511|NCT00842712|524869186|FG005|Randomized Part|Ongoing at cut-off date|0|||
145549512|NCT00842712|524869187|FG006|Randomized Part|Ongoing at cut-off date|2|||
145549513|NCT00410046|524869188|FG000|Overall Study|Adverse Event|3|||
145549514|NCT00410046|524869188|FG000|Overall Study|Withdrawal by Subject|1|||
145282984|NCT02196506|523884418|FG002|Phase B|Lack of Efficacy|2|||
145282985|NCT02196506|523884419|FG003|Phase B|Lack of Efficacy|0|||
145282986|NCT02196506|523884416|FG000|Phase B|Withdrawal by Participant|0|||
145282987|NCT02196506|523884417|FG001|Phase B|Withdrawal by Participant|8|||
145282988|NCT02196506|523884418|FG002|Phase B|Withdrawal by Participant|1|||
145282989|NCT02196506|523884419|FG003|Phase B|Withdrawal by Participant|0|||
145282990|NCT02196506|523884416|FG000|Phase B|Adverse Event|0|||
145282991|NCT02196506|523884417|FG001|Phase B|Adverse Event|4|||
145282992|NCT02196506|523884418|FG002|Phase B|Adverse Event|1|||
145282993|NCT02196506|523884419|FG003|Phase B|Adverse Event|0|||
145282994|NCT02196506|523884416|FG000|Phase B|Lost to Follow-up|0|||
145282995|NCT02196506|523884417|FG001|Phase B|Lost to Follow-up|2|||
145405035|NCT01288430|524340091|FG008|Part 1|Clinical disease progression|0|||
145405036|NCT01288430|524340092|FG009|Part 1|Clinical disease progression|0|||
145282996|NCT02196506|523884418|FG002|Phase B|Lost to Follow-up|1|||
145282997|NCT02196506|523884419|FG003|Phase B|Lost to Follow-up|0|||
145282998|NCT02196506|523884416|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
145549515|NCT00410046|524869188|FG000|Overall Study|Lost to Follow-up|1|||
145549516|NCT03909295|524869189|FG000|Overall Study|Adverse Event|2|||
145549517|NCT03909295|524869189|FG000|Overall Study|Study terminated by sponsor|50|||
145549518|NCT03312933|524869196|FG000|Overall Study|Protocol Violation|15|||
145282999|NCT02196506|523884417|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
145405037|NCT01288430|524340083|FG000|Part 1|Death due to disease progression|0|||
145549519|NCT03312933|524869196|FG000|Overall Study|Lost to Follow-up|36|||
145283000|NCT02196506|523884418|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
145283001|NCT02196506|523884419|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
145405038|NCT01288430|524340084|FG001|Part 1|Death due to disease progression|0|||
145549520|NCT03312933|524869196|FG000|Overall Study|Withdrawal by Subject|3|||
145549521|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
145549522|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
145549523|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
145549524|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
145549525|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
145549526|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
145549527|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
145549528|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
145549529|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
145549530|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
145549531|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|Other|1|||
145549532|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|Other|1|||
145549533|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|Other|0|||
145549534|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|Other|0|||
145549535|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|Other|0|||
145549536|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
145549537|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
145549538|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
145549539|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
145549540|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
145549541|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
145549542|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
145549543|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
145549544|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
145549545|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
145405039|NCT01288430|524340085|FG002|Part 1|Death due to disease progression|0|||
145405040|NCT01288430|524340086|FG003|Part 1|Death due to disease progression|0|||
145405041|NCT01288430|524340087|FG004|Part 1|Death due to disease progression|1|||
145405042|NCT01288430|524340088|FG005|Part 1|Death due to disease progression|0|||
145283002|NCT02196506|523884416|FG000|Phase A+|Withdrawal by Participant|0|||
145283003|NCT02196506|523884417|FG001|Phase A+|Withdrawal by Participant|0|||
145283004|NCT02196506|523884418|FG002|Phase A+|Withdrawal by Participant|0|||
145283005|NCT02196506|523884419|FG003|Phase A+|Withdrawal by Participant|5|||
145283006|NCT02196506|523884416|FG000|Phase A+|Adverse Event|0|||
145283007|NCT02196506|523884417|FG001|Phase A+|Adverse Event|0|||
145283008|NCT02196506|523884418|FG002|Phase A+|Adverse Event|0|||
145283009|NCT02196506|523884419|FG003|Phase A+|Adverse Event|1|||
145283010|NCT02196506|523884416|FG000|Phase A+|Lost to Follow-up|0|||
145283011|NCT02196506|523884417|FG001|Phase A+|Lost to Follow-up|0|||
145283012|NCT02196506|523884418|FG002|Phase A+|Lost to Follow-up|0|||
145405043|NCT01288430|524340089|FG006|Part 1|Death due to disease progression|0|||
145405044|NCT01288430|524340090|FG007|Part 1|Death due to disease progression|0|||
145405045|NCT01288430|524340091|FG008|Part 1|Death due to disease progression|0|||
145549546|NCT02310568|524869197|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
145549547|NCT02310568|524869198|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
145549548|NCT02310568|524869199|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
145549549|NCT02310568|524869200|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
145549550|NCT02310568|524869201|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
145549551|NCT02310568|524869197|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
145549552|NCT02310568|524869198|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
145549553|NCT02310568|524869199|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
145549554|NCT02310568|524869200|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
145549555|NCT02310568|524869201|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
145549556|NCT02310568|524869197|FG000|Stage 2 (4 Weeks)|Other|0|||
145549557|NCT02310568|524869198|FG001|Stage 2 (4 Weeks)|Other|1|||
145549558|NCT02310568|524869199|FG002|Stage 2 (4 Weeks)|Other|1|||
145549559|NCT02310568|524869200|FG003|Stage 2 (4 Weeks)|Other|0|||
145549560|NCT02310568|524869201|FG004|Stage 2 (4 Weeks)|Other|0|||
145549561|NCT02310568|524869197|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
145283013|NCT02196506|523884419|FG003|Phase A+|Lost to Follow-up|6|||
145549562|NCT02310568|524869198|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
145549563|NCT02310568|524869199|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
145283014|NCT02196506|523884416|FG000|Phase A+|Participant withdrawn by investigator|0|||
145283015|NCT02196506|523884417|FG001|Phase A+|Participant withdrawn by investigator|0|||
145283016|NCT02196506|523884418|FG002|Phase A+|Participant withdrawn by investigator|0|||
145405046|NCT01288430|524340092|FG009|Part 1|Death due to disease progression|0|||
145549564|NCT02310568|524869200|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
145549565|NCT02310568|524869201|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
145549566|NCT02310568|524869197|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
145549567|NCT02310568|524869198|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
145405047|NCT01288430|524340083|FG000|Part 1|Adverse Event|0|||
145405048|NCT01288430|524340084|FG001|Part 1|Adverse Event|0|||
145405049|NCT01288430|524340085|FG002|Part 1|Adverse Event|3|||
145405050|NCT01288430|524340086|FG003|Part 1|Adverse Event|1|||
145405051|NCT01288430|524340087|FG004|Part 1|Adverse Event|0|||
145283017|NCT02196506|523884419|FG003|Phase A+|Participant withdrawn by investigator|1|||
145283018|NCT02257632|523886927|FG000|Overall Study|Withdrawal by Subject|0|||
145283019|NCT02257632|523886928|FG001|Overall Study|Withdrawal by Subject|1|||
145283020|NCT02257632|523886927|FG000|Overall Study|Adverse Event|1|||
145283021|NCT02257632|523886928|FG001|Overall Study|Adverse Event|2|||
145283022|NCT02468557|523886929|FG000|Overall Study|Adverse Event|1|||
145283023|NCT02468557|523886929|FG000|Overall Study|Death|1|||
145283024|NCT02468557|523886929|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
145283025|NCT02468557|523886929|FG000|Overall Study|All Enrolled but Never Dosed|4|||
145283026|NCT01393990|523886931|FG000|Overall Study|Adverse Event|0|||
145283027|NCT01393990|523886932|FG001|Overall Study|Adverse Event|0|||
145283028|NCT01393990|523886933|FG002|Overall Study|Adverse Event|0|||
145283029|NCT01393990|523886934|FG003|Overall Study|Adverse Event|0|||
145283030|NCT01393990|523886935|FG004|Overall Study|Adverse Event|0|||
145283031|NCT01393990|523886936|FG005|Overall Study|Adverse Event|0|||
145283032|NCT01393990|523886937|FG006|Overall Study|Adverse Event|0|||
145283033|NCT01393990|523886938|FG007|Overall Study|Adverse Event|0|||
145283034|NCT01393990|523886939|FG008|Overall Study|Adverse Event|0|||
145283035|NCT01393990|523886940|FG009|Overall Study|Adverse Event|0|||
145405052|NCT01288430|524340088|FG005|Part 1|Adverse Event|0|||
145283036|NCT01393990|523886941|FG010|Overall Study|Adverse Event|0|||
145283037|NCT01393990|523886942|FG011|Overall Study|Adverse Event|0|||
145283038|NCT01393990|523886943|FG012|Overall Study|Adverse Event|0|||
145283039|NCT01393990|523886944|FG013|Overall Study|Adverse Event|0|||
145283040|NCT01393990|523886945|FG014|Overall Study|Adverse Event|1|||
145283041|NCT01393990|523886946|FG015|Overall Study|Adverse Event|1|||
145283042|NCT01393990|523886947|FG016|Overall Study|Adverse Event|0|||
145405053|NCT01288430|524340089|FG006|Part 1|Adverse Event|2|||
145405054|NCT01288430|524340090|FG007|Part 1|Adverse Event|0|||
145405055|NCT01288430|524340091|FG008|Part 1|Adverse Event|0|||
145405056|NCT01288430|524340092|FG009|Part 1|Adverse Event|0|||
145405057|NCT01288430|524340083|FG000|Part 1|Other|0|||
145405058|NCT01288430|524340084|FG001|Part 1|Other|2|||
145405059|NCT01288430|524340085|FG002|Part 1|Other|0|||
145405060|NCT01288430|524340086|FG003|Part 1|Other|0|||
145405061|NCT01288430|524340087|FG004|Part 1|Other|0|||
145405062|NCT01288430|524340088|FG005|Part 1|Other|0|||
145405063|NCT01288430|524340089|FG006|Part 1|Other|1|||
145405064|NCT01288430|524340090|FG007|Part 1|Other|0|||
145405065|NCT01288430|524340091|FG008|Part 1|Other|0|||
145405066|NCT01288430|524340092|FG009|Part 1|Other|0|||
145405067|NCT01288430|524340083|FG000|Part 2|Progressive disease|0|||
145405068|NCT01288430|524340084|FG001|Part 2|Progressive disease|0|||
145405069|NCT01288430|524340085|FG002|Part 2|Progressive disease|0|||
145405070|NCT01288430|524340086|FG003|Part 2|Progressive disease|0|||
145405071|NCT01288430|524340087|FG004|Part 2|Progressive disease|0|||
145405072|NCT01288430|524340088|FG005|Part 2|Progressive disease|0|||
145405073|NCT01288430|524340089|FG006|Part 2|Progressive disease|0|||
145405074|NCT01288430|524340090|FG007|Part 2|Progressive disease|8|||
145405075|NCT01288430|524340091|FG008|Part 2|Progressive disease|7|||
145405076|NCT01288430|524340092|FG009|Part 2|Progressive disease|2|||
145405077|NCT01288430|524340083|FG000|Part 2|Clinical disease progression|0|||
145405078|NCT01288430|524340084|FG001|Part 2|Clinical disease progression|0|||
145405079|NCT01288430|524340085|FG002|Part 2|Clinical disease progression|0|||
145405080|NCT01288430|524340086|FG003|Part 2|Clinical disease progression|0|||
145405081|NCT01288430|524340087|FG004|Part 2|Clinical disease progression|0|||
145405082|NCT01288430|524340088|FG005|Part 2|Clinical disease progression|0|||
145611244|NCT03661996|525092634|FG001|Overall Study|Sponsors Decision|0|||
145611245|NCT03661996|525092635|FG002|Overall Study|Sponsors Decision|0|||
145405083|NCT01288430|524340089|FG006|Part 2|Clinical disease progression|0|||
145611246|NCT03661996|525092636|FG003|Overall Study|Sponsors Decision|0|||
145405084|NCT01288430|524340090|FG007|Part 2|Clinical disease progression|2|||
145405085|NCT01288430|524340091|FG008|Part 2|Clinical disease progression|0|||
145405086|NCT01288430|524340092|FG009|Part 2|Clinical disease progression|0|||
145405087|NCT01288430|524340083|FG000|Part 2|Withdrawal by Subject|0|||
145405088|NCT01288430|524340084|FG001|Part 2|Withdrawal by Subject|0|||
145283043|NCT01393990|523886948|FG017|Overall Study|Adverse Event|0|||
145283044|NCT01393990|523886931|FG000|Overall Study|Progressive Disease|1|||
145283045|NCT01393990|523886932|FG001|Overall Study|Progressive Disease|0|||
145283046|NCT01393990|523886933|FG002|Overall Study|Progressive Disease|0|||
145283047|NCT01393990|523886934|FG003|Overall Study|Progressive Disease|1|||
145283048|NCT01393990|523886935|FG004|Overall Study|Progressive Disease|1|||
145283049|NCT01393990|523886936|FG005|Overall Study|Progressive Disease|1|||
145283050|NCT01393990|523886937|FG006|Overall Study|Progressive Disease|1|||
145283051|NCT01393990|523886938|FG007|Overall Study|Progressive Disease|1|||
145283052|NCT01393990|523886939|FG008|Overall Study|Progressive Disease|3|||
145283053|NCT01393990|523886940|FG009|Overall Study|Progressive Disease|1|||
145283054|NCT01393990|523886941|FG010|Overall Study|Progressive Disease|0|||
145283055|NCT01393990|523886942|FG011|Overall Study|Progressive Disease|0|||
145283056|NCT01393990|523886943|FG012|Overall Study|Progressive Disease|0|||
145283057|NCT01393990|523886944|FG013|Overall Study|Progressive Disease|1|||
145283058|NCT01393990|523886945|FG014|Overall Study|Progressive Disease|6|||
145283059|NCT01393990|523886946|FG015|Overall Study|Progressive Disease|1|||
145283060|NCT01393990|523886947|FG016|Overall Study|Progressive Disease|0|||
145283061|NCT01393990|523886948|FG017|Overall Study|Progressive Disease|0|||
145283062|NCT01393990|523886931|FG000|Overall Study|Death|0|||
145283063|NCT01393990|523886932|FG001|Overall Study|Death|0|||
145283064|NCT01393990|523886933|FG002|Overall Study|Death|0|||
145283065|NCT01393990|523886934|FG003|Overall Study|Death|0|||
145283066|NCT01393990|523886935|FG004|Overall Study|Death|1|||
145283067|NCT01393990|523886936|FG005|Overall Study|Death|0|||
145549568|NCT02310568|524869199|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
145549569|NCT02310568|524869200|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
145549570|NCT02310568|524869201|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
145549571|NCT02310568|524869197|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
145549572|NCT02310568|524869198|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
145549573|NCT02310568|524869199|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
145549574|NCT02310568|524869200|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
145283068|NCT01393990|523886937|FG006|Overall Study|Death|0|||
145283069|NCT01393990|523886938|FG007|Overall Study|Death|0|||
145283070|NCT01393990|523886939|FG008|Overall Study|Death|0|||
145283071|NCT01393990|523886940|FG009|Overall Study|Death|0|||
145283072|NCT01393990|523886941|FG010|Overall Study|Death|0|||
145405089|NCT01288430|524340085|FG002|Part 2|Withdrawal by Subject|0|||
145283073|NCT01393990|523886942|FG011|Overall Study|Death|0|||
145405090|NCT01288430|524340086|FG003|Part 2|Withdrawal by Subject|0|||
145283074|NCT01393990|523886943|FG012|Overall Study|Death|0|||
145283075|NCT01393990|523886944|FG013|Overall Study|Death|1|||
145283076|NCT01393990|523886945|FG014|Overall Study|Death|1|||
145283077|NCT01393990|523886946|FG015|Overall Study|Death|0|||
145549575|NCT02310568|524869201|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
145549576|NCT02990910|524869208|FG000|Overall Study|Lack of Efficacy|6|||
145549577|NCT02990910|524869209|FG001|Overall Study|Lack of Efficacy|10|||
145549578|NCT01549860|524869214|FG000|Overall Study|Withdrawal by Subject|1|||
145549579|NCT01549860|524869215|FG001|Overall Study|Withdrawal by Subject|0|||
145549580|NCT01549860|524869214|FG000|Overall Study|Physician Decision|1|||
145549581|NCT01549860|524869215|FG001|Overall Study|Physician Decision|1|||
145549582|NCT01366521|524869216|FG000|Overall Study|Adverse Event|1|||
145549583|NCT01366521|524869217|FG001|Overall Study|Adverse Event|0|||
145549584|NCT01366521|524869218|FG002|Overall Study|Adverse Event|0|||
145549585|NCT01366521|524869219|FG003|Overall Study|Adverse Event|0|||
145549586|NCT01366521|524869216|FG000|Overall Study|Protocol Violation|0|||
145549587|NCT01366521|524869217|FG001|Overall Study|Protocol Violation|0|||
145549588|NCT01366521|524869218|FG002|Overall Study|Protocol Violation|1|||
145549589|NCT01366521|524869219|FG003|Overall Study|Protocol Violation|0|||
145549590|NCT01366521|524869216|FG000|Overall Study|Physician Decision|0|||
145549591|NCT01366521|524869217|FG001|Overall Study|Physician Decision|0|||
145549592|NCT01366521|524869218|FG002|Overall Study|Physician Decision|1|||
145549593|NCT01366521|524869219|FG003|Overall Study|Physician Decision|0|||
145549594|NCT01366521|524869216|FG000|Overall Study|Withdrawal by Subject|0|||
145549595|NCT01366521|524869217|FG001|Overall Study|Withdrawal by Subject|1|||
145549596|NCT01366521|524869218|FG002|Overall Study|Withdrawal by Subject|0|||
145549597|NCT01366521|524869219|FG003|Overall Study|Withdrawal by Subject|0|||
145549598|NCT00660023|524869220|FG000|Overall Study|Adverse Event|2|||
145549599|NCT00660023|524869220|FG000|Overall Study|Death|8|||
145549600|NCT00660023|524869220|FG000|Overall Study|Blood Transfusion|5|||
145549601|NCT00660023|524869220|FG000|Overall Study|Renal Transplantation|3|||
145549602|NCT00660023|524869220|FG000|Overall Study|Withdrawal by Subject|1|||
145549603|NCT00660023|524869220|FG000|Overall Study|Missed Pregnancy Test|1|||
145549604|NCT00660023|524869220|FG000|Overall Study|Other Screening Failure|9|||
145549605|NCT04180488|524869221|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
145405091|NCT01288430|524340087|FG004|Part 2|Withdrawal by Subject|0|||
145405092|NCT01288430|524340088|FG005|Part 2|Withdrawal by Subject|0|||
145405093|NCT01288430|524340089|FG006|Part 2|Withdrawal by Subject|0|||
145405094|NCT01288430|524340090|FG007|Part 2|Withdrawal by Subject|1|||
145405095|NCT01288430|524340091|FG008|Part 2|Withdrawal by Subject|4|||
145405096|NCT01288430|524340092|FG009|Part 2|Withdrawal by Subject|0|||
145405097|NCT01288430|524340083|FG000|Part 2|Adverse Event|0|||
145405098|NCT01288430|524340084|FG001|Part 2|Adverse Event|0|||
145405099|NCT01288430|524340085|FG002|Part 2|Adverse Event|0|||
145405100|NCT01288430|524340086|FG003|Part 2|Adverse Event|0|||
145405101|NCT01288430|524340087|FG004|Part 2|Adverse Event|0|||
145405102|NCT01288430|524340088|FG005|Part 2|Adverse Event|0|||
145405103|NCT01288430|524340089|FG006|Part 2|Adverse Event|0|||
145405104|NCT01288430|524340090|FG007|Part 2|Adverse Event|1|||
145405105|NCT01288430|524340091|FG008|Part 2|Adverse Event|1|||
145405106|NCT01288430|524340092|FG009|Part 2|Adverse Event|0|||
145405107|NCT01288430|524340083|FG000|Part 2|Other|0|||
145405108|NCT01288430|524340084|FG001|Part 2|Other|0|||
145405109|NCT01288430|524340085|FG002|Part 2|Other|0|||
145405110|NCT01288430|524340086|FG003|Part 2|Other|0|||
145405111|NCT01288430|524340087|FG004|Part 2|Other|0|||
145405112|NCT01288430|524340088|FG005|Part 2|Other|0|||
145405113|NCT01288430|524340089|FG006|Part 2|Other|0|||
145405114|NCT01288430|524340090|FG007|Part 2|Other|0|||
145405115|NCT01288430|524340091|FG008|Part 2|Other|0|||
145405116|NCT01288430|524340092|FG009|Part 2|Other|1|||
145405117|NCT05172609|524340093|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
145405118|NCT05172609|524340094|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
145405119|NCT05172609|524340093|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
145405120|NCT05172609|524340094|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
145405121|NCT05172609|524340093|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
145405122|NCT05172609|524340094|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
145405123|NCT00300053|524340103|FG000|Overall Study|Patient/Caregiver Preference|2|||
145405124|NCT00300053|524340104|FG001|Overall Study|Patient/Caregiver Preference|2|||
145405125|NCT00300053|524340105|FG002|Overall Study|Patient/Caregiver Preference|3|||
145405126|NCT00300053|524340103|FG000|Overall Study|Death|0|||
145405127|NCT00300053|524340104|FG001|Overall Study|Death|0|||
145405128|NCT00300053|524340105|FG002|Overall Study|Death|3|||
145405129|NCT00300053|524340103|FG000|Overall Study|Lost to Follow-up|0|||
145405130|NCT00300053|524340104|FG001|Overall Study|Lost to Follow-up|1|||
145405131|NCT00300053|524340105|FG002|Overall Study|Lost to Follow-up|0|||
145405132|NCT00855582|524340107|FG000|Overall Study|Adverse Event|2|||
145405133|NCT00855582|524340108|FG001|Overall Study|Adverse Event|6|||
145549606|NCT04180488|524869222|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
145549607|NCT04180488|524869223|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
145549608|NCT04180488|524869224|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
145549609|NCT04180488|524869225|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
145549610|NCT04180488|524869226|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
145549611|NCT04180488|524869221|FG000|Overall Study|Withdrawal by Subject|8|||
145549612|NCT04180488|524869222|FG001|Overall Study|Withdrawal by Subject|4|||
145549613|NCT04180488|524869223|FG002|Overall Study|Withdrawal by Subject|5|||
145549614|NCT04180488|524869224|FG003|Overall Study|Withdrawal by Subject|2|||
145549615|NCT04180488|524869225|FG004|Overall Study|Withdrawal by Subject|8|||
145549616|NCT04180488|524869226|FG005|Overall Study|Withdrawal by Subject|6|||
145549617|NCT04180488|524869221|FG000|Overall Study|Adverse Event|3|||
145549618|NCT04180488|524869222|FG001|Overall Study|Adverse Event|2|||
145549619|NCT04180488|524869223|FG002|Overall Study|Adverse Event|0|||
145549620|NCT04180488|524869224|FG003|Overall Study|Adverse Event|0|||
145283078|NCT01393990|523886947|FG016|Overall Study|Death|0|||
145405134|NCT00855582|524340109|FG002|Overall Study|Adverse Event|3|||
145549621|NCT04180488|524869225|FG004|Overall Study|Adverse Event|0|||
145549622|NCT04180488|524869226|FG005|Overall Study|Adverse Event|0|||
145283079|NCT01393990|523886948|FG017|Overall Study|Death|0|||
145283080|NCT01393990|523886931|FG000|Overall Study|Withdrawal by Subject|0|||
145283081|NCT01393990|523886932|FG001|Overall Study|Withdrawal by Subject|0|||
145283082|NCT01393990|523886933|FG002|Overall Study|Withdrawal by Subject|0|||
145283083|NCT01393990|523886934|FG003|Overall Study|Withdrawal by Subject|0|||
145283084|NCT01393990|523886935|FG004|Overall Study|Withdrawal by Subject|0|||
145283085|NCT01393990|523886936|FG005|Overall Study|Withdrawal by Subject|0|||
145283086|NCT01393990|523886937|FG006|Overall Study|Withdrawal by Subject|0|||
145283087|NCT01393990|523886938|FG007|Overall Study|Withdrawal by Subject|0|||
145283088|NCT01393990|523886939|FG008|Overall Study|Withdrawal by Subject|0|||
145283089|NCT01393990|523886940|FG009|Overall Study|Withdrawal by Subject|0|||
145283090|NCT01393990|523886941|FG010|Overall Study|Withdrawal by Subject|0|||
145283091|NCT01393990|523886942|FG011|Overall Study|Withdrawal by Subject|0|||
145283092|NCT01393990|523886943|FG012|Overall Study|Withdrawal by Subject|0|||
145283093|NCT01393990|523886944|FG013|Overall Study|Withdrawal by Subject|0|||
145283094|NCT01393990|523886945|FG014|Overall Study|Withdrawal by Subject|1|||
145283095|NCT01393990|523886946|FG015|Overall Study|Withdrawal by Subject|1|||
145283096|NCT01393990|523886947|FG016|Overall Study|Withdrawal by Subject|0|||
145283097|NCT01393990|523886948|FG017|Overall Study|Withdrawal by Subject|0|||
145283098|NCT00331630|523886950|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
145283099|NCT00331630|523886950|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
145283100|NCT00331630|523886950|FG000|Follow up for 5 Years|Death|5|||
145283101|NCT00331630|523886950|FG000|Follow up for 5 Years|Data collection was stopped|24|||
145283102|NCT01312779|523886951|FG000|Overall Study|Withdrawal by Subject|2|||
145283103|NCT01312779|523886951|FG000|Overall Study|Death|3|||
145283104|NCT01312779|523886951|FG000|Overall Study|Not Implanted with Device|27|||
145283105|NCT00549198|523886955|FG000|Overall Study|Adverse Event|28|||
145283106|NCT00549198|523886956|FG001|Overall Study|Adverse Event|26|||
145283107|NCT00549198|523886955|FG000|Overall Study|Insufficient Viral Load Response|4|||
145283108|NCT00549198|523886956|FG001|Overall Study|Insufficient Viral Load Response|2|||
145283109|NCT00549198|523886955|FG000|Overall Study|Protocol-defined Virological Failure|7|||
145283110|NCT00549198|523886956|FG001|Overall Study|Protocol-defined Virological Failure|0|||
145549623|NCT04180488|524869221|FG000|Overall Study|Poor compliance to protocol|0|||
145549624|NCT04180488|524869222|FG001|Overall Study|Poor compliance to protocol|0|||
145283111|NCT00549198|523886955|FG000|Overall Study|Non-compliance|2|||
145283112|NCT00549198|523886956|FG001|Overall Study|Non-compliance|4|||
145283113|NCT00549198|523886955|FG000|Overall Study|Lost to Follow-up|7|||
145283114|NCT00549198|523886956|FG001|Overall Study|Lost to Follow-up|8|||
145283115|NCT00549198|523886955|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
145283116|NCT00549198|523886956|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145283117|NCT00549198|523886955|FG000|Overall Study|Protocol Violation|7|||
145405135|NCT00855582|524340107|FG000|Overall Study|Death|1|||
145405136|NCT00855582|524340108|FG001|Overall Study|Death|0|||
145405137|NCT00855582|524340109|FG002|Overall Study|Death|0|||
145405138|NCT00855582|524340107|FG000|Overall Study|Lack of Efficacy|1|||
145405139|NCT00855582|524340108|FG001|Overall Study|Lack of Efficacy|3|||
145405140|NCT00855582|524340109|FG002|Overall Study|Lack of Efficacy|8|||
145405141|NCT00855582|524340107|FG000|Overall Study|Lost to Follow-up|1|||
145549625|NCT04180488|524869223|FG002|Overall Study|Poor compliance to protocol|1|||
145549626|NCT04180488|524869224|FG003|Overall Study|Poor compliance to protocol|0|||
145549627|NCT04180488|524869225|FG004|Overall Study|Poor compliance to protocol|0|||
145549628|NCT04180488|524869226|FG005|Overall Study|Poor compliance to protocol|0|||
145549629|NCT03506815|524869227|FG000|Overall Study|Adverse Event|8|||
145549630|NCT03506815|524869228|FG001|Overall Study|Adverse Event|0|||
145549631|NCT03506815|524869227|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
145549632|NCT03506815|524869228|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
145405142|NCT00855582|524340108|FG001|Overall Study|Lost to Follow-up|3|||
145611247|NCT03661996|525092637|FG004|Overall Study|Sponsors Decision|0|||
145611248|NCT03661996|525092633|FG000|Overall Study|Other|1|||
145611249|NCT03661996|525092634|FG001|Overall Study|Other|1|||
145611250|NCT03661996|525092635|FG002|Overall Study|Other|1|||
145611251|NCT03661996|525092636|FG003|Overall Study|Other|1|||
145611252|NCT03661996|525092637|FG004|Overall Study|Other|0|||
145611253|NCT03321513|525092638|FG000|Overall Study|Death|11|||
145611254|NCT03321513|525092639|FG001|Overall Study|Death|5|||
145611255|NCT03321513|525092638|FG000|Overall Study|Withdrawal by Subject|5|||
145611256|NCT03321513|525092639|FG001|Overall Study|Withdrawal by Subject|10|||
145405143|NCT00855582|524340109|FG002|Overall Study|Lost to Follow-up|1|||
145405144|NCT00855582|524340107|FG000|Overall Study|Physician Decision|0|||
145405145|NCT00855582|524340108|FG001|Overall Study|Physician Decision|0|||
145549633|NCT03506815|524869227|FG000|Overall Study|Protocol Violation|1|||
145549634|NCT03506815|524869228|FG001|Overall Study|Protocol Violation|0|||
145549635|NCT03506815|524869227|FG000|Overall Study|Elective Surgery|1|||
145549636|NCT03506815|524869228|FG001|Overall Study|Elective Surgery|0|||
145549637|NCT02899988|524869233|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
145549638|NCT02899988|524869234|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
145549639|NCT02899988|524869235|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549640|NCT02899988|524869236|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549641|NCT02899988|524869237|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549642|NCT02899988|524869238|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549643|NCT02899988|524869239|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549644|NCT02899988|524869240|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549645|NCT02899988|524869241|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549646|NCT02899988|524869242|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549647|NCT02899988|524869243|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145549648|NCT02899988|524869233|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
145549649|NCT02899988|524869234|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
145549650|NCT02899988|524869235|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
145549651|NCT02899988|524869236|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
145549652|NCT02899988|524869237|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
145549653|NCT02899988|524869238|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
145549654|NCT02899988|524869239|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
145283118|NCT00549198|523886956|FG001|Overall Study|Protocol Violation|2|||
145549655|NCT02899988|524869240|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
145549656|NCT02899988|524869241|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
145549657|NCT02899988|524869242|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
145549658|NCT02899988|524869243|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
145549659|NCT02899988|524869233|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
145549660|NCT02899988|524869234|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
145549661|NCT02899988|524869235|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
145549662|NCT02899988|524869236|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
145549663|NCT02899988|524869237|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
145549664|NCT02899988|524869238|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
145549665|NCT02899988|524869239|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
145549666|NCT02899988|524869240|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
145549667|NCT02899988|524869241|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
145549668|NCT02899988|524869242|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
145549669|NCT02899988|524869243|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
145549670|NCT02899988|524869233|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
145549671|NCT02899988|524869234|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
145549672|NCT02899988|524869235|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
145549673|NCT02899988|524869236|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
145549674|NCT02899988|524869237|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
145549675|NCT02899988|524869238|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
145549676|NCT02899988|524869239|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
145549677|NCT02899988|524869240|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
145549678|NCT02899988|524869241|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
145549679|NCT02899988|524869242|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
145549680|NCT02899988|524869243|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
145549681|NCT02899988|524869233|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549682|NCT02899988|524869234|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549683|NCT02899988|524869235|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549684|NCT02899988|524869236|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549685|NCT02899988|524869237|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549686|NCT02899988|524869238|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
145549687|NCT02899988|524869239|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549688|NCT02899988|524869240|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
145549689|NCT02899988|524869241|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549690|NCT02899988|524869242|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549691|NCT02899988|524869243|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
145549692|NCT02899988|524869233|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549693|NCT02899988|524869234|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549694|NCT02899988|524869235|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549695|NCT02899988|524869236|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549696|NCT02899988|524869237|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
145549697|NCT02899988|524869238|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549698|NCT02899988|524869239|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
145549699|NCT02899988|524869240|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
145549700|NCT02899988|524869241|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
145549701|NCT02899988|524869242|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
145549702|NCT02899988|524869243|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
145549703|NCT00856284|524869248|FG000|Overall Study|Hyperglycemic rescue|231|||
145549704|NCT00856284|524869249|FG001|Overall Study|Hyperglycemic rescue|201|||
145549705|NCT00856284|524869250|FG002|Overall Study|Hyperglycemic rescue|235|||
145549706|NCT00856284|524869248|FG000|Overall Study|Adverse Event|60|||
145549707|NCT00856284|524869249|FG001|Overall Study|Adverse Event|74|||
145549708|NCT00856284|524869250|FG002|Overall Study|Adverse Event|82|||
145549709|NCT00856284|524869248|FG000|Overall Study|Major protocol deviation|24|||
145549710|NCT00856284|524869249|FG001|Overall Study|Major protocol deviation|16|||
145549711|NCT00856284|524869250|FG002|Overall Study|Major protocol deviation|15|||
145549712|NCT00856284|524869248|FG000|Overall Study|Lost to Follow-up|20|||
145549713|NCT00856284|524869249|FG001|Overall Study|Lost to Follow-up|22|||
145549714|NCT00856284|524869250|FG002|Overall Study|Lost to Follow-up|28|||
145549715|NCT00856284|524869248|FG000|Overall Study|Voluntary withdrawal|48|||
145549716|NCT00856284|524869249|FG001|Overall Study|Voluntary withdrawal|52|||
145549717|NCT00856284|524869250|FG002|Overall Study|Voluntary withdrawal|62|||
145549718|NCT00856284|524869248|FG000|Overall Study|Pregnancy|1|||
145549719|NCT00856284|524869249|FG001|Overall Study|Pregnancy|2|||
145549720|NCT00856284|524869250|FG002|Overall Study|Pregnancy|0|||
145611257|NCT03321513|525092638|FG000|Overall Study|Lost to Follow-up|10|||
145549721|NCT00856284|524869248|FG000|Overall Study|Investigator discretion|9|||
145549722|NCT00856284|524869249|FG001|Overall Study|Investigator discretion|8|||
145549723|NCT00856284|524869250|FG002|Overall Study|Investigator discretion|10|||
145549724|NCT00856284|524869248|FG000|Overall Study|Other|15|||
145549725|NCT00856284|524869249|FG001|Overall Study|Other|17|||
145549726|NCT00856284|524869250|FG002|Overall Study|Other|14|||
145549727|NCT00856284|524869248|FG000|Overall Study|Randomized in error|0|||
145549728|NCT00856284|524869249|FG001|Overall Study|Randomized in error|0|||
145549729|NCT00856284|524869250|FG002|Overall Study|Randomized in error|1|||
145549730|NCT01327885|524869254|FG000|Overall Study|Disease progression-according to RECIST|173|||
145549731|NCT01327885|524869255|FG001|Overall Study|Disease progression-according to RECIST|165|||
145549732|NCT01327885|524869254|FG000|Overall Study|Clinical progression|24|||
145549733|NCT01327885|524869255|FG001|Overall Study|Clinical progression|27|||
145549734|NCT01327885|524869254|FG000|Overall Study|Adverse Event|14|||
145549735|NCT01327885|524869255|FG001|Overall Study|Adverse Event|10|||
145549736|NCT01327885|524869254|FG000|Overall Study|Subject choice|5|||
145549737|NCT01327885|524869255|FG001|Overall Study|Subject choice|10|||
145549738|NCT01327885|524869254|FG000|Overall Study|Other|8|||
145549739|NCT01327885|524869255|FG001|Overall Study|Other|6|||
145549740|NCT01327885|524869254|FG000|Overall Study|Withdrawal of consent from study|3|||
145549741|NCT01327885|524869255|FG001|Overall Study|Withdrawal of consent from study|4|||
145549742|NCT01327885|524869254|FG000|Overall Study|Not treated|1|||
145549743|NCT01327885|524869255|FG001|Overall Study|Not treated|1|||
145549744|NCT01327885|524869254|FG000|Overall Study|Administrative decision|0|||
145549745|NCT01327885|524869255|FG001|Overall Study|Administrative decision|1|||
145549746|NCT03824912|524869259|FG000|Overall Study|Lost to Follow-up|18|||
145549747|NCT03824912|524869260|FG001|Overall Study|Lost to Follow-up|15|||
145549748|NCT03824912|524869261|FG002|Overall Study|Lost to Follow-up|8|||
145549749|NCT03824912|524869259|FG000|Overall Study|Negative Baseline Culture Result|118|||
145549750|NCT03824912|524869260|FG001|Overall Study|Negative Baseline Culture Result|112|||
145549751|NCT03824912|524869261|FG002|Overall Study|Negative Baseline Culture Result|57|||
145283119|NCT00549198|523886955|FG000|Overall Study|Investigator Decision|4|||
145283120|NCT00549198|523886956|FG001|Overall Study|Investigator Decision|3|||
145549752|NCT03824912|524869259|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145549753|NCT03824912|524869260|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145549754|NCT03824912|524869261|FG002|Overall Study|Non-Compliance with Study Drug|1|||
145549755|NCT03824912|524869259|FG000|Overall Study|Protocol Violation|1|||
145549756|NCT03824912|524869260|FG001|Overall Study|Protocol Violation|4|||
145549757|NCT03824912|524869261|FG002|Overall Study|Protocol Violation|1|||
145549758|NCT03824912|524869259|FG000|Overall Study|Withdrawal by Subject|3|||
145283121|NCT00549198|523886955|FG000|Overall Study|Withdrawal by Subject|7|||
145549759|NCT03824912|524869260|FG001|Overall Study|Withdrawal by Subject|2|||
145549760|NCT03824912|524869261|FG002|Overall Study|Withdrawal by Subject|1|||
145549761|NCT03824912|524869259|FG000|Overall Study|Participation in another study|0|||
145549762|NCT03824912|524869260|FG001|Overall Study|Participation in another study|1|||
145549763|NCT03824912|524869261|FG002|Overall Study|Participation in another study|0|||
145549764|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549765|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549766|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549767|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549768|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549769|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
145549770|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
145549771|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549772|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549773|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549774|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549775|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549776|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
145549777|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
145549778|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549779|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549780|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549781|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549782|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549783|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
145549784|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
145549785|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145283122|NCT00549198|523886956|FG001|Overall Study|Withdrawal by Subject|7|||
145283123|NCT00549198|523886955|FG000|Overall Study|Disease Progression|1|||
145283124|NCT00549198|523886956|FG001|Overall Study|Disease Progression|0|||
145283125|NCT00549198|523886955|FG000|Overall Study|Participant Moved|2|||
145283126|NCT00549198|523886956|FG001|Overall Study|Participant Moved|0|||
145283127|NCT00549198|523886955|FG000|Overall Study|Participant not able to perform Week 96|1|||
145283128|NCT00549198|523886956|FG001|Overall Study|Participant not able to perform Week 96|0|||
145283129|NCT00549198|523886955|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
145283130|NCT00549198|523886956|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
145283131|NCT00549198|523886955|FG000|Overall Study|Prohibited Medication|1|||
145283132|NCT00549198|523886956|FG001|Overall Study|Prohibited Medication|2|||
145283133|NCT00549198|523886955|FG000|Overall Study|Participant planning pregnancy|1|||
145283134|NCT00549198|523886956|FG001|Overall Study|Participant planning pregnancy|0|||
145283135|NCT00549198|523886955|FG000|Overall Study|Participant overweight, no scan possible|1|||
145283136|NCT00549198|523886956|FG001|Overall Study|Participant overweight, no scan possible|0|||
145283137|NCT00549198|523886955|FG000|Overall Study|No scan facilities|0|||
145283138|NCT00549198|523886956|FG001|Overall Study|No scan facilities|2|||
145283139|NCT00549198|523886955|FG000|Overall Study|Pregnancy|0|||
145283140|NCT00549198|523886956|FG001|Overall Study|Pregnancy|3|||
145283141|NCT00549198|523886955|FG000|Overall Study|Not Exposed to Study Drug|3|||
145283142|NCT00549198|523886956|FG001|Overall Study|Not Exposed to Study Drug|4|||
145283143|NCT01473758|523886957|FG000|Cycle 1|Adverse Event|10|||
145549786|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145549787|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145549788|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145611258|NCT03321513|525092639|FG001|Overall Study|Lost to Follow-up|11|||
145283144|NCT01473758|523886958|FG001|Cycle 1|Adverse Event|2|||
145283145|NCT01473758|523886959|FG002|Cycle 1|Adverse Event|0|||
145283146|NCT01473758|523886960|FG003|Cycle 1|Adverse Event|0|||
145283147|NCT01473758|523886957|FG000|Cycle 1|Withdrawal by Subject|1|||
145549789|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145549790|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
145549791|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
145549792|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
145549793|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
145549794|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
145549795|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
145549796|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
145549797|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
145549798|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
145549799|NCT01059825|524869265|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
145549800|NCT01059825|524869266|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
145549801|NCT01059825|524869267|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
145549802|NCT01059825|524869268|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
145549803|NCT01059825|524869269|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
145549804|NCT01059825|524869270|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
145549805|NCT01059825|524869271|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
145549806|NCT01059825|524869265|FG000|Treatment Period|Lost to Follow-up|2|||
145549807|NCT01059825|524869266|FG001|Treatment Period|Lost to Follow-up|1|||
145549808|NCT01059825|524869267|FG002|Treatment Period|Lost to Follow-up|0|||
145549809|NCT01059825|524869268|FG003|Treatment Period|Lost to Follow-up|1|||
145549810|NCT01059825|524869269|FG004|Treatment Period|Lost to Follow-up|2|||
145549811|NCT01059825|524869270|FG005|Treatment Period|Lost to Follow-up|0|||
145549812|NCT01059825|524869271|FG006|Treatment Period|Lost to Follow-up|0|||
145549813|NCT01059825|524869265|FG000|Treatment Period|Withdrawal by Subject|3|||
145549814|NCT01059825|524869266|FG001|Treatment Period|Withdrawal by Subject|0|||
145549815|NCT01059825|524869267|FG002|Treatment Period|Withdrawal by Subject|1|||
145549816|NCT01059825|524869268|FG003|Treatment Period|Withdrawal by Subject|5|||
145549817|NCT01059825|524869269|FG004|Treatment Period|Withdrawal by Subject|4|||
145549818|NCT01059825|524869270|FG005|Treatment Period|Withdrawal by Subject|1|||
145549819|NCT01059825|524869271|FG006|Treatment Period|Withdrawal by Subject|0|||
145549820|NCT01059825|524869265|FG000|Treatment Period|Other reason not specified|1|||
145549821|NCT01059825|524869266|FG001|Treatment Period|Other reason not specified|2|||
145549822|NCT01059825|524869267|FG002|Treatment Period|Other reason not specified|1|||
145549823|NCT01059825|524869268|FG003|Treatment Period|Other reason not specified|2|||
145549824|NCT01059825|524869269|FG004|Treatment Period|Other reason not specified|0|||
145549825|NCT01059825|524869270|FG005|Treatment Period|Other reason not specified|0|||
145549826|NCT01059825|524869271|FG006|Treatment Period|Other reason not specified|0|||
145549827|NCT01059825|524869265|FG000|Treatment Period|Protocol Violation|0|||
145549828|NCT01059825|524869266|FG001|Treatment Period|Protocol Violation|0|||
145549829|NCT01059825|524869267|FG002|Treatment Period|Protocol Violation|1|||
145283148|NCT01473758|523886958|FG001|Cycle 1|Withdrawal by Subject|1|||
145549830|NCT01059825|524869268|FG003|Treatment Period|Protocol Violation|1|||
145283149|NCT01473758|523886959|FG002|Cycle 1|Withdrawal by Subject|0|||
145283150|NCT01473758|523886960|FG003|Cycle 1|Withdrawal by Subject|0|||
145283151|NCT01473758|523886957|FG000|Cycle 2|Adverse Event|0|||
145283152|NCT01473758|523886958|FG001|Cycle 2|Adverse Event|0|||
145283153|NCT01473758|523886959|FG002|Cycle 2|Adverse Event|5|||
145283154|NCT01473758|523886960|FG003|Cycle 2|Adverse Event|0|||
145283155|NCT02480010|523886961|FG000|Overall Study|Adverse Event|3|||
145283156|NCT02480010|523886962|FG001|Overall Study|Adverse Event|1|||
145283157|NCT02480010|523886961|FG000|Overall Study|Death|1|||
145283158|NCT02480010|523886962|FG001|Overall Study|Death|0|||
145283159|NCT02480010|523886961|FG000|Overall Study|Insufficient therapeutic response|31|||
145283160|NCT02480010|523886962|FG001|Overall Study|Insufficient therapeutic response|29|||
145283161|NCT02480010|523886961|FG000|Overall Study|Refused Treatment|0|||
145611259|NCT03029247|525092640|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
145611260|NCT03029247|525092641|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
145283162|NCT02480010|523886962|FG001|Overall Study|Refused Treatment|3|||
145283163|NCT02763579|523886972|FG000|Global Period|Death|167|||
145283164|NCT02763579|523886973|FG001|Global Period|Death|151|||
145283165|NCT02763579|523886974|FG002|Global Period|Death|0|||
145283166|NCT02763579|523886975|FG003|Global Period|Death|0|||
145283167|NCT02763579|523886972|FG000|Global Period|Lost to Follow-up|2|||
145611261|NCT03029247|525092640|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
145283168|NCT02763579|523886973|FG001|Global Period|Lost to Follow-up|4|||
145283169|NCT02763579|523886974|FG002|Global Period|Lost to Follow-up|0|||
145549831|NCT01059825|524869269|FG004|Treatment Period|Protocol Violation|1|||
145549832|NCT01059825|524869270|FG005|Treatment Period|Protocol Violation|1|||
145549833|NCT01059825|524869271|FG006|Treatment Period|Protocol Violation|0|||
145549834|NCT01059825|524869265|FG000|Treatment Period|Adverse event related to study drug|1|||
145549835|NCT01059825|524869266|FG001|Treatment Period|Adverse event related to study drug|0|||
145549836|NCT01059825|524869267|FG002|Treatment Period|Adverse event related to study drug|1|||
145549837|NCT01059825|524869268|FG003|Treatment Period|Adverse event related to study drug|1|||
145549838|NCT01059825|524869269|FG004|Treatment Period|Adverse event related to study drug|0|||
145549839|NCT01059825|524869270|FG005|Treatment Period|Adverse event related to study drug|0|||
145549840|NCT01059825|524869271|FG006|Treatment Period|Adverse event related to study drug|0|||
145549841|NCT01059825|524869265|FG000|Treatment Period|Insufficient clinical response|3|||
145549842|NCT01059825|524869266|FG001|Treatment Period|Insufficient clinical response|0|||
145549843|NCT01059825|524869267|FG002|Treatment Period|Insufficient clinical response|0|||
145549844|NCT01059825|524869268|FG003|Treatment Period|Insufficient clinical response|0|||
145549845|NCT01059825|524869269|FG004|Treatment Period|Insufficient clinical response|0|||
145549846|NCT01059825|524869270|FG005|Treatment Period|Insufficient clinical response|0|||
145549847|NCT01059825|524869271|FG006|Treatment Period|Insufficient clinical response|0|||
145549848|NCT01059825|524869265|FG000|Treatment Period|Adverse event not related to study drug|0|||
145549849|NCT01059825|524869266|FG001|Treatment Period|Adverse event not related to study drug|1|||
145549850|NCT01059825|524869267|FG002|Treatment Period|Adverse event not related to study drug|2|||
145549851|NCT01059825|524869268|FG003|Treatment Period|Adverse event not related to study drug|1|||
145549852|NCT01059825|524869269|FG004|Treatment Period|Adverse event not related to study drug|1|||
145549853|NCT01059825|524869270|FG005|Treatment Period|Adverse event not related to study drug|1|||
145549854|NCT01059825|524869271|FG006|Treatment Period|Adverse event not related to study drug|0|||
145549855|NCT03342690|524869276|FG000|Overall Study|Missing Information|9|||
145549856|NCT03342690|524869276|FG000|Overall Study|Protocol Violation|16|||
145549857|NCT02547649|524869279|FG000|Overall Study|Lost to Follow-up|3|||
145549858|NCT02547649|524869280|FG001|Overall Study|Lost to Follow-up|1|||
145549859|NCT02547649|524869281|FG002|Overall Study|Lost to Follow-up|1|||
145549860|NCT02547649|524869279|FG000|Overall Study|Not vaccinated|0|||
145549861|NCT02547649|524869280|FG001|Overall Study|Not vaccinated|0|||
145549862|NCT02547649|524869281|FG002|Overall Study|Not vaccinated|1|||
145611262|NCT03029247|525092641|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
145283170|NCT02763579|523886975|FG003|Global Period|Lost to Follow-up|0|||
145283171|NCT02763579|523886972|FG000|Global Period|Physician Decision|0|||
145549863|NCT02547649|524869279|FG000|Overall Study|Withdrawal by Subject|0|||
145283172|NCT02763579|523886973|FG001|Global Period|Physician Decision|2|||
145549864|NCT02547649|524869280|FG001|Overall Study|Withdrawal by Subject|4|||
145549865|NCT02547649|524869281|FG002|Overall Study|Withdrawal by Subject|2|||
145549866|NCT01906008|524869293|FG000|Overall Study|Lost to Follow-up|2|||
145549867|NCT01906008|524869294|FG001|Overall Study|Lost to Follow-up|0|||
145549868|NCT01906008|524869293|FG000|Overall Study|Oxaliplatin toxicity|2|||
145549869|NCT01906008|524869294|FG001|Overall Study|Oxaliplatin toxicity|0|||
145549870|NCT01906008|524869293|FG000|Overall Study|Protocol Violation|0|||
145549871|NCT01906008|524869294|FG001|Overall Study|Protocol Violation|1|||
145549872|NCT01906008|524869293|FG000|Overall Study|Withdrawal by Subject|1|||
145549873|NCT01906008|524869294|FG001|Overall Study|Withdrawal by Subject|5|||
145549874|NCT01906008|524869293|FG000|Overall Study|Did not start study med|3|||
145549875|NCT01906008|524869294|FG001|Overall Study|Did not start study med|4|||
145549876|NCT01906008|524869293|FG000|Overall Study|Oxaliplatin stops|10|||
145549877|NCT01906008|524869294|FG001|Overall Study|Oxaliplatin stops|8|||
145549878|NCT01906008|524869293|FG000|Overall Study|Hospice|1|||
145549879|NCT01906008|524869294|FG001|Overall Study|Hospice|0|||
145549880|NCT01906008|524869293|FG000|Overall Study|Physician Decision|3|||
145549881|NCT01906008|524869294|FG001|Overall Study|Physician Decision|3|||
145549882|NCT01906008|524869293|FG000|Overall Study|Lack of compliance of study med|5|||
145549883|NCT01906008|524869294|FG001|Overall Study|Lack of compliance of study med|3|||
145549884|NCT01906008|524869293|FG000|Overall Study|Adverse Event|0|||
145549885|NCT01906008|524869294|FG001|Overall Study|Adverse Event|3|||
145549886|NCT02117648|524869295|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
145549887|NCT02117648|524869295|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
145283173|NCT02763579|523886974|FG002|Global Period|Physician Decision|0|||
145283174|NCT02763579|523886975|FG003|Global Period|Physician Decision|0|||
145283175|NCT02763579|523886972|FG000|Global Period|Study Terminated By Sponsor|21|||
145283176|NCT02763579|523886973|FG001|Global Period|Study Terminated By Sponsor|26|||
145283177|NCT02763579|523886974|FG002|Global Period|Study Terminated By Sponsor|0|||
145283178|NCT02763579|523886975|FG003|Global Period|Study Terminated By Sponsor|0|||
145283179|NCT02763579|523886972|FG000|Global Period|Withdrawal by Subject|12|||
145283180|NCT02763579|523886973|FG001|Global Period|Withdrawal by Subject|18|||
145283181|NCT02763579|523886974|FG002|Global Period|Withdrawal by Subject|0|||
145283182|NCT02763579|523886975|FG003|Global Period|Withdrawal by Subject|0|||
145283183|NCT02763579|523886972|FG000|China Period|Death|0|||
145283184|NCT02763579|523886973|FG001|China Period|Death|0|||
145283185|NCT02763579|523886974|FG002|China Period|Death|46|||
145283186|NCT02763579|523886975|FG003|China Period|Death|48|||
145283187|NCT02763579|523886972|FG000|China Period|Lost to Follow-up|0|||
145283188|NCT02763579|523886973|FG001|China Period|Lost to Follow-up|0|||
145283189|NCT02763579|523886974|FG002|China Period|Lost to Follow-up|1|||
145283190|NCT02763579|523886975|FG003|China Period|Lost to Follow-up|1|||
145283191|NCT02763579|523886972|FG000|China Period|Physician Decision|0|||
145283192|NCT02763579|523886973|FG001|China Period|Physician Decision|0|||
145283193|NCT02763579|523886974|FG002|China Period|Physician Decision|0|||
145283194|NCT02763579|523886975|FG003|China Period|Physician Decision|1|||
145283195|NCT02763579|523886972|FG000|China Period|Study Terminated By Sponsor|0|||
145283196|NCT02763579|523886973|FG001|China Period|Study Terminated By Sponsor|0|||
145549888|NCT02117648|524869295|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
145549889|NCT02117648|524869295|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
145549890|NCT02117648|524869295|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
145549891|NCT02117648|524869295|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
145549892|NCT02117648|524869295|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
145616869|NCT03230864|525111361|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
145283197|NCT02763579|523886974|FG002|China Period|Study Terminated By Sponsor|3|||
145283198|NCT02763579|523886975|FG003|China Period|Study Terminated By Sponsor|4|||
145283199|NCT02763579|523886972|FG000|China Period|Withdrawal by Subject|0|||
145283200|NCT02763579|523886973|FG001|China Period|Withdrawal by Subject|0|||
145549893|NCT02117648|524869295|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
145549894|NCT02117648|524869295|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
145549895|NCT02117648|524869295|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
145549896|NCT02117648|524869295|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
145405146|NCT00855582|524340109|FG002|Overall Study|Physician Decision|1|||
145405147|NCT00855582|524340107|FG000|Overall Study|Protocol Violation|6|||
145405148|NCT00855582|524340108|FG001|Overall Study|Protocol Violation|2|||
145405149|NCT00855582|524340109|FG002|Overall Study|Protocol Violation|6|||
145405150|NCT00855582|524340107|FG000|Overall Study|Entry Criteria Not Met|8|||
145405151|NCT00855582|524340108|FG001|Overall Study|Entry Criteria Not Met|6|||
145405152|NCT00855582|524340109|FG002|Overall Study|Entry Criteria Not Met|3|||
145405153|NCT00855582|524340107|FG000|Overall Study|Withdrawal by Subject|7|||
145405154|NCT00855582|524340108|FG001|Overall Study|Withdrawal by Subject|4|||
145405155|NCT00855582|524340109|FG002|Overall Study|Withdrawal by Subject|8|||
145405156|NCT03286504|524340115|FG000|Overall Study|Lost to Follow-up|19|||
145405157|NCT03286504|524340116|FG001|Overall Study|Lost to Follow-up|16|||
145405158|NCT00656617|524340117|FG000|Overall Study|Adverse Event|1|||
145405159|NCT00656617|524340117|FG000|Overall Study|Death|2|||
145405160|NCT00656617|524340117|FG000|Overall Study|Insurance Issues|2|||
145405161|NCT00656617|524340117|FG000|Overall Study|Move to different clinical trial|2|||
145405162|NCT02030600|524340118|FG000|Treatment Period 1|Adverse Event|5|||
145405163|NCT02030600|524340119|FG001|Treatment Period 1|Adverse Event|7|||
145405164|NCT02030600|524340118|FG000|Treatment Period 1|Lack of Efficacy|0|||
145405165|NCT02030600|524340119|FG001|Treatment Period 1|Lack of Efficacy|1|||
145405166|NCT02030600|524340118|FG000|Treatment Period 1|Lost to Follow-up|11|||
145405167|NCT02030600|524340119|FG001|Treatment Period 1|Lost to Follow-up|3|||
145405168|NCT02030600|524340118|FG000|Treatment Period 1|Protocol Violation|22|||
145405169|NCT02030600|524340119|FG001|Treatment Period 1|Protocol Violation|17|||
145405170|NCT02030600|524340118|FG000|Treatment Period 1|Withdrawal by Subject|13|||
145405171|NCT02030600|524340119|FG001|Treatment Period 1|Withdrawal by Subject|17|||
145405172|NCT02030600|524340118|FG000|Treatment Period 1|Casebook Unsigned|1|||
145405173|NCT02030600|524340119|FG001|Treatment Period 1|Casebook Unsigned|0|||
145405174|NCT02030600|524340118|FG000|Treatment Period 1|Unclassified|1|||
145405175|NCT02030600|524340119|FG001|Treatment Period 1|Unclassified|0|||
145405176|NCT02030600|524340118|FG000|Treatment Period 2|Adverse Event|4|||
145405177|NCT02030600|524340119|FG001|Treatment Period 2|Adverse Event|4|||
145405178|NCT02030600|524340118|FG000|Treatment Period 2|Lack of Efficacy|2|||
145405179|NCT02030600|524340119|FG001|Treatment Period 2|Lack of Efficacy|1|||
145405180|NCT02030600|524340118|FG000|Treatment Period 2|Lost to Follow-up|4|||
145405181|NCT02030600|524340119|FG001|Treatment Period 2|Lost to Follow-up|2|||
145405182|NCT02030600|524340118|FG000|Treatment Period 2|Protocol Violation|1|||
145405183|NCT02030600|524340119|FG001|Treatment Period 2|Protocol Violation|2|||
145405184|NCT02030600|524340118|FG000|Treatment Period 2|Withdrawal by Subject|13|||
145405185|NCT02030600|524340119|FG001|Treatment Period 2|Withdrawal by Subject|9|||
145405186|NCT02030600|524340118|FG000|Treatment Period 2|Unclassified|1|||
145405187|NCT02030600|524340119|FG001|Treatment Period 2|Unclassified|0|||
145405188|NCT00634504|524340124|FG000|Overall Study|Protocol Violation|1|||
145405189|NCT00634504|524340125|FG001|Overall Study|Protocol Violation|0|||
145405190|NCT05001620|524340126|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
145405191|NCT05001620|524340127|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
145405192|NCT02736617|524340128|FG000|Treatment|Adverse Event|1|||
145405193|NCT02736617|524340128|FG000|Treatment|Lack of Efficacy|1|||
145405194|NCT02736617|524340128|FG000|Treatment|Withdrawal by Subject|1|||
145405195|NCT02736617|524340128|FG000|Maintenance|Lack of Efficacy|4|||
145405196|NCT02736617|524340128|FG000|Maintenance|Physician Decision|1|||
145549897|NCT00171730|524869297|FG000|Overall Study|Adverse Event|3|||
145283201|NCT02763579|523886974|FG002|China Period|Withdrawal by Subject|3|||
145283202|NCT02763579|523886975|FG003|China Period|Withdrawal by Subject|3|||
145283203|NCT00910858|523886986|FG000|Pharmacokinetic Phase|Adverse Event|1|||
145283204|NCT00910858|523886987|FG001|Pharmacokinetic Phase|Adverse Event|0|||
145283205|NCT00910858|523886988|FG002|Pharmacokinetic Phase|Adverse Event|0|||
145283206|NCT00910858|523886986|FG000|Monotherapy Phase|Adverse Event|3|||
145283207|NCT00910858|523886987|FG001|Monotherapy Phase|Adverse Event|2|||
145283208|NCT00910858|523886988|FG002|Monotherapy Phase|Adverse Event|0|||
145283209|NCT00910858|523886986|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
145283210|NCT00910858|523886987|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
145549898|NCT00171730|524869297|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
145405197|NCT00481676|524340131|FG000|Overall Study|Adverse Event|0|||
145405198|NCT00481676|524340132|FG001|Overall Study|Adverse Event|1|||
145405199|NCT00481676|524340131|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145405200|NCT00481676|524340132|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145405201|NCT00481676|524340131|FG000|Overall Study|Administrative problem|1|||
145405202|NCT00481676|524340132|FG001|Overall Study|Administrative problem|0|||
145283211|NCT00910858|523886988|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
145405203|NCT02911116|524340133|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145405204|NCT02911116|524340134|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145405205|NCT02911116|524340133|FG000|Overall Study|Lost to Follow-up|0|||
145405206|NCT02911116|524340134|FG001|Overall Study|Lost to Follow-up|1|||
145405207|NCT00819039|524340135|FG000|Overall Study|Physician Decision|1|||
145405208|NCT00819039|524340136|FG001|Overall Study|Physician Decision|0|||
145283212|NCT00910858|523886986|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
145283213|NCT00910858|523886987|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
145283214|NCT00910858|523886988|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
145283215|NCT00910858|523886986|FG000|Monotherapy Phase|Protocol Violation|1|||
145283216|NCT00910858|523886987|FG001|Monotherapy Phase|Protocol Violation|0|||
145283217|NCT00910858|523886988|FG002|Monotherapy Phase|Protocol Violation|0|||
145283218|NCT00910858|523886986|FG000|Monotherapy Phase|Other|3|||
145283219|NCT00910858|523886987|FG001|Monotherapy Phase|Other|4|||
145283220|NCT00910858|523886988|FG002|Monotherapy Phase|Other|2|||
145283221|NCT00910858|523886986|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
145283222|NCT00910858|523886987|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
145283223|NCT00910858|523886988|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
145283224|NCT00910858|523886986|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
145283225|NCT00910858|523886987|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
145283226|NCT00910858|523886988|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
145283227|NCT00910858|523886986|FG000|Combined Treatment Phase|Protocol Violation|1|||
145283228|NCT00910858|523886987|FG001|Combined Treatment Phase|Protocol Violation|0|||
145283229|NCT00910858|523886988|FG002|Combined Treatment Phase|Protocol Violation|0|||
145283230|NCT00910858|523886986|FG000|Combined Treatment Phase|Other|0|||
145283231|NCT00910858|523886987|FG001|Combined Treatment Phase|Other|2|||
145283232|NCT00910858|523886988|FG002|Combined Treatment Phase|Other|1|||
145283233|NCT00827827|523886989|FG000|Overall Study|Lost to Follow-up|3|||
145283234|NCT00827827|523886990|FG001|Overall Study|Lost to Follow-up|0|||
145283235|NCT00827827|523886989|FG000|Overall Study|Fall at home- hospitalization|1|||
145283236|NCT00827827|523886990|FG001|Overall Study|Fall at home- hospitalization|0|||
145283237|NCT00827827|523886989|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
145283238|NCT00827827|523886990|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
145283239|NCT00827827|523886989|FG000|Overall Study|Gout|1|||
145283240|NCT00827827|523886990|FG001|Overall Study|Gout|0|||
145283241|NCT00827827|523886989|FG000|Overall Study|Transportation issues|1|||
145283242|NCT00827827|523886990|FG001|Overall Study|Transportation issues|0|||
145283243|NCT00827827|523886989|FG000|Overall Study|Burned with water at home|1|||
145549899|NCT00171730|524869297|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
145549900|NCT00171730|524869297|FG000|Overall Study|Withdrawal by Subject|3|||
145549901|NCT05025241|524869298|FG000|Screening|Failed Screening|5|||
145549902|NCT05025241|524869298|FG000|Treatment and Follow Up|Adverse Event|3|||
145549903|NCT02220205|524869299|FG000|Overall Study|Withdrawal by Subject|1|||
145549904|NCT02220205|524869300|FG001|Overall Study|Withdrawal by Subject|0|||
145549905|NCT01465997|524869301|FG000|Overall Study|Adverse Event|12|||
145549906|NCT01465997|524869302|FG001|Overall Study|Adverse Event|22|||
145549907|NCT01465997|524869301|FG000|Overall Study|Lack of Efficacy|13|||
145549908|NCT01465997|524869302|FG001|Overall Study|Lack of Efficacy|1|||
145549909|NCT01465997|524869301|FG000|Overall Study|Protocol Violation|1|||
145549910|NCT01465997|524869302|FG001|Overall Study|Protocol Violation|4|||
145549911|NCT01465997|524869301|FG000|Overall Study|Lost to Follow-up|6|||
145549912|NCT01465997|524869302|FG001|Overall Study|Lost to Follow-up|9|||
145549913|NCT01465997|524869301|FG000|Overall Study|Withdrawal by Subject|32|||
145549914|NCT01465997|524869302|FG001|Overall Study|Withdrawal by Subject|35|||
145549915|NCT01465997|524869301|FG000|Overall Study|investigator's decision|1|||
145549916|NCT01465997|524869302|FG001|Overall Study|investigator's decision|1|||
145549917|NCT01465997|524869301|FG000|Overall Study|Death|0|||
145549918|NCT01465997|524869302|FG001|Overall Study|Death|1|||
145611263|NCT03029247|525092640|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
145611264|NCT03029247|525092641|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
145549919|NCT01465997|524869301|FG000|Overall Study|sponsor's decision|1|||
145549920|NCT01465997|524869302|FG001|Overall Study|sponsor's decision|1|||
145549921|NCT01465997|524869301|FG000|Overall Study|subject withdrew consent|1|||
145549922|NCT01465997|524869302|FG001|Overall Study|subject withdrew consent|0|||
145549923|NCT01465997|524869301|FG000|Overall Study|local lab unblinded site|1|||
145549924|NCT01465997|524869302|FG001|Overall Study|local lab unblinded site|0|||
145549925|NCT01465997|524869301|FG000|Overall Study|withdrew before follow-up|0|||
145549926|NCT01465997|524869302|FG001|Overall Study|withdrew before follow-up|13|||
145549927|NCT01465997|524869301|FG000|Overall Study|decision by site staff|0|||
145549928|NCT01465997|524869302|FG001|Overall Study|decision by site staff|1|||
145549929|NCT01465997|524869301|FG000|Overall Study|subject left participation SP0993|0|||
145549930|NCT01465997|524869302|FG001|Overall Study|subject left participation SP0993|1|||
145549931|NCT05227027|524869303|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
145549932|NCT05227027|524869304|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
145549933|NCT03552198|524869305|FG000|Overall Study|Lost to Follow-up|42|||
145549934|NCT03552198|524869306|FG001|Overall Study|Lost to Follow-up|48|||
145549935|NCT03552198|524869307|FG002|Overall Study|Lost to Follow-up|15|||
145549936|NCT03552198|524869308|FG003|Overall Study|Lost to Follow-up|19|||
145549937|NCT03552198|524869305|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
145549938|NCT03552198|524869306|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
145549939|NCT03552198|524869307|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
145549940|NCT03552198|524869308|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
145549941|NCT03552198|524869305|FG000|Overall Study|Did not receive air alerts|1|||
145549942|NCT03552198|524869306|FG001|Overall Study|Did not receive air alerts|0|||
145549943|NCT03552198|524869307|FG002|Overall Study|Did not receive air alerts|0|||
145549944|NCT03552198|524869308|FG003|Overall Study|Did not receive air alerts|1|||
145549945|NCT06149247|524869309|FG000|Overall Study|Adverse Event|0|||
145549946|NCT06149247|524869310|FG001|Overall Study|Adverse Event|1|||
145549947|NCT00855920|524869311|FG000|Overall Study|Protocol Violation|0|||
145549948|NCT00855920|524869312|FG001|Overall Study|Protocol Violation|0|||
145549949|NCT00855920|524869313|FG002|Overall Study|Protocol Violation|2|||
145549950|NCT00855920|524869311|FG000|Overall Study|Adverse Event|2|||
145549951|NCT00855920|524869312|FG001|Overall Study|Adverse Event|1|||
145549952|NCT00855920|524869313|FG002|Overall Study|Adverse Event|1|||
145549953|NCT00855920|524869311|FG000|Overall Study|Lack of Efficacy|2|||
145549954|NCT00855920|524869312|FG001|Overall Study|Lack of Efficacy|2|||
145549955|NCT00855920|524869313|FG002|Overall Study|Lack of Efficacy|2|||
145549956|NCT00855920|524869311|FG000|Overall Study|Withdrawal by Subject|2|||
145549957|NCT00855920|524869312|FG001|Overall Study|Withdrawal by Subject|3|||
145549958|NCT00855920|524869313|FG002|Overall Study|Withdrawal by Subject|2|||
145549959|NCT00855920|524869311|FG000|Overall Study|Lost to Follow-up|1|||
145549960|NCT00855920|524869312|FG001|Overall Study|Lost to Follow-up|0|||
145549961|NCT00855920|524869313|FG002|Overall Study|Lost to Follow-up|2|||
145549962|NCT00855920|524869311|FG000|Overall Study|Death|0|||
145549963|NCT00855920|524869312|FG001|Overall Study|Death|1|||
145549964|NCT00855920|524869313|FG002|Overall Study|Death|0|||
145549965|NCT00855920|524869311|FG000|Overall Study|Decision by the sponsor|0|||
145549966|NCT00855920|524869312|FG001|Overall Study|Decision by the sponsor|1|||
145549967|NCT00855920|524869313|FG002|Overall Study|Decision by the sponsor|1|||
145549968|NCT00855920|524869311|FG000|Overall Study|Other than specified above|1|||
145549969|NCT00855920|524869312|FG001|Overall Study|Other than specified above|1|||
145549970|NCT00855920|524869313|FG002|Overall Study|Other than specified above|1|||
145549971|NCT01756898|524869316|FG000|Overall Study|Adverse Event|7|||
145549972|NCT01756898|524869317|FG001|Overall Study|Adverse Event|1|||
145549973|NCT01756898|524869318|FG002|Overall Study|Adverse Event|0|||
145549974|NCT01756898|524869319|FG003|Overall Study|Adverse Event|0|||
145549975|NCT01756898|524869316|FG000|Overall Study|Lack of Efficacy|4|||
145549976|NCT01756898|524869317|FG001|Overall Study|Lack of Efficacy|7|||
145549977|NCT01756898|524869318|FG002|Overall Study|Lack of Efficacy|6|||
145549978|NCT01756898|524869319|FG003|Overall Study|Lack of Efficacy|6|||
145549979|NCT01756898|524869316|FG000|Overall Study|Lost to Follow-up|2|||
145549980|NCT01756898|524869317|FG001|Overall Study|Lost to Follow-up|4|||
145549981|NCT01756898|524869318|FG002|Overall Study|Lost to Follow-up|2|||
145549982|NCT01756898|524869319|FG003|Overall Study|Lost to Follow-up|3|||
145549983|NCT01756898|524869316|FG000|Overall Study|Protocol Violation|1|||
145549984|NCT01756898|524869317|FG001|Overall Study|Protocol Violation|2|||
145549985|NCT01756898|524869318|FG002|Overall Study|Protocol Violation|2|||
145549986|NCT01756898|524869319|FG003|Overall Study|Protocol Violation|1|||
145549987|NCT01756898|524869316|FG000|Overall Study|Withdrew Consent|5|||
145549988|NCT01756898|524869317|FG001|Overall Study|Withdrew Consent|3|||
145549989|NCT01756898|524869318|FG002|Overall Study|Withdrew Consent|5|||
145549990|NCT01756898|524869319|FG003|Overall Study|Withdrew Consent|6|||
145549991|NCT01756898|524869316|FG000|Overall Study|Other|0|||
145549992|NCT01756898|524869317|FG001|Overall Study|Other|2|||
145405209|NCT00819039|524340137|FG002|Overall Study|Physician Decision|1|||
145405210|NCT00819039|524340135|FG000|Overall Study|Protocol Violation|1|||
145405211|NCT00819039|524340136|FG001|Overall Study|Protocol Violation|0|||
145405212|NCT00819039|524340137|FG002|Overall Study|Protocol Violation|0|||
145405213|NCT04796415|524340138|FG000|Overall Study|not interested|12|||
145549993|NCT01756898|524869318|FG002|Overall Study|Other|2|||
145283244|NCT00827827|523886990|FG001|Overall Study|Burned with water at home|0|||
145283245|NCT00447603|523886995|FG000|Screening|Withdrawal by Subject|1|||
145283246|NCT00447603|523886996|FG001|Screening|Withdrawal by Subject|0|||
145283247|NCT00447603|523886997|FG002|Screening|Withdrawal by Subject|0|||
145283248|NCT00447603|523886995|FG000|Screening|Protocol Violation|1|||
145549994|NCT01756898|524869319|FG003|Overall Study|Other|0|||
145549995|NCT01500694|524869320|FG000|Overall Study|Adverse Event|4|||
145549996|NCT01500694|524869321|FG001|Overall Study|Adverse Event|3|||
145549997|NCT01500694|524869320|FG000|Overall Study|Protocol Violation|0|||
145549998|NCT01500694|524869321|FG001|Overall Study|Protocol Violation|1|||
145549999|NCT01500694|524869320|FG000|Overall Study|Withdrawal by Subject|23|||
145550000|NCT01500694|524869321|FG001|Overall Study|Withdrawal by Subject|14|||
145550001|NCT01500694|524869320|FG000|Overall Study|Lost to Follow-up|2|||
145550002|NCT01500694|524869321|FG001|Overall Study|Lost to Follow-up|3|||
145550003|NCT01500694|524869320|FG000|Overall Study|Lack of Efficacy|14|||
145283249|NCT00447603|523886996|FG001|Screening|Protocol Violation|0|||
145550004|NCT01500694|524869321|FG001|Overall Study|Lack of Efficacy|5|||
145550005|NCT01500694|524869320|FG000|Overall Study|Other|9|||
145550006|NCT01500694|524869321|FG001|Overall Study|Other|3|||
145283250|NCT00447603|523886997|FG002|Screening|Protocol Violation|0|||
145283251|NCT00447603|523886995|FG000|Screening|Screen Failure|4|||
145283252|NCT00447603|523886996|FG001|Screening|Screen Failure|0|||
145283253|NCT00447603|523886997|FG002|Screening|Screen Failure|0|||
145283254|NCT00447603|523886995|FG000|Screening|Study Terminated by Sponsor|15|||
145283255|NCT00447603|523886996|FG001|Screening|Study Terminated by Sponsor|0|||
145283256|NCT00447603|523886997|FG002|Screening|Study Terminated by Sponsor|0|||
145283257|NCT00447603|523886995|FG000|Filter Period|Adverse Event|0|||
145283258|NCT00447603|523886996|FG001|Filter Period|Adverse Event|0|||
145283259|NCT00447603|523886997|FG002|Filter Period|Adverse Event|1|||
145283260|NCT00447603|523886995|FG000|Filter Period|Screen Failure|0|||
145283261|NCT00447603|523886996|FG001|Filter Period|Screen Failure|3|||
145283262|NCT00447603|523886997|FG002|Filter Period|Screen Failure|4|||
145283263|NCT00447603|523886995|FG000|Filter Period|Study terminated by Sponsor|0|||
145283264|NCT00447603|523886996|FG001|Filter Period|Study terminated by Sponsor|1|||
145283265|NCT00447603|523886997|FG002|Filter Period|Study terminated by Sponsor|10|||
145283266|NCT01165684|523887004|FG000|Overall Study|Adverse Event|1|||
145283267|NCT01165684|523887005|FG001|Overall Study|Adverse Event|1|||
145283268|NCT01165684|523887004|FG000|Overall Study|Lack of Efficacy|2|||
145283269|NCT01165684|523887005|FG001|Overall Study|Lack of Efficacy|1|||
145283270|NCT01165684|523887004|FG000|Overall Study|Protocol Violation|7|||
145283271|NCT01165684|523887005|FG001|Overall Study|Protocol Violation|15|||
145283272|NCT01165684|523887004|FG000|Overall Study|Withdrawal Criteria|2|||
145283273|NCT01165684|523887005|FG001|Overall Study|Withdrawal Criteria|13|||
145283274|NCT01165684|523887004|FG000|Overall Study|Unclassified|16|||
145283275|NCT01165684|523887005|FG001|Overall Study|Unclassified|22|||
145283276|NCT00901628|523887024|FG000|Overall Study|disconnection of catheter|4|||
145283277|NCT00901628|523887025|FG001|Overall Study|disconnection of catheter|8|||
145550007|NCT03572062|524869322|FG000|Overall Study|Adverse Event|0|||
145550008|NCT03572062|524869323|FG001|Overall Study|Adverse Event|0|||
145550009|NCT03572062|524869324|FG002|Overall Study|Adverse Event|0|||
145550010|NCT03572062|524869325|FG003|Overall Study|Adverse Event|0|||
145550011|NCT03572062|524869326|FG004|Overall Study|Adverse Event|0|||
145283278|NCT00901628|523887024|FG000|Overall Study|disconnection of drain|0|||
145405214|NCT04796415|524340138|FG000|Overall Study|health issue|8|||
145550012|NCT03572062|524869327|FG005|Overall Study|Adverse Event|0|||
145550013|NCT03572062|524869328|FG006|Overall Study|Adverse Event|0|||
145283279|NCT00901628|523887025|FG001|Overall Study|disconnection of drain|1|||
145283280|NCT00901628|523887024|FG000|Overall Study|peroneal nerve palsy|0|||
145550014|NCT03572062|524869329|FG007|Overall Study|Adverse Event|0|||
145283281|NCT00901628|523887025|FG001|Overall Study|peroneal nerve palsy|1|||
145550015|NCT03572062|524869330|FG008|Overall Study|Adverse Event|1|||
145283282|NCT00608205|523887026|FG000|Overall Study|Adverse Event|3|||
145550016|NCT03572062|524869331|FG009|Overall Study|Adverse Event|3|||
145550017|NCT03572062|524869322|FG000|Overall Study|Death|0|||
145283283|NCT00608205|523887027|FG001|Overall Study|Adverse Event|2|||
145283284|NCT00608205|523887026|FG000|Overall Study|Patient non-compliant|0|||
145283285|NCT00608205|523887027|FG001|Overall Study|Patient non-compliant|1|||
145283286|NCT00909727|523887033|FG000|Overall Study|Adverse Event|1|||
145550018|NCT03572062|524869323|FG001|Overall Study|Death|0|||
145550019|NCT03572062|524869324|FG002|Overall Study|Death|0|||
145283287|NCT00909727|523887034|FG001|Overall Study|Adverse Event|0|||
145283288|NCT00909727|523887033|FG000|Overall Study|Wrong Genotype|1|||
145405215|NCT04796415|524340138|FG000|Overall Study|Other|4|||
145405216|NCT04796415|524340138|FG000|Overall Study|discharged from home health service|3|||
145405217|NCT04796415|524340138|FG000|Overall Study|re-hospitalization|2|||
145550020|NCT03572062|524869325|FG003|Overall Study|Death|0|||
145550021|NCT03572062|524869326|FG004|Overall Study|Death|0|||
145550022|NCT03572062|524869327|FG005|Overall Study|Death|1|||
145550023|NCT03572062|524869328|FG006|Overall Study|Death|0|||
145550024|NCT03572062|524869329|FG007|Overall Study|Death|0|||
145550025|NCT03572062|524869330|FG008|Overall Study|Death|0|||
145550026|NCT03572062|524869331|FG009|Overall Study|Death|0|||
145550027|NCT03572062|524869322|FG000|Overall Study|Lost to Follow-up|0|||
145283289|NCT00909727|523887034|FG001|Overall Study|Wrong Genotype|0|||
145283290|NCT00909727|523887033|FG000|Overall Study|Withdrawal of Consent|1|||
145283291|NCT00909727|523887034|FG001|Overall Study|Withdrawal of Consent|0|||
145283292|NCT00909727|523887033|FG000|Overall Study|Prohibited Medication|1|||
145283293|NCT00909727|523887034|FG001|Overall Study|Prohibited Medication|0|||
145283294|NCT01339910|523887036|FG000|Overall Study|Withdrawal by Subject|1|||
145283295|NCT01339910|523887037|FG001|Overall Study|Withdrawal by Subject|0|||
145283296|NCT01339910|523887036|FG000|Overall Study|Physician Decision|1|||
145283297|NCT01339910|523887037|FG001|Overall Study|Physician Decision|0|||
145283298|NCT01339910|523887036|FG000|Overall Study|Disease relapse|1|||
145283299|NCT01339910|523887037|FG001|Overall Study|Disease relapse|4|||
145283300|NCT01567306|523887039|FG000|Overall Study|Protocol Violation|2|||
145283301|NCT01567306|523887040|FG001|Overall Study|Protocol Violation|2|||
145283302|NCT01567306|523887041|FG002|Overall Study|Protocol Violation|0|||
145283303|NCT01567306|523887042|FG003|Overall Study|Protocol Violation|3|||
145283304|NCT01567306|523887043|FG004|Overall Study|Protocol Violation|1|||
145283305|NCT01567306|523887044|FG005|Overall Study|Protocol Violation|1|||
145283306|NCT01567306|523887039|FG000|Overall Study|Change site living|1|||
145283307|NCT01567306|523887040|FG001|Overall Study|Change site living|0|||
145283308|NCT01567306|523887041|FG002|Overall Study|Change site living|0|||
145283309|NCT01567306|523887042|FG003|Overall Study|Change site living|0|||
145283310|NCT01567306|523887043|FG004|Overall Study|Change site living|0|||
145283311|NCT01567306|523887044|FG005|Overall Study|Change site living|0|||
145550028|NCT03572062|524869323|FG001|Overall Study|Lost to Follow-up|0|||
145550029|NCT03572062|524869324|FG002|Overall Study|Lost to Follow-up|0|||
145550030|NCT03572062|524869325|FG003|Overall Study|Lost to Follow-up|0|||
145550031|NCT03572062|524869326|FG004|Overall Study|Lost to Follow-up|0|||
145550032|NCT03572062|524869327|FG005|Overall Study|Lost to Follow-up|1|||
145550033|NCT03572062|524869328|FG006|Overall Study|Lost to Follow-up|1|||
145550034|NCT03572062|524869329|FG007|Overall Study|Lost to Follow-up|0|||
145550035|NCT03572062|524869330|FG008|Overall Study|Lost to Follow-up|0|||
145550036|NCT03572062|524869331|FG009|Overall Study|Lost to Follow-up|0|||
145550037|NCT03572062|524869322|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550038|NCT03572062|524869323|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550039|NCT03572062|524869324|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550040|NCT03572062|524869325|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550041|NCT03572062|524869326|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550042|NCT03572062|524869327|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550043|NCT03572062|524869328|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550044|NCT03572062|524869329|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550045|NCT03572062|524869330|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
145283312|NCT01567306|523887039|FG000|Overall Study|Adverse Event|0|||
145283313|NCT01567306|523887040|FG001|Overall Study|Adverse Event|0|||
145283314|NCT01567306|523887041|FG002|Overall Study|Adverse Event|0|||
145405218|NCT04796415|524340138|FG000|Overall Study|moving to nursing home|1|||
145283315|NCT01567306|523887042|FG003|Overall Study|Adverse Event|2|||
145283316|NCT01567306|523887043|FG004|Overall Study|Adverse Event|4|||
145283317|NCT01567306|523887044|FG005|Overall Study|Adverse Event|1|||
145283318|NCT01567306|523887039|FG000|Overall Study|Lost to Follow-up|0|||
145405219|NCT04796415|524340138|FG000|Overall Study|lost contact|1|||
145405220|NCT01240694|524340139|FG000|Overall Study|Adverse Event|9|||
145550046|NCT03572062|524869331|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
145550047|NCT03572062|524869322|FG000|Overall Study|Study Terminated By Sponsor|0|||
145550048|NCT03572062|524869323|FG001|Overall Study|Study Terminated By Sponsor|0|||
145550049|NCT03572062|524869324|FG002|Overall Study|Study Terminated By Sponsor|0|||
145550050|NCT03572062|524869325|FG003|Overall Study|Study Terminated By Sponsor|0|||
145283319|NCT01567306|523887040|FG001|Overall Study|Lost to Follow-up|0|||
145283320|NCT01567306|523887041|FG002|Overall Study|Lost to Follow-up|0|||
145283321|NCT01567306|523887042|FG003|Overall Study|Lost to Follow-up|0|||
145283322|NCT01567306|523887043|FG004|Overall Study|Lost to Follow-up|2|||
145283323|NCT01567306|523887044|FG005|Overall Study|Lost to Follow-up|0|||
145283324|NCT01567306|523887039|FG000|Overall Study|Withdrawal by Subject|0|||
145550051|NCT03572062|524869326|FG004|Overall Study|Study Terminated By Sponsor|0|||
145550052|NCT03572062|524869327|FG005|Overall Study|Study Terminated By Sponsor|0|||
145283325|NCT01567306|523887040|FG001|Overall Study|Withdrawal by Subject|0|||
145283326|NCT01567306|523887041|FG002|Overall Study|Withdrawal by Subject|0|||
145283327|NCT01567306|523887042|FG003|Overall Study|Withdrawal by Subject|0|||
145283328|NCT01567306|523887043|FG004|Overall Study|Withdrawal by Subject|0|||
145283329|NCT01567306|523887044|FG005|Overall Study|Withdrawal by Subject|1|||
145283330|NCT00829413|523887049|FG000|Overall Study|No study drug admimnistered|13|||
145283331|NCT00829413|523887049|FG000|Overall Study|Training Patients|67|||
145283332|NCT00829413|523887049|FG000|Overall Study|No truth standard procedure available|9|||
145283333|NCT00829413|523887049|FG000|Overall Study|Technically inadequate truth standard|2|||
145283334|NCT00829413|523887049|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
145550053|NCT03572062|524869328|FG006|Overall Study|Study Terminated By Sponsor|0|||
145550054|NCT03572062|524869329|FG007|Overall Study|Study Terminated By Sponsor|0|||
145550055|NCT03572062|524869330|FG008|Overall Study|Study Terminated By Sponsor|29|||
145550056|NCT03572062|524869331|FG009|Overall Study|Study Terminated By Sponsor|27|||
145550057|NCT03572062|524869322|FG000|Overall Study|Physician Decision|0|||
145283335|NCT04272775|523887051|FG000|Overall Study|Study Terminated by Sponsor|1|||
145550058|NCT03572062|524869323|FG001|Overall Study|Physician Decision|0|||
145550059|NCT03572062|524869324|FG002|Overall Study|Physician Decision|0|||
145550060|NCT03572062|524869325|FG003|Overall Study|Physician Decision|0|||
145550061|NCT03572062|524869326|FG004|Overall Study|Physician Decision|0|||
145550062|NCT03572062|524869327|FG005|Overall Study|Physician Decision|0|||
145283336|NCT04272775|523887052|FG001|Overall Study|Study Terminated by Sponsor|0|||
145283337|NCT04272775|523887051|FG000|Overall Study|Protocol Violation|0|||
145283338|NCT04272775|523887052|FG001|Overall Study|Protocol Violation|1|||
145283339|NCT04272775|523887051|FG000|Overall Study|Symptomatic Deterioration|1|||
145283340|NCT04272775|523887052|FG001|Overall Study|Symptomatic Deterioration|1|||
145283341|NCT04272775|523887051|FG000|Overall Study|Withdrawal by Subject|1|||
145283342|NCT04272775|523887052|FG001|Overall Study|Withdrawal by Subject|2|||
145283343|NCT04272775|523887051|FG000|Overall Study|Adverse Event|1|||
145283344|NCT04272775|523887052|FG001|Overall Study|Adverse Event|2|||
145283345|NCT04272775|523887051|FG000|Overall Study|Progressive Disease|3|||
145283346|NCT04272775|523887052|FG001|Overall Study|Progressive Disease|1|||
145283347|NCT00738673|523887053|FG000|Overall Study|Adverse Event|1|||
145283348|NCT00738673|523887054|FG001|Overall Study|Adverse Event|0|||
145283349|NCT00738673|523887053|FG000|Overall Study|Lack of Efficacy|19|||
145283350|NCT00738673|523887054|FG001|Overall Study|Lack of Efficacy|8|||
145283351|NCT00738673|523887053|FG000|Overall Study|Protocol Violation|1|||
145283352|NCT00738673|523887054|FG001|Overall Study|Protocol Violation|2|||
145283353|NCT00738673|523887053|FG000|Overall Study|Withdrawal by Subject|3|||
145283354|NCT00738673|523887054|FG001|Overall Study|Withdrawal by Subject|1|||
145283355|NCT00891774|523887055|FG000|Overall Study|Lost to Follow-up|5|||
145283356|NCT00891774|523887055|FG000|Overall Study|Illness (Self/Mother)|3|||
145283357|NCT00891774|523887055|FG000|Overall Study|Withdrawal by Subject|2|||
145283358|NCT00891774|523887055|FG000|Overall Study|Protocol Violation|4|||
145283359|NCT03175120|523887057|FG000|Overall Study|Adverse Event|2|||
145283360|NCT03175120|523887058|FG001|Overall Study|Adverse Event|2|||
145283361|NCT03175120|523887057|FG000|Overall Study|Protocol Violation|5|||
145283362|NCT03175120|523887058|FG001|Overall Study|Protocol Violation|2|||
145283363|NCT03175120|523887057|FG000|Overall Study|Lost to Follow-up|1|||
145283364|NCT03175120|523887058|FG001|Overall Study|Lost to Follow-up|0|||
145283365|NCT03175120|523887057|FG000|Overall Study|Withdrawal by Subject|2|||
145405221|NCT01240694|524340139|FG000|Overall Study|Lack of Efficacy|6|||
145405222|NCT01240694|524340139|FG000|Overall Study|Withdrawal by Subject|6|||
145550063|NCT03572062|524869328|FG006|Overall Study|Physician Decision|0|||
145550064|NCT03572062|524869329|FG007|Overall Study|Physician Decision|0|||
145405223|NCT01240694|524340139|FG000|Overall Study|Protocol Violation|2|||
145405224|NCT01240694|524340139|FG000|Overall Study|Lost to Follow-up|2|||
145405225|NCT01240694|524340139|FG000|Overall Study|Other than specified|3|||
145283366|NCT03175120|523887058|FG001|Overall Study|Withdrawal by Subject|5|||
145283367|NCT03175120|523887057|FG000|Overall Study|Other|2|||
145283368|NCT03175120|523887058|FG001|Overall Study|Other|3|||
145283369|NCT02436135|523887061|FG000|Overall Study|Progressive Disease|3|||
145283370|NCT02436135|523887062|FG001|Overall Study|Progressive Disease|1|||
145283371|NCT02436135|523887061|FG000|Overall Study|Investigator Discretion|1|||
145283372|NCT02436135|523887062|FG001|Overall Study|Investigator Discretion|2|||
145283373|NCT02436135|523887061|FG000|Overall Study|Adverse Event|1|||
145283374|NCT02436135|523887062|FG001|Overall Study|Adverse Event|0|||
145283375|NCT02436135|523887061|FG000|Overall Study|Withdrawal by Participant|1|||
145283376|NCT02436135|523887062|FG001|Overall Study|Withdrawal by Participant|0|||
145283377|NCT02436135|523887061|FG000|Overall Study|Study Terminated By Sponsor|0|||
145283378|NCT02436135|523887062|FG001|Overall Study|Study Terminated By Sponsor|1|||
145283379|NCT00475852|523887063|FG000|Overall Study|Death|444|||
145283380|NCT00475852|523887064|FG001|Overall Study|Death|456|||
145283381|NCT00475852|523887063|FG000|Overall Study|Withdrawal by Subject|19|||
145283382|NCT00475852|523887064|FG001|Overall Study|Withdrawal by Subject|24|||
145283383|NCT00475852|523887063|FG000|Overall Study|Lost to Follow-up|54|||
145283384|NCT00475852|523887064|FG001|Overall Study|Lost to Follow-up|68|||
145283385|NCT02063698|523887065|FG000|Overall Study|did not complete booklet for days 2-8|1|||
145283386|NCT02063698|523887066|FG001|Overall Study|did not complete booklet for days 2-8|2|||
145283387|NCT00297479|523887067|FG000|Overall Study|Lost to Follow-up|37|||
145283388|NCT00297479|523887068|FG001|Overall Study|Lost to Follow-up|54|||
145283389|NCT00297479|523887069|FG002|Overall Study|Lost to Follow-up|51|||
145283390|NCT01664494|523887070|FG000|Overall Study|Withdrawal by Subject|27|||
145283391|NCT01664494|523887070|FG000|Overall Study|Death|18|||
145283392|NCT01664494|523887070|FG000|Overall Study|Other|49|||
145283393|NCT01664494|523887070|FG000|Overall Study|Lost to Follow-up|99|||
145283394|NCT03263819|523887071|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
145283395|NCT03263819|523887072|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
145283396|NCT01427803|523887074|FG000|Overall Study|Lost to Follow-up|32|||
145283397|NCT01427803|523887075|FG001|Overall Study|Lost to Follow-up|26|||
145283398|NCT01427803|523887074|FG000|Overall Study|Withdrawal by Subject|20|||
145283399|NCT01427803|523887075|FG001|Overall Study|Withdrawal by Subject|0|||
145283400|NCT01427803|523887074|FG000|Overall Study|Unable to complete full treatment period|6|||
145283401|NCT01427803|523887075|FG001|Overall Study|Unable to complete full treatment period|0|||
145283402|NCT01427803|523887074|FG000|Overall Study|Protocol Violation|1|||
145283403|NCT01427803|523887075|FG001|Overall Study|Protocol Violation|0|||
145550065|NCT03572062|524869330|FG008|Overall Study|Physician Decision|1|||
145550066|NCT03572062|524869331|FG009|Overall Study|Physician Decision|0|||
145550067|NCT03572062|524869322|FG000|Overall Study|Withdrawal by Subject|0|||
145550068|NCT03572062|524869323|FG001|Overall Study|Withdrawal by Subject|0|||
145550069|NCT03572062|524869324|FG002|Overall Study|Withdrawal by Subject|0|||
145550070|NCT03572062|524869325|FG003|Overall Study|Withdrawal by Subject|0|||
145550071|NCT03572062|524869326|FG004|Overall Study|Withdrawal by Subject|0|||
145550072|NCT03572062|524869327|FG005|Overall Study|Withdrawal by Subject|0|||
145550073|NCT03572062|524869328|FG006|Overall Study|Withdrawal by Subject|0|||
145550074|NCT03572062|524869329|FG007|Overall Study|Withdrawal by Subject|0|||
145550075|NCT03572062|524869330|FG008|Overall Study|Withdrawal by Subject|0|||
145550076|NCT03572062|524869331|FG009|Overall Study|Withdrawal by Subject|1|||
145550077|NCT03572062|524869322|FG000|Overall Study|Randomized But Not Treated|0|||
145550078|NCT03572062|524869323|FG001|Overall Study|Randomized But Not Treated|0|||
145550079|NCT03572062|524869324|FG002|Overall Study|Randomized But Not Treated|0|||
145550080|NCT03572062|524869325|FG003|Overall Study|Randomized But Not Treated|0|||
145550081|NCT03572062|524869326|FG004|Overall Study|Randomized But Not Treated|1|||
145405226|NCT01240694|524340139|FG000|Overall Study|Withdrawn due to early study termination|107|||
145405227|NCT01513590|524340140|FG000|Overall Study|Adverse Event|2|||
145405228|NCT01513590|524340141|FG001|Overall Study|Adverse Event|3|||
145405229|NCT01513590|524340140|FG000|Overall Study|Withdrawal Criteria|3|||
145550082|NCT03572062|524869327|FG005|Overall Study|Randomized But Not Treated|2|||
145405230|NCT01513590|524340141|FG001|Overall Study|Withdrawal Criteria|0|||
145550083|NCT03572062|524869328|FG006|Overall Study|Randomized But Not Treated|0|||
145550084|NCT03572062|524869329|FG007|Overall Study|Randomized But Not Treated|1|||
145550085|NCT03572062|524869330|FG008|Overall Study|Randomized But Not Treated|0|||
145283404|NCT01427803|523887074|FG000|Overall Study|Physician Decision|3|||
145283405|NCT01427803|523887075|FG001|Overall Study|Physician Decision|0|||
145550086|NCT03572062|524869331|FG009|Overall Study|Randomized But Not Treated|0|||
145550087|NCT01691781|524869332|FG000|Overall Study|Withdrawal by Subject|4|||
145550088|NCT01691781|524869333|FG001|Overall Study|Withdrawal by Subject|3|||
145550089|NCT01691781|524869332|FG000|Overall Study|Physician Decision|1|||
145550090|NCT01691781|524869333|FG001|Overall Study|Physician Decision|1|||
145550091|NCT01691781|524869332|FG000|Overall Study|Protocol Violation|2|||
145550092|NCT01691781|524869333|FG001|Overall Study|Protocol Violation|2|||
145550093|NCT01691781|524869332|FG000|Overall Study|Adverse Event|0|||
145550094|NCT01691781|524869333|FG001|Overall Study|Adverse Event|1|||
145550095|NCT01918085|524869334|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
145550096|NCT01918085|524869335|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
145550097|NCT02132130|524869336|FG000|Overall Study|Lost to Follow-up|0|||
145550098|NCT02132130|524869337|FG001|Overall Study|Lost to Follow-up|2|||
145550099|NCT02132130|524869338|FG002|Overall Study|Lost to Follow-up|0|||
145550100|NCT02132130|524869339|FG003|Overall Study|Lost to Follow-up|0|||
145550101|NCT02132130|524869336|FG000|Overall Study|Withdrawal by Subject|0|||
145550102|NCT02132130|524869337|FG001|Overall Study|Withdrawal by Subject|0|||
145550103|NCT02132130|524869338|FG002|Overall Study|Withdrawal by Subject|0|||
145550104|NCT02132130|524869339|FG003|Overall Study|Withdrawal by Subject|1|||
145550105|NCT02760069|524869342|FG000|Overall Study|Withdrawal by Subject|0|||
145550106|NCT02760069|524869343|FG001|Overall Study|Withdrawal by Subject|1|||
145550107|NCT02760069|524869344|FG002|Overall Study|Withdrawal by Subject|1|||
145550108|NCT00646776|524869352|FG000|Overall Study|Adverse Event|1|||
145550109|NCT00646776|524869353|FG001|Overall Study|Adverse Event|9|||
145550110|NCT00646776|524869352|FG000|Overall Study|Investigator discretion|0|||
145550111|NCT00646776|524869353|FG001|Overall Study|Investigator discretion|4|||
145283406|NCT01427803|523887074|FG000|Overall Study|did not take product|1|||
145550112|NCT00600483|524869357|FG000|Overall Study|Lost to Follow-up|26|||
145550113|NCT00600483|524869358|FG001|Overall Study|Lost to Follow-up|47|||
145550114|NCT00600483|524869357|FG000|Overall Study|Randomized but not treated|10|||
145550115|NCT00600483|524869358|FG001|Overall Study|Randomized but not treated|0|||
145550116|NCT04557371|524869366|FG000|Overall Study|Covid-19-related|0|||
145550117|NCT04557371|524869367|FG001|Overall Study|Covid-19-related|1|||
145405231|NCT01513590|524340140|FG000|Overall Study|Unclassified|5|||
145550118|NCT04557371|524869368|FG002|Overall Study|Covid-19-related|0|||
145283407|NCT01427803|523887075|FG001|Overall Study|did not take product|0|||
145283408|NCT00863057|523887076|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
145283409|NCT00863057|523887077|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
145283410|NCT00863057|523887078|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
145283411|NCT00863057|523887079|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
145283412|NCT00863057|523887076|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
145283413|NCT00863057|523887077|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
145283414|NCT00863057|523887078|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
145405232|NCT01513590|524340141|FG001|Overall Study|Unclassified|10|||
145405233|NCT02110693|524340142|FG000|Overall Study|Withdrawal by Subject|6|||
145550119|NCT04557371|524869366|FG000|Overall Study|Withdrawal by Subject|0|||
145550120|NCT04557371|524869367|FG001|Overall Study|Withdrawal by Subject|1|||
145550121|NCT04557371|524869368|FG002|Overall Study|Withdrawal by Subject|0|||
145550122|NCT04557371|524869366|FG000|Overall Study|Adverse Event|1|||
145550123|NCT04557371|524869367|FG001|Overall Study|Adverse Event|0|||
145550124|NCT04557371|524869368|FG002|Overall Study|Adverse Event|0|||
145550125|NCT01325584|524869373|FG000|Overall Study|Death|1|||
145550126|NCT00524368|524871261|FG000|Overall Study|Adverse Event|10|||
145550127|NCT00524368|524871262|FG001|Overall Study|Adverse Event|12|||
145550128|NCT00524368|524871261|FG000|Overall Study|Lost to Follow-up|9|||
145550129|NCT00524368|524871262|FG001|Overall Study|Lost to Follow-up|13|||
145550130|NCT00524368|524871261|FG000|Overall Study|Withdrawal by Subject|4|||
145550131|NCT00524368|524871262|FG001|Overall Study|Withdrawal by Subject|5|||
145550132|NCT00524368|524871261|FG000|Overall Study|Non-compliant|8|||
145550133|NCT00524368|524871262|FG001|Overall Study|Non-compliant|9|||
145283415|NCT00863057|523887079|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
145283416|NCT00863057|523887076|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
145283417|NCT00863057|523887077|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
145283418|NCT00863057|523887078|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
145283419|NCT00863057|523887079|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
145283420|NCT00863057|523887076|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
145283421|NCT00863057|523887077|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
145283422|NCT00863057|523887078|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
145283423|NCT00863057|523887079|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
145283424|NCT03412019|523887082|FG000|Overall Study|Withdrawal by Subject|1|||
145283425|NCT03412019|523887083|FG001|Overall Study|Withdrawal by Subject|1|||
145283426|NCT01612156|523887087|FG000|Overall Study|Protocol Violation|2|||
145283427|NCT01612156|523887088|FG001|Overall Study|Protocol Violation|0|||
145283428|NCT01023269|523887089|FG000|Overall Study|early termination of the study|2|||
145283429|NCT01023269|523887090|FG001|Overall Study|early termination of the study|0|||
145283430|NCT01953783|523887091|FG000|Overall Study|Progressive disease|2|||
145283431|NCT02974114|523887101|FG000|Overall Study|Other (Not specified)|0|||
145283432|NCT02974114|523887102|FG001|Overall Study|Other (Not specified)|1|||
145283433|NCT02974114|523887103|FG002|Overall Study|Other (Not specified)|2|||
145283434|NCT00545233|523887104|FG000|Overall Study|Adverse Event|10|||
145283435|NCT00545233|523887105|FG001|Overall Study|Adverse Event|5|||
145283436|NCT00545233|523887104|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
145405234|NCT02110693|524340143|FG001|Overall Study|Withdrawal by Subject|7|||
145550134|NCT00524368|524871261|FG000|Overall Study|Reached a Virologic Endpoint|3|||
145550135|NCT00524368|524871262|FG001|Overall Study|Reached a Virologic Endpoint|2|||
145550136|NCT00524368|524871261|FG000|Overall Study|Sponsor's Decision|2|||
145550137|NCT00524368|524871262|FG001|Overall Study|Sponsor's Decision|0|||
145283437|NCT00545233|523887105|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145550138|NCT00524368|524871261|FG000|Overall Study|Ineligible to Continue the study|2|||
145550139|NCT00524368|524871262|FG001|Overall Study|Ineligible to Continue the study|5|||
145550140|NCT00524368|524871261|FG000|Overall Study|Other|3|||
145550141|NCT00524368|524871262|FG001|Overall Study|Other|2|||
145550142|NCT01955733|524871263|FG000|Period 1|Lost to Follow-up|1|||
145550143|NCT01955733|524871264|FG001|Period 1|Lost to Follow-up|0|||
145550144|NCT01955733|524871265|FG002|Period 1|Lost to Follow-up|0|||
145550145|NCT01955733|524871263|FG000|Period 2|Adverse Event|1|||
145550146|NCT01955733|524871264|FG001|Period 2|Adverse Event|0|||
145550147|NCT01955733|524871265|FG002|Period 2|Adverse Event|0|||
145550148|NCT01955733|524871263|FG000|Period 2|Physician Decision|0|||
145550149|NCT01955733|524871264|FG001|Period 2|Physician Decision|0|||
145550150|NCT01955733|524871265|FG002|Period 2|Physician Decision|1|||
145550151|NCT01955733|524871263|FG000|Period 2|Withdrawal by Subject|1|||
145550152|NCT01955733|524871264|FG001|Period 2|Withdrawal by Subject|3|||
145550153|NCT01955733|524871265|FG002|Period 2|Withdrawal by Subject|2|||
145550154|NCT01955733|524871263|FG000|Period 2|Study terminated by sponsor|8|||
145550155|NCT01955733|524871264|FG001|Period 2|Study terminated by sponsor|14|||
145550156|NCT01955733|524871265|FG002|Period 2|Study terminated by sponsor|16|||
145550157|NCT01955733|524871263|FG000|Period 2|Lost to Follow-up|2|||
145550158|NCT01955733|524871264|FG001|Period 2|Lost to Follow-up|0|||
145550159|NCT01955733|524871265|FG002|Period 2|Lost to Follow-up|0|||
145550160|NCT01955733|524871263|FG000|Period 2|Other not defined above|0|||
145550161|NCT01955733|524871264|FG001|Period 2|Other not defined above|2|||
145550162|NCT01955733|524871265|FG002|Period 2|Other not defined above|2|||
145550163|NCT02154490|524871266|FG000|Overall Study|No tissue submitted|23|||
145550164|NCT02154490|524871266|FG000|Overall Study|No biomarker results|167|||
145550165|NCT02154490|524871266|FG000|Overall Study|Not assigned to a sub-study|270|||
145550166|NCT02154490|524871266|FG000|Overall Study|Did not register to a sub-study|749|||
145550167|NCT00418314|524871285|FG000|Overall Study|Withdrawal by Subject|1|||
145550168|NCT00418314|524871286|FG001|Overall Study|Withdrawal by Subject|2|||
145550169|NCT02289690|524871291|FG000|Overall Study|Adverse Event Related to Progression|0|||
145550170|NCT02289690|524871292|FG001|Overall Study|Adverse Event Related to Progression|1|||
145550171|NCT02289690|524871293|FG002|Overall Study|Adverse Event Related to Progression|1|||
145550172|NCT02289690|524871294|FG003|Overall Study|Adverse Event Related to Progression|0|||
145550173|NCT02289690|524871295|FG004|Overall Study|Adverse Event Related to Progression|1|||
145550174|NCT02289690|524871296|FG005|Overall Study|Adverse Event Related to Progression|0|||
145550175|NCT02289690|524871297|FG006|Overall Study|Adverse Event Related to Progression|1|||
145550176|NCT02289690|524871298|FG007|Overall Study|Adverse Event Related to Progression|0|||
145550177|NCT02289690|524871299|FG008|Overall Study|Adverse Event Related to Progression|0|||
145550178|NCT02289690|524871300|FG009|Overall Study|Adverse Event Related to Progression|0|||
145550179|NCT02289690|524871291|FG000|Overall Study|Withdrawal by Subject|1|||
145550180|NCT02289690|524871292|FG001|Overall Study|Withdrawal by Subject|0|||
145550181|NCT02289690|524871293|FG002|Overall Study|Withdrawal by Subject|0|||
145550182|NCT02289690|524871294|FG003|Overall Study|Withdrawal by Subject|0|||
145550183|NCT02289690|524871295|FG004|Overall Study|Withdrawal by Subject|1|||
145550184|NCT02289690|524871296|FG005|Overall Study|Withdrawal by Subject|1|||
145550185|NCT02289690|524871297|FG006|Overall Study|Withdrawal by Subject|0|||
145550186|NCT02289690|524871298|FG007|Overall Study|Withdrawal by Subject|0|||
145550187|NCT02289690|524871299|FG008|Overall Study|Withdrawal by Subject|4|||
145550188|NCT02289690|524871300|FG009|Overall Study|Withdrawal by Subject|2|||
145550189|NCT02289690|524871291|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
145550190|NCT02289690|524871292|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
145550191|NCT02289690|524871293|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
145550192|NCT02289690|524871294|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
145550193|NCT02289690|524871295|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
145550194|NCT02289690|524871296|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
145550195|NCT02289690|524871297|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
145550196|NCT02289690|524871298|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
145550197|NCT02289690|524871299|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
145550198|NCT02289690|524871300|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
145550199|NCT02289690|524871291|FG000|Overall Study|Lost to Follow-up|0|||
145550200|NCT02289690|524871292|FG001|Overall Study|Lost to Follow-up|0|||
145550201|NCT02289690|524871293|FG002|Overall Study|Lost to Follow-up|0|||
145550202|NCT02289690|524871294|FG003|Overall Study|Lost to Follow-up|0|||
145550203|NCT02289690|524871295|FG004|Overall Study|Lost to Follow-up|0|||
145550204|NCT02289690|524871296|FG005|Overall Study|Lost to Follow-up|0|||
145550205|NCT02289690|524871297|FG006|Overall Study|Lost to Follow-up|0|||
145550206|NCT02289690|524871298|FG007|Overall Study|Lost to Follow-up|1|||
145550207|NCT02289690|524871299|FG008|Overall Study|Lost to Follow-up|0|||
145550208|NCT02289690|524871300|FG009|Overall Study|Lost to Follow-up|2|||
145550209|NCT02289690|524871291|FG000|Overall Study|Death|0|||
145550210|NCT02289690|524871292|FG001|Overall Study|Death|0|||
145550211|NCT02289690|524871293|FG002|Overall Study|Death|0|||
145550212|NCT02289690|524871294|FG003|Overall Study|Death|0|||
145550213|NCT02289690|524871295|FG004|Overall Study|Death|0|||
145550214|NCT02289690|524871296|FG005|Overall Study|Death|0|||
145550215|NCT02289690|524871297|FG006|Overall Study|Death|0|||
145550216|NCT02289690|524871298|FG007|Overall Study|Death|49|||
145550217|NCT02289690|524871299|FG008|Overall Study|Death|45|||
145550218|NCT02289690|524871300|FG009|Overall Study|Death|41|||
145550219|NCT02289690|524871291|FG000|Overall Study|Sponsor Discontinued Study|0|||
145550220|NCT02289690|524871292|FG001|Overall Study|Sponsor Discontinued Study|0|||
145550221|NCT02289690|524871293|FG002|Overall Study|Sponsor Discontinued Study|0|||
145550222|NCT02289690|524871294|FG003|Overall Study|Sponsor Discontinued Study|0|||
145550223|NCT02289690|524871295|FG004|Overall Study|Sponsor Discontinued Study|0|||
145550224|NCT02289690|524871296|FG005|Overall Study|Sponsor Discontinued Study|0|||
145550225|NCT02289690|524871297|FG006|Overall Study|Sponsor Discontinued Study|0|||
145550226|NCT02289690|524871298|FG007|Overall Study|Sponsor Discontinued Study|9|||
145550227|NCT02289690|524871299|FG008|Overall Study|Sponsor Discontinued Study|7|||
145550228|NCT02289690|524871300|FG009|Overall Study|Sponsor Discontinued Study|15|||
145550229|NCT02289690|524871291|FG000|Overall Study|Other|0|||
145550230|NCT02289690|524871292|FG001|Overall Study|Other|0|||
145550231|NCT02289690|524871293|FG002|Overall Study|Other|0|||
145550232|NCT02289690|524871294|FG003|Overall Study|Other|1|||
145550233|NCT02289690|524871295|FG004|Overall Study|Other|1|||
145550234|NCT02289690|524871296|FG005|Overall Study|Other|0|||
145550235|NCT02289690|524871297|FG006|Overall Study|Other|1|||
145550236|NCT02289690|524871298|FG007|Overall Study|Other|2|||
145550237|NCT02289690|524871299|FG008|Overall Study|Other|3|||
145550238|NCT02289690|524871300|FG009|Overall Study|Other|1|||
145550239|NCT02085785|524871303|FG000|Overall Study|Withdrawal by Subject|2|||
145550240|NCT02085785|524871304|FG001|Overall Study|Withdrawal by Subject|1|||
145550241|NCT02085785|524871303|FG000|Overall Study|Lost to Follow-up|0|||
145550242|NCT02085785|524871304|FG001|Overall Study|Lost to Follow-up|1|||
145550243|NCT00779467|524871305|FG000|Overall Study|Lack of Efficacy|11|||
145550244|NCT00779467|524871306|FG001|Overall Study|Lack of Efficacy|2|||
145550245|NCT00779467|524871307|FG002|Overall Study|Lack of Efficacy|6|||
145550246|NCT00779467|524871308|FG003|Overall Study|Lack of Efficacy|11|||
145550247|NCT00779467|524871305|FG000|Overall Study|failed inclusion criteria|3|||
145550248|NCT00779467|524871306|FG001|Overall Study|failed inclusion criteria|3|||
145550249|NCT00779467|524871307|FG002|Overall Study|failed inclusion criteria|1|||
145550250|NCT00779467|524871308|FG003|Overall Study|failed inclusion criteria|2|||
145550251|NCT00779467|524871305|FG000|Overall Study|missing data|1|||
145550252|NCT00779467|524871306|FG001|Overall Study|missing data|0|||
145550253|NCT00779467|524871307|FG002|Overall Study|missing data|1|||
145550254|NCT00779467|524871308|FG003|Overall Study|missing data|4|||
145550255|NCT00779467|524871305|FG000|Overall Study|technical issue|0|||
145550256|NCT00779467|524871306|FG001|Overall Study|technical issue|0|||
145550257|NCT00779467|524871307|FG002|Overall Study|technical issue|2|||
145550258|NCT00779467|524871308|FG003|Overall Study|technical issue|1|||
145550259|NCT00779467|524871305|FG000|Overall Study|unavailable research staff|0|||
145550260|NCT00779467|524871306|FG001|Overall Study|unavailable research staff|0|||
145550261|NCT00779467|524871307|FG002|Overall Study|unavailable research staff|0|||
145550262|NCT00779467|524871308|FG003|Overall Study|unavailable research staff|1|||
145550263|NCT04626297|524871309|FG000|Overall Study|Adverse Event|5|||
145550264|NCT04626297|524871310|FG001|Overall Study|Adverse Event|3|||
145550265|NCT04626297|524871309|FG000|Overall Study|Lost to Follow-up|7|||
145550266|NCT04626297|524871310|FG001|Overall Study|Lost to Follow-up|3|||
145550267|NCT04626297|524871309|FG000|Overall Study|Protocol Violation|5|||
145550268|NCT04626297|524871310|FG001|Overall Study|Protocol Violation|1|||
145283438|NCT00545233|523887104|FG000|Overall Study|Protocol Violation|2|||
145283439|NCT00545233|523887105|FG001|Overall Study|Protocol Violation|0|||
145283440|NCT00545233|523887104|FG000|Overall Study|Refused Treatment|9|||
145283441|NCT00545233|523887105|FG001|Overall Study|Refused Treatment|7|||
145283442|NCT00545233|523887104|FG000|Overall Study|Failure to Return|4|||
145283443|NCT00545233|523887105|FG001|Overall Study|Failure to Return|6|||
145283444|NCT00545233|523887104|FG000|Overall Study|Insufficient response|14|||
145283445|NCT00545233|523887105|FG001|Overall Study|Insufficient response|15|||
145283446|NCT00545233|523887104|FG000|Overall Study|Physician Decision|2|||
145550269|NCT04626297|524871309|FG000|Overall Study|Withdrawal by Subject|20|||
145550270|NCT04626297|524871310|FG001|Overall Study|Withdrawal by Subject|6|||
145550271|NCT04626297|524871309|FG000|Overall Study|Sponsor decision|2|||
145550272|NCT04626297|524871310|FG001|Overall Study|Sponsor decision|1|||
145550273|NCT04118166|524871311|FG000|Overall Study|Adverse Event|1|||
145550274|NCT02254486|524871312|FG000|Overall Study|Adverse Event|1|||
145550275|NCT02254486|524871313|FG001|Overall Study|Adverse Event|1|||
145550276|NCT02254486|524871312|FG000|Overall Study|Lack of Efficacy|1|||
145283447|NCT00545233|523887105|FG001|Overall Study|Physician Decision|1|||
145283448|NCT00479401|523887109|FG000|Overall Study|Adverse Event|24|||
145283449|NCT00479401|523887110|FG001|Overall Study|Adverse Event|20|||
145283450|NCT00479401|523887111|FG002|Overall Study|Adverse Event|4|||
145283451|NCT00479401|523887109|FG000|Overall Study|Lack of Efficacy|2|||
145550277|NCT02254486|524871313|FG001|Overall Study|Lack of Efficacy|0|||
145550278|NCT02254486|524871312|FG000|Overall Study|Lost to Follow-up|2|||
145550279|NCT02254486|524871313|FG001|Overall Study|Lost to Follow-up|4|||
145550280|NCT02254486|524871312|FG000|Overall Study|Protocol Violation|1|||
145550281|NCT02254486|524871313|FG001|Overall Study|Protocol Violation|2|||
145550282|NCT02254486|524871312|FG000|Overall Study|Withdrawal by Subject|17|||
145550283|NCT02254486|524871313|FG001|Overall Study|Withdrawal by Subject|15|||
145550284|NCT02254486|524871312|FG000|Overall Study|GFR<60mL/min|16|||
145283452|NCT00479401|523887110|FG001|Overall Study|Lack of Efficacy|2|||
145283453|NCT00479401|523887111|FG002|Overall Study|Lack of Efficacy|4|||
145550285|NCT02254486|524871313|FG001|Overall Study|GFR<60mL/min|21|||
145550286|NCT02254486|524871312|FG000|Overall Study|Various|12|||
145550287|NCT02254486|524871313|FG001|Overall Study|Various|12|||
145550288|NCT01350414|524871320|FG000|Overall Study|Lost to Follow-up|13|||
145550289|NCT01350414|524871320|FG000|Overall Study|Withdrawal by Subject|4|||
145550290|NCT01350414|524871320|FG000|Overall Study|Physician Decision|2|||
145550291|NCT02743520|524871321|FG000|Overall Study|Withdrawal by Subject|1|||
145550292|NCT01749514|524871322|FG000|Overall Study|Lost to Follow-up|0|||
145550293|NCT01749514|524871323|FG001|Overall Study|Lost to Follow-up|0|||
145550294|NCT01749514|524871324|FG002|Overall Study|Lost to Follow-up|0|||
145550295|NCT01749514|524871325|FG003|Overall Study|Lost to Follow-up|0|||
145550296|NCT01749514|524871326|FG004|Overall Study|Lost to Follow-up|0|||
145550297|NCT01749514|524871327|FG005|Overall Study|Lost to Follow-up|0|||
145550298|NCT01749514|524871328|FG006|Overall Study|Lost to Follow-up|0|||
145550299|NCT01749514|524871329|FG007|Overall Study|Lost to Follow-up|1|||
145550300|NCT01749514|524871322|FG000|Overall Study|Withdrawal by Subject|0|||
145550301|NCT01749514|524871323|FG001|Overall Study|Withdrawal by Subject|0|||
145550302|NCT01749514|524871324|FG002|Overall Study|Withdrawal by Subject|0|||
145550303|NCT01749514|524871325|FG003|Overall Study|Withdrawal by Subject|0|||
145550304|NCT01749514|524871326|FG004|Overall Study|Withdrawal by Subject|0|||
145550305|NCT01749514|524871327|FG005|Overall Study|Withdrawal by Subject|1|||
145283454|NCT00479401|523887109|FG000|Overall Study|Protocol Violation|2|||
145283455|NCT00479401|523887110|FG001|Overall Study|Protocol Violation|1|||
145283456|NCT00479401|523887111|FG002|Overall Study|Protocol Violation|1|||
145550306|NCT01749514|524871328|FG006|Overall Study|Withdrawal by Subject|0|||
145550307|NCT01749514|524871329|FG007|Overall Study|Withdrawal by Subject|1|||
145405235|NCT02110693|524340142|FG000|Overall Study|skipped assessment|15|||
145405236|NCT02110693|524340143|FG001|Overall Study|skipped assessment|18|||
145550308|NCT01749514|524871322|FG000|Overall Study|Not Reported|0|||
145550309|NCT01749514|524871323|FG001|Overall Study|Not Reported|0|||
145550310|NCT01749514|524871324|FG002|Overall Study|Not Reported|0|||
145550311|NCT01749514|524871325|FG003|Overall Study|Not Reported|0|||
145550312|NCT01749514|524871326|FG004|Overall Study|Not Reported|0|||
145550313|NCT01749514|524871327|FG005|Overall Study|Not Reported|0|||
145550314|NCT01749514|524871328|FG006|Overall Study|Not Reported|0|||
145405237|NCT02110693|524340142|FG000|Overall Study|technical difficulties|6|||
145405238|NCT02110693|524340143|FG001|Overall Study|technical difficulties|4|||
145550315|NCT01749514|524871329|FG007|Overall Study|Not Reported|5|||
145550316|NCT02509156|524871330|FG000|Randomized Phase|Death|1|||
145550317|NCT02509156|524871331|FG001|Randomized Phase|Death|0|||
145550318|NCT02509156|524871330|FG000|Randomized Phase|Withdrawal by Subject|1|||
145550319|NCT02509156|524871331|FG001|Randomized Phase|Withdrawal by Subject|1|||
145550320|NCT03042533|524871332|FG000|Overall Study|MD left program|1|||
145405239|NCT02110693|524340142|FG000|Overall Study|Other|1|||
145611265|NCT03029247|525092640|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
145611266|NCT03029247|525092641|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
145550321|NCT03042533|524871333|FG001|Overall Study|MD left program|4|||
145550322|NCT03042533|524871334|FG002|Overall Study|MD left program|1|||
145283457|NCT00479401|523887109|FG000|Overall Study|Lost to Follow-up|1|||
145283458|NCT00479401|523887110|FG001|Overall Study|Lost to Follow-up|1|||
145283459|NCT00479401|523887111|FG002|Overall Study|Lost to Follow-up|1|||
145283460|NCT00479401|523887109|FG000|Overall Study|Withdrawal by Subject|16|||
145283461|NCT00479401|523887110|FG001|Overall Study|Withdrawal by Subject|10|||
145283462|NCT00479401|523887111|FG002|Overall Study|Withdrawal by Subject|2|||
145283463|NCT00479401|523887109|FG000|Overall Study|Exclusion criteria, relocation|4|||
145283464|NCT00479401|523887110|FG001|Overall Study|Exclusion criteria, relocation|3|||
145283465|NCT00479401|523887111|FG002|Overall Study|Exclusion criteria, relocation|0|||
145283466|NCT02191579|523887114|FG000|Treatment 1|Multiple Reasons Specified|27|||
145283467|NCT02191579|523887115|FG001|Treatment 1|Multiple Reasons Specified|58|||
145283468|NCT02191579|523887114|FG000|Treatment 2|Multiple Reasons Specified|0|||
145283469|NCT02191579|523887115|FG001|Treatment 2|Multiple Reasons Specified|25|||
145283470|NCT00408876|523887116|FG000|Overall Study|Adverse Event|9|||
145283471|NCT00408876|523887117|FG001|Overall Study|Adverse Event|17|||
145283472|NCT00408876|523887118|FG002|Overall Study|Adverse Event|27|||
145283473|NCT00408876|523887119|FG003|Overall Study|Adverse Event|10|||
145283474|NCT00408876|523887116|FG000|Overall Study|Withdrawal by Subject|3|||
145283475|NCT00408876|523887117|FG001|Overall Study|Withdrawal by Subject|6|||
145283476|NCT00408876|523887118|FG002|Overall Study|Withdrawal by Subject|6|||
145283477|NCT00408876|523887119|FG003|Overall Study|Withdrawal by Subject|14|||
145283478|NCT00408876|523887116|FG000|Overall Study|Lack of Efficacy|2|||
145283479|NCT00408876|523887117|FG001|Overall Study|Lack of Efficacy|4|||
145283480|NCT00408876|523887118|FG002|Overall Study|Lack of Efficacy|5|||
145283481|NCT00408876|523887119|FG003|Overall Study|Lack of Efficacy|6|||
145283482|NCT00408876|523887116|FG000|Overall Study|Lost to Follow-up|1|||
145283483|NCT00408876|523887117|FG001|Overall Study|Lost to Follow-up|6|||
145283484|NCT00408876|523887118|FG002|Overall Study|Lost to Follow-up|5|||
145283485|NCT00408876|523887119|FG003|Overall Study|Lost to Follow-up|2|||
145283486|NCT00408876|523887116|FG000|Overall Study|Protocol Violation|0|||
145283487|NCT00408876|523887117|FG001|Overall Study|Protocol Violation|3|||
145283488|NCT00408876|523887118|FG002|Overall Study|Protocol Violation|4|||
145283489|NCT00408876|523887119|FG003|Overall Study|Protocol Violation|3|||
145283490|NCT00408876|523887116|FG000|Overall Study|Physician Decision|1|||
145283491|NCT00408876|523887117|FG001|Overall Study|Physician Decision|0|||
145283492|NCT00408876|523887118|FG002|Overall Study|Physician Decision|3|||
145283493|NCT00408876|523887119|FG003|Overall Study|Physician Decision|0|||
145283494|NCT03404206|523887120|FG000|Overall Study|Withdrawal by Subject|1|||
145283495|NCT03404206|523887121|FG001|Overall Study|Withdrawal by Subject|1|||
145283496|NCT03404206|523887122|FG002|Overall Study|Withdrawal by Subject|0|||
145283497|NCT03404206|523887120|FG000|Overall Study|Lost to Follow-up|3|||
145283498|NCT03404206|523887121|FG001|Overall Study|Lost to Follow-up|1|||
145283499|NCT03404206|523887122|FG002|Overall Study|Lost to Follow-up|0|||
145283500|NCT05478603|523887123|FG000|Overall Study|Withdrawal by Subject|0|||
145283501|NCT05478603|523887124|FG001|Overall Study|Withdrawal by Subject|1|||
145283502|NCT05478603|523887125|FG002|Overall Study|Withdrawal by Subject|0|||
145283503|NCT05478603|523887126|FG003|Overall Study|Withdrawal by Subject|0|||
145283504|NCT00066807|523887127|FG000|Overall Study|Study was terminated early|14|||
145283505|NCT00066807|523887128|FG001|Overall Study|Study was terminated early|15|||
145283506|NCT05028751|523887129|FG000|Overall Study|Study Terminated by Sponsor|3|||
145283507|NCT05028751|523887130|FG001|Overall Study|Study Terminated by Sponsor|0|||
145283508|NCT05028751|523887131|FG002|Overall Study|Study Terminated by Sponsor|0|||
145405240|NCT02110693|524340143|FG001|Overall Study|Other|0|||
145283509|NCT05028751|523887132|FG003|Overall Study|Study Terminated by Sponsor|0|||
145283510|NCT05028751|523887129|FG000|Overall Study|Death|9|||
145283511|NCT05028751|523887130|FG001|Overall Study|Death|3|||
145283512|NCT05028751|523887131|FG002|Overall Study|Death|2|||
145283513|NCT05028751|523887132|FG003|Overall Study|Death|4|||
145283514|NCT05028751|523887129|FG000|Overall Study|Withdrawal by Subject|0|||
145550323|NCT02551731|524871335|FG000|Overall Study|Withdrawal by Subject|2|||
145550324|NCT00010374|524871336|FG000|Overall Study|False positive phrenic nerve test|1|||
145550325|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
145550326|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
145550327|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
145550328|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
145550329|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
145550330|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
145550331|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
145550332|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
145550333|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Patient Request|1|||
145550334|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Patient Request|0|||
145550335|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
145550336|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
145550337|NCT04649060|524871337|FG000|Arm A/Arm B Treatment|Other|1|||
145550338|NCT04649060|524871338|FG001|Arm A/Arm B Treatment|Other|0|||
145550339|NCT04649060|524871337|FG000|Crossover (Arm B)|Adverse Event|0|||
145550340|NCT04649060|524871338|FG001|Crossover (Arm B)|Adverse Event|1|||
145550341|NCT04649060|524871337|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
145550342|NCT04649060|524871338|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
145550343|NCT02706691|524871339|FG000|Overall Study|Adverse Event|1|||
145550344|NCT04294472|524871340|FG000|Overall Study|Adverse Event|0|||
145550345|NCT04294472|524871341|FG001|Overall Study|Adverse Event|1|||
145550346|NCT04294472|524871342|FG002|Overall Study|Adverse Event|1|||
145550347|NCT04294472|524871340|FG000|Overall Study|Randomized but not treated|0|||
145550348|NCT04294472|524871341|FG001|Overall Study|Randomized but not treated|1|||
145550349|NCT04294472|524871342|FG002|Overall Study|Randomized but not treated|1|||
145550350|NCT02268084|524871345|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
145550351|NCT02268084|524871346|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
145550352|NCT02268084|524871345|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
145550353|NCT02268084|524871346|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
145550354|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
145550355|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
145550356|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
145550357|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
145283515|NCT05028751|523887130|FG001|Overall Study|Withdrawal by Subject|0|||
145283516|NCT05028751|523887131|FG002|Overall Study|Withdrawal by Subject|1|||
145283517|NCT05028751|523887132|FG003|Overall Study|Withdrawal by Subject|0|||
145283518|NCT05028751|523887129|FG000|Overall Study|Miscellaneous|2|||
145283519|NCT05028751|523887130|FG001|Overall Study|Miscellaneous|0|||
145283520|NCT05028751|523887131|FG002|Overall Study|Miscellaneous|0|||
145283521|NCT05028751|523887132|FG003|Overall Study|Miscellaneous|0|||
145283522|NCT04578548|523887133|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
145283523|NCT04578548|523887134|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
145283524|NCT04578548|523887133|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
145405241|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
145405242|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
145405243|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
145405244|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
145405245|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
145405246|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
145405247|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
145405248|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
145405249|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
145405250|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
145550358|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
145550359|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
145550360|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
145550361|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
145550362|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
145550363|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
145550364|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
145550365|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
145550366|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
145550367|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
145550368|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
145550369|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
145550370|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
145550371|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
145550372|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
145550373|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
145550374|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
145550375|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
145550376|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
145550377|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
145550378|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
145550379|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
145550380|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
145550381|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
145550382|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
145550383|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
145550384|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
145550385|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
145550386|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
145550387|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
145550388|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
145550389|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
145550390|NCT02603419|524871347|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
145550391|NCT02603419|524871348|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
145550392|NCT02603419|524871349|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
145550393|NCT02603419|524871350|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
145550394|NCT02603419|524871351|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
145550395|NCT02603419|524871352|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
145550396|NCT02603419|524871347|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
145550397|NCT02603419|524871348|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
145550398|NCT02603419|524871349|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
145550399|NCT02603419|524871350|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
145550400|NCT02603419|524871351|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
145550401|NCT02603419|524871352|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
145550402|NCT02603419|524871347|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
145550403|NCT02603419|524871348|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
145550404|NCT02603419|524871349|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
145550405|NCT02603419|524871350|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
145550406|NCT02603419|524871351|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
145550407|NCT02603419|524871352|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
145550408|NCT02603419|524871347|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
145550409|NCT02603419|524871348|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
145550410|NCT02603419|524871349|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
145550411|NCT02603419|524871350|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
145550412|NCT02603419|524871351|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
145550413|NCT02603419|524871352|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
145550414|NCT02289417|524871356|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
145550415|NCT02289417|524871357|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550416|NCT02289417|524871358|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
145283525|NCT04578548|523887134|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
145283526|NCT04578548|523887133|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
145283527|NCT04578548|523887134|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
145283528|NCT04578548|523887133|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
145283529|NCT04578548|523887134|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
145283530|NCT04578548|523887133|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
145283531|NCT04578548|523887134|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
145283532|NCT04578548|523887133|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
145283533|NCT04578548|523887134|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
145283534|NCT00972153|523887137|FG000|Overall Study|Equipment malfunction during case|0|||
145283535|NCT00972153|523887138|FG001|Overall Study|Equipment malfunction during case|1|||
145283536|NCT00972153|523887139|FG002|Overall Study|Equipment malfunction during case|0|||
145283537|NCT01077713|523887140|FG000|Overall Study|Withdrawal by Subject|1|||
145283538|NCT01077713|523887141|FG001|Overall Study|Withdrawal by Subject|2|||
145283539|NCT01077713|523887140|FG000|Overall Study|Progressive Disease (PD)|0|||
145283540|NCT01077713|523887141|FG001|Overall Study|Progressive Disease (PD)|1|||
145283541|NCT01077713|523887140|FG000|Overall Study|Death|28|||
145283542|NCT01077713|523887141|FG001|Overall Study|Death|29|||
145283543|NCT01077713|523887140|FG000|Overall Study|Lost to Follow-up|1|||
145283544|NCT01077713|523887141|FG001|Overall Study|Lost to Follow-up|1|||
145283545|NCT01077713|523887140|FG000|Overall Study|Adverse Event|2|||
145283546|NCT01077713|523887141|FG001|Overall Study|Adverse Event|1|||
145283547|NCT01077713|523887140|FG000|Overall Study|Other|4|||
145283548|NCT01077713|523887141|FG001|Overall Study|Other|2|||
145283549|NCT00628745|523887142|FG000|Overall Study|Withdrawal by Subject|63|||
145283550|NCT00628745|523887143|FG001|Overall Study|Withdrawal by Subject|3|||
145283551|NCT00628745|523887144|FG002|Overall Study|Withdrawal by Subject|9|||
145283552|NCT00628745|523887145|FG003|Overall Study|Withdrawal by Subject|2|||
145283553|NCT00628745|523887146|FG004|Overall Study|Withdrawal by Subject|69|||
145283554|NCT00628745|523887142|FG000|Overall Study|Does not meet inclusion criteria|0|||
145283555|NCT00628745|523887143|FG001|Overall Study|Does not meet inclusion criteria|12|||
145283556|NCT00628745|523887144|FG002|Overall Study|Does not meet inclusion criteria|0|||
145283557|NCT00628745|523887145|FG003|Overall Study|Does not meet inclusion criteria|0|||
145283558|NCT00628745|523887146|FG004|Overall Study|Does not meet inclusion criteria|18|||
145283559|NCT00628745|523887142|FG000|Overall Study|Participation in an interventional clinical trial|81|||
145283560|NCT00628745|523887143|FG001|Overall Study|Participation in an interventional clinical trial|4|||
145283561|NCT00628745|523887144|FG002|Overall Study|Participation in an interventional clinical trial|7|||
145283562|NCT00628745|523887145|FG003|Overall Study|Participation in an interventional clinical trial|0|||
145283563|NCT00628745|523887146|FG004|Overall Study|Participation in an interventional clinical trial|63|||
145283564|NCT00628745|523887142|FG000|Overall Study|Physician Decision|8|||
145283565|NCT00628745|523887143|FG001|Overall Study|Physician Decision|4|||
145283566|NCT00628745|523887144|FG002|Overall Study|Physician Decision|3|||
145283567|NCT00628745|523887145|FG003|Overall Study|Physician Decision|0|||
145283568|NCT00628745|523887146|FG004|Overall Study|Physician Decision|30|||
145283569|NCT00628745|523887142|FG000|Overall Study|Lost to Follow-up|109|||
145283570|NCT00628745|523887143|FG001|Overall Study|Lost to Follow-up|7|||
145283571|NCT00628745|523887144|FG002|Overall Study|Lost to Follow-up|7|||
145283572|NCT00628745|523887145|FG003|Overall Study|Lost to Follow-up|0|||
145283573|NCT00628745|523887146|FG004|Overall Study|Lost to Follow-up|498|||
145283574|NCT00628745|523887142|FG000|Overall Study|Death|197|||
145283575|NCT00628745|523887143|FG001|Overall Study|Death|81|||
145283576|NCT00628745|523887144|FG002|Overall Study|Death|12|||
145283577|NCT00628745|523887145|FG003|Overall Study|Death|4|||
145283578|NCT00628745|523887146|FG004|Overall Study|Death|939|||
145283579|NCT00628745|523887142|FG000|Overall Study|Participant transferred to another THAOS site|6|||
145283580|NCT00628745|523887143|FG001|Overall Study|Participant transferred to another THAOS site|0|||
145283581|NCT00628745|523887144|FG002|Overall Study|Participant transferred to another THAOS site|0|||
145283582|NCT00628745|523887145|FG003|Overall Study|Participant transferred to another THAOS site|0|||
145283583|NCT00628745|523887146|FG004|Overall Study|Participant transferred to another THAOS site|7|||
145550417|NCT02289417|524871359|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550418|NCT02289417|524871360|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550419|NCT02289417|524871361|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550420|NCT02289417|524871362|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550421|NCT02289417|524871363|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145550422|NCT02289417|524871364|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
145405251|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Death|3|||
145405252|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Death|1|||
145405253|NCT01056276|524340144|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
145405254|NCT01056276|524340145|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
145405255|NCT01056276|524340144|FG000|Maintenance Therapy|Toxicity|0|||
145405256|NCT01056276|524340145|FG001|Maintenance Therapy|Toxicity|2|||
145405257|NCT01056276|524340144|FG000|Maintenance Therapy|Progressive Disease|0|||
145405258|NCT01056276|524340145|FG001|Maintenance Therapy|Progressive Disease|9|||
145405259|NCT01056276|524340144|FG000|Maintenance Therapy|Physician Decision|0|||
145405260|NCT01056276|524340145|FG001|Maintenance Therapy|Physician Decision|1|||
145405261|NCT01056276|524340144|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
145405262|NCT01056276|524340145|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
145405263|NCT01056276|524340144|FG000|Maintenance Therapy|Intercurrent Illness|0|||
145405264|NCT01056276|524340145|FG001|Maintenance Therapy|Intercurrent Illness|1|||
145405265|NCT01056276|524340144|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
145405266|NCT01056276|524340145|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
145405267|NCT01881425|524340146|FG000|Overall Study|Death|5|||
145405268|NCT01881425|524340147|FG001|Overall Study|Death|1|||
145405269|NCT01881425|524340146|FG000|Overall Study|Withdrawal by Subject|8|||
145405270|NCT01881425|524340147|FG001|Overall Study|Withdrawal by Subject|3|||
145405271|NCT01881425|524340146|FG000|Overall Study|Physician Decision|2|||
145405272|NCT01881425|524340147|FG001|Overall Study|Physician Decision|1|||
145405273|NCT01881425|524340146|FG000|Overall Study|Adverse Event|3|||
145405274|NCT01881425|524340147|FG001|Overall Study|Adverse Event|0|||
145405275|NCT01881425|524340146|FG000|Overall Study|General Anesthesia panic attack|0|||
145405276|NCT01881425|524340147|FG001|Overall Study|General Anesthesia panic attack|1|||
145405277|NCT01881425|524340146|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
145405278|NCT01881425|524340147|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
145405279|NCT01881425|524340146|FG000|Overall Study|Lost to Follow-up|7|||
145405280|NCT01881425|524340147|FG001|Overall Study|Lost to Follow-up|2|||
145405281|NCT04154956|524340150|FG000|Overall Study|Death|109|||
145405282|NCT04154956|524340151|FG001|Overall Study|Death|110|||
145405283|NCT04154956|524340150|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
145405284|NCT04154956|524340151|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
145405285|NCT04154956|524340150|FG000|Overall Study|Withdrawal by Subject|1|||
145405286|NCT04154956|524340151|FG001|Overall Study|Withdrawal by Subject|7|||
145405287|NCT04154956|524340150|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
145405288|NCT04154956|524340151|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
145405289|NCT04424901|524340152|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
145405290|NCT04424901|524340153|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
145405291|NCT00147238|524340154|FG000|Overall Study|Inevaluable|8|||
145405292|NCT01348269|524340155|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
145405293|NCT01348269|524340156|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
145405294|NCT01348269|524340155|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
145405295|NCT01348269|524340156|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
145405296|NCT01348269|524340155|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
145405297|NCT01348269|524340156|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
145405298|NCT00805532|524340157|FG000|Overall Study|invalid data|0|||
145405299|NCT00805532|524340158|FG001|Overall Study|invalid data|1|||
145405300|NCT01859741|524340159|FG000|Overall Study|Death|3|||
145405301|NCT01859741|524340160|FG001|Overall Study|Death|2|||
145405302|NCT01859741|524340161|FG002|Overall Study|Death|4|||
145405303|NCT01859741|524340162|FG003|Overall Study|Death|3|||
145405304|NCT01859741|524340163|FG004|Overall Study|Death|5|||
145405305|NCT01859741|524340164|FG005|Overall Study|Death|4|||
145405306|NCT01859741|524340165|FG006|Overall Study|Death|51|||
145405307|NCT01859741|524340166|FG007|Overall Study|Death|51|||
145405308|NCT01859741|524340159|FG000|Overall Study|Lost to Follow-up|0|||
145405309|NCT01859741|524340160|FG001|Overall Study|Lost to Follow-up|0|||
145405310|NCT01859741|524340161|FG002|Overall Study|Lost to Follow-up|0|||
145405311|NCT01859741|524340162|FG003|Overall Study|Lost to Follow-up|0|||
145405312|NCT01859741|524340163|FG004|Overall Study|Lost to Follow-up|0|||
145405313|NCT01859741|524340164|FG005|Overall Study|Lost to Follow-up|1|||
145405314|NCT01859741|524340165|FG006|Overall Study|Lost to Follow-up|0|||
145405315|NCT01859741|524340166|FG007|Overall Study|Lost to Follow-up|4|||
145405316|NCT01859741|524340159|FG000|Overall Study|Withdrawal by Subject|0|||
145405317|NCT01859741|524340160|FG001|Overall Study|Withdrawal by Subject|1|||
145405318|NCT01859741|524340161|FG002|Overall Study|Withdrawal by Subject|2|||
145405319|NCT01859741|524340162|FG003|Overall Study|Withdrawal by Subject|0|||
145405320|NCT01859741|524340163|FG004|Overall Study|Withdrawal by Subject|0|||
145550423|NCT02289417|524871356|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
145550424|NCT02289417|524871357|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
145550425|NCT02289417|524871358|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
145550426|NCT02289417|524871359|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550427|NCT02289417|524871360|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550428|NCT02289417|524871361|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550429|NCT02289417|524871362|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550430|NCT02289417|524871363|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550431|NCT02289417|524871364|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
145550432|NCT02289417|524871356|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550433|NCT02289417|524871357|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
145550434|NCT02289417|524871358|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550435|NCT02289417|524871359|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550436|NCT02289417|524871360|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550437|NCT02289417|524871361|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550438|NCT02289417|524871362|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550439|NCT02289417|524871363|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550440|NCT02289417|524871364|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
145550441|NCT02289417|524871356|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
145550442|NCT02289417|524871357|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550443|NCT02289417|524871358|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550444|NCT02289417|524871359|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550445|NCT02289417|524871360|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550446|NCT02289417|524871361|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550447|NCT02289417|524871362|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550448|NCT02289417|524871363|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550449|NCT02289417|524871364|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
145550450|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
145550451|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
145550452|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
145550453|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
145550454|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
145550455|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
145550456|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
145550457|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
145550458|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
145550459|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550460|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550461|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
145550462|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550463|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550464|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550465|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550466|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550467|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
145550468|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
145550469|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
145550470|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
145405321|NCT01859741|524340164|FG005|Overall Study|Withdrawal by Subject|1|||
145405322|NCT01859741|524340165|FG006|Overall Study|Withdrawal by Subject|1|||
145405323|NCT01859741|524340166|FG007|Overall Study|Withdrawal by Subject|1|||
145405324|NCT01859741|524340159|FG000|Overall Study|Study Terminated by Sponsor|0|||
145405325|NCT01859741|524340160|FG001|Overall Study|Study Terminated by Sponsor|0|||
145405326|NCT01859741|524340161|FG002|Overall Study|Study Terminated by Sponsor|0|||
145405327|NCT01859741|524340162|FG003|Overall Study|Study Terminated by Sponsor|0|||
145405328|NCT01859741|524340163|FG004|Overall Study|Study Terminated by Sponsor|1|||
145405329|NCT01859741|524340164|FG005|Overall Study|Study Terminated by Sponsor|0|||
145405330|NCT01859741|524340165|FG006|Overall Study|Study Terminated by Sponsor|16|||
145405331|NCT01859741|524340166|FG007|Overall Study|Study Terminated by Sponsor|14|||
145405332|NCT01859741|524340159|FG000|Overall Study|Other|0|||
145405333|NCT01859741|524340160|FG001|Overall Study|Other|0|||
145405334|NCT01859741|524340161|FG002|Overall Study|Other|0|||
145405335|NCT01859741|524340162|FG003|Overall Study|Other|0|||
145405336|NCT01859741|524340163|FG004|Overall Study|Other|0|||
145405337|NCT01859741|524340164|FG005|Overall Study|Other|0|||
145405338|NCT01859741|524340165|FG006|Overall Study|Other|2|||
145405339|NCT01859741|524340166|FG007|Overall Study|Other|0|||
145405340|NCT02606253|524340170|FG000|Overall Study|Adverse Event|2|||
145405341|NCT02606253|524340171|FG001|Overall Study|Adverse Event|0|||
145405342|NCT02606253|524340172|FG002|Overall Study|Adverse Event|0|||
145405343|NCT02606253|524340170|FG000|Overall Study|Protocol Violation|2|||
145405344|NCT02606253|524340171|FG001|Overall Study|Protocol Violation|1|||
145405345|NCT02606253|524340172|FG002|Overall Study|Protocol Violation|0|||
145405346|NCT02606253|524340170|FG000|Overall Study|Physician Decision|1|||
145405347|NCT02606253|524340171|FG001|Overall Study|Physician Decision|1|||
145405348|NCT02606253|524340172|FG002|Overall Study|Physician Decision|0|||
145405349|NCT02765165|524340175|FG000|Treatment Period|Progressive disease|3|||
145405350|NCT02765165|524340176|FG001|Treatment Period|Progressive disease|2|||
145405351|NCT02765165|524340177|FG002|Treatment Period|Progressive disease|3|||
145405352|NCT02765165|524340178|FG003|Treatment Period|Progressive disease|3|||
145405353|NCT02765165|524340179|FG004|Treatment Period|Progressive disease|4|||
145405354|NCT02765165|524340180|FG005|Treatment Period|Progressive disease|2|||
145405355|NCT02765165|524340181|FG006|Treatment Period|Progressive disease|2|||
145405356|NCT02765165|524340175|FG000|Treatment Period|Physician Decision|0|||
145405357|NCT02765165|524340176|FG001|Treatment Period|Physician Decision|1|||
145405358|NCT02765165|524340177|FG002|Treatment Period|Physician Decision|0|||
145405359|NCT02765165|524340178|FG003|Treatment Period|Physician Decision|0|||
145550471|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
145550472|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
145550473|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
145550474|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
145550475|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
145550476|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
145550477|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145550478|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145550479|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
145550480|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145283584|NCT00628745|523887142|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
145405360|NCT02765165|524340179|FG004|Treatment Period|Physician Decision|0|||
145405361|NCT02765165|524340180|FG005|Treatment Period|Physician Decision|0|||
145405362|NCT02765165|524340181|FG006|Treatment Period|Physician Decision|0|||
145405363|NCT02765165|524340175|FG000|Treatment Period|Adverse Event|0|||
145405364|NCT02765165|524340176|FG001|Treatment Period|Adverse Event|1|||
145405365|NCT02765165|524340177|FG002|Treatment Period|Adverse Event|0|||
145405366|NCT02765165|524340178|FG003|Treatment Period|Adverse Event|0|||
145405367|NCT02765165|524340179|FG004|Treatment Period|Adverse Event|0|||
145550481|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
145550482|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
145550483|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145550484|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145550485|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
145550486|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550487|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550488|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550489|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550490|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550491|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550492|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
145550493|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550494|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
145550495|NCT02289417|524871356|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550496|NCT02289417|524871357|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550497|NCT02289417|524871358|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550498|NCT02289417|524871359|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
145550499|NCT02289417|524871360|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550500|NCT02289417|524871361|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550501|NCT02289417|524871362|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
145550502|NCT02289417|524871363|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550503|NCT02289417|524871364|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
145550504|NCT02289417|524871356|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
145550505|NCT02289417|524871357|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
145550506|NCT02289417|524871358|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
145550507|NCT02289417|524871359|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
145550508|NCT02289417|524871360|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
145550509|NCT02289417|524871361|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
145550510|NCT02289417|524871362|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
145550511|NCT02289417|524871363|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
145550512|NCT02289417|524871364|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
145550513|NCT02289417|524871356|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550514|NCT02289417|524871357|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550515|NCT02289417|524871358|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550516|NCT02289417|524871359|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550517|NCT02289417|524871360|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550518|NCT02289417|524871361|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550519|NCT02289417|524871362|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
145550520|NCT02289417|524871363|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
145550521|NCT02289417|524871364|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
145550522|NCT02289417|524871356|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550523|NCT02289417|524871357|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550524|NCT02289417|524871358|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550525|NCT02289417|524871359|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550526|NCT02289417|524871360|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550527|NCT02289417|524871361|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550528|NCT02289417|524871362|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
145550529|NCT02289417|524871363|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
145550530|NCT02289417|524871364|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
145550531|NCT02289417|524871356|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550532|NCT02289417|524871357|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550533|NCT02289417|524871358|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550534|NCT02289417|524871359|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550535|NCT02289417|524871360|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550536|NCT02289417|524871361|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550537|NCT02289417|524871362|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
145550538|NCT02289417|524871363|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
145550539|NCT02289417|524871364|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
145283585|NCT00628745|523887143|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
145283586|NCT00628745|523887144|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
145283587|NCT00628745|523887145|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
145283588|NCT00628745|523887146|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
145283589|NCT00628745|523887142|FG000|Overall Study|Site closure|152|||
145283590|NCT00628745|523887143|FG001|Overall Study|Site closure|146|||
145283591|NCT00628745|523887144|FG002|Overall Study|Site closure|6|||
145283592|NCT00628745|523887145|FG003|Overall Study|Site closure|8|||
145283593|NCT00628745|523887146|FG004|Overall Study|Site closure|691|||
145283594|NCT00628745|523887142|FG000|Overall Study|Duplicate participant|0|||
145283595|NCT00628745|523887143|FG001|Overall Study|Duplicate participant|0|||
145283596|NCT00628745|523887144|FG002|Overall Study|Duplicate participant|0|||
145283597|NCT00628745|523887145|FG003|Overall Study|Duplicate participant|0|||
145283598|NCT00628745|523887146|FG004|Overall Study|Duplicate participant|1|||
145283599|NCT00628745|523887142|FG000|Overall Study|Missing|4|||
145283600|NCT00628745|523887143|FG001|Overall Study|Missing|3|||
145283601|NCT00628745|523887144|FG002|Overall Study|Missing|0|||
145283602|NCT00628745|523887145|FG003|Overall Study|Missing|0|||
145283603|NCT00628745|523887146|FG004|Overall Study|Missing|10|||
145283604|NCT00628745|523887142|FG000|Overall Study|Othe reasons|987|||
145283605|NCT00628745|523887143|FG001|Overall Study|Othe reasons|373|||
145283606|NCT00628745|523887144|FG002|Overall Study|Othe reasons|105|||
145283607|NCT00628745|523887145|FG003|Overall Study|Othe reasons|1|||
145283608|NCT00628745|523887146|FG004|Overall Study|Othe reasons|1772|||
145283609|NCT03322462|523889278|FG000|Overall Study|Technical difficulties|2|||
145283610|NCT03322462|523889278|FG000|Overall Study|Other|1|||
145283611|NCT00720798|523889284|FG000|Overall Study|Adverse Event|304|||
145283612|NCT00720798|523889284|FG000|Overall Study|Death|39|||
145283613|NCT00720798|523889284|FG000|Overall Study|Insufficient Therapeutic Response|129|||
145283614|NCT00720798|523889284|FG000|Overall Study|Protocol Violation|4|||
145283615|NCT00720798|523889284|FG000|Overall Study|Refused Treatment|151|||
145283616|NCT00720798|523889284|FG000|Overall Study|Failure to Return|46|||
145283617|NCT00720798|523889284|FG000|Overall Study|Reason not Specified|83|||
145283618|NCT00433381|523889285|FG000|Overall Study|Ineligible / no protocol treatment|3|||
145283619|NCT00433381|523889286|FG001|Overall Study|Ineligible / no protocol treatment|3|||
145283620|NCT00434161|523889287|FG000|Overall Study|Adverse Event|5|||
145283621|NCT00434161|523889288|FG001|Overall Study|Adverse Event|1|||
145283622|NCT00434161|523889289|FG002|Overall Study|Adverse Event|4|||
145283623|NCT00434161|523889287|FG000|Overall Study|Lost to Follow-up|0|||
145283624|NCT00434161|523889288|FG001|Overall Study|Lost to Follow-up|1|||
145283625|NCT00434161|523889289|FG002|Overall Study|Lost to Follow-up|0|||
145283626|NCT00434161|523889287|FG000|Overall Study|Death|1|||
145283627|NCT00434161|523889288|FG001|Overall Study|Death|0|||
145283628|NCT00434161|523889289|FG002|Overall Study|Death|1|||
145283629|NCT00434161|523889287|FG000|Overall Study|Non-Compliance|1|||
145283630|NCT00434161|523889288|FG001|Overall Study|Non-Compliance|1|||
145550540|NCT02007109|524871365|FG000|Overall Study|Diary not returned or excluded|102|||
145283631|NCT00434161|523889289|FG002|Overall Study|Non-Compliance|0|||
145283632|NCT00434161|523889287|FG000|Overall Study|Withdrawal by Subject|2|||
145283633|NCT00434161|523889288|FG001|Overall Study|Withdrawal by Subject|0|||
145405368|NCT02765165|524340180|FG005|Treatment Period|Adverse Event|0|||
145405369|NCT02765165|524340181|FG006|Treatment Period|Adverse Event|0|||
145405370|NCT02765165|524340175|FG000|Treatment Period|Withdrawal by Subject|0|||
145405371|NCT02765165|524340176|FG001|Treatment Period|Withdrawal by Subject|0|||
145405372|NCT02765165|524340177|FG002|Treatment Period|Withdrawal by Subject|0|||
145405373|NCT02765165|524340178|FG003|Treatment Period|Withdrawal by Subject|0|||
145405374|NCT02765165|524340179|FG004|Treatment Period|Withdrawal by Subject|2|||
145405375|NCT02765165|524340180|FG005|Treatment Period|Withdrawal by Subject|0|||
145405376|NCT02765165|524340181|FG006|Treatment Period|Withdrawal by Subject|0|||
145405377|NCT02765165|524340175|FG000|Treatment Period|Study terminated|0|||
145405378|NCT02765165|524340176|FG001|Treatment Period|Study terminated|0|||
145405379|NCT02765165|524340177|FG002|Treatment Period|Study terminated|0|||
145405380|NCT02765165|524340178|FG003|Treatment Period|Study terminated|0|||
145405381|NCT02765165|524340179|FG004|Treatment Period|Study terminated|0|||
145550541|NCT02007109|524871365|FG000|Overall Study|Excluded - Age<7yo|9|||
145550542|NCT01605877|524871366|FG000|Overall Study|Withdrawal by Subject|1|||
145405382|NCT02765165|524340180|FG005|Treatment Period|Study terminated|1|||
145550543|NCT00687323|524871369|FG000|Overall Study|Death|25|||
145550544|NCT00687323|524871369|FG000|Overall Study|Withdrawal by Subject|1|||
145405383|NCT02765165|524340181|FG006|Treatment Period|Study terminated|2|||
145405384|NCT02765165|524340175|FG000|Post-treatment Follow-up|Death|1|||
145405385|NCT02765165|524340176|FG001|Post-treatment Follow-up|Death|2|||
145405386|NCT02765165|524340177|FG002|Post-treatment Follow-up|Death|1|||
145405387|NCT02765165|524340178|FG003|Post-treatment Follow-up|Death|1|||
145550545|NCT00687323|524871369|FG000|Overall Study|Excluded from efficacy evaluations|6|||
145550546|NCT00687323|524871369|FG000|Overall Study|Screen failure|148|||
145405388|NCT02765165|524340179|FG004|Post-treatment Follow-up|Death|1|||
145405389|NCT02765165|524340180|FG005|Post-treatment Follow-up|Death|1|||
145405390|NCT02765165|524340181|FG006|Post-treatment Follow-up|Death|0|||
145405391|NCT02765165|524340175|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
145405392|NCT02765165|524340176|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
145405393|NCT02765165|524340177|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
145405394|NCT02765165|524340178|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
145405395|NCT02765165|524340179|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
145405396|NCT02765165|524340180|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
145405397|NCT02765165|524340181|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
145405398|NCT02765165|524340175|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405399|NCT02765165|524340176|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405400|NCT02765165|524340177|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
145405401|NCT02765165|524340178|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405402|NCT02765165|524340179|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405403|NCT02765165|524340180|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405404|NCT02765165|524340181|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
145405405|NCT02765165|524340175|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145405406|NCT02765165|524340176|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145405407|NCT02765165|524340177|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
145405408|NCT02765165|524340178|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
145405409|NCT02765165|524340179|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145405410|NCT02765165|524340180|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145405411|NCT02765165|524340181|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
145405412|NCT02765165|524340175|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405413|NCT02765165|524340176|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
145405414|NCT02765165|524340177|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405415|NCT02765165|524340178|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405416|NCT02765165|524340179|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405417|NCT02765165|524340180|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405418|NCT02765165|524340181|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
145405419|NCT02765165|524340175|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145405420|NCT02765165|524340176|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145405421|NCT02765165|524340177|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145405422|NCT02765165|524340178|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
145405423|NCT02765165|524340179|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
145405424|NCT02765165|524340180|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
145405425|NCT02765165|524340181|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
145405426|NCT01186770|524340182|FG000|Overall Study|Ineligibility|0|||
145405427|NCT01186770|524340183|FG001|Overall Study|Ineligibility|0|||
145405428|NCT01186770|524340184|FG002|Overall Study|Ineligibility|2|||
145405429|NCT01186770|524340185|FG003|Overall Study|Ineligibility|0|||
145405430|NCT01186770|524340182|FG000|Overall Study|Protocol Violation|7|||
145405431|NCT01186770|524340183|FG001|Overall Study|Protocol Violation|9|||
145405432|NCT01186770|524340184|FG002|Overall Study|Protocol Violation|12|||
145405433|NCT01186770|524340185|FG003|Overall Study|Protocol Violation|14|||
145405434|NCT01186770|524340182|FG000|Overall Study|Adverse Event|2|||
145405435|NCT01186770|524340183|FG001|Overall Study|Adverse Event|9|||
145405436|NCT01186770|524340184|FG002|Overall Study|Adverse Event|7|||
145405437|NCT01186770|524340185|FG003|Overall Study|Adverse Event|9|||
145405438|NCT01186770|524340182|FG000|Overall Study|Withdrawal by Subject|15|||
145405439|NCT01186770|524340183|FG001|Overall Study|Withdrawal by Subject|13|||
145405440|NCT01186770|524340184|FG002|Overall Study|Withdrawal by Subject|11|||
145405441|NCT01186770|524340185|FG003|Overall Study|Withdrawal by Subject|17|||
145405442|NCT01186770|524340182|FG000|Overall Study|Lost to Follow-up|10|||
145405443|NCT01186770|524340183|FG001|Overall Study|Lost to Follow-up|6|||
145405444|NCT01186770|524340184|FG002|Overall Study|Lost to Follow-up|14|||
145405445|NCT01186770|524340185|FG003|Overall Study|Lost to Follow-up|9|||
145405446|NCT01186770|524340182|FG000|Overall Study|Insufficient response to treatment|7|||
145405447|NCT01186770|524340183|FG001|Overall Study|Insufficient response to treatment|8|||
145405448|NCT01186770|524340184|FG002|Overall Study|Insufficient response to treatment|5|||
145405449|NCT01186770|524340185|FG003|Overall Study|Insufficient response to treatment|7|||
145405450|NCT01186770|524340182|FG000|Overall Study|Other than specified|0|||
145405451|NCT01186770|524340183|FG001|Overall Study|Other than specified|1|||
145405452|NCT01186770|524340184|FG002|Overall Study|Other than specified|1|||
145405453|NCT01186770|524340185|FG003|Overall Study|Other than specified|2|||
145405454|NCT02567188|524340186|FG000|Overall Study|Death|10|||
145405455|NCT02567188|524340186|FG000|Overall Study|Terminated Mircera Treatment|9|||
145405456|NCT02567188|524340186|FG000|Overall Study|Lost to Follow-up|5|||
145405457|NCT02567188|524340186|FG000|Overall Study|Adverse Event|1|||
145405458|NCT02567188|524340186|FG000|Overall Study|Withdrawal by Subject|1|||
145405459|NCT02567188|524340186|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
145611267|NCT02593305|525092642|FG000|Post 1|Comparison only group. No intervention.|0|||
145611268|NCT02593305|525092643|FG001|Post 1|Comparison only group. No intervention.|0|||
145611269|NCT02593305|525092644|FG002|Post 1|Comparison only group. No intervention.|10|||
145611270|NCT01993017|525092645|FG000|Overall Study|Death|23|||
145611271|NCT01993017|525092646|FG001|Overall Study|Death|26|||
145611272|NCT01993017|525092647|FG002|Overall Study|Death|18|||
145611273|NCT01993017|525092645|FG000|Overall Study|Could not be contacted|43|||
145611274|NCT01993017|525092646|FG001|Overall Study|Could not be contacted|42|||
145611275|NCT01993017|525092647|FG002|Overall Study|Could not be contacted|38|||
145611276|NCT01993017|525092645|FG000|Overall Study|Dropped out|19|||
145550547|NCT02547454|524871379|FG000|Overall Study|Due to hemodialysis|53|||
145550548|NCT02547454|524871379|FG000|Overall Study|Due to transplantation|1|||
145550549|NCT02547454|524871379|FG000|Overall Study|Due to no further need to treat|4|||
145550550|NCT02547454|524871379|FG000|Overall Study|Death|38|||
145550551|NCT02547454|524871379|FG000|Overall Study|Lost to Follow-up|26|||
145550552|NCT02547454|524871379|FG000|Overall Study|Other|39|||
145550553|NCT02547454|524871379|FG000|Overall Study|No data|11|||
145550554|NCT00580606|524871380|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
145550555|NCT00580606|524871381|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
145550556|NCT00580606|524871380|FG000|Open Label (OL)|Withdrawal by Subject|4|||
145550557|NCT00580606|524871381|FG001|Open Label (OL)|Withdrawal by Subject|6|||
145550558|NCT00580606|524871380|FG000|Open Label (OL)|Dosing Symptoms|0|||
145550559|NCT00580606|524871381|FG001|Open Label (OL)|Dosing Symptoms|1|||
145550560|NCT00580606|524871380|FG000|Open Label (OL)|Lost to Follow-up|0|||
145550561|NCT00580606|524871381|FG001|Open Label (OL)|Lost to Follow-up|1|||
145550562|NCT00580606|524871380|FG000|Open Label (OL)|Pregnancy|0|||
145550563|NCT00580606|524871381|FG001|Open Label (OL)|Pregnancy|1|||
145550564|NCT00580606|524871380|FG000|Open Label (OL)|Non-compliance|2|||
145550565|NCT00580606|524871381|FG001|Open Label (OL)|Non-compliance|0|||
145550566|NCT00580606|524871380|FG000|Open Label (OL)|Physician Decision|1|||
145550567|NCT00580606|524871381|FG001|Open Label (OL)|Physician Decision|1|||
145550568|NCT00580606|524871380|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
145550569|NCT00580606|524871381|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
145550570|NCT03031678|524871383|FG000|Overall Study|Study closed prior to completion|1|||
145550571|NCT03655691|524871384|FG000|Overall Study|Adverse Event|0|||
145550572|NCT03655691|524871385|FG001|Overall Study|Adverse Event|0|||
145550573|NCT03655691|524871386|FG002|Overall Study|Adverse Event|1|||
145550574|NCT03655691|524871384|FG000|Overall Study|Lost to Follow-up|1|||
145550575|NCT03655691|524871385|FG001|Overall Study|Lost to Follow-up|1|||
145550576|NCT03655691|524871386|FG002|Overall Study|Lost to Follow-up|2|||
145550577|NCT03655691|524871384|FG000|Overall Study|Protocol Violation|0|||
145550578|NCT03655691|524871385|FG001|Overall Study|Protocol Violation|1|||
145550579|NCT03655691|524871386|FG002|Overall Study|Protocol Violation|0|||
145550580|NCT03655691|524871384|FG000|Overall Study|Withdrawal by Subject|1|||
145550581|NCT03655691|524871385|FG001|Overall Study|Withdrawal by Subject|1|||
145550582|NCT03655691|524871386|FG002|Overall Study|Withdrawal by Subject|0|||
145550583|NCT03694821|524871389|FG000|Overall Study|Study terminated|4|||
145550584|NCT03694821|524871390|FG001|Overall Study|Study terminated|8|||
145550585|NCT03694821|524871391|FG002|Overall Study|Study terminated|4|||
145550586|NCT04102020|524871392|FG000|Overall Study|Adverse Event|1|||
145283634|NCT00434161|523889289|FG002|Overall Study|Withdrawal by Subject|3|||
145283635|NCT00434161|523889287|FG000|Overall Study|Logistical error study assessments|1|||
145283636|NCT00434161|523889288|FG001|Overall Study|Logistical error study assessments|0|||
145283637|NCT00434161|523889289|FG002|Overall Study|Logistical error study assessments|3|||
145283638|NCT01764854|523889290|FG000|Overall Study|Adverse Event|0|||
145283639|NCT01764854|523889291|FG001|Overall Study|Adverse Event|0|||
145405460|NCT02567188|524340186|FG000|Overall Study|Moved and Changed Clinic|1|||
145405461|NCT02567188|524340186|FG000|Overall Study|Started Hemodialysis|2|||
145405462|NCT02567188|524340186|FG000|Overall Study|Protocol Violation|5|||
145405463|NCT01189266|524340191|FG000|Overall Study|Adverse Event|1|||
145550587|NCT04102020|524871393|FG001|Overall Study|Adverse Event|0|||
145550588|NCT04102020|524871394|FG002|Overall Study|Adverse Event|0|||
145550589|NCT04102020|524871395|FG003|Overall Study|Adverse Event|1|||
145550590|NCT04102020|524871396|FG004|Overall Study|Adverse Event|0|||
145550591|NCT04102020|524871392|FG000|Overall Study|Withdrawal by Subject|0|||
145550592|NCT04102020|524871393|FG001|Overall Study|Withdrawal by Subject|1|||
145550593|NCT04102020|524871394|FG002|Overall Study|Withdrawal by Subject|1|||
145550594|NCT04102020|524871395|FG003|Overall Study|Withdrawal by Subject|1|||
145550595|NCT04102020|524871396|FG004|Overall Study|Withdrawal by Subject|1|||
145550596|NCT04102020|524871392|FG000|Overall Study|Death|1|||
145405464|NCT01189266|524340192|FG001|Overall Study|Adverse Event|0|||
145550597|NCT04102020|524871393|FG001|Overall Study|Death|4|||
145550598|NCT04102020|524871394|FG002|Overall Study|Death|1|||
145550599|NCT04102020|524871395|FG003|Overall Study|Death|1|||
145550600|NCT04102020|524871396|FG004|Overall Study|Death|0|||
145550601|NCT04102020|524871392|FG000|Overall Study|Physician Decision|1|||
145550602|NCT04102020|524871393|FG001|Overall Study|Physician Decision|2|||
145550603|NCT04102020|524871394|FG002|Overall Study|Physician Decision|2|||
145550604|NCT04102020|524871395|FG003|Overall Study|Physician Decision|0|||
145550605|NCT04102020|524871396|FG004|Overall Study|Physician Decision|1|||
145550606|NCT04102020|524871392|FG000|Overall Study|COVID-19 Infection|1|||
145550607|NCT04102020|524871393|FG001|Overall Study|COVID-19 Infection|0|||
145550608|NCT04102020|524871394|FG002|Overall Study|COVID-19 Infection|0|||
145550609|NCT04102020|524871395|FG003|Overall Study|COVID-19 Infection|0|||
145550610|NCT04102020|524871396|FG004|Overall Study|COVID-19 Infection|0|||
145550611|NCT04102020|524871392|FG000|Overall Study|Not disclosed|5|||
145550612|NCT04102020|524871393|FG001|Overall Study|Not disclosed|3|||
145550613|NCT04102020|524871394|FG002|Overall Study|Not disclosed|8|||
145550614|NCT04102020|524871395|FG003|Overall Study|Not disclosed|0|||
145550615|NCT04102020|524871396|FG004|Overall Study|Not disclosed|1|||
145550616|NCT04102020|524871392|FG000|Overall Study|MIssing|1|||
145550617|NCT04102020|524871393|FG001|Overall Study|MIssing|0|||
145550618|NCT04102020|524871394|FG002|Overall Study|MIssing|1|||
145550619|NCT04102020|524871395|FG003|Overall Study|MIssing|1|||
145550620|NCT04102020|524871396|FG004|Overall Study|MIssing|1|||
145550621|NCT04102020|524871392|FG000|Overall Study|Continuing in ongoing study|13|||
145550622|NCT04102020|524871393|FG001|Overall Study|Continuing in ongoing study|13|||
145550623|NCT04102020|524871394|FG002|Overall Study|Continuing in ongoing study|7|||
145550624|NCT04102020|524871395|FG003|Overall Study|Continuing in ongoing study|26|||
145550625|NCT04102020|524871396|FG004|Overall Study|Continuing in ongoing study|12|||
145405465|NCT01189266|524340193|FG002|Overall Study|Adverse Event|5|||
145405466|NCT01189266|524340191|FG000|Overall Study|Death|0|||
145405467|NCT01189266|524340192|FG001|Overall Study|Death|0|||
145405468|NCT01189266|524340193|FG002|Overall Study|Death|5|||
145550626|NCT05109442|524871397|FG000|Overall Study|Withdrawal by Subject|0|||
145550627|NCT05109442|524871398|FG001|Overall Study|Withdrawal by Subject|0|||
145405469|NCT01189266|524340191|FG000|Overall Study|Lack of Efficacy|4|||
145405470|NCT01189266|524340192|FG001|Overall Study|Lack of Efficacy|5|||
145405471|NCT01189266|524340193|FG002|Overall Study|Lack of Efficacy|44|||
145405472|NCT01189266|524340191|FG000|Overall Study|Physician Decision|0|||
145405473|NCT01189266|524340192|FG001|Overall Study|Physician Decision|0|||
145405474|NCT01189266|524340193|FG002|Overall Study|Physician Decision|1|||
145405475|NCT01189266|524340191|FG000|Overall Study|Protocol Violation|0|||
145405476|NCT01189266|524340192|FG001|Overall Study|Protocol Violation|1|||
145405477|NCT01189266|524340193|FG002|Overall Study|Protocol Violation|1|||
145405478|NCT01189266|524340191|FG000|Overall Study|Withdrawal by Subject|0|||
145405479|NCT01189266|524340192|FG001|Overall Study|Withdrawal by Subject|0|||
145405480|NCT01189266|524340193|FG002|Overall Study|Withdrawal by Subject|1|||
145405481|NCT01189266|524340191|FG000|Overall Study|Patient refuses further therapy|1|||
145405482|NCT01189266|524340192|FG001|Overall Study|Patient refuses further therapy|0|||
145405483|NCT01189266|524340193|FG002|Overall Study|Patient refuses further therapy|7|||
145405484|NCT01189266|524340191|FG000|Overall Study|No treatment|0|||
145405485|NCT01189266|524340192|FG001|Overall Study|No treatment|0|||
145405486|NCT01189266|524340193|FG002|Overall Study|No treatment|1|||
145405487|NCT00537277|524340194|FG000|Overall Study|Adverse Event|1|||
145405488|NCT00537277|524340194|FG000|Overall Study|Lack of Efficacy|2|||
145405489|NCT00537277|524340194|FG000|Overall Study|Lost to Follow-up|12|||
145405490|NCT00537277|524340194|FG000|Overall Study|Protocol Violation|11|||
145405491|NCT00537277|524340194|FG000|Overall Study|Unclassified|4|||
145405492|NCT00537277|524340194|FG000|Overall Study|Inability to tolerate trial medication|4|||
145405493|NCT00537277|524340194|FG000|Overall Study|Non-compliance with trial procedures|15|||
145405494|NCT01394276|524340196|FG000|Overall Study|Related Adverse event (AEs)|15|||
145405495|NCT01394276|524340196|FG000|Overall Study|Not related AEs|9|||
145550628|NCT05109442|524871399|FG002|Overall Study|Withdrawal by Subject|1|||
145405496|NCT01394276|524340196|FG000|Overall Study|Remission of disease|2|||
145550629|NCT05109442|524871400|FG003|Overall Study|Withdrawal by Subject|0|||
145550630|NCT05109442|524871401|FG004|Overall Study|Withdrawal by Subject|0|||
145550631|NCT05109442|524871402|FG005|Overall Study|Withdrawal by Subject|0|||
145550632|NCT05109442|524871397|FG000|Overall Study|Adverse Event|0|||
145405497|NCT01394276|524340196|FG000|Overall Study|Insufficient therapeutic effect|17|||
145550633|NCT05109442|524871398|FG001|Overall Study|Adverse Event|1|||
145550634|NCT05109442|524871399|FG002|Overall Study|Adverse Event|5|||
145550635|NCT05109442|524871400|FG003|Overall Study|Adverse Event|0|||
145550636|NCT05109442|524871401|FG004|Overall Study|Adverse Event|0|||
145550637|NCT05109442|524871402|FG005|Overall Study|Adverse Event|2|||
145550638|NCT05109442|524871397|FG000|Overall Study|Death|0|||
145550639|NCT05109442|524871398|FG001|Overall Study|Death|0|||
145550640|NCT05109442|524871399|FG002|Overall Study|Death|4|||
145550641|NCT05109442|524871400|FG003|Overall Study|Death|0|||
145283640|NCT01764854|523889292|FG002|Overall Study|Adverse Event|2|||
145405498|NCT01394276|524340196|FG000|Overall Study|Insufficient compliance|9|||
145550642|NCT05109442|524871401|FG004|Overall Study|Death|0|||
145550643|NCT05109442|524871402|FG005|Overall Study|Death|1|||
145550644|NCT05109442|524871397|FG000|Overall Study|Physician Decision|1|||
145550645|NCT05109442|524871398|FG001|Overall Study|Physician Decision|0|||
145550646|NCT05109442|524871399|FG002|Overall Study|Physician Decision|1|||
145550647|NCT05109442|524871400|FG003|Overall Study|Physician Decision|0|||
145550648|NCT05109442|524871401|FG004|Overall Study|Physician Decision|0|||
145550649|NCT05109442|524871402|FG005|Overall Study|Physician Decision|2|||
145550650|NCT05109442|524871397|FG000|Overall Study|Other than listed|0|||
145550651|NCT05109442|524871398|FG001|Overall Study|Other than listed|0|||
145550652|NCT05109442|524871399|FG002|Overall Study|Other than listed|9|||
145550653|NCT05109442|524871400|FG003|Overall Study|Other than listed|2|||
145550654|NCT05109442|524871401|FG004|Overall Study|Other than listed|0|||
145550655|NCT05109442|524871402|FG005|Overall Study|Other than listed|8|||
145550656|NCT05109442|524871397|FG000|Overall Study|Lack of Efficacy|3|||
145550657|NCT05109442|524871398|FG001|Overall Study|Lack of Efficacy|5|||
145550658|NCT05109442|524871399|FG002|Overall Study|Lack of Efficacy|29|||
145550659|NCT05109442|524871400|FG003|Overall Study|Lack of Efficacy|10|||
145550660|NCT05109442|524871401|FG004|Overall Study|Lack of Efficacy|11|||
145550661|NCT05109442|524871402|FG005|Overall Study|Lack of Efficacy|17|||
145550662|NCT03918447|524871407|FG000|Overall Study|Death|1|||
145550663|NCT03918447|524871408|FG001|Overall Study|Death|0|||
145550664|NCT03918447|524871407|FG000|Overall Study|Lost to Follow-up|13|||
145550665|NCT03918447|524871408|FG001|Overall Study|Lost to Follow-up|6|||
145550666|NCT03918447|524871407|FG000|Overall Study|Withdrawal by Subject|19|||
145550667|NCT03918447|524871408|FG001|Overall Study|Withdrawal by Subject|17|||
145550668|NCT03918447|524871407|FG000|Overall Study|Study Terminated by Sponsor|195|||
145550669|NCT03918447|524871408|FG001|Overall Study|Study Terminated by Sponsor|197|||
145550670|NCT03918447|524871407|FG000|Overall Study|Reason not Specified|0|||
145550671|NCT03918447|524871408|FG001|Overall Study|Reason not Specified|1|||
145550672|NCT03278613|524871409|FG000|Overall Study|Lost to Follow-up|3|||
145550673|NCT03278613|524871410|FG001|Overall Study|Lost to Follow-up|1|||
145283641|NCT01764854|523889293|FG003|Overall Study|Adverse Event|0|||
145283642|NCT01764854|523889290|FG000|Overall Study|Withdrawal by Subject|0|||
145283643|NCT01764854|523889291|FG001|Overall Study|Withdrawal by Subject|0|||
145283644|NCT01764854|523889292|FG002|Overall Study|Withdrawal by Subject|1|||
145283645|NCT01764854|523889293|FG003|Overall Study|Withdrawal by Subject|0|||
145283646|NCT01764854|523889290|FG000|Overall Study|relocation|0|||
145283647|NCT01764854|523889291|FG001|Overall Study|relocation|0|||
145283648|NCT01764854|523889292|FG002|Overall Study|relocation|2|||
145283649|NCT01764854|523889293|FG003|Overall Study|relocation|0|||
145283650|NCT01764854|523889290|FG000|Overall Study|Protocol Violation|0|||
145283651|NCT01764854|523889291|FG001|Overall Study|Protocol Violation|0|||
145283652|NCT01764854|523889292|FG002|Overall Study|Protocol Violation|1|||
145283653|NCT01764854|523889293|FG003|Overall Study|Protocol Violation|2|||
145283654|NCT01003886|523889296|FG000|Overall Study|Lack of Efficacy|5|||
145283655|NCT01003886|523889296|FG000|Overall Study|Lost to Follow-up|169|||
145283656|NCT01003886|523889296|FG000|Overall Study|Withdrawal by Subject|39|||
145283657|NCT01003886|523889296|FG000|Overall Study|Other|14|||
145283658|NCT01003886|523889296|FG000|Overall Study|Adverse Event|3|||
145283659|NCT04467697|523889313|FG000|Overall Study|Adverse Event|2|||
145283660|NCT04467697|523889313|FG000|Overall Study|Lost to Follow-up|6|||
145283661|NCT04467697|523889313|FG000|Overall Study|Withdrawal by Subject|9|||
145283662|NCT04467697|523889313|FG000|Overall Study|Protocol Violation|3|||
145283663|NCT05751629|523889314|FG000|Overall Study|Withdrawal by Subject|6|||
145283664|NCT05751629|523889314|FG000|Overall Study|Death|25|||
145283665|NCT05751629|523889314|FG000|Overall Study|Study Site Closed|9|||
145283666|NCT05751629|523889314|FG000|Overall Study|Physician Decision|1|||
145283667|NCT01909466|523889315|FG000|Overall Study|Lost to Follow-up|5|||
145283668|NCT01909466|523889316|FG001|Overall Study|Lost to Follow-up|7|||
145283669|NCT01909466|523889315|FG000|Overall Study|Adverse Event|3|||
145283670|NCT01909466|523889316|FG001|Overall Study|Adverse Event|4|||
145283671|NCT01909466|523889315|FG000|Overall Study|Met Withdrawal Criteria|0|||
145283672|NCT01909466|523889316|FG001|Overall Study|Met Withdrawal Criteria|3|||
145550674|NCT01405456|524871411|FG000|Overall Study|Lost to Follow-up|2|||
145283673|NCT01909466|523889315|FG000|Overall Study|Physician Decision|2|||
145283674|NCT01909466|523889316|FG001|Overall Study|Physician Decision|0|||
145283675|NCT01909466|523889315|FG000|Overall Study|Withdrawal by Subject|11|||
145283676|NCT01909466|523889316|FG001|Overall Study|Withdrawal by Subject|9|||
145283677|NCT01909466|523889315|FG000|Overall Study|Lack of Efficacy|1|||
145283678|NCT01909466|523889316|FG001|Overall Study|Lack of Efficacy|0|||
145283679|NCT00673361|523889320|FG000|Overall Study|Screen Failure|2|||
145283680|NCT03038113|523889325|FG000|Overall Study|Withdrawal by Subject|0|||
145550675|NCT01405456|524871412|FG001|Overall Study|Lost to Follow-up|1|||
145550676|NCT01405456|524871411|FG000|Overall Study|Physician Decision|1|||
145550677|NCT01405456|524871412|FG001|Overall Study|Physician Decision|0|||
145550678|NCT05475236|524871414|FG000|Overall Study|Withdrawal by Subject|0|||
145550679|NCT05475236|524871415|FG001|Overall Study|Withdrawal by Subject|1|||
145550680|NCT00477971|524871416|FG000|Overall Study|Disease progression|6|||
145283681|NCT03038113|523889326|FG001|Overall Study|Withdrawal by Subject|0|||
145550681|NCT00477971|524871417|FG001|Overall Study|Disease progression|0|||
145550682|NCT00477971|524871416|FG000|Overall Study|Withdrawal by Subject|3|||
145550683|NCT00477971|524871417|FG001|Overall Study|Withdrawal by Subject|1|||
145405499|NCT01394276|524340196|FG000|Overall Study|Lost to Follow-up|5|||
145405500|NCT01394276|524340196|FG000|Overall Study|Participant moved to another site|1|||
145550684|NCT00477971|524871416|FG000|Overall Study|Adverse Event|3|||
145550685|NCT00477971|524871417|FG001|Overall Study|Adverse Event|0|||
145550686|NCT00477971|524871416|FG000|Overall Study|Death|2|||
145550687|NCT00477971|524871417|FG001|Overall Study|Death|4|||
145550688|NCT00477971|524871416|FG000|Overall Study|Alternative treatment|3|||
145550689|NCT00477971|524871417|FG001|Overall Study|Alternative treatment|1|||
145550690|NCT05355805|524871418|FG000|Overall Study|Lost to Follow-up|6|||
145550691|NCT05355805|524871419|FG001|Overall Study|Lost to Follow-up|11|||
145550692|NCT05355805|524871420|FG002|Overall Study|Lost to Follow-up|10|||
145550693|NCT05355805|524871421|FG003|Overall Study|Lost to Follow-up|6|||
145550694|NCT05355805|524871418|FG000|Overall Study|Decision by Sponsor|0|||
145550695|NCT05355805|524871419|FG001|Overall Study|Decision by Sponsor|0|||
145550696|NCT05355805|524871420|FG002|Overall Study|Decision by Sponsor|1|||
145550697|NCT05355805|524871421|FG003|Overall Study|Decision by Sponsor|0|||
145550698|NCT05355805|524871418|FG000|Overall Study|Withdrawal by Subject|7|||
145550699|NCT05355805|524871419|FG001|Overall Study|Withdrawal by Subject|14|||
145550700|NCT05355805|524871420|FG002|Overall Study|Withdrawal by Subject|15|||
145550701|NCT05355805|524871421|FG003|Overall Study|Withdrawal by Subject|13|||
145550702|NCT05353985|524871422|FG000|Overall Study|Adverse Event|5|||
145550703|NCT05353985|524871423|FG001|Overall Study|Adverse Event|7|||
145550704|NCT05353985|524871422|FG000|Overall Study|Lost to Follow-up|1|||
145405501|NCT01394276|524340196|FG000|Overall Study|Pregnancy|1|||
145550705|NCT05353985|524871423|FG001|Overall Study|Lost to Follow-up|1|||
145550706|NCT05353985|524871422|FG000|Overall Study|Protocol Violation|1|||
145550707|NCT05353985|524871423|FG001|Overall Study|Protocol Violation|0|||
145550708|NCT05353985|524871422|FG000|Overall Study|Withdrawal by Subject|13|||
145550709|NCT05353985|524871423|FG001|Overall Study|Withdrawal by Subject|17|||
145550710|NCT05353985|524871422|FG000|Overall Study|Reason Not Specified|1|||
145550711|NCT05353985|524871423|FG001|Overall Study|Reason Not Specified|0|||
145550712|NCT05353985|524871422|FG000|Overall Study|Randomized in Error & Not Treated|0|||
145550713|NCT05353985|524871423|FG001|Overall Study|Randomized in Error & Not Treated|1|||
145550714|NCT04419714|524871425|FG000|Overall Study|Technical Fault|5|||
145550715|NCT04419714|524871425|FG000|Overall Study|Protocol Deviation|2|||
145550716|NCT04419714|524871425|FG000|Overall Study|Withdrawal by Subject|1|||
145550717|NCT04221009|524872854|FG000|Overall Study|Withdrawal by Subject|4|||
145550718|NCT02373202|524872855|FG000|Overall Study|Adverse Event|2|||
145550719|NCT02373202|524872856|FG001|Overall Study|Adverse Event|5|||
145550720|NCT02373202|524872857|FG002|Overall Study|Adverse Event|2|||
145550721|NCT02373202|524872858|FG003|Overall Study|Adverse Event|1|||
145550722|NCT02373202|524872855|FG000|Overall Study|Lack of Efficacy|0|||
145550723|NCT02373202|524872856|FG001|Overall Study|Lack of Efficacy|0|||
145550724|NCT02373202|524872857|FG002|Overall Study|Lack of Efficacy|1|||
145550725|NCT02373202|524872858|FG003|Overall Study|Lack of Efficacy|0|||
145550726|NCT02373202|524872855|FG000|Overall Study|Other|0|||
145550727|NCT02373202|524872856|FG001|Overall Study|Other|1|||
145550728|NCT02373202|524872857|FG002|Overall Study|Other|0|||
145550729|NCT02373202|524872858|FG003|Overall Study|Other|0|||
145550730|NCT00482612|524872861|FG000|In-treatment Period|No study medication administered|0|||
145550731|NCT00482612|524872862|FG001|In-treatment Period|No study medication administered|0|||
145550732|NCT00482612|524872863|FG002|In-treatment Period|No study medication administered|1|||
145550733|NCT00482612|524872864|FG003|In-treatment Period|No study medication administered|0|||
145550734|NCT00482612|524872861|FG000|Follow-up Period|Other|4|||
145550735|NCT00482612|524872862|FG001|Follow-up Period|Other|2|||
145550736|NCT00482612|524872863|FG002|Follow-up Period|Other|1|||
145550737|NCT00482612|524872864|FG003|Follow-up Period|Other|2|||
145550738|NCT00482612|524872861|FG000|Follow-up Period|Lack of compliance|0|||
145550739|NCT00482612|524872862|FG001|Follow-up Period|Lack of compliance|0|||
145550740|NCT00482612|524872863|FG002|Follow-up Period|Lack of compliance|1|||
145550741|NCT00482612|524872864|FG003|Follow-up Period|Lack of compliance|0|||
145550742|NCT00482612|524872861|FG000|Follow-up Period|Lost to Follow-up|0|||
145550743|NCT00482612|524872862|FG001|Follow-up Period|Lost to Follow-up|4|||
145550744|NCT00482612|524872863|FG002|Follow-up Period|Lost to Follow-up|2|||
145550745|NCT00482612|524872864|FG003|Follow-up Period|Lost to Follow-up|1|||
145550746|NCT00482612|524872861|FG000|Follow-up Period|Adverse Event|4|||
145550747|NCT00482612|524872862|FG001|Follow-up Period|Adverse Event|7|||
145550748|NCT00482612|524872863|FG002|Follow-up Period|Adverse Event|9|||
145550749|NCT00482612|524872864|FG003|Follow-up Period|Adverse Event|0|||
145550750|NCT00482612|524872861|FG000|Follow-up Period|Lack of Efficacy|2|||
145550751|NCT00482612|524872862|FG001|Follow-up Period|Lack of Efficacy|0|||
145550752|NCT00482612|524872863|FG002|Follow-up Period|Lack of Efficacy|1|||
145550753|NCT00482612|524872864|FG003|Follow-up Period|Lack of Efficacy|0|||
145611277|NCT01993017|525092646|FG001|Overall Study|Dropped out|6|||
145550754|NCT00482612|524872861|FG000|Follow-up Period|Withdrawal by Subject|3|||
145550755|NCT00482612|524872862|FG001|Follow-up Period|Withdrawal by Subject|5|||
145550756|NCT00482612|524872863|FG002|Follow-up Period|Withdrawal by Subject|7|||
145550757|NCT00482612|524872864|FG003|Follow-up Period|Withdrawal by Subject|2|||
145550758|NCT00482612|524872861|FG000|Follow-up Period|Reasons not related to trial|1|||
145550759|NCT00482612|524872862|FG001|Follow-up Period|Reasons not related to trial|0|||
145550760|NCT00482612|524872863|FG002|Follow-up Period|Reasons not related to trial|1|||
145550761|NCT00482612|524872864|FG003|Follow-up Period|Reasons not related to trial|3|||
145550762|NCT00464087|524872867|FG000|Overall Study|No PCI per inclusion criteria|0|||
145550763|NCT00464087|524872868|FG001|Overall Study|No PCI per inclusion criteria|0|||
145550764|NCT00464087|524872869|FG002|Overall Study|No PCI per inclusion criteria|29|||
145550765|NCT02057406|524872871|FG000|Overall Study|Physician Decision|0|||
145550766|NCT02057406|524872872|FG001|Overall Study|Physician Decision|0|||
145550767|NCT02057406|524872873|FG002|Overall Study|Physician Decision|2|||
145550768|NCT02057406|524872871|FG000|Overall Study|Withdrawal by Subject|0|||
145550769|NCT02057406|524872872|FG001|Overall Study|Withdrawal by Subject|2|||
145550770|NCT02057406|524872873|FG002|Overall Study|Withdrawal by Subject|0|||
145550771|NCT02057406|524872871|FG000|Overall Study|Lost to Follow-up|0|||
145550772|NCT02057406|524872872|FG001|Overall Study|Lost to Follow-up|0|||
145550773|NCT02057406|524872873|FG002|Overall Study|Lost to Follow-up|1|||
145550774|NCT02057406|524872871|FG000|Overall Study|Death|1|||
145550775|NCT02057406|524872872|FG001|Overall Study|Death|0|||
145550776|NCT02057406|524872873|FG002|Overall Study|Death|0|||
145550777|NCT02057406|524872871|FG000|Overall Study|Protocol Violation|0|||
145550778|NCT02057406|524872872|FG001|Overall Study|Protocol Violation|1|||
145550779|NCT02057406|524872873|FG002|Overall Study|Protocol Violation|0|||
145550780|NCT02057406|524872871|FG000|Overall Study|Patient transportation issues|0|||
145550781|NCT02057406|524872872|FG001|Overall Study|Patient transportation issues|0|||
145550782|NCT02057406|524872873|FG002|Overall Study|Patient transportation issues|1|||
145550783|NCT01224431|524872874|FG000|Overall Study|not randomized|0|||
145550784|NCT01224431|524872875|FG001|Overall Study|not randomized|4|||
145550785|NCT01224431|524872874|FG000|Overall Study|no video record|0|||
145550786|NCT01224431|524872875|FG001|Overall Study|no video record|1|||
145550787|NCT03654651|524872877|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145550788|NCT03654651|524872878|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
145550789|NCT01401283|524872879|FG000|Overall Study|surgery cancelled|5|||
145550790|NCT01401283|524872880|FG001|Overall Study|surgery cancelled|8|||
145550791|NCT01401283|524872879|FG000|Overall Study|preoperative arrhythmia|5|||
145550792|NCT01401283|524872880|FG001|Overall Study|preoperative arrhythmia|0|||
145550793|NCT01401283|524872879|FG000|Overall Study|no central venous access|0|||
145550794|NCT01401283|524872880|FG001|Overall Study|no central venous access|1|||
145550795|NCT01401283|524872879|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
145550796|NCT01401283|524872880|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
145550797|NCT02433483|524872881|FG000|Overall Study|Unacceptable toxicity|1|||
145550798|NCT02433483|524872881|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
145550799|NCT02904512|524872883|FG000|Overall Study|Withdrawal by Subject|1|||
145550800|NCT02904512|524872884|FG001|Overall Study|Withdrawal by Subject|0|||
145550801|NCT02904512|524872883|FG000|Overall Study|Transferred to ICU|1|||
145550802|NCT02904512|524872884|FG001|Overall Study|Transferred to ICU|0|||
145550803|NCT02904512|524872883|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
145550804|NCT02904512|524872884|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
145550805|NCT01963403|524872889|FG000|Overall Study|Lost to Follow-up|2|||
145550806|NCT01963403|524872890|FG001|Overall Study|Lost to Follow-up|3|||
145550807|NCT01963403|524872889|FG000|Overall Study|Implant removal|0|||
145550808|NCT01963403|524872890|FG001|Overall Study|Implant removal|1|||
145550809|NCT01414114|524872891|FG000|Overall Study|Adverse Event|2|||
145550810|NCT01414114|524872891|FG000|Overall Study|Withdrawal by Subject|1|||
145550811|NCT01414114|524872891|FG000|Overall Study|Other|2|||
145550812|NCT02692703|524872892|FG000|Overall Study|Lost to Follow-up|1|||
145550813|NCT02692703|524872892|FG000|Overall Study|Other|1|||
145550814|NCT00865124|524872895|FG000|Overall Study|Physician Decision|2|||
145550815|NCT00865124|524872896|FG001|Overall Study|Physician Decision|1|||
145550816|NCT00865124|524872897|FG002|Overall Study|Physician Decision|0|||
145550817|NCT00865124|524872895|FG000|Overall Study|Withdrawn consent|2|||
145550818|NCT00865124|524872896|FG001|Overall Study|Withdrawn consent|0|||
145550819|NCT00865124|524872897|FG002|Overall Study|Withdrawn consent|0|||
145550820|NCT03247530|524872898|FG000|Overall Study|Withdrawal by caregiver|19|||
145550821|NCT03247530|524872899|FG001|Overall Study|Withdrawal by caregiver|8|||
145550822|NCT03247530|524872900|FG002|Overall Study|Withdrawal by caregiver|10|||
145550823|NCT03247530|524872898|FG000|Overall Study|Lost to Follow-up|3|||
145550824|NCT03247530|524872899|FG001|Overall Study|Lost to Follow-up|9|||
145550825|NCT03247530|524872900|FG002|Overall Study|Lost to Follow-up|6|||
145550826|NCT03247530|524872898|FG000|Overall Study|Adverse Event|2|||
145550827|NCT03247530|524872899|FG001|Overall Study|Adverse Event|5|||
145550828|NCT03247530|524872900|FG002|Overall Study|Adverse Event|2|||
145550829|NCT03247530|524872898|FG000|Overall Study|Failure to follow procedure|1|||
145550830|NCT03247530|524872899|FG001|Overall Study|Failure to follow procedure|1|||
145550831|NCT03247530|524872900|FG002|Overall Study|Failure to follow procedure|1|||
145550832|NCT03247530|524872898|FG000|Overall Study|Withdrawal by Subject|1|||
145550833|NCT03247530|524872899|FG001|Overall Study|Withdrawal by Subject|1|||
145550834|NCT03247530|524872900|FG002|Overall Study|Withdrawal by Subject|0|||
145550835|NCT03247530|524872898|FG000|Overall Study|Study medication misuse|0|||
145550836|NCT03247530|524872899|FG001|Overall Study|Study medication misuse|1|||
145550837|NCT03247530|524872900|FG002|Overall Study|Study medication misuse|0|||
145550838|NCT03247530|524872898|FG000|Overall Study|Other, multiple categories|1|||
145550839|NCT03247530|524872899|FG001|Overall Study|Other, multiple categories|3|||
145550840|NCT03247530|524872900|FG002|Overall Study|Other, multiple categories|1|||
145550841|NCT00372112|524872908|FG000|Overall Study|Adverse Event|0|||
145550842|NCT00372112|524872909|FG001|Overall Study|Adverse Event|1|||
145550843|NCT00372112|524872910|FG002|Overall Study|Adverse Event|1|||
145550844|NCT00372112|524872911|FG003|Overall Study|Adverse Event|1|||
145550845|NCT00372112|524872908|FG000|Overall Study|Withdrawal by Subject|0|||
145550846|NCT00372112|524872909|FG001|Overall Study|Withdrawal by Subject|0|||
145550847|NCT00372112|524872910|FG002|Overall Study|Withdrawal by Subject|2|||
145550848|NCT00372112|524872911|FG003|Overall Study|Withdrawal by Subject|1|||
145550849|NCT00372112|524872908|FG000|Overall Study|Exacerbation|0|||
145550850|NCT00372112|524872909|FG001|Overall Study|Exacerbation|0|||
145550851|NCT00372112|524872910|FG002|Overall Study|Exacerbation|0|||
145550852|NCT00372112|524872911|FG003|Overall Study|Exacerbation|1|||
145550853|NCT00372112|524872908|FG000|Overall Study|PR >240 at Visit 3|0|||
145550854|NCT00372112|524872909|FG001|Overall Study|PR >240 at Visit 3|0|||
145550855|NCT00372112|524872910|FG002|Overall Study|PR >240 at Visit 3|0|||
145550856|NCT00372112|524872911|FG003|Overall Study|PR >240 at Visit 3|1|||
145550857|NCT00372112|524872908|FG000|Overall Study|Hepatitis B|1|||
145550858|NCT00372112|524872909|FG001|Overall Study|Hepatitis B|0|||
145550859|NCT00372112|524872910|FG002|Overall Study|Hepatitis B|0|||
145550860|NCT00372112|524872911|FG003|Overall Study|Hepatitis B|0|||
145550861|NCT00372112|524872908|FG000|Overall Study|Other-protocol violation|0|||
145550862|NCT00372112|524872909|FG001|Overall Study|Other-protocol violation|0|||
145550863|NCT00372112|524872910|FG002|Overall Study|Other-protocol violation|1|||
145550864|NCT00372112|524872911|FG003|Overall Study|Other-protocol violation|0|||
145550865|NCT01678911|524872912|FG000|Second Intervention|Lost to Follow-up|2|||
145550866|NCT01678911|524872913|FG001|Second Intervention|Lost to Follow-up|0|||
145550867|NCT00356369|524872914|FG000|Active Phase|Withdrawal by Subject|2|||
145550868|NCT00356369|524872915|FG001|Active Phase|Withdrawal by Subject|1|||
145550869|NCT01985867|524872916|FG000|Overall Study|Lost to Follow-up|3|||
145550870|NCT01985867|524872917|FG001|Overall Study|Lost to Follow-up|4|||
145550871|NCT01985867|524872916|FG000|Overall Study|Adverse Event|3|||
145550872|NCT01985867|524872917|FG001|Overall Study|Adverse Event|2|||
145550873|NCT01985867|524872916|FG000|Overall Study|Lack of Efficacy|1|||
145550874|NCT01985867|524872917|FG001|Overall Study|Lack of Efficacy|0|||
145550875|NCT01919723|524872918|FG000|Overall Study|Blood Samples Hemolyzed|2|||
145550876|NCT01919723|524872919|FG001|Overall Study|Blood Samples Hemolyzed|2|||
145550877|NCT04502589|524872920|FG000|Overall Study|Physician Decision|1|||
145550878|NCT04502589|524872921|FG001|Overall Study|Physician Decision|0|||
145550879|NCT00137046|524872927|FG000|Overall Study|Death|2|||
145550880|NCT00137046|524872928|FG001|Overall Study|Death|1|||
145550881|NCT00137046|524872927|FG000|Overall Study|Adverse Event|16|||
145550882|NCT00137046|524872928|FG001|Overall Study|Adverse Event|5|||
145550883|NCT00137046|524872927|FG000|Overall Study|Laboratory Abnormality|2|||
145550884|NCT00137046|524872928|FG001|Overall Study|Laboratory Abnormality|0|||
145550885|NCT00137046|524872927|FG000|Overall Study|Lack of Efficacy|13|||
145550886|NCT00137046|524872928|FG001|Overall Study|Lack of Efficacy|1|||
145550887|NCT00137046|524872927|FG000|Overall Study|Lost to Follow-up|8|||
145550888|NCT00137046|524872928|FG001|Overall Study|Lost to Follow-up|24|||
145550889|NCT00137046|524872927|FG000|Overall Study|Other|23|||
145550890|NCT00137046|524872928|FG001|Overall Study|Other|19|||
145550891|NCT00137046|524872927|FG000|Overall Study|Withdrawal by Subject|33|||
145550892|NCT00137046|524872928|FG001|Overall Study|Withdrawal by Subject|42|||
145550893|NCT00137046|524872927|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
145550894|NCT00137046|524872928|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
145550895|NCT00137046|524872927|FG000|Overall Study|Withdrew prior to study treatment|1|||
145550896|NCT00137046|524872928|FG001|Overall Study|Withdrew prior to study treatment|1|||
145550897|NCT02532972|524872930|FG000|Overall Study|Withdrawal by Subject|1|||
145550898|NCT02859454|524872933|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
145550899|NCT03944954|524872934|FG000|Overall Study|Withdrawal by Subject|22|||
145550900|NCT03944954|524872935|FG001|Overall Study|Withdrawal by Subject|4|||
145550901|NCT03944954|524872934|FG000|Overall Study|Lost to Follow-up|18|||
145550902|NCT03944954|524872935|FG001|Overall Study|Lost to Follow-up|0|||
145550903|NCT03944954|524872934|FG000|Overall Study|Failed Medical Screening|7|||
145550904|NCT03944954|524872935|FG001|Overall Study|Failed Medical Screening|0|||
145550905|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
145550906|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
145550907|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
145550908|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
145550909|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145550910|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145550911|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
145550912|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
145550913|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Other|1|||
145550914|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Other|4|||
145550915|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Other|3|||
145550916|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Other|6|||
145550917|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
145550918|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
145550919|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
145550920|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
145550921|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
145550922|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
145550923|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
145550924|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
145550925|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145550926|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145550927|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
145550928|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
145550929|NCT02925494|524872936|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
145550930|NCT02925494|524872937|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
145550931|NCT02925494|524872938|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
145550932|NCT02925494|524872939|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
145550933|NCT03334448|524872940|FG000|Washout|Personal Reason|0|||
145550934|NCT03334448|524872941|FG001|Washout|Personal Reason|1|||
145550935|NCT03334448|524872942|FG002|Washout|Personal Reason|0|||
145550936|NCT03334448|524872943|FG003|Washout|Personal Reason|0|||
145550937|NCT03334448|524872940|FG000|Washout|Protocol Violation|0|||
145550938|NCT03334448|524872941|FG001|Washout|Protocol Violation|0|||
145550939|NCT03334448|524872942|FG002|Washout|Protocol Violation|0|||
145550940|NCT03334448|524872943|FG003|Washout|Protocol Violation|1|||
145550941|NCT02496611|524872950|FG000|Overall Study|Lost to Follow-up|2|||
145550942|NCT02496611|524872951|FG001|Overall Study|Lost to Follow-up|1|||
145550943|NCT02496611|524872950|FG000|Overall Study|Withdrawal by Subject|5|||
145550944|NCT02496611|524872951|FG001|Overall Study|Withdrawal by Subject|2|||
145405502|NCT01394276|524340196|FG000|Overall Study|unavailability of drug at the Hospital|2|||
145283682|NCT03038113|523889327|FG002|Overall Study|Withdrawal by Subject|1|||
145550945|NCT02850965|524872952|FG000|Overall Study|Other than listed|3|||
145550946|NCT02850965|524872953|FG001|Overall Study|Other than listed|4|||
145550947|NCT02850965|524872952|FG000|Overall Study|Protocol Violation|0|||
145550948|NCT02850965|524872953|FG001|Overall Study|Protocol Violation|2|||
145550949|NCT02850965|524872952|FG000|Overall Study|Lost to Follow-up|5|||
145550950|NCT02850965|524872953|FG001|Overall Study|Lost to Follow-up|3|||
145550951|NCT02850965|524872952|FG000|Overall Study|Lack of Efficacy|4|||
145550952|NCT02850965|524872953|FG001|Overall Study|Lack of Efficacy|8|||
145550953|NCT02850965|524872952|FG000|Overall Study|Adverse Event|3|||
145550954|NCT02850965|524872953|FG001|Overall Study|Adverse Event|2|||
145550955|NCT02850965|524872952|FG000|Overall Study|Withdrawal by Subject|3|||
145550956|NCT02850965|524872953|FG001|Overall Study|Withdrawal by Subject|4|||
145550957|NCT02850965|524872952|FG000|Overall Study|Physician Decision|0|||
145550958|NCT02850965|524872953|FG001|Overall Study|Physician Decision|1|||
145550959|NCT02850965|524872952|FG000|Overall Study|Randomized but not treated|0|||
145550960|NCT02850965|524872953|FG001|Overall Study|Randomized but not treated|1|||
145405503|NCT01394276|524340196|FG000|Overall Study|Symptoms of concurrent diseases|1|||
145405504|NCT00655889|524340197|FG000|Overall Study|Inadequate cell growth|1|||
145550961|NCT02788357|524872957|FG000|Overall Study|Lost to Follow-up|3|||
145611278|NCT01993017|525092647|FG002|Overall Study|Dropped out|11|||
145611279|NCT01993017|525092645|FG000|Overall Study|Other reasons|17|||
145611280|NCT01993017|525092646|FG001|Overall Study|Other reasons|11|||
145550962|NCT02788357|524872958|FG001|Overall Study|Lost to Follow-up|0|||
145550963|NCT01365910|524872959|FG000|Overall Study|Withdrawal by Subject|7|||
145550964|NCT01365910|524872959|FG000|Overall Study|disease progression|18|||
145550965|NCT01365910|524872959|FG000|Overall Study|Adverse Event|3|||
145550966|NCT01365910|524872959|FG000|Overall Study|other complicating disease|1|||
145550967|NCT01365910|524872959|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
145550968|NCT00371137|524872960|FG000|Overall Study|Adverse Event|20|||
145550969|NCT00371137|524872961|FG001|Overall Study|Adverse Event|35|||
145550970|NCT00371137|524872962|FG002|Overall Study|Adverse Event|42|||
145283683|NCT03038113|523889328|FG003|Overall Study|Withdrawal by Subject|0|||
145550971|NCT00371137|524872960|FG000|Overall Study|Withdrawal by Subject|11|||
145550972|NCT00371137|524872961|FG001|Overall Study|Withdrawal by Subject|10|||
145550973|NCT00371137|524872962|FG002|Overall Study|Withdrawal by Subject|15|||
145550974|NCT00371137|524872960|FG000|Overall Study|Lost to Follow-up|6|||
145611281|NCT01993017|525092647|FG002|Overall Study|Other reasons|7|||
145283684|NCT03038113|523889329|FG004|Overall Study|Withdrawal by Subject|0|||
145550975|NCT00371137|524872961|FG001|Overall Study|Lost to Follow-up|3|||
145550976|NCT00371137|524872962|FG002|Overall Study|Lost to Follow-up|5|||
145550977|NCT00371137|524872960|FG000|Overall Study|Lack of Efficacy|30|||
145550978|NCT00371137|524872961|FG001|Overall Study|Lack of Efficacy|12|||
145550979|NCT00371137|524872962|FG002|Overall Study|Lack of Efficacy|13|||
145550980|NCT00371137|524872960|FG000|Overall Study|Sponsor Decision|2|||
145550981|NCT00371137|524872961|FG001|Overall Study|Sponsor Decision|1|||
145550982|NCT00371137|524872962|FG002|Overall Study|Sponsor Decision|2|||
145550983|NCT00371137|524872960|FG000|Overall Study|Physician Decision|1|||
145550984|NCT00371137|524872961|FG001|Overall Study|Physician Decision|1|||
145550985|NCT00371137|524872962|FG002|Overall Study|Physician Decision|1|||
145550986|NCT00371137|524872960|FG000|Overall Study|Protocol Violation|2|||
145550987|NCT00371137|524872961|FG001|Overall Study|Protocol Violation|1|||
145550988|NCT00371137|524872962|FG002|Overall Study|Protocol Violation|1|||
145550989|NCT02013791|524872963|FG000|Period 1|Lost to Follow-up|0|||
145550990|NCT02013791|524872964|FG001|Period 1|Lost to Follow-up|0|||
145550991|NCT02013791|524872965|FG002|Period 1|Lost to Follow-up|0|||
145550992|NCT02013791|524872966|FG003|Period 1|Lost to Follow-up|1|||
145550993|NCT02013791|524872967|FG004|Period 1|Lost to Follow-up|0|||
145550994|NCT02013791|524872968|FG005|Period 1|Lost to Follow-up|0|||
145550995|NCT02013791|524872969|FG006|Period 1|Lost to Follow-up|1|||
145550996|NCT02013791|524872970|FG007|Period 1|Lost to Follow-up|1|||
145550997|NCT02013791|524872971|FG008|Period 1|Lost to Follow-up|0|||
145550998|NCT02013791|524872963|FG000|Period 1|Other Miscellaneous Reasons|0|||
145550999|NCT02013791|524872964|FG001|Period 1|Other Miscellaneous Reasons|2|||
145551000|NCT02013791|524872965|FG002|Period 1|Other Miscellaneous Reasons|0|||
145551001|NCT02013791|524872966|FG003|Period 1|Other Miscellaneous Reasons|0|||
145551002|NCT02013791|524872967|FG004|Period 1|Other Miscellaneous Reasons|0|||
145551003|NCT02013791|524872968|FG005|Period 1|Other Miscellaneous Reasons|0|||
145551004|NCT02013791|524872969|FG006|Period 1|Other Miscellaneous Reasons|0|||
145551005|NCT02013791|524872970|FG007|Period 1|Other Miscellaneous Reasons|0|||
145551006|NCT02013791|524872971|FG008|Period 1|Other Miscellaneous Reasons|0|||
145551007|NCT02170051|524872972|FG000|Overall Study|Withdrawal by Subject|10|||
145551008|NCT02170051|524872973|FG001|Overall Study|Withdrawal by Subject|10|||
145551009|NCT02170051|524872972|FG000|Overall Study|Lost to Follow-up|1|||
145551010|NCT02170051|524872973|FG001|Overall Study|Lost to Follow-up|3|||
145551011|NCT03798483|524872974|FG000|Overall Study|Lost to Follow-up|2|||
145405505|NCT00655889|524340197|FG000|Overall Study|Protocol Violation|1|||
145551012|NCT00276744|524872975|FG000|PART A|Reason unknown|98|||
145551013|NCT02725710|524872976|FG000|Overall Study|Lost to Follow-up|1|||
145551014|NCT02725710|524872977|FG001|Overall Study|Lost to Follow-up|0|||
145551015|NCT04786990|524872984|FG000|Overall Study|Withdrawal by Subject|1|||
145551016|NCT04786990|524872984|FG000|Overall Study|Adverse Event|1|||
145551017|NCT04786990|524872984|FG000|Overall Study|Lost to Follow-up|1|||
145551018|NCT04786990|524872984|FG000|Overall Study|Noncompliance|1|||
145551019|NCT04786990|524872984|FG000|Overall Study|Unable to complete site visits|1|||
145551020|NCT04786990|524872984|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
145551021|NCT01782222|524872985|FG000|Overall Study|Adverse Event|4|||
145551022|NCT01782222|524872986|FG001|Overall Study|Adverse Event|5|||
145551023|NCT01782222|524872987|FG002|Overall Study|Adverse Event|3|||
145551024|NCT01782222|524872985|FG000|Overall Study|Lack of Efficacy|2|||
145551025|NCT01782222|524872986|FG001|Overall Study|Lack of Efficacy|1|||
145551026|NCT01782222|524872987|FG002|Overall Study|Lack of Efficacy|0|||
145551027|NCT01782222|524872985|FG000|Overall Study|Protocol Violation|1|||
145551028|NCT01782222|524872986|FG001|Overall Study|Protocol Violation|0|||
145551029|NCT01782222|524872987|FG002|Overall Study|Protocol Violation|0|||
145551030|NCT01782222|524872985|FG000|Overall Study|Withdrawal by Subject|1|||
145551031|NCT01782222|524872986|FG001|Overall Study|Withdrawal by Subject|4|||
145405506|NCT04585893|524340198|FG000|Overall Study|Death|1|||
145551032|NCT01782222|524872987|FG002|Overall Study|Withdrawal by Subject|1|||
145551033|NCT01782222|524872985|FG000|Overall Study|Moved to other state|0|||
145551034|NCT01782222|524872986|FG001|Overall Study|Moved to other state|1|||
145405507|NCT04585893|524340199|FG001|Overall Study|Death|0|||
145551035|NCT01782222|524872987|FG002|Overall Study|Moved to other state|0|||
145551036|NCT01858389|524872992|FG000|Overall Study|Death|1|||
145551037|NCT01858389|524872993|FG001|Overall Study|Death|3|||
145551038|NCT01858389|524872992|FG000|Overall Study|Study terminated by sponsor|0|||
145551039|NCT01858389|524872993|FG001|Overall Study|Study terminated by sponsor|2|||
145551040|NCT01858389|524872992|FG000|Overall Study|Withdrawal by Subject|0|||
145405508|NCT03573297|524340200|FG000|Open Label Treatment Period|Adverse Event|67|||
145405509|NCT03573297|524340201|FG001|Open Label Treatment Period|Adverse Event|0|||
145405510|NCT03573297|524340202|FG002|Open Label Treatment Period|Adverse Event|0|||
145405511|NCT03573297|524340203|FG003|Open Label Treatment Period|Adverse Event|0|||
145405512|NCT03573297|524340200|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
145405513|NCT03573297|524340201|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
145405514|NCT03573297|524340202|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
145405515|NCT03573297|524340203|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
145405516|NCT03573297|524340200|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
145405517|NCT03573297|524340201|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
145405518|NCT03573297|524340202|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
145405519|NCT03573297|524340203|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
145405520|NCT03573297|524340200|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
145405521|NCT03573297|524340201|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
145405522|NCT03573297|524340202|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
145405523|NCT03573297|524340203|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
145405524|NCT03573297|524340200|FG000|Open Label Treatment Period|Pregnancy|1|||
145405525|NCT03573297|524340201|FG001|Open Label Treatment Period|Pregnancy|0|||
145405526|NCT03573297|524340202|FG002|Open Label Treatment Period|Pregnancy|0|||
145405527|NCT03573297|524340203|FG003|Open Label Treatment Period|Pregnancy|0|||
145405528|NCT03573297|524340200|FG000|Open Label Treatment Period|Protocol Violation|17|||
145405529|NCT03573297|524340201|FG001|Open Label Treatment Period|Protocol Violation|0|||
145405530|NCT03573297|524340202|FG002|Open Label Treatment Period|Protocol Violation|0|||
145405531|NCT03573297|524340203|FG003|Open Label Treatment Period|Protocol Violation|0|||
145405532|NCT03573297|524340200|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
145405533|NCT03573297|524340201|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145405534|NCT03573297|524340202|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145405535|NCT03573297|524340203|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
145405536|NCT03573297|524340200|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
145405537|NCT03573297|524340201|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145405538|NCT03573297|524340202|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145405539|NCT03573297|524340203|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
145405540|NCT03573297|524340200|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
145405541|NCT03573297|524340201|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145405542|NCT03573297|524340202|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145405543|NCT03573297|524340203|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
145405544|NCT03573297|524340200|FG000|Open Label Treatment Period|Other, Not Specified|7|||
145405545|NCT03573297|524340201|FG001|Open Label Treatment Period|Other, Not Specified|0|||
145405546|NCT03573297|524340202|FG002|Open Label Treatment Period|Other, Not Specified|0|||
145405547|NCT03573297|524340203|FG003|Open Label Treatment Period|Other, Not Specified|0|||
145405548|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
145405549|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
145405550|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
145405551|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
145405552|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145405553|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145405554|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Adverse Event|5|||
145405555|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Adverse Event|1|||
145405556|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145405557|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
145405558|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
145405559|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
145405560|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145551041|NCT01858389|524872993|FG001|Overall Study|Withdrawal by Subject|1|||
145551042|NCT01858389|524872992|FG000|Overall Study|Progressive disease|10|||
145551043|NCT01858389|524872993|FG001|Overall Study|Progressive disease|11|||
145551044|NCT01858389|524872992|FG000|Overall Study|Other|2|||
145551045|NCT01858389|524872993|FG001|Overall Study|Other|4|||
145551046|NCT01858389|524872992|FG000|Overall Study|Adverse Event|3|||
145551047|NCT01858389|524872993|FG001|Overall Study|Adverse Event|1|||
145551048|NCT01858389|524872992|FG000|Overall Study|Did not receive treatment|0|||
145551049|NCT01858389|524872993|FG001|Overall Study|Did not receive treatment|3|||
145551050|NCT03978520|524872994|FG000|Overall Study|Adverse Event|2|||
145551051|NCT03978520|524872995|FG001|Overall Study|Adverse Event|5|||
145551052|NCT03978520|524872996|FG002|Overall Study|Adverse Event|3|||
145551053|NCT03978520|524872997|FG003|Overall Study|Adverse Event|5|||
145551054|NCT03978520|524872998|FG004|Overall Study|Adverse Event|6|||
145551055|NCT03978520|524872994|FG000|Overall Study|Withdrawal by Subject|10|||
145551056|NCT03978520|524872995|FG001|Overall Study|Withdrawal by Subject|4|||
145551057|NCT03978520|524872996|FG002|Overall Study|Withdrawal by Subject|5|||
145551058|NCT03978520|524872997|FG003|Overall Study|Withdrawal by Subject|6|||
145551059|NCT03978520|524872998|FG004|Overall Study|Withdrawal by Subject|5|||
145551060|NCT03978520|524872994|FG000|Overall Study|Lost to Follow-up|2|||
145551061|NCT03978520|524872995|FG001|Overall Study|Lost to Follow-up|2|||
145551062|NCT03978520|524872996|FG002|Overall Study|Lost to Follow-up|2|||
145551063|NCT03978520|524872997|FG003|Overall Study|Lost to Follow-up|0|||
145551064|NCT03978520|524872998|FG004|Overall Study|Lost to Follow-up|1|||
145551065|NCT03978520|524872994|FG000|Overall Study|COVID-19 infection|0|||
145551066|NCT03978520|524872995|FG001|Overall Study|COVID-19 infection|1|||
145551067|NCT03978520|524872996|FG002|Overall Study|COVID-19 infection|0|||
145551068|NCT03978520|524872997|FG003|Overall Study|COVID-19 infection|0|||
145551069|NCT03978520|524872998|FG004|Overall Study|COVID-19 infection|0|||
145551070|NCT03978520|524872994|FG000|Overall Study|Other, not specified|9|||
145551071|NCT03978520|524872995|FG001|Overall Study|Other, not specified|4|||
145551072|NCT03978520|524872996|FG002|Overall Study|Other, not specified|1|||
145551073|NCT03978520|524872997|FG003|Overall Study|Other, not specified|1|||
145551074|NCT03978520|524872998|FG004|Overall Study|Other, not specified|2|||
145551075|NCT03978520|524872994|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
145551076|NCT03978520|524872995|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
145551077|NCT03978520|524872996|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
145551078|NCT03978520|524872997|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
145551079|NCT03978520|524872998|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
145551080|NCT01835587|524873001|FG000|Overall Study|Disease Recurrence or Relapse|0|||
145551081|NCT01835587|524873002|FG001|Overall Study|Disease Recurrence or Relapse|3|||
145405561|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
145405562|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
145405563|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
145551082|NCT01835587|524873003|FG002|Overall Study|Disease Recurrence or Relapse|0|||
145551083|NCT01835587|524873004|FG003|Overall Study|Disease Recurrence or Relapse|3|||
145551084|NCT01835587|524873001|FG000|Overall Study|Withdrawal by Subject|2|||
145551085|NCT01835587|524873002|FG001|Overall Study|Withdrawal by Subject|0|||
145551086|NCT01835587|524873003|FG002|Overall Study|Withdrawal by Subject|0|||
145551087|NCT01835587|524873004|FG003|Overall Study|Withdrawal by Subject|3|||
145551088|NCT01835587|524873001|FG000|Overall Study|Adverse Event|0|||
145551089|NCT01835587|524873002|FG001|Overall Study|Adverse Event|0|||
145551090|NCT01835587|524873003|FG002|Overall Study|Adverse Event|2|||
145551091|NCT01835587|524873004|FG003|Overall Study|Adverse Event|2|||
145551092|NCT01835587|524873001|FG000|Overall Study|Death|0|||
145551093|NCT01835587|524873002|FG001|Overall Study|Death|0|||
145551094|NCT01835587|524873003|FG002|Overall Study|Death|0|||
145551095|NCT01835587|524873004|FG003|Overall Study|Death|1|||
145551096|NCT01835587|524873001|FG000|Overall Study|Miscellaneous|0|||
145551097|NCT01835587|524873002|FG001|Overall Study|Miscellaneous|1|||
145551098|NCT01835587|524873003|FG002|Overall Study|Miscellaneous|0|||
145551099|NCT01835587|524873004|FG003|Overall Study|Miscellaneous|0|||
145551100|NCT03310775|524873008|FG000|Overall Study|Lost to Follow-up|2|||
145551101|NCT03310775|524873009|FG001|Overall Study|Lost to Follow-up|3|||
145551102|NCT03310775|524873008|FG000|Overall Study|aggravation of depression|0|||
145551103|NCT03310775|524873009|FG001|Overall Study|aggravation of depression|1|||
145551104|NCT00126568|524873010|FG000|Overall Study|Death|2|||
145551105|NCT03064451|524873011|FG000|Overall Study|Lost to Follow-up|1|||
145551106|NCT03064451|524873011|FG000|Overall Study|Mapping Failure|4|||
145551107|NCT03064451|524873011|FG000|Overall Study|Exited prior to procedure|8|||
145551108|NCT03064451|524873011|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
145551109|NCT00750204|524873012|FG000|Overall Study|study halted prematurely|1|||
145551110|NCT00750204|524873013|FG001|Overall Study|study halted prematurely|1|||
145551111|NCT03010254|524874530|FG000|Overall Study|Adverse Event|0|||
145551112|NCT03010254|524874531|FG001|Overall Study|Adverse Event|1|||
145551113|NCT03010254|524874530|FG000|Overall Study|Lost to Follow-up|4|||
145551114|NCT03010254|524874531|FG001|Overall Study|Lost to Follow-up|0|||
145551115|NCT03010254|524874530|FG000|Overall Study|Withdrawal by Subject|1|||
145551116|NCT03010254|524874531|FG001|Overall Study|Withdrawal by Subject|1|||
145551117|NCT03010254|524874530|FG000|Overall Study|Other|2|||
145551118|NCT03010254|524874531|FG001|Overall Study|Other|3|||
145551119|NCT01404325|524874532|FG000|Overall Study|Lost to Follow-up|1|||
145551120|NCT01404325|524874533|FG001|Overall Study|Lost to Follow-up|0|||
145551121|NCT01404325|524874532|FG000|Overall Study|Death|2|||
145551122|NCT01404325|524874533|FG001|Overall Study|Death|0|||
145551123|NCT01404325|524874532|FG000|Overall Study|Graft loss/Retransplantation|1|||
145551124|NCT01404325|524874533|FG001|Overall Study|Graft loss/Retransplantation|0|||
145551125|NCT01404325|524874532|FG000|Overall Study|non-specified reason|0|||
145551126|NCT01404325|524874533|FG001|Overall Study|non-specified reason|2|||
145551127|NCT01411228|524874536|FG000|Overall Study|Lost to Follow-up|0|||
145551128|NCT01411228|524874537|FG001|Overall Study|Lost to Follow-up|0|||
145551129|NCT01411228|524874538|FG002|Overall Study|Lost to Follow-up|1|||
145551130|NCT01411228|524874536|FG000|Overall Study|Withdrawal by Subject|1|||
145551131|NCT01411228|524874537|FG001|Overall Study|Withdrawal by Subject|0|||
145551132|NCT01411228|524874538|FG002|Overall Study|Withdrawal by Subject|0|||
145551133|NCT01986855|524874539|FG000|Overall Study|Adverse Event|1|||
145551134|NCT01986855|524874540|FG001|Overall Study|Adverse Event|0|||
145551135|NCT01986855|524874541|FG002|Overall Study|Adverse Event|0|||
145551136|NCT01986855|524874539|FG000|Overall Study|Death|3|||
145551137|NCT01986855|524874540|FG001|Overall Study|Death|4|||
145551138|NCT01986855|524874541|FG002|Overall Study|Death|4|||
145551139|NCT01986855|524874539|FG000|Overall Study|Lost to Follow-up|2|||
145551140|NCT01986855|524874540|FG001|Overall Study|Lost to Follow-up|1|||
145551141|NCT01986855|524874541|FG002|Overall Study|Lost to Follow-up|0|||
145551142|NCT01986855|524874539|FG000|Overall Study|Screen Failure|0|||
145551143|NCT01986855|524874540|FG001|Overall Study|Screen Failure|1|||
145551144|NCT01986855|524874541|FG002|Overall Study|Screen Failure|0|||
145551145|NCT01986855|524874539|FG000|Overall Study|Participant Moved|0|||
145551146|NCT01986855|524874540|FG001|Overall Study|Participant Moved|0|||
145551147|NCT01986855|524874541|FG002|Overall Study|Participant Moved|2|||
145551148|NCT01986855|524874539|FG000|Overall Study|Withdrawal by Subject|7|||
145551149|NCT01986855|524874540|FG001|Overall Study|Withdrawal by Subject|8|||
145551150|NCT01986855|524874541|FG002|Overall Study|Withdrawal by Subject|5|||
145551151|NCT02064868|524874542|FG000|Overall Study|Lost to Follow-up|14|||
145551152|NCT02064868|524874543|FG001|Overall Study|Lost to Follow-up|8|||
145551153|NCT02064868|524874542|FG000|Overall Study|Physician Decision|1|||
145551154|NCT02064868|524874543|FG001|Overall Study|Physician Decision|0|||
145551155|NCT02064868|524874542|FG000|Overall Study|Withdrawal by Subject|14|||
145551156|NCT02064868|524874543|FG001|Overall Study|Withdrawal by Subject|3|||
145551157|NCT02064868|524874542|FG000|Overall Study|Technical Problems or Missing|5|||
145551158|NCT02064868|524874543|FG001|Overall Study|Technical Problems or Missing|2|||
145551159|NCT02670083|524874547|FG000|Overall Study|Adverse Event|16|||
145551160|NCT02670083|524874548|FG001|Overall Study|Adverse Event|13|||
145551161|NCT02670083|524874547|FG000|Overall Study|Death|4|||
145551162|NCT02670083|524874548|FG001|Overall Study|Death|6|||
145551163|NCT02670083|524874547|FG000|Overall Study|Lost to Follow-up|2|||
145551164|NCT02670083|524874548|FG001|Overall Study|Lost to Follow-up|2|||
145551165|NCT02670083|524874547|FG000|Overall Study|Multiple Reasons|9|||
145551166|NCT02670083|524874548|FG001|Overall Study|Multiple Reasons|9|||
145551167|NCT02670083|524874547|FG000|Overall Study|Physician Decision|0|||
145551168|NCT02670083|524874548|FG001|Overall Study|Physician Decision|2|||
145551169|NCT02670083|524874547|FG000|Overall Study|Study Terminated By Sponsor|257|||
145551170|NCT02670083|524874548|FG001|Overall Study|Study Terminated By Sponsor|254|||
145551171|NCT02670083|524874547|FG000|Overall Study|Symptomatic Deterioration|0|||
145551172|NCT02670083|524874548|FG001|Overall Study|Symptomatic Deterioration|2|||
145551173|NCT02670083|524874547|FG000|Overall Study|Withdrawal by Subject|32|||
145551174|NCT02670083|524874548|FG001|Overall Study|Withdrawal by Subject|31|||
145551175|NCT02670083|524874547|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145551176|NCT02670083|524874548|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145551177|NCT02425046|524874554|FG000|Overall Study|Lost to Follow-up|52|||
145551178|NCT02425046|524874555|FG001|Overall Study|Lost to Follow-up|50|||
145551179|NCT02425046|524874556|FG002|Overall Study|Lost to Follow-up|56|||
145551180|NCT02425046|524874554|FG000|Overall Study|Withdrawal by Subject|16|||
145551181|NCT02425046|524874555|FG001|Overall Study|Withdrawal by Subject|12|||
145551182|NCT02425046|524874556|FG002|Overall Study|Withdrawal by Subject|0|||
145551183|NCT02782780|524874557|FG000|Overall Study|dropped out after randomization.|7|||
145551184|NCT02782780|524874558|FG001|Overall Study|dropped out after randomization.|5|||
145551185|NCT02782780|524874557|FG000|Overall Study|Protocol Violation|0|||
145551186|NCT02782780|524874558|FG001|Overall Study|Protocol Violation|2|||
145551187|NCT03562481|524874559|FG000|First Intervention|Lost to Follow-up|1|||
145551188|NCT03562481|524874560|FG001|First Intervention|Lost to Follow-up|0|||
145551189|NCT01413191|524874561|FG000|Overall Study|Lost to Follow-up|5|||
145551190|NCT01413191|524874561|FG000|Overall Study|Disease Progression|5|||
145551191|NCT01413191|524874561|FG000|Overall Study|Death|1|||
145551192|NCT00549302|524874579|FG000|Double-Blind|Death|2|||
145551193|NCT00549302|524874580|FG001|Double-Blind|Death|9|||
145551194|NCT00549302|524874581|FG002|Double-Blind|Death|0|||
145551195|NCT00549302|524874579|FG000|Double-Blind|Adverse Event|3|||
145551196|NCT00549302|524874580|FG001|Double-Blind|Adverse Event|16|||
145551197|NCT00549302|524874581|FG002|Double-Blind|Adverse Event|0|||
145551198|NCT00549302|524874579|FG000|Double-Blind|Withdrawal by Subject|3|||
145551199|NCT00549302|524874580|FG001|Double-Blind|Withdrawal by Subject|8|||
145551200|NCT00549302|524874581|FG002|Double-Blind|Withdrawal by Subject|0|||
145551201|NCT00549302|524874579|FG000|Double-Blind|Investigator Decision|1|||
145551202|NCT00549302|524874580|FG001|Double-Blind|Investigator Decision|5|||
145551203|NCT00549302|524874581|FG002|Double-Blind|Investigator Decision|0|||
145551204|NCT00549302|524874579|FG000|Double-Blind|Sponsor Decision|0|||
145551205|NCT00549302|524874580|FG001|Double-Blind|Sponsor Decision|1|||
145551206|NCT00549302|524874581|FG002|Double-Blind|Sponsor Decision|0|||
145551207|NCT00549302|524874579|FG000|Double-Blind|Lost to Follow-up|1|||
145551208|NCT00549302|524874580|FG001|Double-Blind|Lost to Follow-up|2|||
145551209|NCT00549302|524874581|FG002|Double-Blind|Lost to Follow-up|0|||
145551210|NCT00549302|524874579|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
145551211|NCT00549302|524874580|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
145551212|NCT00549302|524874581|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
145551213|NCT00549302|524874579|FG000|Double-Blind|New condition or starts new therapy|0|||
145551214|NCT00549302|524874580|FG001|Double-Blind|New condition or starts new therapy|2|||
145551215|NCT00549302|524874581|FG002|Double-Blind|New condition or starts new therapy|0|||
145551216|NCT00549302|524874579|FG000|Open-Label|Adverse Event|0|||
145551217|NCT00549302|524874580|FG001|Open-Label|Adverse Event|0|||
145551218|NCT00549302|524874581|FG002|Open-Label|Adverse Event|11|||
145551219|NCT00549302|524874579|FG000|Open-Label|Death|0|||
145551220|NCT00549302|524874580|FG001|Open-Label|Death|0|||
145551221|NCT00549302|524874581|FG002|Open-Label|Death|40|||
145551222|NCT00549302|524874579|FG000|Open-Label|Investigator Decision|0|||
145551223|NCT00549302|524874580|FG001|Open-Label|Investigator Decision|0|||
145551224|NCT00549302|524874581|FG002|Open-Label|Investigator Decision|5|||
145551225|NCT00549302|524874579|FG000|Open-Label|Lost to Follow-up|0|||
145551226|NCT00549302|524874580|FG001|Open-Label|Lost to Follow-up|0|||
145551227|NCT00549302|524874581|FG002|Open-Label|Lost to Follow-up|2|||
145551228|NCT00549302|524874579|FG000|Open-Label|Other|0|||
145551229|NCT00549302|524874580|FG001|Open-Label|Other|0|||
145551230|NCT00549302|524874581|FG002|Open-Label|Other|3|||
145551231|NCT00549302|524874579|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
145551232|NCT00549302|524874580|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
145551233|NCT00549302|524874581|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
145551234|NCT00549302|524874579|FG000|Open-Label|Withdrawal by Subject|0|||
145551235|NCT00549302|524874580|FG001|Open-Label|Withdrawal by Subject|0|||
145551236|NCT00549302|524874581|FG002|Open-Label|Withdrawal by Subject|6|||
145551237|NCT03585504|524874582|FG000|Overall Study|Lost to Follow-up|26|||
145551238|NCT03585504|524874583|FG001|Overall Study|Lost to Follow-up|29|||
145551239|NCT05620563|524874584|FG000|Overall Study|Adverse Event|3|||
145551240|NCT05620563|524874585|FG001|Overall Study|Adverse Event|1|||
145405564|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145405565|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
145405566|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
145405567|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
145405568|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145405569|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
145551241|NCT05620563|524874584|FG000|Overall Study|Lost to Follow-up|0|||
145551242|NCT05620563|524874585|FG001|Overall Study|Lost to Follow-up|2|||
145551243|NCT05620563|524874584|FG000|Overall Study|Protocol Deviation|1|||
145551244|NCT05620563|524874585|FG001|Overall Study|Protocol Deviation|2|||
145551245|NCT05620563|524874584|FG000|Overall Study|Withdrawal by Subject|3|||
145551246|NCT05620563|524874585|FG001|Overall Study|Withdrawal by Subject|3|||
145551247|NCT05620563|524874584|FG000|Overall Study|Physician Decision|0|||
145551248|NCT05620563|524874585|FG001|Overall Study|Physician Decision|1|||
145551249|NCT03590041|524874589|FG000|Overall Study|Protocol Violation|4|||
145551250|NCT03590041|524874590|FG001|Overall Study|Protocol Violation|3|||
145551251|NCT03590041|524874589|FG000|Overall Study|No session data recorded|14|||
145551252|NCT03590041|524874590|FG001|Overall Study|No session data recorded|2|||
145551253|NCT00644995|524874591|FG000|Overall Study|Lost to Follow-up|1|||
145551254|NCT00644995|524874592|FG001|Overall Study|Lost to Follow-up|4|||
145551255|NCT00644995|524874591|FG000|Overall Study|Refused|1|||
145551256|NCT00644995|524874592|FG001|Overall Study|Refused|0|||
145551257|NCT03519932|524874593|FG000|First Intervention|Adverse Event|1|||
145551258|NCT03519932|524874594|FG001|First Intervention|Adverse Event|3|||
145551259|NCT00267046|524874595|FG000|Overall Study|Disease progression|4|||
145551260|NCT00267046|524874596|FG001|Overall Study|Disease progression|2|||
145551261|NCT00267046|524874595|FG000|Overall Study|Chemotoxicity|2|||
145551262|NCT00267046|524874596|FG001|Overall Study|Chemotoxicity|0|||
145551263|NCT00267046|524874595|FG000|Overall Study|Open-label palifermin|2|||
145551264|NCT00267046|524874596|FG001|Overall Study|Open-label palifermin|7|||
145551265|NCT00267046|524874595|FG000|Overall Study|Surgery|3|||
145551266|NCT00267046|524874596|FG001|Overall Study|Surgery|1|||
145551267|NCT00267046|524874595|FG000|Overall Study|Withdrawal by Subject|1|||
145551268|NCT00267046|524874596|FG001|Overall Study|Withdrawal by Subject|0|||
145551269|NCT00267046|524874595|FG000|Overall Study|Radiation|0|||
145551270|NCT00267046|524874596|FG001|Overall Study|Radiation|1|||
145551271|NCT00460408|524874597|FG000|Overall Study|Adverse Event|1|||
145551272|NCT00460408|524874598|FG001|Overall Study|Adverse Event|0|||
145551273|NCT00460408|524874599|FG002|Overall Study|Adverse Event|0|||
145551274|NCT00460408|524874600|FG003|Overall Study|Adverse Event|0|||
145551275|NCT00460408|524874597|FG000|Overall Study|Death|7|||
145551276|NCT00460408|524874598|FG001|Overall Study|Death|0|||
145551277|NCT00460408|524874599|FG002|Overall Study|Death|0|||
145551278|NCT00460408|524874600|FG003|Overall Study|Death|0|||
145551279|NCT00460408|524874597|FG000|Overall Study|Lost to Follow-up|11|||
145551280|NCT00460408|524874598|FG001|Overall Study|Lost to Follow-up|0|||
145551281|NCT00460408|524874599|FG002|Overall Study|Lost to Follow-up|1|||
145551282|NCT00460408|524874600|FG003|Overall Study|Lost to Follow-up|0|||
145551283|NCT00460408|524874597|FG000|Overall Study|Withdrawal by Subject|31|||
145551284|NCT00460408|524874598|FG001|Overall Study|Withdrawal by Subject|0|||
145551285|NCT00460408|524874599|FG002|Overall Study|Withdrawal by Subject|0|||
145551286|NCT00460408|524874600|FG003|Overall Study|Withdrawal by Subject|0|||
145551287|NCT00460408|524874597|FG000|Overall Study|Insufficient clinical response|5|||
145551288|NCT00460408|524874598|FG001|Overall Study|Insufficient clinical response|1|||
145551289|NCT00460408|524874599|FG002|Overall Study|Insufficient clinical response|5|||
145551290|NCT00460408|524874600|FG003|Overall Study|Insufficient clinical response|0|||
145551291|NCT00460408|524874597|FG000|Overall Study|Other|12|||
145551292|NCT00460408|524874598|FG001|Overall Study|Other|2|||
145551293|NCT00460408|524874599|FG002|Overall Study|Other|0|||
145551294|NCT00460408|524874600|FG003|Overall Study|Other|0|||
145551295|NCT01979016|524874601|FG000|Overall Study|Withdrawal by Subject|2|||
145551296|NCT01979016|524874602|FG001|Overall Study|Withdrawal by Subject|0|||
145551297|NCT01979016|524874601|FG000|Overall Study|Adverse Event|0|||
145551298|NCT01979016|524874602|FG001|Overall Study|Adverse Event|1|||
145551299|NCT04983264|524874603|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
145551300|NCT04983264|524874604|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
145551301|NCT04983264|524874605|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
145551302|NCT04983264|524874603|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
145551303|NCT04983264|524874604|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
145551304|NCT04983264|524874605|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
145551305|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
145551306|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
145551307|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
145551308|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
145551309|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
145551310|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
145611282|NCT01993017|525092645|FG000|Overall Study|Ineligible after randomization|4|||
145283685|NCT03038113|523889330|FG005|Overall Study|Withdrawal by Subject|0|||
145283686|NCT03038113|523889331|FG006|Overall Study|Withdrawal by Subject|0|||
145283687|NCT03038113|523889332|FG007|Overall Study|Withdrawal by Subject|0|||
145283688|NCT03038113|523889333|FG008|Overall Study|Withdrawal by Subject|0|||
145283689|NCT03038113|523889334|FG009|Overall Study|Withdrawal by Subject|0|||
145283690|NCT03038113|523889335|FG010|Overall Study|Withdrawal by Subject|0|||
145283691|NCT03038113|523889336|FG011|Overall Study|Withdrawal by Subject|0|||
145283692|NCT03038113|523889337|FG012|Overall Study|Withdrawal by Subject|0|||
145283693|NCT03038113|523889338|FG013|Overall Study|Withdrawal by Subject|1|||
145283694|NCT03038113|523889325|FG000|Overall Study|Lost to Follow-up|0|||
145283695|NCT03038113|523889326|FG001|Overall Study|Lost to Follow-up|0|||
145283696|NCT03038113|523889327|FG002|Overall Study|Lost to Follow-up|0|||
145283697|NCT03038113|523889328|FG003|Overall Study|Lost to Follow-up|0|||
145283698|NCT03038113|523889329|FG004|Overall Study|Lost to Follow-up|0|||
145283699|NCT03038113|523889330|FG005|Overall Study|Lost to Follow-up|0|||
145283700|NCT03038113|523889331|FG006|Overall Study|Lost to Follow-up|1|||
145283701|NCT03038113|523889332|FG007|Overall Study|Lost to Follow-up|0|||
145283702|NCT03038113|523889333|FG008|Overall Study|Lost to Follow-up|0|||
145283703|NCT03038113|523889334|FG009|Overall Study|Lost to Follow-up|0|||
145283704|NCT03038113|523889335|FG010|Overall Study|Lost to Follow-up|0|||
145283705|NCT03038113|523889336|FG011|Overall Study|Lost to Follow-up|0|||
145283706|NCT03038113|523889337|FG012|Overall Study|Lost to Follow-up|0|||
145283707|NCT03038113|523889338|FG013|Overall Study|Lost to Follow-up|0|||
145283708|NCT03882047|523889340|FG000|Overall Study|Adverse Event|0|||
145283709|NCT03882047|523889341|FG001|Overall Study|Adverse Event|2|||
145283710|NCT03882047|523889342|FG002|Overall Study|Adverse Event|2|||
145283711|NCT03882047|523889340|FG000|Overall Study|Treatment Failure|3|||
145283712|NCT03882047|523889341|FG001|Overall Study|Treatment Failure|3|||
145283713|NCT03882047|523889342|FG002|Overall Study|Treatment Failure|12|||
145283714|NCT03882047|523889340|FG000|Overall Study|Lost to Follow-up|0|||
145283715|NCT03882047|523889341|FG001|Overall Study|Lost to Follow-up|1|||
145283716|NCT03882047|523889342|FG002|Overall Study|Lost to Follow-up|0|||
145283717|NCT03882047|523889340|FG000|Overall Study|Did Not Wish to Continue|1|||
145283718|NCT03882047|523889341|FG001|Overall Study|Did Not Wish to Continue|4|||
145283719|NCT03882047|523889342|FG002|Overall Study|Did Not Wish to Continue|1|||
145551311|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
145551312|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
145551313|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
145551314|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
145283720|NCT03882047|523889340|FG000|Overall Study|Noncompliance With Protocol|2|||
145283721|NCT03882047|523889341|FG001|Overall Study|Noncompliance With Protocol|0|||
145283722|NCT03882047|523889342|FG002|Overall Study|Noncompliance With Protocol|0|||
145283723|NCT03882047|523889340|FG000|Overall Study|Did Not Meet Eligibility|0|||
145283724|NCT03882047|523889341|FG001|Overall Study|Did Not Meet Eligibility|0|||
145283725|NCT03882047|523889342|FG002|Overall Study|Did Not Meet Eligibility|1|||
145283726|NCT00723554|523889343|FG000|Overall Study|Adverse Event|12|||
145283727|NCT00723554|523889343|FG000|Overall Study|Investigator's judgement|5|||
145283728|NCT00723554|523889343|FG000|Overall Study|Inhaled medication other than iloprost|4|||
145283729|NCT00723554|523889343|FG000|Overall Study|Withdrawal of consent|3|||
145283730|NCT00723554|523889343|FG000|Overall Study|Other|3|||
145283731|NCT00723554|523889343|FG000|Overall Study|Lost to Follow-up|1|||
145283732|NCT00723554|523889343|FG000|Overall Study|Non-compliance|1|||
145283733|NCT01698320|523889351|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
145283734|NCT01698320|523889352|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
145283735|NCT01698320|523889353|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
145283736|NCT01698320|523889351|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
145283737|NCT01698320|523889352|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
145283738|NCT01698320|523889353|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
145283739|NCT01698320|523889351|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
145283740|NCT01698320|523889352|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
145283741|NCT01698320|523889353|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
145283742|NCT01698320|523889351|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
145283743|NCT01698320|523889352|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
145283744|NCT01698320|523889353|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
145283745|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Adverse Event|0|||
145283746|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Adverse Event|1|||
145283747|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Adverse Event|1|||
145283748|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
145283749|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
145283750|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
145283751|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
145283752|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
145283753|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
145283754|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Pregnancy|0|||
145283755|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Pregnancy|1|||
145283756|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Pregnancy|1|||
145283757|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
145283758|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
145283759|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
145283760|NCT01698320|523889351|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
145283761|NCT01698320|523889352|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
145283762|NCT01698320|523889353|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
145283763|NCT01698320|523889351|FG000|40-Week Open-Label Period|Adverse Event|0|||
145283764|NCT01698320|523889352|FG001|40-Week Open-Label Period|Adverse Event|3|||
145283765|NCT01698320|523889353|FG002|40-Week Open-Label Period|Adverse Event|2|||
145283766|NCT01698320|523889351|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
145283767|NCT01698320|523889352|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
145283768|NCT01698320|523889353|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
145283769|NCT01698320|523889351|FG000|40-Week Open-Label Period|Pregnancy|0|||
145283770|NCT01698320|523889352|FG001|40-Week Open-Label Period|Pregnancy|2|||
145283771|NCT01698320|523889353|FG002|40-Week Open-Label Period|Pregnancy|1|||
145283772|NCT01698320|523889351|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
145551315|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
145551316|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
145551317|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
145551318|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
145283773|NCT01698320|523889352|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
145283774|NCT01698320|523889353|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
145283775|NCT01698320|523889351|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
145283776|NCT01698320|523889352|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
145283777|NCT01698320|523889353|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
145283778|NCT02040766|523889357|FG000|Overall Study|Adverse Event|1|||
145283779|NCT02040766|523889358|FG001|Overall Study|Adverse Event|1|||
145283780|NCT02040766|523889359|FG002|Overall Study|Adverse Event|1|||
145283781|NCT02040766|523889360|FG003|Overall Study|Adverse Event|0|||
145283782|NCT02040766|523889361|FG004|Overall Study|Adverse Event|2|||
145283783|NCT02040766|523889357|FG000|Overall Study|Withdrawal by Subject|4|||
145283784|NCT02040766|523889358|FG001|Overall Study|Withdrawal by Subject|3|||
145283785|NCT02040766|523889359|FG002|Overall Study|Withdrawal by Subject|2|||
145283786|NCT02040766|523889360|FG003|Overall Study|Withdrawal by Subject|3|||
145283787|NCT02040766|523889361|FG004|Overall Study|Withdrawal by Subject|2|||
145283788|NCT02040766|523889357|FG000|Overall Study|Non-compliance|0|||
145283789|NCT02040766|523889358|FG001|Overall Study|Non-compliance|1|||
145283790|NCT02040766|523889359|FG002|Overall Study|Non-compliance|0|||
145283791|NCT02040766|523889360|FG003|Overall Study|Non-compliance|0|||
145283792|NCT02040766|523889361|FG004|Overall Study|Non-compliance|0|||
145283793|NCT02040766|523889357|FG000|Overall Study|Protocol Violation|2|||
145283794|NCT02040766|523889358|FG001|Overall Study|Protocol Violation|1|||
145283795|NCT02040766|523889359|FG002|Overall Study|Protocol Violation|2|||
145283796|NCT02040766|523889360|FG003|Overall Study|Protocol Violation|3|||
145283797|NCT02040766|523889361|FG004|Overall Study|Protocol Violation|0|||
145283798|NCT02040766|523889357|FG000|Overall Study|Lost to Follow-up|4|||
145283799|NCT02040766|523889358|FG001|Overall Study|Lost to Follow-up|1|||
145283800|NCT02040766|523889359|FG002|Overall Study|Lost to Follow-up|3|||
145283801|NCT02040766|523889360|FG003|Overall Study|Lost to Follow-up|1|||
145283802|NCT02040766|523889361|FG004|Overall Study|Lost to Follow-up|4|||
145283803|NCT02040766|523889357|FG000|Overall Study|Not reported|1|||
145283804|NCT02040766|523889358|FG001|Overall Study|Not reported|0|||
145283805|NCT02040766|523889359|FG002|Overall Study|Not reported|0|||
145283806|NCT02040766|523889360|FG003|Overall Study|Not reported|0|||
145283807|NCT02040766|523889361|FG004|Overall Study|Not reported|0|||
145283808|NCT02040766|523889357|FG000|Overall Study|Lack of Efficacy|6|||
145283809|NCT02040766|523889358|FG001|Overall Study|Lack of Efficacy|3|||
145283810|NCT02040766|523889359|FG002|Overall Study|Lack of Efficacy|4|||
145283811|NCT02040766|523889360|FG003|Overall Study|Lack of Efficacy|6|||
145283812|NCT02040766|523889361|FG004|Overall Study|Lack of Efficacy|5|||
145283813|NCT01271933|523889364|FG000|Single-Blind Phase|Lack of Efficacy|37|||
145283814|NCT01271933|523889365|FG001|Single-Blind Phase|Lack of Efficacy|0|||
145283815|NCT01271933|523889366|FG002|Single-Blind Phase|Lack of Efficacy|0|||
145283816|NCT01271933|523889364|FG000|Single-Blind Phase|Lost to Follow-up|10|||
145283817|NCT01271933|523889365|FG001|Single-Blind Phase|Lost to Follow-up|0|||
145283818|NCT01271933|523889366|FG002|Single-Blind Phase|Lost to Follow-up|0|||
145283819|NCT01271933|523889364|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
145283820|NCT01271933|523889365|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
145283821|NCT01271933|523889366|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
145283822|NCT01271933|523889364|FG000|Single-Blind Phase|Protocol Violation|3|||
145283823|NCT01271933|523889365|FG001|Single-Blind Phase|Protocol Violation|0|||
145283824|NCT01271933|523889366|FG002|Single-Blind Phase|Protocol Violation|0|||
145283825|NCT01271933|523889364|FG000|Single-Blind Phase|Adverse Event|52|||
145283826|NCT01271933|523889365|FG001|Single-Blind Phase|Adverse Event|0|||
145283827|NCT01271933|523889366|FG002|Single-Blind Phase|Adverse Event|0|||
145283828|NCT01271933|523889364|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
145283829|NCT01271933|523889365|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
145283830|NCT01271933|523889366|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
145283831|NCT01271933|523889364|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
145283832|NCT01271933|523889365|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
145283833|NCT01271933|523889366|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
145551319|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
145551320|NCT01124422|524874606|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
145551321|NCT01124422|524874607|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
145551322|NCT01124422|524874608|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
145551323|NCT01124422|524874606|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
145551324|NCT01124422|524874607|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
145551325|NCT01124422|524874608|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
145551326|NCT01124422|524874606|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
145551327|NCT01124422|524874607|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
145551328|NCT01124422|524874608|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
145551329|NCT01124422|524874606|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
145551330|NCT01124422|524874607|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
145551331|NCT01124422|524874608|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
145551332|NCT01124422|524874606|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
145551333|NCT01124422|524874607|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
145551334|NCT01124422|524874608|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
145551335|NCT00938639|524874609|FG000|Overall Study|Moved away from study area|0|||
145551336|NCT00938639|524874610|FG001|Overall Study|Moved away from study area|1|||
145551337|NCT00938639|524874609|FG000|Overall Study|Lost to Follow-up|1|||
145551338|NCT00938639|524874610|FG001|Overall Study|Lost to Follow-up|2|||
145551339|NCT00938639|524874609|FG000|Overall Study|Family issues|1|||
145551340|NCT00938639|524874610|FG001|Overall Study|Family issues|1|||
145551341|NCT00938639|524874609|FG000|Overall Study|Participant noncompliance|1|||
145551342|NCT00938639|524874610|FG001|Overall Study|Participant noncompliance|0|||
145551343|NCT04326231|524874616|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
145551344|NCT03303079|524874617|FG000|Overall Study|Adverse Event|0|||
145551345|NCT03303079|524874618|FG001|Overall Study|Adverse Event|1|||
145551346|NCT03303079|524874619|FG002|Overall Study|Adverse Event|3|||
145551347|NCT03303079|524874617|FG000|Overall Study|Protocol Violation|5|||
145551348|NCT03303079|524874618|FG001|Overall Study|Protocol Violation|4|||
145551349|NCT03303079|524874619|FG002|Overall Study|Protocol Violation|7|||
145551350|NCT03303079|524874617|FG000|Overall Study|Withdrawal by Subject|2|||
145551351|NCT03303079|524874618|FG001|Overall Study|Withdrawal by Subject|4|||
145551352|NCT03303079|524874619|FG002|Overall Study|Withdrawal by Subject|2|||
145551353|NCT03303079|524874617|FG000|Overall Study|Other than specified|0|||
145551354|NCT03303079|524874618|FG001|Overall Study|Other than specified|2|||
145551355|NCT03303079|524874619|FG002|Overall Study|Other than specified|0|||
145551356|NCT02670837|524874636|FG000|Overall Study|Death|2|||
145551357|NCT02670837|524874637|FG001|Overall Study|Death|0|||
145551358|NCT02670837|524874638|FG002|Overall Study|Death|0|||
145551359|NCT02205814|524874644|FG000|Overall Study|Lost to Follow-up|0|||
145551360|NCT02205814|524874645|FG001|Overall Study|Lost to Follow-up|0|||
145551361|NCT02205814|524874646|FG002|Overall Study|Lost to Follow-up|0|||
145551362|NCT02205814|524874647|FG003|Overall Study|Lost to Follow-up|1|||
145551363|NCT02205814|524874644|FG000|Overall Study|Lack of Efficacy|1|||
145551364|NCT02205814|524874645|FG001|Overall Study|Lack of Efficacy|0|||
145551365|NCT02205814|524874646|FG002|Overall Study|Lack of Efficacy|1|||
145551366|NCT02205814|524874647|FG003|Overall Study|Lack of Efficacy|1|||
145551367|NCT02205814|524874644|FG000|Overall Study|Physician Decision|0|||
145551368|NCT02205814|524874645|FG001|Overall Study|Physician Decision|0|||
145551369|NCT02205814|524874646|FG002|Overall Study|Physician Decision|1|||
145551370|NCT02205814|524874647|FG003|Overall Study|Physician Decision|0|||
145551371|NCT02205814|524874644|FG000|Overall Study|Protocol Violation|1|||
145551372|NCT02205814|524874645|FG001|Overall Study|Protocol Violation|0|||
145551373|NCT02205814|524874646|FG002|Overall Study|Protocol Violation|0|||
145551374|NCT02205814|524874647|FG003|Overall Study|Protocol Violation|1|||
145551375|NCT02205814|524874644|FG000|Overall Study|Withdrawal by Subject|0|||
145551376|NCT02205814|524874645|FG001|Overall Study|Withdrawal by Subject|1|||
145551377|NCT02205814|524874646|FG002|Overall Study|Withdrawal by Subject|2|||
145551378|NCT02205814|524874647|FG003|Overall Study|Withdrawal by Subject|1|||
145551379|NCT02205814|524874644|FG000|Overall Study|not compliant with study procedures|0|||
145551380|NCT02205814|524874645|FG001|Overall Study|not compliant with study procedures|0|||
145551381|NCT02205814|524874646|FG002|Overall Study|not compliant with study procedures|1|||
145551382|NCT02205814|524874647|FG003|Overall Study|not compliant with study procedures|0|||
145551383|NCT01426373|524874648|FG000|Overall Study|Adverse Event|6|||
145551384|NCT01426373|524874648|FG000|Overall Study|Lost to Follow-up|14|||
145551385|NCT01426373|524874648|FG000|Overall Study|Participant Convenience|10|||
145551386|NCT01426373|524874648|FG000|Overall Study|Miscellaneous Reasons|4|||
145551387|NCT00143403|524874649|FG000|Overall Study|Adverse Event|3|||
145551388|NCT00143403|524874650|FG001|Overall Study|Adverse Event|8|||
145551389|NCT00143403|524874649|FG000|Overall Study|Death|1|||
145551390|NCT00143403|524874650|FG001|Overall Study|Death|0|||
145551391|NCT00143403|524874649|FG000|Overall Study|Withdrawal by Subject|3|||
145551392|NCT00143403|524874650|FG001|Overall Study|Withdrawal by Subject|12|||
145551393|NCT00143403|524874649|FG000|Overall Study|Relapse|15|||
145551394|NCT00143403|524874650|FG001|Overall Study|Relapse|7|||
145551395|NCT00143403|524874649|FG000|Overall Study|Protocol Violation|2|||
145551396|NCT00143403|524874650|FG001|Overall Study|Protocol Violation|2|||
145551397|NCT00143403|524874649|FG000|Overall Study|specified by site|4|||
145551398|NCT00143403|524874650|FG001|Overall Study|specified by site|9|||
145551399|NCT00143403|524874649|FG000|Overall Study|Randomized Not Treated|7|||
145551400|NCT00143403|524874650|FG001|Overall Study|Randomized Not Treated|8|||
145551401|NCT01574326|524874651|FG000|Overall Study|Randomized but not treated|0|||
145551402|NCT01574326|524874652|FG001|Overall Study|Randomized but not treated|1|||
145551403|NCT01574326|524874651|FG000|Overall Study|Withdrawal by Participant|2|||
145551404|NCT01574326|524874652|FG001|Overall Study|Withdrawal by Participant|4|||
145551405|NCT01574326|524874651|FG000|Overall Study|Physician Decision|5|||
145551406|NCT01574326|524874652|FG001|Overall Study|Physician Decision|3|||
145551407|NCT01574326|524874651|FG000|Overall Study|Adverse Event|1|||
145551408|NCT01574326|524874652|FG001|Overall Study|Adverse Event|3|||
145551409|NCT01574326|524874651|FG000|Overall Study|Other: Mainly kidney transplant|8|||
145551410|NCT01574326|524874652|FG001|Overall Study|Other: Mainly kidney transplant|8|||
145551411|NCT01574612|524874655|FG000|Overall Study|Adverse Event|3|||
145551412|NCT01574612|524874655|FG000|Overall Study|non compliant with drug|2|||
145551413|NCT01574612|524874655|FG000|Overall Study|Withdrawal by Subject|1|||
145551414|NCT01574612|524874655|FG000|Overall Study|Lost to Follow-up|2|||
145551415|NCT00582166|524874656|FG000|Overall Study|Death|1|||
145551416|NCT00582166|524874656|FG000|Overall Study|Ineligible pathology|1|||
145551417|NCT01606436|524874657|FG000|Overall Study|Withdrawal by Subject|0|||
145551418|NCT01606436|524874658|FG001|Overall Study|Withdrawal by Subject|0|||
145551419|NCT01606436|524874659|FG002|Overall Study|Withdrawal by Subject|1|||
145551420|NCT01606436|524874660|FG003|Overall Study|Withdrawal by Subject|1|||
145551421|NCT01606436|524874661|FG004|Overall Study|Withdrawal by Subject|1|||
145551422|NCT01606436|524874662|FG005|Overall Study|Withdrawal by Subject|0|||
145551423|NCT01606436|524874657|FG000|Overall Study|Adverse Event|0|||
145551424|NCT01606436|524874658|FG001|Overall Study|Adverse Event|0|||
145551425|NCT01606436|524874659|FG002|Overall Study|Adverse Event|1|||
145551426|NCT01606436|524874660|FG003|Overall Study|Adverse Event|0|||
145551427|NCT01606436|524874661|FG004|Overall Study|Adverse Event|0|||
145551428|NCT01606436|524874662|FG005|Overall Study|Adverse Event|0|||
145551429|NCT01606436|524874657|FG000|Overall Study|Sponsor Decision|0|||
145551430|NCT01606436|524874658|FG001|Overall Study|Sponsor Decision|0|||
145551431|NCT01606436|524874659|FG002|Overall Study|Sponsor Decision|0|||
145551432|NCT01606436|524874660|FG003|Overall Study|Sponsor Decision|1|||
145551433|NCT01606436|524874661|FG004|Overall Study|Sponsor Decision|0|||
145551434|NCT01606436|524874662|FG005|Overall Study|Sponsor Decision|0|||
145551435|NCT00110149|524874663|FG000|Overall Study|Physician Decision|3|||
145551436|NCT01922089|524874666|FG000|Overall Study|Adverse Event|18|||
145551437|NCT01922089|524874667|FG001|Overall Study|Adverse Event|13|||
145551438|NCT01922089|524874666|FG000|Overall Study|Protocol Deviation|10|||
145551439|NCT01922089|524874667|FG001|Overall Study|Protocol Deviation|7|||
145551440|NCT01922089|524874666|FG000|Overall Study|Withdrawal by Subject|3|||
145551441|NCT01922089|524874667|FG001|Overall Study|Withdrawal by Subject|4|||
145551442|NCT01922089|524874666|FG000|Overall Study|administrative problems|4|||
145551443|NCT01922089|524874667|FG001|Overall Study|administrative problems|1|||
145551444|NCT01922089|524874666|FG000|Overall Study|Physician Decision|2|||
145551445|NCT01922089|524874667|FG001|Overall Study|Physician Decision|3|||
145551446|NCT01922089|524874666|FG000|Overall Study|Death|2|||
145551447|NCT01922089|524874667|FG001|Overall Study|Death|1|||
145551448|NCT01922089|524874666|FG000|Overall Study|Lost to Follow-up|0|||
145551449|NCT01922089|524874667|FG001|Overall Study|Lost to Follow-up|1|||
145551450|NCT00848081|524876434|FG000|Overall Study|Adverse Event|6|||
145551451|NCT00848081|524876435|FG001|Overall Study|Adverse Event|7|||
145551452|NCT00848081|524876434|FG000|Overall Study|Protocol Violation|8|||
145551453|NCT00848081|524876435|FG001|Overall Study|Protocol Violation|5|||
145551454|NCT00848081|524876434|FG000|Overall Study|Lost to Follow-up|1|||
145551455|NCT00848081|524876435|FG001|Overall Study|Lost to Follow-up|0|||
145551456|NCT00848081|524876434|FG000|Overall Study|Physician Decision|0|||
145551457|NCT00848081|524876435|FG001|Overall Study|Physician Decision|3|||
145551458|NCT00848081|524876434|FG000|Overall Study|Withdrawal by Subject|5|||
145551459|NCT00848081|524876435|FG001|Overall Study|Withdrawal by Subject|3|||
145551460|NCT00720434|524876436|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
145551461|NCT00720434|524876437|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
145551462|NCT00720434|524876438|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
145551463|NCT00720434|524876439|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
145551464|NCT00720434|524876436|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
145551465|NCT00720434|524876437|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
145551466|NCT00720434|524876438|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
145551467|NCT00720434|524876439|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
145551468|NCT00720434|524876436|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
145551469|NCT00720434|524876437|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
145551470|NCT00720434|524876438|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
145551471|NCT00720434|524876439|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
145551472|NCT00720434|524876436|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
145405570|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
145551473|NCT00720434|524876437|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
145551474|NCT00720434|524876438|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
145551475|NCT00720434|524876439|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
145551476|NCT00720434|524876436|FG000|Open-Label Period (Week 5-72)|Other|4|||
145551477|NCT00720434|524876437|FG001|Open-Label Period (Week 5-72)|Other|3|||
145551478|NCT00720434|524876438|FG002|Open-Label Period (Week 5-72)|Other|3|||
145551479|NCT00720434|524876439|FG003|Open-Label Period (Week 5-72)|Other|2|||
145551480|NCT00609492|524876440|FG000|Overall Study|Withdrawal by Subject|0|||
145551481|NCT00609492|524876441|FG001|Overall Study|Withdrawal by Subject|2|||
145283834|NCT01271933|523889364|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
145283835|NCT01271933|523889365|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
145283836|NCT01271933|523889366|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
145283837|NCT01271933|523889364|FG000|Double-Blind Phase|Randomized but not treated|0|||
145283838|NCT01271933|523889365|FG001|Double-Blind Phase|Randomized but not treated|0|||
145283839|NCT01271933|523889366|FG002|Double-Blind Phase|Randomized but not treated|1|||
145283840|NCT01271933|523889364|FG000|Double-Blind Phase|Lack of Efficacy|0|||
145283841|NCT01271933|523889365|FG001|Double-Blind Phase|Lack of Efficacy|6|||
145283842|NCT01271933|523889366|FG002|Double-Blind Phase|Lack of Efficacy|9|||
145283843|NCT01271933|523889364|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145283844|NCT01271933|523889365|FG001|Double-Blind Phase|Lost to Follow-up|1|||
145283845|NCT01271933|523889366|FG002|Double-Blind Phase|Lost to Follow-up|1|||
145283846|NCT01271933|523889364|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145283847|NCT01271933|523889365|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
145283848|NCT01271933|523889366|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
145551482|NCT00609492|524876442|FG002|Overall Study|Withdrawal by Subject|3|||
145551483|NCT00609492|524876440|FG000|Overall Study|Lost to Follow-up|1|||
145551484|NCT00609492|524876441|FG001|Overall Study|Lost to Follow-up|1|||
145551485|NCT00609492|524876442|FG002|Overall Study|Lost to Follow-up|4|||
145551486|NCT00142584|524876443|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
145551487|NCT00142584|524876444|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
145551488|NCT00142584|524876443|FG000|Overall Study|Withdrawal by Subject|30|||
145551489|NCT00142584|524876444|FG001|Overall Study|Withdrawal by Subject|16|||
145551490|NCT00142584|524876443|FG000|Overall Study|Lost to Follow-up|22|||
145551491|NCT00142584|524876444|FG001|Overall Study|Lost to Follow-up|12|||
145551492|NCT00142584|524876443|FG000|Overall Study|Adverse Event|14|||
145551493|NCT00142584|524876444|FG001|Overall Study|Adverse Event|5|||
145551494|NCT00142584|524876443|FG000|Overall Study|Protocol Violation|4|||
145551495|NCT00142584|524876444|FG001|Overall Study|Protocol Violation|7|||
145551496|NCT00142584|524876443|FG000|Overall Study|Treatment Failure|2|||
145551497|NCT00142584|524876444|FG001|Overall Study|Treatment Failure|0|||
145551498|NCT00759954|524876448|FG000|Overall Study|Personal reason|1|||
145551499|NCT00759954|524876449|FG001|Overall Study|Personal reason|0|||
145551500|NCT00759954|524876448|FG000|Overall Study|Adverse Event|1|||
145551501|NCT00759954|524876449|FG001|Overall Study|Adverse Event|2|||
145551502|NCT03315208|524876450|FG000|Overall Study|Lost to Follow-up|11|||
145551503|NCT03315208|524876451|FG001|Overall Study|Lost to Follow-up|6|||
145551504|NCT03315208|524876450|FG000|Overall Study|Withdrawal by Subject|2|||
145551505|NCT03315208|524876451|FG001|Overall Study|Withdrawal by Subject|0|||
145551506|NCT02875860|524876454|FG000|Overall Study|Withdrawal by Subject|0|||
145551507|NCT02875860|524876455|FG001|Overall Study|Withdrawal by Subject|1|||
145551508|NCT01156311|524876465|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
145551509|NCT01156311|524876466|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
145551510|NCT01156311|524876467|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
145551511|NCT01156311|524876468|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
145551512|NCT01156311|524876465|FG000|2-Month Monotherapy Period|Physician Decision|0|||
145551513|NCT01156311|524876466|FG001|2-Month Monotherapy Period|Physician Decision|1|||
145551514|NCT01156311|524876467|FG002|2-Month Monotherapy Period|Physician Decision|0|||
145551515|NCT01156311|524876468|FG003|2-Month Monotherapy Period|Physician Decision|0|||
145551516|NCT01156311|524876465|FG000|2-Month Monotherapy Period|Other|1|||
145551517|NCT01156311|524876466|FG001|2-Month Monotherapy Period|Other|0|||
145551518|NCT01156311|524876467|FG002|2-Month Monotherapy Period|Other|0|||
145551519|NCT01156311|524876468|FG003|2-Month Monotherapy Period|Other|0|||
145551520|NCT01156311|524876465|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
145551521|NCT01156311|524876466|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
145551522|NCT01156311|524876467|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
145551523|NCT01156311|524876468|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
145551524|NCT01156311|524876465|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
145551525|NCT01156311|524876466|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
145551526|NCT01156311|524876467|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
145551527|NCT01156311|524876468|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
145551528|NCT01156311|524876465|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
145551529|NCT01156311|524876466|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
145551530|NCT01156311|524876467|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
145551531|NCT01156311|524876468|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
145551532|NCT01156311|524876465|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
145551533|NCT01156311|524876466|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
145551534|NCT01156311|524876467|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
145551535|NCT01156311|524876468|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
145551536|NCT01156311|524876465|FG000|6-month Add-on Therapy Period|Other|0|||
145551537|NCT01156311|524876466|FG001|6-month Add-on Therapy Period|Other|0|||
145551538|NCT01156311|524876467|FG002|6-month Add-on Therapy Period|Other|1|||
145551539|NCT01156311|524876468|FG003|6-month Add-on Therapy Period|Other|2|||
145551540|NCT01741701|524876471|FG000|Overall Study|Adverse Event|5|||
145551541|NCT01741701|524876472|FG001|Overall Study|Adverse Event|1|||
145551542|NCT01741701|524876471|FG000|Overall Study|Withdrawal by Subject|0|||
145551543|NCT01741701|524876472|FG001|Overall Study|Withdrawal by Subject|1|||
145551544|NCT03033394|524876479|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
145551545|NCT03033394|524876479|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
145551546|NCT03033394|524876479|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
145551547|NCT03033394|524876479|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
145551548|NCT03033394|524876479|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
145551549|NCT01276353|524876480|FG000|Double-blind|Adverse Event|2|||
145551550|NCT01276353|524876481|FG001|Double-blind|Adverse Event|0|||
145551551|NCT01276353|524876480|FG000|Double-blind|Withdrawal by Subject|1|||
145551552|NCT01276353|524876481|FG001|Double-blind|Withdrawal by Subject|0|||
145551553|NCT01276353|524876480|FG000|Extension|Adverse Event|2|||
145551554|NCT01276353|524876481|FG001|Extension|Adverse Event|5|||
145551555|NCT01276353|524876480|FG000|Extension|Withdrawal by Subject|1|||
145551556|NCT01276353|524876481|FG001|Extension|Withdrawal by Subject|2|||
145551557|NCT01276353|524876480|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
145551558|NCT01276353|524876481|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
145551559|NCT01276353|524876480|FG000|Extension|Physician Decision|1|||
145551560|NCT01276353|524876481|FG001|Extension|Physician Decision|0|||
145551561|NCT01276353|524876480|FG000|Extension|Prohibited concomitant medications|0|||
145551562|NCT01276353|524876481|FG001|Extension|Prohibited concomitant medications|1|||
145551563|NCT00587639|524876484|FG000|Overall Study|Withdrawal by Subject|1|||
145551564|NCT00160251|524876489|FG000|Prior to Amendment 2|Adverse Event|2|||
145551565|NCT00160251|524876490|FG001|Prior to Amendment 2|Adverse Event|1|||
145551566|NCT00160251|524876491|FG002|Prior to Amendment 2|Adverse Event|3|||
145551567|NCT00160251|524876492|FG003|Prior to Amendment 2|Adverse Event|1|||
145611283|NCT01993017|525092646|FG001|Overall Study|Ineligible after randomization|5|||
145611284|NCT01993017|525092647|FG002|Overall Study|Ineligible after randomization|5|||
145611285|NCT00068380|525092648|FG000|Overall Study|Withdrawal by Subject|3|||
145611286|NCT00068380|525092648|FG000|Overall Study|Adverse Event|2|||
145611287|NCT01976364|525092649|FG000|Main Study (36 Months)|Adverse Event|63|||
145611288|NCT01976364|525092650|FG001|Main Study (36 Months)|Adverse Event|0|||
145611289|NCT01976364|525092651|FG002|Main Study (36 Months)|Adverse Event|0|||
145611290|NCT01976364|525092649|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
145611291|NCT01976364|525092650|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
145283849|NCT01271933|523889364|FG000|Double-Blind Phase|Adverse Event|0|||
145611292|NCT01976364|525092651|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
145611293|NCT01976364|525092649|FG000|Main Study (36 Months)|Other|13|||
145611294|NCT01976364|525092650|FG001|Main Study (36 Months)|Other|0|||
145611295|NCT01976364|525092651|FG002|Main Study (36 Months)|Other|0|||
145611296|NCT01976364|525092649|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
145611297|NCT01976364|525092650|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
145611298|NCT01976364|525092651|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
145611299|NCT01976364|525092649|FG000|Main Study (36 Months)|Medication error|1|||
145611300|NCT01976364|525092650|FG001|Main Study (36 Months)|Medication error|0|||
145611301|NCT01976364|525092651|FG002|Main Study (36 Months)|Medication error|0|||
145611302|NCT01976364|525092649|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
145611303|NCT01976364|525092650|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
145611304|NCT01976364|525092651|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
145611305|NCT01976364|525092649|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
145611306|NCT01976364|525092650|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
145611307|NCT01976364|525092651|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
145611308|NCT01976364|525092649|FG000|Main Study (36 Months)|Protocol Violation|13|||
145611309|NCT01976364|525092650|FG001|Main Study (36 Months)|Protocol Violation|0|||
145611310|NCT01976364|525092651|FG002|Main Study (36 Months)|Protocol Violation|0|||
145283850|NCT01271933|523889365|FG001|Double-Blind Phase|Adverse Event|3|||
145283851|NCT01271933|523889366|FG002|Double-Blind Phase|Adverse Event|0|||
145283852|NCT01271933|523889364|FG000|Double-Blind Phase|Participant request-personal reason|0|||
145283853|NCT01271933|523889365|FG001|Double-Blind Phase|Participant request-personal reason|1|||
145551568|NCT00160251|524876493|FG004|Prior to Amendment 2|Adverse Event|1|||
145551569|NCT00160251|524876494|FG005|Prior to Amendment 2|Adverse Event|1|||
145551570|NCT00160251|524876495|FG006|Prior to Amendment 2|Adverse Event|1|||
145551571|NCT00160251|524876496|FG007|Prior to Amendment 2|Adverse Event|0|||
145551572|NCT00160251|524876489|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
145611311|NCT01976364|525092649|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
145611312|NCT01976364|525092650|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
145611313|NCT01976364|525092651|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
145611314|NCT01976364|525092649|FG000|Main Study (36 Months)|Death|5|||
145611315|NCT01976364|525092650|FG001|Main Study (36 Months)|Death|0|||
145611316|NCT01976364|525092651|FG002|Main Study (36 Months)|Death|0|||
145611317|NCT01976364|525092649|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
145611318|NCT01976364|525092650|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
145611319|NCT01976364|525092651|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
145551573|NCT00160251|524876490|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
145551574|NCT00160251|524876491|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
145551575|NCT00160251|524876492|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
145551576|NCT00160251|524876493|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
145283854|NCT01271933|523889366|FG002|Double-Blind Phase|Participant request-personal reason|0|||
145283855|NCT01138150|523889367|FG000|Overall Study|blood unable to be processed|0|||
145283856|NCT01138150|523889368|FG001|Overall Study|blood unable to be processed|1|||
145283857|NCT01138150|523889367|FG000|Overall Study|Physician Decision|1|||
145283858|NCT01138150|523889368|FG001|Overall Study|Physician Decision|0|||
145283859|NCT01620983|523889369|FG000|Overall Study|Lost to Follow-up|8|||
145283860|NCT01620983|523889370|FG001|Overall Study|Lost to Follow-up|4|||
145283861|NCT01620983|523889371|FG002|Overall Study|Lost to Follow-up|9|||
145283862|NCT01620983|523889369|FG000|Overall Study|Withdrawal by Subject|6|||
145283863|NCT01620983|523889370|FG001|Overall Study|Withdrawal by Subject|8|||
145283864|NCT01620983|523889371|FG002|Overall Study|Withdrawal by Subject|1|||
145283865|NCT01620983|523889369|FG000|Overall Study|Death|2|||
145283866|NCT01620983|523889370|FG001|Overall Study|Death|0|||
145283867|NCT01620983|523889371|FG002|Overall Study|Death|0|||
145283868|NCT01620983|523889369|FG000|Overall Study|Physician Decision|3|||
145283869|NCT01620983|523889370|FG001|Overall Study|Physician Decision|10|||
145283870|NCT01620983|523889371|FG002|Overall Study|Physician Decision|5|||
145283871|NCT01724359|523889372|FG000|Overall Study|Adverse Event|10|||
145283872|NCT01724359|523889372|FG000|Overall Study|Death|1|||
145283873|NCT01724359|523889372|FG000|Overall Study|Other|20|||
145283874|NCT01208402|523889373|FG000|Overall Study|Withdrawal by Subject|1|||
145283875|NCT01208402|523889374|FG001|Overall Study|Withdrawal by Subject|0|||
145283876|NCT01571635|523889375|FG000|Overall Study|Adverse Event|3|||
145283877|NCT01571635|523889376|FG001|Overall Study|Adverse Event|0|||
145283878|NCT01571635|523889377|FG002|Overall Study|Adverse Event|2|||
145283879|NCT01571635|523889378|FG003|Overall Study|Adverse Event|3|||
145283880|NCT01571635|523889379|FG004|Overall Study|Adverse Event|5|||
145283881|NCT01571635|523889375|FG000|Overall Study|Other reasons|2|||
145283882|NCT01571635|523889376|FG001|Overall Study|Other reasons|1|||
145283883|NCT01571635|523889377|FG002|Overall Study|Other reasons|2|||
145283884|NCT01571635|523889378|FG003|Overall Study|Other reasons|2|||
145283885|NCT01571635|523889379|FG004|Overall Study|Other reasons|1|||
145283886|NCT01571635|523889375|FG000|Overall Study|Study terminated by sponsor|0|||
145283887|NCT01571635|523889376|FG001|Overall Study|Study terminated by sponsor|4|||
145283888|NCT01571635|523889377|FG002|Overall Study|Study terminated by sponsor|1|||
145283889|NCT01571635|523889378|FG003|Overall Study|Study terminated by sponsor|3|||
145283890|NCT01571635|523889379|FG004|Overall Study|Study terminated by sponsor|1|||
145283891|NCT01571635|523889375|FG000|Overall Study|Withdrew consent|1|||
145283892|NCT01571635|523889376|FG001|Overall Study|Withdrew consent|1|||
145283893|NCT01571635|523889377|FG002|Overall Study|Withdrew consent|2|||
145611320|NCT01976364|525092649|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
145611321|NCT01976364|525092650|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
145611322|NCT01976364|525092651|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
145611323|NCT01976364|525092649|FG000|Sub-study (12 Months)|Protocol Violation|0|||
145611324|NCT01976364|525092650|FG001|Sub-study (12 Months)|Protocol Violation|1|||
145611325|NCT01976364|525092651|FG002|Sub-study (12 Months)|Protocol Violation|1|||
145611326|NCT01976364|525092649|FG000|Sub-study (12 Months)|Adverse Event|0|||
145611327|NCT01976364|525092650|FG001|Sub-study (12 Months)|Adverse Event|4|||
145611328|NCT01976364|525092651|FG002|Sub-study (12 Months)|Adverse Event|3|||
145611329|NCT02757521|525092652|FG000|Overall Study|Adverse Event|1|||
145611330|NCT02757521|525092653|FG001|Overall Study|Adverse Event|0|||
145611331|NCT01190215|525092654|FG000|Up to Month 6|Lost to Follow-up|2|||
145611332|NCT01190215|525092655|FG001|Up to Month 6|Lost to Follow-up|0|||
145611333|NCT00003511|525092656|FG000|Overall Study|Not evaluable|4|||
145611334|NCT00603265|525092660|FG000|Overall Study|Adverse Event|2|||
145611335|NCT00603265|525092661|FG001|Overall Study|Adverse Event|11|||
145611336|NCT00603265|525092662|FG002|Overall Study|Adverse Event|1|||
145611337|NCT00603265|525092660|FG000|Overall Study|Withdrawal by Subject|1|||
145611338|NCT00603265|525092661|FG001|Overall Study|Withdrawal by Subject|2|||
145611339|NCT00603265|525092662|FG002|Overall Study|Withdrawal by Subject|1|||
145611340|NCT00603265|525092660|FG000|Overall Study|Lack of Efficacy|3|||
145611341|NCT00603265|525092661|FG001|Overall Study|Lack of Efficacy|0|||
145551577|NCT00160251|524876494|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
145551578|NCT00160251|524876495|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
145551579|NCT00160251|524876496|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
145551580|NCT00160251|524876489|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
145551581|NCT00160251|524876490|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
145551582|NCT00160251|524876491|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
145551583|NCT00160251|524876492|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
145551584|NCT00160251|524876493|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
145551585|NCT00160251|524876494|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
145611342|NCT00603265|525092662|FG002|Overall Study|Lack of Efficacy|3|||
145611343|NCT00603265|525092660|FG000|Overall Study|Lost to Follow-up|0|||
145611344|NCT00603265|525092661|FG001|Overall Study|Lost to Follow-up|1|||
145551586|NCT00160251|524876495|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
145551587|NCT00160251|524876496|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
145611345|NCT00603265|525092662|FG002|Overall Study|Lost to Follow-up|0|||
145611346|NCT00603265|525092660|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
145283894|NCT01571635|523889378|FG003|Overall Study|Withdrew consent|3|||
145283895|NCT01571635|523889379|FG004|Overall Study|Withdrew consent|0|||
145283896|NCT01571635|523889375|FG000|Overall Study|Lack of Efficacy|0|||
145283897|NCT01571635|523889376|FG001|Overall Study|Lack of Efficacy|2|||
145283898|NCT01571635|523889377|FG002|Overall Study|Lack of Efficacy|0|||
145283899|NCT01571635|523889378|FG003|Overall Study|Lack of Efficacy|1|||
145283900|NCT01571635|523889379|FG004|Overall Study|Lack of Efficacy|2|||
145283901|NCT01335464|523889380|FG000|Overall Study|Adverse Event|15|||
145283902|NCT01335464|523889381|FG001|Overall Study|Adverse Event|25|||
145283903|NCT01335464|523889380|FG000|Overall Study|Non compliant with protocol|2|||
145283904|NCT01335464|523889381|FG001|Overall Study|Non compliant with protocol|0|||
145283905|NCT01335464|523889380|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
145283906|NCT01335464|523889381|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
145283907|NCT01335464|523889380|FG000|Overall Study|Not treated|2|||
145283908|NCT01335464|523889381|FG001|Overall Study|Not treated|0|||
145283909|NCT01335464|523889380|FG000|Overall Study|Reason other than those stated above|1|||
145283910|NCT01335464|523889381|FG001|Overall Study|Reason other than those stated above|1|||
145551588|NCT00160251|524876489|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
145551589|NCT00160251|524876490|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
145551590|NCT00160251|524876491|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
145551591|NCT00160251|524876492|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
145551592|NCT00160251|524876493|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
145551593|NCT00160251|524876494|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
145551594|NCT00160251|524876495|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
145551595|NCT00160251|524876496|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
145551596|NCT00160251|524876489|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
145551597|NCT00160251|524876490|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
145551598|NCT00160251|524876491|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
145551599|NCT00160251|524876492|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
145551600|NCT00160251|524876493|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
145551601|NCT00160251|524876494|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
145551602|NCT00160251|524876495|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
145551603|NCT00160251|524876496|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
145551604|NCT00160251|524876489|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
145551605|NCT00160251|524876490|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
145551606|NCT00160251|524876491|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
145551607|NCT00160251|524876492|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
145551608|NCT00160251|524876493|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
145551609|NCT00160251|524876494|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
145551610|NCT00160251|524876495|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
145551611|NCT00160251|524876496|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
145551612|NCT00160251|524876489|FG000|Post-amendment 2|Adverse Event|0|||
145551613|NCT00160251|524876490|FG001|Post-amendment 2|Adverse Event|0|||
145551614|NCT00160251|524876491|FG002|Post-amendment 2|Adverse Event|0|||
145551615|NCT00160251|524876492|FG003|Post-amendment 2|Adverse Event|0|||
145551616|NCT00160251|524876493|FG004|Post-amendment 2|Adverse Event|0|||
145551617|NCT00160251|524876494|FG005|Post-amendment 2|Adverse Event|0|||
145551618|NCT00160251|524876495|FG006|Post-amendment 2|Adverse Event|0|||
145551619|NCT00160251|524876496|FG007|Post-amendment 2|Adverse Event|20|||
145551620|NCT00160251|524876489|FG000|Post-amendment 2|Lack of Efficacy|0|||
145551621|NCT00160251|524876490|FG001|Post-amendment 2|Lack of Efficacy|0|||
145551622|NCT00160251|524876491|FG002|Post-amendment 2|Lack of Efficacy|0|||
145551623|NCT00160251|524876492|FG003|Post-amendment 2|Lack of Efficacy|0|||
145551624|NCT00160251|524876493|FG004|Post-amendment 2|Lack of Efficacy|0|||
145551625|NCT00160251|524876494|FG005|Post-amendment 2|Lack of Efficacy|0|||
145551626|NCT00160251|524876495|FG006|Post-amendment 2|Lack of Efficacy|0|||
145551627|NCT00160251|524876496|FG007|Post-amendment 2|Lack of Efficacy|24|||
145283911|NCT01783730|523889384|FG000|Overall Study|Failed to meet inclusion criteria|6|||
145283912|NCT02151461|523889385|FG000|Overall Study|Adverse Event|5|||
145283913|NCT02151461|523889386|FG001|Overall Study|Adverse Event|1|||
145283914|NCT02151461|523889387|FG002|Overall Study|Adverse Event|0|||
145283915|NCT02151461|523889388|FG003|Overall Study|Adverse Event|2|||
145283916|NCT02151461|523889385|FG000|Overall Study|Lost to Follow-up|0|||
145283917|NCT02151461|523889386|FG001|Overall Study|Lost to Follow-up|0|||
145283918|NCT02151461|523889387|FG002|Overall Study|Lost to Follow-up|1|||
145283919|NCT02151461|523889388|FG003|Overall Study|Lost to Follow-up|1|||
145283920|NCT02151461|523889385|FG000|Overall Study|Withdrawal by Subject|1|||
145283921|NCT02151461|523889386|FG001|Overall Study|Withdrawal by Subject|0|||
145283922|NCT02151461|523889387|FG002|Overall Study|Withdrawal by Subject|1|||
145283923|NCT02151461|523889388|FG003|Overall Study|Withdrawal by Subject|1|||
145283924|NCT02151461|523889385|FG000|Overall Study|Treatment discontinuation|0|||
145283925|NCT02151461|523889386|FG001|Overall Study|Treatment discontinuation|0|||
145283926|NCT02151461|523889387|FG002|Overall Study|Treatment discontinuation|1|||
145283927|NCT02151461|523889388|FG003|Overall Study|Treatment discontinuation|0|||
145283928|NCT00871169|523889389|FG000|Overall Study|Protocol Violation|1|||
145283929|NCT00871169|523889389|FG000|Overall Study|Patient did not receive study treatment|2|||
145283930|NCT00252187|523889390|FG000|Overall Study|Adverse Event|3|||
145283931|NCT00252187|523889391|FG001|Overall Study|Adverse Event|1|||
145283932|NCT00252187|523889390|FG000|Overall Study|Withdrawal by Subject|1|||
145283933|NCT00252187|523889391|FG001|Overall Study|Withdrawal by Subject|0|||
145283934|NCT00706706|523889392|FG000|Overall Study|Death|53|||
145283935|NCT00706706|523889392|FG000|Overall Study|Lost to Follow-up|7|||
145283936|NCT00706706|523889392|FG000|Overall Study|Study endpoint had reached|45|||
145283937|NCT02280356|523889401|FG000|Overall Study|Not Treated|2|||
145283938|NCT02280356|523889401|FG000|Overall Study|Withdrawal by Subject|1|||
145283939|NCT02280356|523889401|FG000|Overall Study|Not evaluable|2|||
145283940|NCT03493698|523889405|FG000|Treatment Period C|Adverse Event|1|||
145283941|NCT03493698|523889405|FG000|Treatment Period C|Withdrawal by Subject|1|||
145283942|NCT03361956|523889406|FG000|Overall Study|Adverse Event|1|||
145283943|NCT03361956|523889407|FG001|Overall Study|Adverse Event|0|||
145283944|NCT03361956|523889408|FG002|Overall Study|Adverse Event|1|||
145283945|NCT03361956|523889409|FG003|Overall Study|Adverse Event|1|||
145283946|NCT03361956|523889410|FG004|Overall Study|Adverse Event|0|||
145283947|NCT03361956|523889406|FG000|Overall Study|Other|0|||
145283948|NCT03361956|523889407|FG001|Overall Study|Other|0|||
145283949|NCT03361956|523889408|FG002|Overall Study|Other|0|||
145283950|NCT03361956|523889409|FG003|Overall Study|Other|1|||
145283951|NCT03361956|523889410|FG004|Overall Study|Other|0|||
145283952|NCT03361956|523889406|FG000|Overall Study|Withdrawal by Subject|2|||
145283953|NCT03361956|523889407|FG001|Overall Study|Withdrawal by Subject|2|||
145283954|NCT03361956|523889408|FG002|Overall Study|Withdrawal by Subject|2|||
145283955|NCT03361956|523889409|FG003|Overall Study|Withdrawal by Subject|0|||
145283956|NCT03361956|523889410|FG004|Overall Study|Withdrawal by Subject|3|||
145283957|NCT03361956|523889406|FG000|Overall Study|Disease Relapse|0|||
145283958|NCT03361956|523889407|FG001|Overall Study|Disease Relapse|0|||
145283959|NCT03361956|523889408|FG002|Overall Study|Disease Relapse|1|||
145283960|NCT03361956|523889409|FG003|Overall Study|Disease Relapse|0|||
145283961|NCT03361956|523889410|FG004|Overall Study|Disease Relapse|0|||
145283962|NCT03361956|523889406|FG000|Overall Study|Physician Decision|0|||
145283963|NCT03361956|523889407|FG001|Overall Study|Physician Decision|2|||
145283964|NCT03361956|523889408|FG002|Overall Study|Physician Decision|0|||
145283965|NCT03361956|523889409|FG003|Overall Study|Physician Decision|1|||
145283966|NCT03361956|523889410|FG004|Overall Study|Physician Decision|0|||
145283967|NCT03361956|523889406|FG000|Overall Study|Lost to Follow-up|0|||
145283968|NCT03361956|523889407|FG001|Overall Study|Lost to Follow-up|0|||
145283969|NCT03361956|523889408|FG002|Overall Study|Lost to Follow-up|1|||
145283970|NCT03361956|523889409|FG003|Overall Study|Lost to Follow-up|1|||
145283971|NCT03361956|523889410|FG004|Overall Study|Lost to Follow-up|2|||
145283972|NCT01829295|523889412|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
145283973|NCT01829295|523889413|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
145283974|NCT01829295|523889414|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
145283975|NCT01829295|523889415|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
145283976|NCT01829295|523889412|FG000|6-12 Months|Adverse Event|0|||
145283977|NCT01829295|523889413|FG001|6-12 Months|Adverse Event|0|||
145283978|NCT01829295|523889414|FG002|6-12 Months|Adverse Event|3|||
145283979|NCT01829295|523889415|FG003|6-12 Months|Adverse Event|2|||
145283980|NCT01829295|523889412|FG000|6-12 Months|Lost to Follow-up|2|||
145283981|NCT01829295|523889413|FG001|6-12 Months|Lost to Follow-up|0|||
145283982|NCT01829295|523889414|FG002|6-12 Months|Lost to Follow-up|0|||
145283983|NCT01829295|523889415|FG003|6-12 Months|Lost to Follow-up|0|||
145283984|NCT01829295|523889412|FG000|6-12 Months|Withdrawal by Subject|2|||
145283985|NCT01829295|523889413|FG001|6-12 Months|Withdrawal by Subject|2|||
145283986|NCT01829295|523889414|FG002|6-12 Months|Withdrawal by Subject|0|||
145283987|NCT01829295|523889415|FG003|6-12 Months|Withdrawal by Subject|0|||
145283988|NCT02629965|523889418|FG000|Period 1|Adverse Event|1|||
145283989|NCT02629965|523889419|FG001|Period 1|Adverse Event|0|||
145283990|NCT02629965|523889418|FG000|Period 1|Unexpected worsening of disease|2|||
145611347|NCT00603265|525092661|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
145611348|NCT00603265|525092662|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
145611349|NCT00603265|525092660|FG000|Overall Study|Participant Left Country, No Responses|0|||
145611350|NCT00603265|525092661|FG001|Overall Study|Participant Left Country, No Responses|1|||
145611351|NCT00603265|525092662|FG002|Overall Study|Participant Left Country, No Responses|0|||
145611352|NCT00603265|525092660|FG000|Overall Study|Protocol Violation|1|||
145611353|NCT00603265|525092661|FG001|Overall Study|Protocol Violation|0|||
145611354|NCT00603265|525092662|FG002|Overall Study|Protocol Violation|0|||
145611355|NCT01642602|525092678|FG000|Overall Study|Adverse Event|2|||
145611356|NCT02961881|525092679|FG000|Overall Study|Adverse Event|1|||
145611357|NCT02961881|525092680|FG001|Overall Study|Adverse Event|2|||
145611358|NCT02961881|525092681|FG002|Overall Study|Adverse Event|2|||
145405571|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
145405572|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
145405573|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
145611359|NCT02961881|525092682|FG003|Overall Study|Adverse Event|0|||
145611360|NCT02961881|525092683|FG004|Overall Study|Adverse Event|1|||
145551628|NCT00160251|524876489|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551629|NCT00160251|524876490|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551630|NCT00160251|524876491|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551631|NCT00160251|524876492|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551632|NCT00160251|524876493|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551633|NCT00160251|524876494|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551634|NCT00160251|524876495|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
145551635|NCT00160251|524876496|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
145551636|NCT00563381|524876497|FG000|Overall Study|Adverse Event|264|||
145551637|NCT00563381|524876498|FG001|Overall Study|Adverse Event|292|||
145551638|NCT00563381|524876497|FG000|Overall Study|Protocol Violation|66|||
145551639|NCT00563381|524876498|FG001|Overall Study|Protocol Violation|74|||
145551640|NCT00563381|524876497|FG000|Overall Study|Lost to Follow-up|7|||
145551641|NCT00563381|524876498|FG001|Overall Study|Lost to Follow-up|15|||
145551642|NCT00563381|524876497|FG000|Overall Study|Withdrawal by Subject|192|||
145551643|NCT00563381|524876498|FG001|Overall Study|Withdrawal by Subject|209|||
145405574|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
145405575|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
145405576|NCT03573297|524340200|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
145551644|NCT00563381|524876497|FG000|Overall Study|Lack of Efficacy|32|||
145551645|NCT00563381|524876498|FG001|Overall Study|Lack of Efficacy|24|||
145551646|NCT00563381|524876497|FG000|Overall Study|Individual different reasons|24|||
145551647|NCT00563381|524876498|FG001|Overall Study|Individual different reasons|34|||
145551648|NCT02452398|524876501|FG000|Overall Study|Adverse Event|1|||
145551649|NCT02452398|524876501|FG000|Overall Study|Lost to Follow-up|28|||
145551650|NCT02452398|524876501|FG000|Overall Study|Physician Decision|2|||
145551651|NCT02452398|524876501|FG000|Overall Study|Withdrawal by Subject|6|||
145551652|NCT02452398|524876501|FG000|Overall Study|Moved away|4|||
145551653|NCT02407704|524876502|FG000|Overall Study|Lost to Follow-up|0|||
145551654|NCT02407704|524876503|FG001|Overall Study|Lost to Follow-up|0|||
145551655|NCT02407704|524876504|FG002|Overall Study|Lost to Follow-up|0|||
145551656|NCT02407704|524876505|FG003|Overall Study|Lost to Follow-up|2|||
145551657|NCT02407704|524876502|FG000|Overall Study|Protocol Violation|0|||
145551658|NCT02407704|524876503|FG001|Overall Study|Protocol Violation|0|||
145551659|NCT02407704|524876504|FG002|Overall Study|Protocol Violation|0|||
145551660|NCT02407704|524876505|FG003|Overall Study|Protocol Violation|1|||
145551661|NCT02407704|524876502|FG000|Overall Study|Withdrawal by Subject|0|||
145551662|NCT02407704|524876503|FG001|Overall Study|Withdrawal by Subject|0|||
145551663|NCT02407704|524876504|FG002|Overall Study|Withdrawal by Subject|1|||
145611361|NCT02961881|525092679|FG000|Overall Study|Participant request|0|||
145611362|NCT02961881|525092680|FG001|Overall Study|Participant request|2|||
145611363|NCT02961881|525092681|FG002|Overall Study|Participant request|0|||
145611364|NCT02961881|525092682|FG003|Overall Study|Participant request|0|||
145611365|NCT02961881|525092683|FG004|Overall Study|Participant request|0|||
145611366|NCT02961881|525092679|FG000|Overall Study|Disease progression|1|||
145405577|NCT03573297|524340201|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
145611367|NCT02961881|525092680|FG001|Overall Study|Disease progression|0|||
145611368|NCT02961881|525092681|FG002|Overall Study|Disease progression|1|||
145611369|NCT02961881|525092682|FG003|Overall Study|Disease progression|0|||
145611370|NCT02961881|525092683|FG004|Overall Study|Disease progression|0|||
145611371|NCT01118455|525092684|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
145611372|NCT01118455|525092685|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
145611373|NCT01973491|525092686|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
145611374|NCT01973491|525092686|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
145611375|NCT01973491|525092686|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
145611376|NCT01863043|525092688|FG000|Overall Study|Death|6|||
145611377|NCT01863043|525092689|FG001|Overall Study|Death|1|||
145611378|NCT01863043|525092688|FG000|Overall Study|Withdrawal by Subject|0|||
145611379|NCT01863043|525092689|FG001|Overall Study|Withdrawal by Subject|2|||
145611380|NCT01863043|525092688|FG000|Overall Study|Adverse Event|7|||
145611381|NCT01863043|525092689|FG001|Overall Study|Adverse Event|8|||
145405578|NCT03573297|524340202|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
145551664|NCT02407704|524876505|FG003|Overall Study|Withdrawal by Subject|0|||
145551665|NCT02730455|524876506|FG000|Overall Study|Death|5|||
145551666|NCT02730455|524876507|FG001|Overall Study|Death|6|||
145551667|NCT02730455|524876508|FG002|Overall Study|Death|4|||
145551668|NCT02730455|524876506|FG000|Overall Study|Consent withdrawn|2|||
145551669|NCT02730455|524876507|FG001|Overall Study|Consent withdrawn|4|||
145551670|NCT02730455|524876508|FG002|Overall Study|Consent withdrawn|1|||
145551671|NCT02730455|524876506|FG000|Overall Study|Lost to Follow-up|3|||
145551672|NCT02730455|524876507|FG001|Overall Study|Lost to Follow-up|1|||
145551673|NCT02730455|524876508|FG002|Overall Study|Lost to Follow-up|4|||
145551674|NCT02730455|524876506|FG000|Overall Study|Other|1|||
145551675|NCT02730455|524876507|FG001|Overall Study|Other|1|||
145551676|NCT02730455|524876508|FG002|Overall Study|Other|2|||
145611382|NCT01863043|525092688|FG000|Overall Study|exclusion criteria found after enrollment|0|||
145611383|NCT01863043|525092689|FG001|Overall Study|exclusion criteria found after enrollment|1|||
145611384|NCT03377790|525092690|FG000|Overall Study|Withdrawal by Subject|1|||
145405579|NCT03573297|524340203|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
145405580|NCT01366092|524340206|FG000|Overall Study|Progressive cGVHD|2|||
145405581|NCT01366092|524340206|FG000|Overall Study|Physician Decision|1|||
145405582|NCT01366092|524340206|FG000|Overall Study|Withdrawal by Subject|1|||
145405583|NCT02273167|524340208|FG000|Overall Study|Adverse Event|1|||
145405584|NCT02273167|524340209|FG001|Overall Study|Adverse Event|0|||
145405585|NCT02273167|524340210|FG002|Overall Study|Adverse Event|0|||
145405586|NCT02273167|524340208|FG000|Overall Study|Protocol Violation|3|||
145405587|NCT02273167|524340209|FG001|Overall Study|Protocol Violation|1|||
145405588|NCT02273167|524340210|FG002|Overall Study|Protocol Violation|1|||
145405589|NCT02273167|524340208|FG000|Overall Study|Lost to Follow-up|0|||
145405590|NCT02273167|524340209|FG001|Overall Study|Lost to Follow-up|1|||
145405591|NCT02273167|524340210|FG002|Overall Study|Lost to Follow-up|1|||
145405592|NCT02273167|524340208|FG000|Overall Study|Withdrawal by Subject|10|||
145405593|NCT02273167|524340209|FG001|Overall Study|Withdrawal by Subject|12|||
145405594|NCT02273167|524340210|FG002|Overall Study|Withdrawal by Subject|11|||
145405595|NCT02273167|524340208|FG000|Overall Study|Various|10|||
145551677|NCT02730455|524876506|FG000|Overall Study|Other|2|||
145551678|NCT02730455|524876507|FG001|Overall Study|Other|2|||
145551679|NCT02730455|524876508|FG002|Overall Study|Other|0|||
145551680|NCT00748033|524876512|FG000|Overall Study|Adverse Event|0|||
145551681|NCT00748033|524876513|FG001|Overall Study|Adverse Event|1|||
145551682|NCT01018186|524876514|FG000|2-week Run-in Period|Protocol Violation|1|||
145551683|NCT01018186|524876515|FG001|2-week Run-in Period|Protocol Violation|0|||
145551684|NCT01018186|524876516|FG002|2-week Run-in Period|Protocol Violation|0|||
145551685|NCT01018186|524876517|FG003|2-week Run-in Period|Protocol Violation|0|||
145551686|NCT01018186|524876514|FG000|2-week Run-in Period|Lost to Follow-up|2|||
145551687|NCT01018186|524876515|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145551688|NCT01018186|524876516|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145551689|NCT01018186|524876517|FG003|2-week Run-in Period|Lost to Follow-up|0|||
145551690|NCT01018186|524876514|FG000|2-week Run-in Period|Physician Decision|3|||
145551691|NCT01018186|524876515|FG001|2-week Run-in Period|Physician Decision|0|||
145551692|NCT01018186|524876516|FG002|2-week Run-in Period|Physician Decision|0|||
145551693|NCT01018186|524876517|FG003|2-week Run-in Period|Physician Decision|0|||
145551694|NCT01018186|524876514|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
145551695|NCT01018186|524876515|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145551696|NCT01018186|524876516|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145551697|NCT01018186|524876517|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
145551698|NCT01018186|524876514|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
145551699|NCT01018186|524876515|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145551700|NCT01018186|524876516|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145551701|NCT01018186|524876517|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
145551702|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
145551703|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
145551704|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
145551705|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
145551706|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
145551707|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
145551708|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
145551709|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
145405596|NCT02273167|524340209|FG001|Overall Study|Various|9|||
145405597|NCT02273167|524340210|FG002|Overall Study|Various|8|||
145405598|NCT01093846|524340211|FG000|Overall Study|Adverse Event|0|||
145405599|NCT01093846|524340212|FG001|Overall Study|Adverse Event|0|||
145405600|NCT01093846|524340213|FG002|Overall Study|Adverse Event|1|||
145405601|NCT01093846|524340211|FG000|Overall Study|Lack of Efficacy|0|||
145405602|NCT01093846|524340212|FG001|Overall Study|Lack of Efficacy|0|||
145551710|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
145551711|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
145551712|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
145551713|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
145551714|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
145551715|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
145551716|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
145551717|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
145551718|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
145551719|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
145551720|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
145551721|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
145551722|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
145551723|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
145551724|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
145551725|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
145551726|NCT01018186|524876514|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145551727|NCT01018186|524876515|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
145551728|NCT01018186|524876516|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
145551729|NCT01018186|524876517|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
145551730|NCT03235154|524876518|FG000|Overall Study|Withdrawal by Subject|1|||
145551731|NCT03235154|524876518|FG000|Overall Study|Adverse Event|1|||
145551732|NCT03235154|524876518|FG000|Overall Study|Lost to Follow-up|2|||
145551733|NCT01683383|524876519|FG000|Overall Study|Infant was not transported|1|||
145551734|NCT01683383|524876520|FG001|Overall Study|Infant was not transported|0|||
145551735|NCT00996307|524876521|FG000|Overall Study|Adverse Event|0|||
145551736|NCT00996307|524876522|FG001|Overall Study|Adverse Event|1|||
145551737|NCT00996307|524876523|FG002|Overall Study|Adverse Event|0|||
145551738|NCT00996307|524876524|FG003|Overall Study|Adverse Event|0|||
145551739|NCT00996307|524876521|FG000|Overall Study|Withdrawal by Subject|3|||
145551740|NCT00996307|524876522|FG001|Overall Study|Withdrawal by Subject|2|||
145551741|NCT00996307|524876523|FG002|Overall Study|Withdrawal by Subject|5|||
145551742|NCT00996307|524876524|FG003|Overall Study|Withdrawal by Subject|5|||
145551743|NCT00996307|524876521|FG000|Overall Study|Lost to Follow-up|13|||
145551744|NCT00996307|524876522|FG001|Overall Study|Lost to Follow-up|13|||
145551745|NCT00996307|524876523|FG002|Overall Study|Lost to Follow-up|7|||
145551746|NCT00996307|524876524|FG003|Overall Study|Lost to Follow-up|15|||
145551747|NCT00996307|524876521|FG000|Overall Study|Administrative reason|0|||
145551748|NCT00996307|524876522|FG001|Overall Study|Administrative reason|1|||
145551749|NCT00996307|524876523|FG002|Overall Study|Administrative reason|0|||
145551750|NCT00996307|524876524|FG003|Overall Study|Administrative reason|0|||
145551751|NCT00996307|524876521|FG000|Overall Study|Unable to classify|4|||
145551752|NCT00996307|524876522|FG001|Overall Study|Unable to classify|0|||
145551753|NCT00996307|524876523|FG002|Overall Study|Unable to classify|2|||
145551754|NCT00996307|524876524|FG003|Overall Study|Unable to classify|1|||
145551755|NCT02326025|524876525|FG000|Overall Study|Adverse Event|3|||
145551756|NCT02326025|524876526|FG001|Overall Study|Adverse Event|0|||
145551757|NCT02326025|524876525|FG000|Overall Study|Physician Decision|1|||
145551758|NCT02326025|524876526|FG001|Overall Study|Physician Decision|2|||
145551759|NCT02326025|524876525|FG000|Overall Study|Physician and Participant Decision|1|||
145551760|NCT02326025|524876526|FG001|Overall Study|Physician and Participant Decision|0|||
145551761|NCT02326025|524876525|FG000|Overall Study|Withdrawal by Subject|0|||
145551762|NCT02326025|524876526|FG001|Overall Study|Withdrawal by Subject|2|||
145551763|NCT02326025|524876525|FG000|Overall Study|Protocol Violation|0|||
145551764|NCT02326025|524876526|FG001|Overall Study|Protocol Violation|1|||
145611385|NCT03377790|525092691|FG001|Overall Study|Withdrawal by Subject|0|||
145611386|NCT03377790|525092690|FG000|Overall Study|Adverse Event|1|||
145611387|NCT03377790|525092691|FG001|Overall Study|Adverse Event|0|||
145611388|NCT03377790|525092690|FG000|Overall Study|Lost to Follow-up|0|||
145611389|NCT03377790|525092691|FG001|Overall Study|Lost to Follow-up|2|||
145611390|NCT03377790|525092690|FG000|Overall Study|Randomized but not treated|1|||
145611391|NCT03377790|525092691|FG001|Overall Study|Randomized but not treated|0|||
145551765|NCT00536198|524876527|FG000|Overall Study|Lost to Follow-up|15|||
145551766|NCT00536198|524876528|FG001|Overall Study|Lost to Follow-up|14|||
145551767|NCT00536198|524876527|FG000|Overall Study|Withdrawal by Subject|16|||
145551768|NCT00536198|524876528|FG001|Overall Study|Withdrawal by Subject|12|||
145551769|NCT00536198|524876527|FG000|Overall Study|Adverse Event|2|||
145551770|NCT00536198|524876528|FG001|Overall Study|Adverse Event|2|||
145551771|NCT00536198|524876527|FG000|Overall Study|Rescue|3|||
145551772|NCT00536198|524876528|FG001|Overall Study|Rescue|9|||
145551773|NCT00536198|524876527|FG000|Overall Study|Pregnancy|1|||
145551774|NCT00536198|524876528|FG001|Overall Study|Pregnancy|1|||
145551775|NCT00536198|524876527|FG000|Overall Study|Protocol Violation|0|||
145551776|NCT00536198|524876528|FG001|Overall Study|Protocol Violation|1|||
145551777|NCT02505867|524876529|FG000|Overall Study|Lack of Efficacy|6|||
145551778|NCT02505867|524876530|FG001|Overall Study|Lack of Efficacy|6|||
145611392|NCT03377790|525092690|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
145405603|NCT01093846|524340213|FG002|Overall Study|Lack of Efficacy|4|||
145551779|NCT00230607|524876532|FG000|Overall Study|Other|3|||
145551780|NCT02860169|524876533|FG000|Part A|Withdrawal by Subject|1|||
145551781|NCT02860169|524876533|FG000|Part A|Other (Screening failure)|6|||
145551782|NCT02860169|524876533|FG000|Part A|Other (Survey not completed)|3|||
145405604|NCT01093846|524340211|FG000|Overall Study|Condition no longer required study drug|1|||
145405605|NCT01093846|524340212|FG001|Overall Study|Condition no longer required study drug|1|||
145405606|NCT01093846|524340213|FG002|Overall Study|Condition no longer required study drug|1|||
145405607|NCT01093846|524340211|FG000|Overall Study|Administrative Problems|18|||
145405608|NCT01093846|524340212|FG001|Overall Study|Administrative Problems|17|||
145405609|NCT01093846|524340213|FG002|Overall Study|Administrative Problems|15|||
145405610|NCT01963611|524341596|FG000|Overall Study|Adverse Event|1|||
145405611|NCT01963611|524341597|FG001|Overall Study|Adverse Event|1|||
145405612|NCT01963611|524341598|FG002|Overall Study|Adverse Event|3|||
145405613|NCT01963611|524341599|FG003|Overall Study|Adverse Event|4|||
145405614|NCT01963611|524341600|FG004|Overall Study|Adverse Event|3|||
145405615|NCT01963611|524341596|FG000|Overall Study|Protocol Violation|0|||
145405616|NCT01963611|524341597|FG001|Overall Study|Protocol Violation|0|||
145405617|NCT01963611|524341598|FG002|Overall Study|Protocol Violation|0|||
145405618|NCT01963611|524341599|FG003|Overall Study|Protocol Violation|1|||
145405619|NCT01963611|524341600|FG004|Overall Study|Protocol Violation|0|||
145405620|NCT01963611|524341596|FG000|Overall Study|Lack of Efficacy|0|||
145405621|NCT01963611|524341597|FG001|Overall Study|Lack of Efficacy|0|||
145405622|NCT01963611|524341598|FG002|Overall Study|Lack of Efficacy|0|||
145405623|NCT01963611|524341599|FG003|Overall Study|Lack of Efficacy|1|||
145405624|NCT01963611|524341600|FG004|Overall Study|Lack of Efficacy|0|||
145405625|NCT01963611|524341596|FG000|Overall Study|Withdrawal by Subject|3|||
145405626|NCT01963611|524341597|FG001|Overall Study|Withdrawal by Subject|2|||
145405627|NCT01963611|524341598|FG002|Overall Study|Withdrawal by Subject|1|||
145405628|NCT01963611|524341599|FG003|Overall Study|Withdrawal by Subject|1|||
145405629|NCT01963611|524341600|FG004|Overall Study|Withdrawal by Subject|3|||
145405630|NCT01963611|524341596|FG000|Overall Study|Other|47|||
145405631|NCT01963611|524341597|FG001|Overall Study|Other|46|||
145405632|NCT01963611|524341598|FG002|Overall Study|Other|48|||
145405633|NCT01963611|524341599|FG003|Overall Study|Other|45|||
145405634|NCT01963611|524341600|FG004|Overall Study|Other|45|||
145405635|NCT03801252|524341601|FG000|Overall Study|Protocol Violation|1|||
145405636|NCT03801252|524341602|FG001|Overall Study|Protocol Violation|2|||
145405637|NCT02471183|524341603|FG000|Main Treatment Period|Adverse Event|1|||
145405638|NCT02471183|524341603|FG000|Main Treatment Period|Withdrawal by Subject|1|||
145405639|NCT02471183|524341603|FG000|Extended Treatment Period|Lack of Efficacy|1|||
145405640|NCT02328105|524341607|FG000|Overall Study|Death|6|||
145405641|NCT02328105|524341607|FG000|Overall Study|Withdrawal by Subject|1|||
145405642|NCT02328105|524341607|FG000|Overall Study|Still On Study in Follow-Up|4|||
145405643|NCT00614393|524341608|FG000|Overall Study|Adverse Event|20|||
145405644|NCT00614393|524341609|FG001|Overall Study|Adverse Event|2|||
145405645|NCT00614393|524341610|FG002|Overall Study|Adverse Event|3|||
145405646|NCT00614393|524341611|FG003|Overall Study|Adverse Event|13|||
145405647|NCT00614393|524341612|FG004|Overall Study|Adverse Event|21|||
145405648|NCT00614393|524341608|FG000|Overall Study|Lost to Follow-up|0|||
145405649|NCT00614393|524341609|FG001|Overall Study|Lost to Follow-up|0|||
145405650|NCT00614393|524341610|FG002|Overall Study|Lost to Follow-up|0|||
145405651|NCT00614393|524341611|FG003|Overall Study|Lost to Follow-up|1|||
145405652|NCT00614393|524341612|FG004|Overall Study|Lost to Follow-up|2|||
145405653|NCT00614393|524341608|FG000|Overall Study|Physician Decision|17|||
145405654|NCT00614393|524341609|FG001|Overall Study|Physician Decision|0|||
145405655|NCT00614393|524341610|FG002|Overall Study|Physician Decision|1|||
145405656|NCT00614393|524341611|FG003|Overall Study|Physician Decision|8|||
145405657|NCT00614393|524341612|FG004|Overall Study|Physician Decision|9|||
145405658|NCT00614393|524341608|FG000|Overall Study|Progressive Disease|118|||
145405659|NCT00614393|524341609|FG001|Overall Study|Progressive Disease|5|||
145405660|NCT00614393|524341610|FG002|Overall Study|Progressive Disease|5|||
145551783|NCT02860169|524876533|FG000|Part A|Other (did not completed consent)|1|||
145551784|NCT02860169|524876533|FG000|Part B|Other (Screening failure)|10|||
145551785|NCT02860169|524876533|FG000|Part B|Withdrawal by Subject|1|||
145551786|NCT02860169|524876533|FG000|Part C|Other (Screening failure)|1|||
145551787|NCT00165776|524876534|FG000|Overall Study|Lack of Efficacy|0|||
145551788|NCT00165776|524876535|FG001|Overall Study|Lack of Efficacy|0|||
145551789|NCT00165776|524876536|FG002|Overall Study|Lack of Efficacy|0|||
145551790|NCT00165776|524876537|FG003|Overall Study|Lack of Efficacy|1|||
145551791|NCT00165776|524876534|FG000|Overall Study|Withdrawal by Subject|4|||
145551792|NCT00165776|524876535|FG001|Overall Study|Withdrawal by Subject|1|||
145551793|NCT00165776|524876536|FG002|Overall Study|Withdrawal by Subject|2|||
145551794|NCT00165776|524876537|FG003|Overall Study|Withdrawal by Subject|0|||
145611393|NCT03377790|525092691|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
145611394|NCT01987596|525092692|FG000|Overall Study|Physician Decision|1|||
145611395|NCT01987596|525092693|FG001|Overall Study|Physician Decision|0|||
145611396|NCT01987596|525092692|FG000|Overall Study|Progressive Disease; missing all period|0|||
145551795|NCT00165776|524876534|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
145551796|NCT00165776|524876535|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
145551797|NCT00165776|524876536|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
145611397|NCT01987596|525092693|FG001|Overall Study|Progressive Disease; missing all period|1|||
145611398|NCT02632786|525092694|FG000|Overall Study|Adverse Event|2|||
145611399|NCT02632786|525092695|FG001|Overall Study|Adverse Event|1|||
145611400|NCT02632786|525092694|FG000|Overall Study|Death|3|||
145611401|NCT02632786|525092695|FG001|Overall Study|Death|2|||
145405661|NCT00614393|524341611|FG003|Overall Study|Progressive Disease|138|||
145405662|NCT00614393|524341612|FG004|Overall Study|Progressive Disease|130|||
145405663|NCT00614393|524341608|FG000|Overall Study|Protocol Violation|1|||
145405664|NCT00614393|524341609|FG001|Overall Study|Protocol Violation|0|||
145405665|NCT00614393|524341610|FG002|Overall Study|Protocol Violation|0|||
145405666|NCT00614393|524341611|FG003|Overall Study|Protocol Violation|0|||
145405667|NCT00614393|524341612|FG004|Overall Study|Protocol Violation|0|||
145405668|NCT00614393|524341608|FG000|Overall Study|Terminated by Sponsor|0|||
145405669|NCT00614393|524341609|FG001|Overall Study|Terminated by Sponsor|0|||
145405670|NCT00614393|524341610|FG002|Overall Study|Terminated by Sponsor|0|||
145405671|NCT00614393|524341611|FG003|Overall Study|Terminated by Sponsor|0|||
145405672|NCT00614393|524341612|FG004|Overall Study|Terminated by Sponsor|1|||
145405673|NCT00614393|524341608|FG000|Overall Study|Withdrawal by Subject|20|||
145405674|NCT00614393|524341609|FG001|Overall Study|Withdrawal by Subject|1|||
145405675|NCT00614393|524341610|FG002|Overall Study|Withdrawal by Subject|1|||
145405676|NCT00614393|524341611|FG003|Overall Study|Withdrawal by Subject|16|||
145405677|NCT00614393|524341612|FG004|Overall Study|Withdrawal by Subject|13|||
145611402|NCT02632786|525092694|FG000|Overall Study|Physician Decision|5|||
145611403|NCT02632786|525092695|FG001|Overall Study|Physician Decision|4|||
145611404|NCT02632786|525092694|FG000|Overall Study|Withdrawal by Subject|1|||
145611405|NCT02632786|525092695|FG001|Overall Study|Withdrawal by Subject|0|||
145611406|NCT01928225|525092696|FG000|Overall Study|Pregnancy|1|||
145611407|NCT01928225|525092697|FG001|Overall Study|Pregnancy|0|||
145405678|NCT00614393|524341608|FG000|Overall Study|Other|4|||
145405679|NCT00614393|524341609|FG001|Overall Study|Other|0|||
145405680|NCT00614393|524341610|FG002|Overall Study|Other|0|||
145405681|NCT00614393|524341611|FG003|Overall Study|Other|4|||
145405682|NCT00614393|524341612|FG004|Overall Study|Other|2|||
145405683|NCT00614393|524341608|FG000|Overall Study|Not Treated|0|||
145405684|NCT00614393|524341609|FG001|Overall Study|Not Treated|0|||
145405685|NCT00614393|524341610|FG002|Overall Study|Not Treated|0|||
145405686|NCT00614393|524341611|FG003|Overall Study|Not Treated|0|||
145611408|NCT01928225|525092696|FG000|Overall Study|basaloid cervical cancer|1|||
145551798|NCT00165776|524876537|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
145551799|NCT01648205|524876545|FG000|Placebo|Pregnancy|1|||
145551800|NCT01648205|524876545|FG000|Placebo|Withdrawal by Subject|1|||
145551801|NCT01648205|524876545|FG000|Placebo|Protocol Violation|2|||
145551802|NCT01648205|524876545|FG000|Ranolazine|Death|1|||
145551803|NCT01648205|524876545|FG000|Ranolazine|Withdrawal by Subject|1|||
145551804|NCT01648205|524876545|FG000|Ranolazine|Protocol Violation|3|||
145551805|NCT00203996|524876546|FG000|Overall Study|Lost to Follow-up|0|||
145551806|NCT00203996|524876547|FG001|Overall Study|Lost to Follow-up|0|||
145551807|NCT00203996|524876548|FG002|Overall Study|Lost to Follow-up|0|||
145551808|NCT00203996|524876549|FG003|Overall Study|Lost to Follow-up|1|||
145551809|NCT00203996|524876550|FG004|Overall Study|Lost to Follow-up|0|||
145551810|NCT00203996|524876551|FG005|Overall Study|Lost to Follow-up|0|||
145551811|NCT00203996|524876552|FG006|Overall Study|Lost to Follow-up|0|||
145551812|NCT00203996|524876553|FG007|Overall Study|Lost to Follow-up|0|||
145551813|NCT00203996|524876554|FG008|Overall Study|Lost to Follow-up|0|||
145551814|NCT00203996|524876555|FG009|Overall Study|Lost to Follow-up|0|||
145551815|NCT00203996|524876546|FG000|Overall Study|Protocol Violation|0|||
145551816|NCT00203996|524876547|FG001|Overall Study|Protocol Violation|0|||
145551817|NCT00203996|524876548|FG002|Overall Study|Protocol Violation|0|||
145551818|NCT00203996|524876549|FG003|Overall Study|Protocol Violation|6|||
145551819|NCT00203996|524876550|FG004|Overall Study|Protocol Violation|1|||
145551820|NCT00203996|524876551|FG005|Overall Study|Protocol Violation|0|||
145551821|NCT00203996|524876552|FG006|Overall Study|Protocol Violation|0|||
145551822|NCT00203996|524876553|FG007|Overall Study|Protocol Violation|0|||
145551823|NCT00203996|524876554|FG008|Overall Study|Protocol Violation|0|||
145551824|NCT00203996|524876555|FG009|Overall Study|Protocol Violation|0|||
145551825|NCT00203996|524876546|FG000|Overall Study|Physician Decision|0|||
145551826|NCT00203996|524876547|FG001|Overall Study|Physician Decision|0|||
145551827|NCT00203996|524876548|FG002|Overall Study|Physician Decision|0|||
145551828|NCT00203996|524876549|FG003|Overall Study|Physician Decision|2|||
145551829|NCT00203996|524876550|FG004|Overall Study|Physician Decision|0|||
145551830|NCT00203996|524876551|FG005|Overall Study|Physician Decision|0|||
145551831|NCT00203996|524876552|FG006|Overall Study|Physician Decision|0|||
145283991|NCT02629965|523889419|FG001|Period 1|Unexpected worsening of disease|0|||
145283992|NCT02629965|523889418|FG000|Period 1|Other than listed above|1|||
145283993|NCT02629965|523889419|FG001|Period 1|Other than listed above|2|||
145283994|NCT02629965|523889418|FG000|Period 2|Adverse Event|1|||
145283995|NCT02629965|523889419|FG001|Period 2|Adverse Event|0|||
145283996|NCT03443869|523889420|FG000|Overall Study|Death|3|||
145283997|NCT03443869|523889421|FG001|Overall Study|Death|3|||
145283998|NCT03443869|523889420|FG000|Overall Study|Withdrawal by Subject|34|||
145283999|NCT03443869|523889421|FG001|Overall Study|Withdrawal by Subject|22|||
145284000|NCT03443869|523889420|FG000|Overall Study|Lost to Follow-up|1|||
145284001|NCT03443869|523889421|FG001|Overall Study|Lost to Follow-up|2|||
145284002|NCT03443869|523889420|FG000|Overall Study|Physician Decision|3|||
145284003|NCT03443869|523889421|FG001|Overall Study|Physician Decision|3|||
145284004|NCT03443869|523889420|FG000|Overall Study|Other|4|||
145284005|NCT03443869|523889421|FG001|Overall Study|Other|4|||
145284006|NCT02390219|523889422|FG000|Overall Study|Death|1|||
145551832|NCT00203996|524876553|FG007|Overall Study|Physician Decision|0|||
145551833|NCT00203996|524876554|FG008|Overall Study|Physician Decision|0|||
145551834|NCT00203996|524876555|FG009|Overall Study|Physician Decision|1|||
145551835|NCT00203996|524876546|FG000|Overall Study|CPAP machine malfunction|0|||
145551836|NCT00203996|524876547|FG001|Overall Study|CPAP machine malfunction|0|||
145551837|NCT00203996|524876548|FG002|Overall Study|CPAP machine malfunction|0|||
145551838|NCT00203996|524876549|FG003|Overall Study|CPAP machine malfunction|1|||
145551839|NCT00203996|524876550|FG004|Overall Study|CPAP machine malfunction|0|||
145551840|NCT00203996|524876551|FG005|Overall Study|CPAP machine malfunction|0|||
145551841|NCT00203996|524876552|FG006|Overall Study|CPAP machine malfunction|0|||
145284007|NCT02390219|523889422|FG000|Overall Study|Physician Decision|1|||
145551842|NCT00203996|524876553|FG007|Overall Study|CPAP machine malfunction|0|||
145551843|NCT00203996|524876554|FG008|Overall Study|CPAP machine malfunction|0|||
145551844|NCT00203996|524876555|FG009|Overall Study|CPAP machine malfunction|0|||
145551845|NCT00203996|524876546|FG000|Overall Study|Scheduling issue|0|||
145551846|NCT00203996|524876547|FG001|Overall Study|Scheduling issue|0|||
145284008|NCT02390219|523889422|FG000|Overall Study|Adverse Event|6|||
145284009|NCT02390219|523889422|FG000|Overall Study|Withdrawal by Subject|1|||
145284010|NCT02390219|523889422|FG000|Overall Study|Lost to Follow-up|2|||
145284011|NCT02390219|523889422|FG000|Overall Study|Other|2|||
145551847|NCT00203996|524876548|FG002|Overall Study|Scheduling issue|0|||
145551848|NCT00203996|524876549|FG003|Overall Study|Scheduling issue|0|||
145284012|NCT00299728|523889423|FG000|Overall Study|Lost to Follow-up|0|||
145551849|NCT00203996|524876550|FG004|Overall Study|Scheduling issue|0|||
145551850|NCT00203996|524876551|FG005|Overall Study|Scheduling issue|0|||
145551851|NCT00203996|524876552|FG006|Overall Study|Scheduling issue|0|||
145551852|NCT00203996|524876553|FG007|Overall Study|Scheduling issue|2|||
145551853|NCT00203996|524876554|FG008|Overall Study|Scheduling issue|0|||
145284013|NCT00299728|523889424|FG001|Overall Study|Lost to Follow-up|1|||
145551854|NCT00203996|524876555|FG009|Overall Study|Scheduling issue|0|||
145551855|NCT00897104|524876558|FG000|Overall Study|Lost to Follow-up|12|||
145551856|NCT00897104|524876559|FG001|Overall Study|Lost to Follow-up|17|||
145551857|NCT00897104|524876560|FG002|Overall Study|Lost to Follow-up|2|||
145551858|NCT00897104|524876558|FG000|Overall Study|Pregnancy|0|||
145551859|NCT00897104|524876559|FG001|Overall Study|Pregnancy|1|||
145551860|NCT00897104|524876560|FG002|Overall Study|Pregnancy|0|||
145551861|NCT00897104|524876558|FG000|Overall Study|Protocol Violation|0|||
145551862|NCT00897104|524876559|FG001|Overall Study|Protocol Violation|1|||
145551863|NCT00897104|524876560|FG002|Overall Study|Protocol Violation|0|||
145551864|NCT00897104|524876558|FG000|Overall Study|Withdrawal by Subject|23|||
145551865|NCT00897104|524876559|FG001|Overall Study|Withdrawal by Subject|27|||
145551866|NCT00897104|524876560|FG002|Overall Study|Withdrawal by Subject|3|||
145551867|NCT00897104|524876558|FG000|Overall Study|Abnormal Prestudy Labs|2|||
145551868|NCT00897104|524876559|FG001|Overall Study|Abnormal Prestudy Labs|0|||
145551869|NCT00897104|524876560|FG002|Overall Study|Abnormal Prestudy Labs|0|||
145551870|NCT00897104|524876558|FG000|Overall Study|Abnormal Baseline ECG|2|||
145551871|NCT00897104|524876559|FG001|Overall Study|Abnormal Baseline ECG|2|||
145551872|NCT00897104|524876560|FG002|Overall Study|Abnormal Baseline ECG|0|||
145551873|NCT00897104|524876558|FG000|Overall Study|Need for Concom. Med.|0|||
145551874|NCT00897104|524876559|FG001|Overall Study|Need for Concom. Med.|1|||
145551875|NCT00897104|524876560|FG002|Overall Study|Need for Concom. Med.|1|||
145551876|NCT00897104|524876558|FG000|Overall Study|Lack of Migraine Attack|20|||
145551877|NCT00897104|524876559|FG001|Overall Study|Lack of Migraine Attack|22|||
145551878|NCT00897104|524876560|FG002|Overall Study|Lack of Migraine Attack|1|||
145551879|NCT00897104|524876558|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
145551880|NCT00897104|524876559|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145551881|NCT00897104|524876560|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145551882|NCT00897104|524876558|FG000|Overall Study|Other|3|||
145551883|NCT00897104|524876559|FG001|Overall Study|Other|0|||
145551884|NCT00897104|524876560|FG002|Overall Study|Other|0|||
145551885|NCT00897104|524876558|FG000|Overall Study|Protocol Violation|1|||
145551886|NCT00897104|524876559|FG001|Overall Study|Protocol Violation|0|||
145551887|NCT00897104|524876560|FG002|Overall Study|Protocol Violation|0|||
145551888|NCT00897104|524876558|FG000|Overall Study|Withdrawal by Subject|0|||
145551889|NCT00897104|524876559|FG001|Overall Study|Withdrawal by Subject|0|||
145551890|NCT00897104|524876560|FG002|Overall Study|Withdrawal by Subject|1|||
145551891|NCT00434330|524876563|FG000|Overall Study|Adverse Event|0|||
145551892|NCT00434330|524876564|FG001|Overall Study|Adverse Event|0|||
145551893|NCT00434330|524876565|FG002|Overall Study|Adverse Event|1|||
145551894|NCT00434330|524876566|FG003|Overall Study|Adverse Event|0|||
145551895|NCT00434330|524876567|FG004|Overall Study|Adverse Event|0|||
145551896|NCT00434330|524876568|FG005|Overall Study|Adverse Event|0|||
145551897|NCT00434330|524876563|FG000|Overall Study|Death|1|||
145551898|NCT00434330|524876564|FG001|Overall Study|Death|0|||
145551899|NCT00434330|524876565|FG002|Overall Study|Death|0|||
145551900|NCT00434330|524876566|FG003|Overall Study|Death|0|||
145551901|NCT00434330|524876567|FG004|Overall Study|Death|1|||
145551902|NCT00434330|524876568|FG005|Overall Study|Death|1|||
145551903|NCT00434330|524876563|FG000|Overall Study|Withdrawal by Subject|0|||
145551904|NCT00434330|524876564|FG001|Overall Study|Withdrawal by Subject|0|||
145551905|NCT00434330|524876565|FG002|Overall Study|Withdrawal by Subject|1|||
145284014|NCT00299728|523889423|FG000|Overall Study|Withdrawal by Subject|0|||
145284015|NCT00299728|523889424|FG001|Overall Study|Withdrawal by Subject|1|||
145284016|NCT00299728|523889423|FG000|Overall Study|Progressive disease|0|||
145284017|NCT00299728|523889424|FG001|Overall Study|Progressive disease|1|||
145284018|NCT02230085|523889425|FG000|Overall Study|Physician Decision|1|||
145284019|NCT02230085|523889425|FG000|Overall Study|Withdrawal by Subject|3|||
145284020|NCT00580983|523889426|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
145284021|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
145284022|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
145284023|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
145284024|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
145284025|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
145284026|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Adverse Event|60|||
145284027|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Adverse Event|0|||
145284028|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Adverse Event|0|||
145284029|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Adverse Event|0|||
145284030|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Adverse Event|0|||
145284031|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
145284032|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
145284033|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
145284034|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
145284035|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
145284036|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Physician Decision|10|||
145284037|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Physician Decision|0|||
145284038|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Physician Decision|0|||
145284039|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Physician Decision|0|||
145284040|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Physician Decision|0|||
145284041|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
145284042|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
145284043|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
145284044|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
145284045|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
145284046|NCT01360632|523889427|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
145284047|NCT01360632|523889428|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
145284048|NCT01360632|523889429|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
145284049|NCT01360632|523889430|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
145284050|NCT01360632|523889431|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
145284051|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
145284052|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
145284053|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
145284054|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
145284055|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
145284056|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Adverse Event|0|||
145284057|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Adverse Event|3|||
145551906|NCT00434330|524876566|FG003|Overall Study|Withdrawal by Subject|1|||
145284058|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Adverse Event|9|||
145284059|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Adverse Event|3|||
145284060|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Adverse Event|0|||
145284061|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
145284062|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
145284063|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
145551907|NCT00434330|524876567|FG004|Overall Study|Withdrawal by Subject|0|||
145284064|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
145284065|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
145284066|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Physician Decision|0|||
145284067|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Physician Decision|0|||
145551908|NCT00434330|524876568|FG005|Overall Study|Withdrawal by Subject|0|||
145551909|NCT00434330|524876563|FG000|Overall Study|Renal transplant|0|||
145551910|NCT00434330|524876564|FG001|Overall Study|Renal transplant|0|||
145551911|NCT00434330|524876565|FG002|Overall Study|Renal transplant|0|||
145551912|NCT00434330|524876566|FG003|Overall Study|Renal transplant|1|||
145551913|NCT00434330|524876567|FG004|Overall Study|Renal transplant|0|||
145551914|NCT00434330|524876568|FG005|Overall Study|Renal transplant|0|||
145551915|NCT00434330|524876563|FG000|Overall Study|Subject Not Compliant With Study|0|||
145551916|NCT00434330|524876564|FG001|Overall Study|Subject Not Compliant With Study|0|||
145551917|NCT00434330|524876565|FG002|Overall Study|Subject Not Compliant With Study|1|||
145551918|NCT00434330|524876566|FG003|Overall Study|Subject Not Compliant With Study|0|||
145551919|NCT00434330|524876567|FG004|Overall Study|Subject Not Compliant With Study|0|||
145551920|NCT00434330|524876568|FG005|Overall Study|Subject Not Compliant With Study|0|||
145551921|NCT01428453|524876569|FG000|Overall Study|Adverse Event|2|||
145551922|NCT01428453|524876570|FG001|Overall Study|Adverse Event|7|||
145551923|NCT01428453|524876569|FG000|Overall Study|Protocol Violation|1|||
145551924|NCT01428453|524876570|FG001|Overall Study|Protocol Violation|0|||
145551925|NCT01428453|524876569|FG000|Overall Study|Lost to Follow-up|0|||
145551926|NCT01428453|524876570|FG001|Overall Study|Lost to Follow-up|1|||
145551927|NCT01428453|524876569|FG000|Overall Study|Withdrawal by Subject|3|||
145551928|NCT01428453|524876570|FG001|Overall Study|Withdrawal by Subject|1|||
145551929|NCT01996709|524876571|FG000|Overall Study|Withdrawal by Subject|1|||
145551930|NCT01996709|524876572|FG001|Overall Study|Withdrawal by Subject|0|||
145551931|NCT01996709|524876571|FG000|Overall Study|Lost to Follow-up|3|||
145551932|NCT01996709|524876572|FG001|Overall Study|Lost to Follow-up|0|||
145551933|NCT01996709|524876571|FG000|Overall Study|Subject Non-Compliant|1|||
145551934|NCT01996709|524876572|FG001|Overall Study|Subject Non-Compliant|0|||
145551935|NCT01996709|524876571|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145551936|NCT01996709|524876572|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
145551937|NCT04853225|524876575|FG000|Overall Study|Withdrawal by Subject|81|||
145551938|NCT04853225|524876576|FG001|Overall Study|Withdrawal by Subject|4|||
145551939|NCT04853225|524876577|FG002|Overall Study|Withdrawal by Subject|1|||
145551940|NCT04853225|524876575|FG000|Overall Study|Physician Decision|12|||
145551941|NCT04853225|524876576|FG001|Overall Study|Physician Decision|4|||
145551942|NCT04853225|524876577|FG002|Overall Study|Physician Decision|1|||
145551943|NCT04853225|524876575|FG000|Overall Study|Lost to Follow-up|50|||
145551944|NCT04853225|524876576|FG001|Overall Study|Lost to Follow-up|0|||
145551945|NCT04853225|524876577|FG002|Overall Study|Lost to Follow-up|0|||
145551946|NCT04853225|524876575|FG000|Overall Study|Other|102|||
145551947|NCT04853225|524876576|FG001|Overall Study|Other|11|||
145551948|NCT04853225|524876577|FG002|Overall Study|Other|5|||
145551949|NCT04853225|524876575|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
145551950|NCT04853225|524876576|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
145551951|NCT04853225|524876577|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
145551952|NCT04853225|524876575|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
145551953|NCT04853225|524876576|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
145551954|NCT04853225|524876577|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
145551955|NCT00850564|524876578|FG000|Overall Study|Withdrawal by Subject|2|||
145551956|NCT01937559|524876579|FG000|Overall Study|Physician Decision|3|||
145551957|NCT01937559|524876580|FG001|Overall Study|Physician Decision|3|||
145551958|NCT01937559|524876581|FG002|Overall Study|Physician Decision|0|||
145551959|NCT01937559|524876579|FG000|Overall Study|Withdrawal by Subject|6|||
145551960|NCT01937559|524876580|FG001|Overall Study|Withdrawal by Subject|4|||
145551961|NCT01937559|524876581|FG002|Overall Study|Withdrawal by Subject|0|||
145551962|NCT01937559|524876579|FG000|Overall Study|screen fail|2|||
145551963|NCT01937559|524876580|FG001|Overall Study|screen fail|4|||
145551964|NCT01937559|524876581|FG002|Overall Study|screen fail|0|||
145551965|NCT02167893|524876582|FG000|Overall Study|Investigator transferred|85|||
145551966|NCT02167893|524876582|FG000|Overall Study|Investigator health reasons|10|||
145551967|NCT02167893|524876582|FG000|Overall Study|Case report forms not collected|68|||
145551968|NCT04818840|524876583|FG000|Overall Study|Lost to Follow-up|0|||
145551969|NCT04818840|524876584|FG001|Overall Study|Lost to Follow-up|5|||
145551970|NCT04818840|524876583|FG000|Overall Study|Physician Decision|1|||
145551971|NCT04818840|524876584|FG001|Overall Study|Physician Decision|0|||
145551972|NCT04818840|524876583|FG000|Overall Study|Site Terminated by Sponsor|0|||
145551973|NCT04818840|524876584|FG001|Overall Study|Site Terminated by Sponsor|3|||
145551974|NCT04818840|524876583|FG000|Overall Study|Study Terminated by Sponsor|43|||
145551975|NCT04818840|524876584|FG001|Overall Study|Study Terminated by Sponsor|7|||
145551976|NCT04818840|524876583|FG000|Overall Study|Withdrawal by Subject|0|||
145551977|NCT04818840|524876584|FG001|Overall Study|Withdrawal by Subject|1|||
145551978|NCT01438424|524879096|FG000|Overall Study|Continuing treatment|29|||
145551979|NCT01438424|524879096|FG000|Overall Study|Minimal virologic response|95|||
145551980|NCT01438424|524879096|FG000|Overall Study|Not identified|55|||
145551981|NCT01438424|524879096|FG000|Overall Study|Withdrawal by Subject|104|||
145551982|NCT01438424|524879096|FG000|Overall Study|Progression of chronic hepatitis B|22|||
145551983|NCT01438424|524879096|FG000|Overall Study|Death|22|||
145551984|NCT01438424|524879096|FG000|Overall Study|Adverse Event|17|||
145551985|NCT01438424|524879096|FG000|Overall Study|Lost to Follow-up|17|||
145551986|NCT01438424|524879096|FG000|Overall Study|Abnormal laboratory test result|14|||
145551987|NCT01438424|524879096|FG000|Overall Study|Need for drug prohibited by protocol|14|||
145551988|NCT01438424|524879096|FG000|Overall Study|Pregnancy|7|||
145551989|NCT01438424|524879096|FG000|Overall Study|No longer met inclusion criteria|1|||
145551990|NCT01438424|524879096|FG000|Overall Study|Participant noncompliance|20|||
145405687|NCT00614393|524341612|FG004|Overall Study|Not Treated|2|||
145551991|NCT01320085|524879100|FG000|Overall Study|Disease Progression|26|||
145551992|NCT01320085|524879101|FG001|Overall Study|Disease Progression|93|||
145551993|NCT01320085|524879102|FG002|Overall Study|Disease Progression|17|||
145551994|NCT01320085|524879100|FG000|Overall Study|Adverse Event|12|||
145551995|NCT01320085|524879101|FG001|Overall Study|Adverse Event|20|||
145551996|NCT01320085|524879102|FG002|Overall Study|Adverse Event|5|||
145551997|NCT01320085|524879100|FG000|Overall Study|Withdrawal by Subject|2|||
145551998|NCT01320085|524879101|FG001|Overall Study|Withdrawal by Subject|4|||
145551999|NCT01320085|524879102|FG002|Overall Study|Withdrawal by Subject|1|||
145552000|NCT01320085|524879100|FG000|Overall Study|Protocol Deviation|1|||
145552001|NCT01320085|524879101|FG001|Overall Study|Protocol Deviation|0|||
145552002|NCT01320085|524879102|FG002|Overall Study|Protocol Deviation|1|||
145552003|NCT01320085|524879100|FG000|Overall Study|Administrative problems|0|||
145552004|NCT01320085|524879101|FG001|Overall Study|Administrative problems|0|||
145552005|NCT01320085|524879102|FG002|Overall Study|Administrative problems|1|||
145552006|NCT01702454|524879103|FG000|Overall Study|Consent withdrawal|0|||
145552007|NCT01702454|524879104|FG001|Overall Study|Consent withdrawal|1|||
145552008|NCT01702454|524879103|FG000|Overall Study|Migrated/moved from study area|0|||
145552009|NCT01702454|524879104|FG001|Overall Study|Migrated/moved from study area|1|||
145552010|NCT01702454|524879103|FG000|Overall Study|Lost to Follow-up|3|||
145552011|NCT01702454|524879104|FG001|Overall Study|Lost to Follow-up|6|||
145552012|NCT00710710|524879105|FG000|Overall Study|Consent withdrawn|2|||
145552013|NCT00710710|524879106|FG001|Overall Study|Consent withdrawn|2|||
145552014|NCT00710710|524879105|FG000|Overall Study|Protocol Violation|0|||
145552015|NCT00710710|524879106|FG001|Overall Study|Protocol Violation|1|||
145552016|NCT00710710|524879105|FG000|Overall Study|Adverse Event|3|||
145552017|NCT00710710|524879106|FG001|Overall Study|Adverse Event|3|||
145552018|NCT00710710|524879105|FG000|Overall Study|Progressive disease|40|||
145552019|NCT00710710|524879106|FG001|Overall Study|Progressive disease|38|||
145552020|NCT03510884|524879107|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
145552021|NCT03510884|524879108|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
145552022|NCT03510884|524879109|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
145552023|NCT03510884|524879110|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
145552024|NCT03510884|524879107|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
145552025|NCT03510884|524879108|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
145552026|NCT03510884|524879109|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
145552027|NCT03510884|524879110|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
145552028|NCT03510884|524879107|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
145552029|NCT03510884|524879108|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
145552030|NCT03510884|524879109|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
145552031|NCT03510884|524879110|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
145552032|NCT03510884|524879107|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
145552033|NCT03510884|524879108|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
145552034|NCT03510884|524879109|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
145552035|NCT03510884|524879110|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
145552036|NCT03510884|524879107|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
145284068|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Physician Decision|0|||
145284069|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Physician Decision|1|||
145284070|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Physician Decision|0|||
145284071|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
145284072|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
145284073|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
145284074|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
145284075|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
145284076|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
145284077|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
145284078|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
145284079|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
145284080|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
145284081|NCT01360632|523889427|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
145284082|NCT01360632|523889428|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
145284083|NCT01360632|523889429|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
145284084|NCT01360632|523889430|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
145284085|NCT01360632|523889431|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
145284086|NCT01360632|523889427|FG000|Phase A+|Lost to Follow-up|0|||
145284087|NCT01360632|523889428|FG001|Phase A+|Lost to Follow-up|0|||
145284088|NCT01360632|523889429|FG002|Phase A+|Lost to Follow-up|0|||
145284089|NCT01360632|523889430|FG003|Phase A+|Lost to Follow-up|0|||
145284090|NCT01360632|523889431|FG004|Phase A+|Lost to Follow-up|2|||
145284091|NCT01360632|523889427|FG000|Phase A+|Adverse Event|0|||
145284092|NCT01360632|523889428|FG001|Phase A+|Adverse Event|0|||
145284093|NCT01360632|523889429|FG002|Phase A+|Adverse Event|0|||
145284094|NCT01360632|523889430|FG003|Phase A+|Adverse Event|0|||
145284095|NCT01360632|523889431|FG004|Phase A+|Adverse Event|2|||
145284096|NCT01360632|523889427|FG000|Phase A+|Met Withdrawal Criteria|0|||
145284097|NCT01360632|523889428|FG001|Phase A+|Met Withdrawal Criteria|0|||
145284098|NCT01360632|523889429|FG002|Phase A+|Met Withdrawal Criteria|0|||
145284099|NCT01360632|523889430|FG003|Phase A+|Met Withdrawal Criteria|0|||
145284100|NCT01360632|523889431|FG004|Phase A+|Met Withdrawal Criteria|7|||
145284101|NCT01360632|523889427|FG000|Phase A+|Physician Decision|0|||
145284102|NCT01360632|523889428|FG001|Phase A+|Physician Decision|0|||
145284103|NCT01360632|523889429|FG002|Phase A+|Physician Decision|0|||
145284104|NCT01360632|523889430|FG003|Phase A+|Physician Decision|0|||
145552037|NCT03510884|524879108|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
145552038|NCT03510884|524879109|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
145552039|NCT03510884|524879110|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
145552040|NCT03510884|524879107|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
145552041|NCT03510884|524879108|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
145552042|NCT03510884|524879109|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
145552043|NCT03510884|524879110|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
145552044|NCT03510884|524879107|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
145552045|NCT03510884|524879108|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
145552046|NCT03510884|524879109|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
145552047|NCT03510884|524879110|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
145552048|NCT03510884|524879107|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
145552049|NCT03510884|524879108|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
145552050|NCT03510884|524879109|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
145552051|NCT03510884|524879110|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
145552052|NCT03510884|524879107|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
145552053|NCT03510884|524879108|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
145552054|NCT03510884|524879109|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
145552055|NCT03510884|524879110|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
145552056|NCT03510884|524879107|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
145552057|NCT03510884|524879108|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
145552058|NCT03510884|524879109|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
145552059|NCT03510884|524879110|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
145552060|NCT00589914|524879111|FG000|Overall Study|Adverse Event|19|||
145552061|NCT00589914|524879112|FG001|Overall Study|Adverse Event|10|||
145552062|NCT00589914|524879111|FG000|Overall Study|Death|2|||
145552063|NCT00589914|524879112|FG001|Overall Study|Death|0|||
145552064|NCT00589914|524879111|FG000|Overall Study|Lack of Efficacy|40|||
145552065|NCT00589914|524879112|FG001|Overall Study|Lack of Efficacy|43|||
145552066|NCT00589914|524879111|FG000|Overall Study|Lost to Follow-up|11|||
145552067|NCT00589914|524879112|FG001|Overall Study|Lost to Follow-up|18|||
145552068|NCT00589914|524879111|FG000|Overall Study|Pregnancy|1|||
145552069|NCT00589914|524879112|FG001|Overall Study|Pregnancy|0|||
145552070|NCT00589914|524879111|FG000|Overall Study|Withdrawal by Subject|55|||
145552071|NCT00589914|524879112|FG001|Overall Study|Withdrawal by Subject|49|||
145552072|NCT00589914|524879111|FG000|Overall Study|Other|22|||
145552073|NCT00589914|524879112|FG001|Overall Study|Other|17|||
145552074|NCT02564042|524879118|FG000|Overall Study|Adverse Event|4|||
145552075|NCT02564042|524879119|FG001|Overall Study|Adverse Event|4|||
145552076|NCT02564042|524879120|FG002|Overall Study|Adverse Event|3|||
145552077|NCT02564042|524879121|FG003|Overall Study|Adverse Event|0|||
145552078|NCT02564042|524879122|FG004|Overall Study|Adverse Event|0|||
145552079|NCT02564042|524879123|FG005|Overall Study|Adverse Event|1|||
145552080|NCT02564042|524879118|FG000|Overall Study|Lost to Follow-up|1|||
145552081|NCT02564042|524879119|FG001|Overall Study|Lost to Follow-up|1|||
145552082|NCT02564042|524879120|FG002|Overall Study|Lost to Follow-up|1|||
145552083|NCT02564042|524879121|FG003|Overall Study|Lost to Follow-up|0|||
145552084|NCT02564042|524879122|FG004|Overall Study|Lost to Follow-up|1|||
145552085|NCT02564042|524879123|FG005|Overall Study|Lost to Follow-up|1|||
145552086|NCT02564042|524879118|FG000|Overall Study|Physician Decision|1|||
145552087|NCT02564042|524879119|FG001|Overall Study|Physician Decision|0|||
145552088|NCT02564042|524879120|FG002|Overall Study|Physician Decision|0|||
145552089|NCT02564042|524879121|FG003|Overall Study|Physician Decision|1|||
145552090|NCT02564042|524879122|FG004|Overall Study|Physician Decision|0|||
145552091|NCT02564042|524879123|FG005|Overall Study|Physician Decision|0|||
145552092|NCT02564042|524879118|FG000|Overall Study|Withdrawal by Subject|5|||
145552093|NCT02564042|524879119|FG001|Overall Study|Withdrawal by Subject|3|||
145552094|NCT02564042|524879120|FG002|Overall Study|Withdrawal by Subject|2|||
145552095|NCT02564042|524879121|FG003|Overall Study|Withdrawal by Subject|2|||
145552096|NCT02564042|524879122|FG004|Overall Study|Withdrawal by Subject|10|||
145552097|NCT02564042|524879123|FG005|Overall Study|Withdrawal by Subject|12|||
145552098|NCT02289898|524879130|FG000|Overall Study|Death|5|||
145552099|NCT02289898|524879131|FG001|Overall Study|Death|4|||
145552100|NCT02289898|524879132|FG002|Overall Study|Death|3|||
145552101|NCT02289898|524879130|FG000|Overall Study|Physician Decision|2|||
145552102|NCT02289898|524879131|FG001|Overall Study|Physician Decision|5|||
145552103|NCT02289898|524879132|FG002|Overall Study|Physician Decision|2|||
145552104|NCT02289898|524879130|FG000|Overall Study|Withdrawal by Subject|0|||
145552105|NCT02289898|524879131|FG001|Overall Study|Withdrawal by Subject|4|||
145552106|NCT02289898|524879132|FG002|Overall Study|Withdrawal by Subject|1|||
145552107|NCT02289898|524879130|FG000|Overall Study|Adverse Event|3|||
145552108|NCT02289898|524879131|FG001|Overall Study|Adverse Event|5|||
145552109|NCT02289898|524879132|FG002|Overall Study|Adverse Event|5|||
145552110|NCT02289898|524879130|FG000|Overall Study|Disease progression|34|||
145552111|NCT02289898|524879131|FG001|Overall Study|Disease progression|28|||
145552112|NCT02289898|524879132|FG002|Overall Study|Disease progression|34|||
145552113|NCT02289898|524879130|FG000|Overall Study|Use of another anticancer therapy|0|||
145552114|NCT02289898|524879131|FG001|Overall Study|Use of another anticancer therapy|0|||
145552115|NCT02289898|524879132|FG002|Overall Study|Use of another anticancer therapy|1|||
145552116|NCT02289898|524879130|FG000|Overall Study|Other|8|||
145552117|NCT02289898|524879131|FG001|Overall Study|Other|7|||
145552118|NCT02289898|524879132|FG002|Overall Study|Other|10|||
145552119|NCT00885105|524879133|FG000|Overall Study|Withdrawal by Subject|0|||
145552120|NCT00885105|524879134|FG001|Overall Study|Withdrawal by Subject|8|||
145552121|NCT00885105|524879133|FG000|Overall Study|Adverse Event|1|||
145552122|NCT00885105|524879134|FG001|Overall Study|Adverse Event|0|||
145552123|NCT00885105|524879133|FG000|Overall Study|Protocol Violation|0|||
145552124|NCT00885105|524879134|FG001|Overall Study|Protocol Violation|2|||
145552125|NCT01402544|524879135|FG000|Overall Study|Withdrawal by Subject|6|||
145552126|NCT01828281|524879136|FG000|Overall Study|Withdrawal by Subject|1|||
145552127|NCT01828281|524879137|FG001|Overall Study|Withdrawal by Subject|0|||
145552128|NCT01442493|524879138|FG000|Overall Study|withdrawn from study|3|||
145552129|NCT01442493|524879139|FG001|Overall Study|withdrawn from study|2|||
145552130|NCT02927431|524879141|FG000|Overall Study|Withdrawal by Subject|0|||
145552131|NCT02927431|524879142|FG001|Overall Study|Withdrawal by Subject|0|||
145552132|NCT02927431|524879143|FG002|Overall Study|Withdrawal by Subject|1|||
145552133|NCT01830972|524879144|FG000|Part II|Withdrawal by Subject|2|||
145552134|NCT01830972|524879145|FG001|Part II|Withdrawal by Subject|2|||
145552135|NCT01830972|524879144|FG000|Part III|Withdrawal by Subject|1|||
145552136|NCT01830972|524879145|FG001|Part III|Withdrawal by Subject|0|||
145552137|NCT01830972|524879144|FG000|Part III|Noncompliance|1|||
145552138|NCT01830972|524879145|FG001|Part III|Noncompliance|0|||
145552139|NCT01830972|524879144|FG000|Part IV|Withdrawal by Subject|2|||
145552140|NCT01830972|524879145|FG001|Part IV|Withdrawal by Subject|1|||
145552141|NCT01830972|524879144|FG000|Part IV|Non-Compliance|1|||
145552142|NCT01830972|524879145|FG001|Part IV|Non-Compliance|0|||
145552143|NCT00673465|524879146|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552144|NCT00673465|524879147|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552145|NCT00673465|524879148|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552146|NCT00673465|524879149|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552147|NCT00673465|524879150|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
145552148|NCT00673465|524879151|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
145552149|NCT00673465|524879152|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552150|NCT00673465|524879153|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552151|NCT00673465|524879154|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552152|NCT00673465|524879155|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552153|NCT00673465|524879156|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552154|NCT00673465|524879157|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
145552155|NCT00673465|524879146|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552156|NCT00673465|524879147|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552157|NCT00673465|524879148|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552158|NCT00673465|524879149|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552159|NCT00673465|524879150|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
145552160|NCT00673465|524879151|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552161|NCT00673465|524879152|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552162|NCT00673465|524879153|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552163|NCT00673465|524879154|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552164|NCT00673465|524879155|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
145405688|NCT03345004|524341616|FG000|Overall Study|Physician Decision|1|||
145552165|NCT00673465|524879156|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552166|NCT00673465|524879157|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
145552167|NCT01829191|524879158|FG000|Overall Study|Relocation|0|||
145552168|NCT01829191|524879159|FG001|Overall Study|Relocation|1|||
145552169|NCT01829191|524879158|FG000|Overall Study|Lens discomfort|0|||
145552170|NCT01829191|524879159|FG001|Overall Study|Lens discomfort|3|||
145552171|NCT01829191|524879158|FG000|Overall Study|Lens handling difficulty|1|||
145552172|NCT01829191|524879159|FG001|Overall Study|Lens handling difficulty|4|||
145552173|NCT01829191|524879158|FG000|Overall Study|Protocol Violation|4|||
145552174|NCT01829191|524879159|FG001|Overall Study|Protocol Violation|1|||
145552175|NCT01829191|524879158|FG000|Overall Study|Withdrawal by Subject|2|||
145552176|NCT01829191|524879159|FG001|Overall Study|Withdrawal by Subject|3|||
145552177|NCT01829191|524879158|FG000|Overall Study|Lost to Follow-up|0|||
145552178|NCT01829191|524879159|FG001|Overall Study|Lost to Follow-up|1|||
145552179|NCT01829191|524879158|FG000|Overall Study|Subject was fit for ortho - k|0|||
145552180|NCT01829191|524879159|FG001|Overall Study|Subject was fit for ortho - k|1|||
145552181|NCT00553514|524879160|FG000|Overall Study|Protocol deviation|0|||
145552182|NCT00553514|524879161|FG001|Overall Study|Protocol deviation|0|||
145552183|NCT00553514|524879162|FG002|Overall Study|Protocol deviation|0|||
145552184|NCT00553514|524879163|FG003|Overall Study|Protocol deviation|1|||
145552185|NCT00553514|524879164|FG004|Overall Study|Protocol deviation|0|||
145552186|NCT00553514|524879160|FG000|Overall Study|Lack of ovarian response|4|||
145552187|NCT00553514|524879161|FG001|Overall Study|Lack of ovarian response|5|||
145552188|NCT00553514|524879162|FG002|Overall Study|Lack of ovarian response|5|||
145552189|NCT00553514|524879163|FG003|Overall Study|Lack of ovarian response|5|||
145552190|NCT00553514|524879164|FG004|Overall Study|Lack of ovarian response|6|||
145552191|NCT00553514|524879160|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
145552192|NCT00553514|524879161|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
145552193|NCT00553514|524879162|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145552194|NCT00553514|524879163|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
145552195|NCT00553514|524879164|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
145552196|NCT00553514|524879160|FG000|Overall Study|Risk of multiple pregnancy|0|||
145552197|NCT00553514|524879161|FG001|Overall Study|Risk of multiple pregnancy|2|||
145552198|NCT00553514|524879162|FG002|Overall Study|Risk of multiple pregnancy|0|||
145552199|NCT00553514|524879163|FG003|Overall Study|Risk of multiple pregnancy|1|||
145552200|NCT00553514|524879164|FG004|Overall Study|Risk of multiple pregnancy|0|||
145552201|NCT00553514|524879160|FG000|Overall Study|Other|1|||
145284105|NCT01360632|523889431|FG004|Phase A+|Physician Decision|3|||
145552202|NCT00553514|524879161|FG001|Overall Study|Other|1|||
145552203|NCT00553514|524879162|FG002|Overall Study|Other|0|||
145552204|NCT00553514|524879163|FG003|Overall Study|Other|0|||
145552205|NCT00553514|524879164|FG004|Overall Study|Other|1|||
145552206|NCT04952402|524879165|FG000|Overall Study|Lost to Follow-up|1|||
145552207|NCT04952402|524879166|FG001|Overall Study|Lost to Follow-up|3|||
145552208|NCT04952402|524879165|FG000|Overall Study|Lack Of Venous Access|0|||
145552209|NCT04952402|524879166|FG001|Overall Study|Lack Of Venous Access|1|||
145552210|NCT00726661|524879167|FG000|Overall Study|Lost to Follow-up|36|||
145552211|NCT00726661|524879168|FG001|Overall Study|Lost to Follow-up|11|||
145552212|NCT00726661|524879167|FG000|Overall Study|Withdrawal by Subject|17|||
145552213|NCT00726661|524879168|FG001|Overall Study|Withdrawal by Subject|13|||
145552214|NCT00726661|524879167|FG000|Overall Study|Trial terminated by sponsor|214|||
145552215|NCT00726661|524879168|FG001|Overall Study|Trial terminated by sponsor|187|||
145552216|NCT00726661|524879167|FG000|Overall Study|Death|475|||
145552217|NCT00726661|524879168|FG001|Overall Study|Death|159|||
145552218|NCT00726661|524879167|FG000|Overall Study|Physician Decision|25|||
145552219|NCT00726661|524879168|FG001|Overall Study|Physician Decision|13|||
145552220|NCT00726661|524879167|FG000|Overall Study|Other|47|||
145552221|NCT00726661|524879168|FG001|Overall Study|Other|35|||
145552222|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
145552223|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
145552224|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
145552225|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
145552226|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
145552227|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
145552228|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
145552229|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
145552230|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
145552231|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
145552232|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
145552233|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
145552234|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
145552235|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
145552236|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
145552237|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
145552238|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
145552239|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
145552240|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
145552241|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
145552242|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
145552243|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
145552244|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
145552245|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
145552246|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
145552247|NCT01285310|524879171|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
145552248|NCT01285310|524879172|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
145552249|NCT01285310|524879173|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
145552250|NCT01285310|524879174|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
145552251|NCT01285310|524879175|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
145552252|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
145552253|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
145552254|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
145552255|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
145552256|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
145552257|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
145552258|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
145552259|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
145552260|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
145552261|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
145552262|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
145552263|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
145552264|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
145552265|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
145552266|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
145552267|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
145552268|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
145552269|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
145552270|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
145552271|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
145552272|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
145552273|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
145552274|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
145552275|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
145552276|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
145552277|NCT01285310|524879171|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
145552278|NCT01285310|524879172|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
145552279|NCT01285310|524879173|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
145552280|NCT01285310|524879174|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
145552281|NCT01285310|524879175|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
145552282|NCT00514540|524879176|FG000|First-Line Chemo|Withdrawal by Subject|1|||
145552283|NCT00514540|524879176|FG000|First-Line Chemo|Protocol Violation|7|||
145552284|NCT00514540|524879176|FG000|Second-Line|Physician/Patient Decision|31|||
145552285|NCT01996982|524879179|FG000|Overall Study|PI/team left institution|7|||
145552286|NCT01195415|524879200|FG000|Overall Study|No repeat biopsy due to progression|2|||
145552287|NCT00533845|524879203|FG000|Overall Study|Physician Decision|1|||
145552288|NCT00533845|524879204|FG001|Overall Study|Physician Decision|0|||
145552289|NCT01442675|524879219|FG000|Overall Study|Protocol Violation|6|||
145552290|NCT01442675|524879219|FG000|Overall Study|Lost to Follow-up|2|||
145552291|NCT01442675|524879219|FG000|Overall Study|Withdrawal by Subject|4|||
145552292|NCT00752232|524879220|FG000|Overall Study|Protocol Violation|0|||
145552293|NCT00752232|524879221|FG001|Overall Study|Protocol Violation|0|||
145552294|NCT00752232|524879222|FG002|Overall Study|Protocol Violation|0|||
145552295|NCT00752232|524879223|FG003|Overall Study|Protocol Violation|0|||
145552296|NCT00752232|524879224|FG004|Overall Study|Protocol Violation|0|||
145552297|NCT00752232|524879225|FG005|Overall Study|Protocol Violation|1|||
145552298|NCT00752232|524879226|FG006|Overall Study|Protocol Violation|0|||
145552299|NCT00752232|524879220|FG000|Overall Study|Caregiver request|2|||
145552300|NCT00752232|524879221|FG001|Overall Study|Caregiver request|0|||
145552301|NCT00752232|524879222|FG002|Overall Study|Caregiver request|0|||
145552302|NCT00752232|524879223|FG003|Overall Study|Caregiver request|0|||
145552303|NCT00752232|524879224|FG004|Overall Study|Caregiver request|1|||
145552304|NCT00752232|524879225|FG005|Overall Study|Caregiver request|0|||
145405689|NCT03345004|524341617|FG001|Overall Study|Physician Decision|0|||
145405690|NCT03345004|524341616|FG000|Overall Study|Withdrawal by Subject|0|||
145552305|NCT00752232|524879226|FG006|Overall Study|Caregiver request|0|||
145552306|NCT00752232|524879220|FG000|Overall Study|Investigator request|0|||
145552307|NCT00752232|524879221|FG001|Overall Study|Investigator request|0|||
145552308|NCT00752232|524879222|FG002|Overall Study|Investigator request|0|||
145552309|NCT00752232|524879223|FG003|Overall Study|Investigator request|0|||
145552310|NCT00752232|524879224|FG004|Overall Study|Investigator request|1|||
145552311|NCT00752232|524879225|FG005|Overall Study|Investigator request|0|||
145552312|NCT00752232|524879226|FG006|Overall Study|Investigator request|0|||
145552313|NCT00752232|524879220|FG000|Overall Study|Subject request|0|||
145284106|NCT01360632|523889427|FG000|Phase A+|Withdrawal by Subject|0|||
145284107|NCT01360632|523889428|FG001|Phase A+|Withdrawal by Subject|0|||
145552314|NCT00752232|524879221|FG001|Overall Study|Subject request|0|||
145552315|NCT00752232|524879222|FG002|Overall Study|Subject request|1|||
145552316|NCT00752232|524879223|FG003|Overall Study|Subject request|0|||
145552317|NCT00752232|524879224|FG004|Overall Study|Subject request|0|||
145552318|NCT00752232|524879225|FG005|Overall Study|Subject request|0|||
145552319|NCT00752232|524879226|FG006|Overall Study|Subject request|0|||
145284108|NCT01360632|523889429|FG002|Phase A+|Withdrawal by Subject|0|||
145284109|NCT01360632|523889430|FG003|Phase A+|Withdrawal by Subject|0|||
145284110|NCT01360632|523889431|FG004|Phase A+|Withdrawal by Subject|8|||
145284111|NCT01360632|523889427|FG000|Phase A+|Protocol Deviation|0|||
145552320|NCT00752232|524879220|FG000|Overall Study|Group home admission|0|||
145552321|NCT00752232|524879221|FG001|Overall Study|Group home admission|0|||
145552322|NCT00752232|524879222|FG002|Overall Study|Group home admission|0|||
145552323|NCT00752232|524879223|FG003|Overall Study|Group home admission|1|||
145552324|NCT00752232|524879224|FG004|Overall Study|Group home admission|0|||
145552325|NCT00752232|524879225|FG005|Overall Study|Group home admission|0|||
145552326|NCT00752232|524879226|FG006|Overall Study|Group home admission|0|||
145552327|NCT00752232|524879220|FG000|Overall Study|Caregiver could not attend the subject|0|||
145552328|NCT00752232|524879221|FG001|Overall Study|Caregiver could not attend the subject|0|||
145552329|NCT00752232|524879222|FG002|Overall Study|Caregiver could not attend the subject|0|||
145552330|NCT00752232|524879223|FG003|Overall Study|Caregiver could not attend the subject|0|||
145552331|NCT00752232|524879224|FG004|Overall Study|Caregiver could not attend the subject|1|||
145552332|NCT00752232|524879225|FG005|Overall Study|Caregiver could not attend the subject|0|||
145552333|NCT00752232|524879226|FG006|Overall Study|Caregiver could not attend the subject|0|||
145552334|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
145552335|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
145552336|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
145552337|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
145552338|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
145552339|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
145552340|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
145552341|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
145552342|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
145552343|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
145552344|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Death|2|||
145552345|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Death|1|||
145552346|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Death|4|||
145552347|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Death|0|||
145552348|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Death|0|||
145552349|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
145552350|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
145552351|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
145552352|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
145552353|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
145552354|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Other Reason|1|||
145552355|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Other Reason|3|||
145552356|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Other Reason|2|||
145552357|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Other Reason|0|||
145552358|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Other Reason|0|||
145552359|NCT00555321|524879229|FG000|Treatment Phase up to 12-months|Never treated|2|||
145552360|NCT00555321|524879230|FG001|Treatment Phase up to 12-months|Never treated|3|||
145552361|NCT00555321|524879231|FG002|Treatment Phase up to 12-months|Never treated|1|||
145552362|NCT00555321|524879232|FG003|Treatment Phase up to 12-months|Never treated|0|||
145552363|NCT00555321|524879233|FG004|Treatment Phase up to 12-months|Never treated|4|||
145284112|NCT01360632|523889428|FG001|Phase A+|Protocol Deviation|0|||
145552364|NCT00555321|524879229|FG000|Long-term Extension Phase|Adverse Event|2|||
145552365|NCT00555321|524879230|FG001|Long-term Extension Phase|Adverse Event|5|||
145552366|NCT00555321|524879231|FG002|Long-term Extension Phase|Adverse Event|2|||
145552367|NCT00555321|524879232|FG003|Long-term Extension Phase|Adverse Event|1|||
145552368|NCT00555321|524879233|FG004|Long-term Extension Phase|Adverse Event|0|||
145552369|NCT00555321|524879229|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
145552370|NCT00555321|524879230|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
145552371|NCT00555321|524879231|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
145552372|NCT00555321|524879232|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
145552373|NCT00555321|524879233|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
145552374|NCT00555321|524879229|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
145552375|NCT00555321|524879230|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
145552376|NCT00555321|524879231|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
145552377|NCT00555321|524879232|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
145552378|NCT00555321|524879233|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
145552379|NCT00555321|524879229|FG000|Long-term Extension Phase|Death|2|||
145552380|NCT00555321|524879230|FG001|Long-term Extension Phase|Death|0|||
145552381|NCT00555321|524879231|FG002|Long-term Extension Phase|Death|0|||
145552382|NCT00555321|524879232|FG003|Long-term Extension Phase|Death|3|||
145552383|NCT00555321|524879233|FG004|Long-term Extension Phase|Death|0|||
145552384|NCT00555321|524879229|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
145552385|NCT00555321|524879230|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
145552386|NCT00555321|524879231|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
145552387|NCT00555321|524879232|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
145552388|NCT00555321|524879233|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
145552389|NCT00555321|524879229|FG000|Long-term Extension Phase|Other Reason|1|||
145552390|NCT00555321|524879230|FG001|Long-term Extension Phase|Other Reason|0|||
145552391|NCT00555321|524879231|FG002|Long-term Extension Phase|Other Reason|2|||
145552392|NCT00555321|524879232|FG003|Long-term Extension Phase|Other Reason|0|||
145552393|NCT00555321|524879233|FG004|Long-term Extension Phase|Other Reason|0|||
145552394|NCT00005937|524879234|FG000|Overall Study|Lack of Efficacy|5|||
145552395|NCT01288469|524879235|FG000|Overall Study|Adverse Event|4|||
145552396|NCT01288469|524879236|FG001|Overall Study|Adverse Event|1|||
145552397|NCT01288469|524879237|FG002|Overall Study|Adverse Event|1|||
145552398|NCT01288469|524879235|FG000|Overall Study|Poor compliance to protocol|0|||
145552399|NCT01288469|524879236|FG001|Overall Study|Poor compliance to protocol|1|||
145552400|NCT01288469|524879237|FG002|Overall Study|Poor compliance to protocol|0|||
145552401|NCT01288469|524879235|FG000|Overall Study|Participant Moved|1|||
145552402|NCT01288469|524879236|FG001|Overall Study|Participant Moved|0|||
145552403|NCT01288469|524879237|FG002|Overall Study|Participant Moved|0|||
145552404|NCT01288469|524879235|FG000|Overall Study|Consent withdrawn by subject|1|||
145552405|NCT01288469|524879236|FG001|Overall Study|Consent withdrawn by subject|1|||
145552406|NCT01288469|524879237|FG002|Overall Study|Consent withdrawn by subject|1|||
145552407|NCT01288469|524879235|FG000|Overall Study|Exclusion criteria finally met|1|||
145552408|NCT01288469|524879236|FG001|Overall Study|Exclusion criteria finally met|0|||
145552409|NCT01288469|524879237|FG002|Overall Study|Exclusion criteria finally met|0|||
145552410|NCT01957644|524879241|FG000|Overall Study|Adverse Event|4|||
145552411|NCT01957644|524879242|FG001|Overall Study|Adverse Event|2|||
145552412|NCT01957644|524879243|FG002|Overall Study|Adverse Event|0|||
145552413|NCT01957644|524879244|FG003|Overall Study|Adverse Event|0|||
145552414|NCT01957644|524879245|FG004|Overall Study|Adverse Event|1|||
145552415|NCT01957644|524879241|FG000|Overall Study|Progressive disease / relapse|0|||
145552416|NCT01957644|524879242|FG001|Overall Study|Progressive disease / relapse|1|||
145284113|NCT01360632|523889429|FG002|Phase A+|Protocol Deviation|0|||
145552417|NCT01957644|524879243|FG002|Overall Study|Progressive disease / relapse|0|||
145552418|NCT01957644|524879244|FG003|Overall Study|Progressive disease / relapse|1|||
145552419|NCT01957644|524879245|FG004|Overall Study|Progressive disease / relapse|0|||
145552420|NCT01957644|524879241|FG000|Overall Study|Other reason|1|||
145284114|NCT01360632|523889430|FG003|Phase A+|Protocol Deviation|0|||
145284115|NCT01360632|523889431|FG004|Phase A+|Protocol Deviation|3|||
145284116|NCT01298596|523889432|FG000|Overall Study|Withdrawal by Subject|1|||
145284117|NCT01298596|523889433|FG001|Overall Study|Withdrawal by Subject|1|||
145284118|NCT01298596|523889432|FG000|Overall Study|Death|5|||
145284119|NCT01298596|523889433|FG001|Overall Study|Death|3|||
145284120|NCT01298596|523889432|FG000|Overall Study|Lost to Follow-up|6|||
145284121|NCT01298596|523889433|FG001|Overall Study|Lost to Follow-up|14|||
145284122|NCT01298596|523889432|FG000|Overall Study|Referred for further management|16|||
145284123|NCT01298596|523889433|FG001|Overall Study|Referred for further management|15|||
145284124|NCT04128696|523889434|FG000|Overall Study|Lost to Follow-up|3|||
145284125|NCT04128696|523889435|FG001|Overall Study|Lost to Follow-up|7|||
145552421|NCT01957644|524879242|FG001|Overall Study|Other reason|2|||
145552422|NCT01957644|524879243|FG002|Overall Study|Other reason|1|||
145552423|NCT01957644|524879244|FG003|Overall Study|Other reason|1|||
145552424|NCT01957644|524879245|FG004|Overall Study|Other reason|0|||
145552425|NCT01957644|524879241|FG000|Overall Study|Withdrawal by Subject|1|||
145552426|NCT01957644|524879242|FG001|Overall Study|Withdrawal by Subject|0|||
145552427|NCT01957644|524879243|FG002|Overall Study|Withdrawal by Subject|0|||
145552428|NCT01957644|524879244|FG003|Overall Study|Withdrawal by Subject|0|||
145552429|NCT01957644|524879245|FG004|Overall Study|Withdrawal by Subject|0|||
145552430|NCT01957644|524879241|FG000|Overall Study|Protocol Violation|0|||
145552431|NCT01957644|524879242|FG001|Overall Study|Protocol Violation|1|||
145552432|NCT01957644|524879243|FG002|Overall Study|Protocol Violation|0|||
145552433|NCT01957644|524879244|FG003|Overall Study|Protocol Violation|0|||
145284126|NCT04128696|523889434|FG000|Overall Study|Withdrawal by Subject|12|||
145284127|NCT04128696|523889435|FG001|Overall Study|Withdrawal by Subject|11|||
145552434|NCT01957644|524879245|FG004|Overall Study|Protocol Violation|0|||
145552435|NCT03049280|524879249|FG000|Overall Study|Physician Decision|1|||
145552436|NCT00001723|524879252|FG000|Overall Study|Lack of Efficacy|6|||
145552437|NCT00001723|524879253|FG001|Overall Study|Lack of Efficacy|7|||
145552438|NCT00001723|524879252|FG000|Overall Study|Lack of family interest|4|||
145552439|NCT00001723|524879253|FG001|Overall Study|Lack of family interest|5|||
145552440|NCT00001723|524879252|FG000|Overall Study|Lost to Follow-up|2|||
145552441|NCT00001723|524879253|FG001|Overall Study|Lost to Follow-up|2|||
145552442|NCT00001723|524879252|FG000|Overall Study|medication intolerance|1|||
145552443|NCT00001723|524879253|FG001|Overall Study|medication intolerance|2|||
145552444|NCT02643082|524879254|FG000|Period 1|Adverse Event|1|||
145552445|NCT02643082|524879255|FG001|Period 1|Adverse Event|0|||
145552446|NCT01867021|524879256|FG000|Overall Study|Adverse Event|0|||
145552447|NCT01867021|524879257|FG001|Overall Study|Adverse Event|1|||
145552448|NCT01867021|524879256|FG000|Overall Study|Not Eligible|0|||
145552449|NCT01867021|524879257|FG001|Overall Study|Not Eligible|1|||
145552450|NCT01867021|524879256|FG000|Overall Study|Death|1|||
145552451|NCT01867021|524879257|FG001|Overall Study|Death|0|||
145552452|NCT01867021|524879256|FG000|Overall Study|Lost to Follow-up|0|||
145552453|NCT01867021|524879257|FG001|Overall Study|Lost to Follow-up|2|||
145552454|NCT01867021|524879256|FG000|Overall Study|Withdrawal by Subject|1|||
145552455|NCT01867021|524879257|FG001|Overall Study|Withdrawal by Subject|6|||
145552456|NCT00881712|524879258|FG000|Overall Study|Death|1|||
145552457|NCT00881712|524879259|FG001|Overall Study|Death|0|||
145552458|NCT00881712|524879260|FG002|Overall Study|Death|0|||
145552459|NCT00881712|524879258|FG000|Overall Study|Withdrawal by Subject|1|||
145552460|NCT00881712|524879259|FG001|Overall Study|Withdrawal by Subject|0|||
145552461|NCT00881712|524879260|FG002|Overall Study|Withdrawal by Subject|0|||
145552462|NCT01324999|524879261|FG000|Overall Study|Adverse Event|3|||
145552463|NCT01324999|524879261|FG000|Overall Study|Withdrawal by Subject|2|||
145552464|NCT00640601|524879263|FG000|Overall Study|Adverse Event|43|||
145552465|NCT00640601|524879263|FG000|Overall Study|Withdrawal by Subject|20|||
145552466|NCT00640601|524879263|FG000|Overall Study|Protocol Violation|6|||
145552467|NCT00640601|524879263|FG000|Overall Study|Lack of Efficacy|16|||
145284128|NCT04128696|523889434|FG000|Overall Study|Study Closed/Terminated|26|||
145284129|NCT04128696|523889435|FG001|Overall Study|Study Closed/Terminated|38|||
145284130|NCT04128696|523889434|FG000|Overall Study|Physician Decision|2|||
145284131|NCT04128696|523889435|FG001|Overall Study|Physician Decision|3|||
145284132|NCT02173301|523889436|FG000|Overall Study|Adverse Event|7|||
145284133|NCT02173301|523889437|FG001|Overall Study|Adverse Event|8|||
145284134|NCT02173301|523889438|FG002|Overall Study|Adverse Event|13|||
145552468|NCT00640601|524879263|FG000|Overall Study|Lost to Follow-up|9|||
145284135|NCT02173301|523889439|FG003|Overall Study|Adverse Event|5|||
145284136|NCT02173301|523889436|FG000|Overall Study|Withdrawal by Subject|8|||
145552469|NCT00640601|524879263|FG000|Overall Study|Physician Decision|8|||
145552470|NCT00640601|524879263|FG000|Overall Study|treatment naive, combination therapy|10|||
145552471|NCT03681405|524879264|FG000|Overall Study|Found to be ineligible after randomized|1|||
145552472|NCT03681405|524879265|FG001|Overall Study|Found to be ineligible after randomized|0|||
145552473|NCT03789318|524879271|FG000|Overall Study|Adverse Event|0|||
145284137|NCT02173301|523889437|FG001|Overall Study|Withdrawal by Subject|10|||
145405691|NCT03345004|524341617|FG001|Overall Study|Withdrawal by Subject|1|||
145552474|NCT03789318|524879272|FG001|Overall Study|Adverse Event|0|||
145284138|NCT02173301|523889438|FG002|Overall Study|Withdrawal by Subject|4|||
145284139|NCT02173301|523889439|FG003|Overall Study|Withdrawal by Subject|8|||
145284140|NCT02173301|523889436|FG000|Overall Study|Lost to Follow-up|4|||
145284141|NCT02173301|523889437|FG001|Overall Study|Lost to Follow-up|4|||
145284142|NCT02173301|523889438|FG002|Overall Study|Lost to Follow-up|2|||
145284143|NCT02173301|523889439|FG003|Overall Study|Lost to Follow-up|2|||
145284144|NCT02173301|523889436|FG000|Overall Study|Protocol Violation|0|||
145284145|NCT02173301|523889437|FG001|Overall Study|Protocol Violation|1|||
145284146|NCT02173301|523889438|FG002|Overall Study|Protocol Violation|0|||
145284147|NCT02173301|523889439|FG003|Overall Study|Protocol Violation|0|||
145284148|NCT02173301|523889436|FG000|Overall Study|Physician Decision|0|||
145552475|NCT03789318|524879273|FG002|Overall Study|Adverse Event|1|||
145552476|NCT03789318|524879274|FG003|Overall Study|Adverse Event|1|||
145284149|NCT02173301|523889437|FG001|Overall Study|Physician Decision|0|||
145552477|NCT03789318|524879275|FG004|Overall Study|Adverse Event|0|||
145284150|NCT02173301|523889438|FG002|Overall Study|Physician Decision|1|||
145552478|NCT03789318|524879271|FG000|Overall Study|Lost to Follow-up|0|||
145284151|NCT02173301|523889439|FG003|Overall Study|Physician Decision|0|||
145552479|NCT03789318|524879272|FG001|Overall Study|Lost to Follow-up|0|||
145552480|NCT03789318|524879273|FG002|Overall Study|Lost to Follow-up|1|||
145552481|NCT03789318|524879274|FG003|Overall Study|Lost to Follow-up|0|||
145284152|NCT02173301|523889436|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
145284153|NCT02173301|523889437|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
145284154|NCT02173301|523889438|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
145284155|NCT02173301|523889439|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
145284156|NCT03740100|523889440|FG000|Overall Study|Adverse Event|1|||
145284157|NCT03740100|523889440|FG000|Overall Study|Death|1|||
145284158|NCT03120520|523889441|FG000|Overall Study|Lost to Follow-up|1|||
145284159|NCT03120520|523889442|FG001|Overall Study|Lost to Follow-up|1|||
145284160|NCT03120520|523889443|FG002|Overall Study|Lost to Follow-up|1|||
145284161|NCT03120520|523889444|FG003|Overall Study|Lost to Follow-up|1|||
145284162|NCT03120520|523889441|FG000|Overall Study|Withdrawal by Subject|3|||
145284163|NCT03120520|523889442|FG001|Overall Study|Withdrawal by Subject|2|||
145284164|NCT03120520|523889443|FG002|Overall Study|Withdrawal by Subject|3|||
145284165|NCT03120520|523889444|FG003|Overall Study|Withdrawal by Subject|2|||
145284166|NCT03120520|523889441|FG000|Overall Study|Other|0|||
145284167|NCT03120520|523889442|FG001|Overall Study|Other|1|||
145284168|NCT03120520|523889443|FG002|Overall Study|Other|0|||
145284169|NCT03120520|523889444|FG003|Overall Study|Other|0|||
145284170|NCT02123459|523889448|FG000|Washout Period (1 Day)|Adverse Event|1|||
145284171|NCT02123459|523889449|FG001|Washout Period (1 Day)|Adverse Event|0|||
145284172|NCT03387059|523889454|FG000|Overall Study|Study termination|5|||
145284173|NCT03387059|523889455|FG001|Overall Study|Study termination|4|||
145284174|NCT01606137|523889456|FG000|Overall Study|Adverse Event|85|||
145284175|NCT01606137|523889456|FG000|Overall Study|Withdrawal by Subject|74|||
145284176|NCT01606137|523889456|FG000|Overall Study|Lack of Efficacy|56|||
145284177|NCT01606137|523889456|FG000|Overall Study|Lost to Follow-up|15|||
145284178|NCT01606137|523889456|FG000|Overall Study|Protocol Violation|1|||
145284179|NCT01606137|523889456|FG000|Overall Study|Patient non-compliance|9|||
145284180|NCT01606137|523889456|FG000|Overall Study|Death|1|||
145284181|NCT01606137|523889456|FG000|Overall Study|Decreased/no pain|4|||
145284182|NCT01606137|523889456|FG000|Overall Study|Issues with driving|4|||
145284183|NCT01606137|523889456|FG000|Overall Study|multiple sclerosis less stable|1|||
145552482|NCT03789318|524879275|FG004|Overall Study|Lost to Follow-up|0|||
145284184|NCT01606137|523889456|FG000|Overall Study|Increased bilirubin|1|||
145284185|NCT01606137|523889456|FG000|Overall Study|Spray causes nausea|1|||
145284186|NCT01606137|523889456|FG000|Overall Study|Not enough improvement|4|||
145284187|NCT01606137|523889456|FG000|Overall Study|Wanted to try another treatment|1|||
145284188|NCT01606137|523889456|FG000|Overall Study|Patient leaving country|1|||
145284189|NCT01606137|523889456|FG000|Overall Study|Personal reasons|1|||
145284190|NCT01606137|523889456|FG000|Overall Study|Unable to tolerate study med. taste|1|||
145284191|NCT01606137|523889456|FG000|Overall Study|Patient moving|1|||
145284192|NCT01606137|523889456|FG000|Overall Study|Unable to collect consistent data|1|||
145284193|NCT00254397|523889457|FG000|Overall Study|Disease Progression|4|||
145284194|NCT00254397|523889458|FG001|Overall Study|Disease Progression|1|||
145284195|NCT00254397|523889459|FG002|Overall Study|Disease Progression|16|||
145284196|NCT00254397|523889460|FG003|Overall Study|Disease Progression|23|||
145284197|NCT00254397|523889457|FG000|Overall Study|Non-Compliant|0|||
145284198|NCT00254397|523889458|FG001|Overall Study|Non-Compliant|0|||
145284199|NCT00254397|523889459|FG002|Overall Study|Non-Compliant|0|||
145284200|NCT00254397|523889460|FG003|Overall Study|Non-Compliant|1|||
145284201|NCT00254397|523889457|FG000|Overall Study|Adverse Event|2|||
145284202|NCT00254397|523889458|FG001|Overall Study|Adverse Event|0|||
145284203|NCT00254397|523889459|FG002|Overall Study|Adverse Event|3|||
145284204|NCT00254397|523889460|FG003|Overall Study|Adverse Event|1|||
145284205|NCT00395083|523889462|FG000|Overall Study|Withdrawal by Subject|6|||
145284206|NCT00395083|523889463|FG001|Overall Study|Withdrawal by Subject|5|||
145284207|NCT00395083|523889462|FG000|Overall Study|Developed another disease|4|||
145284208|NCT00395083|523889463|FG001|Overall Study|Developed another disease|3|||
145284209|NCT04136626|523889464|FG000|Treatment Phase|Withdrawal by Subject|1|||
145284210|NCT04136626|523889465|FG001|Treatment Phase|Withdrawal by Subject|9|||
145284211|NCT04136626|523889464|FG000|Treatment Phase|Adverse Event|1|||
145284212|NCT04136626|523889465|FG001|Treatment Phase|Adverse Event|0|||
145284213|NCT04136626|523889464|FG000|Treatment Phase|Lost to Follow-up|1|||
145284214|NCT04136626|523889465|FG001|Treatment Phase|Lost to Follow-up|5|||
145284215|NCT04136626|523889464|FG000|12-month Follow-up|Lost to Follow-up|8|||
145284216|NCT04136626|523889465|FG001|12-month Follow-up|Lost to Follow-up|7|||
145284217|NCT02806232|523891569|FG000|Overall Study|Lost to Follow-up|1|||
145284218|NCT02806232|523891570|FG001|Overall Study|Lost to Follow-up|2|||
145284219|NCT02806232|523891571|FG002|Overall Study|Lost to Follow-up|1|||
145284220|NCT02806232|523891572|FG003|Overall Study|Lost to Follow-up|0|||
145284221|NCT02806232|523891573|FG004|Overall Study|Lost to Follow-up|0|||
145284222|NCT02806232|523891574|FG005|Overall Study|Lost to Follow-up|1|||
145284223|NCT02806232|523891575|FG006|Overall Study|Lost to Follow-up|0|||
145284224|NCT02806232|523891576|FG007|Overall Study|Lost to Follow-up|0|||
145284225|NCT02806232|523891577|FG008|Overall Study|Lost to Follow-up|0|||
145284226|NCT02806232|523891569|FG000|Overall Study|Withdrawal by Subject|0|||
145284227|NCT02806232|523891570|FG001|Overall Study|Withdrawal by Subject|2|||
145284228|NCT02806232|523891571|FG002|Overall Study|Withdrawal by Subject|0|||
145284229|NCT02806232|523891572|FG003|Overall Study|Withdrawal by Subject|0|||
145284230|NCT02806232|523891573|FG004|Overall Study|Withdrawal by Subject|2|||
145284231|NCT02806232|523891574|FG005|Overall Study|Withdrawal by Subject|1|||
145284232|NCT02806232|523891575|FG006|Overall Study|Withdrawal by Subject|0|||
145284233|NCT02806232|523891576|FG007|Overall Study|Withdrawal by Subject|0|||
145284234|NCT02806232|523891577|FG008|Overall Study|Withdrawal by Subject|0|||
145284235|NCT01133821|523891578|FG000|Overall Study|Lost to Follow-up|8|||
145284236|NCT01133821|523891579|FG001|Overall Study|Lost to Follow-up|11|||
145284237|NCT01133821|523891578|FG000|Overall Study|Withdrawal by Subject|8|||
145284238|NCT01133821|523891579|FG001|Overall Study|Withdrawal by Subject|3|||
145284239|NCT01133821|523891578|FG000|Overall Study|preferred other treatment|1|||
145284240|NCT01133821|523891579|FG001|Overall Study|preferred other treatment|1|||
145284241|NCT01133821|523891578|FG000|Overall Study|Protocol Violation|0|||
145284242|NCT01133821|523891579|FG001|Overall Study|Protocol Violation|1|||
145284243|NCT01133821|523891578|FG000|Overall Study|Refused participation|1|||
145284244|NCT01133821|523891579|FG001|Overall Study|Refused participation|3|||
145284245|NCT03342898|523891582|FG000|Overall Study|Adverse Event|3|||
145284246|NCT03342898|523891583|FG001|Overall Study|Adverse Event|1|||
145284247|NCT03342898|523891584|FG002|Overall Study|Adverse Event|0|||
145284248|NCT03342898|523891582|FG000|Overall Study|Lost to Follow-up|44|||
145284249|NCT03342898|523891583|FG001|Overall Study|Lost to Follow-up|40|||
145552483|NCT03789318|524879271|FG000|Overall Study|Withdrawal by Subject|0|||
145552484|NCT03789318|524879272|FG001|Overall Study|Withdrawal by Subject|0|||
145284250|NCT03342898|523891584|FG002|Overall Study|Lost to Follow-up|42|||
145284251|NCT03342898|523891582|FG000|Overall Study|Withdrawal of Consent|5|||
145284252|NCT03342898|523891583|FG001|Overall Study|Withdrawal of Consent|9|||
145284253|NCT03342898|523891584|FG002|Overall Study|Withdrawal of Consent|11|||
145284254|NCT03342898|523891582|FG000|Overall Study|Death|0|||
145284255|NCT03342898|523891583|FG001|Overall Study|Death|1|||
145284256|NCT03342898|523891584|FG002|Overall Study|Death|1|||
145284257|NCT03342898|523891582|FG000|Overall Study|Reason not Specified|2|||
145284258|NCT03342898|523891583|FG001|Overall Study|Reason not Specified|2|||
145552485|NCT03789318|524879273|FG002|Overall Study|Withdrawal by Subject|1|||
145552486|NCT03789318|524879274|FG003|Overall Study|Withdrawal by Subject|0|||
145552487|NCT03789318|524879275|FG004|Overall Study|Withdrawal by Subject|0|||
145552488|NCT00733408|524881214|FG000|Overall Study|Adverse Event|4|||
145552489|NCT00531232|524881215|FG000|Overall Study|Investigator decision|0|||
145552490|NCT00531232|524881216|FG001|Overall Study|Investigator decision|0|||
145552491|NCT00531232|524881217|FG002|Overall Study|Investigator decision|4|||
145552492|NCT00531232|524881215|FG000|Overall Study|Participants refused further treatment|0|||
145552493|NCT00531232|524881216|FG001|Overall Study|Participants refused further treatment|1|||
145552494|NCT00531232|524881217|FG002|Overall Study|Participants refused further treatment|2|||
145552495|NCT00531232|524881215|FG000|Overall Study|Adverse events (AEs)|1|||
145552496|NCT00531232|524881216|FG001|Overall Study|Adverse events (AEs)|2|||
145552497|NCT00531232|524881217|FG002|Overall Study|Adverse events (AEs)|2|||
145552498|NCT00531232|524881215|FG000|Overall Study|Treatment failure|1|||
145552499|NCT00531232|524881216|FG001|Overall Study|Treatment failure|3|||
145552500|NCT00531232|524881217|FG002|Overall Study|Treatment failure|7|||
145552501|NCT00531232|524881215|FG000|Overall Study|Disease recurrence|0|||
145552502|NCT00531232|524881216|FG001|Overall Study|Disease recurrence|0|||
145552503|NCT00531232|524881217|FG002|Overall Study|Disease recurrence|1|||
145552504|NCT00531232|524881215|FG000|Overall Study|Deceased|2|||
145552505|NCT00531232|524881216|FG001|Overall Study|Deceased|2|||
145552506|NCT00531232|524881217|FG002|Overall Study|Deceased|2|||
145552507|NCT00531232|524881215|FG000|Overall Study|Withdrawal by Subject|0|||
145552508|NCT00531232|524881216|FG001|Overall Study|Withdrawal by Subject|1|||
145552509|NCT00531232|524881217|FG002|Overall Study|Withdrawal by Subject|2|||
145552510|NCT00531232|524881215|FG000|Overall Study|Other|0|||
145552511|NCT00531232|524881216|FG001|Overall Study|Other|0|||
145552512|NCT00531232|524881217|FG002|Overall Study|Other|5|||
145552513|NCT04232124|524881218|FG000|Overall Study|Lost to Follow-up|3|||
145552514|NCT02329730|524881222|FG000|Overall Study|Protocol Violation|0|||
145552515|NCT02329730|524881223|FG001|Overall Study|Protocol Violation|0|||
145552516|NCT02329730|524881224|FG002|Overall Study|Protocol Violation|0|||
145552517|NCT02329730|524881225|FG003|Overall Study|Protocol Violation|0|||
145552518|NCT02329730|524881226|FG004|Overall Study|Protocol Violation|2|||
145552519|NCT02329730|524881227|FG005|Overall Study|Protocol Violation|2|||
145552520|NCT02329730|524881228|FG006|Overall Study|Protocol Violation|0|||
145552521|NCT02329730|524881229|FG007|Overall Study|Protocol Violation|0|||
145552522|NCT02329730|524881230|FG008|Overall Study|Protocol Violation|0|||
145552523|NCT02329730|524881231|FG009|Overall Study|Protocol Violation|0|||
145552524|NCT02329730|524881232|FG010|Overall Study|Protocol Violation|0|||
145552525|NCT02329730|524881233|FG011|Overall Study|Protocol Violation|0|||
145552526|NCT02329730|524881222|FG000|Overall Study|Withdrawal by Subject|0|||
145552527|NCT02329730|524881223|FG001|Overall Study|Withdrawal by Subject|0|||
145552528|NCT02329730|524881224|FG002|Overall Study|Withdrawal by Subject|0|||
145552529|NCT02329730|524881225|FG003|Overall Study|Withdrawal by Subject|0|||
145552530|NCT02329730|524881226|FG004|Overall Study|Withdrawal by Subject|1|||
145552531|NCT02329730|524881227|FG005|Overall Study|Withdrawal by Subject|0|||
145552532|NCT02329730|524881228|FG006|Overall Study|Withdrawal by Subject|1|||
145552533|NCT02329730|524881229|FG007|Overall Study|Withdrawal by Subject|1|||
145552534|NCT02329730|524881230|FG008|Overall Study|Withdrawal by Subject|1|||
145552535|NCT02329730|524881231|FG009|Overall Study|Withdrawal by Subject|1|||
145552536|NCT02329730|524881232|FG010|Overall Study|Withdrawal by Subject|0|||
145552537|NCT02329730|524881233|FG011|Overall Study|Withdrawal by Subject|0|||
145552538|NCT02345850|524881236|FG000|Overall Study|Not transplanted|10|||
145552539|NCT02345850|524881237|FG001|Overall Study|Not transplanted|5|||
145552540|NCT02345850|524881238|FG002|Overall Study|Not transplanted|4|||
145552541|NCT02345850|524881236|FG000|Overall Study|Lost to Follow-up|2|||
145552542|NCT02345850|524881237|FG001|Overall Study|Lost to Follow-up|3|||
145552543|NCT02345850|524881238|FG002|Overall Study|Lost to Follow-up|2|||
145552544|NCT02345850|524881236|FG000|Overall Study|Withdrawal by Subject|1|||
145552545|NCT02345850|524881237|FG001|Overall Study|Withdrawal by Subject|0|||
145552546|NCT02345850|524881238|FG002|Overall Study|Withdrawal by Subject|0|||
145552547|NCT02392247|524881239|FG000|Overall Study|Withdrawal by Subject|1|||
145552548|NCT02392247|524881239|FG000|Overall Study|Surgery cancelled; no data|1|||
145552549|NCT01991067|524881241|FG000|Overall Study|Lost to Follow-up|6|||
145552550|NCT01991067|524881242|FG001|Overall Study|Lost to Follow-up|5|||
145552551|NCT02068443|524881245|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145552552|NCT02068443|524881246|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
145552553|NCT02068443|524881247|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
145552554|NCT02068443|524881245|FG000|Overall Study|Voluntary Withdrawal|4|||
145552555|NCT02068443|524881246|FG001|Overall Study|Voluntary Withdrawal|0|||
145552556|NCT02068443|524881247|FG002|Overall Study|Voluntary Withdrawal|1|||
145552557|NCT02068443|524881245|FG000|Overall Study|Lack of Efficacy|2|||
145552558|NCT02068443|524881246|FG001|Overall Study|Lack of Efficacy|1|||
145552559|NCT02068443|524881247|FG002|Overall Study|Lack of Efficacy|0|||
145552560|NCT02068443|524881245|FG000|Overall Study|Other Reason Not Specified|1|||
145552561|NCT02068443|524881246|FG001|Overall Study|Other Reason Not Specified|0|||
145552562|NCT02068443|524881247|FG002|Overall Study|Other Reason Not Specified|0|||
145552563|NCT00664742|524881248|FG000|Overall Study|Withdrawn due to adverse events|3|||
145552564|NCT00664742|524881248|FG000|Overall Study|Withdrawal by Subject|31|||
145552565|NCT00664742|524881248|FG000|Overall Study|Lost to Follow-up|92|||
145552566|NCT04317066|524881249|FG000|Overall Study|Sponsor decision|5|||
145552567|NCT04317066|524881249|FG000|Overall Study|Death|2|||
145552568|NCT02014597|524881252|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
145552569|NCT02014597|524881253|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
145552570|NCT02825992|524881254|FG000|Overall Study|Withdrawal by Subject|4|||
145552571|NCT02825992|524881254|FG000|Overall Study|Lost to Follow-up|2|||
145552572|NCT02825992|524881254|FG000|Overall Study|Procedure terminated|2|||
145552573|NCT02279173|524881255|FG000|Overall Study|Protocol-specified Criteria|67|||
145552574|NCT02279173|524881255|FG000|Overall Study|Withdrawal by Subject|20|||
145552575|NCT02279173|524881255|FG000|Overall Study|Decision by Sponsor|4|||
145552576|NCT02279173|524881255|FG000|Overall Study|Lost to Follow-up|3|||
145552577|NCT01164956|524881256|FG000|Overall Study|Side Effects|1|||
145552578|NCT01164956|524881257|FG001|Overall Study|Side Effects|0|||
145552579|NCT01164956|524881258|FG002|Overall Study|Side Effects|1|||
145552580|NCT00931762|524881259|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
145552581|NCT00931762|524881259|FG000|Overall Study|Administrative Problems|5|||
145552582|NCT00931762|524881259|FG000|Overall Study|Death|1|||
145552583|NCT00931762|524881259|FG000|Overall Study|Disease Progression|3|||
145552584|NCT00931762|524881259|FG000|Overall Study|Adverse Event (s)|11|||
145611409|NCT01928225|525092697|FG001|Overall Study|basaloid cervical cancer|0|||
145284259|NCT03342898|523891584|FG002|Overall Study|Reason not Specified|0|||
145284260|NCT01387282|523891585|FG000|Overall Study|Death|47|||
145284261|NCT01387282|523891586|FG001|Overall Study|Death|16|||
145284262|NCT01387282|523891585|FG000|Overall Study|Other|5|||
145284263|NCT01387282|523891586|FG001|Overall Study|Other|1|||
145284264|NCT01387282|523891585|FG000|Overall Study|Unrelated AE|6|||
145284265|NCT01387282|523891586|FG001|Overall Study|Unrelated AE|4|||
145284266|NCT01387282|523891585|FG000|Overall Study|Withdrawal by patient|33|||
145284267|NCT01387282|523891586|FG001|Overall Study|Withdrawal by patient|23|||
145284268|NCT01387282|523891585|FG000|Overall Study|Study drug-related AE|2|||
145284269|NCT01387282|523891586|FG001|Overall Study|Study drug-related AE|2|||
145284270|NCT01387282|523891585|FG000|Overall Study|Lost to Follow-up|4|||
145284271|NCT01387282|523891586|FG001|Overall Study|Lost to Follow-up|1|||
145284272|NCT03997448|523891589|FG000|Study Treatment|Disease Progression|1|||
145284273|NCT03997448|523891589|FG000|Study Treatment|Symptomatic Deterioration|1|||
145284274|NCT03997448|523891589|FG000|Follow up|Death|2|||
145284275|NCT03997448|523891589|FG000|Follow up|study terminated|1|||
145284276|NCT01621490|523891590|FG000|Overall Study|Subject no longer meets study criteria|0|||
145284277|NCT01621490|523891591|FG001|Overall Study|Subject no longer meets study criteria|0|||
145284278|NCT01621490|523891592|FG002|Overall Study|Subject no longer meets study criteria|0|||
145284279|NCT01621490|523891593|FG003|Overall Study|Subject no longer meets study criteria|0|||
145284280|NCT01621490|523891594|FG004|Overall Study|Subject no longer meets study criteria|1|||
145284281|NCT01621490|523891595|FG005|Overall Study|Subject no longer meets study criteria|0|||
145611410|NCT01928225|525092696|FG000|Overall Study|Lost to Follow-up|1|||
145284282|NCT01621490|523891596|FG006|Overall Study|Subject no longer meets study criteria|0|||
145552585|NCT00931762|524881259|FG000|Overall Study|Subject withdrew consent|13|||
145284283|NCT01621490|523891597|FG007|Overall Study|Subject no longer meets study criteria|0|||
145284284|NCT01621490|523891598|FG008|Overall Study|Subject no longer meets study criteria|0|||
145284285|NCT01621490|523891599|FG009|Overall Study|Subject no longer meets study criteria|0|||
145284286|NCT01621490|523891600|FG010|Overall Study|Subject no longer meets study criteria|0|||
145284287|NCT01621490|523891590|FG000|Overall Study|Maximum clinical benefit|3|||
145611411|NCT01928225|525092697|FG001|Overall Study|Lost to Follow-up|3|||
145552586|NCT01356966|524881260|FG000|Overall Study|Withdrawal by Subject|1|||
145552587|NCT01356966|524881261|FG001|Overall Study|Withdrawal by Subject|2|||
145552588|NCT01356966|524881260|FG000|Overall Study|Physician Decision|1|||
145552589|NCT01356966|524881261|FG001|Overall Study|Physician Decision|0|||
145552590|NCT02618434|524881262|FG000|Overall Study|Withdrawal by Subject|0|||
145552591|NCT02618434|524881263|FG001|Overall Study|Withdrawal by Subject|2|||
145552592|NCT02618434|524881264|FG002|Overall Study|Withdrawal by Subject|3|||
145552593|NCT02618434|524881262|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
145552594|NCT02618434|524881263|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
145552595|NCT02618434|524881264|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
145552596|NCT02618434|524881262|FG000|Overall Study|Lost to Follow-up|3|||
145552597|NCT02618434|524881263|FG001|Overall Study|Lost to Follow-up|1|||
145552598|NCT02618434|524881264|FG002|Overall Study|Lost to Follow-up|3|||
145552599|NCT02618434|524881262|FG000|Overall Study|Adverse Event|1|||
145552600|NCT02618434|524881263|FG001|Overall Study|Adverse Event|0|||
145552601|NCT02618434|524881264|FG002|Overall Study|Adverse Event|12|||
145552602|NCT02618434|524881262|FG000|Overall Study|Physician Decision|0|||
145552603|NCT02618434|524881263|FG001|Overall Study|Physician Decision|1|||
145552604|NCT02618434|524881264|FG002|Overall Study|Physician Decision|0|||
145552605|NCT02618434|524881262|FG000|Overall Study|Protocol Violation|0|||
145552606|NCT02618434|524881263|FG001|Overall Study|Protocol Violation|0|||
145552607|NCT02618434|524881264|FG002|Overall Study|Protocol Violation|1|||
145552608|NCT02618434|524881262|FG000|Overall Study|Other, Multiple categories|1|||
145552609|NCT02618434|524881263|FG001|Overall Study|Other, Multiple categories|1|||
145552610|NCT02618434|524881264|FG002|Overall Study|Other, Multiple categories|1|||
145552611|NCT02066233|524881265|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
145552612|NCT02066233|524881266|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
145552613|NCT00103142|524881267|FG000|Overall Study|Adverse Event|1|||
145552614|NCT00103142|524881268|FG001|Overall Study|Adverse Event|0|||
145552615|NCT00103142|524881267|FG000|Overall Study|Progression of disease|2|||
145552616|NCT00103142|524881268|FG001|Overall Study|Progression of disease|1|||
145552617|NCT02772081|524881269|FG000|Overall Study|Physician Decision|1|||
145552618|NCT02772081|524881270|FG001|Overall Study|Physician Decision|1|||
145552619|NCT02772081|524881269|FG000|Overall Study|Death|1|||
145552620|NCT02772081|524881270|FG001|Overall Study|Death|1|||
145552621|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Death|3|||
145552622|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Death|3|||
145552623|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Death|0|||
145552624|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Death|0|||
145552625|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
145552626|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
145552627|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
145552628|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
145552629|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
145552630|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
145552631|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
145552632|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
145552633|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
145552634|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
145552635|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
145552636|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
145552637|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
145552638|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
145552639|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
145552640|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
145552641|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
145552642|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
145552643|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
145552644|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
145552645|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
145552646|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
145552647|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
145552648|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
145552649|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Other|6|||
145552650|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Other|3|||
145552651|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Other|0|||
145552652|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Other|0|||
145284288|NCT01621490|523891591|FG001|Overall Study|Maximum clinical benefit|2|||
145284289|NCT01621490|523891592|FG002|Overall Study|Maximum clinical benefit|0|||
145284290|NCT01621490|523891593|FG003|Overall Study|Maximum clinical benefit|0|||
145284291|NCT01621490|523891594|FG004|Overall Study|Maximum clinical benefit|0|||
145284292|NCT01621490|523891595|FG005|Overall Study|Maximum clinical benefit|0|||
145284293|NCT01621490|523891596|FG006|Overall Study|Maximum clinical benefit|1|||
145284294|NCT01621490|523891597|FG007|Overall Study|Maximum clinical benefit|2|||
145284295|NCT01621490|523891598|FG008|Overall Study|Maximum clinical benefit|2|||
145284296|NCT01621490|523891599|FG009|Overall Study|Maximum clinical benefit|0|||
145284297|NCT01621490|523891600|FG010|Overall Study|Maximum clinical benefit|0|||
145552653|NCT02051608|524881277|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
145552654|NCT02051608|524881278|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
145552655|NCT02051608|524881279|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
145552656|NCT02051608|524881280|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
145552657|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Adverse Event|0|||
145552658|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Adverse Event|0|||
145552659|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Adverse Event|6|||
145552660|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Adverse Event|8|||
145552661|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Death|0|||
145552662|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Death|0|||
145552663|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Death|7|||
145552664|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Death|4|||
145552665|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
145552666|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
145552667|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
145552668|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
145552669|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
145552670|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
145552671|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
145552672|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
145552673|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145552674|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145552675|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
145552676|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
145552677|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
145552678|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
145552679|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
145552680|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
145552681|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Physician Decision|0|||
145552682|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Physician Decision|0|||
145552683|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Physician Decision|8|||
145552684|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Physician Decision|5|||
145552685|NCT02051608|524881277|FG000|Part 2: Open-label Extension|Other|0|||
145284298|NCT01621490|523891590|FG000|Overall Study|Withdrawal by Subject|1|||
145284299|NCT01621490|523891591|FG001|Overall Study|Withdrawal by Subject|0|||
145284300|NCT01621490|523891592|FG002|Overall Study|Withdrawal by Subject|0|||
145284301|NCT01621490|523891593|FG003|Overall Study|Withdrawal by Subject|0|||
145284302|NCT01621490|523891594|FG004|Overall Study|Withdrawal by Subject|0|||
145284303|NCT01621490|523891595|FG005|Overall Study|Withdrawal by Subject|1|||
145552686|NCT02051608|524881278|FG001|Part 2: Open-label Extension|Other|0|||
145552687|NCT02051608|524881279|FG002|Part 2: Open-label Extension|Other|9|||
145552688|NCT02051608|524881280|FG003|Part 2: Open-label Extension|Other|9|||
145552689|NCT01083576|524881281|FG000|Overall Study|Treatment Failure|6|||
145552690|NCT01083576|524881282|FG001|Overall Study|Treatment Failure|1|||
145552691|NCT01986985|524881285|FG000|Overall Study|Withdrawal by Subject|4|||
145552692|NCT01986985|524881285|FG000|Overall Study|Scan not completed due to malfunction|3|||
145552693|NCT02005445|524881286|FG000|Overall Study|Dual study enrollment|0|||
145552694|NCT02005445|524881287|FG001|Overall Study|Dual study enrollment|1|||
145552695|NCT02709785|524881291|FG000|Overall Study|Withdrawal by Subject|1|||
145552696|NCT02709785|524881292|FG001|Overall Study|Withdrawal by Subject|2|||
145552697|NCT02709785|524881293|FG002|Overall Study|Withdrawal by Subject|1|||
145552698|NCT01961323|524881294|FG000|Overall Study|Withdrawal by Subject|7|||
145552699|NCT01961323|524881294|FG000|Overall Study|Lost to Follow-up|8|||
145552700|NCT01961323|524881294|FG000|Overall Study|screen failure|34|||
145552701|NCT01881776|524881296|FG000|Overall Study|Lost to Follow-up|1|||
145552702|NCT01881776|524881297|FG001|Overall Study|Lost to Follow-up|2|||
145552703|NCT01881776|524881298|FG002|Overall Study|Lost to Follow-up|1|||
145552704|NCT01881776|524881296|FG000|Overall Study|Protocol Violation|0|||
145552705|NCT01881776|524881297|FG001|Overall Study|Protocol Violation|2|||
145552706|NCT01881776|524881298|FG002|Overall Study|Protocol Violation|1|||
145552707|NCT02320149|524881299|FG000|Overall Study|Adverse Event|3|||
145552708|NCT02320149|524881300|FG001|Overall Study|Adverse Event|7|||
145552709|NCT02320149|524881299|FG000|Overall Study|Withdrawal of Consent|28|||
145552710|NCT02320149|524881300|FG001|Overall Study|Withdrawal of Consent|32|||
145552711|NCT02320149|524881299|FG000|Overall Study|Lost to Follow-up|21|||
145552712|NCT02320149|524881300|FG001|Overall Study|Lost to Follow-up|34|||
145552713|NCT02320149|524881299|FG000|Overall Study|Protocol Violation|2|||
145552714|NCT02320149|524881300|FG001|Overall Study|Protocol Violation|1|||
145552715|NCT02320149|524881299|FG000|Overall Study|Noncompliance with Study Treatment|7|||
145552716|NCT02320149|524881300|FG001|Overall Study|Noncompliance with Study Treatment|2|||
145552717|NCT02320149|524881299|FG000|Overall Study|Lack of Efficacy|0|||
145552718|NCT02320149|524881300|FG001|Overall Study|Lack of Efficacy|1|||
145552719|NCT02320149|524881299|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145552720|NCT02320149|524881300|FG001|Overall Study|Other Miscellaneous Reasons|3|||
145552721|NCT00022633|524881301|FG000|Overall Study|Adverse Event|11|||
145552722|NCT00022633|524881302|FG001|Overall Study|Adverse Event|1|||
145552723|NCT00022633|524881301|FG000|Overall Study|Refusal unrelated to adverse event|1|||
145552724|NCT00022633|524881302|FG001|Overall Study|Refusal unrelated to adverse event|0|||
145552725|NCT00022633|524881301|FG000|Overall Study|Progression/relapse|9|||
145552726|NCT00022633|524881302|FG001|Overall Study|Progression/relapse|2|||
145552727|NCT00022633|524881301|FG000|Overall Study|Death|4|||
145552728|NCT00022633|524881302|FG001|Overall Study|Death|0|||
145552729|NCT00022633|524881301|FG000|Overall Study|Other - not protocol specified|3|||
145552730|NCT00022633|524881302|FG001|Overall Study|Other - not protocol specified|2|||
145552731|NCT00022633|524881301|FG000|Overall Study|Ineligible|4|||
145552732|NCT00022633|524881302|FG001|Overall Study|Ineligible|0|||
145552733|NCT06133348|524881303|FG000|Overall Study|Death|3|||
145552734|NCT06133348|524881303|FG000|Overall Study|Lost to Follow-up|1|||
145552735|NCT06133348|524881303|FG000|Overall Study|Physician Decision|1|||
145552736|NCT06133348|524881303|FG000|Overall Study|Withdrawal by Subject|5|||
145552737|NCT00487747|524881304|FG000|Overall Study|Adverse Event|1|||
145552738|NCT00487747|524881304|FG000|Overall Study|Lost to Follow-up|9|||
145552739|NCT00487747|524881304|FG000|Overall Study|Lack of Efficacy|1|||
145552740|NCT01359449|524881305|FG000|Overall Study|Lost to Follow-up|1|||
145552741|NCT01359449|524881306|FG001|Overall Study|Lost to Follow-up|0|||
145552742|NCT01359449|524881305|FG000|Overall Study|Protocol Violation|0|||
145552743|NCT01359449|524881306|FG001|Overall Study|Protocol Violation|2|||
145552744|NCT01359449|524881305|FG000|Overall Study|Withdrawal by Subject|3|||
145552745|NCT01359449|524881306|FG001|Overall Study|Withdrawal by Subject|2|||
145552746|NCT02036294|524881307|FG000|Overall Study|Death|7|||
145552747|NCT02036294|524881308|FG001|Overall Study|Death|8|||
145552748|NCT02036294|524881307|FG000|Overall Study|Withdrawal by Subject|2|||
145552749|NCT02036294|524881308|FG001|Overall Study|Withdrawal by Subject|3|||
145552750|NCT00429104|524881311|FG000|Overall Study|Protocol Violation|1|||
145552751|NCT01907815|524881312|FG000|Overall Study|Withdrawal by Subject|1|||
145552752|NCT01907815|524881313|FG001|Overall Study|Withdrawal by Subject|0|||
145552753|NCT04997161|524881314|FG000|Overall Study|Study terminated by sponsor|3|||
145552754|NCT02485574|524881320|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
145611412|NCT00854295|525092698|FG000|Overall Study|Death|7|||
145405692|NCT01013753|524341620|FG000|Overall Study|Adverse Event|8|||
145552755|NCT01408914|524881322|FG000|Overall Study|Could not complete tx in protocol period|5|||
145552756|NCT01408914|524881323|FG001|Overall Study|Could not complete tx in protocol period|5|||
145552757|NCT01408914|524881324|FG002|Overall Study|Could not complete tx in protocol period|6|||
145552758|NCT01408914|524881322|FG000|Overall Study|Lost to Follow-up|4|||
145552759|NCT01408914|524881323|FG001|Overall Study|Lost to Follow-up|1|||
145552760|NCT01408914|524881324|FG002|Overall Study|Lost to Follow-up|2|||
145552761|NCT01408914|524881322|FG000|Overall Study|Physician Decision|1|||
145552762|NCT01408914|524881323|FG001|Overall Study|Physician Decision|1|||
145552763|NCT01408914|524881324|FG002|Overall Study|Physician Decision|0|||
145552764|NCT01408914|524881322|FG000|Overall Study|Withdrawal by Subject|1|||
145552765|NCT01408914|524881323|FG001|Overall Study|Withdrawal by Subject|0|||
145552766|NCT01408914|524881324|FG002|Overall Study|Withdrawal by Subject|1|||
145552767|NCT01408914|524881322|FG000|Overall Study|Moved out of study jurisdiction|1|||
145552768|NCT01408914|524881323|FG001|Overall Study|Moved out of study jurisdiction|1|||
145611413|NCT00854295|525092699|FG001|Overall Study|Death|0|||
145284304|NCT01621490|523891596|FG006|Overall Study|Withdrawal by Subject|0|||
145405693|NCT01013753|524341620|FG000|Overall Study|Protocol Violation|3|||
145405694|NCT01013753|524341620|FG000|Overall Study|Lost to Follow-up|1|||
145405695|NCT01013753|524341620|FG000|Overall Study|Withdrawal by Subject|2|||
145552769|NCT01408914|524881324|FG002|Overall Study|Moved out of study jurisdiction|0|||
145552770|NCT01408914|524881322|FG000|Overall Study|Late exclusion|0|||
145552771|NCT01408914|524881323|FG001|Overall Study|Late exclusion|3|||
145405696|NCT01013753|524341620|FG000|Overall Study|Other|2|||
145405697|NCT04757636|524341621|FG000|Overall Study|Adverse Event|25|||
145405698|NCT04757636|524341622|FG001|Overall Study|Adverse Event|8|||
145405699|NCT04757636|524341623|FG002|Overall Study|Adverse Event|11|||
145405700|NCT04757636|524341621|FG000|Overall Study|Death|9|||
145405701|NCT04757636|524341622|FG001|Overall Study|Death|12|||
145405702|NCT04757636|524341623|FG002|Overall Study|Death|6|||
145405703|NCT04757636|524341621|FG000|Overall Study|Lack of Efficacy|2|||
145405704|NCT04757636|524341622|FG001|Overall Study|Lack of Efficacy|0|||
145405705|NCT04757636|524341623|FG002|Overall Study|Lack of Efficacy|0|||
145405706|NCT04757636|524341621|FG000|Overall Study|Lost to Follow-up|1|||
145405707|NCT04757636|524341622|FG001|Overall Study|Lost to Follow-up|6|||
145405708|NCT04757636|524341623|FG002|Overall Study|Lost to Follow-up|7|||
145405709|NCT04757636|524341621|FG000|Overall Study|Physician Decision|1|||
145405710|NCT04757636|524341622|FG001|Overall Study|Physician Decision|3|||
145405711|NCT04757636|524341623|FG002|Overall Study|Physician Decision|4|||
145405712|NCT04757636|524341621|FG000|Overall Study|Withdrawal by Subject|20|||
145405713|NCT04757636|524341622|FG001|Overall Study|Withdrawal by Subject|23|||
145405714|NCT04757636|524341623|FG002|Overall Study|Withdrawal by Subject|18|||
145405715|NCT04757636|524341621|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
145405716|NCT04757636|524341622|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
145405717|NCT04757636|524341623|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
145552772|NCT01408914|524881324|FG002|Overall Study|Late exclusion|3|||
145552773|NCT01408914|524881322|FG000|Overall Study|Change in local TB/HIV norms|0|||
145552774|NCT01408914|524881323|FG001|Overall Study|Change in local TB/HIV norms|1|||
145552775|NCT01408914|524881324|FG002|Overall Study|Change in local TB/HIV norms|1|||
145552776|NCT04044716|524881329|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
145552777|NCT04044716|524881330|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
145552778|NCT04044716|524881331|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
145284305|NCT01621490|523891597|FG007|Overall Study|Withdrawal by Subject|0|||
145284306|NCT01621490|523891598|FG008|Overall Study|Withdrawal by Subject|0|||
145284307|NCT01621490|523891599|FG009|Overall Study|Withdrawal by Subject|0|||
145284308|NCT01621490|523891600|FG010|Overall Study|Withdrawal by Subject|0|||
145284309|NCT01621490|523891590|FG000|Overall Study|Subject request to discontinue study|1|||
145552779|NCT04044716|524881329|FG000|Overall Study|Lost to Follow-up|2|||
145552780|NCT04044716|524881330|FG001|Overall Study|Lost to Follow-up|3|||
145552781|NCT04044716|524881331|FG002|Overall Study|Lost to Follow-up|0|||
145552782|NCT01957553|524881332|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
145552783|NCT01957553|524881333|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
145552784|NCT01957553|524881332|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
145552785|NCT01957553|524881333|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
145611414|NCT00854295|525092700|FG002|Overall Study|Death|1|||
145611415|NCT00854295|525092701|FG003|Overall Study|Death|1|||
145611416|NCT00854295|525092698|FG000|Overall Study|Adverse Event|6|||
145611417|NCT00854295|525092699|FG001|Overall Study|Adverse Event|1|||
145405718|NCT04757636|524341621|FG000|Overall Study|Study Terminated by Sponsor|103|||
145405719|NCT04757636|524341622|FG001|Overall Study|Study Terminated by Sponsor|104|||
145405720|NCT04757636|524341623|FG002|Overall Study|Study Terminated by Sponsor|114|||
145405721|NCT04757636|524341621|FG000|Overall Study|Sponsor Decision|0|||
145552786|NCT01957553|524881332|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
145552787|NCT01957553|524881333|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
145552788|NCT01957553|524881332|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
145552789|NCT01957553|524881333|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
145552790|NCT01957553|524881332|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
145552791|NCT01957553|524881333|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
145552792|NCT01957553|524881332|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
145552793|NCT01957553|524881333|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
145552794|NCT01957553|524881332|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
145552795|NCT01957553|524881333|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
145552796|NCT01957553|524881332|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
145552797|NCT01957553|524881333|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
145552798|NCT01957553|524881332|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
145552799|NCT01957553|524881333|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
145552800|NCT02733367|524881334|FG000|Overall Study|Withdrawal by Subject|6|||
145552801|NCT01348347|524881335|FG000|Overall Study|Withdrawal by Subject|1|||
145405722|NCT04757636|524341622|FG001|Overall Study|Sponsor Decision|0|||
145405723|NCT04757636|524341623|FG002|Overall Study|Sponsor Decision|1|||
145405724|NCT04757636|524341621|FG000|Overall Study|Randomized in Error|0|||
145405725|NCT04757636|524341622|FG001|Overall Study|Randomized in Error|0|||
145552802|NCT01348347|524881336|FG001|Overall Study|Withdrawal by Subject|1|||
145284310|NCT01621490|523891591|FG001|Overall Study|Subject request to discontinue study|3|||
145284311|NCT01621490|523891592|FG002|Overall Study|Subject request to discontinue study|1|||
145284312|NCT01621490|523891593|FG003|Overall Study|Subject request to discontinue study|1|||
145284313|NCT01621490|523891594|FG004|Overall Study|Subject request to discontinue study|0|||
145284314|NCT01621490|523891595|FG005|Overall Study|Subject request to discontinue study|2|||
145284315|NCT01621490|523891596|FG006|Overall Study|Subject request to discontinue study|1|||
145284316|NCT01621490|523891597|FG007|Overall Study|Subject request to discontinue study|0|||
145284317|NCT01621490|523891598|FG008|Overall Study|Subject request to discontinue study|1|||
145284318|NCT01621490|523891599|FG009|Overall Study|Subject request to discontinue study|0|||
145284319|NCT01621490|523891600|FG010|Overall Study|Subject request to discontinue study|0|||
145284320|NCT01621490|523891590|FG000|Overall Study|Adverse event unrelated to study drug|1|||
145284321|NCT01621490|523891591|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145284322|NCT01621490|523891592|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145284323|NCT01621490|523891593|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145284324|NCT01621490|523891594|FG004|Overall Study|Adverse event unrelated to study drug|0|||
145284325|NCT01621490|523891595|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145284326|NCT01621490|523891596|FG006|Overall Study|Adverse event unrelated to study drug|0|||
145284327|NCT01621490|523891597|FG007|Overall Study|Adverse event unrelated to study drug|2|||
145284328|NCT01621490|523891598|FG008|Overall Study|Adverse event unrelated to study drug|0|||
145284329|NCT01621490|523891599|FG009|Overall Study|Adverse event unrelated to study drug|0|||
145284330|NCT01621490|523891600|FG010|Overall Study|Adverse event unrelated to study drug|0|||
145284331|NCT01621490|523891590|FG000|Overall Study|Disease progression|27|||
145284332|NCT01621490|523891591|FG001|Overall Study|Disease progression|28|||
145284333|NCT01621490|523891592|FG002|Overall Study|Disease progression|1|||
145284334|NCT01621490|523891593|FG003|Overall Study|Disease progression|5|||
145284335|NCT01621490|523891594|FG004|Overall Study|Disease progression|3|||
145284336|NCT01621490|523891595|FG005|Overall Study|Disease progression|8|||
145284337|NCT01621490|523891596|FG006|Overall Study|Disease progression|7|||
145284338|NCT01621490|523891597|FG007|Overall Study|Disease progression|1|||
145284339|NCT01621490|523891598|FG008|Overall Study|Disease progression|4|||
145284340|NCT01621490|523891599|FG009|Overall Study|Disease progression|1|||
145284341|NCT01621490|523891600|FG010|Overall Study|Disease progression|1|||
145284342|NCT01621490|523891590|FG000|Overall Study|Study drug toxicity|1|||
145284343|NCT01621490|523891591|FG001|Overall Study|Study drug toxicity|4|||
145284344|NCT01621490|523891592|FG002|Overall Study|Study drug toxicity|5|||
145284345|NCT01621490|523891593|FG003|Overall Study|Study drug toxicity|3|||
145284346|NCT01621490|523891594|FG004|Overall Study|Study drug toxicity|1|||
145284347|NCT01621490|523891595|FG005|Overall Study|Study drug toxicity|10|||
145284348|NCT01621490|523891596|FG006|Overall Study|Study drug toxicity|1|||
145284349|NCT01621490|523891597|FG007|Overall Study|Study drug toxicity|4|||
145284350|NCT01621490|523891598|FG008|Overall Study|Study drug toxicity|1|||
145284351|NCT01621490|523891599|FG009|Overall Study|Study drug toxicity|0|||
145284352|NCT01621490|523891600|FG010|Overall Study|Study drug toxicity|0|||
145552803|NCT01348347|524881337|FG002|Overall Study|Withdrawal by Subject|1|||
145284353|NCT01621490|523891590|FG000|Overall Study|Death|0|||
145284354|NCT01621490|523891591|FG001|Overall Study|Death|0|||
145284355|NCT01621490|523891592|FG002|Overall Study|Death|0|||
145284356|NCT01621490|523891593|FG003|Overall Study|Death|0|||
145284357|NCT01621490|523891594|FG004|Overall Study|Death|0|||
145284358|NCT01621490|523891595|FG005|Overall Study|Death|0|||
145552804|NCT01348347|524881335|FG000|Overall Study|Progressive disease|2|||
145552805|NCT01348347|524881336|FG001|Overall Study|Progressive disease|5|||
145552806|NCT01348347|524881337|FG002|Overall Study|Progressive disease|5|||
145552807|NCT00071513|524881340|FG000|Intervention Component|Withdrawal by Subject|2|||
145405726|NCT04757636|524341623|FG002|Overall Study|Randomized in Error|2|||
145405727|NCT02349386|524341626|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
145405728|NCT02349386|524341627|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
145405729|NCT02349386|524341628|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
145552808|NCT00071513|524881341|FG001|Intervention Component|Withdrawal by Subject|3|||
145552809|NCT00071513|524881340|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
145552810|NCT00071513|524881341|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
145284359|NCT01621490|523891596|FG006|Overall Study|Death|0|||
145405730|NCT02349386|524341629|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
145405731|NCT02349386|524341626|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
145405732|NCT02349386|524341627|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
145552811|NCT01958008|524881342|FG000|Overall Study|Worsening of disease under study|0|||
145552812|NCT01958008|524881343|FG001|Overall Study|Worsening of disease under study|0|||
145552813|NCT01958008|524881344|FG002|Overall Study|Worsening of disease under study|1|||
145552814|NCT01958008|524881345|FG003|Overall Study|Worsening of disease under study|0|||
145552815|NCT01958008|524881342|FG000|Overall Study|Other adverse event|1|||
145552816|NCT01958008|524881343|FG001|Overall Study|Other adverse event|0|||
145552817|NCT01958008|524881344|FG002|Overall Study|Other adverse event|0|||
145552818|NCT01958008|524881345|FG003|Overall Study|Other adverse event|0|||
145552819|NCT03667924|524881346|FG000|Baseline Completed|Lost to Follow-up|0|||
145552820|NCT03667924|524881347|FG001|Baseline Completed|Lost to Follow-up|2|||
145552821|NCT03667924|524881348|FG002|Baseline Completed|Lost to Follow-up|0|||
145552822|NCT03667924|524881346|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
145552823|NCT03667924|524881347|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
145552824|NCT03667924|524881348|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
145552825|NCT03667924|524881346|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
145552826|NCT03667924|524881347|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
145552827|NCT03667924|524881348|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
145552828|NCT03667924|524881346|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
145552829|NCT03667924|524881347|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
145552830|NCT03667924|524881348|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
145552831|NCT03667924|524881346|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
145552832|NCT03667924|524881347|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
145552833|NCT03667924|524881348|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
145552834|NCT03667924|524881346|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
145552835|NCT03667924|524881347|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
145552836|NCT03667924|524881348|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
145552837|NCT03667924|524881346|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
145552838|NCT03667924|524881347|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
145552839|NCT03667924|524881348|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
145552840|NCT03358290|524881349|FG000|Overall Study|Study discontinued by Sponsor|0|||
145552841|NCT03358290|524881350|FG001|Overall Study|Study discontinued by Sponsor|1|||
145552842|NCT03358290|524881351|FG002|Overall Study|Study discontinued by Sponsor|1|||
145611418|NCT00854295|525092700|FG002|Overall Study|Adverse Event|1|||
145611419|NCT00854295|525092701|FG003|Overall Study|Adverse Event|3|||
145552843|NCT03358290|524881352|FG003|Overall Study|Study discontinued by Sponsor|0|||
145552844|NCT03358290|524881353|FG004|Overall Study|Study discontinued by Sponsor|0|||
145405733|NCT02349386|524341628|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
145405734|NCT02349386|524341629|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
145405735|NCT02349386|524341626|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145405736|NCT02349386|524341627|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145405737|NCT02349386|524341628|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
145552845|NCT03358290|524881349|FG000|Overall Study|Adverse Event|0|||
145552846|NCT03358290|524881350|FG001|Overall Study|Adverse Event|0|||
145552847|NCT03358290|524881351|FG002|Overall Study|Adverse Event|1|||
145552848|NCT03358290|524881352|FG003|Overall Study|Adverse Event|2|||
145552849|NCT03358290|524881353|FG004|Overall Study|Adverse Event|0|||
145552850|NCT03358290|524881349|FG000|Overall Study|Withdrawal by Subject|0|||
145552851|NCT03358290|524881350|FG001|Overall Study|Withdrawal by Subject|0|||
145552852|NCT03358290|524881351|FG002|Overall Study|Withdrawal by Subject|0|||
145552853|NCT03358290|524881352|FG003|Overall Study|Withdrawal by Subject|0|||
145552854|NCT03358290|524881353|FG004|Overall Study|Withdrawal by Subject|1|||
145552855|NCT02743871|524881354|FG000|Overall Study|Lost to Follow-up|0|||
145405738|NCT02349386|524341629|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
145407501|NCT03479905|524347042|FG000|Overall Study|Other airway method used|4|||
145552856|NCT02743871|524881355|FG001|Overall Study|Lost to Follow-up|0|||
145552857|NCT02743871|524881356|FG002|Overall Study|Lost to Follow-up|0|||
145552858|NCT02743871|524881357|FG003|Overall Study|Lost to Follow-up|1|||
145552859|NCT02743871|524881358|FG004|Overall Study|Lost to Follow-up|0|||
145552860|NCT02743871|524881359|FG005|Overall Study|Lost to Follow-up|0|||
145552861|NCT02743871|524881360|FG006|Overall Study|Lost to Follow-up|1|||
145552862|NCT02743871|524881361|FG007|Overall Study|Lost to Follow-up|0|||
145552863|NCT02743871|524881362|FG008|Overall Study|Lost to Follow-up|0|||
145552864|NCT02743871|524881363|FG009|Overall Study|Lost to Follow-up|0|||
145552865|NCT02743871|524881364|FG010|Overall Study|Lost to Follow-up|0|||
145552866|NCT02743871|524881365|FG011|Overall Study|Lost to Follow-up|2|||
145552867|NCT02743871|524881366|FG012|Overall Study|Lost to Follow-up|0|||
145552868|NCT02743871|524881367|FG013|Overall Study|Lost to Follow-up|0|||
145552869|NCT02743871|524881354|FG000|Overall Study|Withdrawal by Subject|0|||
145552870|NCT02743871|524881355|FG001|Overall Study|Withdrawal by Subject|0|||
145552871|NCT02743871|524881356|FG002|Overall Study|Withdrawal by Subject|0|||
145552872|NCT02743871|524881357|FG003|Overall Study|Withdrawal by Subject|0|||
145552873|NCT02743871|524881358|FG004|Overall Study|Withdrawal by Subject|0|||
145552874|NCT02743871|524881359|FG005|Overall Study|Withdrawal by Subject|0|||
145552875|NCT02743871|524881360|FG006|Overall Study|Withdrawal by Subject|0|||
145552876|NCT02743871|524881361|FG007|Overall Study|Withdrawal by Subject|0|||
145552877|NCT02743871|524881362|FG008|Overall Study|Withdrawal by Subject|0|||
145552878|NCT02743871|524881363|FG009|Overall Study|Withdrawal by Subject|0|||
145552879|NCT02743871|524881364|FG010|Overall Study|Withdrawal by Subject|1|||
145552880|NCT02743871|524881365|FG011|Overall Study|Withdrawal by Subject|0|||
145552881|NCT02743871|524881366|FG012|Overall Study|Withdrawal by Subject|12|||
145552882|NCT02743871|524881367|FG013|Overall Study|Withdrawal by Subject|6|||
145552883|NCT02743871|524881354|FG000|Overall Study|Adverse Event|1|||
145552884|NCT02743871|524881355|FG001|Overall Study|Adverse Event|0|||
145552885|NCT02743871|524881356|FG002|Overall Study|Adverse Event|0|||
145552886|NCT02743871|524881357|FG003|Overall Study|Adverse Event|0|||
145552887|NCT02743871|524881358|FG004|Overall Study|Adverse Event|0|||
145405739|NCT02349386|524341626|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145552888|NCT02743871|524881359|FG005|Overall Study|Adverse Event|0|||
145552889|NCT02743871|524881360|FG006|Overall Study|Adverse Event|0|||
145284360|NCT01621490|523891597|FG007|Overall Study|Death|0|||
145284361|NCT01621490|523891598|FG008|Overall Study|Death|1|||
145284362|NCT01621490|523891599|FG009|Overall Study|Death|0|||
145284363|NCT01621490|523891600|FG010|Overall Study|Death|0|||
145552890|NCT02743871|524881361|FG007|Overall Study|Adverse Event|0|||
145552891|NCT02743871|524881362|FG008|Overall Study|Adverse Event|0|||
145284364|NCT01621490|523891590|FG000|Overall Study|Other reasons|7|||
145284365|NCT01621490|523891591|FG001|Overall Study|Other reasons|6|||
145284366|NCT01621490|523891592|FG002|Overall Study|Other reasons|4|||
145284367|NCT01621490|523891593|FG003|Overall Study|Other reasons|1|||
145284368|NCT01621490|523891594|FG004|Overall Study|Other reasons|1|||
145284369|NCT01621490|523891595|FG005|Overall Study|Other reasons|3|||
145284370|NCT01621490|523891596|FG006|Overall Study|Other reasons|1|||
145284371|NCT01621490|523891597|FG007|Overall Study|Other reasons|1|||
145284372|NCT01621490|523891598|FG008|Overall Study|Other reasons|1|||
145284373|NCT01621490|523891599|FG009|Overall Study|Other reasons|0|||
145284374|NCT01621490|523891600|FG010|Overall Study|Other reasons|0|||
145284375|NCT00506753|523891601|FG000|Overall Study|Lost to Follow-up|21|||
145284376|NCT00506753|523891602|FG001|Overall Study|Lost to Follow-up|15|||
145284377|NCT00125359|523891603|FG000|Overall Study|Death|4|||
145284378|NCT00125359|523891603|FG000|Overall Study|Adverse Event|5|||
145284379|NCT00125359|523891603|FG000|Overall Study|Physician Decision|14|||
145284380|NCT02451670|523891604|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
145284381|NCT02451670|523891605|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
145284382|NCT00461500|523891606|FG000|Overall Study|Adverse Event|1|||
145405740|NCT02349386|524341627|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145552892|NCT02743871|524881363|FG009|Overall Study|Adverse Event|0|||
145284383|NCT00461500|523891607|FG001|Overall Study|Adverse Event|0|||
145284384|NCT00461500|523891606|FG000|Overall Study|Lack of Efficacy|0|||
145284385|NCT00461500|523891607|FG001|Overall Study|Lack of Efficacy|1|||
145284386|NCT00461500|523891606|FG000|Overall Study|Expired Drug Treatment|1|||
145284387|NCT00461500|523891607|FG001|Overall Study|Expired Drug Treatment|1|||
145284388|NCT00461500|523891606|FG000|Overall Study|Study Stopped|1|||
145284389|NCT00461500|523891607|FG001|Overall Study|Study Stopped|2|||
145284390|NCT00461500|523891606|FG000|Overall Study|Drug Treatment Misuse|1|||
145284391|NCT00461500|523891607|FG001|Overall Study|Drug Treatment Misuse|0|||
145284392|NCT00461500|523891606|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
145284393|NCT00461500|523891607|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
145284394|NCT00461500|523891606|FG000|Overall Study|Lost to Follow-up|2|||
145284395|NCT00461500|523891607|FG001|Overall Study|Lost to Follow-up|2|||
145284396|NCT01513551|523891612|FG000|Overall Study|Death|0|||
145284397|NCT01513551|523891613|FG001|Overall Study|Death|1|||
145284398|NCT01513551|523891614|FG002|Overall Study|Death|0|||
145284399|NCT01513551|523891612|FG000|Overall Study|Lost to Follow-up|3|||
145284400|NCT01513551|523891613|FG001|Overall Study|Lost to Follow-up|5|||
145284401|NCT01513551|523891614|FG002|Overall Study|Lost to Follow-up|2|||
145284402|NCT01513551|523891612|FG000|Overall Study|Withdrawal by Subject|1|||
145284403|NCT01513551|523891613|FG001|Overall Study|Withdrawal by Subject|0|||
145284404|NCT01513551|523891614|FG002|Overall Study|Withdrawal by Subject|2|||
145284405|NCT01513551|523891612|FG000|Overall Study|Randomized but not vaccinated|0|||
145552893|NCT02743871|524881364|FG010|Overall Study|Adverse Event|0|||
145552894|NCT02743871|524881365|FG011|Overall Study|Adverse Event|0|||
145552895|NCT02743871|524881366|FG012|Overall Study|Adverse Event|0|||
145552896|NCT02743871|524881367|FG013|Overall Study|Adverse Event|0|||
145552897|NCT02743871|524881354|FG000|Overall Study|Other|0|||
145552898|NCT02743871|524881355|FG001|Overall Study|Other|0|||
145552899|NCT02743871|524881356|FG002|Overall Study|Other|0|||
145552900|NCT02743871|524881357|FG003|Overall Study|Other|0|||
145552901|NCT02743871|524881358|FG004|Overall Study|Other|0|||
145552902|NCT02743871|524881359|FG005|Overall Study|Other|0|||
145552903|NCT02743871|524881360|FG006|Overall Study|Other|0|||
145552904|NCT02743871|524881361|FG007|Overall Study|Other|0|||
145552905|NCT02743871|524881362|FG008|Overall Study|Other|0|||
145552906|NCT02743871|524881363|FG009|Overall Study|Other|0|||
145552907|NCT02743871|524881364|FG010|Overall Study|Other|0|||
145552908|NCT02743871|524881365|FG011|Overall Study|Other|1|||
145552909|NCT02743871|524881366|FG012|Overall Study|Other|1|||
145552910|NCT02743871|524881367|FG013|Overall Study|Other|1|||
145552911|NCT02743871|524881354|FG000|Overall Study|Protocol Violation|0|||
145552912|NCT02743871|524881355|FG001|Overall Study|Protocol Violation|0|||
145552913|NCT02743871|524881356|FG002|Overall Study|Protocol Violation|0|||
145552914|NCT02743871|524881357|FG003|Overall Study|Protocol Violation|0|||
145552915|NCT02743871|524881358|FG004|Overall Study|Protocol Violation|0|||
145552916|NCT02743871|524881359|FG005|Overall Study|Protocol Violation|0|||
145552917|NCT02743871|524881360|FG006|Overall Study|Protocol Violation|0|||
145552918|NCT02743871|524881361|FG007|Overall Study|Protocol Violation|0|||
145552919|NCT02743871|524881362|FG008|Overall Study|Protocol Violation|0|||
145552920|NCT02743871|524881363|FG009|Overall Study|Protocol Violation|0|||
145552921|NCT02743871|524881364|FG010|Overall Study|Protocol Violation|0|||
145552922|NCT02743871|524881365|FG011|Overall Study|Protocol Violation|0|||
145552923|NCT02743871|524881366|FG012|Overall Study|Protocol Violation|2|||
145552924|NCT02743871|524881367|FG013|Overall Study|Protocol Violation|0|||
145552925|NCT02927080|524883027|FG000|Overall Study|Withdrawal by Subject|0|||
145552926|NCT02927080|524883028|FG001|Overall Study|Withdrawal by Subject|0|||
145552927|NCT02927080|524883029|FG002|Overall Study|Withdrawal by Subject|0|||
145552928|NCT02927080|524883030|FG003|Overall Study|Withdrawal by Subject|0|||
145552929|NCT02927080|524883031|FG004|Overall Study|Withdrawal by Subject|1|||
145552930|NCT02927080|524883032|FG005|Overall Study|Withdrawal by Subject|0|||
145552931|NCT02927080|524883033|FG006|Overall Study|Withdrawal by Subject|1|||
145552932|NCT02927080|524883034|FG007|Overall Study|Withdrawal by Subject|1|||
145552933|NCT02927080|524883035|FG008|Overall Study|Withdrawal by Subject|0|||
145552934|NCT02927080|524883036|FG009|Overall Study|Withdrawal by Subject|2|||
145552935|NCT02927080|524883027|FG000|Overall Study|Willingness to comply with protocol|0|||
145552936|NCT02927080|524883028|FG001|Overall Study|Willingness to comply with protocol|0|||
145552937|NCT02927080|524883029|FG002|Overall Study|Willingness to comply with protocol|0|||
145552938|NCT02927080|524883030|FG003|Overall Study|Willingness to comply with protocol|0|||
145552939|NCT02927080|524883031|FG004|Overall Study|Willingness to comply with protocol|0|||
145552940|NCT02927080|524883032|FG005|Overall Study|Willingness to comply with protocol|0|||
145552941|NCT02927080|524883033|FG006|Overall Study|Willingness to comply with protocol|0|||
145552942|NCT02927080|524883034|FG007|Overall Study|Willingness to comply with protocol|0|||
145552943|NCT02927080|524883035|FG008|Overall Study|Willingness to comply with protocol|0|||
145552944|NCT02927080|524883036|FG009|Overall Study|Willingness to comply with protocol|1|||
145552945|NCT02927080|524883027|FG000|Overall Study|Study terminated by Sponsor|0|||
145552946|NCT02927080|524883028|FG001|Overall Study|Study terminated by Sponsor|0|||
145552947|NCT02927080|524883029|FG002|Overall Study|Study terminated by Sponsor|0|||
145552948|NCT02927080|524883030|FG003|Overall Study|Study terminated by Sponsor|0|||
145552949|NCT02927080|524883031|FG004|Overall Study|Study terminated by Sponsor|0|||
145552950|NCT02927080|524883032|FG005|Overall Study|Study terminated by Sponsor|0|||
145552951|NCT02927080|524883033|FG006|Overall Study|Study terminated by Sponsor|6|||
145552952|NCT02927080|524883034|FG007|Overall Study|Study terminated by Sponsor|7|||
145552953|NCT02927080|524883035|FG008|Overall Study|Study terminated by Sponsor|2|||
145552954|NCT02927080|524883036|FG009|Overall Study|Study terminated by Sponsor|3|||
145552955|NCT02927080|524883027|FG000|Overall Study|Adverse Event|0|||
145552956|NCT02927080|524883028|FG001|Overall Study|Adverse Event|1|||
145552957|NCT02927080|524883029|FG002|Overall Study|Adverse Event|0|||
145552958|NCT02927080|524883030|FG003|Overall Study|Adverse Event|0|||
145552959|NCT02927080|524883031|FG004|Overall Study|Adverse Event|0|||
145552960|NCT02927080|524883032|FG005|Overall Study|Adverse Event|0|||
145552961|NCT02927080|524883033|FG006|Overall Study|Adverse Event|0|||
145552962|NCT02927080|524883034|FG007|Overall Study|Adverse Event|1|||
145552963|NCT02927080|524883035|FG008|Overall Study|Adverse Event|0|||
145552964|NCT02927080|524883036|FG009|Overall Study|Adverse Event|1|||
145552965|NCT02927080|524883027|FG000|Overall Study|Other|0|||
145611420|NCT00854295|525092698|FG000|Overall Study|Lost to Follow-up|18|||
145407502|NCT03479905|524347043|FG001|Overall Study|Other airway method used|5|||
145611421|NCT00854295|525092699|FG001|Overall Study|Lost to Follow-up|5|||
145552966|NCT02927080|524883028|FG001|Overall Study|Other|0|||
145552967|NCT02927080|524883029|FG002|Overall Study|Other|0|||
145552968|NCT02927080|524883030|FG003|Overall Study|Other|0|||
145552969|NCT02927080|524883031|FG004|Overall Study|Other|0|||
145552970|NCT02927080|524883032|FG005|Overall Study|Other|0|||
145552971|NCT02927080|524883033|FG006|Overall Study|Other|1|||
145552972|NCT02927080|524883034|FG007|Overall Study|Other|0|||
145552973|NCT02927080|524883035|FG008|Overall Study|Other|1|||
145552974|NCT02927080|524883036|FG009|Overall Study|Other|0|||
145552975|NCT00224055|524883037|FG000|Overall Study|Adverse Event|9|||
145552976|NCT00224055|524883038|FG001|Overall Study|Adverse Event|3|||
145552977|NCT00224055|524883037|FG000|Overall Study|Lost to Follow-up|1|||
145552978|NCT00224055|524883038|FG001|Overall Study|Lost to Follow-up|2|||
145552979|NCT00224055|524883037|FG000|Overall Study|Protocol Violation|1|||
145552980|NCT00224055|524883038|FG001|Overall Study|Protocol Violation|1|||
145552981|NCT00224055|524883037|FG000|Overall Study|Inclusion Violation|3|||
145552982|NCT00224055|524883038|FG001|Overall Study|Inclusion Violation|6|||
145552983|NCT00224055|524883037|FG000|Overall Study|Withdrawal by Subject|0|||
145552984|NCT00224055|524883038|FG001|Overall Study|Withdrawal by Subject|2|||
145552985|NCT00224055|524883037|FG000|Overall Study|Other|1|||
145552986|NCT00224055|524883038|FG001|Overall Study|Other|0|||
145552987|NCT05126901|524883039|FG000|Overall Study|Withdrawal by Subject|1|||
145552988|NCT05126901|524883040|FG001|Overall Study|Withdrawal by Subject|1|||
145552989|NCT05126901|524883041|FG002|Overall Study|Withdrawal by Subject|4|||
145552990|NCT05126901|524883039|FG000|Overall Study|Adverse Event|0|||
145552991|NCT05126901|524883040|FG001|Overall Study|Adverse Event|0|||
145552992|NCT05126901|524883041|FG002|Overall Study|Adverse Event|1|||
145552993|NCT05126901|524883039|FG000|Overall Study|Lost to Follow-up|0|||
145405741|NCT02349386|524341628|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
145405742|NCT02349386|524341629|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
145405743|NCT02349386|524341626|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
145552994|NCT05126901|524883040|FG001|Overall Study|Lost to Follow-up|2|||
145284406|NCT01513551|523891613|FG001|Overall Study|Randomized but not vaccinated|0|||
145284407|NCT01513551|523891614|FG002|Overall Study|Randomized but not vaccinated|1|||
145284408|NCT01806597|523891617|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
145552995|NCT05126901|524883041|FG002|Overall Study|Lost to Follow-up|0|||
145552996|NCT00754624|524883042|FG000|Overall Study|Adverse Event|16|||
145552997|NCT00754624|524883042|FG000|Overall Study|Death|1|||
145552998|NCT00754624|524883042|FG000|Overall Study|Physician Decision|8|||
145552999|NCT00754624|524883042|FG000|Overall Study|Protocol Violation|1|||
145553000|NCT00754624|524883042|FG000|Overall Study|Withdrawal by Subject|28|||
145553001|NCT00754624|524883042|FG000|Overall Study|Various|12|||
145553002|NCT00754624|524883042|FG000|Overall Study|Lost to Follow-up|3|||
145553003|NCT04067544|524883043|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
145553004|NCT01529346|524883046|FG000|Overall Study|Lost to Follow-up|2|||
145553005|NCT01529346|524883047|FG001|Overall Study|Lost to Follow-up|0|||
145553006|NCT01529346|524883048|FG002|Overall Study|Lost to Follow-up|1|||
145284409|NCT01806597|523891618|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
145284410|NCT01806597|523891619|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
145284411|NCT01806597|523891620|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
145284412|NCT01806597|523891621|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
145284413|NCT01806597|523891622|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
145284414|NCT01806597|523891617|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
145284415|NCT01806597|523891618|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
145284416|NCT01806597|523891619|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
145284417|NCT01806597|523891620|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
145405744|NCT02349386|524341627|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
145405745|NCT02349386|524341628|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
145405746|NCT02349386|524341629|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
145611422|NCT00854295|525092700|FG002|Overall Study|Lost to Follow-up|21|||
145611423|NCT00854295|525092701|FG003|Overall Study|Lost to Follow-up|21|||
145611424|NCT00854295|525092698|FG000|Overall Study|Physician Decision|10|||
145611425|NCT00854295|525092699|FG001|Overall Study|Physician Decision|0|||
145611426|NCT00854295|525092700|FG002|Overall Study|Physician Decision|0|||
145284418|NCT01806597|523891621|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
145284419|NCT01806597|523891622|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
145284420|NCT01806597|523891617|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
145553007|NCT01529346|524883049|FG003|Overall Study|Lost to Follow-up|0|||
145553008|NCT01529346|524883050|FG004|Overall Study|Lost to Follow-up|0|||
145553009|NCT01529346|524883046|FG000|Overall Study|Other|0|||
145553010|NCT01529346|524883047|FG001|Overall Study|Other|1|||
145553011|NCT01529346|524883048|FG002|Overall Study|Other|1|||
145553012|NCT01529346|524883049|FG003|Overall Study|Other|0|||
145553013|NCT01529346|524883050|FG004|Overall Study|Other|0|||
145553014|NCT02282020|524883051|FG000|Overall Study|Objective Disease Progression|128|||
145553015|NCT02282020|524883052|FG001|Overall Study|Objective Disease Progression|30|||
145553016|NCT02282020|524883051|FG000|Overall Study|Adverse Event|18|||
145553017|NCT02282020|524883052|FG001|Overall Study|Adverse Event|15|||
145553018|NCT02282020|524883051|FG000|Overall Study|Withdrawal by Subject|7|||
145553019|NCT02282020|524883052|FG001|Overall Study|Withdrawal by Subject|10|||
145553020|NCT02282020|524883051|FG000|Overall Study|Miscellaneous|5|||
145553021|NCT02282020|524883052|FG001|Overall Study|Miscellaneous|19|||
145553022|NCT02282020|524883051|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
145553023|NCT02282020|524883052|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
145553024|NCT02282020|524883051|FG000|Overall Study|Developed Discontinuation Criteria|0|||
145553025|NCT02282020|524883052|FG001|Overall Study|Developed Discontinuation Criteria|2|||
145553026|NCT02282020|524883051|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
145553027|NCT02282020|524883052|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
145553028|NCT01500629|524883053|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
145553029|NCT01500629|524883054|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
145553030|NCT01499667|524883055|FG000|Overall Study|administrative problems|4|||
145553031|NCT01499667|524883056|FG001|Overall Study|administrative problems|5|||
145553032|NCT01499667|524883057|FG002|Overall Study|administrative problems|5|||
145553033|NCT01499667|524883055|FG000|Overall Study|Protocol Violation|1|||
145553034|NCT01499667|524883056|FG001|Overall Study|Protocol Violation|3|||
145553035|NCT01499667|524883057|FG002|Overall Study|Protocol Violation|2|||
145553036|NCT01499667|524883055|FG000|Overall Study|Adverse Event|0|||
145553037|NCT01499667|524883056|FG001|Overall Study|Adverse Event|2|||
145553038|NCT01499667|524883057|FG002|Overall Study|Adverse Event|2|||
145553039|NCT01499667|524883055|FG000|Overall Study|Withdrawal by Subject|2|||
145553040|NCT01499667|524883056|FG001|Overall Study|Withdrawal by Subject|1|||
145405747|NCT02349386|524341626|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
145405748|NCT02349386|524341627|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
145405749|NCT02349386|524341628|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
145405750|NCT02349386|524341629|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
145405751|NCT00984867|524341630|FG000|Overall Study|Adverse Event|3|||
145405752|NCT00984867|524341631|FG001|Overall Study|Adverse Event|7|||
145405753|NCT00984867|524341630|FG000|Overall Study|Death|1|||
145405754|NCT00984867|524341631|FG001|Overall Study|Death|0|||
145405755|NCT00984867|524341630|FG000|Overall Study|Withdrawal by Subject|13|||
145405756|NCT00984867|524341631|FG001|Overall Study|Withdrawal by Subject|4|||
145405757|NCT00984867|524341630|FG000|Overall Study|Lost to Follow-up|3|||
145405758|NCT00984867|524341631|FG001|Overall Study|Lost to Follow-up|4|||
145405759|NCT00984867|524341630|FG000|Overall Study|Poor/non-compliance|0|||
145405760|NCT00984867|524341631|FG001|Overall Study|Poor/non-compliance|1|||
145405761|NCT00984867|524341630|FG000|Overall Study|Subject no longer meets study criteria|1|||
145405762|NCT00984867|524341631|FG001|Overall Study|Subject no longer meets study criteria|1|||
145405763|NCT00984867|524341630|FG000|Overall Study|site closing|1|||
145405764|NCT00984867|524341631|FG001|Overall Study|site closing|0|||
145405765|NCT00984867|524341630|FG000|Overall Study|lack of efficacy and subject compliance|1|||
145405766|NCT00984867|524341631|FG001|Overall Study|lack of efficacy and subject compliance|0|||
145405767|NCT06057064|524341632|FG000|Overall Study|Death|2|||
145553041|NCT01499667|524883057|FG002|Overall Study|Withdrawal by Subject|1|||
145553042|NCT01499667|524883055|FG000|Overall Study|Lack of Efficacy|2|||
145553043|NCT01499667|524883056|FG001|Overall Study|Lack of Efficacy|0|||
145553044|NCT01499667|524883057|FG002|Overall Study|Lack of Efficacy|0|||
145405768|NCT06057064|524341633|FG001|Overall Study|Death|0|||
145405769|NCT06057064|524341632|FG000|Overall Study|Physician Decision|1|||
145405770|NCT06057064|524341633|FG001|Overall Study|Physician Decision|0|||
145405771|NCT06057064|524341632|FG000|Overall Study|Withdrawal by Subject|1|||
145405772|NCT06057064|524341633|FG001|Overall Study|Withdrawal by Subject|1|||
145405773|NCT01155141|524341641|FG000|Overall Study|Withdrawal by Subject|1|||
145405774|NCT01155141|524341641|FG000|Overall Study|Screen Failure|1|||
145553045|NCT00849381|524883058|FG000|Overall Study|Adverse Event|1|||
145553046|NCT00849381|524883058|FG000|Overall Study|Lost to Follow-up|129|||
145553047|NCT00849381|524883058|FG000|Overall Study|Protocol Violation|5|||
145553048|NCT00849381|524883058|FG000|Overall Study|Withdrawal by Subject|6|||
145553049|NCT00849381|524883058|FG000|Overall Study|Other|4|||
145553050|NCT00460031|524883064|FG000|Overall Study|Adverse Event|5|||
145553051|NCT00460031|524883064|FG000|Overall Study|Withdrawal by Subject|5|||
145553052|NCT00460031|524883064|FG000|Overall Study|Death|1|||
145553053|NCT04429061|524883065|FG000|Overall Study|Lost to Follow-up|62|||
145553054|NCT04429061|524883066|FG001|Overall Study|Lost to Follow-up|87|||
145553055|NCT04429061|524883065|FG000|Overall Study|Withdrawal by Subject|3|||
145553056|NCT04429061|524883066|FG001|Overall Study|Withdrawal by Subject|4|||
145553057|NCT02506153|524883071|FG000|Overall Study|Adverse Event|359|||
145553058|NCT02506153|524883072|FG001|Overall Study|Adverse Event|114|||
145553059|NCT02506153|524883071|FG000|Overall Study|Refused unrelated to adverse event|127|||
145553060|NCT02506153|524883072|FG001|Overall Study|Refused unrelated to adverse event|18|||
145553061|NCT02506153|524883071|FG000|Overall Study|Progression/relapse|91|||
145553062|NCT02506153|524883072|FG001|Overall Study|Progression/relapse|136|||
145553063|NCT02506153|524883071|FG000|Overall Study|Death|2|||
145553064|NCT02506153|524883072|FG001|Overall Study|Death|1|||
145553065|NCT02506153|524883071|FG000|Overall Study|Other - not protocol specified|23|||
145553066|NCT02506153|524883072|FG001|Overall Study|Other - not protocol specified|12|||
145553067|NCT00311623|524883080|FG000|Overall Study|Physician Decision|0|||
145553068|NCT00311623|524883081|FG001|Overall Study|Physician Decision|0|||
145553069|NCT00311623|524883082|FG002|Overall Study|Physician Decision|2|||
145553070|NCT03103919|524883083|FG000|Overall Study|Adverse Event|2|||
145553071|NCT03103919|524883084|FG001|Overall Study|Adverse Event|2|||
145553072|NCT05682326|524883085|FG000|Overall Study|Withdrawal by Subject|1|||
145553073|NCT05682326|524883086|FG001|Overall Study|Withdrawal by Subject|0|||
145553074|NCT03998189|524883087|FG000|Overall Study|Lack of Efficacy|0|||
145553075|NCT03998189|524883088|FG001|Overall Study|Lack of Efficacy|1|||
145553076|NCT03454893|524883091|FG000|Overall Study|Study Terminated by the Sponsor|5|||
145553077|NCT03454893|524883091|FG000|Overall Study|Did not pass screening|4|||
145553078|NCT03414424|524883092|FG000|Overall Study|Screened out after consent|0|||
145553079|NCT03414424|524883093|FG001|Overall Study|Screened out after consent|2|||
145553080|NCT03414424|524883092|FG000|Overall Study|Lost to Follow-up|0|||
145553081|NCT03414424|524883093|FG001|Overall Study|Lost to Follow-up|1|||
145553082|NCT03070782|524883095|FG000|Overall Study|Adverse Event|3|||
145553083|NCT03070782|524883096|FG001|Overall Study|Adverse Event|0|||
145553084|NCT03070782|524883097|FG002|Overall Study|Adverse Event|3|||
145553085|NCT03070782|524883098|FG003|Overall Study|Adverse Event|1|||
145553086|NCT03070782|524883099|FG004|Overall Study|Adverse Event|6|||
145553087|NCT03070782|524883100|FG005|Overall Study|Adverse Event|2|||
145553088|NCT03070782|524883095|FG000|Overall Study|Withdrawal by Subject|2|||
145553089|NCT03070782|524883096|FG001|Overall Study|Withdrawal by Subject|1|||
145553090|NCT03070782|524883097|FG002|Overall Study|Withdrawal by Subject|1|||
145284421|NCT01806597|523891618|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
145553091|NCT03070782|524883098|FG003|Overall Study|Withdrawal by Subject|0|||
145284422|NCT01806597|523891619|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
145284423|NCT01806597|523891620|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
145553092|NCT03070782|524883099|FG004|Overall Study|Withdrawal by Subject|4|||
145553093|NCT03070782|524883100|FG005|Overall Study|Withdrawal by Subject|3|||
145553094|NCT03070782|524883095|FG000|Overall Study|Reason Not Specified|2|||
145284424|NCT01806597|523891621|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
145611427|NCT00854295|525092701|FG003|Overall Study|Physician Decision|0|||
145611428|NCT00709592|525092702|FG000|Overall Study|Unable to proceed to transplant|0|||
145553095|NCT03070782|524883096|FG001|Overall Study|Reason Not Specified|0|||
145553096|NCT03070782|524883097|FG002|Overall Study|Reason Not Specified|0|||
145553097|NCT03070782|524883098|FG003|Overall Study|Reason Not Specified|1|||
145284425|NCT01806597|523891622|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
145284426|NCT01806597|523891617|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
145284427|NCT01806597|523891618|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
145284428|NCT01806597|523891619|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
145284429|NCT01806597|523891620|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
145284430|NCT01806597|523891621|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
145284431|NCT01806597|523891622|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
145284432|NCT01806597|523891617|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
145284433|NCT01806597|523891618|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
145284434|NCT01806597|523891619|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
145284435|NCT01806597|523891620|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
145284436|NCT01806597|523891621|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
145284437|NCT01806597|523891622|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
145284438|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
145284439|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
145284440|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
145284441|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
145284442|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
145284443|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
145284444|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
145284445|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
145284446|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
145284447|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
145284448|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
145284449|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
145284450|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
145284451|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
145284452|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
145284453|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
145284454|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
145284455|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
145284456|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
145284457|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
145284458|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
145284459|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
145284460|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
145284461|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
145284462|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
145284463|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
145284464|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
145284465|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
145284466|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
145284467|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
145284468|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
145284469|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
145553098|NCT03070782|524883099|FG004|Overall Study|Reason Not Specified|2|||
145553099|NCT03070782|524883100|FG005|Overall Study|Reason Not Specified|1|||
145553100|NCT03070782|524883095|FG000|Overall Study|Ineligibility|0|||
145553101|NCT03070782|524883096|FG001|Overall Study|Ineligibility|0|||
145553102|NCT03070782|524883097|FG002|Overall Study|Ineligibility|0|||
145553103|NCT03070782|524883098|FG003|Overall Study|Ineligibility|1|||
145553104|NCT03070782|524883099|FG004|Overall Study|Ineligibility|0|||
145553105|NCT03070782|524883100|FG005|Overall Study|Ineligibility|1|||
145553106|NCT03070782|524883095|FG000|Overall Study|Pregnancy|0|||
145553107|NCT03070782|524883096|FG001|Overall Study|Pregnancy|0|||
145553108|NCT03070782|524883097|FG002|Overall Study|Pregnancy|0|||
145553109|NCT03070782|524883098|FG003|Overall Study|Pregnancy|1|||
145553110|NCT03070782|524883099|FG004|Overall Study|Pregnancy|0|||
145553111|NCT03070782|524883100|FG005|Overall Study|Pregnancy|0|||
145553112|NCT03070782|524883095|FG000|Overall Study|Investigator Judgement|0|||
145284470|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
145284471|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
145284472|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
145284473|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
145284474|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
145284475|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
145284476|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
145611429|NCT00709592|525092703|FG001|Overall Study|Unable to proceed to transplant|1|||
145611430|NCT02440594|525092707|FG000|Overall Study|Lost to Follow-up|34|||
145611431|NCT02440594|525092708|FG001|Overall Study|Lost to Follow-up|33|||
145611432|NCT02440594|525092709|FG002|Overall Study|Lost to Follow-up|54|||
145611433|NCT02440594|525092710|FG003|Overall Study|Lost to Follow-up|47|||
145611434|NCT02440594|525092711|FG004|Overall Study|Lost to Follow-up|5|||
145611435|NCT02440594|525092712|FG005|Overall Study|Lost to Follow-up|4|||
145611436|NCT02440594|525092713|FG006|Overall Study|Lost to Follow-up|28|||
145611437|NCT02440594|525092714|FG007|Overall Study|Lost to Follow-up|48|||
145611438|NCT02440594|525092707|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
145611439|NCT02440594|525092708|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
145611440|NCT02440594|525092709|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
145611441|NCT02440594|525092710|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
145553113|NCT03070782|524883096|FG001|Overall Study|Investigator Judgement|0|||
145553114|NCT03070782|524883097|FG002|Overall Study|Investigator Judgement|0|||
145553115|NCT03070782|524883098|FG003|Overall Study|Investigator Judgement|1|||
145553116|NCT03070782|524883099|FG004|Overall Study|Investigator Judgement|0|||
145553117|NCT03070782|524883100|FG005|Overall Study|Investigator Judgement|0|||
145553118|NCT03527966|524883101|FG000|Overall Study|Lost to Follow-up|3|||
145553119|NCT03527966|524883102|FG001|Overall Study|Lost to Follow-up|0|||
145553120|NCT02288559|524883103|FG000|Overall Study|Adverse Event|1|||
145553121|NCT02288559|524883104|FG001|Overall Study|Adverse Event|1|||
145553122|NCT02288559|524883105|FG002|Overall Study|Adverse Event|5|||
145553123|NCT02288559|524883106|FG003|Overall Study|Adverse Event|0|||
145553124|NCT02288559|524883103|FG000|Overall Study|Death|0|||
145553125|NCT02288559|524883104|FG001|Overall Study|Death|0|||
145553126|NCT02288559|524883105|FG002|Overall Study|Death|1|||
145553127|NCT02288559|524883106|FG003|Overall Study|Death|0|||
145553128|NCT02288559|524883103|FG000|Overall Study|Lost to Follow-up|0|||
145553129|NCT02288559|524883104|FG001|Overall Study|Lost to Follow-up|0|||
145553130|NCT02288559|524883105|FG002|Overall Study|Lost to Follow-up|0|||
145553131|NCT02288559|524883106|FG003|Overall Study|Lost to Follow-up|1|||
145553132|NCT02288559|524883103|FG000|Overall Study|Withdrawal by Subject|0|||
145553133|NCT02288559|524883104|FG001|Overall Study|Withdrawal by Subject|0|||
145553134|NCT02288559|524883105|FG002|Overall Study|Withdrawal by Subject|2|||
145553135|NCT02288559|524883106|FG003|Overall Study|Withdrawal by Subject|1|||
145553136|NCT02288559|524883103|FG000|Overall Study|Reason Not Specified|0|||
145553137|NCT02288559|524883104|FG001|Overall Study|Reason Not Specified|0|||
145553138|NCT02288559|524883105|FG002|Overall Study|Reason Not Specified|3|||
145553139|NCT02288559|524883106|FG003|Overall Study|Reason Not Specified|0|||
145553140|NCT00558025|524883107|FG000|Overall Study|Adverse Event|1|||
145553141|NCT00558025|524883108|FG001|Overall Study|Adverse Event|1|||
145553142|NCT00558025|524883107|FG000|Overall Study|Withdrawal by Subject|2|||
145553143|NCT00558025|524883108|FG001|Overall Study|Withdrawal by Subject|2|||
145553144|NCT00558025|524883107|FG000|Overall Study|Protocol Violation|1|||
145553145|NCT00558025|524883108|FG001|Overall Study|Protocol Violation|0|||
145553146|NCT01314443|524883109|FG000|Overall Study|Withdrawal by Subject|2|||
145553147|NCT01314443|524883110|FG001|Overall Study|Withdrawal by Subject|1|||
145553148|NCT01314443|524883111|FG002|Overall Study|Withdrawal by Subject|1|||
145553149|NCT01314443|524883112|FG003|Overall Study|Withdrawal by Subject|1|||
145553150|NCT01314443|524883109|FG000|Overall Study|Protocol Violation|2|||
145553151|NCT01314443|524883110|FG001|Overall Study|Protocol Violation|2|||
145553152|NCT01314443|524883111|FG002|Overall Study|Protocol Violation|1|||
145553153|NCT01314443|524883112|FG003|Overall Study|Protocol Violation|1|||
145284477|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
145284478|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
145284479|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
145284480|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
145284481|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
145284482|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
145284483|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
145284484|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
145553154|NCT02567435|524883116|FG000|Overall Study|Death|1|||
145553155|NCT02567435|524883117|FG001|Overall Study|Death|1|||
145553156|NCT02567435|524883118|FG002|Overall Study|Death|0|||
145553157|NCT02567435|524883119|FG003|Overall Study|Death|0|||
145553158|NCT02567435|524883116|FG000|Overall Study|Ineligible|1|||
145553159|NCT02567435|524883117|FG001|Overall Study|Ineligible|3|||
145553160|NCT02567435|524883118|FG002|Overall Study|Ineligible|0|||
145553161|NCT02567435|524883119|FG003|Overall Study|Ineligible|0|||
145611442|NCT02440594|525092711|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
145611443|NCT02440594|525092712|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
145611444|NCT02440594|525092713|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
145611445|NCT02440594|525092714|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
145611446|NCT02440594|525092707|FG000|Overall Study|Withdrawal by Subject|81|||
145611447|NCT02440594|525092708|FG001|Overall Study|Withdrawal by Subject|67|||
145611448|NCT02440594|525092709|FG002|Overall Study|Withdrawal by Subject|59|||
145611449|NCT02440594|525092710|FG003|Overall Study|Withdrawal by Subject|38|||
145611450|NCT02440594|525092711|FG004|Overall Study|Withdrawal by Subject|2|||
145611451|NCT02440594|525092712|FG005|Overall Study|Withdrawal by Subject|2|||
145611452|NCT02440594|525092713|FG006|Overall Study|Withdrawal by Subject|7|||
145611453|NCT02440594|525092714|FG007|Overall Study|Withdrawal by Subject|7|||
145611454|NCT02440594|525092707|FG000|Overall Study|Administratively w/drawn|3|||
145611455|NCT02440594|525092708|FG001|Overall Study|Administratively w/drawn|2|||
145611456|NCT02440594|525092709|FG002|Overall Study|Administratively w/drawn|0|||
145611457|NCT02440594|525092710|FG003|Overall Study|Administratively w/drawn|0|||
145611458|NCT02440594|525092711|FG004|Overall Study|Administratively w/drawn|0|||
145611459|NCT02440594|525092712|FG005|Overall Study|Administratively w/drawn|0|||
145611460|NCT02440594|525092713|FG006|Overall Study|Administratively w/drawn|2|||
145611461|NCT02440594|525092714|FG007|Overall Study|Administratively w/drawn|1|||
145611462|NCT03154359|525092715|FG000|Overall Study|Adverse Event|1|||
145611463|NCT03154359|525092715|FG000|Overall Study|Lack of Efficacy|2|||
145611464|NCT03154359|525092715|FG000|Overall Study|Lost to Follow-up|3|||
145611465|NCT03154359|525092715|FG000|Overall Study|Physician Decision|3|||
145611466|NCT03154359|525092715|FG000|Overall Study|Protocol Violation|4|||
145611467|NCT03154359|525092715|FG000|Overall Study|Withdrawal by Subject|5|||
145611468|NCT03154359|525092715|FG000|Overall Study|Disruption of study due to COVID-19|4|||
145611469|NCT04250337|525092716|FG000|Overall Study|Adverse Event|0|||
145611470|NCT04250337|525092717|FG001|Overall Study|Adverse Event|3|||
145611471|NCT04250337|525092716|FG000|Overall Study|Lack of Efficacy|1|||
145284485|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
145284486|NCT01806597|523891617|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
145284487|NCT01806597|523891618|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
145284488|NCT01806597|523891619|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
145284489|NCT01806597|523891620|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
145284490|NCT01806597|523891621|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
145284491|NCT01806597|523891622|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
145284492|NCT01806597|523891617|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
145284493|NCT01806597|523891618|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
145284494|NCT01806597|523891619|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
145284495|NCT01806597|523891620|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
145284496|NCT01806597|523891621|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
145284497|NCT01806597|523891622|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
145284498|NCT01806597|523891617|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
145284499|NCT01806597|523891618|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
145284500|NCT01806597|523891619|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
145284501|NCT01806597|523891620|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
145284502|NCT01806597|523891621|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
145611472|NCT04250337|525092717|FG001|Overall Study|Lack of Efficacy|3|||
145611473|NCT04250337|525092716|FG000|Overall Study|Physician Decision|1|||
145611474|NCT04250337|525092717|FG001|Overall Study|Physician Decision|0|||
145611475|NCT04250337|525092716|FG000|Overall Study|Protocol Deviation|2|||
145611476|NCT04250337|525092717|FG001|Overall Study|Protocol Deviation|2|||
145611477|NCT04250337|525092716|FG000|Overall Study|Withdrawal by Subject|4|||
145611478|NCT04250337|525092717|FG001|Overall Study|Withdrawal by Subject|3|||
145611479|NCT00152763|525092718|FG000|Overall Study|Death|4|||
145611480|NCT00152763|525092719|FG001|Overall Study|Death|1|||
145611481|NCT00152763|525092720|FG002|Overall Study|Death|2|||
145611482|NCT00152763|525092721|FG003|Overall Study|Death|1|||
145611483|NCT00152763|525092718|FG000|Overall Study|Lost to Follow-up|6|||
145611484|NCT00152763|525092719|FG001|Overall Study|Lost to Follow-up|4|||
145553162|NCT02567435|524883116|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
145553163|NCT02567435|524883117|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
145553164|NCT02567435|524883118|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
145553165|NCT02567435|524883119|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
145611485|NCT00152763|525092720|FG002|Overall Study|Lost to Follow-up|2|||
145553166|NCT00191789|524883125|FG000|Overall Study|Adverse Event|5|||
145553167|NCT00191789|524883125|FG000|Overall Study|Patient: Satisfactory Response|5|||
145553168|NCT00191789|524883125|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
145553169|NCT00191789|524883125|FG000|Overall Study|Withdrawal by Subject|4|||
145553170|NCT00191789|524883125|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
145553171|NCT00191789|524883125|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
145553172|NCT00191789|524883125|FG000|Overall Study|Death - Not Study-Drug Related|1|||
145553173|NCT03060629|524883132|FG000|Overall Study|Death|4|||
145553174|NCT03060629|524883133|FG001|Overall Study|Death|5|||
145553175|NCT03060629|524883132|FG000|Overall Study|Withdrawal by Subject|50|||
145553176|NCT03060629|524883133|FG001|Overall Study|Withdrawal by Subject|35|||
145553177|NCT03060629|524883132|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
145553178|NCT03060629|524883133|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
145553179|NCT03060629|524883132|FG000|Overall Study|Participant Relocate|15|||
145553180|NCT03060629|524883133|FG001|Overall Study|Participant Relocate|15|||
145553181|NCT03060629|524883132|FG000|Overall Study|Unable to Contact Participant|34|||
145553182|NCT03060629|524883133|FG001|Overall Study|Unable to Contact Participant|23|||
145553183|NCT03060629|524883132|FG000|Overall Study|Investigator Decision|7|||
145553184|NCT03060629|524883133|FG001|Overall Study|Investigator Decision|7|||
145553185|NCT03060629|524883132|FG000|Overall Study|Study Terminated by Sponsor|1100|||
145553186|NCT03060629|524883133|FG001|Overall Study|Study Terminated by Sponsor|1123|||
145553187|NCT03060629|524883132|FG000|Overall Study|Other|4|||
145553188|NCT03060629|524883133|FG001|Overall Study|Other|4|||
145553189|NCT01862874|524883134|FG000|Overall Study|Randomized not treated|1|||
145553190|NCT01862874|524883135|FG001|Overall Study|Randomized not treated|0|||
145553191|NCT01862874|524883134|FG000|Overall Study|Adverse Event|0|||
145553192|NCT01862874|524883135|FG001|Overall Study|Adverse Event|3|||
145553193|NCT01862874|524883134|FG000|Overall Study|Lost to Follow-up|26|||
145553194|NCT01862874|524883135|FG001|Overall Study|Lost to Follow-up|29|||
145405775|NCT00785629|524341643|FG000|Overall Study|Adverse Event|2|||
145405776|NCT00785629|524341644|FG001|Overall Study|Adverse Event|1|||
145405777|NCT00785629|524341645|FG002|Overall Study|Adverse Event|1|||
145405778|NCT00785629|524341646|FG003|Overall Study|Adverse Event|5|||
145405779|NCT00785629|524341643|FG000|Overall Study|Protocol Violation|1|||
145405780|NCT00785629|524341644|FG001|Overall Study|Protocol Violation|2|||
145405781|NCT00785629|524341645|FG002|Overall Study|Protocol Violation|4|||
145405782|NCT00785629|524341646|FG003|Overall Study|Protocol Violation|5|||
145405783|NCT00785629|524341643|FG000|Overall Study|administrative decision|5|||
145405784|NCT00785629|524341644|FG001|Overall Study|administrative decision|1|||
145405785|NCT00785629|524341645|FG002|Overall Study|administrative decision|3|||
145405786|NCT00785629|524341646|FG003|Overall Study|administrative decision|4|||
145405787|NCT00785629|524341643|FG000|Overall Study|Withdrawal by Subject|0|||
145405788|NCT00785629|524341644|FG001|Overall Study|Withdrawal by Subject|1|||
145405789|NCT00785629|524341645|FG002|Overall Study|Withdrawal by Subject|2|||
145405790|NCT00785629|524341646|FG003|Overall Study|Withdrawal by Subject|2|||
145405791|NCT00851591|524341648|FG000|Overall Study|Withdrawal by Subject|2|||
145553195|NCT01862874|524883134|FG000|Overall Study|Physician Decision|5|||
145553196|NCT01862874|524883135|FG001|Overall Study|Physician Decision|3|||
145553197|NCT01862874|524883134|FG000|Overall Study|Withdrawn by parent/guardian|1|||
145553198|NCT01862874|524883135|FG001|Overall Study|Withdrawn by parent/guardian|1|||
145553199|NCT01862874|524883134|FG000|Overall Study|Withdrawal by Subject|46|||
145553200|NCT01862874|524883135|FG001|Overall Study|Withdrawal by Subject|40|||
145553201|NCT01862874|524883134|FG000|Overall Study|Death|0|||
145405792|NCT00851591|524341649|FG001|Overall Study|Withdrawal by Subject|0|||
145553202|NCT01862874|524883135|FG001|Overall Study|Death|1|||
145553203|NCT01714635|524883141|FG000|Overall Study|Discontinued|1|||
145553204|NCT01714635|524883142|FG001|Overall Study|Discontinued|0|||
145553205|NCT01714635|524883143|FG002|Overall Study|Discontinued|2|||
145553206|NCT01714635|524883141|FG000|Overall Study|Missed 6-month exam|1|||
145553207|NCT01714635|524883142|FG001|Overall Study|Missed 6-month exam|0|||
145553208|NCT01714635|524883143|FG002|Overall Study|Missed 6-month exam|0|||
145553209|NCT03672747|524883144|FG000|Overall Study|Lost to Follow-up|1|||
145553210|NCT03672747|524883145|FG001|Overall Study|Lost to Follow-up|1|||
145553211|NCT03672747|524883146|FG002|Overall Study|Lost to Follow-up|2|||
145405793|NCT01898130|524341652|FG000|Treatment|Withdrawal by Subject|2|||
145405794|NCT01898130|524341652|FG000|Treatment|Progressive Disease|4|||
145405795|NCT01898130|524341652|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
145611486|NCT00152763|525092721|FG003|Overall Study|Lost to Follow-up|13|||
145611487|NCT00669903|525092722|FG000|Overall Study|Adverse Event|0|||
145611488|NCT00669903|525092723|FG001|Overall Study|Adverse Event|1|||
145611489|NCT00669903|525092724|FG002|Overall Study|Adverse Event|3|||
145611490|NCT00669903|525092725|FG003|Overall Study|Adverse Event|1|||
145611491|NCT00669903|525092722|FG000|Overall Study|Withdrawal by Subject|0|||
145611492|NCT00669903|525092723|FG001|Overall Study|Withdrawal by Subject|2|||
145553212|NCT03672747|524883147|FG003|Overall Study|Lost to Follow-up|2|||
145553213|NCT03672747|524883148|FG004|Overall Study|Lost to Follow-up|2|||
145553214|NCT03672747|524883149|FG005|Overall Study|Lost to Follow-up|1|||
145553215|NCT04285879|524883150|FG000|Overall Study|Lost to Follow-up|1|||
145553216|NCT04285879|524883151|FG001|Overall Study|Lost to Follow-up|8|||
145553217|NCT04285879|524883150|FG000|Overall Study|medical/surgical exclusion|16|||
145553218|NCT04285879|524883151|FG001|Overall Study|medical/surgical exclusion|0|||
145553219|NCT01782495|524883158|FG000|Overall Study|Adverse Event|0|||
145553220|NCT01782495|524883159|FG001|Overall Study|Adverse Event|0|||
145553221|NCT01782495|524883160|FG002|Overall Study|Adverse Event|0|||
145553222|NCT01782495|524883161|FG003|Overall Study|Adverse Event|0|||
145553223|NCT01782495|524883162|FG004|Overall Study|Adverse Event|0|||
145553224|NCT01782495|524883163|FG005|Overall Study|Adverse Event|0|||
145553225|NCT01782495|524883164|FG006|Overall Study|Adverse Event|0|||
145553226|NCT01782495|524883165|FG007|Overall Study|Adverse Event|2|||
145553227|NCT01782495|524883166|FG008|Overall Study|Adverse Event|0|||
145553228|NCT01782495|524883167|FG009|Overall Study|Adverse Event|0|||
145553229|NCT01782495|524883168|FG010|Overall Study|Adverse Event|0|||
145553230|NCT01782495|524883158|FG000|Overall Study|Withdrew Consent|0|||
145553231|NCT01782495|524883159|FG001|Overall Study|Withdrew Consent|1|||
145553232|NCT01782495|524883160|FG002|Overall Study|Withdrew Consent|0|||
145553233|NCT01782495|524883161|FG003|Overall Study|Withdrew Consent|0|||
145553234|NCT01782495|524883162|FG004|Overall Study|Withdrew Consent|0|||
145553235|NCT01782495|524883163|FG005|Overall Study|Withdrew Consent|0|||
145553236|NCT01782495|524883164|FG006|Overall Study|Withdrew Consent|0|||
145553237|NCT01782495|524883165|FG007|Overall Study|Withdrew Consent|1|||
145553238|NCT01782495|524883166|FG008|Overall Study|Withdrew Consent|0|||
145611493|NCT00669903|525092724|FG002|Overall Study|Withdrawal by Subject|2|||
145611494|NCT00669903|525092725|FG003|Overall Study|Withdrawal by Subject|2|||
145611495|NCT00669903|525092722|FG000|Overall Study|Lost to Follow-up|1|||
145611496|NCT00669903|525092723|FG001|Overall Study|Lost to Follow-up|1|||
145611497|NCT00669903|525092724|FG002|Overall Study|Lost to Follow-up|0|||
145611498|NCT00669903|525092725|FG003|Overall Study|Lost to Follow-up|1|||
145611499|NCT00669903|525092722|FG000|Overall Study|Protocol Violation|0|||
145611500|NCT00669903|525092723|FG001|Overall Study|Protocol Violation|1|||
145611501|NCT00669903|525092724|FG002|Overall Study|Protocol Violation|0|||
145611502|NCT00669903|525092725|FG003|Overall Study|Protocol Violation|0|||
145611503|NCT01678820|525092726|FG000|Overall Study|Study Terminated by Sponsor|45|||
145611504|NCT01678820|525092727|FG001|Overall Study|Study Terminated by Sponsor|43|||
145611505|NCT01678820|525092728|FG002|Overall Study|Study Terminated by Sponsor|43|||
145611506|NCT01678820|525092726|FG000|Overall Study|Withdrawal by Subject|2|||
145611507|NCT01678820|525092727|FG001|Overall Study|Withdrawal by Subject|5|||
145611508|NCT01678820|525092728|FG002|Overall Study|Withdrawal by Subject|2|||
145611509|NCT01678820|525092726|FG000|Overall Study|Protocol Specified Criteria|2|||
145611510|NCT01678820|525092727|FG001|Overall Study|Protocol Specified Criteria|3|||
145611511|NCT01678820|525092728|FG002|Overall Study|Protocol Specified Criteria|1|||
145611512|NCT01678820|525092726|FG000|Overall Study|Adverse Event|2|||
145611513|NCT01678820|525092727|FG001|Overall Study|Adverse Event|2|||
145611514|NCT01678820|525092728|FG002|Overall Study|Adverse Event|2|||
145611515|NCT01678820|525092726|FG000|Overall Study|Lost to Follow-up|7|||
145611516|NCT01678820|525092727|FG001|Overall Study|Lost to Follow-up|2|||
145611517|NCT01678820|525092728|FG002|Overall Study|Lost to Follow-up|2|||
145284503|NCT01806597|523891622|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
145284504|NCT01806597|523891617|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
145284505|NCT01806597|523891618|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
145284506|NCT01806597|523891619|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
145284507|NCT01806597|523891620|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
145284508|NCT01806597|523891621|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
145284509|NCT01806597|523891622|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
145284510|NCT01806597|523891617|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
145284511|NCT01806597|523891618|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
145284512|NCT01806597|523891619|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
145284513|NCT01806597|523891620|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
145284514|NCT01806597|523891621|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
145553239|NCT01782495|524883167|FG009|Overall Study|Withdrew Consent|0|||
145553240|NCT01782495|524883168|FG010|Overall Study|Withdrew Consent|0|||
145553241|NCT01927367|524883169|FG000|Overall Study|Withdrawal by Subject|7|||
145553242|NCT01927367|524883170|FG001|Overall Study|Withdrawal by Subject|4|||
145553243|NCT01927367|524883169|FG000|Overall Study|No baseline data|0|||
145553244|NCT01927367|524883170|FG001|Overall Study|No baseline data|1|||
145284515|NCT01806597|523891622|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
145284516|NCT01806597|523891617|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
145284517|NCT01806597|523891618|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
145284518|NCT01806597|523891619|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
145284519|NCT01806597|523891620|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
145284520|NCT01806597|523891621|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
145284521|NCT01806597|523891622|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
145284522|NCT02482805|523891623|FG000|Overall Study|Lost to Follow-up|4|||
145284523|NCT02482805|523891624|FG001|Overall Study|Lost to Follow-up|4|||
145284524|NCT02482805|523891625|FG002|Overall Study|Lost to Follow-up|0|||
145284525|NCT01144663|523891626|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
145284526|NCT01144663|523891627|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
145284527|NCT01144663|523891628|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
145284528|NCT01144663|523891629|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
145284529|NCT01144663|523891626|FG000|Primary Vaccination Phase|Adverse Event|1|||
145553245|NCT00241280|524883175|FG000|Overall Study|Adverse Event|2|||
145553246|NCT00241280|524883176|FG001|Overall Study|Adverse Event|6|||
145553247|NCT00241280|524883175|FG000|Overall Study|Discomfort|11|||
145553248|NCT00241280|524883176|FG001|Overall Study|Discomfort|16|||
145611518|NCT01678820|525092726|FG000|Overall Study|Non-compliance with study drug|0|||
145611519|NCT01678820|525092727|FG001|Overall Study|Non-compliance with study drug|1|||
145611520|NCT01678820|525092728|FG002|Overall Study|Non-compliance with study drug|0|||
145611521|NCT01678820|525092726|FG000|Overall Study|Physician Decision|0|||
145611522|NCT01678820|525092727|FG001|Overall Study|Physician Decision|0|||
145284530|NCT01144663|523891627|FG001|Primary Vaccination Phase|Adverse Event|0|||
145284531|NCT01144663|523891628|FG002|Primary Vaccination Phase|Adverse Event|0|||
145405796|NCT00920816|524341653|FG000|Overall Study|Death|116|||
145611523|NCT01678820|525092728|FG002|Overall Study|Physician Decision|1|||
145611524|NCT01678820|525092726|FG000|Overall Study|Protocol Violation|4|||
145611525|NCT01678820|525092727|FG001|Overall Study|Protocol Violation|5|||
145405797|NCT00920816|524341654|FG001|Overall Study|Death|63|||
145405798|NCT00920816|524341655|FG002|Overall Study|Death|8|||
145405799|NCT00920816|524341656|FG003|Overall Study|Death|3|||
145405800|NCT00920816|524341653|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
145405801|NCT00920816|524341654|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
145405802|NCT00920816|524341655|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
145405803|NCT00920816|524341656|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
145405804|NCT00920816|524341653|FG000|Overall Study|Global deterioration of health status|2|||
145405805|NCT00920816|524341654|FG001|Overall Study|Global deterioration of health status|0|||
145405806|NCT00920816|524341655|FG002|Overall Study|Global deterioration of health status|0|||
145405807|NCT00920816|524341656|FG003|Overall Study|Global deterioration of health status|0|||
145405808|NCT00920816|524341653|FG000|Overall Study|Objective progression or relapse|6|||
145405809|NCT00920816|524341654|FG001|Overall Study|Objective progression or relapse|2|||
145405810|NCT00920816|524341655|FG002|Overall Study|Objective progression or relapse|0|||
145405811|NCT00920816|524341656|FG003|Overall Study|Objective progression or relapse|0|||
145405812|NCT00920816|524341653|FG000|Overall Study|Other|26|||
145405813|NCT00920816|524341654|FG001|Overall Study|Other|15|||
145405814|NCT00920816|524341655|FG002|Overall Study|Other|1|||
145405815|NCT00920816|524341656|FG003|Overall Study|Other|2|||
145405816|NCT00920816|524341653|FG000|Overall Study|Lost to Follow-up|11|||
145405817|NCT00920816|524341654|FG001|Overall Study|Lost to Follow-up|2|||
145405818|NCT00920816|524341655|FG002|Overall Study|Lost to Follow-up|0|||
145405819|NCT00920816|524341656|FG003|Overall Study|Lost to Follow-up|0|||
145405820|NCT00920816|524341653|FG000|Overall Study|Adverse Event|1|||
145405821|NCT00920816|524341654|FG001|Overall Study|Adverse Event|1|||
145405822|NCT00920816|524341655|FG002|Overall Study|Adverse Event|1|||
145405823|NCT00920816|524341656|FG003|Overall Study|Adverse Event|0|||
145405824|NCT00920816|524341653|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
145405825|NCT00920816|524341654|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
145405826|NCT00920816|524341655|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
145405827|NCT00920816|524341656|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
145405828|NCT00920816|524341653|FG000|Overall Study|Randomized but not treated|3|||
145405829|NCT00920816|524341654|FG001|Overall Study|Randomized but not treated|0|||
145405830|NCT00920816|524341655|FG002|Overall Study|Randomized but not treated|0|||
145405831|NCT00920816|524341656|FG003|Overall Study|Randomized but not treated|0|||
145405832|NCT03620162|524341657|FG000|Overall Study|Physician Decision|4|||
145405833|NCT03620162|524341658|FG001|Overall Study|Physician Decision|0|||
145405834|NCT03620162|524341659|FG002|Overall Study|Physician Decision|1|||
145405835|NCT03620162|524341660|FG003|Overall Study|Physician Decision|0|||
145553249|NCT00241280|524883175|FG000|Overall Study|Pregnancy|1|||
145553250|NCT00241280|524883176|FG001|Overall Study|Pregnancy|5|||
145553251|NCT00241280|524883175|FG000|Overall Study|Lost to Follow-up|5|||
145553252|NCT00241280|524883176|FG001|Overall Study|Lost to Follow-up|8|||
145553253|NCT00241280|524883175|FG000|Overall Study|Withdrawal by Subject|7|||
145405836|NCT03620162|524341661|FG004|Overall Study|Physician Decision|2|||
145405837|NCT03620162|524341657|FG000|Overall Study|Lost to Follow-up|2|||
145405838|NCT03620162|524341658|FG001|Overall Study|Lost to Follow-up|6|||
145405839|NCT03620162|524341659|FG002|Overall Study|Lost to Follow-up|7|||
145553254|NCT00241280|524883176|FG001|Overall Study|Withdrawal by Subject|4|||
145611526|NCT01678820|525092728|FG002|Overall Study|Protocol Violation|4|||
145611527|NCT01678820|525092726|FG000|Overall Study|Not treated with double-blind study drug|0|||
145284532|NCT01144663|523891629|FG003|Primary Vaccination Phase|Adverse Event|1|||
145284533|NCT01144663|523891626|FG000|Primary Vaccination Phase|Protocol Violation|2|||
145284534|NCT01144663|523891627|FG001|Primary Vaccination Phase|Protocol Violation|0|||
145284535|NCT01144663|523891628|FG002|Primary Vaccination Phase|Protocol Violation|1|||
145284536|NCT01144663|523891629|FG003|Primary Vaccination Phase|Protocol Violation|0|||
145284537|NCT01144663|523891626|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
145284538|NCT01144663|523891627|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
145284539|NCT01144663|523891628|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
145284540|NCT01144663|523891629|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
145284541|NCT01144663|523891626|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
145284542|NCT01144663|523891627|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
145284543|NCT01144663|523891628|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
145284544|NCT01144663|523891629|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
145284545|NCT01144663|523891626|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
145284546|NCT01144663|523891627|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
145284547|NCT01144663|523891628|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
145284548|NCT01144663|523891629|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
145284549|NCT01144663|523891626|FG000|Primary Vaccination Phase|Other|0|||
145284550|NCT01144663|523891627|FG001|Primary Vaccination Phase|Other|1|||
145284551|NCT01144663|523891628|FG002|Primary Vaccination Phase|Other|0|||
145284552|NCT01144663|523891629|FG003|Primary Vaccination Phase|Other|2|||
145284553|NCT01144663|523891626|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
145284554|NCT01144663|523891627|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
145284555|NCT01144663|523891628|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
145405840|NCT03620162|524341660|FG003|Overall Study|Lost to Follow-up|3|||
145405841|NCT03620162|524341661|FG004|Overall Study|Lost to Follow-up|2|||
145405842|NCT03620162|524341657|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
145405843|NCT03620162|524341658|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
145405844|NCT03620162|524341659|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
145405845|NCT03620162|524341660|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
145405846|NCT03620162|524341661|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
145405847|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
145405848|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
145405849|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
145405850|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
145405851|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
145405852|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
145405853|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
145405854|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
145405855|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
145405856|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
145405857|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
145405858|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
145405859|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
145405860|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
145405861|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
145405862|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
145405863|NCT00410163|524341664|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
145405864|NCT00410163|524341665|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
145405865|NCT00410163|524341664|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
145405866|NCT00410163|524341665|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
145405867|NCT00410163|524341664|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
145405868|NCT00410163|524341665|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
145405869|NCT00410163|524341664|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
145405870|NCT00410163|524341665|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
145405871|NCT00410163|524341664|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
145405872|NCT00410163|524341665|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
145405873|NCT00410163|524341664|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
145405874|NCT00410163|524341665|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
145405875|NCT04009837|524341667|FG000|Overall Study|Withdrawal by Subject|5|||
145405876|NCT04009837|524341668|FG001|Overall Study|Withdrawal by Subject|4|||
145405877|NCT04009837|524341667|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
145405878|NCT04009837|524341668|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
145405879|NCT01572792|524341671|FG000|Lead-in Study|Lost to Follow-up|5|||
145405880|NCT01572792|524341672|FG001|Lead-in Study|Lost to Follow-up|9|||
145405881|NCT01572792|524341673|FG002|Lead-in Study|Lost to Follow-up|4|||
145405882|NCT01572792|524341674|FG003|Lead-in Study|Lost to Follow-up|2|||
145405883|NCT01572792|524341675|FG004|Lead-in Study|Lost to Follow-up|4|||
145405884|NCT01572792|524341671|FG000|Lead-in Study|Withdrawal by Subject|22|||
145405885|NCT01572792|524341672|FG001|Lead-in Study|Withdrawal by Subject|11|||
145405886|NCT01572792|524341673|FG002|Lead-in Study|Withdrawal by Subject|12|||
145405887|NCT01572792|524341674|FG003|Lead-in Study|Withdrawal by Subject|24|||
145405888|NCT01572792|524341675|FG004|Lead-in Study|Withdrawal by Subject|11|||
145405889|NCT01572792|524341671|FG000|Lead-in Study|Protocol Violation|19|||
145405890|NCT01572792|524341672|FG001|Lead-in Study|Protocol Violation|10|||
145405891|NCT01572792|524341673|FG002|Lead-in Study|Protocol Violation|12|||
145405892|NCT01572792|524341674|FG003|Lead-in Study|Protocol Violation|13|||
145611528|NCT01678820|525092727|FG001|Overall Study|Not treated with double-blind study drug|2|||
145405893|NCT01572792|524341675|FG004|Lead-in Study|Protocol Violation|21|||
145405894|NCT01572792|524341671|FG000|Lead-in Study|Lack of Efficacy|20|||
145405895|NCT01572792|524341672|FG001|Lead-in Study|Lack of Efficacy|5|||
145611529|NCT01678820|525092728|FG002|Overall Study|Not treated with double-blind study drug|2|||
145611530|NCT00936221|525092729|FG000|Overall Study|Withdrawal by Subject|1|||
145611531|NCT00936221|525092730|FG001|Overall Study|Withdrawal by Subject|1|||
145611532|NCT01351025|525092732|FG000|Week 0 - 20|Lost to Follow-up|2|||
145611533|NCT01351025|525092733|FG001|Week 0 - 20|Lost to Follow-up|1|||
145611534|NCT01351025|525092732|FG000|Week 0 - 20|Withdrawal by Subject|1|||
145611535|NCT01351025|525092733|FG001|Week 0 - 20|Withdrawal by Subject|0|||
145611536|NCT01351025|525092732|FG000|Week 24 - 44|Lost to Follow-up|0|||
145611537|NCT01351025|525092733|FG001|Week 24 - 44|Lost to Follow-up|2|||
145611538|NCT01351025|525092732|FG000|Week 24 - 44|Site closed|0|||
145611539|NCT01351025|525092733|FG001|Week 24 - 44|Site closed|1|||
145611540|NCT01351025|525092732|FG000|Week 24 - 44|unable to get to clinic|1|||
145611541|NCT01351025|525092733|FG001|Week 24 - 44|unable to get to clinic|1|||
145611542|NCT05067933|525092735|FG000|Overall Study|Withdrawal by Subject|2|||
145611543|NCT05067933|525092736|FG001|Overall Study|Withdrawal by Subject|0|||
145611544|NCT05067933|525092737|FG002|Overall Study|Withdrawal by Subject|0|||
145611545|NCT05067933|525092738|FG003|Overall Study|Withdrawal by Subject|0|||
145405896|NCT01572792|524341673|FG002|Lead-in Study|Lack of Efficacy|4|||
145611546|NCT05067933|525092739|FG004|Overall Study|Withdrawal by Subject|0|||
145611547|NCT05067933|525092740|FG005|Overall Study|Withdrawal by Subject|0|||
145611548|NCT05067933|525092735|FG000|Overall Study|Lost to Follow-up|1|||
145553255|NCT00241280|524883175|FG000|Overall Study|Protocol Violation|4|||
145553256|NCT00241280|524883176|FG001|Overall Study|Protocol Violation|10|||
145553257|NCT00241280|524883175|FG000|Overall Study|Relocation|4|||
145553258|NCT00241280|524883176|FG001|Overall Study|Relocation|4|||
145553259|NCT00241280|524883175|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
145553260|NCT00241280|524883176|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
145553261|NCT00241280|524883175|FG000|Overall Study|Unsatisfactory Visual Response|1|||
145553262|NCT00241280|524883176|FG001|Overall Study|Unsatisfactory Visual Response|1|||
145553263|NCT00241280|524883175|FG000|Overall Study|Diabetic|1|||
145553264|NCT00241280|524883176|FG001|Overall Study|Diabetic|0|||
145553265|NCT00241280|524883175|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
145553266|NCT00241280|524883176|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
145553267|NCT00241280|524883175|FG000|Overall Study|Dispensed incorrect test article|1|||
145553268|NCT00241280|524883176|FG001|Overall Study|Dispensed incorrect test article|2|||
145553269|NCT00241280|524883175|FG000|Overall Study|Unacceptable Fit|0|||
145553270|NCT00241280|524883176|FG001|Overall Study|Unacceptable Fit|1|||
145553271|NCT00241280|524883175|FG000|Overall Study|Scheduling Conflict|0|||
145553272|NCT00241280|524883176|FG001|Overall Study|Scheduling Conflict|2|||
145553273|NCT00241280|524883175|FG000|Overall Study|History of Ocular Surgery|0|||
145553274|NCT00241280|524883176|FG001|Overall Study|History of Ocular Surgery|1|||
145553275|NCT00241280|524883175|FG000|Overall Study|Coating on Lens|1|||
145553276|NCT00241280|524883176|FG001|Overall Study|Coating on Lens|0|||
145553277|NCT00241280|524883175|FG000|Overall Study|Excessive Dryness|0|||
145553278|NCT00241280|524883176|FG001|Overall Study|Excessive Dryness|1|||
145553279|NCT01634360|524883177|FG000|Overall Study|Adverse Event|10|||
145553280|NCT01634360|524883178|FG001|Overall Study|Adverse Event|34|||
145553281|NCT01634360|524883177|FG000|Overall Study|subject withdrew consent|13|||
145553282|NCT01634360|524883178|FG001|Overall Study|subject withdrew consent|23|||
145553283|NCT01634360|524883177|FG000|Overall Study|Protocol Violation|1|||
145553284|NCT01634360|524883178|FG001|Overall Study|Protocol Violation|1|||
145553285|NCT01634360|524883177|FG000|Overall Study|Lack of Efficacy|4|||
145553286|NCT01634360|524883178|FG001|Overall Study|Lack of Efficacy|14|||
145553287|NCT01634360|524883177|FG000|Overall Study|Other|3|||
145553288|NCT01634360|524883178|FG001|Overall Study|Other|20|||
145553289|NCT01634360|524883177|FG000|Overall Study|Study termination by sponsor|18|||
145553290|NCT01634360|524883178|FG001|Overall Study|Study termination by sponsor|44|||
145553291|NCT02999854|524883179|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
145553292|NCT02999854|524883180|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
145553293|NCT02999854|524883179|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
145553294|NCT02999854|524883180|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
145405897|NCT01572792|524341674|FG003|Lead-in Study|Lack of Efficacy|8|||
145553295|NCT02999854|524883179|FG000|Active Study Phase (up to 18 Months)|Death|7|||
145553296|NCT02999854|524883180|FG001|Active Study Phase (up to 18 Months)|Death|5|||
145553297|NCT02999854|524883179|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
145553298|NCT02999854|524883180|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
145553299|NCT02999854|524883179|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
145553300|NCT02999854|524883180|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
145553301|NCT02999854|524883179|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
145553302|NCT02999854|524883180|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
145553303|NCT02999854|524883179|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
145553304|NCT02999854|524883180|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
145553305|NCT02999854|524883179|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
145553306|NCT02999854|524883180|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
145553307|NCT02848651|524883181|FG000|Overall Study|Death|85|||
145553308|NCT02848651|524883181|FG000|Overall Study|Lost to Follow-up|1|||
145553309|NCT02848651|524883181|FG000|Overall Study|Non-Compliance|1|||
145553310|NCT02848651|524883181|FG000|Overall Study|Symptomatic Deterioration|1|||
145553311|NCT02848651|524883181|FG000|Overall Study|Physician Decision|4|||
145553312|NCT02848651|524883181|FG000|Overall Study|Withdrawal by Subject|14|||
145553313|NCT02480114|524883182|FG000|Overall Study|Not completing surveys|3|||
145553314|NCT02480114|524883183|FG001|Overall Study|Not completing surveys|2|||
145553315|NCT02480114|524883182|FG000|Overall Study|Withdrawal by Subject|2|||
145553316|NCT02480114|524883183|FG001|Overall Study|Withdrawal by Subject|4|||
145553317|NCT02480114|524883182|FG000|Overall Study|Disease progression|3|||
145553318|NCT02480114|524883183|FG001|Overall Study|Disease progression|0|||
145553319|NCT02480114|524883182|FG000|Overall Study|Improper completion of survey|1|||
145553320|NCT02480114|524883183|FG001|Overall Study|Improper completion of survey|1|||
145553321|NCT02480114|524883182|FG000|Overall Study|Not eligible|0|||
145553322|NCT02480114|524883183|FG001|Overall Study|Not eligible|1|||
145553323|NCT00512707|524883184|FG000|Overall Study|Lost to Follow-up|5|||
145553324|NCT00512707|524883185|FG001|Overall Study|Lost to Follow-up|11|||
145553325|NCT00512707|524883184|FG000|Overall Study|Developed skin irritation|2|||
145553326|NCT00512707|524883185|FG001|Overall Study|Developed skin irritation|1|||
145553327|NCT00512707|524883184|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
145553328|NCT00512707|524883185|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
145553329|NCT00512707|524883184|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
145553330|NCT00512707|524883185|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
145553331|NCT01317160|524883186|FG000|Overall Study|Incorrect inclusion|1|||
145553332|NCT01317160|524883187|FG001|Overall Study|Incorrect inclusion|1|||
145553333|NCT01317160|524883186|FG000|Overall Study|Lost to Follow-up|3|||
145553334|NCT01317160|524883187|FG001|Overall Study|Lost to Follow-up|3|||
145553335|NCT01317160|524883186|FG000|Overall Study|Withdrawal by Subject|0|||
145553336|NCT01317160|524883187|FG001|Overall Study|Withdrawal by Subject|2|||
145553337|NCT01853826|524884856|FG000|Overall Study|Patients who switched to commercial drug|11|||
145553338|NCT01853826|524884856|FG000|Overall Study|Patient refused to continue medication|21|||
145553339|NCT01853826|524884856|FG000|Overall Study|Lost to Follow-up|2|||
145553340|NCT01853826|524884856|FG000|Overall Study|Non-compliant with protocol|4|||
145553341|NCT01853826|524884856|FG000|Overall Study|Other adverse events (AE)|62|||
145553342|NCT01853826|524884856|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
145553343|NCT01853826|524884856|FG000|Overall Study|Progressive disease|342|||
145553344|NCT01853826|524884856|FG000|Overall Study|Other than listed|13|||
145553345|NCT01853826|524884856|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
145553346|NCT03653637|524884857|FG000|Overall Study|Death|1|||
145553347|NCT03653637|524884858|FG001|Overall Study|Death|3|||
145553348|NCT03653637|524884857|FG000|Overall Study|Lost to Follow-up|29|||
145553349|NCT03653637|524884858|FG001|Overall Study|Lost to Follow-up|30|||
145553350|NCT03653637|524884857|FG000|Overall Study|Physician Decision|1|||
145553351|NCT03653637|524884858|FG001|Overall Study|Physician Decision|1|||
145553352|NCT03653637|524884857|FG000|Overall Study|Withdrawal by Subject|7|||
145553353|NCT03653637|524884858|FG001|Overall Study|Withdrawal by Subject|4|||
145611549|NCT05067933|525092736|FG001|Overall Study|Lost to Follow-up|1|||
145553354|NCT05661942|524884860|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
145553355|NCT05661942|524884861|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
145553356|NCT02664441|524884862|FG000|Randomization|Withdrawal by Subject|0|||
145553357|NCT02664441|524884863|FG001|Randomization|Withdrawal by Subject|1|||
145553358|NCT02664441|524884862|FG000|36-week Randomized Trial|Adverse Event|2|||
145553359|NCT02664441|524884863|FG001|36-week Randomized Trial|Adverse Event|0|||
145553360|NCT02664441|524884862|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
145553361|NCT02664441|524884863|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
145553362|NCT02664441|524884862|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
145553363|NCT02664441|524884863|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
145553364|NCT02664441|524884862|FG000|18-week Open Label Extension|Adverse Event|1|||
145553365|NCT02664441|524884863|FG001|18-week Open Label Extension|Adverse Event|0|||
145553366|NCT02664441|524884862|FG000|18-week Open Label Extension|Physician Decision|1|||
145553367|NCT02664441|524884863|FG001|18-week Open Label Extension|Physician Decision|0|||
145553368|NCT02664441|524884862|FG000|18-week Open Label Extension|Death|1|||
145553369|NCT02664441|524884863|FG001|18-week Open Label Extension|Death|0|||
145553370|NCT02664441|524884862|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
145553371|NCT02664441|524884863|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
145553372|NCT05040386|524884864|FG000|Overall Study|Withdrawal by Subject|1|||
145553373|NCT05040386|524884865|FG001|Overall Study|Withdrawal by Subject|0|||
145553374|NCT05040386|524884866|FG002|Overall Study|Withdrawal by Subject|1|||
145553375|NCT05040386|524884867|FG003|Overall Study|Withdrawal by Subject|0|||
145553376|NCT05040386|524884864|FG000|Overall Study|Lost to Follow-up|0|||
145553377|NCT05040386|524884865|FG001|Overall Study|Lost to Follow-up|0|||
145553378|NCT05040386|524884866|FG002|Overall Study|Lost to Follow-up|1|||
145553379|NCT05040386|524884867|FG003|Overall Study|Lost to Follow-up|0|||
145611550|NCT05067933|525092737|FG002|Overall Study|Lost to Follow-up|1|||
145553380|NCT00082355|524884868|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
145553381|NCT00082355|524884868|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
145553382|NCT00082355|524884868|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
145405898|NCT01572792|524341675|FG004|Lead-in Study|Lack of Efficacy|10|||
145405899|NCT01572792|524341671|FG000|Lead-in Study|Adverse Event|21|||
145405900|NCT01572792|524341672|FG001|Lead-in Study|Adverse Event|21|||
145405901|NCT01572792|524341673|FG002|Lead-in Study|Adverse Event|22|||
145405902|NCT01572792|524341674|FG003|Lead-in Study|Adverse Event|16|||
145405903|NCT01572792|524341675|FG004|Lead-in Study|Adverse Event|14|||
145405904|NCT01572792|524341671|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
145405905|NCT01572792|524341672|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
145553383|NCT01084174|524884869|FG000|Overall Study|gastrointestinal symptoms|1|||
145553384|NCT01084174|524884870|FG001|Overall Study|gastrointestinal symptoms|1|||
145405906|NCT01572792|524341673|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
145405907|NCT01572792|524341674|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
145553385|NCT01084174|524884869|FG000|Overall Study|Eosinophilic esophagitis|0|||
145553386|NCT01084174|524884870|FG001|Overall Study|Eosinophilic esophagitis|1|||
145553387|NCT01084174|524884869|FG000|Overall Study|Anaphylaxis|0|||
145553388|NCT01084174|524884870|FG001|Overall Study|Anaphylaxis|1|||
145553389|NCT01084174|524884869|FG000|Overall Study|Participant noncompliance|0|||
145553390|NCT01084174|524884870|FG001|Overall Study|Participant noncompliance|1|||
145553391|NCT01594125|524884871|FG000|Overall Study|Withdrawal by Subject|1|||
145553392|NCT01594125|524884872|FG001|Overall Study|Withdrawal by Subject|0|||
145553393|NCT01594125|524884873|FG002|Overall Study|Withdrawal by Subject|0|||
145553394|NCT01594125|524884874|FG003|Overall Study|Withdrawal by Subject|1|||
145553395|NCT01594125|524884875|FG004|Overall Study|Withdrawal by Subject|0|||
145553396|NCT01594125|524884871|FG000|Overall Study|Progressive Disease|3|||
145553397|NCT01594125|524884872|FG001|Overall Study|Progressive Disease|12|||
145553398|NCT01594125|524884873|FG002|Overall Study|Progressive Disease|3|||
145553399|NCT01594125|524884874|FG003|Overall Study|Progressive Disease|3|||
145553400|NCT01594125|524884875|FG004|Overall Study|Progressive Disease|7|||
145553401|NCT01484873|524884876|FG000|Overall Study|Withdrawal by Subject|2|||
145553402|NCT01549392|524884877|FG000|Overall Study|Withdrawal by Subject|1|||
145553403|NCT01549392|524884878|FG001|Overall Study|Withdrawal by Subject|0|||
145553404|NCT02743806|524884879|FG000|Overall Study|Adverse Event|9|||
145553405|NCT02743806|524884879|FG000|Overall Study|Lost to Follow-up|8|||
145405908|NCT01572792|524341675|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
145405909|NCT01572792|524341671|FG000|Extension Study|Lost to Follow-up|6|||
145405910|NCT01572792|524341672|FG001|Extension Study|Lost to Follow-up|2|||
145553406|NCT02743806|524884879|FG000|Overall Study|Voluntary Withdrawal|54|||
145553407|NCT02743806|524884879|FG000|Overall Study|Study Termination|65|||
145553408|NCT02743806|524884879|FG000|Overall Study|Pregnancy|6|||
145553409|NCT02743806|524884879|FG000|Overall Study|No Longer Clinically Benefiting|27|||
145553410|NCT02743806|524884879|FG000|Overall Study|Reason Not Specified|12|||
145553411|NCT01988103|524884880|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
145553412|NCT01988103|524884881|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
145553413|NCT01988103|524884882|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
145553414|NCT01988103|524884883|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
145553415|NCT01988103|524884884|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
145553416|NCT01988103|524884880|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
145553417|NCT01988103|524884881|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
145553418|NCT01988103|524884882|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
145553419|NCT01988103|524884883|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
145553420|NCT01988103|524884884|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
145284556|NCT01144663|523891629|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
145284557|NCT01144663|523891626|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
145284558|NCT01144663|523891627|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
145284559|NCT01144663|523891628|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
145284560|NCT01144663|523891629|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
145284561|NCT01144663|523891626|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
145284562|NCT01144663|523891627|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
145284563|NCT01144663|523891628|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
145284564|NCT01144663|523891629|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
145284565|NCT01144663|523891626|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
145284566|NCT01144663|523891627|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
145284567|NCT01144663|523891628|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
145284568|NCT01144663|523891629|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
145284569|NCT01144663|523891626|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
145284570|NCT01144663|523891627|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
145284571|NCT01144663|523891628|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
145284572|NCT01144663|523891629|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
145284573|NCT01144663|523891626|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
145553421|NCT01988103|524884880|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
145553422|NCT01988103|524884881|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
145611551|NCT05067933|525092738|FG003|Overall Study|Lost to Follow-up|2|||
145284574|NCT01144663|523891627|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
145284575|NCT01144663|523891628|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
145284576|NCT01144663|523891629|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
145284577|NCT01267266|523891632|FG000|Enrollment Phase|Withdrawal by Subject|2|||
145284578|NCT01267266|523891633|FG001|Enrollment Phase|Withdrawal by Subject|0|||
145284579|NCT01267266|523891632|FG000|Lead-in Phase|Lack of Efficacy|20|||
145284580|NCT01267266|523891633|FG001|Lead-in Phase|Lack of Efficacy|0|||
145284581|NCT01267266|523891632|FG000|Lead-in Phase|Adverse Event|2|||
145284582|NCT01267266|523891633|FG001|Lead-in Phase|Adverse Event|0|||
145284583|NCT01267266|523891632|FG000|Lead-in Phase|Withdrawal by Subject|1|||
145284584|NCT01267266|523891633|FG001|Lead-in Phase|Withdrawal by Subject|0|||
145284585|NCT01335477|523891635|FG000|Overall Study|Adverse Event|30|||
145284586|NCT01335477|523891636|FG001|Overall Study|Adverse Event|42|||
145284587|NCT01335477|523891635|FG000|Overall Study|Non compliant with protocol|0|||
145284588|NCT01335477|523891636|FG001|Overall Study|Non compliant with protocol|2|||
145284589|NCT01335477|523891635|FG000|Overall Study|Lost to Follow-up|1|||
145284590|NCT01335477|523891636|FG001|Overall Study|Lost to Follow-up|2|||
145284591|NCT01335477|523891635|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
145284592|NCT01335477|523891636|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
145284593|NCT01335477|523891635|FG000|Overall Study|Not treated|1|||
145284594|NCT01335477|523891636|FG001|Overall Study|Not treated|2|||
145284595|NCT01335477|523891635|FG000|Overall Study|Reason other than those stated above|2|||
145284596|NCT01335477|523891636|FG001|Overall Study|Reason other than those stated above|2|||
145284597|NCT02038634|523891638|FG000|Overall Study|Lost to Follow-up|0|||
145611552|NCT05067933|525092739|FG004|Overall Study|Lost to Follow-up|1|||
145611553|NCT05067933|525092740|FG005|Overall Study|Lost to Follow-up|0|||
145611554|NCT05067933|525092735|FG000|Overall Study|Miscellaneous|1|||
145611555|NCT05067933|525092736|FG001|Overall Study|Miscellaneous|0|||
145611556|NCT05067933|525092737|FG002|Overall Study|Miscellaneous|0|||
145611557|NCT05067933|525092738|FG003|Overall Study|Miscellaneous|0|||
145553423|NCT01988103|524884882|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
145553424|NCT01988103|524884883|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145553425|NCT01988103|524884884|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145553426|NCT01988103|524884880|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
145611558|NCT05067933|525092739|FG004|Overall Study|Miscellaneous|0|||
145611559|NCT05067933|525092740|FG005|Overall Study|Miscellaneous|0|||
145611560|NCT05067933|525092735|FG000|Overall Study|Death|0|||
145611561|NCT05067933|525092736|FG001|Overall Study|Death|0|||
145611562|NCT05067933|525092737|FG002|Overall Study|Death|0|||
145611563|NCT05067933|525092738|FG003|Overall Study|Death|1|||
145611564|NCT05067933|525092739|FG004|Overall Study|Death|0|||
145611565|NCT05067933|525092740|FG005|Overall Study|Death|0|||
145284598|NCT02038634|523891639|FG001|Overall Study|Lost to Follow-up|1|||
145284599|NCT01034137|523891641|FG000|Overall Study|Adverse Event|9|||
145284600|NCT01034137|523891642|FG001|Overall Study|Adverse Event|10|||
145284601|NCT01034137|523891643|FG002|Overall Study|Adverse Event|8|||
145284602|NCT01034137|523891641|FG000|Overall Study|Withdrawal by Subject|4|||
145284603|NCT01034137|523891642|FG001|Overall Study|Withdrawal by Subject|3|||
145284604|NCT01034137|523891643|FG002|Overall Study|Withdrawal by Subject|3|||
145284605|NCT01034137|523891641|FG000|Overall Study|Lack of Efficacy|9|||
145284606|NCT01034137|523891642|FG001|Overall Study|Lack of Efficacy|4|||
145284607|NCT01034137|523891643|FG002|Overall Study|Lack of Efficacy|13|||
145284608|NCT01034137|523891641|FG000|Overall Study|Protocol Violation|2|||
145284609|NCT01034137|523891642|FG001|Overall Study|Protocol Violation|2|||
145284610|NCT01034137|523891643|FG002|Overall Study|Protocol Violation|1|||
145284611|NCT01034137|523891641|FG000|Overall Study|Refused treatment or did not cooperate|2|||
145284612|NCT01034137|523891642|FG001|Overall Study|Refused treatment or did not cooperate|0|||
145405911|NCT01572792|524341673|FG002|Extension Study|Lost to Follow-up|0|||
145405912|NCT01572792|524341674|FG003|Extension Study|Lost to Follow-up|3|||
145405913|NCT01572792|524341675|FG004|Extension Study|Lost to Follow-up|3|||
145405914|NCT01572792|524341671|FG000|Extension Study|Withdrawal by Subject|7|||
145611566|NCT01065350|525092741|FG000|Overall Study|Received incorrect drug allocation|0|||
145611567|NCT01065350|525092742|FG001|Overall Study|Received incorrect drug allocation|1|||
145611568|NCT02875834|525092745|FG000|Open-label Phase|Withdrawal by Subject|3|||
145611569|NCT02875834|525092746|FG001|Open-label Phase|Withdrawal by Subject|0|||
145611570|NCT02875834|525092747|FG002|Open-label Phase|Withdrawal by Subject|0|||
145611571|NCT02875834|525092748|FG003|Open-label Phase|Withdrawal by Subject|0|||
145611572|NCT02875834|525092745|FG000|Open-label Phase|(Not collected)|4|||
145611573|NCT02875834|525092746|FG001|Open-label Phase|(Not collected)|0|||
145611574|NCT02875834|525092747|FG002|Open-label Phase|(Not collected)|0|||
145611575|NCT02875834|525092748|FG003|Open-label Phase|(Not collected)|0|||
145611576|NCT02875834|525092745|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
145611577|NCT02875834|525092746|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
145611578|NCT02875834|525092747|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
145611579|NCT02875834|525092748|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
145611580|NCT02875834|525092745|FG000|Randomized Treatment Phase|Protocol Violation|0|||
145611581|NCT02875834|525092746|FG001|Randomized Treatment Phase|Protocol Violation|2|||
145611582|NCT02875834|525092747|FG002|Randomized Treatment Phase|Protocol Violation|0|||
145611583|NCT02875834|525092748|FG003|Randomized Treatment Phase|Protocol Violation|0|||
145611584|NCT02875834|525092745|FG000|Randomized Treatment Phase|(Not collected)|0|||
145611585|NCT02875834|525092746|FG001|Randomized Treatment Phase|(Not collected)|9|||
145611586|NCT02875834|525092747|FG002|Randomized Treatment Phase|(Not collected)|10|||
145611587|NCT02875834|525092748|FG003|Randomized Treatment Phase|(Not collected)|9|||
145611588|NCT00539279|525092750|FG000|Treatment|Withdrawal by Subject|10|||
145611589|NCT00539279|525092751|FG001|Treatment|Withdrawal by Subject|8|||
145611590|NCT00539279|525092750|FG000|Treatment|Death|1|||
145611591|NCT00539279|525092751|FG001|Treatment|Death|0|||
145611592|NCT00539279|525092750|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
145611593|NCT00539279|525092751|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
145611594|NCT00539279|525092750|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
145611595|NCT00539279|525092751|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
145611596|NCT02906683|525093938|FG000|Overall Study|Adverse Event|0|||
145611597|NCT02906683|525093939|FG001|Overall Study|Adverse Event|1|||
145611598|NCT02906683|525093940|FG002|Overall Study|Adverse Event|0|||
145611599|NCT02906683|525093938|FG000|Overall Study|Physician Decision|0|||
145405915|NCT01572792|524341672|FG001|Extension Study|Withdrawal by Subject|6|||
145611600|NCT02906683|525093939|FG001|Overall Study|Physician Decision|1|||
145611601|NCT02906683|525093940|FG002|Overall Study|Physician Decision|1|||
145611602|NCT02906683|525093938|FG000|Overall Study|Withdrawal by Subject|0|||
145611603|NCT02906683|525093939|FG001|Overall Study|Withdrawal by Subject|2|||
145611604|NCT02906683|525093940|FG002|Overall Study|Withdrawal by Subject|1|||
145611605|NCT02906683|525093938|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
145611606|NCT02906683|525093939|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
145611607|NCT02906683|525093940|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
145553427|NCT01988103|524884881|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
145553428|NCT01988103|524884882|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
145553429|NCT01988103|524884883|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
145553430|NCT01988103|524884884|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
145553431|NCT01988103|524884880|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
145553432|NCT01988103|524884881|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
145553433|NCT01988103|524884882|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
145553434|NCT01988103|524884883|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
145553435|NCT01988103|524884884|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
145553436|NCT01988103|524884880|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
145553437|NCT01988103|524884881|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
145553438|NCT01988103|524884882|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
145553439|NCT01988103|524884883|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
145553440|NCT01988103|524884884|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
145553441|NCT01988103|524884880|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
145553442|NCT01988103|524884881|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
145553443|NCT01988103|524884882|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
145553444|NCT01988103|524884883|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
145553445|NCT01988103|524884884|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
145553446|NCT05492942|524884885|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
145553447|NCT05492942|524884886|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
145553448|NCT05492942|524884887|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
145553449|NCT05492942|524884888|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
145553450|NCT02598076|524884891|FG000|Overall Study|Lost to Follow-up|2|||
145553451|NCT02598076|524884892|FG001|Overall Study|Lost to Follow-up|3|||
145553452|NCT01946425|524884894|FG000|Overall Study|Protocol Violation|1|||
145553453|NCT01946425|524884895|FG001|Overall Study|Protocol Violation|0|||
145553454|NCT01946425|524884894|FG000|Overall Study|Withdrawal by Subject|1|||
145553455|NCT01946425|524884895|FG001|Overall Study|Withdrawal by Subject|0|||
145553456|NCT00449540|524884899|FG000|Pretreatment Phase|No migraine experienced|66|||
145553457|NCT00449540|524884900|FG001|Pretreatment Phase|No migraine experienced|0|||
145553458|NCT00449540|524884901|FG002|Pretreatment Phase|No migraine experienced|0|||
145553459|NCT00449540|524884899|FG000|Treatment Phase|did not experience or treat migraine|0|||
145553460|NCT00449540|524884900|FG001|Treatment Phase|did not experience or treat migraine|20|||
145553461|NCT00449540|524884901|FG002|Treatment Phase|did not experience or treat migraine|17|||
145553462|NCT04545866|524884902|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
145553463|NCT04545866|524884903|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
145553464|NCT04545866|524884902|FG000|Overall Study|Withdrawal by Physician|1|||
145553465|NCT04545866|524884903|FG001|Overall Study|Withdrawal by Physician|0|||
145611608|NCT02906683|525093938|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
145611609|NCT02906683|525093939|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
145611610|NCT02906683|525093940|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
145611611|NCT02781506|525093941|FG000|Overall Study|Adverse Event|5|||
145611612|NCT01340482|525093943|FG000|Overall Study|Adverse Event|2|||
145611613|NCT01340482|525093944|FG001|Overall Study|Adverse Event|0|||
145611614|NCT01340482|525093945|FG002|Overall Study|Adverse Event|0|||
145405916|NCT01572792|524341673|FG002|Extension Study|Withdrawal by Subject|11|||
145405917|NCT01572792|524341674|FG003|Extension Study|Withdrawal by Subject|8|||
145405918|NCT01572792|524341675|FG004|Extension Study|Withdrawal by Subject|14|||
145405919|NCT01572792|524341671|FG000|Extension Study|Protocol Violation|0|||
145405920|NCT01572792|524341672|FG001|Extension Study|Protocol Violation|4|||
145405921|NCT01572792|524341673|FG002|Extension Study|Protocol Violation|3|||
145405922|NCT01572792|524341674|FG003|Extension Study|Protocol Violation|4|||
145405923|NCT01572792|524341675|FG004|Extension Study|Protocol Violation|3|||
145405924|NCT01572792|524341671|FG000|Extension Study|Lack of Efficacy|2|||
145405925|NCT01572792|524341672|FG001|Extension Study|Lack of Efficacy|3|||
145405926|NCT01572792|524341673|FG002|Extension Study|Lack of Efficacy|3|||
145405927|NCT01572792|524341674|FG003|Extension Study|Lack of Efficacy|2|||
145405928|NCT01572792|524341675|FG004|Extension Study|Lack of Efficacy|2|||
145405929|NCT01572792|524341671|FG000|Extension Study|Adverse Event|7|||
145405930|NCT01572792|524341672|FG001|Extension Study|Adverse Event|6|||
145405931|NCT01572792|524341673|FG002|Extension Study|Adverse Event|5|||
145405932|NCT01572792|524341674|FG003|Extension Study|Adverse Event|6|||
145405933|NCT01572792|524341675|FG004|Extension Study|Adverse Event|4|||
145405934|NCT01572792|524341671|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
145405935|NCT01572792|524341672|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
145405936|NCT01572792|524341673|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
145405937|NCT01572792|524341674|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
145405938|NCT01572792|524341675|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
145405939|NCT02472353|524341676|FG000|Overall Study|Lost to Follow-up|1|||
145405940|NCT02472353|524341677|FG001|Overall Study|Lost to Follow-up|1|||
145405941|NCT02472353|524341676|FG000|Overall Study|Withdrawal by Subject|2|||
145405942|NCT02472353|524341677|FG001|Overall Study|Withdrawal by Subject|1|||
145405943|NCT02472353|524341676|FG000|Overall Study|Study Termination|1|||
145284613|NCT01034137|523891643|FG002|Overall Study|Refused treatment or did not cooperate|1|||
145405944|NCT02472353|524341677|FG001|Overall Study|Study Termination|4|||
145405945|NCT00797563|524341678|FG000|Overall Study|Adverse Event|1|||
145405946|NCT03416179|524341679|FG000|Overall Study|Death|90|||
145405947|NCT03416179|524341680|FG001|Overall Study|Death|87|||
145405948|NCT03416179|524341681|FG002|Overall Study|Death|117|||
145405949|NCT03416179|524341682|FG003|Overall Study|Death|113|||
145405950|NCT03416179|524341679|FG000|Overall Study|Withdrawal by Subject|15|||
145405951|NCT03416179|524341680|FG001|Overall Study|Withdrawal by Subject|20|||
145405952|NCT03416179|524341681|FG002|Overall Study|Withdrawal by Subject|6|||
145405953|NCT03416179|524341682|FG003|Overall Study|Withdrawal by Subject|9|||
145405954|NCT03416179|524341679|FG000|Overall Study|Lost to Follow-up|1|||
145405955|NCT03416179|524341680|FG001|Overall Study|Lost to Follow-up|1|||
145405956|NCT03416179|524341681|FG002|Overall Study|Lost to Follow-up|0|||
145405957|NCT03416179|524341682|FG003|Overall Study|Lost to Follow-up|3|||
145405958|NCT03416179|524341679|FG000|Overall Study|Study participation terminated by Sponsor|93|||
145553466|NCT05247866|524884904|FG000|Overall Study|Adverse Event|2|||
145553467|NCT05247866|524884904|FG000|Overall Study|Lack of Efficacy|1|||
145553468|NCT05247866|524884904|FG000|Overall Study|Protocol Violation|1|||
145553469|NCT05247866|524884904|FG000|Overall Study|Withdrawal by Subject|3|||
145553470|NCT04463719|524884905|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
145553471|NCT04463719|524884906|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
145553472|NCT04463719|524884907|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
145553473|NCT00333866|524884910|FG000|Overall Study|Adverse Event|23|||
145553474|NCT00333866|524884911|FG001|Overall Study|Adverse Event|37|||
145553475|NCT00333866|524884912|FG002|Overall Study|Adverse Event|38|||
145553476|NCT00333866|524884913|FG003|Overall Study|Adverse Event|47|||
145553477|NCT00333866|524884910|FG000|Overall Study|Other|3|||
145405959|NCT03416179|524341680|FG001|Overall Study|Study participation terminated by Sponsor|91|||
145284614|NCT01034137|523891641|FG000|Overall Study|Administrative or other|2|||
145284615|NCT01034137|523891642|FG001|Overall Study|Administrative or other|3|||
145284616|NCT01034137|523891643|FG002|Overall Study|Administrative or other|4|||
145405960|NCT03416179|524341681|FG002|Overall Study|Study participation terminated by Sponsor|26|||
145405961|NCT03416179|524341682|FG003|Overall Study|Study participation terminated by Sponsor|31|||
145405962|NCT03416179|524341679|FG000|Overall Study|Other|2|||
145405963|NCT03416179|524341680|FG001|Overall Study|Other|3|||
145405964|NCT03416179|524341681|FG002|Overall Study|Other|1|||
145405965|NCT03416179|524341682|FG003|Overall Study|Other|0|||
145405966|NCT00688597|524341684|FG000|Overall Study|Adverse Event|2|||
145405967|NCT00688597|524341685|FG001|Overall Study|Adverse Event|0|||
145405968|NCT00688597|524341686|FG002|Overall Study|Adverse Event|0|||
145405969|NCT00688597|524341684|FG000|Overall Study|Physician Decision|1|||
145405970|NCT00688597|524341685|FG001|Overall Study|Physician Decision|0|||
145405971|NCT00688597|524341686|FG002|Overall Study|Physician Decision|0|||
145405972|NCT06438601|524341687|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
145405973|NCT06438601|524341688|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
145405974|NCT06438601|524341687|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
145405975|NCT06438601|524341688|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
145553478|NCT00333866|524884911|FG001|Overall Study|Other|2|||
145405976|NCT05233761|524341691|FG000|Treatment Period A|Withdrawal by Subject|12|||
145553479|NCT00333866|524884912|FG002|Overall Study|Other|2|||
145405977|NCT05233761|524341692|FG001|Treatment Period A|Withdrawal by Subject|10|||
145405978|NCT05233761|524341691|FG000|Treatment Period A|Lost to Follow-up|6|||
145553480|NCT00333866|524884913|FG003|Overall Study|Other|2|||
145553481|NCT00333866|524884910|FG000|Overall Study|Lack of Efficacy|8|||
145553482|NCT00333866|524884911|FG001|Overall Study|Lack of Efficacy|6|||
145553483|NCT00333866|524884912|FG002|Overall Study|Lack of Efficacy|3|||
145553484|NCT00333866|524884913|FG003|Overall Study|Lack of Efficacy|5|||
145553485|NCT00333866|524884910|FG000|Overall Study|Lost to Follow-up|1|||
145553486|NCT00333866|524884911|FG001|Overall Study|Lost to Follow-up|2|||
145553487|NCT00333866|524884912|FG002|Overall Study|Lost to Follow-up|2|||
145553488|NCT00333866|524884913|FG003|Overall Study|Lost to Follow-up|2|||
145553489|NCT00333866|524884910|FG000|Overall Study|Withdrawal by Subject|8|||
145553490|NCT00333866|524884911|FG001|Overall Study|Withdrawal by Subject|14|||
145553491|NCT00333866|524884912|FG002|Overall Study|Withdrawal by Subject|4|||
145553492|NCT00333866|524884913|FG003|Overall Study|Withdrawal by Subject|9|||
145553493|NCT00333866|524884910|FG000|Overall Study|Randomized but not Treated|5|||
145553494|NCT00333866|524884911|FG001|Overall Study|Randomized but not Treated|3|||
145553495|NCT00333866|524884912|FG002|Overall Study|Randomized but not Treated|2|||
145553496|NCT00333866|524884913|FG003|Overall Study|Randomized but not Treated|1|||
145284617|NCT03572933|523891644|FG000|Overall Study|Adverse Event|4|||
145284618|NCT03572933|523891645|FG001|Overall Study|Adverse Event|1|||
145284619|NCT03572933|523891644|FG000|Overall Study|Withdrawal by Subject|0|||
145284620|NCT03572933|523891645|FG001|Overall Study|Withdrawal by Subject|1|||
145284621|NCT04633837|523891649|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
145284622|NCT04633837|523891650|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
145284623|NCT00112489|523891651|FG000|Overall Study|Refused further treatment|8|||
145284624|NCT00112489|523891651|FG000|Overall Study|Adverse Event|12|||
145284625|NCT00112489|523891651|FG000|Overall Study|Death|2|||
145284626|NCT00112489|523891651|FG000|Overall Study|Other, Not Specified|9|||
145284627|NCT00112489|523891651|FG000|Overall Study|Patient never treated|2|||
145284628|NCT00112489|523891651|FG000|Overall Study|Ineligible|7|||
145284629|NCT00268346|523891654|FG000|Overall Study|Adverse Event|0|||
145284630|NCT00268346|523891655|FG001|Overall Study|Adverse Event|1|||
145284631|NCT00268346|523891654|FG000|Overall Study|Death|0|||
145284632|NCT00268346|523891655|FG001|Overall Study|Death|1|||
145284633|NCT00268346|523891654|FG000|Overall Study|Withdrawal by Subject|0|||
145284634|NCT00268346|523891655|FG001|Overall Study|Withdrawal by Subject|1|||
145284635|NCT01799590|523891656|FG000|Overall Study|Adverse Event|13|||
145284636|NCT01799590|523891657|FG001|Overall Study|Adverse Event|7|||
145284637|NCT01799590|523891658|FG002|Overall Study|Adverse Event|5|||
145284638|NCT01799590|523891656|FG000|Overall Study|Pregnancy|2|||
145284639|NCT01799590|523891657|FG001|Overall Study|Pregnancy|0|||
145284640|NCT01799590|523891658|FG002|Overall Study|Pregnancy|0|||
145284641|NCT01799590|523891656|FG000|Overall Study|Lack of Efficacy|3|||
145284642|NCT01799590|523891657|FG001|Overall Study|Lack of Efficacy|1|||
145284643|NCT01799590|523891658|FG002|Overall Study|Lack of Efficacy|3|||
145284644|NCT01799590|523891656|FG000|Overall Study|Participants convenience|4|||
145284645|NCT01799590|523891657|FG001|Overall Study|Participants convenience|4|||
145553497|NCT06073119|524884914|FG000|Overall Study|Adverse Event|1|||
145553498|NCT06073119|524884915|FG001|Overall Study|Adverse Event|3|||
145553499|NCT06073119|524884916|FG002|Overall Study|Adverse Event|0|||
145553500|NCT06073119|524884917|FG003|Overall Study|Adverse Event|0|||
145553501|NCT06073119|524884918|FG004|Overall Study|Adverse Event|1|||
145553502|NCT06073119|524884919|FG005|Overall Study|Adverse Event|0|||
145553503|NCT06073119|524884914|FG000|Overall Study|Non-compliance with study schedule|1|||
145553504|NCT06073119|524884915|FG001|Overall Study|Non-compliance with study schedule|0|||
145553505|NCT06073119|524884916|FG002|Overall Study|Non-compliance with study schedule|0|||
145553506|NCT06073119|524884917|FG003|Overall Study|Non-compliance with study schedule|0|||
145553507|NCT06073119|524884918|FG004|Overall Study|Non-compliance with study schedule|1|||
145553508|NCT06073119|524884919|FG005|Overall Study|Non-compliance with study schedule|0|||
145553509|NCT06073119|524884914|FG000|Overall Study|Withdrawal by Subject|4|||
145553510|NCT06073119|524884915|FG001|Overall Study|Withdrawal by Subject|4|||
145553511|NCT06073119|524884916|FG002|Overall Study|Withdrawal by Subject|3|||
145553512|NCT06073119|524884917|FG003|Overall Study|Withdrawal by Subject|5|||
145553513|NCT06073119|524884918|FG004|Overall Study|Withdrawal by Subject|3|||
145553514|NCT06073119|524884919|FG005|Overall Study|Withdrawal by Subject|1|||
145553515|NCT06073119|524884914|FG000|Overall Study|Other|2|||
145553516|NCT06073119|524884915|FG001|Overall Study|Other|4|||
145553517|NCT06073119|524884916|FG002|Overall Study|Other|1|||
145553518|NCT06073119|524884917|FG003|Overall Study|Other|0|||
145553519|NCT06073119|524884918|FG004|Overall Study|Other|1|||
145553520|NCT06073119|524884919|FG005|Overall Study|Other|0|||
145553521|NCT02393547|524884922|FG000|Overall Study|Adverse Event|2|||
145553522|NCT02393547|524884922|FG000|Overall Study|Withdrawal by Subject|3|||
145553523|NCT02393547|524884922|FG000|Overall Study|Lost to Follow-up|1|||
145553524|NCT02979522|524884923|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
145553525|NCT02979522|524884924|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
145553526|NCT02979522|524884923|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
145553527|NCT02979522|524884924|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
145553528|NCT05185089|524884925|FG000|First Intervention (4 weeks)|Adverse Event|0|||
145553529|NCT05185089|524884926|FG001|First Intervention (4 weeks)|Adverse Event|0|||
145553530|NCT05185089|524884927|FG002|First Intervention (4 weeks)|Adverse Event|0|||
145553531|NCT05185089|524884928|FG003|First Intervention (4 weeks)|Adverse Event|1|||
145553532|NCT05185089|524884925|FG000|Second Intervention (4 weeks)|Death|0|||
145553533|NCT05185089|524884926|FG001|Second Intervention (4 weeks)|Death|1|||
145553534|NCT05185089|524884927|FG002|Second Intervention (4 weeks)|Death|0|||
145553535|NCT05185089|524884928|FG003|Second Intervention (4 weeks)|Death|0|||
145284646|NCT01799590|523891658|FG002|Overall Study|Participants convenience|2|||
145284647|NCT01799590|523891656|FG000|Overall Study|Aggravation of complications|0|||
145611615|NCT02593539|525093946|FG000|Overall Study|Adverse Event|1|||
145611616|NCT04668989|525093953|FG000|First Intervention|Covid-19 related self-isolation|0|||
145611617|NCT04668989|525093954|FG001|First Intervention|Covid-19 related self-isolation|1|||
145611618|NCT04668989|525093953|FG000|Second Intervention|Adverse Event|0|||
145611619|NCT04668989|525093954|FG001|Second Intervention|Adverse Event|1|||
145611620|NCT01993823|525093955|FG000|Overall Study|Requested by the patient|6|||
145611621|NCT01993823|525093956|FG001|Overall Study|Requested by the patient|11|||
145611622|NCT01993823|525093955|FG000|Overall Study|Protocol Violation|0|||
145611623|NCT01993823|525093956|FG001|Overall Study|Protocol Violation|1|||
145611624|NCT01993823|525093955|FG000|Overall Study|Lost to Follow-up|1|||
145611625|NCT01993823|525093956|FG001|Overall Study|Lost to Follow-up|4|||
145611626|NCT01235975|525093961|FG000|Overall Study|Serious Adverse Event|0|||
145611627|NCT01235975|525093962|FG001|Overall Study|Serious Adverse Event|1|||
145611628|NCT01235975|525093961|FG000|Overall Study|Withdrawal by Subject|8|||
145611629|NCT01235975|525093962|FG001|Overall Study|Withdrawal by Subject|2|||
145611630|NCT01235975|525093961|FG000|Overall Study|Migrated/moved from study area|2|||
145611631|NCT01235975|525093962|FG001|Overall Study|Migrated/moved from study area|1|||
145611632|NCT01235975|525093961|FG000|Overall Study|Lost to Follow-up|7|||
145611633|NCT01235975|525093962|FG001|Overall Study|Lost to Follow-up|3|||
145611634|NCT05033743|525093963|FG000|Overall Study|Lost to Follow-up|1|||
145611635|NCT05033743|525093963|FG000|Overall Study|Protocol Violation|2|||
145611636|NCT05033743|525093963|FG000|Overall Study|Withdrawal by Subject|1|||
145611637|NCT00791921|525093966|FG000|Overall Study|Protocol planed|24|||
145611638|NCT00791921|525093967|FG001|Overall Study|Protocol planed|88|||
145611639|NCT00791921|525093966|FG000|Overall Study|Withdrawal by Subject|1|||
145611640|NCT00791921|525093967|FG001|Overall Study|Withdrawal by Subject|2|||
145611641|NCT00791921|525093966|FG000|Overall Study|Adverse Event|8|||
145611642|NCT00791921|525093967|FG001|Overall Study|Adverse Event|2|||
145611643|NCT00791921|525093966|FG000|Overall Study|Lack of Efficacy|0|||
145611644|NCT00791921|525093967|FG001|Overall Study|Lack of Efficacy|2|||
145611645|NCT00791921|525093966|FG000|Overall Study|Lack of study drug administration|1|||
145611646|NCT00791921|525093967|FG001|Overall Study|Lack of study drug administration|1|||
145611647|NCT00791921|525093966|FG000|Overall Study|Reason other than those above|0|||
145611648|NCT00791921|525093967|FG001|Overall Study|Reason other than those above|1|||
145611649|NCT01592695|525093969|FG000|Overall Study|Lost to Follow-up|8|||
145611650|NCT01592695|525093970|FG001|Overall Study|Lost to Follow-up|4|||
145611651|NCT00422799|525093971|FG000|Overall Study|Withdrawal by Subject|6|||
145611652|NCT00422799|525093971|FG000|Overall Study|Adverse Event|7|||
145611653|NCT01965158|525093972|FG000|Overall Study|Adverse Event|14|||
145611654|NCT01965158|525093973|FG001|Overall Study|Adverse Event|5|||
145611655|NCT01965158|525093972|FG000|Overall Study|Withdrawal by Subject|16|||
145611656|NCT01965158|525093973|FG001|Overall Study|Withdrawal by Subject|24|||
145611657|NCT01965158|525093972|FG000|Overall Study|Lost to Follow-up|7|||
145611658|NCT01965158|525093973|FG001|Overall Study|Lost to Follow-up|5|||
145553536|NCT05185089|524884925|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
145553537|NCT05185089|524884926|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
145553538|NCT05185089|524884927|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
145553539|NCT05185089|524884928|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
145553540|NCT00667368|524884929|FG000|Overall Study|Lost to Follow-up|176|||
145553541|NCT00667368|524884930|FG001|Overall Study|Lost to Follow-up|155|||
145553542|NCT00667368|524884929|FG000|Overall Study|Discontinued early|24|||
145553543|NCT00667368|524884930|FG001|Overall Study|Discontinued early|17|||
145553544|NCT05582889|524884932|FG000|Overall Study|Health event|3|||
145553545|NCT05582889|524884933|FG001|Overall Study|Health event|2|||
145553546|NCT05582889|524884932|FG000|Overall Study|Lost to Follow-up|2|||
145553547|NCT05582889|524884933|FG001|Overall Study|Lost to Follow-up|4|||
145553548|NCT06112756|524884934|FG000|Overall Study|Withdrawal by Subject|0|||
145553549|NCT06112756|524884935|FG001|Overall Study|Withdrawal by Subject|2|||
145553550|NCT06112756|524884934|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
145553551|NCT06112756|524884935|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
145553552|NCT06112756|524884934|FG000|Overall Study|Adverse Event|2|||
145553553|NCT06112756|524884935|FG001|Overall Study|Adverse Event|2|||
145553554|NCT04551092|524884936|FG000|Overall Study|Lost to Follow-up|7|||
145553555|NCT04551092|524884936|FG000|Overall Study|Withdrawal by Subject|4|||
145553556|NCT01712490|524884937|FG000|Overall Study|Ongoing|601|||
145553557|NCT01712490|524884938|FG001|Overall Study|Ongoing|586|||
145553558|NCT01712490|524884937|FG000|Overall Study|Other|11|||
145553559|NCT01712490|524884938|FG001|Overall Study|Other|11|||
145553560|NCT01712490|524884937|FG000|Overall Study|Withdrawal by Subject|36|||
145553561|NCT01712490|524884938|FG001|Overall Study|Withdrawal by Subject|44|||
145553562|NCT01712490|524884937|FG000|Overall Study|Lost to Follow-up|16|||
145553563|NCT01712490|524884938|FG001|Overall Study|Lost to Follow-up|29|||
145553564|NCT02260921|524884945|FG000|Overall Study|Adverse Event|1|||
145553565|NCT02260921|524884946|FG001|Overall Study|Adverse Event|0|||
145553566|NCT02260921|524884945|FG000|Overall Study|Lost to Follow-up|4|||
145553567|NCT02260921|524884946|FG001|Overall Study|Lost to Follow-up|3|||
145553568|NCT02260921|524884945|FG000|Overall Study|Withdraw Consent|4|||
145553569|NCT02260921|524884946|FG001|Overall Study|Withdraw Consent|1|||
145284648|NCT01799590|523891657|FG001|Overall Study|Aggravation of complications|1|||
145284649|NCT01799590|523891658|FG002|Overall Study|Aggravation of complications|1|||
145284650|NCT01799590|523891656|FG000|Overall Study|Using drugs with restricted days of use|0|||
145284651|NCT01799590|523891657|FG001|Overall Study|Using drugs with restricted days of use|3|||
145284652|NCT01799590|523891658|FG002|Overall Study|Using drugs with restricted days of use|2|||
145284653|NCT01799590|523891656|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
145284654|NCT01799590|523891657|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
145284655|NCT01799590|523891658|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
145284656|NCT01799590|523891656|FG000|Overall Study|Other|3|||
145284657|NCT01799590|523891657|FG001|Overall Study|Other|0|||
145284658|NCT01799590|523891658|FG002|Overall Study|Other|1|||
145284659|NCT00294723|523891661|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
145284660|NCT00294723|523891662|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
145284661|NCT00294723|523891663|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
145284662|NCT00294723|523891661|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
145284663|NCT00294723|523891662|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
145284664|NCT00294723|523891663|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
145284665|NCT00294723|523891661|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
145284666|NCT00294723|523891662|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
145284667|NCT00294723|523891663|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
145284668|NCT00294723|523891661|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
145553570|NCT02260921|524884945|FG000|Overall Study|Death|1|||
145553571|NCT02260921|524884946|FG001|Overall Study|Death|0|||
145553572|NCT02260921|524884945|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
145553573|NCT02260921|524884946|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
145553574|NCT01244425|524884947|FG000|Overall Study|Withdrawal by Subject|2|||
145553575|NCT01244425|524884948|FG001|Overall Study|Withdrawal by Subject|2|||
145405979|NCT05233761|524341692|FG001|Treatment Period A|Lost to Follow-up|12|||
145405980|NCT05233761|524341691|FG000|Treatment Period A|Protocol Violation|8|||
145405981|NCT05233761|524341692|FG001|Treatment Period A|Protocol Violation|15|||
145405982|NCT04058717|524341697|FG000|Randomization Period|Lost to Follow-up|2|||
145405983|NCT04058717|524341698|FG001|Randomization Period|Lost to Follow-up|3|||
145405984|NCT04058717|524341699|FG002|Randomization Period|Lost to Follow-up|4|||
145553576|NCT01244425|524884947|FG000|Overall Study|Adverse Event|1|||
145553577|NCT01244425|524884948|FG001|Overall Study|Adverse Event|1|||
145405985|NCT04058717|524341700|FG003|Randomization Period|Lost to Follow-up|4|||
145553578|NCT04140292|524884949|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
145553579|NCT04140292|524884950|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
145553580|NCT01013701|524884951|FG000|Overall Study|study prematurely terminated|7|||
145553581|NCT03241342|524884954|FG000|Overall Study|Adverse Event|5|||
145553582|NCT03241342|524884955|FG001|Overall Study|Adverse Event|8|||
145553583|NCT03241342|524884956|FG002|Overall Study|Adverse Event|4|||
145553584|NCT03241342|524884954|FG000|Overall Study|Lack of Efficacy|0|||
145553585|NCT03241342|524884955|FG001|Overall Study|Lack of Efficacy|0|||
145553586|NCT03241342|524884956|FG002|Overall Study|Lack of Efficacy|1|||
145553587|NCT03241342|524884954|FG000|Overall Study|noncompliance with study drug|2|||
145553588|NCT03241342|524884955|FG001|Overall Study|noncompliance with study drug|1|||
145405986|NCT04058717|524341697|FG000|Randomization Period|Withdrawal by Subject|1|||
145553589|NCT03241342|524884956|FG002|Overall Study|noncompliance with study drug|1|||
145553590|NCT03241342|524884954|FG000|Overall Study|sponsor decision|0|||
145553591|NCT03241342|524884955|FG001|Overall Study|sponsor decision|1|||
145284669|NCT00294723|523891662|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
145284670|NCT00294723|523891663|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
145284671|NCT00294723|523891661|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
145284672|NCT00294723|523891662|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
145553592|NCT03241342|524884956|FG002|Overall Study|sponsor decision|2|||
145553593|NCT03241342|524884954|FG000|Overall Study|not reported|15|||
145553594|NCT03241342|524884955|FG001|Overall Study|not reported|21|||
145553595|NCT03241342|524884956|FG002|Overall Study|not reported|19|||
145553596|NCT00556712|524884958|FG000|Overall Study|Adverse Event|7|||
145553597|NCT00556712|524884959|FG001|Overall Study|Adverse Event|19|||
145553598|NCT00556712|524884958|FG000|Overall Study|Death|5|||
145553599|NCT00556712|524884959|FG001|Overall Study|Death|10|||
145553600|NCT00556712|524884958|FG000|Overall Study|Progressive Disease|383|||
145553601|NCT00556712|524884959|FG001|Overall Study|Progressive Disease|320|||
145553602|NCT00556712|524884958|FG000|Overall Study|Protocol Violation|3|||
145553603|NCT00556712|524884959|FG001|Overall Study|Protocol Violation|2|||
145553604|NCT00556712|524884958|FG000|Overall Study|Refused Treatment|17|||
145553605|NCT00556712|524884959|FG001|Overall Study|Refused Treatment|16|||
145553606|NCT00556712|524884958|FG000|Overall Study|Failure to Return|2|||
145553607|NCT00556712|524884959|FG001|Overall Study|Failure to Return|3|||
145553608|NCT00556712|524884958|FG000|Overall Study|Other|2|||
145553609|NCT00556712|524884959|FG001|Overall Study|Other|2|||
145553610|NCT00556712|524884958|FG000|Overall Study|Ongoing at Data Cutoff|32|||
145553611|NCT00556712|524884959|FG001|Overall Study|Ongoing at Data Cutoff|66|||
145553612|NCT01059799|524884962|FG000|Overall Study|Adverse Event|2|||
145553613|NCT01059799|524884963|FG001|Overall Study|Adverse Event|3|||
145553614|NCT01059799|524884962|FG000|Overall Study|Lack of Efficacy|1|||
145553615|NCT01059799|524884963|FG001|Overall Study|Lack of Efficacy|0|||
145553616|NCT01059799|524884962|FG000|Overall Study|Protocol Violation|3|||
145553617|NCT01059799|524884963|FG001|Overall Study|Protocol Violation|2|||
145553618|NCT01059799|524884962|FG000|Overall Study|Withdrawal criteria|13|||
145553619|NCT01059799|524884963|FG001|Overall Study|Withdrawal criteria|2|||
145553620|NCT01059799|524884962|FG000|Overall Study|Other|12|||
145553621|NCT01059799|524884963|FG001|Overall Study|Other|3|||
145553622|NCT04772755|524884967|FG000|Overall Study|Withdrawal by Subject|1|||
145553623|NCT04772755|524884968|FG001|Overall Study|Withdrawal by Subject|0|||
145553624|NCT04772755|524884967|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
145553625|NCT04772755|524884968|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
145553626|NCT00662363|524884969|FG000|Overall Study|Withdrawal by Subject|6|||
145553627|NCT00662363|524884970|FG001|Overall Study|Withdrawal by Subject|5|||
145553628|NCT00662363|524884969|FG000|Overall Study|Adverse Event|0|||
145553629|NCT00662363|524884970|FG001|Overall Study|Adverse Event|3|||
145553630|NCT00662363|524884969|FG000|Overall Study|Discharged early from rehab|4|||
145553631|NCT00662363|524884970|FG001|Overall Study|Discharged early from rehab|1|||
145553632|NCT00662363|524884969|FG000|Overall Study|Protocol Violation|1|||
145553633|NCT00662363|524884970|FG001|Overall Study|Protocol Violation|1|||
145553634|NCT01905657|524884971|FG000|Overall Study|Adverse Event|23|||
145553635|NCT01905657|524884972|FG001|Overall Study|Adverse Event|17|||
145553636|NCT01905657|524884973|FG002|Overall Study|Adverse Event|18|||
145553637|NCT01905657|524884971|FG000|Overall Study|Clinical Progression|103|||
145553638|NCT01905657|524884972|FG001|Overall Study|Clinical Progression|78|||
145553639|NCT01905657|524884973|FG002|Overall Study|Clinical Progression|59|||
145553640|NCT01905657|524884971|FG000|Overall Study|Death|40|||
145553641|NCT01905657|524884972|FG001|Overall Study|Death|43|||
145553642|NCT01905657|524884973|FG002|Overall Study|Death|47|||
145553643|NCT01905657|524884971|FG000|Overall Study|Excluded Medication|13|||
145553644|NCT01905657|524884972|FG001|Overall Study|Excluded Medication|16|||
145553645|NCT01905657|524884973|FG002|Overall Study|Excluded Medication|9|||
145553646|NCT01905657|524884971|FG000|Overall Study|Lost to Follow-up|1|||
145553647|NCT01905657|524884972|FG001|Overall Study|Lost to Follow-up|2|||
145553648|NCT01905657|524884973|FG002|Overall Study|Lost to Follow-up|1|||
145611659|NCT01965158|525093972|FG000|Overall Study|Protocol Violation|1|||
145553649|NCT01905657|524884971|FG000|Overall Study|Physician Decision|5|||
145611660|NCT01965158|525093973|FG001|Overall Study|Protocol Violation|1|||
145553650|NCT01905657|524884972|FG001|Overall Study|Physician Decision|8|||
145553651|NCT01905657|524884973|FG002|Overall Study|Physician Decision|12|||
145553652|NCT01905657|524884971|FG000|Overall Study|Protocol Violation|2|||
145553653|NCT01905657|524884972|FG001|Overall Study|Protocol Violation|1|||
145553654|NCT01905657|524884973|FG002|Overall Study|Protocol Violation|1|||
145553655|NCT01905657|524884971|FG000|Overall Study|Screen Failure|0|||
145553656|NCT01905657|524884972|FG001|Overall Study|Screen Failure|1|||
145553657|NCT01905657|524884973|FG002|Overall Study|Screen Failure|0|||
145553658|NCT01905657|524884971|FG000|Overall Study|Withdrawal by Subject|15|||
145405987|NCT04058717|524341698|FG001|Randomization Period|Withdrawal by Subject|3|||
145405988|NCT04058717|524341699|FG002|Randomization Period|Withdrawal by Subject|3|||
145405989|NCT04058717|524341700|FG003|Randomization Period|Withdrawal by Subject|3|||
145405990|NCT04058717|524341697|FG000|Randomization Period|PI decision|0|||
145405991|NCT04058717|524341698|FG001|Randomization Period|PI decision|1|||
145405992|NCT04058717|524341699|FG002|Randomization Period|PI decision|0|||
145405993|NCT04058717|524341700|FG003|Randomization Period|PI decision|0|||
145405994|NCT01925417|524341701|FG000|Overall Study|Withdrawal by Subject|2|||
145405995|NCT01925417|524341701|FG000|Overall Study|Death|1|||
145405996|NCT01047319|524341702|FG000|Overall Study|Teva requested participant withdrawal|3|||
145405997|NCT01047319|524341703|FG001|Overall Study|Teva requested participant withdrawal|0|||
145405998|NCT01047319|524341704|FG002|Overall Study|Teva requested participant withdrawal|1|||
145405999|NCT01047319|524341702|FG000|Overall Study|Protocol Violation|3|||
145406000|NCT01047319|524341703|FG001|Overall Study|Protocol Violation|2|||
145406001|NCT01047319|524341704|FG002|Overall Study|Protocol Violation|4|||
145406002|NCT01047319|524341702|FG000|Overall Study|Lack of Efficacy|4|||
145406003|NCT01047319|524341703|FG001|Overall Study|Lack of Efficacy|3|||
145406004|NCT01047319|524341704|FG002|Overall Study|Lack of Efficacy|3|||
145406005|NCT01047319|524341702|FG000|Overall Study|Death|5|||
145406006|NCT01047319|524341703|FG001|Overall Study|Death|1|||
145406007|NCT01047319|524341704|FG002|Overall Study|Death|5|||
145406008|NCT01047319|524341702|FG000|Overall Study|Pregnancy|13|||
145406009|NCT01047319|524341703|FG001|Overall Study|Pregnancy|8|||
145406010|NCT01047319|524341704|FG002|Overall Study|Pregnancy|8|||
145406011|NCT01047319|524341702|FG000|Overall Study|Physician Decision|12|||
145406012|NCT01047319|524341703|FG001|Overall Study|Physician Decision|9|||
145406013|NCT01047319|524341704|FG002|Overall Study|Physician Decision|10|||
145406014|NCT01047319|524341702|FG000|Overall Study|Lost to Follow-up|14|||
145406015|NCT01047319|524341703|FG001|Overall Study|Lost to Follow-up|10|||
145553659|NCT01905657|524884972|FG001|Overall Study|Withdrawal by Subject|21|||
145553660|NCT01905657|524884973|FG002|Overall Study|Withdrawal by Subject|53|||
145553661|NCT01905657|524884971|FG000|Overall Study|Sponsor Decision|1|||
145553662|NCT01905657|524884972|FG001|Overall Study|Sponsor Decision|0|||
145553663|NCT01905657|524884973|FG002|Overall Study|Sponsor Decision|0|||
145553664|NCT04080297|524884974|FG000|Overall Study|Adverse Event|1|||
145553665|NCT04080297|524884975|FG001|Overall Study|Adverse Event|3|||
145553666|NCT04080297|524884974|FG000|Overall Study|concurrent illness|1|||
145553667|NCT04080297|524884975|FG001|Overall Study|concurrent illness|0|||
145553668|NCT02744391|524884976|FG000|Overall Study|Lost to Follow-up|9|||
145553669|NCT02744391|524884976|FG000|Overall Study|Physician Decision|2|||
145553670|NCT02744391|524884976|FG000|Overall Study|Withdrawal by Subject|3|||
145553671|NCT05838742|524884977|FG000|Overall Study|Adverse Event|2|||
145553672|NCT05838742|524884978|FG001|Overall Study|Adverse Event|0|||
145553673|NCT05838742|524884979|FG002|Overall Study|Adverse Event|1|||
145553674|NCT05838742|524884980|FG003|Overall Study|Adverse Event|0|||
145553675|NCT05838742|524884981|FG004|Overall Study|Adverse Event|1|||
145553676|NCT05838742|524884977|FG000|Overall Study|Lost to Follow-up|1|||
145553677|NCT05838742|524884978|FG001|Overall Study|Lost to Follow-up|1|||
145553678|NCT05838742|524884979|FG002|Overall Study|Lost to Follow-up|1|||
145553679|NCT05838742|524884980|FG003|Overall Study|Lost to Follow-up|0|||
145553680|NCT05838742|524884981|FG004|Overall Study|Lost to Follow-up|0|||
145553681|NCT05838742|524884977|FG000|Overall Study|Physician Decision|0|||
145553682|NCT05838742|524884978|FG001|Overall Study|Physician Decision|0|||
145406016|NCT01047319|524341704|FG002|Overall Study|Lost to Follow-up|10|||
145406017|NCT01047319|524341702|FG000|Overall Study|Adverse Event|16|||
145553683|NCT05838742|524884979|FG002|Overall Study|Physician Decision|0|||
145553684|NCT05838742|524884980|FG003|Overall Study|Physician Decision|0|||
145406018|NCT01047319|524341703|FG001|Overall Study|Adverse Event|27|||
145553685|NCT05838742|524884981|FG004|Overall Study|Physician Decision|1|||
145553686|NCT05838742|524884977|FG000|Overall Study|Withdrawal by Subject|8|||
145553687|NCT05838742|524884978|FG001|Overall Study|Withdrawal by Subject|3|||
145406019|NCT01047319|524341704|FG002|Overall Study|Adverse Event|21|||
145406020|NCT01047319|524341702|FG000|Overall Study|Withdrawal by Subject|77|||
145406021|NCT01047319|524341703|FG001|Overall Study|Withdrawal by Subject|75|||
145406022|NCT01047319|524341704|FG002|Overall Study|Withdrawal by Subject|87|||
145284673|NCT00294723|523891663|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
145284674|NCT00294723|523891661|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
145284675|NCT00294723|523891662|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
145284676|NCT00294723|523891663|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
145284677|NCT00294723|523891661|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
145284678|NCT00294723|523891662|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
145284679|NCT00294723|523891663|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
145284680|NCT00294723|523891661|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
145284681|NCT00294723|523891662|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
145284682|NCT00294723|523891663|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
145284683|NCT00294723|523891661|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
145284684|NCT00294723|523891662|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
145284685|NCT00294723|523891663|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
145284686|NCT00294723|523891661|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
145284687|NCT00294723|523891662|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
145284688|NCT00294723|523891663|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
145284689|NCT00294723|523891661|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
145553688|NCT05838742|524884979|FG002|Overall Study|Withdrawal by Subject|3|||
145553689|NCT05838742|524884980|FG003|Overall Study|Withdrawal by Subject|1|||
145553690|NCT05838742|524884981|FG004|Overall Study|Withdrawal by Subject|4|||
145553691|NCT05838742|524884977|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
145553692|NCT05838742|524884978|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
145553693|NCT05838742|524884979|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
145553694|NCT05838742|524884980|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
145553695|NCT05838742|524884981|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
145553696|NCT05838742|524884977|FG000|Overall Study|Lack of Efficacy|0|||
145553697|NCT05838742|524884978|FG001|Overall Study|Lack of Efficacy|0|||
145553698|NCT05838742|524884979|FG002|Overall Study|Lack of Efficacy|0|||
145553699|NCT05838742|524884980|FG003|Overall Study|Lack of Efficacy|1|||
145284690|NCT00294723|523891662|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
145284691|NCT00294723|523891663|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
145284692|NCT00294723|523891661|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
145284693|NCT00294723|523891662|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
145284694|NCT00294723|523891663|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
145284695|NCT00752791|523891664|FG000|Overall Study|Adverse Event|7|||
145284696|NCT00752791|523891664|FG000|Overall Study|Withdrawal by Subject|1|||
145284697|NCT00752791|523891664|FG000|Overall Study|Physician Decision|1|||
145284698|NCT00752791|523891664|FG000|Overall Study|Death|1|||
145284699|NCT00752791|523891664|FG000|Overall Study|Renal transplant|3|||
145284700|NCT00752791|523891664|FG000|Overall Study|Switched to hemodialysis|2|||
145284701|NCT00752791|523891664|FG000|Overall Study|Protocol deviation|1|||
145284702|NCT03255031|523891665|FG000|Overall Study|Adverse Event|5|||
145284703|NCT03255031|523891666|FG001|Overall Study|Adverse Event|3|||
145284704|NCT03255031|523891665|FG000|Overall Study|Physician Decision|2|||
145284705|NCT03255031|523891666|FG001|Overall Study|Physician Decision|1|||
145284706|NCT03255031|523891665|FG000|Overall Study|Withdrawal by Subject|9|||
145284707|NCT03255031|523891666|FG001|Overall Study|Withdrawal by Subject|3|||
145284708|NCT01809314|523891667|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
145284709|NCT01809314|523891667|FG000|Overall Study|Adverse Event|6|||
145284710|NCT01809314|523891667|FG000|Overall Study|Insufficient Therapeutic Response|14|||
145284711|NCT01809314|523891667|FG000|Overall Study|Lost to Follow-up|724|||
145284712|NCT01092702|523891668|FG000|Overall Study|Withdrawal by Subject|7|||
145284713|NCT01092702|523891668|FG000|Overall Study|Lost to Follow-up|2|||
145553700|NCT05838742|524884981|FG004|Overall Study|Lack of Efficacy|0|||
145553701|NCT05838742|524884977|FG000|Overall Study|Randomized, not treated|2|||
145553702|NCT05838742|524884978|FG001|Overall Study|Randomized, not treated|1|||
145553703|NCT05838742|524884979|FG002|Overall Study|Randomized, not treated|0|||
145553704|NCT05838742|524884980|FG003|Overall Study|Randomized, not treated|1|||
145553705|NCT05838742|524884981|FG004|Overall Study|Randomized, not treated|0|||
145553706|NCT01535053|524884987|FG000|Overall Study|Ineligible|1|||
145553707|NCT01535053|524884988|FG001|Overall Study|Ineligible|2|||
145553708|NCT01031069|524884989|FG000|Overall Study|Serious Adverse Event|0|||
145553709|NCT01031069|524884990|FG001|Overall Study|Serious Adverse Event|1|||
145553710|NCT01031069|524884991|FG002|Overall Study|Serious Adverse Event|0|||
145553711|NCT01031069|524884992|FG003|Overall Study|Serious Adverse Event|0|||
145553712|NCT01031069|524884989|FG000|Overall Study|Withdrawal by Subject|2|||
145553713|NCT01031069|524884990|FG001|Overall Study|Withdrawal by Subject|3|||
145553714|NCT01031069|524884991|FG002|Overall Study|Withdrawal by Subject|18|||
145553715|NCT01031069|524884992|FG003|Overall Study|Withdrawal by Subject|18|||
145553716|NCT01031069|524884989|FG000|Overall Study|Migrated/moved from study area|1|||
145553717|NCT01031069|524884990|FG001|Overall Study|Migrated/moved from study area|2|||
145553718|NCT01031069|524884991|FG002|Overall Study|Migrated/moved from study area|1|||
145553719|NCT01031069|524884992|FG003|Overall Study|Migrated/moved from study area|1|||
145553720|NCT01031069|524884989|FG000|Overall Study|Lost to Follow-up|9|||
145553721|NCT01031069|524884990|FG001|Overall Study|Lost to Follow-up|5|||
145553722|NCT01031069|524884991|FG002|Overall Study|Lost to Follow-up|21|||
145553723|NCT01031069|524884992|FG003|Overall Study|Lost to Follow-up|15|||
145553724|NCT01031069|524884989|FG000|Overall Study|Other|0|||
145553725|NCT01031069|524884990|FG001|Overall Study|Other|0|||
145553726|NCT01031069|524884991|FG002|Overall Study|Other|1|||
145553727|NCT01031069|524884992|FG003|Overall Study|Other|0|||
145553728|NCT03700671|524884993|FG000|Overall Study|Lack of Efficacy|1|||
145553729|NCT03700671|524884994|FG001|Overall Study|Lack of Efficacy|2|||
145553730|NCT05371509|524884995|FG000|Overall Study|Physician Decision|1|||
145553731|NCT05371509|524884996|FG001|Overall Study|Physician Decision|0|||
145553732|NCT03032705|524884998|FG000|Overall Study|Lost to Follow-up|16|||
145553733|NCT03032705|524884999|FG001|Overall Study|Lost to Follow-up|17|||
145553734|NCT03032705|524884998|FG000|Overall Study|did not quality|6|||
145553735|NCT03032705|524884999|FG001|Overall Study|did not quality|6|||
145553736|NCT04405037|524885000|FG000|Overall Study|Withdrawal by Subject|1|||
145553737|NCT04405037|524885001|FG001|Overall Study|Withdrawal by Subject|0|||
145553738|NCT04405037|524885000|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
145553739|NCT04405037|524885001|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
145553740|NCT02180867|524885002|FG000|Overall Study|Adverse Event|3|||
145553741|NCT02180867|524885003|FG001|Overall Study|Adverse Event|4|||
145553742|NCT02180867|524885004|FG002|Overall Study|Adverse Event|1|||
145553743|NCT02180867|524885005|FG003|Overall Study|Adverse Event|5|||
145553744|NCT02180867|524885006|FG004|Overall Study|Adverse Event|0|||
145553745|NCT02180867|524885007|FG005|Overall Study|Adverse Event|0|||
145553746|NCT02180867|524885008|FG006|Overall Study|Adverse Event|0|||
145553747|NCT02180867|524885002|FG000|Overall Study|Death|0|||
145553748|NCT02180867|524885003|FG001|Overall Study|Death|0|||
145553749|NCT02180867|524885004|FG002|Overall Study|Death|0|||
145553750|NCT02180867|524885005|FG003|Overall Study|Death|0|||
145553751|NCT02180867|524885006|FG004|Overall Study|Death|1|||
145553752|NCT02180867|524885007|FG005|Overall Study|Death|0|||
145553753|NCT02180867|524885008|FG006|Overall Study|Death|0|||
145553754|NCT02180867|524885002|FG000|Overall Study|Lack of Efficacy|0|||
145553755|NCT02180867|524885003|FG001|Overall Study|Lack of Efficacy|2|||
145553756|NCT02180867|524885004|FG002|Overall Study|Lack of Efficacy|0|||
145553757|NCT02180867|524885005|FG003|Overall Study|Lack of Efficacy|1|||
145553758|NCT02180867|524885006|FG004|Overall Study|Lack of Efficacy|6|||
145553759|NCT02180867|524885007|FG005|Overall Study|Lack of Efficacy|0|||
145553760|NCT02180867|524885008|FG006|Overall Study|Lack of Efficacy|1|||
145553761|NCT02180867|524885002|FG000|Overall Study|Physician Decision|1|||
145553762|NCT02180867|524885003|FG001|Overall Study|Physician Decision|3|||
145553763|NCT02180867|524885004|FG002|Overall Study|Physician Decision|1|||
145553764|NCT02180867|524885005|FG003|Overall Study|Physician Decision|10|||
145553765|NCT02180867|524885006|FG004|Overall Study|Physician Decision|9|||
145553766|NCT02180867|524885007|FG005|Overall Study|Physician Decision|3|||
145553767|NCT02180867|524885008|FG006|Overall Study|Physician Decision|4|||
145553768|NCT02180867|524885002|FG000|Overall Study|Withdrawal by Subject|0|||
145553769|NCT02180867|524885003|FG001|Overall Study|Withdrawal by Subject|0|||
145553770|NCT02180867|524885004|FG002|Overall Study|Withdrawal by Subject|0|||
145553771|NCT02180867|524885005|FG003|Overall Study|Withdrawal by Subject|1|||
145553772|NCT02180867|524885006|FG004|Overall Study|Withdrawal by Subject|1|||
145553773|NCT02180867|524885007|FG005|Overall Study|Withdrawal by Subject|0|||
145553774|NCT02180867|524885008|FG006|Overall Study|Withdrawal by Subject|0|||
145553775|NCT02180867|524885002|FG000|Overall Study|Ineligible|1|||
145553776|NCT02180867|524885003|FG001|Overall Study|Ineligible|2|||
145553777|NCT02180867|524885004|FG002|Overall Study|Ineligible|0|||
145553778|NCT02180867|524885005|FG003|Overall Study|Ineligible|3|||
145553779|NCT02180867|524885006|FG004|Overall Study|Ineligible|5|||
145553780|NCT02180867|524885007|FG005|Overall Study|Ineligible|0|||
145553781|NCT02180867|524885008|FG006|Overall Study|Ineligible|0|||
145553782|NCT02180867|524885002|FG000|Overall Study|Repeat Eligibility Studies|0|||
145553783|NCT02180867|524885003|FG001|Overall Study|Repeat Eligibility Studies|0|||
145553784|NCT02180867|524885004|FG002|Overall Study|Repeat Eligibility Studies|0|||
145553785|NCT02180867|524885005|FG003|Overall Study|Repeat Eligibility Studies|0|||
145553786|NCT02180867|524885006|FG004|Overall Study|Repeat Eligibility Studies|1|||
145553787|NCT02180867|524885007|FG005|Overall Study|Repeat Eligibility Studies|0|||
145553788|NCT02180867|524885008|FG006|Overall Study|Repeat Eligibility Studies|0|||
145553789|NCT02180867|524885002|FG000|Overall Study|Refusal of further protocol therapy|1|||
145553790|NCT02180867|524885003|FG001|Overall Study|Refusal of further protocol therapy|0|||
145553791|NCT02180867|524885004|FG002|Overall Study|Refusal of further protocol therapy|2|||
145553792|NCT02180867|524885005|FG003|Overall Study|Refusal of further protocol therapy|6|||
145553793|NCT02180867|524885006|FG004|Overall Study|Refusal of further protocol therapy|4|||
145553794|NCT02180867|524885007|FG005|Overall Study|Refusal of further protocol therapy|0|||
145553795|NCT02180867|524885008|FG006|Overall Study|Refusal of further protocol therapy|0|||
145553796|NCT03578367|524885009|FG000|Overall Study|Adverse Event|0|||
145553797|NCT03578367|524885010|FG001|Overall Study|Adverse Event|3|||
145553798|NCT03578367|524885011|FG002|Overall Study|Adverse Event|0|||
145553799|NCT03578367|524885012|FG003|Overall Study|Adverse Event|5|||
145553800|NCT03578367|524885009|FG000|Overall Study|Withdrawal by Subject|2|||
145553801|NCT03578367|524885010|FG001|Overall Study|Withdrawal by Subject|2|||
145553802|NCT03578367|524885011|FG002|Overall Study|Withdrawal by Subject|1|||
145553803|NCT03578367|524885012|FG003|Overall Study|Withdrawal by Subject|3|||
145553804|NCT03578367|524885009|FG000|Overall Study|Physician Decision|0|||
145553805|NCT03578367|524885010|FG001|Overall Study|Physician Decision|0|||
145553806|NCT03578367|524885011|FG002|Overall Study|Physician Decision|14|||
145553807|NCT03578367|524885012|FG003|Overall Study|Physician Decision|0|||
145553808|NCT03578367|524885009|FG000|Overall Study|Death|1|||
145553809|NCT03578367|524885010|FG001|Overall Study|Death|0|||
145553810|NCT03578367|524885011|FG002|Overall Study|Death|0|||
145553811|NCT03578367|524885012|FG003|Overall Study|Death|0|||
145553812|NCT03578367|524885009|FG000|Overall Study|Not treated|0|||
145553813|NCT03578367|524885010|FG001|Overall Study|Not treated|0|||
145553814|NCT03578367|524885011|FG002|Overall Study|Not treated|1|||
145553815|NCT03578367|524885012|FG003|Overall Study|Not treated|0|||
145553816|NCT02081690|524886623|FG000|Overall Study|Death|3|||
145553817|NCT02081690|524886623|FG000|Overall Study|Physician Decision|3|||
145553818|NCT02081690|524886623|FG000|Overall Study|Withdrawal by Subject|1|||
145553819|NCT00982488|524886627|FG000|Overall Study|Administrative reason by sponsor|81|||
145553820|NCT00982488|524886628|FG001|Overall Study|Administrative reason by sponsor|3|||
145553821|NCT00982488|524886629|FG002|Overall Study|Administrative reason by sponsor|11|||
145553822|NCT00982488|524886630|FG003|Overall Study|Administrative reason by sponsor|0|||
145553823|NCT00982488|524886631|FG004|Overall Study|Administrative reason by sponsor|0|||
145553824|NCT00982488|524886627|FG000|Overall Study|Adverse event unrelated to study drug|5|||
145553825|NCT00982488|524886628|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145553826|NCT00982488|524886629|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145553827|NCT00982488|524886630|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145553828|NCT00982488|524886631|FG004|Overall Study|Adverse event unrelated to study drug|0|||
145553829|NCT00982488|524886627|FG000|Overall Study|Death|11|||
145553830|NCT00982488|524886628|FG001|Overall Study|Death|0|||
145553831|NCT00982488|524886629|FG002|Overall Study|Death|2|||
145553832|NCT00982488|524886630|FG003|Overall Study|Death|0|||
145553833|NCT00982488|524886631|FG004|Overall Study|Death|0|||
145553834|NCT00982488|524886627|FG000|Overall Study|Disease progression|30|||
145553835|NCT00982488|524886628|FG001|Overall Study|Disease progression|5|||
145553836|NCT00982488|524886629|FG002|Overall Study|Disease progression|10|||
145553837|NCT00982488|524886630|FG003|Overall Study|Disease progression|1|||
145553838|NCT00982488|524886631|FG004|Overall Study|Disease progression|1|||
145553839|NCT00982488|524886627|FG000|Overall Study|Lost to Follow-up|1|||
145553840|NCT00982488|524886628|FG001|Overall Study|Lost to Follow-up|0|||
145553841|NCT00982488|524886629|FG002|Overall Study|Lost to Follow-up|0|||
145553842|NCT00982488|524886630|FG003|Overall Study|Lost to Follow-up|0|||
145553843|NCT00982488|524886631|FG004|Overall Study|Lost to Follow-up|0|||
145553844|NCT00982488|524886627|FG000|Overall Study|Maximum clinical benefit|1|||
145553845|NCT00982488|524886628|FG001|Overall Study|Maximum clinical benefit|1|||
145553846|NCT00982488|524886629|FG002|Overall Study|Maximum clinical benefit|1|||
145553847|NCT00982488|524886630|FG003|Overall Study|Maximum clinical benefit|0|||
145553848|NCT00982488|524886631|FG004|Overall Study|Maximum clinical benefit|0|||
145553849|NCT00982488|524886627|FG000|Overall Study|Other|15|||
145553850|NCT00982488|524886628|FG001|Overall Study|Other|1|||
145553851|NCT00982488|524886629|FG002|Overall Study|Other|3|||
145553852|NCT00982488|524886630|FG003|Overall Study|Other|1|||
145553853|NCT00982488|524886631|FG004|Overall Study|Other|0|||
145553854|NCT00982488|524886627|FG000|Overall Study|Poor compliance/noncompliance|0|||
145553855|NCT00982488|524886628|FG001|Overall Study|Poor compliance/noncompliance|1|||
145553856|NCT00982488|524886629|FG002|Overall Study|Poor compliance/noncompliance|0|||
145553857|NCT00982488|524886630|FG003|Overall Study|Poor compliance/noncompliance|0|||
145553858|NCT00982488|524886631|FG004|Overall Study|Poor compliance/noncompliance|0|||
145553859|NCT00982488|524886627|FG000|Overall Study|Stem cell transplant|2|||
145553860|NCT00982488|524886628|FG001|Overall Study|Stem cell transplant|0|||
145553861|NCT00982488|524886629|FG002|Overall Study|Stem cell transplant|0|||
145553862|NCT00982488|524886630|FG003|Overall Study|Stem cell transplant|1|||
145553863|NCT00982488|524886631|FG004|Overall Study|Stem cell transplant|0|||
145553864|NCT00982488|524886627|FG000|Overall Study|Study drug toxicity|34|||
145553865|NCT00982488|524886628|FG001|Overall Study|Study drug toxicity|1|||
145553866|NCT00982488|524886629|FG002|Overall Study|Study drug toxicity|6|||
145553867|NCT00982488|524886630|FG003|Overall Study|Study drug toxicity|0|||
145553868|NCT00982488|524886631|FG004|Overall Study|Study drug toxicity|0|||
145553869|NCT00982488|524886627|FG000|Overall Study|Withdrawal by Subject|5|||
145553870|NCT00982488|524886628|FG001|Overall Study|Withdrawal by Subject|1|||
145553871|NCT00982488|524886629|FG002|Overall Study|Withdrawal by Subject|1|||
145553872|NCT00982488|524886630|FG003|Overall Study|Withdrawal by Subject|0|||
145553873|NCT00982488|524886631|FG004|Overall Study|Withdrawal by Subject|0|||
145611661|NCT01965158|525093972|FG000|Overall Study|Other - Miscellaneous|3|||
145611662|NCT01965158|525093973|FG001|Overall Study|Other - Miscellaneous|0|||
145611663|NCT00474175|525093974|FG000|Overall Study|Lack of Efficacy|0|||
145611664|NCT00474175|525093975|FG001|Overall Study|Lack of Efficacy|0|||
145611665|NCT00474175|525093976|FG002|Overall Study|Lack of Efficacy|1|||
145611666|NCT00474175|525093974|FG000|Overall Study|Withdrawal by Subject|0|||
145611667|NCT00474175|525093975|FG001|Overall Study|Withdrawal by Subject|1|||
145611668|NCT00474175|525093976|FG002|Overall Study|Withdrawal by Subject|1|||
145611669|NCT00474175|525093974|FG000|Overall Study|Ineligible|1|||
145611670|NCT00474175|525093975|FG001|Overall Study|Ineligible|3|||
145611671|NCT00474175|525093976|FG002|Overall Study|Ineligible|1|||
145611672|NCT00474175|525093974|FG000|Overall Study|Protocol Violation|0|||
145611673|NCT00474175|525093975|FG001|Overall Study|Protocol Violation|2|||
145611674|NCT00474175|525093976|FG002|Overall Study|Protocol Violation|1|||
145611675|NCT00474175|525093974|FG000|Overall Study|Administrative|0|||
145611676|NCT00474175|525093975|FG001|Overall Study|Administrative|1|||
145611677|NCT00474175|525093976|FG002|Overall Study|Administrative|0|||
145611678|NCT01619787|525093980|FG000|Overall Study|Lost to Follow-up|5|||
145611679|NCT03066622|525093985|FG000|Overall Study|Lost to Follow-up|24|||
145611680|NCT03066622|525093986|FG001|Overall Study|Lost to Follow-up|25|||
145611681|NCT03066622|525093985|FG000|Overall Study|Withdrawal by Subject|2|||
145611682|NCT03066622|525093986|FG001|Overall Study|Withdrawal by Subject|1|||
145611683|NCT00641719|525093987|FG000|Overall Study|Lack of Efficacy|1|||
145611684|NCT00641719|525093988|FG001|Overall Study|Lack of Efficacy|2|||
145611685|NCT00641719|525093987|FG000|Overall Study|Adverse Event|24|||
145611686|NCT00641719|525093988|FG001|Overall Study|Adverse Event|29|||
145611687|NCT00641719|525093987|FG000|Overall Study|Withdrawal by Subject|4|||
145611688|NCT00641719|525093988|FG001|Overall Study|Withdrawal by Subject|4|||
145611689|NCT00641719|525093987|FG000|Overall Study|Reason Not Specified|1|||
145611690|NCT00641719|525093988|FG001|Overall Study|Reason Not Specified|2|||
145611691|NCT03303469|525093989|FG000|Overall Study|Lost to Follow-up|2|||
145611692|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
145611693|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
145611694|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
145611695|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
145611696|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
145611697|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
145611698|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
145611699|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
145611700|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
145611701|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
145611702|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
145611703|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
145611704|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
145611705|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
145611706|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
145611707|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
145406023|NCT01047319|524341702|FG000|Overall Study|Study terminated by Sponsor|198|||
145406024|NCT01047319|524341703|FG001|Overall Study|Study terminated by Sponsor|215|||
145611708|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
145406025|NCT01047319|524341704|FG002|Overall Study|Study terminated by Sponsor|203|||
145611709|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
145611710|NCT00365378|525093990|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
145611711|NCT00365378|525093991|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
145611712|NCT00365378|525093992|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
145611713|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
145611714|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
145611715|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
145611716|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
145611717|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
145611718|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
145611719|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
145611720|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
145611721|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
145611722|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
145611723|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
145611724|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
145611725|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
145406026|NCT01277861|524341706|FG000|Overall Study|Physician Decision|2|||
145406027|NCT01277861|524341707|FG001|Overall Study|Physician Decision|2|||
145611726|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
145611727|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
145611728|NCT00365378|525093990|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
145611729|NCT00365378|525093991|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
145611730|NCT00365378|525093992|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
145611731|NCT00365378|525093990|FG000|Extension|Adverse Event|0|||
145611732|NCT00365378|525093991|FG001|Extension|Adverse Event|0|||
145611733|NCT00365378|525093992|FG002|Extension|Adverse Event|1|||
145611734|NCT00365378|525093990|FG000|Extension|Moved|0|||
145611735|NCT00365378|525093991|FG001|Extension|Moved|0|||
145611736|NCT00365378|525093992|FG002|Extension|Moved|8|||
145611737|NCT00365378|525093990|FG000|Extension|Lost to Follow-up|0|||
145611738|NCT00365378|525093991|FG001|Extension|Lost to Follow-up|0|||
145611739|NCT00365378|525093992|FG002|Extension|Lost to Follow-up|57|||
145611740|NCT00365378|525093990|FG000|Extension|Protocol Violation|0|||
145611741|NCT00365378|525093991|FG001|Extension|Protocol Violation|0|||
145611742|NCT00365378|525093992|FG002|Extension|Protocol Violation|2|||
145611743|NCT00365378|525093990|FG000|Extension|Withdrawal by Subject|0|||
145553874|NCT04203238|524886632|FG000|Overall Study|Withdrawal by Subject|1|||
145553875|NCT04203238|524886633|FG001|Overall Study|Withdrawal by Subject|1|||
145553876|NCT04203238|524886632|FG000|Overall Study|Covid-19|3|||
145553877|NCT04203238|524886633|FG001|Overall Study|Covid-19|0|||
145553878|NCT01134783|524886635|FG000|Overall Study|Pregnancy|16|||
145553879|NCT01134783|524886636|FG001|Overall Study|Pregnancy|8|||
145553880|NCT01134783|524886635|FG000|Overall Study|Withdrawal by Subject|15|||
145553881|NCT01134783|524886636|FG001|Overall Study|Withdrawal by Subject|9|||
145553882|NCT01134783|524886635|FG000|Overall Study|Lost to Follow-up|5|||
145553883|NCT01134783|524886636|FG001|Overall Study|Lost to Follow-up|20|||
145553884|NCT00001596|524886637|FG000|Overall Study|Death|1|||
145553885|NCT00001596|524886638|FG001|Overall Study|Death|0|||
145553886|NCT00001596|524886637|FG000|Overall Study|Withdrawal by Subject|3|||
145611744|NCT00365378|525093991|FG001|Extension|Withdrawal by Subject|0|||
145611745|NCT00365378|525093992|FG002|Extension|Withdrawal by Subject|98|||
145611746|NCT00365378|525093990|FG000|Extension|Other|0|||
145611747|NCT00365378|525093991|FG001|Extension|Other|0|||
145611748|NCT00365378|525093992|FG002|Extension|Other|31|||
145611749|NCT00192023|525093997|FG000|Period III - Double-Blind|Adverse Event|3|||
145611750|NCT00192023|525093998|FG001|Period III - Double-Blind|Adverse Event|0|||
145611751|NCT00192023|525093997|FG000|Period III - Double-Blind|Physician Decision|2|||
145611752|NCT00192023|525093998|FG001|Period III - Double-Blind|Physician Decision|0|||
145611753|NCT00192023|525093997|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
145611754|NCT00192023|525093998|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
145611755|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
145611756|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
145611757|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
145611758|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
145611759|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
145611760|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
145611761|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
145611762|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
145611763|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
145611764|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
145611765|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
145611766|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
145611767|NCT00192023|525093997|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
145611768|NCT00192023|525093998|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
145611769|NCT01737996|525094004|FG000|Overall Study|Adverse Event|0|||
145611770|NCT01737996|525094005|FG001|Overall Study|Adverse Event|1|||
145611771|NCT01737996|525094006|FG002|Overall Study|Adverse Event|1|||
145611772|NCT01737996|525094004|FG000|Overall Study|Withdrawal by Subject|0|||
145611773|NCT01737996|525094005|FG001|Overall Study|Withdrawal by Subject|0|||
145611774|NCT01737996|525094006|FG002|Overall Study|Withdrawal by Subject|1|||
145611775|NCT02693834|525094015|FG000|Baseline Measurement|Withdrawal by Subject|1|||
145611776|NCT02693834|525094016|FG001|Baseline Measurement|Withdrawal by Subject|0|||
145611777|NCT02693834|525094015|FG000|Baseline Measurement|Adverse Event|1|||
145611778|NCT02693834|525094016|FG001|Baseline Measurement|Adverse Event|0|||
145611779|NCT02693834|525094015|FG000|Week 2 Practice|Adverse Event|0|||
145611780|NCT02693834|525094016|FG001|Week 2 Practice|Adverse Event|1|||
145611781|NCT02765490|525094019|FG000|Overall Study|Lost to Follow-up|1|||
145611782|NCT02765490|525094020|FG001|Overall Study|Lost to Follow-up|1|||
145611783|NCT02765490|525094019|FG000|Overall Study|Other|0|||
145611784|NCT02765490|525094020|FG001|Overall Study|Other|1|||
145611785|NCT02765490|525094019|FG000|Overall Study|Death|0|||
145611786|NCT02765490|525094020|FG001|Overall Study|Death|1|||
145611787|NCT01468922|525094021|FG000|Overall Study|Screening failure|0|||
145553887|NCT00001596|524886638|FG001|Overall Study|Withdrawal by Subject|1|||
145553888|NCT00001596|524886637|FG000|Overall Study|Study Termination|12|||
145553889|NCT00001596|524886638|FG001|Overall Study|Study Termination|9|||
145611788|NCT01468922|525094022|FG001|Overall Study|Screening failure|0|||
145611789|NCT01468922|525094023|FG002|Overall Study|Screening failure|0|||
145611790|NCT01468922|525094024|FG003|Overall Study|Screening failure|0|||
145611791|NCT01468922|525094025|FG004|Overall Study|Screening failure|0|||
145406028|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
145406029|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
145553890|NCT00001596|524886637|FG000|Overall Study|Adverse Event|1|||
145553891|NCT00001596|524886638|FG001|Overall Study|Adverse Event|0|||
145553892|NCT00180414|524886645|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
145553893|NCT00180414|524886646|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
145553894|NCT03641651|524886652|FG000|Overall Study|organizational issues at one study site|1|||
145553895|NCT00951665|524886653|FG000|Phase 1b|Adverse Event|2|||
145553896|NCT00951665|524886654|FG001|Phase 1b|Adverse Event|1|||
145553897|NCT00951665|524886655|FG002|Phase 1b|Adverse Event|0|||
145553898|NCT00951665|524886656|FG003|Phase 1b|Adverse Event|1|||
145553899|NCT00951665|524886657|FG004|Phase 1b|Adverse Event|0|||
145553900|NCT00951665|524886658|FG005|Phase 1b|Adverse Event|0|||
145553901|NCT00951665|524886653|FG000|Phase 1b|Death|1|||
145553902|NCT00951665|524886654|FG001|Phase 1b|Death|0|||
145553903|NCT00951665|524886655|FG002|Phase 1b|Death|2|||
145553904|NCT00951665|524886656|FG003|Phase 1b|Death|0|||
145553905|NCT00951665|524886657|FG004|Phase 1b|Death|0|||
145553906|NCT00951665|524886658|FG005|Phase 1b|Death|0|||
145553907|NCT00951665|524886653|FG000|Phase 1b|Physician Decision|4|||
145553908|NCT00951665|524886654|FG001|Phase 1b|Physician Decision|0|||
145553909|NCT00951665|524886655|FG002|Phase 1b|Physician Decision|1|||
145553910|NCT00951665|524886656|FG003|Phase 1b|Physician Decision|0|||
145553911|NCT00951665|524886657|FG004|Phase 1b|Physician Decision|0|||
145553912|NCT00951665|524886658|FG005|Phase 1b|Physician Decision|0|||
145553913|NCT00951665|524886653|FG000|Phase 1b|Withdrawal by Subject|0|||
145553914|NCT00951665|524886654|FG001|Phase 1b|Withdrawal by Subject|1|||
145553915|NCT00951665|524886655|FG002|Phase 1b|Withdrawal by Subject|0|||
145553916|NCT00951665|524886656|FG003|Phase 1b|Withdrawal by Subject|0|||
145553917|NCT00951665|524886657|FG004|Phase 1b|Withdrawal by Subject|0|||
145553918|NCT00951665|524886658|FG005|Phase 1b|Withdrawal by Subject|0|||
145553919|NCT00951665|524886653|FG000|Phase 1b|Disease Progression|13|||
145553920|NCT00951665|524886654|FG001|Phase 1b|Disease Progression|2|||
145553921|NCT00951665|524886655|FG002|Phase 1b|Disease Progression|14|||
145553922|NCT00951665|524886656|FG003|Phase 1b|Disease Progression|0|||
145553923|NCT00951665|524886657|FG004|Phase 1b|Disease Progression|0|||
145553924|NCT00951665|524886658|FG005|Phase 1b|Disease Progression|0|||
145553925|NCT00951665|524886653|FG000|Phase 1b|Protocol Violation|2|||
145553926|NCT00951665|524886654|FG001|Phase 1b|Protocol Violation|0|||
145553927|NCT00951665|524886655|FG002|Phase 1b|Protocol Violation|0|||
145553928|NCT00951665|524886656|FG003|Phase 1b|Protocol Violation|0|||
145553929|NCT00951665|524886657|FG004|Phase 1b|Protocol Violation|0|||
145553930|NCT00951665|524886658|FG005|Phase 1b|Protocol Violation|0|||
145553931|NCT00951665|524886653|FG000|Phase 2a|Adverse Event|0|||
145553932|NCT00951665|524886654|FG001|Phase 2a|Adverse Event|0|||
145553933|NCT00951665|524886655|FG002|Phase 2a|Adverse Event|0|||
145553934|NCT00951665|524886656|FG003|Phase 2a|Adverse Event|0|||
145553935|NCT00951665|524886657|FG004|Phase 2a|Adverse Event|2|||
145553936|NCT00951665|524886658|FG005|Phase 2a|Adverse Event|0|||
145553937|NCT00951665|524886653|FG000|Phase 2a|Death|0|||
145553938|NCT00951665|524886654|FG001|Phase 2a|Death|0|||
145553939|NCT00951665|524886655|FG002|Phase 2a|Death|0|||
145553940|NCT00951665|524886656|FG003|Phase 2a|Death|0|||
145553941|NCT00951665|524886657|FG004|Phase 2a|Death|1|||
145553942|NCT00951665|524886658|FG005|Phase 2a|Death|1|||
145553943|NCT00951665|524886653|FG000|Phase 2a|Lost to Follow-up|0|||
145553944|NCT00951665|524886654|FG001|Phase 2a|Lost to Follow-up|0|||
145553945|NCT00951665|524886655|FG002|Phase 2a|Lost to Follow-up|0|||
145553946|NCT00951665|524886656|FG003|Phase 2a|Lost to Follow-up|0|||
145553947|NCT00951665|524886657|FG004|Phase 2a|Lost to Follow-up|1|||
145553948|NCT00951665|524886658|FG005|Phase 2a|Lost to Follow-up|0|||
145406030|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
145553949|NCT00951665|524886653|FG000|Phase 2a|Physician Decision|0|||
145553950|NCT00951665|524886654|FG001|Phase 2a|Physician Decision|0|||
145553951|NCT00951665|524886655|FG002|Phase 2a|Physician Decision|0|||
145553952|NCT00951665|524886656|FG003|Phase 2a|Physician Decision|0|||
145553953|NCT00951665|524886657|FG004|Phase 2a|Physician Decision|0|||
145553954|NCT00951665|524886658|FG005|Phase 2a|Physician Decision|1|||
145553955|NCT00951665|524886653|FG000|Phase 2a|Withdrawal by Subject|0|||
145284714|NCT03567057|523891669|FG000|Overall Study|Adverse Event|56|||
145553956|NCT00951665|524886654|FG001|Phase 2a|Withdrawal by Subject|0|||
145553957|NCT00951665|524886655|FG002|Phase 2a|Withdrawal by Subject|0|||
145553958|NCT00951665|524886656|FG003|Phase 2a|Withdrawal by Subject|0|||
145553959|NCT00951665|524886657|FG004|Phase 2a|Withdrawal by Subject|2|||
145553960|NCT00951665|524886658|FG005|Phase 2a|Withdrawal by Subject|0|||
145553961|NCT00951665|524886653|FG000|Phase 2a|Disease Progression|0|||
145553962|NCT00951665|524886654|FG001|Phase 2a|Disease Progression|0|||
145553963|NCT00951665|524886655|FG002|Phase 2a|Disease Progression|0|||
145553964|NCT00951665|524886656|FG003|Phase 2a|Disease Progression|0|||
145553965|NCT00951665|524886657|FG004|Phase 2a|Disease Progression|6|||
145553966|NCT00951665|524886658|FG005|Phase 2a|Disease Progression|5|||
145553967|NCT02723084|524886659|FG000|Overall Study|Withdrawal by Subject|1|||
145553968|NCT02723084|524886660|FG001|Overall Study|Withdrawal by Subject|1|||
145553969|NCT02723084|524886659|FG000|Overall Study|Lost to Follow-up|3|||
145553970|NCT02723084|524886660|FG001|Overall Study|Lost to Follow-up|0|||
145553971|NCT02734810|524886664|FG000|Overall Study|Adverse Event|1|||
145553972|NCT02734810|524886665|FG001|Overall Study|Adverse Event|0|||
145553973|NCT02734810|524886664|FG000|Overall Study|Lack of Efficacy|1|||
145553974|NCT02734810|524886665|FG001|Overall Study|Lack of Efficacy|0|||
145553975|NCT00127712|524886666|FG000|Overall Study|Adverse Event|3|||
145553976|NCT00127712|524886667|FG001|Overall Study|Adverse Event|0|||
145553977|NCT00127712|524886666|FG000|Overall Study|Lack of GI access to continue|2|||
145553978|NCT00127712|524886667|FG001|Overall Study|Lack of GI access to continue|0|||
145553979|NCT00715078|524886671|FG000|Overall Study|Death|29|||
145553980|NCT00715078|524886672|FG001|Overall Study|Death|36|||
145553981|NCT00715078|524886673|FG002|Overall Study|Death|36|||
145553982|NCT00715078|524886671|FG000|Overall Study|Withdrawal by Subject|1|||
145553983|NCT00715078|524886672|FG001|Overall Study|Withdrawal by Subject|0|||
145553984|NCT00715078|524886673|FG002|Overall Study|Withdrawal by Subject|1|||
145553985|NCT00715078|524886671|FG000|Overall Study|Unable to start due to disease prog.|0|||
145553986|NCT00715078|524886672|FG001|Overall Study|Unable to start due to disease prog.|0|||
145553987|NCT00715078|524886673|FG002|Overall Study|Unable to start due to disease prog.|1|||
145553988|NCT02892760|524886674|FG000|Overall Study|Withdrawal by Subject|3|||
145553989|NCT00386776|524886677|FG000|Overall Study|Withdrawal by Subject|8|||
145553990|NCT00588848|524886678|FG000|Overall Study|Physician Decision|0|||
145553991|NCT00588848|524886679|FG001|Overall Study|Physician Decision|3|||
145553992|NCT00249444|524886680|FG000|Overall Study|Lost to Follow-up|2|||
145553993|NCT00249444|524886681|FG001|Overall Study|Lost to Follow-up|2|||
145553994|NCT00249444|524886680|FG000|Overall Study|non-compliant|9|||
145553995|NCT00249444|524886681|FG001|Overall Study|non-compliant|11|||
145553996|NCT00249444|524886680|FG000|Overall Study|Adverse Event|1|||
145553997|NCT00249444|524886681|FG001|Overall Study|Adverse Event|1|||
145553998|NCT00249444|524886680|FG000|Overall Study|life event|0|||
145553999|NCT00249444|524886681|FG001|Overall Study|life event|1|||
145554000|NCT02673489|524886682|FG000|Treatment Period|Lost to Follow-up|3|||
145554001|NCT02673489|524886683|FG001|Treatment Period|Lost to Follow-up|0|||
145554002|NCT02673489|524886682|FG000|Treatment Period|Participant request to discontinue|1|||
145554003|NCT02673489|524886683|FG001|Treatment Period|Participant request to discontinue|1|||
145554004|NCT02673489|524886682|FG000|Treatment Period|Participant moved to another province|1|||
145554005|NCT02673489|524886683|FG001|Treatment Period|Participant moved to another province|0|||
145554006|NCT02673489|524886682|FG000|Treatment Period|Participant was incarcerated|0|||
145554007|NCT02673489|524886683|FG001|Treatment Period|Participant was incarcerated|1|||
145554008|NCT02673489|524886682|FG000|Treatment Period|Adverse Event|0|||
145554009|NCT02673489|524886683|FG001|Treatment Period|Adverse Event|1|||
145554010|NCT02673489|524886682|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
145611792|NCT01468922|525094026|FG005|Overall Study|Screening failure|0|||
145611793|NCT01468922|525094027|FG006|Overall Study|Screening failure|0|||
145611794|NCT01468922|525094028|FG007|Overall Study|Screening failure|0|||
145611795|NCT01468922|525094029|FG008|Overall Study|Screening failure|1|||
145611796|NCT01468922|525094021|FG000|Overall Study|Per patient choice|1|||
145611797|NCT01468922|525094022|FG001|Overall Study|Per patient choice|0|||
145611798|NCT01468922|525094023|FG002|Overall Study|Per patient choice|0|||
145611799|NCT01468922|525094024|FG003|Overall Study|Per patient choice|0|||
145611800|NCT01468922|525094025|FG004|Overall Study|Per patient choice|0|||
145611801|NCT01468922|525094026|FG005|Overall Study|Per patient choice|0|||
145611802|NCT01468922|525094027|FG006|Overall Study|Per patient choice|0|||
145611803|NCT01468922|525094028|FG007|Overall Study|Per patient choice|0|||
145611804|NCT01468922|525094029|FG008|Overall Study|Per patient choice|0|||
145611805|NCT01468922|525094021|FG000|Overall Study|Switched to alternative treatment|1|||
145611806|NCT01468922|525094022|FG001|Overall Study|Switched to alternative treatment|0|||
145611807|NCT01468922|525094023|FG002|Overall Study|Switched to alternative treatment|0|||
145611808|NCT01468922|525094024|FG003|Overall Study|Switched to alternative treatment|0|||
145611809|NCT01468922|525094025|FG004|Overall Study|Switched to alternative treatment|1|||
145611810|NCT01468922|525094026|FG005|Overall Study|Switched to alternative treatment|0|||
145611811|NCT01468922|525094027|FG006|Overall Study|Switched to alternative treatment|0|||
145611812|NCT01468922|525094028|FG007|Overall Study|Switched to alternative treatment|0|||
145611813|NCT01468922|525094029|FG008|Overall Study|Switched to alternative treatment|0|||
145611814|NCT01468922|525094021|FG000|Overall Study|Enrolled on new protocol|0|||
145611815|NCT01468922|525094022|FG001|Overall Study|Enrolled on new protocol|0|||
145611816|NCT01468922|525094023|FG002|Overall Study|Enrolled on new protocol|0|||
145611817|NCT01468922|525094024|FG003|Overall Study|Enrolled on new protocol|0|||
145611818|NCT01468922|525094025|FG004|Overall Study|Enrolled on new protocol|1|||
145284715|NCT03567057|523891670|FG001|Overall Study|Adverse Event|53|||
145284716|NCT03567057|523891671|FG002|Overall Study|Adverse Event|28|||
145554011|NCT02673489|524886683|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
145554012|NCT02673489|524886682|FG000|Follow Up Period|Unable to return for follow-up|0|||
145554013|NCT02673489|524886683|FG001|Follow Up Period|Unable to return for follow-up|1|||
145554014|NCT00759863|524886684|FG000|Overall Study|Death, moved, or lost contact|20|||
145554015|NCT00759863|524886685|FG001|Overall Study|Death, moved, or lost contact|18|||
145554016|NCT00412854|524886686|FG000|Overall Study|Withdrawn due to adverse events|1|||
145554017|NCT00412854|524886687|FG001|Overall Study|Withdrawn due to adverse events|5|||
145554018|NCT00412854|524886686|FG000|Overall Study|Withdrawn for other reasons|13|||
145611819|NCT01468922|525094026|FG005|Overall Study|Enrolled on new protocol|0|||
145611820|NCT01468922|525094027|FG006|Overall Study|Enrolled on new protocol|0|||
145284717|NCT03567057|523891669|FG000|Overall Study|Withdrawal by Subject|22|||
145554019|NCT00412854|524886687|FG001|Overall Study|Withdrawn for other reasons|11|||
145554020|NCT00503308|524886688|FG000|Overall Study|Protocol Violation|2|||
145554021|NCT00503308|524886689|FG001|Overall Study|Protocol Violation|1|||
145554022|NCT03263442|524886690|FG000|Inpatient Phase|Death|1|||
145554023|NCT03263442|524886691|FG001|Inpatient Phase|Death|0|||
145554024|NCT03263442|524886690|FG000|Inpatient Phase|Withdrawal by Subject|1|||
145554025|NCT03263442|524886691|FG001|Inpatient Phase|Withdrawal by Subject|0|||
145554026|NCT03263442|524886690|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
145554027|NCT03263442|524886691|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
145554028|NCT03263442|524886690|FG000|1-month Follow-Up|Lost to Follow-up|1|||
145554029|NCT03263442|524886691|FG001|1-month Follow-Up|Lost to Follow-up|0|||
145554030|NCT03263442|524886690|FG000|3-month Follow-Up|Lost to Follow-up|1|||
145554031|NCT03263442|524886691|FG001|3-month Follow-Up|Lost to Follow-up|3|||
145554032|NCT03263442|524886690|FG000|6-month Follow-Up|Lost to Follow-up|2|||
145554033|NCT03263442|524886691|FG001|6-month Follow-Up|Lost to Follow-up|2|||
145554034|NCT01463878|524886692|FG000|Overall Study|no longer met criteria for tube feed|2|||
145554035|NCT01463878|524886693|FG001|Overall Study|no longer met criteria for tube feed|2|||
145554036|NCT03804879|524886694|FG000|Overall Study|Adverse Event|3|||
145554037|NCT03804879|524886695|FG001|Overall Study|Adverse Event|0|||
145554038|NCT03804879|524886694|FG000|Overall Study|Study Terminated By Sponsor|10|||
145554039|NCT03804879|524886695|FG001|Overall Study|Study Terminated By Sponsor|12|||
145554040|NCT03804879|524886694|FG000|Overall Study|Withdrawal by Subject|3|||
145554041|NCT03804879|524886695|FG001|Overall Study|Withdrawal by Subject|1|||
145554042|NCT01034462|524886696|FG000|Overall Study|Adverse Event|7|||
145554043|NCT01034462|524886697|FG001|Overall Study|Adverse Event|17|||
145554044|NCT01034462|524886696|FG000|Overall Study|Lack of Efficacy|4|||
145554045|NCT01034462|524886697|FG001|Overall Study|Lack of Efficacy|4|||
145554046|NCT01034462|524886696|FG000|Overall Study|Protocol Violation|10|||
145554047|NCT01034462|524886697|FG001|Overall Study|Protocol Violation|7|||
145554048|NCT01034462|524886696|FG000|Overall Study|Withdrawal by Subject|9|||
145554049|NCT01034462|524886697|FG001|Overall Study|Withdrawal by Subject|8|||
145554050|NCT01034462|524886696|FG000|Overall Study|Lost to Follow-up|14|||
145554051|NCT01034462|524886697|FG001|Overall Study|Lost to Follow-up|16|||
145554052|NCT01034462|524886696|FG000|Overall Study|Other reasons|1|||
145554053|NCT01034462|524886697|FG001|Overall Study|Other reasons|2|||
145554054|NCT00708643|524886698|FG000|Overall Study|Adverse Event|0|||
145554055|NCT00708643|524886699|FG001|Overall Study|Adverse Event|1|||
145554056|NCT04876274|524886700|FG000|Overall Study|Lost to Follow-up|9|||
145554057|NCT04876274|524886701|FG001|Overall Study|Lost to Follow-up|12|||
145554058|NCT01948050|524886702|FG000|Overall Study|Withdrawal by Subject|0|||
145554059|NCT01948050|524886703|FG001|Overall Study|Withdrawal by Subject|1|||
145554060|NCT06079320|524886706|FG000|Follow up Phase|Lost to Follow-up|1|||
145554061|NCT06079320|524886707|FG001|Follow up Phase|Lost to Follow-up|0|||
145554062|NCT01129960|524886708|FG000|Overall Study|Withdrawal by Subject|3|||
145554063|NCT01129960|524886709|FG001|Overall Study|Withdrawal by Subject|0|||
145554064|NCT01129960|524886710|FG002|Overall Study|Withdrawal by Subject|3|||
145554065|NCT01129960|524886711|FG003|Overall Study|Withdrawal by Subject|2|||
145611821|NCT01468922|525094028|FG007|Overall Study|Enrolled on new protocol|0|||
145611822|NCT01468922|525094029|FG008|Overall Study|Enrolled on new protocol|0|||
145611823|NCT01468922|525094021|FG000|Overall Study|Adverse Event|0|||
145611824|NCT01468922|525094022|FG001|Overall Study|Adverse Event|0|||
145611825|NCT01468922|525094023|FG002|Overall Study|Adverse Event|0|||
145611826|NCT01468922|525094024|FG003|Overall Study|Adverse Event|0|||
145611827|NCT01468922|525094025|FG004|Overall Study|Adverse Event|0|||
145611828|NCT01468922|525094026|FG005|Overall Study|Adverse Event|0|||
145611829|NCT01468922|525094027|FG006|Overall Study|Adverse Event|0|||
145611830|NCT01468922|525094028|FG007|Overall Study|Adverse Event|1|||
145611831|NCT01468922|525094029|FG008|Overall Study|Adverse Event|0|||
145611832|NCT01468922|525094021|FG000|Overall Study|Infection of blood|0|||
145284718|NCT03567057|523891670|FG001|Overall Study|Withdrawal by Subject|24|||
145284719|NCT03567057|523891671|FG002|Overall Study|Withdrawal by Subject|13|||
145284720|NCT03567057|523891669|FG000|Overall Study|Lost to Follow-up|3|||
145611833|NCT01468922|525094022|FG001|Overall Study|Infection of blood|0|||
145611834|NCT01468922|525094023|FG002|Overall Study|Infection of blood|0|||
145611835|NCT01468922|525094024|FG003|Overall Study|Infection of blood|0|||
145554066|NCT01129960|524886708|FG000|Overall Study|Lack of Efficacy|1|||
145554067|NCT01129960|524886709|FG001|Overall Study|Lack of Efficacy|1|||
145554068|NCT01129960|524886710|FG002|Overall Study|Lack of Efficacy|1|||
145554069|NCT01129960|524886711|FG003|Overall Study|Lack of Efficacy|1|||
145554070|NCT01129960|524886708|FG000|Overall Study|Adverse Event|23|||
145554071|NCT01129960|524886709|FG001|Overall Study|Adverse Event|16|||
145554072|NCT01129960|524886710|FG002|Overall Study|Adverse Event|16|||
145554073|NCT01129960|524886711|FG003|Overall Study|Adverse Event|7|||
145554074|NCT01129960|524886708|FG000|Overall Study|Protocol Violation|1|||
145554075|NCT01129960|524886709|FG001|Overall Study|Protocol Violation|2|||
145554076|NCT01129960|524886710|FG002|Overall Study|Protocol Violation|3|||
145554077|NCT01129960|524886711|FG003|Overall Study|Protocol Violation|0|||
145554078|NCT01129960|524886708|FG000|Overall Study|Lost to Follow-up|0|||
145554079|NCT01129960|524886709|FG001|Overall Study|Lost to Follow-up|2|||
145554080|NCT01129960|524886710|FG002|Overall Study|Lost to Follow-up|3|||
145554081|NCT01129960|524886711|FG003|Overall Study|Lost to Follow-up|3|||
145554082|NCT01129960|524886708|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
145554083|NCT01129960|524886709|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
145554084|NCT01129960|524886710|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
145554085|NCT01129960|524886711|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
145554086|NCT01129960|524886708|FG000|Overall Study|Physician Decision|1|||
145554087|NCT01129960|524886709|FG001|Overall Study|Physician Decision|0|||
145554088|NCT01129960|524886710|FG002|Overall Study|Physician Decision|0|||
145554089|NCT01129960|524886711|FG003|Overall Study|Physician Decision|0|||
145554090|NCT01129960|524886708|FG000|Overall Study|Pregnancy|1|||
145554091|NCT01129960|524886709|FG001|Overall Study|Pregnancy|0|||
145554092|NCT01129960|524886710|FG002|Overall Study|Pregnancy|0|||
145554093|NCT01129960|524886711|FG003|Overall Study|Pregnancy|0|||
145554094|NCT03198234|524886712|FG000|Overall Study|Relapse of primary disease|0|||
145554095|NCT03198234|524886713|FG001|Overall Study|Relapse of primary disease|1|||
145554096|NCT03198234|524886714|FG002|Overall Study|Relapse of primary disease|0|||
145554097|NCT03228537|524886715|FG000|Neoadjuvant|Adverse Event|2|||
145554098|NCT03228537|524886715|FG000|Neoadjuvant|Progression/Relapse|4|||
145554099|NCT03228537|524886715|FG000|Neoadjuvant|Death|1|||
145554100|NCT03228537|524886715|FG000|Surgery|Death|1|||
145554101|NCT03228537|524886715|FG000|Surgery|Other - Not Protocol Specified|2|||
145554102|NCT03228537|524886715|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
145554103|NCT03228537|524886715|FG000|Maintenance|Progression/Relapse|10|||
145554104|NCT02622321|524886716|FG000|Overall Study|Withdrawal by Subject|2|||
145554105|NCT02622321|524886717|FG001|Overall Study|Withdrawal by Subject|0|||
145554106|NCT02622321|524886718|FG002|Overall Study|Withdrawal by Subject|0|||
145611836|NCT01468922|525094025|FG004|Overall Study|Infection of blood|0|||
145611837|NCT01468922|525094026|FG005|Overall Study|Infection of blood|0|||
145611838|NCT01468922|525094027|FG006|Overall Study|Infection of blood|0|||
145611839|NCT01468922|525094028|FG007|Overall Study|Infection of blood|1|||
145611840|NCT01468922|525094029|FG008|Overall Study|Infection of blood|0|||
145611841|NCT01468922|525094021|FG000|Overall Study|Patient choice - surgery|0|||
145611842|NCT01468922|525094022|FG001|Overall Study|Patient choice - surgery|0|||
145611843|NCT01468922|525094023|FG002|Overall Study|Patient choice - surgery|0|||
145611844|NCT01468922|525094024|FG003|Overall Study|Patient choice - surgery|0|||
145611845|NCT01468922|525094025|FG004|Overall Study|Patient choice - surgery|0|||
145611846|NCT01468922|525094026|FG005|Overall Study|Patient choice - surgery|0|||
145611847|NCT01468922|525094027|FG006|Overall Study|Patient choice - surgery|0|||
145611848|NCT01468922|525094028|FG007|Overall Study|Patient choice - surgery|1|||
145611849|NCT01468922|525094029|FG008|Overall Study|Patient choice - surgery|0|||
145611850|NCT01468922|525094021|FG000|Overall Study|Refused further treatment|0|||
145611851|NCT01468922|525094022|FG001|Overall Study|Refused further treatment|0|||
145611852|NCT01468922|525094023|FG002|Overall Study|Refused further treatment|0|||
145611853|NCT01468922|525094024|FG003|Overall Study|Refused further treatment|0|||
145554107|NCT02622321|524886719|FG003|Overall Study|Withdrawal by Subject|0|||
145554108|NCT02622321|524886716|FG000|Overall Study|Death|0|||
145554109|NCT02622321|524886717|FG001|Overall Study|Death|0|||
145554110|NCT02622321|524886718|FG002|Overall Study|Death|1|||
145554111|NCT02622321|524886719|FG003|Overall Study|Death|0|||
145554112|NCT02622321|524886716|FG000|Overall Study|Physician Decision|1|||
145611854|NCT01468922|525094025|FG004|Overall Study|Refused further treatment|0|||
145611855|NCT01468922|525094026|FG005|Overall Study|Refused further treatment|0|||
145611856|NCT01468922|525094027|FG006|Overall Study|Refused further treatment|0|||
145554113|NCT02622321|524886717|FG001|Overall Study|Physician Decision|0|||
145554114|NCT02622321|524886718|FG002|Overall Study|Physician Decision|0|||
145554115|NCT02622321|524886719|FG003|Overall Study|Physician Decision|0|||
145554116|NCT00965718|524886721|FG000|Overall Study|Withdrawal by Subject|4|||
145554117|NCT03428360|524886722|FG000|Overall Study|Informed consent withdrawn|5|||
145554118|NCT03428360|524886722|FG000|Overall Study|Withdrawal by Subject|4|||
145611857|NCT01468922|525094028|FG007|Overall Study|Refused further treatment|1|||
145611858|NCT01468922|525094029|FG008|Overall Study|Refused further treatment|0|||
145611859|NCT01923389|525094030|FG000|Overall Study|Protocol Violation|1|||
145554119|NCT03428360|524886722|FG000|Overall Study|Lost to Follow-up|5|||
145554120|NCT03428360|524886722|FG000|Overall Study|Physician Decision|2|||
145611860|NCT01923389|525094031|FG001|Overall Study|Protocol Violation|0|||
145611861|NCT02761629|525094037|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
145611862|NCT02761629|525094038|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
145611863|NCT02761629|525094037|FG000|Overall Study|Insufficient Therapeutic Response|2|||
145611864|NCT02761629|525094038|FG001|Overall Study|Insufficient Therapeutic Response|7|||
145611865|NCT02761629|525094037|FG000|Overall Study|Failure to Return|2|||
145611866|NCT02761629|525094038|FG001|Overall Study|Failure to Return|4|||
145611867|NCT02761629|525094037|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
145611868|NCT02761629|525094038|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
145611869|NCT02761629|525094037|FG000|Overall Study|Protocol Violation|2|||
145611870|NCT02761629|525094038|FG001|Overall Study|Protocol Violation|2|||
145611871|NCT02761629|525094037|FG000|Overall Study|Withdrawal by Subject|0|||
145611872|NCT02761629|525094038|FG001|Overall Study|Withdrawal by Subject|3|||
145611873|NCT02761629|525094037|FG000|Overall Study|Other|0|||
145611874|NCT02761629|525094038|FG001|Overall Study|Other|2|||
145611875|NCT02761629|525094037|FG000|Overall Study|Lost to Follow-up|4|||
145611876|NCT02761629|525094038|FG001|Overall Study|Lost to Follow-up|1|||
145611877|NCT02761629|525094037|FG000|Overall Study|Randomized But Not Treated|8|||
145611878|NCT02761629|525094038|FG001|Overall Study|Randomized But Not Treated|4|||
145611879|NCT01348776|525094042|FG000|Overall Study|Lost to Follow-up|3|||
145611880|NCT02340520|525094048|FG000|Overall Study|Lost to Follow-up|1|||
145554121|NCT03428360|524886722|FG000|Overall Study|Informed consent withdrawn|5|||
145554122|NCT03428360|524886722|FG000|Overall Study|Study terminated by sponsor|10|||
145554123|NCT03428360|524886722|FG000|Overall Study|Non-compliant with study|1|||
145554124|NCT03428360|524886722|FG000|Overall Study|Non-compliant with study drug|3|||
145554125|NCT03428360|524886722|FG000|Overall Study|Death|3|||
145554126|NCT03428360|524886722|FG000|Overall Study|Adverse Event|1|||
145554127|NCT03428360|524886722|FG000|Overall Study|Not on antiepileptic drug|1|||
145554128|NCT01414855|524886725|FG000|Overall Study|Death|17|||
145554129|NCT01414855|524886725|FG000|Overall Study|Lost to Follow-up|5|||
145554130|NCT01414855|524886725|FG000|Overall Study|Withdrawal by Subject|7|||
145554131|NCT04851314|524886726|FG000|Overall Study|Unable to complete research set-up procedures|0|||
145554132|NCT04851314|524886727|FG001|Overall Study|Unable to complete research set-up procedures|2|||
145554133|NCT04851314|524886726|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
145554134|NCT04851314|524886727|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
145554135|NCT00368355|524886729|FG000|Overall Study|Adverse Event|1|||
145554136|NCT00368355|524886730|FG001|Overall Study|Adverse Event|0|||
145554137|NCT00368355|524886729|FG000|Overall Study|Death|2|||
145554138|NCT00368355|524886730|FG001|Overall Study|Death|4|||
145554139|NCT00368355|524886729|FG000|Overall Study|Relapse|6|||
145554140|NCT00368355|524886730|FG001|Overall Study|Relapse|10|||
145554141|NCT00368355|524886729|FG000|Overall Study|Subsequent transplant|0|||
145554142|NCT00368355|524886730|FG001|Overall Study|Subsequent transplant|3|||
145554143|NCT00368355|524886729|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
145554144|NCT00368355|524886730|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
145554145|NCT04059094|524886734|FG000|Overall Study|Adverse Event|0|||
145554146|NCT04059094|524886735|FG001|Overall Study|Adverse Event|0|||
145554147|NCT04059094|524886736|FG002|Overall Study|Adverse Event|0|||
145554148|NCT04059094|524886737|FG003|Overall Study|Adverse Event|0|||
145554149|NCT04059094|524886738|FG004|Overall Study|Adverse Event|1|||
145554150|NCT04059094|524886734|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
145554151|NCT04059094|524886735|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
145554152|NCT04059094|524886736|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
145554153|NCT04059094|524886737|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
145554154|NCT04059094|524886738|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
145554155|NCT01339429|524886739|FG000|Overall Study|Withdrawal by Subject|1|||
145554156|NCT01339429|524886739|FG000|Overall Study|Physician Decision|3|||
145554157|NCT00459667|524886748|FG000|Overall Study|Adverse Event|9|||
145554158|NCT00459667|524886749|FG001|Overall Study|Adverse Event|12|||
145554159|NCT00459667|524886750|FG002|Overall Study|Adverse Event|8|||
145554160|NCT00459667|524886748|FG000|Overall Study|Lost to Follow-up|5|||
145554161|NCT00459667|524886749|FG001|Overall Study|Lost to Follow-up|9|||
145554162|NCT00459667|524886750|FG002|Overall Study|Lost to Follow-up|3|||
145611881|NCT02340520|525094048|FG000|Overall Study|Patient did not take drug as specified|1|||
145611882|NCT02340520|525094048|FG000|Overall Study|Withdrawal by Subject|1|||
145611883|NCT04362137|525094049|FG000|Overall Study|Death|9|||
145611884|NCT04362137|525094050|FG001|Overall Study|Death|3|||
145611885|NCT04362137|525094049|FG000|Overall Study|Patient decision|6|||
145554163|NCT00459667|524886748|FG000|Overall Study|Pregnancy|1|||
145554164|NCT00459667|524886749|FG001|Overall Study|Pregnancy|1|||
145554165|NCT00459667|524886750|FG002|Overall Study|Pregnancy|1|||
145554166|NCT00459667|524886748|FG000|Overall Study|Protocol Violation|1|||
145554167|NCT00459667|524886749|FG001|Overall Study|Protocol Violation|0|||
145554168|NCT00459667|524886750|FG002|Overall Study|Protocol Violation|0|||
145554169|NCT00459667|524886748|FG000|Overall Study|Withdrawal by Subject|3|||
145611886|NCT04362137|525094050|FG001|Overall Study|Patient decision|3|||
145284721|NCT03567057|523891670|FG001|Overall Study|Lost to Follow-up|5|||
145554170|NCT00459667|524886749|FG001|Overall Study|Withdrawal by Subject|5|||
145554171|NCT00459667|524886750|FG002|Overall Study|Withdrawal by Subject|5|||
145554172|NCT00459667|524886748|FG000|Overall Study|Other disease modifying treatment|1|||
145554173|NCT00459667|524886749|FG001|Overall Study|Other disease modifying treatment|2|||
145554174|NCT00459667|524886750|FG002|Overall Study|Other disease modifying treatment|1|||
145554175|NCT00459667|524886748|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
145554176|NCT00459667|524886749|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
145554177|NCT00459667|524886750|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
145554178|NCT00459667|524886748|FG000|Overall Study|No treatment administered|6|||
145554179|NCT00459667|524886749|FG001|Overall Study|No treatment administered|3|||
145554180|NCT00459667|524886750|FG002|Overall Study|No treatment administered|1|||
145554181|NCT00396591|524886753|FG000|Overall Study|Disease Progression|13|||
145554182|NCT00396591|524886753|FG000|Overall Study|Adverse Event|2|||
145554183|NCT00396591|524886753|FG000|Overall Study|Participant request|1|||
145554184|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
145554185|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
145554186|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
145554187|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
145554188|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
145554189|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
145554190|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
145554191|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
145554192|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
145554193|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
145554194|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
145554195|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
145554196|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
145554197|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
145554198|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
145554199|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
145554200|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
145554201|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
145554202|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
145554203|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
145554204|NCT01962207|524886755|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
145554205|NCT01962207|524886756|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
145554206|NCT01962207|524886757|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
145554207|NCT01962207|524886758|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
145554208|NCT02671422|524886762|FG000|Overall Study|Lost to Follow-up|1|||
145554209|NCT02671422|524886762|FG000|Overall Study|Adverse Event|68|||
145554210|NCT02671422|524886762|FG000|Overall Study|Lack of Efficacy|1|||
145554211|NCT02671422|524886762|FG000|Overall Study|Lost to Follow-up|4|||
145554212|NCT02671422|524886762|FG000|Overall Study|Withdrawal by Subject|7|||
145554213|NCT02671422|524886762|FG000|Overall Study|Progressive Disease|156|||
145554214|NCT02671422|524886762|FG000|Overall Study|Worsening of Disease|4|||
145554215|NCT02671422|524886762|FG000|Overall Study|Sponsor decision|5|||
145554216|NCT02671422|524886762|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
145554217|NCT02671422|524886762|FG000|Overall Study|Not treated with Vargatef®|3|||
145284722|NCT03567057|523891671|FG002|Overall Study|Lost to Follow-up|2|||
145554218|NCT02671422|524886762|FG000|Overall Study|Other not defined above|3|||
145554219|NCT02289079|524886763|FG000|Overall Study|Physician Decision|2|||
145554220|NCT02289079|524886764|FG001|Overall Study|Physician Decision|0|||
145284723|NCT03567057|523891669|FG000|Overall Study|COVID-19 pandemic|4|||
145554221|NCT02289079|524886763|FG000|Overall Study|Lost to Follow-up|0|||
145554222|NCT02289079|524886764|FG001|Overall Study|Lost to Follow-up|1|||
145554223|NCT03036072|524886765|FG000|Overall Study|Death|0|||
145554224|NCT03036072|524886766|FG001|Overall Study|Death|1|||
145554225|NCT03036072|524886765|FG000|Overall Study|Withdrawal by Subject|0|||
145554226|NCT03036072|524886766|FG001|Overall Study|Withdrawal by Subject|1|||
145554227|NCT03036072|524886765|FG000|Overall Study|Physician Decision|0|||
145554228|NCT03036072|524886766|FG001|Overall Study|Physician Decision|1|||
145554229|NCT02484729|524886767|FG000|Overall Study|Failure of IntelliCap Error|0|||
145554230|NCT02484729|524886768|FG001|Overall Study|Failure of IntelliCap Error|0|||
145554231|NCT02484729|524886769|FG002|Overall Study|Failure of IntelliCap Error|0|||
145554232|NCT02484729|524886770|FG003|Overall Study|Failure of IntelliCap Error|0|||
145554233|NCT02484729|524886771|FG004|Overall Study|Failure of IntelliCap Error|0|||
145554234|NCT02484729|524886772|FG005|Overall Study|Failure of IntelliCap Error|0|||
145554235|NCT02484729|524886773|FG006|Overall Study|Failure of IntelliCap Error|0|||
145554236|NCT02484729|524886774|FG007|Overall Study|Failure of IntelliCap Error|0|||
145554237|NCT02484729|524886775|FG008|Overall Study|Failure of IntelliCap Error|0|||
145554238|NCT02484729|524886776|FG009|Overall Study|Failure of IntelliCap Error|1|||
145554239|NCT05119569|524886777|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
145554240|NCT05119569|524886778|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
145554241|NCT05119569|524886779|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
145554242|NCT05119569|524886780|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
145554243|NCT05119569|524886777|FG000|Double Blind Treatment Phase|Adverse Event|6|||
145554244|NCT05119569|524886778|FG001|Double Blind Treatment Phase|Adverse Event|0|||
145554245|NCT05119569|524886779|FG002|Double Blind Treatment Phase|Adverse Event|0|||
145554246|NCT05119569|524886780|FG003|Double Blind Treatment Phase|Adverse Event|0|||
145554247|NCT05119569|524886777|FG000|Open Label Extension Phase|Ongoing in the study|0|||
145554248|NCT05119569|524886778|FG001|Open Label Extension Phase|Ongoing in the study|0|||
145554249|NCT05119569|524886779|FG002|Open Label Extension Phase|Ongoing in the study|65|||
145554250|NCT05119569|524886780|FG003|Open Label Extension Phase|Ongoing in the study|34|||
145554251|NCT02623439|524886783|FG000|Overall Study|Withdrawal by Subject|1|||
145554252|NCT02623439|524886783|FG000|Overall Study|Screen Failure|1|||
145554253|NCT04484142|524886786|FG000|Overall Study|Adverse Event|13|||
145554254|NCT04484142|524886786|FG000|Overall Study|Progressive Disease|87|||
145554255|NCT04484142|524886786|FG000|Overall Study|Clinical Progression|10|||
145554256|NCT04484142|524886786|FG000|Overall Study|Withdrawal by Subject|6|||
145554257|NCT04484142|524886786|FG000|Overall Study|Physician Decision|1|||
145554258|NCT03851302|524886789|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
145554259|NCT03851302|524886790|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
145554260|NCT03851302|524886791|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
145554261|NCT03851302|524886792|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
145554262|NCT03851302|524886793|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
145554263|NCT03851302|524886794|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
145554264|NCT03851302|524886789|FG000|Screening (1 Day)|Screened out|0|||
145554265|NCT03851302|524886790|FG001|Screening (1 Day)|Screened out|0|||
145554266|NCT03851302|524886791|FG002|Screening (1 Day)|Screened out|1|||
145554267|NCT03851302|524886792|FG003|Screening (1 Day)|Screened out|1|||
145554268|NCT03851302|524886793|FG004|Screening (1 Day)|Screened out|0|||
145554269|NCT03851302|524886794|FG005|Screening (1 Day)|Screened out|0|||
145554270|NCT03851302|524886789|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
145554271|NCT03851302|524886790|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
145554272|NCT03851302|524886791|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
145554273|NCT03851302|524886792|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
145554274|NCT03851302|524886793|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
145554275|NCT03851302|524886794|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
145554276|NCT04434092|524886795|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
145554277|NCT04434092|524886796|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
145554278|NCT04434092|524886797|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
145554279|NCT04434092|524886795|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
145554280|NCT04434092|524886796|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
145554281|NCT04434092|524886797|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
145554282|NCT04434092|524886795|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
145554283|NCT04434092|524886796|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
145554284|NCT04434092|524886797|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
145554285|NCT04434092|524886795|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
145554286|NCT04434092|524886796|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
145554287|NCT04434092|524886797|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
145554288|NCT04434092|524886795|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
145554289|NCT04434092|524886796|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
145554290|NCT04434092|524886797|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
145554291|NCT04434092|524886795|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
145554292|NCT04434092|524886796|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
145554293|NCT04434092|524886797|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
145554294|NCT04434092|524886795|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
145554295|NCT04434092|524886796|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
145554296|NCT04434092|524886797|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
145554297|NCT00463346|524888565|FG000|Overall Study|Withdrawal by Subject|3|||
145554298|NCT00463346|524888566|FG001|Overall Study|Withdrawal by Subject|3|||
145554299|NCT01572909|524888567|FG000|Overall Study|Adverse Event|7|||
145554300|NCT01572909|524888568|FG001|Overall Study|Adverse Event|2|||
145554301|NCT01572909|524888567|FG000|Overall Study|Death|3|||
145554302|NCT01572909|524888568|FG001|Overall Study|Death|1|||
145554303|NCT01572909|524888567|FG000|Overall Study|Lost to Follow-up|8|||
145554304|NCT01572909|524888568|FG001|Overall Study|Lost to Follow-up|7|||
145554305|NCT01572909|524888567|FG000|Overall Study|Physician Decision|1|||
145554306|NCT01572909|524888568|FG001|Overall Study|Physician Decision|1|||
145554307|NCT01572909|524888567|FG000|Overall Study|Technical Issues|1|||
145554308|NCT01572909|524888568|FG001|Overall Study|Technical Issues|0|||
145554309|NCT01572909|524888567|FG000|Overall Study|Withdrawal by Subject|12|||
145554310|NCT01572909|524888568|FG001|Overall Study|Withdrawal by Subject|11|||
145554311|NCT01572909|524888567|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
145554312|NCT01572909|524888568|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
145554313|NCT04779489|524888569|FG000|Overall Study|Physician Decision|1|||
145554314|NCT00415909|524888574|FG000|Overall Study|Withdrawal by Subject|2|||
145554315|NCT00415909|524888574|FG000|Overall Study|Death|1|||
145554316|NCT05024058|524888575|FG000|Treatment|Study terminated by sponsor|5|||
145554317|NCT05024058|524888576|FG001|Treatment|Study terminated by sponsor|6|||
145611887|NCT04362137|525094049|FG000|Overall Study|Adverse Event|1|||
145611888|NCT04362137|525094050|FG001|Overall Study|Adverse Event|0|||
145611889|NCT04362137|525094049|FG000|Overall Study|Lost to Follow-up|1|||
145611890|NCT04362137|525094050|FG001|Overall Study|Lost to Follow-up|0|||
145611891|NCT04362137|525094049|FG000|Overall Study|Protocol deviation|1|||
145611892|NCT04362137|525094050|FG001|Overall Study|Protocol deviation|0|||
145611893|NCT02204579|525094053|FG000|Overall Study|Screen failures|2|||
145611894|NCT00447954|525094055|FG000|Overall Study|Adverse Event|0|||
145611895|NCT00447954|525094056|FG001|Overall Study|Adverse Event|2|||
145611896|NCT00447954|525094057|FG002|Overall Study|Adverse Event|0|||
145611897|NCT00447954|525094055|FG000|Overall Study|Withdrawal by Subject|0|||
145611898|NCT00447954|525094056|FG001|Overall Study|Withdrawal by Subject|1|||
145611899|NCT00447954|525094057|FG002|Overall Study|Withdrawal by Subject|1|||
145611900|NCT00447954|525094055|FG000|Overall Study|Lost to Follow-up|0|||
145611901|NCT00447954|525094056|FG001|Overall Study|Lost to Follow-up|1|||
145611902|NCT00447954|525094057|FG002|Overall Study|Lost to Follow-up|0|||
145611903|NCT00447954|525094055|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
145611904|NCT00447954|525094056|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
145611905|NCT00447954|525094057|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
145611906|NCT03176238|525094060|FG000|Overall Study|Unacceptable AEs|15|||
145611907|NCT03176238|525094061|FG001|Overall Study|Unacceptable AEs|8|||
145611908|NCT03176238|525094060|FG000|Overall Study|Abnormal lab value(s)|2|||
145611909|NCT03176238|525094061|FG001|Overall Study|Abnormal lab value(s)|0|||
145611910|NCT03176238|525094060|FG000|Overall Study|Inter-current illness|0|||
145611911|NCT03176238|525094061|FG001|Overall Study|Inter-current illness|1|||
145611912|NCT03176238|525094060|FG000|Overall Study|Consent withdrawal|14|||
145611913|NCT03176238|525094061|FG001|Overall Study|Consent withdrawal|2|||
145611914|NCT03176238|525094060|FG000|Overall Study|Lost to Follow-up|3|||
145611915|NCT03176238|525094061|FG001|Overall Study|Lost to Follow-up|0|||
145611916|NCT03176238|525094060|FG000|Overall Study|Administrative problems|1|||
145611917|NCT03176238|525094061|FG001|Overall Study|Administrative problems|0|||
145611918|NCT03176238|525094060|FG000|Overall Study|Death|3|||
145611919|NCT03176238|525094061|FG001|Overall Study|Death|0|||
145611920|NCT03176238|525094060|FG000|Overall Study|Disease Progression|133|||
145611921|NCT03176238|525094061|FG001|Overall Study|Disease Progression|22|||
145611922|NCT03176238|525094060|FG000|Overall Study|Tx duration completed per EAP|0|||
145611923|NCT03176238|525094061|FG001|Overall Study|Tx duration completed per EAP|1|||
145611924|NCT03176238|525094060|FG000|Overall Study|Patient is switched to commercial drug|16|||
145611925|NCT03176238|525094061|FG001|Overall Study|Patient is switched to commercial drug|1|||
145611926|NCT03176238|525094060|FG000|Overall Study|Protocol Violation|1|||
145611927|NCT03176238|525094061|FG001|Overall Study|Protocol Violation|0|||
145611928|NCT03176238|525094060|FG000|Overall Study|Changes in the patient's condition|2|||
145611929|NCT03176238|525094061|FG001|Overall Study|Changes in the patient's condition|1|||
145611930|NCT03176238|525094060|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
145611931|NCT03176238|525094061|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
145611932|NCT03556358|525094062|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
145611933|NCT03556358|525094063|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
145611934|NCT03556358|525094062|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
145611935|NCT03556358|525094063|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
145611936|NCT03556358|525094062|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
145611937|NCT03556358|525094063|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
145611938|NCT03556358|525094062|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
145611939|NCT03556358|525094063|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
145611940|NCT03556358|525094062|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
145611941|NCT03556358|525094063|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
145611942|NCT03556358|525094062|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
145611943|NCT03556358|525094063|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
145611944|NCT03556358|525094062|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
145611945|NCT03556358|525094063|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
145611946|NCT05200936|525094068|FG000|Overall Study|Withdrawal by Subject|2|||
145611947|NCT05200936|525094069|FG001|Overall Study|Withdrawal by Subject|2|||
145611948|NCT05200936|525094068|FG000|Overall Study|Lost to Follow-up|2|||
145611949|NCT05200936|525094069|FG001|Overall Study|Lost to Follow-up|0|||
145611950|NCT05200936|525094068|FG000|Overall Study|Pregnancy|0|||
145611951|NCT05200936|525094069|FG001|Overall Study|Pregnancy|1|||
145611952|NCT01811563|525095566|FG000|Overall Study|Lost to Follow-up|5|||
145611953|NCT01811563|525095567|FG001|Overall Study|Lost to Follow-up|2|||
145611954|NCT01811563|525095566|FG000|Overall Study|Incorrect Randomization procedure|0|||
145611955|NCT01811563|525095567|FG001|Overall Study|Incorrect Randomization procedure|1|||
145611956|NCT04424290|525095568|FG000|Overall Study|Not treated|0|||
145406031|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Death|0|||
145406032|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Death|0|||
145284724|NCT03567057|523891670|FG001|Overall Study|COVID-19 pandemic|3|||
145284725|NCT03567057|523891671|FG002|Overall Study|COVID-19 pandemic|0|||
145284726|NCT03567057|523891669|FG000|Overall Study|Non-compliance with study drug|4|||
145284727|NCT03567057|523891670|FG001|Overall Study|Non-compliance with study drug|2|||
145284728|NCT03567057|523891671|FG002|Overall Study|Non-compliance with study drug|0|||
145284729|NCT03567057|523891669|FG000|Overall Study|Lack of Efficacy|3|||
145284730|NCT03567057|523891670|FG001|Overall Study|Lack of Efficacy|0|||
145284731|NCT03567057|523891671|FG002|Overall Study|Lack of Efficacy|1|||
145284732|NCT03567057|523891669|FG000|Overall Study|Death|1|||
145284733|NCT03567057|523891670|FG001|Overall Study|Death|0|||
145284734|NCT03567057|523891671|FG002|Overall Study|Death|0|||
145284735|NCT03567057|523891669|FG000|Overall Study|Physician Decision|1|||
145554318|NCT05024058|524888577|FG002|Treatment|Study terminated by sponsor|4|||
145554319|NCT05024058|524888578|FG003|Treatment|Study terminated by sponsor|2|||
145554320|NCT05024058|524888579|FG004|Treatment|Study terminated by sponsor|3|||
145554321|NCT05024058|524888580|FG005|Treatment|Study terminated by sponsor|3|||
145554322|NCT05024058|524888581|FG006|Treatment|Study terminated by sponsor|1|||
145554323|NCT05024058|524888582|FG007|Treatment|Study terminated by sponsor|3|||
145554324|NCT05024058|524888583|FG008|Treatment|Study terminated by sponsor|6|||
145554325|NCT05024058|524888584|FG009|Treatment|Study terminated by sponsor|6|||
145554326|NCT05024058|524888575|FG000|Follow-up|Withdrawal by Subject|1|||
145554327|NCT05024058|524888576|FG001|Follow-up|Withdrawal by Subject|0|||
145554328|NCT05024058|524888577|FG002|Follow-up|Withdrawal by Subject|1|||
145554329|NCT05024058|524888578|FG003|Follow-up|Withdrawal by Subject|0|||
145554330|NCT05024058|524888579|FG004|Follow-up|Withdrawal by Subject|0|||
145554331|NCT05024058|524888580|FG005|Follow-up|Withdrawal by Subject|0|||
145554332|NCT05024058|524888581|FG006|Follow-up|Withdrawal by Subject|0|||
145554333|NCT05024058|524888582|FG007|Follow-up|Withdrawal by Subject|1|||
145554334|NCT05024058|524888583|FG008|Follow-up|Withdrawal by Subject|0|||
145554335|NCT05024058|524888584|FG009|Follow-up|Withdrawal by Subject|1|||
145554336|NCT00407563|524888588|FG000|Overall Study|Patient continues on treatment|1|||
145554337|NCT02450903|524888589|FG000|Overall Study|Adverse Event|3|||
145554338|NCT02450903|524888589|FG000|Overall Study|Progressive disease|15|||
145554339|NCT02450903|524888589|FG000|Overall Study|Switched to commercial drug|1|||
145554340|NCT02450903|524888589|FG000|Overall Study|Subject/guardian decision|1|||
145554341|NCT00157950|524888595|FG000|Overall Study|Death|1|||
145554342|NCT00157950|524888596|FG001|Overall Study|Death|0|||
145554343|NCT01287897|524888600|FG000|Overall Study|Adverse Event|5|||
145554344|NCT01287897|524888601|FG001|Overall Study|Adverse Event|3|||
145554345|NCT01287897|524888602|FG002|Overall Study|Adverse Event|6|||
145554346|NCT01287897|524888603|FG003|Overall Study|Adverse Event|4|||
145554347|NCT01287897|524888600|FG000|Overall Study|Lack of Efficacy|2|||
145554348|NCT01287897|524888601|FG001|Overall Study|Lack of Efficacy|0|||
145554349|NCT01287897|524888602|FG002|Overall Study|Lack of Efficacy|0|||
145554350|NCT01287897|524888603|FG003|Overall Study|Lack of Efficacy|0|||
145554351|NCT01287897|524888600|FG000|Overall Study|Protocol Violation|1|||
145554352|NCT01287897|524888601|FG001|Overall Study|Protocol Violation|1|||
145554353|NCT01287897|524888602|FG002|Overall Study|Protocol Violation|0|||
145554354|NCT01287897|524888603|FG003|Overall Study|Protocol Violation|1|||
145554355|NCT01287897|524888600|FG000|Overall Study|Lost to Follow-up|0|||
145554356|NCT01287897|524888601|FG001|Overall Study|Lost to Follow-up|0|||
145554357|NCT01287897|524888602|FG002|Overall Study|Lost to Follow-up|2|||
145554358|NCT01287897|524888603|FG003|Overall Study|Lost to Follow-up|0|||
145554359|NCT01287897|524888600|FG000|Overall Study|Withdrawal by Subject|1|||
145554360|NCT01287897|524888601|FG001|Overall Study|Withdrawal by Subject|5|||
145554361|NCT01287897|524888602|FG002|Overall Study|Withdrawal by Subject|3|||
145284736|NCT03567057|523891670|FG001|Overall Study|Physician Decision|0|||
145284737|NCT03567057|523891671|FG002|Overall Study|Physician Decision|0|||
145284738|NCT03567057|523891669|FG000|Overall Study|Unstable medical condition|1|||
145554362|NCT01287897|524888603|FG003|Overall Study|Withdrawal by Subject|2|||
145554363|NCT01287897|524888600|FG000|Overall Study|Not consented properly|0|||
145554364|NCT01287897|524888601|FG001|Overall Study|Not consented properly|1|||
145554365|NCT01287897|524888602|FG002|Overall Study|Not consented properly|0|||
145554366|NCT01287897|524888603|FG003|Overall Study|Not consented properly|0|||
145554367|NCT01287897|524888600|FG000|Overall Study|Not meeting entrance criteria|1|||
145554368|NCT01287897|524888601|FG001|Overall Study|Not meeting entrance criteria|1|||
145554369|NCT01287897|524888602|FG002|Overall Study|Not meeting entrance criteria|0|||
145554370|NCT01287897|524888603|FG003|Overall Study|Not meeting entrance criteria|0|||
145554371|NCT01287897|524888600|FG000|Overall Study|Other|1|||
145554372|NCT01287897|524888601|FG001|Overall Study|Other|0|||
145554373|NCT01287897|524888602|FG002|Overall Study|Other|1|||
145554374|NCT01287897|524888603|FG003|Overall Study|Other|0|||
145554375|NCT02902965|524888608|FG000|Overall Study|Withdrawal by Subject|10|||
145554376|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
145554377|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
145554378|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
145554379|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
145554380|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
145554381|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
145554382|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
145554383|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
145554384|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
145554385|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
145554386|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
145554387|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
145554388|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
145554389|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
145554390|NCT00293254|524888609|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
145554391|NCT00293254|524888610|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
145554392|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
145554393|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
145554394|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Death|4|||
145611957|NCT04424290|525095569|FG001|Overall Study|Not treated|0|||
145611958|NCT04424290|525095570|FG002|Overall Study|Not treated|1|||
145611959|NCT04424290|525095571|FG003|Overall Study|Not treated|0|||
145554395|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Death|1|||
145554396|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
145554397|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
145554398|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
145554399|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
145554400|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
145554401|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
145284739|NCT03567057|523891670|FG001|Overall Study|Unstable medical condition|0|||
145554402|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
145554403|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
145554404|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
145554405|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
145554406|NCT00293254|524888609|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
145611960|NCT04424290|525095572|FG004|Overall Study|Not treated|1|||
145611961|NCT04424290|525095568|FG000|Overall Study|Adverse Event|0|||
145611962|NCT04424290|525095569|FG001|Overall Study|Adverse Event|0|||
145611963|NCT04424290|525095570|FG002|Overall Study|Adverse Event|0|||
145611964|NCT04424290|525095571|FG003|Overall Study|Adverse Event|2|||
145611965|NCT04424290|525095572|FG004|Overall Study|Adverse Event|0|||
145611966|NCT04424290|525095568|FG000|Overall Study|Withdrawal by Subject|0|||
145611967|NCT04424290|525095569|FG001|Overall Study|Withdrawal by Subject|0|||
145611968|NCT04424290|525095570|FG002|Overall Study|Withdrawal by Subject|0|||
145611969|NCT04424290|525095571|FG003|Overall Study|Withdrawal by Subject|0|||
145611970|NCT04424290|525095572|FG004|Overall Study|Withdrawal by Subject|1|||
145611971|NCT04424290|525095568|FG000|Overall Study|Other than listed|0|||
145611972|NCT04424290|525095569|FG001|Overall Study|Other than listed|0|||
145611973|NCT04424290|525095570|FG002|Overall Study|Other than listed|0|||
145611974|NCT04424290|525095571|FG003|Overall Study|Other than listed|1|||
145611975|NCT04424290|525095572|FG004|Overall Study|Other than listed|0|||
145611976|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
145611977|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
145611978|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
145611979|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
145611980|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
145611981|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
145611982|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Death|0|||
145611983|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Death|1|||
145611984|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Adverse Event|11|||
145611985|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Adverse Event|11|||
145611986|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
145611987|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
145611988|NCT02936037|525095573|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145611989|NCT02936037|525095574|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145611990|NCT02936037|525095573|FG000|Open Label Extension|Adverse Event|0|||
145611991|NCT02936037|525095574|FG001|Open Label Extension|Adverse Event|3|||
145611992|NCT02936037|525095573|FG000|Open Label Extension|Other|0|||
145406033|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Death|1|||
145406034|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
145406035|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
145611993|NCT02936037|525095574|FG001|Open Label Extension|Other|3|||
145611994|NCT02936037|525095573|FG000|Open Label Extension|Withdrawal by Subject|0|||
145611995|NCT02936037|525095574|FG001|Open Label Extension|Withdrawal by Subject|4|||
145611996|NCT01267825|525095575|FG000|Overall Study|study terminated. no data collected.|1|||
145611997|NCT01267825|525095576|FG001|Overall Study|study terminated. no data collected.|0|||
145611998|NCT02791490|525095579|FG000|Overall Study|Lost to Follow-up|1|||
145611999|NCT02791490|525095580|FG001|Overall Study|Lost to Follow-up|2|||
145612000|NCT02791490|525095579|FG000|Overall Study|Withdrawal by Subject|2|||
145612001|NCT02791490|525095580|FG001|Overall Study|Withdrawal by Subject|6|||
145612002|NCT00592319|525095581|FG000|Overall Study|Lost to Follow-up|0|||
145612003|NCT00592319|525095582|FG001|Overall Study|Lost to Follow-up|3|||
145406036|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
145406037|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
145406038|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
145406039|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
145406040|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
145406041|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
145406042|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
145406043|NCT02696798|524341708|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
145406044|NCT02696798|524341709|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
145406045|NCT02696798|524341710|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
145406046|NCT02696798|524341708|FG000|Extended Treatment Period|Adverse Event|1|||
145406047|NCT02696798|524341709|FG001|Extended Treatment Period|Adverse Event|4|||
145406048|NCT02696798|524341710|FG002|Extended Treatment Period|Adverse Event|5|||
145406049|NCT02696798|524341708|FG000|Extended Treatment Period|Lack of Efficacy|7|||
145406050|NCT02696798|524341709|FG001|Extended Treatment Period|Lack of Efficacy|2|||
145406051|NCT02696798|524341710|FG002|Extended Treatment Period|Lack of Efficacy|2|||
145406052|NCT02696798|524341708|FG000|Extended Treatment Period|Lost to Follow-up|1|||
145406053|NCT02696798|524341709|FG001|Extended Treatment Period|Lost to Follow-up|0|||
145406054|NCT02696798|524341710|FG002|Extended Treatment Period|Lost to Follow-up|0|||
145406055|NCT02696798|524341708|FG000|Extended Treatment Period|Physician Decision|0|||
145406056|NCT02696798|524341709|FG001|Extended Treatment Period|Physician Decision|1|||
145406057|NCT02696798|524341710|FG002|Extended Treatment Period|Physician Decision|0|||
145406058|NCT02696798|524341708|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
145406059|NCT02696798|524341709|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
145406060|NCT02696798|524341710|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
145406061|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
145406062|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
145406063|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
145406064|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
145406065|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
145406066|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
145406067|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
145406068|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
145406069|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
145406070|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
145406071|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
145406072|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
145406073|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
145406074|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
145406075|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
145554407|NCT00293254|524888610|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
145554408|NCT00293254|524888609|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
145554409|NCT00293254|524888610|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
145554410|NCT00293254|524888609|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
145554411|NCT00293254|524888610|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
145554412|NCT00293254|524888609|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
145554413|NCT00293254|524888610|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
145554414|NCT00293254|524888609|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
145554415|NCT00293254|524888610|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
145554416|NCT00293254|524888609|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
145554417|NCT00293254|524888610|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
145554418|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
145554419|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
145554420|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
145554421|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
145554422|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
145554423|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
145554424|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
145554425|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
145554426|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
145554427|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
145554428|NCT00293254|524888609|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
145554429|NCT00293254|524888610|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
145554430|NCT02335489|524888611|FG000|Overall Study|Sponsor terminated study|4|||
145554431|NCT02335489|524888611|FG000|Overall Study|Lost to Follow-up|1|||
145554432|NCT02335489|524888611|FG000|Overall Study|Withdrawal by Subject|2|||
145554433|NCT02335489|524888611|FG000|Overall Study|Physician Decision|2|||
145612004|NCT01017120|525095583|FG000|Overall Study|Adverse Event|9|||
145554434|NCT02335489|524888611|FG000|Overall Study|Lack of Efficacy|1|||
145612005|NCT01017120|525095584|FG001|Overall Study|Adverse Event|0|||
145612006|NCT01017120|525095583|FG000|Overall Study|Lost to Follow-up|13|||
145612007|NCT01017120|525095584|FG001|Overall Study|Lost to Follow-up|11|||
145612008|NCT01017120|525095583|FG000|Overall Study|Lack of Efficacy|1|||
145612009|NCT01017120|525095584|FG001|Overall Study|Lack of Efficacy|0|||
145612010|NCT01017120|525095583|FG000|Overall Study|Withdrawal by Subject|39|||
145612011|NCT01017120|525095584|FG001|Overall Study|Withdrawal by Subject|21|||
145612012|NCT01017120|525095583|FG000|Overall Study|Pregnancy|1|||
145612013|NCT01017120|525095584|FG001|Overall Study|Pregnancy|1|||
145612014|NCT01017120|525095583|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
145612015|NCT01017120|525095584|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
145612016|NCT01017120|525095583|FG000|Overall Study|Relocated Out of Town|0|||
145284740|NCT03567057|523891671|FG002|Overall Study|Unstable medical condition|0|||
145554435|NCT02259582|524888612|FG000|Overall Study|Physician Decision|0|||
145554436|NCT02259582|524888613|FG001|Overall Study|Physician Decision|1|||
145554437|NCT02259582|524888614|FG002|Overall Study|Physician Decision|0|||
145554438|NCT02259582|524888612|FG000|Overall Study|Death|0|||
145554439|NCT02259582|524888613|FG001|Overall Study|Death|0|||
145554440|NCT02259582|524888614|FG002|Overall Study|Death|1|||
145554441|NCT02259582|524888612|FG000|Overall Study|Adverse Event|1|||
145554442|NCT02259582|524888613|FG001|Overall Study|Adverse Event|0|||
145554443|NCT02259582|524888614|FG002|Overall Study|Adverse Event|1|||
145554444|NCT02259582|524888612|FG000|Overall Study|Withdrawal by Subject|0|||
145554445|NCT02259582|524888613|FG001|Overall Study|Withdrawal by Subject|0|||
145554446|NCT02259582|524888614|FG002|Overall Study|Withdrawal by Subject|1|||
145554447|NCT02259582|524888612|FG000|Overall Study|Disease progression|14|||
145554448|NCT02259582|524888613|FG001|Overall Study|Disease progression|15|||
145554449|NCT02259582|524888614|FG002|Overall Study|Disease progression|17|||
145554450|NCT02259582|524888612|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
145554451|NCT02259582|524888613|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
145554452|NCT02259582|524888614|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
145554453|NCT00531050|524888621|FG000|Part 1: Period 1|Adverse Event|0|||
145554454|NCT00531050|524888622|FG001|Part 1: Period 1|Adverse Event|1|||
145554455|NCT00531050|524888623|FG002|Part 1: Period 1|Adverse Event|0|||
145554456|NCT00531050|524888624|FG003|Part 1: Period 1|Adverse Event|0|||
145554457|NCT00531050|524888625|FG004|Part 1: Period 1|Adverse Event|0|||
145554458|NCT00531050|524888626|FG005|Part 1: Period 1|Adverse Event|0|||
145554459|NCT00531050|524888621|FG000|Part 1: Period 1|Protocol Deviation|0|||
145554460|NCT00531050|524888622|FG001|Part 1: Period 1|Protocol Deviation|0|||
145554461|NCT00531050|524888623|FG002|Part 1: Period 1|Protocol Deviation|0|||
145554462|NCT00531050|524888624|FG003|Part 1: Period 1|Protocol Deviation|1|||
145554463|NCT00531050|524888625|FG004|Part 1: Period 1|Protocol Deviation|0|||
145554464|NCT00531050|524888626|FG005|Part 1: Period 1|Protocol Deviation|0|||
145554465|NCT00531050|524888621|FG000|Part 1: Period 3|Adverse Event|1|||
145554466|NCT00531050|524888622|FG001|Part 1: Period 3|Adverse Event|0|||
145554467|NCT00531050|524888623|FG002|Part 1: Period 3|Adverse Event|0|||
145554468|NCT00531050|524888624|FG003|Part 1: Period 3|Adverse Event|0|||
145554469|NCT00531050|524888625|FG004|Part 1: Period 3|Adverse Event|0|||
145554470|NCT00531050|524888626|FG005|Part 1: Period 3|Adverse Event|0|||
145554471|NCT00531050|524888621|FG000|Part 2: Period 1|Adverse Event|0|||
145554472|NCT00531050|524888622|FG001|Part 2: Period 1|Adverse Event|0|||
145554473|NCT00531050|524888623|FG002|Part 2: Period 1|Adverse Event|0|||
145554474|NCT00531050|524888624|FG003|Part 2: Period 1|Adverse Event|0|||
145554475|NCT00531050|524888625|FG004|Part 2: Period 1|Adverse Event|0|||
145284741|NCT03567057|523891669|FG000|Overall Study|Medical history event|0|||
145554476|NCT00531050|524888626|FG005|Part 2: Period 1|Adverse Event|1|||
145554477|NCT00531050|524888621|FG000|Part 2: Period 3|Abnormal test procedure|1|||
145612017|NCT01017120|525095584|FG001|Overall Study|Relocated Out of Town|2|||
145554478|NCT00531050|524888622|FG001|Part 2: Period 3|Abnormal test procedure|0|||
145554479|NCT00531050|524888623|FG002|Part 2: Period 3|Abnormal test procedure|0|||
145554480|NCT00531050|524888624|FG003|Part 2: Period 3|Abnormal test procedure|0|||
145554481|NCT00531050|524888625|FG004|Part 2: Period 3|Abnormal test procedure|0|||
145554482|NCT00531050|524888626|FG005|Part 2: Period 3|Abnormal test procedure|1|||
145554483|NCT02233309|524888628|FG000|Overall Study|Physician Decision|5|||
145554484|NCT04481750|524888629|FG000|Period 1 (Fasted)|Adverse Event|0|||
145612018|NCT01017120|525095583|FG000|Overall Study|Protocol Violation|1|||
145612019|NCT01017120|525095584|FG001|Overall Study|Protocol Violation|0|||
145612020|NCT01017120|525095583|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
145612021|NCT01017120|525095584|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
145612022|NCT01087723|525095586|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
145612023|NCT01087723|525095587|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
145612024|NCT01087723|525095586|FG000|Overall Study|Withdrawal by Subject|10|||
145612025|NCT01087723|525095587|FG001|Overall Study|Withdrawal by Subject|13|||
145612026|NCT01087723|525095586|FG000|Overall Study|Physician Decision|2|||
145612027|NCT01087723|525095587|FG001|Overall Study|Physician Decision|0|||
145612028|NCT01087723|525095586|FG000|Overall Study|Lost to Follow-up|1|||
145612029|NCT01087723|525095587|FG001|Overall Study|Lost to Follow-up|4|||
145612030|NCT01087723|525095586|FG000|Overall Study|Reason Not Specified|1|||
145612031|NCT01087723|525095587|FG001|Overall Study|Reason Not Specified|2|||
145612032|NCT01868035|525095588|FG000|Overall Study|Lost to Follow-up|3|||
145612033|NCT01868035|525095588|FG000|Overall Study|Withdrawal by Subject|1|||
145612034|NCT01868035|525095588|FG000|Overall Study|Progressive Disease|2|||
145612035|NCT01868035|525095588|FG000|Overall Study|Non-compliance|1|||
145612036|NCT00806624|525095589|FG000|Overall Study|Adverse Event|2|||
145612037|NCT00806624|525095590|FG001|Overall Study|Adverse Event|8|||
145612038|NCT00806624|525095591|FG002|Overall Study|Adverse Event|0|||
145612039|NCT00806624|525095589|FG000|Overall Study|Death|0|||
145612040|NCT00806624|525095590|FG001|Overall Study|Death|1|||
145612041|NCT00806624|525095591|FG002|Overall Study|Death|1|||
145612042|NCT00806624|525095589|FG000|Overall Study|Lost to Follow-up|1|||
145612043|NCT00806624|525095590|FG001|Overall Study|Lost to Follow-up|0|||
145612044|NCT00806624|525095591|FG002|Overall Study|Lost to Follow-up|1|||
145612045|NCT00806624|525095589|FG000|Overall Study|Withdrawal by Subject|6|||
145612046|NCT00806624|525095590|FG001|Overall Study|Withdrawal by Subject|3|||
145612047|NCT00806624|525095591|FG002|Overall Study|Withdrawal by Subject|3|||
145612048|NCT00806624|525095589|FG000|Overall Study|discontinued before start of treatment|0|||
145612049|NCT00806624|525095590|FG001|Overall Study|discontinued before start of treatment|0|||
145612050|NCT00806624|525095591|FG002|Overall Study|discontinued before start of treatment|1|||
145612051|NCT01912222|525095596|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
145612052|NCT01912222|525095597|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
145612053|NCT01912222|525095598|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
145612054|NCT01912222|525095596|FG000|Part B: Treatment Period|Progressive disease|10|||
145612055|NCT01912222|525095597|FG001|Part B: Treatment Period|Progressive disease|12|||
145554485|NCT04481750|524888630|FG001|Period 1 (Fasted)|Adverse Event|0|||
145554486|NCT04481750|524888631|FG002|Period 1 (Fasted)|Adverse Event|1|||
145554487|NCT04481750|524888632|FG003|Period 1 (Fasted)|Adverse Event|0|||
145554488|NCT04481750|524888633|FG004|Period 1 (Fasted)|Adverse Event|0|||
145554489|NCT04481750|524888634|FG005|Period 1 (Fasted)|Adverse Event|0|||
145284742|NCT03567057|523891670|FG001|Overall Study|Medical history event|0|||
145284743|NCT03567057|523891671|FG002|Overall Study|Medical history event|1|||
145284744|NCT03567057|523891669|FG000|Overall Study|Other|0|||
145554490|NCT04481750|524888635|FG006|Period 1 (Fasted)|Adverse Event|0|||
145284745|NCT03567057|523891670|FG001|Overall Study|Other|0|||
145554491|NCT04481750|524888636|FG007|Period 1 (Fasted)|Adverse Event|0|||
145284746|NCT03567057|523891671|FG002|Overall Study|Other|1|||
145284747|NCT00490061|523891672|FG000|Overall Study|Physician Decision|1|||
145612056|NCT01912222|525095598|FG002|Part B: Treatment Period|Progressive disease|15|||
145612057|NCT01912222|525095596|FG000|Part B: Treatment Period|Adverse Event|1|||
145612058|NCT01912222|525095597|FG001|Part B: Treatment Period|Adverse Event|2|||
145612059|NCT01912222|525095598|FG002|Part B: Treatment Period|Adverse Event|3|||
145612060|NCT01912222|525095596|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
145612061|NCT01912222|525095597|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
145612062|NCT01912222|525095598|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
145612063|NCT01804673|525095599|FG000|Overall Study|Adverse Event|4|||
145612064|NCT01804673|525095599|FG000|Overall Study|Withdrawal by Subject|1|||
145612065|NCT01804673|525095599|FG000|Overall Study|Lack of Efficacy|9|||
145612066|NCT01804673|525095599|FG000|Overall Study|Change to Oral Therapy|37|||
145612067|NCT01804673|525095599|FG000|Overall Study|No Further Therapy Required|84|||
145612068|NCT01804673|525095599|FG000|Overall Study|Use of Prohibited Medication|1|||
145612069|NCT01804673|525095599|FG000|Overall Study|Other|4|||
145612070|NCT01024959|525095600|FG000|Overall Study|ineligible|12|||
145612071|NCT01024959|525095600|FG000|Overall Study|results not evaluable|12|||
145612072|NCT01024959|525095600|FG000|Overall Study|missing results required for analysis|17|||
145612073|NCT00313911|525095608|FG000|Overall Study|Serious adverse event|6|||
145612074|NCT00313911|525095609|FG001|Overall Study|Serious adverse event|1|||
145612075|NCT00313911|525095608|FG000|Overall Study|Adverse Event|2|||
145612076|NCT00313911|525095609|FG001|Overall Study|Adverse Event|3|||
145612077|NCT00313911|525095608|FG000|Overall Study|Protocol Violation|19|||
145612078|NCT00313911|525095609|FG001|Overall Study|Protocol Violation|10|||
145612079|NCT00313911|525095608|FG000|Overall Study|Lost to Follow-up|27|||
145612080|NCT00313911|525095609|FG001|Overall Study|Lost to Follow-up|14|||
145612081|NCT00313911|525095608|FG000|Overall Study|Withdrawal by Subject|39|||
145612082|NCT00313911|525095609|FG001|Overall Study|Withdrawal by Subject|12|||
145612083|NCT00313911|525095608|FG000|Overall Study|Did not meet age criteria|1|||
145612084|NCT00313911|525095609|FG001|Overall Study|Did not meet age criteria|1|||
145612085|NCT01912781|525095612|FG000|Overall Study|Withdrawal by Subject|2|||
145612086|NCT01912781|525095613|FG001|Overall Study|Withdrawal by Subject|0|||
145612087|NCT00451217|525095617|FG000|Overall Study|Lost to Follow-up|0|||
145612088|NCT00451217|525095618|FG001|Overall Study|Lost to Follow-up|1|||
145612089|NCT00451217|525095619|FG002|Overall Study|Lost to Follow-up|1|||
145612090|NCT00451217|525095620|FG003|Overall Study|Lost to Follow-up|1|||
145612091|NCT00451217|525095617|FG000|Overall Study|Withdrawal by Subject|1|||
145612092|NCT00451217|525095618|FG001|Overall Study|Withdrawal by Subject|0|||
145612093|NCT00451217|525095619|FG002|Overall Study|Withdrawal by Subject|0|||
145612094|NCT00451217|525095620|FG003|Overall Study|Withdrawal by Subject|0|||
145612095|NCT00451217|525095617|FG000|Overall Study|Not Treated|1|||
145612096|NCT00451217|525095618|FG001|Overall Study|Not Treated|1|||
145612097|NCT00451217|525095619|FG002|Overall Study|Not Treated|3|||
145612098|NCT00451217|525095620|FG003|Overall Study|Not Treated|4|||
145612099|NCT01129336|525095621|FG000|Overall Study|Protocol Violation|1|||
145612100|NCT01129336|525095622|FG001|Overall Study|Protocol Violation|0|||
145612101|NCT01129336|525095621|FG000|Overall Study|Disease Progression|1|||
145612102|NCT01129336|525095622|FG001|Overall Study|Disease Progression|4|||
145612103|NCT01129336|525095621|FG000|Overall Study|Lost to Follow-up|1|||
145612104|NCT01129336|525095622|FG001|Overall Study|Lost to Follow-up|0|||
145612105|NCT01129336|525095621|FG000|Overall Study|Withdrawal by Subject|7|||
145612106|NCT01129336|525095622|FG001|Overall Study|Withdrawal by Subject|4|||
145612107|NCT01129336|525095621|FG000|Overall Study|Adverse Event|0|||
145612108|NCT01129336|525095622|FG001|Overall Study|Adverse Event|1|||
145612109|NCT01129336|525095621|FG000|Overall Study|Missing Study Completion Status|2|||
145612110|NCT01129336|525095622|FG001|Overall Study|Missing Study Completion Status|3|||
145612111|NCT01129336|525095621|FG000|Overall Study|Death|0|||
145612112|NCT01129336|525095622|FG001|Overall Study|Death|4|||
145612113|NCT00569803|525095625|FG000|Overall Study|Lost to Follow-up|1|||
145612114|NCT00569803|525095626|FG001|Overall Study|Lost to Follow-up|0|||
145612115|NCT00569803|525095627|FG002|Overall Study|Lost to Follow-up|0|||
145612116|NCT00569803|525095628|FG003|Overall Study|Lost to Follow-up|0|||
145612117|NCT00569803|525095629|FG004|Overall Study|Lost to Follow-up|0|||
145612118|NCT00569803|525095630|FG005|Overall Study|Lost to Follow-up|0|||
145612119|NCT00569803|525095631|FG006|Overall Study|Lost to Follow-up|0|||
145612120|NCT00569803|525095632|FG007|Overall Study|Lost to Follow-up|0|||
145612121|NCT00569803|525095625|FG000|Overall Study|injection syringe leaked during dosing|0|||
145612122|NCT00569803|525095626|FG001|Overall Study|injection syringe leaked during dosing|0|||
145612123|NCT00569803|525095627|FG002|Overall Study|injection syringe leaked during dosing|0|||
145612124|NCT00569803|525095628|FG003|Overall Study|injection syringe leaked during dosing|1|||
145612125|NCT00569803|525095629|FG004|Overall Study|injection syringe leaked during dosing|0|||
145612126|NCT00569803|525095630|FG005|Overall Study|injection syringe leaked during dosing|0|||
145612127|NCT00569803|525095631|FG006|Overall Study|injection syringe leaked during dosing|0|||
145612128|NCT00569803|525095632|FG007|Overall Study|injection syringe leaked during dosing|0|||
145612129|NCT00569803|525095625|FG000|Overall Study|Withdrawal by Subject|0|||
145612130|NCT00569803|525095626|FG001|Overall Study|Withdrawal by Subject|0|||
145612131|NCT00569803|525095627|FG002|Overall Study|Withdrawal by Subject|0|||
145612132|NCT00569803|525095628|FG003|Overall Study|Withdrawal by Subject|0|||
145612133|NCT00569803|525095629|FG004|Overall Study|Withdrawal by Subject|0|||
145612134|NCT00569803|525095630|FG005|Overall Study|Withdrawal by Subject|0|||
145612135|NCT00569803|525095631|FG006|Overall Study|Withdrawal by Subject|0|||
145612136|NCT00569803|525095632|FG007|Overall Study|Withdrawal by Subject|1|||
145612137|NCT01622348|525095634|FG000|Overall Study|Withdrawal by Subject|1|||
145612138|NCT01622348|525095635|FG001|Overall Study|Withdrawal by Subject|0|||
145612139|NCT01622348|525095636|FG002|Overall Study|Withdrawal by Subject|1|||
145612140|NCT00467142|525095639|FG000|Overall Study|Withdrawal by Subject|1|||
145612141|NCT00467142|525095639|FG000|Overall Study|Adverse Event|1|||
145612142|NCT00467142|525095639|FG000|Overall Study|Protocol Violation|1|||
145612143|NCT04537897|525095640|FG000|Overall Study|Other than listed|0|||
145612144|NCT04537897|525095641|FG001|Overall Study|Other than listed|0|||
145612145|NCT04537897|525095642|FG002|Overall Study|Other than listed|0|||
145612146|NCT04537897|525095643|FG003|Overall Study|Other than listed|0|||
145612147|NCT04537897|525095644|FG004|Overall Study|Other than listed|0|||
145612148|NCT04537897|525095645|FG005|Overall Study|Other than listed|0|||
145612149|NCT04537897|525095646|FG006|Overall Study|Other than listed|1|||
145612150|NCT04537897|525095647|FG007|Overall Study|Other than listed|0|||
145284748|NCT01580020|523891673|FG000|Overall Study|Lack of Efficacy|0|||
145284749|NCT01580020|523891674|FG001|Overall Study|Lack of Efficacy|5|||
145284750|NCT01580020|523891675|FG002|Overall Study|Lack of Efficacy|0|||
145284751|NCT01580020|523891676|FG003|Overall Study|Lack of Efficacy|1|||
145284752|NCT01580020|523891673|FG000|Overall Study|Withdrawal by Subject|0|||
145284753|NCT01580020|523891674|FG001|Overall Study|Withdrawal by Subject|1|||
145284754|NCT01580020|523891675|FG002|Overall Study|Withdrawal by Subject|1|||
145284755|NCT01580020|523891676|FG003|Overall Study|Withdrawal by Subject|0|||
145284756|NCT01580020|523891673|FG000|Overall Study|Adverse Event|1|||
145284757|NCT01580020|523891674|FG001|Overall Study|Adverse Event|1|||
145284758|NCT01580020|523891675|FG002|Overall Study|Adverse Event|1|||
145284759|NCT01580020|523891676|FG003|Overall Study|Adverse Event|1|||
145284760|NCT01580020|523891673|FG000|Overall Study|Administrative Problems|0|||
145284761|NCT01580020|523891674|FG001|Overall Study|Administrative Problems|0|||
145284762|NCT01580020|523891675|FG002|Overall Study|Administrative Problems|1|||
145284763|NCT01580020|523891676|FG003|Overall Study|Administrative Problems|0|||
145284764|NCT01580020|523891673|FG000|Overall Study|Lost to Follow-up|0|||
145284765|NCT01580020|523891674|FG001|Overall Study|Lost to Follow-up|0|||
145284766|NCT01580020|523891675|FG002|Overall Study|Lost to Follow-up|1|||
145284767|NCT01580020|523891676|FG003|Overall Study|Lost to Follow-up|0|||
145284768|NCT00591253|523891678|FG000|Overall Study|Adverse Event|3|||
145284769|NCT00591253|523891679|FG001|Overall Study|Adverse Event|3|||
145284770|NCT00591253|523891680|FG002|Overall Study|Adverse Event|1|||
145284771|NCT00591253|523891678|FG000|Overall Study|Protocol Violation|2|||
145284772|NCT00591253|523891679|FG001|Overall Study|Protocol Violation|2|||
145284773|NCT00591253|523891680|FG002|Overall Study|Protocol Violation|2|||
145612151|NCT04537897|525095648|FG008|Overall Study|Other than listed|0|||
145284774|NCT00591253|523891678|FG000|Overall Study|Lost to Follow-up|2|||
145284775|NCT00591253|523891679|FG001|Overall Study|Lost to Follow-up|4|||
145612152|NCT04537897|525095640|FG000|Overall Study|Adverse Event|0|||
145612153|NCT04537897|525095641|FG001|Overall Study|Adverse Event|0|||
145612154|NCT04537897|525095642|FG002|Overall Study|Adverse Event|0|||
145612155|NCT04537897|525095643|FG003|Overall Study|Adverse Event|1|||
145284776|NCT00591253|523891680|FG002|Overall Study|Lost to Follow-up|0|||
145284777|NCT00591253|523891678|FG000|Overall Study|Withdrawal by Subject|1|||
145612156|NCT04537897|525095644|FG004|Overall Study|Adverse Event|0|||
145612157|NCT04537897|525095645|FG005|Overall Study|Adverse Event|0|||
145612158|NCT04537897|525095646|FG006|Overall Study|Adverse Event|0|||
145284778|NCT00591253|523891679|FG001|Overall Study|Withdrawal by Subject|7|||
145554492|NCT04481750|524888637|FG008|Period 1 (Fasted)|Adverse Event|0|||
145554493|NCT04481750|524888638|FG009|Period 1 (Fasted)|Adverse Event|0|||
145554494|NCT04481750|524888639|FG010|Period 1 (Fasted)|Adverse Event|0|||
145554495|NCT02436889|524888640|FG000|Overall Study|No improvement in symptoms|1|||
145554496|NCT02436889|524888641|FG001|Overall Study|No improvement in symptoms|0|||
145554497|NCT02436889|524888640|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
145554498|NCT02436889|524888641|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
145406076|NCT02696798|524341708|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
145554499|NCT04273217|524888642|FG000|Overall Study|Lost to Follow-up|0|||
145554500|NCT04273217|524888643|FG001|Overall Study|Lost to Follow-up|0|||
145554501|NCT04273217|524888644|FG002|Overall Study|Lost to Follow-up|0|||
145554502|NCT04273217|524888645|FG003|Overall Study|Lost to Follow-up|0|||
145554503|NCT04273217|524888646|FG004|Overall Study|Lost to Follow-up|0|||
145554504|NCT04273217|524888647|FG005|Overall Study|Lost to Follow-up|1|||
145554505|NCT04273217|524888642|FG000|Overall Study|Participant non-compliance|0|||
145554506|NCT04273217|524888643|FG001|Overall Study|Participant non-compliance|0|||
145554507|NCT04273217|524888644|FG002|Overall Study|Participant non-compliance|0|||
145554508|NCT04273217|524888645|FG003|Overall Study|Participant non-compliance|0|||
145554509|NCT04273217|524888646|FG004|Overall Study|Participant non-compliance|1|||
145554510|NCT04273217|524888647|FG005|Overall Study|Participant non-compliance|0|||
145554511|NCT04273217|524888642|FG000|Overall Study|Positive urine drug screen|1|||
145554512|NCT04273217|524888643|FG001|Overall Study|Positive urine drug screen|0|||
145554513|NCT04273217|524888644|FG002|Overall Study|Positive urine drug screen|1|||
145554514|NCT04273217|524888645|FG003|Overall Study|Positive urine drug screen|0|||
145554515|NCT04273217|524888646|FG004|Overall Study|Positive urine drug screen|0|||
145554516|NCT04273217|524888647|FG005|Overall Study|Positive urine drug screen|1|||
145554517|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
145554518|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
145554519|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
145554520|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
145554521|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
145554522|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
145554523|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
145554524|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
145554525|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
145554526|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
145554527|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
145554528|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
145554529|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
145554530|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
145554531|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
145554532|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
145554533|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
145554534|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
145554535|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
145554536|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
145554537|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
145554538|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
145554539|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
145554540|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
145554541|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
145554542|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
145554543|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
145554544|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
145554545|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
145554546|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
145554547|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
145554548|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
145554549|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
145554550|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
145612159|NCT04537897|525095647|FG007|Overall Study|Adverse Event|0|||
145554551|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
145554552|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
145554553|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
145554554|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
145554555|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
145554556|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
145554557|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
145554558|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
145554559|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
145554560|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
145554561|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
145554562|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
145554563|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
145554564|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
145554565|NCT03720470|524888648|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
145554566|NCT03720470|524888649|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
145554567|NCT03720470|524888650|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
145554568|NCT03720470|524888651|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
145554569|NCT03720470|524888652|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
145554570|NCT03720470|524888653|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
145554571|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
145554572|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
145554573|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
145554574|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
145554575|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
145612160|NCT04537897|525095648|FG008|Overall Study|Adverse Event|0|||
145612161|NCT04537897|525095640|FG000|Overall Study|Withdrawal by Subject|0|||
145612162|NCT04537897|525095641|FG001|Overall Study|Withdrawal by Subject|1|||
145612163|NCT04537897|525095642|FG002|Overall Study|Withdrawal by Subject|0|||
145612164|NCT04537897|525095643|FG003|Overall Study|Withdrawal by Subject|0|||
145612165|NCT04537897|525095644|FG004|Overall Study|Withdrawal by Subject|0|||
145612166|NCT04537897|525095645|FG005|Overall Study|Withdrawal by Subject|0|||
145612167|NCT04537897|525095646|FG006|Overall Study|Withdrawal by Subject|0|||
145612168|NCT04537897|525095647|FG007|Overall Study|Withdrawal by Subject|0|||
145612169|NCT04537897|525095648|FG008|Overall Study|Withdrawal by Subject|0|||
145612170|NCT00919893|525095649|FG000|Overall Study|Protocol Violation|19|||
145612171|NCT00919893|525095650|FG001|Overall Study|Protocol Violation|9|||
145612172|NCT03029780|525095656|FG000|Overall Study|Disease Progression|20|||
145612173|NCT03029780|525095657|FG001|Overall Study|Disease Progression|22|||
145612174|NCT03029780|525095656|FG000|Overall Study|Study Drug Toxicity|15|||
145612175|NCT03029780|525095657|FG001|Overall Study|Study Drug Toxicity|11|||
145612176|NCT03029780|525095656|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
145612177|NCT03029780|525095657|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145612178|NCT03029780|525095656|FG000|Overall Study|Participant request to discontinue study treatment|4|||
145612179|NCT03029780|525095657|FG001|Overall Study|Participant request to discontinue study treatment|1|||
145612180|NCT03029780|525095656|FG000|Overall Study|Maximum clinical benefit|1|||
145612181|NCT03029780|525095657|FG001|Overall Study|Maximum clinical benefit|0|||
145612182|NCT03029780|525095656|FG000|Overall Study|Participant no longer meets study criteria|0|||
145612183|NCT03029780|525095657|FG001|Overall Study|Participant no longer meets study criteria|1|||
145612184|NCT03029780|525095656|FG000|Overall Study|Other reasons|6|||
145612185|NCT03029780|525095657|FG001|Overall Study|Other reasons|6|||
145612186|NCT03029780|525095656|FG000|Overall Study|Not reported|1|||
145612187|NCT03029780|525095657|FG001|Overall Study|Not reported|1|||
145612188|NCT03029780|525095656|FG000|Overall Study|Death|2|||
145612189|NCT03029780|525095657|FG001|Overall Study|Death|6|||
145612190|NCT00197028|525095658|FG000|Overall Study|Adverse Event|2|||
145612191|NCT00197028|525095659|FG001|Overall Study|Adverse Event|2|||
145612192|NCT00197028|525095658|FG000|Overall Study|Protocol Violation|2|||
145612193|NCT00197028|525095659|FG001|Overall Study|Protocol Violation|1|||
145612194|NCT00197028|525095658|FG000|Overall Study|Withdrawal by Subject|8|||
145612195|NCT00197028|525095659|FG001|Overall Study|Withdrawal by Subject|12|||
145612196|NCT00197028|525095658|FG000|Overall Study|Lost to Follow-up|1|||
145612197|NCT00197028|525095659|FG001|Overall Study|Lost to Follow-up|0|||
145612198|NCT00197028|525095658|FG000|Overall Study|Other|3|||
145612199|NCT00197028|525095659|FG001|Overall Study|Other|6|||
145284779|NCT00591253|523891680|FG002|Overall Study|Withdrawal by Subject|6|||
145284780|NCT00591253|523891678|FG000|Overall Study|Lack of Efficacy|1|||
145284781|NCT00591253|523891679|FG001|Overall Study|Lack of Efficacy|0|||
145284782|NCT00591253|523891680|FG002|Overall Study|Lack of Efficacy|3|||
145284783|NCT00591253|523891678|FG000|Overall Study|Other|5|||
145284784|NCT00591253|523891679|FG001|Overall Study|Other|5|||
145612200|NCT00178256|525095660|FG000|Overall Study|Adverse Event|2|||
145612201|NCT00178256|525095661|FG001|Overall Study|Adverse Event|0|||
145284785|NCT00591253|523891680|FG002|Overall Study|Other|3|||
145612202|NCT00178256|525095662|FG002|Overall Study|Adverse Event|0|||
145612203|NCT00178256|525095663|FG003|Overall Study|Adverse Event|0|||
145284786|NCT01841359|523891681|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
145612204|NCT00178256|525095660|FG000|Overall Study|Death|0|||
145612205|NCT00178256|525095661|FG001|Overall Study|Death|1|||
145612206|NCT00178256|525095662|FG002|Overall Study|Death|0|||
145612207|NCT00178256|525095663|FG003|Overall Study|Death|1|||
145612208|NCT00178256|525095660|FG000|Overall Study|Cancer progression|2|||
145554576|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
145554577|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
145554578|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
145554579|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
145554580|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
145554581|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
145554582|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
145612209|NCT00178256|525095661|FG001|Overall Study|Cancer progression|0|||
145612210|NCT00178256|525095662|FG002|Overall Study|Cancer progression|0|||
145612211|NCT00178256|525095663|FG003|Overall Study|Cancer progression|1|||
145612212|NCT01763788|525095664|FG000|Overall Study|Lost to Follow-up|0|||
145612213|NCT01763788|525095665|FG001|Overall Study|Lost to Follow-up|0|||
145612214|NCT01763788|525095666|FG002|Overall Study|Lost to Follow-up|1|||
145612215|NCT01763788|525095667|FG003|Overall Study|Lost to Follow-up|0|||
145612216|NCT00885352|525095672|FG000|Overall Study|Adverse Event|2|||
145612217|NCT00885352|525095673|FG001|Overall Study|Adverse Event|3|||
145612218|NCT00885352|525095672|FG000|Overall Study|Lost to Follow-up|2|||
145612219|NCT00885352|525095673|FG001|Overall Study|Lost to Follow-up|2|||
145612220|NCT00885352|525095672|FG000|Overall Study|Physician Decision|0|||
145612221|NCT00885352|525095673|FG001|Overall Study|Physician Decision|3|||
145612222|NCT00885352|525095672|FG000|Overall Study|Protocol Violation|0|||
145612223|NCT00885352|525095673|FG001|Overall Study|Protocol Violation|2|||
145612224|NCT00885352|525095672|FG000|Overall Study|Withdrawal by Subject|1|||
145612225|NCT00885352|525095673|FG001|Overall Study|Withdrawal by Subject|5|||
145612226|NCT00885352|525095672|FG000|Overall Study|Contradiction to study medication|0|||
145612227|NCT00885352|525095673|FG001|Overall Study|Contradiction to study medication|2|||
145612228|NCT00885352|525095672|FG000|Overall Study|Excluded medication|2|||
145612229|NCT00885352|525095673|FG001|Overall Study|Excluded medication|2|||
145612230|NCT00885352|525095672|FG000|Overall Study|Lab abnormalities|1|||
145612231|NCT00885352|525095673|FG001|Overall Study|Lab abnormalities|1|||
145612232|NCT03560258|525095674|FG000|Overall Study|Lost to Follow-up|3|||
145284787|NCT01841359|523891681|FG000|Overall Study|Concommitant medical issues|2|||
145284788|NCT01841359|523891681|FG000|Overall Study|Adverse Event|3|||
145284789|NCT01841359|523891681|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
145284790|NCT01875445|523891684|FG000|Overall Study|Lost to Follow-up|5|||
145284791|NCT01875445|523891685|FG001|Overall Study|Lost to Follow-up|0|||
145284792|NCT01875445|523891684|FG000|Overall Study|Withdrawal by Subject|2|||
145612233|NCT03560258|525095675|FG001|Overall Study|Lost to Follow-up|0|||
145612234|NCT03560258|525095676|FG002|Overall Study|Lost to Follow-up|0|||
145284793|NCT01875445|523891685|FG001|Overall Study|Withdrawal by Subject|0|||
145284794|NCT01102777|523891686|FG000|Overall Study|Death|2|||
145284795|NCT01102777|523891687|FG001|Overall Study|Death|6|||
145284796|NCT01102777|523891686|FG000|Overall Study|Lost to Follow-up|7|||
145284797|NCT01102777|523891687|FG001|Overall Study|Lost to Follow-up|10|||
145284798|NCT01752920|523891692|FG000|Overall Study|Adverse Event|1|||
145612235|NCT03560258|525095674|FG000|Overall Study|Protocol Violation|0|||
145612236|NCT03560258|525095675|FG001|Overall Study|Protocol Violation|1|||
145284799|NCT01752920|523891693|FG001|Overall Study|Adverse Event|0|||
145284800|NCT01752920|523891694|FG002|Overall Study|Adverse Event|5|||
145284801|NCT01752920|523891695|FG003|Overall Study|Adverse Event|10|||
145284802|NCT01752920|523891692|FG000|Overall Study|Clinical Disease Progression|6|||
145284803|NCT01752920|523891693|FG001|Overall Study|Clinical Disease Progression|4|||
145284804|NCT01752920|523891694|FG002|Overall Study|Clinical Disease Progression|1|||
145406077|NCT02696798|524341709|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
145406078|NCT02696798|524341710|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
145406079|NCT01157845|524341711|FG000|Overall Study|Lost to Follow-up|5|||
145554583|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
145554584|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
145406080|NCT01157845|524341711|FG000|Overall Study|Withdrawal by Subject|12|||
145554585|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
145554586|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
145554587|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
145554588|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
145554589|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
145554590|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
145554591|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
145612237|NCT03560258|525095676|FG002|Overall Study|Protocol Violation|0|||
145612238|NCT03560258|525095674|FG000|Overall Study|Withdrawal by Subject|0|||
145612239|NCT03560258|525095675|FG001|Overall Study|Withdrawal by Subject|0|||
145612240|NCT03560258|525095676|FG002|Overall Study|Withdrawal by Subject|1|||
145612241|NCT01460160|525095677|FG000|Treatment Phase|Lack of Efficacy|3|||
145284805|NCT01752920|523891695|FG003|Overall Study|Clinical Disease Progression|13|||
145406081|NCT01157845|524341711|FG000|Overall Study|Physician Decision|3|||
145612242|NCT01460160|525095677|FG000|Treatment Phase|Study Drug Toxicity|2|||
145284806|NCT01752920|523891692|FG000|Overall Study|Physician Decision|1|||
145554592|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
145554593|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
145554594|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
145554595|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
145554596|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
145554597|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
145554598|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
145612243|NCT01460160|525095677|FG000|Treatment Phase|Adverse Event|8|||
145612244|NCT01460160|525095677|FG000|Treatment Phase|Withdrawal by Subject|4|||
145612245|NCT01460160|525095677|FG000|Treatment Phase|Death|2|||
145612246|NCT01460160|525095677|FG000|Treatment Phase|Other reasons|9|||
145612247|NCT01460160|525095677|FG000|Follow-up Phase|Withdrawal by Subject|4|||
145612248|NCT01460160|525095677|FG000|Follow-up Phase|Death|14|||
145612249|NCT01460160|525095677|FG000|Follow-up Phase|Lost to Follow-up|7|||
145612250|NCT01460160|525095677|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
145612251|NCT01460160|525095677|FG000|Follow-up Phase|Other and not reported reasons|5|||
145612252|NCT03893825|525095678|FG000|Overall Study|Death|2|||
145284807|NCT01752920|523891693|FG001|Overall Study|Physician Decision|0|||
145284808|NCT01752920|523891694|FG002|Overall Study|Physician Decision|0|||
145284809|NCT01752920|523891695|FG003|Overall Study|Physician Decision|3|||
145284810|NCT01752920|523891692|FG000|Overall Study|Radiographic Disease Progression|20|||
145284811|NCT01752920|523891693|FG001|Overall Study|Radiographic Disease Progression|7|||
145284812|NCT01752920|523891694|FG002|Overall Study|Radiographic Disease Progression|12|||
145284813|NCT01752920|523891695|FG003|Overall Study|Radiographic Disease Progression|29|||
145284814|NCT01752920|523891692|FG000|Overall Study|Study Terminated by Sponsor|0|||
145284815|NCT01752920|523891693|FG001|Overall Study|Study Terminated by Sponsor|0|||
145284816|NCT01752920|523891694|FG002|Overall Study|Study Terminated by Sponsor|0|||
145284817|NCT01752920|523891695|FG003|Overall Study|Study Terminated by Sponsor|1|||
145284818|NCT01752920|523891692|FG000|Overall Study|Withdrawal by Subject|0|||
145284819|NCT01752920|523891693|FG001|Overall Study|Withdrawal by Subject|1|||
145284820|NCT01752920|523891694|FG002|Overall Study|Withdrawal by Subject|0|||
145284821|NCT01752920|523891695|FG003|Overall Study|Withdrawal by Subject|1|||
145284822|NCT01752920|523891692|FG000|Overall Study|Lack of clinical benefit|1|||
145284823|NCT01752920|523891693|FG001|Overall Study|Lack of clinical benefit|1|||
145554599|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
145554600|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
145554601|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
145554602|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
145554603|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
145612253|NCT03893825|525095679|FG001|Overall Study|Death|1|||
145612254|NCT03893825|525095678|FG000|Overall Study|Adverse Event|0|||
145284824|NCT01752920|523891694|FG002|Overall Study|Lack of clinical benefit|1|||
145284825|NCT01752920|523891695|FG003|Overall Study|Lack of clinical benefit|1|||
145554604|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
145554605|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
145554606|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
145554607|NCT03720470|524888648|FG000|Treatment Period: Final 4 Weeks|Other|0|||
145554608|NCT03720470|524888649|FG001|Treatment Period: Final 4 Weeks|Other|1|||
145554609|NCT03720470|524888650|FG002|Treatment Period: Final 4 Weeks|Other|0|||
145554610|NCT03720470|524888651|FG003|Treatment Period: Final 4 Weeks|Other|2|||
145554611|NCT03720470|524888652|FG004|Treatment Period: Final 4 Weeks|Other|1|||
145554612|NCT03720470|524888653|FG005|Treatment Period: Final 4 Weeks|Other|0|||
145554613|NCT01113801|524888658|FG000|Overall Study|Adverse Event|4|||
145554614|NCT01113801|524888659|FG001|Overall Study|Adverse Event|0|||
145554615|NCT01113801|524888660|FG002|Overall Study|Adverse Event|2|||
145554616|NCT01113801|524888661|FG003|Overall Study|Adverse Event|6|||
145554617|NCT01113801|524888658|FG000|Overall Study|Death|4|||
145554618|NCT01113801|524888659|FG001|Overall Study|Death|5|||
145554619|NCT01113801|524888660|FG002|Overall Study|Death|3|||
145554620|NCT01113801|524888661|FG003|Overall Study|Death|4|||
145554621|NCT01113801|524888658|FG000|Overall Study|Protocol Violation|0|||
145554622|NCT01113801|524888659|FG001|Overall Study|Protocol Violation|1|||
145554623|NCT01113801|524888660|FG002|Overall Study|Protocol Violation|0|||
145554624|NCT01113801|524888661|FG003|Overall Study|Protocol Violation|0|||
145554625|NCT01113801|524888658|FG000|Overall Study|Withdrawal by Subject|9|||
145554626|NCT01113801|524888659|FG001|Overall Study|Withdrawal by Subject|7|||
145554627|NCT01113801|524888660|FG002|Overall Study|Withdrawal by Subject|7|||
145554628|NCT01113801|524888661|FG003|Overall Study|Withdrawal by Subject|8|||
145554629|NCT01113801|524888658|FG000|Overall Study|Physician Decision|2|||
145554630|NCT01113801|524888659|FG001|Overall Study|Physician Decision|2|||
145554631|NCT01113801|524888660|FG002|Overall Study|Physician Decision|3|||
145554632|NCT01113801|524888661|FG003|Overall Study|Physician Decision|3|||
145554633|NCT01113801|524888658|FG000|Overall Study|Sponsor Decision|15|||
145554634|NCT01113801|524888659|FG001|Overall Study|Sponsor Decision|21|||
145554635|NCT01113801|524888660|FG002|Overall Study|Sponsor Decision|20|||
145554636|NCT01113801|524888661|FG003|Overall Study|Sponsor Decision|15|||
145554637|NCT01113801|524888658|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
145554638|NCT01113801|524888659|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
145554639|NCT01113801|524888660|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
145554640|NCT01113801|524888661|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
145554641|NCT03325075|524888662|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
145554642|NCT03325075|524888663|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
145554643|NCT03325075|524888664|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
145554644|NCT03325075|524888665|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
145554645|NCT03325075|524888662|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
145554646|NCT03325075|524888663|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
145554647|NCT03325075|524888664|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
145554648|NCT03325075|524888665|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
145554649|NCT03325075|524888662|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
145554650|NCT03325075|524888663|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
145554651|NCT03325075|524888664|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
145554652|NCT03325075|524888665|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
145554653|NCT01333059|524888668|FG000|Overall Study|Physician Decision|3|||
145554654|NCT01333059|524888669|FG001|Overall Study|Physician Decision|3|||
145554655|NCT01333059|524888668|FG000|Overall Study|Protocol Violation|3|||
145554656|NCT01333059|524888669|FG001|Overall Study|Protocol Violation|0|||
145554657|NCT03035409|524888681|FG000|Overall Study|Adverse Event|5|||
145554658|NCT03035409|524888681|FG000|Overall Study|Death|2|||
145554659|NCT03035409|524888681|FG000|Overall Study|Withdrawal by Subject|2|||
145554660|NCT03035409|524888681|FG000|Overall Study|Non compliance|4|||
145554661|NCT03035409|524888681|FG000|Overall Study|Patient was jittery|1|||
145554662|NCT03035409|524888681|FG000|Overall Study|Did not like Questionnaire|1|||
145554663|NCT03035409|524888681|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
145554664|NCT03035409|524888681|FG000|Overall Study|Did not like taking drugs|1|||
145554665|NCT02056340|524888684|FG000|Overall Study|Lost to Follow-up|5|||
145554666|NCT02056340|524888685|FG001|Overall Study|Lost to Follow-up|5|||
145554667|NCT02056340|524888684|FG000|Overall Study|Withdrawal by Subject|2|||
145554668|NCT02056340|524888685|FG001|Overall Study|Withdrawal by Subject|6|||
145284826|NCT01738581|523891696|FG000|Overall Study|Lost to Follow-up|1|||
145284827|NCT01738581|523891697|FG001|Overall Study|Lost to Follow-up|0|||
145284828|NCT00210626|523891698|FG000|Overall Study|Adverse Event|1|||
145284829|NCT00210626|523891699|FG001|Overall Study|Adverse Event|2|||
145284830|NCT00210626|523891698|FG000|Overall Study|Protocol Violation|1|||
145284831|NCT00210626|523891699|FG001|Overall Study|Protocol Violation|5|||
145284832|NCT00210626|523891698|FG000|Overall Study|Lost to Follow-up|11|||
145284833|NCT00210626|523891699|FG001|Overall Study|Lost to Follow-up|11|||
145284834|NCT00210626|523891698|FG000|Overall Study|Death|1|||
145284835|NCT00210626|523891699|FG001|Overall Study|Death|0|||
145284836|NCT00210626|523891698|FG000|Overall Study|Withdrawal by Subject|29|||
145284837|NCT00210626|523891699|FG001|Overall Study|Withdrawal by Subject|20|||
145284838|NCT00210626|523891698|FG000|Overall Study|Physician Decision|0|||
145284839|NCT00210626|523891699|FG001|Overall Study|Physician Decision|2|||
145284840|NCT00210626|523891698|FG000|Overall Study|Sponser Request|1|||
145284841|NCT00210626|523891699|FG001|Overall Study|Sponser Request|0|||
145284842|NCT00210626|523891698|FG000|Overall Study|Other|4|||
145284843|NCT00210626|523891699|FG001|Overall Study|Other|5|||
145284844|NCT00771901|523891700|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
145284845|NCT00771901|523891701|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
145284846|NCT00771901|523891702|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
145554669|NCT04900220|524888686|FG000|Overall Study|Lost to Follow-up|1|||
145554670|NCT04900220|524888687|FG001|Overall Study|Lost to Follow-up|1|||
145554671|NCT02028065|524888688|FG000|Randomization Through Start Treatment|Not treated|1|||
145284847|NCT02862535|523891703|FG000|Overall Study|Death|7|||
145554672|NCT02028065|524888689|FG001|Randomization Through Start Treatment|Not treated|3|||
145554673|NCT02028065|524888690|FG002|Randomization Through Start Treatment|Not treated|3|||
145554674|NCT02028065|524888688|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
145554675|NCT02028065|524888689|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
145554676|NCT02028065|524888690|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
145554677|NCT02028065|524888688|FG000|Treatment Through Study Completion|Physician Decision|1|||
145554678|NCT02028065|524888689|FG001|Treatment Through Study Completion|Physician Decision|0|||
145554679|NCT02028065|524888690|FG002|Treatment Through Study Completion|Physician Decision|0|||
145554680|NCT02028065|524888688|FG000|Treatment Through Study Completion|Protocol Violation|1|||
145554681|NCT02028065|524888689|FG001|Treatment Through Study Completion|Protocol Violation|4|||
145554682|NCT02028065|524888690|FG002|Treatment Through Study Completion|Protocol Violation|0|||
145554683|NCT02028065|524888688|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
145554684|NCT02028065|524888689|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
145554685|NCT02028065|524888690|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
145554686|NCT02028065|524888688|FG000|Treatment Through Study Completion|Adverse Event|3|||
145554687|NCT02028065|524888689|FG001|Treatment Through Study Completion|Adverse Event|3|||
145554688|NCT02028065|524888690|FG002|Treatment Through Study Completion|Adverse Event|5|||
145554689|NCT00867009|524888694|FG000|Induction Period|Nonserious Adverse Event|5|||
145554690|NCT00867009|524888694|FG000|Induction Period|Serious Adverse Event|10|||
145554691|NCT00867009|524888694|FG000|Induction Period|Death due to serious adverse event|6|||
145554692|NCT00867009|524888694|FG000|Induction Period|Death due to Study Disease|4|||
145284848|NCT02862535|523891704|FG001|Overall Study|Death|3|||
145284849|NCT02862535|523891705|FG002|Overall Study|Death|2|||
145554693|NCT00867009|524888694|FG000|Induction Period|Protocol Violation|1|||
145554694|NCT00867009|524888694|FG000|Induction Period|Withdrawal by Subject|8|||
145554695|NCT00867009|524888694|FG000|Induction Period|Physician Decision|3|||
145284850|NCT02862535|523891706|FG003|Overall Study|Death|5|||
145284851|NCT02862535|523891703|FG000|Overall Study|Study Terminated by Sponsor|1|||
145284852|NCT02862535|523891704|FG001|Overall Study|Study Terminated by Sponsor|3|||
145554696|NCT00867009|524888694|FG000|Induction Period|Progressive Disease (PD)|25|||
145554697|NCT00867009|524888694|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
145554698|NCT03266094|524888697|FG000|Overall Study|Lost to Follow-up|1|||
145554699|NCT03266094|524888697|FG000|Overall Study|Withdrawal by Subject|1|||
145554700|NCT03473808|524888702|FG000|Overall Study|Withdrawal by Subject|1|||
145554701|NCT03171415|524888703|FG000|Overall Study|Lost to Follow-up|0|||
145554702|NCT03171415|524888704|FG001|Overall Study|Lost to Follow-up|0|||
145554703|NCT03171415|524888705|FG002|Overall Study|Lost to Follow-up|0|||
145554704|NCT03171415|524888706|FG003|Overall Study|Lost to Follow-up|0|||
145554705|NCT03171415|524888707|FG004|Overall Study|Lost to Follow-up|2|||
145554706|NCT01085591|524888708|FG000|Overall Study|Adverse Event|0|||
145554707|NCT01085591|524888709|FG001|Overall Study|Adverse Event|1|||
145554708|NCT01085591|524888710|FG002|Overall Study|Adverse Event|3|||
145554709|NCT01085591|524888708|FG000|Overall Study|Physician Decision|1|||
145406082|NCT01157845|524341711|FG000|Overall Study|Protocol Violation|13|||
145554710|NCT01085591|524888709|FG001|Overall Study|Physician Decision|0|||
145554711|NCT01085591|524888710|FG002|Overall Study|Physician Decision|1|||
145554712|NCT01085591|524888708|FG000|Overall Study|Withdrawal by Subject|0|||
145554713|NCT01085591|524888709|FG001|Overall Study|Withdrawal by Subject|2|||
145554714|NCT01085591|524888710|FG002|Overall Study|Withdrawal by Subject|1|||
145554715|NCT01085591|524888708|FG000|Overall Study|Lost to Follow-up|0|||
145554716|NCT01085591|524888709|FG001|Overall Study|Lost to Follow-up|1|||
145554717|NCT01085591|524888710|FG002|Overall Study|Lost to Follow-up|1|||
145554718|NCT01085591|524888708|FG000|Overall Study|Protocol Violation|1|||
145554719|NCT01085591|524888709|FG001|Overall Study|Protocol Violation|1|||
145554720|NCT01085591|524888710|FG002|Overall Study|Protocol Violation|1|||
145554721|NCT01085591|524888708|FG000|Overall Study|Other|0|||
145554722|NCT01085591|524888709|FG001|Overall Study|Other|1|||
145554723|NCT01085591|524888710|FG002|Overall Study|Other|0|||
145554724|NCT01085591|524888708|FG000|Overall Study|Not Properly Consented|1|||
145554725|NCT01085591|524888709|FG001|Overall Study|Not Properly Consented|0|||
145554726|NCT01085591|524888710|FG002|Overall Study|Not Properly Consented|0|||
145554727|NCT00847704|524888714|FG000|Overall Study|Withdrawal by Subject|1|||
145554728|NCT02111850|524888715|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554729|NCT02111850|524888716|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554730|NCT02111850|524888717|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554731|NCT02111850|524888718|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554732|NCT02111850|524888719|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
145554733|NCT02111850|524888720|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554734|NCT02111850|524888721|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554735|NCT02111850|524888722|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554736|NCT02111850|524888723|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554737|NCT02111850|524888724|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554738|NCT02111850|524888725|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
145554739|NCT00397982|524890353|FG000|Overall Study|Withdrawal by Subject|1|||
145554740|NCT00397982|524890353|FG000|Overall Study|Adverse Event|1|||
145554741|NCT00397982|524890353|FG000|Overall Study|noncompliance|1|||
145554742|NCT00397982|524890353|FG000|Overall Study|Unrelated health issues|1|||
145554743|NCT01199289|524890357|FG000|Overall Study|Ineligibility determined|2|||
145554744|NCT01199289|524890358|FG001|Overall Study|Ineligibility determined|1|||
145554745|NCT01199289|524890359|FG002|Overall Study|Ineligibility determined|0|||
145554746|NCT01199289|524890360|FG003|Overall Study|Ineligibility determined|0|||
145554747|NCT01199289|524890357|FG000|Overall Study|Protocol Violation|1|||
145554748|NCT01199289|524890358|FG001|Overall Study|Protocol Violation|0|||
145612255|NCT03893825|525095679|FG001|Overall Study|Adverse Event|2|||
145284853|NCT02862535|523891705|FG002|Overall Study|Study Terminated by Sponsor|8|||
145284854|NCT02862535|523891706|FG003|Overall Study|Study Terminated by Sponsor|5|||
145284855|NCT02862535|523891703|FG000|Overall Study|Enrolled, not Treated|1|||
145284856|NCT02862535|523891704|FG001|Overall Study|Enrolled, not Treated|0|||
145284857|NCT02862535|523891705|FG002|Overall Study|Enrolled, not Treated|0|||
145284858|NCT02862535|523891706|FG003|Overall Study|Enrolled, not Treated|1|||
145284859|NCT04147715|523891707|FG000|Overall Study|Adverse Event|0|||
145284860|NCT04147715|523891708|FG001|Overall Study|Adverse Event|0|||
145284861|NCT04147715|523891709|FG002|Overall Study|Adverse Event|0|||
145284862|NCT04147715|523891710|FG003|Overall Study|Adverse Event|0|||
145284863|NCT04147715|523891711|FG004|Overall Study|Adverse Event|0|||
145284864|NCT04147715|523891712|FG005|Overall Study|Adverse Event|0|||
145284865|NCT04147715|523891713|FG006|Overall Study|Adverse Event|0|||
145284866|NCT04147715|523891714|FG007|Overall Study|Adverse Event|2|||
145284867|NCT04147715|523891715|FG008|Overall Study|Adverse Event|1|||
145284868|NCT04147715|523891716|FG009|Overall Study|Adverse Event|0|||
145284869|NCT04147715|523891717|FG010|Overall Study|Adverse Event|0|||
145284870|NCT04147715|523891718|FG011|Overall Study|Adverse Event|0|||
145284871|NCT02418910|523891720|FG000|Overall Study|Lost to Follow-up|3|||
145284872|NCT02418910|523891720|FG000|Overall Study|Withdrawal by Subject|4|||
145284873|NCT02472977|523891724|FG000|Overall Study|Disease progression|4|||
145284874|NCT02472977|523891725|FG001|Overall Study|Disease progression|25|||
145284875|NCT02472977|523891726|FG002|Overall Study|Disease progression|6|||
145284876|NCT02472977|523891724|FG000|Overall Study|Withdrawal by Subject|0|||
145284877|NCT02472977|523891725|FG001|Overall Study|Withdrawal by Subject|1|||
145406083|NCT01157845|524341711|FG000|Overall Study|Study was ended|1|||
145406084|NCT01157845|524341711|FG000|Overall Study|Device malfunction|1|||
145406085|NCT03311555|524341712|FG000|Overall Study|Adverse Event|1|||
145406086|NCT03836053|524343691|FG000|Overall Study|Protocol-specified criteria|0|||
145554749|NCT01199289|524890359|FG002|Overall Study|Protocol Violation|0|||
145554750|NCT01199289|524890360|FG003|Overall Study|Protocol Violation|1|||
145554751|NCT01199289|524890357|FG000|Overall Study|Noncompliance|1|||
145554752|NCT01199289|524890358|FG001|Overall Study|Noncompliance|0|||
145554753|NCT01199289|524890359|FG002|Overall Study|Noncompliance|2|||
145554754|NCT01199289|524890360|FG003|Overall Study|Noncompliance|0|||
145554755|NCT01199289|524890357|FG000|Overall Study|Adverse Event|0|||
145554756|NCT01199289|524890358|FG001|Overall Study|Adverse Event|3|||
145554757|NCT01199289|524890359|FG002|Overall Study|Adverse Event|1|||
145554758|NCT01199289|524890360|FG003|Overall Study|Adverse Event|4|||
145554759|NCT01199289|524890357|FG000|Overall Study|Full consent withdrawn|2|||
145554760|NCT01199289|524890358|FG001|Overall Study|Full consent withdrawn|2|||
145554761|NCT01199289|524890359|FG002|Overall Study|Full consent withdrawn|2|||
145554762|NCT01199289|524890360|FG003|Overall Study|Full consent withdrawn|3|||
145554763|NCT01199289|524890357|FG000|Overall Study|Administrative decision|0|||
145554764|NCT01199289|524890358|FG001|Overall Study|Administrative decision|0|||
145554765|NCT01199289|524890359|FG002|Overall Study|Administrative decision|0|||
145554766|NCT01199289|524890360|FG003|Overall Study|Administrative decision|1|||
145554767|NCT01199289|524890357|FG000|Overall Study|Lost to Follow-up|0|||
145554768|NCT01199289|524890358|FG001|Overall Study|Lost to Follow-up|0|||
145554769|NCT01199289|524890359|FG002|Overall Study|Lost to Follow-up|0|||
145554770|NCT01199289|524890360|FG003|Overall Study|Lost to Follow-up|1|||
145554771|NCT01199289|524890357|FG000|Overall Study|Protocol-specified criteria|3|||
145554772|NCT01199289|524890358|FG001|Overall Study|Protocol-specified criteria|0|||
145554773|NCT01199289|524890359|FG002|Overall Study|Protocol-specified criteria|0|||
145554774|NCT01199289|524890360|FG003|Overall Study|Protocol-specified criteria|1|||
145554775|NCT01199289|524890357|FG000|Overall Study|Pregnancy|0|||
145554776|NCT01199289|524890358|FG001|Overall Study|Pregnancy|1|||
145554777|NCT01199289|524890359|FG002|Overall Study|Pregnancy|0|||
145554778|NCT01199289|524890360|FG003|Overall Study|Pregnancy|1|||
145554779|NCT03055260|524890361|FG000|Overall Study|Withdrawal by Subject|1|||
145554780|NCT03055260|524890362|FG001|Overall Study|Withdrawal by Subject|0|||
145554781|NCT02507505|524890363|FG000|Overall Study|Withdrawal by Subject|13|||
145554782|NCT02507505|524890364|FG001|Overall Study|Withdrawal by Subject|11|||
145554783|NCT02507505|524890363|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
145284878|NCT02472977|523891726|FG002|Overall Study|Withdrawal by Subject|0|||
145554784|NCT02507505|524890364|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
145554785|NCT02507505|524890363|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
145284879|NCT02472977|523891724|FG000|Overall Study|Study drug toxicity|2|||
145284880|NCT02472977|523891725|FG001|Overall Study|Study drug toxicity|0|||
145284881|NCT02472977|523891726|FG002|Overall Study|Study drug toxicity|2|||
145554786|NCT02507505|524890364|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
145554787|NCT02507505|524890363|FG000|Overall Study|Death before receipt of anesthesia|0|||
145554788|NCT02507505|524890364|FG001|Overall Study|Death before receipt of anesthesia|1|||
145554789|NCT00967798|524890365|FG000|Overall Study|Withdrawal by Subject|5|||
145554790|NCT00967798|524890366|FG001|Overall Study|Withdrawal by Subject|2|||
145554791|NCT00967798|524890365|FG000|Overall Study|Lost to Follow-up|4|||
145554792|NCT00967798|524890366|FG001|Overall Study|Lost to Follow-up|1|||
145554793|NCT01409564|524890367|FG000|Overall Study|low medication compliance|4|||
145554794|NCT01409564|524890368|FG001|Overall Study|low medication compliance|3|||
145554795|NCT01409564|524890367|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
145554796|NCT01409564|524890368|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
145554797|NCT00254540|524890369|FG000|Overall Study|Adverse Event|6|||
145554798|NCT00254540|524890370|FG001|Overall Study|Adverse Event|7|||
145554799|NCT00254540|524890369|FG000|Overall Study|Lack of Efficacy|13|||
145554800|NCT00254540|524890370|FG001|Overall Study|Lack of Efficacy|13|||
145554801|NCT00254540|524890369|FG000|Overall Study|Death|0|||
145554802|NCT00254540|524890370|FG001|Overall Study|Death|1|||
145554803|NCT00254540|524890369|FG000|Overall Study|Laboratory Test Abnormality|0|||
145554804|NCT00254540|524890370|FG001|Overall Study|Laboratory Test Abnormality|1|||
145554805|NCT00225251|524890371|FG000|Overall Study|Withdrawal by Subject|1|||
145554806|NCT00225251|524890372|FG001|Overall Study|Withdrawal by Subject|1|||
145554807|NCT03045328|524890373|FG000|Overall Study|Withdrawal by Subject|2|||
145554808|NCT00592839|524890376|FG000|Overall Study|Withdrawal by Subject|1|||
145554809|NCT00592839|524890377|FG001|Overall Study|Withdrawal by Subject|1|||
145554810|NCT00592839|524890378|FG002|Overall Study|Withdrawal by Subject|3|||
145554811|NCT00592839|524890376|FG000|Overall Study|Protocol Violation|1|||
145554812|NCT00592839|524890377|FG001|Overall Study|Protocol Violation|1|||
145554813|NCT00592839|524890378|FG002|Overall Study|Protocol Violation|2|||
145554814|NCT00592839|524890376|FG000|Overall Study|Adverse Event|0|||
145554815|NCT00592839|524890377|FG001|Overall Study|Adverse Event|1|||
145554816|NCT00592839|524890378|FG002|Overall Study|Adverse Event|0|||
145554817|NCT00592839|524890376|FG000|Overall Study|Lost to Follow-up|0|||
145554818|NCT00592839|524890377|FG001|Overall Study|Lost to Follow-up|1|||
145554819|NCT00592839|524890378|FG002|Overall Study|Lost to Follow-up|1|||
145554820|NCT01313767|524890379|FG000|Overall Study|Adverse Event|1|||
145554821|NCT01313767|524890380|FG001|Overall Study|Adverse Event|0|||
145554822|NCT01313767|524890379|FG000|Overall Study|Lost to Follow-up|1|||
145554823|NCT01313767|524890380|FG001|Overall Study|Lost to Follow-up|0|||
145554824|NCT01313767|524890379|FG000|Overall Study|Withdrawal by Subject|2|||
145554825|NCT01313767|524890380|FG001|Overall Study|Withdrawal by Subject|1|||
145554826|NCT01313767|524890379|FG000|Overall Study|Protocol Violation|3|||
145554827|NCT01313767|524890380|FG001|Overall Study|Protocol Violation|1|||
145554828|NCT04483011|524890386|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
145554829|NCT04483011|524890387|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
145554830|NCT00232817|524890388|FG000|Overall Study|Protocol Violation|2|||
145554831|NCT00232817|524890389|FG001|Overall Study|Protocol Violation|1|||
145554832|NCT00799487|524890390|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
145554833|NCT00799487|524890391|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
145554834|NCT00799487|524890392|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
145554835|NCT00799487|524890390|FG000|Dose Adjustment Period|Adverse Event|2|||
145554836|NCT00799487|524890391|FG001|Dose Adjustment Period|Adverse Event|0|||
145554837|NCT00799487|524890392|FG002|Dose Adjustment Period|Adverse Event|0|||
145554838|NCT00799487|524890390|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
145554839|NCT00799487|524890391|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
145554840|NCT00799487|524890392|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
145554841|NCT00799487|524890390|FG000|Dose Adjustment Period|Investigator Discretion|2|||
145554842|NCT00799487|524890391|FG001|Dose Adjustment Period|Investigator Discretion|0|||
145554843|NCT00799487|524890392|FG002|Dose Adjustment Period|Investigator Discretion|0|||
145554844|NCT00799487|524890390|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
145554845|NCT00799487|524890391|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
145554846|NCT00799487|524890392|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
145554847|NCT00799487|524890390|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
145554848|NCT00799487|524890391|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
145554849|NCT00799487|524890392|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
145554850|NCT00799487|524890390|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
145554851|NCT00799487|524890391|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
145554852|NCT00799487|524890392|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
145554853|NCT00799487|524890390|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
145554854|NCT00799487|524890391|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
145612256|NCT03893825|525095678|FG000|Overall Study|Withdrawal by Subject|19|||
145612257|NCT03893825|525095679|FG001|Overall Study|Withdrawal by Subject|21|||
145612258|NCT03893825|525095678|FG000|Overall Study|Protocol deviation|1|||
145612259|NCT03893825|525095679|FG001|Overall Study|Protocol deviation|0|||
145612260|NCT03893825|525095678|FG000|Overall Study|Lost to Follow-up|10|||
145612261|NCT03893825|525095679|FG001|Overall Study|Lost to Follow-up|10|||
145612262|NCT03893825|525095678|FG000|Overall Study|Other than specified|7|||
145612263|NCT03893825|525095679|FG001|Overall Study|Other than specified|6|||
145612264|NCT04161807|525095680|FG000|Overall Study|Withdrawal by Subject|2|||
145612265|NCT04161807|525095680|FG000|Overall Study|Performed only 1 treatment|2|||
145612266|NCT02006121|525095681|FG000|Double Blind Phase|Adverse Event|6|||
145612267|NCT02006121|525095682|FG001|Double Blind Phase|Adverse Event|0|||
145612268|NCT02006121|525095681|FG000|Double Blind Phase|Lack of Efficacy|1|||
145612269|NCT02006121|525095682|FG001|Double Blind Phase|Lack of Efficacy|16|||
145612270|NCT02006121|525095681|FG000|Double Blind Phase|Withdrawal by Subject|3|||
145554855|NCT00799487|524890392|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
145554856|NCT00799487|524890390|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
145554857|NCT00799487|524890391|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
145554858|NCT00799487|524890392|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
145554859|NCT00799487|524890390|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
145554860|NCT00799487|524890391|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
145554861|NCT00799487|524890392|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
145554862|NCT00799487|524890390|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
145554863|NCT00799487|524890391|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
145554864|NCT00799487|524890392|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
145554865|NCT00799487|524890390|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
145554866|NCT00799487|524890391|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
145554867|NCT00799487|524890392|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
145554868|NCT03518073|524890393|FG000|Overall Study|Adverse Event|2|||
145554869|NCT03518073|524890394|FG001|Overall Study|Adverse Event|4|||
145554870|NCT03518073|524890395|FG002|Overall Study|Adverse Event|2|||
145554871|NCT03518073|524890393|FG000|Overall Study|Death|2|||
145554872|NCT03518073|524890394|FG001|Overall Study|Death|1|||
145554873|NCT03518073|524890395|FG002|Overall Study|Death|3|||
145554874|NCT03518073|524890393|FG000|Overall Study|Lost to Follow-up|1|||
145612271|NCT02006121|525095682|FG001|Double Blind Phase|Withdrawal by Subject|4|||
145612272|NCT02006121|525095681|FG000|Double Blind Phase|Non-compliance with study drug|1|||
145612273|NCT02006121|525095682|FG001|Double Blind Phase|Non-compliance with study drug|3|||
145612274|NCT02006121|525095681|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
145612275|NCT02006121|525095682|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
145284882|NCT02472977|523891724|FG000|Overall Study|Subject request to discontinue treatment|0|||
145612276|NCT02006121|525095681|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
145612277|NCT02006121|525095682|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
145612278|NCT02006121|525095681|FG000|Open Label Phase|Adverse Event|15|||
145554875|NCT03518073|524890394|FG001|Overall Study|Lost to Follow-up|0|||
145554876|NCT03518073|524890395|FG002|Overall Study|Lost to Follow-up|1|||
145554877|NCT03518073|524890393|FG000|Overall Study|Physician Decision|5|||
145554878|NCT03518073|524890394|FG001|Overall Study|Physician Decision|0|||
145554879|NCT03518073|524890395|FG002|Overall Study|Physician Decision|2|||
145554880|NCT03518073|524890393|FG000|Overall Study|Progressive disease|1|||
145554881|NCT03518073|524890394|FG001|Overall Study|Progressive disease|1|||
145554882|NCT03518073|524890395|FG002|Overall Study|Progressive disease|1|||
145554883|NCT03518073|524890393|FG000|Overall Study|Protocol Violation|1|||
145554884|NCT03518073|524890394|FG001|Overall Study|Protocol Violation|0|||
145554885|NCT03518073|524890395|FG002|Overall Study|Protocol Violation|0|||
145554886|NCT03518073|524890393|FG000|Overall Study|Withdrawal by Subject|30|||
145554887|NCT03518073|524890394|FG001|Overall Study|Withdrawal by Subject|34|||
145554888|NCT03518073|524890395|FG002|Overall Study|Withdrawal by Subject|29|||
145554889|NCT03518073|524890393|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
145554890|NCT03518073|524890394|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
145554891|NCT03518073|524890395|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
145554892|NCT03518073|524890393|FG000|Overall Study|Covid-19|1|||
145554893|NCT03518073|524890394|FG001|Overall Study|Covid-19|2|||
145554894|NCT03518073|524890395|FG002|Overall Study|Covid-19|1|||
145554895|NCT03045081|524890396|FG000|Overall Study|Withdrawal by Subject|6|||
145554896|NCT03045081|524890397|FG001|Overall Study|Withdrawal by Subject|11|||
145554897|NCT00475176|524890398|FG000|Overall Study|Adverse Event|2|||
145554898|NCT00475176|524890398|FG000|Overall Study|Withdrawal by Subject|1|||
145554899|NCT00475176|524890398|FG000|Overall Study|Protocol Violation|1|||
145554900|NCT00065507|524890401|FG000|Overall Study|Death|16|||
145554901|NCT00065507|524890402|FG001|Overall Study|Death|17|||
145554902|NCT00065507|524890401|FG000|Overall Study|Adverse Event|4|||
145554903|NCT00065507|524890402|FG001|Overall Study|Adverse Event|3|||
145554904|NCT00065507|524890401|FG000|Overall Study|Lack of Efficacy|0|||
145554905|NCT00065507|524890402|FG001|Overall Study|Lack of Efficacy|6|||
145554906|NCT00065507|524890401|FG000|Overall Study|Poor/Non-compliance|3|||
145554907|NCT00065507|524890402|FG001|Overall Study|Poor/Non-compliance|2|||
145554908|NCT00065507|524890401|FG000|Overall Study|Lost to Follow-up|3|||
145554909|NCT00065507|524890402|FG001|Overall Study|Lost to Follow-up|0|||
145554910|NCT00065507|524890401|FG000|Overall Study|Subject Withdrew Consent|2|||
145554911|NCT00065507|524890402|FG001|Overall Study|Subject Withdrew Consent|1|||
145554912|NCT00065507|524890401|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
145554913|NCT00065507|524890402|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
145554914|NCT00100815|524890403|FG000|Overall Study|Progression|24|||
145554915|NCT00100815|524890403|FG000|Overall Study|Adverse Event|18|||
145554916|NCT00100815|524890403|FG000|Overall Study|Death|4|||
145554917|NCT00100815|524890403|FG000|Overall Study|Other|3|||
145554918|NCT00227903|524890404|FG000|Overall Study|Withdrawal by Subject|2|||
145554919|NCT00227903|524890405|FG001|Overall Study|Withdrawal by Subject|5|||
145554920|NCT00227903|524890404|FG000|Overall Study|Subject moved out of area|1|||
145554921|NCT00227903|524890405|FG001|Overall Study|Subject moved out of area|2|||
145284883|NCT02472977|523891725|FG001|Overall Study|Subject request to discontinue treatment|1|||
145554922|NCT00227903|524890404|FG000|Overall Study|Lost to Follow-up|1|||
145554923|NCT00227903|524890405|FG001|Overall Study|Lost to Follow-up|3|||
145554924|NCT00227903|524890404|FG000|Overall Study|Miscarriage|1|||
145554925|NCT00227903|524890405|FG001|Overall Study|Miscarriage|0|||
145554926|NCT00723892|524890408|FG000|Overall Study|Participant not tracked|33|||
145554927|NCT00723892|524890409|FG001|Overall Study|Participant not tracked|35|||
145554928|NCT00723892|524890408|FG000|Overall Study|Virological criterion|24|||
145554929|NCT00723892|524890409|FG001|Overall Study|Virological criterion|9|||
145554930|NCT00723892|524890408|FG000|Overall Study|Withdrawal by Subject|6|||
145554931|NCT00723892|524890409|FG001|Overall Study|Withdrawal by Subject|9|||
145554932|NCT00723892|524890408|FG000|Overall Study|End planned|11|||
145554933|NCT00723892|524890409|FG001|Overall Study|End planned|7|||
145554934|NCT00723892|524890408|FG000|Overall Study|Bad tolerance|5|||
145554935|NCT00723892|524890409|FG001|Overall Study|Bad tolerance|5|||
145554936|NCT00723892|524890408|FG000|Overall Study|Multiple reasons|17|||
145554937|NCT00723892|524890409|FG001|Overall Study|Multiple reasons|12|||
145554938|NCT00723892|524890408|FG000|Overall Study|Other|6|||
145554939|NCT00723892|524890409|FG001|Overall Study|Other|3|||
145554940|NCT00723892|524890408|FG000|Overall Study|Study end|1|||
145554941|NCT00723892|524890409|FG001|Overall Study|Study end|3|||
145554942|NCT00723892|524890408|FG000|Overall Study|Weight loss|1|||
145554943|NCT00723892|524890409|FG001|Overall Study|Weight loss|3|||
145612279|NCT02006121|525095682|FG001|Open Label Phase|Adverse Event|0|||
145612280|NCT02006121|525095681|FG000|Open Label Phase|Lack of Efficacy|2|||
145612281|NCT02006121|525095682|FG001|Open Label Phase|Lack of Efficacy|0|||
145284884|NCT02472977|523891726|FG002|Overall Study|Subject request to discontinue treatment|0|||
145284885|NCT00291330|523891727|FG000|Overall Study|Adverse Event|47|||
145284886|NCT00291330|523891728|FG001|Overall Study|Adverse Event|40|||
145284887|NCT00291330|523891727|FG000|Overall Study|Protocol Violation|13|||
145284888|NCT00291330|523891728|FG001|Overall Study|Protocol Violation|20|||
145284889|NCT00291330|523891727|FG000|Overall Study|Lost to Follow-up|16|||
145284890|NCT00291330|523891728|FG001|Overall Study|Lost to Follow-up|11|||
145284891|NCT00291330|523891727|FG000|Overall Study|Withdrawal by Subject|22|||
145612282|NCT02006121|525095681|FG000|Open Label Phase|Protocol Violation|2|||
145554944|NCT00723892|524890408|FG000|Overall Study|Alcohol abuse|0|||
145554945|NCT00723892|524890409|FG001|Overall Study|Alcohol abuse|1|||
145612283|NCT02006121|525095682|FG001|Open Label Phase|Protocol Violation|0|||
145554946|NCT00723892|524890408|FG000|Overall Study|Intercurrent infection|2|||
145554947|NCT00723892|524890409|FG001|Overall Study|Intercurrent infection|0|||
145554948|NCT00723892|524890408|FG000|Overall Study|Drug addiction|1|||
145554949|NCT00723892|524890409|FG001|Overall Study|Drug addiction|0|||
145612284|NCT02006121|525095681|FG000|Open Label Phase|Withdrawal by Subject|3|||
145612285|NCT02006121|525095682|FG001|Open Label Phase|Withdrawal by Subject|0|||
145554950|NCT04532099|524890410|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
145554951|NCT04532099|524890411|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
145554952|NCT04532099|524890412|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
145554953|NCT00498602|524890413|FG000|Overall Study|Death|0|||
145554954|NCT00498602|524890414|FG001|Overall Study|Death|0|||
145554955|NCT00498602|524890415|FG002|Overall Study|Death|0|||
145554956|NCT00498602|524890416|FG003|Overall Study|Death|0|||
145554957|NCT00498602|524890417|FG004|Overall Study|Death|0|||
145554958|NCT00498602|524890418|FG005|Overall Study|Death|1|||
145554959|NCT00498602|524890419|FG006|Overall Study|Death|0|||
145554960|NCT00498602|524890413|FG000|Overall Study|Lack of Efficacy|1|||
145554961|NCT00498602|524890414|FG001|Overall Study|Lack of Efficacy|0|||
145554962|NCT00498602|524890415|FG002|Overall Study|Lack of Efficacy|0|||
145554963|NCT00498602|524890416|FG003|Overall Study|Lack of Efficacy|0|||
145554964|NCT00498602|524890417|FG004|Overall Study|Lack of Efficacy|0|||
145554965|NCT00498602|524890418|FG005|Overall Study|Lack of Efficacy|0|||
145554966|NCT00498602|524890419|FG006|Overall Study|Lack of Efficacy|0|||
145554967|NCT00498602|524890413|FG000|Overall Study|Lost to Follow-up|0|||
145554968|NCT00498602|524890414|FG001|Overall Study|Lost to Follow-up|2|||
145554969|NCT00498602|524890415|FG002|Overall Study|Lost to Follow-up|0|||
145554970|NCT00498602|524890416|FG003|Overall Study|Lost to Follow-up|2|||
145554971|NCT00498602|524890417|FG004|Overall Study|Lost to Follow-up|0|||
145554972|NCT00498602|524890418|FG005|Overall Study|Lost to Follow-up|0|||
145554973|NCT00498602|524890419|FG006|Overall Study|Lost to Follow-up|0|||
145554974|NCT00498602|524890413|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
145554975|NCT00498602|524890414|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145554976|NCT00498602|524890415|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
145554977|NCT00498602|524890416|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
145554978|NCT00498602|524890417|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145554979|NCT00498602|524890418|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
145554980|NCT00498602|524890419|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
145554981|NCT00498602|524890413|FG000|Overall Study|AE not related to Study Drug|1|||
145554982|NCT00498602|524890414|FG001|Overall Study|AE not related to Study Drug|3|||
145554983|NCT00498602|524890415|FG002|Overall Study|AE not related to Study Drug|0|||
145554984|NCT00498602|524890416|FG003|Overall Study|AE not related to Study Drug|0|||
145554985|NCT00498602|524890417|FG004|Overall Study|AE not related to Study Drug|2|||
145554986|NCT00498602|524890418|FG005|Overall Study|AE not related to Study Drug|2|||
145554987|NCT00498602|524890419|FG006|Overall Study|AE not related to Study Drug|1|||
145554988|NCT00498602|524890413|FG000|Overall Study|Caregiver Request|2|||
145612286|NCT02006121|525095681|FG000|Open Label Phase|Non-compliance with study drug|3|||
145612287|NCT02006121|525095682|FG001|Open Label Phase|Non-compliance with study drug|0|||
145554989|NCT00498602|524890414|FG001|Overall Study|Caregiver Request|2|||
145554990|NCT00498602|524890415|FG002|Overall Study|Caregiver Request|2|||
145554991|NCT00498602|524890416|FG003|Overall Study|Caregiver Request|0|||
145554992|NCT00498602|524890417|FG004|Overall Study|Caregiver Request|1|||
145554993|NCT00498602|524890418|FG005|Overall Study|Caregiver Request|2|||
145554994|NCT00498602|524890419|FG006|Overall Study|Caregiver Request|0|||
145554995|NCT00498602|524890413|FG000|Overall Study|Investigator Request|0|||
145554996|NCT00498602|524890414|FG001|Overall Study|Investigator Request|0|||
145554997|NCT00498602|524890415|FG002|Overall Study|Investigator Request|1|||
145554998|NCT00498602|524890416|FG003|Overall Study|Investigator Request|0|||
145554999|NCT00498602|524890417|FG004|Overall Study|Investigator Request|0|||
145555000|NCT00498602|524890418|FG005|Overall Study|Investigator Request|0|||
145555001|NCT00498602|524890419|FG006|Overall Study|Investigator Request|0|||
145555002|NCT00498602|524890413|FG000|Overall Study|Subject Request|3|||
145555003|NCT00498602|524890414|FG001|Overall Study|Subject Request|0|||
145555004|NCT00498602|524890415|FG002|Overall Study|Subject Request|1|||
145555005|NCT00498602|524890416|FG003|Overall Study|Subject Request|1|||
145555006|NCT00498602|524890417|FG004|Overall Study|Subject Request|1|||
145555007|NCT00498602|524890418|FG005|Overall Study|Subject Request|4|||
145555008|NCT00498602|524890419|FG006|Overall Study|Subject Request|1|||
145555009|NCT00498602|524890413|FG000|Overall Study|Other|2|||
145555010|NCT00498602|524890414|FG001|Overall Study|Other|3|||
145555011|NCT00498602|524890415|FG002|Overall Study|Other|1|||
145555012|NCT00498602|524890416|FG003|Overall Study|Other|0|||
145555013|NCT00498602|524890417|FG004|Overall Study|Other|0|||
145555014|NCT00498602|524890418|FG005|Overall Study|Other|3|||
145555015|NCT00498602|524890419|FG006|Overall Study|Other|0|||
145555016|NCT01949051|524890425|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
145555017|NCT01949051|524890426|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
145555018|NCT01949051|524890427|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
145555019|NCT01949051|524890428|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
145555020|NCT01949051|524890429|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
145555021|NCT01949051|524890430|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
145555022|NCT01949051|524890425|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
145555023|NCT01949051|524890426|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145555024|NCT01949051|524890427|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145555025|NCT01949051|524890428|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145555026|NCT01949051|524890429|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145555027|NCT01949051|524890430|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
145555028|NCT01949051|524890425|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
145555029|NCT01949051|524890426|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
145555030|NCT01949051|524890427|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
145555031|NCT01949051|524890428|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
145555032|NCT01949051|524890429|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
145555033|NCT01949051|524890430|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
145555034|NCT01949051|524890425|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
145612288|NCT00708305|525095689|FG000|Period 1|Protocol Violation|1|||
145612289|NCT00708305|525095690|FG001|Period 1|Protocol Violation|0|||
145555035|NCT01949051|524890426|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
145612290|NCT00708305|525095691|FG002|Period 1|Protocol Violation|1|||
145612291|NCT00708305|525095692|FG003|Period 1|Protocol Violation|0|||
145612292|NCT00708305|525095689|FG000|Period 1|Other Reason|0|||
145555036|NCT01949051|524890427|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
145612293|NCT00708305|525095690|FG001|Period 1|Other Reason|0|||
145612294|NCT00708305|525095691|FG002|Period 1|Other Reason|0|||
145612295|NCT00708305|525095692|FG003|Period 1|Other Reason|2|||
145612296|NCT00708305|525095689|FG000|Period 2|Lost to Follow-up|0|||
145612297|NCT00708305|525095690|FG001|Period 2|Lost to Follow-up|1|||
145612298|NCT00708305|525095691|FG002|Period 2|Lost to Follow-up|0|||
145612299|NCT00708305|525095692|FG003|Period 2|Lost to Follow-up|0|||
145406087|NCT03836053|524343692|FG001|Overall Study|Protocol-specified criteria|2|||
145406088|NCT03836053|524343693|FG002|Overall Study|Protocol-specified criteria|1|||
145406089|NCT03836053|524343691|FG000|Overall Study|Death|1|||
145406090|NCT03836053|524343692|FG001|Overall Study|Death|6|||
145406091|NCT03836053|524343693|FG002|Overall Study|Death|4|||
145406092|NCT03836053|524343691|FG000|Overall Study|Withdrawal of consent from study|0|||
145406093|NCT03836053|524343692|FG001|Overall Study|Withdrawal of consent from study|0|||
145406094|NCT03836053|524343693|FG002|Overall Study|Withdrawal of consent from study|1|||
145406095|NCT03836053|524343691|FG000|Overall Study|Decision by sponsor|0|||
145406096|NCT03836053|524343692|FG001|Overall Study|Decision by sponsor|2|||
145406097|NCT03836053|524343693|FG002|Overall Study|Decision by sponsor|4|||
145406098|NCT00788671|524343694|FG000|Overall Study|Death|2|||
145406099|NCT00788671|524343694|FG000|Overall Study|Unable to biopsy|1|||
145406100|NCT00788671|524343694|FG000|Overall Study|Withdrawal by Subject|4|||
145406101|NCT00788671|524343694|FG000|Overall Study|IUD expulsed|1|||
145406102|NCT00788671|524343694|FG000|Overall Study|Lost to follow up|2|||
145406103|NCT06125964|524343695|FG000|Overall Study|Lost to Follow-up|0|||
145406104|NCT06125964|524343696|FG001|Overall Study|Lost to Follow-up|1|||
145612300|NCT00708305|525095689|FG000|Period 2|Protocol Violation|0|||
145612301|NCT00708305|525095690|FG001|Period 2|Protocol Violation|1|||
145612302|NCT00708305|525095691|FG002|Period 2|Protocol Violation|0|||
145612303|NCT00708305|525095692|FG003|Period 2|Protocol Violation|0|||
145612304|NCT00708305|525095689|FG000|Period 2|Other Reason|1|||
145612305|NCT00708305|525095690|FG001|Period 2|Other Reason|0|||
145406105|NCT06125964|524343697|FG002|Overall Study|Lost to Follow-up|0|||
145612306|NCT00708305|525095691|FG002|Period 2|Other Reason|0|||
145612307|NCT00708305|525095692|FG003|Period 2|Other Reason|1|||
145612308|NCT00708305|525095689|FG000|Period 3|Protocol Violation|0|||
145612309|NCT00708305|525095690|FG001|Period 3|Protocol Violation|2|||
145612310|NCT00708305|525095691|FG002|Period 3|Protocol Violation|0|||
145284892|NCT00291330|523891728|FG001|Overall Study|Withdrawal by Subject|25|||
145284893|NCT00291330|523891727|FG000|Overall Study|Other|3|||
145284894|NCT00291330|523891728|FG001|Overall Study|Other|1|||
145284895|NCT00566709|523891731|FG000|Overall Study|Protocol Violation|5|||
145284896|NCT00566709|523891732|FG001|Overall Study|Protocol Violation|0|||
145612311|NCT00708305|525095692|FG003|Period 3|Protocol Violation|0|||
145284897|NCT02049359|523893050|FG000|Overall Study|Lost to Follow-up|26|||
145284898|NCT02049359|523893051|FG001|Overall Study|Lost to Follow-up|19|||
145284899|NCT01405950|523893052|FG000|Overall Study|Withdrawal by Subject|1|||
145284900|NCT01405950|523893053|FG001|Overall Study|Withdrawal by Subject|0|||
145284901|NCT01405950|523893054|FG002|Overall Study|Withdrawal by Subject|0|||
145284902|NCT01405950|523893055|FG003|Overall Study|Withdrawal by Subject|0|||
145284903|NCT01381900|523893062|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
145284904|NCT01381900|523893063|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
145284905|NCT01381900|523893064|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
145284906|NCT01381900|523893062|FG000|Overall Study|Adverse Event|4|||
145284907|NCT01381900|523893063|FG001|Overall Study|Adverse Event|6|||
145284908|NCT01381900|523893064|FG002|Overall Study|Adverse Event|7|||
145284909|NCT01381900|523893062|FG000|Overall Study|Noncompliance with study drug|0|||
145284910|NCT01381900|523893063|FG001|Overall Study|Noncompliance with study drug|0|||
145284911|NCT01381900|523893064|FG002|Overall Study|Noncompliance with study drug|1|||
145284912|NCT01381900|523893062|FG000|Overall Study|Physician Decision|0|||
145284913|NCT01381900|523893063|FG001|Overall Study|Physician Decision|1|||
145284914|NCT01381900|523893064|FG002|Overall Study|Physician Decision|1|||
145284915|NCT01381900|523893062|FG000|Overall Study|Protocol Violation|0|||
145284916|NCT01381900|523893063|FG001|Overall Study|Protocol Violation|1|||
145284917|NCT01381900|523893064|FG002|Overall Study|Protocol Violation|1|||
145284918|NCT01381900|523893062|FG000|Overall Study|Withdrawal by Subject|0|||
145284919|NCT01381900|523893063|FG001|Overall Study|Withdrawal by Subject|0|||
145284920|NCT01381900|523893064|FG002|Overall Study|Withdrawal by Subject|1|||
145284921|NCT01381900|523893062|FG000|Overall Study|Early withdraw|3|||
145284922|NCT01381900|523893063|FG001|Overall Study|Early withdraw|1|||
145284923|NCT01381900|523893064|FG002|Overall Study|Early withdraw|1|||
145284924|NCT00387712|523893065|FG000|Overall Study|Physician Decision|6|||
145555037|NCT01949051|524890428|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
145555038|NCT01949051|524890429|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
145555039|NCT01949051|524890430|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
145555040|NCT01949051|524890425|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
145555041|NCT01949051|524890426|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
145284925|NCT00387712|523893066|FG001|Overall Study|Physician Decision|4|||
145284926|NCT00387712|523893065|FG000|Overall Study|Lost to Follow-up|17|||
145284927|NCT00387712|523893066|FG001|Overall Study|Lost to Follow-up|20|||
145284928|NCT00387712|523893065|FG000|Overall Study|Withdrawal by Subject|6|||
145284929|NCT00387712|523893066|FG001|Overall Study|Withdrawal by Subject|12|||
145284930|NCT02040428|523893067|FG000|Overall Study|Death|4|||
145284931|NCT02040428|523893068|FG001|Overall Study|Death|3|||
145284932|NCT02040428|523893067|FG000|Overall Study|Withdrawal by Subject|1|||
145284933|NCT02040428|523893068|FG001|Overall Study|Withdrawal by Subject|1|||
145284934|NCT01772368|523893070|FG000|Overall Study|Adverse Event|1|||
145284935|NCT01772368|523893070|FG000|Overall Study|Withdrawal by Subject|3|||
145284936|NCT01772368|523893070|FG000|Overall Study|Protocol Violation|2|||
145284937|NCT01772368|523893070|FG000|Overall Study|Other|1|||
145284938|NCT03347695|523893084|FG000|Overall Study|Death|0|||
145284939|NCT03347695|523893085|FG001|Overall Study|Death|4|||
145284940|NCT03347695|523893084|FG000|Overall Study|Lost to Follow-up|0|||
145284941|NCT03347695|523893085|FG001|Overall Study|Lost to Follow-up|1|||
145284942|NCT00671879|523893088|FG000|Overall Study|Withdrawal by Subject|0|||
145284943|NCT00671879|523893089|FG001|Overall Study|Withdrawal by Subject|4|||
145284944|NCT00671879|523893090|FG002|Overall Study|Withdrawal by Subject|6|||
145284945|NCT02668783|523893091|FG000|Overall Study|Pregnancy|0|||
145284946|NCT02668783|523893092|FG001|Overall Study|Pregnancy|1|||
145284947|NCT02668783|523893091|FG000|Overall Study|Protocol Violation|2|||
145284948|NCT02668783|523893092|FG001|Overall Study|Protocol Violation|1|||
145284949|NCT02668783|523893091|FG000|Overall Study|Study terminated by sponsor|9|||
145284950|NCT02668783|523893092|FG001|Overall Study|Study terminated by sponsor|10|||
145284951|NCT02668783|523893091|FG000|Overall Study|Subject moved|1|||
145284952|NCT02668783|523893092|FG001|Overall Study|Subject moved|0|||
145284953|NCT02668783|523893091|FG000|Overall Study|Withdrawal by Subject|1|||
145284954|NCT02668783|523893092|FG001|Overall Study|Withdrawal by Subject|0|||
145284955|NCT02884206|523893093|FG000|Valsartan Run-in Period|Death|1|||
145284956|NCT02884206|523893094|FG001|Valsartan Run-in Period|Death|0|||
145284957|NCT02884206|523893095|FG002|Valsartan Run-in Period|Death|0|||
145284958|NCT02884206|523893093|FG000|Valsartan Run-in Period|Adverse Event|31|||
145555042|NCT01949051|524890427|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
145284959|NCT02884206|523893094|FG001|Valsartan Run-in Period|Adverse Event|0|||
145284960|NCT02884206|523893095|FG002|Valsartan Run-in Period|Adverse Event|0|||
145284961|NCT02884206|523893093|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
145284962|NCT02884206|523893094|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
145284963|NCT02884206|523893095|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
145284964|NCT02884206|523893093|FG000|Valsartan Run-in Period|Protocol deviation|4|||
145284965|NCT02884206|523893094|FG001|Valsartan Run-in Period|Protocol deviation|0|||
145555043|NCT01949051|524890428|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
145555044|NCT01949051|524890429|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
145406106|NCT06125964|524343698|FG003|Overall Study|Lost to Follow-up|0|||
145284966|NCT02884206|523893095|FG002|Valsartan Run-in Period|Protocol deviation|0|||
145284967|NCT02884206|523893093|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
145284968|NCT02884206|523893094|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
145284969|NCT02884206|523893095|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
145284970|NCT02884206|523893093|FG000|Valsartan Run-in Period|Physician Decision|1|||
145555045|NCT01949051|524890430|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
145555046|NCT01506479|524890432|FG000|Overall Study|Lost to Follow-up|1|||
145555047|NCT01506479|524890433|FG001|Overall Study|Lost to Follow-up|2|||
145555048|NCT01506479|524890434|FG002|Overall Study|Lost to Follow-up|2|||
145555049|NCT01506479|524890432|FG000|Overall Study|Withdrawal by Subject|1|||
145555050|NCT01506479|524890433|FG001|Overall Study|Withdrawal by Subject|2|||
145555051|NCT01506479|524890434|FG002|Overall Study|Withdrawal by Subject|1|||
145555052|NCT01506479|524890432|FG000|Overall Study|Missing assessment|1|||
145555053|NCT01506479|524890433|FG001|Overall Study|Missing assessment|0|||
145555054|NCT01506479|524890434|FG002|Overall Study|Missing assessment|0|||
145555055|NCT01506479|524890432|FG000|Overall Study|Adverse Event|0|||
145555056|NCT01506479|524890433|FG001|Overall Study|Adverse Event|1|||
145555057|NCT01506479|524890434|FG002|Overall Study|Adverse Event|0|||
145555058|NCT01846507|524890435|FG000|Overall Study|Lost to Follow-up|4|||
145555059|NCT01846507|524890435|FG000|Overall Study|Protocol Violation|1|||
145555060|NCT01846507|524890435|FG000|Overall Study|Missing data|2|||
145555061|NCT01782859|524890436|FG000|Overall Study|Protocol Violation|6|||
145555062|NCT01782859|524890437|FG001|Overall Study|Protocol Violation|6|||
145555063|NCT01782859|524890436|FG000|Overall Study|Withdrawal by Subject|0|||
145555064|NCT01782859|524890437|FG001|Overall Study|Withdrawal by Subject|1|||
145555065|NCT03402386|524890443|FG000|Overall Study|Adverse Event|3|||
145555066|NCT03402386|524890443|FG000|Overall Study|Physician Decision|1|||
145555067|NCT03402386|524890443|FG000|Overall Study|Difficult to control Hb|2|||
145555068|NCT01896531|524890444|FG000|Overall Study|Death|57|||
145555069|NCT01896531|524890445|FG001|Overall Study|Death|59|||
145555070|NCT01896531|524890444|FG000|Overall Study|Lost to Follow-up|3|||
145555071|NCT01896531|524890445|FG001|Overall Study|Lost to Follow-up|0|||
145555072|NCT01896531|524890444|FG000|Overall Study|Non-compliance|0|||
145555073|NCT01896531|524890445|FG001|Overall Study|Non-compliance|1|||
145555074|NCT01896531|524890444|FG000|Overall Study|Study Ended by Sponsor|7|||
145555075|NCT01896531|524890445|FG001|Overall Study|Study Ended by Sponsor|20|||
145555076|NCT01896531|524890444|FG000|Overall Study|Withdrawal by Subject|3|||
145555077|NCT01896531|524890445|FG001|Overall Study|Withdrawal by Subject|2|||
145555078|NCT01896531|524890444|FG000|Overall Study|Death Prior to Treatment|1|||
145555079|NCT01896531|524890445|FG001|Overall Study|Death Prior to Treatment|0|||
145555080|NCT00268996|524890446|FG000|Overall Study|Adverse Event|11|||
145555081|NCT00268996|524890447|FG001|Overall Study|Adverse Event|7|||
145555082|NCT00268996|524890446|FG000|Overall Study|Lost to Follow-up|3|||
145555083|NCT00268996|524890447|FG001|Overall Study|Lost to Follow-up|1|||
145555084|NCT00268996|524890446|FG000|Overall Study|Withdrawal by Subject|5|||
145555085|NCT00268996|524890447|FG001|Overall Study|Withdrawal by Subject|11|||
145555086|NCT00268996|524890446|FG000|Overall Study|Non-compliance|1|||
145555087|NCT00268996|524890447|FG001|Overall Study|Non-compliance|0|||
145555088|NCT00268996|524890446|FG000|Overall Study|Other|1|||
145555089|NCT00268996|524890447|FG001|Overall Study|Other|1|||
145555090|NCT02956486|524890448|FG000|Core Phase|Adverse Event|51|||
145555091|NCT02956486|524890449|FG001|Core Phase|Adverse Event|88|||
145406107|NCT04486716|524343699|FG000|Core Phase|Subject decision|6|||
145406108|NCT04486716|524343699|FG000|Core Phase|Adverse Event|5|||
145406109|NCT04486716|524343699|FG000|Core Phase|Lost to Follow-up|1|||
145406110|NCT04486716|524343699|FG000|Core Phase|Physician Decision|1|||
145406111|NCT04486716|524343699|FG000|Core Phase|Enrolled subjects not treated|9|||
145406112|NCT03405870|524343700|FG000|Overall Study|Withdrawal|1|||
145406113|NCT03405870|524343701|FG001|Overall Study|Withdrawal|0|||
145406114|NCT03405870|524343702|FG002|Overall Study|Withdrawal|1|||
145406115|NCT03405870|524343703|FG003|Overall Study|Withdrawal|0|||
145406116|NCT03405870|524343704|FG004|Overall Study|Withdrawal|0|||
145406117|NCT03405870|524343705|FG005|Overall Study|Withdrawal|0|||
145406118|NCT03405870|524343706|FG006|Overall Study|Withdrawal|1|||
145406119|NCT03405870|524343707|FG007|Overall Study|Withdrawal|0|||
145406120|NCT03737994|524343708|FG000|Overall Study|Withdrawal by Subject|0|||
145406121|NCT03737994|524343709|FG001|Overall Study|Withdrawal by Subject|0|||
145406122|NCT03737994|524343710|FG002|Overall Study|Withdrawal by Subject|0|||
145406123|NCT03737994|524343711|FG003|Overall Study|Withdrawal by Subject|0|||
145406124|NCT03737994|524343712|FG004|Overall Study|Withdrawal by Subject|0|||
145406125|NCT03737994|524343713|FG005|Overall Study|Withdrawal by Subject|0|||
145406126|NCT03737994|524343714|FG006|Overall Study|Withdrawal by Subject|1|||
145406127|NCT03846479|524343715|FG000|Overall Study|Death|8|||
145406128|NCT03846479|524343715|FG000|Overall Study|Lost to Follow-up|1|||
145406129|NCT02332707|524343716|FG000|Overall Study|Adverse Event|0|||
145406130|NCT02332707|524343717|FG001|Overall Study|Adverse Event|0|||
145406131|NCT02332707|524343718|FG002|Overall Study|Adverse Event|0|||
145406132|NCT02332707|524343719|FG003|Overall Study|Adverse Event|0|||
145406133|NCT02332707|524343720|FG004|Overall Study|Adverse Event|0|||
145406134|NCT02332707|524343721|FG005|Overall Study|Adverse Event|0|||
145406135|NCT02332707|524343722|FG006|Overall Study|Adverse Event|0|||
145406136|NCT02332707|524343723|FG007|Overall Study|Adverse Event|0|||
145406137|NCT02332707|524343724|FG008|Overall Study|Adverse Event|0|||
145406138|NCT02332707|524343725|FG009|Overall Study|Adverse Event|0|||
145406139|NCT02332707|524343726|FG010|Overall Study|Adverse Event|0|||
145406140|NCT02332707|524343727|FG011|Overall Study|Adverse Event|0|||
145555092|NCT02956486|524890450|FG002|Core Phase|Adverse Event|0|||
145555093|NCT02956486|524890448|FG000|Core Phase|Lost to Follow-up|8|||
145555094|NCT02956486|524890449|FG001|Core Phase|Lost to Follow-up|6|||
145555095|NCT02956486|524890450|FG002|Core Phase|Lost to Follow-up|0|||
145406141|NCT02332707|524343728|FG012|Overall Study|Adverse Event|1|||
145406142|NCT02332707|524343729|FG013|Overall Study|Adverse Event|0|||
145406143|NCT02332707|524343730|FG014|Overall Study|Adverse Event|0|||
145406144|NCT02332707|524343731|FG015|Overall Study|Adverse Event|0|||
145406145|NCT02332707|524343732|FG016|Overall Study|Adverse Event|0|||
145555096|NCT02956486|524890448|FG000|Core Phase|Inadequate therapeutic effect|4|||
145555097|NCT02956486|524890449|FG001|Core Phase|Inadequate therapeutic effect|5|||
145406146|NCT02332707|524343733|FG017|Overall Study|Adverse Event|0|||
145406147|NCT02332707|524343716|FG000|Overall Study|Lost to Follow-up|0|||
145555098|NCT02956486|524890450|FG002|Core Phase|Inadequate therapeutic effect|0|||
145555099|NCT02956486|524890448|FG000|Core Phase|Withdrawal by Subject|101|||
145555100|NCT02956486|524890449|FG001|Core Phase|Withdrawal by Subject|104|||
145555101|NCT02956486|524890450|FG002|Core Phase|Withdrawal by Subject|0|||
145555102|NCT02956486|524890448|FG000|Core Phase|Study terminated by sponsor|888|||
145555103|NCT02956486|524890449|FG001|Core Phase|Study terminated by sponsor|848|||
145555104|NCT02956486|524890450|FG002|Core Phase|Study terminated by sponsor|0|||
145555105|NCT02956486|524890448|FG000|Core Phase|Other|27|||
145555106|NCT02956486|524890449|FG001|Core Phase|Other|18|||
145555107|NCT02956486|524890450|FG002|Core Phase|Other|0|||
145555108|NCT02956486|524890448|FG000|Core Phase|Not treated|0|||
145555109|NCT02956486|524890449|FG001|Core Phase|Not treated|3|||
145555110|NCT02956486|524890450|FG002|Core Phase|Not treated|0|||
145612312|NCT00708305|525095689|FG000|Period 3|Other Reason|1|||
145284971|NCT02884206|523893094|FG001|Valsartan Run-in Period|Physician Decision|0|||
145284972|NCT02884206|523893095|FG002|Valsartan Run-in Period|Physician Decision|0|||
145284973|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Adverse Event|38|||
145284974|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Adverse Event|0|||
145284975|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Adverse Event|0|||
145284976|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Death|2|||
145284977|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Death|0|||
145284978|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Death|0|||
145284979|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
145284980|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
145284981|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
145284982|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
145284983|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
145555111|NCT02956486|524890448|FG000|Extension Phase|Adverse Event|0|||
145555112|NCT02956486|524890449|FG001|Extension Phase|Adverse Event|0|||
145555113|NCT02956486|524890450|FG002|Extension Phase|Adverse Event|2|||
145612313|NCT00708305|525095690|FG001|Period 3|Other Reason|0|||
145612314|NCT00708305|525095691|FG002|Period 3|Other Reason|0|||
145612315|NCT00708305|525095692|FG003|Period 3|Other Reason|0|||
145612316|NCT00734214|525095696|FG000|Overall Study|Withdrawal by Subject|3|||
145612317|NCT00734214|525095697|FG001|Overall Study|Withdrawal by Subject|4|||
145612318|NCT00734214|525095696|FG000|Overall Study|MD withdrawal|1|||
145612319|NCT00734214|525095697|FG001|Overall Study|MD withdrawal|0|||
145612320|NCT00550550|525095698|FG000|Overall Study|Adverse Event|13|||
145612321|NCT00550550|525095699|FG001|Overall Study|Adverse Event|5|||
145612322|NCT00550550|525095698|FG000|Overall Study|Treatment Failure|0|||
145612323|NCT00550550|525095699|FG001|Overall Study|Treatment Failure|1|||
145612324|NCT00550550|525095698|FG000|Overall Study|Lost to Follow-up|4|||
145612325|NCT00550550|525095699|FG001|Overall Study|Lost to Follow-up|0|||
145612326|NCT00550550|525095698|FG000|Overall Study|Withdrawal by Subject|10|||
145612327|NCT00550550|525095699|FG001|Overall Study|Withdrawal by Subject|8|||
145612328|NCT00550550|525095698|FG000|Overall Study|Protocol Violation|5|||
145612329|NCT00550550|525095699|FG001|Overall Study|Protocol Violation|14|||
145612330|NCT00550550|525095698|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
145612331|NCT00550550|525095699|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
145406148|NCT02332707|524343717|FG001|Overall Study|Lost to Follow-up|0|||
145612332|NCT00550550|525095698|FG000|Overall Study|Randomized But Not Treated|1|||
145612333|NCT00550550|525095699|FG001|Overall Study|Randomized But Not Treated|0|||
145612334|NCT03311230|525095703|FG000|Overall Study|Withdrawal by Subject|1|||
145555114|NCT02956486|524890448|FG000|Extension Phase|Study terminated by sponsor|0|||
145555115|NCT02956486|524890449|FG001|Extension Phase|Study terminated by sponsor|0|||
145555116|NCT02956486|524890450|FG002|Extension Phase|Study terminated by sponsor|16|||
145555117|NCT02956486|524890448|FG000|Extension Phase|Not Treated|0|||
145555118|NCT02956486|524890449|FG001|Extension Phase|Not Treated|0|||
145555119|NCT02956486|524890450|FG002|Extension Phase|Not Treated|1|||
145555120|NCT00422591|524890453|FG000|Overall Study|Physician Decision|4|||
145284984|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
145284985|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
145284986|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
145284987|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
145284988|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Physician Decision|1|||
145284989|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Physician Decision|0|||
145284990|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Physician Decision|0|||
145284991|NCT02884206|523893093|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
145284992|NCT02884206|523893094|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
145284993|NCT02884206|523893095|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
145284994|NCT02884206|523893093|FG000|Double-Blind Period|Death|0|||
145284995|NCT02884206|523893094|FG001|Double-Blind Period|Death|28|||
145406149|NCT02332707|524343718|FG002|Overall Study|Lost to Follow-up|0|||
145406150|NCT02332707|524343719|FG003|Overall Study|Lost to Follow-up|0|||
145406151|NCT02332707|524343720|FG004|Overall Study|Lost to Follow-up|0|||
145555121|NCT00422591|524890453|FG000|Overall Study|Withdrawal by Subject|2|||
145406152|NCT02332707|524343721|FG005|Overall Study|Lost to Follow-up|1|||
145406153|NCT02332707|524343722|FG006|Overall Study|Lost to Follow-up|0|||
145555122|NCT02377466|524890454|FG000|Overall Study|Other: Randomized and not treated|0|||
145555123|NCT02377466|524890455|FG001|Overall Study|Other: Randomized and not treated|2|||
145555124|NCT04210310|524890456|FG000|Overall Study|Lost to Follow-up|32|||
145284996|NCT02884206|523893095|FG002|Double-Blind Period|Death|39|||
145284997|NCT02884206|523893093|FG000|Double-Blind Period|Patient/guardian decision|0|||
145284998|NCT02884206|523893094|FG001|Double-Blind Period|Patient/guardian decision|10|||
145284999|NCT02884206|523893095|FG002|Double-Blind Period|Patient/guardian decision|13|||
145285000|NCT02884206|523893093|FG000|Double-Blind Period|Lost to Follow-up|0|||
145285001|NCT02884206|523893094|FG001|Double-Blind Period|Lost to Follow-up|4|||
145285002|NCT02884206|523893095|FG002|Double-Blind Period|Lost to Follow-up|4|||
145285003|NCT02884206|523893093|FG000|Double-Blind Period|Physician Decision|0|||
145285004|NCT02884206|523893094|FG001|Double-Blind Period|Physician Decision|2|||
145285005|NCT02884206|523893095|FG002|Double-Blind Period|Physician Decision|0|||
145285006|NCT02884206|523893093|FG000|Double-Blind Period|Adverse Event|0|||
145555125|NCT04210310|524890457|FG001|Overall Study|Lost to Follow-up|1|||
145555126|NCT00330616|524890458|FG000|Overall Study|Adverse Event|13|||
145555127|NCT00330616|524890458|FG000|Overall Study|Lack of Efficacy|1|||
145555128|NCT00330616|524890458|FG000|Overall Study|Lost to Follow-up|2|||
145555129|NCT00330616|524890458|FG000|Overall Study|Withdrawal by Subject|4|||
145555130|NCT00330616|524890458|FG000|Overall Study|Other|1|||
145612335|NCT03311230|525095704|FG001|Overall Study|Withdrawal by Subject|4|||
145555131|NCT01585194|524890461|FG000|Overall Study|Withdrawal by Subject|1|||
145555132|NCT01585194|524890461|FG000|Overall Study|Physician Decision|2|||
145612336|NCT03311230|525095705|FG002|Overall Study|Withdrawal by Subject|2|||
145612337|NCT03311230|525095706|FG003|Overall Study|Withdrawal by Subject|7|||
145612338|NCT03311230|525095703|FG000|Overall Study|Unrelated injury|0|||
145612339|NCT03311230|525095704|FG001|Overall Study|Unrelated injury|1|||
145612340|NCT03311230|525095705|FG002|Overall Study|Unrelated injury|0|||
145612341|NCT03311230|525095706|FG003|Overall Study|Unrelated injury|0|||
145612342|NCT01302938|525095707|FG000|Overall Study|Withdrawal by Subject|1|||
145612343|NCT01302938|525095708|FG001|Overall Study|Withdrawal by Subject|0|||
145612344|NCT01302938|525095707|FG000|Overall Study|Adverse Event|1|||
145612345|NCT01302938|525095708|FG001|Overall Study|Adverse Event|0|||
145612346|NCT00171873|525095709|FG000|Overall Study|Withdrawal by Subject|4|||
145612347|NCT00171873|525095710|FG001|Overall Study|Withdrawal by Subject|2|||
145612348|NCT00171873|525095709|FG000|Overall Study|Adverse Event|5|||
145612349|NCT00171873|525095710|FG001|Overall Study|Adverse Event|0|||
145612350|NCT00171873|525095709|FG000|Overall Study|Switched to Octreotide|0|||
145612351|NCT00171873|525095710|FG001|Overall Study|Switched to Octreotide|1|||
145612352|NCT01518946|525095727|FG000|Open-label Phase|Other|4|||
145612353|NCT01518946|525095728|FG001|Open-label Phase|Other|0|||
145612354|NCT01518946|525095729|FG002|Open-label Phase|Other|0|||
145612355|NCT01518946|525095727|FG000|Randomized Phase (First Intervention)|Other|0|||
145612356|NCT01518946|525095728|FG001|Randomized Phase (First Intervention)|Other|1|||
145612357|NCT01518946|525095729|FG002|Randomized Phase (First Intervention)|Other|0|||
145612358|NCT03857841|525095730|FG000|Overall Study|Death|1|||
145612359|NCT03857841|525095731|FG001|Overall Study|Death|0|||
145612360|NCT03857841|525095732|FG002|Overall Study|Death|0|||
145612361|NCT03857841|525095733|FG003|Overall Study|Death|0|||
145612362|NCT03857841|525095730|FG000|Overall Study|Study Terminated by Sponsor|1|||
145612363|NCT03857841|525095731|FG001|Overall Study|Study Terminated by Sponsor|0|||
145612364|NCT03857841|525095732|FG002|Overall Study|Study Terminated by Sponsor|0|||
145612365|NCT03857841|525095733|FG003|Overall Study|Study Terminated by Sponsor|0|||
145612366|NCT00384059|525095734|FG000|Infant Series|Not consented|2|||
145612367|NCT00384059|525095735|FG001|Infant Series|Not consented|6|||
145612368|NCT00384059|525095734|FG000|Infant Series|Withdrawal by Subject|2|||
145612369|NCT00384059|525095735|FG001|Infant Series|Withdrawal by Subject|2|||
145612370|NCT00384059|525095734|FG000|Infant Series|Adverse Event|1|||
145612371|NCT00384059|525095735|FG001|Infant Series|Adverse Event|2|||
145612372|NCT00384059|525095734|FG000|Infant Series|Protocol Violation|1|||
145612373|NCT00384059|525095735|FG001|Infant Series|Protocol Violation|2|||
145612374|NCT00384059|525095734|FG000|Infant Series|Lost to Follow-up|0|||
145612375|NCT00384059|525095735|FG001|Infant Series|Lost to Follow-up|1|||
145612376|NCT00384059|525095734|FG000|After Infant Series|Protocol Violation|2|||
145612377|NCT00384059|525095735|FG001|After Infant Series|Protocol Violation|3|||
145555133|NCT01585194|524890461|FG000|Overall Study|Lack of insurance|1|||
145555134|NCT02642042|524890462|FG000|Overall Study|Adverse Event|22|||
145555135|NCT02642042|524890462|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145555136|NCT02642042|524890462|FG000|Overall Study|Progression/Relapse|28|||
145555137|NCT02642042|524890462|FG000|Overall Study|Death|1|||
145555138|NCT02642042|524890462|FG000|Overall Study|Not Protocol Specified|2|||
145555139|NCT01187043|524890464|FG000|Overall Study|Adverse Event|0|||
145555140|NCT01187043|524890465|FG001|Overall Study|Adverse Event|0|||
145555141|NCT01187043|524890466|FG002|Overall Study|Adverse Event|0|||
145555142|NCT01187043|524890467|FG003|Overall Study|Adverse Event|0|||
145555143|NCT01187043|524890468|FG004|Overall Study|Adverse Event|1|||
145555144|NCT01187043|524890464|FG000|Overall Study|Unable to make scheduled visits|1|||
145555145|NCT01187043|524890465|FG001|Overall Study|Unable to make scheduled visits|0|||
145612378|NCT00384059|525095734|FG000|After Infant Series|Withdrawal by Subject|2|||
145612379|NCT00384059|525095735|FG001|After Infant Series|Withdrawal by Subject|2|||
145555146|NCT01187043|524890466|FG002|Overall Study|Unable to make scheduled visits|4|||
145285007|NCT02884206|523893094|FG001|Double-Blind Period|Adverse Event|0|||
145285008|NCT02884206|523893095|FG002|Double-Blind Period|Adverse Event|3|||
145285009|NCT02884206|523893093|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
145285010|NCT02884206|523893094|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
145285011|NCT02884206|523893095|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
145285012|NCT03907280|523893096|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
145285013|NCT03907280|523893097|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
145285014|NCT03907280|523893098|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
145285015|NCT02231710|523893099|FG000|Overall Study|Physician Decision|1|||
145285016|NCT01399723|523893100|FG000|Overall Study|Lost to Follow-up|0|||
145285017|NCT01399723|523893101|FG001|Overall Study|Lost to Follow-up|1|||
145285018|NCT00124020|523893102|FG000|Overall Study|Death|67|||
145285019|NCT00124020|523893103|FG001|Overall Study|Death|71|||
145285020|NCT00124020|523893102|FG000|Overall Study|Withdrawal by Subject|13|||
145285021|NCT00124020|523893103|FG001|Overall Study|Withdrawal by Subject|11|||
145285022|NCT00124020|523893102|FG000|Overall Study|Lost to Follow-up|5|||
145285023|NCT00124020|523893103|FG001|Overall Study|Lost to Follow-up|8|||
145285024|NCT00124020|523893102|FG000|Overall Study|Other|1|||
145406154|NCT02332707|524343723|FG007|Overall Study|Lost to Follow-up|0|||
145406155|NCT02332707|524343724|FG008|Overall Study|Lost to Follow-up|0|||
145612380|NCT00384059|525095734|FG000|After Infant Series|Failed to Return|0|||
145612381|NCT00384059|525095735|FG001|After Infant Series|Failed to Return|2|||
145612382|NCT00384059|525095734|FG000|After Infant Series|Adverse Event|0|||
145612383|NCT00384059|525095735|FG001|After Infant Series|Adverse Event|1|||
145612384|NCT00384059|525095734|FG000|After Infant Series|Physician Decision|0|||
145612385|NCT00384059|525095735|FG001|After Infant Series|Physician Decision|1|||
145612386|NCT00384059|525095734|FG000|After Infant Series|Lost to Follow-up|0|||
145612387|NCT00384059|525095735|FG001|After Infant Series|Lost to Follow-up|1|||
145612388|NCT00384059|525095734|FG000|Toddler Dose|Lost to Follow-up|1|||
145612389|NCT00384059|525095735|FG001|Toddler Dose|Lost to Follow-up|1|||
145612390|NCT00384059|525095734|FG000|Toddler Dose|Failed to return|0|||
145612391|NCT00384059|525095735|FG001|Toddler Dose|Failed to return|1|||
145612392|NCT00381641|525095736|FG000|Overall Study|Withdrawal by Subject|0|||
145612393|NCT00381641|525095737|FG001|Overall Study|Withdrawal by Subject|2|||
145285025|NCT00124020|523893103|FG001|Overall Study|Other|1|||
145285026|NCT00124020|523893102|FG000|Overall Study|Transfer to another hospital|2|||
145612394|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
145406156|NCT02332707|524343725|FG009|Overall Study|Lost to Follow-up|0|||
145612395|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
145612396|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
145406157|NCT02332707|524343726|FG010|Overall Study|Lost to Follow-up|2|||
145406158|NCT02332707|524343727|FG011|Overall Study|Lost to Follow-up|0|||
145612397|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
145612398|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
145612399|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
145612400|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
145612401|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
145612402|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612403|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612404|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612405|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612406|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612407|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145612408|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
145612409|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
145612410|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
145612411|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145612412|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145612413|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145612414|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145612415|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
145612416|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
145612417|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
145612418|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
145612419|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
145612420|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
145612421|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
145612422|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612423|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612424|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
145612425|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612426|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612427|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612428|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
145612429|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
145612430|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
145612431|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
145612432|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145612433|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145612434|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145612435|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145612436|NCT04921969|525095738|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
145612437|NCT04921969|525095739|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
145612438|NCT04921969|525095740|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
145612439|NCT04921969|525095741|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
145612440|NCT04921969|525095742|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
145612441|NCT04921969|525095743|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
145612442|NCT04921969|525095744|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
145612443|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612444|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612445|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612446|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612447|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612448|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
145612449|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
145612450|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145285027|NCT00124020|523893103|FG001|Overall Study|Transfer to another hospital|0|||
145285028|NCT04604184|523893107|FG000|Overall Study|Adverse Event|5|||
145555147|NCT01187043|524890467|FG003|Overall Study|Unable to make scheduled visits|0|||
145555148|NCT01187043|524890468|FG004|Overall Study|Unable to make scheduled visits|1|||
145555149|NCT04903626|524890469|FG000|Overall Study|Lost to Follow-up|6|||
145555150|NCT04903626|524890469|FG000|Overall Study|Withdrawal by Subject|1|||
145555151|NCT04903626|524890469|FG000|Overall Study|Other, Not Specified|1|||
145555152|NCT00573534|524890470|FG000|Overall Study|oppositional behavior|3|||
145555153|NCT00927784|524890473|FG000|Overall Study|Death|1|||
145555154|NCT00927784|524890474|FG001|Overall Study|Death|0|||
145555155|NCT00927784|524890473|FG000|Overall Study|Withdrawal by Subject|1|||
145555156|NCT00927784|524890474|FG001|Overall Study|Withdrawal by Subject|0|||
145555157|NCT02457910|524890475|FG000|Overall Study|Withdrawal by Subject|0|||
145555158|NCT02457910|524890476|FG001|Overall Study|Withdrawal by Subject|0|||
145555159|NCT02457910|524890477|FG002|Overall Study|Withdrawal by Subject|0|||
145555160|NCT02457910|524890478|FG003|Overall Study|Withdrawal by Subject|0|||
145555161|NCT02457910|524890479|FG004|Overall Study|Withdrawal by Subject|0|||
145555162|NCT02457910|524890480|FG005|Overall Study|Withdrawal by Subject|1|||
145555163|NCT02457910|524890475|FG000|Overall Study|Adverse Event|0|||
145555164|NCT02457910|524890476|FG001|Overall Study|Adverse Event|2|||
145555165|NCT02457910|524890477|FG002|Overall Study|Adverse Event|1|||
145555166|NCT02457910|524890478|FG003|Overall Study|Adverse Event|1|||
145555167|NCT02457910|524890479|FG004|Overall Study|Adverse Event|1|||
145555168|NCT02457910|524890480|FG005|Overall Study|Adverse Event|3|||
145555169|NCT02457910|524890475|FG000|Overall Study|Disease progression|3|||
145285029|NCT04604184|523893108|FG001|Overall Study|Adverse Event|5|||
145285030|NCT04604184|523893107|FG000|Overall Study|Death|2|||
145285031|NCT04604184|523893108|FG001|Overall Study|Death|1|||
145285032|NCT04604184|523893107|FG000|Overall Study|Withdrawal by Subject|1|||
145285033|NCT04604184|523893108|FG001|Overall Study|Withdrawal by Subject|3|||
145285034|NCT04604184|523893107|FG000|Overall Study|Not treated|2|||
145285035|NCT04604184|523893108|FG001|Overall Study|Not treated|2|||
145555170|NCT02457910|524890476|FG001|Overall Study|Disease progression|3|||
145285036|NCT04604184|523893107|FG000|Overall Study|Due to sponsor decision|9|||
145285037|NCT04604184|523893108|FG001|Overall Study|Due to sponsor decision|7|||
145285038|NCT04604184|523893107|FG000|Overall Study|Physician Decision|0|||
145555171|NCT02457910|524890477|FG002|Overall Study|Disease progression|1|||
145555172|NCT02457910|524890478|FG003|Overall Study|Disease progression|1|||
145555173|NCT02457910|524890479|FG004|Overall Study|Disease progression|4|||
145555174|NCT02457910|524890480|FG005|Overall Study|Disease progression|6|||
145555175|NCT02457910|524890475|FG000|Overall Study|Other complicating illness|0|||
145612451|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145612452|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145612453|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
145612454|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145612455|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
145612456|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
145612457|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145555176|NCT02457910|524890476|FG001|Overall Study|Other complicating illness|0|||
145555177|NCT02457910|524890477|FG002|Overall Study|Other complicating illness|0|||
145555178|NCT02457910|524890478|FG003|Overall Study|Other complicating illness|0|||
145555179|NCT02457910|524890479|FG004|Overall Study|Other complicating illness|0|||
145555180|NCT02457910|524890480|FG005|Overall Study|Other complicating illness|1|||
145555181|NCT02457910|524890475|FG000|Overall Study|Death|0|||
145555182|NCT02457910|524890476|FG001|Overall Study|Death|0|||
145555183|NCT02457910|524890477|FG002|Overall Study|Death|1|||
145555184|NCT02457910|524890478|FG003|Overall Study|Death|0|||
145555185|NCT02457910|524890479|FG004|Overall Study|Death|0|||
145555186|NCT02457910|524890480|FG005|Overall Study|Death|0|||
145555187|NCT00467259|524890481|FG000|Overall Study|Adverse Event|24|||
145555188|NCT00467259|524890482|FG001|Overall Study|Adverse Event|90|||
145555189|NCT00467259|524890481|FG000|Overall Study|Protocol Violation|1|||
145555190|NCT00467259|524890482|FG001|Overall Study|Protocol Violation|7|||
145555191|NCT00467259|524890481|FG000|Overall Study|Withdrawal by Subject|34|||
145555192|NCT00467259|524890482|FG001|Overall Study|Withdrawal by Subject|108|||
145555193|NCT00467259|524890481|FG000|Overall Study|Physician Decision|0|||
145555194|NCT00467259|524890482|FG001|Overall Study|Physician Decision|2|||
145555195|NCT00467259|524890481|FG000|Overall Study|Lost to Follow-up|14|||
145555196|NCT00467259|524890482|FG001|Overall Study|Lost to Follow-up|34|||
145555197|NCT00467259|524890481|FG000|Overall Study|Site Closed|2|||
145555198|NCT00467259|524890482|FG001|Overall Study|Site Closed|1|||
145555199|NCT01405742|524890483|FG000|Overall Study|Lost to Follow-up|1|||
145555200|NCT01405742|524890484|FG001|Overall Study|Lost to Follow-up|0|||
145555201|NCT02196558|524890486|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
145555202|NCT02196558|524890487|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
145555203|NCT02196558|524890488|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
145555204|NCT02196558|524890486|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
145555205|NCT02196558|524890487|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
145555206|NCT02196558|524890488|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
145555207|NCT02196558|524890486|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
145555208|NCT02196558|524890487|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
145555209|NCT02196558|524890488|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
145555210|NCT02196558|524890486|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
145555211|NCT02196558|524890487|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
145555212|NCT02196558|524890488|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
145555213|NCT02196558|524890486|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
145555214|NCT02196558|524890487|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
145555215|NCT02196558|524890488|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
145555216|NCT02107482|524890489|FG000|Overall Study|inconveinence|2|||
145555217|NCT02107482|524890489|FG000|Overall Study|Lost to Follow-up|1|||
145555218|NCT02107482|524890489|FG000|Overall Study|Lack of Efficacy|1|||
145555219|NCT03128892|524890492|FG000|Overall Study|Withdrawal by Subject|2|||
145555220|NCT03128892|524890492|FG000|Overall Study|Physician Decision|1|||
145555221|NCT01850524|524890493|FG000|Overall Study|Lost to Follow-up|5|||
145555222|NCT01850524|524890494|FG001|Overall Study|Lost to Follow-up|10|||
145555223|NCT01850524|524890493|FG000|Overall Study|Withdrawal by Subject|24|||
145555224|NCT01850524|524890494|FG001|Overall Study|Withdrawal by Subject|22|||
145555225|NCT01850524|524890493|FG000|Overall Study|Reason not Specified|142|||
145555226|NCT01850524|524890494|FG001|Overall Study|Reason not Specified|141|||
145555227|NCT01846611|524890504|FG000|Overall Study|Lost to Follow-up|4|||
145555228|NCT01846611|524890505|FG001|Overall Study|Lost to Follow-up|6|||
145555229|NCT01846611|524890504|FG000|Overall Study|Withdrawal by Subject|15|||
145555230|NCT01846611|524890505|FG001|Overall Study|Withdrawal by Subject|19|||
145555231|NCT01846611|524890504|FG000|Overall Study|Other|19|||
145555232|NCT01846611|524890505|FG001|Overall Study|Other|18|||
145406159|NCT02332707|524343728|FG012|Overall Study|Lost to Follow-up|3|||
145406160|NCT02332707|524343729|FG013|Overall Study|Lost to Follow-up|0|||
145406161|NCT02332707|524343730|FG014|Overall Study|Lost to Follow-up|0|||
145406162|NCT02332707|524343731|FG015|Overall Study|Lost to Follow-up|0|||
145406163|NCT02332707|524343732|FG016|Overall Study|Lost to Follow-up|0|||
145406164|NCT02332707|524343733|FG017|Overall Study|Lost to Follow-up|0|||
145555233|NCT00680043|524890506|FG000|Overall Study|Withdrawal by Subject|1|||
145406165|NCT02332707|524343716|FG000|Overall Study|Physician Decision|0|||
145406166|NCT02332707|524343717|FG001|Overall Study|Physician Decision|0|||
145285039|NCT04604184|523893108|FG001|Overall Study|Physician Decision|1|||
145555234|NCT00680043|524890507|FG001|Overall Study|Withdrawal by Subject|0|||
145555235|NCT00680043|524890508|FG002|Overall Study|Withdrawal by Subject|0|||
145555236|NCT00680043|524890506|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
145555237|NCT00680043|524890507|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
145555238|NCT00680043|524890508|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
145555239|NCT00680043|524890506|FG000|Overall Study|Renal Transplant|1|||
145555240|NCT00680043|524890507|FG001|Overall Study|Renal Transplant|0|||
145555241|NCT00680043|524890508|FG002|Overall Study|Renal Transplant|4|||
145555242|NCT01686633|524890509|FG000|Overall Study|Lack of Efficacy|33|||
145555243|NCT01686633|524890510|FG001|Overall Study|Lack of Efficacy|13|||
145555244|NCT01686633|524890511|FG002|Overall Study|Lack of Efficacy|11|||
145555245|NCT01686633|524890509|FG000|Overall Study|Withdrawal by Subject|8|||
145555246|NCT01686633|524890510|FG001|Overall Study|Withdrawal by Subject|8|||
145555247|NCT01686633|524890511|FG002|Overall Study|Withdrawal by Subject|5|||
145555248|NCT01686633|524890509|FG000|Overall Study|Physician Decision|3|||
145555249|NCT01686633|524890510|FG001|Overall Study|Physician Decision|4|||
145555250|NCT01686633|524890511|FG002|Overall Study|Physician Decision|4|||
145555251|NCT01686633|524890509|FG000|Overall Study|Adverse Event|4|||
145555252|NCT01686633|524890510|FG001|Overall Study|Adverse Event|3|||
145555253|NCT01686633|524890511|FG002|Overall Study|Adverse Event|3|||
145555254|NCT01686633|524890509|FG000|Overall Study|Protocol Violation|2|||
145555255|NCT01686633|524890510|FG001|Overall Study|Protocol Violation|3|||
145555256|NCT01686633|524890511|FG002|Overall Study|Protocol Violation|0|||
145555257|NCT01686633|524890509|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
145555258|NCT01686633|524890510|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
145555259|NCT01686633|524890511|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
145555260|NCT01686633|524890509|FG000|Overall Study|Lost to Follow-up|0|||
145555261|NCT01686633|524890510|FG001|Overall Study|Lost to Follow-up|1|||
145555262|NCT01686633|524890511|FG002|Overall Study|Lost to Follow-up|1|||
145555263|NCT02839707|524890516|FG000|Phase I|Not eligible for analysis|9|||
145555264|NCT02839707|524890517|FG001|Phase I|Not eligible for analysis|0|||
145555265|NCT02839707|524890518|FG002|Phase I|Not eligible for analysis|0|||
145555266|NCT02839707|524890516|FG000|Phase II|Not treated according to protocol|4|||
145555267|NCT02839707|524890517|FG001|Phase II|Not treated according to protocol|0|||
145555268|NCT02839707|524890518|FG002|Phase II|Not treated according to protocol|2|||
145612458|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145612459|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145612460|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
145612461|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
145612462|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
145612463|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
145612464|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
145285040|NCT04604184|523893107|FG000|Overall Study|Transfer to healthcare|1|||
145285041|NCT04604184|523893108|FG001|Overall Study|Transfer to healthcare|0|||
145285042|NCT01977092|523893109|FG000|Overall Study|Death|3|||
145612465|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
145612466|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
145612467|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
145612468|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
145612469|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
145612470|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
145612471|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145612472|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145612473|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145612474|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
145612475|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
145612476|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
145612477|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
145612478|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
145612479|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
145612480|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
145612481|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
145612482|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
145612483|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
145612484|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
145612485|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
145555269|NCT02839707|524890516|FG000|Phase III|Not treated according to protocol|0|||
145555270|NCT02839707|524890517|FG001|Phase III|Not treated according to protocol|0|||
145555271|NCT02839707|524890518|FG002|Phase III|Not treated according to protocol|4|||
145406167|NCT02332707|524343718|FG002|Overall Study|Physician Decision|0|||
145406168|NCT02332707|524343719|FG003|Overall Study|Physician Decision|1|||
145406169|NCT02332707|524343720|FG004|Overall Study|Physician Decision|0|||
145406170|NCT02332707|524343721|FG005|Overall Study|Physician Decision|0|||
145406171|NCT02332707|524343722|FG006|Overall Study|Physician Decision|0|||
145406172|NCT02332707|524343723|FG007|Overall Study|Physician Decision|0|||
145406173|NCT02332707|524343724|FG008|Overall Study|Physician Decision|0|||
145555272|NCT02890355|524890519|FG000|Overall Study|Adverse Event|5|||
145555273|NCT02890355|524890520|FG001|Overall Study|Adverse Event|5|||
145555274|NCT02890355|524890519|FG000|Overall Study|Refusal unrelated to adverse event|5|||
145555275|NCT02890355|524890520|FG001|Overall Study|Refusal unrelated to adverse event|10|||
145285043|NCT01977092|523893110|FG001|Overall Study|Death|4|||
145555276|NCT02890355|524890519|FG000|Overall Study|Progression/relapse|46|||
145555277|NCT02890355|524890520|FG001|Overall Study|Progression/relapse|39|||
145555278|NCT02890355|524890519|FG000|Overall Study|Not protocol specified|3|||
145555279|NCT02890355|524890520|FG001|Overall Study|Not protocol specified|4|||
145285044|NCT01977092|523893109|FG000|Overall Study|Lost to Follow-up|23|||
145285045|NCT01977092|523893110|FG001|Overall Study|Lost to Follow-up|14|||
145285046|NCT01977092|523893109|FG000|Overall Study|Withdrawal by Subject|2|||
145285047|NCT01977092|523893110|FG001|Overall Study|Withdrawal by Subject|1|||
145285048|NCT01977092|523893109|FG000|Overall Study|In prison|3|||
145285049|NCT01977092|523893110|FG001|Overall Study|In prison|11|||
145285050|NCT00678392|523893111|FG000|Overall Study|Adverse Event|0|||
145285051|NCT00678392|523893112|FG001|Overall Study|Adverse Event|6|||
145285052|NCT00678392|523893111|FG000|Overall Study|Death|280|||
145555280|NCT02636868|524892472|FG000|Overall Study|Death|0|||
145555281|NCT02636868|524892473|FG001|Overall Study|Death|1|||
145555282|NCT02636868|524892474|FG002|Overall Study|Death|2|||
145555283|NCT03220217|524892475|FG000|Overall Study|Withdrawal by Subject|0|||
145285053|NCT00678392|523893112|FG001|Overall Study|Death|269|||
145406174|NCT02332707|524343725|FG009|Overall Study|Physician Decision|0|||
145406175|NCT02332707|524343726|FG010|Overall Study|Physician Decision|0|||
145555284|NCT03220217|524892476|FG001|Overall Study|Withdrawal by Subject|1|||
145555285|NCT03220217|524892477|FG002|Overall Study|Withdrawal by Subject|0|||
145555286|NCT03220217|524892475|FG000|Overall Study|Subject Missed Procedure|0|||
145285054|NCT00678392|523893111|FG000|Overall Study|Lost to Follow-up|15|||
145285055|NCT00678392|523893112|FG001|Overall Study|Lost to Follow-up|13|||
145285056|NCT00678392|523893111|FG000|Overall Study|Objective Progression or Relapse|3|||
145285057|NCT00678392|523893112|FG001|Overall Study|Objective Progression or Relapse|8|||
145285058|NCT00678392|523893111|FG000|Overall Study|Sponsor's Decision|1|||
145285059|NCT00678392|523893112|FG001|Overall Study|Sponsor's Decision|2|||
145285060|NCT00678392|523893111|FG000|Overall Study|Withdrawal by Subject|4|||
145285061|NCT00678392|523893112|FG001|Overall Study|Withdrawal by Subject|4|||
145285062|NCT00678392|523893111|FG000|Overall Study|Randomized But Not Treated|2|||
145285063|NCT00678392|523893112|FG001|Overall Study|Randomized But Not Treated|7|||
145285064|NCT00678392|523893111|FG000|Overall Study|Other|56|||
145285065|NCT00678392|523893112|FG001|Overall Study|Other|53|||
145285066|NCT01958281|523893113|FG000|Overall Study|Lack of Efficacy|5|||
145285067|NCT01958281|523893114|FG001|Overall Study|Lack of Efficacy|2|||
145285068|NCT01958281|523893115|FG002|Overall Study|Lack of Efficacy|0|||
145285069|NCT01958281|523893113|FG000|Overall Study|Adverse Event|0|||
145285070|NCT01958281|523893114|FG001|Overall Study|Adverse Event|2|||
145285071|NCT01958281|523893115|FG002|Overall Study|Adverse Event|0|||
145285072|NCT01958281|523893113|FG000|Overall Study|Withdrew Consent|1|||
145285073|NCT01958281|523893114|FG001|Overall Study|Withdrew Consent|0|||
145285074|NCT01958281|523893115|FG002|Overall Study|Withdrew Consent|0|||
145285075|NCT02927847|523893118|FG000|Overall Study|Lost to Follow-up|1|||
145285076|NCT02927847|523893119|FG001|Overall Study|Lost to Follow-up|0|||
145285077|NCT02927847|523893118|FG000|Overall Study|Withdrawal by Subject|4|||
145285078|NCT02927847|523893119|FG001|Overall Study|Withdrawal by Subject|2|||
145285079|NCT02927847|523893118|FG000|Overall Study|PI withdrawn due to missed visits|1|||
145285080|NCT02927847|523893119|FG001|Overall Study|PI withdrawn due to missed visits|1|||
145285081|NCT01418352|523893122|FG000|Overall Study|Lost to Follow-up|2|||
145285082|NCT01418352|523893123|FG001|Overall Study|Lost to Follow-up|0|||
145285083|NCT01418352|523893124|FG002|Overall Study|Lost to Follow-up|0|||
145285084|NCT01418352|523893125|FG003|Overall Study|Lost to Follow-up|0|||
145285085|NCT01418352|523893122|FG000|Overall Study|Adverse Event|0|||
145285086|NCT01418352|523893123|FG001|Overall Study|Adverse Event|1|||
145285087|NCT01418352|523893124|FG002|Overall Study|Adverse Event|0|||
145285088|NCT01418352|523893125|FG003|Overall Study|Adverse Event|0|||
145285089|NCT01418352|523893122|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
145285090|NCT01418352|523893123|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
145285091|NCT01418352|523893124|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
145285092|NCT01418352|523893125|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
145406176|NCT02332707|524343727|FG011|Overall Study|Physician Decision|0|||
145406177|NCT02332707|524343728|FG012|Overall Study|Physician Decision|1|||
145285093|NCT01418352|523893122|FG000|Overall Study|Subject Withdrew Consent|0|||
145285094|NCT01418352|523893123|FG001|Overall Study|Subject Withdrew Consent|1|||
145285095|NCT01418352|523893124|FG002|Overall Study|Subject Withdrew Consent|2|||
145285096|NCT01418352|523893125|FG003|Overall Study|Subject Withdrew Consent|1|||
145406178|NCT02332707|524343729|FG013|Overall Study|Physician Decision|0|||
145406179|NCT02332707|524343730|FG014|Overall Study|Physician Decision|0|||
145406180|NCT02332707|524343731|FG015|Overall Study|Physician Decision|0|||
145406181|NCT02332707|524343732|FG016|Overall Study|Physician Decision|0|||
145406182|NCT02332707|524343733|FG017|Overall Study|Physician Decision|0|||
145406183|NCT02332707|524343716|FG000|Overall Study|Withdrawal by Subject|0|||
145406184|NCT02332707|524343717|FG001|Overall Study|Withdrawal by Subject|0|||
145406185|NCT02332707|524343718|FG002|Overall Study|Withdrawal by Subject|1|||
145406186|NCT02332707|524343719|FG003|Overall Study|Withdrawal by Subject|0|||
145406187|NCT02332707|524343720|FG004|Overall Study|Withdrawal by Subject|0|||
145612486|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
145406188|NCT02332707|524343721|FG005|Overall Study|Withdrawal by Subject|0|||
145406189|NCT02332707|524343722|FG006|Overall Study|Withdrawal by Subject|0|||
145406190|NCT02332707|524343723|FG007|Overall Study|Withdrawal by Subject|0|||
145406191|NCT02332707|524343724|FG008|Overall Study|Withdrawal by Subject|0|||
145406192|NCT02332707|524343725|FG009|Overall Study|Withdrawal by Subject|3|||
145406193|NCT02332707|524343726|FG010|Overall Study|Withdrawal by Subject|0|||
145612487|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
145612488|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
145612489|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
145612490|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
145612491|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
145612492|NCT04921969|525095738|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
145285097|NCT01418352|523893122|FG000|Overall Study|Protocol Deviation|0|||
145406194|NCT02332707|524343727|FG011|Overall Study|Withdrawal by Subject|0|||
145406195|NCT02332707|524343728|FG012|Overall Study|Withdrawal by Subject|0|||
145406196|NCT02332707|524343729|FG013|Overall Study|Withdrawal by Subject|0|||
145406197|NCT02332707|524343730|FG014|Overall Study|Withdrawal by Subject|0|||
145406198|NCT02332707|524343731|FG015|Overall Study|Withdrawal by Subject|0|||
145406199|NCT02332707|524343732|FG016|Overall Study|Withdrawal by Subject|0|||
145406200|NCT02332707|524343733|FG017|Overall Study|Withdrawal by Subject|0|||
145406201|NCT01473134|524343734|FG000|Overall Study|Lost to Follow-up|21|||
145406202|NCT01473134|524343735|FG001|Overall Study|Lost to Follow-up|13|||
145406203|NCT01473134|524343734|FG000|Overall Study|Protocol Violation|32|||
145406204|NCT01473134|524343735|FG001|Overall Study|Protocol Violation|19|||
145406205|NCT01473134|524343734|FG000|Overall Study|Withdrawal by Subject|1|||
145406206|NCT01473134|524343735|FG001|Overall Study|Withdrawal by Subject|2|||
145406207|NCT01473134|524343734|FG000|Overall Study|Death|0|||
145406208|NCT01473134|524343735|FG001|Overall Study|Death|1|||
145406209|NCT01473134|524343734|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
145406210|NCT01473134|524343735|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
145406211|NCT04761822|524343740|FG000|Overall Study|Adverse Event|3|||
145406212|NCT04761822|524343741|FG001|Overall Study|Adverse Event|1|||
145406213|NCT04761822|524343742|FG002|Overall Study|Adverse Event|1|||
145406214|NCT04761822|524343743|FG003|Overall Study|Adverse Event|3|||
145406215|NCT04761822|524343740|FG000|Overall Study|Lost to Follow-up|1|||
145406216|NCT04761822|524343741|FG001|Overall Study|Lost to Follow-up|0|||
145406217|NCT04761822|524343742|FG002|Overall Study|Lost to Follow-up|2|||
145406218|NCT04761822|524343743|FG003|Overall Study|Lost to Follow-up|3|||
145406219|NCT04761822|524343740|FG000|Overall Study|Physician Decision|0|||
145406220|NCT04761822|524343741|FG001|Overall Study|Physician Decision|1|||
145406221|NCT04761822|524343742|FG002|Overall Study|Physician Decision|0|||
145406222|NCT04761822|524343743|FG003|Overall Study|Physician Decision|0|||
145406223|NCT04761822|524343740|FG000|Overall Study|Withdrawal by Subject|3|||
145406224|NCT04761822|524343741|FG001|Overall Study|Withdrawal by Subject|8|||
145406225|NCT04761822|524343742|FG002|Overall Study|Withdrawal by Subject|1|||
145406226|NCT04761822|524343743|FG003|Overall Study|Withdrawal by Subject|11|||
145406227|NCT04761822|524343740|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
145406228|NCT04761822|524343741|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145406229|NCT04761822|524343742|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145406230|NCT04761822|524343743|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
145406231|NCT04761822|524343740|FG000|Overall Study|Participant requested unblinding|0|||
145406232|NCT04761822|524343741|FG001|Overall Study|Participant requested unblinding|0|||
145612493|NCT04921969|525095739|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
145612494|NCT04921969|525095740|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
145612495|NCT04921969|525095741|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
145612496|NCT04921969|525095742|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
145612497|NCT04921969|525095743|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
145612498|NCT04921969|525095744|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
145612499|NCT04287868|525095745|FG000|Overall Study|Screening fail|1|||
145612500|NCT04287868|525095746|FG001|Overall Study|Screening fail|0|||
145612501|NCT01282476|525097109|FG000|Overall Study|Death|11|||
145612502|NCT01189890|525097113|FG000|Overall Study|Adverse Event|3|||
145612503|NCT01189890|525097114|FG001|Overall Study|Adverse Event|4|||
145612504|NCT01189890|525097113|FG000|Overall Study|Lack of Efficacy|7|||
145285098|NCT01418352|523893123|FG001|Overall Study|Protocol Deviation|0|||
145285099|NCT01418352|523893124|FG002|Overall Study|Protocol Deviation|1|||
145612505|NCT01189890|525097114|FG001|Overall Study|Lack of Efficacy|2|||
145285100|NCT01418352|523893125|FG003|Overall Study|Protocol Deviation|0|||
145285101|NCT01418352|523893122|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
145285102|NCT01418352|523893123|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
145285103|NCT01418352|523893124|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
145612506|NCT01189890|525097113|FG000|Overall Study|Lost to Follow-up|1|||
145612507|NCT01189890|525097114|FG001|Overall Study|Lost to Follow-up|7|||
145285104|NCT01418352|523893125|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
145285105|NCT01401478|523893127|FG000|Overall Study|Study drug not available|6|||
145285106|NCT01401478|523893127|FG000|Overall Study|Adverse Event|5|||
145285107|NCT01401478|523893127|FG000|Overall Study|Hyperphosphatemia|5|||
145285108|NCT01401478|523893127|FG000|Overall Study|Lost to Follow-up|5|||
145285109|NCT01401478|523893127|FG000|Overall Study|Kidney transplantation|3|||
145285110|NCT01401478|523893127|FG000|Overall Study|Withdrawal by Subject|3|||
145285111|NCT01401478|523893127|FG000|Overall Study|Blood samples not available|1|||
145285112|NCT01401478|523893127|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
145285113|NCT01401478|523893127|FG000|Overall Study|Low intact parathyroid hormone|1|||
145285114|NCT01401478|523893127|FG000|Overall Study|Serious adverse event|1|||
145285115|NCT01814137|523893128|FG000|Overall Study|Adverse Event|0|||
145285116|NCT01814137|523893129|FG001|Overall Study|Adverse Event|1|||
145285117|NCT01814137|523893128|FG000|Overall Study|Withdrawal by Subject|2|||
145285118|NCT01814137|523893129|FG001|Overall Study|Withdrawal by Subject|2|||
145285119|NCT01814137|523893128|FG000|Overall Study|Physician Decision|1|||
145285120|NCT01814137|523893129|FG001|Overall Study|Physician Decision|1|||
145285121|NCT01814137|523893128|FG000|Overall Study|Unclassified|2|||
145285122|NCT01814137|523893129|FG001|Overall Study|Unclassified|1|||
145285123|NCT00886483|523893135|FG000|Overall Study|Lost to Follow-up|0|||
145285124|NCT00886483|523893136|FG001|Overall Study|Lost to Follow-up|1|||
145285125|NCT00886483|523893135|FG000|Overall Study|Pursue medications|1|||
145285126|NCT00886483|523893136|FG001|Overall Study|Pursue medications|2|||
145285127|NCT00886483|523893135|FG000|Overall Study|Distance to center, poor grades|1|||
145285128|NCT00886483|523893136|FG001|Overall Study|Distance to center, poor grades|0|||
145285129|NCT02168270|523893138|FG000|Overall Study|Lack of Efficacy|4|||
145285130|NCT00593333|523893139|FG000|Overall Study|Lost to Follow-up|10|||
145285131|NCT00593333|523893140|FG001|Overall Study|Lost to Follow-up|11|||
145285132|NCT02175966|523893141|FG000|Follow-up Period|Lack of Efficacy|10|||
145285133|NCT02175966|523893142|FG001|Follow-up Period|Lack of Efficacy|6|||
145285134|NCT01086215|523893147|FG000|Overall Study|Death|14|||
145285135|NCT01086215|523893148|FG001|Overall Study|Death|8|||
145285136|NCT01086215|523893149|FG002|Overall Study|Death|8|||
145285137|NCT01086215|523893150|FG003|Overall Study|Death|1|||
145285138|NCT01086215|523893147|FG000|Overall Study|Lost to Follow-up|22|||
145285139|NCT01086215|523893148|FG001|Overall Study|Lost to Follow-up|39|||
145285140|NCT01086215|523893149|FG002|Overall Study|Lost to Follow-up|18|||
145285141|NCT01086215|523893150|FG003|Overall Study|Lost to Follow-up|2|||
145555287|NCT03220217|524892476|FG001|Overall Study|Subject Missed Procedure|0|||
145555288|NCT03220217|524892477|FG002|Overall Study|Subject Missed Procedure|1|||
145555289|NCT03025542|524892478|FG000|Overall Study|Adverse Event|0|||
145555290|NCT03025542|524892479|FG001|Overall Study|Adverse Event|2|||
145555291|NCT03025542|524892478|FG000|Overall Study|Lost to Follow-up|1|||
145555292|NCT03025542|524892479|FG001|Overall Study|Lost to Follow-up|0|||
145555293|NCT03025542|524892478|FG000|Overall Study|Withdrawal by Subject|1|||
145555294|NCT03025542|524892479|FG001|Overall Study|Withdrawal by Subject|0|||
145612508|NCT01189890|525097113|FG000|Overall Study|Protocol Violation|1|||
145612509|NCT01189890|525097114|FG001|Overall Study|Protocol Violation|5|||
145612510|NCT01189890|525097113|FG000|Overall Study|Withdrawal by Subject|15|||
145612511|NCT01189890|525097114|FG001|Overall Study|Withdrawal by Subject|11|||
145612512|NCT01189890|525097113|FG000|Overall Study|Non Compliance|0|||
145612513|NCT01189890|525097114|FG001|Overall Study|Non Compliance|1|||
145612514|NCT01189890|525097113|FG000|Overall Study|Physician Decision|5|||
145612515|NCT01189890|525097114|FG001|Overall Study|Physician Decision|4|||
145612516|NCT01189890|525097113|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
145612517|NCT01189890|525097114|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
145612518|NCT00077636|525097115|FG000|Overall Study|Refused Treatment|9|||
145612519|NCT00077636|525097116|FG001|Overall Study|Refused Treatment|31|||
145612520|NCT00077636|525097115|FG000|Overall Study|Admin|3|||
145612521|NCT00077636|525097116|FG001|Overall Study|Admin|3|||
145612522|NCT00077636|525097115|FG000|Overall Study|Withdrawal by Subject|2|||
145612523|NCT00077636|525097116|FG001|Overall Study|Withdrawal by Subject|2|||
145612524|NCT00077636|525097115|FG000|Overall Study|Adverse Event|17|||
145612525|NCT00077636|525097116|FG001|Overall Study|Adverse Event|34|||
145612526|NCT00077636|525097115|FG000|Overall Study|Protocol Violation|0|||
145612527|NCT00077636|525097116|FG001|Overall Study|Protocol Violation|2|||
145612528|NCT00077636|525097115|FG000|Overall Study|Lost to Follow-up|10|||
145612529|NCT00077636|525097116|FG001|Overall Study|Lost to Follow-up|18|||
145612530|NCT00077636|525097115|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
145612531|NCT00077636|525097116|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
145612532|NCT00636792|525097122|FG000|Overall Study|Adverse Event|16|||
145612533|NCT00636792|525097122|FG000|Overall Study|Physician Decision|7|||
145612534|NCT00636792|525097122|FG000|Overall Study|Progressive Disease|4|||
145612535|NCT00636792|525097122|FG000|Overall Study|Withdrawal by Subject|3|||
145612536|NCT00636792|525097122|FG000|Overall Study|Other|3|||
145612537|NCT00251927|525097137|FG000|Overall Study|Adverse Event|3|||
145612538|NCT00251927|525097138|FG001|Overall Study|Adverse Event|15|||
145612539|NCT00251927|525097137|FG000|Overall Study|Lack of Efficacy|22|||
145612540|NCT00251927|525097138|FG001|Overall Study|Lack of Efficacy|16|||
145612541|NCT00251927|525097137|FG000|Overall Study|Lost to Follow-up|22|||
145612542|NCT00251927|525097138|FG001|Overall Study|Lost to Follow-up|8|||
145612543|NCT00251927|525097137|FG000|Overall Study|Protocol Violation|1|||
145612544|NCT00251927|525097138|FG001|Overall Study|Protocol Violation|2|||
145612545|NCT00251927|525097137|FG000|Overall Study|Pregnancy|2|||
145612546|NCT00251927|525097138|FG001|Overall Study|Pregnancy|0|||
145612547|NCT00251927|525097137|FG000|Overall Study|Withdrawal by Subject|40|||
145612548|NCT00251927|525097138|FG001|Overall Study|Withdrawal by Subject|25|||
145612549|NCT00251927|525097137|FG000|Overall Study|Study-specific discont. achieved|13|||
145612550|NCT00251927|525097138|FG001|Overall Study|Study-specific discont. achieved|2|||
145612551|NCT00251927|525097137|FG000|Overall Study|Study procedure non-compliance|5|||
145612552|NCT00251927|525097138|FG001|Overall Study|Study procedure non-compliance|6|||
145612553|NCT00452413|525097142|FG000|Overall Study|Progressive Disease|4|||
145612554|NCT00452413|525097143|FG001|Overall Study|Progressive Disease|11|||
145612555|NCT00452413|525097144|FG002|Overall Study|Progressive Disease|30|||
145612556|NCT00452413|525097142|FG000|Overall Study|Withdrawal by Subject|0|||
145612557|NCT00452413|525097143|FG001|Overall Study|Withdrawal by Subject|1|||
145612558|NCT00452413|525097144|FG002|Overall Study|Withdrawal by Subject|4|||
145612559|NCT00452413|525097142|FG000|Overall Study|Adverse Event|0|||
145612560|NCT00452413|525097143|FG001|Overall Study|Adverse Event|0|||
145612561|NCT00452413|525097144|FG002|Overall Study|Adverse Event|5|||
145612562|NCT00452413|525097142|FG000|Overall Study|Physician Decision|0|||
145612563|NCT00452413|525097143|FG001|Overall Study|Physician Decision|0|||
145612564|NCT00452413|525097144|FG002|Overall Study|Physician Decision|4|||
145612565|NCT00452413|525097142|FG000|Overall Study|Death due to study disease|0|||
145612566|NCT00452413|525097143|FG001|Overall Study|Death due to study disease|0|||
145612567|NCT00452413|525097144|FG002|Overall Study|Death due to study disease|2|||
145612568|NCT00452413|525097142|FG000|Overall Study|Death due to adverse event (AE)|0|||
145555295|NCT00501293|524892480|FG000|Optimization Period|Enrolled in error|1|||
145612569|NCT00452413|525097143|FG001|Overall Study|Death due to adverse event (AE)|0|||
145555296|NCT00501293|524892481|FG001|Optimization Period|Enrolled in error|0|||
145612570|NCT00452413|525097144|FG002|Overall Study|Death due to adverse event (AE)|1|||
145612571|NCT00452413|525097142|FG000|Overall Study|On treatment|0|||
145612572|NCT00452413|525097143|FG001|Overall Study|On treatment|0|||
145612573|NCT00452413|525097144|FG002|Overall Study|On treatment|3|||
145612574|NCT01027364|525097146|FG000|Overall Study|Adverse Event|1|||
145285142|NCT01965652|523893151|FG000|Overall Study|Adverse Event|40|||
145285143|NCT01965652|523893152|FG001|Overall Study|Adverse Event|37|||
145285144|NCT01965652|523893151|FG000|Overall Study|Withdrawal by Subject|62|||
145285145|NCT01965652|523893152|FG001|Overall Study|Withdrawal by Subject|69|||
145285146|NCT01965652|523893151|FG000|Overall Study|Lost to Follow-up|53|||
145285147|NCT01965652|523893152|FG001|Overall Study|Lost to Follow-up|40|||
145285148|NCT01965652|523893151|FG000|Overall Study|Protocol Violation|34|||
145285149|NCT01965652|523893152|FG001|Overall Study|Protocol Violation|38|||
145285150|NCT01965652|523893151|FG000|Overall Study|Death|3|||
145285151|NCT01965652|523893152|FG001|Overall Study|Death|4|||
145285152|NCT01965652|523893151|FG000|Overall Study|Other - Miscellaneous|18|||
145285153|NCT01965652|523893152|FG001|Overall Study|Other - Miscellaneous|21|||
145406233|NCT04761822|524343742|FG002|Overall Study|Participant requested unblinding|0|||
145406234|NCT04761822|524343743|FG003|Overall Study|Participant requested unblinding|1|||
145555297|NCT00501293|524892480|FG000|Maintenance Period|Withdrawal by Subject|14|||
145555298|NCT00501293|524892481|FG001|Maintenance Period|Withdrawal by Subject|13|||
145555299|NCT00501293|524892480|FG000|Maintenance Period|Lost to Follow-up|12|||
145555300|NCT00501293|524892481|FG001|Maintenance Period|Lost to Follow-up|7|||
145555301|NCT00501293|524892480|FG000|Maintenance Period|Adverse Event|6|||
145555302|NCT00501293|524892481|FG001|Maintenance Period|Adverse Event|6|||
145555303|NCT00501293|524892480|FG000|Maintenance Period|Protocol Violation|2|||
145555304|NCT00501293|524892481|FG001|Maintenance Period|Protocol Violation|1|||
145555305|NCT00501293|524892480|FG000|Maintenance Period|Lack of Efficacy|4|||
145555306|NCT00501293|524892481|FG001|Maintenance Period|Lack of Efficacy|1|||
145555307|NCT00501293|524892480|FG000|Maintenance Period|Noncompliant with study medication|5|||
145555308|NCT00501293|524892481|FG001|Maintenance Period|Noncompliant with study medication|0|||
145555309|NCT00501293|524892480|FG000|Maintenance Period|Went into rehabilitation|1|||
145555310|NCT00501293|524892481|FG001|Maintenance Period|Went into rehabilitation|0|||
145555311|NCT00501293|524892480|FG000|Maintenance Period|Would not wear patch|1|||
145555312|NCT00501293|524892481|FG001|Maintenance Period|Would not wear patch|0|||
145555313|NCT00501293|524892480|FG000|Maintenance Period|Application site reaction|1|||
145555314|NCT00501293|524892481|FG001|Maintenance Period|Application site reaction|0|||
145555315|NCT00488345|524892482|FG000|Overall Study|Adverse Event|0|||
145555316|NCT00488345|524892483|FG001|Overall Study|Adverse Event|1|||
145555317|NCT00488345|524892484|FG002|Overall Study|Adverse Event|1|||
145555318|NCT00488345|524892482|FG000|Overall Study|Unable to administer antibiotics at home|0|||
145555319|NCT00488345|524892483|FG001|Overall Study|Unable to administer antibiotics at home|1|||
145555320|NCT00488345|524892484|FG002|Overall Study|Unable to administer antibiotics at home|0|||
145555321|NCT00488345|524892482|FG000|Overall Study|Institutional Review Board review|0|||
145555322|NCT00488345|524892483|FG001|Overall Study|Institutional Review Board review|0|||
145555323|NCT00488345|524892484|FG002|Overall Study|Institutional Review Board review|1|||
145555324|NCT00488345|524892482|FG000|Overall Study|Surgical team recommendation|0|||
145555325|NCT00488345|524892483|FG001|Overall Study|Surgical team recommendation|1|||
145555326|NCT00488345|524892484|FG002|Overall Study|Surgical team recommendation|0|||
145555327|NCT00488345|524892482|FG000|Overall Study|Parent/legal guardian request|0|||
145555328|NCT00488345|524892483|FG001|Overall Study|Parent/legal guardian request|1|||
145555329|NCT00488345|524892484|FG002|Overall Study|Parent/legal guardian request|1|||
145555330|NCT00903617|524892486|FG000|Overall Study|Adverse Event|0|||
145285154|NCT01965652|523893151|FG000|Overall Study|Pregnancy|0|||
145285155|NCT01965652|523893152|FG001|Overall Study|Pregnancy|1|||
145285156|NCT01121900|523893155|FG000|First Intervention Period|Adverse Event|1|||
145285157|NCT01121900|523893156|FG001|First Intervention Period|Adverse Event|1|||
145285158|NCT01121900|523893155|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145285159|NCT01121900|523893156|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145285160|NCT03469271|523893157|FG000|Overall Study|Withdrawal by Subject|2|||
145285161|NCT03469271|523893158|FG001|Overall Study|Withdrawal by Subject|0|||
145285162|NCT03469271|523893159|FG002|Overall Study|Withdrawal by Subject|0|||
145285163|NCT03469271|523893160|FG003|Overall Study|Withdrawal by Subject|1|||
145285164|NCT01328054|523893163|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
145285165|NCT01328054|523893164|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
145285166|NCT01328054|523893163|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
145285167|NCT01328054|523893164|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
145285168|NCT01328054|523893163|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
145285169|NCT01328054|523893164|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
145285170|NCT03760510|523893165|FG000|Overall Study|Not ventilated for 24 hours|105|||
145285171|NCT03760510|523893166|FG001|Overall Study|Not ventilated for 24 hours|97|||
145285172|NCT00871728|523893169|FG000|Overall Study|Adverse Event|1|||
145285173|NCT00871728|523893169|FG000|Overall Study|Protocol Violation|7|||
145285174|NCT00871728|523893169|FG000|Overall Study|Lost to Follow-up|2|||
145285175|NCT00871728|523893169|FG000|Overall Study|Failed to Visit Hospital|4|||
145285176|NCT00871728|523893169|FG000|Overall Study|Participant Non-compliance|1|||
145285177|NCT00871728|523893169|FG000|Overall Study|Withdrawal of Informed Consent|5|||
145285178|NCT03775681|523893175|FG000|Overall Study|Physician Decision|3|||
145285179|NCT00895583|523893176|FG000|Overall Study|Adverse Event|28|||
145285180|NCT00895583|523893177|FG001|Overall Study|Adverse Event|4|||
145285181|NCT00895583|523893176|FG000|Overall Study|Death|2|||
145285182|NCT00895583|523893177|FG001|Overall Study|Death|1|||
145285183|NCT00895583|523893176|FG000|Overall Study|Physician Decision|3|||
145406235|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
145406236|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
145406237|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Death|1|||
145406238|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Death|3|||
145406239|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
145406240|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
145406241|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
145406242|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
145406243|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
145406244|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
145406245|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
145406246|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
145406247|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
145406248|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
145406249|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
145406250|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
145406251|NCT00362232|524343744|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
145406252|NCT00362232|524343745|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
145406253|NCT00362232|524343744|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
145406254|NCT00362232|524343745|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
145555331|NCT00903617|524892487|FG001|Overall Study|Adverse Event|1|||
145555332|NCT00903617|524892488|FG002|Overall Study|Adverse Event|1|||
145555333|NCT00903617|524892489|FG003|Overall Study|Adverse Event|0|||
145555334|NCT00903617|524892486|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145555335|NCT00903617|524892487|FG001|Overall Study|Protocol-defined stopping criteria|2|||
145555336|NCT00903617|524892488|FG002|Overall Study|Protocol-defined stopping criteria|0|||
145555337|NCT00903617|524892489|FG003|Overall Study|Protocol-defined stopping criteria|0|||
145555338|NCT00903617|524892486|FG000|Overall Study|Lost to Follow-up|2|||
145406255|NCT00362232|524343744|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
145406256|NCT00362232|524343745|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
145406257|NCT00362232|524343744|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
145406258|NCT00362232|524343745|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
145406259|NCT00362232|524343744|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
145406260|NCT00362232|524343745|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
145406261|NCT05020015|524343752|FG000|Overall Study|Ongoing on study|1|||
145555339|NCT00903617|524892487|FG001|Overall Study|Lost to Follow-up|0|||
145555340|NCT00903617|524892488|FG002|Overall Study|Lost to Follow-up|1|||
145555341|NCT00903617|524892489|FG003|Overall Study|Lost to Follow-up|1|||
145555342|NCT00903617|524892486|FG000|Overall Study|Withdrawal by Subject|1|||
145555343|NCT00903617|524892487|FG001|Overall Study|Withdrawal by Subject|2|||
145555344|NCT00903617|524892488|FG002|Overall Study|Withdrawal by Subject|3|||
145285184|NCT00895583|523893177|FG001|Overall Study|Physician Decision|1|||
145285185|NCT00895583|523893176|FG000|Overall Study|Lost to Follow-up|1|||
145285186|NCT00895583|523893177|FG001|Overall Study|Lost to Follow-up|3|||
145285187|NCT00895583|523893176|FG000|Overall Study|Protocol Violation|1|||
145285188|NCT00895583|523893177|FG001|Overall Study|Protocol Violation|0|||
145285189|NCT00895583|523893176|FG000|Overall Study|Withdrawal by Subject|4|||
145285190|NCT00895583|523893177|FG001|Overall Study|Withdrawal by Subject|2|||
145285191|NCT00895583|523893176|FG000|Overall Study|Lack of Efficacy|5|||
145285192|NCT00895583|523893177|FG001|Overall Study|Lack of Efficacy|0|||
145285193|NCT00895583|523893176|FG000|Overall Study|Other|0|||
145285194|NCT00895583|523893177|FG001|Overall Study|Other|1|||
145285195|NCT00616928|523893178|FG000|Overall Study|Adverse Event|6|||
145285196|NCT00616928|523893179|FG001|Overall Study|Adverse Event|3|||
145285197|NCT00616928|523893180|FG002|Overall Study|Adverse Event|2|||
145285198|NCT00616928|523893181|FG003|Overall Study|Adverse Event|2|||
145285199|NCT00616928|523893178|FG000|Overall Study|Other|51|||
145285200|NCT00616928|523893179|FG001|Overall Study|Other|8|||
145555345|NCT00903617|524892489|FG003|Overall Study|Withdrawal by Subject|0|||
145555346|NCT01104636|524892490|FG000|Overall Study|Lack of Efficacy|43|||
145285201|NCT00616928|523893180|FG002|Overall Study|Other|15|||
145285202|NCT00616928|523893181|FG003|Overall Study|Other|5|||
145285203|NCT00616928|523893178|FG000|Overall Study|Lost to Follow-up|5|||
145555347|NCT01104636|524892490|FG000|Overall Study|Lost to Follow-up|24|||
145555348|NCT01104636|524892490|FG000|Overall Study|Withdrawal by Subject|4|||
145555349|NCT01104636|524892490|FG000|Overall Study|Other|43|||
145406262|NCT05020015|524343753|FG001|Overall Study|Ongoing on study|3|||
145406263|NCT05020015|524343754|FG002|Overall Study|Ongoing on study|4|||
145406264|NCT05020015|524343755|FG003|Overall Study|Ongoing on study|7|||
145406265|NCT05020015|524343752|FG000|Overall Study|Death|2|||
145406266|NCT05020015|524343753|FG001|Overall Study|Death|3|||
145406267|NCT05020015|524343754|FG002|Overall Study|Death|4|||
145406268|NCT05020015|524343755|FG003|Overall Study|Death|0|||
145406269|NCT05020015|524343752|FG000|Overall Study|Withdrawal by Subject|0|||
145406270|NCT05020015|524343753|FG001|Overall Study|Withdrawal by Subject|0|||
145406271|NCT05020015|524343754|FG002|Overall Study|Withdrawal by Subject|1|||
145555350|NCT01104636|524892490|FG000|Overall Study|Study terminated by sponsor|1|||
145555351|NCT01104636|524892490|FG000|Overall Study|Pregnancy|2|||
145555352|NCT01104636|524892490|FG000|Overall Study|Adverse Event|40|||
145555353|NCT01104636|524892490|FG000|Overall Study|Ongoing|21|||
145555354|NCT01853046|524892495|FG000|Overall Study|Withdrawal by Subject|1|||
145555355|NCT01853046|524892496|FG001|Overall Study|Withdrawal by Subject|1|||
145555356|NCT01853046|524892495|FG000|Overall Study|Adverse Event|4|||
145555357|NCT01853046|524892496|FG001|Overall Study|Adverse Event|2|||
145555358|NCT01853046|524892495|FG000|Overall Study|Disease progression|13|||
145555359|NCT01853046|524892496|FG001|Overall Study|Disease progression|3|||
145555360|NCT00708162|524892501|FG000|Randomized Phase|Randomized but Not Treated|7|||
145555361|NCT00708162|524892502|FG001|Randomized Phase|Randomized but Not Treated|5|||
145555362|NCT00708162|524892501|FG000|Randomized Phase|Participant Noncompliance|40|||
145555363|NCT00708162|524892502|FG001|Randomized Phase|Participant Noncompliance|32|||
145555364|NCT00708162|524892501|FG000|Randomized Phase|Lost to Follow-up|34|||
145555365|NCT00708162|524892502|FG001|Randomized Phase|Lost to Follow-up|34|||
145555366|NCT00708162|524892501|FG000|Randomized Phase|Withdrew Consent|31|||
145555367|NCT00708162|524892502|FG001|Randomized Phase|Withdrew Consent|22|||
145555368|NCT00708162|524892501|FG000|Randomized Phase|Lack of Efficacy|14|||
145555369|NCT00708162|524892502|FG001|Randomized Phase|Lack of Efficacy|19|||
145555370|NCT00708162|524892501|FG000|Randomized Phase|Protocol Violation|10|||
145555371|NCT00708162|524892502|FG001|Randomized Phase|Protocol Violation|11|||
145555372|NCT00708162|524892501|FG000|Randomized Phase|Adverse Event|8|||
145555373|NCT00708162|524892502|FG001|Randomized Phase|Adverse Event|12|||
145555374|NCT00708162|524892501|FG000|Randomized Phase|Investigator's Discretion|7|||
145555375|NCT00708162|524892502|FG001|Randomized Phase|Investigator's Discretion|10|||
145555376|NCT00708162|524892501|FG000|Randomized Phase|Death|2|||
145555377|NCT00708162|524892502|FG001|Randomized Phase|Death|9|||
145555378|NCT00708162|524892501|FG000|Randomized Phase|Pregnancy|3|||
145555379|NCT00708162|524892502|FG001|Randomized Phase|Pregnancy|0|||
145555380|NCT00708162|524892501|FG000|Open-Label Phase|Lost to Follow-up|10|||
145555381|NCT00708162|524892502|FG001|Open-Label Phase|Lost to Follow-up|8|||
145555382|NCT00708162|524892501|FG000|Open-Label Phase|Withdrew Consent|12|||
145555383|NCT00708162|524892502|FG001|Open-Label Phase|Withdrew Consent|6|||
145555384|NCT00708162|524892501|FG000|Open-Label Phase|Participant Noncompliance|7|||
145555385|NCT00708162|524892502|FG001|Open-Label Phase|Participant Noncompliance|7|||
145555386|NCT00708162|524892501|FG000|Open-Label Phase|Lack of Efficacy|7|||
145555387|NCT00708162|524892502|FG001|Open-Label Phase|Lack of Efficacy|4|||
145555388|NCT00708162|524892501|FG000|Open-Label Phase|Investigator's Discretion|3|||
145555389|NCT00708162|524892502|FG001|Open-Label Phase|Investigator's Discretion|2|||
145555390|NCT00708162|524892501|FG000|Open-Label Phase|Death|3|||
145555391|NCT00708162|524892502|FG001|Open-Label Phase|Death|1|||
145555392|NCT00708162|524892501|FG000|Open-Label Phase|Adverse Event|1|||
145555393|NCT00708162|524892502|FG001|Open-Label Phase|Adverse Event|2|||
145555394|NCT00708162|524892501|FG000|Open-Label Phase|Other|1|||
145555395|NCT00708162|524892502|FG001|Open-Label Phase|Other|0|||
145555396|NCT01710033|524892503|FG000|Stage 2|Adverse Event|0|||
145555397|NCT01710033|524892504|FG001|Stage 2|Adverse Event|0|||
145555398|NCT01710033|524892505|FG002|Stage 2|Adverse Event|0|||
145555399|NCT01710033|524892506|FG003|Stage 2|Adverse Event|0|||
145555400|NCT01710033|524892507|FG004|Stage 2|Adverse Event|1|||
145555401|NCT01475331|524892508|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
145555402|NCT01475331|524892509|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
145555403|NCT01475331|524892508|FG000|Overall Study|excessive main duct communication|1|||
145555404|NCT01475331|524892509|FG001|Overall Study|excessive main duct communication|1|||
145555405|NCT01475331|524892508|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
145555406|NCT01475331|524892509|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
145555407|NCT01475331|524892508|FG000|Overall Study|Sign of malignancy during the procedure|2|||
145555408|NCT01475331|524892509|FG001|Overall Study|Sign of malignancy during the procedure|0|||
145555409|NCT01475331|524892508|FG000|Overall Study|cyst found to be prohibitively small|0|||
145555410|NCT01475331|524892509|FG001|Overall Study|cyst found to be prohibitively small|1|||
145555411|NCT01525550|524892510|FG000|Overall Study|Lost to Follow-up|8|||
145406272|NCT05020015|524343755|FG003|Overall Study|Withdrawal by Subject|0|||
145285204|NCT00616928|523893179|FG001|Overall Study|Lost to Follow-up|7|||
145285205|NCT00616928|523893180|FG002|Overall Study|Lost to Follow-up|0|||
145285206|NCT00616928|523893181|FG003|Overall Study|Lost to Follow-up|0|||
145285207|NCT03529955|523893182|FG000|Overall Study|Adverse Event|1|||
145285208|NCT03529955|523893182|FG000|Overall Study|Lack of Efficacy|1|||
145285209|NCT03016078|523893188|FG000|Overall Study|Protocol Violation|1|||
145285210|NCT03016078|523893188|FG000|Overall Study|Protocol Violation|1|||
145285211|NCT02378506|523893190|FG000|Overall Study|Lack of Efficacy|3|||
145285212|NCT02378506|523893190|FG000|Overall Study|Withdrawal by Subject|4|||
145285213|NCT02378506|523893190|FG000|Overall Study|Protocol Violation|2|||
145285214|NCT02378506|523893190|FG000|Overall Study|Death|1|||
145285215|NCT02378506|523893190|FG000|Overall Study|Adverse Event|14|||
145285216|NCT02378506|523893190|FG000|Overall Study|Randomized But Not Treated|1|||
145285217|NCT01070394|523893192|FG000|Overall Study|Adverse Event|6|||
145285218|NCT01070394|523893192|FG000|Overall Study|Withdrawal by Subject|1|||
145285219|NCT01715415|523893204|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
145285220|NCT01715415|523893205|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
145285221|NCT01715415|523893204|FG000|Double-blind Treatment|Adverse Event|3|||
145285222|NCT01715415|523893205|FG001|Double-blind Treatment|Adverse Event|0|||
145285223|NCT01715415|523893204|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
145285224|NCT01715415|523893205|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
145285225|NCT01715415|523893204|FG000|Double-blind Treatment|Other|1|||
145285226|NCT01715415|523893205|FG001|Double-blind Treatment|Other|0|||
145285227|NCT01715415|523893204|FG000|Open-label Treatment|Adverse Event|0|||
145285228|NCT01715415|523893205|FG001|Open-label Treatment|Adverse Event|1|||
145285229|NCT01715415|523893204|FG000|Open-label Treatment|Subject Noncompliant|0|||
145285230|NCT01715415|523893205|FG001|Open-label Treatment|Subject Noncompliant|1|||
145285231|NCT01015612|523893206|FG000|Overall Study|Death|113|||
145285232|NCT01015612|523893206|FG000|Overall Study|Withdrawal by Subject|40|||
145555412|NCT01525550|524892511|FG001|Overall Study|Lost to Follow-up|2|||
145555413|NCT01525550|524892510|FG000|Overall Study|Death|19|||
145555414|NCT01525550|524892511|FG001|Overall Study|Death|28|||
145555415|NCT01525550|524892510|FG000|Overall Study|Other|0|||
145285233|NCT03586830|523893207|FG000|Overall Study|Site terminated by Sponsor|1|||
145285234|NCT03586830|523893208|FG001|Overall Study|Site terminated by Sponsor|4|||
145285235|NCT03586830|523893209|FG002|Overall Study|Site terminated by Sponsor|3|||
145285236|NCT03586830|523893210|FG003|Overall Study|Site terminated by Sponsor|3|||
145285237|NCT03586830|523893207|FG000|Overall Study|Lost to Follow-up|0|||
145285238|NCT03586830|523893208|FG001|Overall Study|Lost to Follow-up|2|||
145285239|NCT03586830|523893209|FG002|Overall Study|Lost to Follow-up|2|||
145555416|NCT01525550|524892511|FG001|Overall Study|Other|4|||
145285240|NCT03586830|523893210|FG003|Overall Study|Lost to Follow-up|1|||
145555417|NCT01525550|524892510|FG000|Overall Study|Sponsor's Decision|30|||
145285241|NCT03586830|523893207|FG000|Overall Study|Withdrawal by Subject|1|||
145285242|NCT03586830|523893208|FG001|Overall Study|Withdrawal by Subject|0|||
145555418|NCT01525550|524892511|FG001|Overall Study|Sponsor's Decision|11|||
145555419|NCT01525550|524892510|FG000|Overall Study|Withdrawal by Subject|4|||
145555420|NCT01525550|524892511|FG001|Overall Study|Withdrawal by Subject|0|||
145555421|NCT00462761|524892512|FG000|Overall Study|Adverse Event|6|||
145612575|NCT01027364|525097147|FG001|Overall Study|Adverse Event|0|||
145612576|NCT01027364|525097148|FG002|Overall Study|Adverse Event|1|||
145612577|NCT01027364|525097149|FG003|Overall Study|Adverse Event|0|||
145612578|NCT01027364|525097146|FG000|Overall Study|Lost to Follow-up|1|||
145612579|NCT01027364|525097147|FG001|Overall Study|Lost to Follow-up|0|||
145612580|NCT01027364|525097148|FG002|Overall Study|Lost to Follow-up|0|||
145612581|NCT01027364|525097149|FG003|Overall Study|Lost to Follow-up|0|||
145612582|NCT01027364|525097146|FG000|Overall Study|Protocol Violation|1|||
145612583|NCT01027364|525097147|FG001|Overall Study|Protocol Violation|0|||
145612584|NCT01027364|525097148|FG002|Overall Study|Protocol Violation|0|||
145612585|NCT01027364|525097149|FG003|Overall Study|Protocol Violation|1|||
145612586|NCT01027364|525097146|FG000|Overall Study|Withdrawal by Subject|1|||
145612587|NCT01027364|525097147|FG001|Overall Study|Withdrawal by Subject|2|||
145612588|NCT01027364|525097148|FG002|Overall Study|Withdrawal by Subject|0|||
145612589|NCT01027364|525097149|FG003|Overall Study|Withdrawal by Subject|0|||
145612590|NCT00114634|525097150|FG000|Overall Study|failure to return forms|3|||
145612591|NCT03283696|525097175|FG000|Overall Study|Physician Decision|5|||
145612592|NCT03283696|525097176|FG001|Overall Study|Physician Decision|6|||
145612593|NCT03283696|525097175|FG000|Overall Study|Withdrawal by Subject|2|||
145612594|NCT03283696|525097176|FG001|Overall Study|Withdrawal by Subject|0|||
145612595|NCT00684762|525097179|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
145612596|NCT00684762|525097180|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
145612597|NCT00258440|525097188|FG000|Overall Study|Withdrawal by Subject|0|||
145612598|NCT00258440|525097189|FG001|Overall Study|Withdrawal by Subject|0|||
145612599|NCT00258440|525097190|FG002|Overall Study|Withdrawal by Subject|1|||
145612600|NCT00737061|525097191|FG000|Waiting Period|Lost to Follow-up|6|||
145612601|NCT00737061|525097191|FG000|Waiting Period|Withdrawal by Subject|1|||
145612602|NCT00737061|525097191|FG000|Waiting Period|Bilateral placement failure|34|||
145612603|NCT00737061|525097191|FG000|Waiting Period|Deemed patent following HSG|26|||
145612604|NCT00737061|525097191|FG000|Waiting Period|Alternative contraception failure|3|||
145612605|NCT00737061|525097191|FG000|Waiting Period|Elected surgical tubal ligation|5|||
145612606|NCT00737061|525097191|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
145612607|NCT00737061|525097191|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
145612608|NCT00737061|525097191|FG000|1 Year Wearing Period|Discontinued reilance|3|||
145612609|NCT00737061|525097191|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
145612610|NCT01372605|525097192|FG000|Overall Study|Death|1|||
145612611|NCT01372605|525097193|FG001|Overall Study|Death|2|||
145612612|NCT01372605|525097192|FG000|Overall Study|Lost to Follow-up|2|||
145612613|NCT01372605|525097193|FG001|Overall Study|Lost to Follow-up|1|||
145612614|NCT01372605|525097192|FG000|Overall Study|Withdrawal by Subject|4|||
145555422|NCT00462761|524892512|FG000|Overall Study|Withdrawal by Subject|9|||
145555423|NCT00462761|524892512|FG000|Overall Study|Physician Decision|5|||
145555424|NCT00462761|524892512|FG000|Overall Study|Disease progression|43|||
145555425|NCT00462761|524892512|FG000|Overall Study|Death|12|||
145555426|NCT00462761|524892512|FG000|Overall Study|Other|1|||
145555427|NCT02877082|524892513|FG000|Overall Study|Trial was closed early|5|||
145555428|NCT01244906|524892514|FG000|Overall Study|Death|2|||
145555429|NCT01244906|524892514|FG000|Overall Study|Progression of disease post treatment|6|||
145555430|NCT03480750|524892515|FG000|Overall Study|Withdrawal by Subject|0|||
145555431|NCT03480750|524892516|FG001|Overall Study|Withdrawal by Subject|1|||
145612615|NCT01372605|525097193|FG001|Overall Study|Withdrawal by Subject|7|||
145612616|NCT01372605|525097192|FG000|Overall Study|Moved|3|||
145612617|NCT01372605|525097193|FG001|Overall Study|Moved|0|||
145612618|NCT01372605|525097192|FG000|Overall Study|Changed medical home|2|||
145612619|NCT01372605|525097193|FG001|Overall Study|Changed medical home|0|||
145612620|NCT00951509|525097194|FG000|Overall Study|Withdrawal by Subject|2|||
145612621|NCT00582491|525097195|FG000|Overall Study|Withdrawal by Subject|1|||
145612622|NCT00582491|525097196|FG001|Overall Study|Withdrawal by Subject|0|||
145612623|NCT01193582|525097197|FG000|Vaccination Series|Withdrawal by Subject|11|||
145612624|NCT01193582|525097198|FG001|Vaccination Series|Withdrawal by Subject|13|||
145612625|NCT01193582|525097199|FG002|Vaccination Series|Withdrawal by Subject|8|||
145612626|NCT01193582|525097200|FG003|Vaccination Series|Withdrawal by Subject|3|||
145612627|NCT01193582|525097197|FG000|12 Month Follow-up|Death|0|||
145612628|NCT01193582|525097198|FG001|12 Month Follow-up|Death|0|||
145612629|NCT01193582|525097199|FG002|12 Month Follow-up|Death|1|||
145612630|NCT01193582|525097200|FG003|12 Month Follow-up|Death|0|||
145612631|NCT01193582|525097197|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
145612632|NCT01193582|525097198|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
145612633|NCT01193582|525097199|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
145612634|NCT01193582|525097200|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
145612635|NCT01425632|525097201|FG000|Overall Study|Adverse Event|0|||
145612636|NCT01425632|525097202|FG001|Overall Study|Adverse Event|1|||
145612637|NCT01425632|525097203|FG002|Overall Study|Adverse Event|1|||
145612638|NCT01425632|525097201|FG000|Overall Study|Physician Decision|1|||
145612639|NCT01425632|525097202|FG001|Overall Study|Physician Decision|0|||
145612640|NCT01425632|525097203|FG002|Overall Study|Physician Decision|0|||
145612641|NCT01425632|525097201|FG000|Overall Study|Protocol Violation|0|||
145612642|NCT01425632|525097202|FG001|Overall Study|Protocol Violation|0|||
145612643|NCT01425632|525097203|FG002|Overall Study|Protocol Violation|2|||
145612644|NCT01425632|525097201|FG000|Overall Study|Withdrawal by Subject|0|||
145612645|NCT01425632|525097202|FG001|Overall Study|Withdrawal by Subject|0|||
145406273|NCT05020015|524343752|FG000|Overall Study|Reason Not Specified|0|||
145406274|NCT05020015|524343753|FG001|Overall Study|Reason Not Specified|0|||
145406275|NCT05020015|524343754|FG002|Overall Study|Reason Not Specified|2|||
145406276|NCT05020015|524343755|FG003|Overall Study|Reason Not Specified|0|||
145406277|NCT02233413|524343756|FG000|Overall Study|Lost to Follow-up|7|||
145406278|NCT02233413|524343757|FG001|Overall Study|Lost to Follow-up|9|||
145406279|NCT02233413|524343756|FG000|Overall Study|Withdrawal by Subject|4|||
145406280|NCT02233413|524343757|FG001|Overall Study|Withdrawal by Subject|5|||
145406281|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
145406282|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
145406283|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
145555432|NCT03480750|524892517|FG002|Overall Study|Withdrawal by Subject|0|||
145555433|NCT03480750|524892518|FG003|Overall Study|Withdrawal by Subject|0|||
145555434|NCT03480750|524892519|FG004|Overall Study|Withdrawal by Subject|0|||
145555435|NCT03480750|524892520|FG005|Overall Study|Withdrawal by Subject|0|||
145555436|NCT03480750|524892515|FG000|Overall Study|The interruption in Trientine shippment|0|||
145555437|NCT03480750|524892516|FG001|Overall Study|The interruption in Trientine shippment|0|||
145555438|NCT03480750|524892517|FG002|Overall Study|The interruption in Trientine shippment|0|||
145555439|NCT03480750|524892518|FG003|Overall Study|The interruption in Trientine shippment|0|||
145555440|NCT03480750|524892519|FG004|Overall Study|The interruption in Trientine shippment|0|||
145555441|NCT03480750|524892520|FG005|Overall Study|The interruption in Trientine shippment|1|||
145555442|NCT03318315|524892521|FG000|Overall Study|Lost to Follow-up|3|||
145555443|NCT03318315|524892522|FG001|Overall Study|Lost to Follow-up|2|||
145555444|NCT03318315|524892523|FG002|Overall Study|Lost to Follow-up|1|||
145555445|NCT03318315|524892521|FG000|Overall Study|Protocol Violation|1|||
145555446|NCT03318315|524892522|FG001|Overall Study|Protocol Violation|1|||
145555447|NCT03318315|524892523|FG002|Overall Study|Protocol Violation|1|||
145555448|NCT03318315|524892521|FG000|Overall Study|Withdrawal by Subject|0|||
145555449|NCT03318315|524892522|FG001|Overall Study|Withdrawal by Subject|0|||
145555450|NCT03318315|524892523|FG002|Overall Study|Withdrawal by Subject|2|||
145555451|NCT02611778|524892528|FG000|Overall Study|Withdrawal by Subject|2|||
145555452|NCT02611778|524892529|FG001|Overall Study|Withdrawal by Subject|8|||
145555453|NCT02611778|524892528|FG000|Overall Study|Adverse Event|1|||
145555454|NCT02611778|524892529|FG001|Overall Study|Adverse Event|2|||
145555455|NCT02611778|524892528|FG000|Overall Study|Death|2|||
145406284|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
145406285|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
145406286|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
145555456|NCT02611778|524892529|FG001|Overall Study|Death|1|||
145555457|NCT02611778|524892528|FG000|Overall Study|Protocol Violation|1|||
145555458|NCT02611778|524892529|FG001|Overall Study|Protocol Violation|0|||
145555459|NCT02611778|524892528|FG000|Overall Study|Lost to Follow-up|3|||
145555460|NCT02611778|524892529|FG001|Overall Study|Lost to Follow-up|1|||
145555461|NCT02611778|524892528|FG000|Overall Study|Need for alternative treatment|1|||
145555462|NCT02611778|524892529|FG001|Overall Study|Need for alternative treatment|0|||
145555463|NCT02611778|524892528|FG000|Overall Study|Other Reason|2|||
145555464|NCT02611778|524892529|FG001|Overall Study|Other Reason|1|||
145555465|NCT02746874|524892530|FG000|Overall Study|Withdrawal by Subject|0|||
145555466|NCT02746874|524892531|FG001|Overall Study|Withdrawal by Subject|1|||
145555467|NCT02746874|524892530|FG000|Overall Study|Surgery Date Changed|0|||
145555468|NCT02746874|524892531|FG001|Overall Study|Surgery Date Changed|2|||
145555469|NCT00276159|524892538|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
145555470|NCT03108027|524892549|FG000|Period 1|Subject/Guardian Decision|0|||
145612646|NCT01425632|525097203|FG002|Overall Study|Withdrawal by Subject|1|||
145612647|NCT00406419|525097210|FG000|Overall Study|Death|3|||
145612648|NCT00406419|525097211|FG001|Overall Study|Death|1|||
145612649|NCT00406419|525097212|FG002|Overall Study|Death|4|||
145612650|NCT00406419|525097210|FG000|Overall Study|Protocol Violation|6|||
145612651|NCT00406419|525097211|FG001|Overall Study|Protocol Violation|2|||
145612652|NCT00406419|525097212|FG002|Overall Study|Protocol Violation|5|||
145612653|NCT00406419|525097210|FG000|Overall Study|Study Terminated by Sponsor|260|||
145612654|NCT00406419|525097211|FG001|Overall Study|Study Terminated by Sponsor|288|||
145612655|NCT00406419|525097212|FG002|Overall Study|Study Terminated by Sponsor|282|||
145612656|NCT00406419|525097210|FG000|Overall Study|Withdrawal by Subject|17|||
145612657|NCT00406419|525097211|FG001|Overall Study|Withdrawal by Subject|24|||
145612658|NCT00406419|525097212|FG002|Overall Study|Withdrawal by Subject|26|||
145612659|NCT00406419|525097210|FG000|Overall Study|Lack of Efficacy|12|||
145612660|NCT00406419|525097211|FG001|Overall Study|Lack of Efficacy|1|||
145612661|NCT00406419|525097212|FG002|Overall Study|Lack of Efficacy|6|||
145612662|NCT00406419|525097210|FG000|Overall Study|Non-Compliance with Study Drug|5|||
145612663|NCT00406419|525097211|FG001|Overall Study|Non-Compliance with Study Drug|6|||
145612664|NCT00406419|525097212|FG002|Overall Study|Non-Compliance with Study Drug|3|||
145612665|NCT00406419|525097210|FG000|Overall Study|Adverse Event|10|||
145612666|NCT00406419|525097211|FG001|Overall Study|Adverse Event|12|||
145612667|NCT00406419|525097212|FG002|Overall Study|Adverse Event|16|||
145612668|NCT00406419|525097210|FG000|Overall Study|Lost to Follow-up|11|||
145612669|NCT00406419|525097211|FG001|Overall Study|Lost to Follow-up|10|||
145612670|NCT00406419|525097212|FG002|Overall Study|Lost to Follow-up|5|||
145612671|NCT01775930|525097213|FG000|Overall Study|Futility stopping boundary met|1|||
145612672|NCT02009696|525097216|FG000|Overall Study|Withdrawal by Subject|2|||
145612673|NCT02120664|525097217|FG000|Overall Study|Withdrawal by Subject|0|||
145612674|NCT02120664|525097218|FG001|Overall Study|Withdrawal by Subject|0|||
145612675|NCT02120664|525097219|FG002|Overall Study|Withdrawal by Subject|0|||
145612676|NCT02120664|525097220|FG003|Overall Study|Withdrawal by Subject|1|||
145612677|NCT02120664|525097221|FG004|Overall Study|Withdrawal by Subject|0|||
145612678|NCT03916744|525097222|FG000|Overall Study|Withdrawal by Subject|0|||
145612679|NCT03916744|525097223|FG001|Overall Study|Withdrawal by Subject|1|||
145612680|NCT03916744|525097224|FG002|Overall Study|Withdrawal by Subject|2|||
145612681|NCT02460263|525097225|FG000|Transition Period|Withdrawal by Subject|1|||
145612682|NCT02460263|525097225|FG000|Transition Period|Death|1|||
145612683|NCT04524598|525097226|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
145612684|NCT04524598|525097227|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
145612685|NCT04524598|525097228|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
145612686|NCT04524598|525097229|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
145612687|NCT04524598|525097230|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
145612688|NCT04524598|525097226|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
145612689|NCT04524598|525097227|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
145612690|NCT04524598|525097228|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612691|NCT04524598|525097229|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612692|NCT04524598|525097230|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612693|NCT04524598|525097226|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
145612694|NCT04524598|525097227|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
145612695|NCT04524598|525097228|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
145612696|NCT04524598|525097229|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
145612697|NCT04524598|525097230|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
145612698|NCT04524598|525097226|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
145612699|NCT04524598|525097227|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
145612700|NCT04524598|525097228|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
145612701|NCT04524598|525097229|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
145612702|NCT04524598|525097230|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
145616870|NCT03230864|525111362|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
145285243|NCT03586830|523893209|FG002|Overall Study|Withdrawal by Subject|3|||
145285244|NCT03586830|523893210|FG003|Overall Study|Withdrawal by Subject|1|||
145285245|NCT02497391|523895322|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
145285246|NCT02497391|523895323|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
145285247|NCT02497391|523895324|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
145285248|NCT02497391|523895325|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
145285249|NCT02497391|523895326|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
145285250|NCT02497391|523895327|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
145285251|NCT02497391|523895322|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
145285252|NCT02497391|523895323|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
145285253|NCT02497391|523895324|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
145285254|NCT02497391|523895325|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
145285255|NCT02497391|523895326|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
145555471|NCT03108027|524892550|FG001|Period 1|Subject/Guardian Decision|0|||
145555472|NCT03108027|524892551|FG002|Period 1|Subject/Guardian Decision|0|||
145555473|NCT03108027|524892552|FG003|Period 1|Subject/Guardian Decision|2|||
145555474|NCT03108027|524892553|FG004|Period 1|Subject/Guardian Decision|0|||
145555475|NCT03108027|524892554|FG005|Period 1|Subject/Guardian Decision|0|||
145285256|NCT02497391|523895327|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
145285257|NCT02497391|523895322|FG000|Period 3 (14 Days)|Adverse Event|0|||
145285258|NCT02497391|523895323|FG001|Period 3 (14 Days)|Adverse Event|1|||
145285259|NCT02497391|523895324|FG002|Period 3 (14 Days)|Adverse Event|0|||
145285260|NCT02497391|523895325|FG003|Period 3 (14 Days)|Adverse Event|0|||
145285261|NCT02497391|523895326|FG004|Period 3 (14 Days)|Adverse Event|0|||
145285262|NCT02497391|523895327|FG005|Period 3 (14 Days)|Adverse Event|0|||
145285263|NCT02497391|523895322|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
145285264|NCT02497391|523895323|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
145285265|NCT02497391|523895324|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
145285266|NCT02497391|523895325|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
145285267|NCT02497391|523895326|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
145285268|NCT02497391|523895327|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
145285269|NCT02497391|523895322|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
145285270|NCT02497391|523895323|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
145285271|NCT02497391|523895324|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
145285272|NCT02497391|523895325|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
145285273|NCT02497391|523895326|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
145285274|NCT02497391|523895327|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
145285275|NCT01664052|523895328|FG000|Phase 1|No device placement|6|||
145285276|NCT01664052|523895329|FG001|Phase 1|No device placement|0|||
145285277|NCT01664052|523895328|FG000|Phase 1|No HSG 1 hr post placement|1|||
145285278|NCT01664052|523895329|FG001|Phase 1|No HSG 1 hr post placement|0|||
145285279|NCT01664052|523895328|FG000|Phase 2|No device placement|0|||
145285280|NCT01664052|523895329|FG001|Phase 2|No device placement|4|||
145285281|NCT03740698|523895331|FG000|Overall Study|Physician Decision|0|||
145285282|NCT03740698|523895332|FG001|Overall Study|Physician Decision|1|||
145285283|NCT03740698|523895333|FG002|Overall Study|Physician Decision|1|||
145285284|NCT01466686|523895346|FG000|Overall Study|Withdrawal by Subject|1|||
145285285|NCT01927757|523895353|FG000|Overall Study|Withdrawal by Subject|14|||
145285286|NCT01927757|523895353|FG000|Overall Study|Lost to Follow-up|2|||
145285287|NCT01927757|523895353|FG000|Overall Study|Decision by Sponsor|2|||
145285288|NCT01927757|523895353|FG000|Overall Study|Other|1|||
145285289|NCT01927757|523895353|FG000|Overall Study|Ethical Reasons|4|||
145285290|NCT04480463|523895356|FG000|Overall Study|Death|0|||
145285291|NCT04480463|523895357|FG001|Overall Study|Death|1|||
145285292|NCT04480463|523895356|FG000|Overall Study|Adverse Event|6|||
145285293|NCT04480463|523895357|FG001|Overall Study|Adverse Event|8|||
145285294|NCT04480463|523895356|FG000|Overall Study|Lost to Follow-up|3|||
145285295|NCT04480463|523895357|FG001|Overall Study|Lost to Follow-up|2|||
145406287|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
145406288|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
145406289|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
145406290|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
145406291|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
145406292|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
145406293|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
145406294|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
145406295|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
145406296|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
145406297|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
145406298|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
145406299|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
145555476|NCT03108027|524892549|FG000|Period 3|Adverse Event|0|||
145555477|NCT03108027|524892550|FG001|Period 3|Adverse Event|1|||
145555478|NCT03108027|524892551|FG002|Period 3|Adverse Event|0|||
145555479|NCT03108027|524892552|FG003|Period 3|Adverse Event|0|||
145555480|NCT03108027|524892553|FG004|Period 3|Adverse Event|0|||
145555481|NCT03108027|524892554|FG005|Period 3|Adverse Event|0|||
145555482|NCT02426892|524892555|FG000|Overall Study|Adverse Event|2|||
145555483|NCT02426892|524892555|FG000|Overall Study|Lack of Efficacy|17|||
145555484|NCT02426892|524892555|FG000|Overall Study|Withdrawal by Subject|1|||
145555485|NCT02574247|524892556|FG000|Overall Study|Withdrawal by Subject|1|||
145555486|NCT02574247|524892557|FG001|Overall Study|Withdrawal by Subject|0|||
145555487|NCT02574247|524892558|FG002|Overall Study|Withdrawal by Subject|0|||
145555488|NCT02574247|524892556|FG000|Overall Study|Did not meet inclusion criteria|4|||
145555489|NCT02574247|524892557|FG001|Overall Study|Did not meet inclusion criteria|3|||
145555490|NCT02574247|524892558|FG002|Overall Study|Did not meet inclusion criteria|5|||
145555491|NCT01382446|524892559|FG000|Overall Study|Withdrawal by Subject|0|||
145555492|NCT01382446|524892560|FG001|Overall Study|Withdrawal by Subject|1|||
145555493|NCT01382446|524892559|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
145555494|NCT01382446|524892560|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
145555495|NCT00495170|524892565|FG000|Overall Study|Lost to Follow-up|9|||
145406300|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
145406301|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
145555496|NCT00495170|524892565|FG000|Overall Study|Withdrawal by Subject|3|||
145555497|NCT00495170|524892565|FG000|Overall Study|Inappropriate staging|8|||
145555498|NCT02617511|524892572|FG000|Overall Study|Withdrawal by Subject|1|||
145555499|NCT02617511|524892573|FG001|Overall Study|Withdrawal by Subject|0|||
145555500|NCT00255047|524892574|FG000|Overall Study|Serious Adverse Events|2|||
145406302|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
145406303|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
145616871|NCT03230864|525111359|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
145285296|NCT04480463|523895356|FG000|Overall Study|Physician Decision|2|||
145285297|NCT04480463|523895357|FG001|Overall Study|Physician Decision|5|||
145285298|NCT04480463|523895356|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
145285299|NCT04480463|523895357|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
145285300|NCT04480463|523895356|FG000|Overall Study|Protocol Violation|2|||
145285301|NCT04480463|523895357|FG001|Overall Study|Protocol Violation|1|||
145285302|NCT04480463|523895356|FG000|Overall Study|Withdrawal by Subject|6|||
145285303|NCT04480463|523895357|FG001|Overall Study|Withdrawal by Subject|7|||
145285304|NCT04480463|523895356|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
145285305|NCT04480463|523895357|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
145285306|NCT04480463|523895356|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
145285307|NCT04480463|523895357|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
145285308|NCT04480463|523895356|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
145285309|NCT04480463|523895357|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
145285310|NCT04480463|523895356|FG000|Overall Study|Other|6|||
145406304|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
145555501|NCT00255047|524892575|FG001|Overall Study|Serious Adverse Events|1|||
145555502|NCT00255047|524892576|FG002|Overall Study|Serious Adverse Events|2|||
145555503|NCT00255047|524892577|FG003|Overall Study|Serious Adverse Events|1|||
145555504|NCT00255047|524892574|FG000|Overall Study|Adverse Event|0|||
145555505|NCT00255047|524892575|FG001|Overall Study|Adverse Event|3|||
145555506|NCT00255047|524892576|FG002|Overall Study|Adverse Event|2|||
145555507|NCT00255047|524892577|FG003|Overall Study|Adverse Event|1|||
145555508|NCT00255047|524892574|FG000|Overall Study|Protocol Violation|13|||
145555509|NCT00255047|524892575|FG001|Overall Study|Protocol Violation|13|||
145555510|NCT00255047|524892576|FG002|Overall Study|Protocol Violation|16|||
145555511|NCT00255047|524892577|FG003|Overall Study|Protocol Violation|20|||
145555512|NCT00255047|524892574|FG000|Overall Study|Lost to Follow-up|9|||
145555513|NCT00255047|524892575|FG001|Overall Study|Lost to Follow-up|8|||
145285311|NCT04480463|523895357|FG001|Overall Study|Other|4|||
145555514|NCT00255047|524892576|FG002|Overall Study|Lost to Follow-up|5|||
145555515|NCT00255047|524892577|FG003|Overall Study|Lost to Follow-up|6|||
145555516|NCT00255047|524892574|FG000|Overall Study|Withdrawal by Subject|24|||
145555517|NCT00255047|524892575|FG001|Overall Study|Withdrawal by Subject|23|||
145555518|NCT00255047|524892576|FG002|Overall Study|Withdrawal by Subject|25|||
145555519|NCT00255047|524892577|FG003|Overall Study|Withdrawal by Subject|18|||
145555520|NCT00811473|524892578|FG000|Overall Study|Adverse Event|3|||
145555521|NCT00811473|524892579|FG001|Overall Study|Adverse Event|12|||
145555522|NCT00811473|524892578|FG000|Overall Study|Lost to Follow-up|5|||
145555523|NCT00811473|524892579|FG001|Overall Study|Lost to Follow-up|1|||
145555524|NCT00811473|524892578|FG000|Overall Study|Withdrawal by Subject|2|||
145555525|NCT00811473|524892579|FG001|Overall Study|Withdrawal by Subject|4|||
145555526|NCT00811473|524892578|FG000|Overall Study|Severe non-compliance to protocol|2|||
145555527|NCT00811473|524892579|FG001|Overall Study|Severe non-compliance to protocol|4|||
145555528|NCT00811473|524892578|FG000|Overall Study|Lack of therapeutic response|4|||
145555529|NCT00811473|524892579|FG001|Overall Study|Lack of therapeutic response|1|||
145555530|NCT00811473|524892578|FG000|Overall Study|Condition under investigation worsened|1|||
145555531|NCT00811473|524892579|FG001|Overall Study|Condition under investigation worsened|3|||
145555532|NCT00811473|524892578|FG000|Overall Study|Other 2|4|||
145555533|NCT00811473|524892579|FG001|Overall Study|Other 2|1|||
145555534|NCT00811473|524892578|FG000|Overall Study|Incorrect Enrollment|1|||
145555535|NCT00811473|524892579|FG001|Overall Study|Incorrect Enrollment|0|||
145555536|NCT00811473|524892578|FG000|Overall Study|Safety Reasons|1|||
145555537|NCT00811473|524892579|FG001|Overall Study|Safety Reasons|0|||
145555538|NCT01119131|524892589|FG000|Overall Study|Adverse Event|1|||
145555539|NCT01119131|524892590|FG001|Overall Study|Adverse Event|1|||
145555540|NCT01119131|524892591|FG002|Overall Study|Adverse Event|1|||
145555541|NCT01119131|524892589|FG000|Overall Study|Non-Compliance|1|||
145555542|NCT01119131|524892590|FG001|Overall Study|Non-Compliance|0|||
145555543|NCT01119131|524892591|FG002|Overall Study|Non-Compliance|4|||
145555544|NCT01119131|524892589|FG000|Overall Study|Physician Decision|0|||
145555545|NCT01119131|524892590|FG001|Overall Study|Physician Decision|0|||
145555546|NCT01119131|524892591|FG002|Overall Study|Physician Decision|1|||
145555547|NCT00732615|524892592|FG000|Overall Study|Withdrawal by Subject|3|||
145555548|NCT00732615|524892593|FG001|Overall Study|Withdrawal by Subject|1|||
145555549|NCT00732615|524892592|FG000|Overall Study|Lost to Follow-up|0|||
145555550|NCT00732615|524892593|FG001|Overall Study|Lost to Follow-up|1|||
145555551|NCT00732615|524892592|FG000|Overall Study|Adverse Event|0|||
145555552|NCT00732615|524892593|FG001|Overall Study|Adverse Event|2|||
145555553|NCT00732615|524892592|FG000|Overall Study|Physician Decision|3|||
145555554|NCT00732615|524892593|FG001|Overall Study|Physician Decision|0|||
145555555|NCT00732615|524892592|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
145555556|NCT00732615|524892593|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
145555557|NCT00993291|524892594|FG000|Overall Study|Withdrawal by Subject|1|||
145285312|NCT00444795|523895358|FG000|Overall Study|Not Treated|1|||
145407503|NCT03479905|524347044|FG002|Overall Study|Other airway method used|5|||
145285313|NCT00444795|523895358|FG000|Overall Study|Treated Prior to the Contract Date|2|||
145407504|NCT00862992|524347045|FG000|Overall Study|Adverse Event|2|||
145285314|NCT02322879|523895359|FG000|First Intervention|Physician Decision|1|||
145285315|NCT02322879|523895360|FG001|First Intervention|Physician Decision|0|||
145285316|NCT04081337|523895361|FG000|Overall Study|Adverse Event|0|||
145285317|NCT04081337|523895362|FG001|Overall Study|Adverse Event|1|||
145285318|NCT04081337|523895361|FG000|Overall Study|Withdrawal by Subject|2|||
145285319|NCT04081337|523895362|FG001|Overall Study|Withdrawal by Subject|0|||
145285320|NCT04081337|523895361|FG000|Overall Study|Physician Decision|1|||
145285321|NCT04081337|523895362|FG001|Overall Study|Physician Decision|2|||
145285322|NCT04081337|523895361|FG000|Overall Study|Lost to Follow-up|1|||
145285323|NCT04081337|523895362|FG001|Overall Study|Lost to Follow-up|0|||
145285324|NCT01464827|523895363|FG000|Overall Study|Adverse Event|0|||
145285325|NCT01464827|523895364|FG001|Overall Study|Adverse Event|0|||
145406305|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
145406306|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
145285326|NCT01464827|523895365|FG002|Overall Study|Adverse Event|0|||
145285327|NCT01464827|523895366|FG003|Overall Study|Adverse Event|0|||
145285328|NCT01464827|523895367|FG004|Overall Study|Adverse Event|0|||
145285329|NCT01464827|523895368|FG005|Overall Study|Adverse Event|0|||
145555558|NCT00003492|524892595|FG000|Overall Study|Not evaluable|6|||
145555559|NCT03566823|524892596|FG000|Overall Study|Lack of Efficacy|0|||
145285330|NCT01464827|523895369|FG006|Overall Study|Adverse Event|0|||
145285331|NCT01464827|523895370|FG007|Overall Study|Adverse Event|0|||
145285332|NCT01464827|523895371|FG008|Overall Study|Adverse Event|0|||
145285333|NCT01464827|523895372|FG009|Overall Study|Adverse Event|0|||
145285334|NCT01464827|523895373|FG010|Overall Study|Adverse Event|0|||
145285335|NCT01464827|523895374|FG011|Overall Study|Adverse Event|0|||
145285336|NCT01464827|523895375|FG012|Overall Study|Adverse Event|1|||
145285337|NCT01464827|523895376|FG013|Overall Study|Adverse Event|0|||
145285338|NCT01464827|523895363|FG000|Overall Study|Withdrawal by Subject|1|||
145285339|NCT01464827|523895364|FG001|Overall Study|Withdrawal by Subject|0|||
145285340|NCT01464827|523895365|FG002|Overall Study|Withdrawal by Subject|0|||
145285341|NCT01464827|523895366|FG003|Overall Study|Withdrawal by Subject|0|||
145285342|NCT01464827|523895367|FG004|Overall Study|Withdrawal by Subject|1|||
145285343|NCT01464827|523895368|FG005|Overall Study|Withdrawal by Subject|0|||
145285344|NCT01464827|523895369|FG006|Overall Study|Withdrawal by Subject|0|||
145285345|NCT01464827|523895370|FG007|Overall Study|Withdrawal by Subject|1|||
145285346|NCT01464827|523895371|FG008|Overall Study|Withdrawal by Subject|0|||
145285347|NCT01464827|523895372|FG009|Overall Study|Withdrawal by Subject|0|||
145285348|NCT01464827|523895373|FG010|Overall Study|Withdrawal by Subject|0|||
145285349|NCT01464827|523895374|FG011|Overall Study|Withdrawal by Subject|0|||
145285350|NCT01464827|523895375|FG012|Overall Study|Withdrawal by Subject|0|||
145285351|NCT01464827|523895376|FG013|Overall Study|Withdrawal by Subject|0|||
145285352|NCT01464827|523895363|FG000|Overall Study|Lost to Follow-up|0|||
145285353|NCT01464827|523895364|FG001|Overall Study|Lost to Follow-up|2|||
145285354|NCT01464827|523895365|FG002|Overall Study|Lost to Follow-up|0|||
145285355|NCT01464827|523895366|FG003|Overall Study|Lost to Follow-up|2|||
145285356|NCT01464827|523895367|FG004|Overall Study|Lost to Follow-up|3|||
145285357|NCT01464827|523895368|FG005|Overall Study|Lost to Follow-up|1|||
145285358|NCT01464827|523895369|FG006|Overall Study|Lost to Follow-up|2|||
145285359|NCT01464827|523895370|FG007|Overall Study|Lost to Follow-up|2|||
145285360|NCT01464827|523895371|FG008|Overall Study|Lost to Follow-up|0|||
145285361|NCT01464827|523895372|FG009|Overall Study|Lost to Follow-up|0|||
145285362|NCT01464827|523895373|FG010|Overall Study|Lost to Follow-up|0|||
145285363|NCT01464827|523895374|FG011|Overall Study|Lost to Follow-up|1|||
145285364|NCT01464827|523895375|FG012|Overall Study|Lost to Follow-up|0|||
145285365|NCT01464827|523895376|FG013|Overall Study|Lost to Follow-up|1|||
145285366|NCT01464827|523895363|FG000|Overall Study|Other|2|||
145285367|NCT01464827|523895364|FG001|Overall Study|Other|3|||
145285368|NCT01464827|523895365|FG002|Overall Study|Other|0|||
145285369|NCT01464827|523895366|FG003|Overall Study|Other|2|||
145285370|NCT01464827|523895367|FG004|Overall Study|Other|3|||
145285371|NCT01464827|523895368|FG005|Overall Study|Other|0|||
145285372|NCT01464827|523895369|FG006|Overall Study|Other|1|||
145285373|NCT01464827|523895370|FG007|Overall Study|Other|0|||
145285374|NCT01464827|523895371|FG008|Overall Study|Other|3|||
145285375|NCT01464827|523895372|FG009|Overall Study|Other|1|||
145285376|NCT01464827|523895373|FG010|Overall Study|Other|2|||
145285377|NCT01464827|523895374|FG011|Overall Study|Other|0|||
145285378|NCT01464827|523895375|FG012|Overall Study|Other|1|||
145555560|NCT03566823|524892597|FG001|Overall Study|Lack of Efficacy|1|||
145555561|NCT03566823|524892598|FG002|Overall Study|Lack of Efficacy|0|||
145555562|NCT03566823|524892596|FG000|Overall Study|Withdrawal by Subject|1|||
145285379|NCT01464827|523895376|FG013|Overall Study|Other|0|||
145285380|NCT01464827|523895363|FG000|Overall Study|Not Treated|0|||
145285381|NCT01464827|523895364|FG001|Overall Study|Not Treated|2|||
145285382|NCT01464827|523895365|FG002|Overall Study|Not Treated|0|||
145285383|NCT01464827|523895366|FG003|Overall Study|Not Treated|0|||
145285384|NCT01464827|523895367|FG004|Overall Study|Not Treated|1|||
145285385|NCT01464827|523895368|FG005|Overall Study|Not Treated|0|||
145285386|NCT01464827|523895369|FG006|Overall Study|Not Treated|1|||
145555563|NCT03566823|524892597|FG001|Overall Study|Withdrawal by Subject|2|||
145285387|NCT01464827|523895370|FG007|Overall Study|Not Treated|0|||
145285388|NCT01464827|523895371|FG008|Overall Study|Not Treated|0|||
145285389|NCT01464827|523895372|FG009|Overall Study|Not Treated|2|||
145285390|NCT01464827|523895373|FG010|Overall Study|Not Treated|0|||
145285391|NCT01464827|523895374|FG011|Overall Study|Not Treated|1|||
145285392|NCT01464827|523895375|FG012|Overall Study|Not Treated|0|||
145285393|NCT01464827|523895376|FG013|Overall Study|Not Treated|2|||
145285394|NCT03487796|523895377|FG000|Overall Study|Lost to Follow-up|18|||
145285395|NCT03487796|523895378|FG001|Overall Study|Lost to Follow-up|6|||
145285396|NCT00613574|523895387|FG000|Overall Study|Adverse Event|3|||
145285397|NCT00613574|523895387|FG000|Overall Study|Lost to Follow-up|2|||
145285398|NCT00613574|523895387|FG000|Overall Study|Other|1|||
145285399|NCT02711956|523895389|FG000|Overall Study|Adverse Event|0|||
145285400|NCT02711956|523895390|FG001|Overall Study|Adverse Event|0|||
145285401|NCT02711956|523895391|FG002|Overall Study|Adverse Event|0|||
145285402|NCT02711956|523895392|FG003|Overall Study|Adverse Event|1|||
145285403|NCT02711956|523895393|FG004|Overall Study|Adverse Event|2|||
145285404|NCT02711956|523895394|FG005|Overall Study|Adverse Event|0|||
145285405|NCT02711956|523895395|FG006|Overall Study|Adverse Event|0|||
145285406|NCT02711956|523895396|FG007|Overall Study|Adverse Event|1|||
145285407|NCT02711956|523895397|FG008|Overall Study|Adverse Event|1|||
145285408|NCT02711956|523895398|FG009|Overall Study|Adverse Event|1|||
145285409|NCT02711956|523895399|FG010|Overall Study|Adverse Event|1|||
145285410|NCT02711956|523895400|FG011|Overall Study|Adverse Event|0|||
145285411|NCT02711956|523895401|FG012|Overall Study|Adverse Event|0|||
145285412|NCT02711956|523895402|FG013|Overall Study|Adverse Event|0|||
145285413|NCT02711956|523895403|FG014|Overall Study|Adverse Event|2|||
145285414|NCT02711956|523895389|FG000|Overall Study|Physician Decision|0|||
145285415|NCT02711956|523895390|FG001|Overall Study|Physician Decision|0|||
145285416|NCT02711956|523895391|FG002|Overall Study|Physician Decision|0|||
145285417|NCT02711956|523895392|FG003|Overall Study|Physician Decision|2|||
145285418|NCT02711956|523895393|FG004|Overall Study|Physician Decision|0|||
145285419|NCT02711956|523895394|FG005|Overall Study|Physician Decision|0|||
145285420|NCT02711956|523895395|FG006|Overall Study|Physician Decision|0|||
145285421|NCT02711956|523895396|FG007|Overall Study|Physician Decision|0|||
145285422|NCT02711956|523895397|FG008|Overall Study|Physician Decision|0|||
145285423|NCT02711956|523895398|FG009|Overall Study|Physician Decision|0|||
145285424|NCT02711956|523895399|FG010|Overall Study|Physician Decision|0|||
145285425|NCT02711956|523895400|FG011|Overall Study|Physician Decision|0|||
145285426|NCT02711956|523895401|FG012|Overall Study|Physician Decision|0|||
145285427|NCT02711956|523895402|FG013|Overall Study|Physician Decision|0|||
145285428|NCT02711956|523895403|FG014|Overall Study|Physician Decision|0|||
145285429|NCT02711956|523895389|FG000|Overall Study|Withdrawal by Subject|0|||
145285430|NCT02711956|523895390|FG001|Overall Study|Withdrawal by Subject|0|||
145285431|NCT02711956|523895391|FG002|Overall Study|Withdrawal by Subject|0|||
145285432|NCT02711956|523895392|FG003|Overall Study|Withdrawal by Subject|0|||
145285433|NCT02711956|523895393|FG004|Overall Study|Withdrawal by Subject|0|||
145285434|NCT02711956|523895394|FG005|Overall Study|Withdrawal by Subject|0|||
145285435|NCT02711956|523895395|FG006|Overall Study|Withdrawal by Subject|1|||
145285436|NCT02711956|523895396|FG007|Overall Study|Withdrawal by Subject|0|||
145285437|NCT02711956|523895397|FG008|Overall Study|Withdrawal by Subject|0|||
145285438|NCT02711956|523895398|FG009|Overall Study|Withdrawal by Subject|0|||
145285439|NCT02711956|523895399|FG010|Overall Study|Withdrawal by Subject|0|||
145285440|NCT02711956|523895400|FG011|Overall Study|Withdrawal by Subject|1|||
145285441|NCT02711956|523895401|FG012|Overall Study|Withdrawal by Subject|6|||
145555564|NCT03566823|524892598|FG002|Overall Study|Withdrawal by Subject|0|||
145555565|NCT03566823|524892596|FG000|Overall Study|Adverse Event|1|||
145555566|NCT03566823|524892597|FG001|Overall Study|Adverse Event|0|||
145555567|NCT03566823|524892598|FG002|Overall Study|Adverse Event|2|||
145285442|NCT02711956|523895402|FG013|Overall Study|Withdrawal by Subject|0|||
145285443|NCT02711956|523895403|FG014|Overall Study|Withdrawal by Subject|1|||
145285444|NCT02711956|523895389|FG000|Overall Study|Clinical progression|1|||
145285445|NCT02711956|523895390|FG001|Overall Study|Clinical progression|0|||
145285446|NCT02711956|523895391|FG002|Overall Study|Clinical progression|0|||
145285447|NCT02711956|523895392|FG003|Overall Study|Clinical progression|0|||
145285448|NCT02711956|523895393|FG004|Overall Study|Clinical progression|0|||
145285449|NCT02711956|523895394|FG005|Overall Study|Clinical progression|0|||
145285450|NCT02711956|523895395|FG006|Overall Study|Clinical progression|1|||
145285451|NCT02711956|523895396|FG007|Overall Study|Clinical progression|0|||
145285452|NCT02711956|523895397|FG008|Overall Study|Clinical progression|1|||
145285453|NCT02711956|523895398|FG009|Overall Study|Clinical progression|0|||
145285454|NCT02711956|523895399|FG010|Overall Study|Clinical progression|0|||
145285455|NCT02711956|523895400|FG011|Overall Study|Clinical progression|2|||
145285456|NCT02711956|523895401|FG012|Overall Study|Clinical progression|4|||
145285457|NCT02711956|523895402|FG013|Overall Study|Clinical progression|1|||
145285458|NCT02711956|523895403|FG014|Overall Study|Clinical progression|1|||
145285459|NCT02711956|523895389|FG000|Overall Study|Radiographic progression|1|||
145285460|NCT02711956|523895390|FG001|Overall Study|Radiographic progression|1|||
145285461|NCT02711956|523895391|FG002|Overall Study|Radiographic progression|2|||
145285462|NCT02711956|523895392|FG003|Overall Study|Radiographic progression|0|||
145285463|NCT02711956|523895393|FG004|Overall Study|Radiographic progression|1|||
145285464|NCT02711956|523895394|FG005|Overall Study|Radiographic progression|0|||
145555568|NCT01528254|524892599|FG000|Overall Study|Administrative problems|96|||
145555569|NCT01528254|524892600|FG001|Overall Study|Administrative problems|94|||
145555570|NCT01528254|524892599|FG000|Overall Study|Adverse Event|28|||
145555571|NCT01528254|524892600|FG001|Overall Study|Adverse Event|44|||
145555572|NCT01528254|524892599|FG000|Overall Study|Lost to Follow-up|17|||
145555573|NCT01528254|524892600|FG001|Overall Study|Lost to Follow-up|24|||
145555574|NCT01528254|524892599|FG000|Overall Study|Death|13|||
145555575|NCT01528254|524892600|FG001|Overall Study|Death|9|||
145555576|NCT01528254|524892599|FG000|Overall Study|Protocol deviation|9|||
145555577|NCT01528254|524892600|FG001|Overall Study|Protocol deviation|19|||
145555578|NCT01528254|524892599|FG000|Overall Study|New therapy for study indication|8|||
145285465|NCT02711956|523895395|FG006|Overall Study|Radiographic progression|0|||
145285466|NCT02711956|523895396|FG007|Overall Study|Radiographic progression|0|||
145285467|NCT02711956|523895397|FG008|Overall Study|Radiographic progression|2|||
145285468|NCT02711956|523895398|FG009|Overall Study|Radiographic progression|1|||
145555579|NCT01528254|524892600|FG001|Overall Study|New therapy for study indication|6|||
145555580|NCT01528254|524892599|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
145555581|NCT01528254|524892600|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
145555582|NCT01528254|524892599|FG000|Overall Study|Withdrawal by Subject|5|||
145285469|NCT02711956|523895399|FG010|Overall Study|Radiographic progression|0|||
145555583|NCT01528254|524892600|FG001|Overall Study|Withdrawal by Subject|4|||
145555584|NCT01528254|524892599|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145407505|NCT00862992|524347046|FG001|Overall Study|Adverse Event|1|||
145555585|NCT01528254|524892600|FG001|Overall Study|Abnormal laboratory value(s)|7|||
145555586|NCT01528254|524892599|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145555587|NCT01528254|524892600|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145555588|NCT01528254|524892599|FG000|Overall Study|No longer requires study drug|1|||
145555589|NCT01528254|524892600|FG001|Overall Study|No longer requires study drug|1|||
145555590|NCT04446377|524892601|FG000|Overall Study|Withdrawal by Subject|6|||
145555591|NCT04446377|524892602|FG001|Overall Study|Withdrawal by Subject|1|||
145555592|NCT04446377|524892601|FG000|Overall Study|Physician Decision|1|||
145555593|NCT04446377|524892602|FG001|Overall Study|Physician Decision|1|||
145555594|NCT04446377|524892601|FG000|Overall Study|Lost to Follow-up|0|||
145555595|NCT04446377|524892602|FG001|Overall Study|Lost to Follow-up|2|||
145555596|NCT04446377|524892601|FG000|Overall Study|Not eligible|0|||
145555597|NCT04446377|524892602|FG001|Overall Study|Not eligible|1|||
145555598|NCT00737282|524892603|FG000|Overall Study|Study prematurely terminated|175|||
145555599|NCT02763189|524892604|FG000|Overall Study|Device failure|0|||
145555600|NCT02763189|524892605|FG001|Overall Study|Device failure|2|||
145555601|NCT02049957|524892606|FG000|Overall Study|Progressive Disease|5|||
145285470|NCT02711956|523895400|FG011|Overall Study|Radiographic progression|5|||
145285471|NCT02711956|523895401|FG012|Overall Study|Radiographic progression|3|||
145285472|NCT02711956|523895402|FG013|Overall Study|Radiographic progression|0|||
145285473|NCT02711956|523895403|FG014|Overall Study|Radiographic progression|1|||
145285474|NCT02711956|523895389|FG000|Overall Study|PSA progression with clinical progression|0|||
145555602|NCT02049957|524892607|FG001|Overall Study|Progressive Disease|4|||
145285475|NCT02711956|523895390|FG001|Overall Study|PSA progression with clinical progression|0|||
145285476|NCT02711956|523895391|FG002|Overall Study|PSA progression with clinical progression|0|||
145285477|NCT02711956|523895392|FG003|Overall Study|PSA progression with clinical progression|0|||
145407506|NCT00862992|524347047|FG002|Overall Study|Adverse Event|1|||
145555603|NCT02049957|524892608|FG002|Overall Study|Progressive Disease|2|||
145555604|NCT02049957|524892609|FG003|Overall Study|Progressive Disease|2|||
145555605|NCT02049957|524892610|FG004|Overall Study|Progressive Disease|6|||
145555606|NCT02049957|524892611|FG005|Overall Study|Progressive Disease|35|||
145555607|NCT02049957|524892612|FG006|Overall Study|Progressive Disease|7|||
145555608|NCT02049957|524892613|FG007|Overall Study|Progressive Disease|26|||
145555609|NCT02049957|524892614|FG008|Overall Study|Progressive Disease|6|||
145555610|NCT02049957|524892606|FG000|Overall Study|Adverse Event|1|||
145555611|NCT02049957|524892607|FG001|Overall Study|Adverse Event|1|||
145555612|NCT02049957|524892608|FG002|Overall Study|Adverse Event|1|||
145555613|NCT02049957|524892609|FG003|Overall Study|Adverse Event|0|||
145555614|NCT02049957|524892610|FG004|Overall Study|Adverse Event|0|||
145555615|NCT02049957|524892611|FG005|Overall Study|Adverse Event|5|||
145285478|NCT02711956|523895393|FG004|Overall Study|PSA progression with clinical progression|1|||
145285479|NCT02711956|523895394|FG005|Overall Study|PSA progression with clinical progression|0|||
145285480|NCT02711956|523895395|FG006|Overall Study|PSA progression with clinical progression|0|||
145285481|NCT02711956|523895396|FG007|Overall Study|PSA progression with clinical progression|0|||
145285482|NCT02711956|523895397|FG008|Overall Study|PSA progression with clinical progression|0|||
145285483|NCT02711956|523895398|FG009|Overall Study|PSA progression with clinical progression|0|||
145555616|NCT02049957|524892612|FG006|Overall Study|Adverse Event|0|||
145555617|NCT02049957|524892613|FG007|Overall Study|Adverse Event|6|||
145285484|NCT02711956|523895399|FG010|Overall Study|PSA progression with clinical progression|0|||
145285485|NCT02711956|523895400|FG011|Overall Study|PSA progression with clinical progression|0|||
145285486|NCT02711956|523895401|FG012|Overall Study|PSA progression with clinical progression|1|||
145285487|NCT02711956|523895402|FG013|Overall Study|PSA progression with clinical progression|1|||
145555618|NCT02049957|524892614|FG008|Overall Study|Adverse Event|1|||
145555619|NCT02049957|524892606|FG000|Overall Study|Study Terminated by Sponsor|0|||
145407507|NCT00862992|524347045|FG000|Overall Study|Physician Decision|1|||
145555620|NCT02049957|524892607|FG001|Overall Study|Study Terminated by Sponsor|1|||
145555621|NCT02049957|524892608|FG002|Overall Study|Study Terminated by Sponsor|0|||
145555622|NCT02049957|524892609|FG003|Overall Study|Study Terminated by Sponsor|0|||
145555623|NCT02049957|524892610|FG004|Overall Study|Study Terminated by Sponsor|0|||
145407508|NCT00862992|524347046|FG001|Overall Study|Physician Decision|0|||
145555624|NCT02049957|524892611|FG005|Overall Study|Study Terminated by Sponsor|0|||
145555625|NCT02049957|524892612|FG006|Overall Study|Study Terminated by Sponsor|1|||
145555626|NCT02049957|524892613|FG007|Overall Study|Study Terminated by Sponsor|0|||
145555627|NCT02049957|524892614|FG008|Overall Study|Study Terminated by Sponsor|0|||
145285488|NCT02711956|523895403|FG014|Overall Study|PSA progression with clinical progression|0|||
145285489|NCT02711956|523895389|FG000|Overall Study|PSA progression with radiographic progression|0|||
145285490|NCT02711956|523895390|FG001|Overall Study|PSA progression with radiographic progression|1|||
145285491|NCT02711956|523895391|FG002|Overall Study|PSA progression with radiographic progression|0|||
145285492|NCT02711956|523895392|FG003|Overall Study|PSA progression with radiographic progression|0|||
145285493|NCT02711956|523895393|FG004|Overall Study|PSA progression with radiographic progression|0|||
145285494|NCT02711956|523895394|FG005|Overall Study|PSA progression with radiographic progression|2|||
145285495|NCT02711956|523895395|FG006|Overall Study|PSA progression with radiographic progression|2|||
145285496|NCT02711956|523895396|FG007|Overall Study|PSA progression with radiographic progression|1|||
145285497|NCT02711956|523895397|FG008|Overall Study|PSA progression with radiographic progression|0|||
145285498|NCT02711956|523895398|FG009|Overall Study|PSA progression with radiographic progression|1|||
145285499|NCT02711956|523895399|FG010|Overall Study|PSA progression with radiographic progression|0|||
145555628|NCT02049957|524892606|FG000|Overall Study|Withdrawal by Subject|0|||
145555629|NCT02049957|524892607|FG001|Overall Study|Withdrawal by Subject|0|||
145555630|NCT02049957|524892608|FG002|Overall Study|Withdrawal by Subject|0|||
145555631|NCT02049957|524892609|FG003|Overall Study|Withdrawal by Subject|1|||
145555632|NCT02049957|524892610|FG004|Overall Study|Withdrawal by Subject|0|||
145555633|NCT02049957|524892611|FG005|Overall Study|Withdrawal by Subject|2|||
145555634|NCT02049957|524892612|FG006|Overall Study|Withdrawal by Subject|0|||
145555635|NCT02049957|524892613|FG007|Overall Study|Withdrawal by Subject|3|||
145555636|NCT02049957|524892614|FG008|Overall Study|Withdrawal by Subject|1|||
145616872|NCT03230864|525111360|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
145406307|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
145406308|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
145285500|NCT02711956|523895400|FG011|Overall Study|PSA progression with radiographic progression|1|||
145406309|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
145555637|NCT02049957|524892606|FG000|Overall Study|Physician Decision|0|||
145555638|NCT02049957|524892607|FG001|Overall Study|Physician Decision|0|||
145555639|NCT02049957|524892608|FG002|Overall Study|Physician Decision|0|||
145555640|NCT02049957|524892609|FG003|Overall Study|Physician Decision|0|||
145555641|NCT02049957|524892610|FG004|Overall Study|Physician Decision|0|||
145555642|NCT02049957|524892611|FG005|Overall Study|Physician Decision|1|||
145555643|NCT02049957|524892612|FG006|Overall Study|Physician Decision|0|||
145555644|NCT02049957|524892613|FG007|Overall Study|Physician Decision|0|||
145555645|NCT02049957|524892614|FG008|Overall Study|Physician Decision|0|||
145555646|NCT01414075|524892615|FG000|Overall Study|Adverse Event|1|||
145555647|NCT01414075|524892616|FG001|Overall Study|Adverse Event|0|||
145555648|NCT01414075|524892617|FG002|Overall Study|Adverse Event|1|||
145555649|NCT01414075|524892618|FG003|Overall Study|Adverse Event|0|||
145555650|NCT01414075|524892615|FG000|Overall Study|Death|1|||
145555651|NCT01414075|524892616|FG001|Overall Study|Death|0|||
145285501|NCT02711956|523895401|FG012|Overall Study|PSA progression with radiographic progression|2|||
145285502|NCT02711956|523895402|FG013|Overall Study|PSA progression with radiographic progression|3|||
145285503|NCT02711956|523895403|FG014|Overall Study|PSA progression with radiographic progression|3|||
145285504|NCT05487456|523895404|FG000|Overall Study|Withdrawal by Subject|0|||
145285505|NCT05487456|523895405|FG001|Overall Study|Withdrawal by Subject|0|||
145285506|NCT05487456|523895406|FG002|Overall Study|Withdrawal by Subject|1|||
145285507|NCT05487456|523895407|FG003|Overall Study|Withdrawal by Subject|0|||
145285508|NCT01625377|523895410|FG000|Overall Study|Death|1|||
145285509|NCT01625377|523895411|FG001|Overall Study|Death|1|||
145285510|NCT01625377|523895410|FG000|Overall Study|Administrative Problem|1|||
145285511|NCT01625377|523895411|FG001|Overall Study|Administrative Problem|1|||
145285512|NCT01625377|523895410|FG000|Overall Study|Protocol Violation|0|||
145285513|NCT01625377|523895411|FG001|Overall Study|Protocol Violation|3|||
145285514|NCT01625377|523895410|FG000|Overall Study|Adverse Event|3|||
145285515|NCT01625377|523895411|FG001|Overall Study|Adverse Event|16|||
145285516|NCT01625377|523895410|FG000|Overall Study|Graft loss|1|||
145285517|NCT01625377|523895411|FG001|Overall Study|Graft loss|0|||
145285518|NCT01625377|523895410|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145406310|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
145406311|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
145285519|NCT01625377|523895411|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145285520|NCT01625377|523895410|FG000|Overall Study|Abnormal laboratory values|1|||
145285521|NCT01625377|523895411|FG001|Overall Study|Abnormal laboratory values|0|||
145285522|NCT02043366|523895412|FG000|Overall Study|Lost to Follow-up|2|||
145285523|NCT02043366|523895413|FG001|Overall Study|Lost to Follow-up|2|||
145406312|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
145406313|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
145406314|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
145407509|NCT00862992|524347047|FG002|Overall Study|Physician Decision|0|||
145285524|NCT02043366|523895414|FG002|Overall Study|Lost to Follow-up|2|||
145285525|NCT02043366|523895415|FG003|Overall Study|Lost to Follow-up|2|||
145285526|NCT02043366|523895416|FG004|Overall Study|Lost to Follow-up|2|||
145285527|NCT02043366|523895417|FG005|Overall Study|Lost to Follow-up|2|||
145555652|NCT01414075|524892617|FG002|Overall Study|Death|0|||
145555653|NCT01414075|524892618|FG003|Overall Study|Death|1|||
145555654|NCT01414075|524892615|FG000|Overall Study|Withdrawal by Subject|0|||
145555655|NCT01414075|524892616|FG001|Overall Study|Withdrawal by Subject|0|||
145555656|NCT01414075|524892617|FG002|Overall Study|Withdrawal by Subject|0|||
145555657|NCT01414075|524892618|FG003|Overall Study|Withdrawal by Subject|1|||
145555658|NCT01414075|524892615|FG000|Overall Study|Other than specified|1|||
145555659|NCT01414075|524892616|FG001|Overall Study|Other than specified|0|||
145555660|NCT01414075|524892617|FG002|Overall Study|Other than specified|1|||
145555661|NCT01414075|524892618|FG003|Overall Study|Other than specified|0|||
145555662|NCT02810392|524892620|FG000|Overall Study|Subject too ill to continue|1|||
145406315|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
145285528|NCT01489956|523895420|FG000|Overall Study|Lost to Follow-up|1|||
145285529|NCT01489956|523895421|FG001|Overall Study|Lost to Follow-up|0|||
145285530|NCT01489956|523895422|FG002|Overall Study|Lost to Follow-up|0|||
145285531|NCT01489956|523895420|FG000|Overall Study|Withdrawal by Subject|0|||
145285532|NCT01489956|523895421|FG001|Overall Study|Withdrawal by Subject|0|||
145285533|NCT01489956|523895422|FG002|Overall Study|Withdrawal by Subject|1|||
145285534|NCT01769378|523895425|FG000|Overall Study|Adverse Event|10|||
145612703|NCT04524598|525097226|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612704|NCT04524598|525097227|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612705|NCT04524598|525097228|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
145612706|NCT04524598|525097229|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
145612707|NCT04524598|525097230|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612708|NCT04524598|525097226|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
145612709|NCT04524598|525097227|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
145612710|NCT04524598|525097228|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
145612711|NCT04524598|525097229|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
145612712|NCT04524598|525097230|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
145612713|NCT04524598|525097226|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612714|NCT04524598|525097227|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612715|NCT04524598|525097228|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612716|NCT04524598|525097229|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
145612717|NCT04524598|525097230|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
145612718|NCT02301156|525097231|FG000|Overall Study|Adverse Event|13|||
145612719|NCT02301156|525097232|FG001|Overall Study|Adverse Event|14|||
145612720|NCT02301156|525097231|FG000|Overall Study|Death|1|||
145612721|NCT02301156|525097232|FG001|Overall Study|Death|5|||
145612722|NCT02301156|525097231|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
145612723|NCT02301156|525097232|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
145612724|NCT02301156|525097231|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
145612725|NCT02301156|525097232|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
145612726|NCT02301156|525097231|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
145612727|NCT02301156|525097232|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
145612728|NCT02301156|525097231|FG000|Overall Study|Reason not Specified|6|||
145612729|NCT02301156|525097232|FG001|Overall Study|Reason not Specified|3|||
145612730|NCT02638623|525097233|FG000|Overall Study|Surgery timing|5|||
145612731|NCT02638623|525097234|FG001|Overall Study|Surgery timing|6|||
145612732|NCT02638623|525097233|FG000|Overall Study|Not given intervention|2|||
145612733|NCT02638623|525097234|FG001|Overall Study|Not given intervention|0|||
145612734|NCT00118092|525097237|FG000|Overall Study|Withdrawal by Subject|1|||
145612735|NCT00118092|525097237|FG000|Overall Study|Protocol Violation|1|||
145612736|NCT02459093|525097242|FG000|Overall Study|Protocol Violation|6|||
145612737|NCT02459093|525097243|FG001|Overall Study|Protocol Violation|11|||
145612738|NCT02459093|525097242|FG000|Overall Study|Lost to Follow-up|6|||
145612739|NCT02459093|525097243|FG001|Overall Study|Lost to Follow-up|7|||
145612740|NCT00591864|525097244|FG000|Overall Study|Incomplete Imaging|5|||
145612741|NCT01164228|525097245|FG000|Overall Study|Progression|24|||
145612742|NCT01164228|525097246|FG001|Overall Study|Progression|25|||
145612743|NCT01164228|525097245|FG000|Overall Study|Adverse Event|13|||
145612744|NCT01164228|525097246|FG001|Overall Study|Adverse Event|7|||
145612745|NCT01164228|525097245|FG000|Overall Study|Death|1|||
145612746|NCT01164228|525097246|FG001|Overall Study|Death|1|||
145612747|NCT01164228|525097245|FG000|Overall Study|Withdrawal by Subject|2|||
145612748|NCT01164228|525097246|FG001|Overall Study|Withdrawal by Subject|0|||
145612749|NCT01164228|525097245|FG000|Overall Study|Physician Decision|1|||
145612750|NCT01164228|525097246|FG001|Overall Study|Physician Decision|2|||
145612751|NCT01164228|525097245|FG000|Overall Study|Symptomatic deterioration|1|||
145612752|NCT01164228|525097246|FG001|Overall Study|Symptomatic deterioration|0|||
145612753|NCT01164228|525097245|FG000|Overall Study|Never started treatment|1|||
145612754|NCT01164228|525097246|FG001|Overall Study|Never started treatment|3|||
145612755|NCT01164228|525097245|FG000|Overall Study|Ineligible|1|||
145612756|NCT01164228|525097246|FG001|Overall Study|Ineligible|0|||
145612757|NCT02090634|525097247|FG000|Overall Study|Lost to Follow-up|0|||
145612758|NCT02090634|525097248|FG001|Overall Study|Lost to Follow-up|1|||
145612759|NCT02090634|525097247|FG000|Overall Study|Death|0|||
145612760|NCT02090634|525097248|FG001|Overall Study|Death|1|||
145612761|NCT02090634|525097247|FG000|Overall Study|Protocol Violation|3|||
145612762|NCT02090634|525097248|FG001|Overall Study|Protocol Violation|1|||
145612763|NCT02090634|525097247|FG000|Overall Study|Adverse Event|2|||
145612764|NCT02090634|525097248|FG001|Overall Study|Adverse Event|0|||
145612765|NCT03342053|525097251|FG000|Overall Study|Adverse Event|2|||
145285535|NCT01769378|523895426|FG001|Overall Study|Adverse Event|0|||
145285536|NCT01769378|523895425|FG000|Overall Study|Entry criteria not met|1|||
145612766|NCT03342053|525097252|FG001|Overall Study|Adverse Event|0|||
145612767|NCT03342053|525097251|FG000|Overall Study|Withdrawal by Subject|0|||
145612768|NCT03342053|525097252|FG001|Overall Study|Withdrawal by Subject|1|||
145612769|NCT00735644|525097253|FG000|Overall Study|Did not receive study vaccine|0|||
145612770|NCT00735644|525097254|FG001|Overall Study|Did not receive study vaccine|1|||
145612771|NCT00735644|525097255|FG002|Overall Study|Did not receive study vaccine|0|||
145612772|NCT00735644|525097256|FG003|Overall Study|Did not receive study vaccine|0|||
145612773|NCT00735644|525097257|FG004|Overall Study|Did not receive study vaccine|0|||
145612774|NCT00735644|525097253|FG000|Overall Study|Withdrawal by Subject|0|||
145612775|NCT00735644|525097254|FG001|Overall Study|Withdrawal by Subject|1|||
145612776|NCT00735644|525097255|FG002|Overall Study|Withdrawal by Subject|1|||
145612777|NCT00735644|525097256|FG003|Overall Study|Withdrawal by Subject|1|||
145612778|NCT00735644|525097257|FG004|Overall Study|Withdrawal by Subject|0|||
145612779|NCT00621296|525097262|FG000|Overall Study|Adverse Event|2|||
145612780|NCT00621296|525097262|FG000|Overall Study|Lack of Efficacy|1|||
145612781|NCT00621296|525097262|FG000|Overall Study|Physician Decision|7|||
145612782|NCT00621296|525097262|FG000|Overall Study|Unmatch Criteria|1|||
145612783|NCT00621296|525097262|FG000|Overall Study|Stopping Criteria|3|||
145612784|NCT04249336|525099202|FG000|Overall Study|Lost to Follow-up|3|||
145612785|NCT04249336|525099203|FG001|Overall Study|Lost to Follow-up|3|||
145612786|NCT04249336|525099204|FG002|Overall Study|Lost to Follow-up|3|||
145612787|NCT04249336|525099205|FG003|Overall Study|Lost to Follow-up|3|||
145612788|NCT01242176|525099206|FG000|Washout Period of 7 Days|Adverse Event|0|||
145612789|NCT01242176|525099207|FG001|Washout Period of 7 Days|Adverse Event|2|||
145612790|NCT01242176|525099206|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
145612791|NCT01242176|525099207|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
145612792|NCT00871351|525099208|FG000|Overall Study|Withdrawal by Subject|1|||
145612793|NCT00871351|525099209|FG001|Overall Study|Withdrawal by Subject|0|||
145612794|NCT00871351|525099210|FG002|Overall Study|Withdrawal by Subject|0|||
145612795|NCT00871351|525099208|FG000|Overall Study|Adverse Event|3|||
145612796|NCT00871351|525099209|FG001|Overall Study|Adverse Event|1|||
145612797|NCT00871351|525099210|FG002|Overall Study|Adverse Event|0|||
145612798|NCT02291289|525099212|FG000|Induction Treatment|Withdrawal by Subject|0|||
145612799|NCT02291289|525099213|FG001|Induction Treatment|Withdrawal by Subject|0|||
145612800|NCT02291289|525099214|FG002|Induction Treatment|Withdrawal by Subject|0|||
145612801|NCT02291289|525099215|FG003|Induction Treatment|Withdrawal by Subject|24|||
145612802|NCT02291289|525099216|FG004|Induction Treatment|Withdrawal by Subject|0|||
145612803|NCT02291289|525099217|FG005|Induction Treatment|Withdrawal by Subject|0|||
145612804|NCT02291289|525099218|FG006|Induction Treatment|Withdrawal by Subject|0|||
145612805|NCT02291289|525099219|FG007|Induction Treatment|Withdrawal by Subject|0|||
145612806|NCT02291289|525099220|FG008|Induction Treatment|Withdrawal by Subject|0|||
145612807|NCT02291289|525099221|FG009|Induction Treatment|Withdrawal by Subject|18|||
145612808|NCT02291289|525099222|FG010|Induction Treatment|Withdrawal by Subject|0|||
145612809|NCT02291289|525099223|FG011|Induction Treatment|Withdrawal by Subject|0|||
145612810|NCT02291289|525099224|FG012|Induction Treatment|Withdrawal by Subject|0|||
145612811|NCT02291289|525099212|FG000|Induction Treatment|Adverse Event|0|||
145612812|NCT02291289|525099213|FG001|Induction Treatment|Adverse Event|0|||
145612813|NCT02291289|525099214|FG002|Induction Treatment|Adverse Event|0|||
145612814|NCT02291289|525099215|FG003|Induction Treatment|Adverse Event|3|||
145612815|NCT02291289|525099216|FG004|Induction Treatment|Adverse Event|0|||
145612816|NCT02291289|525099217|FG005|Induction Treatment|Adverse Event|0|||
145612817|NCT02291289|525099218|FG006|Induction Treatment|Adverse Event|0|||
145612818|NCT02291289|525099219|FG007|Induction Treatment|Adverse Event|0|||
145612819|NCT02291289|525099220|FG008|Induction Treatment|Adverse Event|0|||
145612820|NCT02291289|525099221|FG009|Induction Treatment|Adverse Event|1|||
145612821|NCT02291289|525099222|FG010|Induction Treatment|Adverse Event|0|||
145612822|NCT02291289|525099223|FG011|Induction Treatment|Adverse Event|0|||
145612823|NCT02291289|525099224|FG012|Induction Treatment|Adverse Event|0|||
145612824|NCT02291289|525099212|FG000|Induction Treatment|Death|25|||
145612825|NCT02291289|525099213|FG001|Induction Treatment|Death|0|||
145612826|NCT02291289|525099214|FG002|Induction Treatment|Death|0|||
145612827|NCT02291289|525099215|FG003|Induction Treatment|Death|111|||
145612828|NCT02291289|525099216|FG004|Induction Treatment|Death|0|||
145285537|NCT01769378|523895426|FG001|Overall Study|Entry criteria not met|0|||
145285538|NCT01769378|523895425|FG000|Overall Study|Protocol Violation|1|||
145285539|NCT01769378|523895426|FG001|Overall Study|Protocol Violation|1|||
145285540|NCT01769378|523895425|FG000|Overall Study|Withdrawal by Subject|10|||
145285541|NCT01769378|523895426|FG001|Overall Study|Withdrawal by Subject|3|||
145612829|NCT02291289|525099217|FG005|Induction Treatment|Death|0|||
145285542|NCT01769378|523895425|FG000|Overall Study|Sponsor Decision|1|||
145612830|NCT02291289|525099218|FG006|Induction Treatment|Death|1|||
145285543|NCT01769378|523895426|FG001|Overall Study|Sponsor Decision|0|||
145285544|NCT01769378|523895425|FG000|Overall Study|Lost to Follow-up|2|||
145285545|NCT01769378|523895426|FG001|Overall Study|Lost to Follow-up|0|||
145285546|NCT01090765|523895427|FG000|Overall Study|Patient withdrew consent|0|||
145285547|NCT01090765|523895428|FG001|Overall Study|Patient withdrew consent|0|||
145285548|NCT01090765|523895429|FG002|Overall Study|Patient withdrew consent|0|||
145285549|NCT01090765|523895430|FG003|Overall Study|Patient withdrew consent|0|||
145285550|NCT01090765|523895431|FG004|Overall Study|Patient withdrew consent|1|||
145285551|NCT01090765|523895432|FG005|Overall Study|Patient withdrew consent|1|||
145285552|NCT01090765|523895427|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
145285553|NCT01090765|523895428|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
145285554|NCT01090765|523895429|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
145612831|NCT02291289|525099219|FG007|Induction Treatment|Death|0|||
145285555|NCT01090765|523895430|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
145612832|NCT02291289|525099220|FG008|Induction Treatment|Death|0|||
145612833|NCT02291289|525099221|FG009|Induction Treatment|Death|82|||
145612834|NCT02291289|525099222|FG010|Induction Treatment|Death|0|||
145612835|NCT02291289|525099223|FG011|Induction Treatment|Death|0|||
145612836|NCT02291289|525099224|FG012|Induction Treatment|Death|0|||
145612837|NCT02291289|525099212|FG000|Induction Treatment|Lost to Follow-up|1|||
145612838|NCT02291289|525099213|FG001|Induction Treatment|Lost to Follow-up|0|||
145612839|NCT02291289|525099214|FG002|Induction Treatment|Lost to Follow-up|0|||
145612840|NCT02291289|525099215|FG003|Induction Treatment|Lost to Follow-up|12|||
145612841|NCT02291289|525099216|FG004|Induction Treatment|Lost to Follow-up|0|||
145612842|NCT02291289|525099217|FG005|Induction Treatment|Lost to Follow-up|0|||
145612843|NCT02291289|525099218|FG006|Induction Treatment|Lost to Follow-up|0|||
145612844|NCT02291289|525099219|FG007|Induction Treatment|Lost to Follow-up|0|||
145612845|NCT02291289|525099220|FG008|Induction Treatment|Lost to Follow-up|0|||
145612846|NCT02291289|525099221|FG009|Induction Treatment|Lost to Follow-up|9|||
145612847|NCT02291289|525099222|FG010|Induction Treatment|Lost to Follow-up|0|||
145612848|NCT02291289|525099223|FG011|Induction Treatment|Lost to Follow-up|0|||
145612849|NCT02291289|525099224|FG012|Induction Treatment|Lost to Follow-up|0|||
145612850|NCT02291289|525099212|FG000|Induction Treatment|Non-Compliance|0|||
145612851|NCT02291289|525099213|FG001|Induction Treatment|Non-Compliance|0|||
145612852|NCT02291289|525099214|FG002|Induction Treatment|Non-Compliance|0|||
145612853|NCT02291289|525099215|FG003|Induction Treatment|Non-Compliance|1|||
145285556|NCT01090765|523895431|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
145285557|NCT01090765|523895432|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
145285558|NCT01090765|523895427|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
145285559|NCT01090765|523895428|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
145285560|NCT01090765|523895429|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
145285561|NCT01090765|523895430|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
145285562|NCT01090765|523895431|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
145285563|NCT01090765|523895432|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
145612854|NCT02291289|525099216|FG004|Induction Treatment|Non-Compliance|0|||
145612855|NCT02291289|525099217|FG005|Induction Treatment|Non-Compliance|0|||
145612856|NCT02291289|525099218|FG006|Induction Treatment|Non-Compliance|0|||
145612857|NCT02291289|525099219|FG007|Induction Treatment|Non-Compliance|0|||
145612858|NCT02291289|525099220|FG008|Induction Treatment|Non-Compliance|0|||
145612859|NCT02291289|525099221|FG009|Induction Treatment|Non-Compliance|1|||
145612860|NCT02291289|525099222|FG010|Induction Treatment|Non-Compliance|0|||
145612861|NCT02291289|525099223|FG011|Induction Treatment|Non-Compliance|0|||
145612862|NCT02291289|525099224|FG012|Induction Treatment|Non-Compliance|0|||
145612863|NCT02291289|525099212|FG000|Induction Treatment|Reason Not Specified|0|||
145612864|NCT02291289|525099213|FG001|Induction Treatment|Reason Not Specified|0|||
145612865|NCT02291289|525099214|FG002|Induction Treatment|Reason Not Specified|0|||
145612866|NCT02291289|525099215|FG003|Induction Treatment|Reason Not Specified|4|||
145612867|NCT02291289|525099216|FG004|Induction Treatment|Reason Not Specified|0|||
145612868|NCT02291289|525099217|FG005|Induction Treatment|Reason Not Specified|0|||
145285564|NCT02784106|523895433|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
145612869|NCT02291289|525099218|FG006|Induction Treatment|Reason Not Specified|0|||
145612870|NCT02291289|525099219|FG007|Induction Treatment|Reason Not Specified|0|||
145612871|NCT02291289|525099220|FG008|Induction Treatment|Reason Not Specified|0|||
145612872|NCT02291289|525099221|FG009|Induction Treatment|Reason Not Specified|7|||
145285565|NCT02784106|523895434|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
145285566|NCT02784106|523895435|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145285567|NCT02784106|523895436|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
145285568|NCT02784106|523895433|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
145406316|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
145406317|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
145612873|NCT02291289|525099222|FG010|Induction Treatment|Reason Not Specified|0|||
145612874|NCT02291289|525099223|FG011|Induction Treatment|Reason Not Specified|0|||
145612875|NCT02291289|525099224|FG012|Induction Treatment|Reason Not Specified|0|||
145612876|NCT02291289|525099212|FG000|Induction Treatment|Physician Decision|0|||
145612877|NCT02291289|525099213|FG001|Induction Treatment|Physician Decision|0|||
145612878|NCT02291289|525099214|FG002|Induction Treatment|Physician Decision|0|||
145612879|NCT02291289|525099215|FG003|Induction Treatment|Physician Decision|3|||
145612880|NCT02291289|525099216|FG004|Induction Treatment|Physician Decision|0|||
145612881|NCT02291289|525099217|FG005|Induction Treatment|Physician Decision|0|||
145612882|NCT02291289|525099218|FG006|Induction Treatment|Physician Decision|0|||
145612883|NCT02291289|525099219|FG007|Induction Treatment|Physician Decision|0|||
145612884|NCT02291289|525099220|FG008|Induction Treatment|Physician Decision|0|||
145612885|NCT02291289|525099221|FG009|Induction Treatment|Physician Decision|1|||
145612886|NCT02291289|525099222|FG010|Induction Treatment|Physician Decision|0|||
145612887|NCT02291289|525099223|FG011|Induction Treatment|Physician Decision|0|||
145612888|NCT02291289|525099224|FG012|Induction Treatment|Physician Decision|0|||
145612889|NCT02291289|525099212|FG000|Induction Treatment|Protocol Violation|0|||
145612890|NCT02291289|525099213|FG001|Induction Treatment|Protocol Violation|0|||
145612891|NCT02291289|525099214|FG002|Induction Treatment|Protocol Violation|0|||
145612892|NCT02291289|525099215|FG003|Induction Treatment|Protocol Violation|3|||
145612893|NCT02291289|525099216|FG004|Induction Treatment|Protocol Violation|0|||
145612894|NCT02291289|525099217|FG005|Induction Treatment|Protocol Violation|0|||
145612895|NCT02291289|525099218|FG006|Induction Treatment|Protocol Violation|0|||
145612896|NCT02291289|525099219|FG007|Induction Treatment|Protocol Violation|0|||
145612897|NCT02291289|525099220|FG008|Induction Treatment|Protocol Violation|0|||
145612898|NCT02291289|525099221|FG009|Induction Treatment|Protocol Violation|2|||
145612899|NCT02291289|525099222|FG010|Induction Treatment|Protocol Violation|0|||
145612900|NCT02291289|525099223|FG011|Induction Treatment|Protocol Violation|0|||
145612901|NCT02291289|525099224|FG012|Induction Treatment|Protocol Violation|0|||
145612902|NCT02291289|525099212|FG000|Induction Treatment|Missing|4|||
145612903|NCT02291289|525099213|FG001|Induction Treatment|Missing|0|||
145612904|NCT02291289|525099214|FG002|Induction Treatment|Missing|0|||
145612905|NCT02291289|525099215|FG003|Induction Treatment|Missing|14|||
145612906|NCT02291289|525099216|FG004|Induction Treatment|Missing|0|||
145612907|NCT02291289|525099217|FG005|Induction Treatment|Missing|0|||
145612908|NCT02291289|525099218|FG006|Induction Treatment|Missing|0|||
145612909|NCT02291289|525099219|FG007|Induction Treatment|Missing|0|||
145612910|NCT02291289|525099220|FG008|Induction Treatment|Missing|0|||
145612911|NCT02291289|525099221|FG009|Induction Treatment|Missing|54|||
145612912|NCT02291289|525099222|FG010|Induction Treatment|Missing|0|||
145612913|NCT02291289|525099223|FG011|Induction Treatment|Missing|0|||
145612914|NCT02291289|525099224|FG012|Induction Treatment|Missing|0|||
145612915|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612916|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612917|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612918|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612919|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
145612920|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
145612921|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612922|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612923|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612924|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612925|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
145612926|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
145285569|NCT02784106|523895434|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
145285570|NCT02784106|523895435|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145285571|NCT02784106|523895436|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145285572|NCT02784106|523895433|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
145285573|NCT02784106|523895434|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
145285574|NCT02784106|523895435|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
145285575|NCT02784106|523895436|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
145285576|NCT02784106|523895433|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
145285577|NCT02784106|523895434|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145285578|NCT02784106|523895435|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145285579|NCT02784106|523895436|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145285580|NCT02784106|523895433|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
145285581|NCT02784106|523895434|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
145285582|NCT02784106|523895435|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
145285583|NCT02784106|523895436|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
145285584|NCT02784106|523895433|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
145285585|NCT02784106|523895434|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
145285586|NCT02784106|523895435|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
145285587|NCT02784106|523895436|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
145285588|NCT03341507|523895437|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
145285589|NCT00718159|523895438|FG000|Overall Study|Progressive Disease|3|||
145612927|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145612928|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Death|0|||
145612929|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Death|29|||
145612930|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Death|16|||
145612931|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Death|0|||
145612932|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Death|188|||
145612933|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Death|107|||
145612934|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Death|0|||
145612935|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Death|1|||
145612936|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Death|1|||
145612937|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Death|0|||
145612938|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Death|46|||
145612939|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Death|19|||
145612940|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Death|0|||
145612941|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Adverse Event|0|||
145612942|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Adverse Event|0|||
145612943|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Adverse Event|0|||
145612944|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Adverse Event|0|||
145612945|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Adverse Event|1|||
145612946|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Adverse Event|1|||
145612947|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Adverse Event|0|||
145612948|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Adverse Event|0|||
145612949|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Adverse Event|0|||
145612950|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Adverse Event|0|||
145612951|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Adverse Event|0|||
145612952|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Adverse Event|0|||
145612953|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Adverse Event|0|||
145612954|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612955|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
145612956|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612957|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612958|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
145612959|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
145612960|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612961|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
145612962|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612963|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612964|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
145612965|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
145612966|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
145612967|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
145406318|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
145612968|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
145612969|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
145612970|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
145612971|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
145612972|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
145612973|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
145612974|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
145612975|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
145612976|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
145612977|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
145612978|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
145285590|NCT00718159|523895439|FG001|Overall Study|Progressive Disease|3|||
145285591|NCT00718159|523895440|FG002|Overall Study|Progressive Disease|2|||
145285592|NCT00718159|523895441|FG003|Overall Study|Progressive Disease|0|||
145285593|NCT00718159|523895442|FG004|Overall Study|Progressive Disease|6|||
145285594|NCT00718159|523895443|FG005|Overall Study|Progressive Disease|0|||
145612979|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
145612980|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Physician Decision|0|||
145612981|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Physician Decision|2|||
145612982|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Physician Decision|0|||
145612983|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Physician Decision|0|||
145612984|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Physician Decision|3|||
145612985|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Physician Decision|0|||
145285595|NCT00718159|523895444|FG006|Overall Study|Progressive Disease|0|||
145285596|NCT00718159|523895438|FG000|Overall Study|Death due to Adverse Event|0|||
145612986|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Physician Decision|0|||
145612987|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Physician Decision|0|||
145612988|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Physician Decision|0|||
145612989|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Physician Decision|0|||
145612990|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Physician Decision|1|||
145612991|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Physician Decision|3|||
145612992|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Physician Decision|0|||
145612993|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Not Treated|0|||
145612994|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Not Treated|0|||
145612995|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Not Treated|2|||
145612996|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Not Treated|0|||
145612997|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Not Treated|0|||
145612998|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Not Treated|0|||
145612999|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Not Treated|0|||
145613000|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Not Treated|0|||
145613001|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Not Treated|0|||
145613002|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Not Treated|0|||
145613003|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Not Treated|0|||
145613004|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Not Treated|0|||
145613005|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Not Treated|0|||
145613006|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613007|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
145613008|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613009|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613010|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613011|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613012|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613013|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613014|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613015|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613016|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613017|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613018|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
145613019|NCT02291289|525099212|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
145613020|NCT02291289|525099213|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
145613021|NCT02291289|525099214|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
145613022|NCT02291289|525099215|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
145613023|NCT02291289|525099216|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
145613024|NCT02291289|525099217|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
145613025|NCT02291289|525099218|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
145613026|NCT02291289|525099219|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
145613027|NCT02291289|525099220|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
145613028|NCT02291289|525099221|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
145613029|NCT02291289|525099222|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
145613030|NCT02291289|525099223|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
145613031|NCT02291289|525099224|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
145613032|NCT02291289|525099212|FG000|Early Disease Progression|Death|0|||
145613033|NCT02291289|525099213|FG001|Early Disease Progression|Death|0|||
145613034|NCT02291289|525099214|FG002|Early Disease Progression|Death|0|||
145613035|NCT02291289|525099215|FG003|Early Disease Progression|Death|0|||
145613036|NCT02291289|525099216|FG004|Early Disease Progression|Death|0|||
145613037|NCT02291289|525099217|FG005|Early Disease Progression|Death|0|||
145613038|NCT02291289|525099218|FG006|Early Disease Progression|Death|0|||
145613039|NCT02291289|525099219|FG007|Early Disease Progression|Death|0|||
145613040|NCT02291289|525099220|FG008|Early Disease Progression|Death|0|||
145613041|NCT02291289|525099221|FG009|Early Disease Progression|Death|0|||
145613042|NCT02291289|525099222|FG010|Early Disease Progression|Death|0|||
145613043|NCT02291289|525099223|FG011|Early Disease Progression|Death|0|||
145613044|NCT02291289|525099224|FG012|Early Disease Progression|Death|10|||
145613045|NCT02291289|525099212|FG000|Early Disease Progression|Lost to Follow-up|0|||
145613046|NCT02291289|525099213|FG001|Early Disease Progression|Lost to Follow-up|0|||
145406319|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
145555663|NCT02810392|524892621|FG001|Overall Study|Subject too ill to continue|0|||
145555664|NCT02810392|524892620|FG000|Overall Study|COVID 19 research restrictions|0|||
145555665|NCT02810392|524892621|FG001|Overall Study|COVID 19 research restrictions|1|||
145555666|NCT00840294|524892622|FG000|Overall Study|Withdrawal by Subject|2|||
145555667|NCT00840294|524892623|FG001|Overall Study|Withdrawal by Subject|1|||
145555668|NCT00840294|524892622|FG000|Overall Study|Protocol Violation|1|||
145555669|NCT00840294|524892623|FG001|Overall Study|Protocol Violation|3|||
145555670|NCT00840294|524892622|FG000|Overall Study|Illness|0|||
145555671|NCT00840294|524892623|FG001|Overall Study|Illness|1|||
145555672|NCT02669433|524892624|FG000|Overall Study|Protocol Violation|0|||
145555673|NCT02669433|524892625|FG001|Overall Study|Protocol Violation|4|||
145555674|NCT02669433|524892626|FG002|Overall Study|Protocol Violation|1|||
145555675|NCT02669433|524892624|FG000|Overall Study|Disease Progression|1|||
145555676|NCT02669433|524892625|FG001|Overall Study|Disease Progression|0|||
145555677|NCT02669433|524892626|FG002|Overall Study|Disease Progression|0|||
145555678|NCT02669433|524892624|FG000|Overall Study|Physician Decision|1|||
145555679|NCT02669433|524892625|FG001|Overall Study|Physician Decision|1|||
145555680|NCT02669433|524892626|FG002|Overall Study|Physician Decision|0|||
145555681|NCT02669433|524892624|FG000|Overall Study|Adverse Event|6|||
145555682|NCT02669433|524892625|FG001|Overall Study|Adverse Event|7|||
145555683|NCT02669433|524892626|FG002|Overall Study|Adverse Event|10|||
145555684|NCT02669433|524892624|FG000|Overall Study|Sponsor Termination|1|||
145555685|NCT02669433|524892625|FG001|Overall Study|Sponsor Termination|0|||
145555686|NCT02669433|524892626|FG002|Overall Study|Sponsor Termination|1|||
145555687|NCT02669433|524892624|FG000|Overall Study|Withdrawal by Subject|5|||
145555688|NCT02669433|524892625|FG001|Overall Study|Withdrawal by Subject|1|||
145555689|NCT02669433|524892626|FG002|Overall Study|Withdrawal by Subject|0|||
145555690|NCT02669433|524892624|FG000|Overall Study|Withdrawal by Caregiver|1|||
145555691|NCT02669433|524892625|FG001|Overall Study|Withdrawal by Caregiver|0|||
145555692|NCT02669433|524892626|FG002|Overall Study|Withdrawal by Caregiver|2|||
145555693|NCT02669433|524892624|FG000|Overall Study|Death|0|||
145555694|NCT02669433|524892625|FG001|Overall Study|Death|1|||
145406320|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
145406321|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
145613047|NCT02291289|525099214|FG002|Early Disease Progression|Lost to Follow-up|0|||
145613048|NCT02291289|525099215|FG003|Early Disease Progression|Lost to Follow-up|0|||
145613049|NCT02291289|525099216|FG004|Early Disease Progression|Lost to Follow-up|0|||
145613050|NCT02291289|525099217|FG005|Early Disease Progression|Lost to Follow-up|0|||
145613051|NCT02291289|525099218|FG006|Early Disease Progression|Lost to Follow-up|0|||
145613052|NCT02291289|525099219|FG007|Early Disease Progression|Lost to Follow-up|0|||
145613053|NCT02291289|525099220|FG008|Early Disease Progression|Lost to Follow-up|0|||
145613054|NCT02291289|525099221|FG009|Early Disease Progression|Lost to Follow-up|0|||
145613055|NCT02291289|525099222|FG010|Early Disease Progression|Lost to Follow-up|0|||
145613056|NCT02291289|525099223|FG011|Early Disease Progression|Lost to Follow-up|0|||
145613057|NCT02291289|525099224|FG012|Early Disease Progression|Lost to Follow-up|1|||
145613058|NCT00154063|525099225|FG000|Overall Study|Adverse Event|4|||
145613059|NCT00154063|525099226|FG001|Overall Study|Adverse Event|8|||
145613060|NCT00154063|525099225|FG000|Overall Study|Protocol Violation|1|||
145613061|NCT00154063|525099226|FG001|Overall Study|Protocol Violation|1|||
145406322|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
145613062|NCT00154063|525099225|FG000|Overall Study|Investigator or Sponsor Request|0|||
145285597|NCT00718159|523895439|FG001|Overall Study|Death due to Adverse Event|0|||
145285598|NCT00718159|523895440|FG002|Overall Study|Death due to Adverse Event|0|||
145285599|NCT00718159|523895441|FG003|Overall Study|Death due to Adverse Event|2|||
145285600|NCT00718159|523895442|FG004|Overall Study|Death due to Adverse Event|2|||
145285601|NCT00718159|523895443|FG005|Overall Study|Death due to Adverse Event|0|||
145285602|NCT00718159|523895444|FG006|Overall Study|Death due to Adverse Event|0|||
145285603|NCT00718159|523895438|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
145285604|NCT00718159|523895439|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
145285605|NCT00718159|523895440|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
145285606|NCT00718159|523895441|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
145285607|NCT00718159|523895442|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
145285608|NCT00718159|523895443|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
145285609|NCT00718159|523895444|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
145285610|NCT00718159|523895438|FG000|Overall Study|Investigator Decision|0|||
145285611|NCT00718159|523895439|FG001|Overall Study|Investigator Decision|0|||
145285612|NCT00718159|523895440|FG002|Overall Study|Investigator Decision|0|||
145285613|NCT00718159|523895441|FG003|Overall Study|Investigator Decision|0|||
145285614|NCT00718159|523895442|FG004|Overall Study|Investigator Decision|0|||
145285615|NCT00718159|523895443|FG005|Overall Study|Investigator Decision|1|||
145285616|NCT00718159|523895444|FG006|Overall Study|Investigator Decision|1|||
145285617|NCT01755858|523895447|FG000|Overall Study|Adverse Event|1|||
145285618|NCT01755858|523895448|FG001|Overall Study|Adverse Event|1|||
145285619|NCT00782509|523895449|FG000|Overall Study|Adverse Event|20|||
145285620|NCT00782509|523895450|FG001|Overall Study|Adverse Event|10|||
145285621|NCT00782509|523895451|FG002|Overall Study|Adverse Event|20|||
145285622|NCT00782509|523895449|FG000|Overall Study|Lost to Follow-up|1|||
145285623|NCT00782509|523895450|FG001|Overall Study|Lost to Follow-up|2|||
145285624|NCT00782509|523895451|FG002|Overall Study|Lost to Follow-up|3|||
145285625|NCT00782509|523895449|FG000|Overall Study|Withdrawal by Subject|3|||
145285626|NCT00782509|523895450|FG001|Overall Study|Withdrawal by Subject|5|||
145285627|NCT00782509|523895451|FG002|Overall Study|Withdrawal by Subject|8|||
145285628|NCT00782509|523895449|FG000|Overall Study|Non compliance with protocol|2|||
145285629|NCT00782509|523895450|FG001|Overall Study|Non compliance with protocol|0|||
145285630|NCT00782509|523895451|FG002|Overall Study|Non compliance with protocol|0|||
145285631|NCT00782509|523895449|FG000|Overall Study|Other reasons not stated above|5|||
145285632|NCT00782509|523895450|FG001|Overall Study|Other reasons not stated above|2|||
145285633|NCT00782509|523895451|FG002|Overall Study|Other reasons not stated above|3|||
145285634|NCT00782509|523895449|FG000|Overall Study|Lack of Efficacy|10|||
145285635|NCT00782509|523895450|FG001|Overall Study|Lack of Efficacy|5|||
145285636|NCT00782509|523895451|FG002|Overall Study|Lack of Efficacy|2|||
145285637|NCT00175019|523895453|FG000|Overall Study|Adverse Event|54|||
145285638|NCT00175019|523895454|FG001|Overall Study|Adverse Event|22|||
145285639|NCT00175019|523895455|FG002|Overall Study|Adverse Event|2|||
145285640|NCT00175019|523895453|FG000|Overall Study|Protocol Violation|6|||
145285641|NCT00175019|523895454|FG001|Overall Study|Protocol Violation|3|||
145285642|NCT00175019|523895455|FG002|Overall Study|Protocol Violation|3|||
145613063|NCT00154063|525099226|FG001|Overall Study|Investigator or Sponsor Request|1|||
145285643|NCT00175019|523895453|FG000|Overall Study|Lost to Follow-up|42|||
145285644|NCT00175019|523895454|FG001|Overall Study|Lost to Follow-up|39|||
145285645|NCT00175019|523895455|FG002|Overall Study|Lost to Follow-up|9|||
145285646|NCT00175019|523895453|FG000|Overall Study|Did not continue under Amendment 4|1|||
145285647|NCT00175019|523895454|FG001|Overall Study|Did not continue under Amendment 4|1|||
145285648|NCT00175019|523895455|FG002|Overall Study|Did not continue under Amendment 4|2|||
145285649|NCT00175019|523895453|FG000|Overall Study|Personal Reason(s)|39|||
145285650|NCT00175019|523895454|FG001|Overall Study|Personal Reason(s)|31|||
145285651|NCT00175019|523895455|FG002|Overall Study|Personal Reason(s)|8|||
145285652|NCT00175019|523895453|FG000|Overall Study|Therapeutic Failure|10|||
145285653|NCT00175019|523895454|FG001|Overall Study|Therapeutic Failure|38|||
145285654|NCT00175019|523895455|FG002|Overall Study|Therapeutic Failure|22|||
145285655|NCT00175019|523895453|FG000|Overall Study|Gout Flare|2|||
145285656|NCT00175019|523895454|FG001|Overall Study|Gout Flare|3|||
145285657|NCT00175019|523895455|FG002|Overall Study|Gout Flare|0|||
145285658|NCT00175019|523895453|FG000|Overall Study|Reason Not Specified|40|||
145285659|NCT00175019|523895454|FG001|Overall Study|Reason Not Specified|34|||
145285660|NCT00175019|523895455|FG002|Overall Study|Reason Not Specified|11|||
145285661|NCT01405820|523895465|FG000|Randomized Treatment Period|Adverse Event|3|||
145285662|NCT01405820|523895466|FG001|Randomized Treatment Period|Adverse Event|3|||
145285663|NCT01405820|523895467|FG002|Randomized Treatment Period|Adverse Event|3|||
145555695|NCT02669433|524892626|FG002|Overall Study|Death|1|||
145555696|NCT00576927|524892627|FG000|Clinical Assessment|Lack of Efficacy|24|||
145555697|NCT00576927|524892627|FG000|Clinical Assessment|Death|1|||
145555698|NCT00576927|524892627|FG000|Clinical Assessment|Withdrawal by Subject|10|||
145555699|NCT00576927|524892627|FG000|Clinical Assessment|Physician Decision|1|||
145555700|NCT00576927|524892627|FG000|Baseline|Physician Decision|9|||
145555701|NCT00576927|524892627|FG000|Baseline|Medication Change by PCP of subject|1|||
145285664|NCT01405820|523895468|FG003|Randomized Treatment Period|Adverse Event|0|||
145555702|NCT00576927|524892627|FG000|Baseline|Withdrawal by Subject|3|||
145555703|NCT00576927|524892627|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
145555704|NCT00576927|524892627|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
145555705|NCT00576927|524892627|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
145555706|NCT00576927|524892627|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
145555707|NCT00576927|524892627|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
145555708|NCT00883116|524892628|FG000|Overall Study|Adverse event unrelated to study drug|5|||
145555709|NCT00883116|524892629|FG001|Overall Study|Adverse event unrelated to study drug|10|||
145555710|NCT00883116|524892628|FG000|Overall Study|Death|6|||
145555711|NCT00883116|524892629|FG001|Overall Study|Death|2|||
145555712|NCT00883116|524892628|FG000|Overall Study|Disease progression|130|||
145555713|NCT00883116|524892629|FG001|Overall Study|Disease progression|128|||
145555714|NCT00883116|524892628|FG000|Overall Study|Lost to Follow-up|0|||
145555715|NCT00883116|524892629|FG001|Overall Study|Lost to Follow-up|1|||
145555716|NCT00883116|524892628|FG000|Overall Study|Maximum clinical benefit|13|||
145555717|NCT00883116|524892629|FG001|Overall Study|Maximum clinical benefit|46|||
145555718|NCT00883116|524892628|FG000|Overall Study|Not identified|3|||
145555719|NCT00883116|524892629|FG001|Overall Study|Not identified|6|||
145555720|NCT00883116|524892628|FG000|Overall Study|Study drug toxicity|36|||
145555721|NCT00883116|524892629|FG001|Overall Study|Study drug toxicity|16|||
145555722|NCT00883116|524892628|FG000|Overall Study|Withdrawal by Subject|14|||
145555723|NCT00883116|524892629|FG001|Overall Study|Withdrawal by Subject|8|||
145555724|NCT00883116|524892628|FG000|Overall Study|No longer meets study criteria|2|||
145555725|NCT00883116|524892629|FG001|Overall Study|No longer meets study criteria|2|||
145555726|NCT03715764|524892630|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
145555727|NCT03715764|524892631|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
145555728|NCT03715764|524892630|FG000|3 Month Follow-up|Lost to Follow-up|2|||
145555729|NCT03715764|524892631|FG001|3 Month Follow-up|Lost to Follow-up|2|||
145285665|NCT01405820|523895469|FG004|Randomized Treatment Period|Adverse Event|2|||
145285666|NCT01405820|523895470|FG005|Randomized Treatment Period|Adverse Event|1|||
145285667|NCT01405820|523895465|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
145285668|NCT01405820|523895466|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
145406323|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
145406324|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
145406325|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
145406326|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
145406327|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
145406328|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
145406329|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
145406330|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
145406331|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
145406332|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
145285669|NCT01405820|523895467|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
145285670|NCT01405820|523895468|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
145285671|NCT01405820|523895469|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
145285672|NCT01405820|523895470|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
145285673|NCT01405820|523895465|FG000|Randomized Treatment Period|Other|2|||
145285674|NCT01405820|523895466|FG001|Randomized Treatment Period|Other|2|||
145285675|NCT01405820|523895467|FG002|Randomized Treatment Period|Other|1|||
145285676|NCT01405820|523895468|FG003|Randomized Treatment Period|Other|1|||
145285677|NCT01405820|523895469|FG004|Randomized Treatment Period|Other|0|||
145285678|NCT01405820|523895470|FG005|Randomized Treatment Period|Other|0|||
145285679|NCT01405820|523895465|FG000|Randomized Treatment Period|Physician Decision|0|||
145285680|NCT01405820|523895466|FG001|Randomized Treatment Period|Physician Decision|2|||
145285681|NCT01405820|523895467|FG002|Randomized Treatment Period|Physician Decision|1|||
145285682|NCT01405820|523895468|FG003|Randomized Treatment Period|Physician Decision|0|||
145285683|NCT01405820|523895469|FG004|Randomized Treatment Period|Physician Decision|0|||
145285684|NCT01405820|523895470|FG005|Randomized Treatment Period|Physician Decision|0|||
145285685|NCT01405820|523895465|FG000|Randomized Treatment Period|Rescue|0|||
145285686|NCT01405820|523895466|FG001|Randomized Treatment Period|Rescue|1|||
145285687|NCT01405820|523895467|FG002|Randomized Treatment Period|Rescue|13|||
145285688|NCT01405820|523895468|FG003|Randomized Treatment Period|Rescue|10|||
145285689|NCT01405820|523895469|FG004|Randomized Treatment Period|Rescue|8|||
145285690|NCT01405820|523895470|FG005|Randomized Treatment Period|Rescue|8|||
145285691|NCT01405820|523895465|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
145285692|NCT01405820|523895466|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
145285693|NCT01405820|523895467|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
145285694|NCT01405820|523895468|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
145285695|NCT01405820|523895469|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
145285696|NCT01405820|523895470|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
145285697|NCT01405820|523895465|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
145285698|NCT01405820|523895466|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
145285699|NCT01405820|523895467|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
145285700|NCT01405820|523895468|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
145285701|NCT01405820|523895469|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
145285702|NCT01405820|523895470|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
145285703|NCT01405820|523895465|FG000|Randomized Treatment Period|Death|0|||
145285704|NCT01405820|523895466|FG001|Randomized Treatment Period|Death|0|||
145285705|NCT01405820|523895467|FG002|Randomized Treatment Period|Death|0|||
145285706|NCT01405820|523895468|FG003|Randomized Treatment Period|Death|1|||
145285707|NCT01405820|523895469|FG004|Randomized Treatment Period|Death|0|||
145285708|NCT01405820|523895470|FG005|Randomized Treatment Period|Death|0|||
145285709|NCT01405820|523895465|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
145285710|NCT01405820|523895466|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
145285711|NCT01405820|523895467|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
145285712|NCT01405820|523895468|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
145285713|NCT01405820|523895469|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
145285714|NCT01405820|523895470|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
145285715|NCT01405820|523895465|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
145285716|NCT01405820|523895466|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
145285717|NCT01405820|523895467|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
145285718|NCT01405820|523895468|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
145285719|NCT01405820|523895469|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
145285720|NCT01405820|523895470|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
145285721|NCT01405820|523895465|FG000|Open-Label Treatment Period|Other|1|||
145285722|NCT01405820|523895466|FG001|Open-Label Treatment Period|Other|1|||
145285723|NCT01405820|523895467|FG002|Open-Label Treatment Period|Other|1|||
145285724|NCT01405820|523895468|FG003|Open-Label Treatment Period|Other|1|||
145285725|NCT01405820|523895469|FG004|Open-Label Treatment Period|Other|1|||
145285726|NCT01405820|523895470|FG005|Open-Label Treatment Period|Other|1|||
145613064|NCT00154063|525099225|FG000|Overall Study|Withdrawal by Subject|4|||
145613065|NCT00154063|525099226|FG001|Overall Study|Withdrawal by Subject|9|||
145613066|NCT00154063|525099225|FG000|Overall Study|Other|3|||
145613067|NCT00154063|525099226|FG001|Overall Study|Other|3|||
145613068|NCT01857934|525099234|FG000|Overall Study|Relapse or progression|2|||
145613069|NCT01857934|525099234|FG000|Overall Study|Unacceptable toxicity|3|||
145613070|NCT01857934|525099234|FG000|Overall Study|Unwillingness or inability to comply|2|||
145613071|NCT01857934|525099234|FG000|Overall Study|Physician Decision|3|||
145613072|NCT04789577|525099235|FG000|Overall Study|Withdrawal by Subject|1|||
145613073|NCT04789577|525099236|FG001|Overall Study|Withdrawal by Subject|1|||
145613074|NCT04789577|525099237|FG002|Overall Study|Withdrawal by Subject|1|||
145613075|NCT04789577|525099238|FG003|Overall Study|Withdrawal by Subject|3|||
145613076|NCT04789577|525099239|FG004|Overall Study|Withdrawal by Subject|1|||
145613077|NCT04789577|525099240|FG005|Overall Study|Withdrawal by Subject|7|||
145613078|NCT04789577|525099241|FG006|Overall Study|Withdrawal by Subject|1|||
145555730|NCT03715764|524892630|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
145285727|NCT01405820|523895465|FG000|Open-Label Treatment Period|Physician Decision|0|||
145285728|NCT01405820|523895466|FG001|Open-Label Treatment Period|Physician Decision|0|||
145285729|NCT01405820|523895467|FG002|Open-Label Treatment Period|Physician Decision|1|||
145285730|NCT01405820|523895468|FG003|Open-Label Treatment Period|Physician Decision|2|||
145285731|NCT01405820|523895469|FG004|Open-Label Treatment Period|Physician Decision|1|||
145285732|NCT01405820|523895470|FG005|Open-Label Treatment Period|Physician Decision|0|||
145285733|NCT01405820|523895465|FG000|Open-Label Treatment Period|Adverse Event|0|||
145285734|NCT01405820|523895466|FG001|Open-Label Treatment Period|Adverse Event|0|||
145285735|NCT01405820|523895467|FG002|Open-Label Treatment Period|Adverse Event|0|||
145285736|NCT01405820|523895468|FG003|Open-Label Treatment Period|Adverse Event|1|||
145285737|NCT01405820|523895469|FG004|Open-Label Treatment Period|Adverse Event|0|||
145285738|NCT01405820|523895470|FG005|Open-Label Treatment Period|Adverse Event|0|||
145285739|NCT03222141|523895471|FG000|Overall Study|Death|15|||
145285740|NCT03222141|523895471|FG000|Overall Study|Lost to Follow-up|3|||
145285741|NCT00441584|523895472|FG000|Overall Study|Lack of Efficacy|79|||
145285742|NCT00441584|523895472|FG000|Overall Study|Withdrawal by Subject|8|||
145285743|NCT00441584|523895472|FG000|Overall Study|Adverse Event|6|||
145285744|NCT00441584|523895472|FG000|Overall Study|Protocol Violation|5|||
145285745|NCT00441584|523895472|FG000|Overall Study|Lost to Follow-up|4|||
145285746|NCT00441584|523895472|FG000|Overall Study|Failure to meet eligibility criteria|3|||
145285747|NCT00619619|523895475|FG000|Overall Study|Physician Decision|0|||
145285748|NCT00619619|523895476|FG001|Overall Study|Physician Decision|0|||
145285749|NCT00619619|523895477|FG002|Overall Study|Physician Decision|1|||
145285750|NCT00619619|523895478|FG003|Overall Study|Physician Decision|0|||
145285751|NCT00619619|523895479|FG004|Overall Study|Physician Decision|0|||
145285752|NCT00619619|523895480|FG005|Overall Study|Physician Decision|0|||
145285753|NCT00619619|523895481|FG006|Overall Study|Physician Decision|0|||
145285754|NCT00619619|523895482|FG007|Overall Study|Physician Decision|0|||
145285755|NCT00619619|523895475|FG000|Overall Study|Protocol Violation|0|||
145285756|NCT00619619|523895476|FG001|Overall Study|Protocol Violation|0|||
145285757|NCT00619619|523895477|FG002|Overall Study|Protocol Violation|0|||
145285758|NCT00619619|523895478|FG003|Overall Study|Protocol Violation|1|||
145285759|NCT00619619|523895479|FG004|Overall Study|Protocol Violation|0|||
145285760|NCT00619619|523895480|FG005|Overall Study|Protocol Violation|0|||
145285761|NCT00619619|523895481|FG006|Overall Study|Protocol Violation|1|||
145555731|NCT03715764|524892631|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
145555732|NCT03715764|524892630|FG000|6 Month Follow-up|Lost to Follow-up|3|||
145555733|NCT03715764|524892631|FG001|6 Month Follow-up|Lost to Follow-up|0|||
145555734|NCT03715764|524892630|FG000|12 Month Follow-up|Lost to Follow-up|2|||
145555735|NCT03715764|524892631|FG001|12 Month Follow-up|Lost to Follow-up|3|||
145555736|NCT03715764|524892630|FG000|12 Month Follow-up|Pregnancy|0|||
145285762|NCT00619619|523895482|FG007|Overall Study|Protocol Violation|1|||
145285763|NCT00619619|523895475|FG000|Overall Study|Adverse Event|0|||
145285764|NCT00619619|523895476|FG001|Overall Study|Adverse Event|0|||
145285765|NCT00619619|523895477|FG002|Overall Study|Adverse Event|0|||
145285766|NCT00619619|523895478|FG003|Overall Study|Adverse Event|0|||
145285767|NCT00619619|523895479|FG004|Overall Study|Adverse Event|2|||
145285768|NCT00619619|523895480|FG005|Overall Study|Adverse Event|0|||
145285769|NCT00619619|523895481|FG006|Overall Study|Adverse Event|0|||
145285770|NCT00619619|523895482|FG007|Overall Study|Adverse Event|2|||
145285771|NCT00415532|523895484|FG000|Treatment Period|Adverse Event|2|||
145285772|NCT00415532|523895485|FG001|Treatment Period|Adverse Event|3|||
145285773|NCT00415532|523895484|FG000|Treatment Period|Death|2|||
145285774|NCT00415532|523895485|FG001|Treatment Period|Death|1|||
145285775|NCT00415532|523895484|FG000|Treatment Period|Lost to Follow-up|1|||
145285776|NCT00415532|523895485|FG001|Treatment Period|Lost to Follow-up|1|||
145285777|NCT00415532|523895484|FG000|Treatment Period|Protocol Violation|1|||
145285778|NCT00415532|523895485|FG001|Treatment Period|Protocol Violation|0|||
145285779|NCT00415532|523895484|FG000|Treatment Period|Withdrawal by Subject|6|||
145285780|NCT00415532|523895485|FG001|Treatment Period|Withdrawal by Subject|6|||
145285781|NCT00415532|523895484|FG000|Treatment Period|Other|2|||
145285782|NCT00415532|523895485|FG001|Treatment Period|Other|2|||
145285783|NCT00415532|523895484|FG000|Treatment Period|Ineligibility determined|1|||
145285784|NCT00415532|523895485|FG001|Treatment Period|Ineligibility determined|1|||
145406333|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
145406334|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
145406335|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
145406336|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
145406337|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
145406338|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
145406339|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
145406340|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
145406341|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
145406342|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
145406343|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
145406344|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
145406345|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
145406346|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
145406347|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
145406348|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
145406349|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
145406350|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
145406351|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
145555737|NCT03715764|524892631|FG001|12 Month Follow-up|Pregnancy|1|||
145555738|NCT03715764|524892630|FG000|12 Month Follow-up|Surgery|2|||
145555739|NCT03715764|524892631|FG001|12 Month Follow-up|Surgery|0|||
145555740|NCT03715764|524892630|FG000|12 Month Follow-up|Wrong address|1|||
145285785|NCT00415532|523895484|FG000|Treatment Period|Noncompliance|1|||
145285786|NCT00415532|523895485|FG001|Treatment Period|Noncompliance|1|||
145285787|NCT00415532|523895484|FG000|Treatment Period|Requirement for alternative therapy|1|||
145285788|NCT00415532|523895485|FG001|Treatment Period|Requirement for alternative therapy|0|||
145285789|NCT00415532|523895484|FG000|Safety Follow Up Period|Adverse Event|1|||
145285790|NCT00415532|523895485|FG001|Safety Follow Up Period|Adverse Event|3|||
145285791|NCT00415532|523895484|FG000|Safety Follow Up Period|Death|3|||
145285792|NCT00415532|523895485|FG001|Safety Follow Up Period|Death|0|||
145285793|NCT00415532|523895484|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
145285794|NCT00415532|523895485|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
145285795|NCT00415532|523895484|FG000|Safety Follow Up Period|Other|1|||
145285796|NCT00415532|523895485|FG001|Safety Follow Up Period|Other|4|||
145285797|NCT00415532|523895484|FG000|Safety Follow Up Period|Ineligibility determined|1|||
145285798|NCT00415532|523895485|FG001|Safety Follow Up Period|Ineligibility determined|1|||
145285799|NCT00415532|523895484|FG000|Safety Follow Up Period|Noncompliance|1|||
145285800|NCT00415532|523895485|FG001|Safety Follow Up Period|Noncompliance|0|||
145285801|NCT00415532|523895484|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
145285802|NCT00415532|523895485|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
145285803|NCT01798485|523895486|FG000|Overall Study|Adverse Event|32|||
145285804|NCT01798485|523895487|FG001|Overall Study|Adverse Event|40|||
145285805|NCT01798485|523895486|FG000|Overall Study|Withdrawal by Subject|27|||
145285806|NCT01798485|523895487|FG001|Overall Study|Withdrawal by Subject|31|||
145285807|NCT01798485|523895486|FG000|Overall Study|Lost to Follow-up|0|||
145285808|NCT01798485|523895487|FG001|Overall Study|Lost to Follow-up|3|||
145285809|NCT01798485|523895486|FG000|Overall Study|Physician Decision|14|||
145285810|NCT01798485|523895487|FG001|Overall Study|Physician Decision|10|||
145285811|NCT01798485|523895486|FG000|Overall Study|Objective Disease Progression|152|||
145285812|NCT01798485|523895487|FG001|Overall Study|Objective Disease Progression|106|||
145285813|NCT01798485|523895486|FG000|Overall Study|Death|25|||
145285814|NCT01798485|523895487|FG001|Overall Study|Death|22|||
145285815|NCT01798485|523895486|FG000|Overall Study|Sponsor Decision|61|||
145285816|NCT01798485|523895487|FG001|Overall Study|Sponsor Decision|54|||
145285817|NCT01798485|523895486|FG000|Overall Study|Clinical Progression|35|||
145285818|NCT01798485|523895487|FG001|Overall Study|Clinical Progression|24|||
145285819|NCT01952574|523895488|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
145285820|NCT01952574|523895489|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
145285821|NCT01952574|523895490|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
145285822|NCT01952574|523895491|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
145285823|NCT01952574|523895492|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145285824|NCT01952574|523895493|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145285825|NCT01952574|523895494|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145285826|NCT01952574|523895488|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
145285827|NCT01952574|523895489|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
145285828|NCT01952574|523895490|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
145285829|NCT01952574|523895491|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
145285830|NCT01952574|523895492|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
145285831|NCT01952574|523895493|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
145285832|NCT01952574|523895494|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
145285833|NCT01952574|523895488|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
145285834|NCT01952574|523895489|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
145285835|NCT01952574|523895490|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
145285836|NCT01952574|523895491|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
145285837|NCT01952574|523895492|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
145285838|NCT01952574|523895493|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
145285839|NCT01952574|523895494|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
145285840|NCT01952574|523895488|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285841|NCT01952574|523895489|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285842|NCT01952574|523895490|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285843|NCT01952574|523895491|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285844|NCT01952574|523895492|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
145285845|NCT01952574|523895493|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285846|NCT01952574|523895494|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
145285847|NCT01952574|523895488|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
145285848|NCT01952574|523895489|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
145285849|NCT01952574|523895490|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
145613079|NCT04789577|525099235|FG000|Overall Study|Lost to Follow-up|7|||
145613080|NCT04789577|525099236|FG001|Overall Study|Lost to Follow-up|12|||
145613081|NCT04789577|525099237|FG002|Overall Study|Lost to Follow-up|7|||
145613082|NCT04789577|525099238|FG003|Overall Study|Lost to Follow-up|10|||
145613083|NCT04789577|525099239|FG004|Overall Study|Lost to Follow-up|8|||
145613084|NCT04789577|525099240|FG005|Overall Study|Lost to Follow-up|6|||
145613085|NCT04789577|525099241|FG006|Overall Study|Lost to Follow-up|10|||
145613086|NCT04789577|525099235|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
145613087|NCT04789577|525099236|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
145613088|NCT04789577|525099237|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
145613089|NCT04789577|525099238|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
145613090|NCT04789577|525099239|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
145613091|NCT04789577|525099240|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
145613092|NCT04789577|525099241|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
145613093|NCT04789577|525099235|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
145613094|NCT04789577|525099236|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
145613095|NCT04789577|525099237|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
145613096|NCT04789577|525099238|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
145613097|NCT04789577|525099239|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
145613098|NCT04789577|525099240|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
145613099|NCT04789577|525099241|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
145613100|NCT01275196|525099242|FG000|Overall Study|Adverse Event|3|||
145613101|NCT01275196|525099243|FG001|Overall Study|Adverse Event|5|||
145613102|NCT01275196|525099242|FG000|Overall Study|Withdrawal by Subject|4|||
145613103|NCT01275196|525099243|FG001|Overall Study|Withdrawal by Subject|5|||
145613104|NCT01275196|525099242|FG000|Overall Study|Lost to Follow-up|1|||
145285850|NCT01952574|523895491|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
145285851|NCT01952574|523895492|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
145285852|NCT01952574|523895493|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
145285853|NCT01952574|523895494|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
145285854|NCT01952574|523895488|FG000|Open-label Treatment Phase|Missing|0|||
145285855|NCT01952574|523895489|FG001|Open-label Treatment Phase|Missing|0|||
145285856|NCT01952574|523895490|FG002|Open-label Treatment Phase|Missing|0|||
145285857|NCT01952574|523895491|FG003|Open-label Treatment Phase|Missing|0|||
145285858|NCT01952574|523895492|FG004|Open-label Treatment Phase|Missing|4|||
145555741|NCT03715764|524892631|FG001|12 Month Follow-up|Wrong address|0|||
145555742|NCT03715764|524892630|FG000|12 Month Follow-up|No symptoms|1|||
145555743|NCT03715764|524892631|FG001|12 Month Follow-up|No symptoms|0|||
145555744|NCT03715764|524892630|FG000|12 Month Follow-up|Changed primary care centre|0|||
145555745|NCT03715764|524892631|FG001|12 Month Follow-up|Changed primary care centre|1|||
145555746|NCT01361464|524892634|FG000|Overall Study|Death|1|||
145555747|NCT01361464|524892634|FG000|Overall Study|Withdrawal by Subject|2|||
145555748|NCT01106898|524892635|FG000|Overall Study|Adverse Event|6|||
145555749|NCT03021265|524892636|FG000|Overall Study|Adverse Event|29|||
145555750|NCT03021265|524892636|FG000|Overall Study|Lack of Efficacy|3|||
145555751|NCT03021265|524892636|FG000|Overall Study|Improved|17|||
145555752|NCT03021265|524892636|FG000|Overall Study|Lost to Follow-up|67|||
145555753|NCT03021265|524892636|FG000|Overall Study|No reason given|2|||
145555754|NCT03021265|524892636|FG000|Overall Study|No visit since the first visit|4|||
145555755|NCT01698801|524892637|FG000|Treatment Phase|Adverse Event|4|||
145555756|NCT01698801|524892637|FG000|Treatment Phase|Protocol Violation|1|||
145555757|NCT01698801|524892637|FG000|Treatment Phase|Other|4|||
145285859|NCT01952574|523895493|FG005|Open-label Treatment Phase|Missing|0|||
145285860|NCT01952574|523895494|FG006|Open-label Treatment Phase|Missing|0|||
145285861|NCT01952574|523895488|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
145285862|NCT01952574|523895489|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
145555758|NCT01698801|524892637|FG000|Treatment Phase|Withdrawal by Subject|1|||
145285863|NCT01952574|523895490|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
145285864|NCT01952574|523895491|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
145285865|NCT01952574|523895492|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
145285866|NCT01952574|523895493|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
145285867|NCT01952574|523895494|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
145285868|NCT01952574|523895488|FG000|Open-label Treatment Phase|Death|0|||
145285869|NCT01952574|523895489|FG001|Open-label Treatment Phase|Death|0|||
145285870|NCT01952574|523895490|FG002|Open-label Treatment Phase|Death|0|||
145285871|NCT01952574|523895491|FG003|Open-label Treatment Phase|Death|0|||
145285872|NCT01952574|523895492|FG004|Open-label Treatment Phase|Death|1|||
145285873|NCT01952574|523895493|FG005|Open-label Treatment Phase|Death|0|||
145285874|NCT01952574|523895494|FG006|Open-label Treatment Phase|Death|0|||
145285875|NCT01952574|523895488|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285876|NCT01952574|523895489|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285877|NCT01952574|523895490|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285878|NCT01952574|523895491|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285879|NCT01952574|523895492|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285880|NCT01952574|523895493|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
145285881|NCT01952574|523895494|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
145285882|NCT01952574|523895488|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
145285883|NCT01952574|523895489|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
145285884|NCT01952574|523895490|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
145285885|NCT01952574|523895491|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
145285886|NCT01952574|523895492|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
145285887|NCT01952574|523895493|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
145285888|NCT01952574|523895494|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
145285889|NCT00770991|523895498|FG000|Overall Study|Physician Decision|2|||
145285890|NCT00770991|523895499|FG001|Overall Study|Physician Decision|0|||
145285891|NCT00770991|523895498|FG000|Overall Study|Withdrawal by Subject|1|||
145285892|NCT00770991|523895499|FG001|Overall Study|Withdrawal by Subject|0|||
145285893|NCT00770991|523895498|FG000|Overall Study|Adverse Event|1|||
145285894|NCT00770991|523895499|FG001|Overall Study|Adverse Event|5|||
145285895|NCT00770991|523895498|FG000|Overall Study|Pregnancy|1|||
145285896|NCT00770991|523895499|FG001|Overall Study|Pregnancy|0|||
145285897|NCT02087046|523895500|FG000|Overall Study|Adverse Event|4|||
145285898|NCT02087046|523895500|FG000|Overall Study|Death|1|||
145285899|NCT02087046|523895500|FG000|Overall Study|Lost to Follow-up|3|||
145285900|NCT02087046|523895500|FG000|Overall Study|Withdrawal by Subject|2|||
145285901|NCT02087046|523895500|FG000|Overall Study|Physician Decision|1|||
145285902|NCT01107535|523895501|FG000|Overall Study|Death|5|||
145285903|NCT02444533|523895502|FG000|Overall Study|Not able to complete forms|0|||
145285904|NCT02444533|523895503|FG001|Overall Study|Not able to complete forms|2|||
145285905|NCT02444533|523895502|FG000|Overall Study|Only gave post-procedure complications|2|||
145285906|NCT02444533|523895503|FG001|Overall Study|Only gave post-procedure complications|2|||
145285907|NCT01155583|523895504|FG000|Phase I|Screen failure - did not start treatment|0|||
145285908|NCT01155583|523895505|FG001|Phase I|Screen failure - did not start treatment|0|||
145285909|NCT01155583|523895506|FG002|Phase I|Screen failure - did not start treatment|0|||
145406352|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
145406353|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
145285910|NCT01155583|523895507|FG003|Phase I|Screen failure - did not start treatment|0|||
145285911|NCT01155583|523895508|FG004|Phase I|Screen failure - did not start treatment|1|||
145285912|NCT01155583|523895509|FG005|Phase I|Screen failure - did not start treatment|0|||
145285913|NCT01155583|523895510|FG006|Phase I|Screen failure - did not start treatment|0|||
145285914|NCT01155583|523895511|FG007|Phase I|Screen failure - did not start treatment|2|||
145555759|NCT01698801|524892637|FG000|Treatment Phase|Disease progression|1|||
145555760|NCT01698801|524892637|FG000|Follow Up Phase|Withdrawal by Subject|1|||
145285915|NCT01155583|523895512|FG008|Phase I|Screen failure - did not start treatment|0|||
145285916|NCT01155583|523895504|FG000|Phase I|Withdrawal by Subject|0|||
145285917|NCT01155583|523895505|FG001|Phase I|Withdrawal by Subject|0|||
145285918|NCT01155583|523895506|FG002|Phase I|Withdrawal by Subject|0|||
145285919|NCT01155583|523895507|FG003|Phase I|Withdrawal by Subject|0|||
145285920|NCT01155583|523895508|FG004|Phase I|Withdrawal by Subject|0|||
145285921|NCT01155583|523895509|FG005|Phase I|Withdrawal by Subject|0|||
145285922|NCT01155583|523895510|FG006|Phase I|Withdrawal by Subject|0|||
145285923|NCT01155583|523895511|FG007|Phase I|Withdrawal by Subject|1|||
145285924|NCT01155583|523895512|FG008|Phase I|Withdrawal by Subject|0|||
145285925|NCT00585351|523895513|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
145285926|NCT00585351|523895514|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
145285927|NCT00585351|523895515|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
145285928|NCT00585351|523895516|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
145555761|NCT01698801|524892637|FG000|Follow Up Phase|Death|4|||
145285929|NCT00585351|523895517|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
145555762|NCT01614067|524892638|FG000|Overall Study|Pregnancy|1|||
145555763|NCT01614067|524892639|FG001|Overall Study|Pregnancy|0|||
145555764|NCT01614067|524892638|FG000|Overall Study|Physician Decision|6|||
145285930|NCT00585351|523895518|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
145285931|NCT00585351|523895519|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
145285932|NCT00585351|523895520|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
145285933|NCT00585351|523895513|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
145285934|NCT00585351|523895514|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
145285935|NCT00585351|523895515|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
145285936|NCT00585351|523895516|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
145285937|NCT00585351|523895517|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
145285938|NCT00585351|523895518|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
145285939|NCT00585351|523895519|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
145285940|NCT00585351|523895520|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
145285941|NCT00585351|523895513|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
145285942|NCT00585351|523895514|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
145285943|NCT00585351|523895515|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
145285944|NCT00585351|523895516|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
145285945|NCT00585351|523895517|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
145285946|NCT00585351|523895518|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
145285947|NCT00585351|523895519|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
145285948|NCT00585351|523895520|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
145285949|NCT00585351|523895513|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
145285950|NCT00585351|523895514|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
145285951|NCT00585351|523895515|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285952|NCT00585351|523895516|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285953|NCT00585351|523895517|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285954|NCT00585351|523895518|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285955|NCT00585351|523895519|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285956|NCT00585351|523895520|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
145285957|NCT00585351|523895513|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285958|NCT00585351|523895514|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285959|NCT00585351|523895515|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285960|NCT00585351|523895516|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285961|NCT00585351|523895517|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285962|NCT00585351|523895518|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
145285963|NCT00585351|523895519|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
145285964|NCT00585351|523895520|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
145285965|NCT00585351|523895513|FG000|Enrollment Period (Intervention)|Death|0|||
145285966|NCT00585351|523895514|FG001|Enrollment Period (Intervention)|Death|0|||
145285967|NCT00585351|523895515|FG002|Enrollment Period (Intervention)|Death|0|||
145285968|NCT00585351|523895516|FG003|Enrollment Period (Intervention)|Death|0|||
145285969|NCT00585351|523895517|FG004|Enrollment Period (Intervention)|Death|1|||
145285970|NCT00585351|523895518|FG005|Enrollment Period (Intervention)|Death|0|||
145285971|NCT00585351|523895519|FG006|Enrollment Period (Intervention)|Death|1|||
145285972|NCT00585351|523895520|FG007|Enrollment Period (Intervention)|Death|0|||
145285973|NCT00585351|523895513|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285974|NCT00585351|523895514|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285975|NCT00585351|523895515|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285976|NCT00585351|523895516|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285977|NCT00585351|523895517|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
145285978|NCT00585351|523895518|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
145285979|NCT00585351|523895519|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285980|NCT00585351|523895520|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
145285981|NCT01001169|523895521|FG000|Overall Study|Withdrawal by Subject|2|||
145285982|NCT01001169|523895522|FG001|Overall Study|Withdrawal by Subject|1|||
145285983|NCT02536378|523895527|FG000|Overall Study|Physician Decision|0|||
145285984|NCT02536378|523895528|FG001|Overall Study|Physician Decision|2|||
145285985|NCT02536378|523895527|FG000|Overall Study|Withdrawal by Subject|0|||
145285986|NCT02536378|523895528|FG001|Overall Study|Withdrawal by Subject|1|||
145285987|NCT02536378|523895527|FG000|Overall Study|Death|1|||
145285988|NCT02536378|523895528|FG001|Overall Study|Death|2|||
145285989|NCT02536378|523895527|FG000|Overall Study|Patient refused further follow up|6|||
145285990|NCT02536378|523895528|FG001|Overall Study|Patient refused further follow up|2|||
145285991|NCT00602030|523895529|FG000|Lead-in Phase|Disease Progression|2|||
145285992|NCT00602030|523895530|FG001|Lead-in Phase|Disease Progression|3|||
145285993|NCT00602030|523895531|FG002|Lead-in Phase|Disease Progression|0|||
145285994|NCT00602030|523895532|FG003|Lead-in Phase|Disease Progression|0|||
145285995|NCT00602030|523895533|FG004|Lead-in Phase|Disease Progression|0|||
145285996|NCT00602030|523895529|FG000|Lead-in Phase|Adverse Event|0|||
145285997|NCT00602030|523895530|FG001|Lead-in Phase|Adverse Event|2|||
145285998|NCT00602030|523895531|FG002|Lead-in Phase|Adverse Event|0|||
145285999|NCT00602030|523895532|FG003|Lead-in Phase|Adverse Event|0|||
145286000|NCT00602030|523895533|FG004|Lead-in Phase|Adverse Event|0|||
145286001|NCT00602030|523895529|FG000|Double-blind Phase|Disease progression|0|||
145286002|NCT00602030|523895530|FG001|Double-blind Phase|Disease progression|0|||
145286003|NCT00602030|523895531|FG002|Double-blind Phase|Disease progression|33|||
145286004|NCT00602030|523895532|FG003|Double-blind Phase|Disease progression|30|||
145286005|NCT00602030|523895533|FG004|Double-blind Phase|Disease progression|0|||
145286006|NCT00602030|523895529|FG000|Double-blind Phase|Adverse Event|0|||
145286007|NCT00602030|523895530|FG001|Double-blind Phase|Adverse Event|0|||
145286008|NCT00602030|523895531|FG002|Double-blind Phase|Adverse Event|9|||
145286009|NCT00602030|523895532|FG003|Double-blind Phase|Adverse Event|18|||
145286010|NCT00602030|523895533|FG004|Double-blind Phase|Adverse Event|0|||
145286011|NCT00602030|523895529|FG000|Double-blind Phase|Consent withdrawal|0|||
145286012|NCT00602030|523895530|FG001|Double-blind Phase|Consent withdrawal|0|||
145286013|NCT00602030|523895531|FG002|Double-blind Phase|Consent withdrawal|4|||
145286014|NCT00602030|523895532|FG003|Double-blind Phase|Consent withdrawal|3|||
145286015|NCT00602030|523895533|FG004|Double-blind Phase|Consent withdrawal|0|||
145286016|NCT00602030|523895529|FG000|Double-blind Phase|Death|0|||
145286017|NCT00602030|523895530|FG001|Double-blind Phase|Death|0|||
145286018|NCT00602030|523895531|FG002|Double-blind Phase|Death|3|||
145286019|NCT00602030|523895532|FG003|Double-blind Phase|Death|3|||
145286020|NCT00602030|523895533|FG004|Double-blind Phase|Death|0|||
145286021|NCT00602030|523895529|FG000|Double-blind Phase|Administrative decision|0|||
145286022|NCT00602030|523895530|FG001|Double-blind Phase|Administrative decision|0|||
145286023|NCT00602030|523895531|FG002|Double-blind Phase|Administrative decision|0|||
145286024|NCT00602030|523895532|FG003|Double-blind Phase|Administrative decision|2|||
145286025|NCT00602030|523895533|FG004|Double-blind Phase|Administrative decision|0|||
145286026|NCT00602030|523895529|FG000|Double-blind Phase|Ineligibility|0|||
145286027|NCT00602030|523895530|FG001|Double-blind Phase|Ineligibility|0|||
145286028|NCT00602030|523895531|FG002|Double-blind Phase|Ineligibility|0|||
145286029|NCT00602030|523895532|FG003|Double-blind Phase|Ineligibility|1|||
145286030|NCT00602030|523895533|FG004|Double-blind Phase|Ineligibility|0|||
145286031|NCT00602030|523895529|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
145286032|NCT00602030|523895530|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
145286033|NCT00602030|523895531|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
145286034|NCT00602030|523895532|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
145286035|NCT00602030|523895533|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
145286036|NCT00602030|523895529|FG000|Double-blind Phase|Reason not specified|0|||
145286037|NCT00602030|523895530|FG001|Double-blind Phase|Reason not specified|0|||
145286038|NCT00602030|523895531|FG002|Double-blind Phase|Reason not specified|4|||
145286039|NCT00602030|523895532|FG003|Double-blind Phase|Reason not specified|2|||
145286040|NCT00602030|523895533|FG004|Double-blind Phase|Reason not specified|0|||
145286041|NCT00602030|523895529|FG000|Crossover Phase|Disease Progression|0|||
145286042|NCT00602030|523895530|FG001|Crossover Phase|Disease Progression|0|||
145286043|NCT00602030|523895531|FG002|Crossover Phase|Disease Progression|0|||
145286044|NCT00602030|523895532|FG003|Crossover Phase|Disease Progression|0|||
145286045|NCT00602030|523895533|FG004|Crossover Phase|Disease Progression|11|||
145286046|NCT00602030|523895529|FG000|Crossover Phase|Adverse Event|0|||
145286047|NCT00602030|523895530|FG001|Crossover Phase|Adverse Event|0|||
145406354|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
145286048|NCT00602030|523895531|FG002|Crossover Phase|Adverse Event|0|||
145286049|NCT00602030|523895532|FG003|Crossover Phase|Adverse Event|0|||
145286050|NCT00602030|523895533|FG004|Crossover Phase|Adverse Event|3|||
145286051|NCT00602030|523895529|FG000|Crossover Phase|Consent withdrawal|0|||
145286052|NCT00602030|523895530|FG001|Crossover Phase|Consent withdrawal|0|||
145286053|NCT00602030|523895531|FG002|Crossover Phase|Consent withdrawal|0|||
145286054|NCT00602030|523895532|FG003|Crossover Phase|Consent withdrawal|0|||
145286055|NCT00602030|523895533|FG004|Crossover Phase|Consent withdrawal|2|||
145286056|NCT00798889|523895534|FG000|Overall Study|Adverse Event|53|||
145286057|NCT00798889|523895534|FG000|Overall Study|Protocol Violation|2|||
145286058|NCT00798889|523895534|FG000|Overall Study|Withdrawal by Subject|31|||
145286059|NCT00798889|523895534|FG000|Overall Study|Lost to Follow-up|1|||
145286060|NCT00798889|523895534|FG000|Overall Study|Lack of Efficacy|213|||
145286061|NCT00798889|523895534|FG000|Overall Study|Decision of Sponsor|11|||
145286062|NCT00798889|523895534|FG000|Overall Study|Enrolled, Not treated|3|||
145286063|NCT05085964|523895535|FG000|Overall Study|Premature termination of study|21|||
145286064|NCT05085964|523895536|FG001|Overall Study|Premature termination of study|0|||
145286065|NCT03156270|523895541|FG000|Overall Study|Failed pre-treatment screening|1|||
145286066|NCT03156270|523895541|FG000|Overall Study|Lost to Follow-up|1|||
145286067|NCT00446654|523895542|FG000|Overall Study|Withdrawal by Subject|1|||
145286068|NCT00446654|523895543|FG001|Overall Study|Withdrawal by Subject|0|||
145286069|NCT00446654|523895542|FG000|Overall Study|Adverse Event|1|||
145286070|NCT00446654|523895543|FG001|Overall Study|Adverse Event|0|||
145286071|NCT02087059|523895545|FG000|Overall Study|Disease Progression|1|||
145286072|NCT02087059|523895545|FG000|Overall Study|Adverse Event|5|||
145286073|NCT02087059|523895545|FG000|Overall Study|Lost to Follow-up|1|||
145286074|NCT01261325|523895546|FG000|Overall Study|Lack of Efficacy|1|||
145286075|NCT01261325|523895547|FG001|Overall Study|Lack of Efficacy|1|||
145286076|NCT01261325|523895548|FG002|Overall Study|Lack of Efficacy|0|||
145286077|NCT01261325|523895546|FG000|Overall Study|Withdrawal by Subject|2|||
145286078|NCT01261325|523895547|FG001|Overall Study|Withdrawal by Subject|2|||
145286079|NCT01261325|523895548|FG002|Overall Study|Withdrawal by Subject|4|||
145286080|NCT01261325|523895546|FG000|Overall Study|SAE, non-fatal|1|||
145286081|NCT01261325|523895547|FG001|Overall Study|SAE, non-fatal|5|||
145286082|NCT01261325|523895548|FG002|Overall Study|SAE, non-fatal|1|||
145286083|NCT01261325|523895546|FG000|Overall Study|AE, non-serious non-fatal|9|||
145286084|NCT01261325|523895547|FG001|Overall Study|AE, non-serious non-fatal|15|||
145286085|NCT01261325|523895548|FG002|Overall Study|AE, non-serious non-fatal|13|||
145286086|NCT01261325|523895546|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145286087|NCT01261325|523895547|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145286088|NCT01261325|523895548|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145286089|NCT01261325|523895546|FG000|Overall Study|Non Compliance|2|||
145286090|NCT01261325|523895547|FG001|Overall Study|Non Compliance|0|||
145286091|NCT01261325|523895548|FG002|Overall Study|Non Compliance|0|||
145286092|NCT01261325|523895546|FG000|Overall Study|Patient Randomized by Mistake|0|||
145286093|NCT01261325|523895547|FG001|Overall Study|Patient Randomized by Mistake|1|||
145286094|NCT01261325|523895548|FG002|Overall Study|Patient Randomized by Mistake|0|||
145286095|NCT01261325|523895546|FG000|Overall Study|Erroneously Randomized|1|||
145286096|NCT01261325|523895547|FG001|Overall Study|Erroneously Randomized|0|||
145286097|NCT01261325|523895548|FG002|Overall Study|Erroneously Randomized|0|||
145286098|NCT01261325|523895546|FG000|Overall Study|Screen Failure|1|||
145286099|NCT01261325|523895547|FG001|Overall Study|Screen Failure|0|||
145286100|NCT01261325|523895548|FG002|Overall Study|Screen Failure|0|||
145286101|NCT01261325|523895546|FG000|Overall Study|Randomized in Error|0|||
145286102|NCT01261325|523895547|FG001|Overall Study|Randomized in Error|0|||
145286103|NCT01261325|523895548|FG002|Overall Study|Randomized in Error|1|||
145286104|NCT01261325|523895546|FG000|Overall Study|Protocol Violation|0|||
145286105|NCT01261325|523895547|FG001|Overall Study|Protocol Violation|3|||
145286106|NCT01261325|523895548|FG002|Overall Study|Protocol Violation|1|||
145286107|NCT01261325|523895546|FG000|Overall Study|Lost to Follow-up|0|||
145286108|NCT01261325|523895547|FG001|Overall Study|Lost to Follow-up|1|||
145286109|NCT01261325|523895548|FG002|Overall Study|Lost to Follow-up|3|||
145286110|NCT01261325|523895546|FG000|Overall Study|AE, serious fatal|0|||
145286111|NCT01261325|523895547|FG001|Overall Study|AE, serious fatal|0|||
145286112|NCT01261325|523895548|FG002|Overall Study|AE, serious fatal|2|||
145286113|NCT02330081|523895559|FG000|Overall Study|Adverse Event|1|||
145286114|NCT02330081|523895559|FG000|Overall Study|Donation did not meet criteria|1|||
145286115|NCT02330081|523895559|FG000|Overall Study|Protocol Violation|6|||
145286116|NCT02668302|523895565|FG000|Overall Study|Withdrawal by Subject|1|||
145286117|NCT02668302|523895566|FG001|Overall Study|Withdrawal by Subject|0|||
145286118|NCT03558997|523895567|FG000|Overall Study|Adverse Event|0|||
145286119|NCT03558997|523895568|FG001|Overall Study|Adverse Event|2|||
145286120|NCT03558997|523895569|FG002|Overall Study|Adverse Event|5|||
145286121|NCT03558997|523895570|FG003|Overall Study|Adverse Event|1|||
145286122|NCT03558997|523895567|FG000|Overall Study|Physician Decision|0|||
145286123|NCT03558997|523895568|FG001|Overall Study|Physician Decision|0|||
145286124|NCT03558997|523895569|FG002|Overall Study|Physician Decision|1|||
145286125|NCT03558997|523895570|FG003|Overall Study|Physician Decision|0|||
145286126|NCT03558997|523895567|FG000|Overall Study|Withdrawal by Subject|1|||
145286127|NCT03558997|523895568|FG001|Overall Study|Withdrawal by Subject|0|||
145286128|NCT03558997|523895569|FG002|Overall Study|Withdrawal by Subject|1|||
145286129|NCT03558997|523895570|FG003|Overall Study|Withdrawal by Subject|1|||
145286130|NCT03558997|523895567|FG000|Overall Study|Lost to Follow-up|0|||
145286131|NCT03558997|523895568|FG001|Overall Study|Lost to Follow-up|0|||
145286132|NCT03558997|523895569|FG002|Overall Study|Lost to Follow-up|1|||
145286133|NCT03558997|523895570|FG003|Overall Study|Lost to Follow-up|0|||
145286134|NCT01859702|523895573|FG000|Overall Study|Protocol deviation|3|||
145286135|NCT01859702|523895573|FG000|Overall Study|Adverse Event|2|||
145286136|NCT02034799|523896956|FG000|Overall Study|Withdrawal by Subject|0|||
145286137|NCT02034799|523896957|FG001|Overall Study|Withdrawal by Subject|2|||
145286138|NCT02034799|523896956|FG000|Overall Study|Lost to Follow-up|0|||
145286139|NCT02034799|523896957|FG001|Overall Study|Lost to Follow-up|1|||
145286140|NCT02034799|523896956|FG000|Overall Study|Death|2|||
145286141|NCT02034799|523896957|FG001|Overall Study|Death|1|||
145286142|NCT00633152|523896967|FG000|Overall Study|Adverse Event|1|||
145286143|NCT00633152|523896968|FG001|Overall Study|Adverse Event|0|||
145286144|NCT00633152|523896967|FG000|Overall Study|Randomized, did not receive study drug|5|||
145286145|NCT00633152|523896968|FG001|Overall Study|Randomized, did not receive study drug|2|||
145286146|NCT00633152|523896967|FG000|Overall Study|Withdrawal by Subject|1|||
145286147|NCT00633152|523896968|FG001|Overall Study|Withdrawal by Subject|1|||
145286148|NCT00633152|523896967|FG000|Overall Study|Lost to Follow-up|4|||
145286149|NCT00633152|523896968|FG001|Overall Study|Lost to Follow-up|1|||
145286150|NCT00633152|523896967|FG000|Overall Study|Miscellaneous Other|3|||
145286151|NCT00633152|523896968|FG001|Overall Study|Miscellaneous Other|2|||
145286152|NCT03273387|523896969|FG000|Overall Study|Death|2|||
145286153|NCT03273387|523896970|FG001|Overall Study|Death|2|||
145286154|NCT03273387|523896969|FG000|Overall Study|Withdrawal by Subject|1|||
145286155|NCT03273387|523896970|FG001|Overall Study|Withdrawal by Subject|1|||
145286156|NCT05216978|523896971|FG000|Overall Study|Withdrawal by Subject|3|||
145286157|NCT05216978|523896971|FG000|Overall Study|Lost to Follow-up|5|||
145286158|NCT00658320|523896973|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
145286159|NCT00658320|523896974|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
145286160|NCT00658320|523896973|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
145286161|NCT00658320|523896974|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
145286162|NCT00658320|523896973|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
145286163|NCT00658320|523896974|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
145286164|NCT00658320|523896973|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
145286165|NCT00658320|523896974|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
145286166|NCT02410252|523896978|FG000|Overall Study|Withdrawal by Subject|4|||
145286167|NCT02410252|523896978|FG000|Overall Study|Physician Decision|2|||
145286168|NCT03433001|523896990|FG000|Overall Study|Lack of Efficacy|109|||
145286169|NCT03433001|523896990|FG000|Overall Study|Adverse Event|69|||
145286170|NCT03433001|523896990|FG000|Overall Study|Withdrawal by Subject|10|||
145286171|NCT03433001|523896990|FG000|Overall Study|Death|12|||
145286172|NCT03433001|523896990|FG000|Overall Study|Lost to Follow-up|4|||
145286173|NCT03433001|523896990|FG000|Overall Study|Other|25|||
145286174|NCT01007916|523896991|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
145286175|NCT01007916|523896992|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
145286176|NCT01007916|523896991|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
145613105|NCT01275196|525099243|FG001|Overall Study|Lost to Follow-up|0|||
145286177|NCT01007916|523896992|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
145286178|NCT02961920|523896998|FG000|Overall Study|did not achive stydy protocol schedule|1|||
145286179|NCT02961920|523896999|FG001|Overall Study|did not achive stydy protocol schedule|1|||
145286180|NCT01452529|523897000|FG000|Run-in Period|Adverse Event|96|||
145286181|NCT01452529|523897001|FG001|Run-in Period|Adverse Event|0|||
145286182|NCT01452529|523897002|FG002|Run-in Period|Adverse Event|0|||
145286183|NCT01452529|523897000|FG000|Run-in Period|Withdrawal by Subject|49|||
145286184|NCT01452529|523897001|FG001|Run-in Period|Withdrawal by Subject|0|||
145286185|NCT01452529|523897002|FG002|Run-in Period|Withdrawal by Subject|0|||
145286186|NCT01452529|523897000|FG000|Run-in Period|Lost to Follow-up|19|||
145286187|NCT01452529|523897001|FG001|Run-in Period|Lost to Follow-up|0|||
145286188|NCT01452529|523897002|FG002|Run-in Period|Lost to Follow-up|0|||
145286189|NCT01452529|523897000|FG000|Run-in Period|Lack of Efficacy|46|||
145286190|NCT01452529|523897001|FG001|Run-in Period|Lack of Efficacy|0|||
145286191|NCT01452529|523897002|FG002|Run-in Period|Lack of Efficacy|0|||
145286192|NCT01452529|523897000|FG000|Run-in Period|Confirmed or suspected diversion|23|||
145286193|NCT01452529|523897001|FG001|Run-in Period|Confirmed or suspected diversion|0|||
145286194|NCT01452529|523897002|FG002|Run-in Period|Confirmed or suspected diversion|0|||
145286195|NCT01452529|523897000|FG000|Run-in Period|Administrative|21|||
145286196|NCT01452529|523897001|FG001|Run-in Period|Administrative|0|||
145286197|NCT01452529|523897002|FG002|Run-in Period|Administrative|0|||
145286198|NCT01452529|523897000|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
145286199|NCT01452529|523897001|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
145286200|NCT01452529|523897002|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
145286201|NCT01452529|523897000|FG000|Double-blind (DB) Period|Adverse Event|0|||
145286202|NCT01452529|523897001|FG001|Double-blind (DB) Period|Adverse Event|18|||
145286203|NCT01452529|523897002|FG002|Double-blind (DB) Period|Adverse Event|11|||
145286204|NCT01452529|523897000|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
145286205|NCT01452529|523897001|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
145286206|NCT01452529|523897002|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
145286207|NCT01452529|523897000|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
145286208|NCT01452529|523897001|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
145286209|NCT01452529|523897002|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
145286210|NCT01452529|523897000|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
145286211|NCT01452529|523897001|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
145286212|NCT01452529|523897002|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
145286213|NCT01452529|523897000|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
145286214|NCT01452529|523897001|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
145286215|NCT01452529|523897002|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
145286216|NCT01452529|523897000|FG000|Double-blind (DB) Period|Administrative|0|||
145286217|NCT01452529|523897001|FG001|Double-blind (DB) Period|Administrative|11|||
145286218|NCT01452529|523897002|FG002|Double-blind (DB) Period|Administrative|7|||
145286219|NCT03551730|523897003|FG000|Overall Study|Adverse Event|1|||
145286220|NCT03551730|523897004|FG001|Overall Study|Adverse Event|0|||
145286221|NCT03551730|523897005|FG002|Overall Study|Adverse Event|0|||
145286222|NCT03551730|523897006|FG003|Overall Study|Adverse Event|0|||
145286223|NCT02891200|523897010|FG000|Overall Study|Lost to Follow-up|31|||
145286224|NCT02891200|523897011|FG001|Overall Study|Lost to Follow-up|36|||
145286225|NCT02891200|523897010|FG000|Overall Study|Death|10|||
145286226|NCT02891200|523897011|FG001|Overall Study|Death|9|||
145286227|NCT02891200|523897010|FG000|Overall Study|Withdrawal by Subject|1|||
145286228|NCT02891200|523897011|FG001|Overall Study|Withdrawal by Subject|4|||
145286229|NCT00988169|523897014|FG000|Overall Study|Withdrawal by Subject|1|||
145286230|NCT02637076|523897016|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
145286231|NCT02637076|523897017|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
145286232|NCT02637076|523897016|FG000|Overall Study|Withdrawal by Subject|0|||
145286233|NCT02637076|523897017|FG001|Overall Study|Withdrawal by Subject|4|||
145286234|NCT00130520|523897018|FG000|Overall Study|Adverse Event|11|||
145286235|NCT00130520|523897018|FG000|Overall Study|Death|1|||
145286236|NCT00130520|523897018|FG000|Overall Study|Physician Decision|1|||
145286237|NCT00130520|523897018|FG000|Overall Study|Withdrawal by Subject|1|||
145286238|NCT00130520|523897018|FG000|Overall Study|Disease Progression|23|||
145286239|NCT00130520|523897018|FG000|Overall Study|Protocol non-compliance|1|||
145286240|NCT00130520|523897018|FG000|Overall Study|Did not meet re-treatment criteria|1|||
145286241|NCT02295774|523897020|FG000|Overall Study|Physician Decision|1|||
145286242|NCT02295774|523897020|FG000|Overall Study|Withdrawal by Subject|2|||
145286243|NCT00582036|523897021|FG000|Overall Study|Withdrawal by Subject|0|||
145286244|NCT00582036|523897022|FG001|Overall Study|Withdrawal by Subject|1|||
145286245|NCT03294538|523897023|FG000|Overall Study|Adverse Event|0|||
145286246|NCT03294538|523897024|FG001|Overall Study|Adverse Event|1|||
145286247|NCT03294538|523897025|FG002|Overall Study|Adverse Event|1|||
145286248|NCT03294538|523897023|FG000|Overall Study|Lost to Follow-up|1|||
145286249|NCT03294538|523897024|FG001|Overall Study|Lost to Follow-up|0|||
145286250|NCT03294538|523897025|FG002|Overall Study|Lost to Follow-up|0|||
145286251|NCT03294538|523897023|FG000|Overall Study|Outside of Visit Window|4|||
145286252|NCT03294538|523897024|FG001|Overall Study|Outside of Visit Window|4|||
145286253|NCT03294538|523897025|FG002|Overall Study|Outside of Visit Window|1|||
145286254|NCT02623959|523897028|FG000|Overall Study|Progression|0|||
145286255|NCT02623959|523897029|FG001|Overall Study|Progression|1|||
145286256|NCT03687125|523897031|FG000|Overall Study|Progressive Disease|2|||
145286257|NCT03687125|523897032|FG001|Overall Study|Progressive Disease|1|||
145286258|NCT03687125|523897031|FG000|Overall Study|Protocol Violation|1|||
145286259|NCT03687125|523897032|FG001|Overall Study|Protocol Violation|0|||
145286260|NCT01992107|523897033|FG000|Overall Study|Administrative reasons|2|||
145286261|NCT01992107|523897034|FG001|Overall Study|Administrative reasons|0|||
145286262|NCT01992107|523897035|FG002|Overall Study|Administrative reasons|0|||
145286263|NCT01992107|523897033|FG000|Overall Study|Adverse Event|0|||
145286264|NCT01992107|523897034|FG001|Overall Study|Adverse Event|1|||
145286265|NCT01992107|523897035|FG002|Overall Study|Adverse Event|0|||
145286266|NCT01992107|523897033|FG000|Overall Study|Lost to Follow-up|46|||
145286267|NCT01992107|523897034|FG001|Overall Study|Lost to Follow-up|22|||
145286268|NCT01992107|523897035|FG002|Overall Study|Lost to Follow-up|26|||
145286269|NCT01992107|523897033|FG000|Overall Study|noncompliance and were unavailable|7|||
145286270|NCT01992107|523897034|FG001|Overall Study|noncompliance and were unavailable|3|||
145286271|NCT01992107|523897035|FG002|Overall Study|noncompliance and were unavailable|2|||
145286272|NCT01992107|523897033|FG000|Overall Study|Withdrawal by Subject|13|||
145286273|NCT01992107|523897034|FG001|Overall Study|Withdrawal by Subject|7|||
145286274|NCT01992107|523897035|FG002|Overall Study|Withdrawal by Subject|8|||
145286275|NCT02022007|523897036|FG000|Overall Study|Withdrawal by Subject|1|||
145286276|NCT02022007|523897037|FG001|Overall Study|Withdrawal by Subject|1|||
145286277|NCT02022007|523897038|FG002|Overall Study|Withdrawal by Subject|1|||
145286278|NCT02022007|523897036|FG000|Overall Study|Noncompliant|0|||
145286279|NCT02022007|523897037|FG001|Overall Study|Noncompliant|0|||
145286280|NCT02022007|523897038|FG002|Overall Study|Noncompliant|1|||
145286281|NCT01214603|523897039|FG000|Overall Study|Adverse Event|0|||
145286282|NCT01214603|523897040|FG001|Overall Study|Adverse Event|0|||
145286283|NCT01214603|523897041|FG002|Overall Study|Adverse Event|1|||
145286284|NCT01214603|523897039|FG000|Overall Study|Death|1|||
145286285|NCT01214603|523897040|FG001|Overall Study|Death|0|||
145286286|NCT01214603|523897041|FG002|Overall Study|Death|0|||
145286287|NCT01214603|523897039|FG000|Overall Study|Progressive Disease|4|||
145286288|NCT01214603|523897040|FG001|Overall Study|Progressive Disease|1|||
145286289|NCT01214603|523897041|FG002|Overall Study|Progressive Disease|3|||
145286290|NCT01507896|523897042|FG000|Overall Study|Withdrawal by Subject|1|||
145286291|NCT01507896|523897042|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
145286292|NCT00617461|523897053|FG000|First Treatment Intervention Period|Adverse Event|2|||
145286293|NCT00617461|523897054|FG001|First Treatment Intervention Period|Adverse Event|0|||
145613106|NCT01275196|525099242|FG000|Overall Study|Disease Progression|6|||
145286294|NCT00617461|523897053|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
145286295|NCT00617461|523897054|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
145286296|NCT00617461|523897053|FG000|First Treatment Intervention Period|Protocol Violation|2|||
145286297|NCT00617461|523897054|FG001|First Treatment Intervention Period|Protocol Violation|1|||
145286298|NCT00617461|523897053|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
145286299|NCT00617461|523897054|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
145613107|NCT01275196|525099243|FG001|Overall Study|Disease Progression|5|||
145286300|NCT00617461|523897053|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
145555765|NCT01614067|524892639|FG001|Overall Study|Physician Decision|5|||
145555766|NCT01614067|524892638|FG000|Overall Study|Withdrawal by Subject|0|||
145555767|NCT01614067|524892639|FG001|Overall Study|Withdrawal by Subject|1|||
145555768|NCT01614067|524892638|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
145555769|NCT01614067|524892639|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
145286301|NCT00617461|523897054|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
145286302|NCT00617461|523897053|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
145286303|NCT00617461|523897054|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
145286304|NCT00617461|523897053|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
145286305|NCT00617461|523897054|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
145286306|NCT00617461|523897053|FG000|Second Treatment Intervention Period|Adverse Event|0|||
145286307|NCT00617461|523897054|FG001|Second Treatment Intervention Period|Adverse Event|1|||
145286308|NCT00617461|523897053|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
145286309|NCT00617461|523897054|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
145286310|NCT00617461|523897053|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
145286311|NCT00617461|523897054|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
145286312|NCT00617461|523897053|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
145286313|NCT00617461|523897054|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
145286314|NCT00358826|523897055|FG000|Core Study|Adverse Event|1|||
145286315|NCT00358826|523897056|FG001|Core Study|Adverse Event|3|||
145286316|NCT00358826|523897057|FG002|Core Study|Adverse Event|1|||
145286317|NCT00358826|523897058|FG003|Core Study|Adverse Event|1|||
145286318|NCT00358826|523897059|FG004|Core Study|Adverse Event|0|||
145286319|NCT00358826|523897060|FG005|Core Study|Adverse Event|0|||
145286320|NCT00358826|523897061|FG006|Core Study|Adverse Event|0|||
145286321|NCT00358826|523897062|FG007|Core Study|Adverse Event|0|||
145286322|NCT00358826|523897055|FG000|Core Study|Withdrawal by Subject|2|||
145286323|NCT00358826|523897056|FG001|Core Study|Withdrawal by Subject|2|||
145286324|NCT00358826|523897057|FG002|Core Study|Withdrawal by Subject|0|||
145286325|NCT00358826|523897058|FG003|Core Study|Withdrawal by Subject|0|||
145286326|NCT00358826|523897059|FG004|Core Study|Withdrawal by Subject|0|||
145286327|NCT00358826|523897060|FG005|Core Study|Withdrawal by Subject|0|||
145286328|NCT00358826|523897061|FG006|Core Study|Withdrawal by Subject|0|||
145286329|NCT00358826|523897062|FG007|Core Study|Withdrawal by Subject|0|||
145286330|NCT00358826|523897055|FG000|Core Study|Lost to Follow-up|0|||
145286331|NCT00358826|523897056|FG001|Core Study|Lost to Follow-up|0|||
145286332|NCT00358826|523897057|FG002|Core Study|Lost to Follow-up|0|||
145286333|NCT00358826|523897058|FG003|Core Study|Lost to Follow-up|1|||
145286334|NCT00358826|523897059|FG004|Core Study|Lost to Follow-up|0|||
145286335|NCT00358826|523897060|FG005|Core Study|Lost to Follow-up|0|||
145286336|NCT00358826|523897061|FG006|Core Study|Lost to Follow-up|0|||
145286337|NCT00358826|523897062|FG007|Core Study|Lost to Follow-up|0|||
145286338|NCT00358826|523897055|FG000|Core Study|Physician Decision|0|||
145286339|NCT00358826|523897056|FG001|Core Study|Physician Decision|0|||
145286340|NCT00358826|523897057|FG002|Core Study|Physician Decision|1|||
145286341|NCT00358826|523897058|FG003|Core Study|Physician Decision|0|||
145286342|NCT00358826|523897059|FG004|Core Study|Physician Decision|0|||
145286343|NCT00358826|523897060|FG005|Core Study|Physician Decision|0|||
145286344|NCT00358826|523897061|FG006|Core Study|Physician Decision|0|||
145286345|NCT00358826|523897062|FG007|Core Study|Physician Decision|0|||
145286346|NCT00358826|523897055|FG000|MDCT Substudy|Adverse Event|0|||
145286347|NCT00358826|523897056|FG001|MDCT Substudy|Adverse Event|0|||
145286348|NCT00358826|523897057|FG002|MDCT Substudy|Adverse Event|0|||
145286349|NCT00358826|523897058|FG003|MDCT Substudy|Adverse Event|0|||
145286350|NCT00358826|523897059|FG004|MDCT Substudy|Adverse Event|1|||
145286351|NCT00358826|523897060|FG005|MDCT Substudy|Adverse Event|0|||
145286352|NCT00358826|523897061|FG006|MDCT Substudy|Adverse Event|0|||
145286353|NCT00358826|523897062|FG007|MDCT Substudy|Adverse Event|0|||
145286354|NCT00358826|523897055|FG000|MDCT Substudy|Lost to Follow-up|0|||
145286355|NCT00358826|523897056|FG001|MDCT Substudy|Lost to Follow-up|0|||
145286356|NCT00358826|523897057|FG002|MDCT Substudy|Lost to Follow-up|0|||
145286357|NCT00358826|523897058|FG003|MDCT Substudy|Lost to Follow-up|0|||
145286358|NCT00358826|523897059|FG004|MDCT Substudy|Lost to Follow-up|0|||
145286359|NCT00358826|523897060|FG005|MDCT Substudy|Lost to Follow-up|1|||
145286360|NCT00358826|523897061|FG006|MDCT Substudy|Lost to Follow-up|0|||
145286361|NCT00358826|523897062|FG007|MDCT Substudy|Lost to Follow-up|0|||
145286362|NCT00358826|523897055|FG000|MDCT Substudy|Withdrawal by Subject|0|||
145286363|NCT00358826|523897056|FG001|MDCT Substudy|Withdrawal by Subject|0|||
145286364|NCT00358826|523897057|FG002|MDCT Substudy|Withdrawal by Subject|0|||
145286365|NCT00358826|523897058|FG003|MDCT Substudy|Withdrawal by Subject|0|||
145286366|NCT00358826|523897059|FG004|MDCT Substudy|Withdrawal by Subject|0|||
145286367|NCT00358826|523897060|FG005|MDCT Substudy|Withdrawal by Subject|1|||
145286368|NCT00358826|523897061|FG006|MDCT Substudy|Withdrawal by Subject|0|||
145286369|NCT00358826|523897062|FG007|MDCT Substudy|Withdrawal by Subject|0|||
145286370|NCT01821625|523897064|FG000|Overall Study|Withdrawal by Subject|2|||
145555770|NCT01505868|524892640|FG000|Overall Study|Withdrawal by Subject|1|||
145286371|NCT01821625|523897064|FG000|Overall Study|Lack of Efficacy|2|||
145286372|NCT01821625|523897064|FG000|Overall Study|Adverse Event|1|||
145286373|NCT01821625|523897064|FG000|Overall Study|Medical contraindication|1|||
145286374|NCT01626859|523897076|FG000|Overall Study|Adverse Event|1|||
145286375|NCT01626859|523897077|FG001|Overall Study|Adverse Event|3|||
145286376|NCT01626859|523897078|FG002|Overall Study|Adverse Event|2|||
145286377|NCT01626859|523897076|FG000|Overall Study|Physician Decision|0|||
145286378|NCT01626859|523897077|FG001|Overall Study|Physician Decision|1|||
145286379|NCT01626859|523897078|FG002|Overall Study|Physician Decision|0|||
145286380|NCT01626859|523897076|FG000|Overall Study|Withdrawal by Subject|1|||
145286381|NCT01626859|523897077|FG001|Overall Study|Withdrawal by Subject|4|||
145286382|NCT01626859|523897078|FG002|Overall Study|Withdrawal by Subject|2|||
145286383|NCT02826603|523897079|FG000|Overall Study|Adverse Event|17|||
145286384|NCT02826603|523897080|FG001|Overall Study|Adverse Event|9|||
145286385|NCT02826603|523897079|FG000|Overall Study|Lack of Efficacy|4|||
145286386|NCT02826603|523897080|FG001|Overall Study|Lack of Efficacy|9|||
145286387|NCT02826603|523897079|FG000|Overall Study|Lost to Follow-up|13|||
145286388|NCT02826603|523897080|FG001|Overall Study|Lost to Follow-up|12|||
145286389|NCT02826603|523897079|FG000|Overall Study|Noncompliance with treatment|0|||
145286390|NCT02826603|523897080|FG001|Overall Study|Noncompliance with treatment|2|||
145286391|NCT02826603|523897079|FG000|Overall Study|Physician Decision|1|||
145286392|NCT02826603|523897080|FG001|Overall Study|Physician Decision|7|||
145286393|NCT02826603|523897079|FG000|Overall Study|Pregnancy|1|||
145286394|NCT02826603|523897080|FG001|Overall Study|Pregnancy|2|||
145286395|NCT02826603|523897079|FG000|Overall Study|Protocol Violation|3|||
145286396|NCT02826603|523897080|FG001|Overall Study|Protocol Violation|3|||
145286397|NCT02826603|523897079|FG000|Overall Study|Withdrawal by Subject|20|||
145286398|NCT02826603|523897080|FG001|Overall Study|Withdrawal by Subject|19|||
145286399|NCT02826603|523897079|FG000|Overall Study|Death|2|||
145286400|NCT02826603|523897080|FG001|Overall Study|Death|0|||
145286401|NCT02826603|523897079|FG000|Overall Study|New therapy for study indication|0|||
145286402|NCT02826603|523897080|FG001|Overall Study|New therapy for study indication|1|||
145286403|NCT00905489|523897081|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
145286404|NCT00905489|523897081|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
145286405|NCT00905489|523897081|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
145286406|NCT00583596|523897082|FG000|Overall Study|Lost to Follow-up|110|||
145286407|NCT00583596|523897082|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
145286408|NCT00583596|523897082|FG000|Overall Study|Death|2|||
145286409|NCT00583596|523897082|FG000|Overall Study|Withdrawal by Subject|6|||
145286410|NCT00583596|523897082|FG000|Overall Study|Lost to Follow-up|94|||
145286411|NCT00583596|523897082|FG000|Overall Study|Data not complete|1|||
145286412|NCT00583596|523897082|FG000|Overall Study|Not consented|15|||
145555771|NCT01505868|524892641|FG001|Overall Study|Withdrawal by Subject|0|||
145555772|NCT01505868|524892642|FG002|Overall Study|Withdrawal by Subject|0|||
145286413|NCT00583596|523897082|FG000|Overall Study|Outside f-up window|26|||
145286414|NCT01855126|523897083|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
145286415|NCT01855126|523897084|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
145286416|NCT01855126|523897083|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
145286417|NCT01855126|523897084|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
145286418|NCT01078090|523897094|FG000|Overall Study|Lost to Follow-up|2363|||
145286419|NCT01078090|523897094|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
145286420|NCT01078090|523897094|FG000|Overall Study|Lack of Efficacy|1193|||
145286421|NCT01078090|523897094|FG000|Overall Study|ADR and lack of efficacy|61|||
145286422|NCT01078090|523897094|FG000|Overall Study|Other|523|||
145286423|NCT04535583|523897095|FG000|Overall Study|Lost to Follow-up|1|||
145286424|NCT04535583|523897095|FG000|Overall Study|Physician Decision|1|||
145286425|NCT04535583|523897095|FG000|Overall Study|Withdrawal by Subject|1|||
145286426|NCT01748890|523897097|FG000|Overall Study|Insufficient recruitment for analysis|4|||
145286427|NCT01688037|523897098|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
145286428|NCT01688037|523897099|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
145286429|NCT01688037|523897100|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
145286430|NCT01688037|523897098|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
145286431|NCT01688037|523897099|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
145286432|NCT01688037|523897100|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
145286433|NCT01688037|523897098|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
145286434|NCT01688037|523897099|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
145286435|NCT01688037|523897100|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
145555773|NCT01505868|524892643|FG003|Overall Study|Withdrawal by Subject|0|||
145555774|NCT01505868|524892644|FG004|Overall Study|Withdrawal by Subject|0|||
145555775|NCT03061331|524892647|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
145286436|NCT01688037|523897098|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
145286437|NCT01688037|523897099|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
145286438|NCT01688037|523897100|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
145286439|NCT01688037|523897098|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
145286440|NCT01688037|523897099|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
145286441|NCT01688037|523897100|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
145286442|NCT01688037|523897098|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
145286443|NCT01688037|523897099|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
145286444|NCT01688037|523897100|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
145286445|NCT01688037|523897098|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
145286446|NCT01688037|523897099|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
145286447|NCT01688037|523897100|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
145286448|NCT01688037|523897098|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
145286449|NCT01688037|523897099|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
145286450|NCT01688037|523897100|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
145286451|NCT01688037|523897098|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
145286452|NCT01688037|523897099|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
145286453|NCT01688037|523897100|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
145286454|NCT01688037|523897098|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
145286455|NCT01688037|523897099|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
145286456|NCT01688037|523897100|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
145286457|NCT02100956|523897101|FG000|At Least One Week Between Injections|Adverse Event|0|||
145286458|NCT02100956|523897102|FG001|At Least One Week Between Injections|Adverse Event|1|||
145286459|NCT02220907|523897103|FG000|Overall Study|Adverse Event|7|||
145286460|NCT02220907|523897103|FG000|Overall Study|Physician Decision|1|||
145286461|NCT02220907|523897103|FG000|Overall Study|Withdrawal by Subject|2|||
145286462|NCT02220907|523897103|FG000|Overall Study|Conflict with the stopping criteria|1|||
145286463|NCT01098240|523897104|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
145286464|NCT01098240|523897105|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
145286465|NCT01098240|523897106|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
145286466|NCT01098240|523897104|FG000|Open-Label Phase|Protocol Violation|4|||
145286467|NCT01098240|523897105|FG001|Open-Label Phase|Protocol Violation|0|||
145286468|NCT01098240|523897106|FG002|Open-Label Phase|Protocol Violation|0|||
145286469|NCT01098240|523897104|FG000|Open-Label Phase|Lost to Follow-up|13|||
145286470|NCT01098240|523897105|FG001|Open-Label Phase|Lost to Follow-up|0|||
145286471|NCT01098240|523897106|FG002|Open-Label Phase|Lost to Follow-up|0|||
145286472|NCT01098240|523897104|FG000|Open-Label Phase|Other|19|||
145286473|NCT01098240|523897105|FG001|Open-Label Phase|Other|0|||
145286474|NCT01098240|523897106|FG002|Open-Label Phase|Other|0|||
145286475|NCT01098240|523897104|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
145286476|NCT01098240|523897105|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145286477|NCT01098240|523897106|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145286478|NCT01098240|523897104|FG000|Open-Label Phase|Pregnancy|1|||
145286479|NCT01098240|523897105|FG001|Open-Label Phase|Pregnancy|0|||
145286480|NCT01098240|523897106|FG002|Open-Label Phase|Pregnancy|0|||
145286481|NCT01098240|523897104|FG000|Open-Label Phase|Withdrawal by Subject|9|||
145286482|NCT01098240|523897105|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145286483|NCT01098240|523897106|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145286484|NCT01098240|523897104|FG000|Open-Label Phase|Adverse Event|12|||
145286485|NCT01098240|523897105|FG001|Open-Label Phase|Adverse Event|0|||
145286486|NCT01098240|523897106|FG002|Open-Label Phase|Adverse Event|0|||
145286487|NCT01098240|523897104|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
145286488|NCT01098240|523897105|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
145286489|NCT01098240|523897106|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
145286490|NCT01098240|523897104|FG000|Double-Blind Phase|Protocol Violation|0|||
145286491|NCT01098240|523897105|FG001|Double-Blind Phase|Protocol Violation|2|||
145286492|NCT01098240|523897106|FG002|Double-Blind Phase|Protocol Violation|4|||
145286493|NCT01098240|523897104|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145286494|NCT01098240|523897105|FG001|Double-Blind Phase|Lost to Follow-up|2|||
145286495|NCT01098240|523897106|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145286496|NCT01098240|523897104|FG000|Double-Blind Phase|Other|0|||
145286497|NCT01098240|523897105|FG001|Double-Blind Phase|Other|2|||
145286498|NCT01098240|523897106|FG002|Double-Blind Phase|Other|2|||
145286499|NCT01098240|523897104|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
145286500|NCT01098240|523897105|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
145286501|NCT01098240|523897106|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
145286502|NCT01098240|523897104|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
145286503|NCT01098240|523897105|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
145286504|NCT01098240|523897106|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
145286505|NCT01098240|523897104|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145286506|NCT01098240|523897105|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
145286507|NCT01098240|523897106|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
145406355|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
145286508|NCT01098240|523897104|FG000|Double-Blind Phase|Adverse Event|0|||
145286509|NCT01098240|523897105|FG001|Double-Blind Phase|Adverse Event|3|||
145286510|NCT01098240|523897106|FG002|Double-Blind Phase|Adverse Event|3|||
145286511|NCT03280537|523897107|FG000|Overall Study|Withdrawal by Subject|2|||
145286512|NCT03280537|523897108|FG001|Overall Study|Withdrawal by Subject|4|||
145286513|NCT01588106|523897109|FG000|Overall Study|Withdrawal by Subject|5|||
145406356|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
145406357|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
145406358|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
145406359|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
145406360|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
145406361|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
145406362|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
145406363|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
145406364|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
145406365|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
145406366|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
145406367|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
145406368|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
145406369|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
145555776|NCT03061331|524892648|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
145555777|NCT01980875|524892649|FG000|Overall Study|Withdrew Consent|1|||
145555778|NCT01980875|524892650|FG001|Overall Study|Withdrew Consent|1|||
145555779|NCT01980875|524892651|FG002|Overall Study|Withdrew Consent|1|||
145555780|NCT01980875|524892649|FG000|Overall Study|Study Terminated by Sponsor|7|||
145555781|NCT01980875|524892650|FG001|Overall Study|Study Terminated by Sponsor|24|||
145555782|NCT01980875|524892651|FG002|Overall Study|Study Terminated by Sponsor|22|||
145555783|NCT01980875|524892649|FG000|Overall Study|Lost to Follow-up|0|||
145555784|NCT01980875|524892650|FG001|Overall Study|Lost to Follow-up|0|||
145286514|NCT01588106|523897110|FG001|Overall Study|Withdrawal by Subject|4|||
145286515|NCT02995837|523897111|FG000|Overall Study|Lost to Follow-up|9|||
145286516|NCT02995837|523897112|FG001|Overall Study|Lost to Follow-up|8|||
145286517|NCT02058628|523898713|FG000|Overall Study|Adverse Event|1|||
145286518|NCT02058628|523898714|FG001|Overall Study|Adverse Event|0|||
145286519|NCT02058628|523898713|FG000|Overall Study|Withdrawal by Subject|2|||
145286520|NCT02058628|523898714|FG001|Overall Study|Withdrawal by Subject|2|||
145286521|NCT02058628|523898713|FG000|Overall Study|Lost to Follow-up|2|||
145286522|NCT02058628|523898714|FG001|Overall Study|Lost to Follow-up|4|||
145286523|NCT02058628|523898713|FG000|Overall Study|Not in time schedule|0|||
145286524|NCT02058628|523898714|FG001|Overall Study|Not in time schedule|1|||
145286525|NCT02058628|523898713|FG000|Overall Study|The visit date was not in timeline|0|||
145286526|NCT02058628|523898714|FG001|Overall Study|The visit date was not in timeline|1|||
145286527|NCT02058628|523898713|FG000|Overall Study|A lot of time for study for participant|1|||
145286528|NCT02058628|523898714|FG001|Overall Study|A lot of time for study for participant|0|||
145286529|NCT02058628|523898713|FG000|Overall Study|Non compliance|1|||
145286530|NCT02058628|523898714|FG001|Overall Study|Non compliance|0|||
145286531|NCT00832078|523898715|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
145286532|NCT00832078|523898716|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
145286533|NCT00832078|523898715|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
145286534|NCT00832078|523898716|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
145286535|NCT04527471|523898719|FG000|Overall Study|Adverse Event|1|||
145286536|NCT04527471|523898720|FG001|Overall Study|Adverse Event|0|||
145286537|NCT04527471|523898719|FG000|Overall Study|Lost to Follow-up|1|||
145286538|NCT04527471|523898720|FG001|Overall Study|Lost to Follow-up|0|||
145286539|NCT01628120|523898726|FG000|Overall Study|Withdrawal by Subject|7|||
145286540|NCT01628120|523898726|FG000|Overall Study|Adverse Event|12|||
145286541|NCT01628120|523898726|FG000|Overall Study|Lost to Follow-up|1|||
145286542|NCT01628120|523898726|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
145286543|NCT01628120|523898726|FG000|Overall Study|Non-compliant with Study Procedures|1|||
145286544|NCT01628120|523898726|FG000|Overall Study|Not Treated|3|||
145286545|NCT01628120|523898726|FG000|Overall Study|Sponsor Decision|5|||
145286546|NCT01628120|523898726|FG000|Overall Study|Switched Dialysis Method|2|||
145286547|NCT01628120|523898726|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
145286548|NCT01628120|523898726|FG000|Overall Study|Moved or Relocated|5|||
145286549|NCT01628120|523898726|FG000|Overall Study|Kidney Transplant|2|||
145286550|NCT01628120|523898726|FG000|Overall Study|Use of Standard of Care|1|||
145286551|NCT01165996|523898730|FG000|Overall Study|Death|1|||
145286552|NCT01165996|523898730|FG000|Overall Study|Physician Decision|1|||
145286553|NCT00096265|523898731|FG000|Overall Study|Ineligible|1|||
145286554|NCT00096265|523898732|FG001|Overall Study|Ineligible|0|||
145286555|NCT00096265|523898733|FG002|Overall Study|Ineligible|0|||
145286556|NCT01506323|523898734|FG000|Overall Study|Lost to Follow-up|5|||
145286557|NCT01506323|523898735|FG001|Overall Study|Lost to Follow-up|4|||
145286558|NCT01506323|523898734|FG000|Overall Study|Withdrawal by Subject|4|||
145286559|NCT01506323|523898735|FG001|Overall Study|Withdrawal by Subject|4|||
145286560|NCT01506323|523898734|FG000|Overall Study|Lack of Efficacy|1|||
145286561|NCT01506323|523898735|FG001|Overall Study|Lack of Efficacy|3|||
145286562|NCT01506323|523898734|FG000|Overall Study|Moved out of area|5|||
145286563|NCT01506323|523898735|FG001|Overall Study|Moved out of area|2|||
145286564|NCT01506323|523898734|FG000|Overall Study|Schedule or Transportation conflict|8|||
145286565|NCT01506323|523898735|FG001|Overall Study|Schedule or Transportation conflict|0|||
145286566|NCT01506323|523898734|FG000|Overall Study|Started another treatment|1|||
145286567|NCT01506323|523898735|FG001|Overall Study|Started another treatment|0|||
145286568|NCT00704418|523898737|FG000|Overall Study|Withdrawal by Subject|2|||
145286569|NCT00704418|523898738|FG001|Overall Study|Withdrawal by Subject|0|||
145286570|NCT00704418|523898737|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
145286571|NCT00704418|523898738|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
145286572|NCT01075763|523898739|FG000|Overall Study|Lost to Follow-up|2|||
145286573|NCT01075763|523898740|FG001|Overall Study|Lost to Follow-up|1|||
145286574|NCT01075763|523898739|FG000|Overall Study|Lack of Efficacy|0|||
145286575|NCT01075763|523898740|FG001|Overall Study|Lack of Efficacy|1|||
145286576|NCT01075763|523898739|FG000|Overall Study|Withdrawal by Subject|2|||
145286577|NCT01075763|523898740|FG001|Overall Study|Withdrawal by Subject|2|||
145286578|NCT00586521|523898741|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
145555785|NCT01980875|524892651|FG002|Overall Study|Lost to Follow-up|1|||
145555786|NCT00665847|524892652|FG000|Overall Study|Adverse Event|8|||
145286579|NCT03083483|523898743|FG000|Overall Study|Adverse Event|1|||
145286580|NCT03083483|523898744|FG001|Overall Study|Adverse Event|1|||
145286581|NCT03083483|523898745|FG002|Overall Study|Adverse Event|1|||
145286582|NCT03083483|523898743|FG000|Overall Study|Lost to Follow-up|2|||
145286583|NCT03083483|523898744|FG001|Overall Study|Lost to Follow-up|1|||
145286584|NCT03083483|523898745|FG002|Overall Study|Lost to Follow-up|1|||
145286585|NCT03083483|523898743|FG000|Overall Study|technological issues|1|||
145286586|NCT03083483|523898744|FG001|Overall Study|technological issues|0|||
145286587|NCT03083483|523898745|FG002|Overall Study|technological issues|1|||
145286588|NCT01751412|523898748|FG000|Overall Study|Disease Progression Before Treatment|1|||
145286589|NCT03734237|523898749|FG000|Overall Study|Lost to Follow-up|1|||
145286590|NCT03734237|523898750|FG001|Overall Study|Lost to Follow-up|3|||
145286591|NCT03734237|523898751|FG002|Overall Study|Lost to Follow-up|0|||
145286592|NCT03734237|523898749|FG000|Overall Study|Withdrawal by Subject|7|||
145286593|NCT03734237|523898750|FG001|Overall Study|Withdrawal by Subject|9|||
145286594|NCT03734237|523898751|FG002|Overall Study|Withdrawal by Subject|10|||
145286595|NCT00457665|523898758|FG000|12 Months|Drug allergy|1|||
145286596|NCT00457665|523898759|FG001|12 Months|Drug allergy|1|||
145286597|NCT00457665|523898758|FG000|12 Months|High HIV viral load|5|||
145286598|NCT00457665|523898759|FG001|12 Months|High HIV viral load|1|||
145286599|NCT00457665|523898758|FG000|12 Months|Lipodystrophy|2|||
145286600|NCT00457665|523898759|FG001|12 Months|Lipodystrophy|0|||
145286601|NCT00457665|523898758|FG000|12 Months|Withdrawal by Subject|0|||
145286602|NCT00457665|523898759|FG001|12 Months|Withdrawal by Subject|2|||
145286603|NCT00457665|523898758|FG000|12 Months|Abnormal Liver function tests|0|||
145555787|NCT00665847|524892652|FG000|Overall Study|Withdrawal by Subject|2|||
145555788|NCT00665847|524892652|FG000|Overall Study|Subject non-compliant|8|||
145555789|NCT00665847|524892652|FG000|Overall Study|Subject reached a virologic endpoint|4|||
145555790|NCT00665847|524892652|FG000|Overall Study|Resistance to TMC125|1|||
145555791|NCT00665847|524892652|FG000|Overall Study|Subject ineligible to continue the trial|1|||
145286604|NCT00457665|523898759|FG001|12 Months|Abnormal Liver function tests|5|||
145286605|NCT00457665|523898758|FG000|24 Months|Withdrawal by Subject|3|||
145286606|NCT00457665|523898759|FG001|24 Months|Withdrawal by Subject|2|||
145555792|NCT00665847|524892652|FG000|Overall Study|Switch to Commercial Medication|1|||
145555793|NCT00513474|524892653|FG000|Overall Study|Death|6|||
145613108|NCT01275196|525099242|FG000|Overall Study|Protocol Violation|1|||
145286607|NCT00457665|523898758|FG000|24 Months|Lipodystrophy|1|||
145286608|NCT00457665|523898759|FG001|24 Months|Lipodystrophy|1|||
145286609|NCT00457665|523898758|FG000|24 Months|Abnormal liver function tests|1|||
145286610|NCT00457665|523898759|FG001|24 Months|Abnormal liver function tests|5|||
145286611|NCT02535000|523898760|FG000|Overall Study|Cancellation of surgery.|1|||
145286612|NCT02535000|523898761|FG001|Overall Study|Cancellation of surgery.|2|||
145286613|NCT01620489|523898767|FG000|Overall Study|Adverse Event|17|||
145286614|NCT01620489|523898768|FG001|Overall Study|Adverse Event|4|||
145286615|NCT01620489|523898767|FG000|Overall Study|Protocol Violation|0|||
145286616|NCT01620489|523898768|FG001|Overall Study|Protocol Violation|3|||
145286617|NCT01620489|523898767|FG000|Overall Study|Withdrawal Criteria|17|||
145286618|NCT01620489|523898768|FG001|Overall Study|Withdrawal Criteria|25|||
145286619|NCT01620489|523898767|FG000|Overall Study|Unclassified|1|||
145286620|NCT01620489|523898768|FG001|Overall Study|Unclassified|2|||
145286621|NCT01851590|523898771|FG000|Overall Study|Withdrawal by Subject|0|||
145286622|NCT01851590|523898772|FG001|Overall Study|Withdrawal by Subject|0|||
145286623|NCT01851590|523898773|FG002|Overall Study|Withdrawal by Subject|1|||
145286624|NCT01851590|523898771|FG000|Overall Study|Adverse Event|0|||
145286625|NCT01851590|523898772|FG001|Overall Study|Adverse Event|0|||
145286626|NCT01851590|523898773|FG002|Overall Study|Adverse Event|2|||
145286627|NCT01851590|523898771|FG000|Overall Study|Lack of Efficacy|0|||
145286628|NCT01851590|523898772|FG001|Overall Study|Lack of Efficacy|1|||
145286629|NCT01851590|523898773|FG002|Overall Study|Lack of Efficacy|0|||
145286630|NCT00696709|523898774|FG000|Overall Study|Withdrawal by Subject|1|||
145286631|NCT00696709|523898775|FG001|Overall Study|Withdrawal by Subject|2|||
145286632|NCT00696709|523898776|FG002|Overall Study|Withdrawal by Subject|1|||
145286633|NCT00696709|523898777|FG003|Overall Study|Withdrawal by Subject|4|||
145286634|NCT00696709|523898778|FG004|Overall Study|Withdrawal by Subject|3|||
145286635|NCT00696709|523898774|FG000|Overall Study|Protocol Violation|1|||
145286636|NCT00696709|523898775|FG001|Overall Study|Protocol Violation|0|||
145286637|NCT00696709|523898776|FG002|Overall Study|Protocol Violation|0|||
145286638|NCT00696709|523898777|FG003|Overall Study|Protocol Violation|0|||
145286639|NCT00696709|523898778|FG004|Overall Study|Protocol Violation|0|||
145286640|NCT00696709|523898774|FG000|Overall Study|Lost to Follow-up|1|||
145286641|NCT00696709|523898775|FG001|Overall Study|Lost to Follow-up|1|||
145286642|NCT00696709|523898776|FG002|Overall Study|Lost to Follow-up|0|||
145286643|NCT00696709|523898777|FG003|Overall Study|Lost to Follow-up|0|||
145286644|NCT00696709|523898778|FG004|Overall Study|Lost to Follow-up|0|||
145286645|NCT00696709|523898774|FG000|Overall Study|Adverse Event|0|||
145286646|NCT00696709|523898775|FG001|Overall Study|Adverse Event|0|||
145286647|NCT00696709|523898776|FG002|Overall Study|Adverse Event|0|||
145286648|NCT00696709|523898777|FG003|Overall Study|Adverse Event|1|||
145286649|NCT00696709|523898778|FG004|Overall Study|Adverse Event|0|||
145286650|NCT00310856|523898779|FG000|Overall Study|Withdrawal by Subject|2|||
145286651|NCT00310856|523898780|FG001|Overall Study|Withdrawal by Subject|2|||
145286652|NCT00310856|523898781|FG002|Overall Study|Withdrawal by Subject|2|||
145286653|NCT00310856|523898779|FG000|Overall Study|Lost to Follow-up|1|||
145286654|NCT00310856|523898780|FG001|Overall Study|Lost to Follow-up|2|||
145286655|NCT00310856|523898781|FG002|Overall Study|Lost to Follow-up|6|||
145286656|NCT00310856|523898779|FG000|Overall Study|Inappropriate enrollment|1|||
145286657|NCT00310856|523898780|FG001|Overall Study|Inappropriate enrollment|1|||
145286658|NCT00310856|523898781|FG002|Overall Study|Inappropriate enrollment|0|||
145286659|NCT00310856|523898779|FG000|Overall Study|Unable to classify|1|||
145286660|NCT00310856|523898780|FG001|Overall Study|Unable to classify|0|||
145286661|NCT00310856|523898781|FG002|Overall Study|Unable to classify|0|||
145286662|NCT00321711|523898785|FG000|Part A|Adverse Event|3|||
145286663|NCT00321711|523898786|FG001|Part A|Adverse Event|3|||
145286664|NCT00321711|523898787|FG002|Part A|Adverse Event|2|||
145286665|NCT00321711|523898788|FG003|Part A|Adverse Event|0|||
145286666|NCT00321711|523898789|FG004|Part A|Adverse Event|0|||
145286667|NCT00321711|523898785|FG000|Part A|Withdrawal by Subject|1|||
145286668|NCT00321711|523898786|FG001|Part A|Withdrawal by Subject|1|||
145555794|NCT00513474|524892654|FG001|Overall Study|Death|9|||
145555795|NCT00513474|524892653|FG000|Overall Study|Participant Withdrew Consent|1|||
145286669|NCT00321711|523898787|FG002|Part A|Withdrawal by Subject|1|||
145286670|NCT00321711|523898788|FG003|Part A|Withdrawal by Subject|0|||
145286671|NCT00321711|523898789|FG004|Part A|Withdrawal by Subject|0|||
145286672|NCT00321711|523898785|FG000|Part A|Disease progression|0|||
145286673|NCT00321711|523898786|FG001|Part A|Disease progression|1|||
145286674|NCT00321711|523898787|FG002|Part A|Disease progression|0|||
145286675|NCT00321711|523898788|FG003|Part A|Disease progression|0|||
145286676|NCT00321711|523898789|FG004|Part A|Disease progression|0|||
145286677|NCT00321711|523898785|FG000|Part A|Requirement for alternative therapy|0|||
145286678|NCT00321711|523898786|FG001|Part A|Requirement for alternative therapy|2|||
145286679|NCT00321711|523898787|FG002|Part A|Requirement for alternative therapy|1|||
145286680|NCT00321711|523898788|FG003|Part A|Requirement for alternative therapy|0|||
145286681|NCT00321711|523898789|FG004|Part A|Requirement for alternative therapy|0|||
145286682|NCT00321711|523898785|FG000|Part A|Physician Decision|0|||
145286683|NCT00321711|523898786|FG001|Part A|Physician Decision|1|||
145286684|NCT00321711|523898787|FG002|Part A|Physician Decision|3|||
145286685|NCT00321711|523898788|FG003|Part A|Physician Decision|0|||
145286686|NCT00321711|523898789|FG004|Part A|Physician Decision|0|||
145286687|NCT00321711|523898785|FG000|Part A|Other|1|||
145286688|NCT00321711|523898786|FG001|Part A|Other|2|||
145286689|NCT00321711|523898787|FG002|Part A|Other|3|||
145286690|NCT00321711|523898788|FG003|Part A|Other|0|||
145286691|NCT00321711|523898789|FG004|Part A|Other|0|||
145286692|NCT00321711|523898785|FG000|Part A|Protocol deviation|0|||
145286693|NCT00321711|523898786|FG001|Part A|Protocol deviation|0|||
145286694|NCT00321711|523898787|FG002|Part A|Protocol deviation|1|||
145286695|NCT00321711|523898788|FG003|Part A|Protocol deviation|0|||
145286696|NCT00321711|523898789|FG004|Part A|Protocol deviation|0|||
145286697|NCT00321711|523898785|FG000|Part B|Noncompliance|0|||
145286698|NCT00321711|523898786|FG001|Part B|Noncompliance|0|||
145286699|NCT00321711|523898787|FG002|Part B|Noncompliance|0|||
145286700|NCT00321711|523898788|FG003|Part B|Noncompliance|0|||
145286701|NCT00321711|523898789|FG004|Part B|Noncompliance|1|||
145286702|NCT00321711|523898785|FG000|Part B|Adverse Event|0|||
145286703|NCT00321711|523898786|FG001|Part B|Adverse Event|0|||
145286704|NCT00321711|523898787|FG002|Part B|Adverse Event|0|||
145286705|NCT00321711|523898788|FG003|Part B|Adverse Event|2|||
145286706|NCT00321711|523898789|FG004|Part B|Adverse Event|1|||
145286707|NCT00321711|523898785|FG000|Part B|Disease progression|0|||
145286708|NCT00321711|523898786|FG001|Part B|Disease progression|0|||
145286709|NCT00321711|523898787|FG002|Part B|Disease progression|0|||
145286710|NCT00321711|523898788|FG003|Part B|Disease progression|1|||
145286711|NCT00321711|523898789|FG004|Part B|Disease progression|0|||
145286712|NCT00321711|523898785|FG000|Part B|Physician Decision|0|||
145286713|NCT00321711|523898786|FG001|Part B|Physician Decision|0|||
145286714|NCT00321711|523898787|FG002|Part B|Physician Decision|0|||
145286715|NCT00321711|523898788|FG003|Part B|Physician Decision|1|||
145286716|NCT00321711|523898789|FG004|Part B|Physician Decision|2|||
145286717|NCT00321711|523898785|FG000|Part B|Death|0|||
145286718|NCT00321711|523898786|FG001|Part B|Death|0|||
145286719|NCT00321711|523898787|FG002|Part B|Death|0|||
145286720|NCT00321711|523898788|FG003|Part B|Death|2|||
145286721|NCT00321711|523898789|FG004|Part B|Death|1|||
145286722|NCT01186978|523898790|FG000|Overall Study|Withdrawal by Subject|1|||
145286723|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
145286724|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
145286725|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
145286726|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
145286727|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
145286728|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
145286729|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
145286730|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
145286731|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
145286732|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
145286733|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
145286734|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
145286735|NCT01227668|523898791|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
145286736|NCT01227668|523898792|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
145286737|NCT01227668|523898791|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
145286738|NCT01227668|523898792|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
145286739|NCT01227668|523898791|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
145286740|NCT01227668|523898792|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
145286741|NCT01227668|523898791|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
145286742|NCT01227668|523898792|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
145286743|NCT01227668|523898791|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
145286744|NCT01227668|523898792|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
145286745|NCT01227668|523898791|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
145286746|NCT01227668|523898792|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
145286747|NCT00947856|523898793|FG000|Treatment Period|Progressive Disease|33|||
145286748|NCT00947856|523898794|FG001|Treatment Period|Progressive Disease|12|||
145286749|NCT00947856|523898793|FG000|Treatment Period|Adverse Event|15|||
145286750|NCT00947856|523898794|FG001|Treatment Period|Adverse Event|9|||
145286751|NCT00947856|523898793|FG000|Treatment Period|Physician Decision|14|||
145286752|NCT00947856|523898794|FG001|Treatment Period|Physician Decision|6|||
145286753|NCT00947856|523898793|FG000|Treatment Period|Study Stopped by Sponsor|4|||
145286754|NCT00947856|523898794|FG001|Treatment Period|Study Stopped by Sponsor|4|||
145286755|NCT00947856|523898793|FG000|Treatment Period|Withdrawal by Subject|12|||
145286756|NCT00947856|523898794|FG001|Treatment Period|Withdrawal by Subject|1|||
145286757|NCT00947856|523898793|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
145286758|NCT00947856|523898794|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
145286759|NCT00947856|523898793|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
145286760|NCT00947856|523898794|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
145286761|NCT00947856|523898793|FG000|Follow-up Period|Lost to Follow-up|7|||
145286762|NCT00947856|523898794|FG001|Follow-up Period|Lost to Follow-up|0|||
145286763|NCT00947856|523898793|FG000|Follow-up Period|Patient unavailable for site visits|1|||
145286764|NCT00947856|523898794|FG001|Follow-up Period|Patient unavailable for site visits|0|||
145286765|NCT00947856|523898793|FG000|Follow-up Period|Withdrawal by Subject|1|||
145286766|NCT00947856|523898794|FG001|Follow-up Period|Withdrawal by Subject|0|||
145286767|NCT01306253|523898798|FG000|Overall Study|Lost to Follow-up|1|||
145286768|NCT01306253|523898799|FG001|Overall Study|Lost to Follow-up|1|||
145286769|NCT00543439|523898800|FG000|Period 1|Adverse Event|0|||
145286770|NCT00543439|523898801|FG001|Period 1|Adverse Event|2|||
145286771|NCT00543439|523898802|FG002|Period 1|Adverse Event|1|||
145286772|NCT00543439|523898800|FG000|Period 1|Withdrawal by Subject|1|||
145286773|NCT00543439|523898801|FG001|Period 1|Withdrawal by Subject|1|||
145286774|NCT00543439|523898802|FG002|Period 1|Withdrawal by Subject|0|||
145286775|NCT00543439|523898800|FG000|Period 1|Physician Decision|0|||
145286776|NCT00543439|523898801|FG001|Period 1|Physician Decision|0|||
145286777|NCT00543439|523898802|FG002|Period 1|Physician Decision|1|||
145286778|NCT00543439|523898800|FG000|Period 2|Protocol Violation|1|||
145286779|NCT00543439|523898801|FG001|Period 2|Protocol Violation|0|||
145286780|NCT00543439|523898802|FG002|Period 2|Protocol Violation|1|||
145286781|NCT00543439|523898800|FG000|Period 2|Adverse Event|0|||
145286782|NCT00543439|523898801|FG001|Period 2|Adverse Event|1|||
145286783|NCT00543439|523898802|FG002|Period 2|Adverse Event|1|||
145286784|NCT01709383|523898807|FG000|Overall Study|Lost to Follow-up|1|||
145286785|NCT01709383|523898808|FG001|Overall Study|Lost to Follow-up|0|||
145286786|NCT03264066|523898809|FG000|Overall Study|Adverse Event|1|||
145286787|NCT03264066|523898810|FG001|Overall Study|Adverse Event|1|||
145286788|NCT03264066|523898811|FG002|Overall Study|Adverse Event|0|||
145286789|NCT03264066|523898812|FG003|Overall Study|Adverse Event|0|||
145286790|NCT03264066|523898813|FG004|Overall Study|Adverse Event|0|||
145286791|NCT03264066|523898814|FG005|Overall Study|Adverse Event|0|||
145286792|NCT03264066|523898809|FG000|Overall Study|Death|12|||
145286793|NCT03264066|523898810|FG001|Overall Study|Death|12|||
145286794|NCT03264066|523898811|FG002|Overall Study|Death|8|||
145286795|NCT03264066|523898812|FG003|Overall Study|Death|10|||
145286796|NCT03264066|523898813|FG004|Overall Study|Death|6|||
145286797|NCT03264066|523898814|FG005|Overall Study|Death|1|||
145286798|NCT03264066|523898809|FG000|Overall Study|Lost to Follow-up|1|||
145286799|NCT03264066|523898810|FG001|Overall Study|Lost to Follow-up|0|||
145286800|NCT03264066|523898811|FG002|Overall Study|Lost to Follow-up|0|||
145286801|NCT03264066|523898812|FG003|Overall Study|Lost to Follow-up|0|||
145286802|NCT03264066|523898813|FG004|Overall Study|Lost to Follow-up|0|||
145286803|NCT03264066|523898814|FG005|Overall Study|Lost to Follow-up|0|||
145286804|NCT03264066|523898809|FG000|Overall Study|Progressive Disease|0|||
145286805|NCT03264066|523898810|FG001|Overall Study|Progressive Disease|2|||
145286806|NCT03264066|523898811|FG002|Overall Study|Progressive Disease|1|||
145286807|NCT03264066|523898812|FG003|Overall Study|Progressive Disease|0|||
145286808|NCT03264066|523898813|FG004|Overall Study|Progressive Disease|0|||
145286809|NCT03264066|523898814|FG005|Overall Study|Progressive Disease|0|||
145286810|NCT03264066|523898809|FG000|Overall Study|Study Terminated by Sponsor|5|||
145286811|NCT03264066|523898810|FG001|Overall Study|Study Terminated by Sponsor|5|||
145286812|NCT03264066|523898811|FG002|Overall Study|Study Terminated by Sponsor|8|||
145286813|NCT03264066|523898812|FG003|Overall Study|Study Terminated by Sponsor|5|||
145286814|NCT03264066|523898813|FG004|Overall Study|Study Terminated by Sponsor|1|||
145286815|NCT03264066|523898814|FG005|Overall Study|Study Terminated by Sponsor|2|||
145286816|NCT03264066|523898809|FG000|Overall Study|Withdrawal by Subject|1|||
145286817|NCT03264066|523898810|FG001|Overall Study|Withdrawal by Subject|0|||
145286818|NCT03264066|523898811|FG002|Overall Study|Withdrawal by Subject|0|||
145286819|NCT03264066|523898812|FG003|Overall Study|Withdrawal by Subject|5|||
145286820|NCT03264066|523898813|FG004|Overall Study|Withdrawal by Subject|0|||
145286821|NCT03264066|523898814|FG005|Overall Study|Withdrawal by Subject|0|||
145286822|NCT01484028|523898815|FG000|Period 1|Lost to Follow-up|0|||
145286823|NCT01484028|523898816|FG001|Period 1|Lost to Follow-up|1|||
145286824|NCT01484028|523898817|FG002|Period 1|Lost to Follow-up|0|||
145286825|NCT01484028|523898818|FG003|Period 1|Lost to Follow-up|0|||
145286826|NCT01484028|523898815|FG000|Period 1|Non-Compliance to Protocol|0|||
145286827|NCT01484028|523898816|FG001|Period 1|Non-Compliance to Protocol|1|||
145286828|NCT01484028|523898817|FG002|Period 1|Non-Compliance to Protocol|0|||
145286829|NCT01484028|523898818|FG003|Period 1|Non-Compliance to Protocol|1|||
145286830|NCT01484028|523898815|FG000|Period 1|Lens Discomfort|0|||
145286831|NCT01484028|523898816|FG001|Period 1|Lens Discomfort|1|||
145286832|NCT01484028|523898817|FG002|Period 1|Lens Discomfort|0|||
145286833|NCT01484028|523898818|FG003|Period 1|Lens Discomfort|0|||
145286834|NCT01193517|523898819|FG000|Overall Study|Early Progression|1|||
145286835|NCT01193517|523898820|FG001|Overall Study|Early Progression|0|||
145286836|NCT01193517|523898821|FG002|Overall Study|Early Progression|0|||
145286837|NCT02115256|523898822|FG000|Overall Study|Withdrawal by Subject|0|||
145286838|NCT02115256|523898823|FG001|Overall Study|Withdrawal by Subject|1|||
145286839|NCT00146770|523898824|FG000|Overall Study|Adverse Event|2|||
145286840|NCT00146770|523898825|FG001|Overall Study|Adverse Event|0|||
145286841|NCT00146770|523898824|FG000|Overall Study|Pregnancy|1|||
145286842|NCT00146770|523898825|FG001|Overall Study|Pregnancy|0|||
145286843|NCT00146770|523898824|FG000|Overall Study|Withdrawal by Subject|2|||
145286844|NCT00146770|523898825|FG001|Overall Study|Withdrawal by Subject|0|||
145286845|NCT01626885|523898830|FG000|Overall Study|Adverse Event|8|||
145286846|NCT01626885|523898830|FG000|Overall Study|Withdrawal by Subject|4|||
145286847|NCT01533428|523898831|FG000|Overall Study|Adverse Event|0|||
145286848|NCT01533428|523898832|FG001|Overall Study|Adverse Event|1|||
145286849|NCT01533428|523898831|FG000|Overall Study|Lost to Follow-up|2|||
145286850|NCT01533428|523898832|FG001|Overall Study|Lost to Follow-up|1|||
145286851|NCT01533428|523898831|FG000|Overall Study|Withdrawal by Subject|7|||
145286852|NCT01533428|523898832|FG001|Overall Study|Withdrawal by Subject|6|||
145286853|NCT02669264|523898835|FG000|Overall Study|Death|5|||
145286854|NCT02669264|523898836|FG001|Overall Study|Death|5|||
145286855|NCT02669264|523898837|FG002|Overall Study|Death|3|||
145286856|NCT02669264|523898838|FG003|Overall Study|Death|3|||
145286857|NCT02669264|523898839|FG004|Overall Study|Death|3|||
145286858|NCT02669264|523898840|FG005|Overall Study|Death|6|||
145286859|NCT02669264|523898841|FG006|Overall Study|Death|3|||
145286860|NCT02669264|523898835|FG000|Overall Study|Withdrawal by Subject|0|||
145286861|NCT02669264|523898836|FG001|Overall Study|Withdrawal by Subject|1|||
145286862|NCT02669264|523898837|FG002|Overall Study|Withdrawal by Subject|0|||
145286863|NCT02669264|523898838|FG003|Overall Study|Withdrawal by Subject|0|||
145286864|NCT02669264|523898839|FG004|Overall Study|Withdrawal by Subject|1|||
145286865|NCT02669264|523898840|FG005|Overall Study|Withdrawal by Subject|0|||
145286866|NCT02669264|523898841|FG006|Overall Study|Withdrawal by Subject|0|||
145286867|NCT02669264|523898835|FG000|Overall Study|Lost to Follow-up|0|||
145286868|NCT02669264|523898836|FG001|Overall Study|Lost to Follow-up|0|||
145286869|NCT02669264|523898837|FG002|Overall Study|Lost to Follow-up|0|||
145286870|NCT02669264|523898838|FG003|Overall Study|Lost to Follow-up|0|||
145286871|NCT02669264|523898839|FG004|Overall Study|Lost to Follow-up|1|||
145286872|NCT02669264|523898840|FG005|Overall Study|Lost to Follow-up|0|||
145286873|NCT02669264|523898841|FG006|Overall Study|Lost to Follow-up|0|||
145286874|NCT02669264|523898835|FG000|Overall Study|Miscellaneous|0|||
145286875|NCT02669264|523898836|FG001|Overall Study|Miscellaneous|0|||
145286876|NCT02669264|523898837|FG002|Overall Study|Miscellaneous|0|||
145286877|NCT02669264|523898838|FG003|Overall Study|Miscellaneous|0|||
145286878|NCT02669264|523898839|FG004|Overall Study|Miscellaneous|0|||
145286879|NCT02669264|523898840|FG005|Overall Study|Miscellaneous|0|||
145286880|NCT02669264|523898841|FG006|Overall Study|Miscellaneous|2|||
145286881|NCT00526890|523898842|FG000|Overall Study|Adverse Event|2|||
145286882|NCT03035227|523898843|FG000|Overall Study|study stopped due to PI leaving institut|1|||
145286883|NCT03035227|523898844|FG001|Overall Study|study stopped due to PI leaving institut|1|||
145286884|NCT00859469|523898846|FG000|Overall Study|Adverse Event|2|||
145286885|NCT00859469|523898846|FG000|Overall Study|Lack of Efficacy|9|||
145286886|NCT00859469|523898846|FG000|Overall Study|Withdrawal by Subject|1|||
145286887|NCT00859469|523898846|FG000|Overall Study|Death|16|||
145286888|NCT04345471|523898851|FG000|Overall Study|Adverse Event|8|||
145286889|NCT04345471|523898852|FG001|Overall Study|Adverse Event|5|||
145286890|NCT04345471|523898853|FG002|Overall Study|Adverse Event|6|||
145286891|NCT04345471|523898851|FG000|Overall Study|Lack of Efficacy|1|||
145286892|NCT04345471|523898852|FG001|Overall Study|Lack of Efficacy|1|||
145286893|NCT04345471|523898853|FG002|Overall Study|Lack of Efficacy|0|||
145286894|NCT04345471|523898851|FG000|Overall Study|Protocol Violation|0|||
145286895|NCT04345471|523898852|FG001|Overall Study|Protocol Violation|1|||
145286896|NCT04345471|523898853|FG002|Overall Study|Protocol Violation|2|||
145286897|NCT04345471|523898851|FG000|Overall Study|Withdrawal by Subject|10|||
145286898|NCT04345471|523898852|FG001|Overall Study|Withdrawal by Subject|5|||
145286899|NCT04345471|523898853|FG002|Overall Study|Withdrawal by Subject|10|||
145286900|NCT03083132|523898856|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
145286901|NCT03083132|523898857|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
145286902|NCT03083132|523898856|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
145286903|NCT03083132|523898857|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
145286904|NCT03083132|523898856|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
145286905|NCT03083132|523898857|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
145286906|NCT03118739|523898858|FG000|Overall Study|Physician Decision|0|||
145286907|NCT03118739|523898859|FG001|Overall Study|Physician Decision|1|||
145286908|NCT03118739|523898858|FG000|Overall Study|Withdrawal by Subject|5|||
145286909|NCT03118739|523898859|FG001|Overall Study|Withdrawal by Subject|3|||
145286910|NCT03118739|523898858|FG000|Overall Study|Lost to Follow-up|2|||
145286911|NCT03118739|523898859|FG001|Overall Study|Lost to Follow-up|0|||
145286912|NCT00669955|523898860|FG000|Overall Study|Adverse Event|3|||
145286913|NCT00669955|523898861|FG001|Overall Study|Adverse Event|5|||
145286914|NCT00669955|523898860|FG000|Overall Study|Death|0|||
145286915|NCT00669955|523898861|FG001|Overall Study|Death|1|||
145286916|NCT00669955|523898860|FG000|Overall Study|Withdrawal by Subject|2|||
145286917|NCT00669955|523898861|FG001|Overall Study|Withdrawal by Subject|3|||
145286918|NCT00669955|523898860|FG000|Overall Study|Lost to Follow-up|5|||
145286919|NCT00669955|523898861|FG001|Overall Study|Lost to Follow-up|7|||
145286920|NCT00669955|523898860|FG000|Overall Study|Protocol Violation|2|||
145286921|NCT00669955|523898861|FG001|Overall Study|Protocol Violation|7|||
145286922|NCT00669955|523898860|FG000|Overall Study|Investigator Sponsor Judgement|0|||
145286923|NCT00669955|523898861|FG001|Overall Study|Investigator Sponsor Judgement|1|||
145286924|NCT00669955|523898860|FG000|Overall Study|not compliant with study drug/visit|2|||
145286925|NCT00669955|523898861|FG001|Overall Study|not compliant with study drug/visit|3|||
145286926|NCT00289458|523898865|FG000|Overall Study|Death|1|||
145286927|NCT00289458|523898866|FG001|Overall Study|Death|0|||
145286928|NCT00289458|523898867|FG002|Overall Study|Death|0|||
145286929|NCT00289458|523898865|FG000|Overall Study|Physician Decision|3|||
145286930|NCT00289458|523898866|FG001|Overall Study|Physician Decision|4|||
145286931|NCT00289458|523898867|FG002|Overall Study|Physician Decision|2|||
145286932|NCT00289458|523898865|FG000|Overall Study|Withdrawal by Subject|2|||
145286933|NCT00289458|523898866|FG001|Overall Study|Withdrawal by Subject|2|||
145286934|NCT00289458|523898867|FG002|Overall Study|Withdrawal by Subject|4|||
145286935|NCT04274192|523898868|FG000|Overall Study|Protocol Violation|1|||
145286936|NCT04274192|523898869|FG001|Overall Study|Protocol Violation|0|||
145286937|NCT03507439|523898870|FG000|Overall Study|Other|2|||
145286938|NCT03507439|523898871|FG001|Overall Study|Other|1|||
145406370|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
145406371|NCT00090103|524343758|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
145286939|NCT03507439|523898870|FG000|Overall Study|Withdrawal by Subject|1|||
145406372|NCT00090103|524343759|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
145286940|NCT03507439|523898871|FG001|Overall Study|Withdrawal by Subject|0|||
145406373|NCT00090103|524343760|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
145406374|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
145406375|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
145406376|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
145286941|NCT03507439|523898870|FG000|Overall Study|Death|1|||
145286942|NCT03507439|523898871|FG001|Overall Study|Death|1|||
145286943|NCT00874757|523898872|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
145286944|NCT00982410|523900639|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
145286945|NCT00982410|523900640|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
145286946|NCT00982410|523900639|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
145286947|NCT00982410|523900640|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
145286948|NCT00982410|523900639|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
145286949|NCT00982410|523900640|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
145286950|NCT00982410|523900639|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
145286951|NCT00982410|523900640|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
145286952|NCT00982410|523900639|FG000|6-month Follow-up Assessment|participant no transportation|1|||
145286953|NCT00982410|523900640|FG001|6-month Follow-up Assessment|participant no transportation|0|||
145286954|NCT00982410|523900639|FG000|6-month Follow-up Assessment|incarceration|0|||
145286955|NCT00982410|523900640|FG001|6-month Follow-up Assessment|incarceration|2|||
145286956|NCT00982410|523900639|FG000|6-month Follow-up Assessment|patent surgery|0|||
145286957|NCT00982410|523900640|FG001|6-month Follow-up Assessment|patent surgery|1|||
145286958|NCT00982410|523900639|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
145286959|NCT00982410|523900640|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
145286960|NCT00982410|523900639|FG000|12-month Follow-up Assessment|Death|0|||
145286961|NCT00982410|523900640|FG001|12-month Follow-up Assessment|Death|2|||
145286962|NCT00982410|523900639|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
145286963|NCT00982410|523900640|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
145286964|NCT00982410|523900639|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
145286965|NCT00982410|523900640|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
145406377|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
145406378|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
145406379|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
145406380|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
145406381|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
145406382|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
145406383|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
145406384|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
145406385|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
145406386|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
145406387|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
145406388|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
145406389|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
145406390|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
145406391|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
145406392|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
145406393|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
145406394|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
145406395|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
145406396|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
145406397|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
145406398|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
145406399|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
145406400|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
145406401|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
145406402|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
145406403|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
145406404|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
145406405|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
145406406|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
145406407|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
145406408|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
145613109|NCT01275196|525099243|FG001|Overall Study|Protocol Violation|0|||
145286966|NCT00982410|523900639|FG000|12-month Follow-up Assessment|incarceration|2|||
145286967|NCT00982410|523900640|FG001|12-month Follow-up Assessment|incarceration|1|||
145286968|NCT00982410|523900639|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
145286969|NCT00982410|523900640|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
145286970|NCT04014959|523900641|FG000|Baseline MRI and Assessments|Physician Decision|2|||
145286971|NCT04014959|523900641|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
145286972|NCT04014959|523900641|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
145286973|NCT02004847|523900643|FG000|Overall Study|Protocol Violation|1|||
145286974|NCT02004847|523900644|FG001|Overall Study|Protocol Violation|1|||
145286975|NCT00759148|523900649|FG000|Overall Study|Adverse Event|1|||
145286976|NCT00759148|523900650|FG001|Overall Study|Adverse Event|6|||
145286977|NCT00759148|523900649|FG000|Overall Study|Withdrawal by Subject|3|||
145286978|NCT00759148|523900650|FG001|Overall Study|Withdrawal by Subject|7|||
145286979|NCT00759148|523900649|FG000|Overall Study|Lost to Follow-up|3|||
145286980|NCT00759148|523900650|FG001|Overall Study|Lost to Follow-up|9|||
145286981|NCT00759148|523900649|FG000|Overall Study|Treatment Failure|6|||
145286982|NCT00759148|523900650|FG001|Overall Study|Treatment Failure|10|||
145286983|NCT00759148|523900649|FG000|Overall Study|Reason not given|1|||
145286984|NCT00759148|523900650|FG001|Overall Study|Reason not given|0|||
145286985|NCT03381248|523900651|FG000|0-6 Months|Withdrawal by Subject|4|||
145286986|NCT03381248|523900652|FG001|0-6 Months|Withdrawal by Subject|1|||
145286987|NCT03381248|523900651|FG000|0-6 Months|Lost to Follow-up|3|||
145286988|NCT03381248|523900652|FG001|0-6 Months|Lost to Follow-up|2|||
145286989|NCT03381248|523900651|FG000|0-6 Months|Lack of Efficacy|1|||
145286990|NCT03381248|523900652|FG001|0-6 Months|Lack of Efficacy|0|||
145286991|NCT03381248|523900651|FG000|0-6 Months|Adverse Event|1|||
145286992|NCT03381248|523900652|FG001|0-6 Months|Adverse Event|0|||
145286993|NCT03381248|523900651|FG000|0-6 Months|Protocol Violation|2|||
145286994|NCT03381248|523900652|FG001|0-6 Months|Protocol Violation|1|||
145286995|NCT03381248|523900651|FG000|0-6 Months|Physician Decision|1|||
145286996|NCT03381248|523900652|FG001|0-6 Months|Physician Decision|0|||
145286997|NCT03381248|523900651|FG000|0-6 Months|Planning another procedure|1|||
145286998|NCT03381248|523900652|FG001|0-6 Months|Planning another procedure|2|||
145286999|NCT03381248|523900651|FG000|6-12 Months|Withdrawal by Subject|1|||
145287000|NCT03381248|523900652|FG001|6-12 Months|Withdrawal by Subject|3|||
145287001|NCT03381248|523900651|FG000|6-12 Months|Lost to Follow-up|0|||
145287002|NCT03381248|523900652|FG001|6-12 Months|Lost to Follow-up|2|||
145287003|NCT03381248|523900651|FG000|6-12 Months|Protocol Violation|3|||
145287004|NCT03381248|523900652|FG001|6-12 Months|Protocol Violation|2|||
145287005|NCT03381248|523900651|FG000|6-12 Months|Planning another procedure|6|||
145287006|NCT03381248|523900652|FG001|6-12 Months|Planning another procedure|2|||
145287007|NCT03381248|523900651|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
145287008|NCT03381248|523900652|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
145287009|NCT03381248|523900651|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
145287010|NCT03381248|523900652|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
145287011|NCT03381248|523900651|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
145287012|NCT03381248|523900652|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
145287013|NCT05188521|523900653|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
145287014|NCT05188521|523900654|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
145287015|NCT00458302|523900655|FG000|Overall Study|Adverse Event|4|||
145287016|NCT00458302|523900656|FG001|Overall Study|Adverse Event|14|||
145287017|NCT00458302|523900655|FG000|Overall Study|Pregnancy|2|||
145287018|NCT00458302|523900656|FG001|Overall Study|Pregnancy|1|||
145287019|NCT00458302|523900655|FG000|Overall Study|Protocol Violation|0|||
145287020|NCT00458302|523900656|FG001|Overall Study|Protocol Violation|2|||
145287021|NCT00458302|523900655|FG000|Overall Study|Withdrawal by Subject|6|||
145287022|NCT00458302|523900656|FG001|Overall Study|Withdrawal by Subject|4|||
145287023|NCT00458302|523900655|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
145287024|NCT00458302|523900656|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
145287025|NCT00458302|523900655|FG000|Overall Study|Study Termination By Sponsor|1|||
145287026|NCT00458302|523900656|FG001|Overall Study|Study Termination By Sponsor|0|||
145287027|NCT00458302|523900655|FG000|Overall Study|Lost to Follow-up|2|||
145287028|NCT00458302|523900656|FG001|Overall Study|Lost to Follow-up|0|||
145287029|NCT00458302|523900655|FG000|Overall Study|Other|4|||
145287030|NCT00458302|523900656|FG001|Overall Study|Other|2|||
145287031|NCT04582266|523900657|FG000|Overall Study|Lost to Follow-up|7|||
145287032|NCT04582266|523900658|FG001|Overall Study|Lost to Follow-up|5|||
145287033|NCT04582266|523900657|FG000|Overall Study|Withdrawal by Subject|1|||
145287034|NCT04582266|523900658|FG001|Overall Study|Withdrawal by Subject|0|||
145287035|NCT04582266|523900657|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
145287036|NCT04582266|523900658|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
145287037|NCT01341639|523900659|FG000|Infant Series|Protocol Violation|1|||
145287038|NCT01341639|523900660|FG001|Infant Series|Protocol Violation|0|||
145287039|NCT01341639|523900659|FG000|Infant Series|Not Vaccinated|0|||
145287040|NCT01341639|523900660|FG001|Infant Series|Not Vaccinated|1|||
145287041|NCT01341639|523900659|FG000|Infant Series|Adverse Event|0|||
145287042|NCT01341639|523900660|FG001|Infant Series|Adverse Event|5|||
145287043|NCT01341639|523900659|FG000|Infant Series|Withdrawal by Subject|11|||
145287044|NCT01341639|523900660|FG001|Infant Series|Withdrawal by Subject|8|||
145287045|NCT01341639|523900659|FG000|Infant Series|Lost to Follow-up|0|||
145287046|NCT01341639|523900660|FG001|Infant Series|Lost to Follow-up|2|||
145287047|NCT01341639|523900659|FG000|Infant Series|Site 0048 Participants|17|||
145287048|NCT01341639|523900660|FG001|Infant Series|Site 0048 Participants|16|||
145287049|NCT01341639|523900659|FG000|Interim Period|Withdrawal by Subject|6|||
145287050|NCT01341639|523900660|FG001|Interim Period|Withdrawal by Subject|7|||
145287051|NCT01341639|523900659|FG000|Interim Period|Lost to Follow-up|2|||
145287052|NCT01341639|523900660|FG001|Interim Period|Lost to Follow-up|0|||
145287053|NCT01341639|523900659|FG000|Interim Period|Physician Decision|0|||
145287054|NCT01341639|523900660|FG001|Interim Period|Physician Decision|1|||
145287055|NCT01341639|523900659|FG000|Interim Period|Protocol Violation|0|||
145287056|NCT01341639|523900660|FG001|Interim Period|Protocol Violation|1|||
145287057|NCT01341639|523900659|FG000|Post-Treatment|Withdrawal by Subject|0|||
145287058|NCT01341639|523900660|FG001|Post-Treatment|Withdrawal by Subject|1|||
145287059|NCT01341639|523900659|FG000|Post-Treatment|Adverse Event|0|||
145287060|NCT01341639|523900660|FG001|Post-Treatment|Adverse Event|2|||
145287061|NCT02224456|523900661|FG000|Overall Study|Lack of Efficacy|1|||
145287062|NCT02224456|523900661|FG000|Overall Study|Lost to Follow-up|15|||
145287063|NCT02224456|523900661|FG000|Overall Study|Withdrawal by Subject|9|||
145287064|NCT02224456|523900661|FG000|Overall Study|Physician Decision|3|||
145287065|NCT02224456|523900661|FG000|Overall Study|Death|2|||
145287066|NCT02224456|523900661|FG000|Overall Study|Pregnancy|4|||
145287067|NCT02224456|523900661|FG000|Overall Study|Protocol Violation|1|||
145287068|NCT02224456|523900661|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
145287069|NCT01241461|523900662|FG000|Overall Study|Progressive Disease|3|||
145287070|NCT01241461|523900663|FG001|Overall Study|Progressive Disease|6|||
145287071|NCT01379781|523900667|FG000|Overall Study|Lost to Follow-up|11|||
145287072|NCT01379781|523900668|FG001|Overall Study|Lost to Follow-up|8|||
145287073|NCT02247479|523900669|FG000|Overall Study|Adverse Event|8|||
145287074|NCT02247479|523900670|FG001|Overall Study|Adverse Event|9|||
145287075|NCT02247479|523900671|FG002|Overall Study|Adverse Event|8|||
145287076|NCT02247479|523900669|FG000|Overall Study|Death|5|||
145287077|NCT02247479|523900670|FG001|Overall Study|Death|4|||
145287078|NCT02247479|523900671|FG002|Overall Study|Death|6|||
145287079|NCT02247479|523900669|FG000|Overall Study|Lost to Follow-up|3|||
145287080|NCT02247479|523900670|FG001|Overall Study|Lost to Follow-up|3|||
145287081|NCT02247479|523900671|FG002|Overall Study|Lost to Follow-up|1|||
145287082|NCT02247479|523900669|FG000|Overall Study|Non-compliance|0|||
145287083|NCT02247479|523900670|FG001|Overall Study|Non-compliance|0|||
145287084|NCT02247479|523900671|FG002|Overall Study|Non-compliance|1|||
145287085|NCT02247479|523900669|FG000|Overall Study|Withdrawal by Subject|25|||
145287086|NCT02247479|523900670|FG001|Overall Study|Withdrawal by Subject|29|||
145287087|NCT02247479|523900671|FG002|Overall Study|Withdrawal by Subject|24|||
145287088|NCT02247479|523900669|FG000|Overall Study|Study Terminated by Sponsor|98|||
145287089|NCT02247479|523900670|FG001|Overall Study|Study Terminated by Sponsor|88|||
145287090|NCT02247479|523900671|FG002|Overall Study|Study Terminated by Sponsor|94|||
145287091|NCT02247479|523900669|FG000|Overall Study|Physician Decision|1|||
145287092|NCT02247479|523900670|FG001|Overall Study|Physician Decision|0|||
145287093|NCT02247479|523900671|FG002|Overall Study|Physician Decision|2|||
145287094|NCT02247479|523900669|FG000|Overall Study|Unspecified Reason|2|||
145555796|NCT00513474|524892654|FG001|Overall Study|Participant Withdrew Consent|0|||
145555797|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Adverse Event|82|||
145555798|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Death|6|||
145555799|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
145555800|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
145555801|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
145555802|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
145555803|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
145555804|NCT00195676|524892656|FG000|Period O - Open-label Treatment|Other reasons|68|||
145555805|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
145555806|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
145555807|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
145555808|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
145555809|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
145555810|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
145555811|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
145555812|NCT00195676|524892656|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
145555813|NCT00195676|524892656|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
145555814|NCT00195676|524892656|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
145555815|NCT00195676|524892656|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
145555816|NCT00195676|524892656|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
145555817|NCT00195676|524892656|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
145555818|NCT01189812|524892657|FG000|Overall Study|Withdrawal by Subject|2|||
145287095|NCT02247479|523900670|FG001|Overall Study|Unspecified Reason|5|||
145287096|NCT02247479|523900671|FG002|Overall Study|Unspecified Reason|2|||
145287097|NCT01132118|523900672|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
145287098|NCT01132118|523900673|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
145287099|NCT01132118|523900672|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145287100|NCT01132118|523900673|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
145287101|NCT01132118|523900672|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
145287102|NCT01132118|523900673|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
145287103|NCT01299038|523900680|FG000|Overall Study|Withdrawal by Subject|1|||
145287104|NCT01299038|523900681|FG001|Overall Study|Withdrawal by Subject|0|||
145287105|NCT01162499|523900686|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
145287106|NCT01162499|523900687|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
145287107|NCT00322556|523900688|FG000|Overall Study|Adverse Event|1|||
145287108|NCT00322556|523900688|FG000|Overall Study|Withdrawal by Subject|1|||
145287109|NCT00322556|523900688|FG000|Overall Study|Lost to Follow-up|3|||
145287110|NCT00322556|523900688|FG000|Overall Study|Other Reason|7|||
145287111|NCT01590433|523900689|FG000|Overall Study|Lost to Follow-up|20|||
145287112|NCT01590433|523900690|FG001|Overall Study|Lost to Follow-up|8|||
145287113|NCT01590433|523900689|FG000|Overall Study|Withdrawal by Subject|21|||
145287114|NCT01590433|523900690|FG001|Overall Study|Withdrawal by Subject|11|||
145287115|NCT01590433|523900689|FG000|Overall Study|Adverse Event|11|||
145287116|NCT01590433|523900690|FG001|Overall Study|Adverse Event|3|||
145287117|NCT00555009|523900691|FG000|Overall Study|Withdrawal by Subject|0|||
145287118|NCT00555009|523900692|FG001|Overall Study|Withdrawal by Subject|1|||
145287119|NCT00555009|523900691|FG000|Overall Study|Terminated by Sponsor|2|||
145287120|NCT00555009|523900692|FG001|Overall Study|Terminated by Sponsor|5|||
145287121|NCT02232074|523900694|FG000|Overall Study|Withdrawal by Subject|5|||
145287122|NCT02232074|523900695|FG001|Overall Study|Withdrawal by Subject|3|||
145287123|NCT02232074|523900694|FG000|Overall Study|No legal concerns at baseline|36|||
145287124|NCT02232074|523900695|FG001|Overall Study|No legal concerns at baseline|41|||
145287125|NCT02232074|523900694|FG000|Overall Study|deemed ineligible|0|||
145287126|NCT02232074|523900695|FG001|Overall Study|deemed ineligible|1|||
145287127|NCT01579474|523900696|FG000|Overall Study|Adverse Event|1|||
145287128|NCT01579474|523900697|FG001|Overall Study|Adverse Event|13|||
145287129|NCT01579474|523900698|FG002|Overall Study|Adverse Event|2|||
145287130|NCT01579474|523900699|FG003|Overall Study|Adverse Event|0|||
145287131|NCT01579474|523900700|FG004|Overall Study|Adverse Event|0|||
145287132|NCT01579474|523900701|FG005|Overall Study|Adverse Event|1|||
145287133|NCT01579474|523900696|FG000|Overall Study|Lack of Efficacy|1|||
145287134|NCT01579474|523900697|FG001|Overall Study|Lack of Efficacy|0|||
145287135|NCT01579474|523900698|FG002|Overall Study|Lack of Efficacy|0|||
145287136|NCT01579474|523900699|FG003|Overall Study|Lack of Efficacy|0|||
145287137|NCT01579474|523900700|FG004|Overall Study|Lack of Efficacy|1|||
145287138|NCT01579474|523900701|FG005|Overall Study|Lack of Efficacy|0|||
145287139|NCT01579474|523900696|FG000|Overall Study|Withdrawal by Subject|1|||
145287140|NCT01579474|523900697|FG001|Overall Study|Withdrawal by Subject|0|||
145287141|NCT01579474|523900698|FG002|Overall Study|Withdrawal by Subject|0|||
145287142|NCT01579474|523900699|FG003|Overall Study|Withdrawal by Subject|0|||
145287143|NCT01579474|523900700|FG004|Overall Study|Withdrawal by Subject|0|||
145287144|NCT01579474|523900701|FG005|Overall Study|Withdrawal by Subject|0|||
145287145|NCT02710071|523900705|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
145287146|NCT02710071|523900706|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
145287147|NCT02710071|523900705|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
145287148|NCT02710071|523900706|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
145287149|NCT02637557|523900709|FG000|Overall Study|Adverse Event|3|||
145287150|NCT02637557|523900710|FG001|Overall Study|Adverse Event|1|||
145287151|NCT02637557|523900711|FG002|Overall Study|Adverse Event|3|||
145287152|NCT02637557|523900712|FG003|Overall Study|Adverse Event|3|||
145287153|NCT02637557|523900709|FG000|Overall Study|Lost to Follow-up|1|||
145287154|NCT02637557|523900710|FG001|Overall Study|Lost to Follow-up|1|||
145287155|NCT02637557|523900711|FG002|Overall Study|Lost to Follow-up|0|||
145287156|NCT02637557|523900712|FG003|Overall Study|Lost to Follow-up|1|||
145287157|NCT02637557|523900709|FG000|Overall Study|Physician Decision|1|||
145287158|NCT02637557|523900710|FG001|Overall Study|Physician Decision|0|||
145287159|NCT02637557|523900711|FG002|Overall Study|Physician Decision|0|||
145287160|NCT02637557|523900712|FG003|Overall Study|Physician Decision|0|||
145287161|NCT02637557|523900709|FG000|Overall Study|Protocol Violation|2|||
145287162|NCT02637557|523900710|FG001|Overall Study|Protocol Violation|0|||
145287163|NCT02637557|523900711|FG002|Overall Study|Protocol Violation|2|||
145287164|NCT02637557|523900712|FG003|Overall Study|Protocol Violation|1|||
145287165|NCT02637557|523900709|FG000|Overall Study|Withdrawal by Subject|1|||
145287166|NCT02637557|523900710|FG001|Overall Study|Withdrawal by Subject|3|||
145287167|NCT02637557|523900711|FG002|Overall Study|Withdrawal by Subject|4|||
145287168|NCT02637557|523900712|FG003|Overall Study|Withdrawal by Subject|2|||
145287169|NCT01673009|523900717|FG000|Overall Study|Physician Decision|5|||
145287170|NCT01673009|523900717|FG000|Overall Study|Withdrawal by Subject|8|||
145287171|NCT01844583|523900718|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
145287172|NCT01844583|523900719|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
145287173|NCT01787825|523900723|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
145287174|NCT01787825|523900724|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
145287175|NCT01787825|523900723|FG000|Overall Study|Data Not Analyzable|5|||
145287176|NCT01787825|523900724|FG001|Overall Study|Data Not Analyzable|1|||
145287177|NCT01238848|523900730|FG000|Overall Study|Physician Decision|13|||
145287178|NCT01238848|523900731|FG001|Overall Study|Physician Decision|5|||
145287179|NCT00576901|523900732|FG000|Overall Study|Withdrawal by Subject|1|||
145287180|NCT00576901|523900732|FG000|Overall Study|Disease course|1|||
145287181|NCT00576901|523900732|FG000|Overall Study|Protocol Violation|1|||
145287182|NCT01259869|523900733|FG000|Overall Study|Duplicated registration|1|||
145287183|NCT00755326|523900739|FG000|Overall Study|Lost to Follow-up|2|||
145287184|NCT00755326|523900740|FG001|Overall Study|Lost to Follow-up|3|||
145287185|NCT00368966|523900745|FG000|Infant Series|Withdrawal by Subject|11|||
145287186|NCT00368966|523900746|FG001|Infant Series|Withdrawal by Subject|6|||
145287187|NCT00368966|523900745|FG000|Infant Series|Protocol Violation|2|||
145287188|NCT00368966|523900746|FG001|Infant Series|Protocol Violation|1|||
145287189|NCT00368966|523900745|FG000|Infant Series|Lost to Follow-up|2|||
145287190|NCT00368966|523900746|FG001|Infant Series|Lost to Follow-up|0|||
145287191|NCT00368966|523900745|FG000|Infant Series|Randomization error|0|||
145287192|NCT00368966|523900746|FG001|Infant Series|Randomization error|1|||
145287193|NCT00368966|523900745|FG000|Infant Series|Failed to meet eligibility criteria|0|||
145287194|NCT00368966|523900746|FG001|Infant Series|Failed to meet eligibility criteria|1|||
145287195|NCT00368966|523900745|FG000|Infant Series|Adverse Event|0|||
145287196|NCT00368966|523900746|FG001|Infant Series|Adverse Event|1|||
145287197|NCT00368966|523900745|FG000|Infant Series|Failed to return|1|||
145287198|NCT00368966|523900746|FG001|Infant Series|Failed to return|0|||
145287199|NCT00368966|523900745|FG000|After Infant|Failed to return|3|||
145287200|NCT00368966|523900746|FG001|After Infant|Failed to return|1|||
145287201|NCT00368966|523900745|FG000|After Infant|Adverse Event|1|||
145287202|NCT00368966|523900746|FG001|After Infant|Adverse Event|2|||
145287203|NCT00368966|523900745|FG000|After Infant|Withdrawal by Subject|1|||
145287204|NCT00368966|523900746|FG001|After Infant|Withdrawal by Subject|1|||
145287205|NCT00368966|523900745|FG000|After Infant|Death|1|||
145406409|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
145555819|NCT01189812|524892658|FG001|Overall Study|Withdrawal by Subject|3|||
145555820|NCT01189812|524892657|FG000|Overall Study|Adverse Event|1|||
145555821|NCT01189812|524892658|FG001|Overall Study|Adverse Event|0|||
145555822|NCT01189812|524892657|FG000|Overall Study|Out of Window|4|||
145555823|NCT01189812|524892658|FG001|Overall Study|Out of Window|3|||
145555824|NCT01189812|524892657|FG000|Overall Study|Moved out of State|1|||
145555825|NCT01189812|524892658|FG001|Overall Study|Moved out of State|2|||
145555826|NCT02200445|524892661|FG000|Overall Study|Lack of Efficacy|1|||
145555827|NCT02200445|524892662|FG001|Overall Study|Lack of Efficacy|2|||
145555828|NCT02200445|524892663|FG002|Overall Study|Lack of Efficacy|2|||
145555829|NCT02200445|524892661|FG000|Overall Study|Adverse Event|0|||
145555830|NCT02200445|524892662|FG001|Overall Study|Adverse Event|2|||
145555831|NCT02200445|524892663|FG002|Overall Study|Adverse Event|0|||
145555832|NCT03334903|524892664|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
145555833|NCT03334903|524892665|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
145555834|NCT03334903|524892664|FG000|Overall Study|Protocol Violation|1|||
145555835|NCT03334903|524892665|FG001|Overall Study|Protocol Violation|3|||
145613110|NCT01275196|525099242|FG000|Overall Study|Suboptimal response/treatment failure|5|||
145287206|NCT00368966|523900746|FG001|After Infant|Death|0|||
145287207|NCT00368966|523900745|FG000|After Infant|Lost to Follow-up|0|||
145287208|NCT00368966|523900746|FG001|After Infant|Lost to Follow-up|1|||
145287209|NCT00368966|523900745|FG000|Toddler Dose|Withdrawal by Subject|1|||
145287210|NCT00368966|523900746|FG001|Toddler Dose|Withdrawal by Subject|1|||
145287211|NCT00368966|523900745|FG000|Toddler Dose|Lost to Follow-up|0|||
145287212|NCT00368966|523900746|FG001|Toddler Dose|Lost to Follow-up|2|||
145287213|NCT01689974|523900747|FG000|Overall Study|Termination of Study|5|||
145287214|NCT01689974|523900748|FG001|Overall Study|Termination of Study|5|||
145287215|NCT01333033|523900749|FG000|Overall Study|Ineligible|0|||
145287216|NCT01333033|523900750|FG001|Overall Study|Ineligible|0|||
145555836|NCT03334903|524892664|FG000|Overall Study|Surgery postponed|1|||
145555837|NCT03334903|524892665|FG001|Overall Study|Surgery postponed|0|||
145555838|NCT03334903|524892664|FG000|Overall Study|Adverse Event|1|||
145555839|NCT03334903|524892665|FG001|Overall Study|Adverse Event|1|||
145555840|NCT03334903|524892664|FG000|Overall Study|Withdrawal by Subject|0|||
145555841|NCT03334903|524892665|FG001|Overall Study|Withdrawal by Subject|1|||
145555842|NCT02879305|524892666|FG000|Overall Study|Investigator Site Closed|55|||
145555843|NCT02879305|524892667|FG001|Overall Study|Investigator Site Closed|57|||
145555844|NCT02879305|524892666|FG000|Overall Study|Withdrawal by Subject|44|||
145555845|NCT02879305|524892667|FG001|Overall Study|Withdrawal by Subject|42|||
145555846|NCT02879305|524892666|FG000|Overall Study|Lost to Follow-up|17|||
145555847|NCT02879305|524892667|FG001|Overall Study|Lost to Follow-up|12|||
145555848|NCT02879305|524892666|FG000|Overall Study|Other|1|||
145555849|NCT02879305|524892667|FG001|Overall Study|Other|0|||
145555850|NCT00312494|524894873|FG000|Overall Study|Randomized; not treated with study drug|9|||
145555851|NCT00312494|524894874|FG001|Overall Study|Randomized; not treated with study drug|10|||
145555852|NCT00312494|524894875|FG002|Overall Study|Randomized; not treated with study drug|5|||
145555853|NCT00312494|524894873|FG000|Overall Study|Adverse Event|33|||
145555854|NCT00312494|524894874|FG001|Overall Study|Adverse Event|15|||
145555855|NCT00312494|524894875|FG002|Overall Study|Adverse Event|11|||
145406410|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
145406411|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
145406412|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
145555856|NCT00312494|524894873|FG000|Overall Study|Lack of Efficacy|4|||
145555857|NCT00312494|524894874|FG001|Overall Study|Lack of Efficacy|6|||
145555858|NCT00312494|524894875|FG002|Overall Study|Lack of Efficacy|8|||
145555859|NCT00312494|524894873|FG000|Overall Study|Laboratory abnormality|1|||
145555860|NCT00312494|524894874|FG001|Overall Study|Laboratory abnormality|0|||
145555861|NCT00312494|524894875|FG002|Overall Study|Laboratory abnormality|0|||
145555862|NCT00312494|524894873|FG000|Overall Study|Lost to Follow-up|8|||
145555863|NCT00312494|524894874|FG001|Overall Study|Lost to Follow-up|8|||
145555864|NCT00312494|524894875|FG002|Overall Study|Lost to Follow-up|8|||
145555865|NCT00312494|524894873|FG000|Overall Study|Withdrawal by Subject|6|||
145555866|NCT00312494|524894874|FG001|Overall Study|Withdrawal by Subject|9|||
145555867|NCT00312494|524894875|FG002|Overall Study|Withdrawal by Subject|10|||
145555868|NCT00312494|524894873|FG000|Overall Study|Other|10|||
145555869|NCT00312494|524894874|FG001|Overall Study|Other|10|||
145555870|NCT00312494|524894875|FG002|Overall Study|Other|1|||
145555871|NCT02699554|524894877|FG000|Overall Study|Lost to Follow-up|9|||
145555872|NCT00788151|524894878|FG000|Overall Study|Other adverse event|0|||
145555873|NCT00788151|524894879|FG001|Overall Study|Other adverse event|2|||
145555874|NCT00788151|524894878|FG000|Overall Study|Protocol Violation|0|||
145555875|NCT00788151|524894879|FG001|Overall Study|Protocol Violation|1|||
145555876|NCT00788151|524894878|FG000|Overall Study|Withdrawal by Subject|13|||
145555877|NCT00788151|524894879|FG001|Overall Study|Withdrawal by Subject|6|||
145555878|NCT00788151|524894878|FG000|Overall Study|Enrolled but not treated|1|||
145555879|NCT00788151|524894879|FG001|Overall Study|Enrolled but not treated|1|||
145555880|NCT00503009|524894880|FG000|Overall Study|Protocol Violation|1|||
145613111|NCT01275196|525099243|FG001|Overall Study|Suboptimal response/treatment failure|6|||
145555881|NCT00503009|524894881|FG001|Overall Study|Protocol Violation|0|||
145406413|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
145287217|NCT01333033|523900751|FG002|Overall Study|Ineligible|0|||
145287218|NCT01333033|523900752|FG003|Overall Study|Ineligible|0|||
145287219|NCT01333033|523900753|FG004|Overall Study|Ineligible|6|||
145287220|NCT01333033|523900754|FG005|Overall Study|Ineligible|8|||
145287221|NCT01333033|523900749|FG000|Overall Study|Withdrawal by Subject|0|||
145287222|NCT01333033|523900750|FG001|Overall Study|Withdrawal by Subject|0|||
145287223|NCT01333033|523900751|FG002|Overall Study|Withdrawal by Subject|0|||
145406414|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
145287224|NCT01333033|523900752|FG003|Overall Study|Withdrawal by Subject|0|||
145287225|NCT01333033|523900753|FG004|Overall Study|Withdrawal by Subject|4|||
145287226|NCT01333033|523900754|FG005|Overall Study|Withdrawal by Subject|2|||
145287227|NCT01333033|523900749|FG000|Overall Study|PET inevaluable|0|||
145287228|NCT01333033|523900750|FG001|Overall Study|PET inevaluable|0|||
145287229|NCT01333033|523900751|FG002|Overall Study|PET inevaluable|0|||
145287230|NCT01333033|523900752|FG003|Overall Study|PET inevaluable|0|||
145287231|NCT01333033|523900753|FG004|Overall Study|PET inevaluable|2|||
145287232|NCT01333033|523900754|FG005|Overall Study|PET inevaluable|4|||
145287233|NCT01333033|523900749|FG000|Overall Study|Adverse Event|0|||
145287234|NCT01333033|523900750|FG001|Overall Study|Adverse Event|0|||
145287235|NCT01333033|523900751|FG002|Overall Study|Adverse Event|0|||
145287236|NCT01333033|523900752|FG003|Overall Study|Adverse Event|0|||
145287237|NCT01333033|523900753|FG004|Overall Study|Adverse Event|2|||
145287238|NCT01333033|523900754|FG005|Overall Study|Adverse Event|1|||
145287239|NCT01333033|523900749|FG000|Overall Study|Progression|0|||
145287240|NCT01333033|523900750|FG001|Overall Study|Progression|0|||
145287241|NCT01333033|523900751|FG002|Overall Study|Progression|0|||
145287242|NCT01333033|523900752|FG003|Overall Study|Progression|0|||
145287243|NCT01333033|523900753|FG004|Overall Study|Progression|0|||
145287244|NCT01333033|523900754|FG005|Overall Study|Progression|1|||
145287245|NCT01333033|523900749|FG000|Overall Study|MD Decision|0|||
145287246|NCT01333033|523900750|FG001|Overall Study|MD Decision|0|||
145287247|NCT01333033|523900751|FG002|Overall Study|MD Decision|0|||
145287248|NCT01333033|523900752|FG003|Overall Study|MD Decision|0|||
145287249|NCT01333033|523900753|FG004|Overall Study|MD Decision|0|||
145287250|NCT01333033|523900754|FG005|Overall Study|MD Decision|2|||
145287251|NCT01388647|523900757|FG000|Overall Study|Adverse Event|1|||
145287252|NCT01388647|523900758|FG001|Overall Study|Adverse Event|2|||
145287253|NCT00818623|523900759|FG000|Overall Study|Adverse Event|1|||
145287254|NCT00818623|523900760|FG001|Overall Study|Adverse Event|0|||
145287255|NCT00818623|523900761|FG002|Overall Study|Adverse Event|1|||
145287256|NCT00818623|523900762|FG003|Overall Study|Adverse Event|0|||
145287257|NCT00818623|523900763|FG004|Overall Study|Adverse Event|0|||
145287258|NCT00818623|523900764|FG005|Overall Study|Adverse Event|1|||
145287259|NCT00818623|523900765|FG006|Overall Study|Adverse Event|0|||
145287260|NCT00818623|523900766|FG007|Overall Study|Adverse Event|0|||
145287261|NCT00818623|523900759|FG000|Overall Study|Bad prostate specific antigen response|0|||
145287262|NCT00818623|523900760|FG001|Overall Study|Bad prostate specific antigen response|3|||
145287263|NCT00818623|523900761|FG002|Overall Study|Bad prostate specific antigen response|2|||
145287264|NCT00818623|523900762|FG003|Overall Study|Bad prostate specific antigen response|5|||
145287265|NCT00818623|523900763|FG004|Overall Study|Bad prostate specific antigen response|0|||
145613112|NCT03119610|525099244|FG000|Overall Study|Adverse Event|1|||
145613113|NCT03119610|525099245|FG001|Overall Study|Adverse Event|0|||
145287266|NCT00818623|523900764|FG005|Overall Study|Bad prostate specific antigen response|1|||
145287267|NCT00818623|523900765|FG006|Overall Study|Bad prostate specific antigen response|0|||
145287268|NCT00818623|523900766|FG007|Overall Study|Bad prostate specific antigen response|0|||
145613114|NCT03119610|525099244|FG000|Overall Study|Lost to Follow-up|0|||
145613115|NCT03119610|525099245|FG001|Overall Study|Lost to Follow-up|1|||
145287269|NCT00818623|523900759|FG000|Overall Study|Withdrawal by Subject|0|||
145287270|NCT00818623|523900760|FG001|Overall Study|Withdrawal by Subject|1|||
145287271|NCT00818623|523900761|FG002|Overall Study|Withdrawal by Subject|1|||
145287272|NCT00818623|523900762|FG003|Overall Study|Withdrawal by Subject|0|||
145287273|NCT00818623|523900763|FG004|Overall Study|Withdrawal by Subject|0|||
145287274|NCT00818623|523900764|FG005|Overall Study|Withdrawal by Subject|1|||
145287275|NCT00818623|523900765|FG006|Overall Study|Withdrawal by Subject|1|||
145287276|NCT00818623|523900766|FG007|Overall Study|Withdrawal by Subject|1|||
145287277|NCT00818623|523900759|FG000|Overall Study|Protocol Violation|1|||
145287278|NCT00818623|523900760|FG001|Overall Study|Protocol Violation|0|||
145287279|NCT00818623|523900761|FG002|Overall Study|Protocol Violation|0|||
145287280|NCT00818623|523900762|FG003|Overall Study|Protocol Violation|0|||
145287281|NCT00818623|523900763|FG004|Overall Study|Protocol Violation|1|||
145613116|NCT03237013|525099252|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
145406415|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
145555882|NCT00503009|524894882|FG002|Overall Study|Protocol Violation|1|||
145287282|NCT00818623|523900764|FG005|Overall Study|Protocol Violation|0|||
145287283|NCT00818623|523900765|FG006|Overall Study|Protocol Violation|1|||
145287284|NCT00818623|523900766|FG007|Overall Study|Protocol Violation|0|||
145287285|NCT00818623|523900759|FG000|Overall Study|Need of additional treatment|0|||
145287286|NCT00818623|523900760|FG001|Overall Study|Need of additional treatment|0|||
145287287|NCT00818623|523900761|FG002|Overall Study|Need of additional treatment|0|||
145287288|NCT00818623|523900762|FG003|Overall Study|Need of additional treatment|0|||
145287289|NCT00818623|523900763|FG004|Overall Study|Need of additional treatment|1|||
145287290|NCT00818623|523900764|FG005|Overall Study|Need of additional treatment|0|||
145287291|NCT00818623|523900765|FG006|Overall Study|Need of additional treatment|0|||
145287292|NCT00818623|523900766|FG007|Overall Study|Need of additional treatment|0|||
145287293|NCT00818623|523900759|FG000|Overall Study|Lack of trial drug at site|0|||
145287294|NCT00818623|523900760|FG001|Overall Study|Lack of trial drug at site|0|||
145287295|NCT00818623|523900761|FG002|Overall Study|Lack of trial drug at site|0|||
145287296|NCT00818623|523900762|FG003|Overall Study|Lack of trial drug at site|0|||
145287297|NCT00818623|523900763|FG004|Overall Study|Lack of trial drug at site|2|||
145287298|NCT00818623|523900764|FG005|Overall Study|Lack of trial drug at site|0|||
145287299|NCT00818623|523900765|FG006|Overall Study|Lack of trial drug at site|1|||
145287300|NCT00818623|523900766|FG007|Overall Study|Lack of trial drug at site|0|||
145287301|NCT00818623|523900759|FG000|Overall Study|Disease progression|0|||
145287302|NCT00818623|523900760|FG001|Overall Study|Disease progression|0|||
145287303|NCT00818623|523900761|FG002|Overall Study|Disease progression|0|||
145287304|NCT00818623|523900762|FG003|Overall Study|Disease progression|0|||
145613117|NCT03237013|525099253|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
145613118|NCT03237013|525099254|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
145613119|NCT00439179|525099255|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
145613120|NCT00439179|525099256|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
145613121|NCT00439179|525099257|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
145613122|NCT00439179|525099258|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
145287305|NCT00818623|523900763|FG004|Overall Study|Disease progression|0|||
145287306|NCT00818623|523900764|FG005|Overall Study|Disease progression|0|||
145287307|NCT00818623|523900765|FG006|Overall Study|Disease progression|1|||
145287308|NCT00818623|523900766|FG007|Overall Study|Disease progression|0|||
145287309|NCT00903383|523900770|FG000|Overall Study|Adverse Event|1|||
145287310|NCT00903383|523900771|FG001|Overall Study|Adverse Event|2|||
145287311|NCT00903383|523900772|FG002|Overall Study|Adverse Event|3|||
145287312|NCT00903383|523900773|FG003|Overall Study|Adverse Event|1|||
145287313|NCT00903383|523900770|FG000|Overall Study|Physician Decision|1|||
145287314|NCT00903383|523900771|FG001|Overall Study|Physician Decision|2|||
145287315|NCT00903383|523900772|FG002|Overall Study|Physician Decision|0|||
145287316|NCT00903383|523900773|FG003|Overall Study|Physician Decision|0|||
145287317|NCT00903383|523900770|FG000|Overall Study|Lost to Follow-up|0|||
145287318|NCT00903383|523900771|FG001|Overall Study|Lost to Follow-up|0|||
145287319|NCT00903383|523900772|FG002|Overall Study|Lost to Follow-up|0|||
145287320|NCT00903383|523900773|FG003|Overall Study|Lost to Follow-up|1|||
145287321|NCT00903383|523900770|FG000|Overall Study|Decision of Sponsor|1|||
145287322|NCT00903383|523900771|FG001|Overall Study|Decision of Sponsor|0|||
145287323|NCT00903383|523900772|FG002|Overall Study|Decision of Sponsor|0|||
145287324|NCT00903383|523900773|FG003|Overall Study|Decision of Sponsor|0|||
145287325|NCT00903383|523900770|FG000|Overall Study|Withdrawal by Subject|4|||
145287326|NCT00903383|523900771|FG001|Overall Study|Withdrawal by Subject|1|||
145287327|NCT00903383|523900772|FG002|Overall Study|Withdrawal by Subject|0|||
145287328|NCT00903383|523900773|FG003|Overall Study|Withdrawal by Subject|2|||
145287329|NCT00903383|523900770|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
145287330|NCT00903383|523900771|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
145287331|NCT00903383|523900772|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
145287332|NCT00903383|523900773|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
145287333|NCT00903383|523900770|FG000|Overall Study|Patient Decision|0|||
145287334|NCT00903383|523900771|FG001|Overall Study|Patient Decision|0|||
145287335|NCT00903383|523900772|FG002|Overall Study|Patient Decision|0|||
145287336|NCT00903383|523900773|FG003|Overall Study|Patient Decision|1|||
145287337|NCT02015793|523900778|FG000|Overall Study|Adverse Event|3|||
145287338|NCT02015793|523900779|FG001|Overall Study|Adverse Event|3|||
145287339|NCT02015793|523900778|FG000|Overall Study|Withdrawal by Subject|1|||
145287340|NCT02015793|523900779|FG001|Overall Study|Withdrawal by Subject|1|||
145287341|NCT00320593|523900780|FG000|Overall Study|Lost to Follow-up|3|||
145613123|NCT06173570|525099265|FG000|Overall Study|Adverse Event|1|||
145287342|NCT00320593|523900781|FG001|Overall Study|Lost to Follow-up|0|||
145287343|NCT00320593|523900780|FG000|Overall Study|Moved to another state|1|||
145287344|NCT00320593|523900781|FG001|Overall Study|Moved to another state|0|||
145287345|NCT00320593|523900780|FG000|Overall Study|Withdrawal by Subject|2|||
145287346|NCT00320593|523900781|FG001|Overall Study|Withdrawal by Subject|1|||
145287347|NCT00320593|523900780|FG000|Overall Study|Withdrawal by clinical center|1|||
145287348|NCT00320593|523900781|FG001|Overall Study|Withdrawal by clinical center|0|||
145287349|NCT02110706|523900784|FG000|Overall Study|Adverse Event|2|||
145287350|NCT02110706|523900785|FG001|Overall Study|Adverse Event|3|||
145287351|NCT02110706|523900784|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
145287352|NCT02110706|523900785|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
145287353|NCT02970669|523900786|FG000|Double-blind Period|Adverse Event|4|||
145287354|NCT02970669|523900787|FG001|Double-blind Period|Adverse Event|0|||
145287355|NCT02970669|523900786|FG000|Double-blind Period|Death|1|||
145287356|NCT02970669|523900787|FG001|Double-blind Period|Death|0|||
145287357|NCT02970669|523900786|FG000|Double-blind Period|Study terminated by sponsor|1|||
145287358|NCT02970669|523900787|FG001|Double-blind Period|Study terminated by sponsor|2|||
145287359|NCT02970669|523900786|FG000|Double-blind Period|Physician Decision|0|||
145287360|NCT02970669|523900787|FG001|Double-blind Period|Physician Decision|2|||
145287361|NCT02970669|523900786|FG000|Double-blind Period|Withdrawal by Subject|2|||
145287362|NCT02970669|523900787|FG001|Double-blind Period|Withdrawal by Subject|2|||
145287363|NCT02970669|523900786|FG000|Open-label Period|Withdrawal by Subject|2|||
145287364|NCT02970669|523900787|FG001|Open-label Period|Withdrawal by Subject|2|||
145287365|NCT02970669|523900786|FG000|Open-label Period|Adverse Event|1|||
145287366|NCT02970669|523900787|FG001|Open-label Period|Adverse Event|0|||
145287367|NCT02970669|523900786|FG000|Open-label Period|Physician Decision|1|||
145287368|NCT02970669|523900787|FG001|Open-label Period|Physician Decision|0|||
145287369|NCT00876733|523900791|FG000|Overall Study|Adverse Event|34|||
145287370|NCT00876733|523900792|FG001|Overall Study|Adverse Event|20|||
145287371|NCT00876733|523900793|FG002|Overall Study|Adverse Event|10|||
145287372|NCT00876733|523900794|FG003|Overall Study|Adverse Event|3|||
145287373|NCT00876733|523900791|FG000|Overall Study|Lack of Efficacy|17|||
145287374|NCT00876733|523900792|FG001|Overall Study|Lack of Efficacy|9|||
145287375|NCT00876733|523900793|FG002|Overall Study|Lack of Efficacy|10|||
145287376|NCT00876733|523900794|FG003|Overall Study|Lack of Efficacy|1|||
145287377|NCT00876733|523900791|FG000|Overall Study|Lost to Follow-up|26|||
145287378|NCT00876733|523900792|FG001|Overall Study|Lost to Follow-up|10|||
145287379|NCT00876733|523900793|FG002|Overall Study|Lost to Follow-up|3|||
145287380|NCT00876733|523900794|FG003|Overall Study|Lost to Follow-up|2|||
145287381|NCT00876733|523900791|FG000|Overall Study|Data not available|14|||
145287382|NCT00876733|523900792|FG001|Overall Study|Data not available|3|||
145287383|NCT00876733|523900793|FG002|Overall Study|Data not available|7|||
145287384|NCT00876733|523900794|FG003|Overall Study|Data not available|1|||
145287385|NCT02843074|523900795|FG000|Overall Study|Withdrawal by Subject|5|||
145287386|NCT02843074|523900795|FG000|Overall Study|Progressive disease|1|||
145287387|NCT02843074|523900795|FG000|Overall Study|Physician Decision|1|||
145287388|NCT02843074|523900795|FG000|Overall Study|Lost to Follow-up|1|||
145287389|NCT02843074|523900795|FG000|Overall Study|Death|9|||
145287390|NCT03521999|523900796|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
145287391|NCT03521999|523900797|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
145287392|NCT03521999|523900796|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
145287393|NCT03521999|523900797|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
145287394|NCT03521999|523900796|FG000|Completed 3 Month Follow up|Death|0|||
145287395|NCT03521999|523900797|FG001|Completed 3 Month Follow up|Death|1|||
145287396|NCT03521999|523900796|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
145287397|NCT03521999|523900797|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
145287398|NCT01564758|523900798|FG000|Overall Study|Death|8|||
145287399|NCT01564758|523900798|FG000|Overall Study|Adverse Event|3|||
145287400|NCT01564758|523900798|FG000|Overall Study|Other|3|||
145287401|NCT01185288|523900801|FG000|Overall Study|Adverse Event|7|||
145287402|NCT01185288|523900802|FG001|Overall Study|Adverse Event|6|||
145287403|NCT01185288|523900801|FG000|Overall Study|Withdrawal by Subject|6|||
145287404|NCT01185288|523900802|FG001|Overall Study|Withdrawal by Subject|4|||
145287405|NCT01185288|523900801|FG000|Overall Study|Lost to Follow-up|2|||
145287406|NCT01185288|523900802|FG001|Overall Study|Lost to Follow-up|5|||
145287407|NCT01185288|523900801|FG000|Overall Study|Lack of Efficacy|2|||
145287408|NCT01185288|523900802|FG001|Overall Study|Lack of Efficacy|0|||
145287409|NCT01185288|523900801|FG000|Overall Study|Investigator discretion|1|||
145287410|NCT01185288|523900802|FG001|Overall Study|Investigator discretion|0|||
145287411|NCT01185288|523900801|FG000|Overall Study|Did not meet inclusion criteria|1|||
145287412|NCT01185288|523900802|FG001|Overall Study|Did not meet inclusion criteria|0|||
145287413|NCT01185288|523900801|FG000|Overall Study|Noncompliance|0|||
145287414|NCT01185288|523900802|FG001|Overall Study|Noncompliance|1|||
145287415|NCT00656019|523900803|FG000|Overall Study|Not Eligible|10|||
145287416|NCT00656019|523900804|FG001|Overall Study|Not Eligible|0|||
145287417|NCT00656019|523900805|FG002|Overall Study|Not Eligible|0|||
145287418|NCT00656019|523900806|FG003|Overall Study|Not Eligible|0|||
145287419|NCT00656019|523900803|FG000|Overall Study|Withdrawal by Subject|2|||
145287420|NCT00656019|523900804|FG001|Overall Study|Withdrawal by Subject|0|||
145287421|NCT00656019|523900805|FG002|Overall Study|Withdrawal by Subject|0|||
145287422|NCT00656019|523900806|FG003|Overall Study|Withdrawal by Subject|0|||
145287423|NCT00656019|523900803|FG000|Overall Study|Lost to Follow-up|2|||
145287424|NCT00656019|523900804|FG001|Overall Study|Lost to Follow-up|1|||
145287425|NCT00656019|523900805|FG002|Overall Study|Lost to Follow-up|0|||
145287426|NCT00656019|523900806|FG003|Overall Study|Lost to Follow-up|0|||
145287427|NCT01326026|523900817|FG000|Overall Study|Adverse Event|4|||
145287428|NCT01326026|523900818|FG001|Overall Study|Adverse Event|3|||
145287429|NCT01326026|523900817|FG000|Overall Study|Withdrawal Criteria|5|||
145287430|NCT01326026|523900818|FG001|Overall Study|Withdrawal Criteria|7|||
145287431|NCT01326026|523900817|FG000|Overall Study|Other|3|||
145287432|NCT01326026|523900818|FG001|Overall Study|Other|3|||
145287433|NCT04317053|523900819|FG000|Overall Study|Withdrawn (screen failure)|4|||
145287434|NCT04317053|523900820|FG001|Overall Study|Withdrawn (screen failure)|2|||
145287435|NCT01073020|523902389|FG000|Overall Study|Withdrawal by Subject|6|||
145287436|NCT01073020|523902390|FG001|Overall Study|Withdrawal by Subject|4|||
145287437|NCT01073020|523902391|FG002|Overall Study|Withdrawal by Subject|1|||
145287438|NCT01073020|523902392|FG003|Overall Study|Withdrawal by Subject|2|||
145287439|NCT01073020|523902389|FG000|Overall Study|Physician Decision|1|||
145287440|NCT01073020|523902390|FG001|Overall Study|Physician Decision|0|||
145287441|NCT01073020|523902391|FG002|Overall Study|Physician Decision|2|||
145287442|NCT01073020|523902392|FG003|Overall Study|Physician Decision|0|||
145287443|NCT01073020|523902389|FG000|Overall Study|Death|0|||
145287444|NCT01073020|523902390|FG001|Overall Study|Death|1|||
145287445|NCT01073020|523902391|FG002|Overall Study|Death|0|||
145287446|NCT01073020|523902392|FG003|Overall Study|Death|0|||
145287447|NCT01644890|523902393|FG000|Overall Study|Adverse Event|7|||
145287448|NCT01644890|523902394|FG001|Overall Study|Adverse Event|20|||
145287449|NCT01644890|523902393|FG000|Overall Study|Death|1|||
145287450|NCT01644890|523902394|FG001|Overall Study|Death|3|||
145287451|NCT01644890|523902393|FG000|Overall Study|Physician Decision|3|||
145287452|NCT01644890|523902394|FG001|Overall Study|Physician Decision|9|||
145287453|NCT01644890|523902393|FG000|Overall Study|Protocol Violation|6|||
145287454|NCT01644890|523902394|FG001|Overall Study|Protocol Violation|7|||
145287455|NCT01644890|523902393|FG000|Overall Study|Withdrawal by Subject|19|||
145287456|NCT01644890|523902394|FG001|Overall Study|Withdrawal by Subject|27|||
145287457|NCT01644890|523902393|FG000|Overall Study|Progression Disease|160|||
145287458|NCT01644890|523902394|FG001|Overall Study|Progression Disease|131|||
145287459|NCT01644890|523902393|FG000|Overall Study|Clinical Progression|6|||
145287460|NCT01644890|523902394|FG001|Overall Study|Clinical Progression|6|||
145287461|NCT01644890|523902393|FG000|Overall Study|> 28 days since last dose of study drug|6|||
145287462|NCT01644890|523902394|FG001|Overall Study|> 28 days since last dose of study drug|3|||
145287463|NCT01644890|523902393|FG000|Overall Study|Other|8|||
145287464|NCT01644890|523902394|FG001|Overall Study|Other|9|||
145287465|NCT03031899|523902399|FG000|Overall Study|Protocol Violation|1|||
145287466|NCT03031899|523902399|FG000|Overall Study|lesion disappeared after stopping habit|1|||
145287467|NCT01060670|523902400|FG000|Run In|screen failure|0|||
145287468|NCT01060670|523902401|FG001|Run In|screen failure|238|||
145287469|NCT00094302|523902402|FG000|Overall Study|Lost to Follow-up|43|||
145287470|NCT00094302|523902403|FG001|Overall Study|Lost to Follow-up|41|||
145287471|NCT00094302|523902402|FG000|Overall Study|Physician Decision|5|||
145287472|NCT00094302|523902403|FG001|Overall Study|Physician Decision|8|||
145287473|NCT00094302|523902402|FG000|Overall Study|Withdrawal by Subject|103|||
145287474|NCT00094302|523902403|FG001|Overall Study|Withdrawal by Subject|111|||
145287475|NCT00094302|523902402|FG000|Overall Study|Death|266|||
145287476|NCT00094302|523902403|FG001|Overall Study|Death|246|||
145287477|NCT03705351|523902411|FG000|Overall Study|Study termination|3|||
145287478|NCT03705351|523902411|FG000|Overall Study|Death|1|||
145287479|NCT03705351|523902411|FG000|Overall Study|Lack of Efficacy|2|||
145287480|NCT03705351|523902411|FG000|Overall Study|Withdrawal by Subject|1|||
145613124|NCT06173570|525099266|FG001|Overall Study|Adverse Event|0|||
145406416|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
145406417|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
145406418|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
145406419|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
145406420|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
145613125|NCT06173570|525099267|FG002|Overall Study|Adverse Event|0|||
145613126|NCT06173570|525099268|FG003|Overall Study|Adverse Event|2|||
145613127|NCT06173570|525099269|FG004|Overall Study|Adverse Event|0|||
145613128|NCT06173570|525099265|FG000|Overall Study|Lost to Follow-up|1|||
145613129|NCT06173570|525099266|FG001|Overall Study|Lost to Follow-up|0|||
145613130|NCT06173570|525099267|FG002|Overall Study|Lost to Follow-up|0|||
145613131|NCT06173570|525099268|FG003|Overall Study|Lost to Follow-up|0|||
145613132|NCT06173570|525099269|FG004|Overall Study|Lost to Follow-up|2|||
145613133|NCT06173570|525099265|FG000|Overall Study|Protocol Violation|0|||
145613134|NCT06173570|525099266|FG001|Overall Study|Protocol Violation|2|||
145613135|NCT06173570|525099267|FG002|Overall Study|Protocol Violation|0|||
145613136|NCT06173570|525099268|FG003|Overall Study|Protocol Violation|0|||
145613137|NCT06173570|525099269|FG004|Overall Study|Protocol Violation|1|||
145613138|NCT06173570|525099265|FG000|Overall Study|Withdrawal by Subject|0|||
145613139|NCT06173570|525099266|FG001|Overall Study|Withdrawal by Subject|1|||
145613140|NCT06173570|525099267|FG002|Overall Study|Withdrawal by Subject|1|||
145613141|NCT06173570|525099268|FG003|Overall Study|Withdrawal by Subject|1|||
145613142|NCT06173570|525099269|FG004|Overall Study|Withdrawal by Subject|1|||
145613143|NCT06173570|525099265|FG000|Overall Study|Non-compliance with Study Drug|1|||
145613144|NCT06173570|525099266|FG001|Overall Study|Non-compliance with Study Drug|0|||
145613145|NCT06173570|525099267|FG002|Overall Study|Non-compliance with Study Drug|0|||
145613146|NCT06173570|525099268|FG003|Overall Study|Non-compliance with Study Drug|0|||
145613147|NCT06173570|525099269|FG004|Overall Study|Non-compliance with Study Drug|0|||
145613148|NCT06173570|525099265|FG000|Overall Study|Screen Failure|0|||
145613149|NCT06173570|525099266|FG001|Overall Study|Screen Failure|0|||
145613150|NCT06173570|525099267|FG002|Overall Study|Screen Failure|0|||
145613151|NCT06173570|525099268|FG003|Overall Study|Screen Failure|0|||
145287481|NCT01907087|523902416|FG000|Overall Study|Withdrawal by Subject|1|||
145287482|NCT02180061|523902417|FG000|Overall Study|Adverse Event|4|||
145287483|NCT02180061|523902418|FG001|Overall Study|Adverse Event|2|||
145287484|NCT02180061|523902417|FG000|Overall Study|Clinical Progression|5|||
145287485|NCT02180061|523902418|FG001|Overall Study|Clinical Progression|1|||
145287486|NCT02180061|523902417|FG000|Overall Study|Progressive Disease|15|||
145287487|NCT02180061|523902418|FG001|Overall Study|Progressive Disease|5|||
145287488|NCT02180061|523902417|FG000|Overall Study|Physician Decision|1|||
145287489|NCT02180061|523902418|FG001|Overall Study|Physician Decision|0|||
145287490|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
145287491|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
145287492|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
145287493|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
145287494|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
145287495|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
145287496|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
145287497|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
145287498|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
145287499|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
145287500|NCT00056160|523902421|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
145555883|NCT00503009|524894880|FG000|Overall Study|Withdrawal by Subject|0|||
145555884|NCT00503009|524894881|FG001|Overall Study|Withdrawal by Subject|1|||
145555885|NCT00503009|524894882|FG002|Overall Study|Withdrawal by Subject|1|||
145555886|NCT00503009|524894880|FG000|Overall Study|Physician Decision|0|||
145555887|NCT00503009|524894881|FG001|Overall Study|Physician Decision|1|||
145555888|NCT00503009|524894882|FG002|Overall Study|Physician Decision|1|||
145555889|NCT02169739|524894883|FG000|Overall Study|Lost to Follow-up|0|||
145406421|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
145406422|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Death|1|||
145406423|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Death|0|||
145555890|NCT02169739|524894884|FG001|Overall Study|Lost to Follow-up|4|||
145555891|NCT03635957|524894885|FG000|Run-In Period|Lost to Follow-up|1|||
145555892|NCT03635957|524894885|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
145406424|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Death|1|||
145555893|NCT00350636|524894886|FG000|Overall Study|Adverse Event|19|||
145555894|NCT00350636|524894887|FG001|Overall Study|Adverse Event|13|||
145613152|NCT06173570|525099269|FG004|Overall Study|Screen Failure|1|||
145613153|NCT06173570|525099265|FG000|Overall Study|Other|2|||
145613154|NCT06173570|525099266|FG001|Overall Study|Other|1|||
145613155|NCT06173570|525099267|FG002|Overall Study|Other|0|||
145613156|NCT06173570|525099268|FG003|Overall Study|Other|2|||
145613157|NCT06173570|525099269|FG004|Overall Study|Other|0|||
145613158|NCT01844115|525099272|FG000|Overall Study|Adverse Event|4|||
145613159|NCT01844115|525099273|FG001|Overall Study|Adverse Event|22|||
145613160|NCT01844115|525099272|FG000|Overall Study|Lack of Efficacy|1|||
145613161|NCT01844115|525099273|FG001|Overall Study|Lack of Efficacy|4|||
145613162|NCT01844115|525099272|FG000|Overall Study|Protocol Violation|12|||
145613163|NCT01844115|525099273|FG001|Overall Study|Protocol Violation|10|||
145613164|NCT01844115|525099272|FG000|Overall Study|Withdrawal by Subject|11|||
145613165|NCT01844115|525099273|FG001|Overall Study|Withdrawal by Subject|11|||
145613166|NCT01844115|525099272|FG000|Overall Study|Lost to Follow-up|11|||
145613167|NCT01844115|525099273|FG001|Overall Study|Lost to Follow-up|10|||
145613168|NCT01844115|525099272|FG000|Overall Study|Pregnancy|0|||
145613169|NCT01844115|525099273|FG001|Overall Study|Pregnancy|1|||
145613170|NCT00758160|525099274|FG000|Overall Study|No Longer Requires Study Medication|4|||
145613171|NCT00758160|525099274|FG000|Overall Study|Administration Problems|3|||
145613172|NCT00758160|525099274|FG000|Overall Study|Adverse Event|15|||
145613173|NCT00758160|525099274|FG000|Overall Study|Lack of Efficacy|10|||
145613174|NCT00758160|525099274|FG000|Overall Study|Lost to Follow-up|14|||
145613175|NCT00758160|525099274|FG000|Overall Study|Protocol Violation|12|||
145613176|NCT00758160|525099274|FG000|Overall Study|Withdrawal by Subject|8|||
145613177|NCT00545363|525099275|FG000|Overall Study|Adverse Event|6|||
145613178|NCT00545363|525099276|FG001|Overall Study|Adverse Event|7|||
145613179|NCT00545363|525099275|FG000|Overall Study|Withdrawal by Subject|6|||
145613180|NCT00545363|525099276|FG001|Overall Study|Withdrawal by Subject|5|||
145613181|NCT00545363|525099275|FG000|Overall Study|Non-compliance|3|||
145613182|NCT00545363|525099276|FG001|Overall Study|Non-compliance|1|||
145613183|NCT00545363|525099275|FG000|Overall Study|Did not meet entry criteria|1|||
145613184|NCT00545363|525099276|FG001|Overall Study|Did not meet entry criteria|1|||
145613185|NCT00545363|525099275|FG000|Overall Study|Lost to Follow-up|2|||
145613186|NCT00545363|525099276|FG001|Overall Study|Lost to Follow-up|0|||
145613187|NCT00545363|525099275|FG000|Overall Study|Other|1|||
145613188|NCT00545363|525099276|FG001|Overall Study|Other|1|||
145613189|NCT00366301|525099277|FG000|Overall Study|Lost to Follow-up|4|||
145613190|NCT00366301|525099278|FG001|Overall Study|Lost to Follow-up|4|||
145613191|NCT00366301|525099279|FG002|Overall Study|Lost to Follow-up|3|||
145613192|NCT00366301|525099280|FG003|Overall Study|Lost to Follow-up|7|||
145613193|NCT00366301|525099277|FG000|Overall Study|Withdrawal by Subject|4|||
145613194|NCT00366301|525099278|FG001|Overall Study|Withdrawal by Subject|2|||
145613195|NCT00366301|525099279|FG002|Overall Study|Withdrawal by Subject|1|||
145613196|NCT00366301|525099280|FG003|Overall Study|Withdrawal by Subject|1|||
145613197|NCT01108510|525099281|FG000|Overall Study|Randomized but Not Treated|5|||
145613198|NCT01108510|525099282|FG001|Overall Study|Randomized but Not Treated|1|||
145613199|NCT01108510|525099281|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
145613200|NCT01108510|525099282|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
145613201|NCT01108510|525099281|FG000|Overall Study|Adverse Event|26|||
145613202|NCT01108510|525099282|FG001|Overall Study|Adverse Event|19|||
145613203|NCT01108510|525099281|FG000|Overall Study|Lost to Follow-up|20|||
145613204|NCT01108510|525099282|FG001|Overall Study|Lost to Follow-up|17|||
145613205|NCT01108510|525099281|FG000|Overall Study|Withdrew Consent|21|||
145613206|NCT01108510|525099282|FG001|Overall Study|Withdrew Consent|15|||
145613207|NCT01108510|525099281|FG000|Overall Study|Investigator's Discretion|12|||
145613208|NCT01108510|525099282|FG001|Overall Study|Investigator's Discretion|10|||
145613209|NCT01108510|525099281|FG000|Overall Study|Participant Noncompliance|5|||
145613210|NCT01108510|525099282|FG001|Overall Study|Participant Noncompliance|7|||
145613211|NCT01108510|525099281|FG000|Overall Study|Lack of Efficacy|3|||
145613212|NCT01108510|525099282|FG001|Overall Study|Lack of Efficacy|0|||
145613213|NCT01108510|525099281|FG000|Overall Study|Pregnancy|0|||
145613214|NCT01108510|525099282|FG001|Overall Study|Pregnancy|3|||
145613215|NCT01108510|525099281|FG000|Overall Study|Death|1|||
145613216|NCT01108510|525099282|FG001|Overall Study|Death|1|||
145613217|NCT00210119|525099283|FG000|Overall Study|Protocol Violation|1|||
145613218|NCT00210119|525099283|FG000|Overall Study|Withdrawal by Subject|1|||
145613219|NCT01830881|525099285|FG000|Overall Study|Changed decision to have an abortion|0|||
145613220|NCT01830881|525099286|FG001|Overall Study|Changed decision to have an abortion|1|||
145613221|NCT03125941|525099287|FG000|Overall Study|did not receive intervention|1|||
145613222|NCT03125941|525099288|FG001|Overall Study|did not receive intervention|2|||
145613223|NCT01258660|525099289|FG000|Overall Study|Adverse Event|2|||
145613224|NCT01258660|525099290|FG001|Overall Study|Adverse Event|4|||
145613225|NCT01258660|525099289|FG000|Overall Study|Withdrawal by Subject|3|||
145613226|NCT01258660|525099290|FG001|Overall Study|Withdrawal by Subject|0|||
145613227|NCT01258660|525099289|FG000|Overall Study|due to relocation|2|||
145613228|NCT01258660|525099290|FG001|Overall Study|due to relocation|0|||
145613229|NCT01258660|525099289|FG000|Overall Study|Protocol Violation|0|||
145613230|NCT01258660|525099290|FG001|Overall Study|Protocol Violation|1|||
145613231|NCT01258660|525099289|FG000|Overall Study|Invalid for primary analysis data set|4|||
145613232|NCT01258660|525099290|FG001|Overall Study|Invalid for primary analysis data set|6|||
145613233|NCT04192630|525099293|FG000|Overall Study|Discontinued before surgery|2|||
145613234|NCT04192630|525099294|FG001|Overall Study|Discontinued before surgery|0|||
145613235|NCT04192630|525099293|FG000|Overall Study|Discontinued after surgery|5|||
145613236|NCT04192630|525099294|FG001|Overall Study|Discontinued after surgery|3|||
145613237|NCT01208415|525099295|FG000|Overall Study|Death|1|||
145613238|NCT01208415|525099295|FG000|Overall Study|Lost to Follow-up|2|||
145613239|NCT01208415|525099295|FG000|Overall Study|Withdrawal by Subject|3|||
145613240|NCT01208415|525099295|FG000|Overall Study|Device not placed|1|||
145613241|NCT01208415|525099295|FG000|Overall Study|Still be eligible for follow-up|33|||
145613242|NCT01115491|525099296|FG000|Overall Study|Death|22|||
145613243|NCT01115491|525099296|FG000|Overall Study|Adverse Event|3|||
145613244|NCT01115491|525099296|FG000|Overall Study|Lost to Follow-up|3|||
145613245|NCT01115491|525099296|FG000|Overall Study|Withdrawal by Subject|1|||
145613246|NCT01115491|525099296|FG000|Overall Study|Physician Decision|1|||
145613247|NCT03856996|525099297|FG000|Overall Study|Withdrawal by Subject|1|||
145613248|NCT03856996|525099298|FG001|Overall Study|Withdrawal by Subject|0|||
145613249|NCT03856996|525099297|FG000|Overall Study|Lost to Follow-up|0|||
145613250|NCT03856996|525099298|FG001|Overall Study|Lost to Follow-up|1|||
145613251|NCT03856996|525099297|FG000|Overall Study|Adverse Event|1|||
145613252|NCT03856996|525099298|FG001|Overall Study|Adverse Event|1|||
145613253|NCT03856996|525099297|FG000|Overall Study|Other|1|||
145613254|NCT03856996|525099298|FG001|Overall Study|Other|0|||
145613255|NCT01586338|525099300|FG000|Overall Study|Adverse Event|3|||
145613256|NCT01586338|525099300|FG000|Overall Study|Lost to Follow-up|1|||
145613257|NCT01586338|525099300|FG000|Overall Study|Withdrawal by participant|3|||
145613258|NCT01586338|525099300|FG000|Overall Study|Other|1|||
145613259|NCT03306043|525099303|FG000|Overall Study|Adverse Event|1|||
145613260|NCT03306043|525099303|FG000|Overall Study|Lost to Follow-up|1|||
145613261|NCT03306043|525099303|FG000|Overall Study|Withdrawal by Subject|2|||
145613262|NCT01544491|525099304|FG000|Overall Study|Withdrawal by Subject|3|||
145613263|NCT01544491|525099305|FG001|Overall Study|Withdrawal by Subject|2|||
145613264|NCT01544491|525099304|FG000|Overall Study|Lost to Follow-up|0|||
145613265|NCT01544491|525099305|FG001|Overall Study|Lost to Follow-up|1|||
145613266|NCT01544491|525099304|FG000|Overall Study|administrative problems|2|||
145613267|NCT01544491|525099305|FG001|Overall Study|administrative problems|0|||
145613268|NCT01799720|525099306|FG000|Overall Study|Withdrawal by Subject|3|||
145613269|NCT01799720|525099307|FG001|Overall Study|Withdrawal by Subject|0|||
145613270|NCT01799720|525099308|FG002|Overall Study|Withdrawal by Subject|0|||
145613271|NCT01799720|525099306|FG000|Overall Study|Protocol Violation|0|||
145613272|NCT01799720|525099307|FG001|Overall Study|Protocol Violation|1|||
145613273|NCT01799720|525099308|FG002|Overall Study|Protocol Violation|0|||
145613274|NCT01799720|525099306|FG000|Overall Study|Pregnancy|0|||
145613275|NCT01799720|525099307|FG001|Overall Study|Pregnancy|0|||
145613276|NCT01799720|525099308|FG002|Overall Study|Pregnancy|1|||
145613277|NCT00896454|525099310|FG000|Overall Study|Death|10|||
145613278|NCT00896454|525099310|FG000|Overall Study|Adverse Event|8|||
145613279|NCT00896454|525099310|FG000|Overall Study|Disease Progression|5|||
145613280|NCT00896454|525099310|FG000|Overall Study|Other|4|||
145613281|NCT00896454|525099310|FG000|Overall Study|Requirement for alternative therapy|3|||
145613282|NCT00896454|525099310|FG000|Overall Study|Ongoing in study|2|||
145613283|NCT00896454|525099310|FG000|Overall Study|Withdrawal by Subject|1|||
145613284|NCT01234649|525099311|FG000|Overall Study|Withdrawal by Subject|32|||
145613285|NCT01234649|525099312|FG001|Overall Study|Withdrawal by Subject|26|||
145613286|NCT01234649|525099311|FG000|Overall Study|Pregnancy|6|||
145613287|NCT01234649|525099312|FG001|Overall Study|Pregnancy|6|||
145613288|NCT01234649|525099311|FG000|Overall Study|intolerant to side effects|4|||
145613289|NCT01234649|525099312|FG001|Overall Study|intolerant to side effects|3|||
145613290|NCT01234649|525099311|FG000|Overall Study|Allergic reaction|1|||
145613291|NCT01234649|525099312|FG001|Overall Study|Allergic reaction|0|||
145613292|NCT01234649|525099311|FG000|Overall Study|Lack of Efficacy|0|||
145613293|NCT01234649|525099312|FG001|Overall Study|Lack of Efficacy|3|||
145613294|NCT01461993|525099317|FG000|Overall Study|Withdrawal by Subject|60|||
145613295|NCT01461993|525099318|FG001|Overall Study|Withdrawal by Subject|53|||
145613296|NCT01461993|525099319|FG002|Overall Study|Withdrawal by Subject|16|||
145613297|NCT01461993|525099317|FG000|Overall Study|Lost to Follow-up|44|||
145613298|NCT01461993|525099318|FG001|Overall Study|Lost to Follow-up|48|||
145613299|NCT01461993|525099319|FG002|Overall Study|Lost to Follow-up|22|||
145613300|NCT01461993|525099317|FG000|Overall Study|Protocol Violation|10|||
145613301|NCT01461993|525099318|FG001|Overall Study|Protocol Violation|9|||
145613302|NCT01461993|525099319|FG002|Overall Study|Protocol Violation|7|||
145613303|NCT01461993|525099317|FG000|Overall Study|Adverse Event|9|||
145613304|NCT01461993|525099318|FG001|Overall Study|Adverse Event|11|||
145613305|NCT01461993|525099319|FG002|Overall Study|Adverse Event|3|||
145613306|NCT01461993|525099317|FG000|Overall Study|No longer met eligibility criteria|13|||
145613307|NCT01461993|525099318|FG001|Overall Study|No longer met eligibility criteria|18|||
145613308|NCT01461993|525099319|FG002|Overall Study|No longer met eligibility criteria|10|||
145613309|NCT01461993|525099317|FG000|Overall Study|Did not meet entrance criteria|2|||
145613310|NCT01461993|525099318|FG001|Overall Study|Did not meet entrance criteria|3|||
145613311|NCT01461993|525099319|FG002|Overall Study|Did not meet entrance criteria|0|||
145613312|NCT01461993|525099317|FG000|Overall Study|Other|13|||
145613313|NCT01461993|525099318|FG001|Overall Study|Other|15|||
145613314|NCT01461993|525099319|FG002|Overall Study|Other|6|||
145613315|NCT00680056|525099321|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
145613316|NCT00680056|525099322|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
145613317|NCT00680056|525099321|FG000|Second Intervention|Protocol Violation|3|||
145613318|NCT00680056|525099322|FG001|Second Intervention|Protocol Violation|1|||
145613319|NCT02733042|525099328|FG000|Overall Study|Adverse Event|1|||
145613320|NCT02733042|525099329|FG001|Overall Study|Adverse Event|0|||
145613321|NCT02733042|525099330|FG002|Overall Study|Adverse Event|1|||
145613322|NCT02733042|525099331|FG003|Overall Study|Adverse Event|1|||
145613323|NCT02733042|525099332|FG004|Overall Study|Adverse Event|0|||
145613324|NCT02733042|525099333|FG005|Overall Study|Adverse Event|0|||
145613325|NCT02733042|525099334|FG006|Overall Study|Adverse Event|0|||
145613326|NCT02733042|525099335|FG007|Overall Study|Adverse Event|0|||
145613327|NCT02733042|525099336|FG008|Overall Study|Adverse Event|0|||
145613328|NCT02733042|525099337|FG009|Overall Study|Adverse Event|0|||
145613329|NCT02733042|525099338|FG010|Overall Study|Adverse Event|2|||
145613330|NCT02733042|525099339|FG011|Overall Study|Adverse Event|2|||
145613331|NCT02733042|525099340|FG012|Overall Study|Adverse Event|0|||
145613332|NCT02733042|525099341|FG013|Overall Study|Adverse Event|2|||
145613333|NCT02733042|525099342|FG014|Overall Study|Adverse Event|0|||
145613334|NCT02733042|525099343|FG015|Overall Study|Adverse Event|0|||
145613335|NCT02733042|525099344|FG016|Overall Study|Adverse Event|0|||
145613336|NCT02733042|525099345|FG017|Overall Study|Adverse Event|1|||
145613337|NCT02733042|525099346|FG018|Overall Study|Adverse Event|0|||
145555895|NCT00350636|524894886|FG000|Overall Study|Protocol Violation|1|||
145555896|NCT00350636|524894887|FG001|Overall Study|Protocol Violation|3|||
145555897|NCT00350636|524894886|FG000|Overall Study|Withdrawal by Subject|13|||
145406425|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
145406426|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
145287501|NCT00056160|523902422|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
145287502|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
145287503|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
145287504|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
145287505|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
145287506|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
145287507|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
145287508|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
145287509|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
145287510|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
145287511|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
145287512|NCT00056160|523902421|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
145287513|NCT00056160|523902422|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
145287514|NCT00056160|523902421|FG000|Final Follow-up|Transferred into expanded access study.|3|||
145287515|NCT00056160|523902422|FG001|Final Follow-up|Transferred into expanded access study.|0|||
145555898|NCT00350636|524894887|FG001|Overall Study|Withdrawal by Subject|17|||
145555899|NCT00350636|524894886|FG000|Overall Study|Lost to Follow-up|9|||
145555900|NCT00350636|524894887|FG001|Overall Study|Lost to Follow-up|8|||
145555901|NCT00350636|524894886|FG000|Overall Study|Physician Decision|0|||
145555902|NCT00350636|524894887|FG001|Overall Study|Physician Decision|2|||
145555903|NCT00350636|524894886|FG000|Overall Study|Other|1|||
145555904|NCT00350636|524894887|FG001|Overall Study|Other|2|||
145555905|NCT01647282|524894891|FG000|Overall Study|Physician Decision|7|||
145555906|NCT01647282|524894892|FG001|Overall Study|Physician Decision|5|||
145555907|NCT01163279|524894897|FG000|Overall Study|Withdrawal by Subject|2|||
145555908|NCT01163279|524894898|FG001|Overall Study|Withdrawal by Subject|0|||
145555909|NCT02232425|524894899|FG000|Overall Study|Lost to Follow-up|6|||
145555910|NCT02232425|524894900|FG001|Overall Study|Lost to Follow-up|2|||
145555911|NCT02232425|524894899|FG000|Overall Study|Adverse Event|2|||
145555912|NCT02232425|524894900|FG001|Overall Study|Adverse Event|0|||
145555913|NCT02232425|524894899|FG000|Overall Study|Withdrawal by Subject|5|||
145555914|NCT02232425|524894900|FG001|Overall Study|Withdrawal by Subject|6|||
145555915|NCT02232425|524894899|FG000|Overall Study|Lack of Efficacy|1|||
145555916|NCT02232425|524894900|FG001|Overall Study|Lack of Efficacy|0|||
145555917|NCT01601626|524894901|FG000|Overall Study|Death|1|||
145555918|NCT01601626|524894902|FG001|Overall Study|Death|1|||
145555919|NCT01601626|524894903|FG002|Overall Study|Death|1|||
145555920|NCT01601626|524894901|FG000|Overall Study|Lost to Follow-up|1|||
145555921|NCT01601626|524894902|FG001|Overall Study|Lost to Follow-up|2|||
145287516|NCT00056160|523902421|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
145287517|NCT00056160|523902422|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
145287518|NCT00056160|523902421|FG000|Final Follow-up|Adverse Event|1|||
145287519|NCT00056160|523902422|FG001|Final Follow-up|Adverse Event|0|||
145287520|NCT01469364|523902424|FG000|Overall Study|Adverse Event|1|||
145287521|NCT01469364|523902424|FG000|Overall Study|Withdrawal by Subject|1|||
145287522|NCT02742090|523902425|FG000|Overall Study|Adverse Event|10|||
145287523|NCT02742090|523902425|FG000|Overall Study|Death|3|||
145555922|NCT01601626|524894903|FG002|Overall Study|Lost to Follow-up|0|||
145555923|NCT01601626|524894901|FG000|Overall Study|Unable to Get to Clinic|0|||
145555924|NCT01601626|524894902|FG001|Overall Study|Unable to Get to Clinic|1|||
145555925|NCT01601626|524894903|FG002|Overall Study|Unable to Get to Clinic|0|||
145555926|NCT01601626|524894901|FG000|Overall Study|Withdrawal by Subject|0|||
145555927|NCT01601626|524894902|FG001|Overall Study|Withdrawal by Subject|1|||
145555928|NCT01601626|524894903|FG002|Overall Study|Withdrawal by Subject|1|||
145555929|NCT01601626|524894901|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
145555930|NCT01601626|524894902|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
145555931|NCT01601626|524894903|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
145555932|NCT03914326|524894904|FG000|Overall Study|Withdrawal by Subject|27|||
145287524|NCT02742090|523902425|FG000|Overall Study|Disease Progression|25|||
145287525|NCT02742090|523902425|FG000|Overall Study|Investigator's Decision|1|||
145406427|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
145555933|NCT03914326|524894905|FG001|Overall Study|Withdrawal by Subject|34|||
145555934|NCT03914326|524894904|FG000|Overall Study|Lost to Follow-up|43|||
145555935|NCT03914326|524894905|FG001|Overall Study|Lost to Follow-up|51|||
145555936|NCT03914326|524894904|FG000|Overall Study|Randomised more than once|0|||
145555937|NCT03914326|524894905|FG001|Overall Study|Randomised more than once|1|||
145555938|NCT03274440|524894906|FG000|Overall Study|Time commitment too great|1|||
145555939|NCT03274440|524894907|FG001|Overall Study|Time commitment too great|0|||
145555940|NCT03274440|524894908|FG002|Overall Study|Time commitment too great|0|||
145613338|NCT02733042|525099328|FG000|Overall Study|Progressive Disease|2|||
145613339|NCT02733042|525099329|FG001|Overall Study|Progressive Disease|1|||
145613340|NCT02733042|525099330|FG002|Overall Study|Progressive Disease|3|||
145613341|NCT02733042|525099331|FG003|Overall Study|Progressive Disease|1|||
145555941|NCT03274440|524894909|FG003|Overall Study|Time commitment too great|1|||
145555942|NCT03274440|524894910|FG004|Overall Study|Time commitment too great|0|||
145555943|NCT03274440|524894911|FG005|Overall Study|Time commitment too great|0|||
145555944|NCT02436356|524894915|FG000|Overall Study|Excluded by MRI Screening|0|||
145555945|NCT02436356|524894916|FG001|Overall Study|Excluded by MRI Screening|0|||
145555946|NCT02436356|524894917|FG002|Overall Study|Excluded by MRI Screening|2|||
145555947|NCT02436356|524894915|FG000|Overall Study|Lost to Follow-up|0|||
145555948|NCT02436356|524894916|FG001|Overall Study|Lost to Follow-up|1|||
145613342|NCT02733042|525099332|FG004|Overall Study|Progressive Disease|2|||
145613343|NCT02733042|525099333|FG005|Overall Study|Progressive Disease|3|||
145613344|NCT02733042|525099334|FG006|Overall Study|Progressive Disease|0|||
145613345|NCT02733042|525099335|FG007|Overall Study|Progressive Disease|3|||
145613346|NCT02733042|525099336|FG008|Overall Study|Progressive Disease|3|||
145613347|NCT02733042|525099337|FG009|Overall Study|Progressive Disease|2|||
145613348|NCT02733042|525099338|FG010|Overall Study|Progressive Disease|2|||
145613349|NCT02733042|525099339|FG011|Overall Study|Progressive Disease|2|||
145613350|NCT02733042|525099340|FG012|Overall Study|Progressive Disease|8|||
145613351|NCT02733042|525099341|FG013|Overall Study|Progressive Disease|1|||
145613352|NCT02733042|525099342|FG014|Overall Study|Progressive Disease|4|||
145613353|NCT02733042|525099343|FG015|Overall Study|Progressive Disease|7|||
145613354|NCT02733042|525099344|FG016|Overall Study|Progressive Disease|2|||
145613355|NCT02733042|525099345|FG017|Overall Study|Progressive Disease|3|||
145613356|NCT02733042|525099346|FG018|Overall Study|Progressive Disease|4|||
145613357|NCT02733042|525099328|FG000|Overall Study|Withdrawal by Subject|0|||
145613358|NCT02733042|525099329|FG001|Overall Study|Withdrawal by Subject|1|||
145613359|NCT02733042|525099330|FG002|Overall Study|Withdrawal by Subject|2|||
145613360|NCT02733042|525099331|FG003|Overall Study|Withdrawal by Subject|1|||
145613361|NCT02733042|525099332|FG004|Overall Study|Withdrawal by Subject|1|||
145613362|NCT02733042|525099333|FG005|Overall Study|Withdrawal by Subject|0|||
145613363|NCT02733042|525099334|FG006|Overall Study|Withdrawal by Subject|0|||
145613364|NCT02733042|525099335|FG007|Overall Study|Withdrawal by Subject|0|||
145613365|NCT02733042|525099336|FG008|Overall Study|Withdrawal by Subject|1|||
145613366|NCT02733042|525099337|FG009|Overall Study|Withdrawal by Subject|1|||
145613367|NCT02733042|525099338|FG010|Overall Study|Withdrawal by Subject|0|||
145613368|NCT02733042|525099339|FG011|Overall Study|Withdrawal by Subject|2|||
145613369|NCT02733042|525099340|FG012|Overall Study|Withdrawal by Subject|1|||
145613370|NCT02733042|525099341|FG013|Overall Study|Withdrawal by Subject|1|||
145613371|NCT02733042|525099342|FG014|Overall Study|Withdrawal by Subject|0|||
145613372|NCT02733042|525099343|FG015|Overall Study|Withdrawal by Subject|0|||
145613373|NCT02733042|525099344|FG016|Overall Study|Withdrawal by Subject|0|||
145613374|NCT02733042|525099345|FG017|Overall Study|Withdrawal by Subject|0|||
145613375|NCT02733042|525099346|FG018|Overall Study|Withdrawal by Subject|0|||
145613376|NCT02733042|525099328|FG000|Overall Study|Other Reasons|0|||
145613377|NCT02733042|525099329|FG001|Overall Study|Other Reasons|0|||
145613378|NCT02733042|525099330|FG002|Overall Study|Other Reasons|1|||
145613379|NCT02733042|525099331|FG003|Overall Study|Other Reasons|0|||
145613380|NCT02733042|525099332|FG004|Overall Study|Other Reasons|0|||
145613381|NCT02733042|525099333|FG005|Overall Study|Other Reasons|0|||
145613382|NCT02733042|525099334|FG006|Overall Study|Other Reasons|0|||
145613383|NCT02733042|525099335|FG007|Overall Study|Other Reasons|0|||
145613384|NCT02733042|525099336|FG008|Overall Study|Other Reasons|0|||
145613385|NCT02733042|525099337|FG009|Overall Study|Other Reasons|1|||
145613386|NCT02733042|525099338|FG010|Overall Study|Other Reasons|1|||
145613387|NCT02733042|525099339|FG011|Overall Study|Other Reasons|0|||
145613388|NCT02733042|525099340|FG012|Overall Study|Other Reasons|0|||
145613389|NCT02733042|525099341|FG013|Overall Study|Other Reasons|0|||
145613390|NCT02733042|525099342|FG014|Overall Study|Other Reasons|0|||
145613391|NCT02733042|525099343|FG015|Overall Study|Other Reasons|1|||
145613392|NCT02733042|525099344|FG016|Overall Study|Other Reasons|0|||
145613393|NCT02733042|525099345|FG017|Overall Study|Other Reasons|1|||
145613394|NCT02733042|525099346|FG018|Overall Study|Other Reasons|0|||
145613395|NCT02733042|525099328|FG000|Overall Study|Death|0|||
145613396|NCT02733042|525099329|FG001|Overall Study|Death|0|||
145613397|NCT02733042|525099330|FG002|Overall Study|Death|0|||
145613398|NCT02733042|525099331|FG003|Overall Study|Death|0|||
145613399|NCT02733042|525099332|FG004|Overall Study|Death|0|||
145613400|NCT02733042|525099333|FG005|Overall Study|Death|0|||
145613401|NCT02733042|525099334|FG006|Overall Study|Death|1|||
145613402|NCT02733042|525099335|FG007|Overall Study|Death|0|||
145613403|NCT02733042|525099336|FG008|Overall Study|Death|1|||
145613404|NCT02733042|525099337|FG009|Overall Study|Death|0|||
145613405|NCT02733042|525099338|FG010|Overall Study|Death|1|||
145613406|NCT02733042|525099339|FG011|Overall Study|Death|0|||
145613407|NCT02733042|525099340|FG012|Overall Study|Death|0|||
145613408|NCT02733042|525099341|FG013|Overall Study|Death|0|||
145613409|NCT02733042|525099342|FG014|Overall Study|Death|1|||
145613410|NCT02733042|525099343|FG015|Overall Study|Death|2|||
145613411|NCT02733042|525099344|FG016|Overall Study|Death|0|||
145613412|NCT02733042|525099345|FG017|Overall Study|Death|0|||
145287526|NCT02742090|523902425|FG000|Overall Study|Lost to Follow-up|1|||
145287527|NCT02742090|523902425|FG000|Overall Study|Non-compliance with Study|1|||
145287528|NCT02742090|523902425|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
145287529|NCT02742090|523902425|FG000|Overall Study|Withdrawal by Subject|4|||
145287530|NCT02742090|523902425|FG000|Overall Study|Reason Not Specified|1|||
145287531|NCT01767597|523902426|FG000|Overall Study|Incomplete intervention|3|||
145287532|NCT01767597|523902427|FG001|Overall Study|Incomplete intervention|1|||
145287533|NCT01767597|523902426|FG000|Overall Study|Withdrawal by Subject|1|||
145287534|NCT01767597|523902427|FG001|Overall Study|Withdrawal by Subject|0|||
145287535|NCT03355742|523902428|FG000|Overall Study|Lost to Follow-up|4|||
145287536|NCT03355742|523902428|FG000|Overall Study|Withdrawal by Subject|29|||
145287537|NCT03355742|523902428|FG000|Overall Study|Physician Decision|6|||
145287538|NCT03355742|523902428|FG000|Overall Study|Death|55|||
145287539|NCT03355742|523902428|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
145287540|NCT00836927|523902429|FG000|Overall Study|Progressive disease|2|||
145287541|NCT00836927|523902430|FG001|Overall Study|Progressive disease|0|||
145287542|NCT00836927|523902431|FG002|Overall Study|Progressive disease|0|||
145287543|NCT00836927|523902432|FG003|Overall Study|Progressive disease|1|||
145287544|NCT00836927|523902433|FG004|Overall Study|Progressive disease|1|||
145287545|NCT00836927|523902429|FG000|Overall Study|Withdrawal by Subject|1|||
145287546|NCT00836927|523902430|FG001|Overall Study|Withdrawal by Subject|0|||
145287547|NCT00836927|523902431|FG002|Overall Study|Withdrawal by Subject|0|||
145287548|NCT00836927|523902432|FG003|Overall Study|Withdrawal by Subject|0|||
145287549|NCT00836927|523902433|FG004|Overall Study|Withdrawal by Subject|0|||
145287550|NCT00614055|523902439|FG000|Overall Study|Adverse Event|1|||
145287551|NCT00614055|523902440|FG001|Overall Study|Adverse Event|0|||
145287552|NCT00614055|523902441|FG002|Overall Study|Adverse Event|0|||
145287553|NCT00614055|523902439|FG000|Overall Study|Protocol Violation|2|||
145287554|NCT00614055|523902440|FG001|Overall Study|Protocol Violation|2|||
145287555|NCT00614055|523902441|FG002|Overall Study|Protocol Violation|1|||
145287556|NCT00614055|523902439|FG000|Overall Study|Lack of Efficacy|0|||
145287557|NCT00614055|523902440|FG001|Overall Study|Lack of Efficacy|0|||
145287558|NCT00614055|523902441|FG002|Overall Study|Lack of Efficacy|2|||
145287559|NCT00614055|523902439|FG000|Overall Study|Unclassified|1|||
145287560|NCT00614055|523902440|FG001|Overall Study|Unclassified|4|||
145287561|NCT00614055|523902441|FG002|Overall Study|Unclassified|2|||
145287562|NCT00449072|523902442|FG000|Overall Study|Adverse Event|3|||
145287563|NCT00449072|523902443|FG001|Overall Study|Adverse Event|1|||
145287564|NCT00449072|523902442|FG000|Overall Study|Protocol Violation|14|||
145287565|NCT00449072|523902443|FG001|Overall Study|Protocol Violation|12|||
145287566|NCT00449072|523902442|FG000|Overall Study|Lost to Follow-up|5|||
145287567|NCT00449072|523902443|FG001|Overall Study|Lost to Follow-up|7|||
145287568|NCT00449072|523902442|FG000|Overall Study|Withdrawal by Subject|11|||
145287569|NCT00449072|523902443|FG001|Overall Study|Withdrawal by Subject|8|||
145287570|NCT00449072|523902442|FG000|Overall Study|Lack of Efficacy|1|||
145287571|NCT00449072|523902443|FG001|Overall Study|Lack of Efficacy|1|||
145287572|NCT00449072|523902442|FG000|Overall Study|Physician Decision|1|||
145287573|NCT00449072|523902443|FG001|Overall Study|Physician Decision|0|||
145287574|NCT00449072|523902442|FG000|Overall Study|Not treated|0|||
145287575|NCT00449072|523902443|FG001|Overall Study|Not treated|1|||
145287576|NCT00449072|523902442|FG000|Overall Study|Excluded medication|0|||
145287577|NCT00449072|523902443|FG001|Overall Study|Excluded medication|2|||
145287578|NCT00449072|523902442|FG000|Overall Study|Non-compliance|2|||
145287579|NCT00449072|523902443|FG001|Overall Study|Non-compliance|5|||
145287580|NCT00449072|523902442|FG000|Overall Study|Sponsor decision|1|||
145287581|NCT00449072|523902443|FG001|Overall Study|Sponsor decision|3|||
145287582|NCT00449072|523902442|FG000|Overall Study|Relocation|3|||
145287583|NCT00449072|523902443|FG001|Overall Study|Relocation|2|||
145287584|NCT00989261|523902444|FG000|Overall Study|Still in follow up|12|||
145287585|NCT00989261|523902445|FG001|Overall Study|Still in follow up|21|||
145287586|NCT00989261|523902444|FG000|Overall Study|Withdrawal by Subject|0|||
145287587|NCT00989261|523902445|FG001|Overall Study|Withdrawal by Subject|1|||
145287588|NCT00989261|523902444|FG000|Overall Study|Lost to Follow-up|3|||
145287589|NCT00989261|523902445|FG001|Overall Study|Lost to Follow-up|0|||
145406428|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
145287590|NCT02398188|523902446|FG000|Overall Study|Adverse Event|2|||
145287591|NCT02398188|523902447|FG001|Overall Study|Adverse Event|3|||
145287592|NCT02398188|523902446|FG000|Overall Study|Lost to Follow-up|5|||
145287593|NCT02398188|523902447|FG001|Overall Study|Lost to Follow-up|0|||
145287594|NCT02398188|523902446|FG000|Overall Study|Non-compliance|4|||
145287595|NCT02398188|523902447|FG001|Overall Study|Non-compliance|4|||
145287596|NCT02398188|523902446|FG000|Overall Study|Protocol Violation|6|||
145287597|NCT02398188|523902447|FG001|Overall Study|Protocol Violation|10|||
145287598|NCT02398188|523902446|FG000|Overall Study|Sponsor Decision|2|||
145287599|NCT02398188|523902447|FG001|Overall Study|Sponsor Decision|1|||
145287600|NCT02398188|523902446|FG000|Overall Study|Pregnancy|1|||
145287601|NCT02398188|523902447|FG001|Overall Study|Pregnancy|0|||
145287602|NCT02398188|523902446|FG000|Overall Study|Withdrawal by Subject|7|||
145287603|NCT02398188|523902447|FG001|Overall Study|Withdrawal by Subject|16|||
145555949|NCT02436356|524894917|FG002|Overall Study|Lost to Follow-up|0|||
145555950|NCT02436356|524894915|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
145555951|NCT02436356|524894916|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
145555952|NCT02436356|524894917|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
145555953|NCT02436356|524894915|FG000|Overall Study|Excluded due to other medical conditions|3|||
145555954|NCT02436356|524894916|FG001|Overall Study|Excluded due to other medical conditions|0|||
145555955|NCT02436356|524894917|FG002|Overall Study|Excluded due to other medical conditions|0|||
145555956|NCT02436356|524894915|FG000|Overall Study|Withdrawal by Subject|1|||
145555957|NCT02436356|524894916|FG001|Overall Study|Withdrawal by Subject|0|||
145555958|NCT02436356|524894917|FG002|Overall Study|Withdrawal by Subject|0|||
145555959|NCT04577118|524894918|FG000|Overall Study|Withdrawal by Subject|4|||
145555960|NCT00810407|524894919|FG000|Overall Study|Protocol Violation|3|||
145555961|NCT00810407|524894919|FG000|Overall Study|No Visit After First Day of Treatment|3|||
145555962|NCT02968563|524894920|FG000|Overall Study|Adverse Event|0|||
145555963|NCT02968563|524894921|FG001|Overall Study|Adverse Event|6|||
145555964|NCT02968563|524894920|FG000|Overall Study|Death|1|||
145555965|NCT02968563|524894921|FG001|Overall Study|Death|1|||
145555966|NCT02968563|524894920|FG000|Overall Study|Lost to Follow-up|0|||
145555967|NCT02968563|524894921|FG001|Overall Study|Lost to Follow-up|1|||
145555968|NCT03287804|524894925|FG000|Overall Study|Death|1|||
145555969|NCT03287804|524894925|FG000|Overall Study|Physician Decision|2|||
145555970|NCT03287804|524894925|FG000|Overall Study|Progressive disease|8|||
145555971|NCT04008030|524894928|FG000|Pre-Treatment|Withdrawal by Subject|0|||
145555972|NCT04008030|524894929|FG001|Pre-Treatment|Withdrawal by Subject|0|||
145555973|NCT04008030|524894930|FG002|Pre-Treatment|Withdrawal by Subject|9|||
145555974|NCT04008030|524894928|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
145555975|NCT04008030|524894929|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
145555976|NCT04008030|524894930|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
145555977|NCT04008030|524894928|FG000|Pre-Treatment|Other reasons|0|||
145555978|NCT04008030|524894929|FG001|Pre-Treatment|Other reasons|1|||
145555979|NCT04008030|524894930|FG002|Pre-Treatment|Other reasons|6|||
145555980|NCT04008030|524894928|FG000|Treatment|Withdrawal by Subject|1|||
145555981|NCT04008030|524894929|FG001|Treatment|Withdrawal by Subject|1|||
145555982|NCT04008030|524894930|FG002|Treatment|Withdrawal by Subject|1|||
145555983|NCT04008030|524894928|FG000|Treatment|Death|2|||
145555984|NCT04008030|524894929|FG001|Treatment|Death|4|||
145555985|NCT04008030|524894930|FG002|Treatment|Death|0|||
145555986|NCT04008030|524894928|FG000|Treatment|Pregnancy|0|||
145555987|NCT04008030|524894929|FG001|Treatment|Pregnancy|1|||
145555988|NCT04008030|524894930|FG002|Treatment|Pregnancy|0|||
145555989|NCT04008030|524894928|FG000|Treatment|Participant no longer meets study criteria|0|||
145555990|NCT04008030|524894929|FG001|Treatment|Participant no longer meets study criteria|1|||
145555991|NCT04008030|524894930|FG002|Treatment|Participant no longer meets study criteria|0|||
145555992|NCT04008030|524894928|FG000|Treatment|Other reasons|5|||
145555993|NCT04008030|524894929|FG001|Treatment|Other reasons|13|||
145555994|NCT04008030|524894930|FG002|Treatment|Other reasons|6|||
145555995|NCT04008030|524894928|FG000|Treatment|Disease Progression|137|||
145555996|NCT04008030|524894929|FG001|Treatment|Disease Progression|82|||
145555997|NCT04008030|524894930|FG002|Treatment|Disease Progression|85|||
145555998|NCT04008030|524894928|FG000|Treatment|Study drug toxicity|28|||
145555999|NCT04008030|524894929|FG001|Treatment|Study drug toxicity|48|||
145556000|NCT04008030|524894930|FG002|Treatment|Study drug toxicity|8|||
145556001|NCT04008030|524894928|FG000|Treatment|Adverse Event unrelated to study drug|28|||
145556002|NCT04008030|524894929|FG001|Treatment|Adverse Event unrelated to study drug|22|||
145556003|NCT04008030|524894930|FG002|Treatment|Adverse Event unrelated to study drug|6|||
145556004|NCT04008030|524894928|FG000|Treatment|Maximum Clinical Benefit|0|||
145556005|NCT04008030|524894929|FG001|Treatment|Maximum Clinical Benefit|1|||
145556006|NCT04008030|524894930|FG002|Treatment|Maximum Clinical Benefit|9|||
145556007|NCT04008030|524894928|FG000|Treatment|On-going treatment|13|||
145556008|NCT04008030|524894929|FG001|Treatment|On-going treatment|20|||
145556009|NCT04008030|524894930|FG002|Treatment|On-going treatment|0|||
145556010|NCT03178773|524894931|FG000|Overall Study|Death|0|||
145556011|NCT03178773|524894932|FG001|Overall Study|Death|1|||
145556012|NCT03178773|524894931|FG000|Overall Study|Lost to Follow-up|29|||
145287604|NCT03209570|523902448|FG000|Overall Study|Death|1|||
145287605|NCT03209570|523902449|FG001|Overall Study|Death|0|||
145287606|NCT03209570|523902448|FG000|Overall Study|Incomplete Data|8|||
145287607|NCT03209570|523902449|FG001|Overall Study|Incomplete Data|10|||
145287608|NCT03209570|523902448|FG000|Overall Study|Protocol Violation|1|||
145287609|NCT03209570|523902449|FG001|Overall Study|Protocol Violation|0|||
145287610|NCT03209570|523902448|FG000|Overall Study|Withdrawal by Subject|0|||
145287611|NCT03209570|523902449|FG001|Overall Study|Withdrawal by Subject|3|||
145287612|NCT00220701|523902450|FG000|Overall Study|Lost to Follow-up|5|||
145287613|NCT00220701|523902451|FG001|Overall Study|Lost to Follow-up|4|||
145287614|NCT00952484|523902457|FG000|Overall Study|Withdrawal by Subject|0|||
145287615|NCT00952484|523902458|FG001|Overall Study|Withdrawal by Subject|1|||
145287616|NCT00952484|523902459|FG002|Overall Study|Withdrawal by Subject|0|||
145287617|NCT02750306|523902461|FG000|Overall Study|Withdrawal by Subject|5|||
145287618|NCT02750306|523902462|FG001|Overall Study|Withdrawal by Subject|2|||
145287619|NCT02750306|523902461|FG000|Overall Study|Protocol Violation|1|||
145287620|NCT02750306|523902462|FG001|Overall Study|Protocol Violation|0|||
145287621|NCT00192296|523902464|FG000|Overall Study|Withdrawal by Subject|0|||
145287622|NCT00192296|523902465|FG001|Overall Study|Withdrawal by Subject|1|||
145287623|NCT00192296|523902466|FG002|Overall Study|Withdrawal by Subject|0|||
145287624|NCT00192296|523902467|FG003|Overall Study|Withdrawal by Subject|0|||
145287625|NCT01829477|523902468|FG000|Overall Study|Study Terminated by Sponsor|15|||
145287626|NCT01829477|523902469|FG001|Overall Study|Study Terminated by Sponsor|15|||
145287627|NCT01829477|523902468|FG000|Overall Study|Withdrawal by Subject|1|||
145287628|NCT01829477|523902469|FG001|Overall Study|Withdrawal by Subject|0|||
145287629|NCT03361423|523902470|FG000|Overall Study|Withdrawal by Subject|4|||
145287630|NCT03361423|523902471|FG001|Overall Study|Withdrawal by Subject|3|||
145287631|NCT03361423|523902470|FG000|Overall Study|Did not treat|19|||
145287632|NCT03361423|523902471|FG001|Overall Study|Did not treat|18|||
145287633|NCT03361423|523902470|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
145287634|NCT03361423|523902471|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
145287635|NCT03361423|523902470|FG000|Overall Study|Missing data|4|||
145287636|NCT03361423|523902471|FG001|Overall Study|Missing data|1|||
145287637|NCT01336894|523902472|FG000|Follow-up|Study terminated prematurely|2|||
145287638|NCT01336894|523902473|FG001|Follow-up|Study terminated prematurely|7|||
145287639|NCT05034731|523902474|FG000|Overall Study|Screen fail|1|||
145287640|NCT05034731|523902475|FG001|Overall Study|Screen fail|1|||
145287641|NCT00299156|523902478|FG000|Period 2 (Randomized)|Screen Failure|0|||
145287642|NCT00299156|523902479|FG001|Period 2 (Randomized)|Screen Failure|1|||
145287643|NCT00299156|523902480|FG002|Period 2 (Randomized)|Screen Failure|0|||
145287644|NCT01725451|523902481|FG000|Period 1|Withdrawal by Subject|1|||
145287645|NCT01725451|523902482|FG001|Period 1|Withdrawal by Subject|0|||
145287646|NCT01725451|523902483|FG002|Period 1|Withdrawal by Subject|0|||
145287647|NCT01725451|523902484|FG003|Period 1|Withdrawal by Subject|0|||
145287648|NCT01725451|523902481|FG000|Washout From Period 3|Protocol Violation|0|||
145287649|NCT01725451|523902482|FG001|Washout From Period 3|Protocol Violation|0|||
145287650|NCT01725451|523902483|FG002|Washout From Period 3|Protocol Violation|1|||
145287651|NCT01725451|523902484|FG003|Washout From Period 3|Protocol Violation|0|||
145287652|NCT01725451|523902481|FG000|Washout From Period 3|Adverse Event|0|||
145287653|NCT01725451|523902482|FG001|Washout From Period 3|Adverse Event|1|||
145287654|NCT01725451|523902483|FG002|Washout From Period 3|Adverse Event|0|||
145287655|NCT01725451|523902484|FG003|Washout From Period 3|Adverse Event|0|||
145287656|NCT01725451|523902481|FG000|Period 4|Adverse Event|0|||
145287657|NCT01725451|523902482|FG001|Period 4|Adverse Event|0|||
145287658|NCT01725451|523902483|FG002|Period 4|Adverse Event|1|||
145287659|NCT01725451|523902484|FG003|Period 4|Adverse Event|0|||
145287660|NCT01076166|523902488|FG000|Overall Study|Adverse Event|3|||
145287661|NCT01076166|523902488|FG000|Overall Study|Symptoms improved/resolved|6|||
145287662|NCT01716754|523902489|FG000|Overall Study|Death|0|||
145287663|NCT01716754|523902490|FG001|Overall Study|Death|0|||
145287664|NCT01716754|523902491|FG002|Overall Study|Death|0|||
145287665|NCT01716754|523902492|FG003|Overall Study|Death|1|||
145287666|NCT01716754|523902489|FG000|Overall Study|Protocol deviation|0|||
145287667|NCT01716754|523902490|FG001|Overall Study|Protocol deviation|2|||
145287668|NCT01716754|523902491|FG002|Overall Study|Protocol deviation|7|||
145287669|NCT01716754|523902492|FG003|Overall Study|Protocol deviation|2|||
145287670|NCT01716754|523902489|FG000|Overall Study|Non-compliance with study treatment|0|||
145287671|NCT01716754|523902490|FG001|Overall Study|Non-compliance with study treatment|0|||
145287672|NCT01716754|523902491|FG002|Overall Study|Non-compliance with study treatment|1|||
145287673|NCT01716754|523902492|FG003|Overall Study|Non-compliance with study treatment|0|||
145287674|NCT01716754|523902489|FG000|Overall Study|Physician Decision|1|||
145287675|NCT01716754|523902490|FG001|Overall Study|Physician Decision|0|||
145287676|NCT01716754|523902491|FG002|Overall Study|Physician Decision|0|||
145287677|NCT01716754|523902492|FG003|Overall Study|Physician Decision|0|||
145287678|NCT01716754|523902489|FG000|Overall Study|Lost to Follow-up|1|||
145287679|NCT01716754|523902490|FG001|Overall Study|Lost to Follow-up|0|||
145287680|NCT01716754|523902491|FG002|Overall Study|Lost to Follow-up|0|||
145287681|NCT01716754|523902492|FG003|Overall Study|Lost to Follow-up|1|||
145287682|NCT01716754|523902489|FG000|Overall Study|Adverse Event|4|||
145613413|NCT02733042|525099346|FG018|Overall Study|Death|0|||
145613414|NCT02838628|525099348|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
145613415|NCT02838628|525099349|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
145613416|NCT02838628|525099348|FG000|Recurrence Follow-up Period|Adverse Event|1|||
145613417|NCT02838628|525099349|FG001|Recurrence Follow-up Period|Adverse Event|0|||
145613418|NCT02838628|525099348|FG000|Recurrence Follow-up Period|Non-compliance|0|||
145613419|NCT02838628|525099349|FG001|Recurrence Follow-up Period|Non-compliance|1|||
145613420|NCT02838628|525099348|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
145613421|NCT02838628|525099349|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
145613422|NCT02838628|525099348|FG000|Recurrence Follow-up Period|Other un-specified|1|||
145613423|NCT02838628|525099349|FG001|Recurrence Follow-up Period|Other un-specified|1|||
145613424|NCT01821898|525099350|FG000|Overall Study|Withdrawal by Subject|2|||
145287683|NCT01716754|523902490|FG001|Overall Study|Adverse Event|2|||
145613425|NCT01821898|525099351|FG001|Overall Study|Withdrawal by Subject|1|||
145613426|NCT01155661|525099352|FG000|Overall Study|Adverse Event|101|||
145613427|NCT01155661|525099352|FG000|Overall Study|Death|1|||
145613428|NCT01155661|525099352|FG000|Overall Study|Lack of Efficacy|32|||
145287684|NCT01716754|523902491|FG002|Overall Study|Adverse Event|2|||
145287685|NCT01716754|523902492|FG003|Overall Study|Adverse Event|1|||
145287686|NCT01716754|523902489|FG000|Overall Study|Withdrawal by Subject|5|||
145287687|NCT01716754|523902490|FG001|Overall Study|Withdrawal by Subject|0|||
145287688|NCT01716754|523902491|FG002|Overall Study|Withdrawal by Subject|4|||
145287689|NCT01716754|523902492|FG003|Overall Study|Withdrawal by Subject|3|||
145287690|NCT00481247|523902493|FG000|Overall Study|Death|0|||
145287691|NCT00481247|523902494|FG001|Overall Study|Death|1|||
145287692|NCT00481247|523902493|FG000|Overall Study|Disease progression|18|||
145287693|NCT00481247|523902494|FG001|Overall Study|Disease progression|22|||
145287694|NCT00481247|523902493|FG000|Overall Study|Intolerance|42|||
145287695|NCT00481247|523902494|FG001|Overall Study|Intolerance|17|||
145287696|NCT00481247|523902493|FG000|Overall Study|Treatment failure|10|||
145287697|NCT00481247|523902494|FG001|Overall Study|Treatment failure|14|||
145287698|NCT00481247|523902493|FG000|Overall Study|AE unrelated to study drug|13|||
145287699|NCT00481247|523902494|FG001|Overall Study|AE unrelated to study drug|4|||
145287700|NCT00481247|523902493|FG000|Overall Study|Withdrawal by Subject|8|||
145287701|NCT00481247|523902494|FG001|Overall Study|Withdrawal by Subject|13|||
145287702|NCT00481247|523902493|FG000|Overall Study|Pregnancy|2|||
145287703|NCT00481247|523902494|FG001|Overall Study|Pregnancy|1|||
145287704|NCT00481247|523902493|FG000|Overall Study|Lost to Follow-up|1|||
145287705|NCT00481247|523902494|FG001|Overall Study|Lost to Follow-up|2|||
145287706|NCT00481247|523902493|FG000|Overall Study|Poor compliance/noncompliance|1|||
145287707|NCT00481247|523902494|FG001|Overall Study|Poor compliance/noncompliance|7|||
145287708|NCT00481247|523902493|FG000|Overall Study|Administrative reason by sponsor|157|||
145287709|NCT00481247|523902494|FG001|Overall Study|Administrative reason by sponsor|162|||
145287710|NCT00481247|523902493|FG000|Overall Study|Varied|6|||
145287711|NCT00481247|523902494|FG001|Overall Study|Varied|15|||
145287712|NCT00481247|523902493|FG000|Overall Study|Did not receive treatment|1|||
145287713|NCT00481247|523902494|FG001|Overall Study|Did not receive treatment|2|||
145287714|NCT04317781|523902495|FG000|Overall Study|Adverse Event|1|||
145287715|NCT04317781|523902495|FG000|Overall Study|Disease relapse|1|||
145287716|NCT04317781|523902495|FG000|Overall Study|Withdrawal by Subject|1|||
145287717|NCT00638157|523902513|FG000|Overall Study|Adverse Event|0|||
145287718|NCT00638157|523902514|FG001|Overall Study|Adverse Event|1|||
145287719|NCT00638157|523902513|FG000|Overall Study|Clinical (symptomatic) failure|1|||
145287720|NCT00638157|523902514|FG001|Overall Study|Clinical (symptomatic) failure|1|||
145287721|NCT00638157|523902513|FG000|Overall Study|Microbiological failure|1|||
145287722|NCT00638157|523902514|FG001|Overall Study|Microbiological failure|0|||
145287723|NCT00638157|523902513|FG000|Overall Study|Lost to Follow-up|1|||
145287724|NCT00638157|523902514|FG001|Overall Study|Lost to Follow-up|0|||
145287725|NCT00638157|523902513|FG000|Overall Study|Physician Decision|1|||
145287726|NCT00638157|523902514|FG001|Overall Study|Physician Decision|0|||
145287727|NCT00638157|523902513|FG000|Overall Study|Other|1|||
145287728|NCT00638157|523902514|FG001|Overall Study|Other|2|||
145287729|NCT00638157|523902513|FG000|Overall Study|Randomized, not treated|2|||
145287730|NCT00638157|523902514|FG001|Overall Study|Randomized, not treated|0|||
145287731|NCT02611752|523902520|FG000|Overall Study|Adverse Event|0|||
145287732|NCT02611752|523902521|FG001|Overall Study|Adverse Event|1|||
145287733|NCT02427607|523902524|FG000|Overall Study|Withdrawal by Subject|1|||
145613429|NCT01155661|525099352|FG000|Overall Study|Lost to Follow-up|22|||
145287734|NCT02277769|523902525|FG000|Overall Study|Protocol Violation|3|||
145287735|NCT02277769|523902526|FG001|Overall Study|Protocol Violation|3|||
145613430|NCT01155661|525099352|FG000|Overall Study|Physician Decision|3|||
145613431|NCT01155661|525099352|FG000|Overall Study|Protocol Violation|35|||
145613432|NCT01155661|525099352|FG000|Overall Study|Withdrawal by Subject|73|||
145613433|NCT01155661|525099352|FG000|Overall Study|Sponsor Decision|13|||
145613434|NCT01396395|525099353|FG000|Overall Study|Withdrawal by Subject|10|||
145613435|NCT01396395|525099354|FG001|Overall Study|Withdrawal by Subject|12|||
145613436|NCT01396395|525099353|FG000|Overall Study|Protocol Violation|3|||
145613437|NCT01396395|525099354|FG001|Overall Study|Protocol Violation|1|||
145613438|NCT01396395|525099353|FG000|Overall Study|Adverse Event|10|||
145613439|NCT01396395|525099354|FG001|Overall Study|Adverse Event|2|||
145613440|NCT01396395|525099353|FG000|Overall Study|Lost to Follow-up|17|||
145613441|NCT01396395|525099354|FG001|Overall Study|Lost to Follow-up|11|||
145613442|NCT01396395|525099353|FG000|Overall Study|Other|0|||
145613443|NCT01396395|525099354|FG001|Overall Study|Other|1|||
145613444|NCT00882921|525099355|FG000|Overall Study|Death|2|||
145613445|NCT00882921|525099355|FG000|Overall Study|Other|3|||
145613446|NCT00882921|525099355|FG000|Overall Study|Lost to Follow-up|2|||
145613447|NCT00882921|525099355|FG000|Overall Study|Termination By Investigator|3|||
145613448|NCT00882921|525099355|FG000|Overall Study|Withdrawal Of Consent|1|||
145613449|NCT03691948|525099356|FG000|Overall Study|Lost to Follow-up|1|||
145613450|NCT03691948|525099357|FG001|Overall Study|Lost to Follow-up|3|||
145613451|NCT01370005|525099358|FG000|Overall Study|Not treated|1|||
145613452|NCT01370005|525099359|FG001|Overall Study|Not treated|0|||
145613453|NCT01370005|525099360|FG002|Overall Study|Not treated|0|||
145613454|NCT01370005|525099358|FG000|Overall Study|Adverse Event|5|||
145613455|NCT01370005|525099359|FG001|Overall Study|Adverse Event|5|||
145613456|NCT01370005|525099360|FG002|Overall Study|Adverse Event|6|||
145613457|NCT01370005|525099358|FG000|Overall Study|Lack of Efficacy|1|||
145613458|NCT01370005|525099359|FG001|Overall Study|Lack of Efficacy|0|||
145613459|NCT01370005|525099360|FG002|Overall Study|Lack of Efficacy|0|||
145613460|NCT01370005|525099358|FG000|Overall Study|Non compliant with protocol|0|||
145613461|NCT01370005|525099359|FG001|Overall Study|Non compliant with protocol|1|||
145613462|NCT01370005|525099360|FG002|Overall Study|Non compliant with protocol|2|||
145613463|NCT01370005|525099358|FG000|Overall Study|Lost to Follow-up|1|||
145613464|NCT01370005|525099359|FG001|Overall Study|Lost to Follow-up|1|||
145613465|NCT01370005|525099360|FG002|Overall Study|Lost to Follow-up|1|||
145613466|NCT01370005|525099358|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
145613467|NCT01370005|525099359|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
145613468|NCT01370005|525099360|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
145613469|NCT01370005|525099358|FG000|Overall Study|Other reason not defined above|3|||
145613470|NCT01370005|525099359|FG001|Overall Study|Other reason not defined above|0|||
145613471|NCT01370005|525099360|FG002|Overall Study|Other reason not defined above|2|||
145613472|NCT00180713|525099361|FG000|Overall Study|Withdrawal by Subject|2|||
145287736|NCT02277769|523902527|FG002|Overall Study|Protocol Violation|5|||
145287737|NCT02277769|523902525|FG000|Overall Study|Lack of Efficacy|17|||
145287738|NCT02277769|523902526|FG001|Overall Study|Lack of Efficacy|0|||
145287739|NCT02277769|523902527|FG002|Overall Study|Lack of Efficacy|4|||
145287740|NCT02277769|523902525|FG000|Overall Study|Adverse Event|14|||
145287741|NCT02277769|523902526|FG001|Overall Study|Adverse Event|2|||
145287742|NCT02277769|523902527|FG002|Overall Study|Adverse Event|4|||
145287743|NCT02277769|523902525|FG000|Overall Study|Other than specified above|12|||
145287744|NCT02277769|523902526|FG001|Overall Study|Other than specified above|8|||
145287745|NCT02277769|523902527|FG002|Overall Study|Other than specified above|5|||
145287746|NCT01754259|523902530|FG000|Overall Study|Withdrawal by Subject|2|||
145287747|NCT01754259|523902531|FG001|Overall Study|Withdrawal by Subject|4|||
145287748|NCT01754259|523902530|FG000|Overall Study|Adverse Event|3|||
145287749|NCT01754259|523902531|FG001|Overall Study|Adverse Event|1|||
145287750|NCT01754259|523902530|FG000|Overall Study|Lost to Follow-up|0|||
145287751|NCT01754259|523902531|FG001|Overall Study|Lost to Follow-up|1|||
145287752|NCT01364870|523902536|FG000|Overall Study|Withdrawal by Subject|13|||
145287753|NCT01364870|523902537|FG001|Overall Study|Withdrawal by Subject|24|||
145287754|NCT01364870|523902538|FG002|Overall Study|Withdrawal by Subject|10|||
145287755|NCT01364870|523902536|FG000|Overall Study|Adverse Event|8|||
145287756|NCT01364870|523902537|FG001|Overall Study|Adverse Event|6|||
145287757|NCT01364870|523902538|FG002|Overall Study|Adverse Event|4|||
145287758|NCT01364870|523902536|FG000|Overall Study|Protocol Violation|1|||
145287759|NCT01364870|523902537|FG001|Overall Study|Protocol Violation|0|||
145287760|NCT01364870|523902538|FG002|Overall Study|Protocol Violation|0|||
145287761|NCT00095199|523902543|FG000|Overall Study|Adverse Event|40|||
145287762|NCT00095199|523902544|FG001|Overall Study|Adverse Event|22|||
145287763|NCT00095199|523902545|FG002|Overall Study|Adverse Event|26|||
145287764|NCT00095199|523902546|FG003|Overall Study|Adverse Event|11|||
145287765|NCT00095199|523902543|FG000|Overall Study|Progressive disease|213|||
145287766|NCT00095199|523902544|FG001|Overall Study|Progressive disease|179|||
145287767|NCT00095199|523902545|FG002|Overall Study|Progressive disease|105|||
145287768|NCT00095199|523902546|FG003|Overall Study|Progressive disease|98|||
145287769|NCT00095199|523902543|FG000|Overall Study|Death|10|||
145287770|NCT00095199|523902544|FG001|Overall Study|Death|6|||
145287771|NCT00095199|523902545|FG002|Overall Study|Death|11|||
145287772|NCT00095199|523902546|FG003|Overall Study|Death|9|||
145287773|NCT00095199|523902543|FG000|Overall Study|Withdrawal by Subject|21|||
145287774|NCT00095199|523902544|FG001|Overall Study|Withdrawal by Subject|16|||
145287775|NCT00095199|523902545|FG002|Overall Study|Withdrawal by Subject|13|||
145287776|NCT00095199|523902546|FG003|Overall Study|Withdrawal by Subject|22|||
145287777|NCT00095199|523902543|FG000|Overall Study|Protocol Violation|4|||
145287778|NCT00095199|523902544|FG001|Overall Study|Protocol Violation|4|||
145287779|NCT00095199|523902545|FG002|Overall Study|Protocol Violation|2|||
145287780|NCT00095199|523902546|FG003|Overall Study|Protocol Violation|0|||
145287781|NCT00095199|523902543|FG000|Overall Study|Liver function test results elevated|0|||
145613473|NCT00180713|525099362|FG001|Overall Study|Withdrawal by Subject|0|||
145613474|NCT00180713|525099361|FG000|Overall Study|Adverse Event|3|||
145613475|NCT00180713|525099362|FG001|Overall Study|Adverse Event|3|||
145287782|NCT00095199|523902544|FG001|Overall Study|Liver function test results elevated|0|||
145613476|NCT02322814|525099365|FG000|Overall Study|Death|7|||
145287783|NCT00095199|523902545|FG002|Overall Study|Liver function test results elevated|1|||
145287784|NCT00095199|523902546|FG003|Overall Study|Liver function test results elevated|1|||
145287785|NCT00095199|523902543|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
145287786|NCT00095199|523902544|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
145287787|NCT00095199|523902545|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
145613477|NCT02322814|525099366|FG001|Overall Study|Death|29|||
145613478|NCT02322814|525099367|FG002|Overall Study|Death|32|||
145287788|NCT00095199|523902546|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
145287789|NCT00095199|523902543|FG000|Overall Study|Physician Decision|5|||
145613479|NCT02322814|525099368|FG003|Overall Study|Death|23|||
145287790|NCT00095199|523902544|FG001|Overall Study|Physician Decision|6|||
145287791|NCT00095199|523902545|FG002|Overall Study|Physician Decision|1|||
145287792|NCT00095199|523902546|FG003|Overall Study|Physician Decision|1|||
145613480|NCT02322814|525099369|FG004|Overall Study|Death|14|||
145613481|NCT02322814|525099365|FG000|Overall Study|Lost to Follow-up|1|||
145613482|NCT02322814|525099366|FG001|Overall Study|Lost to Follow-up|3|||
145613483|NCT02322814|525099367|FG002|Overall Study|Lost to Follow-up|3|||
145613484|NCT02322814|525099368|FG003|Overall Study|Lost to Follow-up|1|||
145613485|NCT02322814|525099369|FG004|Overall Study|Lost to Follow-up|0|||
145613486|NCT02322814|525099365|FG000|Overall Study|Various Reasons|2|||
145613487|NCT02322814|525099366|FG001|Overall Study|Various Reasons|0|||
145613488|NCT02322814|525099367|FG002|Overall Study|Various Reasons|1|||
145613489|NCT02322814|525099368|FG003|Overall Study|Various Reasons|1|||
145613490|NCT02322814|525099369|FG004|Overall Study|Various Reasons|0|||
145613491|NCT02322814|525099365|FG000|Overall Study|Progressive Disease|0|||
145613492|NCT02322814|525099366|FG001|Overall Study|Progressive Disease|0|||
145613493|NCT02322814|525099367|FG002|Overall Study|Progressive Disease|0|||
145613494|NCT02322814|525099368|FG003|Overall Study|Progressive Disease|1|||
145287793|NCT00095199|523902543|FG000|Overall Study|Not eligible|1|||
145287794|NCT00095199|523902544|FG001|Overall Study|Not eligible|7|||
145287795|NCT00095199|523902545|FG002|Overall Study|Not eligible|0|||
145287796|NCT00095199|523902546|FG003|Overall Study|Not eligible|1|||
145287797|NCT00095199|523902543|FG000|Overall Study|Started Palliative Radiotherapy|1|||
145287798|NCT00095199|523902544|FG001|Overall Study|Started Palliative Radiotherapy|0|||
145287799|NCT00095199|523902545|FG002|Overall Study|Started Palliative Radiotherapy|0|||
145287800|NCT00095199|523902546|FG003|Overall Study|Started Palliative Radiotherapy|0|||
145287801|NCT00095199|523902543|FG000|Overall Study|Started radiotherapy regimen|0|||
145287802|NCT00095199|523902544|FG001|Overall Study|Started radiotherapy regimen|1|||
145287803|NCT00095199|523902545|FG002|Overall Study|Started radiotherapy regimen|0|||
145287804|NCT00095199|523902546|FG003|Overall Study|Started radiotherapy regimen|0|||
145287805|NCT00095199|523902543|FG000|Overall Study|Primary tumor removed in other surgery|0|||
145287806|NCT00095199|523902544|FG001|Overall Study|Primary tumor removed in other surgery|1|||
145287807|NCT00095199|523902545|FG002|Overall Study|Primary tumor removed in other surgery|0|||
145287808|NCT00095199|523902546|FG003|Overall Study|Primary tumor removed in other surgery|0|||
145287809|NCT00095199|523902543|FG000|Overall Study|Data inadvertently lost by site|1|||
145287810|NCT00095199|523902544|FG001|Overall Study|Data inadvertently lost by site|0|||
145287811|NCT00095199|523902545|FG002|Overall Study|Data inadvertently lost by site|0|||
145287812|NCT00095199|523902546|FG003|Overall Study|Data inadvertently lost by site|0|||
145287813|NCT03896490|523902581|FG000|Overall Study|Withdrawal by Subject|1|||
145287814|NCT03896490|523902582|FG001|Overall Study|Withdrawal by Subject|1|||
145287815|NCT01736553|523902587|FG000|Overall Study|Death|12|||
145287816|NCT01736553|523902588|FG001|Overall Study|Death|0|||
145287817|NCT01736553|523902587|FG000|Overall Study|Withdrawal by Subject|5|||
145287818|NCT01736553|523902588|FG001|Overall Study|Withdrawal by Subject|2|||
145287819|NCT01736553|523902587|FG000|Overall Study|Lost to Follow-up|2|||
145287820|NCT01736553|523902588|FG001|Overall Study|Lost to Follow-up|2|||
145287821|NCT01896297|523902589|FG000|Overall Study|Died in post treatment phase|1|||
145287822|NCT00003782|523902590|FG000|Overall Study|No follow up data|30|||
145287823|NCT00003782|523902591|FG001|Overall Study|No follow up data|31|||
145287824|NCT00003782|523902592|FG002|Overall Study|No follow up data|26|||
145287825|NCT01890707|523902593|FG000|Overall Study|Lost to Follow-up|1|||
145287826|NCT01890707|523902594|FG001|Overall Study|Lost to Follow-up|1|||
145287827|NCT00929708|523902597|FG000|Overall Study|Protocol Violation|2|||
145287828|NCT00929708|523902598|FG001|Overall Study|Protocol Violation|1|||
145287829|NCT00929708|523902599|FG002|Overall Study|Protocol Violation|1|||
145287830|NCT00929708|523902600|FG003|Overall Study|Protocol Violation|1|||
145287831|NCT00929708|523902601|FG004|Overall Study|Protocol Violation|1|||
145287832|NCT00929708|523902597|FG000|Overall Study|Withdrawal by Subject|2|||
145287833|NCT00929708|523902598|FG001|Overall Study|Withdrawal by Subject|0|||
145287834|NCT00929708|523902599|FG002|Overall Study|Withdrawal by Subject|0|||
145287835|NCT00929708|523902600|FG003|Overall Study|Withdrawal by Subject|2|||
145613495|NCT02322814|525099369|FG004|Overall Study|Progressive Disease|1|||
145613496|NCT02322814|525099365|FG000|Overall Study|Protocol Violation|1|||
145287836|NCT00929708|523902601|FG004|Overall Study|Withdrawal by Subject|1|||
145287837|NCT00929708|523902597|FG000|Overall Study|Adverse Event|0|||
145287838|NCT00929708|523902598|FG001|Overall Study|Adverse Event|0|||
145287839|NCT00929708|523902599|FG002|Overall Study|Adverse Event|0|||
145287840|NCT00929708|523902600|FG003|Overall Study|Adverse Event|0|||
145287841|NCT00929708|523902601|FG004|Overall Study|Adverse Event|3|||
145287842|NCT00929708|523902597|FG000|Overall Study|Physician Decision|0|||
145287843|NCT00929708|523902598|FG001|Overall Study|Physician Decision|2|||
145613497|NCT02322814|525099366|FG001|Overall Study|Protocol Violation|0|||
145613498|NCT02322814|525099367|FG002|Overall Study|Protocol Violation|0|||
145613499|NCT02322814|525099368|FG003|Overall Study|Protocol Violation|0|||
145556013|NCT03178773|524894932|FG001|Overall Study|Lost to Follow-up|25|||
145556014|NCT03178773|524894931|FG000|Overall Study|Withdrawal by Subject|10|||
145556015|NCT03178773|524894932|FG001|Overall Study|Withdrawal by Subject|14|||
145556016|NCT00770289|524894936|FG000|Overall Study|Other|6|||
145556017|NCT02733991|524894937|FG000|Overall Study|Adverse Event|1|||
145556018|NCT02733991|524894938|FG001|Overall Study|Adverse Event|0|||
145556019|NCT02733991|524894937|FG000|Overall Study|Withdrawal by Subject|0|||
145556020|NCT02733991|524894938|FG001|Overall Study|Withdrawal by Subject|5|||
145556021|NCT02659631|524894941|FG000|Overall Study|Lost to Follow-up|0|||
145556022|NCT02659631|524894942|FG001|Overall Study|Lost to Follow-up|0|||
145556023|NCT02659631|524894943|FG002|Overall Study|Lost to Follow-up|2|||
145556024|NCT02659631|524894944|FG003|Overall Study|Lost to Follow-up|0|||
145556025|NCT02659631|524894945|FG004|Overall Study|Lost to Follow-up|0|||
145556026|NCT02659631|524894946|FG005|Overall Study|Lost to Follow-up|1|||
145556027|NCT02659631|524894947|FG006|Overall Study|Lost to Follow-up|0|||
145556028|NCT02659631|524894948|FG007|Overall Study|Lost to Follow-up|0|||
145556029|NCT02659631|524894949|FG008|Overall Study|Lost to Follow-up|0|||
145556030|NCT02659631|524894950|FG009|Overall Study|Lost to Follow-up|0|||
145556031|NCT02659631|524894941|FG000|Overall Study|Withdrawal prior to treatment|0|||
145556032|NCT02659631|524894942|FG001|Overall Study|Withdrawal prior to treatment|0|||
145556033|NCT02659631|524894943|FG002|Overall Study|Withdrawal prior to treatment|0|||
145556034|NCT02659631|524894944|FG003|Overall Study|Withdrawal prior to treatment|0|||
145556035|NCT02659631|524894945|FG004|Overall Study|Withdrawal prior to treatment|1|||
145556036|NCT02659631|524894946|FG005|Overall Study|Withdrawal prior to treatment|0|||
145556037|NCT02659631|524894947|FG006|Overall Study|Withdrawal prior to treatment|0|||
145556038|NCT02659631|524894948|FG007|Overall Study|Withdrawal prior to treatment|0|||
145556039|NCT02659631|524894949|FG008|Overall Study|Withdrawal prior to treatment|0|||
145556040|NCT02659631|524894950|FG009|Overall Study|Withdrawal prior to treatment|0|||
145556041|NCT02659631|524894941|FG000|Overall Study|Participant refused further follow-up|0|||
145556042|NCT02659631|524894942|FG001|Overall Study|Participant refused further follow-up|0|||
145556043|NCT02659631|524894943|FG002|Overall Study|Participant refused further follow-up|0|||
145556044|NCT02659631|524894944|FG003|Overall Study|Participant refused further follow-up|1|||
145556045|NCT02659631|524894945|FG004|Overall Study|Participant refused further follow-up|0|||
145556046|NCT02659631|524894946|FG005|Overall Study|Participant refused further follow-up|0|||
145556047|NCT02659631|524894947|FG006|Overall Study|Participant refused further follow-up|0|||
145556048|NCT02659631|524894948|FG007|Overall Study|Participant refused further follow-up|0|||
145556049|NCT02659631|524894949|FG008|Overall Study|Participant refused further follow-up|1|||
145556050|NCT02659631|524894950|FG009|Overall Study|Participant refused further follow-up|0|||
145556051|NCT02659631|524894941|FG000|Overall Study|Death (follow-up phase)|1|||
145556052|NCT02659631|524894942|FG001|Overall Study|Death (follow-up phase)|2|||
145556053|NCT02659631|524894943|FG002|Overall Study|Death (follow-up phase)|1|||
145556054|NCT02659631|524894944|FG003|Overall Study|Death (follow-up phase)|1|||
145556055|NCT02659631|524894945|FG004|Overall Study|Death (follow-up phase)|3|||
145556056|NCT02659631|524894946|FG005|Overall Study|Death (follow-up phase)|2|||
145556057|NCT02659631|524894947|FG006|Overall Study|Death (follow-up phase)|0|||
145556058|NCT02659631|524894948|FG007|Overall Study|Death (follow-up phase)|3|||
145556059|NCT02659631|524894949|FG008|Overall Study|Death (follow-up phase)|1|||
145556060|NCT02659631|524894950|FG009|Overall Study|Death (follow-up phase)|0|||
145556061|NCT02659631|524894941|FG000|Overall Study|Death (treatment phase)|0|||
145556062|NCT02659631|524894942|FG001|Overall Study|Death (treatment phase)|0|||
145556063|NCT02659631|524894943|FG002|Overall Study|Death (treatment phase)|0|||
145556064|NCT02659631|524894944|FG003|Overall Study|Death (treatment phase)|0|||
145613500|NCT02322814|525099369|FG004|Overall Study|Protocol Violation|0|||
145613501|NCT02322814|525099365|FG000|Overall Study|Study Terminated by Sponsor|0|||
145613502|NCT02322814|525099366|FG001|Overall Study|Study Terminated by Sponsor|7|||
145613503|NCT02322814|525099367|FG002|Overall Study|Study Terminated by Sponsor|9|||
145613504|NCT02322814|525099368|FG003|Overall Study|Study Terminated by Sponsor|5|||
145613505|NCT02322814|525099369|FG004|Overall Study|Study Terminated by Sponsor|13|||
145613506|NCT02322814|525099365|FG000|Overall Study|Withdrawal by Subject|5|||
145613507|NCT02322814|525099366|FG001|Overall Study|Withdrawal by Subject|4|||
145613508|NCT02322814|525099367|FG002|Overall Study|Withdrawal by Subject|2|||
145613509|NCT02322814|525099368|FG003|Overall Study|Withdrawal by Subject|1|||
145613510|NCT02322814|525099369|FG004|Overall Study|Withdrawal by Subject|3|||
145613511|NCT03012061|525099370|FG000|Overall Study|Withdrawal by Subject|1|||
145613512|NCT03012061|525099371|FG001|Overall Study|Withdrawal by Subject|5|||
145613513|NCT03012061|525099372|FG002|Overall Study|Withdrawal by Subject|4|||
145613514|NCT03012061|525099370|FG000|Overall Study|Investigator Site Closed|1|||
145613515|NCT03012061|525099371|FG001|Overall Study|Investigator Site Closed|2|||
145613516|NCT03012061|525099372|FG002|Overall Study|Investigator Site Closed|0|||
145613517|NCT03012061|525099370|FG000|Overall Study|Lost to Follow-up|2|||
145613518|NCT03012061|525099371|FG001|Overall Study|Lost to Follow-up|1|||
145613519|NCT03012061|525099372|FG002|Overall Study|Lost to Follow-up|0|||
145613520|NCT03012061|525099370|FG000|Overall Study|Study closed/ Terminated|0|||
145613521|NCT03012061|525099371|FG001|Overall Study|Study closed/ Terminated|0|||
145613522|NCT03012061|525099372|FG002|Overall Study|Study closed/ Terminated|1|||
145613523|NCT03012061|525099370|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
145613524|NCT03012061|525099371|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
145613525|NCT03012061|525099372|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
145613526|NCT03012061|525099370|FG000|Overall Study|Protocol Violation|0|||
145613527|NCT03012061|525099371|FG001|Overall Study|Protocol Violation|0|||
145613528|NCT03012061|525099372|FG002|Overall Study|Protocol Violation|2|||
145613529|NCT03012061|525099370|FG000|Overall Study|Lack of Efficacy|0|||
145613530|NCT03012061|525099371|FG001|Overall Study|Lack of Efficacy|1|||
145613531|NCT03012061|525099372|FG002|Overall Study|Lack of Efficacy|0|||
145613532|NCT03012061|525099370|FG000|Overall Study|Adverse Event|2|||
145613533|NCT03012061|525099371|FG001|Overall Study|Adverse Event|0|||
145613534|NCT03012061|525099372|FG002|Overall Study|Adverse Event|0|||
145613535|NCT04152343|525099373|FG000|Overall Study|Transplanted|5|||
145613536|NCT04152343|525099373|FG000|Overall Study|Death|20|||
145613537|NCT04152343|525099373|FG000|Overall Study|Lost to Follow-up|3|||
145613538|NCT01965938|525099374|FG000|Overall Study|Withdrawal by Subject|1|||
145613539|NCT01965938|525099375|FG001|Overall Study|Withdrawal by Subject|0|||
145613540|NCT03757234|525099376|FG000|Overall Study|Adverse Event|0|||
145613541|NCT03757234|525099377|FG001|Overall Study|Adverse Event|0|||
145613542|NCT03757234|525099378|FG002|Overall Study|Adverse Event|0|||
145613543|NCT03757234|525099379|FG003|Overall Study|Adverse Event|0|||
145613544|NCT03757234|525099380|FG004|Overall Study|Adverse Event|1|||
145613545|NCT03757234|525099376|FG000|Overall Study|Lost to Follow-up|1|||
145613546|NCT03757234|525099377|FG001|Overall Study|Lost to Follow-up|0|||
145613547|NCT03757234|525099378|FG002|Overall Study|Lost to Follow-up|0|||
145613548|NCT03757234|525099379|FG003|Overall Study|Lost to Follow-up|0|||
145613549|NCT03757234|525099380|FG004|Overall Study|Lost to Follow-up|1|||
145613550|NCT03757234|525099376|FG000|Overall Study|Withdrawal by Subject|1|||
145613551|NCT03757234|525099377|FG001|Overall Study|Withdrawal by Subject|1|||
145613552|NCT03757234|525099378|FG002|Overall Study|Withdrawal by Subject|0|||
145613553|NCT03757234|525099379|FG003|Overall Study|Withdrawal by Subject|1|||
145613554|NCT03757234|525099380|FG004|Overall Study|Withdrawal by Subject|2|||
145613555|NCT03757234|525099376|FG000|Overall Study|Other|1|||
145613556|NCT03757234|525099377|FG001|Overall Study|Other|1|||
145613557|NCT03757234|525099378|FG002|Overall Study|Other|0|||
145613558|NCT03757234|525099379|FG003|Overall Study|Other|0|||
145613559|NCT03757234|525099380|FG004|Overall Study|Other|0|||
145613560|NCT02736968|525099384|FG000|Overall Study|Lost to Follow-up|0|||
145613561|NCT02736968|525099385|FG001|Overall Study|Lost to Follow-up|0|||
145613562|NCT02736968|525099386|FG002|Overall Study|Lost to Follow-up|0|||
145613563|NCT02736968|525099387|FG003|Overall Study|Lost to Follow-up|0|||
145613564|NCT02736968|525099388|FG004|Overall Study|Lost to Follow-up|0|||
145613565|NCT02736968|525099389|FG005|Overall Study|Lost to Follow-up|0|||
145613566|NCT02736968|525099390|FG006|Overall Study|Lost to Follow-up|5|||
145613567|NCT02736968|525099391|FG007|Overall Study|Lost to Follow-up|2|||
145613568|NCT02736968|525099384|FG000|Overall Study|COVID-19 Pandemic|0|||
145613569|NCT02736968|525099385|FG001|Overall Study|COVID-19 Pandemic|0|||
145613570|NCT02736968|525099386|FG002|Overall Study|COVID-19 Pandemic|0|||
145613571|NCT02736968|525099387|FG003|Overall Study|COVID-19 Pandemic|0|||
145613572|NCT02736968|525099388|FG004|Overall Study|COVID-19 Pandemic|0|||
145613573|NCT02736968|525099389|FG005|Overall Study|COVID-19 Pandemic|0|||
145613574|NCT02736968|525099390|FG006|Overall Study|COVID-19 Pandemic|2|||
145613575|NCT02736968|525099391|FG007|Overall Study|COVID-19 Pandemic|0|||
145613576|NCT02736968|525099384|FG000|Overall Study|Withdrawal by Subject|0|||
145613577|NCT02736968|525099385|FG001|Overall Study|Withdrawal by Subject|0|||
145613578|NCT02736968|525099386|FG002|Overall Study|Withdrawal by Subject|0|||
145613579|NCT02736968|525099387|FG003|Overall Study|Withdrawal by Subject|0|||
145613580|NCT02736968|525099388|FG004|Overall Study|Withdrawal by Subject|0|||
145613581|NCT02736968|525099389|FG005|Overall Study|Withdrawal by Subject|0|||
145613582|NCT02736968|525099390|FG006|Overall Study|Withdrawal by Subject|1|||
145613583|NCT02736968|525099391|FG007|Overall Study|Withdrawal by Subject|0|||
145613584|NCT02961374|525099394|FG000|Overall Study|Adverse Event|4|||
145613585|NCT02041923|525099397|FG000|Overall Study|Lost to Follow-up|26|||
145613586|NCT02041923|525099398|FG001|Overall Study|Lost to Follow-up|30|||
145613587|NCT04297241|525100896|FG000|Overall Study|Withdrawal by Subject|1|||
145613588|NCT04297241|525100896|FG000|Overall Study|Adverse Event|1|||
145613589|NCT04297241|525100896|FG000|Overall Study|Physician Decision|3|||
145613590|NCT03688711|525100907|FG000|Overall Study|Withdrawal by Subject|0|||
145613591|NCT03688711|525100908|FG001|Overall Study|Withdrawal by Subject|1|||
145613592|NCT04654468|525100910|FG000|Overall Study|Death|1|||
145613593|NCT04654468|525100910|FG000|Overall Study|Ongoing in the Study|50|||
145613594|NCT03915951|525100920|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
145613595|NCT03915951|525100921|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
145613596|NCT03915951|525100920|FG000|Overall Study|Adverse Event|12|||
145613597|NCT03915951|525100921|FG001|Overall Study|Adverse Event|6|||
145613598|NCT03915951|525100920|FG000|Overall Study|Disease progression (radiological)|17|||
145613599|NCT03915951|525100921|FG001|Overall Study|Disease progression (radiological)|15|||
145613600|NCT03915951|525100920|FG000|Overall Study|Disease progression (clinical)|4|||
145613601|NCT03915951|525100921|FG001|Overall Study|Disease progression (clinical)|1|||
145613602|NCT03915951|525100920|FG000|Overall Study|Patient decision|0|||
145613603|NCT03915951|525100921|FG001|Overall Study|Patient decision|4|||
145613604|NCT03915951|525100920|FG000|Overall Study|Investigator decision|0|||
145613605|NCT03915951|525100921|FG001|Overall Study|Investigator decision|1|||
145613606|NCT03915951|525100920|FG000|Overall Study|Consent withdrawn|1|||
145613607|NCT03915951|525100921|FG001|Overall Study|Consent withdrawn|1|||
145613608|NCT03915951|525100920|FG000|Overall Study|Death|0|||
145613609|NCT03915951|525100921|FG001|Overall Study|Death|3|||
145613610|NCT05832437|525100922|FG000|Overall Study|time off work|1|||
145613611|NCT05832437|525100923|FG001|Overall Study|time off work|0|||
145613612|NCT05832437|525100924|FG002|Overall Study|time off work|0|||
145613613|NCT05832437|525100925|FG003|Overall Study|time off work|0|||
145613614|NCT04159415|525100926|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613615|NCT04159415|525100927|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613616|NCT04159415|525100928|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613617|NCT04159415|525100929|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613618|NCT04159415|525100930|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613619|NCT04159415|525100931|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613620|NCT04159415|525100932|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
145613621|NCT04159415|525100933|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
145613622|NCT04159415|525100934|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613623|NCT04159415|525100935|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
145613624|NCT04159415|525100926|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613625|NCT04159415|525100927|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613626|NCT04159415|525100928|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613627|NCT04159415|525100929|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613628|NCT04159415|525100930|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613629|NCT04159415|525100931|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613630|NCT04159415|525100932|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613631|NCT04159415|525100933|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
145613632|NCT04159415|525100934|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613633|NCT04159415|525100935|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
145613634|NCT04159415|525100926|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613635|NCT04159415|525100927|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613636|NCT04159415|525100928|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613637|NCT04159415|525100929|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613638|NCT04159415|525100930|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613639|NCT04159415|525100931|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613640|NCT04159415|525100932|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613641|NCT04159415|525100933|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
145613642|NCT04159415|525100934|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613643|NCT04159415|525100935|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
145613644|NCT04159415|525100926|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613645|NCT04159415|525100927|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613646|NCT04159415|525100928|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613647|NCT04159415|525100929|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613648|NCT04159415|525100930|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613649|NCT04159415|525100931|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613650|NCT04159415|525100932|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613651|NCT04159415|525100933|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613652|NCT04159415|525100934|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
145613653|NCT04159415|525100935|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
145613654|NCT05064735|525100936|FG000|Overall Study|Withdrawal by Subject|7|||
145613655|NCT05064735|525100937|FG001|Overall Study|Withdrawal by Subject|8|||
145613656|NCT05064735|525100936|FG000|Overall Study|Lost to Follow-up|7|||
145613657|NCT05064735|525100937|FG001|Overall Study|Lost to Follow-up|2|||
145613658|NCT05064735|525100936|FG000|Overall Study|Physician Decision|2|||
145613659|NCT05064735|525100937|FG001|Overall Study|Physician Decision|1|||
145613660|NCT05064735|525100936|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
145613661|NCT05064735|525100937|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
145613662|NCT05064735|525100936|FG000|Overall Study|Site Closure|7|||
145613663|NCT05064735|525100937|FG001|Overall Study|Site Closure|2|||
145613664|NCT00337662|525100938|FG000|Study Period II|Lost to Follow-up|0|||
145613665|NCT00337662|525100939|FG001|Study Period II|Lost to Follow-up|0|||
145613666|NCT00337662|525100940|FG002|Study Period II|Lost to Follow-up|0|||
145613667|NCT00337662|525100941|FG003|Study Period II|Lost to Follow-up|35|||
145613668|NCT00337662|525100938|FG000|Study Period II|Withdrawal by Subject|0|||
145613669|NCT00337662|525100939|FG001|Study Period II|Withdrawal by Subject|0|||
145613670|NCT00337662|525100940|FG002|Study Period II|Withdrawal by Subject|0|||
145613671|NCT00337662|525100941|FG003|Study Period II|Withdrawal by Subject|20|||
145613672|NCT00337662|525100938|FG000|Study Period II|Adverse Event|0|||
145613673|NCT00337662|525100939|FG001|Study Period II|Adverse Event|0|||
145613674|NCT00337662|525100940|FG002|Study Period II|Adverse Event|0|||
145613675|NCT00337662|525100941|FG003|Study Period II|Adverse Event|16|||
145613676|NCT00337662|525100938|FG000|Study Period II|Physician Decision|0|||
145613677|NCT00337662|525100939|FG001|Study Period II|Physician Decision|0|||
145613678|NCT00337662|525100940|FG002|Study Period II|Physician Decision|0|||
145613679|NCT00337662|525100941|FG003|Study Period II|Physician Decision|13|||
145613680|NCT00337662|525100938|FG000|Study Period II|Entry Criteria Not Met|0|||
145613681|NCT00337662|525100939|FG001|Study Period II|Entry Criteria Not Met|0|||
145613682|NCT00337662|525100940|FG002|Study Period II|Entry Criteria Not Met|0|||
145613683|NCT00337662|525100941|FG003|Study Period II|Entry Criteria Not Met|6|||
145613684|NCT00337662|525100938|FG000|Study Period II|Protocol Violation|0|||
145613685|NCT00337662|525100939|FG001|Study Period II|Protocol Violation|0|||
145613686|NCT00337662|525100940|FG002|Study Period II|Protocol Violation|0|||
145613687|NCT00337662|525100941|FG003|Study Period II|Protocol Violation|6|||
145613688|NCT00337662|525100938|FG000|Study Period II|Lack of Efficacy|0|||
145613689|NCT00337662|525100939|FG001|Study Period II|Lack of Efficacy|0|||
145613690|NCT00337662|525100940|FG002|Study Period II|Lack of Efficacy|0|||
145613691|NCT00337662|525100941|FG003|Study Period II|Lack of Efficacy|7|||
145613692|NCT00337662|525100938|FG000|Study Period II|Sponsor Decision|0|||
145613693|NCT00337662|525100939|FG001|Study Period II|Sponsor Decision|0|||
145613694|NCT00337662|525100940|FG002|Study Period II|Sponsor Decision|0|||
145613695|NCT00337662|525100941|FG003|Study Period II|Sponsor Decision|2|||
145613696|NCT00337662|525100938|FG000|Study Period II|Parent/Caregiver Decision|0|||
145613697|NCT00337662|525100939|FG001|Study Period II|Parent/Caregiver Decision|0|||
145613698|NCT00337662|525100940|FG002|Study Period II|Parent/Caregiver Decision|0|||
145613699|NCT00337662|525100941|FG003|Study Period II|Parent/Caregiver Decision|1|||
145613700|NCT00337662|525100938|FG000|Study Period III|Lost to Follow-up|14|||
145613701|NCT00337662|525100939|FG001|Study Period III|Lost to Follow-up|16|||
145613702|NCT00337662|525100940|FG002|Study Period III|Lost to Follow-up|14|||
145613703|NCT00337662|525100941|FG003|Study Period III|Lost to Follow-up|0|||
145613704|NCT00337662|525100938|FG000|Study Period III|Withdrawal by Subject|18|||
145613705|NCT00337662|525100939|FG001|Study Period III|Withdrawal by Subject|14|||
145613706|NCT00337662|525100940|FG002|Study Period III|Withdrawal by Subject|12|||
145613707|NCT00337662|525100941|FG003|Study Period III|Withdrawal by Subject|0|||
145613708|NCT00337662|525100938|FG000|Study Period III|Adverse Event|9|||
145613709|NCT00337662|525100939|FG001|Study Period III|Adverse Event|10|||
145613710|NCT00337662|525100940|FG002|Study Period III|Adverse Event|8|||
145613711|NCT00337662|525100941|FG003|Study Period III|Adverse Event|0|||
145287844|NCT00929708|523902599|FG002|Overall Study|Physician Decision|2|||
145287845|NCT00929708|523902600|FG003|Overall Study|Physician Decision|2|||
145287846|NCT00929708|523902601|FG004|Overall Study|Physician Decision|1|||
145287847|NCT00929708|523902597|FG000|Overall Study|Lost to Follow-up|0|||
145287848|NCT00929708|523902598|FG001|Overall Study|Lost to Follow-up|0|||
145287849|NCT00929708|523902599|FG002|Overall Study|Lost to Follow-up|0|||
145287850|NCT00929708|523902600|FG003|Overall Study|Lost to Follow-up|1|||
145287851|NCT00929708|523902601|FG004|Overall Study|Lost to Follow-up|0|||
145287852|NCT01893138|523902602|FG000|Double-Blind Period|Withdrawal by Subject|1|||
145287853|NCT01893138|523902603|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145287854|NCT01893138|523902602|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
145287855|NCT01893138|523902603|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
145287856|NCT01893138|523902602|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
145287857|NCT01893138|523902603|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
145287858|NCT01893138|523902602|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
145287859|NCT01893138|523902603|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
145287860|NCT01893138|523902602|FG000|Open Label - Unblinded Period|Adverse Event|1|||
145287861|NCT01893138|523902603|FG001|Open Label - Unblinded Period|Adverse Event|0|||
145287862|NCT02761980|523904402|FG000|Overall Study|Adverse Event|4|||
145287863|NCT02761980|523904403|FG001|Overall Study|Adverse Event|6|||
145287864|NCT02761980|523904404|FG002|Overall Study|Adverse Event|5|||
145287865|NCT02761980|523904405|FG003|Overall Study|Adverse Event|6|||
145287866|NCT02761980|523904402|FG000|Overall Study|Withdrawal by Subject|0|||
145287867|NCT02761980|523904403|FG001|Overall Study|Withdrawal by Subject|1|||
145287868|NCT02761980|523904404|FG002|Overall Study|Withdrawal by Subject|0|||
145287869|NCT02761980|523904405|FG003|Overall Study|Withdrawal by Subject|0|||
145287870|NCT02761980|523904402|FG000|Overall Study|Other|0|||
145287871|NCT02761980|523904403|FG001|Overall Study|Other|0|||
145287872|NCT02761980|523904404|FG002|Overall Study|Other|1|||
145287873|NCT02761980|523904405|FG003|Overall Study|Other|0|||
145287874|NCT02192905|523904412|FG000|Overall Study|Lost to Follow-up|1|||
145287875|NCT04820842|523904413|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
145287876|NCT04820842|523904414|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
145287877|NCT04820842|523904415|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
145287878|NCT04820842|523904416|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
145287879|NCT04820842|523904417|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
145287880|NCT04820842|523904418|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
145287881|NCT04820842|523904419|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
145287882|NCT04820842|523904413|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
145287883|NCT04820842|523904414|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
145287884|NCT04820842|523904415|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
145287885|NCT04820842|523904416|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287886|NCT04820842|523904417|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287887|NCT04820842|523904418|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287888|NCT04820842|523904419|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287889|NCT04820842|523904413|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287890|NCT04820842|523904414|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
145287891|NCT04820842|523904415|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287892|NCT04820842|523904416|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287893|NCT04820842|523904417|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287894|NCT04820842|523904418|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287895|NCT04820842|523904419|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145287896|NCT04820842|523904413|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287897|NCT04820842|523904414|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287898|NCT04820842|523904415|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287899|NCT04820842|523904416|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
145287900|NCT04820842|523904417|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287901|NCT04820842|523904418|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
145287902|NCT04820842|523904419|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
145287903|NCT01296932|523904420|FG000|Overall Study|Dose limiting toxicity|0|||
145287904|NCT01296932|523904421|FG001|Overall Study|Dose limiting toxicity|0|||
145287905|NCT01296932|523904422|FG002|Overall Study|Dose limiting toxicity|0|||
145613712|NCT00337662|525100938|FG000|Study Period III|Protocol Violation|3|||
145613713|NCT00337662|525100939|FG001|Study Period III|Protocol Violation|8|||
145613714|NCT00337662|525100940|FG002|Study Period III|Protocol Violation|2|||
145613715|NCT00337662|525100941|FG003|Study Period III|Protocol Violation|0|||
145613716|NCT00337662|525100938|FG000|Study Period III|Physician Decision|6|||
145613717|NCT00337662|525100939|FG001|Study Period III|Physician Decision|5|||
145613718|NCT00337662|525100940|FG002|Study Period III|Physician Decision|0|||
145613719|NCT00337662|525100941|FG003|Study Period III|Physician Decision|0|||
145613720|NCT00337662|525100938|FG000|Study Period III|Entry Criteria Not Met|4|||
145613721|NCT00337662|525100939|FG001|Study Period III|Entry Criteria Not Met|1|||
145613722|NCT00337662|525100940|FG002|Study Period III|Entry Criteria Not Met|3|||
145613723|NCT00337662|525100941|FG003|Study Period III|Entry Criteria Not Met|0|||
145613724|NCT00337662|525100938|FG000|Study Period III|Lack of Efficacy|4|||
145613725|NCT00337662|525100939|FG001|Study Period III|Lack of Efficacy|4|||
145613726|NCT00337662|525100940|FG002|Study Period III|Lack of Efficacy|2|||
145613727|NCT00337662|525100941|FG003|Study Period III|Lack of Efficacy|0|||
145613728|NCT00337662|525100938|FG000|Study Period III|Parent/Caregiver Decision|0|||
145613729|NCT00337662|525100939|FG001|Study Period III|Parent/Caregiver Decision|0|||
145613730|NCT00337662|525100940|FG002|Study Period III|Parent/Caregiver Decision|2|||
145613731|NCT00337662|525100941|FG003|Study Period III|Parent/Caregiver Decision|0|||
145613732|NCT00337662|525100938|FG000|Study Period III|Sponsor Decision|1|||
145613733|NCT00337662|525100939|FG001|Study Period III|Sponsor Decision|0|||
145613734|NCT00337662|525100940|FG002|Study Period III|Sponsor Decision|1|||
145613735|NCT00337662|525100941|FG003|Study Period III|Sponsor Decision|0|||
145613736|NCT00337662|525100938|FG000|Study Period III|Clinical Relapse|1|||
145613737|NCT00337662|525100939|FG001|Study Period III|Clinical Relapse|0|||
145613738|NCT00337662|525100940|FG002|Study Period III|Clinical Relapse|0|||
145613739|NCT00337662|525100941|FG003|Study Period III|Clinical Relapse|0|||
145613740|NCT01018563|525100945|FG000|Overall Study|Termination of the study by Sponsor|2|||
145613741|NCT01018563|525100946|FG001|Overall Study|Termination of the study by Sponsor|1|||
145613742|NCT02344537|525100949|FG000|Overall Study|Protocol Violation|1|||
145613743|NCT02344537|525100950|FG001|Overall Study|Protocol Violation|1|||
145613744|NCT02344537|525100949|FG000|Overall Study|Subject started another treatment after wk 6|1|||
145613745|NCT02344537|525100950|FG001|Overall Study|Subject started another treatment after wk 6|0|||
145613746|NCT02344537|525100949|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
145613747|NCT02344537|525100950|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
145613748|NCT00960752|525100959|FG000|Overall Study|Adverse Event|0|||
145613749|NCT00960752|525100960|FG001|Overall Study|Adverse Event|0|||
145613750|NCT00960752|525100961|FG002|Overall Study|Adverse Event|1|||
145613751|NCT00960752|525100959|FG000|Overall Study|Progression|0|||
145613752|NCT00960752|525100960|FG001|Overall Study|Progression|0|||
145613753|NCT00960752|525100961|FG002|Overall Study|Progression|1|||
145613754|NCT04844970|525100962|FG000|Overall Study|Adverse Event|0|||
145613755|NCT04844970|525100963|FG001|Overall Study|Adverse Event|1|||
145613756|NCT04844970|525100962|FG000|Overall Study|Withdrawal by Subject|2|||
145613757|NCT04844970|525100963|FG001|Overall Study|Withdrawal by Subject|0|||
145613758|NCT05490329|525100964|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
145613759|NCT05490329|525100965|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
145613760|NCT05490329|525100964|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
145613761|NCT05490329|525100965|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
145613762|NCT05490329|525100964|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
145613763|NCT05490329|525100965|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
145613764|NCT03169881|525100966|FG000|Overall Study|Incomplete Follow-up|10|||
145613765|NCT03169881|525100967|FG001|Overall Study|Incomplete Follow-up|15|||
145613766|NCT03169881|525100966|FG000|Overall Study|Lost to Follow-up|18|||
145613767|NCT03169881|525100967|FG001|Overall Study|Lost to Follow-up|20|||
145613768|NCT03169881|525100966|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
145613769|NCT03169881|525100967|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
145613770|NCT00856661|525100968|FG000|Overall Study|Death|15|||
145613771|NCT00856661|525100969|FG001|Overall Study|Death|18|||
145613772|NCT00856661|525100968|FG000|Overall Study|Protocol Violation|2|||
145613773|NCT00856661|525100969|FG001|Overall Study|Protocol Violation|1|||
145613774|NCT00856661|525100968|FG000|Overall Study|Withdrawal by Subject|1|||
145613775|NCT00856661|525100969|FG001|Overall Study|Withdrawal by Subject|2|||
145613776|NCT00856661|525100968|FG000|Overall Study|Lost to Follow-up|1|||
145613777|NCT00856661|525100969|FG001|Overall Study|Lost to Follow-up|3|||
145613778|NCT00856661|525100968|FG000|Overall Study|Physician Judgement|8|||
145613779|NCT00856661|525100969|FG001|Overall Study|Physician Judgement|5|||
145613780|NCT03936777|525100970|FG000|Overall Study|Adverse Event|3|||
145613781|NCT03936777|525100970|FG000|Overall Study|Death|3|||
145613782|NCT03936777|525100970|FG000|Overall Study|Lack of Efficacy|24|||
145613783|NCT03936777|525100970|FG000|Overall Study|Lost to Follow-up|3|||
145613784|NCT03936777|525100970|FG000|Overall Study|Physician Decision|1|||
145613785|NCT03936777|525100970|FG000|Overall Study|Withdrawal by Subject|11|||
145613786|NCT03936777|525100970|FG000|Overall Study|Subjected Weaned of ZX008|1|||
145613787|NCT03936777|525100970|FG000|Overall Study|Missing|6|||
145287906|NCT01296932|523904423|FG003|Overall Study|Dose limiting toxicity|0|||
145287907|NCT01296932|523904424|FG004|Overall Study|Dose limiting toxicity|0|||
145287908|NCT01296932|523904425|FG005|Overall Study|Dose limiting toxicity|0|||
145287909|NCT01296932|523904426|FG006|Overall Study|Dose limiting toxicity|1|||
145287910|NCT01296932|523904427|FG007|Overall Study|Dose limiting toxicity|0|||
145287911|NCT01296932|523904428|FG008|Overall Study|Dose limiting toxicity|1|||
145287912|NCT01296932|523904420|FG000|Overall Study|Progressive disease|2|||
145287913|NCT01296932|523904421|FG001|Overall Study|Progressive disease|0|||
145287914|NCT01296932|523904422|FG002|Overall Study|Progressive disease|1|||
145287915|NCT01296932|523904423|FG003|Overall Study|Progressive disease|1|||
145287916|NCT01296932|523904424|FG004|Overall Study|Progressive disease|2|||
145287917|NCT01296932|523904425|FG005|Overall Study|Progressive disease|3|||
145287918|NCT01296932|523904426|FG006|Overall Study|Progressive disease|1|||
145287919|NCT01296932|523904427|FG007|Overall Study|Progressive disease|0|||
145287920|NCT01296932|523904428|FG008|Overall Study|Progressive disease|0|||
145287921|NCT01296932|523904420|FG000|Overall Study|Withdrawal by Subject|0|||
145287922|NCT01296932|523904421|FG001|Overall Study|Withdrawal by Subject|0|||
145287923|NCT01296932|523904422|FG002|Overall Study|Withdrawal by Subject|1|||
145287924|NCT01296932|523904423|FG003|Overall Study|Withdrawal by Subject|1|||
145287925|NCT01296932|523904424|FG004|Overall Study|Withdrawal by Subject|0|||
145287926|NCT01296932|523904425|FG005|Overall Study|Withdrawal by Subject|0|||
145287927|NCT01296932|523904426|FG006|Overall Study|Withdrawal by Subject|3|||
145287928|NCT01296932|523904427|FG007|Overall Study|Withdrawal by Subject|0|||
145287929|NCT01296932|523904428|FG008|Overall Study|Withdrawal by Subject|0|||
145287930|NCT01296932|523904420|FG000|Overall Study|Adverse Event|1|||
145287931|NCT01296932|523904421|FG001|Overall Study|Adverse Event|1|||
145287932|NCT01296932|523904422|FG002|Overall Study|Adverse Event|1|||
145287933|NCT01296932|523904423|FG003|Overall Study|Adverse Event|2|||
145287934|NCT01296932|523904424|FG004|Overall Study|Adverse Event|1|||
145287935|NCT01296932|523904425|FG005|Overall Study|Adverse Event|0|||
145287936|NCT01296932|523904426|FG006|Overall Study|Adverse Event|0|||
145287937|NCT01296932|523904427|FG007|Overall Study|Adverse Event|0|||
145287938|NCT01296932|523904428|FG008|Overall Study|Adverse Event|1|||
145287939|NCT01296932|523904420|FG000|Overall Study|Investigator decision|0|||
145287940|NCT01296932|523904421|FG001|Overall Study|Investigator decision|1|||
145287941|NCT01296932|523904422|FG002|Overall Study|Investigator decision|0|||
145287942|NCT01296932|523904423|FG003|Overall Study|Investigator decision|1|||
145287943|NCT01296932|523904424|FG004|Overall Study|Investigator decision|0|||
145287944|NCT01296932|523904425|FG005|Overall Study|Investigator decision|0|||
145287945|NCT01296932|523904426|FG006|Overall Study|Investigator decision|1|||
145287946|NCT01296932|523904427|FG007|Overall Study|Investigator decision|0|||
145287947|NCT01296932|523904428|FG008|Overall Study|Investigator decision|1|||
145287948|NCT01296932|523904420|FG000|Overall Study|No clinical benefit anymore|0|||
145287949|NCT01296932|523904421|FG001|Overall Study|No clinical benefit anymore|1|||
145287950|NCT01296932|523904422|FG002|Overall Study|No clinical benefit anymore|0|||
145287951|NCT01296932|523904423|FG003|Overall Study|No clinical benefit anymore|0|||
145287952|NCT01296932|523904424|FG004|Overall Study|No clinical benefit anymore|0|||
145287953|NCT01296932|523904425|FG005|Overall Study|No clinical benefit anymore|0|||
145287954|NCT01296932|523904426|FG006|Overall Study|No clinical benefit anymore|0|||
145287955|NCT01296932|523904427|FG007|Overall Study|No clinical benefit anymore|0|||
145287956|NCT01296932|523904428|FG008|Overall Study|No clinical benefit anymore|0|||
145287957|NCT01296932|523904420|FG000|Overall Study|Physician Decision|0|||
145287958|NCT01296932|523904421|FG001|Overall Study|Physician Decision|0|||
145287959|NCT01296932|523904422|FG002|Overall Study|Physician Decision|1|||
145287960|NCT01296932|523904423|FG003|Overall Study|Physician Decision|0|||
145287961|NCT01296932|523904424|FG004|Overall Study|Physician Decision|0|||
145287962|NCT01296932|523904425|FG005|Overall Study|Physician Decision|0|||
145287963|NCT01296932|523904426|FG006|Overall Study|Physician Decision|0|||
145287964|NCT01296932|523904427|FG007|Overall Study|Physician Decision|0|||
145287965|NCT01296932|523904428|FG008|Overall Study|Physician Decision|0|||
145287966|NCT01296932|523904420|FG000|Overall Study|IV problems, administration not possible|0|||
145287967|NCT01296932|523904421|FG001|Overall Study|IV problems, administration not possible|0|||
145287968|NCT01296932|523904422|FG002|Overall Study|IV problems, administration not possible|1|||
145287969|NCT01296932|523904423|FG003|Overall Study|IV problems, administration not possible|0|||
145287970|NCT01296932|523904424|FG004|Overall Study|IV problems, administration not possible|0|||
145287971|NCT01296932|523904425|FG005|Overall Study|IV problems, administration not possible|0|||
145287972|NCT01296932|523904426|FG006|Overall Study|IV problems, administration not possible|0|||
145287973|NCT01296932|523904427|FG007|Overall Study|IV problems, administration not possible|0|||
145287974|NCT01296932|523904428|FG008|Overall Study|IV problems, administration not possible|0|||
145287975|NCT01296932|523904420|FG000|Overall Study|per protocol|0|||
145287976|NCT01296932|523904421|FG001|Overall Study|per protocol|0|||
145287977|NCT01296932|523904422|FG002|Overall Study|per protocol|1|||
145287978|NCT01296932|523904423|FG003|Overall Study|per protocol|1|||
145287979|NCT01296932|523904424|FG004|Overall Study|per protocol|0|||
145287980|NCT01296932|523904425|FG005|Overall Study|per protocol|0|||
145613788|NCT02306122|525100971|FG000|Initial Physician Randomization|Physician Decision|0|||
145613789|NCT02306122|525100972|FG001|Initial Physician Randomization|Physician Decision|0|||
145613790|NCT02306122|525100973|FG002|Initial Physician Randomization|Physician Decision|0|||
145613791|NCT02306122|525100974|FG003|Initial Physician Randomization|Physician Decision|0|||
145613792|NCT02306122|525100975|FG004|Initial Physician Randomization|Physician Decision|0|||
145613793|NCT02306122|525100976|FG005|Initial Physician Randomization|Physician Decision|0|||
145613794|NCT02306122|525100977|FG006|Initial Physician Randomization|Physician Decision|0|||
145613795|NCT02306122|525100978|FG007|Initial Physician Randomization|Physician Decision|0|||
145613796|NCT02306122|525100979|FG008|Initial Physician Randomization|Physician Decision|1|||
145613797|NCT02306122|525100980|FG009|Initial Physician Randomization|Physician Decision|0|||
145613798|NCT02306122|525100981|FG010|Initial Physician Randomization|Physician Decision|0|||
145613799|NCT03734991|525100986|FG000|Overall Study|Adverse Event|4|||
145613800|NCT03734991|525100987|FG001|Overall Study|Adverse Event|0|||
145613801|NCT03734991|525100986|FG000|Overall Study|Lost to Follow-up|4|||
145613802|NCT03734991|525100987|FG001|Overall Study|Lost to Follow-up|0|||
145613803|NCT03734991|525100986|FG000|Overall Study|Physician Decision|0|||
145613804|NCT03734991|525100987|FG001|Overall Study|Physician Decision|1|||
145613805|NCT03734991|525100986|FG000|Overall Study|Pregnancy|1|||
145613806|NCT03734991|525100987|FG001|Overall Study|Pregnancy|0|||
145613807|NCT03734991|525100986|FG000|Overall Study|Withdrawal by Subject|6|||
145613808|NCT03734991|525100987|FG001|Overall Study|Withdrawal by Subject|3|||
145613809|NCT03734991|525100986|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
145613810|NCT03734991|525100987|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
145613811|NCT03734991|525100986|FG000|Overall Study|Other|2|||
145613812|NCT03734991|525100987|FG001|Overall Study|Other|2|||
145613813|NCT05295732|525100988|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
145613814|NCT05295732|525100989|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
145613815|NCT05295732|525100990|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
145613816|NCT05295732|525100991|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
145287981|NCT01296932|523904426|FG006|Overall Study|per protocol|0|||
145613817|NCT05295732|525100992|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
145613818|NCT05295732|525100988|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
145613819|NCT05295732|525100989|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
145287982|NCT01296932|523904427|FG007|Overall Study|per protocol|0|||
145287983|NCT01296932|523904428|FG008|Overall Study|per protocol|0|||
145287984|NCT01296932|523904420|FG000|Overall Study|Low benefit and too many side effects|0|||
145287985|NCT01296932|523904421|FG001|Overall Study|Low benefit and too many side effects|0|||
145287986|NCT01296932|523904422|FG002|Overall Study|Low benefit and too many side effects|0|||
145287987|NCT01296932|523904423|FG003|Overall Study|Low benefit and too many side effects|0|||
145287988|NCT01296932|523904424|FG004|Overall Study|Low benefit and too many side effects|0|||
145287989|NCT01296932|523904425|FG005|Overall Study|Low benefit and too many side effects|0|||
145287990|NCT01296932|523904426|FG006|Overall Study|Low benefit and too many side effects|0|||
145287991|NCT01296932|523904427|FG007|Overall Study|Low benefit and too many side effects|1|||
145287992|NCT01296932|523904428|FG008|Overall Study|Low benefit and too many side effects|0|||
145287993|NCT01296932|523904420|FG000|Overall Study|No adequate treatment response|0|||
145287994|NCT01296932|523904421|FG001|Overall Study|No adequate treatment response|0|||
145287995|NCT01296932|523904422|FG002|Overall Study|No adequate treatment response|0|||
145287996|NCT01296932|523904423|FG003|Overall Study|No adequate treatment response|0|||
145287997|NCT01296932|523904424|FG004|Overall Study|No adequate treatment response|0|||
145287998|NCT01296932|523904425|FG005|Overall Study|No adequate treatment response|0|||
145287999|NCT01296932|523904426|FG006|Overall Study|No adequate treatment response|0|||
145288000|NCT01296932|523904427|FG007|Overall Study|No adequate treatment response|1|||
145288001|NCT01296932|523904428|FG008|Overall Study|No adequate treatment response|0|||
145288002|NCT01296932|523904420|FG000|Overall Study|Dosage already reduced, AE still present|0|||
145288003|NCT01296932|523904421|FG001|Overall Study|Dosage already reduced, AE still present|0|||
145288004|NCT01296932|523904422|FG002|Overall Study|Dosage already reduced, AE still present|0|||
145288005|NCT01296932|523904423|FG003|Overall Study|Dosage already reduced, AE still present|0|||
145288006|NCT01296932|523904424|FG004|Overall Study|Dosage already reduced, AE still present|0|||
145288007|NCT01296932|523904425|FG005|Overall Study|Dosage already reduced, AE still present|0|||
145288008|NCT01296932|523904426|FG006|Overall Study|Dosage already reduced, AE still present|0|||
145288009|NCT01296932|523904427|FG007|Overall Study|Dosage already reduced, AE still present|0|||
145288010|NCT01296932|523904428|FG008|Overall Study|Dosage already reduced, AE still present|1|||
145288011|NCT04161144|523904433|FG000|Overall Study|Withdrawal by Subject|0|||
145288012|NCT04161144|523904434|FG001|Overall Study|Withdrawal by Subject|1|||
145288013|NCT04161144|523904433|FG000|Overall Study|Protocol Violation|1|||
145288014|NCT04161144|523904434|FG001|Overall Study|Protocol Violation|0|||
145406429|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
145288015|NCT04041570|523904436|FG000|Overall Study|Moved from Area|0|||
145288016|NCT04041570|523904437|FG001|Overall Study|Moved from Area|2|||
145406430|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
145613820|NCT05295732|525100990|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
145613821|NCT05295732|525100991|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
145613822|NCT05295732|525100992|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
145613823|NCT04150029|525100993|FG000|Overall Study|Disease Relapse|0|||
145613824|NCT04150029|525100994|FG001|Overall Study|Disease Relapse|18|||
145613825|NCT04150029|525100993|FG000|Overall Study|Progressive Disease|2|||
145613826|NCT04150029|525100994|FG001|Overall Study|Progressive Disease|16|||
145613827|NCT04150029|525100993|FG000|Overall Study|Adverse Event|1|||
145613828|NCT04150029|525100994|FG001|Overall Study|Adverse Event|11|||
145613829|NCT04150029|525100993|FG000|Overall Study|Physician Decision|0|||
145613830|NCT04150029|525100994|FG001|Overall Study|Physician Decision|10|||
145613831|NCT04150029|525100993|FG000|Overall Study|Study Terminated by Sponsor|1|||
145613832|NCT04150029|525100994|FG001|Overall Study|Study Terminated by Sponsor|10|||
145613833|NCT04150029|525100993|FG000|Overall Study|Death|0|||
145613834|NCT04150029|525100994|FG001|Overall Study|Death|8|||
145613835|NCT04150029|525100993|FG000|Overall Study|Participant Decision|0|||
145613836|NCT04150029|525100994|FG001|Overall Study|Participant Decision|7|||
145613837|NCT04150029|525100993|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
145613838|NCT04150029|525100994|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
145613839|NCT02364713|525100995|FG000|Overall Study|Ineligible|2|||
145613840|NCT02364713|525100996|FG001|Overall Study|Ineligible|2|||
145613841|NCT01032044|525100997|FG000|Overall Study|Protocol Violation|14|||
145613842|NCT01032044|525100998|FG001|Overall Study|Protocol Violation|8|||
145613843|NCT01032044|525100997|FG000|Overall Study|Adverse Event|0|||
145613844|NCT01032044|525100998|FG001|Overall Study|Adverse Event|1|||
145613845|NCT01032044|525100997|FG000|Overall Study|Lost to Follow-up|11|||
145613846|NCT01032044|525100998|FG001|Overall Study|Lost to Follow-up|11|||
145613847|NCT01233609|525100999|FG000|Overall Study|Death|1|||
145613848|NCT01233609|525101000|FG001|Overall Study|Death|0|||
145613849|NCT01233609|525100999|FG000|Overall Study|Lost to Follow-up|3|||
145613850|NCT01233609|525101000|FG001|Overall Study|Lost to Follow-up|1|||
145613851|NCT01233609|525100999|FG000|Overall Study|Adverse Event|2|||
145613852|NCT01233609|525101000|FG001|Overall Study|Adverse Event|1|||
145613853|NCT01233609|525100999|FG000|Overall Study|Withdrawal by Subject|3|||
145613854|NCT01233609|525101000|FG001|Overall Study|Withdrawal by Subject|0|||
145613855|NCT00309608|525101003|FG000|Overall Study|Adverse Event|1|||
145613856|NCT00309608|525101004|FG001|Overall Study|Adverse Event|5|||
145613857|NCT00309608|525101005|FG002|Overall Study|Adverse Event|3|||
145613858|NCT00309608|525101006|FG003|Overall Study|Adverse Event|2|||
145613859|NCT00309608|525101007|FG004|Overall Study|Adverse Event|3|||
145613860|NCT00309608|525101003|FG000|Overall Study|Protocol Violation|2|||
145613861|NCT00309608|525101004|FG001|Overall Study|Protocol Violation|0|||
145613862|NCT00309608|525101005|FG002|Overall Study|Protocol Violation|0|||
145613863|NCT00309608|525101006|FG003|Overall Study|Protocol Violation|0|||
145613864|NCT00309608|525101007|FG004|Overall Study|Protocol Violation|0|||
145613865|NCT00309608|525101003|FG000|Overall Study|Lost to Follow-up|0|||
145613866|NCT00309608|525101004|FG001|Overall Study|Lost to Follow-up|0|||
145613867|NCT00309608|525101005|FG002|Overall Study|Lost to Follow-up|2|||
145613868|NCT00309608|525101006|FG003|Overall Study|Lost to Follow-up|0|||
145613869|NCT00309608|525101007|FG004|Overall Study|Lost to Follow-up|1|||
145613870|NCT00309608|525101003|FG000|Overall Study|Withdrawal by Subject|1|||
145613871|NCT00309608|525101004|FG001|Overall Study|Withdrawal by Subject|4|||
145613872|NCT00309608|525101005|FG002|Overall Study|Withdrawal by Subject|2|||
145613873|NCT00309608|525101006|FG003|Overall Study|Withdrawal by Subject|0|||
145613874|NCT00309608|525101007|FG004|Overall Study|Withdrawal by Subject|0|||
145613875|NCT00309608|525101003|FG000|Overall Study|Other incl. Lack of efficacy|10|||
145613876|NCT00309608|525101004|FG001|Overall Study|Other incl. Lack of efficacy|4|||
145613877|NCT00309608|525101005|FG002|Overall Study|Other incl. Lack of efficacy|3|||
145613878|NCT00309608|525101006|FG003|Overall Study|Other incl. Lack of efficacy|4|||
145613879|NCT00309608|525101007|FG004|Overall Study|Other incl. Lack of efficacy|0|||
145613880|NCT00127413|525101008|FG000|Overall Study|Lost to Follow-up|6|||
145613881|NCT00127413|525101009|FG001|Overall Study|Lost to Follow-up|4|||
145613882|NCT00127413|525101010|FG002|Overall Study|Lost to Follow-up|8|||
145613883|NCT00127413|525101011|FG003|Overall Study|Lost to Follow-up|2|||
145613884|NCT01051063|525101012|FG000|Overall Study|Death|2|||
145613885|NCT01051063|525101013|FG001|Overall Study|Death|2|||
145613886|NCT01051063|525101012|FG000|Overall Study|Withdrawal by Subject|1|||
145613887|NCT01051063|525101013|FG001|Overall Study|Withdrawal by Subject|1|||
145613888|NCT01051063|525101012|FG000|Overall Study|Termination of the study|5|||
145613889|NCT01051063|525101013|FG001|Overall Study|Termination of the study|0|||
145613890|NCT01051063|525101012|FG000|Overall Study|Moved from the study site area|1|||
145406431|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
145613891|NCT01051063|525101013|FG001|Overall Study|Moved from the study site area|0|||
145613892|NCT01051063|525101012|FG000|Overall Study|Other|1|||
145613893|NCT01051063|525101013|FG001|Overall Study|Other|0|||
145613894|NCT01051063|525101012|FG000|Overall Study|Lost to Follow-up|0|||
145613895|NCT01051063|525101013|FG001|Overall Study|Lost to Follow-up|1|||
145613896|NCT00874432|525101016|FG000|Overall Study|Withdrawal by Subject|1|||
145613897|NCT00874432|525101017|FG001|Overall Study|Withdrawal by Subject|0|||
145613898|NCT00874432|525101018|FG002|Overall Study|Withdrawal by Subject|0|||
145613899|NCT00874432|525101019|FG003|Overall Study|Withdrawal by Subject|0|||
145613900|NCT00874432|525101016|FG000|Overall Study|Physician Decision|1|||
145613901|NCT00874432|525101017|FG001|Overall Study|Physician Decision|0|||
145613902|NCT00874432|525101018|FG002|Overall Study|Physician Decision|0|||
145613903|NCT00874432|525101019|FG003|Overall Study|Physician Decision|0|||
145613904|NCT00874432|525101016|FG000|Overall Study|Other|1|||
145613905|NCT00874432|525101017|FG001|Overall Study|Other|2|||
145613906|NCT00874432|525101018|FG002|Overall Study|Other|8|||
145613907|NCT00874432|525101019|FG003|Overall Study|Other|3|||
145613908|NCT03713021|525101020|FG000|Overall Study|Did not have CT sim scan available|6|||
145613909|NCT03713021|525101020|FG000|Overall Study|Not eligible|4|||
145613910|NCT03713021|525101020|FG000|Overall Study|Issues with TraceIT markers|5|||
145613911|NCT05256381|525101021|FG000|Overall Study|Withdrawal by Subject|4|||
145613912|NCT05256381|525101022|FG001|Overall Study|Withdrawal by Subject|0|||
145613913|NCT05256381|525101023|FG002|Overall Study|Withdrawal by Subject|2|||
145613914|NCT05256381|525101024|FG003|Overall Study|Withdrawal by Subject|2|||
145613915|NCT05256381|525101025|FG004|Overall Study|Withdrawal by Subject|8|||
145613916|NCT05256381|525101026|FG005|Overall Study|Withdrawal by Subject|6|||
145613917|NCT05256381|525101021|FG000|Overall Study|Physician Decision|0|||
145613918|NCT05256381|525101022|FG001|Overall Study|Physician Decision|0|||
145613919|NCT05256381|525101023|FG002|Overall Study|Physician Decision|1|||
145613920|NCT05256381|525101024|FG003|Overall Study|Physician Decision|0|||
145613921|NCT05256381|525101025|FG004|Overall Study|Physician Decision|2|||
145613922|NCT05256381|525101026|FG005|Overall Study|Physician Decision|0|||
145613923|NCT05256381|525101021|FG000|Overall Study|Death|17|||
145613924|NCT05256381|525101022|FG001|Overall Study|Death|3|||
145613925|NCT05256381|525101023|FG002|Overall Study|Death|4|||
145613926|NCT05256381|525101024|FG003|Overall Study|Death|5|||
145613927|NCT05256381|525101025|FG004|Overall Study|Death|24|||
145613928|NCT05256381|525101026|FG005|Overall Study|Death|21|||
145613929|NCT05256381|525101021|FG000|Overall Study|Other, not specified|0|||
145613930|NCT05256381|525101022|FG001|Overall Study|Other, not specified|0|||
145613931|NCT05256381|525101023|FG002|Overall Study|Other, not specified|0|||
145613932|NCT05256381|525101024|FG003|Overall Study|Other, not specified|0|||
145613933|NCT05256381|525101025|FG004|Overall Study|Other, not specified|2|||
145613934|NCT05256381|525101026|FG005|Overall Study|Other, not specified|1|||
145613935|NCT05256381|525101021|FG000|Overall Study|Study terminated by sponsor|18|||
145613936|NCT05256381|525101022|FG001|Overall Study|Study terminated by sponsor|5|||
145613937|NCT05256381|525101023|FG002|Overall Study|Study terminated by sponsor|5|||
145613938|NCT05256381|525101024|FG003|Overall Study|Study terminated by sponsor|5|||
145613939|NCT05256381|525101025|FG004|Overall Study|Study terminated by sponsor|18|||
145613940|NCT05256381|525101026|FG005|Overall Study|Study terminated by sponsor|11|||
145613941|NCT05256381|525101021|FG000|Overall Study|Lost to Follow-up|1|||
145613942|NCT05256381|525101022|FG001|Overall Study|Lost to Follow-up|0|||
145613943|NCT05256381|525101023|FG002|Overall Study|Lost to Follow-up|0|||
145613944|NCT05256381|525101024|FG003|Overall Study|Lost to Follow-up|0|||
145613945|NCT05256381|525101025|FG004|Overall Study|Lost to Follow-up|1|||
145613946|NCT05256381|525101026|FG005|Overall Study|Lost to Follow-up|0|||
145613947|NCT06017999|525102278|FG000|Overall Study|Withdrawal by Subject|0|||
145613948|NCT06017999|525102279|FG001|Overall Study|Withdrawal by Subject|4|||
145613949|NCT06017999|525102280|FG002|Overall Study|Withdrawal by Subject|3|||
145613950|NCT06017999|525102278|FG000|Overall Study|Adverse Event|2|||
145613951|NCT06017999|525102279|FG001|Overall Study|Adverse Event|1|||
145613952|NCT06017999|525102280|FG002|Overall Study|Adverse Event|1|||
145613953|NCT06017999|525102278|FG000|Overall Study|Lost to Follow-up|0|||
145613954|NCT06017999|525102279|FG001|Overall Study|Lost to Follow-up|0|||
145288017|NCT01338636|523904438|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
145288018|NCT02385526|523904439|FG000|Overall Study|Withdrawal by Subject|0|||
145613955|NCT06017999|525102280|FG002|Overall Study|Lost to Follow-up|1|||
145613956|NCT06017999|525102278|FG000|Overall Study|Physician Decision|1|||
145613957|NCT06017999|525102279|FG001|Overall Study|Physician Decision|1|||
145613958|NCT06017999|525102280|FG002|Overall Study|Physician Decision|0|||
145613959|NCT06017999|525102278|FG000|Overall Study|Non-Compliance|0|||
145613960|NCT06017999|525102279|FG001|Overall Study|Non-Compliance|0|||
145613961|NCT06017999|525102280|FG002|Overall Study|Non-Compliance|1|||
145613962|NCT06017999|525102278|FG000|Overall Study|Lack of Efficacy|1|||
145613963|NCT06017999|525102279|FG001|Overall Study|Lack of Efficacy|0|||
145613964|NCT06017999|525102280|FG002|Overall Study|Lack of Efficacy|7|||
145613965|NCT06017999|525102278|FG000|Overall Study|COVID Positive|0|||
145288019|NCT02385526|523904440|FG001|Overall Study|Withdrawal by Subject|2|||
145613966|NCT06017999|525102279|FG001|Overall Study|COVID Positive|1|||
145613967|NCT06017999|525102280|FG002|Overall Study|COVID Positive|0|||
145613968|NCT06017999|525102278|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
145613969|NCT06017999|525102279|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
145613970|NCT06017999|525102280|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
145613971|NCT04338581|525102281|FG000|Overall Study|Lack of Efficacy|1|||
145613972|NCT04338581|525102282|FG001|Overall Study|Lack of Efficacy|0|||
145613973|NCT04338581|525102281|FG000|Overall Study|Withdrawal by Subject|4|||
145613974|NCT04338581|525102282|FG001|Overall Study|Withdrawal by Subject|4|||
145613975|NCT04338581|525102281|FG000|Overall Study|Prohibited Medication|1|||
145613976|NCT04338581|525102282|FG001|Overall Study|Prohibited Medication|0|||
145613977|NCT01757665|525102283|FG000|Overall Study|Still on Study - Visit Completed|240|||
145613978|NCT01757665|525102284|FG001|Overall Study|Still on Study - Visit Completed|30|||
145613979|NCT01757665|525102283|FG000|Overall Study|Still on Study - Visit Pending|398|||
145613980|NCT01757665|525102284|FG001|Overall Study|Still on Study - Visit Pending|40|||
145613981|NCT01757665|525102283|FG000|Overall Study|Still on Study - Missed Visit|14|||
145613982|NCT01757665|525102284|FG001|Overall Study|Still on Study - Missed Visit|1|||
145613983|NCT01757665|525102283|FG000|Overall Study|Death|25|||
145613984|NCT01757665|525102284|FG001|Overall Study|Death|8|||
145613985|NCT01757665|525102283|FG000|Overall Study|Explant|1|||
145613986|NCT01757665|525102284|FG001|Overall Study|Explant|2|||
145613987|NCT01757665|525102283|FG000|Overall Study|Withdrawal by Subject|10|||
145613988|NCT01757665|525102284|FG001|Overall Study|Withdrawal by Subject|0|||
145613989|NCT01757665|525102283|FG000|Overall Study|Lost to Follow-up|1|||
145613990|NCT01757665|525102284|FG001|Overall Study|Lost to Follow-up|1|||
145613991|NCT01757665|525102283|FG000|Overall Study|Not Implanted with Device|5|||
145613992|NCT01757665|525102284|FG001|Overall Study|Not Implanted with Device|1|||
145613993|NCT02572817|525102289|FG000|Overall Study|Death|6|||
145613994|NCT02572817|525102290|FG001|Overall Study|Death|3|||
145613995|NCT02572817|525102289|FG000|Overall Study|Lost to Follow-up|3|||
145613996|NCT02572817|525102290|FG001|Overall Study|Lost to Follow-up|3|||
145613997|NCT01394250|525102291|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
145613998|NCT01394250|525102292|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
145613999|NCT01394250|525102291|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
145614000|NCT01394250|525102292|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
145614001|NCT02310126|525102293|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
145614002|NCT02310126|525102294|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
145614003|NCT02310126|525102293|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
145614004|NCT02310126|525102294|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
145614005|NCT02222896|525102298|FG000|Abdomen|Did not qualify|34|||
145614006|NCT02222896|525102299|FG001|Abdomen|Did not qualify|10|||
145614007|NCT02222896|525102300|FG002|Abdomen|Did not qualify|32|||
145614008|NCT02222896|525102298|FG000|Groin|Did not qualify|43|||
145614009|NCT02222896|525102299|FG001|Groin|Did not qualify|9|||
145614010|NCT02222896|525102300|FG002|Groin|Did not qualify|40|||
145614011|NCT02441946|525102301|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
145614012|NCT02441946|525102302|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
145614013|NCT02441946|525102303|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
145614014|NCT02441946|525102301|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
145614015|NCT02441946|525102302|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
145614016|NCT02441946|525102303|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
145614017|NCT02441946|525102301|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145614018|NCT02441946|525102302|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
145614019|NCT02441946|525102303|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145614020|NCT02441946|525102301|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
145614021|NCT02441946|525102302|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
145614022|NCT02441946|525102303|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
145614023|NCT02441946|525102301|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
145614024|NCT02441946|525102302|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
145614025|NCT02441946|525102303|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
145614026|NCT02441946|525102301|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
145614027|NCT02441946|525102302|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
145614028|NCT02441946|525102303|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
145614029|NCT02441946|525102301|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
145614030|NCT02441946|525102302|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
145614031|NCT02441946|525102303|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
145614032|NCT02441946|525102301|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
145614033|NCT02441946|525102302|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
145614034|NCT02441946|525102303|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
145614035|NCT02441946|525102301|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
145614036|NCT02441946|525102302|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
145614037|NCT02441946|525102303|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
145614038|NCT02441946|525102301|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
145614039|NCT02441946|525102302|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
145614040|NCT02441946|525102303|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
145614041|NCT02441946|525102301|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
145614042|NCT02441946|525102302|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145614043|NCT02441946|525102303|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
145614044|NCT04422639|525102308|FG000|Overall Study|Death|1|||
145614045|NCT04422639|525102309|FG001|Overall Study|Death|0|||
145614046|NCT04422639|525102308|FG000|Overall Study|study closed prior to completion of FU visits|0|||
145614047|NCT04422639|525102309|FG001|Overall Study|study closed prior to completion of FU visits|2|||
145614048|NCT01964521|525102310|FG000|Overall Study|Lost to Follow-up|4|||
145614049|NCT04267614|525102311|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
145614050|NCT04267614|525102311|FG000|Overall Study|Lost to Follow-up|115|||
145614051|NCT01463293|525102312|FG000|Overall Study|Lost to Follow-up|1|||
145614052|NCT01463293|525102313|FG001|Overall Study|Lost to Follow-up|4|||
145614053|NCT01463293|525102314|FG002|Overall Study|Lost to Follow-up|5|||
145614054|NCT01463293|525102312|FG000|Overall Study|Adverse Event|1|||
145614055|NCT01463293|525102313|FG001|Overall Study|Adverse Event|2|||
145614056|NCT01463293|525102314|FG002|Overall Study|Adverse Event|0|||
145614057|NCT01463293|525102312|FG000|Overall Study|Withdrawal by Subject|4|||
145614058|NCT01463293|525102313|FG001|Overall Study|Withdrawal by Subject|10|||
145614059|NCT01463293|525102314|FG002|Overall Study|Withdrawal by Subject|5|||
145614060|NCT01463293|525102312|FG000|Overall Study|Other|0|||
145614061|NCT01463293|525102313|FG001|Overall Study|Other|0|||
145614062|NCT01463293|525102314|FG002|Overall Study|Other|2|||
145614063|NCT00119262|525102318|FG000|Overall Study|Lack of Efficacy|0|||
145614064|NCT00119262|525102319|FG001|Overall Study|Lack of Efficacy|3|||
145614065|NCT00119262|525102318|FG000|Overall Study|Withdrawal by Subject|12|||
145614066|NCT00119262|525102319|FG001|Overall Study|Withdrawal by Subject|11|||
145614067|NCT00119262|525102318|FG000|Overall Study|Adverse Event|33|||
145614068|NCT00119262|525102319|FG001|Overall Study|Adverse Event|35|||
145614069|NCT00119262|525102318|FG000|Overall Study|other disease|0|||
145614070|NCT00119262|525102319|FG001|Overall Study|other disease|2|||
145614071|NCT00119262|525102318|FG000|Overall Study|ineligble|1|||
145614072|NCT00119262|525102319|FG001|Overall Study|ineligble|2|||
145614073|NCT00119262|525102318|FG000|Overall Study|others|0|||
145614074|NCT00119262|525102319|FG001|Overall Study|others|5|||
145614075|NCT03853317|525102320|FG000|Overall Study|Progressive Disease|5|||
145614076|NCT03853317|525102320|FG000|Overall Study|Adverse Event|1|||
145614077|NCT03853317|525102320|FG000|Overall Study|Death|1|||
145614078|NCT03853317|525102320|FG000|Overall Study|other event|2|||
145614079|NCT00779584|525102325|FG000|Overall Study|Protocol Violation|0|||
145614080|NCT00779584|525102326|FG001|Overall Study|Protocol Violation|0|||
145614081|NCT00779584|525102327|FG002|Overall Study|Protocol Violation|0|||
145614082|NCT00779584|525102328|FG003|Overall Study|Protocol Violation|0|||
145614083|NCT00779584|525102329|FG004|Overall Study|Protocol Violation|0|||
145614084|NCT00779584|525102330|FG005|Overall Study|Protocol Violation|1|||
145614085|NCT00779584|525102331|FG006|Overall Study|Protocol Violation|0|||
145614086|NCT00779584|525102332|FG007|Overall Study|Protocol Violation|0|||
145614087|NCT00779584|525102333|FG008|Overall Study|Protocol Violation|0|||
145614088|NCT00779584|525102325|FG000|Overall Study|Withdrawal by Subject|1|||
145614089|NCT00779584|525102326|FG001|Overall Study|Withdrawal by Subject|1|||
145614090|NCT00779584|525102327|FG002|Overall Study|Withdrawal by Subject|2|||
145614091|NCT00779584|525102328|FG003|Overall Study|Withdrawal by Subject|0|||
145614092|NCT00779584|525102329|FG004|Overall Study|Withdrawal by Subject|0|||
145614093|NCT00779584|525102330|FG005|Overall Study|Withdrawal by Subject|2|||
145614094|NCT00779584|525102331|FG006|Overall Study|Withdrawal by Subject|1|||
145614095|NCT00779584|525102332|FG007|Overall Study|Withdrawal by Subject|0|||
145614096|NCT00779584|525102333|FG008|Overall Study|Withdrawal by Subject|0|||
145614097|NCT00779584|525102325|FG000|Overall Study|Lost to Follow-up|0|||
145614098|NCT00779584|525102326|FG001|Overall Study|Lost to Follow-up|0|||
145614099|NCT00779584|525102327|FG002|Overall Study|Lost to Follow-up|0|||
145614100|NCT00779584|525102328|FG003|Overall Study|Lost to Follow-up|0|||
145614101|NCT00779584|525102329|FG004|Overall Study|Lost to Follow-up|1|||
145614102|NCT00779584|525102330|FG005|Overall Study|Lost to Follow-up|0|||
145614103|NCT00779584|525102331|FG006|Overall Study|Lost to Follow-up|0|||
145614104|NCT00779584|525102332|FG007|Overall Study|Lost to Follow-up|0|||
145614105|NCT00779584|525102333|FG008|Overall Study|Lost to Follow-up|0|||
145614106|NCT00779584|525102325|FG000|Overall Study|Progression of Disease|0|||
145614107|NCT00779584|525102326|FG001|Overall Study|Progression of Disease|1|||
145614108|NCT00779584|525102327|FG002|Overall Study|Progression of Disease|2|||
145614109|NCT00779584|525102328|FG003|Overall Study|Progression of Disease|6|||
145614110|NCT00779584|525102329|FG004|Overall Study|Progression of Disease|5|||
145614111|NCT00779584|525102330|FG005|Overall Study|Progression of Disease|1|||
145614112|NCT00779584|525102331|FG006|Overall Study|Progression of Disease|4|||
145614113|NCT00779584|525102332|FG007|Overall Study|Progression of Disease|2|||
145614114|NCT00779584|525102333|FG008|Overall Study|Progression of Disease|1|||
145614115|NCT00779584|525102325|FG000|Overall Study|Adverse Event|1|||
145614116|NCT00779584|525102326|FG001|Overall Study|Adverse Event|0|||
145614117|NCT00779584|525102327|FG002|Overall Study|Adverse Event|2|||
145614118|NCT00779584|525102328|FG003|Overall Study|Adverse Event|0|||
145614119|NCT00779584|525102329|FG004|Overall Study|Adverse Event|0|||
145614120|NCT00779584|525102330|FG005|Overall Study|Adverse Event|0|||
145614121|NCT00779584|525102331|FG006|Overall Study|Adverse Event|2|||
145614122|NCT00779584|525102332|FG007|Overall Study|Adverse Event|1|||
145614123|NCT00779584|525102333|FG008|Overall Study|Adverse Event|1|||
145614124|NCT00779584|525102325|FG000|Overall Study|Symptomatic Deterioration|1|||
145614125|NCT00779584|525102326|FG001|Overall Study|Symptomatic Deterioration|1|||
145614126|NCT00779584|525102327|FG002|Overall Study|Symptomatic Deterioration|1|||
145614127|NCT00779584|525102328|FG003|Overall Study|Symptomatic Deterioration|0|||
145614128|NCT00779584|525102329|FG004|Overall Study|Symptomatic Deterioration|0|||
145614129|NCT00779584|525102330|FG005|Overall Study|Symptomatic Deterioration|1|||
145614130|NCT00779584|525102331|FG006|Overall Study|Symptomatic Deterioration|1|||
145614131|NCT00779584|525102332|FG007|Overall Study|Symptomatic Deterioration|0|||
145614132|NCT00779584|525102333|FG008|Overall Study|Symptomatic Deterioration|0|||
145614133|NCT00779584|525102325|FG000|Overall Study|Ongoing in Study|0|||
145614134|NCT00779584|525102326|FG001|Overall Study|Ongoing in Study|0|||
145614135|NCT00779584|525102327|FG002|Overall Study|Ongoing in Study|0|||
145614136|NCT00779584|525102328|FG003|Overall Study|Ongoing in Study|0|||
145614137|NCT00779584|525102329|FG004|Overall Study|Ongoing in Study|1|||
145614138|NCT00779584|525102330|FG005|Overall Study|Ongoing in Study|1|||
145614139|NCT00779584|525102331|FG006|Overall Study|Ongoing in Study|0|||
145614140|NCT00779584|525102332|FG007|Overall Study|Ongoing in Study|0|||
145614141|NCT00779584|525102333|FG008|Overall Study|Ongoing in Study|0|||
145614142|NCT03632434|525102336|FG000|Overall Study|Withdrawal by Subject|2|||
145614143|NCT00786474|525102340|FG000|Overall Study|Death|5|||
145614144|NCT00786474|525102341|FG001|Overall Study|Death|4|||
145614145|NCT00786474|525102340|FG000|Overall Study|Withdrawal by Subject|23|||
145614146|NCT00786474|525102341|FG001|Overall Study|Withdrawal by Subject|31|||
145614147|NCT00786474|525102340|FG000|Overall Study|Lost to Follow-up|3|||
145614148|NCT00786474|525102341|FG001|Overall Study|Lost to Follow-up|3|||
145614149|NCT00786474|525102340|FG000|Overall Study|Physician Decision|2|||
145614150|NCT00786474|525102341|FG001|Overall Study|Physician Decision|1|||
145614151|NCT00786474|525102340|FG000|Overall Study|Other|4|||
145614152|NCT00786474|525102341|FG001|Overall Study|Other|4|||
145614153|NCT01868074|525102342|FG000|Overall Study|Lost to Follow-up|3|||
145614154|NCT01868074|525102343|FG001|Overall Study|Lost to Follow-up|2|||
145614155|NCT01868074|525102342|FG000|Overall Study|Withdrawal by Subject|4|||
145614156|NCT01868074|525102343|FG001|Overall Study|Withdrawal by Subject|2|||
145614157|NCT03904693|525102348|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
145614158|NCT03904693|525102349|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
145614159|NCT03904693|525102350|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
145614160|NCT03904693|525102351|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
145614161|NCT03904693|525102352|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
145614162|NCT03904693|525102353|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
145614163|NCT03904693|525102348|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145614164|NCT03904693|525102349|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145614165|NCT03904693|525102350|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
145614166|NCT03904693|525102351|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145614167|NCT03904693|525102352|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145614168|NCT03904693|525102353|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
145614169|NCT03904693|525102348|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145614170|NCT03904693|525102349|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
145614171|NCT03904693|525102350|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
145614172|NCT03904693|525102351|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145614173|NCT03904693|525102352|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145614174|NCT03904693|525102353|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
145614175|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
145614176|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
145614177|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
145614178|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
145614179|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
145614180|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
145614181|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
145614182|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
145614183|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
145614184|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
145614185|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
145614186|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
145614187|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
145614188|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
145614189|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
145614190|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
145614191|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
145288020|NCT02385526|523904441|FG002|Overall Study|Withdrawal by Subject|0|||
145288021|NCT02385526|523904439|FG000|Overall Study|Lost to Follow-up|0|||
145288022|NCT02385526|523904440|FG001|Overall Study|Lost to Follow-up|1|||
145288023|NCT02385526|523904441|FG002|Overall Study|Lost to Follow-up|0|||
145288024|NCT02385526|523904439|FG000|Overall Study|Physician Decision|1|||
145288025|NCT02385526|523904440|FG001|Overall Study|Physician Decision|0|||
145288026|NCT02385526|523904441|FG002|Overall Study|Physician Decision|0|||
145288027|NCT02385526|523904439|FG000|Overall Study|Protocol Violation|1|||
145288028|NCT02385526|523904440|FG001|Overall Study|Protocol Violation|0|||
145288029|NCT02385526|523904441|FG002|Overall Study|Protocol Violation|0|||
145288030|NCT03532009|523904444|FG000|Overall Study|Other|1|||
145288031|NCT03532009|523904445|FG001|Overall Study|Other|1|||
145288032|NCT03532009|523904444|FG000|Overall Study|Death|1|||
145288033|NCT03532009|523904445|FG001|Overall Study|Death|1|||
145288034|NCT03532009|523904444|FG000|Overall Study|Withdrawal by Patient|0|||
145288035|NCT03532009|523904445|FG001|Overall Study|Withdrawal by Patient|2|||
145288036|NCT01694485|523904450|FG000|Overall Study|Withdrawal by Subject|20|||
145288037|NCT01694485|523904451|FG001|Overall Study|Withdrawal by Subject|6|||
145288038|NCT01694485|523904452|FG002|Overall Study|Withdrawal by Subject|7|||
145288039|NCT01694485|523904453|FG003|Overall Study|Withdrawal by Subject|25|||
145288040|NCT01694485|523904454|FG004|Overall Study|Withdrawal by Subject|18|||
145288041|NCT01694485|523904450|FG000|Overall Study|Sponsor Decision|3|||
145288042|NCT01694485|523904451|FG001|Overall Study|Sponsor Decision|0|||
145288043|NCT01694485|523904452|FG002|Overall Study|Sponsor Decision|0|||
145288044|NCT01694485|523904453|FG003|Overall Study|Sponsor Decision|2|||
145288045|NCT01694485|523904454|FG004|Overall Study|Sponsor Decision|0|||
145288046|NCT01694485|523904450|FG000|Overall Study|Lost to Follow-up|9|||
145288047|NCT01694485|523904451|FG001|Overall Study|Lost to Follow-up|1|||
145288048|NCT01694485|523904452|FG002|Overall Study|Lost to Follow-up|6|||
145288049|NCT01694485|523904453|FG003|Overall Study|Lost to Follow-up|10|||
145288050|NCT01694485|523904454|FG004|Overall Study|Lost to Follow-up|7|||
145288051|NCT01694485|523904450|FG000|Overall Study|Death|1|||
145288052|NCT01694485|523904451|FG001|Overall Study|Death|0|||
145288053|NCT01694485|523904452|FG002|Overall Study|Death|0|||
145288054|NCT01694485|523904453|FG003|Overall Study|Death|1|||
145288055|NCT01694485|523904454|FG004|Overall Study|Death|0|||
145288056|NCT02907203|523904455|FG000|Overall Study|Death|1|||
145288057|NCT02907203|523904455|FG000|Overall Study|Lost to Follow-up|3|||
145288058|NCT02907203|523904455|FG000|Overall Study|Withdrawal by Subject|3|||
145288059|NCT02907203|523904455|FG000|Overall Study|Surgical bypass|1|||
145288060|NCT00681863|523904457|FG000|Overall Study|Adverse Event|1|||
145288061|NCT00681863|523904457|FG000|Overall Study|Lost to Follow-up|2|||
145556065|NCT02659631|524894945|FG004|Overall Study|Death (treatment phase)|1|||
145556066|NCT02659631|524894946|FG005|Overall Study|Death (treatment phase)|0|||
145556067|NCT02659631|524894947|FG006|Overall Study|Death (treatment phase)|1|||
145556068|NCT02659631|524894948|FG007|Overall Study|Death (treatment phase)|0|||
145556069|NCT02659631|524894949|FG008|Overall Study|Death (treatment phase)|0|||
145556070|NCT02659631|524894950|FG009|Overall Study|Death (treatment phase)|0|||
145556071|NCT04191499|524894951|FG000|Overall Study|Adverse Event|1|||
145556072|NCT04191499|524894952|FG001|Overall Study|Adverse Event|0|||
145556073|NCT04191499|524894951|FG000|Overall Study|Death|42|||
145556074|NCT04191499|524894952|FG001|Overall Study|Death|55|||
145556075|NCT04191499|524894951|FG000|Overall Study|Lost to Follow-up|4|||
145556076|NCT04191499|524894952|FG001|Overall Study|Lost to Follow-up|1|||
145556077|NCT04191499|524894951|FG000|Overall Study|Physician Decision|1|||
145556078|NCT04191499|524894952|FG001|Overall Study|Physician Decision|0|||
145556079|NCT04191499|524894951|FG000|Overall Study|Progressive Disease|1|||
145556080|NCT04191499|524894952|FG001|Overall Study|Progressive Disease|0|||
145556081|NCT04191499|524894951|FG000|Overall Study|Symptomatic Deterioration|1|||
145556082|NCT04191499|524894952|FG001|Overall Study|Symptomatic Deterioration|0|||
145556083|NCT04191499|524894951|FG000|Overall Study|Withdrawal by Subject|7|||
145556084|NCT04191499|524894952|FG001|Overall Study|Withdrawal by Subject|11|||
145556085|NCT04191499|524894951|FG000|Overall Study|Ongoing in the study|104|||
145556086|NCT04191499|524894952|FG001|Overall Study|Ongoing in the study|97|||
145556087|NCT00680745|524894953|FG000|Overall Study|Withdrawal by Subject|8|||
145288062|NCT00681863|523904457|FG000|Overall Study|Lack of Efficacy|2|||
145288063|NCT00681863|523904457|FG000|Overall Study|Other|18|||
145288064|NCT00384033|523904467|FG000|Overall Study|Adverse Event|10|||
145288065|NCT00384033|523904468|FG001|Overall Study|Adverse Event|8|||
145288066|NCT00384033|523904469|FG002|Overall Study|Adverse Event|11|||
145288067|NCT00384033|523904470|FG003|Overall Study|Adverse Event|20|||
145288068|NCT00384033|523904467|FG000|Overall Study|Failed to return|1|||
145288069|NCT00384033|523904468|FG001|Overall Study|Failed to return|3|||
145556088|NCT00680745|524894954|FG001|Overall Study|Withdrawal by Subject|3|||
145556089|NCT00680745|524894955|FG002|Overall Study|Withdrawal by Subject|2|||
145556090|NCT00680745|524894956|FG003|Overall Study|Withdrawal by Subject|8|||
145288070|NCT00384033|523904469|FG002|Overall Study|Failed to return|2|||
145288071|NCT00384033|523904470|FG003|Overall Study|Failed to return|2|||
145288072|NCT00384033|523904467|FG000|Overall Study|Physician Decision|1|||
145288073|NCT00384033|523904468|FG001|Overall Study|Physician Decision|0|||
145614192|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
145614193|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
145614194|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
145614195|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
145614196|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
145614197|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
145614198|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
145614199|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
145614200|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
145614201|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
145614202|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
145614203|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
145614204|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
145614205|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
145614206|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
145614207|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
145614208|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
145614209|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
145614210|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
145614211|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
145614212|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
145614213|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
145614214|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
145614215|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
145614216|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
145614217|NCT03904693|525102348|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
145614218|NCT03904693|525102349|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
145614219|NCT03904693|525102350|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
145614220|NCT03904693|525102351|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
145614221|NCT03904693|525102352|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
145614222|NCT03904693|525102353|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
145614223|NCT04175912|525102354|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
145614224|NCT04175912|525102355|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
145614225|NCT04175912|525102354|FG000|Overall Study|Adverse Event|0|||
145614226|NCT04175912|525102355|FG001|Overall Study|Adverse Event|3|||
145614227|NCT04175912|525102354|FG000|Overall Study|Never started treatment|3|||
145614228|NCT04175912|525102355|FG001|Overall Study|Never started treatment|3|||
145614229|NCT04175912|525102354|FG000|Overall Study|Death|0|||
145614230|NCT04175912|525102355|FG001|Overall Study|Death|1|||
145614231|NCT06390826|525102356|FG000|Overall Study|Never Start Protocol Therapy|1|||
145614232|NCT06390826|525102356|FG000|Overall Study|Adverse Event|1|||
145614233|NCT06390826|525102356|FG000|Overall Study|Disease Progression|8|||
145614234|NCT02303626|525102359|FG000|Overall Study|Lack of Efficacy|1|||
145614235|NCT02303626|525102360|FG001|Overall Study|Lack of Efficacy|0|||
145614236|NCT02303626|525102361|FG002|Overall Study|Lack of Efficacy|1|||
145614237|NCT02303626|525102359|FG000|Overall Study|Adverse Event|0|||
145614238|NCT02303626|525102360|FG001|Overall Study|Adverse Event|2|||
145614239|NCT02303626|525102361|FG002|Overall Study|Adverse Event|0|||
145614240|NCT02303626|525102359|FG000|Overall Study|Protocol Violation|0|||
145614241|NCT02303626|525102360|FG001|Overall Study|Protocol Violation|1|||
145614242|NCT02303626|525102361|FG002|Overall Study|Protocol Violation|0|||
145614243|NCT02303626|525102359|FG000|Overall Study|Pregnancy|0|||
145614244|NCT02303626|525102360|FG001|Overall Study|Pregnancy|0|||
145614245|NCT02303626|525102361|FG002|Overall Study|Pregnancy|1|||
145614246|NCT02303626|525102359|FG000|Overall Study|Subject Non-Compliance|0|||
145614247|NCT02303626|525102360|FG001|Overall Study|Subject Non-Compliance|0|||
145614248|NCT02303626|525102361|FG002|Overall Study|Subject Non-Compliance|1|||
145614249|NCT03698019|525102362|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
145614250|NCT03698019|525102363|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
145614251|NCT03698019|525102362|FG000|Step 1: Registration|Withdrawal by Subject|7|||
145288074|NCT00384033|523904469|FG002|Overall Study|Physician Decision|0|||
145614252|NCT03698019|525102363|FG001|Step 1: Registration|Withdrawal by Subject|2|||
145614253|NCT03698019|525102362|FG000|Step 1: Registration|Toxicity|0|||
145614254|NCT03698019|525102363|FG001|Step 1: Registration|Toxicity|1|||
145614255|NCT03698019|525102362|FG000|Step 1: Registration|Disease Progression|0|||
145614256|NCT03698019|525102363|FG001|Step 1: Registration|Disease Progression|12|||
145288075|NCT00384033|523904470|FG003|Overall Study|Physician Decision|0|||
145288076|NCT00384033|523904467|FG000|Overall Study|Lost to Follow-up|6|||
145614257|NCT03698019|525102362|FG000|Step 1: Registration|Co-morbidities|0|||
145614258|NCT03698019|525102363|FG001|Step 1: Registration|Co-morbidities|1|||
145614259|NCT03698019|525102362|FG000|Step 1: Registration|Scheduling Issues|1|||
145614260|NCT03698019|525102363|FG001|Step 1: Registration|Scheduling Issues|0|||
145614261|NCT03698019|525102362|FG000|Step 1: Registration|Participant Refusal|0|||
145614262|NCT03698019|525102363|FG001|Step 1: Registration|Participant Refusal|1|||
145614263|NCT03698019|525102362|FG000|Step 2: Surgery|Participant Refusal|2|||
145614264|NCT03698019|525102363|FG001|Step 2: Surgery|Participant Refusal|1|||
145288077|NCT00384033|523904468|FG001|Overall Study|Lost to Follow-up|12|||
145288078|NCT00384033|523904469|FG002|Overall Study|Lost to Follow-up|7|||
145288079|NCT00384033|523904470|FG003|Overall Study|Lost to Follow-up|7|||
145288080|NCT00384033|523904467|FG000|Overall Study|Other|2|||
145288081|NCT00384033|523904468|FG001|Overall Study|Other|0|||
145288082|NCT00384033|523904469|FG002|Overall Study|Other|0|||
145288083|NCT00384033|523904470|FG003|Overall Study|Other|0|||
145288084|NCT00384033|523904467|FG000|Overall Study|Protocol Violation|5|||
145288085|NCT00384033|523904468|FG001|Overall Study|Protocol Violation|0|||
145288086|NCT00384033|523904469|FG002|Overall Study|Protocol Violation|5|||
145288087|NCT00384033|523904470|FG003|Overall Study|Protocol Violation|6|||
145288088|NCT00384033|523904467|FG000|Overall Study|Withdrawal by Subject|6|||
145288089|NCT00384033|523904468|FG001|Overall Study|Withdrawal by Subject|2|||
145288090|NCT00384033|523904469|FG002|Overall Study|Withdrawal by Subject|5|||
145288091|NCT00384033|523904470|FG003|Overall Study|Withdrawal by Subject|2|||
145288092|NCT00384033|523904467|FG000|Overall Study|Lack of Efficacy|7|||
145288093|NCT00384033|523904468|FG001|Overall Study|Lack of Efficacy|3|||
145288094|NCT00384033|523904469|FG002|Overall Study|Lack of Efficacy|3|||
145288095|NCT00384033|523904470|FG003|Overall Study|Lack of Efficacy|1|||
145288096|NCT00384033|523904467|FG000|Overall Study|Randomized but not treated|3|||
145288097|NCT00384033|523904468|FG001|Overall Study|Randomized but not treated|7|||
145288098|NCT00384033|523904469|FG002|Overall Study|Randomized but not treated|10|||
145288099|NCT00384033|523904470|FG003|Overall Study|Randomized but not treated|2|||
145288100|NCT01006707|523904471|FG000|Study Session 1|Lost to Follow-up|2|||
145288101|NCT01006707|523904472|FG001|Study Session 1|Lost to Follow-up|0|||
145288102|NCT01006707|523904473|FG002|Study Session 1|Lost to Follow-up|0|||
145288103|NCT01006707|523904471|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
145288104|NCT01006707|523904472|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
145288105|NCT01006707|523904473|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
145288106|NCT00760383|523904474|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
145288107|NCT00760383|523904475|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
145288108|NCT01842958|523904476|FG000|Overall Study|Lost to Follow-up|1|||
145288109|NCT01842958|523904477|FG001|Overall Study|Lost to Follow-up|1|||
145288110|NCT03465891|523904479|FG000|Overall Study|Withdrawal by Subject|0|||
145288111|NCT03465891|523904480|FG001|Overall Study|Withdrawal by Subject|1|||
145288112|NCT03465891|523904479|FG000|Overall Study|Disease progression|1|||
145288113|NCT03465891|523904480|FG001|Overall Study|Disease progression|0|||
145288114|NCT02737306|523904482|FG000|Overall Study|Adverse Event|3|||
145288115|NCT02737306|523904483|FG001|Overall Study|Adverse Event|0|||
145288116|NCT02737306|523904482|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
145288117|NCT02737306|523904483|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
145288118|NCT03305055|523904484|FG000|Overall Study|Withdrawal by Subject|0|||
145288119|NCT03305055|523904485|FG001|Overall Study|Withdrawal by Subject|1|||
145288120|NCT03305055|523904484|FG000|Overall Study|Adverse Event|1|||
145288121|NCT03305055|523904485|FG001|Overall Study|Adverse Event|1|||
145288122|NCT03937466|523904486|FG000|Overall Study|not eligbile after the 2-week diary|9|||
145288123|NCT03937466|523904486|FG000|Overall Study|never returned their diary|6|||
145288124|NCT03937466|523904486|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
145288125|NCT03937466|523904486|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
145288126|NCT02540356|523904487|FG000|Overall Study|Terminated due to disease progression|1|||
145288127|NCT02540356|523904488|FG001|Overall Study|Terminated due to disease progression|0|||
145288128|NCT00283686|523904491|FG000|Overall Study|Death|1|||
145288129|NCT00283686|523904492|FG001|Overall Study|Death|1|||
145288130|NCT00283686|523904493|FG002|Overall Study|Death|1|||
145288131|NCT00283686|523904494|FG003|Overall Study|Death|0|||
145288132|NCT00283686|523904491|FG000|Overall Study|Lost to Follow-up|21|||
145288133|NCT00283686|523904492|FG001|Overall Study|Lost to Follow-up|31|||
145288134|NCT00283686|523904493|FG002|Overall Study|Lost to Follow-up|26|||
145288135|NCT00283686|523904494|FG003|Overall Study|Lost to Follow-up|20|||
145614265|NCT03698019|525102362|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
145614266|NCT03698019|525102363|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
145614267|NCT03698019|525102362|FG000|Step 2: Surgery|Metastatic Disease|16|||
145614268|NCT03698019|525102363|FG001|Step 2: Surgery|Metastatic Disease|9|||
145614269|NCT03698019|525102362|FG000|Step 2: Surgery|Residual Disease|2|||
145614270|NCT03698019|525102363|FG001|Step 2: Surgery|Residual Disease|1|||
145614271|NCT03698019|525102362|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
145614272|NCT03698019|525102363|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
145614273|NCT03698019|525102362|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
145614274|NCT03698019|525102363|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
145614275|NCT03698019|525102362|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
145614276|NCT03698019|525102363|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
145614277|NCT03698019|525102362|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
145614278|NCT03698019|525102363|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
145614279|NCT03698019|525102362|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
145614280|NCT03698019|525102363|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
145614281|NCT03698019|525102362|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
145614282|NCT03698019|525102363|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
145614283|NCT03698019|525102362|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
145614284|NCT03698019|525102363|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
145614285|NCT03698019|525102362|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
145614286|NCT03698019|525102363|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
145614287|NCT05376371|525102364|FG000|Overall Study|change in release date|10|||
145614288|NCT05407311|525102365|FG000|Overall Study|Withdrawal by Subject|5|||
145614289|NCT05407311|525102365|FG000|Overall Study|Protocol Violation|3|||
145614290|NCT05407311|525102365|FG000|Overall Study|Physician Decision|1|||
145614291|NCT05407311|525102365|FG000|Overall Study|Non-compliance|1|||
145614292|NCT05027074|525102370|FG000|Overall Study|Death|47|||
145614293|NCT05027074|525102371|FG001|Overall Study|Death|42|||
145614294|NCT05027074|525102372|FG002|Overall Study|Death|39|||
145614295|NCT05027074|525102370|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145614296|NCT05027074|525102371|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145614297|NCT05027074|525102372|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145614298|NCT05027074|525102370|FG000|Overall Study|Site Terminated By Sponsor|3|||
145614299|NCT05027074|525102371|FG001|Overall Study|Site Terminated By Sponsor|0|||
145614300|NCT05027074|525102372|FG002|Overall Study|Site Terminated By Sponsor|2|||
145614301|NCT05027074|525102370|FG000|Overall Study|Withdrawal by Subject|13|||
145614302|NCT05027074|525102371|FG001|Overall Study|Withdrawal by Subject|8|||
145614303|NCT05027074|525102372|FG002|Overall Study|Withdrawal by Subject|10|||
145614304|NCT05027074|525102370|FG000|Overall Study|Lost to Follow-up|2|||
145614305|NCT05027074|525102371|FG001|Overall Study|Lost to Follow-up|4|||
145614306|NCT05027074|525102372|FG002|Overall Study|Lost to Follow-up|3|||
145614307|NCT05027074|525102370|FG000|Overall Study|Status Not Recorded|0|||
145614308|NCT05027074|525102371|FG001|Overall Study|Status Not Recorded|0|||
145614309|NCT05027074|525102372|FG002|Overall Study|Status Not Recorded|1|||
145614310|NCT03797326|525102376|FG000|Overall Study|Lost to Follow-up|1|||
145614311|NCT03797326|525102377|FG001|Overall Study|Lost to Follow-up|0|||
145614312|NCT03797326|525102378|FG002|Overall Study|Lost to Follow-up|0|||
145614313|NCT03797326|525102379|FG003|Overall Study|Lost to Follow-up|1|||
145614314|NCT03797326|525102380|FG004|Overall Study|Lost to Follow-up|0|||
145614315|NCT03797326|525102381|FG005|Overall Study|Lost to Follow-up|0|||
145614316|NCT03797326|525102382|FG006|Overall Study|Lost to Follow-up|0|||
145614317|NCT03797326|525102383|FG007|Overall Study|Lost to Follow-up|0|||
145614318|NCT03797326|525102376|FG000|Overall Study|Withdrawal by Subject|0|||
145614319|NCT03797326|525102377|FG001|Overall Study|Withdrawal by Subject|0|||
145614320|NCT03797326|525102378|FG002|Overall Study|Withdrawal by Subject|1|||
145614321|NCT03797326|525102379|FG003|Overall Study|Withdrawal by Subject|3|||
145614322|NCT03797326|525102380|FG004|Overall Study|Withdrawal by Subject|0|||
145614323|NCT03797326|525102381|FG005|Overall Study|Withdrawal by Subject|2|||
145614324|NCT03797326|525102382|FG006|Overall Study|Withdrawal by Subject|2|||
145614325|NCT03797326|525102383|FG007|Overall Study|Withdrawal by Subject|3|||
145614326|NCT03797326|525102376|FG000|Overall Study|Sponsor Decision|3|||
145614327|NCT03797326|525102377|FG001|Overall Study|Sponsor Decision|3|||
145614328|NCT03797326|525102378|FG002|Overall Study|Sponsor Decision|3|||
145614329|NCT03797326|525102379|FG003|Overall Study|Sponsor Decision|6|||
145614330|NCT03797326|525102380|FG004|Overall Study|Sponsor Decision|0|||
145614331|NCT03797326|525102381|FG005|Overall Study|Sponsor Decision|3|||
145614332|NCT03797326|525102382|FG006|Overall Study|Sponsor Decision|3|||
145614333|NCT03797326|525102383|FG007|Overall Study|Sponsor Decision|2|||
145614334|NCT03797326|525102376|FG000|Overall Study|Death|27|||
145614335|NCT03797326|525102377|FG001|Overall Study|Death|28|||
145614336|NCT03797326|525102378|FG002|Overall Study|Death|95|||
145614337|NCT03797326|525102379|FG003|Overall Study|Death|95|||
145614338|NCT03797326|525102380|FG004|Overall Study|Death|30|||
145614339|NCT03797326|525102381|FG005|Overall Study|Death|96|||
145614340|NCT03797326|525102382|FG006|Overall Study|Death|97|||
145614341|NCT03797326|525102383|FG007|Overall Study|Death|98|||
145614342|NCT03797326|525102376|FG000|Overall Study|Enrolled in error|0|||
145614343|NCT03797326|525102377|FG001|Overall Study|Enrolled in error|0|||
145614344|NCT03797326|525102378|FG002|Overall Study|Enrolled in error|3|||
145614345|NCT03797326|525102379|FG003|Overall Study|Enrolled in error|2|||
145614346|NCT03797326|525102380|FG004|Overall Study|Enrolled in error|2|||
145614347|NCT03797326|525102381|FG005|Overall Study|Enrolled in error|1|||
145614348|NCT03797326|525102382|FG006|Overall Study|Enrolled in error|1|||
145614349|NCT03797326|525102383|FG007|Overall Study|Enrolled in error|0|||
145614350|NCT04908449|525102384|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
145614351|NCT04908449|525102385|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
145614352|NCT04908449|525102384|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
145614353|NCT04908449|525102385|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
145614354|NCT00147225|525102386|FG000|Overall Study|Withdrawal by Subject|1|||
145614355|NCT00147225|525102387|FG001|Overall Study|Withdrawal by Subject|0|||
145614356|NCT00147225|525102388|FG002|Overall Study|Withdrawal by Subject|1|||
145614357|NCT00147225|525102389|FG003|Overall Study|Withdrawal by Subject|0|||
145614358|NCT00147225|525102390|FG004|Overall Study|Withdrawal by Subject|0|||
145614359|NCT00147225|525102391|FG005|Overall Study|Withdrawal by Subject|1|||
145614360|NCT00147225|525102386|FG000|Overall Study|Adverse Event|0|||
145614361|NCT00147225|525102387|FG001|Overall Study|Adverse Event|0|||
145614362|NCT00147225|525102388|FG002|Overall Study|Adverse Event|1|||
145614363|NCT00147225|525102389|FG003|Overall Study|Adverse Event|1|||
145614364|NCT00147225|525102390|FG004|Overall Study|Adverse Event|0|||
145614365|NCT00147225|525102391|FG005|Overall Study|Adverse Event|0|||
145614366|NCT00147225|525102386|FG000|Overall Study|Screen Failure|0|||
145614367|NCT00147225|525102387|FG001|Overall Study|Screen Failure|0|||
145614368|NCT00147225|525102388|FG002|Overall Study|Screen Failure|0|||
145614369|NCT00147225|525102389|FG003|Overall Study|Screen Failure|0|||
145614370|NCT00147225|525102390|FG004|Overall Study|Screen Failure|1|||
145614371|NCT00147225|525102391|FG005|Overall Study|Screen Failure|0|||
145614372|NCT00147225|525102386|FG000|Overall Study|Chemotherapy Changed|0|||
145614373|NCT00147225|525102387|FG001|Overall Study|Chemotherapy Changed|0|||
145614374|NCT00147225|525102388|FG002|Overall Study|Chemotherapy Changed|0|||
145614375|NCT00147225|525102389|FG003|Overall Study|Chemotherapy Changed|0|||
145614376|NCT00147225|525102390|FG004|Overall Study|Chemotherapy Changed|0|||
145614377|NCT00147225|525102391|FG005|Overall Study|Chemotherapy Changed|1|||
145614378|NCT01567865|525102392|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
145614379|NCT01567865|525102393|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
145614380|NCT01567865|525102394|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
145614381|NCT01567865|525102395|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
145614382|NCT01567865|525102392|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
145614383|NCT01567865|525102393|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
145614384|NCT01567865|525102394|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
145614385|NCT01567865|525102395|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
145614386|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
145614387|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
145614388|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
145614389|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
145614390|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
145614391|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
145614392|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
145614393|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
145614394|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
145614395|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
145288136|NCT00283686|523904491|FG000|Overall Study|Less than full participation|7|||
145614396|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
145614397|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
145614398|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
145614399|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
145614400|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
145614401|NCT02023879|525102396|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
145614402|NCT02023879|525102397|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
145614403|NCT02023879|525102398|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
145614404|NCT02023879|525102396|FG000|Extension Open Label Treatment|Adverse Event|1|||
145614405|NCT02023879|525102397|FG001|Extension Open Label Treatment|Adverse Event|7|||
145614406|NCT02023879|525102398|FG002|Extension Open Label Treatment|Adverse Event|3|||
145614407|NCT02023879|525102396|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
145614408|NCT02023879|525102397|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
145614409|NCT02023879|525102398|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
145614410|NCT02023879|525102396|FG000|Extension Open Label Treatment|Participant moved|1|||
145614411|NCT02023879|525102397|FG001|Extension Open Label Treatment|Participant moved|2|||
145614412|NCT02023879|525102398|FG002|Extension Open Label Treatment|Participant moved|0|||
145614413|NCT02023879|525102396|FG000|Extension Open Label Treatment|Other than specified above|2|||
145614414|NCT02023879|525102397|FG001|Extension Open Label Treatment|Other than specified above|7|||
145614415|NCT02023879|525102398|FG002|Extension Open Label Treatment|Other than specified above|2|||
145614416|NCT06385483|525102399|FG000|Overall Study|Withdrawal by Subject|2|||
145614417|NCT06385483|525102399|FG000|Overall Study|Never start protocol therapy|2|||
145614418|NCT06385483|525102399|FG000|Overall Study|Disease progression|15|||
145614419|NCT05569954|525102400|FG000|Overall Study|Lost to Follow-up|3|||
145614420|NCT05569954|525102401|FG001|Overall Study|Lost to Follow-up|4|||
145614421|NCT05569954|525102400|FG000|Overall Study|Protocol Violation|1|||
145614422|NCT05569954|525102401|FG001|Overall Study|Protocol Violation|2|||
145614423|NCT05569954|525102400|FG000|Overall Study|Withdrawal by Subject|4|||
145614424|NCT05569954|525102401|FG001|Overall Study|Withdrawal by Subject|2|||
145614425|NCT04213989|525103615|FG000|Overall Study|Withdrawal by Subject|3|||
145614426|NCT04213989|525103616|FG001|Overall Study|Withdrawal by Subject|2|||
145614427|NCT04213989|525103615|FG000|Overall Study|Physician Decision|1|||
145614428|NCT04213989|525103616|FG001|Overall Study|Physician Decision|0|||
145614429|NCT04213989|525103615|FG000|Overall Study|Lost to Follow-up|0|||
145614430|NCT04213989|525103616|FG001|Overall Study|Lost to Follow-up|4|||
145614431|NCT03390036|525103622|FG000|Overall Study|Lost to Follow-up|1|||
145614432|NCT03390036|525103623|FG001|Overall Study|Lost to Follow-up|0|||
145614433|NCT03390036|525103624|FG002|Overall Study|Lost to Follow-up|0|||
145614434|NCT03390036|525103622|FG000|Overall Study|Lack of Efficacy|1|||
145614435|NCT03390036|525103623|FG001|Overall Study|Lack of Efficacy|0|||
145614436|NCT03390036|525103624|FG002|Overall Study|Lack of Efficacy|0|||
145614437|NCT00744237|525103627|FG000|Overall Study|Lack of Efficacy|1|||
145614438|NCT00744237|525103628|FG001|Overall Study|Lack of Efficacy|1|||
145614439|NCT00744237|525103629|FG002|Overall Study|Lack of Efficacy|0|||
145614440|NCT00744237|525103627|FG000|Overall Study|Withdrawal by Subject|9|||
145614441|NCT00744237|525103628|FG001|Overall Study|Withdrawal by Subject|5|||
145614442|NCT00744237|525103629|FG002|Overall Study|Withdrawal by Subject|3|||
145614443|NCT00744237|525103627|FG000|Overall Study|Lost to Follow-up|1|||
145614444|NCT00744237|525103628|FG001|Overall Study|Lost to Follow-up|1|||
145614445|NCT00744237|525103629|FG002|Overall Study|Lost to Follow-up|1|||
145614446|NCT00744237|525103627|FG000|Overall Study|Protocol Violation|3|||
145614447|NCT00744237|525103628|FG001|Overall Study|Protocol Violation|4|||
145614448|NCT00744237|525103629|FG002|Overall Study|Protocol Violation|3|||
145614449|NCT00744237|525103627|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
145614450|NCT00744237|525103628|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
145614451|NCT00744237|525103629|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
145614452|NCT00744237|525103627|FG000|Overall Study|Dosing Error|1|||
145614453|NCT00744237|525103628|FG001|Overall Study|Dosing Error|0|||
145614454|NCT00744237|525103629|FG002|Overall Study|Dosing Error|1|||
145614455|NCT00744237|525103627|FG000|Overall Study|Study Drug Error|1|||
145614456|NCT00744237|525103628|FG001|Overall Study|Study Drug Error|0|||
145614457|NCT00744237|525103629|FG002|Overall Study|Study Drug Error|0|||
145614458|NCT00744237|525103627|FG000|Overall Study|Prohibited Concomitant Medication|0|||
145614459|NCT00744237|525103628|FG001|Overall Study|Prohibited Concomitant Medication|0|||
145614460|NCT00744237|525103629|FG002|Overall Study|Prohibited Concomitant Medication|1|||
145614461|NCT00744237|525103627|FG000|Overall Study|Poor Compliance|0|||
145614462|NCT00744237|525103628|FG001|Overall Study|Poor Compliance|2|||
145614463|NCT00744237|525103629|FG002|Overall Study|Poor Compliance|0|||
145614464|NCT00744237|525103627|FG000|Overall Study|Administrative. Site Closed|1|||
145614465|NCT00744237|525103628|FG001|Overall Study|Administrative. Site Closed|1|||
145614466|NCT00744237|525103629|FG002|Overall Study|Administrative. Site Closed|1|||
145614467|NCT00744237|525103627|FG000|Overall Study|Adverse Event|9|||
145614468|NCT00744237|525103628|FG001|Overall Study|Adverse Event|13|||
145614469|NCT00744237|525103629|FG002|Overall Study|Adverse Event|5|||
145614470|NCT01984424|525103630|FG000|Overall Study|Withdrawal by Subject|3|||
145614471|NCT01984424|525103631|FG001|Overall Study|Withdrawal by Subject|5|||
145614472|NCT01984424|525103630|FG000|Overall Study|Sponsor Decision|0|||
145614473|NCT01984424|525103631|FG001|Overall Study|Sponsor Decision|1|||
145614474|NCT01984424|525103630|FG000|Overall Study|Lost to Follow-up|0|||
145614475|NCT01984424|525103631|FG001|Overall Study|Lost to Follow-up|1|||
145614476|NCT01807221|525103632|FG000|Overall Study|Progressive disease|1|||
145614477|NCT01807221|525103633|FG001|Overall Study|Progressive disease|0|||
145614478|NCT01807221|525103634|FG002|Overall Study|Progressive disease|1|||
145614479|NCT01807221|525103635|FG003|Overall Study|Progressive disease|0|||
145614480|NCT01807221|525103636|FG004|Overall Study|Progressive disease|0|||
145614481|NCT01807221|525103637|FG005|Overall Study|Progressive disease|0|||
145614482|NCT01807221|525103632|FG000|Overall Study|Death|7|||
145614483|NCT01807221|525103633|FG001|Overall Study|Death|9|||
145614484|NCT01807221|525103634|FG002|Overall Study|Death|4|||
145614485|NCT01807221|525103635|FG003|Overall Study|Death|2|||
145614486|NCT01807221|525103636|FG004|Overall Study|Death|1|||
145614487|NCT01807221|525103637|FG005|Overall Study|Death|6|||
145614488|NCT01807221|525103632|FG000|Overall Study|Physician Decision|2|||
145614489|NCT01807221|525103633|FG001|Overall Study|Physician Decision|1|||
145614490|NCT01807221|525103634|FG002|Overall Study|Physician Decision|0|||
145614491|NCT01807221|525103635|FG003|Overall Study|Physician Decision|0|||
145614492|NCT01807221|525103636|FG004|Overall Study|Physician Decision|0|||
145614493|NCT01807221|525103637|FG005|Overall Study|Physician Decision|0|||
145614494|NCT01807221|525103632|FG000|Overall Study|Adverse Event|33|||
145614495|NCT01807221|525103633|FG001|Overall Study|Adverse Event|22|||
145614496|NCT01807221|525103634|FG002|Overall Study|Adverse Event|26|||
145614497|NCT01807221|525103635|FG003|Overall Study|Adverse Event|25|||
145614498|NCT01807221|525103636|FG004|Overall Study|Adverse Event|18|||
145614499|NCT01807221|525103637|FG005|Overall Study|Adverse Event|21|||
145614500|NCT01807221|525103632|FG000|Overall Study|Protocol Violation|0|||
145614501|NCT01807221|525103633|FG001|Overall Study|Protocol Violation|2|||
145614502|NCT01807221|525103634|FG002|Overall Study|Protocol Violation|1|||
145614503|NCT01807221|525103635|FG003|Overall Study|Protocol Violation|2|||
145614504|NCT01807221|525103636|FG004|Overall Study|Protocol Violation|0|||
145614505|NCT01807221|525103637|FG005|Overall Study|Protocol Violation|1|||
145614506|NCT01807221|525103632|FG000|Overall Study|Non-compliance|1|||
145614507|NCT01807221|525103633|FG001|Overall Study|Non-compliance|2|||
145614508|NCT01807221|525103634|FG002|Overall Study|Non-compliance|0|||
145614509|NCT01807221|525103635|FG003|Overall Study|Non-compliance|1|||
145614510|NCT01807221|525103636|FG004|Overall Study|Non-compliance|0|||
145614511|NCT01807221|525103637|FG005|Overall Study|Non-compliance|0|||
145614512|NCT01807221|525103632|FG000|Overall Study|Logistical difficulties|0|||
145614513|NCT01807221|525103633|FG001|Overall Study|Logistical difficulties|1|||
145614514|NCT01807221|525103634|FG002|Overall Study|Logistical difficulties|0|||
145614515|NCT01807221|525103635|FG003|Overall Study|Logistical difficulties|0|||
145614516|NCT01807221|525103636|FG004|Overall Study|Logistical difficulties|1|||
145614517|NCT01807221|525103637|FG005|Overall Study|Logistical difficulties|0|||
145614518|NCT01807221|525103632|FG000|Overall Study|Withdrawal by Subject|33|||
145614519|NCT01807221|525103633|FG001|Overall Study|Withdrawal by Subject|15|||
145614520|NCT01807221|525103634|FG002|Overall Study|Withdrawal by Subject|8|||
145614521|NCT01807221|525103635|FG003|Overall Study|Withdrawal by Subject|14|||
145614522|NCT01807221|525103636|FG004|Overall Study|Withdrawal by Subject|16|||
145614523|NCT01807221|525103637|FG005|Overall Study|Withdrawal by Subject|13|||
145614524|NCT01807221|525103632|FG000|Overall Study|Sponsor decision|2|||
145614525|NCT01807221|525103633|FG001|Overall Study|Sponsor decision|0|||
145614526|NCT01807221|525103634|FG002|Overall Study|Sponsor decision|1|||
145614527|NCT01807221|525103635|FG003|Overall Study|Sponsor decision|1|||
145614528|NCT01807221|525103636|FG004|Overall Study|Sponsor decision|0|||
145614529|NCT01807221|525103637|FG005|Overall Study|Sponsor decision|0|||
145614530|NCT01807221|525103632|FG000|Overall Study|Lost to Follow-up|1|||
145614531|NCT01807221|525103633|FG001|Overall Study|Lost to Follow-up|0|||
145614532|NCT01807221|525103634|FG002|Overall Study|Lost to Follow-up|2|||
145614533|NCT01807221|525103635|FG003|Overall Study|Lost to Follow-up|1|||
145614534|NCT01807221|525103636|FG004|Overall Study|Lost to Follow-up|0|||
145614535|NCT01807221|525103637|FG005|Overall Study|Lost to Follow-up|0|||
145614536|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
145614537|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
145288137|NCT00283686|523904492|FG001|Overall Study|Less than full participation|9|||
145614538|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
145614539|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
145614540|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
145614541|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
145406432|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
145556091|NCT00680745|524894953|FG000|Overall Study|Lost to Follow-up|0|||
145288138|NCT00283686|523904493|FG002|Overall Study|Less than full participation|6|||
145288139|NCT00283686|523904494|FG003|Overall Study|Less than full participation|12|||
145288140|NCT02649231|523904497|FG000|Overall Study|Adverse Event|0|||
145288141|NCT02649231|523904498|FG001|Overall Study|Adverse Event|0|||
145288142|NCT02649231|523904499|FG002|Overall Study|Adverse Event|0|||
145288143|NCT02649231|523904500|FG003|Overall Study|Adverse Event|1|||
145288144|NCT02649231|523904497|FG000|Overall Study|Lost to Follow-up|2|||
145288145|NCT02649231|523904498|FG001|Overall Study|Lost to Follow-up|1|||
145288146|NCT02649231|523904499|FG002|Overall Study|Lost to Follow-up|1|||
145288147|NCT02649231|523904500|FG003|Overall Study|Lost to Follow-up|0|||
145288148|NCT02649231|523904497|FG000|Overall Study|Withdrawal by Subject|0|||
145288149|NCT02649231|523904498|FG001|Overall Study|Withdrawal by Subject|1|||
145288150|NCT02649231|523904499|FG002|Overall Study|Withdrawal by Subject|0|||
145288151|NCT02649231|523904500|FG003|Overall Study|Withdrawal by Subject|1|||
145288152|NCT02649231|523904497|FG000|Overall Study|Protocol Violation|2|||
145288153|NCT02649231|523904498|FG001|Overall Study|Protocol Violation|1|||
145288154|NCT02649231|523904499|FG002|Overall Study|Protocol Violation|1|||
145288155|NCT02649231|523904500|FG003|Overall Study|Protocol Violation|0|||
145288156|NCT00437281|523904501|FG000|Overall Study|Adverse Event|0|||
145288157|NCT00437281|523904502|FG001|Overall Study|Adverse Event|0|||
145288158|NCT00437281|523904503|FG002|Overall Study|Adverse Event|0|||
145288159|NCT00437281|523904504|FG003|Overall Study|Adverse Event|1|||
145288160|NCT00437281|523904505|FG004|Overall Study|Adverse Event|0|||
145288161|NCT00437281|523904506|FG005|Overall Study|Adverse Event|1|||
145288162|NCT00437281|523904507|FG006|Overall Study|Adverse Event|0|||
145288163|NCT00437281|523904508|FG007|Overall Study|Adverse Event|0|||
145288164|NCT00437281|523904509|FG008|Overall Study|Adverse Event|0|||
145288165|NCT00437281|523904510|FG009|Overall Study|Adverse Event|1|||
145288166|NCT00437281|523904511|FG010|Overall Study|Adverse Event|0|||
145288167|NCT00437281|523904512|FG011|Overall Study|Adverse Event|0|||
145288168|NCT00437281|523904513|FG012|Overall Study|Adverse Event|0|||
145288169|NCT00437281|523904514|FG013|Overall Study|Adverse Event|1|||
145288170|NCT00437281|523904515|FG014|Overall Study|Adverse Event|1|||
145288171|NCT00437281|523904516|FG015|Overall Study|Adverse Event|0|||
145288172|NCT00437281|523904517|FG016|Overall Study|Adverse Event|0|||
145288173|NCT00437281|523904518|FG017|Overall Study|Adverse Event|0|||
145288174|NCT00437281|523904519|FG018|Overall Study|Adverse Event|1|||
145288175|NCT00437281|523904520|FG019|Overall Study|Adverse Event|0|||
145288176|NCT00437281|523904501|FG000|Overall Study|Lost to Follow-up|0|||
145288177|NCT00437281|523904502|FG001|Overall Study|Lost to Follow-up|0|||
145288178|NCT00437281|523904503|FG002|Overall Study|Lost to Follow-up|0|||
145288179|NCT00437281|523904504|FG003|Overall Study|Lost to Follow-up|0|||
145288180|NCT00437281|523904505|FG004|Overall Study|Lost to Follow-up|0|||
145288181|NCT00437281|523904506|FG005|Overall Study|Lost to Follow-up|0|||
145288182|NCT00437281|523904507|FG006|Overall Study|Lost to Follow-up|0|||
145288183|NCT00437281|523904508|FG007|Overall Study|Lost to Follow-up|0|||
145288184|NCT00437281|523904509|FG008|Overall Study|Lost to Follow-up|0|||
145288185|NCT00437281|523904510|FG009|Overall Study|Lost to Follow-up|0|||
145288186|NCT00437281|523904511|FG010|Overall Study|Lost to Follow-up|0|||
145288187|NCT00437281|523904512|FG011|Overall Study|Lost to Follow-up|0|||
145288188|NCT00437281|523904513|FG012|Overall Study|Lost to Follow-up|0|||
145288189|NCT00437281|523904514|FG013|Overall Study|Lost to Follow-up|0|||
145288190|NCT00437281|523904515|FG014|Overall Study|Lost to Follow-up|0|||
145288191|NCT00437281|523904516|FG015|Overall Study|Lost to Follow-up|0|||
145288192|NCT00437281|523904517|FG016|Overall Study|Lost to Follow-up|0|||
145288193|NCT00437281|523904518|FG017|Overall Study|Lost to Follow-up|0|||
145288194|NCT00437281|523904519|FG018|Overall Study|Lost to Follow-up|0|||
145288195|NCT00437281|523904520|FG019|Overall Study|Lost to Follow-up|1|||
145288196|NCT01211769|523904523|FG000|Overall Study|Lost to Follow-up|7|||
145288197|NCT01211769|523904524|FG001|Overall Study|Lost to Follow-up|9|||
145288198|NCT01211769|523904525|FG002|Overall Study|Lost to Follow-up|5|||
145288199|NCT01211769|523904526|FG003|Overall Study|Lost to Follow-up|9|||
145288200|NCT01211769|523904523|FG000|Overall Study|Physician Decision|2|||
145288201|NCT01211769|523904524|FG001|Overall Study|Physician Decision|0|||
145288202|NCT01211769|523904525|FG002|Overall Study|Physician Decision|2|||
145288203|NCT01211769|523904526|FG003|Overall Study|Physician Decision|1|||
145288204|NCT01211769|523904523|FG000|Overall Study|Adverse Event|0|||
145288205|NCT01211769|523904524|FG001|Overall Study|Adverse Event|1|||
145288206|NCT01211769|523904525|FG002|Overall Study|Adverse Event|1|||
145288207|NCT01211769|523904526|FG003|Overall Study|Adverse Event|1|||
145288208|NCT01214330|523904527|FG000|Overall Study|Withdrawal by Subject|2|||
145288209|NCT01214330|523904527|FG000|Overall Study|Withdrawal by Subject|2|||
145288210|NCT00947427|523904528|FG000|Overall Study|Withdrawal by Subject|1|||
145288211|NCT00947427|523904529|FG001|Overall Study|Withdrawal by Subject|3|||
145288212|NCT00947427|523904528|FG000|Overall Study|Protocol Violation|0|||
145288213|NCT00947427|523904529|FG001|Overall Study|Protocol Violation|1|||
145288214|NCT01348542|523904530|FG000|Overall Study|Withdrawal by Subject|3|||
145288215|NCT01348542|523904531|FG001|Overall Study|Withdrawal by Subject|0|||
145614542|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
145614543|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
145614544|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
145614545|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
145614546|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
145614547|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
145614548|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
145614549|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
145614550|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
145614551|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
145614552|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
145614553|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
145614554|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
145614555|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
145288216|NCT03402893|523904532|FG000|Overall Study|Withdrawal by Subject|1|||
145288217|NCT00686036|523904537|FG000|Overall Study|Adverse Event|3|||
145288218|NCT00686036|523904538|FG001|Overall Study|Adverse Event|0|||
145288219|NCT00686036|523904537|FG000|Overall Study|Withdrawal by Subject|3|||
145288220|NCT00686036|523904538|FG001|Overall Study|Withdrawal by Subject|1|||
145288221|NCT00686036|523904537|FG000|Overall Study|Study terminated by AstraZeneca|2|||
145288222|NCT00686036|523904538|FG001|Overall Study|Study terminated by AstraZeneca|1|||
145288223|NCT00686036|523904537|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
145288224|NCT00686036|523904538|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
145288225|NCT00686036|523904537|FG000|Overall Study|Other reasons not identified|0|||
145288226|NCT00686036|523904538|FG001|Overall Study|Other reasons not identified|4|||
145288227|NCT01411995|523904539|FG000|Overall Study|Failed IUD insertion|0|||
145288228|NCT01411995|523904540|FG001|Overall Study|Failed IUD insertion|1|||
145288229|NCT00467584|523904541|FG000|Overall Study|Withdrawal by Subject|4|||
145288230|NCT00467584|523904542|FG001|Overall Study|Withdrawal by Subject|5|||
145288231|NCT00467584|523904543|FG002|Overall Study|Withdrawal by Subject|1|||
145288232|NCT00926289|523904549|FG000|Overall Study|Adverse Event|9|||
145288233|NCT00926289|523904550|FG001|Overall Study|Adverse Event|11|||
145288234|NCT00926289|523904549|FG000|Overall Study|Protocol Violation|8|||
145288235|NCT00926289|523904550|FG001|Overall Study|Protocol Violation|12|||
145288236|NCT00926289|523904549|FG000|Overall Study|Lost to Follow-up|3|||
145288237|NCT00926289|523904550|FG001|Overall Study|Lost to Follow-up|6|||
145288238|NCT00926289|523904549|FG000|Overall Study|Withdrawal by Subject|4|||
145288239|NCT00926289|523904550|FG001|Overall Study|Withdrawal by Subject|4|||
145288240|NCT00926289|523904549|FG000|Overall Study|Other|1|||
145288241|NCT00926289|523904550|FG001|Overall Study|Other|3|||
145288242|NCT00319956|523904551|FG000|Overall Study|Death|20|||
145288243|NCT00319956|523904552|FG001|Overall Study|Death|24|||
145288244|NCT00753714|523904553|FG000|Overall Study|Lack of Efficacy|21|||
145288245|NCT00753714|523904554|FG001|Overall Study|Lack of Efficacy|34|||
145288246|NCT00753714|523904553|FG000|Overall Study|Adverse Event|26|||
145288247|NCT00753714|523904554|FG001|Overall Study|Adverse Event|18|||
145288248|NCT00753714|523904553|FG000|Overall Study|Protocol Violation|1|||
145288249|NCT00753714|523904554|FG001|Overall Study|Protocol Violation|0|||
145288250|NCT00753714|523904553|FG000|Overall Study|Lost to Follow-up|0|||
145288251|NCT00753714|523904554|FG001|Overall Study|Lost to Follow-up|1|||
145288252|NCT00753714|523904553|FG000|Overall Study|Withdrawal by Subject|2|||
145288253|NCT00753714|523904554|FG001|Overall Study|Withdrawal by Subject|1|||
145288254|NCT00753714|523904553|FG000|Overall Study|Death|3|||
145288255|NCT00753714|523904554|FG001|Overall Study|Death|3|||
145288256|NCT00753714|523904553|FG000|Overall Study|Other|7|||
145288257|NCT00753714|523904554|FG001|Overall Study|Other|5|||
145614556|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
145614557|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
145614558|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
145614559|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
145288258|NCT01202747|523904555|FG000|Overall Study|Withdrawal by Subject|1|||
145288259|NCT01446913|523904556|FG000|Overall Study|Significant illness|1|||
145288260|NCT01446913|523904557|FG001|Overall Study|Significant illness|1|||
145288261|NCT01446913|523904558|FG002|Overall Study|Significant illness|1|||
145288262|NCT01446913|523904556|FG000|Overall Study|Withdrawal by Subject|5|||
145288263|NCT01446913|523904557|FG001|Overall Study|Withdrawal by Subject|3|||
145288264|NCT01446913|523904558|FG002|Overall Study|Withdrawal by Subject|5|||
145288265|NCT01446913|523904556|FG000|Overall Study|Physician Decision|0|||
145288266|NCT01446913|523904557|FG001|Overall Study|Physician Decision|0|||
145288267|NCT01446913|523904558|FG002|Overall Study|Physician Decision|2|||
145288268|NCT01446913|523904556|FG000|Overall Study|Lost to Follow-up|3|||
145288269|NCT01446913|523904557|FG001|Overall Study|Lost to Follow-up|5|||
145288270|NCT01446913|523904558|FG002|Overall Study|Lost to Follow-up|3|||
145288271|NCT04000009|523904559|FG000|Overall Study|Adverse Event|13|||
145288272|NCT04000009|523904559|FG000|Overall Study|Lack of Efficacy|7|||
145288273|NCT04000009|523904559|FG000|Overall Study|Lost to Follow-up|8|||
145288274|NCT04000009|523904559|FG000|Overall Study|Noncompliance with study drug|4|||
145288275|NCT04000009|523904559|FG000|Overall Study|Physician Decision|1|||
145288276|NCT04000009|523904559|FG000|Overall Study|Use of prohibited medication|3|||
145288277|NCT04000009|523904559|FG000|Overall Study|Pregnancy|1|||
145288278|NCT04000009|523904559|FG000|Overall Study|Withdrawal by Subject|22|||
145288279|NCT04000009|523904559|FG000|Overall Study|Study terminated by sponsor|98|||
145288280|NCT04000009|523904559|FG000|Overall Study|Not further specified|8|||
145288281|NCT02292238|523904560|FG000|Overall Study|Protocol Violation|1|||
145288282|NCT02292238|523904561|FG001|Overall Study|Protocol Violation|2|||
145288283|NCT02292238|523904560|FG000|Overall Study|Withdrawal by Subject|2|||
145288284|NCT02292238|523904561|FG001|Overall Study|Withdrawal by Subject|1|||
145288285|NCT02292238|523904560|FG000|Overall Study|Lost to Follow-up|1|||
145288286|NCT02292238|523904561|FG001|Overall Study|Lost to Follow-up|0|||
145288287|NCT02292238|523904560|FG000|Overall Study|Physician Decision|0|||
145288288|NCT02292238|523904561|FG001|Overall Study|Physician Decision|1|||
145288289|NCT01618305|523904562|FG000|Overall Study|Death|0|||
145288290|NCT01618305|523904563|FG001|Overall Study|Death|1|||
145288291|NCT01618305|523904562|FG000|Overall Study|Lost to Follow-up|11|||
145288292|NCT01618305|523904563|FG001|Overall Study|Lost to Follow-up|7|||
145288293|NCT01618305|523904562|FG000|Overall Study|Protocol Violation|1|||
145288294|NCT01618305|523904563|FG001|Overall Study|Protocol Violation|0|||
145288295|NCT01618305|523904562|FG000|Overall Study|Withdrawal by Subject|3|||
145288296|NCT01618305|523904563|FG001|Overall Study|Withdrawal by Subject|2|||
145288297|NCT01960816|523904564|FG000|Overall Study|Lost to Follow-up|1|||
145288298|NCT01309919|523904579|FG000|Overall Study|Did not receive a postpartum IUD|17|||
145288299|NCT01309919|523904580|FG001|Overall Study|Did not receive a postpartum IUD|48|||
145288300|NCT02102490|523904581|FG000|Overall Study|Death|6|||
145288301|NCT02102490|523904581|FG000|Overall Study|Lost to Follow-up|1|||
145288302|NCT00385541|523904582|FG000|Overall Study|severe pain, clinician requested unblind|0|||
145288303|NCT00385541|523904583|FG001|Overall Study|severe pain, clinician requested unblind|1|||
145288304|NCT02154529|523904584|FG000|Overall Study|Death|1|||
145288305|NCT02154529|523904585|FG001|Overall Study|Death|1|||
145288306|NCT02154529|523904586|FG002|Overall Study|Death|5|||
145288307|NCT02154529|523904587|FG003|Overall Study|Death|1|||
145288308|NCT02154529|523904584|FG000|Overall Study|Termination of study by sponsor|2|||
145288309|NCT02154529|523904585|FG001|Overall Study|Termination of study by sponsor|2|||
145288310|NCT02154529|523904586|FG002|Overall Study|Termination of study by sponsor|3|||
145288311|NCT02154529|523904587|FG003|Overall Study|Termination of study by sponsor|1|||
145288312|NCT02154529|523904584|FG000|Overall Study|Lost to Follow-up|1|||
145288313|NCT02154529|523904585|FG001|Overall Study|Lost to Follow-up|0|||
145288314|NCT02154529|523904586|FG002|Overall Study|Lost to Follow-up|0|||
145288315|NCT02154529|523904587|FG003|Overall Study|Lost to Follow-up|0|||
145288316|NCT04583579|523906410|FG000|Overall Study|Lost to Follow-up|4|||
145288317|NCT01691859|523906411|FG000|Overall Study|Adverse Event|19|||
145288318|NCT01691859|523906411|FG000|Overall Study|Lack of Efficacy|11|||
145288319|NCT01691859|523906411|FG000|Overall Study|Protocol Violation|4|||
145288320|NCT01691859|523906411|FG000|Overall Study|Product commercially available|221|||
145288321|NCT01691859|523906411|FG000|Overall Study|Study closed/terminated|50|||
145288322|NCT01691859|523906411|FG000|Overall Study|Lost to Follow-up|5|||
145288323|NCT01691859|523906411|FG000|Overall Study|Physician Decision|6|||
145288324|NCT01691859|523906411|FG000|Overall Study|Withdrawal by Subject|31|||
145288325|NCT01691508|523906412|FG000|Overall Study|Adverse Event|3|||
145288326|NCT01691508|523906413|FG001|Overall Study|Adverse Event|3|||
145288327|NCT01691508|523906412|FG000|Overall Study|Withdrawal by Subject|1|||
145288328|NCT01691508|523906413|FG001|Overall Study|Withdrawal by Subject|0|||
145288329|NCT02207621|523906418|FG000|Overall Study|Adverse Event|71|||
145288330|NCT02207621|523906419|FG001|Overall Study|Adverse Event|15|||
145288331|NCT02207621|523906420|FG002|Overall Study|Adverse Event|132|||
145288332|NCT02207621|523906418|FG000|Overall Study|Withdrawal by Subject|9|||
145288333|NCT02207621|523906419|FG001|Overall Study|Withdrawal by Subject|9|||
145288334|NCT02207621|523906420|FG002|Overall Study|Withdrawal by Subject|13|||
145288335|NCT02207621|523906418|FG000|Overall Study|Non-Compliant|3|||
145288336|NCT02207621|523906419|FG001|Overall Study|Non-Compliant|3|||
145288337|NCT02207621|523906420|FG002|Overall Study|Non-Compliant|1|||
145288338|NCT02207621|523906418|FG000|Overall Study|Lost to Follow-up|1|||
145288339|NCT02207621|523906419|FG001|Overall Study|Lost to Follow-up|0|||
145288340|NCT02207621|523906420|FG002|Overall Study|Lost to Follow-up|3|||
145288341|NCT02207621|523906418|FG000|Overall Study|Lack of Efficacy|10|||
145288342|NCT02207621|523906419|FG001|Overall Study|Lack of Efficacy|2|||
145288343|NCT02207621|523906420|FG002|Overall Study|Lack of Efficacy|4|||
145288344|NCT02207621|523906418|FG000|Overall Study|Disallowed Concurrent Medication|2|||
145288345|NCT02207621|523906419|FG001|Overall Study|Disallowed Concurrent Medication|5|||
145406433|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
145288346|NCT02207621|523906420|FG002|Overall Study|Disallowed Concurrent Medication|2|||
145288347|NCT02207621|523906418|FG000|Overall Study|Physician Decision|1|||
145406434|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
145288348|NCT02207621|523906419|FG001|Overall Study|Physician Decision|2|||
145288349|NCT02207621|523906420|FG002|Overall Study|Physician Decision|2|||
145288350|NCT02207621|523906418|FG000|Overall Study|Protocol Violation|4|||
145288351|NCT02207621|523906419|FG001|Overall Study|Protocol Violation|10|||
145288352|NCT02207621|523906420|FG002|Overall Study|Protocol Violation|6|||
145288353|NCT02207621|523906418|FG000|Overall Study|Death|2|||
145288354|NCT02207621|523906419|FG001|Overall Study|Death|0|||
145288355|NCT02207621|523906420|FG002|Overall Study|Death|0|||
145288356|NCT02207621|523906418|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
145288357|NCT02207621|523906419|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
145288358|NCT02207621|523906420|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
145288359|NCT03036579|523906423|FG000|2 Years|Lost to Follow-up|1|||
145406435|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
145406436|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
145406437|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
145406438|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
145406439|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
145406440|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
145406441|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
145406442|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
145406443|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
145406444|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
145406445|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
145406446|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Depression|0|||
145406447|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Depression|1|||
145406448|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Depression|0|||
145406449|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
145406450|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
145406451|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
145406452|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Jailed|0|||
145406453|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Jailed|1|||
145406454|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Jailed|0|||
145406455|NCT00090103|524343758|FG000|16-Week Safety Follow-up Period|Other|0|||
145406456|NCT00090103|524343759|FG001|16-Week Safety Follow-up Period|Other|1|||
145406457|NCT00090103|524343760|FG002|16-Week Safety Follow-up Period|Other|0|||
145406458|NCT01799889|524343763|FG000|Overall Study|Adverse Event|4|||
145406459|NCT01799889|524343764|FG001|Overall Study|Adverse Event|4|||
145406460|NCT01799889|524343765|FG002|Overall Study|Adverse Event|5|||
145406461|NCT01799889|524343766|FG003|Overall Study|Adverse Event|1|||
145406462|NCT01799889|524343767|FG004|Overall Study|Adverse Event|11|||
145406463|NCT01799889|524343768|FG005|Overall Study|Adverse Event|1|||
145406464|NCT01799889|524343769|FG006|Overall Study|Adverse Event|5|||
145406465|NCT01799889|524343770|FG007|Overall Study|Adverse Event|2|||
145406466|NCT01799889|524343771|FG008|Overall Study|Adverse Event|3|||
145406467|NCT01799889|524343772|FG009|Overall Study|Adverse Event|1|||
145406468|NCT01799889|524343773|FG010|Overall Study|Adverse Event|1|||
145406469|NCT01799889|524343774|FG011|Overall Study|Adverse Event|0|||
145406470|NCT01799889|524343763|FG000|Overall Study|Death|1|||
145406471|NCT01799889|524343764|FG001|Overall Study|Death|0|||
145406472|NCT01799889|524343765|FG002|Overall Study|Death|5|||
145406473|NCT01799889|524343766|FG003|Overall Study|Death|3|||
145406474|NCT01799889|524343767|FG004|Overall Study|Death|1|||
145288360|NCT03036579|523906424|FG001|2 Years|Lost to Follow-up|0|||
145288361|NCT03036579|523906423|FG000|3 Years|Lost to Follow-up|0|||
145288362|NCT03036579|523906424|FG001|3 Years|Lost to Follow-up|1|||
145288363|NCT02848599|523906425|FG000|Overall Study|Protocol Violation|7|||
145288364|NCT02848599|523906426|FG001|Overall Study|Protocol Violation|9|||
145288365|NCT05431153|523906427|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145288366|NCT05431153|523906428|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145288367|NCT05431153|523906429|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145288368|NCT05431153|523906430|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145288369|NCT05431153|523906431|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
145288370|NCT05431153|523906432|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145288371|NCT04828161|523906433|FG000|Overall Study|Withdrawal by Subject|0|||
145288372|NCT04828161|523906434|FG001|Overall Study|Withdrawal by Subject|3|||
145406475|NCT01799889|524343768|FG005|Overall Study|Death|0|||
145288373|NCT04828161|523906435|FG002|Overall Study|Withdrawal by Subject|3|||
145288374|NCT04828161|523906436|FG003|Overall Study|Withdrawal by Subject|4|||
145406476|NCT01799889|524343769|FG006|Overall Study|Death|0|||
145406477|NCT01799889|524343770|FG007|Overall Study|Death|0|||
145406478|NCT01799889|524343771|FG008|Overall Study|Death|1|||
145614560|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
145614561|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
145614562|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
145614563|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
145614564|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
145614565|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
145614566|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
145614567|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
145614568|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
145614569|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
145614570|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
145614571|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
145614572|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
145614573|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
145614574|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
145614575|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
145614576|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
145614577|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
145614578|NCT01089556|525103640|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
145614579|NCT01089556|525103641|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
145614580|NCT01089556|525103642|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
145614581|NCT01089556|525103643|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
145614582|NCT01089556|525103644|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
145614583|NCT01089556|525103645|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
145614584|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
145614585|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
145614586|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
145614587|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
145614588|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
145614589|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
145614590|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
145614591|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
145614592|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
145614593|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
145614594|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
145614595|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
145614596|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
145614597|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
145614598|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
145614599|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
145614600|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
145614601|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
145614602|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
145614603|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
145614604|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
145614605|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
145614606|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
145614607|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
145288375|NCT04828161|523906433|FG000|Overall Study|Lost to Follow-up|1|||
145614608|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
145614609|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
145614610|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
145614611|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
145614612|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
145614613|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
145614614|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
145614615|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
145614616|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
145614617|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
145614618|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
145614619|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
145614620|NCT01089556|525103640|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
145614621|NCT01089556|525103641|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
145614622|NCT01089556|525103642|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
145614623|NCT01089556|525103643|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
145614624|NCT01089556|525103644|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
145614625|NCT01089556|525103645|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
145614626|NCT01702428|525103648|FG000|Overall Study|Adverse Event|2|||
145614627|NCT01702428|525103649|FG001|Overall Study|Adverse Event|0|||
145614628|NCT01702428|525103650|FG002|Overall Study|Adverse Event|0|||
145614629|NCT01702428|525103651|FG003|Overall Study|Adverse Event|0|||
145614630|NCT01702428|525103648|FG000|Overall Study|Lost to Follow-up|33|||
145614631|NCT01702428|525103649|FG001|Overall Study|Lost to Follow-up|41|||
145614632|NCT01702428|525103650|FG002|Overall Study|Lost to Follow-up|37|||
145288376|NCT04828161|523906434|FG001|Overall Study|Lost to Follow-up|4|||
145288377|NCT04828161|523906435|FG002|Overall Study|Lost to Follow-up|2|||
145288378|NCT04828161|523906436|FG003|Overall Study|Lost to Follow-up|2|||
145288379|NCT04828161|523906433|FG000|Overall Study|Other|2|||
145288380|NCT04828161|523906434|FG001|Overall Study|Other|0|||
145288381|NCT04828161|523906435|FG002|Overall Study|Other|2|||
145288382|NCT04828161|523906436|FG003|Overall Study|Other|0|||
145288383|NCT04828161|523906433|FG000|Overall Study|Death|0|||
145288384|NCT04828161|523906434|FG001|Overall Study|Death|0|||
145288385|NCT04828161|523906435|FG002|Overall Study|Death|0|||
145288386|NCT04828161|523906436|FG003|Overall Study|Death|2|||
145288387|NCT02352337|523906437|FG000|Overall Study|Patients never treated|4|||
145288388|NCT02352337|523906438|FG001|Overall Study|Patients never treated|1|||
145288389|NCT02352337|523906439|FG002|Overall Study|Patients never treated|2|||
145288390|NCT02458638|523906440|FG000|Overall Study|Death|309|||
145288391|NCT02458638|523906440|FG000|Overall Study|End of Cohort/End of Study|67|||
145288392|NCT02458638|523906440|FG000|Overall Study|Lost to Follow-up|31|||
145288393|NCT02458638|523906440|FG000|Overall Study|Other Reasons|4|||
145614633|NCT01702428|525103651|FG003|Overall Study|Lost to Follow-up|44|||
145614634|NCT01702428|525103648|FG000|Overall Study|Parents cannot assist to site|1|||
145614635|NCT01702428|525103649|FG001|Overall Study|Parents cannot assist to site|0|||
145614636|NCT01702428|525103650|FG002|Overall Study|Parents cannot assist to site|1|||
145614637|NCT01702428|525103651|FG003|Overall Study|Parents cannot assist to site|0|||
145614638|NCT01702428|525103648|FG000|Overall Study|Lost Coverage|0|||
145288394|NCT02458638|523906440|FG000|Overall Study|Physician Decision|1|||
145614639|NCT01702428|525103649|FG001|Overall Study|Lost Coverage|0|||
145614640|NCT01702428|525103650|FG002|Overall Study|Lost Coverage|0|||
145288395|NCT02458638|523906440|FG000|Overall Study|Withdrawal by Subject|47|||
145288396|NCT00135707|523906454|FG000|Overall Study|Lost to Follow-up|94|||
145614641|NCT01702428|525103651|FG003|Overall Study|Lost Coverage|1|||
145614642|NCT01702428|525103648|FG000|Overall Study|Lost Health Plan|3|||
145288397|NCT00135707|523906455|FG001|Overall Study|Lost to Follow-up|89|||
145288398|NCT00135707|523906454|FG000|Overall Study|Withdrawal by Subject|0|||
145614643|NCT01702428|525103649|FG001|Overall Study|Lost Health Plan|5|||
145614644|NCT01702428|525103650|FG002|Overall Study|Lost Health Plan|0|||
145614645|NCT01702428|525103651|FG003|Overall Study|Lost Health Plan|2|||
145614646|NCT01702428|525103648|FG000|Overall Study|Mother transferred care|0|||
145614647|NCT01702428|525103649|FG001|Overall Study|Mother transferred care|1|||
145614648|NCT01702428|525103650|FG002|Overall Study|Mother transferred care|0|||
145614649|NCT01702428|525103651|FG003|Overall Study|Mother transferred care|0|||
145614650|NCT01702428|525103648|FG000|Overall Study|Parents too busy|1|||
145614651|NCT01702428|525103649|FG001|Overall Study|Parents too busy|0|||
145614652|NCT01702428|525103650|FG002|Overall Study|Parents too busy|0|||
145614653|NCT01702428|525103651|FG003|Overall Study|Parents too busy|0|||
145614654|NCT01702428|525103648|FG000|Overall Study|Protocol Violation|3|||
145614655|NCT01702428|525103649|FG001|Overall Study|Protocol Violation|0|||
145614656|NCT01702428|525103650|FG002|Overall Study|Protocol Violation|1|||
145614657|NCT01702428|525103651|FG003|Overall Study|Protocol Violation|0|||
145614658|NCT01702428|525103648|FG000|Overall Study|Withdrawal by Subject|21|||
145614659|NCT01702428|525103649|FG001|Overall Study|Withdrawal by Subject|23|||
145614660|NCT01702428|525103650|FG002|Overall Study|Withdrawal by Subject|14|||
145614661|NCT01702428|525103651|FG003|Overall Study|Withdrawal by Subject|10|||
145614662|NCT02091869|525103654|FG000|Overall Study|Withdrawal by Subject|0|||
145614663|NCT02091869|525103655|FG001|Overall Study|Withdrawal by Subject|3|||
145614664|NCT00594906|525103656|FG000|Overall Study|Physician Decision|1|||
145614665|NCT00594906|525103657|FG001|Overall Study|Physician Decision|0|||
145614666|NCT00594906|525103656|FG000|Overall Study|Physician Decision|0|||
145614667|NCT00594906|525103657|FG001|Overall Study|Physician Decision|1|||
145614668|NCT00594906|525103656|FG000|Overall Study|Death|0|||
145614669|NCT00594906|525103657|FG001|Overall Study|Death|1|||
145614670|NCT01533714|525103659|FG000|Overall Study|Adverse Event|0|||
145614671|NCT01533714|525103660|FG001|Overall Study|Adverse Event|1|||
145614672|NCT01533714|525103661|FG002|Overall Study|Adverse Event|2|||
145406479|NCT01799889|524343772|FG009|Overall Study|Death|0|||
145406480|NCT01799889|524343773|FG010|Overall Study|Death|1|||
145614673|NCT01533714|525103662|FG003|Overall Study|Adverse Event|2|||
145614674|NCT01533714|525103663|FG004|Overall Study|Adverse Event|2|||
145614675|NCT01533714|525103664|FG005|Overall Study|Adverse Event|1|||
145614676|NCT01533714|525103659|FG000|Overall Study|Lack of Efficacy|0|||
145614677|NCT01533714|525103660|FG001|Overall Study|Lack of Efficacy|0|||
145614678|NCT01533714|525103661|FG002|Overall Study|Lack of Efficacy|0|||
145614679|NCT01533714|525103662|FG003|Overall Study|Lack of Efficacy|0|||
145614680|NCT01533714|525103663|FG004|Overall Study|Lack of Efficacy|0|||
145614681|NCT01533714|525103664|FG005|Overall Study|Lack of Efficacy|1|||
145614682|NCT01533714|525103659|FG000|Overall Study|Withdrawal by Subject|0|||
145614683|NCT01533714|525103660|FG001|Overall Study|Withdrawal by Subject|1|||
145614684|NCT01533714|525103661|FG002|Overall Study|Withdrawal by Subject|0|||
145614685|NCT01533714|525103662|FG003|Overall Study|Withdrawal by Subject|1|||
145614686|NCT01533714|525103663|FG004|Overall Study|Withdrawal by Subject|1|||
145614687|NCT01533714|525103664|FG005|Overall Study|Withdrawal by Subject|0|||
145614688|NCT01533714|525103659|FG000|Overall Study|Exclusion criteria|0|||
145614689|NCT01533714|525103660|FG001|Overall Study|Exclusion criteria|1|||
145614690|NCT01533714|525103661|FG002|Overall Study|Exclusion criteria|0|||
145614691|NCT01533714|525103662|FG003|Overall Study|Exclusion criteria|0|||
145614692|NCT01533714|525103663|FG004|Overall Study|Exclusion criteria|0|||
145614693|NCT01533714|525103664|FG005|Overall Study|Exclusion criteria|0|||
145614694|NCT01533714|525103659|FG000|Overall Study|Positive for purified protein derivative|0|||
145614695|NCT01533714|525103660|FG001|Overall Study|Positive for purified protein derivative|0|||
145614696|NCT01533714|525103661|FG002|Overall Study|Positive for purified protein derivative|1|||
145614697|NCT01533714|525103662|FG003|Overall Study|Positive for purified protein derivative|0|||
145614698|NCT01533714|525103663|FG004|Overall Study|Positive for purified protein derivative|1|||
145614699|NCT01533714|525103664|FG005|Overall Study|Positive for purified protein derivative|0|||
145614700|NCT01533714|525103659|FG000|Overall Study|Withdrawal criteria|0|||
145406481|NCT01799889|524343774|FG011|Overall Study|Death|0|||
145614701|NCT01533714|525103660|FG001|Overall Study|Withdrawal criteria|0|||
145614702|NCT01533714|525103661|FG002|Overall Study|Withdrawal criteria|1|||
145614703|NCT01533714|525103662|FG003|Overall Study|Withdrawal criteria|0|||
145614704|NCT01533714|525103663|FG004|Overall Study|Withdrawal criteria|3|||
145614705|NCT01533714|525103664|FG005|Overall Study|Withdrawal criteria|1|||
145614706|NCT01533714|525103659|FG000|Overall Study|Ineligibility reason|0|||
145614707|NCT01533714|525103660|FG001|Overall Study|Ineligibility reason|0|||
145614708|NCT01533714|525103661|FG002|Overall Study|Ineligibility reason|0|||
145614709|NCT01533714|525103662|FG003|Overall Study|Ineligibility reason|1|||
145406482|NCT01799889|524343763|FG000|Overall Study|Lack of Efficacy|1|||
145614710|NCT01533714|525103663|FG004|Overall Study|Ineligibility reason|0|||
145614711|NCT01533714|525103664|FG005|Overall Study|Ineligibility reason|0|||
145406483|NCT01799889|524343764|FG001|Overall Study|Lack of Efficacy|1|||
145614712|NCT02564055|525103669|FG000|Overall Study|Adverse Event|1|||
145614713|NCT02564055|525103670|FG001|Overall Study|Adverse Event|0|||
145614714|NCT02564055|525103671|FG002|Overall Study|Adverse Event|4|||
145614715|NCT02564055|525103672|FG003|Overall Study|Adverse Event|1|||
145614716|NCT02564055|525103673|FG004|Overall Study|Adverse Event|4|||
145614717|NCT02564055|525103674|FG005|Overall Study|Adverse Event|1|||
145614718|NCT02564055|525103669|FG000|Overall Study|Protocol Violation|1|||
145614719|NCT02564055|525103670|FG001|Overall Study|Protocol Violation|0|||
145614720|NCT02564055|525103671|FG002|Overall Study|Protocol Violation|0|||
145614721|NCT02564055|525103672|FG003|Overall Study|Protocol Violation|0|||
145614722|NCT02564055|525103673|FG004|Overall Study|Protocol Violation|0|||
145614723|NCT02564055|525103674|FG005|Overall Study|Protocol Violation|0|||
145614724|NCT02564055|525103669|FG000|Overall Study|Reached stopping criteria|0|||
145614725|NCT02564055|525103670|FG001|Overall Study|Reached stopping criteria|0|||
145614726|NCT02564055|525103671|FG002|Overall Study|Reached stopping criteria|0|||
145614727|NCT02564055|525103672|FG003|Overall Study|Reached stopping criteria|0|||
145614728|NCT02564055|525103673|FG004|Overall Study|Reached stopping criteria|0|||
145614729|NCT02564055|525103674|FG005|Overall Study|Reached stopping criteria|1|||
145614730|NCT02564055|525103669|FG000|Overall Study|Lost to Follow-up|0|||
145614731|NCT02564055|525103670|FG001|Overall Study|Lost to Follow-up|1|||
145614732|NCT02564055|525103671|FG002|Overall Study|Lost to Follow-up|4|||
145614733|NCT02564055|525103672|FG003|Overall Study|Lost to Follow-up|2|||
145614734|NCT02564055|525103673|FG004|Overall Study|Lost to Follow-up|1|||
145614735|NCT02564055|525103674|FG005|Overall Study|Lost to Follow-up|0|||
145614736|NCT02564055|525103669|FG000|Overall Study|Physician Decision|0|||
145288399|NCT00135707|523906455|FG001|Overall Study|Withdrawal by Subject|1|||
145288400|NCT00135707|523906454|FG000|Overall Study|Institutional review board request|1|||
145288401|NCT00135707|523906455|FG001|Overall Study|Institutional review board request|0|||
145288402|NCT03093454|523906458|FG000|Overall Study|Withdrawal by Subject|1|||
145288403|NCT03093454|523906459|FG001|Overall Study|Withdrawal by Subject|1|||
145288404|NCT03093454|523906458|FG000|Overall Study|Scheduling conflict|3|||
145288405|NCT03093454|523906459|FG001|Overall Study|Scheduling conflict|1|||
145288406|NCT03093454|523906458|FG000|Overall Study|Physician Decision|2|||
145288407|NCT03093454|523906459|FG001|Overall Study|Physician Decision|1|||
145288408|NCT04540497|523906460|FG000|Overall Study|Adverse Event|0|||
145288409|NCT04540497|523906461|FG001|Overall Study|Adverse Event|2|||
145288410|NCT04540497|523906460|FG000|Overall Study|Lost to Follow-up|1|||
145614737|NCT02564055|525103670|FG001|Overall Study|Physician Decision|0|||
145614738|NCT02564055|525103671|FG002|Overall Study|Physician Decision|1|||
145614739|NCT02564055|525103672|FG003|Overall Study|Physician Decision|0|||
145614740|NCT02564055|525103673|FG004|Overall Study|Physician Decision|0|||
145288411|NCT04540497|523906461|FG001|Overall Study|Lost to Follow-up|0|||
145288412|NCT04540497|523906460|FG000|Overall Study|Withdrawal by Subject|1|||
145614741|NCT02564055|525103674|FG005|Overall Study|Physician Decision|0|||
145288413|NCT04540497|523906461|FG001|Overall Study|Withdrawal by Subject|1|||
145288414|NCT04540497|523906460|FG000|Overall Study|Miscellaneous|2|||
145288415|NCT04540497|523906461|FG001|Overall Study|Miscellaneous|1|||
145288416|NCT00421174|523906463|FG000|Overall Study|Withdrawal by Subject|0|||
145288417|NCT00421174|523906464|FG001|Overall Study|Withdrawal by Subject|1|||
145288418|NCT00421174|523906463|FG000|Overall Study|Ineligible due to infection|2|||
145288419|NCT00421174|523906464|FG001|Overall Study|Ineligible due to infection|0|||
145288420|NCT01829464|523906468|FG000|Overall Study|Adverse Event|1|||
145288421|NCT01829464|523906469|FG001|Overall Study|Adverse Event|0|||
145288422|NCT01829464|523906470|FG002|Overall Study|Adverse Event|0|||
145288423|NCT01829464|523906468|FG000|Overall Study|Lost to Follow-up|0|||
145288424|NCT01829464|523906469|FG001|Overall Study|Lost to Follow-up|0|||
145288425|NCT01829464|523906470|FG002|Overall Study|Lost to Follow-up|1|||
145288426|NCT01829464|523906468|FG000|Overall Study|Withdrawal by Subject|2|||
145288427|NCT01829464|523906469|FG001|Overall Study|Withdrawal by Subject|0|||
145288428|NCT01829464|523906470|FG002|Overall Study|Withdrawal by Subject|0|||
145288429|NCT01829464|523906468|FG000|Overall Study|Study terminated by sponsor|25|||
145288430|NCT01829464|523906469|FG001|Overall Study|Study terminated by sponsor|28|||
145288431|NCT01829464|523906470|FG002|Overall Study|Study terminated by sponsor|25|||
145288432|NCT01829464|523906468|FG000|Overall Study|Lack of Efficacy|0|||
145288433|NCT01829464|523906469|FG001|Overall Study|Lack of Efficacy|1|||
145288434|NCT01829464|523906470|FG002|Overall Study|Lack of Efficacy|0|||
145288435|NCT00992407|523906475|FG000|Overall Study|Protocol Violation|2|||
145288436|NCT00992407|523906476|FG001|Overall Study|Protocol Violation|1|||
145288437|NCT00992407|523906475|FG000|Overall Study|Lost to Follow-up|3|||
145288438|NCT00992407|523906476|FG001|Overall Study|Lost to Follow-up|3|||
145288439|NCT00992407|523906475|FG000|Overall Study|Adverse Event|3|||
145288440|NCT00992407|523906476|FG001|Overall Study|Adverse Event|2|||
145288441|NCT00992407|523906475|FG000|Overall Study|protocol Violation & Adverse events|2|||
145288442|NCT00992407|523906476|FG001|Overall Study|protocol Violation & Adverse events|4|||
145288443|NCT00992407|523906475|FG000|Overall Study|Other|2|||
145288444|NCT00992407|523906476|FG001|Overall Study|Other|0|||
145288445|NCT00992407|523906475|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
145288446|NCT00992407|523906476|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
145288447|NCT00992407|523906475|FG000|Overall Study|Study medication not administered|17|||
145288448|NCT00992407|523906476|FG001|Overall Study|Study medication not administered|13|||
145288449|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
145288450|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
145288451|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
145288452|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
145288453|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
145288454|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
145288455|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
145288456|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
145288457|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
145288458|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
145288459|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
145288460|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
145288461|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
145288462|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
145288463|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
145288464|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
145288465|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
145288466|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
145288467|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
145288468|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
145288469|NCT04700449|523906481|FG000|Stage 1: Double-Blind Period|Other|0|||
145288470|NCT04700449|523906482|FG001|Stage 1: Double-Blind Period|Other|0|||
145288471|NCT04700449|523906483|FG002|Stage 1: Double-Blind Period|Other|1|||
145288472|NCT04700449|523906484|FG003|Stage 1: Double-Blind Period|Other|0|||
145288473|NCT04700449|523906481|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
145288474|NCT04700449|523906482|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
145288475|NCT04700449|523906483|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
145288476|NCT04700449|523906484|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
145288477|NCT04700449|523906481|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
145288478|NCT04700449|523906482|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
145614742|NCT02564055|525103669|FG000|Overall Study|Withdrawal by Subject|4|||
145406484|NCT01799889|524343765|FG002|Overall Study|Lack of Efficacy|0|||
145406485|NCT01799889|524343766|FG003|Overall Study|Lack of Efficacy|1|||
145406486|NCT01799889|524343767|FG004|Overall Study|Lack of Efficacy|2|||
145406487|NCT01799889|524343768|FG005|Overall Study|Lack of Efficacy|2|||
145406488|NCT01799889|524343769|FG006|Overall Study|Lack of Efficacy|0|||
145406489|NCT01799889|524343770|FG007|Overall Study|Lack of Efficacy|0|||
145406490|NCT01799889|524343771|FG008|Overall Study|Lack of Efficacy|2|||
145288479|NCT04700449|523906483|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
145288480|NCT04700449|523906484|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
145288481|NCT04700449|523906481|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
145288482|NCT04700449|523906482|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
145288483|NCT04700449|523906483|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
145288484|NCT04700449|523906484|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
145288485|NCT04700449|523906481|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
145288486|NCT04700449|523906482|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
145288487|NCT04700449|523906483|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
145288488|NCT04700449|523906484|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
145288489|NCT04700449|523906481|FG000|Stage 2 Sub-study 1|Other|1|||
145288490|NCT04700449|523906482|FG001|Stage 2 Sub-study 1|Other|2|||
145288491|NCT04700449|523906483|FG002|Stage 2 Sub-study 1|Other|0|||
145288492|NCT04700449|523906484|FG003|Stage 2 Sub-study 1|Other|0|||
145288493|NCT04700449|523906481|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
145288494|NCT04700449|523906482|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
145288495|NCT04700449|523906483|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
145288496|NCT04700449|523906484|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
145288497|NCT04700449|523906481|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
145288498|NCT04700449|523906482|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
145288499|NCT04700449|523906483|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
145288500|NCT04700449|523906484|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
145288501|NCT04700449|523906481|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
145288502|NCT04700449|523906482|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
145288503|NCT04700449|523906483|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
145288504|NCT04700449|523906484|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
145288505|NCT04700449|523906481|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
145288506|NCT04700449|523906482|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
145288507|NCT04700449|523906483|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
145288508|NCT04700449|523906484|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
145288509|NCT04700449|523906481|FG000|Stage 2 Sub-study 2|Other|0|||
145288510|NCT04700449|523906482|FG001|Stage 2 Sub-study 2|Other|0|||
145288511|NCT04700449|523906483|FG002|Stage 2 Sub-study 2|Other|0|||
145288512|NCT04700449|523906484|FG003|Stage 2 Sub-study 2|Other|5|||
145288513|NCT03738332|523906485|FG000|Overall Study|Withdrawal by Subject|1|||
145288514|NCT02336737|523906486|FG000|Overall Study|Withdrawal by Subject|5|||
145288515|NCT02336737|523906486|FG000|Overall Study|Physician Decision|8|||
145288516|NCT02396381|523906487|FG000|Overall Study|Adverse Event|3|||
145288517|NCT02396381|523906488|FG001|Overall Study|Adverse Event|2|||
145288518|NCT02396381|523906487|FG000|Overall Study|Withdrawal by Subject|33|||
145288519|NCT02396381|523906488|FG001|Overall Study|Withdrawal by Subject|24|||
145288520|NCT02396381|523906487|FG000|Overall Study|Lost to Follow-up|49|||
145288521|NCT02396381|523906488|FG001|Overall Study|Lost to Follow-up|31|||
145288522|NCT02396381|523906487|FG000|Overall Study|Protocol Violation|1|||
145288523|NCT02396381|523906488|FG001|Overall Study|Protocol Violation|0|||
145288524|NCT02396381|523906487|FG000|Overall Study|Site terminated by sponsor|7|||
145288525|NCT02396381|523906488|FG001|Overall Study|Site terminated by sponsor|8|||
145288526|NCT02396381|523906487|FG000|Overall Study|Physician Decision|5|||
145288527|NCT02396381|523906488|FG001|Overall Study|Physician Decision|5|||
145288528|NCT02396381|523906487|FG000|Overall Study|Pregnancy|2|||
145288529|NCT02396381|523906488|FG001|Overall Study|Pregnancy|0|||
145288530|NCT02396381|523906487|FG000|Overall Study|Non-compliance with study procedures|1|||
145288531|NCT02396381|523906488|FG001|Overall Study|Non-compliance with study procedures|0|||
145288532|NCT02396381|523906487|FG000|Overall Study|Moved out of town/state|1|||
145288533|NCT02396381|523906488|FG001|Overall Study|Moved out of town/state|3|||
145288534|NCT02396381|523906487|FG000|Overall Study|Could not complete visit|1|||
145288535|NCT02396381|523906488|FG001|Overall Study|Could not complete visit|0|||
145288536|NCT02396381|523906487|FG000|Overall Study|Possible conflict of interest|1|||
145288537|NCT02396381|523906488|FG001|Overall Study|Possible conflict of interest|0|||
145288538|NCT02396381|523906487|FG000|Overall Study|Randomization/Screening Error|3|||
145288539|NCT02396381|523906488|FG001|Overall Study|Randomization/Screening Error|1|||
145288540|NCT00356200|523906490|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
145288541|NCT00356200|523906491|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
145288542|NCT00356200|523906490|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
145406491|NCT01799889|524343772|FG009|Overall Study|Lack of Efficacy|0|||
145288543|NCT00356200|523906491|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
145288544|NCT00635778|523906492|FG000|Overall Study|Adverse Event|1|||
145288545|NCT00635778|523906493|FG001|Overall Study|Adverse Event|0|||
145288546|NCT00635778|523906494|FG002|Overall Study|Adverse Event|0|||
145406492|NCT01799889|524343773|FG010|Overall Study|Lack of Efficacy|1|||
145614743|NCT02564055|525103670|FG001|Overall Study|Withdrawal by Subject|4|||
145614744|NCT02564055|525103671|FG002|Overall Study|Withdrawal by Subject|3|||
145614745|NCT02564055|525103672|FG003|Overall Study|Withdrawal by Subject|3|||
145614746|NCT02564055|525103673|FG004|Overall Study|Withdrawal by Subject|10|||
145614747|NCT02564055|525103674|FG005|Overall Study|Withdrawal by Subject|10|||
145614748|NCT01375959|525103675|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
145614749|NCT01375959|525103676|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
145614750|NCT01375959|525103675|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
145614751|NCT01375959|525103676|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
145614752|NCT01375959|525103675|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
145614753|NCT01375959|525103676|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
145614754|NCT02771210|525103678|FG000|Period 1|Adverse Event|5|||
145614755|NCT02771210|525103679|FG001|Period 1|Adverse Event|3|||
145614756|NCT02771210|525103678|FG000|Period 1|Lack of Efficacy|3|||
145614757|NCT02771210|525103679|FG001|Period 1|Lack of Efficacy|6|||
145614758|NCT02771210|525103678|FG000|Period 1|Lost to Follow-up|2|||
145614759|NCT02771210|525103679|FG001|Period 1|Lost to Follow-up|0|||
145614760|NCT02771210|525103678|FG000|Period 1|Physician Decision|0|||
145614761|NCT02771210|525103679|FG001|Period 1|Physician Decision|1|||
145614762|NCT02771210|525103678|FG000|Period 1|Withdrawal by Subject|0|||
145614763|NCT02771210|525103679|FG001|Period 1|Withdrawal by Subject|3|||
145614764|NCT02771210|525103678|FG000|Period 1|Withdrawal of informed consent|1|||
145614765|NCT02771210|525103679|FG001|Period 1|Withdrawal of informed consent|5|||
145614766|NCT02771210|525103678|FG000|Period 2|Adverse Event|1|||
145614767|NCT02771210|525103679|FG001|Period 2|Adverse Event|0|||
145614768|NCT02771210|525103678|FG000|Period 2|Lack of Efficacy|0|||
145614769|NCT02771210|525103679|FG001|Period 2|Lack of Efficacy|1|||
145614770|NCT02771210|525103678|FG000|Period 2|Withdrawal by Subject|1|||
145614771|NCT02771210|525103679|FG001|Period 2|Withdrawal by Subject|0|||
145614772|NCT02771210|525103678|FG000|Period 2|Withdrawal of informed consent|0|||
145614773|NCT02771210|525103679|FG001|Period 2|Withdrawal of informed consent|2|||
145614774|NCT04012814|525103683|FG000|Overall Study|Lost to Follow-up|4|||
145614775|NCT04012814|525103683|FG000|Overall Study|Withdrawal by Subject|2|||
145614776|NCT04012814|525103683|FG000|Overall Study|Protocol Violation|1|||
145614777|NCT04012814|525103683|FG000|Overall Study|Adverse Event|1|||
145614778|NCT04397523|525103684|FG000|Overall Study|Lost to Follow-up|3|||
145614779|NCT04397523|525103684|FG000|Overall Study|Transfer from/to other hospital|8|||
145614780|NCT01613027|525103692|FG000|Overall Study|Lost to Follow-up|5|||
145614781|NCT01613027|525103692|FG000|Overall Study|Switched Physician|1|||
145614782|NCT01613027|525103692|FG000|Overall Study|Lack of Efficacy|1|||
145614783|NCT01613027|525103692|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
145614784|NCT02153359|525103693|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
145614785|NCT02153359|525103694|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
145614786|NCT01040780|525105262|FG000|Overall Study|Protocol Violation|1|||
145614787|NCT01040780|525105263|FG001|Overall Study|Protocol Violation|3|||
145614788|NCT03681639|525105264|FG000|Overall Study|Death|4|||
145614789|NCT03681639|525105264|FG000|Overall Study|Lost to Follow-up|2|||
145614790|NCT03681639|525105264|FG000|Overall Study|Withdrawal by Subject|1|||
145614791|NCT03681639|525105264|FG000|Overall Study|Adverse Event|2|||
145614792|NCT00802737|525105265|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
145614793|NCT00802737|525105266|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
145614794|NCT00802737|525105267|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
145614795|NCT00802737|525105265|FG000|Overall Study|Death|6|||
145614796|NCT00802737|525105266|FG001|Overall Study|Death|5|||
145614797|NCT00802737|525105267|FG002|Overall Study|Death|1|||
145614798|NCT00802737|525105265|FG000|Overall Study|Adverse Event|1|||
145614799|NCT00802737|525105266|FG001|Overall Study|Adverse Event|0|||
145614800|NCT00802737|525105267|FG002|Overall Study|Adverse Event|0|||
145614801|NCT00802737|525105265|FG000|Overall Study|Received Prohibited Therapy|1|||
145614802|NCT00802737|525105266|FG001|Overall Study|Received Prohibited Therapy|0|||
145614803|NCT00802737|525105267|FG002|Overall Study|Received Prohibited Therapy|0|||
145614804|NCT00802737|525105265|FG000|Overall Study|Ongoing CLL-Treatment|0|||
145614805|NCT00802737|525105266|FG001|Overall Study|Ongoing CLL-Treatment|1|||
145614806|NCT00802737|525105267|FG002|Overall Study|Ongoing CLL-Treatment|0|||
145614807|NCT00802737|525105265|FG000|Overall Study|Participant too Unwell|0|||
145614808|NCT00802737|525105266|FG001|Overall Study|Participant too Unwell|2|||
145614809|NCT00802737|525105267|FG002|Overall Study|Participant too Unwell|0|||
145614810|NCT03864926|525105275|FG000|Overall Study|Death|0|||
145614811|NCT03864926|525105276|FG001|Overall Study|Death|2|||
145614812|NCT00445601|525105277|FG000|Overall Study|Withdrawal by Subject|11|||
145614813|NCT00445601|525105278|FG001|Overall Study|Withdrawal by Subject|11|||
145614814|NCT00445601|525105277|FG000|Overall Study|TURBT Complication|12|||
145614815|NCT00445601|525105278|FG001|Overall Study|TURBT Complication|8|||
145614816|NCT00445601|525105277|FG000|Overall Study|Incorrect Disease Status|6|||
145614817|NCT00445601|525105278|FG001|Overall Study|Incorrect Disease Status|6|||
145614818|NCT00445601|525105277|FG000|Overall Study|Drug Delivery Issue|2|||
145614819|NCT00445601|525105278|FG001|Overall Study|Drug Delivery Issue|2|||
145614820|NCT00445601|525105277|FG000|Overall Study|Adverse Event|2|||
145614821|NCT00445601|525105278|FG001|Overall Study|Adverse Event|0|||
145614822|NCT00445601|525105277|FG000|Overall Study|Death prior to TURBT|0|||
145614823|NCT00445601|525105278|FG001|Overall Study|Death prior to TURBT|1|||
145614824|NCT01091428|525105279|FG000|Phase 1|Progressive Disease|24|||
145614825|NCT01091428|525105280|FG001|Phase 1|Progressive Disease|8|||
145614826|NCT01091428|525105281|FG002|Phase 1|Progressive Disease|0|||
145614827|NCT01091428|525105282|FG003|Phase 1|Progressive Disease|0|||
145614828|NCT01091428|525105279|FG000|Phase 1|Symptomatic Deterioration|3|||
145614829|NCT01091428|525105280|FG001|Phase 1|Symptomatic Deterioration|2|||
145614830|NCT01091428|525105281|FG002|Phase 1|Symptomatic Deterioration|0|||
145614831|NCT01091428|525105282|FG003|Phase 1|Symptomatic Deterioration|0|||
145614832|NCT01091428|525105279|FG000|Phase 1|Adverse Event|2|||
145614833|NCT01091428|525105280|FG001|Phase 1|Adverse Event|0|||
145614834|NCT01091428|525105281|FG002|Phase 1|Adverse Event|0|||
145614835|NCT01091428|525105282|FG003|Phase 1|Adverse Event|0|||
145614836|NCT01091428|525105279|FG000|Phase 1|Withdrawal by Subject|7|||
145614837|NCT01091428|525105280|FG001|Phase 1|Withdrawal by Subject|0|||
145614838|NCT01091428|525105281|FG002|Phase 1|Withdrawal by Subject|0|||
145614839|NCT01091428|525105282|FG003|Phase 1|Withdrawal by Subject|0|||
145614840|NCT01091428|525105279|FG000|Phase 1|Reason not specified|0|||
145614841|NCT01091428|525105280|FG001|Phase 1|Reason not specified|1|||
145614842|NCT01091428|525105281|FG002|Phase 1|Reason not specified|0|||
145614843|NCT01091428|525105282|FG003|Phase 1|Reason not specified|0|||
145614844|NCT01091428|525105279|FG000|Phase 1|Single-Patient IND|2|||
145614845|NCT01091428|525105280|FG001|Phase 1|Single-Patient IND|0|||
145614846|NCT01091428|525105281|FG002|Phase 1|Single-Patient IND|0|||
145614847|NCT01091428|525105282|FG003|Phase 1|Single-Patient IND|0|||
145614848|NCT01091428|525105279|FG000|Phase 2|Progressive Disease|0|||
145614849|NCT01091428|525105280|FG001|Phase 2|Progressive Disease|0|||
145614850|NCT01091428|525105281|FG002|Phase 2|Progressive Disease|44|||
145614851|NCT01091428|525105282|FG003|Phase 2|Progressive Disease|46|||
145556092|NCT00680745|524894954|FG001|Overall Study|Lost to Follow-up|1|||
145288547|NCT00635778|523906495|FG003|Overall Study|Adverse Event|3|||
145288548|NCT00635778|523906496|FG004|Overall Study|Adverse Event|3|||
145288549|NCT00635778|523906497|FG005|Overall Study|Adverse Event|6|||
145288550|NCT00635778|523906498|FG006|Overall Study|Adverse Event|1|||
145288551|NCT00635778|523906492|FG000|Overall Study|Withdrawal by Subject|0|||
145288552|NCT00635778|523906493|FG001|Overall Study|Withdrawal by Subject|0|||
145288553|NCT00635778|523906494|FG002|Overall Study|Withdrawal by Subject|0|||
145288554|NCT00635778|523906495|FG003|Overall Study|Withdrawal by Subject|1|||
145288555|NCT00635778|523906496|FG004|Overall Study|Withdrawal by Subject|0|||
145288556|NCT00635778|523906497|FG005|Overall Study|Withdrawal by Subject|1|||
145288557|NCT00635778|523906498|FG006|Overall Study|Withdrawal by Subject|1|||
145288558|NCT00635778|523906492|FG000|Overall Study|Progressive disease|0|||
145288559|NCT00635778|523906493|FG001|Overall Study|Progressive disease|3|||
145288560|NCT00635778|523906494|FG002|Overall Study|Progressive disease|3|||
145288561|NCT00635778|523906495|FG003|Overall Study|Progressive disease|4|||
145288562|NCT00635778|523906496|FG004|Overall Study|Progressive disease|5|||
145288563|NCT00635778|523906497|FG005|Overall Study|Progressive disease|14|||
145288564|NCT00635778|523906498|FG006|Overall Study|Progressive disease|4|||
145288565|NCT01000337|523906504|FG000|Overall Study|Lost to Follow-up|4|||
145288566|NCT01000337|523906505|FG001|Overall Study|Lost to Follow-up|3|||
145288567|NCT01612000|523906506|FG000|Overall Study|Lost to Follow-up|6|||
145288568|NCT01612000|523906507|FG001|Overall Study|Lost to Follow-up|4|||
145288569|NCT01612000|523906508|FG002|Overall Study|Lost to Follow-up|4|||
145288570|NCT01612000|523906509|FG003|Overall Study|Lost to Follow-up|8|||
145288571|NCT01612000|523906506|FG000|Overall Study|Physician Decision|0|||
145288572|NCT01612000|523906507|FG001|Overall Study|Physician Decision|0|||
145288573|NCT01612000|523906508|FG002|Overall Study|Physician Decision|1|||
145288574|NCT01612000|523906509|FG003|Overall Study|Physician Decision|0|||
145288575|NCT01612000|523906506|FG000|Overall Study|Withdrawal by Subject|3|||
145288576|NCT01612000|523906507|FG001|Overall Study|Withdrawal by Subject|1|||
145288577|NCT01612000|523906508|FG002|Overall Study|Withdrawal by Subject|2|||
145288578|NCT01612000|523906509|FG003|Overall Study|Withdrawal by Subject|2|||
145288579|NCT02173704|523906510|FG000|Overall Study|Adverse Event|1|||
145556093|NCT00680745|524894955|FG002|Overall Study|Lost to Follow-up|1|||
145556094|NCT00680745|524894956|FG003|Overall Study|Lost to Follow-up|0|||
145556095|NCT00680745|524894953|FG000|Overall Study|Death|1|||
145556096|NCT00680745|524894954|FG001|Overall Study|Death|0|||
145556097|NCT00680745|524894955|FG002|Overall Study|Death|1|||
145556098|NCT00680745|524894956|FG003|Overall Study|Death|0|||
145556099|NCT00680745|524894953|FG000|Overall Study|Adverse Event|5|||
145556100|NCT00680745|524894954|FG001|Overall Study|Adverse Event|3|||
145556101|NCT00680745|524894955|FG002|Overall Study|Adverse Event|3|||
145556102|NCT00680745|524894956|FG003|Overall Study|Adverse Event|3|||
145556103|NCT00680745|524894953|FG000|Overall Study|Poor/Non-compliance|0|||
145556104|NCT00680745|524894954|FG001|Overall Study|Poor/Non-compliance|3|||
145556105|NCT00680745|524894955|FG002|Overall Study|Poor/Non-compliance|0|||
145556106|NCT00680745|524894956|FG003|Overall Study|Poor/Non-compliance|0|||
145556107|NCT00680745|524894953|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
145556108|NCT00680745|524894954|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
145556109|NCT00680745|524894955|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
145556110|NCT00680745|524894956|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
145556111|NCT00680745|524894953|FG000|Overall Study|False Treatment|0|||
145556112|NCT00680745|524894954|FG001|Overall Study|False Treatment|1|||
145556113|NCT00680745|524894955|FG002|Overall Study|False Treatment|3|||
145556114|NCT00680745|524894956|FG003|Overall Study|False Treatment|0|||
145556115|NCT01928329|524894959|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
145556116|NCT01928329|524894960|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
145556117|NCT01928329|524894959|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
145556118|NCT01928329|524894960|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
145556119|NCT01928329|524894959|FG000|Overall Study|Adverse Event|5|||
145556120|NCT01928329|524894960|FG001|Overall Study|Adverse Event|3|||
145556121|NCT01928329|524894959|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
145556122|NCT01928329|524894960|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
145556123|NCT01928329|524894959|FG000|Overall Study|Withdrawal by Subject|1|||
145556124|NCT01928329|524894960|FG001|Overall Study|Withdrawal by Subject|5|||
145556125|NCT01928329|524894959|FG000|Overall Study|Physician Decision|1|||
145556126|NCT01928329|524894960|FG001|Overall Study|Physician Decision|1|||
145556127|NCT02141997|524894962|FG000|Overall Study|Adverse Event|0|||
145556128|NCT02141997|524894963|FG001|Overall Study|Adverse Event|2|||
145556129|NCT02141997|524894964|FG002|Overall Study|Adverse Event|0|||
145556130|NCT02141997|524894965|FG003|Overall Study|Adverse Event|1|||
145556131|NCT02141997|524894962|FG000|Overall Study|Participant noncompliance|1|||
145556132|NCT02141997|524894963|FG001|Overall Study|Participant noncompliance|0|||
145556133|NCT02141997|524894964|FG002|Overall Study|Participant noncompliance|0|||
145288580|NCT02173704|523906511|FG001|Overall Study|Adverse Event|0|||
145288581|NCT02173704|523906510|FG000|Overall Study|Lost to Follow-up|1|||
145288582|NCT02173704|523906511|FG001|Overall Study|Lost to Follow-up|0|||
145614852|NCT01091428|525105279|FG000|Phase 2|Symptomatic Deterioration|0|||
145614853|NCT01091428|525105280|FG001|Phase 2|Symptomatic Deterioration|0|||
145614854|NCT01091428|525105281|FG002|Phase 2|Symptomatic Deterioration|1|||
145614855|NCT01091428|525105282|FG003|Phase 2|Symptomatic Deterioration|6|||
145614856|NCT01091428|525105279|FG000|Phase 2|Adverse Event|0|||
145614857|NCT01091428|525105280|FG001|Phase 2|Adverse Event|0|||
145614858|NCT01091428|525105281|FG002|Phase 2|Adverse Event|12|||
145614859|NCT01091428|525105282|FG003|Phase 2|Adverse Event|5|||
145614860|NCT01091428|525105279|FG000|Phase 2|Withdrawal by Subject|0|||
145614861|NCT01091428|525105280|FG001|Phase 2|Withdrawal by Subject|0|||
145614862|NCT01091428|525105281|FG002|Phase 2|Withdrawal by Subject|9|||
145614863|NCT01091428|525105282|FG003|Phase 2|Withdrawal by Subject|8|||
145614864|NCT01091428|525105279|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
145614865|NCT01091428|525105280|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
145614866|NCT01091428|525105281|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
145614867|NCT01091428|525105282|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
145614868|NCT01091428|525105279|FG000|Phase 2|Reason not specified|0|||
145614869|NCT01091428|525105280|FG001|Phase 2|Reason not specified|0|||
145614870|NCT01091428|525105281|FG002|Phase 2|Reason not specified|4|||
145614871|NCT01091428|525105282|FG003|Phase 2|Reason not specified|3|||
145614872|NCT01091428|525105279|FG000|Phase 2|Physician Decision|0|||
145614873|NCT01091428|525105280|FG001|Phase 2|Physician Decision|0|||
145614874|NCT01091428|525105281|FG002|Phase 2|Physician Decision|2|||
145614875|NCT01091428|525105282|FG003|Phase 2|Physician Decision|0|||
145614876|NCT01625910|525105289|FG000|Overall Study|Lost to Follow-up|3|||
145614877|NCT01625910|525105290|FG001|Overall Study|Lost to Follow-up|4|||
145614878|NCT02391038|525105291|FG000|Overall Study|Progressive disease|3|||
145614879|NCT02391038|525105292|FG001|Overall Study|Progressive disease|3|||
145614880|NCT02391038|525105293|FG002|Overall Study|Progressive disease|6|||
145614881|NCT02959138|525105294|FG000|Overall Study|Enrolled but Never Treated|0|||
145614882|NCT02959138|525105295|FG001|Overall Study|Enrolled but Never Treated|1|||
145614883|NCT02959138|525105296|FG002|Overall Study|Enrolled but Never Treated|0|||
145614884|NCT01327547|525105302|FG000|Overall Study|Adverse Event|4|||
145614885|NCT01327547|525105303|FG001|Overall Study|Adverse Event|1|||
145614886|NCT01327547|525105302|FG000|Overall Study|Death|1|||
145614887|NCT01327547|525105303|FG001|Overall Study|Death|2|||
145614888|NCT01327547|525105302|FG000|Overall Study|Lost to Follow-up|6|||
145614889|NCT01327547|525105303|FG001|Overall Study|Lost to Follow-up|6|||
145614890|NCT01327547|525105302|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
145614891|NCT01327547|525105303|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
145614892|NCT01327547|525105302|FG000|Overall Study|Withdrawal by Subject|3|||
145614893|NCT01327547|525105303|FG001|Overall Study|Withdrawal by Subject|7|||
145614894|NCT01327547|525105302|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
145614895|NCT01327547|525105303|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
145614896|NCT01327547|525105302|FG000|Overall Study|Protocol Violation|1|||
145614897|NCT01327547|525105303|FG001|Overall Study|Protocol Violation|0|||
145614898|NCT01327547|525105302|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
145614899|NCT01327547|525105303|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
145614900|NCT01327547|525105302|FG000|Overall Study|Required prohibited medication|2|||
145614901|NCT01327547|525105303|FG001|Overall Study|Required prohibited medication|0|||
145614902|NCT01327547|525105302|FG000|Overall Study|Non-compliance with study procedures|1|||
145614903|NCT01327547|525105303|FG001|Overall Study|Non-compliance with study procedures|0|||
145614904|NCT01327547|525105302|FG000|Overall Study|By investigator in subject's interest|0|||
145614905|NCT01327547|525105303|FG001|Overall Study|By investigator in subject's interest|1|||
145614906|NCT00329719|525105304|FG000|Overall Study|Lost to Follow-up|0|||
145614907|NCT00329719|525105305|FG001|Overall Study|Lost to Follow-up|0|||
145614908|NCT00329719|525105306|FG002|Overall Study|Lost to Follow-up|0|||
145614909|NCT00329719|525105307|FG003|Overall Study|Lost to Follow-up|1|||
145614910|NCT03918239|525105308|FG000|Overall Study|Lost to Follow-up|3|||
145614911|NCT03918239|525105309|FG001|Overall Study|Lost to Follow-up|1|||
145614912|NCT03918239|525105308|FG000|Overall Study|Pregnancy|0|||
145614913|NCT03918239|525105309|FG001|Overall Study|Pregnancy|2|||
145614914|NCT03918239|525105308|FG000|Overall Study|Withdrawal by Subject|3|||
145614915|NCT03918239|525105309|FG001|Overall Study|Withdrawal by Subject|3|||
145614916|NCT03918239|525105308|FG000|Overall Study|positive urine drug screening results|4|||
145614917|NCT03918239|525105309|FG001|Overall Study|positive urine drug screening results|1|||
145614918|NCT02930122|525105310|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
145614919|NCT02930122|525105311|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
145614920|NCT00358215|525105312|FG000|Overall Study|Ineligibility determined|4|||
145614921|NCT00358215|525105313|FG001|Overall Study|Ineligibility determined|3|||
145614922|NCT00358215|525105312|FG000|Overall Study|Adverse Event|83|||
145614923|NCT00358215|525105313|FG001|Overall Study|Adverse Event|65|||
145614924|NCT00358215|525105312|FG000|Overall Study|Withdrawal by Subject|111|||
145614925|NCT00358215|525105313|FG001|Overall Study|Withdrawal by Subject|102|||
145288583|NCT02173704|523906510|FG000|Overall Study|Other|1|||
145614926|NCT00358215|525105312|FG000|Overall Study|Participant request|65|||
145614927|NCT00358215|525105313|FG001|Overall Study|Participant request|64|||
145614928|NCT00358215|525105312|FG000|Overall Study|Physician Decision|47|||
145614929|NCT00358215|525105313|FG001|Overall Study|Physician Decision|39|||
145614930|NCT00358215|525105312|FG000|Overall Study|Lost to Follow-up|16|||
145614931|NCT00358215|525105313|FG001|Overall Study|Lost to Follow-up|22|||
145614932|NCT00358215|525105312|FG000|Overall Study|Death|265|||
145614933|NCT00358215|525105313|FG001|Overall Study|Death|281|||
145614934|NCT00358215|525105312|FG000|Overall Study|Protocol Violation|64|||
145614935|NCT00358215|525105313|FG001|Overall Study|Protocol Violation|59|||
145614936|NCT00358215|525105312|FG000|Overall Study|Pregnancy|1|||
145614937|NCT00358215|525105313|FG001|Overall Study|Pregnancy|0|||
145614938|NCT00358215|525105312|FG000|Overall Study|Other|21|||
145614939|NCT00358215|525105313|FG001|Overall Study|Other|14|||
145614940|NCT00358215|525105312|FG000|Overall Study|Did not receive investigational product|2|||
145614941|NCT00358215|525105313|FG001|Overall Study|Did not receive investigational product|3|||
145614942|NCT01681368|525105316|FG000|Overall Study|Refused further treatment|1|||
145614943|NCT01681368|525105316|FG000|Overall Study|Refused further follow up|1|||
145614944|NCT00373295|525105319|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145614945|NCT00373295|525105320|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
145614946|NCT00373295|525105321|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145614947|NCT00373295|525105322|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145614948|NCT00373295|525105323|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
145614949|NCT00373295|525105324|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
145614950|NCT01238575|525105334|FG000|Overall Study|Lack of Efficacy|2|||
145614951|NCT01238575|525105335|FG001|Overall Study|Lack of Efficacy|4|||
145614952|NCT01238575|525105334|FG000|Overall Study|Adverse Event|2|||
145614953|NCT01238575|525105335|FG001|Overall Study|Adverse Event|0|||
145614954|NCT02111213|525105338|FG000|Overall Study|Withdrawal by Subject|3|||
145614955|NCT02111213|525105339|FG001|Overall Study|Withdrawal by Subject|2|||
145614956|NCT02111213|525105338|FG000|Overall Study|Lost to Follow-up|3|||
145614957|NCT02111213|525105339|FG001|Overall Study|Lost to Follow-up|4|||
145614958|NCT01865617|525105342|FG000|Overall Study|Death|27|||
145614959|NCT01865617|525105343|FG001|Overall Study|Death|3|||
145614960|NCT01865617|525105344|FG002|Overall Study|Death|1|||
145614961|NCT01865617|525105345|FG003|Overall Study|Death|1|||
145614962|NCT01865617|525105346|FG004|Overall Study|Death|5|||
145614963|NCT01865617|525105347|FG005|Overall Study|Death|1|||
145614964|NCT01865617|525105348|FG006|Overall Study|Death|11|||
145614965|NCT01865617|525105349|FG007|Overall Study|Death|1|||
145614966|NCT01865617|525105350|FG008|Overall Study|Death|11|||
145614967|NCT01865617|525105351|FG009|Overall Study|Death|3|||
145614968|NCT01865617|525105352|FG010|Overall Study|Death|32|||
145614969|NCT01865617|525105353|FG011|Overall Study|Death|6|||
145614970|NCT01865617|525105354|FG012|Overall Study|Death|13|||
145614971|NCT01865617|525105342|FG000|Overall Study|Lost to Follow-up|2|||
145614972|NCT01865617|525105343|FG001|Overall Study|Lost to Follow-up|0|||
145614973|NCT01865617|525105344|FG002|Overall Study|Lost to Follow-up|0|||
145614974|NCT01865617|525105345|FG003|Overall Study|Lost to Follow-up|0|||
145614975|NCT01865617|525105346|FG004|Overall Study|Lost to Follow-up|0|||
145614976|NCT01865617|525105347|FG005|Overall Study|Lost to Follow-up|0|||
145614977|NCT01865617|525105348|FG006|Overall Study|Lost to Follow-up|0|||
145614978|NCT01865617|525105349|FG007|Overall Study|Lost to Follow-up|0|||
145614979|NCT01865617|525105350|FG008|Overall Study|Lost to Follow-up|0|||
145614980|NCT01865617|525105351|FG009|Overall Study|Lost to Follow-up|0|||
145614981|NCT01865617|525105352|FG010|Overall Study|Lost to Follow-up|0|||
145614982|NCT01865617|525105353|FG011|Overall Study|Lost to Follow-up|0|||
145614983|NCT01865617|525105354|FG012|Overall Study|Lost to Follow-up|0|||
145614984|NCT01865617|525105342|FG000|Overall Study|Withdrawal by Subject|1|||
145614985|NCT01865617|525105343|FG001|Overall Study|Withdrawal by Subject|0|||
145614986|NCT01865617|525105344|FG002|Overall Study|Withdrawal by Subject|0|||
145614987|NCT01865617|525105345|FG003|Overall Study|Withdrawal by Subject|0|||
145614988|NCT01865617|525105346|FG004|Overall Study|Withdrawal by Subject|0|||
145614989|NCT01865617|525105347|FG005|Overall Study|Withdrawal by Subject|0|||
145614990|NCT01865617|525105348|FG006|Overall Study|Withdrawal by Subject|0|||
145614991|NCT01865617|525105349|FG007|Overall Study|Withdrawal by Subject|0|||
145614992|NCT01865617|525105350|FG008|Overall Study|Withdrawal by Subject|0|||
145614993|NCT01865617|525105351|FG009|Overall Study|Withdrawal by Subject|0|||
145614994|NCT01865617|525105352|FG010|Overall Study|Withdrawal by Subject|0|||
145614995|NCT01865617|525105353|FG011|Overall Study|Withdrawal by Subject|0|||
145614996|NCT01865617|525105354|FG012|Overall Study|Withdrawal by Subject|0|||
145614997|NCT01865617|525105342|FG000|Overall Study|Patient proceeded to new therapy|0|||
145614998|NCT01865617|525105343|FG001|Overall Study|Patient proceeded to new therapy|0|||
145614999|NCT01865617|525105344|FG002|Overall Study|Patient proceeded to new therapy|0|||
145615000|NCT01865617|525105345|FG003|Overall Study|Patient proceeded to new therapy|0|||
145615001|NCT01865617|525105346|FG004|Overall Study|Patient proceeded to new therapy|2|||
145615002|NCT01865617|525105347|FG005|Overall Study|Patient proceeded to new therapy|0|||
145615003|NCT01865617|525105348|FG006|Overall Study|Patient proceeded to new therapy|0|||
145615004|NCT01865617|525105349|FG007|Overall Study|Patient proceeded to new therapy|0|||
145615005|NCT01865617|525105350|FG008|Overall Study|Patient proceeded to new therapy|0|||
145615006|NCT01865617|525105351|FG009|Overall Study|Patient proceeded to new therapy|0|||
145615007|NCT01865617|525105352|FG010|Overall Study|Patient proceeded to new therapy|0|||
145615008|NCT01865617|525105353|FG011|Overall Study|Patient proceeded to new therapy|0|||
145615009|NCT01865617|525105354|FG012|Overall Study|Patient proceeded to new therapy|0|||
145615010|NCT01865617|525105342|FG000|Overall Study|Other|0|||
145615011|NCT01865617|525105343|FG001|Overall Study|Other|0|||
145615012|NCT01865617|525105344|FG002|Overall Study|Other|0|||
145615013|NCT01865617|525105345|FG003|Overall Study|Other|0|||
145615014|NCT01865617|525105346|FG004|Overall Study|Other|0|||
145615015|NCT01865617|525105347|FG005|Overall Study|Other|0|||
145615016|NCT01865617|525105348|FG006|Overall Study|Other|1|||
145615017|NCT01865617|525105349|FG007|Overall Study|Other|0|||
145615018|NCT01865617|525105350|FG008|Overall Study|Other|0|||
145615019|NCT01865617|525105351|FG009|Overall Study|Other|0|||
145615020|NCT01865617|525105352|FG010|Overall Study|Other|0|||
145615021|NCT01865617|525105353|FG011|Overall Study|Other|0|||
145615022|NCT01865617|525105354|FG012|Overall Study|Other|0|||
145615023|NCT02226172|525105355|FG000|Overall Study|Participant refused further follow-up|4|||
145615024|NCT02226172|525105355|FG000|Overall Study|Other|5|||
145615025|NCT02226172|525105355|FG000|Overall Study|Death|1|||
145615026|NCT02226172|525105355|FG000|Overall Study|Study terminated by sponsor|1|||
145615027|NCT02226172|525105355|FG000|Overall Study|Adverse Event|6|||
145615028|NCT00502996|525105356|FG000|Overall Study|Lost to Follow-up|9|||
145615029|NCT00502996|525105356|FG000|Overall Study|Protocol Violation|2|||
145615030|NCT00502996|525105356|FG000|Overall Study|Treatment failure|25|||
145615031|NCT00502996|525105356|FG000|Overall Study|Withdrawal Informed Consent|6|||
145615032|NCT00502996|525105356|FG000|Overall Study|Adverse Event|2|||
145615033|NCT02500979|525105357|FG000|Period 1|Hyperglycemia|1|||
145615034|NCT02500979|525105358|FG001|Period 1|Hyperglycemia|0|||
145615035|NCT02500979|525105357|FG000|Period 1|Severe non-compliance to protocol|0|||
145615036|NCT02500979|525105358|FG001|Period 1|Severe non-compliance to protocol|1|||
145615037|NCT02500979|525105357|FG000|Period 1|Adverse Event|1|||
145615038|NCT02500979|525105358|FG001|Period 1|Adverse Event|0|||
145615039|NCT02500979|525105357|FG000|Period 1|Subject decision|2|||
145615040|NCT02500979|525105358|FG001|Period 1|Subject decision|0|||
145615041|NCT02500979|525105357|FG000|Period 2|Change in risk|1|||
145615042|NCT02500979|525105358|FG001|Period 2|Change in risk|0|||
145615043|NCT02796963|525105359|FG000|Overall Study|Lost to Follow-up|89|||
145615044|NCT02796963|525105360|FG001|Overall Study|Lost to Follow-up|76|||
145615045|NCT02796963|525105361|FG002|Overall Study|Lost to Follow-up|69|||
145615046|NCT02796963|525105362|FG003|Overall Study|Lost to Follow-up|72|||
145615047|NCT00988351|525105364|FG000|Overall Study|Withdrawal by Subject|8|||
145615048|NCT00988351|525105365|FG001|Overall Study|Withdrawal by Subject|0|||
145615049|NCT00988351|525105364|FG000|Overall Study|Lost to Follow-up|6|||
145615050|NCT00988351|525105365|FG001|Overall Study|Lost to Follow-up|9|||
145615051|NCT00988351|525105364|FG000|Overall Study|not using CPAP|5|||
145615052|NCT00988351|525105365|FG001|Overall Study|not using CPAP|3|||
145615053|NCT01551303|525105376|FG000|Overall Study|failed awareness check on vision test|4|||
145615054|NCT01551303|525105377|FG001|Overall Study|failed awareness check on vision test|7|||
145615055|NCT02878213|525105378|FG000|Overall Study|Withdrawal by Subject|2|||
145615056|NCT02878213|525105378|FG000|Overall Study|Adverse Event|1|||
145615057|NCT02471404|525105384|FG000|Overall Study|Adverse Event|7|||
145615058|NCT02471404|525105385|FG001|Overall Study|Adverse Event|1|||
145615059|NCT02471404|525105386|FG002|Overall Study|Adverse Event|2|||
145615060|NCT02471404|525105384|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
145615061|NCT02471404|525105385|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
145615062|NCT02471404|525105386|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
145615063|NCT02471404|525105384|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
145615064|NCT02471404|525105385|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145615065|NCT02471404|525105386|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
145615066|NCT02471404|525105384|FG000|Overall Study|Lost to Follow-up|1|||
145615067|NCT02471404|525105385|FG001|Overall Study|Lost to Follow-up|1|||
145615068|NCT02471404|525105386|FG002|Overall Study|Lost to Follow-up|3|||
145615069|NCT02471404|525105384|FG000|Overall Study|Protocol Violation|1|||
145615070|NCT02471404|525105385|FG001|Overall Study|Protocol Violation|0|||
145615071|NCT02471404|525105386|FG002|Overall Study|Protocol Violation|0|||
145615072|NCT02471404|525105384|FG000|Overall Study|Withdrawal by Subject|8|||
145615073|NCT02471404|525105385|FG001|Overall Study|Withdrawal by Subject|4|||
145615074|NCT02471404|525105386|FG002|Overall Study|Withdrawal by Subject|5|||
145615075|NCT02471404|525105384|FG000|Overall Study|Other reasons not specified|10|||
145615076|NCT02471404|525105385|FG001|Overall Study|Other reasons not specified|7|||
145615077|NCT02471404|525105386|FG002|Overall Study|Other reasons not specified|12|||
145615078|NCT01927731|525105387|FG000|Overall Study|Graft Failure|1|||
145615079|NCT01927731|525105388|FG001|Overall Study|Graft Failure|2|||
145615080|NCT01927731|525105387|FG000|Overall Study|Physician Decision|2|||
145615081|NCT01927731|525105388|FG001|Overall Study|Physician Decision|3|||
145615082|NCT01927731|525105387|FG000|Overall Study|Withdrawal by Subject|0|||
145615083|NCT01927731|525105388|FG001|Overall Study|Withdrawal by Subject|2|||
145288584|NCT02173704|523906511|FG001|Overall Study|Other|0|||
145288585|NCT02173704|523906510|FG000|Overall Study|Protocol Violation|1|||
145288586|NCT02173704|523906511|FG001|Overall Study|Protocol Violation|0|||
145288587|NCT02173704|523906510|FG000|Overall Study|Withdrawal by Subject|9|||
145288588|NCT02173704|523906511|FG001|Overall Study|Withdrawal by Subject|4|||
145288589|NCT00419926|523906512|FG000|Overall Study|Withdrawal by Subject|7|||
145288590|NCT00419926|523906513|FG001|Overall Study|Withdrawal by Subject|3|||
145288591|NCT00419926|523906512|FG000|Overall Study|Administrative Problem|4|||
145288592|NCT00419926|523906513|FG001|Overall Study|Administrative Problem|4|||
145288593|NCT00419926|523906512|FG000|Overall Study|Lost to Follow-up|1|||
145288594|NCT00419926|523906513|FG001|Overall Study|Lost to Follow-up|2|||
145288595|NCT00419926|523906512|FG000|Overall Study|Death|2|||
145288596|NCT00419926|523906513|FG001|Overall Study|Death|1|||
145288597|NCT01180244|523906516|FG000|Overall Study|Lack of Efficacy|0|||
145288598|NCT01180244|523906517|FG001|Overall Study|Lack of Efficacy|7|||
145288599|NCT01180244|523906516|FG000|Overall Study|Physician Decision|3|||
145288600|NCT01180244|523906517|FG001|Overall Study|Physician Decision|0|||
145288601|NCT01180244|523906516|FG000|Overall Study|Adverse Event|1|||
145288602|NCT01180244|523906517|FG001|Overall Study|Adverse Event|0|||
145288603|NCT01180244|523906516|FG000|Overall Study|Withdrawal by Subject|0|||
145288604|NCT01180244|523906517|FG001|Overall Study|Withdrawal by Subject|1|||
145288605|NCT01180244|523906516|FG000|Overall Study|Protocol Violation|1|||
145288606|NCT01180244|523906517|FG001|Overall Study|Protocol Violation|0|||
145288607|NCT01180244|523906516|FG000|Overall Study|Lost to Follow-up|1|||
145288608|NCT01180244|523906517|FG001|Overall Study|Lost to Follow-up|0|||
145288609|NCT01595009|523906518|FG000|Core|Patients completed per protocol|85|||
145288610|NCT01595009|523906519|FG001|Core|Patients completed per protocol|44|||
145288611|NCT01595009|523906520|FG002|Core|Patients completed per protocol|0|||
145288612|NCT01595009|523906521|FG003|Core|Patients completed per protocol|0|||
145288613|NCT01595009|523906518|FG000|Core|Adverse Event|19|||
145288614|NCT01595009|523906519|FG001|Core|Adverse Event|23|||
145288615|NCT01595009|523906520|FG002|Core|Adverse Event|0|||
145288616|NCT01595009|523906521|FG003|Core|Adverse Event|0|||
145288617|NCT01595009|523906518|FG000|Core|Disease progression|14|||
145288618|NCT01595009|523906519|FG001|Core|Disease progression|26|||
145288619|NCT01595009|523906520|FG002|Core|Disease progression|0|||
145288620|NCT01595009|523906521|FG003|Core|Disease progression|0|||
145288621|NCT01595009|523906518|FG000|Core|Withdrawal by Subject|4|||
145288622|NCT01595009|523906519|FG001|Core|Withdrawal by Subject|17|||
145288623|NCT01595009|523906520|FG002|Core|Withdrawal by Subject|0|||
145288624|NCT01595009|523906521|FG003|Core|Withdrawal by Subject|0|||
145288625|NCT01595009|523906518|FG000|Core|Death|3|||
145288626|NCT01595009|523906519|FG001|Core|Death|6|||
145288627|NCT01595009|523906520|FG002|Core|Death|0|||
145288628|NCT01595009|523906521|FG003|Core|Death|0|||
145288629|NCT01595009|523906518|FG000|Core|Lost to Follow-up|1|||
145288630|NCT01595009|523906519|FG001|Core|Lost to Follow-up|2|||
145288631|NCT01595009|523906520|FG002|Core|Lost to Follow-up|0|||
145288632|NCT01595009|523906521|FG003|Core|Lost to Follow-up|0|||
145288633|NCT01595009|523906518|FG000|Core|Protocol deviation|0|||
145288634|NCT01595009|523906519|FG001|Core|Protocol deviation|1|||
145288635|NCT01595009|523906520|FG002|Core|Protocol deviation|0|||
145288636|NCT01595009|523906521|FG003|Core|Protocol deviation|0|||
145288637|NCT01595009|523906518|FG000|Core|Administrative problems|0|||
145288638|NCT01595009|523906519|FG001|Core|Administrative problems|1|||
145288639|NCT01595009|523906520|FG002|Core|Administrative problems|0|||
145288640|NCT01595009|523906521|FG003|Core|Administrative problems|0|||
145288641|NCT01595009|523906518|FG000|Extension|Administrative problems|0|||
145288642|NCT01595009|523906519|FG001|Extension|Administrative problems|0|||
145288643|NCT01595009|523906520|FG002|Extension|Administrative problems|0|||
145288644|NCT01595009|523906521|FG003|Extension|Administrative problems|1|||
145288645|NCT01595009|523906518|FG000|Extension|Patients completed per protocol|0|||
145288646|NCT01595009|523906519|FG001|Extension|Patients completed per protocol|0|||
145288647|NCT01595009|523906520|FG002|Extension|Patients completed per protocol|0|||
145288648|NCT01595009|523906521|FG003|Extension|Patients completed per protocol|2|||
145288649|NCT01595009|523906518|FG000|Extension|Disease progression|0|||
145288650|NCT01595009|523906519|FG001|Extension|Disease progression|0|||
145288651|NCT01595009|523906520|FG002|Extension|Disease progression|4|||
145288652|NCT01595009|523906521|FG003|Extension|Disease progression|7|||
145288653|NCT01595009|523906518|FG000|Extension|Adverse Event|0|||
145288654|NCT01595009|523906519|FG001|Extension|Adverse Event|0|||
145288655|NCT01595009|523906520|FG002|Extension|Adverse Event|0|||
145288656|NCT01595009|523906521|FG003|Extension|Adverse Event|1|||
145288657|NCT00783796|523906522|FG000|Overall Study|Did not receive any stent|4|||
145288658|NCT00783796|523906522|FG000|Overall Study|Received non-XIENCE V stent|1|||
145288659|NCT00783796|523906522|FG000|Overall Study|Received commercial XIENCE V stent|1|||
145288660|NCT00626925|523906527|FG000|Overall Study|Lost to Follow-up|1|||
145288661|NCT00626925|523906528|FG001|Overall Study|Lost to Follow-up|2|||
145288662|NCT00626925|523906527|FG000|Overall Study|relapse|1|||
145288663|NCT00626925|523906528|FG001|Overall Study|relapse|0|||
145288664|NCT00626925|523906527|FG000|Overall Study|Adverse effect|6|||
145615084|NCT01927731|525105387|FG000|Overall Study|Death|0|||
145615085|NCT01927731|525105388|FG001|Overall Study|Death|3|||
145615086|NCT01464255|525105389|FG000|Overall Study|unresolve corneal staining|0|||
145615087|NCT01464255|525105390|FG001|Overall Study|unresolve corneal staining|1|||
145615088|NCT00785538|525105391|FG000|Treatment Period|Adverse Event|1|||
145615089|NCT00785538|525105392|FG001|Treatment Period|Adverse Event|2|||
145615090|NCT00785538|525105393|FG002|Treatment Period|Adverse Event|2|||
145615091|NCT00785538|525105394|FG003|Treatment Period|Adverse Event|0|||
145615092|NCT00785538|525105391|FG000|Treatment Period|Withdrawal by Subject|0|||
145615093|NCT00785538|525105392|FG001|Treatment Period|Withdrawal by Subject|0|||
145615094|NCT00785538|525105393|FG002|Treatment Period|Withdrawal by Subject|0|||
145615095|NCT00785538|525105394|FG003|Treatment Period|Withdrawal by Subject|1|||
145615096|NCT02066532|525105397|FG000|Phase II|Withdrawal by Subject|1|||
145615097|NCT02066532|525105398|FG001|Phase II|Withdrawal by Subject|0|||
145615098|NCT02066532|525105399|FG002|Phase II|Withdrawal by Subject|0|||
145615099|NCT02066532|525105400|FG003|Phase II|Withdrawal by Subject|0|||
145615100|NCT05033080|525105401|FG000|Overall Study|Adverse Event|4|||
145615101|NCT05033080|525105402|FG001|Overall Study|Adverse Event|4|||
145615102|NCT05033080|525105401|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
145615103|NCT05033080|525105402|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
145615104|NCT05033080|525105401|FG000|Overall Study|Lost to Follow-up|1|||
145615105|NCT05033080|525105402|FG001|Overall Study|Lost to Follow-up|0|||
145615106|NCT05033080|525105401|FG000|Overall Study|Other non-compliance|0|||
145615107|NCT05033080|525105402|FG001|Overall Study|Other non-compliance|1|||
145615108|NCT05033080|525105401|FG000|Overall Study|Physician Decision|0|||
145615109|NCT05033080|525105402|FG001|Overall Study|Physician Decision|1|||
145615110|NCT05033080|525105401|FG000|Overall Study|Other|1|||
145615111|NCT05033080|525105402|FG001|Overall Study|Other|1|||
145615112|NCT03560245|525105403|FG000|Overall Study|Withdrawal by Subject|3|||
145615113|NCT03560245|525105404|FG001|Overall Study|Withdrawal by Subject|2|||
145615114|NCT03560245|525105403|FG000|Overall Study|Adverse Event|1|||
145615115|NCT03560245|525105404|FG001|Overall Study|Adverse Event|1|||
145615116|NCT03560245|525105403|FG000|Overall Study|Protocol Violation|1|||
145615117|NCT03560245|525105404|FG001|Overall Study|Protocol Violation|0|||
145615118|NCT03560245|525105403|FG000|Overall Study|Death|0|||
145615119|NCT03560245|525105404|FG001|Overall Study|Death|1|||
145615120|NCT03560245|525105403|FG000|Overall Study|Lost to Follow-up|0|||
145615121|NCT03560245|525105404|FG001|Overall Study|Lost to Follow-up|1|||
145615122|NCT03560245|525105403|FG000|Overall Study|Physician Decision|0|||
145615123|NCT03560245|525105404|FG001|Overall Study|Physician Decision|1|||
145615124|NCT03560245|525105403|FG000|Overall Study|Other|0|||
145615125|NCT03560245|525105404|FG001|Overall Study|Other|1|||
145615126|NCT01265823|525105405|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
145615127|NCT01265823|525105405|FG000|Overall Study|Failure to Return|4|||
145615128|NCT01265823|525105405|FG000|Overall Study|Protocol Violation|1|||
145615129|NCT01265823|525105405|FG000|Overall Study|Participant Request|1|||
145615130|NCT01263106|525105406|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
145615131|NCT01263106|525105407|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
145615132|NCT01794117|525105411|FG000|Overall Study|Adverse Event|1|||
145615133|NCT01794117|525105412|FG001|Overall Study|Adverse Event|0|||
145615134|NCT01794117|525105413|FG002|Overall Study|Adverse Event|0|||
145615135|NCT01794117|525105414|FG003|Overall Study|Adverse Event|0|||
145615136|NCT01794117|525105411|FG000|Overall Study|Participant noncompliance|0|||
145615137|NCT01794117|525105412|FG001|Overall Study|Participant noncompliance|1|||
145615138|NCT01794117|525105413|FG002|Overall Study|Participant noncompliance|0|||
145615139|NCT01794117|525105414|FG003|Overall Study|Participant noncompliance|0|||
145615140|NCT01794117|525105411|FG000|Overall Study|Refused further treatment|0|||
145615141|NCT01794117|525105412|FG001|Overall Study|Refused further treatment|2|||
145615142|NCT01794117|525105413|FG002|Overall Study|Refused further treatment|0|||
145615143|NCT01794117|525105414|FG003|Overall Study|Refused further treatment|0|||
145615144|NCT02401308|525105416|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
145615145|NCT02401308|525105417|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
145615146|NCT02998021|525105418|FG000|Overall Study|Withdrawal by Subject|3|||
145615147|NCT02998021|525105419|FG001|Overall Study|Withdrawal by Subject|1|||
145615148|NCT02998021|525105418|FG000|Overall Study|unsafe home|0|||
145615149|NCT02998021|525105419|FG001|Overall Study|unsafe home|1|||
145615150|NCT01734434|525105420|FG000|Overall Study|Death Infant|3|||
145615151|NCT01734434|525105421|FG001|Overall Study|Death Infant|1|||
145615152|NCT01734434|525105422|FG002|Overall Study|Death Infant|17|||
145615153|NCT01734434|525105423|FG003|Overall Study|Death Infant|5|||
145615154|NCT01734434|525105420|FG000|Overall Study|Lost to Follow-up|2|||
145615155|NCT01734434|525105421|FG001|Overall Study|Lost to Follow-up|9|||
145615156|NCT01734434|525105422|FG002|Overall Study|Lost to Follow-up|67|||
145615157|NCT01734434|525105423|FG003|Overall Study|Lost to Follow-up|11|||
145615158|NCT01734434|525105420|FG000|Overall Study|No Live Birth|1|||
145615159|NCT01734434|525105421|FG001|Overall Study|No Live Birth|2|||
145615160|NCT01734434|525105422|FG002|Overall Study|No Live Birth|32|||
145615161|NCT01734434|525105423|FG003|Overall Study|No Live Birth|6|||
145615162|NCT01734434|525105420|FG000|Overall Study|Withdrawal by Subject|4|||
145615163|NCT01734434|525105421|FG001|Overall Study|Withdrawal by Subject|0|||
145615164|NCT01734434|525105422|FG002|Overall Study|Withdrawal by Subject|8|||
145615165|NCT01734434|525105423|FG003|Overall Study|Withdrawal by Subject|1|||
145615166|NCT01734434|525105420|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
145615167|NCT01734434|525105421|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
145615168|NCT01734434|525105422|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
145615169|NCT01734434|525105423|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
145615170|NCT01734434|525105420|FG000|Overall Study|Subject Not Reachable|0|||
145615171|NCT01734434|525105421|FG001|Overall Study|Subject Not Reachable|0|||
145615172|NCT01734434|525105422|FG002|Overall Study|Subject Not Reachable|1|||
145615173|NCT01734434|525105423|FG003|Overall Study|Subject Not Reachable|0|||
145615174|NCT01734434|525105420|FG000|Overall Study|Treatment Defaulter|0|||
145615175|NCT01734434|525105421|FG001|Overall Study|Treatment Defaulter|0|||
145615176|NCT01734434|525105422|FG002|Overall Study|Treatment Defaulter|1|||
145615177|NCT01734434|525105423|FG003|Overall Study|Treatment Defaulter|0|||
145615178|NCT01734434|525105420|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
145615179|NCT01734434|525105421|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
145615180|NCT01734434|525105422|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
145615181|NCT01734434|525105423|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
145615182|NCT01734434|525105420|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
145615183|NCT01734434|525105421|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
145615184|NCT01734434|525105422|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
145615185|NCT01734434|525105423|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
145615186|NCT00654940|525106840|FG000|Period 1|Adverse Event|0|||
145615187|NCT00654940|525106841|FG001|Period 1|Adverse Event|1|||
145615188|NCT00654940|525106840|FG000|Period 1|Intolerable Pain Level|1|||
145615189|NCT00654940|525106841|FG001|Period 1|Intolerable Pain Level|0|||
145615190|NCT00962585|525106845|FG000|Overall Study|Adverse Event|0|||
145615191|NCT00962585|525106846|FG001|Overall Study|Adverse Event|2|||
145615192|NCT00962585|525106847|FG002|Overall Study|Adverse Event|1|||
145615193|NCT00962585|525106848|FG003|Overall Study|Adverse Event|0|||
145615194|NCT00962585|525106845|FG000|Overall Study|Lost to Follow-up|3|||
145615195|NCT00962585|525106846|FG001|Overall Study|Lost to Follow-up|0|||
145615196|NCT00962585|525106847|FG002|Overall Study|Lost to Follow-up|1|||
145615197|NCT00962585|525106848|FG003|Overall Study|Lost to Follow-up|0|||
145615198|NCT00962585|525106845|FG000|Overall Study|Protocol Violation|0|||
145615199|NCT00962585|525106846|FG001|Overall Study|Protocol Violation|0|||
145615200|NCT00962585|525106847|FG002|Overall Study|Protocol Violation|1|||
145615201|NCT00962585|525106848|FG003|Overall Study|Protocol Violation|0|||
145615202|NCT00962585|525106845|FG000|Overall Study|Withdrawal by Subject|1|||
145615203|NCT00962585|525106846|FG001|Overall Study|Withdrawal by Subject|0|||
145615204|NCT00962585|525106847|FG002|Overall Study|Withdrawal by Subject|0|||
145615205|NCT00962585|525106848|FG003|Overall Study|Withdrawal by Subject|0|||
145615206|NCT00962585|525106845|FG000|Overall Study|Withdrew Consent|2|||
145615207|NCT00962585|525106846|FG001|Overall Study|Withdrew Consent|0|||
145615208|NCT00962585|525106847|FG002|Overall Study|Withdrew Consent|0|||
145615209|NCT00962585|525106848|FG003|Overall Study|Withdrew Consent|0|||
145615210|NCT02254421|525106849|FG000|Overall Study|Randomized but Not Treated|1|||
145615211|NCT02254421|525106850|FG001|Overall Study|Randomized but Not Treated|0|||
145615212|NCT02254421|525106849|FG000|Overall Study|Death|0|||
145615213|NCT02254421|525106850|FG001|Overall Study|Death|2|||
145615214|NCT02254421|525106849|FG000|Overall Study|Withdrew Consent|1|||
145615215|NCT02254421|525106850|FG001|Overall Study|Withdrew Consent|1|||
145615216|NCT01729728|525106857|FG000|Overall Study|Adverse Event|0|||
145615217|NCT01729728|525106858|FG001|Overall Study|Adverse Event|6|||
145615218|NCT01729728|525106859|FG002|Overall Study|Adverse Event|0|||
145615219|NCT01729728|525106857|FG000|Overall Study|Protocol Violation|1|||
145615220|NCT01729728|525106858|FG001|Overall Study|Protocol Violation|0|||
145615221|NCT01729728|525106859|FG002|Overall Study|Protocol Violation|1|||
145615222|NCT01009047|525106862|FG000|Overall Study|Adverse Event|5|||
145615223|NCT01009047|525106863|FG001|Overall Study|Adverse Event|0|||
145615224|NCT01009047|525106862|FG000|Overall Study|Lost to Follow-up|0|||
145615225|NCT01009047|525106863|FG001|Overall Study|Lost to Follow-up|2|||
145615226|NCT01009047|525106862|FG000|Overall Study|Lack of Efficacy|4|||
145615227|NCT01009047|525106863|FG001|Overall Study|Lack of Efficacy|11|||
145615228|NCT01009047|525106862|FG000|Overall Study|Withdrawal by consent|16|||
145615229|NCT01009047|525106863|FG001|Overall Study|Withdrawal by consent|11|||
145615230|NCT01009047|525106862|FG000|Overall Study|Other|3|||
145615231|NCT01009047|525106863|FG001|Overall Study|Other|2|||
145615232|NCT01630590|525106864|FG000|Overall Study|Adverse Event|9|||
145615233|NCT01630590|525106864|FG000|Overall Study|Lack of Efficacy|37|||
145615234|NCT01630590|525106864|FG000|Overall Study|Withdrawal by Subject|4|||
145615235|NCT01630590|525106864|FG000|Overall Study|2nd primary tumor|2|||
145615236|NCT01630590|525106864|FG000|Overall Study|Automobile accident|1|||
145615237|NCT01630590|525106864|FG000|Overall Study|Maximum benefit|4|||
145615238|NCT02366936|525106866|FG000|Overall Study|Withdrawal by Subject|2|||
145615239|NCT02366936|525106866|FG000|Overall Study|Lost to Follow-up|4|||
145615240|NCT02366936|525106866|FG000|Overall Study|Physician Decision|2|||
145615241|NCT01751113|525106869|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145615242|NCT01751113|525106870|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145615243|NCT01751113|525106871|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145615244|NCT01751113|525106872|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
145615245|NCT01751113|525106873|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
145615246|NCT01751113|525106874|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
145615247|NCT01751113|525106869|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
145615248|NCT01751113|525106870|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
145615249|NCT01751113|525106871|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
145615250|NCT01751113|525106872|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
145615251|NCT01751113|525106873|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
145615252|NCT01751113|525106874|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
145615253|NCT00305864|525106875|FG000|Overall Study|Ineligible / No protocol treatment|0|||
145615254|NCT00305864|525106876|FG001|Overall Study|Ineligible / No protocol treatment|1|||
145615255|NCT00305864|525106877|FG002|Overall Study|Ineligible / No protocol treatment|1|||
145615256|NCT00305864|525106878|FG003|Overall Study|Ineligible / No protocol treatment|13|||
145615257|NCT02743793|525106879|FG000|Overall Study|Death|1|||
145615258|NCT02743793|525106880|FG001|Overall Study|Death|1|||
145615259|NCT02743793|525106879|FG000|Overall Study|Withdrawal by Subject|0|||
145615260|NCT02743793|525106880|FG001|Overall Study|Withdrawal by Subject|1|||
145615261|NCT02743793|525106879|FG000|Overall Study|Screen Failure|4|||
145615262|NCT02743793|525106880|FG001|Overall Study|Screen Failure|0|||
145615263|NCT02743793|525106879|FG000|Overall Study|No Primary Care Physician|0|||
145615264|NCT02743793|525106880|FG001|Overall Study|No Primary Care Physician|1|||
145615265|NCT02743793|525106879|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
145615266|NCT02743793|525106880|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
145615267|NCT02743793|525106879|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
145615268|NCT02743793|525106880|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
145615269|NCT00849680|525106887|FG000|Overall Study|Adverse Event|0|||
145615270|NCT00849680|525106888|FG001|Overall Study|Adverse Event|0|||
145615271|NCT00849680|525106889|FG002|Overall Study|Adverse Event|0|||
145615272|NCT00849680|525106890|FG003|Overall Study|Adverse Event|0|||
145615273|NCT00849680|525106891|FG004|Overall Study|Adverse Event|0|||
145615274|NCT00849680|525106892|FG005|Overall Study|Adverse Event|0|||
145615275|NCT00849680|525106893|FG006|Overall Study|Adverse Event|2|||
145615276|NCT00849680|525106894|FG007|Overall Study|Adverse Event|0|||
145615277|NCT00849680|525106887|FG000|Overall Study|Lost to Follow-up|7|||
145615278|NCT00849680|525106888|FG001|Overall Study|Lost to Follow-up|3|||
145615279|NCT00849680|525106889|FG002|Overall Study|Lost to Follow-up|12|||
145615280|NCT00849680|525106890|FG003|Overall Study|Lost to Follow-up|11|||
145615281|NCT00849680|525106891|FG004|Overall Study|Lost to Follow-up|8|||
145615282|NCT00849680|525106892|FG005|Overall Study|Lost to Follow-up|11|||
145615283|NCT00849680|525106893|FG006|Overall Study|Lost to Follow-up|12|||
145615284|NCT00849680|525106894|FG007|Overall Study|Lost to Follow-up|5|||
145615285|NCT00849680|525106887|FG000|Overall Study|Subject moved|1|||
145615286|NCT00849680|525106888|FG001|Overall Study|Subject moved|0|||
145288665|NCT00626925|523906528|FG001|Overall Study|Adverse effect|2|||
145288666|NCT00626925|523906527|FG000|Overall Study|Lack of Efficacy|1|||
145288667|NCT00626925|523906528|FG001|Overall Study|Lack of Efficacy|4|||
145288668|NCT00626925|523906527|FG000|Overall Study|Time constraints|3|||
145288669|NCT00626925|523906528|FG001|Overall Study|Time constraints|1|||
145288670|NCT01215942|523906531|FG000|Treatment Period|Adverse Event|15|||
145288671|NCT01215942|523906532|FG001|Treatment Period|Adverse Event|26|||
145288672|NCT01215942|523906531|FG000|Treatment Period|Death|2|||
145288673|NCT01215942|523906532|FG001|Treatment Period|Death|4|||
145288674|NCT01215942|523906531|FG000|Treatment Period|Lack of Efficacy|23|||
145288675|NCT01215942|523906532|FG001|Treatment Period|Lack of Efficacy|62|||
145288676|NCT01215942|523906531|FG000|Treatment Period|Lost to Follow-up|3|||
145288677|NCT01215942|523906532|FG001|Treatment Period|Lost to Follow-up|4|||
145288678|NCT01215942|523906531|FG000|Treatment Period|Withdrawal by Subject|17|||
145288679|NCT01215942|523906532|FG001|Treatment Period|Withdrawal by Subject|40|||
145288680|NCT01215942|523906531|FG000|Treatment Period|Physician Decision|5|||
145288681|NCT01215942|523906532|FG001|Treatment Period|Physician Decision|5|||
145288682|NCT01215942|523906531|FG000|Treatment Period|Protocol Violation|0|||
145288683|NCT01215942|523906532|FG001|Treatment Period|Protocol Violation|1|||
145288684|NCT01215942|523906531|FG000|Treatment Period|Sponsor Decision|349|||
145288685|NCT01215942|523906532|FG001|Treatment Period|Sponsor Decision|530|||
145288686|NCT01215942|523906531|FG000|Post-Treatment Follow-Up Period|Death|0|||
145288687|NCT01215942|523906532|FG001|Post-Treatment Follow-Up Period|Death|1|||
145288688|NCT01215942|523906531|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
145288689|NCT01215942|523906532|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
145288690|NCT01215942|523906531|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
145288691|NCT01215942|523906532|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
145288692|NCT01215942|523906531|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
145288693|NCT01215942|523906532|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
145288694|NCT01215942|523906531|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
145288695|NCT01215942|523906532|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
145288696|NCT00622908|523906533|FG000|Overall Study|Protocol Violation|1|||
145288697|NCT00622908|523906534|FG001|Overall Study|Protocol Violation|0|||
145288698|NCT00622908|523906533|FG000|Overall Study|Adverse Event|0|||
145288699|NCT00622908|523906534|FG001|Overall Study|Adverse Event|1|||
145288700|NCT00622908|523906533|FG000|Overall Study|Lack of Efficacy|1|||
145288701|NCT00622908|523906534|FG001|Overall Study|Lack of Efficacy|7|||
145288702|NCT00622908|523906533|FG000|Overall Study|Lost to Follow-up|1|||
145288703|NCT00622908|523906534|FG001|Overall Study|Lost to Follow-up|0|||
145288704|NCT00622908|523906533|FG000|Overall Study|Refusal|0|||
145288705|NCT00622908|523906534|FG001|Overall Study|Refusal|1|||
145288706|NCT00622908|523906533|FG000|Overall Study|Termination by study sponser|0|||
145288707|NCT00622908|523906534|FG001|Overall Study|Termination by study sponser|1|||
145288708|NCT03213210|523906535|FG000|Overall Study|Lost to Follow-up|2|||
145288709|NCT03213210|523906535|FG000|Overall Study|Study termination|3|||
145288710|NCT01166568|523906541|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
145288711|NCT01166568|523906542|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
145288712|NCT01166568|523906543|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
145288713|NCT01166568|523906541|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
145288714|NCT01166568|523906542|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
145288715|NCT01166568|523906543|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
145615287|NCT00849680|525106889|FG002|Overall Study|Subject moved|3|||
145615288|NCT00849680|525106890|FG003|Overall Study|Subject moved|1|||
145615289|NCT00849680|525106891|FG004|Overall Study|Subject moved|0|||
145288716|NCT01166568|523906541|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
145615290|NCT00849680|525106892|FG005|Overall Study|Subject moved|2|||
145288717|NCT01166568|523906542|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
145288718|NCT01166568|523906543|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
145288719|NCT03335371|523906544|FG000|Overall Study|Lost to Follow-up|0|||
145288720|NCT03335371|523906545|FG001|Overall Study|Lost to Follow-up|0|||
145288721|NCT03335371|523906546|FG002|Overall Study|Lost to Follow-up|0|||
145615291|NCT00849680|525106893|FG006|Overall Study|Subject moved|2|||
145288722|NCT03335371|523906547|FG003|Overall Study|Lost to Follow-up|0|||
145615292|NCT00849680|525106894|FG007|Overall Study|Subject moved|2|||
145615293|NCT00849680|525106887|FG000|Overall Study|Withdrawal by Subject|2|||
145615294|NCT00849680|525106888|FG001|Overall Study|Withdrawal by Subject|0|||
145615295|NCT00849680|525106889|FG002|Overall Study|Withdrawal by Subject|0|||
145615296|NCT00849680|525106890|FG003|Overall Study|Withdrawal by Subject|2|||
145615297|NCT00849680|525106891|FG004|Overall Study|Withdrawal by Subject|2|||
145615298|NCT00849680|525106892|FG005|Overall Study|Withdrawal by Subject|2|||
145615299|NCT00849680|525106893|FG006|Overall Study|Withdrawal by Subject|1|||
145615300|NCT00849680|525106894|FG007|Overall Study|Withdrawal by Subject|1|||
145615301|NCT00849680|525106887|FG000|Overall Study|Subject unable to comply with protocol|1|||
145615302|NCT00849680|525106888|FG001|Overall Study|Subject unable to comply with protocol|0|||
145615303|NCT00849680|525106889|FG002|Overall Study|Subject unable to comply with protocol|0|||
145615304|NCT00849680|525106890|FG003|Overall Study|Subject unable to comply with protocol|0|||
145615305|NCT00849680|525106891|FG004|Overall Study|Subject unable to comply with protocol|0|||
145615306|NCT00849680|525106892|FG005|Overall Study|Subject unable to comply with protocol|0|||
145615307|NCT00849680|525106893|FG006|Overall Study|Subject unable to comply with protocol|0|||
145615308|NCT00849680|525106894|FG007|Overall Study|Subject unable to comply with protocol|0|||
145615309|NCT03053492|525106895|FG000|Overall Study|Adverse Event|1|||
145615310|NCT03053492|525106896|FG001|Overall Study|Adverse Event|1|||
145615311|NCT03053492|525106895|FG000|Overall Study|Withdrawal by Subject|7|||
145615312|NCT03053492|525106896|FG001|Overall Study|Withdrawal by Subject|5|||
145615313|NCT03382600|525106898|FG000|Overall Study|Adverse Event|3|||
145615314|NCT03382600|525106899|FG001|Overall Study|Adverse Event|3|||
145615315|NCT03382600|525106898|FG000|Overall Study|Clinical Disease Progression|2|||
145615316|NCT03382600|525106899|FG001|Overall Study|Clinical Disease Progression|4|||
145615317|NCT03382600|525106898|FG000|Overall Study|Radiological Progression|40|||
145406493|NCT01799889|524343774|FG011|Overall Study|Lack of Efficacy|0|||
145288723|NCT03335371|523906548|FG004|Overall Study|Lost to Follow-up|1|||
145288724|NCT03335371|523906544|FG000|Overall Study|Withdrawal by Subject|0|||
145288725|NCT03335371|523906545|FG001|Overall Study|Withdrawal by Subject|0|||
145288726|NCT03335371|523906546|FG002|Overall Study|Withdrawal by Subject|0|||
145288727|NCT03335371|523906547|FG003|Overall Study|Withdrawal by Subject|0|||
145288728|NCT03335371|523906548|FG004|Overall Study|Withdrawal by Subject|1|||
145288729|NCT03335371|523906544|FG000|Overall Study|Randomization Error|0|||
145288730|NCT03335371|523906545|FG001|Overall Study|Randomization Error|0|||
145288731|NCT03335371|523906546|FG002|Overall Study|Randomization Error|1|||
145288732|NCT03335371|523906547|FG003|Overall Study|Randomization Error|0|||
145288733|NCT03335371|523906548|FG004|Overall Study|Randomization Error|0|||
145288734|NCT00684671|523906549|FG000|Overall Study|Adverse Event|1|||
145288735|NCT00684671|523906550|FG001|Overall Study|Adverse Event|0|||
145288736|NCT00684671|523906551|FG002|Overall Study|Adverse Event|0|||
145288737|NCT00684671|523906549|FG000|Overall Study|Lost to Follow-up|1|||
145288738|NCT00684671|523906550|FG001|Overall Study|Lost to Follow-up|0|||
145288739|NCT00684671|523906551|FG002|Overall Study|Lost to Follow-up|0|||
145288740|NCT00684671|523906549|FG000|Overall Study|Alcoholic dependance|1|||
145288741|NCT00684671|523906550|FG001|Overall Study|Alcoholic dependance|0|||
145288742|NCT00684671|523906551|FG002|Overall Study|Alcoholic dependance|0|||
145288743|NCT00249821|523906552|FG000|Overall Study|Technical problem|0|||
145288744|NCT00249821|523906553|FG001|Overall Study|Technical problem|1|||
145288745|NCT02041702|523906561|FG000|Overall Study|Lost to Follow-up|1|||
145288746|NCT02041702|523906562|FG001|Overall Study|Lost to Follow-up|6|||
145288747|NCT02041702|523906561|FG000|Overall Study|Death|4|||
145288748|NCT02041702|523906562|FG001|Overall Study|Death|0|||
145288749|NCT02041702|523906561|FG000|Overall Study|Withdrawal by Subject|4|||
145288750|NCT02041702|523906562|FG001|Overall Study|Withdrawal by Subject|3|||
145288751|NCT02041702|523906561|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
145288752|NCT02041702|523906562|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
145288753|NCT02041702|523906561|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
145288754|NCT02041702|523906562|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
145288755|NCT00203307|523906563|FG000|First Intervention|Adverse Event|2|||
145288756|NCT00203307|523906564|FG001|First Intervention|Adverse Event|0|||
145288757|NCT03731182|523907951|FG000|Overall Study|Lost to Follow-up|2|||
145288758|NCT03731182|523907952|FG001|Overall Study|Lost to Follow-up|0|||
145615318|NCT03382600|525106899|FG001|Overall Study|Radiological Progression|31|||
145615319|NCT03382600|525106898|FG000|Overall Study|Withdrawal by Subject|0|||
145615320|NCT03382600|525106899|FG001|Overall Study|Withdrawal by Subject|1|||
145615321|NCT03382600|525106898|FG000|Overall Study|Other|9|||
145615322|NCT03382600|525106899|FG001|Overall Study|Other|7|||
145288759|NCT03731182|523907951|FG000|Overall Study|Physician Decision|1|||
145288760|NCT03731182|523907952|FG001|Overall Study|Physician Decision|0|||
145288761|NCT03731182|523907951|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
145288762|NCT03731182|523907952|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145288763|NCT02006706|523907953|FG000|Overall Study|Lost to Follow-up|1|||
145615323|NCT00967018|525106900|FG000|Overall Study|Adverse Event|2|||
145288764|NCT00958256|523907955|FG000|Overall Study|Adverse Event|3|||
145288765|NCT03519256|523907956|FG000|Overall Study|Disease recurrence|4|||
145288766|NCT03519256|523907957|FG001|Overall Study|Disease recurrence|4|||
145615324|NCT00967018|525106900|FG000|Overall Study|Physician Decision|7|||
145615325|NCT00967018|525106900|FG000|Overall Study|Lost to Follow-up|2|||
145615326|NCT00967018|525106900|FG000|Overall Study|Withdrawal by Subject|1|||
145288767|NCT03519256|523907958|FG002|Overall Study|Disease recurrence|5|||
145288768|NCT03519256|523907959|FG003|Overall Study|Disease recurrence|2|||
145288769|NCT03519256|523907956|FG000|Overall Study|Study drug toxicity|0|||
145288770|NCT03519256|523907957|FG001|Overall Study|Study drug toxicity|2|||
145288771|NCT03519256|523907958|FG002|Overall Study|Study drug toxicity|5|||
145288772|NCT03519256|523907959|FG003|Overall Study|Study drug toxicity|2|||
145288773|NCT03519256|523907956|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145288774|NCT03519256|523907957|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145288775|NCT03519256|523907958|FG002|Overall Study|Adverse event unrelated to study drug|1|||
145288776|NCT03519256|523907959|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145288777|NCT03519256|523907956|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145288778|NCT03519256|523907957|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145288779|NCT03519256|523907958|FG002|Overall Study|Participant request to discontinue study treatment|0|||
145288780|NCT03519256|523907959|FG003|Overall Study|Participant request to discontinue study treatment|2|||
145288781|NCT03519256|523907956|FG000|Overall Study|Other reasons|0|||
145288782|NCT03519256|523907957|FG001|Overall Study|Other reasons|0|||
145288783|NCT03519256|523907958|FG002|Overall Study|Other reasons|2|||
145288784|NCT03519256|523907959|FG003|Overall Study|Other reasons|0|||
145288785|NCT03519256|523907956|FG000|Overall Study|Disease progression|6|||
145288786|NCT03519256|523907957|FG001|Overall Study|Disease progression|3|||
145288787|NCT03519256|523907958|FG002|Overall Study|Disease progression|2|||
145288788|NCT03519256|523907959|FG003|Overall Study|Disease progression|1|||
145288789|NCT03519256|523907956|FG000|Overall Study|Lost to Follow-up|0|||
145288790|NCT03519256|523907957|FG001|Overall Study|Lost to Follow-up|1|||
145288791|NCT03519256|523907958|FG002|Overall Study|Lost to Follow-up|0|||
145615327|NCT00967018|525106900|FG000|Overall Study|Miscellaneous Reasons|9|||
145615328|NCT04276090|525106903|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
145615329|NCT04276090|525106904|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
145288792|NCT03519256|523907959|FG003|Overall Study|Lost to Follow-up|0|||
145615330|NCT04642469|525106905|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
145615331|NCT04642469|525106906|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
145615332|NCT04642469|525106905|FG000|Overall Study|Death|1|||
145615333|NCT04642469|525106906|FG001|Overall Study|Death|2|||
145615334|NCT04642469|525106905|FG000|Overall Study|Study/site closed following amendment 1|11|||
145615335|NCT04642469|525106906|FG001|Overall Study|Study/site closed following amendment 1|11|||
145615336|NCT04642469|525106905|FG000|Overall Study|Other|1|||
145615337|NCT04642469|525106906|FG001|Overall Study|Other|1|||
145615338|NCT04642469|525106905|FG000|Overall Study|Withdrawal by Subject|1|||
145615339|NCT04642469|525106906|FG001|Overall Study|Withdrawal by Subject|0|||
145615340|NCT01088529|525106908|FG000|Overall Study|Did not receive study treatment|0|||
145615341|NCT01088529|525106909|FG001|Overall Study|Did not receive study treatment|1|||
145615342|NCT01680458|525106915|FG000|Overall Study|Protocol Violation|3|||
145615343|NCT02302066|525106916|FG000|Overall Study|Adverse Event|1|||
145615344|NCT02302066|525106917|FG001|Overall Study|Adverse Event|1|||
145615345|NCT02302066|525106918|FG002|Overall Study|Adverse Event|3|||
145615346|NCT02302066|525106919|FG003|Overall Study|Adverse Event|0|||
145615347|NCT02302066|525106916|FG000|Overall Study|Lost to Follow-up|4|||
145615348|NCT02302066|525106917|FG001|Overall Study|Lost to Follow-up|5|||
145615349|NCT02302066|525106918|FG002|Overall Study|Lost to Follow-up|24|||
145615350|NCT02302066|525106919|FG003|Overall Study|Lost to Follow-up|7|||
145615351|NCT02302066|525106916|FG000|Overall Study|Withdrawal by Subject|25|||
145615352|NCT02302066|525106917|FG001|Overall Study|Withdrawal by Subject|58|||
145615353|NCT02302066|525106918|FG002|Overall Study|Withdrawal by Subject|124|||
145615354|NCT02302066|525106919|FG003|Overall Study|Withdrawal by Subject|33|||
145615355|NCT02302066|525106916|FG000|Overall Study|Pregnancy|2|||
145615356|NCT02302066|525106917|FG001|Overall Study|Pregnancy|10|||
145615357|NCT02302066|525106918|FG002|Overall Study|Pregnancy|12|||
145615358|NCT02302066|525106919|FG003|Overall Study|Pregnancy|0|||
145615359|NCT02302066|525106916|FG000|Overall Study|Reason Not Specified|1|||
145615360|NCT02302066|525106917|FG001|Overall Study|Reason Not Specified|1|||
145615361|NCT02302066|525106918|FG002|Overall Study|Reason Not Specified|9|||
145615362|NCT02302066|525106919|FG003|Overall Study|Reason Not Specified|1|||
145288793|NCT02524379|523907965|FG000|Overall Study|Death|1|||
145288794|NCT00812253|523907966|FG000|Overall Study|Withdrawal by Subject|3|||
145288795|NCT00812253|523907967|FG001|Overall Study|Withdrawal by Subject|2|||
145288796|NCT00812253|523907966|FG000|Overall Study|Protocol Violation|1|||
145615363|NCT02180438|525106935|FG000|Overall Study|Lost to Follow-up|1|||
145615364|NCT02058290|525106936|FG000|Overall Study|Protocol Violation|2|||
145615365|NCT02058290|525106937|FG001|Overall Study|Protocol Violation|1|||
145615366|NCT02058290|525106936|FG000|Overall Study|Physician Decision|1|||
145615367|NCT02058290|525106937|FG001|Overall Study|Physician Decision|0|||
145288797|NCT00812253|523907967|FG001|Overall Study|Protocol Violation|1|||
145288798|NCT00812253|523907966|FG000|Overall Study|Lost to Follow-up|2|||
145288799|NCT00812253|523907967|FG001|Overall Study|Lost to Follow-up|0|||
145288800|NCT01884025|523907968|FG000|Overall Study|Lost to Follow-up|3|||
145288801|NCT01884025|523907969|FG001|Overall Study|Lost to Follow-up|4|||
145288802|NCT02655237|523907970|FG000|Overall Study|Adverse Event|10|||
145288803|NCT02655237|523907971|FG001|Overall Study|Adverse Event|7|||
145288804|NCT02655237|523907970|FG000|Overall Study|Protocol Deviation|2|||
145288805|NCT02655237|523907971|FG001|Overall Study|Protocol Deviation|0|||
145288806|NCT02655237|523907970|FG000|Overall Study|Withdrawal by Participant|1|||
145288807|NCT02655237|523907971|FG001|Overall Study|Withdrawal by Participant|2|||
145288808|NCT02655237|523907970|FG000|Overall Study|Lack of Efficacy|0|||
145288809|NCT02655237|523907971|FG001|Overall Study|Lack of Efficacy|1|||
145288810|NCT02655237|523907970|FG000|Overall Study|Recovery Leading to Surgery|2|||
145288811|NCT02655237|523907971|FG001|Overall Study|Recovery Leading to Surgery|1|||
145288812|NCT02655237|523907970|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
145288813|NCT02655237|523907971|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
145288814|NCT02655237|523907970|FG000|Overall Study|Randomized but Not Treated|1|||
145288815|NCT02655237|523907971|FG001|Overall Study|Randomized but Not Treated|0|||
145288816|NCT03679741|523907972|FG000|Period 1|No longer meet eligibility criteria|1|||
145288817|NCT03679741|523907973|FG001|Period 1|No longer meet eligibility criteria|0|||
145288818|NCT03679741|523907972|FG000|Period 1|Lost to Follow-up|0|||
145288819|NCT03679741|523907973|FG001|Period 1|Lost to Follow-up|1|||
145288820|NCT03679741|523907972|FG000|Period 1|Adverse Event|1|||
145288821|NCT03679741|523907973|FG001|Period 1|Adverse Event|1|||
145288822|NCT03679741|523907972|FG000|Period 1|Withdrawal by Subject|0|||
145288823|NCT03679741|523907973|FG001|Period 1|Withdrawal by Subject|1|||
145288824|NCT03679741|523907972|FG000|Period 2|Adverse Event|2|||
145288825|NCT03679741|523907973|FG001|Period 2|Adverse Event|1|||
145288826|NCT03679741|523907972|FG000|Period 2|Withdrawal by Subject|1|||
145288827|NCT03679741|523907973|FG001|Period 2|Withdrawal by Subject|1|||
145288828|NCT02750761|523907978|FG000|Overall Study|Lost to Follow-up|0|||
145288829|NCT02750761|523907979|FG001|Overall Study|Lost to Follow-up|0|||
145288830|NCT02750761|523907980|FG002|Overall Study|Lost to Follow-up|1|||
145288831|NCT02750761|523907981|FG003|Overall Study|Lost to Follow-up|0|||
145288832|NCT02750761|523907982|FG004|Overall Study|Lost to Follow-up|0|||
145288833|NCT02750761|523907983|FG005|Overall Study|Lost to Follow-up|0|||
145288834|NCT02227862|523907984|FG000|Overall Study|Protocol Violation|7|||
145288835|NCT02227862|523907985|FG001|Overall Study|Protocol Violation|9|||
145288836|NCT02227862|523907984|FG000|Overall Study|Other|0|||
145288837|NCT02227862|523907985|FG001|Overall Study|Other|2|||
145288838|NCT02227862|523907984|FG000|Overall Study|Adverse Event|4|||
145288839|NCT02227862|523907985|FG001|Overall Study|Adverse Event|3|||
145288840|NCT02227862|523907984|FG000|Overall Study|Withdrawal by Subject|7|||
145288841|NCT02227862|523907985|FG001|Overall Study|Withdrawal by Subject|6|||
145288842|NCT02227862|523907984|FG000|Overall Study|Lost to Follow-up|1|||
145288843|NCT02227862|523907985|FG001|Overall Study|Lost to Follow-up|2|||
145288844|NCT00634907|523907990|FG000|Overall Study|Withdrawal by Subject|3|||
145288845|NCT00634907|523907991|FG001|Overall Study|Withdrawal by Subject|0|||
145288846|NCT00634907|523907990|FG000|Overall Study|Physician Decision|3|||
145288847|NCT00634907|523907991|FG001|Overall Study|Physician Decision|9|||
145288848|NCT00634907|523907990|FG000|Overall Study|Withdrawal by Subject|11|||
145288849|NCT00634907|523907991|FG001|Overall Study|Withdrawal by Subject|8|||
145288850|NCT00620763|523908000|FG000|Period: First Intervention|Withdrawal by Subject|0|||
145288851|NCT00620763|523908001|FG001|Period: First Intervention|Withdrawal by Subject|2|||
145288852|NCT00620763|523908000|FG000|Period: First Intervention|Protocol Violation|0|||
145288853|NCT00620763|523908001|FG001|Period: First Intervention|Protocol Violation|3|||
145288854|NCT00620763|523908000|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
145288855|NCT00620763|523908001|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
145288856|NCT02866175|523908002|FG000|Overall Study|Adverse Event|56|||
145288857|NCT02866175|523908003|FG001|Overall Study|Adverse Event|54|||
145288858|NCT02866175|523908002|FG000|Overall Study|Withdrawal by Subject|31|||
145288859|NCT02866175|523908003|FG001|Overall Study|Withdrawal by Subject|52|||
145288860|NCT02866175|523908002|FG000|Overall Study|Death|30|||
145288861|NCT02866175|523908003|FG001|Overall Study|Death|23|||
145288862|NCT02866175|523908002|FG000|Overall Study|Other|7|||
145288863|NCT02866175|523908003|FG001|Overall Study|Other|14|||
145288864|NCT02866175|523908002|FG000|Overall Study|Progressive disease|1|||
145288865|NCT02866175|523908003|FG001|Overall Study|Progressive disease|1|||
145288866|NCT02866175|523908002|FG000|Overall Study|Lost to Follow-up|2|||
145288867|NCT02866175|523908003|FG001|Overall Study|Lost to Follow-up|0|||
145615368|NCT02058290|525106936|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
145615369|NCT02058290|525106937|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
145615370|NCT02058290|525106936|FG000|Overall Study|Withdrawal by Subject|0|||
145615371|NCT02058290|525106937|FG001|Overall Study|Withdrawal by Subject|1|||
145615372|NCT00785707|525106939|FG000|Overall Study|Lost to Follow-up|7|||
145615373|NCT00105586|525106942|FG000|Overall Study|Adverse Event|4|||
145615374|NCT00105586|525106943|FG001|Overall Study|Adverse Event|3|||
145615375|NCT00105586|525106942|FG000|Overall Study|Physician Decision|13|||
145615376|NCT00105586|525106943|FG001|Overall Study|Physician Decision|13|||
145615377|NCT02262260|525106944|FG000|Overall Study|Adverse Event|4|||
145615378|NCT02262260|525106945|FG001|Overall Study|Adverse Event|1|||
145615379|NCT02262260|525106944|FG000|Overall Study|Withdrawal of consent|4|||
145615380|NCT02262260|525106945|FG001|Overall Study|Withdrawal of consent|2|||
145615381|NCT02262260|525106944|FG000|Overall Study|Lost to Follow-up|1|||
145615382|NCT02262260|525106945|FG001|Overall Study|Lost to Follow-up|2|||
145615383|NCT02262260|525106944|FG000|Overall Study|Protocol deviation|2|||
145615384|NCT02262260|525106945|FG001|Overall Study|Protocol deviation|5|||
145615385|NCT02696902|525106950|FG000|Overall Study|Lost to Follow-up|0|||
145615386|NCT02696902|525106951|FG001|Overall Study|Lost to Follow-up|1|||
145615387|NCT02696902|525106952|FG002|Overall Study|Lost to Follow-up|1|||
145615388|NCT02696902|525106950|FG000|Overall Study|Withdrawal by Subject|0|||
145615389|NCT02696902|525106951|FG001|Overall Study|Withdrawal by Subject|0|||
145615390|NCT02696902|525106952|FG002|Overall Study|Withdrawal by Subject|1|||
145615391|NCT02696902|525106950|FG000|Overall Study|Death|19|||
145615392|NCT02696902|525106951|FG001|Overall Study|Death|3|||
145615393|NCT02696902|525106952|FG002|Overall Study|Death|24|||
145615394|NCT02696902|525106950|FG000|Overall Study|Participant not fit post-randomization|0|||
145615395|NCT02696902|525106951|FG001|Overall Study|Participant not fit post-randomization|0|||
145615396|NCT02696902|525106952|FG002|Overall Study|Participant not fit post-randomization|1|||
145615397|NCT02696902|525106950|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
145615398|NCT02696902|525106951|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
145615399|NCT02696902|525106952|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
145615400|NCT02696902|525106950|FG000|Overall Study|Principal investigator's decision|1|||
145615401|NCT02696902|525106951|FG001|Overall Study|Principal investigator's decision|0|||
145615402|NCT02696902|525106952|FG002|Overall Study|Principal investigator's decision|0|||
145615403|NCT02696902|525106950|FG000|Overall Study|Sponsor's decision|1|||
145615404|NCT02696902|525106951|FG001|Overall Study|Sponsor's decision|0|||
145615405|NCT02696902|525106952|FG002|Overall Study|Sponsor's decision|0|||
145615406|NCT02696902|525106950|FG000|Overall Study|Transferred to other hospital|1|||
145615407|NCT02696902|525106951|FG001|Overall Study|Transferred to other hospital|0|||
145615408|NCT02696902|525106952|FG002|Overall Study|Transferred to other hospital|0|||
145615409|NCT03406702|525106957|FG000|Overall Study|Missed Day 27 Dosing|1|||
145615410|NCT00514046|525106965|FG000|Overall Study|transferred to another protocol|2|||
145615411|NCT00514046|525106966|FG001|Overall Study|transferred to another protocol|1|||
145615412|NCT00514046|525106967|FG002|Overall Study|transferred to another protocol|3|||
145615413|NCT00514046|525106968|FG003|Overall Study|transferred to another protocol|0|||
145615414|NCT00514046|525106969|FG004|Overall Study|transferred to another protocol|1|||
145615415|NCT00514046|525106970|FG005|Overall Study|transferred to another protocol|0|||
145615416|NCT00514046|525106971|FG006|Overall Study|transferred to another protocol|0|||
145615417|NCT00514046|525106972|FG007|Overall Study|transferred to another protocol|0|||
145615418|NCT00514046|525106973|FG008|Overall Study|transferred to another protocol|0|||
145615419|NCT00514046|525106965|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
145615420|NCT00514046|525106966|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
145615421|NCT00514046|525106967|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
145615422|NCT00514046|525106968|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
145615423|NCT00514046|525106969|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
145615424|NCT00514046|525106970|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
145615425|NCT00514046|525106971|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
145615426|NCT00514046|525106972|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
145615427|NCT00514046|525106973|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
145615428|NCT00514046|525106965|FG000|Overall Study|Disease progression on study|0|||
145615429|NCT00514046|525106966|FG001|Overall Study|Disease progression on study|0|||
145615430|NCT00514046|525106967|FG002|Overall Study|Disease progression on study|2|||
145615431|NCT00514046|525106968|FG003|Overall Study|Disease progression on study|0|||
145615432|NCT00514046|525106969|FG004|Overall Study|Disease progression on study|0|||
145615433|NCT00514046|525106970|FG005|Overall Study|Disease progression on study|1|||
145615434|NCT00514046|525106971|FG006|Overall Study|Disease progression on study|0|||
145615435|NCT00514046|525106972|FG007|Overall Study|Disease progression on study|0|||
145615436|NCT00514046|525106973|FG008|Overall Study|Disease progression on study|0|||
145615437|NCT00655551|525106974|FG000|All Periods Combined|Adverse Event|0|||
145615438|NCT00655551|525106975|FG001|All Periods Combined|Adverse Event|3|||
145615439|NCT00655551|525106976|FG002|All Periods Combined|Adverse Event|4|||
145406494|NCT01799889|524343763|FG000|Overall Study|Lost to Follow-up|0|||
145615440|NCT00655551|525106974|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
145615441|NCT00655551|525106975|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
145615442|NCT00655551|525106976|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
145615443|NCT00655551|525106974|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
145615444|NCT00655551|525106975|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
145615445|NCT00655551|525106976|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
145615446|NCT00655551|525106974|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
145615447|NCT00655551|525106975|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
145615448|NCT00655551|525106976|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
145615449|NCT00383240|525106981|FG000|Overall Study|Adverse Event|4|||
145615450|NCT00383240|525106982|FG001|Overall Study|Adverse Event|6|||
145615451|NCT00383240|525106983|FG002|Overall Study|Adverse Event|9|||
145615452|NCT00383240|525106984|FG003|Overall Study|Adverse Event|7|||
145615453|NCT00383240|525106981|FG000|Overall Study|Treatment Failure|8|||
145615454|NCT00383240|525106982|FG001|Overall Study|Treatment Failure|13|||
145615455|NCT00383240|525106983|FG002|Overall Study|Treatment Failure|47|||
145615456|NCT00383240|525106984|FG003|Overall Study|Treatment Failure|46|||
145615457|NCT00383240|525106981|FG000|Overall Study|Lost to Follow-up|3|||
145615458|NCT00383240|525106982|FG001|Overall Study|Lost to Follow-up|0|||
145615459|NCT00383240|525106983|FG002|Overall Study|Lost to Follow-up|0|||
145615460|NCT00383240|525106984|FG003|Overall Study|Lost to Follow-up|2|||
145615461|NCT00383240|525106981|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
145615462|NCT00383240|525106982|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
145615463|NCT00383240|525106983|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
145615464|NCT00383240|525106984|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
145615465|NCT00383240|525106981|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
145615466|NCT00383240|525106982|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
145615467|NCT00383240|525106983|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
145615468|NCT00383240|525106984|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
145615469|NCT00383240|525106981|FG000|Overall Study|Protocol Violation|4|||
145615470|NCT00383240|525106982|FG001|Overall Study|Protocol Violation|5|||
145615471|NCT00383240|525106983|FG002|Overall Study|Protocol Violation|9|||
145615472|NCT00383240|525106984|FG003|Overall Study|Protocol Violation|6|||
145615473|NCT00383240|525106981|FG000|Overall Study|Did not meet protocol eligibility|9|||
145615474|NCT00383240|525106982|FG001|Overall Study|Did not meet protocol eligibility|4|||
145615475|NCT00383240|525106983|FG002|Overall Study|Did not meet protocol eligibility|9|||
145615476|NCT00383240|525106984|FG003|Overall Study|Did not meet protocol eligibility|3|||
145615477|NCT00383240|525106981|FG000|Overall Study|Administrative|1|||
145615478|NCT00383240|525106982|FG001|Overall Study|Administrative|1|||
145615479|NCT00383240|525106983|FG002|Overall Study|Administrative|0|||
145615480|NCT00383240|525106984|FG003|Overall Study|Administrative|0|||
145615481|NCT02049710|525106985|FG000|Overall Study|Lost to Follow-up|319|||
145615482|NCT02049710|525106986|FG001|Overall Study|Lost to Follow-up|324|||
145615483|NCT02044458|525106987|FG000|Overall Study|Protocol Violation|3|||
145615484|NCT02044458|525106988|FG001|Overall Study|Protocol Violation|8|||
145615485|NCT03391960|525106989|FG000|Overall Study|Protocol Violation|0|||
145615486|NCT03391960|525106990|FG001|Overall Study|Protocol Violation|0|||
145615487|NCT02924389|525106992|FG000|Overall Study|Lost to Follow-up|1|||
145615488|NCT02924389|525106993|FG001|Overall Study|Lost to Follow-up|0|||
145615489|NCT02924389|525106992|FG000|Overall Study|Physician Decision|2|||
145615490|NCT02924389|525106993|FG001|Overall Study|Physician Decision|0|||
145615491|NCT02924389|525106992|FG000|Overall Study|Withdrawal by Subject|3|||
145615492|NCT02924389|525106993|FG001|Overall Study|Withdrawal by Subject|0|||
145615493|NCT02924389|525106992|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
145615494|NCT02924389|525106993|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
145615495|NCT00581113|525109136|FG000|Overall Study|Withdrawal by Subject|0|||
145615496|NCT00581113|525109137|FG001|Overall Study|Withdrawal by Subject|1|||
145615497|NCT01818141|525109138|FG000|Overall Study|Withdrawal by Subject|2|||
145615498|NCT01818141|525109139|FG001|Overall Study|Withdrawal by Subject|0|||
145615499|NCT01818141|525109138|FG000|Overall Study|No baseline C.diff colonies|1|||
145615500|NCT01818141|525109139|FG001|Overall Study|No baseline C.diff colonies|1|||
145615501|NCT01818141|525109138|FG000|Overall Study|Lost to Follow-up|0|||
145615502|NCT01818141|525109139|FG001|Overall Study|Lost to Follow-up|2|||
145615503|NCT00619476|525109140|FG000|Overall Study|Adverse Event|12|||
145615504|NCT00619476|525109141|FG001|Overall Study|Adverse Event|6|||
145615505|NCT00619476|525109142|FG002|Overall Study|Adverse Event|12|||
145615506|NCT00619476|525109143|FG003|Overall Study|Adverse Event|16|||
145615507|NCT00619476|525109140|FG000|Overall Study|Lack of Efficacy|6|||
145615508|NCT00619476|525109141|FG001|Overall Study|Lack of Efficacy|1|||
145615509|NCT00619476|525109142|FG002|Overall Study|Lack of Efficacy|1|||
145615510|NCT00619476|525109143|FG003|Overall Study|Lack of Efficacy|4|||
145615511|NCT00619476|525109140|FG000|Overall Study|Protocol Violation|5|||
145615512|NCT00619476|525109141|FG001|Overall Study|Protocol Violation|4|||
145615513|NCT00619476|525109142|FG002|Overall Study|Protocol Violation|4|||
145615514|NCT00619476|525109143|FG003|Overall Study|Protocol Violation|9|||
145615515|NCT00619476|525109140|FG000|Overall Study|Lost to Follow-up|1|||
145615516|NCT00619476|525109141|FG001|Overall Study|Lost to Follow-up|2|||
145615517|NCT00619476|525109142|FG002|Overall Study|Lost to Follow-up|0|||
145615518|NCT00619476|525109143|FG003|Overall Study|Lost to Follow-up|1|||
145615519|NCT00619476|525109140|FG000|Overall Study|Investigator Discretion|2|||
145615520|NCT00619476|525109141|FG001|Overall Study|Investigator Discretion|2|||
145615521|NCT00619476|525109142|FG002|Overall Study|Investigator Discretion|2|||
145615522|NCT00619476|525109143|FG003|Overall Study|Investigator Discretion|0|||
145615523|NCT00619476|525109140|FG000|Overall Study|Withdrawal by Subject|5|||
145615524|NCT00619476|525109141|FG001|Overall Study|Withdrawal by Subject|7|||
145406495|NCT01799889|524343764|FG001|Overall Study|Lost to Follow-up|1|||
145288868|NCT02866175|523908002|FG000|Overall Study|Lack of Efficacy|0|||
145288869|NCT02866175|523908003|FG001|Overall Study|Lack of Efficacy|1|||
145288870|NCT02866175|523908002|FG000|Overall Study|Physician Decision|3|||
145288871|NCT02866175|523908003|FG001|Overall Study|Physician Decision|15|||
145288872|NCT02866175|523908002|FG000|Overall Study|Did not receive treatment|5|||
145288873|NCT02866175|523908003|FG001|Overall Study|Did not receive treatment|15|||
145288874|NCT04956666|523908005|FG000|Overall Study|Adverse Event|18|||
145288875|NCT04956666|523908005|FG000|Overall Study|Physician Decision|5|||
145288876|NCT00729859|523908006|FG000|Overall Study|Adverse Event|0|||
145288877|NCT00729859|523908007|FG001|Overall Study|Adverse Event|1|||
145288878|NCT00729859|523908008|FG002|Overall Study|Adverse Event|0|||
145288879|NCT00729859|523908006|FG000|Overall Study|Withdrawal by Subject|0|||
145288880|NCT00729859|523908007|FG001|Overall Study|Withdrawal by Subject|1|||
145288881|NCT00729859|523908008|FG002|Overall Study|Withdrawal by Subject|0|||
145288882|NCT02623829|523908015|FG000|Overall Study|Lost to Follow-up|1|||
145288883|NCT02623829|523908016|FG001|Overall Study|Lost to Follow-up|1|||
145288884|NCT00662025|523908017|FG000|Overall Study|Objective progression or relapse|51|||
145288885|NCT00662025|523908017|FG000|Overall Study|Adverse Event|7|||
145288886|NCT00662025|523908017|FG000|Overall Study|Withdrawal by Subject|1|||
145288887|NCT00662025|523908017|FG000|Overall Study|Results of other clinical study|2|||
145288888|NCT00662025|523908017|FG000|Overall Study|Target lesion cannot be evaluated|1|||
145288889|NCT00662025|523908017|FG000|Overall Study|Domestic circumstances|1|||
145288890|NCT01700621|523908018|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
145288891|NCT01700621|523908019|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
145288892|NCT01700621|523908018|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
145288893|NCT01700621|523908019|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
145288894|NCT01700621|523908018|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
145288895|NCT01700621|523908019|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
145288896|NCT02035137|523908022|FG000|Overall Study|Physician Decision|0|||
145288897|NCT02035137|523908023|FG001|Overall Study|Physician Decision|0|||
145288898|NCT02035137|523908024|FG002|Overall Study|Physician Decision|1|||
145288899|NCT02035137|523908022|FG000|Overall Study|Withdrawal by Subject|0|||
145288900|NCT02035137|523908023|FG001|Overall Study|Withdrawal by Subject|1|||
145288901|NCT02035137|523908024|FG002|Overall Study|Withdrawal by Subject|2|||
145288902|NCT02035137|523908022|FG000|Overall Study|Ineligible|0|||
145288903|NCT02035137|523908023|FG001|Overall Study|Ineligible|1|||
145288904|NCT02035137|523908024|FG002|Overall Study|Ineligible|2|||
145288905|NCT02035137|523908022|FG000|Overall Study|Disease progression prior to treatment start|2|||
145288906|NCT02035137|523908023|FG001|Overall Study|Disease progression prior to treatment start|0|||
145288907|NCT02035137|523908024|FG002|Overall Study|Disease progression prior to treatment start|0|||
145288908|NCT02985151|523908031|FG000|Original Randomization|Withdrawal by Subject|0|||
145288909|NCT02985151|523908032|FG001|Original Randomization|Withdrawal by Subject|1|||
145288910|NCT00290745|523908033|FG000|Overall Study|Withdrawal by Subject|4|||
145288911|NCT00290745|523908033|FG000|Overall Study|Physician Decision|2|||
145288912|NCT00290745|523908033|FG000|Overall Study|Surgery after 3 months for progression|3|||
145288913|NCT00290745|523908033|FG000|Overall Study|Baseline MRI not available|3|||
145288914|NCT00113490|523908037|FG000|Overall Study|Withdrawal by Subject|1|||
145288915|NCT00113490|523908038|FG001|Overall Study|Withdrawal by Subject|3|||
145288916|NCT00113490|523908037|FG000|Overall Study|Lost to Follow-up|1|||
145288917|NCT00113490|523908038|FG001|Overall Study|Lost to Follow-up|0|||
145288918|NCT00819247|523908039|FG000|Overall Study|Adverse Event|0|||
145288919|NCT00819247|523908040|FG001|Overall Study|Adverse Event|5|||
145288920|NCT00819247|523908041|FG002|Overall Study|Adverse Event|3|||
145288921|NCT00819247|523908039|FG000|Overall Study|Insufficient testosterone response|5|||
145288922|NCT00819247|523908040|FG001|Overall Study|Insufficient testosterone response|8|||
145406496|NCT01799889|524343765|FG002|Overall Study|Lost to Follow-up|0|||
145556134|NCT02141997|524894965|FG003|Overall Study|Participant noncompliance|0|||
145615525|NCT00619476|525109142|FG002|Overall Study|Withdrawal by Subject|5|||
145615526|NCT00619476|525109143|FG003|Overall Study|Withdrawal by Subject|4|||
145615527|NCT02169830|525109146|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
145615528|NCT02169830|525109147|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
145615529|NCT02169830|525109148|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
145615530|NCT02169830|525109146|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
145615531|NCT02169830|525109147|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
145615532|NCT02169830|525109148|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
145615533|NCT02169830|525109146|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
145288923|NCT00819247|523908041|FG002|Overall Study|Insufficient testosterone response|10|||
145288924|NCT00819247|523908039|FG000|Overall Study|Withdrawal by Subject|1|||
145556135|NCT02141997|524894962|FG000|Overall Study|Withdrew consent|1|||
145556136|NCT02141997|524894963|FG001|Overall Study|Withdrew consent|0|||
145288925|NCT00819247|523908040|FG001|Overall Study|Withdrawal by Subject|0|||
145288926|NCT00819247|523908041|FG002|Overall Study|Withdrawal by Subject|0|||
145288927|NCT00819247|523908039|FG000|Overall Study|Protocol Violation|1|||
145288928|NCT00819247|523908040|FG001|Overall Study|Protocol Violation|0|||
145288929|NCT00819247|523908041|FG002|Overall Study|Protocol Violation|1|||
145556137|NCT02141997|524894964|FG002|Overall Study|Withdrew consent|3|||
145556138|NCT02141997|524894965|FG003|Overall Study|Withdrew consent|0|||
145556139|NCT02141997|524894962|FG000|Overall Study|Other|1|||
145556140|NCT02141997|524894963|FG001|Overall Study|Other|4|||
145556141|NCT02141997|524894964|FG002|Overall Study|Other|0|||
145556142|NCT02141997|524894965|FG003|Overall Study|Other|0|||
145556143|NCT00909389|524894967|FG000|Overall Study|Adverse Event|6|||
145556144|NCT00909389|524894967|FG000|Overall Study|Death|4|||
145556145|NCT00909389|524894967|FG000|Overall Study|Poor Compliance|16|||
145556146|NCT00909389|524894967|FG000|Overall Study|Lost to Follow-up|4|||
145556147|NCT00909389|524894967|FG000|Overall Study|No Information|103|||
145556148|NCT03557151|524894968|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
145556149|NCT03557151|524894969|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
145288930|NCT00819247|523908039|FG000|Overall Study|Mistakenly withdrawn|0|||
145288931|NCT00819247|523908040|FG001|Overall Study|Mistakenly withdrawn|1|||
145288932|NCT00819247|523908041|FG002|Overall Study|Mistakenly withdrawn|0|||
145556150|NCT03557151|524894968|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
145556151|NCT03557151|524894969|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
145556152|NCT03557151|524894968|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
145556153|NCT03557151|524894969|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
145556154|NCT04868890|524894979|FG000|Overall Study|Death|2|||
145556155|NCT04868890|524894980|FG001|Overall Study|Death|1|||
145556156|NCT04868890|524894979|FG000|Overall Study|Withdrawal by Subject|1|||
145556157|NCT04868890|524894980|FG001|Overall Study|Withdrawal by Subject|5|||
145556158|NCT00818662|524894984|FG000|Overall Study|Adverse Event|5|||
145556159|NCT00818662|524894985|FG001|Overall Study|Adverse Event|14|||
145556160|NCT00818662|524894986|FG002|Overall Study|Adverse Event|4|||
145556161|NCT00818662|524894987|FG003|Overall Study|Adverse Event|3|||
145556162|NCT00818662|524894984|FG000|Overall Study|Withdrawal by Subject|5|||
145556163|NCT00818662|524894985|FG001|Overall Study|Withdrawal by Subject|4|||
145556164|NCT00818662|524894986|FG002|Overall Study|Withdrawal by Subject|2|||
145556165|NCT00818662|524894987|FG003|Overall Study|Withdrawal by Subject|2|||
145556166|NCT00818662|524894984|FG000|Overall Study|Death|1|||
145556167|NCT00818662|524894985|FG001|Overall Study|Death|3|||
145556168|NCT00818662|524894986|FG002|Overall Study|Death|0|||
145556169|NCT00818662|524894987|FG003|Overall Study|Death|0|||
145556170|NCT00818662|524894984|FG000|Overall Study|Physician Decision|1|||
145556171|NCT00818662|524894985|FG001|Overall Study|Physician Decision|0|||
145556172|NCT00818662|524894986|FG002|Overall Study|Physician Decision|0|||
145556173|NCT00818662|524894987|FG003|Overall Study|Physician Decision|0|||
145556174|NCT00818662|524894984|FG000|Overall Study|Lost to Follow-up|0|||
145556175|NCT00818662|524894985|FG001|Overall Study|Lost to Follow-up|0|||
145556176|NCT00818662|524894986|FG002|Overall Study|Lost to Follow-up|0|||
145556177|NCT00818662|524894987|FG003|Overall Study|Lost to Follow-up|1|||
145556178|NCT00818662|524894984|FG000|Overall Study|Unwilling or Unable to Participate|4|||
145556179|NCT00818662|524894985|FG001|Overall Study|Unwilling or Unable to Participate|6|||
145556180|NCT00818662|524894986|FG002|Overall Study|Unwilling or Unable to Participate|2|||
145556181|NCT00818662|524894987|FG003|Overall Study|Unwilling or Unable to Participate|4|||
145556182|NCT00818662|524894984|FG000|Overall Study|Protocol Violation|1|||
145556183|NCT00818662|524894985|FG001|Overall Study|Protocol Violation|1|||
145556184|NCT00818662|524894986|FG002|Overall Study|Protocol Violation|0|||
145556185|NCT00818662|524894987|FG003|Overall Study|Protocol Violation|0|||
145556186|NCT00818662|524894984|FG000|Overall Study|Requires a Prohibited Medication|1|||
145556187|NCT00818662|524894985|FG001|Overall Study|Requires a Prohibited Medication|0|||
145556188|NCT00818662|524894986|FG002|Overall Study|Requires a Prohibited Medication|0|||
145556189|NCT00818662|524894987|FG003|Overall Study|Requires a Prohibited Medication|0|||
145556190|NCT00818662|524894984|FG000|Overall Study|Safety Risk|1|||
145556191|NCT00818662|524894985|FG001|Overall Study|Safety Risk|1|||
145556192|NCT00818662|524894986|FG002|Overall Study|Safety Risk|0|||
145556193|NCT00818662|524894987|FG003|Overall Study|Safety Risk|1|||
145556194|NCT00818662|524894984|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
145556195|NCT00818662|524894985|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
145556196|NCT00818662|524894986|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
145556197|NCT00818662|524894987|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
145556198|NCT00818662|524894984|FG000|Overall Study|Participant's health declined|0|||
145556199|NCT00818662|524894985|FG001|Overall Study|Participant's health declined|0|||
145556200|NCT00818662|524894986|FG002|Overall Study|Participant's health declined|0|||
145556201|NCT00818662|524894987|FG003|Overall Study|Participant's health declined|1|||
145556202|NCT00818662|524894984|FG000|Overall Study|Caregiver to pursue other treatment|0|||
145288933|NCT00819247|523908039|FG000|Overall Study|Bad prostate-specific antigen response|3|||
145288934|NCT00819247|523908040|FG001|Overall Study|Bad prostate-specific antigen response|2|||
145288935|NCT00819247|523908041|FG002|Overall Study|Bad prostate-specific antigen response|0|||
145556203|NCT00818662|524894985|FG001|Overall Study|Caregiver to pursue other treatment|1|||
145288936|NCT00819247|523908039|FG000|Overall Study|Other|1|||
145288937|NCT00819247|523908040|FG001|Overall Study|Other|0|||
145288938|NCT00819247|523908041|FG002|Overall Study|Other|0|||
145288939|NCT02162758|523908042|FG000|Overall Study|Study termination|0|||
145288940|NCT02162758|523908043|FG001|Overall Study|Study termination|1|||
145288941|NCT04471935|523908044|FG000|Overall Study|Withdrawal by Subject|1|||
145288942|NCT04471935|523908044|FG000|Overall Study|Deemed ineligible to participate|1|||
145288943|NCT01766921|523908049|FG000|Overall Study|Administrative Reason|5|||
145288944|NCT01766921|523908050|FG001|Overall Study|Administrative Reason|5|||
145288945|NCT01766921|523908049|FG000|Overall Study|Death|1|||
145288946|NCT01766921|523908050|FG001|Overall Study|Death|1|||
145288947|NCT01766921|523908049|FG000|Overall Study|Lost to Follow-up|1|||
145288948|NCT01766921|523908050|FG001|Overall Study|Lost to Follow-up|3|||
145288949|NCT01766921|523908049|FG000|Overall Study|Unclassified|2|||
145288950|NCT01766921|523908050|FG001|Overall Study|Unclassified|2|||
145288951|NCT01766921|523908049|FG000|Overall Study|Protocol Violation|1|||
145288952|NCT01766921|523908050|FG001|Overall Study|Protocol Violation|1|||
145288953|NCT01766921|523908049|FG000|Overall Study|Withdrawal by Subject|14|||
145288954|NCT01766921|523908050|FG001|Overall Study|Withdrawal by Subject|5|||
145288955|NCT00708422|523908051|FG000|Overall Study|Adverse Event|3|||
145288956|NCT00708422|523908052|FG001|Overall Study|Adverse Event|1|||
145288957|NCT00708422|523908051|FG000|Overall Study|Withdrawal by Subject|1|||
145288958|NCT00708422|523908052|FG001|Overall Study|Withdrawal by Subject|0|||
145288959|NCT05476679|523908056|FG000|Overall Study|Withdrawal by Subject|0|||
145288960|NCT05476679|523908057|FG001|Overall Study|Withdrawal by Subject|0|||
145288961|NCT05476679|523908058|FG002|Overall Study|Withdrawal by Subject|0|||
145288962|NCT05476679|523908059|FG003|Overall Study|Withdrawal by Subject|1|||
145288963|NCT05476679|523908060|FG004|Overall Study|Withdrawal by Subject|0|||
145288964|NCT05476679|523908056|FG000|Overall Study|Lost to Follow-up|0|||
145288965|NCT05476679|523908057|FG001|Overall Study|Lost to Follow-up|0|||
145288966|NCT05476679|523908058|FG002|Overall Study|Lost to Follow-up|0|||
145288967|NCT05476679|523908059|FG003|Overall Study|Lost to Follow-up|1|||
145288968|NCT05476679|523908060|FG004|Overall Study|Lost to Follow-up|0|||
145288969|NCT00601354|523908061|FG000|Overall Study|Lost to Follow-up|4|||
145288970|NCT00601354|523908062|FG001|Overall Study|Lost to Follow-up|5|||
145288971|NCT00278512|523908064|FG000|Overall Study|Death|1|||
145288972|NCT00278512|523908065|FG001|Overall Study|Death|0|||
145288973|NCT01620177|523908066|FG000|Overall Study|Failure at Screening Visit|43|||
145288974|NCT01620177|523908066|FG000|Overall Study|Withdrawal by Subject|26|||
145288975|NCT01620177|523908066|FG000|Overall Study|Lost to Follow-up|7|||
145288976|NCT01620177|523908066|FG000|Overall Study|Physician Decision|2|||
145288977|NCT01620177|523908066|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
145288978|NCT01789320|523908070|FG000|Overall Study|Re-enrolled into study|1|||
145288979|NCT01789320|523908070|FG000|Overall Study|Lost to Follow-up|1|||
145288980|NCT00619385|523908075|FG000|Overall Study|Adverse Event|0|||
145288981|NCT00619385|523908076|FG001|Overall Study|Adverse Event|0|||
145556204|NCT00818662|524894986|FG002|Overall Study|Caregiver to pursue other treatment|0|||
145288982|NCT00619385|523908077|FG002|Overall Study|Adverse Event|3|||
145288983|NCT00619385|523908075|FG000|Overall Study|Other|1|||
145288984|NCT00619385|523908076|FG001|Overall Study|Other|2|||
145288985|NCT00619385|523908077|FG002|Overall Study|Other|1|||
145288986|NCT02789111|523908078|FG000|Overall Study|Withdrawal by Subject|1|||
145288987|NCT02789111|523908079|FG001|Overall Study|Withdrawal by Subject|4|||
145288988|NCT03271528|523908080|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
145288989|NCT03271528|523908081|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
145288990|NCT03271528|523908080|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
145288991|NCT03271528|523908081|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
145288992|NCT03271528|523908080|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
145288993|NCT03271528|523908081|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
145292780|NCT05014412|523922234|FG002|Overall Study|Withdrawal by Subject|1|||
145406497|NCT01799889|524343766|FG003|Overall Study|Lost to Follow-up|0|||
145406498|NCT01799889|524343767|FG004|Overall Study|Lost to Follow-up|0|||
145406499|NCT01799889|524343768|FG005|Overall Study|Lost to Follow-up|0|||
145615534|NCT02169830|525109147|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
145615535|NCT02169830|525109148|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145406500|NCT01799889|524343769|FG006|Overall Study|Lost to Follow-up|0|||
145288994|NCT03271528|523908080|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
145288995|NCT03271528|523908081|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
145288996|NCT03271528|523908080|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
145288997|NCT03271528|523908081|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
145288998|NCT03271528|523908080|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
145288999|NCT03271528|523908081|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
145289000|NCT03271528|523908080|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
145556205|NCT00818662|524894987|FG003|Overall Study|Caregiver to pursue other treatment|0|||
145406501|NCT01799889|524343770|FG007|Overall Study|Lost to Follow-up|0|||
145556206|NCT00818662|524894984|FG000|Overall Study|Moving out of state|0|||
145615536|NCT02169830|525109146|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
145615537|NCT02169830|525109147|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
145615538|NCT02169830|525109148|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
145615539|NCT02169830|525109146|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
145615540|NCT02169830|525109147|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
145615541|NCT02169830|525109148|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
145289001|NCT03271528|523908081|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
145615542|NCT03204695|525109149|FG000|Overall Study|Death|1|||
145615543|NCT03204695|525109149|FG000|Overall Study|Participant was treated with another device|1|||
145615544|NCT03204695|525109149|FG000|Overall Study|Physician Decision|2|||
145615545|NCT04834362|525109150|FG000|Overall Study|Death|1|||
145615546|NCT04834362|525109151|FG001|Overall Study|Death|2|||
145615547|NCT02555371|525109152|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
145615548|NCT02555371|525109153|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
145615549|NCT02555371|525109154|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
145615550|NCT02555371|525109155|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
145615551|NCT02555371|525109156|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
145615552|NCT02555371|525109152|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
145615553|NCT02555371|525109153|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
145615554|NCT02555371|525109154|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
145615555|NCT02555371|525109155|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
145615556|NCT02555371|525109156|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
145615557|NCT02555371|525109152|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
145615558|NCT02555371|525109153|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
145615559|NCT02555371|525109154|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
145615560|NCT02555371|525109155|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
145615561|NCT02555371|525109156|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
145615562|NCT02555371|525109152|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
145615563|NCT02555371|525109153|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
145615564|NCT02555371|525109154|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
145615565|NCT02555371|525109155|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
145615566|NCT02555371|525109156|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
145615567|NCT02555371|525109152|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
145615568|NCT02555371|525109153|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
145615569|NCT02555371|525109154|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
145615570|NCT02555371|525109155|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
145615571|NCT02555371|525109156|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
145289002|NCT00306384|523908083|FG000|Overall Study|Adverse Event|103|||
145289003|NCT00306384|523908084|FG001|Overall Study|Adverse Event|87|||
145289004|NCT00306384|523908085|FG002|Overall Study|Adverse Event|40|||
145289005|NCT00306384|523908083|FG000|Overall Study|Major protocol deviation|43|||
145289006|NCT00306384|523908084|FG001|Overall Study|Major protocol deviation|51|||
145289007|NCT00306384|523908085|FG002|Overall Study|Major protocol deviation|18|||
145289008|NCT00306384|523908083|FG000|Overall Study|Lost to Follow-up|57|||
145289009|NCT00306384|523908084|FG001|Overall Study|Lost to Follow-up|41|||
145289010|NCT00306384|523908085|FG002|Overall Study|Lost to Follow-up|35|||
145289011|NCT00306384|523908083|FG000|Overall Study|Voluntary withdrawal|199|||
145289012|NCT00306384|523908084|FG001|Overall Study|Voluntary withdrawal|187|||
145289013|NCT00306384|523908085|FG002|Overall Study|Voluntary withdrawal|91|||
145289014|NCT00306384|523908083|FG000|Overall Study|Study termination|1|||
145289015|NCT00306384|523908084|FG001|Overall Study|Study termination|0|||
145289016|NCT00306384|523908085|FG002|Overall Study|Study termination|1|||
145289017|NCT00306384|523908083|FG000|Overall Study|Pregnancy|3|||
145289018|NCT00306384|523908084|FG001|Overall Study|Pregnancy|1|||
145289019|NCT00306384|523908085|FG002|Overall Study|Pregnancy|1|||
145289020|NCT00306384|523908083|FG000|Overall Study|Lack of Efficacy|26|||
145289021|NCT00306384|523908084|FG001|Overall Study|Lack of Efficacy|40|||
145289022|NCT00306384|523908085|FG002|Overall Study|Lack of Efficacy|38|||
145289023|NCT00306384|523908083|FG000|Overall Study|Investigator discretion|28|||
145289024|NCT00306384|523908084|FG001|Overall Study|Investigator discretion|31|||
145615572|NCT02555371|525109152|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
145289025|NCT00306384|523908085|FG002|Overall Study|Investigator discretion|21|||
145289026|NCT00306384|523908083|FG000|Overall Study|Other|80|||
145406502|NCT01799889|524343771|FG008|Overall Study|Lost to Follow-up|0|||
145615573|NCT02555371|525109153|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
145615574|NCT02555371|525109154|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
145289027|NCT00306384|523908084|FG001|Overall Study|Other|70|||
145289028|NCT00306384|523908085|FG002|Overall Study|Other|32|||
145289029|NCT00306384|523908083|FG000|Overall Study|Site closure|2|||
145289030|NCT00306384|523908084|FG001|Overall Study|Site closure|0|||
145289031|NCT00306384|523908085|FG002|Overall Study|Site closure|0|||
145289032|NCT00673790|523908086|FG000|Overall Study|Adverse Event|23|||
145289033|NCT00673790|523908087|FG001|Overall Study|Adverse Event|14|||
145289034|NCT00673790|523908088|FG002|Overall Study|Adverse Event|2|||
145289035|NCT00673790|523908086|FG000|Overall Study|Lack of Efficacy|2|||
145289036|NCT00673790|523908087|FG001|Overall Study|Lack of Efficacy|2|||
145289037|NCT00673790|523908088|FG002|Overall Study|Lack of Efficacy|2|||
145289038|NCT00673790|523908086|FG000|Overall Study|Protocol Violation|6|||
145289039|NCT00673790|523908087|FG001|Overall Study|Protocol Violation|9|||
145289040|NCT00673790|523908088|FG002|Overall Study|Protocol Violation|1|||
145289041|NCT00673790|523908086|FG000|Overall Study|Withdrawal by Subject|7|||
145289042|NCT00673790|523908087|FG001|Overall Study|Withdrawal by Subject|4|||
145289043|NCT00673790|523908088|FG002|Overall Study|Withdrawal by Subject|1|||
145289044|NCT00673790|523908086|FG000|Overall Study|Lost to Follow-up|6|||
145289045|NCT00673790|523908087|FG001|Overall Study|Lost to Follow-up|6|||
145289046|NCT00673790|523908088|FG002|Overall Study|Lost to Follow-up|5|||
145289047|NCT00673790|523908086|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
145289048|NCT00673790|523908087|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
145289049|NCT00673790|523908088|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
145289050|NCT00673790|523908086|FG000|Overall Study|Poor compliance|1|||
145289051|NCT00673790|523908087|FG001|Overall Study|Poor compliance|0|||
145289052|NCT00673790|523908088|FG002|Overall Study|Poor compliance|0|||
145289053|NCT00673790|523908086|FG000|Overall Study|Participated in two Nebivolol studies|0|||
145289054|NCT00673790|523908087|FG001|Overall Study|Participated in two Nebivolol studies|0|||
145289055|NCT00673790|523908088|FG002|Overall Study|Participated in two Nebivolol studies|1|||
145289056|NCT00673790|523908086|FG000|Overall Study|Unconfirmed pregnancy|0|||
145289057|NCT00673790|523908087|FG001|Overall Study|Unconfirmed pregnancy|1|||
145289058|NCT00673790|523908088|FG002|Overall Study|Unconfirmed pregnancy|0|||
145289059|NCT00673790|523908086|FG000|Overall Study|Randomization criteria not met|0|||
145289060|NCT00673790|523908087|FG001|Overall Study|Randomization criteria not met|1|||
145289061|NCT00673790|523908088|FG002|Overall Study|Randomization criteria not met|0|||
145289062|NCT00717756|523908089|FG000|Overall Study|Withdrawal by Subject|1|||
145289063|NCT00745251|523908090|FG000|Overall Study|Adverse Event|1|||
145289064|NCT00745251|523908091|FG001|Overall Study|Adverse Event|2|||
145289065|NCT00745251|523908090|FG000|Overall Study|Withdrawal by Subject|1|||
145289066|NCT00745251|523908091|FG001|Overall Study|Withdrawal by Subject|1|||
145289067|NCT02928848|523908092|FG000|Arm 2|Withdrawal by Subject|1|||
145289068|NCT02928848|523908093|FG001|Arm 2|Withdrawal by Subject|0|||
145289069|NCT03850509|523908094|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
145289070|NCT03850509|523908095|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
145289071|NCT00969332|523908096|FG000|Overall Study|Physician Decision|8|||
145289072|NCT00969332|523908096|FG000|Overall Study|Withdrawal by Subject|3|||
145289073|NCT02666430|523908097|FG000|Period 1|Lost to Follow-up|1|||
145289074|NCT02666430|523908098|FG001|Period 1|Lost to Follow-up|0|||
145289075|NCT02666430|523908097|FG000|Period 1|Adverse Event|0|||
145289076|NCT02666430|523908098|FG001|Period 1|Adverse Event|1|||
145289077|NCT02666430|523908097|FG000|Period 2|Withdrawal by Subject|1|||
145289078|NCT02666430|523908098|FG001|Period 2|Withdrawal by Subject|4|||
145289079|NCT02666430|523908097|FG000|Period 3|Lost to Follow-up|1|||
145289080|NCT02666430|523908098|FG001|Period 3|Lost to Follow-up|0|||
145289081|NCT03828461|523908099|FG000|Overall Study|Lost to Follow-up|1|||
145289082|NCT03828461|523908099|FG000|Overall Study|Withdrawal by Subject|3|||
145289083|NCT00576199|523908100|FG000|Overall Study|Adverse Event|12|||
145289084|NCT00576199|523908100|FG000|Overall Study|Insufficient Therapeutic Response|14|||
145289085|NCT00576199|523908100|FG000|Overall Study|Refused Treatment|2|||
145289086|NCT00576199|523908100|FG000|Overall Study|Reason Unspecified|2|||
145289087|NCT03111147|523908102|FG000|Overall Study|Lost to Follow-up|2|||
145289088|NCT03111147|523908103|FG001|Overall Study|Lost to Follow-up|5|||
145289089|NCT03111147|523908102|FG000|Overall Study|Withdrawal by Subject|4|||
145289090|NCT03111147|523908103|FG001|Overall Study|Withdrawal by Subject|3|||
145289091|NCT03111147|523908102|FG000|Overall Study|Protocol Violation|2|||
145289092|NCT03111147|523908103|FG001|Overall Study|Protocol Violation|1|||
145289093|NCT03111147|523908102|FG000|Overall Study|Death|1|||
145289094|NCT03111147|523908103|FG001|Overall Study|Death|1|||
145289095|NCT01463683|523908104|FG000|Overall Study|Adverse Event|2|||
145289096|NCT01463683|523908105|FG001|Overall Study|Adverse Event|0|||
145289097|NCT01463683|523908106|FG002|Overall Study|Adverse Event|0|||
145289098|NCT01463683|523908104|FG000|Overall Study|Lost to Follow-up|10|||
145289099|NCT01463683|523908105|FG001|Overall Study|Lost to Follow-up|9|||
145615575|NCT02555371|525109155|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
145406503|NCT01799889|524343772|FG009|Overall Study|Lost to Follow-up|0|||
145406504|NCT01799889|524343773|FG010|Overall Study|Lost to Follow-up|0|||
145289100|NCT01463683|523908106|FG002|Overall Study|Lost to Follow-up|7|||
145289101|NCT01463683|523908104|FG000|Overall Study|Physician Decision|0|||
145289102|NCT01463683|523908105|FG001|Overall Study|Physician Decision|3|||
145289103|NCT01463683|523908106|FG002|Overall Study|Physician Decision|1|||
145289104|NCT01463683|523908104|FG000|Overall Study|Pregnancy|2|||
145289105|NCT01463683|523908105|FG001|Overall Study|Pregnancy|2|||
145289106|NCT01463683|523908106|FG002|Overall Study|Pregnancy|1|||
145289107|NCT01463683|523908104|FG000|Overall Study|Withdrawal by Subject|5|||
145289108|NCT01463683|523908105|FG001|Overall Study|Withdrawal by Subject|17|||
145289109|NCT01463683|523908106|FG002|Overall Study|Withdrawal by Subject|2|||
145289110|NCT01565083|523908107|FG000|Overall Study|Withdrawal by Subject|6|||
145289111|NCT01565083|523908108|FG001|Overall Study|Withdrawal by Subject|4|||
145289112|NCT01565083|523908107|FG000|Overall Study|Lost to Follow-up|2|||
145289113|NCT01565083|523908108|FG001|Overall Study|Lost to Follow-up|7|||
145289114|NCT01565083|523908107|FG000|Overall Study|Death|22|||
145289115|NCT01565083|523908108|FG001|Overall Study|Death|23|||
145289116|NCT01565083|523908107|FG000|Overall Study|Other|3|||
145289117|NCT01565083|523908108|FG001|Overall Study|Other|5|||
145289118|NCT02178709|523909979|FG000|Overall Study|Adverse Event|5|||
145289119|NCT02178709|523909979|FG000|Overall Study|Death|2|||
145289120|NCT02178709|523909979|FG000|Overall Study|Withdrawal by Subject|2|||
145289121|NCT02178709|523909979|FG000|Overall Study|Physician Decision|2|||
145289122|NCT02178709|523909979|FG000|Overall Study|Disease Progression|5|||
145289123|NCT02946385|523909980|FG000|Overall Study|Lost to Follow-up|0|||
145406505|NCT01799889|524343774|FG011|Overall Study|Lost to Follow-up|0|||
145406506|NCT01799889|524343763|FG000|Overall Study|Physician Decision|3|||
145289124|NCT02946385|523909981|FG001|Overall Study|Lost to Follow-up|0|||
145289125|NCT02946385|523909982|FG002|Overall Study|Lost to Follow-up|3|||
145289126|NCT02946385|523909983|FG003|Overall Study|Lost to Follow-up|0|||
145289127|NCT02946385|523909984|FG004|Overall Study|Lost to Follow-up|2|||
145289128|NCT02946385|523909985|FG005|Overall Study|Lost to Follow-up|1|||
145289129|NCT00313703|523909986|FG000|Overall Study|Lost to Follow-up|11|||
145289130|NCT00313703|523909987|FG001|Overall Study|Lost to Follow-up|2|||
145289131|NCT00313703|523909988|FG002|Overall Study|Lost to Follow-up|5|||
145289132|NCT00313703|523909989|FG003|Overall Study|Lost to Follow-up|12|||
145289133|NCT03329027|523909994|FG000|Overall Study|Lost to Follow-up|1|||
145289134|NCT03329027|523909995|FG001|Overall Study|Lost to Follow-up|0|||
145289135|NCT03329027|523909996|FG002|Overall Study|Lost to Follow-up|1|||
145289136|NCT03329027|523909994|FG000|Overall Study|Protocol Violation|9|||
145289137|NCT03329027|523909995|FG001|Overall Study|Protocol Violation|5|||
145289138|NCT03329027|523909996|FG002|Overall Study|Protocol Violation|7|||
145289139|NCT04849988|523909997|FG000|Overall Study|Lack of Efficacy|3|||
145289140|NCT04849988|523909998|FG001|Overall Study|Lack of Efficacy|4|||
145289141|NCT04849988|523909999|FG002|Overall Study|Lack of Efficacy|1|||
145289142|NCT04849988|523910000|FG003|Overall Study|Lack of Efficacy|4|||
145289143|NCT04849988|523909997|FG000|Overall Study|Other reasons|1|||
145289144|NCT04849988|523909998|FG001|Overall Study|Other reasons|2|||
145289145|NCT04849988|523909999|FG002|Overall Study|Other reasons|2|||
145289146|NCT04849988|523910000|FG003|Overall Study|Other reasons|1|||
145289147|NCT00101582|523910007|FG000|Overall Study|Ineligibility determined|0|||
145289148|NCT00101582|523910008|FG001|Overall Study|Ineligibility determined|1|||
145289149|NCT00101582|523910007|FG000|Overall Study|Adverse Event|1|||
145289150|NCT00101582|523910008|FG001|Overall Study|Adverse Event|4|||
145289151|NCT00101582|523910007|FG000|Overall Study|Withdrawal by Subject|6|||
145289152|NCT00101582|523910008|FG001|Overall Study|Withdrawal by Subject|4|||
145289153|NCT00101582|523910007|FG000|Overall Study|Physician Decision|1|||
145289154|NCT00101582|523910008|FG001|Overall Study|Physician Decision|0|||
145289155|NCT00101582|523910007|FG000|Overall Study|Death|3|||
145289156|NCT00101582|523910008|FG001|Overall Study|Death|5|||
145289157|NCT00101582|523910007|FG000|Overall Study|Other|0|||
145289158|NCT00101582|523910008|FG001|Overall Study|Other|1|||
145289159|NCT01919190|523910009|FG000|Overall Study|Intra-op findings, etc.|3|||
145289160|NCT01919190|523910010|FG001|Overall Study|Intra-op findings, etc.|0|||
145289161|NCT02146430|523910011|FG000|Overall Study|Protocol Violation|5|||
145289162|NCT02146430|523910012|FG001|Overall Study|Protocol Violation|4|||
145289163|NCT02146430|523910013|FG002|Overall Study|Protocol Violation|8|||
145289164|NCT02146430|523910014|FG003|Overall Study|Protocol Violation|6|||
145289165|NCT02146430|523910011|FG000|Overall Study|Lack of Efficacy|13|||
145289166|NCT02146430|523910012|FG001|Overall Study|Lack of Efficacy|11|||
145289167|NCT02146430|523910013|FG002|Overall Study|Lack of Efficacy|8|||
145289168|NCT02146430|523910014|FG003|Overall Study|Lack of Efficacy|5|||
145289169|NCT02146430|523910011|FG000|Overall Study|Adverse Event|20|||
145289170|NCT02146430|523910012|FG001|Overall Study|Adverse Event|40|||
145289171|NCT02146430|523910013|FG002|Overall Study|Adverse Event|32|||
145289172|NCT02146430|523910014|FG003|Overall Study|Adverse Event|49|||
145289173|NCT02146430|523910011|FG000|Overall Study|Reason missing or not reported|2|||
145289174|NCT02146430|523910012|FG001|Overall Study|Reason missing or not reported|3|||
145289175|NCT02146430|523910013|FG002|Overall Study|Reason missing or not reported|4|||
145289176|NCT02146430|523910014|FG003|Overall Study|Reason missing or not reported|5|||
145289177|NCT02146430|523910011|FG000|Overall Study|Withdrawal by Subject|27|||
145289178|NCT02146430|523910012|FG001|Overall Study|Withdrawal by Subject|29|||
145289179|NCT02146430|523910013|FG002|Overall Study|Withdrawal by Subject|30|||
145289180|NCT02146430|523910014|FG003|Overall Study|Withdrawal by Subject|34|||
145289181|NCT01893905|523910015|FG000|Overall Study|Withdrawal by Subject|1|||
145289182|NCT01893905|523910016|FG001|Overall Study|Withdrawal by Subject|0|||
145289183|NCT01893905|523910015|FG000|Overall Study|Adverse Event|9|||
145289184|NCT01893905|523910016|FG001|Overall Study|Adverse Event|3|||
145289185|NCT01893905|523910015|FG000|Overall Study|Lack of Efficacy|5|||
145289186|NCT01893905|523910016|FG001|Overall Study|Lack of Efficacy|7|||
145289187|NCT01893905|523910015|FG000|Overall Study|Lost to Follow-up|1|||
145289188|NCT01893905|523910016|FG001|Overall Study|Lost to Follow-up|0|||
145289189|NCT01893905|523910015|FG000|Overall Study|Protocol Violation|6|||
145289190|NCT01893905|523910016|FG001|Overall Study|Protocol Violation|1|||
145289191|NCT01893905|523910015|FG000|Overall Study|Lack of adherence to treatment|2|||
145289192|NCT01893905|523910016|FG001|Overall Study|Lack of adherence to treatment|0|||
145289193|NCT01893905|523910015|FG000|Overall Study|Other reason|1|||
145289194|NCT01893905|523910016|FG001|Overall Study|Other reason|3|||
145289195|NCT01768858|523910017|FG000|Overall Study|Lost to Follow-up|9|||
145289196|NCT01768858|523910017|FG000|Overall Study|Lack of Efficacy|8|||
145289197|NCT01768858|523910017|FG000|Overall Study|Serious Adverse Event|1|||
145289198|NCT01768858|523910017|FG000|Overall Study|Participant moved to Germany|1|||
145289199|NCT01768858|523910017|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
145289200|NCT01768858|523910017|FG000|Overall Study|Exanthema|1|||
145289201|NCT01768858|523910017|FG000|Overall Study|Withdrawal by Subject|1|||
145289202|NCT03312530|523910018|FG000|Overall Study|Death|5|||
145289203|NCT03312530|523910019|FG001|Overall Study|Death|5|||
145289204|NCT03312530|523910020|FG002|Overall Study|Death|4|||
145289205|NCT03312530|523910021|FG003|Overall Study|Death|10|||
145289206|NCT03312530|523910022|FG004|Overall Study|Death|8|||
145289207|NCT03312530|523910018|FG000|Overall Study|Lost to Follow-up|0|||
145289208|NCT03312530|523910019|FG001|Overall Study|Lost to Follow-up|0|||
145289209|NCT03312530|523910020|FG002|Overall Study|Lost to Follow-up|0|||
145289210|NCT03312530|523910021|FG003|Overall Study|Lost to Follow-up|1|||
145289211|NCT03312530|523910022|FG004|Overall Study|Lost to Follow-up|0|||
145289212|NCT03312530|523910018|FG000|Overall Study|Participant in another sponsor study.|0|||
145289213|NCT03312530|523910019|FG001|Overall Study|Participant in another sponsor study.|0|||
145289214|NCT03312530|523910020|FG002|Overall Study|Participant in another sponsor study.|0|||
145289215|NCT03312530|523910021|FG003|Overall Study|Participant in another sponsor study.|1|||
145289216|NCT03312530|523910022|FG004|Overall Study|Participant in another sponsor study.|0|||
145289217|NCT03312530|523910018|FG000|Overall Study|Study terminated by sponsor|1|||
145289218|NCT03312530|523910019|FG001|Overall Study|Study terminated by sponsor|0|||
145289219|NCT03312530|523910020|FG002|Overall Study|Study terminated by sponsor|2|||
145289220|NCT03312530|523910021|FG003|Overall Study|Study terminated by sponsor|3|||
145289221|NCT03312530|523910022|FG004|Overall Study|Study terminated by sponsor|7|||
145289222|NCT03312530|523910018|FG000|Overall Study|Withdrawal by Subject|0|||
145289223|NCT03312530|523910019|FG001|Overall Study|Withdrawal by Subject|1|||
145289224|NCT03312530|523910020|FG002|Overall Study|Withdrawal by Subject|0|||
145289225|NCT03312530|523910021|FG003|Overall Study|Withdrawal by Subject|0|||
145289226|NCT03312530|523910022|FG004|Overall Study|Withdrawal by Subject|0|||
145289227|NCT03312530|523910018|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
145289228|NCT03312530|523910019|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
145289229|NCT03312530|523910020|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
145289230|NCT03312530|523910021|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
145289231|NCT03312530|523910022|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
145289232|NCT03093324|523910024|FG000|Overall Study|Adverse Event|4|||
145289233|NCT03093324|523910025|FG001|Overall Study|Adverse Event|15|||
145289234|NCT03093324|523910024|FG000|Overall Study|Lost to Follow-up|1|||
145289235|NCT03093324|523910025|FG001|Overall Study|Lost to Follow-up|0|||
145289236|NCT03093324|523910024|FG000|Overall Study|Protocol Deviation|2|||
145289237|NCT03093324|523910025|FG001|Overall Study|Protocol Deviation|2|||
145289238|NCT03093324|523910024|FG000|Overall Study|Withdrawal by Subject|2|||
145289239|NCT03093324|523910025|FG001|Overall Study|Withdrawal by Subject|2|||
145289240|NCT02688400|523910031|FG000|Overall Study|Protocol Violation|2|||
145289241|NCT02688400|523910032|FG001|Overall Study|Protocol Violation|5|||
145289242|NCT02688400|523910031|FG000|Overall Study|Lack of Efficacy|7|||
145289243|NCT02688400|523910032|FG001|Overall Study|Lack of Efficacy|7|||
145289244|NCT02688400|523910031|FG000|Overall Study|Adverse Event|21|||
145289245|NCT02688400|523910032|FG001|Overall Study|Adverse Event|12|||
145289246|NCT02688400|523910031|FG000|Overall Study|Withdrawal by Subject|15|||
145289247|NCT02688400|523910032|FG001|Overall Study|Withdrawal by Subject|13|||
145289248|NCT02688400|523910031|FG000|Overall Study|No study medication intake|1|||
145289249|NCT02688400|523910032|FG001|Overall Study|No study medication intake|4|||
145289250|NCT02688400|523910031|FG000|Overall Study|Lost to Follow-up|0|||
145289251|NCT02688400|523910032|FG001|Overall Study|Lost to Follow-up|3|||
145289252|NCT03349333|523910038|FG000|Overall Study|Progression of Disease|36|||
145289253|NCT03349333|523910038|FG000|Overall Study|Adverse Event|11|||
145289254|NCT03349333|523910038|FG000|Overall Study|Other|6|||
145289255|NCT03349333|523910038|FG000|Overall Study|Withdrawal by Subject|5|||
145289256|NCT03349333|523910038|FG000|Overall Study|Conditions interfere with participation|2|||
145289257|NCT03349333|523910038|FG000|Overall Study|Physician Decision|2|||
145289258|NCT03349333|523910038|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
145289259|NCT03349333|523910038|FG000|Overall Study|Patients in treatment less than 24 month|8|||
145289260|NCT01816477|523910041|FG000|Overall Study|Withdrawal by Subject|13|||
145289261|NCT01816477|523910042|FG001|Overall Study|Withdrawal by Subject|1|||
145289262|NCT01816477|523910041|FG000|Overall Study|Unable to tolerate catheter placement|3|||
145289263|NCT01816477|523910042|FG001|Overall Study|Unable to tolerate catheter placement|0|||
145289264|NCT00108732|523910043|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
145289265|NCT00108732|523910043|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
145289266|NCT00108732|523910043|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
145289267|NCT00108732|523910043|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
145289268|NCT00108732|523910043|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
145289269|NCT00108732|523910043|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
145289270|NCT00108732|523910043|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
145289271|NCT02116803|523910045|FG000|Overall Study|Adverse Event|2|||
145289272|NCT02116803|523910046|FG001|Overall Study|Adverse Event|1|||
145289273|NCT02116803|523910045|FG000|Overall Study|Physician Decision|1|||
145289274|NCT02116803|523910046|FG001|Overall Study|Physician Decision|0|||
145289275|NCT02116803|523910045|FG000|Overall Study|Progressive disease|4|||
145289276|NCT02116803|523910046|FG001|Overall Study|Progressive disease|0|||
145289277|NCT02116803|523910045|FG000|Overall Study|Study terminated by sponsor|2|||
145289278|NCT02116803|523910046|FG001|Overall Study|Study terminated by sponsor|1|||
145289279|NCT02116803|523910045|FG000|Overall Study|Death|1|||
145289280|NCT02116803|523910046|FG001|Overall Study|Death|0|||
145289281|NCT01901055|523910047|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
145406507|NCT01799889|524343764|FG001|Overall Study|Physician Decision|2|||
145289282|NCT01901055|523910048|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
145289283|NCT01901055|523910047|FG000|Randomization But Not Titrated|Physician Decision|0|||
145289284|NCT01901055|523910048|FG001|Randomization But Not Titrated|Physician Decision|1|||
145289285|NCT01901055|523910047|FG000|Started Protocol to Week 6|Physician Decision|2|||
145289286|NCT01901055|523910048|FG001|Started Protocol to Week 6|Physician Decision|1|||
145289287|NCT01901055|523910047|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
145289288|NCT01901055|523910048|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
145289289|NCT01901055|523910047|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
145289290|NCT01901055|523910048|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
145289291|NCT01901055|523910047|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
145289292|NCT01901055|523910048|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
145615576|NCT02555371|525109156|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
145615577|NCT02555371|525109152|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
145615578|NCT02555371|525109153|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
145615579|NCT02555371|525109154|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
145615580|NCT02555371|525109155|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
145615581|NCT02555371|525109156|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
145289293|NCT01901055|523910047|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
145289294|NCT01901055|523910048|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
145289295|NCT01901055|523910047|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
145289296|NCT01901055|523910048|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
145615582|NCT02555371|525109152|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
145289297|NCT01901055|523910047|FG000|Week 24|Withdrawal by Subject|13|||
145289298|NCT01901055|523910048|FG001|Week 24|Withdrawal by Subject|19|||
145289299|NCT01901055|523910047|FG000|Week 24|Physician Decision|1|||
145289300|NCT01901055|523910048|FG001|Week 24|Physician Decision|0|||
145289301|NCT01901055|523910047|FG000|Week 36|Withdrawal by Subject|0|||
145289302|NCT01901055|523910048|FG001|Week 36|Withdrawal by Subject|5|||
145289303|NCT03019965|523910051|FG000|Overall Study|Withdrawal by Subject|1|||
145289304|NCT03019965|523910052|FG001|Overall Study|Withdrawal by Subject|0|||
145289305|NCT03019965|523910051|FG000|Overall Study|Protocol Violation|1|||
145289306|NCT03019965|523910052|FG001|Overall Study|Protocol Violation|3|||
145289307|NCT03019965|523910051|FG000|Overall Study|viral or fungal infection|3|||
145289308|NCT03019965|523910052|FG001|Overall Study|viral or fungal infection|4|||
145289309|NCT03019965|523910051|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
145289310|NCT03019965|523910052|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
145289311|NCT03019965|523910051|FG000|Overall Study|Physician Decision|1|||
145289312|NCT03019965|523910052|FG001|Overall Study|Physician Decision|1|||
145615583|NCT02555371|525109153|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
145289313|NCT01659567|523910053|FG000|Overall Study|Lack of Efficacy|22|||
145289314|NCT01659567|523910053|FG000|Overall Study|Switched to Pegferon|6|||
145289315|NCT01659567|523910053|FG000|Overall Study|Adverse Event|12|||
145289316|NCT01659567|523910053|FG000|Overall Study|Good result at early stage of treatment|5|||
145289317|NCT01659567|523910053|FG000|Overall Study|Withdrawal by Subject|64|||
145289318|NCT01659567|523910053|FG000|Overall Study|Progression of the main disease|1|||
145289319|NCT01659567|523910053|FG000|Overall Study|Other|13|||
145289320|NCT01915732|523910061|FG000|Overall Study|Withdrawal by Subject|18|||
145289321|NCT01915732|523910062|FG001|Overall Study|Withdrawal by Subject|18|||
145289322|NCT01915732|523910061|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
145289323|NCT01915732|523910062|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145289324|NCT01915732|523910061|FG000|Overall Study|Adverse Event|12|||
145289325|NCT01915732|523910062|FG001|Overall Study|Adverse Event|4|||
145289326|NCT01915732|523910061|FG000|Overall Study|Protocol Violation|5|||
145289327|NCT01915732|523910062|FG001|Overall Study|Protocol Violation|5|||
145289328|NCT01915732|523910061|FG000|Overall Study|Lack of Efficacy|6|||
145289329|NCT01915732|523910062|FG001|Overall Study|Lack of Efficacy|11|||
145289330|NCT01915732|523910061|FG000|Overall Study|Lost to Follow-up|22|||
145289331|NCT01915732|523910062|FG001|Overall Study|Lost to Follow-up|26|||
145289332|NCT01915732|523910061|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
145615584|NCT02555371|525109154|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
145289333|NCT01915732|523910062|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
145289334|NCT01915732|523910061|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
145289335|NCT01915732|523910062|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
145289336|NCT01915732|523910061|FG000|Overall Study|Drug Release Error|1|||
145289337|NCT01915732|523910062|FG001|Overall Study|Drug Release Error|0|||
145289338|NCT01915732|523910061|FG000|Overall Study|Recovered|1|||
145289339|NCT01915732|523910062|FG001|Overall Study|Recovered|0|||
145289340|NCT01915732|523910061|FG000|Overall Study|Pregnancy|1|||
145289341|NCT01915732|523910062|FG001|Overall Study|Pregnancy|0|||
145289342|NCT01915732|523910061|FG000|Overall Study|Poor Perceived Efficacy|1|||
145289343|NCT01915732|523910062|FG001|Overall Study|Poor Perceived Efficacy|0|||
145406508|NCT01799889|524343765|FG002|Overall Study|Physician Decision|4|||
145289344|NCT01915732|523910061|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
145289345|NCT01915732|523910062|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
145289346|NCT01915732|523910061|FG000|Overall Study|Got Well|0|||
145289347|NCT01915732|523910062|FG001|Overall Study|Got Well|1|||
145289348|NCT01915732|523910061|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
145289349|NCT01915732|523910062|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
145289350|NCT01915732|523910061|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
145289351|NCT01915732|523910062|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
145289352|NCT01915732|523910061|FG000|Overall Study|Job Transfer|0|||
145289353|NCT01915732|523910062|FG001|Overall Study|Job Transfer|1|||
145289354|NCT01915732|523910061|FG000|Overall Study|Improper Facial Procedure|0|||
145289355|NCT01915732|523910062|FG001|Overall Study|Improper Facial Procedure|1|||
145289356|NCT01915732|523910061|FG000|Overall Study|Poor Conscious Effect|0|||
145289357|NCT01915732|523910062|FG001|Overall Study|Poor Conscious Effect|1|||
145289358|NCT01325207|523910063|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
145289359|NCT01325207|523910064|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
145289360|NCT01325207|523910065|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
145289361|NCT01325207|523910066|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
145289362|NCT01325207|523910067|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
145289363|NCT01325207|523910068|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
145406509|NCT01799889|524343766|FG003|Overall Study|Physician Decision|4|||
145289364|NCT01325207|523910063|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
145289365|NCT01325207|523910064|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
145289366|NCT01325207|523910065|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
145289367|NCT01325207|523910066|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
145289368|NCT01325207|523910067|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
145289369|NCT01325207|523910068|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
145289370|NCT01325207|523910063|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
145289371|NCT01325207|523910064|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
145289372|NCT01325207|523910065|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
145289373|NCT01325207|523910066|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
145289374|NCT01325207|523910067|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
145289375|NCT01325207|523910068|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
145289376|NCT01325207|523910063|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
145289377|NCT01325207|523910064|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
145289378|NCT01325207|523910065|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
145289379|NCT01325207|523910066|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
145289380|NCT01325207|523910067|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
145289381|NCT01325207|523910068|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
145289382|NCT01325207|523910063|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
145289383|NCT01325207|523910064|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
145289384|NCT01325207|523910065|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
145289385|NCT01325207|523910066|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
145289386|NCT01325207|523910067|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
145289387|NCT01325207|523910068|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
145289388|NCT01325207|523910063|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
145289389|NCT01325207|523910064|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
145289390|NCT01325207|523910065|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
145289391|NCT01325207|523910066|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
145289392|NCT01325207|523910067|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
145289393|NCT01325207|523910068|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
145289394|NCT01325207|523910063|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
145289395|NCT01325207|523910064|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
145289396|NCT01325207|523910065|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
145289397|NCT01325207|523910066|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
145289398|NCT01325207|523910067|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
145289399|NCT01325207|523910068|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
145406510|NCT01799889|524343767|FG004|Overall Study|Physician Decision|5|||
145406511|NCT01799889|524343768|FG005|Overall Study|Physician Decision|5|||
145406512|NCT01799889|524343769|FG006|Overall Study|Physician Decision|5|||
145406513|NCT01799889|524343770|FG007|Overall Study|Physician Decision|2|||
145406514|NCT01799889|524343771|FG008|Overall Study|Physician Decision|6|||
145406515|NCT01799889|524343772|FG009|Overall Study|Physician Decision|0|||
145289400|NCT01254409|523910069|FG000|Overall Study|Adverse Event|0|||
145289401|NCT01254409|523910070|FG001|Overall Study|Adverse Event|1|||
145289402|NCT01254409|523910071|FG002|Overall Study|Adverse Event|0|||
145289403|NCT01254409|523910072|FG003|Overall Study|Adverse Event|0|||
145289404|NCT01974895|523910075|FG000|Overall Study|Protocol Violation|1|||
145289405|NCT01974895|523910076|FG001|Overall Study|Protocol Violation|0|||
145289406|NCT01974895|523910075|FG000|Overall Study|Lost to Follow-up|4|||
145289407|NCT01974895|523910076|FG001|Overall Study|Lost to Follow-up|6|||
145289408|NCT01974895|523910075|FG000|Overall Study|Withdrawal by Subject|0|||
145289409|NCT01974895|523910076|FG001|Overall Study|Withdrawal by Subject|1|||
145289410|NCT01974895|523910075|FG000|Overall Study|Other (Missed Visit)|1|||
145289411|NCT01974895|523910076|FG001|Overall Study|Other (Missed Visit)|0|||
145289412|NCT01974895|523910075|FG000|Overall Study|Other (Reason unknown)|9|||
145289413|NCT01974895|523910076|FG001|Overall Study|Other (Reason unknown)|8|||
145289414|NCT00635154|523910077|FG000|Overall Study|Alternative Treatment|8|||
145289415|NCT00635154|523910077|FG000|Overall Study|Other|4|||
145289416|NCT00635154|523910077|FG000|Overall Study|Still on treatment|21|||
145289417|NCT03500484|523910078|FG000|Overall Study|Adverse Event|2|||
145289418|NCT03500484|523910079|FG001|Overall Study|Adverse Event|0|||
145289419|NCT03500484|523910078|FG000|Overall Study|Physician Decision|1|||
145289420|NCT03500484|523910079|FG001|Overall Study|Physician Decision|0|||
145289421|NCT03500484|523910078|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
145289422|NCT03500484|523910079|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
145289423|NCT01862328|523910082|FG000|Overall Study|Progressive Disease|3|||
145289424|NCT01862328|523910083|FG001|Overall Study|Progressive Disease|11|||
145289425|NCT01862328|523910084|FG002|Overall Study|Progressive Disease|5|||
145289426|NCT01862328|523910085|FG003|Overall Study|Progressive Disease|6|||
145289427|NCT01862328|523910086|FG004|Overall Study|Progressive Disease|7|||
145406516|NCT01799889|524343773|FG010|Overall Study|Physician Decision|0|||
145406517|NCT01799889|524343774|FG011|Overall Study|Physician Decision|1|||
145289428|NCT01862328|523910087|FG005|Overall Study|Progressive Disease|4|||
145406518|NCT01799889|524343763|FG000|Overall Study|Progressive Disease|30|||
145615585|NCT02555371|525109155|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
145615586|NCT02555371|525109156|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
145615587|NCT02555371|525109152|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
145615588|NCT02555371|525109153|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
145615589|NCT02555371|525109154|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
145615590|NCT02555371|525109155|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
145615591|NCT02555371|525109156|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
145615592|NCT02555371|525109152|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
145615593|NCT02555371|525109153|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
145615594|NCT02555371|525109154|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
145615595|NCT02555371|525109155|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
145615596|NCT02555371|525109156|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
145615597|NCT02555371|525109152|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
145615598|NCT02555371|525109153|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
145615599|NCT02555371|525109154|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
145615600|NCT02555371|525109155|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
145615601|NCT02555371|525109156|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
145615602|NCT02555371|525109152|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
145615603|NCT02555371|525109153|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
145615604|NCT02555371|525109154|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
145615605|NCT02555371|525109155|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
145615606|NCT02555371|525109156|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
145615607|NCT02555371|525109152|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
145615608|NCT02555371|525109153|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
145289429|NCT01862328|523910088|FG006|Overall Study|Progressive Disease|3|||
145289430|NCT01862328|523910082|FG000|Overall Study|Adverse Event|0|||
145615609|NCT02555371|525109154|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
145615610|NCT02555371|525109155|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
145289431|NCT01862328|523910083|FG001|Overall Study|Adverse Event|4|||
145289432|NCT01862328|523910084|FG002|Overall Study|Adverse Event|0|||
145289433|NCT01862328|523910085|FG003|Overall Study|Adverse Event|1|||
145289434|NCT01862328|523910086|FG004|Overall Study|Adverse Event|0|||
145289435|NCT01862328|523910087|FG005|Overall Study|Adverse Event|2|||
145289436|NCT01862328|523910088|FG006|Overall Study|Adverse Event|4|||
145289437|NCT01862328|523910082|FG000|Overall Study|Other|0|||
145289438|NCT01862328|523910083|FG001|Overall Study|Other|2|||
145289439|NCT01862328|523910084|FG002|Overall Study|Other|1|||
145289440|NCT01862328|523910085|FG003|Overall Study|Other|0|||
145289441|NCT01862328|523910086|FG004|Overall Study|Other|4|||
145289442|NCT01862328|523910087|FG005|Overall Study|Other|0|||
145406519|NCT01799889|524343764|FG001|Overall Study|Progressive Disease|26|||
145289443|NCT01862328|523910088|FG006|Overall Study|Other|1|||
145289444|NCT01862328|523910082|FG000|Overall Study|Withdrawal by Subject|1|||
145289445|NCT01862328|523910083|FG001|Overall Study|Withdrawal by Subject|1|||
145615611|NCT02555371|525109156|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
145615612|NCT02555371|525109152|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
145615613|NCT02555371|525109153|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
145289446|NCT01862328|523910084|FG002|Overall Study|Withdrawal by Subject|0|||
145289447|NCT01862328|523910085|FG003|Overall Study|Withdrawal by Subject|0|||
145615614|NCT02555371|525109154|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
145615615|NCT02555371|525109155|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
145615616|NCT02555371|525109156|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
145615617|NCT03095599|525109157|FG000|Overall Study|Withdrawal by Subject|1|||
145615618|NCT03095599|525109158|FG001|Overall Study|Withdrawal by Subject|0|||
145615619|NCT03095599|525109157|FG000|Overall Study|Lost to Follow-up|1|||
145615620|NCT03095599|525109158|FG001|Overall Study|Lost to Follow-up|0|||
145615621|NCT03095599|525109157|FG000|Overall Study|Withdrawal prior to vaccination|1|||
145615622|NCT03095599|525109158|FG001|Overall Study|Withdrawal prior to vaccination|0|||
145615623|NCT00742885|525109162|FG000|Overall Study|Lost to Follow-up|1|||
145615624|NCT00742885|525109163|FG001|Overall Study|Lost to Follow-up|0|||
145615625|NCT04781647|525109164|FG000|Overall Study|Study terminated by Sponsor|11|||
145615626|NCT04781647|525109165|FG001|Overall Study|Study terminated by Sponsor|9|||
145615627|NCT04781647|525109166|FG002|Overall Study|Study terminated by Sponsor|9|||
145615628|NCT04781647|525109164|FG000|Overall Study|Withdrawal by Subject|1|||
145615629|NCT04781647|525109165|FG001|Overall Study|Withdrawal by Subject|2|||
145615630|NCT04781647|525109166|FG002|Overall Study|Withdrawal by Subject|0|||
145615631|NCT04781647|525109164|FG000|Overall Study|Adverse Event|0|||
145615632|NCT04781647|525109165|FG001|Overall Study|Adverse Event|1|||
145615633|NCT04781647|525109166|FG002|Overall Study|Adverse Event|1|||
145615634|NCT04781647|525109164|FG000|Overall Study|Protocol Violation|1|||
145615635|NCT04781647|525109165|FG001|Overall Study|Protocol Violation|0|||
145615636|NCT04781647|525109166|FG002|Overall Study|Protocol Violation|0|||
145615637|NCT04781647|525109164|FG000|Overall Study|Pregnancy|0|||
145615638|NCT04781647|525109165|FG001|Overall Study|Pregnancy|0|||
145615639|NCT04781647|525109166|FG002|Overall Study|Pregnancy|1|||
145615640|NCT04781647|525109164|FG000|Overall Study|Virology rebounded|1|||
145615641|NCT04781647|525109165|FG001|Overall Study|Virology rebounded|0|||
145615642|NCT04781647|525109166|FG002|Overall Study|Virology rebounded|0|||
145615643|NCT01755689|525109167|FG000|Overall Study|Withdrawal by Subject|1|||
145615644|NCT01755689|525109168|FG001|Overall Study|Withdrawal by Subject|3|||
145615645|NCT01755689|525109169|FG002|Overall Study|Withdrawal by Subject|2|||
145289448|NCT01862328|523910086|FG004|Overall Study|Withdrawal by Subject|1|||
145289449|NCT01862328|523910087|FG005|Overall Study|Withdrawal by Subject|1|||
145289450|NCT01862328|523910088|FG006|Overall Study|Withdrawal by Subject|1|||
145289451|NCT01862328|523910082|FG000|Overall Study|Symptomatic Deterioration|0|||
145289452|NCT01862328|523910083|FG001|Overall Study|Symptomatic Deterioration|0|||
145615646|NCT01755689|525109170|FG003|Overall Study|Withdrawal by Subject|1|||
145615647|NCT01755689|525109171|FG004|Overall Study|Withdrawal by Subject|1|||
145615648|NCT01755689|525109167|FG000|Overall Study|Migrated/moved from study area|0|||
145615649|NCT01755689|525109168|FG001|Overall Study|Migrated/moved from study area|1|||
145289453|NCT01862328|523910084|FG002|Overall Study|Symptomatic Deterioration|0|||
145289454|NCT01862328|523910085|FG003|Overall Study|Symptomatic Deterioration|0|||
145289455|NCT01862328|523910086|FG004|Overall Study|Symptomatic Deterioration|0|||
145289456|NCT01862328|523910087|FG005|Overall Study|Symptomatic Deterioration|0|||
145289457|NCT01862328|523910088|FG006|Overall Study|Symptomatic Deterioration|1|||
145289458|NCT00936975|523910089|FG000|Overall Study|Withdrawal by Subject|1|||
145289459|NCT00936975|523910089|FG000|Overall Study|Disease progression|3|||
145289460|NCT00936975|523910089|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
145289461|NCT02482571|523910090|FG000|Overall Study|Adverse Event|1|||
145289462|NCT02482571|523910090|FG000|Overall Study|Scanner or Respiract failure|3|||
145289463|NCT02482571|523910090|FG000|Overall Study|Withdrawal by Subject|4|||
145289464|NCT03922477|523910091|FG000|Overall Study|Death|9|||
145289465|NCT03922477|523910091|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
145289466|NCT03922477|523910091|FG000|Overall Study|Physician Decision|1|||
145289467|NCT03922477|523910091|FG000|Overall Study|Withdrawal by Subject|2|||
145289468|NCT01498484|523910093|FG000|Overall Study|Death|6|||
145289469|NCT01498484|523910094|FG001|Overall Study|Death|3|||
145289470|NCT01498484|523910095|FG002|Overall Study|Death|1|||
145289471|NCT01498484|523910096|FG003|Overall Study|Death|1|||
145289472|NCT01498484|523910097|FG004|Overall Study|Death|0|||
145289473|NCT01498484|523910098|FG005|Overall Study|Death|0|||
145289474|NCT01498484|523910099|FG006|Overall Study|Death|10|||
145289475|NCT01498484|523910100|FG007|Overall Study|Death|1|||
145289476|NCT01498484|523910101|FG008|Overall Study|Death|0|||
145289477|NCT01498484|523910093|FG000|Overall Study|Physician Decision|3|||
145289478|NCT01498484|523910094|FG001|Overall Study|Physician Decision|2|||
145289479|NCT01498484|523910095|FG002|Overall Study|Physician Decision|1|||
145289480|NCT01498484|523910096|FG003|Overall Study|Physician Decision|1|||
145289481|NCT01498484|523910097|FG004|Overall Study|Physician Decision|0|||
145289482|NCT01498484|523910098|FG005|Overall Study|Physician Decision|0|||
145289483|NCT01498484|523910099|FG006|Overall Study|Physician Decision|8|||
145289484|NCT01498484|523910100|FG007|Overall Study|Physician Decision|13|||
145289485|NCT01498484|523910101|FG008|Overall Study|Physician Decision|1|||
145289486|NCT01498484|523910093|FG000|Overall Study|Adverse Event|0|||
145289487|NCT01498484|523910094|FG001|Overall Study|Adverse Event|0|||
145289488|NCT01498484|523910095|FG002|Overall Study|Adverse Event|0|||
145289489|NCT01498484|523910096|FG003|Overall Study|Adverse Event|0|||
145289490|NCT01498484|523910097|FG004|Overall Study|Adverse Event|0|||
145289491|NCT01498484|523910098|FG005|Overall Study|Adverse Event|1|||
145289492|NCT01498484|523910099|FG006|Overall Study|Adverse Event|0|||
145289493|NCT01498484|523910100|FG007|Overall Study|Adverse Event|0|||
145289494|NCT01498484|523910101|FG008|Overall Study|Adverse Event|0|||
145289495|NCT01498484|523910093|FG000|Overall Study|Withdrawal by Subject|0|||
145289496|NCT01498484|523910094|FG001|Overall Study|Withdrawal by Subject|0|||
145289497|NCT01498484|523910095|FG002|Overall Study|Withdrawal by Subject|0|||
145289498|NCT01498484|523910096|FG003|Overall Study|Withdrawal by Subject|1|||
145289499|NCT01498484|523910097|FG004|Overall Study|Withdrawal by Subject|0|||
145289500|NCT01498484|523910098|FG005|Overall Study|Withdrawal by Subject|0|||
145289501|NCT01498484|523910099|FG006|Overall Study|Withdrawal by Subject|1|||
145289502|NCT01498484|523910100|FG007|Overall Study|Withdrawal by Subject|0|||
145289503|NCT01498484|523910101|FG008|Overall Study|Withdrawal by Subject|0|||
145289504|NCT01498484|523910093|FG000|Overall Study|Other|5|||
145289505|NCT01498484|523910094|FG001|Overall Study|Other|2|||
145289506|NCT01498484|523910095|FG002|Overall Study|Other|0|||
145289507|NCT01498484|523910096|FG003|Overall Study|Other|0|||
145289508|NCT01498484|523910097|FG004|Overall Study|Other|1|||
145289509|NCT01498484|523910098|FG005|Overall Study|Other|0|||
145289510|NCT01498484|523910099|FG006|Overall Study|Other|3|||
145289511|NCT01498484|523910100|FG007|Overall Study|Other|0|||
145289512|NCT01498484|523910101|FG008|Overall Study|Other|1|||
145289513|NCT01199601|523910102|FG000|Overall Study|Lost to Follow-up|47|||
145289514|NCT01199601|523910103|FG001|Overall Study|Lost to Follow-up|66|||
145289515|NCT01199601|523910102|FG000|Overall Study|Withdrawal by Subject|15|||
145289516|NCT01199601|523910103|FG001|Overall Study|Withdrawal by Subject|3|||
145289517|NCT01199601|523910102|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
145289518|NCT01199601|523910103|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
145289519|NCT03387098|523910104|FG000|Overall Study|progressive disease|1|||
145289520|NCT03387098|523910104|FG000|Overall Study|Withdrawal by Subject|2|||
145615650|NCT01755689|525109169|FG002|Overall Study|Migrated/moved from study area|1|||
145615651|NCT01755689|525109170|FG003|Overall Study|Migrated/moved from study area|1|||
145615652|NCT01755689|525109171|FG004|Overall Study|Migrated/moved from study area|1|||
145615653|NCT01755689|525109167|FG000|Overall Study|Lost to Follow-up|1|||
145289521|NCT03387098|523910104|FG000|Overall Study|study terminated by sponsor|1|||
145289522|NCT02486796|523910105|FG000|Overall Study|Withdrawal by Subject|1|||
145289523|NCT02486796|523910106|FG001|Overall Study|Withdrawal by Subject|1|||
145289524|NCT02486796|523910105|FG000|Overall Study|Physician Decision|1|||
145289525|NCT02486796|523910106|FG001|Overall Study|Physician Decision|0|||
145289526|NCT02974153|523910107|FG000|Overall Study|Adverse Event|6|||
145289527|NCT02974153|523910108|FG001|Overall Study|Adverse Event|0|||
145289528|NCT02974153|523910109|FG002|Overall Study|Adverse Event|1|||
145289529|NCT02974153|523910107|FG000|Overall Study|Lack of Efficacy|6|||
145289530|NCT02974153|523910108|FG001|Overall Study|Lack of Efficacy|5|||
145289531|NCT02974153|523910109|FG002|Overall Study|Lack of Efficacy|10|||
145289532|NCT02974153|523910107|FG000|Overall Study|Lost to Follow-up|9|||
145406520|NCT01799889|524343765|FG002|Overall Study|Progressive Disease|25|||
145615654|NCT01755689|525109168|FG001|Overall Study|Lost to Follow-up|0|||
145289533|NCT02974153|523910108|FG001|Overall Study|Lost to Follow-up|10|||
145289534|NCT02974153|523910109|FG002|Overall Study|Lost to Follow-up|17|||
145289535|NCT02974153|523910107|FG000|Overall Study|Physician Decision|0|||
145289536|NCT02974153|523910108|FG001|Overall Study|Physician Decision|2|||
145289537|NCT02974153|523910109|FG002|Overall Study|Physician Decision|1|||
145289538|NCT02974153|523910107|FG000|Overall Study|Withdrawal by Subject|9|||
145289539|NCT02974153|523910108|FG001|Overall Study|Withdrawal by Subject|16|||
145289540|NCT02974153|523910109|FG002|Overall Study|Withdrawal by Subject|11|||
145289541|NCT02974153|523910107|FG000|Overall Study|Study Burden|8|||
145289542|NCT02974153|523910108|FG001|Overall Study|Study Burden|7|||
145406521|NCT01799889|524343766|FG003|Overall Study|Progressive Disease|30|||
145406522|NCT01799889|524343767|FG004|Overall Study|Progressive Disease|23|||
145406523|NCT01799889|524343768|FG005|Overall Study|Progressive Disease|9|||
145289543|NCT02974153|523910109|FG002|Overall Study|Study Burden|3|||
145289544|NCT02974153|523910107|FG000|Overall Study|Other|14|||
145289545|NCT02974153|523910108|FG001|Overall Study|Other|8|||
145289546|NCT02974153|523910109|FG002|Overall Study|Other|7|||
145289547|NCT02521948|523910110|FG000|Overall Study|Adverse Event|2|||
145289548|NCT02521948|523910110|FG000|Overall Study|Death|4|||
145289549|NCT02521948|523910110|FG000|Overall Study|Lost to Follow-up|1|||
145289550|NCT02521948|523910110|FG000|Overall Study|Did not attend one or both follow-ups|6|||
145289551|NCT00423800|523910111|FG000|Overall Study|Protocol Violation|0|||
145289552|NCT00423800|523910112|FG001|Overall Study|Protocol Violation|1|||
145289553|NCT00679783|523910114|FG000|Overall Study|Adverse Event|0|||
145289554|NCT00679783|523910115|FG001|Overall Study|Adverse Event|0|||
145289555|NCT00679783|523910116|FG002|Overall Study|Adverse Event|0|||
145289556|NCT00679783|523910117|FG003|Overall Study|Adverse Event|3|||
145289557|NCT00679783|523910118|FG004|Overall Study|Adverse Event|0|||
145289558|NCT00679783|523910119|FG005|Overall Study|Adverse Event|0|||
145289559|NCT00679783|523910120|FG006|Overall Study|Adverse Event|1|||
145289560|NCT00679783|523910114|FG000|Overall Study|Lack of Efficacy|0|||
145289561|NCT00679783|523910115|FG001|Overall Study|Lack of Efficacy|1|||
145289562|NCT00679783|523910116|FG002|Overall Study|Lack of Efficacy|0|||
145289563|NCT00679783|523910117|FG003|Overall Study|Lack of Efficacy|2|||
145289564|NCT00679783|523910118|FG004|Overall Study|Lack of Efficacy|0|||
145289565|NCT00679783|523910119|FG005|Overall Study|Lack of Efficacy|0|||
145289566|NCT00679783|523910120|FG006|Overall Study|Lack of Efficacy|0|||
145289567|NCT00679783|523910114|FG000|Overall Study|Withdrawal by Subject|0|||
145289568|NCT00679783|523910115|FG001|Overall Study|Withdrawal by Subject|0|||
145289569|NCT00679783|523910116|FG002|Overall Study|Withdrawal by Subject|1|||
145289570|NCT00679783|523910117|FG003|Overall Study|Withdrawal by Subject|1|||
145289571|NCT00679783|523910118|FG004|Overall Study|Withdrawal by Subject|0|||
145289572|NCT00679783|523910119|FG005|Overall Study|Withdrawal by Subject|0|||
145289573|NCT00679783|523910120|FG006|Overall Study|Withdrawal by Subject|0|||
145289574|NCT00679783|523910114|FG000|Overall Study|Not Captured|0|||
145289575|NCT00679783|523910115|FG001|Overall Study|Not Captured|0|||
145289576|NCT00679783|523910116|FG002|Overall Study|Not Captured|0|||
145289577|NCT00679783|523910117|FG003|Overall Study|Not Captured|5|||
145289578|NCT00679783|523910118|FG004|Overall Study|Not Captured|0|||
145289579|NCT00679783|523910119|FG005|Overall Study|Not Captured|0|||
145289580|NCT00679783|523910120|FG006|Overall Study|Not Captured|0|||
145289581|NCT00679783|523910114|FG000|Overall Study|Ongoing at data cut-off|2|||
145289582|NCT00679783|523910115|FG001|Overall Study|Ongoing at data cut-off|2|||
145289583|NCT00679783|523910116|FG002|Overall Study|Ongoing at data cut-off|0|||
145289584|NCT00679783|523910117|FG003|Overall Study|Ongoing at data cut-off|9|||
145289585|NCT00679783|523910118|FG004|Overall Study|Ongoing at data cut-off|1|||
145289586|NCT00679783|523910119|FG005|Overall Study|Ongoing at data cut-off|0|||
145289587|NCT00679783|523910120|FG006|Overall Study|Ongoing at data cut-off|0|||
145289588|NCT00814320|523910121|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
145289589|NCT00814320|523910122|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
145289590|NCT00814320|523910121|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
145289591|NCT00814320|523910122|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
145289592|NCT00814320|523910121|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
145289593|NCT00814320|523910122|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
145289594|NCT00814320|523910121|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
145289595|NCT00814320|523910122|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
145289596|NCT00814320|523910121|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
145289597|NCT00814320|523910122|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
145289598|NCT00814320|523910121|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
145289599|NCT00814320|523910122|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
145406524|NCT01799889|524343769|FG006|Overall Study|Progressive Disease|8|||
145615655|NCT01755689|525109169|FG002|Overall Study|Lost to Follow-up|1|||
145615656|NCT01755689|525109170|FG003|Overall Study|Lost to Follow-up|0|||
145615657|NCT01755689|525109171|FG004|Overall Study|Lost to Follow-up|2|||
145615658|NCT01755689|525109167|FG000|Overall Study|Pregnancy|1|||
145615659|NCT01755689|525109168|FG001|Overall Study|Pregnancy|1|||
145615660|NCT01755689|525109169|FG002|Overall Study|Pregnancy|2|||
145615661|NCT01755689|525109170|FG003|Overall Study|Pregnancy|4|||
145615662|NCT01755689|525109171|FG004|Overall Study|Pregnancy|2|||
145615663|NCT02609659|525109176|FG000|Overall Study|Adverse Event|1|||
145615664|NCT02609659|525109176|FG000|Overall Study|Lost to Follow-up|6|||
145615665|NCT02609659|525109176|FG000|Overall Study|Other|1|||
145615666|NCT01155388|525109179|FG000|Overall Study|Adverse Event|1|||
145615667|NCT01155388|525109180|FG001|Overall Study|Adverse Event|0|||
145615668|NCT01004250|525109181|FG000|Induction Therapy Period|Adverse Event|10|||
145615669|NCT01004250|525109181|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
145615670|NCT01004250|525109181|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
145615671|NCT01004250|525109181|FG000|Induction Therapy Period|Physician Decision|2|||
145615672|NCT01004250|525109181|FG000|Maintenance Therapy Period|Adverse Event|15|||
145615673|NCT01004250|525109181|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
145615674|NCT01004250|525109181|FG000|Maintenance Therapy Period|Protocol Violation|1|||
145615675|NCT01004250|525109181|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
145615676|NCT01004250|525109181|FG000|Maintenance Therapy Period|Physician Decision|4|||
145615677|NCT01004250|525109181|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
145615678|NCT03943589|525109182|FG000|Overall Study|Death|1|||
145615679|NCT03943589|525109182|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
145615680|NCT04329104|525109183|FG000|Efficacy Study|Withdrawal by Subject|0|||
145615681|NCT04329104|525109184|FG001|Efficacy Study|Withdrawal by Subject|0|||
145615682|NCT04329104|525109185|FG002|Efficacy Study|Withdrawal by Subject|0|||
145615683|NCT04329104|525109186|FG003|Efficacy Study|Withdrawal by Subject|5|||
145615684|NCT04329104|525109187|FG004|Efficacy Study|Withdrawal by Subject|6|||
145615685|NCT04329104|525109188|FG005|Efficacy Study|Withdrawal by Subject|8|||
145615686|NCT03884231|525109189|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
145615687|NCT03884231|525109189|FG000|Overall Study|Subject Withdrew Consent|1|||
145615688|NCT03884231|525109189|FG000|Overall Study|MRI Scan Not Performed|1|||
145615689|NCT00900627|525109190|FG000|Overall Study|Condition under investigation worsened|4|||
145615690|NCT00900627|525109191|FG001|Overall Study|Condition under investigation worsened|0|||
145615691|NCT00900627|525109192|FG002|Overall Study|Condition under investigation worsened|5|||
145615692|NCT00900627|525109193|FG003|Overall Study|Condition under investigation worsened|3|||
145615693|NCT00900627|525109194|FG004|Overall Study|Condition under investigation worsened|0|||
145615694|NCT00900627|525109195|FG005|Overall Study|Condition under investigation worsened|0|||
145615695|NCT00900627|525109190|FG000|Overall Study|Withdrawal by Subject|1|||
145615696|NCT00900627|525109191|FG001|Overall Study|Withdrawal by Subject|0|||
145615697|NCT00900627|525109192|FG002|Overall Study|Withdrawal by Subject|1|||
145615698|NCT00900627|525109193|FG003|Overall Study|Withdrawal by Subject|0|||
145615699|NCT00900627|525109194|FG004|Overall Study|Withdrawal by Subject|1|||
145615700|NCT00900627|525109195|FG005|Overall Study|Withdrawal by Subject|2|||
145615701|NCT00900627|525109190|FG000|Overall Study|Adverse Event|1|||
145615702|NCT00900627|525109191|FG001|Overall Study|Adverse Event|2|||
145615703|NCT00900627|525109192|FG002|Overall Study|Adverse Event|0|||
145615704|NCT00900627|525109193|FG003|Overall Study|Adverse Event|3|||
145615705|NCT00900627|525109194|FG004|Overall Study|Adverse Event|0|||
145615706|NCT00900627|525109195|FG005|Overall Study|Adverse Event|0|||
145615707|NCT00900627|525109190|FG000|Overall Study|Death|0|||
145615708|NCT00900627|525109191|FG001|Overall Study|Death|0|||
145615709|NCT00900627|525109192|FG002|Overall Study|Death|0|||
145615710|NCT00900627|525109193|FG003|Overall Study|Death|0|||
145615711|NCT00900627|525109194|FG004|Overall Study|Death|28|||
145615712|NCT00900627|525109195|FG005|Overall Study|Death|24|||
145615713|NCT00830947|525109196|FG000|Overall Study|Lost to Follow-up|4|||
145615714|NCT00830947|525109197|FG001|Overall Study|Lost to Follow-up|4|||
145615715|NCT00867490|525109199|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
145615716|NCT00867490|525109199|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
145615717|NCT00867490|525109199|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
145615718|NCT00867490|525109199|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
145615719|NCT00867490|525109199|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
145615720|NCT00358150|525109200|FG000|Overall Study|Adverse Event|3|||
145615721|NCT00358150|525109200|FG000|Overall Study|Withdrawal by Subject|1|||
145615722|NCT00358150|525109200|FG000|Overall Study|Undefined|3|||
145615723|NCT03685708|525109201|FG000|Overall Study|Withdrawal by Subject|0|||
145615724|NCT03685708|525109202|FG001|Overall Study|Withdrawal by Subject|0|||
145615725|NCT03685708|525109203|FG002|Overall Study|Withdrawal by Subject|1|||
145615726|NCT03685708|525109201|FG000|Overall Study|Screen Fail|0|||
145615727|NCT03685708|525109202|FG001|Overall Study|Screen Fail|1|||
145615728|NCT03685708|525109203|FG002|Overall Study|Screen Fail|1|||
145615729|NCT03685708|525109201|FG000|Overall Study|COVID 19 Pandemic|1|||
145615730|NCT03685708|525109202|FG001|Overall Study|COVID 19 Pandemic|1|||
145615731|NCT03685708|525109203|FG002|Overall Study|COVID 19 Pandemic|6|||
145615732|NCT03685708|525109201|FG000|Overall Study|Disease Progression|0|||
145615733|NCT03685708|525109202|FG001|Overall Study|Disease Progression|0|||
145615734|NCT03685708|525109203|FG002|Overall Study|Disease Progression|1|||
145615735|NCT00179010|525109204|FG000|Overall Study|Muscle probe defective|1|||
145615736|NCT00179010|525109205|FG001|Overall Study|Muscle probe defective|1|||
145615737|NCT00179010|525109204|FG000|Overall Study|Failure to place arterial line|0|||
145615738|NCT00179010|525109205|FG001|Overall Study|Failure to place arterial line|1|||
145615739|NCT02823964|525109247|FG000|Overall Study|Adverse Event|2|||
145615740|NCT02823964|525109247|FG000|Overall Study|Physician Decision|1|||
145289600|NCT00814320|523910121|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
145289601|NCT00814320|523910122|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
145615741|NCT02823964|525109247|FG000|Overall Study|Lack of Efficacy|1|||
145615742|NCT02823964|525109247|FG000|Overall Study|Withdrawal by Subject|1|||
145615743|NCT01744496|525109263|FG000|Titration Period|Adverse Event|2|||
145615744|NCT01744496|525109264|FG001|Titration Period|Adverse Event|1|||
145289602|NCT00814320|523910121|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
145289603|NCT00814320|523910122|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
145289604|NCT00814320|523910121|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
145289605|NCT00814320|523910122|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
145289606|NCT00814320|523910121|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
145289607|NCT00814320|523910122|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
145289608|NCT00491504|523910123|FG000|Overall Study|Adverse Event|0|||
145289609|NCT00491504|523910124|FG001|Overall Study|Adverse Event|1|||
145289610|NCT00491504|523910125|FG002|Overall Study|Adverse Event|0|||
145289611|NCT00491504|523910126|FG003|Overall Study|Adverse Event|0|||
145289612|NCT00491504|523910123|FG000|Overall Study|Withdrawal by Subject|0|||
145289613|NCT00491504|523910124|FG001|Overall Study|Withdrawal by Subject|0|||
145289614|NCT00491504|523910125|FG002|Overall Study|Withdrawal by Subject|1|||
145289615|NCT00491504|523910126|FG003|Overall Study|Withdrawal by Subject|2|||
145289616|NCT00491504|523910123|FG000|Overall Study|Protocol Violation|0|||
145289617|NCT00491504|523910124|FG001|Overall Study|Protocol Violation|0|||
145289618|NCT00491504|523910125|FG002|Overall Study|Protocol Violation|3|||
145289619|NCT00491504|523910126|FG003|Overall Study|Protocol Violation|2|||
145289620|NCT02568384|523910129|FG000|Overall Study|Mobile devices incompatible with App|2|||
145289621|NCT01485536|523910130|FG000|Overall Study|Withdrawal by Subject|3|||
145289622|NCT01485536|523910130|FG000|Overall Study|Adverse Event|1|||
145289623|NCT02799602|523910131|FG000|Overall Study|Protocol Violation|1|||
145289624|NCT02799602|523910132|FG001|Overall Study|Protocol Violation|0|||
145289625|NCT02799602|523910131|FG000|Overall Study|Physician Decision|5|||
145289626|NCT02799602|523910132|FG001|Overall Study|Physician Decision|6|||
145289627|NCT02799602|523910131|FG000|Overall Study|Lost to Follow-up|4|||
145289628|NCT02799602|523910132|FG001|Overall Study|Lost to Follow-up|2|||
145289629|NCT02799602|523910131|FG000|Overall Study|Additional primary malignancy|11|||
145289630|NCT02799602|523910132|FG001|Overall Study|Additional primary malignancy|6|||
145289631|NCT02799602|523910131|FG000|Overall Study|Non-compliance with study drug|14|||
145289632|NCT02799602|523910132|FG001|Overall Study|Non-compliance with study drug|12|||
145289633|NCT02799602|523910131|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
145289634|NCT02799602|523910132|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
145289635|NCT02799602|523910131|FG000|Overall Study|Withdrawal by Subject|26|||
145289636|NCT02799602|523910132|FG001|Overall Study|Withdrawal by Subject|40|||
145289637|NCT02799602|523910131|FG000|Overall Study|Progressive disease - clinical progression|131|||
145289638|NCT02799602|523910132|FG001|Overall Study|Progressive disease - clinical progression|276|||
145289639|NCT02799602|523910131|FG000|Overall Study|Progressive disease - radiological progression|90|||
145289640|NCT02799602|523910132|FG001|Overall Study|Progressive disease - radiological progression|133|||
145289641|NCT02799602|523910131|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
145289642|NCT02799602|523910132|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
145289643|NCT02799602|523910131|FG000|Overall Study|Death|9|||
145289644|NCT02799602|523910132|FG001|Overall Study|Death|5|||
145289645|NCT02799602|523910131|FG000|Overall Study|Other|287|||
145289646|NCT02799602|523910132|FG001|Overall Study|Other|118|||
145289647|NCT02799602|523910131|FG000|Overall Study|Study drug never administered|0|||
145289648|NCT02799602|523910132|FG001|Overall Study|Study drug never administered|3|||
145289649|NCT03730103|523910133|FG000|Overall Study|Did not meet inclusion criteria|0|||
145289650|NCT03730103|523910134|FG001|Overall Study|Did not meet inclusion criteria|5|||
145289651|NCT02626949|523910135|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
145289652|NCT02626949|523910136|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
145289653|NCT02626949|523910135|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
145289654|NCT02626949|523910136|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
145289655|NCT02626949|523910135|FG000|Enrolled|Lost to Follow-up|7|||
145289656|NCT02626949|523910136|FG001|Enrolled|Lost to Follow-up|6|||
145289657|NCT02626949|523910135|FG000|Enrolled|Withdrawal by Subject|3|||
145289658|NCT02626949|523910136|FG001|Enrolled|Withdrawal by Subject|2|||
145289659|NCT01488578|523910137|FG000|Overall Study|Protocol Violation|1836|||
145289660|NCT02308111|523910138|FG000|Overall Study|Adverse Event|31|||
145289661|NCT02308111|523910139|FG001|Overall Study|Adverse Event|19|||
145289662|NCT02308111|523910138|FG000|Overall Study|Death|9|||
145289663|NCT02308111|523910139|FG001|Overall Study|Death|6|||
145289664|NCT02308111|523910138|FG000|Overall Study|Lost to Follow-up|2|||
145289665|NCT02308111|523910139|FG001|Overall Study|Lost to Follow-up|7|||
145289666|NCT02308111|523910138|FG000|Overall Study|Physician Decision|6|||
145289667|NCT02308111|523910139|FG001|Overall Study|Physician Decision|17|||
145289668|NCT02308111|523910138|FG000|Overall Study|Protocol Violation|0|||
145289669|NCT02308111|523910139|FG001|Overall Study|Protocol Violation|1|||
145289670|NCT02308111|523910138|FG000|Overall Study|Withdrawal by Subject|28|||
145289671|NCT02308111|523910139|FG001|Overall Study|Withdrawal by Subject|38|||
145289672|NCT02308111|523910138|FG000|Overall Study|Study Terminated by Sponsor|72|||
145289673|NCT02308111|523910139|FG001|Overall Study|Study Terminated by Sponsor|61|||
145406525|NCT01799889|524343770|FG007|Overall Study|Progressive Disease|13|||
145289674|NCT02308111|523910138|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
145289675|NCT02308111|523910139|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
145289676|NCT02308111|523910138|FG000|Overall Study|Site Closure|3|||
145289677|NCT02308111|523910139|FG001|Overall Study|Site Closure|3|||
145289678|NCT02308111|523910138|FG000|Overall Study|Non-compliance with Study Drug|3|||
145289679|NCT02308111|523910139|FG001|Overall Study|Non-compliance with Study Drug|1|||
145289680|NCT02308111|523910138|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
145289681|NCT02308111|523910139|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
145289682|NCT02308111|523910138|FG000|Overall Study|Liver Transplant|3|||
145289683|NCT02308111|523910139|FG001|Overall Study|Liver Transplant|3|||
145289684|NCT02308111|523910138|FG000|Overall Study|Liver Transplant Waitlist|2|||
145289685|NCT02308111|523910139|FG001|Overall Study|Liver Transplant Waitlist|2|||
145289686|NCT02308111|523910138|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
145289687|NCT02308111|523910139|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
145289688|NCT01873859|523910144|FG000|Overall Study|Withdrawal by Subject|0|||
145289689|NCT01873859|523910145|FG001|Overall Study|Withdrawal by Subject|4|||
145289690|NCT00601484|523910147|FG000|Overall Study|Adverse Event|0|||
145289691|NCT00601484|523910148|FG001|Overall Study|Adverse Event|1|||
145289692|NCT00601484|523910147|FG000|Overall Study|Lost to Follow-up|4|||
145289693|NCT00601484|523910148|FG001|Overall Study|Lost to Follow-up|3|||
145289694|NCT00601484|523910147|FG000|Overall Study|Lack of Efficacy|0|||
145289695|NCT00601484|523910148|FG001|Overall Study|Lack of Efficacy|2|||
145289696|NCT00601484|523910147|FG000|Overall Study|Withdrawal by Subject|1|||
145289697|NCT00601484|523910148|FG001|Overall Study|Withdrawal by Subject|1|||
145289698|NCT00601484|523910147|FG000|Overall Study|Randomized, but not treated|0|||
145289699|NCT00601484|523910148|FG001|Overall Study|Randomized, but not treated|1|||
145289700|NCT03977584|523910149|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
145289701|NCT03977584|523910150|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
145289702|NCT03977584|523910151|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
145289703|NCT03504852|523910155|FG000|Overall Study|Withdrawal of informed consent|2|||
145289704|NCT03504852|523910156|FG001|Overall Study|Withdrawal of informed consent|1|||
145289705|NCT03504852|523910157|FG002|Overall Study|Withdrawal of informed consent|0|||
145289706|NCT03504852|523910155|FG000|Overall Study|Withdrawal by Subject|5|||
145289707|NCT03504852|523910156|FG001|Overall Study|Withdrawal by Subject|5|||
145289708|NCT03504852|523910157|FG002|Overall Study|Withdrawal by Subject|1|||
145289709|NCT03504852|523910155|FG000|Overall Study|Lost to Follow-up|4|||
145289710|NCT03504852|523910156|FG001|Overall Study|Lost to Follow-up|1|||
145289711|NCT03504852|523910157|FG002|Overall Study|Lost to Follow-up|0|||
145289712|NCT03504852|523910155|FG000|Overall Study|New therapy for study indication|1|||
145289713|NCT03504852|523910156|FG001|Overall Study|New therapy for study indication|0|||
145289714|NCT03504852|523910157|FG002|Overall Study|New therapy for study indication|0|||
145289715|NCT03504852|523910155|FG000|Overall Study|Lack of Efficacy|1|||
145289716|NCT03504852|523910156|FG001|Overall Study|Lack of Efficacy|2|||
145289717|NCT03504852|523910157|FG002|Overall Study|Lack of Efficacy|0|||
145289718|NCT03504852|523910155|FG000|Overall Study|Death|0|||
145289719|NCT03504852|523910156|FG001|Overall Study|Death|1|||
145289720|NCT03504852|523910157|FG002|Overall Study|Death|0|||
145289721|NCT03504852|523910155|FG000|Overall Study|Adverse Event|4|||
145289722|NCT03504852|523910156|FG001|Overall Study|Adverse Event|8|||
145289723|NCT03504852|523910157|FG002|Overall Study|Adverse Event|2|||
145289724|NCT01118728|523910158|FG000|Overall Study|Adverse Event|17|||
145289725|NCT01118728|523910158|FG000|Overall Study|Lack of Efficacy|27|||
145289726|NCT01118728|523910158|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
145289727|NCT01118728|523910158|FG000|Overall Study|Withdrawal by Subject|3|||
145289728|NCT01118728|523910158|FG000|Overall Study|Lost to Follow-up|4|||
145289729|NCT05328375|523911836|FG000|Overall Study|Withdrawal by Subject|0|||
145289730|NCT05328375|523911837|FG001|Overall Study|Withdrawal by Subject|1|||
145289731|NCT01052116|523911838|FG000|Overall Study|Lost to Follow-up|11|||
145289732|NCT01052116|523911839|FG001|Overall Study|Lost to Follow-up|17|||
145289733|NCT01052116|523911838|FG000|Overall Study|Withdrawal by Subject|3|||
145289734|NCT01052116|523911839|FG001|Overall Study|Withdrawal by Subject|6|||
145289735|NCT01052116|523911838|FG000|Overall Study|Spirometry not performed|0|||
145289736|NCT01052116|523911839|FG001|Overall Study|Spirometry not performed|4|||
145289737|NCT00275002|523911840|FG000|Overall Study|Death|1|||
145289738|NCT00275002|523911841|FG001|Overall Study|Death|0|||
145289739|NCT00275002|523911840|FG000|Overall Study|Disease progression|21|||
145289740|NCT00275002|523911841|FG001|Overall Study|Disease progression|15|||
145289741|NCT00275002|523911840|FG000|Overall Study|Adverse Event|0|||
145289742|NCT00275002|523911841|FG001|Overall Study|Adverse Event|1|||
145289743|NCT05456529|523911842|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
145289744|NCT05456529|523911842|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
145289745|NCT05456529|523911842|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
145289746|NCT05456529|523911842|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
145289747|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
145289748|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
145289749|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Physician Decision|2|||
145289750|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
145289751|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
145289752|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
145289753|NCT05456529|523911842|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
145289754|NCT02374918|523911844|FG000|Overall Study|Protocol Violation|2|||
145289755|NCT02374918|523911845|FG001|Overall Study|Protocol Violation|0|||
145289756|NCT02374918|523911846|FG002|Overall Study|Protocol Violation|2|||
145289757|NCT02374918|523911847|FG003|Overall Study|Protocol Violation|1|||
145289758|NCT02374918|523911844|FG000|Overall Study|Withdrawal by Subject|1|||
145289759|NCT02374918|523911845|FG001|Overall Study|Withdrawal by Subject|1|||
145289760|NCT02374918|523911846|FG002|Overall Study|Withdrawal by Subject|1|||
145289761|NCT02374918|523911847|FG003|Overall Study|Withdrawal by Subject|0|||
145289762|NCT02374918|523911844|FG000|Overall Study|Lack of Efficacy|0|||
145289763|NCT02374918|523911845|FG001|Overall Study|Lack of Efficacy|0|||
145289764|NCT02374918|523911846|FG002|Overall Study|Lack of Efficacy|1|||
145289765|NCT02374918|523911847|FG003|Overall Study|Lack of Efficacy|1|||
145289766|NCT01506947|523911848|FG000|Overall Study|Lost to Follow-up|7|||
145289767|NCT01506947|523911848|FG000|Overall Study|Adverse Event|5|||
145289768|NCT01506947|523911848|FG000|Overall Study|Death|1|||
145289769|NCT01506947|523911848|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
145289770|NCT02752776|523911852|FG000|Overall Study|Adverse Event|15|||
145289771|NCT02752776|523911853|FG001|Overall Study|Adverse Event|23|||
145289772|NCT02752776|523911854|FG002|Overall Study|Adverse Event|11|||
145289773|NCT02752776|523911852|FG000|Overall Study|Lack of Efficacy|2|||
145289774|NCT02752776|523911853|FG001|Overall Study|Lack of Efficacy|6|||
145289775|NCT02752776|523911854|FG002|Overall Study|Lack of Efficacy|14|||
145289776|NCT02752776|523911852|FG000|Overall Study|Lost to Follow-up|11|||
145289777|NCT02752776|523911853|FG001|Overall Study|Lost to Follow-up|12|||
145289778|NCT02752776|523911854|FG002|Overall Study|Lost to Follow-up|4|||
145289779|NCT02752776|523911852|FG000|Overall Study|Non-compliance with study treatment|0|||
145289780|NCT02752776|523911853|FG001|Overall Study|Non-compliance with study treatment|0|||
145289781|NCT02752776|523911854|FG002|Overall Study|Non-compliance with study treatment|1|||
145289782|NCT02752776|523911852|FG000|Overall Study|Physician Decision|2|||
145289783|NCT02752776|523911853|FG001|Overall Study|Physician Decision|6|||
145289784|NCT02752776|523911854|FG002|Overall Study|Physician Decision|2|||
145289785|NCT02752776|523911852|FG000|Overall Study|Pregnancy|1|||
145289786|NCT02752776|523911853|FG001|Overall Study|Pregnancy|6|||
145289787|NCT02752776|523911854|FG002|Overall Study|Pregnancy|3|||
145289788|NCT02752776|523911852|FG000|Overall Study|Protocol Violation|10|||
145289789|NCT02752776|523911853|FG001|Overall Study|Protocol Violation|13|||
145289790|NCT02752776|523911854|FG002|Overall Study|Protocol Violation|6|||
145289791|NCT02752776|523911852|FG000|Overall Study|Subject/guardian decision|8|||
145289792|NCT02752776|523911853|FG001|Overall Study|Subject/guardian decision|6|||
145289793|NCT02752776|523911854|FG002|Overall Study|Subject/guardian decision|4|||
145289794|NCT02752776|523911852|FG000|Overall Study|Death|0|||
145289795|NCT02752776|523911853|FG001|Overall Study|Death|0|||
145289796|NCT02752776|523911854|FG002|Overall Study|Death|1|||
145289797|NCT02752776|523911852|FG000|Overall Study|Withdrawal by Subject|3|||
145289798|NCT02752776|523911853|FG001|Overall Study|Withdrawal by Subject|4|||
145289799|NCT02752776|523911854|FG002|Overall Study|Withdrawal by Subject|2|||
145289800|NCT01946165|523911855|FG000|Overall Study|Physician Decision|2|||
145289801|NCT01946165|523911856|FG001|Overall Study|Physician Decision|0|||
145289802|NCT01946165|523911855|FG000|Overall Study|Withdrawal by Subject|0|||
145289803|NCT01946165|523911856|FG001|Overall Study|Withdrawal by Subject|2|||
145289804|NCT01179919|523911857|FG000|Overall Study|Protocol Violation|1|||
145289805|NCT01179919|523911857|FG000|Overall Study|Adverse Event|1|||
145289806|NCT00698685|523911861|FG000|Overall Study|Sister withdrew as donor|1|||
145289807|NCT00698685|523911861|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
145289808|NCT01513148|523911868|FG000|Overall Study|Protocol Violation|2|||
145289809|NCT01513148|523911869|FG001|Overall Study|Protocol Violation|2|||
145289810|NCT01399736|523911870|FG000|Overall Study|Withdrawal by Subject|4|||
145289811|NCT01399736|523911871|FG001|Overall Study|Withdrawal by Subject|2|||
145289812|NCT01399736|523911870|FG000|Overall Study|Lost to Follow-up|0|||
145289813|NCT01399736|523911871|FG001|Overall Study|Lost to Follow-up|2|||
145615745|NCT01744496|525109263|FG000|Titration Period|Personal reasons|0|||
145615746|NCT01744496|525109264|FG001|Titration Period|Personal reasons|1|||
145615747|NCT01744496|525109263|FG000|Maintenance Period|Adverse Event|1|||
145615748|NCT01744496|525109264|FG001|Maintenance Period|Adverse Event|3|||
145615749|NCT01744496|525109263|FG000|Maintenance Period|Protocol Violation|1|||
145289814|NCT02795104|523911872|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
145289815|NCT02795104|523911873|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
145289816|NCT02795104|523911874|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
145289817|NCT02795104|523911872|FG000|Overall Study|Withdrawal by Subject|0|||
145289818|NCT02795104|523911873|FG001|Overall Study|Withdrawal by Subject|2|||
145289819|NCT02795104|523911874|FG002|Overall Study|Withdrawal by Subject|0|||
145289820|NCT02795104|523911872|FG000|Overall Study|Lost to Follow-up|0|||
145289821|NCT02795104|523911873|FG001|Overall Study|Lost to Follow-up|0|||
145289822|NCT02795104|523911874|FG002|Overall Study|Lost to Follow-up|1|||
145289823|NCT01654380|523911878|FG000|Part B, Period 1|Physician Decision|0|||
145289824|NCT01654380|523911879|FG001|Part B, Period 1|Physician Decision|0|||
145289825|NCT01654380|523911880|FG002|Part B, Period 1|Physician Decision|1|||
145289826|NCT01654380|523911881|FG003|Part B, Period 1|Physician Decision|0|||
145289827|NCT04652453|523911884|FG000|Overall Study|Death|8|||
145289828|NCT04652453|523911885|FG001|Overall Study|Death|2|||
145289829|NCT04652453|523911886|FG002|Overall Study|Death|0|||
145289830|NCT04652453|523911884|FG000|Overall Study|Hospice|5|||
145289831|NCT04652453|523911885|FG001|Overall Study|Hospice|5|||
145289832|NCT04652453|523911886|FG002|Overall Study|Hospice|0|||
145289833|NCT04652453|523911884|FG000|Overall Study|Withdrawal by Subject|2|||
145289834|NCT04652453|523911885|FG001|Overall Study|Withdrawal by Subject|0|||
145289835|NCT04652453|523911886|FG002|Overall Study|Withdrawal by Subject|0|||
145289836|NCT04543136|523911887|FG000|Overall Study|Withdrawal by Subject|0|||
145289837|NCT04543136|523911888|FG001|Overall Study|Withdrawal by Subject|1|||
145289838|NCT04543136|523911889|FG002|Overall Study|Withdrawal by Subject|0|||
145289839|NCT04543136|523911890|FG003|Overall Study|Withdrawal by Subject|1|||
145289840|NCT04543136|523911891|FG004|Overall Study|Withdrawal by Subject|0|||
145289841|NCT04543136|523911892|FG005|Overall Study|Withdrawal by Subject|0|||
145289842|NCT02192099|523911893|FG000|Overall Study|Adverse Event|1|||
145289843|NCT02192099|523911893|FG000|Overall Study|Lost to Follow-up|2|||
145289844|NCT02192099|523911893|FG000|Overall Study|Physician Decision|1|||
145289845|NCT02192099|523911893|FG000|Overall Study|Pregnancy|1|||
145289846|NCT02192099|523911893|FG000|Overall Study|Protocol Violation|8|||
145289847|NCT02192099|523911893|FG000|Overall Study|Study Terminated by Sponsor|32|||
145289848|NCT02192099|523911893|FG000|Overall Study|Withdrawal by Subject|11|||
145289849|NCT02192099|523911893|FG000|Overall Study|Miscellaneous Reasons|5|||
145289850|NCT00386009|523911894|FG000|Overall Study|Adverse Event|0|||
145289851|NCT00386009|523911895|FG001|Overall Study|Adverse Event|2|||
145289852|NCT00386009|523911894|FG000|Overall Study|Death|1|||
145289853|NCT00386009|523911895|FG001|Overall Study|Death|0|||
145289854|NCT00386009|523911894|FG000|Overall Study|Entry Criteria Not Met|0|||
145289855|NCT00386009|523911895|FG001|Overall Study|Entry Criteria Not Met|2|||
145289856|NCT00386009|523911894|FG000|Overall Study|Lost to Follow-up|1|||
145289857|NCT00386009|523911895|FG001|Overall Study|Lost to Follow-up|1|||
145289858|NCT00386009|523911894|FG000|Overall Study|Protocol Violation|1|||
145289859|NCT00386009|523911895|FG001|Overall Study|Protocol Violation|0|||
145289860|NCT00386009|523911894|FG000|Overall Study|Sponsor Decision|1|||
145289861|NCT00386009|523911895|FG001|Overall Study|Sponsor Decision|1|||
145289862|NCT00386009|523911894|FG000|Overall Study|Withdrawal by Subject|5|||
145289863|NCT00386009|523911895|FG001|Overall Study|Withdrawal by Subject|4|||
145289864|NCT04128007|523911904|FG000|Overall Study|Withdrawal by Subject|9|||
145289865|NCT04128007|523911905|FG001|Overall Study|Withdrawal by Subject|6|||
145289866|NCT04128007|523911904|FG000|Overall Study|Protocol Violation|1|||
145289867|NCT04128007|523911905|FG001|Overall Study|Protocol Violation|0|||
145289868|NCT04128007|523911904|FG000|Overall Study|Lost to Follow-up|8|||
145289869|NCT04128007|523911905|FG001|Overall Study|Lost to Follow-up|7|||
145289870|NCT04128007|523911904|FG000|Overall Study|Adverse Event|5|||
145289871|NCT04128007|523911905|FG001|Overall Study|Adverse Event|2|||
145289872|NCT04128007|523911904|FG000|Overall Study|Not reported|0|||
145289873|NCT04128007|523911905|FG001|Overall Study|Not reported|2|||
145289874|NCT00429923|523911912|FG000|Overall Study|Adverse Event|0|||
145289875|NCT00429923|523911913|FG001|Overall Study|Adverse Event|2|||
145289876|NCT00429923|523911914|FG002|Overall Study|Adverse Event|3|||
145289877|NCT00429923|523911912|FG000|Overall Study|Lack of Efficacy|4|||
145289878|NCT00429923|523911913|FG001|Overall Study|Lack of Efficacy|1|||
145289879|NCT00429923|523911914|FG002|Overall Study|Lack of Efficacy|33|||
145289880|NCT00429923|523911912|FG000|Overall Study|Lost to Follow-up|0|||
145289881|NCT00429923|523911913|FG001|Overall Study|Lost to Follow-up|0|||
145289882|NCT00429923|523911914|FG002|Overall Study|Lost to Follow-up|2|||
145289883|NCT00429923|523911912|FG000|Overall Study|Withdrew Consent|1|||
145289884|NCT00429923|523911913|FG001|Overall Study|Withdrew Consent|0|||
145289885|NCT00429923|523911914|FG002|Overall Study|Withdrew Consent|1|||
145289886|NCT00429923|523911912|FG000|Overall Study|Early Termination|0|||
145289887|NCT00429923|523911913|FG001|Overall Study|Early Termination|1|||
145289888|NCT00429923|523911914|FG002|Overall Study|Early Termination|0|||
145289889|NCT01937364|523911915|FG000|Overall Study|Adverse Event|2|||
145289890|NCT01937364|523911916|FG001|Overall Study|Adverse Event|1|||
145289891|NCT04799158|523911917|FG000|Run-In Period|Adverse Event|6|||
145289892|NCT04799158|523911918|FG001|Run-In Period|Adverse Event|0|||
145289893|NCT04799158|523911919|FG002|Run-In Period|Adverse Event|0|||
145289894|NCT04799158|523911920|FG003|Run-In Period|Adverse Event|0|||
145289895|NCT04799158|523911921|FG004|Run-In Period|Adverse Event|0|||
145289896|NCT04799158|523911917|FG000|Run-In Period|Lost to Follow-up|4|||
145289897|NCT04799158|523911918|FG001|Run-In Period|Lost to Follow-up|0|||
145289898|NCT04799158|523911919|FG002|Run-In Period|Lost to Follow-up|0|||
145289899|NCT04799158|523911920|FG003|Run-In Period|Lost to Follow-up|0|||
145289900|NCT04799158|523911921|FG004|Run-In Period|Lost to Follow-up|0|||
145289901|NCT04799158|523911917|FG000|Run-In Period|Significant Protocol Deviation|1|||
145289902|NCT04799158|523911918|FG001|Run-In Period|Significant Protocol Deviation|0|||
145289903|NCT04799158|523911919|FG002|Run-In Period|Significant Protocol Deviation|0|||
145289904|NCT04799158|523911920|FG003|Run-In Period|Significant Protocol Deviation|0|||
145289905|NCT04799158|523911921|FG004|Run-In Period|Significant Protocol Deviation|0|||
145289906|NCT04799158|523911917|FG000|Run-In Period|Withdrawal by Subject|11|||
145289907|NCT04799158|523911918|FG001|Run-In Period|Withdrawal by Subject|0|||
145289908|NCT04799158|523911919|FG002|Run-In Period|Withdrawal by Subject|0|||
145289909|NCT04799158|523911920|FG003|Run-In Period|Withdrawal by Subject|0|||
145289910|NCT04799158|523911921|FG004|Run-In Period|Withdrawal by Subject|0|||
145289911|NCT04799158|523911917|FG000|Run-In Period|Miscellaneous|3|||
145289912|NCT04799158|523911918|FG001|Run-In Period|Miscellaneous|0|||
145289913|NCT04799158|523911919|FG002|Run-In Period|Miscellaneous|0|||
145289914|NCT04799158|523911920|FG003|Run-In Period|Miscellaneous|0|||
145289915|NCT04799158|523911921|FG004|Run-In Period|Miscellaneous|0|||
145289916|NCT04799158|523911917|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
145289917|NCT04799158|523911918|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
145289918|NCT04799158|523911919|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
145289919|NCT04799158|523911920|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
145289920|NCT04799158|523911921|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
145289921|NCT04799158|523911917|FG000|On-Demand Treatment Period|Adverse Event|0|||
145289922|NCT04799158|523911918|FG001|On-Demand Treatment Period|Adverse Event|1|||
145289923|NCT04799158|523911919|FG002|On-Demand Treatment Period|Adverse Event|0|||
145289924|NCT04799158|523911920|FG003|On-Demand Treatment Period|Adverse Event|0|||
145289925|NCT04799158|523911921|FG004|On-Demand Treatment Period|Adverse Event|1|||
145289926|NCT04799158|523911917|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
145289927|NCT04799158|523911918|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
145289928|NCT04799158|523911919|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
145289929|NCT04799158|523911920|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
145289930|NCT04799158|523911921|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
145289931|NCT04799158|523911917|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
145289932|NCT04799158|523911918|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
145289933|NCT04799158|523911919|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
145289934|NCT04799158|523911920|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
145289935|NCT04799158|523911921|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
145289936|NCT04799158|523911917|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
145289937|NCT04799158|523911918|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
145289938|NCT04799158|523911919|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
145289939|NCT04799158|523911920|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
145289940|NCT04799158|523911921|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
145289941|NCT04799158|523911917|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
145289942|NCT04799158|523911918|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
145289943|NCT04799158|523911919|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
145289944|NCT04799158|523911920|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
145289945|NCT04799158|523911921|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
145289946|NCT04799158|523911917|FG000|On-Demand Treatment Period|Miscellaneous|0|||
145289947|NCT04799158|523911918|FG001|On-Demand Treatment Period|Miscellaneous|0|||
145289948|NCT04799158|523911919|FG002|On-Demand Treatment Period|Miscellaneous|0|||
145289949|NCT04799158|523911920|FG003|On-Demand Treatment Period|Miscellaneous|0|||
145289950|NCT04799158|523911921|FG004|On-Demand Treatment Period|Miscellaneous|1|||
145289951|NCT04104646|523911924|FG000|Overall Study|Withdrawal by Subject|1|||
145289952|NCT04104646|523911925|FG001|Overall Study|Withdrawal by Subject|1|||
145289953|NCT04104646|523911924|FG000|Overall Study|Lost to Follow-up|1|||
145289954|NCT04104646|523911925|FG001|Overall Study|Lost to Follow-up|0|||
145289955|NCT04104646|523911924|FG000|Overall Study|Physician Decision|2|||
145289956|NCT04104646|523911925|FG001|Overall Study|Physician Decision|0|||
145289957|NCT02607800|523911926|FG000|Overall Study|Lost to Follow-up|7|||
145289958|NCT02607800|523911927|FG001|Overall Study|Lost to Follow-up|10|||
145289959|NCT02607800|523911926|FG000|Overall Study|Withdrew Consent|2|||
145289960|NCT02607800|523911927|FG001|Overall Study|Withdrew Consent|0|||
145289961|NCT02607800|523911926|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
145289962|NCT02607800|523911927|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
145289963|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
145289964|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
145289965|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Death|0|||
145289966|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Death|1|||
145289967|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
145289968|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
145289969|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
145289970|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
145289971|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
145289972|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
145289973|NCT01656889|523911928|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
145289974|NCT01656889|523911929|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
145289975|NCT01656889|523911928|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
145289976|NCT01656889|523911929|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
145289977|NCT01656889|523911928|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
145289978|NCT01656889|523911929|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
145289979|NCT01656889|523911928|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
145289980|NCT01656889|523911929|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
145289981|NCT01656889|523911928|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
145289982|NCT01656889|523911929|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
145289983|NCT01734772|523911931|FG000|Overall Study|Adverse Event|1|||
145289984|NCT01734772|523911932|FG001|Overall Study|Adverse Event|2|||
145289985|NCT01734772|523911931|FG000|Overall Study|Withdrawal by Subject|0|||
145289986|NCT01734772|523911932|FG001|Overall Study|Withdrawal by Subject|1|||
145289987|NCT00329602|523911933|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
145289988|NCT00329602|523911934|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
145289989|NCT00329602|523911935|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
145289990|NCT00329602|523911933|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
145289991|NCT00329602|523911934|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
145289992|NCT00329602|523911935|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
145289993|NCT00329602|523911933|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
145289994|NCT00329602|523911934|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
145289995|NCT00329602|523911935|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
145289996|NCT00329602|523911933|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
145289997|NCT00329602|523911934|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
145289998|NCT00329602|523911935|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
145289999|NCT00329602|523911933|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
145290000|NCT00329602|523911934|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
145290001|NCT00329602|523911935|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
145290002|NCT00329602|523911933|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
145290003|NCT00329602|523911934|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
145290004|NCT00329602|523911935|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
145290005|NCT02275364|523911936|FG000|Period 1|Withdrawal by Subject|1|||
145290006|NCT02275364|523911937|FG001|Period 1|Withdrawal by Subject|0|||
145290007|NCT02275364|523911936|FG000|Period 1|Other reason|1|||
145290008|NCT02275364|523911937|FG001|Period 1|Other reason|0|||
145290009|NCT03595657|523911938|FG000|Overall Study|Adverse Event|14|||
145290010|NCT03595657|523911938|FG000|Overall Study|Death|1|||
145290011|NCT03595657|523911938|FG000|Overall Study|Lack of Efficacy|40|||
145290012|NCT03595657|523911938|FG000|Overall Study|Withdrawal by Subject|10|||
145290013|NCT03595657|523911938|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
145290014|NCT03595657|523911938|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
145290015|NCT01200394|523911939|FG000|Overall Study|Adverse Event|0|||
145290016|NCT01200394|523911940|FG001|Overall Study|Adverse Event|14|||
145290017|NCT01200394|523911939|FG000|Overall Study|Death|1|||
145290018|NCT01200394|523911940|FG001|Overall Study|Death|0|||
145290019|NCT01200394|523911939|FG000|Overall Study|Lost to Follow-up|0|||
145290020|NCT01200394|523911940|FG001|Overall Study|Lost to Follow-up|1|||
145406526|NCT01799889|524343771|FG008|Overall Study|Progressive Disease|18|||
145406527|NCT01799889|524343772|FG009|Overall Study|Progressive Disease|5|||
145406528|NCT01799889|524343773|FG010|Overall Study|Progressive Disease|3|||
145406529|NCT01799889|524343774|FG011|Overall Study|Progressive Disease|1|||
145290021|NCT01200394|523911939|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145290022|NCT01200394|523911940|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
145406530|NCT01799889|524343763|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
145406531|NCT01799889|524343764|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
145290023|NCT01200394|523911939|FG000|Overall Study|Protocol Violation|0|||
145290024|NCT01200394|523911940|FG001|Overall Study|Protocol Violation|3|||
145556207|NCT00818662|524894985|FG001|Overall Study|Moving out of state|0|||
145290025|NCT01200394|523911939|FG000|Overall Study|Withdrawal by Subject|0|||
145290026|NCT01200394|523911940|FG001|Overall Study|Withdrawal by Subject|5|||
145290027|NCT01200394|523911939|FG000|Overall Study|Other|0|||
145290028|NCT01200394|523911940|FG001|Overall Study|Other|1|||
145290029|NCT02729896|523911945|FG000|Overall Study|Death|0|||
145290030|NCT02729896|523911946|FG001|Overall Study|Death|2|||
145290031|NCT02729896|523911947|FG002|Overall Study|Death|13|||
145290032|NCT02729896|523911945|FG000|Overall Study|Lost to Follow-up|0|||
145290033|NCT02729896|523911946|FG001|Overall Study|Lost to Follow-up|2|||
145290034|NCT02729896|523911947|FG002|Overall Study|Lost to Follow-up|3|||
145290035|NCT02729896|523911945|FG000|Overall Study|Other|0|||
145290036|NCT02729896|523911946|FG001|Overall Study|Other|2|||
145290037|NCT02729896|523911947|FG002|Overall Study|Other|0|||
145290038|NCT02729896|523911945|FG000|Overall Study|Physician Decision|1|||
145290039|NCT02729896|523911946|FG001|Overall Study|Physician Decision|2|||
145290040|NCT02729896|523911947|FG002|Overall Study|Physician Decision|3|||
145290041|NCT02729896|523911945|FG000|Overall Study|Progressive Disease|0|||
145290042|NCT02729896|523911946|FG001|Overall Study|Progressive Disease|1|||
145290043|NCT02729896|523911947|FG002|Overall Study|Progressive Disease|0|||
145556208|NCT00818662|524894986|FG002|Overall Study|Moving out of state|0|||
145290044|NCT02729896|523911945|FG000|Overall Study|Withdrawal by Subject|1|||
145290045|NCT02729896|523911946|FG001|Overall Study|Withdrawal by Subject|0|||
145290046|NCT02729896|523911947|FG002|Overall Study|Withdrawal by Subject|3|||
145290047|NCT01835145|523911948|FG000|Overall Study|Ineligible prior to treatment|1|||
145290048|NCT01835145|523911949|FG001|Overall Study|Ineligible prior to treatment|0|||
145290049|NCT00582309|523911950|FG000|Overall Study|Protocol Violation|0|||
145290050|NCT00582309|523911951|FG001|Overall Study|Protocol Violation|0|||
145290051|NCT00582309|523911952|FG002|Overall Study|Protocol Violation|2|||
145290052|NCT02708277|523911957|FG000|Overall Study|Lost to Follow-up|7|||
145290053|NCT02708277|523911958|FG001|Overall Study|Lost to Follow-up|4|||
145290054|NCT01058421|523911959|FG000|1 Month Outcomes|Death|10|||
145290055|NCT01058421|523911960|FG001|1 Month Outcomes|Death|6|||
145290056|NCT01058421|523911959|FG000|1 Month Outcomes|Lost to Follow-up|8|||
145290057|NCT01058421|523911960|FG001|1 Month Outcomes|Lost to Follow-up|7|||
145290058|NCT01058421|523911959|FG000|1 Month Outcomes|Remained in Hospital|5|||
145290059|NCT01058421|523911960|FG001|1 Month Outcomes|Remained in Hospital|12|||
145290060|NCT01058421|523911959|FG000|1 Month Outcomes|Remained in Other Facility|16|||
145290061|NCT01058421|523911960|FG001|1 Month Outcomes|Remained in Other Facility|17|||
145290062|NCT01058421|523911959|FG000|3 Month Outcomes|Death|3|||
145290063|NCT01058421|523911960|FG001|3 Month Outcomes|Death|5|||
145290064|NCT01058421|523911959|FG000|3 Month Outcomes|Lost to Follow-up|12|||
145290065|NCT01058421|523911960|FG001|3 Month Outcomes|Lost to Follow-up|11|||
145290066|NCT01058421|523911959|FG000|3 Month Outcomes|Remained in Hospital|0|||
145290067|NCT01058421|523911960|FG001|3 Month Outcomes|Remained in Hospital|2|||
145290068|NCT01058421|523911959|FG000|3 Month Outcomes|Remained in Other Facility|5|||
145290069|NCT01058421|523911960|FG001|3 Month Outcomes|Remained in Other Facility|8|||
145290070|NCT01058421|523911959|FG000|6 Month Outcomes|Death|2|||
145290071|NCT01058421|523911960|FG001|6 Month Outcomes|Death|2|||
145290072|NCT01058421|523911959|FG000|6 Month Outcomes|Lost to Follow-up|16|||
145290073|NCT01058421|523911960|FG001|6 Month Outcomes|Lost to Follow-up|21|||
145290074|NCT01058421|523911959|FG000|6 Month Outcomes|Remained in Other Facility|1|||
145290075|NCT01058421|523911960|FG001|6 Month Outcomes|Remained in Other Facility|3|||
145290076|NCT02984683|523911963|FG000|Overall Study|Adverse Event|3|||
145290077|NCT02984683|523911964|FG001|Overall Study|Adverse Event|3|||
145290078|NCT02984683|523911963|FG000|Overall Study|Withdrawal by Subject|1|||
145290079|NCT02984683|523911964|FG001|Overall Study|Withdrawal by Subject|0|||
145290080|NCT02984683|523911963|FG000|Overall Study|Disease progression|7|||
145290081|NCT02984683|523911964|FG001|Overall Study|Disease progression|9|||
145290082|NCT02415959|523911969|FG000|Overall Study|Adverse Event|0|||
145556209|NCT00818662|524894987|FG003|Overall Study|Moving out of state|1|||
145556210|NCT00818662|524894984|FG000|Overall Study|Declined move to another study site|1|||
145615750|NCT01744496|525109264|FG001|Maintenance Period|Protocol Violation|0|||
145615751|NCT01744496|525109263|FG000|Maintenance Period|Withdrawal by Subject|1|||
145615752|NCT01744496|525109264|FG001|Maintenance Period|Withdrawal by Subject|1|||
145615753|NCT01744496|525109263|FG000|Maintenance Period|Subject left town|1|||
145615754|NCT01744496|525109264|FG001|Maintenance Period|Subject left town|0|||
145615755|NCT03537261|525109265|FG000|Overall Study|Lost to Follow-up|4|||
145615756|NCT03537261|525109266|FG001|Overall Study|Lost to Follow-up|5|||
145615757|NCT03537261|525109265|FG000|Overall Study|Withdrawal by Subject|4|||
145615758|NCT03537261|525109266|FG001|Overall Study|Withdrawal by Subject|6|||
145615759|NCT03537261|525109265|FG000|Overall Study|Did not return study questionnaires|0|||
145615760|NCT03537261|525109266|FG001|Overall Study|Did not return study questionnaires|1|||
145615761|NCT01177813|525109269|FG000|Overall Study|Adverse Event|8|||
145615762|NCT01177813|525109270|FG001|Overall Study|Adverse Event|2|||
145615763|NCT01177813|525109271|FG002|Overall Study|Adverse Event|4|||
145615764|NCT01177813|525109272|FG003|Overall Study|Adverse Event|6|||
145615765|NCT01177813|525109273|FG004|Overall Study|Adverse Event|3|||
145615766|NCT01177813|525109269|FG000|Overall Study|Lack of Efficacy|1|||
145615767|NCT01177813|525109270|FG001|Overall Study|Lack of Efficacy|0|||
145615768|NCT01177813|525109271|FG002|Overall Study|Lack of Efficacy|0|||
145615769|NCT01177813|525109272|FG003|Overall Study|Lack of Efficacy|0|||
145615770|NCT01177813|525109273|FG004|Overall Study|Lack of Efficacy|0|||
145615771|NCT01177813|525109269|FG000|Overall Study|Protocol Violation|3|||
145615772|NCT01177813|525109270|FG001|Overall Study|Protocol Violation|2|||
145615773|NCT01177813|525109271|FG002|Overall Study|Protocol Violation|2|||
145615774|NCT01177813|525109272|FG003|Overall Study|Protocol Violation|0|||
145615775|NCT01177813|525109273|FG004|Overall Study|Protocol Violation|1|||
145615776|NCT01177813|525109269|FG000|Overall Study|Lost to Follow-up|12|||
145615777|NCT01177813|525109270|FG001|Overall Study|Lost to Follow-up|5|||
145615778|NCT01177813|525109271|FG002|Overall Study|Lost to Follow-up|6|||
145615779|NCT01177813|525109272|FG003|Overall Study|Lost to Follow-up|3|||
145615780|NCT01177813|525109273|FG004|Overall Study|Lost to Follow-up|0|||
145615781|NCT01177813|525109269|FG000|Overall Study|Withdrawal by Subject|12|||
145615782|NCT01177813|525109270|FG001|Overall Study|Withdrawal by Subject|7|||
145615783|NCT01177813|525109271|FG002|Overall Study|Withdrawal by Subject|6|||
145615784|NCT01177813|525109272|FG003|Overall Study|Withdrawal by Subject|5|||
145615785|NCT01177813|525109273|FG004|Overall Study|Withdrawal by Subject|3|||
145615786|NCT01177813|525109269|FG000|Overall Study|Other reason not defined above|5|||
145615787|NCT01177813|525109270|FG001|Overall Study|Other reason not defined above|2|||
145615788|NCT01177813|525109271|FG002|Overall Study|Other reason not defined above|2|||
145615789|NCT01177813|525109272|FG003|Overall Study|Other reason not defined above|3|||
145615790|NCT01177813|525109273|FG004|Overall Study|Other reason not defined above|2|||
145615791|NCT03772314|525109282|FG000|Overall Study|Adverse Event|7|||
145615792|NCT03772314|525109283|FG001|Overall Study|Adverse Event|2|||
145615793|NCT02001974|525109284|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
145615794|NCT02001974|525109285|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
145615795|NCT02001974|525109286|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
145615796|NCT02001974|525109284|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
145615797|NCT02001974|525109285|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
145615798|NCT02001974|525109286|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
145615799|NCT02001974|525109284|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
145615800|NCT02001974|525109285|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
145615801|NCT02001974|525109286|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
145615802|NCT02001974|525109284|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
145615803|NCT02001974|525109285|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
145615804|NCT02001974|525109286|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
145615805|NCT01380990|525109287|FG000|Overall Study|Treatment Failure|1|||
145615806|NCT01380990|525109288|FG001|Overall Study|Treatment Failure|0|||
145615807|NCT01380990|525109287|FG000|Overall Study|Death|0|||
145615808|NCT01380990|525109288|FG001|Overall Study|Death|1|||
145615809|NCT02038764|525109289|FG000|Overall Study|Adverse Event|0|||
145615810|NCT02038764|525109290|FG001|Overall Study|Adverse Event|0|||
145615811|NCT02038764|525109291|FG002|Overall Study|Adverse Event|1|||
145615812|NCT02038764|525109292|FG003|Overall Study|Adverse Event|0|||
145290083|NCT02415959|523911970|FG001|Overall Study|Adverse Event|1|||
145290084|NCT02415959|523911971|FG002|Overall Study|Adverse Event|0|||
145290085|NCT02415959|523911972|FG003|Overall Study|Adverse Event|0|||
145290086|NCT02415959|523911973|FG004|Overall Study|Adverse Event|0|||
145290087|NCT02415959|523911969|FG000|Overall Study|Protocol Violation|0|||
145290088|NCT02415959|523911970|FG001|Overall Study|Protocol Violation|0|||
145290089|NCT02415959|523911971|FG002|Overall Study|Protocol Violation|0|||
145290090|NCT02415959|523911972|FG003|Overall Study|Protocol Violation|1|||
145290091|NCT02415959|523911973|FG004|Overall Study|Protocol Violation|0|||
145290092|NCT03008460|523911978|FG000|Overall Study|Protocol deviation|0|||
145290093|NCT03008460|523911979|FG001|Overall Study|Protocol deviation|2|||
145290094|NCT03008460|523911978|FG000|Overall Study|Study drug not dispensed|0|||
145290095|NCT03008460|523911979|FG001|Overall Study|Study drug not dispensed|1|||
145290096|NCT03008460|523911978|FG000|Overall Study|Adverse Event|0|||
145290097|NCT03008460|523911979|FG001|Overall Study|Adverse Event|1|||
145290098|NCT03008460|523911978|FG000|Overall Study|Withdrawal by Subject|5|||
145290099|NCT03008460|523911979|FG001|Overall Study|Withdrawal by Subject|6|||
145290100|NCT03008460|523911978|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
145290101|NCT03008460|523911979|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
145290102|NCT03008460|523911978|FG000|Overall Study|End of study visit outside permitted time window|0|||
145290103|NCT03008460|523911979|FG001|Overall Study|End of study visit outside permitted time window|1|||
145290104|NCT03008460|523911978|FG000|Overall Study|Lost to Follow-up|1|||
145290105|NCT03008460|523911979|FG001|Overall Study|Lost to Follow-up|3|||
145290106|NCT03131999|523911984|FG000|Overall Study|Withdrawal by Subject|0|||
145290107|NCT03131999|523911985|FG001|Overall Study|Withdrawal by Subject|1|||
145290108|NCT02260492|523911986|FG000|Overall Study|Adverse Event|6|||
145290109|NCT02260492|523911987|FG001|Overall Study|Adverse Event|1|||
145290110|NCT02260492|523911988|FG002|Overall Study|Adverse Event|2|||
145290111|NCT02260492|523911986|FG000|Overall Study|Death|0|||
145290112|NCT02260492|523911987|FG001|Overall Study|Death|1|||
145290113|NCT02260492|523911988|FG002|Overall Study|Death|0|||
145290114|NCT02260492|523911986|FG000|Overall Study|Lost to Follow-up|12|||
145290115|NCT02260492|523911987|FG001|Overall Study|Lost to Follow-up|9|||
145290116|NCT02260492|523911988|FG002|Overall Study|Lost to Follow-up|0|||
145290117|NCT02260492|523911986|FG000|Overall Study|Physician Decision|2|||
145290118|NCT02260492|523911987|FG001|Overall Study|Physician Decision|0|||
145290119|NCT02260492|523911988|FG002|Overall Study|Physician Decision|1|||
145290120|NCT02260492|523911986|FG000|Overall Study|Withdrawal by Subject|3|||
145290121|NCT02260492|523911987|FG001|Overall Study|Withdrawal by Subject|2|||
145290122|NCT02260492|523911988|FG002|Overall Study|Withdrawal by Subject|2|||
145290123|NCT03495869|523911991|FG000|Overall Study|Lost to Follow-up|4|||
145406532|NCT01799889|524343765|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
145406533|NCT01799889|524343766|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
145406534|NCT01799889|524343767|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
145290124|NCT03495869|523911992|FG001|Overall Study|Lost to Follow-up|17|||
145290125|NCT03495869|523911993|FG002|Overall Study|Lost to Follow-up|8|||
145290126|NCT03495869|523911994|FG003|Overall Study|Lost to Follow-up|14|||
145290127|NCT03495869|523911991|FG000|Overall Study|Withdrawal by Subject|0|||
145290128|NCT03495869|523911992|FG001|Overall Study|Withdrawal by Subject|3|||
145290129|NCT03495869|523911993|FG002|Overall Study|Withdrawal by Subject|0|||
145406535|NCT01799889|524343768|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
145406536|NCT01799889|524343769|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
145290130|NCT03495869|523911994|FG003|Overall Study|Withdrawal by Subject|3|||
145290131|NCT03495869|523911991|FG000|Overall Study|Dropped from study|0|||
145290132|NCT03495869|523911992|FG001|Overall Study|Dropped from study|7|||
145290133|NCT03495869|523911993|FG002|Overall Study|Dropped from study|2|||
145290134|NCT03495869|523911994|FG003|Overall Study|Dropped from study|4|||
145290135|NCT04634409|523911995|FG000|Overall Study|Death|0|||
145290136|NCT04634409|523911996|FG001|Overall Study|Death|0|||
145290137|NCT04634409|523911997|FG002|Overall Study|Death|0|||
145406537|NCT01799889|524343770|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
145615813|NCT02038764|525109293|FG004|Overall Study|Adverse Event|0|||
145615814|NCT02038764|525109289|FG000|Overall Study|Lost to Follow-up|0|||
145615815|NCT02038764|525109290|FG001|Overall Study|Lost to Follow-up|1|||
145406538|NCT01799889|524343771|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
145406539|NCT01799889|524343772|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
145406540|NCT01799889|524343773|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
145406541|NCT01799889|524343774|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
145406542|NCT01799889|524343763|FG000|Overall Study|Study Terminated By Sponsor|1|||
145406543|NCT01799889|524343764|FG001|Overall Study|Study Terminated By Sponsor|0|||
145406544|NCT01799889|524343765|FG002|Overall Study|Study Terminated By Sponsor|0|||
145406545|NCT01799889|524343766|FG003|Overall Study|Study Terminated By Sponsor|0|||
145406546|NCT01799889|524343767|FG004|Overall Study|Study Terminated By Sponsor|2|||
145406547|NCT01799889|524343768|FG005|Overall Study|Study Terminated By Sponsor|1|||
145406548|NCT01799889|524343769|FG006|Overall Study|Study Terminated By Sponsor|0|||
145406549|NCT01799889|524343770|FG007|Overall Study|Study Terminated By Sponsor|2|||
145406550|NCT01799889|524343771|FG008|Overall Study|Study Terminated By Sponsor|1|||
145406551|NCT01799889|524343772|FG009|Overall Study|Study Terminated By Sponsor|1|||
145406552|NCT01799889|524343773|FG010|Overall Study|Study Terminated By Sponsor|0|||
145406553|NCT01799889|524343774|FG011|Overall Study|Study Terminated By Sponsor|0|||
145406554|NCT01799889|524343763|FG000|Overall Study|Withdrawal by Subject|1|||
145406555|NCT01799889|524343764|FG001|Overall Study|Withdrawal by Subject|6|||
145406556|NCT01799889|524343765|FG002|Overall Study|Withdrawal by Subject|4|||
145406557|NCT01799889|524343766|FG003|Overall Study|Withdrawal by Subject|0|||
145406558|NCT01799889|524343767|FG004|Overall Study|Withdrawal by Subject|5|||
145406559|NCT01799889|524343768|FG005|Overall Study|Withdrawal by Subject|1|||
145615816|NCT02038764|525109291|FG002|Overall Study|Lost to Follow-up|0|||
145615817|NCT02038764|525109292|FG003|Overall Study|Lost to Follow-up|0|||
145615818|NCT02038764|525109293|FG004|Overall Study|Lost to Follow-up|0|||
145615819|NCT02038764|525109289|FG000|Overall Study|Withdrawal by Subject|0|||
145406560|NCT01799889|524343769|FG006|Overall Study|Withdrawal by Subject|3|||
145406561|NCT01799889|524343770|FG007|Overall Study|Withdrawal by Subject|1|||
145406562|NCT01799889|524343771|FG008|Overall Study|Withdrawal by Subject|2|||
145406563|NCT01799889|524343772|FG009|Overall Study|Withdrawal by Subject|1|||
145615820|NCT02038764|525109290|FG001|Overall Study|Withdrawal by Subject|0|||
145615821|NCT02038764|525109291|FG002|Overall Study|Withdrawal by Subject|0|||
145290138|NCT04634409|523911998|FG003|Overall Study|Death|0|||
145290139|NCT04634409|523911999|FG004|Overall Study|Death|0|||
145290140|NCT04634409|523912000|FG005|Overall Study|Death|0|||
145290141|NCT04634409|523912001|FG006|Overall Study|Death|0|||
145290142|NCT04634409|523912002|FG007|Overall Study|Death|0|||
145290143|NCT04634409|523912003|FG008|Overall Study|Death|0|||
145290144|NCT04634409|523912004|FG009|Overall Study|Death|0|||
145290145|NCT04634409|523912005|FG010|Overall Study|Death|1|||
145290146|NCT04634409|523912006|FG011|Overall Study|Death|0|||
145290147|NCT04634409|523912007|FG012|Overall Study|Death|1|||
145290148|NCT04634409|523912008|FG013|Overall Study|Death|0|||
145290149|NCT04634409|523912009|FG014|Overall Study|Death|0|||
145290150|NCT04634409|523912010|FG015|Overall Study|Death|0|||
145290151|NCT04634409|523912011|FG016|Overall Study|Death|0|||
145290152|NCT04634409|523912012|FG017|Overall Study|Death|0|||
145290153|NCT04634409|523912013|FG018|Overall Study|Death|0|||
145290154|NCT04634409|523912014|FG019|Overall Study|Death|0|||
145290155|NCT04634409|523912015|FG020|Overall Study|Death|0|||
145290156|NCT04634409|523912016|FG021|Overall Study|Death|0|||
145290157|NCT04634409|523912017|FG022|Overall Study|Death|0|||
145290158|NCT04634409|523912018|FG023|Overall Study|Death|0|||
145290159|NCT04634409|523912019|FG024|Overall Study|Death|0|||
145290160|NCT04634409|523912020|FG025|Overall Study|Death|0|||
145290161|NCT04634409|523912021|FG026|Overall Study|Death|0|||
145290162|NCT04634409|523911995|FG000|Overall Study|Adverse Event|0|||
145290163|NCT04634409|523911996|FG001|Overall Study|Adverse Event|0|||
145290164|NCT04634409|523911997|FG002|Overall Study|Adverse Event|1|||
145290165|NCT04634409|523911998|FG003|Overall Study|Adverse Event|0|||
145290166|NCT04634409|523911999|FG004|Overall Study|Adverse Event|0|||
145290167|NCT04634409|523912000|FG005|Overall Study|Adverse Event|1|||
145290168|NCT04634409|523912001|FG006|Overall Study|Adverse Event|0|||
145290169|NCT04634409|523912002|FG007|Overall Study|Adverse Event|0|||
145290170|NCT04634409|523912003|FG008|Overall Study|Adverse Event|0|||
145290171|NCT04634409|523912004|FG009|Overall Study|Adverse Event|0|||
145290172|NCT04634409|523912005|FG010|Overall Study|Adverse Event|0|||
145290173|NCT04634409|523912006|FG011|Overall Study|Adverse Event|0|||
145290174|NCT04634409|523912007|FG012|Overall Study|Adverse Event|0|||
145290175|NCT04634409|523912008|FG013|Overall Study|Adverse Event|0|||
145290176|NCT04634409|523912009|FG014|Overall Study|Adverse Event|0|||
145290177|NCT04634409|523912010|FG015|Overall Study|Adverse Event|0|||
145290178|NCT04634409|523912011|FG016|Overall Study|Adverse Event|0|||
145290179|NCT04634409|523912012|FG017|Overall Study|Adverse Event|0|||
145290180|NCT04634409|523912013|FG018|Overall Study|Adverse Event|0|||
145290181|NCT04634409|523912014|FG019|Overall Study|Adverse Event|0|||
145290182|NCT04634409|523912015|FG020|Overall Study|Adverse Event|0|||
145290183|NCT04634409|523912016|FG021|Overall Study|Adverse Event|0|||
145290184|NCT04634409|523912017|FG022|Overall Study|Adverse Event|0|||
145290185|NCT04634409|523912018|FG023|Overall Study|Adverse Event|0|||
145290186|NCT04634409|523912019|FG024|Overall Study|Adverse Event|0|||
145290187|NCT04634409|523912020|FG025|Overall Study|Adverse Event|0|||
145290188|NCT04634409|523912021|FG026|Overall Study|Adverse Event|0|||
145290189|NCT04634409|523911995|FG000|Overall Study|Lost to Follow-up|3|||
145290190|NCT04634409|523911996|FG001|Overall Study|Lost to Follow-up|1|||
145290191|NCT04634409|523911997|FG002|Overall Study|Lost to Follow-up|1|||
145290192|NCT04634409|523911998|FG003|Overall Study|Lost to Follow-up|3|||
145290193|NCT04634409|523911999|FG004|Overall Study|Lost to Follow-up|1|||
145290194|NCT04634409|523912000|FG005|Overall Study|Lost to Follow-up|1|||
145290195|NCT04634409|523912001|FG006|Overall Study|Lost to Follow-up|1|||
145290196|NCT04634409|523912002|FG007|Overall Study|Lost to Follow-up|3|||
145290197|NCT04634409|523912003|FG008|Overall Study|Lost to Follow-up|3|||
145290198|NCT04634409|523912004|FG009|Overall Study|Lost to Follow-up|11|||
145290199|NCT04634409|523912005|FG010|Overall Study|Lost to Follow-up|8|||
145290200|NCT04634409|523912006|FG011|Overall Study|Lost to Follow-up|15|||
145290201|NCT04634409|523912007|FG012|Overall Study|Lost to Follow-up|3|||
145290202|NCT04634409|523912008|FG013|Overall Study|Lost to Follow-up|2|||
145290203|NCT04634409|523912009|FG014|Overall Study|Lost to Follow-up|7|||
145290204|NCT04634409|523912010|FG015|Overall Study|Lost to Follow-up|0|||
145290205|NCT04634409|523912011|FG016|Overall Study|Lost to Follow-up|0|||
145290206|NCT04634409|523912012|FG017|Overall Study|Lost to Follow-up|0|||
145290207|NCT04634409|523912013|FG018|Overall Study|Lost to Follow-up|0|||
145290208|NCT04634409|523912014|FG019|Overall Study|Lost to Follow-up|0|||
145290209|NCT04634409|523912015|FG020|Overall Study|Lost to Follow-up|0|||
145290210|NCT04634409|523912016|FG021|Overall Study|Lost to Follow-up|0|||
145290211|NCT04634409|523912017|FG022|Overall Study|Lost to Follow-up|0|||
145290212|NCT04634409|523912018|FG023|Overall Study|Lost to Follow-up|0|||
145290213|NCT04634409|523912019|FG024|Overall Study|Lost to Follow-up|0|||
145290214|NCT04634409|523912020|FG025|Overall Study|Lost to Follow-up|0|||
145290215|NCT04634409|523912021|FG026|Overall Study|Lost to Follow-up|0|||
145290216|NCT04634409|523911995|FG000|Overall Study|Withdrawal by Subject|3|||
145290217|NCT04634409|523911996|FG001|Overall Study|Withdrawal by Subject|1|||
145615822|NCT02038764|525109292|FG003|Overall Study|Withdrawal by Subject|0|||
145615823|NCT02038764|525109293|FG004|Overall Study|Withdrawal by Subject|1|||
145290218|NCT04634409|523911997|FG002|Overall Study|Withdrawal by Subject|6|||
145290219|NCT04634409|523911998|FG003|Overall Study|Withdrawal by Subject|4|||
145290220|NCT04634409|523911999|FG004|Overall Study|Withdrawal by Subject|2|||
145290221|NCT04634409|523912000|FG005|Overall Study|Withdrawal by Subject|0|||
145290222|NCT04634409|523912001|FG006|Overall Study|Withdrawal by Subject|0|||
145290223|NCT04634409|523912002|FG007|Overall Study|Withdrawal by Subject|2|||
145290224|NCT04634409|523912003|FG008|Overall Study|Withdrawal by Subject|3|||
145290225|NCT04634409|523912004|FG009|Overall Study|Withdrawal by Subject|2|||
145290226|NCT04634409|523912005|FG010|Overall Study|Withdrawal by Subject|3|||
145290227|NCT04634409|523912006|FG011|Overall Study|Withdrawal by Subject|2|||
145290228|NCT04634409|523912007|FG012|Overall Study|Withdrawal by Subject|2|||
145290229|NCT04634409|523912008|FG013|Overall Study|Withdrawal by Subject|1|||
145290230|NCT04634409|523912009|FG014|Overall Study|Withdrawal by Subject|5|||
145290231|NCT04634409|523912010|FG015|Overall Study|Withdrawal by Subject|0|||
145290232|NCT04634409|523912011|FG016|Overall Study|Withdrawal by Subject|0|||
145290233|NCT04634409|523912012|FG017|Overall Study|Withdrawal by Subject|1|||
145290234|NCT04634409|523912013|FG018|Overall Study|Withdrawal by Subject|0|||
145290235|NCT04634409|523912014|FG019|Overall Study|Withdrawal by Subject|0|||
145290236|NCT04634409|523912015|FG020|Overall Study|Withdrawal by Subject|0|||
145290237|NCT04634409|523912016|FG021|Overall Study|Withdrawal by Subject|0|||
145290238|NCT04634409|523912017|FG022|Overall Study|Withdrawal by Subject|0|||
145290239|NCT04634409|523912018|FG023|Overall Study|Withdrawal by Subject|1|||
145290240|NCT04634409|523912019|FG024|Overall Study|Withdrawal by Subject|0|||
145290241|NCT04634409|523912020|FG025|Overall Study|Withdrawal by Subject|0|||
145290242|NCT04634409|523912021|FG026|Overall Study|Withdrawal by Subject|0|||
145290243|NCT04634409|523911995|FG000|Overall Study|Other - As reported by Investigator|1|||
145290244|NCT04634409|523911996|FG001|Overall Study|Other - As reported by Investigator|0|||
145290245|NCT04634409|523911997|FG002|Overall Study|Other - As reported by Investigator|0|||
145290246|NCT04634409|523911998|FG003|Overall Study|Other - As reported by Investigator|0|||
145290247|NCT04634409|523911999|FG004|Overall Study|Other - As reported by Investigator|0|||
145290248|NCT04634409|523912000|FG005|Overall Study|Other - As reported by Investigator|0|||
145290249|NCT04634409|523912001|FG006|Overall Study|Other - As reported by Investigator|0|||
145290250|NCT04634409|523912002|FG007|Overall Study|Other - As reported by Investigator|6|||
145290251|NCT04634409|523912003|FG008|Overall Study|Other - As reported by Investigator|4|||
145290252|NCT04634409|523912004|FG009|Overall Study|Other - As reported by Investigator|0|||
145290253|NCT04634409|523912005|FG010|Overall Study|Other - As reported by Investigator|1|||
145290254|NCT04634409|523912006|FG011|Overall Study|Other - As reported by Investigator|2|||
145290255|NCT04634409|523912007|FG012|Overall Study|Other - As reported by Investigator|2|||
145290256|NCT04634409|523912008|FG013|Overall Study|Other - As reported by Investigator|1|||
145290257|NCT04634409|523912009|FG014|Overall Study|Other - As reported by Investigator|0|||
145290258|NCT04634409|523912010|FG015|Overall Study|Other - As reported by Investigator|0|||
145290259|NCT04634409|523912011|FG016|Overall Study|Other - As reported by Investigator|0|||
145290260|NCT04634409|523912012|FG017|Overall Study|Other - As reported by Investigator|0|||
145290261|NCT04634409|523912013|FG018|Overall Study|Other - As reported by Investigator|0|||
145290262|NCT04634409|523912014|FG019|Overall Study|Other - As reported by Investigator|0|||
145615824|NCT02038764|525109289|FG000|Overall Study|Other|1|||
145615825|NCT02038764|525109290|FG001|Overall Study|Other|0|||
145615826|NCT02038764|525109291|FG002|Overall Study|Other|1|||
145615827|NCT02038764|525109292|FG003|Overall Study|Other|0|||
145615828|NCT02038764|525109293|FG004|Overall Study|Other|0|||
145615829|NCT00363896|525109297|FG000|Overall Study|Withdrawal by Subject|29|||
145615830|NCT00363896|525109298|FG001|Overall Study|Withdrawal by Subject|16|||
145615831|NCT00363896|525109297|FG000|Overall Study|Adverse Event|24|||
145615832|NCT00363896|525109298|FG001|Overall Study|Adverse Event|13|||
145615833|NCT00363896|525109297|FG000|Overall Study|COPD exacerbation|13|||
145615834|NCT00363896|525109298|FG001|Overall Study|COPD exacerbation|7|||
145615835|NCT00363896|525109297|FG000|Overall Study|Lack of Efficacy|12|||
145615836|NCT00363896|525109298|FG001|Overall Study|Lack of Efficacy|8|||
145615837|NCT00363896|525109297|FG000|Overall Study|Protocol Violation|6|||
145615838|NCT00363896|525109298|FG001|Overall Study|Protocol Violation|1|||
145615839|NCT00363896|525109297|FG000|Overall Study|Lost to Follow-up|3|||
145615840|NCT00363896|525109298|FG001|Overall Study|Lost to Follow-up|0|||
145615841|NCT00363896|525109297|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
145615842|NCT00363896|525109298|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
145615843|NCT00363896|525109297|FG000|Overall Study|Other|1|||
145615844|NCT00363896|525109298|FG001|Overall Study|Other|2|||
145615845|NCT01558674|525109299|FG000|Part 1|Study Terminated by Sponsor|10|||
145615846|NCT01558674|525109300|FG001|Part 1|Study Terminated by Sponsor|0|||
145615847|NCT01558674|525109299|FG000|Part 1|Withdrawal by Subject|1|||
145615848|NCT01558674|525109300|FG001|Part 1|Withdrawal by Subject|0|||
145615849|NCT00924469|525109301|FG000|Overall Study|Adverse Event|2|||
145615850|NCT00924469|525109302|FG001|Overall Study|Adverse Event|0|||
145615851|NCT00924469|525109301|FG000|Overall Study|Withdrawal by Subject|0|||
145615852|NCT00924469|525109302|FG001|Overall Study|Withdrawal by Subject|1|||
145615853|NCT00924469|525109301|FG000|Overall Study|Lost to Follow-up|0|||
145615854|NCT00924469|525109302|FG001|Overall Study|Lost to Follow-up|1|||
145615855|NCT00630058|525109305|FG000|Overall Study|Adverse Event|1|||
145615856|NCT00630058|525109306|FG001|Overall Study|Adverse Event|1|||
145615857|NCT00630058|525109305|FG000|Overall Study|Withdrawal by Subject|0|||
145615858|NCT00630058|525109306|FG001|Overall Study|Withdrawal by Subject|1|||
145615859|NCT00630058|525109305|FG000|Overall Study|stopping criteria|3|||
145615860|NCT00630058|525109306|FG001|Overall Study|stopping criteria|2|||
145615861|NCT01651936|525109307|FG000|Base Study|Adverse Event|3|||
145615862|NCT01651936|525109308|FG001|Base Study|Adverse Event|0|||
145615863|NCT01651936|525109309|FG002|Base Study|Adverse Event|0|||
145615864|NCT01651936|525109307|FG000|Base Study|Withdrawal by Subject|1|||
145615865|NCT01651936|525109308|FG001|Base Study|Withdrawal by Subject|1|||
145615866|NCT01651936|525109309|FG002|Base Study|Withdrawal by Subject|0|||
145615867|NCT01651936|525109307|FG000|Base Study|Early Escape|2|||
145615868|NCT01651936|525109308|FG001|Base Study|Early Escape|8|||
145615869|NCT01651936|525109309|FG002|Base Study|Early Escape|0|||
145615870|NCT01651936|525109307|FG000|Base Study|Study terminated by sponsor|21|||
145615871|NCT01651936|525109308|FG001|Base Study|Study terminated by sponsor|16|||
145615872|NCT01651936|525109309|FG002|Base Study|Study terminated by sponsor|0|||
145615873|NCT01651936|525109307|FG000|Extension Study|Lack of Efficacy|0|||
145615874|NCT01651936|525109308|FG001|Extension Study|Lack of Efficacy|0|||
145615875|NCT01651936|525109309|FG002|Extension Study|Lack of Efficacy|1|||
145615876|NCT01651936|525109307|FG000|Extension Study|Study terminated by sponsor|0|||
145615877|NCT01651936|525109308|FG001|Extension Study|Study terminated by sponsor|0|||
145615878|NCT01651936|525109309|FG002|Extension Study|Study terminated by sponsor|13|||
145615879|NCT03044353|525109310|FG000|Overall Study|Adverse Event|0|||
145615880|NCT03044353|525109311|FG001|Overall Study|Adverse Event|1|||
145290263|NCT04634409|523912015|FG020|Overall Study|Other - As reported by Investigator|0|||
145406564|NCT01799889|524343773|FG010|Overall Study|Withdrawal by Subject|1|||
145406565|NCT01799889|524343774|FG011|Overall Study|Withdrawal by Subject|1|||
145406566|NCT01799889|524343763|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145406567|NCT01799889|524343764|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145406568|NCT01799889|524343765|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145406569|NCT01799889|524343766|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145406570|NCT01799889|524343767|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145406571|NCT01799889|524343768|FG005|Overall Study|Non-Compliance With Study Drug|1|||
145406572|NCT01799889|524343769|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145406573|NCT01799889|524343770|FG007|Overall Study|Non-Compliance With Study Drug|0|||
145406574|NCT01799889|524343771|FG008|Overall Study|Non-Compliance With Study Drug|0|||
145406575|NCT01799889|524343772|FG009|Overall Study|Non-Compliance With Study Drug|0|||
145406576|NCT01799889|524343773|FG010|Overall Study|Non-Compliance With Study Drug|0|||
145406577|NCT01799889|524343774|FG011|Overall Study|Non-Compliance With Study Drug|0|||
145406578|NCT04476043|524343777|FG000|Overall Study|Withdrawal by Subject|1|||
145406579|NCT04476043|524343778|FG001|Overall Study|Withdrawal by Subject|3|||
145406580|NCT04476043|524343779|FG002|Overall Study|Withdrawal by Subject|4|||
145406581|NCT04476043|524343780|FG003|Overall Study|Withdrawal by Subject|1|||
145406582|NCT04476043|524343777|FG000|Overall Study|Lost to Follow-up|1|||
145406583|NCT04476043|524343778|FG001|Overall Study|Lost to Follow-up|1|||
145406584|NCT04476043|524343779|FG002|Overall Study|Lost to Follow-up|2|||
145406585|NCT04476043|524343780|FG003|Overall Study|Lost to Follow-up|1|||
145406586|NCT04476043|524343777|FG000|Overall Study|Adverse Event|2|||
145406587|NCT04476043|524343778|FG001|Overall Study|Adverse Event|0|||
145406588|NCT04476043|524343779|FG002|Overall Study|Adverse Event|1|||
145406589|NCT04476043|524343780|FG003|Overall Study|Adverse Event|0|||
145290264|NCT04634409|523912016|FG021|Overall Study|Other - As reported by Investigator|0|||
145290265|NCT04634409|523912017|FG022|Overall Study|Other - As reported by Investigator|0|||
145290266|NCT04634409|523912018|FG023|Overall Study|Other - As reported by Investigator|0|||
145290267|NCT04634409|523912019|FG024|Overall Study|Other - As reported by Investigator|0|||
145290268|NCT04634409|523912020|FG025|Overall Study|Other - As reported by Investigator|0|||
145290269|NCT04634409|523912021|FG026|Overall Study|Other - As reported by Investigator|0|||
145290270|NCT01497938|523912022|FG000|Overall Study|Adverse Event|0|||
145290271|NCT01497938|523912023|FG001|Overall Study|Adverse Event|1|||
145290272|NCT01497938|523912022|FG000|Overall Study|Physician Decision|0|||
145290273|NCT01497938|523912023|FG001|Overall Study|Physician Decision|1|||
145290274|NCT01497938|523912022|FG000|Overall Study|Withdrawal by Subject|4|||
145290275|NCT01497938|523912023|FG001|Overall Study|Withdrawal by Subject|0|||
145290276|NCT01497938|523912022|FG000|Overall Study|Device Violation|1|||
145290277|NCT01497938|523912023|FG001|Overall Study|Device Violation|0|||
145290278|NCT00365352|523912024|FG000|Overall Study|Adverse Event|6|||
145290279|NCT00365352|523912025|FG001|Overall Study|Adverse Event|7|||
145290280|NCT00365352|523912026|FG002|Overall Study|Adverse Event|8|||
145290281|NCT00365352|523912024|FG000|Overall Study|Participant Withdrew Consent|8|||
145290282|NCT00365352|523912025|FG001|Overall Study|Participant Withdrew Consent|3|||
145290283|NCT00365352|523912026|FG002|Overall Study|Participant Withdrew Consent|4|||
145290284|NCT00365352|523912024|FG000|Overall Study|Lack of Efficacy|3|||
145290285|NCT00365352|523912025|FG001|Overall Study|Lack of Efficacy|0|||
145290286|NCT00365352|523912026|FG002|Overall Study|Lack of Efficacy|0|||
145290287|NCT00365352|523912024|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
145290288|NCT00365352|523912025|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
145290289|NCT00365352|523912026|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
145290290|NCT00365352|523912024|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
145290291|NCT00365352|523912025|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
145290292|NCT00365352|523912026|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
145290293|NCT00365352|523912024|FG000|Overall Study|Lost to Follow-up|1|||
145290294|NCT00365352|523912025|FG001|Overall Study|Lost to Follow-up|1|||
145290295|NCT00365352|523912026|FG002|Overall Study|Lost to Follow-up|0|||
145290296|NCT00365352|523912024|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
145290297|NCT00365352|523912025|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
145290298|NCT00365352|523912026|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
145290299|NCT00462982|523912031|FG000|Overall Study|Adverse Event|1|||
145406590|NCT04476043|524343777|FG000|Overall Study|Protocol Violation|0|||
145406591|NCT04476043|524343778|FG001|Overall Study|Protocol Violation|1|||
145406592|NCT04476043|524343779|FG002|Overall Study|Protocol Violation|0|||
145406593|NCT04476043|524343780|FG003|Overall Study|Protocol Violation|0|||
145556211|NCT00818662|524894985|FG001|Overall Study|Declined move to another study site|0|||
145290300|NCT00462982|523912031|FG000|Overall Study|Patient Not Treated|2|||
145290301|NCT04736199|523913702|FG000|Overall Study|Adverse Event|28|||
145290302|NCT04736199|523913703|FG001|Overall Study|Adverse Event|22|||
145290303|NCT04736199|523913702|FG000|Overall Study|Death|9|||
145290304|NCT04736199|523913703|FG001|Overall Study|Death|3|||
145290305|NCT04736199|523913702|FG000|Overall Study|Lost to Follow-up|4|||
145290306|NCT04736199|523913703|FG001|Overall Study|Lost to Follow-up|1|||
145406594|NCT06217380|524343781|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
145290307|NCT04736199|523913702|FG000|Overall Study|Physician Decision|5|||
145290308|NCT04736199|523913703|FG001|Overall Study|Physician Decision|9|||
145290309|NCT04736199|523913702|FG000|Overall Study|Withdrawal by Subject|21|||
145290310|NCT04736199|523913703|FG001|Overall Study|Withdrawal by Subject|9|||
145290311|NCT04736199|523913702|FG000|Overall Study|Progressive disease|120|||
145290312|NCT04736199|523913703|FG001|Overall Study|Progressive disease|101|||
145290313|NCT04736199|523913702|FG000|Overall Study|Subject decision|13|||
145290314|NCT04736199|523913703|FG001|Overall Study|Subject decision|13|||
145290315|NCT04736199|523913702|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
145290316|NCT04736199|523913703|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
145290317|NCT04736199|523913702|FG000|Overall Study|Additional primary malignancy|1|||
145290318|NCT04736199|523913703|FG001|Overall Study|Additional primary malignancy|0|||
145290319|NCT04736199|523913702|FG000|Overall Study|Non-compliance with study drug|0|||
145290320|NCT04736199|523913703|FG001|Overall Study|Non-compliance with study drug|1|||
145290321|NCT04736199|523913702|FG000|Overall Study|Other reason|0|||
145290322|NCT04736199|523913703|FG001|Overall Study|Other reason|1|||
145290323|NCT04736199|523913702|FG000|Overall Study|Ongoing with study drug|240|||
145290324|NCT04736199|523913703|FG001|Overall Study|Ongoing with study drug|63|||
145290325|NCT04736199|523913702|FG000|Overall Study|Study drug never administered|3|||
145290326|NCT04736199|523913703|FG001|Overall Study|Study drug never administered|0|||
145290327|NCT05514119|523913707|FG000|Overall Study|Ineligible due to disease progression|1|||
145290328|NCT00278200|523913708|FG000|Overall Study|Death|1|||
145290329|NCT00278200|523913709|FG001|Overall Study|Death|3|||
145290330|NCT00278200|523913708|FG000|Overall Study|Physician Decision|0|||
145290331|NCT00278200|523913709|FG001|Overall Study|Physician Decision|1|||
145290332|NCT05568225|523913710|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
145290333|NCT05568225|523913711|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
145290334|NCT05568225|523913712|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
145290335|NCT05568225|523913710|FG000|Primary Treatment Period|Physician Decision|0|||
145290336|NCT05568225|523913711|FG001|Primary Treatment Period|Physician Decision|1|||
145290337|NCT05568225|523913712|FG002|Primary Treatment Period|Physician Decision|0|||
145290338|NCT05568225|523913710|FG000|Primary Treatment Period|Disease progression|0|||
145290339|NCT05568225|523913711|FG001|Primary Treatment Period|Disease progression|1|||
145290340|NCT05568225|523913712|FG002|Primary Treatment Period|Disease progression|0|||
145290341|NCT05568225|523913710|FG000|Primary Treatment Period|Lack of Efficacy|0|||
145290342|NCT05568225|523913711|FG001|Primary Treatment Period|Lack of Efficacy|1|||
145290343|NCT05568225|523913712|FG002|Primary Treatment Period|Lack of Efficacy|0|||
145290344|NCT05568225|523913710|FG000|Primary Treatment Period|Withdrawal of conset|1|||
145290345|NCT05568225|523913711|FG001|Primary Treatment Period|Withdrawal of conset|0|||
145290346|NCT05568225|523913712|FG002|Primary Treatment Period|Withdrawal of conset|4|||
145290347|NCT05568225|523913710|FG000|Primary Treatment Period|Adverse Event|1|||
145290348|NCT05568225|523913711|FG001|Primary Treatment Period|Adverse Event|0|||
145290349|NCT05568225|523913712|FG002|Primary Treatment Period|Adverse Event|0|||
145615881|NCT03044353|525109312|FG002|Overall Study|Adverse Event|0|||
145615882|NCT02141659|525109313|FG000|Overall Study|Major Protocol Deviation|0|||
145615883|NCT02141659|525109314|FG001|Overall Study|Major Protocol Deviation|1|||
145615884|NCT02141659|525109315|FG002|Overall Study|Major Protocol Deviation|0|||
145615885|NCT02141659|525109316|FG003|Overall Study|Major Protocol Deviation|0|||
145615886|NCT02141659|525109317|FG004|Overall Study|Major Protocol Deviation|0|||
145615887|NCT02141659|525109318|FG005|Overall Study|Major Protocol Deviation|0|||
145406595|NCT06217380|524343781|FG000|Overall Study|Physician Decision|1|||
145615888|NCT02141659|525109313|FG000|Overall Study|Lack of Efficacy|0|||
145290350|NCT05568225|523913710|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
145290351|NCT05568225|523913711|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
145290352|NCT05568225|523913712|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
145290353|NCT05568225|523913710|FG000|Extension Treatment Period|Protocol Violation|0|||
145290354|NCT05568225|523913711|FG001|Extension Treatment Period|Protocol Violation|0|||
145290355|NCT05568225|523913712|FG002|Extension Treatment Period|Protocol Violation|1|||
145290356|NCT05568225|523913710|FG000|Extension Treatment Period|Lack of Efficacy|0|||
145290357|NCT05568225|523913711|FG001|Extension Treatment Period|Lack of Efficacy|0|||
145290358|NCT05568225|523913712|FG002|Extension Treatment Period|Lack of Efficacy|1|||
145290359|NCT01290263|523913713|FG000|Overall Study|Adverse Event|0|||
145406596|NCT06217380|524343781|FG000|Overall Study|Withdrawal by Subject|2|||
145290360|NCT01290263|523913714|FG001|Overall Study|Adverse Event|0|||
145290361|NCT01290263|523913715|FG002|Overall Study|Adverse Event|0|||
145290362|NCT01290263|523913716|FG003|Overall Study|Adverse Event|1|||
145290363|NCT01290263|523913717|FG004|Overall Study|Adverse Event|1|||
145290364|NCT01290263|523913713|FG000|Overall Study|Lack of Efficacy|8|||
145290365|NCT01290263|523913714|FG001|Overall Study|Lack of Efficacy|2|||
145290366|NCT01290263|523913715|FG002|Overall Study|Lack of Efficacy|7|||
145290367|NCT01290263|523913716|FG003|Overall Study|Lack of Efficacy|24|||
145406597|NCT06633965|524343782|FG000|Overall Study|Withdrawal by Subject|0|||
145406598|NCT06633965|524343783|FG001|Overall Study|Withdrawal by Subject|1|||
145406599|NCT02469233|524343784|FG000|Overall Study|Death|1|||
145406600|NCT02469233|524343785|FG001|Overall Study|Death|1|||
145406601|NCT02469233|524343784|FG000|Overall Study|Lost to post or 6 month follow up|7|||
145290368|NCT01290263|523913717|FG004|Overall Study|Lack of Efficacy|33|||
145290369|NCT01290263|523913713|FG000|Overall Study|Withdrawal by Subject|3|||
145290370|NCT01290263|523913714|FG001|Overall Study|Withdrawal by Subject|1|||
145290371|NCT01290263|523913715|FG002|Overall Study|Withdrawal by Subject|0|||
145290372|NCT01290263|523913716|FG003|Overall Study|Withdrawal by Subject|1|||
145290373|NCT01290263|523913717|FG004|Overall Study|Withdrawal by Subject|2|||
145290374|NCT01290263|523913713|FG000|Overall Study|Participant Non-Compliance|0|||
145290375|NCT01290263|523913714|FG001|Overall Study|Participant Non-Compliance|0|||
145290376|NCT01290263|523913715|FG002|Overall Study|Participant Non-Compliance|0|||
145290377|NCT01290263|523913716|FG003|Overall Study|Participant Non-Compliance|1|||
145290378|NCT01290263|523913717|FG004|Overall Study|Participant Non-Compliance|1|||
145290379|NCT01521559|523913718|FG000|Overall Study|Adverse Event|0|||
145290380|NCT01521559|523913719|FG001|Overall Study|Adverse Event|4|||
145290381|NCT01521559|523913718|FG000|Overall Study|Death|1|||
145290382|NCT01521559|523913719|FG001|Overall Study|Death|0|||
145290383|NCT01521559|523913718|FG000|Overall Study|Withdrawal by Subject|9|||
145290384|NCT01521559|523913719|FG001|Overall Study|Withdrawal by Subject|11|||
145406602|NCT02469233|524343785|FG001|Overall Study|Lost to post or 6 month follow up|2|||
145406603|NCT02566005|524343788|FG000|Overall Study|vaginal bleeding|0|||
145290385|NCT01521559|523913718|FG000|Overall Study|Lost to Follow-up|3|||
145290386|NCT01521559|523913719|FG001|Overall Study|Lost to Follow-up|1|||
145290387|NCT01521559|523913718|FG000|Overall Study|Protocol Violation|1|||
145290388|NCT01521559|523913719|FG001|Overall Study|Protocol Violation|0|||
145290389|NCT01521559|523913718|FG000|Overall Study|Other|1|||
145290390|NCT01521559|523913719|FG001|Overall Study|Other|2|||
145406604|NCT02566005|524343789|FG001|Overall Study|vaginal bleeding|1|||
145406605|NCT02566005|524343788|FG000|Overall Study|received foley|8|||
145406606|NCT02566005|524343789|FG001|Overall Study|received foley|0|||
145556212|NCT00818662|524894986|FG002|Overall Study|Declined move to another study site|0|||
145556213|NCT00818662|524894987|FG003|Overall Study|Declined move to another study site|0|||
145556214|NCT00818662|524894984|FG000|Overall Study|Change in living situation|0|||
145556215|NCT00818662|524894985|FG001|Overall Study|Change in living situation|0|||
145556216|NCT00818662|524894986|FG002|Overall Study|Change in living situation|0|||
145556217|NCT00818662|524894987|FG003|Overall Study|Change in living situation|1|||
145556218|NCT00818662|524894984|FG000|Overall Study|Study partner decision|0|||
145556219|NCT00818662|524894985|FG001|Overall Study|Study partner decision|0|||
145556220|NCT00818662|524894986|FG002|Overall Study|Study partner decision|0|||
145556221|NCT00818662|524894987|FG003|Overall Study|Study partner decision|1|||
145556222|NCT00818662|524894984|FG000|Overall Study|Admitted to long term nursing care|0|||
145556223|NCT00818662|524894985|FG001|Overall Study|Admitted to long term nursing care|1|||
145556224|NCT00818662|524894986|FG002|Overall Study|Admitted to long term nursing care|0|||
145556225|NCT00818662|524894987|FG003|Overall Study|Admitted to long term nursing care|0|||
145556226|NCT01472081|524894988|FG000|Overall Study|Continuing treatment at time of analysis|1|||
145556227|NCT01472081|524894989|FG001|Overall Study|Continuing treatment at time of analysis|4|||
145556228|NCT01472081|524894990|FG002|Overall Study|Continuing treatment at time of analysis|1|||
145556229|NCT01472081|524894991|FG003|Overall Study|Continuing treatment at time of analysis|8|||
145556230|NCT01472081|524894992|FG004|Overall Study|Continuing treatment at time of analysis|9|||
145556231|NCT01472081|524894993|FG005|Overall Study|Continuing treatment at time of analysis|0|||
145556232|NCT01472081|524894988|FG000|Overall Study|Disease Progression|4|||
145556233|NCT01472081|524894989|FG001|Overall Study|Disease Progression|10|||
145556234|NCT01472081|524894990|FG002|Overall Study|Disease Progression|12|||
145615889|NCT02141659|525109314|FG001|Overall Study|Lack of Efficacy|0|||
145615890|NCT02141659|525109315|FG002|Overall Study|Lack of Efficacy|0|||
145615891|NCT02141659|525109316|FG003|Overall Study|Lack of Efficacy|0|||
145615892|NCT02141659|525109317|FG004|Overall Study|Lack of Efficacy|0|||
145615893|NCT02141659|525109318|FG005|Overall Study|Lack of Efficacy|1|||
145615894|NCT02141659|525109313|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
145615895|NCT02141659|525109314|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
145615896|NCT02141659|525109315|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
145615897|NCT02141659|525109316|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
145615898|NCT02141659|525109317|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
145615899|NCT02141659|525109318|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
145615900|NCT02836613|525109325|FG000|Overall Study|Accidental drowning|1|||
145615901|NCT02836613|525109326|FG001|Overall Study|Accidental drowning|0|||
145615902|NCT02836613|525109325|FG000|Overall Study|Lost to Follow-up|0|||
145615903|NCT02836613|525109326|FG001|Overall Study|Lost to Follow-up|1|||
145615904|NCT02836613|525109325|FG000|Overall Study|Withdrawal by Subject|0|||
145615905|NCT02836613|525109326|FG001|Overall Study|Withdrawal by Subject|2|||
145615906|NCT03881059|525109327|FG000|Treatment Period - Part A|Adverse Event|1|||
145615907|NCT03881059|525109328|FG001|Treatment Period - Part A|Adverse Event|3|||
145615908|NCT03881059|525109329|FG002|Treatment Period - Part A|Adverse Event|4|||
145615909|NCT03881059|525109327|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
145615910|NCT03881059|525109328|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
145615911|NCT03881059|525109329|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
145615912|NCT03881059|525109327|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
145615913|NCT03881059|525109328|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
145615914|NCT03881059|525109329|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
145615915|NCT03881059|525109327|FG000|Treatment Period - Part A|Other reasons|2|||
145615916|NCT03881059|525109328|FG001|Treatment Period - Part A|Other reasons|1|||
145615917|NCT03881059|525109329|FG002|Treatment Period - Part A|Other reasons|0|||
145615918|NCT03881059|525109327|FG000|Treatment Period - Part B|Adverse Event|0|||
145615919|NCT03881059|525109328|FG001|Treatment Period - Part B|Adverse Event|0|||
145615920|NCT03881059|525109329|FG002|Treatment Period - Part B|Adverse Event|3|||
145615921|NCT03881059|525109327|FG000|Treatment Period - Part B|Death|0|||
145290391|NCT02228382|523913720|FG000|Overall Study|Death|5|||
145290392|NCT02228382|523913721|FG001|Overall Study|Death|7|||
145290393|NCT02228382|523913722|FG002|Overall Study|Death|5|||
145290394|NCT02228382|523913723|FG003|Overall Study|Death|0|||
145290395|NCT02228382|523913724|FG004|Overall Study|Death|2|||
145290396|NCT02228382|523913720|FG000|Overall Study|Participant refused further follow-up|0|||
145290397|NCT02228382|523913721|FG001|Overall Study|Participant refused further follow-up|0|||
145290398|NCT02228382|523913722|FG002|Overall Study|Participant refused further follow-up|1|||
145290399|NCT02228382|523913723|FG003|Overall Study|Participant refused further follow-up|0|||
145290400|NCT02228382|523913724|FG004|Overall Study|Participant refused further follow-up|0|||
145556235|NCT01472081|524894991|FG003|Overall Study|Disease Progression|31|||
145556236|NCT01472081|524894992|FG004|Overall Study|Disease Progression|22|||
145556237|NCT01472081|524894993|FG005|Overall Study|Disease Progression|3|||
145556238|NCT01472081|524894988|FG000|Overall Study|Study drug toxicity|2|||
145556239|NCT01472081|524894989|FG001|Overall Study|Study drug toxicity|9|||
145556240|NCT01472081|524894990|FG002|Overall Study|Study drug toxicity|4|||
145556241|NCT01472081|524894991|FG003|Overall Study|Study drug toxicity|6|||
145556242|NCT01472081|524894992|FG004|Overall Study|Study drug toxicity|13|||
145556243|NCT01472081|524894993|FG005|Overall Study|Study drug toxicity|2|||
145556244|NCT01472081|524894988|FG000|Overall Study|Death|0|||
145556245|NCT01472081|524894989|FG001|Overall Study|Death|0|||
145556246|NCT01472081|524894990|FG002|Overall Study|Death|0|||
145556247|NCT01472081|524894991|FG003|Overall Study|Death|0|||
145556248|NCT01472081|524894992|FG004|Overall Study|Death|1|||
145556249|NCT01472081|524894993|FG005|Overall Study|Death|0|||
145556250|NCT01472081|524894988|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
145556251|NCT01472081|524894989|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
145556252|NCT01472081|524894990|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
145556253|NCT01472081|524894991|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
145615922|NCT03881059|525109328|FG001|Treatment Period - Part B|Death|1|||
145615923|NCT03881059|525109329|FG002|Treatment Period - Part B|Death|1|||
145615924|NCT03881059|525109327|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
145290401|NCT02228382|523913720|FG000|Overall Study|Study terminated by sponsor|3|||
145290402|NCT02228382|523913721|FG001|Overall Study|Study terminated by sponsor|5|||
145290403|NCT02228382|523913722|FG002|Overall Study|Study terminated by sponsor|7|||
145290404|NCT02228382|523913723|FG003|Overall Study|Study terminated by sponsor|0|||
145556254|NCT01472081|524894992|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
145615925|NCT03881059|525109328|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
145615926|NCT03881059|525109329|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
145615927|NCT03881059|525109327|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
145556255|NCT01472081|524894993|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
145556256|NCT01472081|524894988|FG000|Overall Study|Withdrawal by Subject|0|||
145290405|NCT02228382|523913724|FG004|Overall Study|Study terminated by sponsor|0|||
145290406|NCT02228382|523913720|FG000|Overall Study|Lost to Follow-up|0|||
145290407|NCT02228382|523913721|FG001|Overall Study|Lost to Follow-up|0|||
145290408|NCT02228382|523913722|FG002|Overall Study|Lost to Follow-up|3|||
145290409|NCT02228382|523913723|FG003|Overall Study|Lost to Follow-up|1|||
145290410|NCT02228382|523913724|FG004|Overall Study|Lost to Follow-up|0|||
145290411|NCT02228382|523913720|FG000|Overall Study|Withdrawal by Subject|0|||
145290412|NCT02228382|523913721|FG001|Overall Study|Withdrawal by Subject|3|||
145290413|NCT02228382|523913722|FG002|Overall Study|Withdrawal by Subject|2|||
145290414|NCT02228382|523913723|FG003|Overall Study|Withdrawal by Subject|1|||
145290415|NCT02228382|523913724|FG004|Overall Study|Withdrawal by Subject|0|||
145290416|NCT02228382|523913720|FG000|Overall Study|Other|2|||
145290417|NCT02228382|523913721|FG001|Overall Study|Other|3|||
145290418|NCT02228382|523913722|FG002|Overall Study|Other|3|||
145290419|NCT02228382|523913723|FG003|Overall Study|Other|0|||
145290420|NCT02228382|523913724|FG004|Overall Study|Other|0|||
145290421|NCT02918162|523913726|FG000|Overall Study|Withdrawal by Subject|1|||
145290422|NCT02918162|523913726|FG000|Overall Study|Omental Disease|1|||
145290423|NCT00395226|523913727|FG000|Overall Study|Adverse Event|4|||
145290424|NCT00395226|523913728|FG001|Overall Study|Adverse Event|3|||
145290425|NCT00395226|523913727|FG000|Overall Study|Withdrawal by Subject|0|||
145290426|NCT00395226|523913728|FG001|Overall Study|Withdrawal by Subject|1|||
145290427|NCT00395226|523913727|FG000|Overall Study|Lost to Follow-up|0|||
145290428|NCT00395226|523913728|FG001|Overall Study|Lost to Follow-up|1|||
145290429|NCT00576381|523913732|FG000|Overall Study|Reoperation|3|||
145556257|NCT01472081|524894989|FG001|Overall Study|Withdrawal by Subject|0|||
145556258|NCT01472081|524894990|FG002|Overall Study|Withdrawal by Subject|0|||
145556259|NCT01472081|524894991|FG003|Overall Study|Withdrawal by Subject|0|||
145556260|NCT01472081|524894992|FG004|Overall Study|Withdrawal by Subject|0|||
145290430|NCT00576381|523913732|FG000|Overall Study|Adverse Event|4|||
145290431|NCT02324465|523913736|FG000|Overall Study|device failure|0|||
145556261|NCT01472081|524894993|FG005|Overall Study|Withdrawal by Subject|1|||
145556262|NCT01472081|524894988|FG000|Overall Study|Poor/non-compliance|0|||
145556263|NCT01472081|524894989|FG001|Overall Study|Poor/non-compliance|0|||
145556264|NCT01472081|524894990|FG002|Overall Study|Poor/non-compliance|1|||
145556265|NCT01472081|524894991|FG003|Overall Study|Poor/non-compliance|0|||
145556266|NCT01472081|524894992|FG004|Overall Study|Poor/non-compliance|1|||
145556267|NCT01472081|524894993|FG005|Overall Study|Poor/non-compliance|0|||
145556268|NCT01472081|524894988|FG000|Overall Study|No longer meets study criteria|0|||
145556269|NCT01472081|524894989|FG001|Overall Study|No longer meets study criteria|0|||
145556270|NCT01472081|524894990|FG002|Overall Study|No longer meets study criteria|1|||
145556271|NCT01472081|524894991|FG003|Overall Study|No longer meets study criteria|0|||
145556272|NCT01472081|524894992|FG004|Overall Study|No longer meets study criteria|0|||
145556273|NCT01472081|524894993|FG005|Overall Study|No longer meets study criteria|0|||
145556274|NCT01472081|524894988|FG000|Overall Study|Subject request to discontinue treatment|0|||
145556275|NCT01472081|524894989|FG001|Overall Study|Subject request to discontinue treatment|3|||
145556276|NCT01472081|524894990|FG002|Overall Study|Subject request to discontinue treatment|1|||
145556277|NCT01472081|524894991|FG003|Overall Study|Subject request to discontinue treatment|1|||
145556278|NCT01472081|524894992|FG004|Overall Study|Subject request to discontinue treatment|0|||
145556279|NCT01472081|524894993|FG005|Overall Study|Subject request to discontinue treatment|0|||
145556280|NCT01705652|524894995|FG000|Overall Study|Adverse Event|1|||
145556281|NCT01705652|524894996|FG001|Overall Study|Adverse Event|0|||
145556282|NCT01705652|524894995|FG000|Overall Study|Withdrawal by Subject|1|||
145556283|NCT01705652|524894996|FG001|Overall Study|Withdrawal by Subject|2|||
145556284|NCT01705652|524894995|FG000|Overall Study|non-compliance|1|||
145556285|NCT01705652|524894996|FG001|Overall Study|non-compliance|1|||
145556286|NCT00541034|524894997|FG000|Overall Study|Non-Compliance|3|||
145556287|NCT02998840|524894999|FG000|Overall Study|Lost to Follow-up|1|||
145556288|NCT02998840|524895000|FG001|Overall Study|Lost to Follow-up|1|||
145556289|NCT02998840|524895001|FG002|Overall Study|Lost to Follow-up|2|||
145556290|NCT02998840|524895002|FG003|Overall Study|Lost to Follow-up|3|||
145556291|NCT02998840|524894999|FG000|Overall Study|Withdrawal by Subject|1|||
145556292|NCT02998840|524895000|FG001|Overall Study|Withdrawal by Subject|1|||
145290432|NCT02324465|523913737|FG001|Overall Study|device failure|1|||
145556293|NCT02998840|524895001|FG002|Overall Study|Withdrawal by Subject|0|||
145556294|NCT02998840|524895002|FG003|Overall Study|Withdrawal by Subject|1|||
145556295|NCT02998840|524894999|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
145556296|NCT02998840|524895000|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
145615928|NCT03881059|525109328|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
145556297|NCT02998840|524895001|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
145556298|NCT02998840|524895002|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
145556299|NCT02625259|524895003|FG000|First Intervention (Day 1)|Other|0|||
145290433|NCT01031537|523913738|FG000|Overall Study|medical reasons not related to study|3|||
145290434|NCT01031537|523913738|FG000|Overall Study|Lack of Efficacy|1|||
145290435|NCT01031537|523913738|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
145290436|NCT01031537|523913738|FG000|Overall Study|moved, met exclusion criteria|10|||
145290437|NCT01031537|523913738|FG000|Overall Study|Withdrawal by Subject|5|||
145290438|NCT01031537|523913738|FG000|Overall Study|PI removal, no longer met eligibility|12|||
145290439|NCT00266409|523913746|FG000|Overall Study|Lack of Efficacy|2|||
145290440|NCT00266409|523913747|FG001|Overall Study|Lack of Efficacy|6|||
145290441|NCT00266409|523913748|FG002|Overall Study|Lack of Efficacy|1|||
145290442|NCT00266409|523913749|FG003|Overall Study|Lack of Efficacy|2|||
145290443|NCT00266409|523913746|FG000|Overall Study|Adverse Event|7|||
145290444|NCT00266409|523913747|FG001|Overall Study|Adverse Event|2|||
145290445|NCT00266409|523913748|FG002|Overall Study|Adverse Event|1|||
145290446|NCT00266409|523913749|FG003|Overall Study|Adverse Event|1|||
145290447|NCT00266409|523913746|FG000|Overall Study|Lost to Follow-up|18|||
145290448|NCT00266409|523913747|FG001|Overall Study|Lost to Follow-up|21|||
145290449|NCT00266409|523913748|FG002|Overall Study|Lost to Follow-up|6|||
145290450|NCT00266409|523913749|FG003|Overall Study|Lost to Follow-up|8|||
145290451|NCT00266409|523913746|FG000|Overall Study|Withdrawal by Subject|6|||
145290452|NCT00266409|523913747|FG001|Overall Study|Withdrawal by Subject|10|||
145290453|NCT00266409|523913748|FG002|Overall Study|Withdrawal by Subject|3|||
145290454|NCT00266409|523913749|FG003|Overall Study|Withdrawal by Subject|9|||
145290455|NCT00266409|523913746|FG000|Overall Study|Protocol Violation|5|||
145290456|NCT00266409|523913747|FG001|Overall Study|Protocol Violation|3|||
145290457|NCT00266409|523913748|FG002|Overall Study|Protocol Violation|4|||
145290458|NCT00266409|523913749|FG003|Overall Study|Protocol Violation|2|||
145290459|NCT00266409|523913746|FG000|Overall Study|Other|7|||
145556300|NCT02625259|524895004|FG001|First Intervention (Day 1)|Other|0|||
145556301|NCT02625259|524895005|FG002|First Intervention (Day 1)|Other|1|||
145556302|NCT02625259|524895006|FG003|First Intervention (Day 1)|Other|0|||
145556303|NCT02625259|524895007|FG004|First Intervention (Day 1)|Other|0|||
145556304|NCT02625259|524895003|FG000|First Intervention (Day 1)|Adverse Event|2|||
145556305|NCT02625259|524895004|FG001|First Intervention (Day 1)|Adverse Event|1|||
145556306|NCT02625259|524895005|FG002|First Intervention (Day 1)|Adverse Event|0|||
145556307|NCT02625259|524895006|FG003|First Intervention (Day 1)|Adverse Event|0|||
145556308|NCT02625259|524895007|FG004|First Intervention (Day 1)|Adverse Event|0|||
145290460|NCT00266409|523913747|FG001|Overall Study|Other|4|||
145290461|NCT00266409|523913748|FG002|Overall Study|Other|2|||
145290462|NCT00266409|523913749|FG003|Overall Study|Other|0|||
145290463|NCT00712010|523913752|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
145290464|NCT02187042|523913753|FG000|Overall Study|Death|1|||
145290465|NCT02187042|523913754|FG001|Overall Study|Death|1|||
145290466|NCT02187042|523913753|FG000|Overall Study|Toxicity|6|||
145290467|NCT02187042|523913754|FG001|Overall Study|Toxicity|5|||
145290468|NCT02187042|523913753|FG000|Overall Study|Participant choice|1|||
145290469|NCT02187042|523913754|FG001|Overall Study|Participant choice|0|||
145290470|NCT02187042|523913753|FG000|Overall Study|Doctor choice|1|||
145290471|NCT02187042|523913754|FG001|Overall Study|Doctor choice|0|||
145290472|NCT02187042|523913753|FG000|Overall Study|Progressive disease|4|||
145290473|NCT02187042|523913754|FG001|Overall Study|Progressive disease|8|||
145290474|NCT00337571|523913755|FG000|Overall Study|Lack of Efficacy|3|||
145290475|NCT00337571|523913756|FG001|Overall Study|Lack of Efficacy|0|||
145290476|NCT00337571|523913757|FG002|Overall Study|Lack of Efficacy|0|||
145290477|NCT00337571|523913758|FG003|Overall Study|Lack of Efficacy|0|||
145290478|NCT00337571|523913755|FG000|Overall Study|Adverse Event|4|||
145290479|NCT00337571|523913756|FG001|Overall Study|Adverse Event|5|||
145290480|NCT00337571|523913757|FG002|Overall Study|Adverse Event|8|||
145290481|NCT00337571|523913758|FG003|Overall Study|Adverse Event|4|||
145290482|NCT00337571|523913755|FG000|Overall Study|Withdrawal by Subject|2|||
145290483|NCT00337571|523913756|FG001|Overall Study|Withdrawal by Subject|2|||
145290484|NCT00337571|523913757|FG002|Overall Study|Withdrawal by Subject|1|||
145290485|NCT00337571|523913758|FG003|Overall Study|Withdrawal by Subject|0|||
145290486|NCT00337571|523913755|FG000|Overall Study|Lost to Follow-up|3|||
145290487|NCT00337571|523913756|FG001|Overall Study|Lost to Follow-up|1|||
145290488|NCT00337571|523913757|FG002|Overall Study|Lost to Follow-up|0|||
145290489|NCT00337571|523913758|FG003|Overall Study|Lost to Follow-up|1|||
145290490|NCT00337571|523913755|FG000|Overall Study|Poor/noncompliance|1|||
145290491|NCT00337571|523913756|FG001|Overall Study|Poor/noncompliance|1|||
145290492|NCT00337571|523913757|FG002|Overall Study|Poor/noncompliance|1|||
145290493|NCT00337571|523913758|FG003|Overall Study|Poor/noncompliance|1|||
145290494|NCT00337571|523913755|FG000|Overall Study|No longer met study criteria|1|||
145290495|NCT00337571|523913756|FG001|Overall Study|No longer met study criteria|0|||
145290496|NCT00337571|523913757|FG002|Overall Study|No longer met study criteria|0|||
145290497|NCT00337571|523913758|FG003|Overall Study|No longer met study criteria|0|||
145290498|NCT00337571|523913755|FG000|Overall Study|High Potassium level|0|||
145290499|NCT00337571|523913756|FG001|Overall Study|High Potassium level|0|||
145290500|NCT00337571|523913757|FG002|Overall Study|High Potassium level|0|||
145290501|NCT00337571|523913758|FG003|Overall Study|High Potassium level|1|||
145290502|NCT02978326|523913759|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
145290503|NCT02978326|523913760|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
145290504|NCT02978326|523913761|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
145290505|NCT02978326|523913759|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
145290506|NCT02978326|523913760|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
145290507|NCT02978326|523913761|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
145290508|NCT02978326|523913759|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
145290509|NCT02978326|523913760|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
145290510|NCT02978326|523913761|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
145290511|NCT02978326|523913759|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
145290512|NCT02978326|523913760|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
145290513|NCT02978326|523913761|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
145290514|NCT00865709|523913766|FG000|Treatment|Adverse Event|9|||
145290515|NCT00865709|523913767|FG001|Treatment|Adverse Event|6|||
145290516|NCT00865709|523913766|FG000|Treatment|Withdrawal by Subject|10|||
145406607|NCT02566005|524343788|FG000|Overall Study|did not receive foley|0|||
145290517|NCT00865709|523913767|FG001|Treatment|Withdrawal by Subject|7|||
145290518|NCT00865709|523913766|FG000|Treatment|Physician Decision|3|||
145406608|NCT02566005|524343789|FG001|Overall Study|did not receive foley|1|||
145556309|NCT02625259|524895003|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
145556310|NCT02625259|524895004|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
145290519|NCT00865709|523913767|FG001|Treatment|Physician Decision|2|||
145290520|NCT00865709|523913766|FG000|Treatment|Surgery|8|||
145290521|NCT00865709|523913767|FG001|Treatment|Surgery|3|||
145290522|NCT01265784|523913768|FG000|Overall Study|Lost to Follow-up|5|||
145290523|NCT01265784|523913769|FG001|Overall Study|Lost to Follow-up|3|||
145290524|NCT01265784|523913770|FG002|Overall Study|Lost to Follow-up|2|||
145290525|NCT01265784|523913768|FG000|Overall Study|Withdrawal by Subject|0|||
145406609|NCT02566005|524343788|FG000|Overall Study|labor after randomization|0|||
145406610|NCT02566005|524343789|FG001|Overall Study|labor after randomization|4|||
145406611|NCT00141921|524343793|FG000|Overall Study|Remain on Study|28|||
145406612|NCT00141921|524343793|FG000|Overall Study|Withdrawal by Subject|42|||
145556311|NCT02625259|524895005|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145406613|NCT00141921|524343793|FG000|Overall Study|Lost to Follow-up|19|||
145406614|NCT00141921|524343793|FG000|Overall Study|Noncompliance|17|||
145406615|NCT00141921|524343793|FG000|Overall Study|Disease Progression|7|||
145406616|NCT00141921|524343793|FG000|Overall Study|Protocol Deviation|7|||
145406617|NCT00141921|524343793|FG000|Overall Study|Adverse Event|5|||
145406618|NCT00141921|524343793|FG000|Overall Study|Administrative Decision|2|||
145406619|NCT00141921|524343793|FG000|Overall Study|Pregnancy|4|||
145406620|NCT00141921|524343793|FG000|Overall Study|Ineligibility Determined|2|||
145406621|NCT00141921|524343793|FG000|Overall Study|Other|8|||
145406622|NCT01208051|524343809|FG000|Total Enrollment|Withdrawal by Subject|0|||
145406623|NCT01208051|524343810|FG001|Total Enrollment|Withdrawal by Subject|1|||
145406624|NCT01208051|524343811|FG002|Total Enrollment|Withdrawal by Subject|0|||
145406625|NCT01208051|524343812|FG003|Total Enrollment|Withdrawal by Subject|0|||
145406626|NCT01208051|524343813|FG004|Total Enrollment|Withdrawal by Subject|2|||
145290526|NCT01265784|523913769|FG001|Overall Study|Withdrawal by Subject|5|||
145290527|NCT01265784|523913770|FG002|Overall Study|Withdrawal by Subject|0|||
145290528|NCT01265784|523913768|FG000|Overall Study|Physician Decision|1|||
145290529|NCT01265784|523913769|FG001|Overall Study|Physician Decision|0|||
145290530|NCT01265784|523913770|FG002|Overall Study|Physician Decision|1|||
145290531|NCT01265784|523913768|FG000|Overall Study|Adverse Event|1|||
145290532|NCT01265784|523913769|FG001|Overall Study|Adverse Event|0|||
145290533|NCT01265784|523913770|FG002|Overall Study|Adverse Event|0|||
145406627|NCT01208051|524343809|FG000|Total Enrollment|Brain metastases|0|||
145406628|NCT01208051|524343810|FG001|Total Enrollment|Brain metastases|0|||
145406629|NCT01208051|524343811|FG002|Total Enrollment|Brain metastases|1|||
145406630|NCT01208051|524343812|FG003|Total Enrollment|Brain metastases|0|||
145406631|NCT01208051|524343813|FG004|Total Enrollment|Brain metastases|0|||
145556312|NCT02625259|524895006|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
145556313|NCT02625259|524895007|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
145556314|NCT03564145|524895011|FG000|Overall Study|Adverse Event|4|||
145556315|NCT03564145|524895011|FG000|Overall Study|Lost to Follow-up|21|||
145556316|NCT03564145|524895011|FG000|Overall Study|Protocol Violation|2|||
145556317|NCT03564145|524895011|FG000|Overall Study|Withdrawal by Subject|48|||
145556318|NCT03564145|524895011|FG000|Overall Study|Study Terminated by Sponsor|146|||
145556319|NCT03564145|524895011|FG000|Overall Study|Physician Decision|1|||
145556320|NCT03564145|524895011|FG000|Overall Study|Other Than Specified|1|||
145556321|NCT03564145|524895011|FG000|Overall Study|Pregnancy|1|||
145556322|NCT04702997|524895012|FG000|Overall Study|Withdrawal by Subject|1|||
145556323|NCT04702997|524895013|FG001|Overall Study|Withdrawal by Subject|1|||
145556324|NCT01386554|524895019|FG000|Overall Study|Lost to Follow-up|0|||
145556325|NCT01386554|524895020|FG001|Overall Study|Lost to Follow-up|0|||
145556326|NCT01386554|524895021|FG002|Overall Study|Lost to Follow-up|1|||
145556327|NCT01386554|524895019|FG000|Overall Study|Adverse Event|2|||
145556328|NCT01386554|524895020|FG001|Overall Study|Adverse Event|5|||
145556329|NCT01386554|524895021|FG002|Overall Study|Adverse Event|2|||
145556330|NCT01386554|524895019|FG000|Overall Study|Progressive disease|1|||
145556331|NCT01386554|524895020|FG001|Overall Study|Progressive disease|2|||
145556332|NCT01386554|524895021|FG002|Overall Study|Progressive disease|2|||
145556333|NCT01386554|524895019|FG000|Overall Study|Administration of live vaccines|0|||
145556334|NCT01386554|524895020|FG001|Overall Study|Administration of live vaccines|1|||
145556335|NCT01386554|524895021|FG002|Overall Study|Administration of live vaccines|0|||
145556336|NCT01386554|524895019|FG000|Overall Study|Investigator discretion|0|||
145556337|NCT01386554|524895020|FG001|Overall Study|Investigator discretion|0|||
145556338|NCT01386554|524895021|FG002|Overall Study|Investigator discretion|1|||
145556339|NCT01386554|524895019|FG000|Overall Study|Reason not collected|0|||
145556340|NCT01386554|524895020|FG001|Overall Study|Reason not collected|1|||
145290534|NCT01265784|523913768|FG000|Overall Study|Death|3|||
145406632|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
145406633|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
145406634|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
145556341|NCT01386554|524895021|FG002|Overall Study|Reason not collected|0|||
145290535|NCT01265784|523913769|FG001|Overall Study|Death|0|||
145406635|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
145406636|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
145406637|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
145406638|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
145406639|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
145406640|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
145406641|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
145406642|NCT00973973|524343815|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
145406643|NCT00973973|524343816|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
145406644|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
145406645|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
145406646|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
145556342|NCT02759471|524895022|FG000|Overall Study|discomfort|2|||
145556343|NCT02554812|524895023|FG000|Overall Study|Adverse Event|2|||
145556344|NCT02554812|524895024|FG001|Overall Study|Adverse Event|5|||
145556345|NCT02554812|524895025|FG002|Overall Study|Adverse Event|3|||
145406647|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
145406648|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
145406649|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
145406650|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
145406651|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
145406652|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
145406653|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
145406654|NCT00973973|524343815|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
145556346|NCT02554812|524895026|FG003|Overall Study|Adverse Event|0|||
145556347|NCT02554812|524895027|FG004|Overall Study|Adverse Event|5|||
145556348|NCT02554812|524895028|FG005|Overall Study|Adverse Event|0|||
145556349|NCT02554812|524895029|FG006|Overall Study|Adverse Event|1|||
145556350|NCT02554812|524895030|FG007|Overall Study|Adverse Event|6|||
145556351|NCT02554812|524895031|FG008|Overall Study|Adverse Event|2|||
145556352|NCT02554812|524895032|FG009|Overall Study|Adverse Event|2|||
145556353|NCT02554812|524895033|FG010|Overall Study|Adverse Event|1|||
145556354|NCT02554812|524895034|FG011|Overall Study|Adverse Event|2|||
145556355|NCT02554812|524895035|FG012|Overall Study|Adverse Event|0|||
145556356|NCT02554812|524895036|FG013|Overall Study|Adverse Event|3|||
145556357|NCT02554812|524895037|FG014|Overall Study|Adverse Event|2|||
145556358|NCT02554812|524895038|FG015|Overall Study|Adverse Event|1|||
145556359|NCT02554812|524895039|FG016|Overall Study|Adverse Event|0|||
145556360|NCT02554812|524895040|FG017|Overall Study|Adverse Event|1|||
145556361|NCT02554812|524895041|FG018|Overall Study|Adverse Event|0|||
145556362|NCT02554812|524895042|FG019|Overall Study|Adverse Event|0|||
145556363|NCT02554812|524895043|FG020|Overall Study|Adverse Event|0|||
145556364|NCT02554812|524895044|FG021|Overall Study|Adverse Event|2|||
145556365|NCT02554812|524895045|FG022|Overall Study|Adverse Event|1|||
145556366|NCT02554812|524895046|FG023|Overall Study|Adverse Event|1|||
145556367|NCT02554812|524895047|FG024|Overall Study|Adverse Event|1|||
145556368|NCT02554812|524895048|FG025|Overall Study|Adverse Event|2|||
145556369|NCT02554812|524895049|FG026|Overall Study|Adverse Event|1|||
145556370|NCT02554812|524895023|FG000|Overall Study|Death|1|||
145556371|NCT02554812|524895024|FG001|Overall Study|Death|2|||
145556372|NCT02554812|524895025|FG002|Overall Study|Death|2|||
145556373|NCT02554812|524895026|FG003|Overall Study|Death|2|||
145556374|NCT02554812|524895027|FG004|Overall Study|Death|0|||
145556375|NCT02554812|524895028|FG005|Overall Study|Death|1|||
145556376|NCT02554812|524895029|FG006|Overall Study|Death|1|||
145556377|NCT02554812|524895030|FG007|Overall Study|Death|1|||
145556378|NCT02554812|524895031|FG008|Overall Study|Death|0|||
145556379|NCT02554812|524895032|FG009|Overall Study|Death|0|||
145556380|NCT02554812|524895033|FG010|Overall Study|Death|0|||
145556381|NCT02554812|524895034|FG011|Overall Study|Death|0|||
145556382|NCT02554812|524895035|FG012|Overall Study|Death|0|||
145556383|NCT02554812|524895036|FG013|Overall Study|Death|0|||
145556384|NCT02554812|524895037|FG014|Overall Study|Death|1|||
145406655|NCT00973973|524343816|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
145290536|NCT01265784|523913770|FG002|Overall Study|Death|0|||
145290537|NCT01265784|523913768|FG000|Overall Study|Protocol Violation|2|||
145290538|NCT01265784|523913769|FG001|Overall Study|Protocol Violation|0|||
145290539|NCT01265784|523913770|FG002|Overall Study|Protocol Violation|0|||
145290540|NCT01265784|523913768|FG000|Overall Study|Incorrectly Randomized|0|||
145290541|NCT01265784|523913769|FG001|Overall Study|Incorrectly Randomized|0|||
145290542|NCT01265784|523913770|FG002|Overall Study|Incorrectly Randomized|1|||
145290543|NCT03072459|523913776|FG000|Overall Study|Device revised/removed|1|||
145290544|NCT03072459|523913776|FG000|Overall Study|Subject not able to return|1|||
145290545|NCT00510510|523913777|FG000|Overall Study|Adverse Event|4|||
145290546|NCT00510510|523913778|FG001|Overall Study|Adverse Event|3|||
145290547|NCT00510510|523913779|FG002|Overall Study|Adverse Event|6|||
145290548|NCT00510510|523913777|FG000|Overall Study|Lack of Efficacy|0|||
145290549|NCT00510510|523913778|FG001|Overall Study|Lack of Efficacy|1|||
145290550|NCT00510510|523913779|FG002|Overall Study|Lack of Efficacy|1|||
145290551|NCT00510510|523913777|FG000|Overall Study|Subjects no longer requires study drug|0|||
145290552|NCT00510510|523913778|FG001|Overall Study|Subjects no longer requires study drug|0|||
145406656|NCT02471339|524343817|FG000|Overall Study|Did not provide follow-up data|2|||
145406657|NCT02471339|524343818|FG001|Overall Study|Did not provide follow-up data|0|||
145290553|NCT00510510|523913779|FG002|Overall Study|Subjects no longer requires study drug|2|||
145290554|NCT00510510|523913777|FG000|Overall Study|Withdrawal by Subject|1|||
145290555|NCT00510510|523913778|FG001|Overall Study|Withdrawal by Subject|2|||
145290556|NCT00510510|523913779|FG002|Overall Study|Withdrawal by Subject|3|||
145290557|NCT00510510|523913777|FG000|Overall Study|Lost to Follow-up|0|||
145290558|NCT00510510|523913778|FG001|Overall Study|Lost to Follow-up|0|||
145290559|NCT00510510|523913779|FG002|Overall Study|Lost to Follow-up|1|||
145290560|NCT00510510|523913777|FG000|Overall Study|Protocol Violation|0|||
145290561|NCT00510510|523913778|FG001|Overall Study|Protocol Violation|3|||
145290562|NCT00510510|523913779|FG002|Overall Study|Protocol Violation|4|||
145556385|NCT02554812|524895038|FG015|Overall Study|Death|1|||
145556386|NCT02554812|524895039|FG016|Overall Study|Death|1|||
145290563|NCT01066052|523913780|FG000|Overall Study|Enrolled But Not Treated|3|||
145290564|NCT01066052|523913781|FG001|Overall Study|Enrolled But Not Treated|0|||
145556387|NCT02554812|524895040|FG017|Overall Study|Death|0|||
145290565|NCT00663871|523913782|FG000|Overall Study|Lost to Follow-up|5|||
145290566|NCT00663871|523913783|FG001|Overall Study|Lost to Follow-up|5|||
145290567|NCT00663871|523913782|FG000|Overall Study|Withdrawal by Subject|5|||
145290568|NCT00663871|523913783|FG001|Overall Study|Withdrawal by Subject|2|||
145556388|NCT02554812|524895041|FG018|Overall Study|Death|1|||
145290569|NCT04094870|523913784|FG000|Overall Study|Lost to Follow-up|1|||
145290570|NCT04094870|523913785|FG001|Overall Study|Lost to Follow-up|1|||
145290571|NCT03384745|523913786|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
145290572|NCT03384745|523913787|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
145290573|NCT03384745|523913788|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
145290574|NCT03384745|523913789|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
145556389|NCT02554812|524895042|FG019|Overall Study|Death|2|||
145290575|NCT03384745|523913790|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
145290576|NCT03384745|523913791|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
145290577|NCT03384745|523913786|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
145290578|NCT03384745|523913787|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
145290579|NCT03384745|523913788|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
145290580|NCT03384745|523913789|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
145290581|NCT03384745|523913790|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
145290582|NCT03384745|523913791|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
145290583|NCT03384745|523913786|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
145290584|NCT03384745|523913787|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
145290585|NCT03384745|523913788|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
145290586|NCT03384745|523913789|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
145290587|NCT03384745|523913790|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
145290588|NCT03384745|523913791|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
145290589|NCT03384745|523913786|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
145290590|NCT03384745|523913787|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
145290591|NCT03384745|523913788|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
145290592|NCT03384745|523913789|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
145290593|NCT03384745|523913790|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
145290594|NCT03384745|523913791|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
145290595|NCT03384745|523913786|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
145290596|NCT03384745|523913787|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
145290597|NCT03384745|523913788|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
145556390|NCT02554812|524895043|FG020|Overall Study|Death|0|||
145290598|NCT03384745|523913789|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
145290599|NCT03384745|523913790|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
145290600|NCT03384745|523913791|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
145290601|NCT03384745|523913786|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
145556391|NCT02554812|524895044|FG021|Overall Study|Death|1|||
145556392|NCT02554812|524895045|FG022|Overall Study|Death|1|||
145556393|NCT02554812|524895046|FG023|Overall Study|Death|0|||
145290602|NCT03384745|523913787|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
145290603|NCT03384745|523913788|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
145290604|NCT03384745|523913789|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
145290605|NCT03384745|523913790|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
145290606|NCT03384745|523913791|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
145290607|NCT03384745|523913786|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
145290608|NCT03384745|523913787|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
145290609|NCT03384745|523913788|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
145290610|NCT03384745|523913789|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
145290611|NCT03384745|523913790|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
145290612|NCT03384745|523913791|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
145290613|NCT03384745|523913786|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
145290614|NCT03384745|523913787|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
145290615|NCT03384745|523913788|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
145290616|NCT03384745|523913789|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
145290617|NCT03384745|523913790|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
145290618|NCT03384745|523913791|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
145290619|NCT03384745|523913786|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
145290620|NCT03384745|523913787|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
145290621|NCT03384745|523913788|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
145290622|NCT03384745|523913789|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
145290623|NCT03384745|523913790|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
145290624|NCT03384745|523913791|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
145290625|NCT03384745|523913786|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
145290626|NCT03384745|523913787|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
145290627|NCT03384745|523913788|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
145290628|NCT03384745|523913789|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
145290629|NCT03384745|523913790|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
145290630|NCT03384745|523913791|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
145290631|NCT03384745|523913786|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
145290632|NCT03384745|523913787|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
145290633|NCT03384745|523913788|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
145290634|NCT03384745|523913789|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
145290635|NCT03384745|523913790|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
145290636|NCT03384745|523913791|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
145290637|NCT01592370|523913794|FG000|Overall Study|Disease Progression|62|||
145290638|NCT01592370|523913795|FG001|Overall Study|Disease Progression|16|||
145290639|NCT01592370|523913796|FG002|Overall Study|Disease Progression|52|||
145290640|NCT01592370|523913797|FG003|Overall Study|Disease Progression|3|||
145290641|NCT01592370|523913798|FG004|Overall Study|Disease Progression|3|||
145290642|NCT01592370|523913799|FG005|Overall Study|Disease Progression|31|||
145290643|NCT01592370|523913800|FG006|Overall Study|Disease Progression|14|||
145290644|NCT01592370|523913794|FG000|Overall Study|Study Drug Toxicity|14|||
145290645|NCT01592370|523913795|FG001|Overall Study|Study Drug Toxicity|3|||
145290646|NCT01592370|523913796|FG002|Overall Study|Study Drug Toxicity|0|||
145290647|NCT01592370|523913797|FG003|Overall Study|Study Drug Toxicity|0|||
145290648|NCT01592370|523913798|FG004|Overall Study|Study Drug Toxicity|0|||
145406658|NCT00626639|524343819|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
145290649|NCT01592370|523913799|FG005|Overall Study|Study Drug Toxicity|0|||
145290650|NCT01592370|523913800|FG006|Overall Study|Study Drug Toxicity|1|||
145290651|NCT01592370|523913794|FG000|Overall Study|AE unrelated to study drug|4|||
145290652|NCT01592370|523913795|FG001|Overall Study|AE unrelated to study drug|3|||
145290653|NCT01592370|523913796|FG002|Overall Study|AE unrelated to study drug|0|||
145290654|NCT01592370|523913797|FG003|Overall Study|AE unrelated to study drug|0|||
145290655|NCT01592370|523913798|FG004|Overall Study|AE unrelated to study drug|0|||
145290656|NCT01592370|523913799|FG005|Overall Study|AE unrelated to study drug|0|||
145556394|NCT02554812|524895047|FG024|Overall Study|Death|0|||
145406659|NCT00626639|524343820|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
145406660|NCT01461551|524343821|FG000|Overall Study|Physician Decision|2|||
145406661|NCT01461551|524343822|FG001|Overall Study|Physician Decision|1|||
145406662|NCT01461551|524343823|FG002|Overall Study|Physician Decision|2|||
145406663|NCT02326883|524343826|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
145406664|NCT02326883|524343827|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
145406665|NCT02326883|524343828|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
145406666|NCT02107898|524343829|FG000|Overall Study|Adverse Event|4|||
145406667|NCT02107898|524343830|FG001|Overall Study|Adverse Event|7|||
145406668|NCT02107898|524343829|FG000|Overall Study|Poor compliance to protocol|0|||
145406669|NCT02107898|524343830|FG001|Overall Study|Poor compliance to protocol|1|||
145406670|NCT02107898|524343829|FG000|Overall Study|Participant moved|0|||
145406671|NCT02107898|524343830|FG001|Overall Study|Participant moved|2|||
145406672|NCT02107898|524343829|FG000|Overall Study|Consent withdrawn by participant|2|||
145406673|NCT02107898|524343830|FG001|Overall Study|Consent withdrawn by participant|1|||
145406674|NCT02107898|524343829|FG000|Overall Study|Randomized but not treated|0|||
145406675|NCT02107898|524343830|FG001|Overall Study|Randomized but not treated|1|||
145406676|NCT03329989|524343831|FG000|Overall Study|Withdrawal by Subject|9|||
145406677|NCT03329989|524343831|FG000|Overall Study|Lost to Follow-up|8|||
145406678|NCT03329989|524343831|FG000|Overall Study|Adverse Event|5|||
145406679|NCT03329989|524343831|FG000|Overall Study|Protocol Violation|1|||
145406680|NCT00297167|524343832|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
145406681|NCT00297167|524343833|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
145406682|NCT00297167|524343834|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
145406683|NCT00297167|524343832|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
145406684|NCT00297167|524343833|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
145406685|NCT00297167|524343834|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
145290657|NCT01592370|523913800|FG006|Overall Study|AE unrelated to study drug|1|||
145290658|NCT01592370|523913794|FG000|Overall Study|Request to discontinue study treatment|5|||
145290659|NCT01592370|523913795|FG001|Overall Study|Request to discontinue study treatment|0|||
145290660|NCT01592370|523913796|FG002|Overall Study|Request to discontinue study treatment|2|||
145290661|NCT01592370|523913797|FG003|Overall Study|Request to discontinue study treatment|0|||
145290662|NCT01592370|523913798|FG004|Overall Study|Request to discontinue study treatment|1|||
145290663|NCT01592370|523913799|FG005|Overall Study|Request to discontinue study treatment|2|||
145290664|NCT01592370|523913800|FG006|Overall Study|Request to discontinue study treatment|0|||
145290665|NCT01592370|523913794|FG000|Overall Study|Withdrew consent|1|||
145290666|NCT01592370|523913795|FG001|Overall Study|Withdrew consent|2|||
145406686|NCT01033136|524343836|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
145406687|NCT01033136|524343837|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
145406688|NCT00142415|524343838|FG000|Overall Study|Physician Decision|0|||
145406689|NCT00142415|524343839|FG001|Overall Study|Physician Decision|0|||
145406690|NCT00142415|524343840|FG002|Overall Study|Physician Decision|0|||
145406691|NCT00142415|524343841|FG003|Overall Study|Physician Decision|0|||
145406692|NCT00142415|524343842|FG004|Overall Study|Physician Decision|1|||
145406693|NCT00142415|524343843|FG005|Overall Study|Physician Decision|2|||
145406694|NCT00844519|524343844|FG000|Overall Study|Withdrawal by Subject|1|||
145406695|NCT00844519|524343845|FG001|Overall Study|Withdrawal by Subject|1|||
145406696|NCT00844519|524343844|FG000|Overall Study|Adverse Event|1|||
145406697|NCT00844519|524343845|FG001|Overall Study|Adverse Event|0|||
145406698|NCT01056536|524343846|FG000|Overall Study|Lost to Follow-up|202|||
145406699|NCT01056536|524343847|FG001|Overall Study|Lost to Follow-up|116|||
145406700|NCT01056536|524343848|FG002|Overall Study|Lost to Follow-up|248|||
145406701|NCT01654276|524343861|FG000|Overall Study|Lack of Efficacy|1|||
145406702|NCT01654276|524343861|FG000|Overall Study|Lost to Follow-up|4|||
145290667|NCT01592370|523913796|FG002|Overall Study|Withdrew consent|1|||
145290668|NCT01592370|523913797|FG003|Overall Study|Withdrew consent|1|||
145290669|NCT01592370|523913798|FG004|Overall Study|Withdrew consent|0|||
145290670|NCT01592370|523913799|FG005|Overall Study|Withdrew consent|0|||
145290671|NCT01592370|523913800|FG006|Overall Study|Withdrew consent|0|||
145406703|NCT01654276|524343861|FG000|Overall Study|Withdrawal by Subject|1|||
145406704|NCT01977846|524343864|FG000|Total Study - Prospective|Death|0|||
145406705|NCT01977846|524343865|FG001|Total Study - Prospective|Death|1|||
145406706|NCT01977846|524343864|FG000|Total Study - Prospective|Lost to Follow-up|0|||
145406707|NCT01977846|524343865|FG001|Total Study - Prospective|Lost to Follow-up|8|||
145406708|NCT01977846|524343864|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
145290672|NCT01592370|523913794|FG000|Overall Study|Maximum clinical benefit|11|||
145290673|NCT01592370|523913795|FG001|Overall Study|Maximum clinical benefit|1|||
145556395|NCT02554812|524895048|FG025|Overall Study|Death|0|||
145406709|NCT01977846|524343865|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
145406710|NCT01977846|524343864|FG000|Total Study - Prospective|Not available at time of visit|0|||
145406711|NCT01977846|524343865|FG001|Total Study - Prospective|Not available at time of visit|5|||
145406712|NCT01977846|524343864|FG000|Total Study - Prospective|No show|0|||
145406713|NCT01977846|524343865|FG001|Total Study - Prospective|No show|1|||
145406714|NCT01977846|524343864|FG000|Total Study - Prospective|Protocol Violation|0|||
145406715|NCT01977846|524343865|FG001|Total Study - Prospective|Protocol Violation|1|||
145406716|NCT00596635|524343867|FG000|Overall Study|Lost to Follow-up|0|||
145406717|NCT00596635|524343868|FG001|Overall Study|Lost to Follow-up|2|||
145406718|NCT00596635|524343869|FG002|Overall Study|Lost to Follow-up|0|||
145406719|NCT00596635|524343867|FG000|Overall Study|Treatment for symptomatic UTI|4|||
145406720|NCT00596635|524343868|FG001|Overall Study|Treatment for symptomatic UTI|6|||
145406721|NCT00596635|524343869|FG002|Overall Study|Treatment for symptomatic UTI|3|||
145406722|NCT00596635|524343867|FG000|Overall Study|Hip fracture|2|||
145406723|NCT00596635|524343868|FG001|Overall Study|Hip fracture|3|||
145406724|NCT00596635|524343869|FG002|Overall Study|Hip fracture|3|||
145406725|NCT00596635|524343867|FG000|Overall Study|Could not provide urine specimen|1|||
145406726|NCT00596635|524343868|FG001|Overall Study|Could not provide urine specimen|2|||
145406727|NCT00596635|524343869|FG002|Overall Study|Could not provide urine specimen|2|||
145406728|NCT00127803|524343872|FG000|Overall Study|Adverse Event|2|||
145406729|NCT00127803|524343873|FG001|Overall Study|Adverse Event|0|||
145406730|NCT00127803|524343874|FG002|Overall Study|Adverse Event|0|||
145406731|NCT00127803|524343875|FG003|Overall Study|Adverse Event|0|||
145406732|NCT00127803|524343872|FG000|Overall Study|Withdrawal by Subject|1|||
145406733|NCT00127803|524343873|FG001|Overall Study|Withdrawal by Subject|0|||
145406734|NCT00127803|524343874|FG002|Overall Study|Withdrawal by Subject|0|||
145406735|NCT00127803|524343875|FG003|Overall Study|Withdrawal by Subject|0|||
145406736|NCT00127803|524343872|FG000|Overall Study|Lost to Follow-up|0|||
145406737|NCT00127803|524343873|FG001|Overall Study|Lost to Follow-up|0|||
145406738|NCT00127803|524343874|FG002|Overall Study|Lost to Follow-up|0|||
145406739|NCT00127803|524343875|FG003|Overall Study|Lost to Follow-up|1|||
145406740|NCT01020123|524343876|FG000|Main Period|Withdrawal by Subject|6|||
145406741|NCT01020123|524343877|FG001|Main Period|Withdrawal by Subject|5|||
145406742|NCT01020123|524343878|FG002|Main Period|Withdrawal by Subject|3|||
145406743|NCT01020123|524343879|FG003|Main Period|Withdrawal by Subject|1|||
145406744|NCT01020123|524343880|FG004|Main Period|Withdrawal by Subject|6|||
145406745|NCT01020123|524343881|FG005|Main Period|Withdrawal by Subject|3|||
145406746|NCT01020123|524343882|FG006|Main Period|Withdrawal by Subject|2|||
145406747|NCT01020123|524343876|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
145406748|NCT01020123|524343877|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
145406749|NCT01020123|524343878|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
145406750|NCT01020123|524343879|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
145406751|NCT01020123|524343880|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
145406752|NCT01020123|524343881|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
145406753|NCT01020123|524343882|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
145406754|NCT01020123|524343876|FG000|Main Period|Adverse Event|5|||
145406755|NCT01020123|524343877|FG001|Main Period|Adverse Event|2|||
145406756|NCT01020123|524343878|FG002|Main Period|Adverse Event|2|||
145406757|NCT01020123|524343879|FG003|Main Period|Adverse Event|1|||
145406758|NCT01020123|524343880|FG004|Main Period|Adverse Event|1|||
145406759|NCT01020123|524343881|FG005|Main Period|Adverse Event|2|||
145406760|NCT01020123|524343882|FG006|Main Period|Adverse Event|1|||
145406761|NCT01020123|524343876|FG000|Main Period|Protocol Violation|4|||
145406762|NCT01020123|524343877|FG001|Main Period|Protocol Violation|4|||
145406763|NCT01020123|524343878|FG002|Main Period|Protocol Violation|2|||
145406764|NCT01020123|524343879|FG003|Main Period|Protocol Violation|5|||
145406765|NCT01020123|524343880|FG004|Main Period|Protocol Violation|2|||
145406766|NCT01020123|524343881|FG005|Main Period|Protocol Violation|3|||
145406767|NCT01020123|524343882|FG006|Main Period|Protocol Violation|2|||
145406768|NCT01020123|524343876|FG000|Main Period|Lost to Follow-up|0|||
145290674|NCT01592370|523913796|FG002|Overall Study|Maximum clinical benefit|7|||
145290675|NCT01592370|523913797|FG003|Overall Study|Maximum clinical benefit|1|||
145290676|NCT01592370|523913798|FG004|Overall Study|Maximum clinical benefit|0|||
145290677|NCT01592370|523913799|FG005|Overall Study|Maximum clinical benefit|0|||
145290678|NCT01592370|523913800|FG006|Overall Study|Maximum clinical benefit|0|||
145290679|NCT01592370|523913794|FG000|Overall Study|No longer meets study criteria|1|||
145290680|NCT01592370|523913795|FG001|Overall Study|No longer meets study criteria|0|||
145290681|NCT01592370|523913796|FG002|Overall Study|No longer meets study criteria|0|||
145406769|NCT01020123|524343877|FG001|Main Period|Lost to Follow-up|2|||
145406770|NCT01020123|524343878|FG002|Main Period|Lost to Follow-up|0|||
145406771|NCT01020123|524343879|FG003|Main Period|Lost to Follow-up|0|||
145406772|NCT01020123|524343880|FG004|Main Period|Lost to Follow-up|0|||
145406773|NCT01020123|524343881|FG005|Main Period|Lost to Follow-up|0|||
145406774|NCT01020123|524343882|FG006|Main Period|Lost to Follow-up|0|||
145406775|NCT01020123|524343876|FG000|Main Period|Unclasified|2|||
145406776|NCT01020123|524343877|FG001|Main Period|Unclasified|0|||
145406777|NCT01020123|524343878|FG002|Main Period|Unclasified|1|||
145406778|NCT01020123|524343879|FG003|Main Period|Unclasified|0|||
145406779|NCT01020123|524343880|FG004|Main Period|Unclasified|1|||
145406780|NCT01020123|524343881|FG005|Main Period|Unclasified|3|||
145290682|NCT01592370|523913797|FG003|Overall Study|No longer meets study criteria|0|||
145290683|NCT01592370|523913798|FG004|Overall Study|No longer meets study criteria|0|||
145290684|NCT01592370|523913799|FG005|Overall Study|No longer meets study criteria|0|||
145290685|NCT01592370|523913800|FG006|Overall Study|No longer meets study criteria|0|||
145290686|NCT01592370|523913794|FG000|Overall Study|Other Reasons|6|||
145290687|NCT01592370|523913795|FG001|Overall Study|Other Reasons|0|||
145290688|NCT01592370|523913796|FG002|Overall Study|Other Reasons|10|||
145290689|NCT01592370|523913797|FG003|Overall Study|Other Reasons|0|||
145290690|NCT01592370|523913798|FG004|Overall Study|Other Reasons|0|||
145290691|NCT01592370|523913799|FG005|Overall Study|Other Reasons|1|||
145290692|NCT01592370|523913800|FG006|Overall Study|Other Reasons|0|||
145290693|NCT01592370|523913794|FG000|Overall Study|Not Treated|0|||
145290694|NCT01592370|523913795|FG001|Overall Study|Not Treated|0|||
145290695|NCT01592370|523913796|FG002|Overall Study|Not Treated|0|||
145406781|NCT01020123|524343882|FG006|Main Period|Unclasified|6|||
145406782|NCT01020123|524343876|FG000|Extention Period|Withdrawal by Subject|2|||
145406783|NCT01020123|524343877|FG001|Extention Period|Withdrawal by Subject|1|||
145406784|NCT01020123|524343878|FG002|Extention Period|Withdrawal by Subject|1|||
145406785|NCT01020123|524343879|FG003|Extention Period|Withdrawal by Subject|0|||
145406786|NCT01020123|524343880|FG004|Extention Period|Withdrawal by Subject|0|||
145406787|NCT01020123|524343881|FG005|Extention Period|Withdrawal by Subject|0|||
145406788|NCT01020123|524343882|FG006|Extention Period|Withdrawal by Subject|0|||
145406789|NCT01020123|524343876|FG000|Extention Period|Adverse Event|0|||
145406790|NCT01020123|524343877|FG001|Extention Period|Adverse Event|0|||
145406791|NCT01020123|524343878|FG002|Extention Period|Adverse Event|0|||
145406792|NCT01020123|524343879|FG003|Extention Period|Adverse Event|1|||
145406793|NCT01020123|524343880|FG004|Extention Period|Adverse Event|0|||
145406794|NCT01020123|524343881|FG005|Extention Period|Adverse Event|0|||
145406795|NCT01020123|524343882|FG006|Extention Period|Adverse Event|0|||
145406796|NCT01020123|524343876|FG000|Extention Period|Protocol Violation|1|||
145406797|NCT01020123|524343877|FG001|Extention Period|Protocol Violation|1|||
145406798|NCT01020123|524343878|FG002|Extention Period|Protocol Violation|1|||
145290696|NCT01592370|523913797|FG003|Overall Study|Not Treated|0|||
145290697|NCT01592370|523913798|FG004|Overall Study|Not Treated|2|||
145290698|NCT01592370|523913799|FG005|Overall Study|Not Treated|2|||
145290699|NCT01592370|523913800|FG006|Overall Study|Not Treated|0|||
145290700|NCT01048333|523913801|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
145290701|NCT01048333|523913802|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
145556396|NCT02554812|524895049|FG026|Overall Study|Death|0|||
145290702|NCT01048333|523913803|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
145290703|NCT01048333|523913804|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
145290704|NCT01048333|523913805|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
145290705|NCT01048333|523913806|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
145290706|NCT00767325|523913808|FG000|Overall Study|Lack of Efficacy|2|||
145290707|NCT00767325|523913808|FG000|Overall Study|Adverse Event|7|||
145290708|NCT00767325|523913808|FG000|Overall Study|Lost to Follow-up|3|||
145290709|NCT00767325|523913808|FG000|Overall Study|No longer met study criteria|2|||
145290710|NCT00767325|523913808|FG000|Overall Study|Missed visit due to family reasons|1|||
145290711|NCT03538756|523913809|FG000|Long-Term Follow-up|Adverse Event|0|||
145290712|NCT03538756|523913810|FG001|Long-Term Follow-up|Adverse Event|0|||
145290713|NCT03538756|523913811|FG002|Long-Term Follow-up|Adverse Event|6|||
145290714|NCT03538756|523913809|FG000|Long-Term Follow-up|Death|0|||
145290715|NCT03538756|523913810|FG001|Long-Term Follow-up|Death|0|||
145290716|NCT03538756|523913811|FG002|Long-Term Follow-up|Death|1|||
145290717|NCT03538756|523913809|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
145290718|NCT03538756|523913810|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
145290719|NCT03538756|523913811|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
145290720|NCT03538756|523913809|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
145290721|NCT03538756|523913810|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
145290722|NCT03538756|523913811|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
145290723|NCT03538756|523913809|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
145290724|NCT03538756|523913810|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
145290725|NCT03538756|523913811|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
145290726|NCT00752856|523913812|FG000|Overall Study|randomized but did not do viral kinetics|0|||
145290727|NCT00752856|523913813|FG001|Overall Study|randomized but did not do viral kinetics|1|||
145290728|NCT00996736|523913819|FG000|Overall Study|Death|1|||
145290729|NCT00996736|523913820|FG001|Overall Study|Death|1|||
145290730|NCT00996736|523913819|FG000|Overall Study|Lost to Follow-up|15|||
145290731|NCT00996736|523913820|FG001|Overall Study|Lost to Follow-up|14|||
145290732|NCT00996736|523913819|FG000|Overall Study|Visit not within 3-month window|5|||
145290733|NCT00996736|523913820|FG001|Overall Study|Visit not within 3-month window|3|||
145290734|NCT02688608|523913821|FG000|Overall Study|Lost to Follow-up|1|||
145290735|NCT02346201|523913823|FG000|Overall Study|Adverse Event|3|||
145290736|NCT02346201|523913824|FG001|Overall Study|Adverse Event|2|||
145290737|NCT02346201|523913823|FG000|Overall Study|Lost to Follow-up|1|||
145290738|NCT02346201|523913824|FG001|Overall Study|Lost to Follow-up|0|||
145290739|NCT02346201|523913823|FG000|Overall Study|Withdrawal by Subject|6|||
145290740|NCT02346201|523913824|FG001|Overall Study|Withdrawal by Subject|3|||
145290741|NCT02346201|523913823|FG000|Overall Study|Unavailable for future follow-up|0|||
145290742|NCT02346201|523913824|FG001|Overall Study|Unavailable for future follow-up|1|||
145290743|NCT02346201|523913823|FG000|Overall Study|Physician Decision|0|||
145290744|NCT02346201|523913824|FG001|Overall Study|Physician Decision|1|||
145290745|NCT02346201|523913823|FG000|Overall Study|Missed final visit|0|||
145290746|NCT02346201|523913824|FG001|Overall Study|Missed final visit|2|||
145290747|NCT03708211|523913826|FG000|Overall Study|Progressive Disease|10|||
145290748|NCT03708211|523913827|FG001|Overall Study|Progressive Disease|7|||
145290749|NCT03708211|523913826|FG000|Overall Study|Withdrawal by Subject|0|||
145290750|NCT03708211|523913827|FG001|Overall Study|Withdrawal by Subject|1|||
145290751|NCT03708211|523913826|FG000|Overall Study|Other|2|||
145290752|NCT03708211|523913827|FG001|Overall Study|Other|0|||
145406799|NCT01020123|524343879|FG003|Extention Period|Protocol Violation|0|||
145406800|NCT01020123|524343880|FG004|Extention Period|Protocol Violation|0|||
145290753|NCT05200858|523913828|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
145290754|NCT05200858|523913829|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
145290755|NCT05200858|523913830|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
145290756|NCT05200858|523913831|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
145290757|NCT00409578|523913832|FG000|Overall Study|Adverse Event|27|||
145406801|NCT01020123|524343881|FG005|Extention Period|Protocol Violation|0|||
145406802|NCT01020123|524343882|FG006|Extention Period|Protocol Violation|1|||
145290758|NCT00409578|523913833|FG001|Overall Study|Adverse Event|37|||
145290759|NCT00409578|523913834|FG002|Overall Study|Adverse Event|25|||
145290760|NCT00409578|523913835|FG003|Overall Study|Adverse Event|33|||
145290761|NCT00409578|523913832|FG000|Overall Study|Abnormal laboratory value(s)|2|||
145290762|NCT00409578|523913833|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145290763|NCT00409578|523913834|FG002|Overall Study|Abnormal laboratory value(s)|2|||
145290764|NCT00409578|523913835|FG003|Overall Study|Abnormal laboratory value(s)|4|||
145290765|NCT00409578|523913832|FG000|Overall Study|Lack of Efficacy|0|||
145290766|NCT00409578|523913833|FG001|Overall Study|Lack of Efficacy|0|||
145290767|NCT00409578|523913834|FG002|Overall Study|Lack of Efficacy|0|||
145290768|NCT00409578|523913835|FG003|Overall Study|Lack of Efficacy|2|||
145290769|NCT00409578|523913832|FG000|Overall Study|Subject no longer requires study drug|0|||
145290770|NCT00409578|523913833|FG001|Overall Study|Subject no longer requires study drug|0|||
145290771|NCT00409578|523913834|FG002|Overall Study|Subject no longer requires study drug|0|||
145290772|NCT00409578|523913835|FG003|Overall Study|Subject no longer requires study drug|1|||
145290773|NCT00409578|523913832|FG000|Overall Study|Withdrawal by Subject|8|||
145290774|NCT00409578|523913833|FG001|Overall Study|Withdrawal by Subject|15|||
145290775|NCT00409578|523913834|FG002|Overall Study|Withdrawal by Subject|16|||
145290776|NCT00409578|523913835|FG003|Overall Study|Withdrawal by Subject|17|||
145290777|NCT00409578|523913832|FG000|Overall Study|Lost to Follow-up|2|||
145290778|NCT00409578|523913833|FG001|Overall Study|Lost to Follow-up|0|||
145290779|NCT00409578|523913834|FG002|Overall Study|Lost to Follow-up|2|||
145290780|NCT00409578|523913835|FG003|Overall Study|Lost to Follow-up|2|||
145290781|NCT00409578|523913832|FG000|Overall Study|Administrative problems|8|||
145290782|NCT00409578|523913833|FG001|Overall Study|Administrative problems|9|||
145290783|NCT00409578|523913834|FG002|Overall Study|Administrative problems|2|||
145290784|NCT00409578|523913835|FG003|Overall Study|Administrative problems|4|||
145290785|NCT00409578|523913832|FG000|Overall Study|Death|2|||
145290786|NCT00409578|523913833|FG001|Overall Study|Death|4|||
145290787|NCT00409578|523913834|FG002|Overall Study|Death|4|||
145290788|NCT00409578|523913835|FG003|Overall Study|Death|2|||
145290789|NCT00409578|523913832|FG000|Overall Study|Protocol Violation|3|||
145290790|NCT00409578|523913833|FG001|Overall Study|Protocol Violation|2|||
145290791|NCT00409578|523913834|FG002|Overall Study|Protocol Violation|3|||
145290792|NCT00409578|523913835|FG003|Overall Study|Protocol Violation|1|||
145290793|NCT00409578|523913832|FG000|Overall Study|Missing|0|||
145290794|NCT00409578|523913833|FG001|Overall Study|Missing|1|||
145290795|NCT00409578|523913834|FG002|Overall Study|Missing|0|||
145290796|NCT00409578|523913835|FG003|Overall Study|Missing|1|||
145290797|NCT02109133|523913836|FG000|Overall Study|Lost to Follow-up|1|||
145290798|NCT02109133|523913837|FG001|Overall Study|Lost to Follow-up|0|||
145290799|NCT02448771|523913840|FG000|Overall Study|Disease Progression|30|||
145290800|NCT02448771|523913840|FG000|Overall Study|Unacceptable Toxicity|1|||
145290801|NCT02448771|523913840|FG000|Overall Study|Physician Decision|3|||
145290802|NCT02448771|523913840|FG000|Overall Study|Started new therapy|2|||
145290803|NCT00770315|523913842|FG000|Overall Study|Adverse Event|11|||
145290804|NCT00770315|523913843|FG001|Overall Study|Adverse Event|17|||
145290805|NCT00770315|523913844|FG002|Overall Study|Adverse Event|16|||
145290806|NCT00770315|523913845|FG003|Overall Study|Adverse Event|6|||
145290807|NCT00770315|523913842|FG000|Overall Study|Lost to Follow-up|9|||
145290808|NCT00770315|523913843|FG001|Overall Study|Lost to Follow-up|5|||
145290809|NCT00770315|523913844|FG002|Overall Study|Lost to Follow-up|10|||
145290810|NCT00770315|523913845|FG003|Overall Study|Lost to Follow-up|3|||
145290811|NCT00770315|523913842|FG000|Overall Study|Withdrawal by Subject|13|||
145290812|NCT00770315|523913843|FG001|Overall Study|Withdrawal by Subject|17|||
145290813|NCT00770315|523913844|FG002|Overall Study|Withdrawal by Subject|24|||
145290814|NCT00770315|523913845|FG003|Overall Study|Withdrawal by Subject|20|||
145290815|NCT00770315|523913842|FG000|Overall Study|Noncompliance with Protocol|7|||
145556397|NCT02554812|524895023|FG000|Overall Study|Lost to Follow-up|0|||
145556398|NCT02554812|524895024|FG001|Overall Study|Lost to Follow-up|1|||
145556399|NCT02554812|524895025|FG002|Overall Study|Lost to Follow-up|0|||
145556400|NCT02554812|524895026|FG003|Overall Study|Lost to Follow-up|0|||
145556401|NCT02554812|524895027|FG004|Overall Study|Lost to Follow-up|0|||
145556402|NCT02554812|524895028|FG005|Overall Study|Lost to Follow-up|0|||
145556403|NCT02554812|524895029|FG006|Overall Study|Lost to Follow-up|0|||
145556404|NCT02554812|524895030|FG007|Overall Study|Lost to Follow-up|0|||
145556405|NCT02554812|524895031|FG008|Overall Study|Lost to Follow-up|0|||
145556406|NCT02554812|524895032|FG009|Overall Study|Lost to Follow-up|0|||
145556407|NCT02554812|524895033|FG010|Overall Study|Lost to Follow-up|0|||
145556408|NCT02554812|524895034|FG011|Overall Study|Lost to Follow-up|0|||
145556409|NCT02554812|524895035|FG012|Overall Study|Lost to Follow-up|0|||
145290816|NCT00770315|523913843|FG001|Overall Study|Noncompliance with Protocol|4|||
145290817|NCT00770315|523913844|FG002|Overall Study|Noncompliance with Protocol|7|||
145290818|NCT00770315|523913845|FG003|Overall Study|Noncompliance with Protocol|9|||
145290819|NCT02683187|523913846|FG000|Overall Study|Failed IV access|3|||
145290820|NCT02683187|523913846|FG000|Overall Study|Withdrawal by Subject|5|||
145290821|NCT04256421|523913849|FG000|Overall Study|Death|171|||
145290822|NCT04256421|523913850|FG001|Overall Study|Death|180|||
145290823|NCT04256421|523913849|FG000|Overall Study|Lost to Follow-up|1|||
145290824|NCT04256421|523913850|FG001|Overall Study|Lost to Follow-up|1|||
145290825|NCT04256421|523913849|FG000|Overall Study|Withdrawal by Subject|9|||
145290826|NCT04256421|523913850|FG001|Overall Study|Withdrawal by Subject|10|||
145290827|NCT04256421|523913849|FG000|Overall Study|Ongoing in Study|66|||
145290828|NCT04256421|523913850|FG001|Overall Study|Ongoing in Study|52|||
145290829|NCT02309099|523915323|FG000|Overall Study|Adverse Event|2|||
145290830|NCT02309099|523915324|FG001|Overall Study|Adverse Event|0|||
145290831|NCT02819362|523915326|FG000|Overall Study|On-site MRI could not be performed|70|||
145290832|NCT05301751|523915327|FG000|Overall Study|Withdrawal by Subject|0|||
145290833|NCT05301751|523915328|FG001|Overall Study|Withdrawal by Subject|0|||
145290834|NCT05301751|523915329|FG002|Overall Study|Withdrawal by Subject|1|||
145290835|NCT05301751|523915330|FG003|Overall Study|Withdrawal by Subject|0|||
145290836|NCT02132247|523915331|FG000|Overall Study|Protocol Violation|1|||
145290837|NCT02132247|523915332|FG001|Overall Study|Protocol Violation|0|||
145290838|NCT00520741|523915339|FG000|Overall Study|Adverse Event|16|||
145290839|NCT00520741|523915340|FG001|Overall Study|Adverse Event|56|||
145290840|NCT00520741|523915339|FG000|Overall Study|Lack of Efficacy|11|||
145290841|NCT00520741|523915340|FG001|Overall Study|Lack of Efficacy|30|||
145290842|NCT00520741|523915339|FG000|Overall Study|Withdrawal by Subject|0|||
145290843|NCT00520741|523915340|FG001|Overall Study|Withdrawal by Subject|11|||
145290844|NCT00520741|523915339|FG000|Overall Study|Protocol Violation|2|||
145290845|NCT00520741|523915340|FG001|Overall Study|Protocol Violation|15|||
145290846|NCT00520741|523915339|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
145290847|NCT00520741|523915340|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
145290848|NCT00520741|523915339|FG000|Overall Study|Lost to Follow-up|4|||
145290849|NCT00520741|523915340|FG001|Overall Study|Lost to Follow-up|4|||
145290850|NCT00520741|523915339|FG000|Overall Study|Other reasons for premature termination|0|||
145290851|NCT00520741|523915340|FG001|Overall Study|Other reasons for premature termination|6|||
145290852|NCT03702621|523915341|FG000|Overall Study|Physician Decision|6|||
145290853|NCT03702621|523915342|FG001|Overall Study|Physician Decision|6|||
145290854|NCT02402166|523915345|FG000|Overall Study|Adverse Event|2|||
145290855|NCT02402166|523915345|FG000|Overall Study|Withdrawal by Subject|2|||
145290856|NCT02402166|523915345|FG000|Overall Study|Lost to Follow-up|1|||
145290857|NCT02204371|523915347|FG000|Overall Study|Adverse Event|1|||
145290858|NCT03803943|523915356|FG000|Overall Study|Withdrawal by Subject|2|||
145290859|NCT03803943|523915357|FG001|Overall Study|Withdrawal by Subject|2|||
145290860|NCT03803943|523915358|FG002|Overall Study|Withdrawal by Subject|2|||
145290861|NCT03803943|523915359|FG003|Overall Study|Withdrawal by Subject|2|||
145290862|NCT01574248|523915360|FG000|Overall Study|Withdrawal by Subject|2|||
145290863|NCT01574248|523915361|FG001|Overall Study|Withdrawal by Subject|0|||
145290864|NCT01574248|523915360|FG000|Overall Study|Missing primary endpoint data|1|||
145290865|NCT01574248|523915361|FG001|Overall Study|Missing primary endpoint data|0|||
145290866|NCT01781286|523915364|FG000|Overall Study|Lost to Follow-up|0|||
145290867|NCT01781286|523915365|FG001|Overall Study|Lost to Follow-up|0|||
145290868|NCT01781286|523915366|FG002|Overall Study|Lost to Follow-up|0|||
145290869|NCT01781286|523915367|FG003|Overall Study|Lost to Follow-up|0|||
145290870|NCT01781286|523915368|FG004|Overall Study|Lost to Follow-up|0|||
145556410|NCT02554812|524895036|FG013|Overall Study|Lost to Follow-up|0|||
145290871|NCT01781286|523915369|FG005|Overall Study|Lost to Follow-up|1|||
145290872|NCT01781286|523915364|FG000|Overall Study|Time Constraints|2|||
145290873|NCT01781286|523915365|FG001|Overall Study|Time Constraints|0|||
145290874|NCT01781286|523915366|FG002|Overall Study|Time Constraints|2|||
145290875|NCT01781286|523915367|FG003|Overall Study|Time Constraints|0|||
145290876|NCT01781286|523915368|FG004|Overall Study|Time Constraints|0|||
145290877|NCT01781286|523915369|FG005|Overall Study|Time Constraints|0|||
145556411|NCT02554812|524895037|FG014|Overall Study|Lost to Follow-up|0|||
145290878|NCT01781286|523915364|FG000|Overall Study|Noncompliance|0|||
145290879|NCT01781286|523915365|FG001|Overall Study|Noncompliance|0|||
145290880|NCT01781286|523915366|FG002|Overall Study|Noncompliance|0|||
145290881|NCT01781286|523915367|FG003|Overall Study|Noncompliance|1|||
145290882|NCT01781286|523915368|FG004|Overall Study|Noncompliance|0|||
145290883|NCT01781286|523915369|FG005|Overall Study|Noncompliance|0|||
145556412|NCT02554812|524895038|FG015|Overall Study|Lost to Follow-up|0|||
145556413|NCT02554812|524895039|FG016|Overall Study|Lost to Follow-up|0|||
145556414|NCT02554812|524895040|FG017|Overall Study|Lost to Follow-up|0|||
145290884|NCT00995410|523915370|FG000|Overall Study|Adverse Event|51|||
145290885|NCT00995410|523915370|FG000|Overall Study|Withdrawal by Subject|7|||
145290886|NCT00995410|523915370|FG000|Overall Study|Lost to Follow-up|2|||
145290887|NCT00995410|523915370|FG000|Overall Study|Misc|28|||
145556415|NCT02554812|524895041|FG018|Overall Study|Lost to Follow-up|0|||
145556416|NCT02554812|524895042|FG019|Overall Study|Lost to Follow-up|0|||
145556417|NCT02554812|524895043|FG020|Overall Study|Lost to Follow-up|0|||
145556418|NCT02554812|524895044|FG021|Overall Study|Lost to Follow-up|0|||
145556419|NCT02554812|524895045|FG022|Overall Study|Lost to Follow-up|0|||
145556420|NCT02554812|524895046|FG023|Overall Study|Lost to Follow-up|0|||
145556421|NCT02554812|524895047|FG024|Overall Study|Lost to Follow-up|0|||
145556422|NCT02554812|524895048|FG025|Overall Study|Lost to Follow-up|0|||
145290888|NCT03594123|523915371|FG000|Overall Study|Lost to Follow-up|0|||
145290889|NCT03594123|523915372|FG001|Overall Study|Lost to Follow-up|1|||
145290890|NCT03594123|523915371|FG000|Overall Study|Adverse Event|8|||
145290891|NCT03594123|523915372|FG001|Overall Study|Adverse Event|5|||
145290892|NCT03594123|523915371|FG000|Overall Study|Site Terminated by Sponsor|4|||
145290893|NCT03594123|523915372|FG001|Overall Study|Site Terminated by Sponsor|1|||
145290894|NCT03594123|523915371|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
145290895|NCT03594123|523915372|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
145290896|NCT03594123|523915371|FG000|Overall Study|Lack of Efficacy|1|||
145290897|NCT03594123|523915372|FG001|Overall Study|Lack of Efficacy|0|||
145290898|NCT03594123|523915371|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
145290899|NCT03594123|523915372|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
145290900|NCT03365375|523915373|FG000|Overall Study|Withdrawal by Subject|0|||
145290901|NCT03365375|523915374|FG001|Overall Study|Withdrawal by Subject|1|||
145290902|NCT03365375|523915373|FG000|Overall Study|Lost to Follow-up|0|||
145556423|NCT02554812|524895049|FG026|Overall Study|Lost to Follow-up|0|||
145556424|NCT02554812|524895023|FG000|Overall Study|Global deterioration of health status|4|||
145556425|NCT02554812|524895024|FG001|Overall Study|Global deterioration of health status|3|||
145556426|NCT02554812|524895025|FG002|Overall Study|Global deterioration of health status|3|||
145556427|NCT02554812|524895026|FG003|Overall Study|Global deterioration of health status|2|||
145556428|NCT02554812|524895027|FG004|Overall Study|Global deterioration of health status|5|||
145556429|NCT02554812|524895028|FG005|Overall Study|Global deterioration of health status|0|||
145556430|NCT02554812|524895029|FG006|Overall Study|Global deterioration of health status|2|||
145290903|NCT03365375|523915374|FG001|Overall Study|Lost to Follow-up|4|||
145290904|NCT02483975|523915375|FG000|Overall Study|Adverse Event|0|||
145290905|NCT02483975|523915376|FG001|Overall Study|Adverse Event|1|||
145290906|NCT02483975|523915375|FG000|Overall Study|Lost to Follow-up|0|||
145290907|NCT02483975|523915376|FG001|Overall Study|Lost to Follow-up|1|||
145290908|NCT02483975|523915375|FG000|Overall Study|Physician Decision|2|||
145290909|NCT02483975|523915376|FG001|Overall Study|Physician Decision|0|||
145290910|NCT02166697|523915377|FG000|Overall Study|Protocol Violation|347|||
145556431|NCT02554812|524895030|FG007|Overall Study|Global deterioration of health status|1|||
145556432|NCT02554812|524895031|FG008|Overall Study|Global deterioration of health status|1|||
145290911|NCT01505530|523915381|FG000|Overall Study|Progressive Disease|19|||
145290912|NCT01505530|523915382|FG001|Overall Study|Progressive Disease|17|||
145615929|NCT03881059|525109329|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
145406803|NCT01020123|524343876|FG000|Extention Period|Lost to Follow-up|0|||
145406804|NCT01020123|524343877|FG001|Extention Period|Lost to Follow-up|0|||
145406805|NCT01020123|524343878|FG002|Extention Period|Lost to Follow-up|0|||
145406806|NCT01020123|524343879|FG003|Extention Period|Lost to Follow-up|0|||
145406807|NCT01020123|524343880|FG004|Extention Period|Lost to Follow-up|0|||
145406808|NCT01020123|524343881|FG005|Extention Period|Lost to Follow-up|2|||
145406809|NCT01020123|524343882|FG006|Extention Period|Lost to Follow-up|0|||
145406810|NCT00846365|524343883|FG000|Overall Study|Adverse Event|20|||
145406811|NCT00846365|524343884|FG001|Overall Study|Adverse Event|30|||
145406812|NCT00846365|524343885|FG002|Overall Study|Adverse Event|11|||
145406813|NCT00846365|524343883|FG000|Overall Study|Protocol Violation|5|||
145406814|NCT00846365|524343884|FG001|Overall Study|Protocol Violation|4|||
145406815|NCT00846365|524343885|FG002|Overall Study|Protocol Violation|0|||
145406816|NCT00846365|524343883|FG000|Overall Study|Lost to Follow-up|8|||
145406817|NCT00846365|524343884|FG001|Overall Study|Lost to Follow-up|2|||
145406818|NCT00846365|524343885|FG002|Overall Study|Lost to Follow-up|5|||
145406819|NCT00846365|524343883|FG000|Overall Study|Withdrawal by Subject|11|||
145406820|NCT00846365|524343884|FG001|Overall Study|Withdrawal by Subject|11|||
145406821|NCT00846365|524343885|FG002|Overall Study|Withdrawal by Subject|9|||
145406822|NCT00846365|524343883|FG000|Overall Study|Pregnancy|1|||
145406823|NCT00846365|524343884|FG001|Overall Study|Pregnancy|0|||
145406824|NCT00846365|524343885|FG002|Overall Study|Pregnancy|0|||
145406825|NCT00846365|524343883|FG000|Overall Study|Lack of Efficacy|1|||
145406826|NCT00846365|524343884|FG001|Overall Study|Lack of Efficacy|1|||
145406827|NCT00846365|524343885|FG002|Overall Study|Lack of Efficacy|2|||
145406828|NCT00846365|524343883|FG000|Overall Study|Other|9|||
145406829|NCT00846365|524343884|FG001|Overall Study|Other|1|||
145406830|NCT00846365|524343885|FG002|Overall Study|Other|6|||
145406831|NCT05493111|524345532|FG000|Overall Study|Adverse Event|3|||
145406832|NCT05493111|524345533|FG001|Overall Study|Adverse Event|4|||
145290913|NCT01505530|523915383|FG002|Overall Study|Progressive Disease|18|||
145290914|NCT01505530|523915381|FG000|Overall Study|Adverse Event|1|||
145290915|NCT01505530|523915382|FG001|Overall Study|Adverse Event|1|||
145290916|NCT01505530|523915383|FG002|Overall Study|Adverse Event|0|||
145290917|NCT01505530|523915381|FG000|Overall Study|Withdrawal by Subject|7|||
145290918|NCT01505530|523915382|FG001|Overall Study|Withdrawal by Subject|8|||
145290919|NCT01505530|523915383|FG002|Overall Study|Withdrawal by Subject|6|||
145290920|NCT01505530|523915381|FG000|Overall Study|Physician Decision|6|||
145290921|NCT01505530|523915382|FG001|Overall Study|Physician Decision|2|||
145290922|NCT01505530|523915383|FG002|Overall Study|Physician Decision|5|||
145290923|NCT01505530|523915381|FG000|Overall Study|Sponsor Decision|1|||
145290924|NCT01505530|523915382|FG001|Overall Study|Sponsor Decision|8|||
145290925|NCT01505530|523915383|FG002|Overall Study|Sponsor Decision|7|||
145290926|NCT01505530|523915381|FG000|Overall Study|Death|7|||
145290927|NCT01505530|523915382|FG001|Overall Study|Death|6|||
145290928|NCT01505530|523915383|FG002|Overall Study|Death|5|||
145290929|NCT01505530|523915381|FG000|Overall Study|entry criteria not met|0|||
145290930|NCT01505530|523915382|FG001|Overall Study|entry criteria not met|1|||
145290931|NCT01505530|523915383|FG002|Overall Study|entry criteria not met|0|||
145290932|NCT02720510|523915389|FG000|Overall Study|Study Terminated by the sponsor|2|||
145615930|NCT03881059|525109327|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
145290933|NCT02720510|523915390|FG001|Overall Study|Study Terminated by the sponsor|0|||
145290934|NCT02720510|523915389|FG000|Overall Study|Adverse Event|0|||
145290935|NCT02720510|523915390|FG001|Overall Study|Adverse Event|1|||
145290936|NCT02720510|523915389|FG000|Overall Study|Physician Decision|1|||
145290937|NCT02720510|523915390|FG001|Overall Study|Physician Decision|2|||
145290938|NCT01618266|523915399|FG000|Overall Study|Lost to Follow-up|9|||
145290939|NCT01618266|523915399|FG000|Overall Study|Treatment satisfaction|10|||
145290940|NCT01618266|523915399|FG000|Overall Study|Other reasons|11|||
145290941|NCT01618266|523915399|FG000|Overall Study|Lack of Efficacy|23|||
145290942|NCT01618266|523915399|FG000|Overall Study|Protocol Violation|43|||
145290943|NCT01966042|523915400|FG000|Overall Study|Death|2|||
145290944|NCT00625807|523915401|FG000|Overall Study|schedule conflict|2|||
145290945|NCT00625807|523915402|FG001|Overall Study|schedule conflict|8|||
145290946|NCT03267264|523915403|FG000|Overall Study|Withdrawal by Subject|1|||
145290947|NCT03267264|523915404|FG001|Overall Study|Withdrawal by Subject|0|||
145290948|NCT03267264|523915405|FG002|Overall Study|Withdrawal by Subject|2|||
145290949|NCT03267264|523915406|FG003|Overall Study|Withdrawal by Subject|4|||
145290950|NCT02224391|523915407|FG000|Overall Study|Lost to Follow-up|26|||
145290951|NCT02224391|523915408|FG001|Overall Study|Lost to Follow-up|19|||
145290952|NCT02224391|523915407|FG000|Overall Study|Withdrawal by Subject|6|||
145290953|NCT02224391|523915408|FG001|Overall Study|Withdrawal by Subject|5|||
145290954|NCT02492958|523915409|FG000|Overall Study|Withdrawal by Subject|0|||
145290955|NCT02492958|523915410|FG001|Overall Study|Withdrawal by Subject|0|||
145290956|NCT02492958|523915411|FG002|Overall Study|Withdrawal by Subject|1|||
145290957|NCT02492958|523915412|FG003|Overall Study|Withdrawal by Subject|0|||
145290958|NCT02492958|523915409|FG000|Overall Study|Adverse Event|1|||
145290959|NCT02492958|523915410|FG001|Overall Study|Adverse Event|0|||
145290960|NCT02492958|523915411|FG002|Overall Study|Adverse Event|1|||
145290961|NCT02492958|523915412|FG003|Overall Study|Adverse Event|0|||
145290962|NCT03522948|523915413|FG000|Overall Study|Lost to Follow-up|1|||
145290963|NCT00084084|523915414|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
145290964|NCT00084084|523915414|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
145290965|NCT01802879|523915415|FG000|Overall Study|Administrative problems|2|||
145290966|NCT01802879|523915415|FG000|Overall Study|Disease progression|6|||
145290967|NCT01047345|523915420|FG000|Base Study|Adverse Event|3|||
145290968|NCT01047345|523915421|FG001|Base Study|Adverse Event|0|||
145290969|NCT01047345|523915422|FG002|Base Study|Adverse Event|0|||
145290970|NCT01047345|523915420|FG000|Base Study|Lost to Follow-up|4|||
145290971|NCT01047345|523915421|FG001|Base Study|Lost to Follow-up|1|||
145290972|NCT01047345|523915422|FG002|Base Study|Lost to Follow-up|0|||
145290973|NCT01047345|523915420|FG000|Base Study|Protocol Violation|3|||
145290974|NCT01047345|523915421|FG001|Base Study|Protocol Violation|1|||
145290975|NCT01047345|523915422|FG002|Base Study|Protocol Violation|0|||
145290976|NCT01047345|523915420|FG000|Base Study|Withdrawal by Subject|12|||
145290977|NCT01047345|523915421|FG001|Base Study|Withdrawal by Subject|4|||
145290978|NCT01047345|523915422|FG002|Base Study|Withdrawal by Subject|0|||
145290979|NCT01047345|523915420|FG000|Extension|Withdrawal by Subject|0|||
145290980|NCT01047345|523915421|FG001|Extension|Withdrawal by Subject|0|||
145290981|NCT01047345|523915422|FG002|Extension|Withdrawal by Subject|1|||
145290982|NCT01047345|523915420|FG000|Extension|Lost to Follow-up|0|||
145290983|NCT01047345|523915421|FG001|Extension|Lost to Follow-up|0|||
145290984|NCT01047345|523915422|FG002|Extension|Lost to Follow-up|5|||
145556433|NCT02554812|524895032|FG009|Overall Study|Global deterioration of health status|1|||
145290985|NCT00282256|523915425|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
145290986|NCT00282256|523915425|FG000|Extension Treatment Period|Adverse Event|2|||
145290987|NCT00948675|523915427|FG000|Overall Study|Lost to Follow-up|1|||
145290988|NCT00948675|523915428|FG001|Overall Study|Lost to Follow-up|0|||
145290989|NCT01984242|523915429|FG000|Overall Study|Death|52|||
145290990|NCT01984242|523915430|FG001|Overall Study|Death|50|||
145290991|NCT01984242|523915431|FG002|Overall Study|Death|52|||
145290992|NCT01984242|523915429|FG000|Overall Study|Withdrawal by Subject|5|||
145290993|NCT01984242|523915430|FG001|Overall Study|Withdrawal by Subject|3|||
145290994|NCT01984242|523915431|FG002|Overall Study|Withdrawal by Subject|10|||
145290995|NCT01984242|523915429|FG000|Overall Study|Physician Decision|0|||
145290996|NCT01984242|523915430|FG001|Overall Study|Physician Decision|0|||
145290997|NCT01984242|523915431|FG002|Overall Study|Physician Decision|1|||
145290998|NCT01984242|523915429|FG000|Overall Study|Lost to Follow-up|4|||
145290999|NCT01984242|523915430|FG001|Overall Study|Lost to Follow-up|0|||
145291000|NCT01984242|523915431|FG002|Overall Study|Lost to Follow-up|3|||
145291001|NCT01984242|523915429|FG000|Overall Study|Sponsor Decision|1|||
145291002|NCT01984242|523915430|FG001|Overall Study|Sponsor Decision|0|||
145291003|NCT01984242|523915431|FG002|Overall Study|Sponsor Decision|0|||
145291004|NCT01984242|523915429|FG000|Overall Study|Non-Compliance|1|||
145291005|NCT01984242|523915430|FG001|Overall Study|Non-Compliance|0|||
145291006|NCT01984242|523915431|FG002|Overall Study|Non-Compliance|0|||
145291007|NCT01984242|523915429|FG000|Overall Study|Study terminated by Sponsor|38|||
145291008|NCT01984242|523915430|FG001|Overall Study|Study terminated by Sponsor|50|||
145291009|NCT01984242|523915431|FG002|Overall Study|Study terminated by Sponsor|34|||
145291010|NCT01984242|523915429|FG000|Overall Study|Disease Progression|0|||
145291011|NCT01984242|523915430|FG001|Overall Study|Disease Progression|0|||
145291012|NCT01984242|523915431|FG002|Overall Study|Disease Progression|1|||
145291013|NCT06331156|523915432|FG000|Overall Study|Adverse Event|1|||
145291014|NCT06331156|523915433|FG001|Overall Study|Adverse Event|0|||
145291015|NCT06331156|523915432|FG000|Overall Study|Lost to Follow-up|1|||
145291016|NCT06331156|523915433|FG001|Overall Study|Lost to Follow-up|0|||
145291017|NCT06331156|523915432|FG000|Overall Study|Migrated / Moved from the study area|4|||
145291018|NCT06331156|523915433|FG001|Overall Study|Migrated / Moved from the study area|3|||
145291019|NCT06331156|523915432|FG000|Overall Study|Other|7|||
145291020|NCT06331156|523915433|FG001|Overall Study|Other|0|||
145291021|NCT06331156|523915432|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
145291022|NCT06331156|523915433|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
145291023|NCT01457053|523915440|FG000|Overall Study|Unable to undergo selected treatment|1|||
145291024|NCT01457053|523915441|FG001|Overall Study|Unable to undergo selected treatment|1|||
145291025|NCT00662129|523915442|FG000|Overall Study|Protocol Violation|1|||
145291026|NCT00662129|523915442|FG000|Overall Study|Cancel prior to beginning treatment|1|||
145291027|NCT00662129|523915442|FG000|Overall Study|Ineligible|1|||
145291028|NCT03276975|523915443|FG000|Overall Study|Withdrawal by Subject|1|||
145291029|NCT03276975|523915444|FG001|Overall Study|Withdrawal by Subject|0|||
145291030|NCT02153736|523915451|FG000|Overall Study|Lost to Follow-up|1|||
145291031|NCT02153736|523915452|FG001|Overall Study|Lost to Follow-up|0|||
145291032|NCT02153736|523915451|FG000|Overall Study|Medical status change made ineligible|1|||
145291033|NCT02153736|523915452|FG001|Overall Study|Medical status change made ineligible|0|||
145291034|NCT02153736|523915451|FG000|Overall Study|Death|0|||
145291035|NCT02153736|523915452|FG001|Overall Study|Death|1|||
145291036|NCT02153736|523915451|FG000|Overall Study|Withdrawal by Subject|0|||
145291037|NCT02153736|523915452|FG001|Overall Study|Withdrawal by Subject|1|||
145291038|NCT00796510|523915461|FG000|Overall Study|Death|1|||
145291039|NCT00796510|523915462|FG001|Overall Study|Death|0|||
145291040|NCT00796510|523915461|FG000|Overall Study|Study Terminated|2|||
145291041|NCT00796510|523915462|FG001|Overall Study|Study Terminated|0|||
145291042|NCT05030753|523915463|FG000|9-week|Lost to Follow-up|10|||
145291043|NCT05030753|523915464|FG001|9-week|Lost to Follow-up|7|||
145291044|NCT05030753|523915463|FG000|9-week|Withdrawal by Subject|1|||
145291045|NCT05030753|523915464|FG001|9-week|Withdrawal by Subject|0|||
145291046|NCT05030753|523915463|FG000|9-week|Excluded from analysis due to missing covariates|2|||
145291047|NCT05030753|523915464|FG001|9-week|Excluded from analysis due to missing covariates|1|||
145291048|NCT05030753|523915463|FG000|6-month post intervention|Lost to Follow-up|5|||
145291049|NCT05030753|523915464|FG001|6-month post intervention|Lost to Follow-up|4|||
145291050|NCT05030753|523915463|FG000|6-month post intervention|Withdrawal by Subject|4|||
145291051|NCT05030753|523915464|FG001|6-month post intervention|Withdrawal by Subject|0|||
145291052|NCT05030753|523915463|FG000|18-month post intervention|Lost to Follow-up|3|||
145291053|NCT05030753|523915464|FG001|18-month post intervention|Lost to Follow-up|1|||
145291054|NCT00720122|523915470|FG000|Overall Study|Lost to Follow-up|1|||
145291055|NCT00720122|523915470|FG000|Overall Study|Physician Decision|1|||
145291056|NCT00720122|523915470|FG000|Overall Study|Withdrawal by Subject|7|||
145291057|NCT02742181|523915471|FG000|Overall Study|Physician Decision|1|||
145291058|NCT02742181|523915472|FG001|Overall Study|Physician Decision|0|||
145291059|NCT00319449|523915475|FG000|Overall Study|Subject did not wish to continue|1|||
145291060|NCT00319449|523915476|FG001|Overall Study|Subject did not wish to continue|0|||
145291061|NCT00319449|523915475|FG000|Overall Study|Noncompliance with the protocol|1|||
145291062|NCT00319449|523915476|FG001|Overall Study|Noncompliance with the protocol|0|||
145291063|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
145291064|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
145291065|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
145291066|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
145291067|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
145291068|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
145406833|NCT05493111|524345532|FG000|Overall Study|Withdrawal of Consent|19|||
145406834|NCT05493111|524345533|FG001|Overall Study|Withdrawal of Consent|10|||
145406835|NCT05493111|524345532|FG000|Overall Study|Non-compliance|1|||
145406836|NCT05493111|524345533|FG001|Overall Study|Non-compliance|1|||
145406837|NCT05493111|524345532|FG000|Overall Study|Lost to Follow-up|8|||
145406838|NCT05493111|524345533|FG001|Overall Study|Lost to Follow-up|1|||
145406839|NCT05493111|524345532|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
145406840|NCT05493111|524345533|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
145406841|NCT05493111|524345532|FG000|Overall Study|Withdrawal by Subject|1|||
145291069|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
145291070|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
145291071|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
145291072|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
145291073|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
145291074|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
145291075|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
145291076|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
145291077|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
145291078|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
145291079|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
145291080|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
145291081|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
145291082|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
145291083|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
145291084|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
145291085|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
145291086|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
145291087|NCT00455533|523915477|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
145291088|NCT00455533|523915478|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
145406842|NCT05493111|524345533|FG001|Overall Study|Withdrawal by Subject|1|||
145406843|NCT00947544|524345534|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
145406844|NCT00947544|524345535|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
145291089|NCT00455533|523915479|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
145291090|NCT00455533|523915477|FG000|Period Two: Randomized Period|Death|0|||
145291091|NCT00455533|523915478|FG001|Period Two: Randomized Period|Death|0|||
145291092|NCT00455533|523915479|FG002|Period Two: Randomized Period|Death|3|||
145291093|NCT00455533|523915477|FG000|Period Two: Randomized Period|Disease Progression|0|||
145291094|NCT00455533|523915478|FG001|Period Two: Randomized Period|Disease Progression|1|||
145291095|NCT00455533|523915479|FG002|Period Two: Randomized Period|Disease Progression|1|||
145291096|NCT00455533|523915477|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
145291097|NCT00455533|523915478|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
145291098|NCT00455533|523915479|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
145291099|NCT00455533|523915477|FG000|Period Two: Randomized Period|Other - need reasons|0|||
145291100|NCT00455533|523915478|FG001|Period Two: Randomized Period|Other - need reasons|1|||
145291101|NCT00455533|523915479|FG002|Period Two: Randomized Period|Other - need reasons|0|||
145291102|NCT00455533|523915477|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
145291103|NCT00455533|523915478|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
145291104|NCT00455533|523915479|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
145291105|NCT00455533|523915477|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
145291106|NCT00455533|523915478|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
145291107|NCT00455533|523915479|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
145291108|NCT02739984|523915480|FG000|Overall Study|Sponsor Decision|1|||
145291109|NCT02739984|523915481|FG001|Overall Study|Sponsor Decision|0|||
145291110|NCT02739984|523915480|FG000|Overall Study|Withdrawal by Subject|1|||
145291111|NCT02739984|523915481|FG001|Overall Study|Withdrawal by Subject|1|||
145291112|NCT02739984|523915480|FG000|Overall Study|Death|0|||
145406845|NCT03095287|524345539|FG000|Overall Study|Treatment Failure|1|||
145291113|NCT02739984|523915481|FG001|Overall Study|Death|1|||
145291114|NCT02739984|523915480|FG000|Overall Study|Lost to Follow-up|3|||
145291115|NCT02739984|523915481|FG001|Overall Study|Lost to Follow-up|0|||
145291116|NCT01346410|523915482|FG000|Overall Study|Death|1|||
145291117|NCT02576990|523915483|FG000|Overall Study|Death|29|||
145291118|NCT02576990|523915484|FG001|Overall Study|Death|18|||
145291119|NCT02576990|523915483|FG000|Overall Study|Physician Decision|1|||
145291120|NCT02576990|523915484|FG001|Overall Study|Physician Decision|0|||
145291121|NCT02576990|523915483|FG000|Overall Study|Screen failure|2|||
145291122|NCT02576990|523915484|FG001|Overall Study|Screen failure|0|||
145291123|NCT02576990|523915483|FG000|Overall Study|Sponsor's decision|24|||
145291124|NCT02576990|523915484|FG001|Overall Study|Sponsor's decision|4|||
145291125|NCT02576990|523915483|FG000|Overall Study|Withdrawal by Subject|0|||
145291126|NCT02576990|523915484|FG001|Overall Study|Withdrawal by Subject|2|||
145291127|NCT00979628|523915485|FG000|Overall Study|received regimen < 24 hours|7|||
145291128|NCT00979628|523915486|FG001|Overall Study|received regimen < 24 hours|6|||
145291129|NCT00979628|523915487|FG002|Overall Study|received regimen < 24 hours|5|||
145291130|NCT00979628|523915485|FG000|Overall Study|received steroids|1|||
145291131|NCT00979628|523915486|FG001|Overall Study|received steroids|1|||
145291132|NCT00979628|523915487|FG002|Overall Study|received steroids|0|||
145291133|NCT00979628|523915485|FG000|Overall Study|transferred to ICU|1|||
145291134|NCT00979628|523915486|FG001|Overall Study|transferred to ICU|2|||
145291135|NCT00979628|523915487|FG002|Overall Study|transferred to ICU|1|||
145291136|NCT00911859|523915488|FG000|Treatment Period|Adverse Event|3|||
145406846|NCT03095287|524345539|FG000|Overall Study|Adverse Event|1|||
145406847|NCT01294514|524345540|FG000|Overall Study|Excluded due to Arrhythmia|1|||
145406848|NCT02394275|524345541|FG000|Overall Study|Adverse Event|22|||
145291137|NCT00911859|523915489|FG001|Treatment Period|Adverse Event|3|||
145291138|NCT00911859|523915490|FG002|Treatment Period|Adverse Event|7|||
145291139|NCT00911859|523915488|FG000|Treatment Period|Death|1|||
145291140|NCT00911859|523915489|FG001|Treatment Period|Death|3|||
145291141|NCT00911859|523915490|FG002|Treatment Period|Death|5|||
145291142|NCT00911859|523915488|FG000|Treatment Period|Lack of Efficacy|1|||
145291143|NCT00911859|523915489|FG001|Treatment Period|Lack of Efficacy|7|||
145291144|NCT00911859|523915490|FG002|Treatment Period|Lack of Efficacy|5|||
145291145|NCT00911859|523915488|FG000|Treatment Period|Physician Decision|3|||
145291146|NCT00911859|523915489|FG001|Treatment Period|Physician Decision|3|||
145291147|NCT00911859|523915490|FG002|Treatment Period|Physician Decision|3|||
145291148|NCT00911859|523915488|FG000|Treatment Period|Withdrawal by Subject|0|||
145291149|NCT00911859|523915489|FG001|Treatment Period|Withdrawal by Subject|4|||
145406849|NCT02394275|524345541|FG000|Overall Study|Lost to Follow-up|7|||
145406850|NCT00782067|524345542|FG000|Overall Study|Adverse Event|35|||
145406851|NCT00782067|524345542|FG000|Overall Study|Subject withdrew consent|11|||
145406852|NCT00782067|524345542|FG000|Overall Study|Lost to Follow-up|2|||
145406853|NCT00782067|524345542|FG000|Overall Study|Administrative problems|14|||
145406854|NCT00782067|524345542|FG000|Overall Study|Death|9|||
145406855|NCT00782067|524345542|FG000|Overall Study|Disease progression|43|||
145406856|NCT00782067|524345542|FG000|Overall Study|Protocol deviation|2|||
145406857|NCT03813654|524345546|FG000|Overall Study|Protocol Violation|0|||
145406858|NCT03813654|524345547|FG001|Overall Study|Protocol Violation|1|||
145406859|NCT03813654|524345548|FG002|Overall Study|Protocol Violation|2|||
145406860|NCT03813654|524345546|FG000|Overall Study|Withdrawal by Subject|1|||
145406861|NCT03813654|524345547|FG001|Overall Study|Withdrawal by Subject|0|||
145406862|NCT03813654|524345548|FG002|Overall Study|Withdrawal by Subject|0|||
145406863|NCT01732692|524345550|FG000|Overall Study|Adverse Event|0|||
145406864|NCT01732692|524345551|FG001|Overall Study|Adverse Event|1|||
145406865|NCT01155323|524345552|FG000|First Intervention|exclusion criteria|1|||
145406866|NCT01155323|524345553|FG001|First Intervention|exclusion criteria|1|||
145406867|NCT01155323|524345552|FG000|Second Intervention|Lost to Follow-up|1|||
145406868|NCT01155323|524345553|FG001|Second Intervention|Lost to Follow-up|1|||
145406869|NCT00671060|524345554|FG000|Overall Study|Protocol Violation|1|||
145406870|NCT00671060|524345555|FG001|Overall Study|Protocol Violation|0|||
145406871|NCT00671060|524345554|FG000|Overall Study|Physician Decision|0|||
145406872|NCT00671060|524345555|FG001|Overall Study|Physician Decision|1|||
145406873|NCT01541748|524345556|FG000|Overall Study|Lost to Follow-up|17|||
145406874|NCT01541748|524345556|FG000|Overall Study|Moved out of state|1|||
145406875|NCT01541748|524345556|FG000|Overall Study|Withdrawal by Subject|7|||
145406876|NCT01541748|524345556|FG000|Overall Study|Screen failure|5|||
145406877|NCT01541748|524345556|FG000|Overall Study|Did not receive study device|1|||
145406878|NCT00303186|524345557|FG000|Overall Study|Other|52|||
145406879|NCT03473197|524345558|FG000|Overall Study|Adverse Event|4|||
145406880|NCT03473197|524345558|FG000|Overall Study|Lost to Follow-up|1|||
145406881|NCT03473197|524345558|FG000|Overall Study|Withdrawal by Subject|5|||
145406882|NCT01283386|524345563|FG000|Overall Study|Death|2|||
145406883|NCT01283386|524345564|FG001|Overall Study|Death|0|||
145406884|NCT01283386|524345563|FG000|Overall Study|Withdrawal by Subject|2|||
145406885|NCT01283386|524345564|FG001|Overall Study|Withdrawal by Subject|1|||
145406886|NCT01283386|524345563|FG000|Overall Study|Relapse of underlying disease|1|||
145406887|NCT01283386|524345564|FG001|Overall Study|Relapse of underlying disease|3|||
145406888|NCT01283386|524345563|FG000|Overall Study|Progression of underlying disease|2|||
145406889|NCT01283386|524345564|FG001|Overall Study|Progression of underlying disease|7|||
145406890|NCT01283386|524345563|FG000|Overall Study|Reason not specified|1|||
145406891|NCT01283386|524345564|FG001|Overall Study|Reason not specified|0|||
145406892|NCT01283386|524345563|FG000|Overall Study|Protocol Violation|0|||
145406893|NCT01283386|524345564|FG001|Overall Study|Protocol Violation|1|||
145406894|NCT02469857|524345565|FG000|Overall Study|Death|24|||
145406895|NCT02469857|524345566|FG001|Overall Study|Death|29|||
145406896|NCT02469857|524345565|FG000|Overall Study|Discontinuation|1|||
145406897|NCT02469857|524345566|FG001|Overall Study|Discontinuation|3|||
145406898|NCT00937950|524345567|FG000|Overall Study|Withdrawal by Subject|23|||
145406899|NCT00937950|524345567|FG000|Overall Study|Migrated/moved from study area|27|||
145406900|NCT00937950|524345567|FG000|Overall Study|Lost to Follow-up|144|||
145406901|NCT00937950|524345567|FG000|Overall Study|Missing confirmed|4|||
145406902|NCT00937950|524345567|FG000|Overall Study|Other|18|||
145406903|NCT01531153|524345570|FG000|Overall Study|Withdrawal by Subject|10|||
145406904|NCT01531153|524345571|FG001|Overall Study|Withdrawal by Subject|9|||
145406905|NCT01531153|524345572|FG002|Overall Study|Withdrawal by Subject|15|||
145406906|NCT03483103|524345573|FG000|Pre-Treatment Phase|Other reasons|1|||
145406907|NCT03483103|524345573|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
145406908|NCT03483103|524345573|FG000|Pre-Treatment Phase|Disease-related complications|1|||
145406909|NCT03483103|524345573|FG000|Pre-Treatment Phase|Death|5|||
145406910|NCT03483103|524345573|FG000|Treatment Phase|Withdrawal by Subject|7|||
145406911|NCT03483103|524345573|FG000|Treatment Phase|Other reasons|1|||
145406912|NCT03483103|524345573|FG000|Treatment Phase|Death|23|||
145406913|NCT03483103|524345573|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
145406914|NCT03483103|524345573|FG000|Treatment Phase|Received nonconforming product|1|||
145406915|NCT00435942|524345574|FG000|Overall Study|Death|17|||
145406916|NCT00435942|524345575|FG001|Overall Study|Death|10|||
145406917|NCT00435942|524345574|FG000|Overall Study|Withdrawal by Subject|2|||
145291150|NCT00911859|523915490|FG002|Treatment Period|Withdrawal by Subject|5|||
145291151|NCT00911859|523915488|FG000|Treatment Period|Did not receive study treatment|0|||
145291152|NCT00911859|523915489|FG001|Treatment Period|Did not receive study treatment|1|||
145291153|NCT00911859|523915490|FG002|Treatment Period|Did not receive study treatment|0|||
145291154|NCT00911859|523915488|FG000|Maintainance Period|Lack of Efficacy|0|||
145291155|NCT00911859|523915489|FG001|Maintainance Period|Lack of Efficacy|0|||
145291156|NCT00911859|523915490|FG002|Maintainance Period|Lack of Efficacy|9|||
145291157|NCT00911859|523915488|FG000|Maintainance Period|Physician Decision|0|||
145291158|NCT00911859|523915489|FG001|Maintainance Period|Physician Decision|0|||
145291159|NCT00911859|523915490|FG002|Maintainance Period|Physician Decision|9|||
145291160|NCT00911859|523915488|FG000|Maintainance Period|Withdrawal by Subject|0|||
145291161|NCT00911859|523915489|FG001|Maintainance Period|Withdrawal by Subject|0|||
145291162|NCT00911859|523915490|FG002|Maintainance Period|Withdrawal by Subject|3|||
145291163|NCT00911859|523915488|FG000|Follow-up Period|Death|5|||
145291164|NCT00911859|523915489|FG001|Follow-up Period|Death|8|||
145291165|NCT00911859|523915490|FG002|Follow-up Period|Death|10|||
145291166|NCT00911859|523915488|FG000|Follow-up Period|Lost to Follow-up|1|||
145291167|NCT00911859|523915489|FG001|Follow-up Period|Lost to Follow-up|1|||
145291168|NCT00911859|523915490|FG002|Follow-up Period|Lost to Follow-up|0|||
145291169|NCT00911859|523915488|FG000|Follow-up Period|Withdrawal by Subject|0|||
145291170|NCT00911859|523915489|FG001|Follow-up Period|Withdrawal by Subject|4|||
145291171|NCT00911859|523915490|FG002|Follow-up Period|Withdrawal by Subject|4|||
145291172|NCT00911859|523915488|FG000|Follow-up Period|Study terminated by sponsor|5|||
145291173|NCT00911859|523915489|FG001|Follow-up Period|Study terminated by sponsor|33|||
145291174|NCT00911859|523915490|FG002|Follow-up Period|Study terminated by sponsor|27|||
145291175|NCT02841709|523918340|FG000|5th Intervention|Adverse Event|2|||
145291176|NCT02841709|523918341|FG001|5th Intervention|Adverse Event|0|||
145291177|NCT02841709|523918342|FG002|5th Intervention|Adverse Event|0|||
145291178|NCT02841709|523918343|FG003|5th Intervention|Adverse Event|0|||
145291179|NCT02841709|523918344|FG004|5th Intervention|Adverse Event|2|||
145291180|NCT00797108|523918345|FG000|Overall Study|Adverse Event|1|||
145291181|NCT00797108|523918346|FG001|Overall Study|Adverse Event|0|||
145291182|NCT00797108|523918347|FG002|Overall Study|Adverse Event|3|||
145291183|NCT00797108|523918345|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
145291184|NCT00797108|523918346|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
145291185|NCT00797108|523918347|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
145291186|NCT00797108|523918345|FG000|Overall Study|Global Deterioration of Health Status|0|||
145291187|NCT00797108|523918346|FG001|Overall Study|Global Deterioration of Health Status|1|||
145291188|NCT00797108|523918347|FG002|Overall Study|Global Deterioration of Health Status|0|||
145291189|NCT00797108|523918345|FG000|Overall Study|Lack of Efficacy|1|||
145556434|NCT02554812|524895033|FG010|Overall Study|Global deterioration of health status|2|||
145556435|NCT02554812|524895034|FG011|Overall Study|Global deterioration of health status|1|||
145556436|NCT02554812|524895035|FG012|Overall Study|Global deterioration of health status|0|||
145291190|NCT00797108|523918346|FG001|Overall Study|Lack of Efficacy|0|||
145291191|NCT00797108|523918347|FG002|Overall Study|Lack of Efficacy|1|||
145291192|NCT00797108|523918345|FG000|Overall Study|Other|0|||
145291193|NCT00797108|523918346|FG001|Overall Study|Other|0|||
145291194|NCT00797108|523918347|FG002|Overall Study|Other|2|||
145291195|NCT00797108|523918345|FG000|Overall Study|Randomized but not Treated|2|||
145615931|NCT03881059|525109328|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
145615932|NCT03881059|525109329|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
145615933|NCT03881059|525109327|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
145615934|NCT03881059|525109328|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
145615935|NCT03881059|525109329|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
145615936|NCT03881059|525109327|FG000|Treatment Period - Part B|Other reasons|4|||
145615937|NCT03881059|525109328|FG001|Treatment Period - Part B|Other reasons|3|||
145615938|NCT03881059|525109329|FG002|Treatment Period - Part B|Other reasons|3|||
145291196|NCT00797108|523918346|FG001|Overall Study|Randomized but not Treated|0|||
145291197|NCT00797108|523918347|FG002|Overall Study|Randomized but not Treated|0|||
145291198|NCT02518113|523918348|FG000|Overall Study|Adverse Event|1|||
145291199|NCT02518113|523918349|FG001|Overall Study|Adverse Event|0|||
145291200|NCT02518113|523918350|FG002|Overall Study|Adverse Event|1|||
145291201|NCT02518113|523918351|FG003|Overall Study|Adverse Event|0|||
145291202|NCT02518113|523918348|FG000|Overall Study|Death|1|||
145291203|NCT02518113|523918349|FG001|Overall Study|Death|2|||
145291204|NCT02518113|523918350|FG002|Overall Study|Death|0|||
145291205|NCT02518113|523918351|FG003|Overall Study|Death|0|||
145291206|NCT02518113|523918348|FG000|Overall Study|Physician Decision|0|||
145291207|NCT02518113|523918349|FG001|Overall Study|Physician Decision|1|||
145291208|NCT02518113|523918350|FG002|Overall Study|Physician Decision|0|||
145291209|NCT02518113|523918351|FG003|Overall Study|Physician Decision|0|||
145291210|NCT02518113|523918348|FG000|Overall Study|Progressive Disease|1|||
145291211|NCT02518113|523918349|FG001|Overall Study|Progressive Disease|2|||
145291212|NCT02518113|523918350|FG002|Overall Study|Progressive Disease|3|||
145291213|NCT02518113|523918351|FG003|Overall Study|Progressive Disease|0|||
145291214|NCT00287118|523918352|FG000|Overall Study|Adverse Event|30|||
145291215|NCT00287118|523918352|FG000|Overall Study|Death|1|||
145291216|NCT00287118|523918352|FG000|Overall Study|Lack of Efficacy|11|||
145291217|NCT00287118|523918352|FG000|Overall Study|Lost to Follow-up|1|||
145291218|NCT00287118|523918352|FG000|Overall Study|Protocol Violation|2|||
145291219|NCT00287118|523918352|FG000|Overall Study|Other|7|||
145291220|NCT01631864|523918353|FG000|Overall Study|Withdrawal by Subject|0|||
145291221|NCT01631864|523918354|FG001|Overall Study|Withdrawal by Subject|1|||
145291222|NCT01631864|523918353|FG000|Overall Study|Adverse Event|2|||
145291223|NCT01631864|523918354|FG001|Overall Study|Adverse Event|3|||
145291224|NCT04373434|523918359|FG000|Overall Study|Lost to Follow-up|37|||
145291225|NCT04373434|523918360|FG001|Overall Study|Lost to Follow-up|32|||
145291226|NCT04373434|523918359|FG000|Overall Study|Refused at 9 months|1|||
145291227|NCT04373434|523918360|FG001|Overall Study|Refused at 9 months|2|||
145291228|NCT04373434|523918359|FG000|Overall Study|Refused at 4 months|7|||
145291229|NCT04373434|523918360|FG001|Overall Study|Refused at 4 months|3|||
145291230|NCT04373434|523918359|FG000|Overall Study|Excluded|2|||
145291231|NCT04373434|523918360|FG001|Overall Study|Excluded|0|||
145291232|NCT00527423|523918361|FG000|Overall Study|Protocol Violation|1|||
145615939|NCT05284019|525109330|FG000|Overall Study|Study terminated|2|||
145291233|NCT00527423|523918361|FG000|Overall Study|Adverse Event|5|||
145291234|NCT00527423|523918361|FG000|Overall Study|Physician Decision|4|||
145291235|NCT00527423|523918361|FG000|Overall Study|Withdrawal by Subject|10|||
145291236|NCT00527423|523918361|FG000|Overall Study|Lost to Follow-up|4|||
145291237|NCT00527423|523918361|FG000|Overall Study|OTHER|4|||
145291238|NCT00527423|523918361|FG000|Overall Study|Death|9|||
145291239|NCT03194464|523918365|FG000|Overall Study|data not usable|2|||
145291240|NCT01860976|523918372|FG000|Blinded Treatment|Adverse Event|1|||
145291241|NCT01860976|523918373|FG001|Blinded Treatment|Adverse Event|3|||
145406918|NCT00435942|524345575|FG001|Overall Study|Withdrawal by Subject|0|||
145406919|NCT00435942|524345574|FG000|Overall Study|Lost to Follow-up|0|||
145406920|NCT00435942|524345575|FG001|Overall Study|Lost to Follow-up|16|||
145406921|NCT00435942|524345574|FG000|Overall Study|Conversion to Open Repair|1|||
145406922|NCT00435942|524345575|FG001|Overall Study|Conversion to Open Repair|0|||
145406923|NCT00435942|524345574|FG000|Overall Study|Technical Failure|3|||
145406924|NCT00435942|524345575|FG001|Overall Study|Technical Failure|0|||
145406925|NCT00435942|524345574|FG000|Overall Study|Other|0|||
145406926|NCT00435942|524345575|FG001|Overall Study|Other|1|||
145406927|NCT01180777|524345576|FG000|Overall Study|Protocol Violation|6|||
145406928|NCT01180777|524345576|FG000|Overall Study|Poor lens fit|4|||
145406929|NCT01180777|524345576|FG000|Overall Study|Lost to Follow-up|1|||
145406930|NCT01180777|524345576|FG000|Overall Study|Adverse Event|1|||
145406931|NCT04167462|524345579|FG000|Overall Study|Other reasons|3|||
145406932|NCT04167462|524345580|FG001|Overall Study|Other reasons|2|||
145406933|NCT04167462|524345579|FG000|Overall Study|Withdrawal by Subject|6|||
145406934|NCT04167462|524345580|FG001|Overall Study|Withdrawal by Subject|7|||
145406935|NCT04167462|524345579|FG000|Overall Study|Adverse Event|4|||
145406936|NCT04167462|524345580|FG001|Overall Study|Adverse Event|0|||
145406937|NCT04167462|524345579|FG000|Overall Study|Pregnancy|1|||
145406938|NCT04167462|524345580|FG001|Overall Study|Pregnancy|0|||
145406939|NCT04167462|524345579|FG000|Overall Study|Lack of Efficacy|0|||
145406940|NCT04167462|524345580|FG001|Overall Study|Lack of Efficacy|1|||
145406941|NCT02320396|524345581|FG000|Overall Study|Adverse Event|2|||
145406942|NCT02320396|524345582|FG001|Overall Study|Adverse Event|2|||
145406943|NCT02320396|524345581|FG000|Overall Study|Pregnancy|0|||
145406944|NCT02320396|524345582|FG001|Overall Study|Pregnancy|1|||
145291242|NCT01860976|523918372|FG000|Blinded Treatment|Lack of Efficacy|5|||
145291243|NCT01860976|523918373|FG001|Blinded Treatment|Lack of Efficacy|12|||
145291244|NCT01860976|523918372|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
145291245|NCT01860976|523918373|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
145291246|NCT01860976|523918372|FG000|Blinded Treatment|Withdrawal by Subject|3|||
145291247|NCT01860976|523918373|FG001|Blinded Treatment|Withdrawal by Subject|5|||
145291248|NCT01860976|523918372|FG000|Blinded Treatment|Subject no longer met criteria|1|||
145291249|NCT01860976|523918373|FG001|Blinded Treatment|Subject no longer met criteria|0|||
145291250|NCT01860976|523918372|FG000|Blinded Treatment|Entered Open-Label in error|0|||
145291251|NCT01860976|523918373|FG001|Blinded Treatment|Entered Open-Label in error|1|||
145291252|NCT01860976|523918372|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
145291253|NCT01860976|523918373|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
145291254|NCT01860976|523918372|FG000|Open-Label|Adverse Event|2|||
145291255|NCT01860976|523918373|FG001|Open-Label|Adverse Event|4|||
145291256|NCT01860976|523918372|FG000|Open-Label|Lack of Efficacy|16|||
145291257|NCT01860976|523918373|FG001|Open-Label|Lack of Efficacy|8|||
145291258|NCT01860976|523918372|FG000|Open-Label|Lost to Follow-up|1|||
145291259|NCT01860976|523918373|FG001|Open-Label|Lost to Follow-up|2|||
145291260|NCT01860976|523918372|FG000|Open-Label|Subject request discontinue treatment|4|||
145291261|NCT01860976|523918373|FG001|Open-Label|Subject request discontinue treatment|3|||
145291262|NCT01860976|523918372|FG000|Open-Label|Withdrawal by Subject|4|||
145291263|NCT01860976|523918373|FG001|Open-Label|Withdrawal by Subject|1|||
145291264|NCT01860976|523918372|FG000|Open-Label|Other Reasons|1|||
145291265|NCT01860976|523918373|FG001|Open-Label|Other Reasons|1|||
145291266|NCT01860976|523918372|FG000|Long Term Extension|Adverse Event|4|||
145291267|NCT01860976|523918373|FG001|Long Term Extension|Adverse Event|0|||
145291268|NCT01860976|523918372|FG000|Long Term Extension|Lack of Efficacy|2|||
145291269|NCT01860976|523918373|FG001|Long Term Extension|Lack of Efficacy|0|||
145291270|NCT01860976|523918372|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
145291271|NCT01860976|523918373|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
145291272|NCT01860976|523918372|FG000|Long Term Extension|Lost to Follow-up|2|||
145291273|NCT01860976|523918373|FG001|Long Term Extension|Lost to Follow-up|0|||
145291274|NCT01860976|523918372|FG000|Long Term Extension|subject withdrew consent|7|||
145291275|NCT01860976|523918373|FG001|Long Term Extension|subject withdrew consent|0|||
145291276|NCT02354586|523918374|FG000|Overall Study|Death|230|||
145406945|NCT02320396|524345581|FG000|Overall Study|Protocol Violation|0|||
145406946|NCT02320396|524345582|FG001|Overall Study|Protocol Violation|1|||
145406947|NCT02320396|524345581|FG000|Overall Study|Withdrawal by Subject|2|||
145291277|NCT02354586|523918374|FG000|Overall Study|Withdrawal by Subject|59|||
145291278|NCT02354586|523918374|FG000|Overall Study|Lost to Follow-up|11|||
145406948|NCT02320396|524345582|FG001|Overall Study|Withdrawal by Subject|0|||
145406949|NCT03331562|524345583|FG000|Overall Study|Adverse Event|2|||
145406950|NCT03331562|524345584|FG001|Overall Study|Adverse Event|0|||
145291279|NCT02354586|523918374|FG000|Overall Study|Sponsor decision|51|||
145291280|NCT02354586|523918374|FG000|Overall Study|Site closure|2|||
145291281|NCT02354586|523918374|FG000|Overall Study|Intercurrent illness|1|||
145291282|NCT02354586|523918374|FG000|Overall Study|Protocol Violation|3|||
145291283|NCT02354586|523918374|FG000|Overall Study|Physician Decision|13|||
145291284|NCT02354586|523918374|FG000|Overall Study|Lack of Efficacy|86|||
145291285|NCT02354586|523918374|FG000|Overall Study|Adverse Event|7|||
145291286|NCT02153398|523918375|FG000|Overall Study|Withdrawal by Subject|1|||
145291287|NCT02153398|523918376|FG001|Overall Study|Withdrawal by Subject|0|||
145291288|NCT02153398|523918377|FG002|Overall Study|Withdrawal by Subject|0|||
145291289|NCT02153398|523918378|FG003|Overall Study|Withdrawal by Subject|0|||
145291290|NCT02153398|523918379|FG004|Overall Study|Withdrawal by Subject|0|||
145291291|NCT02153398|523918375|FG000|Overall Study|Adverse Event|0|||
145291292|NCT02153398|523918376|FG001|Overall Study|Adverse Event|0|||
145291293|NCT02153398|523918377|FG002|Overall Study|Adverse Event|1|||
145291294|NCT02153398|523918378|FG003|Overall Study|Adverse Event|1|||
145291295|NCT02153398|523918379|FG004|Overall Study|Adverse Event|0|||
145291296|NCT01400425|523918380|FG000|Overall Study|Withdrawal by Subject|10|||
145291297|NCT00818883|523918381|FG000|Overall Study|Adverse Event|28|||
145291298|NCT00818883|523918382|FG001|Overall Study|Adverse Event|19|||
145291299|NCT00818883|523918381|FG000|Overall Study|Protocol Violation|2|||
145291300|NCT00818883|523918382|FG001|Overall Study|Protocol Violation|2|||
145291301|NCT00818883|523918381|FG000|Overall Study|Lost to Follow-up|3|||
145291302|NCT00818883|523918382|FG001|Overall Study|Lost to Follow-up|2|||
145291303|NCT00818883|523918381|FG000|Overall Study|Withdrawal by Subject|16|||
145291304|NCT00818883|523918382|FG001|Overall Study|Withdrawal by Subject|14|||
145291305|NCT00818883|523918381|FG000|Overall Study|Lack of Efficacy|0|||
145291306|NCT00818883|523918382|FG001|Overall Study|Lack of Efficacy|2|||
145291307|NCT00818883|523918381|FG000|Overall Study|Other|2|||
145291308|NCT00818883|523918382|FG001|Overall Study|Other|7|||
145291309|NCT00454636|523918383|FG000|Overall Study|Adverse Event|10|||
145291310|NCT00454636|523918384|FG001|Overall Study|Adverse Event|6|||
145291311|NCT00454636|523918385|FG002|Overall Study|Adverse Event|9|||
145291312|NCT00454636|523918386|FG003|Overall Study|Adverse Event|15|||
145291313|NCT00454636|523918383|FG000|Overall Study|Disease Progression|11|||
145291314|NCT00454636|523918384|FG001|Overall Study|Disease Progression|12|||
145291315|NCT00454636|523918385|FG002|Overall Study|Disease Progression|4|||
145291316|NCT00454636|523918386|FG003|Overall Study|Disease Progression|11|||
145291317|NCT00454636|523918383|FG000|Overall Study|Protocol Violation|3|||
145291318|NCT00454636|523918384|FG001|Overall Study|Protocol Violation|2|||
145291319|NCT00454636|523918385|FG002|Overall Study|Protocol Violation|3|||
145291320|NCT00454636|523918386|FG003|Overall Study|Protocol Violation|3|||
145291321|NCT00454636|523918383|FG000|Overall Study|Death|6|||
145291322|NCT00454636|523918384|FG001|Overall Study|Death|1|||
145291323|NCT00454636|523918385|FG002|Overall Study|Death|1|||
145291324|NCT00454636|523918386|FG003|Overall Study|Death|1|||
145291325|NCT00454636|523918383|FG000|Overall Study|Patient refusal|1|||
145291326|NCT00454636|523918384|FG001|Overall Study|Patient refusal|1|||
145291327|NCT00454636|523918385|FG002|Overall Study|Patient refusal|3|||
145291328|NCT00454636|523918386|FG003|Overall Study|Patient refusal|2|||
145291329|NCT00454636|523918383|FG000|Overall Study|Lost to Follow-up|0|||
145291330|NCT00454636|523918384|FG001|Overall Study|Lost to Follow-up|1|||
145291331|NCT00454636|523918385|FG002|Overall Study|Lost to Follow-up|0|||
145291332|NCT00454636|523918386|FG003|Overall Study|Lost to Follow-up|0|||
145291333|NCT01400113|523918387|FG000|Overall Study|Withdrawal by Subject|1|||
145291334|NCT01400113|523918388|FG001|Overall Study|Withdrawal by Subject|1|||
145406951|NCT03331562|524345583|FG000|Overall Study|Death|1|||
145406952|NCT03331562|524345584|FG001|Overall Study|Death|0|||
145406953|NCT03718000|524345585|FG000|Overall Study|Relocation|2|||
145406954|NCT03718000|524345586|FG001|Overall Study|Relocation|4|||
145406955|NCT03718000|524345585|FG000|Overall Study|Pregnancy|0|||
145556437|NCT02554812|524895036|FG013|Overall Study|Global deterioration of health status|0|||
145291335|NCT01890915|523918396|FG000|Overall Study|Adverse Event|1|||
145556438|NCT02554812|524895037|FG014|Overall Study|Global deterioration of health status|0|||
145291336|NCT01890915|523918397|FG001|Overall Study|Adverse Event|0|||
145406956|NCT03718000|524345586|FG001|Overall Study|Pregnancy|1|||
145291337|NCT01890915|523918396|FG000|Overall Study|Protocol Violation|2|||
145291338|NCT01890915|523918397|FG001|Overall Study|Protocol Violation|0|||
145291339|NCT01890915|523918396|FG000|Overall Study|Equipment Malfunction|0|||
145291340|NCT01890915|523918397|FG001|Overall Study|Equipment Malfunction|1|||
145291341|NCT02114697|523918398|FG000|Overall Study|Study terminated|5|||
145291342|NCT02114697|523918399|FG001|Overall Study|Study terminated|4|||
145291343|NCT00424489|523918400|FG000|Overall Study|Death|3|||
145291344|NCT00449150|523918401|FG000|Overall Study|Adverse Event|11|||
145291345|NCT00449150|523918402|FG001|Overall Study|Adverse Event|18|||
145291346|NCT00449150|523918403|FG002|Overall Study|Adverse Event|9|||
145291347|NCT00449150|523918401|FG000|Overall Study|Lack of Efficacy|1|||
145291348|NCT00449150|523918402|FG001|Overall Study|Lack of Efficacy|2|||
145291349|NCT00449150|523918403|FG002|Overall Study|Lack of Efficacy|2|||
145291350|NCT00449150|523918401|FG000|Overall Study|Other|16|||
145291351|NCT00449150|523918402|FG001|Overall Study|Other|13|||
145291352|NCT00449150|523918403|FG002|Overall Study|Other|14|||
145291353|NCT00449150|523918401|FG000|Overall Study|Withdrawal by Subject|17|||
145291354|NCT00449150|523918402|FG001|Overall Study|Withdrawal by Subject|18|||
145291355|NCT00449150|523918403|FG002|Overall Study|Withdrawal by Subject|21|||
145291356|NCT00449150|523918401|FG000|Overall Study|Protocol Violation|1|||
145291357|NCT00449150|523918402|FG001|Overall Study|Protocol Violation|2|||
145291358|NCT00449150|523918403|FG002|Overall Study|Protocol Violation|1|||
145291359|NCT03552757|523918405|FG000|Overall Study|Withdrawal by Subject|10|||
145291360|NCT03552757|523918406|FG001|Overall Study|Withdrawal by Subject|5|||
145291361|NCT03552757|523918407|FG002|Overall Study|Withdrawal by Subject|12|||
145291362|NCT03552757|523918405|FG000|Overall Study|Lost to Follow-up|2|||
145291363|NCT03552757|523918406|FG001|Overall Study|Lost to Follow-up|7|||
145291364|NCT03552757|523918407|FG002|Overall Study|Lost to Follow-up|7|||
145291365|NCT03552757|523918405|FG000|Overall Study|Death|1|||
145291366|NCT03552757|523918406|FG001|Overall Study|Death|1|||
145291367|NCT03552757|523918407|FG002|Overall Study|Death|1|||
145291368|NCT00770510|523918409|FG000|Overall Study|Lost to Follow-up|2|||
145291369|NCT00770510|523918409|FG000|Overall Study|Pregnancy|1|||
145291370|NCT00770510|523918409|FG000|Overall Study|Withdrawal by Subject|2|||
145291371|NCT02246478|523918414|FG000|Multiple-dose Phase|Protocol Violation|1|||
145291372|NCT02246478|523918415|FG001|Multiple-dose Phase|Protocol Violation|0|||
145291373|NCT02246478|523918416|FG002|Multiple-dose Phase|Protocol Violation|0|||
145291374|NCT02246478|523918417|FG003|Multiple-dose Phase|Protocol Violation|1|||
145291375|NCT00536575|523918420|FG000|Overall Study|Withdrawal by Subject|1|||
145291376|NCT00536575|523918420|FG000|Overall Study|Death|1|||
145291377|NCT01089647|523918421|FG000|Overall Study|Lost to Follow-up|2|||
145291378|NCT01089647|523918422|FG001|Overall Study|Lost to Follow-up|2|||
145291379|NCT01089647|523918421|FG000|Overall Study|Withdrawal by Subject|2|||
145291380|NCT01089647|523918422|FG001|Overall Study|Withdrawal by Subject|1|||
145291381|NCT01089647|523918421|FG000|Overall Study|Adverse Event|0|||
145291382|NCT01089647|523918422|FG001|Overall Study|Adverse Event|1|||
145291383|NCT00927810|523918423|FG000|Overall Study|Withdrawal by Subject|0|||
145291384|NCT00927810|523918424|FG001|Overall Study|Withdrawal by Subject|3|||
145291385|NCT00927810|523918425|FG002|Overall Study|Withdrawal by Subject|0|||
145291386|NCT00927810|523918426|FG003|Overall Study|Withdrawal by Subject|1|||
145291387|NCT00927810|523918423|FG000|Overall Study|Lost to Follow-up|0|||
145291388|NCT00927810|523918424|FG001|Overall Study|Lost to Follow-up|2|||
145291389|NCT00927810|523918425|FG002|Overall Study|Lost to Follow-up|1|||
145291390|NCT00927810|523918426|FG003|Overall Study|Lost to Follow-up|1|||
145291391|NCT00927810|523918423|FG000|Overall Study|Death|0|||
145291392|NCT00927810|523918424|FG001|Overall Study|Death|2|||
145291393|NCT00927810|523918425|FG002|Overall Study|Death|0|||
145291394|NCT00927810|523918426|FG003|Overall Study|Death|0|||
145291395|NCT00927810|523918423|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145291396|NCT00927810|523918424|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145291397|NCT00927810|523918425|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145291398|NCT00927810|523918426|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145291399|NCT00198029|523918430|FG000|Overall Study|Withdrawal by Subject|4|||
145291400|NCT02465567|523918431|FG000|Overall Study|Adverse Event|118|||
145291401|NCT02465567|523918432|FG001|Overall Study|Adverse Event|113|||
145291402|NCT02465567|523918433|FG002|Overall Study|Adverse Event|147|||
145291403|NCT02465567|523918434|FG003|Overall Study|Adverse Event|138|||
145291404|NCT02465567|523918431|FG000|Overall Study|Lack of Efficacy|103|||
145291405|NCT02465567|523918432|FG001|Overall Study|Lack of Efficacy|102|||
145291406|NCT02465567|523918433|FG002|Overall Study|Lack of Efficacy|171|||
145291407|NCT02465567|523918434|FG003|Overall Study|Lack of Efficacy|135|||
145291408|NCT02465567|523918431|FG000|Overall Study|Withdrawal by Subject|104|||
145291409|NCT02465567|523918432|FG001|Overall Study|Withdrawal by Subject|94|||
145291410|NCT02465567|523918433|FG002|Overall Study|Withdrawal by Subject|123|||
145291411|NCT02465567|523918434|FG003|Overall Study|Withdrawal by Subject|130|||
145291412|NCT02465567|523918431|FG000|Overall Study|Physician Decision|23|||
145291413|NCT02465567|523918432|FG001|Overall Study|Physician Decision|33|||
145291414|NCT02465567|523918433|FG002|Overall Study|Physician Decision|38|||
145291415|NCT02465567|523918434|FG003|Overall Study|Physician Decision|28|||
145291416|NCT02465567|523918431|FG000|Overall Study|Major Protocol Deviation|24|||
145291417|NCT02465567|523918432|FG001|Overall Study|Major Protocol Deviation|26|||
145291418|NCT02465567|523918433|FG002|Overall Study|Major Protocol Deviation|22|||
145291419|NCT02465567|523918434|FG003|Overall Study|Major Protocol Deviation|25|||
145291420|NCT02465567|523918431|FG000|Overall Study|Lost to Follow-up|25|||
145291421|NCT02465567|523918432|FG001|Overall Study|Lost to Follow-up|21|||
145291422|NCT02465567|523918433|FG002|Overall Study|Lost to Follow-up|19|||
145291423|NCT02465567|523918434|FG003|Overall Study|Lost to Follow-up|15|||
145291424|NCT02465567|523918431|FG000|Overall Study|Protocol Specified Criteria|20|||
145291425|NCT02465567|523918432|FG001|Overall Study|Protocol Specified Criteria|10|||
145291426|NCT02465567|523918433|FG002|Overall Study|Protocol Specified Criteria|9|||
145291427|NCT02465567|523918434|FG003|Overall Study|Protocol Specified Criteria|12|||
145291428|NCT02465567|523918431|FG000|Overall Study|Administrative Reasons|12|||
145406957|NCT02475213|524345589|FG000|Overall Study|Adverse Event|2|||
145291429|NCT02465567|523918432|FG001|Overall Study|Administrative Reasons|9|||
145291430|NCT02465567|523918433|FG002|Overall Study|Administrative Reasons|11|||
145291431|NCT02465567|523918434|FG003|Overall Study|Administrative Reasons|5|||
145291432|NCT02465567|523918431|FG000|Overall Study|Randomized but not treated|1|||
145291433|NCT02465567|523918432|FG001|Overall Study|Randomized but not treated|5|||
145291434|NCT02465567|523918433|FG002|Overall Study|Randomized but not treated|4|||
145291435|NCT02465567|523918434|FG003|Overall Study|Randomized but not treated|5|||
145291436|NCT02465567|523918431|FG000|Overall Study|enrolled in >1 studies|18|||
145615940|NCT05284019|525109331|FG001|Overall Study|Study terminated|2|||
145615941|NCT05284019|525109332|FG002|Overall Study|Study terminated|2|||
145615942|NCT05284019|525109333|FG003|Overall Study|Study terminated|5|||
145291437|NCT02465567|523918432|FG001|Overall Study|enrolled in >1 studies|11|||
145291438|NCT02465567|523918433|FG002|Overall Study|enrolled in >1 studies|19|||
145291439|NCT02465567|523918434|FG003|Overall Study|enrolled in >1 studies|15|||
145291440|NCT02465567|523918431|FG000|Overall Study|missing PI Signature|1|||
145406958|NCT02475213|524345590|FG001|Overall Study|Adverse Event|0|||
145406959|NCT02475213|524345591|FG002|Overall Study|Adverse Event|0|||
145406960|NCT02475213|524345592|FG003|Overall Study|Adverse Event|1|||
145406961|NCT02475213|524345593|FG004|Overall Study|Adverse Event|1|||
145406962|NCT02475213|524345594|FG005|Overall Study|Adverse Event|4|||
145406963|NCT02475213|524345595|FG006|Overall Study|Adverse Event|6|||
145406964|NCT02475213|524345596|FG007|Overall Study|Adverse Event|2|||
145406965|NCT02475213|524345589|FG000|Overall Study|Physician Decision|1|||
145406966|NCT02475213|524345590|FG001|Overall Study|Physician Decision|1|||
145406967|NCT02475213|524345591|FG002|Overall Study|Physician Decision|1|||
145291441|NCT02465567|523918432|FG001|Overall Study|missing PI Signature|0|||
145291442|NCT02465567|523918433|FG002|Overall Study|missing PI Signature|0|||
145291443|NCT02465567|523918434|FG003|Overall Study|missing PI Signature|0|||
145291444|NCT02001558|523918435|FG000|Overall Study|Lost to Follow-up|8|||
145291445|NCT02001558|523918436|FG001|Overall Study|Lost to Follow-up|14|||
145291446|NCT04117607|523918437|FG000|Overall Study|Early Termination|0|||
145291447|NCT04117607|523918438|FG001|Overall Study|Early Termination|1|||
145291448|NCT04117607|523918439|FG002|Overall Study|Early Termination|0|||
145291449|NCT04117607|523918440|FG003|Overall Study|Early Termination|0|||
145291450|NCT04117607|523918441|FG004|Overall Study|Early Termination|0|||
145291451|NCT04117607|523918442|FG005|Overall Study|Early Termination|0|||
145291452|NCT04117607|523918443|FG006|Overall Study|Early Termination|1|||
145291453|NCT04117607|523918444|FG007|Overall Study|Early Termination|0|||
145291454|NCT04117607|523918445|FG008|Overall Study|Early Termination|0|||
145291455|NCT04117607|523918446|FG009|Overall Study|Early Termination|0|||
145291456|NCT04117607|523918447|FG010|Overall Study|Early Termination|0|||
145291457|NCT04117607|523918448|FG011|Overall Study|Early Termination|0|||
145291458|NCT04117607|523918449|FG012|Overall Study|Early Termination|0|||
145291459|NCT04117607|523918450|FG013|Overall Study|Early Termination|0|||
145291460|NCT01626079|523918452|FG000|Overall Study|Death|167|||
145291461|NCT01626079|523918453|FG001|Overall Study|Death|192|||
145291462|NCT01626079|523918454|FG002|Overall Study|Death|39|||
145291463|NCT01626079|523918452|FG000|Overall Study|Withdrawal by Subject|23|||
145291464|NCT01626079|523918453|FG001|Overall Study|Withdrawal by Subject|37|||
145291465|NCT01626079|523918454|FG002|Overall Study|Withdrawal by Subject|5|||
145291466|NCT01626079|523918452|FG000|Overall Study|Lost to Follow-up|7|||
145291467|NCT01626079|523918453|FG001|Overall Study|Lost to Follow-up|4|||
145291468|NCT01626079|523918454|FG002|Overall Study|Lost to Follow-up|2|||
145291469|NCT01626079|523918452|FG000|Overall Study|Missed Visits|1|||
145291470|NCT01626079|523918453|FG001|Overall Study|Missed Visits|4|||
145615943|NCT05284019|525109334|FG004|Overall Study|Study terminated|15|||
145291471|NCT01626079|523918454|FG002|Overall Study|Missed Visits|6|||
145615944|NCT05284019|525109330|FG000|Overall Study|Withdrawal by Subject|0|||
145291472|NCT00814463|523918456|FG000|Overall Study|Lost to Follow-up|1|||
145291473|NCT02780687|523918458|FG000|Overall Study|Adverse Event|1|||
145291474|NCT02780687|523918459|FG001|Overall Study|Adverse Event|1|||
145291475|NCT02780687|523918458|FG000|Overall Study|Withdrawal by Subject|2|||
145291476|NCT02780687|523918459|FG001|Overall Study|Withdrawal by Subject|1|||
145291477|NCT02780687|523918458|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
145291478|NCT02780687|523918459|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
145291479|NCT02780687|523918458|FG000|Overall Study|progressive disease|29|||
145291480|NCT02780687|523918459|FG001|Overall Study|progressive disease|6|||
145291481|NCT02430870|523918460|FG000|Part 2|Voluntary Withdrawal|0|||
145291482|NCT02430870|523918461|FG001|Part 2|Voluntary Withdrawal|0|||
145291483|NCT02430870|523918462|FG002|Part 2|Voluntary Withdrawal|0|||
145291484|NCT02430870|523918463|FG003|Part 2|Voluntary Withdrawal|0|||
145291485|NCT02430870|523918464|FG004|Part 2|Voluntary Withdrawal|0|||
145291486|NCT02430870|523918465|FG005|Part 2|Voluntary Withdrawal|0|||
145291487|NCT02430870|523918466|FG006|Part 2|Voluntary Withdrawal|1|||
145291488|NCT02430870|523918467|FG007|Part 2|Voluntary Withdrawal|0|||
145291489|NCT02430870|523918460|FG000|Part 2|Other Reason Not Specified|0|||
145291490|NCT02430870|523918461|FG001|Part 2|Other Reason Not Specified|0|||
145291491|NCT02430870|523918462|FG002|Part 2|Other Reason Not Specified|0|||
145291492|NCT02430870|523918463|FG003|Part 2|Other Reason Not Specified|0|||
145291493|NCT02430870|523918464|FG004|Part 2|Other Reason Not Specified|0|||
145291494|NCT02430870|523918465|FG005|Part 2|Other Reason Not Specified|0|||
145291495|NCT02430870|523918466|FG006|Part 2|Other Reason Not Specified|0|||
145291496|NCT02430870|523918467|FG007|Part 2|Other Reason Not Specified|1|||
145291497|NCT03982433|523918468|FG000|Overall Study|Lost to Follow-up|1|||
145291498|NCT04257929|523918471|FG000|Overall Study|Adverse Event|1|||
145291499|NCT04257929|523918472|FG001|Overall Study|Adverse Event|0|||
145291500|NCT04257929|523918473|FG002|Overall Study|Adverse Event|1|||
145291501|NCT04257929|523918471|FG000|Overall Study|Withdrawal by Subject|1|||
145291502|NCT04257929|523918472|FG001|Overall Study|Withdrawal by Subject|0|||
145291503|NCT04257929|523918473|FG002|Overall Study|Withdrawal by Subject|0|||
145291504|NCT04257929|523918471|FG000|Overall Study|COVID-19|0|||
145291505|NCT04257929|523918472|FG001|Overall Study|COVID-19|1|||
145291506|NCT04257929|523918473|FG002|Overall Study|COVID-19|1|||
145291507|NCT04257929|523918471|FG000|Overall Study|Lost to Follow-up|0|||
145291508|NCT04257929|523918472|FG001|Overall Study|Lost to Follow-up|0|||
145291509|NCT04257929|523918473|FG002|Overall Study|Lost to Follow-up|1|||
145291510|NCT05049460|523918474|FG000|Overall Study|Withdrawal by Subject|2|||
145291511|NCT05049460|523918475|FG001|Overall Study|Withdrawal by Subject|2|||
145291512|NCT05049460|523918474|FG000|Overall Study|Lost to Follow-up|2|||
145291513|NCT05049460|523918475|FG001|Overall Study|Lost to Follow-up|2|||
145291514|NCT04333095|523918480|FG000|Overall Study|Protocol Violation|4|||
145291515|NCT04333095|523918481|FG001|Overall Study|Protocol Violation|0|||
145291516|NCT04333095|523918480|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
145291517|NCT04333095|523918481|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
145291518|NCT04333095|523918480|FG000|Overall Study|Mini Sternotomy|4|||
145291519|NCT04333095|523918481|FG001|Overall Study|Mini Sternotomy|5|||
145291520|NCT00984295|523918482|FG000|Overall Study|Lost to Follow-up|31|||
145291521|NCT00984295|523918483|FG001|Overall Study|Lost to Follow-up|12|||
145291522|NCT00984295|523918484|FG002|Overall Study|Lost to Follow-up|13|||
145291523|NCT00984295|523918482|FG000|Overall Study|Protocol Violation|2|||
145291524|NCT00984295|523918483|FG001|Overall Study|Protocol Violation|1|||
145291525|NCT00984295|523918484|FG002|Overall Study|Protocol Violation|4|||
145291526|NCT00984295|523918482|FG000|Overall Study|Withdrawal by Subject|18|||
145291527|NCT00984295|523918483|FG001|Overall Study|Withdrawal by Subject|9|||
145556439|NCT02554812|524895038|FG015|Overall Study|Global deterioration of health status|1|||
145291528|NCT00984295|523918484|FG002|Overall Study|Withdrawal by Subject|12|||
145291529|NCT00984295|523918482|FG000|Overall Study|CAE - discontinued test vaccine|0|||
145291530|NCT00984295|523918483|FG001|Overall Study|CAE - discontinued test vaccine|1|||
145291531|NCT00984295|523918484|FG002|Overall Study|CAE - discontinued test vaccine|3|||
145291532|NCT00984295|523918482|FG000|Overall Study|Missed one or more blood samplings|3|||
145291533|NCT00984295|523918483|FG001|Overall Study|Missed one or more blood samplings|7|||
145291534|NCT00984295|523918484|FG002|Overall Study|Missed one or more blood samplings|2|||
145291535|NCT00984295|523918482|FG000|Overall Study|Incomplete safety follow-up|11|||
145291536|NCT00984295|523918483|FG001|Overall Study|Incomplete safety follow-up|2|||
145291537|NCT00984295|523918484|FG002|Overall Study|Incomplete safety follow-up|3|||
145291538|NCT03740165|523918485|FG000|Overall Study|Death|232|||
145291539|NCT03740165|523918486|FG001|Overall Study|Death|242|||
145291540|NCT03740165|523918487|FG002|Overall Study|Death|229|||
145291541|NCT03740165|523918485|FG000|Overall Study|Lost to Follow-up|0|||
145291542|NCT03740165|523918486|FG001|Overall Study|Lost to Follow-up|0|||
145291543|NCT03740165|523918487|FG002|Overall Study|Lost to Follow-up|1|||
145291544|NCT03740165|523918485|FG000|Overall Study|Withdrawal by Subject|7|||
145291545|NCT03740165|523918486|FG001|Overall Study|Withdrawal by Subject|4|||
145291546|NCT03740165|523918487|FG002|Overall Study|Withdrawal by Subject|3|||
145291547|NCT03740165|523918485|FG000|Overall Study|Ongoing in Study|216|||
145291548|NCT03740165|523918486|FG001|Overall Study|Ongoing in Study|212|||
145291549|NCT03740165|523918487|FG002|Overall Study|Ongoing in Study|221|||
145291550|NCT03049618|523918488|FG000|Overall Study|Death|1|||
145291551|NCT03049618|523918489|FG001|Overall Study|Death|0|||
145291552|NCT03049618|523918488|FG000|Overall Study|Lack of Efficacy|1|||
145291553|NCT03049618|523918489|FG001|Overall Study|Lack of Efficacy|2|||
145291554|NCT04582539|523918490|FG000|Overall Study|Death|1|||
145291555|NCT04582539|523918491|FG001|Overall Study|Death|1|||
145291556|NCT04582539|523918492|FG002|Overall Study|Death|0|||
145291557|NCT04582539|523918493|FG003|Overall Study|Death|1|||
145291558|NCT04582539|523918494|FG004|Overall Study|Death|0|||
145291559|NCT04582539|523918490|FG000|Overall Study|Lost to Follow-up|1|||
145291560|NCT04582539|523918491|FG001|Overall Study|Lost to Follow-up|0|||
145291561|NCT04582539|523918492|FG002|Overall Study|Lost to Follow-up|0|||
145291562|NCT04582539|523918493|FG003|Overall Study|Lost to Follow-up|0|||
145291563|NCT04582539|523918494|FG004|Overall Study|Lost to Follow-up|0|||
145291564|NCT04582539|523918490|FG000|Overall Study|Study Terminated by Sponsor|1|||
145291565|NCT04582539|523918491|FG001|Overall Study|Study Terminated by Sponsor|3|||
145291566|NCT04582539|523918492|FG002|Overall Study|Study Terminated by Sponsor|2|||
145291567|NCT04582539|523918493|FG003|Overall Study|Study Terminated by Sponsor|2|||
145291568|NCT04582539|523918494|FG004|Overall Study|Study Terminated by Sponsor|3|||
145291569|NCT04582539|523918490|FG000|Overall Study|Physician Decision|0|||
145291570|NCT04582539|523918491|FG001|Overall Study|Physician Decision|1|||
145291571|NCT04582539|523918492|FG002|Overall Study|Physician Decision|0|||
145291572|NCT04582539|523918493|FG003|Overall Study|Physician Decision|0|||
145291573|NCT04582539|523918494|FG004|Overall Study|Physician Decision|0|||
145291574|NCT04582539|523918490|FG000|Overall Study|Withdrawal by Subject|1|||
145291575|NCT04582539|523918491|FG001|Overall Study|Withdrawal by Subject|0|||
145291576|NCT04582539|523918492|FG002|Overall Study|Withdrawal by Subject|2|||
145291577|NCT04582539|523918493|FG003|Overall Study|Withdrawal by Subject|1|||
145291578|NCT04582539|523918494|FG004|Overall Study|Withdrawal by Subject|0|||
145291579|NCT04582539|523918490|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
145291580|NCT04582539|523918491|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
145291581|NCT04582539|523918492|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
145291582|NCT04582539|523918493|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
145291583|NCT04582539|523918494|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
145291584|NCT00788957|523918503|FG000|Part 1|Death|8|||
145291585|NCT00788957|523918504|FG001|Part 1|Death|0|||
145291586|NCT00788957|523918505|FG002|Part 1|Death|0|||
145291587|NCT00788957|523918506|FG003|Part 1|Death|0|||
145291588|NCT00788957|523918507|FG004|Part 1|Death|0|||
145291589|NCT00788957|523918508|FG005|Part 1|Death|0|||
145291590|NCT00788957|523918503|FG000|Part 1|Lost to Follow-up|1|||
145556440|NCT02554812|524895039|FG016|Overall Study|Global deterioration of health status|0|||
145291591|NCT00788957|523918504|FG001|Part 1|Lost to Follow-up|0|||
145291592|NCT00788957|523918505|FG002|Part 1|Lost to Follow-up|0|||
145291593|NCT00788957|523918506|FG003|Part 1|Lost to Follow-up|0|||
145291594|NCT00788957|523918507|FG004|Part 1|Lost to Follow-up|0|||
145291595|NCT00788957|523918508|FG005|Part 1|Lost to Follow-up|0|||
145291596|NCT00788957|523918503|FG000|Part 2|Withdrawal by Subject|0|||
145291597|NCT00788957|523918504|FG001|Part 2|Withdrawal by Subject|9|||
145291598|NCT00788957|523918505|FG002|Part 2|Withdrawal by Subject|5|||
145291599|NCT00788957|523918506|FG003|Part 2|Withdrawal by Subject|3|||
145291600|NCT00788957|523918507|FG004|Part 2|Withdrawal by Subject|0|||
145291601|NCT00788957|523918508|FG005|Part 2|Withdrawal by Subject|0|||
145291602|NCT00788957|523918503|FG000|Part 2|Death|0|||
145291603|NCT00788957|523918504|FG001|Part 2|Death|32|||
145291604|NCT00788957|523918505|FG002|Part 2|Death|35|||
145291605|NCT00788957|523918506|FG003|Part 2|Death|37|||
145291606|NCT00788957|523918507|FG004|Part 2|Death|0|||
145615945|NCT05284019|525109331|FG001|Overall Study|Withdrawal by Subject|0|||
145291607|NCT00788957|523918508|FG005|Part 2|Death|0|||
145291608|NCT00788957|523918503|FG000|Part 2|Lost to Follow-up|0|||
145291609|NCT00788957|523918504|FG001|Part 2|Lost to Follow-up|0|||
145291610|NCT00788957|523918505|FG002|Part 2|Lost to Follow-up|3|||
145291611|NCT00788957|523918506|FG003|Part 2|Lost to Follow-up|0|||
145291612|NCT00788957|523918507|FG004|Part 2|Lost to Follow-up|0|||
145291613|NCT00788957|523918508|FG005|Part 2|Lost to Follow-up|0|||
145291614|NCT00788957|523918503|FG000|Part 2|On-study at time of data cut-off|0|||
145291615|NCT00788957|523918504|FG001|Part 2|On-study at time of data cut-off|1|||
145291616|NCT00788957|523918505|FG002|Part 2|On-study at time of data cut-off|1|||
145291617|NCT00788957|523918506|FG003|Part 2|On-study at time of data cut-off|1|||
145291618|NCT00788957|523918507|FG004|Part 2|On-study at time of data cut-off|0|||
145291619|NCT00788957|523918508|FG005|Part 2|On-study at time of data cut-off|0|||
145291620|NCT00788957|523918503|FG000|Part 3|Withdrawal by Subject|0|||
145291621|NCT00788957|523918504|FG001|Part 3|Withdrawal by Subject|0|||
145291622|NCT00788957|523918505|FG002|Part 3|Withdrawal by Subject|0|||
145291623|NCT00788957|523918506|FG003|Part 3|Withdrawal by Subject|0|||
145291624|NCT00788957|523918507|FG004|Part 3|Withdrawal by Subject|0|||
145291625|NCT00788957|523918508|FG005|Part 3|Withdrawal by Subject|2|||
145291626|NCT00788957|523918503|FG000|Part 3|Death|0|||
145291627|NCT00788957|523918504|FG001|Part 3|Death|0|||
145291628|NCT00788957|523918505|FG002|Part 3|Death|0|||
145291629|NCT00788957|523918506|FG003|Part 3|Death|0|||
145291630|NCT00788957|523918507|FG004|Part 3|Death|8|||
145291631|NCT00788957|523918508|FG005|Part 3|Death|8|||
145291632|NCT00788957|523918503|FG000|Part 3|On-study at time of data cut-off|0|||
145291633|NCT00788957|523918504|FG001|Part 3|On-study at time of data cut-off|0|||
145291634|NCT00788957|523918505|FG002|Part 3|On-study at time of data cut-off|0|||
145291635|NCT00788957|523918506|FG003|Part 3|On-study at time of data cut-off|0|||
145291636|NCT00788957|523918507|FG004|Part 3|On-study at time of data cut-off|1|||
145291637|NCT00788957|523918508|FG005|Part 3|On-study at time of data cut-off|0|||
145291638|NCT02579096|523918509|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
145291639|NCT02579096|523918510|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
145291640|NCT02579096|523918509|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
145291641|NCT02579096|523918510|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
145291642|NCT02579096|523918509|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
145291643|NCT02579096|523918510|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
145291644|NCT02579096|523918509|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
145291645|NCT02579096|523918510|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
145291646|NCT02579096|523918509|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
145291647|NCT02579096|523918510|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
145291648|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Death|2|||
145291649|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Death|4|||
145291650|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
145291651|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
145291652|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
145291653|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
145291654|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
145291655|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
145291656|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
145291657|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
145291658|NCT02579096|523918509|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
145291659|NCT02579096|523918510|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
145291660|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Death|3|||
145291661|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Death|2|||
145291662|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
145291663|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
145291664|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
145291665|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
145291666|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
145291667|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
145291668|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
145291669|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
145291670|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
145291671|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
145291672|NCT02579096|523918509|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
145291673|NCT02579096|523918510|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
145291674|NCT02097121|523918515|FG000|Overall Study|Other, not specified|4|||
145291675|NCT02097121|523918516|FG001|Overall Study|Other, not specified|2|||
145291676|NCT02097121|523918517|FG002|Overall Study|Other, not specified|3|||
145291677|NCT02097121|523918515|FG000|Overall Study|Lack of Efficacy|2|||
145291678|NCT02097121|523918516|FG001|Overall Study|Lack of Efficacy|1|||
145291679|NCT02097121|523918517|FG002|Overall Study|Lack of Efficacy|3|||
145291680|NCT02097121|523918515|FG000|Overall Study|Withdrawal by Subject|0|||
145291681|NCT02097121|523918516|FG001|Overall Study|Withdrawal by Subject|1|||
145291682|NCT02097121|523918517|FG002|Overall Study|Withdrawal by Subject|2|||
145291683|NCT02097121|523918515|FG000|Overall Study|Adverse Event|0|||
145615946|NCT05284019|525109332|FG002|Overall Study|Withdrawal by Subject|0|||
145291684|NCT02097121|523918516|FG001|Overall Study|Adverse Event|1|||
145291685|NCT02097121|523918517|FG002|Overall Study|Adverse Event|0|||
145291686|NCT02097121|523918515|FG000|Overall Study|Lost to Follow-up|1|||
145291687|NCT02097121|523918516|FG001|Overall Study|Lost to Follow-up|1|||
145291688|NCT02097121|523918517|FG002|Overall Study|Lost to Follow-up|2|||
145291689|NCT03066999|523918518|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
145291690|NCT03066999|523918519|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
145291691|NCT00661999|523918520|FG000|Overall Study|Adverse Event|11|||
145291692|NCT00661999|523918521|FG001|Overall Study|Adverse Event|5|||
145291693|NCT00661999|523918522|FG002|Overall Study|Adverse Event|8|||
145291694|NCT00661999|523918520|FG000|Overall Study|Death|8|||
145291695|NCT00661999|523918521|FG001|Overall Study|Death|6|||
145291696|NCT00661999|523918522|FG002|Overall Study|Death|3|||
145291697|NCT00661999|523918520|FG000|Overall Study|Other Reasons|5|||
145291698|NCT00661999|523918521|FG001|Overall Study|Other Reasons|12|||
145291699|NCT00661999|523918522|FG002|Overall Study|Other Reasons|23|||
145291700|NCT00661999|523918520|FG000|Overall Study|Withdrawal by Subject|30|||
145291701|NCT00661999|523918521|FG001|Overall Study|Withdrawal by Subject|23|||
145291702|NCT00661999|523918522|FG002|Overall Study|Withdrawal by Subject|14|||
145291703|NCT00661999|523918520|FG000|Overall Study|Alternative Treatment|1|||
145291704|NCT00661999|523918521|FG001|Overall Study|Alternative Treatment|0|||
145291705|NCT00661999|523918522|FG002|Overall Study|Alternative Treatment|0|||
145291706|NCT00661999|523918520|FG000|Overall Study|Other Medical Problems|4|||
145291707|NCT00661999|523918521|FG001|Overall Study|Other Medical Problems|4|||
145291708|NCT00661999|523918522|FG002|Overall Study|Other Medical Problems|9|||
145291709|NCT01790568|523918523|FG000|Overall Study|Progression prior to transplant|0|||
145291710|NCT01790568|523918524|FG001|Overall Study|Progression prior to transplant|1|||
145291711|NCT01361126|523918525|FG000|Overall Study|Sponsor decision|0|||
145291712|NCT01361126|523918526|FG001|Overall Study|Sponsor decision|2|||
145291713|NCT02994056|523918527|FG000|Overall Study|Death|8|||
145291714|NCT02994056|523918527|FG000|Overall Study|Withdrew Consent|1|||
145291715|NCT01508936|523918529|FG000|Overall Study|Adverse Event|11|||
145291716|NCT01508936|523918530|FG001|Overall Study|Adverse Event|32|||
145291717|NCT01508936|523918529|FG000|Overall Study|Lack of Efficacy|0|||
145291718|NCT01508936|523918530|FG001|Overall Study|Lack of Efficacy|1|||
145291719|NCT01508936|523918529|FG000|Overall Study|Withdrawal by Subject|4|||
145291720|NCT01508936|523918530|FG001|Overall Study|Withdrawal by Subject|18|||
145291721|NCT01508936|523918529|FG000|Overall Study|Protocol Violation|2|||
145291722|NCT01508936|523918530|FG001|Overall Study|Protocol Violation|3|||
145291723|NCT01508936|523918529|FG000|Overall Study|Lost to Follow-up|2|||
145291724|NCT01508936|523918530|FG001|Overall Study|Lost to Follow-up|9|||
145291725|NCT01508936|523918529|FG000|Overall Study|Other|0|||
145291726|NCT01508936|523918530|FG001|Overall Study|Other|5|||
145291727|NCT01508936|523918529|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
145291728|NCT01508936|523918530|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
145291729|NCT00679367|523918531|FG000|Overall Study|Adverse Event|7|||
145291730|NCT00679367|523918531|FG000|Overall Study|inability to swallow oral drugs|1|||
145291731|NCT00679367|523918531|FG000|Overall Study|Lack of Efficacy|3|||
145291732|NCT00679367|523918531|FG000|Overall Study|Withdrawal by Subject|1|||
145291733|NCT03365947|523918532|FG000|Overall Study|Lost to Follow-up|0|||
145291734|NCT03365947|523918533|FG001|Overall Study|Lost to Follow-up|0|||
145291735|NCT03365947|523918534|FG002|Overall Study|Lost to Follow-up|0|||
145291736|NCT03365947|523918535|FG003|Overall Study|Lost to Follow-up|0|||
145291737|NCT03365947|523918536|FG004|Overall Study|Lost to Follow-up|0|||
145291738|NCT03365947|523918537|FG005|Overall Study|Lost to Follow-up|1|||
145291739|NCT03365947|523918538|FG006|Overall Study|Lost to Follow-up|0|||
145291740|NCT03365947|523918539|FG007|Overall Study|Lost to Follow-up|0|||
145291741|NCT03365947|523918540|FG008|Overall Study|Lost to Follow-up|0|||
145291742|NCT03365947|523918541|FG009|Overall Study|Lost to Follow-up|0|||
145291743|NCT03365947|523918542|FG010|Overall Study|Lost to Follow-up|0|||
145291744|NCT03365947|523918543|FG011|Overall Study|Lost to Follow-up|0|||
145291745|NCT03365947|523918544|FG012|Overall Study|Lost to Follow-up|0|||
145291746|NCT03365947|523918545|FG013|Overall Study|Lost to Follow-up|0|||
145291747|NCT03365947|523918546|FG014|Overall Study|Lost to Follow-up|0|||
145291748|NCT03365947|523918547|FG015|Overall Study|Lost to Follow-up|0|||
145291749|NCT03365947|523918548|FG016|Overall Study|Lost to Follow-up|0|||
145291750|NCT03365947|523918549|FG017|Overall Study|Lost to Follow-up|0|||
145291751|NCT03365947|523918550|FG018|Overall Study|Lost to Follow-up|0|||
145291752|NCT02518685|523918551|FG000|Overall Study|Adverse Event|29|||
145291753|NCT02518685|523918552|FG001|Overall Study|Adverse Event|1|||
145291754|NCT02518685|523918551|FG000|Overall Study|Withdrawal by Subject|10|||
145291755|NCT02518685|523918552|FG001|Overall Study|Withdrawal by Subject|3|||
145291756|NCT02518685|523918551|FG000|Overall Study|relocation, study fatigue|7|||
145291757|NCT02518685|523918552|FG001|Overall Study|relocation, study fatigue|2|||
145291758|NCT02518685|523918551|FG000|Overall Study|Pregnancy|1|||
145291759|NCT02518685|523918552|FG001|Overall Study|Pregnancy|0|||
145291760|NCT02518685|523918551|FG000|Overall Study|Physician Decision|1|||
145291761|NCT02518685|523918552|FG001|Overall Study|Physician Decision|0|||
145291762|NCT02518685|523918551|FG000|Overall Study|Lost to Follow-up|1|||
145291763|NCT02518685|523918552|FG001|Overall Study|Lost to Follow-up|4|||
145291764|NCT02785913|523920805|FG000|Overall Study|Adverse Event|5|||
145291765|NCT02785913|523920805|FG000|Overall Study|Death|2|||
145291766|NCT02785913|523920805|FG000|Overall Study|Progression|18|||
145291767|NCT02785913|523920805|FG000|Overall Study|Not protocol specified|1|||
145291768|NCT01929109|523920806|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
145291769|NCT01929109|523920807|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
145291770|NCT01929109|523920808|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
145291771|NCT01929109|523920809|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
145291772|NCT01929109|523920810|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
145291773|NCT01402908|523920811|FG000|Overall Study|Withdrawal by Subject|30|||
145291774|NCT01402908|523920812|FG001|Overall Study|Withdrawal by Subject|17|||
145291775|NCT01402908|523920811|FG000|Overall Study|Lost to Follow-up|3|||
145291776|NCT01402908|523920812|FG001|Overall Study|Lost to Follow-up|1|||
145291777|NCT01402908|523920811|FG000|Overall Study|Physician Decision|1|||
145291778|NCT01402908|523920812|FG001|Overall Study|Physician Decision|0|||
145291779|NCT01739790|523920813|FG000|Overall Study|Early Trial Termination|2|||
145291780|NCT01739790|523920814|FG001|Overall Study|Early Trial Termination|4|||
145291781|NCT02581345|523920815|FG000|Part 1: up to Week 16|Adverse Event|3|||
145291782|NCT02581345|523920816|FG001|Part 1: up to Week 16|Adverse Event|8|||
145291783|NCT02581345|523920817|FG002|Part 1: up to Week 16|Adverse Event|0|||
145291784|NCT02581345|523920818|FG003|Part 1: up to Week 16|Adverse Event|0|||
145291785|NCT02581345|523920815|FG000|Part 1: up to Week 16|Physician Decision|2|||
145291786|NCT02581345|523920816|FG001|Part 1: up to Week 16|Physician Decision|4|||
145291787|NCT02581345|523920817|FG002|Part 1: up to Week 16|Physician Decision|0|||
145291788|NCT02581345|523920818|FG003|Part 1: up to Week 16|Physician Decision|0|||
145291789|NCT02581345|523920815|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
145291790|NCT02581345|523920816|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
145291791|NCT02581345|523920817|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
145291792|NCT02581345|523920818|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
145291793|NCT02581345|523920815|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
145291794|NCT02581345|523920816|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
145291795|NCT02581345|523920817|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
145291796|NCT02581345|523920818|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
145291797|NCT02581345|523920815|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
145291798|NCT02581345|523920816|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
145291799|NCT02581345|523920817|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
145291800|NCT02581345|523920818|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
145291801|NCT02581345|523920815|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
145291802|NCT02581345|523920816|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
145291803|NCT02581345|523920817|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
145291804|NCT02581345|523920818|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
145291805|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
145291806|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
145291807|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
145291808|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
145291809|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
145291810|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
145291811|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
145291812|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
145291813|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
145406968|NCT02475213|524345592|FG003|Overall Study|Physician Decision|0|||
145291814|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
145291815|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
145291816|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
145291817|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
145291818|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
145291819|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
145291820|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
145291821|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
145291822|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
145291823|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
145291824|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
145291825|NCT02581345|523920815|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
145291826|NCT02581345|523920816|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
145291827|NCT02581345|523920817|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
145291828|NCT02581345|523920818|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
145291829|NCT03471078|523920822|FG000|Overall Study|Withdrawal by Subject|9|||
145291830|NCT03471078|523920823|FG001|Overall Study|Withdrawal by Subject|1|||
145291831|NCT03471078|523920822|FG000|Overall Study|Adverse Event|4|||
145291832|NCT03471078|523920823|FG001|Overall Study|Adverse Event|1|||
145291833|NCT03471078|523920822|FG000|Overall Study|Physician Decision|3|||
145291834|NCT03471078|523920823|FG001|Overall Study|Physician Decision|2|||
145291835|NCT03471078|523920822|FG000|Overall Study|Death|2|||
145291836|NCT03471078|523920823|FG001|Overall Study|Death|0|||
145291837|NCT03471078|523920822|FG000|Overall Study|Other|3|||
145291838|NCT03471078|523920823|FG001|Overall Study|Other|2|||
145291839|NCT00862979|523920833|FG000|Overall Study|Adverse Event|6|||
145291840|NCT00862979|523920834|FG001|Overall Study|Adverse Event|3|||
145291841|NCT00862979|523920833|FG000|Overall Study|Protocol Violation|0|||
145291842|NCT00862979|523920834|FG001|Overall Study|Protocol Violation|1|||
145291843|NCT00862979|523920833|FG000|Overall Study|Patient withdrew consent|2|||
145291844|NCT00862979|523920834|FG001|Overall Study|Patient withdrew consent|1|||
145291845|NCT00862979|523920833|FG000|Overall Study|Administrative problems|0|||
145291846|NCT00862979|523920834|FG001|Overall Study|Administrative problems|1|||
145291847|NCT00862979|523920833|FG000|Overall Study|Death|0|||
145291848|NCT00862979|523920834|FG001|Overall Study|Death|1|||
145291849|NCT01027143|523920837|FG000|Overall Study|Lost to Follow-up|9|||
145291850|NCT01027143|523920838|FG001|Overall Study|Lost to Follow-up|4|||
145291851|NCT00502775|523920850|FG000|Overall Study|Adverse Event|1|||
145291852|NCT00502775|523920851|FG001|Overall Study|Adverse Event|2|||
145291853|NCT00502775|523920852|FG002|Overall Study|Adverse Event|1|||
145291854|NCT00502775|523920850|FG000|Overall Study|Protocol Violation|1|||
145291855|NCT00502775|523920851|FG001|Overall Study|Protocol Violation|5|||
145291856|NCT00502775|523920852|FG002|Overall Study|Protocol Violation|2|||
145291857|NCT00502775|523920850|FG000|Overall Study|Withdrawal by Subject|1|||
145291858|NCT00502775|523920851|FG001|Overall Study|Withdrawal by Subject|1|||
145291859|NCT00502775|523920852|FG002|Overall Study|Withdrawal by Subject|2|||
145291860|NCT00502775|523920850|FG000|Overall Study|Sponsor Terminated Study|1|||
145291861|NCT00502775|523920851|FG001|Overall Study|Sponsor Terminated Study|0|||
145291862|NCT00502775|523920852|FG002|Overall Study|Sponsor Terminated Study|1|||
145291863|NCT00502775|523920850|FG000|Overall Study|Non-compliance with eDiary|4|||
145291864|NCT00502775|523920851|FG001|Overall Study|Non-compliance with eDiary|1|||
145291865|NCT00502775|523920852|FG002|Overall Study|Non-compliance with eDiary|1|||
145291866|NCT00502775|523920850|FG000|Overall Study|Subject unable to swallow capsule|1|||
145291867|NCT00502775|523920851|FG001|Overall Study|Subject unable to swallow capsule|0|||
145291868|NCT00502775|523920852|FG002|Overall Study|Subject unable to swallow capsule|1|||
145291869|NCT00502775|523920850|FG000|Overall Study|Logpad compliance <80%|1|||
145291870|NCT00502775|523920851|FG001|Overall Study|Logpad compliance <80%|0|||
145291871|NCT00502775|523920852|FG002|Overall Study|Logpad compliance <80%|0|||
145291872|NCT00502775|523920850|FG000|Overall Study|Randomized in error|0|||
145291873|NCT00502775|523920851|FG001|Overall Study|Randomized in error|1|||
145291874|NCT00502775|523920852|FG002|Overall Study|Randomized in error|1|||
145291875|NCT00502775|523920850|FG000|Overall Study|Non-compliance|0|||
145291876|NCT00502775|523920851|FG001|Overall Study|Non-compliance|2|||
145291877|NCT00502775|523920852|FG002|Overall Study|Non-compliance|2|||
145291878|NCT00502775|523920850|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
145291879|NCT00502775|523920851|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
145291880|NCT00502775|523920852|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
145291881|NCT00502775|523920850|FG000|Overall Study|Declining pollen counts|0|||
145291882|NCT00502775|523920851|FG001|Overall Study|Declining pollen counts|1|||
145291883|NCT00502775|523920852|FG002|Overall Study|Declining pollen counts|1|||
145291884|NCT00502775|523920850|FG000|Overall Study|Subject in jail|0|||
145291885|NCT00502775|523920851|FG001|Overall Study|Subject in jail|1|||
145291886|NCT00502775|523920852|FG002|Overall Study|Subject in jail|0|||
145291887|NCT00502775|523920850|FG000|Overall Study|Subject took disallowed drug|0|||
145291888|NCT00502775|523920851|FG001|Overall Study|Subject took disallowed drug|0|||
145291889|NCT00502775|523920852|FG002|Overall Study|Subject took disallowed drug|1|||
145291890|NCT02016300|523920856|FG000|Overall Study|Lost to Follow-up|0|||
145291891|NCT02016300|523920857|FG001|Overall Study|Lost to Follow-up|3|||
145406969|NCT02475213|524345593|FG004|Overall Study|Physician Decision|0|||
145406970|NCT02475213|524345594|FG005|Overall Study|Physician Decision|1|||
145406971|NCT02475213|524345595|FG006|Overall Study|Physician Decision|4|||
145406972|NCT02475213|524345596|FG007|Overall Study|Physician Decision|0|||
145406973|NCT02475213|524345589|FG000|Overall Study|Progressive Disease|3|||
145406974|NCT02475213|524345590|FG001|Overall Study|Progressive Disease|2|||
145406975|NCT02475213|524345591|FG002|Overall Study|Progressive Disease|2|||
145406976|NCT02475213|524345592|FG003|Overall Study|Progressive Disease|13|||
145406977|NCT02475213|524345593|FG004|Overall Study|Progressive Disease|15|||
145406978|NCT02475213|524345594|FG005|Overall Study|Progressive Disease|25|||
145406979|NCT02475213|524345595|FG006|Overall Study|Progressive Disease|30|||
145406980|NCT02475213|524345596|FG007|Overall Study|Progressive Disease|10|||
145406981|NCT02475213|524345589|FG000|Overall Study|Death|0|||
145406982|NCT02475213|524345590|FG001|Overall Study|Death|0|||
145406983|NCT02475213|524345591|FG002|Overall Study|Death|0|||
145406984|NCT02475213|524345592|FG003|Overall Study|Death|0|||
145406985|NCT02475213|524345593|FG004|Overall Study|Death|0|||
145406986|NCT02475213|524345594|FG005|Overall Study|Death|4|||
145406987|NCT02475213|524345595|FG006|Overall Study|Death|1|||
145406988|NCT02475213|524345596|FG007|Overall Study|Death|0|||
145406989|NCT02475213|524345589|FG000|Overall Study|Protocol Violation|0|||
145406990|NCT02475213|524345590|FG001|Overall Study|Protocol Violation|0|||
145406991|NCT02475213|524345591|FG002|Overall Study|Protocol Violation|0|||
145406992|NCT02475213|524345592|FG003|Overall Study|Protocol Violation|0|||
145406993|NCT02475213|524345593|FG004|Overall Study|Protocol Violation|1|||
145406994|NCT02475213|524345594|FG005|Overall Study|Protocol Violation|0|||
145406995|NCT02475213|524345595|FG006|Overall Study|Protocol Violation|0|||
145406996|NCT02475213|524345596|FG007|Overall Study|Protocol Violation|0|||
145406997|NCT02475213|524345589|FG000|Overall Study|Withdrawal by Subject|0|||
145406998|NCT02475213|524345590|FG001|Overall Study|Withdrawal by Subject|0|||
145406999|NCT02475213|524345591|FG002|Overall Study|Withdrawal by Subject|0|||
145407000|NCT02475213|524345592|FG003|Overall Study|Withdrawal by Subject|1|||
145407001|NCT02475213|524345593|FG004|Overall Study|Withdrawal by Subject|0|||
145407002|NCT02475213|524345594|FG005|Overall Study|Withdrawal by Subject|2|||
145407003|NCT02475213|524345595|FG006|Overall Study|Withdrawal by Subject|2|||
145407004|NCT02475213|524345596|FG007|Overall Study|Withdrawal by Subject|0|||
145407005|NCT02475213|524345589|FG000|Overall Study|Other|0|||
145407006|NCT02475213|524345590|FG001|Overall Study|Other|0|||
145407007|NCT02475213|524345591|FG002|Overall Study|Other|0|||
145407008|NCT02475213|524345592|FG003|Overall Study|Other|1|||
145407009|NCT02475213|524345593|FG004|Overall Study|Other|3|||
145407010|NCT02475213|524345594|FG005|Overall Study|Other|1|||
145407011|NCT02475213|524345595|FG006|Overall Study|Other|0|||
145407012|NCT02475213|524345596|FG007|Overall Study|Other|0|||
145407013|NCT00505921|524345597|FG000|Overall Study|Ineligible|1|||
145407014|NCT00505921|524345597|FG000|Overall Study|Failed to Mobilize|8|||
145407015|NCT02441283|524345598|FG000|Overall Study|Withdrew consent|15|||
145407016|NCT02441283|524345598|FG000|Overall Study|Lost to Follow-up|42|||
145407017|NCT02441283|524345598|FG000|Overall Study|Death|1|||
145407018|NCT02441283|524345598|FG000|Overall Study|Other, not specified|32|||
145407019|NCT00630292|524345599|FG000|Overall Study|Withdrawal by Subject|1|||
145407020|NCT02382939|524345600|FG000|Overall Study|Adverse Event|1|||
145407021|NCT02382939|524345601|FG001|Overall Study|Adverse Event|1|||
145407022|NCT02382939|524345600|FG000|Overall Study|Withdrawal by Subject|2|||
145407023|NCT02382939|524345601|FG001|Overall Study|Withdrawal by Subject|2|||
145407024|NCT05383209|524345604|FG000|Overall Study|Adverse Event: Non-ocular|0|||
145407025|NCT05383209|524345605|FG001|Overall Study|Adverse Event: Non-ocular|1|||
145407026|NCT05383209|524345606|FG002|Overall Study|Adverse Event: Non-ocular|0|||
145407027|NCT05383209|524345604|FG000|Overall Study|Lost to Follow-up|2|||
145407028|NCT05383209|524345605|FG001|Overall Study|Lost to Follow-up|1|||
145407029|NCT05383209|524345606|FG002|Overall Study|Lost to Follow-up|4|||
145407030|NCT05383209|524345604|FG000|Overall Study|Withdrawal by Subject|2|||
145407031|NCT05383209|524345605|FG001|Overall Study|Withdrawal by Subject|0|||
145407032|NCT05383209|524345606|FG002|Overall Study|Withdrawal by Subject|1|||
145407033|NCT05383209|524345604|FG000|Overall Study|Death|1|||
145291892|NCT06165744|523920864|FG000|Overall Study|Non device-related adverse event|1|||
145291893|NCT01545076|523920865|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
145291894|NCT01545076|523920866|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
145291895|NCT01545076|523920867|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
145291896|NCT01545076|523920868|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
145291897|NCT01545076|523920869|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
145291898|NCT01545076|523920865|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
145291899|NCT01545076|523920866|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
145291900|NCT01545076|523920867|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
145291901|NCT01545076|523920868|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
145291902|NCT01545076|523920869|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
145291903|NCT01545076|523920865|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
145291904|NCT01545076|523920866|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
145291905|NCT01545076|523920867|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
145291906|NCT01545076|523920868|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
145291907|NCT01545076|523920869|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
145291908|NCT01545076|523920865|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
145291909|NCT01545076|523920866|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
145291910|NCT01545076|523920867|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
145291911|NCT01545076|523920868|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
145291912|NCT01545076|523920869|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
145291913|NCT01545076|523920865|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
145291914|NCT01545076|523920866|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
145291915|NCT01545076|523920867|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
145291916|NCT01545076|523920868|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
145291917|NCT01545076|523920869|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
145291918|NCT01545076|523920865|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
145291919|NCT01545076|523920866|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
145291920|NCT01545076|523920867|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
145291921|NCT01545076|523920868|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
145291922|NCT01545076|523920869|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
145291923|NCT01545076|523920865|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
145291924|NCT01545076|523920866|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
145291925|NCT01545076|523920867|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
145291926|NCT01545076|523920868|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
145291927|NCT01545076|523920869|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
145291928|NCT01545076|523920865|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
145291929|NCT01545076|523920866|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
145291930|NCT01545076|523920867|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
145291931|NCT01545076|523920868|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
145291932|NCT01545076|523920869|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
145291933|NCT01545076|523920865|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
145291934|NCT01545076|523920866|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
145291935|NCT01545076|523920867|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
145291936|NCT01545076|523920868|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
145407034|NCT05383209|524345605|FG001|Overall Study|Death|0|||
145407035|NCT05383209|524345606|FG002|Overall Study|Death|0|||
145407036|NCT05383209|524345604|FG000|Overall Study|Other|0|||
145407037|NCT05383209|524345605|FG001|Overall Study|Other|1|||
145407038|NCT05383209|524345606|FG002|Overall Study|Other|0|||
145407039|NCT00321763|524345608|FG000|Overall Study|Adverse Event|1|||
145407040|NCT00321763|524345609|FG001|Overall Study|Adverse Event|1|||
145407041|NCT00321763|524345610|FG002|Overall Study|Adverse Event|0|||
145407042|NCT00321763|524345611|FG003|Overall Study|Adverse Event|1|||
145407043|NCT00321763|524345608|FG000|Overall Study|Withdrawal by Subject|2|||
145407044|NCT00321763|524345609|FG001|Overall Study|Withdrawal by Subject|0|||
145407045|NCT00321763|524345610|FG002|Overall Study|Withdrawal by Subject|1|||
145407046|NCT00321763|524345611|FG003|Overall Study|Withdrawal by Subject|0|||
145407047|NCT00321763|524345608|FG000|Overall Study|Lost to Follow-up|3|||
145407048|NCT00321763|524345609|FG001|Overall Study|Lost to Follow-up|1|||
145407049|NCT00321763|524345610|FG002|Overall Study|Lost to Follow-up|5|||
145407050|NCT00321763|524345611|FG003|Overall Study|Lost to Follow-up|4|||
145407051|NCT00717886|524345612|FG000|Overall Study|Withdrawal by Subject|3|||
145407052|NCT00717886|524345612|FG000|Overall Study|Treatment Failure|1|||
145407053|NCT01553851|524345613|FG000|Overall Study|Adverse Event|2|||
145407054|NCT01553851|524345613|FG000|Overall Study|constipation|1|||
145407055|NCT03530696|524345615|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
145407056|NCT03530696|524345616|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
145407057|NCT02101294|524345617|FG000|Overall Study|Withdrawal by Subject|5|||
145407058|NCT02101294|524345617|FG000|Overall Study|Lost to Follow-up|6|||
145407059|NCT01129128|524345620|FG000|Overall Study|Lost to Follow-up|2|||
145407060|NCT01129128|524345621|FG001|Overall Study|Lost to Follow-up|2|||
145407061|NCT01129128|524345622|FG002|Overall Study|Lost to Follow-up|1|||
145407062|NCT01129128|524345620|FG000|Overall Study|Protocol Violation|0|||
145407063|NCT01129128|524345621|FG001|Overall Study|Protocol Violation|1|||
145407064|NCT01129128|524345622|FG002|Overall Study|Protocol Violation|0|||
145407065|NCT01129128|524345620|FG000|Overall Study|Withdrawal by Subject|0|||
145407066|NCT01129128|524345621|FG001|Overall Study|Withdrawal by Subject|1|||
145407067|NCT01129128|524345622|FG002|Overall Study|Withdrawal by Subject|3|||
145291937|NCT01545076|523920869|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
145291938|NCT01546987|523920870|FG000|Overall Study|Protocol Violation|3|||
145291939|NCT01546987|523920871|FG001|Overall Study|Protocol Violation|4|||
145291940|NCT02270736|523920872|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
145291941|NCT02270736|523920873|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
145291942|NCT02270736|523920874|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
145291943|NCT02270736|523920875|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
145291944|NCT02270736|523920876|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
145291945|NCT02270736|523920872|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
145291946|NCT02270736|523920873|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
145291947|NCT02270736|523920874|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
145291948|NCT02270736|523920875|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
145291949|NCT02270736|523920876|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
145291950|NCT02270736|523920872|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
145291951|NCT02270736|523920873|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
145407068|NCT01129128|524345620|FG000|Overall Study|Physician Decision|1|||
145407069|NCT01129128|524345621|FG001|Overall Study|Physician Decision|0|||
145407070|NCT01129128|524345622|FG002|Overall Study|Physician Decision|0|||
145407071|NCT03822416|524345623|FG000|Overall Study|Lost to Follow-up|1|||
145407072|NCT03822416|524345624|FG001|Overall Study|Lost to Follow-up|0|||
145407073|NCT03822416|524345623|FG000|Overall Study|Withdrawal by Subject|0|||
145407074|NCT03822416|524345624|FG001|Overall Study|Withdrawal by Subject|1|||
145407075|NCT02755090|524345625|FG000|Overall Study|equipment malfunction|1|||
145407076|NCT02755090|524345626|FG001|Overall Study|equipment malfunction|0|||
145407077|NCT01564407|524345627|FG000|Overall Study|Lost to Follow-up|0|||
145407078|NCT01564407|524345628|FG001|Overall Study|Lost to Follow-up|1|||
145407079|NCT01564407|524345629|FG002|Overall Study|Lost to Follow-up|0|||
145407080|NCT01564407|524345630|FG003|Overall Study|Lost to Follow-up|0|||
145407081|NCT01564407|524345631|FG004|Overall Study|Lost to Follow-up|0|||
145407082|NCT01564407|524345627|FG000|Overall Study|Withdrawal by Subject|0|||
145407083|NCT01564407|524345628|FG001|Overall Study|Withdrawal by Subject|1|||
145407084|NCT01564407|524345629|FG002|Overall Study|Withdrawal by Subject|0|||
145291952|NCT02270736|523920874|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
145291953|NCT02270736|523920875|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
145291954|NCT02270736|523920876|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
145291955|NCT02270736|523920872|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
145291956|NCT02270736|523920873|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
145291957|NCT02270736|523920874|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
145291958|NCT02270736|523920875|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
145291959|NCT02270736|523920876|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
145291960|NCT02270736|523920872|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
145291961|NCT02270736|523920873|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
145291962|NCT02270736|523920874|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
145291963|NCT02270736|523920875|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
145291964|NCT02270736|523920876|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
145291965|NCT02270736|523920872|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
145291966|NCT02270736|523920873|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
145291967|NCT02270736|523920874|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
145291968|NCT02270736|523920875|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
145291969|NCT02270736|523920876|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
145291970|NCT02270736|523920872|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145291971|NCT02270736|523920873|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145291972|NCT02270736|523920874|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145291973|NCT02270736|523920875|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
145291974|NCT02270736|523920876|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
145291975|NCT02270736|523920872|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
145291976|NCT02270736|523920873|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
145291977|NCT02270736|523920874|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
145291978|NCT02270736|523920875|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
145291979|NCT02270736|523920876|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
145291980|NCT02270736|523920872|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145291981|NCT02270736|523920873|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145291982|NCT02270736|523920874|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145291983|NCT02270736|523920875|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
145291984|NCT02270736|523920876|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
145291985|NCT00262600|523920877|FG000|Overall Study|Lost to Follow-up|17|||
145291986|NCT00262600|523920878|FG001|Overall Study|Lost to Follow-up|31|||
145291987|NCT00262600|523920879|FG002|Overall Study|Lost to Follow-up|41|||
145291988|NCT00262600|523920877|FG000|Overall Study|Withdrawal by Subject|128|||
145291989|NCT00262600|523920878|FG001|Overall Study|Withdrawal by Subject|145|||
145291990|NCT00262600|523920879|FG002|Overall Study|Withdrawal by Subject|139|||
145291991|NCT00262600|523920877|FG000|Overall Study|Not Treated|32|||
145291992|NCT00262600|523920878|FG001|Overall Study|Not Treated|17|||
145291993|NCT00262600|523920879|FG002|Overall Study|Not Treated|24|||
145291994|NCT00262600|523920877|FG000|Overall Study|Other|58|||
145291995|NCT00262600|523920878|FG001|Overall Study|Other|59|||
145291996|NCT00262600|523920879|FG002|Overall Study|Other|62|||
145291997|NCT05381948|523920882|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
145407085|NCT01564407|524345630|FG003|Overall Study|Withdrawal by Subject|0|||
145407086|NCT01564407|524345631|FG004|Overall Study|Withdrawal by Subject|0|||
145291998|NCT05381948|523920883|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
145291999|NCT05381948|523920884|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
145292000|NCT05381948|523920882|FG000|Overall Study|Adverse Event: Non-ocular|0|||
145407087|NCT01564407|524345627|FG000|Overall Study|funding lost, study ended|0|||
145292001|NCT05381948|523920883|FG001|Overall Study|Adverse Event: Non-ocular|1|||
145292002|NCT05381948|523920884|FG002|Overall Study|Adverse Event: Non-ocular|0|||
145292003|NCT05381948|523920882|FG000|Overall Study|Lost to Follow-up|1|||
145407088|NCT01564407|524345628|FG001|Overall Study|funding lost, study ended|0|||
145407089|NCT01564407|524345629|FG002|Overall Study|funding lost, study ended|0|||
145407090|NCT01564407|524345630|FG003|Overall Study|funding lost, study ended|1|||
145292004|NCT05381948|523920883|FG001|Overall Study|Lost to Follow-up|0|||
145615947|NCT05284019|525109333|FG003|Overall Study|Withdrawal by Subject|1|||
145615948|NCT05284019|525109334|FG004|Overall Study|Withdrawal by Subject|1|||
145615949|NCT05284019|525109330|FG000|Overall Study|Lost to Follow-up|1|||
145407091|NCT01564407|524345631|FG004|Overall Study|funding lost, study ended|0|||
145407092|NCT01551173|524345632|FG000|Overall Study|Withdrawal by Subject|11|||
145407093|NCT01551173|524345633|FG001|Overall Study|Withdrawal by Subject|16|||
145407094|NCT01551173|524345632|FG000|Overall Study|Adverse Event|7|||
145407095|NCT01551173|524345633|FG001|Overall Study|Adverse Event|6|||
145407096|NCT01551173|524345632|FG000|Overall Study|Lost to Follow-up|5|||
145407097|NCT01551173|524345633|FG001|Overall Study|Lost to Follow-up|7|||
145407098|NCT01551173|524345632|FG000|Overall Study|Other|5|||
145407099|NCT01551173|524345633|FG001|Overall Study|Other|3|||
145407100|NCT04530344|524345634|FG000|Overall Study|Lost to Follow-up|3|||
145407101|NCT04530344|524345635|FG001|Overall Study|Lost to Follow-up|3|||
145407102|NCT04530344|524345636|FG002|Overall Study|Lost to Follow-up|3|||
145407103|NCT04530344|524345637|FG003|Overall Study|Lost to Follow-up|10|||
145407104|NCT04530344|524345634|FG000|Overall Study|Withdrawal by Subject|14|||
145407105|NCT04530344|524345635|FG001|Overall Study|Withdrawal by Subject|5|||
145407106|NCT04530344|524345636|FG002|Overall Study|Withdrawal by Subject|18|||
145407107|NCT04530344|524345637|FG003|Overall Study|Withdrawal by Subject|33|||
145407108|NCT04530344|524345634|FG000|Overall Study|Adverse Event|0|||
145407109|NCT04530344|524345635|FG001|Overall Study|Adverse Event|0|||
145407110|NCT04530344|524345636|FG002|Overall Study|Adverse Event|0|||
145407111|NCT04530344|524345637|FG003|Overall Study|Adverse Event|1|||
145407112|NCT04530344|524345634|FG000|Overall Study|Lack of Efficacy|0|||
145407113|NCT04530344|524345635|FG001|Overall Study|Lack of Efficacy|0|||
145407114|NCT04530344|524345636|FG002|Overall Study|Lack of Efficacy|0|||
145292005|NCT05381948|523920884|FG002|Overall Study|Lost to Follow-up|0|||
145292006|NCT05381948|523920882|FG000|Overall Study|Protocol Deviation|0|||
145292007|NCT05381948|523920883|FG001|Overall Study|Protocol Deviation|2|||
145292008|NCT05381948|523920884|FG002|Overall Study|Protocol Deviation|0|||
145292009|NCT05381948|523920882|FG000|Overall Study|Withdrawal by Subject|1|||
145292010|NCT05381948|523920883|FG001|Overall Study|Withdrawal by Subject|0|||
145292011|NCT05381948|523920884|FG002|Overall Study|Withdrawal by Subject|1|||
145292012|NCT05381948|523920882|FG000|Overall Study|Death|0|||
145292013|NCT05381948|523920883|FG001|Overall Study|Death|2|||
145292014|NCT05381948|523920884|FG002|Overall Study|Death|0|||
145292015|NCT05381948|523920882|FG000|Overall Study|Discontinued study without receiving study drug|0|||
145292016|NCT05381948|523920883|FG001|Overall Study|Discontinued study without receiving study drug|0|||
145292017|NCT05381948|523920884|FG002|Overall Study|Discontinued study without receiving study drug|1|||
145292018|NCT04471207|523920885|FG000|Overall Study|Lost to Follow-up|4|||
145292019|NCT04471207|523920886|FG001|Overall Study|Lost to Follow-up|1|||
145292020|NCT04471207|523920885|FG000|Overall Study|Medication Contraindication|0|||
145292021|NCT04471207|523920886|FG001|Overall Study|Medication Contraindication|1|||
145292022|NCT04471207|523920885|FG000|Overall Study|Loss of Interest|2|||
145292023|NCT04471207|523920886|FG001|Overall Study|Loss of Interest|1|||
145292024|NCT04471207|523920885|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
145292025|NCT04471207|523920886|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
145292026|NCT04471207|523920885|FG000|Overall Study|Scheduling Conflicts|3|||
145292027|NCT04471207|523920886|FG001|Overall Study|Scheduling Conflicts|1|||
145292028|NCT04471207|523920885|FG000|Overall Study|Physician Decision|1|||
145292029|NCT04471207|523920886|FG001|Overall Study|Physician Decision|0|||
145292030|NCT04471207|523920885|FG000|Overall Study|Unwilling to Use System|0|||
145292031|NCT04471207|523920886|FG001|Overall Study|Unwilling to Use System|1|||
145292032|NCT00561730|523920889|FG000|Overall Study|Adverse Event|2|||
145292033|NCT00561730|523920889|FG000|Overall Study|Handling of the drug|1|||
145292034|NCT00561730|523920889|FG000|Overall Study|Lost to Follow-up|5|||
145292035|NCT00561730|523920889|FG000|Overall Study|Not specified reasons|1|||
145292036|NCT03444038|523920906|FG000|Overall Study|Adverse Event|12|||
145292037|NCT03444038|523920906|FG000|Overall Study|Withdrawal by Subject|7|||
145292038|NCT03444038|523920906|FG000|Overall Study|Lost to Follow-up|1|||
145292039|NCT03444038|523920906|FG000|Overall Study|Physician Decision|2|||
145292040|NCT03444038|523920906|FG000|Overall Study|Lack of Efficacy|7|||
145292041|NCT00977106|523920907|FG000|Overall Study|Adverse Event|5|||
145292042|NCT00977106|523920908|FG001|Overall Study|Adverse Event|6|||
145292043|NCT00977106|523920907|FG000|Overall Study|Withdrawal by Subject|2|||
145292044|NCT00977106|523920908|FG001|Overall Study|Withdrawal by Subject|2|||
145292045|NCT00977106|523920907|FG000|Overall Study|Lack of Efficacy|2|||
145292046|NCT00977106|523920908|FG001|Overall Study|Lack of Efficacy|2|||
145292047|NCT00977106|523920907|FG000|Overall Study|Protocol Violation|0|||
145292048|NCT00977106|523920908|FG001|Overall Study|Protocol Violation|1|||
145292049|NCT00977106|523920907|FG000|Overall Study|Other|1|||
145292050|NCT00977106|523920908|FG001|Overall Study|Other|0|||
145292051|NCT00436007|523920909|FG000|Overall Study|Withdrawal by Subject|5|||
145292052|NCT00436007|523920910|FG001|Overall Study|Withdrawal by Subject|3|||
145292053|NCT00436007|523920911|FG002|Overall Study|Withdrawal by Subject|4|||
145292054|NCT00436007|523920909|FG000|Overall Study|Lost to Follow-up|14|||
145292055|NCT00436007|523920910|FG001|Overall Study|Lost to Follow-up|10|||
145292056|NCT00436007|523920911|FG002|Overall Study|Lost to Follow-up|13|||
145292057|NCT00436007|523920909|FG000|Overall Study|Physician Decision|0|||
145292058|NCT00436007|523920910|FG001|Overall Study|Physician Decision|0|||
145292059|NCT00436007|523920911|FG002|Overall Study|Physician Decision|2|||
145292060|NCT00436007|523920909|FG000|Overall Study|Death|0|||
145292061|NCT00436007|523920910|FG001|Overall Study|Death|1|||
145292062|NCT00436007|523920911|FG002|Overall Study|Death|3|||
145292063|NCT00436007|523920909|FG000|Overall Study|Other|0|||
145292064|NCT00436007|523920910|FG001|Overall Study|Other|0|||
145292065|NCT00436007|523920911|FG002|Overall Study|Other|1|||
145292066|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
145292067|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
145292068|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
145292069|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
145292070|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
145292071|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
145292072|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
145292073|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
145292074|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
145292075|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
145292076|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
145292077|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
145292078|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
145292079|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
145292080|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
145292081|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
145292082|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
145292083|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
145292084|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145292085|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145292086|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
145292087|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
145292088|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
145292089|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
145292090|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
145292091|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
145292092|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
145292093|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
145292094|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
145292095|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
145292096|NCT01957488|523920912|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
145292097|NCT01957488|523920913|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
145292098|NCT01957488|523920914|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
145292099|NCT01957488|523920915|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
145292100|NCT01957488|523920916|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
145292101|NCT01957488|523920917|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
145292102|NCT01957488|523920912|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
145292103|NCT01957488|523920913|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
145292104|NCT01957488|523920914|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
145292105|NCT01957488|523920915|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
145292106|NCT01957488|523920916|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
145292107|NCT01957488|523920917|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
145292108|NCT01957488|523920912|FG000|Test Period 2 (2 Weeks)|Other|1|||
145292109|NCT01957488|523920913|FG001|Test Period 2 (2 Weeks)|Other|0|||
145292110|NCT01957488|523920914|FG002|Test Period 2 (2 Weeks)|Other|0|||
145292111|NCT01957488|523920915|FG003|Test Period 2 (2 Weeks)|Other|0|||
145292112|NCT01957488|523920916|FG004|Test Period 2 (2 Weeks)|Other|0|||
145292113|NCT01957488|523920917|FG005|Test Period 2 (2 Weeks)|Other|0|||
145292114|NCT01957488|523920912|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
145292115|NCT01957488|523920913|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
145292116|NCT01957488|523920914|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
145615950|NCT05284019|525109331|FG001|Overall Study|Lost to Follow-up|0|||
145292117|NCT01957488|523920915|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
145292118|NCT01957488|523920916|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
145407115|NCT04530344|524345637|FG003|Overall Study|Lack of Efficacy|1|||
145407116|NCT04530344|524345634|FG000|Overall Study|Physician Decision|0|||
145407117|NCT04530344|524345635|FG001|Overall Study|Physician Decision|0|||
145407118|NCT04530344|524345636|FG002|Overall Study|Physician Decision|1|||
145407119|NCT04530344|524345637|FG003|Overall Study|Physician Decision|1|||
145407120|NCT04530344|524345634|FG000|Overall Study|Pregnancy|0|||
145407121|NCT04530344|524345635|FG001|Overall Study|Pregnancy|0|||
145407122|NCT04530344|524345636|FG002|Overall Study|Pregnancy|2|||
145407123|NCT04530344|524345637|FG003|Overall Study|Pregnancy|1|||
145407124|NCT04530344|524345634|FG000|Overall Study|Protocol Violation|0|||
145407125|NCT04530344|524345635|FG001|Overall Study|Protocol Violation|0|||
145407126|NCT04530344|524345636|FG002|Overall Study|Protocol Violation|0|||
145407127|NCT04530344|524345637|FG003|Overall Study|Protocol Violation|1|||
145407128|NCT04530344|524345634|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
145407129|NCT04530344|524345635|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
145407130|NCT04530344|524345636|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
145407131|NCT04530344|524345637|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
145407132|NCT04530344|524345634|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145407133|NCT04530344|524345635|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145407134|NCT04530344|524345636|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
145407135|NCT04530344|524345637|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
145407136|NCT04530344|524345634|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
145407137|NCT04530344|524345635|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
145407138|NCT04530344|524345636|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
145407139|NCT04530344|524345637|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
145407140|NCT04530344|524345634|FG000|Overall Study|Personal Reasons|0|||
145407141|NCT04530344|524345635|FG001|Overall Study|Personal Reasons|0|||
145407142|NCT04530344|524345636|FG002|Overall Study|Personal Reasons|0|||
145407143|NCT04530344|524345637|FG003|Overall Study|Personal Reasons|1|||
145407144|NCT04530344|524345634|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145407145|NCT04530344|524345635|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145407146|NCT04530344|524345636|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
145407147|NCT04530344|524345637|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
145407148|NCT05049122|524345638|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
145407149|NCT05049122|524345638|FG000|Overall Study|Participant moved|1|||
145407150|NCT05049122|524345638|FG000|Overall Study|At the direction of the doctor|1|||
145407151|NCT05722015|524345639|FG000|Overall Study|Death|57|||
145407152|NCT05722015|524345640|FG001|Overall Study|Death|37|||
145407153|NCT05722015|524345639|FG000|Overall Study|Lost to Follow-up|1|||
145407154|NCT05722015|524345640|FG001|Overall Study|Lost to Follow-up|0|||
145407155|NCT05722015|524345639|FG000|Overall Study|Withdrawal by Subject|5|||
145407156|NCT05722015|524345640|FG001|Overall Study|Withdrawal by Subject|1|||
145407157|NCT05722015|524345639|FG000|Overall Study|Participants Ongoing|188|||
145407158|NCT05722015|524345640|FG001|Overall Study|Participants Ongoing|88|||
145407159|NCT02657551|524345641|FG000|Overall Study|Adverse Event|2|||
145407160|NCT02657551|524345641|FG000|Overall Study|Withdrawal by Subject|1|||
145407161|NCT02657551|524345641|FG000|Overall Study|Non-Compliance|1|||
145407162|NCT02657551|524345641|FG000|Overall Study|Progression / Relapse|4|||
145615951|NCT05284019|525109332|FG002|Overall Study|Lost to Follow-up|0|||
145407163|NCT04478266|524345642|FG000|Overall Study|Adverse Event|20|||
145407164|NCT04478266|524345643|FG001|Overall Study|Adverse Event|21|||
145407165|NCT04478266|524345642|FG000|Overall Study|Progressive disease|146|||
145407166|NCT04478266|524345643|FG001|Overall Study|Progressive disease|168|||
145407167|NCT04478266|524345642|FG000|Overall Study|Poor compliance to protocol|1|||
145407168|NCT04478266|524345643|FG001|Overall Study|Poor compliance to protocol|0|||
145407169|NCT04478266|524345642|FG000|Overall Study|Withdrawal by Subject|19|||
145407170|NCT04478266|524345643|FG001|Overall Study|Withdrawal by Subject|16|||
145407171|NCT04478266|524345642|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
145407172|NCT04478266|524345643|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
145407173|NCT04478266|524345642|FG000|Overall Study|Study terminated by sponsor|33|||
145407174|NCT04478266|524345643|FG001|Overall Study|Study terminated by sponsor|35|||
145407175|NCT04478266|524345642|FG000|Overall Study|Other: unspecified|5|||
145407176|NCT04478266|524345643|FG001|Overall Study|Other: unspecified|7|||
145407177|NCT04478266|524345642|FG000|Overall Study|Randomized but not treated|1|||
145407178|NCT04478266|524345643|FG001|Overall Study|Randomized but not treated|1|||
145407179|NCT01101178|524345644|FG000|Period 1|Withdrawal by Subject|1|||
145407180|NCT01101178|524345645|FG001|Period 1|Withdrawal by Subject|2|||
145407181|NCT01101178|524345644|FG000|Period 1|Positive drug screen|1|||
145407182|NCT01101178|524345645|FG001|Period 1|Positive drug screen|1|||
145407183|NCT01101178|524345644|FG000|Period 1|Adverse Event|2|||
145407184|NCT01101178|524345645|FG001|Period 1|Adverse Event|1|||
145407185|NCT01101178|524345644|FG000|Period 2|Withdrawal by Subject|0|||
145407186|NCT01101178|524345645|FG001|Period 2|Withdrawal by Subject|1|||
145407187|NCT01850641|524345646|FG000|Overall Study|Physician Decision|1|||
145407188|NCT01850641|524345646|FG000|Overall Study|Decrease in serum phosphorus|1|||
145407189|NCT01850641|524345646|FG000|Overall Study|Decrease in serum calcium|2|||
145407190|NCT01850641|524345646|FG000|Overall Study|Increase in serum ferritin|1|||
145407191|NCT00720759|524345649|FG000|Overall Study|Lost to Follow-up|0|||
145407192|NCT00720759|524345650|FG001|Overall Study|Lost to Follow-up|1|||
145407193|NCT00720759|524345651|FG002|Overall Study|Lost to Follow-up|1|||
145407194|NCT00720759|524345652|FG003|Overall Study|Lost to Follow-up|0|||
145407195|NCT05032196|524345656|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145407196|NCT05032196|524345657|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
145407197|NCT05032196|524345658|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145407198|NCT05032196|524345659|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145407199|NCT05032196|524345660|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145407200|NCT05032196|524345661|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
145407201|NCT05032196|524345656|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145407202|NCT05032196|524345657|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145407203|NCT05032196|524345658|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145407204|NCT05032196|524345659|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
145407205|NCT05032196|524345660|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145407206|NCT05032196|524345661|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
145407207|NCT05032196|524345656|FG000|Period 2 (Multidose)|Physician Decision|0|||
145407208|NCT05032196|524345657|FG001|Period 2 (Multidose)|Physician Decision|0|||
145407209|NCT05032196|524345658|FG002|Period 2 (Multidose)|Physician Decision|0|||
145407210|NCT05032196|524345659|FG003|Period 2 (Multidose)|Physician Decision|0|||
145407211|NCT05032196|524345660|FG004|Period 2 (Multidose)|Physician Decision|1|||
145407212|NCT05032196|524345661|FG005|Period 2 (Multidose)|Physician Decision|0|||
145407213|NCT00857389|524345662|FG000|Overall Study|Did not proceed to transplant|2|||
145407214|NCT05260008|524345663|FG000|Overall Study|Physician Decision|0|||
145407215|NCT05260008|524345664|FG001|Overall Study|Physician Decision|1|||
145407216|NCT05260008|524345665|FG002|Overall Study|Physician Decision|0|||
145407217|NCT05260008|524345666|FG003|Overall Study|Physician Decision|0|||
145407218|NCT02472405|524346919|FG000|Overall Study|Lost to Follow-up|9|||
145407219|NCT02472405|524346919|FG000|Overall Study|Adverse Event|1|||
145407220|NCT01134042|524346920|FG000|Overall Study|Adverse Event|3|||
145407221|NCT01134042|524346921|FG001|Overall Study|Adverse Event|7|||
145407222|NCT01134042|524346922|FG002|Overall Study|Adverse Event|2|||
145407223|NCT01134042|524346920|FG000|Overall Study|Lack of Efficacy|21|||
145407224|NCT01134042|524346921|FG001|Overall Study|Lack of Efficacy|6|||
145407225|NCT01134042|524346922|FG002|Overall Study|Lack of Efficacy|18|||
145407226|NCT01134042|524346920|FG000|Overall Study|Protocol Violation|5|||
145407227|NCT01134042|524346921|FG001|Overall Study|Protocol Violation|3|||
145407228|NCT01134042|524346922|FG002|Overall Study|Protocol Violation|5|||
145407229|NCT01134042|524346920|FG000|Overall Study|Lost to Follow-up|2|||
145407230|NCT01134042|524346921|FG001|Overall Study|Lost to Follow-up|0|||
145407231|NCT01134042|524346922|FG002|Overall Study|Lost to Follow-up|1|||
145407232|NCT01134042|524346920|FG000|Overall Study|Physician Decision|4|||
145407233|NCT01134042|524346921|FG001|Overall Study|Physician Decision|8|||
145407234|NCT01134042|524346922|FG002|Overall Study|Physician Decision|1|||
145556441|NCT02554812|524895040|FG017|Overall Study|Global deterioration of health status|0|||
145615952|NCT05284019|525109333|FG003|Overall Study|Lost to Follow-up|2|||
145407235|NCT01134042|524346920|FG000|Overall Study|Withdrawal by Subject|13|||
145407236|NCT01134042|524346921|FG001|Overall Study|Withdrawal by Subject|4|||
145407237|NCT01134042|524346922|FG002|Overall Study|Withdrawal by Subject|7|||
145407238|NCT05350423|524346929|FG000|Overall Study|Lost to Follow-up|3|||
145292119|NCT01957488|523920917|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
145292120|NCT01957488|523920912|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
145292121|NCT01957488|523920913|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
145292122|NCT01957488|523920914|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
145292123|NCT01957488|523920915|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
145292124|NCT01957488|523920916|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
145292125|NCT01957488|523920917|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
145292126|NCT01957488|523920912|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
145292127|NCT01957488|523920913|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
145292128|NCT01957488|523920914|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
145292129|NCT01957488|523920915|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
145292130|NCT01957488|523920916|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
145292131|NCT01957488|523920917|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
145292132|NCT01957488|523920912|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
145292133|NCT01957488|523920913|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
145292134|NCT01957488|523920914|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
145292135|NCT01957488|523920915|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
145292136|NCT01957488|523920916|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
145292137|NCT01957488|523920917|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
145292138|NCT01957488|523920912|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
145292139|NCT01957488|523920913|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
145292140|NCT01957488|523920914|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
145292141|NCT01957488|523920915|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
145292142|NCT01957488|523920916|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
145292143|NCT01957488|523920917|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
145292144|NCT00721409|523920919|FG000|Overall Study|Global deterioration of health status|2|||
145292145|NCT00721409|523920920|FG001|Overall Study|Global deterioration of health status|6|||
145292146|NCT00721409|523920921|FG002|Overall Study|Global deterioration of health status|3|||
145292147|NCT00721409|523920919|FG000|Overall Study|Death|0|||
145292148|NCT00721409|523920920|FG001|Overall Study|Death|1|||
145292149|NCT00721409|523920921|FG002|Overall Study|Death|0|||
145292150|NCT00721409|523920919|FG000|Overall Study|Randomized not Treated|0|||
145292151|NCT00721409|523920920|FG001|Overall Study|Randomized not Treated|1|||
145292152|NCT00721409|523920921|FG002|Overall Study|Randomized not Treated|4|||
145292153|NCT00721409|523920919|FG000|Overall Study|Reason not specified|1|||
145292154|NCT00721409|523920920|FG001|Overall Study|Reason not specified|0|||
145292155|NCT00721409|523920921|FG002|Overall Study|Reason not specified|2|||
145292156|NCT00721409|523920919|FG000|Overall Study|Adverse Event|0|||
145292157|NCT00721409|523920920|FG001|Overall Study|Adverse Event|13|||
145292158|NCT00721409|523920921|FG002|Overall Study|Adverse Event|2|||
145292159|NCT00721409|523920919|FG000|Overall Study|Lost to Follow-up|0|||
145292160|NCT00721409|523920920|FG001|Overall Study|Lost to Follow-up|0|||
145292161|NCT00721409|523920921|FG002|Overall Study|Lost to Follow-up|1|||
145292162|NCT00721409|523920919|FG000|Overall Study|Withdrawal by Subject|1|||
145292163|NCT00721409|523920920|FG001|Overall Study|Withdrawal by Subject|6|||
145292164|NCT00721409|523920921|FG002|Overall Study|Withdrawal by Subject|5|||
145292165|NCT00721409|523920919|FG000|Overall Study|Objective progression or relapse|8|||
145292166|NCT00721409|523920920|FG001|Overall Study|Objective progression or relapse|55|||
145292167|NCT00721409|523920921|FG002|Overall Study|Objective progression or relapse|62|||
145292168|NCT02419313|523920922|FG000|First Intervention|Lost to Follow-up|2|||
145292169|NCT02419313|523920923|FG001|First Intervention|Lost to Follow-up|0|||
145292170|NCT02419313|523920922|FG000|Second Intervention|Lost to Follow-up|1|||
145292171|NCT02419313|523920923|FG001|Second Intervention|Lost to Follow-up|0|||
145292172|NCT00810368|523920924|FG000|Overall Study|Lost to Follow-up|4|||
145292173|NCT00810368|523920925|FG001|Overall Study|Lost to Follow-up|2|||
145292174|NCT00810368|523920924|FG000|Overall Study|Lack of Efficacy|2|||
145292175|NCT00810368|523920925|FG001|Overall Study|Lack of Efficacy|0|||
145292176|NCT00623103|523920926|FG000|Overall Study|Adverse Event|70|||
145292177|NCT00623103|523920927|FG001|Overall Study|Adverse Event|60|||
145292178|NCT00623103|523920926|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145292179|NCT00623103|523920927|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
145292180|NCT00623103|523920926|FG000|Overall Study|Withdrawal by Subject|18|||
145292181|NCT00623103|523920927|FG001|Overall Study|Withdrawal by Subject|24|||
145292182|NCT00623103|523920926|FG000|Overall Study|Lost to Follow-up|4|||
145292183|NCT00623103|523920927|FG001|Overall Study|Lost to Follow-up|1|||
145292184|NCT00623103|523920926|FG000|Overall Study|Administrative problems|2|||
145292185|NCT00623103|523920927|FG001|Overall Study|Administrative problems|4|||
145292186|NCT00623103|523920926|FG000|Overall Study|Death|11|||
145292187|NCT00623103|523920927|FG001|Overall Study|Death|11|||
145292188|NCT00623103|523920926|FG000|Overall Study|Protocol deviation|2|||
145292189|NCT00623103|523920927|FG001|Overall Study|Protocol deviation|1|||
145292190|NCT00442936|523920931|FG000|Overall Study|Protocol Violation|1|||
145292191|NCT00442936|523920932|FG001|Overall Study|Protocol Violation|0|||
145292192|NCT00442936|523920933|FG002|Overall Study|Protocol Violation|1|||
145292193|NCT00442936|523920934|FG003|Overall Study|Protocol Violation|1|||
145556442|NCT02554812|524895041|FG018|Overall Study|Global deterioration of health status|0|||
145556443|NCT02554812|524895042|FG019|Overall Study|Global deterioration of health status|0|||
145292194|NCT00524459|523920936|FG000|Overall Study|Withdrawal by Subject|1|||
145292195|NCT00524459|523920936|FG000|Overall Study|Other|1|||
145292196|NCT02428699|523920937|FG000|Washout Period 1|Screen Failure|1|||
145292197|NCT02428699|523920938|FG001|Washout Period 1|Screen Failure|2|||
145292198|NCT02433678|523920939|FG000|Overall Study|Lost to Follow-up|1|||
145292199|NCT02433678|523920940|FG001|Overall Study|Lost to Follow-up|2|||
145292200|NCT04424407|523920941|FG000|Overall Study|Withdrawal by Subject|2|||
145292201|NCT04424407|523920941|FG000|Overall Study|Lost to Follow-up|1|||
145292202|NCT01424722|523920944|FG000|Overall Study|Sponsor terminated investigation|2258|||
145292203|NCT02684578|523920945|FG000|Overall Study|Withdrawal by Subject|10|||
145292204|NCT02684578|523920946|FG001|Overall Study|Withdrawal by Subject|7|||
145292205|NCT02684578|523920945|FG000|Overall Study|Lost to Follow-up|0|||
145292206|NCT02684578|523920946|FG001|Overall Study|Lost to Follow-up|3|||
145292207|NCT02684578|523920945|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
145292208|NCT02684578|523920946|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
145292209|NCT02684578|523920945|FG000|Overall Study|Missing follow-up data|0|||
145292210|NCT02684578|523920946|FG001|Overall Study|Missing follow-up data|1|||
145292211|NCT01153984|523920947|FG000|Overall Study|Withdrawal by Subject|1|||
145292212|NCT01153984|523920947|FG000|Overall Study|Adverse Event|1|||
145292213|NCT02460159|523920948|FG000|Overall Study|Adverse Event|4|||
145292214|NCT02460159|523920949|FG001|Overall Study|Adverse Event|1|||
145292215|NCT02460159|523920948|FG000|Overall Study|Withdrawal by Subject|2|||
145292216|NCT02460159|523920949|FG001|Overall Study|Withdrawal by Subject|0|||
145292217|NCT00973700|523920950|FG000|Overall Study|Withdrawal by Subject|2|||
145292218|NCT00973700|523920951|FG001|Overall Study|Withdrawal by Subject|2|||
145292219|NCT00973700|523920952|FG002|Overall Study|Withdrawal by Subject|8|||
145292220|NCT00973700|523920953|FG003|Overall Study|Withdrawal by Subject|4|||
145292221|NCT00973700|523920954|FG004|Overall Study|Withdrawal by Subject|4|||
145292222|NCT00973700|523920950|FG000|Overall Study|Lost to Follow-up|5|||
145292223|NCT00973700|523920951|FG001|Overall Study|Lost to Follow-up|0|||
145292224|NCT00973700|523920952|FG002|Overall Study|Lost to Follow-up|1|||
145292225|NCT00973700|523920953|FG003|Overall Study|Lost to Follow-up|8|||
145292226|NCT00973700|523920954|FG004|Overall Study|Lost to Follow-up|5|||
145292227|NCT00973700|523920950|FG000|Overall Study|Inappropriate enrolment|0|||
145292228|NCT00973700|523920951|FG001|Overall Study|Inappropriate enrolment|0|||
145292229|NCT00973700|523920952|FG002|Overall Study|Inappropriate enrolment|0|||
145292230|NCT00973700|523920953|FG003|Overall Study|Inappropriate enrolment|4|||
145292231|NCT00973700|523920954|FG004|Overall Study|Inappropriate enrolment|0|||
145292232|NCT00973700|523920950|FG000|Overall Study|Unable to Classify|0|||
145292233|NCT00973700|523920951|FG001|Overall Study|Unable to Classify|0|||
145292234|NCT00973700|523920952|FG002|Overall Study|Unable to Classify|1|||
145292235|NCT00973700|523920953|FG003|Overall Study|Unable to Classify|2|||
145292236|NCT00973700|523920954|FG004|Overall Study|Unable to Classify|1|||
145292237|NCT03499964|523920955|FG000|Overall Study|Lack of Efficacy|6|||
145292238|NCT03499964|523920956|FG001|Overall Study|Lack of Efficacy|26|||
145292239|NCT03499964|523920955|FG000|Overall Study|Adverse Event|1|||
145292240|NCT03499964|523920956|FG001|Overall Study|Adverse Event|0|||
145292241|NCT03499964|523920955|FG000|Overall Study|Death|1|||
145292242|NCT03499964|523920956|FG001|Overall Study|Death|0|||
145292243|NCT03499964|523920955|FG000|Overall Study|Withdrawal by Subject|2|||
145292244|NCT03499964|523920956|FG001|Overall Study|Withdrawal by Subject|1|||
145292245|NCT03499964|523920955|FG000|Overall Study|Lost to Follow-up|1|||
145292246|NCT03499964|523920956|FG001|Overall Study|Lost to Follow-up|0|||
145292247|NCT01193608|523920958|FG000|Overall Study|Other|0|||
145292248|NCT01193608|523920959|FG001|Overall Study|Other|1|||
145292249|NCT01193608|523920960|FG002|Overall Study|Other|0|||
145292250|NCT01193608|523920961|FG003|Overall Study|Other|0|||
145292251|NCT01193608|523920962|FG004|Overall Study|Other|0|||
145292252|NCT01193608|523920963|FG005|Overall Study|Other|0|||
145292253|NCT01193608|523920958|FG000|Overall Study|Withdrawal by Subject|0|||
145407239|NCT05350423|524346930|FG001|Overall Study|Lost to Follow-up|3|||
145292254|NCT01193608|523920959|FG001|Overall Study|Withdrawal by Subject|1|||
145292255|NCT01193608|523920960|FG002|Overall Study|Withdrawal by Subject|2|||
145292256|NCT01193608|523920961|FG003|Overall Study|Withdrawal by Subject|3|||
145292257|NCT01193608|523920962|FG004|Overall Study|Withdrawal by Subject|3|||
145292258|NCT01193608|523920963|FG005|Overall Study|Withdrawal by Subject|0|||
145292259|NCT01193608|523920958|FG000|Overall Study|Lost to Follow-up|0|||
145292260|NCT01193608|523920959|FG001|Overall Study|Lost to Follow-up|0|||
145292261|NCT01193608|523920960|FG002|Overall Study|Lost to Follow-up|0|||
145292262|NCT01193608|523920961|FG003|Overall Study|Lost to Follow-up|0|||
145292263|NCT01193608|523920962|FG004|Overall Study|Lost to Follow-up|1|||
145292264|NCT01193608|523920963|FG005|Overall Study|Lost to Follow-up|2|||
145292265|NCT01193608|523920958|FG000|Overall Study|Adverse Event|0|||
145292266|NCT01193608|523920959|FG001|Overall Study|Adverse Event|0|||
145292267|NCT01193608|523920960|FG002|Overall Study|Adverse Event|0|||
145292268|NCT01193608|523920961|FG003|Overall Study|Adverse Event|0|||
145292269|NCT01193608|523920962|FG004|Overall Study|Adverse Event|1|||
145292270|NCT01193608|523920963|FG005|Overall Study|Adverse Event|0|||
145292271|NCT00806156|523920967|FG000|Overall Study|Death|35|||
145292272|NCT00806156|523920968|FG001|Overall Study|Death|95|||
145292273|NCT00806156|523920967|FG000|Overall Study|Did not meet eligibility criteria|1|||
145292274|NCT00806156|523920968|FG001|Overall Study|Did not meet eligibility criteria|0|||
145292275|NCT00806156|523920967|FG000|Overall Study|Study terminated by Sponsor|2|||
145292276|NCT00806156|523920968|FG001|Overall Study|Study terminated by Sponsor|40|||
145292277|NCT00806156|523920967|FG000|Overall Study|Consent withdrawn by subject|1|||
145292278|NCT00806156|523920968|FG001|Overall Study|Consent withdrawn by subject|3|||
145292279|NCT00806156|523920967|FG000|Overall Study|Lost to Follow-up|0|||
145292280|NCT00806156|523920968|FG001|Overall Study|Lost to Follow-up|1|||
145292281|NCT01025037|523920969|FG000|Overall Study|Adverse Event|3|||
145292282|NCT01025037|523920969|FG000|Overall Study|Lost to Follow-up|7|||
145292283|NCT01025037|523920969|FG000|Overall Study|Withdrawal by Subject|1|||
145292284|NCT02660242|523920977|FG000|Glucose Tabs|Lost to Follow-up|1|||
145292285|NCT02660242|523920977|FG000|Glucagon Injection|Lost to Follow-up|1|||
145292286|NCT02796664|523920978|FG000|Overall Study|Withdrawal by Subject|0|||
145292287|NCT02796664|523920979|FG001|Overall Study|Withdrawal by Subject|3|||
145292288|NCT02796664|523920978|FG000|Overall Study|Noncompliance|1|||
145292289|NCT02796664|523920979|FG001|Overall Study|Noncompliance|1|||
145292290|NCT02796664|523920978|FG000|Overall Study|Death|0|||
145292291|NCT02796664|523920979|FG001|Overall Study|Death|1|||
145292292|NCT01531205|523920981|FG000|Overall Study|Did not proceed to surgery|1|||
145292293|NCT04803357|523920982|FG000|Overall Study|Withdrawal by Subject|31|||
145292294|NCT04803357|523920983|FG001|Overall Study|Withdrawal by Subject|5|||
145292295|NCT02879643|523920984|FG000|Overall Study|Adverse Event|0|||
145292296|NCT02879643|523920985|FG001|Overall Study|Adverse Event|0|||
145292297|NCT02879643|523920986|FG002|Overall Study|Adverse Event|1|||
145292298|NCT02879643|523920987|FG003|Overall Study|Adverse Event|1|||
145292299|NCT02879643|523920988|FG004|Overall Study|Adverse Event|0|||
145292300|NCT00182091|523920989|FG000|Overall Study|Withdrawal by Subject|1|||
145292301|NCT00182091|523920990|FG001|Overall Study|Withdrawal by Subject|0|||
145292302|NCT00182091|523920991|FG002|Overall Study|Withdrawal by Subject|0|||
145292303|NCT00182091|523920992|FG003|Overall Study|Withdrawal by Subject|0|||
145292304|NCT05905783|523920994|FG000|Overall Study|Lost to Follow-up|12|||
145292305|NCT05905783|523920995|FG001|Overall Study|Lost to Follow-up|18|||
145556444|NCT02554812|524895043|FG020|Overall Study|Global deterioration of health status|0|||
145556445|NCT02554812|524895044|FG021|Overall Study|Global deterioration of health status|0|||
145556446|NCT02554812|524895045|FG022|Overall Study|Global deterioration of health status|0|||
145292306|NCT05905783|523920994|FG000|Overall Study|Withdrawal by Subject|29|||
145292307|NCT05905783|523920995|FG001|Overall Study|Withdrawal by Subject|37|||
145292308|NCT05905783|523920994|FG000|Overall Study|Decision by sponsor|69|||
145292309|NCT05905783|523920995|FG001|Overall Study|Decision by sponsor|65|||
145292310|NCT03968224|523920996|FG000|Overall Study|Lost to Follow-up|11|||
145292311|NCT03968224|523920997|FG001|Overall Study|Lost to Follow-up|18|||
145407240|NCT05350423|524346929|FG000|Overall Study|screen failure|5|||
145292312|NCT05665595|523922169|FG000|Overall Study|Ongoing|692|||
145556447|NCT02554812|524895046|FG023|Overall Study|Global deterioration of health status|0|||
145292313|NCT05665595|523922170|FG001|Overall Study|Ongoing|698|||
145292314|NCT05665595|523922169|FG000|Overall Study|Withdrawal by Subject|2|||
145292315|NCT05665595|523922170|FG001|Overall Study|Withdrawal by Subject|2|||
145292316|NCT05665595|523922169|FG000|Overall Study|Lost to Follow-up|1|||
145292317|NCT05665595|523922170|FG001|Overall Study|Lost to Follow-up|0|||
145292318|NCT05665595|523922169|FG000|Overall Study|Death|6|||
145292319|NCT05665595|523922170|FG001|Overall Study|Death|1|||
145292320|NCT05771428|523922171|FG000|Overall Study|Adverse Event|0|||
145292321|NCT05771428|523922172|FG001|Overall Study|Adverse Event|1|||
145292322|NCT05771428|523922173|FG002|Overall Study|Adverse Event|1|||
145292323|NCT05771428|523922174|FG003|Overall Study|Adverse Event|1|||
145292324|NCT05771428|523922171|FG000|Overall Study|Withdrawal by Subject|3|||
145292325|NCT05771428|523922172|FG001|Overall Study|Withdrawal by Subject|2|||
145292326|NCT05771428|523922173|FG002|Overall Study|Withdrawal by Subject|1|||
145292327|NCT05771428|523922174|FG003|Overall Study|Withdrawal by Subject|4|||
145292328|NCT05771428|523922171|FG000|Overall Study|Other|0|||
145292329|NCT05771428|523922172|FG001|Overall Study|Other|1|||
145292330|NCT05771428|523922173|FG002|Overall Study|Other|2|||
145292331|NCT05771428|523922174|FG003|Overall Study|Other|1|||
145292332|NCT05771428|523922171|FG000|Overall Study|Randomized but Not Treated|0|||
145292333|NCT05771428|523922172|FG001|Overall Study|Randomized but Not Treated|0|||
145292334|NCT05771428|523922173|FG002|Overall Study|Randomized but Not Treated|1|||
145292335|NCT05771428|523922174|FG003|Overall Study|Randomized but Not Treated|0|||
145292336|NCT04025229|523922175|FG000|Overall Study|Adverse Event|1|||
145292337|NCT04025229|523922176|FG001|Overall Study|Adverse Event|0|||
145292338|NCT04025229|523922175|FG000|Overall Study|Withdrawal by Subject|0|||
145292339|NCT04025229|523922176|FG001|Overall Study|Withdrawal by Subject|2|||
145292340|NCT04025229|523922175|FG000|Overall Study|Death|0|||
145292341|NCT04025229|523922176|FG001|Overall Study|Death|1|||
145292342|NCT04025229|523922175|FG000|Overall Study|Physician Decision|0|||
145292343|NCT04025229|523922176|FG001|Overall Study|Physician Decision|1|||
145292344|NCT03815942|523922177|FG000|Overall Study|Withdrawal by Subject|0|||
145292345|NCT03815942|523922178|FG001|Overall Study|Withdrawal by Subject|17|||
145292346|NCT01298570|523922179|FG000|Overall Study|Disease progression, relapse during acti|64|||
145292347|NCT01298570|523922180|FG001|Overall Study|Disease progression, relapse during acti|40|||
145292348|NCT01298570|523922179|FG000|Overall Study|Adverse Event|20|||
145292349|NCT01298570|523922180|FG001|Overall Study|Adverse Event|2|||
145292350|NCT01298570|523922179|FG000|Overall Study|Withdrawal by Subject|21|||
145407241|NCT05350423|524346930|FG001|Overall Study|screen failure|6|||
145407242|NCT02097277|524346932|FG000|Overall Study|Subject no longer meets study criteria|0|||
145407243|NCT02097277|524346933|FG001|Overall Study|Subject no longer meets study criteria|1|||
145292351|NCT01298570|523922180|FG001|Overall Study|Withdrawal by Subject|6|||
145292352|NCT01298570|523922179|FG000|Overall Study|Treatment delay > 4 weeks|4|||
145407244|NCT02097277|524346934|FG002|Overall Study|Subject no longer meets study criteria|0|||
145407245|NCT02097277|524346935|FG003|Overall Study|Subject no longer meets study criteria|1|||
145407246|NCT02097277|524346936|FG004|Overall Study|Subject no longer meets study criteria|0|||
145292353|NCT01298570|523922180|FG001|Overall Study|Treatment delay > 4 weeks|5|||
145292354|NCT01298570|523922179|FG000|Overall Study|Physician Decision|4|||
145292355|NCT01298570|523922180|FG001|Overall Study|Physician Decision|2|||
145292356|NCT01298570|523922179|FG000|Overall Study|Other complicating disease|2|||
145292357|NCT01298570|523922180|FG001|Overall Study|Other complicating disease|1|||
145292358|NCT01298570|523922179|FG000|Overall Study|Surgery|2|||
145292359|NCT01298570|523922180|FG001|Overall Study|Surgery|1|||
145292360|NCT01298570|523922179|FG000|Overall Study|Symptomatic progression/deterioration|3|||
145292361|NCT01298570|523922180|FG001|Overall Study|Symptomatic progression/deterioration|2|||
145292362|NCT01298570|523922179|FG000|Overall Study|Death|0|||
145292363|NCT01298570|523922180|FG001|Overall Study|Death|1|||
145292364|NCT01298570|523922179|FG000|Overall Study|Ineligibility|0|||
145292365|NCT01298570|523922180|FG001|Overall Study|Ineligibility|1|||
145292366|NCT00076102|523922181|FG000|Overall Study|Clinical progression|1|||
145292367|NCT00076102|523922181|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
145292368|NCT00076102|523922181|FG000|Overall Study|plexiform neurofibroma surgery|1|||
145292369|NCT00076102|523922181|FG000|Overall Study|refusal of further therapy|2|||
145292370|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
145292371|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
145292372|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
145292373|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
145292374|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
145292375|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
145292376|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
145292377|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
145292378|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
145292379|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
145292380|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
145292381|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
145407247|NCT02097277|524346932|FG000|Overall Study|Subject request to discontinue treatment|0|||
145556448|NCT02554812|524895047|FG024|Overall Study|Global deterioration of health status|0|||
145556449|NCT02554812|524895048|FG025|Overall Study|Global deterioration of health status|0|||
145556450|NCT02554812|524895049|FG026|Overall Study|Global deterioration of health status|0|||
145556451|NCT02554812|524895023|FG000|Overall Study|Progressive disease|20|||
145556452|NCT02554812|524895024|FG001|Overall Study|Progressive disease|16|||
145556453|NCT02554812|524895025|FG002|Overall Study|Progressive disease|19|||
145556454|NCT02554812|524895026|FG003|Overall Study|Progressive disease|18|||
145556455|NCT02554812|524895027|FG004|Overall Study|Progressive disease|21|||
145556456|NCT02554812|524895028|FG005|Overall Study|Progressive disease|15|||
145556457|NCT02554812|524895029|FG006|Overall Study|Progressive disease|6|||
145556458|NCT02554812|524895030|FG007|Overall Study|Progressive disease|13|||
145556459|NCT02554812|524895031|FG008|Overall Study|Progressive disease|6|||
145556460|NCT02554812|524895032|FG009|Overall Study|Progressive disease|6|||
145556461|NCT02554812|524895033|FG010|Overall Study|Progressive disease|8|||
145556462|NCT02554812|524895034|FG011|Overall Study|Progressive disease|8|||
145556463|NCT02554812|524895035|FG012|Overall Study|Progressive disease|6|||
145556464|NCT02554812|524895036|FG013|Overall Study|Progressive disease|10|||
145556465|NCT02554812|524895037|FG014|Overall Study|Progressive disease|20|||
145556466|NCT02554812|524895038|FG015|Overall Study|Progressive disease|6|||
145556467|NCT02554812|524895039|FG016|Overall Study|Progressive disease|3|||
145556468|NCT02554812|524895040|FG017|Overall Study|Progressive disease|3|||
145556469|NCT02554812|524895041|FG018|Overall Study|Progressive disease|11|||
145556470|NCT02554812|524895042|FG019|Overall Study|Progressive disease|7|||
145292382|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
145292383|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
145292384|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
145292385|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
145292386|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
145292387|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
145292388|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
145292389|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
145292390|NCT02207231|523922183|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
145292391|NCT02207231|523922184|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
145556471|NCT02554812|524895043|FG020|Overall Study|Progressive disease|11|||
145556472|NCT02554812|524895044|FG021|Overall Study|Progressive disease|6|||
145556473|NCT02554812|524895045|FG022|Overall Study|Progressive disease|9|||
145615953|NCT05284019|525109334|FG004|Overall Study|Lost to Follow-up|1|||
145615954|NCT02065570|525109335|FG000|Induction Study|Adverse Event|5|||
145615955|NCT02065570|525109336|FG001|Induction Study|Adverse Event|12|||
145615956|NCT02065570|525109337|FG002|Induction Study|Adverse Event|0|||
145615957|NCT02065570|525109338|FG003|Induction Study|Adverse Event|0|||
145615958|NCT02065570|525109335|FG000|Induction Study|Withdrawal by Subject|2|||
145615959|NCT02065570|525109336|FG001|Induction Study|Withdrawal by Subject|3|||
145615960|NCT02065570|525109337|FG002|Induction Study|Withdrawal by Subject|0|||
145615961|NCT02065570|525109338|FG003|Induction Study|Withdrawal by Subject|0|||
145615962|NCT02065570|525109335|FG000|Induction Study|Lost to Follow-up|1|||
145615963|NCT02065570|525109336|FG001|Induction Study|Lost to Follow-up|1|||
145615964|NCT02065570|525109337|FG002|Induction Study|Lost to Follow-up|0|||
145615965|NCT02065570|525109338|FG003|Induction Study|Lost to Follow-up|0|||
145615966|NCT02065570|525109335|FG000|Induction Study|Other, Not Specified|6|||
145615967|NCT02065570|525109336|FG001|Induction Study|Other, Not Specified|5|||
145615968|NCT02065570|525109337|FG002|Induction Study|Other, Not Specified|0|||
145615969|NCT02065570|525109338|FG003|Induction Study|Other, Not Specified|0|||
145615970|NCT02065570|525109335|FG000|Maintenance Study|Adverse Event|0|||
145615971|NCT02065570|525109336|FG001|Maintenance Study|Adverse Event|0|||
145615972|NCT02065570|525109337|FG002|Maintenance Study|Adverse Event|8|||
145615973|NCT02065570|525109338|FG003|Maintenance Study|Adverse Event|8|||
145615974|NCT02065570|525109335|FG000|Maintenance Study|Withdrawal by Subject|0|||
145615975|NCT02065570|525109336|FG001|Maintenance Study|Withdrawal by Subject|0|||
145615976|NCT02065570|525109337|FG002|Maintenance Study|Withdrawal by Subject|1|||
145292392|NCT02207231|523922185|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
145292393|NCT02207231|523922186|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
145292394|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
145292395|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
145292396|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
145292397|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
145292398|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
145292399|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
145292400|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
145292401|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
145292402|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
145292403|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
145292404|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
145292405|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
145292406|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
145292407|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
145292408|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
145292409|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
145292410|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
145292411|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
145292412|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
145556474|NCT02554812|524895046|FG023|Overall Study|Progressive disease|9|||
145556475|NCT02554812|524895047|FG024|Overall Study|Progressive disease|4|||
145556476|NCT02554812|524895048|FG025|Overall Study|Progressive disease|5|||
145556477|NCT02554812|524895049|FG026|Overall Study|Progressive disease|5|||
145556478|NCT02554812|524895023|FG000|Overall Study|Other|0|||
145556479|NCT02554812|524895024|FG001|Overall Study|Other|0|||
145556480|NCT02554812|524895025|FG002|Overall Study|Other|2|||
145556481|NCT02554812|524895026|FG003|Overall Study|Other|3|||
145556482|NCT02554812|524895027|FG004|Overall Study|Other|2|||
145292413|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
145292414|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
145292415|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
145292416|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
145292417|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
145292418|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
145292419|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
145292420|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
145292421|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
145292422|NCT02207231|523922183|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
145292423|NCT02207231|523922184|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
145292424|NCT02207231|523922185|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
145292425|NCT02207231|523922186|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
145292426|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
145292427|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
145556483|NCT02554812|524895028|FG005|Overall Study|Other|1|||
145556484|NCT02554812|524895029|FG006|Overall Study|Other|0|||
145556485|NCT02554812|524895030|FG007|Overall Study|Other|0|||
145556486|NCT02554812|524895031|FG008|Overall Study|Other|1|||
145556487|NCT02554812|524895032|FG009|Overall Study|Other|1|||
145556488|NCT02554812|524895033|FG010|Overall Study|Other|0|||
145556489|NCT02554812|524895034|FG011|Overall Study|Other|0|||
145556490|NCT02554812|524895035|FG012|Overall Study|Other|1|||
145615977|NCT02065570|525109338|FG003|Maintenance Study|Withdrawal by Subject|4|||
145556491|NCT02554812|524895036|FG013|Overall Study|Other|0|||
145556492|NCT02554812|524895037|FG014|Overall Study|Other|1|||
145556493|NCT02554812|524895038|FG015|Overall Study|Other|0|||
145556494|NCT02554812|524895039|FG016|Overall Study|Other|0|||
145615978|NCT02065570|525109335|FG000|Maintenance Study|Lost to Follow-up|0|||
145556495|NCT02554812|524895040|FG017|Overall Study|Other|0|||
145556496|NCT02554812|524895041|FG018|Overall Study|Other|0|||
145556497|NCT02554812|524895042|FG019|Overall Study|Other|0|||
145556498|NCT02554812|524895043|FG020|Overall Study|Other|0|||
145556499|NCT02554812|524895044|FG021|Overall Study|Other|2|||
145556500|NCT02554812|524895045|FG022|Overall Study|Other|0|||
145292428|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
145292429|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
145292430|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
145292431|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
145292432|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
145292433|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
145292434|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
145292435|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
145292436|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
145292437|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
145556501|NCT02554812|524895046|FG023|Overall Study|Other|0|||
145556502|NCT02554812|524895047|FG024|Overall Study|Other|0|||
145556503|NCT02554812|524895048|FG025|Overall Study|Other|0|||
145556504|NCT02554812|524895049|FG026|Overall Study|Other|0|||
145556505|NCT02554812|524895023|FG000|Overall Study|Withdrawal by Subject|1|||
145292438|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
145292439|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
145292440|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
145292441|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
145292442|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
145292443|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
145292444|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
145292445|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
145556506|NCT02554812|524895024|FG001|Overall Study|Withdrawal by Subject|0|||
145556507|NCT02554812|524895025|FG002|Overall Study|Withdrawal by Subject|0|||
145556508|NCT02554812|524895026|FG003|Overall Study|Withdrawal by Subject|2|||
145556509|NCT02554812|524895027|FG004|Overall Study|Withdrawal by Subject|2|||
145556510|NCT02554812|524895028|FG005|Overall Study|Withdrawal by Subject|3|||
145556511|NCT02554812|524895029|FG006|Overall Study|Withdrawal by Subject|0|||
145556512|NCT02554812|524895030|FG007|Overall Study|Withdrawal by Subject|0|||
145556513|NCT02554812|524895031|FG008|Overall Study|Withdrawal by Subject|1|||
145556514|NCT02554812|524895032|FG009|Overall Study|Withdrawal by Subject|1|||
145556515|NCT02554812|524895033|FG010|Overall Study|Withdrawal by Subject|0|||
145556516|NCT02554812|524895034|FG011|Overall Study|Withdrawal by Subject|1|||
145556517|NCT02554812|524895035|FG012|Overall Study|Withdrawal by Subject|1|||
145556518|NCT02554812|524895036|FG013|Overall Study|Withdrawal by Subject|1|||
145556519|NCT02554812|524895037|FG014|Overall Study|Withdrawal by Subject|1|||
145556520|NCT02554812|524895038|FG015|Overall Study|Withdrawal by Subject|1|||
145556521|NCT02554812|524895039|FG016|Overall Study|Withdrawal by Subject|3|||
145556522|NCT02554812|524895040|FG017|Overall Study|Withdrawal by Subject|1|||
145556523|NCT02554812|524895041|FG018|Overall Study|Withdrawal by Subject|0|||
145556524|NCT02554812|524895042|FG019|Overall Study|Withdrawal by Subject|2|||
145556525|NCT02554812|524895043|FG020|Overall Study|Withdrawal by Subject|0|||
145556526|NCT02554812|524895044|FG021|Overall Study|Withdrawal by Subject|1|||
145556527|NCT02554812|524895045|FG022|Overall Study|Withdrawal by Subject|0|||
145556528|NCT02554812|524895046|FG023|Overall Study|Withdrawal by Subject|1|||
145556529|NCT02554812|524895047|FG024|Overall Study|Withdrawal by Subject|0|||
145556530|NCT02554812|524895048|FG025|Overall Study|Withdrawal by Subject|0|||
145556531|NCT02554812|524895049|FG026|Overall Study|Withdrawal by Subject|1|||
145556532|NCT02554812|524895023|FG000|Overall Study|Physician Decision|1|||
145556533|NCT02554812|524895024|FG001|Overall Study|Physician Decision|0|||
145556534|NCT02554812|524895025|FG002|Overall Study|Physician Decision|0|||
145556535|NCT02554812|524895026|FG003|Overall Study|Physician Decision|1|||
145556536|NCT02554812|524895027|FG004|Overall Study|Physician Decision|0|||
145556537|NCT02554812|524895028|FG005|Overall Study|Physician Decision|1|||
145556538|NCT02554812|524895029|FG006|Overall Study|Physician Decision|0|||
145556539|NCT02554812|524895030|FG007|Overall Study|Physician Decision|0|||
145556540|NCT02554812|524895031|FG008|Overall Study|Physician Decision|0|||
145556541|NCT02554812|524895032|FG009|Overall Study|Physician Decision|0|||
145556542|NCT02554812|524895033|FG010|Overall Study|Physician Decision|1|||
145556543|NCT02554812|524895034|FG011|Overall Study|Physician Decision|0|||
145556544|NCT02554812|524895035|FG012|Overall Study|Physician Decision|0|||
145556545|NCT02554812|524895036|FG013|Overall Study|Physician Decision|0|||
145556546|NCT02554812|524895037|FG014|Overall Study|Physician Decision|0|||
145556547|NCT02554812|524895038|FG015|Overall Study|Physician Decision|0|||
145556548|NCT02554812|524895039|FG016|Overall Study|Physician Decision|1|||
145556549|NCT02554812|524895040|FG017|Overall Study|Physician Decision|1|||
145556550|NCT02554812|524895041|FG018|Overall Study|Physician Decision|0|||
145556551|NCT02554812|524895042|FG019|Overall Study|Physician Decision|1|||
145556552|NCT02554812|524895043|FG020|Overall Study|Physician Decision|1|||
145556553|NCT02554812|524895044|FG021|Overall Study|Physician Decision|0|||
145556554|NCT02554812|524895045|FG022|Overall Study|Physician Decision|1|||
145556555|NCT02554812|524895046|FG023|Overall Study|Physician Decision|0|||
145556556|NCT02554812|524895047|FG024|Overall Study|Physician Decision|0|||
145556557|NCT02554812|524895048|FG025|Overall Study|Physician Decision|0|||
145556558|NCT02554812|524895049|FG026|Overall Study|Physician Decision|0|||
145556559|NCT02554812|524895023|FG000|Overall Study|Study terminated by sponsor|0|||
145556560|NCT02554812|524895024|FG001|Overall Study|Study terminated by sponsor|0|||
145556561|NCT02554812|524895025|FG002|Overall Study|Study terminated by sponsor|0|||
145556562|NCT02554812|524895026|FG003|Overall Study|Study terminated by sponsor|0|||
145556563|NCT02554812|524895027|FG004|Overall Study|Study terminated by sponsor|0|||
145556564|NCT02554812|524895028|FG005|Overall Study|Study terminated by sponsor|0|||
145556565|NCT02554812|524895029|FG006|Overall Study|Study terminated by sponsor|0|||
145556566|NCT02554812|524895030|FG007|Overall Study|Study terminated by sponsor|0|||
145556567|NCT02554812|524895031|FG008|Overall Study|Study terminated by sponsor|0|||
145556568|NCT02554812|524895032|FG009|Overall Study|Study terminated by sponsor|0|||
145556569|NCT02554812|524895033|FG010|Overall Study|Study terminated by sponsor|0|||
145556570|NCT02554812|524895034|FG011|Overall Study|Study terminated by sponsor|0|||
145556571|NCT02554812|524895035|FG012|Overall Study|Study terminated by sponsor|0|||
145556572|NCT02554812|524895036|FG013|Overall Study|Study terminated by sponsor|0|||
145556573|NCT02554812|524895037|FG014|Overall Study|Study terminated by sponsor|0|||
145556574|NCT02554812|524895038|FG015|Overall Study|Study terminated by sponsor|0|||
145556575|NCT02554812|524895039|FG016|Overall Study|Study terminated by sponsor|0|||
145556576|NCT02554812|524895040|FG017|Overall Study|Study terminated by sponsor|0|||
145556577|NCT02554812|524895041|FG018|Overall Study|Study terminated by sponsor|0|||
145556578|NCT02554812|524895042|FG019|Overall Study|Study terminated by sponsor|0|||
145556579|NCT02554812|524895043|FG020|Overall Study|Study terminated by sponsor|0|||
145615979|NCT02065570|525109336|FG001|Maintenance Study|Lost to Follow-up|0|||
145615980|NCT02065570|525109337|FG002|Maintenance Study|Lost to Follow-up|2|||
145615981|NCT02065570|525109338|FG003|Maintenance Study|Lost to Follow-up|2|||
145615982|NCT02065570|525109335|FG000|Maintenance Study|Other, Not Specified|0|||
145615983|NCT02065570|525109336|FG001|Maintenance Study|Other, Not Specified|0|||
145615984|NCT02065570|525109337|FG002|Maintenance Study|Other, Not Specified|11|||
145615985|NCT02065570|525109338|FG003|Maintenance Study|Other, Not Specified|5|||
145615986|NCT01231503|525109339|FG000|Overall Study|Adverse Event|0|||
145615987|NCT01231503|525109340|FG001|Overall Study|Adverse Event|0|||
145615988|NCT01231503|525109341|FG002|Overall Study|Adverse Event|0|||
145615989|NCT01231503|525109342|FG003|Overall Study|Adverse Event|0|||
145615990|NCT01231503|525109343|FG004|Overall Study|Adverse Event|0|||
145615991|NCT01231503|525109344|FG005|Overall Study|Adverse Event|1|||
145615992|NCT01231503|525109345|FG006|Overall Study|Adverse Event|0|||
145615993|NCT01231503|525109346|FG007|Overall Study|Adverse Event|0|||
145615994|NCT01231503|525109339|FG000|Overall Study|Adverse event, serious fatal|0|||
145615995|NCT01231503|525109340|FG001|Overall Study|Adverse event, serious fatal|0|||
145615996|NCT01231503|525109341|FG002|Overall Study|Adverse event, serious fatal|1|||
145615997|NCT01231503|525109342|FG003|Overall Study|Adverse event, serious fatal|1|||
145615998|NCT01231503|525109343|FG004|Overall Study|Adverse event, serious fatal|0|||
145615999|NCT01231503|525109344|FG005|Overall Study|Adverse event, serious fatal|1|||
145616000|NCT01231503|525109345|FG006|Overall Study|Adverse event, serious fatal|0|||
145616001|NCT01231503|525109346|FG007|Overall Study|Adverse event, serious fatal|0|||
145616002|NCT01231503|525109339|FG000|Overall Study|Withdrawal by Subject|6|||
145616003|NCT01231503|525109340|FG001|Overall Study|Withdrawal by Subject|3|||
145616004|NCT01231503|525109341|FG002|Overall Study|Withdrawal by Subject|3|||
145616005|NCT01231503|525109342|FG003|Overall Study|Withdrawal by Subject|1|||
145616006|NCT01231503|525109343|FG004|Overall Study|Withdrawal by Subject|3|||
145616007|NCT01231503|525109344|FG005|Overall Study|Withdrawal by Subject|5|||
145616008|NCT01231503|525109345|FG006|Overall Study|Withdrawal by Subject|1|||
145616009|NCT01231503|525109346|FG007|Overall Study|Withdrawal by Subject|2|||
145556580|NCT02554812|524895044|FG021|Overall Study|Study terminated by sponsor|0|||
145556581|NCT02554812|524895045|FG022|Overall Study|Study terminated by sponsor|0|||
145556582|NCT02554812|524895046|FG023|Overall Study|Study terminated by sponsor|0|||
145616010|NCT01231503|525109339|FG000|Overall Study|Lost to Follow-up|8|||
145616011|NCT01231503|525109340|FG001|Overall Study|Lost to Follow-up|10|||
145616012|NCT01231503|525109341|FG002|Overall Study|Lost to Follow-up|8|||
145616013|NCT01231503|525109342|FG003|Overall Study|Lost to Follow-up|5|||
145616014|NCT01231503|525109343|FG004|Overall Study|Lost to Follow-up|7|||
145616015|NCT01231503|525109344|FG005|Overall Study|Lost to Follow-up|9|||
145616016|NCT01231503|525109345|FG006|Overall Study|Lost to Follow-up|6|||
145556583|NCT02554812|524895047|FG024|Overall Study|Study terminated by sponsor|1|||
145556584|NCT02554812|524895048|FG025|Overall Study|Study terminated by sponsor|0|||
145616017|NCT01231503|525109346|FG007|Overall Study|Lost to Follow-up|6|||
145616018|NCT01231503|525109339|FG000|Overall Study|Protocol Violation|0|||
145616019|NCT01231503|525109340|FG001|Overall Study|Protocol Violation|0|||
145616020|NCT01231503|525109341|FG002|Overall Study|Protocol Violation|0|||
145616021|NCT01231503|525109342|FG003|Overall Study|Protocol Violation|1|||
145616022|NCT01231503|525109343|FG004|Overall Study|Protocol Violation|0|||
145556585|NCT02554812|524895049|FG026|Overall Study|Study terminated by sponsor|0|||
145556586|NCT02554812|524895023|FG000|Overall Study|No longer meets eligibility criteria|0|||
145616023|NCT01231503|525109344|FG005|Overall Study|Protocol Violation|0|||
145616024|NCT01231503|525109345|FG006|Overall Study|Protocol Violation|0|||
145616025|NCT01231503|525109346|FG007|Overall Study|Protocol Violation|0|||
145616026|NCT01146574|525109347|FG000|Overall Study|Death|0|||
145616027|NCT01146574|525109348|FG001|Overall Study|Death|1|||
145616028|NCT01146574|525109349|FG002|Overall Study|Death|1|||
145616029|NCT01146574|525109350|FG003|Overall Study|Death|0|||
145616030|NCT01146574|525109351|FG004|Overall Study|Death|0|||
145616031|NCT01146574|525109352|FG005|Overall Study|Death|0|||
145616032|NCT01146574|525109353|FG006|Overall Study|Death|0|||
145616033|NCT01146574|525109347|FG000|Overall Study|Other reasons|0|||
145616034|NCT01146574|525109348|FG001|Overall Study|Other reasons|0|||
145616035|NCT01146574|525109349|FG002|Overall Study|Other reasons|3|||
145616036|NCT01146574|525109350|FG003|Overall Study|Other reasons|0|||
145616037|NCT01146574|525109351|FG004|Overall Study|Other reasons|0|||
145616038|NCT01146574|525109352|FG005|Overall Study|Other reasons|0|||
145616039|NCT01146574|525109353|FG006|Overall Study|Other reasons|0|||
145616040|NCT01146574|525109347|FG000|Overall Study|Kidney transplant|0|||
145616041|NCT01146574|525109348|FG001|Overall Study|Kidney transplant|0|||
145616042|NCT01146574|525109349|FG002|Overall Study|Kidney transplant|1|||
145616043|NCT01146574|525109350|FG003|Overall Study|Kidney transplant|1|||
145616044|NCT01146574|525109351|FG004|Overall Study|Kidney transplant|0|||
145616045|NCT01146574|525109352|FG005|Overall Study|Kidney transplant|0|||
145616046|NCT01146574|525109353|FG006|Overall Study|Kidney transplant|0|||
145616047|NCT01146574|525109347|FG000|Overall Study|Withdrew consent|0|||
145616048|NCT01146574|525109348|FG001|Overall Study|Withdrew consent|0|||
145616049|NCT01146574|525109349|FG002|Overall Study|Withdrew consent|1|||
145616050|NCT01146574|525109350|FG003|Overall Study|Withdrew consent|1|||
145616051|NCT01146574|525109351|FG004|Overall Study|Withdrew consent|2|||
145616052|NCT01146574|525109352|FG005|Overall Study|Withdrew consent|1|||
145616053|NCT01146574|525109353|FG006|Overall Study|Withdrew consent|1|||
145616054|NCT03285113|525109354|FG000|Overall Study|Unable to implant leads|2|||
145616055|NCT00513019|525111286|FG000|Overall Study|Adverse Event|1|||
145616056|NCT00513019|525111287|FG001|Overall Study|Adverse Event|0|||
145616057|NCT00513019|525111286|FG000|Overall Study|Withdrawal by Subject|4|||
145616058|NCT00513019|525111287|FG001|Overall Study|Withdrawal by Subject|5|||
145616059|NCT01853254|525111288|FG000|Overall Study|Abnormal Laboratory Test|1|||
145616060|NCT01853254|525111288|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
145616061|NCT01853254|525111288|FG000|Overall Study|Death|1|||
145556587|NCT02554812|524895024|FG001|Overall Study|No longer meets eligibility criteria|1|||
145556588|NCT02554812|524895025|FG002|Overall Study|No longer meets eligibility criteria|0|||
145556589|NCT02554812|524895026|FG003|Overall Study|No longer meets eligibility criteria|0|||
145556590|NCT02554812|524895027|FG004|Overall Study|No longer meets eligibility criteria|0|||
145556591|NCT02554812|524895028|FG005|Overall Study|No longer meets eligibility criteria|0|||
145556592|NCT02554812|524895029|FG006|Overall Study|No longer meets eligibility criteria|0|||
145556593|NCT02554812|524895030|FG007|Overall Study|No longer meets eligibility criteria|0|||
145556594|NCT02554812|524895031|FG008|Overall Study|No longer meets eligibility criteria|0|||
145616062|NCT01853254|525111288|FG000|Overall Study|Failure to Return|43|||
145616063|NCT01853254|525111288|FG000|Overall Study|Insufficient Therapeutic Response|22|||
145616064|NCT01853254|525111288|FG000|Overall Study|Refusal of Treatment|1|||
145616065|NCT01853254|525111288|FG000|Overall Study|Other Protocol Violation|1|||
145616066|NCT01853254|525111288|FG000|Overall Study|Withdrawal of Consent|16|||
145616067|NCT01853254|525111288|FG000|Overall Study|Administrative/Other|16|||
145616068|NCT02462083|525111289|FG000|Overall Study|Sponsor request|39|||
145616069|NCT02462083|525111289|FG000|Overall Study|Withdrawal by Subject|87|||
145616070|NCT02462083|525111289|FG000|Overall Study|Lost to Follow-up|41|||
145616071|NCT02462083|525111289|FG000|Overall Study|Lack of Efficacy|151|||
145616072|NCT02462083|525111289|FG000|Overall Study|Pregnancy|1|||
145616073|NCT02462083|525111289|FG000|Overall Study|Protocol Violation|6|||
145616074|NCT02462083|525111289|FG000|Overall Study|Adverse Event|33|||
145616075|NCT02462083|525111289|FG000|Overall Study|Worsening condition|16|||
145616076|NCT02462083|525111289|FG000|Overall Study|Other than specified|45|||
145616077|NCT01642186|525111290|FG000|Overall Study|Death|0|||
145616078|NCT01642186|525111291|FG001|Overall Study|Death|2|||
145616079|NCT01642186|525111292|FG002|Overall Study|Death|2|||
145616080|NCT01642186|525111290|FG000|Overall Study|Lost to Follow-up|0|||
145616081|NCT01642186|525111291|FG001|Overall Study|Lost to Follow-up|0|||
145616082|NCT01642186|525111292|FG002|Overall Study|Lost to Follow-up|1|||
145616083|NCT01668147|525111293|FG000|Overall Study|Withdrawal by Subject|6|||
145556595|NCT02554812|524895032|FG009|Overall Study|No longer meets eligibility criteria|0|||
145556596|NCT02554812|524895033|FG010|Overall Study|No longer meets eligibility criteria|0|||
145556597|NCT02554812|524895034|FG011|Overall Study|No longer meets eligibility criteria|0|||
145556598|NCT02554812|524895035|FG012|Overall Study|No longer meets eligibility criteria|0|||
145556599|NCT02554812|524895036|FG013|Overall Study|No longer meets eligibility criteria|0|||
145556600|NCT02554812|524895037|FG014|Overall Study|No longer meets eligibility criteria|0|||
145556601|NCT02554812|524895038|FG015|Overall Study|No longer meets eligibility criteria|0|||
145556602|NCT02554812|524895039|FG016|Overall Study|No longer meets eligibility criteria|0|||
145556603|NCT02554812|524895040|FG017|Overall Study|No longer meets eligibility criteria|0|||
145556604|NCT02554812|524895041|FG018|Overall Study|No longer meets eligibility criteria|0|||
145556605|NCT02554812|524895042|FG019|Overall Study|No longer meets eligibility criteria|0|||
145556606|NCT02554812|524895043|FG020|Overall Study|No longer meets eligibility criteria|0|||
145556607|NCT02554812|524895044|FG021|Overall Study|No longer meets eligibility criteria|0|||
145556608|NCT02554812|524895045|FG022|Overall Study|No longer meets eligibility criteria|0|||
145556609|NCT02554812|524895046|FG023|Overall Study|No longer meets eligibility criteria|0|||
145556610|NCT02554812|524895047|FG024|Overall Study|No longer meets eligibility criteria|0|||
145556611|NCT02554812|524895048|FG025|Overall Study|No longer meets eligibility criteria|0|||
145556612|NCT02554812|524895049|FG026|Overall Study|No longer meets eligibility criteria|0|||
145556613|NCT00587561|524897144|FG000|Overall Study|Lost to Follow-up|6|||
145556614|NCT00587561|524897145|FG001|Overall Study|Lost to Follow-up|4|||
145556615|NCT03204981|524897147|FG000|Overall Study|Physician Decision|2|||
145556616|NCT03204981|524897147|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
145556617|NCT04244786|524897148|FG000|Overall Study|Adverse Event|0|||
145556618|NCT04244786|524897149|FG001|Overall Study|Adverse Event|0|||
145556619|NCT04244786|524897150|FG002|Overall Study|Adverse Event|2|||
145556620|NCT04244786|524897148|FG000|Overall Study|Withdrawal by Subject|0|||
145556621|NCT04244786|524897149|FG001|Overall Study|Withdrawal by Subject|0|||
145556622|NCT04244786|524897150|FG002|Overall Study|Withdrawal by Subject|5|||
145556623|NCT03274687|524897151|FG000|Overall Study|Protocol Violation|1|||
145556624|NCT03274687|524897152|FG001|Overall Study|Protocol Violation|1|||
145556625|NCT00613938|524897153|FG000|Overall Study|Withdrawal by Subject|2|||
145556626|NCT00613938|524897154|FG001|Overall Study|Withdrawal by Subject|4|||
145556627|NCT00613938|524897155|FG002|Overall Study|Withdrawal by Subject|9|||
145556628|NCT00613938|524897156|FG003|Overall Study|Withdrawal by Subject|9|||
145556629|NCT00613938|524897153|FG000|Overall Study|Adverse Event|1|||
145556630|NCT00613938|524897154|FG001|Overall Study|Adverse Event|4|||
145556631|NCT00613938|524897155|FG002|Overall Study|Adverse Event|8|||
145556632|NCT00613938|524897156|FG003|Overall Study|Adverse Event|5|||
145556633|NCT00613938|524897153|FG000|Overall Study|Lack of Efficacy|16|||
145556634|NCT00613938|524897154|FG001|Overall Study|Lack of Efficacy|18|||
145556635|NCT00613938|524897155|FG002|Overall Study|Lack of Efficacy|5|||
145556636|NCT00613938|524897156|FG003|Overall Study|Lack of Efficacy|9|||
145556637|NCT00613938|524897153|FG000|Overall Study|Other|1|||
145556638|NCT00613938|524897154|FG001|Overall Study|Other|2|||
145556639|NCT00613938|524897155|FG002|Overall Study|Other|1|||
145556640|NCT00613938|524897156|FG003|Overall Study|Other|3|||
145556641|NCT00623727|524897157|FG000|Double Blind (DB)|Adverse Event|1|||
145556642|NCT00623727|524897158|FG001|Double Blind (DB)|Adverse Event|3|||
145556643|NCT00623727|524897157|FG000|Double Blind (DB)|Physician Decision|0|||
145556644|NCT00623727|524897158|FG001|Double Blind (DB)|Physician Decision|1|||
145556645|NCT00623727|524897157|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
145556646|NCT00623727|524897158|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
145556647|NCT00623727|524897157|FG000|Double Blind (DB)|Lack of Efficacy|2|||
145556648|NCT00623727|524897158|FG001|Double Blind (DB)|Lack of Efficacy|2|||
145556649|NCT00623727|524897157|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
145616084|NCT01474512|525111295|FG000|Induction Period|Adverse Event|6|||
145616085|NCT01474512|525111296|FG001|Induction Period|Adverse Event|10|||
145616086|NCT01474512|525111297|FG002|Induction Period|Adverse Event|10|||
145616087|NCT01474512|525111298|FG003|Induction Period|Adverse Event|0|||
145616088|NCT01474512|525111299|FG004|Induction Period|Adverse Event|0|||
145616089|NCT01474512|525111300|FG005|Induction Period|Adverse Event|0|||
145616090|NCT01474512|525111301|FG006|Induction Period|Adverse Event|0|||
145616091|NCT01474512|525111302|FG007|Induction Period|Adverse Event|0|||
145616092|NCT01474512|525111303|FG008|Induction Period|Adverse Event|0|||
145556650|NCT00623727|524897158|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
145556651|NCT00623727|524897157|FG000|Double Blind (DB)|Lost to Follow-up|1|||
145556652|NCT00623727|524897158|FG001|Double Blind (DB)|Lost to Follow-up|1|||
145616093|NCT01474512|525111304|FG009|Induction Period|Adverse Event|0|||
145616094|NCT01474512|525111305|FG010|Induction Period|Adverse Event|0|||
145556653|NCT00623727|524897157|FG000|Double Blind (DB)|Protocol Violation|2|||
145556654|NCT00623727|524897158|FG001|Double Blind (DB)|Protocol Violation|2|||
145616095|NCT01474512|525111306|FG011|Induction Period|Adverse Event|0|||
145556655|NCT00623727|524897157|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
145556656|NCT00623727|524897158|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
145556657|NCT00623727|524897157|FG000|Open Label Follow-up|Study termination|0|||
145556658|NCT00623727|524897158|FG001|Open Label Follow-up|Study termination|6|||
145556659|NCT00623727|524897157|FG000|Open Label Follow-up|Participant convenience|0|||
145556660|NCT00623727|524897158|FG001|Open Label Follow-up|Participant convenience|1|||
145556661|NCT03745937|524897159|FG000|Overall Study|Withdrawal by Subject|0|||
145556662|NCT03745937|524897160|FG001|Overall Study|Withdrawal by Subject|0|||
145556663|NCT03745937|524897161|FG002|Overall Study|Withdrawal by Subject|0|||
145556664|NCT03745937|524897162|FG003|Overall Study|Withdrawal by Subject|1|||
145556665|NCT03745937|524897159|FG000|Overall Study|Not-specifed|0|||
145556666|NCT03745937|524897160|FG001|Overall Study|Not-specifed|1|||
145556667|NCT03745937|524897161|FG002|Overall Study|Not-specifed|0|||
145556668|NCT03745937|524897162|FG003|Overall Study|Not-specifed|1|||
145556669|NCT01706003|524897168|FG000|Overall Study|Withdrawal by Subject|2|||
145616096|NCT01474512|525111307|FG012|Induction Period|Adverse Event|0|||
145616097|NCT01474512|525111308|FG013|Induction Period|Adverse Event|0|||
145616098|NCT01474512|525111309|FG014|Induction Period|Adverse Event|0|||
145616099|NCT01474512|525111310|FG015|Induction Period|Adverse Event|0|||
145616100|NCT01474512|525111311|FG016|Induction Period|Adverse Event|0|||
145616101|NCT01474512|525111312|FG017|Induction Period|Adverse Event|0|||
145616102|NCT01474512|525111295|FG000|Induction Period|Lack of Efficacy|7|||
145616103|NCT01474512|525111296|FG001|Induction Period|Lack of Efficacy|1|||
145616104|NCT01474512|525111297|FG002|Induction Period|Lack of Efficacy|0|||
145616105|NCT01474512|525111298|FG003|Induction Period|Lack of Efficacy|0|||
145616106|NCT01474512|525111299|FG004|Induction Period|Lack of Efficacy|0|||
145616107|NCT01474512|525111300|FG005|Induction Period|Lack of Efficacy|0|||
145616108|NCT01474512|525111301|FG006|Induction Period|Lack of Efficacy|0|||
145616109|NCT01474512|525111302|FG007|Induction Period|Lack of Efficacy|0|||
145616110|NCT01474512|525111303|FG008|Induction Period|Lack of Efficacy|0|||
145616111|NCT01474512|525111304|FG009|Induction Period|Lack of Efficacy|0|||
145616112|NCT01474512|525111305|FG010|Induction Period|Lack of Efficacy|0|||
145556670|NCT01706003|524897169|FG001|Overall Study|Withdrawal by Subject|0|||
145556671|NCT01706003|524897168|FG000|Overall Study|Not scheduled|3|||
145556672|NCT01706003|524897169|FG001|Overall Study|Not scheduled|0|||
145556673|NCT01706003|524897168|FG000|Overall Study|Lost to Follow-up|6|||
145292446|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
145556674|NCT01706003|524897169|FG001|Overall Study|Lost to Follow-up|4|||
145556675|NCT05608005|524897172|FG000|Overall Study|Adverse Event|2|||
145616113|NCT01474512|525111306|FG011|Induction Period|Lack of Efficacy|0|||
145616114|NCT01474512|525111307|FG012|Induction Period|Lack of Efficacy|0|||
145616115|NCT01474512|525111308|FG013|Induction Period|Lack of Efficacy|0|||
145616116|NCT01474512|525111309|FG014|Induction Period|Lack of Efficacy|0|||
145407248|NCT02097277|524346933|FG001|Overall Study|Subject request to discontinue treatment|0|||
145407249|NCT02097277|524346934|FG002|Overall Study|Subject request to discontinue treatment|0|||
145407250|NCT02097277|524346935|FG003|Overall Study|Subject request to discontinue treatment|0|||
145407251|NCT02097277|524346936|FG004|Overall Study|Subject request to discontinue treatment|1|||
145407252|NCT02097277|524346932|FG000|Overall Study|Lost to Follow-up|0|||
145407253|NCT02097277|524346933|FG001|Overall Study|Lost to Follow-up|1|||
145407254|NCT02097277|524346934|FG002|Overall Study|Lost to Follow-up|1|||
145407255|NCT02097277|524346935|FG003|Overall Study|Lost to Follow-up|0|||
145407256|NCT02097277|524346936|FG004|Overall Study|Lost to Follow-up|0|||
145407257|NCT02097277|524346932|FG000|Overall Study|Withdrawal by Subject|2|||
145407258|NCT02097277|524346933|FG001|Overall Study|Withdrawal by Subject|1|||
145407259|NCT02097277|524346934|FG002|Overall Study|Withdrawal by Subject|0|||
145407260|NCT02097277|524346935|FG003|Overall Study|Withdrawal by Subject|1|||
145407261|NCT02097277|524346936|FG004|Overall Study|Withdrawal by Subject|0|||
145407262|NCT02097277|524346932|FG000|Overall Study|Adverse Event|0|||
145407263|NCT02097277|524346933|FG001|Overall Study|Adverse Event|0|||
145407264|NCT02097277|524346934|FG002|Overall Study|Adverse Event|1|||
145407265|NCT02097277|524346935|FG003|Overall Study|Adverse Event|2|||
145407266|NCT02097277|524346936|FG004|Overall Study|Adverse Event|0|||
145407267|NCT01091259|524346939|FG000|Overall Study|Adverse Event|3|||
145407268|NCT01091259|524346939|FG000|Overall Study|Lack of Efficacy|2|||
145407269|NCT03320369|524346940|FG000|Overall Study|Adverse Event|1|||
145407270|NCT03320369|524346940|FG000|Overall Study|Withdrawal by Subject|2|||
145407271|NCT02020941|524346941|FG000|Overall Study|Adverse Event|1|||
145407272|NCT02020941|524346941|FG000|Overall Study|Physician Decision|2|||
145407273|NCT02020941|524346941|FG000|Overall Study|Withdrawal by Subject|1|||
145407274|NCT02020941|524346941|FG000|Overall Study|Disease Progression|4|||
145407275|NCT02832037|524346942|FG000|Overall Study|Administrative reasons|0|||
145407276|NCT02832037|524346943|FG001|Overall Study|Administrative reasons|0|||
145407277|NCT02832037|524346944|FG002|Overall Study|Administrative reasons|1|||
145407278|NCT02832037|524346945|FG003|Overall Study|Administrative reasons|0|||
145407279|NCT02832037|524346946|FG004|Overall Study|Administrative reasons|0|||
145407280|NCT02832037|524346942|FG000|Overall Study|Protocol Violation|3|||
145407281|NCT02832037|524346943|FG001|Overall Study|Protocol Violation|0|||
145407282|NCT02832037|524346944|FG002|Overall Study|Protocol Violation|4|||
145407283|NCT02832037|524346945|FG003|Overall Study|Protocol Violation|1|||
145407284|NCT02832037|524346946|FG004|Overall Study|Protocol Violation|2|||
145407285|NCT02832037|524346942|FG000|Overall Study|Lost to Follow-up|2|||
145407286|NCT02832037|524346943|FG001|Overall Study|Lost to Follow-up|0|||
145407287|NCT02832037|524346944|FG002|Overall Study|Lost to Follow-up|3|||
145407288|NCT02832037|524346945|FG003|Overall Study|Lost to Follow-up|0|||
145407289|NCT02832037|524346946|FG004|Overall Study|Lost to Follow-up|5|||
145407290|NCT02832037|524346942|FG000|Overall Study|Withdrawal by Subject|9|||
145407291|NCT02832037|524346943|FG001|Overall Study|Withdrawal by Subject|8|||
145556676|NCT05608005|524897173|FG001|Overall Study|Adverse Event|1|||
145556677|NCT05608005|524897174|FG002|Overall Study|Adverse Event|3|||
145556678|NCT05608005|524897172|FG000|Overall Study|Protocol Violation|2|||
145556679|NCT05608005|524897173|FG001|Overall Study|Protocol Violation|3|||
145556680|NCT05608005|524897174|FG002|Overall Study|Protocol Violation|0|||
145556681|NCT05608005|524897172|FG000|Overall Study|Withdrawal by Subject|10|||
145556682|NCT05608005|524897173|FG001|Overall Study|Withdrawal by Subject|12|||
145556683|NCT05608005|524897174|FG002|Overall Study|Withdrawal by Subject|4|||
145556684|NCT05608005|524897172|FG000|Overall Study|Lost to Follow-up|25|||
145556685|NCT05608005|524897173|FG001|Overall Study|Lost to Follow-up|27|||
145556686|NCT05608005|524897174|FG002|Overall Study|Lost to Follow-up|15|||
145556687|NCT05608005|524897172|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
145556688|NCT05608005|524897173|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
145556689|NCT05608005|524897174|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
145556690|NCT03020407|524897176|FG000|Overall Study|Withdrawal by Subject|2|||
145556691|NCT03020407|524897177|FG001|Overall Study|Withdrawal by Subject|1|||
145556692|NCT03020407|524897176|FG000|Overall Study|Lost to Follow-up|2|||
145556693|NCT03020407|524897177|FG001|Overall Study|Lost to Follow-up|3|||
145556694|NCT03020407|524897176|FG000|Overall Study|Protocol Violation|0|||
145556695|NCT03020407|524897177|FG001|Overall Study|Protocol Violation|1|||
145556696|NCT01585428|524897178|FG000|Overall Study|Death during treatment|1|||
145556697|NCT01585428|524897179|FG001|Overall Study|Death during treatment|0|||
145556698|NCT01349803|524897183|FG000|Overall Study|Adverse Event|0|||
145556699|NCT01349803|524897184|FG001|Overall Study|Adverse Event|0|||
145407292|NCT02832037|524346944|FG002|Overall Study|Withdrawal by Subject|0|||
145556700|NCT01349803|524897185|FG002|Overall Study|Adverse Event|0|||
145556701|NCT01349803|524897186|FG003|Overall Study|Adverse Event|2|||
145556702|NCT01349803|524897183|FG000|Overall Study|Withdrawal by Subject|1|||
145556703|NCT01349803|524897184|FG001|Overall Study|Withdrawal by Subject|0|||
145407293|NCT02832037|524346945|FG003|Overall Study|Withdrawal by Subject|4|||
145407294|NCT02832037|524346946|FG004|Overall Study|Withdrawal by Subject|8|||
145407295|NCT02832037|524346942|FG000|Overall Study|Adverse Event|5|||
145407296|NCT02832037|524346943|FG001|Overall Study|Adverse Event|4|||
145556704|NCT01349803|524897185|FG002|Overall Study|Withdrawal by Subject|0|||
145556705|NCT01349803|524897186|FG003|Overall Study|Withdrawal by Subject|0|||
145556706|NCT01349803|524897183|FG000|Overall Study|Protocol-specified criteria|0|||
145556707|NCT01349803|524897184|FG001|Overall Study|Protocol-specified criteria|1|||
145556708|NCT01349803|524897185|FG002|Overall Study|Protocol-specified criteria|3|||
145556709|NCT01349803|524897186|FG003|Overall Study|Protocol-specified criteria|0|||
145556710|NCT01042236|524897189|FG000|Treatment Period 1|Adverse Event|0|||
145556711|NCT01042236|524897190|FG001|Treatment Period 1|Adverse Event|1|||
145616117|NCT01474512|525111310|FG015|Induction Period|Lack of Efficacy|0|||
145616118|NCT01474512|525111311|FG016|Induction Period|Lack of Efficacy|0|||
145616119|NCT01474512|525111312|FG017|Induction Period|Lack of Efficacy|0|||
145616120|NCT01474512|525111295|FG000|Induction Period|Withdrawal by Subject|6|||
145616121|NCT01474512|525111296|FG001|Induction Period|Withdrawal by Subject|6|||
145616122|NCT01474512|525111297|FG002|Induction Period|Withdrawal by Subject|5|||
145616123|NCT01474512|525111298|FG003|Induction Period|Withdrawal by Subject|0|||
145616124|NCT01474512|525111299|FG004|Induction Period|Withdrawal by Subject|0|||
145616125|NCT01474512|525111300|FG005|Induction Period|Withdrawal by Subject|0|||
145616126|NCT01474512|525111301|FG006|Induction Period|Withdrawal by Subject|0|||
145616127|NCT01474512|525111302|FG007|Induction Period|Withdrawal by Subject|0|||
145616128|NCT01474512|525111303|FG008|Induction Period|Withdrawal by Subject|0|||
145616129|NCT01474512|525111304|FG009|Induction Period|Withdrawal by Subject|0|||
145407297|NCT02832037|524346944|FG002|Overall Study|Adverse Event|0|||
145407298|NCT02832037|524346945|FG003|Overall Study|Adverse Event|2|||
145407299|NCT02832037|524346946|FG004|Overall Study|Adverse Event|4|||
145407300|NCT01137786|524346952|FG000|Overall Study|Lost to Follow-up|0|||
145407301|NCT01137786|524346953|FG001|Overall Study|Lost to Follow-up|2|||
145407302|NCT01137786|524346952|FG000|Overall Study|Withdrawal by Subject|1|||
145407303|NCT01137786|524346953|FG001|Overall Study|Withdrawal by Subject|1|||
145407304|NCT00770367|524346954|FG000|First Intervention|Withdrawal by Subject|0|||
145407305|NCT00770367|524346955|FG001|First Intervention|Withdrawal by Subject|2|||
145407306|NCT00770367|524346954|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
145407307|NCT00770367|524346955|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
145407308|NCT00770367|524346954|FG000|Second Intervention|Lost to Follow-up|2|||
145407309|NCT00770367|524346955|FG001|Second Intervention|Lost to Follow-up|0|||
145407310|NCT04727749|524346956|FG000|Overall Study|Lost to Follow-up|10|||
145407311|NCT04727749|524346957|FG001|Overall Study|Lost to Follow-up|3|||
145407312|NCT02378181|524346959|FG000|Overall Study|Lost to Follow-up|2|||
145407313|NCT02378181|524346960|FG001|Overall Study|Lost to Follow-up|5|||
145407314|NCT02378181|524346959|FG000|Overall Study|Withdrawal by Subject|1|||
145407315|NCT02378181|524346960|FG001|Overall Study|Withdrawal by Subject|1|||
145407316|NCT02378181|524346959|FG000|Overall Study|Incarcerated|0|||
145407317|NCT02378181|524346960|FG001|Overall Study|Incarcerated|1|||
145407318|NCT04491994|524346961|FG000|Overall Study|Withdrawal by Subject|10|||
145407319|NCT04491994|524346962|FG001|Overall Study|Withdrawal by Subject|5|||
145407320|NCT04491994|524346961|FG000|Overall Study|developed fever > 3 days|4|||
145407321|NCT04491994|524346962|FG001|Overall Study|developed fever > 3 days|1|||
145407322|NCT04491994|524346961|FG000|Overall Study|Protocol Violation|11|||
145407323|NCT04491994|524346962|FG001|Overall Study|Protocol Violation|2|||
145407324|NCT04491994|524346961|FG000|Overall Study|Lost to Follow-up|4|||
145407325|NCT04491994|524346962|FG001|Overall Study|Lost to Follow-up|3|||
145407326|NCT00716417|524346963|FG000|Overall Study|Adverse Event|0|||
145407327|NCT00716417|524346964|FG001|Overall Study|Adverse Event|0|||
145407328|NCT00716417|524346965|FG002|Overall Study|Adverse Event|2|||
145407329|NCT00716417|524346966|FG003|Overall Study|Adverse Event|1|||
145407330|NCT00716417|524346967|FG004|Overall Study|Adverse Event|0|||
145407331|NCT00716417|524346968|FG005|Overall Study|Adverse Event|0|||
145407332|NCT00716417|524346969|FG006|Overall Study|Adverse Event|3|||
145407333|NCT00716417|524346970|FG007|Overall Study|Adverse Event|1|||
145407334|NCT00716417|524346971|FG008|Overall Study|Adverse Event|0|||
145407335|NCT00716417|524346972|FG009|Overall Study|Adverse Event|3|||
145407336|NCT00716417|524346963|FG000|Overall Study|Withdrawal by Subject|0|||
145407337|NCT00716417|524346964|FG001|Overall Study|Withdrawal by Subject|1|||
145407338|NCT00716417|524346965|FG002|Overall Study|Withdrawal by Subject|0|||
145407339|NCT00716417|524346966|FG003|Overall Study|Withdrawal by Subject|2|||
145407340|NCT00716417|524346967|FG004|Overall Study|Withdrawal by Subject|0|||
145407341|NCT00716417|524346968|FG005|Overall Study|Withdrawal by Subject|0|||
145407342|NCT00716417|524346969|FG006|Overall Study|Withdrawal by Subject|1|||
145407343|NCT00716417|524346970|FG007|Overall Study|Withdrawal by Subject|0|||
145407344|NCT00716417|524346971|FG008|Overall Study|Withdrawal by Subject|0|||
145407345|NCT00716417|524346972|FG009|Overall Study|Withdrawal by Subject|0|||
145407346|NCT00716417|524346963|FG000|Overall Study|Progressive disease|3|||
145407347|NCT00716417|524346964|FG001|Overall Study|Progressive disease|5|||
145407348|NCT00716417|524346965|FG002|Overall Study|Progressive disease|3|||
145556712|NCT01042236|524897191|FG002|Treatment Period 1|Adverse Event|0|||
145556713|NCT01042236|524897192|FG003|Treatment Period 1|Adverse Event|0|||
145556714|NCT01042236|524897193|FG004|Treatment Period 1|Adverse Event|1|||
145407349|NCT00716417|524346966|FG003|Overall Study|Progressive disease|8|||
145407350|NCT00716417|524346967|FG004|Overall Study|Progressive disease|0|||
145556715|NCT01042236|524897194|FG005|Treatment Period 1|Adverse Event|0|||
145556716|NCT01042236|524897189|FG000|Treatment Period 3|Adverse Event|0|||
145556717|NCT01042236|524897190|FG001|Treatment Period 3|Adverse Event|0|||
145556718|NCT01042236|524897191|FG002|Treatment Period 3|Adverse Event|0|||
145556719|NCT01042236|524897192|FG003|Treatment Period 3|Adverse Event|1|||
145556720|NCT01042236|524897193|FG004|Treatment Period 3|Adverse Event|0|||
145407351|NCT00716417|524346968|FG005|Overall Study|Progressive disease|3|||
145407352|NCT00716417|524346969|FG006|Overall Study|Progressive disease|3|||
145556721|NCT01042236|524897194|FG005|Treatment Period 3|Adverse Event|0|||
145556722|NCT01042236|524897189|FG000|Treatment Period 3|Protocol Violation|0|||
145556723|NCT01042236|524897190|FG001|Treatment Period 3|Protocol Violation|0|||
145407353|NCT00716417|524346970|FG007|Overall Study|Progressive disease|1|||
145407354|NCT00716417|524346971|FG008|Overall Study|Progressive disease|5|||
145407355|NCT00716417|524346972|FG009|Overall Study|Progressive disease|0|||
145556724|NCT01042236|524897191|FG002|Treatment Period 3|Protocol Violation|0|||
145556725|NCT01042236|524897192|FG003|Treatment Period 3|Protocol Violation|1|||
145556726|NCT01042236|524897193|FG004|Treatment Period 3|Protocol Violation|0|||
145556727|NCT01042236|524897194|FG005|Treatment Period 3|Protocol Violation|0|||
145556728|NCT02522286|524897195|FG000|Overall Study|Withdrawal by Subject|3|||
145556729|NCT02522286|524897196|FG001|Overall Study|Withdrawal by Subject|0|||
145556730|NCT02522286|524897197|FG002|Overall Study|Withdrawal by Subject|0|||
145556731|NCT02522286|524897198|FG003|Overall Study|Withdrawal by Subject|3|||
145556732|NCT03683758|524897205|FG000|Overall Study|Non-study commitment conflict|1|||
145556733|NCT03683758|524897206|FG001|Overall Study|Non-study commitment conflict|3|||
145556734|NCT03683758|524897205|FG000|Overall Study|Illness preventing participation|1|||
145556735|NCT03683758|524897206|FG001|Overall Study|Illness preventing participation|0|||
145556736|NCT03683758|524897205|FG000|Overall Study|Adverse Event|1|||
145556737|NCT03683758|524897206|FG001|Overall Study|Adverse Event|0|||
145556738|NCT01172847|524897207|FG000|Overall Study|Withdrawal by Subject|3|||
145556739|NCT02411292|524897209|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
145556740|NCT02411292|524897209|FG000|Overall Study|Death|2|||
145556741|NCT02411292|524897209|FG000|Overall Study|Lost to Follow-up|3|||
145556742|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
145556743|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
145556744|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
145556745|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
145556746|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
145556747|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
145556748|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
145556749|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
145556750|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Other|4|||
145556751|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Other|1|||
145556752|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
145556753|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
145556754|NCT00303498|524897210|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
145556755|NCT00303498|524897211|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
145556756|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
145556757|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
145556758|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Death|1|||
145556759|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Death|0|||
145556760|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
145556761|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
145556762|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
145556763|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
145556764|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
145556765|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
145556766|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
145556767|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
145556768|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Other|1|||
145556769|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Other|0|||
145556770|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
145556771|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
145556772|NCT00303498|524897210|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
145556773|NCT00303498|524897211|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
145556774|NCT00453921|524897214|FG000|Overall Study|Withdrawal by Subject|1|||
145556775|NCT00453921|524897215|FG001|Overall Study|Withdrawal by Subject|1|||
145556776|NCT00453921|524897216|FG002|Overall Study|Withdrawal by Subject|1|||
145556777|NCT00453921|524897217|FG003|Overall Study|Withdrawal by Subject|1|||
145556778|NCT00453921|524897214|FG000|Overall Study|Lost to Follow-up|0|||
145556779|NCT00453921|524897215|FG001|Overall Study|Lost to Follow-up|0|||
145556780|NCT00453921|524897216|FG002|Overall Study|Lost to Follow-up|1|||
145556781|NCT00453921|524897217|FG003|Overall Study|Lost to Follow-up|0|||
145556782|NCT00174915|524897218|FG000|Overall Study|Lost to Follow-up|19|||
145556783|NCT00174915|524897219|FG001|Overall Study|Lost to Follow-up|17|||
145556784|NCT00174915|524897220|FG002|Overall Study|Lost to Follow-up|9|||
145556785|NCT00174915|524897221|FG003|Overall Study|Lost to Follow-up|17|||
145556786|NCT00174915|524897222|FG004|Overall Study|Lost to Follow-up|10|||
145556787|NCT00174915|524897218|FG000|Overall Study|Adverse Event|18|||
145556788|NCT00174915|524897219|FG001|Overall Study|Adverse Event|16|||
145556789|NCT00174915|524897220|FG002|Overall Study|Adverse Event|11|||
145556790|NCT00174915|524897221|FG003|Overall Study|Adverse Event|18|||
145616130|NCT01474512|525111305|FG010|Induction Period|Withdrawal by Subject|0|||
145407356|NCT00716417|524346963|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
145407357|NCT00716417|524346964|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
145407358|NCT00716417|524346965|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
145407359|NCT00716417|524346966|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
145407360|NCT00716417|524346967|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
145407361|NCT00716417|524346968|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
145407362|NCT00716417|524346969|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
145556791|NCT00174915|524897222|FG004|Overall Study|Adverse Event|5|||
145556792|NCT00174915|524897218|FG000|Overall Study|Personal Reason(s)|16|||
145616131|NCT01474512|525111306|FG011|Induction Period|Withdrawal by Subject|0|||
145616132|NCT01474512|525111307|FG012|Induction Period|Withdrawal by Subject|0|||
145616133|NCT01474512|525111308|FG013|Induction Period|Withdrawal by Subject|0|||
145616134|NCT01474512|525111309|FG014|Induction Period|Withdrawal by Subject|0|||
145616135|NCT01474512|525111310|FG015|Induction Period|Withdrawal by Subject|0|||
145556793|NCT00174915|524897219|FG001|Overall Study|Personal Reason(s)|16|||
145556794|NCT00174915|524897220|FG002|Overall Study|Personal Reason(s)|9|||
145556795|NCT00174915|524897221|FG003|Overall Study|Personal Reason(s)|9|||
145556796|NCT00174915|524897222|FG004|Overall Study|Personal Reason(s)|9|||
145556797|NCT00174915|524897218|FG000|Overall Study|Other|15|||
145556798|NCT00174915|524897219|FG001|Overall Study|Other|8|||
145556799|NCT00174915|524897220|FG002|Overall Study|Other|6|||
145556800|NCT00174915|524897221|FG003|Overall Study|Other|5|||
145556801|NCT00174915|524897222|FG004|Overall Study|Other|3|||
145556802|NCT00174915|524897218|FG000|Overall Study|Gout Flare|13|||
145556803|NCT00174915|524897219|FG001|Overall Study|Gout Flare|6|||
145556804|NCT00174915|524897220|FG002|Overall Study|Gout Flare|8|||
145556805|NCT00174915|524897221|FG003|Overall Study|Gout Flare|1|||
145556806|NCT00174915|524897222|FG004|Overall Study|Gout Flare|0|||
145556807|NCT00174915|524897218|FG000|Overall Study|Protocol Violation|6|||
145556808|NCT00174915|524897219|FG001|Overall Study|Protocol Violation|3|||
145556809|NCT00174915|524897220|FG002|Overall Study|Protocol Violation|3|||
145556810|NCT00174915|524897221|FG003|Overall Study|Protocol Violation|6|||
145556811|NCT00174915|524897222|FG004|Overall Study|Protocol Violation|3|||
145556812|NCT00174915|524897218|FG000|Overall Study|Therapeutic Failure|6|||
145556813|NCT00174915|524897219|FG001|Overall Study|Therapeutic Failure|3|||
145556814|NCT00174915|524897220|FG002|Overall Study|Therapeutic Failure|2|||
145556815|NCT00174915|524897221|FG003|Overall Study|Therapeutic Failure|1|||
145556816|NCT00174915|524897222|FG004|Overall Study|Therapeutic Failure|3|||
145556817|NCT03060447|524897223|FG000|Overall Study|Withdrawal by Subject|2|||
145556818|NCT03060447|524897224|FG001|Overall Study|Withdrawal by Subject|0|||
145556819|NCT00665353|524897225|FG000|Study Step 1|Adverse Event|1|||
145556820|NCT00665353|524897225|FG000|Study Step 1|Withdrawal by Subject|2|||
145556821|NCT00665353|524897225|FG000|Study Step 2|Lost to Follow-up|2|||
145616136|NCT01474512|525111311|FG016|Induction Period|Withdrawal by Subject|0|||
145616137|NCT01474512|525111312|FG017|Induction Period|Withdrawal by Subject|0|||
145616138|NCT01474512|525111295|FG000|Induction Period|Protocol Violation|3|||
145616139|NCT01474512|525111296|FG001|Induction Period|Protocol Violation|6|||
145616140|NCT01474512|525111297|FG002|Induction Period|Protocol Violation|0|||
145616141|NCT01474512|525111298|FG003|Induction Period|Protocol Violation|0|||
145616142|NCT01474512|525111299|FG004|Induction Period|Protocol Violation|0|||
145616143|NCT01474512|525111300|FG005|Induction Period|Protocol Violation|0|||
145616144|NCT01474512|525111301|FG006|Induction Period|Protocol Violation|0|||
145616145|NCT01474512|525111302|FG007|Induction Period|Protocol Violation|0|||
145616146|NCT01474512|525111303|FG008|Induction Period|Protocol Violation|0|||
145616147|NCT01474512|525111304|FG009|Induction Period|Protocol Violation|0|||
145616148|NCT01474512|525111305|FG010|Induction Period|Protocol Violation|0|||
145616149|NCT01474512|525111306|FG011|Induction Period|Protocol Violation|0|||
145616150|NCT01474512|525111307|FG012|Induction Period|Protocol Violation|0|||
145616151|NCT01474512|525111308|FG013|Induction Period|Protocol Violation|0|||
145616152|NCT01474512|525111309|FG014|Induction Period|Protocol Violation|0|||
145616153|NCT01474512|525111310|FG015|Induction Period|Protocol Violation|0|||
145616154|NCT01474512|525111311|FG016|Induction Period|Protocol Violation|0|||
145407363|NCT00716417|524346970|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
145407364|NCT00716417|524346971|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
145407365|NCT00716417|524346972|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
145556822|NCT00665353|524897225|FG000|Study Step 2|Lack of Efficacy|12|||
145556823|NCT01870583|524897226|FG000|Overall Study|Protocol Violation|0|||
145556824|NCT01870583|524897227|FG001|Overall Study|Protocol Violation|5|||
145556825|NCT01870583|524897228|FG002|Overall Study|Protocol Violation|3|||
145556826|NCT01870583|524897226|FG000|Overall Study|Lost to Follow-up|11|||
145556827|NCT01870583|524897227|FG001|Overall Study|Lost to Follow-up|13|||
145616155|NCT01474512|525111312|FG017|Induction Period|Protocol Violation|0|||
145556828|NCT01870583|524897228|FG002|Overall Study|Lost to Follow-up|5|||
145556829|NCT03045887|524897233|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
145556830|NCT03045887|524897234|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556831|NCT03045887|524897235|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145407366|NCT00716417|524346963|FG000|Overall Study|On patient request due to toxicities|0|||
145407367|NCT00716417|524346964|FG001|Overall Study|On patient request due to toxicities|0|||
145407368|NCT00716417|524346965|FG002|Overall Study|On patient request due to toxicities|0|||
145407369|NCT00716417|524346966|FG003|Overall Study|On patient request due to toxicities|0|||
145407370|NCT00716417|524346967|FG004|Overall Study|On patient request due to toxicities|0|||
145556832|NCT03045887|524897236|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556833|NCT03045887|524897237|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556834|NCT03045887|524897238|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556835|NCT03045887|524897239|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556836|NCT03045887|524897240|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556837|NCT03045887|524897241|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556838|NCT03045887|524897242|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
145556839|NCT03045887|524897233|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556840|NCT03045887|524897234|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556841|NCT03045887|524897235|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556842|NCT03045887|524897236|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
145556843|NCT03045887|524897237|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556844|NCT03045887|524897238|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556845|NCT03045887|524897239|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556846|NCT03045887|524897240|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556847|NCT03045887|524897241|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556848|NCT03045887|524897242|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
145556849|NCT03045887|524897233|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
145556850|NCT03045887|524897234|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556851|NCT03045887|524897235|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556852|NCT03045887|524897236|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556853|NCT03045887|524897237|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556854|NCT03045887|524897238|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556855|NCT03045887|524897239|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556856|NCT03045887|524897240|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556857|NCT03045887|524897241|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556858|NCT03045887|524897242|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
145556859|NCT03045887|524897233|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556860|NCT03045887|524897234|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556861|NCT03045887|524897235|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
145556862|NCT03045887|524897236|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
145556863|NCT03045887|524897237|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556864|NCT03045887|524897238|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556865|NCT03045887|524897239|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556866|NCT03045887|524897240|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556867|NCT03045887|524897241|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145292447|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
145292448|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
145292449|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
145292450|NCT02207231|523922183|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
145292451|NCT02207231|523922184|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
145292452|NCT02207231|523922185|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
145292453|NCT02207231|523922186|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
145292454|NCT02710123|523922187|FG000|Overall Study|Lost to Follow-up|3|||
145292455|NCT02710123|523922188|FG001|Overall Study|Lost to Follow-up|4|||
145292456|NCT02710123|523922187|FG000|Overall Study|Withdrawal by Subject|1|||
145292457|NCT02710123|523922188|FG001|Overall Study|Withdrawal by Subject|1|||
145292458|NCT02710123|523922187|FG000|Overall Study|Illness unrelated to study intervention|1|||
145292459|NCT02710123|523922188|FG001|Overall Study|Illness unrelated to study intervention|0|||
145292460|NCT02446132|523922189|FG000|Overall Study|Adverse Event|10|||
145292461|NCT02446132|523922190|FG001|Overall Study|Adverse Event|27|||
145292462|NCT02446132|523922191|FG002|Overall Study|Adverse Event|27|||
145292463|NCT02446132|523922189|FG000|Overall Study|Death|2|||
145292464|NCT02446132|523922190|FG001|Overall Study|Death|13|||
145292465|NCT02446132|523922191|FG002|Overall Study|Death|10|||
145292466|NCT02446132|523922189|FG000|Overall Study|Lack of Efficacy|1|||
145292467|NCT02446132|523922190|FG001|Overall Study|Lack of Efficacy|10|||
145292468|NCT02446132|523922191|FG002|Overall Study|Lack of Efficacy|6|||
145292469|NCT02446132|523922189|FG000|Overall Study|Lost to Follow-up|2|||
145292470|NCT02446132|523922190|FG001|Overall Study|Lost to Follow-up|4|||
145292471|NCT02446132|523922191|FG002|Overall Study|Lost to Follow-up|5|||
145292472|NCT02446132|523922189|FG000|Overall Study|Non-compliance With Study Drug|2|||
145292473|NCT02446132|523922190|FG001|Overall Study|Non-compliance With Study Drug|2|||
145292474|NCT02446132|523922191|FG002|Overall Study|Non-compliance With Study Drug|3|||
145292475|NCT02446132|523922189|FG000|Overall Study|Physician Decision|1|||
145616156|NCT01474512|525111295|FG000|Induction Period|Sponsor Decision|1|||
145616157|NCT01474512|525111296|FG001|Induction Period|Sponsor Decision|1|||
145616158|NCT01474512|525111297|FG002|Induction Period|Sponsor Decision|1|||
145292476|NCT02446132|523922190|FG001|Overall Study|Physician Decision|8|||
145292477|NCT02446132|523922191|FG002|Overall Study|Physician Decision|13|||
145292478|NCT02446132|523922189|FG000|Overall Study|Protocol Deviation|0|||
145292479|NCT02446132|523922190|FG001|Overall Study|Protocol Deviation|0|||
145292480|NCT02446132|523922191|FG002|Overall Study|Protocol Deviation|1|||
145292481|NCT02446132|523922189|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
145292482|NCT02446132|523922190|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
145292483|NCT02446132|523922191|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
145292484|NCT02446132|523922189|FG000|Overall Study|Study Terminated by Sponsor|4|||
145292485|NCT02446132|523922190|FG001|Overall Study|Study Terminated by Sponsor|35|||
145292486|NCT02446132|523922191|FG002|Overall Study|Study Terminated by Sponsor|58|||
145292487|NCT02446132|523922189|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
145292488|NCT02446132|523922190|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
145292489|NCT02446132|523922191|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
145292490|NCT02446132|523922189|FG000|Overall Study|Withdrawal by Subject|11|||
145292491|NCT02446132|523922190|FG001|Overall Study|Withdrawal by Subject|29|||
145292492|NCT02446132|523922191|FG002|Overall Study|Withdrawal by Subject|25|||
145292493|NCT02446132|523922189|FG000|Overall Study|Reason not Specified|4|||
145292494|NCT02446132|523922190|FG001|Overall Study|Reason not Specified|16|||
145292495|NCT02446132|523922191|FG002|Overall Study|Reason not Specified|10|||
145292496|NCT02446132|523922189|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
145292497|NCT02446132|523922190|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
145292498|NCT02446132|523922191|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
145292499|NCT05526248|523922192|FG000|Overall Study|Lost to Follow-up|1|||
145292500|NCT05526248|523922192|FG000|Overall Study|Adverse Event|2|||
145292501|NCT05526248|523922192|FG000|Overall Study|Withdrawal by Subject|1|||
145292502|NCT02674334|523922195|FG000|Overall Study|Lost to Follow-up|5|||
145292503|NCT02674334|523922196|FG001|Overall Study|Lost to Follow-up|3|||
145292504|NCT02674334|523922195|FG000|Overall Study|participant difficulty breathing|1|||
145292505|NCT02674334|523922196|FG001|Overall Study|participant difficulty breathing|0|||
145292506|NCT02674334|523922195|FG000|Overall Study|NIRS not recording|1|||
145292507|NCT02674334|523922196|FG001|Overall Study|NIRS not recording|0|||
145292508|NCT00995553|523922197|FG000|Overall Study|Withdrawal by Subject|2|||
145292509|NCT00995553|523922198|FG001|Overall Study|Withdrawal by Subject|6|||
145292510|NCT00950807|523922203|FG000|Treatment Period 1|Lack of Efficacy|1|||
145292511|NCT00950807|523922204|FG001|Treatment Period 1|Lack of Efficacy|0|||
145292512|NCT00950807|523922205|FG002|Treatment Period 1|Lack of Efficacy|0|||
145292513|NCT00950807|523922206|FG003|Treatment Period 1|Lack of Efficacy|0|||
145292514|NCT00950807|523922207|FG004|Treatment Period 1|Lack of Efficacy|0|||
145292515|NCT00950807|523922208|FG005|Treatment Period 1|Lack of Efficacy|1|||
145292516|NCT00950807|523922209|FG006|Treatment Period 1|Lack of Efficacy|0|||
145292517|NCT00950807|523922210|FG007|Treatment Period 1|Lack of Efficacy|0|||
145292518|NCT00950807|523922211|FG008|Treatment Period 1|Lack of Efficacy|0|||
145292519|NCT00950807|523922212|FG009|Treatment Period 1|Lack of Efficacy|0|||
145292520|NCT00950807|523922203|FG000|Treatment Period 1|Protocol Violation|1|||
145292521|NCT00950807|523922204|FG001|Treatment Period 1|Protocol Violation|0|||
145292522|NCT00950807|523922205|FG002|Treatment Period 1|Protocol Violation|0|||
145292523|NCT00950807|523922206|FG003|Treatment Period 1|Protocol Violation|0|||
145292524|NCT00950807|523922207|FG004|Treatment Period 1|Protocol Violation|0|||
145292525|NCT00950807|523922208|FG005|Treatment Period 1|Protocol Violation|0|||
145292526|NCT00950807|523922209|FG006|Treatment Period 1|Protocol Violation|0|||
145292527|NCT00950807|523922210|FG007|Treatment Period 1|Protocol Violation|0|||
145292528|NCT00950807|523922211|FG008|Treatment Period 1|Protocol Violation|0|||
145292529|NCT00950807|523922212|FG009|Treatment Period 1|Protocol Violation|0|||
145292530|NCT00950807|523922203|FG000|Treatment Period 1|Lost to Follow-up|0|||
145292531|NCT00950807|523922204|FG001|Treatment Period 1|Lost to Follow-up|0|||
145292532|NCT00950807|523922205|FG002|Treatment Period 1|Lost to Follow-up|1|||
145292533|NCT00950807|523922206|FG003|Treatment Period 1|Lost to Follow-up|0|||
145292534|NCT00950807|523922207|FG004|Treatment Period 1|Lost to Follow-up|0|||
145292535|NCT00950807|523922208|FG005|Treatment Period 1|Lost to Follow-up|0|||
145292536|NCT00950807|523922209|FG006|Treatment Period 1|Lost to Follow-up|0|||
145292537|NCT00950807|523922210|FG007|Treatment Period 1|Lost to Follow-up|0|||
145292538|NCT00950807|523922211|FG008|Treatment Period 1|Lost to Follow-up|0|||
145292539|NCT00950807|523922212|FG009|Treatment Period 1|Lost to Follow-up|0|||
145292540|NCT00950807|523922203|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145292541|NCT00950807|523922204|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145292542|NCT00950807|523922205|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145616159|NCT01474512|525111298|FG003|Induction Period|Sponsor Decision|0|||
145616160|NCT01474512|525111299|FG004|Induction Period|Sponsor Decision|0|||
145292543|NCT00950807|523922206|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145292544|NCT00950807|523922207|FG004|Treatment Period 1|Withdrawal by Subject|1|||
145556868|NCT03045887|524897242|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
145556869|NCT03045887|524897233|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556870|NCT03045887|524897234|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556871|NCT03045887|524897235|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556872|NCT03045887|524897236|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
145556873|NCT03045887|524897237|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556874|NCT03045887|524897238|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556875|NCT03045887|524897239|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556876|NCT03045887|524897240|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556877|NCT03045887|524897241|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556878|NCT03045887|524897242|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
145556879|NCT02632552|524897243|FG000|Overall Study|Lost to Follow-up|14|||
145556880|NCT02632552|524897244|FG001|Overall Study|Lost to Follow-up|8|||
145556881|NCT02632552|524897243|FG000|Overall Study|Withdrawal by Subject|2|||
145556882|NCT02632552|524897244|FG001|Overall Study|Withdrawal by Subject|0|||
145556883|NCT02632552|524897243|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
145556884|NCT02632552|524897244|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
145556885|NCT02132767|524897245|FG000|Overall Study|Death|3|||
145556886|NCT02132767|524897246|FG001|Overall Study|Death|2|||
145556887|NCT02132767|524897245|FG000|Overall Study|Withdrawal by Subject|10|||
145556888|NCT02132767|524897246|FG001|Overall Study|Withdrawal by Subject|9|||
145556889|NCT02132767|524897245|FG000|Overall Study|Lost to Follow-up|4|||
145556890|NCT02132767|524897246|FG001|Overall Study|Lost to Follow-up|4|||
145556891|NCT00778700|524897249|FG000|Overall Study|Adverse Event|6|||
145556892|NCT00778700|524897250|FG001|Overall Study|Adverse Event|1|||
145556893|NCT00778700|524897251|FG002|Overall Study|Adverse Event|3|||
145556894|NCT00778700|524897252|FG003|Overall Study|Adverse Event|5|||
145556895|NCT00778700|524897249|FG000|Overall Study|Protocol Violation|1|||
145556896|NCT00778700|524897250|FG001|Overall Study|Protocol Violation|1|||
145556897|NCT00778700|524897251|FG002|Overall Study|Protocol Violation|0|||
145556898|NCT00778700|524897252|FG003|Overall Study|Protocol Violation|0|||
145556899|NCT00778700|524897249|FG000|Overall Study|Subject Withdrew Consent|6|||
145556900|NCT00778700|524897250|FG001|Overall Study|Subject Withdrew Consent|4|||
145556901|NCT00778700|524897251|FG002|Overall Study|Subject Withdrew Consent|1|||
145556902|NCT00778700|524897252|FG003|Overall Study|Subject Withdrew Consent|4|||
145556903|NCT00778700|524897249|FG000|Overall Study|Lost to Follow-up|3|||
145556904|NCT00778700|524897250|FG001|Overall Study|Lost to Follow-up|1|||
145556905|NCT00778700|524897251|FG002|Overall Study|Lost to Follow-up|0|||
145556906|NCT00778700|524897252|FG003|Overall Study|Lost to Follow-up|1|||
145556907|NCT00778700|524897249|FG000|Overall Study|Reason not Specified|2|||
145556908|NCT00778700|524897250|FG001|Overall Study|Reason not Specified|0|||
145556909|NCT00778700|524897251|FG002|Overall Study|Reason not Specified|1|||
145556910|NCT00778700|524897252|FG003|Overall Study|Reason not Specified|3|||
145556911|NCT00778700|524897249|FG000|Overall Study|Other|0|||
145556912|NCT00778700|524897250|FG001|Overall Study|Other|0|||
145556913|NCT00778700|524897251|FG002|Overall Study|Other|1|||
145556914|NCT00778700|524897252|FG003|Overall Study|Other|0|||
145556915|NCT03227029|524897255|FG000|Overall Study|Child Wheezed (no treatment)|0|||
145556916|NCT03227029|524897256|FG001|Overall Study|Child Wheezed (no treatment)|1|||
145556917|NCT03227029|524897257|FG002|Overall Study|Child Wheezed (no treatment)|0|||
145556918|NCT03227029|524897255|FG000|Overall Study|No post RSV season visit due to COVID|3|||
145556919|NCT03227029|524897256|FG001|Overall Study|No post RSV season visit due to COVID|3|||
145556920|NCT03227029|524897257|FG002|Overall Study|No post RSV season visit due to COVID|2|||
145556921|NCT03227029|524897255|FG000|Overall Study|Not able to get to clinic|0|||
145556922|NCT03227029|524897256|FG001|Overall Study|Not able to get to clinic|0|||
145556923|NCT03227029|524897257|FG002|Overall Study|Not able to get to clinic|1|||
145556924|NCT03227029|524897255|FG000|Overall Study|Withdrawal by Subject|1|||
145556925|NCT03227029|524897256|FG001|Overall Study|Withdrawal by Subject|0|||
145556926|NCT03227029|524897257|FG002|Overall Study|Withdrawal by Subject|0|||
145556927|NCT03227029|524897255|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
145556928|NCT03227029|524897256|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
145556929|NCT03227029|524897257|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
145556930|NCT01291173|524897258|FG000|Overall Study|Adverse Event|0|||
145556931|NCT01291173|524897259|FG001|Overall Study|Adverse Event|3|||
145556932|NCT01291173|524897260|FG002|Overall Study|Adverse Event|1|||
145556933|NCT01291173|524897261|FG003|Overall Study|Adverse Event|3|||
145556934|NCT01291173|524897258|FG000|Overall Study|Protocol Violation|7|||
145556935|NCT01291173|524897259|FG001|Overall Study|Protocol Violation|2|||
145556936|NCT01291173|524897260|FG002|Overall Study|Protocol Violation|2|||
145556937|NCT01291173|524897261|FG003|Overall Study|Protocol Violation|5|||
145556938|NCT01291173|524897258|FG000|Overall Study|Withdrawal by Subject|6|||
145556939|NCT01291173|524897259|FG001|Overall Study|Withdrawal by Subject|4|||
145556940|NCT01291173|524897260|FG002|Overall Study|Withdrawal by Subject|4|||
145556941|NCT01291173|524897261|FG003|Overall Study|Withdrawal by Subject|2|||
145556942|NCT01291173|524897258|FG000|Overall Study|Lost to Follow-up|4|||
145556943|NCT01291173|524897259|FG001|Overall Study|Lost to Follow-up|6|||
145556944|NCT01291173|524897260|FG002|Overall Study|Lost to Follow-up|3|||
145556945|NCT01291173|524897261|FG003|Overall Study|Lost to Follow-up|2|||
145556946|NCT01291173|524897258|FG000|Overall Study|Unable to meet visit schedule|0|||
145556947|NCT01291173|524897259|FG001|Overall Study|Unable to meet visit schedule|0|||
145556948|NCT01291173|524897260|FG002|Overall Study|Unable to meet visit schedule|1|||
145556949|NCT01291173|524897261|FG003|Overall Study|Unable to meet visit schedule|0|||
145556950|NCT01291173|524897258|FG000|Overall Study|Lack of compliance|0|||
145556951|NCT01291173|524897259|FG001|Overall Study|Lack of compliance|0|||
145556952|NCT01291173|524897260|FG002|Overall Study|Lack of compliance|0|||
145556953|NCT01291173|524897261|FG003|Overall Study|Lack of compliance|1|||
145556954|NCT01291173|524897258|FG000|Overall Study|Subject was unblinded|0|||
145556955|NCT01291173|524897259|FG001|Overall Study|Subject was unblinded|0|||
145556956|NCT01291173|524897260|FG002|Overall Study|Subject was unblinded|1|||
145556957|NCT01291173|524897261|FG003|Overall Study|Subject was unblinded|0|||
145556958|NCT01291173|524897258|FG000|Overall Study|Excluded therapy|0|||
145556959|NCT01291173|524897259|FG001|Overall Study|Excluded therapy|0|||
145556960|NCT01291173|524897260|FG002|Overall Study|Excluded therapy|1|||
145556961|NCT01291173|524897261|FG003|Overall Study|Excluded therapy|0|||
145556962|NCT00390858|524897262|FG000|Overall Study|Adverse Event|6|||
145556963|NCT00390858|524897263|FG001|Overall Study|Adverse Event|2|||
145556964|NCT00390858|524897262|FG000|Overall Study|Lack of Efficacy|0|||
145556965|NCT00390858|524897263|FG001|Overall Study|Lack of Efficacy|1|||
145556966|NCT00390858|524897262|FG000|Overall Study|Withdrawal by Subject|3|||
145556967|NCT00390858|524897263|FG001|Overall Study|Withdrawal by Subject|4|||
145556968|NCT00450450|524897264|FG000|Overall Study|Death|1|||
145556969|NCT00450450|524897265|FG001|Overall Study|Death|3|||
145556970|NCT00450450|524897264|FG000|Overall Study|Relapse|2|||
145556971|NCT00450450|524897265|FG001|Overall Study|Relapse|0|||
145556972|NCT00450450|524897264|FG000|Overall Study|Missing Data|2|||
145556973|NCT00450450|524897265|FG001|Overall Study|Missing Data|0|||
145556974|NCT04984993|524897266|FG000|Overall Study|Withdrawal by Subject|8|||
145556975|NCT04984993|524897267|FG001|Overall Study|Withdrawal by Subject|2|||
145556976|NCT04984993|524897266|FG000|Overall Study|Lost to Follow-up|2|||
145556977|NCT04984993|524897267|FG001|Overall Study|Lost to Follow-up|2|||
145556978|NCT04984993|524897266|FG000|Overall Study|Both patients moved to another country|4|||
145556979|NCT04984993|524897267|FG001|Overall Study|Both patients moved to another country|0|||
145556980|NCT01496313|524897268|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
145556981|NCT01496313|524897269|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
145556982|NCT01496313|524897270|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
145556983|NCT01496313|524897271|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
145556984|NCT01496313|524897272|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
145556985|NCT01496313|524897273|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
145556986|NCT01496313|524897268|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
145556987|NCT01496313|524897269|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
145556988|NCT01496313|524897270|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
145556989|NCT01496313|524897271|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
145556990|NCT01496313|524897272|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
145556991|NCT01496313|524897273|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
145556992|NCT01496313|524897268|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
145556993|NCT01496313|524897269|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
145556994|NCT01496313|524897270|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
145556995|NCT01496313|524897271|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
145292545|NCT00950807|523922208|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145292546|NCT00950807|523922209|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145292547|NCT00950807|523922210|FG007|Treatment Period 1|Withdrawal by Subject|0|||
145292548|NCT00950807|523922211|FG008|Treatment Period 1|Withdrawal by Subject|1|||
145292549|NCT00950807|523922212|FG009|Treatment Period 1|Withdrawal by Subject|0|||
145292550|NCT00950807|523922203|FG000|Treatment Period 1|Adverse Event|0|||
145292551|NCT00950807|523922204|FG001|Treatment Period 1|Adverse Event|0|||
145292552|NCT00950807|523922205|FG002|Treatment Period 1|Adverse Event|0|||
145292553|NCT00950807|523922206|FG003|Treatment Period 1|Adverse Event|0|||
145292554|NCT00950807|523922207|FG004|Treatment Period 1|Adverse Event|0|||
145556996|NCT01496313|524897272|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
145556997|NCT01496313|524897273|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
145556998|NCT01496313|524897268|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
145556999|NCT01496313|524897269|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
145557000|NCT01496313|524897270|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
145557001|NCT01496313|524897271|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
145616161|NCT01474512|525111300|FG005|Induction Period|Sponsor Decision|0|||
145557002|NCT01496313|524897272|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
145557003|NCT01496313|524897273|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
145557004|NCT01496313|524897268|FG000|Randomized Period (up to 14 Months)|Other|1|||
145557005|NCT01496313|524897269|FG001|Randomized Period (up to 14 Months)|Other|2|||
145557006|NCT01496313|524897270|FG002|Randomized Period (up to 14 Months)|Other|0|||
145557007|NCT01496313|524897271|FG003|Randomized Period (up to 14 Months)|Other|0|||
145557008|NCT01496313|524897272|FG004|Randomized Period (up to 14 Months)|Other|0|||
145557009|NCT01496313|524897273|FG005|Randomized Period (up to 14 Months)|Other|0|||
145557010|NCT01496313|524897268|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
145557011|NCT01496313|524897269|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
145557012|NCT01496313|524897270|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
145557013|NCT01496313|524897271|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
145557014|NCT01496313|524897272|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
145557015|NCT01496313|524897273|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
145557016|NCT01496313|524897268|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
145557017|NCT01496313|524897269|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
145557018|NCT01496313|524897270|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
145557019|NCT01496313|524897271|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
145557020|NCT01496313|524897272|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
145557021|NCT01496313|524897273|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
145557022|NCT01496313|524897268|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
145557023|NCT01496313|524897269|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
145557024|NCT01496313|524897270|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
145557025|NCT01496313|524897271|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
145557026|NCT01496313|524897272|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
145557027|NCT01496313|524897273|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
145557028|NCT00451321|524897279|FG000|Overall Study|Lost to Follow-up|3|||
145557029|NCT00451321|524897280|FG001|Overall Study|Lost to Follow-up|3|||
145557030|NCT00451321|524897281|FG002|Overall Study|Lost to Follow-up|1|||
145557031|NCT00451321|524897282|FG003|Overall Study|Lost to Follow-up|3|||
145557032|NCT00451321|524897283|FG004|Overall Study|Lost to Follow-up|0|||
145557033|NCT00451321|524897284|FG005|Overall Study|Lost to Follow-up|1|||
145557034|NCT00451321|524897285|FG006|Overall Study|Lost to Follow-up|0|||
145557035|NCT00451321|524897286|FG007|Overall Study|Lost to Follow-up|0|||
145557036|NCT00451321|524897279|FG000|Overall Study|Withdrawal by Subject|3|||
145557037|NCT00451321|524897280|FG001|Overall Study|Withdrawal by Subject|1|||
145557038|NCT00451321|524897281|FG002|Overall Study|Withdrawal by Subject|0|||
145557039|NCT00451321|524897282|FG003|Overall Study|Withdrawal by Subject|4|||
145557040|NCT00451321|524897283|FG004|Overall Study|Withdrawal by Subject|0|||
145557041|NCT00451321|524897284|FG005|Overall Study|Withdrawal by Subject|0|||
145557042|NCT00451321|524897285|FG006|Overall Study|Withdrawal by Subject|0|||
145557043|NCT00451321|524897286|FG007|Overall Study|Withdrawal by Subject|0|||
145557044|NCT00451321|524897279|FG000|Overall Study|Study closed/terminated|1|||
145557045|NCT00451321|524897280|FG001|Overall Study|Study closed/terminated|1|||
145557046|NCT00451321|524897281|FG002|Overall Study|Study closed/terminated|17|||
145557047|NCT00451321|524897282|FG003|Overall Study|Study closed/terminated|5|||
145557048|NCT00451321|524897283|FG004|Overall Study|Study closed/terminated|7|||
145557049|NCT00451321|524897284|FG005|Overall Study|Study closed/terminated|7|||
145557050|NCT00451321|524897285|FG006|Overall Study|Study closed/terminated|5|||
145557051|NCT00451321|524897286|FG007|Overall Study|Study closed/terminated|3|||
145557052|NCT00451321|524897279|FG000|Overall Study|Sponsor decision to amend protocol|0|||
145557053|NCT00451321|524897280|FG001|Overall Study|Sponsor decision to amend protocol|0|||
145557054|NCT00451321|524897281|FG002|Overall Study|Sponsor decision to amend protocol|0|||
145557055|NCT00451321|524897282|FG003|Overall Study|Sponsor decision to amend protocol|0|||
145557056|NCT00451321|524897283|FG004|Overall Study|Sponsor decision to amend protocol|0|||
145557057|NCT00451321|524897284|FG005|Overall Study|Sponsor decision to amend protocol|1|||
145557058|NCT00451321|524897285|FG006|Overall Study|Sponsor decision to amend protocol|1|||
145557059|NCT00451321|524897286|FG007|Overall Study|Sponsor decision to amend protocol|3|||
145557060|NCT02064166|524897287|FG000|Overall Study|Adverse Event|1|||
145557061|NCT02064166|524897288|FG001|Overall Study|Adverse Event|0|||
145557062|NCT00877383|524897297|FG000|Overall Study|Adverse Event|13|||
145616162|NCT01474512|525111301|FG006|Induction Period|Sponsor Decision|0|||
145557063|NCT00877383|524897298|FG001|Overall Study|Adverse Event|14|||
145557064|NCT00877383|524897297|FG000|Overall Study|Lost to Follow-up|5|||
145557065|NCT00877383|524897298|FG001|Overall Study|Lost to Follow-up|3|||
145557066|NCT00877383|524897297|FG000|Overall Study|Subject withdrew consent|3|||
145557067|NCT00877383|524897298|FG001|Overall Study|Subject withdrew consent|12|||
145557068|NCT00877383|524897297|FG000|Overall Study|Subject no longer requires study drug|2|||
145616163|NCT01474512|525111302|FG007|Induction Period|Sponsor Decision|0|||
145616164|NCT01474512|525111303|FG008|Induction Period|Sponsor Decision|0|||
145557069|NCT00877383|524897298|FG001|Overall Study|Subject no longer requires study drug|0|||
145557070|NCT00877383|524897297|FG000|Overall Study|Administrative problems|2|||
145557071|NCT00877383|524897298|FG001|Overall Study|Administrative problems|0|||
145557072|NCT00877383|524897297|FG000|Overall Study|Protocol deviation|2|||
145557073|NCT00877383|524897298|FG001|Overall Study|Protocol deviation|6|||
145557074|NCT00877383|524897297|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145557075|NCT00877383|524897298|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145557076|NCT00877383|524897297|FG000|Overall Study|Death|1|||
145557077|NCT00877383|524897298|FG001|Overall Study|Death|2|||
145557078|NCT00459108|524897299|FG000|Overall Study|Withdrawal by Subject|5|||
145557079|NCT00459108|524897299|FG000|Overall Study|Adverse Event|3|||
145557080|NCT00459108|524897299|FG000|Overall Study|Death|2|||
145557081|NCT00459108|524897299|FG000|Overall Study|Progression|1|||
145557082|NCT02157298|524897302|FG000|Overall Study|Adverse Event|1|||
145557083|NCT02157298|524897303|FG001|Overall Study|Adverse Event|0|||
145557084|NCT02157298|524897302|FG000|Overall Study|Subject no longer meets study criteria|1|||
145557085|NCT02157298|524897303|FG001|Overall Study|Subject no longer meets study criteria|2|||
145557086|NCT02157298|524897302|FG000|Overall Study|Poor/Non-compliance|1|||
145557087|NCT02157298|524897303|FG001|Overall Study|Poor/Non-compliance|0|||
145557088|NCT02157298|524897302|FG000|Overall Study|Withdrawal by Subject|1|||
145557089|NCT02157298|524897303|FG001|Overall Study|Withdrawal by Subject|0|||
145557090|NCT01722071|524897304|FG000|Overall Study|Protocol Violation|1|||
145557091|NCT01722071|524897305|FG001|Overall Study|Protocol Violation|0|||
145557092|NCT01338493|524897306|FG000|Enrolled|Withdrawal by Subject|1|||
145557093|NCT01338493|524897306|FG000|Enrolled|Patient not implanted|4|||
145557094|NCT01338493|524897306|FG000|Discharge|Death|1|||
145557095|NCT01338493|524897306|FG000|Discharge|Missed visit|1|||
145557096|NCT01338493|524897306|FG000|6 Months Follow up|Lost to Follow-up|11|||
145557097|NCT01338493|524897306|FG000|6 Months Follow up|Missed visit|8|||
145557098|NCT01338493|524897306|FG000|12 Months Follow up|Lost to Follow-up|9|||
145557099|NCT00656474|524897307|FG000|Overall Study|Other Reason|1|||
145557100|NCT02062879|524897308|FG000|Overall Study|Withdrawal by Subject|4|||
145557101|NCT02062879|524897309|FG001|Overall Study|Withdrawal by Subject|1|||
145557102|NCT00353262|524897310|FG000|Overall Study|Adverse Event|8|||
145557103|NCT00353262|524897310|FG000|Overall Study|Withdrawal by Subject|2|||
145557104|NCT00353262|524897310|FG000|Overall Study|Insufficient Therapeutic Response|13|||
145557105|NCT00353262|524897310|FG000|Overall Study|Progression|1|||
145557106|NCT00353262|524897310|FG000|Overall Study|Surgery|4|||
145557107|NCT00353262|524897310|FG000|Overall Study|Break from Chemotherapy|1|||
145557108|NCT05286307|524897311|FG000|Overall Study|Incomplete outcome assessments|2|||
145557109|NCT05286307|524897312|FG001|Overall Study|Incomplete outcome assessments|1|||
145557110|NCT05286307|524897311|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
145557111|NCT05286307|524897312|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
145557112|NCT05286307|524897311|FG000|Overall Study|Lost to follow up at 6 months|25|||
145557113|NCT05286307|524897312|FG001|Overall Study|Lost to follow up at 6 months|35|||
145557114|NCT05286307|524897311|FG000|Overall Study|Study medication not available|1|||
145557115|NCT05286307|524897312|FG001|Overall Study|Study medication not available|1|||
145557116|NCT01103284|524897313|FG000|Overall Study|Death|2|||
145557117|NCT01103284|524897314|FG001|Overall Study|Death|0|||
145557118|NCT01103284|524897313|FG000|Overall Study|Lost to Follow-up|9|||
145557119|NCT01103284|524897314|FG001|Overall Study|Lost to Follow-up|10|||
145557120|NCT01103284|524897313|FG000|Overall Study|Pregnancy|3|||
145557121|NCT01103284|524897314|FG001|Overall Study|Pregnancy|1|||
145557122|NCT01103284|524897313|FG000|Overall Study|Protocol Violation|12|||
145557123|NCT01103284|524897314|FG001|Overall Study|Protocol Violation|5|||
145557124|NCT01103284|524897313|FG000|Overall Study|Adverse Event|0|||
145557125|NCT01103284|524897314|FG001|Overall Study|Adverse Event|5|||
145557126|NCT01103284|524897313|FG000|Overall Study|Withdrawal by Subject|14|||
145557127|NCT01103284|524897314|FG001|Overall Study|Withdrawal by Subject|18|||
145557128|NCT01103284|524897313|FG000|Overall Study|Dermal Hypersensitivity|0|||
145557129|NCT01103284|524897314|FG001|Overall Study|Dermal Hypersensitivity|1|||
145557130|NCT01103284|524897313|FG000|Overall Study|Termination by the Sponsor|0|||
145557131|NCT01103284|524897314|FG001|Overall Study|Termination by the Sponsor|1|||
145557132|NCT01103284|524897313|FG000|Overall Study|Not described|2|||
145557133|NCT01103284|524897314|FG001|Overall Study|Not described|1|||
145557134|NCT01103284|524897313|FG000|Overall Study|Missing CRF entries for study completion|0|||
145557135|NCT01103284|524897314|FG001|Overall Study|Missing CRF entries for study completion|2|||
145557136|NCT00696696|524898519|FG000|Overall Study|Adverse Event|5|||
145557137|NCT00696696|524898519|FG000|Overall Study|Withdrawal by Subject|8|||
145557138|NCT00696696|524898519|FG000|Overall Study|Physician Decision|2|||
145557139|NCT00696696|524898519|FG000|Overall Study|Death|3|||
145557140|NCT02642614|524898520|FG000|Overall Study|Adverse Event|1|||
145557141|NCT02642614|524898521|FG001|Overall Study|Adverse Event|1|||
145557142|NCT02642614|524898522|FG002|Overall Study|Adverse Event|2|||
145557143|NCT02642614|524898523|FG003|Overall Study|Adverse Event|2|||
145557144|NCT02642614|524898520|FG000|Overall Study|Lost to Follow-up|1|||
145557145|NCT02642614|524898521|FG001|Overall Study|Lost to Follow-up|0|||
145557146|NCT02642614|524898522|FG002|Overall Study|Lost to Follow-up|0|||
145557147|NCT02642614|524898523|FG003|Overall Study|Lost to Follow-up|0|||
145557148|NCT02642614|524898520|FG000|Overall Study|Withdrawal by Subject|1|||
145557149|NCT02642614|524898521|FG001|Overall Study|Withdrawal by Subject|1|||
145557150|NCT02642614|524898522|FG002|Overall Study|Withdrawal by Subject|0|||
145557151|NCT02642614|524898523|FG003|Overall Study|Withdrawal by Subject|0|||
145557152|NCT03182829|524898524|FG000|Overall Study|Protocol Violation|12|||
145557153|NCT03182829|524898525|FG001|Overall Study|Protocol Violation|12|||
145557154|NCT03182829|524898524|FG000|Overall Study|Other|4|||
145557155|NCT03182829|524898525|FG001|Overall Study|Other|3|||
145557156|NCT03316131|524898526|FG000|Treatment Period 2|Protocol deviation|1|||
145557157|NCT03316131|524898527|FG001|Treatment Period 2|Protocol deviation|0|||
145616165|NCT01474512|525111304|FG009|Induction Period|Sponsor Decision|0|||
145616166|NCT01474512|525111305|FG010|Induction Period|Sponsor Decision|0|||
145292555|NCT00950807|523922208|FG005|Treatment Period 1|Adverse Event|1|||
145292556|NCT00950807|523922209|FG006|Treatment Period 1|Adverse Event|0|||
145292557|NCT00950807|523922210|FG007|Treatment Period 1|Adverse Event|0|||
145292558|NCT00950807|523922211|FG008|Treatment Period 1|Adverse Event|0|||
145557158|NCT00936910|524898531|FG000|Overall Study|Lack of Efficacy|3|||
145557159|NCT01485640|524898532|FG000|Overall Study|Adverse Event|10|||
145557160|NCT01485640|524898532|FG000|Overall Study|Lack of Efficacy|2|||
145557161|NCT01485640|524898532|FG000|Overall Study|Protocol Violation|1|||
145557162|NCT01485640|524898532|FG000|Overall Study|Withdrawal by Subject|14|||
145557163|NCT01485640|524898532|FG000|Overall Study|Terminated by Sponsor|95|||
145557164|NCT02057198|524898535|FG000|Overall Study|Death|0|||
145557165|NCT02057198|524898536|FG001|Overall Study|Death|0|||
145557166|NCT02057198|524898537|FG002|Overall Study|Death|1|||
145557167|NCT02057198|524898535|FG000|Overall Study|Discharged early; lost to followup|0|||
145557168|NCT02057198|524898536|FG001|Overall Study|Discharged early; lost to followup|1|||
145557169|NCT02057198|524898537|FG002|Overall Study|Discharged early; lost to followup|0|||
145557170|NCT02355691|524898538|FG000|Overall Study|Loss of Research Personnel|7|||
145557171|NCT02355691|524898539|FG001|Overall Study|Loss of Research Personnel|9|||
145557172|NCT03232281|524898541|FG000|Overall Study|Adverse Event|1|||
145557173|NCT03232281|524898542|FG001|Overall Study|Adverse Event|1|||
145557174|NCT03232281|524898541|FG000|Overall Study|Withdrawal by Subject|5|||
145557175|NCT03232281|524898542|FG001|Overall Study|Withdrawal by Subject|4|||
145557176|NCT03232281|524898541|FG000|Overall Study|Protocol Deviation|1|||
145557177|NCT03232281|524898542|FG001|Overall Study|Protocol Deviation|1|||
145557178|NCT02345811|524898544|FG000|First Intervention|Withdrawal by Subject|1|||
145557179|NCT02345811|524898545|FG001|First Intervention|Withdrawal by Subject|1|||
145557180|NCT02489344|524898547|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
145557181|NCT02489344|524898547|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
145557182|NCT02489344|524898547|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
145557183|NCT02489344|524898547|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
145557184|NCT00605813|524898548|FG000|Overall Study|Protocol Violation|25|||
145557185|NCT00573755|524898553|FG000|Overall Study|Still receiving treatment|1|||
145557186|NCT00573755|524898554|FG001|Overall Study|Still receiving treatment|0|||
145557187|NCT00546637|524898559|FG000|Overall Study|Adverse Event|46|||
145557188|NCT00546637|524898560|FG001|Overall Study|Adverse Event|20|||
145557189|NCT00546637|524898559|FG000|Overall Study|Lack of Efficacy|5|||
145557190|NCT00546637|524898560|FG001|Overall Study|Lack of Efficacy|5|||
145557191|NCT00546637|524898559|FG000|Overall Study|Lost to Follow-up|2|||
145557192|NCT00546637|524898560|FG001|Overall Study|Lost to Follow-up|2|||
145557193|NCT00546637|524898559|FG000|Overall Study|Other|10|||
145557194|NCT00546637|524898560|FG001|Overall Study|Other|12|||
145557195|NCT00546637|524898559|FG000|Overall Study|Withdrawal by Subject|7|||
145557196|NCT00546637|524898560|FG001|Overall Study|Withdrawal by Subject|9|||
145557197|NCT00546637|524898559|FG000|Overall Study|Randomized, but not treated|3|||
145557198|NCT00546637|524898560|FG001|Overall Study|Randomized, but not treated|1|||
145557199|NCT02024867|524898563|FG000|Overall Study|Protocol Violation|3|||
145557200|NCT02024867|524898564|FG001|Overall Study|Protocol Violation|3|||
145557201|NCT02024867|524898563|FG000|Overall Study|Lost to Follow-up|6|||
145557202|NCT02024867|524898564|FG001|Overall Study|Lost to Follow-up|4|||
145557203|NCT02865187|524898565|FG000|Overall Study|Lost to Follow-up|12|||
145292559|NCT00950807|523922212|FG009|Treatment Period 1|Adverse Event|0|||
145292560|NCT00950807|523922203|FG000|Washout Period 1|Lack of Efficacy|0|||
145292561|NCT00950807|523922204|FG001|Washout Period 1|Lack of Efficacy|0|||
145292562|NCT00950807|523922205|FG002|Washout Period 1|Lack of Efficacy|0|||
145292563|NCT00950807|523922206|FG003|Washout Period 1|Lack of Efficacy|0|||
145292564|NCT00950807|523922207|FG004|Washout Period 1|Lack of Efficacy|0|||
145292565|NCT00950807|523922208|FG005|Washout Period 1|Lack of Efficacy|0|||
145292566|NCT00950807|523922209|FG006|Washout Period 1|Lack of Efficacy|1|||
145292567|NCT00950807|523922210|FG007|Washout Period 1|Lack of Efficacy|0|||
145292568|NCT00950807|523922211|FG008|Washout Period 1|Lack of Efficacy|0|||
145292569|NCT00950807|523922212|FG009|Washout Period 1|Lack of Efficacy|0|||
145557204|NCT02865187|524898566|FG001|Overall Study|Lost to Follow-up|7|||
145557205|NCT02865187|524898565|FG000|Overall Study|Adverse Event|1|||
145557206|NCT02865187|524898566|FG001|Overall Study|Adverse Event|0|||
145557207|NCT04267133|524898567|FG000|Overall Study|Withdrawal by Subject|1|||
145557208|NCT04267133|524898567|FG000|Overall Study|Adverse Event|4|||
145557209|NCT01110707|524898568|FG000|Overall Study|Protocol Violation|0|||
145557210|NCT01110707|524898569|FG001|Overall Study|Protocol Violation|3|||
145557211|NCT02369341|524898571|FG000|Overall Study|Migrated/moved from study area|1|||
145557212|NCT02369341|524898572|FG001|Overall Study|Migrated/moved from study area|0|||
145557213|NCT00674661|524898573|FG000|Overall Study|Other|5|||
145557214|NCT00674661|524898574|FG001|Overall Study|Other|7|||
145557215|NCT00674661|524898573|FG000|Overall Study|Lost to Follow-up|6|||
145292570|NCT00950807|523922203|FG000|Washout Period 1|Withdrawal by Subject|0|||
145292571|NCT00950807|523922204|FG001|Washout Period 1|Withdrawal by Subject|0|||
145292572|NCT00950807|523922205|FG002|Washout Period 1|Withdrawal by Subject|0|||
145292573|NCT00950807|523922206|FG003|Washout Period 1|Withdrawal by Subject|0|||
145292574|NCT00950807|523922207|FG004|Washout Period 1|Withdrawal by Subject|0|||
145292575|NCT00950807|523922208|FG005|Washout Period 1|Withdrawal by Subject|0|||
145292576|NCT00950807|523922209|FG006|Washout Period 1|Withdrawal by Subject|0|||
145292577|NCT00950807|523922210|FG007|Washout Period 1|Withdrawal by Subject|0|||
145292578|NCT00950807|523922211|FG008|Washout Period 1|Withdrawal by Subject|1|||
145292579|NCT00950807|523922212|FG009|Washout Period 1|Withdrawal by Subject|0|||
145292580|NCT00950807|523922203|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
145407371|NCT00716417|524346968|FG005|Overall Study|On patient request due to toxicities|0|||
145407372|NCT00716417|524346969|FG006|Overall Study|On patient request due to toxicities|0|||
145407373|NCT00716417|524346970|FG007|Overall Study|On patient request due to toxicities|1|||
145407374|NCT00716417|524346971|FG008|Overall Study|On patient request due to toxicities|0|||
145407375|NCT00716417|524346972|FG009|Overall Study|On patient request due to toxicities|0|||
145407376|NCT01303419|524346975|FG000|Overall Study|Discontinuation of study|60|||
145407377|NCT01303419|524346975|FG000|Overall Study|Did not complete both imaging methods|5|||
145407378|NCT01303419|524346975|FG000|Overall Study|Did not meet all I/E after screening|31|||
145407379|NCT01138046|524346976|FG000|Overall Study|Withdrawal due to death|6|||
145407380|NCT02709369|524346978|FG000|Overall Study|Lost to Follow-up|15|||
145407381|NCT02709369|524346978|FG000|Overall Study|Withdrawal by Subject|10|||
145407382|NCT02709369|524346978|FG000|Overall Study|Did not received intervention|2|||
145407383|NCT01900314|524346979|FG000|Overall Study|Lost to Follow-up|1|||
145407384|NCT01900314|524346980|FG001|Overall Study|Lost to Follow-up|0|||
145407385|NCT01900314|524346979|FG000|Overall Study|Protocol Violation|0|||
145407386|NCT01900314|524346980|FG001|Overall Study|Protocol Violation|1|||
145407387|NCT01900314|524346979|FG000|Overall Study|Withdrawal by Subject|3|||
145407388|NCT01900314|524346980|FG001|Overall Study|Withdrawal by Subject|3|||
145616167|NCT01474512|525111306|FG011|Induction Period|Sponsor Decision|0|||
145616168|NCT01474512|525111307|FG012|Induction Period|Sponsor Decision|0|||
145292581|NCT00950807|523922204|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292582|NCT00950807|523922205|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292583|NCT00950807|523922206|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292584|NCT00950807|523922207|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292585|NCT00950807|523922208|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292586|NCT00950807|523922209|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
145292587|NCT00950807|523922210|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
145292588|NCT00950807|523922211|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145292589|NCT00950807|523922212|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
145616169|NCT01474512|525111308|FG013|Induction Period|Sponsor Decision|0|||
145616170|NCT01474512|525111309|FG014|Induction Period|Sponsor Decision|0|||
145616171|NCT01474512|525111310|FG015|Induction Period|Sponsor Decision|0|||
145616172|NCT01474512|525111311|FG016|Induction Period|Sponsor Decision|0|||
145616173|NCT01474512|525111312|FG017|Induction Period|Sponsor Decision|0|||
145616174|NCT01474512|525111295|FG000|Induction Period|Lost to Follow-up|1|||
145616175|NCT01474512|525111296|FG001|Induction Period|Lost to Follow-up|0|||
145616176|NCT01474512|525111297|FG002|Induction Period|Lost to Follow-up|2|||
145616177|NCT01474512|525111298|FG003|Induction Period|Lost to Follow-up|0|||
145616178|NCT01474512|525111299|FG004|Induction Period|Lost to Follow-up|0|||
145616179|NCT01474512|525111300|FG005|Induction Period|Lost to Follow-up|0|||
145616180|NCT01474512|525111301|FG006|Induction Period|Lost to Follow-up|0|||
145616181|NCT01474512|525111302|FG007|Induction Period|Lost to Follow-up|0|||
145616182|NCT01474512|525111303|FG008|Induction Period|Lost to Follow-up|0|||
145616183|NCT01474512|525111304|FG009|Induction Period|Lost to Follow-up|0|||
145616184|NCT01474512|525111305|FG010|Induction Period|Lost to Follow-up|0|||
145616185|NCT01474512|525111306|FG011|Induction Period|Lost to Follow-up|0|||
145616186|NCT01474512|525111307|FG012|Induction Period|Lost to Follow-up|0|||
145616187|NCT01474512|525111308|FG013|Induction Period|Lost to Follow-up|0|||
145616188|NCT01474512|525111309|FG014|Induction Period|Lost to Follow-up|0|||
145616189|NCT01474512|525111310|FG015|Induction Period|Lost to Follow-up|0|||
145616190|NCT01474512|525111311|FG016|Induction Period|Lost to Follow-up|0|||
145616191|NCT01474512|525111312|FG017|Induction Period|Lost to Follow-up|0|||
145616192|NCT01474512|525111295|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616193|NCT01474512|525111296|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616194|NCT01474512|525111297|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616195|NCT01474512|525111298|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
145616196|NCT01474512|525111299|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
145407389|NCT01104766|524346981|FG000|Overall Study|Did not meet inc/exc criteria|1|||
145407390|NCT01104766|524346982|FG001|Overall Study|Did not meet inc/exc criteria|0|||
145407391|NCT01104766|524346983|FG002|Overall Study|Did not meet inc/exc criteria|0|||
145407392|NCT01104766|524346984|FG003|Overall Study|Did not meet inc/exc criteria|0|||
145407393|NCT01104766|524346981|FG000|Overall Study|Adverse Event|17|||
145616197|NCT01474512|525111300|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
145616198|NCT01474512|525111301|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
145616199|NCT01474512|525111302|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616200|NCT01474512|525111303|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616201|NCT01474512|525111304|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616202|NCT01474512|525111305|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616203|NCT01474512|525111306|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616204|NCT01474512|525111307|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616205|NCT01474512|525111308|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616206|NCT01474512|525111309|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616207|NCT01474512|525111310|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616208|NCT01474512|525111311|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616209|NCT01474512|525111312|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
145616210|NCT01474512|525111295|FG000|Maintenance Period|Adverse Event|0|||
145616211|NCT01474512|525111296|FG001|Maintenance Period|Adverse Event|0|||
145616212|NCT01474512|525111297|FG002|Maintenance Period|Adverse Event|0|||
145616213|NCT01474512|525111298|FG003|Maintenance Period|Adverse Event|4|||
145616214|NCT01474512|525111299|FG004|Maintenance Period|Adverse Event|2|||
145616215|NCT01474512|525111300|FG005|Maintenance Period|Adverse Event|7|||
145616216|NCT01474512|525111301|FG006|Maintenance Period|Adverse Event|0|||
145616217|NCT01474512|525111302|FG007|Maintenance Period|Adverse Event|19|||
145616218|NCT01474512|525111303|FG008|Maintenance Period|Adverse Event|1|||
145616219|NCT01474512|525111304|FG009|Maintenance Period|Adverse Event|3|||
145616220|NCT01474512|525111305|FG010|Maintenance Period|Adverse Event|0|||
145616221|NCT01474512|525111306|FG011|Maintenance Period|Adverse Event|0|||
145616222|NCT01474512|525111307|FG012|Maintenance Period|Adverse Event|0|||
145616223|NCT01474512|525111308|FG013|Maintenance Period|Adverse Event|0|||
145616224|NCT01474512|525111309|FG014|Maintenance Period|Adverse Event|0|||
145616225|NCT01474512|525111310|FG015|Maintenance Period|Adverse Event|0|||
145616226|NCT01474512|525111311|FG016|Maintenance Period|Adverse Event|0|||
145616227|NCT01474512|525111312|FG017|Maintenance Period|Adverse Event|0|||
145616228|NCT01474512|525111295|FG000|Maintenance Period|Withdrawal by Subject|0|||
145616229|NCT01474512|525111296|FG001|Maintenance Period|Withdrawal by Subject|0|||
145616230|NCT01474512|525111297|FG002|Maintenance Period|Withdrawal by Subject|0|||
145616231|NCT01474512|525111298|FG003|Maintenance Period|Withdrawal by Subject|6|||
145616232|NCT01474512|525111299|FG004|Maintenance Period|Withdrawal by Subject|2|||
145616233|NCT01474512|525111300|FG005|Maintenance Period|Withdrawal by Subject|3|||
145616234|NCT01474512|525111301|FG006|Maintenance Period|Withdrawal by Subject|1|||
145616235|NCT01474512|525111302|FG007|Maintenance Period|Withdrawal by Subject|6|||
145616236|NCT01474512|525111303|FG008|Maintenance Period|Withdrawal by Subject|3|||
145616237|NCT01474512|525111304|FG009|Maintenance Period|Withdrawal by Subject|1|||
145616238|NCT01474512|525111305|FG010|Maintenance Period|Withdrawal by Subject|0|||
145616239|NCT01474512|525111306|FG011|Maintenance Period|Withdrawal by Subject|0|||
145616240|NCT01474512|525111307|FG012|Maintenance Period|Withdrawal by Subject|0|||
145616241|NCT01474512|525111308|FG013|Maintenance Period|Withdrawal by Subject|0|||
145616242|NCT01474512|525111309|FG014|Maintenance Period|Withdrawal by Subject|0|||
145616243|NCT01474512|525111310|FG015|Maintenance Period|Withdrawal by Subject|0|||
145616244|NCT01474512|525111311|FG016|Maintenance Period|Withdrawal by Subject|0|||
145616245|NCT01474512|525111312|FG017|Maintenance Period|Withdrawal by Subject|0|||
145616246|NCT01474512|525111295|FG000|Maintenance Period|Lost to Follow-up|0|||
145616247|NCT01474512|525111296|FG001|Maintenance Period|Lost to Follow-up|0|||
145616248|NCT01474512|525111297|FG002|Maintenance Period|Lost to Follow-up|0|||
145616249|NCT01474512|525111298|FG003|Maintenance Period|Lost to Follow-up|3|||
145616250|NCT01474512|525111299|FG004|Maintenance Period|Lost to Follow-up|3|||
145616251|NCT01474512|525111300|FG005|Maintenance Period|Lost to Follow-up|0|||
145616252|NCT01474512|525111301|FG006|Maintenance Period|Lost to Follow-up|0|||
145616253|NCT01474512|525111302|FG007|Maintenance Period|Lost to Follow-up|2|||
145557216|NCT00674661|524898574|FG001|Overall Study|Lost to Follow-up|3|||
145557217|NCT00674661|524898573|FG000|Overall Study|Withdrawal by Subject|0|||
145557218|NCT00674661|524898574|FG001|Overall Study|Withdrawal by Subject|5|||
145557219|NCT00003901|524898575|FG000|Overall Study|Adverse Event|1|||
145557220|NCT00003901|524898575|FG000|Overall Study|Withdrawal by Subject|1|||
145557221|NCT00003901|524898575|FG000|Overall Study|Ineligible|6|||
145557222|NCT00003901|524898575|FG000|Overall Study|CT Scan not within protocol requirement|2|||
145557223|NCT00003901|524898575|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
145557224|NCT00003901|524898575|FG000|Overall Study|Medical problems|6|||
145557225|NCT02707991|524898576|FG000|Overall Study|Protocol Violation|1|||
145557226|NCT02707991|524898577|FG001|Overall Study|Protocol Violation|0|||
145557227|NCT02707991|524898576|FG000|Overall Study|Became ineligible|0|||
145557228|NCT02707991|524898577|FG001|Overall Study|Became ineligible|1|||
145557229|NCT02268864|524898578|FG000|Overall Study|Withdrawal by Subject|2|||
145557230|NCT02268864|524898579|FG001|Overall Study|Withdrawal by Subject|0|||
145557231|NCT02268864|524898580|FG002|Overall Study|Withdrawal by Subject|0|||
145557232|NCT02268864|524898578|FG000|Overall Study|Death|0|||
145557233|NCT02268864|524898579|FG001|Overall Study|Death|1|||
145557234|NCT02268864|524898580|FG002|Overall Study|Death|0|||
145557235|NCT00857220|524898583|FG000|Overall Study|Adverse Event|35|||
145557236|NCT00857220|524898583|FG000|Overall Study|Death|1|||
145557237|NCT00857220|524898583|FG000|Overall Study|Lack of Efficacy|11|||
145557238|NCT00857220|524898583|FG000|Overall Study|Lost to Follow-up|30|||
145557239|NCT00857220|524898583|FG000|Overall Study|Physician Decision|4|||
145557240|NCT00857220|524898583|FG000|Overall Study|Protocol Violation|16|||
145557241|NCT00857220|524898583|FG000|Overall Study|Withdrawal by Subject|67|||
145616254|NCT01474512|525111303|FG008|Maintenance Period|Lost to Follow-up|1|||
145616255|NCT01474512|525111304|FG009|Maintenance Period|Lost to Follow-up|1|||
145616256|NCT01474512|525111305|FG010|Maintenance Period|Lost to Follow-up|0|||
145616257|NCT01474512|525111306|FG011|Maintenance Period|Lost to Follow-up|0|||
145557242|NCT00857220|524898583|FG000|Overall Study|Clinical Hold|6|||
145557243|NCT00857220|524898583|FG000|Overall Study|Site Closed|5|||
145557244|NCT00857220|524898583|FG000|Overall Study|Miscellaneous|8|||
145557245|NCT02612428|524898584|FG000|VTL-308|Death|14|||
145557246|NCT02612428|524898585|FG001|VTL-308|Death|16|||
145557247|NCT02612428|524898584|FG000|VTL-308|Withdrawal by Subject|0|||
145557248|NCT02612428|524898585|FG001|VTL-308|Withdrawal by Subject|1|||
145557249|NCT02612428|524898584|FG000|VTL-308E|Death|9|||
145557250|NCT02612428|524898585|FG001|VTL-308E|Death|7|||
145557251|NCT02612428|524898584|FG000|VTL-308E|Lost to Follow-up|2|||
145557252|NCT02612428|524898585|FG001|VTL-308E|Lost to Follow-up|0|||
145557253|NCT03187262|524898586|FG000|Induction|Lack of Efficacy|2|||
145557254|NCT03187262|524898586|FG000|Induction|Progressive Disease|4|||
145557255|NCT03187262|524898586|FG000|Consolidation|Progressive Disease|5|||
145557256|NCT00597766|524898589|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
145557257|NCT00597766|524898590|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
145557258|NCT00597766|524898591|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
145557259|NCT00597766|524898589|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
145557260|NCT00597766|524898590|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
145557261|NCT00597766|524898591|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
145557262|NCT01166763|524898593|FG000|Overall Study|Withdrawal by Subject|3|||
145557263|NCT04339296|524898594|FG000|Overall Study|Refuse to participate after allocation|1|||
145557264|NCT04339296|524898595|FG001|Overall Study|Refuse to participate after allocation|1|||
145557265|NCT04339296|524898594|FG000|Overall Study|Withdrew after completion of baseline|2|||
145557266|NCT04339296|524898595|FG001|Overall Study|Withdrew after completion of baseline|1|||
145557267|NCT04339296|524898594|FG000|Overall Study|Lost to Follow-up|0|||
145557268|NCT04339296|524898595|FG001|Overall Study|Lost to Follow-up|4|||
145557269|NCT04339296|524898594|FG000|Overall Study|Discontinued intervention|5|||
145557270|NCT04339296|524898595|FG001|Overall Study|Discontinued intervention|3|||
145557271|NCT01909479|524898596|FG000|From Baseline to Week 26|Adverse Event|3|||
145557272|NCT01909479|524898597|FG001|From Baseline to Week 26|Adverse Event|2|||
145557273|NCT01909479|524898596|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
145557274|NCT01909479|524898597|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
145557275|NCT01909479|524898596|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
145557276|NCT01909479|524898597|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
145557277|NCT01909479|524898596|FG000|26 - 52 Weeks|Adverse Event|0|||
145557278|NCT01909479|524898597|FG001|26 - 52 Weeks|Adverse Event|1|||
145557279|NCT01909479|524898596|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
145557280|NCT01909479|524898597|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
145557281|NCT01909479|524898596|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
145557282|NCT01909479|524898597|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
145557283|NCT01909479|524898596|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
145557284|NCT01909479|524898597|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
145557285|NCT01909479|524898596|FG000|52 Weeks to End of Study|Adverse Event|2|||
145557286|NCT01909479|524898597|FG001|52 Weeks to End of Study|Adverse Event|1|||
145557287|NCT01909479|524898596|FG000|52 Weeks to End of Study|Death|0|||
145557288|NCT01909479|524898597|FG001|52 Weeks to End of Study|Death|1|||
145557289|NCT01909479|524898596|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
145557290|NCT01909479|524898597|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
145557291|NCT01909479|524898596|FG000|52 Weeks to End of Study|Protocol Violation|1|||
145557292|NCT01909479|524898597|FG001|52 Weeks to End of Study|Protocol Violation|0|||
145557293|NCT01909479|524898596|FG000|52 Weeks to End of Study|Progressive disease|1|||
145557294|NCT01909479|524898597|FG001|52 Weeks to End of Study|Progressive disease|1|||
145557295|NCT01909479|524898596|FG000|52 Weeks to End of Study|Personal reasons|2|||
145557296|NCT01909479|524898597|FG001|52 Weeks to End of Study|Personal reasons|1|||
145557297|NCT01909479|524898596|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
145557298|NCT01909479|524898597|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
145557299|NCT01909479|524898596|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
145557300|NCT01909479|524898597|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
145557301|NCT01909479|524898596|FG000|52 Weeks to End of Study|Lack of contact|1|||
145557302|NCT01909479|524898597|FG001|52 Weeks to End of Study|Lack of contact|0|||
145557303|NCT01909479|524898596|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
145557304|NCT01909479|524898597|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
145557305|NCT01909479|524898596|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
145557306|NCT01909479|524898597|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
145557307|NCT02375113|524898600|FG000|Overall Study|Undisclosed Reason(s).|1|||
145557308|NCT02375113|524898601|FG001|Overall Study|Undisclosed Reason(s).|1|||
145557309|NCT02375113|524898600|FG000|Overall Study|Poor adherence (<70%).|1|||
145557310|NCT02375113|524898601|FG001|Overall Study|Poor adherence (<70%).|0|||
145557311|NCT02375113|524898600|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
145557312|NCT02375113|524898601|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
145557313|NCT00511667|524898615|FG000|Overall Study|Adverse Event|1|||
145557314|NCT00511667|524898616|FG001|Overall Study|Adverse Event|0|||
145557315|NCT00511667|524898615|FG000|Overall Study|Protocol Violation|1|||
145557316|NCT00511667|524898616|FG001|Overall Study|Protocol Violation|1|||
145557317|NCT00511667|524898615|FG000|Overall Study|Withdrawal by Subject|2|||
145557318|NCT00511667|524898616|FG001|Overall Study|Withdrawal by Subject|0|||
145557319|NCT00511667|524898615|FG000|Overall Study|Site terminated|6|||
145557320|NCT00511667|524898616|FG001|Overall Study|Site terminated|1|||
145557321|NCT00511667|524898615|FG000|Overall Study|Other|2|||
145557322|NCT00511667|524898616|FG001|Overall Study|Other|1|||
145557323|NCT00056407|524898617|FG000|Overall Study|Adverse Event|282|||
145557324|NCT00056407|524898618|FG001|Overall Study|Adverse Event|364|||
145557325|NCT00056407|524898617|FG000|Overall Study|Withdrawal by Subject|377|||
145557326|NCT00056407|524898618|FG001|Overall Study|Withdrawal by Subject|361|||
145557327|NCT00056407|524898617|FG000|Overall Study|Lost to Follow-up|123|||
145557328|NCT00056407|524898618|FG001|Overall Study|Lost to Follow-up|113|||
145557329|NCT00056407|524898617|FG000|Overall Study|Protocol Violation|104|||
145557330|NCT00056407|524898618|FG001|Overall Study|Protocol Violation|95|||
145557331|NCT00056407|524898617|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
145557332|NCT00056407|524898618|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
145557333|NCT00056407|524898617|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
145557334|NCT00056407|524898618|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
145557335|NCT00056407|524898617|FG000|Overall Study|Missing|25|||
145557336|NCT00056407|524898618|FG001|Overall Study|Missing|34|||
145557337|NCT00616655|524898619|FG000|Overall Study|Adverse Event|10|||
145557338|NCT00616655|524898620|FG001|Overall Study|Adverse Event|7|||
145557339|NCT00616655|524898621|FG002|Overall Study|Adverse Event|12|||
145557340|NCT00616655|524898619|FG000|Overall Study|Lack of Efficacy|5|||
145557341|NCT00616655|524898620|FG001|Overall Study|Lack of Efficacy|5|||
145557342|NCT00616655|524898621|FG002|Overall Study|Lack of Efficacy|5|||
145557343|NCT00616655|524898619|FG000|Overall Study|Lost to Follow-up|3|||
145557344|NCT00616655|524898620|FG001|Overall Study|Lost to Follow-up|12|||
145557345|NCT00616655|524898621|FG002|Overall Study|Lost to Follow-up|10|||
145557346|NCT00616655|524898619|FG000|Overall Study|Protocol Violation|2|||
145557347|NCT00616655|524898620|FG001|Overall Study|Protocol Violation|4|||
145557348|NCT00616655|524898621|FG002|Overall Study|Protocol Violation|3|||
145557349|NCT00616655|524898619|FG000|Overall Study|Withdrawal by Subject|9|||
145557350|NCT00616655|524898620|FG001|Overall Study|Withdrawal by Subject|7|||
145557351|NCT00616655|524898621|FG002|Overall Study|Withdrawal by Subject|11|||
145557352|NCT00616655|524898619|FG000|Overall Study|Does not meet in/ex criteria|0|||
145557353|NCT00616655|524898620|FG001|Overall Study|Does not meet in/ex criteria|0|||
145557354|NCT00616655|524898621|FG002|Overall Study|Does not meet in/ex criteria|2|||
145557355|NCT00616655|524898619|FG000|Overall Study|Other|6|||
145557356|NCT00616655|524898620|FG001|Overall Study|Other|6|||
145557357|NCT00616655|524898621|FG002|Overall Study|Other|5|||
145292590|NCT00950807|523922203|FG000|Washout Period 1|Adverse Event|2|||
145557358|NCT03605303|524898622|FG000|Period 1|Study Terminated|2|||
145557359|NCT03605303|524898623|FG001|Period 1|Study Terminated|1|||
145557360|NCT00309842|524898624|FG000|Overall Study|Lost to Follow-up|1|||
145557361|NCT02626520|524898625|FG000|Overall Study|Physician Decision|1|||
145557362|NCT02626520|524898626|FG001|Overall Study|Physician Decision|1|||
145557363|NCT02626520|524898625|FG000|Overall Study|Adverse Event|0|||
145557364|NCT02626520|524898626|FG001|Overall Study|Adverse Event|4|||
145557365|NCT02626520|524898625|FG000|Overall Study|Lack of Efficacy|0|||
145292591|NCT00950807|523922204|FG001|Washout Period 1|Adverse Event|0|||
145557366|NCT02626520|524898626|FG001|Overall Study|Lack of Efficacy|2|||
145557367|NCT02626520|524898625|FG000|Overall Study|Did not start protocol therapy|0|||
145616258|NCT01474512|525111307|FG012|Maintenance Period|Lost to Follow-up|0|||
145616259|NCT01474512|525111308|FG013|Maintenance Period|Lost to Follow-up|0|||
145292592|NCT00950807|523922205|FG002|Washout Period 1|Adverse Event|0|||
145292593|NCT00950807|523922206|FG003|Washout Period 1|Adverse Event|1|||
145292594|NCT00950807|523922207|FG004|Washout Period 1|Adverse Event|1|||
145292595|NCT00950807|523922208|FG005|Washout Period 1|Adverse Event|0|||
145292596|NCT00950807|523922209|FG006|Washout Period 1|Adverse Event|0|||
145292597|NCT00950807|523922210|FG007|Washout Period 1|Adverse Event|0|||
145292598|NCT00950807|523922211|FG008|Washout Period 1|Adverse Event|0|||
145292599|NCT00950807|523922212|FG009|Washout Period 1|Adverse Event|0|||
145292600|NCT00950807|523922203|FG000|Treatment Period 2|Lack of Efficacy|1|||
145292601|NCT00950807|523922204|FG001|Treatment Period 2|Lack of Efficacy|0|||
145292602|NCT00950807|523922205|FG002|Treatment Period 2|Lack of Efficacy|0|||
145292603|NCT00950807|523922206|FG003|Treatment Period 2|Lack of Efficacy|0|||
145292604|NCT00950807|523922207|FG004|Treatment Period 2|Lack of Efficacy|0|||
145292605|NCT00950807|523922208|FG005|Treatment Period 2|Lack of Efficacy|0|||
145292606|NCT00950807|523922209|FG006|Treatment Period 2|Lack of Efficacy|0|||
145557368|NCT02626520|524898626|FG001|Overall Study|Did not start protocol therapy|2|||
145557369|NCT02626520|524898625|FG000|Overall Study|Study terminated|0|||
145557370|NCT02626520|524898626|FG001|Overall Study|Study terminated|1|||
145557371|NCT00492115|524898627|FG000|Overall Study|Withdrawal by Subject|3|||
145557372|NCT00492115|524898628|FG001|Overall Study|Withdrawal by Subject|4|||
145557373|NCT02045797|524898631|FG000|Overall Study|Adverse Event|3|||
145557374|NCT02045797|524898632|FG001|Overall Study|Adverse Event|1|||
145557375|NCT02045797|524898633|FG002|Overall Study|Adverse Event|0|||
145557376|NCT02045797|524898631|FG000|Overall Study|Lack of Efficacy|1|||
145292607|NCT00950807|523922210|FG007|Treatment Period 2|Lack of Efficacy|0|||
145292608|NCT00950807|523922211|FG008|Treatment Period 2|Lack of Efficacy|0|||
145292609|NCT00950807|523922212|FG009|Treatment Period 2|Lack of Efficacy|0|||
145292610|NCT00950807|523922203|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145292611|NCT00950807|523922204|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145557377|NCT02045797|524898632|FG001|Overall Study|Lack of Efficacy|0|||
145557378|NCT02045797|524898633|FG002|Overall Study|Lack of Efficacy|0|||
145557379|NCT02045797|524898631|FG000|Overall Study|Lost to Follow-up|2|||
145557380|NCT02045797|524898632|FG001|Overall Study|Lost to Follow-up|3|||
145557381|NCT02045797|524898633|FG002|Overall Study|Lost to Follow-up|1|||
145557382|NCT02045797|524898631|FG000|Overall Study|Physician Decision|0|||
145292612|NCT00950807|523922205|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145292613|NCT00950807|523922206|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145292614|NCT00950807|523922207|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145292615|NCT00950807|523922208|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145292616|NCT00950807|523922209|FG006|Treatment Period 2|Withdrawal by Subject|1|||
145292617|NCT00950807|523922210|FG007|Treatment Period 2|Withdrawal by Subject|2|||
145292618|NCT00950807|523922211|FG008|Treatment Period 2|Withdrawal by Subject|0|||
145292619|NCT00950807|523922212|FG009|Treatment Period 2|Withdrawal by Subject|0|||
145557383|NCT02045797|524898632|FG001|Overall Study|Physician Decision|1|||
145557384|NCT02045797|524898633|FG002|Overall Study|Physician Decision|0|||
145557385|NCT02045797|524898631|FG000|Overall Study|Withdrawal by Subject|1|||
145557386|NCT02045797|524898632|FG001|Overall Study|Withdrawal by Subject|2|||
145557387|NCT02045797|524898633|FG002|Overall Study|Withdrawal by Subject|0|||
145557388|NCT05407675|524900340|FG000|Overall Study|Withdrawal by Subject|0|||
145292620|NCT00950807|523922203|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
145292621|NCT00950807|523922204|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145407394|NCT01104766|524346982|FG001|Overall Study|Adverse Event|15|||
145557389|NCT05407675|524900341|FG001|Overall Study|Withdrawal by Subject|2|||
145557390|NCT05407675|524900342|FG002|Overall Study|Withdrawal by Subject|3|||
145557391|NCT05407675|524900343|FG003|Overall Study|Withdrawal by Subject|5|||
145557392|NCT05407675|524900344|FG004|Overall Study|Withdrawal by Subject|0|||
145407395|NCT01104766|524346983|FG002|Overall Study|Adverse Event|20|||
145407396|NCT01104766|524346984|FG003|Overall Study|Adverse Event|14|||
145407397|NCT01104766|524346981|FG000|Overall Study|Lack of Efficacy|20|||
145407398|NCT01104766|524346982|FG001|Overall Study|Lack of Efficacy|15|||
145407399|NCT01104766|524346983|FG002|Overall Study|Lack of Efficacy|14|||
145407400|NCT01104766|524346984|FG003|Overall Study|Lack of Efficacy|8|||
145407401|NCT01104766|524346981|FG000|Overall Study|Protocol Violation|2|||
145407402|NCT01104766|524346982|FG001|Overall Study|Protocol Violation|0|||
145407403|NCT01104766|524346983|FG002|Overall Study|Protocol Violation|0|||
145407404|NCT01104766|524346984|FG003|Overall Study|Protocol Violation|0|||
145407405|NCT01104766|524346981|FG000|Overall Study|Withdrawal by Subject|17|||
145407406|NCT01104766|524346982|FG001|Overall Study|Withdrawal by Subject|19|||
145407407|NCT01104766|524346983|FG002|Overall Study|Withdrawal by Subject|25|||
145407408|NCT01104766|524346984|FG003|Overall Study|Withdrawal by Subject|15|||
145407409|NCT01104766|524346981|FG000|Overall Study|Lost to Follow-up|1|||
145407410|NCT01104766|524346982|FG001|Overall Study|Lost to Follow-up|2|||
145407411|NCT01104766|524346983|FG002|Overall Study|Lost to Follow-up|1|||
145407412|NCT01104766|524346984|FG003|Overall Study|Lost to Follow-up|1|||
145407413|NCT01136915|524346986|FG000|Overall Study|Lost to Follow-up|2|||
145407414|NCT01136915|524346987|FG001|Overall Study|Lost to Follow-up|0|||
145407415|NCT01136915|524346986|FG000|Overall Study|Exclusion criterion met|0|||
145407416|NCT01136915|524346987|FG001|Overall Study|Exclusion criterion met|1|||
145407417|NCT03282097|524346990|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
145407418|NCT03282097|524346991|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
145407419|NCT03282097|524346990|FG000|Intervention Visit Complete|Patient Death|13|||
145407420|NCT03282097|524346991|FG001|Intervention Visit Complete|Patient Death|15|||
145407421|NCT03282097|524346990|FG000|Intervention Visit Complete|Caregiver Death|0|||
145407422|NCT03282097|524346991|FG001|Intervention Visit Complete|Caregiver Death|3|||
145407423|NCT03282097|524346990|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
145407424|NCT03282097|524346991|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
145407425|NCT03282097|524346990|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
145407426|NCT03282097|524346991|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
145407427|NCT03282097|524346990|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
145407428|NCT03282097|524346991|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
145407429|NCT03282097|524346990|FG000|Primary Outcome Data Collection Complete|Missing|2|||
145407430|NCT03282097|524346991|FG001|Primary Outcome Data Collection Complete|Missing|3|||
145407431|NCT03282097|524346990|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
145407432|NCT03282097|524346991|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
145407433|NCT03282097|524346990|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
145407434|NCT03282097|524346991|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
145407435|NCT03282097|524346990|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
145407436|NCT03282097|524346991|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
145407437|NCT03839641|524346996|FG000|Overall Study|Withdrawal by Subject|1|||
145407438|NCT03839641|524346997|FG001|Overall Study|Withdrawal by Subject|1|||
145407439|NCT03806296|524346998|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
145407440|NCT03806296|524346999|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
145407441|NCT03806296|524347000|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
145292622|NCT00950807|523922205|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292623|NCT00950807|523922206|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292624|NCT00950807|523922207|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292625|NCT00950807|523922208|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292626|NCT00950807|523922209|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292627|NCT00950807|523922210|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292628|NCT00950807|523922211|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292629|NCT00950807|523922212|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145292630|NCT00950807|523922203|FG000|Treatment Period 2|Adverse Event|0|||
145557393|NCT05407675|524900345|FG005|Overall Study|Withdrawal by Subject|2|||
145557394|NCT05407675|524900346|FG006|Overall Study|Withdrawal by Subject|0|||
145557395|NCT05407675|524900347|FG007|Overall Study|Withdrawal by Subject|0|||
145557396|NCT05407675|524900348|FG008|Overall Study|Withdrawal by Subject|2|||
145557397|NCT05407675|524900349|FG009|Overall Study|Withdrawal by Subject|0|||
145557398|NCT05407675|524900350|FG010|Overall Study|Withdrawal by Subject|1|||
145557399|NCT05407675|524900351|FG011|Overall Study|Withdrawal by Subject|0|||
145557400|NCT05407675|524900352|FG012|Overall Study|Withdrawal by Subject|0|||
145557401|NCT05407675|524900340|FG000|Overall Study|Site terminated by sponsor|0|||
145557402|NCT05407675|524900341|FG001|Overall Study|Site terminated by sponsor|0|||
145557403|NCT05407675|524900342|FG002|Overall Study|Site terminated by sponsor|1|||
145557404|NCT05407675|524900343|FG003|Overall Study|Site terminated by sponsor|0|||
145557405|NCT05407675|524900344|FG004|Overall Study|Site terminated by sponsor|2|||
145557406|NCT05407675|524900345|FG005|Overall Study|Site terminated by sponsor|0|||
145557407|NCT05407675|524900346|FG006|Overall Study|Site terminated by sponsor|1|||
145557408|NCT05407675|524900347|FG007|Overall Study|Site terminated by sponsor|0|||
145557409|NCT05407675|524900348|FG008|Overall Study|Site terminated by sponsor|0|||
145557410|NCT05407675|524900349|FG009|Overall Study|Site terminated by sponsor|2|||
145557411|NCT05407675|524900350|FG010|Overall Study|Site terminated by sponsor|2|||
145557412|NCT05407675|524900351|FG011|Overall Study|Site terminated by sponsor|2|||
145557413|NCT05407675|524900352|FG012|Overall Study|Site terminated by sponsor|1|||
145557414|NCT05407675|524900340|FG000|Overall Study|Disease Progression|0|||
145557415|NCT05407675|524900341|FG001|Overall Study|Disease Progression|0|||
145557416|NCT05407675|524900342|FG002|Overall Study|Disease Progression|0|||
145557417|NCT05407675|524900343|FG003|Overall Study|Disease Progression|0|||
145557418|NCT05407675|524900344|FG004|Overall Study|Disease Progression|0|||
145557419|NCT05407675|524900345|FG005|Overall Study|Disease Progression|0|||
145557420|NCT05407675|524900346|FG006|Overall Study|Disease Progression|0|||
145557421|NCT05407675|524900347|FG007|Overall Study|Disease Progression|0|||
145557422|NCT05407675|524900348|FG008|Overall Study|Disease Progression|0|||
145557423|NCT05407675|524900349|FG009|Overall Study|Disease Progression|0|||
145557424|NCT05407675|524900350|FG010|Overall Study|Disease Progression|1|||
145557425|NCT05407675|524900351|FG011|Overall Study|Disease Progression|0|||
145557426|NCT05407675|524900352|FG012|Overall Study|Disease Progression|0|||
145557427|NCT05407675|524900340|FG000|Overall Study|Physician Decision|0|||
145557428|NCT05407675|524900341|FG001|Overall Study|Physician Decision|0|||
145557429|NCT05407675|524900342|FG002|Overall Study|Physician Decision|0|||
145557430|NCT05407675|524900343|FG003|Overall Study|Physician Decision|0|||
145557431|NCT05407675|524900344|FG004|Overall Study|Physician Decision|0|||
145557432|NCT05407675|524900345|FG005|Overall Study|Physician Decision|0|||
145557433|NCT05407675|524900346|FG006|Overall Study|Physician Decision|0|||
145557434|NCT05407675|524900347|FG007|Overall Study|Physician Decision|0|||
145557435|NCT05407675|524900348|FG008|Overall Study|Physician Decision|0|||
145557436|NCT05407675|524900349|FG009|Overall Study|Physician Decision|0|||
145557437|NCT05407675|524900350|FG010|Overall Study|Physician Decision|1|||
145557438|NCT05407675|524900351|FG011|Overall Study|Physician Decision|0|||
145557439|NCT05407675|524900352|FG012|Overall Study|Physician Decision|0|||
145557440|NCT05407675|524900340|FG000|Overall Study|Other reasons|0|||
145557441|NCT05407675|524900341|FG001|Overall Study|Other reasons|0|||
145557442|NCT05407675|524900342|FG002|Overall Study|Other reasons|0|||
145557443|NCT05407675|524900343|FG003|Overall Study|Other reasons|0|||
145557444|NCT05407675|524900344|FG004|Overall Study|Other reasons|0|||
145557445|NCT05407675|524900345|FG005|Overall Study|Other reasons|0|||
145557446|NCT05407675|524900346|FG006|Overall Study|Other reasons|0|||
145557447|NCT05407675|524900347|FG007|Overall Study|Other reasons|0|||
145557448|NCT05407675|524900348|FG008|Overall Study|Other reasons|1|||
145557449|NCT05407675|524900349|FG009|Overall Study|Other reasons|1|||
145557450|NCT05407675|524900350|FG010|Overall Study|Other reasons|1|||
145292631|NCT00950807|523922204|FG001|Treatment Period 2|Adverse Event|1|||
145557451|NCT05407675|524900351|FG011|Overall Study|Other reasons|1|||
145557452|NCT05407675|524900352|FG012|Overall Study|Other reasons|0|||
145557453|NCT05407675|524900340|FG000|Overall Study|Death|3|||
145557454|NCT05407675|524900341|FG001|Overall Study|Death|4|||
145557455|NCT05407675|524900342|FG002|Overall Study|Death|3|||
145557456|NCT05407675|524900343|FG003|Overall Study|Death|6|||
145557457|NCT05407675|524900344|FG004|Overall Study|Death|0|||
145557458|NCT05407675|524900345|FG005|Overall Study|Death|2|||
145557459|NCT05407675|524900346|FG006|Overall Study|Death|4|||
145557460|NCT05407675|524900347|FG007|Overall Study|Death|2|||
145557461|NCT05407675|524900348|FG008|Overall Study|Death|2|||
145557462|NCT05407675|524900349|FG009|Overall Study|Death|4|||
145557463|NCT05407675|524900350|FG010|Overall Study|Death|2|||
145557464|NCT05407675|524900351|FG011|Overall Study|Death|1|||
145557465|NCT05407675|524900352|FG012|Overall Study|Death|0|||
145557466|NCT05407675|524900340|FG000|Overall Study|Adverse Event|0|||
145557467|NCT05407675|524900341|FG001|Overall Study|Adverse Event|0|||
145557468|NCT05407675|524900342|FG002|Overall Study|Adverse Event|0|||
145557469|NCT05407675|524900343|FG003|Overall Study|Adverse Event|0|||
145557470|NCT05407675|524900344|FG004|Overall Study|Adverse Event|1|||
145557471|NCT05407675|524900345|FG005|Overall Study|Adverse Event|0|||
145557472|NCT05407675|524900346|FG006|Overall Study|Adverse Event|0|||
145557473|NCT05407675|524900347|FG007|Overall Study|Adverse Event|0|||
145557474|NCT05407675|524900348|FG008|Overall Study|Adverse Event|0|||
145557475|NCT05407675|524900349|FG009|Overall Study|Adverse Event|0|||
145557476|NCT05407675|524900350|FG010|Overall Study|Adverse Event|0|||
145557477|NCT05407675|524900351|FG011|Overall Study|Adverse Event|1|||
145557478|NCT05407675|524900352|FG012|Overall Study|Adverse Event|0|||
145292632|NCT00950807|523922205|FG002|Treatment Period 2|Adverse Event|0|||
145292633|NCT00950807|523922206|FG003|Treatment Period 2|Adverse Event|1|||
145557479|NCT05407675|524900340|FG000|Overall Study|Ongoing Treatment|0|||
145557480|NCT05407675|524900341|FG001|Overall Study|Ongoing Treatment|0|||
145557481|NCT05407675|524900342|FG002|Overall Study|Ongoing Treatment|0|||
145557482|NCT05407675|524900343|FG003|Overall Study|Ongoing Treatment|0|||
145557483|NCT05407675|524900344|FG004|Overall Study|Ongoing Treatment|0|||
145557484|NCT05407675|524900345|FG005|Overall Study|Ongoing Treatment|0|||
145557485|NCT05407675|524900346|FG006|Overall Study|Ongoing Treatment|0|||
145557486|NCT05407675|524900347|FG007|Overall Study|Ongoing Treatment|0|||
145557487|NCT05407675|524900348|FG008|Overall Study|Ongoing Treatment|1|||
145557488|NCT05407675|524900349|FG009|Overall Study|Ongoing Treatment|0|||
145557489|NCT05407675|524900350|FG010|Overall Study|Ongoing Treatment|0|||
145557490|NCT05407675|524900351|FG011|Overall Study|Ongoing Treatment|0|||
145292634|NCT00950807|523922207|FG004|Treatment Period 2|Adverse Event|0|||
145292635|NCT00950807|523922208|FG005|Treatment Period 2|Adverse Event|1|||
145292636|NCT00950807|523922209|FG006|Treatment Period 2|Adverse Event|0|||
145292637|NCT00950807|523922210|FG007|Treatment Period 2|Adverse Event|1|||
145292638|NCT00950807|523922211|FG008|Treatment Period 2|Adverse Event|0|||
145292639|NCT00950807|523922212|FG009|Treatment Period 2|Adverse Event|0|||
145292640|NCT00950807|523922203|FG000|Washout Period 2|Lack of Efficacy|1|||
145292641|NCT00950807|523922204|FG001|Washout Period 2|Lack of Efficacy|0|||
145292642|NCT00950807|523922205|FG002|Washout Period 2|Lack of Efficacy|0|||
145292643|NCT00950807|523922206|FG003|Washout Period 2|Lack of Efficacy|0|||
145292644|NCT00950807|523922207|FG004|Washout Period 2|Lack of Efficacy|0|||
145292645|NCT00950807|523922208|FG005|Washout Period 2|Lack of Efficacy|0|||
145292646|NCT00950807|523922209|FG006|Washout Period 2|Lack of Efficacy|0|||
145557491|NCT05407675|524900352|FG012|Overall Study|Ongoing Treatment|0|||
145292647|NCT00950807|523922210|FG007|Washout Period 2|Lack of Efficacy|0|||
145292648|NCT00950807|523922211|FG008|Washout Period 2|Lack of Efficacy|0|||
145557492|NCT03698994|524900353|FG000|Overall Study|Adverse Event|2|||
145557493|NCT03698994|524900353|FG000|Overall Study|Death|1|||
145557494|NCT03698994|524900353|FG000|Overall Study|Physician Decision|1|||
145557495|NCT03698994|524900353|FG000|Overall Study|Withdrawal by Subject|3|||
145557496|NCT03698994|524900353|FG000|Overall Study|Progressive Disease|12|||
145557497|NCT00742001|524900354|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
145557498|NCT00742001|524900355|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
145557499|NCT00742001|524900356|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
145557500|NCT00137423|524900357|FG000|Overall Study|Adverse Event|7|||
145557501|NCT00137423|524900358|FG001|Overall Study|Adverse Event|9|||
145557502|NCT00137423|524900357|FG000|Overall Study|consent withdrawn|1|||
145557503|NCT00137423|524900358|FG001|Overall Study|consent withdrawn|1|||
145557504|NCT00137423|524900357|FG000|Overall Study|Lack of Efficacy|31|||
145557505|NCT00137423|524900358|FG001|Overall Study|Lack of Efficacy|33|||
145557506|NCT00137423|524900357|FG000|Overall Study|Death|0|||
145557507|NCT00137423|524900358|FG001|Overall Study|Death|1|||
145557508|NCT04105998|524900360|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
145557509|NCT04105998|524900361|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
145557510|NCT01050257|524900362|FG000|Overall Study|Adverse Event|4|||
145557511|NCT01050257|524900363|FG001|Overall Study|Adverse Event|4|||
145557512|NCT01050257|524900364|FG002|Overall Study|Adverse Event|2|||
145557513|NCT01050257|524900362|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
145557514|NCT01050257|524900363|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
145557515|NCT01050257|524900364|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
145557516|NCT01050257|524900362|FG000|Overall Study|Withdrawal by Subject|0|||
145557517|NCT01050257|524900363|FG001|Overall Study|Withdrawal by Subject|3|||
145557518|NCT01050257|524900364|FG002|Overall Study|Withdrawal by Subject|0|||
145557519|NCT01050257|524900362|FG000|Overall Study|No reason specified|0|||
145557520|NCT01050257|524900363|FG001|Overall Study|No reason specified|0|||
145557521|NCT01050257|524900364|FG002|Overall Study|No reason specified|2|||
145292649|NCT00950807|523922212|FG009|Washout Period 2|Lack of Efficacy|0|||
145557522|NCT01050257|524900362|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
145616260|NCT01474512|525111309|FG014|Maintenance Period|Lost to Follow-up|0|||
145616261|NCT01474512|525111310|FG015|Maintenance Period|Lost to Follow-up|0|||
145616262|NCT01474512|525111311|FG016|Maintenance Period|Lost to Follow-up|0|||
145616263|NCT01474512|525111312|FG017|Maintenance Period|Lost to Follow-up|0|||
145616264|NCT01474512|525111295|FG000|Maintenance Period|Death|0|||
145616265|NCT01474512|525111296|FG001|Maintenance Period|Death|0|||
145616266|NCT01474512|525111297|FG002|Maintenance Period|Death|0|||
145616267|NCT01474512|525111298|FG003|Maintenance Period|Death|0|||
145616268|NCT01474512|525111299|FG004|Maintenance Period|Death|0|||
145616269|NCT01474512|525111300|FG005|Maintenance Period|Death|2|||
145616270|NCT01474512|525111301|FG006|Maintenance Period|Death|0|||
145616271|NCT01474512|525111302|FG007|Maintenance Period|Death|0|||
145616272|NCT01474512|525111303|FG008|Maintenance Period|Death|0|||
145616273|NCT01474512|525111304|FG009|Maintenance Period|Death|0|||
145616274|NCT01474512|525111305|FG010|Maintenance Period|Death|0|||
145616275|NCT01474512|525111306|FG011|Maintenance Period|Death|0|||
145616276|NCT01474512|525111307|FG012|Maintenance Period|Death|0|||
145616277|NCT01474512|525111308|FG013|Maintenance Period|Death|0|||
145616278|NCT01474512|525111309|FG014|Maintenance Period|Death|0|||
145616279|NCT01474512|525111310|FG015|Maintenance Period|Death|0|||
145616280|NCT01474512|525111311|FG016|Maintenance Period|Death|0|||
145616281|NCT01474512|525111312|FG017|Maintenance Period|Death|0|||
145616282|NCT01474512|525111295|FG000|Maintenance Period|Physician Decision|0|||
145557523|NCT01050257|524900363|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
145557524|NCT01050257|524900364|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
145616283|NCT01474512|525111296|FG001|Maintenance Period|Physician Decision|0|||
145616284|NCT01474512|525111297|FG002|Maintenance Period|Physician Decision|0|||
145616285|NCT01474512|525111298|FG003|Maintenance Period|Physician Decision|0|||
145616286|NCT01474512|525111299|FG004|Maintenance Period|Physician Decision|0|||
145557525|NCT01050257|524900362|FG000|Overall Study|Violation criteria|0|||
145557526|NCT01050257|524900363|FG001|Overall Study|Violation criteria|1|||
145557527|NCT01050257|524900364|FG002|Overall Study|Violation criteria|0|||
145557528|NCT01050257|524900362|FG000|Overall Study|Failure to return|0|||
145557529|NCT01050257|524900363|FG001|Overall Study|Failure to return|2|||
145557530|NCT01050257|524900364|FG002|Overall Study|Failure to return|0|||
145557531|NCT01050257|524900362|FG000|Overall Study|Death|0|||
145557532|NCT01050257|524900363|FG001|Overall Study|Death|0|||
145557533|NCT01050257|524900364|FG002|Overall Study|Death|1|||
145557534|NCT00171223|524900365|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
145557535|NCT00171223|524900366|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
145557536|NCT00171223|524900367|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
145557537|NCT00171223|524900365|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
145557538|NCT00171223|524900366|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
145557539|NCT00171223|524900367|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
145557540|NCT00171223|524900365|FG000|Overall Study|Abnormal Procedure|1|||
145557541|NCT00171223|524900366|FG001|Overall Study|Abnormal Procedure|0|||
145557542|NCT00171223|524900367|FG002|Overall Study|Abnormal Procedure|0|||
145557543|NCT00171223|524900365|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
145557544|NCT00171223|524900366|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
145557545|NCT00171223|524900367|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
145557546|NCT00171223|524900365|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
145557547|NCT00171223|524900366|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
145557548|NCT00171223|524900367|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
145557549|NCT00171223|524900365|FG000|Overall Study|Protocol Violation|2|||
145557550|NCT00171223|524900366|FG001|Overall Study|Protocol Violation|2|||
145557551|NCT00171223|524900367|FG002|Overall Study|Protocol Violation|3|||
145557552|NCT00171223|524900365|FG000|Overall Study|Participant Withdrew Consent|12|||
145557553|NCT00171223|524900366|FG001|Overall Study|Participant Withdrew Consent|21|||
145557554|NCT00171223|524900367|FG002|Overall Study|Participant Withdrew Consent|15|||
145557555|NCT00171223|524900365|FG000|Overall Study|Lost to Follow-up|5|||
145557556|NCT00171223|524900366|FG001|Overall Study|Lost to Follow-up|2|||
145557557|NCT00171223|524900367|FG002|Overall Study|Lost to Follow-up|3|||
145557558|NCT00171223|524900365|FG000|Overall Study|Administrative Problems|4|||
145557559|NCT00171223|524900366|FG001|Overall Study|Administrative Problems|7|||
145557560|NCT00171223|524900367|FG002|Overall Study|Administrative Problems|6|||
145557561|NCT00171223|524900365|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
145557562|NCT00171223|524900366|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
145557563|NCT00171223|524900367|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
145557564|NCT00171223|524900365|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
145557565|NCT00171223|524900366|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
145557566|NCT00171223|524900367|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
145557567|NCT02604212|524900369|FG000|Overall Study|Study Terminated by Sponsor|2|||
145557568|NCT02604212|524900370|FG001|Overall Study|Study Terminated by Sponsor|1|||
145557569|NCT02604212|524900371|FG002|Overall Study|Study Terminated by Sponsor|3|||
145557570|NCT02604212|524900372|FG003|Overall Study|Study Terminated by Sponsor|3|||
145557571|NCT02604212|524900369|FG000|Overall Study|Withdrawal by Subject|0|||
145557572|NCT02604212|524900370|FG001|Overall Study|Withdrawal by Subject|0|||
145557573|NCT02604212|524900371|FG002|Overall Study|Withdrawal by Subject|1|||
145557574|NCT02604212|524900372|FG003|Overall Study|Withdrawal by Subject|0|||
145557575|NCT00278109|524900373|FG000|Overall Study|Adverse Event|3|||
145557576|NCT00278109|524900373|FG000|Overall Study|social circumstances|1|||
145557577|NCT02580357|524900374|FG000|Overall Study|Lost to Follow-up|2|||
145557578|NCT02580357|524900375|FG001|Overall Study|Lost to Follow-up|0|||
145557579|NCT02580357|524900376|FG002|Overall Study|Lost to Follow-up|0|||
145557580|NCT02580357|524900374|FG000|Overall Study|Protocol Violation|1|||
145557581|NCT02580357|524900375|FG001|Overall Study|Protocol Violation|0|||
145557582|NCT02580357|524900376|FG002|Overall Study|Protocol Violation|0|||
145557583|NCT00383149|524900392|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
145557584|NCT00383149|524900392|FG000|Overall Study|Death|2|||
145557585|NCT00383149|524900392|FG000|Overall Study|Disease Progression|38|||
145557586|NCT00383149|524900392|FG000|Overall Study|Lost to Follow-up|1|||
145557587|NCT00383149|524900392|FG000|Overall Study|Other|1|||
145557588|NCT00383149|524900392|FG000|Overall Study|Study Drug Toxicity|4|||
145557589|NCT00383149|524900392|FG000|Overall Study|Request to Discontinue Treatment|4|||
145557590|NCT00383149|524900392|FG000|Overall Study|Participant Withdrew Consent|1|||
145557591|NCT00453544|524900393|FG000|Overall Study|Withdrawal by Subject|1|||
145557592|NCT00453544|524900394|FG001|Overall Study|Withdrawal by Subject|0|||
145557593|NCT00453544|524900395|FG002|Overall Study|Withdrawal by Subject|0|||
145557594|NCT00453544|524900396|FG003|Overall Study|Withdrawal by Subject|0|||
145557595|NCT00453544|524900393|FG000|Overall Study|Primary outcome measure not completed|1|||
145557596|NCT00453544|524900394|FG001|Overall Study|Primary outcome measure not completed|1|||
145557597|NCT00453544|524900395|FG002|Overall Study|Primary outcome measure not completed|0|||
145557598|NCT00453544|524900396|FG003|Overall Study|Primary outcome measure not completed|1|||
145557599|NCT03721276|524900399|FG000|Overall Study|Lost to Follow-up|5|||
145557600|NCT03721276|524900400|FG001|Overall Study|Lost to Follow-up|3|||
145557601|NCT03721276|524900399|FG000|Overall Study|Adverse Event|0|||
145557602|NCT03721276|524900400|FG001|Overall Study|Adverse Event|1|||
145557603|NCT00450333|524900401|FG000|Overall Study|Study terminated|47|||
145557604|NCT00450333|524900402|FG001|Overall Study|Study terminated|54|||
145557605|NCT00450333|524900403|FG002|Overall Study|Study terminated|16|||
145557606|NCT00450333|524900404|FG003|Overall Study|Study terminated|21|||
145557607|NCT00450333|524900401|FG000|Overall Study|Adverse Event|1|||
145557608|NCT00450333|524900402|FG001|Overall Study|Adverse Event|7|||
145557609|NCT00450333|524900403|FG002|Overall Study|Adverse Event|2|||
145557610|NCT00450333|524900404|FG003|Overall Study|Adverse Event|2|||
145557611|NCT00450333|524900401|FG000|Overall Study|Protocol Violation|1|||
145557612|NCT00450333|524900402|FG001|Overall Study|Protocol Violation|0|||
145557613|NCT00450333|524900403|FG002|Overall Study|Protocol Violation|1|||
145557614|NCT00450333|524900404|FG003|Overall Study|Protocol Violation|0|||
145557615|NCT00450333|524900401|FG000|Overall Study|Withdrawal by Subject|1|||
145557616|NCT00450333|524900402|FG001|Overall Study|Withdrawal by Subject|0|||
145557617|NCT00450333|524900403|FG002|Overall Study|Withdrawal by Subject|3|||
145557618|NCT00450333|524900404|FG003|Overall Study|Withdrawal by Subject|0|||
145557619|NCT00450333|524900401|FG000|Overall Study|Kidney transplant|1|||
145557620|NCT00450333|524900402|FG001|Overall Study|Kidney transplant|0|||
145557621|NCT00450333|524900403|FG002|Overall Study|Kidney transplant|1|||
145557622|NCT00450333|524900404|FG003|Overall Study|Kidney transplant|3|||
145557623|NCT00450333|524900401|FG000|Overall Study|Death|3|||
145557624|NCT00450333|524900402|FG001|Overall Study|Death|2|||
145557625|NCT00450333|524900403|FG002|Overall Study|Death|2|||
145557626|NCT00450333|524900404|FG003|Overall Study|Death|2|||
145557627|NCT01340898|524900409|FG000|Primary Phase|Serious Adverse Events|0|||
145557628|NCT01340898|524900410|FG001|Primary Phase|Serious Adverse Events|0|||
145557629|NCT01340898|524900411|FG002|Primary Phase|Serious Adverse Events|1|||
145557630|NCT01340898|524900409|FG000|Primary Phase|Withdrawal by Subject|8|||
145557631|NCT01340898|524900410|FG001|Primary Phase|Withdrawal by Subject|7|||
145557632|NCT01340898|524900411|FG002|Primary Phase|Withdrawal by Subject|5|||
145557633|NCT01340898|524900409|FG000|Primary Phase|Migrated/moved from study area|4|||
145557634|NCT01340898|524900410|FG001|Primary Phase|Migrated/moved from study area|1|||
145557635|NCT01340898|524900411|FG002|Primary Phase|Migrated/moved from study area|0|||
145557636|NCT01340898|524900409|FG000|Primary Phase|Lost to Follow-up|4|||
145557637|NCT01340898|524900410|FG001|Primary Phase|Lost to Follow-up|1|||
145557638|NCT01340898|524900411|FG002|Primary Phase|Lost to Follow-up|0|||
145557639|NCT01340898|524900409|FG000|Booster Phase|Withdrawal by Subject|3|||
145557640|NCT01340898|524900410|FG001|Booster Phase|Withdrawal by Subject|0|||
145557641|NCT01340898|524900411|FG002|Booster Phase|Withdrawal by Subject|4|||
145557642|NCT01340898|524900409|FG000|Booster Phase|Migrated/moved from study area|3|||
145557643|NCT01340898|524900410|FG001|Booster Phase|Migrated/moved from study area|0|||
145557644|NCT01340898|524900411|FG002|Booster Phase|Migrated/moved from study area|0|||
145557645|NCT01340898|524900409|FG000|Booster Phase|Lost to Follow-up|4|||
145557646|NCT01340898|524900410|FG001|Booster Phase|Lost to Follow-up|2|||
145557647|NCT01340898|524900411|FG002|Booster Phase|Lost to Follow-up|3|||
145557648|NCT01214629|524900413|FG000|Overall Study|Progressive Disease|1|||
145557649|NCT01214629|524900414|FG001|Overall Study|Progressive Disease|1|||
145557650|NCT01214629|524900415|FG002|Overall Study|Progressive Disease|0|||
145557651|NCT01214629|524900416|FG003|Overall Study|Progressive Disease|1|||
145557652|NCT01214629|524900417|FG004|Overall Study|Progressive Disease|2|||
145557653|NCT01214629|524900418|FG005|Overall Study|Progressive Disease|3|||
145557654|NCT01214629|524900419|FG006|Overall Study|Progressive Disease|1|||
145557655|NCT01214629|524900420|FG007|Overall Study|Progressive Disease|1|||
145557656|NCT01214629|524900421|FG008|Overall Study|Progressive Disease|1|||
145557657|NCT01214629|524900422|FG009|Overall Study|Progressive Disease|5|||
145557658|NCT01214629|524900423|FG010|Overall Study|Progressive Disease|1|||
145557659|NCT01214629|524900413|FG000|Overall Study|Adverse Event|0|||
145557660|NCT01214629|524900414|FG001|Overall Study|Adverse Event|0|||
145557661|NCT01214629|524900415|FG002|Overall Study|Adverse Event|0|||
145557662|NCT01214629|524900416|FG003|Overall Study|Adverse Event|1|||
145557663|NCT01214629|524900417|FG004|Overall Study|Adverse Event|0|||
145557664|NCT01214629|524900418|FG005|Overall Study|Adverse Event|1|||
145557665|NCT01214629|524900419|FG006|Overall Study|Adverse Event|0|||
145557666|NCT01214629|524900420|FG007|Overall Study|Adverse Event|0|||
145557667|NCT01214629|524900421|FG008|Overall Study|Adverse Event|0|||
145557668|NCT01214629|524900422|FG009|Overall Study|Adverse Event|1|||
145616287|NCT01474512|525111300|FG005|Maintenance Period|Physician Decision|1|||
145616288|NCT01474512|525111301|FG006|Maintenance Period|Physician Decision|0|||
145616289|NCT01474512|525111302|FG007|Maintenance Period|Physician Decision|2|||
145616290|NCT01474512|525111303|FG008|Maintenance Period|Physician Decision|0|||
145616291|NCT01474512|525111304|FG009|Maintenance Period|Physician Decision|0|||
145616292|NCT01474512|525111305|FG010|Maintenance Period|Physician Decision|0|||
145616293|NCT01474512|525111306|FG011|Maintenance Period|Physician Decision|0|||
145616294|NCT01474512|525111307|FG012|Maintenance Period|Physician Decision|0|||
145616295|NCT01474512|525111308|FG013|Maintenance Period|Physician Decision|0|||
145616296|NCT01474512|525111309|FG014|Maintenance Period|Physician Decision|0|||
145616297|NCT01474512|525111310|FG015|Maintenance Period|Physician Decision|0|||
145616298|NCT01474512|525111311|FG016|Maintenance Period|Physician Decision|0|||
145616299|NCT01474512|525111312|FG017|Maintenance Period|Physician Decision|0|||
145616300|NCT01474512|525111295|FG000|Maintenance Period|Clinical Relapse|0|||
145616301|NCT01474512|525111296|FG001|Maintenance Period|Clinical Relapse|0|||
145616302|NCT01474512|525111297|FG002|Maintenance Period|Clinical Relapse|0|||
145616303|NCT01474512|525111298|FG003|Maintenance Period|Clinical Relapse|1|||
145616304|NCT01474512|525111299|FG004|Maintenance Period|Clinical Relapse|0|||
145616305|NCT01474512|525111300|FG005|Maintenance Period|Clinical Relapse|0|||
145616306|NCT01474512|525111301|FG006|Maintenance Period|Clinical Relapse|0|||
145616307|NCT01474512|525111302|FG007|Maintenance Period|Clinical Relapse|0|||
145616308|NCT01474512|525111303|FG008|Maintenance Period|Clinical Relapse|0|||
145616309|NCT01474512|525111304|FG009|Maintenance Period|Clinical Relapse|0|||
145616310|NCT01474512|525111305|FG010|Maintenance Period|Clinical Relapse|0|||
145616311|NCT01474512|525111306|FG011|Maintenance Period|Clinical Relapse|0|||
145616312|NCT01474512|525111307|FG012|Maintenance Period|Clinical Relapse|0|||
145616313|NCT01474512|525111308|FG013|Maintenance Period|Clinical Relapse|0|||
145616314|NCT01474512|525111309|FG014|Maintenance Period|Clinical Relapse|0|||
145616315|NCT01474512|525111310|FG015|Maintenance Period|Clinical Relapse|0|||
145616316|NCT01474512|525111311|FG016|Maintenance Period|Clinical Relapse|0|||
145616317|NCT01474512|525111312|FG017|Maintenance Period|Clinical Relapse|0|||
145616318|NCT01474512|525111295|FG000|Maintenance Period|Lack of Efficacy|0|||
145616319|NCT01474512|525111296|FG001|Maintenance Period|Lack of Efficacy|0|||
145616320|NCT01474512|525111297|FG002|Maintenance Period|Lack of Efficacy|0|||
145616321|NCT01474512|525111298|FG003|Maintenance Period|Lack of Efficacy|1|||
145616322|NCT01474512|525111299|FG004|Maintenance Period|Lack of Efficacy|0|||
145616323|NCT01474512|525111300|FG005|Maintenance Period|Lack of Efficacy|0|||
145616324|NCT01474512|525111301|FG006|Maintenance Period|Lack of Efficacy|0|||
145616325|NCT01474512|525111302|FG007|Maintenance Period|Lack of Efficacy|11|||
145616326|NCT01474512|525111303|FG008|Maintenance Period|Lack of Efficacy|11|||
145616327|NCT01474512|525111304|FG009|Maintenance Period|Lack of Efficacy|12|||
145616328|NCT01474512|525111305|FG010|Maintenance Period|Lack of Efficacy|0|||
145616329|NCT01474512|525111306|FG011|Maintenance Period|Lack of Efficacy|0|||
145616330|NCT01474512|525111307|FG012|Maintenance Period|Lack of Efficacy|0|||
145616331|NCT01474512|525111308|FG013|Maintenance Period|Lack of Efficacy|0|||
145616332|NCT01474512|525111309|FG014|Maintenance Period|Lack of Efficacy|0|||
145616333|NCT01474512|525111310|FG015|Maintenance Period|Lack of Efficacy|0|||
145616334|NCT01474512|525111311|FG016|Maintenance Period|Lack of Efficacy|0|||
145616335|NCT01474512|525111312|FG017|Maintenance Period|Lack of Efficacy|0|||
145616336|NCT01474512|525111295|FG000|Maintenance Period|Protocol Violation|0|||
145616337|NCT01474512|525111296|FG001|Maintenance Period|Protocol Violation|0|||
145616338|NCT01474512|525111297|FG002|Maintenance Period|Protocol Violation|0|||
145616339|NCT01474512|525111298|FG003|Maintenance Period|Protocol Violation|1|||
145616340|NCT01474512|525111299|FG004|Maintenance Period|Protocol Violation|0|||
145616341|NCT01474512|525111300|FG005|Maintenance Period|Protocol Violation|0|||
145616342|NCT01474512|525111301|FG006|Maintenance Period|Protocol Violation|0|||
145616343|NCT01474512|525111302|FG007|Maintenance Period|Protocol Violation|1|||
145616344|NCT01474512|525111303|FG008|Maintenance Period|Protocol Violation|0|||
145616345|NCT01474512|525111304|FG009|Maintenance Period|Protocol Violation|1|||
145616346|NCT01474512|525111305|FG010|Maintenance Period|Protocol Violation|0|||
145616347|NCT01474512|525111306|FG011|Maintenance Period|Protocol Violation|0|||
145616348|NCT01474512|525111307|FG012|Maintenance Period|Protocol Violation|0|||
145616349|NCT01474512|525111308|FG013|Maintenance Period|Protocol Violation|0|||
145616350|NCT01474512|525111309|FG014|Maintenance Period|Protocol Violation|0|||
145616351|NCT01474512|525111310|FG015|Maintenance Period|Protocol Violation|0|||
145616352|NCT01474512|525111311|FG016|Maintenance Period|Protocol Violation|0|||
145616353|NCT01474512|525111312|FG017|Maintenance Period|Protocol Violation|0|||
145616354|NCT01474512|525111295|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
145616355|NCT01474512|525111296|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
145616356|NCT01474512|525111297|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
145616357|NCT01474512|525111298|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
145616358|NCT01474512|525111299|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
145616359|NCT01474512|525111300|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
145616360|NCT01474512|525111301|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
145616361|NCT01474512|525111302|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
145616362|NCT01474512|525111303|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
145616363|NCT01474512|525111304|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
145616364|NCT01474512|525111305|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
145407442|NCT03806296|524346998|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
145616365|NCT01474512|525111306|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
145616366|NCT01474512|525111307|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
145616367|NCT01474512|525111308|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
145616368|NCT01474512|525111309|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
145616369|NCT01474512|525111310|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
145616370|NCT01474512|525111311|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
145616371|NCT01474512|525111312|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
145616372|NCT01474512|525111295|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
145616373|NCT01474512|525111296|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
145616374|NCT01474512|525111297|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
145616375|NCT01474512|525111298|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
145616376|NCT01474512|525111299|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
145616377|NCT01474512|525111300|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
145616378|NCT01474512|525111301|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
145616379|NCT01474512|525111302|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
145616380|NCT01474512|525111303|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
145616381|NCT01474512|525111304|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
145616382|NCT01474512|525111305|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
145616383|NCT01474512|525111306|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
145616384|NCT01474512|525111307|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
145616385|NCT01474512|525111308|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
145616386|NCT01474512|525111309|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
145616387|NCT01474512|525111310|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
145616388|NCT01474512|525111311|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
145616389|NCT01474512|525111312|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
145616390|NCT01474512|525111295|FG000|Long-Term Extension Period|Adverse Event|0|||
145616391|NCT01474512|525111296|FG001|Long-Term Extension Period|Adverse Event|0|||
145616392|NCT01474512|525111297|FG002|Long-Term Extension Period|Adverse Event|0|||
145616393|NCT01474512|525111298|FG003|Long-Term Extension Period|Adverse Event|0|||
145616394|NCT01474512|525111299|FG004|Long-Term Extension Period|Adverse Event|0|||
145616395|NCT01474512|525111300|FG005|Long-Term Extension Period|Adverse Event|0|||
145616396|NCT01474512|525111301|FG006|Long-Term Extension Period|Adverse Event|0|||
145616397|NCT01474512|525111302|FG007|Long-Term Extension Period|Adverse Event|0|||
145616398|NCT01474512|525111303|FG008|Long-Term Extension Period|Adverse Event|0|||
145616399|NCT01474512|525111304|FG009|Long-Term Extension Period|Adverse Event|0|||
145616400|NCT01474512|525111305|FG010|Long-Term Extension Period|Adverse Event|0|||
145616401|NCT01474512|525111306|FG011|Long-Term Extension Period|Adverse Event|1|||
145616402|NCT01474512|525111307|FG012|Long-Term Extension Period|Adverse Event|57|||
145616403|NCT01474512|525111308|FG013|Long-Term Extension Period|Adverse Event|58|||
145616404|NCT01474512|525111309|FG014|Long-Term Extension Period|Adverse Event|0|||
145616405|NCT01474512|525111310|FG015|Long-Term Extension Period|Adverse Event|0|||
145616406|NCT01474512|525111311|FG016|Long-Term Extension Period|Adverse Event|0|||
145616407|NCT01474512|525111312|FG017|Long-Term Extension Period|Adverse Event|0|||
145616408|NCT01474512|525111295|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
145616409|NCT01474512|525111296|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
145616410|NCT01474512|525111297|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
145616411|NCT01474512|525111298|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
145557669|NCT01214629|524900423|FG010|Overall Study|Adverse Event|0|||
145557670|NCT01214629|524900413|FG000|Overall Study|Physician Decision|0|||
145557671|NCT01214629|524900414|FG001|Overall Study|Physician Decision|0|||
145557672|NCT01214629|524900415|FG002|Overall Study|Physician Decision|0|||
145557673|NCT01214629|524900416|FG003|Overall Study|Physician Decision|0|||
145557674|NCT01214629|524900417|FG004|Overall Study|Physician Decision|0|||
145557675|NCT01214629|524900418|FG005|Overall Study|Physician Decision|0|||
145557676|NCT01214629|524900419|FG006|Overall Study|Physician Decision|0|||
145557677|NCT01214629|524900420|FG007|Overall Study|Physician Decision|0|||
145557678|NCT01214629|524900421|FG008|Overall Study|Physician Decision|0|||
145557679|NCT01214629|524900422|FG009|Overall Study|Physician Decision|0|||
145557680|NCT01214629|524900423|FG010|Overall Study|Physician Decision|1|||
145557681|NCT01214629|524900413|FG000|Overall Study|Withdrawal by Subject|0|||
145557682|NCT01214629|524900414|FG001|Overall Study|Withdrawal by Subject|0|||
145557683|NCT01214629|524900415|FG002|Overall Study|Withdrawal by Subject|0|||
145557684|NCT01214629|524900416|FG003|Overall Study|Withdrawal by Subject|0|||
145557685|NCT01214629|524900417|FG004|Overall Study|Withdrawal by Subject|0|||
145557686|NCT01214629|524900418|FG005|Overall Study|Withdrawal by Subject|0|||
145557687|NCT01214629|524900419|FG006|Overall Study|Withdrawal by Subject|0|||
145557688|NCT01214629|524900420|FG007|Overall Study|Withdrawal by Subject|0|||
145557689|NCT01214629|524900421|FG008|Overall Study|Withdrawal by Subject|0|||
145557690|NCT01214629|524900422|FG009|Overall Study|Withdrawal by Subject|1|||
145616412|NCT01474512|525111299|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
145616413|NCT01474512|525111300|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
145616414|NCT01474512|525111301|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
145616415|NCT01474512|525111302|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
145616416|NCT01474512|525111303|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
145616417|NCT01474512|525111304|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
145616418|NCT01474512|525111305|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
145616419|NCT01474512|525111306|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
145616420|NCT01474512|525111307|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
145616421|NCT01474512|525111308|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
145616422|NCT01474512|525111309|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
145616423|NCT01474512|525111310|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
145616424|NCT01474512|525111311|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
145616425|NCT01474512|525111312|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
145616426|NCT01474512|525111295|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
145616427|NCT01474512|525111296|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
145616428|NCT01474512|525111297|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
145616429|NCT01474512|525111298|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
145616430|NCT01474512|525111299|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
145616431|NCT01474512|525111300|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
145616432|NCT01474512|525111301|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
145616433|NCT01474512|525111302|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
145616434|NCT01474512|525111303|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
145616435|NCT01474512|525111304|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
145292650|NCT00950807|523922203|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145292651|NCT00950807|523922204|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
145616436|NCT01474512|525111305|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
145616437|NCT01474512|525111306|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
145616438|NCT01474512|525111307|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
145616439|NCT01474512|525111308|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
145616440|NCT01474512|525111309|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
145557691|NCT01214629|524900423|FG010|Overall Study|Withdrawal by Subject|0|||
145557692|NCT00416078|524900429|FG000|Overall Study|Death|3|||
145557693|NCT00416078|524900430|FG001|Overall Study|Death|4|||
145557694|NCT00416078|524900429|FG000|Overall Study|Withdrawal by Subject|3|||
145557695|NCT00416078|524900430|FG001|Overall Study|Withdrawal by Subject|2|||
145557696|NCT00416078|524900429|FG000|Overall Study|Physician Decision|1|||
145557697|NCT00416078|524900430|FG001|Overall Study|Physician Decision|0|||
145557698|NCT00416078|524900429|FG000|Overall Study|Lost to Follow-up|4|||
145557699|NCT00416078|524900430|FG001|Overall Study|Lost to Follow-up|2|||
145557700|NCT01829230|524900431|FG000|Overall Study|Protocol Violation|0|||
145557701|NCT01829230|524900432|FG001|Overall Study|Protocol Violation|2|||
145557702|NCT01829230|524900431|FG000|Overall Study|Withdrawal by Subject|0|||
145557703|NCT01829230|524900432|FG001|Overall Study|Withdrawal by Subject|1|||
145557704|NCT01829230|524900431|FG000|Overall Study|Lost to Follow-up|1|||
145557705|NCT01829230|524900432|FG001|Overall Study|Lost to Follow-up|1|||
145557706|NCT04128267|524900434|FG000|Overall Study|Withdrawal by Subject|6|||
145557707|NCT04128267|524900434|FG000|Overall Study|Death|2|||
145557708|NCT04128267|524900434|FG000|Overall Study|Disease progression|1|||
145557709|NCT04128267|524900434|FG000|Overall Study|Participant had other medical issues|4|||
145557710|NCT04128267|524900434|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
145557711|NCT04501666|524900435|FG000|Overall Study|Physician Decision|0|||
145557712|NCT04501666|524900436|FG001|Overall Study|Physician Decision|1|||
145557713|NCT04501666|524900435|FG000|Overall Study|Adverse Event|12|||
145557714|NCT04501666|524900436|FG001|Overall Study|Adverse Event|4|||
145557715|NCT04501666|524900435|FG000|Overall Study|Subject's request|10|||
145557716|NCT04501666|524900436|FG001|Overall Study|Subject's request|6|||
145557717|NCT04501666|524900435|FG000|Overall Study|Protocol Deviation|2|||
145557718|NCT04501666|524900436|FG001|Overall Study|Protocol Deviation|1|||
145557719|NCT04501666|524900435|FG000|Overall Study|Other-- site permanently closing|0|||
145557720|NCT04501666|524900436|FG001|Overall Study|Other-- site permanently closing|1|||
145557721|NCT00553150|524900437|FG000|Overall Study|Withdrawal by Subject|0|||
145557722|NCT00553150|524900438|FG001|Overall Study|Withdrawal by Subject|0|||
145557723|NCT00553150|524900439|FG002|Overall Study|Withdrawal by Subject|0|||
145557724|NCT00553150|524900440|FG003|Overall Study|Withdrawal by Subject|2|||
145557725|NCT00553150|524900437|FG000|Overall Study|Protocol Violation|0|||
145557726|NCT00553150|524900438|FG001|Overall Study|Protocol Violation|0|||
145557727|NCT00553150|524900439|FG002|Overall Study|Protocol Violation|0|||
145557728|NCT00553150|524900440|FG003|Overall Study|Protocol Violation|1|||
145557729|NCT00553150|524900437|FG000|Overall Study|Ineligible|0|||
145557730|NCT00553150|524900438|FG001|Overall Study|Ineligible|0|||
145557731|NCT00553150|524900439|FG002|Overall Study|Ineligible|0|||
145557732|NCT00553150|524900440|FG003|Overall Study|Ineligible|1|||
145557733|NCT03761147|524900441|FG000|Overall Study|Withdrawal by Subject|6|||
145557734|NCT03761147|524900442|FG001|Overall Study|Withdrawal by Subject|1|||
145557735|NCT03761147|524900441|FG000|Overall Study|Adverse Event|1|||
145557736|NCT03761147|524900442|FG001|Overall Study|Adverse Event|3|||
145557737|NCT01026792|524900445|FG000|Overall Study|Protocol Violation|1|||
145557738|NCT03204305|524900446|FG000|Overall Study|Lost to Follow-up|6|||
145557739|NCT03204305|524900447|FG001|Overall Study|Lost to Follow-up|4|||
145557740|NCT03204305|524900448|FG002|Overall Study|Lost to Follow-up|0|||
145557741|NCT03204305|524900449|FG003|Overall Study|Lost to Follow-up|0|||
145557742|NCT03204305|524900446|FG000|Overall Study|Physician Decision|1|||
145557743|NCT03204305|524900447|FG001|Overall Study|Physician Decision|0|||
145557744|NCT03204305|524900448|FG002|Overall Study|Physician Decision|0|||
145557745|NCT03204305|524900449|FG003|Overall Study|Physician Decision|0|||
145557746|NCT03204305|524900446|FG000|Overall Study|failure to place arterial line|2|||
145557747|NCT03204305|524900447|FG001|Overall Study|failure to place arterial line|1|||
145557748|NCT03204305|524900448|FG002|Overall Study|failure to place arterial line|0|||
145557749|NCT03204305|524900449|FG003|Overall Study|failure to place arterial line|0|||
145557750|NCT03204305|524900446|FG000|Overall Study|Withdrawal by Subject|2|||
145557751|NCT03204305|524900447|FG001|Overall Study|Withdrawal by Subject|0|||
145557752|NCT03204305|524900448|FG002|Overall Study|Withdrawal by Subject|0|||
145557753|NCT03204305|524900449|FG003|Overall Study|Withdrawal by Subject|0|||
145557754|NCT01165554|524900450|FG000|Overall Study|Withdrawal by Subject|23|||
145557755|NCT02953314|524900454|FG000|Overall Study|Adverse Event|0|||
145557756|NCT02953314|524900455|FG001|Overall Study|Adverse Event|1|||
145557757|NCT02953314|524900454|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
145557758|NCT02953314|524900455|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
145557759|NCT00535223|524900456|FG000|Overall Study|Withdrawal by Subject|4|||
145557760|NCT00535223|524900457|FG001|Overall Study|Withdrawal by Subject|1|||
145557761|NCT00101907|524900461|FG000|Overall Study|Adverse Event|1|||
145557762|NCT00101907|524900462|FG001|Overall Study|Adverse Event|0|||
145557763|NCT00101907|524900463|FG002|Overall Study|Adverse Event|0|||
145557764|NCT00101907|524900464|FG003|Overall Study|Adverse Event|0|||
145557765|NCT00101907|524900465|FG004|Overall Study|Adverse Event|0|||
145557766|NCT00101907|524900466|FG005|Overall Study|Adverse Event|0|||
145557767|NCT00101907|524900461|FG000|Overall Study|Death|0|||
145557768|NCT00101907|524900462|FG001|Overall Study|Death|1|||
145557769|NCT00101907|524900463|FG002|Overall Study|Death|0|||
145557770|NCT00101907|524900464|FG003|Overall Study|Death|0|||
145557771|NCT00101907|524900465|FG004|Overall Study|Death|3|||
145557772|NCT00101907|524900466|FG005|Overall Study|Death|0|||
145557773|NCT00101907|524900461|FG000|Overall Study|Physician Decision|0|||
145557774|NCT00101907|524900462|FG001|Overall Study|Physician Decision|0|||
145557775|NCT00101907|524900463|FG002|Overall Study|Physician Decision|0|||
145557776|NCT00101907|524900464|FG003|Overall Study|Physician Decision|1|||
145557777|NCT00101907|524900465|FG004|Overall Study|Physician Decision|1|||
145557778|NCT00101907|524900466|FG005|Overall Study|Physician Decision|0|||
145557779|NCT00101907|524900461|FG000|Overall Study|Withdrawal by Subject|1|||
145557780|NCT00101907|524900462|FG001|Overall Study|Withdrawal by Subject|0|||
145557781|NCT00101907|524900463|FG002|Overall Study|Withdrawal by Subject|1|||
145557782|NCT00101907|524900464|FG003|Overall Study|Withdrawal by Subject|0|||
145557783|NCT00101907|524900465|FG004|Overall Study|Withdrawal by Subject|1|||
145557784|NCT00101907|524900466|FG005|Overall Study|Withdrawal by Subject|0|||
145557785|NCT01765153|524900467|FG000|Training Phase 1|Format of intervention differed|1|||
145557786|NCT01765153|524900468|FG001|Training Phase 1|Format of intervention differed|0|||
145557787|NCT01765153|524900467|FG000|Training Phase 1|Poor participation in intervention|0|||
145557788|NCT01765153|524900468|FG001|Training Phase 1|Poor participation in intervention|1|||
145557789|NCT01765153|524900467|FG000|Rest Phase 1|Withdrawal by Subject|0|||
145557790|NCT01765153|524900468|FG001|Rest Phase 1|Withdrawal by Subject|1|||
145557791|NCT01765153|524900467|FG000|Training Phase 2|Withdrawal by Subject|0|||
145557792|NCT01765153|524900468|FG001|Training Phase 2|Withdrawal by Subject|1|||
145557793|NCT01765153|524900467|FG000|Rest Phase 2|Lost to Follow-up|2|||
145557794|NCT01765153|524900468|FG001|Rest Phase 2|Lost to Follow-up|1|||
145557795|NCT03915496|524900471|FG000|Overall Study|Adverse Event|2|||
145557796|NCT03915496|524900472|FG001|Overall Study|Adverse Event|1|||
145557797|NCT03915496|524900473|FG002|Overall Study|Adverse Event|2|||
145557798|NCT02663674|524900474|FG000|Overall Study|Lost to Follow-up|5|||
145557799|NCT02663674|524900475|FG001|Overall Study|Lost to Follow-up|4|||
145557800|NCT02663674|524900474|FG000|Overall Study|Withdrawal by Subject|1|||
145557801|NCT02663674|524900475|FG001|Overall Study|Withdrawal by Subject|4|||
145557802|NCT02663674|524900474|FG000|Overall Study|Physician Decision|1|||
145557803|NCT02663674|524900475|FG001|Overall Study|Physician Decision|1|||
145557804|NCT02663674|524900474|FG000|Overall Study|Other Event (Health Related)|0|||
145557805|NCT02663674|524900475|FG001|Overall Study|Other Event (Health Related)|1|||
145557806|NCT04219891|524900477|FG000|Overall Study|Lost to Follow-up|3|||
145557807|NCT04219891|524900477|FG000|Overall Study|Withdrawal by Subject|2|||
145557808|NCT04708886|524901365|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
145557809|NCT04708886|524901365|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
145557810|NCT01372501|524901370|FG000|Overall Study|Adverse Event|4|||
145557811|NCT01372501|524901370|FG000|Overall Study|Device migration|1|||
145557812|NCT05333900|524901371|FG000|Overall Study|Protocol Violation|0|||
145557813|NCT05333900|524901372|FG001|Overall Study|Protocol Violation|1|||
145557814|NCT05333900|524901371|FG000|Overall Study|Withdrawal by Subject|0|||
145557815|NCT05333900|524901372|FG001|Overall Study|Withdrawal by Subject|1|||
145557816|NCT05333900|524901371|FG000|Overall Study|COVID-19 Pandemic|1|||
145557817|NCT05333900|524901372|FG001|Overall Study|COVID-19 Pandemic|1|||
145557818|NCT01277523|524901375|FG000|Overall Study|Adverse Event|1|||
145557819|NCT01277523|524901376|FG001|Overall Study|Adverse Event|0|||
145557820|NCT01277523|524901377|FG002|Overall Study|Adverse Event|0|||
145557821|NCT01277523|524901375|FG000|Overall Study|Protocol Violation|2|||
145557822|NCT01277523|524901376|FG001|Overall Study|Protocol Violation|0|||
145557823|NCT01277523|524901377|FG002|Overall Study|Protocol Violation|0|||
145557824|NCT01277523|524901375|FG000|Overall Study|Other Reason not Defined|0|||
145557825|NCT01277523|524901376|FG001|Overall Study|Other Reason not Defined|1|||
145557826|NCT01277523|524901377|FG002|Overall Study|Other Reason not Defined|0|||
145557827|NCT03724812|524901378|FG000|Overall Study|Missed Visit|1|||
145557828|NCT03724812|524901378|FG000|Overall Study|Death|2|||
145557829|NCT03724812|524901378|FG000|Overall Study|Withdrawal by Subject|1|||
145557830|NCT01851720|524901379|FG000|Overall Study|Lost to Follow-up|0|||
145557831|NCT01851720|524901380|FG001|Overall Study|Lost to Follow-up|1|||
145557832|NCT02389998|524901383|FG000|Overall Study|car accident|1|||
145557833|NCT02389998|524901384|FG001|Overall Study|car accident|0|||
145557834|NCT03525574|524901385|FG000|Overall Study|Adverse Event|15|||
145557835|NCT03525574|524901386|FG001|Overall Study|Adverse Event|0|||
145557836|NCT03525574|524901385|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
145557837|NCT03525574|524901386|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
145557838|NCT03525574|524901385|FG000|Overall Study|Lost to Follow-up|4|||
145557839|NCT03525574|524901386|FG001|Overall Study|Lost to Follow-up|0|||
145557840|NCT03525574|524901385|FG000|Overall Study|Commercial drug is Available for participant|48|||
145557841|NCT03525574|524901386|FG001|Overall Study|Commercial drug is Available for participant|0|||
145557842|NCT03525574|524901385|FG000|Overall Study|Death|1|||
145557843|NCT03525574|524901386|FG001|Overall Study|Death|0|||
145557844|NCT03525574|524901385|FG000|Overall Study|Other non-compliance|2|||
145557845|NCT03525574|524901386|FG001|Overall Study|Other non-compliance|0|||
145557846|NCT03525574|524901385|FG000|Overall Study|Physician Decision|6|||
145557847|NCT03525574|524901386|FG001|Overall Study|Physician Decision|0|||
145557848|NCT03525574|524901385|FG000|Overall Study|Other|58|||
145616441|NCT01474512|525111310|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
145616442|NCT01474512|525111311|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
145616443|NCT01474512|525111312|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
145616444|NCT01474512|525111295|FG000|Long-Term Extension Period|Physician Decision|0|||
145616445|NCT01474512|525111296|FG001|Long-Term Extension Period|Physician Decision|0|||
145616446|NCT01474512|525111297|FG002|Long-Term Extension Period|Physician Decision|0|||
145616447|NCT01474512|525111298|FG003|Long-Term Extension Period|Physician Decision|0|||
145616448|NCT01474512|525111299|FG004|Long-Term Extension Period|Physician Decision|0|||
145616449|NCT01474512|525111300|FG005|Long-Term Extension Period|Physician Decision|0|||
145616450|NCT01474512|525111301|FG006|Long-Term Extension Period|Physician Decision|0|||
145616451|NCT01474512|525111302|FG007|Long-Term Extension Period|Physician Decision|0|||
145616452|NCT01474512|525111303|FG008|Long-Term Extension Period|Physician Decision|0|||
145616453|NCT01474512|525111304|FG009|Long-Term Extension Period|Physician Decision|0|||
145616454|NCT01474512|525111305|FG010|Long-Term Extension Period|Physician Decision|0|||
145616455|NCT01474512|525111306|FG011|Long-Term Extension Period|Physician Decision|0|||
145616456|NCT01474512|525111307|FG012|Long-Term Extension Period|Physician Decision|21|||
145616457|NCT01474512|525111308|FG013|Long-Term Extension Period|Physician Decision|21|||
145616458|NCT01474512|525111309|FG014|Long-Term Extension Period|Physician Decision|0|||
145616459|NCT01474512|525111310|FG015|Long-Term Extension Period|Physician Decision|0|||
145616460|NCT01474512|525111311|FG016|Long-Term Extension Period|Physician Decision|0|||
145616461|NCT01474512|525111312|FG017|Long-Term Extension Period|Physician Decision|0|||
145616462|NCT01474512|525111295|FG000|Long-Term Extension Period|Clinical Relapse|0|||
145616463|NCT01474512|525111296|FG001|Long-Term Extension Period|Clinical Relapse|0|||
145616464|NCT01474512|525111297|FG002|Long-Term Extension Period|Clinical Relapse|0|||
145616465|NCT01474512|525111298|FG003|Long-Term Extension Period|Clinical Relapse|0|||
145616466|NCT01474512|525111299|FG004|Long-Term Extension Period|Clinical Relapse|0|||
145616467|NCT01474512|525111300|FG005|Long-Term Extension Period|Clinical Relapse|0|||
145616468|NCT01474512|525111301|FG006|Long-Term Extension Period|Clinical Relapse|0|||
145616469|NCT01474512|525111302|FG007|Long-Term Extension Period|Clinical Relapse|0|||
145616470|NCT01474512|525111303|FG008|Long-Term Extension Period|Clinical Relapse|0|||
145616471|NCT01474512|525111304|FG009|Long-Term Extension Period|Clinical Relapse|0|||
145616472|NCT01474512|525111305|FG010|Long-Term Extension Period|Clinical Relapse|0|||
145616473|NCT01474512|525111306|FG011|Long-Term Extension Period|Clinical Relapse|0|||
145616474|NCT01474512|525111307|FG012|Long-Term Extension Period|Clinical Relapse|9|||
145616475|NCT01474512|525111308|FG013|Long-Term Extension Period|Clinical Relapse|9|||
145616476|NCT01474512|525111309|FG014|Long-Term Extension Period|Clinical Relapse|0|||
145616477|NCT01474512|525111310|FG015|Long-Term Extension Period|Clinical Relapse|0|||
145616478|NCT01474512|525111311|FG016|Long-Term Extension Period|Clinical Relapse|0|||
145616479|NCT01474512|525111312|FG017|Long-Term Extension Period|Clinical Relapse|0|||
145616480|NCT01474512|525111295|FG000|Long-Term Extension Period|Death|0|||
145616481|NCT01474512|525111296|FG001|Long-Term Extension Period|Death|0|||
145616482|NCT01474512|525111297|FG002|Long-Term Extension Period|Death|0|||
145616483|NCT01474512|525111298|FG003|Long-Term Extension Period|Death|0|||
145616484|NCT01474512|525111299|FG004|Long-Term Extension Period|Death|0|||
145616485|NCT01474512|525111300|FG005|Long-Term Extension Period|Death|0|||
145616486|NCT01474512|525111301|FG006|Long-Term Extension Period|Death|0|||
145616487|NCT01474512|525111302|FG007|Long-Term Extension Period|Death|0|||
145616488|NCT01474512|525111303|FG008|Long-Term Extension Period|Death|0|||
145616489|NCT01474512|525111304|FG009|Long-Term Extension Period|Death|0|||
145616490|NCT01474512|525111305|FG010|Long-Term Extension Period|Death|0|||
145616491|NCT01474512|525111306|FG011|Long-Term Extension Period|Death|0|||
145616492|NCT01474512|525111307|FG012|Long-Term Extension Period|Death|9|||
145616493|NCT01474512|525111308|FG013|Long-Term Extension Period|Death|9|||
145616494|NCT01474512|525111309|FG014|Long-Term Extension Period|Death|0|||
145616495|NCT01474512|525111310|FG015|Long-Term Extension Period|Death|0|||
145616496|NCT01474512|525111311|FG016|Long-Term Extension Period|Death|0|||
145616497|NCT01474512|525111312|FG017|Long-Term Extension Period|Death|0|||
145616498|NCT01474512|525111295|FG000|Long-Term Extension Period|Sponsor Decision|0|||
145616499|NCT01474512|525111296|FG001|Long-Term Extension Period|Sponsor Decision|0|||
145616500|NCT01474512|525111297|FG002|Long-Term Extension Period|Sponsor Decision|0|||
145616501|NCT01474512|525111298|FG003|Long-Term Extension Period|Sponsor Decision|0|||
145616502|NCT01474512|525111299|FG004|Long-Term Extension Period|Sponsor Decision|0|||
145616503|NCT01474512|525111300|FG005|Long-Term Extension Period|Sponsor Decision|0|||
145616504|NCT01474512|525111301|FG006|Long-Term Extension Period|Sponsor Decision|0|||
145616505|NCT01474512|525111302|FG007|Long-Term Extension Period|Sponsor Decision|0|||
145616506|NCT01474512|525111303|FG008|Long-Term Extension Period|Sponsor Decision|0|||
145616507|NCT01474512|525111304|FG009|Long-Term Extension Period|Sponsor Decision|0|||
145616508|NCT01474512|525111305|FG010|Long-Term Extension Period|Sponsor Decision|0|||
145616509|NCT01474512|525111306|FG011|Long-Term Extension Period|Sponsor Decision|0|||
145616510|NCT01474512|525111307|FG012|Long-Term Extension Period|Sponsor Decision|6|||
145616511|NCT01474512|525111308|FG013|Long-Term Extension Period|Sponsor Decision|6|||
145616512|NCT01474512|525111309|FG014|Long-Term Extension Period|Sponsor Decision|0|||
145616513|NCT01474512|525111310|FG015|Long-Term Extension Period|Sponsor Decision|0|||
145616514|NCT01474512|525111311|FG016|Long-Term Extension Period|Sponsor Decision|0|||
145616515|NCT01474512|525111312|FG017|Long-Term Extension Period|Sponsor Decision|0|||
145616516|NCT01474512|525111295|FG000|Long-Term Extension Period|Protocol Violation|0|||
145616517|NCT01474512|525111296|FG001|Long-Term Extension Period|Protocol Violation|0|||
145616518|NCT01474512|525111297|FG002|Long-Term Extension Period|Protocol Violation|0|||
145616519|NCT01474512|525111298|FG003|Long-Term Extension Period|Protocol Violation|0|||
145616520|NCT01474512|525111299|FG004|Long-Term Extension Period|Protocol Violation|0|||
145616521|NCT01474512|525111300|FG005|Long-Term Extension Period|Protocol Violation|0|||
145616522|NCT01474512|525111301|FG006|Long-Term Extension Period|Protocol Violation|0|||
145616523|NCT01474512|525111302|FG007|Long-Term Extension Period|Protocol Violation|0|||
145616524|NCT01474512|525111303|FG008|Long-Term Extension Period|Protocol Violation|0|||
145616525|NCT01474512|525111304|FG009|Long-Term Extension Period|Protocol Violation|0|||
145616526|NCT01474512|525111305|FG010|Long-Term Extension Period|Protocol Violation|0|||
145616527|NCT01474512|525111306|FG011|Long-Term Extension Period|Protocol Violation|0|||
145616528|NCT01474512|525111307|FG012|Long-Term Extension Period|Protocol Violation|5|||
145616529|NCT01474512|525111308|FG013|Long-Term Extension Period|Protocol Violation|5|||
145616530|NCT01474512|525111309|FG014|Long-Term Extension Period|Protocol Violation|0|||
145616531|NCT01474512|525111310|FG015|Long-Term Extension Period|Protocol Violation|0|||
145616532|NCT01474512|525111311|FG016|Long-Term Extension Period|Protocol Violation|0|||
145616533|NCT01474512|525111312|FG017|Long-Term Extension Period|Protocol Violation|0|||
145616534|NCT01474512|525111295|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616535|NCT01474512|525111296|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616536|NCT01474512|525111297|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616537|NCT01474512|525111298|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616538|NCT01474512|525111299|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616539|NCT01474512|525111300|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616540|NCT01474512|525111301|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616541|NCT01474512|525111302|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616542|NCT01474512|525111303|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616543|NCT01474512|525111304|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616544|NCT01474512|525111305|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616545|NCT01474512|525111306|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616546|NCT01474512|525111307|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
145616547|NCT01474512|525111308|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
145616548|NCT01474512|525111309|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616549|NCT01474512|525111310|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616550|NCT01474512|525111311|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616551|NCT01474512|525111312|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
145616552|NCT01474512|525111295|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616553|NCT01474512|525111296|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616554|NCT01474512|525111297|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616555|NCT01474512|525111298|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145292652|NCT00950807|523922205|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145292653|NCT00950807|523922206|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145292654|NCT00950807|523922207|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
145292655|NCT00950807|523922208|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145557849|NCT03525574|524901386|FG001|Overall Study|Other|0|||
145557850|NCT03525574|524901385|FG000|Overall Study|Enrolled but never dosed|1|||
145557851|NCT03525574|524901386|FG001|Overall Study|Enrolled but never dosed|0|||
145557852|NCT03525574|524901385|FG000|Overall Study|Not enrolled in 105 study|0|||
145557853|NCT03525574|524901386|FG001|Overall Study|Not enrolled in 105 study|3|||
145557854|NCT01770379|524901389|FG000|Overall Study|Technical issues|1|||
145557855|NCT01770379|524901390|FG001|Overall Study|Technical issues|0|||
145557856|NCT01770379|524901391|FG002|Overall Study|Technical issues|0|||
145557857|NCT01770379|524901389|FG000|Overall Study|Withdrawal by Subject|7|||
145557858|NCT01770379|524901390|FG001|Overall Study|Withdrawal by Subject|10|||
145557859|NCT01770379|524901391|FG002|Overall Study|Withdrawal by Subject|7|||
145557860|NCT01770379|524901389|FG000|Overall Study|study terminated by sponsor|22|||
145557861|NCT01770379|524901390|FG001|Overall Study|study terminated by sponsor|23|||
145557862|NCT01770379|524901391|FG002|Overall Study|study terminated by sponsor|22|||
145557863|NCT01770379|524901389|FG000|Overall Study|Protocol Violation|0|||
145557864|NCT01770379|524901390|FG001|Overall Study|Protocol Violation|1|||
145557865|NCT01770379|524901391|FG002|Overall Study|Protocol Violation|1|||
145557866|NCT01770379|524901389|FG000|Overall Study|Physician Decision|0|||
145557867|NCT01770379|524901390|FG001|Overall Study|Physician Decision|1|||
145616556|NCT01474512|525111299|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616557|NCT01474512|525111300|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616558|NCT01474512|525111301|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616559|NCT01474512|525111302|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616560|NCT01474512|525111303|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616561|NCT01474512|525111304|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616562|NCT01474512|525111305|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616563|NCT01474512|525111306|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
145616564|NCT01474512|525111307|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145557868|NCT01770379|524901391|FG002|Overall Study|Physician Decision|2|||
145557869|NCT01770379|524901389|FG000|Overall Study|Lost to Follow-up|0|||
145557870|NCT01770379|524901390|FG001|Overall Study|Lost to Follow-up|0|||
145557871|NCT01770379|524901391|FG002|Overall Study|Lost to Follow-up|2|||
145557872|NCT01770379|524901389|FG000|Overall Study|Lack of Efficacy|8|||
145557873|NCT01770379|524901390|FG001|Overall Study|Lack of Efficacy|6|||
145557874|NCT01770379|524901391|FG002|Overall Study|Lack of Efficacy|6|||
145557875|NCT01770379|524901389|FG000|Overall Study|Adverse Event|1|||
145557876|NCT01770379|524901390|FG001|Overall Study|Adverse Event|3|||
145557877|NCT01770379|524901391|FG002|Overall Study|Adverse Event|2|||
145557878|NCT01074450|524901400|FG000|First Intervention|Emesis in Dosing Interval|0|||
145557879|NCT01074450|524901401|FG001|First Intervention|Emesis in Dosing Interval|2|||
145557880|NCT01074450|524901400|FG000|Second Intervention|Protocol Violation|1|||
145557881|NCT01074450|524901401|FG001|Second Intervention|Protocol Violation|0|||
145557882|NCT01074450|524901400|FG000|Second Intervention|Physician Decision|0|||
145557883|NCT01074450|524901401|FG001|Second Intervention|Physician Decision|1|||
145557884|NCT02728895|524901402|FG000|Overall Study|Other|1|||
145557885|NCT02728895|524901403|FG001|Overall Study|Other|2|||
145557886|NCT02728895|524901402|FG000|Overall Study|Withdrawal by Subject|0|||
145557887|NCT02728895|524901403|FG001|Overall Study|Withdrawal by Subject|3|||
145557888|NCT02769247|524901404|FG000|Overall Study|Withdrawal by Subject|1|||
145557889|NCT02769247|524901405|FG001|Overall Study|Withdrawal by Subject|0|||
145557890|NCT02769247|524901406|FG002|Overall Study|Withdrawal by Subject|0|||
145557891|NCT02769247|524901407|FG003|Overall Study|Withdrawal by Subject|1|||
145557892|NCT02769247|524901404|FG000|Overall Study|Protocol Violation|0|||
145557893|NCT02769247|524901405|FG001|Overall Study|Protocol Violation|0|||
145557894|NCT02769247|524901406|FG002|Overall Study|Protocol Violation|1|||
145557895|NCT02769247|524901407|FG003|Overall Study|Protocol Violation|0|||
145557896|NCT02769247|524901404|FG000|Overall Study|Physician Decision|1|||
145616565|NCT01474512|525111308|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616566|NCT01474512|525111309|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145616567|NCT01474512|525111310|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145557897|NCT02769247|524901405|FG001|Overall Study|Physician Decision|0|||
145616568|NCT01474512|525111311|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145557898|NCT02769247|524901406|FG002|Overall Study|Physician Decision|0|||
145616569|NCT01474512|525111312|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
145557899|NCT02769247|524901407|FG003|Overall Study|Physician Decision|0|||
145616570|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
145292656|NCT00950807|523922209|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
145557900|NCT03164928|524901417|FG000|Overall Study|Lost to Follow-up|1|||
145557901|NCT03164928|524901418|FG001|Overall Study|Lost to Follow-up|0|||
145557902|NCT01998737|524901419|FG000|Overall Study|Corrupted database|23|||
145557903|NCT01998737|524901420|FG001|Overall Study|Corrupted database|0|||
145557904|NCT00326950|524901421|FG000|Overall Study|Progressive Disease|1|||
145557905|NCT03855280|524901437|FG000|Treatment Phase|Adverse Event|1|||
145557906|NCT03855280|524901437|FG000|Treatment Phase|Withdrawal by Subject|1|||
145557907|NCT03855280|524901437|FG000|Continuation Phase|Protocol Violation|1|||
145557908|NCT03855280|524901437|FG000|Continuation Phase|Adverse Event|1|||
145616571|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
145616572|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
145616573|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
145616574|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
145616575|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
145616576|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
145616577|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
145616578|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
145616579|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
145616580|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
145616581|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
145616582|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
145616583|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
145616584|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
145616585|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
145616586|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
145616587|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
145616588|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616589|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616590|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616591|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616592|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616593|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616594|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616595|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616596|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616597|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616598|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616599|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616600|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616601|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
145616602|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
145616603|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
145616604|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
145616605|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
145616606|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616607|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616608|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616609|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616610|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616611|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616612|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616613|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616614|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616615|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616616|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616617|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616618|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616619|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
145616620|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
145616621|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
145616622|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
145616623|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
145616624|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616625|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616626|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616627|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616628|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616629|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616630|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616631|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616632|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616633|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616634|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616635|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616636|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616637|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616638|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616639|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
145616640|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
145616641|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
145616642|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
145616643|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
145616644|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
145616645|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
145616646|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
145616647|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
145616648|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
145616649|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
145616650|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
145616651|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
145616652|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
145616653|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
145616654|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
145616655|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
145616656|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
145616657|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
145616658|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
145616659|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
145616660|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616661|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616662|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616663|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616664|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616665|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616666|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616667|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616668|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616669|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616670|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616671|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616672|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616673|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616674|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616675|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
145616676|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
145616677|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
145616678|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
145616679|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
145616680|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
145616681|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
145616682|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
145616683|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
145616684|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
145616685|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
145616686|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
145616687|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
145616688|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
145616689|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
145616690|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
145616691|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
145616692|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
145616693|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
145616694|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
145616695|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
145616696|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616697|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616698|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616699|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
145407443|NCT03806296|524346999|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
145557909|NCT03855280|524901437|FG000|Continuation Phase|Sponsor Concluded Study|1|||
145557910|NCT00969150|524901438|FG000|Overall Study|Adverse Event|4|||
145557911|NCT00969150|524901439|FG001|Overall Study|Adverse Event|14|||
145557912|NCT00969150|524901438|FG000|Overall Study|Lack of Efficacy|1|||
145557913|NCT00969150|524901439|FG001|Overall Study|Lack of Efficacy|1|||
145557914|NCT00969150|524901438|FG000|Overall Study|Protocol Violation|9|||
145557915|NCT00969150|524901439|FG001|Overall Study|Protocol Violation|12|||
145557916|NCT00969150|524901438|FG000|Overall Study|Withdrawal by Subject|13|||
145557917|NCT00969150|524901439|FG001|Overall Study|Withdrawal by Subject|9|||
145557918|NCT00969150|524901438|FG000|Overall Study|Lost to Follow-up|5|||
145557919|NCT00969150|524901439|FG001|Overall Study|Lost to Follow-up|4|||
145557920|NCT00969150|524901438|FG000|Overall Study|Other reasons|1|||
145557921|NCT00969150|524901439|FG001|Overall Study|Other reasons|0|||
145557922|NCT00461682|524901443|FG000|Overall Study|Protocol Violation|1|||
145557923|NCT00642941|524901452|FG000|Overall Study|Physician Decision|3|||
145557924|NCT00642941|524901453|FG001|Overall Study|Physician Decision|1|||
145557925|NCT00642941|524901454|FG002|Overall Study|Physician Decision|0|||
145557926|NCT00642941|524901455|FG003|Overall Study|Physician Decision|0|||
145557927|NCT00642941|524901456|FG004|Overall Study|Physician Decision|0|||
145557928|NCT00642941|524901457|FG005|Overall Study|Physician Decision|0|||
145557929|NCT00642941|524901458|FG006|Overall Study|Physician Decision|1|||
145557930|NCT00642941|524901459|FG007|Overall Study|Physician Decision|0|||
145557931|NCT00642941|524901460|FG008|Overall Study|Physician Decision|0|||
145557932|NCT00642941|524901461|FG009|Overall Study|Physician Decision|1|||
145557933|NCT00642941|524901462|FG010|Overall Study|Physician Decision|0|||
145557934|NCT00642941|524901463|FG011|Overall Study|Physician Decision|1|||
145557935|NCT00642941|524901452|FG000|Overall Study|Death|4|||
145557936|NCT00642941|524901453|FG001|Overall Study|Death|0|||
145557937|NCT00642941|524901454|FG002|Overall Study|Death|1|||
145557938|NCT00642941|524901455|FG003|Overall Study|Death|1|||
145557939|NCT00642941|524901456|FG004|Overall Study|Death|2|||
145557940|NCT00642941|524901457|FG005|Overall Study|Death|1|||
145557941|NCT00642941|524901458|FG006|Overall Study|Death|0|||
145557942|NCT00642941|524901459|FG007|Overall Study|Death|0|||
145557943|NCT00642941|524901460|FG008|Overall Study|Death|0|||
145557944|NCT00642941|524901461|FG009|Overall Study|Death|0|||
145557945|NCT00642941|524901462|FG010|Overall Study|Death|0|||
145557946|NCT00642941|524901463|FG011|Overall Study|Death|1|||
145557947|NCT00642941|524901452|FG000|Overall Study|Study closed by Sponsor|0|||
145557948|NCT00642941|524901453|FG001|Overall Study|Study closed by Sponsor|1|||
145557949|NCT00642941|524901454|FG002|Overall Study|Study closed by Sponsor|0|||
145557950|NCT00642941|524901455|FG003|Overall Study|Study closed by Sponsor|0|||
145557951|NCT00642941|524901456|FG004|Overall Study|Study closed by Sponsor|0|||
145557952|NCT00642941|524901457|FG005|Overall Study|Study closed by Sponsor|0|||
145557953|NCT00642941|524901458|FG006|Overall Study|Study closed by Sponsor|0|||
145557954|NCT00642941|524901459|FG007|Overall Study|Study closed by Sponsor|0|||
145557955|NCT00642941|524901460|FG008|Overall Study|Study closed by Sponsor|0|||
145557956|NCT00642941|524901461|FG009|Overall Study|Study closed by Sponsor|0|||
145557957|NCT00642941|524901462|FG010|Overall Study|Study closed by Sponsor|0|||
145557958|NCT00642941|524901463|FG011|Overall Study|Study closed by Sponsor|0|||
145557959|NCT00642941|524901452|FG000|Overall Study|Withdrawal by Subject|1|||
145557960|NCT00642941|524901453|FG001|Overall Study|Withdrawal by Subject|0|||
145557961|NCT00642941|524901454|FG002|Overall Study|Withdrawal by Subject|0|||
145557962|NCT00642941|524901455|FG003|Overall Study|Withdrawal by Subject|2|||
145557963|NCT00642941|524901456|FG004|Overall Study|Withdrawal by Subject|0|||
145557964|NCT00642941|524901457|FG005|Overall Study|Withdrawal by Subject|0|||
145557965|NCT00642941|524901458|FG006|Overall Study|Withdrawal by Subject|2|||
145557966|NCT00642941|524901459|FG007|Overall Study|Withdrawal by Subject|0|||
145557967|NCT00642941|524901460|FG008|Overall Study|Withdrawal by Subject|1|||
145557968|NCT00642941|524901461|FG009|Overall Study|Withdrawal by Subject|0|||
145557969|NCT00642941|524901462|FG010|Overall Study|Withdrawal by Subject|0|||
145557970|NCT00642941|524901463|FG011|Overall Study|Withdrawal by Subject|1|||
145557971|NCT00642941|524901452|FG000|Overall Study|Protocol Violation|0|||
145557972|NCT00642941|524901453|FG001|Overall Study|Protocol Violation|0|||
145557973|NCT00642941|524901454|FG002|Overall Study|Protocol Violation|0|||
145557974|NCT00642941|524901455|FG003|Overall Study|Protocol Violation|0|||
145557975|NCT00642941|524901456|FG004|Overall Study|Protocol Violation|0|||
145557976|NCT00642941|524901457|FG005|Overall Study|Protocol Violation|0|||
145557977|NCT00642941|524901458|FG006|Overall Study|Protocol Violation|1|||
145557978|NCT00642941|524901459|FG007|Overall Study|Protocol Violation|0|||
145557979|NCT00642941|524901460|FG008|Overall Study|Protocol Violation|0|||
145557980|NCT00642941|524901461|FG009|Overall Study|Protocol Violation|0|||
145557981|NCT00642941|524901462|FG010|Overall Study|Protocol Violation|0|||
145557982|NCT00642941|524901463|FG011|Overall Study|Protocol Violation|0|||
145557983|NCT00642941|524901452|FG000|Overall Study|Adverse Event|1|||
145557984|NCT00642941|524901453|FG001|Overall Study|Adverse Event|1|||
145557985|NCT00642941|524901454|FG002|Overall Study|Adverse Event|0|||
145557986|NCT00642941|524901455|FG003|Overall Study|Adverse Event|0|||
145557987|NCT00642941|524901456|FG004|Overall Study|Adverse Event|0|||
145557988|NCT00642941|524901457|FG005|Overall Study|Adverse Event|0|||
145557989|NCT00642941|524901458|FG006|Overall Study|Adverse Event|1|||
145557990|NCT00642941|524901459|FG007|Overall Study|Adverse Event|1|||
145557991|NCT00642941|524901460|FG008|Overall Study|Adverse Event|0|||
145557992|NCT00642941|524901461|FG009|Overall Study|Adverse Event|1|||
145557993|NCT00642941|524901462|FG010|Overall Study|Adverse Event|0|||
145557994|NCT00642941|524901463|FG011|Overall Study|Adverse Event|0|||
145557995|NCT00642941|524901452|FG000|Overall Study|Other|1|||
145557996|NCT00642941|524901453|FG001|Overall Study|Other|1|||
145557997|NCT00642941|524901454|FG002|Overall Study|Other|1|||
145557998|NCT00642941|524901455|FG003|Overall Study|Other|1|||
145557999|NCT00642941|524901456|FG004|Overall Study|Other|0|||
145558000|NCT00642941|524901457|FG005|Overall Study|Other|1|||
145558001|NCT00642941|524901458|FG006|Overall Study|Other|0|||
145558002|NCT00642941|524901459|FG007|Overall Study|Other|1|||
145558003|NCT00642941|524901460|FG008|Overall Study|Other|0|||
145558004|NCT00642941|524901461|FG009|Overall Study|Other|0|||
145558005|NCT00642941|524901462|FG010|Overall Study|Other|0|||
145558006|NCT00642941|524901463|FG011|Overall Study|Other|1|||
145558007|NCT00642941|524901452|FG000|Overall Study|Disease progression|60|||
145558008|NCT00642941|524901453|FG001|Overall Study|Disease progression|50|||
145558009|NCT00642941|524901454|FG002|Overall Study|Disease progression|5|||
145558010|NCT00642941|524901455|FG003|Overall Study|Disease progression|36|||
145616700|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616701|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616702|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616703|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616704|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616705|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616706|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616707|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616708|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616709|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616710|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
145616711|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616712|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
145616713|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
145616714|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616715|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616716|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616717|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616718|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616719|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616720|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616721|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616722|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616723|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616724|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616725|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616726|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616727|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616728|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
145616729|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616730|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
145616731|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
145616732|NCT01474512|525111295|FG000|Post-Treatment Follow-Up|Death|0|||
145616733|NCT01474512|525111296|FG001|Post-Treatment Follow-Up|Death|0|||
145616734|NCT01474512|525111297|FG002|Post-Treatment Follow-Up|Death|0|||
145558011|NCT00642941|524901456|FG004|Overall Study|Disease progression|23|||
145558012|NCT00642941|524901457|FG005|Overall Study|Disease progression|39|||
145558013|NCT00642941|524901458|FG006|Overall Study|Disease progression|18|||
145558014|NCT00642941|524901459|FG007|Overall Study|Disease progression|12|||
145558015|NCT00642941|524901460|FG008|Overall Study|Disease progression|10|||
145558016|NCT00642941|524901461|FG009|Overall Study|Disease progression|7|||
145558017|NCT00642941|524901462|FG010|Overall Study|Disease progression|12|||
145558018|NCT00642941|524901463|FG011|Overall Study|Disease progression|7|||
145558019|NCT02472795|524901464|FG000|Overall Study|Adverse Event|0|||
145558020|NCT02472795|524901465|FG001|Overall Study|Adverse Event|1|||
145558021|NCT02472795|524901466|FG002|Overall Study|Adverse Event|0|||
145558022|NCT02472795|524901467|FG003|Overall Study|Adverse Event|0|||
145558023|NCT02472795|524901468|FG004|Overall Study|Adverse Event|2|||
145558024|NCT02472795|524901464|FG000|Overall Study|Withdrawal by Subject|0|||
145558025|NCT02472795|524901465|FG001|Overall Study|Withdrawal by Subject|0|||
145558026|NCT02472795|524901466|FG002|Overall Study|Withdrawal by Subject|0|||
145558027|NCT02472795|524901467|FG003|Overall Study|Withdrawal by Subject|0|||
145616735|NCT01474512|525111298|FG003|Post-Treatment Follow-Up|Death|0|||
145616736|NCT01474512|525111299|FG004|Post-Treatment Follow-Up|Death|0|||
145616737|NCT01474512|525111300|FG005|Post-Treatment Follow-Up|Death|0|||
145558028|NCT02472795|524901468|FG004|Overall Study|Withdrawal by Subject|1|||
145558029|NCT04166513|524901469|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
145558030|NCT04166513|524901470|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
145558031|NCT04166513|524901471|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
145616738|NCT01474512|525111301|FG006|Post-Treatment Follow-Up|Death|0|||
145616739|NCT01474512|525111302|FG007|Post-Treatment Follow-Up|Death|0|||
145616740|NCT01474512|525111303|FG008|Post-Treatment Follow-Up|Death|0|||
145616741|NCT01474512|525111304|FG009|Post-Treatment Follow-Up|Death|0|||
145616742|NCT01474512|525111305|FG010|Post-Treatment Follow-Up|Death|0|||
145616743|NCT01474512|525111306|FG011|Post-Treatment Follow-Up|Death|0|||
145558032|NCT04166513|524901472|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
145558033|NCT04166513|524901469|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
145616744|NCT01474512|525111307|FG012|Post-Treatment Follow-Up|Death|0|||
145558034|NCT04166513|524901470|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
145558035|NCT04166513|524901471|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
145558036|NCT04166513|524901472|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
145558037|NCT04166513|524901469|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
145558038|NCT04166513|524901470|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
145558039|NCT04166513|524901471|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
145558040|NCT04166513|524901472|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
145558041|NCT04166513|524901469|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
145558042|NCT04166513|524901470|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
145292657|NCT00950807|523922210|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
145558043|NCT04166513|524901471|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
145558044|NCT04166513|524901472|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
145558045|NCT04166513|524901469|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
145558046|NCT04166513|524901470|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
145558047|NCT04166513|524901471|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
145558048|NCT04166513|524901472|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
145558049|NCT00597012|524901473|FG000|Overall Study|Death|1|||
145558050|NCT00597012|524901474|FG001|Overall Study|Death|1|||
145558051|NCT00597012|524901473|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
145558052|NCT00597012|524901474|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
145558053|NCT00597012|524901473|FG000|Overall Study|Withdrawal by Subject|7|||
145558054|NCT00597012|524901474|FG001|Overall Study|Withdrawal by Subject|4|||
145558055|NCT00597012|524901473|FG000|Overall Study|Ineligible|2|||
145558056|NCT00597012|524901474|FG001|Overall Study|Ineligible|0|||
145558057|NCT00597012|524901473|FG000|Overall Study|Lost to Follow-up|0|||
145558058|NCT00597012|524901474|FG001|Overall Study|Lost to Follow-up|2|||
145558059|NCT00670800|524902414|FG000|Overall Study|2 controls were insulin resistant|0|||
145558060|NCT00670800|524902415|FG001|Overall Study|2 controls were insulin resistant|2|||
145558061|NCT01786629|524902416|FG000|Overall Study|Lack of Efficacy|0|||
145558062|NCT01786629|524902417|FG001|Overall Study|Lack of Efficacy|4|||
145558063|NCT01786629|524902416|FG000|Overall Study|Adverse Event|0|||
145558064|NCT01786629|524902417|FG001|Overall Study|Adverse Event|1|||
145558065|NCT00410761|524902418|FG000|Randomized Treatment Period|Adverse Event|34|||
145558066|NCT00410761|524902419|FG001|Randomized Treatment Period|Adverse Event|3|||
145558067|NCT00410761|524902418|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
145558068|NCT00410761|524902419|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
145558069|NCT00410761|524902418|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
145558070|NCT00410761|524902419|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
145558071|NCT00410761|524902418|FG000|Randomized Treatment Period|Other|69|||
145558072|NCT00410761|524902419|FG001|Randomized Treatment Period|Other|21|||
145558073|NCT00410761|524902418|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
145558074|NCT00410761|524902419|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
145558075|NCT00410761|524902418|FG000|Open-Label Treatment Period|Adverse Event|13|||
145558076|NCT00410761|524902419|FG001|Open-Label Treatment Period|Adverse Event|15|||
145558077|NCT00410761|524902418|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
145558078|NCT00410761|524902419|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
145558079|NCT00410761|524902418|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
145558080|NCT00410761|524902419|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
145558081|NCT00410761|524902418|FG000|Open-Label Treatment Period|Other|18|||
145558082|NCT00410761|524902419|FG001|Open-Label Treatment Period|Other|9|||
145558083|NCT03712904|524902421|FG000|Overall Study|Death|0|||
145558084|NCT03712904|524902422|FG001|Overall Study|Death|1|||
145558085|NCT03712904|524902421|FG000|Overall Study|Withdrawal by Subject|0|||
145558086|NCT03712904|524902422|FG001|Overall Study|Withdrawal by Subject|1|||
145558087|NCT03712904|524902421|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
145558088|NCT03712904|524902422|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
145558089|NCT00202644|524902424|FG000|Overall Study|Adverse Event|12|||
145558090|NCT00202644|524902425|FG001|Overall Study|Adverse Event|13|||
145558091|NCT00202644|524902424|FG000|Overall Study|Withdrawal by Subject|8|||
145558092|NCT00202644|524902425|FG001|Overall Study|Withdrawal by Subject|6|||
145558093|NCT00202644|524902424|FG000|Overall Study|Lack of Efficacy|6|||
145558094|NCT00202644|524902425|FG001|Overall Study|Lack of Efficacy|6|||
145558095|NCT00202644|524902424|FG000|Overall Study|Lost to Follow-up|0|||
145558096|NCT00202644|524902425|FG001|Overall Study|Lost to Follow-up|1|||
145558097|NCT00202644|524902424|FG000|Overall Study|Other|9|||
145558098|NCT00202644|524902425|FG001|Overall Study|Other|1|||
145558099|NCT02750592|524902427|FG000|Overall Study|Adverse Event|3|||
145558100|NCT02750592|524902427|FG000|Overall Study|Lack of Efficacy|2|||
145558101|NCT02981342|524902430|FG000|Overall Study|Adverse Event|0|||
145558102|NCT02981342|524902431|FG001|Overall Study|Adverse Event|0|||
145558103|NCT02981342|524902432|FG002|Overall Study|Adverse Event|0|||
145558104|NCT02981342|524902433|FG003|Overall Study|Adverse Event|1|||
145558105|NCT02981342|524902430|FG000|Overall Study|Death|0|||
145558106|NCT02981342|524902431|FG001|Overall Study|Death|9|||
145558107|NCT02981342|524902432|FG002|Overall Study|Death|9|||
145558108|NCT02981342|524902433|FG003|Overall Study|Death|4|||
145616745|NCT01474512|525111308|FG013|Post-Treatment Follow-Up|Death|0|||
145616746|NCT01474512|525111309|FG014|Post-Treatment Follow-Up|Death|0|||
145616747|NCT01474512|525111310|FG015|Post-Treatment Follow-Up|Death|0|||
145616748|NCT01474512|525111311|FG016|Post-Treatment Follow-Up|Death|1|||
145616749|NCT01474512|525111312|FG017|Post-Treatment Follow-Up|Death|0|||
145616750|NCT01118962|525111315|FG000|Overall Study|Adverse Event|2|||
145616751|NCT01118962|525111315|FG000|Overall Study|Lack of Efficacy|1|||
145616752|NCT01118962|525111315|FG000|Overall Study|Protocol Violation|1|||
145616753|NCT01118962|525111315|FG000|Overall Study|Withdrawal by Subject|4|||
145616754|NCT01118962|525111315|FG000|Overall Study|Pregnancy|1|||
145616755|NCT01118962|525111315|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
145616756|NCT00506285|525111320|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
145616757|NCT00506285|525111321|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
145616758|NCT00506285|525111320|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
145616759|NCT00506285|525111321|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
145616760|NCT00506285|525111320|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
145616761|NCT00506285|525111321|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
145616762|NCT00506285|525111320|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
145616763|NCT00506285|525111321|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
145616764|NCT00506285|525111320|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
145616765|NCT00506285|525111321|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
145616766|NCT00551213|525111322|FG000|Overall Study|Adverse Event|6|||
145616767|NCT00551213|525111323|FG001|Overall Study|Adverse Event|3|||
145616768|NCT00551213|525111322|FG000|Overall Study|Progressive Disease|41|||
145616769|NCT00551213|525111323|FG001|Overall Study|Progressive Disease|12|||
145292658|NCT00950807|523922211|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145292659|NCT00950807|523922212|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
145558109|NCT02981342|524902430|FG000|Overall Study|Withdrawal by Subject|0|||
145558110|NCT02981342|524902431|FG001|Overall Study|Withdrawal by Subject|0|||
145558111|NCT02981342|524902432|FG002|Overall Study|Withdrawal by Subject|3|||
145558112|NCT02981342|524902433|FG003|Overall Study|Withdrawal by Subject|1|||
145558113|NCT02981342|524902430|FG000|Overall Study|Study closed by sponsor|0|||
145558114|NCT02981342|524902431|FG001|Overall Study|Study closed by sponsor|0|||
145558115|NCT02981342|524902432|FG002|Overall Study|Study closed by sponsor|1|||
145558116|NCT02981342|524902433|FG003|Overall Study|Study closed by sponsor|1|||
145558117|NCT02981342|524902430|FG000|Overall Study|Randomized, Never Treated|0|||
145558118|NCT02981342|524902431|FG001|Overall Study|Randomized, Never Treated|1|||
145558119|NCT02981342|524902432|FG002|Overall Study|Randomized, Never Treated|0|||
145558120|NCT02981342|524902433|FG003|Overall Study|Randomized, Never Treated|7|||
145558121|NCT02981342|524902430|FG000|Overall Study|Lost to Follow-up|0|||
145558122|NCT02981342|524902431|FG001|Overall Study|Lost to Follow-up|1|||
145558123|NCT02981342|524902432|FG002|Overall Study|Lost to Follow-up|0|||
145558124|NCT02981342|524902433|FG003|Overall Study|Lost to Follow-up|0|||
145558125|NCT01132482|524902434|FG000|Overall Study|Adverse Event|1|||
145558126|NCT01132482|524902435|FG001|Overall Study|Adverse Event|0|||
145558127|NCT02150954|524902436|FG000|Overall Study|Protocol Violation|1|||
145558128|NCT02150954|524902437|FG001|Overall Study|Protocol Violation|0|||
145558129|NCT01086540|524902439|FG000|Overall Study|Death|3|||
145558130|NCT01086540|524902440|FG001|Overall Study|Death|1|||
145558131|NCT01086540|524902439|FG000|Overall Study|Physician Decision|2|||
145558132|NCT01086540|524902440|FG001|Overall Study|Physician Decision|1|||
145558133|NCT01086540|524902439|FG000|Overall Study|Addition of new therapy for PAH|1|||
145558134|NCT01086540|524902440|FG001|Overall Study|Addition of new therapy for PAH|0|||
145558135|NCT05811234|524902450|FG000|Overall Study|Loss of Effectiveness|2|||
145558136|NCT05811234|524902450|FG000|Overall Study|Adverse Event|4|||
145558137|NCT05811234|524902450|FG000|Overall Study|Pregnancy|1|||
145558138|NCT05811234|524902450|FG000|Overall Study|Disease progression|1|||
145558139|NCT05811234|524902450|FG000|Overall Study|Withdrawal by Subject|4|||
145558140|NCT05811234|524902450|FG000|Overall Study|Lost to Follow-up|13|||
145558141|NCT05811234|524902450|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
145558142|NCT04499781|524902451|FG000|Overall Study|Lost to Follow-up|2|||
145558143|NCT04499781|524902452|FG001|Overall Study|Lost to Follow-up|3|||
145558144|NCT04499781|524902451|FG000|Overall Study|Withdrawal by Subject|2|||
145558145|NCT04499781|524902452|FG001|Overall Study|Withdrawal by Subject|0|||
145558146|NCT01275833|524902453|FG000|Overall Study|Study terminated|1|||
145558147|NCT01275833|524902454|FG001|Overall Study|Study terminated|1|||
145558148|NCT00227305|524902455|FG000|Overall Study|Adverse Event|40|||
145558149|NCT00227305|524902455|FG000|Overall Study|Withdrawal by Subject|42|||
145558150|NCT00227305|524902455|FG000|Overall Study|Lost to Follow-up|33|||
145558151|NCT00227305|524902455|FG000|Overall Study|Study specific discontinuation|13|||
145558152|NCT00227305|524902455|FG000|Overall Study|MOVED OUT OF AREA|3|||
145558153|NCT00227305|524902455|FG000|Overall Study|Lack of Efficacy|7|||
145558154|NCT00227305|524902455|FG000|Overall Study|Physician Decision|3|||
145616770|NCT00551213|525111322|FG000|Overall Study|Withdrawal by Subject|2|||
145616771|NCT00551213|525111323|FG001|Overall Study|Withdrawal by Subject|0|||
145616772|NCT00551213|525111322|FG000|Overall Study|Not Treated|1|||
145616773|NCT00551213|525111323|FG001|Overall Study|Not Treated|2|||
145616774|NCT01254565|525111331|FG000|Overall Study|Non-compliance to Study Procedures|0|||
145616775|NCT01254565|525111332|FG001|Overall Study|Non-compliance to Study Procedures|0|||
145616776|NCT01254565|525111333|FG002|Overall Study|Non-compliance to Study Procedures|0|||
145616777|NCT01254565|525111334|FG003|Overall Study|Non-compliance to Study Procedures|0|||
145616778|NCT01254565|525111335|FG004|Overall Study|Non-compliance to Study Procedures|1|||
145616779|NCT01254565|525111336|FG005|Overall Study|Non-compliance to Study Procedures|0|||
145616780|NCT01254565|525111331|FG000|Overall Study|Did not Receive Treatment|1|||
145616781|NCT01254565|525111332|FG001|Overall Study|Did not Receive Treatment|1|||
145616782|NCT01254565|525111333|FG002|Overall Study|Did not Receive Treatment|0|||
145558155|NCT00227305|524902455|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
145558156|NCT00227305|524902455|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
145558157|NCT00227305|524902455|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
145558158|NCT02118012|524902456|FG000|Overall Study|Adverse Event|0|||
145558159|NCT02118012|524902457|FG001|Overall Study|Adverse Event|1|||
145558160|NCT02118012|524902456|FG000|Overall Study|Physician Decision|0|||
145558161|NCT02118012|524902457|FG001|Overall Study|Physician Decision|1|||
145558162|NCT04519645|524902461|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
145558163|NCT04519645|524902462|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
145558164|NCT04519645|524902463|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
145558165|NCT04519645|524902461|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
145558166|NCT04519645|524902462|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
145558167|NCT04519645|524902463|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
145558168|NCT04519645|524902461|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
145558169|NCT04519645|524902462|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
145558170|NCT04519645|524902463|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
145558171|NCT04519645|524902461|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
145558172|NCT04519645|524902462|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
145558173|NCT04519645|524902463|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
145558174|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558175|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
145558176|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558177|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558178|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558179|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558180|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
145558181|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
145558182|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
145558183|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
145558184|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
145558185|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
145558186|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
145558187|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
145558188|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
145558189|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
145558190|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
145558191|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
145558192|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
145558193|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
145558194|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
145558195|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
145558196|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
145558197|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
145558198|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
145558199|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
145558200|NCT03742037|524902469|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
145558201|NCT03742037|524902470|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
145558202|NCT03742037|524902464|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
145558203|NCT03742037|524902465|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
145558204|NCT03742037|524902466|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
145558205|NCT03742037|524902467|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
145558206|NCT03742037|524902468|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
145616783|NCT01254565|525111334|FG003|Overall Study|Did not Receive Treatment|0|||
145616784|NCT01254565|525111335|FG004|Overall Study|Did not Receive Treatment|3|||
145616785|NCT01254565|525111336|FG005|Overall Study|Did not Receive Treatment|4|||
145616786|NCT01254565|525111331|FG000|Overall Study|Other|0|||
145616787|NCT01254565|525111332|FG001|Overall Study|Other|0|||
145616788|NCT01254565|525111333|FG002|Overall Study|Other|0|||
145616873|NCT03230864|525111361|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
145616874|NCT03230864|525111362|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
145616875|NCT00610675|525111367|FG000|Overall Study|Untreated|4|||
145616876|NCT00610675|525111367|FG000|Overall Study|Adverse Event|67|||
145616877|NCT00610675|525111367|FG000|Overall Study|Insufficient Effect|31|||
145616878|NCT00610675|525111367|FG000|Overall Study|Withdrawal by Subject|28|||
145616879|NCT00610675|525111367|FG000|Overall Study|Reasons unrelated to trial|27|||
145616880|NCT00610675|525111367|FG000|Overall Study|Lack of Compliance|7|||
145616881|NCT00610675|525111367|FG000|Overall Study|Lost to Follow-up|31|||
145616882|NCT00610675|525111367|FG000|Overall Study|Other reason (not specified)|25|||
145616883|NCT04011384|525111370|FG000|Overall Study|Withdrawal by Subject|2|||
145616884|NCT04011384|525111371|FG001|Overall Study|Withdrawal by Subject|0|||
145616885|NCT00993317|525111372|FG000|Overall Study|Adverse Event|2|||
145616886|NCT00993317|525111373|FG001|Overall Study|Adverse Event|4|||
145616887|NCT00993317|525111372|FG000|Overall Study|Lack of Efficacy|18|||
145616888|NCT00993317|525111373|FG001|Overall Study|Lack of Efficacy|18|||
145616889|NCT00993317|525111372|FG000|Overall Study|Withdrawal by Subject|0|||
145616890|NCT00993317|525111373|FG001|Overall Study|Withdrawal by Subject|2|||
145616891|NCT00993317|525111372|FG000|Overall Study|Investigator's opinion|0|||
145616892|NCT00993317|525111373|FG001|Overall Study|Investigator's opinion|1|||
145616893|NCT00993317|525111372|FG000|Overall Study|Early study termination at the site|1|||
145616894|NCT00993317|525111373|FG001|Overall Study|Early study termination at the site|0|||
145616895|NCT00672958|525111374|FG000|Overall Study|Adverse Event|11|||
145616896|NCT00672958|525111375|FG001|Overall Study|Adverse Event|9|||
145616897|NCT00672958|525111374|FG000|Overall Study|Lack of Efficacy|6|||
145616898|NCT00672958|525111375|FG001|Overall Study|Lack of Efficacy|11|||
145616899|NCT00672958|525111374|FG000|Overall Study|Non-compliance with study drug|2|||
145616900|NCT00672958|525111375|FG001|Overall Study|Non-compliance with study drug|3|||
145616901|NCT00672958|525111374|FG000|Overall Study|Protocol deviations|11|||
145616902|NCT00672958|525111375|FG001|Overall Study|Protocol deviations|5|||
145616903|NCT00672958|525111374|FG000|Overall Study|Voluntary withdrawal|12|||
145616904|NCT00672958|525111375|FG001|Overall Study|Voluntary withdrawal|8|||
145616905|NCT00672958|525111374|FG000|Overall Study|Lost to Follow-up|22|||
145616906|NCT00672958|525111375|FG001|Overall Study|Lost to Follow-up|17|||
145616907|NCT00672958|525111374|FG000|Overall Study|Reason not specified|0|||
145616908|NCT00672958|525111375|FG001|Overall Study|Reason not specified|3|||
145616909|NCT02374593|525111376|FG000|Overall Study|non-compliant|2|||
145616910|NCT02374593|525111377|FG001|Overall Study|non-compliant|0|||
145616911|NCT00579982|525111378|FG000|Overall Study|Adverse Event|4|||
145616912|NCT00579982|525111378|FG000|Overall Study|Protocol Violation|4|||
145616913|NCT03192215|525111379|FG000|Overall Study|Death|28|||
145616914|NCT03192215|525111380|FG001|Overall Study|Death|23|||
145616915|NCT03192215|525111379|FG000|Overall Study|Lost to Follow-up|10|||
145616916|NCT03192215|525111380|FG001|Overall Study|Lost to Follow-up|15|||
145616917|NCT03192215|525111379|FG000|Overall Study|Withdrawal by Subject|49|||
145616918|NCT03192215|525111380|FG001|Overall Study|Withdrawal by Subject|48|||
145616919|NCT03192215|525111379|FG000|Overall Study|Other as reported in analysis|4|||
145616920|NCT03192215|525111380|FG001|Overall Study|Other as reported in analysis|1|||
145616921|NCT04844918|525111382|FG000|Overall Study|Adverse Event|7|||
145616922|NCT04844918|525111383|FG001|Overall Study|Adverse Event|8|||
145616923|NCT04844918|525111384|FG002|Overall Study|Adverse Event|5|||
145616924|NCT04844918|525111382|FG000|Overall Study|Physician Decision|0|||
145616925|NCT04844918|525111383|FG001|Overall Study|Physician Decision|1|||
145616926|NCT04844918|525111384|FG002|Overall Study|Physician Decision|0|||
145616927|NCT04844918|525111382|FG000|Overall Study|Withdrawal by Subject|6|||
145616928|NCT04844918|525111383|FG001|Overall Study|Withdrawal by Subject|3|||
145616929|NCT04844918|525111384|FG002|Overall Study|Withdrawal by Subject|3|||
145616930|NCT04844918|525111382|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
145616931|NCT04844918|525111383|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
145616932|NCT04844918|525111384|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
145616933|NCT04716881|525111386|FG000|Overall Study|Adverse Event|1|||
145616934|NCT04716881|525111386|FG000|Overall Study|Lost to Follow-up|1|||
145616935|NCT01076088|525111399|FG000|Overall Study|Adverse Event|1|||
145616936|NCT01076088|525111400|FG001|Overall Study|Adverse Event|6|||
145616937|NCT01076088|525111401|FG002|Overall Study|Adverse Event|3|||
145616938|NCT01076088|525111402|FG003|Overall Study|Adverse Event|2|||
145616939|NCT01076088|525111403|FG004|Overall Study|Adverse Event|3|||
145616940|NCT01076088|525111404|FG005|Overall Study|Adverse Event|3|||
145616941|NCT01076088|525111399|FG000|Overall Study|Lost to Follow-up|1|||
145616942|NCT01076088|525111400|FG001|Overall Study|Lost to Follow-up|1|||
145616943|NCT01076088|525111401|FG002|Overall Study|Lost to Follow-up|0|||
145616944|NCT01076088|525111402|FG003|Overall Study|Lost to Follow-up|1|||
145616945|NCT01076088|525111403|FG004|Overall Study|Lost to Follow-up|1|||
145616946|NCT01076088|525111404|FG005|Overall Study|Lost to Follow-up|2|||
145616947|NCT01076088|525111399|FG000|Overall Study|Non-compliance with study drug|0|||
145616948|NCT01076088|525111400|FG001|Overall Study|Non-compliance with study drug|0|||
145616949|NCT01076088|525111401|FG002|Overall Study|Non-compliance with study drug|0|||
145616950|NCT01076088|525111402|FG003|Overall Study|Non-compliance with study drug|1|||
145616951|NCT01076088|525111403|FG004|Overall Study|Non-compliance with study drug|0|||
145616952|NCT01076088|525111404|FG005|Overall Study|Non-compliance with study drug|0|||
145616953|NCT01076088|525111399|FG000|Overall Study|Physician Decision|1|||
145616954|NCT01076088|525111400|FG001|Overall Study|Physician Decision|3|||
145616955|NCT01076088|525111401|FG002|Overall Study|Physician Decision|0|||
145616956|NCT01076088|525111402|FG003|Overall Study|Physician Decision|1|||
145616957|NCT01076088|525111403|FG004|Overall Study|Physician Decision|1|||
145616958|NCT01076088|525111404|FG005|Overall Study|Physician Decision|0|||
145616959|NCT01076088|525111399|FG000|Overall Study|Withdrawal by Subject|8|||
145616960|NCT01076088|525111400|FG001|Overall Study|Withdrawal by Subject|8|||
145616961|NCT01076088|525111401|FG002|Overall Study|Withdrawal by Subject|14|||
145616962|NCT01076088|525111402|FG003|Overall Study|Withdrawal by Subject|10|||
145616963|NCT01076088|525111403|FG004|Overall Study|Withdrawal by Subject|11|||
145616964|NCT01076088|525111404|FG005|Overall Study|Withdrawal by Subject|17|||
145616965|NCT01076088|525111399|FG000|Overall Study|Other protocol specified criteria|0|||
145616966|NCT01076088|525111400|FG001|Overall Study|Other protocol specified criteria|0|||
145616967|NCT01076088|525111401|FG002|Overall Study|Other protocol specified criteria|0|||
145616968|NCT01076088|525111402|FG003|Overall Study|Other protocol specified criteria|0|||
145616969|NCT01076088|525111403|FG004|Overall Study|Other protocol specified criteria|0|||
145616970|NCT01076088|525111404|FG005|Overall Study|Other protocol specified criteria|1|||
145616971|NCT02207374|525111407|FG000|Overall Study|Withdrawal by Subject|5|||
145616972|NCT02207374|525111408|FG001|Overall Study|Withdrawal by Subject|9|||
145616973|NCT02207374|525111409|FG002|Overall Study|Withdrawal by Subject|4|||
145616974|NCT02207374|525111407|FG000|Overall Study|Death|1|||
145616975|NCT02207374|525111408|FG001|Overall Study|Death|0|||
145616976|NCT02207374|525111409|FG002|Overall Study|Death|1|||
145616977|NCT02207374|525111407|FG000|Overall Study|Missing follow-up information|0|||
145616978|NCT02207374|525111408|FG001|Overall Study|Missing follow-up information|1|||
145616979|NCT02207374|525111409|FG002|Overall Study|Missing follow-up information|1|||
145616980|NCT01000376|525111411|FG000|Cycle 1 Day 1|Adverse Event|1|||
145616981|NCT01000376|525111412|FG001|Cycle 1 Day 1|Adverse Event|0|||
145616982|NCT01000376|525111411|FG000|Cycle 1 Day 1|Progressive Disease|1|||
145616983|NCT01000376|525111412|FG001|Cycle 1 Day 1|Progressive Disease|0|||
145616984|NCT00318149|525111413|FG000|Overall Study|Adverse Event|0|||
145616985|NCT00318149|525111414|FG001|Overall Study|Adverse Event|0|||
145616986|NCT00318149|525111415|FG002|Overall Study|Adverse Event|0|||
145616987|NCT00318149|525111416|FG003|Overall Study|Adverse Event|0|||
145616988|NCT00318149|525111417|FG004|Overall Study|Adverse Event|0|||
145616989|NCT00318149|525111418|FG005|Overall Study|Adverse Event|2|||
145616990|NCT00219141|525111419|FG000|Overall Study|Adverse Event|4|||
145616991|NCT00219141|525111420|FG001|Overall Study|Adverse Event|10|||
145616992|NCT00219141|525111421|FG002|Overall Study|Adverse Event|5|||
145616993|NCT00219141|525111419|FG000|Overall Study|Lack of Efficacy|3|||
145616994|NCT00219141|525111420|FG001|Overall Study|Lack of Efficacy|2|||
145616995|NCT00219141|525111421|FG002|Overall Study|Lack of Efficacy|0|||
145616996|NCT00219141|525111419|FG000|Overall Study|Administrative problems|0|||
145616997|NCT00219141|525111420|FG001|Overall Study|Administrative problems|1|||
145616998|NCT00219141|525111421|FG002|Overall Study|Administrative problems|0|||
145616999|NCT00219141|525111419|FG000|Overall Study|Lost to Follow-up|2|||
145617000|NCT00219141|525111420|FG001|Overall Study|Lost to Follow-up|4|||
145617001|NCT00219141|525111421|FG002|Overall Study|Lost to Follow-up|1|||
145617002|NCT00219141|525111419|FG000|Overall Study|Protocol Violation|3|||
145407510|NCT00862992|524347045|FG000|Overall Study|Withdrawal by Subject|0|||
145407511|NCT00862992|524347046|FG001|Overall Study|Withdrawal by Subject|0|||
145407512|NCT00862992|524347047|FG002|Overall Study|Withdrawal by Subject|2|||
145407513|NCT02318940|524347048|FG000|Overall Study|lost the record|1|||
145407514|NCT02318940|524347049|FG001|Overall Study|lost the record|0|||
145407515|NCT04584788|524347060|FG000|Overall Study|Physician Decision|8|||
145407516|NCT04584788|524347060|FG000|Overall Study|Withdrawal by Subject|1|||
145407517|NCT04584788|524347060|FG000|Overall Study|Adverse Event|3|||
145407518|NCT04817410|524349707|FG000|Overall Study|Withdrawal by Subject|5|||
145407519|NCT04817410|524349707|FG000|Overall Study|Physician Decision|3|||
145407520|NCT01431976|524349708|FG000|Overall Study|Adverse Event|6|||
145407521|NCT01431976|524349708|FG000|Overall Study|Lack of Efficacy|2|||
145407522|NCT01431976|524349708|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
145407523|NCT01431976|524349708|FG000|Overall Study|Physician Decision|1|||
145407524|NCT01431976|524349708|FG000|Overall Study|Withdrawal by Subject|1|||
145407525|NCT00460798|524349710|FG000|Overall Study|Death|59|||
145407526|NCT00460798|524349710|FG000|Overall Study|Adverse Event|27|||
145617003|NCT00219141|525111420|FG001|Overall Study|Protocol Violation|1|||
145617004|NCT00219141|525111421|FG002|Overall Study|Protocol Violation|1|||
145617005|NCT00219141|525111419|FG000|Overall Study|Withdrawal by Subject|1|||
145617006|NCT00219141|525111420|FG001|Overall Study|Withdrawal by Subject|3|||
145617007|NCT00219141|525111421|FG002|Overall Study|Withdrawal by Subject|5|||
145617008|NCT00219141|525111419|FG000|Overall Study|Condition no longer requires study drug|1|||
145617009|NCT00219141|525111420|FG001|Overall Study|Condition no longer requires study drug|0|||
145617010|NCT00219141|525111421|FG002|Overall Study|Condition no longer requires study drug|0|||
145617011|NCT01994720|525111422|FG000|Overall Study|Withdrawal by Subject|46|||
145617012|NCT01994720|525111423|FG001|Overall Study|Withdrawal by Subject|56|||
145617013|NCT00903786|525111431|FG000|Overall Study|Physician Decision|6|||
145617014|NCT00903786|525111431|FG000|Overall Study|Lack of Efficacy|5|||
145617015|NCT00903786|525111431|FG000|Overall Study|Reason other than lack of efficacy|4|||
145617016|NCT00845871|525111434|FG000|Assessment Period|Adverse Event|2|||
145617017|NCT00845871|525111434|FG000|Assessment Period|Abnormal laboratory values|1|||
145617018|NCT00845871|525111434|FG000|Assessment Period|Abnormal test procedure results|1|||
145617019|NCT00845871|525111434|FG000|Assessment Period|Patient withdrew consent|3|||
145617020|NCT01857622|525111435|FG000|Overall Study|Adverse Event|5|||
145617021|NCT01857622|525111436|FG001|Overall Study|Adverse Event|0|||
145617022|NCT01857622|525111437|FG002|Overall Study|Adverse Event|2|||
145617023|NCT01857622|525111435|FG000|Overall Study|Physician Decision|1|||
145617024|NCT01857622|525111436|FG001|Overall Study|Physician Decision|0|||
145617025|NCT01857622|525111437|FG002|Overall Study|Physician Decision|0|||
145617026|NCT01857622|525111435|FG000|Overall Study|Protocol Violation|4|||
145617027|NCT01857622|525111436|FG001|Overall Study|Protocol Violation|1|||
145617028|NCT01857622|525111437|FG002|Overall Study|Protocol Violation|0|||
145617029|NCT01857622|525111435|FG000|Overall Study|Withdrawal by Subject|1|||
145617030|NCT01857622|525111436|FG001|Overall Study|Withdrawal by Subject|0|||
145617031|NCT01857622|525111437|FG002|Overall Study|Withdrawal by Subject|0|||
145617032|NCT01291225|525111441|FG000|Overall Study|Lost to Follow-up|85|||
145617033|NCT01291225|525111442|FG001|Overall Study|Lost to Follow-up|39|||
145617034|NCT01267253|525111443|FG000|Overall Study|Ineligible - required test not done|1|||
145617035|NCT01267253|525111443|FG000|Overall Study|Inevaluable-never received study treatme|2|||
145617036|NCT04318093|525111444|FG000|Overall Study|Adverse Event|2|||
145617037|NCT04318093|525111445|FG001|Overall Study|Adverse Event|2|||
145617038|NCT04318093|525111444|FG000|Overall Study|Participant withdrew consent|1|||
145617039|NCT04318093|525111445|FG001|Overall Study|Participant withdrew consent|0|||
145617040|NCT04318093|525111444|FG000|Overall Study|Other reasons|0|||
145617041|NCT04318093|525111445|FG001|Overall Study|Other reasons|1|||
145617042|NCT02855164|525111453|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
145617043|NCT02855164|525111454|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
145617044|NCT02855164|525111455|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
145617045|NCT02855164|525111456|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
145617046|NCT02855164|525111457|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
145617047|NCT02855164|525111458|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
145617048|NCT02855164|525111459|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
145617049|NCT02855164|525111460|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
145617050|NCT02855164|525111453|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
145617051|NCT02855164|525111454|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
145617052|NCT02855164|525111455|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
145617053|NCT02855164|525111456|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
145617054|NCT02855164|525111457|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
145617055|NCT02855164|525111458|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
145617056|NCT02855164|525111459|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
145617057|NCT02855164|525111460|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
145617058|NCT02855164|525111453|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
145617059|NCT02855164|525111454|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
145617060|NCT02855164|525111455|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
145617061|NCT02855164|525111456|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
145617062|NCT02855164|525111457|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
145617063|NCT02855164|525111458|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
145617064|NCT02855164|525111459|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
145617065|NCT02855164|525111460|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
145617066|NCT02855164|525111453|FG000|Part C (Randomized Set)|Adverse Event|0|||
145617067|NCT02855164|525111454|FG001|Part C (Randomized Set)|Adverse Event|0|||
145617068|NCT02855164|525111455|FG002|Part C (Randomized Set)|Adverse Event|0|||
145617069|NCT02855164|525111456|FG003|Part C (Randomized Set)|Adverse Event|0|||
145617070|NCT02855164|525111457|FG004|Part C (Randomized Set)|Adverse Event|0|||
145617071|NCT02855164|525111458|FG005|Part C (Randomized Set)|Adverse Event|5|||
145617072|NCT02855164|525111459|FG006|Part C (Randomized Set)|Adverse Event|9|||
145617073|NCT02855164|525111460|FG007|Part C (Randomized Set)|Adverse Event|2|||
145617074|NCT02855164|525111453|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
145617075|NCT02855164|525111454|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
145617076|NCT02855164|525111455|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
145617077|NCT02855164|525111456|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
145617078|NCT02855164|525111457|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
145617079|NCT02855164|525111458|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
145617080|NCT02855164|525111459|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
145617081|NCT02855164|525111460|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
145617082|NCT02855164|525111453|FG000|Part C (Randomized Set)|Physician Decision|0|||
145617083|NCT02855164|525111454|FG001|Part C (Randomized Set)|Physician Decision|0|||
145617084|NCT02855164|525111455|FG002|Part C (Randomized Set)|Physician Decision|0|||
145617085|NCT02855164|525111456|FG003|Part C (Randomized Set)|Physician Decision|0|||
145617086|NCT02855164|525111457|FG004|Part C (Randomized Set)|Physician Decision|0|||
145617087|NCT02855164|525111458|FG005|Part C (Randomized Set)|Physician Decision|1|||
145617088|NCT02855164|525111459|FG006|Part C (Randomized Set)|Physician Decision|0|||
145617089|NCT02855164|525111460|FG007|Part C (Randomized Set)|Physician Decision|1|||
145617090|NCT02855164|525111453|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
145617091|NCT02855164|525111454|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
145617092|NCT02855164|525111455|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
145617093|NCT02855164|525111456|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
145617094|NCT02855164|525111457|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
145617095|NCT02855164|525111458|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
145617096|NCT02855164|525111459|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
145617097|NCT02855164|525111460|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
145617098|NCT00876460|525111461|FG000|Combination Therapy Phase|Progressive disease|2|||
145617099|NCT00876460|525111462|FG001|Combination Therapy Phase|Progressive disease|3|||
145617100|NCT00876460|525111463|FG002|Combination Therapy Phase|Progressive disease|3|||
145617101|NCT00876460|525111464|FG003|Combination Therapy Phase|Progressive disease|3|||
145617102|NCT00876460|525111465|FG004|Combination Therapy Phase|Progressive disease|3|||
145617103|NCT00876460|525111466|FG005|Combination Therapy Phase|Progressive disease|1|||
145617104|NCT00876460|525111467|FG006|Combination Therapy Phase|Progressive disease|1|||
145617105|NCT00876460|525111468|FG007|Combination Therapy Phase|Progressive disease|1|||
145617106|NCT00876460|525111461|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
145617107|NCT00876460|525111462|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
145617108|NCT00876460|525111463|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
145617109|NCT00876460|525111464|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
145617110|NCT00876460|525111465|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
145617111|NCT00876460|525111466|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
145617112|NCT00876460|525111467|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
145617113|NCT00876460|525111468|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
145617114|NCT00876460|525111461|FG000|Combination Therapy Phase|Adverse Event|0|||
145617115|NCT00876460|525111462|FG001|Combination Therapy Phase|Adverse Event|2|||
145617116|NCT00876460|525111463|FG002|Combination Therapy Phase|Adverse Event|0|||
145617117|NCT00876460|525111464|FG003|Combination Therapy Phase|Adverse Event|2|||
145617118|NCT00876460|525111465|FG004|Combination Therapy Phase|Adverse Event|2|||
145617119|NCT00876460|525111466|FG005|Combination Therapy Phase|Adverse Event|0|||
145617120|NCT00876460|525111467|FG006|Combination Therapy Phase|Adverse Event|3|||
145617121|NCT00876460|525111468|FG007|Combination Therapy Phase|Adverse Event|2|||
145617122|NCT00876460|525111461|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
145617123|NCT00876460|525111462|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
145617124|NCT00876460|525111463|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
145617125|NCT00876460|525111464|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
145617126|NCT00876460|525111465|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
145617127|NCT00876460|525111466|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
145617128|NCT00876460|525111467|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
145617129|NCT00876460|525111468|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
145617130|NCT00876460|525111461|FG000|Combination Therapy Phase|Other reason not defined above|0|||
145617131|NCT00876460|525111462|FG001|Combination Therapy Phase|Other reason not defined above|0|||
145617132|NCT00876460|525111463|FG002|Combination Therapy Phase|Other reason not defined above|0|||
145617133|NCT00876460|525111464|FG003|Combination Therapy Phase|Other reason not defined above|0|||
145617134|NCT00876460|525111465|FG004|Combination Therapy Phase|Other reason not defined above|0|||
145617135|NCT00876460|525111466|FG005|Combination Therapy Phase|Other reason not defined above|0|||
145617136|NCT00876460|525111467|FG006|Combination Therapy Phase|Other reason not defined above|1|||
145617137|NCT00876460|525111468|FG007|Combination Therapy Phase|Other reason not defined above|2|||
145617138|NCT00876460|525111461|FG000|Combination Therapy Phase|Not treated|0|||
145617139|NCT00876460|525111462|FG001|Combination Therapy Phase|Not treated|0|||
145617140|NCT00876460|525111463|FG002|Combination Therapy Phase|Not treated|0|||
145617141|NCT00876460|525111464|FG003|Combination Therapy Phase|Not treated|0|||
145617142|NCT00876460|525111465|FG004|Combination Therapy Phase|Not treated|0|||
145617143|NCT00876460|525111466|FG005|Combination Therapy Phase|Not treated|0|||
145617144|NCT00876460|525111467|FG006|Combination Therapy Phase|Not treated|1|||
145617145|NCT00876460|525111468|FG007|Combination Therapy Phase|Not treated|0|||
145617146|NCT00876460|525111461|FG000|Mono Therapy Phase|Progressive disease|0|||
145617147|NCT00876460|525111462|FG001|Mono Therapy Phase|Progressive disease|0|||
145617148|NCT00876460|525111463|FG002|Mono Therapy Phase|Progressive disease|0|||
145617149|NCT00876460|525111464|FG003|Mono Therapy Phase|Progressive disease|0|||
145617150|NCT00876460|525111465|FG004|Mono Therapy Phase|Progressive disease|2|||
145407527|NCT00460798|524349710|FG000|Overall Study|Lost to Follow-up|19|||
145292781|NCT05014412|523922235|FG003|Overall Study|Withdrawal by Subject|2|||
145292782|NCT05014412|523922232|FG000|Overall Study|Ongoing|21|||
145292783|NCT05014412|523922233|FG001|Overall Study|Ongoing|4|||
145292784|NCT05014412|523922234|FG002|Overall Study|Ongoing|6|||
145292785|NCT05014412|523922235|FG003|Overall Study|Ongoing|20|||
145292786|NCT02353169|523922236|FG000|Overall Study|QTc > 450 msec|1|||
145292787|NCT02353169|523922237|FG001|Overall Study|QTc > 450 msec|1|||
145292788|NCT02353169|523922238|FG002|Overall Study|QTc > 450 msec|1|||
145292789|NCT02353169|523922239|FG003|Overall Study|QTc > 450 msec|1|||
145292790|NCT02353169|523922236|FG000|Overall Study|OR team declined|2|||
145292791|NCT02353169|523922237|FG001|Overall Study|OR team declined|0|||
145292792|NCT02353169|523922238|FG002|Overall Study|OR team declined|0|||
145292793|NCT02353169|523922239|FG003|Overall Study|OR team declined|0|||
145292794|NCT02353169|523922236|FG000|Overall Study|Inhalational induction|0|||
145292795|NCT02353169|523922237|FG001|Overall Study|Inhalational induction|2|||
145292796|NCT02353169|523922238|FG002|Overall Study|Inhalational induction|0|||
145292797|NCT02353169|523922239|FG003|Overall Study|Inhalational induction|0|||
145292798|NCT02353169|523922236|FG000|Overall Study|ECG data error|0|||
145292799|NCT02353169|523922237|FG001|Overall Study|ECG data error|3|||
145292800|NCT02353169|523922238|FG002|Overall Study|ECG data error|2|||
145292801|NCT02353169|523922239|FG003|Overall Study|ECG data error|2|||
145292802|NCT02353169|523922236|FG000|Overall Study|Pre-op medication|0|||
145292803|NCT02353169|523922237|FG001|Overall Study|Pre-op medication|0|||
145292804|NCT02353169|523922238|FG002|Overall Study|Pre-op medication|1|||
145292805|NCT02353169|523922239|FG003|Overall Study|Pre-op medication|0|||
145292806|NCT00486837|523922242|FG000|Overall Study|Withdrawal by Subject|1|||
145558240|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
145558241|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
145558242|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
145558243|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
145558244|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
145558245|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
145558246|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
145558247|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
145558248|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
145558249|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
145558250|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
145558251|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
145558252|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
145558253|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
145558254|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
145558255|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
145558256|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
145558257|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
145558258|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
145558259|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
145558260|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
145558261|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
145558262|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
145558263|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
145292807|NCT00486837|523922243|FG001|Overall Study|Withdrawal by Subject|0|||
145292808|NCT00486837|523922242|FG000|Overall Study|Adverse Event|1|||
145292809|NCT00486837|523922243|FG001|Overall Study|Adverse Event|1|||
145292810|NCT00486837|523922242|FG000|Overall Study|Protocol Violation|4|||
145292811|NCT00486837|523922243|FG001|Overall Study|Protocol Violation|2|||
145292812|NCT00486837|523922242|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
145292813|NCT00486837|523922243|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
145617151|NCT00876460|525111466|FG005|Mono Therapy Phase|Progressive disease|0|||
145617152|NCT00876460|525111467|FG006|Mono Therapy Phase|Progressive disease|1|||
145617153|NCT00876460|525111468|FG007|Mono Therapy Phase|Progressive disease|3|||
145617154|NCT00876460|525111461|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
145617155|NCT00876460|525111462|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
145617156|NCT00876460|525111463|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
145617157|NCT00876460|525111464|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
145617158|NCT00876460|525111465|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
145617159|NCT00876460|525111466|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
145617160|NCT00876460|525111467|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
145617161|NCT00876460|525111468|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
145617162|NCT00876460|525111461|FG000|Mono Therapy Phase|Adverse Event|0|||
145617163|NCT00876460|525111462|FG001|Mono Therapy Phase|Adverse Event|0|||
145617164|NCT00876460|525111463|FG002|Mono Therapy Phase|Adverse Event|0|||
145617165|NCT00876460|525111464|FG003|Mono Therapy Phase|Adverse Event|1|||
145617166|NCT00876460|525111465|FG004|Mono Therapy Phase|Adverse Event|0|||
145617167|NCT00876460|525111466|FG005|Mono Therapy Phase|Adverse Event|0|||
145617168|NCT00876460|525111467|FG006|Mono Therapy Phase|Adverse Event|0|||
145617169|NCT00876460|525111468|FG007|Mono Therapy Phase|Adverse Event|0|||
145407528|NCT00460798|524349710|FG000|Overall Study|Progressive Disease|99|||
145617170|NCT00064025|525111469|FG000|Overall Study|Ineligible|4|||
145617171|NCT00064025|525111469|FG000|Overall Study|Inevaluable|3|||
145617172|NCT02468934|525111470|FG000|Overall Study|Withdrawal by Subject|4|||
145617173|NCT02468934|525111470|FG000|Overall Study|Screen Failure|3|||
145617174|NCT00547911|525111474|FG000|Overall Study|Adverse Event|0|||
145617175|NCT00547911|525111475|FG001|Overall Study|Adverse Event|0|||
145617176|NCT00547911|525111476|FG002|Overall Study|Adverse Event|0|||
145617177|NCT00547911|525111477|FG003|Overall Study|Adverse Event|1|||
145617178|NCT00547911|525111478|FG004|Overall Study|Adverse Event|0|||
145617179|NCT00547911|525111479|FG005|Overall Study|Adverse Event|0|||
145617180|NCT01644474|525111480|FG000|Overall Study|Poor compliance to protocol|1|||
145617181|NCT01644474|525111481|FG001|Overall Study|Poor compliance to protocol|0|||
145617182|NCT01644474|525111480|FG000|Overall Study|Consent withdrawn by participant|0|||
145617183|NCT01644474|525111481|FG001|Overall Study|Consent withdrawn by participant|1|||
145617184|NCT01644474|525111480|FG000|Overall Study|Participant moved|0|||
145617185|NCT01644474|525111481|FG001|Overall Study|Participant moved|1|||
145617186|NCT01644474|525111480|FG000|Overall Study|Adverse Event|4|||
145617187|NCT01644474|525111481|FG001|Overall Study|Adverse Event|5|||
145617188|NCT01644474|525111480|FG000|Overall Study|Site scheduling error|1|||
145617189|NCT01644474|525111481|FG001|Overall Study|Site scheduling error|1|||
145617190|NCT01644474|525111480|FG000|Overall Study|Protocol Violation|1|||
145617191|NCT01644474|525111481|FG001|Overall Study|Protocol Violation|0|||
145617192|NCT01500226|525113343|FG000|Overall Study|Adverse Event|31|||
145617193|NCT01500226|525113344|FG001|Overall Study|Adverse Event|38|||
145617194|NCT01500226|525113343|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
145617195|NCT01500226|525113344|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
145617196|NCT01500226|525113343|FG000|Overall Study|Withdrawal by Subject|93|||
145617197|NCT01500226|525113344|FG001|Overall Study|Withdrawal by Subject|96|||
145617198|NCT01500226|525113343|FG000|Overall Study|Death|12|||
145617199|NCT01500226|525113344|FG001|Overall Study|Death|4|||
145617200|NCT01500226|525113343|FG000|Overall Study|Disease Progression|16|||
145617201|NCT01500226|525113344|FG001|Overall Study|Disease Progression|14|||
145617202|NCT01500226|525113343|FG000|Overall Study|Protocol Violation|53|||
145617203|NCT01500226|525113344|FG001|Overall Study|Protocol Violation|39|||
145617204|NCT01500226|525113343|FG000|Overall Study|Physician Decision|17|||
145617205|NCT01500226|525113344|FG001|Overall Study|Physician Decision|15|||
145617206|NCT01500226|525113343|FG000|Overall Study|Lack of Efficacy|14|||
145617207|NCT01500226|525113344|FG001|Overall Study|Lack of Efficacy|30|||
145617208|NCT01500226|525113343|FG000|Overall Study|Lost to Follow-up|9|||
145617209|NCT01500226|525113344|FG001|Overall Study|Lost to Follow-up|5|||
145617210|NCT01500226|525113343|FG000|Overall Study|Other Reasons|19|||
145617211|NCT01500226|525113344|FG001|Overall Study|Other Reasons|16|||
145617212|NCT04212169|525113345|FG000|Overall Study|Adverse Event|0|||
145617213|NCT04212169|525113346|FG001|Overall Study|Adverse Event|0|||
145617214|NCT04212169|525113347|FG002|Overall Study|Adverse Event|0|||
145617215|NCT04212169|525113348|FG003|Overall Study|Adverse Event|2|||
145617216|NCT04212169|525113345|FG000|Overall Study|Lost to Follow-up|1|||
145617217|NCT04212169|525113346|FG001|Overall Study|Lost to Follow-up|0|||
145617218|NCT04212169|525113347|FG002|Overall Study|Lost to Follow-up|0|||
145617219|NCT04212169|525113348|FG003|Overall Study|Lost to Follow-up|2|||
145617220|NCT04212169|525113345|FG000|Overall Study|Withdrawal by Subject|10|||
145617221|NCT04212169|525113346|FG001|Overall Study|Withdrawal by Subject|2|||
145617222|NCT04212169|525113347|FG002|Overall Study|Withdrawal by Subject|5|||
145617223|NCT04212169|525113348|FG003|Overall Study|Withdrawal by Subject|7|||
145617224|NCT04212169|525113345|FG000|Overall Study|Other reason, unspecified|3|||
145617225|NCT04212169|525113346|FG001|Overall Study|Other reason, unspecified|1|||
145617226|NCT04212169|525113347|FG002|Overall Study|Other reason, unspecified|0|||
145617227|NCT04212169|525113348|FG003|Overall Study|Other reason, unspecified|2|||
145617228|NCT02176928|525113349|FG000|Overall Study|Lost to Follow-up|2|||
145407529|NCT00460798|524349710|FG000|Overall Study|Other|27|||
145407530|NCT00460798|524349710|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
145407531|NCT00460798|524349710|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
145407532|NCT04666298|524349718|FG000|Overall Study|Subject decision|1|||
145407533|NCT04666298|524349719|FG001|Overall Study|Subject decision|0|||
145407534|NCT04666298|524349720|FG002|Overall Study|Subject decision|0|||
145407535|NCT04666298|524349721|FG003|Overall Study|Subject decision|2|||
145407536|NCT04666298|524349718|FG000|Overall Study|Death|1|||
145407537|NCT04666298|524349719|FG001|Overall Study|Death|0|||
145407538|NCT04666298|524349720|FG002|Overall Study|Death|0|||
145407539|NCT04666298|524349721|FG003|Overall Study|Death|0|||
145407540|NCT04666298|524349718|FG000|Overall Study|Lost to Follow-up|0|||
145407541|NCT04666298|524349719|FG001|Overall Study|Lost to Follow-up|0|||
145617229|NCT02176928|525113350|FG001|Overall Study|Lost to Follow-up|4|||
145617230|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
145617231|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
145617232|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
145617233|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
145617234|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
145617235|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
145617236|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
145617237|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
145617238|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
145617239|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
145617240|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617241|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617242|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617243|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
145617244|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
145617245|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617246|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617247|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617248|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617249|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
145617250|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
145617251|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
145617252|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
145617253|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
145617254|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
145617255|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
145617256|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
145617257|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
145617258|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
145617259|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
145617260|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
145617261|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617262|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617263|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
145617264|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
145617265|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617266|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617267|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617268|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617269|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
145617270|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617271|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617272|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
145617273|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
145617274|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617275|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617276|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617277|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617278|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617279|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
145617280|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617281|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617282|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617283|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617284|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
145617285|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617286|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617287|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617288|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617289|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
145617290|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617291|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617292|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617293|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
145617294|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
145617295|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
145617296|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617297|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617298|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617299|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
145617300|NCT02018861|525113358|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617301|NCT02018861|525113359|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617302|NCT02018861|525113360|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617303|NCT02018861|525113361|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
145617304|NCT02018861|525113362|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
145617305|NCT02018861|525113363|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617306|NCT02018861|525113364|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617307|NCT02018861|525113365|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617308|NCT02018861|525113366|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617309|NCT02018861|525113367|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
145617310|NCT02018861|525113358|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617311|NCT02018861|525113359|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617312|NCT02018861|525113360|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617313|NCT02018861|525113361|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617314|NCT02018861|525113362|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617315|NCT02018861|525113363|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617316|NCT02018861|525113364|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
145617317|NCT02018861|525113365|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
145617318|NCT02018861|525113366|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617319|NCT02018861|525113367|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
145617320|NCT02018861|525113358|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617321|NCT02018861|525113359|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617322|NCT02018861|525113360|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617323|NCT02018861|525113361|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617324|NCT02018861|525113362|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617325|NCT02018861|525113363|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617326|NCT02018861|525113364|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
145617327|NCT02018861|525113365|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
145617328|NCT02018861|525113366|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617329|NCT02018861|525113367|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
145617330|NCT02018861|525113358|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617331|NCT02018861|525113359|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617332|NCT02018861|525113360|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617333|NCT02018861|525113361|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617334|NCT02018861|525113362|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617335|NCT02018861|525113363|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617336|NCT02018861|525113364|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617337|NCT02018861|525113365|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617338|NCT02018861|525113366|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
145617339|NCT02018861|525113367|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
145617340|NCT02018861|525113358|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617341|NCT02018861|525113359|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617342|NCT02018861|525113360|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617343|NCT02018861|525113361|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617344|NCT02018861|525113362|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617345|NCT02018861|525113363|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617346|NCT02018861|525113364|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617347|NCT02018861|525113365|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617348|NCT02018861|525113366|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
145617349|NCT02018861|525113367|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
145617350|NCT02018861|525113358|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617351|NCT02018861|525113359|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617352|NCT02018861|525113360|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617353|NCT02018861|525113361|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617354|NCT02018861|525113362|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617355|NCT02018861|525113363|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145292814|NCT02468778|523922244|FG000|Overall Study|Death|2|||
145292815|NCT02468778|523922245|FG001|Overall Study|Death|1|||
145292816|NCT02468778|523922246|FG002|Overall Study|Death|0|||
145292817|NCT02468778|523922244|FG000|Overall Study|Lost to Follow-up|1|||
145292818|NCT02468778|523922245|FG001|Overall Study|Lost to Follow-up|2|||
145292819|NCT02468778|523922246|FG002|Overall Study|Lost to Follow-up|2|||
145292820|NCT02468778|523922244|FG000|Overall Study|Withdrawal by Subject|0|||
145292821|NCT02468778|523922245|FG001|Overall Study|Withdrawal by Subject|1|||
145292822|NCT02468778|523922246|FG002|Overall Study|Withdrawal by Subject|1|||
145292823|NCT03257462|523922249|FG000|Cohort A|Lost to Follow-up|1|||
145292824|NCT03257462|523922250|FG001|Cohort A|Lost to Follow-up|0|||
145292825|NCT03257462|523922251|FG002|Cohort A|Lost to Follow-up|0|||
145292826|NCT03257462|523922252|FG003|Cohort A|Lost to Follow-up|0|||
145292827|NCT03257462|523922249|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
145292828|NCT03257462|523922250|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
145292829|NCT03257462|523922251|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
145292830|NCT03257462|523922252|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
145292831|NCT00368277|523922253|FG000|Overall Study|Adverse Event|33|||
145292832|NCT00368277|523922254|FG001|Overall Study|Adverse Event|49|||
145292833|NCT00368277|523922253|FG000|Overall Study|Death|2|||
145407542|NCT04666298|524349720|FG002|Overall Study|Lost to Follow-up|0|||
145407543|NCT04666298|524349721|FG003|Overall Study|Lost to Follow-up|1|||
145407544|NCT04666298|524349718|FG000|Overall Study|Physician Decision|0|||
145407545|NCT04666298|524349719|FG001|Overall Study|Physician Decision|0|||
145407546|NCT04666298|524349720|FG002|Overall Study|Physician Decision|0|||
145407547|NCT04666298|524349721|FG003|Overall Study|Physician Decision|1|||
145407548|NCT04666298|524349718|FG000|Overall Study|Protocol deviation|0|||
145407549|NCT04666298|524349719|FG001|Overall Study|Protocol deviation|0|||
145407550|NCT04666298|524349720|FG002|Overall Study|Protocol deviation|1|||
145407551|NCT04666298|524349721|FG003|Overall Study|Protocol deviation|0|||
145407552|NCT02178956|524349722|FG000|Overall Study|Lost to Follow-up|4|||
145407553|NCT02178956|524349723|FG001|Overall Study|Lost to Follow-up|4|||
145407554|NCT02178956|524349722|FG000|Overall Study|Sponsor terminated study|49|||
145407555|NCT02178956|524349723|FG001|Overall Study|Sponsor terminated study|58|||
145407556|NCT02178956|524349722|FG000|Overall Study|Withdrawal by Subject|15|||
145407557|NCT02178956|524349723|FG001|Overall Study|Withdrawal by Subject|11|||
145407558|NCT02178956|524349722|FG000|Overall Study|Various Reasons|3|||
145407559|NCT02178956|524349723|FG001|Overall Study|Various Reasons|5|||
145407560|NCT01756235|524349724|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
145407561|NCT02327078|524349725|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145407562|NCT02327078|524349726|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145407563|NCT02327078|524349727|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
145407564|NCT02327078|524349728|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145407565|NCT02327078|524349729|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
145407566|NCT02327078|524349730|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145407567|NCT02327078|524349731|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
145407568|NCT02327078|524349732|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
145407569|NCT02327078|524349733|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
145407570|NCT02327078|524349725|FG000|Overall Study|Death|2|||
145407571|NCT02327078|524349726|FG001|Overall Study|Death|4|||
145407572|NCT02327078|524349727|FG002|Overall Study|Death|10|||
145407573|NCT02327078|524349728|FG003|Overall Study|Death|6|||
145407574|NCT02327078|524349729|FG004|Overall Study|Death|4|||
145407575|NCT02327078|524349730|FG005|Overall Study|Death|3|||
145407576|NCT02327078|524349731|FG006|Overall Study|Death|2|||
145407577|NCT02327078|524349732|FG007|Overall Study|Death|51|||
145407578|NCT02327078|524349733|FG008|Overall Study|Death|97|||
145407579|NCT02327078|524349725|FG000|Overall Study|Lost to Follow-up|0|||
145407580|NCT02327078|524349726|FG001|Overall Study|Lost to Follow-up|1|||
145407581|NCT02327078|524349727|FG002|Overall Study|Lost to Follow-up|1|||
145407582|NCT02327078|524349728|FG003|Overall Study|Lost to Follow-up|0|||
145407583|NCT02327078|524349729|FG004|Overall Study|Lost to Follow-up|0|||
145407584|NCT02327078|524349730|FG005|Overall Study|Lost to Follow-up|0|||
145407585|NCT02327078|524349731|FG006|Overall Study|Lost to Follow-up|0|||
145407586|NCT02327078|524349732|FG007|Overall Study|Lost to Follow-up|2|||
145558264|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
145558265|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
145558266|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
145558267|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
145558268|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
145558269|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
145558270|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
145558271|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
145617356|NCT02018861|525113364|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145292834|NCT00368277|523922254|FG001|Overall Study|Death|1|||
145407587|NCT02327078|524349733|FG008|Overall Study|Lost to Follow-up|5|||
145407588|NCT02327078|524349725|FG000|Overall Study|Site Terminated by Sponsor|1|||
145407589|NCT02327078|524349726|FG001|Overall Study|Site Terminated by Sponsor|0|||
145407590|NCT02327078|524349727|FG002|Overall Study|Site Terminated by Sponsor|1|||
145292835|NCT00368277|523922253|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
145407591|NCT02327078|524349728|FG003|Overall Study|Site Terminated by Sponsor|4|||
145617357|NCT02018861|525113365|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617358|NCT02018861|525113366|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
145617359|NCT02018861|525113367|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
145617360|NCT00504348|525113371|FG000|Overall Study|Adverse Event|3|||
145617361|NCT00504348|525113371|FG000|Overall Study|Lack of Efficacy|4|||
145617362|NCT00504348|525113371|FG000|Overall Study|Physician Decision|1|||
145617363|NCT00224133|525113372|FG000|Overall Study|Adverse Event|93|||
145617364|NCT00224133|525113372|FG000|Overall Study|Protocol Violation|6|||
145617365|NCT00224133|525113372|FG000|Overall Study|Withdrawal by Subject|33|||
145617366|NCT00224133|525113372|FG000|Overall Study|Lack of Efficacy|58|||
145617367|NCT00224133|525113372|FG000|Overall Study|Lost to Follow-up|21|||
145617368|NCT00224133|525113372|FG000|Overall Study|Physician Decision|1|||
145617369|NCT00224133|525113372|FG000|Overall Study|Other|14|||
145617370|NCT03699124|525113374|FG000|Overall Study|Adverse Event|6|||
145617371|NCT03699124|525113375|FG001|Overall Study|Adverse Event|5|||
145617372|NCT03699124|525113376|FG002|Overall Study|Adverse Event|2|||
145617373|NCT03699124|525113374|FG000|Overall Study|Death|0|||
145617374|NCT03699124|525113375|FG001|Overall Study|Death|2|||
145617375|NCT03699124|525113376|FG002|Overall Study|Death|0|||
145617376|NCT03699124|525113374|FG000|Overall Study|Lost to Follow-up|20|||
145617377|NCT03699124|525113375|FG001|Overall Study|Lost to Follow-up|16|||
145617378|NCT03699124|525113376|FG002|Overall Study|Lost to Follow-up|15|||
145617379|NCT03699124|525113374|FG000|Overall Study|Protocol Violation|1|||
145617380|NCT03699124|525113375|FG001|Overall Study|Protocol Violation|0|||
145617381|NCT03699124|525113376|FG002|Overall Study|Protocol Violation|0|||
145617382|NCT03699124|525113374|FG000|Overall Study|Withdrawal by Subject|13|||
145407592|NCT02327078|524349729|FG004|Overall Study|Site Terminated by Sponsor|0|||
145407593|NCT02327078|524349730|FG005|Overall Study|Site Terminated by Sponsor|0|||
145617383|NCT03699124|525113375|FG001|Overall Study|Withdrawal by Subject|14|||
145617384|NCT03699124|525113376|FG002|Overall Study|Withdrawal by Subject|13|||
145617385|NCT03699124|525113374|FG000|Overall Study|Other reasons|5|||
145617386|NCT03699124|525113375|FG001|Overall Study|Other reasons|3|||
145617387|NCT03699124|525113376|FG002|Overall Study|Other reasons|10|||
145617388|NCT01890967|525113380|FG000|Overall Study|Adverse Event|3|||
145617389|NCT01890967|525113381|FG001|Overall Study|Adverse Event|3|||
145617390|NCT01890967|525113382|FG002|Overall Study|Adverse Event|3|||
145617391|NCT01890967|525113383|FG003|Overall Study|Adverse Event|2|||
145617392|NCT01890967|525113384|FG004|Overall Study|Adverse Event|1|||
145617393|NCT01890967|525113385|FG005|Overall Study|Adverse Event|7|||
145617394|NCT01890967|525113380|FG000|Overall Study|Death|1|||
145617395|NCT01890967|525113381|FG001|Overall Study|Death|0|||
145617396|NCT01890967|525113382|FG002|Overall Study|Death|0|||
145407594|NCT02327078|524349731|FG006|Overall Study|Site Terminated by Sponsor|0|||
145407595|NCT02327078|524349732|FG007|Overall Study|Site Terminated by Sponsor|11|||
145407596|NCT02327078|524349733|FG008|Overall Study|Site Terminated by Sponsor|25|||
145407597|NCT02327078|524349725|FG000|Overall Study|Physician Decision|0|||
145407598|NCT02327078|524349726|FG001|Overall Study|Physician Decision|0|||
145407599|NCT02327078|524349727|FG002|Overall Study|Physician Decision|0|||
145407600|NCT02327078|524349728|FG003|Overall Study|Physician Decision|1|||
145407601|NCT02327078|524349729|FG004|Overall Study|Physician Decision|0|||
145407602|NCT02327078|524349730|FG005|Overall Study|Physician Decision|0|||
145407603|NCT02327078|524349731|FG006|Overall Study|Physician Decision|0|||
145407604|NCT02327078|524349732|FG007|Overall Study|Physician Decision|0|||
145407605|NCT02327078|524349733|FG008|Overall Study|Physician Decision|1|||
145407606|NCT02327078|524349725|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145407607|NCT02327078|524349726|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145407608|NCT02327078|524349727|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145407609|NCT02327078|524349728|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145407610|NCT02327078|524349729|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145617397|NCT01890967|525113383|FG003|Overall Study|Death|0|||
145617398|NCT01890967|525113384|FG004|Overall Study|Death|0|||
145617399|NCT01890967|525113385|FG005|Overall Study|Death|0|||
145617400|NCT01890967|525113380|FG000|Overall Study|Lost to Follow-up|1|||
145617401|NCT01890967|525113381|FG001|Overall Study|Lost to Follow-up|1|||
145617402|NCT01890967|525113382|FG002|Overall Study|Lost to Follow-up|1|||
145617403|NCT01890967|525113383|FG003|Overall Study|Lost to Follow-up|1|||
145617404|NCT01890967|525113384|FG004|Overall Study|Lost to Follow-up|0|||
145617405|NCT01890967|525113385|FG005|Overall Study|Lost to Follow-up|1|||
145617406|NCT01890967|525113380|FG000|Overall Study|Protocol Violation|0|||
145617407|NCT01890967|525113381|FG001|Overall Study|Protocol Violation|3|||
145407611|NCT02327078|524349730|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
145407612|NCT02327078|524349731|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
145407613|NCT02327078|524349732|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
145407614|NCT02327078|524349733|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
145407615|NCT02327078|524349725|FG000|Overall Study|Reason not Specified|0|||
145617408|NCT01890967|525113382|FG002|Overall Study|Protocol Violation|3|||
145407616|NCT02327078|524349726|FG001|Overall Study|Reason not Specified|0|||
145617409|NCT01890967|525113383|FG003|Overall Study|Protocol Violation|2|||
145292836|NCT00368277|523922254|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
145292837|NCT00368277|523922253|FG000|Overall Study|Protocol deviation|7|||
145292838|NCT00368277|523922254|FG001|Overall Study|Protocol deviation|0|||
145292839|NCT00368277|523922253|FG000|Overall Study|Patient withdrew consent|32|||
145292840|NCT00368277|523922254|FG001|Overall Study|Patient withdrew consent|28|||
145292841|NCT00368277|523922253|FG000|Overall Study|Lost to Follow-up|8|||
145292842|NCT00368277|523922254|FG001|Overall Study|Lost to Follow-up|6|||
145292843|NCT04347239|523922255|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
145558272|NCT03742037|524902464|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558273|NCT03742037|524902465|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558274|NCT03742037|524902466|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
145558275|NCT03742037|524902467|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558276|NCT03742037|524902468|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558277|NCT03742037|524902469|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558278|NCT03742037|524902470|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
145558279|NCT04447755|524902471|FG000|Overall Study|Death|9|||
145558280|NCT04447755|524902472|FG001|Overall Study|Death|16|||
145558281|NCT04447755|524902473|FG002|Overall Study|Death|8|||
145558282|NCT04447755|524902474|FG003|Overall Study|Death|9|||
145558283|NCT04447755|524902475|FG004|Overall Study|Death|8|||
145558284|NCT04447755|524902476|FG005|Overall Study|Death|9|||
145558285|NCT04447755|524902477|FG006|Overall Study|Death|55|||
145558286|NCT04447755|524902471|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145558287|NCT04447755|524902472|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145558288|NCT04447755|524902473|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145558289|NCT04447755|524902474|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145558290|NCT04447755|524902475|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145558291|NCT04447755|524902476|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145558292|NCT04447755|524902477|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
145558293|NCT04447755|524902471|FG000|Overall Study|Sponsor Decision|0|||
145558294|NCT04447755|524902472|FG001|Overall Study|Sponsor Decision|0|||
145558295|NCT04447755|524902473|FG002|Overall Study|Sponsor Decision|0|||
145558296|NCT04447755|524902474|FG003|Overall Study|Sponsor Decision|0|||
145558297|NCT04447755|524902475|FG004|Overall Study|Sponsor Decision|1|||
145558298|NCT04447755|524902476|FG005|Overall Study|Sponsor Decision|0|||
145558299|NCT04447755|524902477|FG006|Overall Study|Sponsor Decision|10|||
145558300|NCT04447755|524902471|FG000|Overall Study|Lost to Follow-up|0|||
145558301|NCT04447755|524902472|FG001|Overall Study|Lost to Follow-up|0|||
145558302|NCT04447755|524902473|FG002|Overall Study|Lost to Follow-up|0|||
145558303|NCT04447755|524902474|FG003|Overall Study|Lost to Follow-up|0|||
145558304|NCT04447755|524902475|FG004|Overall Study|Lost to Follow-up|0|||
145558305|NCT04447755|524902476|FG005|Overall Study|Lost to Follow-up|0|||
145558306|NCT04447755|524902477|FG006|Overall Study|Lost to Follow-up|1|||
145558307|NCT00619801|524902480|FG000|Overall Study|Lack of Efficacy|0|||
145558308|NCT00619801|524902481|FG001|Overall Study|Lack of Efficacy|1|||
145558309|NCT00619801|524902480|FG000|Overall Study|Withdrawal by Subject|1|||
145558310|NCT00619801|524902481|FG001|Overall Study|Withdrawal by Subject|1|||
145558311|NCT00619801|524902480|FG000|Overall Study|Loss of efficacy|0|||
145558312|NCT00619801|524902481|FG001|Overall Study|Loss of efficacy|1|||
145558313|NCT03051607|524902484|FG000|Overall Study|Adverse Event|66|||
145558314|NCT03338855|524902486|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
145558315|NCT03338855|524902487|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
145558316|NCT00455429|524902488|FG000|Overall Study|Study Terminated by Sponsor|0|||
145558317|NCT00455429|524902489|FG001|Overall Study|Study Terminated by Sponsor|0|||
145558318|NCT00455429|524902490|FG002|Overall Study|Study Terminated by Sponsor|0|||
145558319|NCT00455429|524902491|FG003|Overall Study|Study Terminated by Sponsor|3|||
145558320|NCT00455429|524902488|FG000|Overall Study|Lost to Follow-up|1|||
145558321|NCT00455429|524902489|FG001|Overall Study|Lost to Follow-up|0|||
145558322|NCT00455429|524902490|FG002|Overall Study|Lost to Follow-up|0|||
145558323|NCT00455429|524902491|FG003|Overall Study|Lost to Follow-up|3|||
145558324|NCT00455429|524902488|FG000|Overall Study|Withdrawal by Subject|0|||
145558325|NCT00455429|524902489|FG001|Overall Study|Withdrawal by Subject|1|||
145558326|NCT00455429|524902490|FG002|Overall Study|Withdrawal by Subject|1|||
145558327|NCT00455429|524902491|FG003|Overall Study|Withdrawal by Subject|0|||
145558328|NCT00455429|524902488|FG000|Overall Study|Lack of Efficacy|0|||
145558329|NCT00455429|524902489|FG001|Overall Study|Lack of Efficacy|1|||
145558330|NCT00455429|524902490|FG002|Overall Study|Lack of Efficacy|0|||
145558331|NCT00455429|524902491|FG003|Overall Study|Lack of Efficacy|1|||
145558332|NCT00455429|524902488|FG000|Overall Study|Adverse Event|0|||
145292844|NCT04347239|523922256|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
145558333|NCT00455429|524902489|FG001|Overall Study|Adverse Event|1|||
145617410|NCT01890967|525113384|FG004|Overall Study|Protocol Violation|4|||
145617411|NCT01890967|525113385|FG005|Overall Study|Protocol Violation|1|||
145617412|NCT01890967|525113380|FG000|Overall Study|Sponsor Decision|2|||
145617413|NCT01890967|525113381|FG001|Overall Study|Sponsor Decision|0|||
145617414|NCT01890967|525113382|FG002|Overall Study|Sponsor Decision|1|||
145617415|NCT01890967|525113383|FG003|Overall Study|Sponsor Decision|3|||
145617416|NCT01890967|525113384|FG004|Overall Study|Sponsor Decision|2|||
145617417|NCT01890967|525113385|FG005|Overall Study|Sponsor Decision|3|||
145617418|NCT01890967|525113380|FG000|Overall Study|Withdrawal by Subject|3|||
145617419|NCT01890967|525113381|FG001|Overall Study|Withdrawal by Subject|4|||
145617420|NCT01890967|525113382|FG002|Overall Study|Withdrawal by Subject|2|||
145617421|NCT01890967|525113383|FG003|Overall Study|Withdrawal by Subject|3|||
145617422|NCT01890967|525113384|FG004|Overall Study|Withdrawal by Subject|3|||
145617423|NCT01890967|525113385|FG005|Overall Study|Withdrawal by Subject|1|||
145617424|NCT01383993|525113388|FG000|Overall Study|Adverse Event|1|||
145617425|NCT01383993|525113389|FG001|Overall Study|Adverse Event|1|||
145617426|NCT01383993|525113390|FG002|Overall Study|Adverse Event|0|||
145617427|NCT01383993|525113388|FG000|Overall Study|Withdrawal by Subject|0|||
145617428|NCT01383993|525113389|FG001|Overall Study|Withdrawal by Subject|0|||
145617429|NCT01383993|525113390|FG002|Overall Study|Withdrawal by Subject|1|||
145617430|NCT01383993|525113388|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
145617431|NCT01383993|525113389|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
145617432|NCT01383993|525113390|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
145617433|NCT00593554|525113391|FG000|Overall Study|Death|1|||
145617434|NCT00593554|525113392|FG001|Overall Study|Death|2|||
145617435|NCT00593554|525113391|FG000|Overall Study|Physician Decision|0|||
145617436|NCT00593554|525113392|FG001|Overall Study|Physician Decision|1|||
145617437|NCT00593554|525113391|FG000|Overall Study|Withdrawal by Subject|1|||
145617438|NCT00593554|525113392|FG001|Overall Study|Withdrawal by Subject|0|||
145617439|NCT00593554|525113391|FG000|Overall Study|Disease Progression|1|||
145617440|NCT00593554|525113392|FG001|Overall Study|Disease Progression|2|||
145617441|NCT00795132|525113396|FG000|Overall Study|Death|1|||
145617442|NCT00795132|525113396|FG000|Overall Study|Relapse|2|||
145617443|NCT02561455|525113397|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
145617444|NCT02561455|525113398|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
145617445|NCT02561455|525113399|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
145617446|NCT02561455|525113400|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
145617447|NCT02561455|525113397|FG000|Overall Study|Withdrawal by Subject|1|||
145617448|NCT02561455|525113398|FG001|Overall Study|Withdrawal by Subject|0|||
145617449|NCT02561455|525113399|FG002|Overall Study|Withdrawal by Subject|1|||
145617450|NCT02561455|525113400|FG003|Overall Study|Withdrawal by Subject|0|||
145617451|NCT02561455|525113397|FG000|Overall Study|Disease Progression|0|||
145617452|NCT02561455|525113398|FG001|Overall Study|Disease Progression|1|||
145617453|NCT02561455|525113399|FG002|Overall Study|Disease Progression|0|||
145617454|NCT02561455|525113400|FG003|Overall Study|Disease Progression|0|||
145617455|NCT04254679|525113401|FG000|Overall Study|Protocol Violation|1|||
145617456|NCT04254679|525113402|FG001|Overall Study|Protocol Violation|1|||
145617457|NCT04254679|525113401|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
145617458|NCT04254679|525113402|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
145617459|NCT02086552|525113403|FG000|Overall Study|Withdrawal by Subject|1|||
145617460|NCT00478608|525113408|FG000|Overall Study|Adverse Event|1|||
145617461|NCT00478608|525113408|FG000|Overall Study|Serious Adverse Event|14|||
145617462|NCT00478608|525113408|FG000|Overall Study|Withdrawal by Subject|2|||
145617463|NCT00478608|525113408|FG000|Overall Study|Protocol Violation|3|||
145617464|NCT02080520|525113409|FG000|Overall Study|Self-reported symptoms|5|||
145617465|NCT02080520|525113410|FG001|Overall Study|Self-reported symptoms|6|||
145617466|NCT02080520|525113409|FG000|Overall Study|Unable to contact|2|||
145617467|NCT02080520|525113410|FG001|Overall Study|Unable to contact|1|||
145617468|NCT02080520|525113409|FG000|Overall Study|Initiated aspirin|2|||
145617469|NCT02080520|525113410|FG001|Overall Study|Initiated aspirin|0|||
145617470|NCT02080520|525113409|FG000|Overall Study|Atrial fibrillation|1|||
145617471|NCT02080520|525113410|FG001|Overall Study|Atrial fibrillation|1|||
145617472|NCT02080520|525113409|FG000|Overall Study|Cancer|1|||
145617473|NCT02080520|525113410|FG001|Overall Study|Cancer|2|||
145617474|NCT02080520|525113409|FG000|Overall Study|Not interested in study|1|||
145617475|NCT02080520|525113410|FG001|Overall Study|Not interested in study|3|||
145617476|NCT02080520|525113409|FG000|Overall Study|Too busy|1|||
145617477|NCT02080520|525113410|FG001|Overall Study|Too busy|1|||
145617478|NCT02080520|525113409|FG000|Overall Study|Work-related injury|1|||
145617479|NCT02080520|525113410|FG001|Overall Study|Work-related injury|0|||
145617480|NCT02080520|525113409|FG000|Overall Study|Personal reasons|0|||
145617481|NCT02080520|525113410|FG001|Overall Study|Personal reasons|3|||
145617482|NCT00390455|525113411|FG000|Overall Study|Adverse Event|17|||
145617483|NCT00390455|525113412|FG001|Overall Study|Adverse Event|3|||
145617484|NCT00390455|525113411|FG000|Overall Study|Withdrawal by Subject|8|||
145617485|NCT00390455|525113412|FG001|Overall Study|Withdrawal by Subject|8|||
145292845|NCT04347239|523922257|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
145292846|NCT04347239|523922255|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
145292847|NCT04347239|523922256|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
145292848|NCT04347239|523922257|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
145292849|NCT00918567|523922258|FG000|Overall Study|Lack of Efficacy|3|||
145292850|NCT00918567|523922259|FG001|Overall Study|Lack of Efficacy|1|||
145617486|NCT00390455|525113411|FG000|Overall Study|Alternate Treatment|0|||
145617487|NCT00390455|525113412|FG001|Overall Study|Alternate Treatment|1|||
145617488|NCT00390455|525113411|FG000|Overall Study|Other Medical Reasons|7|||
145617489|NCT00390455|525113412|FG001|Overall Study|Other Medical Reasons|11|||
145617490|NCT00432679|525113417|FG000|Overall Study|Adverse Event|2|||
145617491|NCT00432679|525113418|FG001|Overall Study|Adverse Event|1|||
145617492|NCT00432679|525113417|FG000|Overall Study|Withdrawal by Subject|3|||
145617493|NCT00432679|525113418|FG001|Overall Study|Withdrawal by Subject|2|||
145617494|NCT01316692|525113423|FG000|Overall Study|Adverse Event|5|||
145617495|NCT01316692|525113423|FG000|Overall Study|Disease Progression|7|||
145617496|NCT01686932|525113426|FG000|Period 1|Adverse Event|1|||
145617497|NCT01686932|525113427|FG001|Period 1|Adverse Event|1|||
145617498|NCT01284140|525113428|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
145617499|NCT01284140|525113429|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
145617500|NCT01284140|525113428|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
145617501|NCT01284140|525113429|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
145617502|NCT04147260|525113431|FG000|Overall Study|Adverse Event|1|||
145617503|NCT04147260|525113432|FG001|Overall Study|Adverse Event|0|||
145617504|NCT04147260|525113433|FG002|Overall Study|Adverse Event|1|||
145617505|NCT04147260|525113434|FG003|Overall Study|Adverse Event|2|||
145617506|NCT04147260|525113435|FG004|Overall Study|Adverse Event|0|||
145617507|NCT04147260|525113431|FG000|Overall Study|Withdrawal by Subject|0|||
145617508|NCT04147260|525113432|FG001|Overall Study|Withdrawal by Subject|0|||
145617509|NCT04147260|525113433|FG002|Overall Study|Withdrawal by Subject|1|||
145617510|NCT04147260|525113434|FG003|Overall Study|Withdrawal by Subject|1|||
145617511|NCT04147260|525113435|FG004|Overall Study|Withdrawal by Subject|0|||
145617512|NCT01555021|525113436|FG000|Overall Study|Lost to Follow-up|1|||
145617513|NCT01555021|525113437|FG001|Overall Study|Lost to Follow-up|2|||
145617514|NCT01313923|525113441|FG000|Overall Study|Physician Decision|3|||
145617515|NCT01388530|525113442|FG000|Overall Study|Lost to Follow-up|5|||
145617516|NCT02420327|525113443|FG000|Overall Study|Adverse Event|7|||
145292851|NCT00918567|523922258|FG000|Overall Study|Withdrawal by Subject|1|||
145617517|NCT02420327|525113443|FG000|Overall Study|Pregnancy|1|||
145617518|NCT02420327|525113443|FG000|Overall Study|Withdrawal by Subject|6|||
145617519|NCT02420327|525113443|FG000|Overall Study|Lost to Follow-up|1|||
145617520|NCT02420327|525113443|FG000|Overall Study|Protocol Violation|1|||
145617521|NCT01990300|525113444|FG000|Overall Study|Case Report Forms Uncollected|89|||
145617522|NCT01990300|525113444|FG000|Overall Study|Protocol Deviation|53|||
145617523|NCT02204293|525113445|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
145617524|NCT02204293|525113446|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
145617525|NCT02204293|525113447|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
145558334|NCT00455429|524902490|FG002|Overall Study|Adverse Event|0|||
145558335|NCT00455429|524902491|FG003|Overall Study|Adverse Event|3|||
145558336|NCT00455429|524902488|FG000|Overall Study|Randomly assigned but not treated|0|||
145407617|NCT02327078|524349727|FG002|Overall Study|Reason not Specified|0|||
145617526|NCT02204293|525113448|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
145617527|NCT02204293|525113449|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
145617528|NCT02204293|525113450|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
145617529|NCT02204293|525113445|FG000|Core Study Part I|Adverse Event|1|||
145617530|NCT02204293|525113446|FG001|Core Study Part I|Adverse Event|0|||
145558337|NCT00455429|524902489|FG001|Overall Study|Randomly assigned but not treated|0|||
145617531|NCT02204293|525113447|FG002|Core Study Part I|Adverse Event|0|||
145617532|NCT02204293|525113448|FG003|Core Study Part I|Adverse Event|0|||
145617533|NCT02204293|525113449|FG004|Core Study Part I|Adverse Event|0|||
145617534|NCT02204293|525113450|FG005|Core Study Part I|Adverse Event|0|||
145617535|NCT02204293|525113445|FG000|Core Study Part I|Physician Decision|0|||
145617536|NCT02204293|525113446|FG001|Core Study Part I|Physician Decision|3|||
145617537|NCT02204293|525113447|FG002|Core Study Part I|Physician Decision|0|||
145617538|NCT02204293|525113448|FG003|Core Study Part I|Physician Decision|0|||
145617539|NCT02204293|525113449|FG004|Core Study Part I|Physician Decision|0|||
145617540|NCT02204293|525113450|FG005|Core Study Part I|Physician Decision|0|||
145617541|NCT02204293|525113445|FG000|LTE Phase|Study Suspended|0|||
145617542|NCT02204293|525113446|FG001|LTE Phase|Study Suspended|0|||
145617543|NCT02204293|525113447|FG002|LTE Phase|Study Suspended|0|||
145617544|NCT02204293|525113448|FG003|LTE Phase|Study Suspended|0|||
145617545|NCT02204293|525113449|FG004|LTE Phase|Study Suspended|0|||
145617546|NCT02204293|525113450|FG005|LTE Phase|Study Suspended|7|||
145617547|NCT01225835|525113453|FG000|Overall Study|Completed protocol|2|||
145617548|NCT01225835|525113454|FG001|Overall Study|Completed protocol|1|||
145617549|NCT01225835|525113453|FG000|Overall Study|Did not meet hCG criterion|2|||
145617550|NCT01225835|525113454|FG001|Overall Study|Did not meet hCG criterion|0|||
145617551|NCT01225835|525113453|FG000|Overall Study|Adverse Event|2|||
145617552|NCT01225835|525113454|FG001|Overall Study|Adverse Event|1|||
145617553|NCT01225835|525113453|FG000|Overall Study|Other|1|||
145617554|NCT01225835|525113454|FG001|Overall Study|Other|1|||
145617555|NCT01266993|525113455|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
145617556|NCT01266993|525113456|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
145617557|NCT01266993|525113455|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
145617558|NCT01266993|525113456|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
145617559|NCT02589392|525113457|FG000|Overall Study|Adverse Event|1|||
145617560|NCT02589392|525113458|FG001|Overall Study|Adverse Event|1|||
145617561|NCT02589392|525113457|FG000|Overall Study|Withdrawal by Subject|1|||
145617562|NCT02589392|525113458|FG001|Overall Study|Withdrawal by Subject|2|||
145617563|NCT02589392|525113457|FG000|Overall Study|Protocol Violation|1|||
145617564|NCT02589392|525113458|FG001|Overall Study|Protocol Violation|1|||
145617565|NCT02589392|525113457|FG000|Overall Study|Lost to Follow-up|2|||
145617566|NCT02589392|525113458|FG001|Overall Study|Lost to Follow-up|2|||
145617567|NCT02589392|525113457|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
145617568|NCT02589392|525113458|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
145617569|NCT03051659|525113459|FG000|Treatment Period|Withdrawal by Subject|0|||
145617570|NCT03051659|525113460|FG001|Treatment Period|Withdrawal by Subject|2|||
145407618|NCT02327078|524349728|FG003|Overall Study|Reason not Specified|0|||
145558338|NCT00455429|524902490|FG002|Overall Study|Randomly assigned but not treated|0|||
145558339|NCT00455429|524902491|FG003|Overall Study|Randomly assigned but not treated|2|||
145558340|NCT00455429|524902488|FG000|Overall Study|Personal Reason|1|||
145558341|NCT00455429|524902489|FG001|Overall Study|Personal Reason|0|||
145558342|NCT00455429|524902490|FG002|Overall Study|Personal Reason|0|||
145617571|NCT03051659|525113459|FG000|Survival Follow-up|Lost to Follow-up|23|||
145617572|NCT03051659|525113460|FG001|Survival Follow-up|Lost to Follow-up|22|||
145617573|NCT02293837|525113461|FG000|Overall Study|Lost to Follow-up|0|||
145617574|NCT02293837|525113462|FG001|Overall Study|Lost to Follow-up|2|||
145617575|NCT02293837|525113463|FG002|Overall Study|Lost to Follow-up|1|||
145617576|NCT02293837|525113464|FG003|Overall Study|Lost to Follow-up|0|||
145407619|NCT02327078|524349729|FG004|Overall Study|Reason not Specified|0|||
145558343|NCT00455429|524902491|FG003|Overall Study|Personal Reason|0|||
145617577|NCT02293837|525113461|FG000|Overall Study|Withdrawal by Subject|2|||
145617578|NCT02293837|525113462|FG001|Overall Study|Withdrawal by Subject|1|||
145617579|NCT02293837|525113463|FG002|Overall Study|Withdrawal by Subject|2|||
145617580|NCT02293837|525113464|FG003|Overall Study|Withdrawal by Subject|1|||
145617581|NCT02293837|525113461|FG000|Overall Study|COVID-19 Related|1|||
145617582|NCT02293837|525113462|FG001|Overall Study|COVID-19 Related|1|||
145407620|NCT02327078|524349730|FG005|Overall Study|Reason not Specified|0|||
145407621|NCT02327078|524349731|FG006|Overall Study|Reason not Specified|0|||
145407622|NCT02327078|524349732|FG007|Overall Study|Reason not Specified|5|||
145407623|NCT02327078|524349733|FG008|Overall Study|Reason not Specified|12|||
145407624|NCT04797169|524349736|FG000|Overall Study|Lost to Follow-up|84|||
145407625|NCT04797169|524349737|FG001|Overall Study|Lost to Follow-up|67|||
145407626|NCT04797169|524349736|FG000|Overall Study|Pregnancy|1|||
145407627|NCT04797169|524349737|FG001|Overall Study|Pregnancy|3|||
145407628|NCT04797169|524349736|FG000|Overall Study|Withdrawal by Subject|27|||
145407629|NCT04797169|524349737|FG001|Overall Study|Withdrawal by Subject|35|||
145407630|NCT03765073|524349741|FG000|Stage 1|Lost to Follow-up|1|||
145407631|NCT03765073|524349742|FG001|Stage 1|Lost to Follow-up|0|||
145407632|NCT03765073|524349743|FG002|Stage 1|Lost to Follow-up|0|||
145407633|NCT03765073|524349744|FG003|Stage 1|Lost to Follow-up|0|||
145407634|NCT03765073|524349745|FG004|Stage 1|Lost to Follow-up|0|||
145407635|NCT03765073|524349746|FG005|Stage 1|Lost to Follow-up|0|||
145407636|NCT03765073|524349747|FG006|Stage 1|Lost to Follow-up|0|||
145407637|NCT03765073|524349748|FG007|Stage 1|Lost to Follow-up|0|||
145407638|NCT03765073|524349749|FG008|Stage 1|Lost to Follow-up|0|||
145407639|NCT03765073|524349750|FG009|Stage 1|Lost to Follow-up|0|||
145407640|NCT03765073|524349751|FG010|Stage 1|Lost to Follow-up|0|||
145407641|NCT03765073|524349752|FG011|Stage 1|Lost to Follow-up|0|||
145407642|NCT03765073|524349753|FG012|Stage 1|Lost to Follow-up|0|||
145407643|NCT03765073|524349754|FG013|Stage 1|Lost to Follow-up|0|||
145407644|NCT03765073|524349755|FG014|Stage 1|Lost to Follow-up|0|||
145407645|NCT03765073|524349756|FG015|Stage 1|Lost to Follow-up|0|||
145407646|NCT03765073|524349757|FG016|Stage 1|Lost to Follow-up|0|||
145407647|NCT03765073|524349758|FG017|Stage 1|Lost to Follow-up|0|||
145407648|NCT03765073|524349759|FG018|Stage 1|Lost to Follow-up|0|||
145407649|NCT03765073|524349760|FG019|Stage 1|Lost to Follow-up|0|||
145407650|NCT03765073|524349761|FG020|Stage 1|Lost to Follow-up|0|||
145407651|NCT03765073|524349741|FG000|Stage 1|Withdrawal by participant|0|||
145407652|NCT03765073|524349742|FG001|Stage 1|Withdrawal by participant|1|||
145407653|NCT03765073|524349743|FG002|Stage 1|Withdrawal by participant|0|||
145407654|NCT03765073|524349744|FG003|Stage 1|Withdrawal by participant|0|||
145407655|NCT03765073|524349745|FG004|Stage 1|Withdrawal by participant|0|||
145407656|NCT03765073|524349746|FG005|Stage 1|Withdrawal by participant|0|||
145407657|NCT03765073|524349747|FG006|Stage 1|Withdrawal by participant|0|||
145407658|NCT03765073|524349748|FG007|Stage 1|Withdrawal by participant|0|||
145407659|NCT03765073|524349749|FG008|Stage 1|Withdrawal by participant|0|||
145407660|NCT03765073|524349750|FG009|Stage 1|Withdrawal by participant|0|||
145407661|NCT03765073|524349751|FG010|Stage 1|Withdrawal by participant|0|||
145407662|NCT03765073|524349752|FG011|Stage 1|Withdrawal by participant|0|||
145407663|NCT03765073|524349753|FG012|Stage 1|Withdrawal by participant|0|||
145407664|NCT03765073|524349754|FG013|Stage 1|Withdrawal by participant|0|||
145407665|NCT03765073|524349755|FG014|Stage 1|Withdrawal by participant|0|||
145407666|NCT03765073|524349756|FG015|Stage 1|Withdrawal by participant|0|||
145407667|NCT03765073|524349757|FG016|Stage 1|Withdrawal by participant|0|||
145407668|NCT03765073|524349758|FG017|Stage 1|Withdrawal by participant|0|||
145407669|NCT03765073|524349759|FG018|Stage 1|Withdrawal by participant|0|||
145407670|NCT03765073|524349760|FG019|Stage 1|Withdrawal by participant|0|||
145407671|NCT03765073|524349761|FG020|Stage 1|Withdrawal by participant|0|||
145407672|NCT03765073|524349741|FG000|Stage 2|Death|0|||
145407673|NCT03765073|524349742|FG001|Stage 2|Death|0|||
145407674|NCT03765073|524349743|FG002|Stage 2|Death|0|||
145407675|NCT03765073|524349744|FG003|Stage 2|Death|0|||
145407676|NCT03765073|524349745|FG004|Stage 2|Death|0|||
145407677|NCT03765073|524349746|FG005|Stage 2|Death|0|||
145407678|NCT03765073|524349747|FG006|Stage 2|Death|0|||
145407679|NCT03765073|524349748|FG007|Stage 2|Death|0|||
145407680|NCT03765073|524349749|FG008|Stage 2|Death|0|||
145407681|NCT03765073|524349750|FG009|Stage 2|Death|1|||
145407682|NCT03765073|524349751|FG010|Stage 2|Death|0|||
145407683|NCT03765073|524349752|FG011|Stage 2|Death|1|||
145407684|NCT03765073|524349753|FG012|Stage 2|Death|0|||
145407685|NCT03765073|524349754|FG013|Stage 2|Death|0|||
145407686|NCT03765073|524349755|FG014|Stage 2|Death|0|||
145407687|NCT03765073|524349756|FG015|Stage 2|Death|0|||
145407688|NCT03765073|524349757|FG016|Stage 2|Death|2|||
145407689|NCT03765073|524349758|FG017|Stage 2|Death|0|||
145407690|NCT03765073|524349759|FG018|Stage 2|Death|0|||
145407691|NCT03765073|524349760|FG019|Stage 2|Death|0|||
145407692|NCT03765073|524349761|FG020|Stage 2|Death|0|||
145407693|NCT03765073|524349741|FG000|Stage 2|Lost to Follow-up|0|||
145407694|NCT03765073|524349742|FG001|Stage 2|Lost to Follow-up|0|||
145407695|NCT03765073|524349743|FG002|Stage 2|Lost to Follow-up|0|||
145407696|NCT03765073|524349744|FG003|Stage 2|Lost to Follow-up|5|||
145407697|NCT03765073|524349745|FG004|Stage 2|Lost to Follow-up|1|||
145407698|NCT03765073|524349746|FG005|Stage 2|Lost to Follow-up|0|||
145407699|NCT03765073|524349747|FG006|Stage 2|Lost to Follow-up|3|||
145407700|NCT03765073|524349748|FG007|Stage 2|Lost to Follow-up|3|||
145407701|NCT03765073|524349749|FG008|Stage 2|Lost to Follow-up|1|||
145407702|NCT03765073|524349750|FG009|Stage 2|Lost to Follow-up|6|||
145407703|NCT03765073|524349751|FG010|Stage 2|Lost to Follow-up|5|||
145407704|NCT03765073|524349752|FG011|Stage 2|Lost to Follow-up|1|||
145407705|NCT03765073|524349753|FG012|Stage 2|Lost to Follow-up|1|||
145407706|NCT03765073|524349754|FG013|Stage 2|Lost to Follow-up|3|||
145558344|NCT00455429|524902488|FG000|Overall Study|Non-compliance|0|||
145558345|NCT00455429|524902489|FG001|Overall Study|Non-compliance|0|||
145558346|NCT00455429|524902490|FG002|Overall Study|Non-compliance|0|||
145558347|NCT00455429|524902491|FG003|Overall Study|Non-compliance|1|||
145558348|NCT00455429|524902488|FG000|Overall Study|Other|0|||
145558349|NCT00455429|524902489|FG001|Overall Study|Other|2|||
145558350|NCT00455429|524902490|FG002|Overall Study|Other|0|||
145558351|NCT00455429|524902491|FG003|Overall Study|Other|1|||
145558352|NCT03658538|524902498|FG000|Overall Study|Death|2|||
145558353|NCT03658538|524902499|FG001|Overall Study|Death|1|||
145558354|NCT03658538|524902498|FG000|Overall Study|Cancer diagnosis|1|||
145558355|NCT03658538|524902499|FG001|Overall Study|Cancer diagnosis|0|||
145558356|NCT03658538|524902498|FG000|Overall Study|Change residence|1|||
145558357|NCT03658538|524902499|FG001|Overall Study|Change residence|2|||
145558358|NCT03658538|524902498|FG000|Overall Study|Lost to Follow-up|3|||
145558359|NCT03658538|524902499|FG001|Overall Study|Lost to Follow-up|3|||
145558360|NCT03658538|524902498|FG000|Overall Study|Unblinded|2|||
145558361|NCT03658538|524902499|FG001|Overall Study|Unblinded|3|||
145558362|NCT03658538|524902498|FG000|Overall Study|Physician Decision|0|||
145558363|NCT03658538|524902499|FG001|Overall Study|Physician Decision|1|||
145558364|NCT03658538|524902498|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
145558365|NCT03658538|524902499|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
145558366|NCT03658538|524902498|FG000|Overall Study|Evicted from home|1|||
145558367|NCT03658538|524902499|FG001|Overall Study|Evicted from home|0|||
145558368|NCT04318080|524904472|FG000|Overall Study|Study closed by sponsor|10|||
145558369|NCT04318080|524904473|FG001|Overall Study|Study closed by sponsor|22|||
145558370|NCT04318080|524904472|FG000|Overall Study|Death|3|||
145558371|NCT04318080|524904473|FG001|Overall Study|Death|9|||
145558372|NCT04318080|524904472|FG000|Overall Study|Withdrawal by Subject|1|||
145558373|NCT04318080|524904473|FG001|Overall Study|Withdrawal by Subject|0|||
145558374|NCT04318080|524904472|FG000|Overall Study|Protocol Deviation|1|||
145558375|NCT04318080|524904473|FG001|Overall Study|Protocol Deviation|0|||
145558376|NCT06308822|524904474|FG000|Overall Study|Mutation Status Not Confirmed|17|||
145558377|NCT06308822|524904474|FG000|Overall Study|Adverse Event|1|||
145558378|NCT06308822|524904474|FG000|Overall Study|Death|5|||
145558379|NCT06308822|524904474|FG000|Overall Study|Disease progression|8|||
145558380|NCT06308822|524904474|FG000|Overall Study|Withdrawal by Subject|1|||
145558381|NCT06308822|524904474|FG000|Overall Study|Physician Decision|3|||
145558382|NCT01852942|524904480|FG000|Overall Study|Physician Decision|1|||
145558383|NCT01852942|524904481|FG001|Overall Study|Physician Decision|0|||
145558384|NCT01852942|524904480|FG000|Overall Study|Death|1|||
145558385|NCT01852942|524904481|FG001|Overall Study|Death|1|||
145558386|NCT01852942|524904480|FG000|Overall Study|Withdrawal by Subject|2|||
145558387|NCT01852942|524904481|FG001|Overall Study|Withdrawal by Subject|3|||
145558388|NCT01852942|524904480|FG000|Overall Study|Lost to Follow-up|1|||
145558389|NCT01852942|524904481|FG001|Overall Study|Lost to Follow-up|2|||
145558390|NCT04568590|524904482|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
145558391|NCT00542919|524904487|FG000|Overall Study|Adverse Event|1|||
145558392|NCT00542919|524904488|FG001|Overall Study|Adverse Event|5|||
145558393|NCT00542919|524904489|FG002|Overall Study|Adverse Event|1|||
145558394|NCT00542919|524904487|FG000|Overall Study|Withdrawal by Subject|1|||
145558395|NCT00542919|524904488|FG001|Overall Study|Withdrawal by Subject|0|||
145558396|NCT00542919|524904489|FG002|Overall Study|Withdrawal by Subject|3|||
145558397|NCT00542919|524904487|FG000|Overall Study|Physician Decision|2|||
145558398|NCT00542919|524904488|FG001|Overall Study|Physician Decision|2|||
145558399|NCT00542919|524904489|FG002|Overall Study|Physician Decision|1|||
145558400|NCT00542919|524904487|FG000|Overall Study|Sponsor Decision|1|||
145558401|NCT00542919|524904488|FG001|Overall Study|Sponsor Decision|0|||
145558402|NCT00542919|524904489|FG002|Overall Study|Sponsor Decision|0|||
145558403|NCT00542919|524904487|FG000|Overall Study|Lost to Follow-up|2|||
145558404|NCT00542919|524904488|FG001|Overall Study|Lost to Follow-up|0|||
145558405|NCT00542919|524904489|FG002|Overall Study|Lost to Follow-up|1|||
145558406|NCT01394523|524904492|FG000|Overall Study|Unable to place block|1|||
145558407|NCT01394523|524904493|FG001|Overall Study|Unable to place block|0|||
145558408|NCT01394523|524904494|FG002|Overall Study|Unable to place block|0|||
145558409|NCT04788953|524904498|FG000|Overall Study|Adverse Event|1|||
145558410|NCT04788953|524904499|FG001|Overall Study|Adverse Event|1|||
145558411|NCT04788953|524904498|FG000|Overall Study|Withdrawal by Subject|1|||
145558412|NCT04788953|524904499|FG001|Overall Study|Withdrawal by Subject|0|||
145558413|NCT04788953|524904498|FG000|Overall Study|Protocol Violation|0|||
145558414|NCT04788953|524904499|FG001|Overall Study|Protocol Violation|1|||
145558415|NCT00469092|524904500|FG000|Overall Study|Adverse Event|5|||
145558416|NCT00469092|524904501|FG001|Overall Study|Adverse Event|4|||
145558417|NCT00469092|524904500|FG000|Overall Study|Lack of Efficacy|1|||
145558418|NCT00469092|524904501|FG001|Overall Study|Lack of Efficacy|0|||
145558419|NCT00469092|524904500|FG000|Overall Study|Lost to Follow-up|1|||
145558420|NCT00469092|524904501|FG001|Overall Study|Lost to Follow-up|2|||
145558421|NCT00469092|524904500|FG000|Overall Study|Protocol Violation|3|||
145558422|NCT00469092|524904501|FG001|Overall Study|Protocol Violation|3|||
145558423|NCT00469092|524904500|FG000|Overall Study|Withdrawal by Subject|4|||
145558424|NCT00469092|524904501|FG001|Overall Study|Withdrawal by Subject|4|||
145558425|NCT00469092|524904500|FG000|Overall Study|Withdrawal Criteria|3|||
145558426|NCT00469092|524904501|FG001|Overall Study|Withdrawal Criteria|4|||
145558427|NCT00469092|524904500|FG000|Overall Study|Incorrectly Randomised|4|||
145558428|NCT00469092|524904501|FG001|Overall Study|Incorrectly Randomised|3|||
145558429|NCT00469092|524904500|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
145558430|NCT00469092|524904501|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
145558431|NCT00469092|524904500|FG000|Overall Study|Use of lipid lowering drug|1|||
145558432|NCT00469092|524904501|FG001|Overall Study|Use of lipid lowering drug|0|||
145558433|NCT00469092|524904500|FG000|Overall Study|Hypoglycaemic Episodes|1|||
145558434|NCT00469092|524904501|FG001|Overall Study|Hypoglycaemic Episodes|1|||
145558435|NCT00469092|524904500|FG000|Overall Study|Abnormal lab value|1|||
145558436|NCT00469092|524904501|FG001|Overall Study|Abnormal lab value|0|||
145558437|NCT00469092|524904500|FG000|Overall Study|Use of Corticosteroid|1|||
145558438|NCT00469092|524904501|FG001|Overall Study|Use of Corticosteroid|0|||
145558439|NCT02278263|524904502|FG000|Overall Study|Protocol Violation|7|||
145558440|NCT02278263|524904503|FG001|Overall Study|Protocol Violation|0|||
145558441|NCT02278263|524904504|FG002|Overall Study|Protocol Violation|9|||
145558442|NCT02092662|524904505|FG000|Overall Study|Lost to Follow-up|13|||
145558443|NCT02092662|524904506|FG001|Overall Study|Lost to Follow-up|0|||
145558444|NCT02710045|524904507|FG000|Overall Study|Death|1|||
145558445|NCT02710045|524904508|FG001|Overall Study|Death|2|||
145558446|NCT02710045|524904509|FG002|Overall Study|Death|0|||
145558447|NCT02710045|524904507|FG000|Overall Study|Withdrawal by Subject|6|||
145558448|NCT02710045|524904508|FG001|Overall Study|Withdrawal by Subject|6|||
145558449|NCT02710045|524904509|FG002|Overall Study|Withdrawal by Subject|2|||
145558450|NCT02710045|524904507|FG000|Overall Study|Protocol Violation|1|||
145558451|NCT02710045|524904508|FG001|Overall Study|Protocol Violation|2|||
145558452|NCT02710045|524904509|FG002|Overall Study|Protocol Violation|3|||
145558453|NCT02710045|524904507|FG000|Overall Study|Lost to Follow-up|3|||
145558454|NCT02710045|524904508|FG001|Overall Study|Lost to Follow-up|6|||
145558455|NCT02710045|524904509|FG002|Overall Study|Lost to Follow-up|7|||
145558456|NCT02710045|524904507|FG000|Overall Study|Physician Decision|0|||
145558457|NCT02710045|524904508|FG001|Overall Study|Physician Decision|0|||
145558458|NCT02710045|524904509|FG002|Overall Study|Physician Decision|1|||
145558459|NCT02710045|524904507|FG000|Overall Study|Poor Attendance|0|||
145558460|NCT02710045|524904508|FG001|Overall Study|Poor Attendance|1|||
145558461|NCT02710045|524904509|FG002|Overall Study|Poor Attendance|0|||
145558462|NCT03424265|524904513|FG000|Overall Study|screening failure|1|||
145558463|NCT03424265|524904514|FG001|Overall Study|screening failure|0|||
145558464|NCT03424265|524904513|FG000|Overall Study|Withdrawal by Subject|0|||
145558465|NCT03424265|524904514|FG001|Overall Study|Withdrawal by Subject|2|||
145558466|NCT03447990|524904515|FG000|Overall Study|Withdrawal by Subject|0|||
145558467|NCT03447990|524904516|FG001|Overall Study|Withdrawal by Subject|0|||
145558468|NCT03447990|524904517|FG002|Overall Study|Withdrawal by Subject|0|||
145558469|NCT03447990|524904518|FG003|Overall Study|Withdrawal by Subject|0|||
145558470|NCT03447990|524904519|FG004|Overall Study|Withdrawal by Subject|0|||
145558471|NCT03447990|524904520|FG005|Overall Study|Withdrawal by Subject|0|||
145558472|NCT03447990|524904521|FG006|Overall Study|Withdrawal by Subject|1|||
145558473|NCT01603459|524904530|FG000|Overall Study|Adverse Event|5|||
145558474|NCT01603459|524904530|FG000|Overall Study|Withdrawal by Subject|5|||
145558475|NCT01603459|524904530|FG000|Overall Study|Lost to Follow-up|3|||
145558476|NCT01603459|524904530|FG000|Overall Study|Predefined discontinuation criteria|3|||
145558477|NCT01603459|524904530|FG000|Overall Study|Non-compliance|1|||
145558478|NCT01603459|524904530|FG000|Overall Study|Administrative reason|1|||
145558479|NCT00399360|524904532|FG000|Overall Study|Lost to Follow-up|2|||
145558480|NCT00399360|524904533|FG001|Overall Study|Lost to Follow-up|1|||
145558481|NCT00399360|524904534|FG002|Overall Study|Lost to Follow-up|2|||
145558482|NCT00399360|524904535|FG003|Overall Study|Lost to Follow-up|4|||
145558483|NCT00399360|524904532|FG000|Overall Study|Adverse Event|0|||
145558484|NCT00399360|524904533|FG001|Overall Study|Adverse Event|0|||
145558485|NCT00399360|524904534|FG002|Overall Study|Adverse Event|1|||
145558486|NCT00399360|524904535|FG003|Overall Study|Adverse Event|0|||
145558487|NCT00399360|524904532|FG000|Overall Study|Withdrawal by Subject|0|||
145558488|NCT00399360|524904533|FG001|Overall Study|Withdrawal by Subject|2|||
145617583|NCT02293837|525113463|FG002|Overall Study|COVID-19 Related|0|||
145617584|NCT02293837|525113464|FG003|Overall Study|COVID-19 Related|0|||
145617585|NCT02293837|525113461|FG000|Overall Study|Participant ill and could not be infused|0|||
145617586|NCT02293837|525113462|FG001|Overall Study|Participant ill and could not be infused|0|||
145617587|NCT02293837|525113463|FG002|Overall Study|Participant ill and could not be infused|1|||
145617588|NCT02293837|525113464|FG003|Overall Study|Participant ill and could not be infused|0|||
145617589|NCT04779242|525113465|FG000|Overall Study|Adverse Event|1|||
145617590|NCT04779242|525113466|FG001|Overall Study|Adverse Event|1|||
145617591|NCT04779242|525113465|FG000|Overall Study|Lost to Follow-up|2|||
145617592|NCT04779242|525113466|FG001|Overall Study|Lost to Follow-up|4|||
145617593|NCT04779242|525113465|FG000|Overall Study|Withdrawal by Subject|7|||
145617594|NCT04779242|525113466|FG001|Overall Study|Withdrawal by Subject|9|||
145617595|NCT04779242|525113465|FG000|Overall Study|Death|6|||
145617596|NCT04779242|525113466|FG001|Overall Study|Death|6|||
145617597|NCT04779242|525113465|FG000|Overall Study|COVID-19 related reasons|2|||
145617598|NCT04779242|525113466|FG001|Overall Study|COVID-19 related reasons|1|||
145617599|NCT04779242|525113465|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
145617600|NCT04779242|525113466|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
145617601|NCT04779242|525113465|FG000|Overall Study|Martial Law in Ukraine|2|||
145617602|NCT04779242|525113466|FG001|Overall Study|Martial Law in Ukraine|3|||
145617603|NCT02087150|525113467|FG000|Overall Study|Death|0|||
145617604|NCT02087150|525113468|FG001|Overall Study|Death|1|||
145617605|NCT02087150|525113469|FG002|Overall Study|Death|0|||
145617606|NCT02087150|525113467|FG000|Overall Study|Lost to Follow-up|6|||
145617607|NCT02087150|525113468|FG001|Overall Study|Lost to Follow-up|13|||
145617608|NCT02087150|525113469|FG002|Overall Study|Lost to Follow-up|7|||
145617609|NCT02087150|525113467|FG000|Overall Study|Withdrawal by Subject|2|||
145617610|NCT02087150|525113468|FG001|Overall Study|Withdrawal by Subject|5|||
145617611|NCT02087150|525113469|FG002|Overall Study|Withdrawal by Subject|3|||
145617612|NCT02087150|525113467|FG000|Overall Study|Physician Decision|0|||
145617613|NCT02087150|525113468|FG001|Overall Study|Physician Decision|1|||
145617614|NCT02087150|525113469|FG002|Overall Study|Physician Decision|0|||
145617615|NCT02087150|525113467|FG000|Overall Study|Procedure not done|1|||
145617616|NCT02087150|525113468|FG001|Overall Study|Procedure not done|13|||
145617617|NCT02087150|525113469|FG002|Overall Study|Procedure not done|0|||
145617618|NCT02087150|525113467|FG000|Overall Study|F/U not completed w/in study window|0|||
145617619|NCT02087150|525113468|FG001|Overall Study|F/U not completed w/in study window|0|||
145617620|NCT02087150|525113469|FG002|Overall Study|F/U not completed w/in study window|1|||
145617621|NCT02087150|525113467|FG000|Overall Study|Other|1|||
145617622|NCT02087150|525113468|FG001|Overall Study|Other|0|||
145617623|NCT02087150|525113469|FG002|Overall Study|Other|0|||
145617624|NCT02087150|525113467|FG000|Overall Study|Pt moved out of town|0|||
145617625|NCT02087150|525113468|FG001|Overall Study|Pt moved out of town|1|||
145617626|NCT02087150|525113469|FG002|Overall Study|Pt moved out of town|0|||
145617627|NCT00322374|525113471|FG000|Starting Dose|Physician Decision|2|||
145617628|NCT00322374|525113472|FG001|Starting Dose|Physician Decision|0|||
145617629|NCT00322374|525113473|FG002|Starting Dose|Physician Decision|0|||
145617630|NCT00322374|525113474|FG003|Starting Dose|Physician Decision|0|||
145617631|NCT00322374|525113471|FG000|Starting Dose|Study Drug Toxicity|4|||
145617632|NCT00322374|525113472|FG001|Starting Dose|Study Drug Toxicity|0|||
145558489|NCT00399360|524904534|FG002|Overall Study|Withdrawal by Subject|0|||
145558490|NCT00399360|524904535|FG003|Overall Study|Withdrawal by Subject|2|||
145558491|NCT01288287|524904538|FG000|Overall Study|Lost to Follow-up|8|||
145558492|NCT01288287|524904538|FG000|Overall Study|Withdrawal by Subject|4|||
145558493|NCT01288287|524904538|FG000|Overall Study|Lack of Efficacy|13|||
145558494|NCT01288287|524904538|FG000|Overall Study|Other Reason|13|||
145558495|NCT01288287|524904538|FG000|Overall Study|Unknown Reason|1|||
145558496|NCT01288287|524904538|FG000|Overall Study|Unknown Status|7|||
145617633|NCT00322374|525113473|FG002|Starting Dose|Study Drug Toxicity|0|||
145617634|NCT00322374|525113474|FG003|Starting Dose|Study Drug Toxicity|0|||
145617635|NCT00322374|525113471|FG000|First Escalation|Documented Disease Progression|0|||
145617636|NCT00322374|525113472|FG001|First Escalation|Documented Disease Progression|6|||
145617637|NCT00322374|525113473|FG002|First Escalation|Documented Disease Progression|0|||
145617638|NCT00322374|525113474|FG003|First Escalation|Documented Disease Progression|0|||
145617639|NCT00322374|525113471|FG000|First Escalation|Physician Decision|0|||
145617640|NCT00322374|525113472|FG001|First Escalation|Physician Decision|12|||
145617641|NCT00322374|525113473|FG002|First Escalation|Physician Decision|0|||
145617642|NCT00322374|525113474|FG003|First Escalation|Physician Decision|0|||
145617643|NCT00322374|525113471|FG000|First Escalation|Study Drug Toxicity|0|||
145558497|NCT00238121|524904541|FG000|Overall Study|Withdrawal by Subject|1|||
145558498|NCT00238121|524904542|FG001|Overall Study|Withdrawal by Subject|1|||
145558499|NCT00238121|524904541|FG000|Overall Study|Adverse Event|2|||
145558500|NCT00238121|524904542|FG001|Overall Study|Adverse Event|1|||
145558501|NCT00484939|524904543|FG000|Overall Study|Death|9|||
145558502|NCT00484939|524904544|FG001|Overall Study|Death|13|||
145558503|NCT00484939|524904543|FG000|Overall Study|Adverse Event|22|||
145558504|NCT00484939|524904544|FG001|Overall Study|Adverse Event|12|||
145558505|NCT00484939|524904543|FG000|Overall Study|Patient Withdrew Consent|19|||
145558506|NCT00484939|524904544|FG001|Overall Study|Patient Withdrew Consent|10|||
145558507|NCT00484939|524904543|FG000|Overall Study|Protocol Violation|3|||
145558508|NCT00484939|524904544|FG001|Overall Study|Protocol Violation|3|||
145558509|NCT00484939|524904543|FG000|Overall Study|Lost to Follow-up|0|||
145558510|NCT00484939|524904544|FG001|Overall Study|Lost to Follow-up|3|||
145558511|NCT00484939|524904543|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
145558512|NCT00484939|524904544|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
145558513|NCT00484939|524904543|FG000|Overall Study|Disease progression|67|||
145558514|NCT00484939|524904544|FG001|Overall Study|Disease progression|88|||
145558515|NCT00484939|524904543|FG000|Overall Study|Screen Failure|2|||
145558516|NCT00484939|524904544|FG001|Overall Study|Screen Failure|2|||
145558517|NCT00484939|524904543|FG000|Overall Study|Reason Not Specified|11|||
145558518|NCT00484939|524904544|FG001|Overall Study|Reason Not Specified|6|||
145558519|NCT04948450|524904545|FG000|Overall Study|Return home|1|||
145558520|NCT04948450|524904546|FG001|Overall Study|Return home|3|||
145558521|NCT01474876|524904550|FG000|Overall Study|Adverse Event|11|||
145558522|NCT01474876|524904551|FG001|Overall Study|Adverse Event|5|||
145558523|NCT01474876|524904552|FG002|Overall Study|Adverse Event|0|||
145558524|NCT01474876|524904550|FG000|Overall Study|Serious Adverse Event|2|||
145292852|NCT00918567|523922259|FG001|Overall Study|Withdrawal by Subject|1|||
145292853|NCT00918567|523922258|FG000|Overall Study|Adverse Event|1|||
145292854|NCT00918567|523922259|FG001|Overall Study|Adverse Event|0|||
145292855|NCT03283709|523922262|FG000|Overall Study|trial terminated|0|||
145292856|NCT03283709|523922263|FG001|Overall Study|trial terminated|1|||
145292857|NCT05275998|523922264|FG000|Overall Study|Adverse Event|0|||
145292858|NCT05275998|523922265|FG001|Overall Study|Adverse Event|0|||
145292859|NCT05275998|523922266|FG002|Overall Study|Adverse Event|0|||
145292860|NCT05275998|523922267|FG003|Overall Study|Adverse Event|1|||
145292861|NCT05275998|523922264|FG000|Overall Study|Withdrawal by Subject|0|||
145292862|NCT05275998|523922265|FG001|Overall Study|Withdrawal by Subject|0|||
145407707|NCT03765073|524349755|FG014|Stage 2|Lost to Follow-up|3|||
145407708|NCT03765073|524349756|FG015|Stage 2|Lost to Follow-up|1|||
145407709|NCT03765073|524349757|FG016|Stage 2|Lost to Follow-up|6|||
145407710|NCT03765073|524349758|FG017|Stage 2|Lost to Follow-up|0|||
145407711|NCT03765073|524349759|FG018|Stage 2|Lost to Follow-up|0|||
145407712|NCT03765073|524349760|FG019|Stage 2|Lost to Follow-up|0|||
145407713|NCT03765073|524349761|FG020|Stage 2|Lost to Follow-up|0|||
145407714|NCT03765073|524349741|FG000|Stage 2|Other|0|||
145407715|NCT03765073|524349742|FG001|Stage 2|Other|0|||
145407716|NCT03765073|524349743|FG002|Stage 2|Other|0|||
145558525|NCT01474876|524904551|FG001|Overall Study|Serious Adverse Event|3|||
145292863|NCT05275998|523922266|FG002|Overall Study|Withdrawal by Subject|0|||
145292864|NCT05275998|523922267|FG003|Overall Study|Withdrawal by Subject|1|||
145292865|NCT05275998|523922264|FG000|Overall Study|Physician Decision|0|||
145558526|NCT01474876|524904552|FG002|Overall Study|Serious Adverse Event|0|||
145558527|NCT01474876|524904550|FG000|Overall Study|Lost to Follow-up|5|||
145407717|NCT03765073|524349744|FG003|Stage 2|Other|0|||
145407718|NCT03765073|524349745|FG004|Stage 2|Other|0|||
145407719|NCT03765073|524349746|FG005|Stage 2|Other|0|||
145558528|NCT01474876|524904551|FG001|Overall Study|Lost to Follow-up|4|||
145292866|NCT05275998|523922265|FG001|Overall Study|Physician Decision|0|||
145292867|NCT05275998|523922266|FG002|Overall Study|Physician Decision|0|||
145292868|NCT05275998|523922267|FG003|Overall Study|Physician Decision|1|||
145292869|NCT05275998|523922264|FG000|Overall Study|Protocol Violation|0|||
145292870|NCT05275998|523922265|FG001|Overall Study|Protocol Violation|0|||
145292871|NCT05275998|523922266|FG002|Overall Study|Protocol Violation|1|||
145292872|NCT05275998|523922267|FG003|Overall Study|Protocol Violation|0|||
145292873|NCT01867242|523922268|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
145292874|NCT01867242|523922269|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
145292875|NCT01867242|523922270|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
145292876|NCT02199509|523922272|FG000|Overall Study|Suicidal Ideation|0|||
145292877|NCT02199509|523922273|FG001|Overall Study|Suicidal Ideation|1|||
145292878|NCT02199509|523922272|FG000|Overall Study|Misunderstood titration schedule|1|||
145292879|NCT02199509|523922273|FG001|Overall Study|Misunderstood titration schedule|0|||
145292880|NCT02093689|523922275|FG000|Overall Study|Physician Decision|4|||
145292881|NCT02093689|523922276|FG001|Overall Study|Physician Decision|0|||
145292882|NCT02093689|523922277|FG002|Overall Study|Physician Decision|0|||
145292883|NCT00634179|523922283|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
145292884|NCT04947579|523922284|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
145407720|NCT03765073|524349747|FG006|Stage 2|Other|0|||
145407721|NCT03765073|524349748|FG007|Stage 2|Other|1|||
145407722|NCT03765073|524349749|FG008|Stage 2|Other|1|||
145407723|NCT03765073|524349750|FG009|Stage 2|Other|3|||
145407724|NCT03765073|524349751|FG010|Stage 2|Other|0|||
145407725|NCT03765073|524349752|FG011|Stage 2|Other|0|||
145407726|NCT03765073|524349753|FG012|Stage 2|Other|0|||
145407727|NCT03765073|524349754|FG013|Stage 2|Other|0|||
145407728|NCT03765073|524349755|FG014|Stage 2|Other|0|||
145407729|NCT03765073|524349756|FG015|Stage 2|Other|1|||
145407730|NCT03765073|524349757|FG016|Stage 2|Other|2|||
145407731|NCT03765073|524349758|FG017|Stage 2|Other|0|||
145407732|NCT03765073|524349759|FG018|Stage 2|Other|0|||
145407733|NCT03765073|524349760|FG019|Stage 2|Other|0|||
145407734|NCT03765073|524349761|FG020|Stage 2|Other|0|||
145407735|NCT03765073|524349741|FG000|Stage 2|Withdrawal by parent/guardian|0|||
145407736|NCT03765073|524349742|FG001|Stage 2|Withdrawal by parent/guardian|0|||
145407737|NCT03765073|524349743|FG002|Stage 2|Withdrawal by parent/guardian|0|||
145407738|NCT03765073|524349744|FG003|Stage 2|Withdrawal by parent/guardian|0|||
145407739|NCT03765073|524349745|FG004|Stage 2|Withdrawal by parent/guardian|0|||
145407740|NCT03765073|524349746|FG005|Stage 2|Withdrawal by parent/guardian|0|||
145407741|NCT03765073|524349747|FG006|Stage 2|Withdrawal by parent/guardian|0|||
145407742|NCT03765073|524349748|FG007|Stage 2|Withdrawal by parent/guardian|0|||
145407743|NCT03765073|524349749|FG008|Stage 2|Withdrawal by parent/guardian|0|||
145407744|NCT03765073|524349750|FG009|Stage 2|Withdrawal by parent/guardian|0|||
145407745|NCT03765073|524349751|FG010|Stage 2|Withdrawal by parent/guardian|3|||
145407746|NCT03765073|524349752|FG011|Stage 2|Withdrawal by parent/guardian|3|||
145407747|NCT03765073|524349753|FG012|Stage 2|Withdrawal by parent/guardian|3|||
145407748|NCT03765073|524349754|FG013|Stage 2|Withdrawal by parent/guardian|1|||
145407749|NCT03765073|524349755|FG014|Stage 2|Withdrawal by parent/guardian|1|||
145407750|NCT03765073|524349756|FG015|Stage 2|Withdrawal by parent/guardian|0|||
145292885|NCT04947579|523922285|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
145292886|NCT04947579|523922286|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
145407751|NCT03765073|524349757|FG016|Stage 2|Withdrawal by parent/guardian|3|||
145407752|NCT03765073|524349758|FG017|Stage 2|Withdrawal by parent/guardian|0|||
145407753|NCT03765073|524349759|FG018|Stage 2|Withdrawal by parent/guardian|0|||
145407754|NCT03765073|524349760|FG019|Stage 2|Withdrawal by parent/guardian|0|||
145407755|NCT03765073|524349761|FG020|Stage 2|Withdrawal by parent/guardian|0|||
145407756|NCT03765073|524349741|FG000|Stage 2|Withdrawal by Subject|0|||
145407757|NCT03765073|524349742|FG001|Stage 2|Withdrawal by Subject|0|||
145407758|NCT03765073|524349743|FG002|Stage 2|Withdrawal by Subject|0|||
145407759|NCT03765073|524349744|FG003|Stage 2|Withdrawal by Subject|3|||
145407760|NCT03765073|524349745|FG004|Stage 2|Withdrawal by Subject|3|||
145617644|NCT00322374|525113472|FG001|First Escalation|Study Drug Toxicity|11|||
145617645|NCT00322374|525113473|FG002|First Escalation|Study Drug Toxicity|0|||
145617646|NCT00322374|525113474|FG003|First Escalation|Study Drug Toxicity|0|||
145617647|NCT00322374|525113471|FG000|First Escalation|Participant Request|0|||
145617648|NCT00322374|525113472|FG001|First Escalation|Participant Request|1|||
145617649|NCT00322374|525113473|FG002|First Escalation|Participant Request|0|||
145617650|NCT00322374|525113474|FG003|First Escalation|Participant Request|0|||
145617651|NCT00322374|525113471|FG000|Second Escalation|Physician Decision|0|||
145617652|NCT00322374|525113472|FG001|Second Escalation|Physician Decision|0|||
145617653|NCT00322374|525113473|FG002|Second Escalation|Physician Decision|5|||
145617654|NCT00322374|525113474|FG003|Second Escalation|Physician Decision|0|||
145617655|NCT00322374|525113471|FG000|Second Escalation|Study Drug Toxicity|0|||
145617656|NCT00322374|525113472|FG001|Second Escalation|Study Drug Toxicity|0|||
145617657|NCT00322374|525113473|FG002|Second Escalation|Study Drug Toxicity|1|||
145617658|NCT00322374|525113474|FG003|Second Escalation|Study Drug Toxicity|0|||
145617659|NCT01448044|525113477|FG000|Treatment Period|Adverse Event|4|||
145617660|NCT01448044|525113478|FG001|Treatment Period|Adverse Event|3|||
145617661|NCT01448044|525113477|FG000|Treatment Period|Lack of Efficacy|5|||
145617662|NCT01448044|525113478|FG001|Treatment Period|Lack of Efficacy|12|||
145617663|NCT01448044|525113477|FG000|Treatment Period|Subject requested discontinue study drug|1|||
145617664|NCT01448044|525113478|FG001|Treatment Period|Subject requested discontinue study drug|0|||
145617665|NCT01448044|525113477|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
145617666|NCT01448044|525113478|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
145617667|NCT01448044|525113477|FG000|Treatment Period|Participant does not meet study criteria|1|||
145617668|NCT01448044|525113478|FG001|Treatment Period|Participant does not meet study criteria|0|||
145617669|NCT01448044|525113477|FG000|Treatment Period|Lost to Follow-up|2|||
145617670|NCT01448044|525113478|FG001|Treatment Period|Lost to Follow-up|1|||
145617671|NCT01448044|525113477|FG000|Treatment Period|Other reason|2|||
145617672|NCT01448044|525113478|FG001|Treatment Period|Other reason|0|||
145617673|NCT01448044|525113477|FG000|Follow Up Period|Withdrawal by Subject|1|||
145617674|NCT01448044|525113478|FG001|Follow Up Period|Withdrawal by Subject|1|||
145617675|NCT01448044|525113477|FG000|Follow Up Period|Lost to Follow-up|6|||
145617676|NCT01448044|525113478|FG001|Follow Up Period|Lost to Follow-up|2|||
145617677|NCT01448044|525113477|FG000|Follow Up Period|Other|5|||
145617678|NCT01448044|525113478|FG001|Follow Up Period|Other|11|||
145617679|NCT04230980|525113481|FG000|Overall Study|Lost to Follow-up|1|||
145617680|NCT04230980|525113482|FG001|Overall Study|Lost to Follow-up|2|||
145617681|NCT04230980|525113481|FG000|Overall Study|Adverse Event|0|||
145617682|NCT04230980|525113482|FG001|Overall Study|Adverse Event|1|||
145407761|NCT03765073|524349746|FG005|Stage 2|Withdrawal by Subject|3|||
145617683|NCT02372058|525113483|FG000|Overall Study|Withdrawal by Subject|3|||
145617684|NCT00972179|525113484|FG000|Overall Study|Noncompliance|1|||
145617685|NCT00972179|525113485|FG001|Overall Study|Noncompliance|0|||
145617686|NCT00972179|525113486|FG002|Overall Study|Noncompliance|0|||
145617687|NCT00972179|525113487|FG003|Overall Study|Noncompliance|0|||
145617688|NCT00972179|525113488|FG004|Overall Study|Noncompliance|1|||
145617689|NCT00972179|525113489|FG005|Overall Study|Noncompliance|0|||
145617690|NCT00972179|525113490|FG006|Overall Study|Noncompliance|1|||
145617691|NCT00972179|525113484|FG000|Overall Study|Withdrawal by Subject|0|||
145617692|NCT00972179|525113485|FG001|Overall Study|Withdrawal by Subject|3|||
145617693|NCT00972179|525113486|FG002|Overall Study|Withdrawal by Subject|0|||
145617694|NCT00972179|525113487|FG003|Overall Study|Withdrawal by Subject|1|||
145617695|NCT00972179|525113488|FG004|Overall Study|Withdrawal by Subject|0|||
145617696|NCT00972179|525113489|FG005|Overall Study|Withdrawal by Subject|0|||
145617697|NCT00972179|525113490|FG006|Overall Study|Withdrawal by Subject|2|||
145617698|NCT00972179|525113484|FG000|Overall Study|Administrative Decision|0|||
145617699|NCT00972179|525113485|FG001|Overall Study|Administrative Decision|0|||
145407762|NCT03765073|524349747|FG006|Stage 2|Withdrawal by Subject|0|||
145617700|NCT00972179|525113486|FG002|Overall Study|Administrative Decision|0|||
145617701|NCT00972179|525113487|FG003|Overall Study|Administrative Decision|0|||
145617702|NCT00972179|525113488|FG004|Overall Study|Administrative Decision|1|||
145617703|NCT00972179|525113489|FG005|Overall Study|Administrative Decision|0|||
145617704|NCT00972179|525113490|FG006|Overall Study|Administrative Decision|0|||
145617705|NCT00972179|525113484|FG000|Overall Study|Lost to Follow-up|0|||
145617706|NCT00972179|525113485|FG001|Overall Study|Lost to Follow-up|0|||
145617707|NCT00972179|525113486|FG002|Overall Study|Lost to Follow-up|1|||
145617708|NCT00972179|525113487|FG003|Overall Study|Lost to Follow-up|0|||
145617709|NCT00972179|525113488|FG004|Overall Study|Lost to Follow-up|0|||
145617710|NCT00972179|525113489|FG005|Overall Study|Lost to Follow-up|3|||
145617711|NCT00972179|525113490|FG006|Overall Study|Lost to Follow-up|1|||
145617712|NCT00195715|525113499|FG000|Overall Study|Adverse Event|122|||
145617713|NCT00195715|525113499|FG000|Overall Study|Withdrawal by Subject|58|||
145617714|NCT00195715|525113499|FG000|Overall Study|Lost to Follow-up|27|||
145617715|NCT00195715|525113499|FG000|Overall Study|Protocol Violation|13|||
145617716|NCT00195715|525113499|FG000|Overall Study|Lack of Efficacy|93|||
145617717|NCT00195715|525113499|FG000|Overall Study|Pregnancy|14|||
145617718|NCT00195715|525113499|FG000|Overall Study|Investigative site closure|8|||
145617719|NCT00195715|525113499|FG000|Overall Study|Subject moved/relocated|7|||
145617720|NCT00195715|525113499|FG000|Overall Study|Subject non-compliance|6|||
145617721|NCT00195715|525113499|FG000|Overall Study|Subject started commercial Humira|5|||
145617722|NCT00195715|525113499|FG000|Overall Study|Subject choice|3|||
145617723|NCT00195715|525113499|FG000|Overall Study|Loss of response/no improvement|3|||
145617724|NCT00195715|525113499|FG000|Overall Study|Sponsor stopped study|1|||
145617725|NCT00195715|525113499|FG000|Overall Study|Administrative reasons|2|||
145617726|NCT00195715|525113499|FG000|Overall Study|Investigator's decision|2|||
145617727|NCT00195715|525113499|FG000|Overall Study|Subject wants to get pregnant|4|||
145617728|NCT00195715|525113499|FG000|Overall Study|Use of prohibited medication|2|||
145617729|NCT00195715|525113499|FG000|Overall Study|Planned surgery|2|||
145617730|NCT00195715|525113499|FG000|Overall Study|Increased infection rate|1|||
145617731|NCT00195715|525113499|FG000|Overall Study|Ineligible|1|||
145617732|NCT00195715|525113499|FG000|Overall Study|Colonic stricture|1|||
145617733|NCT00195715|525113499|FG000|Overall Study|Sponsor discontinued trial|1|||
145617734|NCT00195715|525113499|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
145617735|NCT01370603|525113505|FG000|Period 1|Adverse Event|5|||
145617736|NCT01370603|525113506|FG001|Period 1|Adverse Event|3|||
145617737|NCT01370603|525113505|FG000|Period 1|Lost to Follow-up|2|||
145617738|NCT01370603|525113506|FG001|Period 1|Lost to Follow-up|0|||
145617739|NCT01370603|525113505|FG000|Period 1|Protocol Violation|2|||
145617740|NCT01370603|525113506|FG001|Period 1|Protocol Violation|2|||
145617741|NCT01370603|525113505|FG000|Period 1|Withdrawal by Subject|5|||
145617742|NCT01370603|525113506|FG001|Period 1|Withdrawal by Subject|5|||
145617743|NCT01370603|525113505|FG000|Crossover Washout|Adverse Event|2|||
145617744|NCT01370603|525113506|FG001|Crossover Washout|Adverse Event|1|||
145617745|NCT01370603|525113505|FG000|Crossover Washout|Lost to Follow-up|2|||
145617746|NCT01370603|525113506|FG001|Crossover Washout|Lost to Follow-up|0|||
145617747|NCT01370603|525113505|FG000|Crossover Washout|Protocol Violation|1|||
145617748|NCT01370603|525113506|FG001|Crossover Washout|Protocol Violation|0|||
145617749|NCT01370603|525113505|FG000|Crossover Washout|Withdrawal by Subject|4|||
145617750|NCT01370603|525113506|FG001|Crossover Washout|Withdrawal by Subject|1|||
145617751|NCT01370603|525113505|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
145617752|NCT01370603|525113506|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
145617753|NCT01370603|525113505|FG000|Period 2|Adverse Event|1|||
145617754|NCT01370603|525113506|FG001|Period 2|Adverse Event|4|||
145617755|NCT01370603|525113505|FG000|Period 2|Lost to Follow-up|1|||
145617756|NCT01370603|525113506|FG001|Period 2|Lost to Follow-up|0|||
145617757|NCT01370603|525113505|FG000|Period 2|Withdrawal by Subject|1|||
145617758|NCT01370603|525113506|FG001|Period 2|Withdrawal by Subject|0|||
145617759|NCT02133924|525113511|FG000|Overall Study|Death|38|||
145617760|NCT02133924|525113511|FG000|Overall Study|Physician Decision|1|||
145617761|NCT02133924|525113511|FG000|Overall Study|Withdrawal by Subject|3|||
145617762|NCT00003458|525113512|FG000|Overall Study|Not evaluable|4|||
145617763|NCT01216293|525113518|FG000|Main Study|Adverse Event|1|||
145617764|NCT01216293|525113519|FG001|Main Study|Adverse Event|4|||
145617765|NCT01216293|525113520|FG002|Main Study|Adverse Event|2|||
145617766|NCT01216293|525113518|FG000|Main Study|Major Protocol Deviation|1|||
145617767|NCT01216293|525113519|FG001|Main Study|Major Protocol Deviation|0|||
145617768|NCT01216293|525113520|FG002|Main Study|Major Protocol Deviation|1|||
145617769|NCT01216293|525113518|FG000|Main Study|Lost to Follow-up|3|||
145617770|NCT01216293|525113519|FG001|Main Study|Lost to Follow-up|1|||
145617771|NCT01216293|525113520|FG002|Main Study|Lost to Follow-up|0|||
145617772|NCT01216293|525113518|FG000|Main Study|Voluntary Withdrawal|2|||
145617773|NCT01216293|525113519|FG001|Main Study|Voluntary Withdrawal|2|||
145617774|NCT01216293|525113520|FG002|Main Study|Voluntary Withdrawal|2|||
145617775|NCT01216293|525113518|FG000|Main Study|Other Reason Not Specified|0|||
145617776|NCT01216293|525113519|FG001|Main Study|Other Reason Not Specified|1|||
145617777|NCT01216293|525113520|FG002|Main Study|Other Reason Not Specified|1|||
145617778|NCT01216293|525113518|FG000|Main Study|Randomized, Not Treated|1|||
145617779|NCT01216293|525113519|FG001|Main Study|Randomized, Not Treated|0|||
145617780|NCT01216293|525113520|FG002|Main Study|Randomized, Not Treated|0|||
145617781|NCT01216293|525113518|FG000|Calcium Absorption Substudy|Adverse Event|0|||
145617782|NCT01216293|525113519|FG001|Calcium Absorption Substudy|Adverse Event|2|||
145617783|NCT01216293|525113520|FG002|Calcium Absorption Substudy|Adverse Event|0|||
145617784|NCT01216293|525113518|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
145617785|NCT01216293|525113519|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
145617786|NCT01216293|525113520|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
145617787|NCT01216293|525113518|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
145617788|NCT01216293|525113519|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
145617789|NCT01216293|525113520|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
145617790|NCT02451930|525115251|FG000|Overall Study|Death|0|||
145617791|NCT02451930|525115252|FG001|Overall Study|Death|15|||
145617792|NCT02451930|525115251|FG000|Overall Study|Lost to Follow-up|0|||
145617793|NCT02451930|525115252|FG001|Overall Study|Lost to Follow-up|3|||
145617794|NCT02451930|525115251|FG000|Overall Study|Sponsor Decision|2|||
145617795|NCT02451930|525115252|FG001|Overall Study|Sponsor Decision|10|||
145617796|NCT02451930|525115251|FG000|Overall Study|Withdrawal by Subject|0|||
145617797|NCT02451930|525115252|FG001|Overall Study|Withdrawal by Subject|1|||
145617798|NCT02451930|525115251|FG000|Overall Study|Other|0|||
145617799|NCT02451930|525115252|FG001|Overall Study|Other|1|||
145617800|NCT00262743|525115253|FG000|Overall Study|Adverse Event|0|||
145617801|NCT00262743|525115254|FG001|Overall Study|Adverse Event|9|||
145617802|NCT00262743|525115253|FG000|Overall Study|Disease progression|0|||
145617803|NCT00262743|525115254|FG001|Overall Study|Disease progression|3|||
145617804|NCT01950273|525115264|FG000|Overall Study|Protocol Violation|1|||
145617805|NCT01950273|525115265|FG001|Overall Study|Protocol Violation|0|||
145617806|NCT01950273|525115264|FG000|Overall Study|Withdrawal by Subject|2|||
145617807|NCT01950273|525115265|FG001|Overall Study|Withdrawal by Subject|0|||
145617808|NCT01950273|525115264|FG000|Overall Study|Other not defined above|1|||
145617809|NCT01950273|525115265|FG001|Overall Study|Other not defined above|0|||
145617810|NCT00472186|525115266|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
145617811|NCT00472186|525115267|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
145617812|NCT02264574|525115272|FG000|Overall Study|Death|21|||
145617813|NCT02264574|525115273|FG001|Overall Study|Death|21|||
145292887|NCT04947579|523922287|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
145292888|NCT04947579|523922288|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
145292889|NCT04947579|523922289|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
145292890|NCT04947579|523922284|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
145292891|NCT04947579|523922285|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
145292892|NCT04947579|523922286|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
145292893|NCT04947579|523922287|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
145292894|NCT04947579|523922288|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
145292895|NCT04947579|523922289|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
145292896|NCT04947579|523922284|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
145407763|NCT03765073|524349748|FG007|Stage 2|Withdrawal by Subject|1|||
145617814|NCT02264574|525115272|FG000|Overall Study|Withdrawal by Subject|8|||
145617815|NCT02264574|525115273|FG001|Overall Study|Withdrawal by Subject|6|||
145617816|NCT02264574|525115272|FG000|Overall Study|Other, Not Specified|0|||
145617817|NCT02264574|525115273|FG001|Overall Study|Other, Not Specified|3|||
145617818|NCT03405662|525115276|FG000|Overall Study|COVID-19 restriction|1|||
145617819|NCT03405662|525115277|FG001|Overall Study|COVID-19 restriction|0|||
145617820|NCT03405662|525115276|FG000|Overall Study|unblinding|0|||
145617821|NCT03405662|525115277|FG001|Overall Study|unblinding|1|||
145617822|NCT03405662|525115276|FG000|Overall Study|placement in memory care facility|0|||
145617823|NCT03405662|525115277|FG001|Overall Study|placement in memory care facility|2|||
145617824|NCT00280293|525115278|FG000|Overall Study|Protocol Violation|3|||
145558529|NCT01474876|524904552|FG002|Overall Study|Lost to Follow-up|0|||
145558530|NCT01474876|524904550|FG000|Overall Study|Investigator's decision|28|||
145558531|NCT01474876|524904551|FG001|Overall Study|Investigator's decision|6|||
145558532|NCT01474876|524904552|FG002|Overall Study|Investigator's decision|0|||
145558533|NCT01474876|524904550|FG000|Overall Study|Patient's request|19|||
145558534|NCT01474876|524904551|FG001|Overall Study|Patient's request|5|||
145558535|NCT01474876|524904552|FG002|Overall Study|Patient's request|0|||
145558536|NCT01474876|524904550|FG000|Overall Study|Investigator's decision and pt request|1|||
145558537|NCT01474876|524904551|FG001|Overall Study|Investigator's decision and pt request|0|||
145558538|NCT01474876|524904552|FG002|Overall Study|Investigator's decision and pt request|0|||
145558539|NCT01523886|524904556|FG000|Overall Study|surgery cancelled|0|||
145617825|NCT00280293|525115279|FG001|Overall Study|Protocol Violation|0|||
145617826|NCT00280293|525115278|FG000|Overall Study|Physician Decision|5|||
145617827|NCT00280293|525115279|FG001|Overall Study|Physician Decision|4|||
145617828|NCT00280293|525115278|FG000|Overall Study|Lost to Follow-up|14|||
145617829|NCT00280293|525115279|FG001|Overall Study|Lost to Follow-up|12|||
145617830|NCT00280293|525115278|FG000|Overall Study|Withdrawal by Subject|3|||
145617831|NCT00280293|525115279|FG001|Overall Study|Withdrawal by Subject|5|||
145617832|NCT00280293|525115278|FG000|Overall Study|Incarceration/Legal Reasons|1|||
145617833|NCT00280293|525115279|FG001|Overall Study|Incarceration/Legal Reasons|1|||
145617834|NCT00280293|525115278|FG000|Overall Study|Adverse Event|0|||
145617835|NCT00280293|525115279|FG001|Overall Study|Adverse Event|1|||
145617836|NCT03358329|525115290|FG000|Overall Study|Lost to Follow-up|2|||
145558540|NCT01523886|524904557|FG001|Overall Study|surgery cancelled|1|||
145617837|NCT03358329|525115290|FG000|Overall Study|Withdrawal by Subject|2|||
145617838|NCT02982720|525115291|FG000|Overall Study|Adverse Event|3|||
145617839|NCT02982720|525115291|FG000|Overall Study|Death|1|||
145558541|NCT01173718|524904566|FG000|Overall Study|Death|17|||
145558542|NCT01173718|524904566|FG000|Overall Study|Abandonment of study graft|27|||
145558543|NCT01367158|524904567|FG000|Overall Study|Withdrew consent|0|||
145558544|NCT01367158|524904568|FG001|Overall Study|Withdrew consent|2|||
145558545|NCT01367158|524904569|FG002|Overall Study|Withdrew consent|1|||
145558546|NCT01367158|524904570|FG003|Overall Study|Withdrew consent|0|||
145558547|NCT01367158|524904571|FG004|Overall Study|Withdrew consent|2|||
145558548|NCT01367158|524904572|FG005|Overall Study|Withdrew consent|0|||
145558549|NCT01367158|524904573|FG006|Overall Study|Withdrew consent|0|||
145558550|NCT01367158|524904574|FG007|Overall Study|Withdrew consent|1|||
145558551|NCT01367158|524904575|FG008|Overall Study|Withdrew consent|0|||
145558552|NCT01367158|524904576|FG009|Overall Study|Withdrew consent|0|||
145558553|NCT01367158|524904577|FG010|Overall Study|Withdrew consent|0|||
145558554|NCT01367158|524904567|FG000|Overall Study|Lost to Follow-up|0|||
145558555|NCT01367158|524904568|FG001|Overall Study|Lost to Follow-up|0|||
145558556|NCT01367158|524904569|FG002|Overall Study|Lost to Follow-up|0|||
145558557|NCT01367158|524904570|FG003|Overall Study|Lost to Follow-up|1|||
145558558|NCT01367158|524904571|FG004|Overall Study|Lost to Follow-up|0|||
145558559|NCT01367158|524904572|FG005|Overall Study|Lost to Follow-up|2|||
145558560|NCT01367158|524904573|FG006|Overall Study|Lost to Follow-up|0|||
145558561|NCT01367158|524904574|FG007|Overall Study|Lost to Follow-up|1|||
145558562|NCT01367158|524904575|FG008|Overall Study|Lost to Follow-up|0|||
145558563|NCT01367158|524904576|FG009|Overall Study|Lost to Follow-up|0|||
145558564|NCT01367158|524904577|FG010|Overall Study|Lost to Follow-up|1|||
145558565|NCT01367158|524904567|FG000|Overall Study|Protocol Violation|0|||
145558566|NCT01367158|524904568|FG001|Overall Study|Protocol Violation|1|||
145558567|NCT01367158|524904569|FG002|Overall Study|Protocol Violation|0|||
145558568|NCT01367158|524904570|FG003|Overall Study|Protocol Violation|0|||
145558569|NCT01367158|524904571|FG004|Overall Study|Protocol Violation|0|||
145558570|NCT01367158|524904572|FG005|Overall Study|Protocol Violation|0|||
145558571|NCT01367158|524904573|FG006|Overall Study|Protocol Violation|0|||
145558572|NCT01367158|524904574|FG007|Overall Study|Protocol Violation|0|||
145558573|NCT01367158|524904575|FG008|Overall Study|Protocol Violation|0|||
145558574|NCT01367158|524904576|FG009|Overall Study|Protocol Violation|0|||
145558575|NCT01367158|524904577|FG010|Overall Study|Protocol Violation|0|||
145558576|NCT02226003|524904578|FG000|Overall Study|Lost to Follow-up|2|||
145558577|NCT02226003|524904579|FG001|Overall Study|Lost to Follow-up|1|||
145558578|NCT02226003|524904580|FG002|Overall Study|Lost to Follow-up|3|||
145558579|NCT02226003|524904578|FG000|Overall Study|Withdrawal by Subject|0|||
145558580|NCT02226003|524904579|FG001|Overall Study|Withdrawal by Subject|0|||
145558581|NCT02226003|524904580|FG002|Overall Study|Withdrawal by Subject|3|||
145558582|NCT01499563|524904583|FG000|Overall Study|Withdrawal by Subject|10|||
145558583|NCT01499563|524904584|FG001|Overall Study|Withdrawal by Subject|11|||
145558584|NCT01499563|524904585|FG002|Overall Study|Withdrawal by Subject|7|||
145558585|NCT01499563|524904586|FG003|Overall Study|Withdrawal by Subject|8|||
145558586|NCT01499563|524904583|FG000|Overall Study|Physician Decision|2|||
145558587|NCT01499563|524904584|FG001|Overall Study|Physician Decision|1|||
145558588|NCT01499563|524904585|FG002|Overall Study|Physician Decision|3|||
145558589|NCT01499563|524904586|FG003|Overall Study|Physician Decision|0|||
145558590|NCT01499563|524904583|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
145292897|NCT04947579|523922285|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
145292898|NCT04947579|523922286|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
145292899|NCT04947579|523922287|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
145292900|NCT04947579|523922288|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
145292901|NCT04947579|523922289|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
145292902|NCT04947579|523922284|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
145292903|NCT04947579|523922285|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
145292904|NCT04947579|523922286|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
145292905|NCT04947579|523922287|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
145292906|NCT04947579|523922288|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
145292907|NCT04947579|523922289|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
145292908|NCT04947579|523922284|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
145292909|NCT04947579|523922285|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
145292910|NCT04947579|523922286|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
145292911|NCT04947579|523922287|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
145292912|NCT04947579|523922288|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
145292913|NCT04947579|523922289|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
145292914|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
145292915|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
145292916|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
145292917|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
145292918|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
145292919|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
145292920|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
145292921|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
145292922|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
145292923|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
145292924|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
145292925|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
145292926|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
145292927|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
145292928|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
145292929|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
145292930|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
145292931|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
145292932|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
145292933|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
145292934|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
145292935|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
145292936|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
145292937|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
145292938|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
145292939|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
145292940|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
145292941|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
145292942|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
145292943|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
145292944|NCT04947579|523922284|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
145292945|NCT04947579|523922285|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
145292946|NCT04947579|523922286|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
145292947|NCT04947579|523922287|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
145292948|NCT04947579|523922288|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
145292949|NCT04947579|523922289|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
145292950|NCT04272801|523922290|FG000|Overall Study|Withdrawal by Subject|4|||
145292951|NCT04272801|523922290|FG000|Overall Study|Lost to Follow-up|4|||
145292952|NCT04272801|523922290|FG000|Overall Study|Ineligible|1|||
145292953|NCT00475020|523922291|FG000|Overall Study|Physician Decision|3|||
145292954|NCT00475020|523922291|FG000|Overall Study|Insurance Denial|1|||
145292955|NCT00475020|523922291|FG000|Overall Study|Donor not able to donate the last minute|1|||
145292956|NCT02456909|523922292|FG000|Overall Study|Did not receive allocated intervention|24|||
145292957|NCT02456909|523922293|FG001|Overall Study|Did not receive allocated intervention|26|||
145292958|NCT02456909|523922292|FG000|Overall Study|Did not complete the primary outcome|0|||
145292959|NCT02456909|523922293|FG001|Overall Study|Did not complete the primary outcome|1|||
145292960|NCT01575054|523922294|FG000|Overall Study|Other Reasons|5|||
145292961|NCT01575054|523922295|FG001|Overall Study|Other Reasons|3|||
145292962|NCT01575054|523922294|FG000|Overall Study|Protocol Violation|2|||
145292963|NCT01575054|523922295|FG001|Overall Study|Protocol Violation|1|||
145292964|NCT01575054|523922294|FG000|Overall Study|Personal Reasons|10|||
145292965|NCT01575054|523922295|FG001|Overall Study|Personal Reasons|11|||
145292966|NCT01575054|523922294|FG000|Overall Study|Lost to Follow-up|3|||
145292967|NCT01575054|523922295|FG001|Overall Study|Lost to Follow-up|3|||
145292968|NCT01575054|523922294|FG000|Overall Study|Adverse Event|9|||
145292969|NCT01575054|523922295|FG001|Overall Study|Adverse Event|8|||
145292970|NCT03481309|523922296|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
145292971|NCT03481309|523922297|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
145558591|NCT01499563|524904584|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
145558592|NCT01499563|524904585|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
145558593|NCT01499563|524904586|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
145558594|NCT01499563|524904583|FG000|Overall Study|Adverse Event|2|||
145558595|NCT01499563|524904584|FG001|Overall Study|Adverse Event|0|||
145558596|NCT01499563|524904585|FG002|Overall Study|Adverse Event|1|||
145558597|NCT01499563|524904586|FG003|Overall Study|Adverse Event|3|||
145558598|NCT01499563|524904583|FG000|Overall Study|Lack of Efficacy|0|||
145558599|NCT01499563|524904584|FG001|Overall Study|Lack of Efficacy|1|||
145558600|NCT01499563|524904585|FG002|Overall Study|Lack of Efficacy|6|||
145558601|NCT01499563|524904586|FG003|Overall Study|Lack of Efficacy|3|||
145558602|NCT01499563|524904583|FG000|Overall Study|Other|8|||
145558603|NCT01499563|524904584|FG001|Overall Study|Other|6|||
145558604|NCT01499563|524904585|FG002|Overall Study|Other|6|||
145558605|NCT01499563|524904586|FG003|Overall Study|Other|4|||
145558606|NCT03279692|524904587|FG000|Overall Study|Withdrawal by Subject|1|||
145558607|NCT05198843|524904590|FG000|Overall Study|Lack of Efficacy|1|||
145558608|NCT02588833|524904591|FG000|Part 1|Withdrawal by Subject|1|||
145558609|NCT02588833|524904592|FG001|Part 1|Withdrawal by Subject|0|||
145558610|NCT02588833|524904591|FG000|Part 2A|Physician Decision|0|||
145558611|NCT02588833|524904592|FG001|Part 2A|Physician Decision|1|||
145558612|NCT02588833|524904591|FG000|Part 2A|Withdrawal by Subject|0|||
145558613|NCT02588833|524904592|FG001|Part 2A|Withdrawal by Subject|1|||
145558614|NCT02588833|524904591|FG000|Part 2B|Adverse Event|0|||
145558615|NCT02588833|524904592|FG001|Part 2B|Adverse Event|1|||
145558616|NCT02588833|524904591|FG000|Part 2C|Adverse Event|0|||
145558617|NCT02588833|524904592|FG001|Part 2C|Adverse Event|1|||
145558618|NCT02588833|524904591|FG000|Part 2C|Withdrawal by Subject|0|||
145558619|NCT02588833|524904592|FG001|Part 2C|Withdrawal by Subject|1|||
145558620|NCT02588833|524904591|FG000|Part 3 (Safety Follow-up)|Other|0|||
145558621|NCT02588833|524904592|FG001|Part 3 (Safety Follow-up)|Other|2|||
145558622|NCT03333044|524904596|FG000|Overall Study|Pregnancy|1|||
145558623|NCT03333044|524904597|FG001|Overall Study|Pregnancy|0|||
145558624|NCT03333044|524904598|FG002|Overall Study|Pregnancy|0|||
145558625|NCT03333044|524904596|FG000|Overall Study|Lost to Follow-up|0|||
145558626|NCT03333044|524904597|FG001|Overall Study|Lost to Follow-up|14|||
145558627|NCT03333044|524904598|FG002|Overall Study|Lost to Follow-up|6|||
145558628|NCT03649711|524904601|FG000|Overall Study|Adverse Event|0|||
145558629|NCT03649711|524904602|FG001|Overall Study|Adverse Event|1|||
145558630|NCT03649711|524904603|FG002|Overall Study|Adverse Event|0|||
145558631|NCT03649711|524904601|FG000|Overall Study|Kidney Transplant|1|||
145558632|NCT03649711|524904602|FG001|Overall Study|Kidney Transplant|0|||
145558633|NCT03649711|524904603|FG002|Overall Study|Kidney Transplant|0|||
145558634|NCT02921776|524904604|FG000|Overall Study|patient deterioration, fatigue|2|||
145558635|NCT02921776|524904605|FG001|Overall Study|patient deterioration, fatigue|6|||
145558636|NCT02921776|524904606|FG002|Overall Study|patient deterioration, fatigue|0|||
145558637|NCT02921776|524904607|FG003|Overall Study|patient deterioration, fatigue|0|||
145558638|NCT02921776|524904608|FG004|Overall Study|patient deterioration, fatigue|0|||
145558639|NCT02921776|524904609|FG005|Overall Study|patient deterioration, fatigue|0|||
145558640|NCT02921776|524904610|FG006|Overall Study|patient deterioration, fatigue|0|||
145558641|NCT02921776|524904611|FG007|Overall Study|patient deterioration, fatigue|0|||
145558642|NCT02921776|524904604|FG000|Overall Study|Withdrawal by Subject|0|||
145558643|NCT02921776|524904605|FG001|Overall Study|Withdrawal by Subject|2|||
145558644|NCT02921776|524904606|FG002|Overall Study|Withdrawal by Subject|0|||
145558645|NCT02921776|524904607|FG003|Overall Study|Withdrawal by Subject|1|||
145558646|NCT02921776|524904608|FG004|Overall Study|Withdrawal by Subject|1|||
145558647|NCT02921776|524904609|FG005|Overall Study|Withdrawal by Subject|0|||
145558648|NCT02921776|524904610|FG006|Overall Study|Withdrawal by Subject|8|||
145292972|NCT03481309|523922298|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
145292973|NCT03481309|523922299|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
145292974|NCT03481309|523922300|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
145292975|NCT03481309|523922301|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
145292976|NCT02768298|523922304|FG000|Overall Study|Adverse Event|1|||
145292977|NCT02768298|523922305|FG001|Overall Study|Adverse Event|4|||
145558649|NCT02921776|524904611|FG007|Overall Study|Withdrawal by Subject|1|||
145292978|NCT02768298|523922304|FG000|Overall Study|Death|2|||
145292979|NCT02768298|523922305|FG001|Overall Study|Death|1|||
145292980|NCT02768298|523922304|FG000|Overall Study|Non-compliance with study treatment|0|||
145407764|NCT03765073|524349749|FG008|Stage 2|Withdrawal by Subject|0|||
145407765|NCT03765073|524349750|FG009|Stage 2|Withdrawal by Subject|5|||
145407766|NCT03765073|524349751|FG010|Stage 2|Withdrawal by Subject|0|||
145407767|NCT03765073|524349752|FG011|Stage 2|Withdrawal by Subject|0|||
145407768|NCT03765073|524349753|FG012|Stage 2|Withdrawal by Subject|0|||
145407769|NCT03765073|524349754|FG013|Stage 2|Withdrawal by Subject|0|||
145407770|NCT03765073|524349755|FG014|Stage 2|Withdrawal by Subject|0|||
145407771|NCT03765073|524349756|FG015|Stage 2|Withdrawal by Subject|0|||
145407772|NCT03765073|524349757|FG016|Stage 2|Withdrawal by Subject|0|||
145407773|NCT03765073|524349758|FG017|Stage 2|Withdrawal by Subject|0|||
145407774|NCT03765073|524349759|FG018|Stage 2|Withdrawal by Subject|0|||
145407775|NCT03765073|524349760|FG019|Stage 2|Withdrawal by Subject|0|||
145407776|NCT03765073|524349761|FG020|Stage 2|Withdrawal by Subject|0|||
145407777|NCT03765073|524349741|FG000|Stage 3|Adverse Event|0|||
145407778|NCT03765073|524349742|FG001|Stage 3|Adverse Event|0|||
145407779|NCT03765073|524349743|FG002|Stage 3|Adverse Event|0|||
145407780|NCT03765073|524349744|FG003|Stage 3|Adverse Event|0|||
145407781|NCT03765073|524349745|FG004|Stage 3|Adverse Event|0|||
145407782|NCT03765073|524349746|FG005|Stage 3|Adverse Event|0|||
145407783|NCT03765073|524349747|FG006|Stage 3|Adverse Event|0|||
145407784|NCT03765073|524349748|FG007|Stage 3|Adverse Event|0|||
145407785|NCT03765073|524349749|FG008|Stage 3|Adverse Event|0|||
145407786|NCT03765073|524349750|FG009|Stage 3|Adverse Event|0|||
145407787|NCT03765073|524349751|FG010|Stage 3|Adverse Event|0|||
145407788|NCT03765073|524349752|FG011|Stage 3|Adverse Event|0|||
145407789|NCT03765073|524349753|FG012|Stage 3|Adverse Event|0|||
145407790|NCT03765073|524349754|FG013|Stage 3|Adverse Event|0|||
145407791|NCT03765073|524349755|FG014|Stage 3|Adverse Event|0|||
145407792|NCT03765073|524349756|FG015|Stage 3|Adverse Event|0|||
145558650|NCT02921776|524904604|FG000|Overall Study|Death|0|||
145558651|NCT02921776|524904605|FG001|Overall Study|Death|0|||
145558652|NCT02921776|524904606|FG002|Overall Study|Death|0|||
145558653|NCT02921776|524904607|FG003|Overall Study|Death|2|||
145558654|NCT02921776|524904608|FG004|Overall Study|Death|0|||
145407793|NCT03765073|524349757|FG016|Stage 3|Adverse Event|0|||
145407794|NCT03765073|524349758|FG017|Stage 3|Adverse Event|0|||
145407795|NCT03765073|524349759|FG018|Stage 3|Adverse Event|1|||
145558655|NCT02921776|524904609|FG005|Overall Study|Death|0|||
145558656|NCT02921776|524904610|FG006|Overall Study|Death|0|||
145407796|NCT03765073|524349760|FG019|Stage 3|Adverse Event|0|||
145265309|NCT03323034|523819271|FG000|Overall Study|Withdrawal by Subject|1|||
145407797|NCT03765073|524349761|FG020|Stage 3|Adverse Event|0|||
145407798|NCT03765073|524349741|FG000|Stage 3|Death|0|||
145558657|NCT02921776|524904611|FG007|Overall Study|Death|0|||
145617840|NCT03875911|525115294|FG000|Overall Study|Lost to Follow-up|3|||
145617841|NCT03875911|525115295|FG001|Overall Study|Lost to Follow-up|6|||
145617842|NCT03875911|525115296|FG002|Overall Study|Lost to Follow-up|2|||
145617843|NCT03875911|525115294|FG000|Overall Study|Surgery cancelled|1|||
145617844|NCT03875911|525115295|FG001|Overall Study|Surgery cancelled|0|||
145617845|NCT03875911|525115296|FG002|Overall Study|Surgery cancelled|1|||
145617846|NCT03875911|525115294|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
145617847|NCT03875911|525115295|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
145617848|NCT03875911|525115296|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
145655500|NCT02975882|525257247|FG002|Overall Study|Death|0|||
145407799|NCT03765073|524349742|FG001|Stage 3|Death|0|||
145407800|NCT03765073|524349743|FG002|Stage 3|Death|0|||
145407801|NCT03765073|524349744|FG003|Stage 3|Death|0|||
145407802|NCT03765073|524349745|FG004|Stage 3|Death|0|||
145407803|NCT03765073|524349746|FG005|Stage 3|Death|0|||
145558658|NCT02921776|524904604|FG000|Overall Study|extubation or early discharge|0|||
145558659|NCT02921776|524904605|FG001|Overall Study|extubation or early discharge|0|||
145407804|NCT03765073|524349747|FG006|Stage 3|Death|0|||
145407805|NCT03765073|524349748|FG007|Stage 3|Death|0|||
145407806|NCT03765073|524349749|FG008|Stage 3|Death|0|||
145292981|NCT02768298|523922305|FG001|Overall Study|Non-compliance with study treatment|1|||
145292982|NCT02768298|523922304|FG000|Overall Study|Subject/guardian decision|1|||
145292983|NCT02768298|523922305|FG001|Overall Study|Subject/guardian decision|0|||
145292984|NCT02768298|523922304|FG000|Overall Study|Withdrawal of informed consent|0|||
145292985|NCT02768298|523922305|FG001|Overall Study|Withdrawal of informed consent|1|||
145558660|NCT02921776|524904606|FG002|Overall Study|extubation or early discharge|0|||
145558661|NCT02921776|524904607|FG003|Overall Study|extubation or early discharge|5|||
145558662|NCT02921776|524904608|FG004|Overall Study|extubation or early discharge|5|||
145558663|NCT02921776|524904609|FG005|Overall Study|extubation or early discharge|0|||
145558664|NCT02921776|524904610|FG006|Overall Study|extubation or early discharge|0|||
145558665|NCT02921776|524904611|FG007|Overall Study|extubation or early discharge|0|||
145558666|NCT02921776|524904604|FG000|Overall Study|Lost to Follow-up|0|||
145558667|NCT02921776|524904605|FG001|Overall Study|Lost to Follow-up|0|||
145558668|NCT02921776|524904606|FG002|Overall Study|Lost to Follow-up|0|||
145558669|NCT02921776|524904607|FG003|Overall Study|Lost to Follow-up|0|||
145558670|NCT02921776|524904608|FG004|Overall Study|Lost to Follow-up|0|||
145558671|NCT02921776|524904609|FG005|Overall Study|Lost to Follow-up|2|||
145558672|NCT02921776|524904610|FG006|Overall Study|Lost to Follow-up|3|||
145558673|NCT02921776|524904611|FG007|Overall Study|Lost to Follow-up|6|||
145558674|NCT04537234|524904612|FG000|Overall Study|Withdrawal by Subject|2|||
145558675|NCT04537234|524904613|FG001|Overall Study|Withdrawal by Subject|0|||
145558676|NCT07114198|524904614|FG000|Overall Study|Protocol Violation|1|||
145558677|NCT07114198|524904615|FG001|Overall Study|Protocol Violation|1|||
145558678|NCT01721330|524904616|FG000|Overall Study|Withdrawal by Subject|0|||
145558679|NCT01721330|524904617|FG001|Overall Study|Withdrawal by Subject|1|||
145558680|NCT00296374|524904618|FG000|Overall Study|Adverse Event|14|||
145558681|NCT00296374|524904619|FG001|Overall Study|Adverse Event|10|||
145558682|NCT00296374|524904620|FG002|Overall Study|Adverse Event|7|||
145558683|NCT00296374|524904618|FG000|Overall Study|Withdrawal by Subject|3|||
145558684|NCT00296374|524904619|FG001|Overall Study|Withdrawal by Subject|5|||
145558685|NCT00296374|524904620|FG002|Overall Study|Withdrawal by Subject|11|||
145558686|NCT00296374|524904618|FG000|Overall Study|Incorrect enrollment|3|||
145558687|NCT00296374|524904619|FG001|Overall Study|Incorrect enrollment|3|||
145558688|NCT00296374|524904620|FG002|Overall Study|Incorrect enrollment|4|||
145558689|NCT00296374|524904618|FG000|Overall Study|Protocol Violation|1|||
145558690|NCT00296374|524904619|FG001|Overall Study|Protocol Violation|2|||
145558691|NCT00296374|524904620|FG002|Overall Study|Protocol Violation|3|||
145558692|NCT00296374|524904618|FG000|Overall Study|Lost to Follow-up|3|||
145558693|NCT00296374|524904619|FG001|Overall Study|Lost to Follow-up|1|||
145558694|NCT00296374|524904620|FG002|Overall Study|Lost to Follow-up|1|||
145558695|NCT00296374|524904618|FG000|Overall Study|Relocated to another state|1|||
145558696|NCT00296374|524904619|FG001|Overall Study|Relocated to another state|0|||
145558697|NCT00296374|524904620|FG002|Overall Study|Relocated to another state|0|||
145558698|NCT00296374|524904618|FG000|Overall Study|Stopped drug before end of study visit|0|||
145558699|NCT00296374|524904619|FG001|Overall Study|Stopped drug before end of study visit|1|||
145558700|NCT00296374|524904620|FG002|Overall Study|Stopped drug before end of study visit|0|||
145558701|NCT00296374|524904618|FG000|Overall Study|Nephrologist introduced ACE|0|||
145558702|NCT00296374|524904619|FG001|Overall Study|Nephrologist introduced ACE|1|||
145558703|NCT00296374|524904620|FG002|Overall Study|Nephrologist introduced ACE|0|||
145558704|NCT00296374|524904618|FG000|Overall Study|Pregnancy|0|||
145558705|NCT00296374|524904619|FG001|Overall Study|Pregnancy|0|||
145558706|NCT00296374|524904620|FG002|Overall Study|Pregnancy|2|||
145292986|NCT04603937|523922306|FG000|Overall Study|Adverse Event|9|||
145292987|NCT04603937|523922307|FG001|Overall Study|Adverse Event|10|||
145292988|NCT04603937|523922306|FG000|Overall Study|Withdrawal by Subject|7|||
145292989|NCT04603937|523922307|FG001|Overall Study|Withdrawal by Subject|6|||
145558707|NCT00296374|524904618|FG000|Overall Study|Other|0|||
145558708|NCT00296374|524904619|FG001|Overall Study|Other|0|||
145558709|NCT00296374|524904620|FG002|Overall Study|Other|1|||
145558710|NCT04734652|524906476|FG000|Overall Study|Withdrawal by Subject|2|||
145558711|NCT04734652|524906477|FG001|Overall Study|Withdrawal by Subject|0|||
145558712|NCT04734652|524906476|FG000|Overall Study|Death|0|||
145292990|NCT04603937|523922306|FG000|Overall Study|Lost to Follow-up|5|||
145558713|NCT04734652|524906477|FG001|Overall Study|Death|1|||
145558714|NCT01921179|524906479|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
145558715|NCT01921179|524906480|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
145558716|NCT01921179|524906479|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
145558717|NCT01921179|524906480|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
145407807|NCT03765073|524349750|FG009|Stage 3|Death|0|||
145407808|NCT03765073|524349751|FG010|Stage 3|Death|0|||
145407809|NCT03765073|524349752|FG011|Stage 3|Death|0|||
145407810|NCT03765073|524349753|FG012|Stage 3|Death|0|||
145407811|NCT03765073|524349754|FG013|Stage 3|Death|0|||
145407812|NCT03765073|524349755|FG014|Stage 3|Death|0|||
145407813|NCT03765073|524349756|FG015|Stage 3|Death|0|||
145407814|NCT03765073|524349757|FG016|Stage 3|Death|0|||
145407815|NCT03765073|524349758|FG017|Stage 3|Death|0|||
145407816|NCT03765073|524349759|FG018|Stage 3|Death|0|||
145407817|NCT03765073|524349760|FG019|Stage 3|Death|3|||
145407818|NCT03765073|524349761|FG020|Stage 3|Death|2|||
145407819|NCT03765073|524349741|FG000|Stage 3|Lost to Follow-up|0|||
145407820|NCT03765073|524349742|FG001|Stage 3|Lost to Follow-up|0|||
145407821|NCT03765073|524349743|FG002|Stage 3|Lost to Follow-up|0|||
145407822|NCT03765073|524349744|FG003|Stage 3|Lost to Follow-up|0|||
145407823|NCT03765073|524349745|FG004|Stage 3|Lost to Follow-up|0|||
145407824|NCT03765073|524349746|FG005|Stage 3|Lost to Follow-up|0|||
145407825|NCT03765073|524349747|FG006|Stage 3|Lost to Follow-up|0|||
145407826|NCT03765073|524349748|FG007|Stage 3|Lost to Follow-up|0|||
145407827|NCT03765073|524349749|FG008|Stage 3|Lost to Follow-up|0|||
145407828|NCT03765073|524349750|FG009|Stage 3|Lost to Follow-up|0|||
145407829|NCT03765073|524349751|FG010|Stage 3|Lost to Follow-up|0|||
145407830|NCT03765073|524349752|FG011|Stage 3|Lost to Follow-up|0|||
145407831|NCT03765073|524349753|FG012|Stage 3|Lost to Follow-up|0|||
145407832|NCT03765073|524349754|FG013|Stage 3|Lost to Follow-up|0|||
145407833|NCT03765073|524349755|FG014|Stage 3|Lost to Follow-up|0|||
145617849|NCT00287469|525115302|FG000|Overall Study|serious adverse event|1|||
145407834|NCT03765073|524349756|FG015|Stage 3|Lost to Follow-up|0|||
145407835|NCT03765073|524349757|FG016|Stage 3|Lost to Follow-up|0|||
145407836|NCT03765073|524349758|FG017|Stage 3|Lost to Follow-up|8|||
145407837|NCT03765073|524349759|FG018|Stage 3|Lost to Follow-up|5|||
145407838|NCT03765073|524349760|FG019|Stage 3|Lost to Follow-up|7|||
145407839|NCT03765073|524349761|FG020|Stage 3|Lost to Follow-up|4|||
145407840|NCT03765073|524349741|FG000|Stage 3|No longer meets eligibility criteria|0|||
145292991|NCT04603937|523922307|FG001|Overall Study|Lost to Follow-up|6|||
145407841|NCT03765073|524349742|FG001|Stage 3|No longer meets eligibility criteria|0|||
145407842|NCT03765073|524349743|FG002|Stage 3|No longer meets eligibility criteria|0|||
145407843|NCT03765073|524349744|FG003|Stage 3|No longer meets eligibility criteria|0|||
145407844|NCT03765073|524349745|FG004|Stage 3|No longer meets eligibility criteria|0|||
145558718|NCT01190254|524906483|FG000|Overall Study|Adverse Event|3|||
145558719|NCT01190254|524906484|FG001|Overall Study|Adverse Event|6|||
145558720|NCT01190254|524906485|FG002|Overall Study|Adverse Event|8|||
145558721|NCT01190254|524906483|FG000|Overall Study|Lack of Efficacy|7|||
145558722|NCT01190254|524906484|FG001|Overall Study|Lack of Efficacy|4|||
145558723|NCT01190254|524906485|FG002|Overall Study|Lack of Efficacy|5|||
145558724|NCT01190254|524906483|FG000|Overall Study|Lost to Follow-up|4|||
145558725|NCT01190254|524906484|FG001|Overall Study|Lost to Follow-up|2|||
145558726|NCT01190254|524906485|FG002|Overall Study|Lost to Follow-up|0|||
145558727|NCT01190254|524906483|FG000|Overall Study|Withdrawal by Subject|4|||
145558728|NCT01190254|524906484|FG001|Overall Study|Withdrawal by Subject|5|||
145558729|NCT01190254|524906485|FG002|Overall Study|Withdrawal by Subject|7|||
145558730|NCT01190254|524906483|FG000|Overall Study|Protocol Violation|2|||
145558731|NCT01190254|524906484|FG001|Overall Study|Protocol Violation|0|||
145558732|NCT01190254|524906485|FG002|Overall Study|Protocol Violation|2|||
145558733|NCT01190254|524906483|FG000|Overall Study|Did not meet protocol eligibility|1|||
145558734|NCT01190254|524906484|FG001|Overall Study|Did not meet protocol eligibility|0|||
145558735|NCT01190254|524906485|FG002|Overall Study|Did not meet protocol eligibility|0|||
145558736|NCT04146545|524906486|FG000|Overall Study|deemed ineligible after randomization|1|||
145558737|NCT04146545|524906487|FG001|Overall Study|deemed ineligible after randomization|0|||
145558738|NCT01729754|524906488|FG000|Part 1|Adverse Event|2|||
145558739|NCT01729754|524906489|FG001|Part 1|Adverse Event|0|||
145558740|NCT01729754|524906490|FG002|Part 1|Adverse Event|0|||
145558741|NCT01729754|524906491|FG003|Part 1|Adverse Event|1|||
145558742|NCT01729754|524906492|FG004|Part 1|Adverse Event|0|||
145558743|NCT01729754|524906493|FG005|Part 1|Adverse Event|0|||
145558744|NCT01729754|524906494|FG006|Part 1|Adverse Event|2|||
145558745|NCT01729754|524906495|FG007|Part 1|Adverse Event|0|||
145558746|NCT01729754|524906496|FG008|Part 1|Adverse Event|0|||
145558747|NCT01729754|524906497|FG009|Part 1|Adverse Event|5|||
145558748|NCT01729754|524906488|FG000|Part 1|Lack of Efficacy|1|||
145558749|NCT01729754|524906489|FG001|Part 1|Lack of Efficacy|0|||
145558750|NCT01729754|524906490|FG002|Part 1|Lack of Efficacy|0|||
145558751|NCT01729754|524906491|FG003|Part 1|Lack of Efficacy|0|||
145558752|NCT01729754|524906492|FG004|Part 1|Lack of Efficacy|0|||
145558753|NCT01729754|524906493|FG005|Part 1|Lack of Efficacy|0|||
145558754|NCT01729754|524906494|FG006|Part 1|Lack of Efficacy|2|||
145558755|NCT01729754|524906495|FG007|Part 1|Lack of Efficacy|0|||
145558756|NCT01729754|524906496|FG008|Part 1|Lack of Efficacy|0|||
145558757|NCT01729754|524906497|FG009|Part 1|Lack of Efficacy|0|||
145558758|NCT01729754|524906488|FG000|Part 1|Lost to Follow-up|1|||
145558759|NCT01729754|524906489|FG001|Part 1|Lost to Follow-up|0|||
145558760|NCT01729754|524906490|FG002|Part 1|Lost to Follow-up|0|||
145558761|NCT01729754|524906491|FG003|Part 1|Lost to Follow-up|2|||
145558762|NCT01729754|524906492|FG004|Part 1|Lost to Follow-up|0|||
145558763|NCT01729754|524906493|FG005|Part 1|Lost to Follow-up|0|||
145558764|NCT01729754|524906494|FG006|Part 1|Lost to Follow-up|3|||
145558765|NCT01729754|524906495|FG007|Part 1|Lost to Follow-up|0|||
145558766|NCT01729754|524906496|FG008|Part 1|Lost to Follow-up|0|||
145558767|NCT01729754|524906497|FG009|Part 1|Lost to Follow-up|3|||
145558768|NCT01729754|524906488|FG000|Part 1|Non-compliance with Study Drug|1|||
145558769|NCT01729754|524906489|FG001|Part 1|Non-compliance with Study Drug|0|||
145558770|NCT01729754|524906490|FG002|Part 1|Non-compliance with Study Drug|0|||
145558771|NCT01729754|524906491|FG003|Part 1|Non-compliance with Study Drug|0|||
145558772|NCT01729754|524906492|FG004|Part 1|Non-compliance with Study Drug|0|||
145558773|NCT01729754|524906493|FG005|Part 1|Non-compliance with Study Drug|0|||
145558774|NCT01729754|524906494|FG006|Part 1|Non-compliance with Study Drug|0|||
145558775|NCT01729754|524906495|FG007|Part 1|Non-compliance with Study Drug|0|||
145558776|NCT01729754|524906496|FG008|Part 1|Non-compliance with Study Drug|0|||
145558777|NCT01729754|524906497|FG009|Part 1|Non-compliance with Study Drug|0|||
145558778|NCT01729754|524906488|FG000|Part 1|Physician Decision|0|||
145558779|NCT01729754|524906489|FG001|Part 1|Physician Decision|0|||
145558780|NCT01729754|524906490|FG002|Part 1|Physician Decision|0|||
145558781|NCT01729754|524906491|FG003|Part 1|Physician Decision|0|||
145558782|NCT01729754|524906492|FG004|Part 1|Physician Decision|0|||
145558783|NCT01729754|524906493|FG005|Part 1|Physician Decision|0|||
145558784|NCT01729754|524906494|FG006|Part 1|Physician Decision|0|||
145558785|NCT01729754|524906495|FG007|Part 1|Physician Decision|0|||
145558786|NCT01729754|524906496|FG008|Part 1|Physician Decision|0|||
145558787|NCT01729754|524906497|FG009|Part 1|Physician Decision|4|||
145558788|NCT01729754|524906488|FG000|Part 1|Pregnancy|0|||
145558789|NCT01729754|524906489|FG001|Part 1|Pregnancy|0|||
145558790|NCT01729754|524906490|FG002|Part 1|Pregnancy|0|||
145558791|NCT01729754|524906491|FG003|Part 1|Pregnancy|1|||
145558792|NCT01729754|524906492|FG004|Part 1|Pregnancy|0|||
145558793|NCT01729754|524906493|FG005|Part 1|Pregnancy|0|||
145558794|NCT01729754|524906494|FG006|Part 1|Pregnancy|0|||
145558795|NCT01729754|524906495|FG007|Part 1|Pregnancy|0|||
145558796|NCT01729754|524906496|FG008|Part 1|Pregnancy|0|||
145558797|NCT01729754|524906497|FG009|Part 1|Pregnancy|1|||
145558798|NCT01729754|524906488|FG000|Part 1|Progressive Disease|0|||
145558799|NCT01729754|524906489|FG001|Part 1|Progressive Disease|0|||
145558800|NCT01729754|524906490|FG002|Part 1|Progressive Disease|0|||
145558801|NCT01729754|524906491|FG003|Part 1|Progressive Disease|0|||
145558802|NCT01729754|524906492|FG004|Part 1|Progressive Disease|0|||
145558803|NCT01729754|524906493|FG005|Part 1|Progressive Disease|0|||
145558804|NCT01729754|524906494|FG006|Part 1|Progressive Disease|0|||
145558805|NCT01729754|524906495|FG007|Part 1|Progressive Disease|0|||
145558806|NCT01729754|524906496|FG008|Part 1|Progressive Disease|0|||
145558807|NCT01729754|524906497|FG009|Part 1|Progressive Disease|1|||
145558808|NCT01729754|524906488|FG000|Part 1|Protocol Violation|2|||
145558809|NCT01729754|524906489|FG001|Part 1|Protocol Violation|0|||
145558810|NCT01729754|524906490|FG002|Part 1|Protocol Violation|0|||
145558811|NCT01729754|524906491|FG003|Part 1|Protocol Violation|1|||
145292992|NCT04603937|523922306|FG000|Overall Study|Physician Decision|0|||
145558812|NCT01729754|524906492|FG004|Part 1|Protocol Violation|0|||
145558813|NCT01729754|524906493|FG005|Part 1|Protocol Violation|0|||
145558814|NCT01729754|524906494|FG006|Part 1|Protocol Violation|1|||
145558815|NCT01729754|524906495|FG007|Part 1|Protocol Violation|0|||
145617850|NCT00287469|525115303|FG001|Overall Study|serious adverse event|6|||
145617851|NCT00287469|525115302|FG000|Overall Study|Adverse Event|1|||
145617852|NCT00287469|525115303|FG001|Overall Study|Adverse Event|1|||
145617853|NCT00287469|525115302|FG000|Overall Study|moved from area|144|||
145617854|NCT00287469|525115303|FG001|Overall Study|moved from area|138|||
145617855|NCT00287469|525115302|FG000|Overall Study|Lost to Follow-up|74|||
145617856|NCT00287469|525115303|FG001|Overall Study|Lost to Follow-up|69|||
145617857|NCT00065468|525115304|FG000|Overall Study|Death|172|||
145617858|NCT00065468|525115305|FG001|Overall Study|Death|169|||
145617859|NCT00065468|525115306|FG002|Overall Study|Death|171|||
145617860|NCT00065468|525115304|FG000|Overall Study|Withdrawal by Subject|3|||
145617861|NCT00065468|525115305|FG001|Overall Study|Withdrawal by Subject|4|||
145617862|NCT00065468|525115306|FG002|Overall Study|Withdrawal by Subject|5|||
145617863|NCT00065468|525115304|FG000|Overall Study|Lost to Follow-up|5|||
145617864|NCT00065468|525115305|FG001|Overall Study|Lost to Follow-up|3|||
145617865|NCT00065468|525115306|FG002|Overall Study|Lost to Follow-up|2|||
145617866|NCT00065468|525115304|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
145617867|NCT00065468|525115305|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
145617868|NCT00065468|525115306|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
145617869|NCT00065468|525115304|FG000|Overall Study|Disease progression|0|||
145617870|NCT00065468|525115305|FG001|Overall Study|Disease progression|0|||
145617871|NCT00065468|525115306|FG002|Overall Study|Disease progression|1|||
145617872|NCT00065468|525115304|FG000|Overall Study|Other|14|||
145617873|NCT00065468|525115305|FG001|Overall Study|Other|24|||
145617874|NCT00065468|525115306|FG002|Overall Study|Other|18|||
145617875|NCT02019602|525115312|FG000|Screening Period|Ineligibility|4|||
145617876|NCT02019602|525115313|FG001|Screening Period|Ineligibility|0|||
145617877|NCT02019602|525115312|FG000|Screening Period|Adverse Event|1|||
145617878|NCT02019602|525115313|FG001|Screening Period|Adverse Event|0|||
145617879|NCT00683449|525115314|FG000|Overall Study|Lost to Follow-up|0|||
145617880|NCT00683449|525115315|FG001|Overall Study|Lost to Follow-up|1|||
145617881|NCT00683449|525115316|FG002|Overall Study|Lost to Follow-up|0|||
145617882|NCT00683449|525115317|FG003|Overall Study|Lost to Follow-up|0|||
145617883|NCT00683449|525115318|FG004|Overall Study|Lost to Follow-up|0|||
145617884|NCT00507026|525115319|FG000|Overall Study|Lack of Efficacy|6|||
145617885|NCT00507026|525115320|FG001|Overall Study|Lack of Efficacy|4|||
145617886|NCT00507026|525115321|FG002|Overall Study|Lack of Efficacy|21|||
145292993|NCT04603937|523922307|FG001|Overall Study|Physician Decision|1|||
145292994|NCT04603937|523922306|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
145558816|NCT01729754|524906496|FG008|Part 1|Protocol Violation|0|||
145558817|NCT01729754|524906497|FG009|Part 1|Protocol Violation|0|||
145558818|NCT01729754|524906488|FG000|Part 1|Withdrawal by Subject|5|||
145558819|NCT01729754|524906489|FG001|Part 1|Withdrawal by Subject|0|||
145558820|NCT01729754|524906490|FG002|Part 1|Withdrawal by Subject|0|||
145558821|NCT01729754|524906491|FG003|Part 1|Withdrawal by Subject|7|||
145558822|NCT01729754|524906492|FG004|Part 1|Withdrawal by Subject|0|||
145558823|NCT01729754|524906493|FG005|Part 1|Withdrawal by Subject|0|||
145558824|NCT01729754|524906494|FG006|Part 1|Withdrawal by Subject|5|||
145558825|NCT01729754|524906495|FG007|Part 1|Withdrawal by Subject|0|||
145558826|NCT01729754|524906496|FG008|Part 1|Withdrawal by Subject|0|||
145558827|NCT01729754|524906497|FG009|Part 1|Withdrawal by Subject|6|||
145558828|NCT01729754|524906488|FG000|Part 1|Other Protocol Specified Criteria|2|||
145558829|NCT01729754|524906489|FG001|Part 1|Other Protocol Specified Criteria|0|||
145558830|NCT01729754|524906490|FG002|Part 1|Other Protocol Specified Criteria|0|||
145558831|NCT01729754|524906491|FG003|Part 1|Other Protocol Specified Criteria|0|||
145558832|NCT01729754|524906492|FG004|Part 1|Other Protocol Specified Criteria|0|||
145558833|NCT01729754|524906493|FG005|Part 1|Other Protocol Specified Criteria|0|||
145558834|NCT01729754|524906494|FG006|Part 1|Other Protocol Specified Criteria|1|||
145558835|NCT01729754|524906495|FG007|Part 1|Other Protocol Specified Criteria|0|||
145558836|NCT01729754|524906496|FG008|Part 1|Other Protocol Specified Criteria|0|||
145558837|NCT01729754|524906497|FG009|Part 1|Other Protocol Specified Criteria|4|||
145558838|NCT01729754|524906488|FG000|Part 2|Adverse Event|2|||
145558839|NCT01729754|524906489|FG001|Part 2|Adverse Event|0|||
145558840|NCT01729754|524906490|FG002|Part 2|Adverse Event|0|||
145558841|NCT01729754|524906491|FG003|Part 2|Adverse Event|0|||
145558842|NCT01729754|524906492|FG004|Part 2|Adverse Event|0|||
145558843|NCT01729754|524906493|FG005|Part 2|Adverse Event|0|||
145558844|NCT01729754|524906494|FG006|Part 2|Adverse Event|0|||
145558845|NCT01729754|524906495|FG007|Part 2|Adverse Event|0|||
145558846|NCT01729754|524906496|FG008|Part 2|Adverse Event|1|||
145558847|NCT01729754|524906497|FG009|Part 2|Adverse Event|2|||
145558848|NCT01729754|524906488|FG000|Part 2|Lack of Efficacy|0|||
145558849|NCT01729754|524906489|FG001|Part 2|Lack of Efficacy|0|||
145558850|NCT01729754|524906490|FG002|Part 2|Lack of Efficacy|0|||
145558851|NCT01729754|524906491|FG003|Part 2|Lack of Efficacy|0|||
145558852|NCT01729754|524906492|FG004|Part 2|Lack of Efficacy|0|||
145558853|NCT01729754|524906493|FG005|Part 2|Lack of Efficacy|0|||
145558854|NCT01729754|524906494|FG006|Part 2|Lack of Efficacy|0|||
145558855|NCT01729754|524906495|FG007|Part 2|Lack of Efficacy|0|||
145558856|NCT01729754|524906496|FG008|Part 2|Lack of Efficacy|2|||
145558857|NCT01729754|524906497|FG009|Part 2|Lack of Efficacy|2|||
145558858|NCT01729754|524906488|FG000|Part 2|Lost to Follow-up|0|||
145558859|NCT01729754|524906489|FG001|Part 2|Lost to Follow-up|0|||
145558860|NCT01729754|524906490|FG002|Part 2|Lost to Follow-up|0|||
145558861|NCT01729754|524906491|FG003|Part 2|Lost to Follow-up|2|||
145558862|NCT01729754|524906492|FG004|Part 2|Lost to Follow-up|0|||
145558863|NCT01729754|524906493|FG005|Part 2|Lost to Follow-up|0|||
145558864|NCT01729754|524906494|FG006|Part 2|Lost to Follow-up|0|||
145292995|NCT04603937|523922307|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
145558865|NCT01729754|524906495|FG007|Part 2|Lost to Follow-up|1|||
145558866|NCT01729754|524906496|FG008|Part 2|Lost to Follow-up|0|||
145292996|NCT01611090|523922308|FG000|Randomized Period|Lost to Follow-up|8|||
145558867|NCT01729754|524906497|FG009|Part 2|Lost to Follow-up|2|||
145558868|NCT01729754|524906488|FG000|Part 2|Non-Compliance with Study Drug|0|||
145558869|NCT01729754|524906489|FG001|Part 2|Non-Compliance with Study Drug|0|||
145558870|NCT01729754|524906490|FG002|Part 2|Non-Compliance with Study Drug|0|||
145558871|NCT01729754|524906491|FG003|Part 2|Non-Compliance with Study Drug|0|||
145558872|NCT01729754|524906492|FG004|Part 2|Non-Compliance with Study Drug|0|||
145558873|NCT01729754|524906493|FG005|Part 2|Non-Compliance with Study Drug|0|||
145558874|NCT01729754|524906494|FG006|Part 2|Non-Compliance with Study Drug|0|||
145558875|NCT01729754|524906495|FG007|Part 2|Non-Compliance with Study Drug|0|||
145558876|NCT01729754|524906496|FG008|Part 2|Non-Compliance with Study Drug|0|||
145558877|NCT01729754|524906497|FG009|Part 2|Non-Compliance with Study Drug|1|||
145558878|NCT01729754|524906488|FG000|Part 2|Pregnancy|0|||
145558879|NCT01729754|524906489|FG001|Part 2|Pregnancy|0|||
145558880|NCT01729754|524906490|FG002|Part 2|Pregnancy|0|||
145558881|NCT01729754|524906491|FG003|Part 2|Pregnancy|1|||
145558882|NCT01729754|524906492|FG004|Part 2|Pregnancy|0|||
145558883|NCT01729754|524906493|FG005|Part 2|Pregnancy|0|||
145558884|NCT01729754|524906494|FG006|Part 2|Pregnancy|0|||
145558885|NCT01729754|524906495|FG007|Part 2|Pregnancy|0|||
145558886|NCT01729754|524906496|FG008|Part 2|Pregnancy|0|||
145558887|NCT01729754|524906497|FG009|Part 2|Pregnancy|1|||
145558888|NCT01729754|524906488|FG000|Part 2|Withdrawal by Subject|3|||
145558889|NCT01729754|524906489|FG001|Part 2|Withdrawal by Subject|0|||
145558890|NCT01729754|524906490|FG002|Part 2|Withdrawal by Subject|0|||
145558891|NCT01729754|524906491|FG003|Part 2|Withdrawal by Subject|2|||
145558892|NCT01729754|524906492|FG004|Part 2|Withdrawal by Subject|0|||
145558893|NCT01729754|524906493|FG005|Part 2|Withdrawal by Subject|0|||
145558894|NCT01729754|524906494|FG006|Part 2|Withdrawal by Subject|0|||
145558895|NCT01729754|524906495|FG007|Part 2|Withdrawal by Subject|1|||
145558896|NCT01729754|524906496|FG008|Part 2|Withdrawal by Subject|1|||
145558897|NCT01729754|524906497|FG009|Part 2|Withdrawal by Subject|4|||
145558898|NCT01729754|524906488|FG000|Part 2|Other Protocol Specified Criteria|1|||
145558899|NCT01729754|524906489|FG001|Part 2|Other Protocol Specified Criteria|0|||
145407845|NCT03765073|524349746|FG005|Stage 3|No longer meets eligibility criteria|0|||
145558900|NCT01729754|524906490|FG002|Part 2|Other Protocol Specified Criteria|0|||
145558901|NCT01729754|524906491|FG003|Part 2|Other Protocol Specified Criteria|0|||
145407846|NCT03765073|524349747|FG006|Stage 3|No longer meets eligibility criteria|0|||
145558902|NCT01729754|524906492|FG004|Part 2|Other Protocol Specified Criteria|0|||
145558903|NCT01729754|524906493|FG005|Part 2|Other Protocol Specified Criteria|0|||
145558904|NCT01729754|524906494|FG006|Part 2|Other Protocol Specified Criteria|0|||
145558905|NCT01729754|524906495|FG007|Part 2|Other Protocol Specified Criteria|1|||
145558906|NCT01729754|524906496|FG008|Part 2|Other Protocol Specified Criteria|0|||
145558907|NCT01729754|524906497|FG009|Part 2|Other Protocol Specified Criteria|0|||
145558908|NCT01729754|524906488|FG000|Part 3|Adverse Event|0|||
145558909|NCT01729754|524906489|FG001|Part 3|Adverse Event|0|||
145558910|NCT01729754|524906490|FG002|Part 3|Adverse Event|1|||
145558911|NCT01729754|524906491|FG003|Part 3|Adverse Event|0|||
145558912|NCT01729754|524906492|FG004|Part 3|Adverse Event|0|||
145558913|NCT01729754|524906493|FG005|Part 3|Adverse Event|5|||
145558914|NCT01729754|524906494|FG006|Part 3|Adverse Event|0|||
145558915|NCT01729754|524906495|FG007|Part 3|Adverse Event|0|||
145558916|NCT01729754|524906496|FG008|Part 3|Adverse Event|0|||
145558917|NCT01729754|524906497|FG009|Part 3|Adverse Event|3|||
145558918|NCT01729754|524906488|FG000|Part 3|Death|0|||
145558919|NCT01729754|524906489|FG001|Part 3|Death|0|||
145558920|NCT01729754|524906490|FG002|Part 3|Death|0|||
145558921|NCT01729754|524906491|FG003|Part 3|Death|0|||
145558922|NCT01729754|524906492|FG004|Part 3|Death|0|||
145558923|NCT01729754|524906493|FG005|Part 3|Death|2|||
145558924|NCT01729754|524906494|FG006|Part 3|Death|0|||
145558925|NCT01729754|524906495|FG007|Part 3|Death|0|||
145558926|NCT01729754|524906496|FG008|Part 3|Death|0|||
145558927|NCT01729754|524906497|FG009|Part 3|Death|0|||
145558928|NCT01729754|524906488|FG000|Part 3|Lack of Efficacy|0|||
145558929|NCT01729754|524906489|FG001|Part 3|Lack of Efficacy|0|||
145558930|NCT01729754|524906490|FG002|Part 3|Lack of Efficacy|0|||
145558931|NCT01729754|524906491|FG003|Part 3|Lack of Efficacy|0|||
145558932|NCT01729754|524906492|FG004|Part 3|Lack of Efficacy|2|||
145558933|NCT01729754|524906493|FG005|Part 3|Lack of Efficacy|0|||
145558934|NCT01729754|524906494|FG006|Part 3|Lack of Efficacy|0|||
145558935|NCT01729754|524906495|FG007|Part 3|Lack of Efficacy|0|||
145558936|NCT01729754|524906496|FG008|Part 3|Lack of Efficacy|0|||
145558937|NCT01729754|524906497|FG009|Part 3|Lack of Efficacy|4|||
145558938|NCT01729754|524906488|FG000|Part 3|Lost to Follow-up|0|||
145558939|NCT01729754|524906489|FG001|Part 3|Lost to Follow-up|1|||
145558940|NCT01729754|524906490|FG002|Part 3|Lost to Follow-up|2|||
145558941|NCT01729754|524906491|FG003|Part 3|Lost to Follow-up|0|||
145558942|NCT01729754|524906492|FG004|Part 3|Lost to Follow-up|0|||
145558943|NCT01729754|524906493|FG005|Part 3|Lost to Follow-up|3|||
145558944|NCT01729754|524906494|FG006|Part 3|Lost to Follow-up|0|||
145558945|NCT01729754|524906495|FG007|Part 3|Lost to Follow-up|0|||
145558946|NCT01729754|524906496|FG008|Part 3|Lost to Follow-up|1|||
145558947|NCT01729754|524906497|FG009|Part 3|Lost to Follow-up|0|||
145558948|NCT01729754|524906488|FG000|Part 3|Physician Decision|0|||
145558949|NCT01729754|524906489|FG001|Part 3|Physician Decision|0|||
145558950|NCT01729754|524906490|FG002|Part 3|Physician Decision|1|||
145558951|NCT01729754|524906491|FG003|Part 3|Physician Decision|0|||
145558952|NCT01729754|524906492|FG004|Part 3|Physician Decision|0|||
145558953|NCT01729754|524906493|FG005|Part 3|Physician Decision|0|||
145558954|NCT01729754|524906494|FG006|Part 3|Physician Decision|0|||
145558955|NCT01729754|524906495|FG007|Part 3|Physician Decision|0|||
145558956|NCT01729754|524906496|FG008|Part 3|Physician Decision|0|||
145558957|NCT01729754|524906497|FG009|Part 3|Physician Decision|0|||
145558958|NCT01729754|524906488|FG000|Part 3|Withdrawal by Subject|0|||
145558959|NCT01729754|524906489|FG001|Part 3|Withdrawal by Subject|4|||
145558960|NCT01729754|524906490|FG002|Part 3|Withdrawal by Subject|1|||
145558961|NCT01729754|524906491|FG003|Part 3|Withdrawal by Subject|0|||
145558962|NCT01729754|524906492|FG004|Part 3|Withdrawal by Subject|2|||
145558963|NCT01729754|524906493|FG005|Part 3|Withdrawal by Subject|1|||
145558964|NCT01729754|524906494|FG006|Part 3|Withdrawal by Subject|0|||
145558965|NCT01729754|524906495|FG007|Part 3|Withdrawal by Subject|2|||
145558966|NCT01729754|524906496|FG008|Part 3|Withdrawal by Subject|0|||
145558967|NCT01729754|524906497|FG009|Part 3|Withdrawal by Subject|0|||
145558968|NCT01729754|524906488|FG000|Part 3|Other Protocol Specified Criteria|0|||
145558969|NCT01729754|524906489|FG001|Part 3|Other Protocol Specified Criteria|0|||
145558970|NCT01729754|524906490|FG002|Part 3|Other Protocol Specified Criteria|0|||
145558971|NCT01729754|524906491|FG003|Part 3|Other Protocol Specified Criteria|0|||
145558972|NCT01729754|524906492|FG004|Part 3|Other Protocol Specified Criteria|0|||
145558973|NCT01729754|524906493|FG005|Part 3|Other Protocol Specified Criteria|2|||
145558974|NCT01729754|524906494|FG006|Part 3|Other Protocol Specified Criteria|0|||
145558975|NCT01729754|524906495|FG007|Part 3|Other Protocol Specified Criteria|1|||
145558976|NCT01729754|524906496|FG008|Part 3|Other Protocol Specified Criteria|0|||
145558977|NCT01729754|524906497|FG009|Part 3|Other Protocol Specified Criteria|0|||
145558978|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Death|3|||
145558979|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Death|2|||
145558980|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Death|4|||
145558981|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Death|3|||
145558982|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Death|0|||
145558983|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Death|0|||
145558984|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
145558985|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
145558986|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
145558987|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
145558988|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
145558989|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
145558990|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
145558991|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
145558992|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
145558993|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
145558994|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
145558995|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
145558996|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
145558997|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
145558998|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
145558999|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
145559000|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
145559001|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
145559002|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
145559003|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
145559004|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
145559005|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
145559006|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
145559007|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
145559008|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
145559009|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
145559010|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
145559011|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
145559012|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
145559013|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
145559014|NCT02432846|524906498|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
145559015|NCT02432846|524906499|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
145559016|NCT02432846|524906500|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
145559017|NCT02432846|524906501|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
145559018|NCT02432846|524906502|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
145559019|NCT02432846|524906503|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
145559020|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
145559021|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
145559022|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
145559023|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
145559024|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
145559025|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
145559026|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
145559027|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
145559028|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
145559029|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
145559030|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
145559031|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
145559032|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
145559033|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
145559034|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
145559035|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
145559036|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
145559037|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
145559038|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
145559039|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
145559040|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
145559041|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
145559042|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
145559043|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
145559044|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
145559045|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
145559046|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
145559047|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
145559048|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
145559049|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
145559050|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
145617887|NCT00507026|525115319|FG000|Overall Study|Withdrawal by Subject|2|||
145617888|NCT00507026|525115320|FG001|Overall Study|Withdrawal by Subject|0|||
145617889|NCT00507026|525115321|FG002|Overall Study|Withdrawal by Subject|0|||
145617890|NCT00507026|525115319|FG000|Overall Study|Investigator Decision|1|||
145617891|NCT00507026|525115320|FG001|Overall Study|Investigator Decision|0|||
145617892|NCT00507026|525115321|FG002|Overall Study|Investigator Decision|0|||
145617893|NCT00507026|525115319|FG000|Overall Study|Adverse Event|2|||
145617894|NCT00507026|525115320|FG001|Overall Study|Adverse Event|0|||
145617895|NCT00507026|525115321|FG002|Overall Study|Adverse Event|0|||
145617896|NCT00507026|525115319|FG000|Overall Study|Protocol Violation|1|||
145617897|NCT00507026|525115320|FG001|Overall Study|Protocol Violation|0|||
145617898|NCT00507026|525115321|FG002|Overall Study|Protocol Violation|0|||
145617899|NCT00507026|525115319|FG000|Overall Study|Other|1|||
145617900|NCT00507026|525115320|FG001|Overall Study|Other|0|||
145617901|NCT00507026|525115321|FG002|Overall Study|Other|0|||
145617902|NCT03653416|525115322|FG000|Overall Study|Protocol Violation|6|||
145617903|NCT03653416|525115323|FG001|Overall Study|Protocol Violation|1|||
145617904|NCT00681187|525115324|FG000|Overall Study|Withdrawal by Subject|1|||
145617905|NCT00681187|525115325|FG001|Overall Study|Withdrawal by Subject|0|||
145617906|NCT00681187|525115324|FG000|Overall Study|Death|0|||
145617907|NCT00681187|525115325|FG001|Overall Study|Death|1|||
145617908|NCT00681187|525115324|FG000|Overall Study|Adverse Event|0|||
145617909|NCT00681187|525115325|FG001|Overall Study|Adverse Event|1|||
145617910|NCT02788006|525115331|FG000|Overall Study|Patient not treated|1|||
145617911|NCT02269943|525115332|FG000|Treatment Period|Death|0|||
145617912|NCT02269943|525115333|FG001|Treatment Period|Death|1|||
145617913|NCT02269943|525115332|FG000|Treatment Period|Adverse Event|1|||
145617914|NCT02269943|525115333|FG001|Treatment Period|Adverse Event|10|||
145617915|NCT02269943|525115332|FG000|Treatment Period|Progressive Disease|5|||
145617916|NCT02269943|525115333|FG001|Treatment Period|Progressive Disease|17|||
145617917|NCT02269943|525115332|FG000|Treatment Period|Symptomatic Deterioration|0|||
145617918|NCT02269943|525115333|FG001|Treatment Period|Symptomatic Deterioration|2|||
145617919|NCT02269943|525115332|FG000|Follow-Up Survival Period|Death|3|||
145617920|NCT02269943|525115333|FG001|Follow-Up Survival Period|Death|16|||
145617921|NCT02269943|525115332|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
145617922|NCT02269943|525115333|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
145617923|NCT02269943|525115332|FG000|Follow-Up Survival Period|Alive|2|||
145617924|NCT02269943|525115333|FG001|Follow-Up Survival Period|Alive|8|||
145617925|NCT03541642|525115336|FG000|Overall Study|Withdrawal by Subject|1|||
145617926|NCT03541642|525115337|FG001|Overall Study|Withdrawal by Subject|2|||
145292997|NCT01611090|523922309|FG001|Randomized Period|Lost to Follow-up|3|||
145292998|NCT01611090|523922310|FG002|Randomized Period|Lost to Follow-up|0|||
145559051|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
145559052|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
145559053|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
145559054|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
145559055|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
145559056|NCT02432846|524906498|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
145559057|NCT02432846|524906499|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
145559058|NCT02432846|524906500|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
145559059|NCT02432846|524906501|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
145559060|NCT02432846|524906502|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
145559061|NCT02432846|524906503|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
145559062|NCT01912287|524906504|FG000|Overall Study|Ineligible|1|||
145559063|NCT01912287|524906505|FG001|Overall Study|Ineligible|0|||
145559064|NCT01912287|524906506|FG002|Overall Study|Ineligible|1|||
145559065|NCT01912287|524906504|FG000|Overall Study|No-show|0|||
145559066|NCT01912287|524906505|FG001|Overall Study|No-show|0|||
145559067|NCT01912287|524906506|FG002|Overall Study|No-show|1|||
145559068|NCT01912287|524906504|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
145559069|NCT01912287|524906505|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
145559070|NCT01912287|524906506|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
145559071|NCT01912287|524906504|FG000|Overall Study|Felt treatment no longer needed|0|||
145617927|NCT03541642|525115336|FG000|Overall Study|Lost to Follow-up|16|||
145617928|NCT03541642|525115337|FG001|Overall Study|Lost to Follow-up|12|||
145292999|NCT01611090|523922308|FG000|Randomized Period|Withdrawal by Subject|22|||
145617929|NCT03541642|525115336|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
145617930|NCT03541642|525115337|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
145617931|NCT03050398|525115340|FG000|Overall Study|Study terminated by sponsor|8|||
145617932|NCT03523871|525115341|FG000|Overall Study|Death|1|||
145617933|NCT03619174|525115343|FG000|Overall Study|Lost to Follow-up|3|||
145617934|NCT03619174|525115344|FG001|Overall Study|Lost to Follow-up|0|||
145617935|NCT03619174|525115343|FG000|Overall Study|Withdrawal by Subject|4|||
145617936|NCT03619174|525115344|FG001|Overall Study|Withdrawal by Subject|3|||
145617937|NCT03619174|525115343|FG000|Overall Study|Pregnancy|1|||
145617938|NCT03619174|525115344|FG001|Overall Study|Pregnancy|1|||
145293000|NCT01611090|523922309|FG001|Randomized Period|Withdrawal by Subject|26|||
145293001|NCT01611090|523922310|FG002|Randomized Period|Withdrawal by Subject|0|||
145293002|NCT01611090|523922308|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
145293003|NCT01611090|523922309|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
145293004|NCT01611090|523922310|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
145293005|NCT01611090|523922308|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
145293006|NCT01611090|523922309|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
145617939|NCT03619174|525115343|FG000|Overall Study|Discomfort during treatment|1|||
145655501|NCT02975882|525257248|FG003|Overall Study|Death|0|||
145559072|NCT01912287|524906505|FG001|Overall Study|Felt treatment no longer needed|1|||
145559073|NCT01912287|524906506|FG002|Overall Study|Felt treatment no longer needed|0|||
145559074|NCT01912287|524906504|FG000|Overall Study|Life circumstances|4|||
145559075|NCT01912287|524906505|FG001|Overall Study|Life circumstances|2|||
145559076|NCT01912287|524906506|FG002|Overall Study|Life circumstances|0|||
145559077|NCT01912287|524906504|FG000|Overall Study|Lost Interest|1|||
145559078|NCT01912287|524906505|FG001|Overall Study|Lost Interest|0|||
145559079|NCT01912287|524906506|FG002|Overall Study|Lost Interest|0|||
145559080|NCT01912287|524906504|FG000|Overall Study|Uknown reason - subject drop out|5|||
145559081|NCT01912287|524906505|FG001|Overall Study|Uknown reason - subject drop out|7|||
145559082|NCT01912287|524906506|FG002|Overall Study|Uknown reason - subject drop out|3|||
145559083|NCT01912287|524906504|FG000|Overall Study|Missed Assesment|1|||
145559084|NCT01912287|524906505|FG001|Overall Study|Missed Assesment|1|||
145559085|NCT01912287|524906506|FG002|Overall Study|Missed Assesment|1|||
145559086|NCT01912287|524906504|FG000|Overall Study|Scheduling/change in availability|17|||
145559087|NCT01912287|524906505|FG001|Overall Study|Scheduling/change in availability|10|||
145559088|NCT01912287|524906506|FG002|Overall Study|Scheduling/change in availability|8|||
145559089|NCT03226392|524906507|FG000|Overall Study|Protocol Deviation|1|||
145559090|NCT03226392|524906508|FG001|Overall Study|Protocol Deviation|0|||
145559091|NCT03226392|524906507|FG000|Overall Study|Physician Decision|1|||
145559092|NCT03226392|524906508|FG001|Overall Study|Physician Decision|0|||
145559093|NCT03226392|524906507|FG000|Overall Study|Lost to Follow-up|1|||
145559094|NCT03226392|524906508|FG001|Overall Study|Lost to Follow-up|0|||
145559095|NCT03226392|524906507|FG000|Overall Study|Adverse Event|1|||
145559096|NCT03226392|524906508|FG001|Overall Study|Adverse Event|0|||
145559097|NCT03226392|524906507|FG000|Overall Study|Technical Problems|0|||
145559098|NCT03226392|524906508|FG001|Overall Study|Technical Problems|2|||
145559099|NCT03226392|524906507|FG000|Overall Study|Subject/Guardian Decision|7|||
145559100|NCT03226392|524906508|FG001|Overall Study|Subject/Guardian Decision|6|||
145559101|NCT00937157|524906509|FG000|Overall Study|Pregnancy|1|||
145559102|NCT00937157|524906509|FG000|Overall Study|Lost to Follow-up|3|||
145559103|NCT01998633|524906510|FG000|Overall Study|Death|1|||
145559104|NCT02631850|524906511|FG000|Treatment Period|Lost to Follow-up|0|||
145559105|NCT02631850|524906512|FG001|Treatment Period|Lost to Follow-up|1|||
145559106|NCT02631850|524906513|FG002|Treatment Period|Lost to Follow-up|0|||
145559107|NCT02631850|524906514|FG003|Treatment Period|Lost to Follow-up|0|||
145559108|NCT02631850|524906511|FG000|Treatment Period|Protocol Violation|1|||
145559109|NCT02631850|524906512|FG001|Treatment Period|Protocol Violation|0|||
145559110|NCT02631850|524906513|FG002|Treatment Period|Protocol Violation|0|||
145559111|NCT02631850|524906514|FG003|Treatment Period|Protocol Violation|0|||
145559112|NCT02631850|524906511|FG000|Treatment Period|Withdrawal by Subject|0|||
145559113|NCT02631850|524906512|FG001|Treatment Period|Withdrawal by Subject|5|||
145559114|NCT02631850|524906513|FG002|Treatment Period|Withdrawal by Subject|2|||
145559115|NCT02631850|524906514|FG003|Treatment Period|Withdrawal by Subject|2|||
145559116|NCT02631850|524906511|FG000|Treatment Period|Adverse Event|1|||
145559117|NCT02631850|524906512|FG001|Treatment Period|Adverse Event|0|||
145559118|NCT02631850|524906513|FG002|Treatment Period|Adverse Event|2|||
145559119|NCT02631850|524906514|FG003|Treatment Period|Adverse Event|3|||
145559120|NCT02631850|524906511|FG000|Treatment Period|Family medical issue|1|||
145559121|NCT02631850|524906512|FG001|Treatment Period|Family medical issue|0|||
145559122|NCT02631850|524906513|FG002|Treatment Period|Family medical issue|0|||
145559123|NCT02631850|524906514|FG003|Treatment Period|Family medical issue|0|||
145559124|NCT02631850|524906511|FG000|6 Month Follow up|Lost to Follow-up|5|||
145559125|NCT02631850|524906512|FG001|6 Month Follow up|Lost to Follow-up|8|||
145559126|NCT02631850|524906513|FG002|6 Month Follow up|Lost to Follow-up|3|||
145559127|NCT02631850|524906514|FG003|6 Month Follow up|Lost to Follow-up|5|||
145559128|NCT02631850|524906511|FG000|6 Month Follow up|Withdrawal by Subject|1|||
145559129|NCT02631850|524906512|FG001|6 Month Follow up|Withdrawal by Subject|0|||
145559130|NCT02631850|524906513|FG002|6 Month Follow up|Withdrawal by Subject|0|||
145559131|NCT02631850|524906514|FG003|6 Month Follow up|Withdrawal by Subject|2|||
145559132|NCT02631850|524906511|FG000|6 Month Follow up|Adverse Event|1|||
145559133|NCT02631850|524906512|FG001|6 Month Follow up|Adverse Event|4|||
145559134|NCT02631850|524906513|FG002|6 Month Follow up|Adverse Event|1|||
145559135|NCT02631850|524906514|FG003|6 Month Follow up|Adverse Event|3|||
145559136|NCT02631850|524906511|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
145559137|NCT02631850|524906512|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
145559138|NCT02631850|524906513|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
145559139|NCT02631850|524906514|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
145559140|NCT01462084|524906516|FG000|Overall Study|Withdrawal by Subject|1|||
145559141|NCT01462084|524906517|FG001|Overall Study|Withdrawal by Subject|0|||
145559142|NCT01462084|524906516|FG000|Overall Study|Protocol Violation|1|||
145559143|NCT01462084|524906517|FG001|Overall Study|Protocol Violation|1|||
145559144|NCT03992781|524906518|FG000|Overall Study|Lost to Follow-up|5|||
145559145|NCT03992781|524906518|FG000|Overall Study|Adverse Event|1|||
145559146|NCT03992781|524906518|FG000|Overall Study|Lack of Efficacy|5|||
145559147|NCT00695396|524906519|FG000|Overall Study|Study Closed Prematurely|5|||
145293007|NCT01611090|523922310|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
145293008|NCT05109234|523922311|FG000|Overall Study|Adverse Event|2|||
145293009|NCT05109234|523922312|FG001|Overall Study|Adverse Event|2|||
145293010|NCT05109234|523922311|FG000|Overall Study|Lack of Efficacy|5|||
145293011|NCT05109234|523922312|FG001|Overall Study|Lack of Efficacy|0|||
145293012|NCT05109234|523922311|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
145293013|NCT05109234|523922312|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
145293014|NCT05109234|523922311|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
145293015|NCT05109234|523922312|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
145293016|NCT05109234|523922311|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
145293017|NCT05109234|523922312|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
145293018|NCT05109234|523922311|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
145293019|NCT05109234|523922312|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
145293020|NCT00336024|523922314|FG000|Overall Study|Death|2|||
145293021|NCT00336024|523922315|FG001|Overall Study|Death|1|||
145293022|NCT00336024|523922314|FG000|Overall Study|Physician Decision|4|||
145293023|NCT00336024|523922315|FG001|Overall Study|Physician Decision|1|||
145293024|NCT00336024|523922314|FG000|Overall Study|Protocol Violation|1|||
145293025|NCT00336024|523922315|FG001|Overall Study|Protocol Violation|0|||
145293026|NCT00336024|523922314|FG000|Overall Study|Withdrawal by Subject|1|||
145293027|NCT00336024|523922315|FG001|Overall Study|Withdrawal by Subject|2|||
145293028|NCT00336024|523922314|FG000|Overall Study|Failure to fulfill consolidation|1|||
145293029|NCT00336024|523922315|FG001|Overall Study|Failure to fulfill consolidation|1|||
145293030|NCT00336024|523922314|FG000|Overall Study|Progressive Disease|4|||
145293031|NCT00336024|523922315|FG001|Overall Study|Progressive Disease|7|||
145293032|NCT00336024|523922314|FG000|Overall Study|Ineligible|7|||
145293033|NCT00336024|523922315|FG001|Overall Study|Ineligible|7|||
145407847|NCT03765073|524349748|FG007|Stage 3|No longer meets eligibility criteria|0|||
145293034|NCT02585258|523922316|FG000|Overall Study|Adverse Event|28|||
145293035|NCT02585258|523922317|FG001|Overall Study|Adverse Event|29|||
145559148|NCT00695396|524906520|FG001|Overall Study|Study Closed Prematurely|6|||
145559149|NCT00695396|524906521|FG002|Overall Study|Study Closed Prematurely|8|||
145559150|NCT00695396|524906519|FG000|Overall Study|Withdrawal by Subject|2|||
145559151|NCT00695396|524906520|FG001|Overall Study|Withdrawal by Subject|2|||
145559152|NCT00695396|524906521|FG002|Overall Study|Withdrawal by Subject|0|||
145559153|NCT00518323|524906523|FG000|Overall Study|Lack of Efficacy|14|||
145559154|NCT00518323|524906524|FG001|Overall Study|Lack of Efficacy|2|||
145559155|NCT00518323|524906525|FG002|Overall Study|Lack of Efficacy|4|||
145559156|NCT00518323|524906526|FG003|Overall Study|Lack of Efficacy|20|||
145559157|NCT00518323|524906523|FG000|Overall Study|Withdrawal by Subject|1|||
145559158|NCT00518323|524906524|FG001|Overall Study|Withdrawal by Subject|2|||
145559159|NCT00518323|524906525|FG002|Overall Study|Withdrawal by Subject|4|||
145559160|NCT00518323|524906526|FG003|Overall Study|Withdrawal by Subject|2|||
145559161|NCT00518323|524906523|FG000|Overall Study|Lost to Follow-up|0|||
145559162|NCT00518323|524906524|FG001|Overall Study|Lost to Follow-up|2|||
145559163|NCT00518323|524906525|FG002|Overall Study|Lost to Follow-up|1|||
145559164|NCT00518323|524906526|FG003|Overall Study|Lost to Follow-up|3|||
145559165|NCT00518323|524906523|FG000|Overall Study|Adverse Event|1|||
145559166|NCT00518323|524906524|FG001|Overall Study|Adverse Event|1|||
145559167|NCT00518323|524906525|FG002|Overall Study|Adverse Event|1|||
145559168|NCT00518323|524906526|FG003|Overall Study|Adverse Event|0|||
145559169|NCT00518323|524906523|FG000|Overall Study|Prohibited medication and others|3|||
145559170|NCT00518323|524906524|FG001|Overall Study|Prohibited medication and others|1|||
145559171|NCT00518323|524906525|FG002|Overall Study|Prohibited medication and others|1|||
145559172|NCT00518323|524906526|FG003|Overall Study|Prohibited medication and others|0|||
145559173|NCT03880019|524906528|FG000|Overall Study|Competing disease|1|||
145559174|NCT01514760|524906529|FG000|Overall Study|Lost to Follow-up|2|||
145559175|NCT01132547|524906530|FG000|Overall Study|Withdrawal by Subject|3|||
145559176|NCT01132547|524906531|FG001|Overall Study|Withdrawal by Subject|1|||
145559177|NCT01132547|524906530|FG000|Overall Study|Death|1|||
145559178|NCT01132547|524906531|FG001|Overall Study|Death|0|||
145559179|NCT02337907|524906534|FG000|Overall Study|Other than listed|1|||
145559180|NCT02337907|524906535|FG001|Overall Study|Other than listed|0|||
145559181|NCT02337907|524906536|FG002|Overall Study|Other than listed|0|||
145559182|NCT02337907|524906537|FG003|Overall Study|Other than listed|1|||
145559183|NCT02337907|524906538|FG004|Overall Study|Other than listed|1|||
145559184|NCT02337907|524906539|FG005|Overall Study|Other than listed|0|||
145559185|NCT02337907|524906534|FG000|Overall Study|Withdrawal by Subject|2|||
145559186|NCT02337907|524906535|FG001|Overall Study|Withdrawal by Subject|3|||
145559187|NCT02337907|524906536|FG002|Overall Study|Withdrawal by Subject|0|||
145559188|NCT02337907|524906537|FG003|Overall Study|Withdrawal by Subject|2|||
145559189|NCT02337907|524906538|FG004|Overall Study|Withdrawal by Subject|5|||
145559190|NCT02337907|524906539|FG005|Overall Study|Withdrawal by Subject|0|||
145559191|NCT02337907|524906534|FG000|Overall Study|Lost to Follow-up|0|||
145559192|NCT02337907|524906535|FG001|Overall Study|Lost to Follow-up|0|||
145559193|NCT02337907|524906536|FG002|Overall Study|Lost to Follow-up|0|||
145559194|NCT02337907|524906537|FG003|Overall Study|Lost to Follow-up|0|||
145559195|NCT02337907|524906538|FG004|Overall Study|Lost to Follow-up|0|||
145559196|NCT02337907|524906539|FG005|Overall Study|Lost to Follow-up|1|||
145559197|NCT02337907|524906534|FG000|Overall Study|Adverse Event|1|||
145559198|NCT02337907|524906535|FG001|Overall Study|Adverse Event|1|||
145559199|NCT02337907|524906536|FG002|Overall Study|Adverse Event|1|||
145559200|NCT02337907|524906537|FG003|Overall Study|Adverse Event|1|||
145559201|NCT02337907|524906538|FG004|Overall Study|Adverse Event|4|||
145559202|NCT02337907|524906539|FG005|Overall Study|Adverse Event|0|||
145559203|NCT01592344|524906540|FG000|Overall Study|Adverse Event|1|||
145559204|NCT01592344|524906541|FG001|Overall Study|Adverse Event|1|||
145559205|NCT01592344|524906540|FG000|Overall Study|Lack of Efficacy|1|||
145559206|NCT01592344|524906541|FG001|Overall Study|Lack of Efficacy|0|||
145559207|NCT01592344|524906540|FG000|Overall Study|not available at primary outcome visit|2|||
145293036|NCT02585258|523922316|FG000|Overall Study|Death|3|||
145293037|NCT02585258|523922317|FG001|Overall Study|Death|2|||
145293038|NCT02585258|523922316|FG000|Overall Study|Lack of Efficacy|7|||
145293039|NCT02585258|523922317|FG001|Overall Study|Lack of Efficacy|9|||
145293040|NCT02585258|523922316|FG000|Overall Study|includes covid-related access problems|42|||
145293041|NCT02585258|523922317|FG001|Overall Study|includes covid-related access problems|46|||
145293042|NCT02585258|523922316|FG000|Overall Study|Lost to Follow-up|5|||
145293043|NCT02585258|523922317|FG001|Overall Study|Lost to Follow-up|2|||
145293044|NCT05125952|523922318|FG000|Overall Study|Physician Decision|1|||
145293045|NCT03946449|523922319|FG000|Treatment Extension II|Rolled over to another study|0|||
145293046|NCT03946449|523922320|FG001|Treatment Extension II|Rolled over to another study|0|||
145293047|NCT03946449|523922321|FG002|Treatment Extension II|Rolled over to another study|2|||
145293048|NCT03946449|523922319|FG000|Treatment Extension II|Withdrawal by Subject|0|||
145407848|NCT03765073|524349749|FG008|Stage 3|No longer meets eligibility criteria|0|||
145407849|NCT03765073|524349750|FG009|Stage 3|No longer meets eligibility criteria|0|||
145407850|NCT03765073|524349751|FG010|Stage 3|No longer meets eligibility criteria|0|||
145407851|NCT03765073|524349752|FG011|Stage 3|No longer meets eligibility criteria|0|||
145407852|NCT03765073|524349753|FG012|Stage 3|No longer meets eligibility criteria|0|||
145407853|NCT03765073|524349754|FG013|Stage 3|No longer meets eligibility criteria|0|||
145407854|NCT03765073|524349755|FG014|Stage 3|No longer meets eligibility criteria|0|||
145407855|NCT03765073|524349756|FG015|Stage 3|No longer meets eligibility criteria|0|||
145407856|NCT03765073|524349757|FG016|Stage 3|No longer meets eligibility criteria|0|||
145407857|NCT03765073|524349758|FG017|Stage 3|No longer meets eligibility criteria|0|||
145407858|NCT03765073|524349759|FG018|Stage 3|No longer meets eligibility criteria|1|||
145407859|NCT03765073|524349760|FG019|Stage 3|No longer meets eligibility criteria|0|||
145407860|NCT03765073|524349761|FG020|Stage 3|No longer meets eligibility criteria|1|||
145407861|NCT03765073|524349741|FG000|Stage 3|Other|0|||
145407862|NCT03765073|524349742|FG001|Stage 3|Other|0|||
145407863|NCT03765073|524349743|FG002|Stage 3|Other|0|||
145407864|NCT03765073|524349744|FG003|Stage 3|Other|0|||
145407865|NCT03765073|524349745|FG004|Stage 3|Other|0|||
145407866|NCT03765073|524349746|FG005|Stage 3|Other|0|||
145407867|NCT03765073|524349747|FG006|Stage 3|Other|0|||
145407868|NCT03765073|524349748|FG007|Stage 3|Other|0|||
145407869|NCT03765073|524349749|FG008|Stage 3|Other|0|||
145407870|NCT03765073|524349750|FG009|Stage 3|Other|0|||
145407871|NCT03765073|524349751|FG010|Stage 3|Other|0|||
145407872|NCT03765073|524349752|FG011|Stage 3|Other|0|||
145407873|NCT03765073|524349753|FG012|Stage 3|Other|0|||
145407874|NCT03765073|524349754|FG013|Stage 3|Other|0|||
145407875|NCT03765073|524349755|FG014|Stage 3|Other|0|||
145407876|NCT03765073|524349756|FG015|Stage 3|Other|0|||
145407877|NCT03765073|524349757|FG016|Stage 3|Other|0|||
145407878|NCT03765073|524349758|FG017|Stage 3|Other|1|||
145407879|NCT03765073|524349759|FG018|Stage 3|Other|2|||
145407880|NCT03765073|524349760|FG019|Stage 3|Other|2|||
145407881|NCT03765073|524349761|FG020|Stage 3|Other|2|||
145407882|NCT03765073|524349741|FG000|Stage 3|Withdrawal by parent/guardian|0|||
145407883|NCT03765073|524349742|FG001|Stage 3|Withdrawal by parent/guardian|0|||
145407884|NCT03765073|524349743|FG002|Stage 3|Withdrawal by parent/guardian|0|||
145293049|NCT03946449|523922320|FG001|Treatment Extension II|Withdrawal by Subject|0|||
145407885|NCT03765073|524349744|FG003|Stage 3|Withdrawal by parent/guardian|0|||
145407886|NCT03765073|524349745|FG004|Stage 3|Withdrawal by parent/guardian|0|||
145407887|NCT03765073|524349746|FG005|Stage 3|Withdrawal by parent/guardian|0|||
145407888|NCT03765073|524349747|FG006|Stage 3|Withdrawal by parent/guardian|0|||
145559208|NCT01592344|524906541|FG001|Overall Study|not available at primary outcome visit|4|||
145559209|NCT03311659|524906547|FG000|Overall Study|Protocol Violation|1|||
145559210|NCT01558752|524906555|FG000|Overall Study|Physician Decision|2|||
145559211|NCT01558752|524906556|FG001|Overall Study|Physician Decision|0|||
145559212|NCT00894322|524906566|FG000|Overall Study|Withdrawal by Subject|1|||
145559213|NCT00894322|524906567|FG001|Overall Study|Withdrawal by Subject|0|||
145559214|NCT00894322|524906568|FG002|Overall Study|Withdrawal by Subject|0|||
145559215|NCT02738450|524906578|FG000|Overall Study|Withdrawal by Subject|0|||
145559216|NCT02738450|524906579|FG001|Overall Study|Withdrawal by Subject|2|||
145559217|NCT02738450|524906580|FG002|Overall Study|Withdrawal by Subject|0|||
145559218|NCT03251079|524906581|FG000|Overall Study|Withdrawal by Subject|1|||
145559219|NCT02335099|524906585|FG000|Treatment|Withdrawal by Subject|1|||
145559220|NCT02335099|524906586|FG001|Treatment|Withdrawal by Subject|3|||
145559221|NCT02335099|524906585|FG000|Treatment|Lost to Follow-up|2|||
145559222|NCT02335099|524906586|FG001|Treatment|Lost to Follow-up|0|||
145559223|NCT02335099|524906585|FG000|Treatment|Death|1|||
145559224|NCT02335099|524906586|FG001|Treatment|Death|0|||
145559225|NCT02335099|524906585|FG000|Treatment|Adverse Event|1|||
145559226|NCT02335099|524906586|FG001|Treatment|Adverse Event|2|||
145559227|NCT02335099|524906585|FG000|Follow-up|Death|0|||
145559228|NCT02335099|524906586|FG001|Follow-up|Death|1|||
145559229|NCT03519347|524906587|FG000|Interventional Crossover Period 1|Death|0|||
145559230|NCT03519347|524906588|FG001|Interventional Crossover Period 1|Death|0|||
145559231|NCT03519347|524906589|FG002|Interventional Crossover Period 1|Death|0|||
145559232|NCT03519347|524906590|FG003|Interventional Crossover Period 1|Death|1|||
145559233|NCT01641692|524906596|FG000|Treatment Period 1|Adverse Event|1|||
145559234|NCT01641692|524906597|FG001|Treatment Period 1|Adverse Event|0|||
145559235|NCT01641692|524906598|FG002|Treatment Period 1|Adverse Event|0|||
145559236|NCT01641692|524906599|FG003|Treatment Period 1|Adverse Event|0|||
145559237|NCT01641692|524906600|FG004|Treatment Period 1|Adverse Event|0|||
145559238|NCT01641692|524906601|FG005|Treatment Period 1|Adverse Event|0|||
145559239|NCT01641692|524906602|FG006|Treatment Period 1|Adverse Event|0|||
145559240|NCT01641692|524906603|FG007|Treatment Period 1|Adverse Event|0|||
145559241|NCT01641692|524906596|FG000|Treatment Period 1|Lack of Efficacy|0|||
145559242|NCT01641692|524906597|FG001|Treatment Period 1|Lack of Efficacy|0|||
145559243|NCT01641692|524906598|FG002|Treatment Period 1|Lack of Efficacy|0|||
145559244|NCT01641692|524906599|FG003|Treatment Period 1|Lack of Efficacy|0|||
145559245|NCT01641692|524906600|FG004|Treatment Period 1|Lack of Efficacy|0|||
145559246|NCT01641692|524906601|FG005|Treatment Period 1|Lack of Efficacy|0|||
145559247|NCT01641692|524906602|FG006|Treatment Period 1|Lack of Efficacy|0|||
145559248|NCT01641692|524906603|FG007|Treatment Period 1|Lack of Efficacy|1|||
145559249|NCT01641692|524906596|FG000|Treatment Period 1|Protocol Violation|1|||
145293050|NCT03946449|523922321|FG002|Treatment Extension II|Withdrawal by Subject|1|||
145293051|NCT03717064|523923855|FG000|Period 2|Adverse Event|1|||
145559250|NCT01641692|524906597|FG001|Treatment Period 1|Protocol Violation|0|||
145559251|NCT01641692|524906598|FG002|Treatment Period 1|Protocol Violation|0|||
145559252|NCT01641692|524906599|FG003|Treatment Period 1|Protocol Violation|0|||
145559253|NCT01641692|524906600|FG004|Treatment Period 1|Protocol Violation|2|||
145559254|NCT01641692|524906601|FG005|Treatment Period 1|Protocol Violation|0|||
145559255|NCT01641692|524906602|FG006|Treatment Period 1|Protocol Violation|0|||
145559256|NCT01641692|524906603|FG007|Treatment Period 1|Protocol Violation|0|||
145559257|NCT01641692|524906596|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559258|NCT01641692|524906597|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559259|NCT01641692|524906598|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559260|NCT01641692|524906599|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559261|NCT01641692|524906600|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
145559262|NCT01641692|524906601|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559263|NCT01641692|524906602|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
145559264|NCT01641692|524906603|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
145559265|NCT01641692|524906596|FG000|Treatment Period 1|Lost to Follow-up|0|||
145559266|NCT01641692|524906597|FG001|Treatment Period 1|Lost to Follow-up|0|||
145559267|NCT01641692|524906598|FG002|Treatment Period 1|Lost to Follow-up|1|||
145559268|NCT01641692|524906599|FG003|Treatment Period 1|Lost to Follow-up|0|||
145559269|NCT01641692|524906600|FG004|Treatment Period 1|Lost to Follow-up|0|||
145559270|NCT01641692|524906601|FG005|Treatment Period 1|Lost to Follow-up|0|||
145559271|NCT01641692|524906602|FG006|Treatment Period 1|Lost to Follow-up|0|||
145559272|NCT01641692|524906603|FG007|Treatment Period 1|Lost to Follow-up|0|||
145559273|NCT01641692|524906596|FG000|Treatment Period 1|Physician Decision|0|||
145559274|NCT01641692|524906597|FG001|Treatment Period 1|Physician Decision|0|||
145559275|NCT01641692|524906598|FG002|Treatment Period 1|Physician Decision|0|||
145559276|NCT01641692|524906599|FG003|Treatment Period 1|Physician Decision|0|||
145559277|NCT01641692|524906600|FG004|Treatment Period 1|Physician Decision|1|||
145559278|NCT01641692|524906601|FG005|Treatment Period 1|Physician Decision|0|||
145559279|NCT01641692|524906602|FG006|Treatment Period 1|Physician Decision|0|||
145559280|NCT01641692|524906603|FG007|Treatment Period 1|Physician Decision|0|||
145559281|NCT01641692|524906596|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145559282|NCT01641692|524906597|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145559283|NCT01641692|524906598|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145559284|NCT01641692|524906599|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145559285|NCT01641692|524906600|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145559286|NCT01641692|524906601|FG005|Treatment Period 1|Withdrawal by Subject|2|||
145559287|NCT01641692|524906602|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145559288|NCT01641692|524906603|FG007|Treatment Period 1|Withdrawal by Subject|1|||
145559289|NCT01641692|524906596|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
145559290|NCT01641692|524906597|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559291|NCT01641692|524906598|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559292|NCT01641692|524906599|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559293|NCT01641692|524906600|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559294|NCT01641692|524906601|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145655502|NCT02975882|525257245|FG000|Overall Study|Lack of Efficacy|3|||
145559295|NCT01641692|524906602|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559296|NCT01641692|524906603|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
145559297|NCT01641692|524906596|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559298|NCT01641692|524906597|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559299|NCT01641692|524906598|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559300|NCT01641692|524906599|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559301|NCT01641692|524906600|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559302|NCT01641692|524906601|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559303|NCT01641692|524906602|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
145559304|NCT01641692|524906603|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145559305|NCT01641692|524906596|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
145559306|NCT01641692|524906597|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559307|NCT01641692|524906598|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
145559308|NCT01641692|524906599|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
145559309|NCT01641692|524906600|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
145559310|NCT01641692|524906601|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559311|NCT01641692|524906602|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559312|NCT01641692|524906603|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
145559313|NCT01641692|524906596|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145559314|NCT01641692|524906597|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145559315|NCT01641692|524906598|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145559316|NCT01641692|524906599|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145559317|NCT01641692|524906600|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145559318|NCT01641692|524906601|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145559319|NCT01641692|524906602|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145559320|NCT01641692|524906603|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145559321|NCT01641692|524906596|FG000|Treatment Period 2|Lack of Efficacy|1|||
145559322|NCT01641692|524906597|FG001|Treatment Period 2|Lack of Efficacy|0|||
145559323|NCT01641692|524906598|FG002|Treatment Period 2|Lack of Efficacy|0|||
145559324|NCT01641692|524906599|FG003|Treatment Period 2|Lack of Efficacy|0|||
145559325|NCT01641692|524906600|FG004|Treatment Period 2|Lack of Efficacy|0|||
145559326|NCT01641692|524906601|FG005|Treatment Period 2|Lack of Efficacy|0|||
145559327|NCT01641692|524906602|FG006|Treatment Period 2|Lack of Efficacy|0|||
145559328|NCT01641692|524906603|FG007|Treatment Period 2|Lack of Efficacy|0|||
145559329|NCT01641692|524906596|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
145559330|NCT01641692|524906597|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559331|NCT01641692|524906598|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559332|NCT01641692|524906599|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559333|NCT01641692|524906600|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559334|NCT01641692|524906601|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559335|NCT01641692|524906602|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559336|NCT01641692|524906603|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
145559337|NCT01641692|524906596|FG000|Treatment Period 2|Lost to Follow-up|0|||
145559338|NCT01641692|524906597|FG001|Treatment Period 2|Lost to Follow-up|0|||
145559339|NCT01641692|524906598|FG002|Treatment Period 2|Lost to Follow-up|0|||
145559340|NCT01641692|524906599|FG003|Treatment Period 2|Lost to Follow-up|0|||
145559341|NCT01641692|524906600|FG004|Treatment Period 2|Lost to Follow-up|0|||
145559342|NCT01641692|524906601|FG005|Treatment Period 2|Lost to Follow-up|1|||
145559343|NCT01641692|524906602|FG006|Treatment Period 2|Lost to Follow-up|0|||
145655503|NCT02975882|525257246|FG001|Overall Study|Lack of Efficacy|7|||
145559344|NCT01641692|524906603|FG007|Treatment Period 2|Lost to Follow-up|0|||
145559345|NCT01641692|524906596|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145559346|NCT01641692|524906597|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145559347|NCT01641692|524906598|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145559348|NCT01641692|524906599|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145559349|NCT01641692|524906600|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145559350|NCT01641692|524906601|FG005|Treatment Period 2|Withdrawal by Subject|1|||
145559351|NCT01641692|524906602|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145559352|NCT01641692|524906603|FG007|Treatment Period 2|Withdrawal by Subject|1|||
145559353|NCT01641692|524906596|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559354|NCT01641692|524906597|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559355|NCT01641692|524906598|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559356|NCT01641692|524906599|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559357|NCT01641692|524906600|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
145559358|NCT01641692|524906601|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559359|NCT01641692|524906602|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
145559360|NCT01641692|524906603|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
145559361|NCT01641692|524906596|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145559362|NCT01641692|524906597|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145559363|NCT01641692|524906598|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
145559364|NCT01641692|524906599|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145559365|NCT01641692|524906600|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145559366|NCT01641692|524906601|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
145559367|NCT01641692|524906602|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145559368|NCT01641692|524906603|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
145559369|NCT01641692|524906596|FG000|Treatment Period 3|Adverse Event|0|||
145559370|NCT01641692|524906597|FG001|Treatment Period 3|Adverse Event|0|||
145559371|NCT01641692|524906598|FG002|Treatment Period 3|Adverse Event|0|||
145559372|NCT01641692|524906599|FG003|Treatment Period 3|Adverse Event|0|||
145559373|NCT01641692|524906600|FG004|Treatment Period 3|Adverse Event|0|||
145559374|NCT01641692|524906601|FG005|Treatment Period 3|Adverse Event|0|||
145559375|NCT01641692|524906602|FG006|Treatment Period 3|Adverse Event|1|||
145559376|NCT01641692|524906603|FG007|Treatment Period 3|Adverse Event|0|||
145559377|NCT01641692|524906596|FG000|Treatment Period 3|Protocol Violation|0|||
145559378|NCT01641692|524906597|FG001|Treatment Period 3|Protocol Violation|0|||
145559379|NCT01641692|524906598|FG002|Treatment Period 3|Protocol Violation|1|||
145559380|NCT01641692|524906599|FG003|Treatment Period 3|Protocol Violation|0|||
145559381|NCT01641692|524906600|FG004|Treatment Period 3|Protocol Violation|0|||
145559382|NCT01641692|524906601|FG005|Treatment Period 3|Protocol Violation|0|||
145559383|NCT01641692|524906602|FG006|Treatment Period 3|Protocol Violation|0|||
145559384|NCT01641692|524906603|FG007|Treatment Period 3|Protocol Violation|0|||
145559385|NCT01641692|524906596|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559386|NCT01641692|524906597|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559387|NCT01641692|524906598|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559388|NCT01641692|524906599|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559389|NCT01641692|524906600|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559390|NCT01641692|524906601|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559391|NCT01641692|524906602|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
145559392|NCT01641692|524906603|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
145559393|NCT01641692|524906596|FG000|Treatment Period 3|Lost to Follow-up|0|||
145617940|NCT03619174|525115344|FG001|Overall Study|Discomfort during treatment|0|||
145559394|NCT01641692|524906597|FG001|Treatment Period 3|Lost to Follow-up|1|||
145559395|NCT01641692|524906598|FG002|Treatment Period 3|Lost to Follow-up|0|||
145559396|NCT01641692|524906599|FG003|Treatment Period 3|Lost to Follow-up|0|||
145617941|NCT01991197|525115345|FG000|Overall Study|Lost to Follow-up|1|||
145559397|NCT01641692|524906600|FG004|Treatment Period 3|Lost to Follow-up|0|||
145559398|NCT01641692|524906601|FG005|Treatment Period 3|Lost to Follow-up|0|||
145559399|NCT01641692|524906602|FG006|Treatment Period 3|Lost to Follow-up|0|||
145559400|NCT01641692|524906603|FG007|Treatment Period 3|Lost to Follow-up|0|||
145293052|NCT02684344|523923857|FG000|Overall Study|Withdrawal by Subject|0|||
145293053|NCT02684344|523923858|FG001|Overall Study|Withdrawal by Subject|1|||
145293054|NCT00863746|523923861|FG000|Treatment|Not treated|4|||
145293055|NCT00863746|523923862|FG001|Treatment|Not treated|2|||
145293056|NCT00863746|523923861|FG000|Treatment|Adverse Event|41|||
145293057|NCT00863746|523923862|FG001|Treatment|Adverse Event|16|||
145293058|NCT00863746|523923861|FG000|Treatment|non-compliant with study medication|4|||
145293059|NCT00863746|523923862|FG001|Treatment|non-compliant with study medication|0|||
145293060|NCT00863746|523923861|FG000|Treatment|Consent withdrawn|15|||
145293061|NCT00863746|523923862|FG001|Treatment|Consent withdrawn|14|||
145293062|NCT00863746|523923861|FG000|Treatment|Lost to Follow-up|1|||
145293063|NCT00863746|523923862|FG001|Treatment|Lost to Follow-up|0|||
145293064|NCT00863746|523923861|FG000|Treatment|Protocol Violation|5|||
145293065|NCT00863746|523923862|FG001|Treatment|Protocol Violation|3|||
145293066|NCT00863746|523923861|FG000|Treatment|Other|1|||
145293067|NCT00863746|523923862|FG001|Treatment|Other|0|||
145293068|NCT00863746|523923861|FG000|Survival Follow up|Death|244|||
145293069|NCT00863746|523923862|FG001|Survival Follow up|Death|271|||
145293070|NCT00863746|523923861|FG000|Survival Follow up|Lost to Follow-up|2|||
145293071|NCT00863746|523923862|FG001|Survival Follow up|Lost to Follow-up|1|||
145293072|NCT00863746|523923861|FG000|Survival Follow up|Consent Withdrawn|7|||
145293073|NCT00863746|523923862|FG001|Survival Follow up|Consent Withdrawn|8|||
145293074|NCT03292653|523923865|FG000|Overall Study|Adverse Event|0|||
145293075|NCT03292653|523923866|FG001|Overall Study|Adverse Event|0|||
145293076|NCT03292653|523923867|FG002|Overall Study|Adverse Event|1|||
145293077|NCT03292653|523923865|FG000|Overall Study|Did not Receive Treatment|1|||
145293078|NCT03292653|523923866|FG001|Overall Study|Did not Receive Treatment|0|||
145293079|NCT03292653|523923867|FG002|Overall Study|Did not Receive Treatment|0|||
145293080|NCT04720664|523923868|FG000|Overall Study|Adverse Event|2|||
145293081|NCT04720664|523923868|FG000|Overall Study|Lack of Efficacy|9|||
145293082|NCT05037097|523923869|FG000|Overall Study|Withdrawal by Subject|0|||
145293083|NCT05037097|523923870|FG001|Overall Study|Withdrawal by Subject|1|||
145293084|NCT05037097|523923871|FG002|Overall Study|Withdrawal by Subject|0|||
145293085|NCT05037097|523923872|FG003|Overall Study|Withdrawal by Subject|1|||
145293086|NCT05037097|523923873|FG004|Overall Study|Withdrawal by Subject|0|||
145293087|NCT05037097|523923874|FG005|Overall Study|Withdrawal by Subject|2|||
145293088|NCT05037097|523923875|FG006|Overall Study|Withdrawal by Subject|0|||
145293089|NCT05037097|523923876|FG007|Overall Study|Withdrawal by Subject|0|||
145293090|NCT05037097|523923869|FG000|Overall Study|Lost to Follow-up|0|||
145293091|NCT05037097|523923870|FG001|Overall Study|Lost to Follow-up|1|||
145293092|NCT05037097|523923871|FG002|Overall Study|Lost to Follow-up|0|||
145293093|NCT05037097|523923872|FG003|Overall Study|Lost to Follow-up|0|||
145293094|NCT05037097|523923873|FG004|Overall Study|Lost to Follow-up|1|||
145293095|NCT05037097|523923874|FG005|Overall Study|Lost to Follow-up|1|||
145293096|NCT05037097|523923875|FG006|Overall Study|Lost to Follow-up|0|||
145293097|NCT05037097|523923876|FG007|Overall Study|Lost to Follow-up|0|||
145293098|NCT02322047|523923877|FG000|Overall Study|Physician Decision|1|||
145293099|NCT02322047|523923878|FG001|Overall Study|Physician Decision|0|||
145293100|NCT02322047|523923879|FG002|Overall Study|Physician Decision|0|||
145293101|NCT02322047|523923880|FG003|Overall Study|Physician Decision|0|||
145293102|NCT02322047|523923877|FG000|Overall Study|Withdrawal by Subject|1|||
145293103|NCT02322047|523923878|FG001|Overall Study|Withdrawal by Subject|0|||
145293104|NCT02322047|523923879|FG002|Overall Study|Withdrawal by Subject|0|||
145293105|NCT02322047|523923880|FG003|Overall Study|Withdrawal by Subject|1|||
145293106|NCT02322047|523923877|FG000|Overall Study|Adverse Event|0|||
145293107|NCT02322047|523923878|FG001|Overall Study|Adverse Event|1|||
145293108|NCT02322047|523923879|FG002|Overall Study|Adverse Event|0|||
145559401|NCT01641692|524906596|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559402|NCT01641692|524906597|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559403|NCT01641692|524906598|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559404|NCT01641692|524906599|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559405|NCT01641692|524906600|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559406|NCT01641692|524906601|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
145559407|NCT01641692|524906602|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559408|NCT01641692|524906603|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
145559409|NCT01641692|524906596|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
145559410|NCT01641692|524906597|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
145559411|NCT01641692|524906598|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
145559412|NCT01641692|524906599|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
145559413|NCT01641692|524906600|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
145559414|NCT01641692|524906601|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
145559415|NCT01641692|524906602|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
145559416|NCT01641692|524906603|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
145559417|NCT02515045|524906607|FG000|Overall Study|Adverse Event|0|||
145559418|NCT02515045|524906608|FG001|Overall Study|Adverse Event|3|||
145559419|NCT02515045|524906609|FG002|Overall Study|Adverse Event|3|||
145559420|NCT02515045|524906607|FG000|Overall Study|Lost to Follow-up|0|||
145559421|NCT02515045|524906608|FG001|Overall Study|Lost to Follow-up|1|||
145559422|NCT02515045|524906609|FG002|Overall Study|Lost to Follow-up|1|||
145559423|NCT01412021|524906610|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
145559424|NCT01412021|524906610|FG000|Overall Study|Treatment Prior to Approval|3|||
145559425|NCT01412021|524906610|FG000|Overall Study|Transferred to Other Hospital|9|||
145559426|NCT00449644|524906615|FG000|Overall Study|Adverse Event|0|||
145617942|NCT01991197|525115346|FG001|Overall Study|Lost to Follow-up|1|||
145617943|NCT01991197|525115345|FG000|Overall Study|Physician Decision|0|||
145559427|NCT00449644|524906616|FG001|Overall Study|Adverse Event|0|||
145559428|NCT00449644|524906617|FG002|Overall Study|Adverse Event|3|||
145559429|NCT00449644|524906618|FG003|Overall Study|Adverse Event|5|||
145293109|NCT02322047|523923880|FG003|Overall Study|Adverse Event|0|||
145293110|NCT02322047|523923877|FG000|Overall Study|Lost to Follow-up|0|||
145293111|NCT02322047|523923878|FG001|Overall Study|Lost to Follow-up|0|||
145293112|NCT02322047|523923879|FG002|Overall Study|Lost to Follow-up|1|||
145293113|NCT02322047|523923880|FG003|Overall Study|Lost to Follow-up|1|||
145293114|NCT03103100|523923881|FG000|Overall Study|Adverse Event|1|||
145293115|NCT03103100|523923882|FG001|Overall Study|Adverse Event|0|||
145293116|NCT03103100|523923883|FG002|Overall Study|Adverse Event|0|||
145293117|NCT03103100|523923881|FG000|Overall Study|Physician Decision|1|||
145293118|NCT03103100|523923882|FG001|Overall Study|Physician Decision|0|||
145293119|NCT03103100|523923883|FG002|Overall Study|Physician Decision|2|||
145293120|NCT02906709|523923884|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
145293121|NCT02906709|523923885|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
145293122|NCT02906709|523923884|FG000|Phase A (Week 0 to Week 16)|Death|0|||
145293123|NCT02906709|523923885|FG001|Phase A (Week 0 to Week 16)|Death|1|||
145293124|NCT02906709|523923884|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
145293125|NCT02906709|523923885|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
145293126|NCT02906709|523923884|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
145407889|NCT03765073|524349748|FG007|Stage 3|Withdrawal by parent/guardian|0|||
145407890|NCT03765073|524349749|FG008|Stage 3|Withdrawal by parent/guardian|0|||
145407891|NCT03765073|524349750|FG009|Stage 3|Withdrawal by parent/guardian|0|||
145293127|NCT02906709|523923885|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
145293128|NCT01124149|523923887|FG000|Acute Phase|Withdrawal by Subject|22|||
145293129|NCT01124149|523923887|FG000|Acute Phase|Adverse Event|21|||
145293130|NCT01124149|523923887|FG000|Acute Phase|Lack of Efficacy|17|||
145293131|NCT01124149|523923887|FG000|Acute Phase|Protocol Violation|14|||
145407892|NCT03765073|524349751|FG010|Stage 3|Withdrawal by parent/guardian|0|||
145559430|NCT00449644|524906615|FG000|Overall Study|Death|1|||
145559431|NCT00449644|524906616|FG001|Overall Study|Death|0|||
145559432|NCT00449644|524906617|FG002|Overall Study|Death|6|||
145559433|NCT00449644|524906618|FG003|Overall Study|Death|1|||
145559434|NCT00449644|524906615|FG000|Overall Study|Lost to Follow-up|1|||
145559435|NCT00449644|524906616|FG001|Overall Study|Lost to Follow-up|1|||
145559436|NCT00449644|524906617|FG002|Overall Study|Lost to Follow-up|5|||
145293132|NCT01124149|523923887|FG000|Acute Phase|Lost to Follow-up|2|||
145559437|NCT00449644|524906618|FG003|Overall Study|Lost to Follow-up|3|||
145559438|NCT00449644|524906615|FG000|Overall Study|Pregnancy|0|||
145559439|NCT00449644|524906616|FG001|Overall Study|Pregnancy|0|||
145559440|NCT00449644|524906617|FG002|Overall Study|Pregnancy|3|||
145559441|NCT00449644|524906618|FG003|Overall Study|Pregnancy|2|||
145559442|NCT00449644|524906615|FG000|Overall Study|Protocol Violation|4|||
145559443|NCT00449644|524906616|FG001|Overall Study|Protocol Violation|4|||
145559444|NCT00449644|524906617|FG002|Overall Study|Protocol Violation|3|||
145559445|NCT00449644|524906618|FG003|Overall Study|Protocol Violation|7|||
145559446|NCT00449644|524906615|FG000|Overall Study|Withdrawal by Subject|3|||
145559447|NCT00449644|524906616|FG001|Overall Study|Withdrawal by Subject|4|||
145559448|NCT00449644|524906617|FG002|Overall Study|Withdrawal by Subject|6|||
145559449|NCT00449644|524906618|FG003|Overall Study|Withdrawal by Subject|7|||
145559450|NCT00449644|524906615|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
145559451|NCT00449644|524906616|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
145559452|NCT00449644|524906617|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
145559453|NCT00449644|524906618|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
145559454|NCT00449644|524906615|FG000|Overall Study|Other|1|||
145559455|NCT00449644|524906616|FG001|Overall Study|Other|4|||
145559456|NCT00449644|524906617|FG002|Overall Study|Other|1|||
145559457|NCT00449644|524906618|FG003|Overall Study|Other|0|||
145559458|NCT00449644|524906615|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
145559459|NCT00449644|524906616|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
145559460|NCT00449644|524906617|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
145559461|NCT00449644|524906618|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
145559462|NCT00529542|524906619|FG000|Overall Study|Withdrawal by Subject|1|||
145559463|NCT00529542|524906620|FG001|Overall Study|Withdrawal by Subject|0|||
145559464|NCT00529542|524906619|FG000|Overall Study|Lost to Follow-up|0|||
145559465|NCT00529542|524906620|FG001|Overall Study|Lost to Follow-up|1|||
145559466|NCT02291055|524906625|FG000|Overall Study|Death|2|||
145559467|NCT02291055|524906626|FG001|Overall Study|Death|2|||
145559468|NCT02291055|524906627|FG002|Overall Study|Death|5|||
145559469|NCT02291055|524906628|FG003|Overall Study|Death|8|||
145559470|NCT02291055|524906629|FG004|Overall Study|Death|12|||
145559471|NCT02291055|524906625|FG000|Overall Study|Lost to Follow-up|0|||
145559472|NCT02291055|524906626|FG001|Overall Study|Lost to Follow-up|0|||
145559473|NCT02291055|524906627|FG002|Overall Study|Lost to Follow-up|0|||
145559474|NCT02291055|524906628|FG003|Overall Study|Lost to Follow-up|1|||
145559475|NCT02291055|524906629|FG004|Overall Study|Lost to Follow-up|2|||
145559476|NCT02291055|524906625|FG000|Overall Study|Withdrawal by Subject|3|||
145559477|NCT02291055|524906626|FG001|Overall Study|Withdrawal by Subject|1|||
145559478|NCT02291055|524906627|FG002|Overall Study|Withdrawal by Subject|1|||
145559479|NCT02291055|524906628|FG003|Overall Study|Withdrawal by Subject|5|||
145559480|NCT02291055|524906629|FG004|Overall Study|Withdrawal by Subject|10|||
145617944|NCT01991197|525115346|FG001|Overall Study|Physician Decision|2|||
145559481|NCT02291055|524906625|FG000|Overall Study|Progressive Disease|0|||
145559482|NCT02291055|524906626|FG001|Overall Study|Progressive Disease|0|||
145559483|NCT02291055|524906627|FG002|Overall Study|Progressive Disease|1|||
145559484|NCT02291055|524906628|FG003|Overall Study|Progressive Disease|4|||
145559485|NCT02291055|524906629|FG004|Overall Study|Progressive Disease|2|||
145617945|NCT01991197|525115345|FG000|Overall Study|Withdrawal by Subject|2|||
145559486|NCT02291055|524906625|FG000|Overall Study|Study Terminated by Sponsor|0|||
145559487|NCT02291055|524906626|FG001|Overall Study|Study Terminated by Sponsor|0|||
145559488|NCT02291055|524906627|FG002|Overall Study|Study Terminated by Sponsor|0|||
145559489|NCT02291055|524906628|FG003|Overall Study|Study Terminated by Sponsor|5|||
145559490|NCT02291055|524906629|FG004|Overall Study|Study Terminated by Sponsor|1|||
145559491|NCT02291055|524906625|FG000|Overall Study|Other|0|||
145559492|NCT02291055|524906626|FG001|Overall Study|Other|2|||
145559493|NCT02291055|524906627|FG002|Overall Study|Other|1|||
145559494|NCT02291055|524906628|FG003|Overall Study|Other|4|||
145559495|NCT02291055|524906629|FG004|Overall Study|Other|0|||
145559496|NCT00733746|524906634|FG000|Overall Study|Ineligible|5|||
145559497|NCT02113956|524906635|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
145559498|NCT02113956|524906636|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
145559499|NCT02113956|524906635|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
145559500|NCT02113956|524906636|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
145559501|NCT02113956|524906635|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
145559502|NCT02113956|524906636|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
145559503|NCT02446990|524906637|FG000|Overall Study|Death|485|||
145559504|NCT02446990|524906638|FG001|Overall Study|Death|458|||
145559505|NCT02446990|524906637|FG000|Overall Study|Lost to Follow-up|3|||
145559506|NCT02446990|524906638|FG001|Overall Study|Lost to Follow-up|1|||
145559507|NCT02446990|524906637|FG000|Overall Study|Physician Decision|1|||
145559508|NCT02446990|524906638|FG001|Overall Study|Physician Decision|0|||
145559509|NCT02446990|524906637|FG000|Overall Study|Withdrawal by Subject|231|||
145559510|NCT02446990|524906638|FG001|Overall Study|Withdrawal by Subject|199|||
145559511|NCT01064401|524906639|FG000|Overall Study|Adverse Event|47|||
145559512|NCT01064401|524906640|FG001|Overall Study|Adverse Event|56|||
145559513|NCT01064401|524906639|FG000|Overall Study|Lack of Efficacy|46|||
145559514|NCT01064401|524906640|FG001|Overall Study|Lack of Efficacy|23|||
145559515|NCT01064401|524906639|FG000|Overall Study|Lost to Follow-up|12|||
145559516|NCT01064401|524906640|FG001|Overall Study|Lost to Follow-up|9|||
145559517|NCT01064401|524906639|FG000|Overall Study|Consent Withdrawn|98|||
145559518|NCT01064401|524906640|FG001|Overall Study|Consent Withdrawn|80|||
145559519|NCT01064401|524906639|FG000|Overall Study|Investigator Decision|4|||
145559520|NCT01064401|524906640|FG001|Overall Study|Investigator Decision|6|||
145559521|NCT01064401|524906639|FG000|Overall Study|Death|4|||
145559522|NCT01064401|524906640|FG001|Overall Study|Death|0|||
145559523|NCT01064401|524906639|FG000|Overall Study|Pregnancy|4|||
145559524|NCT01064401|524906640|FG001|Overall Study|Pregnancy|7|||
145559525|NCT01064401|524906639|FG000|Overall Study|Noncompliance|7|||
145617946|NCT01991197|525115346|FG001|Overall Study|Withdrawal by Subject|0|||
145559526|NCT01064401|524906640|FG001|Overall Study|Noncompliance|8|||
145559527|NCT01064401|524906639|FG000|Overall Study|Site Closure|4|||
145559528|NCT01064401|524906640|FG001|Overall Study|Site Closure|5|||
145559529|NCT01064401|524906639|FG000|Overall Study|Other|2|||
145559530|NCT01064401|524906640|FG001|Overall Study|Other|1|||
145559531|NCT03158051|524906641|FG000|Overall Study|Lost to Follow-up|41|||
145559532|NCT03158051|524906642|FG001|Overall Study|Lost to Follow-up|47|||
145559533|NCT03158051|524906641|FG000|Overall Study|Physician Decision|6|||
145559534|NCT03158051|524906642|FG001|Overall Study|Physician Decision|7|||
145559535|NCT03158051|524906641|FG000|Overall Study|Withdrawal by Subject|24|||
145559536|NCT03158051|524906642|FG001|Overall Study|Withdrawal by Subject|15|||
145559537|NCT03158051|524906641|FG000|Overall Study|Death|0|||
145559538|NCT03158051|524906642|FG001|Overall Study|Death|1|||
145559539|NCT02738151|524906643|FG000|Overall Study|Randomized but not treated|4|||
145559540|NCT02738151|524906644|FG001|Overall Study|Randomized but not treated|1|||
145559541|NCT02738151|524906643|FG000|Overall Study|Adverse Event|4|||
145559542|NCT02738151|524906644|FG001|Overall Study|Adverse Event|5|||
145559543|NCT02738151|524906643|FG000|Overall Study|Hypoglycemia|0|||
145559544|NCT02738151|524906644|FG001|Overall Study|Hypoglycemia|1|||
145559545|NCT02738151|524906643|FG000|Overall Study|Poor Compliance to Protocol|4|||
145559546|NCT02738151|524906644|FG001|Overall Study|Poor Compliance to Protocol|3|||
145559547|NCT02738151|524906643|FG000|Overall Study|Other than specified above|11|||
145559548|NCT02738151|524906644|FG001|Overall Study|Other than specified above|21|||
145559549|NCT02926924|524908629|FG000|Overall Study|withdrawal - reason unknown|0|||
145559550|NCT02926924|524908630|FG001|Overall Study|withdrawal - reason unknown|1|||
145559551|NCT00773292|524908631|FG000|Treatment 48 Weeks|Adverse Event|1|||
145559552|NCT00773292|524908631|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
145559553|NCT04729127|524908632|FG000|Overall Study|Suspended/Terminated EI Services|4|||
145559554|NCT04729127|524908633|FG001|Overall Study|Suspended/Terminated EI Services|0|||
145559555|NCT04729127|524908634|FG002|Overall Study|Suspended/Terminated EI Services|4|||
145559556|NCT04729127|524908635|FG003|Overall Study|Suspended/Terminated EI Services|6|||
145559557|NCT04729127|524908636|FG004|Overall Study|Suspended/Terminated EI Services|0|||
145559558|NCT04729127|524908637|FG005|Overall Study|Suspended/Terminated EI Services|6|||
145559559|NCT04729127|524908638|FG006|Overall Study|Suspended/Terminated EI Services|2|||
145559560|NCT04729127|524908639|FG007|Overall Study|Suspended/Terminated EI Services|0|||
145559561|NCT04729127|524908640|FG008|Overall Study|Suspended/Terminated EI Services|2|||
145559562|NCT04729127|524908632|FG000|Overall Study|Withdrawal by Subject|1|||
145559563|NCT04729127|524908633|FG001|Overall Study|Withdrawal by Subject|0|||
145559564|NCT04729127|524908634|FG002|Overall Study|Withdrawal by Subject|1|||
145559565|NCT04729127|524908635|FG003|Overall Study|Withdrawal by Subject|0|||
145559566|NCT04729127|524908636|FG004|Overall Study|Withdrawal by Subject|0|||
145559567|NCT04729127|524908637|FG005|Overall Study|Withdrawal by Subject|0|||
145559568|NCT04729127|524908638|FG006|Overall Study|Withdrawal by Subject|0|||
145559569|NCT04729127|524908639|FG007|Overall Study|Withdrawal by Subject|0|||
145559570|NCT04729127|524908640|FG008|Overall Study|Withdrawal by Subject|0|||
145559571|NCT04729127|524908632|FG000|Overall Study|Switched Agency/Setting|1|||
145559572|NCT04729127|524908633|FG001|Overall Study|Switched Agency/Setting|0|||
145559573|NCT04729127|524908634|FG002|Overall Study|Switched Agency/Setting|1|||
145559574|NCT04729127|524908635|FG003|Overall Study|Switched Agency/Setting|1|||
145559575|NCT04729127|524908636|FG004|Overall Study|Switched Agency/Setting|0|||
145559576|NCT04729127|524908637|FG005|Overall Study|Switched Agency/Setting|1|||
145559577|NCT04729127|524908638|FG006|Overall Study|Switched Agency/Setting|1|||
145559578|NCT04729127|524908639|FG007|Overall Study|Switched Agency/Setting|0|||
145559579|NCT04729127|524908640|FG008|Overall Study|Switched Agency/Setting|1|||
145559580|NCT02385266|524908643|FG000|Overall Study|Withdrawal by Subject|1|||
145559581|NCT02385266|524908644|FG001|Overall Study|Withdrawal by Subject|3|||
145559582|NCT03388138|524908646|FG000|Overall Study|Protocol Violation|1|||
145559583|NCT03388138|524908647|FG001|Overall Study|Protocol Violation|0|||
145559584|NCT01528072|524908648|FG000|Overall Study|Withdrawal by Subject|5|||
145559585|NCT01528072|524908648|FG000|Overall Study|Physician Decision|1|||
145559586|NCT01528072|524908648|FG000|Overall Study|Determined not eligible by AEAC|1|||
145559587|NCT01528072|524908648|FG000|Overall Study|Missed Visit|2|||
145559588|NCT01528072|524908648|FG000|Overall Study|Lost to Follow-up|5|||
145559589|NCT01528072|524908648|FG000|Overall Study|Explanted|2|||
145559590|NCT01528072|524908648|FG000|Overall Study|Site Closure|4|||
145559591|NCT01528072|524908648|FG000|Overall Study|Death|2|||
145559592|NCT01528072|524908648|FG000|Overall Study|Early Termination of Study|52|||
145559593|NCT01859494|524908649|FG000|Overall Study|Adverse Event|1|||
145559594|NCT04014075|524908652|FG000|Overall Study|Progressive Disease|53|||
145559595|NCT04014075|524908652|FG000|Overall Study|Adverse Event|15|||
145559596|NCT04014075|524908652|FG000|Overall Study|Clinical Progression|4|||
145559597|NCT04014075|524908652|FG000|Overall Study|Death|2|||
145559598|NCT04014075|524908652|FG000|Overall Study|Withdrawal by Subject|2|||
145559599|NCT04014075|524908652|FG000|Overall Study|Miscellaneous|2|||
145293133|NCT01124149|523923887|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
145293134|NCT01124149|523923887|FG000|Acute Phase|Sponsor request|1|||
145293135|NCT01124149|523923887|FG000|Acute Phase|UC symptoms not ameliorated|1|||
145293136|NCT01124149|523923887|FG000|Acute Phase|Non-compliance|1|||
145293137|NCT01124149|523923887|FG000|Acute Phase|Low hemoglobin|1|||
145293138|NCT01124149|523923887|FG000|Acute Phase|Travelling to another country|1|||
145617947|NCT01010217|525115349|FG000|Overall Study|Lost to Follow-up|4|||
145293139|NCT01124149|523923887|FG000|Acute Phase|Sponsor decision|1|||
145293140|NCT01124149|523923887|FG000|Maintenance Phase|Lack of Efficacy|40|||
145293141|NCT01124149|523923887|FG000|Maintenance Phase|Adverse Event|24|||
145293142|NCT01124149|523923887|FG000|Maintenance Phase|Lost to Follow-up|15|||
145293143|NCT01124149|523923887|FG000|Maintenance Phase|Withdrawal by Subject|10|||
145559600|NCT04014075|524908652|FG000|Overall Study|Physician Decision|1|||
145559601|NCT04741074|524908655|FG000|Overall Study|Withdrawal by Subject|1|||
145559602|NCT04741074|524908656|FG001|Overall Study|Withdrawal by Subject|1|||
145559603|NCT04741074|524908655|FG000|Overall Study|Study terminated prematurely|1|||
145559604|NCT04741074|524908656|FG001|Overall Study|Study terminated prematurely|0|||
145559605|NCT02357901|524908661|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
145559606|NCT02357901|524908662|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
145559607|NCT02357901|524908663|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
145559608|NCT02357901|524908664|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
145559609|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
145559610|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
145559611|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
145559612|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
145559613|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
145559614|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
145559615|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
145293144|NCT01124149|523923887|FG000|Maintenance Phase|Protocol Violation|5|||
145293145|NCT01124149|523923887|FG000|Maintenance Phase|Coordinator error|1|||
145559616|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
145293146|NCT01124149|523923887|FG000|Maintenance Phase|Non-compliance|1|||
145617948|NCT01010217|525115350|FG001|Overall Study|Lost to Follow-up|5|||
145617949|NCT01010217|525115351|FG002|Overall Study|Lost to Follow-up|1|||
145617950|NCT01010217|525115352|FG003|Overall Study|Lost to Follow-up|0|||
145617951|NCT01010217|525115353|FG004|Overall Study|Lost to Follow-up|0|||
145617952|NCT01010217|525115349|FG000|Overall Study|Withdrawal by Subject|1|||
145617953|NCT01010217|525115350|FG001|Overall Study|Withdrawal by Subject|0|||
145617954|NCT01010217|525115351|FG002|Overall Study|Withdrawal by Subject|0|||
145617955|NCT01010217|525115352|FG003|Overall Study|Withdrawal by Subject|0|||
145617956|NCT01010217|525115353|FG004|Overall Study|Withdrawal by Subject|0|||
145617957|NCT01010217|525115349|FG000|Overall Study|Physician Decision|0|||
145617958|NCT01010217|525115350|FG001|Overall Study|Physician Decision|0|||
145617959|NCT01010217|525115351|FG002|Overall Study|Physician Decision|0|||
145617960|NCT01010217|525115352|FG003|Overall Study|Physician Decision|6|||
145617961|NCT01010217|525115353|FG004|Overall Study|Physician Decision|3|||
145617962|NCT04285229|525115356|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145617963|NCT04285229|525115357|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145617964|NCT04285229|525115358|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145617965|NCT04285229|525115359|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145617966|NCT04285229|525115360|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145617967|NCT04285229|525115361|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145617968|NCT04285229|525115356|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
145617969|NCT04285229|525115357|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
145617970|NCT04285229|525115358|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
145617971|NCT04285229|525115359|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
145293147|NCT01644500|523923888|FG000|Overall Study|Adverse Event|6|||
145293148|NCT01644500|523923889|FG001|Overall Study|Adverse Event|1|||
145293149|NCT01644500|523923890|FG002|Overall Study|Adverse Event|2|||
145293150|NCT01644500|523923888|FG000|Overall Study|Death|0|||
145293151|NCT01644500|523923889|FG001|Overall Study|Death|1|||
145293152|NCT01644500|523923890|FG002|Overall Study|Death|0|||
145293153|NCT01644500|523923888|FG000|Overall Study|Lost to Follow-up|3|||
145293154|NCT01644500|523923889|FG001|Overall Study|Lost to Follow-up|8|||
145293155|NCT01644500|523923890|FG002|Overall Study|Lost to Follow-up|0|||
145293156|NCT01644500|523923888|FG000|Overall Study|Protocol Violation|1|||
145293157|NCT01644500|523923889|FG001|Overall Study|Protocol Violation|1|||
145293158|NCT01644500|523923890|FG002|Overall Study|Protocol Violation|0|||
145293159|NCT01644500|523923888|FG000|Overall Study|Withdrawal by Subject|11|||
145293160|NCT01644500|523923889|FG001|Overall Study|Withdrawal by Subject|12|||
145293161|NCT01644500|523923890|FG002|Overall Study|Withdrawal by Subject|12|||
145293162|NCT01644500|523923888|FG000|Overall Study|Physician Decision|1|||
145293163|NCT01644500|523923889|FG001|Overall Study|Physician Decision|1|||
145293164|NCT01644500|523923890|FG002|Overall Study|Physician Decision|1|||
145293165|NCT01439165|523923897|FG000|Overall Study|Protocol Violation|3|||
145293166|NCT01439165|523923898|FG001|Overall Study|Protocol Violation|0|||
145293167|NCT01439165|523923897|FG000|Overall Study|Lost to Follow-up|11|||
145293168|NCT01439165|523923898|FG001|Overall Study|Lost to Follow-up|1|||
145293169|NCT01439165|523923897|FG000|Overall Study|Withdrawal by Subject|7|||
145293170|NCT01439165|523923898|FG001|Overall Study|Withdrawal by Subject|1|||
145293171|NCT03331042|523923902|FG000|Overall Study|Protocol Violation|1|||
145293172|NCT03331042|523923903|FG001|Overall Study|Protocol Violation|0|||
145293173|NCT03331042|523923904|FG002|Overall Study|Protocol Violation|0|||
145293174|NCT03331042|523923905|FG003|Overall Study|Protocol Violation|0|||
145293175|NCT03331042|523923902|FG000|Overall Study|Physician Decision|0|||
145293176|NCT03331042|523923903|FG001|Overall Study|Physician Decision|0|||
145293177|NCT03331042|523923904|FG002|Overall Study|Physician Decision|1|||
145293178|NCT03331042|523923905|FG003|Overall Study|Physician Decision|0|||
145293179|NCT03331042|523923902|FG000|Overall Study|Lost to Follow-up|0|||
145293180|NCT03331042|523923903|FG001|Overall Study|Lost to Follow-up|0|||
145293181|NCT03331042|523923904|FG002|Overall Study|Lost to Follow-up|0|||
145293182|NCT03331042|523923905|FG003|Overall Study|Lost to Follow-up|1|||
145293183|NCT00322491|523923911|FG000|Overall Study|Adverse Event|1|||
145293184|NCT00322491|523923912|FG001|Overall Study|Adverse Event|0|||
145293185|NCT00322491|523923911|FG000|Overall Study|Death|1|||
145293186|NCT00322491|523923912|FG001|Overall Study|Death|2|||
145293187|NCT00688064|523923914|FG000|Overall Study|Protocol Violation|0|||
145293188|NCT00688064|523923915|FG001|Overall Study|Protocol Violation|1|||
145293189|NCT00688064|523923914|FG000|Overall Study|Adverse Event|2|||
145293190|NCT00688064|523923915|FG001|Overall Study|Adverse Event|4|||
145293191|NCT00688064|523923914|FG000|Overall Study|Withdrawal by Subject|7|||
145293192|NCT00688064|523923915|FG001|Overall Study|Withdrawal by Subject|7|||
145293193|NCT00688064|523923914|FG000|Overall Study|Lost to Follow-up|10|||
145293194|NCT00688064|523923915|FG001|Overall Study|Lost to Follow-up|10|||
145293195|NCT00688064|523923914|FG000|Overall Study|Lack of Efficacy|0|||
145293196|NCT00688064|523923915|FG001|Overall Study|Lack of Efficacy|1|||
145293197|NCT00688064|523923914|FG000|Overall Study|Pregnancy|1|||
145655504|NCT02975882|525257247|FG002|Overall Study|Lack of Efficacy|4|||
145617972|NCT04285229|525115360|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
145617973|NCT04285229|525115361|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
145617974|NCT04285229|525115356|FG000|Extended Treatment Period|Adverse Event|0|||
145617975|NCT04285229|525115357|FG001|Extended Treatment Period|Adverse Event|0|||
145617976|NCT04285229|525115358|FG002|Extended Treatment Period|Adverse Event|0|||
145617977|NCT04285229|525115359|FG003|Extended Treatment Period|Adverse Event|1|||
145617978|NCT04285229|525115360|FG004|Extended Treatment Period|Adverse Event|0|||
145617979|NCT04285229|525115361|FG005|Extended Treatment Period|Adverse Event|0|||
145617980|NCT04285229|525115356|FG000|Extended Treatment Period|Physician Decision|0|||
145617981|NCT04285229|525115357|FG001|Extended Treatment Period|Physician Decision|0|||
145617982|NCT04285229|525115358|FG002|Extended Treatment Period|Physician Decision|1|||
145617983|NCT04285229|525115359|FG003|Extended Treatment Period|Physician Decision|0|||
145617984|NCT04285229|525115360|FG004|Extended Treatment Period|Physician Decision|0|||
145617985|NCT04285229|525115361|FG005|Extended Treatment Period|Physician Decision|0|||
145617986|NCT04285229|525115356|FG000|Follow-up Period|Adverse Event|0|||
145617987|NCT04285229|525115357|FG001|Follow-up Period|Adverse Event|0|||
145617988|NCT04285229|525115358|FG002|Follow-up Period|Adverse Event|0|||
145617989|NCT04285229|525115359|FG003|Follow-up Period|Adverse Event|0|||
145617990|NCT04285229|525115360|FG004|Follow-up Period|Adverse Event|1|||
145617991|NCT04285229|525115361|FG005|Follow-up Period|Adverse Event|4|||
145617992|NCT04285229|525115356|FG000|Follow-up Period|Withdrawal by Subject|0|||
145617993|NCT04285229|525115357|FG001|Follow-up Period|Withdrawal by Subject|0|||
145617994|NCT04285229|525115358|FG002|Follow-up Period|Withdrawal by Subject|0|||
145617995|NCT04285229|525115359|FG003|Follow-up Period|Withdrawal by Subject|0|||
145617996|NCT04285229|525115360|FG004|Follow-up Period|Withdrawal by Subject|0|||
145617997|NCT04285229|525115361|FG005|Follow-up Period|Withdrawal by Subject|5|||
145617998|NCT04285229|525115356|FG000|Follow-up Period|Covid-19|0|||
145617999|NCT04285229|525115357|FG001|Follow-up Period|Covid-19|0|||
145618000|NCT04285229|525115358|FG002|Follow-up Period|Covid-19|0|||
145618001|NCT04285229|525115359|FG003|Follow-up Period|Covid-19|0|||
145618002|NCT04285229|525115360|FG004|Follow-up Period|Covid-19|0|||
145618003|NCT04285229|525115361|FG005|Follow-up Period|Covid-19|2|||
145618004|NCT04285229|525115356|FG000|Follow-up Period|Physician Decision|0|||
145618005|NCT04285229|525115357|FG001|Follow-up Period|Physician Decision|0|||
145618006|NCT04285229|525115358|FG002|Follow-up Period|Physician Decision|0|||
145618007|NCT04285229|525115359|FG003|Follow-up Period|Physician Decision|0|||
145618008|NCT04285229|525115360|FG004|Follow-up Period|Physician Decision|0|||
145618009|NCT04285229|525115361|FG005|Follow-up Period|Physician Decision|1|||
145618010|NCT01012973|525115362|FG000|Overall Study|Adverse Event|5|||
145618011|NCT01012973|525115363|FG001|Overall Study|Adverse Event|5|||
145618012|NCT01012973|525115362|FG000|Overall Study|Lack of Efficacy|0|||
145618013|NCT01012973|525115363|FG001|Overall Study|Lack of Efficacy|5|||
145618014|NCT01012973|525115362|FG000|Overall Study|Lost to Follow-up|1|||
145618015|NCT01012973|525115363|FG001|Overall Study|Lost to Follow-up|0|||
145618016|NCT01012973|525115362|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
145618017|NCT01012973|525115363|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
145618018|NCT01012973|525115362|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
145618019|NCT01012973|525115363|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
145293198|NCT00688064|523923915|FG001|Overall Study|Pregnancy|0|||
145293199|NCT00688064|523923914|FG000|Overall Study|Any other reasons|1|||
145293200|NCT00688064|523923915|FG001|Overall Study|Any other reasons|3|||
145293201|NCT00048048|523923916|FG000|Core Treatment|Withdrawal by Subject|0|||
145293202|NCT00048048|523923917|FG001|Core Treatment|Withdrawal by Subject|0|||
145293203|NCT00048048|523923918|FG002|Core Treatment|Withdrawal by Subject|1|||
145293204|NCT00048048|523923919|FG003|Core Treatment|Withdrawal by Subject|0|||
145293205|NCT00048048|523923920|FG004|Core Treatment|Withdrawal by Subject|0|||
145407893|NCT03765073|524349752|FG011|Stage 3|Withdrawal by parent/guardian|0|||
145618020|NCT01012973|525115362|FG000|Overall Study|Protocol Violation|5|||
145618021|NCT01012973|525115363|FG001|Overall Study|Protocol Violation|2|||
145618022|NCT01012973|525115362|FG000|Overall Study|Withdrawal by Subject|4|||
145293206|NCT00048048|523923921|FG005|Core Treatment|Withdrawal by Subject|0|||
145618023|NCT01012973|525115363|FG001|Overall Study|Withdrawal by Subject|6|||
145407894|NCT03765073|524349753|FG012|Stage 3|Withdrawal by parent/guardian|0|||
145293207|NCT00048048|523923922|FG006|Core Treatment|Withdrawal by Subject|0|||
145293208|NCT00048048|523923923|FG007|Core Treatment|Withdrawal by Subject|0|||
145559617|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
145559618|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
145559619|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
145559620|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
145559621|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
145559622|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
145559623|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
145559624|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
145559625|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
145559626|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
145559627|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
145559628|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
145618024|NCT02061761|525115366|FG000|Overall Study|Disease progression|2|||
145293209|NCT00048048|523923924|FG008|Core Treatment|Withdrawal by Subject|0|||
145293210|NCT00048048|523923925|FG009|Core Treatment|Withdrawal by Subject|0|||
145293211|NCT00048048|523923926|FG010|Core Treatment|Withdrawal by Subject|0|||
145293212|NCT00048048|523923927|FG011|Core Treatment|Withdrawal by Subject|0|||
145293213|NCT00048048|523923916|FG000|Core Treatment|Adverse Event|0|||
145293214|NCT00048048|523923917|FG001|Core Treatment|Adverse Event|0|||
145293215|NCT00048048|523923918|FG002|Core Treatment|Adverse Event|0|||
145293216|NCT00048048|523923919|FG003|Core Treatment|Adverse Event|0|||
145293217|NCT00048048|523923920|FG004|Core Treatment|Adverse Event|0|||
145407895|NCT03765073|524349754|FG013|Stage 3|Withdrawal by parent/guardian|0|||
145293218|NCT00048048|523923921|FG005|Core Treatment|Adverse Event|0|||
145293219|NCT00048048|523923922|FG006|Core Treatment|Adverse Event|0|||
145293220|NCT00048048|523923923|FG007|Core Treatment|Adverse Event|1|||
145293221|NCT00048048|523923924|FG008|Core Treatment|Adverse Event|0|||
145293222|NCT00048048|523923925|FG009|Core Treatment|Adverse Event|0|||
145407896|NCT03765073|524349755|FG014|Stage 3|Withdrawal by parent/guardian|0|||
145293223|NCT00048048|523923926|FG010|Core Treatment|Adverse Event|0|||
145293224|NCT00048048|523923927|FG011|Core Treatment|Adverse Event|0|||
145293225|NCT00048048|523923916|FG000|Extension Year 1|Early withdrawals|0|||
145293226|NCT00048048|523923917|FG001|Extension Year 1|Early withdrawals|0|||
145559629|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
145559630|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
145559631|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
145559632|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
145559633|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
145559634|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
145559635|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
145559636|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
145559637|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
145559638|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
145559639|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
145559640|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
145559641|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
145559642|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
145559643|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
145559644|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
145559645|NCT02357901|524908661|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
145559646|NCT02357901|524908662|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
145559647|NCT02357901|524908663|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
145559648|NCT02357901|524908664|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
145559649|NCT00491387|524908673|FG000|Overall Study|study terminated|20|||
145559650|NCT00413192|524908676|FG000|Overall Study|Disease progression|26|||
145559651|NCT00413192|524908677|FG001|Overall Study|Disease progression|31|||
145559652|NCT00413192|524908678|FG002|Overall Study|Disease progression|16|||
145559653|NCT00413192|524908679|FG003|Overall Study|Disease progression|25|||
145559654|NCT00413192|524908676|FG000|Overall Study|Toxicity|3|||
145559655|NCT00413192|524908677|FG001|Overall Study|Toxicity|2|||
145559656|NCT00413192|524908678|FG002|Overall Study|Toxicity|2|||
145559657|NCT00413192|524908679|FG003|Overall Study|Toxicity|2|||
145559658|NCT00413192|524908676|FG000|Overall Study|Withdrawal by Subject|3|||
145559659|NCT00413192|524908677|FG001|Overall Study|Withdrawal by Subject|5|||
145559660|NCT00413192|524908678|FG002|Overall Study|Withdrawal by Subject|0|||
145559661|NCT00413192|524908679|FG003|Overall Study|Withdrawal by Subject|1|||
145559662|NCT00413192|524908676|FG000|Overall Study|Intercurrent illness|0|||
145559663|NCT00413192|524908677|FG001|Overall Study|Intercurrent illness|0|||
145559664|NCT00413192|524908678|FG002|Overall Study|Intercurrent illness|0|||
145559665|NCT00413192|524908679|FG003|Overall Study|Intercurrent illness|1|||
145559666|NCT00413192|524908676|FG000|Overall Study|Intercurrent death|0|||
145559667|NCT00413192|524908677|FG001|Overall Study|Intercurrent death|1|||
145559668|NCT00413192|524908678|FG002|Overall Study|Intercurrent death|0|||
145559669|NCT00413192|524908679|FG003|Overall Study|Intercurrent death|0|||
145559670|NCT00413192|524908676|FG000|Overall Study|Other|5|||
145559671|NCT00413192|524908677|FG001|Overall Study|Other|1|||
145559672|NCT00413192|524908678|FG002|Overall Study|Other|1|||
145559673|NCT00413192|524908679|FG003|Overall Study|Other|2|||
145559674|NCT00413192|524908676|FG000|Overall Study|Not treated|0|||
145559675|NCT00413192|524908677|FG001|Overall Study|Not treated|0|||
145559676|NCT00413192|524908678|FG002|Overall Study|Not treated|0|||
145559677|NCT00413192|524908679|FG003|Overall Study|Not treated|1|||
145559678|NCT03814746|524908680|FG000|Overall Study|Participant decision|9|||
145559679|NCT03814746|524908681|FG001|Overall Study|Participant decision|6|||
145559680|NCT03814746|524908682|FG002|Overall Study|Participant decision|15|||
145559681|NCT03814746|524908680|FG000|Overall Study|Physician Decision|2|||
145559682|NCT03814746|524908681|FG001|Overall Study|Physician Decision|2|||
145559683|NCT03814746|524908682|FG002|Overall Study|Physician Decision|4|||
145618025|NCT02061761|525115367|FG001|Overall Study|Disease progression|8|||
145618026|NCT02061761|525115368|FG002|Overall Study|Disease progression|4|||
145618027|NCT02061761|525115369|FG003|Overall Study|Disease progression|5|||
145559684|NCT03814746|524908680|FG000|Overall Study|Death|2|||
145559685|NCT03814746|524908681|FG001|Overall Study|Death|2|||
145559686|NCT03814746|524908682|FG002|Overall Study|Death|2|||
145559687|NCT03814746|524908680|FG000|Overall Study|Adverse Event|2|||
145618028|NCT02061761|525115370|FG004|Overall Study|Disease progression|9|||
145618029|NCT02061761|525115371|FG005|Overall Study|Disease progression|3|||
145293227|NCT00048048|523923918|FG002|Extension Year 1|Early withdrawals|0|||
145293228|NCT00048048|523923919|FG003|Extension Year 1|Early withdrawals|0|||
145293229|NCT00048048|523923920|FG004|Extension Year 1|Early withdrawals|0|||
145293230|NCT00048048|523923921|FG005|Extension Year 1|Early withdrawals|0|||
145293231|NCT00048048|523923922|FG006|Extension Year 1|Early withdrawals|0|||
145293232|NCT00048048|523923923|FG007|Extension Year 1|Early withdrawals|0|||
145293233|NCT00048048|523923924|FG008|Extension Year 1|Early withdrawals|0|||
145293234|NCT00048048|523923925|FG009|Extension Year 1|Early withdrawals|2|||
145293235|NCT00048048|523923926|FG010|Extension Year 1|Early withdrawals|2|||
145559688|NCT03814746|524908681|FG001|Overall Study|Adverse Event|2|||
145559689|NCT03814746|524908682|FG002|Overall Study|Adverse Event|1|||
145559690|NCT03814746|524908680|FG000|Overall Study|Lost to Follow-up|2|||
145559691|NCT03814746|524908681|FG001|Overall Study|Lost to Follow-up|1|||
145559692|NCT03814746|524908682|FG002|Overall Study|Lost to Follow-up|2|||
145559693|NCT03814746|524908680|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145618030|NCT02061761|525115372|FG006|Overall Study|Disease progression|1|||
145293236|NCT00048048|523923927|FG011|Extension Year 1|Early withdrawals|4|||
145293237|NCT00048048|523923916|FG000|Extension Year 2|Early withdrawals|0|||
145293238|NCT00048048|523923917|FG001|Extension Year 2|Early withdrawals|0|||
145293239|NCT00048048|523923918|FG002|Extension Year 2|Early withdrawals|0|||
145293240|NCT00048048|523923919|FG003|Extension Year 2|Early withdrawals|0|||
145293241|NCT00048048|523923920|FG004|Extension Year 2|Early withdrawals|0|||
145293242|NCT00048048|523923921|FG005|Extension Year 2|Early withdrawals|0|||
145293243|NCT00048048|523923922|FG006|Extension Year 2|Early withdrawals|0|||
145407897|NCT03765073|524349756|FG015|Stage 3|Withdrawal by parent/guardian|0|||
145407898|NCT03765073|524349757|FG016|Stage 3|Withdrawal by parent/guardian|0|||
145407899|NCT03765073|524349758|FG017|Stage 3|Withdrawal by parent/guardian|0|||
145407900|NCT03765073|524349759|FG018|Stage 3|Withdrawal by parent/guardian|0|||
145407901|NCT03765073|524349760|FG019|Stage 3|Withdrawal by parent/guardian|6|||
145407902|NCT03765073|524349761|FG020|Stage 3|Withdrawal by parent/guardian|9|||
145293244|NCT00048048|523923923|FG007|Extension Year 2|Early withdrawals|0|||
145293245|NCT00048048|523923924|FG008|Extension Year 2|Early withdrawals|0|||
145618031|NCT02061761|525115373|FG007|Overall Study|Disease progression|2|||
145293246|NCT00048048|523923925|FG009|Extension Year 2|Early withdrawals|0|||
145293247|NCT00048048|523923926|FG010|Extension Year 2|Early withdrawals|4|||
145618032|NCT02061761|525115374|FG008|Overall Study|Disease progression|28|||
145618033|NCT02061761|525115366|FG000|Overall Study|Study Drug toxicity|0|||
145559694|NCT03814746|524908681|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145559695|NCT03814746|524908682|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145293248|NCT00048048|523923927|FG011|Extension Year 2|Early withdrawals|2|||
145293249|NCT03992196|523923928|FG000|Enrollment|lost to follow-up prior dosing|1|||
145293250|NCT03992196|523923929|FG001|Enrollment|lost to follow-up prior dosing|0|||
145293251|NCT03992196|523923930|FG002|Enrollment|lost to follow-up prior dosing|0|||
145559696|NCT03814746|524908680|FG000|Overall Study|Pregnancy|0|||
145559697|NCT03814746|524908681|FG001|Overall Study|Pregnancy|1|||
145559698|NCT03814746|524908682|FG002|Overall Study|Pregnancy|1|||
145559699|NCT03814746|524908680|FG000|Overall Study|Protocol Violation|1|||
145559700|NCT03814746|524908681|FG001|Overall Study|Protocol Violation|0|||
145559701|NCT03814746|524908682|FG002|Overall Study|Protocol Violation|0|||
145559702|NCT05089682|524908683|FG000|Overall Study|Withdrawal by Subject|2|||
145559703|NCT01996826|524908686|FG000|Overall Study|Lost to Follow-up|6|||
145559704|NCT01996826|524908687|FG001|Overall Study|Lost to Follow-up|2|||
145559705|NCT01996826|524908686|FG000|Overall Study|Physician Decision|1|||
145559706|NCT01996826|524908687|FG001|Overall Study|Physician Decision|1|||
145559707|NCT01266460|524908688|FG000|Overall Study|Adverse Event|3|||
145559708|NCT01266460|524908688|FG000|Overall Study|Withdrawal by Subject|5|||
145559709|NCT01266460|524908688|FG000|Overall Study|Disease Progression|18|||
145559710|NCT01266460|524908688|FG000|Overall Study|Not otherwise specified|8|||
145559711|NCT00483379|524908693|FG000|Treatment Period|Adverse Event|1|||
145559712|NCT00483379|524908694|FG001|Treatment Period|Adverse Event|0|||
145559713|NCT00483379|524908693|FG000|Treatment Period|Withdrawal by Subject|1|||
145559714|NCT00483379|524908694|FG001|Treatment Period|Withdrawal by Subject|0|||
145407903|NCT03765073|524349741|FG000|Stage 3|Withdrawal by Subject|0|||
145559715|NCT00536107|524908696|FG000|Overall Study|Death|5|||
145559716|NCT00536107|524908697|FG001|Overall Study|Death|1|||
145559717|NCT00536107|524908696|FG000|Overall Study|Incorrect enrolment|1|||
145559718|NCT00536107|524908697|FG001|Overall Study|Incorrect enrolment|0|||
145559719|NCT00536107|524908696|FG000|Overall Study|Withdrawal by Subject|0|||
145407904|NCT03765073|524349742|FG001|Stage 3|Withdrawal by Subject|0|||
145559720|NCT00536107|524908697|FG001|Overall Study|Withdrawal by Subject|1|||
145559721|NCT00536107|524908696|FG000|Overall Study|Study Termination|2|||
145293252|NCT03992196|523923928|FG000|Treatment|Protocol Violation|0|||
145293253|NCT03992196|523923929|FG001|Treatment|Protocol Violation|0|||
145293254|NCT03992196|523923930|FG002|Treatment|Protocol Violation|1|||
145293255|NCT03992196|523923928|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
145618034|NCT02061761|525115367|FG001|Overall Study|Study Drug toxicity|0|||
145618035|NCT02061761|525115368|FG002|Overall Study|Study Drug toxicity|0|||
145618036|NCT02061761|525115369|FG003|Overall Study|Study Drug toxicity|0|||
145407905|NCT03765073|524349743|FG002|Stage 3|Withdrawal by Subject|0|||
145407906|NCT03765073|524349744|FG003|Stage 3|Withdrawal by Subject|0|||
145407907|NCT03765073|524349745|FG004|Stage 3|Withdrawal by Subject|0|||
145407908|NCT03765073|524349746|FG005|Stage 3|Withdrawal by Subject|0|||
145559722|NCT00536107|524908697|FG001|Overall Study|Study Termination|4|||
145559723|NCT00371254|524908698|FG000|Overall Study|Disease progression|13|||
145559724|NCT00371254|524908699|FG001|Overall Study|Disease progression|13|||
145559725|NCT00371254|524908698|FG000|Overall Study|Study drug toxicity|3|||
145559726|NCT00371254|524908699|FG001|Overall Study|Study drug toxicity|5|||
145559727|NCT00371254|524908698|FG000|Overall Study|Subject request|5|||
145559728|NCT00371254|524908699|FG001|Overall Study|Subject request|0|||
145559729|NCT00371254|524908698|FG000|Overall Study|Investigator Decision|2|||
145559730|NCT00371254|524908699|FG001|Overall Study|Investigator Decision|0|||
145559731|NCT00371254|524908698|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145559732|NCT00371254|524908699|FG001|Overall Study|Adverse event unrelated to study drug|1|||
145559733|NCT00371254|524908698|FG000|Overall Study|Lost to Follow-up|0|||
145559734|NCT00371254|524908699|FG001|Overall Study|Lost to Follow-up|1|||
145559735|NCT00371254|524908698|FG000|Overall Study|Withdrawal by Subject|0|||
145559736|NCT00371254|524908699|FG001|Overall Study|Withdrawal by Subject|1|||
145559737|NCT03329690|524908702|FG000|Overall Study|Progressive disease per RECIST|85|||
145559738|NCT03329690|524908703|FG001|Overall Study|Progressive disease per RECIST|44|||
145559739|NCT03329690|524908704|FG002|Overall Study|Progressive disease per RECIST|6|||
145559740|NCT03329690|524908705|FG003|Overall Study|Progressive disease per RECIST|16|||
145559741|NCT03329690|524908706|FG004|Overall Study|Progressive disease per RECIST|20|||
145559742|NCT03329690|524908702|FG000|Overall Study|Clinical progression|7|||
145559743|NCT03329690|524908703|FG001|Overall Study|Clinical progression|4|||
145559744|NCT03329690|524908704|FG002|Overall Study|Clinical progression|1|||
145559745|NCT03329690|524908705|FG003|Overall Study|Clinical progression|1|||
145559746|NCT03329690|524908706|FG004|Overall Study|Clinical progression|1|||
145559747|NCT03329690|524908702|FG000|Overall Study|Adverse Event|22|||
145618037|NCT02061761|525115370|FG004|Overall Study|Study Drug toxicity|0|||
145618038|NCT02061761|525115371|FG005|Overall Study|Study Drug toxicity|1|||
145618039|NCT02061761|525115372|FG006|Overall Study|Study Drug toxicity|0|||
145559748|NCT03329690|524908703|FG001|Overall Study|Adverse Event|4|||
145559749|NCT03329690|524908704|FG002|Overall Study|Adverse Event|0|||
145559750|NCT03329690|524908705|FG003|Overall Study|Adverse Event|1|||
145559751|NCT03329690|524908706|FG004|Overall Study|Adverse Event|2|||
145559752|NCT03329690|524908702|FG000|Overall Study|Death|2|||
145293256|NCT03992196|523923929|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
145293257|NCT03992196|523923930|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
145293258|NCT03992196|523923928|FG000|Treatment|Withdrawal due to non-compliance|0|||
145293259|NCT03992196|523923929|FG001|Treatment|Withdrawal due to non-compliance|0|||
145293260|NCT03992196|523923930|FG002|Treatment|Withdrawal due to non-compliance|1|||
145559753|NCT03329690|524908703|FG001|Overall Study|Death|0|||
145559754|NCT03329690|524908704|FG002|Overall Study|Death|0|||
145559755|NCT03329690|524908705|FG003|Overall Study|Death|1|||
145559756|NCT03329690|524908706|FG004|Overall Study|Death|0|||
145559757|NCT03329690|524908702|FG000|Overall Study|Withdrawal by Subject|2|||
145559758|NCT03329690|524908703|FG001|Overall Study|Withdrawal by Subject|3|||
145559759|NCT03329690|524908704|FG002|Overall Study|Withdrawal by Subject|0|||
145559760|NCT03329690|524908705|FG003|Overall Study|Withdrawal by Subject|1|||
145559761|NCT03329690|524908706|FG004|Overall Study|Withdrawal by Subject|0|||
145559762|NCT03329690|524908702|FG000|Overall Study|Physician Decision|1|||
145559763|NCT03329690|524908703|FG001|Overall Study|Physician Decision|0|||
145559764|NCT03329690|524908704|FG002|Overall Study|Physician Decision|0|||
145559765|NCT03329690|524908705|FG003|Overall Study|Physician Decision|0|||
145559766|NCT03329690|524908706|FG004|Overall Study|Physician Decision|1|||
145559767|NCT03329690|524908702|FG000|Overall Study|Miscellaneous|6|||
145559768|NCT03329690|524908703|FG001|Overall Study|Miscellaneous|0|||
145559769|NCT03329690|524908704|FG002|Overall Study|Miscellaneous|0|||
145559770|NCT03329690|524908705|FG003|Overall Study|Miscellaneous|0|||
145559771|NCT03329690|524908706|FG004|Overall Study|Miscellaneous|0|||
145559772|NCT03329690|524908702|FG000|Overall Study|Did not receive treatment|1|||
145559773|NCT03329690|524908703|FG001|Overall Study|Did not receive treatment|0|||
145559774|NCT03329690|524908704|FG002|Overall Study|Did not receive treatment|0|||
145559775|NCT03329690|524908705|FG003|Overall Study|Did not receive treatment|1|||
145559776|NCT03329690|524908706|FG004|Overall Study|Did not receive treatment|0|||
145559777|NCT01817725|524908707|FG000|Overall Study|Withdrawal by Subject|1|||
145559778|NCT03165110|524908708|FG000|Overall Study|Anroid phone software incompatibility|1|||
145559779|NCT00730912|524908711|FG000|Overall Study|Discontinued|0|||
145559780|NCT00730912|524908712|FG001|Overall Study|Discontinued|0|||
145559781|NCT00730912|524908713|FG002|Overall Study|Discontinued|1|||
145559782|NCT00613015|524908716|FG000|Overall Study|Lost to Follow-up|0|||
145559783|NCT00613015|524908717|FG001|Overall Study|Lost to Follow-up|1|||
145559784|NCT00613015|524908718|FG002|Overall Study|Lost to Follow-up|3|||
145559785|NCT00613015|524908719|FG003|Overall Study|Lost to Follow-up|3|||
145559786|NCT00613015|524908720|FG004|Overall Study|Lost to Follow-up|2|||
145559787|NCT00613015|524908721|FG005|Overall Study|Lost to Follow-up|3|||
145559788|NCT01179477|524908722|FG000|Overall Study|Death|542|||
145559789|NCT01179477|524908722|FG000|Overall Study|Unsuccessful implant|80|||
145559790|NCT01179477|524908722|FG000|Overall Study|Non-death withdrawal|438|||
145559791|NCT01179477|524908722|FG000|Overall Study|Did not complete final visit|27|||
145559792|NCT04327388|524908724|FG000|Overall Study|Adverse Event|17|||
145559793|NCT04327388|524908725|FG001|Overall Study|Adverse Event|18|||
145559794|NCT04327388|524908726|FG002|Overall Study|Adverse Event|9|||
145559795|NCT04327388|524908724|FG000|Overall Study|Other|1|||
145559796|NCT04327388|524908725|FG001|Overall Study|Other|2|||
145559797|NCT04327388|524908726|FG002|Overall Study|Other|0|||
145559798|NCT04327388|524908724|FG000|Overall Study|Randomized and not treated|2|||
145559799|NCT04327388|524908725|FG001|Overall Study|Randomized and not treated|0|||
145559800|NCT04327388|524908726|FG002|Overall Study|Randomized and not treated|2|||
145559801|NCT04053023|524908727|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
145559802|NCT04053023|524908728|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
145559803|NCT00071760|524908729|FG000|Overall Study|Adverse Event|2|||
145559804|NCT00071760|524908730|FG001|Overall Study|Adverse Event|1|||
145559805|NCT00071760|524908729|FG000|Overall Study|Lost to Follow-up|0|||
145559806|NCT00071760|524908730|FG001|Overall Study|Lost to Follow-up|3|||
145559807|NCT00071760|524908729|FG000|Overall Study|Protocol Violation|1|||
145559808|NCT00071760|524908730|FG001|Overall Study|Protocol Violation|0|||
145559809|NCT00071760|524908729|FG000|Overall Study|Withdrawal by Subject|0|||
145559810|NCT00071760|524908730|FG001|Overall Study|Withdrawal by Subject|1|||
145559811|NCT00071760|524908729|FG000|Overall Study|Insufficient Viral Load Response|1|||
145559812|NCT00071760|524908730|FG001|Overall Study|Insufficient Viral Load Response|1|||
145559813|NCT00071760|524908729|FG000|Overall Study|Lack of availability of RTV|1|||
145559814|NCT00071760|524908730|FG001|Overall Study|Lack of availability of RTV|0|||
145559815|NCT00071760|524908729|FG000|Overall Study|Physician Decision|2|||
145559816|NCT00071760|524908730|FG001|Overall Study|Physician Decision|1|||
145559817|NCT00071760|524908729|FG000|Overall Study|Relocation|0|||
145559818|NCT00071760|524908730|FG001|Overall Study|Relocation|1|||
145559819|NCT02073279|524908731|FG000|Double-blind Period|Adverse Event|1|||
145559820|NCT02073279|524908732|FG001|Double-blind Period|Adverse Event|1|||
145559821|NCT02073279|524908731|FG000|Double-blind Period|Switched to another treatment|1|||
145559822|NCT02073279|524908732|FG001|Double-blind Period|Switched to another treatment|2|||
145559823|NCT02073279|524908731|FG000|Double-blind Period|Protocol Violation|0|||
145559824|NCT02073279|524908732|FG001|Double-blind Period|Protocol Violation|1|||
145559825|NCT02073279|524908731|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
145559826|NCT02073279|524908732|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
145559827|NCT02073279|524908731|FG000|Double-blind Period|Withdrawal by Subject|2|||
145559828|NCT02073279|524908732|FG001|Double-blind Period|Withdrawal by Subject|2|||
145559829|NCT02073279|524908731|FG000|Open-label Extension Period|Adverse Event|1|||
145559830|NCT02073279|524908732|FG001|Open-label Extension Period|Adverse Event|0|||
145559831|NCT02073279|524908731|FG000|Open-label Extension Period|Lack of Efficacy|1|||
145559832|NCT02073279|524908732|FG001|Open-label Extension Period|Lack of Efficacy|0|||
145407909|NCT03765073|524349747|FG006|Stage 3|Withdrawal by Subject|0|||
145559833|NCT02073279|524908731|FG000|Open-label Extension Period|Lost to Follow-up|0|||
145559834|NCT02073279|524908732|FG001|Open-label Extension Period|Lost to Follow-up|4|||
145559835|NCT02073279|524908731|FG000|Open-label Extension Period|Switched to another treatment|1|||
145559836|NCT02073279|524908732|FG001|Open-label Extension Period|Switched to another treatment|4|||
145559837|NCT02073279|524908731|FG000|Open-label Extension Period|Protocol Violation|0|||
145559838|NCT02073279|524908732|FG001|Open-label Extension Period|Protocol Violation|1|||
145559839|NCT02073279|524908731|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
145559840|NCT02073279|524908732|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
145559841|NCT02073279|524908731|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
145559842|NCT02073279|524908732|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
145559843|NCT04387435|524908733|FG000|Overall Study|Physician Decision|1|||
145559844|NCT00391274|524908738|FG000|Overall Study|Death Due to Study Disease|55|||
145559845|NCT00391274|524908739|FG001|Overall Study|Death Due to Study Disease|45|||
145559846|NCT00391274|524908738|FG000|Overall Study|Lost to Follow-up|0|||
145559847|NCT00391274|524908739|FG001|Overall Study|Lost to Follow-up|3|||
145559848|NCT00391274|524908738|FG000|Overall Study|Physician Decision|4|||
145559849|NCT00391274|524908739|FG001|Overall Study|Physician Decision|2|||
145559850|NCT00391274|524908738|FG000|Overall Study|Withdrawal by Subject|0|||
145559851|NCT00391274|524908739|FG001|Overall Study|Withdrawal by Subject|3|||
145559852|NCT00391274|524908738|FG000|Overall Study|Death Due to Adverse Event|1|||
145559853|NCT00391274|524908739|FG001|Overall Study|Death Due to Adverse Event|3|||
145559854|NCT00391274|524908738|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
145559855|NCT00391274|524908739|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
145559856|NCT00391274|524908738|FG000|Overall Study|Death Not Study Related|0|||
145559857|NCT00391274|524908739|FG001|Overall Study|Death Not Study Related|1|||
145559858|NCT03559257|524908743|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
145559859|NCT03559257|524908744|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
145559860|NCT03559257|524908743|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145559861|NCT03559257|524908744|FG001|Double Blind Treatment Period|Protocol Violation|4|||
145559862|NCT03559257|524908743|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
145559863|NCT03559257|524908744|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
145559864|NCT03559257|524908743|FG000|Double Blind Treatment Period|Adverse Event|0|||
145559865|NCT03559257|524908744|FG001|Double Blind Treatment Period|Adverse Event|1|||
145559866|NCT03559257|524908743|FG000|Double Blind Treatment Period|Screen Failure|0|||
145559867|NCT03559257|524908744|FG001|Double Blind Treatment Period|Screen Failure|1|||
145559868|NCT03559257|524908743|FG000|Open-label Treatment Period|Adverse Event|1|||
145559869|NCT03559257|524908744|FG001|Open-label Treatment Period|Adverse Event|4|||
145559870|NCT03559257|524908743|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
145559871|NCT03559257|524908744|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
145559872|NCT03559257|524908743|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
145559873|NCT03559257|524908744|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145559874|NCT03559257|524908743|FG000|Open-label Treatment Period|Protocol Violation|2|||
145559875|NCT03559257|524908744|FG001|Open-label Treatment Period|Protocol Violation|0|||
145559876|NCT03559257|524908743|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
145559877|NCT03559257|524908744|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
145559878|NCT03559257|524908743|FG000|Open-label Treatment Period|Physician Decision|0|||
145559879|NCT03559257|524908744|FG001|Open-label Treatment Period|Physician Decision|1|||
145559880|NCT03630120|524908746|FG000|Overall Study|Disease progression|0|||
145559881|NCT03630120|524908747|FG001|Overall Study|Disease progression|1|||
145559882|NCT03630120|524908748|FG002|Overall Study|Disease progression|1|||
145559883|NCT03630120|524908749|FG003|Overall Study|Disease progression|1|||
145559884|NCT01519960|524908750|FG000|Overall Study|Withdrawal from the study|26|||
145559885|NCT01519960|524908751|FG001|Overall Study|Withdrawal from the study|22|||
145559886|NCT01519960|524908752|FG002|Overall Study|Withdrawal from the study|5|||
145559887|NCT01387347|524908753|FG000|Overall Study|Lost to Follow-up|2|||
145559888|NCT01387347|524908754|FG001|Overall Study|Lost to Follow-up|1|||
145559889|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
145559890|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
145559891|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
145559892|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
145559893|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
145559894|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
145559895|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
145293261|NCT03992196|523923928|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
145293262|NCT03992196|523923929|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
145559896|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
145559897|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
145559898|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
145559899|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
145559900|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
145618040|NCT02061761|525115373|FG007|Overall Study|Study Drug toxicity|2|||
145293263|NCT03992196|523923930|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
145293264|NCT03992196|523923928|FG000|Treatment|Withdrawal by parent/guardian|0|||
145293265|NCT03992196|523923929|FG001|Treatment|Withdrawal by parent/guardian|0|||
145293266|NCT03992196|523923930|FG002|Treatment|Withdrawal by parent/guardian|2|||
145293267|NCT02497781|523923931|FG000|Overall Study|Withdrawal by Subject|2|||
145293268|NCT02497781|523923932|FG001|Overall Study|Withdrawal by Subject|0|||
145293269|NCT02497781|523923931|FG000|Overall Study|Lack of Efficacy|0|||
145293270|NCT02497781|523923932|FG001|Overall Study|Lack of Efficacy|1|||
145293271|NCT02497781|523923931|FG000|Overall Study|Randomised but not treated|1|||
145293272|NCT02497781|523923932|FG001|Overall Study|Randomised but not treated|1|||
145293273|NCT02497781|523923931|FG000|Overall Study|Lost to Follow-up|1|||
145293274|NCT02497781|523923932|FG001|Overall Study|Lost to Follow-up|1|||
145559901|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
145559902|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
145559903|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
145559904|NCT00561080|524908760|FG000|Vaccination Period (up to Month 4)|Other|0|||
145559905|NCT00561080|524908761|FG001|Vaccination Period (up to Month 4)|Other|2|||
145559906|NCT00561080|524908762|FG002|Vaccination Period (up to Month 4)|Other|1|||
145559907|NCT00561080|524908760|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
145559908|NCT00561080|524908761|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
145559909|NCT00561080|524908762|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
145559910|NCT00561080|524908760|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
145559911|NCT00561080|524908761|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
145559912|NCT00561080|524908762|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
145559913|NCT00561080|524908760|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
145559914|NCT00561080|524908761|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
145559915|NCT00561080|524908762|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
145559916|NCT00561080|524908760|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
145559917|NCT00561080|524908761|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
145559918|NCT00561080|524908762|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
145559919|NCT00423150|524908763|FG000|Overall Study|Adverse Event|11|||
145559920|NCT00423150|524908763|FG000|Overall Study|Progression of disease being studied|69|||
145559921|NCT00423150|524908763|FG000|Overall Study|Withdrawal by Subject|1|||
145559922|NCT00423150|524908763|FG000|Overall Study|Non-compliance with protocol|1|||
145559923|NCT00423150|524908763|FG000|Overall Study|Administrative|4|||
145559924|NCT01092182|524908764|FG000|Overall Study|Death|0|||
145559925|NCT01092182|524908765|FG001|Overall Study|Death|5|||
145559926|NCT01092182|524908766|FG002|Overall Study|Death|3|||
145559927|NCT01092182|524908764|FG000|Overall Study|participant safety|1|||
145559928|NCT01092182|524908765|FG001|Overall Study|participant safety|2|||
145559929|NCT01092182|524908766|FG002|Overall Study|participant safety|0|||
145559930|NCT01092182|524908764|FG000|Overall Study|Physician Decision|0|||
145559931|NCT01092182|524908765|FG001|Overall Study|Physician Decision|6|||
145559932|NCT01092182|524908766|FG002|Overall Study|Physician Decision|0|||
145559933|NCT01092182|524908764|FG000|Overall Study|Did not meet criteria|0|||
145559934|NCT01092182|524908765|FG001|Overall Study|Did not meet criteria|0|||
145559935|NCT01092182|524908766|FG002|Overall Study|Did not meet criteria|25|||
145559936|NCT01092182|524908764|FG000|Overall Study|Non-compliance|0|||
145559937|NCT01092182|524908765|FG001|Overall Study|Non-compliance|3|||
145559938|NCT01092182|524908766|FG002|Overall Study|Non-compliance|0|||
145559939|NCT01092182|524908764|FG000|Overall Study|Participant refused follow-up|0|||
145559940|NCT01092182|524908765|FG001|Overall Study|Participant refused follow-up|2|||
145559941|NCT01092182|524908766|FG002|Overall Study|Participant refused follow-up|0|||
145559942|NCT03255382|524908767|FG000|Overall Study|Adverse Event|3|||
145559943|NCT03255382|524908768|FG001|Overall Study|Adverse Event|0|||
145559944|NCT03255382|524908767|FG000|Overall Study|Lost to Follow-up|2|||
145559945|NCT03255382|524908768|FG001|Overall Study|Lost to Follow-up|0|||
145559946|NCT03255382|524908767|FG000|Overall Study|Withdrawal by Subject|2|||
145559947|NCT03255382|524908768|FG001|Overall Study|Withdrawal by Subject|0|||
145559948|NCT03255382|524908767|FG000|Overall Study|Other|6|||
145559949|NCT03255382|524908768|FG001|Overall Study|Other|0|||
145559950|NCT02221284|524908769|FG000|Overall Study|Case Report Forms Uncollected|56|||
145559951|NCT02221284|524908769|FG000|Overall Study|Protocol Deviation|5|||
145559952|NCT01166178|524908773|FG000|Overall Study|Withdrawal by Subject|1|||
145559953|NCT01166178|524908774|FG001|Overall Study|Withdrawal by Subject|0|||
145559954|NCT01166178|524908773|FG000|Overall Study|Study was terminated|20|||
145559955|NCT01166178|524908774|FG001|Overall Study|Study was terminated|8|||
145559956|NCT00380978|524911258|FG000|Overall Study|Refused allocated intervention|0|||
145559957|NCT00380978|524911259|FG001|Overall Study|Refused allocated intervention|6|||
145559958|NCT00380978|524911258|FG000|Overall Study|Wrong study envelope|0|||
145559959|NCT00380978|524911259|FG001|Overall Study|Wrong study envelope|2|||
145559960|NCT00380978|524911258|FG000|Overall Study|Allocation prior to analgesia request|1|||
145293275|NCT02236130|523923933|FG000|Overall Study|Lost to Follow-up|7|||
145293276|NCT02236130|523923934|FG001|Overall Study|Lost to Follow-up|12|||
145559961|NCT00380978|524911259|FG001|Overall Study|Allocation prior to analgesia request|2|||
145559962|NCT00380978|524911258|FG000|Overall Study|Parous patient|1|||
145559963|NCT00380978|524911259|FG001|Overall Study|Parous patient|0|||
145559964|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
145559965|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
145559966|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
145559967|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
145559968|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
145618041|NCT02061761|525115374|FG008|Overall Study|Study Drug toxicity|6|||
145293277|NCT00525590|523923935|FG000|Overall Study|Adverse Event|3|||
145618042|NCT02061761|525115366|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
145618043|NCT02061761|525115367|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
145618044|NCT02061761|525115368|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
145618045|NCT02061761|525115369|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
145618046|NCT02061761|525115370|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
145618047|NCT02061761|525115371|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
145618048|NCT02061761|525115372|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
145618049|NCT02061761|525115373|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
145618050|NCT02061761|525115374|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
145618051|NCT02061761|525115366|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145618052|NCT02061761|525115367|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145618053|NCT02061761|525115368|FG002|Overall Study|Participant request to discontinue study treatment|2|||
145618054|NCT02061761|525115369|FG003|Overall Study|Participant request to discontinue study treatment|2|||
145618055|NCT02061761|525115370|FG004|Overall Study|Participant request to discontinue study treatment|0|||
145618056|NCT02061761|525115371|FG005|Overall Study|Participant request to discontinue study treatment|1|||
145618057|NCT02061761|525115372|FG006|Overall Study|Participant request to discontinue study treatment|0|||
145618058|NCT02061761|525115373|FG007|Overall Study|Participant request to discontinue study treatment|0|||
145618059|NCT02061761|525115374|FG008|Overall Study|Participant request to discontinue study treatment|2|||
145618060|NCT02061761|525115366|FG000|Overall Study|Withdrawal by Subject|0|||
145618061|NCT02061761|525115367|FG001|Overall Study|Withdrawal by Subject|0|||
145618062|NCT02061761|525115368|FG002|Overall Study|Withdrawal by Subject|0|||
145618063|NCT02061761|525115369|FG003|Overall Study|Withdrawal by Subject|0|||
145618064|NCT02061761|525115370|FG004|Overall Study|Withdrawal by Subject|0|||
145618065|NCT02061761|525115371|FG005|Overall Study|Withdrawal by Subject|0|||
145618066|NCT02061761|525115372|FG006|Overall Study|Withdrawal by Subject|0|||
145618067|NCT02061761|525115373|FG007|Overall Study|Withdrawal by Subject|0|||
145618068|NCT02061761|525115374|FG008|Overall Study|Withdrawal by Subject|2|||
145618069|NCT02061761|525115366|FG000|Overall Study|Maximum clinical benefit|0|||
145618070|NCT02061761|525115367|FG001|Overall Study|Maximum clinical benefit|0|||
145618071|NCT02061761|525115368|FG002|Overall Study|Maximum clinical benefit|0|||
145618072|NCT02061761|525115369|FG003|Overall Study|Maximum clinical benefit|1|||
145618073|NCT02061761|525115370|FG004|Overall Study|Maximum clinical benefit|0|||
145618074|NCT02061761|525115371|FG005|Overall Study|Maximum clinical benefit|0|||
145618075|NCT02061761|525115372|FG006|Overall Study|Maximum clinical benefit|0|||
145618076|NCT02061761|525115373|FG007|Overall Study|Maximum clinical benefit|0|||
145618077|NCT02061761|525115374|FG008|Overall Study|Maximum clinical benefit|6|||
145618078|NCT02061761|525115366|FG000|Overall Study|Participant no longer meets study criteria|0|||
145618079|NCT02061761|525115367|FG001|Overall Study|Participant no longer meets study criteria|0|||
145618080|NCT02061761|525115368|FG002|Overall Study|Participant no longer meets study criteria|0|||
145618081|NCT02061761|525115369|FG003|Overall Study|Participant no longer meets study criteria|0|||
145618082|NCT02061761|525115370|FG004|Overall Study|Participant no longer meets study criteria|0|||
145618083|NCT02061761|525115371|FG005|Overall Study|Participant no longer meets study criteria|0|||
145618084|NCT02061761|525115372|FG006|Overall Study|Participant no longer meets study criteria|0|||
145618085|NCT02061761|525115373|FG007|Overall Study|Participant no longer meets study criteria|0|||
145618086|NCT02061761|525115374|FG008|Overall Study|Participant no longer meets study criteria|1|||
145618087|NCT02061761|525115366|FG000|Overall Study|Other reasons|0|||
145618088|NCT02061761|525115367|FG001|Overall Study|Other reasons|0|||
145618089|NCT02061761|525115368|FG002|Overall Study|Other reasons|0|||
145618090|NCT02061761|525115369|FG003|Overall Study|Other reasons|0|||
145618091|NCT02061761|525115370|FG004|Overall Study|Other reasons|2|||
145559969|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
145559970|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
145559971|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
145559972|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
145559973|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
145559974|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
145559975|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
145559976|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
145293278|NCT00525590|523923935|FG000|Overall Study|Physician Decision|3|||
145559977|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
145559978|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
145559979|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
145559980|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
145559981|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
145559982|NCT00887354|524911260|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
145618092|NCT02061761|525115371|FG005|Overall Study|Other reasons|0|||
145618093|NCT02061761|525115372|FG006|Overall Study|Other reasons|0|||
145618094|NCT02061761|525115373|FG007|Overall Study|Other reasons|0|||
145618095|NCT02061761|525115374|FG008|Overall Study|Other reasons|6|||
145559983|NCT00887354|524911261|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
145559984|NCT00887354|524911260|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
145559985|NCT00887354|524911261|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
145559986|NCT00887354|524911260|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
145559987|NCT00887354|524911261|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
145559988|NCT00887354|524911260|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
145559989|NCT00887354|524911261|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
145559990|NCT00887354|524911260|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
145559991|NCT00887354|524911261|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
145559992|NCT00887354|524911260|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
145559993|NCT00887354|524911261|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
145559994|NCT01466348|524911264|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
145559995|NCT01466348|524911265|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
145559996|NCT03970733|524911266|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
145559997|NCT03970733|524911267|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
145559998|NCT03970733|524911268|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
145559999|NCT03970733|524911269|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
145560000|NCT03970733|524911270|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
145560001|NCT03970733|524911266|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
145560002|NCT03970733|524911267|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
145560003|NCT03970733|524911268|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
145560004|NCT03970733|524911269|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
145560005|NCT03970733|524911270|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
145560006|NCT03970733|524911266|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
145560007|NCT03970733|524911267|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
145560008|NCT03970733|524911268|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
145560009|NCT03970733|524911269|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
145560010|NCT03970733|524911270|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
145560011|NCT03970733|524911266|FG000|Main Study Phase (18 Months)|Other|1|||
145560012|NCT03970733|524911267|FG001|Main Study Phase (18 Months)|Other|1|||
145560013|NCT03970733|524911268|FG002|Main Study Phase (18 Months)|Other|0|||
145560014|NCT03970733|524911269|FG003|Main Study Phase (18 Months)|Other|0|||
145560015|NCT03970733|524911270|FG004|Main Study Phase (18 Months)|Other|0|||
145560016|NCT03970733|524911266|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
145560017|NCT03970733|524911267|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
145560018|NCT03970733|524911268|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
145560019|NCT03970733|524911269|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
145560020|NCT03970733|524911270|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
145560021|NCT01955161|524911274|FG000|Overall Study|Withdrawal before treatment|2|||
145560022|NCT01955161|524911275|FG001|Overall Study|Withdrawal before treatment|0|||
145560023|NCT01955161|524911276|FG002|Overall Study|Withdrawal before treatment|1|||
145560024|NCT01955161|524911274|FG000|Overall Study|Adverse Event|10|||
145560025|NCT01955161|524911275|FG001|Overall Study|Adverse Event|14|||
145560026|NCT01955161|524911276|FG002|Overall Study|Adverse Event|15|||
145560027|NCT01955161|524911274|FG000|Overall Study|Death|1|||
145560028|NCT01955161|524911275|FG001|Overall Study|Death|1|||
145560029|NCT01955161|524911276|FG002|Overall Study|Death|3|||
145560030|NCT01955161|524911274|FG000|Overall Study|Withdrawal by Subject|9|||
145560031|NCT01955161|524911275|FG001|Overall Study|Withdrawal by Subject|8|||
145560032|NCT01955161|524911276|FG002|Overall Study|Withdrawal by Subject|12|||
145560033|NCT01955161|524911274|FG000|Overall Study|Protocol Violation|2|||
145560034|NCT01955161|524911275|FG001|Overall Study|Protocol Violation|0|||
145560035|NCT01955161|524911276|FG002|Overall Study|Protocol Violation|0|||
145560036|NCT01955161|524911274|FG000|Overall Study|Other reason: physician decision|0|||
145560037|NCT01955161|524911275|FG001|Overall Study|Other reason: physician decision|1|||
145560038|NCT01955161|524911276|FG002|Overall Study|Other reason: physician decision|1|||
145560039|NCT01955161|524911274|FG000|Overall Study|Other reason: disallowed medication|1|||
145560040|NCT01955161|524911275|FG001|Overall Study|Other reason: disallowed medication|0|||
145560041|NCT01955161|524911276|FG002|Overall Study|Other reason: disallowed medication|1|||
145560042|NCT01955161|524911274|FG000|Overall Study|Other reason: caregiver unavailable|1|||
145560043|NCT01955161|524911275|FG001|Overall Study|Other reason: caregiver unavailable|0|||
145560044|NCT01955161|524911276|FG002|Overall Study|Other reason: caregiver unavailable|0|||
145560045|NCT01955161|524911274|FG000|Overall Study|Other reason: moved to nursing home|0|||
145560046|NCT01955161|524911275|FG001|Overall Study|Other reason: moved to nursing home|1|||
145560047|NCT01955161|524911276|FG002|Overall Study|Other reason: moved to nursing home|0|||
145560048|NCT01955161|524911274|FG000|Overall Study|Other reason: insufficient compliance|0|||
145560049|NCT01955161|524911275|FG001|Overall Study|Other reason: insufficient compliance|0|||
145560050|NCT01955161|524911276|FG002|Overall Study|Other reason: insufficient compliance|1|||
145560051|NCT01955161|524911274|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
145560052|NCT01955161|524911275|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
145560053|NCT01955161|524911276|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
145560054|NCT01955161|524911274|FG000|Overall Study|Other reason: patient's will|0|||
145560055|NCT01955161|524911275|FG001|Overall Study|Other reason: patient's will|0|||
145560056|NCT01955161|524911276|FG002|Overall Study|Other reason: patient's will|1|||
145560057|NCT02784821|524911277|FG000|Overall Study|Death|0|||
145560058|NCT02784821|524911278|FG001|Overall Study|Death|5|||
145560059|NCT02784821|524911279|FG002|Overall Study|Death|4|||
145560060|NCT02784821|524911280|FG003|Overall Study|Death|5|||
145560061|NCT02794103|524911281|FG000|Overall Study|Loss to follow up due to high sedation|3|||
145560062|NCT01139450|524911282|FG000|Overall Study|Withdrawal by Subject|7|||
145560063|NCT01139450|524911283|FG001|Overall Study|Withdrawal by Subject|10|||
145560064|NCT01139450|524911284|FG002|Overall Study|Withdrawal by Subject|13|||
145560065|NCT01139450|524911282|FG000|Overall Study|Lack of Efficacy|3|||
145560066|NCT01139450|524911283|FG001|Overall Study|Lack of Efficacy|1|||
145560067|NCT01139450|524911284|FG002|Overall Study|Lack of Efficacy|8|||
145560068|NCT01139450|524911282|FG000|Overall Study|Protocol Violation|6|||
145560069|NCT01139450|524911283|FG001|Overall Study|Protocol Violation|5|||
145560070|NCT01139450|524911284|FG002|Overall Study|Protocol Violation|2|||
145560071|NCT01139450|524911282|FG000|Overall Study|Lost to Follow-up|9|||
145560072|NCT01139450|524911283|FG001|Overall Study|Lost to Follow-up|7|||
145560073|NCT01139450|524911284|FG002|Overall Study|Lost to Follow-up|11|||
145560074|NCT01139450|524911282|FG000|Overall Study|Administrative|0|||
145560075|NCT01139450|524911283|FG001|Overall Study|Administrative|0|||
145560076|NCT01139450|524911284|FG002|Overall Study|Administrative|1|||
145560077|NCT01139450|524911282|FG000|Overall Study|Adverse Event|2|||
145560078|NCT01139450|524911283|FG001|Overall Study|Adverse Event|2|||
145560079|NCT01139450|524911284|FG002|Overall Study|Adverse Event|3|||
145560080|NCT02608268|524911296|FG000|Overall Study|Adverse Event|0|||
145560081|NCT02608268|524911297|FG001|Overall Study|Adverse Event|0|||
145560082|NCT02608268|524911298|FG002|Overall Study|Adverse Event|1|||
145560083|NCT02608268|524911299|FG003|Overall Study|Adverse Event|0|||
145560084|NCT02608268|524911300|FG004|Overall Study|Adverse Event|0|||
145560085|NCT02608268|524911301|FG005|Overall Study|Adverse Event|0|||
145560086|NCT02608268|524911302|FG006|Overall Study|Adverse Event|0|||
145560087|NCT02608268|524911303|FG007|Overall Study|Adverse Event|0|||
145560088|NCT02608268|524911304|FG008|Overall Study|Adverse Event|0|||
145560089|NCT02608268|524911305|FG009|Overall Study|Adverse Event|0|||
145560090|NCT02608268|524911306|FG010|Overall Study|Adverse Event|0|||
145560091|NCT02608268|524911307|FG011|Overall Study|Adverse Event|0|||
145560092|NCT02608268|524911308|FG012|Overall Study|Adverse Event|2|||
145560093|NCT02608268|524911309|FG013|Overall Study|Adverse Event|0|||
145560094|NCT02608268|524911310|FG014|Overall Study|Adverse Event|0|||
145560095|NCT02608268|524911311|FG015|Overall Study|Adverse Event|0|||
145560096|NCT02608268|524911312|FG016|Overall Study|Adverse Event|0|||
145560097|NCT02608268|524911313|FG017|Overall Study|Adverse Event|0|||
145560098|NCT02608268|524911314|FG018|Overall Study|Adverse Event|0|||
145560099|NCT02608268|524911315|FG019|Overall Study|Adverse Event|0|||
145560100|NCT02608268|524911316|FG020|Overall Study|Adverse Event|1|||
145560101|NCT02608268|524911317|FG021|Overall Study|Adverse Event|1|||
145560102|NCT02608268|524911318|FG022|Overall Study|Adverse Event|0|||
145560103|NCT02608268|524911319|FG023|Overall Study|Adverse Event|0|||
145560104|NCT02608268|524911320|FG024|Overall Study|Adverse Event|1|||
145560105|NCT02608268|524911321|FG025|Overall Study|Adverse Event|0|||
145560106|NCT02608268|524911322|FG026|Overall Study|Adverse Event|0|||
145560107|NCT02608268|524911323|FG027|Overall Study|Adverse Event|0|||
145560108|NCT02608268|524911324|FG028|Overall Study|Adverse Event|1|||
145618096|NCT01556763|525115378|FG000|Overall Study|Withdrawal by Subject|0|||
145618097|NCT01556763|525115379|FG001|Overall Study|Withdrawal by Subject|1|||
145407910|NCT03765073|524349748|FG007|Stage 3|Withdrawal by Subject|0|||
145560109|NCT02608268|524911325|FG029|Overall Study|Adverse Event|0|||
145560110|NCT02608268|524911296|FG000|Overall Study|Death|1|||
145560111|NCT02608268|524911297|FG001|Overall Study|Death|0|||
145560112|NCT02608268|524911298|FG002|Overall Study|Death|0|||
145560113|NCT02608268|524911299|FG003|Overall Study|Death|0|||
145560114|NCT02608268|524911300|FG004|Overall Study|Death|0|||
145560115|NCT02608268|524911301|FG005|Overall Study|Death|0|||
145560116|NCT02608268|524911302|FG006|Overall Study|Death|0|||
145618098|NCT01556763|525115380|FG002|Overall Study|Withdrawal by Subject|0|||
145293279|NCT00525590|523923935|FG000|Overall Study|Withdrawal by Subject|16|||
145293280|NCT00525590|523923935|FG000|Overall Study|Lost to Follow-up|1|||
145293281|NCT00525590|523923935|FG000|Overall Study|Death|9|||
145293282|NCT00525590|523923935|FG000|Overall Study|Other|13|||
145293283|NCT01345019|523923944|FG000|Blinded Treatment Phase|Death|147|||
145293284|NCT01345019|523923945|FG001|Blinded Treatment Phase|Death|137|||
145293285|NCT01345019|523923944|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
145293286|NCT01345019|523923945|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
145293287|NCT01345019|523923944|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
145293288|NCT01345019|523923945|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
145293289|NCT01345019|523923944|FG000|Blinded Treatment Phase|Disease Progression|12|||
145293290|NCT01345019|523923945|FG001|Blinded Treatment Phase|Disease Progression|10|||
145293291|NCT01345019|523923944|FG000|Blinded Treatment Phase|Adverse Event|6|||
145293292|NCT01345019|523923945|FG001|Blinded Treatment Phase|Adverse Event|13|||
145293293|NCT01345019|523923944|FG000|Blinded Treatment Phase|Administrative Decision|10|||
145293294|NCT01345019|523923945|FG001|Blinded Treatment Phase|Administrative Decision|8|||
145293295|NCT01345019|523923944|FG000|Blinded Treatment Phase|Noncompliance|5|||
145293296|NCT01345019|523923945|FG001|Blinded Treatment Phase|Noncompliance|3|||
145293297|NCT01345019|523923944|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
145293298|NCT01345019|523923945|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
145293299|NCT01345019|523923944|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
145293300|NCT01345019|523923945|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
145293301|NCT01345019|523923944|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
145293302|NCT01345019|523923945|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
145293303|NCT01345019|523923944|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
145293304|NCT01345019|523923945|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
145293305|NCT01345019|523923944|FG000|Open Label Treatment Phase|Death|49|||
145293306|NCT01345019|523923945|FG001|Open Label Treatment Phase|Death|48|||
145293307|NCT01345019|523923944|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
145293308|NCT01345019|523923945|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
145293309|NCT01345019|523923944|FG000|Open Label Treatment Phase|Adverse Event|30|||
145293310|NCT01345019|523923945|FG001|Open Label Treatment Phase|Adverse Event|51|||
145293311|NCT01345019|523923944|FG000|Open Label Treatment Phase|Administrative Decision|30|||
145293312|NCT01345019|523923945|FG001|Open Label Treatment Phase|Administrative Decision|15|||
145293313|NCT01345019|523923944|FG000|Open Label Treatment Phase|Disease Progression|17|||
145293314|NCT01345019|523923945|FG001|Open Label Treatment Phase|Disease Progression|18|||
145293315|NCT01345019|523923944|FG000|Open Label Treatment Phase|Noncompliance|5|||
145293316|NCT01345019|523923945|FG001|Open Label Treatment Phase|Noncompliance|4|||
145293317|NCT01345019|523923944|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
145293318|NCT01345019|523923945|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
145293319|NCT01345019|523923944|FG000|Open Label Treatment Phase|Pregnancy|1|||
145293320|NCT01345019|523923945|FG001|Open Label Treatment Phase|Pregnancy|0|||
145293321|NCT01345019|523923944|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
145293322|NCT01345019|523923945|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
145293323|NCT01345019|523923944|FG000|Open Label Treatment Phase|Protocol Violation|0|||
145293324|NCT01345019|523923945|FG001|Open Label Treatment Phase|Protocol Violation|1|||
145293325|NCT03830164|523923947|FG000|Overall Study|Adverse Event|0|||
145293326|NCT03830164|523923948|FG001|Overall Study|Adverse Event|2|||
145293327|NCT03830164|523923949|FG002|Overall Study|Adverse Event|0|||
145293328|NCT03830164|523923947|FG000|Overall Study|Lack of Efficacy|1|||
145293329|NCT03830164|523923948|FG001|Overall Study|Lack of Efficacy|5|||
145293330|NCT03830164|523923949|FG002|Overall Study|Lack of Efficacy|0|||
145293331|NCT03830164|523923947|FG000|Overall Study|Lost to Follow-up|0|||
145293332|NCT03830164|523923948|FG001|Overall Study|Lost to Follow-up|1|||
145293333|NCT03830164|523923949|FG002|Overall Study|Lost to Follow-up|0|||
145293334|NCT03830164|523923947|FG000|Overall Study|Withdrawal by Subject|1|||
145293335|NCT03830164|523923948|FG001|Overall Study|Withdrawal by Subject|0|||
145293336|NCT03830164|523923949|FG002|Overall Study|Withdrawal by Subject|0|||
145293337|NCT00320112|523923954|FG000|Overall Study|Lost to Follow-up|3|||
145293338|NCT00320112|523923955|FG001|Overall Study|Lost to Follow-up|4|||
145293339|NCT00320112|523923954|FG000|Overall Study|Withdrawal by Subject|3|||
145293340|NCT00320112|523923955|FG001|Overall Study|Withdrawal by Subject|0|||
145293341|NCT00320112|523923954|FG000|Overall Study|Death|2|||
145293342|NCT00320112|523923955|FG001|Overall Study|Death|1|||
145293343|NCT00414765|523923956|FG000|Overall Study|Adverse Event|5|||
145293344|NCT00414765|523923957|FG001|Overall Study|Adverse Event|9|||
145293345|NCT00414765|523923956|FG000|Overall Study|Withdrawal by Subject|1|||
145293346|NCT00414765|523923957|FG001|Overall Study|Withdrawal by Subject|1|||
145293347|NCT00414765|523923956|FG000|Overall Study|Disease Progression|0|||
145293348|NCT00414765|523923957|FG001|Overall Study|Disease Progression|1|||
145293349|NCT05295953|523923959|FG000|Overall Study|Withdrawal by Subject|0|||
145293350|NCT05295953|523923960|FG001|Overall Study|Withdrawal by Subject|1|||
145293351|NCT05694013|523923962|FG000|Overall Study|Death|6|||
145293352|NCT05694013|523923963|FG001|Overall Study|Death|2|||
145293353|NCT05694013|523923962|FG000|Overall Study|Participant Decision|0|||
145618099|NCT02258464|525115381|FG000|Overall Study|Progressive disease (PD)|9|||
145618100|NCT02258464|525115382|FG001|Overall Study|Progressive disease (PD)|17|||
145618101|NCT02258464|525115381|FG000|Overall Study|Study drug never administered|1|||
145618102|NCT02258464|525115382|FG001|Overall Study|Study drug never administered|1|||
145618103|NCT02258464|525115381|FG000|Overall Study|AE not related to clinical PD|1|||
145618104|NCT02258464|525115382|FG001|Overall Study|AE not related to clinical PD|3|||
145618105|NCT02258464|525115381|FG000|Overall Study|Withdrawal by Subject|5|||
145618106|NCT02258464|525115382|FG001|Overall Study|Withdrawal by Subject|4|||
145618107|NCT02258464|525115381|FG000|Overall Study|AE related to clinical PD|1|||
145618108|NCT02258464|525115382|FG001|Overall Study|AE related to clinical PD|0|||
145618109|NCT04170296|525115383|FG000|Overall Study|Adverse Event|1|||
145618110|NCT04170296|525115384|FG001|Overall Study|Adverse Event|0|||
145618111|NCT04170296|525115383|FG000|Overall Study|Withdrawal by Subject|3|||
145618112|NCT04170296|525115384|FG001|Overall Study|Withdrawal by Subject|2|||
145618113|NCT04170296|525115383|FG000|Overall Study|Lost to Follow-up|4|||
145618114|NCT04170296|525115384|FG001|Overall Study|Lost to Follow-up|2|||
145618115|NCT02138747|525115385|FG000|Treatment Period 1|Adverse Event|10|||
145618116|NCT02138747|525115386|FG001|Treatment Period 1|Adverse Event|14|||
145618117|NCT02138747|525115387|FG002|Treatment Period 1|Adverse Event|2|||
145618118|NCT02138747|525115388|FG003|Treatment Period 1|Adverse Event|1|||
145618119|NCT02138747|525115385|FG000|Treatment Period 1|Lost to Follow-up|0|||
145618120|NCT02138747|525115386|FG001|Treatment Period 1|Lost to Follow-up|1|||
145618121|NCT02138747|525115387|FG002|Treatment Period 1|Lost to Follow-up|1|||
145618122|NCT02138747|525115388|FG003|Treatment Period 1|Lost to Follow-up|0|||
145618123|NCT02138747|525115385|FG000|Treatment Period 1|Protocol Violation|0|||
145618124|NCT02138747|525115386|FG001|Treatment Period 1|Protocol Violation|2|||
145618125|NCT02138747|525115387|FG002|Treatment Period 1|Protocol Violation|0|||
145618126|NCT02138747|525115388|FG003|Treatment Period 1|Protocol Violation|0|||
145618127|NCT02138747|525115385|FG000|Treatment Period 1|Withdrawal by Subject|8|||
145618128|NCT02138747|525115386|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145618129|NCT02138747|525115387|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145618130|NCT02138747|525115388|FG003|Treatment Period 1|Withdrawal by Subject|3|||
145618131|NCT02138747|525115385|FG000|Treatment Period 1|Other - Miscellaneous|2|||
145618132|NCT02138747|525115386|FG001|Treatment Period 1|Other - Miscellaneous|4|||
145618133|NCT02138747|525115387|FG002|Treatment Period 1|Other - Miscellaneous|0|||
145618134|NCT02138747|525115388|FG003|Treatment Period 1|Other - Miscellaneous|0|||
145618135|NCT02138747|525115385|FG000|Treatment Period 2|Adverse Event|6|||
145618136|NCT02138747|525115386|FG001|Treatment Period 2|Adverse Event|3|||
145618137|NCT02138747|525115387|FG002|Treatment Period 2|Adverse Event|1|||
145618138|NCT02138747|525115388|FG003|Treatment Period 2|Adverse Event|1|||
145618139|NCT02138747|525115385|FG000|Treatment Period 2|Lost to Follow-up|2|||
145618140|NCT02138747|525115386|FG001|Treatment Period 2|Lost to Follow-up|0|||
145618141|NCT02138747|525115387|FG002|Treatment Period 2|Lost to Follow-up|0|||
145618142|NCT02138747|525115388|FG003|Treatment Period 2|Lost to Follow-up|0|||
145618143|NCT02138747|525115385|FG000|Treatment Period 2|Protocol Violation|1|||
145618144|NCT02138747|525115386|FG001|Treatment Period 2|Protocol Violation|0|||
145618145|NCT02138747|525115387|FG002|Treatment Period 2|Protocol Violation|0|||
145618146|NCT02138747|525115388|FG003|Treatment Period 2|Protocol Violation|0|||
145618147|NCT02138747|525115385|FG000|Treatment Period 2|Withdrawal by Subject|5|||
145618148|NCT02138747|525115386|FG001|Treatment Period 2|Withdrawal by Subject|4|||
145618149|NCT02138747|525115387|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145618150|NCT02138747|525115388|FG003|Treatment Period 2|Withdrawal by Subject|2|||
145618151|NCT02138747|525115385|FG000|Treatment Period 2|Other - Miscellaneous|3|||
145618152|NCT02138747|525115386|FG001|Treatment Period 2|Other - Miscellaneous|0|||
145618153|NCT02138747|525115387|FG002|Treatment Period 2|Other - Miscellaneous|0|||
145618154|NCT02138747|525115388|FG003|Treatment Period 2|Other - Miscellaneous|0|||
145618155|NCT00932646|525115389|FG000|Overall Study|Adverse Event|2|||
145618156|NCT00932646|525115390|FG001|Overall Study|Adverse Event|1|||
145618157|NCT00932646|525115391|FG002|Overall Study|Adverse Event|1|||
145618158|NCT00932646|525115392|FG003|Overall Study|Adverse Event|1|||
145618159|NCT00932646|525115389|FG000|Overall Study|Lost to Follow-up|2|||
145407911|NCT03765073|524349749|FG008|Stage 3|Withdrawal by Subject|0|||
145618160|NCT00932646|525115390|FG001|Overall Study|Lost to Follow-up|1|||
145618161|NCT00932646|525115391|FG002|Overall Study|Lost to Follow-up|0|||
145618162|NCT00932646|525115392|FG003|Overall Study|Lost to Follow-up|0|||
145618163|NCT00932646|525115389|FG000|Overall Study|Withdrawal by Subject|1|||
145618164|NCT00932646|525115390|FG001|Overall Study|Withdrawal by Subject|1|||
145618165|NCT00932646|525115391|FG002|Overall Study|Withdrawal by Subject|3|||
145618166|NCT00932646|525115392|FG003|Overall Study|Withdrawal by Subject|0|||
145618167|NCT00653263|525115393|FG000|Overall Study|Withdrawal by Subject|1|||
145618168|NCT00653263|525115393|FG000|Overall Study|Physician Decision|1|||
145618169|NCT02611830|525115394|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
145618170|NCT02611830|525115395|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
145618171|NCT02611830|525115396|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
145655505|NCT02975882|525257248|FG003|Overall Study|Lack of Efficacy|3|||
145293354|NCT05694013|523923963|FG001|Overall Study|Participant Decision|1|||
145293355|NCT05694013|523923962|FG000|Overall Study|Physician Decision|1|||
145293356|NCT05694013|523923963|FG001|Overall Study|Physician Decision|0|||
145293357|NCT05694013|523923962|FG000|Overall Study|Progressive Disease|0|||
145293358|NCT05694013|523923963|FG001|Overall Study|Progressive Disease|1|||
145293359|NCT05694013|523923962|FG000|Overall Study|Study Terminated by Sponsor|12|||
145293360|NCT05694013|523923963|FG001|Overall Study|Study Terminated by Sponsor|17|||
145293361|NCT05694013|523923962|FG000|Overall Study|Withdrawal by Subject|3|||
145293362|NCT05694013|523923963|FG001|Overall Study|Withdrawal by Subject|0|||
145293363|NCT01199861|523923964|FG000|Overall Study|Administrative problems|1|||
145293364|NCT01199861|523923965|FG001|Overall Study|Administrative problems|0|||
145293365|NCT01199861|523923964|FG000|Overall Study|Adverse Event|1|||
145293366|NCT01199861|523923965|FG001|Overall Study|Adverse Event|0|||
145293367|NCT04817891|523923966|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
145293368|NCT04817891|523923966|FG000|Overall Study|Adverse Event|1|||
145293369|NCT04817891|523923966|FG000|Overall Study|Withdrawal by Subject|1|||
145293370|NCT04981912|523923967|FG000|Overall Study|Physician Decision|2|||
145293371|NCT04534283|523923968|FG000|Overall Study|Physician Decision|2|||
145293372|NCT04534283|523923968|FG000|Overall Study|Withdrawal by Subject|1|||
145293373|NCT04534283|523923968|FG000|Overall Study|Disease Progression|12|||
145293374|NCT04534283|523923968|FG000|Overall Study|Adverse Event|1|||
145293375|NCT00661505|523923969|FG000|Overall Study|Adverse Event|3|||
145293376|NCT00661505|523923969|FG000|Overall Study|Protocol Violation|14|||
145293377|NCT00661505|523923969|FG000|Overall Study|Withdrawal by Subject|8|||
145293378|NCT00661505|523923969|FG000|Overall Study|Lost to Follow-up|3|||
145293379|NCT00661505|523923969|FG000|Overall Study|Other|2|||
145293380|NCT05630547|523923970|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
145293381|NCT05630547|523923971|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
145293382|NCT05630547|523923972|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
145293383|NCT05630547|523923973|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
145293384|NCT05630547|523923970|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
145293385|NCT05630547|523923971|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
145293386|NCT05630547|523923972|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
145293387|NCT05630547|523923973|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
145293388|NCT05630547|523923970|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
145293389|NCT05630547|523923971|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
145293390|NCT05630547|523923972|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
145293391|NCT05630547|523923973|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
145293392|NCT05630547|523923970|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
145293393|NCT05630547|523923971|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
145293394|NCT05630547|523923972|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
145293395|NCT05630547|523923973|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
145293396|NCT05630547|523923970|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
145293397|NCT05630547|523923971|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
145293398|NCT05630547|523923972|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
145293399|NCT05630547|523923973|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
145293400|NCT05630547|523923970|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
145293401|NCT05630547|523923971|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
145293402|NCT05630547|523923972|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
145293403|NCT05630547|523923973|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
145293404|NCT05630547|523923970|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
145293405|NCT05630547|523923971|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
145293406|NCT05630547|523923972|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
145293407|NCT05630547|523923973|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
145293408|NCT05630547|523923970|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
145293409|NCT05630547|523923971|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
145293410|NCT05630547|523923972|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
145293411|NCT05630547|523923973|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
145293412|NCT05630547|523923970|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
145560117|NCT02608268|524911303|FG007|Overall Study|Death|0|||
145560118|NCT02608268|524911304|FG008|Overall Study|Death|1|||
145560119|NCT02608268|524911305|FG009|Overall Study|Death|1|||
145560120|NCT02608268|524911306|FG010|Overall Study|Death|0|||
145560121|NCT02608268|524911307|FG011|Overall Study|Death|0|||
145560122|NCT02608268|524911308|FG012|Overall Study|Death|0|||
145560123|NCT02608268|524911309|FG013|Overall Study|Death|0|||
145560124|NCT02608268|524911310|FG014|Overall Study|Death|0|||
145560125|NCT02608268|524911311|FG015|Overall Study|Death|1|||
145560126|NCT02608268|524911312|FG016|Overall Study|Death|0|||
145560127|NCT02608268|524911313|FG017|Overall Study|Death|1|||
145618172|NCT02611830|525115397|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
145618173|NCT02611830|525115394|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
145618174|NCT02611830|525115395|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
145618175|NCT02611830|525115396|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
145618176|NCT02611830|525115397|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
145618177|NCT02611830|525115394|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
145618178|NCT02611830|525115395|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
145618179|NCT02611830|525115396|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
145618180|NCT02611830|525115397|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
145618181|NCT02611830|525115394|FG000|OL Induction Phase|Lack of Efficacy|9|||
145618182|NCT02611830|525115395|FG001|OL Induction Phase|Lack of Efficacy|0|||
145618183|NCT02611830|525115396|FG002|OL Induction Phase|Lack of Efficacy|0|||
145618184|NCT02611830|525115397|FG003|OL Induction Phase|Lack of Efficacy|0|||
145618185|NCT02611830|525115394|FG000|OL Induction Phase|Reason not specified|3|||
145618186|NCT02611830|525115395|FG001|OL Induction Phase|Reason not specified|0|||
145618187|NCT02611830|525115396|FG002|OL Induction Phase|Reason not specified|0|||
145618188|NCT02611830|525115397|FG003|OL Induction Phase|Reason not specified|0|||
145618189|NCT02611830|525115394|FG000|Maintenance Phase|Lack of Efficacy|0|||
145618190|NCT02611830|525115395|FG001|Maintenance Phase|Lack of Efficacy|29|||
145618191|NCT02611830|525115396|FG002|Maintenance Phase|Lack of Efficacy|18|||
145618192|NCT02611830|525115397|FG003|Maintenance Phase|Lack of Efficacy|6|||
145618193|NCT02611830|525115394|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
145618194|NCT02611830|525115395|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
145618195|NCT02611830|525115396|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
145618196|NCT02611830|525115397|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
145618197|NCT02611830|525115394|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
145618198|NCT02611830|525115395|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
145618199|NCT02611830|525115396|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
145618200|NCT02611830|525115397|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
145618201|NCT02611830|525115394|FG000|Maintenance Phase|Lost to Follow-up|0|||
145618202|NCT02611830|525115395|FG001|Maintenance Phase|Lost to Follow-up|0|||
145618203|NCT02611830|525115396|FG002|Maintenance Phase|Lost to Follow-up|0|||
145618204|NCT02611830|525115397|FG003|Maintenance Phase|Lost to Follow-up|1|||
145618205|NCT02611830|525115394|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
145618206|NCT02611830|525115395|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
145618207|NCT02611830|525115396|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
145618208|NCT02611830|525115397|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
145618209|NCT02611830|525115394|FG000|Maintenance Phase|Pregnancy|0|||
145618210|NCT02611830|525115395|FG001|Maintenance Phase|Pregnancy|0|||
145618211|NCT02611830|525115396|FG002|Maintenance Phase|Pregnancy|1|||
145618212|NCT02611830|525115397|FG003|Maintenance Phase|Pregnancy|0|||
145618213|NCT02611830|525115394|FG000|Maintenance Phase|Reason not specified|0|||
145618214|NCT02611830|525115395|FG001|Maintenance Phase|Reason not specified|1|||
145618215|NCT02611830|525115396|FG002|Maintenance Phase|Reason not specified|4|||
145618216|NCT02611830|525115397|FG003|Maintenance Phase|Reason not specified|0|||
145618217|NCT00776100|525115400|FG000|Overall Study|Disease Progression|1|||
145618218|NCT00776100|525115401|FG001|Overall Study|Disease Progression|0|||
145618219|NCT03567993|525115402|FG000|Overall Study|Lost to Follow-up|4|||
145618220|NCT03567993|525115403|FG001|Overall Study|Lost to Follow-up|2|||
145618221|NCT03567993|525115402|FG000|Overall Study|Death|1|||
145618222|NCT03567993|525115403|FG001|Overall Study|Death|1|||
145618223|NCT03567993|525115402|FG000|Overall Study|Withdrawal by Subject|1|||
145618224|NCT03567993|525115403|FG001|Overall Study|Withdrawal by Subject|0|||
145618225|NCT04793464|525115404|FG000|Overall Study|Lost to Follow-up|458|||
145618226|NCT04793464|525115405|FG001|Overall Study|Lost to Follow-up|168|||
145618227|NCT04793464|525115406|FG002|Overall Study|Lost to Follow-up|5|||
145618228|NCT04793464|525115404|FG000|Overall Study|Withdrawal by Subject|43|||
145618229|NCT04793464|525115405|FG001|Overall Study|Withdrawal by Subject|15|||
145618230|NCT04793464|525115406|FG002|Overall Study|Withdrawal by Subject|0|||
145618231|NCT02285595|525115408|FG000|Overall Study|Lost to Follow-up|14|||
145618232|NCT02285595|525115408|FG000|Overall Study|Withdrawal by Subject|1|||
145407912|NCT03765073|524349750|FG009|Stage 3|Withdrawal by Subject|0|||
145407913|NCT03765073|524349751|FG010|Stage 3|Withdrawal by Subject|0|||
145618233|NCT01960790|525115409|FG000|Overall Study|Survey forms could not be recovered|3|||
145618234|NCT01960790|525115409|FG000|Overall Study|Treat with Humira outside survey period|3|||
145618235|NCT01960790|525115409|FG000|Overall Study|Transferred to another hospital|4|||
145618236|NCT01960790|525115409|FG000|Overall Study|Unevaluable for safety|1|||
145618237|NCT05822921|525115414|FG000|Overall Study|Lost to Follow-up|1|||
145618238|NCT05822921|525115415|FG001|Overall Study|Lost to Follow-up|1|||
145407914|NCT03765073|524349752|FG011|Stage 3|Withdrawal by Subject|0|||
145618239|NCT00544544|525115417|FG000|Overall Study|Withdrawal by Subject|1|||
145618240|NCT00544544|525115417|FG000|Overall Study|Adverse Event|1|||
145618241|NCT00544544|525115417|FG000|Overall Study|Lost to Follow-up|1|||
145618242|NCT01163747|525115418|FG000|Overall Study|Adverse Event|0|||
145618243|NCT01163747|525115419|FG001|Overall Study|Adverse Event|5|||
145618244|NCT01163747|525115418|FG000|Overall Study|Insufficient Therapeutic Response|0|||
145618245|NCT01163747|525115419|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145618246|NCT01163747|525115418|FG000|Overall Study|Protocol Violation|0|||
145618247|NCT01163747|525115419|FG001|Overall Study|Protocol Violation|1|||
145618248|NCT01163747|525115418|FG000|Overall Study|Refused Treatment|6|||
145618249|NCT01163747|525115419|FG001|Overall Study|Refused Treatment|4|||
145618250|NCT01671748|525115420|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
145618251|NCT01671748|525115421|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
145618252|NCT01671748|525115420|FG000|4 Week run-in Phase|Adverse Event|1|||
145618253|NCT01671748|525115421|FG001|4 Week run-in Phase|Adverse Event|0|||
145618254|NCT01671748|525115420|FG000|4 Week run-in Phase|Not eligible|9|||
145618255|NCT01671748|525115421|FG001|4 Week run-in Phase|Not eligible|0|||
145618256|NCT04714216|525117467|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
145618257|NCT04714216|525117467|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
145618258|NCT01349829|525117471|FG000|Overall Study|Lost to Follow-up|4|||
145618259|NCT01349829|525117472|FG001|Overall Study|Lost to Follow-up|8|||
145618260|NCT01349829|525117471|FG000|Overall Study|Consent withdrawal|3|||
145618261|NCT01349829|525117472|FG001|Overall Study|Consent withdrawal|8|||
145618262|NCT01349829|525117471|FG000|Overall Study|Migrated/moved|2|||
145618263|NCT01349829|525117472|FG001|Overall Study|Migrated/moved|7|||
145618264|NCT00777803|525117473|FG000|Overall Study|Lost to Follow-up|12|||
145618265|NCT00777803|525117474|FG001|Overall Study|Lost to Follow-up|5|||
145618266|NCT00777803|525117473|FG000|Overall Study|Adverse Event|1|||
145618267|NCT00777803|525117474|FG001|Overall Study|Adverse Event|0|||
145618268|NCT00777803|525117473|FG000|Overall Study|Non-compliance|2|||
145618269|NCT00777803|525117474|FG001|Overall Study|Non-compliance|2|||
145618270|NCT01995357|525117477|FG000|Period 5|Lack of Efficacy|1|||
145618271|NCT01995357|525117478|FG001|Period 5|Lack of Efficacy|0|||
145618272|NCT01995357|525117479|FG002|Period 5|Lack of Efficacy|0|||
145618273|NCT01995357|525117480|FG003|Period 5|Lack of Efficacy|0|||
145618274|NCT01995357|525117481|FG004|Period 5|Lack of Efficacy|0|||
145618275|NCT01995357|525117482|FG005|Period 5|Lack of Efficacy|0|||
145618276|NCT01995357|525117477|FG000|Period 5|Adverse Event|1|||
145618277|NCT01995357|525117478|FG001|Period 5|Adverse Event|0|||
145618278|NCT01995357|525117479|FG002|Period 5|Adverse Event|1|||
145618279|NCT01995357|525117480|FG003|Period 5|Adverse Event|0|||
145618280|NCT01995357|525117481|FG004|Period 5|Adverse Event|0|||
145618281|NCT01995357|525117482|FG005|Period 5|Adverse Event|0|||
145618282|NCT04129580|525117483|FG000|Overall Study|Lost to Follow-up|14|||
145618283|NCT04129580|525117484|FG001|Overall Study|Lost to Follow-up|25|||
145618284|NCT02711995|525117487|FG000|Washout (90 Days)|Conflicting medication|1|||
145618285|NCT00322868|525117488|FG000|Overall Study|disease progression|1|||
145618286|NCT03615482|525117489|FG000|Overall Study|Death|1|||
145618287|NCT03615482|525117490|FG001|Overall Study|Death|0|||
145618288|NCT03615482|525117489|FG000|Overall Study|Lost to Follow-up|7|||
145618289|NCT03615482|525117490|FG001|Overall Study|Lost to Follow-up|7|||
145618290|NCT03615482|525117489|FG000|Overall Study|Physician Decision|2|||
145618291|NCT03615482|525117490|FG001|Overall Study|Physician Decision|3|||
145618292|NCT03615482|525117489|FG000|Overall Study|Withdrawal by Subject|7|||
145618293|NCT03615482|525117490|FG001|Overall Study|Withdrawal by Subject|7|||
145618294|NCT01852162|525117491|FG000|Overall Study|Adverse Event|1|||
145618295|NCT01852162|525117492|FG001|Overall Study|Adverse Event|0|||
145618296|NCT01852162|525117491|FG000|Overall Study|Withdrawal by Subject|3|||
145618297|NCT01852162|525117492|FG001|Overall Study|Withdrawal by Subject|1|||
145618298|NCT02955277|525117495|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
145618299|NCT02955277|525117496|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
145618300|NCT02955277|525117495|FG000|Post to Follow-up|Lost to Follow-up|8|||
145618301|NCT02955277|525117496|FG001|Post to Follow-up|Lost to Follow-up|11|||
145618302|NCT00163215|525117506|FG000|Overall Study|Lack of Efficacy|3|||
145618303|NCT00163215|525117506|FG000|Overall Study|Withdrawal by Subject|5|||
145618304|NCT00163215|525117506|FG000|Overall Study|Other|7|||
145618305|NCT01809210|525117509|FG000|Overall Study|Withdrawal by Subject|0|||
145618306|NCT01809210|525117510|FG001|Overall Study|Withdrawal by Subject|0|||
145618307|NCT01809210|525117511|FG002|Overall Study|Withdrawal by Subject|1|||
145618308|NCT01809210|525117512|FG003|Overall Study|Withdrawal by Subject|1|||
145618309|NCT01809210|525117513|FG004|Overall Study|Withdrawal by Subject|1|||
145618310|NCT01809210|525117514|FG005|Overall Study|Withdrawal by Subject|0|||
145618311|NCT01809210|525117515|FG006|Overall Study|Withdrawal by Subject|4|||
145618312|NCT01809210|525117509|FG000|Overall Study|Death|1|||
145618313|NCT01809210|525117510|FG001|Overall Study|Death|1|||
145618314|NCT01809210|525117511|FG002|Overall Study|Death|2|||
145618315|NCT01809210|525117512|FG003|Overall Study|Death|0|||
145618316|NCT01809210|525117513|FG004|Overall Study|Death|1|||
145618317|NCT01809210|525117514|FG005|Overall Study|Death|3|||
145618318|NCT01809210|525117515|FG006|Overall Study|Death|1|||
145618319|NCT01115998|525117517|FG000|Overall Study|Lost to Follow-up|6|||
145618320|NCT01115998|525117518|FG001|Overall Study|Lost to Follow-up|6|||
145618321|NCT00590980|525117519|FG000|Overall Study|Did not meet all inclusion criteria|10|||
145618322|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
145618323|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
145618324|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
145293413|NCT05630547|523923971|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
145293414|NCT05630547|523923972|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
145560128|NCT02608268|524911314|FG018|Overall Study|Death|0|||
145560129|NCT02608268|524911315|FG019|Overall Study|Death|1|||
145560130|NCT02608268|524911316|FG020|Overall Study|Death|1|||
145560131|NCT02608268|524911317|FG021|Overall Study|Death|0|||
145560132|NCT02608268|524911318|FG022|Overall Study|Death|0|||
145560133|NCT02608268|524911319|FG023|Overall Study|Death|0|||
145560134|NCT02608268|524911320|FG024|Overall Study|Death|1|||
145560135|NCT02608268|524911321|FG025|Overall Study|Death|2|||
145560136|NCT02608268|524911322|FG026|Overall Study|Death|0|||
145560137|NCT02608268|524911323|FG027|Overall Study|Death|1|||
145560138|NCT02608268|524911324|FG028|Overall Study|Death|4|||
145560139|NCT02608268|524911325|FG029|Overall Study|Death|0|||
145560140|NCT02608268|524911296|FG000|Overall Study|Physician Decision|0|||
145560141|NCT02608268|524911297|FG001|Overall Study|Physician Decision|0|||
145560142|NCT02608268|524911298|FG002|Overall Study|Physician Decision|0|||
145560143|NCT02608268|524911299|FG003|Overall Study|Physician Decision|0|||
145560144|NCT02608268|524911300|FG004|Overall Study|Physician Decision|0|||
145560145|NCT02608268|524911301|FG005|Overall Study|Physician Decision|0|||
145560146|NCT02608268|524911302|FG006|Overall Study|Physician Decision|0|||
145560147|NCT02608268|524911303|FG007|Overall Study|Physician Decision|0|||
145560148|NCT02608268|524911304|FG008|Overall Study|Physician Decision|0|||
145560149|NCT02608268|524911305|FG009|Overall Study|Physician Decision|0|||
145560150|NCT02608268|524911306|FG010|Overall Study|Physician Decision|1|||
145560151|NCT02608268|524911307|FG011|Overall Study|Physician Decision|0|||
145560152|NCT02608268|524911308|FG012|Overall Study|Physician Decision|0|||
145560153|NCT02608268|524911309|FG013|Overall Study|Physician Decision|1|||
145560154|NCT02608268|524911310|FG014|Overall Study|Physician Decision|0|||
145560155|NCT02608268|524911311|FG015|Overall Study|Physician Decision|0|||
145560156|NCT02608268|524911312|FG016|Overall Study|Physician Decision|0|||
145560157|NCT02608268|524911313|FG017|Overall Study|Physician Decision|0|||
145560158|NCT02608268|524911314|FG018|Overall Study|Physician Decision|0|||
145560159|NCT02608268|524911315|FG019|Overall Study|Physician Decision|0|||
145560160|NCT02608268|524911316|FG020|Overall Study|Physician Decision|0|||
145560161|NCT02608268|524911317|FG021|Overall Study|Physician Decision|0|||
145560162|NCT02608268|524911318|FG022|Overall Study|Physician Decision|1|||
145560163|NCT02608268|524911319|FG023|Overall Study|Physician Decision|1|||
145560164|NCT02608268|524911320|FG024|Overall Study|Physician Decision|1|||
145560165|NCT02608268|524911321|FG025|Overall Study|Physician Decision|0|||
145560166|NCT02608268|524911322|FG026|Overall Study|Physician Decision|0|||
145560167|NCT02608268|524911323|FG027|Overall Study|Physician Decision|2|||
145560168|NCT02608268|524911324|FG028|Overall Study|Physician Decision|1|||
145560169|NCT02608268|524911325|FG029|Overall Study|Physician Decision|1|||
145560170|NCT02608268|524911296|FG000|Overall Study|Progressive disease|12|||
145560171|NCT02608268|524911297|FG001|Overall Study|Progressive disease|8|||
145560172|NCT02608268|524911298|FG002|Overall Study|Progressive disease|13|||
145560173|NCT02608268|524911299|FG003|Overall Study|Progressive disease|5|||
145560174|NCT02608268|524911300|FG004|Overall Study|Progressive disease|2|||
145560175|NCT02608268|524911301|FG005|Overall Study|Progressive disease|4|||
145560176|NCT02608268|524911302|FG006|Overall Study|Progressive disease|6|||
145560177|NCT02608268|524911303|FG007|Overall Study|Progressive disease|2|||
145560178|NCT02608268|524911304|FG008|Overall Study|Progressive disease|5|||
145560179|NCT02608268|524911305|FG009|Overall Study|Progressive disease|6|||
145560180|NCT02608268|524911306|FG010|Overall Study|Progressive disease|5|||
145560181|NCT02608268|524911307|FG011|Overall Study|Progressive disease|5|||
145560182|NCT02608268|524911308|FG012|Overall Study|Progressive disease|4|||
145560183|NCT02608268|524911309|FG013|Overall Study|Progressive disease|11|||
145618325|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
145560184|NCT02608268|524911310|FG014|Overall Study|Progressive disease|6|||
145560185|NCT02608268|524911311|FG015|Overall Study|Progressive disease|3|||
145560186|NCT02608268|524911312|FG016|Overall Study|Progressive disease|5|||
145618326|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
145618327|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
145618328|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
145618329|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
145618330|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
145618331|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
145618332|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
145618333|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
145618334|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
145618335|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
145618336|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
145618337|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
145618338|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
145618339|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
145618340|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
145618341|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
145618342|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
145618343|NCT02718417|525117522|FG000|Chemotherapy Phase (CP)|Other|2|||
145618344|NCT02718417|525117523|FG001|Chemotherapy Phase (CP)|Other|0|||
145618345|NCT02718417|525117524|FG002|Chemotherapy Phase (CP)|Other|1|||
145618346|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Adverse Event|21|||
145618347|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Adverse Event|26|||
145618348|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Adverse Event|0|||
145618349|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
145618350|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
145618351|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
145618352|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
145618353|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
145618354|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
145618355|NCT02718417|525117522|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
145618356|NCT02718417|525117523|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
145618357|NCT02718417|525117524|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
145618358|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Physician's decision|6|||
145618359|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Physician's decision|7|||
145618360|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Physician's decision|0|||
145618361|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Progressive disease|100|||
145618362|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Progressive disease|88|||
145618363|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Progressive disease|0|||
145618364|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Other|2|||
145618365|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Other|1|||
145618366|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Other|0|||
145618367|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
145618368|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
145618369|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
145293415|NCT05630547|523923973|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
145293416|NCT05630547|523923970|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
145293417|NCT05630547|523923971|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
145293418|NCT05630547|523923972|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
145293419|NCT05630547|523923973|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
145293420|NCT00977470|523923974|FG000|Overall Study|Lack of Efficacy|32|||
145293421|NCT00977470|523923975|FG001|Overall Study|Lack of Efficacy|30|||
145293422|NCT00977470|523923974|FG000|Overall Study|Physician Decision|2|||
145560187|NCT02608268|524911313|FG017|Overall Study|Progressive disease|5|||
145560188|NCT02608268|524911314|FG018|Overall Study|Progressive disease|5|||
145560189|NCT02608268|524911315|FG019|Overall Study|Progressive disease|2|||
145560190|NCT02608268|524911316|FG020|Overall Study|Progressive disease|10|||
145560191|NCT02608268|524911317|FG021|Overall Study|Progressive disease|4|||
145560192|NCT02608268|524911318|FG022|Overall Study|Progressive disease|5|||
145560193|NCT02608268|524911319|FG023|Overall Study|Progressive disease|5|||
145560194|NCT02608268|524911320|FG024|Overall Study|Progressive disease|3|||
145560195|NCT02608268|524911321|FG025|Overall Study|Progressive disease|11|||
145293423|NCT00977470|523923975|FG001|Overall Study|Physician Decision|0|||
145293424|NCT00977470|523923974|FG000|Overall Study|Adverse Event|1|||
145407915|NCT03765073|524349753|FG012|Stage 3|Withdrawal by Subject|0|||
145407916|NCT03765073|524349754|FG013|Stage 3|Withdrawal by Subject|0|||
145407917|NCT03765073|524349755|FG014|Stage 3|Withdrawal by Subject|0|||
145618370|NCT02718417|525117522|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
145618371|NCT02718417|525117523|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
145618372|NCT02718417|525117524|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
145618373|NCT02718417|525117522|FG000|Observation Phase (OP)|Adverse Event|0|||
145407918|NCT03765073|524349756|FG015|Stage 3|Withdrawal by Subject|0|||
145618374|NCT02718417|525117523|FG001|Observation Phase (OP)|Adverse Event|0|||
145618375|NCT02718417|525117524|FG002|Observation Phase (OP)|Adverse Event|1|||
145618376|NCT02718417|525117522|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
145618377|NCT02718417|525117523|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
145618378|NCT02718417|525117524|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
145618379|NCT02718417|525117522|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
145618380|NCT02718417|525117523|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
145618381|NCT02718417|525117524|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
145618382|NCT02718417|525117522|FG000|Observation Phase (OP)|Physician Decision|0|||
145618383|NCT02718417|525117523|FG001|Observation Phase (OP)|Physician Decision|0|||
145618384|NCT02718417|525117524|FG002|Observation Phase (OP)|Physician Decision|9|||
145618385|NCT02718417|525117522|FG000|Observation Phase (OP)|Progressive disease|0|||
145618386|NCT02718417|525117523|FG001|Observation Phase (OP)|Progressive disease|0|||
145618387|NCT02718417|525117524|FG002|Observation Phase (OP)|Progressive disease|92|||
145618388|NCT02718417|525117522|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
145618389|NCT02718417|525117523|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
145618390|NCT02718417|525117524|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
145618391|NCT02718417|525117522|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
145618392|NCT02718417|525117523|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
145618393|NCT02718417|525117524|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
145618394|NCT02718417|525117522|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
145618395|NCT02718417|525117523|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
145618396|NCT02718417|525117524|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
145618397|NCT02718417|525117522|FG000|Observation Phase (OP)|Other|0|||
145618398|NCT02718417|525117523|FG001|Observation Phase (OP)|Other|0|||
145618399|NCT02718417|525117524|FG002|Observation Phase (OP)|Other|7|||
145618400|NCT02718417|525117522|FG000|Follow-up Phase|Adverse Event|3|||
145293425|NCT00977470|523923975|FG001|Overall Study|Adverse Event|2|||
145293426|NCT00977470|523923974|FG000|Overall Study|Protocol Violation|1|||
145293427|NCT00977470|523923975|FG001|Overall Study|Protocol Violation|0|||
145293428|NCT00977470|523923974|FG000|Overall Study|Withdrawal by Subject|0|||
145293429|NCT00977470|523923975|FG001|Overall Study|Withdrawal by Subject|2|||
145293430|NCT00977470|523923974|FG000|Overall Study|Death|0|||
145293431|NCT00977470|523923975|FG001|Overall Study|Death|2|||
145293432|NCT00977470|523923974|FG000|Overall Study|clinical decline|0|||
145293433|NCT00977470|523923975|FG001|Overall Study|clinical decline|1|||
145293434|NCT00977470|523923974|FG000|Overall Study|prolonged recovery post-surgery|0|||
145293435|NCT00977470|523923975|FG001|Overall Study|prolonged recovery post-surgery|1|||
145293436|NCT00977470|523923974|FG000|Overall Study|Still on-study|2|||
145293437|NCT00977470|523923975|FG001|Overall Study|Still on-study|0|||
145293438|NCT00796822|523923976|FG000|Overall Study|Lost to Follow-up|2|||
145293439|NCT00796822|523923977|FG001|Overall Study|Lost to Follow-up|0|||
145293440|NCT00796822|523923976|FG000|Overall Study|Adverse Event|1|||
145293441|NCT00796822|523923977|FG001|Overall Study|Adverse Event|0|||
145293442|NCT02364557|523923978|FG000|Overall Study|Protocol Violation|3|||
145293443|NCT02364557|523923979|FG001|Overall Study|Protocol Violation|1|||
145293444|NCT03978624|523923980|FG000|Overall Study|Protocol Violation|1|||
145293445|NCT03978624|523923981|FG001|Overall Study|Protocol Violation|0|||
145293446|NCT05097989|523923983|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293447|NCT05097989|523923984|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293448|NCT05097989|523923985|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293449|NCT05097989|523923986|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293450|NCT05097989|523923987|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293451|NCT05097989|523923988|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
145293452|NCT05097989|523923989|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293453|NCT05097989|523923990|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293454|NCT05097989|523923991|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
145293455|NCT05097989|523923983|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
145293456|NCT05097989|523923984|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
145293457|NCT05097989|523923985|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
145293458|NCT05097989|523923986|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
145293459|NCT05097989|523923987|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
145293460|NCT05097989|523923988|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
145293461|NCT05097989|523923989|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
145293462|NCT05097989|523923990|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
145293463|NCT05097989|523923991|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
145293464|NCT05097989|523923983|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145618401|NCT02718417|525117523|FG001|Follow-up Phase|Adverse Event|1|||
145618402|NCT02718417|525117524|FG002|Follow-up Phase|Adverse Event|1|||
145618403|NCT02718417|525117522|FG000|Follow-up Phase|Other|4|||
145618404|NCT02718417|525117523|FG001|Follow-up Phase|Other|6|||
145618405|NCT02718417|525117524|FG002|Follow-up Phase|Other|4|||
145618406|NCT02718417|525117522|FG000|Follow-up Phase|Withdrawal by Subject|19|||
145293465|NCT05097989|523923984|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145293466|NCT05097989|523923985|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145293467|NCT05097989|523923986|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145293468|NCT05097989|523923987|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145293469|NCT05097989|523923988|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
145293470|NCT05097989|523923989|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
145293471|NCT05097989|523923990|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
145293472|NCT05097989|523923991|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
145293473|NCT05097989|523923983|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293474|NCT05097989|523923984|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293475|NCT05097989|523923985|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
145293476|NCT05097989|523923986|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293477|NCT05097989|523923987|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293478|NCT05097989|523923988|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
145293479|NCT05097989|523923989|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293480|NCT05097989|523923990|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
145293481|NCT05097989|523923991|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
145293482|NCT05097989|523923983|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293483|NCT05097989|523923984|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293484|NCT05097989|523923985|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
145293485|NCT05097989|523923986|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293486|NCT05097989|523923987|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293487|NCT05097989|523923988|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293488|NCT05097989|523923989|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293489|NCT05097989|523923990|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293490|NCT05097989|523923991|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
145293491|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293492|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
145293493|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293494|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293495|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293496|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293497|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293498|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293499|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
145293500|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293501|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293502|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293503|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293504|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145293505|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293506|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293507|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293508|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145293509|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293510|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293511|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293512|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293513|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
145560196|NCT02608268|524911322|FG026|Overall Study|Progressive disease|16|||
145560197|NCT02608268|524911323|FG027|Overall Study|Progressive disease|11|||
145560198|NCT02608268|524911324|FG028|Overall Study|Progressive disease|10|||
145560199|NCT02608268|524911325|FG029|Overall Study|Progressive disease|15|||
145560200|NCT02608268|524911296|FG000|Overall Study|Subject/guardian decision|1|||
145560201|NCT02608268|524911297|FG001|Overall Study|Subject/guardian decision|1|||
145560202|NCT02608268|524911298|FG002|Overall Study|Subject/guardian decision|2|||
145560203|NCT02608268|524911299|FG003|Overall Study|Subject/guardian decision|0|||
145560204|NCT02608268|524911300|FG004|Overall Study|Subject/guardian decision|0|||
145560205|NCT02608268|524911301|FG005|Overall Study|Subject/guardian decision|0|||
145560206|NCT02608268|524911302|FG006|Overall Study|Subject/guardian decision|0|||
145560207|NCT02608268|524911303|FG007|Overall Study|Subject/guardian decision|0|||
145560208|NCT02608268|524911304|FG008|Overall Study|Subject/guardian decision|2|||
145560209|NCT02608268|524911305|FG009|Overall Study|Subject/guardian decision|2|||
145560210|NCT02608268|524911306|FG010|Overall Study|Subject/guardian decision|0|||
145560211|NCT02608268|524911307|FG011|Overall Study|Subject/guardian decision|1|||
145560212|NCT02608268|524911308|FG012|Overall Study|Subject/guardian decision|0|||
145293514|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145655506|NCT02975882|525257245|FG000|Overall Study|Physician Decision|0|||
145560213|NCT02608268|524911309|FG013|Overall Study|Subject/guardian decision|1|||
145560214|NCT02608268|524911310|FG014|Overall Study|Subject/guardian decision|0|||
145560215|NCT02608268|524911311|FG015|Overall Study|Subject/guardian decision|1|||
145560216|NCT02608268|524911312|FG016|Overall Study|Subject/guardian decision|0|||
145560217|NCT02608268|524911313|FG017|Overall Study|Subject/guardian decision|0|||
145560218|NCT02608268|524911314|FG018|Overall Study|Subject/guardian decision|1|||
145560219|NCT02608268|524911315|FG019|Overall Study|Subject/guardian decision|0|||
145560220|NCT02608268|524911316|FG020|Overall Study|Subject/guardian decision|0|||
145560221|NCT02608268|524911317|FG021|Overall Study|Subject/guardian decision|0|||
145560222|NCT02608268|524911318|FG022|Overall Study|Subject/guardian decision|1|||
145560223|NCT02608268|524911319|FG023|Overall Study|Subject/guardian decision|0|||
145560224|NCT02608268|524911320|FG024|Overall Study|Subject/guardian decision|0|||
145560225|NCT02608268|524911321|FG025|Overall Study|Subject/guardian decision|1|||
145560226|NCT02608268|524911322|FG026|Overall Study|Subject/guardian decision|1|||
145560227|NCT02608268|524911323|FG027|Overall Study|Subject/guardian decision|1|||
145560228|NCT02608268|524911324|FG028|Overall Study|Subject/guardian decision|1|||
145560229|NCT02608268|524911325|FG029|Overall Study|Subject/guardian decision|0|||
145560230|NCT01030523|524911326|FG000|Initial Study (5 Years)|Death|1|||
145560231|NCT01030523|524911327|FG001|Initial Study (5 Years)|Death|0|||
145560232|NCT01030523|524911326|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
145560233|NCT01030523|524911327|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
145560234|NCT01030523|524911326|FG000|Initial Study (5 Years)|Implant failure|1|||
145560235|NCT01030523|524911327|FG001|Initial Study (5 Years)|Implant failure|0|||
145560236|NCT01030523|524911326|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
145560237|NCT01030523|524911327|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
145560238|NCT01030523|524911326|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
145560239|NCT01030523|524911327|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
145560240|NCT01030523|524911326|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
145560241|NCT01030523|524911327|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
145560242|NCT03662542|524911330|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
145560243|NCT03662542|524911331|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560244|NCT03662542|524911332|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560245|NCT03662542|524911333|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560246|NCT03662542|524911334|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560247|NCT03662542|524911335|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560248|NCT03662542|524911336|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560249|NCT03662542|524911337|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560250|NCT03662542|524911338|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
145560251|NCT03662542|524911330|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560252|NCT03662542|524911331|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
145560253|NCT03662542|524911332|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560254|NCT03662542|524911333|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560255|NCT03662542|524911334|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560256|NCT03662542|524911335|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560257|NCT03662542|524911336|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560258|NCT03662542|524911337|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560259|NCT03662542|524911338|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
145560260|NCT03662542|524911330|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
145560261|NCT03662542|524911331|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
145560262|NCT03662542|524911332|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
145560263|NCT03662542|524911333|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
145560264|NCT03662542|524911334|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
145560265|NCT03662542|524911335|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
145560266|NCT03662542|524911336|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
145560267|NCT03662542|524911337|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
145560268|NCT03662542|524911338|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
145560269|NCT03662542|524911330|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
145560270|NCT03662542|524911331|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560271|NCT03662542|524911332|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560272|NCT03662542|524911333|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560273|NCT03662542|524911334|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560274|NCT03662542|524911335|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560275|NCT03662542|524911336|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560276|NCT03662542|524911337|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560277|NCT03662542|524911338|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
145560278|NCT03662542|524911330|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560279|NCT03662542|524911331|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560280|NCT03662542|524911332|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560281|NCT03662542|524911333|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145407919|NCT03765073|524349757|FG016|Stage 3|Withdrawal by Subject|0|||
145618407|NCT02718417|525117523|FG001|Follow-up Phase|Withdrawal by Subject|17|||
145618408|NCT02718417|525117524|FG002|Follow-up Phase|Withdrawal by Subject|5|||
145618409|NCT02718417|525117522|FG000|Follow-up Phase|Study terminated by sponsor|100|||
145618410|NCT02718417|525117523|FG001|Follow-up Phase|Study terminated by sponsor|138|||
145618411|NCT02718417|525117524|FG002|Follow-up Phase|Study terminated by sponsor|6|||
145618412|NCT02718417|525117522|FG000|Follow-up Phase|Lost to Follow-up|2|||
145618413|NCT02718417|525117523|FG001|Follow-up Phase|Lost to Follow-up|3|||
145618414|NCT02718417|525117524|FG002|Follow-up Phase|Lost to Follow-up|0|||
145618415|NCT02718417|525117522|FG000|Follow-up Phase|Death leading to discontinuation|7|||
145618416|NCT02718417|525117523|FG001|Follow-up Phase|Death leading to discontinuation|7|||
145618417|NCT02718417|525117524|FG002|Follow-up Phase|Death leading to discontinuation|3|||
145618418|NCT02718417|525117522|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
145618419|NCT02718417|525117523|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
145618420|NCT02718417|525117524|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
145618421|NCT02718417|525117522|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
145618422|NCT02718417|525117523|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
145618423|NCT02718417|525117524|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
145618424|NCT02718417|525117522|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
145618425|NCT02718417|525117523|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
145618426|NCT02718417|525117524|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
145618427|NCT02718417|525117522|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
145618428|NCT02718417|525117523|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
145618429|NCT02718417|525117524|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
145618430|NCT02718417|525117522|FG000|Long-term Follow-up Phase|Other|0|||
145618431|NCT02718417|525117523|FG001|Long-term Follow-up Phase|Other|2|||
145618432|NCT02718417|525117524|FG002|Long-term Follow-up Phase|Other|0|||
145618433|NCT01023308|525117525|FG000|Overall Study|Abnormal test proceedure results|3|||
145618434|NCT01023308|525117526|FG001|Overall Study|Abnormal test proceedure results|8|||
145618435|NCT01023308|525117525|FG000|Overall Study|Administrative problems|2|||
145618436|NCT01023308|525117526|FG001|Overall Study|Administrative problems|1|||
145618437|NCT01023308|525117525|FG000|Overall Study|Adverse Event|130|||
145618438|NCT01023308|525117526|FG001|Overall Study|Adverse Event|66|||
145618439|NCT01023308|525117525|FG000|Overall Study|Death|21|||
145618440|NCT01023308|525117526|FG001|Overall Study|Death|17|||
145618441|NCT01023308|525117525|FG000|Overall Study|Disease progression|82|||
145618442|NCT01023308|525117526|FG001|Overall Study|Disease progression|153|||
145618443|NCT01023308|525117525|FG000|Overall Study|New Cancer therapy|4|||
145618444|NCT01023308|525117526|FG001|Overall Study|New Cancer therapy|7|||
145618445|NCT01023308|525117525|FG000|Overall Study|Protocol Violation|3|||
145618446|NCT01023308|525117526|FG001|Overall Study|Protocol Violation|4|||
145618447|NCT01023308|525117525|FG000|Overall Study|Untreated|5|||
145618448|NCT01023308|525117526|FG001|Overall Study|Untreated|5|||
145618449|NCT01023308|525117525|FG000|Overall Study|Lost to Follow-up|1|||
145618450|NCT01023308|525117526|FG001|Overall Study|Lost to Follow-up|0|||
145618451|NCT01023308|525117525|FG000|Overall Study|Withdrawal by Subject|34|||
145618452|NCT01023308|525117526|FG001|Overall Study|Withdrawal by Subject|18|||
145618453|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
145618454|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
145618455|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
145618456|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
145618457|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
145618458|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
145618459|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
145618460|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
145618461|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
145618462|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
145618463|NCT01646320|525117531|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
145618464|NCT01646320|525117532|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
145618465|NCT01646320|525117531|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
145618466|NCT01646320|525117532|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
145618467|NCT01646320|525117531|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
145618468|NCT01646320|525117532|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
145618469|NCT01646320|525117531|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
145618470|NCT01646320|525117532|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
145618471|NCT01646320|525117531|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
145618472|NCT01646320|525117532|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
145618473|NCT01646320|525117531|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
145618474|NCT01646320|525117532|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
145618475|NCT02485353|525117535|FG000|Overall Study|Death|1|||
145618476|NCT02485353|525117535|FG000|Overall Study|Disease Progression|1|||
145618477|NCT03354637|525117536|FG000|Double-blind Period|Protocol Violation|2|||
145655507|NCT02975882|525257246|FG001|Overall Study|Physician Decision|2|||
145293515|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293516|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293517|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
145293518|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293519|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145293520|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293521|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145293522|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293523|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293524|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293525|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293526|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145293527|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
145293528|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
145293529|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
145293530|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
145407920|NCT03765073|524349758|FG017|Stage 3|Withdrawal by Subject|8|||
145407921|NCT03765073|524349759|FG018|Stage 3|Withdrawal by Subject|11|||
145407922|NCT03765073|524349760|FG019|Stage 3|Withdrawal by Subject|0|||
145407923|NCT03765073|524349761|FG020|Stage 3|Withdrawal by Subject|0|||
145407924|NCT03188822|524349769|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
145407925|NCT03188822|524349769|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
145407926|NCT04537299|524349770|FG000|Overall Study|Withdrawal by Subject|2|||
145407927|NCT04537299|524349771|FG001|Overall Study|Withdrawal by Subject|0|||
145560282|NCT03662542|524911334|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560283|NCT03662542|524911335|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
145560284|NCT03662542|524911336|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560285|NCT03662542|524911337|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560286|NCT03662542|524911338|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
145560287|NCT03662542|524911330|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560288|NCT03662542|524911331|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560289|NCT03662542|524911332|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560290|NCT03662542|524911333|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
145560291|NCT03662542|524911334|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
145560292|NCT03662542|524911335|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560293|NCT03662542|524911336|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560294|NCT03662542|524911337|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560295|NCT03662542|524911338|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
145560296|NCT03662542|524911330|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560297|NCT03662542|524911331|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560298|NCT03662542|524911332|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560299|NCT03662542|524911333|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
145560300|NCT03662542|524911334|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
145560301|NCT03662542|524911335|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
145560302|NCT03662542|524911336|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560303|NCT03662542|524911337|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560304|NCT03662542|524911338|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
145560305|NCT03662542|524911330|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560306|NCT03662542|524911331|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560307|NCT03662542|524911332|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560308|NCT03662542|524911333|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560309|NCT03662542|524911334|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
145560310|NCT03662542|524911335|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
145560311|NCT03662542|524911336|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560312|NCT03662542|524911337|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560313|NCT03662542|524911338|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
145560314|NCT03662542|524911330|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560315|NCT03662542|524911331|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560316|NCT03662542|524911332|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560317|NCT03662542|524911333|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560318|NCT03662542|524911334|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560319|NCT03662542|524911335|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
145560320|NCT03662542|524911336|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560321|NCT03662542|524911337|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560322|NCT03662542|524911338|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
145560323|NCT03662542|524911330|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560324|NCT03662542|524911331|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
145293531|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
145293532|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
145293533|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
145293534|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
145293535|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
145293536|NCT05097989|523923983|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
145293537|NCT05097989|523923984|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
145293538|NCT05097989|523923985|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
145293539|NCT05097989|523923986|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
145293540|NCT05097989|523923987|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
145293541|NCT05097989|523923988|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
145293542|NCT05097989|523923989|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
145293543|NCT05097989|523923990|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
145293544|NCT05097989|523923991|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
145293545|NCT05097989|523923983|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293546|NCT05097989|523923984|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293547|NCT05097989|523923985|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293548|NCT05097989|523923986|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293549|NCT05097989|523923987|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
145293550|NCT05097989|523923988|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293551|NCT05097989|523923989|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293552|NCT05097989|523923990|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293553|NCT05097989|523923991|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
145293554|NCT05097989|523923983|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
145293555|NCT05097989|523923984|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
145293556|NCT05097989|523923985|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293557|NCT05097989|523923986|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293558|NCT05097989|523923987|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293559|NCT05097989|523923988|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293560|NCT05097989|523923989|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293561|NCT05097989|523923990|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293562|NCT05097989|523923991|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
145293563|NCT05097989|523923983|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
145293564|NCT05097989|523923984|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
145293565|NCT05097989|523923985|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
145293566|NCT05097989|523923986|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
145293567|NCT05097989|523923987|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
145293568|NCT05097989|523923988|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
145293569|NCT05097989|523923989|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
145293570|NCT05097989|523923990|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
145293571|NCT05097989|523923991|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
145293572|NCT00117949|523924006|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
145293573|NCT00117949|523924007|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
145293574|NCT00117949|523924008|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
145293575|NCT00117949|523924009|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
145293576|NCT00117949|523924006|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
145293577|NCT00117949|523924007|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
145293578|NCT00117949|523924008|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
145293579|NCT00117949|523924009|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
145293580|NCT00117949|523924006|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
145293581|NCT00117949|523924007|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
145293582|NCT00117949|523924008|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
145293583|NCT00117949|523924009|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
145293584|NCT00117949|523924006|FG000|Overall Study|PSA increase >=10ng/mL|0|||
145293585|NCT00117949|523924007|FG001|Overall Study|PSA increase >=10ng/mL|1|||
145293586|NCT00117949|523924008|FG002|Overall Study|PSA increase >=10ng/mL|1|||
145293587|NCT00117949|523924009|FG003|Overall Study|PSA increase >=10ng/mL|0|||
145560325|NCT03662542|524911332|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560326|NCT03662542|524911333|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560327|NCT03662542|524911334|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560328|NCT03662542|524911335|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560329|NCT03662542|524911336|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
145560330|NCT03662542|524911337|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
145560331|NCT03662542|524911338|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
145407928|NCT04537299|524349770|FG000|Overall Study|Protocol Violation|1|||
145560332|NCT03662542|524911330|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560333|NCT03662542|524911331|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145618478|NCT03354637|525117537|FG001|Double-blind Period|Protocol Violation|0|||
145618479|NCT03354637|525117538|FG002|Double-blind Period|Protocol Violation|0|||
145618480|NCT03354637|525117536|FG000|Double-blind Period|Adverse Event|1|||
145618481|NCT03354637|525117537|FG001|Double-blind Period|Adverse Event|2|||
145618482|NCT03354637|525117538|FG002|Double-blind Period|Adverse Event|0|||
145618483|NCT03354637|525117536|FG000|Double-blind Period|Lost to Follow-up|3|||
145618484|NCT03354637|525117537|FG001|Double-blind Period|Lost to Follow-up|4|||
145618485|NCT03354637|525117538|FG002|Double-blind Period|Lost to Follow-up|3|||
145618486|NCT03354637|525117536|FG000|Double-blind Period|Withdrawal by Subject|10|||
145618487|NCT03354637|525117537|FG001|Double-blind Period|Withdrawal by Subject|6|||
145618488|NCT03354637|525117538|FG002|Double-blind Period|Withdrawal by Subject|4|||
145618489|NCT03354637|525117536|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
145618490|NCT03354637|525117537|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
145618491|NCT03354637|525117538|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
145618492|NCT03354637|525117536|FG000|Open Label Extension|Adverse Event|0|||
145618493|NCT03354637|525117537|FG001|Open Label Extension|Adverse Event|0|||
145618494|NCT03354637|525117538|FG002|Open Label Extension|Adverse Event|1|||
145618495|NCT03354637|525117536|FG000|Open Label Extension|Lost to Follow-up|0|||
145618496|NCT03354637|525117537|FG001|Open Label Extension|Lost to Follow-up|0|||
145293588|NCT00117949|523924006|FG000|Overall Study|PSA reduction <=50%|0|||
145293589|NCT00117949|523924007|FG001|Overall Study|PSA reduction <=50%|2|||
145293590|NCT00117949|523924008|FG002|Overall Study|PSA reduction <=50%|2|||
145560334|NCT03662542|524911332|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560335|NCT03662542|524911333|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560336|NCT03662542|524911334|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560337|NCT03662542|524911335|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560338|NCT03662542|524911336|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
145560339|NCT03662542|524911337|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
145560340|NCT03662542|524911338|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
145560341|NCT03662542|524911330|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560342|NCT03662542|524911331|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560343|NCT03662542|524911332|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560344|NCT03662542|524911333|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560345|NCT03662542|524911334|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560346|NCT03662542|524911335|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560347|NCT03662542|524911336|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
145560348|NCT03662542|524911337|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
145560349|NCT03662542|524911338|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
145560350|NCT03662542|524911330|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560351|NCT03662542|524911331|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560352|NCT03662542|524911332|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560353|NCT03662542|524911333|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560354|NCT03662542|524911334|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560355|NCT03662542|524911335|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
145560356|NCT03662542|524911336|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
145560357|NCT03662542|524911337|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
145560358|NCT03662542|524911338|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
145560359|NCT01217060|524911340|FG000|Overall Study|Withdrawal by Subject|1|||
145560360|NCT01994629|524911365|FG000|Overall Study|Withdrawal by Subject|1|||
145560361|NCT01994629|524911366|FG001|Overall Study|Withdrawal by Subject|0|||
145560362|NCT01994629|524911365|FG000|Overall Study|Lost to Follow-up|0|||
145560363|NCT01994629|524911366|FG001|Overall Study|Lost to Follow-up|3|||
145560364|NCT03338062|524911367|FG000|Overall Study|Alternative Therapy|1|||
145560365|NCT03338062|524911368|FG001|Overall Study|Alternative Therapy|0|||
145560366|NCT04340362|524911372|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
145560367|NCT00975481|524911375|FG000|Second Intervention Period|Adverse Event|2|||
145560368|NCT00975481|524911376|FG001|Second Intervention Period|Adverse Event|1|||
145560369|NCT00975481|524911377|FG002|Second Intervention Period|Adverse Event|0|||
145560370|NCT00975481|524911378|FG003|Second Intervention Period|Adverse Event|0|||
145560371|NCT00975481|524911379|FG004|Second Intervention Period|Adverse Event|0|||
145560372|NCT00975481|524911380|FG005|Second Intervention Period|Adverse Event|0|||
145560373|NCT00975481|524911375|FG000|Second Intervention Period|Withdrawal by Subject|0|||
145560374|NCT00975481|524911376|FG001|Second Intervention Period|Withdrawal by Subject|0|||
145560375|NCT00975481|524911377|FG002|Second Intervention Period|Withdrawal by Subject|1|||
145560376|NCT00975481|524911378|FG003|Second Intervention Period|Withdrawal by Subject|0|||
145560377|NCT00975481|524911379|FG004|Second Intervention Period|Withdrawal by Subject|0|||
145560378|NCT00975481|524911380|FG005|Second Intervention Period|Withdrawal by Subject|0|||
145560379|NCT00975481|524911375|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
145560380|NCT00975481|524911376|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
145560381|NCT00975481|524911377|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
145293591|NCT00117949|523924009|FG003|Overall Study|PSA reduction <=50%|4|||
145618497|NCT03354637|525117538|FG002|Open Label Extension|Lost to Follow-up|2|||
145618498|NCT03354637|525117536|FG000|Open Label Extension|Withdrawal by Subject|0|||
145618499|NCT03354637|525117537|FG001|Open Label Extension|Withdrawal by Subject|0|||
145618500|NCT03354637|525117538|FG002|Open Label Extension|Withdrawal by Subject|5|||
145618501|NCT03354637|525117536|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
145618502|NCT03354637|525117537|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
145618503|NCT03354637|525117538|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
145618504|NCT03354637|525117536|FG000|Open Label Extension|Subject Noncompliance|0|||
145618505|NCT03354637|525117537|FG001|Open Label Extension|Subject Noncompliance|0|||
145618506|NCT03354637|525117538|FG002|Open Label Extension|Subject Noncompliance|1|||
145618507|NCT03354637|525117536|FG000|Open Label Extension|Lack of Efficacy|0|||
145618508|NCT03354637|525117537|FG001|Open Label Extension|Lack of Efficacy|0|||
145618509|NCT03354637|525117538|FG002|Open Label Extension|Lack of Efficacy|1|||
145618510|NCT03354637|525117536|FG000|Open Label Extension|Physician Decision|0|||
145618511|NCT03354637|525117537|FG001|Open Label Extension|Physician Decision|0|||
145618512|NCT03354637|525117538|FG002|Open Label Extension|Physician Decision|1|||
145618513|NCT04006366|525117541|FG000|Overall Study|Withdrawal by Subject|1|||
145618514|NCT03249376|525117551|FG000|Overall Study|Adverse Event|11|||
145618515|NCT03249376|525117552|FG001|Overall Study|Adverse Event|5|||
145618516|NCT03249376|525117551|FG000|Overall Study|Lack of Efficacy|2|||
145618517|NCT03249376|525117552|FG001|Overall Study|Lack of Efficacy|4|||
145618518|NCT03249376|525117551|FG000|Overall Study|Protocol Violation|3|||
145618519|NCT03249376|525117552|FG001|Overall Study|Protocol Violation|2|||
145618520|NCT03249376|525117551|FG000|Overall Study|Physician Decision|0|||
145618521|NCT03249376|525117552|FG001|Overall Study|Physician Decision|2|||
145618522|NCT03249376|525117551|FG000|Overall Study|Withdrawal by Subject|3|||
145618523|NCT03249376|525117552|FG001|Overall Study|Withdrawal by Subject|9|||
145618524|NCT03249376|525117551|FG000|Overall Study|LTFU|2|||
145618525|NCT03249376|525117552|FG001|Overall Study|LTFU|1|||
145618526|NCT00627042|525117553|FG000|Overall Study|Withdrawal by Subject|2|||
145618527|NCT01154036|525117554|FG000|Phase I|Physician Decision|0|||
145618528|NCT01154036|525117555|FG001|Phase I|Physician Decision|1|||
145618529|NCT01154036|525117556|FG002|Phase I|Physician Decision|0|||
145618530|NCT01154036|525117557|FG003|Phase I|Physician Decision|0|||
145618531|NCT01154036|525117558|FG004|Phase I|Physician Decision|0|||
145618532|NCT01154036|525117559|FG005|Phase I|Physician Decision|0|||
145618533|NCT01154036|525117560|FG006|Phase I|Physician Decision|0|||
145618534|NCT01154036|525117561|FG007|Phase I|Physician Decision|0|||
145618535|NCT01154036|525117554|FG000|Phase I|Lost to Follow-up|0|||
145618536|NCT01154036|525117555|FG001|Phase I|Lost to Follow-up|3|||
145618537|NCT01154036|525117556|FG002|Phase I|Lost to Follow-up|6|||
145618538|NCT01154036|525117557|FG003|Phase I|Lost to Follow-up|0|||
145618539|NCT01154036|525117558|FG004|Phase I|Lost to Follow-up|0|||
145618540|NCT01154036|525117559|FG005|Phase I|Lost to Follow-up|0|||
145618541|NCT01154036|525117560|FG006|Phase I|Lost to Follow-up|0|||
145618542|NCT01154036|525117561|FG007|Phase I|Lost to Follow-up|0|||
145618543|NCT01154036|525117554|FG000|Phase I|Protocol Violation|0|||
145618544|NCT01154036|525117555|FG001|Phase I|Protocol Violation|3|||
145618545|NCT01154036|525117556|FG002|Phase I|Protocol Violation|9|||
145618546|NCT01154036|525117557|FG003|Phase I|Protocol Violation|0|||
145618547|NCT01154036|525117558|FG004|Phase I|Protocol Violation|0|||
145618548|NCT01154036|525117559|FG005|Phase I|Protocol Violation|0|||
145618549|NCT01154036|525117560|FG006|Phase I|Protocol Violation|0|||
145618550|NCT01154036|525117561|FG007|Phase I|Protocol Violation|0|||
145618551|NCT01154036|525117554|FG000|Phase I|Withdrawal by Subject|2|||
145618552|NCT01154036|525117555|FG001|Phase I|Withdrawal by Subject|10|||
145618553|NCT01154036|525117556|FG002|Phase I|Withdrawal by Subject|29|||
145618554|NCT01154036|525117557|FG003|Phase I|Withdrawal by Subject|0|||
145618555|NCT01154036|525117558|FG004|Phase I|Withdrawal by Subject|0|||
145618556|NCT01154036|525117559|FG005|Phase I|Withdrawal by Subject|0|||
145618557|NCT01154036|525117560|FG006|Phase I|Withdrawal by Subject|0|||
145618558|NCT01154036|525117561|FG007|Phase I|Withdrawal by Subject|0|||
145618559|NCT01154036|525117554|FG000|Phase I|Adverse Event|1|||
145618560|NCT01154036|525117555|FG001|Phase I|Adverse Event|11|||
145618561|NCT01154036|525117556|FG002|Phase I|Adverse Event|12|||
145618562|NCT01154036|525117557|FG003|Phase I|Adverse Event|0|||
145618563|NCT01154036|525117558|FG004|Phase I|Adverse Event|0|||
145618564|NCT01154036|525117559|FG005|Phase I|Adverse Event|0|||
145618565|NCT01154036|525117560|FG006|Phase I|Adverse Event|0|||
145618566|NCT01154036|525117561|FG007|Phase I|Adverse Event|0|||
145618567|NCT01154036|525117554|FG000|Phase II|Adverse Event|0|||
145618568|NCT01154036|525117555|FG001|Phase II|Adverse Event|0|||
145618569|NCT01154036|525117556|FG002|Phase II|Adverse Event|0|||
145618570|NCT01154036|525117557|FG003|Phase II|Adverse Event|0|||
145618571|NCT01154036|525117558|FG004|Phase II|Adverse Event|1|||
145618572|NCT01154036|525117559|FG005|Phase II|Adverse Event|1|||
145618573|NCT01154036|525117560|FG006|Phase II|Adverse Event|1|||
145618574|NCT01154036|525117561|FG007|Phase II|Adverse Event|1|||
145618575|NCT01154036|525117554|FG000|Phase II|Physician Decision|0|||
145618576|NCT01154036|525117555|FG001|Phase II|Physician Decision|0|||
145618577|NCT01154036|525117556|FG002|Phase II|Physician Decision|0|||
145618578|NCT01154036|525117557|FG003|Phase II|Physician Decision|0|||
145560382|NCT00975481|524911378|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
145560383|NCT00975481|524911379|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
145560384|NCT00975481|524911380|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
145560385|NCT00975481|524911375|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
145560386|NCT00975481|524911376|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
145560387|NCT00975481|524911377|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
145560388|NCT00975481|524911378|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
145560389|NCT00975481|524911379|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
145560390|NCT00975481|524911380|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
145560391|NCT02951156|524911382|FG000|Overall Study|Death|3|||
145560392|NCT02951156|524911383|FG001|Overall Study|Death|8|||
145560393|NCT02951156|524911384|FG002|Overall Study|Death|5|||
145560394|NCT02951156|524911382|FG000|Overall Study|Progressive disease|1|||
145560395|NCT02951156|524911383|FG001|Overall Study|Progressive disease|0|||
145560396|NCT02951156|524911384|FG002|Overall Study|Progressive disease|1|||
145560397|NCT02951156|524911382|FG000|Overall Study|Withdrawal by Subject|0|||
145560398|NCT02951156|524911383|FG001|Overall Study|Withdrawal by Subject|0|||
145560399|NCT02951156|524911384|FG002|Overall Study|Withdrawal by Subject|1|||
145560400|NCT02951156|524911382|FG000|Overall Study|Study terminated by sponsor|0|||
145560401|NCT02951156|524911383|FG001|Overall Study|Study terminated by sponsor|0|||
145560402|NCT02951156|524911384|FG002|Overall Study|Study terminated by sponsor|1|||
145560403|NCT02951156|524911382|FG000|Overall Study|Other|5|||
145560404|NCT02951156|524911383|FG001|Overall Study|Other|1|||
145560405|NCT02951156|524911384|FG002|Overall Study|Other|2|||
145560406|NCT04351087|524911385|FG000|Overall Study|Lost to Follow-up|7|||
145560407|NCT04351087|524911386|FG001|Overall Study|Lost to Follow-up|3|||
145560408|NCT04351087|524911385|FG000|Overall Study|Withdrawal by Subject|3|||
145560409|NCT04351087|524911386|FG001|Overall Study|Withdrawal by Subject|4|||
145560410|NCT04351087|524911385|FG000|Overall Study|Lack of Efficacy|3|||
145560411|NCT04351087|524911386|FG001|Overall Study|Lack of Efficacy|2|||
145560412|NCT05517382|524911387|FG000|Overall Study|Lost to Follow-up|0|||
145560413|NCT05517382|524911388|FG001|Overall Study|Lost to Follow-up|1|||
145560414|NCT01374087|524911393|FG000|Overall Study|Adverse Event|1|||
145560415|NCT01374087|524911394|FG001|Overall Study|Adverse Event|0|||
145560416|NCT01374087|524911393|FG000|Overall Study|Disease progression|2|||
145560417|NCT01374087|524911394|FG001|Overall Study|Disease progression|2|||
145560418|NCT01374087|524911393|FG000|Overall Study|Study discontinued|13|||
145560419|NCT01374087|524911394|FG001|Overall Study|Study discontinued|13|||
145560420|NCT00624052|524911397|FG000|Overall Study|Adverse Event|7|||
145560421|NCT00624052|524911398|FG001|Overall Study|Adverse Event|6|||
145560422|NCT00624052|524911399|FG002|Overall Study|Adverse Event|0|||
145560423|NCT00624052|524911400|FG003|Overall Study|Adverse Event|3|||
145560424|NCT00624052|524911397|FG000|Overall Study|Lack of Efficacy|1|||
145560425|NCT00624052|524911398|FG001|Overall Study|Lack of Efficacy|1|||
145560426|NCT00624052|524911399|FG002|Overall Study|Lack of Efficacy|0|||
145560427|NCT00624052|524911400|FG003|Overall Study|Lack of Efficacy|0|||
145560428|NCT00624052|524911397|FG000|Overall Study|Lost to Follow-up|2|||
145560429|NCT00624052|524911398|FG001|Overall Study|Lost to Follow-up|3|||
145560430|NCT00624052|524911399|FG002|Overall Study|Lost to Follow-up|1|||
145560431|NCT00624052|524911400|FG003|Overall Study|Lost to Follow-up|0|||
145560432|NCT00624052|524911397|FG000|Overall Study|Non compliant with the protocol|2|||
145560433|NCT00624052|524911398|FG001|Overall Study|Non compliant with the protocol|1|||
145560434|NCT00624052|524911399|FG002|Overall Study|Non compliant with the protocol|1|||
145560435|NCT00624052|524911400|FG003|Overall Study|Non compliant with the protocol|1|||
145560436|NCT00624052|524911397|FG000|Overall Study|Consent withdrawn|3|||
145560437|NCT00624052|524911398|FG001|Overall Study|Consent withdrawn|1|||
145560438|NCT00624052|524911399|FG002|Overall Study|Consent withdrawn|1|||
145560439|NCT00624052|524911400|FG003|Overall Study|Consent withdrawn|0|||
145560440|NCT00624052|524911397|FG000|Overall Study|Changed job/ran out if meds|0|||
145560441|NCT00624052|524911398|FG001|Overall Study|Changed job/ran out if meds|2|||
145560442|NCT00624052|524911399|FG002|Overall Study|Changed job/ran out if meds|0|||
145560443|NCT00624052|524911400|FG003|Overall Study|Changed job/ran out if meds|0|||
145560444|NCT03839212|524911406|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
145560445|NCT00679263|524911407|FG000|Visit 2/Dose 1|Adverse Event|1|||
145560446|NCT00679263|524911408|FG001|Visit 2/Dose 1|Adverse Event|0|||
145560447|NCT00679263|524911409|FG002|Visit 2/Dose 1|Adverse Event|0|||
145560448|NCT00679263|524911407|FG000|Visit 2/Dose 1|subject not compliance|1|||
145560449|NCT00679263|524911408|FG001|Visit 2/Dose 1|subject not compliance|1|||
145560450|NCT00679263|524911409|FG002|Visit 2/Dose 1|subject not compliance|0|||
145560451|NCT05104567|524911410|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145560452|NCT05104567|524911411|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
145560453|NCT05104567|524911412|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145560454|NCT05104567|524911413|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145560455|NCT05104567|524911414|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145560456|NCT05104567|524911415|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145293592|NCT00117949|523924006|FG000|Overall Study|Hepatic abnormalities|0|||
145293593|NCT00117949|523924007|FG001|Overall Study|Hepatic abnormalities|1|||
145293594|NCT00117949|523924008|FG002|Overall Study|Hepatic abnormalities|0|||
145293595|NCT00117949|523924009|FG003|Overall Study|Hepatic abnormalities|1|||
145293596|NCT00264810|523924016|FG000|Baseline|Withdrawal by Subject|10|||
145293597|NCT00264810|523924017|FG001|Baseline|Withdrawal by Subject|10|||
145293598|NCT00264810|523924016|FG000|Baseline|Physician Decision|7|||
145293599|NCT00264810|523924017|FG001|Baseline|Physician Decision|8|||
145293600|NCT00264810|523924016|FG000|Baseline|Subject Compliance Failure|3|||
145293601|NCT00264810|523924017|FG001|Baseline|Subject Compliance Failure|3|||
145293602|NCT00264810|523924016|FG000|Baseline|Insufficient Seizure Frequency|2|||
145293603|NCT00264810|523924017|FG001|Baseline|Insufficient Seizure Frequency|2|||
145293604|NCT00264810|523924016|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
145293605|NCT00264810|523924017|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
145618579|NCT01154036|525117558|FG004|Phase II|Physician Decision|0|||
145618580|NCT01154036|525117559|FG005|Phase II|Physician Decision|0|||
145618581|NCT01154036|525117560|FG006|Phase II|Physician Decision|1|||
145618582|NCT01154036|525117561|FG007|Phase II|Physician Decision|0|||
145618583|NCT01154036|525117554|FG000|Phase II|Lost to Follow-up|0|||
145618584|NCT01154036|525117555|FG001|Phase II|Lost to Follow-up|0|||
145293606|NCT00264810|523924016|FG000|Baseline|Other|0|||
145293607|NCT00264810|523924017|FG001|Baseline|Other|1|||
145293608|NCT00264810|523924016|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
145293609|NCT00264810|523924017|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
145293610|NCT00264810|523924016|FG000|Stimulation Optimization Period|Death|0|||
145293611|NCT00264810|523924017|FG001|Stimulation Optimization Period|Death|1|||
145293612|NCT00264810|523924016|FG000|Blinded Evaluation Period|Explant due to infection|1|||
145293613|NCT00264810|523924017|FG001|Blinded Evaluation Period|Explant due to infection|1|||
145293614|NCT00264810|523924016|FG000|Open Label Evaluation Period|Explant due to infection|1|||
145293615|NCT00264810|523924017|FG001|Open Label Evaluation Period|Explant due to infection|1|||
145293616|NCT00264810|523924016|FG000|Open Label Evaluation Period|Death|3|||
145618585|NCT01154036|525117556|FG002|Phase II|Lost to Follow-up|0|||
145618586|NCT01154036|525117557|FG003|Phase II|Lost to Follow-up|1|||
145618587|NCT01154036|525117558|FG004|Phase II|Lost to Follow-up|2|||
145618588|NCT01154036|525117559|FG005|Phase II|Lost to Follow-up|0|||
145618589|NCT01154036|525117560|FG006|Phase II|Lost to Follow-up|2|||
145618590|NCT01154036|525117561|FG007|Phase II|Lost to Follow-up|1|||
145618591|NCT01154036|525117554|FG000|Phase II|Protocol Violation|0|||
145618592|NCT01154036|525117555|FG001|Phase II|Protocol Violation|0|||
145618593|NCT01154036|525117556|FG002|Phase II|Protocol Violation|0|||
145618594|NCT01154036|525117557|FG003|Phase II|Protocol Violation|0|||
145618595|NCT01154036|525117558|FG004|Phase II|Protocol Violation|1|||
145618596|NCT01154036|525117559|FG005|Phase II|Protocol Violation|2|||
145618597|NCT01154036|525117560|FG006|Phase II|Protocol Violation|0|||
145618598|NCT01154036|525117561|FG007|Phase II|Protocol Violation|0|||
145618599|NCT01154036|525117554|FG000|Phase II|Withdrawal by Subject|0|||
145618600|NCT01154036|525117555|FG001|Phase II|Withdrawal by Subject|0|||
145618601|NCT01154036|525117556|FG002|Phase II|Withdrawal by Subject|0|||
145618602|NCT01154036|525117557|FG003|Phase II|Withdrawal by Subject|0|||
145618603|NCT01154036|525117558|FG004|Phase II|Withdrawal by Subject|4|||
145618604|NCT01154036|525117559|FG005|Phase II|Withdrawal by Subject|2|||
145618605|NCT01154036|525117560|FG006|Phase II|Withdrawal by Subject|5|||
145618606|NCT01154036|525117561|FG007|Phase II|Withdrawal by Subject|4|||
145618607|NCT01567163|525117566|FG000|Overall Study|Progressive Disease|2|||
145618608|NCT01567163|525117566|FG000|Overall Study|Lost to Follow-up|2|||
145618609|NCT01458249|525117568|FG000|Overall Study|Not treated|1|||
145618610|NCT01458249|525117568|FG000|Overall Study|Adverse Event|4|||
145618611|NCT01458249|525117568|FG000|Overall Study|Other|2|||
145618612|NCT01458249|525117568|FG000|Overall Study|Ongoing|1|||
145618613|NCT02056119|525117569|FG000|Overall Study|Death|1|||
145293617|NCT00264810|523924017|FG001|Open Label Evaluation Period|Death|2|||
145293618|NCT00264810|523924016|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
145293619|NCT00264810|523924017|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
145293620|NCT01658943|523924020|FG000|Overall Study|Adverse Event|6|||
145293621|NCT01658943|523924021|FG001|Overall Study|Adverse Event|13|||
145293622|NCT01658943|523924020|FG000|Overall Study|Withdrawal by Subject|9|||
145293623|NCT01658943|523924021|FG001|Overall Study|Withdrawal by Subject|2|||
145293624|NCT01658943|523924020|FG000|Overall Study|Progression/Relapse|39|||
145618614|NCT02056119|525117570|FG001|Overall Study|Death|2|||
145618615|NCT02056119|525117569|FG000|Overall Study|Intubated for less than 24 hrs|2|||
145618616|NCT02056119|525117570|FG001|Overall Study|Intubated for less than 24 hrs|7|||
145618617|NCT02056119|525117569|FG000|Overall Study|No aerosol treatments were given.|3|||
145293625|NCT01658943|523924021|FG001|Overall Study|Progression/Relapse|40|||
145293626|NCT01658943|523924020|FG000|Overall Study|Death|4|||
145293627|NCT01658943|523924021|FG001|Overall Study|Death|2|||
145618618|NCT02056119|525117570|FG001|Overall Study|No aerosol treatments were given.|2|||
145618619|NCT02056119|525117569|FG000|Overall Study|Received Metaneb treatment|0|||
145618620|NCT02056119|525117570|FG001|Overall Study|Received Metaneb treatment|2|||
145293628|NCT01658943|523924020|FG000|Overall Study|not protocol specified|4|||
145293629|NCT01658943|523924021|FG001|Overall Study|not protocol specified|1|||
145293630|NCT01658943|523924020|FG000|Overall Study|Not eligible|7|||
145293631|NCT01658943|523924021|FG001|Overall Study|Not eligible|9|||
145293632|NCT01658943|523924020|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
145293633|NCT01658943|523924021|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
145293634|NCT03309956|523924022|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
145293635|NCT05067504|523924023|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
145293636|NCT05067504|523924024|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
145293637|NCT05067504|523924023|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
145293638|NCT05067504|523924024|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
145293639|NCT05067504|523924023|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
145293640|NCT05067504|523924024|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
145293641|NCT01210001|523925528|FG000|Overall Study|Not treated|1|||
145293642|NCT01210001|523925529|FG001|Overall Study|Not treated|0|||
145293643|NCT01210001|523925530|FG002|Overall Study|Not treated|0|||
145293644|NCT01210001|523925528|FG000|Overall Study|Adverse Event|4|||
145293645|NCT01210001|523925529|FG001|Overall Study|Adverse Event|2|||
145293646|NCT01210001|523925530|FG002|Overall Study|Adverse Event|5|||
145293647|NCT01210001|523925528|FG000|Overall Study|Non compliant with protocol|2|||
145293648|NCT01210001|523925529|FG001|Overall Study|Non compliant with protocol|2|||
145293649|NCT01210001|523925530|FG002|Overall Study|Non compliant with protocol|3|||
145293650|NCT01210001|523925528|FG000|Overall Study|Lost to Follow-up|4|||
145293651|NCT01210001|523925529|FG001|Overall Study|Lost to Follow-up|3|||
145293652|NCT01210001|523925530|FG002|Overall Study|Lost to Follow-up|2|||
145293653|NCT01210001|523925528|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
145293654|NCT01210001|523925529|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
145293655|NCT01210001|523925530|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
145293656|NCT01210001|523925528|FG000|Overall Study|Other reason not defined above|2|||
145293657|NCT01210001|523925529|FG001|Overall Study|Other reason not defined above|2|||
145293658|NCT01210001|523925530|FG002|Overall Study|Other reason not defined above|1|||
145293659|NCT00788125|523925531|FG000|Overall Study|Death|6|||
145560457|NCT05104567|524911416|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
145560458|NCT05104567|524911410|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
145560459|NCT05104567|524911411|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
145560460|NCT05104567|524911412|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
145560461|NCT05104567|524911413|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
145560462|NCT05104567|524911414|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
145560463|NCT05104567|524911415|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
145560464|NCT05104567|524911416|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
145560465|NCT05104567|524911410|FG000|Overall Study|Progressive disease|3|||
145560466|NCT05104567|524911411|FG001|Overall Study|Progressive disease|13|||
145560467|NCT05104567|524911412|FG002|Overall Study|Progressive disease|13|||
145560468|NCT05104567|524911413|FG003|Overall Study|Progressive disease|17|||
145560469|NCT05104567|524911414|FG004|Overall Study|Progressive disease|17|||
145560470|NCT05104567|524911415|FG005|Overall Study|Progressive disease|28|||
145560471|NCT05104567|524911416|FG006|Overall Study|Progressive disease|24|||
145560472|NCT05104567|524911410|FG000|Overall Study|Withdrawal by Subject|1|||
145560473|NCT05104567|524911411|FG001|Overall Study|Withdrawal by Subject|1|||
145560474|NCT05104567|524911412|FG002|Overall Study|Withdrawal by Subject|2|||
145560475|NCT05104567|524911413|FG003|Overall Study|Withdrawal by Subject|0|||
145560476|NCT05104567|524911414|FG004|Overall Study|Withdrawal by Subject|0|||
145560477|NCT05104567|524911415|FG005|Overall Study|Withdrawal by Subject|0|||
145560478|NCT05104567|524911416|FG006|Overall Study|Withdrawal by Subject|0|||
145560479|NCT05104567|524911410|FG000|Overall Study|Other|1|||
145560480|NCT05104567|524911411|FG001|Overall Study|Other|1|||
145560481|NCT05104567|524911412|FG002|Overall Study|Other|1|||
145560482|NCT05104567|524911413|FG003|Overall Study|Other|0|||
145560483|NCT05104567|524911414|FG004|Overall Study|Other|0|||
145560484|NCT05104567|524911415|FG005|Overall Study|Other|0|||
145560485|NCT05104567|524911416|FG006|Overall Study|Other|0|||
145560486|NCT01464346|524911420|FG000|Overall Study|Withdrawal by Subject|0|||
145560487|NCT01464346|524911421|FG001|Overall Study|Withdrawal by Subject|0|||
145560488|NCT01464346|524911422|FG002|Overall Study|Withdrawal by Subject|1|||
145560489|NCT02295995|524911423|FG000|Overall Study|Lost to Follow-up|5|||
145560490|NCT02295995|524911424|FG001|Overall Study|Lost to Follow-up|1|||
145293660|NCT02180711|523925536|FG000|Overall Study|Death|0|||
145293661|NCT02180711|523925537|FG001|Overall Study|Death|1|||
145293662|NCT02180711|523925538|FG002|Overall Study|Death|0|||
145407929|NCT04537299|524349771|FG001|Overall Study|Protocol Violation|1|||
145407930|NCT03034967|524349776|FG000|Overall Study|Withdrawal by Subject|9|||
145560491|NCT01498458|524911426|FG000|Overall Study|Adverse Event|4|||
145560492|NCT01498458|524911426|FG000|Overall Study|Physician Decision|3|||
145560493|NCT02005250|524911427|FG000|Overall Study|Lost to Follow-up|15|||
145560494|NCT02005250|524911428|FG001|Overall Study|Lost to Follow-up|5|||
145560495|NCT03188094|524911433|FG000|Overall Study|Screen failure|1|||
145293663|NCT02180711|523925539|FG003|Overall Study|Death|0|||
145293664|NCT02180711|523925540|FG004|Overall Study|Death|7|||
145293665|NCT02180711|523925541|FG005|Overall Study|Death|0|||
145293666|NCT02180711|523925542|FG006|Overall Study|Death|1|||
145293667|NCT02180711|523925543|FG007|Overall Study|Death|3|||
145293668|NCT02180711|523925536|FG000|Overall Study|Lost to Follow-up|0|||
145293669|NCT02180711|523925537|FG001|Overall Study|Lost to Follow-up|1|||
145293670|NCT02180711|523925538|FG002|Overall Study|Lost to Follow-up|0|||
145293671|NCT02180711|523925539|FG003|Overall Study|Lost to Follow-up|0|||
145293672|NCT02180711|523925540|FG004|Overall Study|Lost to Follow-up|1|||
145293673|NCT02180711|523925541|FG005|Overall Study|Lost to Follow-up|1|||
145293674|NCT02180711|523925542|FG006|Overall Study|Lost to Follow-up|0|||
145293675|NCT02180711|523925543|FG007|Overall Study|Lost to Follow-up|3|||
145293676|NCT02180711|523925536|FG000|Overall Study|Withdrawal by Subject|2|||
145293677|NCT02180711|523925537|FG001|Overall Study|Withdrawal by Subject|1|||
145293678|NCT02180711|523925538|FG002|Overall Study|Withdrawal by Subject|0|||
145293679|NCT02180711|523925539|FG003|Overall Study|Withdrawal by Subject|4|||
145293680|NCT02180711|523925540|FG004|Overall Study|Withdrawal by Subject|3|||
145560496|NCT03188094|524911434|FG001|Overall Study|Screen failure|0|||
145560497|NCT03188094|524911435|FG002|Overall Study|Screen failure|0|||
145560498|NCT03188094|524911433|FG000|Overall Study|Pregnancy|3|||
145560499|NCT03188094|524911434|FG001|Overall Study|Pregnancy|0|||
145560500|NCT03188094|524911435|FG002|Overall Study|Pregnancy|0|||
145560501|NCT03188094|524911433|FG000|Overall Study|Ineligible|1|||
145560502|NCT03188094|524911434|FG001|Overall Study|Ineligible|0|||
145560503|NCT03188094|524911435|FG002|Overall Study|Ineligible|0|||
145560504|NCT03188094|524911433|FG000|Overall Study|Lost to Follow-up|0|||
145560505|NCT03188094|524911434|FG001|Overall Study|Lost to Follow-up|0|||
145560506|NCT03188094|524911435|FG002|Overall Study|Lost to Follow-up|17|||
145560507|NCT04007094|524911436|FG000|Overall Study|Lost to Follow-up|1|||
145560508|NCT04007094|524911437|FG001|Overall Study|Lost to Follow-up|1|||
145560509|NCT04350788|524911443|FG000|Overall Study|Lost to Follow-up|6|||
145560510|NCT04350788|524911444|FG001|Overall Study|Lost to Follow-up|2|||
145560511|NCT04350788|524911443|FG000|Overall Study|Withdrawal by Subject|2|||
145560512|NCT04350788|524911444|FG001|Overall Study|Withdrawal by Subject|4|||
145560513|NCT04350788|524911443|FG000|Overall Study|Protocol Violation|4|||
145560514|NCT04350788|524911444|FG001|Overall Study|Protocol Violation|0|||
145560515|NCT01581307|524911445|FG000|Overall Study|Withdrawal by Subject|1|||
145560516|NCT00378209|524911448|FG000|Overall Study|Progressive disease|11|||
145560517|NCT00378209|524911448|FG000|Overall Study|Adverse Event|3|||
145560518|NCT00378209|524911448|FG000|Overall Study|Initiation of non-protocol therapy|3|||
145560519|NCT00378209|524911448|FG000|Overall Study|Physician Decision|3|||
145560520|NCT00378209|524911448|FG000|Overall Study|Death|1|||
145560521|NCT00378209|524911448|FG000|Overall Study|Treatment delay|1|||
145560522|NCT02070744|524911451|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
145560523|NCT02070744|524911452|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
145560524|NCT02070744|524911453|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
145560525|NCT02070744|524911454|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
145560526|NCT02070744|524911455|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
145560527|NCT02070744|524911451|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
145560528|NCT02070744|524911452|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
145560529|NCT02070744|524911453|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
145560530|NCT02070744|524911454|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
145560531|NCT02070744|524911455|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
145560532|NCT02070744|524911451|FG000|OLE Phase (48 Weeks)|Other|0|||
145560533|NCT02070744|524911452|FG001|OLE Phase (48 Weeks)|Other|0|||
145560534|NCT02070744|524911453|FG002|OLE Phase (48 Weeks)|Other|0|||
145560535|NCT02070744|524911454|FG003|OLE Phase (48 Weeks)|Other|0|||
145560536|NCT02070744|524911455|FG004|OLE Phase (48 Weeks)|Other|1|||
145560537|NCT01894581|524911456|FG000|Overall Study|Withdrawal by Subject|2|||
145560538|NCT01894581|524911457|FG001|Overall Study|Withdrawal by Subject|3|||
145560539|NCT01894581|524911456|FG000|Overall Study|Screen Failure|3|||
145560540|NCT01894581|524911457|FG001|Overall Study|Screen Failure|4|||
145560541|NCT03795298|524911461|FG000|Overall Study|Death|34|||
145560542|NCT03795298|524911462|FG001|Overall Study|Death|29|||
145560543|NCT03795298|524911461|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
145560544|NCT03795298|524911462|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
145560545|NCT03795298|524911461|FG000|Overall Study|Lost to Follow-up|28|||
145293681|NCT02180711|523925541|FG005|Overall Study|Withdrawal by Subject|0|||
145560546|NCT03795298|524911462|FG001|Overall Study|Lost to Follow-up|17|||
145560547|NCT03795298|524911461|FG000|Overall Study|Physician Decision|5|||
145560548|NCT03795298|524911462|FG001|Overall Study|Physician Decision|4|||
145560549|NCT03795298|524911461|FG000|Overall Study|Withdrawal by Subject|43|||
145560550|NCT03795298|524911462|FG001|Overall Study|Withdrawal by Subject|28|||
145560551|NCT03795298|524911461|FG000|Overall Study|Reason not reported|7|||
145618621|NCT02056119|525117569|FG000|Overall Study|Protocol Violation|4|||
145293682|NCT02180711|523925542|FG006|Overall Study|Withdrawal by Subject|3|||
145293683|NCT02180711|523925543|FG007|Overall Study|Withdrawal by Subject|2|||
145560552|NCT03795298|524911462|FG001|Overall Study|Reason not reported|9|||
145618622|NCT02056119|525117570|FG001|Overall Study|Protocol Violation|7|||
145560553|NCT01252940|524911463|FG000|Main Study Phase|Randomized but not treated|4|||
145560554|NCT01252940|524911464|FG001|Main Study Phase|Randomized but not treated|2|||
145560555|NCT01252940|524911463|FG000|Main Study Phase|Adverse Event|3|||
145560556|NCT01252940|524911464|FG001|Main Study Phase|Adverse Event|1|||
145560557|NCT01252940|524911463|FG000|Main Study Phase|Lack of Efficacy|1|||
145560558|NCT01252940|524911464|FG001|Main Study Phase|Lack of Efficacy|0|||
145560559|NCT01252940|524911463|FG000|Main Study Phase|Lost to Follow-up|6|||
145560560|NCT01252940|524911464|FG001|Main Study Phase|Lost to Follow-up|1|||
145560561|NCT01252940|524911463|FG000|Main Study Phase|Physician Decision|1|||
145560562|NCT01252940|524911464|FG001|Main Study Phase|Physician Decision|0|||
145560563|NCT01252940|524911463|FG000|Main Study Phase|Protocol Violation|4|||
145560564|NCT01252940|524911464|FG001|Main Study Phase|Protocol Violation|2|||
145560565|NCT01252940|524911463|FG000|Main Study Phase|Withdrawal by Subject|6|||
145560566|NCT01252940|524911464|FG001|Main Study Phase|Withdrawal by Subject|5|||
145560567|NCT01252940|524911463|FG000|Main Study Phase|Subject Non-compliance|1|||
145560568|NCT01252940|524911464|FG001|Main Study Phase|Subject Non-compliance|1|||
145560569|NCT01252940|524911463|FG000|Extension Phase|Adverse Event|2|||
145560570|NCT01252940|524911464|FG001|Extension Phase|Adverse Event|1|||
145560571|NCT01252940|524911463|FG000|Extension Phase|Lack of Efficacy|1|||
145560572|NCT01252940|524911464|FG001|Extension Phase|Lack of Efficacy|0|||
145560573|NCT01252940|524911463|FG000|Extension Phase|Lost to Follow-up|5|||
145560574|NCT01252940|524911464|FG001|Extension Phase|Lost to Follow-up|0|||
145560575|NCT01252940|524911463|FG000|Extension Phase|Physician Decision|0|||
145560576|NCT01252940|524911464|FG001|Extension Phase|Physician Decision|1|||
145560577|NCT01252940|524911463|FG000|Extension Phase|Subject Non-compliance|1|||
145560578|NCT01252940|524911464|FG001|Extension Phase|Subject Non-compliance|0|||
145560579|NCT01252940|524911463|FG000|Extension Phase|Withdrawal by Subject|1|||
145560580|NCT01252940|524911464|FG001|Extension Phase|Withdrawal by Subject|1|||
145560581|NCT04199117|524911465|FG000|Overall Study|Withdrawal by Subject|3|||
145560582|NCT04199117|524911466|FG001|Overall Study|Withdrawal by Subject|0|||
145560583|NCT04199117|524911467|FG002|Overall Study|Withdrawal by Subject|0|||
145560584|NCT04199117|524911468|FG003|Overall Study|Withdrawal by Subject|1|||
145560585|NCT04199117|524911469|FG004|Overall Study|Withdrawal by Subject|1|||
145560586|NCT04199117|524911470|FG005|Overall Study|Withdrawal by Subject|0|||
145560587|NCT04199117|524911471|FG006|Overall Study|Withdrawal by Subject|0|||
145560588|NCT04199117|524911472|FG007|Overall Study|Withdrawal by Subject|2|||
145560589|NCT04199117|524911473|FG008|Overall Study|Withdrawal by Subject|0|||
145560590|NCT04199117|524911474|FG009|Overall Study|Withdrawal by Subject|0|||
145560591|NCT04199117|524911475|FG010|Overall Study|Withdrawal by Subject|1|||
145560592|NCT04199117|524911476|FG011|Overall Study|Withdrawal by Subject|1|||
145560593|NCT04199117|524911477|FG012|Overall Study|Withdrawal by Subject|2|||
145560594|NCT04199117|524911478|FG013|Overall Study|Withdrawal by Subject|1|||
145560595|NCT04199117|524911479|FG014|Overall Study|Withdrawal by Subject|1|||
145560596|NCT04199117|524911480|FG015|Overall Study|Withdrawal by Subject|1|||
145560597|NCT04199117|524911465|FG000|Overall Study|Death|1|||
145560598|NCT04199117|524911466|FG001|Overall Study|Death|1|||
145560599|NCT04199117|524911467|FG002|Overall Study|Death|0|||
145560600|NCT04199117|524911468|FG003|Overall Study|Death|0|||
145560601|NCT04199117|524911469|FG004|Overall Study|Death|0|||
145560602|NCT04199117|524911470|FG005|Overall Study|Death|0|||
145560603|NCT04199117|524911471|FG006|Overall Study|Death|0|||
145560604|NCT04199117|524911472|FG007|Overall Study|Death|0|||
145560605|NCT04199117|524911473|FG008|Overall Study|Death|0|||
145560606|NCT04199117|524911474|FG009|Overall Study|Death|0|||
145560607|NCT04199117|524911475|FG010|Overall Study|Death|0|||
145560608|NCT04199117|524911476|FG011|Overall Study|Death|1|||
145560609|NCT04199117|524911477|FG012|Overall Study|Death|0|||
145560610|NCT04199117|524911478|FG013|Overall Study|Death|1|||
145560611|NCT04199117|524911479|FG014|Overall Study|Death|0|||
145560612|NCT04199117|524911480|FG015|Overall Study|Death|0|||
145560613|NCT04199117|524911465|FG000|Overall Study|Withdrawal by PI|0|||
145560614|NCT04199117|524911466|FG001|Overall Study|Withdrawal by PI|0|||
145560615|NCT04199117|524911467|FG002|Overall Study|Withdrawal by PI|0|||
145560616|NCT04199117|524911468|FG003|Overall Study|Withdrawal by PI|0|||
145560617|NCT04199117|524911469|FG004|Overall Study|Withdrawal by PI|0|||
145560618|NCT04199117|524911470|FG005|Overall Study|Withdrawal by PI|0|||
145560619|NCT04199117|524911471|FG006|Overall Study|Withdrawal by PI|0|||
145560620|NCT04199117|524911472|FG007|Overall Study|Withdrawal by PI|0|||
145560621|NCT04199117|524911473|FG008|Overall Study|Withdrawal by PI|0|||
145560622|NCT04199117|524911474|FG009|Overall Study|Withdrawal by PI|0|||
145560623|NCT04199117|524911475|FG010|Overall Study|Withdrawal by PI|0|||
145560624|NCT04199117|524911476|FG011|Overall Study|Withdrawal by PI|0|||
145560625|NCT04199117|524911477|FG012|Overall Study|Withdrawal by PI|1|||
145560626|NCT04199117|524911478|FG013|Overall Study|Withdrawal by PI|0|||
145560627|NCT04199117|524911479|FG014|Overall Study|Withdrawal by PI|0|||
145560628|NCT04199117|524911480|FG015|Overall Study|Withdrawal by PI|0|||
145560629|NCT04383743|524911481|FG000|Overall Study|Withdrawal by Subject|1|||
145560630|NCT04383743|524911481|FG000|Overall Study|Adverse Event|1|||
145618623|NCT03220737|525117571|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
145618624|NCT03220737|525117572|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
145618625|NCT03220737|525117573|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
145618626|NCT03220737|525117574|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
145618627|NCT03220737|525117575|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
145618628|NCT03220737|525117576|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
145618629|NCT03220737|525117577|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
145618630|NCT03220737|525117571|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
145618631|NCT03220737|525117572|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
145618632|NCT03220737|525117573|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
145618633|NCT03220737|525117574|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
145618634|NCT03220737|525117575|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
145618635|NCT03220737|525117576|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
145618636|NCT03220737|525117577|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
145618637|NCT03220737|525117571|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
145618638|NCT03220737|525117572|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
145618639|NCT03220737|525117573|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
145618640|NCT03220737|525117574|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
145618641|NCT03220737|525117575|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
145618642|NCT03220737|525117576|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
145293684|NCT02180711|523925536|FG000|Overall Study|- Disease Progression|0|||
145293685|NCT02180711|523925537|FG001|Overall Study|- Disease Progression|1|||
145293686|NCT02180711|523925538|FG002|Overall Study|- Disease Progression|0|||
145293687|NCT02180711|523925539|FG003|Overall Study|- Disease Progression|0|||
145293688|NCT02180711|523925540|FG004|Overall Study|- Disease Progression|0|||
145293689|NCT02180711|523925541|FG005|Overall Study|- Disease Progression|0|||
145293690|NCT02180711|523925542|FG006|Overall Study|- Disease Progression|0|||
145293691|NCT02180711|523925543|FG007|Overall Study|- Disease Progression|0|||
145293692|NCT02180711|523925536|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
145293693|NCT02180711|523925537|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
145618643|NCT03220737|525117577|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
145618644|NCT03220737|525117571|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618645|NCT03220737|525117572|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618646|NCT03220737|525117573|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
145618647|NCT03220737|525117574|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618648|NCT03220737|525117575|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618649|NCT03220737|525117576|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618650|NCT03220737|525117577|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
145618651|NCT03220737|525117571|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145618652|NCT03220737|525117572|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145618653|NCT03220737|525117573|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145618654|NCT03220737|525117574|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145618655|NCT03220737|525117575|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
145618656|NCT03220737|525117576|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145293694|NCT02180711|523925538|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
145293695|NCT02180711|523925539|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
145293696|NCT02180711|523925540|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
145293697|NCT02180711|523925541|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
145293698|NCT02180711|523925542|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
145293699|NCT02180711|523925543|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
145293700|NCT02180711|523925536|FG000|Overall Study|- Study Terminated by Sponsor|2|||
145293701|NCT02180711|523925537|FG001|Overall Study|- Study Terminated by Sponsor|3|||
145293702|NCT02180711|523925538|FG002|Overall Study|- Study Terminated by Sponsor|0|||
145293703|NCT02180711|523925539|FG003|Overall Study|- Study Terminated by Sponsor|5|||
145293704|NCT02180711|523925540|FG004|Overall Study|- Study Terminated by Sponsor|32|||
145293705|NCT02180711|523925541|FG005|Overall Study|- Study Terminated by Sponsor|0|||
145293706|NCT02180711|523925542|FG006|Overall Study|- Study Terminated by Sponsor|4|||
145293707|NCT02180711|523925543|FG007|Overall Study|- Study Terminated by Sponsor|13|||
145293708|NCT02180711|523925536|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
145293709|NCT02180711|523925537|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
145293710|NCT02180711|523925538|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
145293711|NCT02180711|523925539|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
145293712|NCT02180711|523925540|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
145293713|NCT02180711|523925541|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
145293714|NCT02180711|523925542|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
145618657|NCT03220737|525117577|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
145618658|NCT03220737|525117571|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
145618659|NCT03220737|525117572|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145293715|NCT02180711|523925543|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
145293716|NCT02180711|523925536|FG000|Overall Study|- Other|1|||
145293717|NCT02180711|523925537|FG001|Overall Study|- Other|0|||
145293718|NCT02180711|523925538|FG002|Overall Study|- Other|0|||
145293719|NCT02180711|523925539|FG003|Overall Study|- Other|1|||
145293720|NCT02180711|523925540|FG004|Overall Study|- Other|0|||
145293721|NCT02180711|523925541|FG005|Overall Study|- Other|0|||
145293722|NCT02180711|523925542|FG006|Overall Study|- Other|0|||
145293723|NCT02180711|523925543|FG007|Overall Study|- Other|0|||
145293724|NCT03805438|523925550|FG000|Overall Study|Lack of Efficacy|1|||
145293725|NCT03805438|523925550|FG000|Overall Study|Protocol Violation|1|||
145293726|NCT01374919|523925551|FG000|Overall Study|Withdrawal by Subject|2|||
145293727|NCT00366899|523925552|FG000|Infant Series|Withdrawal by Subject|4|||
145293728|NCT00366899|523925553|FG001|Infant Series|Withdrawal by Subject|7|||
145293729|NCT00366899|523925552|FG000|Infant Series|Protocol Violation|2|||
145293730|NCT00366899|523925553|FG001|Infant Series|Protocol Violation|1|||
145293731|NCT00366899|523925552|FG000|Infant Series|Failed to return|1|||
145293732|NCT00366899|523925553|FG001|Infant Series|Failed to return|1|||
145293733|NCT00366899|523925552|FG000|Infant Series|Lost to Follow-up|0|||
145293734|NCT00366899|523925553|FG001|Infant Series|Lost to Follow-up|2|||
145293735|NCT00366899|523925552|FG000|Infant Series|Adverse Event|0|||
145293736|NCT00366899|523925553|FG001|Infant Series|Adverse Event|1|||
145293737|NCT00366899|523925552|FG000|Infant Series|Physician Decision|1|||
145293738|NCT00366899|523925553|FG001|Infant Series|Physician Decision|0|||
145293739|NCT00366899|523925552|FG000|Infant Series|Randomized but not consented|1|||
145293740|NCT00366899|523925553|FG001|Infant Series|Randomized but not consented|0|||
145293741|NCT00366899|523925552|FG000|After Infant Series|Lost to Follow-up|4|||
145293742|NCT00366899|523925553|FG001|After Infant Series|Lost to Follow-up|3|||
145293743|NCT00366899|523925552|FG000|After Infant Series|Withdrawal by Subject|1|||
145293744|NCT00366899|523925553|FG001|After Infant Series|Withdrawal by Subject|4|||
145293745|NCT00366899|523925552|FG000|After Infant Series|Adverse Event|1|||
145407931|NCT03034967|524349777|FG001|Overall Study|Withdrawal by Subject|2|||
145560631|NCT05478252|524911484|FG000|Overall Study|Withdrawal by Subject|2|||
145560632|NCT05478252|524911485|FG001|Overall Study|Withdrawal by Subject|3|||
145560633|NCT05478252|524911484|FG000|Overall Study|Lost to Follow-up|4|||
145560634|NCT05478252|524911485|FG001|Overall Study|Lost to Follow-up|2|||
145560635|NCT05478252|524911484|FG000|Overall Study|Physician Decision|1|||
145560636|NCT05478252|524911485|FG001|Overall Study|Physician Decision|1|||
145560637|NCT05478252|524911484|FG000|Overall Study|Death|1|||
145560638|NCT05478252|524911485|FG001|Overall Study|Death|0|||
145560639|NCT01536379|524912781|FG000|Overall Study|Adverse Event|1|||
145560640|NCT01536379|524912782|FG001|Overall Study|Adverse Event|2|||
145560641|NCT01536379|524912781|FG000|Overall Study|Withdrawal by Subject|1|||
145560642|NCT01536379|524912782|FG001|Overall Study|Withdrawal by Subject|1|||
145560643|NCT04439253|524912791|FG000|Overall Study|Adverse Event|1|||
145560644|NCT04439253|524912791|FG000|Overall Study|Disease progression|2|||
145560645|NCT04439253|524912791|FG000|Overall Study|Complicating disease|1|||
145560646|NCT03971695|524912792|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560647|NCT03971695|524912793|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560648|NCT03971695|524912794|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560649|NCT03971695|524912795|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
145560650|NCT03971695|524912796|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
145560651|NCT03971695|524912797|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560652|NCT03971695|524912798|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560653|NCT03971695|524912799|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560654|NCT03971695|524912800|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
145560655|NCT03971695|524912801|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
145560656|NCT03971695|524912802|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
145560657|NCT03971695|524912803|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
145560658|NCT03971695|524912804|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
145560659|NCT00939809|524912805|FG000|Overall Study|Adverse Event|2|||
145560660|NCT00939809|524912805|FG000|Overall Study|Death|1|||
145560661|NCT04447417|524912806|FG000|Overall Study|Withdrawal by Subject|1|||
145560662|NCT04447417|524912807|FG001|Overall Study|Withdrawal by Subject|0|||
145560663|NCT04447417|524912806|FG000|Overall Study|Failure to meet inclusion criteria|1|||
145560664|NCT04447417|524912807|FG001|Overall Study|Failure to meet inclusion criteria|0|||
145618660|NCT03220737|525117573|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145407932|NCT03034967|524349778|FG002|Overall Study|Withdrawal by Subject|6|||
145293746|NCT00366899|523925553|FG001|After Infant Series|Adverse Event|2|||
145293747|NCT00366899|523925552|FG000|After Infant Series|Protocol Violation|1|||
145293748|NCT00366899|523925553|FG001|After Infant Series|Protocol Violation|0|||
145293749|NCT00366899|523925552|FG000|Toddler Dose|Withdrawal by Subject|1|||
145293750|NCT00366899|523925553|FG001|Toddler Dose|Withdrawal by Subject|1|||
145618661|NCT03220737|525117574|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145618662|NCT03220737|525117575|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145618663|NCT03220737|525117576|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145618664|NCT03220737|525117577|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
145618665|NCT03220737|525117571|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
145618666|NCT03220737|525117572|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618667|NCT03220737|525117573|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618668|NCT03220737|525117574|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618669|NCT03220737|525117575|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618670|NCT03220737|525117576|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618671|NCT03220737|525117577|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
145618672|NCT03220737|525117571|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
145618673|NCT03220737|525117572|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618674|NCT03220737|525117573|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618675|NCT03220737|525117574|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618676|NCT03220737|525117575|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618677|NCT03220737|525117576|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618678|NCT03220737|525117577|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
145618679|NCT01720797|525117578|FG000|Overall Study|Withdrawal by Subject|3|||
145618680|NCT01720797|525117579|FG001|Overall Study|Withdrawal by Subject|0|||
145618681|NCT00983619|525117586|FG000|Overall Study|Lost to Follow-up|0|||
145618682|NCT00983619|525117587|FG001|Overall Study|Lost to Follow-up|1|||
145618683|NCT00983619|525117588|FG002|Overall Study|Lost to Follow-up|0|||
145618684|NCT00983619|525117589|FG003|Overall Study|Lost to Follow-up|0|||
145618685|NCT00983619|525117590|FG004|Overall Study|Lost to Follow-up|0|||
145618686|NCT00983619|525117591|FG005|Overall Study|Lost to Follow-up|2|||
145618687|NCT00983619|525117592|FG006|Overall Study|Lost to Follow-up|0|||
145618688|NCT00983619|525117593|FG007|Overall Study|Lost to Follow-up|0|||
145618689|NCT00983619|525117594|FG008|Overall Study|Lost to Follow-up|0|||
145618690|NCT00983619|525117595|FG009|Overall Study|Lost to Follow-up|0|||
145618691|NCT00983619|525117596|FG010|Overall Study|Lost to Follow-up|0|||
145618692|NCT00983619|525117597|FG011|Overall Study|Lost to Follow-up|2|||
145618693|NCT00983619|525117586|FG000|Overall Study|Withdrawal by Subject|2|||
145618694|NCT00983619|525117587|FG001|Overall Study|Withdrawal by Subject|1|||
145618695|NCT00983619|525117588|FG002|Overall Study|Withdrawal by Subject|1|||
145618696|NCT00983619|525117589|FG003|Overall Study|Withdrawal by Subject|3|||
145618697|NCT00983619|525117590|FG004|Overall Study|Withdrawal by Subject|1|||
145618698|NCT00983619|525117591|FG005|Overall Study|Withdrawal by Subject|23|||
145618699|NCT00983619|525117592|FG006|Overall Study|Withdrawal by Subject|0|||
145618700|NCT00983619|525117593|FG007|Overall Study|Withdrawal by Subject|0|||
145618701|NCT00983619|525117594|FG008|Overall Study|Withdrawal by Subject|0|||
145618702|NCT00983619|525117595|FG009|Overall Study|Withdrawal by Subject|0|||
145618703|NCT00983619|525117596|FG010|Overall Study|Withdrawal by Subject|1|||
145618704|NCT00983619|525117597|FG011|Overall Study|Withdrawal by Subject|1|||
145618705|NCT00983619|525117586|FG000|Overall Study|Death|0|||
145618706|NCT00983619|525117587|FG001|Overall Study|Death|2|||
145618707|NCT00983619|525117588|FG002|Overall Study|Death|2|||
145618708|NCT00983619|525117589|FG003|Overall Study|Death|1|||
145618709|NCT00983619|525117590|FG004|Overall Study|Death|2|||
145618710|NCT00983619|525117591|FG005|Overall Study|Death|30|||
145618711|NCT00983619|525117592|FG006|Overall Study|Death|1|||
145618712|NCT00983619|525117593|FG007|Overall Study|Death|0|||
145618713|NCT00983619|525117594|FG008|Overall Study|Death|1|||
145618714|NCT00983619|525117595|FG009|Overall Study|Death|2|||
145618715|NCT00983619|525117596|FG010|Overall Study|Death|9|||
145618716|NCT00983619|525117597|FG011|Overall Study|Death|8|||
145618717|NCT00983619|525117586|FG000|Overall Study|Other|1|||
145618718|NCT00983619|525117587|FG001|Overall Study|Other|0|||
145618719|NCT00983619|525117588|FG002|Overall Study|Other|0|||
145618720|NCT00983619|525117589|FG003|Overall Study|Other|1|||
145618721|NCT00983619|525117590|FG004|Overall Study|Other|0|||
145618722|NCT00983619|525117591|FG005|Overall Study|Other|12|||
145618723|NCT00983619|525117592|FG006|Overall Study|Other|2|||
145618724|NCT00983619|525117593|FG007|Overall Study|Other|2|||
145618725|NCT00983619|525117594|FG008|Overall Study|Other|0|||
145618726|NCT00983619|525117595|FG009|Overall Study|Other|1|||
145618727|NCT00983619|525117596|FG010|Overall Study|Other|1|||
145618728|NCT00983619|525117597|FG011|Overall Study|Other|0|||
145618729|NCT04827134|525117598|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
145618730|NCT04827134|525117599|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
145618731|NCT04827134|525117600|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
145618732|NCT04827134|525117601|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
145618733|NCT02443103|525117602|FG000|Overall Study|Adverse Event|2|||
145618734|NCT02443103|525117602|FG000|Overall Study|Noncompliance|1|||
145618735|NCT03824938|525117609|FG000|Overall Study|Withdrawal by Subject|2|||
145618736|NCT03824938|525117610|FG001|Overall Study|Withdrawal by Subject|1|||
145618737|NCT03824938|525117611|FG002|Overall Study|Withdrawal by Subject|0|||
145618738|NCT03824938|525117612|FG003|Overall Study|Withdrawal by Subject|2|||
145618739|NCT03824938|525117613|FG004|Overall Study|Withdrawal by Subject|0|||
145618740|NCT03824938|525117614|FG005|Overall Study|Withdrawal by Subject|1|||
145618741|NCT03824938|525117609|FG000|Overall Study|Lost to Follow-up|0|||
145618742|NCT03824938|525117610|FG001|Overall Study|Lost to Follow-up|1|||
145618743|NCT03824938|525117611|FG002|Overall Study|Lost to Follow-up|0|||
145618744|NCT03824938|525117612|FG003|Overall Study|Lost to Follow-up|0|||
145618745|NCT03824938|525117613|FG004|Overall Study|Lost to Follow-up|1|||
145618746|NCT03824938|525117614|FG005|Overall Study|Lost to Follow-up|0|||
145618747|NCT01058863|525117615|FG000|Overall Study|Lost to Follow-up|1|||
145618748|NCT01058863|525117615|FG000|Overall Study|Withdrawal by Subject|1|||
145618749|NCT01058863|525117615|FG000|Overall Study|Sponsor requested withdrawal|1|||
145618750|NCT01058863|525117615|FG000|Overall Study|Randomized in error|1|||
145618751|NCT03055832|525117616|FG000|Week 2|Withdrawal by Subject|1|||
145618752|NCT03055832|525117617|FG001|Week 2|Withdrawal by Subject|0|||
145618753|NCT04242875|525117618|FG000|Overall Study|Adverse Event|2|||
145618754|NCT02397460|525117619|FG000|Treatment Period 2|Adverse Event|0|||
145618755|NCT02397460|525117620|FG001|Treatment Period 2|Adverse Event|0|||
145618756|NCT02397460|525117621|FG002|Treatment Period 2|Adverse Event|0|||
145618757|NCT02397460|525117622|FG003|Treatment Period 2|Adverse Event|0|||
145618758|NCT02397460|525117623|FG004|Treatment Period 2|Adverse Event|0|||
145618759|NCT02397460|525117624|FG005|Treatment Period 2|Adverse Event|0|||
145618760|NCT02397460|525117625|FG006|Treatment Period 2|Adverse Event|0|||
145618761|NCT02397460|525117626|FG007|Treatment Period 2|Adverse Event|1|||
145618762|NCT02397460|525117619|FG000|Treatment Period 4|Adverse Event|0|||
145618763|NCT02397460|525117620|FG001|Treatment Period 4|Adverse Event|1|||
145618764|NCT02397460|525117621|FG002|Treatment Period 4|Adverse Event|0|||
145618765|NCT02397460|525117622|FG003|Treatment Period 4|Adverse Event|0|||
145618766|NCT02397460|525117623|FG004|Treatment Period 4|Adverse Event|0|||
145618767|NCT02397460|525117624|FG005|Treatment Period 4|Adverse Event|0|||
145618768|NCT02397460|525117625|FG006|Treatment Period 4|Adverse Event|0|||
145618769|NCT02397460|525117626|FG007|Treatment Period 4|Adverse Event|0|||
145560665|NCT04447417|524912806|FG000|Overall Study|Lost to Follow-up|1|||
145560666|NCT04447417|524912807|FG001|Overall Study|Lost to Follow-up|0|||
145560667|NCT00858442|524912812|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
145560668|NCT00858442|524912813|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
145560669|NCT02155738|524912816|FG000|Overall Study|Missing critical information|1|||
145560670|NCT02155738|524912817|FG001|Overall Study|Missing critical information|0|||
145560671|NCT02155738|524912818|FG002|Overall Study|Missing critical information|0|||
145560672|NCT02155738|524912819|FG003|Overall Study|Missing critical information|1|||
145560673|NCT02016625|524912820|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
145560674|NCT02016625|524912821|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
145560675|NCT02016625|524912820|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
145560676|NCT02016625|524912821|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
145560677|NCT02016625|524912820|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
145618770|NCT02397460|525117619|FG000|Treatment Period 4|Physician Decision|0|||
145618771|NCT02397460|525117620|FG001|Treatment Period 4|Physician Decision|0|||
145618772|NCT02397460|525117621|FG002|Treatment Period 4|Physician Decision|0|||
145618773|NCT02397460|525117622|FG003|Treatment Period 4|Physician Decision|0|||
145618774|NCT02397460|525117623|FG004|Treatment Period 4|Physician Decision|1|||
145618775|NCT02397460|525117624|FG005|Treatment Period 4|Physician Decision|0|||
145618776|NCT02397460|525117625|FG006|Treatment Period 4|Physician Decision|0|||
145618777|NCT02397460|525117626|FG007|Treatment Period 4|Physician Decision|0|||
145407933|NCT03034967|524349779|FG003|Overall Study|Withdrawal by Subject|6|||
145560678|NCT02016625|524912821|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
145618778|NCT02819479|525119119|FG000|Overall Study|Adverse Event|2|||
145618779|NCT00839917|525119122|FG000|Overall Study|Lost to Follow-up|1|||
145618780|NCT00839917|525119123|FG001|Overall Study|Lost to Follow-up|0|||
145618781|NCT00839917|525119122|FG000|Overall Study|Did not receive vaccine|0|||
145618782|NCT00839917|525119123|FG001|Overall Study|Did not receive vaccine|1|||
145560679|NCT02356783|524912823|FG000|Overall Study|Lost to Follow-up|1|||
145560680|NCT02356783|524912824|FG001|Overall Study|Lost to Follow-up|3|||
145560681|NCT02603809|524912825|FG000|Overall Study|Withdrawal by Subject|4|||
145560682|NCT02603809|524912826|FG001|Overall Study|Withdrawal by Subject|1|||
145560683|NCT02603809|524912827|FG002|Overall Study|Withdrawal by Subject|2|||
145560684|NCT02603809|524912828|FG003|Overall Study|Withdrawal by Subject|3|||
145560685|NCT02603809|524912829|FG004|Overall Study|Withdrawal by Subject|3|||
145293751|NCT00366899|523925552|FG000|Toddler Dose|Protocol Violation|1|||
145293752|NCT00366899|523925553|FG001|Toddler Dose|Protocol Violation|0|||
145293753|NCT02848326|523925554|FG000|Treatment Period|Adverse Event|5|||
145293754|NCT02848326|523925555|FG001|Treatment Period|Adverse Event|4|||
145293755|NCT02848326|523925556|FG002|Treatment Period|Adverse Event|11|||
145293756|NCT02848326|523925557|FG003|Treatment Period|Adverse Event|6|||
145293757|NCT02848326|523925558|FG004|Treatment Period|Adverse Event|5|||
145293758|NCT02848326|523925559|FG005|Treatment Period|Adverse Event|7|||
145293759|NCT02848326|523925554|FG000|Treatment Period|Withdrawal of Consent|20|||
145293760|NCT02848326|523925555|FG001|Treatment Period|Withdrawal of Consent|6|||
145560686|NCT02603809|524912830|FG005|Overall Study|Withdrawal by Subject|4|||
145293761|NCT02848326|523925556|FG002|Treatment Period|Withdrawal of Consent|9|||
145293762|NCT02848326|523925557|FG003|Treatment Period|Withdrawal of Consent|6|||
145293763|NCT02848326|523925558|FG004|Treatment Period|Withdrawal of Consent|9|||
145293764|NCT02848326|523925559|FG005|Treatment Period|Withdrawal of Consent|6|||
145293765|NCT02848326|523925554|FG000|Treatment Period|Lost to Follow-up|5|||
145293766|NCT02848326|523925555|FG001|Treatment Period|Lost to Follow-up|1|||
145293767|NCT02848326|523925556|FG002|Treatment Period|Lost to Follow-up|11|||
145293768|NCT02848326|523925557|FG003|Treatment Period|Lost to Follow-up|7|||
145293769|NCT02848326|523925558|FG004|Treatment Period|Lost to Follow-up|2|||
145293770|NCT02848326|523925559|FG005|Treatment Period|Lost to Follow-up|3|||
145293771|NCT02848326|523925554|FG000|Treatment Period|Pregnancy|0|||
145293772|NCT02848326|523925555|FG001|Treatment Period|Pregnancy|0|||
145293773|NCT02848326|523925556|FG002|Treatment Period|Pregnancy|1|||
145293774|NCT02848326|523925557|FG003|Treatment Period|Pregnancy|1|||
145293775|NCT02848326|523925558|FG004|Treatment Period|Pregnancy|0|||
145293776|NCT02848326|523925559|FG005|Treatment Period|Pregnancy|1|||
145293777|NCT02848326|523925554|FG000|Treatment Period|Protocol Violation|4|||
145293778|NCT02848326|523925555|FG001|Treatment Period|Protocol Violation|3|||
145293779|NCT02848326|523925556|FG002|Treatment Period|Protocol Violation|4|||
145293780|NCT02848326|523925557|FG003|Treatment Period|Protocol Violation|2|||
145293781|NCT02848326|523925558|FG004|Treatment Period|Protocol Violation|3|||
145293782|NCT02848326|523925559|FG005|Treatment Period|Protocol Violation|3|||
145293783|NCT02848326|523925554|FG000|Treatment Period|Non-compliance with Study Drug|4|||
145293784|NCT02848326|523925555|FG001|Treatment Period|Non-compliance with Study Drug|0|||
145293785|NCT02848326|523925556|FG002|Treatment Period|Non-compliance with Study Drug|0|||
145293786|NCT02848326|523925557|FG003|Treatment Period|Non-compliance with Study Drug|1|||
145293787|NCT02848326|523925558|FG004|Treatment Period|Non-compliance with Study Drug|0|||
145293788|NCT02848326|523925559|FG005|Treatment Period|Non-compliance with Study Drug|0|||
145560687|NCT02603809|524912825|FG000|Overall Study|Lost to Follow-up|2|||
145560688|NCT02603809|524912826|FG001|Overall Study|Lost to Follow-up|3|||
145560689|NCT02603809|524912827|FG002|Overall Study|Lost to Follow-up|1|||
145560690|NCT02603809|524912828|FG003|Overall Study|Lost to Follow-up|4|||
145560691|NCT02603809|524912829|FG004|Overall Study|Lost to Follow-up|2|||
145560692|NCT02603809|524912830|FG005|Overall Study|Lost to Follow-up|2|||
145560693|NCT02603809|524912825|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
145560694|NCT02603809|524912826|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
145560695|NCT02603809|524912827|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
145560696|NCT02603809|524912828|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
145560697|NCT02603809|524912829|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
145560698|NCT02603809|524912830|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
145560699|NCT02603809|524912825|FG000|Overall Study|Physician Decision|0|||
145560700|NCT02603809|524912826|FG001|Overall Study|Physician Decision|0|||
145560701|NCT02603809|524912827|FG002|Overall Study|Physician Decision|0|||
145560702|NCT02603809|524912828|FG003|Overall Study|Physician Decision|1|||
145560703|NCT02603809|524912829|FG004|Overall Study|Physician Decision|2|||
145560704|NCT02603809|524912830|FG005|Overall Study|Physician Decision|1|||
145560705|NCT02603809|524912825|FG000|Overall Study|Adverse Event|3|||
145560706|NCT02603809|524912826|FG001|Overall Study|Adverse Event|0|||
145560707|NCT02603809|524912827|FG002|Overall Study|Adverse Event|2|||
145560708|NCT02603809|524912828|FG003|Overall Study|Adverse Event|2|||
145560709|NCT02603809|524912829|FG004|Overall Study|Adverse Event|1|||
145560710|NCT02603809|524912830|FG005|Overall Study|Adverse Event|1|||
145293789|NCT02848326|523925554|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
145293790|NCT02848326|523925555|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
145293791|NCT02848326|523925556|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
145560711|NCT02603809|524912825|FG000|Overall Study|Lack of Efficacy|0|||
145560712|NCT02603809|524912826|FG001|Overall Study|Lack of Efficacy|1|||
145293792|NCT02848326|523925557|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
145560713|NCT02603809|524912827|FG002|Overall Study|Lack of Efficacy|0|||
145560714|NCT02603809|524912828|FG003|Overall Study|Lack of Efficacy|0|||
145560715|NCT02603809|524912829|FG004|Overall Study|Lack of Efficacy|0|||
145560716|NCT02603809|524912830|FG005|Overall Study|Lack of Efficacy|1|||
145560717|NCT04608500|524912833|FG000|Overall Study|Adverse Event|2|||
145560718|NCT04608500|524912834|FG001|Overall Study|Adverse Event|0|||
145560719|NCT04608500|524912833|FG000|Overall Study|Lost to Follow-up|15|||
145560720|NCT04608500|524912834|FG001|Overall Study|Lost to Follow-up|9|||
145560721|NCT04608500|524912833|FG000|Overall Study|Participant request|11|||
145560722|NCT04608500|524912834|FG001|Overall Study|Participant request|7|||
145293793|NCT02848326|523925558|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
145560723|NCT04608500|524912833|FG000|Overall Study|Protocol Violation|1|||
145560724|NCT04608500|524912834|FG001|Overall Study|Protocol Violation|0|||
145560725|NCT04608500|524912833|FG000|Overall Study|Other|6|||
145560726|NCT04608500|524912834|FG001|Overall Study|Other|2|||
145560727|NCT01881230|524912835|FG000|Overall Study|Death|2|||
145293794|NCT02848326|523925559|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
145293795|NCT02848326|523925554|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
145293796|NCT02848326|523925555|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
145293797|NCT02848326|523925556|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
145293798|NCT02848326|523925557|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
145293799|NCT02848326|523925558|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
145293800|NCT02848326|523925559|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
145293801|NCT00414466|523925560|FG000|Overall Study|Adverse Event|0|||
145293802|NCT00414466|523925561|FG001|Overall Study|Adverse Event|0|||
145293803|NCT00414466|523925562|FG002|Overall Study|Adverse Event|1|||
145293804|NCT00414466|523925563|FG003|Overall Study|Adverse Event|1|||
145293805|NCT00414466|523925560|FG000|Overall Study|Lack of Efficacy|1|||
145293806|NCT00414466|523925561|FG001|Overall Study|Lack of Efficacy|0|||
145293807|NCT00414466|523925562|FG002|Overall Study|Lack of Efficacy|0|||
145293808|NCT00414466|523925563|FG003|Overall Study|Lack of Efficacy|0|||
145293809|NCT00414466|523925560|FG000|Overall Study|Withdrawn by Sponsor|1|||
145293810|NCT00414466|523925561|FG001|Overall Study|Withdrawn by Sponsor|0|||
145293811|NCT00414466|523925562|FG002|Overall Study|Withdrawn by Sponsor|0|||
145293812|NCT00414466|523925563|FG003|Overall Study|Withdrawn by Sponsor|0|||
145293813|NCT03480425|523925565|FG000|Overall Study|Force transducer technical failure|1|||
145293814|NCT01451762|523925566|FG000|Overall Study|Lost to Follow-up|3|||
145293815|NCT01451762|523925567|FG001|Overall Study|Lost to Follow-up|6|||
145293816|NCT01451762|523925568|FG002|Overall Study|Lost to Follow-up|6|||
145293817|NCT00630305|523925569|FG000|Overall Study|Withdrawal by Subject|1|||
145293818|NCT00630305|523925569|FG000|Overall Study|Inability to insert contact lens|1|||
145293819|NCT00376220|523925574|FG000|Overall Study|Lost to Follow-up|7|||
145293820|NCT00376220|523925575|FG001|Overall Study|Lost to Follow-up|10|||
145293821|NCT00376220|523925574|FG000|Overall Study|Withdrawal by Subject|3|||
145293822|NCT00376220|523925575|FG001|Overall Study|Withdrawal by Subject|2|||
145293823|NCT02564263|523925578|FG000|Overall Study|Adverse Event|31|||
145293824|NCT02564263|523925579|FG001|Overall Study|Adverse Event|29|||
145293825|NCT02564263|523925578|FG000|Overall Study|Death|270|||
145293826|NCT02564263|523925579|FG001|Overall Study|Death|262|||
145293827|NCT02564263|523925578|FG000|Overall Study|Withdrawal by Subject|4|||
145293828|NCT02564263|523925579|FG001|Overall Study|Withdrawal by Subject|19|||
145293829|NCT02564263|523925578|FG000|Overall Study|Sponsor's decision|9|||
145293830|NCT02564263|523925579|FG001|Overall Study|Sponsor's decision|4|||
145293831|NCT03311646|523925580|FG000|Overall Study|Physician Decision|1|||
145293832|NCT03311646|523925580|FG000|Overall Study|Withdrawal by Subject|5|||
145293833|NCT03311646|523925580|FG000|Overall Study|Lost to Follow-up|5|||
145293834|NCT03311646|523925580|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
145293835|NCT00531206|523925581|FG000|Overall Study|Adverse Event related|5|||
145293836|NCT00531206|523925581|FG000|Overall Study|Lack of Efficacy|2|||
145293837|NCT00531206|523925581|FG000|Overall Study|Lost to Follow-up|5|||
145293838|NCT00531206|523925581|FG000|Overall Study|including non-related adverse events|8|||
145293839|NCT00720096|523925582|FG000|Overall Study|Withdrawal by Subject|0|||
145293840|NCT00720096|523925583|FG001|Overall Study|Withdrawal by Subject|2|||
145293841|NCT04557124|523925584|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
145293842|NCT04557124|523925585|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
145293843|NCT04557124|523925584|FG000|Mid-point (1 Month)|Missed testing|5|||
145560728|NCT01881230|524912836|FG001|Overall Study|Death|0|||
145293844|NCT04557124|523925585|FG001|Mid-point (1 Month)|Missed testing|4|||
145293845|NCT04557124|523925584|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
145293846|NCT04557124|523925585|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
145407934|NCT03034967|524349780|FG004|Overall Study|Withdrawal by Subject|9|||
145560729|NCT01881230|524912837|FG002|Overall Study|Death|1|||
145293847|NCT04557124|523925584|FG000|Post-testing (2 Months)|Missed testing|1|||
145293848|NCT04557124|523925585|FG001|Post-testing (2 Months)|Missed testing|5|||
145293849|NCT04557124|523925584|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
145293850|NCT04557124|523925585|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
145293851|NCT04557124|523925584|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
145293852|NCT04557124|523925585|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
145293853|NCT00001849|523925586|FG000|Overall Study|Death|4|||
145560730|NCT01881230|524912835|FG000|Overall Study|Adverse Event|9|||
145293854|NCT00001849|523925586|FG000|Overall Study|Lost to Follow-up|2|||
145560731|NCT01881230|524912836|FG001|Overall Study|Adverse Event|13|||
145293855|NCT00001849|523925586|FG000|Overall Study|Withdrawal by Subject|2|||
145293856|NCT00001849|523925586|FG000|Overall Study|tumor remained occult|6|||
145293857|NCT03127137|523925590|FG000|Overall Study|Requested sedation after consent|1|||
145293858|NCT03127137|523925591|FG001|Overall Study|Requested sedation after consent|0|||
145293859|NCT03127137|523925590|FG000|Overall Study|Malfunction in electronic data collection|1|||
145293860|NCT03127137|523925591|FG001|Overall Study|Malfunction in electronic data collection|0|||
145293861|NCT03127137|523925590|FG000|Overall Study|Post procedure testing could not be obtained|0|||
145293862|NCT03127137|523925591|FG001|Overall Study|Post procedure testing could not be obtained|1|||
145293863|NCT02319148|523925595|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
145293864|NCT02319148|523925596|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
145293865|NCT02319148|523925597|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
145293866|NCT02319148|523925598|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
145293867|NCT02319148|523925595|FG000|Second Intervention Period|No longer willing to participate|0|||
145293868|NCT02319148|523925596|FG001|Second Intervention Period|No longer willing to participate|1|||
145293869|NCT02319148|523925597|FG002|Second Intervention Period|No longer willing to participate|0|||
145293870|NCT02319148|523925598|FG003|Second Intervention Period|No longer willing to participate|0|||
145293871|NCT02319148|523925595|FG000|Second Intervention Period|Other|0|||
145293872|NCT02319148|523925596|FG001|Second Intervention Period|Other|0|||
145293873|NCT02319148|523925597|FG002|Second Intervention Period|Other|0|||
145293874|NCT02319148|523925598|FG003|Second Intervention Period|Other|1|||
145293875|NCT00264797|523925599|FG000|Overall Study|Withdrawal by Subject|11|||
145293876|NCT00264797|523925600|FG001|Overall Study|Withdrawal by Subject|11|||
145293877|NCT00264797|523925599|FG000|Overall Study|Lost to Follow-up|9|||
145293878|NCT00264797|523925600|FG001|Overall Study|Lost to Follow-up|17|||
145293879|NCT00264797|523925599|FG000|Overall Study|Moved from area|3|||
145293880|NCT00264797|523925600|FG001|Overall Study|Moved from area|1|||
145293881|NCT00264797|523925599|FG000|Overall Study|Practical Problems|2|||
145560732|NCT01881230|524912837|FG002|Overall Study|Adverse Event|12|||
145293882|NCT00264797|523925600|FG001|Overall Study|Practical Problems|3|||
145293883|NCT00264797|523925599|FG000|Overall Study|Incarceration|4|||
145293884|NCT00264797|523925600|FG001|Overall Study|Incarceration|5|||
145293885|NCT00264797|523925599|FG000|Overall Study|Pressure/advice from Outsiders|1|||
145293886|NCT00264797|523925600|FG001|Overall Study|Pressure/advice from Outsiders|1|||
145293887|NCT00264797|523925599|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
145293888|NCT00264797|523925600|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
145293889|NCT00264797|523925599|FG000|Overall Study|Other|3|||
145293890|NCT00264797|523925600|FG001|Overall Study|Other|4|||
145293891|NCT02388763|523925603|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
145560733|NCT01881230|524912835|FG000|Overall Study|Progressive Disease|31|||
145560734|NCT01881230|524912836|FG001|Overall Study|Progressive Disease|35|||
145560735|NCT01881230|524912837|FG002|Overall Study|Progressive Disease|36|||
145560736|NCT01881230|524912835|FG000|Overall Study|Symptomatic Deterioration|3|||
145560737|NCT01881230|524912836|FG001|Overall Study|Symptomatic Deterioration|3|||
145560738|NCT01881230|524912837|FG002|Overall Study|Symptomatic Deterioration|1|||
145293892|NCT02388763|523925604|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
145293893|NCT02388763|523925603|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
145655508|NCT02975882|525257247|FG002|Overall Study|Physician Decision|4|||
145560739|NCT01881230|524912835|FG000|Overall Study|Withdrawal by Subject|6|||
145293894|NCT02388763|523925604|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
145293895|NCT05518487|523925605|FG000|Overall Study|Withdrawal by Subject|3|||
145293896|NCT01458405|523925608|FG000|Phase 1 (up to 12 Months)|Other|0|||
145293897|NCT01458405|523925609|FG001|Phase 1 (up to 12 Months)|Other|1|||
145293898|NCT01458405|523925610|FG002|Phase 1 (up to 12 Months)|Other|0|||
145293899|NCT01458405|523925611|FG003|Phase 1 (up to 12 Months)|Other|0|||
145293900|NCT01458405|523925608|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
145293901|NCT01458405|523925609|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
145293902|NCT01458405|523925610|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
145293903|NCT01458405|523925611|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
145293904|NCT01458405|523925608|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
145293905|NCT01458405|523925609|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
145293906|NCT01458405|523925610|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
145293907|NCT01458405|523925611|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
145293908|NCT01458405|523925608|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
145293909|NCT01458405|523925609|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
145293910|NCT01458405|523925610|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
145293911|NCT01458405|523925611|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
145293912|NCT02194998|523925614|FG000|On-HCV Treatment|Did not pick up study medication|0|||
145293913|NCT02194998|523925615|FG001|On-HCV Treatment|Did not pick up study medication|1|||
145293914|NCT02194998|523925616|FG002|On-HCV Treatment|Did not pick up study medication|0|||
145293915|NCT02194998|523925617|FG003|On-HCV Treatment|Did not pick up study medication|0|||
145293916|NCT02194998|523925614|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
145293917|NCT02194998|523925615|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
145293918|NCT02194998|523925616|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
145293919|NCT02194998|523925617|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
145293920|NCT01249664|523925618|FG000|Overall Study|Withdrawal by Subject|5|||
145293921|NCT01249664|523925619|FG001|Overall Study|Withdrawal by Subject|0|||
145293922|NCT01249664|523925618|FG000|Overall Study|Adverse Event|1|||
145293923|NCT01249664|523925619|FG001|Overall Study|Adverse Event|0|||
145293924|NCT00762086|523925622|FG000|Overall Study|Adverse Event|2|||
145293925|NCT00762086|523925623|FG001|Overall Study|Adverse Event|0|||
145293926|NCT00762086|523925622|FG000|Overall Study|Lost to Follow-up|0|||
145293927|NCT00762086|523925623|FG001|Overall Study|Lost to Follow-up|2|||
145293928|NCT00762086|523925622|FG000|Overall Study|Non compliance|1|||
145293929|NCT00762086|523925623|FG001|Overall Study|Non compliance|0|||
145293930|NCT00762086|523925622|FG000|Overall Study|Withdrawal by Subject|2|||
145293931|NCT00762086|523925623|FG001|Overall Study|Withdrawal by Subject|2|||
145293932|NCT00762086|523925622|FG000|Overall Study|Ineligible to participate in the study|1|||
145293933|NCT00762086|523925623|FG001|Overall Study|Ineligible to participate in the study|0|||
145293934|NCT00860405|523925624|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
145293935|NCT00860405|523925625|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
145293936|NCT01074554|523925627|FG000|Overall Study|Adverse Event|3|||
145293937|NCT01074554|523925628|FG001|Overall Study|Adverse Event|3|||
145293938|NCT01074554|523925627|FG000|Overall Study|Lost to Follow-up|0|||
145407935|NCT03034967|524349781|FG005|Overall Study|Withdrawal by Subject|2|||
145293939|NCT01074554|523925628|FG001|Overall Study|Lost to Follow-up|1|||
145293940|NCT00497796|523925629|FG000|Overall Study|Adverse event (not related)|9|||
145293941|NCT00497796|523925630|FG001|Overall Study|Adverse event (not related)|9|||
145293942|NCT00497796|523925629|FG000|Overall Study|Adverse event (related)|5|||
145293943|NCT00497796|523925630|FG001|Overall Study|Adverse event (related)|4|||
145293944|NCT00497796|523925629|FG000|Overall Study|CMV infection or disease treatment|30|||
145293945|NCT00497796|523925630|FG001|Overall Study|CMV infection or disease treatment|4|||
145293946|NCT00497796|523925629|FG000|Overall Study|Consent withdrawn|10|||
145293947|NCT00497796|523925630|FG001|Overall Study|Consent withdrawn|3|||
145293948|NCT00497796|523925629|FG000|Overall Study|Investigator/sponsor discretion|31|||
145293949|NCT00497796|523925630|FG001|Overall Study|Investigator/sponsor discretion|34|||
145293950|NCT00497796|523925629|FG000|Overall Study|Lost to Follow-up|0|||
145293951|NCT00497796|523925630|FG001|Overall Study|Lost to Follow-up|1|||
145293952|NCT00497796|523925629|FG000|Overall Study|Not applicable (randomized not treated)|0|||
145293953|NCT00497796|523925630|FG001|Overall Study|Not applicable (randomized not treated)|4|||
145293954|NCT04276883|523925631|FG000|Overall Study|Withdrawal by Subject|2|||
145293955|NCT04276883|523925632|FG001|Overall Study|Withdrawal by Subject|3|||
145293956|NCT04276883|523925633|FG002|Overall Study|Withdrawal by Subject|6|||
145293957|NCT04276883|523925631|FG000|Overall Study|Lost to Follow-up|1|||
145293958|NCT04276883|523925632|FG001|Overall Study|Lost to Follow-up|3|||
145293959|NCT04276883|523925633|FG002|Overall Study|Lost to Follow-up|0|||
145293960|NCT04276883|523925631|FG000|Overall Study|Adverse Event|0|||
145293961|NCT04276883|523925632|FG001|Overall Study|Adverse Event|1|||
145293962|NCT04276883|523925633|FG002|Overall Study|Adverse Event|0|||
145293963|NCT04276883|523925631|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
145293964|NCT04276883|523925632|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
145293965|NCT04276883|523925633|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
145293966|NCT02073643|523925636|FG000|Overall Study|Lost to Follow-up|24|||
145293967|NCT02101853|523925643|FG000|Block 1 Induction|Adverse Event|11|||
145293968|NCT02101853|523925644|FG001|Block 1 Induction|Adverse Event|0|||
145293969|NCT02101853|523925645|FG002|Block 1 Induction|Adverse Event|0|||
145293970|NCT02101853|523925646|FG003|Block 1 Induction|Adverse Event|0|||
145293971|NCT02101853|523925647|FG004|Block 1 Induction|Adverse Event|0|||
145293972|NCT02101853|523925648|FG005|Block 1 Induction|Adverse Event|0|||
145293973|NCT02101853|523925643|FG000|Block 1 Induction|Death|20|||
145293974|NCT02101853|523925644|FG001|Block 1 Induction|Death|0|||
145293975|NCT02101853|523925645|FG002|Block 1 Induction|Death|0|||
145293976|NCT02101853|523925646|FG003|Block 1 Induction|Death|0|||
145293977|NCT02101853|523925647|FG004|Block 1 Induction|Death|0|||
145293978|NCT02101853|523925648|FG005|Block 1 Induction|Death|0|||
145560740|NCT01881230|524912836|FG001|Overall Study|Withdrawal by Subject|4|||
145560741|NCT01881230|524912837|FG002|Overall Study|Withdrawal by Subject|6|||
145560742|NCT01881230|524912835|FG000|Overall Study|Physician Decision|4|||
145293979|NCT02101853|523925643|FG000|Block 1 Induction|Lack of Efficacy|6|||
145293980|NCT02101853|523925644|FG001|Block 1 Induction|Lack of Efficacy|0|||
145293981|NCT02101853|523925645|FG002|Block 1 Induction|Lack of Efficacy|0|||
145293982|NCT02101853|523925646|FG003|Block 1 Induction|Lack of Efficacy|0|||
145293983|NCT02101853|523925647|FG004|Block 1 Induction|Lack of Efficacy|0|||
145293984|NCT02101853|523925648|FG005|Block 1 Induction|Lack of Efficacy|0|||
145293985|NCT02101853|523925643|FG000|Block 1 Induction|Physician Decision|61|||
145293986|NCT02101853|523925644|FG001|Block 1 Induction|Physician Decision|0|||
145560743|NCT01881230|524912836|FG001|Overall Study|Physician Decision|3|||
145293987|NCT02101853|523925645|FG002|Block 1 Induction|Physician Decision|0|||
145293988|NCT02101853|523925646|FG003|Block 1 Induction|Physician Decision|0|||
145618783|NCT04430335|525119128|FG000|Overall Study|Withdrawal by Subject|1|||
145618784|NCT03583541|525119135|FG000|Overall Study|Lost to Follow-up|31|||
145293989|NCT02101853|523925647|FG004|Block 1 Induction|Physician Decision|0|||
145293990|NCT02101853|523925648|FG005|Block 1 Induction|Physician Decision|0|||
145293991|NCT02101853|523925643|FG000|Block 1 Induction|Protocol Violation|2|||
145293992|NCT02101853|523925644|FG001|Block 1 Induction|Protocol Violation|0|||
145407936|NCT03034967|524349776|FG000|Overall Study|Physician Decision|1|||
145618785|NCT03583541|525119136|FG001|Overall Study|Lost to Follow-up|65|||
145618786|NCT04102540|525119137|FG000|Overall Study|Withdrawn by PI|2|||
145618787|NCT04102540|525119137|FG000|Overall Study|Lost to Follow-up|6|||
145618788|NCT01196104|525119140|FG000|Overall Study|Lost to Follow-up|1|||
145618789|NCT01196104|525119141|FG001|Overall Study|Lost to Follow-up|0|||
145618790|NCT01196104|525119140|FG000|Overall Study|Physician Decision|0|||
145618791|NCT01196104|525119141|FG001|Overall Study|Physician Decision|1|||
145407937|NCT03034967|524349777|FG001|Overall Study|Physician Decision|0|||
145618792|NCT01196104|525119140|FG000|Overall Study|Withdrawal by Subject|3|||
145618793|NCT01196104|525119141|FG001|Overall Study|Withdrawal by Subject|3|||
145560744|NCT01881230|524912837|FG002|Overall Study|Physician Decision|6|||
145560745|NCT01881230|524912835|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145560746|NCT01881230|524912836|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145560747|NCT01881230|524912837|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145560748|NCT01881230|524912835|FG000|Overall Study|Given Commercially Available Drug|0|||
145560749|NCT01881230|524912836|FG001|Overall Study|Given Commercially Available Drug|0|||
145560750|NCT01881230|524912837|FG002|Overall Study|Given Commercially Available Drug|2|||
145560751|NCT01881230|524912835|FG000|Overall Study|Protocol Violation|1|||
145407938|NCT03034967|524349778|FG002|Overall Study|Physician Decision|1|||
145560752|NCT01881230|524912836|FG001|Overall Study|Protocol Violation|1|||
145560753|NCT01881230|524912837|FG002|Overall Study|Protocol Violation|0|||
145560754|NCT01881230|524912835|FG000|Overall Study|Miscellaneous|3|||
145560755|NCT01881230|524912836|FG001|Overall Study|Miscellaneous|3|||
145560756|NCT01881230|524912837|FG002|Overall Study|Miscellaneous|0|||
145560757|NCT01881230|524912835|FG000|Overall Study|Untreated: Other|0|||
145560758|NCT01881230|524912836|FG001|Overall Study|Untreated: Other|0|||
145560759|NCT01881230|524912837|FG002|Overall Study|Untreated: Other|1|||
145560760|NCT01881230|524912835|FG000|Overall Study|Untreated: Death|0|||
145560761|NCT01881230|524912836|FG001|Overall Study|Untreated: Death|0|||
145560762|NCT01881230|524912837|FG002|Overall Study|Untreated: Death|1|||
145560763|NCT01881230|524912835|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
145560764|NCT01881230|524912836|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
145618794|NCT01196104|525119140|FG000|Overall Study|Various|0|||
145560765|NCT01881230|524912837|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
145560766|NCT00112502|524912838|FG000|Overall Study|Withdrawal by Subject|0|||
145560767|NCT00112502|524912839|FG001|Overall Study|Withdrawal by Subject|1|||
145560768|NCT00112502|524912840|FG002|Overall Study|Withdrawal by Subject|1|||
145560769|NCT00112502|524912841|FG003|Overall Study|Withdrawal by Subject|4|||
145560770|NCT00112502|524912842|FG004|Overall Study|Withdrawal by Subject|2|||
145407939|NCT03034967|524349779|FG003|Overall Study|Physician Decision|1|||
145560771|NCT00112502|524912843|FG005|Overall Study|Withdrawal by Subject|5|||
145560772|NCT00112502|524912844|FG006|Overall Study|Withdrawal by Subject|3|||
145560773|NCT00112502|524912845|FG007|Overall Study|Withdrawal by Subject|7|||
145560774|NCT02747420|524912846|FG000|Overall Study|Lost to Follow-up|4|||
145560775|NCT02747420|524912847|FG001|Overall Study|Lost to Follow-up|2|||
145293993|NCT02101853|523925645|FG002|Block 1 Induction|Protocol Violation|0|||
145293994|NCT02101853|523925646|FG003|Block 1 Induction|Protocol Violation|0|||
145293995|NCT02101853|523925647|FG004|Block 1 Induction|Protocol Violation|0|||
145293996|NCT02101853|523925648|FG005|Block 1 Induction|Protocol Violation|0|||
145293997|NCT02101853|523925643|FG000|Block 1 Induction|Withdrawal by Subject|65|||
145293998|NCT02101853|523925644|FG001|Block 1 Induction|Withdrawal by Subject|0|||
145293999|NCT02101853|523925645|FG002|Block 1 Induction|Withdrawal by Subject|0|||
145294000|NCT02101853|523925646|FG003|Block 1 Induction|Withdrawal by Subject|0|||
145294001|NCT02101853|523925647|FG004|Block 1 Induction|Withdrawal by Subject|0|||
145294002|NCT02101853|523925648|FG005|Block 1 Induction|Withdrawal by Subject|0|||
145294003|NCT02101853|523925643|FG000|Block 1 Induction|Ineligible|8|||
145294004|NCT02101853|523925644|FG001|Block 1 Induction|Ineligible|0|||
145294005|NCT02101853|523925645|FG002|Block 1 Induction|Ineligible|0|||
145294006|NCT02101853|523925646|FG003|Block 1 Induction|Ineligible|0|||
145294007|NCT02101853|523925647|FG004|Block 1 Induction|Ineligible|0|||
145294008|NCT02101853|523925648|FG005|Block 1 Induction|Ineligible|0|||
145560776|NCT02747420|524912846|FG000|Overall Study|Withdrawal by Subject|3|||
145294009|NCT02101853|523925643|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
145294010|NCT02101853|523925644|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
145294011|NCT02101853|523925645|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
145560777|NCT02747420|524912847|FG001|Overall Study|Withdrawal by Subject|2|||
145294012|NCT02101853|523925646|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
145294013|NCT02101853|523925647|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
145407940|NCT03034967|524349780|FG004|Overall Study|Physician Decision|1|||
145560778|NCT05129488|524912848|FG000|Overall Study|Protocol Violation|3|||
145294014|NCT02101853|523925648|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
145294015|NCT02101853|523925643|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
145294016|NCT02101853|523925644|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294017|NCT02101853|523925645|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294018|NCT02101853|523925646|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294019|NCT02101853|523925647|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294020|NCT02101853|523925648|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294021|NCT02101853|523925643|FG000|Post Induction Randomization|Adverse Event|0|||
145294022|NCT02101853|523925644|FG001|Post Induction Randomization|Adverse Event|3|||
145294023|NCT02101853|523925645|FG002|Post Induction Randomization|Adverse Event|8|||
145294024|NCT02101853|523925646|FG003|Post Induction Randomization|Adverse Event|4|||
145294025|NCT02101853|523925647|FG004|Post Induction Randomization|Adverse Event|4|||
145294026|NCT02101853|523925648|FG005|Post Induction Randomization|Adverse Event|0|||
145294027|NCT02101853|523925643|FG000|Post Induction Randomization|Death|0|||
145294028|NCT02101853|523925644|FG001|Post Induction Randomization|Death|9|||
145294029|NCT02101853|523925645|FG002|Post Induction Randomization|Death|2|||
145294030|NCT02101853|523925646|FG003|Post Induction Randomization|Death|2|||
145294031|NCT02101853|523925647|FG004|Post Induction Randomization|Death|0|||
145294032|NCT02101853|523925648|FG005|Post Induction Randomization|Death|0|||
145294033|NCT02101853|523925643|FG000|Post Induction Randomization|Lack of Efficacy|0|||
145294034|NCT02101853|523925644|FG001|Post Induction Randomization|Lack of Efficacy|14|||
145294035|NCT02101853|523925645|FG002|Post Induction Randomization|Lack of Efficacy|23|||
145294036|NCT02101853|523925646|FG003|Post Induction Randomization|Lack of Efficacy|18|||
145294037|NCT02101853|523925647|FG004|Post Induction Randomization|Lack of Efficacy|21|||
145294038|NCT02101853|523925648|FG005|Post Induction Randomization|Lack of Efficacy|0|||
145294039|NCT02101853|523925643|FG000|Post Induction Randomization|Physician Decision|0|||
145294040|NCT02101853|523925644|FG001|Post Induction Randomization|Physician Decision|43|||
145294041|NCT02101853|523925645|FG002|Post Induction Randomization|Physician Decision|23|||
145294042|NCT02101853|523925646|FG003|Post Induction Randomization|Physician Decision|14|||
145294043|NCT02101853|523925647|FG004|Post Induction Randomization|Physician Decision|14|||
145294044|NCT02101853|523925648|FG005|Post Induction Randomization|Physician Decision|0|||
145294045|NCT02101853|523925643|FG000|Post Induction Randomization|Protocol Violation|0|||
145294046|NCT02101853|523925644|FG001|Post Induction Randomization|Protocol Violation|3|||
145294047|NCT02101853|523925645|FG002|Post Induction Randomization|Protocol Violation|0|||
145294048|NCT02101853|523925646|FG003|Post Induction Randomization|Protocol Violation|0|||
145294049|NCT02101853|523925647|FG004|Post Induction Randomization|Protocol Violation|0|||
145407941|NCT03034967|524349781|FG005|Overall Study|Physician Decision|0|||
145407942|NCT03034967|524349776|FG000|Overall Study|Lost to Follow-up|0|||
145560779|NCT01290666|524912852|FG000|Overall Study|Lost to Follow-up|11|||
145560780|NCT01290666|524912852|FG000|Overall Study|Withdrawal by Subject|23|||
145560781|NCT01290666|524912852|FG000|Overall Study|Early Termination of Study|4|||
145560782|NCT01652664|524912853|FG000|Overall Study|Treatment Failure|5|||
145560783|NCT01652664|524912854|FG001|Overall Study|Treatment Failure|1|||
145560784|NCT01652664|524912853|FG000|Overall Study|Inadequate IOP control|1|||
145560785|NCT01652664|524912854|FG001|Overall Study|Inadequate IOP control|0|||
145560786|NCT03538158|524912855|FG000|Overall Study|Lost to Follow-up|13|||
145560787|NCT03538158|524912856|FG001|Overall Study|Lost to Follow-up|7|||
145560788|NCT03538158|524912855|FG000|Overall Study|Withdrawal by Subject|2|||
145560789|NCT03538158|524912856|FG001|Overall Study|Withdrawal by Subject|1|||
145560790|NCT01454570|524912859|FG000|Overall Study|Withdrawal by Subject|2|||
145560791|NCT01454570|524912859|FG000|Overall Study|Screen Failure|7|||
145294050|NCT02101853|523925648|FG005|Post Induction Randomization|Protocol Violation|0|||
145294051|NCT02101853|523925643|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
145294052|NCT02101853|523925644|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
145294053|NCT02101853|523925645|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
145294054|NCT02101853|523925646|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
145294055|NCT02101853|523925647|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
145560792|NCT00772707|524912860|FG000|Overall Study|Withdrawn|3|||
145294056|NCT02101853|523925648|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
145560793|NCT00909779|524912862|FG000|Overall Study|Adverse Event|53|||
145407943|NCT03034967|524349777|FG001|Overall Study|Lost to Follow-up|0|||
145560794|NCT00909779|524912863|FG001|Overall Study|Adverse Event|55|||
145560795|NCT00909779|524912862|FG000|Overall Study|Lack of Efficacy|7|||
145560796|NCT00909779|524912863|FG001|Overall Study|Lack of Efficacy|4|||
145560797|NCT00909779|524912862|FG000|Overall Study|Lost to Follow-up|19|||
145560798|NCT00909779|524912863|FG001|Overall Study|Lost to Follow-up|15|||
145560799|NCT00909779|524912862|FG000|Overall Study|Physician Decision|8|||
145560800|NCT00909779|524912863|FG001|Overall Study|Physician Decision|2|||
145560801|NCT00909779|524912862|FG000|Overall Study|Protocol Violation|2|||
145560802|NCT00909779|524912863|FG001|Overall Study|Protocol Violation|5|||
145560803|NCT00909779|524912862|FG000|Overall Study|Withdrawal by Subject|116|||
145294057|NCT02101853|523925643|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294058|NCT02101853|523925644|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294059|NCT02101853|523925645|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294060|NCT02101853|523925646|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
145294061|NCT02101853|523925647|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145560804|NCT00909779|524912863|FG001|Overall Study|Withdrawal by Subject|80|||
145560805|NCT00909779|524912862|FG000|Overall Study|Site Ceasing Operation|2|||
145294062|NCT02101853|523925648|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
145294063|NCT02101853|523925643|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
145560806|NCT00909779|524912863|FG001|Overall Study|Site Ceasing Operation|2|||
145560807|NCT00909779|524912862|FG000|Overall Study|Medical Monitor Decision|1|||
145294064|NCT02101853|523925644|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
145294065|NCT02101853|523925645|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
145294066|NCT02101853|523925646|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
145294067|NCT02101853|523925647|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
145294068|NCT02101853|523925648|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
145560808|NCT00909779|524912863|FG001|Overall Study|Medical Monitor Decision|0|||
145560809|NCT00909779|524912862|FG000|Overall Study|Noncompliance|1|||
145560810|NCT00909779|524912863|FG001|Overall Study|Noncompliance|1|||
145560811|NCT00909779|524912862|FG000|Overall Study|Randomized in error|1|||
145560812|NCT00909779|524912863|FG001|Overall Study|Randomized in error|1|||
145294069|NCT02101853|523925643|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
145618795|NCT01196104|525119141|FG001|Overall Study|Various|1|||
145618796|NCT01348854|525119142|FG000|Overall Study|Lost to Follow-up|2|||
145618797|NCT01348854|525119143|FG001|Overall Study|Lost to Follow-up|1|||
145560813|NCT00099437|524912866|FG000|Overall Study|Lost to Follow-up|30|||
145560814|NCT00099437|524912867|FG001|Overall Study|Lost to Follow-up|33|||
145560815|NCT00099437|524912866|FG000|Overall Study|Death|293|||
145294070|NCT02101853|523925644|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
145294071|NCT02101853|523925645|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
145294072|NCT02101853|523925646|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
145294073|NCT02101853|523925647|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
145294074|NCT02101853|523925648|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
145294075|NCT02101853|523925643|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
145294076|NCT02101853|523925644|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
145294077|NCT02101853|523925645|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
145294078|NCT02101853|523925646|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
145294079|NCT02101853|523925647|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
145294080|NCT02101853|523925648|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
145294081|NCT02101853|523925643|FG000|Blinatumomab Salvage Therapy|Death|0|||
145294082|NCT02101853|523925644|FG001|Blinatumomab Salvage Therapy|Death|0|||
145294083|NCT02101853|523925645|FG002|Blinatumomab Salvage Therapy|Death|0|||
145294084|NCT02101853|523925646|FG003|Blinatumomab Salvage Therapy|Death|0|||
145294085|NCT02101853|523925647|FG004|Blinatumomab Salvage Therapy|Death|0|||
145560816|NCT00099437|524912867|FG001|Overall Study|Death|261|||
145560817|NCT00099437|524912866|FG000|Overall Study|Withdrawal by Subject|6|||
145560818|NCT00099437|524912867|FG001|Overall Study|Withdrawal by Subject|10|||
145560819|NCT00099437|524912866|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
145560820|NCT00099437|524912867|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
145560821|NCT02410954|524912868|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
145294086|NCT02101853|523925648|FG005|Blinatumomab Salvage Therapy|Death|2|||
145294087|NCT02101853|523925643|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
145294088|NCT02101853|523925644|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
145294089|NCT02101853|523925645|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
145294090|NCT02101853|523925646|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
145407944|NCT03034967|524349778|FG002|Overall Study|Lost to Follow-up|0|||
145407945|NCT03034967|524349779|FG003|Overall Study|Lost to Follow-up|1|||
145407946|NCT03034967|524349780|FG004|Overall Study|Lost to Follow-up|0|||
145407947|NCT03034967|524349781|FG005|Overall Study|Lost to Follow-up|2|||
145560822|NCT02410954|524912869|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
145560823|NCT02410954|524912868|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
145560824|NCT02410954|524912869|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
145560825|NCT02738333|524912870|FG000|Overall Study|Death|1|||
145560826|NCT02738333|524912871|FG001|Overall Study|Death|0|||
145560827|NCT02738333|524912872|FG002|Overall Study|Death|0|||
145560828|NCT02738333|524912870|FG000|Overall Study|Lost to Follow-up|1|||
145560829|NCT02738333|524912871|FG001|Overall Study|Lost to Follow-up|0|||
145560830|NCT02738333|524912872|FG002|Overall Study|Lost to Follow-up|0|||
145560831|NCT00791518|524912873|FG000|Overall Study|Protocol Violation|93|||
145560832|NCT01498952|524912874|FG000|Overall Study|Death|2|||
145618798|NCT01348854|525119142|FG000|Overall Study|Withdrawal by Subject|1|||
145618799|NCT01348854|525119143|FG001|Overall Study|Withdrawal by Subject|0|||
145618800|NCT00724061|525119144|FG000|Dose Escalation Phase|Adverse Event|2|||
145618801|NCT00724061|525119144|FG000|Dose Escalation Phase|Disease Progression|3|||
145618802|NCT01094171|525119149|FG000|Overall Study|Lost to Follow-up|2|||
145618803|NCT01094171|525119149|FG000|Overall Study|Informed consent withdrawal|4|||
145618804|NCT01094171|525119149|FG000|Overall Study|Migration from the study area|3|||
145618805|NCT01094171|525119149|FG000|Overall Study|Other|1|||
145618806|NCT00594932|525119150|FG000|First 3 Months|Withdrawal by Subject|1|||
145560833|NCT01498952|524912875|FG001|Overall Study|Death|2|||
145560834|NCT01498952|524912876|FG002|Overall Study|Death|0|||
145560835|NCT01498952|524912877|FG003|Overall Study|Death|0|||
145560836|NCT01498952|524912878|FG004|Overall Study|Death|0|||
145560837|NCT02726074|524912879|FG000|Overall Study|Withdrawal by Subject|4|||
145560838|NCT02726074|524912879|FG000|Overall Study|Adverse Event|14|||
145560839|NCT02726074|524912879|FG000|Overall Study|Protocol Violation|3|||
145560840|NCT02726074|524912879|FG000|Overall Study|Lost to Follow-up|2|||
145560841|NCT02726074|524912879|FG000|Overall Study|Others|3|||
145560842|NCT01679002|524912880|FG000|Overall Study|Adverse Event|1|||
145560843|NCT01679002|524912881|FG001|Overall Study|Adverse Event|1|||
145560844|NCT01679002|524912882|FG002|Overall Study|Adverse Event|0|||
145560845|NCT05172544|524912883|FG000|Overall Study|Withdrawal by Subject|1|||
145618807|NCT00594932|525119151|FG001|First 3 Months|Withdrawal by Subject|3|||
145618808|NCT00594932|525119150|FG000|Final 3 Months|Withdrawal by Subject|4|||
145618809|NCT00594932|525119151|FG001|Final 3 Months|Withdrawal by Subject|3|||
145618810|NCT01536145|525119152|FG000|Overall Study|Progressive disease|3|||
145618811|NCT01536145|525119153|FG001|Overall Study|Progressive disease|4|||
145560846|NCT05172544|524912884|FG001|Overall Study|Withdrawal by Subject|0|||
145618812|NCT01536145|525119154|FG002|Overall Study|Progressive disease|1|||
145618813|NCT01536145|525119155|FG003|Overall Study|Progressive disease|2|||
145294091|NCT02101853|523925647|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
145294092|NCT02101853|523925648|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
145618814|NCT01536145|525119156|FG004|Overall Study|Progressive disease|1|||
145618815|NCT01536145|525119157|FG005|Overall Study|Progressive disease|2|||
145560847|NCT05172544|524912885|FG002|Overall Study|Withdrawal by Subject|0|||
145560848|NCT05172544|524912883|FG000|Overall Study|Physician Decision|0|||
145560849|NCT05172544|524912884|FG001|Overall Study|Physician Decision|0|||
145294093|NCT02101853|523925643|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
145294094|NCT02101853|523925644|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
145294095|NCT02101853|523925645|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
145294096|NCT02101853|523925646|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
145294097|NCT02101853|523925647|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
145294098|NCT02101853|523925648|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
145294099|NCT02101853|523925643|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
145294100|NCT02101853|523925644|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
145294101|NCT02101853|523925645|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
145294102|NCT02101853|523925646|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
145294103|NCT02101853|523925647|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
145294104|NCT02101853|523925648|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
145294105|NCT00860028|523925649|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
145294106|NCT00860028|523925650|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
145294107|NCT00936390|523925651|FG000|Overall Study|Protocol Violation|21|||
145294108|NCT00936390|523925652|FG001|Overall Study|Protocol Violation|25|||
145294109|NCT02514174|523925656|FG000|Overall Study|Patient refused to continue medication|1|||
145294110|NCT02514174|523925656|FG000|Overall Study|Adverse Event|2|||
145294111|NCT02514174|523925656|FG000|Overall Study|Study closed by sponsor|9|||
145407948|NCT03034967|524349776|FG000|Overall Study|Liver function test abnormality|0|||
145407949|NCT03034967|524349777|FG001|Overall Study|Liver function test abnormality|0|||
145407950|NCT03034967|524349778|FG002|Overall Study|Liver function test abnormality|1|||
145560850|NCT05172544|524912885|FG002|Overall Study|Physician Decision|1|||
145407951|NCT03034967|524349779|FG003|Overall Study|Liver function test abnormality|0|||
145407952|NCT03034967|524349780|FG004|Overall Study|Liver function test abnormality|0|||
145407953|NCT03034967|524349781|FG005|Overall Study|Liver function test abnormality|0|||
145407954|NCT03034967|524349776|FG000|Overall Study|Protocol Violation|1|||
145407955|NCT03034967|524349777|FG001|Overall Study|Protocol Violation|0|||
145560851|NCT00454987|524912886|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
145560852|NCT00454987|524912887|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
145560853|NCT00454987|524912888|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
145294112|NCT02514174|523925656|FG000|Overall Study|Progressive disease|11|||
145560854|NCT00454987|524912886|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
145560855|NCT00454987|524912887|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
145560856|NCT00454987|524912888|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
145560857|NCT00454987|524912886|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
145560858|NCT00454987|524912887|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
145560859|NCT00454987|524912888|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
145560860|NCT01176266|524912889|FG000|Overall Study|Death|6|||
145560861|NCT01176266|524912889|FG000|Overall Study|Withdrawal by Subject|3|||
145560862|NCT04829318|524912890|FG000|Overall Study|Adverse Event|6|||
145560863|NCT04829318|524912890|FG000|Overall Study|Death|1|||
145560864|NCT04829318|524912890|FG000|Overall Study|Lost to Follow-up|1|||
145560865|NCT04829318|524912890|FG000|Overall Study|Physician Decision|1|||
145560866|NCT04829318|524912890|FG000|Overall Study|Withdrawal by Subject|19|||
145560867|NCT04829318|524912890|FG000|Overall Study|Site terminated by sponsor|1|||
145560868|NCT04829318|524912890|FG000|Overall Study|Sponsor decision|5|||
145560869|NCT04829318|524912890|FG000|Overall Study|Other|1|||
145560870|NCT00728130|524912891|FG000|Overall Study|Withdrawal by Subject|1|||
145560871|NCT00728130|524912891|FG000|Overall Study|Paperwork not completed in time|1|||
145560872|NCT00728130|524912891|FG000|Overall Study|Physician Decision|1|||
145560873|NCT00271947|524912894|FG000|Overall Study|Lost to Follow-up|1|||
145560874|NCT01522365|524912897|FG000|Overall Study|Withdrawal by Subject|1|||
145560875|NCT01522365|524912898|FG001|Overall Study|Withdrawal by Subject|1|||
145560876|NCT01522365|524912897|FG000|Overall Study|Lost to Follow-up|1|||
145560877|NCT01522365|524912898|FG001|Overall Study|Lost to Follow-up|1|||
145560878|NCT00651755|524912899|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
145560879|NCT00651755|524912900|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
145560880|NCT00651755|524912899|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
145560881|NCT00651755|524912900|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
145560882|NCT02466555|524912901|FG000|Overall Study|Lost to Follow-up|2|||
145560883|NCT04170348|524912902|FG000|Overall Study|Lost to Follow-up|2|||
145560884|NCT04170348|524912903|FG001|Overall Study|Lost to Follow-up|2|||
145560885|NCT04170348|524912902|FG000|Overall Study|Withdrawal by Subject|1|||
145560886|NCT04170348|524912903|FG001|Overall Study|Withdrawal by Subject|5|||
145560887|NCT04170348|524912902|FG000|Overall Study|Non-adherence|1|||
145560888|NCT04170348|524912903|FG001|Overall Study|Non-adherence|1|||
145560889|NCT04170348|524912902|FG000|Overall Study|Adverse Event|1|||
145560890|NCT04170348|524912903|FG001|Overall Study|Adverse Event|0|||
145560891|NCT01120756|524912904|FG000|Overall Study|Withdrawal by Subject|1|||
145560892|NCT01120756|524912905|FG001|Overall Study|Withdrawal by Subject|1|||
145560893|NCT03482791|524912909|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
145560894|NCT03482791|524912910|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
145560895|NCT01816893|524912912|FG000|Washout Period|Withdrawal by Subject|2|||
145560896|NCT01816893|524912913|FG001|Washout Period|Withdrawal by Subject|0|||
145560897|NCT01239368|524914355|FG000|Overall Study|Principal investigator discretion|1|||
145560898|NCT01239368|524914356|FG001|Overall Study|Principal investigator discretion|0|||
145560899|NCT01239368|524914357|FG002|Overall Study|Principal investigator discretion|0|||
145560900|NCT01239368|524914358|FG003|Overall Study|Principal investigator discretion|0|||
145560901|NCT01239368|524914359|FG004|Overall Study|Principal investigator discretion|1|||
145560902|NCT01239368|524914360|FG005|Overall Study|Principal investigator discretion|2|||
145560903|NCT01239368|524914361|FG006|Overall Study|Principal investigator discretion|0|||
145560904|NCT01239368|524914362|FG007|Overall Study|Principal investigator discretion|0|||
145560905|NCT01239368|524914363|FG008|Overall Study|Principal investigator discretion|0|||
145560906|NCT01239368|524914364|FG009|Overall Study|Principal investigator discretion|1|||
145294113|NCT02514174|523925656|FG000|Overall Study|Treatment change|1|||
145294114|NCT02514174|523925656|FG000|Overall Study|Treated off study with Afatinib.|1|||
145294115|NCT02130466|523925657|FG000|Overall Study|Death|4|||
145294116|NCT02130466|523925658|FG001|Overall Study|Death|1|||
145294117|NCT02130466|523925659|FG002|Overall Study|Death|1|||
145294118|NCT02130466|523925660|FG003|Overall Study|Death|3|||
145294119|NCT02130466|523925661|FG004|Overall Study|Death|2|||
145294120|NCT02130466|523925662|FG005|Overall Study|Death|30|||
145294121|NCT02130466|523925663|FG006|Overall Study|Death|45|||
145294122|NCT02130466|523925664|FG007|Overall Study|Death|2|||
145294123|NCT02130466|523925665|FG008|Overall Study|Death|3|||
145294124|NCT02130466|523925666|FG009|Overall Study|Death|4|||
145294125|NCT02130466|523925667|FG010|Overall Study|Death|5|||
145294126|NCT02130466|523925668|FG011|Overall Study|Death|3|||
145294127|NCT02130466|523925669|FG012|Overall Study|Death|11|||
145294128|NCT02130466|523925670|FG013|Overall Study|Death|7|||
145294129|NCT02130466|523925657|FG000|Overall Study|Lost to Follow-up|1|||
145294130|NCT02130466|523925658|FG001|Overall Study|Lost to Follow-up|0|||
145294131|NCT02130466|523925659|FG002|Overall Study|Lost to Follow-up|0|||
145294132|NCT02130466|523925660|FG003|Overall Study|Lost to Follow-up|0|||
145294133|NCT02130466|523925661|FG004|Overall Study|Lost to Follow-up|0|||
145294134|NCT02130466|523925662|FG005|Overall Study|Lost to Follow-up|1|||
145294135|NCT02130466|523925663|FG006|Overall Study|Lost to Follow-up|0|||
145294136|NCT02130466|523925664|FG007|Overall Study|Lost to Follow-up|0|||
145294137|NCT02130466|523925665|FG008|Overall Study|Lost to Follow-up|0|||
145294138|NCT02130466|523925666|FG009|Overall Study|Lost to Follow-up|0|||
145294139|NCT02130466|523925667|FG010|Overall Study|Lost to Follow-up|0|||
145294140|NCT02130466|523925668|FG011|Overall Study|Lost to Follow-up|0|||
145294141|NCT02130466|523925669|FG012|Overall Study|Lost to Follow-up|1|||
145294142|NCT02130466|523925670|FG013|Overall Study|Lost to Follow-up|0|||
145294143|NCT02130466|523925657|FG000|Overall Study|Physician Decision|0|||
145294144|NCT02130466|523925658|FG001|Overall Study|Physician Decision|0|||
145294145|NCT02130466|523925659|FG002|Overall Study|Physician Decision|0|||
145294146|NCT02130466|523925660|FG003|Overall Study|Physician Decision|0|||
145294147|NCT02130466|523925661|FG004|Overall Study|Physician Decision|0|||
145294148|NCT02130466|523925662|FG005|Overall Study|Physician Decision|1|||
145294149|NCT02130466|523925663|FG006|Overall Study|Physician Decision|1|||
145294150|NCT02130466|523925664|FG007|Overall Study|Physician Decision|0|||
145294151|NCT02130466|523925665|FG008|Overall Study|Physician Decision|0|||
145294152|NCT02130466|523925666|FG009|Overall Study|Physician Decision|0|||
145294153|NCT02130466|523925667|FG010|Overall Study|Physician Decision|0|||
145294154|NCT02130466|523925668|FG011|Overall Study|Physician Decision|0|||
145294155|NCT02130466|523925669|FG012|Overall Study|Physician Decision|0|||
145294156|NCT02130466|523925670|FG013|Overall Study|Physician Decision|0|||
145294157|NCT02130466|523925657|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
145407956|NCT03034967|524349778|FG002|Overall Study|Protocol Violation|0|||
145294158|NCT02130466|523925658|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
145294159|NCT02130466|523925659|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
145294160|NCT02130466|523925660|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
145294161|NCT02130466|523925661|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
145294162|NCT02130466|523925662|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
145294163|NCT02130466|523925663|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
145294164|NCT02130466|523925664|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
145294165|NCT02130466|523925665|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
145294166|NCT02130466|523925666|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
145294167|NCT02130466|523925667|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
145294168|NCT02130466|523925668|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
145294169|NCT02130466|523925669|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
145294170|NCT02130466|523925670|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
145294171|NCT02130466|523925657|FG000|Overall Study|Withdrawal by Subject|1|||
145294172|NCT02130466|523925658|FG001|Overall Study|Withdrawal by Subject|0|||
145294173|NCT02130466|523925659|FG002|Overall Study|Withdrawal by Subject|0|||
145294174|NCT02130466|523925660|FG003|Overall Study|Withdrawal by Subject|0|||
145294175|NCT02130466|523925661|FG004|Overall Study|Withdrawal by Subject|0|||
145294176|NCT02130466|523925662|FG005|Overall Study|Withdrawal by Subject|1|||
145294177|NCT02130466|523925663|FG006|Overall Study|Withdrawal by Subject|0|||
145294178|NCT02130466|523925664|FG007|Overall Study|Withdrawal by Subject|0|||
145294179|NCT02130466|523925665|FG008|Overall Study|Withdrawal by Subject|1|||
145294180|NCT02130466|523925666|FG009|Overall Study|Withdrawal by Subject|0|||
145294181|NCT02130466|523925667|FG010|Overall Study|Withdrawal by Subject|0|||
145294182|NCT02130466|523925668|FG011|Overall Study|Withdrawal by Subject|0|||
145294183|NCT02130466|523925669|FG012|Overall Study|Withdrawal by Subject|0|||
145294184|NCT02130466|523925670|FG013|Overall Study|Withdrawal by Subject|0|||
145294185|NCT04529109|523925671|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
145294186|NCT04529109|523925672|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
145294187|NCT01922349|523925673|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
145294188|NCT01922349|523925674|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
145294189|NCT01922349|523925675|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
145294190|NCT01922349|523925676|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
145294191|NCT00922779|523925677|FG000|Overall Study|Adverse Event|67|||
145294192|NCT00922779|523925677|FG000|Overall Study|Pregnancy|7|||
145294193|NCT00922779|523925677|FG000|Overall Study|Withdrawal by Subject|308|||
145294194|NCT00922779|523925677|FG000|Overall Study|Lost to Follow-up|44|||
145294195|NCT00922779|523925677|FG000|Overall Study|Other|27|||
145294196|NCT00922779|523925677|FG000|Overall Study|Missing|1874|||
145294197|NCT00993616|523925678|FG000|Overall Study|No tumor at entry|1|||
145294198|NCT00993616|523925678|FG000|Overall Study|Never treated|1|||
145377799|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377800|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377801|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377802|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377803|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377804|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377805|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
145377806|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
145377807|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
145377808|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145407957|NCT03034967|524349779|FG003|Overall Study|Protocol Violation|0|||
145407958|NCT03034967|524349780|FG004|Overall Study|Protocol Violation|0|||
145377809|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145377810|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145377811|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145377812|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145560907|NCT01239368|524914355|FG000|Overall Study|Disease progression on study|1|||
145560908|NCT01239368|524914356|FG001|Overall Study|Disease progression on study|1|||
145294199|NCT00444145|523927522|FG000|Overall Study|Withdrawal by Subject|2|||
145294200|NCT00444145|523927522|FG000|Overall Study|Lost to Follow-up|1|||
145294201|NCT00444145|523927522|FG000|Overall Study|non-compliant|11|||
145294202|NCT00444145|523927522|FG000|Overall Study|Screen Failures|5|||
145294203|NCT01619800|523927523|FG000|Overall Study|study terminated|2|||
145294204|NCT01619800|523927524|FG001|Overall Study|study terminated|0|||
145294205|NCT01781637|523927529|FG000|Overall Study|Adverse Event|1|||
145294206|NCT01781637|523927530|FG001|Overall Study|Adverse Event|0|||
145294207|NCT01781637|523927529|FG000|Overall Study|Lack of Efficacy|2|||
145294208|NCT01781637|523927530|FG001|Overall Study|Lack of Efficacy|6|||
145294209|NCT01781637|523927529|FG000|Overall Study|Withdrawal by Subject|1|||
145294210|NCT01781637|523927530|FG001|Overall Study|Withdrawal by Subject|0|||
145294211|NCT01085045|523927536|FG000|Part A|Withdrawal by Subject|4|||
145294212|NCT01085045|523927536|FG000|Part A|Adverse Event|6|||
145294213|NCT01085045|523927536|FG000|Part A|Protocol Violation|1|||
145294214|NCT01085045|523927536|FG000|Part A|Protocol Specified Criteria|7|||
145294215|NCT01085045|523927536|FG000|Part B|Withdrawal by Subject|2|||
145294216|NCT01085045|523927536|FG000|Part B|Protocol Specified Criteria|6|||
145294217|NCT01085045|523927536|FG000|Part B|Lost to Follow-up|1|||
145294218|NCT01085045|523927536|FG000|Part B|Adverse Event|6|||
145294219|NCT02395822|523927540|FG000|Overall Study|Withdrawal by Subject|1|||
145294220|NCT02395822|523927540|FG000|Overall Study|Death|1|||
145294221|NCT02127281|523927541|FG000|Overall Study|Lost to Follow-up|1|||
145294222|NCT02127281|523927542|FG001|Overall Study|Lost to Follow-up|0|||
145294223|NCT04510857|523927543|FG000|Overall Study|Withdrawal by Subject|1|||
145294224|NCT04510857|523927544|FG001|Overall Study|Withdrawal by Subject|2|||
145294225|NCT00920140|523927545|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
145294226|NCT00920140|523927546|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
145294227|NCT00920140|523927547|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
145294228|NCT00920140|523927548|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
145294229|NCT00920140|523927549|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
145294230|NCT00920140|523927545|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
145294231|NCT00920140|523927546|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
145294232|NCT00920140|523927547|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
145294233|NCT00920140|523927548|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
145294234|NCT00920140|523927549|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
145294235|NCT00920140|523927545|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145294236|NCT00920140|523927546|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
145294237|NCT00920140|523927547|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145294238|NCT00920140|523927548|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145560909|NCT01239368|524914357|FG002|Overall Study|Disease progression on study|1|||
145560910|NCT01239368|524914358|FG003|Overall Study|Disease progression on study|1|||
145294239|NCT00920140|523927549|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145294240|NCT00920140|523927545|FG000|Phase 2|Adverse Event|0|||
145294241|NCT00920140|523927546|FG001|Phase 2|Adverse Event|0|||
145294242|NCT00920140|523927547|FG002|Phase 2|Adverse Event|14|||
145294243|NCT00920140|523927548|FG003|Phase 2|Adverse Event|2|||
145560911|NCT01239368|524914359|FG004|Overall Study|Disease progression on study|4|||
145294244|NCT00920140|523927549|FG004|Phase 2|Adverse Event|3|||
145294245|NCT00920140|523927545|FG000|Phase 2|Lack of Efficacy|0|||
145294246|NCT00920140|523927546|FG001|Phase 2|Lack of Efficacy|0|||
145560912|NCT01239368|524914360|FG005|Overall Study|Disease progression on study|2|||
145294247|NCT00920140|523927547|FG002|Phase 2|Lack of Efficacy|29|||
145407959|NCT03034967|524349781|FG005|Overall Study|Protocol Violation|2|||
145407960|NCT03034967|524349776|FG000|Overall Study|Lack of Efficacy|0|||
145407961|NCT03034967|524349777|FG001|Overall Study|Lack of Efficacy|1|||
145407962|NCT03034967|524349778|FG002|Overall Study|Lack of Efficacy|2|||
145407963|NCT03034967|524349779|FG003|Overall Study|Lack of Efficacy|1|||
145407964|NCT03034967|524349780|FG004|Overall Study|Lack of Efficacy|1|||
145407965|NCT03034967|524349781|FG005|Overall Study|Lack of Efficacy|0|||
145407966|NCT03034967|524349776|FG000|Overall Study|Adverse Event, non-fatal|3|||
145407967|NCT03034967|524349777|FG001|Overall Study|Adverse Event, non-fatal|1|||
145407968|NCT03034967|524349778|FG002|Overall Study|Adverse Event, non-fatal|2|||
145407969|NCT03034967|524349779|FG003|Overall Study|Adverse Event, non-fatal|0|||
145560913|NCT01239368|524914361|FG006|Overall Study|Disease progression on study|5|||
145407970|NCT03034967|524349780|FG004|Overall Study|Adverse Event, non-fatal|2|||
145407971|NCT03034967|524349781|FG005|Overall Study|Adverse Event, non-fatal|8|||
145560914|NCT01239368|524914362|FG007|Overall Study|Disease progression on study|0|||
145294248|NCT00920140|523927548|FG003|Phase 2|Lack of Efficacy|14|||
145294249|NCT00920140|523927549|FG004|Phase 2|Lack of Efficacy|5|||
145294250|NCT00920140|523927545|FG000|Phase 2|Lost to Follow-up|0|||
145294251|NCT00920140|523927546|FG001|Phase 2|Lost to Follow-up|0|||
145294252|NCT00920140|523927547|FG002|Phase 2|Lost to Follow-up|0|||
145294253|NCT00920140|523927548|FG003|Phase 2|Lost to Follow-up|1|||
145294254|NCT00920140|523927549|FG004|Phase 2|Lost to Follow-up|0|||
145294255|NCT00920140|523927545|FG000|Phase 2|Physician Decision|0|||
145294256|NCT00920140|523927546|FG001|Phase 2|Physician Decision|0|||
145294257|NCT00920140|523927547|FG002|Phase 2|Physician Decision|3|||
145618816|NCT01536145|525119158|FG006|Overall Study|Progressive disease|1|||
145294258|NCT00920140|523927548|FG003|Phase 2|Physician Decision|3|||
145294259|NCT00920140|523927549|FG004|Phase 2|Physician Decision|2|||
145294260|NCT00920140|523927545|FG000|Phase 2|Withdrawal by Subject|0|||
145294261|NCT00920140|523927546|FG001|Phase 2|Withdrawal by Subject|0|||
145294262|NCT00920140|523927547|FG002|Phase 2|Withdrawal by Subject|4|||
145294263|NCT00920140|523927548|FG003|Phase 2|Withdrawal by Subject|2|||
145294264|NCT00920140|523927549|FG004|Phase 2|Withdrawal by Subject|1|||
145294265|NCT00755196|523927555|FG000|Overall Study|Lost to Follow-up|1|||
145618817|NCT01536145|525119159|FG007|Overall Study|Progressive disease|2|||
145560915|NCT01239368|524914363|FG008|Overall Study|Disease progression on study|0|||
145560916|NCT01239368|524914364|FG009|Overall Study|Disease progression on study|2|||
145560917|NCT01239368|524914355|FG000|Overall Study|Refused further treatment|0|||
145560918|NCT01239368|524914356|FG001|Overall Study|Refused further treatment|0|||
145294266|NCT00755196|523927555|FG000|Overall Study|Lack of Efficiency|1|||
145560919|NCT01239368|524914357|FG002|Overall Study|Refused further treatment|0|||
145294267|NCT01604850|523927556|FG000|Overall Study|Enrolled but never treated|0|||
145560920|NCT01239368|524914358|FG003|Overall Study|Refused further treatment|0|||
145560921|NCT01239368|524914359|FG004|Overall Study|Refused further treatment|0|||
145560922|NCT01239368|524914360|FG005|Overall Study|Refused further treatment|0|||
145560923|NCT01239368|524914361|FG006|Overall Study|Refused further treatment|0|||
145560924|NCT01239368|524914362|FG007|Overall Study|Refused further treatment|0|||
145560925|NCT01239368|524914363|FG008|Overall Study|Refused further treatment|0|||
145294268|NCT01604850|523927557|FG001|Overall Study|Enrolled but never treated|1|||
145294269|NCT01604850|523927556|FG000|Overall Study|Efficacy Failure|50|||
145294270|NCT01604850|523927557|FG001|Overall Study|Efficacy Failure|29|||
145294271|NCT01604850|523927556|FG000|Overall Study|Lost to Follow-up|1|||
145294272|NCT01604850|523927557|FG001|Overall Study|Lost to Follow-up|0|||
145294273|NCT01604850|523927556|FG000|Overall Study|Subject withdrew consent|1|||
145294274|NCT01604850|523927557|FG001|Overall Study|Subject withdrew consent|0|||
145294275|NCT01703832|523927558|FG000|Overall Study|Withdrawal by Subject|1|||
145294276|NCT01703832|523927559|FG001|Overall Study|Withdrawal by Subject|0|||
145294277|NCT00243932|523927560|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
145294278|NCT00243932|523927561|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
145294279|NCT00243932|523927562|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
145294280|NCT00543309|523927563|FG000|Overall Study|Physician Decision|0|||
145294281|NCT00543309|523927564|FG001|Overall Study|Physician Decision|1|||
145294282|NCT00543309|523927565|FG002|Overall Study|Physician Decision|0|||
145294283|NCT04538170|523927577|FG000|Overall Study|Withdrawal by Subject|104|||
145294284|NCT04538170|523927578|FG001|Overall Study|Withdrawal by Subject|210|||
145294285|NCT01682083|523927583|FG000|Overall Study|Lost to Follow-up|11|||
145294286|NCT01682083|523927584|FG001|Overall Study|Lost to Follow-up|18|||
145294287|NCT01682083|523927583|FG000|Overall Study|Withdrawal by Subject|31|||
145294288|NCT01682083|523927584|FG001|Overall Study|Withdrawal by Subject|40|||
145294289|NCT01682083|523927583|FG000|Overall Study|Death|60|||
145294290|NCT01682083|523927584|FG001|Overall Study|Death|93|||
145294291|NCT01682083|523927583|FG000|Overall Study|Physician Decision|5|||
145294292|NCT01682083|523927584|FG001|Overall Study|Physician Decision|4|||
145294293|NCT00864097|523927585|FG000|Overall Study|Death|0|||
145294294|NCT00864097|523927586|FG001|Overall Study|Death|1|||
145294295|NCT00864097|523927587|FG002|Overall Study|Death|0|||
145294296|NCT00864097|523927588|FG003|Overall Study|Death|0|||
145294297|NCT00864097|523927585|FG000|Overall Study|Adverse Event|6|||
145294298|NCT00864097|523927586|FG001|Overall Study|Adverse Event|8|||
145294299|NCT00864097|523927587|FG002|Overall Study|Adverse Event|11|||
145294300|NCT00864097|523927588|FG003|Overall Study|Adverse Event|9|||
145294301|NCT00864097|523927585|FG000|Overall Study|Lack of Efficacy|9|||
145294302|NCT00864097|523927586|FG001|Overall Study|Lack of Efficacy|3|||
145294303|NCT00864097|523927587|FG002|Overall Study|Lack of Efficacy|7|||
145294304|NCT00864097|523927588|FG003|Overall Study|Lack of Efficacy|2|||
145294305|NCT00864097|523927585|FG000|Overall Study|Lost to Follow-up|0|||
145560926|NCT01239368|524914364|FG009|Overall Study|Refused further treatment|1|||
145560927|NCT01239368|524914355|FG000|Overall Study|Death|0|||
145560928|NCT01239368|524914356|FG001|Overall Study|Death|0|||
145294306|NCT00864097|523927586|FG001|Overall Study|Lost to Follow-up|1|||
145294307|NCT00864097|523927587|FG002|Overall Study|Lost to Follow-up|0|||
145294308|NCT00864097|523927588|FG003|Overall Study|Lost to Follow-up|1|||
145294309|NCT00864097|523927585|FG000|Overall Study|Withdrawal by Subject|15|||
145294310|NCT00864097|523927586|FG001|Overall Study|Withdrawal by Subject|11|||
145294311|NCT00864097|523927587|FG002|Overall Study|Withdrawal by Subject|11|||
145294312|NCT00864097|523927588|FG003|Overall Study|Withdrawal by Subject|12|||
145294313|NCT00864097|523927585|FG000|Overall Study|Protocol Violation|2|||
145294314|NCT00864097|523927586|FG001|Overall Study|Protocol Violation|1|||
145294315|NCT00864097|523927587|FG002|Overall Study|Protocol Violation|0|||
145294316|NCT00864097|523927588|FG003|Overall Study|Protocol Violation|1|||
145294317|NCT00864097|523927585|FG000|Overall Study|Terminated by sponsor|105|||
145294318|NCT00864097|523927586|FG001|Overall Study|Terminated by sponsor|112|||
145294319|NCT00864097|523927587|FG002|Overall Study|Terminated by sponsor|102|||
145560929|NCT01239368|524914357|FG002|Overall Study|Death|0|||
145560930|NCT01239368|524914358|FG003|Overall Study|Death|0|||
145560931|NCT01239368|524914359|FG004|Overall Study|Death|0|||
145560932|NCT01239368|524914360|FG005|Overall Study|Death|0|||
145560933|NCT01239368|524914361|FG006|Overall Study|Death|1|||
145560934|NCT01239368|524914362|FG007|Overall Study|Death|0|||
145560935|NCT01239368|524914363|FG008|Overall Study|Death|0|||
145560936|NCT01239368|524914364|FG009|Overall Study|Death|0|||
145560937|NCT04709575|524914365|FG000|Overall Study|Withdrawal by Subject|6|||
145560938|NCT04709575|524914366|FG001|Overall Study|Withdrawal by Subject|2|||
145294320|NCT00864097|523927588|FG003|Overall Study|Terminated by sponsor|99|||
145294321|NCT00864097|523927585|FG000|Overall Study|Randomized but not treated|2|||
145294322|NCT00864097|523927586|FG001|Overall Study|Randomized but not treated|0|||
145294323|NCT00864097|523927587|FG002|Overall Study|Randomized but not treated|1|||
145294324|NCT00864097|523927588|FG003|Overall Study|Randomized but not treated|0|||
145294325|NCT00864097|523927585|FG000|Overall Study|Other|0|||
145294326|NCT00864097|523927586|FG001|Overall Study|Other|0|||
145560939|NCT04709575|524914365|FG000|Overall Study|Lost to Follow-up|2|||
145560940|NCT04709575|524914366|FG001|Overall Study|Lost to Follow-up|2|||
145560941|NCT04709575|524914365|FG000|Overall Study|Adverse Event|1|||
145560942|NCT04709575|524914366|FG001|Overall Study|Adverse Event|0|||
145560943|NCT04709575|524914365|FG000|Overall Study|Protocol Violation|1|||
145560944|NCT04709575|524914366|FG001|Overall Study|Protocol Violation|1|||
145560945|NCT00702403|524914367|FG000|From Consent to Engraftment|Progressive leukemia|6|||
145560946|NCT00702403|524914367|FG000|From Consent to Engraftment|Critically ill|2|||
145560947|NCT00702403|524914367|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
145560948|NCT00702403|524914367|FG000|From Consent to Engraftment|Myocardial infarction|1|||
145560949|NCT00702403|524914367|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
145560950|NCT00702403|524914367|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
145560951|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
145560952|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
145560953|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Non-compliance|2|||
145560954|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
145560955|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
145560956|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Suicide|1|||
145560957|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
145560958|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
145560959|NCT00702403|524914367|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
145560960|NCT03989440|524914368|FG000|Overall Study|COVID-19 travel restrictions|0|||
145294327|NCT00864097|523927587|FG002|Overall Study|Other|0|||
145560961|NCT03989440|524914369|FG001|Overall Study|COVID-19 travel restrictions|0|||
145560962|NCT03989440|524914370|FG002|Overall Study|COVID-19 travel restrictions|1|||
145560963|NCT03989440|524914371|FG003|Overall Study|COVID-19 travel restrictions|0|||
145560964|NCT03989440|524914372|FG004|Overall Study|COVID-19 travel restrictions|0|||
145560965|NCT03989440|524914373|FG005|Overall Study|COVID-19 travel restrictions|0|||
145560966|NCT03989440|524914368|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
145560967|NCT03989440|524914369|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
145560968|NCT03989440|524914370|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
145560969|NCT03989440|524914371|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
145618818|NCT01536145|525119160|FG008|Overall Study|Progressive disease|1|||
145618819|NCT01536145|525119161|FG009|Overall Study|Progressive disease|3|||
145618820|NCT01536145|525119162|FG010|Overall Study|Progressive disease|3|||
145618821|NCT01536145|525119152|FG000|Overall Study|Withdrawal by Subject|0|||
145618822|NCT01536145|525119153|FG001|Overall Study|Withdrawal by Subject|0|||
145618823|NCT01536145|525119154|FG002|Overall Study|Withdrawal by Subject|1|||
145618824|NCT01536145|525119155|FG003|Overall Study|Withdrawal by Subject|0|||
145618825|NCT01536145|525119156|FG004|Overall Study|Withdrawal by Subject|0|||
145618826|NCT01536145|525119157|FG005|Overall Study|Withdrawal by Subject|1|||
145618827|NCT01536145|525119158|FG006|Overall Study|Withdrawal by Subject|0|||
145618828|NCT01536145|525119159|FG007|Overall Study|Withdrawal by Subject|0|||
145618829|NCT01536145|525119160|FG008|Overall Study|Withdrawal by Subject|2|||
145618830|NCT01536145|525119161|FG009|Overall Study|Withdrawal by Subject|0|||
145618831|NCT01536145|525119162|FG010|Overall Study|Withdrawal by Subject|2|||
145618832|NCT01536145|525119152|FG000|Overall Study|Other|0|||
145618833|NCT01536145|525119153|FG001|Overall Study|Other|0|||
145560970|NCT03989440|524914372|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
145560971|NCT03989440|524914373|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
145560972|NCT00588822|524914374|FG000|Overall Study|progression of disease|8|||
145560973|NCT02082210|524914375|FG000|Overall Study|Death|0|||
145560974|NCT02082210|524914376|FG001|Overall Study|Death|0|||
145560975|NCT02082210|524914377|FG002|Overall Study|Death|1|||
145618834|NCT01536145|525119154|FG002|Overall Study|Other|0|||
145618835|NCT01536145|525119155|FG003|Overall Study|Other|0|||
145618836|NCT01536145|525119156|FG004|Overall Study|Other|1|||
145618837|NCT01536145|525119157|FG005|Overall Study|Other|0|||
145618838|NCT01536145|525119158|FG006|Overall Study|Other|0|||
145618839|NCT01536145|525119159|FG007|Overall Study|Other|0|||
145618840|NCT01536145|525119160|FG008|Overall Study|Other|0|||
145618841|NCT01536145|525119161|FG009|Overall Study|Other|3|||
145618842|NCT01536145|525119162|FG010|Overall Study|Other|2|||
145618843|NCT01536145|525119152|FG000|Overall Study|Death|0|||
145618844|NCT01536145|525119153|FG001|Overall Study|Death|0|||
145618845|NCT01536145|525119154|FG002|Overall Study|Death|0|||
145618846|NCT01536145|525119155|FG003|Overall Study|Death|0|||
145618847|NCT01536145|525119156|FG004|Overall Study|Death|0|||
145618848|NCT01536145|525119157|FG005|Overall Study|Death|0|||
145618849|NCT01536145|525119158|FG006|Overall Study|Death|1|||
145618850|NCT01536145|525119159|FG007|Overall Study|Death|0|||
145618851|NCT01536145|525119160|FG008|Overall Study|Death|0|||
145618852|NCT01536145|525119161|FG009|Overall Study|Death|0|||
145618853|NCT01536145|525119162|FG010|Overall Study|Death|0|||
145618854|NCT01536145|525119152|FG000|Overall Study|Adverse Event|0|||
145618855|NCT01536145|525119153|FG001|Overall Study|Adverse Event|0|||
145618856|NCT01536145|525119154|FG002|Overall Study|Adverse Event|0|||
145618857|NCT01536145|525119155|FG003|Overall Study|Adverse Event|0|||
145618858|NCT01536145|525119156|FG004|Overall Study|Adverse Event|0|||
145618859|NCT01536145|525119157|FG005|Overall Study|Adverse Event|0|||
145618860|NCT01536145|525119158|FG006|Overall Study|Adverse Event|0|||
145618861|NCT01536145|525119159|FG007|Overall Study|Adverse Event|2|||
145618862|NCT01536145|525119160|FG008|Overall Study|Adverse Event|0|||
145618863|NCT01536145|525119161|FG009|Overall Study|Adverse Event|0|||
145618864|NCT01536145|525119162|FG010|Overall Study|Adverse Event|3|||
145618865|NCT00088205|525119165|FG000|Overall Study|Adverse Event|4|||
145618866|NCT00088205|525119165|FG000|Overall Study|Progressive Disease|51|||
145407972|NCT03034967|524349776|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
145560976|NCT02082210|524914378|FG003|Overall Study|Death|1|||
145560977|NCT02082210|524914379|FG004|Overall Study|Death|1|||
145560978|NCT02082210|524914380|FG005|Overall Study|Death|0|||
145560979|NCT02082210|524914375|FG000|Overall Study|Withdrawal by Subject|0|||
145618867|NCT00088205|525119165|FG000|Overall Study|Physician Decision|1|||
145618868|NCT00088205|525119165|FG000|Overall Study|Death Due to Study Disease|4|||
145618869|NCT05199233|525119166|FG000|Overall Study|Lack of Efficacy|1|||
145618870|NCT01364727|525119171|FG000|Overall Study|Not Eligible|2|||
145618871|NCT00688259|525119172|FG000|Overall Study|Lost to Follow-up|2|||
145618872|NCT00688259|525119173|FG001|Overall Study|Lost to Follow-up|4|||
145618873|NCT00688259|525119172|FG000|Overall Study|Physician Decision|1|||
145618874|NCT00688259|525119173|FG001|Overall Study|Physician Decision|0|||
145618875|NCT00688259|525119172|FG000|Overall Study|Withdrawal by Subject|2|||
145618876|NCT00688259|525119173|FG001|Overall Study|Withdrawal by Subject|0|||
145618877|NCT00688259|525119172|FG000|Overall Study|Declined Interview|2|||
145618878|NCT00688259|525119173|FG001|Overall Study|Declined Interview|3|||
145618879|NCT00688259|525119172|FG000|Overall Study|Hospitalized at Follow-up|0|||
145618880|NCT00688259|525119173|FG001|Overall Study|Hospitalized at Follow-up|1|||
145618881|NCT01676220|525119175|FG000|Overall Study|Randomized But Not Treated|4|||
145618882|NCT01676220|525119176|FG001|Overall Study|Randomized But Not Treated|1|||
145618883|NCT01676220|525119175|FG000|Overall Study|Adverse Event|10|||
145618884|NCT01676220|525119176|FG001|Overall Study|Adverse Event|8|||
145618885|NCT01676220|525119175|FG000|Overall Study|Lack of Efficacy|2|||
145618886|NCT01676220|525119176|FG001|Overall Study|Lack of Efficacy|5|||
145618887|NCT01676220|525119175|FG000|Overall Study|Protocol Violation|11|||
145618888|NCT01676220|525119176|FG001|Overall Study|Protocol Violation|12|||
145618889|NCT01676220|525119175|FG000|Overall Study|Received Rescue Therapy|14|||
145618890|NCT01676220|525119176|FG001|Overall Study|Received Rescue Therapy|22|||
145618891|NCT01676220|525119175|FG000|Overall Study|Personal Reason|34|||
145618892|NCT01676220|525119176|FG001|Overall Study|Personal Reason|45|||
145618893|NCT01676220|525119175|FG000|Overall Study|Lost to Follow-up|11|||
145618894|NCT01676220|525119176|FG001|Overall Study|Lost to Follow-up|18|||
145618895|NCT01676220|525119175|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
145618896|NCT01676220|525119176|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
145618897|NCT01676220|525119175|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
145618898|NCT01676220|525119176|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
145618899|NCT01676220|525119175|FG000|Overall Study|Perceived Lack of Efficacy|3|||
145618900|NCT01676220|525119176|FG001|Overall Study|Perceived Lack of Efficacy|1|||
145618901|NCT01676220|525119175|FG000|Overall Study|Non Serious Hypoglycemia|2|||
145618902|NCT01676220|525119176|FG001|Overall Study|Non Serious Hypoglycemia|0|||
145618903|NCT01676220|525119175|FG000|Overall Study|No More Need of Insulin|1|||
145618904|NCT01676220|525119176|FG001|Overall Study|No More Need of Insulin|0|||
145618905|NCT00393094|525119179|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
145618906|NCT00393094|525119179|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
145618907|NCT00136916|525119180|FG000|Overall Study|Never received study treatment|3|||
145618908|NCT00136916|525119181|FG001|Overall Study|Never received study treatment|5|||
145618909|NCT00136916|525119180|FG000|Overall Study|Death|1|||
145618910|NCT00136916|525119181|FG001|Overall Study|Death|3|||
145618911|NCT00136916|525119180|FG000|Overall Study|Adverse Event|27|||
145618912|NCT00136916|525119181|FG001|Overall Study|Adverse Event|8|||
145618913|NCT00136916|525119180|FG000|Overall Study|Laboratory abnormality|0|||
145618914|NCT00136916|525119181|FG001|Overall Study|Laboratory abnormality|1|||
145618915|NCT00136916|525119180|FG000|Overall Study|Lack of Efficacy|13|||
145618916|NCT00136916|525119181|FG001|Overall Study|Lack of Efficacy|3|||
145618917|NCT00136916|525119180|FG000|Overall Study|Lost to Follow-up|12|||
145618918|NCT00136916|525119181|FG001|Overall Study|Lost to Follow-up|14|||
145618919|NCT00136916|525119180|FG000|Overall Study|Withdrawal by Subject|44|||
145618920|NCT00136916|525119181|FG001|Overall Study|Withdrawal by Subject|46|||
145618921|NCT00136916|525119180|FG000|Overall Study|Other|22|||
145618922|NCT00136916|525119181|FG001|Overall Study|Other|24|||
145618923|NCT00136916|525119180|FG000|Overall Study|Discontinued in follow up period|3|||
145618924|NCT00136916|525119181|FG001|Overall Study|Discontinued in follow up period|0|||
145618925|NCT02213055|525119183|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
145618926|NCT02213055|525119184|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
145618927|NCT02213055|525119183|FG000|Overall Study|Protocol was not Followed during Study|1|||
145618928|NCT02213055|525119184|FG001|Overall Study|Protocol was not Followed during Study|0|||
145618929|NCT02213055|525119183|FG000|Overall Study|Documentation Issue at Enrollment|1|||
145618930|NCT02213055|525119184|FG001|Overall Study|Documentation Issue at Enrollment|0|||
145618931|NCT02213055|525119183|FG000|Overall Study|Documentation Issue during Study|10|||
145618932|NCT02213055|525119184|FG001|Overall Study|Documentation Issue during Study|0|||
145618933|NCT02213055|525119183|FG000|Overall Study|Did not have Live Lice|8|||
145618934|NCT02213055|525119184|FG001|Overall Study|Did not have Live Lice|0|||
145618935|NCT02213055|525119183|FG000|Overall Study|Had another Treatment during the Study|3|||
145618936|NCT02213055|525119184|FG001|Overall Study|Had another Treatment during the Study|0|||
145618937|NCT02213055|525119183|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
145618938|NCT02213055|525119184|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
145618939|NCT02213055|525119183|FG000|Overall Study|Did not Return to School|5|||
145618940|NCT02213055|525119184|FG001|Overall Study|Did not Return to School|0|||
145618941|NCT00231894|525119185|FG000|Overall Study|Withdrawal by Subject|1|||
145618942|NCT00231894|525119186|FG001|Overall Study|Withdrawal by Subject|1|||
145618943|NCT02025205|525119188|FG000|Overall Study|Withdrawal by Subject|1|||
145618944|NCT02025205|525119189|FG001|Overall Study|Withdrawal by Subject|1|||
145618945|NCT02025205|525119188|FG000|Overall Study|Protocol Violation|2|||
145618946|NCT02025205|525119189|FG001|Overall Study|Protocol Violation|1|||
145618947|NCT02025205|525119188|FG000|Overall Study|Death|0|||
145618948|NCT02025205|525119189|FG001|Overall Study|Death|1|||
145618949|NCT01767129|525119190|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
145618950|NCT01767129|525119191|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145618951|NCT01024751|525119192|FG000|Enrolled Participants|Ineligible at baseline|3|||
145618952|NCT01024751|525119193|FG001|Enrolled Participants|Ineligible at baseline|4|||
145618953|NCT01024751|525119192|FG000|Eligible Participants|Withdrawal by Subject|0|||
145560980|NCT02082210|524914376|FG001|Overall Study|Withdrawal by Subject|0|||
145560981|NCT02082210|524914377|FG002|Overall Study|Withdrawal by Subject|0|||
145560982|NCT02082210|524914378|FG003|Overall Study|Withdrawal by Subject|1|||
145560983|NCT02082210|524914379|FG004|Overall Study|Withdrawal by Subject|2|||
145560984|NCT02082210|524914380|FG005|Overall Study|Withdrawal by Subject|2|||
145560985|NCT02082210|524914375|FG000|Overall Study|Clinical Progression|0|||
145560986|NCT02082210|524914376|FG001|Overall Study|Clinical Progression|0|||
145560987|NCT02082210|524914377|FG002|Overall Study|Clinical Progression|0|||
145560988|NCT02082210|524914378|FG003|Overall Study|Clinical Progression|1|||
145560989|NCT02082210|524914379|FG004|Overall Study|Clinical Progression|0|||
145560990|NCT02082210|524914380|FG005|Overall Study|Clinical Progression|0|||
145560991|NCT02082210|524914375|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
145560992|NCT02082210|524914376|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
145560993|NCT02082210|524914377|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
145560994|NCT02082210|524914378|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
145560995|NCT02082210|524914379|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
145560996|NCT02082210|524914380|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
145560997|NCT02082210|524914375|FG000|Overall Study|Physician Decision|0|||
145560998|NCT02082210|524914376|FG001|Overall Study|Physician Decision|0|||
145560999|NCT02082210|524914377|FG002|Overall Study|Physician Decision|1|||
145561000|NCT02082210|524914378|FG003|Overall Study|Physician Decision|1|||
145561001|NCT02082210|524914379|FG004|Overall Study|Physician Decision|0|||
145561002|NCT02082210|524914380|FG005|Overall Study|Physician Decision|0|||
145561003|NCT01727141|524914385|FG000|Overall Study|Physician Decision|0|||
145561004|NCT01727141|524914386|FG001|Overall Study|Physician Decision|1|||
145561005|NCT01727141|524914387|FG002|Overall Study|Physician Decision|0|||
145561006|NCT01727141|524914388|FG003|Overall Study|Physician Decision|2|||
145561007|NCT01727141|524914385|FG000|Overall Study|Lost to Follow-up|0|||
145561008|NCT01727141|524914386|FG001|Overall Study|Lost to Follow-up|2|||
145561009|NCT01727141|524914387|FG002|Overall Study|Lost to Follow-up|0|||
145561010|NCT01727141|524914388|FG003|Overall Study|Lost to Follow-up|0|||
145561011|NCT01727141|524914385|FG000|Overall Study|Death|0|||
145561012|NCT01727141|524914386|FG001|Overall Study|Death|1|||
145561013|NCT01727141|524914387|FG002|Overall Study|Death|1|||
145561014|NCT01727141|524914388|FG003|Overall Study|Death|1|||
145561015|NCT01727141|524914385|FG000|Overall Study|Protocol deviation|1|||
145561016|NCT01727141|524914386|FG001|Overall Study|Protocol deviation|1|||
145561017|NCT01727141|524914387|FG002|Overall Study|Protocol deviation|0|||
145561018|NCT01727141|524914388|FG003|Overall Study|Protocol deviation|1|||
145561019|NCT01727141|524914385|FG000|Overall Study|Withdrawal by Subject|4|||
145561020|NCT01727141|524914386|FG001|Overall Study|Withdrawal by Subject|4|||
145561021|NCT01727141|524914387|FG002|Overall Study|Withdrawal by Subject|2|||
145561022|NCT01727141|524914388|FG003|Overall Study|Withdrawal by Subject|11|||
145561023|NCT02584504|524914389|FG000|Double-blind Treatment|Participant withdrew consent|0|||
145561024|NCT02584504|524914390|FG001|Double-blind Treatment|Participant withdrew consent|0|||
145561025|NCT02584504|524914391|FG002|Double-blind Treatment|Participant withdrew consent|1|||
145561026|NCT02584504|524914389|FG000|Double-blind Treatment|Adverse Event|0|||
145561027|NCT02584504|524914390|FG001|Double-blind Treatment|Adverse Event|1|||
145561028|NCT02584504|524914391|FG002|Double-blind Treatment|Adverse Event|0|||
145561029|NCT02584504|524914389|FG000|Double-blind Treatment|Family Matter|0|||
145561030|NCT02584504|524914390|FG001|Double-blind Treatment|Family Matter|1|||
145561031|NCT02584504|524914391|FG002|Double-blind Treatment|Family Matter|0|||
145561032|NCT02584504|524914389|FG000|Open-label Treatment|Participant withdrew consent|0|||
145561033|NCT02584504|524914390|FG001|Open-label Treatment|Participant withdrew consent|0|||
145561034|NCT02584504|524914391|FG002|Open-label Treatment|Participant withdrew consent|4|||
145561035|NCT02584504|524914389|FG000|Open-label Treatment|Adverse Event|2|||
145561036|NCT02584504|524914390|FG001|Open-label Treatment|Adverse Event|2|||
145561037|NCT02584504|524914391|FG002|Open-label Treatment|Adverse Event|3|||
145561038|NCT02584504|524914389|FG000|Open-label Treatment|Physician Decision|0|||
145561039|NCT02584504|524914390|FG001|Open-label Treatment|Physician Decision|1|||
145561040|NCT02584504|524914391|FG002|Open-label Treatment|Physician Decision|0|||
145561041|NCT02584504|524914389|FG000|Open-label Treatment|Entered but not treated|0|||
145561042|NCT02584504|524914390|FG001|Open-label Treatment|Entered but not treated|1|||
145561043|NCT02584504|524914391|FG002|Open-label Treatment|Entered but not treated|1|||
145561044|NCT03425331|524914392|FG000|Overall Study|Withdrawal by Subject|1|||
145561045|NCT03425331|524914392|FG000|Overall Study|Death|1|||
145561046|NCT03425331|524914392|FG000|Overall Study|Adverse Event|1|||
145561047|NCT03425331|524914392|FG000|Overall Study|Disease Progression|2|||
145561048|NCT01413360|524914395|FG000|Overall Study|Lost to Follow-up|2|||
145561049|NCT01413360|524914395|FG000|Overall Study|Adverse Event|1|||
145561050|NCT02246673|524914398|FG000|Overall Study|Sponsor Decision|1|||
145561051|NCT02246673|524914399|FG001|Overall Study|Sponsor Decision|0|||
145561052|NCT02246673|524914400|FG002|Overall Study|Sponsor Decision|0|||
145561053|NCT02246673|524914401|FG003|Overall Study|Sponsor Decision|0|||
145561054|NCT02246673|524914402|FG004|Overall Study|Sponsor Decision|0|||
145561055|NCT02246673|524914398|FG000|Overall Study|Withdrawal by Subject|0|||
145561056|NCT02246673|524914399|FG001|Overall Study|Withdrawal by Subject|0|||
145561057|NCT02246673|524914400|FG002|Overall Study|Withdrawal by Subject|0|||
145561058|NCT02246673|524914401|FG003|Overall Study|Withdrawal by Subject|0|||
145561059|NCT02246673|524914402|FG004|Overall Study|Withdrawal by Subject|1|||
145561060|NCT02246673|524914398|FG000|Overall Study|Lost to Follow-up|0|||
145561061|NCT02246673|524914399|FG001|Overall Study|Lost to Follow-up|0|||
145561062|NCT02246673|524914400|FG002|Overall Study|Lost to Follow-up|0|||
145561063|NCT02246673|524914401|FG003|Overall Study|Lost to Follow-up|1|||
145561064|NCT02246673|524914402|FG004|Overall Study|Lost to Follow-up|0|||
145561065|NCT02246673|524914398|FG000|Overall Study|Protocol Violation|0|||
145561066|NCT02246673|524914399|FG001|Overall Study|Protocol Violation|0|||
145561067|NCT02246673|524914400|FG002|Overall Study|Protocol Violation|0|||
145561068|NCT02246673|524914401|FG003|Overall Study|Protocol Violation|1|||
145561069|NCT02246673|524914402|FG004|Overall Study|Protocol Violation|0|||
145561070|NCT02418468|524914404|FG000|Overall Study|Adverse Event|1|||
145561071|NCT02418468|524914405|FG001|Overall Study|Adverse Event|0|||
145561072|NCT02418468|524914404|FG000|Overall Study|Withdrawal of informed consent|1|||
145561073|NCT02418468|524914405|FG001|Overall Study|Withdrawal of informed consent|1|||
145561074|NCT02914769|524914406|FG000|Overall Study|Protocol Violation|3|||
145561075|NCT02914769|524914407|FG001|Overall Study|Protocol Violation|2|||
145561076|NCT02914769|524914406|FG000|Overall Study|Withdrawal by Subject|0|||
145561077|NCT02914769|524914407|FG001|Overall Study|Withdrawal by Subject|1|||
145561078|NCT04356963|524914411|FG000|First Session|Withdrawal by Subject|1|||
145561079|NCT04356963|524914411|FG000|Second Session|Withdrawal by Subject|3|||
145561080|NCT04356963|524914411|FG000|Second Session|Lost to Follow-up|1|||
145561081|NCT04356963|524914411|FG000|Third Session|Lost to Follow-up|6|||
145561082|NCT04356963|524914411|FG000|Third Session|Withdrawal by Subject|1|||
145618954|NCT01024751|525119193|FG001|Eligible Participants|Withdrawal by Subject|1|||
145618955|NCT01024751|525119192|FG000|Eligible Participants|Lost to Follow-up|0|||
145561083|NCT02488681|524914413|FG000|Overall Study|Implant unsuccessful|7|||
145561084|NCT05413369|524914414|FG000|Overall Study|Adverse Event|1|||
145561085|NCT05413369|524914415|FG001|Overall Study|Adverse Event|1|||
145561086|NCT05413369|524914414|FG000|Overall Study|Withdrawal by Subject|13|||
145561087|NCT05413369|524914415|FG001|Overall Study|Withdrawal by Subject|4|||
145561088|NCT05413369|524914414|FG000|Overall Study|Non-compliance with study schedule|2|||
145561089|NCT05413369|524914415|FG001|Overall Study|Non-compliance with study schedule|1|||
145561090|NCT05413369|524914414|FG000|Overall Study|Other|1|||
145561091|NCT05413369|524914415|FG001|Overall Study|Other|1|||
145561092|NCT02809677|524914417|FG000|Overall Study|Withdrawal by Subject|8|||
145294328|NCT00864097|523927588|FG003|Overall Study|Other|1|||
145294329|NCT05956665|523927600|FG000|Overall Study|Death|1|||
145561093|NCT00720057|524914418|FG000|Overall Study|Lost to Follow-up|0|||
145561094|NCT00720057|524914419|FG001|Overall Study|Lost to Follow-up|2|||
145561095|NCT00720057|524914418|FG000|Overall Study|Protocol Violation|1|||
145561096|NCT00720057|524914419|FG001|Overall Study|Protocol Violation|0|||
145561097|NCT00720057|524914418|FG000|Overall Study|Withdrawal by Subject|0|||
145561098|NCT00720057|524914419|FG001|Overall Study|Withdrawal by Subject|1|||
145294330|NCT05956665|523927600|FG000|Overall Study|Withdrawal by Subject|1|||
145294331|NCT01939197|523927601|FG000|Overall Study|Withdrawal by Subject|1|||
145561099|NCT04969224|524914424|FG000|Overall Study|Adverse Event|1|||
145561100|NCT04969224|524914424|FG000|Overall Study|Enrolled but never dosed|1|||
145561101|NCT00579826|524914429|FG000|Overall Study|Withdrawal by Subject|5|||
145561102|NCT00579826|524914430|FG001|Overall Study|Withdrawal by Subject|3|||
145561103|NCT00304356|524914432|FG000|Nitazoxanide|Physician Decision|5|||
145561104|NCT00304356|524914432|FG000|Nitazoxanide|Physician Decision|1|||
145561105|NCT00304356|524914432|FG000|Nitazoxanide|number is 0|1|||
145561106|NCT00304356|524914432|FG000|Nitazoxanide|Physician Decision|1|||
145561107|NCT00304356|524914432|FG000|Nitazoxanide|Physician Decision|1|||
145561108|NCT00304356|524914432|FG000|Nitazoxanide|Physician Decision|1|||
145561109|NCT04120974|524914436|FG000|Overall Study|Death|1|||
145561110|NCT04120974|524914436|FG000|Overall Study|Physician Decision|1|||
145561111|NCT04120974|524914436|FG000|Overall Study|Lost to Follow-up|6|||
145561112|NCT00973479|524914439|FG000|Overall Study|Lost to Follow-up|0|||
145561113|NCT00973479|524914440|FG001|Overall Study|Lost to Follow-up|3|||
145561114|NCT00973479|524914439|FG000|Overall Study|Death|2|||
145561115|NCT00973479|524914440|FG001|Overall Study|Death|2|||
145561116|NCT00973479|524914439|FG000|Overall Study|Withdrawal by Subject|15|||
145561117|NCT00973479|524914440|FG001|Overall Study|Withdrawal by Subject|16|||
145561118|NCT00973479|524914439|FG000|Overall Study|Lack of Efficacy|5|||
145561119|NCT00973479|524914440|FG001|Overall Study|Lack of Efficacy|7|||
145561120|NCT00973479|524914439|FG000|Overall Study|Adverse Event|12|||
145561121|NCT00973479|524914440|FG001|Overall Study|Adverse Event|32|||
145561122|NCT00973479|524914439|FG000|Overall Study|Protocol Violation|2|||
145561123|NCT00973479|524914440|FG001|Overall Study|Protocol Violation|2|||
145561124|NCT00973479|524914439|FG000|Overall Study|Other|1|||
145561125|NCT00973479|524914440|FG001|Overall Study|Other|7|||
145561126|NCT05075850|524914441|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
145561127|NCT04256785|524914442|FG000|Overall Study|Adverse Event|8|||
145561128|NCT04256785|524914443|FG001|Overall Study|Adverse Event|6|||
145561129|NCT04256785|524914442|FG000|Overall Study|Lack of Efficacy|3|||
145561130|NCT04256785|524914443|FG001|Overall Study|Lack of Efficacy|4|||
145561131|NCT04256785|524914442|FG000|Overall Study|Lost to Follow-up|7|||
145561132|NCT04256785|524914443|FG001|Overall Study|Lost to Follow-up|7|||
145561133|NCT04256785|524914442|FG000|Overall Study|Protocol Violation|1|||
145561134|NCT04256785|524914443|FG001|Overall Study|Protocol Violation|0|||
145561135|NCT04256785|524914442|FG000|Overall Study|Withdrawal by Subject|4|||
145561136|NCT04256785|524914443|FG001|Overall Study|Withdrawal by Subject|1|||
145561137|NCT04256785|524914442|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
145561138|NCT04256785|524914443|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
145561139|NCT01265849|524914444|FG000|Overall Study|Randomized//Treatment not initiated|1|||
145561140|NCT01265849|524914445|FG001|Overall Study|Randomized//Treatment not initiated|4|||
145561141|NCT01265849|524914446|FG002|Overall Study|Randomized//Treatment not initiated|0|||
145561142|NCT01265849|524914444|FG000|Overall Study|Physician Decision|1|||
145561143|NCT01265849|524914445|FG001|Overall Study|Physician Decision|2|||
145561144|NCT01265849|524914446|FG002|Overall Study|Physician Decision|0|||
145561145|NCT01265849|524914444|FG000|Overall Study|Lost to Follow-up|18|||
145561146|NCT01265849|524914445|FG001|Overall Study|Lost to Follow-up|15|||
145561147|NCT01265849|524914446|FG002|Overall Study|Lost to Follow-up|5|||
145561148|NCT01265849|524914444|FG000|Overall Study|Not otherwise specified|1|||
145561149|NCT01265849|524914445|FG001|Overall Study|Not otherwise specified|6|||
145561150|NCT01265849|524914446|FG002|Overall Study|Not otherwise specified|1|||
145561151|NCT01265849|524914444|FG000|Overall Study|Withdrawal by Subject|25|||
145561152|NCT01265849|524914445|FG001|Overall Study|Withdrawal by Subject|34|||
145561153|NCT01265849|524914446|FG002|Overall Study|Withdrawal by Subject|13|||
145561154|NCT01170091|524914448|FG000|Overall Study|Missing efficacy evaluation|3|||
145561155|NCT01170091|524914448|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
145561156|NCT03194321|524914449|FG000|Overall Study|Withdrawal by Subject|1|||
145561157|NCT03194321|524914449|FG000|Overall Study|Lost to Follow-up|1|||
145561158|NCT03194321|524914449|FG000|Overall Study|Travel for Follow-up|1|||
145561159|NCT00271609|524914450|FG000|Overall Study|Adverse Event|11|||
145561160|NCT00271609|524914451|FG001|Overall Study|Adverse Event|3|||
145561161|NCT00271609|524914450|FG000|Overall Study|Withdrawal by Subject|2|||
145561162|NCT00271609|524914451|FG001|Overall Study|Withdrawal by Subject|0|||
145561163|NCT02188589|524914452|FG000|Overall Study|Withdrawal by Subject|5|||
145561164|NCT03341533|524914453|FG000|Overall Study|Withdrawal by Subject|1|||
145561165|NCT03341533|524914454|FG001|Overall Study|Withdrawal by Subject|1|||
145561166|NCT03341533|524914453|FG000|Overall Study|Not eligible after randomization|2|||
145561167|NCT03341533|524914454|FG001|Overall Study|Not eligible after randomization|1|||
145561168|NCT01675128|524914455|FG000|Overall Study|Disease progression on study|1|||
145561169|NCT01675128|524914456|FG001|Overall Study|Disease progression on study|1|||
145561170|NCT01675128|524914457|FG002|Overall Study|Disease progression on study|1|||
145561171|NCT01675128|524914455|FG000|Overall Study|Refused further treatment|1|||
145561172|NCT01675128|524914456|FG001|Overall Study|Refused further treatment|0|||
145407973|NCT03034967|524349777|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
145407974|NCT03034967|524349778|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
145407975|NCT03034967|524349779|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
145561173|NCT01675128|524914457|FG002|Overall Study|Refused further treatment|0|||
145561174|NCT01675128|524914455|FG000|Overall Study|Pulmonary complication; off study|0|||
145561175|NCT01675128|524914456|FG001|Overall Study|Pulmonary complication; off study|1|||
145561176|NCT01675128|524914457|FG002|Overall Study|Pulmonary complication; off study|0|||
145561177|NCT03526458|524914458|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
145561178|NCT03526458|524914459|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
145561179|NCT03526458|524914458|FG000|Overall Study|Stone passed, surgery cancelled|2|||
145561180|NCT03526458|524914459|FG001|Overall Study|Stone passed, surgery cancelled|1|||
145561181|NCT03526458|524914458|FG000|Overall Study|Withdrawal by Subject|1|||
145561182|NCT03526458|524914459|FG001|Overall Study|Withdrawal by Subject|0|||
145561183|NCT03526458|524914458|FG000|Overall Study|Physician Decision|2|||
145561184|NCT03526458|524914459|FG001|Overall Study|Physician Decision|1|||
145561185|NCT03526458|524914458|FG000|Overall Study|Lack of equipment|1|||
145561186|NCT03526458|524914459|FG001|Overall Study|Lack of equipment|1|||
145561187|NCT03011307|524914460|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
145561188|NCT03011307|524914461|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
145561189|NCT03011307|524914460|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
145561190|NCT03011307|524914461|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
145561191|NCT03011307|524914460|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
145561192|NCT03011307|524914461|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
145561193|NCT01782664|524914462|FG000|Overall Study|Adverse Event|2|||
145561194|NCT01782664|524914463|FG001|Overall Study|Adverse Event|2|||
145561195|NCT01782664|524914464|FG002|Overall Study|Adverse Event|2|||
145561196|NCT01782664|524914465|FG003|Overall Study|Adverse Event|2|||
145561197|NCT01782664|524914466|FG004|Overall Study|Adverse Event|0|||
145561198|NCT01782664|524914467|FG005|Overall Study|Adverse Event|0|||
145561199|NCT01782664|524914462|FG000|Overall Study|Lack of Efficacy|2|||
145561200|NCT01782664|524914463|FG001|Overall Study|Lack of Efficacy|0|||
145561201|NCT01782664|524914464|FG002|Overall Study|Lack of Efficacy|2|||
145561202|NCT01782664|524914465|FG003|Overall Study|Lack of Efficacy|2|||
145407976|NCT03034967|524349780|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
145618956|NCT01024751|525119193|FG001|Eligible Participants|Lost to Follow-up|1|||
145618957|NCT01024751|525119192|FG000|Eligible Participants|Ineligible|0|||
145618958|NCT01024751|525119193|FG001|Eligible Participants|Ineligible|1|||
145618959|NCT03246672|525119195|FG000|Overall Study|Lost to Follow-up|2|||
145618960|NCT02500316|525119196|FG000|Overall Study|Adverse Event|3|||
145618961|NCT02500316|525119196|FG000|Overall Study|Lost to Follow-up|2|||
145618962|NCT02500316|525119196|FG000|Overall Study|Protocol Violation|1|||
145618963|NCT02500316|525119196|FG000|Overall Study|Withdrawal by Subject|15|||
145618964|NCT02500316|525119196|FG000|Overall Study|Final height achieved|5|||
145618965|NCT02500316|525119196|FG000|Overall Study|Due to war activity|1|||
145618966|NCT01406717|525119197|FG000|Overall Study|Subject non-compliance|4|||
145618967|NCT01406717|525119198|FG001|Overall Study|Subject non-compliance|3|||
145618968|NCT01406717|525119197|FG000|Overall Study|Protocol Violation|5|||
145618969|NCT01406717|525119198|FG001|Overall Study|Protocol Violation|1|||
145618970|NCT01406717|525119197|FG000|Overall Study|Lost to Follow-up|14|||
145618971|NCT01406717|525119198|FG001|Overall Study|Lost to Follow-up|8|||
145618972|NCT01406717|525119197|FG000|Overall Study|Withdrawal by Subject|19|||
145618973|NCT01406717|525119198|FG001|Overall Study|Withdrawal by Subject|15|||
145618974|NCT01406717|525119197|FG000|Overall Study|Adverse Event|1|||
145618975|NCT01406717|525119198|FG001|Overall Study|Adverse Event|2|||
145618976|NCT01406717|525119197|FG000|Overall Study|Lack of Efficacy|0|||
145618977|NCT01406717|525119198|FG001|Overall Study|Lack of Efficacy|1|||
145618978|NCT01406717|525119197|FG000|Overall Study|Non-completion of visit activity|0|||
145618979|NCT01406717|525119198|FG001|Overall Study|Non-completion of visit activity|1|||
145618980|NCT03257995|525119199|FG000|Overall Study|Adverse Event|0|||
145618981|NCT03257995|525119200|FG001|Overall Study|Adverse Event|1|||
145618982|NCT03257995|525119201|FG002|Overall Study|Adverse Event|0|||
145618983|NCT03257995|525119202|FG003|Overall Study|Adverse Event|0|||
145618984|NCT03257995|525119203|FG004|Overall Study|Adverse Event|0|||
145618985|NCT03257995|525119204|FG005|Overall Study|Adverse Event|0|||
145618986|NCT03257995|525119199|FG000|Overall Study|Protocol deviation|0|||
145618987|NCT03257995|525119200|FG001|Overall Study|Protocol deviation|0|||
145618988|NCT03257995|525119201|FG002|Overall Study|Protocol deviation|0|||
145618989|NCT03257995|525119202|FG003|Overall Study|Protocol deviation|0|||
145618990|NCT03257995|525119203|FG004|Overall Study|Protocol deviation|0|||
145618991|NCT03257995|525119204|FG005|Overall Study|Protocol deviation|2|||
145618992|NCT01987830|525119213|FG000|Overall Study|Never received baseline scan|1|||
145618993|NCT00057811|525119222|FG000|Overall Study|Lack of Efficacy|1|||
145618994|NCT00057811|525119223|FG001|Overall Study|Lack of Efficacy|4|||
145618995|NCT00057811|525119222|FG000|Overall Study|Physician Decision|1|||
145618996|NCT00057811|525119223|FG001|Overall Study|Physician Decision|0|||
145618997|NCT00057811|525119222|FG000|Overall Study|Withdrawal by Subject|3|||
145618998|NCT00057811|525119223|FG001|Overall Study|Withdrawal by Subject|4|||
145618999|NCT00057811|525119222|FG000|Overall Study|Ineligible|4|||
145619000|NCT00057811|525119223|FG001|Overall Study|Ineligible|2|||
145619001|NCT00057811|525119222|FG000|Overall Study|Inevaluable|1|||
145619002|NCT00057811|525119223|FG001|Overall Study|Inevaluable|2|||
145619003|NCT00556374|525119224|FG000|Overall Study|Withdrawal by Subject|235|||
145619004|NCT00556374|525119225|FG001|Overall Study|Withdrawal by Subject|205|||
145619005|NCT00556374|525119224|FG000|Overall Study|Death|158|||
145619006|NCT00556374|525119225|FG001|Overall Study|Death|127|||
145619007|NCT00556374|525119224|FG000|Overall Study|Lost to Follow-up|24|||
145619008|NCT00556374|525119225|FG001|Overall Study|Lost to Follow-up|17|||
145619009|NCT00556374|525119224|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
145619010|NCT00556374|525119225|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
145619011|NCT04131907|525119226|FG000|Overall Study|Adverse Event|2|||
145619012|NCT04131907|525119227|FG001|Overall Study|Adverse Event|0|||
145619013|NCT04131907|525119228|FG002|Overall Study|Adverse Event|0|||
145619014|NCT04131907|525119226|FG000|Overall Study|Physician Decision|4|||
145619015|NCT04131907|525119227|FG001|Overall Study|Physician Decision|22|||
145619016|NCT04131907|525119228|FG002|Overall Study|Physician Decision|0|||
145619017|NCT04131907|525119226|FG000|Overall Study|Withdrawal by Subject|2|||
145619018|NCT04131907|525119227|FG001|Overall Study|Withdrawal by Subject|0|||
145619019|NCT04131907|525119228|FG002|Overall Study|Withdrawal by Subject|1|||
145619020|NCT04131907|525119226|FG000|Overall Study|Treatment failure|2|||
145619021|NCT04131907|525119227|FG001|Overall Study|Treatment failure|0|||
145619022|NCT04131907|525119228|FG002|Overall Study|Treatment failure|1|||
145619023|NCT02036515|525119229|FG000|Overall Study|Adverse Event|1|||
145619024|NCT02036515|525119230|FG001|Overall Study|Adverse Event|1|||
145619025|NCT02036515|525119231|FG002|Overall Study|Adverse Event|2|||
145619026|NCT02036515|525119229|FG000|Overall Study|Lost to Follow-up|0|||
145619027|NCT02036515|525119230|FG001|Overall Study|Lost to Follow-up|2|||
145619028|NCT02036515|525119231|FG002|Overall Study|Lost to Follow-up|0|||
145619029|NCT02036515|525119229|FG000|Overall Study|Non-compliance with study drug|0|||
145619030|NCT02036515|525119230|FG001|Overall Study|Non-compliance with study drug|0|||
145619031|NCT02036515|525119231|FG002|Overall Study|Non-compliance with study drug|2|||
145619032|NCT02036515|525119229|FG000|Overall Study|Screen failure|0|||
145619033|NCT02036515|525119230|FG001|Overall Study|Screen failure|2|||
145619034|NCT02036515|525119231|FG002|Overall Study|Screen failure|0|||
145619035|NCT02036515|525119229|FG000|Overall Study|Withdrawal by Subject|4|||
145619036|NCT02036515|525119230|FG001|Overall Study|Withdrawal by Subject|7|||
145619037|NCT02036515|525119231|FG002|Overall Study|Withdrawal by Subject|9|||
145619038|NCT02036515|525119229|FG000|Overall Study|Hyperglycemia|0|||
145619039|NCT02036515|525119230|FG001|Overall Study|Hyperglycemia|0|||
145619040|NCT02036515|525119231|FG002|Overall Study|Hyperglycemia|1|||
145619041|NCT02218489|525119234|FG000|Overall Study|Withdrawal by Subject|4|||
145619042|NCT02218489|525119235|FG001|Overall Study|Withdrawal by Subject|3|||
145619043|NCT02218489|525119234|FG000|Overall Study|Lost to Follow-up|1|||
145619044|NCT02218489|525119235|FG001|Overall Study|Lost to Follow-up|0|||
145619045|NCT01700348|525119236|FG000|Overall Study|Withdrawal by Subject|22|||
145619046|NCT01700348|525119236|FG000|Overall Study|Lost to Follow-up|1|||
145619047|NCT02404493|525119237|FG000|Overall Study|Adverse Event|1|||
145619048|NCT02404493|525119238|FG001|Overall Study|Adverse Event|1|||
145619049|NCT03958630|525119239|FG000|Overall Study|Withdrawal by Subject|0|||
145619050|NCT03958630|525119240|FG001|Overall Study|Withdrawal by Subject|0|||
145619051|NCT03958630|525119241|FG002|Overall Study|Withdrawal by Subject|1|||
145619052|NCT03958630|525119239|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
145619053|NCT03958630|525119240|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
145619054|NCT03958630|525119241|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
145619055|NCT04157686|525119246|FG000|Overall Study|Adverse Event|1|||
145619056|NCT04157686|525119247|FG001|Overall Study|Adverse Event|0|||
145619057|NCT04157686|525119248|FG002|Overall Study|Adverse Event|1|||
145619058|NCT04157686|525119249|FG003|Overall Study|Adverse Event|0|||
145619059|NCT04157686|525119250|FG004|Overall Study|Adverse Event|1|||
145561203|NCT01782664|524914466|FG004|Overall Study|Lack of Efficacy|0|||
145561204|NCT01782664|524914467|FG005|Overall Study|Lack of Efficacy|0|||
145561205|NCT01782664|524914462|FG000|Overall Study|Protocol Violation|0|||
145561206|NCT01782664|524914463|FG001|Overall Study|Protocol Violation|1|||
145561207|NCT01782664|524914464|FG002|Overall Study|Protocol Violation|0|||
145619060|NCT04157686|525119251|FG005|Overall Study|Adverse Event|0|||
145619061|NCT04157686|525119252|FG006|Overall Study|Adverse Event|0|||
145619062|NCT04157686|525119253|FG007|Overall Study|Adverse Event|0|||
145619063|NCT04157686|525119246|FG000|Overall Study|Pregnancy|0|||
145619064|NCT04157686|525119247|FG001|Overall Study|Pregnancy|1|||
145619065|NCT04157686|525119248|FG002|Overall Study|Pregnancy|3|||
145619066|NCT04157686|525119249|FG003|Overall Study|Pregnancy|0|||
145619067|NCT04157686|525119250|FG004|Overall Study|Pregnancy|0|||
145619068|NCT04157686|525119251|FG005|Overall Study|Pregnancy|0|||
145619069|NCT04157686|525119252|FG006|Overall Study|Pregnancy|3|||
145619070|NCT04157686|525119253|FG007|Overall Study|Pregnancy|0|||
145619071|NCT04157686|525119246|FG000|Overall Study|Lost to Follow-up|1|||
145619072|NCT04157686|525119247|FG001|Overall Study|Lost to Follow-up|2|||
145561208|NCT01782664|524914465|FG003|Overall Study|Protocol Violation|1|||
145619073|NCT04157686|525119248|FG002|Overall Study|Lost to Follow-up|8|||
145619074|NCT04157686|525119249|FG003|Overall Study|Lost to Follow-up|6|||
145619075|NCT04157686|525119250|FG004|Overall Study|Lost to Follow-up|6|||
145619076|NCT04157686|525119251|FG005|Overall Study|Lost to Follow-up|3|||
145561209|NCT01782664|524914466|FG004|Overall Study|Protocol Violation|0|||
145561210|NCT01782664|524914467|FG005|Overall Study|Protocol Violation|0|||
145561211|NCT01782664|524914462|FG000|Overall Study|Withdrawal by Subject|2|||
145619077|NCT04157686|525119252|FG006|Overall Study|Lost to Follow-up|7|||
145561212|NCT01782664|524914463|FG001|Overall Study|Withdrawal by Subject|2|||
145561213|NCT01782664|524914464|FG002|Overall Study|Withdrawal by Subject|0|||
145561214|NCT01782664|524914465|FG003|Overall Study|Withdrawal by Subject|0|||
145619078|NCT04157686|525119253|FG007|Overall Study|Lost to Follow-up|9|||
145561215|NCT01782664|524914466|FG004|Overall Study|Withdrawal by Subject|0|||
145619079|NCT04157686|525119246|FG000|Overall Study|Lack of Efficacy|0|||
145619080|NCT04157686|525119247|FG001|Overall Study|Lack of Efficacy|0|||
145619081|NCT04157686|525119248|FG002|Overall Study|Lack of Efficacy|0|||
145619082|NCT04157686|525119249|FG003|Overall Study|Lack of Efficacy|0|||
145619083|NCT04157686|525119250|FG004|Overall Study|Lack of Efficacy|0|||
145619084|NCT04157686|525119251|FG005|Overall Study|Lack of Efficacy|2|||
145619085|NCT04157686|525119252|FG006|Overall Study|Lack of Efficacy|0|||
145619086|NCT04157686|525119253|FG007|Overall Study|Lack of Efficacy|1|||
145619087|NCT04157686|525119246|FG000|Overall Study|Withdrawal by Subject|10|||
145407977|NCT03034967|524349781|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
145407978|NCT02763566|524349798|FG000|Overall Study|Lost to Follow-up|1|||
145561216|NCT01782664|524914467|FG005|Overall Study|Withdrawal by Subject|0|||
145561217|NCT00698581|524914470|FG000|Overall Study|Lack of Efficacy|23|||
145561218|NCT00698581|524914471|FG001|Overall Study|Lack of Efficacy|11|||
145561219|NCT00698581|524914470|FG000|Overall Study|Withdrawal by Subject|6|||
145561220|NCT00698581|524914471|FG001|Overall Study|Withdrawal by Subject|0|||
145561221|NCT00698581|524914470|FG000|Overall Study|Other reason|9|||
145561222|NCT00698581|524914471|FG001|Overall Study|Other reason|1|||
145561223|NCT00698581|524914470|FG000|Overall Study|SAE, non-fatal|1|||
145561224|NCT00698581|524914471|FG001|Overall Study|SAE, non-fatal|0|||
145561225|NCT00698581|524914470|FG000|Overall Study|AE, non-serious non-fatal|4|||
145561226|NCT00698581|524914471|FG001|Overall Study|AE, non-serious non-fatal|0|||
145561227|NCT00698581|524914470|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145561228|NCT00698581|524914471|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145561229|NCT00698581|524914470|FG000|Overall Study|AE of unknown type|1|||
145561230|NCT00698581|524914471|FG001|Overall Study|AE of unknown type|0|||
145561231|NCT03760146|524914472|FG000|Overall Study|Adverse Event|11|||
145561232|NCT03760146|524914473|FG001|Overall Study|Adverse Event|8|||
145561233|NCT03760146|524914474|FG002|Overall Study|Adverse Event|0|||
145561234|NCT03760146|524914475|FG003|Overall Study|Adverse Event|0|||
145561235|NCT03760146|524914476|FG004|Overall Study|Adverse Event|0|||
145561236|NCT03760146|524914477|FG005|Overall Study|Adverse Event|0|||
145561237|NCT03760146|524914472|FG000|Overall Study|Death|1|||
145294332|NCT01939197|523927602|FG001|Overall Study|Withdrawal by Subject|0|||
145561238|NCT03760146|524914473|FG001|Overall Study|Death|0|||
145561239|NCT03760146|524914474|FG002|Overall Study|Death|0|||
145561240|NCT03760146|524914475|FG003|Overall Study|Death|0|||
145561241|NCT03760146|524914476|FG004|Overall Study|Death|0|||
145561242|NCT03760146|524914477|FG005|Overall Study|Death|0|||
145561243|NCT03760146|524914472|FG000|Overall Study|Lost to Follow-up|41|||
145561244|NCT03760146|524914473|FG001|Overall Study|Lost to Follow-up|28|||
145561245|NCT03760146|524914474|FG002|Overall Study|Lost to Follow-up|9|||
145561246|NCT03760146|524914475|FG003|Overall Study|Lost to Follow-up|2|||
145619088|NCT04157686|525119247|FG001|Overall Study|Withdrawal by Subject|10|||
145619089|NCT04157686|525119248|FG002|Overall Study|Withdrawal by Subject|12|||
145619090|NCT04157686|525119249|FG003|Overall Study|Withdrawal by Subject|20|||
145619091|NCT04157686|525119250|FG004|Overall Study|Withdrawal by Subject|12|||
145619092|NCT04157686|525119251|FG005|Overall Study|Withdrawal by Subject|11|||
145619093|NCT04157686|525119252|FG006|Overall Study|Withdrawal by Subject|18|||
145619094|NCT04157686|525119253|FG007|Overall Study|Withdrawal by Subject|24|||
145619095|NCT04157686|525119246|FG000|Overall Study|Physician Decision|0|||
145619096|NCT04157686|525119247|FG001|Overall Study|Physician Decision|0|||
145619097|NCT04157686|525119248|FG002|Overall Study|Physician Decision|1|||
145619098|NCT04157686|525119249|FG003|Overall Study|Physician Decision|0|||
145619099|NCT04157686|525119250|FG004|Overall Study|Physician Decision|1|||
145619100|NCT04157686|525119251|FG005|Overall Study|Physician Decision|0|||
145619101|NCT04157686|525119252|FG006|Overall Study|Physician Decision|3|||
145619102|NCT04157686|525119253|FG007|Overall Study|Physician Decision|0|||
145619103|NCT04157686|525119246|FG000|Overall Study|Death|0|||
145619104|NCT04157686|525119247|FG001|Overall Study|Death|0|||
145561247|NCT03760146|524914476|FG004|Overall Study|Lost to Follow-up|14|||
145561248|NCT03760146|524914477|FG005|Overall Study|Lost to Follow-up|8|||
145561249|NCT03760146|524914472|FG000|Overall Study|No longer met eligibility criteria|3|||
145561250|NCT03760146|524914473|FG001|Overall Study|No longer met eligibility criteria|9|||
145561251|NCT03760146|524914474|FG002|Overall Study|No longer met eligibility criteria|0|||
145561252|NCT03760146|524914475|FG003|Overall Study|No longer met eligibility criteria|0|||
145561253|NCT03760146|524914476|FG004|Overall Study|No longer met eligibility criteria|1|||
145561254|NCT03760146|524914477|FG005|Overall Study|No longer met eligibility criteria|0|||
145561255|NCT03760146|524914472|FG000|Overall Study|Protocol Violation|21|||
145561256|NCT03760146|524914473|FG001|Overall Study|Protocol Violation|13|||
145561257|NCT03760146|524914474|FG002|Overall Study|Protocol Violation|1|||
145561258|NCT03760146|524914475|FG003|Overall Study|Protocol Violation|0|||
145619105|NCT04157686|525119248|FG002|Overall Study|Death|0|||
145619106|NCT04157686|525119249|FG003|Overall Study|Death|2|||
145619107|NCT04157686|525119250|FG004|Overall Study|Death|0|||
145619108|NCT04157686|525119251|FG005|Overall Study|Death|0|||
145619109|NCT04157686|525119252|FG006|Overall Study|Death|0|||
145619110|NCT04157686|525119253|FG007|Overall Study|Death|0|||
145619111|NCT04157686|525119246|FG000|Overall Study|Protocol Violation|0|||
145619112|NCT04157686|525119247|FG001|Overall Study|Protocol Violation|0|||
145619113|NCT04157686|525119248|FG002|Overall Study|Protocol Violation|0|||
145619114|NCT04157686|525119249|FG003|Overall Study|Protocol Violation|0|||
145619115|NCT04157686|525119250|FG004|Overall Study|Protocol Violation|1|||
145619116|NCT04157686|525119251|FG005|Overall Study|Protocol Violation|0|||
145619117|NCT04157686|525119252|FG006|Overall Study|Protocol Violation|0|||
145619118|NCT04157686|525119253|FG007|Overall Study|Protocol Violation|0|||
145619119|NCT04157686|525119246|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
145619120|NCT04157686|525119247|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
145619121|NCT04157686|525119248|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
145619122|NCT04157686|525119249|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
145619123|NCT04157686|525119250|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
145619124|NCT04157686|525119251|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
145619125|NCT04157686|525119252|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
145619126|NCT04157686|525119253|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
145619127|NCT02601937|525119260|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619128|NCT02601937|525119261|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619129|NCT02601937|525119262|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619130|NCT02601937|525119263|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619131|NCT02601937|525119264|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619132|NCT02601937|525119265|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
145619133|NCT02601937|525119266|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619134|NCT02601937|525119267|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619135|NCT02601937|525119268|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619136|NCT02601937|525119269|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619137|NCT02601937|525119270|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
145619138|NCT02601937|525119260|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
145619139|NCT02601937|525119261|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619140|NCT02601937|525119262|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619141|NCT02601937|525119263|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619142|NCT02601937|525119264|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619143|NCT02601937|525119265|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619144|NCT02601937|525119266|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
145619145|NCT02601937|525119267|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619146|NCT02601937|525119268|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619147|NCT02601937|525119269|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145655509|NCT02975882|525257248|FG003|Overall Study|Physician Decision|2|||
145407979|NCT02763566|524349799|FG001|Overall Study|Lost to Follow-up|4|||
145561259|NCT03760146|524914476|FG004|Overall Study|Protocol Violation|1|||
145561260|NCT03760146|524914477|FG005|Overall Study|Protocol Violation|0|||
145561261|NCT03760146|524914472|FG000|Overall Study|Withdrawal by Subject|19|||
145561262|NCT03760146|524914473|FG001|Overall Study|Withdrawal by Subject|20|||
145561263|NCT03760146|524914474|FG002|Overall Study|Withdrawal by Subject|1|||
145561264|NCT03760146|524914475|FG003|Overall Study|Withdrawal by Subject|0|||
145561265|NCT03760146|524914476|FG004|Overall Study|Withdrawal by Subject|1|||
145561266|NCT03760146|524914477|FG005|Overall Study|Withdrawal by Subject|0|||
145561267|NCT01082965|524914478|FG000|Overall Study|Protocol Violation|0|||
145561268|NCT01082965|524914479|FG001|Overall Study|Protocol Violation|1|||
145561269|NCT01082965|524914478|FG000|Overall Study|Other|1|||
145561270|NCT01082965|524914479|FG001|Overall Study|Other|1|||
145561271|NCT02587065|524914480|FG000|Overall Study|Adverse Event|14|||
145561272|NCT02587065|524914480|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
145561273|NCT02587065|524914480|FG000|Overall Study|Non-adherence to the Protocol|3|||
145561274|NCT02587065|524914480|FG000|Overall Study|Discontinuation of Study Medication|2|||
145561275|NCT02587065|524914480|FG000|Overall Study|Reason not Specified|3|||
145561276|NCT02642432|524914481|FG000|Overall Study|Adverse Event|2|||
145561277|NCT02642432|524914481|FG000|Overall Study|Withdrew Consent|1|||
145561278|NCT02642432|524914481|FG000|Overall Study|Lost to Follow-up|2|||
145561279|NCT02642432|524914481|FG000|Overall Study|Other|3|||
145561280|NCT03999892|524914482|FG000|Overall Study|Lost to Follow-up|1|||
145561281|NCT01848756|524914483|FG000|Overall Study|Adverse Event|1|||
145561282|NCT01848756|524914483|FG000|Overall Study|Withdrawal by Subject|1|||
145561283|NCT01848756|524914483|FG000|Overall Study|Enrolled in Error|1|||
145561284|NCT03245008|524914484|FG000|Overall Study|Adverse Event|15|||
145561285|NCT03245008|524914485|FG001|Overall Study|Adverse Event|18|||
145561286|NCT03245008|524914486|FG002|Overall Study|Adverse Event|15|||
145561287|NCT03245008|524914487|FG003|Overall Study|Adverse Event|0|||
145561288|NCT03245008|524914488|FG004|Overall Study|Adverse Event|1|||
145561289|NCT03245008|524914484|FG000|Overall Study|Lack of Efficacy|0|||
145561290|NCT03245008|524914485|FG001|Overall Study|Lack of Efficacy|1|||
145561291|NCT03245008|524914486|FG002|Overall Study|Lack of Efficacy|0|||
145619148|NCT02601937|525119270|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
145619149|NCT02601937|525119260|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619150|NCT02601937|525119261|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619151|NCT02601937|525119262|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
145619152|NCT02601937|525119263|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619153|NCT02601937|525119264|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619154|NCT02601937|525119265|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619155|NCT02601937|525119266|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619156|NCT02601937|525119267|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619157|NCT02601937|525119268|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619158|NCT02601937|525119269|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619159|NCT02601937|525119270|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
145619160|NCT02601937|525119260|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
145619161|NCT02601937|525119261|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
145619162|NCT02601937|525119262|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
145619163|NCT02601937|525119263|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
145619164|NCT02601937|525119264|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
145619165|NCT02601937|525119265|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
145619166|NCT02601937|525119266|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
145619167|NCT02601937|525119267|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
145619168|NCT02601937|525119268|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
145619169|NCT02601937|525119269|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
145619170|NCT02601937|525119270|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
145619171|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619172|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619173|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619174|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145655510|NCT02975882|525257245|FG000|Overall Study|Ineligible|0|||
145619175|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145294333|NCT01939197|523927603|FG002|Overall Study|Withdrawal by Subject|0|||
145294334|NCT01939197|523927604|FG003|Overall Study|Withdrawal by Subject|0|||
145294335|NCT01939197|523927605|FG004|Overall Study|Withdrawal by Subject|1|||
145294336|NCT01939197|523927606|FG005|Overall Study|Withdrawal by Subject|0|||
145294337|NCT01939197|523927607|FG006|Overall Study|Withdrawal by Subject|0|||
145294338|NCT01939197|523927601|FG000|Overall Study|Lost to Follow-up|0|||
145294339|NCT01939197|523927602|FG001|Overall Study|Lost to Follow-up|1|||
145294340|NCT01939197|523927603|FG002|Overall Study|Lost to Follow-up|0|||
145294341|NCT01939197|523927604|FG003|Overall Study|Lost to Follow-up|1|||
145619176|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145294342|NCT01939197|523927605|FG004|Overall Study|Lost to Follow-up|3|||
145619177|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619178|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619179|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619180|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
145619181|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
145619182|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619183|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619184|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619185|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619186|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619187|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619188|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619189|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
145619190|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619191|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619192|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
145619193|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619194|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619195|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619196|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619197|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145294343|NCT01939197|523927606|FG005|Overall Study|Lost to Follow-up|1|||
145294344|NCT01939197|523927607|FG006|Overall Study|Lost to Follow-up|2|||
145294345|NCT02545998|523927608|FG000|Overall Study|Lost to Follow-up|12|||
145561292|NCT03245008|524914487|FG003|Overall Study|Lack of Efficacy|0|||
145561293|NCT03245008|524914488|FG004|Overall Study|Lack of Efficacy|0|||
145561294|NCT03245008|524914484|FG000|Overall Study|Lost to Follow-up|4|||
145561295|NCT03245008|524914485|FG001|Overall Study|Lost to Follow-up|1|||
145561296|NCT03245008|524914486|FG002|Overall Study|Lost to Follow-up|0|||
145561297|NCT03245008|524914487|FG003|Overall Study|Lost to Follow-up|0|||
145561298|NCT03245008|524914488|FG004|Overall Study|Lost to Follow-up|1|||
145561299|NCT03245008|524914484|FG000|Overall Study|Physician Decision|1|||
145561300|NCT03245008|524914485|FG001|Overall Study|Physician Decision|3|||
145561301|NCT03245008|524914486|FG002|Overall Study|Physician Decision|4|||
145561302|NCT03245008|524914487|FG003|Overall Study|Physician Decision|0|||
145561303|NCT03245008|524914488|FG004|Overall Study|Physician Decision|0|||
145561304|NCT03245008|524914484|FG000|Overall Study|Protocol Violation|0|||
145561305|NCT03245008|524914485|FG001|Overall Study|Protocol Violation|1|||
145561306|NCT03245008|524914486|FG002|Overall Study|Protocol Violation|0|||
145561307|NCT03245008|524914487|FG003|Overall Study|Protocol Violation|0|||
145561308|NCT03245008|524914488|FG004|Overall Study|Protocol Violation|0|||
145561309|NCT03245008|524914484|FG000|Overall Study|Withdrawal by Subject|20|||
145561310|NCT03245008|524914485|FG001|Overall Study|Withdrawal by Subject|19|||
145561311|NCT03245008|524914486|FG002|Overall Study|Withdrawal by Subject|11|||
145561312|NCT03245008|524914487|FG003|Overall Study|Withdrawal by Subject|0|||
145561313|NCT03245008|524914488|FG004|Overall Study|Withdrawal by Subject|0|||
145561314|NCT03245008|524914484|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
145561315|NCT03245008|524914485|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
145561316|NCT03245008|524914486|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
145561317|NCT03245008|524914487|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
145561318|NCT03245008|524914488|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
145561319|NCT03245008|524914484|FG000|Overall Study|Failure to meet randomization criteria|0|||
145561320|NCT03245008|524914485|FG001|Overall Study|Failure to meet randomization criteria|1|||
145561321|NCT03245008|524914486|FG002|Overall Study|Failure to meet randomization criteria|0|||
145561322|NCT03245008|524914487|FG003|Overall Study|Failure to meet randomization criteria|1|||
145561323|NCT03245008|524914488|FG004|Overall Study|Failure to meet randomization criteria|0|||
145561324|NCT02075658|524914489|FG000|Overall Study|Physician Decision|2|||
145561325|NCT02075658|524914490|FG001|Overall Study|Physician Decision|2|||
145561326|NCT01286012|524914491|FG000|Overall Study|Adverse Event|3|||
145561327|NCT01286012|524914492|FG001|Overall Study|Adverse Event|3|||
145561328|NCT01286012|524914491|FG000|Overall Study|Death|2|||
145561329|NCT01286012|524914492|FG001|Overall Study|Death|3|||
145561330|NCT01286012|524914491|FG000|Overall Study|Protocol Violation|1|||
145561331|NCT01286012|524914492|FG001|Overall Study|Protocol Violation|1|||
145561332|NCT01286012|524914491|FG000|Overall Study|Withdrawal by Subject|4|||
145561333|NCT01286012|524914492|FG001|Overall Study|Withdrawal by Subject|4|||
145561334|NCT01286012|524914491|FG000|Overall Study|Physician Decision|2|||
145561335|NCT01286012|524914492|FG001|Overall Study|Physician Decision|0|||
145561336|NCT01286012|524914491|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
145561337|NCT01286012|524914492|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
145561338|NCT01602380|524914496|FG000|Overall Study|Death|147|||
145561339|NCT01602380|524914497|FG001|Overall Study|Death|145|||
145561340|NCT01602380|524914496|FG000|Overall Study|Withdrawal by Subject|39|||
145561341|NCT01602380|524914497|FG001|Overall Study|Withdrawal by Subject|41|||
145561342|NCT01602380|524914496|FG000|Overall Study|Lost to Follow-up|15|||
145561343|NCT01602380|524914497|FG001|Overall Study|Lost to Follow-up|12|||
145561344|NCT01602380|524914496|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145561345|NCT01602380|524914497|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
145561346|NCT01602380|524914496|FG000|Overall Study|Other|2|||
145561347|NCT01602380|524914497|FG001|Overall Study|Other|0|||
145561348|NCT03181399|524916693|FG000|6 Months on Treatment|Protocol non-compliance|7|||
145561349|NCT03181399|524916693|FG000|6 Months on Treatment|Adverse Event|4|||
145561350|NCT03181399|524916693|FG000|6 Months on Treatment|Tried alternative treatment|2|||
145561351|NCT03181399|524916693|FG000|6 Months on Treatment|Lost to Follow-up|2|||
145561352|NCT03181399|524916693|FG000|6 Months on Treatment|Personal reasons|1|||
145561353|NCT03181399|524916693|FG000|3 Months Off-treatment|Parent unable to travel|1|||
145294346|NCT02545998|523927609|FG001|Overall Study|Lost to Follow-up|3|||
145294347|NCT02545998|523927608|FG000|Overall Study|Withdrawal by Subject|3|||
145561354|NCT01254227|524916694|FG000|Overall Study|Withdrawal by Subject|6|||
145561355|NCT01254227|524916694|FG000|Overall Study|Lost to Follow-up|6|||
145561356|NCT01254227|524916694|FG000|Overall Study|Adverse Event|5|||
145561357|NCT01254227|524916694|FG000|Overall Study|Abnormal test procedure result|5|||
145561358|NCT01254227|524916694|FG000|Overall Study|Administrative problems|2|||
145561359|NCT01254227|524916694|FG000|Overall Study|Death|1|||
145561360|NCT01254227|524916694|FG000|Overall Study|Protocol deviation|1|||
145561361|NCT00192504|524916697|FG000|Overall Study|Lost to Follow-up|1|||
145561362|NCT00192504|524916698|FG001|Overall Study|Lost to Follow-up|0|||
145561363|NCT00192504|524916699|FG002|Overall Study|Lost to Follow-up|0|||
145561364|NCT00192504|524916700|FG003|Overall Study|Lost to Follow-up|0|||
145561365|NCT00192504|524916697|FG000|Overall Study|Dosing window missed|0|||
145561366|NCT00192504|524916698|FG001|Overall Study|Dosing window missed|0|||
145561367|NCT00192504|524916699|FG002|Overall Study|Dosing window missed|1|||
145561368|NCT00192504|524916700|FG003|Overall Study|Dosing window missed|0|||
145561369|NCT02189473|524916701|FG000|Overall Study|Death|22|||
145561370|NCT02189473|524916702|FG001|Overall Study|Death|23|||
145561371|NCT02189473|524916701|FG000|Overall Study|Lost to Follow-up|1|||
145561372|NCT02189473|524916702|FG001|Overall Study|Lost to Follow-up|2|||
145561373|NCT05123222|524916703|FG000|Overall Study|Lost to Follow-up|2|||
145561374|NCT05123222|524916704|FG001|Overall Study|Lost to Follow-up|0|||
145561375|NCT05123222|524916705|FG002|Overall Study|Lost to Follow-up|0|||
145561376|NCT05123222|524916706|FG003|Overall Study|Lost to Follow-up|0|||
145561377|NCT05123222|524916703|FG000|Overall Study|Protocol Violation|0|||
145561378|NCT05123222|524916704|FG001|Overall Study|Protocol Violation|0|||
145561379|NCT05123222|524916705|FG002|Overall Study|Protocol Violation|1|||
145619198|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619199|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619200|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619201|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
145619202|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
145619203|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
145619204|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619205|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619206|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619207|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619208|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619209|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619210|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
145619211|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
145619212|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
145619213|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
145619214|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
145619215|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Other|0|||
145619216|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Other|0|||
145619217|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Other|0|||
145619218|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Other|0|||
145619219|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Other|0|||
145619220|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Other|0|||
145619221|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Other|0|||
145619222|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Other|0|||
145619223|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Other|2|||
145619224|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Other|2|||
145619225|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Other|0|||
145619226|NCT02601937|525119260|FG000|Period 2: Dose Expansion Cohort|Death|0|||
145619227|NCT02601937|525119261|FG001|Period 2: Dose Expansion Cohort|Death|0|||
145619228|NCT02601937|525119262|FG002|Period 2: Dose Expansion Cohort|Death|0|||
145619229|NCT02601937|525119263|FG003|Period 2: Dose Expansion Cohort|Death|0|||
145619230|NCT02601937|525119264|FG004|Period 2: Dose Expansion Cohort|Death|0|||
145619231|NCT02601937|525119265|FG005|Period 2: Dose Expansion Cohort|Death|0|||
145619232|NCT02601937|525119266|FG006|Period 2: Dose Expansion Cohort|Death|0|||
145619233|NCT02601937|525119267|FG007|Period 2: Dose Expansion Cohort|Death|0|||
145619234|NCT02601937|525119268|FG008|Period 2: Dose Expansion Cohort|Death|1|||
145619235|NCT02601937|525119269|FG009|Period 2: Dose Expansion Cohort|Death|0|||
145619236|NCT02601937|525119270|FG010|Period 2: Dose Expansion Cohort|Death|0|||
145619237|NCT01489020|525120919|FG000|Overall Study|Withdrawal by Subject|1|||
145619238|NCT01489020|525120920|FG001|Overall Study|Withdrawal by Subject|0|||
145619239|NCT01489020|525120921|FG002|Overall Study|Withdrawal by Subject|0|||
145619240|NCT01489020|525120922|FG003|Overall Study|Withdrawal by Subject|0|||
145619241|NCT01489020|525120923|FG004|Overall Study|Withdrawal by Subject|0|||
145619242|NCT01489020|525120924|FG005|Overall Study|Withdrawal by Subject|0|||
145619243|NCT01489020|525120919|FG000|Overall Study|Adverse Event|0|||
145619244|NCT01489020|525120920|FG001|Overall Study|Adverse Event|0|||
145619245|NCT01489020|525120921|FG002|Overall Study|Adverse Event|3|||
145619246|NCT01489020|525120922|FG003|Overall Study|Adverse Event|0|||
145619247|NCT01489020|525120923|FG004|Overall Study|Adverse Event|3|||
145619248|NCT01489020|525120924|FG005|Overall Study|Adverse Event|0|||
145619249|NCT01489020|525120919|FG000|Overall Study|Concomitant disease|0|||
145619250|NCT01489020|525120920|FG001|Overall Study|Concomitant disease|0|||
145619251|NCT01489020|525120921|FG002|Overall Study|Concomitant disease|0|||
145619252|NCT01489020|525120922|FG003|Overall Study|Concomitant disease|0|||
145619253|NCT01489020|525120923|FG004|Overall Study|Concomitant disease|3|||
145619254|NCT01489020|525120924|FG005|Overall Study|Concomitant disease|0|||
145294348|NCT02545998|523927609|FG001|Overall Study|Withdrawal by Subject|2|||
145294349|NCT00958243|523927629|FG000|Overall Study|Withdrawal by Subject|0|||
145294350|NCT00958243|523927630|FG001|Overall Study|Withdrawal by Subject|1|||
145619255|NCT01174550|525120925|FG000|Overall Study|Death|75|||
145619256|NCT01174550|525120926|FG001|Overall Study|Death|74|||
145619257|NCT01174550|525120925|FG000|Overall Study|Lost to Follow-up|652|||
145619258|NCT01174550|525120926|FG001|Overall Study|Lost to Follow-up|510|||
145407980|NCT02763566|524349800|FG002|Overall Study|Lost to Follow-up|0|||
145619259|NCT01174550|525120925|FG000|Overall Study|Withdrawal by Subject|543|||
145619260|NCT01174550|525120926|FG001|Overall Study|Withdrawal by Subject|289|||
145619261|NCT01440049|525120931|FG000|Overall Study|Adverse Event|5|||
145619262|NCT02268552|525120932|FG000|Part 1|Death|1|||
145619263|NCT02268552|525120933|FG001|Part 1|Death|1|||
145619264|NCT02268552|525120934|FG002|Part 1|Death|1|||
145619265|NCT02268552|525120935|FG003|Part 1|Death|2|||
145619266|NCT02268552|525120936|FG004|Part 1|Death|0|||
145619267|NCT02268552|525120937|FG005|Part 1|Death|0|||
145619268|NCT02268552|525120938|FG006|Part 1|Death|0|||
145619269|NCT02268552|525120932|FG000|Part 1|Subject/guardian decision|0|||
145294351|NCT00958243|523927631|FG002|Overall Study|Withdrawal by Subject|3|||
145294352|NCT00958243|523927632|FG003|Overall Study|Withdrawal by Subject|1|||
145294353|NCT00958243|523927633|FG004|Overall Study|Withdrawal by Subject|1|||
145294354|NCT00958243|523927634|FG005|Overall Study|Withdrawal by Subject|5|||
145294355|NCT00958243|523927629|FG000|Overall Study|Lost to Follow-up|2|||
145294356|NCT00958243|523927630|FG001|Overall Study|Lost to Follow-up|5|||
145294357|NCT00958243|523927631|FG002|Overall Study|Lost to Follow-up|11|||
145294358|NCT00958243|523927632|FG003|Overall Study|Lost to Follow-up|2|||
145294359|NCT00958243|523927633|FG004|Overall Study|Lost to Follow-up|8|||
145294360|NCT00958243|523927634|FG005|Overall Study|Lost to Follow-up|5|||
145294361|NCT04646109|523927635|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
145561380|NCT05123222|524916706|FG003|Overall Study|Protocol Violation|0|||
145561381|NCT00914810|524916709|FG000|Overall Study|Withdrawal by Subject|1|||
145561382|NCT00914810|524916710|FG001|Overall Study|Withdrawal by Subject|0|||
145561383|NCT00914810|524916709|FG000|Overall Study|Relocated out of state|1|||
145561384|NCT00914810|524916710|FG001|Overall Study|Relocated out of state|0|||
145561385|NCT00914810|524916709|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
145561386|NCT00914810|524916710|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
145561387|NCT00265343|524916711|FG000|Overall Study|Adverse Event|10|||
145561388|NCT00265343|524916712|FG001|Overall Study|Adverse Event|7|||
145561389|NCT00265343|524916711|FG000|Overall Study|Withdrawal by Subject|3|||
145561390|NCT00265343|524916712|FG001|Overall Study|Withdrawal by Subject|9|||
145561391|NCT00265343|524916711|FG000|Overall Study|Other|8|||
145561392|NCT00265343|524916712|FG001|Overall Study|Other|3|||
145561393|NCT00706641|524916719|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
145561394|NCT00706641|524916719|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
145561395|NCT00706641|524916719|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
145561396|NCT04782856|524916721|FG000|Overall Study|Withdrawal by Subject|0|||
145561397|NCT04782856|524916722|FG001|Overall Study|Withdrawal by Subject|1|||
145561398|NCT02535741|524916723|FG000|Overall Study|Adverse Event|3|||
145561399|NCT02535741|524916723|FG000|Overall Study|Withdrawal by Subject|9|||
145561400|NCT02535741|524916723|FG000|Overall Study|Lost to Follow-up|10|||
145561401|NCT02535741|524916723|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
145561402|NCT02535741|524916723|FG000|Overall Study|Missing data|6|||
145561403|NCT00798369|524916724|FG000|Overall Study|Subject withdrew consent|0|||
145561404|NCT00798369|524916725|FG001|Overall Study|Subject withdrew consent|0|||
145561405|NCT00798369|524916726|FG002|Overall Study|Subject withdrew consent|1|||
145619270|NCT02268552|525120933|FG001|Part 1|Subject/guardian decision|0|||
145561406|NCT00798369|524916727|FG003|Overall Study|Subject withdrew consent|1|||
145561407|NCT00798369|524916728|FG004|Overall Study|Subject withdrew consent|0|||
145561408|NCT00798369|524916729|FG005|Overall Study|Subject withdrew consent|2|||
145561409|NCT00798369|524916724|FG000|Overall Study|Lost to Follow-up|1|||
145561410|NCT00798369|524916725|FG001|Overall Study|Lost to Follow-up|1|||
145561411|NCT00798369|524916726|FG002|Overall Study|Lost to Follow-up|1|||
145561412|NCT00798369|524916727|FG003|Overall Study|Lost to Follow-up|0|||
145561413|NCT00798369|524916728|FG004|Overall Study|Lost to Follow-up|1|||
145561414|NCT00798369|524916729|FG005|Overall Study|Lost to Follow-up|0|||
145561415|NCT00798369|524916724|FG000|Overall Study|Adminstrative problems|0|||
145561416|NCT00798369|524916725|FG001|Overall Study|Adminstrative problems|0|||
145561417|NCT00798369|524916726|FG002|Overall Study|Adminstrative problems|0|||
145561418|NCT00798369|524916727|FG003|Overall Study|Adminstrative problems|0|||
145561419|NCT00798369|524916728|FG004|Overall Study|Adminstrative problems|0|||
145561420|NCT00798369|524916729|FG005|Overall Study|Adminstrative problems|1|||
145561421|NCT04475588|524916730|FG000|Overall Study|Adverse Event|2|||
145561422|NCT04475588|524916731|FG001|Overall Study|Adverse Event|0|||
145561423|NCT01327300|524916732|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
145561424|NCT01327300|524916733|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
145561425|NCT03020823|524916734|FG000|Overall Study|Physician Decision|4|||
145561426|NCT03020823|524916734|FG000|Overall Study|Lack of Efficacy|4|||
145561427|NCT03020823|524916734|FG000|Overall Study|Adverse Event|2|||
145561428|NCT03739112|524916736|FG000|Overall Study|Adverse Event|2|||
145561429|NCT03739112|524916737|FG001|Overall Study|Adverse Event|2|||
145561430|NCT03739112|524916736|FG000|Overall Study|Withdrawal by Subject|38|||
145561431|NCT03739112|524916737|FG001|Overall Study|Withdrawal by Subject|19|||
145561432|NCT03739112|524916736|FG000|Overall Study|Lost to Follow-up|31|||
145561433|NCT03739112|524916737|FG001|Overall Study|Lost to Follow-up|33|||
145561434|NCT03739112|524916736|FG000|Overall Study|Protocol Deviation|12|||
145561435|NCT03739112|524916737|FG001|Overall Study|Protocol Deviation|9|||
145561436|NCT03739112|524916736|FG000|Overall Study|Physician Decision|1|||
145561437|NCT03739112|524916737|FG001|Overall Study|Physician Decision|0|||
145561438|NCT03739112|524916736|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
145561439|NCT03739112|524916737|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
145561440|NCT03739112|524916736|FG000|Overall Study|Site went on hold|65|||
145561441|NCT03739112|524916737|FG001|Overall Study|Site went on hold|67|||
145561442|NCT03739112|524916736|FG000|Overall Study|Other than specified|8|||
145561443|NCT03739112|524916737|FG001|Overall Study|Other than specified|5|||
145561444|NCT03739112|524916736|FG000|Overall Study|Randomized but not vaccinated|31|||
145561445|NCT03739112|524916737|FG001|Overall Study|Randomized but not vaccinated|25|||
145561446|NCT04762680|524916739|FG000|Phase 2|Adverse Event|0|||
145561447|NCT04762680|524916740|FG001|Phase 2|Adverse Event|1|||
145561448|NCT04762680|524916741|FG002|Phase 2|Adverse Event|0|||
145561449|NCT04762680|524916742|FG003|Phase 2|Adverse Event|0|||
145561450|NCT04762680|524916743|FG004|Phase 2|Adverse Event|0|||
145561451|NCT04762680|524916744|FG005|Phase 2|Adverse Event|0|||
145561452|NCT04762680|524916745|FG006|Phase 2|Adverse Event|0|||
145561453|NCT04762680|524916746|FG007|Phase 2|Adverse Event|0|||
145561454|NCT04762680|524916747|FG008|Phase 2|Adverse Event|0|||
145561455|NCT04762680|524916748|FG009|Phase 2|Adverse Event|0|||
145561456|NCT04762680|524916749|FG010|Phase 2|Adverse Event|0|||
145561457|NCT04762680|524916750|FG011|Phase 2|Adverse Event|0|||
145561458|NCT04762680|524916751|FG012|Phase 2|Adverse Event|0|||
145561459|NCT04762680|524916752|FG013|Phase 2|Adverse Event|0|||
145561460|NCT04762680|524916753|FG014|Phase 2|Adverse Event|0|||
145561461|NCT04762680|524916754|FG015|Phase 2|Adverse Event|0|||
145561462|NCT04762680|524916755|FG016|Phase 2|Adverse Event|0|||
145561463|NCT04762680|524916756|FG017|Phase 2|Adverse Event|0|||
145561464|NCT04762680|524916757|FG018|Phase 2|Adverse Event|0|||
145561465|NCT04762680|524916758|FG019|Phase 2|Adverse Event|0|||
145561466|NCT04762680|524916759|FG020|Phase 2|Adverse Event|0|||
145561467|NCT04762680|524916760|FG021|Phase 2|Adverse Event|0|||
145561468|NCT04762680|524916739|FG000|Phase 2|Protocol Violation|5|||
145561469|NCT04762680|524916740|FG001|Phase 2|Protocol Violation|5|||
145561470|NCT04762680|524916741|FG002|Phase 2|Protocol Violation|1|||
145561471|NCT04762680|524916742|FG003|Phase 2|Protocol Violation|0|||
145561472|NCT04762680|524916743|FG004|Phase 2|Protocol Violation|0|||
145561473|NCT04762680|524916744|FG005|Phase 2|Protocol Violation|0|||
145561474|NCT04762680|524916745|FG006|Phase 2|Protocol Violation|0|||
145561475|NCT04762680|524916746|FG007|Phase 2|Protocol Violation|0|||
145619271|NCT02268552|525120934|FG002|Part 1|Subject/guardian decision|0|||
145619272|NCT02268552|525120935|FG003|Part 1|Subject/guardian decision|1|||
145561476|NCT04762680|524916747|FG008|Phase 2|Protocol Violation|0|||
145561477|NCT04762680|524916748|FG009|Phase 2|Protocol Violation|0|||
145561478|NCT04762680|524916749|FG010|Phase 2|Protocol Violation|0|||
145561479|NCT04762680|524916750|FG011|Phase 2|Protocol Violation|0|||
145561480|NCT04762680|524916751|FG012|Phase 2|Protocol Violation|0|||
145561481|NCT04762680|524916752|FG013|Phase 2|Protocol Violation|0|||
145561482|NCT04762680|524916753|FG014|Phase 2|Protocol Violation|0|||
145561483|NCT04762680|524916754|FG015|Phase 2|Protocol Violation|0|||
145619273|NCT02268552|525120936|FG004|Part 1|Subject/guardian decision|0|||
145619274|NCT02268552|525120937|FG005|Part 1|Subject/guardian decision|0|||
145619275|NCT02268552|525120938|FG006|Part 1|Subject/guardian decision|0|||
145619276|NCT02268552|525120932|FG000|Part 2|Death|0|||
145619277|NCT02268552|525120933|FG001|Part 2|Death|0|||
145619278|NCT02268552|525120934|FG002|Part 2|Death|0|||
145619279|NCT02268552|525120935|FG003|Part 2|Death|0|||
145619280|NCT02268552|525120936|FG004|Part 2|Death|0|||
145619281|NCT02268552|525120937|FG005|Part 2|Death|0|||
145619282|NCT02268552|525120938|FG006|Part 2|Death|2|||
145619283|NCT02268552|525120932|FG000|Part 2|Subject/guardian decision|0|||
145619284|NCT02268552|525120933|FG001|Part 2|Subject/guardian decision|0|||
145619285|NCT02268552|525120934|FG002|Part 2|Subject/guardian decision|0|||
145619286|NCT02268552|525120935|FG003|Part 2|Subject/guardian decision|0|||
145619287|NCT02268552|525120936|FG004|Part 2|Subject/guardian decision|0|||
145619288|NCT02268552|525120937|FG005|Part 2|Subject/guardian decision|0|||
145619289|NCT02268552|525120938|FG006|Part 2|Subject/guardian decision|1|||
145619290|NCT02268552|525120932|FG000|Part 3 Extension|Death|0|||
145619291|NCT02268552|525120933|FG001|Part 3 Extension|Death|1|||
145619292|NCT02268552|525120934|FG002|Part 3 Extension|Death|1|||
145619293|NCT02268552|525120935|FG003|Part 3 Extension|Death|1|||
145619294|NCT02268552|525120936|FG004|Part 3 Extension|Death|1|||
145619295|NCT02268552|525120937|FG005|Part 3 Extension|Death|1|||
145619296|NCT02268552|525120938|FG006|Part 3 Extension|Death|0|||
145619297|NCT02268552|525120932|FG000|Part 3 Extension|Early termination of trial|1|||
145619298|NCT02268552|525120933|FG001|Part 3 Extension|Early termination of trial|0|||
145294362|NCT04646109|523927636|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
145619299|NCT02268552|525120934|FG002|Part 3 Extension|Early termination of trial|0|||
145619300|NCT02268552|525120935|FG003|Part 3 Extension|Early termination of trial|0|||
145619301|NCT02268552|525120936|FG004|Part 3 Extension|Early termination of trial|2|||
145619302|NCT02268552|525120937|FG005|Part 3 Extension|Early termination of trial|9|||
145619303|NCT02268552|525120938|FG006|Part 3 Extension|Early termination of trial|11|||
145619304|NCT02268552|525120932|FG000|Part 3 Extension|Subject/guardian decision|0|||
145619305|NCT02268552|525120933|FG001|Part 3 Extension|Subject/guardian decision|0|||
145619306|NCT02268552|525120934|FG002|Part 3 Extension|Subject/guardian decision|0|||
145561484|NCT04762680|524916755|FG016|Phase 2|Protocol Violation|0|||
145561485|NCT04762680|524916756|FG017|Phase 2|Protocol Violation|0|||
145561486|NCT04762680|524916757|FG018|Phase 2|Protocol Violation|0|||
145561487|NCT04762680|524916758|FG019|Phase 2|Protocol Violation|0|||
145561488|NCT04762680|524916759|FG020|Phase 2|Protocol Violation|0|||
145561489|NCT04762680|524916760|FG021|Phase 2|Protocol Violation|0|||
145561490|NCT04762680|524916739|FG000|Phase 2|Withdrawal by Subject|23|||
145561491|NCT04762680|524916740|FG001|Phase 2|Withdrawal by Subject|21|||
145561492|NCT04762680|524916741|FG002|Phase 2|Withdrawal by Subject|28|||
145561493|NCT04762680|524916742|FG003|Phase 2|Withdrawal by Subject|0|||
145561494|NCT04762680|524916743|FG004|Phase 2|Withdrawal by Subject|0|||
145561495|NCT04762680|524916744|FG005|Phase 2|Withdrawal by Subject|0|||
145561496|NCT04762680|524916745|FG006|Phase 2|Withdrawal by Subject|0|||
145561497|NCT04762680|524916746|FG007|Phase 2|Withdrawal by Subject|0|||
145561498|NCT04762680|524916747|FG008|Phase 2|Withdrawal by Subject|0|||
145561499|NCT04762680|524916748|FG009|Phase 2|Withdrawal by Subject|0|||
145561500|NCT04762680|524916749|FG010|Phase 2|Withdrawal by Subject|0|||
145561501|NCT04762680|524916750|FG011|Phase 2|Withdrawal by Subject|0|||
145561502|NCT04762680|524916751|FG012|Phase 2|Withdrawal by Subject|0|||
145561503|NCT04762680|524916752|FG013|Phase 2|Withdrawal by Subject|0|||
145561504|NCT04762680|524916753|FG014|Phase 2|Withdrawal by Subject|0|||
145561505|NCT04762680|524916754|FG015|Phase 2|Withdrawal by Subject|0|||
145294363|NCT06176768|523927637|FG000|Overall Study|Adverse Event|1|||
145561506|NCT04762680|524916755|FG016|Phase 2|Withdrawal by Subject|0|||
145561507|NCT04762680|524916756|FG017|Phase 2|Withdrawal by Subject|0|||
145561508|NCT04762680|524916757|FG018|Phase 2|Withdrawal by Subject|0|||
145561509|NCT04762680|524916758|FG019|Phase 2|Withdrawal by Subject|0|||
145561510|NCT04762680|524916759|FG020|Phase 2|Withdrawal by Subject|0|||
145561511|NCT04762680|524916760|FG021|Phase 2|Withdrawal by Subject|0|||
145561512|NCT04762680|524916739|FG000|Phase 2|Lost to Follow-up|14|||
145561513|NCT04762680|524916740|FG001|Phase 2|Lost to Follow-up|8|||
145561514|NCT04762680|524916741|FG002|Phase 2|Lost to Follow-up|9|||
145561515|NCT04762680|524916742|FG003|Phase 2|Lost to Follow-up|0|||
145561516|NCT04762680|524916743|FG004|Phase 2|Lost to Follow-up|0|||
145561517|NCT04762680|524916744|FG005|Phase 2|Lost to Follow-up|0|||
145561518|NCT04762680|524916745|FG006|Phase 2|Lost to Follow-up|0|||
145561519|NCT04762680|524916746|FG007|Phase 2|Lost to Follow-up|0|||
145561520|NCT04762680|524916747|FG008|Phase 2|Lost to Follow-up|0|||
145561521|NCT04762680|524916748|FG009|Phase 2|Lost to Follow-up|0|||
145561522|NCT04762680|524916749|FG010|Phase 2|Lost to Follow-up|0|||
145561523|NCT04762680|524916750|FG011|Phase 2|Lost to Follow-up|0|||
145561524|NCT04762680|524916751|FG012|Phase 2|Lost to Follow-up|0|||
145561525|NCT04762680|524916752|FG013|Phase 2|Lost to Follow-up|0|||
145561526|NCT04762680|524916753|FG014|Phase 2|Lost to Follow-up|0|||
145561527|NCT04762680|524916754|FG015|Phase 2|Lost to Follow-up|0|||
145561528|NCT04762680|524916755|FG016|Phase 2|Lost to Follow-up|0|||
145561529|NCT04762680|524916756|FG017|Phase 2|Lost to Follow-up|0|||
145561530|NCT04762680|524916757|FG018|Phase 2|Lost to Follow-up|0|||
145561531|NCT04762680|524916758|FG019|Phase 2|Lost to Follow-up|0|||
145561532|NCT04762680|524916759|FG020|Phase 2|Lost to Follow-up|0|||
145561533|NCT04762680|524916760|FG021|Phase 2|Lost to Follow-up|0|||
145561534|NCT04762680|524916739|FG000|Phase 3|Adverse Event|0|||
145561535|NCT04762680|524916740|FG001|Phase 3|Adverse Event|0|||
145561536|NCT04762680|524916741|FG002|Phase 3|Adverse Event|0|||
145561537|NCT04762680|524916742|FG003|Phase 3|Adverse Event|1|||
145561538|NCT04762680|524916743|FG004|Phase 3|Adverse Event|0|||
145561539|NCT04762680|524916744|FG005|Phase 3|Adverse Event|0|||
145561540|NCT04762680|524916745|FG006|Phase 3|Adverse Event|0|||
145561541|NCT04762680|524916746|FG007|Phase 3|Adverse Event|0|||
145561542|NCT04762680|524916747|FG008|Phase 3|Adverse Event|0|||
145561543|NCT04762680|524916748|FG009|Phase 3|Adverse Event|0|||
145561544|NCT04762680|524916749|FG010|Phase 3|Adverse Event|0|||
145561545|NCT04762680|524916750|FG011|Phase 3|Adverse Event|0|||
145561546|NCT04762680|524916751|FG012|Phase 3|Adverse Event|0|||
145561547|NCT04762680|524916752|FG013|Phase 3|Adverse Event|0|||
145561548|NCT04762680|524916753|FG014|Phase 3|Adverse Event|0|||
145561549|NCT04762680|524916754|FG015|Phase 3|Adverse Event|0|||
145561550|NCT04762680|524916755|FG016|Phase 3|Adverse Event|0|||
145561551|NCT04762680|524916756|FG017|Phase 3|Adverse Event|3|||
145561552|NCT04762680|524916757|FG018|Phase 3|Adverse Event|0|||
145561553|NCT04762680|524916758|FG019|Phase 3|Adverse Event|0|||
145561554|NCT04762680|524916759|FG020|Phase 3|Adverse Event|0|||
145561555|NCT04762680|524916760|FG021|Phase 3|Adverse Event|0|||
145561556|NCT04762680|524916739|FG000|Phase 3|Protocol Violation|0|||
145561557|NCT04762680|524916740|FG001|Phase 3|Protocol Violation|0|||
145561558|NCT04762680|524916741|FG002|Phase 3|Protocol Violation|0|||
145561559|NCT04762680|524916742|FG003|Phase 3|Protocol Violation|4|||
145561560|NCT04762680|524916743|FG004|Phase 3|Protocol Violation|1|||
145561561|NCT04762680|524916744|FG005|Phase 3|Protocol Violation|5|||
145561562|NCT04762680|524916745|FG006|Phase 3|Protocol Violation|1|||
145561563|NCT04762680|524916746|FG007|Phase 3|Protocol Violation|0|||
145561564|NCT04762680|524916747|FG008|Phase 3|Protocol Violation|0|||
145561565|NCT04762680|524916748|FG009|Phase 3|Protocol Violation|0|||
145561566|NCT04762680|524916749|FG010|Phase 3|Protocol Violation|0|||
145561567|NCT04762680|524916750|FG011|Phase 3|Protocol Violation|2|||
145561568|NCT04762680|524916751|FG012|Phase 3|Protocol Violation|3|||
145561569|NCT04762680|524916752|FG013|Phase 3|Protocol Violation|0|||
145561570|NCT04762680|524916753|FG014|Phase 3|Protocol Violation|0|||
145561571|NCT04762680|524916754|FG015|Phase 3|Protocol Violation|1|||
145561572|NCT04762680|524916755|FG016|Phase 3|Protocol Violation|0|||
145561573|NCT04762680|524916756|FG017|Phase 3|Protocol Violation|10|||
145561574|NCT04762680|524916757|FG018|Phase 3|Protocol Violation|0|||
145561575|NCT04762680|524916758|FG019|Phase 3|Protocol Violation|0|||
145561576|NCT04762680|524916759|FG020|Phase 3|Protocol Violation|0|||
145561577|NCT04762680|524916760|FG021|Phase 3|Protocol Violation|0|||
145561578|NCT04762680|524916739|FG000|Phase 3|Withdrawal by Subject|0|||
145561579|NCT04762680|524916740|FG001|Phase 3|Withdrawal by Subject|0|||
145561580|NCT04762680|524916741|FG002|Phase 3|Withdrawal by Subject|0|||
145561581|NCT04762680|524916742|FG003|Phase 3|Withdrawal by Subject|13|||
145561582|NCT04762680|524916743|FG004|Phase 3|Withdrawal by Subject|17|||
145561583|NCT04762680|524916744|FG005|Phase 3|Withdrawal by Subject|12|||
145561584|NCT04762680|524916745|FG006|Phase 3|Withdrawal by Subject|8|||
145561585|NCT04762680|524916746|FG007|Phase 3|Withdrawal by Subject|3|||
145561586|NCT04762680|524916747|FG008|Phase 3|Withdrawal by Subject|2|||
145561587|NCT04762680|524916748|FG009|Phase 3|Withdrawal by Subject|4|||
145294364|NCT06176768|523927638|FG001|Overall Study|Adverse Event|0|||
145561588|NCT04762680|524916749|FG010|Phase 3|Withdrawal by Subject|3|||
145561589|NCT04762680|524916750|FG011|Phase 3|Withdrawal by Subject|1|||
145561590|NCT04762680|524916751|FG012|Phase 3|Withdrawal by Subject|3|||
145619307|NCT02268552|525120935|FG003|Part 3 Extension|Subject/guardian decision|0|||
145619308|NCT02268552|525120936|FG004|Part 3 Extension|Subject/guardian decision|0|||
145619309|NCT02268552|525120937|FG005|Part 3 Extension|Subject/guardian decision|0|||
145619310|NCT02268552|525120938|FG006|Part 3 Extension|Subject/guardian decision|1|||
145619311|NCT02139982|525120940|FG000|Overall Study|Lack of Efficacy|0|||
145619312|NCT02139982|525120941|FG001|Overall Study|Lack of Efficacy|1|||
145619313|NCT02139982|525120942|FG002|Overall Study|Lack of Efficacy|0|||
145619314|NCT02139982|525120943|FG003|Overall Study|Lack of Efficacy|1|||
145619315|NCT02139982|525120944|FG004|Overall Study|Lack of Efficacy|0|||
145619316|NCT02139982|525120945|FG005|Overall Study|Lack of Efficacy|0|||
145619317|NCT02139982|525120946|FG006|Overall Study|Lack of Efficacy|0|||
145619318|NCT02139982|525120947|FG007|Overall Study|Lack of Efficacy|0|||
145619319|NCT02139982|525120948|FG008|Overall Study|Lack of Efficacy|0|||
145619320|NCT02139982|525120949|FG009|Overall Study|Lack of Efficacy|0|||
145619321|NCT02748512|525120952|FG000|Overall Study|Lost to Follow-up|1|||
145619322|NCT02748512|525120953|FG001|Overall Study|Lost to Follow-up|1|||
145619323|NCT00997243|525120954|FG000|Overall Study|Early termination of study by sponsor|7|||
145619324|NCT03415022|525120957|FG000|Overall Study|Withdrawal by Subject|1|||
145619325|NCT03415022|525120958|FG001|Overall Study|Withdrawal by Subject|2|||
145619326|NCT03415022|525120957|FG000|Overall Study|COVID-19 Suspension|2|||
145619327|NCT03415022|525120958|FG001|Overall Study|COVID-19 Suspension|3|||
145619328|NCT03415022|525120957|FG000|Overall Study|Lost to Follow-up|2|||
145619329|NCT03415022|525120958|FG001|Overall Study|Lost to Follow-up|0|||
145619330|NCT04466618|525120959|FG000|Overall Study|Withdrawal by Subject|0|||
145619331|NCT04466618|525120960|FG001|Overall Study|Withdrawal by Subject|1|||
145619332|NCT00884286|525120966|FG000|Overall Study|Progressive disease|21|||
145619333|NCT00884286|525120967|FG001|Overall Study|Progressive disease|28|||
145619334|NCT00884286|525120966|FG000|Overall Study|Toxicity|4|||
145619335|NCT00884286|525120967|FG001|Overall Study|Toxicity|1|||
145619336|NCT00884286|525120966|FG000|Overall Study|Death|2|||
145619337|NCT00884286|525120967|FG001|Overall Study|Death|2|||
145619338|NCT00884286|525120966|FG000|Overall Study|Physician Decision|1|||
145619339|NCT00884286|525120967|FG001|Overall Study|Physician Decision|0|||
145619340|NCT00884286|525120966|FG000|Overall Study|Septic shock|1|||
145619341|NCT00884286|525120967|FG001|Overall Study|Septic shock|0|||
145619342|NCT00884286|525120966|FG000|Overall Study|Thrombus in right auricle|1|||
145619343|NCT00884286|525120967|FG001|Overall Study|Thrombus in right auricle|0|||
145619344|NCT00884286|525120966|FG000|Overall Study|Not treated|2|||
145619345|NCT00884286|525120967|FG001|Overall Study|Not treated|1|||
145619346|NCT00884286|525120966|FG000|Overall Study|Comprised lung carcinoma|0|||
145619347|NCT00884286|525120967|FG001|Overall Study|Comprised lung carcinoma|1|||
145619348|NCT00109928|525120968|FG000|Overall Study|Adverse Event|2|||
145619349|NCT00109928|525120968|FG000|Overall Study|Progression|6|||
145619350|NCT00109928|525120968|FG000|Overall Study|Death|2|||
145619351|NCT00109928|525120968|FG000|Overall Study|not protocol specified|2|||
145619352|NCT00109928|525120968|FG000|Overall Study|not eligible|1|||
145619353|NCT02411591|525120973|FG000|Overall Study|Adverse Event|0|||
145619354|NCT02411591|525120974|FG001|Overall Study|Adverse Event|4|||
145619355|NCT02411591|525120975|FG002|Overall Study|Adverse Event|2|||
145619356|NCT02411591|525120973|FG000|Overall Study|Withdrawal by Subject|0|||
145561591|NCT04762680|524916752|FG013|Phase 3|Withdrawal by Subject|2|||
145561592|NCT04762680|524916753|FG014|Phase 3|Withdrawal by Subject|1|||
145561593|NCT04762680|524916754|FG015|Phase 3|Withdrawal by Subject|4|||
145561594|NCT04762680|524916755|FG016|Phase 3|Withdrawal by Subject|6|||
145561595|NCT04762680|524916756|FG017|Phase 3|Withdrawal by Subject|32|||
145561596|NCT04762680|524916757|FG018|Phase 3|Withdrawal by Subject|0|||
145561597|NCT04762680|524916758|FG019|Phase 3|Withdrawal by Subject|0|||
145561598|NCT04762680|524916759|FG020|Phase 3|Withdrawal by Subject|0|||
145561599|NCT04762680|524916760|FG021|Phase 3|Withdrawal by Subject|0|||
145561600|NCT04762680|524916739|FG000|Phase 3|Lost to Follow-up|0|||
145561601|NCT04762680|524916740|FG001|Phase 3|Lost to Follow-up|0|||
145561602|NCT04762680|524916741|FG002|Phase 3|Lost to Follow-up|0|||
145561603|NCT04762680|524916742|FG003|Phase 3|Lost to Follow-up|9|||
145561604|NCT04762680|524916743|FG004|Phase 3|Lost to Follow-up|22|||
145561605|NCT04762680|524916744|FG005|Phase 3|Lost to Follow-up|24|||
145561606|NCT04762680|524916745|FG006|Phase 3|Lost to Follow-up|2|||
145619357|NCT02411591|525120974|FG001|Overall Study|Withdrawal by Subject|3|||
145619358|NCT02411591|525120975|FG002|Overall Study|Withdrawal by Subject|0|||
145619359|NCT02411591|525120973|FG000|Overall Study|Physician Decision|0|||
145619360|NCT02411591|525120974|FG001|Overall Study|Physician Decision|3|||
145619361|NCT02411591|525120975|FG002|Overall Study|Physician Decision|1|||
145619362|NCT02491892|525120976|FG000|Overall Study|Adverse Event|1|||
145619363|NCT02491892|525120977|FG001|Overall Study|Adverse Event|1|||
145619364|NCT02491892|525120976|FG000|Overall Study|Death|1|||
145619365|NCT02491892|525120977|FG001|Overall Study|Death|1|||
145619366|NCT02491892|525120976|FG000|Overall Study|Lack of Efficacy|37|||
145619367|NCT02491892|525120977|FG001|Overall Study|Lack of Efficacy|36|||
145619368|NCT02491892|525120976|FG000|Overall Study|Refused Treatment|1|||
145619369|NCT02491892|525120977|FG001|Overall Study|Refused Treatment|0|||
145619370|NCT02491892|525120976|FG000|Overall Study|Lost to Follow-up|1|||
145561607|NCT04762680|524916746|FG007|Phase 3|Lost to Follow-up|4|||
145619371|NCT02491892|525120977|FG001|Overall Study|Lost to Follow-up|0|||
145619372|NCT04227340|525120978|FG000|Overall Study|Withdrawal by Subject|3|||
145619373|NCT00750893|525120979|FG000|Overall Study|Adverse Event|5|||
145619374|NCT00750893|525120979|FG000|Overall Study|Withdrawal by Subject|10|||
145619375|NCT00750893|525120979|FG000|Overall Study|Lost to Follow-up|510|||
145619376|NCT00750893|525120979|FG000|Overall Study|Other|17|||
145619377|NCT01734850|525120980|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
145619378|NCT01734850|525120981|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
145619379|NCT01734850|525120982|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
145619380|NCT01734850|525120980|FG000|Overall Study|Not infused due to manufacturing failure|0|||
145619381|NCT01734850|525120981|FG001|Overall Study|Not infused due to manufacturing failure|0|||
145619382|NCT01734850|525120982|FG002|Overall Study|Not infused due to manufacturing failure|1|||
145619383|NCT00661258|525120984|FG000|Overall Study|Death|1|||
145619384|NCT00661258|525120985|FG001|Overall Study|Death|0|||
145619385|NCT00661258|525120984|FG000|Overall Study|caught by police and in detox center|2|||
145619386|NCT00661258|525120985|FG001|Overall Study|caught by police and in detox center|1|||
145619387|NCT04496167|525120986|FG000|Overall Study|Adverse Event|6|||
145619388|NCT04496167|525120987|FG001|Overall Study|Adverse Event|2|||
145619389|NCT04496167|525120986|FG000|Overall Study|Withdrawal by Subject|7|||
145619390|NCT04496167|525120987|FG001|Overall Study|Withdrawal by Subject|6|||
145619391|NCT04496167|525120986|FG000|Overall Study|Lost to Follow-up|3|||
145619392|NCT04496167|525120987|FG001|Overall Study|Lost to Follow-up|5|||
145619393|NCT04496167|525120986|FG000|Overall Study|Not Treated|1|||
145619394|NCT04496167|525120987|FG001|Overall Study|Not Treated|2|||
145619395|NCT04496167|525120986|FG000|Overall Study|Other Than Specified|1|||
145619396|NCT04496167|525120987|FG001|Overall Study|Other Than Specified|1|||
145619397|NCT00598481|525120990|FG000|Treatment|Physician Decision|1|||
145619398|NCT01083160|525120991|FG000|Overall Study|Adverse Event|1|||
145619399|NCT01951092|525120994|FG000|Overall Study|Lost to Follow-up|10|||
145619400|NCT01951092|525120994|FG000|Overall Study|Incarceration|1|||
145619401|NCT01951092|525120994|FG000|Overall Study|Transfer of Care|1|||
145619402|NCT00918749|525120995|FG000|Overall Study|Adverse Event|1|||
145619403|NCT00918749|525120996|FG001|Overall Study|Adverse Event|0|||
145619404|NCT00918749|525120997|FG002|Overall Study|Adverse Event|1|||
145619405|NCT00918749|525120995|FG000|Overall Study|Lost to Follow-up|0|||
145619406|NCT00918749|525120996|FG001|Overall Study|Lost to Follow-up|0|||
145619407|NCT00918749|525120997|FG002|Overall Study|Lost to Follow-up|1|||
145619408|NCT00918749|525120995|FG000|Overall Study|Withdrawal by Subject|5|||
145619409|NCT00918749|525120996|FG001|Overall Study|Withdrawal by Subject|3|||
145619410|NCT00918749|525120997|FG002|Overall Study|Withdrawal by Subject|5|||
145619411|NCT00918749|525120995|FG000|Overall Study|No Study Medication Taken|1|||
145619412|NCT00918749|525120996|FG001|Overall Study|No Study Medication Taken|0|||
145619413|NCT00918749|525120997|FG002|Overall Study|No Study Medication Taken|0|||
145619414|NCT01712789|525120998|FG000|Overall Study|Lack of Efficacy|2|||
145619415|NCT01712789|525120998|FG000|Overall Study|Lost to Follow-up|1|||
145619416|NCT01712789|525120998|FG000|Overall Study|Progressive Disease|504|||
145619417|NCT01712789|525120998|FG000|Overall Study|Death|57|||
145619418|NCT01712789|525120998|FG000|Overall Study|Adverse Event|52|||
145619419|NCT01712789|525120998|FG000|Overall Study|Miscellaneous|31|||
145619420|NCT01712789|525120998|FG000|Overall Study|Withdrawal by Subject|21|||
145619421|NCT01712789|525120998|FG000|Overall Study|Transition to Commercial Treatment|8|||
145619422|NCT01712789|525120998|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
145619423|NCT01708187|525120999|FG000|Overall Study|Lost to Follow-up|0|||
145619424|NCT01708187|525121000|FG001|Overall Study|Lost to Follow-up|1|||
145619425|NCT03018106|525121002|FG000|Overall Study|Lost to Follow-up|0|||
145619426|NCT03018106|525121003|FG001|Overall Study|Lost to Follow-up|1|||
145619427|NCT01439711|525121004|FG000|Overall Study|Ineligible|13|||
145619428|NCT01439711|525121004|FG000|Overall Study|Cancel|3|||
145619429|NCT01439711|525121004|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
145619430|NCT01439711|525121004|FG000|Overall Study|Adverse Event|5|||
145619431|NCT01439711|525121004|FG000|Overall Study|Withdrawal by Subject|3|||
145619432|NCT01439711|525121004|FG000|Overall Study|Progression During Active Tx|3|||
145619433|NCT01439711|525121004|FG000|Overall Study|Noncompliance|3|||
145619434|NCT01439711|525121004|FG000|Overall Study|No MRI|9|||
145619435|NCT01603121|525121014|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
145619436|NCT01603121|525121015|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
145619437|NCT00577720|525121016|FG000|Overall Study|Adverse Event|2|||
145619438|NCT00577720|525121017|FG001|Overall Study|Adverse Event|1|||
145619439|NCT00577720|525121018|FG002|Overall Study|Adverse Event|0|||
145619440|NCT00577720|525121019|FG003|Overall Study|Adverse Event|4|||
145619441|NCT00577720|525121016|FG000|Overall Study|Lost to Follow-up|0|||
145619442|NCT00577720|525121017|FG001|Overall Study|Lost to Follow-up|0|||
145619443|NCT00577720|525121018|FG002|Overall Study|Lost to Follow-up|1|||
145619444|NCT00577720|525121019|FG003|Overall Study|Lost to Follow-up|0|||
145619445|NCT00577720|525121016|FG000|Overall Study|Protocol Violation|0|||
145619446|NCT00577720|525121017|FG001|Overall Study|Protocol Violation|0|||
145619447|NCT00577720|525121018|FG002|Overall Study|Protocol Violation|0|||
145619448|NCT00577720|525121019|FG003|Overall Study|Protocol Violation|1|||
145561608|NCT04762680|524916747|FG008|Phase 3|Lost to Follow-up|6|||
145619449|NCT00577720|525121016|FG000|Overall Study|Withdrawal by Subject|2|||
145619450|NCT00577720|525121017|FG001|Overall Study|Withdrawal by Subject|0|||
145619451|NCT00577720|525121018|FG002|Overall Study|Withdrawal by Subject|0|||
145619452|NCT00577720|525121019|FG003|Overall Study|Withdrawal by Subject|2|||
145619453|NCT01656759|525121023|FG000|Overall Study|Protocol Violation|2|||
145619454|NCT01656759|525121024|FG001|Overall Study|Protocol Violation|3|||
145619455|NCT01628510|525121025|FG000|Overall Study|Withdrawal by Subject|0|||
145619456|NCT01628510|525121026|FG001|Overall Study|Withdrawal by Subject|4|||
145619457|NCT01628510|525121025|FG000|Overall Study|Death|3|||
145619458|NCT01628510|525121026|FG001|Overall Study|Death|1|||
145561609|NCT04762680|524916748|FG009|Phase 3|Lost to Follow-up|4|||
145561610|NCT04762680|524916749|FG010|Phase 3|Lost to Follow-up|3|||
145561611|NCT04762680|524916750|FG011|Phase 3|Lost to Follow-up|0|||
145561612|NCT04762680|524916751|FG012|Phase 3|Lost to Follow-up|5|||
145561613|NCT04762680|524916752|FG013|Phase 3|Lost to Follow-up|4|||
145561614|NCT04762680|524916753|FG014|Phase 3|Lost to Follow-up|6|||
145561615|NCT04762680|524916754|FG015|Phase 3|Lost to Follow-up|1|||
145561616|NCT04762680|524916755|FG016|Phase 3|Lost to Follow-up|1|||
145561617|NCT04762680|524916756|FG017|Phase 3|Lost to Follow-up|66|||
145561618|NCT04762680|524916757|FG018|Phase 3|Lost to Follow-up|0|||
145561619|NCT04762680|524916758|FG019|Phase 3|Lost to Follow-up|0|||
145561620|NCT04762680|524916759|FG020|Phase 3|Lost to Follow-up|0|||
145561621|NCT04762680|524916760|FG021|Phase 3|Lost to Follow-up|0|||
145561622|NCT04762680|524916739|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561623|NCT04762680|524916740|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561624|NCT04762680|524916741|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561625|NCT04762680|524916742|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561626|NCT04762680|524916743|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561627|NCT04762680|524916744|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561628|NCT04762680|524916745|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561629|NCT04762680|524916746|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561630|NCT04762680|524916747|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561631|NCT04762680|524916748|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561632|NCT04762680|524916749|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561633|NCT04762680|524916750|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561634|NCT04762680|524916751|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561635|NCT04762680|524916752|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561636|NCT04762680|524916753|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561637|NCT04762680|524916754|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561638|NCT04762680|524916755|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561639|NCT04762680|524916756|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561640|NCT04762680|524916757|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561641|NCT04762680|524916758|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561642|NCT04762680|524916759|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
145561643|NCT04762680|524916760|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
145561644|NCT04762680|524916739|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561645|NCT04762680|524916740|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561646|NCT04762680|524916741|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561647|NCT04762680|524916742|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561648|NCT04762680|524916743|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
145619459|NCT04707391|525121027|FG000|Overall Study|Adverse Event|5|||
145619460|NCT04707391|525121028|FG001|Overall Study|Adverse Event|8|||
145619461|NCT04707391|525121027|FG000|Overall Study|Lost to Follow-up|44|||
145561649|NCT04762680|524916744|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561650|NCT04762680|524916745|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561651|NCT04762680|524916746|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561652|NCT04762680|524916747|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561653|NCT04762680|524916748|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561654|NCT04762680|524916749|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561655|NCT04762680|524916750|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561656|NCT04762680|524916751|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561657|NCT04762680|524916752|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561658|NCT04762680|524916753|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561659|NCT04762680|524916754|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561660|NCT04762680|524916755|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561661|NCT04762680|524916756|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561662|NCT04762680|524916757|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561663|NCT04762680|524916758|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
145619462|NCT04707391|525121028|FG001|Overall Study|Lost to Follow-up|31|||
145619463|NCT04707391|525121027|FG000|Overall Study|Protocol Violation|1|||
145619464|NCT04707391|525121028|FG001|Overall Study|Protocol Violation|5|||
145619465|NCT04707391|525121027|FG000|Overall Study|Withdrawal by Subject|27|||
145619466|NCT04707391|525121028|FG001|Overall Study|Withdrawal by Subject|25|||
145619467|NCT04707391|525121027|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
145619468|NCT04707391|525121028|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
145619469|NCT04707391|525121027|FG000|Overall Study|Other|0|||
145619470|NCT04707391|525121028|FG001|Overall Study|Other|2|||
145619471|NCT01932996|525121029|FG000|Overall Study|Protocol Violation|2|||
145619472|NCT01932996|525121030|FG001|Overall Study|Protocol Violation|0|||
145619473|NCT02040090|525121034|FG000|Overall Study|Adverse Event|2|||
145619474|NCT02040090|525121035|FG001|Overall Study|Adverse Event|0|||
145619475|NCT02040090|525121034|FG000|Overall Study|Physician Decision|1|||
145619476|NCT02040090|525121035|FG001|Overall Study|Physician Decision|0|||
145619477|NCT02040090|525121034|FG000|Overall Study|Withdrawal by Subject|0|||
145619478|NCT02040090|525121035|FG001|Overall Study|Withdrawal by Subject|1|||
145619479|NCT02040090|525121034|FG000|Overall Study|Lost to Follow-up|0|||
145619480|NCT02040090|525121035|FG001|Overall Study|Lost to Follow-up|1|||
145619481|NCT02584855|525121041|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
145619482|NCT02584855|525121042|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
145619483|NCT02584855|525121043|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
145619484|NCT02584855|525121044|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
145619485|NCT02584855|525121045|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
145619486|NCT02584855|525121046|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
145619487|NCT02584855|525121041|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
145619488|NCT02584855|525121042|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
145619489|NCT02584855|525121043|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
145619490|NCT02584855|525121044|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
145619491|NCT02584855|525121045|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
145619492|NCT02584855|525121046|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
145619493|NCT02584855|525121041|FG000|Open-Label Treatment Period|Adverse Event|14|||
145619494|NCT02584855|525121042|FG001|Open-Label Treatment Period|Adverse Event|0|||
145619495|NCT02584855|525121043|FG002|Open-Label Treatment Period|Adverse Event|0|||
145619496|NCT02584855|525121044|FG003|Open-Label Treatment Period|Adverse Event|0|||
145619497|NCT02584855|525121045|FG004|Open-Label Treatment Period|Adverse Event|0|||
145619498|NCT02584855|525121046|FG005|Open-Label Treatment Period|Adverse Event|0|||
145619499|NCT02584855|525121041|FG000|Open-Label Treatment Period|Death|2|||
145619500|NCT02584855|525121042|FG001|Open-Label Treatment Period|Death|0|||
145619501|NCT02584855|525121043|FG002|Open-Label Treatment Period|Death|0|||
145619502|NCT02584855|525121044|FG003|Open-Label Treatment Period|Death|0|||
145619503|NCT02584855|525121045|FG004|Open-Label Treatment Period|Death|0|||
145619504|NCT02584855|525121046|FG005|Open-Label Treatment Period|Death|0|||
145619505|NCT02584855|525121041|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
145619506|NCT02584855|525121042|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
145619507|NCT02584855|525121043|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
145619508|NCT02584855|525121044|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
145619509|NCT02584855|525121045|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
145619510|NCT02584855|525121046|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
145619511|NCT02584855|525121041|FG000|Open-Label Treatment Period|Protocol Violation|1|||
145619512|NCT02584855|525121042|FG001|Open-Label Treatment Period|Protocol Violation|0|||
145619513|NCT02584855|525121043|FG002|Open-Label Treatment Period|Protocol Violation|0|||
145619514|NCT02584855|525121044|FG003|Open-Label Treatment Period|Protocol Violation|0|||
145619515|NCT02584855|525121045|FG004|Open-Label Treatment Period|Protocol Violation|0|||
145619516|NCT02584855|525121046|FG005|Open-Label Treatment Period|Protocol Violation|0|||
145561664|NCT04762680|524916759|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
145619517|NCT02584855|525121041|FG000|Open-Label Treatment Period|No PI Available|2|||
145561665|NCT04762680|524916760|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
145561666|NCT04307446|524916764|FG000|Overall Study|Lost to Follow-up|2|||
145619518|NCT02584855|525121042|FG001|Open-Label Treatment Period|No PI Available|0|||
145619519|NCT02584855|525121043|FG002|Open-Label Treatment Period|No PI Available|0|||
145619520|NCT02584855|525121044|FG003|Open-Label Treatment Period|No PI Available|0|||
145619521|NCT02584855|525121045|FG004|Open-Label Treatment Period|No PI Available|0|||
145619522|NCT02584855|525121046|FG005|Open-Label Treatment Period|No PI Available|0|||
145619523|NCT02584855|525121041|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
145619524|NCT02584855|525121042|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
145619525|NCT02584855|525121043|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
145619526|NCT02584855|525121044|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
145619527|NCT02584855|525121045|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
145619528|NCT02584855|525121046|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
145619529|NCT02584855|525121041|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
145619530|NCT02584855|525121042|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
145619531|NCT02584855|525121043|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
145619532|NCT02584855|525121044|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
145619533|NCT02584855|525121045|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
145619534|NCT02584855|525121046|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
145619535|NCT02584855|525121041|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
145619536|NCT02584855|525121042|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
145619537|NCT02584855|525121043|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
145619538|NCT02584855|525121044|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
145619539|NCT02584855|525121045|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
145619540|NCT02584855|525121046|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
145619541|NCT02584855|525121041|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
145619542|NCT02584855|525121042|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
145619543|NCT02584855|525121043|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
145619544|NCT02584855|525121044|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
145619545|NCT02584855|525121045|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
145619546|NCT02584855|525121046|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
145619547|NCT02584855|525121041|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
145619548|NCT02584855|525121042|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
145619549|NCT02584855|525121043|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
145619550|NCT02584855|525121044|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
145619551|NCT02584855|525121045|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
145619552|NCT02584855|525121046|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
145619553|NCT02584855|525121041|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145619554|NCT02584855|525121042|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145619555|NCT02584855|525121043|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145619556|NCT02584855|525121044|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145619557|NCT02584855|525121045|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
145619558|NCT02584855|525121046|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
145619559|NCT02584855|525121041|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
145619560|NCT02584855|525121042|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
145619561|NCT02584855|525121043|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
145619562|NCT02584855|525121044|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
145619563|NCT02584855|525121045|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
145619564|NCT02584855|525121046|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
145619565|NCT02337478|525121047|FG000|Overall Study|Lack of Efficacy|5|||
145619566|NCT00895843|525121048|FG000|Overall Study|Protocol Violation|12|||
145619567|NCT00895843|525121049|FG001|Overall Study|Protocol Violation|12|||
145619568|NCT04963062|525121056|FG000|Overall Study|withdrew by the study team|4|||
145619569|NCT04963062|525121057|FG001|Overall Study|withdrew by the study team|2|||
145619570|NCT04504916|525121065|FG000|Overall Study|Study terminated|7|||
145619571|NCT04504916|525121066|FG001|Overall Study|Study terminated|8|||
145619572|NCT04504916|525121065|FG000|Overall Study|Death|54|||
145619573|NCT04504916|525121066|FG001|Overall Study|Death|18|||
145619574|NCT04504916|525121065|FG000|Overall Study|Lost to Follow-up|1|||
145619575|NCT04504916|525121066|FG001|Overall Study|Lost to Follow-up|1|||
145619576|NCT04504916|525121065|FG000|Overall Study|Withdrawal by Subject|8|||
145619577|NCT04504916|525121066|FG001|Overall Study|Withdrawal by Subject|4|||
145619578|NCT04504916|525121065|FG000|Overall Study|Did not agree to follow-up|0|||
145619579|NCT04504916|525121066|FG001|Overall Study|Did not agree to follow-up|1|||
145619580|NCT01368211|525121067|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
145619581|NCT01368211|525121068|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
145619582|NCT01513967|525121072|FG000|Overall Study|Pregnancy|0|||
145619583|NCT01513967|525121073|FG001|Overall Study|Pregnancy|0|||
145619584|NCT01513967|525121074|FG002|Overall Study|Pregnancy|0|||
145619585|NCT01513967|525121075|FG003|Overall Study|Pregnancy|0|||
145561667|NCT04307446|524916765|FG001|Overall Study|Lost to Follow-up|0|||
145561668|NCT00697515|524916769|FG000|Dose Optimization Period|Adverse Event|4|||
145561669|NCT00697515|524916770|FG001|Dose Optimization Period|Adverse Event|0|||
145561670|NCT00697515|524916769|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
145561671|NCT00697515|524916770|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
145561672|NCT00697515|524916769|FG000|Dose Optimization Period|Lost to Follow-up|2|||
145561673|NCT00697515|524916770|FG001|Dose Optimization Period|Lost to Follow-up|0|||
145561674|NCT00697515|524916769|FG000|Dose Optimization Period|sponsor request|2|||
145561675|NCT00697515|524916770|FG001|Dose Optimization Period|sponsor request|0|||
145561676|NCT00697515|524916769|FG000|Dose Optimization Period|called to active duty|1|||
145561677|NCT00697515|524916770|FG001|Dose Optimization Period|called to active duty|0|||
145561678|NCT00697515|524916769|FG000|Dose Optimization Period|elevated QTc|1|||
145561679|NCT00697515|524916770|FG001|Dose Optimization Period|elevated QTc|0|||
145561680|NCT00697515|524916769|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
145561681|NCT00697515|524916770|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
145561682|NCT00697515|524916769|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
145561683|NCT00697515|524916770|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
145561684|NCT00697515|524916769|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
145561685|NCT00697515|524916770|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
145561686|NCT00697515|524916769|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
145561687|NCT00697515|524916770|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
145561688|NCT02603432|524916771|FG000|Overall Study|Adverse Event|1|||
145561689|NCT02603432|524916772|FG001|Overall Study|Adverse Event|0|||
145561690|NCT02603432|524916771|FG000|Overall Study|Death|221|||
145561691|NCT02603432|524916772|FG001|Overall Study|Death|242|||
145561692|NCT02603432|524916771|FG000|Overall Study|Lost to Follow-up|3|||
145561693|NCT02603432|524916772|FG001|Overall Study|Lost to Follow-up|9|||
145561694|NCT02603432|524916771|FG000|Overall Study|Progressive Disease|7|||
145561695|NCT02603432|524916772|FG001|Overall Study|Progressive Disease|5|||
145561696|NCT02603432|524916771|FG000|Overall Study|Withdrawal by Subject|12|||
145561697|NCT02603432|524916772|FG001|Overall Study|Withdrawal by Subject|18|||
145561698|NCT02603432|524916771|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
145561699|NCT02603432|524916772|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145561700|NCT02603432|524916771|FG000|Overall Study|Study terminated by sponsor|74|||
145561701|NCT02603432|524916772|FG001|Overall Study|Study terminated by sponsor|75|||
145561702|NCT02603432|524916771|FG000|Overall Study|Other|13|||
145561703|NCT02603432|524916772|FG001|Overall Study|Other|0|||
145561704|NCT00581776|524916773|FG000|Overall Study|Disease progression or no response|3|||
145561705|NCT02063854|524916777|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
145561706|NCT02063854|524916778|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
145561707|NCT02063854|524916779|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
145561708|NCT02063854|524916780|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
145561709|NCT02063854|524916781|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
145561710|NCT02063854|524916782|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
145561711|NCT02063854|524916783|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
145561712|NCT02063854|524916777|FG000|Overall Study|Major Protocol Deviation|0|||
145561713|NCT02063854|524916778|FG001|Overall Study|Major Protocol Deviation|0|||
145561714|NCT02063854|524916779|FG002|Overall Study|Major Protocol Deviation|3|||
145561715|NCT02063854|524916780|FG003|Overall Study|Major Protocol Deviation|0|||
145561716|NCT02063854|524916781|FG004|Overall Study|Major Protocol Deviation|0|||
145561717|NCT02063854|524916782|FG005|Overall Study|Major Protocol Deviation|0|||
145561718|NCT02063854|524916783|FG006|Overall Study|Major Protocol Deviation|0|||
145561719|NCT02063854|524916777|FG000|Overall Study|Voluntary Withdrawal|2|||
145561720|NCT02063854|524916778|FG001|Overall Study|Voluntary Withdrawal|0|||
145561721|NCT02063854|524916779|FG002|Overall Study|Voluntary Withdrawal|8|||
145561722|NCT02063854|524916780|FG003|Overall Study|Voluntary Withdrawal|1|||
145561723|NCT02063854|524916781|FG004|Overall Study|Voluntary Withdrawal|3|||
145561724|NCT02063854|524916782|FG005|Overall Study|Voluntary Withdrawal|6|||
145561725|NCT02063854|524916783|FG006|Overall Study|Voluntary Withdrawal|1|||
145561726|NCT02063854|524916777|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
145407981|NCT02763566|524349801|FG003|Overall Study|Lost to Follow-up|1|||
145561727|NCT02063854|524916778|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
145561728|NCT02063854|524916779|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
145561729|NCT02063854|524916780|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
145561730|NCT02063854|524916781|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
145561731|NCT02063854|524916782|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
145561732|NCT02063854|524916783|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
145561733|NCT02063854|524916777|FG000|Overall Study|Reason Not Specified|1|||
145561734|NCT02063854|524916778|FG001|Overall Study|Reason Not Specified|0|||
145561735|NCT02063854|524916779|FG002|Overall Study|Reason Not Specified|0|||
145561736|NCT02063854|524916780|FG003|Overall Study|Reason Not Specified|0|||
145561737|NCT02063854|524916781|FG004|Overall Study|Reason Not Specified|0|||
145619586|NCT01513967|525121076|FG004|Overall Study|Pregnancy|0|||
145561738|NCT02063854|524916782|FG005|Overall Study|Reason Not Specified|0|||
145561739|NCT02063854|524916783|FG006|Overall Study|Reason Not Specified|0|||
145561740|NCT02063854|524916777|FG000|Overall Study|Did Not Receive Study Drug|0|||
145561741|NCT02063854|524916778|FG001|Overall Study|Did Not Receive Study Drug|0|||
145561742|NCT02063854|524916779|FG002|Overall Study|Did Not Receive Study Drug|0|||
145561743|NCT02063854|524916780|FG003|Overall Study|Did Not Receive Study Drug|0|||
145561744|NCT02063854|524916781|FG004|Overall Study|Did Not Receive Study Drug|0|||
145561745|NCT02063854|524916782|FG005|Overall Study|Did Not Receive Study Drug|1|||
145561746|NCT02063854|524916783|FG006|Overall Study|Did Not Receive Study Drug|0|||
145561747|NCT00930579|524916786|FG000|Overall Study|Withdrawal by Subject|1|||
145561748|NCT00930579|524916786|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
145561749|NCT02255981|524916787|FG000|Overall Study|Lost to Follow-up|3|||
145561750|NCT02255981|524916787|FG000|Overall Study|Withdrawal by Subject|1|||
145561751|NCT01046682|524916788|FG000|Overall Study|Adverse Event|2|||
145561752|NCT01046682|524916789|FG001|Overall Study|Adverse Event|0|||
145561753|NCT00949325|524916795|FG000|Overall Study|Adverse Event|0|||
145561754|NCT00949325|524916796|FG001|Overall Study|Adverse Event|2|||
145561755|NCT00949325|524916797|FG002|Overall Study|Adverse Event|0|||
145561756|NCT05533632|524916798|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
145561757|NCT05533632|524916798|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
145561758|NCT05533632|524916798|FG000|Overall Study|Lost to Follow-up|1|||
145561759|NCT05533632|524916798|FG000|Overall Study|Withdrawal by Subject|4|||
145561760|NCT05533632|524916798|FG000|Overall Study|Adverse Event|4|||
145561761|NCT02205333|524916802|FG000|Overall Study|Death|5|||
145561762|NCT02205333|524916803|FG001|Overall Study|Death|6|||
145561763|NCT02205333|524916804|FG002|Overall Study|Death|2|||
145561764|NCT02205333|524916805|FG003|Overall Study|Death|6|||
145561765|NCT02205333|524916806|FG004|Overall Study|Death|5|||
145561766|NCT02205333|524916807|FG005|Overall Study|Death|3|||
145561767|NCT02205333|524916808|FG006|Overall Study|Death|3|||
145619587|NCT01513967|525121077|FG005|Overall Study|Pregnancy|0|||
145619588|NCT01513967|525121078|FG006|Overall Study|Pregnancy|1|||
145561768|NCT02205333|524916809|FG007|Overall Study|Death|2|||
145619589|NCT01513967|525121079|FG007|Overall Study|Pregnancy|0|||
145561769|NCT02205333|524916810|FG008|Overall Study|Death|0|||
145561770|NCT02205333|524916802|FG000|Overall Study|Withdrawal by Subject|1|||
145619590|NCT01513967|525121072|FG000|Overall Study|missed a study visit|0|||
145561771|NCT02205333|524916803|FG001|Overall Study|Withdrawal by Subject|0|||
145561772|NCT02205333|524916804|FG002|Overall Study|Withdrawal by Subject|0|||
145561773|NCT02205333|524916805|FG003|Overall Study|Withdrawal by Subject|1|||
145561774|NCT02205333|524916806|FG004|Overall Study|Withdrawal by Subject|0|||
145561775|NCT02205333|524916807|FG005|Overall Study|Withdrawal by Subject|0|||
145561776|NCT02205333|524916808|FG006|Overall Study|Withdrawal by Subject|2|||
145561777|NCT02205333|524916809|FG007|Overall Study|Withdrawal by Subject|0|||
145561778|NCT02205333|524916810|FG008|Overall Study|Withdrawal by Subject|0|||
145561779|NCT03054870|524916811|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
145619591|NCT01513967|525121073|FG001|Overall Study|missed a study visit|0|||
145619592|NCT01513967|525121074|FG002|Overall Study|missed a study visit|0|||
145619593|NCT01513967|525121075|FG003|Overall Study|missed a study visit|0|||
145561780|NCT03054870|524916811|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
145619594|NCT01513967|525121076|FG004|Overall Study|missed a study visit|0|||
145561781|NCT00643682|524916814|FG000|Overall Study|did not keep appointment|522|||
145561782|NCT00643682|524916815|FG001|Overall Study|did not keep appointment|509|||
145561783|NCT03755414|524916817|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
145655511|NCT02975882|525257246|FG001|Overall Study|Ineligible|1|||
145619595|NCT01513967|525121077|FG005|Overall Study|missed a study visit|0|||
145619596|NCT01513967|525121078|FG006|Overall Study|missed a study visit|1|||
145619597|NCT01513967|525121079|FG007|Overall Study|missed a study visit|0|||
145619598|NCT01513967|525121072|FG000|Overall Study|excluded due to positive drug screen|0|||
145619599|NCT01513967|525121073|FG001|Overall Study|excluded due to positive drug screen|0|||
145619600|NCT01513967|525121074|FG002|Overall Study|excluded due to positive drug screen|0|||
145619601|NCT01513967|525121075|FG003|Overall Study|excluded due to positive drug screen|0|||
145619602|NCT01513967|525121076|FG004|Overall Study|excluded due to positive drug screen|0|||
145619603|NCT01513967|525121077|FG005|Overall Study|excluded due to positive drug screen|0|||
145619604|NCT01513967|525121078|FG006|Overall Study|excluded due to positive drug screen|0|||
145619605|NCT01513967|525121079|FG007|Overall Study|excluded due to positive drug screen|2|||
145619606|NCT01513967|525121072|FG000|Overall Study|Physician Decision|0|||
145619607|NCT01513967|525121073|FG001|Overall Study|Physician Decision|0|||
145619608|NCT01513967|525121074|FG002|Overall Study|Physician Decision|0|||
145619609|NCT01513967|525121075|FG003|Overall Study|Physician Decision|0|||
145619610|NCT01513967|525121076|FG004|Overall Study|Physician Decision|0|||
145619611|NCT01513967|525121077|FG005|Overall Study|Physician Decision|1|||
145619612|NCT01513967|525121078|FG006|Overall Study|Physician Decision|0|||
145619613|NCT01513967|525121079|FG007|Overall Study|Physician Decision|0|||
145619614|NCT02906202|525121080|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
145619615|NCT01349660|525121081|FG000|Overall Study|Still Receiving Study Treatment|0|||
145619616|NCT01349660|525121082|FG001|Overall Study|Still Receiving Study Treatment|0|||
145619617|NCT01349660|525121083|FG002|Overall Study|Still Receiving Study Treatment|1|||
145619618|NCT01349660|525121081|FG000|Overall Study|Disease Progression|2|||
145619619|NCT01349660|525121082|FG001|Overall Study|Disease Progression|4|||
145619620|NCT01349660|525121083|FG002|Overall Study|Disease Progression|50|||
145619621|NCT01349660|525121081|FG000|Overall Study|Adverse Event|1|||
145619622|NCT01349660|525121082|FG001|Overall Study|Adverse Event|1|||
145619623|NCT01349660|525121083|FG002|Overall Study|Adverse Event|12|||
145619624|NCT01349660|525121081|FG000|Overall Study|Withdrawal by Subject|2|||
145619625|NCT01349660|525121082|FG001|Overall Study|Withdrawal by Subject|0|||
145619626|NCT01349660|525121083|FG002|Overall Study|Withdrawal by Subject|9|||
145407982|NCT02763566|524349798|FG000|Overall Study|On study treatment at study conclusion|114|||
145407983|NCT02763566|524349799|FG001|Overall Study|On study treatment at study conclusion|34|||
145407984|NCT02763566|524349800|FG002|Overall Study|On study treatment at study conclusion|54|||
145407985|NCT02763566|524349801|FG003|Overall Study|On study treatment at study conclusion|13|||
145407986|NCT02763566|524349798|FG000|Overall Study|Withdrawal by Subject|3|||
145407987|NCT02763566|524349799|FG001|Overall Study|Withdrawal by Subject|1|||
145407988|NCT02763566|524349800|FG002|Overall Study|Withdrawal by Subject|0|||
145407989|NCT02763566|524349801|FG003|Overall Study|Withdrawal by Subject|0|||
145407990|NCT04896385|524349802|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
145407991|NCT04896385|524349803|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
145407992|NCT04896385|524349804|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
145407993|NCT04896385|524349805|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
145407994|NCT04896385|524349802|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
145561784|NCT03755414|524916818|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
145561785|NCT03755414|524916819|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
145561786|NCT03755414|524916817|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
145561787|NCT03755414|524916818|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
145619627|NCT01349660|525121081|FG000|Overall Study|Death|1|||
145407995|NCT04896385|524349803|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
145407996|NCT04896385|524349804|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145407997|NCT04896385|524349805|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145407998|NCT04896385|524349802|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
145561788|NCT03755414|524916819|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
145561789|NCT03755414|524916817|FG000|Overall Study|Non-compliance|0|||
145561790|NCT03755414|524916818|FG001|Overall Study|Non-compliance|1|||
145561791|NCT03755414|524916819|FG002|Overall Study|Non-compliance|0|||
145619628|NCT01349660|525121082|FG001|Overall Study|Death|1|||
145619629|NCT01349660|525121083|FG002|Overall Study|Death|0|||
145619630|NCT01349660|525121081|FG000|Overall Study|Non-Permitted Interventions|0|||
145619631|NCT01349660|525121082|FG001|Overall Study|Non-Permitted Interventions|0|||
145407999|NCT04896385|524349803|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
145619632|NCT01349660|525121083|FG002|Overall Study|Non-Permitted Interventions|2|||
145619633|NCT01349660|525121081|FG000|Overall Study|Study Compliance|0|||
145619634|NCT01349660|525121082|FG001|Overall Study|Study Compliance|0|||
145408000|NCT04896385|524349804|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
145408001|NCT04896385|524349805|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
145408002|NCT04896385|524349802|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145408003|NCT04896385|524349803|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145408004|NCT04896385|524349804|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
145619635|NCT01349660|525121083|FG002|Overall Study|Study Compliance|1|||
145619636|NCT01349660|525121081|FG000|Overall Study|Declining Performance Status|0|||
145561792|NCT02153112|524916820|FG000|Overall Study|Adverse Event|0|||
145561793|NCT02153112|524916821|FG001|Overall Study|Adverse Event|0|||
145561794|NCT02153112|524916822|FG002|Overall Study|Adverse Event|1|||
145408005|NCT04896385|524349805|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
145408006|NCT04896385|524349802|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
145408007|NCT04896385|524349803|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
145561795|NCT02153112|524916823|FG003|Overall Study|Adverse Event|0|||
145561796|NCT02153112|524916824|FG004|Overall Study|Adverse Event|0|||
145619637|NCT01349660|525121082|FG001|Overall Study|Declining Performance Status|0|||
145619638|NCT01349660|525121083|FG002|Overall Study|Declining Performance Status|1|||
145619639|NCT00847301|525121086|FG000|Overall Study|Adverse Event|35|||
145619640|NCT00847301|525121086|FG000|Overall Study|Switch to other anticoagulants|16|||
145619641|NCT00847301|525121086|FG000|Overall Study|Lost to Follow-up|1|||
145619642|NCT00847301|525121086|FG000|Overall Study|No prescription after hospital discharge|1|||
145619643|NCT00847301|525121086|FG000|Overall Study|Other reason not defined above|1|||
145619644|NCT04248465|525121090|FG000|Randomized-Controlled Period|Death|12|||
145619645|NCT04248465|525121091|FG001|Randomized-Controlled Period|Death|5|||
145619646|NCT04248465|525121090|FG000|Randomized-Controlled Period|Adverse Event|2|||
145619647|NCT04248465|525121091|FG001|Randomized-Controlled Period|Adverse Event|0|||
145619648|NCT04248465|525121090|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
145619649|NCT04248465|525121091|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
145619650|NCT04248465|525121090|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
145619651|NCT04248465|525121091|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
145619652|NCT04248465|525121090|FG000|Randomized-Controlled Period|Physician Decision|1|||
145619653|NCT04248465|525121091|FG001|Randomized-Controlled Period|Physician Decision|1|||
145619654|NCT04248465|525121090|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
145619655|NCT04248465|525121091|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
145619656|NCT04248465|525121090|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
145619657|NCT04248465|525121091|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
145619658|NCT04248465|525121090|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
145619659|NCT04248465|525121091|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
145619660|NCT05708846|525121092|FG000|Overall Study|Death|5|||
145619661|NCT05708846|525121092|FG000|Overall Study|Withdrawal by Subject|20|||
145619662|NCT05221749|525121093|FG000|Overall Study|Lost to Follow-up|2|||
145561797|NCT02153112|524916825|FG005|Overall Study|Adverse Event|0|||
145561798|NCT02153112|524916826|FG006|Overall Study|Adverse Event|0|||
145561799|NCT02153112|524916827|FG007|Overall Study|Adverse Event|0|||
145561800|NCT02153112|524916828|FG008|Overall Study|Adverse Event|0|||
145561801|NCT02153112|524916829|FG009|Overall Study|Adverse Event|0|||
145561802|NCT02153112|524916820|FG000|Overall Study|Lost to Follow-up|1|||
145561803|NCT02153112|524916821|FG001|Overall Study|Lost to Follow-up|1|||
145561804|NCT02153112|524916822|FG002|Overall Study|Lost to Follow-up|0|||
145561805|NCT02153112|524916823|FG003|Overall Study|Lost to Follow-up|0|||
145561806|NCT02153112|524916824|FG004|Overall Study|Lost to Follow-up|2|||
145561807|NCT02153112|524916825|FG005|Overall Study|Lost to Follow-up|1|||
145561808|NCT02153112|524916826|FG006|Overall Study|Lost to Follow-up|1|||
145619663|NCT05221749|525121094|FG001|Overall Study|Lost to Follow-up|3|||
145619664|NCT03428815|525121095|FG000|Overall Study|Lost to Follow-up|2|||
145619665|NCT03428815|525121096|FG001|Overall Study|Lost to Follow-up|2|||
145619666|NCT03428815|525121095|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
145619667|NCT03428815|525121096|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
145619668|NCT03428815|525121095|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
145619669|NCT03428815|525121096|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
145619670|NCT00519636|525121097|FG000|Treatment Period 1|Adverse Event|1|||
145619671|NCT00519636|525121098|FG001|Treatment Period 1|Adverse Event|0|||
145619672|NCT00519636|525121099|FG002|Treatment Period 1|Adverse Event|1|||
145619673|NCT00519636|525121100|FG003|Treatment Period 1|Adverse Event|0|||
145619674|NCT00519636|525121097|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
145619675|NCT00519636|525121098|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
145619676|NCT00519636|525121099|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
145619677|NCT00519636|525121100|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
145619678|NCT00519636|525121097|FG000|Washout Period|Adverse Event|2|||
145619679|NCT00519636|525121098|FG001|Washout Period|Adverse Event|1|||
145619680|NCT00519636|525121099|FG002|Washout Period|Adverse Event|1|||
145619681|NCT00519636|525121100|FG003|Washout Period|Adverse Event|0|||
145619682|NCT00519636|525121097|FG000|Washout Period|Lost to Follow-up|1|||
145619683|NCT00519636|525121098|FG001|Washout Period|Lost to Follow-up|0|||
145619684|NCT00519636|525121099|FG002|Washout Period|Lost to Follow-up|0|||
145619685|NCT00519636|525121100|FG003|Washout Period|Lost to Follow-up|0|||
145619686|NCT00519636|525121097|FG000|Washout Period|Protocol Violation|0|||
145619687|NCT00519636|525121098|FG001|Washout Period|Protocol Violation|0|||
145619688|NCT00519636|525121099|FG002|Washout Period|Protocol Violation|1|||
145619689|NCT00519636|525121100|FG003|Washout Period|Protocol Violation|2|||
145619690|NCT00519636|525121097|FG000|Washout Period|Withdrawal by Subject|1|||
145561809|NCT02153112|524916827|FG007|Overall Study|Lost to Follow-up|0|||
145619691|NCT00519636|525121098|FG001|Washout Period|Withdrawal by Subject|0|||
145619692|NCT00519636|525121099|FG002|Washout Period|Withdrawal by Subject|1|||
145619693|NCT00519636|525121100|FG003|Washout Period|Withdrawal by Subject|0|||
145619694|NCT00519636|525121097|FG000|Washout Period|Failed to meet continuation criteria|14|||
145619695|NCT00519636|525121098|FG001|Washout Period|Failed to meet continuation criteria|11|||
145619696|NCT00519636|525121099|FG002|Washout Period|Failed to meet continuation criteria|9|||
145619697|NCT00519636|525121100|FG003|Washout Period|Failed to meet continuation criteria|3|||
145619698|NCT00519636|525121097|FG000|Washout Period|Out of pollen area > 48 hours|1|||
145619699|NCT00519636|525121098|FG001|Washout Period|Out of pollen area > 48 hours|0|||
145619700|NCT00519636|525121099|FG002|Washout Period|Out of pollen area > 48 hours|0|||
145619701|NCT00519636|525121100|FG003|Washout Period|Out of pollen area > 48 hours|0|||
145619702|NCT00519636|525121097|FG000|Washout Period|Participating in study at another site|1|||
145619703|NCT00519636|525121098|FG001|Washout Period|Participating in study at another site|0|||
145561810|NCT02153112|524916828|FG008|Overall Study|Lost to Follow-up|1|||
145561811|NCT02153112|524916829|FG009|Overall Study|Lost to Follow-up|1|||
145561812|NCT02153112|524916820|FG000|Overall Study|Withdrawal by Subject|3|||
145619704|NCT00519636|525121099|FG002|Washout Period|Participating in study at another site|0|||
145619705|NCT00519636|525121100|FG003|Washout Period|Participating in study at another site|0|||
145619706|NCT00519636|525121097|FG000|Washout Period|Non-compliant|0|||
145619707|NCT00519636|525121098|FG001|Washout Period|Non-compliant|1|||
145619708|NCT00519636|525121099|FG002|Washout Period|Non-compliant|0|||
145619709|NCT00519636|525121100|FG003|Washout Period|Non-compliant|0|||
145619710|NCT00519636|525121097|FG000|Washout Period|Per doctors request|0|||
145619711|NCT00519636|525121098|FG001|Washout Period|Per doctors request|1|||
145619712|NCT00519636|525121099|FG002|Washout Period|Per doctors request|0|||
145619713|NCT00519636|525121100|FG003|Washout Period|Per doctors request|0|||
145619714|NCT00519636|525121097|FG000|Washout Period|Subject randomized in error|0|||
145619715|NCT00519636|525121098|FG001|Washout Period|Subject randomized in error|0|||
145619716|NCT00519636|525121099|FG002|Washout Period|Subject randomized in error|1|||
145619717|NCT00519636|525121100|FG003|Washout Period|Subject randomized in error|0|||
145619718|NCT00519636|525121097|FG000|Washout Period|Prohibited medications|0|||
145619719|NCT00519636|525121098|FG001|Washout Period|Prohibited medications|0|||
145619720|NCT00519636|525121099|FG002|Washout Period|Prohibited medications|1|||
145619721|NCT00519636|525121100|FG003|Washout Period|Prohibited medications|0|||
145619722|NCT00519636|525121097|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
145619723|NCT00519636|525121098|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
145619724|NCT00519636|525121099|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
145619725|NCT00519636|525121100|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
145619726|NCT00519636|525121097|FG000|Treatment Period 2|Subject randomized in error|0|||
145619727|NCT00519636|525121098|FG001|Treatment Period 2|Subject randomized in error|1|||
145619728|NCT00519636|525121099|FG002|Treatment Period 2|Subject randomized in error|0|||
145619729|NCT00519636|525121100|FG003|Treatment Period 2|Subject randomized in error|0|||
145619730|NCT00519636|525121097|FG000|Treatment Period 2|Per doctors request|0|||
145619731|NCT00519636|525121098|FG001|Treatment Period 2|Per doctors request|0|||
145619732|NCT00519636|525121099|FG002|Treatment Period 2|Per doctors request|1|||
145619733|NCT00519636|525121100|FG003|Treatment Period 2|Per doctors request|0|||
145619734|NCT00519636|525121097|FG000|Treatment Period 2|Subject misrandomized|0|||
145619735|NCT00519636|525121098|FG001|Treatment Period 2|Subject misrandomized|0|||
145619736|NCT00519636|525121099|FG002|Treatment Period 2|Subject misrandomized|0|||
145619737|NCT00519636|525121100|FG003|Treatment Period 2|Subject misrandomized|1|||
145619738|NCT00519636|525121097|FG000|Post Study Period|Subject randomized in error|0|||
145619739|NCT00519636|525121098|FG001|Post Study Period|Subject randomized in error|0|||
145619740|NCT00519636|525121099|FG002|Post Study Period|Subject randomized in error|0|||
145619741|NCT00519636|525121100|FG003|Post Study Period|Subject randomized in error|1|||
145619742|NCT02388074|525121101|FG000|Overall Study|Lost in Transit|2|||
145619743|NCT02388074|525121101|FG000|Overall Study|Sample Not Returned|1|||
145619744|NCT01254890|525121106|FG000|Overall Study|Ineligible|0|||
145619745|NCT01254890|525121107|FG001|Overall Study|Ineligible|3|||
145619746|NCT01254890|525121106|FG000|Overall Study|Withdrawal by Subject|1|||
145619747|NCT01254890|525121107|FG001|Overall Study|Withdrawal by Subject|2|||
145619748|NCT01254890|525121106|FG000|Overall Study|Disease Progression|0|||
145619749|NCT01254890|525121107|FG001|Overall Study|Disease Progression|5|||
145619750|NCT03363659|525121109|FG000|Overall Study|Adverse Event|1|||
145619751|NCT03363659|525121109|FG000|Overall Study|Screen fail|1|||
145619752|NCT03363659|525121109|FG000|Overall Study|Withdrawal by Subject|1|||
145619753|NCT00904150|525121110|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
145619754|NCT00904150|525121111|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
145619755|NCT00904150|525121110|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
145619756|NCT00904150|525121111|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
145619757|NCT03872388|525121112|FG000|Overall Study|Disease Progression|0|||
145619758|NCT03872388|525121113|FG001|Overall Study|Disease Progression|0|||
145619759|NCT03872388|525121114|FG002|Overall Study|Disease Progression|0|||
145619760|NCT03872388|525121115|FG003|Overall Study|Disease Progression|0|||
145619761|NCT03872388|525121116|FG004|Overall Study|Disease Progression|0|||
145619762|NCT03872388|525121117|FG005|Overall Study|Disease Progression|0|||
145619763|NCT03872388|525121118|FG006|Overall Study|Disease Progression|1|||
145619764|NCT03872388|525121119|FG007|Overall Study|Disease Progression|1|||
145619765|NCT03038672|525123556|FG000|Initial Treatment|Unacceptable chemistry|0|||
145619766|NCT03038672|525123557|FG001|Initial Treatment|Unacceptable chemistry|1|||
145619767|NCT03038672|525123556|FG000|Initial Treatment|Progression prior to treatment|1|||
145619768|NCT03038672|525123557|FG001|Initial Treatment|Progression prior to treatment|0|||
145619769|NCT03038672|525123556|FG000|Initial Treatment|No treatment per protocol|1|||
145619770|NCT03038672|525123557|FG001|Initial Treatment|No treatment per protocol|0|||
145619771|NCT04423393|525123558|FG000|Overall Study|Withdrawal by Subject|0|||
145619772|NCT04423393|525123559|FG001|Overall Study|Withdrawal by Subject|0|||
145619773|NCT04423393|525123560|FG002|Overall Study|Withdrawal by Subject|0|||
145619774|NCT04423393|525123561|FG003|Overall Study|Withdrawal by Subject|0|||
145619775|NCT04423393|525123562|FG004|Overall Study|Withdrawal by Subject|0|||
145619776|NCT04423393|525123563|FG005|Overall Study|Withdrawal by Subject|1|||
145619777|NCT04423393|525123564|FG006|Overall Study|Withdrawal by Subject|0|||
145619778|NCT04423393|525123565|FG007|Overall Study|Withdrawal by Subject|0|||
145619779|NCT04423393|525123566|FG008|Overall Study|Withdrawal by Subject|0|||
145294365|NCT06176768|523927637|FG000|Overall Study|Assigned treatment by mistake|1|||
145294366|NCT06176768|523927638|FG001|Overall Study|Assigned treatment by mistake|0|||
145294367|NCT06176768|523927637|FG000|Overall Study|Lost to Follow-up|0|||
145294368|NCT06176768|523927638|FG001|Overall Study|Lost to Follow-up|3|||
145294369|NCT06176768|523927637|FG000|Overall Study|Physician Decision|1|||
145294370|NCT06176768|523927638|FG001|Overall Study|Physician Decision|0|||
145294371|NCT06176768|523927637|FG000|Overall Study|Protocol deviation|3|||
145294372|NCT06176768|523927638|FG001|Overall Study|Protocol deviation|1|||
145294373|NCT06176768|523927637|FG000|Overall Study|Other|1|||
145294374|NCT06176768|523927638|FG001|Overall Study|Other|0|||
145294375|NCT06176768|523927637|FG000|Overall Study|Withdrawal by Subject|6|||
145294376|NCT06176768|523927638|FG001|Overall Study|Withdrawal by Subject|9|||
145294377|NCT01226797|523927641|FG000|Overall Study|Adverse Event|1|||
145294378|NCT01226797|523927642|FG001|Overall Study|Adverse Event|0|||
145294379|NCT01226797|523927641|FG000|Overall Study|No longer willing to participate|1|||
145294380|NCT01226797|523927642|FG001|Overall Study|No longer willing to participate|0|||
145294381|NCT01226797|523927641|FG000|Overall Study|Protocol Violation|0|||
145294382|NCT01226797|523927642|FG001|Overall Study|Protocol Violation|1|||
145294383|NCT00577460|523927643|FG000|Overall Study|Adverse Event|11|||
145294384|NCT00577460|523927644|FG001|Overall Study|Adverse Event|7|||
145294385|NCT00577460|523927645|FG002|Overall Study|Adverse Event|14|||
145294386|NCT00577460|523927643|FG000|Overall Study|Protocol Violation|0|||
145294387|NCT00577460|523927644|FG001|Overall Study|Protocol Violation|1|||
145294388|NCT00577460|523927645|FG002|Overall Study|Protocol Violation|1|||
145294389|NCT00577460|523927643|FG000|Overall Study|Lost to Follow-up|0|||
145294390|NCT00577460|523927644|FG001|Overall Study|Lost to Follow-up|3|||
145294391|NCT00577460|523927645|FG002|Overall Study|Lost to Follow-up|4|||
145294392|NCT00577460|523927643|FG000|Overall Study|Withdrawal by Subject|5|||
145294393|NCT00577460|523927644|FG001|Overall Study|Withdrawal by Subject|5|||
145294394|NCT00577460|523927645|FG002|Overall Study|Withdrawal by Subject|6|||
145294395|NCT00577460|523927643|FG000|Overall Study|Other|0|||
145294396|NCT00577460|523927644|FG001|Overall Study|Other|3|||
145294397|NCT00577460|523927645|FG002|Overall Study|Other|2|||
145294398|NCT01318499|523927648|FG000|Overall Study|Adverse Event|16|||
145294399|NCT01318499|523927649|FG001|Overall Study|Adverse Event|11|||
145294400|NCT01318499|523927650|FG002|Overall Study|Adverse Event|6|||
145294401|NCT01318499|523927648|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
145294402|NCT01318499|523927649|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
145294403|NCT01318499|523927650|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
145294404|NCT01318499|523927648|FG000|Overall Study|Noncompliance|2|||
145294405|NCT01318499|523927649|FG001|Overall Study|Noncompliance|3|||
145294406|NCT01318499|523927650|FG002|Overall Study|Noncompliance|0|||
145294407|NCT01318499|523927648|FG000|Overall Study|Treatment Failure|19|||
145294408|NCT01318499|523927649|FG001|Overall Study|Treatment Failure|19|||
145619780|NCT04423393|525123567|FG009|Overall Study|Withdrawal by Subject|0|||
145619781|NCT04423393|525123568|FG010|Overall Study|Withdrawal by Subject|0|||
145294409|NCT01318499|523927650|FG002|Overall Study|Treatment Failure|101|||
145294410|NCT01318499|523927648|FG000|Overall Study|Protocol Violation|2|||
145294411|NCT01318499|523927649|FG001|Overall Study|Protocol Violation|4|||
145294412|NCT01318499|523927650|FG002|Overall Study|Protocol Violation|2|||
145294413|NCT01318499|523927648|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
145619782|NCT04423393|525123569|FG011|Overall Study|Withdrawal by Subject|0|||
145294414|NCT01318499|523927649|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
145294415|NCT01318499|523927650|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
145294416|NCT01318499|523927648|FG000|Overall Study|Other|7|||
145294417|NCT01318499|523927649|FG001|Overall Study|Other|10|||
145619783|NCT04423393|525123570|FG012|Overall Study|Withdrawal by Subject|0|||
145294418|NCT01318499|523927650|FG002|Overall Study|Other|22|||
145561813|NCT02153112|524916821|FG001|Overall Study|Withdrawal by Subject|1|||
145561814|NCT02153112|524916822|FG002|Overall Study|Withdrawal by Subject|2|||
145655512|NCT02975882|525257247|FG002|Overall Study|Ineligible|0|||
145408008|NCT04896385|524349804|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
145408009|NCT04896385|524349805|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
145408010|NCT04896385|524349802|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
145408011|NCT04896385|524349803|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
145408012|NCT04896385|524349804|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
145408013|NCT04896385|524349805|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
145408014|NCT03197129|524349806|FG000|Overall Study|did not answer the VPT: shyness|4|||
145408015|NCT03197129|524349807|FG001|Overall Study|did not answer the VPT: shyness|5|||
145408016|NCT02442349|524349808|FG000|Overall Study|Death|95|||
145294419|NCT01974141|523927656|FG000|Overall Study|Other Reasons|28|||
145294420|NCT01974141|523927657|FG001|Overall Study|Other Reasons|18|||
145294421|NCT01974141|523927656|FG000|Overall Study|Protocol Violation|2|||
145294422|NCT01974141|523927657|FG001|Overall Study|Protocol Violation|6|||
145294423|NCT01974141|523927656|FG000|Overall Study|Personal Reasons|21|||
145294424|NCT01974141|523927657|FG001|Overall Study|Personal Reasons|20|||
145294425|NCT01974141|523927656|FG000|Overall Study|Lost to Follow-up|38|||
145294426|NCT01974141|523927657|FG001|Overall Study|Lost to Follow-up|29|||
145294427|NCT01974141|523927656|FG000|Overall Study|Pregnancy|3|||
145294428|NCT01974141|523927657|FG001|Overall Study|Pregnancy|3|||
145408017|NCT02442349|524349808|FG000|Overall Study|Withdrawal by Subject|27|||
145408018|NCT02442349|524349808|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
145561815|NCT02153112|524916823|FG003|Overall Study|Withdrawal by Subject|2|||
145561816|NCT02153112|524916824|FG004|Overall Study|Withdrawal by Subject|1|||
145561817|NCT02153112|524916825|FG005|Overall Study|Withdrawal by Subject|1|||
145294429|NCT01974141|523927656|FG000|Overall Study|Lack of Efficacy|0|||
145294430|NCT01974141|523927657|FG001|Overall Study|Lack of Efficacy|1|||
145561818|NCT02153112|524916826|FG006|Overall Study|Withdrawal by Subject|7|||
145561819|NCT02153112|524916827|FG007|Overall Study|Withdrawal by Subject|2|||
145561820|NCT02153112|524916828|FG008|Overall Study|Withdrawal by Subject|13|||
145561821|NCT02153112|524916829|FG009|Overall Study|Withdrawal by Subject|12|||
145561822|NCT02153112|524916820|FG000|Overall Study|Reason not Specified|0|||
145561823|NCT02153112|524916821|FG001|Overall Study|Reason not Specified|0|||
145294431|NCT01974141|523927656|FG000|Overall Study|Adverse Event|4|||
145408019|NCT02442349|524349808|FG000|Overall Study|Lost to Follow-up|1|||
145408020|NCT01285518|524349809|FG000|Overall Study|Lost to Follow-up|0|||
145408021|NCT01285518|524349810|FG001|Overall Study|Lost to Follow-up|0|||
145408022|NCT01285518|524349811|FG002|Overall Study|Lost to Follow-up|0|||
145408023|NCT01285518|524349812|FG003|Overall Study|Lost to Follow-up|0|||
145561824|NCT02153112|524916822|FG002|Overall Study|Reason not Specified|0|||
145561825|NCT02153112|524916823|FG003|Overall Study|Reason not Specified|0|||
145561826|NCT02153112|524916824|FG004|Overall Study|Reason not Specified|0|||
145408024|NCT01285518|524349813|FG004|Overall Study|Lost to Follow-up|0|||
145561827|NCT02153112|524916825|FG005|Overall Study|Reason not Specified|0|||
145561828|NCT02153112|524916826|FG006|Overall Study|Reason not Specified|0|||
145561829|NCT02153112|524916827|FG007|Overall Study|Reason not Specified|0|||
145561830|NCT02153112|524916828|FG008|Overall Study|Reason not Specified|1|||
145561831|NCT02153112|524916829|FG009|Overall Study|Reason not Specified|1|||
145561832|NCT00003641|524916835|FG000|Overall Study|Withdrawal by Subject|0|||
145561833|NCT00003641|524916836|FG001|Overall Study|Withdrawal by Subject|100|||
145408025|NCT01285518|524349814|FG005|Overall Study|Lost to Follow-up|1|||
145561834|NCT00003641|524916835|FG000|Overall Study|Adverse Event|0|||
145655513|NCT02975882|525257248|FG003|Overall Study|Ineligible|0|||
145408026|NCT01285518|524349815|FG006|Overall Study|Lost to Follow-up|0|||
145561835|NCT00003641|524916836|FG001|Overall Study|Adverse Event|38|||
145561836|NCT00003641|524916835|FG000|Overall Study|Disease progression|0|||
145561837|NCT00003641|524916836|FG001|Overall Study|Disease progression|2|||
145619784|NCT04423393|525123571|FG013|Overall Study|Withdrawal by Subject|1|||
145619785|NCT04423393|525123572|FG014|Overall Study|Withdrawal by Subject|0|||
145619786|NCT04423393|525123573|FG015|Overall Study|Withdrawal by Subject|0|||
145294432|NCT01974141|523927657|FG001|Overall Study|Adverse Event|5|||
145408027|NCT01285518|524349816|FG007|Overall Study|Lost to Follow-up|0|||
145408028|NCT00879658|524349819|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145408029|NCT00879658|524349820|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145408030|NCT00879658|524349821|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145408031|NCT00879658|524349822|FG003|Overall Study|Abnormal laboratory value(s)|1|||
145408032|NCT00879658|524349823|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145408033|NCT00879658|524349824|FG005|Overall Study|Abnormal laboratory value(s)|0|||
145619787|NCT04423393|525123574|FG016|Overall Study|Withdrawal by Subject|0|||
145619788|NCT04423393|525123575|FG017|Overall Study|Withdrawal by Subject|0|||
145619789|NCT04423393|525123558|FG000|Overall Study|Sponsor Decision|0|||
145619790|NCT04423393|525123559|FG001|Overall Study|Sponsor Decision|0|||
145619791|NCT04423393|525123560|FG002|Overall Study|Sponsor Decision|0|||
145294433|NCT04028843|523927660|FG000|Overall Study|Lost to Follow-up|32|||
145408034|NCT00879658|524349825|FG006|Overall Study|Abnormal laboratory value(s)|0|||
145408035|NCT00879658|524349819|FG000|Overall Study|Administrative problems|2|||
145408036|NCT00879658|524349820|FG001|Overall Study|Administrative problems|1|||
145408037|NCT00879658|524349821|FG002|Overall Study|Administrative problems|0|||
145408038|NCT00879658|524349822|FG003|Overall Study|Administrative problems|1|||
145561838|NCT00003641|524916835|FG000|Overall Study|Unknown/missing|0|||
145561839|NCT00003641|524916836|FG001|Overall Study|Unknown/missing|22|||
145408039|NCT00879658|524349823|FG004|Overall Study|Administrative problems|0|||
145561840|NCT00003641|524916835|FG000|Overall Study|Should not receive interferon therapy|2|||
145561841|NCT00003641|524916836|FG001|Overall Study|Should not receive interferon therapy|0|||
145561842|NCT00003641|524916835|FG000|Overall Study|Never started interferon|567|||
145561843|NCT00003641|524916836|FG001|Overall Study|Never started interferon|12|||
145561844|NCT02154581|524916840|FG000|Overall Study|Lost to Follow-up|7|||
145561845|NCT02154581|524916841|FG001|Overall Study|Lost to Follow-up|8|||
145561846|NCT02068222|524916844|FG000|Overall Study|Lost to Follow-up|1|||
145294434|NCT04028843|523927661|FG001|Overall Study|Lost to Follow-up|39|||
145294435|NCT04028843|523927660|FG000|Overall Study|Adverse Event|1|||
145294436|NCT04028843|523927661|FG001|Overall Study|Adverse Event|0|||
145294437|NCT04028843|523927660|FG000|Overall Study|Non-viable Pregnancy|0|||
145294438|NCT04028843|523927661|FG001|Overall Study|Non-viable Pregnancy|1|||
145294439|NCT04028843|523927660|FG000|Overall Study|Withdrawal by Subject|4|||
145294440|NCT04028843|523927661|FG001|Overall Study|Withdrawal by Subject|2|||
145294441|NCT04977336|523927662|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
145294442|NCT04977336|523927663|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145408040|NCT00879658|524349824|FG005|Overall Study|Administrative problems|0|||
145408041|NCT00879658|524349825|FG006|Overall Study|Administrative problems|0|||
145294443|NCT04977336|523927664|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
145294444|NCT04977336|523927665|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
145408042|NCT00879658|524349819|FG000|Overall Study|Adverse Event|6|||
145561847|NCT00281684|524916847|FG000|Overall Study|Lost to Follow-up|0|||
145561848|NCT00281684|524916848|FG001|Overall Study|Lost to Follow-up|0|||
145561849|NCT00281684|524916849|FG002|Overall Study|Lost to Follow-up|1|||
145561850|NCT00281684|524916850|FG003|Overall Study|Lost to Follow-up|0|||
145561851|NCT00281684|524916847|FG000|Overall Study|Withdrawal by Subject|1|||
145619792|NCT04423393|525123561|FG003|Overall Study|Sponsor Decision|0|||
145561852|NCT00281684|524916848|FG001|Overall Study|Withdrawal by Subject|0|||
145561853|NCT00281684|524916849|FG002|Overall Study|Withdrawal by Subject|0|||
145561854|NCT00281684|524916850|FG003|Overall Study|Withdrawal by Subject|0|||
145561855|NCT03642717|524916853|FG000|Overall Study|Lost to Follow-up|2|||
145561856|NCT03642717|524916853|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
145561857|NCT03642717|524916853|FG000|Overall Study|Taken study drug prior to contract date|3|||
145561858|NCT01559012|524916854|FG000|Overall Study|Withdrawal by Subject|0|||
145561859|NCT01559012|524916855|FG001|Overall Study|Withdrawal by Subject|1|||
145561860|NCT02447081|524916856|FG000|Overall Study|Death|161|||
145561861|NCT02447081|524916856|FG000|Overall Study|Lost to Follow-up|36|||
145561862|NCT02447081|524916856|FG000|Overall Study|Visit not completed|17|||
145561863|NCT02447081|524916856|FG000|Overall Study|unsuccessful implant procedure|10|||
145561864|NCT05778786|524916857|FG000|Period 1|COVID-19 Related|3|||
145561865|NCT05778786|524916858|FG001|Period 1|COVID-19 Related|3|||
145561866|NCT05778786|524916857|FG000|Period 1|Withdrew Consent during Study|1|||
145561867|NCT05778786|524916858|FG001|Period 1|Withdrew Consent during Study|0|||
145294445|NCT04977336|523927666|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
145561868|NCT05778786|524916857|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
145619793|NCT04423393|525123562|FG004|Overall Study|Sponsor Decision|0|||
145294446|NCT04977336|523927662|FG000|Overall Study|Lost to Follow-up|0|||
145408043|NCT00879658|524349820|FG001|Overall Study|Adverse Event|4|||
145408044|NCT00879658|524349821|FG002|Overall Study|Adverse Event|3|||
145408045|NCT00879658|524349822|FG003|Overall Study|Adverse Event|1|||
145408046|NCT00879658|524349823|FG004|Overall Study|Adverse Event|2|||
145408047|NCT00879658|524349824|FG005|Overall Study|Adverse Event|0|||
145408048|NCT00879658|524349825|FG006|Overall Study|Adverse Event|0|||
145408049|NCT00879658|524349819|FG000|Overall Study|Protocol Violation|1|||
145408050|NCT00879658|524349820|FG001|Overall Study|Protocol Violation|0|||
145408051|NCT00879658|524349821|FG002|Overall Study|Protocol Violation|0|||
145408052|NCT00879658|524349822|FG003|Overall Study|Protocol Violation|0|||
145408053|NCT00879658|524349823|FG004|Overall Study|Protocol Violation|0|||
145408054|NCT00879658|524349824|FG005|Overall Study|Protocol Violation|0|||
145408055|NCT00879658|524349825|FG006|Overall Study|Protocol Violation|0|||
145408056|NCT00879658|524349819|FG000|Overall Study|Withdrawal by Subject|3|||
145408057|NCT00879658|524349820|FG001|Overall Study|Withdrawal by Subject|0|||
145408058|NCT00879658|524349821|FG002|Overall Study|Withdrawal by Subject|2|||
145408059|NCT00879658|524349822|FG003|Overall Study|Withdrawal by Subject|0|||
145408060|NCT00879658|524349823|FG004|Overall Study|Withdrawal by Subject|0|||
145408061|NCT00879658|524349824|FG005|Overall Study|Withdrawal by Subject|1|||
145408062|NCT00879658|524349825|FG006|Overall Study|Withdrawal by Subject|0|||
145408063|NCT00879658|524349819|FG000|Overall Study|Lack of Efficacy|0|||
145408064|NCT00879658|524349820|FG001|Overall Study|Lack of Efficacy|0|||
145408065|NCT00879658|524349821|FG002|Overall Study|Lack of Efficacy|2|||
145408066|NCT00879658|524349822|FG003|Overall Study|Lack of Efficacy|0|||
145408067|NCT00879658|524349823|FG004|Overall Study|Lack of Efficacy|0|||
145408068|NCT00879658|524349824|FG005|Overall Study|Lack of Efficacy|0|||
145294447|NCT04977336|523927663|FG001|Overall Study|Lost to Follow-up|0|||
145294448|NCT04977336|523927664|FG002|Overall Study|Lost to Follow-up|1|||
145561869|NCT05778786|524916858|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
145561870|NCT05778786|524916857|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
145561871|NCT05778786|524916858|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
145561872|NCT02406651|524916863|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
145561873|NCT00718328|524916868|FG000|Overall Study|Lost to Follow-up|1|||
145561874|NCT00718328|524916869|FG001|Overall Study|Lost to Follow-up|0|||
145294449|NCT04977336|523927665|FG003|Overall Study|Lost to Follow-up|0|||
145561875|NCT02865915|524916870|FG000|Overall Study|Pregnancy|1|||
145561876|NCT02865915|524916871|FG001|Overall Study|Pregnancy|0|||
145561877|NCT02865915|524916870|FG000|Overall Study|Withdrawal by Subject|1|||
145619794|NCT04423393|525123563|FG005|Overall Study|Sponsor Decision|0|||
145561878|NCT02865915|524916871|FG001|Overall Study|Withdrawal by Subject|1|||
145561879|NCT02865915|524916870|FG000|Overall Study|Adverse Event|0|||
145561880|NCT02865915|524916871|FG001|Overall Study|Adverse Event|4|||
145561881|NCT02865915|524916870|FG000|Overall Study|Lost to Follow-up|0|||
145619795|NCT04423393|525123564|FG006|Overall Study|Sponsor Decision|0|||
145619796|NCT04423393|525123565|FG007|Overall Study|Sponsor Decision|0|||
145619797|NCT04423393|525123566|FG008|Overall Study|Sponsor Decision|0|||
145619798|NCT04423393|525123567|FG009|Overall Study|Sponsor Decision|0|||
145619799|NCT04423393|525123568|FG010|Overall Study|Sponsor Decision|0|||
145619800|NCT04423393|525123569|FG011|Overall Study|Sponsor Decision|0|||
145619801|NCT04423393|525123570|FG012|Overall Study|Sponsor Decision|0|||
145561882|NCT02865915|524916871|FG001|Overall Study|Lost to Follow-up|1|||
145561883|NCT02865915|524916870|FG000|Overall Study|Protocol Violation|0|||
145561884|NCT02865915|524916871|FG001|Overall Study|Protocol Violation|1|||
145561885|NCT02865915|524916870|FG000|Overall Study|Study terminated by sponsor|23|||
145561886|NCT02865915|524916871|FG001|Overall Study|Study terminated by sponsor|18|||
145619802|NCT04423393|525123571|FG013|Overall Study|Sponsor Decision|1|||
145619803|NCT04423393|525123572|FG014|Overall Study|Sponsor Decision|0|||
145561887|NCT02865915|524916870|FG000|Overall Study|Dosing group discontinued|0|||
145561888|NCT02865915|524916871|FG001|Overall Study|Dosing group discontinued|5|||
145619804|NCT04423393|525123573|FG015|Overall Study|Sponsor Decision|0|||
145294450|NCT04977336|523927666|FG004|Overall Study|Lost to Follow-up|0|||
145294451|NCT03298451|523927667|FG000|Overall Study|Death|275|||
145294452|NCT03298451|523927668|FG001|Overall Study|Death|260|||
145294453|NCT03298451|523927669|FG002|Overall Study|Death|122|||
145294454|NCT03298451|523927670|FG003|Overall Study|Death|280|||
145294455|NCT03298451|523927667|FG000|Overall Study|Lost to Follow-up|1|||
145294456|NCT03298451|523927668|FG001|Overall Study|Lost to Follow-up|1|||
145294457|NCT03298451|523927669|FG002|Overall Study|Lost to Follow-up|0|||
145294458|NCT03298451|523927670|FG003|Overall Study|Lost to Follow-up|7|||
145294459|NCT03298451|523927667|FG000|Overall Study|Withdrawal by Subject|9|||
145294460|NCT03298451|523927668|FG001|Overall Study|Withdrawal by Subject|7|||
145294461|NCT03298451|523927669|FG002|Overall Study|Withdrawal by Subject|1|||
145294462|NCT03298451|523927670|FG003|Overall Study|Withdrawal by Subject|20|||
145294463|NCT01347710|523927671|FG000|Overall Study|Withdrawal by Subject|2|||
145294464|NCT01347710|523927671|FG000|Overall Study|Adverse Event|4|||
145294465|NCT01347710|523927671|FG000|Overall Study|Angio or SPECT not completed|18|||
145294466|NCT01347710|523927671|FG000|Overall Study|issue with vitals prior to dosing|1|||
145294467|NCT01347710|523927671|FG000|Overall Study|Lost to Follow-up|1|||
145294468|NCT01347710|523927671|FG000|Overall Study|Physician Decision|2|||
145294469|NCT01347710|523927671|FG000|Overall Study|Other|3|||
145561889|NCT00663052|524916874|FG000|Overall Study|Adverse Event|6|||
145561890|NCT00663052|524916875|FG001|Overall Study|Adverse Event|3|||
145561891|NCT00663052|524916874|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
145561892|NCT00663052|524916875|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145561893|NCT00663052|524916874|FG000|Overall Study|Protocol Violation|1|||
145561894|NCT00663052|524916875|FG001|Overall Study|Protocol Violation|0|||
145561895|NCT00663052|524916874|FG000|Overall Study|Withdrawal by Subject|2|||
145561896|NCT00663052|524916875|FG001|Overall Study|Withdrawal by Subject|5|||
145561897|NCT00663052|524916874|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
145561898|NCT00663052|524916875|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
145561899|NCT00663052|524916874|FG000|Overall Study|Other|0|||
145561900|NCT00663052|524916875|FG001|Overall Study|Other|1|||
145294470|NCT04591626|523927673|FG000|Overall Study|Adverse Event|4|||
145561901|NCT05041322|524916880|FG000|Baseline|Withdrawal by Subject|1|||
145561902|NCT05041322|524916881|FG001|Baseline|Withdrawal by Subject|0|||
145561903|NCT05041322|524916880|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
145561904|NCT05041322|524916881|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
145294471|NCT04591626|523927674|FG001|Overall Study|Adverse Event|0|||
145561905|NCT05041322|524916880|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
145561906|NCT05041322|524916881|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
145561907|NCT04814433|524916882|FG000|Overall Study|Survey not returned|4|||
145294472|NCT04591626|523927673|FG000|Overall Study|Withdrawal by Subject|5|||
145561908|NCT04814433|524916883|FG001|Overall Study|Survey not returned|8|||
145561909|NCT04814433|524916884|FG002|Overall Study|Survey not returned|4|||
145294473|NCT04591626|523927674|FG001|Overall Study|Withdrawal by Subject|3|||
145294474|NCT04591626|523927673|FG000|Overall Study|Physician Decision|0|||
145294475|NCT04591626|523927674|FG001|Overall Study|Physician Decision|1|||
145294476|NCT04591626|523927673|FG000|Overall Study|Death|0|||
145294477|NCT04591626|523927674|FG001|Overall Study|Death|1|||
145294478|NCT04591626|523927673|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145294479|NCT04591626|523927674|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145294480|NCT01139164|523927678|FG000|Overall Study|Withdrawn prior to study start|0|||
145294481|NCT01139164|523927679|FG001|Overall Study|Withdrawn prior to study start|2|||
145294482|NCT01139164|523927680|FG002|Overall Study|Withdrawn prior to study start|0|||
145294483|NCT00878995|523927681|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
145294484|NCT00878995|523927682|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
145294485|NCT00406848|523927683|FG000|Overall Study|Withdrawal by Subject|27|||
145294486|NCT00406848|523927684|FG001|Overall Study|Withdrawal by Subject|22|||
145294487|NCT00406848|523927683|FG000|Overall Study|Adverse Event|38|||
145294488|NCT00406848|523927684|FG001|Overall Study|Adverse Event|7|||
145561910|NCT04814433|524916885|FG003|Overall Study|Survey not returned|5|||
145561911|NCT01545817|524918591|FG000|Pazopanib|Disease progression|51|||
145561912|NCT01545817|524918592|FG001|Pazopanib|Disease progression|0|||
145561913|NCT01545817|524918591|FG000|Pazopanib|Adverse Event|19|||
145561914|NCT01545817|524918592|FG001|Pazopanib|Adverse Event|0|||
145561915|NCT01545817|524918591|FG000|Pazopanib|Other reason|4|||
145561916|NCT01545817|524918592|FG001|Pazopanib|Other reason|0|||
145561917|NCT01545817|524918591|FG000|Everolimus|Other reason|0|||
145561918|NCT01545817|524918592|FG001|Everolimus|Other reason|7|||
145561919|NCT01545817|524918591|FG000|Everolimus|Disease progression|0|||
145561920|NCT01545817|524918592|FG001|Everolimus|Disease progression|25|||
145561921|NCT01545817|524918591|FG000|Everolimus|Adverse Event|0|||
145561922|NCT01545817|524918592|FG001|Everolimus|Adverse Event|6|||
145561923|NCT01063764|524918595|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
145561924|NCT01063764|524918595|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
145561925|NCT01063764|524918595|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
145561926|NCT01063764|524918595|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
145561927|NCT01063764|524918595|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
145294489|NCT00406848|523927683|FG000|Overall Study|Lack of Efficacy|9|||
145294490|NCT00406848|523927684|FG001|Overall Study|Lack of Efficacy|14|||
145294491|NCT00406848|523927683|FG000|Overall Study|Protocol Violation|10|||
145294492|NCT00406848|523927684|FG001|Overall Study|Protocol Violation|6|||
145561928|NCT01063764|524918595|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
145561929|NCT01063764|524918595|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
145561930|NCT03257631|524918596|FG000|Overall Study|Death|1|||
145561931|NCT03257631|524918597|FG001|Overall Study|Death|0|||
145561932|NCT03257631|524918598|FG002|Overall Study|Death|1|||
145561933|NCT03257631|524918599|FG003|Overall Study|Death|1|||
145561934|NCT03257631|524918596|FG000|Overall Study|Progressive Disease|10|||
145561935|NCT03257631|524918597|FG001|Overall Study|Progressive Disease|9|||
145561936|NCT03257631|524918598|FG002|Overall Study|Progressive Disease|17|||
145561937|NCT03257631|524918599|FG003|Overall Study|Progressive Disease|8|||
145561938|NCT03257631|524918596|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145561939|NCT03257631|524918597|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145561940|NCT03257631|524918598|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145561941|NCT03257631|524918599|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
145561942|NCT03257631|524918596|FG000|Overall Study|Adverse Event|0|||
145561943|NCT03257631|524918597|FG001|Overall Study|Adverse Event|0|||
145561944|NCT03257631|524918598|FG002|Overall Study|Adverse Event|2|||
145561945|NCT03257631|524918599|FG003|Overall Study|Adverse Event|0|||
145561946|NCT02436759|524918600|FG000|Overall Study|Adverse Event|3|||
145294493|NCT00406848|523927683|FG000|Overall Study|Lost to Follow-up|6|||
145294494|NCT00406848|523927684|FG001|Overall Study|Lost to Follow-up|2|||
145561947|NCT02436759|524918601|FG001|Overall Study|Adverse Event|0|||
145561948|NCT02436759|524918600|FG000|Overall Study|Protocol Violation|1|||
145619805|NCT04423393|525123574|FG016|Overall Study|Sponsor Decision|0|||
145619806|NCT04423393|525123575|FG017|Overall Study|Sponsor Decision|0|||
145619807|NCT05220501|525123576|FG000|Overall Study|Withdrawal by Subject|11|||
145619808|NCT05220501|525123577|FG001|Overall Study|Withdrawal by Subject|21|||
145619809|NCT05220501|525123578|FG002|Overall Study|Withdrawal by Subject|32|||
145619810|NCT05220501|525123576|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
145619811|NCT05220501|525123577|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
145619812|NCT05220501|525123578|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
145619813|NCT02692235|525123579|FG000|Overall Study|Withdrawal by Subject|2|||
145619814|NCT02692235|525123580|FG001|Overall Study|Withdrawal by Subject|1|||
145619815|NCT02692235|525123579|FG000|Overall Study|Adverse Event|1|||
145619816|NCT02692235|525123580|FG001|Overall Study|Adverse Event|2|||
145619817|NCT01929993|525123584|FG000|Overall Study|Protocol Violation|4|||
145619818|NCT01929993|525123585|FG001|Overall Study|Protocol Violation|6|||
145619819|NCT01929993|525123584|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
145561949|NCT02436759|524918601|FG001|Overall Study|Protocol Violation|0|||
145561950|NCT02436759|524918600|FG000|Overall Study|Withdrawal by Subject|0|||
145561951|NCT02436759|524918601|FG001|Overall Study|Withdrawal by Subject|1|||
145561952|NCT02529137|524918604|FG000|Overall Study|Discontinuation for different reasons|8|||
145561953|NCT01649375|524918605|FG000|Up to Week 16|Adverse Event|2|||
145561954|NCT01649375|524918606|FG001|Up to Week 16|Adverse Event|5|||
145561955|NCT01649375|524918607|FG002|Up to Week 16|Adverse Event|4|||
145561956|NCT01649375|524918608|FG003|Up to Week 16|Adverse Event|0|||
145561957|NCT01649375|524918609|FG004|Up to Week 16|Adverse Event|0|||
145561958|NCT01649375|524918605|FG000|Up to Week 16|Lack of Efficacy|0|||
145619820|NCT01929993|525123585|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
145619821|NCT00107380|525123586|FG000|Overall Study|Adverse Event|7|||
145619822|NCT00107380|525123586|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
145561959|NCT01649375|524918606|FG001|Up to Week 16|Lack of Efficacy|0|||
145561960|NCT01649375|524918607|FG002|Up to Week 16|Lack of Efficacy|1|||
145561961|NCT01649375|524918608|FG003|Up to Week 16|Lack of Efficacy|0|||
145408069|NCT00879658|524349825|FG006|Overall Study|Lack of Efficacy|0|||
145561962|NCT01649375|524918609|FG004|Up to Week 16|Lack of Efficacy|0|||
145561963|NCT01649375|524918605|FG000|Up to Week 16|Physician Decision|0|||
145561964|NCT01649375|524918606|FG001|Up to Week 16|Physician Decision|0|||
145561965|NCT01649375|524918607|FG002|Up to Week 16|Physician Decision|1|||
145561966|NCT01649375|524918608|FG003|Up to Week 16|Physician Decision|0|||
145408070|NCT00879658|524349819|FG000|Overall Study|misrandomized (never received study med)|0|||
145408071|NCT00879658|524349820|FG001|Overall Study|misrandomized (never received study med)|0|||
145561967|NCT01649375|524918609|FG004|Up to Week 16|Physician Decision|0|||
145561968|NCT01649375|524918605|FG000|Up to Week 16|Withdrawal by Subject|2|||
145408072|NCT00879658|524349821|FG002|Overall Study|misrandomized (never received study med)|0|||
145408073|NCT00879658|524349822|FG003|Overall Study|misrandomized (never received study med)|1|||
145408074|NCT00879658|524349823|FG004|Overall Study|misrandomized (never received study med)|0|||
145561969|NCT01649375|524918606|FG001|Up to Week 16|Withdrawal by Subject|1|||
145561970|NCT01649375|524918607|FG002|Up to Week 16|Withdrawal by Subject|2|||
145561971|NCT01649375|524918608|FG003|Up to Week 16|Withdrawal by Subject|0|||
145561972|NCT01649375|524918609|FG004|Up to Week 16|Withdrawal by Subject|0|||
145561973|NCT01649375|524918605|FG000|Up to Week 16|Death|1|||
145408075|NCT00879658|524349824|FG005|Overall Study|misrandomized (never received study med)|0|||
145408076|NCT00879658|524349825|FG006|Overall Study|misrandomized (never received study med)|0|||
145408077|NCT00639509|524349826|FG000|Overall Study|Death|1|||
145408078|NCT03507790|524349828|FG000|Overall Study|Adverse Event|0|||
145561974|NCT01649375|524918606|FG001|Up to Week 16|Death|0|||
145294495|NCT00406848|523927683|FG000|Overall Study|Physician Decision|2|||
145294496|NCT00406848|523927684|FG001|Overall Study|Physician Decision|2|||
145294497|NCT00406848|523927683|FG000|Overall Study|Sponsor Decision|1|||
145294498|NCT00406848|523927684|FG001|Overall Study|Sponsor Decision|1|||
145408079|NCT03507790|524349829|FG001|Overall Study|Adverse Event|11|||
145561975|NCT01649375|524918607|FG002|Up to Week 16|Death|0|||
145561976|NCT01649375|524918608|FG003|Up to Week 16|Death|0|||
145561977|NCT01649375|524918609|FG004|Up to Week 16|Death|0|||
145561978|NCT01649375|524918605|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
145561979|NCT01649375|524918606|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
145561980|NCT01649375|524918607|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
145561981|NCT01649375|524918608|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
145561982|NCT01649375|524918609|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
145408080|NCT03507790|524349830|FG002|Overall Study|Adverse Event|3|||
145408081|NCT03507790|524349828|FG000|Overall Study|Withdrawal by Subject|2|||
145408082|NCT03507790|524349829|FG001|Overall Study|Withdrawal by Subject|0|||
145408083|NCT03507790|524349830|FG002|Overall Study|Withdrawal by Subject|0|||
145408084|NCT03507790|524349828|FG000|Overall Study|Subject moved to another location|1|||
145408085|NCT03507790|524349829|FG001|Overall Study|Subject moved to another location|2|||
145408086|NCT03507790|524349830|FG002|Overall Study|Subject moved to another location|0|||
145408087|NCT03507790|524349828|FG000|Overall Study|Non-compliance with study drug|0|||
145408088|NCT03507790|524349829|FG001|Overall Study|Non-compliance with study drug|0|||
145408089|NCT03507790|524349830|FG002|Overall Study|Non-compliance with study drug|1|||
145408090|NCT03507790|524349828|FG000|Overall Study|COVID 19 Pandemic|0|||
145408091|NCT03507790|524349829|FG001|Overall Study|COVID 19 Pandemic|1|||
145408092|NCT03507790|524349830|FG002|Overall Study|COVID 19 Pandemic|0|||
145408093|NCT03507790|524349828|FG000|Overall Study|Lost to Follow-up|0|||
145408094|NCT03507790|524349829|FG001|Overall Study|Lost to Follow-up|1|||
145408095|NCT03507790|524349830|FG002|Overall Study|Lost to Follow-up|0|||
145408096|NCT03507790|524349828|FG000|Overall Study|Discontinuation of the trial at the site|1|||
145408097|NCT03507790|524349829|FG001|Overall Study|Discontinuation of the trial at the site|1|||
145408098|NCT03507790|524349830|FG002|Overall Study|Discontinuation of the trial at the site|0|||
145408099|NCT03507790|524349828|FG000|Overall Study|Randomized in error|0|||
145408100|NCT03507790|524349829|FG001|Overall Study|Randomized in error|0|||
145408101|NCT03507790|524349830|FG002|Overall Study|Randomized in error|1|||
145408102|NCT00157755|524349832|FG000|Overall Study|Death|2|||
145408103|NCT00157755|524349833|FG001|Overall Study|Death|3|||
145408104|NCT00157755|524349834|FG002|Overall Study|Death|3|||
145408105|NCT00157755|524349835|FG003|Overall Study|Death|2|||
145408106|NCT00157755|524349836|FG004|Overall Study|Death|0|||
145408107|NCT00157755|524349837|FG005|Overall Study|Death|0|||
145408108|NCT00157755|524349832|FG000|Overall Study|Lost to Follow-up|0|||
145408109|NCT00157755|524349833|FG001|Overall Study|Lost to Follow-up|0|||
145408110|NCT00157755|524349834|FG002|Overall Study|Lost to Follow-up|1|||
145408111|NCT00157755|524349835|FG003|Overall Study|Lost to Follow-up|0|||
145408112|NCT00157755|524349836|FG004|Overall Study|Lost to Follow-up|0|||
145408113|NCT00157755|524349837|FG005|Overall Study|Lost to Follow-up|0|||
145408114|NCT00157755|524349832|FG000|Overall Study|Withdrawal by Subject|0|||
145408115|NCT00157755|524349833|FG001|Overall Study|Withdrawal by Subject|0|||
145408116|NCT00157755|524349834|FG002|Overall Study|Withdrawal by Subject|1|||
145408117|NCT00157755|524349835|FG003|Overall Study|Withdrawal by Subject|1|||
145408118|NCT00157755|524349836|FG004|Overall Study|Withdrawal by Subject|1|||
145408119|NCT00157755|524349837|FG005|Overall Study|Withdrawal by Subject|2|||
145408120|NCT00157755|524349832|FG000|Overall Study|Explant due to infection|0|||
145408121|NCT00157755|524349833|FG001|Overall Study|Explant due to infection|0|||
145408122|NCT00157755|524349834|FG002|Overall Study|Explant due to infection|1|||
145408123|NCT00157755|524349835|FG003|Overall Study|Explant due to infection|0|||
145408124|NCT00157755|524349836|FG004|Overall Study|Explant due to infection|0|||
145408125|NCT00157755|524349837|FG005|Overall Study|Explant due to infection|0|||
145408126|NCT00157755|524349832|FG000|Overall Study|Medical reason|0|||
145561983|NCT01649375|524918605|FG000|Week 16 up to Week 260|Non-compliance|0|||
145561984|NCT01649375|524918606|FG001|Week 16 up to Week 260|Non-compliance|1|||
145561985|NCT01649375|524918607|FG002|Week 16 up to Week 260|Non-compliance|0|||
145561986|NCT01649375|524918608|FG003|Week 16 up to Week 260|Non-compliance|1|||
145561987|NCT01649375|524918609|FG004|Week 16 up to Week 260|Non-compliance|0|||
145561988|NCT01649375|524918605|FG000|Week 16 up to Week 260|Physician Decision|0|||
145561989|NCT01649375|524918606|FG001|Week 16 up to Week 260|Physician Decision|2|||
145561990|NCT01649375|524918607|FG002|Week 16 up to Week 260|Physician Decision|0|||
145561991|NCT01649375|524918608|FG003|Week 16 up to Week 260|Physician Decision|0|||
145561992|NCT01649375|524918609|FG004|Week 16 up to Week 260|Physician Decision|0|||
145561993|NCT01649375|524918605|FG000|Week 16 up to Week 260|Technical issues|0|||
145561994|NCT01649375|524918606|FG001|Week 16 up to Week 260|Technical issues|1|||
145561995|NCT01649375|524918607|FG002|Week 16 up to Week 260|Technical issues|0|||
145561996|NCT01649375|524918608|FG003|Week 16 up to Week 260|Technical issues|1|||
145561997|NCT01649375|524918609|FG004|Week 16 up to Week 260|Technical issues|0|||
145561998|NCT01649375|524918605|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
145561999|NCT01649375|524918606|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
145562000|NCT01649375|524918607|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
145408127|NCT00157755|524349833|FG001|Overall Study|Medical reason|0|||
145619823|NCT00107380|525123586|FG000|Overall Study|Progression/relapse|4|||
145408128|NCT00157755|524349834|FG002|Overall Study|Medical reason|1|||
145562001|NCT01649375|524918608|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
145562002|NCT01649375|524918609|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
145562003|NCT01649375|524918605|FG000|Week 16 up to Week 260|Death|1|||
145562004|NCT01649375|524918606|FG001|Week 16 up to Week 260|Death|1|||
145408129|NCT00157755|524349835|FG003|Overall Study|Medical reason|1|||
145408130|NCT00157755|524349836|FG004|Overall Study|Medical reason|0|||
145408131|NCT00157755|524349837|FG005|Overall Study|Medical reason|0|||
145408132|NCT00157755|524349832|FG000|Overall Study|Study site closure|0|||
145408133|NCT00157755|524349833|FG001|Overall Study|Study site closure|1|||
145408134|NCT00157755|524349834|FG002|Overall Study|Study site closure|0|||
145408135|NCT00157755|524349835|FG003|Overall Study|Study site closure|0|||
145408136|NCT00157755|524349836|FG004|Overall Study|Study site closure|0|||
145408137|NCT00157755|524349837|FG005|Overall Study|Study site closure|0|||
145562005|NCT01649375|524918607|FG002|Week 16 up to Week 260|Death|0|||
145562006|NCT01649375|524918608|FG003|Week 16 up to Week 260|Death|0|||
145562007|NCT01649375|524918609|FG004|Week 16 up to Week 260|Death|0|||
145562008|NCT01649375|524918605|FG000|Week 16 up to Week 260|Adverse Event|5|||
145562009|NCT01649375|524918606|FG001|Week 16 up to Week 260|Adverse Event|2|||
145562010|NCT01649375|524918607|FG002|Week 16 up to Week 260|Adverse Event|0|||
145562011|NCT01649375|524918608|FG003|Week 16 up to Week 260|Adverse Event|3|||
145562012|NCT01649375|524918609|FG004|Week 16 up to Week 260|Adverse Event|2|||
145562013|NCT01124604|524918610|FG000|Overall Study|Adverse Event|10|||
145562014|NCT01124604|524918611|FG001|Overall Study|Adverse Event|1|||
145562015|NCT01124604|524918610|FG000|Overall Study|Lack of Efficacy|1|||
145562016|NCT01124604|524918611|FG001|Overall Study|Lack of Efficacy|0|||
145562017|NCT01124604|524918610|FG000|Overall Study|Withdrawal by Subject|4|||
145562018|NCT01124604|524918611|FG001|Overall Study|Withdrawal by Subject|0|||
145562019|NCT01124604|524918610|FG000|Overall Study|Disease Progression|0|||
145562020|NCT01124604|524918611|FG001|Overall Study|Disease Progression|1|||
145562021|NCT03102918|524918616|FG000|Overall Study|Protocol Violation|1|||
145562022|NCT03102918|524918617|FG001|Overall Study|Protocol Violation|0|||
145562023|NCT00952341|524918619|FG000|Cycle 1|Adverse Event|4|||
145562024|NCT00952341|524918620|FG001|Cycle 1|Adverse Event|1|||
145562025|NCT00952341|524918619|FG000|Cycle 1|Withdrawal by Subject|3|||
145562026|NCT00952341|524918620|FG001|Cycle 1|Withdrawal by Subject|8|||
145562027|NCT00952341|524918619|FG000|Cycle 1|Protocol Violation|2|||
145562028|NCT00952341|524918620|FG001|Cycle 1|Protocol Violation|1|||
145562029|NCT00952341|524918619|FG000|Cycle 1|Lost to Follow-up|11|||
145562030|NCT00952341|524918620|FG001|Cycle 1|Lost to Follow-up|2|||
145562031|NCT00952341|524918619|FG000|Cycle 1|Physician Decision|0|||
145562032|NCT00952341|524918620|FG001|Cycle 1|Physician Decision|1|||
145562033|NCT00952341|524918619|FG000|Cycle 2|Withdrawal by Subject|1|||
145562034|NCT00952341|524918620|FG001|Cycle 2|Withdrawal by Subject|1|||
145562035|NCT00952341|524918619|FG000|Cycle 2|Protocol Violation|1|||
145562036|NCT00952341|524918620|FG001|Cycle 2|Protocol Violation|0|||
145562037|NCT00952341|524918619|FG000|Cycle 2|Lost to Follow-up|6|||
145562038|NCT00952341|524918620|FG001|Cycle 2|Lost to Follow-up|9|||
145562039|NCT00952341|524918619|FG000|Cycle 2|Physician Decision|1|||
145562040|NCT00952341|524918620|FG001|Cycle 2|Physician Decision|1|||
145562041|NCT00952341|524918619|FG000|Cycle 2|Progressive Disease|0|||
145562042|NCT00952341|524918620|FG001|Cycle 2|Progressive Disease|1|||
145562043|NCT02066467|524918623|FG000|Overall Study|Did not undergo implant procedure|24|||
145562044|NCT02066467|524918623|FG000|Overall Study|Attempted to implant withoput success|43|||
145562045|NCT02066467|524918623|FG000|Overall Study|Consent ineligible|1|||
145562046|NCT02066467|524918623|FG000|Overall Study|Death|54|||
145562047|NCT02066467|524918623|FG000|Overall Study|Lost to Follow-up|51|||
145562048|NCT02066467|524918623|FG000|Overall Study|Adverse Event|20|||
145562049|NCT02066467|524918623|FG000|Overall Study|Withdrawal by Subject|16|||
145562050|NCT02066467|524918623|FG000|Overall Study|Physician Decision|2|||
145562051|NCT02066467|524918623|FG000|Overall Study|Not defined|4|||
145562052|NCT00297037|524918626|FG000|Overall Study|Withdrawal by Subject|2|||
145562053|NCT00297037|524918627|FG001|Overall Study|Withdrawal by Subject|0|||
145562054|NCT05352815|524918628|FG000|Overall Study|Withdrawal by Subject|28|||
145294499|NCT01355081|523927687|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
145562055|NCT05352815|524918629|FG001|Overall Study|Withdrawal by Subject|24|||
145562056|NCT05352815|524918628|FG000|Overall Study|Lost to Follow-up|4|||
145562057|NCT05352815|524918629|FG001|Overall Study|Lost to Follow-up|7|||
145562058|NCT05352815|524918628|FG000|Overall Study|Death|2|||
145562059|NCT05352815|524918629|FG001|Overall Study|Death|3|||
145562060|NCT05352815|524918628|FG000|Overall Study|Site closure|1|||
145562061|NCT05352815|524918629|FG001|Overall Study|Site closure|0|||
145562062|NCT02759120|524918632|FG000|Overall Study|Death|34|||
145562063|NCT02759120|524918633|FG001|Overall Study|Death|36|||
145562064|NCT02759120|524918632|FG000|Overall Study|Lost to Follow-up|4|||
145562065|NCT02759120|524918633|FG001|Overall Study|Lost to Follow-up|7|||
145562066|NCT02759120|524918632|FG000|Overall Study|Physician Decision|3|||
145562067|NCT02759120|524918633|FG001|Overall Study|Physician Decision|0|||
145562068|NCT02759120|524918632|FG000|Overall Study|Withdrawal by Subject|28|||
145562069|NCT02759120|524918633|FG001|Overall Study|Withdrawal by Subject|15|||
145562070|NCT02759120|524918632|FG000|Overall Study|Moved out of area|3|||
145562071|NCT02759120|524918633|FG001|Overall Study|Moved out of area|4|||
145562072|NCT02759120|524918632|FG000|Overall Study|Lung transplant|3|||
145562073|NCT02759120|524918633|FG001|Overall Study|Lung transplant|5|||
145562074|NCT02759120|524918632|FG000|Overall Study|Other reason not completed|10|||
145562075|NCT02759120|524918633|FG001|Overall Study|Other reason not completed|12|||
145562076|NCT03056755|524918634|FG000|Treatment- Core Phase|Progressive disease|89|||
145562077|NCT03056755|524918635|FG001|Treatment- Core Phase|Progressive disease|88|||
145562078|NCT03056755|524918636|FG002|Treatment- Core Phase|Progressive disease|90|||
145562079|NCT03056755|524918634|FG000|Treatment- Core Phase|Adverse Event|20|||
145562080|NCT03056755|524918635|FG001|Treatment- Core Phase|Adverse Event|14|||
145562081|NCT03056755|524918636|FG002|Treatment- Core Phase|Adverse Event|13|||
145562082|NCT03056755|524918634|FG000|Treatment- Core Phase|Physician Decision|7|||
145562083|NCT03056755|524918635|FG001|Treatment- Core Phase|Physician Decision|13|||
145562084|NCT03056755|524918636|FG002|Treatment- Core Phase|Physician Decision|5|||
145562085|NCT03056755|524918634|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
145562086|NCT03056755|524918635|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
145562087|NCT03056755|524918636|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
145562088|NCT03056755|524918634|FG000|Treatment- Core Phase|Death|3|||
145562089|NCT03056755|524918635|FG001|Treatment- Core Phase|Death|2|||
145294500|NCT01355081|523927688|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
145562090|NCT03056755|524918636|FG002|Treatment- Core Phase|Death|4|||
145562091|NCT03056755|524918634|FG000|Treatment- Core Phase|Protocol deviation|1|||
145562092|NCT03056755|524918635|FG001|Treatment- Core Phase|Protocol deviation|1|||
145562093|NCT03056755|524918636|FG002|Treatment- Core Phase|Protocol deviation|0|||
145562094|NCT03056755|524918634|FG000|Treatment- Core Phase|Technical problems|1|||
145562095|NCT03056755|524918635|FG001|Treatment- Core Phase|Technical problems|0|||
145562096|NCT03056755|524918636|FG002|Treatment- Core Phase|Technical problems|0|||
145562097|NCT03056755|524918634|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
145562098|NCT03056755|524918635|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
145562099|NCT03056755|524918636|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
145562100|NCT03056755|524918634|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
145562101|NCT03056755|524918635|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
145562102|NCT03056755|524918636|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
145562103|NCT03056755|524918634|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
145562104|NCT03056755|524918635|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
145562105|NCT03056755|524918636|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
145562106|NCT03056755|524918634|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
145562107|NCT03056755|524918635|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
145562108|NCT03056755|524918636|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
145562109|NCT04461015|524918639|FG000|Overall Study|IV access lost during the study|0|||
145562110|NCT04461015|524918640|FG001|Overall Study|IV access lost during the study|1|||
145562111|NCT04461015|524918639|FG000|Overall Study|Withdrawal by Subject|0|||
145562112|NCT04461015|524918640|FG001|Overall Study|Withdrawal by Subject|1|||
145562113|NCT00464568|524918641|FG000|Overall Study|Adverse Event|2|||
145562114|NCT02864251|524918655|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
145562115|NCT02864251|524918656|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
145562116|NCT02864251|524918657|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
145562117|NCT02864251|524918655|FG000|Pre-Treatment|Withdrawal by Participant|0|||
145562118|NCT02864251|524918656|FG001|Pre-Treatment|Withdrawal by Participant|0|||
145562119|NCT02864251|524918657|FG002|Pre-Treatment|Withdrawal by Participant|4|||
145562120|NCT02864251|524918655|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
145562121|NCT02864251|524918656|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
145562122|NCT02864251|524918657|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
145294501|NCT01355081|523927689|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
145294502|NCT01355081|523927687|FG000|Overall Study|Major Protocol Deviation|0|||
145294503|NCT01355081|523927688|FG001|Overall Study|Major Protocol Deviation|1|||
145294504|NCT01355081|523927689|FG002|Overall Study|Major Protocol Deviation|0|||
145294505|NCT01355081|523927687|FG000|Overall Study|Lost to Follow-up|0|||
145294506|NCT01355081|523927688|FG001|Overall Study|Lost to Follow-up|0|||
145294507|NCT01355081|523927689|FG002|Overall Study|Lost to Follow-up|1|||
145294508|NCT01355081|523927687|FG000|Overall Study|Withdrawal of Consent|2|||
145294509|NCT01355081|523927688|FG001|Overall Study|Withdrawal of Consent|3|||
145294510|NCT01355081|523927689|FG002|Overall Study|Withdrawal of Consent|3|||
145294511|NCT01355081|523927687|FG000|Overall Study|Lack of Efficacy|2|||
145294512|NCT01355081|523927688|FG001|Overall Study|Lack of Efficacy|1|||
145294513|NCT01355081|523927689|FG002|Overall Study|Lack of Efficacy|1|||
145294514|NCT01355081|523927687|FG000|Overall Study|Non Compliance with Study Medication|0|||
145294515|NCT01355081|523927688|FG001|Overall Study|Non Compliance with Study Medication|1|||
145294516|NCT01355081|523927689|FG002|Overall Study|Non Compliance with Study Medication|0|||
145562123|NCT02864251|524918655|FG000|Pre-Treatment|Other Reasons|0|||
145294517|NCT02480764|523927690|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
145294518|NCT02480764|523927691|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
145294519|NCT02480764|523927692|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
145294520|NCT02480764|523927690|FG000|Overall Study|Major Protocol Deviation|1|||
145294521|NCT02480764|523927691|FG001|Overall Study|Major Protocol Deviation|4|||
145294522|NCT02480764|523927692|FG002|Overall Study|Major Protocol Deviation|3|||
145294523|NCT02480764|523927690|FG000|Overall Study|Lost to Follow-up|0|||
145294524|NCT02480764|523927691|FG001|Overall Study|Lost to Follow-up|1|||
145562124|NCT02864251|524918656|FG001|Pre-Treatment|Other Reasons|1|||
145562125|NCT02864251|524918657|FG002|Pre-Treatment|Other Reasons|1|||
145562126|NCT02864251|524918655|FG000|Treatment|Disease Progression|109|||
145562127|NCT02864251|524918656|FG001|Treatment|Disease Progression|52|||
145562128|NCT02864251|524918657|FG002|Treatment|Disease Progression|101|||
145562129|NCT02864251|524918655|FG000|Treatment|Study Drug Toxicity|9|||
145562130|NCT02864251|524918656|FG001|Treatment|Study Drug Toxicity|4|||
145562131|NCT02864251|524918657|FG002|Treatment|Study Drug Toxicity|10|||
145562132|NCT02864251|524918655|FG000|Treatment|Death|0|||
145562133|NCT02864251|524918656|FG001|Treatment|Death|2|||
145562134|NCT02864251|524918657|FG002|Treatment|Death|3|||
145562135|NCT02864251|524918655|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
145562136|NCT02864251|524918656|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
145562137|NCT02864251|524918657|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
145562138|NCT02864251|524918655|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
145562139|NCT02864251|524918656|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
145562140|NCT02864251|524918657|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
145619824|NCT00107380|525123586|FG000|Overall Study|Death|3|||
145294525|NCT02480764|523927692|FG002|Overall Study|Lost to Follow-up|2|||
145294526|NCT02480764|523927690|FG000|Overall Study|Voluntary Withdrawal|6|||
145294527|NCT02480764|523927691|FG001|Overall Study|Voluntary Withdrawal|5|||
145294528|NCT02480764|523927692|FG002|Overall Study|Voluntary Withdrawal|10|||
145562141|NCT02864251|524918655|FG000|Treatment|Withdrawal by Participant|8|||
145294529|NCT02480764|523927690|FG000|Overall Study|Lack of Efficacy|0|||
145294530|NCT02480764|523927691|FG001|Overall Study|Lack of Efficacy|3|||
145562142|NCT02864251|524918656|FG001|Treatment|Withdrawal by Participant|5|||
145562143|NCT02864251|524918657|FG002|Treatment|Withdrawal by Participant|13|||
145562144|NCT02864251|524918655|FG000|Treatment|Maximum Clinical Benefit|1|||
145294531|NCT02480764|523927692|FG002|Overall Study|Lack of Efficacy|3|||
145294532|NCT02480764|523927690|FG000|Overall Study|Reason not Specified|0|||
145408138|NCT00157755|524349832|FG000|Overall Study|Subject non-compliance|0|||
145408139|NCT00157755|524349833|FG001|Overall Study|Subject non-compliance|0|||
145408140|NCT00157755|524349834|FG002|Overall Study|Subject non-compliance|0|||
145562145|NCT02864251|524918656|FG001|Treatment|Maximum Clinical Benefit|0|||
145562146|NCT02864251|524918657|FG002|Treatment|Maximum Clinical Benefit|1|||
145294533|NCT02480764|523927691|FG001|Overall Study|Reason not Specified|1|||
145294534|NCT02480764|523927692|FG002|Overall Study|Reason not Specified|0|||
145655514|NCT02105766|525257249|FG000|Overall Study|Physician Decision|1|||
145408141|NCT00157755|524349835|FG003|Overall Study|Subject non-compliance|0|||
145294535|NCT02719522|523927693|FG000|Overall Study|Implant Failure|4|||
145294536|NCT02719522|523927693|FG000|Overall Study|Death|2|||
145294537|NCT02719522|523927693|FG000|Overall Study|Lost to Follow-up|5|||
145294538|NCT02457832|523927694|FG000|Training|Lost to Follow-up|10|||
145294539|NCT02457832|523927695|FG001|Training|Lost to Follow-up|6|||
145294540|NCT02457832|523927696|FG002|Training|Lost to Follow-up|3|||
145294541|NCT02457832|523927694|FG000|One Month Washout|Lost to Follow-up|0|||
145294542|NCT02457832|523927695|FG001|One Month Washout|Lost to Follow-up|1|||
145408142|NCT00157755|524349836|FG004|Overall Study|Subject non-compliance|0|||
145655515|NCT02105766|525257250|FG001|Overall Study|Physician Decision|1|||
145655516|NCT02105766|525257251|FG002|Overall Study|Physician Decision|0|||
145562147|NCT02864251|524918655|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
145294543|NCT02457832|523927696|FG002|One Month Washout|Lost to Follow-up|1|||
145294544|NCT03184441|523927697|FG000|Overall Study|Withdrawal by Subject|1|||
145408143|NCT00157755|524349837|FG005|Overall Study|Subject non-compliance|1|||
145408144|NCT00157755|524349832|FG000|Overall Study|Study completion|0|||
145408145|NCT00157755|524349833|FG001|Overall Study|Study completion|0|||
145408146|NCT00157755|524349834|FG002|Overall Study|Study completion|0|||
145408147|NCT00157755|524349835|FG003|Overall Study|Study completion|0|||
145408148|NCT00157755|524349836|FG004|Overall Study|Study completion|1|||
145408149|NCT00157755|524349837|FG005|Overall Study|Study completion|2|||
145408150|NCT03314935|524349846|FG000|Phase 1|Death|4|||
145408151|NCT03314935|524349847|FG001|Phase 1|Death|2|||
145408152|NCT03314935|524349848|FG002|Phase 1|Death|5|||
145408153|NCT03314935|524349849|FG003|Phase 1|Death|4|||
145408154|NCT03314935|524349850|FG004|Phase 1|Death|3|||
145408155|NCT03314935|524349851|FG005|Phase 1|Death|4|||
145408156|NCT03314935|524349852|FG006|Phase 1|Death|5|||
145408157|NCT03314935|524349853|FG007|Phase 1|Death|4|||
145408158|NCT03314935|524349854|FG008|Phase 1|Death|3|||
145408159|NCT03314935|524349855|FG009|Phase 1|Death|0|||
145408160|NCT03314935|524349856|FG010|Phase 1|Death|0|||
145408161|NCT03314935|524349857|FG011|Phase 1|Death|0|||
145408162|NCT03314935|524349858|FG012|Phase 1|Death|0|||
145408163|NCT03314935|524349859|FG013|Phase 1|Death|0|||
145408164|NCT03314935|524349860|FG014|Phase 1|Death|0|||
145408165|NCT03314935|524349846|FG000|Phase 1|Withdrawal by Subject|2|||
145408166|NCT03314935|524349847|FG001|Phase 1|Withdrawal by Subject|1|||
145408167|NCT03314935|524349848|FG002|Phase 1|Withdrawal by Subject|1|||
145408168|NCT03314935|524349849|FG003|Phase 1|Withdrawal by Subject|2|||
145408169|NCT03314935|524349850|FG004|Phase 1|Withdrawal by Subject|1|||
145408170|NCT03314935|524349851|FG005|Phase 1|Withdrawal by Subject|0|||
145408171|NCT03314935|524349852|FG006|Phase 1|Withdrawal by Subject|1|||
145408172|NCT03314935|524349853|FG007|Phase 1|Withdrawal by Subject|0|||
145408173|NCT03314935|524349854|FG008|Phase 1|Withdrawal by Subject|1|||
145408174|NCT03314935|524349855|FG009|Phase 1|Withdrawal by Subject|0|||
145408175|NCT03314935|524349856|FG010|Phase 1|Withdrawal by Subject|0|||
145408176|NCT03314935|524349857|FG011|Phase 1|Withdrawal by Subject|0|||
145408177|NCT03314935|524349858|FG012|Phase 1|Withdrawal by Subject|0|||
145408178|NCT03314935|524349859|FG013|Phase 1|Withdrawal by Subject|0|||
145408179|NCT03314935|524349860|FG014|Phase 1|Withdrawal by Subject|0|||
145408180|NCT03314935|524349846|FG000|Phase 1|Progressive Disease|2|||
145408181|NCT03314935|524349847|FG001|Phase 1|Progressive Disease|0|||
145408182|NCT03314935|524349848|FG002|Phase 1|Progressive Disease|0|||
145408183|NCT03314935|524349849|FG003|Phase 1|Progressive Disease|1|||
145408184|NCT03314935|524349850|FG004|Phase 1|Progressive Disease|0|||
145408185|NCT03314935|524349851|FG005|Phase 1|Progressive Disease|0|||
145408186|NCT03314935|524349852|FG006|Phase 1|Progressive Disease|0|||
145408187|NCT03314935|524349853|FG007|Phase 1|Progressive Disease|0|||
145294545|NCT01868009|523927700|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
145294546|NCT01868009|523927701|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
145562148|NCT02864251|524918656|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
145562149|NCT02864251|524918657|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
145562150|NCT02864251|524918655|FG000|Treatment|Other Reasons|1|||
145562151|NCT02864251|524918656|FG001|Treatment|Other Reasons|1|||
145562152|NCT02864251|524918657|FG002|Treatment|Other Reasons|4|||
145562153|NCT02864251|524918655|FG000|Treatment|Administrative Reason by Sponsor|1|||
145408188|NCT03314935|524349854|FG008|Phase 1|Progressive Disease|0|||
145562154|NCT02864251|524918656|FG001|Treatment|Administrative Reason by Sponsor|0|||
145562155|NCT02864251|524918657|FG002|Treatment|Administrative Reason by Sponsor|0|||
145562156|NCT03506373|524918658|FG000|Overall Study|Adverse Event|6|||
145562157|NCT03506373|524918658|FG000|Overall Study|Withdrawal by Subject|2|||
145408189|NCT03314935|524349855|FG009|Phase 1|Progressive Disease|0|||
145562158|NCT03506373|524918658|FG000|Overall Study|Disease progression|5|||
145619825|NCT00107380|525123586|FG000|Overall Study|Other - not protocol specified|7|||
145619826|NCT00107380|525123586|FG000|Overall Study|Ineligible|2|||
145408190|NCT03314935|524349856|FG010|Phase 1|Progressive Disease|0|||
145408191|NCT03314935|524349857|FG011|Phase 1|Progressive Disease|0|||
145619827|NCT03673098|525123587|FG000|Overall Study|Lost to Follow-up|2|||
145619828|NCT03673098|525123588|FG001|Overall Study|Lost to Follow-up|3|||
145619829|NCT03673098|525123587|FG000|Overall Study|Withdrawal by Subject|6|||
145619830|NCT03673098|525123588|FG001|Overall Study|Withdrawal by Subject|1|||
145619831|NCT03673098|525123587|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
145619832|NCT03673098|525123588|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
145619833|NCT01268059|525123596|FG000|Overall Study|Lost to Follow-up|0|||
145619834|NCT01268059|525123597|FG001|Overall Study|Lost to Follow-up|1|||
145619835|NCT01268059|525123598|FG002|Overall Study|Lost to Follow-up|0|||
145619836|NCT01268059|525123599|FG003|Overall Study|Lost to Follow-up|0|||
145619837|NCT01268059|525123596|FG000|Overall Study|Withdrawal by Subject|7|||
145619838|NCT01268059|525123597|FG001|Overall Study|Withdrawal by Subject|4|||
145619839|NCT01268059|525123598|FG002|Overall Study|Withdrawal by Subject|0|||
145619840|NCT01268059|525123599|FG003|Overall Study|Withdrawal by Subject|0|||
145619841|NCT01268059|525123596|FG000|Overall Study|Death|20|||
145619842|NCT01268059|525123597|FG001|Overall Study|Death|30|||
145619843|NCT01268059|525123598|FG002|Overall Study|Death|3|||
145619844|NCT01268059|525123599|FG003|Overall Study|Death|5|||
145619845|NCT01268059|525123596|FG000|Overall Study|Progression of disease|1|||
145619846|NCT01268059|525123597|FG001|Overall Study|Progression of disease|0|||
145408192|NCT03314935|524349858|FG012|Phase 1|Progressive Disease|0|||
145408193|NCT03314935|524349859|FG013|Phase 1|Progressive Disease|0|||
145408194|NCT03314935|524349860|FG014|Phase 1|Progressive Disease|0|||
145408195|NCT03314935|524349846|FG000|Phase 1|Study Terminated by Sponsor|0|||
145408196|NCT03314935|524349847|FG001|Phase 1|Study Terminated by Sponsor|1|||
145294547|NCT01868009|523927700|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
145619847|NCT01268059|525123598|FG002|Overall Study|Progression of disease|0|||
145619848|NCT01268059|525123599|FG003|Overall Study|Progression of disease|0|||
145619849|NCT03660943|525123600|FG000|Overall Study|Adverse Event|5|||
145619850|NCT03660943|525123601|FG001|Overall Study|Adverse Event|3|||
145619851|NCT03660943|525123600|FG000|Overall Study|Death|0|||
145619852|NCT03660943|525123601|FG001|Overall Study|Death|2|||
145619853|NCT03660943|525123600|FG000|Overall Study|Lost to Follow-up|7|||
145562159|NCT03506373|524918658|FG000|Overall Study|Other|3|||
145562160|NCT00885755|524918659|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
145562161|NCT00885755|524918660|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
145562162|NCT00885755|524918661|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
145562163|NCT00885755|524918659|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
145562164|NCT00885755|524918660|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
145562165|NCT00885755|524918661|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
145562166|NCT00885755|524918659|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
145562167|NCT00885755|524918660|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
145619854|NCT03660943|525123601|FG001|Overall Study|Lost to Follow-up|3|||
145619855|NCT03660943|525123600|FG000|Overall Study|Protocol Violation|3|||
145619856|NCT03660943|525123601|FG001|Overall Study|Protocol Violation|5|||
145562168|NCT00885755|524918661|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
145408197|NCT03314935|524349848|FG002|Phase 1|Study Terminated by Sponsor|0|||
145619857|NCT03660943|525123600|FG000|Overall Study|Withdrawal by Subject|8|||
145562169|NCT00885755|524918659|FG000|Part I: Trastuzumab+Taxane|Death|0|||
145562170|NCT00885755|524918660|FG001|Part I: Trastuzumab+Taxane|Death|0|||
145562171|NCT00885755|524918661|FG002|Part I: Trastuzumab+Taxane|Death|1|||
145562172|NCT00885755|524918659|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
145562173|NCT00885755|524918660|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
145562174|NCT00885755|524918661|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
145294548|NCT01868009|523927701|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
145294549|NCT01868009|523927700|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
145294550|NCT01868009|523927701|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
145294551|NCT00419770|523928822|FG000|Overall Study|Withdrawal by Subject|5|||
145562175|NCT00107198|524918662|FG000|Overall Study|Lack of Efficacy|28|||
145294552|NCT00419770|523928823|FG001|Overall Study|Withdrawal by Subject|1|||
145294553|NCT04526210|523928829|FG000|Overall Study|Sponsor decision|7|||
145562176|NCT00107198|524918662|FG000|Overall Study|Lost to Follow-up|12|||
145562177|NCT00107198|524918662|FG000|Overall Study|Protocol Violation|1|||
145562178|NCT00107198|524918662|FG000|Overall Study|Withdrawal by Subject|6|||
145562179|NCT00107198|524918662|FG000|Overall Study|Ineligible|5|||
145562180|NCT02120950|524918668|FG000|Overall Study|Adverse Event|5|||
145562181|NCT02120950|524918669|FG001|Overall Study|Adverse Event|4|||
145562182|NCT02120950|524918670|FG002|Overall Study|Adverse Event|3|||
145562183|NCT02120950|524918668|FG000|Overall Study|Death|3|||
145294554|NCT04526210|523928830|FG001|Overall Study|Sponsor decision|5|||
145294555|NCT04526210|523928829|FG000|Overall Study|Withdrawal by Subject|3|||
145294556|NCT04526210|523928830|FG001|Overall Study|Withdrawal by Subject|2|||
145294557|NCT02637232|523928831|FG000|Overall Study|Lost to Follow-up|42|||
145294558|NCT02637232|523928831|FG000|Overall Study|Adverse Event|11|||
145294559|NCT02637232|523928831|FG000|Overall Study|patient 's decision|2|||
145294560|NCT02999178|523928832|FG000|Overall Study|Adverse Event|85|||
145294561|NCT02999178|523928833|FG001|Overall Study|Adverse Event|62|||
145294562|NCT02999178|523928832|FG000|Overall Study|Protocol Violation|1|||
145294563|NCT02999178|523928833|FG001|Overall Study|Protocol Violation|2|||
145294564|NCT02999178|523928832|FG000|Overall Study|Lost to Follow-up|0|||
145294565|NCT02999178|523928833|FG001|Overall Study|Lost to Follow-up|2|||
145294566|NCT02999178|523928832|FG000|Overall Study|Withdrawal by Subject|21|||
145294567|NCT02999178|523928833|FG001|Overall Study|Withdrawal by Subject|21|||
145294568|NCT02999178|523928832|FG000|Overall Study|Other reason not defined above|7|||
145294569|NCT02999178|523928833|FG001|Overall Study|Other reason not defined above|13|||
145294570|NCT00090857|523928834|FG000|Overall Study|Lost to Follow-up|0|||
145294571|NCT00090857|523928835|FG001|Overall Study|Lost to Follow-up|1|||
145294572|NCT00090857|523928834|FG000|Overall Study|Withdrawal by Subject|2|||
145294573|NCT00090857|523928835|FG001|Overall Study|Withdrawal by Subject|0|||
145562184|NCT02120950|524918669|FG001|Overall Study|Death|0|||
145562185|NCT02120950|524918670|FG002|Overall Study|Death|1|||
145294574|NCT00090857|523928834|FG000|Overall Study|Adverse Event|2|||
145294575|NCT00090857|523928835|FG001|Overall Study|Adverse Event|2|||
145294576|NCT05097326|523928836|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
145562186|NCT02120950|524918668|FG000|Overall Study|Withdrawal by Subject|6|||
145294577|NCT05097326|523928837|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
145294578|NCT01244126|523928838|FG000|Overall Study|Protocol Violation|3|||
145294579|NCT01244126|523928839|FG001|Overall Study|Protocol Violation|3|||
145619858|NCT03660943|525123601|FG001|Overall Study|Withdrawal by Subject|15|||
145562187|NCT02120950|524918669|FG001|Overall Study|Withdrawal by Subject|3|||
145562188|NCT02120950|524918670|FG002|Overall Study|Withdrawal by Subject|2|||
145562189|NCT02120950|524918668|FG000|Overall Study|Protocol Violation|1|||
145562190|NCT02120950|524918669|FG001|Overall Study|Protocol Violation|1|||
145294580|NCT01244126|523928840|FG002|Overall Study|Protocol Violation|9|||
145562191|NCT02120950|524918670|FG002|Overall Study|Protocol Violation|7|||
145294581|NCT02424188|523928843|FG000|Overall Study|Death|2|||
145294582|NCT02424188|523928844|FG001|Overall Study|Death|2|||
145294583|NCT02424188|523928843|FG000|Overall Study|Lost to Follow-up|1|||
145294584|NCT02424188|523928844|FG001|Overall Study|Lost to Follow-up|3|||
145294585|NCT02424188|523928843|FG000|Overall Study|Incarceration|1|||
145294586|NCT02424188|523928844|FG001|Overall Study|Incarceration|0|||
145294587|NCT01494506|523928853|FG000|Overall Study|Lack of Efficacy|77|||
145294588|NCT01494506|523928854|FG001|Overall Study|Lack of Efficacy|83|||
145294589|NCT01494506|523928855|FG002|Overall Study|Lack of Efficacy|57|||
145294590|NCT01494506|523928853|FG000|Overall Study|Adverse Event|17|||
145294591|NCT01494506|523928854|FG001|Overall Study|Adverse Event|10|||
145294592|NCT01494506|523928855|FG002|Overall Study|Adverse Event|11|||
145294593|NCT01494506|523928853|FG000|Overall Study|Death|9|||
145294594|NCT01494506|523928854|FG001|Overall Study|Death|5|||
145294595|NCT01494506|523928855|FG002|Overall Study|Death|2|||
145294596|NCT01494506|523928853|FG000|Overall Study|Physician Decision|7|||
145294597|NCT01494506|523928854|FG001|Overall Study|Physician Decision|5|||
145294598|NCT01494506|523928855|FG002|Overall Study|Physician Decision|4|||
145294599|NCT01494506|523928853|FG000|Overall Study|Withdrawal by Subject|17|||
145294600|NCT01494506|523928854|FG001|Overall Study|Withdrawal by Subject|20|||
145294601|NCT01494506|523928855|FG002|Overall Study|Withdrawal by Subject|14|||
145294602|NCT01494506|523928853|FG000|Overall Study|Clinical Deterioration|21|||
145294603|NCT01494506|523928854|FG001|Overall Study|Clinical Deterioration|17|||
145294604|NCT01494506|523928855|FG002|Overall Study|Clinical Deterioration|13|||
145294605|NCT01494506|523928853|FG000|Overall Study|Sponsor Decision|0|||
145294606|NCT01494506|523928854|FG001|Overall Study|Sponsor Decision|0|||
145294607|NCT01494506|523928855|FG002|Overall Study|Sponsor Decision|1|||
145294608|NCT01494506|523928853|FG000|Overall Study|Other|0|||
145294609|NCT01494506|523928854|FG001|Overall Study|Other|3|||
145294610|NCT01494506|523928855|FG002|Overall Study|Other|1|||
145294611|NCT02924038|523928857|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
145294612|NCT02924038|523928858|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
145294613|NCT02473640|523928861|FG000|Treatment Period 1|Adverse Event|1|||
145294614|NCT02777528|523928864|FG000|Overall Study|Still in study|24|||
145294615|NCT02777528|523928865|FG001|Overall Study|Still in study|10|||
145294616|NCT02777528|523928866|FG002|Overall Study|Still in study|1|||
145294617|NCT02777528|523928864|FG000|Overall Study|Study Device Explanted|1|||
145294618|NCT02777528|523928865|FG001|Overall Study|Study Device Explanted|0|||
145294619|NCT02777528|523928866|FG002|Overall Study|Study Device Explanted|0|||
145294620|NCT02777528|523928864|FG000|Overall Study|Death|14|||
145294621|NCT02777528|523928865|FG001|Overall Study|Death|7|||
145294622|NCT02777528|523928866|FG002|Overall Study|Death|1|||
145294623|NCT02777528|523928864|FG000|Overall Study|Withdrawal by Subject|2|||
145294624|NCT02777528|523928865|FG001|Overall Study|Withdrawal by Subject|2|||
145294625|NCT02777528|523928866|FG002|Overall Study|Withdrawal by Subject|1|||
145294626|NCT02777528|523928864|FG000|Overall Study|Physician Decision|2|||
145294627|NCT02777528|523928865|FG001|Overall Study|Physician Decision|1|||
145294628|NCT02777528|523928866|FG002|Overall Study|Physician Decision|0|||
145294629|NCT02777528|523928864|FG000|Overall Study|Lost to Follow-up|2|||
145294630|NCT02777528|523928865|FG001|Overall Study|Lost to Follow-up|0|||
145294631|NCT02777528|523928866|FG002|Overall Study|Lost to Follow-up|0|||
145294632|NCT02777528|523928864|FG000|Overall Study|Discontinued due to Other|1|||
145562192|NCT02120950|524918668|FG000|Overall Study|Other reasons|5|||
145562193|NCT02120950|524918669|FG001|Overall Study|Other reasons|4|||
145294633|NCT02777528|523928865|FG001|Overall Study|Discontinued due to Other|0|||
145294634|NCT02777528|523928866|FG002|Overall Study|Discontinued due to Other|0|||
145294635|NCT00453362|523928869|FG000|Overall Study|Adverse Event|5|||
145294636|NCT00453362|523928869|FG000|Overall Study|Death|7|||
145294637|NCT00453362|523928869|FG000|Overall Study|Physician Decision|2|||
145294638|NCT00453362|523928869|FG000|Overall Study|Withdrawal by Subject|3|||
145294639|NCT00453362|523928869|FG000|Overall Study|Progression of disease|56|||
145294640|NCT00453362|523928869|FG000|Overall Study|Screening Failure|14|||
145294641|NCT04885296|523928870|FG000|Period 1|Covid-19 Related|1|||
145294642|NCT04885296|523928871|FG001|Period 1|Covid-19 Related|0|||
145294643|NCT04885296|523928870|FG000|Period 1|Adverse Event|0|||
145294644|NCT04885296|523928871|FG001|Period 1|Adverse Event|1|||
145294645|NCT04885296|523928870|FG000|Period 1|Withdrawal by Subject|1|||
145294646|NCT04885296|523928871|FG001|Period 1|Withdrawal by Subject|1|||
145294647|NCT04885296|523928870|FG000|Period 1|Test Article No Longer Available|1|||
145294648|NCT04885296|523928871|FG001|Period 1|Test Article No Longer Available|0|||
145294649|NCT04885296|523928870|FG000|Period 1|Dispensed Study lens in Error|1|||
145294650|NCT04885296|523928871|FG001|Period 1|Dispensed Study lens in Error|0|||
145294651|NCT04885296|523928870|FG000|Period 1|Lost to Follow-up|1|||
145294652|NCT04885296|523928871|FG001|Period 1|Lost to Follow-up|0|||
145294653|NCT04885296|523928870|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
145294654|NCT04885296|523928871|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
145294655|NCT00433147|523928873|FG000|Overall Study|Adverse Event|0|||
145294656|NCT00433147|523928874|FG001|Overall Study|Adverse Event|1|||
145294657|NCT00433147|523928875|FG002|Overall Study|Adverse Event|0|||
145294658|NCT00433147|523928876|FG003|Overall Study|Adverse Event|0|||
145294659|NCT01882647|523928877|FG000|Overall Study|Lost to Follow-up|2|||
145294660|NCT01882647|523928878|FG001|Overall Study|Lost to Follow-up|2|||
145294661|NCT01882647|523928877|FG000|Overall Study|Withdrawal by Subject|0|||
145294662|NCT01882647|523928878|FG001|Overall Study|Withdrawal by Subject|4|||
145294663|NCT02937701|523928879|FG000|Day 1 to Week 22|Adverse Event|11|||
145294664|NCT02937701|523928880|FG001|Day 1 to Week 22|Adverse Event|14|||
145294665|NCT02937701|523928881|FG002|Day 1 to Week 22|Adverse Event|0|||
145619859|NCT03660943|525123600|FG000|Overall Study|Lack of Efficacy|9|||
145294666|NCT02937701|523928882|FG003|Day 1 to Week 22|Adverse Event|0|||
145619860|NCT03660943|525123601|FG001|Overall Study|Lack of Efficacy|12|||
145655517|NCT02105766|525257249|FG000|Overall Study|Lost to Follow-up|2|||
145562194|NCT02120950|524918670|FG002|Overall Study|Other reasons|1|||
145562195|NCT02120950|524918668|FG000|Overall Study|Lost to Follow-up|0|||
145562196|NCT02120950|524918669|FG001|Overall Study|Lost to Follow-up|2|||
145294667|NCT02937701|523928883|FG004|Day 1 to Week 22|Adverse Event|0|||
145562197|NCT02120950|524918670|FG002|Overall Study|Lost to Follow-up|1|||
145562198|NCT02625090|524918673|FG000|Overall Study|Participant wants to be pregnant|2|||
145294668|NCT02937701|523928879|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
145562199|NCT02625090|524918673|FG000|Overall Study|For the Promoter|1|||
145294669|NCT02937701|523928880|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
145562200|NCT02625090|524918673|FG000|Overall Study|Sponsor's Decision|9|||
145562201|NCT02625090|524918673|FG000|Overall Study|Somnolence|1|||
145562202|NCT02625090|524918673|FG000|Overall Study|Study terminated by Sponsor|7|||
145562203|NCT02625090|524918673|FG000|Overall Study|Negative Benefit/Risk|1|||
145562204|NCT02625090|524918673|FG000|Overall Study|Protocol Deviation|2|||
145562205|NCT02625090|524918673|FG000|Overall Study|Lack of Efficacy|16|||
145562206|NCT02625090|524918673|FG000|Overall Study|Adverse Event|3|||
145562207|NCT02250443|524918674|FG000|Overall Study|Administrative problems|7|||
145562208|NCT02250443|524918674|FG000|Overall Study|Adverse Event|3|||
145562209|NCT01549964|524918675|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
145562210|NCT01549964|524918676|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
145562211|NCT01549964|524918677|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
145562212|NCT01549964|524918678|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
145562213|NCT01549964|524918675|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
145562214|NCT01549964|524918676|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
145562215|NCT01549964|524918677|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
145562216|NCT01549964|524918678|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
145562217|NCT01549964|524918675|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
145562218|NCT01549964|524918676|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
145562219|NCT01549964|524918677|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
145562220|NCT01549964|524918678|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
145562221|NCT01549964|524918675|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
145562222|NCT01549964|524918676|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
145562223|NCT01549964|524918677|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
145562224|NCT01549964|524918678|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
145562225|NCT01549964|524918675|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
145562226|NCT01549964|524918676|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
145562227|NCT01549964|524918677|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
145562228|NCT01549964|524918678|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
145562229|NCT01549964|524918675|FG000|24-Week Treatment Period|Other|1|||
145562230|NCT01549964|524918676|FG001|24-Week Treatment Period|Other|0|||
145562231|NCT01549964|524918677|FG002|24-Week Treatment Period|Other|1|||
145562232|NCT01549964|524918678|FG003|24-Week Treatment Period|Other|0|||
145562233|NCT01549964|524918675|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
145562234|NCT01549964|524918676|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
145562235|NCT01549964|524918677|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
145562236|NCT01549964|524918678|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
145562237|NCT01549964|524918675|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
145562238|NCT01549964|524918676|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
145562239|NCT01549964|524918677|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
145562240|NCT01549964|524918678|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
145562241|NCT01549964|524918675|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
145562242|NCT01549964|524918676|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
145294670|NCT02937701|523928881|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
145294671|NCT02937701|523928882|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
145294672|NCT02937701|523928883|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
145294673|NCT02937701|523928879|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
145294674|NCT02937701|523928880|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
145294675|NCT02937701|523928881|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
145294676|NCT02937701|523928882|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
145294677|NCT02937701|523928883|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
145294678|NCT02937701|523928879|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
145294679|NCT02937701|523928880|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
145294680|NCT02937701|523928881|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
145294681|NCT02937701|523928882|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
145294682|NCT02937701|523928883|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
145294683|NCT02937701|523928879|FG000|Day 1 to Week 22|Death|1|||
145408198|NCT03314935|524349849|FG003|Phase 1|Study Terminated by Sponsor|0|||
145562243|NCT01549964|524918677|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
145294684|NCT02937701|523928880|FG001|Day 1 to Week 22|Death|1|||
145294685|NCT02937701|523928881|FG002|Day 1 to Week 22|Death|0|||
145294686|NCT02937701|523928882|FG003|Day 1 to Week 22|Death|0|||
145294687|NCT02937701|523928883|FG004|Day 1 to Week 22|Death|0|||
145294688|NCT02937701|523928879|FG000|Day 1 to Week 22|Protocol Violation|1|||
145294689|NCT02937701|523928880|FG001|Day 1 to Week 22|Protocol Violation|1|||
145294690|NCT02937701|523928881|FG002|Day 1 to Week 22|Protocol Violation|0|||
145294691|NCT02937701|523928882|FG003|Day 1 to Week 22|Protocol Violation|0|||
145294692|NCT02937701|523928883|FG004|Day 1 to Week 22|Protocol Violation|0|||
145294693|NCT02937701|523928879|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
145294694|NCT02937701|523928880|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
145294695|NCT02937701|523928881|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
145294696|NCT02937701|523928882|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
145562244|NCT01549964|524918678|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
145562245|NCT01549964|524918675|FG000|80-Week Extension Period|Pregnancy|0|||
145562246|NCT01549964|524918676|FG001|80-Week Extension Period|Pregnancy|0|||
145562247|NCT01549964|524918677|FG002|80-Week Extension Period|Pregnancy|1|||
145562248|NCT01549964|524918678|FG003|80-Week Extension Period|Pregnancy|0|||
145562249|NCT01549964|524918675|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
145562250|NCT01549964|524918676|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
145562251|NCT01549964|524918677|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
145562252|NCT01549964|524918678|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
145294697|NCT02937701|523928883|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
145294698|NCT02937701|523928879|FG000|Day 1 to Week 22|Physician Decision|2|||
145294699|NCT02937701|523928880|FG001|Day 1 to Week 22|Physician Decision|0|||
145294700|NCT02937701|523928881|FG002|Day 1 to Week 22|Physician Decision|0|||
145294701|NCT02937701|523928882|FG003|Day 1 to Week 22|Physician Decision|0|||
145294702|NCT02937701|523928883|FG004|Day 1 to Week 22|Physician Decision|0|||
145562253|NCT01549964|524918675|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
145562254|NCT01549964|524918676|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
145619861|NCT03660943|525123600|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
145655518|NCT02105766|525257250|FG001|Overall Study|Lost to Follow-up|0|||
145562255|NCT01549964|524918677|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
145294703|NCT02937701|523928879|FG000|Day 1 to Week 22|Other|1|||
145294704|NCT02937701|523928880|FG001|Day 1 to Week 22|Other|0|||
145294705|NCT02937701|523928881|FG002|Day 1 to Week 22|Other|0|||
145294706|NCT02937701|523928882|FG003|Day 1 to Week 22|Other|0|||
145294707|NCT02937701|523928883|FG004|Day 1 to Week 22|Other|0|||
145294708|NCT02937701|523928879|FG000|Week 22 to Week 50|Adverse Event|0|||
145294709|NCT02937701|523928880|FG001|Week 22 to Week 50|Adverse Event|0|||
145562256|NCT01549964|524918678|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
145562257|NCT01549964|524918675|FG000|80-Week Extension Period|Lost to Follow-up|1|||
145562258|NCT01549964|524918676|FG001|80-Week Extension Period|Lost to Follow-up|0|||
145562259|NCT01549964|524918677|FG002|80-Week Extension Period|Lost to Follow-up|2|||
145562260|NCT01549964|524918678|FG003|80-Week Extension Period|Lost to Follow-up|1|||
145562261|NCT01549964|524918675|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
145562262|NCT01549964|524918676|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
145562263|NCT01549964|524918677|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
145562264|NCT01549964|524918678|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
145562265|NCT00751348|524918686|FG000|Overall Study|Withdrawal by Subject|5|||
145562266|NCT00751348|524918687|FG001|Overall Study|Withdrawal by Subject|2|||
145562267|NCT00751348|524918686|FG000|Overall Study|Migration from study area|1|||
145562268|NCT00751348|524918687|FG001|Overall Study|Migration from study area|0|||
145562269|NCT04191382|524918691|FG000|Overall Study|Withdrawal by Subject|1|||
145562270|NCT04191382|524918692|FG001|Overall Study|Withdrawal by Subject|0|||
145562271|NCT04191382|524918693|FG002|Overall Study|Withdrawal by Subject|0|||
145562272|NCT05237206|524918694|FG000|Overall Study|screen failure-did not receive treatment|8|||
145562273|NCT05237206|524918694|FG000|Overall Study|did not receive treatment|3|||
145562274|NCT01476696|524918699|FG000|Overall Study|Sponsor decision|2|||
145294710|NCT02937701|523928881|FG002|Week 22 to Week 50|Adverse Event|10|||
145619862|NCT03660943|525123601|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
145562275|NCT01476696|524918700|FG001|Overall Study|Sponsor decision|1|||
145562276|NCT01476696|524918701|FG002|Overall Study|Sponsor decision|0|||
145619863|NCT03850444|525123602|FG000|Overall Study|Adverse Event|16|||
145294711|NCT02937701|523928882|FG003|Week 22 to Week 50|Adverse Event|3|||
145294712|NCT02937701|523928883|FG004|Week 22 to Week 50|Adverse Event|3|||
145294713|NCT02937701|523928879|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
145294714|NCT02937701|523928880|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
145294715|NCT02937701|523928881|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
145294716|NCT02937701|523928882|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
145294717|NCT02937701|523928883|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
145294718|NCT02937701|523928879|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
145294719|NCT02937701|523928880|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
145294720|NCT02937701|523928881|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
145294721|NCT02937701|523928882|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
145294722|NCT02937701|523928883|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
145294723|NCT02937701|523928879|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
145294724|NCT02937701|523928880|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
145294725|NCT02937701|523928881|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
145294726|NCT02937701|523928882|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
145294727|NCT02937701|523928883|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
145294728|NCT02937701|523928879|FG000|Week 22 to Week 50|Physician Decision|0|||
145562277|NCT01476696|524918699|FG000|Overall Study|Withdrawal by Subject|1|||
145294729|NCT02937701|523928880|FG001|Week 22 to Week 50|Physician Decision|0|||
145294730|NCT02937701|523928881|FG002|Week 22 to Week 50|Physician Decision|2|||
145562278|NCT01476696|524918700|FG001|Overall Study|Withdrawal by Subject|0|||
145562279|NCT01476696|524918701|FG002|Overall Study|Withdrawal by Subject|0|||
145562280|NCT02009046|524918703|FG000|Overall Study|Lost to Follow-up|256|||
145562281|NCT02009046|524918704|FG001|Overall Study|Lost to Follow-up|206|||
145562282|NCT03965962|524918710|FG000|Overall Study|Adverse Event|1|||
145562283|NCT03965962|524918711|FG001|Overall Study|Adverse Event|0|||
145562284|NCT03965962|524918712|FG002|Overall Study|Adverse Event|0|||
145562285|NCT03965962|524918713|FG003|Overall Study|Adverse Event|0|||
145562286|NCT03965962|524918710|FG000|Overall Study|Protocol Violation|21|||
145562287|NCT03965962|524918711|FG001|Overall Study|Protocol Violation|4|||
145294731|NCT02937701|523928882|FG003|Week 22 to Week 50|Physician Decision|0|||
145619864|NCT03850444|525123603|FG001|Overall Study|Adverse Event|10|||
145294732|NCT02937701|523928883|FG004|Week 22 to Week 50|Physician Decision|1|||
145619865|NCT03850444|525123602|FG000|Overall Study|Death|87|||
145294733|NCT02937701|523928879|FG000|Week 22 to Week 50|Other|0|||
145562288|NCT03965962|524918712|FG002|Overall Study|Protocol Violation|10|||
145562289|NCT03965962|524918713|FG003|Overall Study|Protocol Violation|5|||
145562290|NCT03965962|524918710|FG000|Overall Study|Lost to Follow-up|0|||
145562291|NCT03965962|524918711|FG001|Overall Study|Lost to Follow-up|1|||
145562292|NCT03965962|524918712|FG002|Overall Study|Lost to Follow-up|0|||
145562293|NCT03965962|524918713|FG003|Overall Study|Lost to Follow-up|0|||
145562294|NCT03965962|524918710|FG000|Overall Study|Withdrawal by Subject|3|||
145562295|NCT03965962|524918711|FG001|Overall Study|Withdrawal by Subject|0|||
145562296|NCT03965962|524918712|FG002|Overall Study|Withdrawal by Subject|0|||
145562297|NCT03965962|524918713|FG003|Overall Study|Withdrawal by Subject|1|||
145562298|NCT00741039|524918714|FG000|Overall Study|Patient non-compliance|2|||
145619866|NCT03850444|525123603|FG001|Overall Study|Death|107|||
145619867|NCT03850444|525123602|FG000|Overall Study|Lost to Follow-up|1|||
145408199|NCT03314935|524349850|FG004|Phase 1|Study Terminated by Sponsor|0|||
145562299|NCT00741039|524918715|FG001|Overall Study|Patient non-compliance|0|||
145619868|NCT03850444|525123603|FG001|Overall Study|Lost to Follow-up|1|||
145562300|NCT00878709|524918716|FG000|Overall Study|Withdrawal by Subject|197|||
145294734|NCT02937701|523928880|FG001|Week 22 to Week 50|Other|0|||
145294735|NCT02937701|523928881|FG002|Week 22 to Week 50|Other|0|||
145294736|NCT02937701|523928882|FG003|Week 22 to Week 50|Other|0|||
145294737|NCT02937701|523928883|FG004|Week 22 to Week 50|Other|1|||
145294738|NCT00416520|523928885|FG000|Open-label Period|Adverse Event|28|||
145294739|NCT00416520|523928886|FG001|Open-label Period|Adverse Event|10|||
145294740|NCT00416520|523928887|FG002|Open-label Period|Adverse Event|0|||
145294741|NCT00416520|523928888|FG003|Open-label Period|Adverse Event|0|||
145619869|NCT03850444|525123602|FG000|Overall Study|Withdrawal by Subject|1|||
145562301|NCT00878709|524918717|FG001|Overall Study|Withdrawal by Subject|120|||
145562302|NCT00878709|524918716|FG000|Overall Study|Lost to Follow-up|35|||
145562303|NCT00878709|524918717|FG001|Overall Study|Lost to Follow-up|33|||
145562304|NCT00878709|524918716|FG000|Overall Study|Other Reasons|93|||
145562305|NCT00878709|524918717|FG001|Overall Study|Other Reasons|84|||
145562306|NCT01712854|524918718|FG000|Overall Study|Physician Decision|1|||
145562307|NCT02225743|524918719|FG000|Overall Study|Withdrawal by Subject|18|||
145562308|NCT03886220|524918722|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
145562309|NCT03886220|524918723|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
145562310|NCT03886220|524918722|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
145562311|NCT03886220|524918723|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145562312|NCT03886220|524918722|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
145562313|NCT03886220|524918723|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145562314|NCT00768300|524918724|FG000|Overall Study|Randomized but not treated|1|||
145562315|NCT00768300|524918725|FG001|Overall Study|Randomized but not treated|1|||
145562316|NCT00768300|524918724|FG000|Overall Study|Adverse Event|10|||
145562317|NCT00768300|524918725|FG001|Overall Study|Adverse Event|2|||
145562318|NCT00768300|524918724|FG000|Overall Study|Protocol Violation|6|||
145562319|NCT00768300|524918725|FG001|Overall Study|Protocol Violation|1|||
145562320|NCT00768300|524918724|FG000|Overall Study|Withdrawal by Subject|13|||
145562321|NCT00768300|524918725|FG001|Overall Study|Withdrawal by Subject|7|||
145562322|NCT00768300|524918724|FG000|Overall Study|Physician Decision|2|||
145294742|NCT00416520|523928885|FG000|Open-label Period|Death|2|||
145294743|NCT00416520|523928886|FG001|Open-label Period|Death|1|||
145294744|NCT00416520|523928887|FG002|Open-label Period|Death|0|||
145562323|NCT00768300|524918725|FG001|Overall Study|Physician Decision|3|||
145562324|NCT00768300|524918724|FG000|Overall Study|Study discontinued by Sponsor|271|||
145294745|NCT00416520|523928888|FG003|Open-label Period|Death|0|||
145562325|NCT00768300|524918725|FG001|Overall Study|Study discontinued by Sponsor|140|||
145562326|NCT00768300|524918724|FG000|Overall Study|Death|21|||
145562327|NCT00768300|524918725|FG001|Overall Study|Death|5|||
145562328|NCT00768300|524918724|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
145562329|NCT00768300|524918725|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
145562330|NCT00768300|524918724|FG000|Overall Study|Screen failure following randomization|1|||
145562331|NCT00768300|524918725|FG001|Overall Study|Screen failure following randomization|0|||
145562332|NCT00768300|524918724|FG000|Overall Study|Received lung transplant|1|||
145562333|NCT00768300|524918725|FG001|Overall Study|Received lung transplant|1|||
145562334|NCT00768300|524918724|FG000|Overall Study|Lost to Follow-up|0|||
145562335|NCT00768300|524918725|FG001|Overall Study|Lost to Follow-up|1|||
145562336|NCT00768300|524918724|FG000|Overall Study|Began prohibited concomitant medication|0|||
145562337|NCT00768300|524918725|FG001|Overall Study|Began prohibited concomitant medication|1|||
145562338|NCT00768300|524918724|FG000|Overall Study|Treated but never dosed with Study drug|1|||
145655519|NCT02105766|525257251|FG002|Overall Study|Lost to Follow-up|0|||
145294746|NCT00416520|523928885|FG000|Open-label Period|Lack of Efficacy|8|||
145562339|NCT00768300|524918725|FG001|Overall Study|Treated but never dosed with Study drug|0|||
145562340|NCT00768300|524918724|FG000|Overall Study|Missing data|1|||
145562341|NCT00768300|524918725|FG001|Overall Study|Missing data|0|||
145562342|NCT00322842|524918726|FG000|Overall Study|Withdrawal by Subject|0|||
145562343|NCT00322842|524918727|FG001|Overall Study|Withdrawal by Subject|1|||
145562344|NCT00322842|524918726|FG000|Overall Study|Lost to Follow-up|0|||
145562345|NCT00322842|524918727|FG001|Overall Study|Lost to Follow-up|1|||
145562346|NCT00322842|524918726|FG000|Overall Study|Refused transplant|1|||
145562347|NCT00322842|524918727|FG001|Overall Study|Refused transplant|0|||
145562348|NCT00322842|524918726|FG000|Overall Study|Death|1|||
145562349|NCT00322842|524918727|FG001|Overall Study|Death|0|||
145562350|NCT03082599|524918730|FG000|Overall Study|Lost to Follow-up|1|||
145562351|NCT03082599|524918731|FG001|Overall Study|Lost to Follow-up|0|||
145562352|NCT00946712|524918734|FG000|Overall Study|Adverse Event|118|||
145562353|NCT00946712|524918735|FG001|Overall Study|Adverse Event|124|||
145562354|NCT00946712|524918734|FG000|Overall Study|Disease progression|308|||
145562355|NCT00946712|524918735|FG001|Overall Study|Disease progression|404|||
145562356|NCT00946712|524918734|FG000|Overall Study|Death|21|||
145562357|NCT00946712|524918735|FG001|Overall Study|Death|22|||
145562358|NCT00946712|524918734|FG000|Overall Study|No treatment given|25|||
145562359|NCT00946712|524918735|FG001|Overall Study|No treatment given|29|||
145562360|NCT00946712|524918734|FG000|Overall Study|Other reasons|61|||
145562361|NCT00946712|524918735|FG001|Overall Study|Other reasons|73|||
145562362|NCT00946712|524918734|FG000|Overall Study|On Treatment|0|||
145562363|NCT00946712|524918735|FG001|Overall Study|On Treatment|4|||
145562364|NCT00946712|524918734|FG000|Overall Study|Ineligible|14|||
145562365|NCT00946712|524918735|FG001|Overall Study|Ineligible|6|||
145619870|NCT03850444|525123603|FG001|Overall Study|Withdrawal by Subject|5|||
145562366|NCT00302458|524918738|FG000|Overall Study|Lost to Follow-up|1|||
145562367|NCT00302458|524918738|FG000|Overall Study|Ineligible after screening|1|||
145562368|NCT00302458|524918738|FG000|Overall Study|Withdrawal by Subject|1|||
145562369|NCT00853723|524918740|FG000|Overall Study|Adverse Event|3|||
145562370|NCT00853723|524918741|FG001|Overall Study|Adverse Event|4|||
145562371|NCT00853723|524918742|FG002|Overall Study|Adverse Event|1|||
145562372|NCT00853723|524918740|FG000|Overall Study|Withdrawal by Subject|2|||
145562373|NCT00853723|524918741|FG001|Overall Study|Withdrawal by Subject|1|||
145562374|NCT00853723|524918742|FG002|Overall Study|Withdrawal by Subject|0|||
145562375|NCT00853723|524918740|FG000|Overall Study|Protocol Violation|1|||
145294747|NCT00416520|523928886|FG001|Open-label Period|Lack of Efficacy|1|||
145294748|NCT00416520|523928887|FG002|Open-label Period|Lack of Efficacy|0|||
145562376|NCT00853723|524918741|FG001|Overall Study|Protocol Violation|2|||
145562377|NCT00853723|524918742|FG002|Overall Study|Protocol Violation|1|||
145619871|NCT03850444|525123602|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
145562378|NCT00445965|524918743|FG000|Overall Study|Adverse Event|2|||
145408200|NCT03314935|524349851|FG005|Phase 1|Study Terminated by Sponsor|0|||
145408201|NCT03314935|524349852|FG006|Phase 1|Study Terminated by Sponsor|0|||
145408202|NCT03314935|524349853|FG007|Phase 1|Study Terminated by Sponsor|0|||
145562379|NCT00445965|524918743|FG000|Overall Study|Physician Decision|1|||
145562380|NCT00445965|524918743|FG000|Overall Study|Enrolled but not treated|1|||
145562381|NCT00445965|524918743|FG000|Overall Study|Removed due to progressive disease|29|||
145562382|NCT02867709|524918744|FG000|Treatment Period|Adverse Event|1|||
145562383|NCT02867709|524918745|FG001|Treatment Period|Adverse Event|1|||
145562384|NCT02867709|524918746|FG002|Treatment Period|Adverse Event|2|||
145562385|NCT02867709|524918744|FG000|Treatment Period|Withdrawal of Consent|7|||
145562386|NCT02867709|524918745|FG001|Treatment Period|Withdrawal of Consent|9|||
145562387|NCT02867709|524918746|FG002|Treatment Period|Withdrawal of Consent|8|||
145562388|NCT02867709|524918744|FG000|Treatment Period|Lost to Follow-up|17|||
145562389|NCT02867709|524918745|FG001|Treatment Period|Lost to Follow-up|20|||
145562390|NCT02867709|524918746|FG002|Treatment Period|Lost to Follow-up|20|||
145562391|NCT02867709|524918744|FG000|Treatment Period|Lack of Qualifying Event|42|||
145562392|NCT02867709|524918745|FG001|Treatment Period|Lack of Qualifying Event|55|||
145562393|NCT02867709|524918746|FG002|Treatment Period|Lack of Qualifying Event|42|||
145562394|NCT02867709|524918744|FG000|Treatment Period|Protocol Violation|3|||
145562395|NCT02867709|524918745|FG001|Treatment Period|Protocol Violation|2|||
145562396|NCT02867709|524918746|FG002|Treatment Period|Protocol Violation|3|||
145562397|NCT02867709|524918744|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
145562398|NCT02867709|524918745|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
145562399|NCT02867709|524918746|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
145562400|NCT02867709|524918744|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
145294749|NCT00416520|523928888|FG003|Open-label Period|Lack of Efficacy|0|||
145294750|NCT00416520|523928885|FG000|Open-label Period|Protocol Violation|3|||
145294751|NCT00416520|523928886|FG001|Open-label Period|Protocol Violation|3|||
145294752|NCT00416520|523928887|FG002|Open-label Period|Protocol Violation|0|||
145294753|NCT00416520|523928888|FG003|Open-label Period|Protocol Violation|0|||
145294754|NCT00416520|523928885|FG000|Open-label Period|Withdrawal by Subject|16|||
145294755|NCT00416520|523928886|FG001|Open-label Period|Withdrawal by Subject|5|||
145294756|NCT00416520|523928887|FG002|Open-label Period|Withdrawal by Subject|0|||
145294757|NCT00416520|523928888|FG003|Open-label Period|Withdrawal by Subject|0|||
145294758|NCT00416520|523928885|FG000|Open-label Period|Other Reasons|3|||
145294759|NCT00416520|523928886|FG001|Open-label Period|Other Reasons|12|||
145294760|NCT00416520|523928887|FG002|Open-label Period|Other Reasons|0|||
145294761|NCT00416520|523928888|FG003|Open-label Period|Other Reasons|0|||
145294762|NCT00416520|523928885|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
145294763|NCT00416520|523928886|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
145294764|NCT00416520|523928887|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
145294765|NCT00416520|523928888|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
145294766|NCT00416520|523928885|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
145294767|NCT00416520|523928886|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
145294768|NCT00416520|523928887|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
145294769|NCT00416520|523928888|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
145294770|NCT00416520|523928885|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
145294771|NCT00416520|523928886|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
145294772|NCT00416520|523928887|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
145294773|NCT00416520|523928888|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
145294774|NCT03601637|523928890|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
145294775|NCT03601637|523928891|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
145562401|NCT02867709|524918745|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
145562402|NCT02867709|524918746|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
145294776|NCT03601637|523928890|FG000|Overall Study|Adverse Event|1|||
145294777|NCT03601637|523928891|FG001|Overall Study|Adverse Event|1|||
145294778|NCT03601637|523928890|FG000|Overall Study|Other|0|||
145294779|NCT03601637|523928891|FG001|Overall Study|Other|1|||
145294780|NCT01108094|523928895|FG000|Overall Study|Adverse Event|2|||
145294781|NCT01108094|523928896|FG001|Overall Study|Adverse Event|0|||
145562403|NCT02867709|524918744|FG000|Safety Follow-up Period|Pregnancy|0|||
145294782|NCT01108094|523928897|FG002|Overall Study|Adverse Event|0|||
145562404|NCT02867709|524918745|FG001|Safety Follow-up Period|Pregnancy|1|||
145562405|NCT02867709|524918746|FG002|Safety Follow-up Period|Pregnancy|0|||
145562406|NCT02867709|524918744|FG000|Safety Follow-up Period|Protocol Violation|0|||
145294783|NCT01108094|523928898|FG003|Overall Study|Adverse Event|0|||
145294784|NCT01108094|523928895|FG000|Overall Study|Withdrawal by Subject|1|||
145294785|NCT01108094|523928896|FG001|Overall Study|Withdrawal by Subject|0|||
145294786|NCT01108094|523928897|FG002|Overall Study|Withdrawal by Subject|0|||
145294787|NCT01108094|523928898|FG003|Overall Study|Withdrawal by Subject|0|||
145294788|NCT05346055|523928908|FG000|Overall Study|Withdrawal by Subject|1|||
145294789|NCT05346055|523928908|FG000|Overall Study|Protocol Violation|1|||
145294790|NCT05346055|523928908|FG000|Overall Study|Therapist decision|1|||
145294791|NCT00728949|523928909|FG000|Overall Study|Adverse Event|8|||
145294792|NCT00728949|523928910|FG001|Overall Study|Adverse Event|0|||
145562407|NCT02867709|524918745|FG001|Safety Follow-up Period|Protocol Violation|1|||
145562408|NCT02867709|524918746|FG002|Safety Follow-up Period|Protocol Violation|1|||
145562409|NCT04056195|524918747|FG000|Overall Study|Adverse Event|1|||
145294793|NCT00728949|523928909|FG000|Overall Study|Withdrawal by Subject|2|||
145294794|NCT00728949|523928910|FG001|Overall Study|Withdrawal by Subject|2|||
145294795|NCT00728949|523928909|FG000|Overall Study|Abnormal Lab Results|0|||
145294796|NCT00728949|523928910|FG001|Overall Study|Abnormal Lab Results|2|||
145562410|NCT04056195|524918748|FG001|Overall Study|Adverse Event|0|||
145294797|NCT00728949|523928909|FG000|Overall Study|On treatment at cutoff date|1|||
145294798|NCT00728949|523928910|FG001|Overall Study|On treatment at cutoff date|0|||
145562411|NCT04056195|524918749|FG002|Overall Study|Adverse Event|0|||
145294799|NCT01996033|523928911|FG000|Overall Study|Death|1|||
145294800|NCT01996033|523928911|FG000|Overall Study|Physician Decision|1|||
145562412|NCT04056195|524918747|FG000|Overall Study|Withdrawal by Subject|0|||
145294801|NCT01996033|523928911|FG000|Overall Study|Withdrawal by Subject|4|||
145619872|NCT03850444|525123603|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
145619873|NCT03531905|525123604|FG000|Overall Study|Withdrawal by Subject|3|||
145619874|NCT03531905|525123605|FG001|Overall Study|Withdrawal by Subject|3|||
145619875|NCT03531905|525123606|FG002|Overall Study|Withdrawal by Subject|2|||
145619876|NCT03531905|525123604|FG000|Overall Study|Lost to Follow-up|2|||
145619877|NCT03531905|525123605|FG001|Overall Study|Lost to Follow-up|2|||
145619878|NCT03531905|525123606|FG002|Overall Study|Lost to Follow-up|1|||
145294802|NCT01996033|523928911|FG000|Overall Study|Lost to Follow-up|3|||
145562413|NCT04056195|524918748|FG001|Overall Study|Withdrawal by Subject|1|||
145562414|NCT04056195|524918749|FG002|Overall Study|Withdrawal by Subject|1|||
145562415|NCT04056195|524918747|FG000|Overall Study|Physician Decision|1|||
145562416|NCT04056195|524918748|FG001|Overall Study|Physician Decision|1|||
145562417|NCT04056195|524918749|FG002|Overall Study|Physician Decision|1|||
145562418|NCT05497284|524918750|FG000|Overall Study|Adverse Event|1|||
145408203|NCT03314935|524349854|FG008|Phase 1|Study Terminated by Sponsor|1|||
145408204|NCT03314935|524349855|FG009|Phase 1|Study Terminated by Sponsor|0|||
145408205|NCT03314935|524349856|FG010|Phase 1|Study Terminated by Sponsor|0|||
145408206|NCT03314935|524349857|FG011|Phase 1|Study Terminated by Sponsor|0|||
145408207|NCT03314935|524349858|FG012|Phase 1|Study Terminated by Sponsor|0|||
145408208|NCT03314935|524349859|FG013|Phase 1|Study Terminated by Sponsor|0|||
145408209|NCT03314935|524349860|FG014|Phase 1|Study Terminated by Sponsor|0|||
145408210|NCT03314935|524349846|FG000|Phase 1|"Captured as Other in Database"|0|||
145408211|NCT03314935|524349847|FG001|Phase 1|"Captured as Other in Database"|2|||
145408212|NCT03314935|524349848|FG002|Phase 1|"Captured as Other in Database"|0|||
145408213|NCT03314935|524349849|FG003|Phase 1|"Captured as Other in Database"|0|||
145408214|NCT03314935|524349850|FG004|Phase 1|"Captured as Other in Database"|0|||
145408215|NCT03314935|524349851|FG005|Phase 1|"Captured as Other in Database"|0|||
145408216|NCT03314935|524349852|FG006|Phase 1|"Captured as Other in Database"|1|||
145408217|NCT03314935|524349853|FG007|Phase 1|"Captured as Other in Database"|1|||
145408218|NCT03314935|524349854|FG008|Phase 1|"Captured as Other in Database"|1|||
145408219|NCT03314935|524349855|FG009|Phase 1|"Captured as Other in Database"|0|||
145408220|NCT03314935|524349856|FG010|Phase 1|"Captured as Other in Database"|0|||
145408221|NCT03314935|524349857|FG011|Phase 1|"Captured as Other in Database"|0|||
145408222|NCT03314935|524349858|FG012|Phase 1|"Captured as Other in Database"|0|||
145562419|NCT05497284|524918751|FG001|Overall Study|Adverse Event|0|||
145562420|NCT05497284|524918750|FG000|Overall Study|Physician Decision|0|||
145562421|NCT05497284|524918751|FG001|Overall Study|Physician Decision|1|||
145408223|NCT03314935|524349859|FG013|Phase 1|"Captured as Other in Database"|0|||
145408224|NCT03314935|524349860|FG014|Phase 1|"Captured as Other in Database"|0|||
145408225|NCT03314935|524349846|FG000|Phase 1|Lost to Follow-up|0|||
145408226|NCT03314935|524349847|FG001|Phase 1|Lost to Follow-up|0|||
145408227|NCT03314935|524349848|FG002|Phase 1|Lost to Follow-up|0|||
145408228|NCT03314935|524349849|FG003|Phase 1|Lost to Follow-up|0|||
145408229|NCT03314935|524349850|FG004|Phase 1|Lost to Follow-up|0|||
145408230|NCT03314935|524349851|FG005|Phase 1|Lost to Follow-up|0|||
145562422|NCT05497284|524918750|FG000|Overall Study|Study terminated by sponsor|7|||
145562423|NCT05497284|524918751|FG001|Overall Study|Study terminated by sponsor|4|||
145408231|NCT03314935|524349852|FG006|Phase 1|Lost to Follow-up|0|||
145408232|NCT03314935|524349853|FG007|Phase 1|Lost to Follow-up|0|||
145408233|NCT03314935|524349854|FG008|Phase 1|Lost to Follow-up|1|||
145408234|NCT03314935|524349855|FG009|Phase 1|Lost to Follow-up|0|||
145562424|NCT05497284|524918750|FG000|Overall Study|Subject Decision|0|||
145408235|NCT03314935|524349856|FG010|Phase 1|Lost to Follow-up|0|||
145408236|NCT03314935|524349857|FG011|Phase 1|Lost to Follow-up|0|||
145562425|NCT05497284|524918751|FG001|Overall Study|Subject Decision|1|||
145408237|NCT03314935|524349858|FG012|Phase 1|Lost to Follow-up|0|||
145408238|NCT03314935|524349859|FG013|Phase 1|Lost to Follow-up|0|||
145408239|NCT03314935|524349860|FG014|Phase 1|Lost to Follow-up|0|||
145408240|NCT03314935|524349846|FG000|Phase 2|Death|0|||
145408241|NCT03314935|524349847|FG001|Phase 2|Death|0|||
145408242|NCT03314935|524349848|FG002|Phase 2|Death|0|||
145408243|NCT03314935|524349849|FG003|Phase 2|Death|0|||
145562426|NCT05760300|524918752|FG000|Overall Study|Adverse Event|0|||
145562427|NCT05760300|524918753|FG001|Overall Study|Adverse Event|0|||
145562428|NCT05760300|524918754|FG002|Overall Study|Adverse Event|1|||
145294803|NCT01087970|523928916|FG000|Overall Study|Protocol Violation|2|||
145294804|NCT02143102|523928919|FG000|Overall Study|Lost to Follow-up|11|||
145562429|NCT05760300|524918755|FG003|Overall Study|Adverse Event|0|||
145562430|NCT05760300|524918752|FG000|Overall Study|Participant Decision|1|||
145619879|NCT03531905|525123604|FG000|Overall Study|Participant was out of town|1|||
145619880|NCT03531905|525123605|FG001|Overall Study|Participant was out of town|0|||
145619881|NCT03531905|525123606|FG002|Overall Study|Participant was out of town|0|||
145619882|NCT03531905|525123604|FG000|Overall Study|Could not speak with the participant|1|||
145619883|NCT03531905|525123605|FG001|Overall Study|Could not speak with the participant|0|||
145619884|NCT03531905|525123606|FG002|Overall Study|Could not speak with the participant|0|||
145619885|NCT01036087|525123607|FG000|Overall Study|Adverse Event|2|||
145619886|NCT01036087|525123607|FG000|Overall Study|Lack of Efficacy|1|||
145619887|NCT01021878|525123608|FG000|Overall Study|Lost to Follow-up|4|||
145619888|NCT01021878|525123609|FG001|Overall Study|Lost to Follow-up|3|||
145619889|NCT01021878|525123608|FG000|Overall Study|Death|0|||
145619890|NCT01021878|525123609|FG001|Overall Study|Death|1|||
145619891|NCT01021878|525123608|FG000|Overall Study|Adverse Event|6|||
145619892|NCT01021878|525123609|FG001|Overall Study|Adverse Event|5|||
145619893|NCT01021878|525123608|FG000|Overall Study|Transplantation|6|||
145619894|NCT01021878|525123609|FG001|Overall Study|Transplantation|1|||
145294805|NCT02143102|523928920|FG001|Overall Study|Lost to Follow-up|0|||
145294806|NCT02636907|523928923|FG000|Autoinjector Assessment Period|Adverse Event|2|||
145408244|NCT03314935|524349850|FG004|Phase 2|Death|0|||
145619895|NCT01155726|525123612|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
145619896|NCT01155726|525123613|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
145562431|NCT05760300|524918753|FG001|Overall Study|Participant Decision|0|||
145562432|NCT05760300|524918754|FG002|Overall Study|Participant Decision|0|||
145655520|NCT02105766|525257249|FG000|Overall Study|Death|1|||
145619897|NCT01155726|525123614|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
145294807|NCT02636907|523928923|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
145294808|NCT02636907|523928923|FG000|Extension Phase|Adverse Event|2|||
145294809|NCT02636907|523928923|FG000|Extension Phase|Withdrawal by Subject|4|||
145294810|NCT02636907|523928923|FG000|Extension Phase|Physician Decision|1|||
145294811|NCT02636907|523928923|FG000|Extension Phase|Lost to Follow-up|2|||
145294812|NCT02636907|523928923|FG000|Extension Phase|Lack of Efficacy|1|||
145294813|NCT04099888|523928924|FG000|Overall Study|Study terminated by sponsor|9|||
145294814|NCT04099888|523928925|FG001|Overall Study|Study terminated by sponsor|11|||
145294815|NCT04099888|523928924|FG000|Overall Study|Lost to Follow-up|1|||
145294816|NCT04099888|523928925|FG001|Overall Study|Lost to Follow-up|1|||
145294817|NCT04099888|523928924|FG000|Overall Study|Withdrawal by Subject|5|||
145294818|NCT04099888|523928925|FG001|Overall Study|Withdrawal by Subject|6|||
145294819|NCT04099888|523928924|FG000|Overall Study|Death|5|||
145294820|NCT04099888|523928925|FG001|Overall Study|Death|2|||
145294821|NCT04099888|523928924|FG000|Overall Study|Other|1|||
145294822|NCT04099888|523928925|FG001|Overall Study|Other|0|||
145294823|NCT01225146|523928930|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
145294824|NCT01225146|523928931|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
145294825|NCT03883906|523928934|FG000|Overall Study|Withdrawal by Subject|2|||
145294826|NCT03883906|523928934|FG000|Overall Study|Physician Decision|5|||
145294827|NCT02603952|523928937|FG000|Overall Study|Withdrawal by Subject|1|||
145408245|NCT03314935|524349851|FG005|Phase 2|Death|0|||
145294828|NCT02603952|523928938|FG001|Overall Study|Withdrawal by Subject|0|||
145294829|NCT02603952|523928939|FG002|Overall Study|Withdrawal by Subject|0|||
145294830|NCT02603952|523928940|FG003|Overall Study|Withdrawal by Subject|0|||
145294831|NCT02603952|523928937|FG000|Overall Study|Received oseltamivir by error|0|||
145294832|NCT02603952|523928938|FG001|Overall Study|Received oseltamivir by error|0|||
145562433|NCT05760300|524918755|FG003|Overall Study|Participant Decision|0|||
145562434|NCT03878446|524918756|FG000|Overall Study|Withdrawn by parent or guardian|1|||
145562435|NCT03878446|524918757|FG001|Overall Study|Withdrawn by parent or guardian|0|||
145562436|NCT03878446|524918758|FG002|Overall Study|Withdrawn by parent or guardian|0|||
145562437|NCT03878446|524918759|FG003|Overall Study|Withdrawn by parent or guardian|0|||
145562438|NCT03878446|524918760|FG004|Overall Study|Withdrawn by parent or guardian|0|||
145408246|NCT03314935|524349852|FG006|Phase 2|Death|0|||
145562439|NCT03615105|524918761|FG000|Overall Study|Protocol Violation|1|||
145562440|NCT03615105|524918762|FG001|Overall Study|Protocol Violation|0|||
145294833|NCT02603952|523928939|FG002|Overall Study|Received oseltamivir by error|0|||
145294834|NCT02603952|523928940|FG003|Overall Study|Received oseltamivir by error|1|||
145562441|NCT03615105|524918763|FG002|Overall Study|Protocol Violation|0|||
145562442|NCT03615105|524918761|FG000|Overall Study|Death|0|||
145562443|NCT03615105|524918762|FG001|Overall Study|Death|2|||
145562444|NCT03615105|524918763|FG002|Overall Study|Death|0|||
145562445|NCT03313804|524918764|FG000|Treatment|Death|5|||
145562446|NCT03313804|524918764|FG000|Treatment|still on treatment|2|||
145562447|NCT03313804|524918764|FG000|Follow Up|still on follow up|3|||
145294835|NCT01004172|523928942|FG000|Overall Study|Progressive Disease in CNS Only|16|||
145562448|NCT01502423|524918765|FG000|Overall Study|Withdrawal by Subject|0|||
145655521|NCT02105766|525257250|FG001|Overall Study|Death|1|||
145294836|NCT01004172|523928942|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
145294837|NCT01004172|523928942|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
145294838|NCT01004172|523928942|FG000|Overall Study|Adverse Event|1|||
145294839|NCT01004172|523928942|FG000|Overall Study|Physician Decision|1|||
145294840|NCT01004172|523928942|FG000|Overall Study|Symptomatic Deterioration|2|||
145294841|NCT01691248|523928948|FG000|Overall Study|Protocol Violation|43|||
145294842|NCT01691248|523928949|FG001|Overall Study|Protocol Violation|27|||
145294843|NCT01691248|523928948|FG000|Overall Study|Adverse Event|24|||
145294844|NCT01691248|523928949|FG001|Overall Study|Adverse Event|22|||
145408247|NCT03314935|524349853|FG007|Phase 2|Death|0|||
145408248|NCT03314935|524349854|FG008|Phase 2|Death|0|||
145408249|NCT03314935|524349855|FG009|Phase 2|Death|5|||
145408250|NCT03314935|524349856|FG010|Phase 2|Death|20|||
145231350|NCT02499575|523693164|FG000|Overall Study|Protocol Violation|0|||
145231351|NCT02499575|523693165|FG001|Overall Study|Protocol Violation|1|||
145231352|NCT00781963|523693170|FG000|Overall Study|Death|3|||
145231353|NCT00781963|523693171|FG001|Overall Study|Death|0|||
145231354|NCT00781963|523693170|FG000|Overall Study|Lost to Follow-up|2|||
145231355|NCT00781963|523693171|FG001|Overall Study|Lost to Follow-up|1|||
145231356|NCT00781963|523693170|FG000|Overall Study|Withdrawal by Subject|3|||
145231357|NCT00781963|523693171|FG001|Overall Study|Withdrawal by Subject|1|||
145294845|NCT01691248|523928948|FG000|Overall Study|Withdrawal by Subject|20|||
145294846|NCT01691248|523928949|FG001|Overall Study|Withdrawal by Subject|18|||
145294847|NCT01691248|523928948|FG000|Overall Study|Confirmed CDAD|14|||
145294848|NCT01691248|523928949|FG001|Overall Study|Confirmed CDAD|31|||
145294849|NCT01691248|523928948|FG000|Overall Study|Lost to Follow-up|2|||
145294850|NCT01691248|523928949|FG001|Overall Study|Lost to Follow-up|5|||
145294851|NCT01691248|523928948|FG000|Overall Study|Reason not provided|4|||
145294852|NCT01691248|523928949|FG001|Overall Study|Reason not provided|4|||
145231358|NCT00781963|523693170|FG000|Overall Study|Refused follow-up|9|||
145231359|NCT00781963|523693171|FG001|Overall Study|Refused follow-up|0|||
145231360|NCT03434418|523693172|FG000|Overall Study|Disease Progression|11|||
145231361|NCT03434418|523693172|FG000|Overall Study|Adverse Event|2|||
145231362|NCT03434418|523693172|FG000|Overall Study|Physician Decision|1|||
145231363|NCT03434418|523693172|FG000|Overall Study|Decline in Performance Status (PS)|1|||
145231364|NCT03039738|523693175|FG000|Overall Study|Incomplete data sets|54|||
145231365|NCT03039738|523693176|FG001|Overall Study|Incomplete data sets|0|||
145231366|NCT01517412|523693179|FG000|Overall Study|Adverse Event|10|||
145231367|NCT01517412|523693180|FG001|Overall Study|Adverse Event|11|||
145231368|NCT01517412|523693179|FG000|Overall Study|Lack of Efficacy|10|||
145231369|NCT01517412|523693180|FG001|Overall Study|Lack of Efficacy|5|||
145231370|NCT01517412|523693179|FG000|Overall Study|Poor compliance to protocol|8|||
145231371|NCT01517412|523693180|FG001|Overall Study|Poor compliance to protocol|3|||
145231372|NCT01517412|523693179|FG000|Overall Study|Other than specified above|8|||
145231373|NCT01517412|523693180|FG001|Overall Study|Other than specified above|5|||
145231374|NCT02062463|523693181|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
145231375|NCT02062463|523693182|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
145231376|NCT02062463|523693183|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
145231377|NCT02062463|523693184|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
145231378|NCT02062463|523693181|FG000|Stage 2|Adverse Event|0|||
145231379|NCT02062463|523693182|FG001|Stage 2|Adverse Event|0|||
145231380|NCT02062463|523693183|FG002|Stage 2|Adverse Event|12|||
145231381|NCT02062463|523693184|FG003|Stage 2|Adverse Event|20|||
145231382|NCT02062463|523693181|FG000|Stage 2|Lack of Efficacy|0|||
145231383|NCT02062463|523693182|FG001|Stage 2|Lack of Efficacy|0|||
145231384|NCT02062463|523693183|FG002|Stage 2|Lack of Efficacy|3|||
145231385|NCT02062463|523693184|FG003|Stage 2|Lack of Efficacy|4|||
145231386|NCT02062463|523693181|FG000|Stage 2|Lost to Follow-up|0|||
145231387|NCT02062463|523693182|FG001|Stage 2|Lost to Follow-up|0|||
145231388|NCT02062463|523693183|FG002|Stage 2|Lost to Follow-up|20|||
145231389|NCT02062463|523693184|FG003|Stage 2|Lost to Follow-up|20|||
145231390|NCT02062463|523693181|FG000|Stage 2|Non-Compliance|0|||
145231391|NCT02062463|523693182|FG001|Stage 2|Non-Compliance|0|||
145231392|NCT02062463|523693183|FG002|Stage 2|Non-Compliance|0|||
145231393|NCT02062463|523693184|FG003|Stage 2|Non-Compliance|1|||
145231394|NCT02062463|523693181|FG000|Stage 2|Other than specified|0|||
145231395|NCT02062463|523693182|FG001|Stage 2|Other than specified|0|||
145231396|NCT02062463|523693183|FG002|Stage 2|Other than specified|3|||
145231397|NCT02062463|523693184|FG003|Stage 2|Other than specified|1|||
145231398|NCT02062463|523693181|FG000|Stage 2|Withdrawal by Subject|0|||
145231399|NCT02062463|523693182|FG001|Stage 2|Withdrawal by Subject|0|||
145231400|NCT02062463|523693183|FG002|Stage 2|Withdrawal by Subject|15|||
145231401|NCT02062463|523693184|FG003|Stage 2|Withdrawal by Subject|10|||
145231402|NCT04124692|523693198|FG000|Overall Study|Medical reason|0|||
145231403|NCT04124692|523693199|FG001|Overall Study|Medical reason|1|||
145231404|NCT04124692|523693198|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
145231405|NCT04124692|523693199|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
145231406|NCT04124692|523693198|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
145231407|NCT04124692|523693199|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
145231408|NCT04124692|523693198|FG000|Overall Study|Lost to Follow-up|2|||
145231409|NCT04124692|523693199|FG001|Overall Study|Lost to Follow-up|4|||
145231410|NCT04124692|523693198|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
145231411|NCT04124692|523693199|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
145231412|NCT02716194|523693200|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
145231413|NCT02716194|523693201|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
145231414|NCT02716194|523693202|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
145231415|NCT00363051|523693206|FG000|Overall Study|Adminstrative problems|1|||
145231416|NCT00363051|523693207|FG001|Overall Study|Adminstrative problems|1|||
145231417|NCT00363051|523693206|FG000|Overall Study|Adverse Event|21|||
145231418|NCT00363051|523693207|FG001|Overall Study|Adverse Event|12|||
145231419|NCT00363051|523693206|FG000|Overall Study|New Cancer Therapy|2|||
145231420|NCT00363051|523693207|FG001|Overall Study|New Cancer Therapy|1|||
145231421|NCT00363051|523693206|FG000|Overall Study|Withdrawal by Subject|11|||
145231422|NCT00363051|523693207|FG001|Overall Study|Withdrawal by Subject|3|||
145231423|NCT00363051|523693206|FG000|Overall Study|Lost to Follow-up|0|||
145231424|NCT00363051|523693207|FG001|Overall Study|Lost to Follow-up|1|||
145231425|NCT00363051|523693206|FG000|Overall Study|Protocol Violation|0|||
145294853|NCT01691248|523928948|FG000|Overall Study|Not Treated|4|||
145231426|NCT00363051|523693207|FG001|Overall Study|Protocol Violation|2|||
145231427|NCT00363051|523693206|FG000|Overall Study|Death|3|||
145231428|NCT00363051|523693207|FG001|Overall Study|Death|2|||
145231429|NCT00830115|523693213|FG000|Overall Study|Adverse Event|2|||
145231430|NCT00830115|523693213|FG000|Overall Study|Improvement/recovery|1|||
145231431|NCT01925612|523693220|FG000|Overall Study|Progressive Disease|1|||
145231432|NCT01925612|523693221|FG001|Overall Study|Progressive Disease|1|||
145231433|NCT01925612|523693222|FG002|Overall Study|Progressive Disease|1|||
145231434|NCT01925612|523693223|FG003|Overall Study|Progressive Disease|0|||
145231435|NCT01925612|523693224|FG004|Overall Study|Progressive Disease|0|||
145231436|NCT01925612|523693220|FG000|Overall Study|Adverse Event|3|||
145231437|NCT01925612|523693221|FG001|Overall Study|Adverse Event|3|||
145231438|NCT01925612|523693222|FG002|Overall Study|Adverse Event|0|||
145231439|NCT01925612|523693223|FG003|Overall Study|Adverse Event|1|||
145231440|NCT01925612|523693224|FG004|Overall Study|Adverse Event|2|||
145231441|NCT01885078|523693225|FG000|Treatment Period|Adverse Event|52|||
145231442|NCT01885078|523693226|FG001|Treatment Period|Adverse Event|136|||
145231443|NCT01885078|523693227|FG002|Treatment Period|Adverse Event|30|||
145231444|NCT01885078|523693228|FG003|Treatment Period|Adverse Event|73|||
145231445|NCT01885078|523693229|FG004|Treatment Period|Adverse Event|17|||
145231446|NCT01885078|523693230|FG005|Treatment Period|Adverse Event|72|||
145231447|NCT01885078|523693231|FG006|Treatment Period|Adverse Event|24|||
145231448|NCT01885078|523693232|FG007|Treatment Period|Adverse Event|5|||
145231449|NCT01885078|523693233|FG008|Treatment Period|Adverse Event|0|||
145231450|NCT01885078|523693234|FG009|Treatment Period|Adverse Event|0|||
145231451|NCT01885078|523693225|FG000|Treatment Period|Death|13|||
145231452|NCT01885078|523693226|FG001|Treatment Period|Death|33|||
145231453|NCT01885078|523693227|FG002|Treatment Period|Death|5|||
145231454|NCT01885078|523693228|FG003|Treatment Period|Death|9|||
145231455|NCT01885078|523693229|FG004|Treatment Period|Death|2|||
145231456|NCT01885078|523693230|FG005|Treatment Period|Death|10|||
145231457|NCT01885078|523693231|FG006|Treatment Period|Death|3|||
145231458|NCT01885078|523693232|FG007|Treatment Period|Death|2|||
145231459|NCT01885078|523693233|FG008|Treatment Period|Death|0|||
145231460|NCT01885078|523693234|FG009|Treatment Period|Death|0|||
145231461|NCT01885078|523693225|FG000|Treatment Period|Lack of Efficacy|12|||
145231462|NCT01885078|523693226|FG001|Treatment Period|Lack of Efficacy|33|||
145231463|NCT01885078|523693227|FG002|Treatment Period|Lack of Efficacy|10|||
145231464|NCT01885078|523693228|FG003|Treatment Period|Lack of Efficacy|23|||
145231465|NCT01885078|523693229|FG004|Treatment Period|Lack of Efficacy|24|||
145231466|NCT01885078|523693230|FG005|Treatment Period|Lack of Efficacy|58|||
145231467|NCT01885078|523693231|FG006|Treatment Period|Lack of Efficacy|9|||
145231468|NCT01885078|523693232|FG007|Treatment Period|Lack of Efficacy|5|||
145231469|NCT01885078|523693233|FG008|Treatment Period|Lack of Efficacy|0|||
145231470|NCT01885078|523693234|FG009|Treatment Period|Lack of Efficacy|0|||
145231471|NCT01885078|523693225|FG000|Treatment Period|Lost to Follow-up|16|||
145231472|NCT01885078|523693226|FG001|Treatment Period|Lost to Follow-up|19|||
145562449|NCT01502423|524918766|FG001|Overall Study|Withdrawal by Subject|1|||
145562450|NCT02967692|524920027|FG000|Overall Study|Progressive disease|3|||
145562451|NCT02967692|524920028|FG001|Overall Study|Progressive disease|15|||
145562452|NCT02967692|524920029|FG002|Overall Study|Progressive disease|114|||
145562453|NCT02967692|524920030|FG003|Overall Study|Progressive disease|151|||
145562454|NCT02967692|524920027|FG000|Overall Study|Subject/guardian decision|1|||
145231473|NCT01885078|523693227|FG002|Treatment Period|Lost to Follow-up|7|||
145231474|NCT01885078|523693228|FG003|Treatment Period|Lost to Follow-up|9|||
145231475|NCT01885078|523693229|FG004|Treatment Period|Lost to Follow-up|2|||
145231476|NCT01885078|523693230|FG005|Treatment Period|Lost to Follow-up|8|||
145231477|NCT01885078|523693231|FG006|Treatment Period|Lost to Follow-up|2|||
145231478|NCT01885078|523693232|FG007|Treatment Period|Lost to Follow-up|0|||
145231479|NCT01885078|523693233|FG008|Treatment Period|Lost to Follow-up|0|||
145231480|NCT01885078|523693234|FG009|Treatment Period|Lost to Follow-up|0|||
145294854|NCT01691248|523928949|FG001|Overall Study|Not Treated|7|||
145231481|NCT01885078|523693225|FG000|Treatment Period|Physician Decision|19|||
145231482|NCT01885078|523693226|FG001|Treatment Period|Physician Decision|21|||
145231483|NCT01885078|523693227|FG002|Treatment Period|Physician Decision|5|||
145231484|NCT01885078|523693228|FG003|Treatment Period|Physician Decision|12|||
145231485|NCT01885078|523693229|FG004|Treatment Period|Physician Decision|9|||
145231486|NCT01885078|523693230|FG005|Treatment Period|Physician Decision|24|||
145231487|NCT01885078|523693231|FG006|Treatment Period|Physician Decision|4|||
145231488|NCT01885078|523693232|FG007|Treatment Period|Physician Decision|3|||
145231489|NCT01885078|523693233|FG008|Treatment Period|Physician Decision|0|||
145231490|NCT01885078|523693234|FG009|Treatment Period|Physician Decision|0|||
145231491|NCT01885078|523693225|FG000|Treatment Period|Protocol Violation|3|||
145231492|NCT01885078|523693226|FG001|Treatment Period|Protocol Violation|5|||
145231493|NCT01885078|523693227|FG002|Treatment Period|Protocol Violation|0|||
145231494|NCT01885078|523693228|FG003|Treatment Period|Protocol Violation|3|||
145231495|NCT01885078|523693229|FG004|Treatment Period|Protocol Violation|1|||
145231496|NCT01885078|523693230|FG005|Treatment Period|Protocol Violation|6|||
145231497|NCT01885078|523693231|FG006|Treatment Period|Protocol Violation|0|||
145562455|NCT02967692|524920028|FG001|Overall Study|Subject/guardian decision|1|||
145231498|NCT01885078|523693232|FG007|Treatment Period|Protocol Violation|0|||
145231499|NCT01885078|523693233|FG008|Treatment Period|Protocol Violation|0|||
145231500|NCT01885078|523693234|FG009|Treatment Period|Protocol Violation|0|||
145231501|NCT01885078|523693225|FG000|Treatment Period|Sponsor Decision|245|||
145231502|NCT01885078|523693226|FG001|Treatment Period|Sponsor Decision|648|||
145231503|NCT01885078|523693227|FG002|Treatment Period|Sponsor Decision|49|||
145231504|NCT01885078|523693228|FG003|Treatment Period|Sponsor Decision|90|||
145231505|NCT01885078|523693229|FG004|Treatment Period|Sponsor Decision|20|||
145231506|NCT01885078|523693230|FG005|Treatment Period|Sponsor Decision|38|||
145231507|NCT01885078|523693231|FG006|Treatment Period|Sponsor Decision|162|||
145231508|NCT01885078|523693232|FG007|Treatment Period|Sponsor Decision|3|||
145231509|NCT01885078|523693233|FG008|Treatment Period|Sponsor Decision|0|||
145231510|NCT01885078|523693234|FG009|Treatment Period|Sponsor Decision|0|||
145231511|NCT01885078|523693225|FG000|Treatment Period|Withdrawal by Subject|72|||
145231512|NCT01885078|523693226|FG001|Treatment Period|Withdrawal by Subject|132|||
145231513|NCT01885078|523693227|FG002|Treatment Period|Withdrawal by Subject|25|||
145231514|NCT01885078|523693228|FG003|Treatment Period|Withdrawal by Subject|63|||
145231515|NCT01885078|523693229|FG004|Treatment Period|Withdrawal by Subject|15|||
145231516|NCT01885078|523693230|FG005|Treatment Period|Withdrawal by Subject|34|||
145231517|NCT01885078|523693231|FG006|Treatment Period|Withdrawal by Subject|17|||
145231518|NCT01885078|523693232|FG007|Treatment Period|Withdrawal by Subject|10|||
145231519|NCT01885078|523693233|FG008|Treatment Period|Withdrawal by Subject|0|||
145231520|NCT01885078|523693234|FG009|Treatment Period|Withdrawal by Subject|0|||
145231521|NCT01885078|523693225|FG000|Treatment Period|Other|0|||
145231522|NCT01885078|523693226|FG001|Treatment Period|Other|0|||
145231523|NCT01885078|523693227|FG002|Treatment Period|Other|0|||
145231524|NCT01885078|523693228|FG003|Treatment Period|Other|1|||
145231525|NCT01885078|523693229|FG004|Treatment Period|Other|0|||
145231526|NCT01885078|523693230|FG005|Treatment Period|Other|0|||
145231527|NCT01885078|523693231|FG006|Treatment Period|Other|0|||
145231528|NCT01885078|523693232|FG007|Treatment Period|Other|0|||
145231529|NCT01885078|523693233|FG008|Treatment Period|Other|0|||
145231530|NCT01885078|523693234|FG009|Treatment Period|Other|0|||
145231531|NCT01885078|523693225|FG000|Step-down Period|Sponsor Decision|0|||
145231532|NCT01885078|523693226|FG001|Step-down Period|Sponsor Decision|0|||
145231533|NCT01885078|523693227|FG002|Step-down Period|Sponsor Decision|0|||
145231534|NCT01885078|523693228|FG003|Step-down Period|Sponsor Decision|0|||
145231535|NCT01885078|523693229|FG004|Step-down Period|Sponsor Decision|0|||
145231536|NCT01885078|523693230|FG005|Step-down Period|Sponsor Decision|0|||
145231537|NCT01885078|523693231|FG006|Step-down Period|Sponsor Decision|0|||
145231538|NCT01885078|523693232|FG007|Step-down Period|Sponsor Decision|0|||
145231539|NCT01885078|523693233|FG008|Step-down Period|Sponsor Decision|1|||
145231540|NCT01885078|523693234|FG009|Step-down Period|Sponsor Decision|1|||
145231541|NCT01885078|523693225|FG000|Step-down Period|Adverse Event|0|||
145231542|NCT01885078|523693226|FG001|Step-down Period|Adverse Event|0|||
145231543|NCT01885078|523693227|FG002|Step-down Period|Adverse Event|0|||
145231544|NCT01885078|523693228|FG003|Step-down Period|Adverse Event|0|||
145231545|NCT01885078|523693229|FG004|Step-down Period|Adverse Event|0|||
145231546|NCT01885078|523693230|FG005|Step-down Period|Adverse Event|0|||
145231547|NCT01885078|523693231|FG006|Step-down Period|Adverse Event|0|||
145231548|NCT01885078|523693232|FG007|Step-down Period|Adverse Event|0|||
145231549|NCT01885078|523693233|FG008|Step-down Period|Adverse Event|29|||
145231550|NCT01885078|523693234|FG009|Step-down Period|Adverse Event|38|||
145231551|NCT01885078|523693225|FG000|Step-down Period|Withdrawal by Subject|0|||
145231552|NCT01885078|523693226|FG001|Step-down Period|Withdrawal by Subject|0|||
145231553|NCT01885078|523693227|FG002|Step-down Period|Withdrawal by Subject|0|||
145231554|NCT01885078|523693228|FG003|Step-down Period|Withdrawal by Subject|0|||
145231555|NCT01885078|523693229|FG004|Step-down Period|Withdrawal by Subject|0|||
145231556|NCT01885078|523693230|FG005|Step-down Period|Withdrawal by Subject|0|||
145231557|NCT01885078|523693231|FG006|Step-down Period|Withdrawal by Subject|0|||
145231558|NCT01885078|523693232|FG007|Step-down Period|Withdrawal by Subject|0|||
145231559|NCT01885078|523693233|FG008|Step-down Period|Withdrawal by Subject|25|||
145408251|NCT03314935|524349857|FG011|Phase 2|Death|6|||
145231560|NCT01885078|523693234|FG009|Step-down Period|Withdrawal by Subject|15|||
145231561|NCT01885078|523693225|FG000|Step-down Period|Physician Decision|0|||
145231562|NCT01885078|523693226|FG001|Step-down Period|Physician Decision|0|||
145231563|NCT01885078|523693227|FG002|Step-down Period|Physician Decision|0|||
145231564|NCT01885078|523693228|FG003|Step-down Period|Physician Decision|0|||
145231565|NCT01885078|523693229|FG004|Step-down Period|Physician Decision|0|||
145231566|NCT01885078|523693230|FG005|Step-down Period|Physician Decision|0|||
145231567|NCT01885078|523693231|FG006|Step-down Period|Physician Decision|0|||
145231568|NCT01885078|523693232|FG007|Step-down Period|Physician Decision|0|||
145231569|NCT01885078|523693233|FG008|Step-down Period|Physician Decision|7|||
145231570|NCT01885078|523693234|FG009|Step-down Period|Physician Decision|2|||
145231571|NCT01885078|523693225|FG000|Step-down Period|Death|0|||
145231572|NCT01885078|523693226|FG001|Step-down Period|Death|0|||
145231573|NCT01885078|523693227|FG002|Step-down Period|Death|0|||
145231574|NCT01885078|523693228|FG003|Step-down Period|Death|0|||
145231575|NCT01885078|523693229|FG004|Step-down Period|Death|0|||
145231576|NCT01885078|523693230|FG005|Step-down Period|Death|0|||
145231577|NCT01885078|523693231|FG006|Step-down Period|Death|0|||
145231578|NCT01885078|523693232|FG007|Step-down Period|Death|0|||
145231579|NCT01885078|523693233|FG008|Step-down Period|Death|4|||
145231580|NCT01885078|523693234|FG009|Step-down Period|Death|3|||
145231581|NCT01885078|523693225|FG000|Step-down Period|Lost to Follow-up|0|||
145231582|NCT01885078|523693226|FG001|Step-down Period|Lost to Follow-up|0|||
145231583|NCT01885078|523693227|FG002|Step-down Period|Lost to Follow-up|0|||
145231584|NCT01885078|523693228|FG003|Step-down Period|Lost to Follow-up|0|||
145231585|NCT01885078|523693229|FG004|Step-down Period|Lost to Follow-up|0|||
145231586|NCT01885078|523693230|FG005|Step-down Period|Lost to Follow-up|0|||
145231587|NCT01885078|523693231|FG006|Step-down Period|Lost to Follow-up|0|||
145231588|NCT01885078|523693232|FG007|Step-down Period|Lost to Follow-up|0|||
145231589|NCT01885078|523693233|FG008|Step-down Period|Lost to Follow-up|1|||
145231590|NCT01885078|523693234|FG009|Step-down Period|Lost to Follow-up|1|||
145231591|NCT01885078|523693225|FG000|Step-down Period|Lack of Efficacy|0|||
145231592|NCT01885078|523693226|FG001|Step-down Period|Lack of Efficacy|0|||
145231593|NCT01885078|523693227|FG002|Step-down Period|Lack of Efficacy|0|||
145231594|NCT01885078|523693228|FG003|Step-down Period|Lack of Efficacy|0|||
145231595|NCT01885078|523693229|FG004|Step-down Period|Lack of Efficacy|0|||
145231596|NCT01885078|523693230|FG005|Step-down Period|Lack of Efficacy|0|||
145231597|NCT01885078|523693231|FG006|Step-down Period|Lack of Efficacy|0|||
145231598|NCT01885078|523693232|FG007|Step-down Period|Lack of Efficacy|0|||
145231599|NCT01885078|523693233|FG008|Step-down Period|Lack of Efficacy|1|||
145231600|NCT01885078|523693234|FG009|Step-down Period|Lack of Efficacy|0|||
145231601|NCT01885078|523693225|FG000|Step-down Period|Protocol Violation|0|||
145231602|NCT01885078|523693226|FG001|Step-down Period|Protocol Violation|0|||
145231603|NCT01885078|523693227|FG002|Step-down Period|Protocol Violation|0|||
145231604|NCT01885078|523693228|FG003|Step-down Period|Protocol Violation|0|||
145231605|NCT01885078|523693229|FG004|Step-down Period|Protocol Violation|0|||
145231606|NCT01885078|523693230|FG005|Step-down Period|Protocol Violation|0|||
145231607|NCT01885078|523693231|FG006|Step-down Period|Protocol Violation|0|||
145231608|NCT01885078|523693232|FG007|Step-down Period|Protocol Violation|0|||
145231609|NCT01885078|523693233|FG008|Step-down Period|Protocol Violation|1|||
145231610|NCT01885078|523693234|FG009|Step-down Period|Protocol Violation|1|||
145231611|NCT04321252|523693235|FG000|Overall Study|Withdrawal by Subject|0|||
145231612|NCT04321252|523693236|FG001|Overall Study|Withdrawal by Subject|0|||
145231613|NCT04321252|523693237|FG002|Overall Study|Withdrawal by Subject|0|||
145231614|NCT04321252|523693238|FG003|Overall Study|Withdrawal by Subject|0|||
145231615|NCT04321252|523693239|FG004|Overall Study|Withdrawal by Subject|0|||
145231616|NCT04321252|523693240|FG005|Overall Study|Withdrawal by Subject|1|||
145231617|NCT04321252|523693241|FG006|Overall Study|Withdrawal by Subject|0|||
145231618|NCT04321252|523693242|FG007|Overall Study|Withdrawal by Subject|0|||
145231619|NCT04321252|523693243|FG008|Overall Study|Withdrawal by Subject|0|||
145231620|NCT01844830|523693246|FG000|Overall Study|Withdrawal by Subject|1|||
145231621|NCT01844830|523693247|FG001|Overall Study|Withdrawal by Subject|0|||
145231622|NCT03150095|523693261|FG000|Overall Study|Death|0|||
145231623|NCT03150095|523693262|FG001|Overall Study|Death|1|||
145231624|NCT03150095|523693261|FG000|Overall Study|Lost to Follow-up|1|||
145231625|NCT03150095|523693262|FG001|Overall Study|Lost to Follow-up|1|||
145231626|NCT03150095|523693261|FG000|Overall Study|Withdrawal by Subject|4|||
145231627|NCT03150095|523693262|FG001|Overall Study|Withdrawal by Subject|0|||
145231628|NCT03150095|523693261|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
145231629|NCT03150095|523693262|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
145231630|NCT01153893|523693267|FG000|Overall Study|Adverse Event|1|||
145231631|NCT01153893|523693268|FG001|Overall Study|Adverse Event|0|||
145231632|NCT01354431|523693269|FG000|Pre-Treatment Period|Not reported|1|||
145231633|NCT01354431|523693270|FG001|Pre-Treatment Period|Not reported|0|||
145231634|NCT01354431|523693271|FG002|Pre-Treatment Period|Not reported|0|||
145562456|NCT02967692|524920029|FG002|Overall Study|Subject/guardian decision|14|||
145562457|NCT02967692|524920030|FG003|Overall Study|Subject/guardian decision|22|||
145231635|NCT01354431|523693269|FG000|Treatment Period|Disease Progression|50|||
145231636|NCT01354431|523693270|FG001|Treatment Period|Disease Progression|40|||
145231637|NCT01354431|523693271|FG002|Treatment Period|Disease Progression|44|||
145231638|NCT01354431|523693269|FG000|Treatment Period|Study Drug Toxicity|5|||
145231639|NCT01354431|523693270|FG001|Treatment Period|Study Drug Toxicity|8|||
145231640|NCT01354431|523693271|FG002|Treatment Period|Study Drug Toxicity|4|||
145231641|NCT01354431|523693269|FG000|Treatment Period|Death|0|||
145231642|NCT01354431|523693270|FG001|Treatment Period|Death|1|||
145231643|NCT01354431|523693271|FG002|Treatment Period|Death|0|||
145231644|NCT01354431|523693269|FG000|Treatment Period|AE unrelated to study drug|1|||
145231645|NCT01354431|523693270|FG001|Treatment Period|AE unrelated to study drug|2|||
145231646|NCT01354431|523693271|FG002|Treatment Period|AE unrelated to study drug|5|||
145231647|NCT01354431|523693269|FG000|Treatment Period|Participant request to discontinue|2|||
145231648|NCT01354431|523693270|FG001|Treatment Period|Participant request to discontinue|2|||
145231649|NCT01354431|523693271|FG002|Treatment Period|Participant request to discontinue|1|||
145231650|NCT01354431|523693269|FG000|Treatment Period|Participant withdrew consent|0|||
145562458|NCT02967692|524920027|FG000|Overall Study|Death|0|||
145231651|NCT01354431|523693270|FG001|Treatment Period|Participant withdrew consent|1|||
145231652|NCT01354431|523693271|FG002|Treatment Period|Participant withdrew consent|0|||
145231653|NCT01354431|523693269|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
145231654|NCT01354431|523693270|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
145231655|NCT01354431|523693271|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
145231656|NCT01551758|523693276|FG000|Overall Study|Adverse Event|29|||
145231657|NCT01551758|523693277|FG001|Overall Study|Adverse Event|43|||
145231658|NCT01551758|523693276|FG000|Overall Study|Lack of Efficacy|0|||
145231659|NCT01551758|523693277|FG001|Overall Study|Lack of Efficacy|1|||
145231660|NCT01551758|523693276|FG000|Overall Study|Protocol Violation|5|||
145231661|NCT01551758|523693277|FG001|Overall Study|Protocol Violation|6|||
145231662|NCT01551758|523693276|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
145562459|NCT02967692|524920028|FG001|Overall Study|Death|1|||
145562460|NCT02967692|524920029|FG002|Overall Study|Death|13|||
145231663|NCT01551758|523693277|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
145231664|NCT01551758|523693276|FG000|Overall Study|Lost to Follow-up|29|||
145231665|NCT01551758|523693277|FG001|Overall Study|Lost to Follow-up|25|||
145231666|NCT01551758|523693276|FG000|Overall Study|Physician Decision|9|||
145231667|NCT01551758|523693277|FG001|Overall Study|Physician Decision|3|||
145231668|NCT01551758|523693276|FG000|Overall Study|Withdrawal by Subject|14|||
145231669|NCT01551758|523693277|FG001|Overall Study|Withdrawal by Subject|17|||
145231670|NCT02128763|523693278|FG000|Overall Study|Death|1|||
145231671|NCT02128763|523693279|FG001|Overall Study|Death|0|||
145231672|NCT02128763|523693278|FG000|Overall Study|Lost to Follow-up|19|||
145231673|NCT02128763|523693279|FG001|Overall Study|Lost to Follow-up|16|||
145231674|NCT00916370|523693280|FG000|Overall Study|Death|3|||
145231675|NCT00916370|523693281|FG001|Overall Study|Death|1|||
145231676|NCT00916370|523693280|FG000|Overall Study|Withdrawal by Subject|2|||
145231677|NCT00916370|523693281|FG001|Overall Study|Withdrawal by Subject|0|||
145231678|NCT00916370|523693280|FG000|Overall Study|Physician Decision|0|||
145231679|NCT00916370|523693281|FG001|Overall Study|Physician Decision|1|||
145231680|NCT02921919|523693282|FG000|Overall Study|Other|5|||
145231681|NCT02921919|523693283|FG001|Overall Study|Other|6|||
145231682|NCT02921919|523693282|FG000|Overall Study|Lost to Follow-up|0|||
145231683|NCT02921919|523693283|FG001|Overall Study|Lost to Follow-up|1|||
145231684|NCT02921919|523693282|FG000|Overall Study|Withdrawal by Subject|5|||
145231685|NCT02921919|523693283|FG001|Overall Study|Withdrawal by Subject|1|||
145231686|NCT02921919|523693282|FG000|Overall Study|Disease Progression|47|||
145231687|NCT02921919|523693283|FG001|Overall Study|Disease Progression|38|||
145231688|NCT02921919|523693282|FG000|Overall Study|Physician Decision|3|||
145231689|NCT02921919|523693283|FG001|Overall Study|Physician Decision|2|||
145231690|NCT02921919|523693282|FG000|Overall Study|Adverse Event|6|||
145231691|NCT02921919|523693283|FG001|Overall Study|Adverse Event|4|||
145231692|NCT03666858|523693285|FG000|Cohort 1|Adverse Event|1|||
145231693|NCT03666858|523693286|FG001|Cohort 1|Adverse Event|0|||
145231694|NCT03666858|523693285|FG000|Cohort 2|Adverse Event|0|||
145231695|NCT03666858|523693286|FG001|Cohort 2|Adverse Event|1|||
145231696|NCT00980980|523693287|FG000|Overall Study|Withdrawal by Hospital|0|||
145231697|NCT00980980|523693288|FG001|Overall Study|Withdrawal by Hospital|1|||
145231698|NCT00980980|523693289|FG002|Overall Study|Withdrawal by Hospital|0|||
145231699|NCT00121992|523693290|FG000|Overall Study|Treatment not received|2|||
145231700|NCT00121992|523693291|FG001|Overall Study|Treatment not received|11|||
145231701|NCT00363246|523693292|FG000|Overall Study|Death|40|||
145231702|NCT00363246|523693292|FG000|Overall Study|Withdrawal by Subject|19|||
145231703|NCT00363246|523693292|FG000|Overall Study|Lost to Follow-up|14|||
145231704|NCT00363246|523693292|FG000|Overall Study|Bad health|6|||
145231705|NCT00363246|523693292|FG000|Overall Study|Stopped using wheelchair|11|||
145231706|NCT00363246|523693292|FG000|Overall Study|Subject expressed security concerns|2|||
145231707|NCT00363246|523693292|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
145294855|NCT02863575|523928950|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
145562461|NCT02967692|524920030|FG003|Overall Study|Death|13|||
145562462|NCT02967692|524920027|FG000|Overall Study|Protocol deviation|1|||
145562463|NCT02967692|524920028|FG001|Overall Study|Protocol deviation|0|||
145231708|NCT01608724|523693293|FG000|Overall Study|Withdrawal by Subject|131|||
145231709|NCT01608724|523693293|FG000|Overall Study|Lost to Follow-up|41|||
145231710|NCT01608724|523693293|FG000|Overall Study|Study-specific discontinuation criteria|32|||
145231711|NCT01608724|523693293|FG000|Overall Study|Adverse Event|29|||
145231712|NCT01608724|523693293|FG000|Overall Study|Protocol Violation|6|||
145231713|NCT01608724|523693293|FG000|Overall Study|bood sugar too high, etc.|3|||
145231714|NCT01608724|523693293|FG000|Overall Study|Safety reasons|1|||
145231715|NCT03730194|523693296|FG000|First Stage Treatment|Withdrawal by Subject|1|||
145231716|NCT03730194|523693297|FG001|First Stage Treatment|Withdrawal by Subject|1|||
145231717|NCT03730194|523693298|FG002|First Stage Treatment|Withdrawal by Subject|0|||
145231718|NCT03730194|523693299|FG003|First Stage Treatment|Withdrawal by Subject|0|||
145231719|NCT03730194|523693300|FG004|First Stage Treatment|Withdrawal by Subject|0|||
145231720|NCT03730194|523693301|FG005|First Stage Treatment|Withdrawal by Subject|0|||
145562464|NCT02967692|524920029|FG002|Overall Study|Protocol deviation|1|||
145562465|NCT02967692|524920030|FG003|Overall Study|Protocol deviation|1|||
145231721|NCT03730194|523693296|FG000|First Stage Treatment|Protocol Violation|3|||
145231722|NCT03730194|523693297|FG001|First Stage Treatment|Protocol Violation|3|||
145231723|NCT03730194|523693298|FG002|First Stage Treatment|Protocol Violation|0|||
145231724|NCT03730194|523693299|FG003|First Stage Treatment|Protocol Violation|0|||
145231725|NCT03730194|523693300|FG004|First Stage Treatment|Protocol Violation|0|||
145231726|NCT03730194|523693301|FG005|First Stage Treatment|Protocol Violation|0|||
145408252|NCT03314935|524349858|FG012|Phase 2|Death|7|||
145408253|NCT03314935|524349859|FG013|Phase 2|Death|6|||
145408254|NCT03314935|524349860|FG014|Phase 2|Death|17|||
145408255|NCT03314935|524349846|FG000|Phase 2|Withdrawal by Subject|0|||
145408256|NCT03314935|524349847|FG001|Phase 2|Withdrawal by Subject|0|||
145408257|NCT03314935|524349848|FG002|Phase 2|Withdrawal by Subject|0|||
145408258|NCT03314935|524349849|FG003|Phase 2|Withdrawal by Subject|0|||
145408259|NCT03314935|524349850|FG004|Phase 2|Withdrawal by Subject|0|||
145408260|NCT03314935|524349851|FG005|Phase 2|Withdrawal by Subject|0|||
145408261|NCT03314935|524349852|FG006|Phase 2|Withdrawal by Subject|0|||
145408262|NCT03314935|524349853|FG007|Phase 2|Withdrawal by Subject|0|||
145408263|NCT03314935|524349854|FG008|Phase 2|Withdrawal by Subject|0|||
145408264|NCT03314935|524349855|FG009|Phase 2|Withdrawal by Subject|1|||
145408265|NCT03314935|524349856|FG010|Phase 2|Withdrawal by Subject|4|||
145408266|NCT03314935|524349857|FG011|Phase 2|Withdrawal by Subject|0|||
145408267|NCT03314935|524349858|FG012|Phase 2|Withdrawal by Subject|1|||
145408268|NCT03314935|524349859|FG013|Phase 2|Withdrawal by Subject|0|||
145408269|NCT03314935|524349860|FG014|Phase 2|Withdrawal by Subject|1|||
145408270|NCT03314935|524349846|FG000|Phase 2|Progressive Disease|0|||
145408271|NCT03314935|524349847|FG001|Phase 2|Progressive Disease|0|||
145408272|NCT03314935|524349848|FG002|Phase 2|Progressive Disease|0|||
145408273|NCT03314935|524349849|FG003|Phase 2|Progressive Disease|0|||
145408274|NCT03314935|524349850|FG004|Phase 2|Progressive Disease|0|||
145408275|NCT03314935|524349851|FG005|Phase 2|Progressive Disease|0|||
145408276|NCT03314935|524349852|FG006|Phase 2|Progressive Disease|0|||
145408277|NCT03314935|524349853|FG007|Phase 2|Progressive Disease|0|||
145408278|NCT03314935|524349854|FG008|Phase 2|Progressive Disease|0|||
145408279|NCT03314935|524349855|FG009|Phase 2|Progressive Disease|1|||
145408280|NCT03314935|524349856|FG010|Phase 2|Progressive Disease|1|||
145408281|NCT03314935|524349857|FG011|Phase 2|Progressive Disease|1|||
145408282|NCT03314935|524349858|FG012|Phase 2|Progressive Disease|2|||
145408283|NCT03314935|524349859|FG013|Phase 2|Progressive Disease|0|||
145408284|NCT03314935|524349860|FG014|Phase 2|Progressive Disease|1|||
145408285|NCT03314935|524349846|FG000|Phase 2|Study Terminated by Sponsor|0|||
145408286|NCT03314935|524349847|FG001|Phase 2|Study Terminated by Sponsor|0|||
145408287|NCT03314935|524349848|FG002|Phase 2|Study Terminated by Sponsor|0|||
145408288|NCT03314935|524349849|FG003|Phase 2|Study Terminated by Sponsor|0|||
145408289|NCT03314935|524349850|FG004|Phase 2|Study Terminated by Sponsor|0|||
145408290|NCT03314935|524349851|FG005|Phase 2|Study Terminated by Sponsor|0|||
145408291|NCT03314935|524349852|FG006|Phase 2|Study Terminated by Sponsor|0|||
145408292|NCT03314935|524349853|FG007|Phase 2|Study Terminated by Sponsor|0|||
145408293|NCT03314935|524349854|FG008|Phase 2|Study Terminated by Sponsor|0|||
145408294|NCT03314935|524349855|FG009|Phase 2|Study Terminated by Sponsor|0|||
145408295|NCT03314935|524349856|FG010|Phase 2|Study Terminated by Sponsor|7|||
145408296|NCT03314935|524349857|FG011|Phase 2|Study Terminated by Sponsor|2|||
145408297|NCT03314935|524349858|FG012|Phase 2|Study Terminated by Sponsor|1|||
145408298|NCT03314935|524349859|FG013|Phase 2|Study Terminated by Sponsor|4|||
145408299|NCT03314935|524349860|FG014|Phase 2|Study Terminated by Sponsor|4|||
145408300|NCT03314935|524349846|FG000|Phase 2|Lost to Follow-up|0|||
145408301|NCT03314935|524349847|FG001|Phase 2|Lost to Follow-up|0|||
145619898|NCT01155726|525123615|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
145231779|NCT01255306|523695039|FG000|Overall Study|Physician Decision|1|||
145231780|NCT01255306|523695040|FG001|Overall Study|Physician Decision|1|||
145231781|NCT01179347|523695041|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
145231782|NCT01179347|523695042|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
145231783|NCT01179347|523695041|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
145231784|NCT01179347|523695042|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
145231785|NCT01179347|523695041|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
145231786|NCT01179347|523695042|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
145231787|NCT01179347|523695041|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
145231788|NCT01179347|523695042|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
145231789|NCT01179347|523695041|FG000|Double-blind Period (12 Weeks)|Other|2|||
145231790|NCT01179347|523695042|FG001|Double-blind Period (12 Weeks)|Other|4|||
145231791|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
145231792|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
145231793|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
145231794|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
145231795|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
145231796|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
145231797|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
145231798|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
145231799|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
145231800|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
145231801|NCT01179347|523695041|FG000|Open-label Period (12 Weeks)|Other|7|||
145231802|NCT01179347|523695042|FG001|Open-label Period (12 Weeks)|Other|4|||
145231803|NCT01337167|523695043|FG000|Infant Series|Adverse Event|1|||
145231804|NCT01337167|523695044|FG001|Infant Series|Adverse Event|1|||
145231805|NCT01337167|523695043|FG000|Infant Series|Death|1|||
145231806|NCT01337167|523695044|FG001|Infant Series|Death|1|||
145231807|NCT01337167|523695043|FG000|Infant Series|Lost to Follow-up|13|||
145231808|NCT01337167|523695044|FG001|Infant Series|Lost to Follow-up|7|||
145231809|NCT01337167|523695043|FG000|Infant Series|Non-compliance with study drug|2|||
145619899|NCT02892409|525123616|FG000|Overall Study|Adverse Event|1|||
145231810|NCT01337167|523695044|FG001|Infant Series|Non-compliance with study drug|1|||
145231811|NCT01337167|523695043|FG000|Infant Series|Physician Decision|3|||
145231812|NCT01337167|523695044|FG001|Infant Series|Physician Decision|1|||
145231813|NCT01337167|523695043|FG000|Infant Series|Protocol Violation|22|||
145231814|NCT01337167|523695044|FG001|Infant Series|Protocol Violation|9|||
145231815|NCT01337167|523695043|FG000|Infant Series|Withdrawal by Subject|15|||
145231816|NCT01337167|523695044|FG001|Infant Series|Withdrawal by Subject|4|||
145231817|NCT01337167|523695043|FG000|Infant Series|Randomized but not vaccinated|5|||
145231818|NCT01337167|523695044|FG001|Infant Series|Randomized but not vaccinated|3|||
145231819|NCT01337167|523695043|FG000|Interim Period|Lost to Follow-up|51|||
145231820|NCT01337167|523695044|FG001|Interim Period|Lost to Follow-up|23|||
145231821|NCT01337167|523695043|FG000|Interim Period|Non-compliance with study drug|1|||
145231822|NCT01337167|523695044|FG001|Interim Period|Non-compliance with study drug|0|||
145231823|NCT01337167|523695043|FG000|Interim Period|Physician Decision|6|||
145231824|NCT01337167|523695044|FG001|Interim Period|Physician Decision|3|||
145231825|NCT01337167|523695043|FG000|Interim Period|Protocol Violation|5|||
145231826|NCT01337167|523695044|FG001|Interim Period|Protocol Violation|3|||
145231827|NCT01337167|523695043|FG000|Interim Period|Withdrawal by Subject|18|||
145231828|NCT01337167|523695044|FG001|Interim Period|Withdrawal by Subject|10|||
145231829|NCT01337167|523695043|FG000|Interim Period|Other protocol criterion not met|0|||
145231830|NCT01337167|523695044|FG001|Interim Period|Other protocol criterion not met|1|||
145231831|NCT01337167|523695043|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
145231832|NCT01337167|523695044|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
145231833|NCT01337167|523695043|FG000|Toddler Vaccinations|Protocol Violation|0|||
145231834|NCT01337167|523695044|FG001|Toddler Vaccinations|Protocol Violation|1|||
145231835|NCT01337167|523695043|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
145231836|NCT01337167|523695044|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
145231837|NCT03363919|523695047|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
145231838|NCT03363919|523695048|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
145231839|NCT03363919|523695047|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
145231840|NCT03363919|523695048|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
145231841|NCT01646398|523695049|FG000|Overall Study|Withdrawal by Subject|1|||
145231842|NCT01646398|523695050|FG001|Overall Study|Withdrawal by Subject|0|||
145231843|NCT01827319|523695051|FG000|Overall Study|Lost to Follow-up|3|||
145231844|NCT00571519|523695052|FG000|Overall Study|Subject withdrew consent|0|||
145231845|NCT00571519|523695053|FG001|Overall Study|Subject withdrew consent|1|||
145231846|NCT00571519|523695054|FG002|Overall Study|Subject withdrew consent|0|||
145231847|NCT00571519|523695055|FG003|Overall Study|Subject withdrew consent|2|||
145231848|NCT00571519|523695056|FG004|Overall Study|Subject withdrew consent|1|||
145231849|NCT00571519|523695057|FG005|Overall Study|Subject withdrew consent|1|||
145231850|NCT00571519|523695058|FG006|Overall Study|Subject withdrew consent|2|||
145231851|NCT00571519|523695052|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
145231852|NCT00571519|523695053|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
145231853|NCT00571519|523695054|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
145231854|NCT00571519|523695055|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
145231855|NCT00571519|523695056|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
145231856|NCT00571519|523695057|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
145231857|NCT00571519|523695058|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
145231858|NCT00571519|523695052|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231859|NCT00571519|523695053|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
145231860|NCT00571519|523695054|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231861|NCT00571519|523695055|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231862|NCT00571519|523695056|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231863|NCT00571519|523695057|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231864|NCT00571519|523695058|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
145231865|NCT00571519|523695052|FG000|Overall Study|Termination of study by Sponsor|2|||
145231866|NCT00571519|523695053|FG001|Overall Study|Termination of study by Sponsor|7|||
145231867|NCT00571519|523695054|FG002|Overall Study|Termination of study by Sponsor|10|||
145231868|NCT00571519|523695055|FG003|Overall Study|Termination of study by Sponsor|24|||
145231869|NCT00571519|523695056|FG004|Overall Study|Termination of study by Sponsor|8|||
145231870|NCT00571519|523695057|FG005|Overall Study|Termination of study by Sponsor|9|||
145231871|NCT00571519|523695058|FG006|Overall Study|Termination of study by Sponsor|22|||
145231872|NCT00571519|523695052|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145231873|NCT00571519|523695053|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145231874|NCT00571519|523695054|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
145231875|NCT00571519|523695055|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145231876|NCT00571519|523695056|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145231877|NCT00571519|523695057|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145231878|NCT00571519|523695058|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
145562466|NCT02967692|524920027|FG000|Overall Study|Lost to Follow-up|0|||
145562467|NCT02967692|524920028|FG001|Overall Study|Lost to Follow-up|0|||
145562468|NCT02967692|524920029|FG002|Overall Study|Lost to Follow-up|1|||
145562469|NCT02967692|524920030|FG003|Overall Study|Lost to Follow-up|0|||
145562470|NCT02967692|524920027|FG000|Overall Study|Physician Decision|0|||
145562471|NCT02967692|524920028|FG001|Overall Study|Physician Decision|0|||
145562472|NCT02967692|524920029|FG002|Overall Study|Physician Decision|22|||
145562473|NCT02967692|524920030|FG003|Overall Study|Physician Decision|13|||
145562474|NCT02967692|524920027|FG000|Overall Study|Adverse Event|2|||
145231879|NCT03947255|523695060|FG000|Overall Study|Study Closure by Sponsor|2|||
145231880|NCT03947255|523695061|FG001|Overall Study|Study Closure by Sponsor|2|||
145562475|NCT02967692|524920028|FG001|Overall Study|Adverse Event|9|||
145562476|NCT02967692|524920029|FG002|Overall Study|Adverse Event|60|||
145231881|NCT03947255|523695060|FG000|Overall Study|Withdrawal by Subject|2|||
145231882|NCT03947255|523695061|FG001|Overall Study|Withdrawal by Subject|2|||
145231883|NCT03947255|523695060|FG000|Overall Study|Lost to Follow-up|2|||
145231884|NCT03947255|523695061|FG001|Overall Study|Lost to Follow-up|0|||
145231885|NCT03947255|523695060|FG000|Overall Study|Death|0|||
145231886|NCT03947255|523695061|FG001|Overall Study|Death|2|||
145231887|NCT00574119|523695062|FG000|Overall Study|Adverse Event|1|||
145231888|NCT00574119|523695062|FG000|Overall Study|Protocol Violation|1|||
145231889|NCT00574119|523695062|FG000|Overall Study|Withdrawal by Subject|1|||
145231890|NCT00574119|523695062|FG000|Overall Study|Physician Decision|1|||
145231891|NCT04656418|523695068|FG000|Overall Study|Withdrawal by Subject|1|||
145231892|NCT04656418|523695069|FG001|Overall Study|Withdrawal by Subject|3|||
145231893|NCT02586077|523695070|FG000|Overall Study|Withdrawal by Subject|1|||
145231894|NCT02586077|523695070|FG000|Overall Study|Physician Decision|4|||
145231895|NCT02586077|523695070|FG000|Overall Study|Lost to Follow-up|3|||
145231896|NCT01245764|523695071|FG000|Study Phase A|Other|3|||
145231897|NCT01245764|523695072|FG001|Study Phase A|Other|2|||
145231898|NCT01245764|523695073|FG002|Study Phase A|Other|3|||
145231899|NCT01245764|523695074|FG003|Study Phase A|Other|1|||
145231900|NCT01245764|523695071|FG000|Study Phase A|Protocol Violation|6|||
145231901|NCT01245764|523695072|FG001|Study Phase A|Protocol Violation|3|||
145231902|NCT01245764|523695073|FG002|Study Phase A|Protocol Violation|2|||
145231903|NCT01245764|523695074|FG003|Study Phase A|Protocol Violation|2|||
145231904|NCT01245764|523695071|FG000|Study Phase A|Lost to Follow-up|0|||
145231905|NCT01245764|523695072|FG001|Study Phase A|Lost to Follow-up|0|||
145231906|NCT01245764|523695073|FG002|Study Phase A|Lost to Follow-up|5|||
145231907|NCT01245764|523695074|FG003|Study Phase A|Lost to Follow-up|0|||
145231908|NCT00003476|523695075|FG000|Overall Study|Not evaluable|1|||
145231909|NCT02475850|523695076|FG000|Overall Study|Death|155|||
145231910|NCT02475850|523695077|FG001|Overall Study|Death|141|||
145231911|NCT02475850|523695076|FG000|Overall Study|Lost to Follow-up|217|||
145231912|NCT02475850|523695077|FG001|Overall Study|Lost to Follow-up|188|||
145231913|NCT02475850|523695076|FG000|Overall Study|Withdrawal by Subject|221|||
145231914|NCT02475850|523695077|FG001|Overall Study|Withdrawal by Subject|155|||
145231915|NCT03297216|523695082|FG000|Overall Study|Death|0|||
145231916|NCT03297216|523695083|FG001|Overall Study|Death|1|||
145231917|NCT03297216|523695082|FG000|Overall Study|Miscarriage|0|||
145231918|NCT03297216|523695083|FG001|Overall Study|Miscarriage|2|||
145231919|NCT03297216|523695082|FG000|Overall Study|Lost to Follow-up|3|||
145231920|NCT03297216|523695083|FG001|Overall Study|Lost to Follow-up|2|||
145231921|NCT00696436|523695087|FG000|Overall Study|Adverse Event|7|||
145231922|NCT00696436|523695088|FG001|Overall Study|Adverse Event|9|||
145231923|NCT00696436|523695089|FG002|Overall Study|Adverse Event|8|||
145231924|NCT00696436|523695090|FG003|Overall Study|Adverse Event|6|||
145231925|NCT00696436|523695091|FG004|Overall Study|Adverse Event|4|||
145231926|NCT00696436|523695087|FG000|Overall Study|Protocol Violation|3|||
145231927|NCT00696436|523695088|FG001|Overall Study|Protocol Violation|2|||
145231928|NCT00696436|523695089|FG002|Overall Study|Protocol Violation|2|||
145231929|NCT00696436|523695090|FG003|Overall Study|Protocol Violation|0|||
145231930|NCT00696436|523695091|FG004|Overall Study|Protocol Violation|1|||
145231931|NCT00696436|523695087|FG000|Overall Study|Lost to Follow-up|1|||
145231932|NCT00696436|523695088|FG001|Overall Study|Lost to Follow-up|6|||
145231933|NCT00696436|523695089|FG002|Overall Study|Lost to Follow-up|2|||
145231934|NCT00696436|523695090|FG003|Overall Study|Lost to Follow-up|4|||
145231935|NCT00696436|523695091|FG004|Overall Study|Lost to Follow-up|3|||
145231936|NCT00696436|523695087|FG000|Overall Study|Withdrawal by Subject|4|||
145231937|NCT00696436|523695088|FG001|Overall Study|Withdrawal by Subject|11|||
145231938|NCT00696436|523695089|FG002|Overall Study|Withdrawal by Subject|5|||
145231939|NCT00696436|523695090|FG003|Overall Study|Withdrawal by Subject|7|||
145231940|NCT00696436|523695091|FG004|Overall Study|Withdrawal by Subject|1|||
145231941|NCT00696436|523695087|FG000|Overall Study|Lack of Efficacy|3|||
145562477|NCT02967692|524920030|FG003|Overall Study|Adverse Event|28|||
145562478|NCT02967692|524920027|FG000|Overall Study|Study terminated by sponsor|2|||
145562479|NCT02967692|524920028|FG001|Overall Study|Study terminated by sponsor|1|||
145562480|NCT02967692|524920029|FG002|Overall Study|Study terminated by sponsor|42|||
145562481|NCT02967692|524920030|FG003|Overall Study|Study terminated by sponsor|37|||
145562482|NCT00066066|524920033|FG000|Overall Study|Lost to Follow-up|6|||
145231942|NCT00696436|523695088|FG001|Overall Study|Lack of Efficacy|1|||
145231943|NCT00696436|523695089|FG002|Overall Study|Lack of Efficacy|5|||
145231944|NCT00696436|523695090|FG003|Overall Study|Lack of Efficacy|2|||
145231945|NCT00696436|523695091|FG004|Overall Study|Lack of Efficacy|4|||
145231946|NCT00696436|523695087|FG000|Overall Study|Participant Unavailability|2|||
145231947|NCT00696436|523695088|FG001|Overall Study|Participant Unavailability|0|||
145231948|NCT00696436|523695089|FG002|Overall Study|Participant Unavailability|2|||
145231949|NCT00696436|523695090|FG003|Overall Study|Participant Unavailability|1|||
145231950|NCT00696436|523695091|FG004|Overall Study|Participant Unavailability|0|||
145231951|NCT00696436|523695087|FG000|Overall Study|Administrative Error|2|||
145231952|NCT00696436|523695088|FG001|Overall Study|Administrative Error|0|||
145231953|NCT00696436|523695089|FG002|Overall Study|Administrative Error|2|||
145562483|NCT00066066|524920034|FG001|Overall Study|Lost to Follow-up|4|||
145231954|NCT00696436|523695090|FG003|Overall Study|Administrative Error|0|||
145231955|NCT00696436|523695091|FG004|Overall Study|Administrative Error|0|||
145231956|NCT00696436|523695087|FG000|Overall Study|Participant Non-compliance|0|||
145231957|NCT00696436|523695088|FG001|Overall Study|Participant Non-compliance|0|||
145231958|NCT00696436|523695089|FG002|Overall Study|Participant Non-compliance|1|||
145231959|NCT00696436|523695090|FG003|Overall Study|Participant Non-compliance|2|||
145231960|NCT00696436|523695091|FG004|Overall Study|Participant Non-compliance|0|||
145231961|NCT00696436|523695087|FG000|Overall Study|Administrative Decision|1|||
145231962|NCT00696436|523695088|FG001|Overall Study|Administrative Decision|0|||
145231963|NCT00696436|523695089|FG002|Overall Study|Administrative Decision|0|||
145231964|NCT00696436|523695090|FG003|Overall Study|Administrative Decision|0|||
145231965|NCT00696436|523695091|FG004|Overall Study|Administrative Decision|0|||
145231966|NCT00696436|523695087|FG000|Overall Study|Missing|0|||
145231967|NCT00696436|523695088|FG001|Overall Study|Missing|1|||
145231968|NCT00696436|523695089|FG002|Overall Study|Missing|1|||
145231969|NCT00696436|523695090|FG003|Overall Study|Missing|0|||
145231970|NCT00696436|523695091|FG004|Overall Study|Missing|0|||
145231971|NCT00912340|523695093|FG000|Overall Study|Adverse Event|2|||
145231972|NCT00912340|523695094|FG001|Overall Study|Adverse Event|4|||
145231973|NCT00912340|523695095|FG002|Overall Study|Adverse Event|0|||
145231974|NCT00912340|523695093|FG000|Overall Study|Protocol revised to remove arm|0|||
145231975|NCT00912340|523695094|FG001|Overall Study|Protocol revised to remove arm|0|||
145231976|NCT00912340|523695095|FG002|Overall Study|Protocol revised to remove arm|4|||
145231977|NCT01830816|523695098|FG000|Overall Study|Progressive Disease|12|||
145231978|NCT01830816|523695099|FG001|Overall Study|Progressive Disease|7|||
145231979|NCT01830816|523695100|FG002|Overall Study|Progressive Disease|7|||
145231980|NCT01830816|523695098|FG000|Overall Study|Adverse Event|3|||
145231981|NCT01830816|523695099|FG001|Overall Study|Adverse Event|4|||
145231982|NCT01830816|523695100|FG002|Overall Study|Adverse Event|0|||
145231983|NCT01830816|523695098|FG000|Overall Study|Study Terminated by Sponsor|1|||
145231984|NCT01830816|523695099|FG001|Overall Study|Study Terminated by Sponsor|1|||
145231985|NCT01830816|523695100|FG002|Overall Study|Study Terminated by Sponsor|0|||
145231986|NCT01830816|523695098|FG000|Overall Study|Withdrawal by Subject|1|||
145231987|NCT01830816|523695099|FG001|Overall Study|Withdrawal by Subject|1|||
145231988|NCT01830816|523695100|FG002|Overall Study|Withdrawal by Subject|0|||
145231989|NCT01830816|523695098|FG000|Overall Study|Lost to Follow-up|0|||
145231990|NCT01830816|523695099|FG001|Overall Study|Lost to Follow-up|1|||
145231991|NCT01830816|523695100|FG002|Overall Study|Lost to Follow-up|0|||
145231992|NCT01830816|523695098|FG000|Overall Study|Symptomatic Deterioration|1|||
145231993|NCT01830816|523695099|FG001|Overall Study|Symptomatic Deterioration|0|||
145231994|NCT01830816|523695100|FG002|Overall Study|Symptomatic Deterioration|0|||
145231995|NCT01830816|523695098|FG000|Overall Study|Reason not Specified|2|||
145231996|NCT01830816|523695099|FG001|Overall Study|Reason not Specified|0|||
145231997|NCT01830816|523695100|FG002|Overall Study|Reason not Specified|0|||
145231998|NCT00205699|523695101|FG000|Overall Study|Lost to Follow-up|1|||
145231999|NCT00205699|523695102|FG001|Overall Study|Lost to Follow-up|3|||
145232000|NCT00205699|523695103|FG002|Overall Study|Lost to Follow-up|5|||
145232001|NCT00205699|523695101|FG000|Overall Study|Adverse Event|1|||
145232002|NCT00205699|523695102|FG001|Overall Study|Adverse Event|0|||
145232003|NCT00205699|523695103|FG002|Overall Study|Adverse Event|0|||
145232004|NCT00205699|523695101|FG000|Overall Study|Withdrawal by Subject|1|||
145232005|NCT00205699|523695102|FG001|Overall Study|Withdrawal by Subject|2|||
145232006|NCT00205699|523695103|FG002|Overall Study|Withdrawal by Subject|1|||
145232007|NCT00205699|523695101|FG000|Overall Study|Lack of Efficacy|0|||
145232008|NCT00205699|523695102|FG001|Overall Study|Lack of Efficacy|1|||
145232009|NCT00205699|523695103|FG002|Overall Study|Lack of Efficacy|0|||
145232010|NCT01754922|523695108|FG000|Overall Study|Adverse Event|0|||
145232011|NCT01754922|523695109|FG001|Overall Study|Adverse Event|1|||
145232012|NCT01207388|523695110|FG000|Overall Study|Death|67|||
145232013|NCT01207388|523695110|FG000|Overall Study|Withdrawal by Subject|1|||
145232014|NCT01610076|523695111|FG000|Overall Study|Technical issue with video|0|||
145232015|NCT01610076|523695112|FG001|Overall Study|Technical issue with video|1|||
145232016|NCT01610076|523695111|FG000|Overall Study|Lost to Follow-up|3|||
145232017|NCT01610076|523695112|FG001|Overall Study|Lost to Follow-up|4|||
145232018|NCT01895452|523695119|FG000|Overall Study|Adverse Event|1|||
145232019|NCT01895452|523695120|FG001|Overall Study|Adverse Event|4|||
145232020|NCT01895452|523695119|FG000|Overall Study|Lost to Follow-up|1|||
145232021|NCT01895452|523695120|FG001|Overall Study|Lost to Follow-up|5|||
145619900|NCT02892409|525123617|FG001|Overall Study|Adverse Event|0|||
145232022|NCT01895452|523695119|FG000|Overall Study|Pregnancy|0|||
145232023|NCT01895452|523695120|FG001|Overall Study|Pregnancy|1|||
145232024|NCT01895452|523695119|FG000|Overall Study|Withdrawal by Subject|2|||
145232025|NCT01895452|523695120|FG001|Overall Study|Withdrawal by Subject|14|||
145232026|NCT01895452|523695119|FG000|Overall Study|Underlying disease|0|||
145232027|NCT01895452|523695120|FG001|Overall Study|Underlying disease|3|||
145232028|NCT01895452|523695119|FG000|Overall Study|Noncompliance with study drug|0|||
145232029|NCT01895452|523695120|FG001|Overall Study|Noncompliance with study drug|1|||
145232030|NCT01653158|523695121|FG000|Overall Study|Death|0|||
145232031|NCT01653158|523695122|FG001|Overall Study|Death|0|||
145562484|NCT00066066|524920035|FG002|Overall Study|Lost to Follow-up|7|||
145562485|NCT00066066|524920036|FG003|Overall Study|Lost to Follow-up|4|||
145562486|NCT00066066|524920037|FG004|Overall Study|Lost to Follow-up|3|||
145562487|NCT00066066|524920038|FG005|Overall Study|Lost to Follow-up|5|||
145232032|NCT01653158|523695123|FG002|Overall Study|Death|0|||
145294856|NCT02863575|523928951|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
145294857|NCT02863575|523928952|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
145294858|NCT02863575|523928950|FG000|Overall Study|Withdrawal by Subject|0|||
145294859|NCT02863575|523928951|FG001|Overall Study|Withdrawal by Subject|1|||
145294860|NCT02863575|523928952|FG002|Overall Study|Withdrawal by Subject|1|||
145294861|NCT02863575|523928950|FG000|Overall Study|Adverse Event|0|||
145294862|NCT02863575|523928951|FG001|Overall Study|Adverse Event|1|||
145294863|NCT02863575|523928952|FG002|Overall Study|Adverse Event|0|||
145294864|NCT05628675|523930630|FG000|Overall Study|Lost to Follow-up|2|||
145294865|NCT05628675|523930630|FG000|Overall Study|Withdrawal by Subject|1|||
145294866|NCT02918877|523930635|FG000|Overall Study|Withdrawal by Subject|2|||
145294867|NCT02918877|523930636|FG001|Overall Study|Withdrawal by Subject|2|||
145294868|NCT02918877|523930635|FG000|Overall Study|Surgery cancelled|1|||
145294869|NCT02918877|523930636|FG001|Overall Study|Surgery cancelled|0|||
145294870|NCT02918877|523930635|FG000|Overall Study|Physician Decision|1|||
145294871|NCT02918877|523930636|FG001|Overall Study|Physician Decision|0|||
145294872|NCT02918877|523930635|FG000|Overall Study|Received intraoperative steroids|1|||
145294873|NCT02918877|523930636|FG001|Overall Study|Received intraoperative steroids|0|||
145294874|NCT02918877|523930635|FG000|Overall Study|Unable to obtain lab samples|1|||
145294875|NCT02918877|523930636|FG001|Overall Study|Unable to obtain lab samples|0|||
145294876|NCT02918877|523930635|FG000|Overall Study|Unsafe to perform BAL|0|||
145294877|NCT02918877|523930636|FG001|Overall Study|Unsafe to perform BAL|1|||
145294878|NCT05818137|523930637|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
145294879|NCT05818137|523930637|FG000|Extension Treatment Period|Ongoing participants|44|||
145294880|NCT01367275|523930638|FG000|Overall Study|Ineligible|1|||
145294881|NCT01367275|523930638|FG000|Overall Study|Disease Progression|2|||
145294882|NCT01648166|523930639|FG000|Overall Study|inadequate toenail samples|53|||
145294883|NCT01648166|523930640|FG001|Overall Study|inadequate toenail samples|100|||
145294884|NCT00883090|523930641|FG000|Overall Study|Sponsor's decision|1|||
145294885|NCT00883090|523930641|FG000|Overall Study|Withdrawal by Subject|1|||
145232033|NCT01653158|523695124|FG003|Overall Study|Death|1|||
145232034|NCT01653158|523695125|FG004|Overall Study|Death|0|||
145232035|NCT01653158|523695126|FG005|Overall Study|Death|0|||
145232036|NCT01653158|523695127|FG006|Overall Study|Death|0|||
145232037|NCT01653158|523695128|FG007|Overall Study|Death|2|||
145232038|NCT01653158|523695121|FG000|Overall Study|Adverse Event|0|||
145232039|NCT01653158|523695122|FG001|Overall Study|Adverse Event|0|||
145232040|NCT01653158|523695123|FG002|Overall Study|Adverse Event|0|||
145232041|NCT01653158|523695124|FG003|Overall Study|Adverse Event|1|||
145232042|NCT01653158|523695125|FG004|Overall Study|Adverse Event|0|||
145232043|NCT01653158|523695126|FG005|Overall Study|Adverse Event|0|||
145232044|NCT01653158|523695127|FG006|Overall Study|Adverse Event|0|||
145232045|NCT01653158|523695128|FG007|Overall Study|Adverse Event|3|||
145232046|NCT01653158|523695121|FG000|Overall Study|Other|0|||
145232047|NCT01653158|523695122|FG001|Overall Study|Other|0|||
145232048|NCT01653158|523695123|FG002|Overall Study|Other|0|||
145232049|NCT01653158|523695124|FG003|Overall Study|Other|0|||
145232050|NCT01653158|523695125|FG004|Overall Study|Other|0|||
145232051|NCT01653158|523695126|FG005|Overall Study|Other|0|||
145232052|NCT01653158|523695127|FG006|Overall Study|Other|0|||
145232053|NCT01653158|523695128|FG007|Overall Study|Other|1|||
145232054|NCT01653158|523695121|FG000|Overall Study|Progressive disease|0|||
145232055|NCT01653158|523695122|FG001|Overall Study|Progressive disease|0|||
145232056|NCT01653158|523695123|FG002|Overall Study|Progressive disease|0|||
145232057|NCT01653158|523695124|FG003|Overall Study|Progressive disease|0|||
145232058|NCT01653158|523695125|FG004|Overall Study|Progressive disease|1|||
145232059|NCT01653158|523695126|FG005|Overall Study|Progressive disease|1|||
145232060|NCT01653158|523695127|FG006|Overall Study|Progressive disease|2|||
145294886|NCT02532764|523930642|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294887|NCT02532764|523930643|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294888|NCT02532764|523930644|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294889|NCT02532764|523930645|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294890|NCT02532764|523930646|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294891|NCT02532764|523930647|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145562488|NCT00156533|524920047|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
145232061|NCT01653158|523695128|FG007|Overall Study|Progressive disease|9|||
145232062|NCT01653158|523695121|FG000|Overall Study|Withdrawal by Subject|1|||
145232063|NCT01653158|523695122|FG001|Overall Study|Withdrawal by Subject|0|||
145232064|NCT01653158|523695123|FG002|Overall Study|Withdrawal by Subject|0|||
145232065|NCT01653158|523695124|FG003|Overall Study|Withdrawal by Subject|0|||
145232066|NCT01653158|523695125|FG004|Overall Study|Withdrawal by Subject|0|||
145232067|NCT01653158|523695126|FG005|Overall Study|Withdrawal by Subject|0|||
145232068|NCT01653158|523695127|FG006|Overall Study|Withdrawal by Subject|0|||
145232069|NCT01653158|523695128|FG007|Overall Study|Withdrawal by Subject|0|||
145232070|NCT00980343|523695131|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
145232071|NCT00980343|523695132|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
145232072|NCT02899377|523695139|FG000|Overall Study|Adverse Event|1|||
145232073|NCT02899377|523695140|FG001|Overall Study|Adverse Event|0|||
145232074|NCT01231607|523695141|FG000|Overall Study|Adverse Event|0|||
145232075|NCT01231607|523695142|FG001|Overall Study|Adverse Event|8|||
145232076|NCT01231607|523695143|FG002|Overall Study|Adverse Event|4|||
145232077|NCT01231607|523695144|FG003|Overall Study|Adverse Event|4|||
145232078|NCT01231607|523695145|FG004|Overall Study|Adverse Event|5|||
145232079|NCT01231607|523695141|FG000|Overall Study|Lost to Follow-up|13|||
145232080|NCT01231607|523695142|FG001|Overall Study|Lost to Follow-up|11|||
145232081|NCT01231607|523695143|FG002|Overall Study|Lost to Follow-up|10|||
145232082|NCT01231607|523695144|FG003|Overall Study|Lost to Follow-up|10|||
145232083|NCT01231607|523695145|FG004|Overall Study|Lost to Follow-up|4|||
145232084|NCT01231607|523695141|FG000|Overall Study|Physician Decision|4|||
145232085|NCT01231607|523695142|FG001|Overall Study|Physician Decision|4|||
145232086|NCT01231607|523695143|FG002|Overall Study|Physician Decision|3|||
145294892|NCT02532764|523930648|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
145294893|NCT02532764|523930649|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
145232087|NCT01231607|523695144|FG003|Overall Study|Physician Decision|5|||
145232088|NCT01231607|523695145|FG004|Overall Study|Physician Decision|4|||
145232089|NCT01231607|523695141|FG000|Overall Study|Protocol Violation|3|||
145232090|NCT01231607|523695142|FG001|Overall Study|Protocol Violation|2|||
145232091|NCT01231607|523695143|FG002|Overall Study|Protocol Violation|0|||
145232092|NCT01231607|523695144|FG003|Overall Study|Protocol Violation|2|||
145232093|NCT01231607|523695145|FG004|Overall Study|Protocol Violation|2|||
145232094|NCT01231607|523695141|FG000|Overall Study|Withdrawal by Subject|9|||
145232095|NCT01231607|523695142|FG001|Overall Study|Withdrawal by Subject|9|||
145232096|NCT01231607|523695143|FG002|Overall Study|Withdrawal by Subject|14|||
145232097|NCT01231607|523695144|FG003|Overall Study|Withdrawal by Subject|17|||
145232098|NCT01231607|523695145|FG004|Overall Study|Withdrawal by Subject|9|||
145232099|NCT01677507|523695146|FG000|Initial Assignment|Adverse Event|0|||
145232100|NCT01677507|523695147|FG001|Initial Assignment|Adverse Event|1|||
145232101|NCT01677507|523695146|FG000|Initial Assignment|Protocol Violation|0|||
145232102|NCT01677507|523695147|FG001|Initial Assignment|Protocol Violation|1|||
145232103|NCT01677507|523695146|FG000|Second Assigment|Withdrawal by Subject|2|||
145232104|NCT01677507|523695147|FG001|Second Assigment|Withdrawal by Subject|2|||
145232105|NCT01677507|523695146|FG000|Second Assigment|Adverse Event|1|||
145232106|NCT01677507|523695147|FG001|Second Assigment|Adverse Event|3|||
145232107|NCT00259740|523695148|FG000|Overall Study|Physician Decision|1|||
145232108|NCT00259740|523695149|FG001|Overall Study|Physician Decision|1|||
145232109|NCT00259740|523695148|FG000|Overall Study|Adverse Event|0|||
145232110|NCT00259740|523695149|FG001|Overall Study|Adverse Event|2|||
145232111|NCT00259740|523695148|FG000|Overall Study|Withdrawal by Subject|2|||
145232112|NCT00259740|523695149|FG001|Overall Study|Withdrawal by Subject|6|||
145232113|NCT00259740|523695148|FG000|Overall Study|Death|1|||
145232114|NCT00259740|523695149|FG001|Overall Study|Death|1|||
145232115|NCT00259740|523695148|FG000|Overall Study|Disease progression|19|||
145232116|NCT00259740|523695149|FG001|Overall Study|Disease progression|36|||
145232117|NCT00259740|523695148|FG000|Overall Study|Ongoing|17|||
145232118|NCT00259740|523695149|FG001|Overall Study|Ongoing|3|||
145232119|NCT00259740|523695148|FG000|Overall Study|Other|3|||
145232120|NCT00259740|523695149|FG001|Overall Study|Other|0|||
145232121|NCT00259740|523695148|FG000|Overall Study|Requirement for alternative therapy|0|||
145232122|NCT00259740|523695149|FG001|Overall Study|Requirement for alternative therapy|4|||
145232123|NCT01840228|523695155|FG000|Overall Study|Lost to Follow-up|1|||
145294894|NCT02532764|523930650|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
145294895|NCT02532764|523930651|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
145294896|NCT01717976|523930652|FG000|Overall Study|Protocol Violation|0|||
145294897|NCT01717976|523930653|FG001|Overall Study|Protocol Violation|1|||
145294898|NCT00262223|523930656|FG000|Treatment Phase|Withdrawal by Subject|3|||
145232124|NCT01840228|523695156|FG001|Overall Study|Lost to Follow-up|1|||
145232125|NCT03495453|523695157|FG000|Overall Study|Withdrawal by Subject|0|||
145232126|NCT03495453|523695158|FG001|Overall Study|Withdrawal by Subject|1|||
145294899|NCT00262223|523930657|FG001|Treatment Phase|Withdrawal by Subject|6|||
145232127|NCT01360762|523695165|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
145232128|NCT01360762|523695165|FG000|Main Study Period (12-month Treatment)|Death|5|||
145232129|NCT01360762|523695165|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
145232130|NCT01360762|523695165|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
145232131|NCT01360762|523695165|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
145294900|NCT00262223|523930656|FG000|Treatment Phase|Adverse Event|1|||
145294901|NCT00262223|523930657|FG001|Treatment Phase|Adverse Event|2|||
145232132|NCT01360762|523695165|FG000|Whole Study Period|Lost to Follow-up|10|||
145232133|NCT01360762|523695165|FG000|Whole Study Period|Death|7|||
145232134|NCT01360762|523695165|FG000|Whole Study Period|Patient relapsed|18|||
145294902|NCT00262223|523930656|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
145294903|NCT00262223|523930657|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
145294904|NCT00262223|523930656|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
145294905|NCT00262223|523930657|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
145294906|NCT00262223|523930656|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
145232135|NCT01360762|523695165|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
145232136|NCT01103778|523695166|FG000|Overall Study|Lost to Follow-up|1|||
145232137|NCT01103778|523695166|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
145232138|NCT01103778|523695166|FG000|Overall Study|Screen failure|1|||
145232139|NCT01658579|523695167|FG000|Treatment Period A|Other|0|||
145232140|NCT01658579|523695168|FG001|Treatment Period A|Other|0|||
145232141|NCT01658579|523695169|FG002|Treatment Period A|Other|1|||
145232142|NCT01658579|523695170|FG003|Treatment Period A|Other|1|||
145232143|NCT01658579|523695167|FG000|Treatment Period A|Adverse Event|1|||
145232144|NCT01658579|523695168|FG001|Treatment Period A|Adverse Event|0|||
145232145|NCT01658579|523695169|FG002|Treatment Period A|Adverse Event|0|||
145232146|NCT01658579|523695170|FG003|Treatment Period A|Adverse Event|0|||
145232147|NCT01658579|523695167|FG000|Treatment Period B|Other|0|||
145232148|NCT01658579|523695168|FG001|Treatment Period B|Other|0|||
145232149|NCT01658579|523695169|FG002|Treatment Period B|Other|0|||
145232150|NCT01658579|523695170|FG003|Treatment Period B|Other|1|||
145232151|NCT04580394|523695171|FG000|First Intervention|Incorrectly Randomized|1|||
145232152|NCT04580394|523695171|FG000|First Intervention|Physician Decision|1|||
145232153|NCT04580394|523695171|FG000|First Intervention|Lost to Follow-up|1|||
145232154|NCT04580394|523695171|FG000|Washout (One Week)|Withdrawal by Subject|1|||
145232155|NCT04580394|523695171|FG000|Washout (One Week)|Adverse Event|1|||
145232156|NCT04580394|523695171|FG000|Washout (One Week)|Withdrawal by Subject|2|||
145232157|NCT04580394|523695171|FG000|Third Intervention|Adverse Event|1|||
145232158|NCT04580394|523695171|FG000|Third Intervention|Withdrawal by Subject|1|||
145232159|NCT04580394|523695171|FG000|Washout (One Week)|Withdrawal by Subject|2|||
145232160|NCT01464788|523695172|FG000|Overall Study|Lost to Follow-up|0|||
145232161|NCT01464788|523695173|FG001|Overall Study|Lost to Follow-up|1|||
145232162|NCT01464788|523695174|FG002|Overall Study|Lost to Follow-up|0|||
145232163|NCT01464788|523695172|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
145232164|NCT01464788|523695173|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
145232165|NCT01464788|523695174|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
145232166|NCT04397718|523695177|FG000|Overall Study|Death|7|||
145232167|NCT04397718|523695178|FG001|Overall Study|Death|11|||
145232168|NCT04397718|523695177|FG000|Overall Study|Lost to Follow-up|0|||
145232169|NCT04397718|523695178|FG001|Overall Study|Lost to Follow-up|4|||
145232170|NCT00304915|523695179|FG000|Overall Study|Lost to Follow-up|11|||
145232171|NCT00304915|523695180|FG001|Overall Study|Lost to Follow-up|11|||
145232172|NCT00304915|523695179|FG000|Overall Study|Death|4|||
145232173|NCT00304915|523695180|FG001|Overall Study|Death|5|||
145232174|NCT00304915|523695179|FG000|Overall Study|Withdrawal by Subject|3|||
145232175|NCT00304915|523695180|FG001|Overall Study|Withdrawal by Subject|0|||
145232176|NCT00973921|523695181|FG000|Overall Study|IVUS results were not available|9|||
145232177|NCT02120157|523695192|FG000|Overall Study|Death|8|||
145232178|NCT02756650|523695195|FG000|Overall Study|Physician Decision|1|||
145232179|NCT02756650|523695195|FG000|Overall Study|Adverse Event|1|||
145232180|NCT04348591|523695197|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
145232181|NCT04348591|523695198|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
145232182|NCT04348591|523695197|FG000|Imaging Session (120 Min)|Physician Decision|0|||
145232183|NCT04348591|523695198|FG001|Imaging Session (120 Min)|Physician Decision|1|||
145232184|NCT04348591|523695197|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
145232185|NCT04348591|523695198|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
145232186|NCT03722784|523695201|FG000|Overall Study|Withdrawal by Subject|1|||
145232187|NCT03722784|523695202|FG001|Overall Study|Withdrawal by Subject|0|||
145232188|NCT03722784|523695201|FG000|Overall Study|Physician Decision|1|||
145232189|NCT03722784|523695202|FG001|Overall Study|Physician Decision|1|||
145232190|NCT03722784|523695201|FG000|Overall Study|Protocol Violation|0|||
145232191|NCT03722784|523695202|FG001|Overall Study|Protocol Violation|1|||
145232192|NCT00438399|523695205|FG000|Overall Study|Lost to Follow-up|2|||
145232193|NCT00438399|523695206|FG001|Overall Study|Lost to Follow-up|2|||
145232194|NCT00438399|523695207|FG002|Overall Study|Lost to Follow-up|1|||
145232195|NCT00438399|523695208|FG003|Overall Study|Lost to Follow-up|1|||
145232196|NCT00438399|523695209|FG004|Overall Study|Lost to Follow-up|1|||
145232197|NCT00438399|523695210|FG005|Overall Study|Lost to Follow-up|1|||
145232198|NCT00438399|523695205|FG000|Overall Study|Adverse Event|0|||
145232199|NCT00438399|523695206|FG001|Overall Study|Adverse Event|0|||
145232200|NCT00438399|523695207|FG002|Overall Study|Adverse Event|1|||
145232201|NCT00438399|523695208|FG003|Overall Study|Adverse Event|1|||
145232202|NCT00438399|523695209|FG004|Overall Study|Adverse Event|0|||
145294907|NCT00262223|523930657|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
145232203|NCT00438399|523695210|FG005|Overall Study|Adverse Event|1|||
145232204|NCT00438399|523695205|FG000|Overall Study|Withdrawal by Subject|5|||
145232205|NCT00438399|523695206|FG001|Overall Study|Withdrawal by Subject|6|||
145232206|NCT00438399|523695207|FG002|Overall Study|Withdrawal by Subject|3|||
145232207|NCT00438399|523695208|FG003|Overall Study|Withdrawal by Subject|2|||
145232208|NCT00438399|523695209|FG004|Overall Study|Withdrawal by Subject|2|||
145232209|NCT00438399|523695210|FG005|Overall Study|Withdrawal by Subject|2|||
145232210|NCT00438399|523695205|FG000|Overall Study|Protocol Violation|0|||
145232211|NCT00438399|523695206|FG001|Overall Study|Protocol Violation|0|||
145232212|NCT00438399|523695207|FG002|Overall Study|Protocol Violation|1|||
145232213|NCT00438399|523695208|FG003|Overall Study|Protocol Violation|0|||
145232214|NCT00438399|523695209|FG004|Overall Study|Protocol Violation|0|||
145232215|NCT00438399|523695210|FG005|Overall Study|Protocol Violation|1|||
145232216|NCT00438399|523695205|FG000|Overall Study|Subje stopped study|0|||
145232217|NCT00438399|523695206|FG001|Overall Study|Subje stopped study|0|||
145232218|NCT00438399|523695207|FG002|Overall Study|Subje stopped study|1|||
145232219|NCT00438399|523695208|FG003|Overall Study|Subje stopped study|0|||
145232220|NCT00438399|523695209|FG004|Overall Study|Subje stopped study|0|||
145232221|NCT00438399|523695210|FG005|Overall Study|Subje stopped study|0|||
145232222|NCT00438399|523695205|FG000|Overall Study|Pregnancy|0|||
145232223|NCT00438399|523695206|FG001|Overall Study|Pregnancy|0|||
145232224|NCT00438399|523695207|FG002|Overall Study|Pregnancy|0|||
145232225|NCT00438399|523695208|FG003|Overall Study|Pregnancy|0|||
145232226|NCT00438399|523695209|FG004|Overall Study|Pregnancy|0|||
145232227|NCT00438399|523695210|FG005|Overall Study|Pregnancy|1|||
145232228|NCT00438399|523695205|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
145232229|NCT00438399|523695206|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
145232230|NCT00438399|523695207|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
145232231|NCT00438399|523695208|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
145232232|NCT00438399|523695209|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
145232233|NCT00438399|523695210|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
145232234|NCT00865189|523697307|FG000|Overall Study|Other|1|||
145232235|NCT00865189|523697308|FG001|Overall Study|Other|2|||
145232236|NCT00865189|523697307|FG000|Overall Study|Death|4|||
145232237|NCT00865189|523697308|FG001|Overall Study|Death|11|||
145232238|NCT00865189|523697307|FG000|Overall Study|Lost to Follow-up|6|||
145232239|NCT00865189|523697308|FG001|Overall Study|Lost to Follow-up|6|||
145232240|NCT00865189|523697307|FG000|Overall Study|Withdrawal by Subject|1|||
145232241|NCT00865189|523697308|FG001|Overall Study|Withdrawal by Subject|0|||
145232242|NCT05590767|523697313|FG000|Overall Study|Protocol Violation|1|||
145232243|NCT05590767|523697313|FG000|Overall Study|surgery canceled|1|||
145232244|NCT05590767|523697313|FG000|Overall Study|interscalene brachial block not performed|1|||
145232245|NCT00084929|523697315|FG000|Overall Study|ineligible - medical contraindication|1|||
145232246|NCT00084929|523697315|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
145232247|NCT00084929|523697315|FG000|Overall Study|Ineligible - Medical history|6|||
145232248|NCT00084929|523697315|FG000|Overall Study|Withdrawal by Subject|10|||
145232249|NCT00084929|523697315|FG000|Overall Study|Missing/incomplete CTC exam|9|||
145232250|NCT00084929|523697315|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
145232251|NCT00844649|523697316|FG000|Overall Study|Progressive Disease|196|||
145232252|NCT00844649|523697317|FG001|Overall Study|Progressive Disease|245|||
145232253|NCT00844649|523697316|FG000|Overall Study|Adverse Event|128|||
145232254|NCT00844649|523697317|FG001|Overall Study|Adverse Event|73|||
145232255|NCT00844649|523697316|FG000|Overall Study|Physician Decision|25|||
145232256|NCT00844649|523697317|FG001|Overall Study|Physician Decision|18|||
145232257|NCT00844649|523697316|FG000|Overall Study|Protocol Violation|10|||
145232258|NCT00844649|523697317|FG001|Overall Study|Protocol Violation|6|||
145232259|NCT00844649|523697316|FG000|Overall Study|Withdrawal by Subject|28|||
145232260|NCT00844649|523697317|FG001|Overall Study|Withdrawal by Subject|39|||
145232261|NCT00844649|523697316|FG000|Overall Study|Other|7|||
145232262|NCT00844649|523697317|FG001|Overall Study|Other|10|||
145232263|NCT00844649|523697316|FG000|Overall Study|Withdrew prior to starting treatment|11|||
145232264|NCT00844649|523697317|FG001|Overall Study|Withdrew prior to starting treatment|27|||
145232265|NCT00091026|523697320|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
145232266|NCT00091026|523697321|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
145232267|NCT00091026|523697320|FG000|Overall Study|Patient withdrew and never received trea|0|||
145232268|NCT00091026|523697321|FG001|Overall Study|Patient withdrew and never received trea|2|||
145232269|NCT00091026|523697320|FG000|Overall Study|Unknown-never received treatment|0|||
145232270|NCT00091026|523697321|FG001|Overall Study|Unknown-never received treatment|1|||
145232271|NCT00065442|523697324|FG000|Overall Study|Lost to Follow-up|1|||
145232272|NCT00065442|523697325|FG001|Overall Study|Lost to Follow-up|1|||
145232273|NCT00065442|523697324|FG000|Overall Study|Death|121|||
145232274|NCT00065442|523697325|FG001|Overall Study|Death|210|||
145232275|NCT00065442|523697324|FG000|Overall Study|Withdrawal by Subject|3|||
145232276|NCT00065442|523697325|FG001|Overall Study|Withdrawal by Subject|9|||
145232277|NCT01797965|523697326|FG000|Overall Study|Adverse Event|104|||
145232278|NCT01797965|523697327|FG001|Overall Study|Adverse Event|129|||
145232279|NCT01797965|523697328|FG002|Overall Study|Adverse Event|4|||
145232280|NCT01797965|523697329|FG003|Overall Study|Adverse Event|21|||
145232281|NCT01797965|523697326|FG000|Overall Study|Lost to Follow-up|9|||
145232282|NCT01797965|523697327|FG001|Overall Study|Lost to Follow-up|8|||
145232283|NCT01797965|523697328|FG002|Overall Study|Lost to Follow-up|1|||
145232284|NCT01797965|523697329|FG003|Overall Study|Lost to Follow-up|2|||
145232285|NCT01797965|523697326|FG000|Overall Study|Consent withdrawn|130|||
145232286|NCT01797965|523697327|FG001|Overall Study|Consent withdrawn|117|||
145232287|NCT01797965|523697328|FG002|Overall Study|Consent withdrawn|3|||
145232288|NCT01797965|523697329|FG003|Overall Study|Consent withdrawn|35|||
145232289|NCT01797965|523697326|FG000|Overall Study|Investigator decision|21|||
145232290|NCT01797965|523697327|FG001|Overall Study|Investigator decision|15|||
145232291|NCT01797965|523697328|FG002|Overall Study|Investigator decision|0|||
145232292|NCT01797965|523697329|FG003|Overall Study|Investigator decision|0|||
145232293|NCT01797965|523697326|FG000|Overall Study|Death|2|||
145232294|NCT01797965|523697327|FG001|Overall Study|Death|4|||
145232295|NCT01797965|523697328|FG002|Overall Study|Death|0|||
145232296|NCT01797965|523697329|FG003|Overall Study|Death|0|||
145232297|NCT01797965|523697326|FG000|Overall Study|Disease progression, defined by protocol|3|||
145232298|NCT01797965|523697327|FG001|Overall Study|Disease progression, defined by protocol|1|||
145232299|NCT01797965|523697328|FG002|Overall Study|Disease progression, defined by protocol|0|||
145232300|NCT01797965|523697329|FG003|Overall Study|Disease progression, defined by protocol|0|||
145232301|NCT01797965|523697326|FG000|Overall Study|Reason Not Specified|280|||
145232302|NCT01797965|523697327|FG001|Overall Study|Reason Not Specified|295|||
145232303|NCT01797965|523697328|FG002|Overall Study|Reason Not Specified|0|||
145232304|NCT01797965|523697329|FG003|Overall Study|Reason Not Specified|15|||
145232305|NCT00712322|523697330|FG000|Overall Study|Protocol deviation|0|||
145232306|NCT00712322|523697331|FG001|Overall Study|Protocol deviation|1|||
145232307|NCT00712322|523697332|FG002|Overall Study|Protocol deviation|0|||
145232308|NCT02670330|523697335|FG000|Overall Study|Protocol Deviation|1|||
145232309|NCT02670330|523697336|FG001|Overall Study|Protocol Deviation|0|||
145232310|NCT02670330|523697335|FG000|Overall Study|Study Terminated By Sponsor|36|||
145232311|NCT02670330|523697336|FG001|Overall Study|Study Terminated By Sponsor|43|||
145232312|NCT02670330|523697335|FG000|Overall Study|Adverse Event|1|||
145232313|NCT02670330|523697336|FG001|Overall Study|Adverse Event|3|||
145232314|NCT02670330|523697335|FG000|Overall Study|Withdrawal by Subject|34|||
145232315|NCT02670330|523697336|FG001|Overall Study|Withdrawal by Subject|29|||
145232316|NCT02670330|523697335|FG000|Overall Study|Lost to Follow-up|3|||
145232317|NCT02670330|523697336|FG001|Overall Study|Lost to Follow-up|2|||
145232318|NCT04404010|523697337|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
145232319|NCT04404010|523697338|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
145232320|NCT02802878|523697342|FG000|Overall Study|Withdrawal by Subject|3|||
145232321|NCT02802878|523697343|FG001|Overall Study|Withdrawal by Subject|3|||
145232322|NCT02802878|523697342|FG000|Overall Study|Protocol Violation|1|||
145232323|NCT02802878|523697343|FG001|Overall Study|Protocol Violation|0|||
145232324|NCT01599754|523697344|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
145232325|NCT01599754|523697345|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
145232326|NCT01599754|523697344|FG000|Overall Study|Participant noncompliance|4|||
145232327|NCT01599754|523697345|FG001|Overall Study|Participant noncompliance|4|||
145232328|NCT01599754|523697344|FG000|Overall Study|Lost to Follow-up|13|||
145232329|NCT01599754|523697345|FG001|Overall Study|Lost to Follow-up|6|||
145232330|NCT01599754|523697344|FG000|Overall Study|Death|31|||
145232331|NCT01599754|523697345|FG001|Overall Study|Death|33|||
145232332|NCT01599754|523697344|FG000|Overall Study|Adverse Event|3|||
145232333|NCT01599754|523697345|FG001|Overall Study|Adverse Event|2|||
145232334|NCT01599754|523697344|FG000|Overall Study|Investigator decision|1|||
145232335|NCT01599754|523697345|FG001|Overall Study|Investigator decision|3|||
145232336|NCT01599754|523697344|FG000|Overall Study|Withdrawal by Subject|24|||
145232337|NCT01599754|523697345|FG001|Overall Study|Withdrawal by Subject|25|||
145232338|NCT01599754|523697344|FG000|Overall Study|Study terminated by sponsor|282|||
145232339|NCT01599754|523697345|FG001|Overall Study|Study terminated by sponsor|285|||
145232340|NCT00702052|523697346|FG000|Overall Study|Adverse Event|23|||
145232341|NCT00702052|523697346|FG000|Overall Study|Disease Progression|30|||
145232342|NCT00702052|523697346|FG000|Overall Study|Withdrawal by Subject|5|||
145232343|NCT01577160|523697347|FG000|Overall Study|Adverse Event|9|||
145232344|NCT01577160|523697347|FG000|Overall Study|Lack of Efficacy|15|||
145232345|NCT01577160|523697347|FG000|Overall Study|Lost to Follow-up|40|||
145232346|NCT01577160|523697347|FG000|Overall Study|Withdrawal by Subject|18|||
145232347|NCT01577160|523697347|FG000|Overall Study|Subject Uncooperative|7|||
145232348|NCT01577160|523697347|FG000|Overall Study|Other|9|||
145232349|NCT00101192|523697348|FG000|Overall Study|Ineligible|6|||
145232350|NCT00101192|523697348|FG000|Overall Study|Inevaluable|1|||
145232351|NCT03670641|523697349|FG000|Overall Study|Lost to Follow-up|3|||
145232352|NCT03691610|523697350|FG000|Overall Study|Adverse Event|0|||
145232353|NCT03691610|523697351|FG001|Overall Study|Adverse Event|1|||
145232354|NCT03691610|523697352|FG002|Overall Study|Adverse Event|0|||
145232355|NCT03691610|523697353|FG003|Overall Study|Adverse Event|0|||
145232356|NCT03691610|523697350|FG000|Overall Study|Protocol Deviation|15|||
145232357|NCT03691610|523697351|FG001|Overall Study|Protocol Deviation|8|||
145232358|NCT03691610|523697352|FG002|Overall Study|Protocol Deviation|1|||
145294908|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
145294909|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
145294910|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
145294911|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
145294912|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
145294913|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
145294914|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
145294915|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
145294916|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
145294917|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
145294918|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
145232359|NCT03691610|523697353|FG003|Overall Study|Protocol Deviation|2|||
145232360|NCT03691610|523697350|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
145232361|NCT03691610|523697351|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
145232362|NCT03691610|523697352|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
145232363|NCT03691610|523697353|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
145232364|NCT03691610|523697350|FG000|Overall Study|Lost to Follow-up|20|||
145232365|NCT03691610|523697351|FG001|Overall Study|Lost to Follow-up|11|||
145232366|NCT03691610|523697352|FG002|Overall Study|Lost to Follow-up|5|||
145232367|NCT03691610|523697353|FG003|Overall Study|Lost to Follow-up|2|||
145232368|NCT00242580|523697356|FG000|Overall Study|Adverse Event|3|||
145232369|NCT00242580|523697357|FG001|Overall Study|Adverse Event|0|||
145232370|NCT00242580|523697358|FG002|Overall Study|Adverse Event|2|||
145232371|NCT00242580|523697356|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145232372|NCT00242580|523697357|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
145232373|NCT00242580|523697358|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
145232374|NCT00242580|523697356|FG000|Overall Study|Protocol Violation|0|||
145232375|NCT00242580|523697357|FG001|Overall Study|Protocol Violation|0|||
145232376|NCT00242580|523697358|FG002|Overall Study|Protocol Violation|1|||
145232377|NCT00242580|523697356|FG000|Overall Study|Subject withdrew consent|2|||
145232378|NCT00242580|523697357|FG001|Overall Study|Subject withdrew consent|2|||
145232379|NCT00242580|523697358|FG002|Overall Study|Subject withdrew consent|5|||
145232380|NCT00242580|523697356|FG000|Overall Study|Lost to Follow-up|0|||
145232381|NCT00242580|523697357|FG001|Overall Study|Lost to Follow-up|3|||
145232382|NCT00242580|523697358|FG002|Overall Study|Lost to Follow-up|0|||
145232383|NCT00242580|523697356|FG000|Overall Study|Death|1|||
145232384|NCT00242580|523697357|FG001|Overall Study|Death|2|||
145232385|NCT00242580|523697358|FG002|Overall Study|Death|1|||
145232386|NCT01232894|523697360|FG000|Overall Study|Lost to Follow-up|0|||
145232387|NCT01232894|523697361|FG001|Overall Study|Lost to Follow-up|1|||
145232388|NCT01232894|523697360|FG000|Overall Study|Death|1|||
145232389|NCT01232894|523697361|FG001|Overall Study|Death|0|||
145232390|NCT01232894|523697360|FG000|Overall Study|Protocol Violation|1|||
145232391|NCT01232894|523697361|FG001|Overall Study|Protocol Violation|1|||
145232392|NCT01232894|523697360|FG000|Overall Study|Withdrawal by Subject|8|||
145232393|NCT01232894|523697361|FG001|Overall Study|Withdrawal by Subject|5|||
145232394|NCT01232894|523697360|FG000|Overall Study|Physician Decision|2|||
145232395|NCT01232894|523697361|FG001|Overall Study|Physician Decision|1|||
145232396|NCT03970395|523697366|FG000|Overall Study|Withdrawal by Subject|3|||
145232397|NCT03970395|523697367|FG001|Overall Study|Withdrawal by Subject|4|||
145232398|NCT03970395|523697366|FG000|Overall Study|Lost to Follow-up|4|||
145232399|NCT03970395|523697367|FG001|Overall Study|Lost to Follow-up|8|||
145232400|NCT00929734|523697368|FG000|Overall Study|Lost to Follow-up|2|||
145232401|NCT00929734|523697369|FG001|Overall Study|Lost to Follow-up|1|||
145232402|NCT00929734|523697368|FG000|Overall Study|Withdrawal by Subject|0|||
145232403|NCT00929734|523697369|FG001|Overall Study|Withdrawal by Subject|2|||
145232404|NCT01553916|523697370|FG000|Overall Study|Withdrawal by Subject|2|||
145232405|NCT01553916|523697370|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
145232406|NCT00910429|523697375|FG000|Overall Study|Death|18|||
145232407|NCT00910429|523697376|FG001|Overall Study|Death|12|||
145232408|NCT00910429|523697375|FG000|Overall Study|Withdrawal by Subject|3|||
145232409|NCT00910429|523697376|FG001|Overall Study|Withdrawal by Subject|2|||
145232410|NCT00910429|523697375|FG000|Overall Study|Protocol Violation|1|||
145232411|NCT00910429|523697376|FG001|Overall Study|Protocol Violation|0|||
145232412|NCT00910429|523697375|FG000|Overall Study|Lost to Follow-up|2|||
145232413|NCT00910429|523697376|FG001|Overall Study|Lost to Follow-up|1|||
145232414|NCT00910429|523697375|FG000|Overall Study|Adverse Event|10|||
145232415|NCT00910429|523697376|FG001|Overall Study|Adverse Event|5|||
145232416|NCT00910429|523697375|FG000|Overall Study|Drug non-compliance|1|||
145232417|NCT00910429|523697376|FG001|Overall Study|Drug non-compliance|0|||
145294919|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
145408302|NCT03314935|524349848|FG002|Phase 2|Lost to Follow-up|0|||
145408303|NCT03314935|524349849|FG003|Phase 2|Lost to Follow-up|0|||
145232418|NCT00910429|523697375|FG000|Overall Study|Lack of Efficacy|4|||
145232419|NCT00910429|523697376|FG001|Overall Study|Lack of Efficacy|1|||
145232420|NCT01317615|523697377|FG000|Overall Study|Disease progression|25|||
145232421|NCT01317615|523697377|FG000|Overall Study|New cancer therapy|5|||
145232422|NCT01317615|523697377|FG000|Overall Study|Death|6|||
145232423|NCT01317615|523697377|FG000|Overall Study|Withdrawal by Subject|5|||
145232424|NCT01317615|523697377|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145232425|NCT01317615|523697377|FG000|Overall Study|Adverse Event|7|||
145232426|NCT04465396|523697380|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
145232427|NCT04465396|523697381|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
145232428|NCT04465396|523697382|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
145232429|NCT04465396|523697383|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
145232430|NCT01364233|523697384|FG000|Overall Study|Lost to Follow-up|1|||
145232431|NCT00302718|523697388|FG000|Overall Study|Participant left the hospital|1|||
145232432|NCT00302718|523697389|FG001|Overall Study|Participant left the hospital|0|||
145232433|NCT00302718|523697390|FG002|Overall Study|Participant left the hospital|0|||
145232434|NCT00302718|523697391|FG003|Overall Study|Participant left the hospital|1|||
145232435|NCT00302718|523697388|FG000|Overall Study|Withdrawal by Subject|0|||
145232436|NCT00302718|523697389|FG001|Overall Study|Withdrawal by Subject|1|||
145232437|NCT00302718|523697390|FG002|Overall Study|Withdrawal by Subject|0|||
145232438|NCT00302718|523697391|FG003|Overall Study|Withdrawal by Subject|0|||
145232439|NCT00302718|523697388|FG000|Overall Study|Participant left primary care setting|0|||
145232440|NCT00302718|523697389|FG001|Overall Study|Participant left primary care setting|0|||
145232441|NCT00302718|523697390|FG002|Overall Study|Participant left primary care setting|2|||
145232442|NCT00302718|523697391|FG003|Overall Study|Participant left primary care setting|1|||
145232443|NCT00349752|523697392|FG000|Overall Study|Adverse Event|8|||
145232444|NCT00349752|523697393|FG001|Overall Study|Adverse Event|12|||
145232445|NCT00349752|523697392|FG000|Overall Study|Lack of Efficacy|37|||
145232446|NCT00349752|523697393|FG001|Overall Study|Lack of Efficacy|42|||
145232447|NCT00349752|523697392|FG000|Overall Study|Lost to Follow-up|4|||
145232448|NCT00349752|523697393|FG001|Overall Study|Lost to Follow-up|2|||
145232449|NCT00349752|523697392|FG000|Overall Study|Personal reasons|6|||
145232450|NCT00349752|523697393|FG001|Overall Study|Personal reasons|5|||
145232451|NCT00349752|523697392|FG000|Overall Study|Other: Required exclusionary medication|0|||
145232452|NCT00349752|523697393|FG001|Overall Study|Other: Required exclusionary medication|1|||
145232453|NCT00349752|523697392|FG000|Overall Study|Other: Non compliance|0|||
145232454|NCT00349752|523697393|FG001|Overall Study|Other: Non compliance|1|||
145232455|NCT00349752|523697392|FG000|Overall Study|Other: Patient stopped steroids|0|||
145232456|NCT00349752|523697393|FG001|Overall Study|Other: Patient stopped steroids|1|||
145232457|NCT00349752|523697392|FG000|Overall Study|Other: Patient's steroid use|1|||
145232458|NCT00349752|523697393|FG001|Overall Study|Other: Patient's steroid use|0|||
145232459|NCT00349752|523697392|FG000|Overall Study|Other: Ineligible|1|||
145232460|NCT00349752|523697393|FG001|Overall Study|Other: Ineligible|0|||
145232461|NCT00349752|523697392|FG000|Overall Study|Other: Inadvertently unblinded|1|||
145232462|NCT00349752|523697393|FG001|Overall Study|Other: Inadvertently unblinded|0|||
145232463|NCT00349752|523697392|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
145232464|NCT00349752|523697393|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
145232465|NCT00819585|523697394|FG000|Core Study|Adverse Event|2|||
145232466|NCT00819585|523697395|FG001|Core Study|Adverse Event|1|||
145232467|NCT00819585|523697396|FG002|Core Study|Adverse Event|1|||
145232468|NCT00819585|523697397|FG003|Core Study|Adverse Event|4|||
145232469|NCT00819585|523697398|FG004|Core Study|Adverse Event|1|||
145232470|NCT00819585|523697399|FG005|Core Study|Adverse Event|0|||
145232471|NCT00819585|523697400|FG006|Core Study|Adverse Event|2|||
145232472|NCT00819585|523697401|FG007|Core Study|Adverse Event|0|||
145294920|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
145232473|NCT00819585|523697402|FG008|Core Study|Adverse Event|0|||
145232474|NCT00819585|523697403|FG009|Core Study|Adverse Event|0|||
145294921|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
145294922|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
145294923|NCT00437658|523930658|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
145294924|NCT00437658|523930659|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
145294925|NCT00437658|523930660|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
145294926|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
145294927|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
145232475|NCT00819585|523697404|FG010|Core Study|Adverse Event|0|||
145232476|NCT00819585|523697394|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
145232477|NCT00819585|523697395|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
145232478|NCT00819585|523697396|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
145232479|NCT00819585|523697397|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
145232480|NCT00819585|523697398|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
145232481|NCT00819585|523697399|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
145232482|NCT00819585|523697400|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
145232483|NCT00819585|523697401|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
145232484|NCT00819585|523697402|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
145232485|NCT00819585|523697403|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
145232486|NCT00819585|523697404|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
145232487|NCT00819585|523697394|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
145294928|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
145232488|NCT00819585|523697395|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
145232489|NCT00819585|523697396|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232490|NCT00819585|523697397|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232491|NCT00819585|523697398|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232492|NCT00819585|523697399|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232493|NCT00819585|523697400|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
145232494|NCT00819585|523697401|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
145294929|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
145294930|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
145294931|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
145294932|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
145232495|NCT00819585|523697402|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232496|NCT00819585|523697403|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232497|NCT00819585|523697404|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
145232498|NCT00819585|523697394|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
145232499|NCT00819585|523697395|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
145232500|NCT00819585|523697396|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
145232501|NCT00819585|523697397|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
145232502|NCT00819585|523697398|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
145232503|NCT00819585|523697399|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
145294933|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
145294934|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
145294935|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
145294936|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
145294937|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
145294938|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
145294939|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
145294940|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
145294941|NCT00437658|523930658|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
145294942|NCT00437658|523930659|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
145294943|NCT00437658|523930660|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
145294944|NCT03952143|523930661|FG000|Lead-In Period|Adverse Event|2|||
145294945|NCT03952143|523930662|FG001|Lead-In Period|Adverse Event|0|||
145294946|NCT03952143|523930663|FG002|Lead-In Period|Adverse Event|0|||
145294947|NCT03952143|523930661|FG000|Lead-In Period|Lack of Efficacy|2|||
145294948|NCT03952143|523930662|FG001|Lead-In Period|Lack of Efficacy|0|||
145294949|NCT03952143|523930663|FG002|Lead-In Period|Lack of Efficacy|0|||
145294950|NCT03952143|523930661|FG000|Lead-In Period|Physician Decision|5|||
145294951|NCT03952143|523930662|FG001|Lead-In Period|Physician Decision|0|||
145294952|NCT03952143|523930663|FG002|Lead-In Period|Physician Decision|0|||
145294953|NCT03952143|523930661|FG000|Lead-In Period|Protocol Violation|5|||
145294954|NCT03952143|523930662|FG001|Lead-In Period|Protocol Violation|0|||
145294955|NCT03952143|523930663|FG002|Lead-In Period|Protocol Violation|0|||
145294956|NCT03952143|523930661|FG000|Lead-In Period|Withdrawal by Subject|19|||
145294957|NCT03952143|523930662|FG001|Lead-In Period|Withdrawal by Subject|0|||
145294958|NCT03952143|523930663|FG002|Lead-In Period|Withdrawal by Subject|0|||
145294959|NCT03952143|523930661|FG000|Treatment Period|Adverse Event|0|||
145232504|NCT00819585|523697400|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
145232505|NCT00819585|523697401|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
145232506|NCT00819585|523697402|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
145232507|NCT00819585|523697403|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
145232508|NCT00819585|523697404|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
145232509|NCT00819585|523697394|FG000|Core Study|Subject Withdrew Consent|0|||
145232510|NCT00819585|523697395|FG001|Core Study|Subject Withdrew Consent|3|||
145232511|NCT00819585|523697396|FG002|Core Study|Subject Withdrew Consent|2|||
145232512|NCT00819585|523697397|FG003|Core Study|Subject Withdrew Consent|1|||
145232513|NCT00819585|523697398|FG004|Core Study|Subject Withdrew Consent|0|||
145294960|NCT03952143|523930662|FG001|Treatment Period|Adverse Event|0|||
145232514|NCT00819585|523697399|FG005|Core Study|Subject Withdrew Consent|0|||
145232515|NCT00819585|523697400|FG006|Core Study|Subject Withdrew Consent|3|||
145232516|NCT00819585|523697401|FG007|Core Study|Subject Withdrew Consent|0|||
145232517|NCT00819585|523697402|FG008|Core Study|Subject Withdrew Consent|0|||
145294961|NCT03952143|523930663|FG002|Treatment Period|Adverse Event|1|||
145294962|NCT03952143|523930661|FG000|Treatment Period|Lost to Follow-up|0|||
145294963|NCT03952143|523930662|FG001|Treatment Period|Lost to Follow-up|2|||
145294964|NCT03952143|523930663|FG002|Treatment Period|Lost to Follow-up|0|||
145232518|NCT00819585|523697403|FG009|Core Study|Subject Withdrew Consent|0|||
145232519|NCT00819585|523697404|FG010|Core Study|Subject Withdrew Consent|0|||
145294965|NCT03952143|523930661|FG000|Treatment Period|Physician Decision|0|||
145294966|NCT03952143|523930662|FG001|Treatment Period|Physician Decision|0|||
145294967|NCT03952143|523930663|FG002|Treatment Period|Physician Decision|2|||
145294968|NCT03952143|523930661|FG000|Treatment Period|Protocol Violation|0|||
145294969|NCT03952143|523930662|FG001|Treatment Period|Protocol Violation|0|||
145294970|NCT03952143|523930663|FG002|Treatment Period|Protocol Violation|1|||
145232520|NCT00819585|523697394|FG000|Core Study|Lost to Follow-up|2|||
145232521|NCT00819585|523697395|FG001|Core Study|Lost to Follow-up|1|||
145232522|NCT00819585|523697396|FG002|Core Study|Lost to Follow-up|2|||
145232523|NCT00819585|523697397|FG003|Core Study|Lost to Follow-up|0|||
145232524|NCT00819585|523697398|FG004|Core Study|Lost to Follow-up|1|||
145232525|NCT00819585|523697399|FG005|Core Study|Lost to Follow-up|1|||
145232526|NCT00819585|523697400|FG006|Core Study|Lost to Follow-up|1|||
145232527|NCT00819585|523697401|FG007|Core Study|Lost to Follow-up|0|||
145232528|NCT00819585|523697402|FG008|Core Study|Lost to Follow-up|0|||
145232529|NCT00819585|523697403|FG009|Core Study|Lost to Follow-up|0|||
145232530|NCT00819585|523697404|FG010|Core Study|Lost to Follow-up|0|||
145232531|NCT00819585|523697394|FG000|Core Study|Administrative Problems|0|||
145232532|NCT00819585|523697395|FG001|Core Study|Administrative Problems|0|||
145232533|NCT00819585|523697396|FG002|Core Study|Administrative Problems|0|||
145232534|NCT00819585|523697397|FG003|Core Study|Administrative Problems|0|||
145232535|NCT00819585|523697398|FG004|Core Study|Administrative Problems|0|||
145232536|NCT00819585|523697399|FG005|Core Study|Administrative Problems|0|||
145232537|NCT00819585|523697400|FG006|Core Study|Administrative Problems|2|||
145232538|NCT00819585|523697401|FG007|Core Study|Administrative Problems|0|||
145232539|NCT00819585|523697402|FG008|Core Study|Administrative Problems|0|||
145232540|NCT00819585|523697403|FG009|Core Study|Administrative Problems|0|||
145232541|NCT00819585|523697404|FG010|Core Study|Administrative Problems|0|||
145232542|NCT00819585|523697394|FG000|Core Study|Death|0|||
145232543|NCT00819585|523697395|FG001|Core Study|Death|0|||
145232544|NCT00819585|523697396|FG002|Core Study|Death|0|||
145232545|NCT00819585|523697397|FG003|Core Study|Death|0|||
145232546|NCT00819585|523697398|FG004|Core Study|Death|0|||
145232547|NCT00819585|523697399|FG005|Core Study|Death|0|||
145232548|NCT00819585|523697400|FG006|Core Study|Death|1|||
145232549|NCT00819585|523697401|FG007|Core Study|Death|0|||
145232550|NCT00819585|523697402|FG008|Core Study|Death|0|||
145232551|NCT00819585|523697403|FG009|Core Study|Death|0|||
145232552|NCT00819585|523697404|FG010|Core Study|Death|0|||
145232553|NCT00819585|523697394|FG000|Core Study|Protocol Violation|0|||
145232554|NCT00819585|523697395|FG001|Core Study|Protocol Violation|0|||
145232555|NCT00819585|523697396|FG002|Core Study|Protocol Violation|1|||
145232556|NCT00819585|523697397|FG003|Core Study|Protocol Violation|0|||
145232557|NCT00819585|523697398|FG004|Core Study|Protocol Violation|0|||
145232558|NCT00819585|523697399|FG005|Core Study|Protocol Violation|1|||
145232559|NCT00819585|523697400|FG006|Core Study|Protocol Violation|3|||
145232560|NCT00819585|523697401|FG007|Core Study|Protocol Violation|0|||
145232561|NCT00819585|523697402|FG008|Core Study|Protocol Violation|0|||
145232562|NCT00819585|523697403|FG009|Core Study|Protocol Violation|0|||
145232563|NCT00819585|523697404|FG010|Core Study|Protocol Violation|0|||
145232564|NCT00819585|523697394|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
145232565|NCT00819585|523697395|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
145232566|NCT00819585|523697396|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
145232567|NCT00819585|523697397|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
145232568|NCT00819585|523697398|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
145232569|NCT00819585|523697399|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
145232570|NCT00819585|523697400|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
145232571|NCT00819585|523697401|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
145232572|NCT00819585|523697402|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
145232573|NCT00819585|523697403|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
145232574|NCT00819585|523697404|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
145232575|NCT00819585|523697394|FG000|Extension Study|Subject Withdrew Consent|0|||
145232576|NCT00819585|523697395|FG001|Extension Study|Subject Withdrew Consent|0|||
145232577|NCT00819585|523697396|FG002|Extension Study|Subject Withdrew Consent|0|||
145232578|NCT00819585|523697397|FG003|Extension Study|Subject Withdrew Consent|0|||
145232579|NCT00819585|523697398|FG004|Extension Study|Subject Withdrew Consent|0|||
145232580|NCT00819585|523697399|FG005|Extension Study|Subject Withdrew Consent|0|||
145232581|NCT00819585|523697400|FG006|Extension Study|Subject Withdrew Consent|0|||
145232582|NCT00819585|523697401|FG007|Extension Study|Subject Withdrew Consent|0|||
145232583|NCT00819585|523697402|FG008|Extension Study|Subject Withdrew Consent|3|||
145232584|NCT00819585|523697403|FG009|Extension Study|Subject Withdrew Consent|0|||
145232585|NCT00819585|523697404|FG010|Extension Study|Subject Withdrew Consent|1|||
145232586|NCT00819585|523697394|FG000|Extension Study|Lost to Follow-up|0|||
145232587|NCT00819585|523697395|FG001|Extension Study|Lost to Follow-up|0|||
145232588|NCT00819585|523697396|FG002|Extension Study|Lost to Follow-up|0|||
145232589|NCT00819585|523697397|FG003|Extension Study|Lost to Follow-up|0|||
145232590|NCT00819585|523697398|FG004|Extension Study|Lost to Follow-up|0|||
145294971|NCT03952143|523930661|FG000|Treatment Period|Withdrawal by Subject|0|||
145232591|NCT00819585|523697399|FG005|Extension Study|Lost to Follow-up|0|||
145232592|NCT00819585|523697400|FG006|Extension Study|Lost to Follow-up|0|||
145232593|NCT00819585|523697401|FG007|Extension Study|Lost to Follow-up|0|||
145232594|NCT00819585|523697402|FG008|Extension Study|Lost to Follow-up|2|||
145294972|NCT03952143|523930662|FG001|Treatment Period|Withdrawal by Subject|5|||
145232595|NCT00819585|523697403|FG009|Extension Study|Lost to Follow-up|1|||
145232596|NCT00819585|523697404|FG010|Extension Study|Lost to Follow-up|1|||
145294973|NCT03952143|523930663|FG002|Treatment Period|Withdrawal by Subject|26|||
145232597|NCT00819585|523697394|FG000|Extension Study|Death|0|||
145232598|NCT00819585|523697395|FG001|Extension Study|Death|0|||
145232599|NCT00819585|523697396|FG002|Extension Study|Death|0|||
145232600|NCT00819585|523697397|FG003|Extension Study|Death|0|||
145232601|NCT00819585|523697398|FG004|Extension Study|Death|0|||
145232602|NCT00819585|523697399|FG005|Extension Study|Death|0|||
145232603|NCT00819585|523697400|FG006|Extension Study|Death|0|||
145232604|NCT00819585|523697401|FG007|Extension Study|Death|0|||
145232605|NCT00819585|523697402|FG008|Extension Study|Death|2|||
145232606|NCT00819585|523697403|FG009|Extension Study|Death|0|||
145232607|NCT00819585|523697404|FG010|Extension Study|Death|0|||
145232608|NCT00738374|523697405|FG000|Induction Treatment Phase|Adverse Event|14|||
145232609|NCT00738374|523697406|FG001|Induction Treatment Phase|Adverse Event|0|||
145232610|NCT00738374|523697407|FG002|Induction Treatment Phase|Adverse Event|0|||
145232611|NCT00738374|523697408|FG003|Induction Treatment Phase|Adverse Event|0|||
145232612|NCT00738374|523697405|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
145232613|NCT00738374|523697406|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
145232614|NCT00738374|523697407|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
145232615|NCT00738374|523697408|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
145232616|NCT00738374|523697405|FG000|Induction Treatment Phase|Physician Decision|2|||
145232617|NCT00738374|523697406|FG001|Induction Treatment Phase|Physician Decision|0|||
145232618|NCT00738374|523697407|FG002|Induction Treatment Phase|Physician Decision|0|||
145232619|NCT00738374|523697408|FG003|Induction Treatment Phase|Physician Decision|0|||
145232620|NCT00738374|523697405|FG000|Induction Treatment Phase|Protocol Violation|2|||
145232621|NCT00738374|523697406|FG001|Induction Treatment Phase|Protocol Violation|0|||
145232622|NCT00738374|523697407|FG002|Induction Treatment Phase|Protocol Violation|0|||
145232623|NCT00738374|523697408|FG003|Induction Treatment Phase|Protocol Violation|0|||
145232624|NCT00738374|523697405|FG000|Induction Treatment Phase|Non-compliance|1|||
145232625|NCT00738374|523697406|FG001|Induction Treatment Phase|Non-compliance|0|||
145232626|NCT00738374|523697407|FG002|Induction Treatment Phase|Non-compliance|0|||
145232627|NCT00738374|523697408|FG003|Induction Treatment Phase|Non-compliance|0|||
145232628|NCT00738374|523697405|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
145232629|NCT00738374|523697406|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
145232630|NCT00738374|523697407|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
145232631|NCT00738374|523697408|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
145232632|NCT00738374|523697405|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
145232633|NCT00738374|523697406|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
145232634|NCT00738374|523697407|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
145232635|NCT00738374|523697408|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
145232636|NCT00738374|523697405|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
145232637|NCT00738374|523697406|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
145232638|NCT00738374|523697407|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
145232639|NCT00738374|523697408|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
145232640|NCT00738374|523697405|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
145232641|NCT00738374|523697406|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
145232642|NCT00738374|523697407|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
145232643|NCT00738374|523697408|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
145232644|NCT00738374|523697405|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
145232645|NCT00738374|523697406|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
145232646|NCT00738374|523697407|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
145232647|NCT00738374|523697408|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
145232648|NCT00738374|523697405|FG000|Maintenance Treatment/Observation Phase|Other|0|||
145232649|NCT00738374|523697406|FG001|Maintenance Treatment/Observation Phase|Other|1|||
145232650|NCT00738374|523697407|FG002|Maintenance Treatment/Observation Phase|Other|0|||
145232651|NCT00738374|523697408|FG003|Maintenance Treatment/Observation Phase|Other|0|||
145232652|NCT00632541|523697409|FG000|Overall Study|Adverse Event|7|||
145232653|NCT03334396|523697410|FG000|Overall Study|Adverse Event|1|||
145232654|NCT03334396|523697411|FG001|Overall Study|Adverse Event|0|||
145232655|NCT03334396|523697412|FG002|Overall Study|Adverse Event|1|||
145232656|NCT03334396|523697413|FG003|Overall Study|Adverse Event|0|||
145232657|NCT03334396|523697414|FG004|Overall Study|Adverse Event|0|||
145232658|NCT03334396|523697415|FG005|Overall Study|Adverse Event|0|||
145232659|NCT03334396|523697416|FG006|Overall Study|Adverse Event|0|||
145232660|NCT03334396|523697417|FG007|Overall Study|Adverse Event|0|||
145232661|NCT03334396|523697410|FG000|Overall Study|Lack of Efficacy|10|||
145232662|NCT03334396|523697411|FG001|Overall Study|Lack of Efficacy|4|||
145232663|NCT03334396|523697412|FG002|Overall Study|Lack of Efficacy|1|||
145232664|NCT03334396|523697413|FG003|Overall Study|Lack of Efficacy|3|||
145232665|NCT03334396|523697414|FG004|Overall Study|Lack of Efficacy|1|||
145294974|NCT03952143|523930661|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
145294975|NCT03952143|523930662|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
145232666|NCT03334396|523697415|FG005|Overall Study|Lack of Efficacy|0|||
145232667|NCT03334396|523697416|FG006|Overall Study|Lack of Efficacy|0|||
145232668|NCT03334396|523697417|FG007|Overall Study|Lack of Efficacy|1|||
145232669|NCT03334396|523697410|FG000|Overall Study|Lost to Follow-up|0|||
145232670|NCT03334396|523697411|FG001|Overall Study|Lost to Follow-up|0|||
145232671|NCT03334396|523697412|FG002|Overall Study|Lost to Follow-up|1|||
145232672|NCT03334396|523697413|FG003|Overall Study|Lost to Follow-up|0|||
145232673|NCT03334396|523697414|FG004|Overall Study|Lost to Follow-up|0|||
145232674|NCT03334396|523697415|FG005|Overall Study|Lost to Follow-up|0|||
145232675|NCT03334396|523697416|FG006|Overall Study|Lost to Follow-up|1|||
145232676|NCT03334396|523697417|FG007|Overall Study|Lost to Follow-up|0|||
145232677|NCT03334396|523697410|FG000|Overall Study|Physician Decision|1|||
145232678|NCT03334396|523697411|FG001|Overall Study|Physician Decision|0|||
145232679|NCT03334396|523697412|FG002|Overall Study|Physician Decision|0|||
145232680|NCT03334396|523697413|FG003|Overall Study|Physician Decision|0|||
145232681|NCT03334396|523697414|FG004|Overall Study|Physician Decision|0|||
145232682|NCT03334396|523697415|FG005|Overall Study|Physician Decision|0|||
145232683|NCT03334396|523697416|FG006|Overall Study|Physician Decision|0|||
145232684|NCT03334396|523697417|FG007|Overall Study|Physician Decision|0|||
145232685|NCT03334396|523697410|FG000|Overall Study|Withdrawal by Subject|10|||
145232686|NCT03334396|523697411|FG001|Overall Study|Withdrawal by Subject|5|||
145232687|NCT03334396|523697412|FG002|Overall Study|Withdrawal by Subject|7|||
145232688|NCT03334396|523697413|FG003|Overall Study|Withdrawal by Subject|2|||
145232689|NCT03334396|523697414|FG004|Overall Study|Withdrawal by Subject|2|||
145232690|NCT03334396|523697415|FG005|Overall Study|Withdrawal by Subject|1|||
145232691|NCT03334396|523697416|FG006|Overall Study|Withdrawal by Subject|2|||
145232692|NCT03334396|523697417|FG007|Overall Study|Withdrawal by Subject|0|||
145232693|NCT03334396|523697410|FG000|Overall Study|Pregnancy|0|||
145232694|NCT03334396|523697411|FG001|Overall Study|Pregnancy|1|||
145232695|NCT03334396|523697412|FG002|Overall Study|Pregnancy|0|||
145232696|NCT03334396|523697413|FG003|Overall Study|Pregnancy|0|||
145232697|NCT03334396|523697414|FG004|Overall Study|Pregnancy|0|||
145232698|NCT03334396|523697415|FG005|Overall Study|Pregnancy|0|||
145232699|NCT03334396|523697416|FG006|Overall Study|Pregnancy|0|||
145232700|NCT03334396|523697417|FG007|Overall Study|Pregnancy|0|||
145232701|NCT03334396|523697410|FG000|Overall Study|Ineligible|0|||
145232702|NCT03334396|523697411|FG001|Overall Study|Ineligible|1|||
145232703|NCT03334396|523697412|FG002|Overall Study|Ineligible|0|||
145232704|NCT03334396|523697413|FG003|Overall Study|Ineligible|0|||
145232705|NCT03334396|523697414|FG004|Overall Study|Ineligible|0|||
145232706|NCT03334396|523697415|FG005|Overall Study|Ineligible|0|||
145232707|NCT03334396|523697416|FG006|Overall Study|Ineligible|0|||
145232708|NCT03334396|523697417|FG007|Overall Study|Ineligible|0|||
145232709|NCT03334396|523697410|FG000|Overall Study|Started New Job|1|||
145232710|NCT03334396|523697411|FG001|Overall Study|Started New Job|0|||
145232711|NCT03334396|523697412|FG002|Overall Study|Started New Job|0|||
145232712|NCT03334396|523697413|FG003|Overall Study|Started New Job|0|||
145232713|NCT03334396|523697414|FG004|Overall Study|Started New Job|0|||
145232714|NCT03334396|523697415|FG005|Overall Study|Started New Job|0|||
145232715|NCT03334396|523697416|FG006|Overall Study|Started New Job|0|||
145232716|NCT03334396|523697417|FG007|Overall Study|Started New Job|0|||
145232717|NCT02927873|523697422|FG000|Overall Study|Lost to Follow-up|0|||
145232718|NCT02927873|523697423|FG001|Overall Study|Lost to Follow-up|1|||
145232719|NCT02927873|523697424|FG002|Overall Study|Lost to Follow-up|0|||
145232720|NCT02927873|523697425|FG003|Overall Study|Lost to Follow-up|0|||
145232721|NCT02927873|523697426|FG004|Overall Study|Lost to Follow-up|0|||
145232722|NCT02927873|523697427|FG005|Overall Study|Lost to Follow-up|0|||
145232723|NCT02927873|523697422|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145232724|NCT02927873|523697423|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145232725|NCT02927873|523697424|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145232726|NCT02927873|523697425|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145232727|NCT02927873|523697426|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145232728|NCT02927873|523697427|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145232729|NCT02927873|523697422|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232730|NCT02927873|523697423|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232731|NCT02927873|523697424|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232732|NCT02927873|523697425|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232733|NCT02927873|523697426|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232734|NCT02927873|523697427|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145232735|NCT02927873|523697422|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
145232736|NCT02927873|523697423|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
145232737|NCT02927873|523697424|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
145232738|NCT02927873|523697425|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
145232739|NCT02927873|523697426|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
145232740|NCT02927873|523697427|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
145232741|NCT02927873|523697422|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
145232742|NCT02927873|523697423|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
145232743|NCT02927873|523697424|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
145619901|NCT02892409|525123616|FG000|Overall Study|Withdrawal by Subject|2|||
145619902|NCT02892409|525123617|FG001|Overall Study|Withdrawal by Subject|1|||
145619903|NCT05305040|525123618|FG000|Overall Study|Not Dosed|37|||
145619904|NCT05305040|525123619|FG001|Overall Study|Not Dosed|37|||
145619905|NCT05305040|525123618|FG000|Overall Study|Study Closure|34|||
145232744|NCT02927873|523697425|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
145232745|NCT02927873|523697426|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
145232746|NCT02927873|523697427|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
145232747|NCT02927873|523697422|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
145232748|NCT02927873|523697423|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
145232749|NCT02927873|523697424|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
145232750|NCT02927873|523697425|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
145232751|NCT02927873|523697426|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
145232752|NCT02927873|523697427|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
145232753|NCT01766817|523697430|FG000|Overall Study|Drug-related adverse event|1|||
145232754|NCT01766817|523697431|FG001|Overall Study|Drug-related adverse event|2|||
145232755|NCT01766817|523697432|FG002|Overall Study|Drug-related adverse event|1|||
145232756|NCT01766817|523697430|FG000|Overall Study|Drug-unrelated adverse event|3|||
145232757|NCT01766817|523697431|FG001|Overall Study|Drug-unrelated adverse event|3|||
145232758|NCT01766817|523697432|FG002|Overall Study|Drug-unrelated adverse event|3|||
145232759|NCT01766817|523697430|FG000|Overall Study|Death|1|||
145232760|NCT01766817|523697431|FG001|Overall Study|Death|1|||
145232761|NCT01766817|523697432|FG002|Overall Study|Death|0|||
145232762|NCT01766817|523697430|FG000|Overall Study|Unable to take study drug|0|||
145232763|NCT01766817|523697431|FG001|Overall Study|Unable to take study drug|1|||
145232764|NCT01766817|523697432|FG002|Overall Study|Unable to take study drug|0|||
145232765|NCT01766817|523697430|FG000|Overall Study|Withdrawal by Subject|2|||
145232766|NCT01766817|523697431|FG001|Overall Study|Withdrawal by Subject|0|||
145232767|NCT01766817|523697432|FG002|Overall Study|Withdrawal by Subject|3|||
145232768|NCT01766817|523697430|FG000|Overall Study|Subject non-compliance|0|||
145232769|NCT01766817|523697431|FG001|Overall Study|Subject non-compliance|1|||
145232770|NCT01766817|523697432|FG002|Overall Study|Subject non-compliance|2|||
145232771|NCT01766817|523697430|FG000|Overall Study|Physician Decision|3|||
145232772|NCT01766817|523697431|FG001|Overall Study|Physician Decision|3|||
145232773|NCT01766817|523697432|FG002|Overall Study|Physician Decision|4|||
145232774|NCT01766817|523697430|FG000|Overall Study|Other|1|||
145232775|NCT01766817|523697431|FG001|Overall Study|Other|0|||
145232776|NCT01766817|523697432|FG002|Overall Study|Other|0|||
145232777|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
145232778|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
145232779|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
145232780|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
145232781|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
145232782|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
145232783|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
145232784|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
145232785|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
145232786|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
145232787|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
145232788|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
145232789|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
145232790|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
145232791|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
145232792|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
145232793|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
145232794|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
145232795|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
145232796|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
145232797|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
145232798|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
145232799|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
145619906|NCT05305040|525123619|FG001|Overall Study|Study Closure|46|||
145232800|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
145232801|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
145232802|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
145232803|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
145619907|NCT05305040|525123618|FG000|Overall Study|Death|14|||
145232804|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
145232805|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
145232806|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
145232807|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
145232808|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
145232809|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
145232810|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
145232811|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
145232812|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
145232813|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
145232814|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
145232815|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
145232816|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
145232817|NCT00383721|523697439|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
145232818|NCT00383721|523697440|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
145232819|NCT00383721|523697441|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
145232820|NCT00383721|523697442|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
145232821|NCT00383721|523697443|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
145232822|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
145232823|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
145232824|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
145232825|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
145232826|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
145232827|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
145232828|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
145232829|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
145232830|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
145232831|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
145232832|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
145232833|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
145232834|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
145232835|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
145232836|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
145232837|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
145232838|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
145232839|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
145232840|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
145232841|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
145232842|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145232843|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145232844|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145232845|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145232846|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
145232847|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
145232848|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
145232849|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
145232850|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
145232851|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
145232852|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
145232853|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
145232854|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
145232855|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
145232856|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
145232857|NCT00383721|523697439|FG000|26-Week Treatment Safety Extension|Administrative|1|||
145232858|NCT00383721|523697440|FG001|26-Week Treatment Safety Extension|Administrative|2|||
145232859|NCT00383721|523697441|FG002|26-Week Treatment Safety Extension|Administrative|3|||
145232860|NCT00383721|523697442|FG003|26-Week Treatment Safety Extension|Administrative|1|||
145232861|NCT00383721|523697443|FG004|26-Week Treatment Safety Extension|Administrative|0|||
145232862|NCT03814590|523697444|FG000|Overall Study|Adverse Event|0|||
145232863|NCT03814590|523697445|FG001|Overall Study|Adverse Event|0|||
145232864|NCT03814590|523697446|FG002|Overall Study|Adverse Event|0|||
145232865|NCT03814590|523697447|FG003|Overall Study|Adverse Event|0|||
145232866|NCT03814590|523697448|FG004|Overall Study|Adverse Event|0|||
145619908|NCT05305040|525123619|FG001|Overall Study|Death|13|||
145619909|NCT05305040|525123618|FG000|Overall Study|Withdrawal by Subject|15|||
145232867|NCT03814590|523697449|FG005|Overall Study|Adverse Event|1|||
145232868|NCT03814590|523697450|FG006|Overall Study|Adverse Event|1|||
145232869|NCT03814590|523697451|FG007|Overall Study|Adverse Event|1|||
145294976|NCT03952143|523930663|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
145294977|NCT03952143|523930661|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
145294978|NCT03952143|523930662|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
145294979|NCT03952143|523930663|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
145294980|NCT01866319|523930664|FG000|Overall Study|Adverse Event|12|||
145232870|NCT03814590|523697452|FG008|Overall Study|Adverse Event|0|||
145232871|NCT03814590|523697453|FG009|Overall Study|Adverse Event|0|||
145232872|NCT03814590|523697454|FG010|Overall Study|Adverse Event|1|||
145232873|NCT03814590|523697455|FG011|Overall Study|Adverse Event|0|||
145232874|NCT03814590|523697456|FG012|Overall Study|Adverse Event|3|||
145232875|NCT03814590|523697457|FG013|Overall Study|Adverse Event|0|||
145232876|NCT03814590|523697444|FG000|Overall Study|Lost to Follow-up|0|||
145232877|NCT03814590|523697445|FG001|Overall Study|Lost to Follow-up|2|||
145232878|NCT03814590|523697446|FG002|Overall Study|Lost to Follow-up|1|||
145232879|NCT03814590|523697447|FG003|Overall Study|Lost to Follow-up|0|||
145232880|NCT03814590|523697448|FG004|Overall Study|Lost to Follow-up|1|||
145232881|NCT03814590|523697449|FG005|Overall Study|Lost to Follow-up|1|||
145232882|NCT03814590|523697450|FG006|Overall Study|Lost to Follow-up|1|||
145232883|NCT03814590|523697451|FG007|Overall Study|Lost to Follow-up|1|||
145232884|NCT03814590|523697452|FG008|Overall Study|Lost to Follow-up|0|||
145232885|NCT03814590|523697453|FG009|Overall Study|Lost to Follow-up|0|||
145232886|NCT03814590|523697454|FG010|Overall Study|Lost to Follow-up|1|||
145232887|NCT03814590|523697455|FG011|Overall Study|Lost to Follow-up|0|||
145232888|NCT03814590|523697456|FG012|Overall Study|Lost to Follow-up|0|||
145232889|NCT03814590|523697457|FG013|Overall Study|Lost to Follow-up|1|||
145232890|NCT03814590|523697444|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232891|NCT03814590|523697445|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232892|NCT03814590|523697446|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232893|NCT03814590|523697447|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232894|NCT03814590|523697448|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232895|NCT03814590|523697449|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232896|NCT03814590|523697450|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232897|NCT03814590|523697451|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232898|NCT03814590|523697452|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232899|NCT03814590|523697453|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
145232900|NCT03814590|523697454|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232901|NCT03814590|523697455|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232902|NCT03814590|523697456|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232903|NCT03814590|523697457|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
145232904|NCT03814590|523697444|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232905|NCT03814590|523697445|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232906|NCT03814590|523697446|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232907|NCT03814590|523697447|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232908|NCT03814590|523697448|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232909|NCT03814590|523697449|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
145232910|NCT03814590|523697450|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
145232911|NCT03814590|523697451|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
145232912|NCT03814590|523697452|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232913|NCT03814590|523697453|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
145232914|NCT03814590|523697454|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
145232915|NCT03814590|523697455|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
145232916|NCT03814590|523697456|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
145232917|NCT03814590|523697457|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
145232918|NCT03814590|523697444|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232919|NCT03814590|523697445|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232920|NCT03814590|523697446|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232921|NCT03814590|523697447|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232922|NCT03814590|523697448|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232923|NCT03814590|523697449|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232924|NCT03814590|523697450|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145294981|NCT01866319|523930665|FG001|Overall Study|Adverse Event|5|||
145232925|NCT03814590|523697451|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145232926|NCT03814590|523697452|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232927|NCT03814590|523697453|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145232928|NCT03814590|523697454|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232929|NCT03814590|523697455|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232930|NCT03814590|523697456|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232931|NCT03814590|523697457|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145232932|NCT03814590|523697444|FG000|Overall Study|UNKNOWN REASON|0|||
145232933|NCT03814590|523697445|FG001|Overall Study|UNKNOWN REASON|0|||
145232934|NCT03814590|523697446|FG002|Overall Study|UNKNOWN REASON|0|||
145232935|NCT03814590|523697447|FG003|Overall Study|UNKNOWN REASON|0|||
145232936|NCT03814590|523697448|FG004|Overall Study|UNKNOWN REASON|0|||
145232937|NCT03814590|523697449|FG005|Overall Study|UNKNOWN REASON|0|||
145232938|NCT03814590|523697450|FG006|Overall Study|UNKNOWN REASON|0|||
145232939|NCT03814590|523697451|FG007|Overall Study|UNKNOWN REASON|1|||
145232940|NCT03814590|523697452|FG008|Overall Study|UNKNOWN REASON|0|||
145232941|NCT03814590|523697453|FG009|Overall Study|UNKNOWN REASON|0|||
145232942|NCT03814590|523697454|FG010|Overall Study|UNKNOWN REASON|0|||
145232943|NCT03814590|523697455|FG011|Overall Study|UNKNOWN REASON|0|||
145232944|NCT03814590|523697456|FG012|Overall Study|UNKNOWN REASON|0|||
145232945|NCT03814590|523697457|FG013|Overall Study|UNKNOWN REASON|0|||
145232946|NCT03519516|523697458|FG000|Overall Study|Adverse Event|0|||
145232947|NCT03519516|523697459|FG001|Overall Study|Adverse Event|1|||
145232948|NCT02379390|523697460|FG000|Overall Study|Adverse Event|1|||
145232949|NCT02379390|523697461|FG001|Overall Study|Adverse Event|1|||
145232950|NCT02379390|523697460|FG000|Overall Study|Investigator's decision|1|||
145232951|NCT02379390|523697461|FG001|Overall Study|Investigator's decision|0|||
145232952|NCT02379390|523697460|FG000|Overall Study|Study Termination|0|||
145232953|NCT02379390|523697461|FG001|Overall Study|Study Termination|1|||
145232954|NCT00077376|523697470|FG000|Overall Study|Adverse Event|8|||
145232955|NCT00077376|523697470|FG000|Overall Study|Withdrawal by Subject|2|||
145232956|NCT00077376|523697470|FG000|Overall Study|Death|1|||
145232957|NCT00077376|523697470|FG000|Overall Study|Physician Decision|1|||
145232958|NCT00077376|523697470|FG000|Overall Study|Alternative therapy|5|||
145232959|NCT00077376|523697470|FG000|Overall Study|Complicating disease|1|||
145232960|NCT00077376|523697470|FG000|Overall Study|Still on treatment|1|||
145232961|NCT00077376|523697470|FG000|Overall Study|Symptomatic deterioration|1|||
145232962|NCT00077376|523697470|FG000|Overall Study|Surgery|1|||
145232963|NCT00077376|523697470|FG000|Overall Study|Insurance ran out|1|||
145232964|NCT03784027|523697471|FG000|Period 1|Withdrawal by Subject|0|||
145232965|NCT03784027|523697472|FG001|Period 1|Withdrawal by Subject|1|||
145232966|NCT03833817|523699295|FG000|Overall Study|Withdrawal by Subject|3|||
145232967|NCT03833817|523699296|FG001|Overall Study|Withdrawal by Subject|3|||
145232968|NCT03833817|523699295|FG000|Overall Study|Lost to Follow-up|3|||
145232969|NCT03833817|523699296|FG001|Overall Study|Lost to Follow-up|3|||
145232970|NCT00884221|523699297|FG000|Overall Study|Withdrawal by Subject|0|||
145232971|NCT00884221|523699298|FG001|Overall Study|Withdrawal by Subject|3|||
145232972|NCT00884221|523699297|FG000|Overall Study|Adverse Event|6|||
145232973|NCT00884221|523699298|FG001|Overall Study|Adverse Event|3|||
145232974|NCT00884221|523699297|FG000|Overall Study|Protocol Violation|16|||
145232975|NCT00884221|523699298|FG001|Overall Study|Protocol Violation|13|||
145232976|NCT00884221|523699297|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
145232977|NCT00884221|523699298|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
145232978|NCT02126670|523699301|FG000|Overall Study|Withdrawal by Subject|1|||
145232979|NCT02126670|523699302|FG001|Overall Study|Withdrawal by Subject|0|||
145232980|NCT02126670|523699303|FG002|Overall Study|Withdrawal by Subject|0|||
145232981|NCT02126670|523699304|FG003|Overall Study|Withdrawal by Subject|1|||
145232982|NCT01975246|523699307|FG000|Overall Study|Adverse Event|2|||
145232983|NCT01975246|523699308|FG001|Overall Study|Adverse Event|1|||
145232984|NCT01975246|523699307|FG000|Overall Study|Lack of Efficacy|1|||
145232985|NCT01975246|523699308|FG001|Overall Study|Lack of Efficacy|0|||
145232986|NCT01975246|523699307|FG000|Overall Study|Protocol Violation|1|||
145232987|NCT01975246|523699308|FG001|Overall Study|Protocol Violation|0|||
145232988|NCT01975246|523699307|FG000|Overall Study|Other than stated|0|||
145232989|NCT01975246|523699308|FG001|Overall Study|Other than stated|1|||
145232990|NCT00255034|523699309|FG000|Overall Study|Withdrawal by Subject|15|||
145232991|NCT00255034|523699310|FG001|Overall Study|Withdrawal by Subject|38|||
145232992|NCT01263093|523699311|FG000|Washout|Physician Decision|1|||
145232993|NCT01263093|523699312|FG001|Washout|Physician Decision|0|||
145232994|NCT01263093|523699311|FG000|Period 2|Adverse Event|1|||
145232995|NCT01263093|523699312|FG001|Period 2|Adverse Event|0|||
145232996|NCT00424346|523699313|FG000|Core Study|Adverse Event|5|||
145232997|NCT00424346|523699314|FG001|Core Study|Adverse Event|3|||
145232998|NCT00424346|523699315|FG002|Core Study|Adverse Event|1|||
145232999|NCT00424346|523699316|FG003|Core Study|Adverse Event|1|||
145233000|NCT00424346|523699313|FG000|Core Study|Abnormal Laboratory Values|0|||
145233001|NCT00424346|523699314|FG001|Core Study|Abnormal Laboratory Values|1|||
145233002|NCT00424346|523699315|FG002|Core Study|Abnormal Laboratory Values|0|||
145233003|NCT00424346|523699316|FG003|Core Study|Abnormal Laboratory Values|0|||
145233004|NCT00424346|523699313|FG000|Core Study|Lack of Efficacy|1|||
145233005|NCT00424346|523699314|FG001|Core Study|Lack of Efficacy|3|||
145233006|NCT00424346|523699315|FG002|Core Study|Lack of Efficacy|0|||
145233007|NCT00424346|523699316|FG003|Core Study|Lack of Efficacy|4|||
145233008|NCT00424346|523699313|FG000|Core Study|Withdrawal by Subject|1|||
145233009|NCT00424346|523699314|FG001|Core Study|Withdrawal by Subject|0|||
145562489|NCT00156533|524920048|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
145562490|NCT00156533|524920049|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
145233010|NCT00424346|523699315|FG002|Core Study|Withdrawal by Subject|0|||
145233011|NCT00424346|523699316|FG003|Core Study|Withdrawal by Subject|2|||
145233012|NCT00424346|523699313|FG000|Core Study|Lost to Follow-up|1|||
145233013|NCT00424346|523699314|FG001|Core Study|Lost to Follow-up|1|||
145233014|NCT00424346|523699315|FG002|Core Study|Lost to Follow-up|0|||
145233015|NCT00424346|523699316|FG003|Core Study|Lost to Follow-up|0|||
145233016|NCT00424346|523699313|FG000|Core Study|Administrative Problems|1|||
145233017|NCT00424346|523699314|FG001|Core Study|Administrative Problems|0|||
145233018|NCT00424346|523699315|FG002|Core Study|Administrative Problems|1|||
145233019|NCT00424346|523699316|FG003|Core Study|Administrative Problems|0|||
145233020|NCT00424346|523699313|FG000|Core Study|Protocol Violation|0|||
145233021|NCT00424346|523699314|FG001|Core Study|Protocol Violation|0|||
145233022|NCT00424346|523699315|FG002|Core Study|Protocol Violation|2|||
145233023|NCT00424346|523699316|FG003|Core Study|Protocol Violation|0|||
145233024|NCT00424346|523699313|FG000|Extension Phase|Adverse Event|0|||
145233025|NCT00424346|523699314|FG001|Extension Phase|Adverse Event|9|||
145233026|NCT00424346|523699315|FG002|Extension Phase|Adverse Event|5|||
145233027|NCT00424346|523699316|FG003|Extension Phase|Adverse Event|4|||
145233028|NCT00424346|523699313|FG000|Extension Phase|Lack of Efficacy|0|||
145233029|NCT00424346|523699314|FG001|Extension Phase|Lack of Efficacy|16|||
145233030|NCT00424346|523699315|FG002|Extension Phase|Lack of Efficacy|14|||
145233031|NCT00424346|523699316|FG003|Extension Phase|Lack of Efficacy|11|||
145233032|NCT00424346|523699313|FG000|Extension Phase|Withdrawal by Subject|0|||
145233033|NCT00424346|523699314|FG001|Extension Phase|Withdrawal by Subject|5|||
145233034|NCT00424346|523699315|FG002|Extension Phase|Withdrawal by Subject|3|||
145233035|NCT00424346|523699316|FG003|Extension Phase|Withdrawal by Subject|4|||
145233036|NCT00424346|523699313|FG000|Extension Phase|Lost to Follow-up|0|||
145233037|NCT00424346|523699314|FG001|Extension Phase|Lost to Follow-up|2|||
145233038|NCT00424346|523699315|FG002|Extension Phase|Lost to Follow-up|0|||
145233039|NCT00424346|523699316|FG003|Extension Phase|Lost to Follow-up|0|||
145233040|NCT00424346|523699313|FG000|Extension Phase|Administrative Problems|0|||
145233041|NCT00424346|523699314|FG001|Extension Phase|Administrative Problems|69|||
145233042|NCT00424346|523699315|FG002|Extension Phase|Administrative Problems|32|||
145233043|NCT00424346|523699316|FG003|Extension Phase|Administrative Problems|35|||
145233044|NCT00424346|523699313|FG000|Extension Phase|Death|0|||
145233045|NCT00424346|523699314|FG001|Extension Phase|Death|0|||
145233046|NCT00424346|523699315|FG002|Extension Phase|Death|0|||
145233047|NCT00424346|523699316|FG003|Extension Phase|Death|1|||
145233048|NCT00424346|523699313|FG000|Extension Phase|Protocol Violation|0|||
145233049|NCT00424346|523699314|FG001|Extension Phase|Protocol Violation|1|||
145233050|NCT00424346|523699315|FG002|Extension Phase|Protocol Violation|1|||
145233051|NCT00424346|523699316|FG003|Extension Phase|Protocol Violation|0|||
145233052|NCT03287245|523699317|FG000|Overall Study|Study terminated by sponsor|3|||
145233053|NCT03287245|523699318|FG001|Overall Study|Study terminated by sponsor|0|||
145233054|NCT03287245|523699319|FG002|Overall Study|Study terminated by sponsor|3|||
145233055|NCT03287245|523699320|FG003|Overall Study|Study terminated by sponsor|1|||
145233056|NCT03287245|523699317|FG000|Overall Study|Adverse Event|1|||
145233057|NCT03287245|523699318|FG001|Overall Study|Adverse Event|0|||
145233058|NCT03287245|523699319|FG002|Overall Study|Adverse Event|0|||
145233059|NCT03287245|523699320|FG003|Overall Study|Adverse Event|0|||
145233060|NCT03287245|523699317|FG000|Overall Study|Withdrawal by Subject|8|||
145233061|NCT03287245|523699318|FG001|Overall Study|Withdrawal by Subject|3|||
145233062|NCT03287245|523699319|FG002|Overall Study|Withdrawal by Subject|3|||
145233063|NCT03287245|523699320|FG003|Overall Study|Withdrawal by Subject|0|||
145233064|NCT03287245|523699317|FG000|Overall Study|Physician Decision|3|||
145233065|NCT03287245|523699318|FG001|Overall Study|Physician Decision|2|||
145233066|NCT03287245|523699319|FG002|Overall Study|Physician Decision|0|||
145233067|NCT03287245|523699320|FG003|Overall Study|Physician Decision|0|||
145233068|NCT02701192|523699321|FG000|Overall Study|Protocol Violation|2|||
145233069|NCT02701192|523699321|FG000|Overall Study|Lost to Follow-up|4|||
145233070|NCT02862548|523699322|FG000|Randomized Phase (Up to Week 48)|Death|0|||
145233071|NCT02862548|523699323|FG001|Randomized Phase (Up to Week 48)|Death|1|||
145233072|NCT02862548|523699322|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
145233073|NCT02862548|523699323|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
145233074|NCT02862548|523699322|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
145233075|NCT02862548|523699323|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
145233076|NCT02862548|523699322|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
145233077|NCT02862548|523699323|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
145233078|NCT00880763|523699324|FG000|Extension Period (Part 2)|Adverse Event|0|||
145233079|NCT00880763|523699325|FG001|Extension Period (Part 2)|Adverse Event|0|||
145233080|NCT00880763|523699326|FG002|Extension Period (Part 2)|Adverse Event|1|||
145233081|NCT00880763|523699327|FG003|Extension Period (Part 2)|Adverse Event|1|||
145233082|NCT00880763|523699324|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
145233083|NCT00880763|523699325|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
145233084|NCT00880763|523699326|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
145233085|NCT00880763|523699327|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
145294982|NCT01866319|523930666|FG002|Overall Study|Adverse Event|9|||
145294983|NCT01866319|523930664|FG000|Overall Study|Clinical progression|3|||
145294984|NCT01866319|523930665|FG001|Overall Study|Clinical progression|2|||
145294985|NCT01866319|523930666|FG002|Overall Study|Clinical progression|2|||
145294986|NCT01866319|523930664|FG000|Overall Study|Death|153|||
145294987|NCT01866319|523930665|FG001|Overall Study|Death|154|||
145294988|NCT01866319|523930666|FG002|Overall Study|Death|147|||
145294989|NCT01866319|523930664|FG000|Overall Study|Lost to Follow-up|6|||
145294990|NCT01866319|523930665|FG001|Overall Study|Lost to Follow-up|3|||
145294991|NCT01866319|523930666|FG002|Overall Study|Lost to Follow-up|8|||
145294992|NCT01866319|523930664|FG000|Overall Study|Physician Decision|1|||
145294993|NCT01866319|523930665|FG001|Overall Study|Physician Decision|0|||
145294994|NCT01866319|523930666|FG002|Overall Study|Physician Decision|1|||
145294995|NCT01866319|523930664|FG000|Overall Study|Protocol Violation|0|||
145294996|NCT01866319|523930665|FG001|Overall Study|Protocol Violation|0|||
145294997|NCT01866319|523930666|FG002|Overall Study|Protocol Violation|1|||
145294998|NCT01866319|523930664|FG000|Overall Study|Withdrawal by Subject|32|||
145294999|NCT01866319|523930665|FG001|Overall Study|Withdrawal by Subject|14|||
145295000|NCT01866319|523930666|FG002|Overall Study|Withdrawal by Subject|12|||
145295001|NCT00623779|523930670|FG000|Overall Study|Adverse Event|1|||
145295002|NCT00623779|523930671|FG001|Overall Study|Adverse Event|3|||
145295003|NCT00623779|523930672|FG002|Overall Study|Adverse Event|0|||
145295004|NCT00623779|523930670|FG000|Overall Study|Criteria from CSR|2|||
145295005|NCT00623779|523930671|FG001|Overall Study|Criteria from CSR|0|||
145295006|NCT00623779|523930672|FG002|Overall Study|Criteria from CSR|1|||
145295007|NCT01856309|523930673|FG000|Overall Study|Death|4|||
145295008|NCT01856309|523930674|FG001|Overall Study|Death|6|||
145295009|NCT01856309|523930675|FG002|Overall Study|Death|11|||
145295010|NCT01856309|523930676|FG003|Overall Study|Death|6|||
145295011|NCT01856309|523930673|FG000|Overall Study|Lost to Follow-up|6|||
145295012|NCT01856309|523930674|FG001|Overall Study|Lost to Follow-up|2|||
145295013|NCT01856309|523930675|FG002|Overall Study|Lost to Follow-up|4|||
145295014|NCT01856309|523930676|FG003|Overall Study|Lost to Follow-up|8|||
145295015|NCT01856309|523930673|FG000|Overall Study|Withdrawal by Subject|11|||
145295016|NCT01856309|523930674|FG001|Overall Study|Withdrawal by Subject|13|||
145295017|NCT01856309|523930675|FG002|Overall Study|Withdrawal by Subject|28|||
145295018|NCT01856309|523930676|FG003|Overall Study|Withdrawal by Subject|26|||
145295019|NCT01856309|523930673|FG000|Overall Study|Other|227|||
145295020|NCT01856309|523930674|FG001|Overall Study|Other|225|||
145295021|NCT01856309|523930675|FG002|Overall Study|Other|447|||
145295022|NCT01856309|523930676|FG003|Overall Study|Other|469|||
145295023|NCT01856309|523930673|FG000|Overall Study|Lack of Efficacy|14|||
145295024|NCT01856309|523930674|FG001|Overall Study|Lack of Efficacy|9|||
145295025|NCT01856309|523930675|FG002|Overall Study|Lack of Efficacy|40|||
145295026|NCT01856309|523930676|FG003|Overall Study|Lack of Efficacy|25|||
145295027|NCT01856309|523930673|FG000|Overall Study|Adverse Event|31|||
145295028|NCT01856309|523930674|FG001|Overall Study|Adverse Event|31|||
145295029|NCT01856309|523930675|FG002|Overall Study|Adverse Event|55|||
145295030|NCT01856309|523930676|FG003|Overall Study|Adverse Event|65|||
145295031|NCT01856309|523930673|FG000|Overall Study|Pregnancy|0|||
145295032|NCT01856309|523930674|FG001|Overall Study|Pregnancy|0|||
145295033|NCT01856309|523930675|FG002|Overall Study|Pregnancy|0|||
145295034|NCT01856309|523930676|FG003|Overall Study|Pregnancy|1|||
145295035|NCT01856309|523930673|FG000|Overall Study|Physician Decision|6|||
145295036|NCT01856309|523930674|FG001|Overall Study|Physician Decision|1|||
145295037|NCT01856309|523930675|FG002|Overall Study|Physician Decision|6|||
145295038|NCT01856309|523930676|FG003|Overall Study|Physician Decision|8|||
145295039|NCT01856309|523930673|FG000|Overall Study|Noncompliance With Study Drug|0|||
145295040|NCT01856309|523930674|FG001|Overall Study|Noncompliance With Study Drug|1|||
145295041|NCT01856309|523930675|FG002|Overall Study|Noncompliance With Study Drug|4|||
145295042|NCT01856309|523930676|FG003|Overall Study|Noncompliance With Study Drug|1|||
145295043|NCT00832377|523930677|FG000|Overall Study|Protocol Violation|1|||
145295044|NCT00220337|523930678|FG000|Overall Study|Adverse Event|70|||
145295045|NCT00220337|523930678|FG000|Overall Study|Lack of Efficacy|17|||
145295046|NCT00220337|523930678|FG000|Overall Study|Withdrawal by Subject|68|||
145295047|NCT00220337|523930678|FG000|Overall Study|Protocol Violation|2|||
145295048|NCT00220337|523930678|FG000|Overall Study|Lost to Follow-up|5|||
145295049|NCT00220337|523930678|FG000|Overall Study|Other|12|||
145295050|NCT00220337|523930678|FG000|Overall Study|Unsatisfactory compliance|5|||
145295051|NCT01273181|523930679|FG000|Phase I, Dose 1|Study termination|1|||
145295052|NCT01273181|523930680|FG001|Phase I, Dose 1|Study termination|0|||
145295053|NCT01273181|523930681|FG002|Phase I, Dose 1|Study termination|0|||
145295054|NCT01273181|523930682|FG003|Phase I, Dose 1|Study termination|0|||
145295055|NCT01273181|523930679|FG000|Phase I, Dose 2|Death during treatment|0|||
145295056|NCT01273181|523930680|FG001|Phase I, Dose 2|Death during treatment|1|||
145295057|NCT01273181|523930681|FG002|Phase I, Dose 2|Death during treatment|0|||
145295058|NCT01273181|523930682|FG003|Phase I, Dose 2|Death during treatment|0|||
145295059|NCT01273181|523930679|FG000|Phase 2, Dose 1|Study termination|0|||
145295060|NCT01273181|523930680|FG001|Phase 2, Dose 1|Study termination|0|||
145233086|NCT00880763|523699324|FG000|Extension Period (Part 2)|Physician Decision|0|||
145233087|NCT00880763|523699325|FG001|Extension Period (Part 2)|Physician Decision|1|||
145233088|NCT00880763|523699326|FG002|Extension Period (Part 2)|Physician Decision|1|||
145233089|NCT00880763|523699327|FG003|Extension Period (Part 2)|Physician Decision|0|||
145233090|NCT00880763|523699324|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
145233091|NCT00880763|523699325|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
145233092|NCT00880763|523699326|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
145233093|NCT00880763|523699327|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
145233094|NCT02667457|523699329|FG000|Overall Study|Withdrawal by Subject|1|||
145233095|NCT02667457|523699330|FG001|Overall Study|Withdrawal by Subject|0|||
145233096|NCT02667457|523699329|FG000|Overall Study|Other Reason|0|||
145233097|NCT02667457|523699330|FG001|Overall Study|Other Reason|2|||
145233098|NCT00603733|523699333|FG000|Active Phase ITT|Adverse Event|8|||
145233099|NCT00603733|523699334|FG001|Active Phase ITT|Adverse Event|7|||
145233100|NCT00603733|523699333|FG000|Active Phase ITT|Withdrawal by Subject|0|||
145233101|NCT00603733|523699334|FG001|Active Phase ITT|Withdrawal by Subject|3|||
145233102|NCT00603733|523699333|FG000|Active Phase ITT|Lost to Follow-up|0|||
145233103|NCT00603733|523699334|FG001|Active Phase ITT|Lost to Follow-up|1|||
145233104|NCT00603733|523699333|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
145233105|NCT00603733|523699334|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
145233106|NCT00603733|523699333|FG000|Active Phase ITT|Lack of Efficacy|1|||
145233107|NCT00603733|523699334|FG001|Active Phase ITT|Lack of Efficacy|2|||
145233108|NCT00603733|523699333|FG000|Active Phase ITT|Subject moved, site closed|1|||
145233109|NCT00603733|523699334|FG001|Active Phase ITT|Subject moved, site closed|1|||
145233110|NCT00603733|523699333|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
145233111|NCT00603733|523699334|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
145233112|NCT00603733|523699333|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
145233113|NCT00603733|523699334|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
145233114|NCT00603733|523699333|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
145233115|NCT00603733|523699334|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
145233116|NCT00603733|523699333|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
145233117|NCT00603733|523699334|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
145233118|NCT00603733|523699333|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
145233119|NCT00603733|523699334|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
145233120|NCT00603733|523699333|FG000|Maintenance Phase ITT|Adverse Event|3|||
145233121|NCT00603733|523699334|FG001|Maintenance Phase ITT|Adverse Event|6|||
145233122|NCT00603733|523699333|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
145233123|NCT00603733|523699334|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
145233124|NCT00603733|523699333|FG000|Maintenance Phase ITT|Protocol Violation|1|||
145233125|NCT00603733|523699334|FG001|Maintenance Phase ITT|Protocol Violation|1|||
145233126|NCT00603733|523699333|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
145233127|NCT00603733|523699334|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
145233128|NCT00603733|523699333|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
145233129|NCT00603733|523699334|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
145233130|NCT00603733|523699333|FG000|Maintenance Phase ITT|Physician Decision|0|||
145233131|NCT00603733|523699334|FG001|Maintenance Phase ITT|Physician Decision|1|||
145233132|NCT00603733|523699333|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
145233133|NCT00603733|523699334|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
145233134|NCT01253187|523699344|FG000|Period 2|Withdrawal by Subject|0|||
145233135|NCT01253187|523699345|FG001|Period 2|Withdrawal by Subject|0|||
145233136|NCT01253187|523699346|FG002|Period 2|Withdrawal by Subject|0|||
145233137|NCT01253187|523699347|FG003|Period 2|Withdrawal by Subject|0|||
145233138|NCT01253187|523699348|FG004|Period 2|Withdrawal by Subject|1|||
145233139|NCT01253187|523699349|FG005|Period 2|Withdrawal by Subject|0|||
145562491|NCT00156533|524920050|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
145233140|NCT01253187|523699344|FG000|Period 3|Pregnancy|1|||
145233141|NCT01253187|523699345|FG001|Period 3|Pregnancy|0|||
145233142|NCT01253187|523699346|FG002|Period 3|Pregnancy|0|||
145233143|NCT01253187|523699347|FG003|Period 3|Pregnancy|0|||
145233144|NCT01253187|523699348|FG004|Period 3|Pregnancy|0|||
145233145|NCT01253187|523699349|FG005|Period 3|Pregnancy|0|||
145233146|NCT01253187|523699344|FG000|Period 3|difficulty with blood sampling|0|||
145295061|NCT01273181|523930681|FG002|Phase 2, Dose 1|Study termination|1|||
145295062|NCT01273181|523930682|FG003|Phase 2, Dose 1|Study termination|0|||
145233147|NCT01253187|523699345|FG001|Period 3|difficulty with blood sampling|1|||
145233148|NCT01253187|523699346|FG002|Period 3|difficulty with blood sampling|0|||
145233149|NCT01253187|523699347|FG003|Period 3|difficulty with blood sampling|0|||
145233150|NCT01253187|523699348|FG004|Period 3|difficulty with blood sampling|0|||
145233151|NCT01253187|523699349|FG005|Period 3|difficulty with blood sampling|0|||
145295063|NCT01273181|523930679|FG000|Phase 2, Dose 2|Death during treatment|0|||
145295064|NCT01273181|523930680|FG001|Phase 2, Dose 2|Death during treatment|0|||
145295065|NCT01273181|523930681|FG002|Phase 2, Dose 2|Death during treatment|0|||
145233152|NCT01253187|523699344|FG000|Period 3|non-compliance|0|||
145233153|NCT01253187|523699345|FG001|Period 3|non-compliance|0|||
145233154|NCT01253187|523699346|FG002|Period 3|non-compliance|0|||
145233155|NCT01253187|523699347|FG003|Period 3|non-compliance|0|||
145233156|NCT01253187|523699348|FG004|Period 3|non-compliance|1|||
145233157|NCT01253187|523699349|FG005|Period 3|non-compliance|0|||
145233158|NCT01293006|523699353|FG000|Period 2|Lost to Follow-up|1|||
145233159|NCT01293006|523699354|FG001|Period 2|Lost to Follow-up|0|||
145233160|NCT01293006|523699355|FG002|Period 2|Lost to Follow-up|0|||
145233161|NCT01293006|523699356|FG003|Period 2|Lost to Follow-up|0|||
145233162|NCT01494987|523699357|FG000|Overall Study|Adverse Event|6|||
145233163|NCT01494987|523699358|FG001|Overall Study|Adverse Event|5|||
145233164|NCT01494987|523699357|FG000|Overall Study|Hyperglycemia|6|||
145233165|NCT01494987|523699358|FG001|Overall Study|Hyperglycemia|4|||
145295066|NCT01273181|523930682|FG003|Phase 2, Dose 2|Death during treatment|1|||
145233166|NCT01494987|523699357|FG000|Overall Study|Investigator's Discretion|1|||
145233167|NCT01494987|523699358|FG001|Overall Study|Investigator's Discretion|2|||
145233168|NCT01494987|523699357|FG000|Overall Study|Lost to Follow-up|1|||
145233169|NCT01494987|523699358|FG001|Overall Study|Lost to Follow-up|1|||
145233170|NCT01494987|523699357|FG000|Overall Study|Protocol Violation|3|||
145233171|NCT01494987|523699358|FG001|Overall Study|Protocol Violation|3|||
145233172|NCT01494987|523699357|FG000|Overall Study|Subject Non-Compliance|9|||
145233173|NCT01494987|523699358|FG001|Overall Study|Subject Non-Compliance|10|||
145233174|NCT01494987|523699357|FG000|Overall Study|Subject Withdrew Consent|2|||
145233175|NCT01494987|523699358|FG001|Overall Study|Subject Withdrew Consent|3|||
145233176|NCT00600028|523699359|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145233177|NCT00600028|523699360|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
145233178|NCT00600028|523699359|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
145233179|NCT00600028|523699360|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
145233180|NCT00600028|523699359|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
145233181|NCT00600028|523699360|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
145233182|NCT03172481|523699361|FG000|Double-blind|Withdrawal by Subject|1|||
145233183|NCT03172481|523699362|FG001|Double-blind|Withdrawal by Subject|0|||
145233184|NCT04019795|523699363|FG000|Overall Study|Withdrawal by Subject|1|||
145233185|NCT04019795|523699364|FG001|Overall Study|Withdrawal by Subject|2|||
145233186|NCT04019795|523699365|FG002|Overall Study|Withdrawal by Subject|2|||
145233187|NCT04019795|523699366|FG003|Overall Study|Withdrawal by Subject|1|||
145233188|NCT04019795|523699363|FG000|Overall Study|Lost to Follow-up|0|||
145233189|NCT04019795|523699364|FG001|Overall Study|Lost to Follow-up|1|||
145233190|NCT04019795|523699365|FG002|Overall Study|Lost to Follow-up|1|||
145233191|NCT04019795|523699366|FG003|Overall Study|Lost to Follow-up|2|||
145233192|NCT04019795|523699363|FG000|Overall Study|Treatment non-compliance|3|||
145233193|NCT04019795|523699364|FG001|Overall Study|Treatment non-compliance|1|||
145233194|NCT04019795|523699365|FG002|Overall Study|Treatment non-compliance|2|||
145233195|NCT04019795|523699366|FG003|Overall Study|Treatment non-compliance|0|||
145233196|NCT04019795|523699363|FG000|Overall Study|Physician Decision|0|||
145233197|NCT04019795|523699364|FG001|Overall Study|Physician Decision|0|||
145233198|NCT04019795|523699365|FG002|Overall Study|Physician Decision|1|||
145233199|NCT04019795|523699366|FG003|Overall Study|Physician Decision|0|||
145233200|NCT04019795|523699363|FG000|Overall Study|Adverse Event|1|||
145233201|NCT04019795|523699364|FG001|Overall Study|Adverse Event|0|||
145233202|NCT04019795|523699365|FG002|Overall Study|Adverse Event|0|||
145233203|NCT04019795|523699366|FG003|Overall Study|Adverse Event|0|||
145233204|NCT01107405|523699371|FG000|Overall Study|Adverse Event|1|||
145233205|NCT01107405|523699372|FG001|Overall Study|Adverse Event|1|||
145233206|NCT01107405|523699373|FG002|Overall Study|Adverse Event|0|||
145233207|NCT01107405|523699374|FG003|Overall Study|Adverse Event|0|||
145233208|NCT01107405|523699375|FG004|Overall Study|Adverse Event|2|||
145233209|NCT01107405|523699371|FG000|Overall Study|Withdrawal by Subject|1|||
145233210|NCT01107405|523699372|FG001|Overall Study|Withdrawal by Subject|0|||
145233211|NCT01107405|523699373|FG002|Overall Study|Withdrawal by Subject|1|||
145233212|NCT01107405|523699374|FG003|Overall Study|Withdrawal by Subject|2|||
145233213|NCT01107405|523699375|FG004|Overall Study|Withdrawal by Subject|1|||
145233214|NCT01107405|523699371|FG000|Overall Study|Protocol Violation|0|||
145233215|NCT01107405|523699372|FG001|Overall Study|Protocol Violation|0|||
145233216|NCT01107405|523699373|FG002|Overall Study|Protocol Violation|1|||
145295067|NCT00944697|523930683|FG000|Overall Study|Withdrawal by Subject|1|||
145233217|NCT01107405|523699374|FG003|Overall Study|Protocol Violation|1|||
145233218|NCT01107405|523699375|FG004|Overall Study|Protocol Violation|0|||
145233219|NCT00712933|523699381|FG000|Overall Study|Adverse Event|69|||
145295068|NCT00944697|523930684|FG001|Overall Study|Withdrawal by Subject|1|||
145233220|NCT00712933|523699381|FG000|Overall Study|Lack of Efficacy|6|||
145233221|NCT00712933|523699381|FG000|Overall Study|Lost to Follow-up|22|||
145233222|NCT00712933|523699381|FG000|Overall Study|Non-compliance with study drug|13|||
145233223|NCT00712933|523699381|FG000|Overall Study|Other Pregnancy|37|||
145233224|NCT00712933|523699381|FG000|Overall Study|Sponsor decision|14|||
145233225|NCT00712933|523699381|FG000|Overall Study|Withdrew consent|4|||
145233226|NCT00712933|523699381|FG000|Overall Study|Hip replacement surgery|1|||
145233227|NCT00712933|523699381|FG000|Overall Study|Involved in Clinical research|3|||
145233228|NCT00712933|523699381|FG000|Overall Study|Participant hospitalized|1|||
145233229|NCT00712933|523699381|FG000|Overall Study|Participant travelled overseas|2|||
145233230|NCT00712933|523699381|FG000|Overall Study|Death of patient|1|||
145233231|NCT00712933|523699381|FG000|Overall Study|Other Physician decision|1|||
145233232|NCT00712933|523699381|FG000|Overall Study|Not committed to contraception|1|||
145233233|NCT00712933|523699381|FG000|Overall Study|Participant received medication|1|||
145233234|NCT00712933|523699381|FG000|Overall Study|Physician Decision|36|||
145233235|NCT00712933|523699381|FG000|Overall Study|Protocol Violation|4|||
145233236|NCT00712933|523699381|FG000|Overall Study|Withdrawal by Subject|151|||
145233237|NCT00085917|523699382|FG000|Overall Study|Adverse Event|4|||
145233238|NCT00085917|523699383|FG001|Overall Study|Adverse Event|3|||
145233239|NCT02022033|523699387|FG000|Overall Study|Physician Decision|1|||
145233240|NCT01429077|523699388|FG000|Overall Study|Lost to Follow-up|0|||
145233241|NCT01429077|523699389|FG001|Overall Study|Lost to Follow-up|3|||
145233242|NCT01413542|523699391|FG000|Overall Study|Physician Decision|1|||
145233243|NCT01413542|523699392|FG001|Overall Study|Physician Decision|0|||
145233244|NCT01413542|523699393|FG002|Overall Study|Physician Decision|3|||
145233245|NCT01413542|523699394|FG003|Overall Study|Physician Decision|0|||
145233246|NCT01413542|523699391|FG000|Overall Study|Adverse Event|0|||
145233247|NCT01413542|523699392|FG001|Overall Study|Adverse Event|0|||
145233248|NCT01413542|523699393|FG002|Overall Study|Adverse Event|0|||
145233249|NCT01413542|523699394|FG003|Overall Study|Adverse Event|1|||
145233250|NCT03084718|523699395|FG000|Overall Study|Withdrawal by Subject|4|||
145233251|NCT03084718|523699396|FG001|Overall Study|Withdrawal by Subject|3|||
145295069|NCT00944697|523930683|FG000|Overall Study|Adverse Event|0|||
145655522|NCT02105766|525257251|FG002|Overall Study|Death|0|||
145233252|NCT03084718|523699397|FG002|Overall Study|Withdrawal by Subject|4|||
145233253|NCT03084718|523699398|FG003|Overall Study|Withdrawal by Subject|0|||
145233254|NCT03084718|523699399|FG004|Overall Study|Withdrawal by Subject|0|||
145233255|NCT03084718|523699395|FG000|Overall Study|Physician Decision|1|||
145233256|NCT03084718|523699396|FG001|Overall Study|Physician Decision|0|||
145233257|NCT03084718|523699397|FG002|Overall Study|Physician Decision|0|||
145233258|NCT03084718|523699398|FG003|Overall Study|Physician Decision|0|||
145233259|NCT03084718|523699399|FG004|Overall Study|Physician Decision|0|||
145233260|NCT03084718|523699395|FG000|Overall Study|Adverse Event|3|||
145233261|NCT03084718|523699396|FG001|Overall Study|Adverse Event|5|||
145233262|NCT03084718|523699397|FG002|Overall Study|Adverse Event|5|||
145233263|NCT03084718|523699398|FG003|Overall Study|Adverse Event|8|||
145233264|NCT03084718|523699399|FG004|Overall Study|Adverse Event|2|||
145233265|NCT03084718|523699395|FG000|Overall Study|Lack of Efficacy|2|||
145233266|NCT03084718|523699396|FG001|Overall Study|Lack of Efficacy|0|||
145233267|NCT03084718|523699397|FG002|Overall Study|Lack of Efficacy|1|||
145233268|NCT03084718|523699398|FG003|Overall Study|Lack of Efficacy|4|||
145233269|NCT03084718|523699399|FG004|Overall Study|Lack of Efficacy|0|||
145233270|NCT03084718|523699395|FG000|Overall Study|Lost to Follow-up|0|||
145233271|NCT03084718|523699396|FG001|Overall Study|Lost to Follow-up|1|||
145233272|NCT03084718|523699397|FG002|Overall Study|Lost to Follow-up|0|||
145233273|NCT03084718|523699398|FG003|Overall Study|Lost to Follow-up|0|||
145233274|NCT03084718|523699399|FG004|Overall Study|Lost to Follow-up|2|||
145233275|NCT03084718|523699395|FG000|Overall Study|Protocol Violation|0|||
145233276|NCT03084718|523699396|FG001|Overall Study|Protocol Violation|0|||
145233277|NCT03084718|523699397|FG002|Overall Study|Protocol Violation|1|||
145233278|NCT03084718|523699398|FG003|Overall Study|Protocol Violation|0|||
145233279|NCT03084718|523699399|FG004|Overall Study|Protocol Violation|0|||
145233280|NCT03084718|523699395|FG000|Overall Study|Death|0|||
145233281|NCT03084718|523699396|FG001|Overall Study|Death|1|||
145233282|NCT03084718|523699397|FG002|Overall Study|Death|0|||
145233283|NCT03084718|523699398|FG003|Overall Study|Death|0|||
145233284|NCT03084718|523699399|FG004|Overall Study|Death|0|||
145233285|NCT03084718|523699395|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
145233286|NCT03084718|523699396|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
145233287|NCT03084718|523699397|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
145233288|NCT03084718|523699398|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
145233289|NCT03084718|523699399|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
145233290|NCT03341923|523699400|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
145233291|NCT03341923|523699401|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
145233292|NCT03986190|523699402|FG000|Overall Study|Withdrawal by Subject|12|||
145233293|NCT03986190|523699403|FG001|Overall Study|Withdrawal by Subject|0|||
145233294|NCT02806947|523699404|FG000|Overall Study|Withdrawal by Subject|5|||
145233295|NCT02806947|523699405|FG001|Overall Study|Withdrawal by Subject|1|||
145295070|NCT00944697|523930684|FG001|Overall Study|Adverse Event|3|||
145233296|NCT04511819|523699406|FG000|Overall Study|Non-compliance with study drug|5|||
145295071|NCT00944697|523930683|FG000|Overall Study|Administrative|1|||
145233297|NCT04511819|523699407|FG001|Overall Study|Non-compliance with study drug|1|||
145233298|NCT04511819|523699406|FG000|Overall Study|Withdrawal by Subject|0|||
145233299|NCT04511819|523699407|FG001|Overall Study|Withdrawal by Subject|3|||
145233300|NCT04511819|523699406|FG000|Overall Study|Adverse Event|0|||
145233301|NCT04511819|523699407|FG001|Overall Study|Adverse Event|1|||
145233302|NCT04511819|523699406|FG000|Overall Study|Protocol deviation|1|||
145233303|NCT04511819|523699407|FG001|Overall Study|Protocol deviation|0|||
145233304|NCT02767856|523699418|FG000|Overall Study|Lost to Follow-up|9|||
145233305|NCT02767856|523699419|FG001|Overall Study|Lost to Follow-up|1|||
145233306|NCT02767856|523699418|FG000|Overall Study|Withdrawal by Subject|2|||
145233307|NCT02767856|523699419|FG001|Overall Study|Withdrawal by Subject|1|||
145233308|NCT01594333|523699420|FG000|Overall Study|Death|96|||
145233309|NCT01594333|523699421|FG001|Overall Study|Death|83|||
145233310|NCT01594333|523699420|FG000|Overall Study|Lost to Follow-up|5|||
145233311|NCT01594333|523699421|FG001|Overall Study|Lost to Follow-up|5|||
145295072|NCT00944697|523930684|FG001|Overall Study|Administrative|1|||
145295073|NCT03661528|523930685|FG000|Overall Study|Death|1|||
145295074|NCT03661528|523930686|FG001|Overall Study|Death|0|||
145233312|NCT01594333|523699420|FG000|Overall Study|Withdrawal by Subject|60|||
145233313|NCT01594333|523699421|FG001|Overall Study|Withdrawal by Subject|63|||
145233314|NCT00589979|523699422|FG000|Run-In Period|Adverse Event|5|||
145233315|NCT00589979|523699423|FG001|Run-In Period|Adverse Event|0|||
145233316|NCT00589979|523699424|FG002|Run-In Period|Adverse Event|0|||
145233317|NCT00589979|523699422|FG000|Run-In Period|Protocol Violation|3|||
145233318|NCT00589979|523699423|FG001|Run-In Period|Protocol Violation|0|||
145233319|NCT00589979|523699424|FG002|Run-In Period|Protocol Violation|0|||
145233320|NCT00589979|523699422|FG000|Run-In Period|Did not qualify for randomization|54|||
145233321|NCT00589979|523699423|FG001|Run-In Period|Did not qualify for randomization|0|||
145233322|NCT00589979|523699424|FG002|Run-In Period|Did not qualify for randomization|0|||
145233323|NCT00589979|523699422|FG000|Run-In Period|Withdrawal by Subject|10|||
145233324|NCT00589979|523699423|FG001|Run-In Period|Withdrawal by Subject|0|||
145233325|NCT00589979|523699424|FG002|Run-In Period|Withdrawal by Subject|0|||
145233326|NCT00589979|523699422|FG000|Run-In Period|Informed Consent Withdrawn|4|||
145233327|NCT00589979|523699423|FG001|Run-In Period|Informed Consent Withdrawn|0|||
145233328|NCT00589979|523699424|FG002|Run-In Period|Informed Consent Withdrawn|0|||
145233329|NCT00589979|523699422|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
145233330|NCT00589979|523699423|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
145233331|NCT00589979|523699424|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
145233332|NCT00589979|523699422|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
145233333|NCT00589979|523699423|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
145233334|NCT00589979|523699424|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
145233335|NCT00589979|523699422|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
145233336|NCT00589979|523699423|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
145233337|NCT00589979|523699424|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
145233338|NCT00589979|523699422|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
145233339|NCT00589979|523699423|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
145233340|NCT00589979|523699424|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
145233341|NCT00589979|523699422|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
145233342|NCT00589979|523699423|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
145233343|NCT00589979|523699424|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
145233344|NCT00589979|523699422|FG000|Double-Blind Treatment Period 2|Other|0|||
145233345|NCT00589979|523699423|FG001|Double-Blind Treatment Period 2|Other|0|||
145233346|NCT00589979|523699424|FG002|Double-Blind Treatment Period 2|Other|1|||
145233347|NCT00589979|523699422|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
145233348|NCT00589979|523699423|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
145233349|NCT00589979|523699424|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
145233350|NCT00589979|523699422|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
145233351|NCT00589979|523699423|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
145233352|NCT00589979|523699424|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
145233353|NCT04685499|523699427|FG000|Overall Study|Study Terminated Early|1|||
145233354|NCT03176277|523699428|FG000|Part A Dose Escalation Study|Adverse Event|1|||
145233355|NCT03176277|523699429|FG001|Part A Dose Escalation Study|Adverse Event|0|||
145233356|NCT03176277|523699430|FG002|Part A Dose Escalation Study|Adverse Event|1|||
145233357|NCT03176277|523699431|FG003|Part A Dose Escalation Study|Adverse Event|0|||
145233358|NCT03176277|523699428|FG000|Part A Dose Escalation Study|Physician Decision|1|||
145233359|NCT03176277|523699429|FG001|Part A Dose Escalation Study|Physician Decision|1|||
145233360|NCT03176277|523699430|FG002|Part A Dose Escalation Study|Physician Decision|2|||
145233361|NCT03176277|523699431|FG003|Part A Dose Escalation Study|Physician Decision|0|||
145233362|NCT03176277|523699428|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
145233363|NCT03176277|523699429|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
145233364|NCT03176277|523699430|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
145233365|NCT03176277|523699431|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
145295075|NCT03661528|523930685|FG000|Overall Study|Physician Decision|3|||
145233366|NCT03176277|523699428|FG000|Part A Dose Escalation Study|Progressive disease|3|||
145233367|NCT03176277|523699429|FG001|Part A Dose Escalation Study|Progressive disease|1|||
145233368|NCT03176277|523699430|FG002|Part A Dose Escalation Study|Progressive disease|3|||
145233369|NCT03176277|523699431|FG003|Part A Dose Escalation Study|Progressive disease|0|||
145233370|NCT00634114|523699432|FG000|Overall Study|Adverse Event|6|||
145233371|NCT00634114|523699433|FG001|Overall Study|Adverse Event|8|||
145233372|NCT00634114|523699434|FG002|Overall Study|Adverse Event|3|||
145233373|NCT00634114|523699432|FG000|Overall Study|Withdrawal by Subject|9|||
145233374|NCT00634114|523699433|FG001|Overall Study|Withdrawal by Subject|6|||
145233375|NCT00634114|523699434|FG002|Overall Study|Withdrawal by Subject|11|||
145233376|NCT00634114|523699432|FG000|Overall Study|Lost to Follow-up|0|||
145233377|NCT00634114|523699433|FG001|Overall Study|Lost to Follow-up|0|||
145233378|NCT00634114|523699434|FG002|Overall Study|Lost to Follow-up|1|||
145233379|NCT00634114|523699432|FG000|Overall Study|Protocol Violation|3|||
145233380|NCT00634114|523699433|FG001|Overall Study|Protocol Violation|3|||
145233381|NCT00634114|523699434|FG002|Overall Study|Protocol Violation|1|||
145233382|NCT00634114|523699432|FG000|Overall Study|Pregnancy|1|||
145233383|NCT00634114|523699433|FG001|Overall Study|Pregnancy|0|||
145233384|NCT00634114|523699434|FG002|Overall Study|Pregnancy|0|||
145233385|NCT00634114|523699432|FG000|Overall Study|Incorrect enrolment|0|||
145233386|NCT00634114|523699433|FG001|Overall Study|Incorrect enrolment|1|||
145233387|NCT00634114|523699434|FG002|Overall Study|Incorrect enrolment|0|||
145233388|NCT00634114|523699432|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
145233389|NCT00634114|523699433|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
145233390|NCT00634114|523699434|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
145295076|NCT03661528|523930686|FG001|Overall Study|Physician Decision|1|||
145295077|NCT03661528|523930685|FG000|Overall Study|Other than Specified|5|||
145295078|NCT03661528|523930686|FG001|Overall Study|Other than Specified|2|||
145295079|NCT03661528|523930685|FG000|Overall Study|Withdrawal by Subject|5|||
145295080|NCT03661528|523930686|FG001|Overall Study|Withdrawal by Subject|3|||
145295081|NCT03661528|523930685|FG000|Overall Study|Disease Progression|8|||
145295082|NCT03661528|523930686|FG001|Overall Study|Disease Progression|13|||
145295083|NCT03661528|523930685|FG000|Overall Study|Adverse Event|61|||
145295084|NCT03661528|523930686|FG001|Overall Study|Adverse Event|55|||
145295085|NCT02732210|523930687|FG000|Overall Study|Site Closed|0|||
145295086|NCT02732210|523930688|FG001|Overall Study|Site Closed|11|||
145295087|NCT02732210|523930687|FG000|Overall Study|Study Ended|13|||
145295088|NCT02732210|523930688|FG001|Overall Study|Study Ended|13|||
145295089|NCT02732210|523930687|FG000|Overall Study|Withdrawal by Subject|28|||
145295090|NCT02732210|523930688|FG001|Overall Study|Withdrawal by Subject|87|||
145295091|NCT02732210|523930687|FG000|Overall Study|Lost to Follow-up|5|||
145295092|NCT02732210|523930688|FG001|Overall Study|Lost to Follow-up|57|||
145295093|NCT02732210|523930687|FG000|Overall Study|Death|4|||
145295094|NCT02732210|523930688|FG001|Overall Study|Death|15|||
145295095|NCT02732210|523930687|FG000|Overall Study|Other|35|||
145295096|NCT02732210|523930688|FG001|Overall Study|Other|103|||
145295097|NCT02732210|523930687|FG000|Overall Study|Missing|0|||
145295098|NCT02732210|523930688|FG001|Overall Study|Missing|8|||
145295099|NCT01876706|523930691|FG000|Overall Study|BPH Intervention|9|||
145295100|NCT01876706|523930691|FG000|Overall Study|Lost to Follow-up|7|||
145295101|NCT01876706|523930691|FG000|Overall Study|Withdrawals|6|||
145295102|NCT01876706|523930691|FG000|Overall Study|Death|3|||
145295103|NCT00604500|523930692|FG000|Overall Study|Adverse Event|2|||
145295104|NCT00604500|523930692|FG000|Overall Study|Protocol Violation|2|||
145295105|NCT00604500|523930692|FG000|Overall Study|Treatment Failure|1|||
145295106|NCT00604500|523930692|FG000|Overall Study|Withdrawal by Subject|4|||
145295107|NCT00604500|523930692|FG000|Overall Study|Administrative|1|||
145295108|NCT00604500|523930692|FG000|Overall Study|Did not meet protocol eligibility|1|||
145295109|NCT02191891|523930694|FG000|Overall Study|Withdrawal by Subject|0|||
145295110|NCT02191891|523930695|FG001|Overall Study|Withdrawal by Subject|1|||
145295111|NCT02191891|523930696|FG002|Overall Study|Withdrawal by Subject|0|||
145295112|NCT02191891|523930697|FG003|Overall Study|Withdrawal by Subject|0|||
145295113|NCT02191891|523930698|FG004|Overall Study|Withdrawal by Subject|1|||
145295114|NCT02191891|523930694|FG000|Overall Study|Adverse Event|0|||
145295115|NCT02191891|523930695|FG001|Overall Study|Adverse Event|1|||
145295116|NCT02191891|523930696|FG002|Overall Study|Adverse Event|0|||
145295117|NCT02191891|523930697|FG003|Overall Study|Adverse Event|0|||
145295118|NCT02191891|523930698|FG004|Overall Study|Adverse Event|2|||
145295119|NCT02191891|523930694|FG000|Overall Study|Disease Progression|4|||
145295120|NCT02191891|523930695|FG001|Overall Study|Disease Progression|10|||
145295121|NCT02191891|523930696|FG002|Overall Study|Disease Progression|4|||
145295122|NCT02191891|523930697|FG003|Overall Study|Disease Progression|2|||
145295123|NCT02191891|523930698|FG004|Overall Study|Disease Progression|7|||
145295124|NCT01062256|523930700|FG000|Overall Study|Adverse Event|1|||
145295125|NCT01062256|523930701|FG001|Overall Study|Adverse Event|0|||
145233391|NCT00634114|523699432|FG000|Overall Study|Difficult to continue|3|||
145295126|NCT01062256|523930702|FG002|Overall Study|Adverse Event|0|||
145295127|NCT01062256|523930700|FG000|Overall Study|Withdrawal by Subject|1|||
145295128|NCT01062256|523930701|FG001|Overall Study|Withdrawal by Subject|1|||
145295129|NCT01062256|523930702|FG002|Overall Study|Withdrawal by Subject|1|||
145233392|NCT00634114|523699433|FG001|Overall Study|Difficult to continue|1|||
145233393|NCT00634114|523699434|FG002|Overall Study|Difficult to continue|1|||
145233394|NCT00634114|523699432|FG000|Overall Study|Other reason|1|||
145233395|NCT00634114|523699433|FG001|Overall Study|Other reason|1|||
145233396|NCT00634114|523699434|FG002|Overall Study|Other reason|1|||
145233397|NCT03282357|523699436|FG000|Overall Study|Lost to Follow-up|3|||
145233398|NCT03282357|523699436|FG000|Overall Study|Withdrawal by Subject|4|||
145233399|NCT03282357|523699436|FG000|Overall Study|Adverse Event|1|||
145233400|NCT03282357|523699436|FG000|Overall Study|Other|9|||
145233401|NCT03550131|523699437|FG000|Overall Study|Lost to Follow-up|16|||
145233402|NCT03550131|523699438|FG001|Overall Study|Lost to Follow-up|24|||
145233403|NCT03550131|523699437|FG000|Overall Study|Withdrawal by Subject|36|||
145233404|NCT03550131|523699438|FG001|Overall Study|Withdrawal by Subject|28|||
145233405|NCT03550131|523699437|FG000|Overall Study|Illness of dyad member|10|||
145233406|NCT03550131|523699438|FG001|Overall Study|Illness of dyad member|2|||
145233407|NCT03550131|523699437|FG000|Overall Study|Death of person with dementia|4|||
145233408|NCT03550131|523699438|FG001|Overall Study|Death of person with dementia|8|||
145233409|NCT01318512|523699439|FG000|Maintenance Period (6 Months)|Death|2|||
145233410|NCT01318512|523699439|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
145233411|NCT01822691|523699444|FG000|Overall Study|Withdrawal by Subject|2|||
145233412|NCT00622869|523699445|FG000|Overall Study|Subject Withdrew Consent|13|||
145233413|NCT00622869|523699446|FG001|Overall Study|Subject Withdrew Consent|17|||
145233414|NCT00622869|523699447|FG002|Overall Study|Subject Withdrew Consent|11|||
145233415|NCT00622869|523699445|FG000|Overall Study|Administrative Problems|11|||
145233416|NCT00622869|523699446|FG001|Overall Study|Administrative Problems|17|||
145233417|NCT00622869|523699447|FG002|Overall Study|Administrative Problems|13|||
145233418|NCT00622869|523699445|FG000|Overall Study|Death|12|||
145233419|NCT00622869|523699446|FG001|Overall Study|Death|15|||
145233420|NCT00622869|523699447|FG002|Overall Study|Death|10|||
145233421|NCT00622869|523699445|FG000|Overall Study|Lost to Follow-up|2|||
145233422|NCT00622869|523699446|FG001|Overall Study|Lost to Follow-up|4|||
145233423|NCT00622869|523699447|FG002|Overall Study|Lost to Follow-up|2|||
145233424|NCT00622869|523699445|FG000|Overall Study|Graft Loss|5|||
145233425|NCT00622869|523699446|FG001|Overall Study|Graft Loss|3|||
145233426|NCT00622869|523699447|FG002|Overall Study|Graft Loss|2|||
145233427|NCT00622869|523699445|FG000|Overall Study|Missing|0|||
145233428|NCT00622869|523699446|FG001|Overall Study|Missing|1|||
145233429|NCT00622869|523699447|FG002|Overall Study|Missing|1|||
145233430|NCT00645567|523699448|FG000|Overall Study|Adverse Event|1|||
145233431|NCT02648724|523699449|FG000|Overall Study|Withdrawal by Subject|0|||
145233432|NCT02648724|523699450|FG001|Overall Study|Withdrawal by Subject|1|||
145233433|NCT02648724|523699451|FG002|Overall Study|Withdrawal by Subject|1|||
145233434|NCT02648724|523699452|FG003|Overall Study|Withdrawal by Subject|0|||
145233435|NCT02648724|523699453|FG004|Overall Study|Withdrawal by Subject|1|||
145233436|NCT02648724|523699454|FG005|Overall Study|Withdrawal by Subject|0|||
145233437|NCT02648724|523699455|FG006|Overall Study|Withdrawal by Subject|0|||
145233438|NCT02648724|523699449|FG000|Overall Study|Progressive disease|2|||
145233439|NCT02648724|523699450|FG001|Overall Study|Progressive disease|2|||
145233440|NCT02648724|523699451|FG002|Overall Study|Progressive disease|2|||
145233441|NCT02648724|523699452|FG003|Overall Study|Progressive disease|3|||
145233442|NCT02648724|523699453|FG004|Overall Study|Progressive disease|22|||
145233443|NCT02648724|523699454|FG005|Overall Study|Progressive disease|7|||
145233444|NCT02648724|523699455|FG006|Overall Study|Progressive disease|8|||
145295130|NCT01062256|523930700|FG000|Overall Study|Ineligible|1|||
145562492|NCT00156533|524920047|FG000|Overall Study|Withdrawal by Subject|1|||
145233445|NCT02648724|523699449|FG000|Overall Study|Other reason (unknown)|1|||
145233446|NCT02648724|523699450|FG001|Overall Study|Other reason (unknown)|0|||
145233447|NCT02648724|523699451|FG002|Overall Study|Other reason (unknown)|0|||
145233448|NCT02648724|523699452|FG003|Overall Study|Other reason (unknown)|0|||
145233449|NCT02648724|523699453|FG004|Overall Study|Other reason (unknown)|0|||
145233450|NCT02648724|523699454|FG005|Overall Study|Other reason (unknown)|0|||
145233451|NCT02648724|523699455|FG006|Overall Study|Other reason (unknown)|0|||
145233452|NCT02648724|523699449|FG000|Overall Study|Protocol Violation|0|||
145233453|NCT02648724|523699450|FG001|Overall Study|Protocol Violation|0|||
145233454|NCT02648724|523699451|FG002|Overall Study|Protocol Violation|0|||
145233455|NCT02648724|523699452|FG003|Overall Study|Protocol Violation|0|||
145233456|NCT02648724|523699453|FG004|Overall Study|Protocol Violation|1|||
145233457|NCT02648724|523699454|FG005|Overall Study|Protocol Violation|0|||
145233458|NCT02648724|523699455|FG006|Overall Study|Protocol Violation|0|||
145233459|NCT02648724|523699449|FG000|Overall Study|Death|0|||
145233460|NCT02648724|523699450|FG001|Overall Study|Death|0|||
145233461|NCT02648724|523699451|FG002|Overall Study|Death|0|||
145562493|NCT00156533|524920048|FG001|Overall Study|Withdrawal by Subject|0|||
145233462|NCT02648724|523699452|FG003|Overall Study|Death|0|||
145233463|NCT02648724|523699453|FG004|Overall Study|Death|0|||
145233464|NCT02648724|523699454|FG005|Overall Study|Death|0|||
145233465|NCT02648724|523699455|FG006|Overall Study|Death|3|||
145233466|NCT02648724|523699449|FG000|Overall Study|Physician Decision|0|||
145233467|NCT02648724|523699450|FG001|Overall Study|Physician Decision|0|||
145233468|NCT02648724|523699451|FG002|Overall Study|Physician Decision|0|||
145233469|NCT02648724|523699452|FG003|Overall Study|Physician Decision|0|||
145233470|NCT02648724|523699453|FG004|Overall Study|Physician Decision|1|||
145233471|NCT02648724|523699454|FG005|Overall Study|Physician Decision|0|||
145233472|NCT02648724|523699455|FG006|Overall Study|Physician Decision|1|||
145233473|NCT02648724|523699449|FG000|Overall Study|Transferred to named patient program|0|||
145233474|NCT02648724|523699450|FG001|Overall Study|Transferred to named patient program|0|||
145233475|NCT02648724|523699451|FG002|Overall Study|Transferred to named patient program|0|||
145233476|NCT02648724|523699452|FG003|Overall Study|Transferred to named patient program|0|||
145233477|NCT02648724|523699453|FG004|Overall Study|Transferred to named patient program|0|||
145233478|NCT02648724|523699454|FG005|Overall Study|Transferred to named patient program|1|||
145233479|NCT02648724|523699455|FG006|Overall Study|Transferred to named patient program|0|||
145233480|NCT04664855|523699456|FG000|Overall Study|Withdrawal by Subject|0|||
145233481|NCT04664855|523699457|FG001|Overall Study|Withdrawal by Subject|2|||
145233482|NCT03076190|523699459|FG000|Overall Study|Lost to Follow-up|9|||
145233483|NCT03076190|523699460|FG001|Overall Study|Lost to Follow-up|34|||
145233484|NCT03076190|523699459|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
145233485|NCT03076190|523699460|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
145233486|NCT03245723|523699461|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
145233487|NCT03245723|523699462|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
145233488|NCT03245723|523699461|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
145233489|NCT03245723|523699462|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
145233490|NCT03245723|523699461|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
145233491|NCT03245723|523699462|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
145233492|NCT03245723|523699461|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
145233493|NCT03245723|523699462|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
145233494|NCT00953225|523700450|FG000|Overall Study|Withdrawal by Subject|2|||
145233495|NCT00953225|523700451|FG001|Overall Study|Withdrawal by Subject|0|||
145233496|NCT02254551|523700457|FG000|Dose Escalation|Physician Decision|1|||
145233497|NCT02254551|523700457|FG000|Dose Escalation|Dose-limiting toxicity|2|||
145233498|NCT01956240|523700460|FG000|Overall Study|Lost to Follow-up|6|||
145233499|NCT01956240|523700461|FG001|Overall Study|Lost to Follow-up|20|||
145233500|NCT01956240|523700460|FG000|Overall Study|Adverse Event|17|||
145233501|NCT01956240|523700461|FG001|Overall Study|Adverse Event|4|||
145233502|NCT02759562|523700465|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
145233503|NCT02759562|523700466|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
145233504|NCT02759562|523700465|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
145233505|NCT02759562|523700466|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
145233506|NCT02293993|523700467|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
145233507|NCT02293993|523700468|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
145233508|NCT02293993|523700469|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
145233509|NCT02293993|523700470|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
145233510|NCT02293993|523700467|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
145233511|NCT02293993|523700468|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
145233512|NCT02293993|523700469|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
145233513|NCT02293993|523700470|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
145233514|NCT02293993|523700467|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
145233515|NCT02293993|523700468|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
145233516|NCT02293993|523700469|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
145233517|NCT02293993|523700470|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
145233518|NCT02293993|523700467|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
145233519|NCT02293993|523700468|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
145233520|NCT02293993|523700469|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
145265310|NCT03323034|523819272|FG001|Overall Study|Withdrawal by Subject|1|||
145265311|NCT03323034|523819273|FG002|Overall Study|Withdrawal by Subject|0|||
145265312|NCT03323034|523819274|FG003|Overall Study|Withdrawal by Subject|1|||
145265313|NCT03323034|523819275|FG004|Overall Study|Withdrawal by Subject|0|||
145265314|NCT02815540|523819279|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
145265315|NCT02222246|523819280|FG000|Overall Study|No Emergency Department Visits|27|||
145265316|NCT02222246|523819281|FG001|Overall Study|No Emergency Department Visits|26|||
145265317|NCT02222246|523819280|FG000|Overall Study|Physician Decision|0|||
145265318|NCT02222246|523819281|FG001|Overall Study|Physician Decision|1|||
145265319|NCT04887922|523819289|FG000|1st Randomization|Decided not to have surgery|0|||
145265320|NCT04887922|523819290|FG001|1st Randomization|Decided not to have surgery|1|||
145265321|NCT04887922|523819291|FG002|1st Randomization|Decided not to have surgery|0|||
145265322|NCT04887922|523819292|FG003|1st Randomization|Decided not to have surgery|0|||
145265323|NCT04887922|523819293|FG004|1st Randomization|Decided not to have surgery|0|||
145233521|NCT02293993|523700470|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
145233522|NCT02293993|523700467|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
145233523|NCT02293993|523700468|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
145233524|NCT02293993|523700469|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
145233525|NCT02293993|523700470|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
145233526|NCT01957709|523700471|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
145233527|NCT03587584|523700472|FG000|Overall Study|SOC deviations|4|||
145233528|NCT03587584|523700473|FG001|Overall Study|SOC deviations|6|||
145233529|NCT03587584|523700472|FG000|Overall Study|Incomplete data|0|||
145408304|NCT03314935|524349850|FG004|Phase 2|Lost to Follow-up|0|||
145408305|NCT03314935|524349851|FG005|Phase 2|Lost to Follow-up|0|||
145408306|NCT03314935|524349852|FG006|Phase 2|Lost to Follow-up|0|||
145408307|NCT03314935|524349853|FG007|Phase 2|Lost to Follow-up|0|||
145408308|NCT03314935|524349854|FG008|Phase 2|Lost to Follow-up|0|||
145408309|NCT03314935|524349855|FG009|Phase 2|Lost to Follow-up|1|||
145408310|NCT03314935|524349856|FG010|Phase 2|Lost to Follow-up|0|||
145408311|NCT03314935|524349857|FG011|Phase 2|Lost to Follow-up|0|||
145408312|NCT03314935|524349858|FG012|Phase 2|Lost to Follow-up|0|||
145408313|NCT03314935|524349859|FG013|Phase 2|Lost to Follow-up|0|||
145408314|NCT03314935|524349860|FG014|Phase 2|Lost to Follow-up|1|||
145408315|NCT03314935|524349846|FG000|Phase 2|Physician Decision|0|||
145408316|NCT03314935|524349847|FG001|Phase 2|Physician Decision|0|||
145619910|NCT05305040|525123619|FG001|Overall Study|Withdrawal by Subject|10|||
145295131|NCT01062256|523930701|FG001|Overall Study|Ineligible|4|||
145295132|NCT01062256|523930702|FG002|Overall Study|Ineligible|3|||
145233530|NCT03587584|523700473|FG001|Overall Study|Incomplete data|3|||
145233531|NCT01061736|523700478|FG000|Overall Study|Dose regimen not selected|0|||
145233532|NCT01061736|523700479|FG001|Overall Study|Dose regimen not selected|0|||
145233533|NCT01061736|523700480|FG002|Overall Study|Dose regimen not selected|0|||
145233534|NCT01061736|523700481|FG003|Overall Study|Dose regimen not selected|0|||
145233535|NCT01061736|523700482|FG004|Overall Study|Dose regimen not selected|0|||
145233536|NCT01061736|523700483|FG005|Overall Study|Dose regimen not selected|0|||
145233537|NCT01061736|523700484|FG006|Overall Study|Dose regimen not selected|79|||
145233538|NCT01061736|523700485|FG007|Overall Study|Dose regimen not selected|0|||
145233539|NCT01061736|523700486|FG008|Overall Study|Dose regimen not selected|0|||
145233540|NCT01061736|523700487|FG009|Overall Study|Dose regimen not selected|0|||
145233541|NCT01061736|523700478|FG000|Overall Study|Adverse Event|13|||
145233542|NCT01061736|523700479|FG001|Overall Study|Adverse Event|1|||
145233543|NCT01061736|523700480|FG002|Overall Study|Adverse Event|3|||
145233544|NCT01061736|523700481|FG003|Overall Study|Adverse Event|2|||
145233545|NCT01061736|523700482|FG004|Overall Study|Adverse Event|4|||
145233546|NCT01061736|523700483|FG005|Overall Study|Adverse Event|1|||
145233547|NCT01061736|523700484|FG006|Overall Study|Adverse Event|4|||
145233548|NCT01061736|523700485|FG007|Overall Study|Adverse Event|63|||
145233549|NCT01061736|523700486|FG008|Overall Study|Adverse Event|67|||
145233550|NCT01061736|523700487|FG009|Overall Study|Adverse Event|34|||
145233551|NCT01061736|523700478|FG000|Overall Study|Lack of Efficacy|0|||
145233552|NCT01061736|523700479|FG001|Overall Study|Lack of Efficacy|2|||
145233553|NCT01061736|523700480|FG002|Overall Study|Lack of Efficacy|1|||
145233554|NCT01061736|523700481|FG003|Overall Study|Lack of Efficacy|1|||
145233555|NCT01061736|523700482|FG004|Overall Study|Lack of Efficacy|1|||
145233556|NCT01061736|523700483|FG005|Overall Study|Lack of Efficacy|2|||
145233557|NCT01061736|523700484|FG006|Overall Study|Lack of Efficacy|1|||
145233558|NCT01061736|523700485|FG007|Overall Study|Lack of Efficacy|9|||
145295133|NCT01062256|523930700|FG000|Overall Study|Administrative|0|||
145295134|NCT01062256|523930701|FG001|Overall Study|Administrative|2|||
145233559|NCT01061736|523700486|FG008|Overall Study|Lack of Efficacy|9|||
145233560|NCT01061736|523700487|FG009|Overall Study|Lack of Efficacy|10|||
145233561|NCT01061736|523700478|FG000|Overall Study|Poor compliance to protocol|0|||
145295135|NCT01062256|523930702|FG002|Overall Study|Administrative|0|||
145295136|NCT03049488|523930703|FG000|Overall Study|Lost to Follow-up|1|||
145295137|NCT03049488|523930704|FG001|Overall Study|Lost to Follow-up|1|||
145295138|NCT03049488|523930705|FG002|Overall Study|Lost to Follow-up|0|||
145619911|NCT05305040|525123618|FG000|Overall Study|Other|13|||
145233562|NCT01061736|523700479|FG001|Overall Study|Poor compliance to protocol|0|||
145233563|NCT01061736|523700480|FG002|Overall Study|Poor compliance to protocol|0|||
145233564|NCT01061736|523700481|FG003|Overall Study|Poor compliance to protocol|0|||
145233565|NCT01061736|523700482|FG004|Overall Study|Poor compliance to protocol|0|||
145233566|NCT01061736|523700483|FG005|Overall Study|Poor compliance to protocol|0|||
145233567|NCT01061736|523700484|FG006|Overall Study|Poor compliance to protocol|0|||
145233568|NCT01061736|523700485|FG007|Overall Study|Poor compliance to protocol|2|||
145233569|NCT01061736|523700486|FG008|Overall Study|Poor compliance to protocol|5|||
145295139|NCT03049488|523930706|FG003|Overall Study|Lost to Follow-up|0|||
145408317|NCT03314935|524349848|FG002|Phase 2|Physician Decision|0|||
145408318|NCT03314935|524349849|FG003|Phase 2|Physician Decision|0|||
145408319|NCT03314935|524349850|FG004|Phase 2|Physician Decision|0|||
145408320|NCT03314935|524349851|FG005|Phase 2|Physician Decision|0|||
145295140|NCT03049488|523930707|FG004|Overall Study|Lost to Follow-up|0|||
145233570|NCT01061736|523700487|FG009|Overall Study|Poor compliance to protocol|9|||
145233571|NCT01061736|523700478|FG000|Overall Study|Not treated|0|||
145233572|NCT01061736|523700479|FG001|Overall Study|Not treated|0|||
145233573|NCT01061736|523700480|FG002|Overall Study|Not treated|0|||
145233574|NCT01061736|523700481|FG003|Overall Study|Not treated|0|||
145233575|NCT01061736|523700482|FG004|Overall Study|Not treated|1|||
145233576|NCT01061736|523700483|FG005|Overall Study|Not treated|0|||
145233577|NCT01061736|523700484|FG006|Overall Study|Not treated|0|||
145233578|NCT01061736|523700485|FG007|Overall Study|Not treated|2|||
145233579|NCT01061736|523700486|FG008|Overall Study|Not treated|1|||
145233580|NCT01061736|523700487|FG009|Overall Study|Not treated|0|||
145233581|NCT01061736|523700478|FG000|Overall Study|Other than specified above|0|||
145233582|NCT01061736|523700479|FG001|Overall Study|Other than specified above|1|||
145233583|NCT01061736|523700480|FG002|Overall Study|Other than specified above|2|||
145233584|NCT01061736|523700481|FG003|Overall Study|Other than specified above|0|||
145233585|NCT01061736|523700482|FG004|Overall Study|Other than specified above|1|||
145233586|NCT01061736|523700483|FG005|Overall Study|Other than specified above|0|||
145233587|NCT01061736|523700484|FG006|Overall Study|Other than specified above|0|||
145233588|NCT01061736|523700485|FG007|Overall Study|Other than specified above|18|||
145233589|NCT01061736|523700486|FG008|Overall Study|Other than specified above|15|||
145233590|NCT01061736|523700487|FG009|Overall Study|Other than specified above|21|||
145233591|NCT01093755|523700491|FG000|Overall Study|Withdrawal by Subject|3|||
145233592|NCT01093755|523700492|FG001|Overall Study|Withdrawal by Subject|4|||
145233593|NCT03115112|523700493|FG000|Overall Study|Adverse Event|5|||
145233594|NCT03115112|523700494|FG001|Overall Study|Adverse Event|1|||
145233595|NCT03115112|523700493|FG000|Overall Study|Withdrawal by Subject|4|||
145233596|NCT03115112|523700494|FG001|Overall Study|Withdrawal by Subject|2|||
145233597|NCT03115112|523700493|FG000|Overall Study|Lost to Follow-up|0|||
145233598|NCT03115112|523700494|FG001|Overall Study|Lost to Follow-up|1|||
145233599|NCT03115112|523700493|FG000|Overall Study|Death|1|||
145233600|NCT03115112|523700494|FG001|Overall Study|Death|0|||
145233601|NCT03115112|523700493|FG000|Overall Study|Pregnancy|1|||
145233602|NCT03115112|523700494|FG001|Overall Study|Pregnancy|0|||
145233603|NCT03115112|523700493|FG000|Overall Study|Site closure|1|||
145233604|NCT03115112|523700494|FG001|Overall Study|Site closure|1|||
145233605|NCT01204697|523700499|FG000|Overall Study|Death|26|||
145233606|NCT01204697|523700500|FG001|Overall Study|Death|27|||
145233607|NCT01204697|523700499|FG000|Overall Study|Lost to Follow-up|3|||
145233608|NCT01204697|523700500|FG001|Overall Study|Lost to Follow-up|4|||
145233609|NCT01204697|523700499|FG000|Overall Study|Withdrawal by Subject|2|||
145233610|NCT01204697|523700500|FG001|Overall Study|Withdrawal by Subject|4|||
145233611|NCT01204697|523700499|FG000|Overall Study|Randomized, but not treated|0|||
145233612|NCT01204697|523700500|FG001|Overall Study|Randomized, but not treated|1|||
145233613|NCT01170702|523700501|FG000|Overall Study|Exclusion criteria met after consent|1|||
145233614|NCT01170702|523700502|FG001|Overall Study|Exclusion criteria met after consent|2|||
145233615|NCT01170702|523700503|FG002|Overall Study|Exclusion criteria met after consent|0|||
145233616|NCT01170702|523700504|FG003|Overall Study|Exclusion criteria met after consent|2|||
145233617|NCT00098020|523700507|FG000|Overall Study|Adverse Event|2|||
145295141|NCT03049488|523930708|FG005|Overall Study|Lost to Follow-up|0|||
145295142|NCT03049488|523930703|FG000|Overall Study|Moved from Area|1|||
145295143|NCT03049488|523930704|FG001|Overall Study|Moved from Area|0|||
145295144|NCT03049488|523930705|FG002|Overall Study|Moved from Area|0|||
145295145|NCT03049488|523930706|FG003|Overall Study|Moved from Area|1|||
145233618|NCT00098020|523700507|FG000|Overall Study|Lost to Follow-up|1|||
145233619|NCT00098020|523700507|FG000|Overall Study|elevated liver enzymes|1|||
145233620|NCT00098020|523700507|FG000|Overall Study|Low urine PCR|1|||
145233621|NCT00098020|523700507|FG000|Overall Study|Low epidermal growth factor receptor|1|||
145233622|NCT01453998|523700508|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
145233623|NCT01453998|523700509|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
145233624|NCT01453998|523700510|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
145233625|NCT01879319|523700513|FG000|Overall Study|Withdrawal by Subject|1|||
145233626|NCT01879319|523700514|FG001|Overall Study|Withdrawal by Subject|0|||
145233627|NCT01879319|523700513|FG000|Overall Study|Lost to Follow-up|1|||
145233628|NCT01879319|523700514|FG001|Overall Study|Lost to Follow-up|5|||
145233629|NCT03483116|523700527|FG000|Overall Study|Adverse Event|0|||
145233630|NCT03483116|523700528|FG001|Overall Study|Adverse Event|1|||
145233631|NCT03483116|523700529|FG002|Overall Study|Adverse Event|0|||
145233632|NCT03483116|523700530|FG003|Overall Study|Adverse Event|1|||
145233633|NCT03483116|523700527|FG000|Overall Study|Protocol Violation|1|||
145233634|NCT03483116|523700528|FG001|Overall Study|Protocol Violation|0|||
145233635|NCT03483116|523700529|FG002|Overall Study|Protocol Violation|0|||
145233636|NCT03483116|523700530|FG003|Overall Study|Protocol Violation|7|||
145295146|NCT03049488|523930707|FG004|Overall Study|Moved from Area|1|||
145233637|NCT03483116|523700527|FG000|Overall Study|Lost to Follow-up|9|||
145233638|NCT03483116|523700528|FG001|Overall Study|Lost to Follow-up|4|||
145233639|NCT03483116|523700529|FG002|Overall Study|Lost to Follow-up|9|||
145233640|NCT03483116|523700530|FG003|Overall Study|Lost to Follow-up|5|||
145233641|NCT03483116|523700527|FG000|Overall Study|Death|1|||
145233642|NCT03483116|523700528|FG001|Overall Study|Death|0|||
145233643|NCT03483116|523700529|FG002|Overall Study|Death|2|||
145233644|NCT03483116|523700530|FG003|Overall Study|Death|1|||
145233645|NCT03483116|523700527|FG000|Overall Study|Withdrawal by Subject|14|||
145233646|NCT03483116|523700528|FG001|Overall Study|Withdrawal by Subject|16|||
145233647|NCT03483116|523700529|FG002|Overall Study|Withdrawal by Subject|14|||
145233648|NCT03483116|523700530|FG003|Overall Study|Withdrawal by Subject|16|||
145233649|NCT03483116|523700527|FG000|Overall Study|Unknown other reason|3|||
145233650|NCT03483116|523700528|FG001|Overall Study|Unknown other reason|2|||
145233651|NCT03483116|523700529|FG002|Overall Study|Unknown other reason|1|||
145233652|NCT03483116|523700530|FG003|Overall Study|Unknown other reason|1|||
145233653|NCT00239837|523700532|FG000|Overall Study|Lost to Follow-up|3|||
145233654|NCT00239837|523700533|FG001|Overall Study|Lost to Follow-up|7|||
145233655|NCT01838590|523700534|FG000|Overall Study|Lack of Efficacy|12|||
145233656|NCT01838590|523700535|FG001|Overall Study|Lack of Efficacy|4|||
145233657|NCT01838590|523700534|FG000|Overall Study|Lost to Follow-up|0|||
145233658|NCT01838590|523700535|FG001|Overall Study|Lost to Follow-up|1|||
145233659|NCT00536978|523700536|FG000|Overall Study|Not eligible for Adback Infusion|22|||
145233660|NCT02475395|523700539|FG000|Overall Study|Protocol Violation|30|||
145233661|NCT02475395|523700540|FG001|Overall Study|Protocol Violation|3|||
145233662|NCT00393913|523700541|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
145233663|NCT00393913|523700541|FG000|Initial Assessment|Withdrawal by Subject|16|||
145233664|NCT00393913|523700541|FG000|CPAP|Withdrawal by Subject|3|||
145233665|NCT00393913|523700541|FG000|CPAP|Physician Decision|1|||
145233666|NCT00393913|523700541|FG000|CPAP|TEchnical problem with CPAP|3|||
145233667|NCT01518244|523700542|FG000|Overall Study|Adverse Event|3|||
145233668|NCT00870818|523700543|FG000|Overall Study|Lost to Follow-up|3|||
145233669|NCT00870818|523700544|FG001|Overall Study|Lost to Follow-up|2|||
145233670|NCT00870818|523700545|FG002|Overall Study|Lost to Follow-up|1|||
145233671|NCT00870818|523700546|FG003|Overall Study|Lost to Follow-up|0|||
145233672|NCT00870818|523700547|FG004|Overall Study|Lost to Follow-up|0|||
145233673|NCT00870818|523700543|FG000|Overall Study|Withdrawal by Subject|0|||
145233674|NCT00870818|523700544|FG001|Overall Study|Withdrawal by Subject|0|||
145233675|NCT00870818|523700545|FG002|Overall Study|Withdrawal by Subject|1|||
145233676|NCT00870818|523700546|FG003|Overall Study|Withdrawal by Subject|2|||
145233677|NCT00870818|523700547|FG004|Overall Study|Withdrawal by Subject|0|||
145233678|NCT00870818|523700543|FG000|Overall Study|Terminated by sponsor|29|||
145233679|NCT00870818|523700544|FG001|Overall Study|Terminated by sponsor|70|||
145233680|NCT00870818|523700545|FG002|Overall Study|Terminated by sponsor|36|||
145233681|NCT00870818|523700546|FG003|Overall Study|Terminated by sponsor|36|||
145233682|NCT00870818|523700547|FG004|Overall Study|Terminated by sponsor|38|||
145233683|NCT00870818|523700543|FG000|Overall Study|Other|0|||
145233684|NCT00870818|523700544|FG001|Overall Study|Other|1|||
145233685|NCT00870818|523700545|FG002|Overall Study|Other|0|||
145408321|NCT03314935|524349852|FG006|Phase 2|Physician Decision|0|||
145408322|NCT03314935|524349853|FG007|Phase 2|Physician Decision|0|||
145619912|NCT05305040|525123619|FG001|Overall Study|Other|10|||
145619913|NCT05305040|525123618|FG000|Overall Study|Primary Malignancy Relapse|3|||
145619914|NCT05305040|525123619|FG001|Overall Study|Primary Malignancy Relapse|4|||
145233686|NCT00870818|523700546|FG003|Overall Study|Other|0|||
145233687|NCT00870818|523700547|FG004|Overall Study|Other|0|||
145233688|NCT04900038|523700550|FG000|Overall Study|Adverse Event|1|||
145233689|NCT04900038|523700551|FG001|Overall Study|Adverse Event|0|||
145233690|NCT04900038|523700552|FG002|Overall Study|Adverse Event|1|||
145233691|NCT04900038|523700553|FG003|Overall Study|Adverse Event|1|||
145233692|NCT04900038|523700550|FG000|Overall Study|Withdrawal by Subject|0|||
145233693|NCT04900038|523700551|FG001|Overall Study|Withdrawal by Subject|1|||
145233694|NCT04900038|523700552|FG002|Overall Study|Withdrawal by Subject|0|||
145233695|NCT04900038|523700553|FG003|Overall Study|Withdrawal by Subject|0|||
145233696|NCT04900038|523700550|FG000|Overall Study|Study terminated by sponsor|18|||
145233697|NCT04900038|523700551|FG001|Overall Study|Study terminated by sponsor|15|||
145233698|NCT04900038|523700552|FG002|Overall Study|Study terminated by sponsor|17|||
145233699|NCT04900038|523700553|FG003|Overall Study|Study terminated by sponsor|14|||
145233700|NCT04900038|523700550|FG000|Overall Study|Protocol Deviation|1|||
145233701|NCT04900038|523700551|FG001|Overall Study|Protocol Deviation|1|||
145233702|NCT04900038|523700552|FG002|Overall Study|Protocol Deviation|0|||
145233703|NCT04900038|523700553|FG003|Overall Study|Protocol Deviation|0|||
145233704|NCT04900038|523700550|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
145233705|NCT04900038|523700551|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
145233706|NCT04900038|523700552|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
145233707|NCT04900038|523700553|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
145233708|NCT04900038|523700550|FG000|Overall Study|Lost to Follow-up|0|||
145233709|NCT04900038|523700551|FG001|Overall Study|Lost to Follow-up|0|||
145233710|NCT04900038|523700552|FG002|Overall Study|Lost to Follow-up|0|||
145233711|NCT04900038|523700553|FG003|Overall Study|Lost to Follow-up|1|||
145233712|NCT01512108|523702100|FG000|Overall Study|Adverse Event|9|||
145233713|NCT01512108|523702101|FG001|Overall Study|Adverse Event|4|||
145233714|NCT01512108|523702100|FG000|Overall Study|Protocol Violation|1|||
145233715|NCT01512108|523702101|FG001|Overall Study|Protocol Violation|2|||
145233716|NCT01512108|523702100|FG000|Overall Study|Withdrawal Criteria|1|||
145233717|NCT01512108|523702101|FG001|Overall Study|Withdrawal Criteria|0|||
145233718|NCT01512108|523702100|FG000|Overall Study|Unclassified|11|||
145233719|NCT01512108|523702101|FG001|Overall Study|Unclassified|3|||
145233720|NCT01283997|523702102|FG000|Overall Study|Physician Decision|8|||
145233721|NCT01283997|523702103|FG001|Overall Study|Physician Decision|10|||
145233722|NCT01283997|523702102|FG000|Overall Study|Withdrawal by Subject|3|||
145233723|NCT01283997|523702103|FG001|Overall Study|Withdrawal by Subject|2|||
145233724|NCT01283997|523702102|FG000|Overall Study|Physically unable to continue|0|||
145233725|NCT01283997|523702103|FG001|Overall Study|Physically unable to continue|1|||
145233726|NCT01283997|523702102|FG000|Overall Study|Progressive disease|1|||
145233727|NCT01283997|523702103|FG001|Overall Study|Progressive disease|0|||
145233728|NCT01283997|523702102|FG000|Overall Study|Other|4|||
145233729|NCT01283997|523702103|FG001|Overall Study|Other|4|||
145233730|NCT02017899|523702104|FG000|Overall Study|Withdrawal by Subject|0|||
145233731|NCT02017899|523702105|FG001|Overall Study|Withdrawal by Subject|0|||
145233732|NCT02017899|523702106|FG002|Overall Study|Withdrawal by Subject|0|||
145233733|NCT02017899|523702107|FG003|Overall Study|Withdrawal by Subject|1|||
145233734|NCT02017899|523702108|FG004|Overall Study|Withdrawal by Subject|1|||
145233735|NCT02017899|523702109|FG005|Overall Study|Withdrawal by Subject|0|||
145233736|NCT02843178|523702112|FG000|Overall Study|Lost to Follow-up|8|||
145233737|NCT02843178|523702113|FG001|Overall Study|Lost to Follow-up|8|||
145233738|NCT02843178|523702114|FG002|Overall Study|Lost to Follow-up|6|||
145233739|NCT02843178|523702115|FG003|Overall Study|Lost to Follow-up|3|||
145233740|NCT02843178|523702112|FG000|Overall Study|Withdrawal by Subject|0|||
145233741|NCT02843178|523702113|FG001|Overall Study|Withdrawal by Subject|0|||
145233742|NCT02843178|523702114|FG002|Overall Study|Withdrawal by Subject|1|||
145233743|NCT02843178|523702115|FG003|Overall Study|Withdrawal by Subject|1|||
145233744|NCT02109744|523702119|FG000|Overall Study|Death|1|||
145233745|NCT02109744|523702120|FG001|Overall Study|Death|1|||
145233746|NCT02109744|523702119|FG000|Overall Study|no marrow exam|1|||
145233747|NCT02109744|523702120|FG001|Overall Study|no marrow exam|0|||
145233748|NCT04095442|523702121|FG000|Overall Study|Lost to Follow-up|0|||
145233749|NCT04095442|523702122|FG001|Overall Study|Lost to Follow-up|1|||
145233750|NCT04095442|523702121|FG000|Overall Study|Screen failure|1|||
145233751|NCT04095442|523702122|FG001|Overall Study|Screen failure|0|||
145233752|NCT01677624|523702127|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
145233753|NCT00804843|523702128|FG000|Overall Study|Protocol Violation|1|||
145233754|NCT00804843|523702129|FG001|Overall Study|Protocol Violation|0|||
145233755|NCT00804843|523702128|FG000|Overall Study|Adverse Event|8|||
145233756|NCT00804843|523702129|FG001|Overall Study|Adverse Event|5|||
145233757|NCT00804843|523702128|FG000|Overall Study|Withdrawal by Subject|1|||
145233758|NCT00804843|523702129|FG001|Overall Study|Withdrawal by Subject|2|||
145233759|NCT02420795|523702132|FG000|Overall Study|Withdrawal by Subject|1|||
145233760|NCT02420795|523702133|FG001|Overall Study|Withdrawal by Subject|0|||
145233761|NCT02420795|523702134|FG002|Overall Study|Withdrawal by Subject|0|||
145233762|NCT02420795|523702132|FG000|Overall Study|Adverse Event|1|||
145233763|NCT02420795|523702133|FG001|Overall Study|Adverse Event|0|||
145233764|NCT02420795|523702134|FG002|Overall Study|Adverse Event|0|||
145233765|NCT02420795|523702132|FG000|Overall Study|Progressive disease|2|||
145233766|NCT02420795|523702133|FG001|Overall Study|Progressive disease|2|||
145233767|NCT02420795|523702134|FG002|Overall Study|Progressive disease|4|||
145233768|NCT02420795|523702132|FG000|Overall Study|Death|0|||
145233769|NCT02420795|523702133|FG001|Overall Study|Death|0|||
145233770|NCT02420795|523702134|FG002|Overall Study|Death|1|||
145233771|NCT02658968|523702135|FG000|Received Rituximab|Adverse Event|0|||
145233772|NCT02658968|523702136|FG001|Received Rituximab|Adverse Event|0|||
145233773|NCT02658968|523702137|FG002|Received Rituximab|Adverse Event|0|||
145233774|NCT02658968|523702138|FG003|Received Rituximab|Adverse Event|0|||
145233775|NCT02658968|523702139|FG004|Received Rituximab|Adverse Event|1|||
145233776|NCT02658968|523702135|FG000|Received Rituximab|Progressive disease|0|||
145233777|NCT02658968|523702136|FG001|Received Rituximab|Progressive disease|0|||
145233778|NCT02658968|523702137|FG002|Received Rituximab|Progressive disease|0|||
145233779|NCT02658968|523702138|FG003|Received Rituximab|Progressive disease|0|||
145233780|NCT02658968|523702139|FG004|Received Rituximab|Progressive disease|1|||
145233781|NCT02658968|523702135|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
145265324|NCT00953017|523819294|FG000|Overall Study|DId not show up for colonoscopy|4|||
145265325|NCT00953017|523819295|FG001|Overall Study|DId not show up for colonoscopy|4|||
145265326|NCT00953017|523819296|FG002|Overall Study|DId not show up for colonoscopy|5|||
145265327|NCT00953017|523819297|FG003|Overall Study|DId not show up for colonoscopy|4|||
145265328|NCT00953017|523819294|FG000|Overall Study|Incomplete data|1|||
145265329|NCT00953017|523819295|FG001|Overall Study|Incomplete data|1|||
145265330|NCT00953017|523819296|FG002|Overall Study|Incomplete data|0|||
145265331|NCT00953017|523819297|FG003|Overall Study|Incomplete data|0|||
145265332|NCT00953017|523819294|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
145265333|NCT00953017|523819295|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
145233782|NCT02658968|523702136|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
145233783|NCT02658968|523702137|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
145233784|NCT02658968|523702138|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
145233785|NCT02658968|523702139|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
145233786|NCT02658968|523702135|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
145233787|NCT02658968|523702136|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
145233788|NCT02658968|523702137|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
145233789|NCT02658968|523702138|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
145233790|NCT02658968|523702139|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
145233791|NCT02658968|523702135|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
145233792|NCT02658968|523702136|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
145233793|NCT02658968|523702137|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
145233794|NCT02658968|523702138|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
145233795|NCT02658968|523702139|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
145233796|NCT02658968|523702135|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
145233797|NCT02658968|523702136|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
145233798|NCT02658968|523702137|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
145233799|NCT02658968|523702138|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
145233800|NCT02658968|523702139|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
145233801|NCT02658968|523702135|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
145233802|NCT02658968|523702136|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
145233803|NCT02658968|523702137|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
145233804|NCT02658968|523702138|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
145233805|NCT02658968|523702139|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
145233806|NCT03097614|523702143|FG000|Overall Study|Adverse Event|3|||
145233807|NCT00436982|523702144|FG000|Overall Study|Withdrawal by Subject|3|||
145233808|NCT00436982|523702145|FG001|Overall Study|Withdrawal by Subject|1|||
145233809|NCT00436982|523702144|FG000|Overall Study|Did not receive allocated intervention|0|||
145233810|NCT00436982|523702145|FG001|Overall Study|Did not receive allocated intervention|1|||
145233811|NCT00436982|523702144|FG000|Overall Study|no RSA data|1|||
145233812|NCT00436982|523702145|FG001|Overall Study|no RSA data|2|||
145233813|NCT04058158|523702146|FG000|Period 1|Death|1|||
145233814|NCT04058158|523702147|FG001|Period 1|Death|0|||
145233815|NCT04058158|523702146|FG000|Period 1|Adverse Event|1|||
145233816|NCT04058158|523702147|FG001|Period 1|Adverse Event|1|||
145233817|NCT04058158|523702146|FG000|Period 1|Pregnancy|0|||
145233818|NCT04058158|523702147|FG001|Period 1|Pregnancy|1|||
145295147|NCT03049488|523930708|FG005|Overall Study|Moved from Area|0|||
145295148|NCT03049488|523930703|FG000|Overall Study|Physician Decision|0|||
145233819|NCT02215616|523702148|FG000|Overall Study|Sponsor requested to stop study drug|0|||
145233820|NCT02215616|523702149|FG001|Overall Study|Sponsor requested to stop study drug|0|||
145233821|NCT02215616|523702150|FG002|Overall Study|Sponsor requested to stop study drug|1|||
145233822|NCT02215616|523702151|FG003|Overall Study|Sponsor requested to stop study drug|4|||
145233823|NCT02215616|523702148|FG000|Overall Study|Death|1|||
145233824|NCT02215616|523702149|FG001|Overall Study|Death|0|||
145233825|NCT02215616|523702150|FG002|Overall Study|Death|0|||
145295149|NCT03049488|523930704|FG001|Overall Study|Physician Decision|1|||
145295150|NCT03049488|523930705|FG002|Overall Study|Physician Decision|0|||
145295151|NCT03049488|523930706|FG003|Overall Study|Physician Decision|0|||
145295152|NCT03049488|523930707|FG004|Overall Study|Physician Decision|0|||
145295153|NCT03049488|523930708|FG005|Overall Study|Physician Decision|0|||
145233826|NCT02215616|523702151|FG003|Overall Study|Death|0|||
145233827|NCT02215616|523702148|FG000|Overall Study|Adverse Event|7|||
145233828|NCT02215616|523702149|FG001|Overall Study|Adverse Event|4|||
145295154|NCT03049488|523930703|FG000|Overall Study|Withdrawal by Subject|0|||
145295155|NCT03049488|523930704|FG001|Overall Study|Withdrawal by Subject|0|||
145295156|NCT03049488|523930705|FG002|Overall Study|Withdrawal by Subject|0|||
145295157|NCT03049488|523930706|FG003|Overall Study|Withdrawal by Subject|1|||
145233829|NCT02215616|523702150|FG002|Overall Study|Adverse Event|9|||
145233830|NCT02215616|523702151|FG003|Overall Study|Adverse Event|2|||
145233831|NCT02215616|523702148|FG000|Overall Study|Withdrawal by Subject|1|||
145233832|NCT02215616|523702149|FG001|Overall Study|Withdrawal by Subject|8|||
145233833|NCT02215616|523702150|FG002|Overall Study|Withdrawal by Subject|2|||
145233834|NCT02215616|523702151|FG003|Overall Study|Withdrawal by Subject|5|||
145233835|NCT02215616|523702148|FG000|Overall Study|Non-compliance|0|||
145233836|NCT02215616|523702149|FG001|Overall Study|Non-compliance|2|||
145233837|NCT02215616|523702150|FG002|Overall Study|Non-compliance|1|||
145233838|NCT02215616|523702151|FG003|Overall Study|Non-compliance|0|||
145233839|NCT02215616|523702148|FG000|Overall Study|Protocol Violation|0|||
145233840|NCT02215616|523702149|FG001|Overall Study|Protocol Violation|2|||
145233841|NCT02215616|523702150|FG002|Overall Study|Protocol Violation|0|||
145233842|NCT02215616|523702151|FG003|Overall Study|Protocol Violation|0|||
145233843|NCT02215616|523702148|FG000|Overall Study|Lost to Follow-up|1|||
145233844|NCT02215616|523702149|FG001|Overall Study|Lost to Follow-up|1|||
145233845|NCT02215616|523702150|FG002|Overall Study|Lost to Follow-up|0|||
145233846|NCT02215616|523702151|FG003|Overall Study|Lost to Follow-up|1|||
145233847|NCT02215616|523702148|FG000|Overall Study|Other than specified|1|||
145233848|NCT02215616|523702149|FG001|Overall Study|Other than specified|0|||
145233849|NCT02215616|523702150|FG002|Overall Study|Other than specified|1|||
145233850|NCT02215616|523702151|FG003|Overall Study|Other than specified|1|||
145233851|NCT01634113|523702152|FG000|Overall Study|Not treated|0|||
145233852|NCT01634113|523702153|FG001|Overall Study|Not treated|0|||
145233853|NCT01634113|523702154|FG002|Overall Study|Not treated|1|||
145233854|NCT01352845|523702155|FG000|Overall Study|Lost to Follow-up|313|||
145233855|NCT01352845|523702156|FG001|Overall Study|Lost to Follow-up|92|||
145233856|NCT01352845|523702155|FG000|Overall Study|No Longer Willing to Participate|205|||
145233857|NCT01352845|523702156|FG001|Overall Study|No Longer Willing to Participate|58|||
145233858|NCT01352845|523702155|FG000|Overall Study|Withdrawal by Subject|48|||
145233859|NCT01352845|523702156|FG001|Overall Study|Withdrawal by Subject|16|||
145233860|NCT01352845|523702155|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
145233861|NCT01352845|523702156|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
145233862|NCT01352845|523702155|FG000|Overall Study|Pregnancy|27|||
145233863|NCT01352845|523702156|FG001|Overall Study|Pregnancy|7|||
145233864|NCT01352845|523702155|FG000|Overall Study|Adverse Event|22|||
145233865|NCT01352845|523702156|FG001|Overall Study|Adverse Event|6|||
145233866|NCT01352845|523702155|FG000|Overall Study|Other|17|||
145233867|NCT01352845|523702156|FG001|Overall Study|Other|7|||
145233868|NCT01352845|523702155|FG000|Overall Study|Protocol Violation|12|||
145233869|NCT01352845|523702156|FG001|Overall Study|Protocol Violation|6|||
145233870|NCT01352845|523702155|FG000|Overall Study|Death|3|||
145233871|NCT01352845|523702156|FG001|Overall Study|Death|0|||
145233872|NCT00387348|523702157|FG000|Overall Study|Death|1|||
145233873|NCT00387348|523702158|FG001|Overall Study|Death|1|||
145233874|NCT00387348|523702159|FG002|Overall Study|Death|0|||
145233875|NCT00387348|523702157|FG000|Overall Study|Physician Decision|1|||
145233876|NCT00387348|523702158|FG001|Overall Study|Physician Decision|0|||
145233877|NCT00387348|523702159|FG002|Overall Study|Physician Decision|1|||
145233878|NCT00387348|523702157|FG000|Overall Study|Withdrawal by Subject|0|||
145233879|NCT00387348|523702158|FG001|Overall Study|Withdrawal by Subject|2|||
145233880|NCT00387348|523702159|FG002|Overall Study|Withdrawal by Subject|2|||
145233881|NCT00387348|523702157|FG000|Overall Study|Adverse Event|1|||
145233882|NCT00387348|523702158|FG001|Overall Study|Adverse Event|0|||
145233883|NCT00387348|523702159|FG002|Overall Study|Adverse Event|1|||
145233884|NCT00505752|523702160|FG000|Overall Study|Adverse Event|1|||
145233885|NCT00505752|523702161|FG001|Overall Study|Adverse Event|0|||
145233886|NCT00505752|523702162|FG002|Overall Study|Adverse Event|1|||
145233887|NCT00505752|523702163|FG003|Overall Study|Adverse Event|0|||
145233888|NCT00505752|523702160|FG000|Overall Study|Lost to Follow-up|1|||
145233889|NCT00505752|523702161|FG001|Overall Study|Lost to Follow-up|0|||
145233890|NCT00505752|523702162|FG002|Overall Study|Lost to Follow-up|0|||
145233891|NCT00505752|523702163|FG003|Overall Study|Lost to Follow-up|0|||
145295158|NCT03049488|523930707|FG004|Overall Study|Withdrawal by Subject|1|||
145295159|NCT03049488|523930708|FG005|Overall Study|Withdrawal by Subject|0|||
145295160|NCT00891293|523930710|FG000|Overall Study|Adverse Event|2|||
145295161|NCT00891293|523930710|FG000|Overall Study|Protocol Violation|2|||
145295162|NCT00891293|523930710|FG000|Overall Study|Laboratory abnormality|4|||
145233892|NCT00505752|523702160|FG000|Overall Study|Lack of ovarian response|1|||
145233893|NCT00505752|523702161|FG001|Overall Study|Lack of ovarian response|3|||
145233894|NCT00505752|523702162|FG002|Overall Study|Lack of ovarian response|0|||
145233895|NCT00505752|523702163|FG003|Overall Study|Lack of ovarian response|0|||
145233896|NCT00505752|523702160|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145233897|NCT00505752|523702161|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145233898|NCT00505752|523702162|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
145233899|NCT00505752|523702163|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145233900|NCT00505752|523702160|FG000|Overall Study|No oocytes retrieved|0|||
145233901|NCT00505752|523702161|FG001|Overall Study|No oocytes retrieved|2|||
145233902|NCT00505752|523702162|FG002|Overall Study|No oocytes retrieved|0|||
145233903|NCT00505752|523702163|FG003|Overall Study|No oocytes retrieved|1|||
145233904|NCT00505752|523702160|FG000|Overall Study|No Fertilization|1|||
145233905|NCT00505752|523702161|FG001|Overall Study|No Fertilization|1|||
145233906|NCT00505752|523702162|FG002|Overall Study|No Fertilization|2|||
145233907|NCT00505752|523702163|FG003|Overall Study|No Fertilization|1|||
145233908|NCT00505752|523702160|FG000|Overall Study|All embryos/blastocysts discarded|0|||
145233909|NCT00505752|523702161|FG001|Overall Study|All embryos/blastocysts discarded|0|||
145233910|NCT00505752|523702162|FG002|Overall Study|All embryos/blastocysts discarded|1|||
145233911|NCT00505752|523702163|FG003|Overall Study|All embryos/blastocysts discarded|1|||
145233912|NCT00505752|523702160|FG000|Overall Study|Other|1|||
145233913|NCT00505752|523702161|FG001|Overall Study|Other|2|||
145233914|NCT00505752|523702162|FG002|Overall Study|Other|1|||
145233915|NCT00505752|523702163|FG003|Overall Study|Other|2|||
145233916|NCT04624672|523702164|FG000|Overall Study|Early Study Closure|2|||
145233917|NCT04624672|523702165|FG001|Overall Study|Early Study Closure|1|||
145233918|NCT03250377|523702171|FG000|Overall Study|Adverse Event|2|||
145233919|NCT03250377|523702172|FG001|Overall Study|Adverse Event|4|||
145233920|NCT03250377|523702173|FG002|Overall Study|Adverse Event|0|||
145233921|NCT03250377|523702174|FG003|Overall Study|Adverse Event|4|||
145233922|NCT03250377|523702171|FG000|Overall Study|Lack of Efficacy|5|||
145233923|NCT03250377|523702172|FG001|Overall Study|Lack of Efficacy|14|||
145233924|NCT03250377|523702173|FG002|Overall Study|Lack of Efficacy|1|||
145233925|NCT03250377|523702174|FG003|Overall Study|Lack of Efficacy|3|||
145233926|NCT03250377|523702171|FG000|Overall Study|Protocol Violation|0|||
145233927|NCT03250377|523702172|FG001|Overall Study|Protocol Violation|2|||
145233928|NCT03250377|523702173|FG002|Overall Study|Protocol Violation|0|||
145233929|NCT03250377|523702174|FG003|Overall Study|Protocol Violation|1|||
145233930|NCT03250377|523702171|FG000|Overall Study|Lost to Follow-up|0|||
145233931|NCT03250377|523702172|FG001|Overall Study|Lost to Follow-up|1|||
145233932|NCT03250377|523702173|FG002|Overall Study|Lost to Follow-up|0|||
145233933|NCT03250377|523702174|FG003|Overall Study|Lost to Follow-up|0|||
145233934|NCT03250377|523702171|FG000|Overall Study|Withdrawal by Subject|7|||
145233935|NCT03250377|523702172|FG001|Overall Study|Withdrawal by Subject|7|||
145233936|NCT03250377|523702173|FG002|Overall Study|Withdrawal by Subject|0|||
145233937|NCT03250377|523702174|FG003|Overall Study|Withdrawal by Subject|4|||
145233938|NCT03250377|523702171|FG000|Overall Study|Investigator's Judgment|1|||
145233939|NCT03250377|523702172|FG001|Overall Study|Investigator's Judgment|0|||
145233940|NCT03250377|523702173|FG002|Overall Study|Investigator's Judgment|0|||
145233941|NCT03250377|523702174|FG003|Overall Study|Investigator's Judgment|0|||
145233942|NCT03250377|523702171|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
145233943|NCT03250377|523702172|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
145233944|NCT03250377|523702173|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
145233945|NCT03250377|523702174|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
145233946|NCT03250377|523702171|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
145233947|NCT03250377|523702172|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
145233948|NCT03250377|523702173|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
145233949|NCT03250377|523702174|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
145233950|NCT03250377|523702171|FG000|Overall Study|Epilepsy Surgery|0|||
145233951|NCT03250377|523702172|FG001|Overall Study|Epilepsy Surgery|1|||
145233952|NCT03250377|523702173|FG002|Overall Study|Epilepsy Surgery|2|||
145233953|NCT03250377|523702174|FG003|Overall Study|Epilepsy Surgery|0|||
145233954|NCT03250377|523702171|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
145233955|NCT03250377|523702172|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
145233956|NCT03250377|523702173|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
145233957|NCT03250377|523702174|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
145233958|NCT03250377|523702171|FG000|Overall Study|Request From The Sponsor|0|||
145233959|NCT03250377|523702172|FG001|Overall Study|Request From The Sponsor|1|||
145233960|NCT03250377|523702173|FG002|Overall Study|Request From The Sponsor|0|||
145233961|NCT03250377|523702174|FG003|Overall Study|Request From The Sponsor|0|||
145233962|NCT03250377|523702171|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
145233963|NCT03250377|523702172|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
145233964|NCT03250377|523702173|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
145233965|NCT03250377|523702174|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
145233966|NCT03250377|523702171|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
145233967|NCT03250377|523702172|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
145233968|NCT03250377|523702173|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
145233969|NCT03250377|523702174|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
145233970|NCT03250377|523702171|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
145233971|NCT03250377|523702172|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
145233972|NCT03250377|523702173|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
145295163|NCT00891293|523930710|FG000|Overall Study|Lost to Follow-up|7|||
145295164|NCT00891293|523930710|FG000|Overall Study|Subject withdrew consent|7|||
145295165|NCT00891293|523930710|FG000|Overall Study|Sponsor termination|62|||
145233973|NCT03250377|523702174|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
145233974|NCT03250377|523702171|FG000|Overall Study|Pregnancy Event|0|||
145233975|NCT03250377|523702172|FG001|Overall Study|Pregnancy Event|1|||
145233976|NCT03250377|523702173|FG002|Overall Study|Pregnancy Event|0|||
145233977|NCT03250377|523702174|FG003|Overall Study|Pregnancy Event|0|||
145233978|NCT03250377|523702171|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
145233979|NCT03250377|523702172|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
145233980|NCT03250377|523702173|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
145295166|NCT01448057|523930711|FG000|Overall Study|Protocol Violation|3|||
145233981|NCT03250377|523702174|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
145295167|NCT01448057|523930712|FG001|Overall Study|Protocol Violation|2|||
145295168|NCT01448057|523930711|FG000|Overall Study|Lost to Follow-up|3|||
145233982|NCT03250377|523702171|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
145233983|NCT03250377|523702172|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
145233984|NCT03250377|523702173|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
145233985|NCT03250377|523702174|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
145233986|NCT03250377|523702171|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
145233987|NCT03250377|523702172|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
145233988|NCT03250377|523702173|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
145233989|NCT03250377|523702174|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
145233990|NCT03250377|523702171|FG000|Overall Study|Patient requested to change hospital|0|||
145233991|NCT03250377|523702172|FG001|Overall Study|Patient requested to change hospital|0|||
145233992|NCT03250377|523702173|FG002|Overall Study|Patient requested to change hospital|0|||
145233993|NCT03250377|523702174|FG003|Overall Study|Patient requested to change hospital|1|||
145233994|NCT03250377|523702171|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
145233995|NCT03250377|523702172|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
145233996|NCT03250377|523702173|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
145233997|NCT03250377|523702174|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
145233998|NCT02168803|523702176|FG000|Overall Study|Lost to Follow-up|1|||
145233999|NCT02168803|523702177|FG001|Overall Study|Lost to Follow-up|0|||
145234000|NCT02168803|523702178|FG002|Overall Study|Lost to Follow-up|1|||
145234001|NCT02168803|523702176|FG000|Overall Study|Withdrawal by Subject|1|||
145234002|NCT02168803|523702177|FG001|Overall Study|Withdrawal by Subject|1|||
145234003|NCT02168803|523702178|FG002|Overall Study|Withdrawal by Subject|2|||
145234004|NCT02168803|523702176|FG000|Overall Study|Physician Decision|0|||
145234005|NCT02168803|523702177|FG001|Overall Study|Physician Decision|1|||
145234006|NCT02168803|523702178|FG002|Overall Study|Physician Decision|0|||
145234007|NCT02168803|523702176|FG000|Overall Study|Adverse Event|0|||
145234008|NCT02168803|523702177|FG001|Overall Study|Adverse Event|1|||
145234009|NCT02168803|523702178|FG002|Overall Study|Adverse Event|1|||
145234010|NCT02168803|523702176|FG000|Overall Study|Death|0|||
145234011|NCT02168803|523702177|FG001|Overall Study|Death|0|||
145234012|NCT02168803|523702178|FG002|Overall Study|Death|1|||
145234013|NCT02168803|523702176|FG000|Overall Study|Sponsor Decision|0|||
145234014|NCT02168803|523702177|FG001|Overall Study|Sponsor Decision|0|||
145234015|NCT02168803|523702178|FG002|Overall Study|Sponsor Decision|1|||
145234016|NCT01114373|523702179|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
145234017|NCT01114373|523702180|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
145234018|NCT01114373|523702179|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
145234019|NCT01114373|523702180|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
145234020|NCT01114373|523702179|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
145234021|NCT01114373|523702180|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
145234022|NCT01114373|523702179|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
145234023|NCT01114373|523702180|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
145234024|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
145234025|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
145234026|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
145234027|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
145234028|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
145234029|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
145234030|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
145234031|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
145234032|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
145295169|NCT01448057|523930712|FG001|Overall Study|Lost to Follow-up|0|||
145234033|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
145234034|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
145234035|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
145234036|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
145234037|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
145234038|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
145234039|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145234040|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145234041|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
145295170|NCT01448057|523930711|FG000|Overall Study|Adverse Event|0|||
145234042|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
145234043|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
145234044|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
145234045|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
145234046|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
145234047|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
145295171|NCT01448057|523930712|FG001|Overall Study|Adverse Event|2|||
145234048|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
145234049|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
145234050|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
145234051|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
145234052|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
145234053|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
145234054|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
145234055|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
145234056|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
145234057|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
145234058|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
145234059|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
145234060|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
145234061|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
145234062|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
145234063|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
145234064|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
145234065|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
145234066|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
145234067|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
145234068|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
145234069|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
145234070|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
145234071|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
145234072|NCT03444870|523702181|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
145234073|NCT03444870|523702182|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
145234074|NCT03444870|523702183|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
145234075|NCT03444870|523702184|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
145234076|NCT03444870|523702185|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
145234077|NCT03444870|523702186|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
145234078|NCT03444870|523702181|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145234079|NCT03444870|523702182|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145234080|NCT03444870|523702183|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145234081|NCT03444870|523702184|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145234082|NCT03444870|523702185|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
145234083|NCT03444870|523702186|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
145234084|NCT03444870|523702181|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
145234085|NCT03444870|523702182|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
145234086|NCT03444870|523702183|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
145295172|NCT01448057|523930711|FG000|Overall Study|Withdrawal by Subject|2|||
145295173|NCT01448057|523930712|FG001|Overall Study|Withdrawal by Subject|0|||
145295174|NCT00874237|523930717|FG000|Overall Study|Physician Decision|0|||
145295175|NCT00874237|523930718|FG001|Overall Study|Physician Decision|1|||
145295176|NCT00874237|523930719|FG002|Overall Study|Physician Decision|0|||
145295177|NCT00874237|523930720|FG003|Overall Study|Physician Decision|0|||
145295178|NCT00874237|523930721|FG004|Overall Study|Physician Decision|0|||
145295179|NCT00874237|523930722|FG005|Overall Study|Physician Decision|0|||
145295180|NCT00874237|523930717|FG000|Overall Study|Withdrawal by Subject|0|||
145295181|NCT00874237|523930718|FG001|Overall Study|Withdrawal by Subject|0|||
145295182|NCT00874237|523930719|FG002|Overall Study|Withdrawal by Subject|1|||
145295183|NCT00874237|523930720|FG003|Overall Study|Withdrawal by Subject|0|||
145295184|NCT00874237|523930721|FG004|Overall Study|Withdrawal by Subject|0|||
145295185|NCT00874237|523930722|FG005|Overall Study|Withdrawal by Subject|0|||
145295186|NCT03912337|523930730|FG000|Overall Study|Withdrawal of Consent From Study|1|||
145295187|NCT03912337|523930731|FG001|Overall Study|Withdrawal of Consent From Study|0|||
145295188|NCT03912337|523930730|FG000|Overall Study|Lost to Follow-up|1|||
145295189|NCT03912337|523930731|FG001|Overall Study|Lost to Follow-up|1|||
145295190|NCT02458469|523930732|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145295191|NCT02458469|523930733|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145295192|NCT02458469|523930734|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
145295193|NCT02458469|523930735|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145295194|NCT02458469|523930736|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145295195|NCT02458469|523930737|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145295196|NCT02458469|523930732|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
145295197|NCT02458469|523930733|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
145295198|NCT02458469|523930734|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
145295199|NCT02458469|523930735|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
145295200|NCT02458469|523930736|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
145295201|NCT02458469|523930737|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
145295202|NCT02458469|523930732|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145234087|NCT03444870|523702184|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
145234088|NCT03444870|523702185|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
145234089|NCT03444870|523702186|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
145234090|NCT03444870|523702181|FG000|Open-Label Extension (OLE) Period|Death|0|||
145234091|NCT03444870|523702182|FG001|Open-Label Extension (OLE) Period|Death|0|||
145234092|NCT03444870|523702183|FG002|Open-Label Extension (OLE) Period|Death|0|||
145234093|NCT03444870|523702184|FG003|Open-Label Extension (OLE) Period|Death|0|||
145234094|NCT03444870|523702185|FG004|Open-Label Extension (OLE) Period|Death|1|||
145234095|NCT03444870|523702186|FG005|Open-Label Extension (OLE) Period|Death|0|||
145234096|NCT00868166|523702187|FG000|Overall Study|Death|58|||
145234097|NCT00868166|523702188|FG001|Overall Study|Death|65|||
145234098|NCT00868166|523702187|FG000|Overall Study|Withdrawal by Subject|33|||
145234099|NCT00868166|523702188|FG001|Overall Study|Withdrawal by Subject|25|||
145234100|NCT00868166|523702187|FG000|Overall Study|Protocol Violation|1|||
145234101|NCT00868166|523702188|FG001|Overall Study|Protocol Violation|0|||
145234102|NCT00868166|523702187|FG000|Overall Study|Lost to Follow-up|1|||
145234103|NCT00868166|523702188|FG001|Overall Study|Lost to Follow-up|3|||
145234104|NCT00868166|523702187|FG000|Overall Study|Adverse Event|9|||
145234105|NCT00868166|523702188|FG001|Overall Study|Adverse Event|10|||
145234106|NCT00868166|523702187|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
145234107|NCT00868166|523702188|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
145234108|NCT00868166|523702187|FG000|Overall Study|Non-compliance with IMP|1|||
145234109|NCT00868166|523702188|FG001|Overall Study|Non-compliance with IMP|1|||
145234110|NCT02267278|523702189|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
145234111|NCT02267278|523702189|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
145234112|NCT02267278|523702189|FG000|Overall Study|Developed new cancer diagnoses|2|||
145234113|NCT02267278|523702189|FG000|Overall Study|prescribed prohibited medication|1|||
145234114|NCT00650091|523702190|FG000|Amended Study Design|Withdrawal by Subject|12|||
145234115|NCT00650091|523702191|FG001|Amended Study Design|Withdrawal by Subject|11|||
145234116|NCT00650091|523702192|FG002|Amended Study Design|Withdrawal by Subject|0|||
145234117|NCT00650091|523702190|FG000|Amended Study Design|Physician Decision|5|||
145234118|NCT00650091|523702191|FG001|Amended Study Design|Physician Decision|0|||
145234119|NCT00650091|523702192|FG002|Amended Study Design|Physician Decision|0|||
145234120|NCT00650091|523702190|FG000|Amended Study Design|Adverse Event|1|||
145234121|NCT00650091|523702191|FG001|Amended Study Design|Adverse Event|4|||
145234122|NCT00650091|523702192|FG002|Amended Study Design|Adverse Event|0|||
145234123|NCT00650091|523702190|FG000|Amended Study Design|Lung transplantation|4|||
145234124|NCT00650091|523702191|FG001|Amended Study Design|Lung transplantation|2|||
145234125|NCT00650091|523702192|FG002|Amended Study Design|Lung transplantation|0|||
145234126|NCT00650091|523702190|FG000|Amended Study Design|Other|1|||
145234127|NCT00650091|523702191|FG001|Amended Study Design|Other|3|||
145234128|NCT00650091|523702192|FG002|Amended Study Design|Other|0|||
145234129|NCT01280266|523702199|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
145234130|NCT01280266|523702200|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
145234131|NCT01280266|523702199|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
145234132|NCT01280266|523702200|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
145234133|NCT00469209|523702207|FG000|Overall Study|Adverse Event|1|||
145234134|NCT00469209|523702208|FG001|Overall Study|Adverse Event|0|||
145234135|NCT00469209|523702209|FG002|Overall Study|Adverse Event|1|||
145234136|NCT04268004|523702212|FG000|Overall Study|Excluded from analyses|0|||
145234137|NCT04268004|523702213|FG001|Overall Study|Excluded from analyses|1|||
145234138|NCT01082367|523702214|FG000|Double-blind Period|Administrative problems|0|||
145234139|NCT01082367|523702215|FG001|Double-blind Period|Administrative problems|1|||
145234140|NCT01082367|523702214|FG000|Double-blind Period|Lack of Efficacy|5|||
145234141|NCT01082367|523702215|FG001|Double-blind Period|Lack of Efficacy|11|||
145234142|NCT01082367|523702214|FG000|Double-blind Period|Adverse Event|0|||
145234143|NCT01082367|523702215|FG001|Double-blind Period|Adverse Event|1|||
145234144|NCT01082367|523702214|FG000|Follow-up (F-U) Period|Administrative problems|1|||
145234145|NCT01082367|523702215|FG001|Follow-up (F-U) Period|Administrative problems|0|||
145234146|NCT01082367|523702214|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
145234147|NCT01082367|523702215|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
145234148|NCT01082367|523702214|FG000|Follow-up (F-U) Period|Adverse Event|0|||
145234149|NCT01082367|523702215|FG001|Follow-up (F-U) Period|Adverse Event|1|||
145234150|NCT04724733|523702221|FG000|Overall Study|Lost to Follow-up|1|||
145234151|NCT04724733|523702222|FG001|Overall Study|Lost to Follow-up|1|||
145234152|NCT04724733|523702223|FG002|Overall Study|Lost to Follow-up|1|||
145234153|NCT03067129|523702224|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
145234154|NCT03067129|523702225|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
145234155|NCT03067129|523702226|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
145234156|NCT03067129|523702227|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
145408323|NCT03314935|524349854|FG008|Phase 2|Physician Decision|0|||
145234157|NCT03067129|523702224|FG000|Overall Study|Withdrawal by Subject|0|||
145234158|NCT03067129|523702225|FG001|Overall Study|Withdrawal by Subject|0|||
145234159|NCT03067129|523702226|FG002|Overall Study|Withdrawal by Subject|1|||
145234160|NCT03067129|523702227|FG003|Overall Study|Withdrawal by Subject|2|||
145234161|NCT03067129|523702224|FG000|Overall Study|Lost to Follow-up|5|||
145234162|NCT03067129|523702225|FG001|Overall Study|Lost to Follow-up|5|||
145234163|NCT03067129|523702226|FG002|Overall Study|Lost to Follow-up|4|||
145234164|NCT03067129|523702227|FG003|Overall Study|Lost to Follow-up|3|||
145234165|NCT03372603|523702228|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
145234166|NCT03372603|523702229|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
145234167|NCT03372603|523702228|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
145234168|NCT03372603|523702229|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
145234169|NCT04929613|523702230|FG000|Overall Study|Withdrawal by Subject|12|||
145234170|NCT00664209|523702236|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
145234171|NCT00664209|523702236|FG000|Study Treatment Period|Physician Decision|4|||
145234172|NCT00664209|523702236|FG000|Study Treatment Period|Withdrawal by Subject|2|||
145234173|NCT00843843|523702237|FG000|Overall Study|Physician Decision|1|||
145234174|NCT00843843|523702238|FG001|Overall Study|Physician Decision|1|||
145234175|NCT00843843|523702237|FG000|Overall Study|Protocol Violation|1|||
145234176|NCT00843843|523702238|FG001|Overall Study|Protocol Violation|1|||
145234177|NCT00418379|523702239|FG000|Year 1|Adverse Event|9|||
145234178|NCT00418379|523702240|FG001|Year 1|Adverse Event|15|||
145234179|NCT00418379|523702241|FG002|Year 1|Adverse Event|3|||
145234180|NCT00418379|523702239|FG000|Year 1|Withdrawal by Subject|7|||
145234181|NCT00418379|523702240|FG001|Year 1|Withdrawal by Subject|8|||
145234182|NCT00418379|523702241|FG002|Year 1|Withdrawal by Subject|5|||
145234183|NCT00418379|523702239|FG000|Year 1|Any other reason not above-mentioned|2|||
145234184|NCT00418379|523702240|FG001|Year 1|Any other reason not above-mentioned|5|||
145234185|NCT00418379|523702241|FG002|Year 1|Any other reason not above-mentioned|7|||
145234186|NCT00418379|523702239|FG000|Year 2|Adverse Event|5|||
145234187|NCT00418379|523702240|FG001|Year 2|Adverse Event|2|||
145234188|NCT00418379|523702241|FG002|Year 2|Adverse Event|1|||
145234189|NCT00418379|523702239|FG000|Year 2|Withdrawal by Subject|1|||
145234190|NCT00418379|523702240|FG001|Year 2|Withdrawal by Subject|1|||
145234191|NCT00418379|523702241|FG002|Year 2|Withdrawal by Subject|3|||
145234192|NCT00418379|523702239|FG000|Year 2|Any other reason not above-mentioned|2|||
145234193|NCT00418379|523702240|FG001|Year 2|Any other reason not above-mentioned|1|||
145234194|NCT00418379|523702241|FG002|Year 2|Any other reason not above-mentioned|6|||
145234195|NCT00418379|523702239|FG000|Year 3|Withdrawal by Subject|1|||
145234196|NCT00418379|523702240|FG001|Year 3|Withdrawal by Subject|1|||
145234197|NCT00418379|523702241|FG002|Year 3|Withdrawal by Subject|2|||
145234198|NCT00418379|523702239|FG000|Year 3|Any other reason not above-mentioned|2|||
145234199|NCT00418379|523702240|FG001|Year 3|Any other reason not above-mentioned|1|||
145234200|NCT00418379|523702241|FG002|Year 3|Any other reason not above-mentioned|1|||
145234201|NCT00418379|523702239|FG000|Year 4|Adverse Event|0|||
145234202|NCT00418379|523702240|FG001|Year 4|Adverse Event|1|||
145234203|NCT00418379|523702241|FG002|Year 4|Adverse Event|0|||
145234204|NCT00418379|523702239|FG000|Year 4|Withdrawal by Subject|2|||
145234205|NCT00418379|523702240|FG001|Year 4|Withdrawal by Subject|3|||
145234206|NCT00418379|523702241|FG002|Year 4|Withdrawal by Subject|2|||
145234207|NCT00418379|523702239|FG000|Year 4|Any other reason not above-mentioned|1|||
145234208|NCT00418379|523702240|FG001|Year 4|Any other reason not above-mentioned|1|||
145234209|NCT00418379|523702241|FG002|Year 4|Any other reason not above-mentioned|0|||
145234210|NCT00418379|523702239|FG000|Year 5|Adverse Event|0|||
145234211|NCT00418379|523702240|FG001|Year 5|Adverse Event|1|||
145234212|NCT00418379|523702241|FG002|Year 5|Adverse Event|0|||
145234213|NCT00418379|523702239|FG000|Year 5|Any other reason not above-mentioned|2|||
145234214|NCT00418379|523702240|FG001|Year 5|Any other reason not above-mentioned|4|||
145234215|NCT00418379|523702241|FG002|Year 5|Any other reason not above-mentioned|3|||
145234216|NCT01764256|523702242|FG000|Received All Vaccinations|Adverse Event|1|||
145234217|NCT01764256|523702243|FG001|Received All Vaccinations|Adverse Event|1|||
145234218|NCT01764256|523702244|FG002|Received All Vaccinations|Adverse Event|0|||
145234219|NCT01764256|523702245|FG003|Received All Vaccinations|Adverse Event|0|||
145234220|NCT01764256|523702242|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
145234221|NCT01764256|523702243|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
145234222|NCT01764256|523702244|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
145234223|NCT01764256|523702245|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
145234224|NCT01764256|523702242|FG000|Received All Vaccinations|Lost to Follow-up|1|||
145234225|NCT01764256|523702243|FG001|Received All Vaccinations|Lost to Follow-up|0|||
145234226|NCT01764256|523702244|FG002|Received All Vaccinations|Lost to Follow-up|0|||
145234227|NCT01764256|523702245|FG003|Received All Vaccinations|Lost to Follow-up|0|||
145234228|NCT01764256|523702242|FG000|Completed Study|Lost to Follow-up|0|||
145234229|NCT01764256|523702243|FG001|Completed Study|Lost to Follow-up|0|||
145234230|NCT01764256|523702244|FG002|Completed Study|Lost to Follow-up|0|||
145234231|NCT01764256|523702245|FG003|Completed Study|Lost to Follow-up|1|||
145234232|NCT00565058|523702246|FG000|Overall Study|Adverse Event|1|||
145234233|NCT00565058|523702247|FG001|Overall Study|Adverse Event|0|||
145234234|NCT02029638|523702248|FG000|Overall Study|Death|0|||
145234235|NCT02029638|523702249|FG001|Overall Study|Death|0|||
145234236|NCT02029638|523702250|FG002|Overall Study|Death|1|||
145234237|NCT02029638|523702248|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
145234238|NCT02029638|523702249|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
145234239|NCT02029638|523702250|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
145234240|NCT01153841|523702251|FG000|Overall Study|Adverse Event|1|||
145234241|NCT01153841|523702252|FG001|Overall Study|Adverse Event|0|||
145234242|NCT01153841|523702251|FG000|Overall Study|Withdrawal by Subject|1|||
145234243|NCT01153841|523702252|FG001|Overall Study|Withdrawal by Subject|0|||
145234244|NCT01153841|523702251|FG000|Overall Study|Protocol Violation|2|||
145234245|NCT01153841|523702252|FG001|Overall Study|Protocol Violation|0|||
145234246|NCT01153841|523702251|FG000|Overall Study|Lost to Follow-up|2|||
145234247|NCT01153841|523702252|FG001|Overall Study|Lost to Follow-up|0|||
145234248|NCT00830804|523702253|FG000|Overall Study|Lost to Follow-up|4|||
145234249|NCT00830804|523702253|FG000|Overall Study|Death|1|||
145234250|NCT00830804|523702253|FG000|Overall Study|Unable to get to clinic|7|||
145234251|NCT00830804|523702253|FG000|Overall Study|Consent withdrawn|2|||
145234252|NCT00830804|523702253|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
145234253|NCT03428997|523702254|FG000|Overall Study|Sponsor decision.|1|||
145234254|NCT03428997|523702254|FG000|Overall Study|Withdrawal by Subject|3|||
145234255|NCT03428997|523702254|FG000|Overall Study|Lost to Follow-up|4|||
145234256|NCT01397448|523702261|FG000|Overall Study|Adverse Event|4|||
145234257|NCT01397448|523702262|FG001|Overall Study|Adverse Event|4|||
145234258|NCT01397448|523702263|FG002|Overall Study|Adverse Event|6|||
145234259|NCT01397448|523702261|FG000|Overall Study|Withdrawal by Subject|4|||
145234260|NCT01397448|523702262|FG001|Overall Study|Withdrawal by Subject|4|||
145234261|NCT01397448|523702263|FG002|Overall Study|Withdrawal by Subject|3|||
145234262|NCT01397448|523702261|FG000|Overall Study|Lack of Efficacy|2|||
145234263|NCT01397448|523702262|FG001|Overall Study|Lack of Efficacy|0|||
145234264|NCT01397448|523702263|FG002|Overall Study|Lack of Efficacy|5|||
145234265|NCT01397448|523702261|FG000|Overall Study|Other|8|||
145234266|NCT01397448|523702262|FG001|Overall Study|Other|7|||
145234267|NCT01397448|523702263|FG002|Overall Study|Other|4|||
145234268|NCT02180217|523702268|FG000|Overall Study|Adverse Event|3|||
145234269|NCT02180217|523702269|FG001|Overall Study|Adverse Event|2|||
145234270|NCT02180217|523702270|FG002|Overall Study|Adverse Event|22|||
145234271|NCT02180217|523702268|FG000|Overall Study|Death|1|||
145234272|NCT02180217|523702269|FG001|Overall Study|Death|1|||
145234273|NCT02180217|523702270|FG002|Overall Study|Death|0|||
145234274|NCT02180217|523702268|FG000|Overall Study|Withdrawal by Subject|1|||
145234275|NCT02180217|523702269|FG001|Overall Study|Withdrawal by Subject|1|||
145234276|NCT02180217|523702270|FG002|Overall Study|Withdrawal by Subject|4|||
145234277|NCT02180217|523702268|FG000|Overall Study|Subject/Guardian decision|5|||
145234278|NCT02180217|523702269|FG001|Overall Study|Subject/Guardian decision|3|||
145234279|NCT02180217|523702270|FG002|Overall Study|Subject/Guardian decision|6|||
145234280|NCT02180217|523702268|FG000|Overall Study|Physician Decision|1|||
145234281|NCT02180217|523702269|FG001|Overall Study|Physician Decision|1|||
145234282|NCT02180217|523702270|FG002|Overall Study|Physician Decision|6|||
145234283|NCT02180217|523702268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145234284|NCT02180217|523702269|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145295203|NCT02458469|523930733|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145295204|NCT02458469|523930734|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145295205|NCT02458469|523930735|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145234285|NCT02180217|523702270|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145234286|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
145234287|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
145234288|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
145234289|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
145234290|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
145234291|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
145234292|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Death|1|||
145234293|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Death|3|||
145234294|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
145234295|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
145234296|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
145234297|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
145234298|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
145234299|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
145295206|NCT02458469|523930736|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
145295207|NCT02458469|523930737|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
145295208|NCT03561883|523930740|FG000|Overall Study|Adverse Event|10|||
145295209|NCT03561883|523930741|FG001|Overall Study|Adverse Event|13|||
145234300|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
145234301|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
145408324|NCT03314935|524349855|FG009|Phase 2|Physician Decision|0|||
145234302|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
145234303|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
145234304|NCT02553317|523702271|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
145234305|NCT02553317|523702272|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
145234306|NCT04093258|523702275|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
145234307|NCT04093258|523702276|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
145234308|NCT00567541|523702277|FG000|Overall Study|Adverse Event|0|||
145234309|NCT00567541|523702278|FG001|Overall Study|Adverse Event|1|||
145234310|NCT00986427|523702279|FG000|Overall Study|Lost to Follow-up|2|||
145234311|NCT00986427|523702280|FG001|Overall Study|Lost to Follow-up|0|||
145234312|NCT00986427|523702279|FG000|Overall Study|Lack of Efficacy|1|||
145234313|NCT00986427|523702280|FG001|Overall Study|Lack of Efficacy|0|||
145234314|NCT00986427|523702279|FG000|Overall Study|Withdrawal by Subject|1|||
145234315|NCT00986427|523702280|FG001|Overall Study|Withdrawal by Subject|0|||
145234316|NCT06025396|523704878|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
145234317|NCT06025396|523704879|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
145234318|NCT06025396|523704880|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
145234319|NCT06025396|523704881|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
145234320|NCT06025396|523704882|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
145234321|NCT06025396|523704878|FG000|Overall Study|Withdrawal by Subject|0|||
145234322|NCT06025396|523704879|FG001|Overall Study|Withdrawal by Subject|1|||
145234323|NCT06025396|523704880|FG002|Overall Study|Withdrawal by Subject|1|||
145234324|NCT06025396|523704881|FG003|Overall Study|Withdrawal by Subject|0|||
145234325|NCT06025396|523704882|FG004|Overall Study|Withdrawal by Subject|0|||
145234326|NCT06422377|523704887|FG000|Overall Study|Study Terminated by Sponsor|1|||
145234327|NCT00646113|523704888|FG000|Overall Study|Lost to Follow-up|5|||
145234328|NCT00646113|523704888|FG000|Overall Study|Adverse Event|3|||
145234329|NCT00949910|523704889|FG000|Overall Study|Progressive Disease|3750|||
145234330|NCT00949910|523704889|FG000|Overall Study|Symptomatic Deterioration|1088|||
145234331|NCT00949910|523704889|FG000|Overall Study|Lost to Follow-up|100|||
145234332|NCT00949910|523704889|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
145234333|NCT00949910|523704889|FG000|Overall Study|Participant Refusal|390|||
145234334|NCT00949910|523704889|FG000|Overall Study|Death Due to Malignant Disease|456|||
145234335|NCT00949910|523704889|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
145234336|NCT00949910|523704889|FG000|Overall Study|Death Due to Adverse Event|115|||
145234337|NCT00949910|523704889|FG000|Overall Study|Death Due to Toxicity|3|||
145234338|NCT00949910|523704889|FG000|Overall Study|Death from Unknown Cause|5|||
145234339|NCT00949910|523704889|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
145234340|NCT00949910|523704889|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
145234341|NCT00949910|523704889|FG000|Overall Study|Switched to Commercial Treatment|4|||
145234342|NCT00949910|523704889|FG000|Overall Study|Violation of Eligibility|23|||
145234343|NCT00949910|523704889|FG000|Overall Study|Logistical Reasons|13|||
145234344|NCT00949910|523704889|FG000|Overall Study|Non-Compliance|10|||
145234345|NCT00949910|523704889|FG000|Overall Study|Prolonged Dosing Interruption|4|||
145234346|NCT00949910|523704889|FG000|Overall Study|Adverse Event|83|||
145234347|NCT00949910|523704889|FG000|Overall Study|Serious Adverse Event|6|||
145234348|NCT00949910|523704889|FG000|Overall Study|Physician/Participant Decision|7|||
145234349|NCT00949910|523704889|FG000|Overall Study|Other|4|||
145234350|NCT00949910|523704889|FG000|Overall Study|No Data|9|||
145234351|NCT03287869|523704890|FG000|Overall Study|Adverse Event|14|||
145234352|NCT03287869|523704891|FG001|Overall Study|Adverse Event|12|||
145234353|NCT03287869|523704890|FG000|Overall Study|Lack of Efficacy|1|||
145234354|NCT03287869|523704891|FG001|Overall Study|Lack of Efficacy|0|||
145234355|NCT03287869|523704890|FG000|Overall Study|Lost to Follow-up|13|||
145619915|NCT05305040|525123618|FG000|Overall Study|Adverse Event|3|||
145619916|NCT05305040|525123619|FG001|Overall Study|Adverse Event|3|||
145619917|NCT05305040|525123618|FG000|Overall Study|Lost to Follow-up|2|||
145619918|NCT05305040|525123619|FG001|Overall Study|Lost to Follow-up|1|||
145619919|NCT05305040|525123618|FG000|Overall Study|Graft versus host disease|2|||
145234356|NCT03287869|523704891|FG001|Overall Study|Lost to Follow-up|19|||
145234357|NCT03287869|523704890|FG000|Overall Study|Non-Compliance With Study Drug|5|||
145234358|NCT03287869|523704891|FG001|Overall Study|Non-Compliance With Study Drug|9|||
145234359|NCT03287869|523704890|FG000|Overall Study|Progressive Disease|1|||
145234360|NCT03287869|523704891|FG001|Overall Study|Progressive Disease|0|||
145234361|NCT03287869|523704890|FG000|Overall Study|Protocol Deviation|2|||
145234362|NCT03287869|523704891|FG001|Overall Study|Protocol Deviation|1|||
145234363|NCT03287869|523704890|FG000|Overall Study|Withdrawal by Subject|36|||
145234364|NCT03287869|523704891|FG001|Overall Study|Withdrawal by Subject|43|||
145234365|NCT03287869|523704890|FG000|Overall Study|Early Closure of the Site|0|||
145234366|NCT03287869|523704891|FG001|Overall Study|Early Closure of the Site|1|||
145234367|NCT03287869|523704890|FG000|Overall Study|Physician Decision|5|||
145234368|NCT03287869|523704891|FG001|Overall Study|Physician Decision|5|||
145234369|NCT03287869|523704890|FG000|Overall Study|Reason not Specified|6|||
145234370|NCT03287869|523704891|FG001|Overall Study|Reason not Specified|3|||
145234371|NCT02455388|523704895|FG000|Overall Study|Protocol Violation|1|||
145234372|NCT02455388|523704896|FG001|Overall Study|Protocol Violation|0|||
145234373|NCT02455388|523704897|FG002|Overall Study|Protocol Violation|4|||
145234374|NCT02455388|523704895|FG000|Overall Study|Withdrawal by Subject|0|||
145234375|NCT02455388|523704896|FG001|Overall Study|Withdrawal by Subject|0|||
145234376|NCT02455388|523704897|FG002|Overall Study|Withdrawal by Subject|7|||
145234377|NCT04847141|523704898|FG000|Overall Study|Adverse Event|1|||
145234378|NCT04847141|523704899|FG001|Overall Study|Adverse Event|0|||
145234379|NCT04847141|523704900|FG002|Overall Study|Adverse Event|1|||
145234380|NCT04847141|523704898|FG000|Overall Study|Withdrawal by Subject|2|||
145234381|NCT04847141|523704899|FG001|Overall Study|Withdrawal by Subject|4|||
145234382|NCT04847141|523704900|FG002|Overall Study|Withdrawal by Subject|3|||
145234383|NCT04847141|523704898|FG000|Overall Study|Lost to Follow-up|7|||
145234384|NCT04847141|523704899|FG001|Overall Study|Lost to Follow-up|5|||
145234385|NCT04847141|523704900|FG002|Overall Study|Lost to Follow-up|7|||
145234386|NCT04847141|523704898|FG000|Overall Study|Reason not Specified|0|||
145234387|NCT04847141|523704899|FG001|Overall Study|Reason not Specified|1|||
145234388|NCT04847141|523704900|FG002|Overall Study|Reason not Specified|0|||
145234389|NCT00324740|523704901|FG000|Overall Study|Withdrawal by Subject|1|||
145234390|NCT00324740|523704902|FG001|Overall Study|Withdrawal by Subject|0|||
145234391|NCT00324740|523704903|FG002|Overall Study|Withdrawal by Subject|1|||
145234392|NCT00520299|523704906|FG000|Overall Study|Withdrawal by Subject|0|||
145234393|NCT00520299|523704907|FG001|Overall Study|Withdrawal by Subject|0|||
145234394|NCT00520299|523704908|FG002|Overall Study|Withdrawal by Subject|2|||
145234395|NCT00520299|523704906|FG000|Overall Study|Progressive disease|0|||
145234396|NCT00520299|523704907|FG001|Overall Study|Progressive disease|3|||
145234397|NCT00520299|523704908|FG002|Overall Study|Progressive disease|4|||
145234398|NCT00971425|523704912|FG000|Overall Study|Adverse Event|1|||
145234399|NCT00971425|523704913|FG001|Overall Study|Adverse Event|1|||
145234400|NCT00971425|523704912|FG000|Overall Study|Withdrawal by Subject|0|||
145234401|NCT00971425|523704913|FG001|Overall Study|Withdrawal by Subject|1|||
145234402|NCT02528253|523704916|FG000|Overall Study|Adverse Event|3|||
145234403|NCT02528253|523704917|FG001|Overall Study|Adverse Event|4|||
145234404|NCT02528253|523704918|FG002|Overall Study|Adverse Event|4|||
145234405|NCT02528253|523704919|FG003|Overall Study|Adverse Event|8|||
145234406|NCT02528253|523704920|FG004|Overall Study|Adverse Event|18|||
145234407|NCT02528253|523704916|FG000|Overall Study|Death|2|||
145234408|NCT02528253|523704917|FG001|Overall Study|Death|2|||
145234409|NCT02528253|523704918|FG002|Overall Study|Death|1|||
145234410|NCT02528253|523704919|FG003|Overall Study|Death|0|||
145234411|NCT02528253|523704920|FG004|Overall Study|Death|1|||
145234412|NCT02528253|523704916|FG000|Overall Study|Insufficient clinical response|7|||
145234413|NCT02528253|523704917|FG001|Overall Study|Insufficient clinical response|10|||
145234414|NCT02528253|523704918|FG002|Overall Study|Insufficient clinical response|13|||
145234415|NCT02528253|523704919|FG003|Overall Study|Insufficient clinical response|12|||
145234416|NCT02528253|523704920|FG004|Overall Study|Insufficient clinical response|16|||
145234417|NCT02528253|523704916|FG000|Overall Study|Lost to Follow-up|16|||
145234418|NCT02528253|523704917|FG001|Overall Study|Lost to Follow-up|9|||
145234419|NCT02528253|523704918|FG002|Overall Study|Lost to Follow-up|31|||
145234420|NCT02528253|523704919|FG003|Overall Study|Lost to Follow-up|16|||
145234421|NCT02528253|523704920|FG004|Overall Study|Lost to Follow-up|34|||
145234422|NCT02528253|523704916|FG000|Overall Study|Other|21|||
145234423|NCT02528253|523704917|FG001|Overall Study|Other|22|||
145234424|NCT02528253|523704918|FG002|Overall Study|Other|58|||
145234425|NCT02528253|523704919|FG003|Overall Study|Other|52|||
145234426|NCT02528253|523704920|FG004|Overall Study|Other|76|||
145234427|NCT02528253|523704916|FG000|Overall Study|Withdrawal by Subject|25|||
145234428|NCT02528253|523704917|FG001|Overall Study|Withdrawal by Subject|20|||
145234429|NCT02528253|523704918|FG002|Overall Study|Withdrawal by Subject|29|||
145234430|NCT02528253|523704919|FG003|Overall Study|Withdrawal by Subject|48|||
145234431|NCT02528253|523704920|FG004|Overall Study|Withdrawal by Subject|73|||
145234432|NCT02528253|523704916|FG000|Overall Study|Protocol Violation|1|||
145234433|NCT02528253|523704917|FG001|Overall Study|Protocol Violation|2|||
145234434|NCT02528253|523704918|FG002|Overall Study|Protocol Violation|4|||
145234435|NCT02528253|523704919|FG003|Overall Study|Protocol Violation|0|||
145234436|NCT02528253|523704920|FG004|Overall Study|Protocol Violation|4|||
145234437|NCT02528253|523704916|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
145234438|NCT02528253|523704917|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
145234439|NCT02528253|523704918|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
145234440|NCT02528253|523704919|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
145234441|NCT02528253|523704920|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
145234442|NCT01357980|523704921|FG000|Overall Study|Lack of Efficacy|0|||
145234443|NCT01357980|523704922|FG001|Overall Study|Lack of Efficacy|1|||
145295210|NCT03561883|523930740|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145295211|NCT03561883|523930741|FG001|Overall Study|Non-Compliance With Study Drug|2|||
145295212|NCT03561883|523930740|FG000|Overall Study|Protocol Violation|2|||
145234444|NCT01357980|523704923|FG002|Overall Study|Lack of Efficacy|0|||
145234445|NCT01357980|523704924|FG003|Overall Study|Lack of Efficacy|0|||
145234446|NCT01357980|523704921|FG000|Overall Study|Consent withdrawn|0|||
145234447|NCT01357980|523704922|FG001|Overall Study|Consent withdrawn|0|||
145234448|NCT01357980|523704923|FG002|Overall Study|Consent withdrawn|1|||
145234449|NCT01357980|523704924|FG003|Overall Study|Consent withdrawn|0|||
145234450|NCT00094835|523704927|FG000|Overall Study|Physician Decision|1|||
145234451|NCT00094835|523704928|FG001|Overall Study|Physician Decision|0|||
145234452|NCT00094835|523704929|FG002|Overall Study|Physician Decision|0|||
145234453|NCT00094835|523704930|FG003|Overall Study|Physician Decision|0|||
145234454|NCT00094835|523704931|FG004|Overall Study|Physician Decision|0|||
145234455|NCT00094835|523704932|FG005|Overall Study|Physician Decision|1|||
145234456|NCT00094835|523704933|FG006|Overall Study|Physician Decision|0|||
145234457|NCT00094835|523704927|FG000|Overall Study|Withdrawal by Subject|0|||
145234458|NCT00094835|523704928|FG001|Overall Study|Withdrawal by Subject|0|||
145234459|NCT00094835|523704929|FG002|Overall Study|Withdrawal by Subject|0|||
145234460|NCT00094835|523704930|FG003|Overall Study|Withdrawal by Subject|0|||
145234461|NCT00094835|523704931|FG004|Overall Study|Withdrawal by Subject|0|||
145234462|NCT00094835|523704932|FG005|Overall Study|Withdrawal by Subject|0|||
145234463|NCT00094835|523704933|FG006|Overall Study|Withdrawal by Subject|1|||
145234464|NCT00094835|523704927|FG000|Overall Study|Lost to Follow-up|0|||
145234465|NCT00094835|523704928|FG001|Overall Study|Lost to Follow-up|0|||
145234466|NCT00094835|523704929|FG002|Overall Study|Lost to Follow-up|0|||
145234467|NCT00094835|523704930|FG003|Overall Study|Lost to Follow-up|0|||
145234468|NCT00094835|523704931|FG004|Overall Study|Lost to Follow-up|1|||
145234469|NCT00094835|523704932|FG005|Overall Study|Lost to Follow-up|0|||
145234470|NCT00094835|523704933|FG006|Overall Study|Lost to Follow-up|0|||
145234471|NCT00094835|523704927|FG000|Overall Study|Death|1|||
145234472|NCT00094835|523704928|FG001|Overall Study|Death|0|||
145234473|NCT00094835|523704929|FG002|Overall Study|Death|0|||
145234474|NCT00094835|523704930|FG003|Overall Study|Death|0|||
145234475|NCT00094835|523704931|FG004|Overall Study|Death|1|||
145234476|NCT00094835|523704932|FG005|Overall Study|Death|0|||
145234477|NCT00094835|523704933|FG006|Overall Study|Death|0|||
145234478|NCT00094835|523704927|FG000|Overall Study|Non-compliance|1|||
145234479|NCT00094835|523704928|FG001|Overall Study|Non-compliance|2|||
145234480|NCT00094835|523704929|FG002|Overall Study|Non-compliance|2|||
145234481|NCT00094835|523704930|FG003|Overall Study|Non-compliance|0|||
145234482|NCT00094835|523704931|FG004|Overall Study|Non-compliance|2|||
145234483|NCT00094835|523704932|FG005|Overall Study|Non-compliance|2|||
145234484|NCT00094835|523704933|FG006|Overall Study|Non-compliance|1|||
145234485|NCT00094835|523704927|FG000|Overall Study|Other|1|||
145234486|NCT00094835|523704928|FG001|Overall Study|Other|1|||
145234487|NCT00094835|523704929|FG002|Overall Study|Other|1|||
145234488|NCT00094835|523704930|FG003|Overall Study|Other|1|||
145234489|NCT00094835|523704931|FG004|Overall Study|Other|0|||
145234490|NCT00094835|523704932|FG005|Overall Study|Other|0|||
145234491|NCT00094835|523704933|FG006|Overall Study|Other|0|||
145234492|NCT01149343|523704934|FG000|Overall Study|Withdrawal by Subject|1|||
145234493|NCT01149343|523704935|FG001|Overall Study|Withdrawal by Subject|1|||
145234494|NCT01149343|523704936|FG002|Overall Study|Withdrawal by Subject|1|||
145234495|NCT01149343|523704937|FG003|Overall Study|Withdrawal by Subject|5|||
145234496|NCT01149343|523704934|FG000|Overall Study|Death|10|||
145234497|NCT01149343|523704935|FG001|Overall Study|Death|13|||
145234498|NCT01149343|523704936|FG002|Overall Study|Death|18|||
145234499|NCT01149343|523704937|FG003|Overall Study|Death|18|||
145234500|NCT01149343|523704934|FG000|Overall Study|Lost to Follow-up|1|||
145234501|NCT01149343|523704935|FG001|Overall Study|Lost to Follow-up|0|||
145234502|NCT01149343|523704936|FG002|Overall Study|Lost to Follow-up|0|||
145234503|NCT01149343|523704937|FG003|Overall Study|Lost to Follow-up|1|||
145234504|NCT01149343|523704934|FG000|Overall Study|Other|8|||
145234505|NCT01149343|523704935|FG001|Overall Study|Other|10|||
145234506|NCT01149343|523704936|FG002|Overall Study|Other|2|||
145234507|NCT01149343|523704937|FG003|Overall Study|Other|14|||
145234508|NCT01149343|523704934|FG000|Overall Study|Sponsor study termination|0|||
145234509|NCT01149343|523704935|FG001|Overall Study|Sponsor study termination|0|||
145234510|NCT01149343|523704936|FG002|Overall Study|Sponsor study termination|0|||
145234511|NCT01149343|523704937|FG003|Overall Study|Sponsor study termination|2|||
145234512|NCT01149343|523704934|FG000|Overall Study|Recurrence / Progressive disease|0|||
145234513|NCT01149343|523704935|FG001|Overall Study|Recurrence / Progressive disease|0|||
145234514|NCT01149343|523704936|FG002|Overall Study|Recurrence / Progressive disease|1|||
145295213|NCT03561883|523930741|FG001|Overall Study|Protocol Violation|3|||
145295214|NCT03561883|523930740|FG000|Overall Study|Withdrawal by Subject|14|||
145234515|NCT01149343|523704937|FG003|Overall Study|Recurrence / Progressive disease|0|||
145234516|NCT03472040|523704941|FG000|Overall Study|Physician Decision|0|||
145234517|NCT03472040|523704942|FG001|Overall Study|Physician Decision|3|||
145234518|NCT03472040|523704941|FG000|Overall Study|Withdrawal by Subject|10|||
145234519|NCT03472040|523704942|FG001|Overall Study|Withdrawal by Subject|23|||
145234520|NCT03472040|523704941|FG000|Overall Study|Perceived Lack of Efficacy|29|||
145234521|NCT03472040|523704942|FG001|Overall Study|Perceived Lack of Efficacy|30|||
145234522|NCT03472040|523704941|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
145234523|NCT03472040|523704942|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
145234524|NCT03472040|523704941|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
145234525|NCT03472040|523704942|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
145234526|NCT03472040|523704941|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
145234527|NCT03472040|523704942|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
145234528|NCT03472040|523704941|FG000|Overall Study|Subject Non-compliance|2|||
145234529|NCT03472040|523704942|FG001|Overall Study|Subject Non-compliance|5|||
145234530|NCT03472040|523704941|FG000|Overall Study|Discontinuation due to Rash|0|||
145234531|NCT03472040|523704942|FG001|Overall Study|Discontinuation due to Rash|1|||
145234532|NCT03472040|523704941|FG000|Overall Study|Subsequent Ineligibility|0|||
145234533|NCT03472040|523704942|FG001|Overall Study|Subsequent Ineligibility|2|||
145234534|NCT03472040|523704941|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
145234535|NCT03472040|523704942|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
145234536|NCT02769832|523704943|FG000|Overall Study|Death|30|||
145234537|NCT00225147|523704950|FG000|Open-label Phase|Lost to Follow-up|0|||
145234538|NCT00225147|523704951|FG001|Open-label Phase|Lost to Follow-up|0|||
145234539|NCT00225147|523704952|FG002|Open-label Phase|Lost to Follow-up|0|||
145234540|NCT00225147|523704953|FG003|Open-label Phase|Lost to Follow-up|4|||
145234541|NCT00225147|523704950|FG000|Open-label Phase|Withdrawal by Subject|0|||
145234542|NCT00225147|523704951|FG001|Open-label Phase|Withdrawal by Subject|0|||
145234543|NCT00225147|523704952|FG002|Open-label Phase|Withdrawal by Subject|0|||
145234544|NCT00225147|523704953|FG003|Open-label Phase|Withdrawal by Subject|6|||
145234545|NCT02685995|523704956|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
145234546|NCT02685995|523704957|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
145234547|NCT03625141|523704958|FG000|Overall Study|Adverse Event|0|||
145234548|NCT03625141|523704959|FG001|Overall Study|Adverse Event|2|||
145234549|NCT03625141|523704958|FG000|Overall Study|Study Terminated By Sponsor|1|||
145234550|NCT03625141|523704959|FG001|Overall Study|Study Terminated By Sponsor|13|||
145234551|NCT03625141|523704958|FG000|Overall Study|Withdrawal by Subject|3|||
145234552|NCT03625141|523704959|FG001|Overall Study|Withdrawal by Subject|0|||
145234553|NCT03625141|523704958|FG000|Overall Study|Withdrawal Of Consent|0|||
145234554|NCT03625141|523704959|FG001|Overall Study|Withdrawal Of Consent|1|||
145234555|NCT03625141|523704958|FG000|Overall Study|Death|11|||
145234556|NCT03625141|523704959|FG001|Overall Study|Death|47|||
145234557|NCT03625141|523704958|FG000|Overall Study|Progressive Disease|0|||
145234558|NCT03625141|523704959|FG001|Overall Study|Progressive Disease|2|||
145234559|NCT02034552|523704964|FG000|Overall Study|Never treated|3|||
145234560|NCT02034552|523704965|FG001|Overall Study|Never treated|2|||
145234561|NCT02034552|523704966|FG002|Overall Study|Never treated|0|||
145234562|NCT02034552|523704964|FG000|Overall Study|Radiological progression|3|||
145234563|NCT02034552|523704965|FG001|Overall Study|Radiological progression|5|||
145234564|NCT02034552|523704966|FG002|Overall Study|Radiological progression|4|||
145234565|NCT02034552|523704964|FG000|Overall Study|AE not assoc. with disease progression|1|||
145234566|NCT02034552|523704965|FG001|Overall Study|AE not assoc. with disease progression|4|||
145234567|NCT02034552|523704966|FG002|Overall Study|AE not assoc. with disease progression|2|||
145234568|NCT02034552|523704964|FG000|Overall Study|AE associated with disease progression|0|||
145234569|NCT02034552|523704965|FG001|Overall Study|AE associated with disease progression|1|||
145234570|NCT02034552|523704966|FG002|Overall Study|AE associated with disease progression|0|||
145234571|NCT02034552|523704964|FG000|Overall Study|Withdrawal by Subject|2|||
145234572|NCT02034552|523704965|FG001|Overall Study|Withdrawal by Subject|1|||
145234573|NCT02034552|523704966|FG002|Overall Study|Withdrawal by Subject|1|||
145234574|NCT02034552|523704964|FG000|Overall Study|Non-compliance with study drug|0|||
145234575|NCT02034552|523704965|FG001|Overall Study|Non-compliance with study drug|0|||
145234576|NCT02034552|523704966|FG002|Overall Study|Non-compliance with study drug|1|||
145234577|NCT02034552|523704964|FG000|Overall Study|Clinical progression|5|||
145234578|NCT02034552|523704965|FG001|Overall Study|Clinical progression|7|||
145234579|NCT02034552|523704966|FG002|Overall Study|Clinical progression|9|||
145234580|NCT02310906|523704967|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
145234581|NCT02310906|523704968|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
145295215|NCT03561883|523930741|FG001|Overall Study|Withdrawal by Subject|6|||
145295216|NCT03561883|523930740|FG000|Overall Study|Lost to Follow-up|2|||
145295217|NCT03561883|523930741|FG001|Overall Study|Lost to Follow-up|6|||
145295218|NCT03561883|523930740|FG000|Overall Study|Study Terminated by Sponsor|12|||
145295219|NCT03561883|523930741|FG001|Overall Study|Study Terminated by Sponsor|11|||
145295220|NCT03561883|523930740|FG000|Overall Study|Physician Decision|1|||
145234582|NCT02310906|523704969|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
145234583|NCT02310906|523704970|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
145234584|NCT02310906|523704967|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
145234585|NCT02310906|523704968|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
145234586|NCT02310906|523704969|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
145234587|NCT02310906|523704970|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
145295221|NCT03561883|523930741|FG001|Overall Study|Physician Decision|0|||
145295222|NCT03561883|523930740|FG000|Overall Study|Randomized by Mistake|1|||
145295223|NCT03561883|523930741|FG001|Overall Study|Randomized by Mistake|0|||
145295224|NCT03561883|523930740|FG000|Overall Study|Other, Not Specified|3|||
145295225|NCT03561883|523930741|FG001|Overall Study|Other, Not Specified|2|||
145295226|NCT02365207|523930753|FG000|Overall Study|Withdrawal by Subject|1|||
145295227|NCT02365207|523930753|FG000|Overall Study|Physician Decision|1|||
145295228|NCT00408902|523930758|FG000|Overall Study|Lack of Efficacy|7|||
145295229|NCT00408902|523930758|FG000|Overall Study|Adverse Event|3|||
145295230|NCT01759290|523930759|FG000|Overall Study|Subjects withdrawn consent|5|||
145295231|NCT01759290|523930759|FG000|Overall Study|Physician Decision|2|||
145295232|NCT01759290|523930759|FG000|Overall Study|Death|17|||
145234588|NCT02310906|523704967|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
145408325|NCT03314935|524349856|FG010|Phase 2|Physician Decision|1|||
145234589|NCT02310906|523704968|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
145234590|NCT02310906|523704969|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
145234591|NCT02310906|523704970|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
145234592|NCT02310906|523704967|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
145234593|NCT02310906|523704968|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
145234594|NCT02310906|523704969|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
145234595|NCT02310906|523704970|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
145234596|NCT03819218|523704973|FG000|Overall Study|Protocol Violation|1|||
145234597|NCT00433446|523704974|FG000|Overall Study|Adverse Event|4|||
145234598|NCT00433446|523704974|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145234599|NCT00433446|523704974|FG000|Overall Study|Progression|44|||
145234600|NCT00433446|523704974|FG000|Overall Study|Other - Not Protocol specified|3|||
145234601|NCT00433446|523704974|FG000|Overall Study|Ineligible|9|||
145234602|NCT01188538|523704975|FG000|Overall Study|Lost to Follow-up|0|||
145234603|NCT01188538|523704976|FG001|Overall Study|Lost to Follow-up|1|||
145234604|NCT02513771|523704977|FG000|Overall Study|Lost to Follow-up|1|||
145234605|NCT02513771|523704978|FG001|Overall Study|Lost to Follow-up|1|||
145234606|NCT02513771|523704977|FG000|Overall Study|Not being able to get to clinic|1|||
145234607|NCT02513771|523704978|FG001|Overall Study|Not being able to get to clinic|0|||
145234608|NCT01797445|523704979|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
145234609|NCT01797445|523704980|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
145234610|NCT01797445|523704979|FG000|Double-Blind Phase|Adverse Event|3|||
145234611|NCT01797445|523704980|FG001|Double-Blind Phase|Adverse Event|0|||
145234612|NCT01797445|523704979|FG000|Double-Blind Phase|Death|5|||
145234613|NCT01797445|523704980|FG001|Double-Blind Phase|Death|4|||
145234614|NCT01797445|523704979|FG000|Double-Blind Phase|Pregnancy|0|||
145234615|NCT01797445|523704980|FG001|Double-Blind Phase|Pregnancy|1|||
145234616|NCT01797445|523704979|FG000|Double-Blind Phase|Lack of Efficacy|1|||
145234617|NCT01797445|523704980|FG001|Double-Blind Phase|Lack of Efficacy|2|||
145234618|NCT01797445|523704979|FG000|Double-Blind Phase|Investigator's Discretion|15|||
145234619|NCT01797445|523704980|FG001|Double-Blind Phase|Investigator's Discretion|17|||
145234620|NCT01797445|523704979|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
145234621|NCT01797445|523704980|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
145234622|NCT01797445|523704979|FG000|Double-Blind Phase|Protocol Violation|0|||
145234623|NCT01797445|523704980|FG001|Double-Blind Phase|Protocol Violation|1|||
145234624|NCT01797445|523704979|FG000|Double-Blind Phase|Withdrew Consent|20|||
145234625|NCT01797445|523704980|FG001|Double-Blind Phase|Withdrew Consent|35|||
145234626|NCT01797445|523704979|FG000|Double-Blind Phase|Lost to Follow-up|34|||
145234627|NCT01797445|523704980|FG001|Double-Blind Phase|Lost to Follow-up|26|||
145234628|NCT01797445|523704979|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
145234629|NCT01797445|523704980|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
145234630|NCT01878097|523704981|FG000|Baseline|Surveys not fully completed|2497|||
145234631|NCT01878097|523704982|FG001|Baseline|Surveys not fully completed|1800|||
145234632|NCT01878097|523704981|FG000|Implementation Year 1|Surveys not fully completed|3202|||
145234633|NCT01878097|523704982|FG001|Implementation Year 1|Surveys not fully completed|2549|||
145234634|NCT01878097|523704981|FG000|Implementation Year 2|Surveys not fully completed|3281|||
145234635|NCT01878097|523704982|FG001|Implementation Year 2|Surveys not fully completed|2841|||
145234636|NCT01878097|523704981|FG000|Implementation Year 3|Surveys not fully completed|3494|||
145295233|NCT01759290|523930759|FG000|Overall Study|Lost to Follow-up|53|||
145295234|NCT01759290|523930759|FG000|Overall Study|Unknown reason|4|||
145295235|NCT00841100|523930760|FG000|Phase 1 (28 Days)|Adverse Event|1|||
145295236|NCT00841100|523930760|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
145295237|NCT03338972|523930761|FG000|Overall Study|Death|1|||
145295238|NCT03338972|523930762|FG001|Overall Study|Death|1|||
145562494|NCT00156533|524920049|FG002|Overall Study|Withdrawal by Subject|0|||
145562495|NCT00156533|524920050|FG003|Overall Study|Withdrawal by Subject|1|||
145562496|NCT00156533|524920047|FG000|Overall Study|Failed Screening|1|||
145562497|NCT00156533|524920048|FG001|Overall Study|Failed Screening|0|||
145562498|NCT00156533|524920049|FG002|Overall Study|Failed Screening|1|||
145562499|NCT00156533|524920050|FG003|Overall Study|Failed Screening|1|||
145562500|NCT01541969|524920053|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
145562501|NCT01541969|524920054|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
145619920|NCT05305040|525123619|FG001|Overall Study|Graft versus host disease|0|||
145619921|NCT05305040|525123618|FG000|Overall Study|Investigator's Decision|1|||
145234637|NCT01878097|523704982|FG001|Implementation Year 3|Surveys not fully completed|2980|||
145234638|NCT01878097|523704981|FG000|Implementation Year 4|Surveys not fully completed|3604|||
145234639|NCT01878097|523704982|FG001|Implementation Year 4|Surveys not fully completed|3007|||
145234640|NCT01595438|523704985|FG000|Overall Study|Lost to Follow-up|20|||
145234641|NCT01595438|523704986|FG001|Overall Study|Lost to Follow-up|20|||
145234642|NCT01595438|523704985|FG000|Overall Study|Withdrawal by Subject|12|||
145234643|NCT01595438|523704986|FG001|Overall Study|Withdrawal by Subject|12|||
145234644|NCT01595438|523704985|FG000|Overall Study|Other Eligibility criteria|11|||
145234645|NCT01595438|523704986|FG001|Overall Study|Other Eligibility criteria|9|||
145234646|NCT00510068|523704988|FG000|Double-blind Period|Disease progression|98|||
145234647|NCT00510068|523704989|FG001|Double-blind Period|Disease progression|169|||
145234648|NCT00510068|523704988|FG000|Double-blind Period|Final primary analysis|52|||
145234649|NCT00510068|523704989|FG001|Double-blind Period|Final primary analysis|18|||
145234650|NCT00510068|523704988|FG000|Double-blind Period|Adverse Event|37|||
145234651|NCT00510068|523704989|FG001|Double-blind Period|Adverse Event|7|||
145234652|NCT00510068|523704988|FG000|Double-blind Period|Withdrawal by Subject|8|||
145234653|NCT00510068|523704989|FG001|Double-blind Period|Withdrawal by Subject|6|||
145234654|NCT00510068|523704988|FG000|Double-blind Period|Death|4|||
145234655|NCT00510068|523704989|FG001|Double-blind Period|Death|3|||
145234656|NCT00510068|523704988|FG000|Double-blind Period|Abnormal test result (s)|1|||
145234657|NCT00510068|523704989|FG001|Double-blind Period|Abnormal test result (s)|0|||
145234658|NCT00510068|523704988|FG000|Double-blind Period|Lost to Follow-up|1|||
145234659|NCT00510068|523704989|FG001|Double-blind Period|Lost to Follow-up|0|||
145234660|NCT00510068|523704988|FG000|Double-blind Period|Protocol Violation|6|||
145234661|NCT00510068|523704989|FG001|Double-blind Period|Protocol Violation|0|||
145234662|NCT00510068|523704988|FG000|Open-label Period|Disease Progression|124|||
145234663|NCT00510068|523704989|FG001|Open-label Period|Disease Progression|0|||
145234664|NCT00510068|523704988|FG000|Open-label Period|Adverse Event|46|||
145234665|NCT00510068|523704989|FG001|Open-label Period|Adverse Event|0|||
145234666|NCT00510068|523704988|FG000|Open-label Period|Withdrawal by Subject|21|||
145234667|NCT00510068|523704989|FG001|Open-label Period|Withdrawal by Subject|0|||
145234668|NCT00510068|523704988|FG000|Open-label Period|Administrative problems|17|||
145234669|NCT00510068|523704989|FG001|Open-label Period|Administrative problems|0|||
145234670|NCT00510068|523704988|FG000|Open-label Period|Death|7|||
145234671|NCT00510068|523704989|FG001|Open-label Period|Death|0|||
145234672|NCT00510068|523704988|FG000|Open-label Period|New cancer therapy|7|||
145234673|NCT00510068|523704989|FG001|Open-label Period|New cancer therapy|0|||
145234674|NCT00510068|523704988|FG000|Open-label Period|Protocol Violation|2|||
145234675|NCT00510068|523704989|FG001|Open-label Period|Protocol Violation|0|||
145234676|NCT00510068|523704988|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
145234677|NCT00510068|523704989|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
145234678|NCT00400712|523704990|FG000|Overall Study|Death|1|||
145234679|NCT00400712|523704991|FG001|Overall Study|Death|0|||
145234680|NCT00400712|523704990|FG000|Overall Study|Withdrawal by Subject|11|||
145234681|NCT00400712|523704991|FG001|Overall Study|Withdrawal by Subject|12|||
145234682|NCT00400712|523704990|FG000|Overall Study|Physician Decision|5|||
145234683|NCT00400712|523704991|FG001|Overall Study|Physician Decision|4|||
145234684|NCT00776555|523704992|FG000|Overall Study|Study terminated|3|||
145234685|NCT00776555|523704993|FG001|Overall Study|Study terminated|0|||
145234686|NCT01890512|523704996|FG000|Overall Study|Physician Decision|1|||
145234687|NCT01890512|523704996|FG000|Overall Study|Withdrawal by Subject|1|||
145234688|NCT01890512|523704996|FG000|Overall Study|Protocol Violation|1|||
145234689|NCT01529385|523704997|FG000|Overall Study|Lost to Follow-up|2|||
145234690|NCT01529385|523704998|FG001|Overall Study|Lost to Follow-up|1|||
145234691|NCT01401465|523704999|FG000|Treatment Period 1|Adverse Event|4|||
145234692|NCT01401465|523705000|FG001|Treatment Period 1|Adverse Event|1|||
145234693|NCT01401465|523704999|FG000|Treatment Period 1|Pregnancy|0|||
145234694|NCT01401465|523705000|FG001|Treatment Period 1|Pregnancy|1|||
145234695|NCT01401465|523704999|FG000|Treatment Period 1|Protocol Violation|5|||
145234696|NCT01401465|523705000|FG001|Treatment Period 1|Protocol Violation|0|||
145234697|NCT01401465|523704999|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145234698|NCT01401465|523705000|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145234699|NCT01401465|523704999|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
145234700|NCT01401465|523705000|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
145234701|NCT01401465|523704999|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
145234702|NCT01401465|523705000|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
145234703|NCT01401465|523704999|FG000|Treatment Period 1|Scheduling Difficulties|1|||
145234704|NCT01401465|523705000|FG001|Treatment Period 1|Scheduling Difficulties|1|||
145234705|NCT01401465|523704999|FG000|Treatment Period 2|Lost to Follow-up|0|||
145234706|NCT01401465|523705000|FG001|Treatment Period 2|Lost to Follow-up|1|||
145234707|NCT01401465|523704999|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145234708|NCT01401465|523705000|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145234709|NCT00575094|523705003|FG000|Overall Study|Adverse Event|2|||
145234710|NCT00575094|523705003|FG000|Overall Study|Withdrawal by Subject|1|||
145234711|NCT00772382|523705004|FG000|Overall Study|Adverse Event|19|||
145234712|NCT00772382|523705004|FG000|Overall Study|Death|6|||
145234713|NCT00772382|523705004|FG000|Overall Study|Lack of Efficacy|4|||
145234714|NCT00772382|523705004|FG000|Overall Study|Physician Decision|5|||
145234715|NCT00772382|523705004|FG000|Overall Study|Protocol Violation|1|||
145234716|NCT00772382|523705004|FG000|Overall Study|Withdrawal by Subject|10|||
145234717|NCT00772382|523705004|FG000|Overall Study|Other Reasons|10|||
145234718|NCT00643604|523705007|FG000|Overall Study|Death|1|||
145234719|NCT02721251|523705008|FG000|Overall Study|Withdrawal by Subject|8|||
145234720|NCT02721251|523705009|FG001|Overall Study|Withdrawal by Subject|7|||
145234721|NCT02721251|523705010|FG002|Overall Study|Withdrawal by Subject|9|||
145234722|NCT02721251|523705008|FG000|Overall Study|poor adherence|2|||
145234723|NCT02721251|523705009|FG001|Overall Study|poor adherence|2|||
145234724|NCT02721251|523705010|FG002|Overall Study|poor adherence|2|||
145234725|NCT02921763|523705011|FG000|Overall Study|Adverse Event|4|||
145234726|NCT02921763|523705011|FG000|Overall Study|Lost to Follow-up|4|||
145234727|NCT02921763|523705011|FG000|Overall Study|Lack of Efficacy|3|||
145234728|NCT02921763|523705011|FG000|Overall Study|Protocol Violation|2|||
145234729|NCT02921763|523705011|FG000|Overall Study|Withdrawal by Subject|2|||
145234730|NCT02921763|523705011|FG000|Overall Study|Physician Decision|1|||
145234731|NCT02921763|523705011|FG000|Overall Study|No data obtained|2|||
145234732|NCT00862121|523705016|FG000|Overall Study|Adverse Event|1|||
145234733|NCT00862121|523705017|FG001|Overall Study|Adverse Event|2|||
145234734|NCT00862121|523705016|FG000|Overall Study|Lack of Efficacy|0|||
145234735|NCT00862121|523705017|FG001|Overall Study|Lack of Efficacy|3|||
145234736|NCT00862121|523705016|FG000|Overall Study|Protocol Violation|0|||
145234737|NCT00862121|523705017|FG001|Overall Study|Protocol Violation|1|||
145234738|NCT00862121|523705016|FG000|Overall Study|Exclusion criterion violation|0|||
145234739|NCT00862121|523705017|FG001|Overall Study|Exclusion criterion violation|1|||
145234740|NCT00862121|523705016|FG000|Overall Study|Incorrect randomisation|0|||
145234741|NCT00862121|523705017|FG001|Overall Study|Incorrect randomisation|1|||
145234742|NCT01582971|523705018|FG000|Overall Study|Death|2|||
145234743|NCT01582971|523705019|FG001|Overall Study|Death|1|||
145234744|NCT01582971|523705018|FG000|Overall Study|Lost to Follow-up|18|||
145234745|NCT01582971|523705019|FG001|Overall Study|Lost to Follow-up|21|||
145234746|NCT01582971|523705018|FG000|Overall Study|Withdrawal by Subject|4|||
145234747|NCT01582971|523705019|FG001|Overall Study|Withdrawal by Subject|2|||
145234748|NCT01582971|523705018|FG000|Overall Study|Other|15|||
145234749|NCT01582971|523705019|FG001|Overall Study|Other|13|||
145234750|NCT02007954|523705020|FG000|Overall Study|Received liver transplant|3|||
145234751|NCT02007954|523705020|FG000|Overall Study|Switch in treatment modality|2|||
145234752|NCT02007954|523705020|FG000|Overall Study|Disease progression and unrelated AE|1|||
145234753|NCT02007954|523705020|FG000|Overall Study|Death|1|||
145234754|NCT01054976|523705025|FG000|Overall Study|Adverse Event|16|||
145234755|NCT01054976|523705025|FG000|Overall Study|Uncooperative participations to study|7|||
145234756|NCT01054976|523705025|FG000|Overall Study|Withdrawal by Subject|4|||
145295239|NCT03338972|523930763|FG002|Overall Study|Death|0|||
145295240|NCT03338972|523930764|FG003|Overall Study|Death|0|||
145295241|NCT03338972|523930761|FG000|Overall Study|Withdrawal by Subject|1|||
145295242|NCT03338972|523930762|FG001|Overall Study|Withdrawal by Subject|0|||
145295243|NCT03338972|523930763|FG002|Overall Study|Withdrawal by Subject|0|||
145295244|NCT03338972|523930764|FG003|Overall Study|Withdrawal by Subject|0|||
145408326|NCT03314935|524349857|FG011|Phase 2|Physician Decision|0|||
145408327|NCT03314935|524349858|FG012|Phase 2|Physician Decision|0|||
145234757|NCT01054976|523705025|FG000|Overall Study|Other|8|||
145234758|NCT01195363|523705027|FG000|Overall Study|Lost to Follow-up|7|||
145234759|NCT01195363|523705028|FG001|Overall Study|Lost to Follow-up|4|||
145234760|NCT01195363|523705027|FG000|Overall Study|Adverse Event|3|||
145408328|NCT03314935|524349859|FG013|Phase 2|Physician Decision|0|||
145408329|NCT03314935|524349860|FG014|Phase 2|Physician Decision|0|||
145408330|NCT05845619|524349861|FG000|Overall Study|duplicate enrollment|2|||
145408331|NCT05845619|524349862|FG001|Overall Study|duplicate enrollment|2|||
145408332|NCT05845619|524349863|FG002|Overall Study|duplicate enrollment|1|||
145408333|NCT03636477|524349867|FG000|Overall Study|Adverse Event|0|||
145408334|NCT03636477|524349868|FG001|Overall Study|Adverse Event|0|||
145234761|NCT01195363|523705028|FG001|Overall Study|Adverse Event|1|||
145234762|NCT01195363|523705027|FG000|Overall Study|Lack of Efficacy|0|||
145234763|NCT01195363|523705028|FG001|Overall Study|Lack of Efficacy|4|||
145234764|NCT01195363|523705027|FG000|Overall Study|incarceration|1|||
145234765|NCT01195363|523705028|FG001|Overall Study|incarceration|0|||
145295245|NCT03629249|523930765|FG000|Overall Study|Study terminated by sponsor|197|||
145295246|NCT03629249|523930766|FG001|Overall Study|Study terminated by sponsor|197|||
145295247|NCT03629249|523930767|FG002|Overall Study|Study terminated by sponsor|194|||
145234766|NCT01763866|523705030|FG000|Overall Study|Withdrawal by Subject|2|||
145234767|NCT01763866|523705031|FG001|Overall Study|Withdrawal by Subject|1|||
145234768|NCT01763866|523705032|FG002|Overall Study|Withdrawal by Subject|4|||
145234769|NCT01763866|523705033|FG003|Overall Study|Withdrawal by Subject|0|||
145234770|NCT01763866|523705034|FG004|Overall Study|Withdrawal by Subject|0|||
145408335|NCT03636477|524349869|FG002|Overall Study|Adverse Event|1|||
145408336|NCT05168800|524349870|FG000|Time 1 Survey|Did not start T1 survey|182|||
145408337|NCT05168800|524349871|FG001|Time 1 Survey|Did not start T1 survey|150|||
145408338|NCT05168800|524349872|FG002|Time 1 Survey|Did not start T1 survey|140|||
145408339|NCT05168800|524349870|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
145408340|NCT05168800|524349871|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
145408341|NCT05168800|524349872|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
145408342|NCT05168800|524349870|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
145408343|NCT05168800|524349871|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
145408344|NCT05168800|524349872|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
145408345|NCT05168800|524349870|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
145295248|NCT03629249|523930765|FG000|Overall Study|Protocol deviation|0|||
145295249|NCT03629249|523930766|FG001|Overall Study|Protocol deviation|2|||
145295250|NCT03629249|523930767|FG002|Overall Study|Protocol deviation|5|||
145295251|NCT03629249|523930765|FG000|Overall Study|Subject decision|1|||
145295252|NCT03629249|523930766|FG001|Overall Study|Subject decision|1|||
145295253|NCT03629249|523930767|FG002|Overall Study|Subject decision|3|||
145295254|NCT03629249|523930765|FG000|Overall Study|Adverse Event|1|||
145295255|NCT03629249|523930766|FG001|Overall Study|Adverse Event|1|||
145295256|NCT03629249|523930767|FG002|Overall Study|Adverse Event|0|||
145295257|NCT03629249|523930765|FG000|Overall Study|Death|1|||
145234771|NCT01763866|523705035|FG005|Overall Study|Withdrawal by Subject|3|||
145234772|NCT01763866|523705036|FG006|Overall Study|Withdrawal by Subject|4|||
145234773|NCT01763866|523705037|FG007|Overall Study|Withdrawal by Subject|0|||
145234774|NCT01763866|523705038|FG008|Overall Study|Withdrawal by Subject|1|||
145234775|NCT01763866|523705039|FG009|Overall Study|Withdrawal by Subject|1|||
145234776|NCT01763866|523705040|FG010|Overall Study|Withdrawal by Subject|2|||
145234777|NCT01763866|523705041|FG011|Overall Study|Withdrawal by Subject|2|||
145234778|NCT01763866|523705042|FG012|Overall Study|Withdrawal by Subject|2|||
145234779|NCT01763866|523705043|FG013|Overall Study|Withdrawal by Subject|0|||
145234780|NCT01763866|523705044|FG014|Overall Study|Withdrawal by Subject|6|||
145234781|NCT01763866|523705045|FG015|Overall Study|Withdrawal by Subject|3|||
145234782|NCT01763866|523705046|FG016|Overall Study|Withdrawal by Subject|0|||
145234783|NCT01763866|523705047|FG017|Overall Study|Withdrawal by Subject|1|||
145234784|NCT01763866|523705048|FG018|Overall Study|Withdrawal by Subject|1|||
145234785|NCT01763866|523705049|FG019|Overall Study|Withdrawal by Subject|1|||
145234786|NCT01763866|523705050|FG020|Overall Study|Withdrawal by Subject|2|||
145234787|NCT01763866|523705051|FG021|Overall Study|Withdrawal by Subject|1|||
145234788|NCT01763866|523705052|FG022|Overall Study|Withdrawal by Subject|2|||
145234789|NCT01763866|523705053|FG023|Overall Study|Withdrawal by Subject|1|||
145234790|NCT01763866|523705030|FG000|Overall Study|Decision by sponsor|0|||
145234791|NCT01763866|523705031|FG001|Overall Study|Decision by sponsor|0|||
145234792|NCT01763866|523705032|FG002|Overall Study|Decision by sponsor|1|||
145234793|NCT01763866|523705033|FG003|Overall Study|Decision by sponsor|0|||
145234794|NCT01763866|523705034|FG004|Overall Study|Decision by sponsor|2|||
145234795|NCT01763866|523705035|FG005|Overall Study|Decision by sponsor|0|||
145234796|NCT01763866|523705036|FG006|Overall Study|Decision by sponsor|2|||
145234797|NCT01763866|523705037|FG007|Overall Study|Decision by sponsor|0|||
145234798|NCT01763866|523705038|FG008|Overall Study|Decision by sponsor|2|||
145234799|NCT01763866|523705039|FG009|Overall Study|Decision by sponsor|0|||
145234800|NCT01763866|523705040|FG010|Overall Study|Decision by sponsor|6|||
145234801|NCT01763866|523705041|FG011|Overall Study|Decision by sponsor|0|||
145234802|NCT01763866|523705042|FG012|Overall Study|Decision by sponsor|1|||
145234803|NCT01763866|523705043|FG013|Overall Study|Decision by sponsor|0|||
145234804|NCT01763866|523705044|FG014|Overall Study|Decision by sponsor|5|||
145234805|NCT01763866|523705045|FG015|Overall Study|Decision by sponsor|0|||
145234806|NCT01763866|523705046|FG016|Overall Study|Decision by sponsor|0|||
145234807|NCT01763866|523705047|FG017|Overall Study|Decision by sponsor|0|||
145234808|NCT01763866|523705048|FG018|Overall Study|Decision by sponsor|4|||
145234809|NCT01763866|523705049|FG019|Overall Study|Decision by sponsor|0|||
145295258|NCT03629249|523930766|FG001|Overall Study|Death|0|||
145408346|NCT05168800|524349871|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
145408347|NCT05168800|524349872|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
145408348|NCT05168800|524349870|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
145408349|NCT05168800|524349871|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
145234810|NCT01763866|523705050|FG020|Overall Study|Decision by sponsor|2|||
145234811|NCT01763866|523705051|FG021|Overall Study|Decision by sponsor|0|||
145234812|NCT01763866|523705052|FG022|Overall Study|Decision by sponsor|1|||
145234813|NCT01763866|523705053|FG023|Overall Study|Decision by sponsor|0|||
145234814|NCT01763866|523705030|FG000|Overall Study|Lost to Follow-up|0|||
145234815|NCT01763866|523705031|FG001|Overall Study|Lost to Follow-up|0|||
145295259|NCT03629249|523930767|FG002|Overall Study|Death|0|||
145295260|NCT03629249|523930765|FG000|Overall Study|Physician Decision|1|||
145295261|NCT03629249|523930766|FG001|Overall Study|Physician Decision|0|||
145295262|NCT03629249|523930767|FG002|Overall Study|Physician Decision|0|||
145234816|NCT01763866|523705032|FG002|Overall Study|Lost to Follow-up|0|||
145234817|NCT01763866|523705033|FG003|Overall Study|Lost to Follow-up|0|||
145234818|NCT01763866|523705034|FG004|Overall Study|Lost to Follow-up|0|||
145234819|NCT01763866|523705035|FG005|Overall Study|Lost to Follow-up|0|||
145295263|NCT00352690|523930768|FG000|Overall Study|Determined to be ineligible|2|||
145295264|NCT00352690|523930769|FG001|Overall Study|Determined to be ineligible|0|||
145295265|NCT03633721|523930774|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
145295266|NCT03633721|523930775|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
145295267|NCT03633721|523930776|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
145234820|NCT01763866|523705036|FG006|Overall Study|Lost to Follow-up|1|||
145234821|NCT01763866|523705037|FG007|Overall Study|Lost to Follow-up|0|||
145234822|NCT01763866|523705038|FG008|Overall Study|Lost to Follow-up|0|||
145234823|NCT01763866|523705039|FG009|Overall Study|Lost to Follow-up|0|||
145234824|NCT01763866|523705040|FG010|Overall Study|Lost to Follow-up|0|||
145234825|NCT01763866|523705041|FG011|Overall Study|Lost to Follow-up|0|||
145234826|NCT01763866|523705042|FG012|Overall Study|Lost to Follow-up|1|||
145234827|NCT01763866|523705043|FG013|Overall Study|Lost to Follow-up|0|||
145295268|NCT03633721|523930777|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
145234828|NCT01763866|523705044|FG014|Overall Study|Lost to Follow-up|1|||
145234829|NCT01763866|523705045|FG015|Overall Study|Lost to Follow-up|0|||
145234830|NCT01763866|523705046|FG016|Overall Study|Lost to Follow-up|0|||
145234831|NCT01763866|523705047|FG017|Overall Study|Lost to Follow-up|0|||
145234832|NCT01763866|523705048|FG018|Overall Study|Lost to Follow-up|1|||
145234833|NCT01763866|523705049|FG019|Overall Study|Lost to Follow-up|1|||
145234834|NCT01763866|523705050|FG020|Overall Study|Lost to Follow-up|0|||
145234835|NCT01763866|523705051|FG021|Overall Study|Lost to Follow-up|0|||
145234836|NCT01763866|523705052|FG022|Overall Study|Lost to Follow-up|0|||
145234837|NCT01763866|523705053|FG023|Overall Study|Lost to Follow-up|1|||
145234838|NCT01763866|523705030|FG000|Overall Study|Death|0|||
145234839|NCT01763866|523705031|FG001|Overall Study|Death|0|||
145234840|NCT01763866|523705032|FG002|Overall Study|Death|0|||
145234841|NCT01763866|523705033|FG003|Overall Study|Death|0|||
145234842|NCT01763866|523705034|FG004|Overall Study|Death|0|||
145234843|NCT01763866|523705035|FG005|Overall Study|Death|0|||
145234844|NCT01763866|523705036|FG006|Overall Study|Death|0|||
145234845|NCT01763866|523705037|FG007|Overall Study|Death|0|||
145234846|NCT01763866|523705038|FG008|Overall Study|Death|0|||
145234847|NCT01763866|523705039|FG009|Overall Study|Death|0|||
145234848|NCT01763866|523705040|FG010|Overall Study|Death|0|||
145234849|NCT01763866|523705041|FG011|Overall Study|Death|0|||
145234850|NCT01763866|523705042|FG012|Overall Study|Death|0|||
145234851|NCT01763866|523705043|FG013|Overall Study|Death|0|||
145234852|NCT01763866|523705044|FG014|Overall Study|Death|0|||
145234853|NCT01763866|523705045|FG015|Overall Study|Death|0|||
145234854|NCT01763866|523705046|FG016|Overall Study|Death|1|||
145234855|NCT01763866|523705047|FG017|Overall Study|Death|0|||
145234856|NCT01763866|523705048|FG018|Overall Study|Death|0|||
145234857|NCT01763866|523705049|FG019|Overall Study|Death|0|||
145234858|NCT01763866|523705050|FG020|Overall Study|Death|0|||
145234859|NCT01763866|523705051|FG021|Overall Study|Death|0|||
145234860|NCT01763866|523705052|FG022|Overall Study|Death|0|||
145234861|NCT01763866|523705053|FG023|Overall Study|Death|0|||
145234862|NCT00171314|523705057|FG000|Overall Study|Adverse Event|44|||
145234863|NCT00171314|523705058|FG001|Overall Study|Adverse Event|41|||
145234864|NCT00171314|523705057|FG000|Overall Study|Lack of Efficacy|19|||
145234865|NCT00171314|523705058|FG001|Overall Study|Lack of Efficacy|14|||
145234866|NCT00171314|523705057|FG000|Overall Study|Withdrawal by Subject|9|||
145234867|NCT00171314|523705058|FG001|Overall Study|Withdrawal by Subject|6|||
145234868|NCT00171314|523705057|FG000|Overall Study|Abnormal Test Procedure Results|9|||
145234869|NCT00171314|523705058|FG001|Overall Study|Abnormal Test Procedure Results|3|||
145234870|NCT00171314|523705057|FG000|Overall Study|Protocol Violation|3|||
145234871|NCT00171314|523705058|FG001|Overall Study|Protocol Violation|7|||
145234872|NCT00171314|523705057|FG000|Overall Study|Administrative Problems|4|||
145295269|NCT01475474|523930781|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
145295270|NCT01475474|523930781|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
145295271|NCT05277389|523930782|FG000|Overall Study|Lost to Follow-up|1|||
145295272|NCT05277389|523930783|FG001|Overall Study|Lost to Follow-up|4|||
145234873|NCT00171314|523705058|FG001|Overall Study|Administrative Problems|3|||
145295273|NCT03069937|523930784|FG000|Overall Study|Second primary malignancy noted|1|||
145234874|NCT00171314|523705057|FG000|Overall Study|Lost to Follow-up|1|||
145234875|NCT00171314|523705058|FG001|Overall Study|Lost to Follow-up|3|||
145234876|NCT00171314|523705057|FG000|Overall Study|Death|2|||
145234877|NCT00171314|523705058|FG001|Overall Study|Death|1|||
145234878|NCT01669811|523705059|FG000|Overall Study|Investigator decision|0|||
145234879|NCT01669811|523705060|FG001|Overall Study|Investigator decision|1|||
145234880|NCT01669811|523705059|FG000|Overall Study|Withdrawal by Subject|1|||
145234881|NCT01669811|523705060|FG001|Overall Study|Withdrawal by Subject|2|||
145234882|NCT01669811|523705059|FG000|Overall Study|Adverse Event|2|||
145234883|NCT01669811|523705060|FG001|Overall Study|Adverse Event|6|||
145234884|NCT01669811|523705059|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145234885|NCT01669811|523705060|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
145234886|NCT03337139|523705061|FG000|Phase I|Withdrawal by Subject|10|||
145234887|NCT03337139|523705062|FG001|Phase I|Withdrawal by Subject|0|||
145234888|NCT03288493|523705063|FG000|Overall Study|Withdrawal by Subject|4|||
145234889|NCT03288493|523705064|FG001|Overall Study|Withdrawal by Subject|0|||
145234890|NCT03288493|523705065|FG002|Overall Study|Withdrawal by Subject|0|||
145234891|NCT03288493|523705066|FG003|Overall Study|Withdrawal by Subject|0|||
145234892|NCT03288493|523705067|FG004|Overall Study|Withdrawal by Subject|0|||
145234893|NCT03288493|523705068|FG005|Overall Study|Withdrawal by Subject|2|||
145234894|NCT03288493|523705069|FG006|Overall Study|Withdrawal by Subject|0|||
145234895|NCT03288493|523705063|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
145234896|NCT03288493|523705064|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
145234897|NCT03288493|523705065|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
145234898|NCT03288493|523705066|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
145234899|NCT03288493|523705067|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
145234900|NCT03288493|523705068|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
145234901|NCT03288493|523705069|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
145234902|NCT03288493|523705063|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
145234903|NCT03288493|523705064|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
145234904|NCT03288493|523705065|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
145234905|NCT03288493|523705066|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
145234906|NCT03288493|523705067|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
145234907|NCT03288493|523705068|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
145234908|NCT03288493|523705069|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
145234909|NCT03288493|523705063|FG000|Overall Study|Death|2|||
145234910|NCT03288493|523705064|FG001|Overall Study|Death|0|||
145234911|NCT03288493|523705065|FG002|Overall Study|Death|0|||
145234912|NCT03288493|523705066|FG003|Overall Study|Death|0|||
145234913|NCT03288493|523705067|FG004|Overall Study|Death|0|||
145234914|NCT03288493|523705068|FG005|Overall Study|Death|0|||
145234915|NCT03288493|523705069|FG006|Overall Study|Death|0|||
145234916|NCT03288493|523705063|FG000|Overall Study|other reason not listed above|2|||
145234917|NCT03288493|523705064|FG001|Overall Study|other reason not listed above|0|||
145234918|NCT03288493|523705065|FG002|Overall Study|other reason not listed above|0|||
145234919|NCT03288493|523705066|FG003|Overall Study|other reason not listed above|0|||
145295274|NCT06096168|523930785|FG000|Overall Study|Death|30|||
145295275|NCT06096168|523930785|FG000|Overall Study|Revision|2|||
145295276|NCT01046253|523930788|FG000|Second Intervention|Adverse Event|0|||
145295277|NCT01046253|523930789|FG001|Second Intervention|Adverse Event|1|||
145234920|NCT03288493|523705067|FG004|Overall Study|other reason not listed above|0|||
145234921|NCT03288493|523705068|FG005|Overall Study|other reason not listed above|0|||
145234922|NCT03288493|523705069|FG006|Overall Study|other reason not listed above|0|||
145234923|NCT05691829|523706605|FG000|Overall Study|Physician Decision|2|||
145234924|NCT05691829|523706605|FG000|Overall Study|Eligibility criteria not met|3|||
145234925|NCT00453180|523706606|FG000|Overall Study|Lost to Follow-up|2|||
145234926|NCT00453180|523706607|FG001|Overall Study|Lost to Follow-up|1|||
145234927|NCT00453180|523706606|FG000|Overall Study|Adverse Event|1|||
145234928|NCT00453180|523706607|FG001|Overall Study|Adverse Event|2|||
145234929|NCT03326869|523706612|FG000|Overall Study|Study data has been lost to natural disa|1|||
145234930|NCT03326869|523706613|FG001|Overall Study|Study data has been lost to natural disa|1|||
145234931|NCT01002742|523706616|FG000|Overall Study|Determined to be ineligible|0|||
145234932|NCT01002742|523706617|FG001|Overall Study|Determined to be ineligible|1|||
145234933|NCT01824693|523706618|FG000|Overall Study|Death|0|||
145234934|NCT01824693|523706619|FG001|Overall Study|Death|1|||
145234935|NCT01824693|523706620|FG002|Overall Study|Death|0|||
145234936|NCT01824693|523706618|FG000|Overall Study|Physician Decision|1|||
145234937|NCT01824693|523706619|FG001|Overall Study|Physician Decision|1|||
145234938|NCT01824693|523706620|FG002|Overall Study|Physician Decision|1|||
145234939|NCT01824693|523706618|FG000|Overall Study|Withdrawal by Subject|0|||
145234940|NCT01824693|523706619|FG001|Overall Study|Withdrawal by Subject|0|||
145234941|NCT01824693|523706620|FG002|Overall Study|Withdrawal by Subject|1|||
145234942|NCT01824693|523706618|FG000|Overall Study|Progressive Disease|0|||
145234943|NCT01824693|523706619|FG001|Overall Study|Progressive Disease|5|||
145234944|NCT01824693|523706620|FG002|Overall Study|Progressive Disease|0|||
145234945|NCT01824693|523706618|FG000|Overall Study|Ineligible|0|||
145234946|NCT01824693|523706619|FG001|Overall Study|Ineligible|0|||
145295278|NCT01046253|523930788|FG000|Second Intervention|Protocol Violation|0|||
145295279|NCT01046253|523930789|FG001|Second Intervention|Protocol Violation|1|||
145295280|NCT02339909|523930790|FG000|Overall Study|Became ineligible after randomisation|89|||
145234947|NCT01824693|523706620|FG002|Overall Study|Ineligible|3|||
145234948|NCT01824693|523706618|FG000|Overall Study|No Transplant Planned|0|||
145295281|NCT02339909|523930791|FG001|Overall Study|Became ineligible after randomisation|63|||
145234949|NCT01824693|523706619|FG001|Overall Study|No Transplant Planned|0|||
145234950|NCT01824693|523706620|FG002|Overall Study|No Transplant Planned|10|||
145234951|NCT02150213|523706624|FG000|Overall Study|Lost to Follow-up|1|||
145234952|NCT02150213|523706624|FG000|Overall Study|Withdrawal by Subject|1|||
145234953|NCT01297309|523706625|FG000|Overall Study|Eligibility failure|2|||
145234954|NCT01297309|523706625|FG000|Overall Study|Screen failure|2|||
145234955|NCT01297309|523706625|FG000|Overall Study|Withdrawal by Subject|5|||
145234956|NCT01297309|523706625|FG000|Overall Study|Adverse Event|1|||
145234957|NCT01297309|523706625|FG000|Overall Study|Investigator Decision|2|||
145234958|NCT01297309|523706625|FG000|Overall Study|Death|1|||
145234959|NCT01297309|523706625|FG000|Overall Study|Participant not entering extensionperiod|1|||
145234960|NCT02678312|523706626|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
145234961|NCT02678312|523706627|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
145234962|NCT02678312|523706628|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
145234963|NCT02678312|523706629|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
145234964|NCT02678312|523706630|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
145234965|NCT02678312|523706626|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
145234966|NCT02678312|523706627|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
145234967|NCT02678312|523706628|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
145234968|NCT02678312|523706629|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
145234969|NCT02678312|523706630|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
145234970|NCT02678312|523706626|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
145234971|NCT02678312|523706627|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
145234972|NCT02678312|523706628|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
145234973|NCT02678312|523706629|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
145234974|NCT02678312|523706630|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
145234975|NCT02678312|523706626|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
145234976|NCT02678312|523706627|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
145234977|NCT02678312|523706628|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
145234978|NCT02678312|523706629|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
145234979|NCT02678312|523706630|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
145234980|NCT02678312|523706626|FG000|Part 2 Double Blind Epoch|Death|0|||
145234981|NCT02678312|523706627|FG001|Part 2 Double Blind Epoch|Death|0|||
145234982|NCT02678312|523706628|FG002|Part 2 Double Blind Epoch|Death|0|||
145234983|NCT02678312|523706629|FG003|Part 2 Double Blind Epoch|Death|8|||
145234984|NCT02678312|523706630|FG004|Part 2 Double Blind Epoch|Death|12|||
145234985|NCT02678312|523706626|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
145234986|NCT02678312|523706627|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
145234987|NCT02678312|523706628|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
145234988|NCT02678312|523706629|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
145234989|NCT02678312|523706630|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
145234990|NCT02678312|523706626|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
145234991|NCT02678312|523706627|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
145234992|NCT02678312|523706628|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
145234993|NCT02678312|523706629|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
145234994|NCT02678312|523706630|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
145234995|NCT02678312|523706626|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
145234996|NCT02678312|523706627|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
145234997|NCT02678312|523706628|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
145234998|NCT02678312|523706629|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
145234999|NCT02678312|523706630|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
145235000|NCT00656084|523706631|FG000|Overall Study|Adverse Event|4|||
145235001|NCT00656084|523706631|FG000|Overall Study|Withdrawal by Subject|1|||
145235002|NCT00656084|523706631|FG000|Overall Study|Patient Request|1|||
145235003|NCT00656084|523706631|FG000|Overall Study|Investigator Request|1|||
145235004|NCT00640146|523706633|FG000|Overall Study|Adverse Event|2|||
145235005|NCT00640146|523706634|FG001|Overall Study|Adverse Event|0|||
145235006|NCT00640146|523706633|FG000|Overall Study|Lost to Follow-up|0|||
145235007|NCT00640146|523706634|FG001|Overall Study|Lost to Follow-up|1|||
145235008|NCT00640146|523706633|FG000|Overall Study|Lack of Efficacy|0|||
145235009|NCT00640146|523706634|FG001|Overall Study|Lack of Efficacy|1|||
145619922|NCT05305040|525123619|FG001|Overall Study|Investigator's Decision|1|||
145235010|NCT00640146|523706633|FG000|Overall Study|Withdrawal by Subject|1|||
145235011|NCT00640146|523706634|FG001|Overall Study|Withdrawal by Subject|1|||
145235012|NCT00640146|523706633|FG000|Overall Study|Randomized but not treated|1|||
145235013|NCT00640146|523706634|FG001|Overall Study|Randomized but not treated|3|||
145235014|NCT03024255|523706635|FG000|Overall Study|Adverse Event|1|||
145235015|NCT03024255|523706636|FG001|Overall Study|Adverse Event|4|||
145235016|NCT03024255|523706637|FG002|Overall Study|Adverse Event|8|||
145235017|NCT03024255|523706638|FG003|Overall Study|Adverse Event|0|||
145235018|NCT03024255|523706635|FG000|Overall Study|Withdrawal by Subject|3|||
145235019|NCT03024255|523706636|FG001|Overall Study|Withdrawal by Subject|1|||
145235020|NCT03024255|523706637|FG002|Overall Study|Withdrawal by Subject|0|||
145235021|NCT03024255|523706638|FG003|Overall Study|Withdrawal by Subject|3|||
145235022|NCT03024255|523706635|FG000|Overall Study|Protocol Violation|0|||
145235023|NCT03024255|523706636|FG001|Overall Study|Protocol Violation|0|||
145235024|NCT03024255|523706637|FG002|Overall Study|Protocol Violation|2|||
145235025|NCT03024255|523706638|FG003|Overall Study|Protocol Violation|0|||
145235026|NCT03024255|523706635|FG000|Overall Study|Lost to Follow-up|1|||
145235027|NCT03024255|523706636|FG001|Overall Study|Lost to Follow-up|2|||
145235028|NCT03024255|523706637|FG002|Overall Study|Lost to Follow-up|1|||
145235029|NCT03024255|523706638|FG003|Overall Study|Lost to Follow-up|1|||
145235030|NCT03024255|523706635|FG000|Overall Study|Lack of Efficacy|1|||
145235031|NCT03024255|523706636|FG001|Overall Study|Lack of Efficacy|0|||
145235032|NCT03024255|523706637|FG002|Overall Study|Lack of Efficacy|0|||
145235033|NCT03024255|523706638|FG003|Overall Study|Lack of Efficacy|0|||
145235034|NCT03024255|523706635|FG000|Overall Study|Protocol Noncompliance|1|||
145235035|NCT03024255|523706636|FG001|Overall Study|Protocol Noncompliance|1|||
145235036|NCT03024255|523706637|FG002|Overall Study|Protocol Noncompliance|0|||
145235037|NCT03024255|523706638|FG003|Overall Study|Protocol Noncompliance|1|||
145235038|NCT01415908|523706639|FG000|Overall Study|Withdrawal by Subject|1|||
145235039|NCT01415908|523706640|FG001|Overall Study|Withdrawal by Subject|0|||
145235040|NCT02197897|523706646|FG000|Overall Study|not eligible|1|||
145235041|NCT02501902|523706647|FG000|Overall Study|Subject Refused Further Follow-up|0|||
145235042|NCT02501902|523706648|FG001|Overall Study|Subject Refused Further Follow-up|0|||
145235043|NCT02501902|523706649|FG002|Overall Study|Subject Refused Further Follow-up|0|||
145235044|NCT02501902|523706650|FG003|Overall Study|Subject Refused Further Follow-up|0|||
145235045|NCT02501902|523706651|FG004|Overall Study|Subject Refused Further Follow-up|0|||
145235046|NCT02501902|523706652|FG005|Overall Study|Subject Refused Further Follow-up|0|||
145235047|NCT02501902|523706653|FG006|Overall Study|Subject Refused Further Follow-up|0|||
145235048|NCT02501902|523706654|FG007|Overall Study|Subject Refused Further Follow-up|1|||
145235049|NCT02501902|523706647|FG000|Overall Study|Study Terminated by Sponsor|0|||
145235050|NCT02501902|523706648|FG001|Overall Study|Study Terminated by Sponsor|3|||
145235051|NCT02501902|523706649|FG002|Overall Study|Study Terminated by Sponsor|0|||
145235052|NCT02501902|523706650|FG003|Overall Study|Study Terminated by Sponsor|1|||
145235053|NCT02501902|523706651|FG004|Overall Study|Study Terminated by Sponsor|1|||
145235054|NCT02501902|523706652|FG005|Overall Study|Study Terminated by Sponsor|0|||
145235055|NCT02501902|523706653|FG006|Overall Study|Study Terminated by Sponsor|2|||
145235056|NCT02501902|523706654|FG007|Overall Study|Study Terminated by Sponsor|4|||
145235057|NCT02501902|523706647|FG000|Overall Study|Death|3|||
145235058|NCT02501902|523706648|FG001|Overall Study|Death|4|||
145235059|NCT02501902|523706649|FG002|Overall Study|Death|4|||
145235060|NCT02501902|523706650|FG003|Overall Study|Death|10|||
145235061|NCT02501902|523706651|FG004|Overall Study|Death|10|||
145235062|NCT02501902|523706652|FG005|Overall Study|Death|11|||
145235063|NCT02501902|523706653|FG006|Overall Study|Death|7|||
145235064|NCT02501902|523706654|FG007|Overall Study|Death|15|||
145235065|NCT00688545|523706657|FG000|Overall Study|Lost to Follow-up|1|||
145235066|NCT00688545|523706658|FG001|Overall Study|Lost to Follow-up|4|||
145235067|NCT00688545|523706657|FG000|Overall Study|Insurance/cost of drug|0|||
145235068|NCT00688545|523706658|FG001|Overall Study|Insurance/cost of drug|1|||
145235069|NCT00688545|523706657|FG000|Overall Study|Withdrawal by Subject|2|||
145235070|NCT00688545|523706658|FG001|Overall Study|Withdrawal by Subject|3|||
145235071|NCT00688545|523706657|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
145235072|NCT00688545|523706658|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
145235073|NCT04295356|523706659|FG000|Overall Study|Physician Decision|1|||
145295282|NCT02339909|523930792|FG002|Overall Study|Became ineligible after randomisation|71|||
145295283|NCT01766778|523930797|FG000|Overall Study|Adverse Event|4|||
145295284|NCT01766778|523930798|FG001|Overall Study|Adverse Event|4|||
145235074|NCT04295356|523706660|FG001|Overall Study|Physician Decision|0|||
145235075|NCT04295356|523706659|FG000|Overall Study|Lost to Follow-up|0|||
145235076|NCT04295356|523706660|FG001|Overall Study|Lost to Follow-up|3|||
145235077|NCT04295356|523706659|FG000|Overall Study|Protocol Violation|0|||
145235078|NCT04295356|523706660|FG001|Overall Study|Protocol Violation|1|||
145235079|NCT03004976|523706663|FG000|Overall Study|Lost to Follow-up|7|||
145235080|NCT03004976|523706664|FG001|Overall Study|Lost to Follow-up|5|||
145235081|NCT03004976|523706663|FG000|Overall Study|Physician Decision|1|||
145235082|NCT03004976|523706664|FG001|Overall Study|Physician Decision|0|||
145235083|NCT03004976|523706663|FG000|Overall Study|Withdrawal by Subject|1|||
145235084|NCT03004976|523706664|FG001|Overall Study|Withdrawal by Subject|0|||
145235085|NCT03004976|523706663|FG000|Overall Study|Death|4|||
145235086|NCT03004976|523706664|FG001|Overall Study|Death|1|||
145235087|NCT04116073|523706669|FG000|Overall Study|Withdrawal by Subject|2|||
145235088|NCT04116073|523706669|FG000|Overall Study|failed to maintained eligibility|1|||
145235089|NCT03939637|523706672|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
145235090|NCT03939637|523706673|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
145295285|NCT01766778|523930797|FG000|Overall Study|Withdrawal by Subject|1|||
145235091|NCT03939637|523706672|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
145235092|NCT03939637|523706673|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
145408350|NCT05168800|524349872|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
145408351|NCT05168800|524349870|FG000|Time 1 Survey|Withdrawal by Subject|6|||
145408352|NCT05168800|524349871|FG001|Time 1 Survey|Withdrawal by Subject|3|||
145408353|NCT05168800|524349872|FG002|Time 1 Survey|Withdrawal by Subject|2|||
145408354|NCT05168800|524349870|FG000|Time 2 Survey|Already excluded at Time 1|228|||
145408355|NCT05168800|524349871|FG001|Time 2 Survey|Already excluded at Time 1|202|||
145408356|NCT05168800|524349872|FG002|Time 2 Survey|Already excluded at Time 1|173|||
145408357|NCT05168800|524349870|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
145408358|NCT05168800|524349871|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
145408359|NCT05168800|524349872|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
145408360|NCT05168800|524349870|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
145408361|NCT05168800|524349871|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
145408362|NCT05168800|524349872|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
145235093|NCT03783442|523706676|FG000|Overall Study|Death|252|||
145235094|NCT03783442|523706677|FG001|Overall Study|Death|268|||
145235095|NCT03783442|523706676|FG000|Overall Study|Withdrawal by Subject|19|||
145235096|NCT03783442|523706677|FG001|Overall Study|Withdrawal by Subject|21|||
145235097|NCT03783442|523706676|FG000|Overall Study|Lost to Follow-up|7|||
145235098|NCT03783442|523706677|FG001|Overall Study|Lost to Follow-up|6|||
145235099|NCT03783442|523706676|FG000|Overall Study|Sponsor Ended Study|48|||
145235100|NCT03783442|523706677|FG001|Overall Study|Sponsor Ended Study|28|||
145235101|NCT01381718|523706678|FG000|Overall Study|Withdrawal by Subject|2|||
145235102|NCT01381718|523706679|FG001|Overall Study|Withdrawal by Subject|5|||
145235103|NCT01381718|523706678|FG000|Overall Study|Lost to Follow-up|3|||
145235104|NCT01381718|523706679|FG001|Overall Study|Lost to Follow-up|5|||
145235105|NCT01381718|523706678|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
145235106|NCT01381718|523706679|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
145235107|NCT01181102|523706680|FG000|Overall Study|Adverse Event|28|||
145235108|NCT01181102|523706681|FG001|Overall Study|Adverse Event|26|||
145235109|NCT01181102|523706680|FG000|Overall Study|Lack of Efficacy|3|||
145408363|NCT05168800|524349870|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
145235110|NCT01181102|523706681|FG001|Overall Study|Lack of Efficacy|1|||
145235111|NCT01181102|523706680|FG000|Overall Study|Lost to Follow-up|2|||
145235112|NCT01181102|523706681|FG001|Overall Study|Lost to Follow-up|0|||
145235113|NCT01181102|523706680|FG000|Overall Study|Physician Decision|3|||
145235114|NCT01181102|523706681|FG001|Overall Study|Physician Decision|1|||
145235115|NCT01181102|523706680|FG000|Overall Study|Protocol Violation|5|||
145235116|NCT01181102|523706681|FG001|Overall Study|Protocol Violation|6|||
145235117|NCT01181102|523706680|FG000|Overall Study|Withdrawal by Subject|10|||
145235118|NCT01181102|523706681|FG001|Overall Study|Withdrawal by Subject|12|||
145235119|NCT01309841|523706684|FG000|Overall Study|Other|0|||
145235120|NCT01309841|523706685|FG001|Overall Study|Other|1|||
145235121|NCT01309841|523706686|FG002|Overall Study|Other|1|||
145235122|NCT01309841|523706684|FG000|Overall Study|Lost to Follow-up|7|||
145235123|NCT01309841|523706685|FG001|Overall Study|Lost to Follow-up|6|||
145235124|NCT01309841|523706686|FG002|Overall Study|Lost to Follow-up|4|||
145235125|NCT01309841|523706684|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
145235126|NCT01309841|523706685|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145235127|NCT01309841|523706686|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
145235128|NCT01309841|523706684|FG000|Overall Study|Lack of Efficacy|0|||
145235129|NCT01309841|523706685|FG001|Overall Study|Lack of Efficacy|0|||
145235130|NCT01309841|523706686|FG002|Overall Study|Lack of Efficacy|2|||
145235131|NCT01309841|523706684|FG000|Overall Study|Adverse Event|9|||
145235132|NCT01309841|523706685|FG001|Overall Study|Adverse Event|22|||
145235133|NCT01309841|523706686|FG002|Overall Study|Adverse Event|11|||
145235134|NCT01309841|523706684|FG000|Overall Study|Death|1|||
145235135|NCT01309841|523706685|FG001|Overall Study|Death|0|||
145235136|NCT01309841|523706686|FG002|Overall Study|Death|0|||
145235137|NCT01309841|523706684|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145235138|NCT01309841|523706685|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145235139|NCT01309841|523706686|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
145235140|NCT01309841|523706684|FG000|Overall Study|Withdrawal by Subject|17|||
145235141|NCT01309841|523706685|FG001|Overall Study|Withdrawal by Subject|6|||
145235142|NCT01309841|523706686|FG002|Overall Study|Withdrawal by Subject|13|||
145235143|NCT01309841|523706684|FG000|Overall Study|Did Not Receive Treatment|2|||
145235144|NCT01309841|523706685|FG001|Overall Study|Did Not Receive Treatment|0|||
145235145|NCT01309841|523706686|FG002|Overall Study|Did Not Receive Treatment|1|||
145235146|NCT01309841|523706684|FG000|Overall Study|Severe non-compliance with protocol|0|||
145235147|NCT01309841|523706685|FG001|Overall Study|Severe non-compliance with protocol|5|||
145235148|NCT01309841|523706686|FG002|Overall Study|Severe non-compliance with protocol|2|||
145235149|NCT05127421|523706688|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
145235150|NCT05127421|523706689|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
145235151|NCT05127421|523706690|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
145235152|NCT05127421|523706691|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
145235153|NCT05127421|523706688|FG000|4-Week Double-Blind Period|Physician Decision|1|||
145408364|NCT05168800|524349871|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
145408365|NCT05168800|524349872|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
145408366|NCT05168800|524349870|FG000|Time 2 Survey|Withdrawal by Subject|1|||
145408367|NCT05168800|524349871|FG001|Time 2 Survey|Withdrawal by Subject|0|||
145408368|NCT05168800|524349872|FG002|Time 2 Survey|Withdrawal by Subject|1|||
145408369|NCT05168800|524349870|FG000|Time 3 Survey|Already excluded at Time 1|228|||
145408370|NCT05168800|524349871|FG001|Time 3 Survey|Already excluded at Time 1|200|||
145408371|NCT05168800|524349872|FG002|Time 3 Survey|Already excluded at Time 1|173|||
145408372|NCT05168800|524349870|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
145408373|NCT05168800|524349871|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
145408374|NCT05168800|524349872|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
145408375|NCT05168800|524349870|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
145408376|NCT05168800|524349871|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
145408377|NCT05168800|524349872|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
145408378|NCT05168800|524349870|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
145408379|NCT05168800|524349871|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
145408380|NCT05168800|524349872|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
145408381|NCT04958707|524349873|FG000|Post Intervention|Withdrawal by Subject|1|||
145408382|NCT04958707|524349874|FG001|Post Intervention|Withdrawal by Subject|0|||
145408383|NCT04958707|524349875|FG002|Post Intervention|Withdrawal by Subject|0|||
145408384|NCT04958707|524349873|FG000|3 Months Follow- up|Lost to Follow-up|0|||
145408385|NCT04958707|524349874|FG001|3 Months Follow- up|Lost to Follow-up|3|||
145408386|NCT04958707|524349875|FG002|3 Months Follow- up|Lost to Follow-up|0|||
145408387|NCT04958707|524349873|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
145408388|NCT04958707|524349874|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
145408389|NCT04958707|524349875|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
145408390|NCT04279522|524349878|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
145408391|NCT04279522|524349879|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
145408392|NCT04279522|524349878|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
145408393|NCT04279522|524349879|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
145408394|NCT04279522|524349878|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
145408395|NCT04279522|524349879|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
145408396|NCT04279522|524349878|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
145408397|NCT04279522|524349879|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
145408398|NCT04279522|524349878|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
145408399|NCT04279522|524349879|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
145408400|NCT04279522|524349878|FG000|Period 2: Open Label Phase|Physician Decision|0|||
145408401|NCT04279522|524349879|FG001|Period 2: Open Label Phase|Physician Decision|3|||
145408402|NCT04279522|524349878|FG000|Period 2: Open Label Phase|Adverse Event|0|||
145408403|NCT04279522|524349879|FG001|Period 2: Open Label Phase|Adverse Event|1|||
145408404|NCT04279522|524349878|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
145408405|NCT04279522|524349879|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
145408406|NCT02629159|524349882|FG000|Overall Study|Adverse Event|17|||
145408407|NCT02629159|524349883|FG001|Overall Study|Adverse Event|20|||
145408408|NCT02629159|524349884|FG002|Overall Study|Adverse Event|22|||
145408409|NCT02629159|524349882|FG000|Overall Study|Withdrawal by Subject|22|||
145408410|NCT02629159|524349883|FG001|Overall Study|Withdrawal by Subject|11|||
145408411|NCT02629159|524349884|FG002|Overall Study|Withdrawal by Subject|15|||
145408412|NCT02629159|524349882|FG000|Overall Study|Lost to Follow-up|7|||
145408413|NCT02629159|524349883|FG001|Overall Study|Lost to Follow-up|4|||
145408414|NCT02629159|524349884|FG002|Overall Study|Lost to Follow-up|5|||
145408415|NCT02629159|524349882|FG000|Overall Study|Lack of Efficacy|4|||
145408416|NCT02629159|524349883|FG001|Overall Study|Lack of Efficacy|0|||
145408417|NCT02629159|524349884|FG002|Overall Study|Lack of Efficacy|1|||
145408418|NCT02629159|524349882|FG000|Overall Study|Other|6|||
145408419|NCT02629159|524349883|FG001|Overall Study|Other|4|||
145408420|NCT02629159|524349884|FG002|Overall Study|Other|8|||
145408421|NCT05352399|524349892|FG000|Overall Study|Discontinued intervention|6|||
145408422|NCT05523297|524349893|FG000|Overall Study|Death|7|||
145408423|NCT05523297|524349894|FG001|Overall Study|Death|8|||
145408424|NCT05523297|524349893|FG000|Overall Study|Lost to Follow-up|2|||
145408425|NCT05523297|524349894|FG001|Overall Study|Lost to Follow-up|1|||
145408426|NCT02401230|524349895|FG000|Overall Study|Adverse Event|3|||
145408427|NCT02401230|524349896|FG001|Overall Study|Adverse Event|2|||
145408428|NCT02401230|524349897|FG002|Overall Study|Adverse Event|0|||
145408429|NCT02401230|524349895|FG000|Overall Study|Withdrawal by Subject|2|||
145619923|NCT05305040|525123618|FG000|Overall Study|COVID-19 Reasons|1|||
145619924|NCT05305040|525123619|FG001|Overall Study|COVID-19 Reasons|0|||
145235154|NCT05127421|523706689|FG001|4-Week Double-Blind Period|Physician Decision|0|||
145235155|NCT05127421|523706690|FG002|4-Week Double-Blind Period|Physician Decision|0|||
145408430|NCT02401230|524349896|FG001|Overall Study|Withdrawal by Subject|1|||
145408431|NCT02401230|524349897|FG002|Overall Study|Withdrawal by Subject|1|||
145408432|NCT02401230|524349895|FG000|Overall Study|Lost to Follow-up|1|||
145408433|NCT02401230|524349896|FG001|Overall Study|Lost to Follow-up|3|||
145408434|NCT02401230|524349897|FG002|Overall Study|Lost to Follow-up|3|||
145408435|NCT00831844|524349900|FG000|Overall Study|Adverse Event|2|||
145235156|NCT05127421|523706691|FG003|4-Week Double-Blind Period|Physician Decision|0|||
145235157|NCT05127421|523706688|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
145235158|NCT05127421|523706689|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
145235159|NCT05127421|523706690|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
145235160|NCT05127421|523706691|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
145235161|NCT05127421|523706688|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
145235162|NCT05127421|523706689|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
145235163|NCT05127421|523706690|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
145235164|NCT05127421|523706691|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
145235165|NCT05127421|523706688|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
145235166|NCT05127421|523706689|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
145235167|NCT05127421|523706690|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
145235168|NCT05127421|523706691|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
145235169|NCT05127421|523706688|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
145235170|NCT05127421|523706689|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
145235171|NCT05127421|523706690|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
145235172|NCT05127421|523706691|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
145235173|NCT05127421|523706688|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
145235174|NCT05127421|523706689|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
145235175|NCT05127421|523706690|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
145235176|NCT05127421|523706691|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
145235177|NCT05127421|523706688|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
145235178|NCT05127421|523706689|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
145235179|NCT05127421|523706690|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
145235180|NCT05127421|523706691|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
145235181|NCT01441115|523706692|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
145235182|NCT00878215|523706696|FG000|Overall Study|Determined to be ineligible|0|||
145235183|NCT00878215|523706697|FG001|Overall Study|Determined to be ineligible|10|||
145235184|NCT00878215|523706698|FG002|Overall Study|Determined to be ineligible|0|||
145235185|NCT00878215|523706699|FG003|Overall Study|Determined to be ineligible|0|||
145235186|NCT00574496|523706704|FG000|Overall Study|Withdrawal by Subject|1|||
145235187|NCT01969799|523706705|FG000|Overall Study|Adverse Event|0|||
145235188|NCT01969799|523706706|FG001|Overall Study|Adverse Event|1|||
145235189|NCT01969799|523706705|FG000|Overall Study|Death|16|||
145235190|NCT01969799|523706706|FG001|Overall Study|Death|11|||
145235191|NCT01969799|523706705|FG000|Overall Study|Lost to Follow-up|0|||
145235192|NCT01969799|523706706|FG001|Overall Study|Lost to Follow-up|2|||
145235193|NCT01969799|523706705|FG000|Overall Study|Physician Decision|1|||
145235194|NCT01969799|523706706|FG001|Overall Study|Physician Decision|0|||
145235195|NCT01681576|523706707|FG000|Period 1|Adverse Event|1|||
145235196|NCT01681576|523706708|FG001|Period 1|Adverse Event|0|||
145235197|NCT01681576|523706707|FG000|Period 1|Protocol Deviation|1|||
145235198|NCT01681576|523706708|FG001|Period 1|Protocol Deviation|0|||
145235199|NCT01681576|523706707|FG000|Period 2|subject/guardian decision|3|||
145235200|NCT01681576|523706708|FG001|Period 2|subject/guardian decision|1|||
145235201|NCT01681576|523706707|FG000|Period 2|Non-compliance with study treatment|1|||
145235202|NCT01681576|523706708|FG001|Period 2|Non-compliance with study treatment|0|||
145235203|NCT00178464|523706710|FG000|Overall Study|Withdrawal by Subject|1|||
145235204|NCT00178464|523706710|FG000|Overall Study|Physician Decision|1|||
145235205|NCT02227108|523706711|FG000|Overall Study|Did not receive treatment|2|||
145235206|NCT02227108|523706711|FG000|Overall Study|Other|3|||
145235207|NCT02227108|523706711|FG000|Overall Study|Progressive disease|17|||
145235208|NCT02227108|523706711|FG000|Overall Study|Initiation of alternative therapy|2|||
145235209|NCT02227108|523706711|FG000|Overall Study|Investigator discretion|1|||
145235210|NCT02227108|523706711|FG000|Overall Study|Adverse Event|6|||
145235211|NCT02486952|523706712|FG000|Overall Study|Not Started Induction Therapy|3|||
145408436|NCT00831844|524349901|FG001|Overall Study|Adverse Event|0|||
145408437|NCT00831844|524349902|FG002|Overall Study|Adverse Event|0|||
145235212|NCT02486952|523706712|FG000|Overall Study|Adverse Event|1|||
145235213|NCT02486952|523706712|FG000|Overall Study|Death|15|||
145235214|NCT02486952|523706712|FG000|Overall Study|Lack of Efficacy|3|||
145235215|NCT02486952|523706712|FG000|Overall Study|Lost to Follow-up|26|||
145235216|NCT02486952|523706712|FG000|Overall Study|Other|2|||
145235217|NCT04111107|523706713|FG000|Overall Study|Withdrawal by Subject|6|||
145235218|NCT04111107|523706713|FG000|Overall Study|Declining Health|5|||
145235219|NCT03956225|523706714|FG000|Overall Study|Lack of Efficacy|1|||
145235220|NCT03956225|523706715|FG001|Overall Study|Lack of Efficacy|1|||
145235221|NCT03956225|523706714|FG000|Overall Study|Lost to Follow-up|0|||
145235222|NCT03956225|523706715|FG001|Overall Study|Lost to Follow-up|1|||
145235223|NCT03956225|523706714|FG000|Overall Study|Withdrawal by Subject|2|||
145235224|NCT03956225|523706715|FG001|Overall Study|Withdrawal by Subject|1|||
145235225|NCT03956225|523706714|FG000|Overall Study|Other Reasons|2|||
145235226|NCT03956225|523706715|FG001|Overall Study|Other Reasons|1|||
145235227|NCT02260648|523706716|FG000|Overall Study|Adverse Event|3|||
145235228|NCT02260648|523706717|FG001|Overall Study|Adverse Event|0|||
145295286|NCT01766778|523930798|FG001|Overall Study|Withdrawal by Subject|0|||
145295287|NCT01411332|523930799|FG000|Enrollment|Protocol Violation|0|||
145295288|NCT01411332|523930800|FG001|Enrollment|Protocol Violation|1|||
145235229|NCT02260648|523706718|FG002|Overall Study|Adverse Event|1|||
145235230|NCT02260648|523706716|FG000|Overall Study|Withdrawal by Subject|1|||
145235231|NCT02260648|523706717|FG001|Overall Study|Withdrawal by Subject|1|||
145235232|NCT02260648|523706718|FG002|Overall Study|Withdrawal by Subject|0|||
145235233|NCT02260648|523706716|FG000|Overall Study|Protocol Violation|1|||
145235234|NCT02260648|523706717|FG001|Overall Study|Protocol Violation|0|||
145235235|NCT02260648|523706718|FG002|Overall Study|Protocol Violation|0|||
145235236|NCT02260648|523706716|FG000|Overall Study|Discontinue Due to Study Termination|13|||
145235237|NCT02260648|523706717|FG001|Overall Study|Discontinue Due to Study Termination|12|||
145235238|NCT02260648|523706718|FG002|Overall Study|Discontinue Due to Study Termination|7|||
145235239|NCT00594204|523706719|FG000|Overall Study|Adverse Event|15|||
145235240|NCT00594204|523706720|FG001|Overall Study|Adverse Event|3|||
145235241|NCT00594204|523706719|FG000|Overall Study|Lost to Follow-up|9|||
145235242|NCT00594204|523706720|FG001|Overall Study|Lost to Follow-up|5|||
145235243|NCT00594204|523706719|FG000|Overall Study|Withdrawal by Subject|23|||
145235244|NCT00594204|523706720|FG001|Overall Study|Withdrawal by Subject|29|||
145235245|NCT00594204|523706719|FG000|Overall Study|Other|4|||
145235246|NCT00594204|523706720|FG001|Overall Study|Other|3|||
145235247|NCT00594204|523706719|FG000|Overall Study|Lack of Efficacy|3|||
145235248|NCT00594204|523706720|FG001|Overall Study|Lack of Efficacy|4|||
145235249|NCT00594204|523706719|FG000|Overall Study|Randomized but not treated|4|||
145235250|NCT00594204|523706720|FG001|Overall Study|Randomized but not treated|1|||
145235251|NCT01115738|523706721|FG000|Overall Study|Death|1|||
145235252|NCT01115738|523706722|FG001|Overall Study|Death|0|||
145235253|NCT01115738|523706723|FG002|Overall Study|Death|0|||
145235254|NCT01115738|523706721|FG000|Overall Study|Lost to Follow-up|0|||
145235255|NCT01115738|523706722|FG001|Overall Study|Lost to Follow-up|0|||
145235256|NCT01115738|523706723|FG002|Overall Study|Lost to Follow-up|1|||
145235257|NCT01115738|523706721|FG000|Overall Study|Physician Decision|18|||
145235258|NCT01115738|523706722|FG001|Overall Study|Physician Decision|15|||
145235259|NCT01115738|523706723|FG002|Overall Study|Physician Decision|17|||
145235260|NCT01115738|523706721|FG000|Overall Study|Withdrawal by Subject|6|||
145235261|NCT01115738|523706722|FG001|Overall Study|Withdrawal by Subject|6|||
145235262|NCT01115738|523706723|FG002|Overall Study|Withdrawal by Subject|9|||
145235263|NCT02702011|523706730|FG000|Overall Study|Withdrawal by Subject|0|||
145235264|NCT02702011|523706731|FG001|Overall Study|Withdrawal by Subject|1|||
145235265|NCT02702011|523706732|FG002|Overall Study|Withdrawal by Subject|0|||
145235266|NCT02702011|523706733|FG003|Overall Study|Withdrawal by Subject|0|||
145295289|NCT01411332|523930799|FG000|Enrollment|Withdrawal by Subject|0|||
145619925|NCT01195675|525123623|FG000|Overall Study|Adverse Event|1|||
145619926|NCT01195675|525123623|FG000|Overall Study|Withdrawal by Subject|2|||
145619927|NCT02424344|525123624|FG000|Overall Study|Lack of Efficacy|0|||
145619928|NCT02424344|525123625|FG001|Overall Study|Lack of Efficacy|1|||
145619929|NCT02424344|525123624|FG000|Overall Study|Withdrawal by Subject|2|||
145619930|NCT02424344|525123625|FG001|Overall Study|Withdrawal by Subject|1|||
145619931|NCT02424344|525123624|FG000|Overall Study|Lost to Follow-up|1|||
145619932|NCT02424344|525123625|FG001|Overall Study|Lost to Follow-up|0|||
145619933|NCT02424344|525123624|FG000|Overall Study|Adverse Event|4|||
145619934|NCT02424344|525123625|FG001|Overall Study|Adverse Event|8|||
145619935|NCT01536262|525123626|FG000|Overall Study|Adverse Event|6|||
145619936|NCT01536262|525123627|FG001|Overall Study|Adverse Event|1|||
145619937|NCT01536262|525123628|FG002|Overall Study|Adverse Event|2|||
145619938|NCT01536262|525123626|FG000|Overall Study|Withdrawal by Subject|1|||
145619939|NCT01536262|525123627|FG001|Overall Study|Withdrawal by Subject|1|||
145619940|NCT01536262|525123628|FG002|Overall Study|Withdrawal by Subject|0|||
145619941|NCT01536262|525123626|FG000|Overall Study|Other than stated above|1|||
145619942|NCT01536262|525123627|FG001|Overall Study|Other than stated above|0|||
145235267|NCT02559206|523706742|FG000|Overall Study|Adverse Event|0|||
145295290|NCT01411332|523930800|FG001|Enrollment|Withdrawal by Subject|1|||
145295291|NCT01411332|523930799|FG000|Treatment|Lost to Follow-up|1|||
145295292|NCT01411332|523930800|FG001|Treatment|Lost to Follow-up|0|||
145295293|NCT01471522|523930801|FG000|Overall Study|Withdrawal by Subject|28|||
145295294|NCT01471522|523930802|FG001|Overall Study|Withdrawal by Subject|22|||
145619943|NCT01536262|525123628|FG002|Overall Study|Other than stated above|0|||
145619944|NCT05257837|525123632|FG000|Overall Study|Excluded (did not find the guns)|4|||
145235268|NCT02559206|523706743|FG001|Overall Study|Adverse Event|4|||
145295295|NCT01471522|523930801|FG000|Overall Study|Lost to Follow-up|36|||
145619945|NCT05257837|525123633|FG001|Overall Study|Excluded (did not find the guns)|2|||
145619946|NCT05257837|525123634|FG002|Overall Study|Excluded (did not find the guns)|4|||
145619947|NCT05257837|525123635|FG003|Overall Study|Excluded (did not find the guns)|0|||
145619948|NCT01781611|525123636|FG000|Overall Study|Adverse Event|4|||
145235269|NCT02559206|523706744|FG002|Overall Study|Adverse Event|1|||
145235270|NCT02559206|523706745|FG003|Overall Study|Adverse Event|5|||
145235271|NCT02559206|523706746|FG004|Overall Study|Adverse Event|3|||
145235272|NCT02559206|523706747|FG005|Overall Study|Adverse Event|0|||
145235273|NCT02559206|523706748|FG006|Overall Study|Adverse Event|1|||
145235274|NCT02559206|523706749|FG007|Overall Study|Adverse Event|0|||
145235275|NCT02559206|523706742|FG000|Overall Study|Protocol Violation|1|||
145235276|NCT02559206|523706743|FG001|Overall Study|Protocol Violation|0|||
145235277|NCT02559206|523706744|FG002|Overall Study|Protocol Violation|1|||
145235278|NCT02559206|523706745|FG003|Overall Study|Protocol Violation|0|||
145235279|NCT02559206|523706746|FG004|Overall Study|Protocol Violation|0|||
145235280|NCT02559206|523706747|FG005|Overall Study|Protocol Violation|2|||
145235281|NCT02559206|523706748|FG006|Overall Study|Protocol Violation|0|||
145235282|NCT02559206|523706749|FG007|Overall Study|Protocol Violation|0|||
145235283|NCT02559206|523706742|FG000|Overall Study|Withdrawal by Subject|3|||
145235284|NCT02559206|523706743|FG001|Overall Study|Withdrawal by Subject|3|||
145235285|NCT02559206|523706744|FG002|Overall Study|Withdrawal by Subject|1|||
145235286|NCT02559206|523706745|FG003|Overall Study|Withdrawal by Subject|3|||
145235287|NCT02559206|523706746|FG004|Overall Study|Withdrawal by Subject|5|||
145235288|NCT02559206|523706747|FG005|Overall Study|Withdrawal by Subject|4|||
145235289|NCT02559206|523706748|FG006|Overall Study|Withdrawal by Subject|1|||
145235290|NCT02559206|523706749|FG007|Overall Study|Withdrawal by Subject|2|||
145235291|NCT02559206|523706742|FG000|Overall Study|Lost to Follow-up|3|||
145235292|NCT02559206|523706743|FG001|Overall Study|Lost to Follow-up|5|||
145235293|NCT02559206|523706744|FG002|Overall Study|Lost to Follow-up|3|||
145235294|NCT02559206|523706745|FG003|Overall Study|Lost to Follow-up|3|||
145235295|NCT02559206|523706746|FG004|Overall Study|Lost to Follow-up|2|||
145235296|NCT02559206|523706747|FG005|Overall Study|Lost to Follow-up|5|||
145235297|NCT02559206|523706748|FG006|Overall Study|Lost to Follow-up|1|||
145235298|NCT02559206|523706749|FG007|Overall Study|Lost to Follow-up|4|||
145235299|NCT02559206|523706742|FG000|Overall Study|Lack of Efficacy|1|||
145235300|NCT02559206|523706743|FG001|Overall Study|Lack of Efficacy|0|||
145235301|NCT02559206|523706744|FG002|Overall Study|Lack of Efficacy|3|||
145235302|NCT02559206|523706745|FG003|Overall Study|Lack of Efficacy|2|||
145235303|NCT02559206|523706746|FG004|Overall Study|Lack of Efficacy|2|||
145235304|NCT02559206|523706747|FG005|Overall Study|Lack of Efficacy|3|||
145235305|NCT02559206|523706748|FG006|Overall Study|Lack of Efficacy|3|||
145235306|NCT02559206|523706749|FG007|Overall Study|Lack of Efficacy|3|||
145235307|NCT02559206|523706742|FG000|Overall Study|Other Not Specified|0|||
145235308|NCT02559206|523706743|FG001|Overall Study|Other Not Specified|0|||
145235309|NCT02559206|523706744|FG002|Overall Study|Other Not Specified|0|||
145235310|NCT02559206|523706745|FG003|Overall Study|Other Not Specified|1|||
145235311|NCT02559206|523706746|FG004|Overall Study|Other Not Specified|0|||
145235312|NCT02559206|523706747|FG005|Overall Study|Other Not Specified|0|||
145235313|NCT02559206|523706748|FG006|Overall Study|Other Not Specified|0|||
145235314|NCT02559206|523706749|FG007|Overall Study|Other Not Specified|0|||
145235315|NCT01871896|523706752|FG000|Overall Study|Lost to Follow-up|1|||
145295296|NCT01471522|523930802|FG001|Overall Study|Lost to Follow-up|26|||
145295297|NCT01432171|523930803|FG000|Overall Study|Death|1|||
145295298|NCT01432171|523930804|FG001|Overall Study|Death|2|||
145295299|NCT01432171|523930803|FG000|Overall Study|Lost to Follow-up|6|||
145295300|NCT01432171|523930804|FG001|Overall Study|Lost to Follow-up|5|||
145295301|NCT01432171|523930803|FG000|Overall Study|Withdrawal by Subject|3|||
145295302|NCT01432171|523930804|FG001|Overall Study|Withdrawal by Subject|1|||
145295303|NCT01432171|523930803|FG000|Overall Study|Noncompliance|2|||
145295304|NCT01432171|523930804|FG001|Overall Study|Noncompliance|3|||
145295305|NCT01432171|523930803|FG000|Overall Study|Insurance denial trial coverage|1|||
145295306|NCT01432171|523930804|FG001|Overall Study|Insurance denial trial coverage|0|||
145295307|NCT01432171|523930803|FG000|Overall Study|Patient moved to palliative care|1|||
145295308|NCT01432171|523930804|FG001|Overall Study|Patient moved to palliative care|0|||
145295309|NCT01101022|523932445|FG000|Overall Study|Adverse Event|6|||
145295310|NCT01101022|523932446|FG001|Overall Study|Adverse Event|2|||
145295311|NCT01101022|523932445|FG000|Overall Study|Protocol Violation|4|||
145295312|NCT01101022|523932446|FG001|Overall Study|Protocol Violation|3|||
145295313|NCT01101022|523932445|FG000|Overall Study|Withdrawal by Subject|3|||
145295314|NCT01101022|523932446|FG001|Overall Study|Withdrawal by Subject|8|||
145295315|NCT01101022|523932445|FG000|Overall Study|Lost to Follow-up|1|||
145295316|NCT01101022|523932446|FG001|Overall Study|Lost to Follow-up|4|||
145295317|NCT01101022|523932445|FG000|Overall Study|Lack of Efficacy|0|||
145295318|NCT01101022|523932446|FG001|Overall Study|Lack of Efficacy|7|||
145235316|NCT03927911|523708154|FG000|Overall Study|problems with eDiary|0|||
145235317|NCT03927911|523708155|FG001|Overall Study|problems with eDiary|1|||
145235318|NCT03927911|523708156|FG002|Overall Study|problems with eDiary|0|||
145235319|NCT03927911|523708157|FG003|Overall Study|problems with eDiary|1|||
145235320|NCT03927911|523708158|FG004|Overall Study|problems with eDiary|0|||
145235321|NCT03927911|523708159|FG005|Overall Study|problems with eDiary|4|||
145235322|NCT03927911|523708154|FG000|Overall Study|Adverse Event|0|||
145295319|NCT01101022|523932445|FG000|Overall Study|Sponsor decision|1|||
145295320|NCT01101022|523932446|FG001|Overall Study|Sponsor decision|1|||
145295321|NCT01101022|523932445|FG000|Overall Study|Non-compliance|1|||
145295322|NCT01101022|523932446|FG001|Overall Study|Non-compliance|0|||
145235323|NCT03927911|523708155|FG001|Overall Study|Adverse Event|0|||
145235324|NCT03927911|523708156|FG002|Overall Study|Adverse Event|0|||
145235325|NCT03927911|523708157|FG003|Overall Study|Adverse Event|0|||
145235326|NCT03927911|523708158|FG004|Overall Study|Adverse Event|0|||
145235327|NCT03927911|523708159|FG005|Overall Study|Adverse Event|1|||
145235328|NCT03927911|523708154|FG000|Overall Study|not treated -study terminated by sponsor|0|||
145235329|NCT03927911|523708155|FG001|Overall Study|not treated -study terminated by sponsor|1|||
145235330|NCT03927911|523708156|FG002|Overall Study|not treated -study terminated by sponsor|0|||
145235331|NCT03927911|523708157|FG003|Overall Study|not treated -study terminated by sponsor|0|||
145235332|NCT03927911|523708158|FG004|Overall Study|not treated -study terminated by sponsor|0|||
145235333|NCT03927911|523708159|FG005|Overall Study|not treated -study terminated by sponsor|0|||
145235334|NCT03927911|523708154|FG000|Overall Study|Surgery cancelled|0|||
145235335|NCT03927911|523708155|FG001|Overall Study|Surgery cancelled|0|||
145235336|NCT03927911|523708156|FG002|Overall Study|Surgery cancelled|0|||
145235337|NCT03927911|523708157|FG003|Overall Study|Surgery cancelled|1|||
145235338|NCT03927911|523708158|FG004|Overall Study|Surgery cancelled|0|||
145235339|NCT03927911|523708159|FG005|Overall Study|Surgery cancelled|1|||
145235340|NCT03927911|523708154|FG000|Overall Study|Protocol Violation|0|||
145235341|NCT03927911|523708155|FG001|Overall Study|Protocol Violation|0|||
145235342|NCT03927911|523708156|FG002|Overall Study|Protocol Violation|0|||
145235343|NCT03927911|523708157|FG003|Overall Study|Protocol Violation|0|||
145235344|NCT03927911|523708158|FG004|Overall Study|Protocol Violation|0|||
145235345|NCT03927911|523708159|FG005|Overall Study|Protocol Violation|1|||
145235346|NCT00562640|523708160|FG000|Overall Study|Death|0|||
145235347|NCT00562640|523708161|FG001|Overall Study|Death|1|||
145235348|NCT00562640|523708162|FG002|Overall Study|Death|1|||
145235349|NCT00562640|523708163|FG003|Overall Study|Death|0|||
145235350|NCT05263921|523708164|FG000|Overall Study|Other: family emergency.|0|||
145235351|NCT05263921|523708165|FG001|Overall Study|Other: family emergency.|0|||
145235352|NCT05263921|523708166|FG002|Overall Study|Other: family emergency.|1|||
145235353|NCT05263921|523708167|FG003|Overall Study|Other: family emergency.|0|||
145235354|NCT01412151|523708168|FG000|Week 0 - 306 - Treatment Period|Death|1|||
145235355|NCT01412151|523708168|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
145235356|NCT01412151|523708168|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
145235357|NCT01412151|523708168|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
145235358|NCT03127852|523708169|FG000|Overall Study|Withdrawal by Subject|4|||
145235359|NCT03127852|523708170|FG001|Overall Study|Withdrawal by Subject|1|||
145235360|NCT03127852|523708169|FG000|Overall Study|Death|1|||
145235361|NCT03127852|523708170|FG001|Overall Study|Death|1|||
145235362|NCT02670928|523708171|FG000|Overall Study|Adverse Event|3|||
145235363|NCT02670928|523708172|FG001|Overall Study|Adverse Event|1|||
145235364|NCT02670928|523708171|FG000|Overall Study|Withdrawal by Subject|4|||
145235365|NCT02670928|523708172|FG001|Overall Study|Withdrawal by Subject|0|||
145562502|NCT01541969|524920053|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
145235366|NCT02670928|523708171|FG000|Overall Study|Lost to Follow-up|1|||
145235367|NCT02670928|523708172|FG001|Overall Study|Lost to Follow-up|0|||
145235368|NCT02670928|523708171|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
145235369|NCT02670928|523708172|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
145235370|NCT02591238|523708173|FG000|Overall Study|Pregnancy|1|||
145235371|NCT02591238|523708174|FG001|Overall Study|Pregnancy|0|||
145562503|NCT01541969|524920054|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
145562504|NCT01541969|524920053|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
145562505|NCT01541969|524920054|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
145235372|NCT02591238|523708175|FG002|Overall Study|Pregnancy|0|||
145235373|NCT02591238|523708176|FG003|Overall Study|Pregnancy|0|||
145235374|NCT02591238|523708173|FG000|Overall Study|Withdrawal by Subject|0|||
145235375|NCT02591238|523708174|FG001|Overall Study|Withdrawal by Subject|0|||
145235376|NCT02591238|523708175|FG002|Overall Study|Withdrawal by Subject|0|||
145235377|NCT02591238|523708176|FG003|Overall Study|Withdrawal by Subject|1|||
145235378|NCT02591238|523708173|FG000|Overall Study|influenza|0|||
145235379|NCT02591238|523708174|FG001|Overall Study|influenza|0|||
145235380|NCT02591238|523708175|FG002|Overall Study|influenza|0|||
145235381|NCT02591238|523708176|FG003|Overall Study|influenza|1|||
145295323|NCT01101022|523932445|FG000|Overall Study|Work schedule|1|||
145295324|NCT01101022|523932446|FG001|Overall Study|Work schedule|1|||
145295325|NCT01101022|523932445|FG000|Overall Study|Vacation|0|||
145295326|NCT01101022|523932446|FG001|Overall Study|Vacation|1|||
145295327|NCT01519661|523932447|FG000|Overall Study|Protocol deviation|6|||
145295328|NCT01519661|523932447|FG000|Overall Study|Lost to Follow-up|3|||
145295329|NCT01519661|523932447|FG000|Overall Study|Withdrawal by Subject|17|||
145295330|NCT01519661|523932447|FG000|Overall Study|Lack of Efficacy|6|||
145295331|NCT01519661|523932447|FG000|Overall Study|Adverse Event|29|||
145295332|NCT01139047|523932448|FG000|Overall Study|Withdrawal by Subject|1|||
145295333|NCT00420303|523932449|FG000|Overall Study|Serious Adverse Event|1|||
145295334|NCT00420303|523932450|FG001|Overall Study|Serious Adverse Event|0|||
145295335|NCT00420303|523932449|FG000|Overall Study|Lack of Efficacy|0|||
145295336|NCT00420303|523932450|FG001|Overall Study|Lack of Efficacy|3|||
145295337|NCT00420303|523932449|FG000|Overall Study|Physician Decision|0|||
145295338|NCT00420303|523932450|FG001|Overall Study|Physician Decision|1|||
145235382|NCT02591238|523708173|FG000|Overall Study|personal circumstances|0|||
145235383|NCT02591238|523708174|FG001|Overall Study|personal circumstances|0|||
145235384|NCT02591238|523708175|FG002|Overall Study|personal circumstances|0|||
145235385|NCT02591238|523708176|FG003|Overall Study|personal circumstances|1|||
145235386|NCT02591238|523708173|FG000|Overall Study|personal circumstances|0|||
145235387|NCT02591238|523708174|FG001|Overall Study|personal circumstances|1|||
145235388|NCT02591238|523708175|FG002|Overall Study|personal circumstances|0|||
145235389|NCT02591238|523708176|FG003|Overall Study|personal circumstances|0|||
145235390|NCT00525785|523708180|FG000|Overall Study|Withdrawal by Subject|1|||
145235391|NCT00525785|523708180|FG000|Overall Study|Lack of Efficacy|1|||
145235392|NCT00525785|523708180|FG000|Overall Study|Physician Decision|1|||
145235393|NCT03628599|523708181|FG000|Overall Study|Adverse Event|0|||
145235394|NCT03628599|523708182|FG001|Overall Study|Adverse Event|1|||
145235395|NCT01624506|523708183|FG000|Overall Study|Lost to Follow-up|29|||
145235396|NCT01624506|523708184|FG001|Overall Study|Lost to Follow-up|15|||
145235397|NCT01624506|523708183|FG000|Overall Study|Withdrawal by Subject|9|||
145235398|NCT01624506|523708184|FG001|Overall Study|Withdrawal by Subject|2|||
145295339|NCT01941095|523932451|FG000|Overall Study|Insufficient therapeutic response|13|||
145295340|NCT01941095|523932451|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
145295341|NCT01941095|523932451|FG000|Overall Study|Adverse Event|11|||
145295342|NCT01941095|523932451|FG000|Overall Study|Physician Decision|3|||
145295343|NCT01941095|523932451|FG000|Overall Study|Withdrawal by Subject|17|||
145295344|NCT01941095|523932451|FG000|Overall Study|Lost to Follow-up|10|||
145295345|NCT00088829|523932459|FG000|Overall Study|PI left institution and study was close|22|||
145295346|NCT01475838|523932463|FG000|Randomized Phase|Randomized but Not Treated|0|||
145295347|NCT01475838|523932464|FG001|Randomized Phase|Randomized but Not Treated|5|||
145295348|NCT01475838|523932463|FG000|Randomized Phase|Adverse Event|6|||
145295349|NCT01475838|523932464|FG001|Randomized Phase|Adverse Event|1|||
145295350|NCT01475838|523932463|FG000|Randomized Phase|Pregnancy|0|||
145295351|NCT01475838|523932464|FG001|Randomized Phase|Pregnancy|1|||
145295352|NCT01475838|523932463|FG000|Randomized Phase|Investigators Discretion|1|||
145295353|NCT01475838|523932464|FG001|Randomized Phase|Investigators Discretion|2|||
145295354|NCT01475838|523932463|FG000|Randomized Phase|Withdrew Consent|10|||
145295355|NCT01475838|523932464|FG001|Randomized Phase|Withdrew Consent|14|||
145295356|NCT01475838|523932463|FG000|Randomized Phase|Lost to Follow-up|3|||
145295357|NCT01475838|523932464|FG001|Randomized Phase|Lost to Follow-up|4|||
145295358|NCT01475838|523932463|FG000|Randomized Phase|Participant Noncompliance|1|||
145295359|NCT01475838|523932464|FG001|Randomized Phase|Participant Noncompliance|5|||
145295360|NCT01475838|523932463|FG000|Randomized Phase|Protocol Violation|9|||
145295361|NCT01475838|523932464|FG001|Randomized Phase|Protocol Violation|4|||
145295362|NCT01475838|523932463|FG000|Extension Phase|Participant Noncompliance|1|||
145295363|NCT01475838|523932464|FG001|Extension Phase|Participant Noncompliance|0|||
145295364|NCT00048568|523932470|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
145295365|NCT00048568|523932471|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
145295366|NCT00048568|523932472|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
145295367|NCT00048568|523932470|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
145295368|NCT00048568|523932471|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
145295369|NCT00048568|523932472|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
145295370|NCT00048568|523932470|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
145295371|NCT00048568|523932471|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
145295372|NCT00048568|523932472|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
145295373|NCT00048568|523932470|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
145295374|NCT00048568|523932471|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
145295375|NCT00048568|523932472|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
145295376|NCT00048568|523932470|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
145295377|NCT00048568|523932471|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
145295378|NCT00048568|523932472|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
145295379|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Death|1|||
145295380|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Death|1|||
145295381|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Death|0|||
145295382|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
145295383|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
145295384|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
145295385|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
145295386|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
145295387|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
145295388|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
145295389|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
145295390|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
145235399|NCT01624506|523708183|FG000|Overall Study|Death|1|||
145235400|NCT01624506|523708184|FG001|Overall Study|Death|0|||
145562506|NCT01541969|524920053|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
145235401|NCT01624506|523708183|FG000|Overall Study|LINX explants|23|||
145408438|NCT00831844|524349903|FG003|Overall Study|Adverse Event|0|||
145408439|NCT00831844|524349904|FG004|Overall Study|Adverse Event|1|||
145408440|NCT00831844|524349905|FG005|Overall Study|Adverse Event|1|||
145408441|NCT00831844|524349906|FG006|Overall Study|Adverse Event|2|||
145408442|NCT00831844|524349907|FG007|Overall Study|Adverse Event|0|||
145408443|NCT00831844|524349908|FG008|Overall Study|Adverse Event|0|||
145408444|NCT00831844|524349909|FG009|Overall Study|Adverse Event|0|||
145408445|NCT00831844|524349900|FG000|Overall Study|Death|0|||
145408446|NCT00831844|524349901|FG001|Overall Study|Death|0|||
145408447|NCT00831844|524349902|FG002|Overall Study|Death|0|||
145408448|NCT00831844|524349903|FG003|Overall Study|Death|1|||
145408449|NCT00831844|524349904|FG004|Overall Study|Death|0|||
145408450|NCT00831844|524349905|FG005|Overall Study|Death|0|||
145408451|NCT00831844|524349906|FG006|Overall Study|Death|0|||
145408452|NCT00831844|524349907|FG007|Overall Study|Death|0|||
145408453|NCT00831844|524349908|FG008|Overall Study|Death|0|||
145408454|NCT00831844|524349909|FG009|Overall Study|Death|0|||
145408455|NCT00831844|524349900|FG000|Overall Study|Lack of Efficacy|8|||
145408456|NCT00831844|524349901|FG001|Overall Study|Lack of Efficacy|10|||
145408457|NCT00831844|524349902|FG002|Overall Study|Lack of Efficacy|15|||
145408458|NCT00831844|524349903|FG003|Overall Study|Lack of Efficacy|8|||
145408459|NCT00831844|524349904|FG004|Overall Study|Lack of Efficacy|11|||
145408460|NCT00831844|524349905|FG005|Overall Study|Lack of Efficacy|17|||
145408461|NCT00831844|524349906|FG006|Overall Study|Lack of Efficacy|8|||
145408462|NCT00831844|524349907|FG007|Overall Study|Lack of Efficacy|9|||
145408463|NCT00831844|524349908|FG008|Overall Study|Lack of Efficacy|7|||
145408464|NCT00831844|524349909|FG009|Overall Study|Lack of Efficacy|0|||
145408465|NCT00831844|524349900|FG000|Overall Study|Physician Decision|0|||
145408466|NCT00831844|524349901|FG001|Overall Study|Physician Decision|1|||
145408467|NCT00831844|524349902|FG002|Overall Study|Physician Decision|3|||
145408468|NCT00831844|524349903|FG003|Overall Study|Physician Decision|1|||
145408469|NCT00831844|524349904|FG004|Overall Study|Physician Decision|1|||
145408470|NCT00831844|524349905|FG005|Overall Study|Physician Decision|1|||
145408471|NCT00831844|524349906|FG006|Overall Study|Physician Decision|0|||
145408472|NCT00831844|524349907|FG007|Overall Study|Physician Decision|0|||
145408473|NCT00831844|524349908|FG008|Overall Study|Physician Decision|1|||
145408474|NCT00831844|524349909|FG009|Overall Study|Physician Decision|0|||
145408475|NCT00831844|524349900|FG000|Overall Study|Withdrawal by Subject|0|||
145408476|NCT00831844|524349901|FG001|Overall Study|Withdrawal by Subject|0|||
145408477|NCT00831844|524349902|FG002|Overall Study|Withdrawal by Subject|1|||
145408478|NCT00831844|524349903|FG003|Overall Study|Withdrawal by Subject|0|||
145408479|NCT00831844|524349904|FG004|Overall Study|Withdrawal by Subject|0|||
145408480|NCT00831844|524349905|FG005|Overall Study|Withdrawal by Subject|0|||
145408481|NCT00831844|524349906|FG006|Overall Study|Withdrawal by Subject|0|||
145408482|NCT00831844|524349907|FG007|Overall Study|Withdrawal by Subject|1|||
145408483|NCT00831844|524349908|FG008|Overall Study|Withdrawal by Subject|1|||
145408484|NCT00831844|524349909|FG009|Overall Study|Withdrawal by Subject|0|||
145408485|NCT00831844|524349900|FG000|Overall Study|Ineligible|0|||
145408486|NCT00831844|524349901|FG001|Overall Study|Ineligible|1|||
145408487|NCT00831844|524349902|FG002|Overall Study|Ineligible|1|||
145408488|NCT00831844|524349903|FG003|Overall Study|Ineligible|0|||
145408489|NCT00831844|524349904|FG004|Overall Study|Ineligible|1|||
145408490|NCT00831844|524349905|FG005|Overall Study|Ineligible|0|||
145408491|NCT00831844|524349906|FG006|Overall Study|Ineligible|0|||
145408492|NCT00831844|524349907|FG007|Overall Study|Ineligible|0|||
145408493|NCT00831844|524349908|FG008|Overall Study|Ineligible|0|||
145408494|NCT00831844|524349909|FG009|Overall Study|Ineligible|0|||
145408495|NCT00830765|524349910|FG000|Overall Study|Protocol Violation|3|||
145408496|NCT00830765|524349911|FG001|Overall Study|Protocol Violation|2|||
145408497|NCT00315445|524349912|FG000|Overall Study|Adverse Event|7|||
145408498|NCT00315445|524349913|FG001|Overall Study|Adverse Event|12|||
145408499|NCT00315445|524349914|FG002|Overall Study|Adverse Event|15|||
145408500|NCT00315445|524349912|FG000|Overall Study|Lack of Efficacy|16|||
145408501|NCT00315445|524349913|FG001|Overall Study|Lack of Efficacy|1|||
145408502|NCT00315445|524349914|FG002|Overall Study|Lack of Efficacy|7|||
145408503|NCT00315445|524349912|FG000|Overall Study|Lost to Follow-up|1|||
145408504|NCT00315445|524349913|FG001|Overall Study|Lost to Follow-up|0|||
145408505|NCT00315445|524349914|FG002|Overall Study|Lost to Follow-up|1|||
145408506|NCT00315445|524349912|FG000|Overall Study|Protocol Violation|2|||
145408507|NCT00315445|524349913|FG001|Overall Study|Protocol Violation|0|||
145408508|NCT00315445|524349914|FG002|Overall Study|Protocol Violation|1|||
145408509|NCT00315445|524349912|FG000|Overall Study|Other|1|||
145235402|NCT01624506|523708184|FG001|Overall Study|LINX explants|0|||
145235403|NCT01624506|523708183|FG000|Overall Study|Adverse Event|3|||
145408510|NCT00315445|524349913|FG001|Overall Study|Other|3|||
145408511|NCT00315445|524349914|FG002|Overall Study|Other|0|||
145408512|NCT01299909|524349915|FG000|Overall Study|Lost to Follow-up|22|||
145408513|NCT01299909|524349916|FG001|Overall Study|Lost to Follow-up|18|||
145408514|NCT01299909|524349917|FG002|Overall Study|Lost to Follow-up|17|||
145408515|NCT01192178|524349918|FG000|Overall Study|Withdrawal by Subject|6|||
145408516|NCT01192178|524349919|FG001|Overall Study|Withdrawal by Subject|10|||
145408517|NCT01192178|524349918|FG000|Overall Study|Protocol Violation|10|||
145235404|NCT01624506|523708184|FG001|Overall Study|Adverse Event|0|||
145235405|NCT00132314|523708185|FG000|Overall Study|Lost to Follow-up|70|||
145235406|NCT00132314|523708186|FG001|Overall Study|Lost to Follow-up|62|||
145235407|NCT00132314|523708185|FG000|Overall Study|Lacked SSN|1|||
145235408|NCT00132314|523708186|FG001|Overall Study|Lacked SSN|3|||
145235409|NCT00132314|523708185|FG000|Overall Study|Refused intervention at baseline|2|||
145235410|NCT00132314|523708186|FG001|Overall Study|Refused intervention at baseline|7|||
145235411|NCT02966353|523708195|FG000|Overall Study|Withdrawal by Subject|7|||
145235412|NCT02966353|523708195|FG000|Overall Study|Adverse Event|4|||
145235413|NCT02966353|523708195|FG000|Overall Study|Death|4|||
145235414|NCT02966353|523708195|FG000|Overall Study|Physician Decision|3|||
145235415|NCT02966353|523708195|FG000|Overall Study|Progressive disease|2|||
145235416|NCT02966353|523708195|FG000|Overall Study|Protocol deviation|2|||
145235417|NCT02514772|523708198|FG000|Overall Study|Adverse Event|1|||
145235418|NCT02514772|523708199|FG001|Overall Study|Adverse Event|0|||
145235419|NCT02514772|523708198|FG000|Overall Study|Death|0|||
145235420|NCT02514772|523708199|FG001|Overall Study|Death|1|||
145235421|NCT02514772|523708198|FG000|Overall Study|Withdrawal by Subject|2|||
145235422|NCT02514772|523708199|FG001|Overall Study|Withdrawal by Subject|1|||
145235423|NCT03728140|523708200|FG000|Overall Study|Abnormal embryo transfer operation|10|||
145235424|NCT03728140|523708201|FG001|Overall Study|Abnormal embryo transfer operation|7|||
145235425|NCT02384395|523708202|FG000|Overall Study|Physician Decision|4|||
145235426|NCT02384395|523708202|FG000|Overall Study|Withdrawal by Subject|3|||
145235427|NCT02384395|523708202|FG000|Overall Study|Lost to Follow-up|3|||
145235428|NCT01143714|523708206|FG000|Overall Study|Adverse Event|4|||
145235429|NCT01143714|523708207|FG001|Overall Study|Adverse Event|2|||
145235430|NCT01143714|523708206|FG000|Overall Study|Withdrawal by Subject|1|||
145235431|NCT01143714|523708207|FG001|Overall Study|Withdrawal by Subject|0|||
145235432|NCT01143714|523708206|FG000|Overall Study|Subject non-compliance|0|||
145235433|NCT01143714|523708207|FG001|Overall Study|Subject non-compliance|1|||
145235434|NCT01143714|523708206|FG000|Overall Study|wound closed = deemed healed|1|||
145235435|NCT01143714|523708207|FG001|Overall Study|wound closed = deemed healed|0|||
145235436|NCT01143714|523708206|FG000|Overall Study|wound size increased|1|||
145235437|NCT01143714|523708207|FG001|Overall Study|wound size increased|0|||
145235438|NCT01106391|523708208|FG000|Overall Study|Death|12|||
145235439|NCT01106391|523708208|FG000|Overall Study|Withdrawal by Subject|7|||
145235440|NCT00150345|523708209|FG000|Overall Study|Death|5|||
145235441|NCT00150345|523708210|FG001|Overall Study|Death|2|||
145235442|NCT00150345|523708209|FG000|Overall Study|Adverse Event|8|||
145235443|NCT00150345|523708210|FG001|Overall Study|Adverse Event|6|||
145235444|NCT00150345|523708209|FG000|Overall Study|Lack of Efficacy|5|||
145235445|NCT00150345|523708210|FG001|Overall Study|Lack of Efficacy|4|||
145235446|NCT00150345|523708209|FG000|Overall Study|Withdrawal by Subject|3|||
145235447|NCT00150345|523708210|FG001|Overall Study|Withdrawal by Subject|4|||
145235448|NCT00150345|523708209|FG000|Overall Study|Laboratory abnormality|1|||
145235449|NCT00150345|523708210|FG001|Overall Study|Laboratory abnormality|2|||
145235450|NCT00150345|523708209|FG000|Overall Study|Other|12|||
145235451|NCT00150345|523708210|FG001|Overall Study|Other|14|||
145235452|NCT04325906|523708212|FG000|Overall Study|Withdrawal by Subject|2|||
145235453|NCT04325906|523708213|FG001|Overall Study|Withdrawal by Subject|0|||
145235454|NCT02016898|523708214|FG000|Overall Study|Death|1|||
145235455|NCT02016898|523708215|FG001|Overall Study|Death|1|||
145235456|NCT02016898|523708214|FG000|Overall Study|Lost to Follow-up|4|||
145235457|NCT02016898|523708215|FG001|Overall Study|Lost to Follow-up|4|||
145235458|NCT02505542|523708220|FG000|Part A: Open-Label Period|Adverse Event|31|||
145235459|NCT02505542|523708221|FG001|Part A: Open-Label Period|Adverse Event|0|||
145235460|NCT02505542|523708222|FG002|Part A: Open-Label Period|Adverse Event|0|||
145235461|NCT02505542|523708223|FG003|Part A: Open-Label Period|Adverse Event|0|||
145235462|NCT02505542|523708220|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
145235463|NCT02505542|523708221|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
145235464|NCT02505542|523708222|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
145235465|NCT02505542|523708223|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
145235466|NCT02505542|523708220|FG000|Part A: Open-Label Period|Protocol Violation|1|||
145235467|NCT02505542|523708221|FG001|Part A: Open-Label Period|Protocol Violation|0|||
145235468|NCT02505542|523708222|FG002|Part A: Open-Label Period|Protocol Violation|0|||
145235469|NCT02505542|523708223|FG003|Part A: Open-Label Period|Protocol Violation|0|||
145235470|NCT02505542|523708220|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
145235471|NCT02505542|523708221|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
145235472|NCT02505542|523708222|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
145235473|NCT02505542|523708223|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
145235474|NCT02505542|523708220|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
145235475|NCT02505542|523708221|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
145235476|NCT02505542|523708222|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
145235477|NCT02505542|523708223|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
145235478|NCT02505542|523708220|FG000|Part A: Open-Label Period|New medical history available|1|||
145235479|NCT02505542|523708221|FG001|Part A: Open-Label Period|New medical history available|0|||
145235480|NCT02505542|523708222|FG002|Part A: Open-Label Period|New medical history available|0|||
145235481|NCT02505542|523708223|FG003|Part A: Open-Label Period|New medical history available|0|||
145235482|NCT02505542|523708220|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
145235483|NCT02505542|523708221|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
145235484|NCT02505542|523708222|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
145235485|NCT02505542|523708223|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
145235486|NCT02505542|523708220|FG000|Part A: Open-Label Period|Pregnancy|2|||
145235487|NCT02505542|523708221|FG001|Part A: Open-Label Period|Pregnancy|0|||
145235488|NCT02505542|523708222|FG002|Part A: Open-Label Period|Pregnancy|0|||
145235489|NCT02505542|523708223|FG003|Part A: Open-Label Period|Pregnancy|0|||
145235490|NCT02505542|523708220|FG000|Part A: Open-Label Period|Sponsor directive|1|||
145235491|NCT02505542|523708221|FG001|Part A: Open-Label Period|Sponsor directive|0|||
145235492|NCT02505542|523708222|FG002|Part A: Open-Label Period|Sponsor directive|0|||
145235493|NCT02505542|523708223|FG003|Part A: Open-Label Period|Sponsor directive|0|||
145235494|NCT02505542|523708220|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
145235495|NCT02505542|523708221|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
145235496|NCT02505542|523708222|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
145235497|NCT02505542|523708223|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
145235498|NCT02505542|523708220|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
145235499|NCT02505542|523708221|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
145235500|NCT02505542|523708222|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
145235501|NCT02505542|523708223|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
145235502|NCT02505542|523708220|FG000|Part A: Open-Label Period|Non-compliance|1|||
145235503|NCT02505542|523708221|FG001|Part A: Open-Label Period|Non-compliance|0|||
145235504|NCT02505542|523708222|FG002|Part A: Open-Label Period|Non-compliance|0|||
145235505|NCT02505542|523708223|FG003|Part A: Open-Label Period|Non-compliance|0|||
145235506|NCT02505542|523708220|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
145235507|NCT02505542|523708221|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
145235508|NCT02505542|523708222|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
145235509|NCT02505542|523708223|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
145235510|NCT02505542|523708220|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
145235511|NCT02505542|523708221|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
145235512|NCT02505542|523708222|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
145235513|NCT02505542|523708223|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
145235514|NCT02505542|523708220|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
145235515|NCT02505542|523708221|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
145235516|NCT02505542|523708222|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
145235517|NCT02505542|523708223|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
145235518|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Adverse Event|0|||
145235519|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Adverse Event|0|||
145235520|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Adverse Event|1|||
145235521|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Adverse Event|3|||
145235522|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
145295391|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
145295392|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
145295393|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
145295394|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
145295395|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
145295396|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
145295397|NCT00048568|523932470|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
145295398|NCT00048568|523932471|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
145295399|NCT00048568|523932472|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
145295400|NCT00048568|523932470|FG000|Open-Label Period|Death|0|||
145295401|NCT00048568|523932471|FG001|Open-Label Period|Death|0|||
145295402|NCT00048568|523932472|FG002|Open-Label Period|Death|13|||
145295403|NCT00048568|523932470|FG000|Open-Label Period|Adverse Event|0|||
145295404|NCT00048568|523932471|FG001|Open-Label Period|Adverse Event|0|||
145295405|NCT00048568|523932472|FG002|Open-Label Period|Adverse Event|49|||
145295406|NCT00048568|523932470|FG000|Open-Label Period|Lack of Efficacy|0|||
145295407|NCT00048568|523932471|FG001|Open-Label Period|Lack of Efficacy|0|||
145295408|NCT00048568|523932472|FG002|Open-Label Period|Lack of Efficacy|32|||
145295409|NCT00048568|523932470|FG000|Open-Label Period|Withdrawal by Subject|0|||
145295410|NCT00048568|523932471|FG001|Open-Label Period|Withdrawal by Subject|0|||
145295411|NCT00048568|523932472|FG002|Open-Label Period|Withdrawal by Subject|26|||
145295412|NCT00048568|523932470|FG000|Open-Label Period|Pregnancy|0|||
145295413|NCT00048568|523932471|FG001|Open-Label Period|Pregnancy|0|||
145295414|NCT00048568|523932472|FG002|Open-Label Period|Pregnancy|5|||
145295415|NCT00048568|523932470|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
145235523|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
145235524|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
145235525|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
145235526|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
145235527|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
145235528|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
145235529|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
145235530|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
145235531|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
145235532|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
145235533|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
145235534|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
145235535|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
145235536|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
145235537|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
145235538|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
145235539|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
145235540|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
145235541|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
145235542|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
145235543|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
145235544|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
145235545|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
145235546|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Miscalculation|0|||
145235547|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Miscalculation|1|||
145235548|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Miscalculation|0|||
145235549|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Miscalculation|0|||
145235550|NCT02505542|523708220|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
145235551|NCT02505542|523708221|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
145235552|NCT02505542|523708222|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
145235553|NCT02505542|523708223|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
145235554|NCT00992186|523708224|FG000|Overall Study|Withdrawal by Subject|2|||
145235555|NCT00992186|523708224|FG000|Overall Study|Protocol Violation|1|||
145235556|NCT00992186|523708224|FG000|Overall Study|Physician Decision|1|||
145235557|NCT00992186|523708224|FG000|Overall Study|Adverse Event|9|||
145235558|NCT00992186|523708224|FG000|Overall Study|Progressive Disease|30|||
145235559|NCT00992186|523708224|FG000|Overall Study|Refusal To Receive Study Agent|3|||
145235560|NCT00168064|523708225|FG000|Overall Study|Adverse Event|26|||
145235561|NCT00168064|523708226|FG001|Overall Study|Adverse Event|22|||
145235562|NCT00168064|523708225|FG000|Overall Study|Withdrawal by Subject|3|||
145235563|NCT00168064|523708226|FG001|Overall Study|Withdrawal by Subject|4|||
145235564|NCT00168064|523708225|FG000|Overall Study|Lack of Efficacy|4|||
145235565|NCT00168064|523708226|FG001|Overall Study|Lack of Efficacy|4|||
145235566|NCT00168064|523708225|FG000|Overall Study|Lost to Follow-up|4|||
145235567|NCT00168064|523708226|FG001|Overall Study|Lost to Follow-up|3|||
145235568|NCT00168064|523708225|FG000|Overall Study|Non-compliance|2|||
145235569|NCT00168064|523708226|FG001|Overall Study|Non-compliance|3|||
145235570|NCT00168064|523708225|FG000|Overall Study|Concurrent Illness|4|||
145235571|NCT00168064|523708226|FG001|Overall Study|Concurrent Illness|3|||
145235572|NCT00168064|523708225|FG000|Overall Study|Subject's Best interest|2|||
145235573|NCT00168064|523708226|FG001|Overall Study|Subject's Best interest|2|||
145235574|NCT00168064|523708225|FG000|Overall Study|Various|4|||
145235575|NCT00168064|523708226|FG001|Overall Study|Various|3|||
145235576|NCT05489081|523708235|FG000|Overall Study|student left classroom|0|||
145235577|NCT05489081|523708236|FG001|Overall Study|student left classroom|1|||
145235578|NCT05489081|523708235|FG000|Overall Study|teacher left school|0|||
145235579|NCT05489081|523708236|FG001|Overall Study|teacher left school|2|||
145235580|NCT05159362|523708239|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
145235581|NCT05159362|523708240|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
145235582|NCT05159362|523708241|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
145235583|NCT02940626|523708242|FG000|Overall Study|Death|40|||
145235584|NCT02940626|523708243|FG001|Overall Study|Death|32|||
145235585|NCT02940626|523708242|FG000|Overall Study|Lost to Follow-up|5|||
145235586|NCT02940626|523708243|FG001|Overall Study|Lost to Follow-up|2|||
145235587|NCT02940626|523708242|FG000|Overall Study|Withdrawal by Subject|1|||
145235588|NCT02940626|523708243|FG001|Overall Study|Withdrawal by Subject|0|||
145235589|NCT02940626|523708242|FG000|Overall Study|Transfer to Hospice Care|1|||
145295416|NCT00048568|523932471|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
145235590|NCT02940626|523708243|FG001|Overall Study|Transfer to Hospice Care|0|||
145235591|NCT02940626|523708242|FG000|Overall Study|Prohibited Concomitant Medication|0|||
145235592|NCT02940626|523708243|FG001|Overall Study|Prohibited Concomitant Medication|1|||
145235593|NCT01996904|523708244|FG000|Overall Study|Lost to Follow-up|38|||
145235594|NCT01996904|523708245|FG001|Overall Study|Lost to Follow-up|27|||
145295417|NCT00048568|523932472|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
145295418|NCT00048568|523932470|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
145295419|NCT00048568|523932471|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
145295420|NCT00048568|523932472|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
145295421|NCT00048568|523932470|FG000|Open-Label Period|Unknown Reasons|0|||
145295422|NCT00048568|523932471|FG001|Open-Label Period|Unknown Reasons|0|||
145235595|NCT01324622|523708246|FG000|Overall Study|Lost to Follow-up|7|||
145235596|NCT01324622|523708247|FG001|Overall Study|Lost to Follow-up|7|||
145235597|NCT01324622|523708246|FG000|Overall Study|Death|1|||
145235598|NCT01324622|523708247|FG001|Overall Study|Death|0|||
145235599|NCT01324622|523708246|FG000|Overall Study|Lack of Efficacy|1|||
145235600|NCT01324622|523708247|FG001|Overall Study|Lack of Efficacy|0|||
145235601|NCT02219087|523708248|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
145235602|NCT02219087|523708249|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
145235603|NCT00618449|523708250|FG000|Overall Study|Lost to Follow-up|98|||
145235604|NCT00618449|523708251|FG001|Overall Study|Lost to Follow-up|110|||
145235605|NCT00413062|523708252|FG000|Overall Study|Adverse event/serious adverse event|289|||
145235606|NCT00413062|523708253|FG001|Overall Study|Adverse event/serious adverse event|56|||
145235607|NCT00413062|523708252|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
145235608|NCT00413062|523708253|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
145235609|NCT00413062|523708252|FG000|Overall Study|Withdrawal of informed consent|111|||
145235610|NCT00413062|523708253|FG001|Overall Study|Withdrawal of informed consent|36|||
145235611|NCT00413062|523708252|FG000|Overall Study|Pregnancy|15|||
145235612|NCT00413062|523708253|FG001|Overall Study|Pregnancy|5|||
145235613|NCT00413062|523708252|FG000|Overall Study|Pregnancy wish|17|||
145235614|NCT00413062|523708253|FG001|Overall Study|Pregnancy wish|6|||
145235615|NCT00413062|523708252|FG000|Overall Study|Lost to Follow-up|175|||
145235616|NCT00413062|523708253|FG001|Overall Study|Lost to Follow-up|73|||
145235617|NCT00413062|523708252|FG000|Overall Study|Other reason|70|||
145235618|NCT00413062|523708253|FG001|Overall Study|Other reason|34|||
145235619|NCT02815293|523708256|FG000|Overall Study|Study termination by sponsor|10|||
145235620|NCT02815293|523708257|FG001|Overall Study|Study termination by sponsor|7|||
145235621|NCT02815293|523708258|FG002|Overall Study|Study termination by sponsor|0|||
145235622|NCT02815293|523708256|FG000|Overall Study|Participants not randomized|0|||
145235623|NCT02815293|523708257|FG001|Overall Study|Participants not randomized|0|||
145235624|NCT02815293|523708258|FG002|Overall Study|Participants not randomized|18|||
145235625|NCT02815293|523708256|FG000|Overall Study|Adverse Event|0|||
145235626|NCT02815293|523708257|FG001|Overall Study|Adverse Event|1|||
145235627|NCT02815293|523708258|FG002|Overall Study|Adverse Event|0|||
145235628|NCT00006604|523708261|FG000|Overall Study|Met study objective - no further FU|1|||
145235629|NCT00006604|523708262|FG001|Overall Study|Met study objective - no further FU|0|||
145235630|NCT00006604|523708263|FG002|Overall Study|Met study objective - no further FU|0|||
145235631|NCT00006604|523708264|FG003|Overall Study|Met study objective - no further FU|0|||
145235632|NCT00006604|523708265|FG004|Overall Study|Met study objective - no further FU|0|||
145235633|NCT00006604|523708266|FG005|Overall Study|Met study objective - no further FU|0|||
145235634|NCT00006604|523708267|FG006|Overall Study|Met study objective - no further FU|0|||
145235635|NCT00006604|523708268|FG007|Overall Study|Met study objective - no further FU|0|||
145235636|NCT00006604|523708269|FG008|Overall Study|Met study objective - no further FU|0|||
145235637|NCT00006604|523708270|FG009|Overall Study|Met study objective - no further FU|0|||
145235638|NCT00006604|523708271|FG010|Overall Study|Met study objective - no further FU|0|||
145235639|NCT00006604|523708272|FG011|Overall Study|Met study objective - no further FU|0|||
145235640|NCT00006604|523708273|FG012|Overall Study|Met study objective - no further FU|0|||
145235641|NCT00006604|523708274|FG013|Overall Study|Met study objective - no further FU|0|||
145235642|NCT00006604|523708275|FG014|Overall Study|Met study objective - no further FU|1|||
145235643|NCT00006604|523708276|FG015|Overall Study|Met study objective - no further FU|1|||
145235644|NCT00006604|523708277|FG016|Overall Study|Met study objective - no further FU|0|||
145235645|NCT00006604|523708261|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
145235646|NCT00006604|523708262|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
145235647|NCT00006604|523708263|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
145295423|NCT00048568|523932472|FG002|Open-Label Period|Unknown Reasons|25|||
145295424|NCT00048568|523932470|FG000|Open-Label Period|Lost to Follow-up|0|||
145295425|NCT00048568|523932471|FG001|Open-Label Period|Lost to Follow-up|0|||
145295426|NCT00048568|523932472|FG002|Open-Label Period|Lost to Follow-up|7|||
145295427|NCT03831048|523932473|FG000|Overall Study|Protocol Violation|9|||
145235648|NCT00006604|523708264|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
145295428|NCT03831048|523932474|FG001|Overall Study|Protocol Violation|3|||
145295429|NCT03831048|523932473|FG000|Overall Study|Death|4|||
145295430|NCT03831048|523932474|FG001|Overall Study|Death|9|||
145295431|NCT03831048|523932473|FG000|Overall Study|Re-transplant|0|||
145295432|NCT03831048|523932474|FG001|Overall Study|Re-transplant|2|||
145295433|NCT03831048|523932473|FG000|Overall Study|Protocol violation and death|1|||
145295434|NCT03831048|523932474|FG001|Overall Study|Protocol violation and death|1|||
145295435|NCT01315249|523932479|FG000|Overall Study|Adverse Event|22|||
145295436|NCT01315249|523932480|FG001|Overall Study|Adverse Event|26|||
145235649|NCT00006604|523708265|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
145235650|NCT00006604|523708266|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
145235651|NCT00006604|523708267|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
145235652|NCT00006604|523708268|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
145235653|NCT00006604|523708269|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
145235654|NCT00006604|523708270|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
145235655|NCT00006604|523708271|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
145235656|NCT00006604|523708272|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
145235657|NCT00006604|523708273|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
145235658|NCT00006604|523708274|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
145235659|NCT00006604|523708275|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
145235660|NCT00006604|523708276|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
145235661|NCT00006604|523708277|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
145235662|NCT00006604|523708261|FG000|Overall Study|Death|0|||
145235663|NCT00006604|523708262|FG001|Overall Study|Death|0|||
145235664|NCT00006604|523708263|FG002|Overall Study|Death|0|||
145235665|NCT00006604|523708264|FG003|Overall Study|Death|0|||
145235666|NCT00006604|523708265|FG004|Overall Study|Death|0|||
145235667|NCT00006604|523708266|FG005|Overall Study|Death|0|||
145235668|NCT00006604|523708267|FG006|Overall Study|Death|0|||
145235669|NCT00006604|523708268|FG007|Overall Study|Death|0|||
145235670|NCT00006604|523708269|FG008|Overall Study|Death|0|||
145235671|NCT00006604|523708270|FG009|Overall Study|Death|1|||
145235672|NCT00006604|523708271|FG010|Overall Study|Death|1|||
145235673|NCT00006604|523708272|FG011|Overall Study|Death|1|||
145235674|NCT00006604|523708273|FG012|Overall Study|Death|0|||
145235675|NCT00006604|523708274|FG013|Overall Study|Death|0|||
145235676|NCT00006604|523708275|FG014|Overall Study|Death|0|||
145235677|NCT00006604|523708276|FG015|Overall Study|Death|0|||
145235678|NCT00006604|523708277|FG016|Overall Study|Death|0|||
145235679|NCT00006604|523708261|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145235680|NCT00006604|523708262|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145235681|NCT00006604|523708263|FG002|Overall Study|Severe debilitation, unable to continue|0|||
145235682|NCT00006604|523708264|FG003|Overall Study|Severe debilitation, unable to continue|0|||
145235683|NCT00006604|523708265|FG004|Overall Study|Severe debilitation, unable to continue|0|||
145235684|NCT00006604|523708266|FG005|Overall Study|Severe debilitation, unable to continue|0|||
145235685|NCT00006604|523708267|FG006|Overall Study|Severe debilitation, unable to continue|3|||
145235686|NCT00006604|523708268|FG007|Overall Study|Severe debilitation, unable to continue|0|||
145235687|NCT00006604|523708269|FG008|Overall Study|Severe debilitation, unable to continue|0|||
145235688|NCT00006604|523708270|FG009|Overall Study|Severe debilitation, unable to continue|5|||
145235689|NCT00006604|523708271|FG010|Overall Study|Severe debilitation, unable to continue|0|||
145235690|NCT00006604|523708272|FG011|Overall Study|Severe debilitation, unable to continue|2|||
145235691|NCT00006604|523708273|FG012|Overall Study|Severe debilitation, unable to continue|1|||
145235692|NCT00006604|523708274|FG013|Overall Study|Severe debilitation, unable to continue|0|||
145235693|NCT00006604|523708275|FG014|Overall Study|Severe debilitation, unable to continue|2|||
145235694|NCT00006604|523708276|FG015|Overall Study|Severe debilitation, unable to continue|0|||
145235695|NCT00006604|523708277|FG016|Overall Study|Severe debilitation, unable to continue|0|||
145235696|NCT00006604|523708261|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
145235697|NCT00006604|523708262|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
145235698|NCT00006604|523708263|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
145235699|NCT00006604|523708264|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
145235700|NCT00006604|523708265|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
145235701|NCT00006604|523708266|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
145235702|NCT00006604|523708267|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
145235703|NCT00006604|523708268|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
145235704|NCT00006604|523708269|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
145235705|NCT00006604|523708270|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
145235706|NCT00006604|523708271|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
145235707|NCT00006604|523708272|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
145235708|NCT00006604|523708273|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
145235709|NCT00006604|523708274|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
145235710|NCT00006604|523708275|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
145235711|NCT00006604|523708276|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
145235712|NCT00006604|523708277|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
145235713|NCT00006604|523708261|FG000|Overall Study|Site closing|0|||
145235714|NCT00006604|523708262|FG001|Overall Study|Site closing|0|||
145295437|NCT01315249|523932479|FG000|Overall Study|Withdrawal by Subject|11|||
145295438|NCT01315249|523932480|FG001|Overall Study|Withdrawal by Subject|10|||
145235715|NCT00006604|523708263|FG002|Overall Study|Site closing|1|||
145235716|NCT00006604|523708264|FG003|Overall Study|Site closing|1|||
145235717|NCT00006604|523708265|FG004|Overall Study|Site closing|0|||
145235718|NCT00006604|523708266|FG005|Overall Study|Site closing|0|||
145235719|NCT00006604|523708267|FG006|Overall Study|Site closing|0|||
145235720|NCT00006604|523708268|FG007|Overall Study|Site closing|1|||
145235721|NCT00006604|523708269|FG008|Overall Study|Site closing|0|||
145235722|NCT00006604|523708270|FG009|Overall Study|Site closing|0|||
145235723|NCT00006604|523708271|FG010|Overall Study|Site closing|0|||
145235724|NCT00006604|523708272|FG011|Overall Study|Site closing|1|||
145235725|NCT00006604|523708273|FG012|Overall Study|Site closing|1|||
145235726|NCT00006604|523708274|FG013|Overall Study|Site closing|1|||
145235727|NCT00006604|523708275|FG014|Overall Study|Site closing|0|||
145235728|NCT00006604|523708276|FG015|Overall Study|Site closing|0|||
145235729|NCT00006604|523708277|FG016|Overall Study|Site closing|1|||
145235730|NCT00006604|523708261|FG000|Overall Study|Withdrawal by Subject|1|||
145235731|NCT00006604|523708262|FG001|Overall Study|Withdrawal by Subject|0|||
145235732|NCT00006604|523708263|FG002|Overall Study|Withdrawal by Subject|2|||
145235733|NCT00006604|523708264|FG003|Overall Study|Withdrawal by Subject|0|||
145235734|NCT00006604|523708265|FG004|Overall Study|Withdrawal by Subject|1|||
145235735|NCT00006604|523708266|FG005|Overall Study|Withdrawal by Subject|2|||
145235736|NCT00006604|523708267|FG006|Overall Study|Withdrawal by Subject|2|||
145235737|NCT00006604|523708268|FG007|Overall Study|Withdrawal by Subject|0|||
145235738|NCT00006604|523708269|FG008|Overall Study|Withdrawal by Subject|1|||
145235739|NCT00006604|523708270|FG009|Overall Study|Withdrawal by Subject|3|||
145235740|NCT00006604|523708271|FG010|Overall Study|Withdrawal by Subject|2|||
145235741|NCT00006604|523708272|FG011|Overall Study|Withdrawal by Subject|0|||
145235742|NCT00006604|523708273|FG012|Overall Study|Withdrawal by Subject|1|||
145235743|NCT00006604|523708274|FG013|Overall Study|Withdrawal by Subject|2|||
145235744|NCT00006604|523708275|FG014|Overall Study|Withdrawal by Subject|1|||
145235745|NCT00006604|523708276|FG015|Overall Study|Withdrawal by Subject|0|||
145235746|NCT00006604|523708277|FG016|Overall Study|Withdrawal by Subject|1|||
145235747|NCT00006604|523708261|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
145235748|NCT00006604|523708262|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
145235749|NCT00006604|523708263|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
145235750|NCT00006604|523708264|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
145235751|NCT00006604|523708265|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
145235752|NCT00006604|523708266|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
145235753|NCT00006604|523708267|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
145235754|NCT00006604|523708268|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
145235755|NCT00006604|523708269|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
145235756|NCT00006604|523708270|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
145235757|NCT00006604|523708271|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
145235758|NCT00006604|523708272|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
145235759|NCT00006604|523708273|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
145235760|NCT00006604|523708274|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
145235761|NCT00006604|523708275|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
145235762|NCT00006604|523708276|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
145235763|NCT00006604|523708277|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
145235764|NCT00006604|523708261|FG000|Overall Study|Lost to Follow-up|0|||
145235765|NCT00006604|523708262|FG001|Overall Study|Lost to Follow-up|0|||
145235766|NCT00006604|523708263|FG002|Overall Study|Lost to Follow-up|0|||
145235767|NCT00006604|523708264|FG003|Overall Study|Lost to Follow-up|0|||
145235768|NCT00006604|523708265|FG004|Overall Study|Lost to Follow-up|0|||
145235769|NCT00006604|523708266|FG005|Overall Study|Lost to Follow-up|0|||
145235770|NCT00006604|523708267|FG006|Overall Study|Lost to Follow-up|0|||
145235771|NCT00006604|523708268|FG007|Overall Study|Lost to Follow-up|1|||
145235772|NCT00006604|523708269|FG008|Overall Study|Lost to Follow-up|0|||
145235773|NCT00006604|523708270|FG009|Overall Study|Lost to Follow-up|2|||
145235774|NCT00006604|523708271|FG010|Overall Study|Lost to Follow-up|0|||
145235775|NCT00006604|523708272|FG011|Overall Study|Lost to Follow-up|0|||
145235776|NCT00006604|523708273|FG012|Overall Study|Lost to Follow-up|0|||
145235777|NCT00006604|523708274|FG013|Overall Study|Lost to Follow-up|0|||
145235778|NCT00006604|523708275|FG014|Overall Study|Lost to Follow-up|0|||
145235779|NCT00006604|523708276|FG015|Overall Study|Lost to Follow-up|1|||
145235780|NCT00006604|523708277|FG016|Overall Study|Lost to Follow-up|3|||
145235781|NCT00006604|523708261|FG000|Overall Study|Other Reason|0|||
145235782|NCT00006604|523708262|FG001|Overall Study|Other Reason|0|||
145235783|NCT00006604|523708263|FG002|Overall Study|Other Reason|0|||
145235784|NCT00006604|523708264|FG003|Overall Study|Other Reason|0|||
145235785|NCT00006604|523708265|FG004|Overall Study|Other Reason|0|||
145235786|NCT00006604|523708266|FG005|Overall Study|Other Reason|1|||
145235787|NCT00006604|523708267|FG006|Overall Study|Other Reason|0|||
145235788|NCT00006604|523708268|FG007|Overall Study|Other Reason|0|||
145235789|NCT00006604|523708269|FG008|Overall Study|Other Reason|0|||
145235790|NCT00006604|523708270|FG009|Overall Study|Other Reason|1|||
145235791|NCT00006604|523708271|FG010|Overall Study|Other Reason|0|||
145235792|NCT00006604|523708272|FG011|Overall Study|Other Reason|0|||
145235793|NCT00006604|523708273|FG012|Overall Study|Other Reason|0|||
145235794|NCT00006604|523708274|FG013|Overall Study|Other Reason|0|||
145235795|NCT00006604|523708275|FG014|Overall Study|Other Reason|0|||
145235796|NCT00006604|523708276|FG015|Overall Study|Other Reason|0|||
145235797|NCT00006604|523708277|FG016|Overall Study|Other Reason|0|||
145235798|NCT02431468|523708278|FG000|Overall Study|Adverse Event|2|||
145235799|NCT02431468|523708279|FG001|Overall Study|Adverse Event|4|||
145235800|NCT02431468|523708280|FG002|Overall Study|Adverse Event|5|||
145235801|NCT02431468|523708278|FG000|Overall Study|Withdrawal by Subject|4|||
145235802|NCT02431468|523708279|FG001|Overall Study|Withdrawal by Subject|12|||
145235803|NCT02431468|523708280|FG002|Overall Study|Withdrawal by Subject|2|||
145235804|NCT02431468|523708278|FG000|Overall Study|noncompliance, investigator termination,|2|||
145235805|NCT02431468|523708279|FG001|Overall Study|noncompliance, investigator termination,|2|||
145235806|NCT02431468|523708280|FG002|Overall Study|noncompliance, investigator termination,|2|||
145235807|NCT01056341|523708281|FG000|Overall Study|Treatment Intolerance|0|||
145235808|NCT01056341|523708282|FG001|Overall Study|Treatment Intolerance|2|||
145235809|NCT01056341|523708283|FG002|Overall Study|Treatment Intolerance|0|||
145235810|NCT01056341|523708284|FG003|Overall Study|Treatment Intolerance|2|||
145235811|NCT01056341|523708285|FG004|Overall Study|Treatment Intolerance|0|||
145235812|NCT01056341|523708281|FG000|Overall Study|Lack of Efficacy|32|||
145235813|NCT01056341|523708282|FG001|Overall Study|Lack of Efficacy|30|||
145235814|NCT01056341|523708283|FG002|Overall Study|Lack of Efficacy|7|||
145235815|NCT01056341|523708284|FG003|Overall Study|Lack of Efficacy|25|||
145235816|NCT01056341|523708285|FG004|Overall Study|Lack of Efficacy|9|||
145235817|NCT01056341|523708281|FG000|Overall Study|Other reasons|4|||
145235818|NCT01056341|523708282|FG001|Overall Study|Other reasons|4|||
145235819|NCT01056341|523708283|FG002|Overall Study|Other reasons|8|||
145235820|NCT01056341|523708284|FG003|Overall Study|Other reasons|9|||
145235821|NCT01056341|523708285|FG004|Overall Study|Other reasons|5|||
145235822|NCT01361919|523708286|FG000|Overall Study|technical issues|10|||
145235823|NCT01361919|523708287|FG001|Overall Study|technical issues|12|||
145235824|NCT01361919|523708288|FG002|Overall Study|technical issues|10|||
145235825|NCT01086150|523708289|FG000|Overall Study|Withdrawal by Subject|0|||
145235826|NCT01086150|523708290|FG001|Overall Study|Withdrawal by Subject|4|||
145235827|NCT01086150|523708291|FG002|Overall Study|Withdrawal by Subject|1|||
145235828|NCT01086150|523708289|FG000|Overall Study|Lost to Follow-up|0|||
145235829|NCT01086150|523708290|FG001|Overall Study|Lost to Follow-up|1|||
145235830|NCT01086150|523708291|FG002|Overall Study|Lost to Follow-up|0|||
145235831|NCT01086150|523708289|FG000|Overall Study|Screen Failure|0|||
145235832|NCT01086150|523708290|FG001|Overall Study|Screen Failure|1|||
145235833|NCT01086150|523708291|FG002|Overall Study|Screen Failure|0|||
145235834|NCT03543358|523708296|FG000|Overall Study|Death|1|||
145235835|NCT03543358|523708297|FG001|Overall Study|Death|0|||
145235836|NCT03543358|523708296|FG000|Overall Study|Disease Progression|1|||
145235837|NCT03543358|523708297|FG001|Overall Study|Disease Progression|0|||
145235838|NCT03543358|523708296|FG000|Overall Study|Parent Study Closure|1|||
145235839|NCT03543358|523708297|FG001|Overall Study|Parent Study Closure|0|||
145235840|NCT03589885|523708298|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
145235841|NCT03589885|523708299|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
145295439|NCT01315249|523932479|FG000|Overall Study|Protocol Violation|8|||
145295440|NCT01315249|523932480|FG001|Overall Study|Protocol Violation|5|||
145295441|NCT01315249|523932479|FG000|Overall Study|Abnormal test results|1|||
145295442|NCT01315249|523932480|FG001|Overall Study|Abnormal test results|2|||
145295443|NCT01315249|523932479|FG000|Overall Study|Administrative problems|1|||
145295444|NCT01315249|523932480|FG001|Overall Study|Administrative problems|0|||
145235842|NCT03589885|523708300|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
145235843|NCT03589885|523708301|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
145235844|NCT03589885|523708302|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
145235845|NCT03589885|523708298|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
145235846|NCT03589885|523708299|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
145295445|NCT01315249|523932479|FG000|Overall Study|inability to use device|1|||
145295446|NCT01315249|523932480|FG001|Overall Study|inability to use device|0|||
145295447|NCT01315249|523932479|FG000|Overall Study|Lack of Efficacy|0|||
145408518|NCT01192178|524349919|FG001|Overall Study|Protocol Violation|3|||
145235847|NCT03589885|523708300|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
145235848|NCT03589885|523708301|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
145235849|NCT03589885|523708302|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
145235850|NCT03589885|523708298|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
145235851|NCT03589885|523708299|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
145235852|NCT03589885|523708300|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
145235853|NCT03589885|523708301|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
145235854|NCT03589885|523708302|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
145295448|NCT01315249|523932480|FG001|Overall Study|Lack of Efficacy|1|||
145295449|NCT01315249|523932479|FG000|Overall Study|Lost to Follow-up|0|||
145408519|NCT01192178|524349918|FG000|Overall Study|Physician Decision|2|||
145408520|NCT01192178|524349919|FG001|Overall Study|Physician Decision|4|||
145295450|NCT01315249|523932480|FG001|Overall Study|Lost to Follow-up|2|||
145235855|NCT03589885|523708298|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
145235856|NCT03589885|523708299|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
145235857|NCT03589885|523708300|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
145235858|NCT03589885|523708301|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
145235859|NCT03589885|523708302|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
145235860|NCT03589885|523708298|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
145235861|NCT03589885|523708299|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
145235862|NCT03589885|523708300|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
145235863|NCT03589885|523708301|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
145235864|NCT03589885|523708302|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
145235865|NCT03589885|523708298|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
145235866|NCT03589885|523708299|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
145235867|NCT03589885|523708300|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
145235868|NCT03589885|523708301|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
145235869|NCT03589885|523708302|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
145235870|NCT03589885|523708298|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
145235871|NCT03589885|523708299|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
145235872|NCT03589885|523708300|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
145235873|NCT03589885|523708301|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
145235874|NCT03589885|523708302|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
145235875|NCT03589885|523708298|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
145235876|NCT03589885|523708299|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
145235877|NCT03589885|523708300|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
145235878|NCT03589885|523708301|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
145235879|NCT03589885|523708302|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
145235880|NCT00805545|523708305|FG000|Overall Study|Protocol Violation|3|||
145235881|NCT00805545|523708306|FG001|Overall Study|Protocol Violation|2|||
145235882|NCT00805545|523708305|FG000|Overall Study|Protocol Violation|3|||
145235883|NCT00805545|523708306|FG001|Overall Study|Protocol Violation|1|||
145235884|NCT02157506|523708309|FG000|Overall Study|Adverse Event|0|||
145235885|NCT02157506|523708310|FG001|Overall Study|Adverse Event|1|||
145235886|NCT02157506|523708311|FG002|Overall Study|Adverse Event|0|||
145235887|NCT02157506|523708312|FG003|Overall Study|Adverse Event|0|||
145235888|NCT02157506|523708313|FG004|Overall Study|Adverse Event|0|||
145235889|NCT02157506|523708309|FG000|Overall Study|Lost to Follow-up|0|||
145235890|NCT02157506|523708310|FG001|Overall Study|Lost to Follow-up|0|||
145235891|NCT02157506|523708311|FG002|Overall Study|Lost to Follow-up|1|||
145235892|NCT02157506|523708312|FG003|Overall Study|Lost to Follow-up|0|||
145235893|NCT02157506|523708313|FG004|Overall Study|Lost to Follow-up|0|||
145235894|NCT01578785|523708318|FG000|Overall Study|Withdrawal by Subject|0|||
145235895|NCT01578785|523708319|FG001|Overall Study|Withdrawal by Subject|1|||
145235896|NCT01578785|523708318|FG000|Overall Study|Study terminated by sponsor|59|||
145235897|NCT01578785|523708319|FG001|Overall Study|Study terminated by sponsor|118|||
145235898|NCT01164865|523708320|FG000|Overall Study|Lost to Follow-up|2|||
145235899|NCT01164865|523708321|FG001|Overall Study|Lost to Follow-up|1|||
145235900|NCT00377429|523708322|FG000|Overall Study|Withdrawal by Subject|5|||
145235901|NCT00377429|523708322|FG000|Overall Study|Adverse Event|8|||
145235902|NCT00377429|523708322|FG000|Overall Study|Physician Decision|1|||
145235903|NCT00377429|523708322|FG000|Overall Study|Patient non-compliance|1|||
145235904|NCT02394795|523708325|FG000|Overall Study|Adverse Event|92|||
145235905|NCT02394795|523708326|FG001|Overall Study|Adverse Event|70|||
145235906|NCT02394795|523708325|FG000|Overall Study|Lost to Follow-up|0|||
145235907|NCT02394795|523708326|FG001|Overall Study|Lost to Follow-up|1|||
145235908|NCT02394795|523708325|FG000|Overall Study|Withdrawal by Subject|17|||
145235909|NCT02394795|523708326|FG001|Overall Study|Withdrawal by Subject|26|||
145235910|NCT02394795|523708325|FG000|Overall Study|Lack of Efficacy|181|||
145235911|NCT02394795|523708326|FG001|Overall Study|Lack of Efficacy|211|||
145235912|NCT02394795|523708325|FG000|Overall Study|Death|4|||
145235913|NCT02394795|523708326|FG001|Overall Study|Death|5|||
145235914|NCT02394795|523708325|FG000|Overall Study|Physician Decision|109|||
145235915|NCT02394795|523708326|FG001|Overall Study|Physician Decision|93|||
145235916|NCT02939599|523708328|FG000|Overall Study|Adverse Event|1|||
145235917|NCT02939599|523708329|FG001|Overall Study|Adverse Event|0|||
145235918|NCT02939599|523708328|FG000|Overall Study|Study Terminated By Sponsor|2|||
145235919|NCT02939599|523708329|FG001|Overall Study|Study Terminated By Sponsor|2|||
145235920|NCT00093470|523710107|FG000|Overall Study|Disease progression|39|||
145235921|NCT00093470|523710108|FG001|Overall Study|Disease progression|0|||
145235922|NCT00093470|523710107|FG000|Overall Study|Adverse Event|15|||
145235923|NCT00093470|523710108|FG001|Overall Study|Adverse Event|0|||
145235924|NCT00093470|523710107|FG000|Overall Study|Death|2|||
145235925|NCT00093470|523710108|FG001|Overall Study|Death|0|||
145235926|NCT00093470|523710107|FG000|Overall Study|Withdrawal by Subject|8|||
145235927|NCT00093470|523710108|FG001|Overall Study|Withdrawal by Subject|0|||
145235928|NCT00093470|523710107|FG000|Overall Study|Alternative therapy|2|||
145235929|NCT00093470|523710108|FG001|Overall Study|Alternative therapy|0|||
145235930|NCT00093470|523710107|FG000|Overall Study|Other complicating disease|3|||
145235931|NCT00093470|523710108|FG001|Overall Study|Other complicating disease|0|||
145235932|NCT00093470|523710107|FG000|Overall Study|Physician Decision|2|||
145235933|NCT00093470|523710108|FG001|Overall Study|Physician Decision|0|||
145235934|NCT00093470|523710107|FG000|Overall Study|Never started treatment|1|||
145235935|NCT00093470|523710108|FG001|Overall Study|Never started treatment|0|||
145235936|NCT00093470|523710107|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
145235937|NCT00093470|523710108|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
145235938|NCT00877006|523710109|FG000|Treatment Period|Death|2|||
145235939|NCT00877006|523710110|FG001|Treatment Period|Death|1|||
145235940|NCT00877006|523710109|FG000|Treatment Period|Adverse Event|10|||
145235941|NCT00877006|523710110|FG001|Treatment Period|Adverse Event|3|||
145235942|NCT00877006|523710109|FG000|Treatment Period|Withdrawal by Subject|2|||
145235943|NCT00877006|523710110|FG001|Treatment Period|Withdrawal by Subject|3|||
145235944|NCT00877006|523710109|FG000|Treatment Period|Protocol Violation|1|||
145235945|NCT00877006|523710110|FG001|Treatment Period|Protocol Violation|0|||
145235946|NCT00877006|523710109|FG000|Treatment Period|Lost to Follow-up|0|||
145235947|NCT00877006|523710110|FG001|Treatment Period|Lost to Follow-up|1|||
145235948|NCT00877006|523710109|FG000|Treatment Period|Disease Progression|1|||
145235949|NCT00877006|523710110|FG001|Treatment Period|Disease Progression|2|||
145235950|NCT00877006|523710109|FG000|Treatment Period|Started New Treatment Regimen|2|||
145235951|NCT00877006|523710110|FG001|Treatment Period|Started New Treatment Regimen|5|||
145235952|NCT00877006|523710109|FG000|Treatment Period|Other|4|||
145235953|NCT00877006|523710110|FG001|Treatment Period|Other|4|||
145235954|NCT00877006|523710109|FG000|Treatment Period|Randomized but Not Treated|3|||
145235955|NCT00877006|523710110|FG001|Treatment Period|Randomized but Not Treated|8|||
145235956|NCT00877006|523710109|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
145235957|NCT00877006|523710110|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
145235958|NCT00877006|523710109|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
145235959|NCT00877006|523710110|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
145235960|NCT00877006|523710109|FG000|Long-Term Follow-up Period|Death|26|||
145235961|NCT00877006|523710110|FG001|Long-Term Follow-up Period|Death|18|||
145235962|NCT00877006|523710109|FG000|Long-Term Follow-up Period|Other|7|||
145235963|NCT00877006|523710110|FG001|Long-Term Follow-up Period|Other|9|||
145235964|NCT00817206|523710111|FG000|Overall Study|Adverse Event|10|||
145235965|NCT00817206|523710112|FG001|Overall Study|Adverse Event|3|||
145235966|NCT00817206|523710111|FG000|Overall Study|Protocol Violation|0|||
145235967|NCT00817206|523710112|FG001|Overall Study|Protocol Violation|2|||
145235968|NCT00817206|523710111|FG000|Overall Study|Lost to Follow-up|0|||
145235969|NCT00817206|523710112|FG001|Overall Study|Lost to Follow-up|1|||
145235970|NCT00817206|523710111|FG000|Overall Study|Death|2|||
145235971|NCT00817206|523710112|FG001|Overall Study|Death|0|||
145235972|NCT00817206|523710111|FG000|Overall Study|Withdrawal by Subject|7|||
145235973|NCT00817206|523710112|FG001|Overall Study|Withdrawal by Subject|3|||
145235974|NCT00817206|523710111|FG000|Overall Study|Physician Decision|2|||
145235975|NCT00817206|523710112|FG001|Overall Study|Physician Decision|0|||
145235976|NCT00126581|523710113|FG000|Overall Study|Adverse Event|3|||
145235977|NCT00126581|523710114|FG001|Overall Study|Adverse Event|7|||
145235978|NCT00126581|523710113|FG000|Overall Study|Death|3|||
145235979|NCT00126581|523710114|FG001|Overall Study|Death|2|||
145235980|NCT00126581|523710113|FG000|Overall Study|Withdrawal by Subject|1|||
145235981|NCT00126581|523710114|FG001|Overall Study|Withdrawal by Subject|4|||
145235982|NCT00126581|523710113|FG000|Overall Study|Alternative therapy|3|||
145235983|NCT00126581|523710114|FG001|Overall Study|Alternative therapy|3|||
145235984|NCT00126581|523710113|FG000|Overall Study|Other illness/MD discretion|3|||
145235985|NCT00126581|523710114|FG001|Overall Study|Other illness/MD discretion|4|||
145235986|NCT01188096|523710116|FG000|Overall Study|progression of disease|4|||
145295451|NCT01315249|523932479|FG000|Overall Study|Death|0|||
145295452|NCT01315249|523932480|FG001|Overall Study|Death|1|||
145295453|NCT03227445|523932481|FG000|Period 1 (28 Days)|Adverse Event|1|||
145295454|NCT03227445|523932482|FG001|Period 1 (28 Days)|Adverse Event|2|||
145295455|NCT03227445|523932483|FG002|Period 1 (28 Days)|Adverse Event|0|||
145295456|NCT03227445|523932484|FG003|Period 1 (28 Days)|Adverse Event|1|||
145619949|NCT01781611|525123637|FG001|Overall Study|Adverse Event|0|||
145619950|NCT01625338|525123638|FG000|Overall Study|Enrolled but not Treated|0|||
145235987|NCT01188096|523710116|FG000|Overall Study|Withdrawal by Subject|2|||
145235988|NCT03485222|523710117|FG000|Overall Study|Death|0|||
145295457|NCT03227445|523932481|FG000|Period 1 (28 Days)|Protocol Violation|1|||
145295458|NCT03227445|523932482|FG001|Period 1 (28 Days)|Protocol Violation|0|||
145295459|NCT03227445|523932483|FG002|Period 1 (28 Days)|Protocol Violation|0|||
145619951|NCT01625338|525123639|FG001|Overall Study|Enrolled but not Treated|0|||
145235989|NCT03485222|523710118|FG001|Overall Study|Death|1|||
145235990|NCT03485222|523710117|FG000|Overall Study|Lost to Follow-up|2|||
145235991|NCT03485222|523710118|FG001|Overall Study|Lost to Follow-up|1|||
145235992|NCT00973622|523710120|FG000|Overall Study|did not attend MRI|14|||
145295460|NCT03227445|523932484|FG003|Period 1 (28 Days)|Protocol Violation|0|||
145295461|NCT03227445|523932481|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
145235993|NCT00973622|523710121|FG001|Overall Study|did not attend MRI|3|||
145408521|NCT01192178|524349918|FG000|Overall Study|Lost to Follow-up|3|||
145408522|NCT01192178|524349919|FG001|Overall Study|Lost to Follow-up|3|||
145235994|NCT00973622|523710120|FG000|Overall Study|did not pass MRI screen|6|||
145235995|NCT00973622|523710121|FG001|Overall Study|did not pass MRI screen|0|||
145235996|NCT00973622|523710120|FG000|Overall Study|did not complete rTMS sessions|11|||
145235997|NCT00973622|523710121|FG001|Overall Study|did not complete rTMS sessions|2|||
145235998|NCT00830960|523710122|FG000|Overall Study|Death|5|||
145235999|NCT00830960|523710123|FG001|Overall Study|Death|4|||
145236000|NCT00830960|523710124|FG002|Overall Study|Death|3|||
145236001|NCT00830960|523710125|FG003|Overall Study|Death|2|||
145236002|NCT00830960|523710126|FG004|Overall Study|Death|6|||
145236003|NCT00830960|523710127|FG005|Overall Study|Death|1|||
145236004|NCT00830960|523710122|FG000|Overall Study|Lost to Follow-up|1|||
145236005|NCT00830960|523710123|FG001|Overall Study|Lost to Follow-up|1|||
145236006|NCT00830960|523710124|FG002|Overall Study|Lost to Follow-up|1|||
145236007|NCT00830960|523710125|FG003|Overall Study|Lost to Follow-up|0|||
145236008|NCT00830960|523710126|FG004|Overall Study|Lost to Follow-up|0|||
145236009|NCT00830960|523710127|FG005|Overall Study|Lost to Follow-up|1|||
145236010|NCT00830960|523710122|FG000|Overall Study|Withdrawal by Subject|19|||
145236011|NCT00830960|523710123|FG001|Overall Study|Withdrawal by Subject|19|||
145236012|NCT00830960|523710124|FG002|Overall Study|Withdrawal by Subject|18|||
145236013|NCT00830960|523710125|FG003|Overall Study|Withdrawal by Subject|23|||
145236014|NCT00830960|523710126|FG004|Overall Study|Withdrawal by Subject|16|||
145236015|NCT00830960|523710127|FG005|Overall Study|Withdrawal by Subject|21|||
145236016|NCT00830960|523710122|FG000|Overall Study|Sponsor Decision|1|||
145236017|NCT00830960|523710123|FG001|Overall Study|Sponsor Decision|2|||
145236018|NCT00830960|523710124|FG002|Overall Study|Sponsor Decision|3|||
145236019|NCT00830960|523710125|FG003|Overall Study|Sponsor Decision|4|||
145236020|NCT00830960|523710126|FG004|Overall Study|Sponsor Decision|5|||
145236021|NCT00830960|523710127|FG005|Overall Study|Sponsor Decision|7|||
145236022|NCT00830960|523710122|FG000|Overall Study|No study drug received|7|||
145236023|NCT00830960|523710123|FG001|Overall Study|No study drug received|2|||
145236024|NCT00830960|523710124|FG002|Overall Study|No study drug received|4|||
145236025|NCT00830960|523710125|FG003|Overall Study|No study drug received|3|||
145236026|NCT00830960|523710126|FG004|Overall Study|No study drug received|5|||
145236027|NCT00830960|523710127|FG005|Overall Study|No study drug received|7|||
145236028|NCT03074149|523710130|FG000|Overall Study|Reason unknown|22|||
145236029|NCT03074149|523710131|FG001|Overall Study|Reason unknown|35|||
145236030|NCT03074149|523710130|FG000|Overall Study|Death|10|||
145236031|NCT03074149|523710131|FG001|Overall Study|Death|45|||
145236032|NCT02855450|523710134|FG000|Overall Study|Adverse Event|1|||
145236033|NCT02855450|523710135|FG001|Overall Study|Adverse Event|0|||
145236034|NCT02855450|523710134|FG000|Overall Study|Lost to Follow-up|4|||
145236035|NCT02855450|523710135|FG001|Overall Study|Lost to Follow-up|0|||
145236036|NCT01504971|523710136|FG000|Overall Study|Physician Decision|13|||
145236037|NCT01803711|523710143|FG000|Overall Study|Adverse Event|1|||
145236038|NCT01803711|523710144|FG001|Overall Study|Adverse Event|1|||
145236039|NCT00225212|523710145|FG000|Overall Study|Disease progression|2|||
145236040|NCT00225212|523710145|FG000|Overall Study|Death|1|||
145236041|NCT00225212|523710145|FG000|Overall Study|Adverse Event|2|||
145236042|NCT00225212|523710145|FG000|Overall Study|Intercurrent illness|1|||
145236043|NCT01376245|523710148|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
145236044|NCT01376245|523710149|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
145236045|NCT01376245|523710150|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
145236046|NCT01376245|523710151|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
145236047|NCT01376245|523710152|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
145236048|NCT01376245|523710148|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
145236049|NCT01376245|523710149|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
145236050|NCT01376245|523710150|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
145408523|NCT01192178|524349918|FG000|Overall Study|Adverse Event|2|||
145408524|NCT01192178|524349919|FG001|Overall Study|Adverse Event|1|||
145408525|NCT01192178|524349918|FG000|Overall Study|Lack of Efficacy|1|||
145408526|NCT01192178|524349919|FG001|Overall Study|Lack of Efficacy|2|||
145408527|NCT02460289|524349920|FG000|Overall Study|Adverse Event|1|||
145408528|NCT02460289|524349920|FG000|Overall Study|Withdrawal by Subject|8|||
145408529|NCT02460289|524349920|FG000|Overall Study|Lost to Follow-up|1|||
145236051|NCT01376245|523710151|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
145236052|NCT01376245|523710152|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
145236053|NCT01376245|523710148|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
145236054|NCT01376245|523710149|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
145236055|NCT01376245|523710150|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
145236056|NCT01376245|523710151|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
145236057|NCT01376245|523710152|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
145408530|NCT02164916|524349921|FG000|Overall Study|Adverse Event|3|||
145408531|NCT02164916|524349922|FG001|Overall Study|Adverse Event|8|||
145408532|NCT02164916|524349921|FG000|Overall Study|Death|1|||
145236058|NCT01376245|523710148|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
145236059|NCT01376245|523710149|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
145236060|NCT01376245|523710150|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
145295462|NCT03227445|523932482|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
145295463|NCT03227445|523932483|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
145295464|NCT03227445|523932484|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
145295465|NCT03227445|523932481|FG000|Period 2 (28 Days)|Adverse Event|1|||
145295466|NCT03227445|523932482|FG001|Period 2 (28 Days)|Adverse Event|0|||
145295467|NCT03227445|523932483|FG002|Period 2 (28 Days)|Adverse Event|2|||
145295468|NCT03227445|523932484|FG003|Period 2 (28 Days)|Adverse Event|1|||
145295469|NCT03227445|523932481|FG000|Period 2 (28 Days)|Protocol Violation|0|||
145295470|NCT03227445|523932482|FG001|Period 2 (28 Days)|Protocol Violation|0|||
145295471|NCT03227445|523932483|FG002|Period 2 (28 Days)|Protocol Violation|0|||
145295472|NCT03227445|523932484|FG003|Period 2 (28 Days)|Protocol Violation|1|||
145295473|NCT03227445|523932481|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
145295474|NCT03227445|523932482|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
145295475|NCT03227445|523932483|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
145295476|NCT03227445|523932484|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
145295477|NCT00365300|523932487|FG000|Open-label Phase|Adverse Event|4|||
145295478|NCT00365300|523932488|FG001|Open-label Phase|Adverse Event|0|||
145295479|NCT00365300|523932487|FG000|Open-label Phase|Failed to Return|1|||
145295480|NCT00365300|523932488|FG001|Open-label Phase|Failed to Return|0|||
145295481|NCT00365300|523932487|FG000|Open-label Phase|Physician Decision|1|||
145295482|NCT00365300|523932488|FG001|Open-label Phase|Physician Decision|0|||
145295483|NCT00365300|523932487|FG000|Open-label Phase|Noncompliance|9|||
145295484|NCT00365300|523932488|FG001|Open-label Phase|Noncompliance|0|||
145295485|NCT00365300|523932487|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
145295486|NCT00365300|523932488|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
145295487|NCT00365300|523932487|FG000|Open-label Phase|Protocol Violation|1|||
145295488|NCT00365300|523932488|FG001|Open-label Phase|Protocol Violation|0|||
145236061|NCT01376245|523710151|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
145236062|NCT01376245|523710152|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
145236063|NCT01376245|523710148|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
145236064|NCT01376245|523710149|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
145236065|NCT01376245|523710150|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
145236066|NCT01376245|523710151|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
145236067|NCT01376245|523710152|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
145236068|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
145236069|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
145236070|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
145236071|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
145236072|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
145236073|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
145236074|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
145236075|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
145236076|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
145236077|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
145236078|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
145236079|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
145236080|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
145236081|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
145236082|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
145236083|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
145236084|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
145236085|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
145236086|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
145236087|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
145236088|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145236089|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
145236090|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145236091|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
145295489|NCT00365300|523932487|FG000|Open-label Phase|Lack of Efficacy|1|||
145295490|NCT00365300|523932488|FG001|Open-label Phase|Lack of Efficacy|0|||
145295491|NCT00365300|523932487|FG000|Open-label Phase|Patient skipped open label phase|1|||
145295492|NCT00365300|523932488|FG001|Open-label Phase|Patient skipped open label phase|0|||
145236092|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
145295493|NCT00365300|523932487|FG000|Double-blind Phase|Failed to return|1|||
145295494|NCT00365300|523932488|FG001|Double-blind Phase|Failed to return|0|||
145295495|NCT00365300|523932487|FG000|Double-blind Phase|Noncompliance|1|||
145236093|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
145236094|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
145236095|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
145236096|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
145236097|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
145236098|NCT01376245|523710148|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145236099|NCT01376245|523710149|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
145236100|NCT01376245|523710150|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
145236101|NCT01376245|523710151|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
145236102|NCT01376245|523710152|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
145236103|NCT01335698|523710153|FG000|Treatment Stage 1|Lack of Efficacy|3|||
145236104|NCT01335698|523710154|FG001|Treatment Stage 1|Lack of Efficacy|1|||
145236105|NCT01335698|523710155|FG002|Treatment Stage 1|Lack of Efficacy|3|||
145236106|NCT01335698|523710156|FG003|Treatment Stage 1|Lack of Efficacy|3|||
145236107|NCT01335698|523710157|FG004|Treatment Stage 1|Lack of Efficacy|1|||
145236108|NCT01335698|523710153|FG000|Treatment Stage 1|Adverse Event|1|||
145236109|NCT01335698|523710154|FG001|Treatment Stage 1|Adverse Event|2|||
145236110|NCT01335698|523710155|FG002|Treatment Stage 1|Adverse Event|2|||
145236111|NCT01335698|523710156|FG003|Treatment Stage 1|Adverse Event|1|||
145236112|NCT01335698|523710157|FG004|Treatment Stage 1|Adverse Event|1|||
145236113|NCT01335698|523710153|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
145236114|NCT01335698|523710154|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
145236115|NCT01335698|523710155|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
145236116|NCT01335698|523710156|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
145236117|NCT01335698|523710157|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
145236118|NCT01335698|523710153|FG000|Treatment Stage 1|Lost to Follow-up|1|||
145236119|NCT01335698|523710154|FG001|Treatment Stage 1|Lost to Follow-up|1|||
145236120|NCT01335698|523710155|FG002|Treatment Stage 1|Lost to Follow-up|0|||
145236121|NCT01335698|523710156|FG003|Treatment Stage 1|Lost to Follow-up|0|||
145236122|NCT01335698|523710157|FG004|Treatment Stage 1|Lost to Follow-up|0|||
145236123|NCT01335698|523710153|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
145236124|NCT01335698|523710154|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
145236125|NCT01335698|523710155|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
145236126|NCT01335698|523710156|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
145236127|NCT01335698|523710157|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
145236128|NCT01335698|523710153|FG000|Treatment Stage 1|No longer meets study criteria|1|||
145236129|NCT01335698|523710154|FG001|Treatment Stage 1|No longer meets study criteria|1|||
145236130|NCT01335698|523710155|FG002|Treatment Stage 1|No longer meets study criteria|0|||
145236131|NCT01335698|523710156|FG003|Treatment Stage 1|No longer meets study criteria|1|||
145236132|NCT01335698|523710157|FG004|Treatment Stage 1|No longer meets study criteria|0|||
145236133|NCT01335698|523710153|FG000|Treatment Stage 1|Other|1|||
145236134|NCT01335698|523710154|FG001|Treatment Stage 1|Other|0|||
145236135|NCT01335698|523710155|FG002|Treatment Stage 1|Other|0|||
145236136|NCT01335698|523710156|FG003|Treatment Stage 1|Other|1|||
145236137|NCT01335698|523710157|FG004|Treatment Stage 1|Other|0|||
145236138|NCT01335698|523710153|FG000|Treatment Stage 2|Lack of Efficacy|2|||
145236139|NCT01335698|523710154|FG001|Treatment Stage 2|Lack of Efficacy|1|||
145236140|NCT01335698|523710155|FG002|Treatment Stage 2|Lack of Efficacy|3|||
145236141|NCT01335698|523710156|FG003|Treatment Stage 2|Lack of Efficacy|1|||
145236142|NCT01335698|523710157|FG004|Treatment Stage 2|Lack of Efficacy|0|||
145236143|NCT01335698|523710153|FG000|Treatment Stage 2|Adverse Event|2|||
145236144|NCT01335698|523710154|FG001|Treatment Stage 2|Adverse Event|0|||
145236145|NCT01335698|523710155|FG002|Treatment Stage 2|Adverse Event|0|||
145236146|NCT01335698|523710156|FG003|Treatment Stage 2|Adverse Event|3|||
145236147|NCT01335698|523710157|FG004|Treatment Stage 2|Adverse Event|0|||
145236148|NCT01335698|523710153|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
145236149|NCT01335698|523710154|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
145236150|NCT01335698|523710155|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
145236151|NCT01335698|523710156|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
145236152|NCT01335698|523710157|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
145236153|NCT01335698|523710153|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
145236154|NCT01335698|523710154|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
145236155|NCT01335698|523710155|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
145236156|NCT01335698|523710156|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
145236157|NCT01335698|523710157|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
145236158|NCT01335698|523710153|FG000|Treatment Stage 2|Lost to Follow-up|1|||
145236159|NCT01335698|523710154|FG001|Treatment Stage 2|Lost to Follow-up|0|||
145236160|NCT01335698|523710155|FG002|Treatment Stage 2|Lost to Follow-up|0|||
145236161|NCT01335698|523710156|FG003|Treatment Stage 2|Lost to Follow-up|0|||
145236162|NCT01335698|523710157|FG004|Treatment Stage 2|Lost to Follow-up|0|||
145236163|NCT01335698|523710153|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
145236164|NCT01335698|523710154|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
145236165|NCT01335698|523710155|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
145619952|NCT01625338|525123640|FG002|Overall Study|Enrolled but not Treated|1|||
145236166|NCT01335698|523710156|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
145236167|NCT01335698|523710157|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
145236168|NCT01335698|523710153|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
145236169|NCT01335698|523710154|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
145236170|NCT01335698|523710155|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
145236171|NCT01335698|523710156|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
145236172|NCT01335698|523710157|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
145236173|NCT01335698|523710153|FG000|Treatment Stage 2|Switched to another formulation|1|||
145236174|NCT01335698|523710154|FG001|Treatment Stage 2|Switched to another formulation|1|||
145236175|NCT01335698|523710155|FG002|Treatment Stage 2|Switched to another formulation|0|||
145236176|NCT01335698|523710156|FG003|Treatment Stage 2|Switched to another formulation|0|||
145236177|NCT01335698|523710157|FG004|Treatment Stage 2|Switched to another formulation|0|||
145236178|NCT01357889|523710158|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
145236179|NCT01357889|523710159|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
145236180|NCT01357889|523710158|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
145236181|NCT01357889|523710159|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
145236182|NCT01357889|523710158|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
145236183|NCT01357889|523710159|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
145236184|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
145236185|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
145236186|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
145236187|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
145236188|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
145236189|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
145236190|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
145236191|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
145236192|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
145236193|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
145236194|NCT01357889|523710158|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
145236195|NCT01357889|523710159|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
145236196|NCT01357889|523710158|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
145236197|NCT01357889|523710159|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
145236198|NCT01357889|523710158|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
145236199|NCT01357889|523710159|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
145236200|NCT01357889|523710158|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
145236201|NCT01357889|523710159|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
145236202|NCT01357889|523710158|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
145236203|NCT01357889|523710159|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
145236204|NCT00585923|523710160|FG000|Overall Study|Physician decided not to continue|31|||
145236205|NCT00585923|523710161|FG001|Overall Study|Physician decided not to continue|33|||
145236206|NCT00138424|523710164|FG000|Overall Study|Physician Decision|0|||
145236207|NCT00138424|523710165|FG001|Overall Study|Physician Decision|1|||
145236208|NCT00138424|523710166|FG002|Overall Study|Physician Decision|0|||
145236209|NCT00138424|523710167|FG003|Overall Study|Physician Decision|0|||
145236210|NCT04311177|523710168|FG000|Overall Study|Adverse Event|3|||
145236211|NCT04311177|523710169|FG001|Overall Study|Adverse Event|1|||
145236212|NCT04311177|523710168|FG000|Overall Study|Physician Decision|4|||
145236213|NCT04311177|523710169|FG001|Overall Study|Physician Decision|3|||
145236214|NCT04311177|523710168|FG000|Overall Study|Withdrawal by Subject|1|||
145236215|NCT04311177|523710169|FG001|Overall Study|Withdrawal by Subject|0|||
145236216|NCT02176291|523710174|FG000|Overall Study|Death|1|||
145236217|NCT02176291|523710175|FG001|Overall Study|Death|0|||
145236218|NCT02176291|523710174|FG000|Overall Study|non compliance with protocol|2|||
145236219|NCT02176291|523710175|FG001|Overall Study|non compliance with protocol|0|||
145619953|NCT01625338|525123638|FG000|Overall Study|Efficacy Failure|27|||
145236220|NCT02176291|523710174|FG000|Overall Study|Withdrawal by Subject|2|||
145236221|NCT02176291|523710175|FG001|Overall Study|Withdrawal by Subject|0|||
145236222|NCT03448224|523710176|FG000|Overall Study|Provided same answer to every question|1|||
145236223|NCT03448224|523710177|FG001|Overall Study|Provided same answer to every question|0|||
145236224|NCT03103906|523710178|FG000|Overall Study|Adverse Event|2|||
145236225|NCT03103906|523710179|FG001|Overall Study|Adverse Event|3|||
145236226|NCT03103906|523710178|FG000|Overall Study|Other|2|||
145295496|NCT00365300|523932488|FG001|Double-blind Phase|Noncompliance|1|||
145295497|NCT00365300|523932487|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145295498|NCT00365300|523932488|FG001|Double-blind Phase|Withdrawal by Subject|1|||
145236227|NCT03103906|523710179|FG001|Overall Study|Other|0|||
145236228|NCT00764478|523710180|FG000|Overall Study|Adverse Event|1|||
145236229|NCT00764478|523710181|FG001|Overall Study|Adverse Event|1|||
145236230|NCT00764478|523710182|FG002|Overall Study|Adverse Event|1|||
145236231|NCT00764478|523710180|FG000|Overall Study|Withdrawal by Subject|7|||
145236232|NCT00764478|523710181|FG001|Overall Study|Withdrawal by Subject|12|||
145236233|NCT00764478|523710182|FG002|Overall Study|Withdrawal by Subject|1|||
145236234|NCT00764478|523710180|FG000|Overall Study|Lost to Follow-up|7|||
145236235|NCT00764478|523710181|FG001|Overall Study|Lost to Follow-up|8|||
145236236|NCT00764478|523710182|FG002|Overall Study|Lost to Follow-up|5|||
145408533|NCT02164916|524349922|FG001|Overall Study|Death|1|||
145408534|NCT02164916|524349921|FG000|Overall Study|Refusal unrelated to adverse event|3|||
145408535|NCT02164916|524349922|FG001|Overall Study|Refusal unrelated to adverse event|7|||
145408536|NCT02164916|524349921|FG000|Overall Study|Progression|37|||
145408537|NCT02164916|524349922|FG001|Overall Study|Progression|26|||
145408538|NCT02164916|524349921|FG000|Overall Study|Not protocol specified|5|||
145408539|NCT02164916|524349922|FG001|Overall Study|Not protocol specified|1|||
145408540|NCT02164916|524349921|FG000|Overall Study|Reason under review|1|||
145408541|NCT02164916|524349922|FG001|Overall Study|Reason under review|6|||
145408542|NCT02164916|524349921|FG000|Overall Study|Not eligible|2|||
145408543|NCT02164916|524349922|FG001|Overall Study|Not eligible|5|||
145408544|NCT01155570|524349923|FG000|Overall Study|Adverse Event|39|||
145408545|NCT01155570|524349923|FG000|Overall Study|Lack of Efficacy|46|||
145408546|NCT01155570|524349923|FG000|Overall Study|Participant's Economic Reasons|17|||
145408547|NCT01155570|524349923|FG000|Overall Study|No Hospital Visits|7|||
145408548|NCT01155570|524349923|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
145408549|NCT01155570|524349923|FG000|Overall Study|Adverse Event + Other Reasons|7|||
145408550|NCT01155570|524349923|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
145408551|NCT01155570|524349923|FG000|Overall Study|Other Reasons|23|||
145408552|NCT01349595|524349926|FG000|Overall Study|Lack of funding|2|||
145408553|NCT01349595|524349927|FG001|Overall Study|Lack of funding|2|||
145408554|NCT00549055|524351842|FG000|Overall Study|Adverse Event|4|||
145408555|NCT00549055|524351842|FG000|Overall Study|Lack of Efficacy|18|||
145408556|NCT00549055|524351842|FG000|Overall Study|Stabilization|5|||
145408557|NCT00549055|524351842|FG000|Overall Study|Progression to fibrosis|2|||
145408558|NCT00549055|524351842|FG000|Overall Study|Decrease of size|1|||
145408559|NCT00549055|524351842|FG000|Overall Study|Active choroidal neovascula increased|1|||
145408560|NCT00549055|524351842|FG000|Overall Study|Vitreous hemorrhage|1|||
145408561|NCT00549055|524351842|FG000|Overall Study|Growth choroidal neovascularisation|1|||
145408562|NCT00549055|524351842|FG000|Overall Study|Choroidal neovascularization|1|||
145408563|NCT00549055|524351842|FG000|Overall Study|Very low visual acuity (VA)|1|||
145408564|NCT01787838|524351844|FG000|Overall Study|refused|1413|||
145408565|NCT01240746|524351845|FG000|Overall Study|Adverse Event|2|||
145408566|NCT01240746|524351846|FG001|Overall Study|Adverse Event|0|||
145408567|NCT01240746|524351847|FG002|Overall Study|Adverse Event|10|||
145408568|NCT01240746|524351845|FG000|Overall Study|Lost to Follow-up|23|||
145408569|NCT01240746|524351846|FG001|Overall Study|Lost to Follow-up|20|||
145408570|NCT01240746|524351847|FG002|Overall Study|Lost to Follow-up|102|||
145408571|NCT01240746|524351845|FG000|Overall Study|Protocol Violation|24|||
145408572|NCT01240746|524351846|FG001|Overall Study|Protocol Violation|15|||
145408573|NCT01240746|524351847|FG002|Overall Study|Protocol Violation|72|||
145408574|NCT01240746|524351845|FG000|Overall Study|Withdrawal by Subject|10|||
145408575|NCT01240746|524351846|FG001|Overall Study|Withdrawal by Subject|13|||
145408576|NCT01240746|524351847|FG002|Overall Study|Withdrawal by Subject|59|||
145408577|NCT00764517|524351854|FG000|Overall Study|Adverse Event|9|||
145408578|NCT00764517|524351855|FG001|Overall Study|Adverse Event|3|||
145408579|NCT00764517|524351854|FG000|Overall Study|Death|3|||
145408580|NCT00764517|524351855|FG001|Overall Study|Death|11|||
145408581|NCT00764517|524351854|FG000|Overall Study|Physician Decision|3|||
145408582|NCT00764517|524351855|FG001|Overall Study|Physician Decision|0|||
145408583|NCT02239328|524351859|FG000|Overall Study|Benign disease noted at time of surgery|6|||
145408584|NCT02239328|524351859|FG000|Overall Study|Equipment or website malfunction|2|||
145408585|NCT03517137|524351864|FG000|Overall Study|Lack of Efficacy|1|||
145408586|NCT03517137|524351864|FG000|Overall Study|Adverse Event|2|||
145408587|NCT03517137|524351864|FG000|Overall Study|Withdrawal by Subject|2|||
145408588|NCT03517137|524351864|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
145408589|NCT02313155|524351871|FG000|Overall Study|Lost to Follow-up|0|||
145408590|NCT02313155|524351872|FG001|Overall Study|Lost to Follow-up|1|||
145619954|NCT01625338|525123639|FG001|Overall Study|Efficacy Failure|39|||
145408591|NCT03881371|524351875|FG000|Overall Study|Adverse Event|8|||
145408592|NCT03881371|524351876|FG001|Overall Study|Adverse Event|9|||
145408593|NCT03881371|524351875|FG000|Overall Study|Death|1|||
145408594|NCT03881371|524351876|FG001|Overall Study|Death|0|||
145408595|NCT03881371|524351875|FG000|Overall Study|Lost to Follow-up|1|||
145408596|NCT03881371|524351876|FG001|Overall Study|Lost to Follow-up|0|||
145408597|NCT03881371|524351875|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145408598|NCT03881371|524351876|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145408599|NCT03881371|524351875|FG000|Overall Study|Physician Decision|3|||
145408600|NCT03881371|524351876|FG001|Overall Study|Physician Decision|3|||
145236237|NCT00764478|523710180|FG000|Overall Study|Protocol Violation|0|||
145408601|NCT03881371|524351875|FG000|Overall Study|Withdrawal by Subject|2|||
145408602|NCT03881371|524351876|FG001|Overall Study|Withdrawal by Subject|10|||
145408603|NCT03881371|524351875|FG000|Overall Study|Discontinuation from Study|1|||
145408604|NCT03881371|524351876|FG001|Overall Study|Discontinuation from Study|0|||
145408605|NCT00933933|524351877|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
145408606|NCT00933933|524351878|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
145408607|NCT00933933|524351879|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
145408608|NCT00933933|524351877|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
145408609|NCT00933933|524351878|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
145408610|NCT00933933|524351879|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
145408611|NCT01995201|524351884|FG000|From Baseline Until Week 24|Adverse Event|4|||
145408612|NCT01995201|524351885|FG001|From Baseline Until Week 24|Adverse Event|15|||
145408613|NCT01995201|524351886|FG002|From Baseline Until Week 24|Adverse Event|0|||
145408614|NCT01995201|524351887|FG003|From Baseline Until Week 24|Adverse Event|0|||
145408615|NCT01995201|524351888|FG004|From Baseline Until Week 24|Adverse Event|0|||
145408616|NCT01995201|524351889|FG005|From Baseline Until Week 24|Adverse Event|0|||
145408617|NCT01995201|524351890|FG006|From Baseline Until Week 24|Adverse Event|0|||
145408618|NCT01995201|524351884|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408619|NCT01995201|524351885|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
145408620|NCT01995201|524351886|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408621|NCT01995201|524351887|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408622|NCT01995201|524351888|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408623|NCT01995201|524351889|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408624|NCT01995201|524351890|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
145408625|NCT01995201|524351884|FG000|From Baseline Until Week 24|Death|0|||
145408626|NCT01995201|524351885|FG001|From Baseline Until Week 24|Death|1|||
145408627|NCT01995201|524351886|FG002|From Baseline Until Week 24|Death|0|||
145408628|NCT01995201|524351887|FG003|From Baseline Until Week 24|Death|0|||
145408629|NCT01995201|524351888|FG004|From Baseline Until Week 24|Death|0|||
145236238|NCT00764478|523710181|FG001|Overall Study|Protocol Violation|1|||
145236239|NCT00764478|523710182|FG002|Overall Study|Protocol Violation|1|||
145236240|NCT03571256|523710183|FG000|Overall Study|Adverse Event|3|||
145236241|NCT03571256|523710184|FG001|Overall Study|Adverse Event|0|||
145236242|NCT03571256|523710185|FG002|Overall Study|Adverse Event|1|||
145236243|NCT03571256|523710183|FG000|Overall Study|Withdrawal by Subject|3|||
145236244|NCT03571256|523710184|FG001|Overall Study|Withdrawal by Subject|1|||
145236245|NCT03571256|523710185|FG002|Overall Study|Withdrawal by Subject|1|||
145236246|NCT03571256|523710183|FG000|Overall Study|Other than specified|0|||
145236247|NCT03571256|523710184|FG001|Overall Study|Other than specified|1|||
145236248|NCT03571256|523710185|FG002|Overall Study|Other than specified|1|||
145236249|NCT03571256|523710183|FG000|Overall Study|Protocol Violation|0|||
145236250|NCT03571256|523710184|FG001|Overall Study|Protocol Violation|1|||
145236251|NCT03571256|523710185|FG002|Overall Study|Protocol Violation|1|||
145236252|NCT03498287|523710192|FG000|Overall Study|Withdrawal by Subject|3|||
145236253|NCT03498287|523710193|FG001|Overall Study|Withdrawal by Subject|0|||
145236254|NCT03498287|523710192|FG000|Overall Study|Protocol Violation|0|||
145236255|NCT03498287|523710193|FG001|Overall Study|Protocol Violation|4|||
145236256|NCT03498287|523710192|FG000|Overall Study|Adverse Event|0|||
145236257|NCT03498287|523710193|FG001|Overall Study|Adverse Event|1|||
145236258|NCT01714817|523710194|FG000|Year 1 Period|Lack of Efficacy|11|||
145236259|NCT01714817|523710195|FG001|Year 1 Period|Lack of Efficacy|9|||
145236260|NCT01714817|523710194|FG000|Year 1 Period|Adverse Event|20|||
145236261|NCT01714817|523710195|FG001|Year 1 Period|Adverse Event|17|||
145236262|NCT01714817|523710194|FG000|Year 1 Period|Withdrawal by Subject|6|||
145236263|NCT01714817|523710195|FG001|Year 1 Period|Withdrawal by Subject|7|||
145236264|NCT01714817|523710194|FG000|Year 1 Period|Death|1|||
145236265|NCT01714817|523710195|FG001|Year 1 Period|Death|1|||
145236266|NCT01714817|523710194|FG000|Year 1 Period|Lost to Follow-up|0|||
145236267|NCT01714817|523710195|FG001|Year 1 Period|Lost to Follow-up|2|||
145236268|NCT01714817|523710194|FG000|Year 1 Period|Poor / non-compliance|0|||
145236269|NCT01714817|523710195|FG001|Year 1 Period|Poor / non-compliance|1|||
145236270|NCT01714817|523710194|FG000|Year 1 Period|Pregnancy|2|||
145236271|NCT01714817|523710195|FG001|Year 1 Period|Pregnancy|0|||
145236272|NCT01714817|523710194|FG000|Year 1 Period|Participant no longer meets criteria|6|||
145236273|NCT01714817|523710195|FG001|Year 1 Period|Participant no longer meets criteria|2|||
145236274|NCT01714817|523710194|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
145236275|NCT01714817|523710195|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
145236276|NCT01714817|523710194|FG000|Year 1 Period|Change in Concomitant Medication|0|||
145236277|NCT01714817|523710195|FG001|Year 1 Period|Change in Concomitant Medication|1|||
145236278|NCT01714817|523710194|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
145236279|NCT01714817|523710195|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
145408630|NCT01995201|524351889|FG005|From Baseline Until Week 24|Death|0|||
145408631|NCT01995201|524351890|FG006|From Baseline Until Week 24|Death|0|||
145408632|NCT01995201|524351884|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
145236280|NCT01714817|523710194|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
145295499|NCT00365300|523932487|FG000|Double-blind Phase|Protocol Violation|3|||
145236281|NCT01714817|523710195|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
145236282|NCT01714817|523710194|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
145236283|NCT01714817|523710195|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
145236284|NCT01714817|523710194|FG000|Year 2 Period|Lack of Efficacy|4|||
145236285|NCT01714817|523710195|FG001|Year 2 Period|Lack of Efficacy|12|||
145236286|NCT01714817|523710194|FG000|Year 2 Period|Adverse Event|7|||
145236287|NCT01714817|523710195|FG001|Year 2 Period|Adverse Event|6|||
145236288|NCT01714817|523710194|FG000|Year 2 Period|Participant request to stop treatment|4|||
145236289|NCT01714817|523710195|FG001|Year 2 Period|Participant request to stop treatment|4|||
145236290|NCT01714817|523710194|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
145236291|NCT01714817|523710195|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
145236292|NCT01714817|523710194|FG000|Year 2 Period|Participant withdrew consent|1|||
145236293|NCT01714817|523710195|FG001|Year 2 Period|Participant withdrew consent|5|||
145236294|NCT01714817|523710194|FG000|Year 2 Period|Participant no longer meets criteria|1|||
145236295|NCT01714817|523710195|FG001|Year 2 Period|Participant no longer meets criteria|4|||
145236296|NCT01714817|523710194|FG000|Year 2 Period|Lost to Follow-up|2|||
145236297|NCT01714817|523710195|FG001|Year 2 Period|Lost to Follow-up|0|||
145236298|NCT01714817|523710194|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
145236299|NCT01714817|523710195|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
145236300|NCT01714817|523710194|FG000|Year 2 Period|Pregnancy|1|||
145236301|NCT01714817|523710195|FG001|Year 2 Period|Pregnancy|1|||
145236302|NCT01714817|523710194|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
145236303|NCT01714817|523710195|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
145236304|NCT01714817|523710194|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
145236305|NCT01714817|523710195|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
145236306|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
145236307|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
145236308|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
145236309|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
145236310|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
145236311|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
145236312|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
145236313|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
145236314|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
145236315|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
145236316|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
145236317|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
145236318|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145236319|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
145236320|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
145236321|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
145236322|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
145236323|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
145236324|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
145236325|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
145236326|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
145236327|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
145236328|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
145236329|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
145236330|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
145236331|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
145236332|NCT01714817|523710194|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
145236333|NCT01714817|523710195|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
145236334|NCT01740388|523710198|FG000|Overall Study|Withdrawal by Subject|1|||
145236335|NCT01740388|523710199|FG001|Overall Study|Withdrawal by Subject|2|||
145236336|NCT01740388|523710198|FG000|Overall Study|Lost to Follow-up|2|||
145236337|NCT01740388|523710199|FG001|Overall Study|Lost to Follow-up|0|||
145295500|NCT00365300|523932488|FG001|Double-blind Phase|Protocol Violation|1|||
145295501|NCT00365300|523932487|FG000|Double-blind Phase|Lack of Efficacy|6|||
145295502|NCT00365300|523932488|FG001|Double-blind Phase|Lack of Efficacy|6|||
145295503|NCT01991470|523932489|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
145236338|NCT01740388|523710198|FG000|Overall Study|Physician Decision|2|||
145236339|NCT01740388|523710199|FG001|Overall Study|Physician Decision|6|||
145236340|NCT01740388|523710198|FG000|Overall Study|Subjects missing data, completed|41|||
145236341|NCT01740388|523710199|FG001|Overall Study|Subjects missing data, completed|36|||
145236342|NCT04142216|523710200|FG000|Overall Study|Hospitalization|0|||
145236343|NCT04142216|523710201|FG001|Overall Study|Hospitalization|2|||
145295504|NCT01991470|523932489|FG000|Enlite 1 Period|Adverse Event|1|||
145295505|NCT01991470|523932489|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
145295506|NCT01991470|523932489|FG000|Enlite 3 Period|Lost to Follow-up|1|||
145295507|NCT01991470|523932489|FG000|Enlite 3 Period|Physician Decision|2|||
145295508|NCT01991470|523932489|FG000|Enlite 3 Period|Physician Decision|8|||
145562507|NCT01541969|524920054|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
145562508|NCT01541969|524920053|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
145562509|NCT01541969|524920054|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
145562510|NCT01541969|524920053|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
145562511|NCT01541969|524920054|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
145562512|NCT01541969|524920053|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
145562513|NCT01541969|524920054|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
145562514|NCT01541969|524920053|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
145562515|NCT01541969|524920054|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
145562516|NCT01541969|524920053|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
145562517|NCT01541969|524920054|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
145562518|NCT01541969|524920053|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
145562519|NCT01541969|524920054|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
145562520|NCT03265249|524920057|FG000|Overall Study|Withdrawal by Subject|0|||
145562521|NCT03265249|524920058|FG001|Overall Study|Withdrawal by Subject|1|||
145562522|NCT01614990|524920059|FG000|Overall Study|Protocol Violation|1|||
145562523|NCT01614990|524920060|FG001|Overall Study|Protocol Violation|1|||
145562524|NCT02255500|524920067|FG000|Overall Study|Withdrawal by Subject|1|||
145562525|NCT02255500|524920068|FG001|Overall Study|Withdrawal by Subject|0|||
145562526|NCT04765358|524920069|FG000|Overall Study|Withdrawal by Subject|1|||
145562527|NCT03406858|524920071|FG000|Overall Study|Failure to receive treatment drug.|1|||
145562528|NCT03406858|524920071|FG000|Overall Study|ineligible|1|||
145562529|NCT00405587|524920072|FG000|Overall Study|Death|0|||
145236344|NCT04142216|523710200|FG000|Overall Study|Death|3|||
145236345|NCT04142216|523710201|FG001|Overall Study|Death|1|||
145236346|NCT04142216|523710200|FG000|Overall Study|Referral to another hemodialysis unit|3|||
145236347|NCT04142216|523710201|FG001|Overall Study|Referral to another hemodialysis unit|2|||
145236348|NCT04142216|523710200|FG000|Overall Study|Use of clove|0|||
145236349|NCT04142216|523710201|FG001|Overall Study|Use of clove|1|||
145236350|NCT01641991|523710202|FG000|Overall Study|Physician Decision|0|||
145236351|NCT01641991|523710203|FG001|Overall Study|Physician Decision|1|||
145236352|NCT01641991|523710204|FG002|Overall Study|Physician Decision|7|||
145236353|NCT01641991|523710205|FG003|Overall Study|Physician Decision|5|||
145236354|NCT01641991|523710202|FG000|Overall Study|Withdrawal by Subject|4|||
145236355|NCT01641991|523710203|FG001|Overall Study|Withdrawal by Subject|2|||
145236356|NCT01641991|523710204|FG002|Overall Study|Withdrawal by Subject|1|||
145236357|NCT01641991|523710205|FG003|Overall Study|Withdrawal by Subject|5|||
145236358|NCT01641991|523710202|FG000|Overall Study|Adverse Event|2|||
145236359|NCT01641991|523710203|FG001|Overall Study|Adverse Event|1|||
145236360|NCT01641991|523710204|FG002|Overall Study|Adverse Event|2|||
145236361|NCT01641991|523710205|FG003|Overall Study|Adverse Event|1|||
145236362|NCT01641991|523710202|FG000|Overall Study|Lost to Follow-up|0|||
145236363|NCT01641991|523710203|FG001|Overall Study|Lost to Follow-up|2|||
145236364|NCT01641991|523710204|FG002|Overall Study|Lost to Follow-up|3|||
145562530|NCT00405587|524920073|FG001|Overall Study|Death|0|||
145562531|NCT00405587|524920074|FG002|Overall Study|Death|0|||
145562532|NCT00405587|524920075|FG003|Overall Study|Death|1|||
145562533|NCT00405587|524920072|FG000|Overall Study|Disease Progression|22|||
145562534|NCT00405587|524920073|FG001|Overall Study|Disease Progression|23|||
145562535|NCT00405587|524920074|FG002|Overall Study|Disease Progression|21|||
145562536|NCT00405587|524920075|FG003|Overall Study|Disease Progression|17|||
145562537|NCT00405587|524920072|FG000|Overall Study|Physician Decision|3|||
145562538|NCT00405587|524920073|FG001|Overall Study|Physician Decision|2|||
145236365|NCT01641991|523710205|FG003|Overall Study|Lost to Follow-up|1|||
145236366|NCT01641991|523710202|FG000|Overall Study|Protocol Violation|1|||
145236367|NCT01641991|523710203|FG001|Overall Study|Protocol Violation|1|||
145236368|NCT01641991|523710204|FG002|Overall Study|Protocol Violation|3|||
145236369|NCT01641991|523710205|FG003|Overall Study|Protocol Violation|0|||
145295509|NCT01991470|523932489|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
145562539|NCT00405587|524920074|FG002|Overall Study|Physician Decision|0|||
145562540|NCT00405587|524920075|FG003|Overall Study|Physician Decision|0|||
145562541|NCT00405587|524920072|FG000|Overall Study|Adverse Event|1|||
145562542|NCT00405587|524920073|FG001|Overall Study|Adverse Event|0|||
145562543|NCT00405587|524920074|FG002|Overall Study|Adverse Event|0|||
145562544|NCT00405587|524920075|FG003|Overall Study|Adverse Event|0|||
145562545|NCT00405587|524920072|FG000|Overall Study|Lost to Follow-up|0|||
145562546|NCT00405587|524920073|FG001|Overall Study|Lost to Follow-up|1|||
145562547|NCT00405587|524920074|FG002|Overall Study|Lost to Follow-up|1|||
145236370|NCT01641991|523710202|FG000|Overall Study|Pregnancy|0|||
145236371|NCT01641991|523710203|FG001|Overall Study|Pregnancy|0|||
145236372|NCT01641991|523710204|FG002|Overall Study|Pregnancy|1|||
145295510|NCT02896361|523932506|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
145236373|NCT01641991|523710205|FG003|Overall Study|Pregnancy|0|||
145236374|NCT01641991|523710202|FG000|Overall Study|no longer eligible|2|||
145236375|NCT01641991|523710203|FG001|Overall Study|no longer eligible|1|||
145236376|NCT01641991|523710204|FG002|Overall Study|no longer eligible|0|||
145236377|NCT01641991|523710205|FG003|Overall Study|no longer eligible|4|||
145236378|NCT02555657|523710206|FG000|Overall Study|Death|274|||
145236379|NCT02555657|523710207|FG001|Overall Study|Death|262|||
145236380|NCT02555657|523710206|FG000|Overall Study|Physician Decision|0|||
145236381|NCT02555657|523710207|FG001|Overall Study|Physician Decision|1|||
145236382|NCT02555657|523710206|FG000|Overall Study|Sponsor Decision|27|||
145236383|NCT02555657|523710207|FG001|Overall Study|Sponsor Decision|15|||
145236384|NCT02555657|523710206|FG000|Overall Study|Withdrawal by Subject|11|||
145236385|NCT02555657|523710207|FG001|Overall Study|Withdrawal by Subject|32|||
145236386|NCT00599027|523710213|FG000|Overall Study|Withdrawal by Subject|1|||
145236387|NCT00599027|523710214|FG001|Overall Study|Withdrawal by Subject|1|||
145236388|NCT00599027|523710213|FG000|Overall Study|Adverse Event|0|||
145236389|NCT00599027|523710214|FG001|Overall Study|Adverse Event|1|||
145236390|NCT00599027|523710213|FG000|Overall Study|Treatment Failure|0|||
145236391|NCT00599027|523710214|FG001|Overall Study|Treatment Failure|1|||
145236392|NCT00475540|523710215|FG000|36 Months|Lost to Follow-up|4|||
145236393|NCT00475540|523710216|FG001|36 Months|Lost to Follow-up|4|||
145236394|NCT00475540|523710215|FG000|36 Months|Death|1|||
145236395|NCT00475540|523710216|FG001|36 Months|Death|2|||
145236396|NCT00475540|523710215|FG000|36 Months|Censored due to reoperation|3|||
145236397|NCT00475540|523710216|FG001|36 Months|Censored due to reoperation|0|||
145236398|NCT02133742|523710231|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
145236399|NCT02133742|523710231|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
145236400|NCT02133742|523710231|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
145236401|NCT02133742|523710231|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
145236402|NCT02133742|523710231|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
145236403|NCT03479216|523710232|FG000|Overall Study|Withdrawal by Subject|3|||
145236404|NCT03479216|523710233|FG001|Overall Study|Withdrawal by Subject|2|||
145236405|NCT03479216|523710232|FG000|Overall Study|Physician Decision|2|||
145236406|NCT03479216|523710233|FG001|Overall Study|Physician Decision|3|||
145236407|NCT02031432|523710234|FG000|Overall Study|Protocol Violation|1|||
145236408|NCT02031432|523710234|FG000|Overall Study|Lack of Efficacy|5|||
145236409|NCT02031432|523710234|FG000|Overall Study|Cancer Progression|2|||
145236410|NCT02031432|523710234|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
145236411|NCT02031432|523710234|FG000|Overall Study|Adverse Event|8|||
145236412|NCT02031432|523710234|FG000|Overall Study|Withdrawal by Subject|5|||
145236413|NCT02031432|523710234|FG000|Overall Study|Lost to Follow-up|1|||
145236414|NCT02031432|523710234|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
145236415|NCT02031432|523710234|FG000|Overall Study|Death|10|||
145236416|NCT01181778|523710235|FG000|Overall Study|Physician Decision|48|||
145236417|NCT02148211|523710236|FG000|Overall Study|Lost to Follow-up|352|||
145236418|NCT02726113|523710237|FG000|Total Enrollment|Physician Decision|0|||
145236419|NCT02726113|523710238|FG001|Total Enrollment|Physician Decision|1|||
145236420|NCT02726113|523710237|FG000|Total Enrollment|Protocol Violation|1|||
145236421|NCT02726113|523710238|FG001|Total Enrollment|Protocol Violation|0|||
145236422|NCT02726113|523710237|FG000|Total Enrollment|Withdrawal by Subject|2|||
145236423|NCT02726113|523710238|FG001|Total Enrollment|Withdrawal by Subject|1|||
145236424|NCT02726113|523710237|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
145236425|NCT02726113|523710238|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
145236426|NCT02726113|523710237|FG000|Genomic Analysis|Protocol Violation|1|||
145236427|NCT02726113|523710238|FG001|Genomic Analysis|Protocol Violation|0|||
145236428|NCT02726113|523710237|FG000|Genomic Analysis|Withdrawal by Subject|2|||
145562548|NCT00405587|524920075|FG003|Overall Study|Lost to Follow-up|0|||
145562549|NCT00405587|524920072|FG000|Overall Study|Radiation induced necrosis|0|||
145562550|NCT00405587|524920073|FG001|Overall Study|Radiation induced necrosis|1|||
145236429|NCT02726113|523710238|FG001|Genomic Analysis|Withdrawal by Subject|1|||
145236430|NCT02726113|523710237|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
145236431|NCT02726113|523710238|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
145236432|NCT01617187|523710240|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
145236433|NCT01617187|523710241|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
145236434|NCT01617187|523710242|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
145236435|NCT01617187|523710243|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
145236436|NCT01617187|523710240|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
145236437|NCT01617187|523710241|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
145295511|NCT02896361|523932507|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
145295512|NCT02896361|523932508|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
145562551|NCT00405587|524920074|FG002|Overall Study|Radiation induced necrosis|0|||
145236438|NCT01617187|523710242|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
145295513|NCT02896361|523932506|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
145562552|NCT00405587|524920075|FG003|Overall Study|Radiation induced necrosis|0|||
145236439|NCT01617187|523710243|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
145236440|NCT01617187|523710240|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
145236441|NCT01617187|523710241|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
145236442|NCT01617187|523710242|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
145236443|NCT01617187|523710243|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
145236444|NCT01617187|523710240|FG000|Treatment Through Study Completion|Adverse Event|1|||
145236445|NCT01617187|523710241|FG001|Treatment Through Study Completion|Adverse Event|1|||
145236446|NCT01617187|523710242|FG002|Treatment Through Study Completion|Adverse Event|0|||
145236447|NCT01617187|523710243|FG003|Treatment Through Study Completion|Adverse Event|1|||
145236448|NCT01617187|523710240|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
145236449|NCT01617187|523710241|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
145236450|NCT01617187|523710242|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
145236451|NCT01617187|523710243|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
145236452|NCT01617187|523710240|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
145236453|NCT01617187|523710241|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
145236454|NCT01617187|523710242|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
145236455|NCT01617187|523710243|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
145236456|NCT01617187|523710240|FG000|Treatment Through Study Completion|Protocol Violation|1|||
145236457|NCT01617187|523710241|FG001|Treatment Through Study Completion|Protocol Violation|0|||
145236458|NCT01617187|523710242|FG002|Treatment Through Study Completion|Protocol Violation|0|||
145236459|NCT01617187|523710243|FG003|Treatment Through Study Completion|Protocol Violation|1|||
145236460|NCT01265420|523710244|FG000|Overall Study|Lost to Follow-up|1|||
145236461|NCT02554253|523710249|FG000|Overall Study|ineligible after enrollment|1|||
145236462|NCT02554253|523710250|FG001|Overall Study|ineligible after enrollment|0|||
145236463|NCT02554253|523710249|FG000|Overall Study|converted to transcatheter procedure|0|||
145236464|NCT02554253|523710250|FG001|Overall Study|converted to transcatheter procedure|1|||
145236465|NCT02554253|523710249|FG000|Overall Study|received both drugs|0|||
145236466|NCT02554253|523710250|FG001|Overall Study|received both drugs|1|||
145236467|NCT01736254|523710254|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
145236468|NCT01736254|523710254|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
145236469|NCT01561560|523710255|FG000|First Two Weeks of Wear|Time/job conflict|0|||
145236470|NCT01561560|523710256|FG001|First Two Weeks of Wear|Time/job conflict|1|||
145236471|NCT01561560|523710255|FG000|First Two Weeks of Wear|Adverse Event|0|||
145236472|NCT01561560|523710256|FG001|First Two Weeks of Wear|Adverse Event|1|||
145236473|NCT01561560|523710255|FG000|Second Two Weeks of Wear|Adverse Event|0|||
145236474|NCT01561560|523710256|FG001|Second Two Weeks of Wear|Adverse Event|1|||
145236475|NCT03862131|523710257|FG000|Overall Study|Lost to Follow-up|1|||
145236476|NCT03862131|523710258|FG001|Overall Study|Lost to Follow-up|0|||
145236477|NCT03862131|523710259|FG002|Overall Study|Lost to Follow-up|1|||
145236478|NCT03862131|523710257|FG000|Overall Study|Determined to be ineligible|0|||
145236479|NCT03862131|523710258|FG001|Overall Study|Determined to be ineligible|0|||
145236480|NCT03862131|523710259|FG002|Overall Study|Determined to be ineligible|5|||
145236481|NCT03862131|523710257|FG000|Overall Study|Death|4|||
145236482|NCT03862131|523710258|FG001|Overall Study|Death|4|||
145236483|NCT03862131|523710259|FG002|Overall Study|Death|0|||
145236484|NCT03862131|523710257|FG000|Overall Study|Withdrawal by Subject|5|||
145236485|NCT03862131|523710258|FG001|Overall Study|Withdrawal by Subject|3|||
145236486|NCT03862131|523710259|FG002|Overall Study|Withdrawal by Subject|0|||
145236487|NCT03862131|523710257|FG000|Overall Study|Physician Decision|0|||
145236488|NCT03862131|523710258|FG001|Overall Study|Physician Decision|1|||
145236489|NCT03862131|523710259|FG002|Overall Study|Physician Decision|0|||
145236490|NCT00859573|523712259|FG000|Overall Study|Withdrawal by Subject|4|||
145236491|NCT00859573|523712260|FG001|Overall Study|Withdrawal by Subject|1|||
145236492|NCT00859573|523712259|FG000|Overall Study|Physician Decision|1|||
145562553|NCT00405587|524920072|FG000|Overall Study|Withdrawal by Subject|0|||
145562554|NCT00405587|524920073|FG001|Overall Study|Withdrawal by Subject|0|||
145562555|NCT00405587|524920074|FG002|Overall Study|Withdrawal by Subject|0|||
145562556|NCT00405587|524920075|FG003|Overall Study|Withdrawal by Subject|2|||
145562557|NCT00405587|524920072|FG000|Overall Study|Participant not dosed|0|||
145562558|NCT00405587|524920073|FG001|Overall Study|Participant not dosed|1|||
145236493|NCT00859573|523712260|FG001|Overall Study|Physician Decision|1|||
145236494|NCT03488238|523712261|FG000|Overall Study|Equipment malfunction|1|||
145236495|NCT03488238|523712261|FG000|Overall Study|Adverse Event|1|||
145236496|NCT01316939|523712262|FG000|Overall Study|Study closed/terminated|26|||
145562559|NCT00405587|524920074|FG002|Overall Study|Participant not dosed|0|||
145236497|NCT01316939|523712263|FG001|Overall Study|Study closed/terminated|25|||
145236498|NCT01316939|523712264|FG002|Overall Study|Study closed/terminated|23|||
145236499|NCT01316939|523712262|FG000|Overall Study|Lack of Efficacy|24|||
145562560|NCT00405587|524920075|FG003|Overall Study|Participant not dosed|0|||
145562561|NCT02419742|524920076|FG000|Overall Study|Adverse Event|2|||
145236500|NCT01316939|523712263|FG001|Overall Study|Lack of Efficacy|25|||
145236501|NCT01316939|523712264|FG002|Overall Study|Lack of Efficacy|25|||
145562562|NCT02419742|524920077|FG001|Overall Study|Adverse Event|0|||
145236502|NCT01316939|523712262|FG000|Overall Study|Adverse Event|9|||
145236503|NCT01316939|523712263|FG001|Overall Study|Adverse Event|12|||
145236504|NCT01316939|523712264|FG002|Overall Study|Adverse Event|11|||
145236505|NCT01316939|523712262|FG000|Overall Study|Withdrawal by Subject|1|||
145236506|NCT01316939|523712263|FG001|Overall Study|Withdrawal by Subject|3|||
145236507|NCT01316939|523712264|FG002|Overall Study|Withdrawal by Subject|6|||
145236508|NCT01316939|523712262|FG000|Overall Study|Physician Decision|2|||
145236509|NCT01316939|523712263|FG001|Overall Study|Physician Decision|2|||
145236510|NCT01316939|523712264|FG002|Overall Study|Physician Decision|1|||
145236511|NCT01316939|523712262|FG000|Overall Study|Lost to Follow-up|0|||
145236512|NCT01316939|523712263|FG001|Overall Study|Lost to Follow-up|0|||
145236513|NCT01316939|523712264|FG002|Overall Study|Lost to Follow-up|2|||
145236514|NCT01316939|523712262|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
145236515|NCT01316939|523712263|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
145236516|NCT01316939|523712264|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
145236517|NCT01316939|523712262|FG000|Overall Study|Protocol Violation|0|||
145236518|NCT01316939|523712263|FG001|Overall Study|Protocol Violation|1|||
145236519|NCT01316939|523712264|FG002|Overall Study|Protocol Violation|0|||
145236520|NCT01432457|523712265|FG000|Overall Study|Adverse Event|7|||
145236521|NCT01432457|523712266|FG001|Overall Study|Adverse Event|10|||
145236522|NCT01432457|523712267|FG002|Overall Study|Adverse Event|16|||
145236523|NCT01432457|523712265|FG000|Overall Study|Lack of Efficacy|2|||
145236524|NCT01432457|523712266|FG001|Overall Study|Lack of Efficacy|1|||
145236525|NCT01432457|523712267|FG002|Overall Study|Lack of Efficacy|1|||
145236526|NCT01432457|523712265|FG000|Overall Study|Lost to Follow-up|11|||
145236527|NCT01432457|523712266|FG001|Overall Study|Lost to Follow-up|15|||
145236528|NCT01432457|523712267|FG002|Overall Study|Lost to Follow-up|20|||
145236529|NCT01432457|523712265|FG000|Overall Study|Protocol Violation|3|||
145236530|NCT01432457|523712266|FG001|Overall Study|Protocol Violation|2|||
145236531|NCT01432457|523712267|FG002|Overall Study|Protocol Violation|6|||
145236532|NCT01432457|523712265|FG000|Overall Study|Withdrawal by Subject|6|||
145236533|NCT01432457|523712266|FG001|Overall Study|Withdrawal by Subject|11|||
145236534|NCT01432457|523712267|FG002|Overall Study|Withdrawal by Subject|9|||
145236535|NCT01432457|523712265|FG000|Overall Study|Reasons not defined|2|||
145236536|NCT01432457|523712266|FG001|Overall Study|Reasons not defined|3|||
145236537|NCT01432457|523712267|FG002|Overall Study|Reasons not defined|4|||
145295514|NCT02896361|523932507|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
145295515|NCT02896361|523932508|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
145295516|NCT03164772|523932509|FG000|Overall Study|Death|4|||
145295517|NCT03164772|523932510|FG001|Overall Study|Death|2|||
145295518|NCT03164772|523932509|FG000|Overall Study|Adverse Event|1|||
145295519|NCT03164772|523932510|FG001|Overall Study|Adverse Event|4|||
145295520|NCT03164772|523932509|FG000|Overall Study|Progressive Disease|11|||
145295521|NCT03164772|523932510|FG001|Overall Study|Progressive Disease|21|||
145295522|NCT03164772|523932509|FG000|Overall Study|Physician Decision|2|||
145295523|NCT03164772|523932510|FG001|Overall Study|Physician Decision|0|||
145295524|NCT03164772|523932509|FG000|Overall Study|Withdrawal by Subject|0|||
145295525|NCT03164772|523932510|FG001|Overall Study|Withdrawal by Subject|4|||
145295526|NCT01029353|523932512|FG000|Overall Study|Lost to Follow-up|4|||
145295527|NCT01029353|523932513|FG001|Overall Study|Lost to Follow-up|5|||
145295528|NCT01029353|523932514|FG002|Overall Study|Lost to Follow-up|5|||
145295529|NCT01029353|523932515|FG003|Overall Study|Lost to Follow-up|4|||
145236538|NCT01432457|523712265|FG000|Overall Study|Did not take study drug|6|||
145236539|NCT01432457|523712266|FG001|Overall Study|Did not take study drug|6|||
145236540|NCT01432457|523712267|FG002|Overall Study|Did not take study drug|3|||
145236541|NCT05905601|523712269|FG000|Overall Study|Lost to Follow-up|1|||
145236542|NCT05905601|523712270|FG001|Overall Study|Lost to Follow-up|3|||
145236543|NCT03583606|523712271|FG000|Overall Study|Lost to Follow-up|0|||
145236544|NCT03583606|523712272|FG001|Overall Study|Lost to Follow-up|1|||
145236545|NCT03583606|523712273|FG002|Overall Study|Lost to Follow-up|0|||
145236546|NCT03583606|523712271|FG000|Overall Study|Ineligible at baseline|1|||
145236547|NCT03583606|523712272|FG001|Overall Study|Ineligible at baseline|0|||
145236548|NCT03583606|523712273|FG002|Overall Study|Ineligible at baseline|0|||
145236549|NCT00793182|523712278|FG000|Overall Study|Adverse Event|0|||
145236550|NCT00793182|523712279|FG001|Overall Study|Adverse Event|1|||
145236551|NCT00851253|523712280|FG000|Overall Study|Disease Progression|1|||
145295530|NCT01029353|523932512|FG000|Overall Study|Consent Withdrawn|2|||
145295531|NCT01029353|523932513|FG001|Overall Study|Consent Withdrawn|0|||
145562563|NCT02419742|524920076|FG000|Overall Study|Disease Progression|0|||
145236552|NCT00851253|523712281|FG001|Overall Study|Disease Progression|0|||
145236553|NCT01779648|523712282|FG000|Overall Study|Protocol Violation|1|||
145236554|NCT01779648|523712283|FG001|Overall Study|Protocol Violation|0|||
145236555|NCT00367341|523712286|FG000|Overall Study|Physician Decision|1|||
145236556|NCT00367341|523712287|FG001|Overall Study|Physician Decision|0|||
145295532|NCT01029353|523932514|FG002|Overall Study|Consent Withdrawn|0|||
145295533|NCT01029353|523932515|FG003|Overall Study|Consent Withdrawn|0|||
145295534|NCT01029353|523932512|FG000|Overall Study|Primary Outcome Indeterminate|1|||
145295535|NCT01029353|523932513|FG001|Overall Study|Primary Outcome Indeterminate|3|||
145236557|NCT00367341|523712286|FG000|Overall Study|Protocol Violation|1|||
145236558|NCT00367341|523712287|FG001|Overall Study|Protocol Violation|0|||
145236559|NCT02119026|523712290|FG000|1st-line Treatment|Adverse Event|9|||
145236560|NCT02119026|523712291|FG001|1st-line Treatment|Adverse Event|14|||
145236561|NCT02119026|523712290|FG000|1st-line Treatment|Physician Decision|3|||
145236562|NCT02119026|523712291|FG001|1st-line Treatment|Physician Decision|8|||
145236563|NCT02119026|523712290|FG000|1st-line Treatment|Withdrawal by Subject|4|||
145236564|NCT02119026|523712291|FG001|1st-line Treatment|Withdrawal by Subject|10|||
145236565|NCT02119026|523712290|FG000|1st-line Treatment|Patient condition or compliance|6|||
145236566|NCT02119026|523712291|FG001|1st-line Treatment|Patient condition or compliance|4|||
145236567|NCT02119026|523712290|FG000|1st-line Treatment|Surgery of metastases|2|||
145236568|NCT02119026|523712291|FG001|1st-line Treatment|Surgery of metastases|1|||
145236569|NCT02119026|523712290|FG000|1st-line Treatment|Death|2|||
145236570|NCT02119026|523712291|FG001|1st-line Treatment|Death|1|||
145236571|NCT02119026|523712290|FG000|2nd-line Treatment|Lost to Follow-up|2|||
145236572|NCT02119026|523712291|FG001|2nd-line Treatment|Lost to Follow-up|0|||
145236573|NCT02119026|523712290|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
145236574|NCT02119026|523712291|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
145236575|NCT02119026|523712290|FG000|2nd-line Treatment|Adverse Event|4|||
145236576|NCT02119026|523712291|FG001|2nd-line Treatment|Adverse Event|1|||
145236577|NCT01373918|523712292|FG000|Overall Study|Physician Decision|0|||
145236578|NCT01373918|523712293|FG001|Overall Study|Physician Decision|1|||
145236579|NCT00340834|523712294|FG000|Core Phase of Study|Adverse Event|26|||
145236580|NCT00340834|523712295|FG001|Core Phase of Study|Adverse Event|9|||
145236581|NCT00340834|523712296|FG002|Core Phase of Study|Adverse Event|9|||
145236582|NCT00340834|523712297|FG003|Core Phase of Study|Adverse Event|0|||
145236583|NCT00340834|523712298|FG004|Core Phase of Study|Adverse Event|0|||
145236584|NCT00340834|523712294|FG000|Core Phase of Study|Withdrawal by Subject|11|||
145236585|NCT00340834|523712295|FG001|Core Phase of Study|Withdrawal by Subject|9|||
145236586|NCT00340834|523712296|FG002|Core Phase of Study|Withdrawal by Subject|16|||
145236587|NCT00340834|523712297|FG003|Core Phase of Study|Withdrawal by Subject|0|||
145236588|NCT00340834|523712298|FG004|Core Phase of Study|Withdrawal by Subject|0|||
145236589|NCT00340834|523712294|FG000|Core Phase of Study|Administrative Problems|6|||
145236590|NCT00340834|523712295|FG001|Core Phase of Study|Administrative Problems|2|||
145236591|NCT00340834|523712296|FG002|Core Phase of Study|Administrative Problems|7|||
145236592|NCT00340834|523712297|FG003|Core Phase of Study|Administrative Problems|0|||
145236593|NCT00340834|523712298|FG004|Core Phase of Study|Administrative Problems|0|||
145236594|NCT00340834|523712294|FG000|Core Phase of Study|Lack of Efficacy|3|||
145236595|NCT00340834|523712295|FG001|Core Phase of Study|Lack of Efficacy|3|||
145236596|NCT00340834|523712296|FG002|Core Phase of Study|Lack of Efficacy|7|||
145236597|NCT00340834|523712297|FG003|Core Phase of Study|Lack of Efficacy|0|||
145236598|NCT00340834|523712298|FG004|Core Phase of Study|Lack of Efficacy|0|||
145236599|NCT00340834|523712294|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
145236600|NCT00340834|523712295|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
145236601|NCT00340834|523712296|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
145236602|NCT00340834|523712297|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
145236603|NCT00340834|523712298|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
145236604|NCT00340834|523712294|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
145236605|NCT00340834|523712295|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
145236606|NCT00340834|523712296|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
145236607|NCT00340834|523712297|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
145236608|NCT00340834|523712298|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
145236609|NCT00340834|523712294|FG000|Core Phase of Study|Lost to Follow-up|1|||
145236610|NCT00340834|523712295|FG001|Core Phase of Study|Lost to Follow-up|1|||
145236611|NCT00340834|523712296|FG002|Core Phase of Study|Lost to Follow-up|4|||
145236612|NCT00340834|523712297|FG003|Core Phase of Study|Lost to Follow-up|0|||
145236613|NCT00340834|523712298|FG004|Core Phase of Study|Lost to Follow-up|0|||
145236614|NCT00340834|523712294|FG000|Core Phase of Study|Death|2|||
145236615|NCT00340834|523712295|FG001|Core Phase of Study|Death|0|||
145236616|NCT00340834|523712296|FG002|Core Phase of Study|Death|0|||
145236617|NCT00340834|523712297|FG003|Core Phase of Study|Death|0|||
145236618|NCT00340834|523712298|FG004|Core Phase of Study|Death|0|||
145236619|NCT00340834|523712294|FG000|Core Phase of Study|Protocol Violation|0|||
145236620|NCT00340834|523712295|FG001|Core Phase of Study|Protocol Violation|0|||
145236621|NCT00340834|523712296|FG002|Core Phase of Study|Protocol Violation|2|||
145236622|NCT00340834|523712297|FG003|Core Phase of Study|Protocol Violation|0|||
145236623|NCT00340834|523712298|FG004|Core Phase of Study|Protocol Violation|0|||
145236624|NCT00340834|523712294|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
145236625|NCT00340834|523712295|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
145236626|NCT00340834|523712296|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
145236627|NCT00340834|523712297|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
145236628|NCT00340834|523712298|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
145236629|NCT00340834|523712294|FG000|Extension Phase of Study|Subject withdrew consent|26|||
145236630|NCT00340834|523712295|FG001|Extension Phase of Study|Subject withdrew consent|31|||
145236631|NCT00340834|523712296|FG002|Extension Phase of Study|Subject withdrew consent|0|||
145236632|NCT00340834|523712297|FG003|Extension Phase of Study|Subject withdrew consent|12|||
145236633|NCT00340834|523712298|FG004|Extension Phase of Study|Subject withdrew consent|15|||
145236634|NCT00340834|523712294|FG000|Extension Phase of Study|Adverse Event|21|||
145236635|NCT00340834|523712295|FG001|Extension Phase of Study|Adverse Event|22|||
145236636|NCT00340834|523712296|FG002|Extension Phase of Study|Adverse Event|0|||
145236637|NCT00340834|523712297|FG003|Extension Phase of Study|Adverse Event|19|||
145236638|NCT00340834|523712298|FG004|Extension Phase of Study|Adverse Event|7|||
145236639|NCT00340834|523712294|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
145236640|NCT00340834|523712295|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
145236641|NCT00340834|523712296|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
145236642|NCT00340834|523712297|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
145236643|NCT00340834|523712298|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
145236644|NCT00340834|523712294|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
145236645|NCT00340834|523712295|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
145236646|NCT00340834|523712296|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
145236647|NCT00340834|523712297|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
145236648|NCT00340834|523712298|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
145236649|NCT00340834|523712294|FG000|Extension Phase of Study|Lost to Follow-up|1|||
145236650|NCT00340834|523712295|FG001|Extension Phase of Study|Lost to Follow-up|1|||
145236651|NCT00340834|523712296|FG002|Extension Phase of Study|Lost to Follow-up|0|||
145236652|NCT00340834|523712297|FG003|Extension Phase of Study|Lost to Follow-up|2|||
145236653|NCT00340834|523712298|FG004|Extension Phase of Study|Lost to Follow-up|3|||
145236654|NCT00340834|523712294|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
145236655|NCT00340834|523712295|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
145236656|NCT00340834|523712296|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
145236657|NCT00340834|523712297|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
145236658|NCT00340834|523712298|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
145236659|NCT00340834|523712294|FG000|Extension Phase of Study|Administrative problems|3|||
145236660|NCT00340834|523712295|FG001|Extension Phase of Study|Administrative problems|0|||
145236661|NCT00340834|523712296|FG002|Extension Phase of Study|Administrative problems|0|||
145236662|NCT00340834|523712297|FG003|Extension Phase of Study|Administrative problems|1|||
145236663|NCT00340834|523712298|FG004|Extension Phase of Study|Administrative problems|1|||
145236664|NCT00340834|523712294|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
145236665|NCT00340834|523712295|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
145236666|NCT00340834|523712296|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
145236667|NCT00340834|523712297|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
145236668|NCT00340834|523712298|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
145236669|NCT00340834|523712294|FG000|Extension Phase of Study|Protocol Violation|3|||
145236670|NCT00340834|523712295|FG001|Extension Phase of Study|Protocol Violation|0|||
145236671|NCT00340834|523712296|FG002|Extension Phase of Study|Protocol Violation|0|||
145236672|NCT00340834|523712297|FG003|Extension Phase of Study|Protocol Violation|0|||
145236673|NCT00340834|523712298|FG004|Extension Phase of Study|Protocol Violation|0|||
145236674|NCT00340834|523712294|FG000|Extension Phase of Study|Death|0|||
145236675|NCT00340834|523712295|FG001|Extension Phase of Study|Death|0|||
145236676|NCT00340834|523712296|FG002|Extension Phase of Study|Death|0|||
145236677|NCT00340834|523712297|FG003|Extension Phase of Study|Death|0|||
145236678|NCT00340834|523712298|FG004|Extension Phase of Study|Death|1|||
145236679|NCT00291499|523712299|FG000|Overall Study|Adverse Event|3|||
145236680|NCT00291499|523712300|FG001|Overall Study|Adverse Event|8|||
145236681|NCT00291499|523712299|FG000|Overall Study|Change to other therapy|2|||
145236682|NCT00291499|523712300|FG001|Overall Study|Change to other therapy|1|||
145236683|NCT00291499|523712299|FG000|Overall Study|Intercurrent illness|1|||
145236684|NCT00291499|523712300|FG001|Overall Study|Intercurrent illness|0|||
145236685|NCT00291499|523712299|FG000|Overall Study|Protocol Violation|2|||
145236686|NCT00291499|523712300|FG001|Overall Study|Protocol Violation|2|||
145236687|NCT00291499|523712299|FG000|Overall Study|Other reasons|1|||
145236688|NCT00291499|523712300|FG001|Overall Study|Other reasons|4|||
145236689|NCT02786836|523712303|FG000|Overall Study|Death|1|||
145236690|NCT02786836|523712303|FG000|Overall Study|Lack of Efficacy|2|||
145562564|NCT02419742|524920077|FG001|Overall Study|Disease Progression|1|||
145236691|NCT02786836|523712303|FG000|Overall Study|Protocol Violation|3|||
145236692|NCT02786836|523712303|FG000|Overall Study|Withdrawal by Subject|3|||
145236693|NCT02786836|523712303|FG000|Overall Study|Liver Transplantation|2|||
145236694|NCT02786836|523712303|FG000|Overall Study|Device or Pharmacy Issues|3|||
145236695|NCT01387074|523712306|FG000|Overall Study|Lost to Follow-up|7|||
145295536|NCT01029353|523932514|FG002|Overall Study|Primary Outcome Indeterminate|2|||
145295537|NCT01029353|523932515|FG003|Overall Study|Primary Outcome Indeterminate|0|||
145295538|NCT02932878|523932518|FG000|Overall Study|Due to Lab Results|2|||
145236696|NCT01387074|523712306|FG000|Overall Study|Lack of Efficacy|1|||
145236697|NCT01532570|523712316|FG000|Overall Study|Lack of Efficacy|1|||
145562565|NCT02419742|524920076|FG000|Overall Study|Withdrew Consent|2|||
145236698|NCT01532570|523712317|FG001|Overall Study|Lack of Efficacy|0|||
145236699|NCT01532570|523712318|FG002|Overall Study|Lack of Efficacy|0|||
145236700|NCT01532570|523712319|FG003|Overall Study|Lack of Efficacy|0|||
145236701|NCT01532570|523712316|FG000|Overall Study|Withdrawal by Subject|0|||
145236702|NCT01532570|523712317|FG001|Overall Study|Withdrawal by Subject|1|||
145236703|NCT01532570|523712318|FG002|Overall Study|Withdrawal by Subject|0|||
145236704|NCT01532570|523712319|FG003|Overall Study|Withdrawal by Subject|0|||
145236705|NCT03892707|523712322|FG000|Overall Study|Screen failure|6|||
145236706|NCT03892707|523712323|FG001|Overall Study|Screen failure|0|||
145236707|NCT03892707|523712322|FG000|Overall Study|Pain resolution|0|||
145236708|NCT03892707|523712323|FG001|Overall Study|Pain resolution|4|||
145236709|NCT03892707|523712322|FG000|Overall Study|Withdrawal by Subject|0|||
145236710|NCT03892707|523712323|FG001|Overall Study|Withdrawal by Subject|1|||
145236711|NCT03892707|523712322|FG000|Overall Study|Other (long business trip)|0|||
145236712|NCT03892707|523712323|FG001|Overall Study|Other (long business trip)|1|||
145236713|NCT05224076|523712327|FG000|Overall Study|Lost to Follow-up|24|||
145236714|NCT01807949|523712329|FG000|Overall Study|Adverse Event|1|||
145236715|NCT01807949|523712330|FG001|Overall Study|Adverse Event|2|||
145236716|NCT01807949|523712331|FG002|Overall Study|Adverse Event|2|||
145236717|NCT01807949|523712329|FG000|Overall Study|Withdrawal by Subject|1|||
145236718|NCT01807949|523712330|FG001|Overall Study|Withdrawal by Subject|2|||
145236719|NCT01807949|523712331|FG002|Overall Study|Withdrawal by Subject|2|||
145236720|NCT01807949|523712329|FG000|Overall Study|Non-Compliance|0|||
145236721|NCT01807949|523712330|FG001|Overall Study|Non-Compliance|0|||
145236722|NCT01807949|523712331|FG002|Overall Study|Non-Compliance|1|||
145236723|NCT01807949|523712329|FG000|Overall Study|Undefined|0|||
145295539|NCT02932878|523932519|FG001|Overall Study|Due to Lab Results|1|||
145295540|NCT00849901|523932520|FG000|Acute Treatment Phase|Adverse Event|9|||
145295541|NCT00849901|523932521|FG001|Acute Treatment Phase|Adverse Event|1|||
145295542|NCT00849901|523932522|FG002|Acute Treatment Phase|Adverse Event|3|||
145295543|NCT00849901|523932520|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
145295544|NCT00849901|523932521|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
145295545|NCT00849901|523932522|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
145295546|NCT00849901|523932520|FG000|Acute Treatment Phase|Protocol Violation|0|||
145295547|NCT00849901|523932521|FG001|Acute Treatment Phase|Protocol Violation|2|||
145295548|NCT00849901|523932522|FG002|Acute Treatment Phase|Protocol Violation|1|||
145295549|NCT00849901|523932520|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
145295550|NCT00849901|523932521|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
145295551|NCT00849901|523932522|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
145295552|NCT00849901|523932520|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
145295553|NCT00849901|523932521|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
145295554|NCT00849901|523932522|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
145295555|NCT00849901|523932520|FG000|Acute Treatment Phase|Physician Decision|1|||
145295556|NCT00849901|523932521|FG001|Acute Treatment Phase|Physician Decision|1|||
145295557|NCT00849901|523932522|FG002|Acute Treatment Phase|Physician Decision|1|||
145295558|NCT00849901|523932520|FG000|Acute Treatment Phase|Sponsor Decision|1|||
145295559|NCT00849901|523932521|FG001|Acute Treatment Phase|Sponsor Decision|0|||
145295560|NCT00849901|523932522|FG002|Acute Treatment Phase|Sponsor Decision|0|||
145295561|NCT00849901|523932520|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
145295562|NCT00849901|523932521|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
145295563|NCT00849901|523932522|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
145295564|NCT00849901|523932520|FG000|Extension Phase|Adverse Event|2|||
145295565|NCT00849901|523932521|FG001|Extension Phase|Adverse Event|8|||
145295566|NCT00849901|523932522|FG002|Extension Phase|Adverse Event|4|||
145295567|NCT00849901|523932520|FG000|Extension Phase|Lost to Follow-up|3|||
145295568|NCT00849901|523932521|FG001|Extension Phase|Lost to Follow-up|0|||
145295569|NCT00849901|523932522|FG002|Extension Phase|Lost to Follow-up|1|||
145295570|NCT00849901|523932520|FG000|Extension Phase|Protocol Violation|2|||
145295571|NCT00849901|523932521|FG001|Extension Phase|Protocol Violation|2|||
145295572|NCT00849901|523932522|FG002|Extension Phase|Protocol Violation|4|||
145295573|NCT00849901|523932520|FG000|Extension Phase|Withdrawal by Subject|7|||
145562566|NCT02419742|524920077|FG001|Overall Study|Withdrew Consent|1|||
145562567|NCT02419742|524920076|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
145619955|NCT01625338|525123640|FG002|Overall Study|Efficacy Failure|31|||
145236724|NCT01807949|523712330|FG001|Overall Study|Undefined|1|||
145236725|NCT01807949|523712331|FG002|Overall Study|Undefined|2|||
145236726|NCT01807949|523712329|FG000|Overall Study|Randomized But Not Treated|0|||
145236727|NCT01807949|523712330|FG001|Overall Study|Randomized But Not Treated|2|||
145236728|NCT01807949|523712331|FG002|Overall Study|Randomized But Not Treated|2|||
145236729|NCT04190186|523712332|FG000|Overall Study|ILR is no longer functioning|0|||
145295574|NCT00849901|523932521|FG001|Extension Phase|Withdrawal by Subject|6|||
145295575|NCT00849901|523932522|FG002|Extension Phase|Withdrawal by Subject|3|||
145236730|NCT04190186|523712333|FG001|Overall Study|ILR is no longer functioning|1|||
145295576|NCT00849901|523932520|FG000|Extension Phase|Parent or Caregiver Decision|10|||
145295577|NCT00849901|523932521|FG001|Extension Phase|Parent or Caregiver Decision|4|||
145236731|NCT04190186|523712332|FG000|Overall Study|Lost to Follow-up|0|||
145236732|NCT04190186|523712333|FG001|Overall Study|Lost to Follow-up|1|||
145236733|NCT04190186|523712332|FG000|Overall Study|Withdrawal by Subject|2|||
145236734|NCT04190186|523712333|FG001|Overall Study|Withdrawal by Subject|0|||
145236735|NCT04190186|523712332|FG000|Overall Study|Subject choice to explant|1|||
145236736|NCT04190186|523712333|FG001|Overall Study|Subject choice to explant|0|||
145236737|NCT04190186|523712332|FG000|Overall Study|Physician Decision|0|||
145236738|NCT04190186|523712333|FG001|Overall Study|Physician Decision|1|||
145236739|NCT04190186|523712332|FG000|Overall Study|Study was stopped|4|||
145236740|NCT04190186|523712333|FG001|Overall Study|Study was stopped|5|||
145236741|NCT01665768|523712334|FG000|Overall Study|Adverse Event|3|||
145236742|NCT01665768|523712334|FG000|Overall Study|Lack of Efficacy|19|||
145236743|NCT01665768|523712334|FG000|Overall Study|Withdrawal by Subject|1|||
145236744|NCT02151682|523712335|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
145236745|NCT02151682|523712336|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
145236746|NCT02151682|523712337|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
145236747|NCT02151682|523712338|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
145236748|NCT02151682|523712339|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
145236749|NCT02151682|523712340|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
145236750|NCT02151682|523712335|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
145236751|NCT02151682|523712336|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
145236752|NCT02151682|523712337|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
145236753|NCT02151682|523712338|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
145236754|NCT02151682|523712339|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
145236755|NCT02151682|523712340|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
145236756|NCT02151682|523712335|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
145236757|NCT02151682|523712336|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
145236758|NCT02151682|523712337|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
145236759|NCT02151682|523712338|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
145236760|NCT02151682|523712339|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
145236761|NCT02151682|523712340|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
145236762|NCT02151682|523712335|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
145236763|NCT02151682|523712336|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
145236764|NCT02151682|523712337|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
145236765|NCT02151682|523712338|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
145236766|NCT02151682|523712339|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
145236767|NCT02151682|523712340|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
145236768|NCT02151682|523712335|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
145236769|NCT02151682|523712336|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
145236770|NCT02151682|523712337|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
145236771|NCT02151682|523712338|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
145236772|NCT02151682|523712339|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
145236773|NCT02151682|523712340|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
145236774|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
145236775|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
145236776|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
145236777|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
145236778|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
145236779|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
145236780|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
145236781|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
145236782|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
145236783|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
145236784|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
145236785|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
145236786|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
145236787|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
145236788|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
145236789|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
145236790|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
145236791|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
145236792|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
145236793|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
145236794|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
145236795|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
145236796|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
145236797|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
145236798|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
145408633|NCT01995201|524351885|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
145408634|NCT01995201|524351886|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
145408635|NCT01995201|524351887|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
145408636|NCT01995201|524351888|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
145408637|NCT01995201|524351889|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
145408638|NCT01995201|524351890|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
145408639|NCT01995201|524351884|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
145408640|NCT01995201|524351885|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
145408641|NCT01995201|524351886|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
145408642|NCT01995201|524351887|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
145408643|NCT01995201|524351888|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
145236799|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
145236800|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
145236801|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
145236802|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
145236803|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
145236804|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
145236805|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
145236806|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
145236807|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
145236808|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
145236809|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
145236810|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
145236811|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
145236812|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
145236813|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
145236814|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
145236815|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
145236816|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
145236817|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
145236818|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
145236819|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
145236820|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
145236821|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
145236822|NCT02151682|523712335|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
145236823|NCT02151682|523712336|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
145236824|NCT02151682|523712337|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
145236825|NCT02151682|523712338|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
145236826|NCT02151682|523712339|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
145236827|NCT02151682|523712340|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
145236828|NCT02151682|523712335|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
145236829|NCT02151682|523712336|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
145236830|NCT02151682|523712337|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
145236831|NCT02151682|523712338|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
145236832|NCT02151682|523712339|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
145236833|NCT02151682|523712340|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
145236834|NCT02151682|523712335|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
145236835|NCT02151682|523712336|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
145236836|NCT02151682|523712337|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
145236837|NCT02151682|523712338|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
145236838|NCT02151682|523712339|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
145236839|NCT02151682|523712340|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
145236840|NCT02151682|523712335|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
145236841|NCT02151682|523712336|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
145236842|NCT02151682|523712337|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
145236843|NCT02151682|523712338|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
145236844|NCT02151682|523712339|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
145236845|NCT02151682|523712340|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
145236846|NCT02151682|523712335|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
145236847|NCT02151682|523712336|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
145236848|NCT02151682|523712337|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
145236849|NCT02151682|523712338|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
145236850|NCT02151682|523712339|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
145236851|NCT02151682|523712340|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
145408644|NCT01995201|524351889|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
145236852|NCT03260894|523712341|FG000|Overall Study|Death|6|||
145236853|NCT03260894|523712342|FG001|Overall Study|Death|8|||
145236854|NCT03260894|523712341|FG000|Overall Study|Withdrawal by Subject|4|||
145236855|NCT03260894|523712342|FG001|Overall Study|Withdrawal by Subject|11|||
145236856|NCT03260894|523712341|FG000|Overall Study|On-going at clinical cut off date|36|||
145236857|NCT03260894|523712342|FG001|Overall Study|On-going at clinical cut off date|31|||
145236858|NCT00290589|523712343|FG000|Overall Study|Lost to Follow-up|2|||
145236859|NCT00290589|523712344|FG001|Overall Study|Lost to Follow-up|2|||
145236860|NCT02378883|523712345|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
145236861|NCT02378883|523712345|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
145236862|NCT02378883|523712345|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
145236863|NCT02378883|523712345|FG000|30 Day Follow-Up|Physician Decision|2|||
145236864|NCT02378883|523712345|FG000|30 Day Follow-Up|Missed Visit|2|||
145236865|NCT02378883|523712345|FG000|30 Day Follow-Up|Death|1|||
145236866|NCT02378883|523712345|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
145236867|NCT02378883|523712345|FG000|12 Months Follow-Up|Death|2|||
145236868|NCT02677220|523712349|FG000|Overall Study|Adverse Event|1|||
145236869|NCT00050622|523712350|FG000|Overall Study|Adverse Event|1|||
145236870|NCT04581863|523712353|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
145236871|NCT04581863|523712354|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
145236872|NCT01170221|523712355|FG000|Overall Study|Lost to Follow-up|22|||
145236873|NCT01170221|523712356|FG001|Overall Study|Lost to Follow-up|21|||
145236874|NCT01170221|523712355|FG000|Overall Study|Withdrawal by Subject|9|||
145236875|NCT01170221|523712356|FG001|Overall Study|Withdrawal by Subject|7|||
145236876|NCT01170221|523712355|FG000|Overall Study|Subject completed only screening and LFU|1|||
145236877|NCT01170221|523712356|FG001|Overall Study|Subject completed only screening and LFU|0|||
145236878|NCT01170221|523712355|FG000|Overall Study|Randomized but not treated|1|||
145236879|NCT01170221|523712356|FG001|Overall Study|Randomized but not treated|0|||
145236880|NCT02693691|523712357|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
145236881|NCT02693691|523712357|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
145236882|NCT02693691|523712357|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
145236883|NCT02693691|523712357|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
145236884|NCT02693691|523712357|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
145236885|NCT02693691|523712357|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
145236886|NCT02693691|523712357|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
145236887|NCT00050960|523712359|FG000|Overall Study|Progressive Disease|137|||
145236888|NCT00050960|523712360|FG001|Overall Study|Progressive Disease|93|||
145236889|NCT00050960|523712359|FG000|Overall Study|Stable Disease|19|||
145236890|NCT00050960|523712360|FG001|Overall Study|Stable Disease|48|||
145236891|NCT00050960|523712359|FG000|Overall Study|Partial Response|14|||
145236892|NCT00050960|523712360|FG001|Overall Study|Partial Response|19|||
145236893|NCT00050960|523712359|FG000|Overall Study|Complete Response|0|||
145236894|NCT00050960|523712360|FG001|Overall Study|Complete Response|2|||
145236895|NCT00050960|523712359|FG000|Overall Study|Adverse Event|62|||
145236896|NCT00050960|523712360|FG001|Overall Study|Adverse Event|61|||
145236897|NCT00050960|523712359|FG000|Overall Study|Lost to Follow-up|0|||
145236898|NCT00050960|523712360|FG001|Overall Study|Lost to Follow-up|1|||
145236899|NCT00050960|523712359|FG000|Overall Study|Withdrawal by Subject|23|||
145236900|NCT00050960|523712360|FG001|Overall Study|Withdrawal by Subject|18|||
145236901|NCT00050960|523712359|FG000|Overall Study|Administrative|31|||
145236902|NCT00050960|523712360|FG001|Overall Study|Administrative|46|||
145236903|NCT00050960|523712359|FG000|Overall Study|Non-compliance|3|||
145236904|NCT00050960|523712360|FG001|Overall Study|Non-compliance|1|||
145236905|NCT00050960|523712359|FG000|Overall Study|Death|13|||
145236906|NCT00050960|523712360|FG001|Overall Study|Death|15|||
145236907|NCT02727660|523712361|FG000|Overall Study|Lack of Efficacy|40|||
145236908|NCT02727660|523712362|FG001|Overall Study|Lack of Efficacy|40|||
145236909|NCT02727660|523712363|FG002|Overall Study|Lack of Efficacy|70|||
145236910|NCT02727660|523712361|FG000|Overall Study|Adverse Event|28|||
145236911|NCT02727660|523712362|FG001|Overall Study|Adverse Event|21|||
145236912|NCT02727660|523712363|FG002|Overall Study|Adverse Event|32|||
145236913|NCT02727660|523712361|FG000|Overall Study|Withdrawal by Subject|26|||
145236914|NCT02727660|523712362|FG001|Overall Study|Withdrawal by Subject|25|||
145408645|NCT01995201|524351890|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
145408646|NCT01995201|524351884|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
145408647|NCT01995201|524351885|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
145236915|NCT02727660|523712363|FG002|Overall Study|Withdrawal by Subject|30|||
145408648|NCT01995201|524351886|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
145236916|NCT02727660|523712361|FG000|Overall Study|Physician Decision|3|||
145236917|NCT02727660|523712362|FG001|Overall Study|Physician Decision|8|||
145236918|NCT02727660|523712363|FG002|Overall Study|Physician Decision|14|||
145236919|NCT02727660|523712361|FG000|Overall Study|Lost to Follow-up|5|||
145236920|NCT02727660|523712362|FG001|Overall Study|Lost to Follow-up|9|||
145236921|NCT02727660|523712363|FG002|Overall Study|Lost to Follow-up|8|||
145236922|NCT02727660|523712361|FG000|Overall Study|Protocol Violation|7|||
145236923|NCT02727660|523712362|FG001|Overall Study|Protocol Violation|5|||
145236924|NCT02727660|523712363|FG002|Overall Study|Protocol Violation|5|||
145236925|NCT02727660|523712361|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
145236926|NCT02727660|523712362|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
145236927|NCT02727660|523712363|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
145236928|NCT02727660|523712361|FG000|Overall Study|Administrative Reasons|2|||
145236929|NCT02727660|523712362|FG001|Overall Study|Administrative Reasons|3|||
145236930|NCT02727660|523712363|FG002|Overall Study|Administrative Reasons|4|||
145236931|NCT00764946|523712369|FG000|Overall Study|Lack of Efficacy|1|||
145236932|NCT00764946|523712370|FG001|Overall Study|Lack of Efficacy|0|||
145236933|NCT00764946|523712371|FG002|Overall Study|Lack of Efficacy|0|||
145408649|NCT01995201|524351887|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
145408650|NCT01995201|524351888|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
145408651|NCT01995201|524351889|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
145408652|NCT01995201|524351890|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
145408653|NCT01995201|524351884|FG000|From Baseline Until Week 24|Physician Decision|0|||
145408654|NCT01995201|524351885|FG001|From Baseline Until Week 24|Physician Decision|2|||
145408655|NCT01995201|524351886|FG002|From Baseline Until Week 24|Physician Decision|0|||
145236934|NCT00764946|523712369|FG000|Overall Study|Lost to Follow-up|3|||
145236935|NCT00764946|523712370|FG001|Overall Study|Lost to Follow-up|4|||
145236936|NCT00764946|523712371|FG002|Overall Study|Lost to Follow-up|0|||
145236937|NCT00764946|523712369|FG000|Overall Study|Physician Decision|2|||
145236938|NCT00764946|523712370|FG001|Overall Study|Physician Decision|4|||
145236939|NCT00764946|523712371|FG002|Overall Study|Physician Decision|0|||
145236940|NCT00764946|523712369|FG000|Overall Study|Adverse Event|3|||
145236941|NCT00764946|523712370|FG001|Overall Study|Adverse Event|2|||
145236942|NCT00764946|523712371|FG002|Overall Study|Adverse Event|1|||
145236943|NCT00764946|523712369|FG000|Overall Study|Withdrawal by Subject|3|||
145408656|NCT01995201|524351887|FG003|From Baseline Until Week 24|Physician Decision|0|||
145408657|NCT01995201|524351888|FG004|From Baseline Until Week 24|Physician Decision|0|||
145408658|NCT01995201|524351889|FG005|From Baseline Until Week 24|Physician Decision|0|||
145408659|NCT01995201|524351890|FG006|From Baseline Until Week 24|Physician Decision|0|||
145408660|NCT01995201|524351884|FG000|From Baseline Until Week 24|Protocol Violation|0|||
145408661|NCT01995201|524351885|FG001|From Baseline Until Week 24|Protocol Violation|9|||
145408662|NCT01995201|524351886|FG002|From Baseline Until Week 24|Protocol Violation|0|||
145408663|NCT01995201|524351887|FG003|From Baseline Until Week 24|Protocol Violation|0|||
145408664|NCT01995201|524351888|FG004|From Baseline Until Week 24|Protocol Violation|0|||
145408665|NCT01995201|524351889|FG005|From Baseline Until Week 24|Protocol Violation|0|||
145408666|NCT01995201|524351890|FG006|From Baseline Until Week 24|Protocol Violation|0|||
145408667|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Adverse Event|0|||
145408668|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Adverse Event|0|||
145408669|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Adverse Event|2|||
145408670|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Adverse Event|1|||
145408671|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Adverse Event|1|||
145408672|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Adverse Event|3|||
145408673|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Adverse Event|1|||
145408674|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Death|0|||
145408675|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Death|0|||
145408676|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Death|0|||
145408677|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Death|0|||
145408678|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Death|0|||
145408679|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Death|2|||
145408680|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Death|0|||
145408681|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
145408682|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
145408683|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
145408684|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
145408685|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
145408686|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
145408687|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
145408688|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
145408689|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
145408690|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
145408691|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
145619956|NCT01625338|525123638|FG000|Overall Study|Lost to Follow-up|3|||
145236944|NCT00764946|523712370|FG001|Overall Study|Withdrawal by Subject|6|||
145236945|NCT00764946|523712371|FG002|Overall Study|Withdrawal by Subject|2|||
145236946|NCT00764946|523712369|FG000|Overall Study|Never Treated|1|||
145236947|NCT00764946|523712370|FG001|Overall Study|Never Treated|1|||
145236948|NCT00764946|523712371|FG002|Overall Study|Never Treated|1|||
145236949|NCT01162304|523712372|FG000|Overall Study|Beck scale to high|11|||
145236950|NCT03454412|523712373|FG000|Baseline Assesment|Physician Decision|12|||
145236951|NCT01167582|523712374|FG000|Overall Study|Lost to Follow-up|0|||
145236952|NCT01167582|523712375|FG001|Overall Study|Lost to Follow-up|1|||
145236953|NCT01928485|523712376|FG000|Overall Study|Physician Decision|0|||
145236954|NCT01928485|523712377|FG001|Overall Study|Physician Decision|1|||
145236955|NCT00039741|523712378|FG000|Overall Study|Death|0|||
145236956|NCT00039741|523712379|FG001|Overall Study|Death|1|||
145236957|NCT00039741|523712380|FG002|Overall Study|Death|0|||
145236958|NCT00039741|523712381|FG003|Overall Study|Death|0|||
145236959|NCT00039741|523712378|FG000|Overall Study|Lost to Follow-up|3|||
145236960|NCT00039741|523712379|FG001|Overall Study|Lost to Follow-up|1|||
145236961|NCT00039741|523712380|FG002|Overall Study|Lost to Follow-up|5|||
145236962|NCT00039741|523712381|FG003|Overall Study|Lost to Follow-up|2|||
145236963|NCT00039741|523712378|FG000|Overall Study|Confounding medical condition|1|||
145236964|NCT00039741|523712379|FG001|Overall Study|Confounding medical condition|0|||
145236965|NCT00039741|523712380|FG002|Overall Study|Confounding medical condition|0|||
145236966|NCT00039741|523712381|FG003|Overall Study|Confounding medical condition|0|||
145236967|NCT00039741|523712378|FG000|Overall Study|Not able to get to clinic|5|||
145236968|NCT00039741|523712379|FG001|Overall Study|Not able to get to clinic|2|||
145236969|NCT00039741|523712380|FG002|Overall Study|Not able to get to clinic|0|||
145236970|NCT00039741|523712381|FG003|Overall Study|Not able to get to clinic|3|||
145236971|NCT00039741|523712378|FG000|Overall Study|Moved|3|||
145236972|NCT00039741|523712379|FG001|Overall Study|Moved|2|||
145236973|NCT00039741|523712380|FG002|Overall Study|Moved|3|||
145236974|NCT00039741|523712381|FG003|Overall Study|Moved|6|||
145236975|NCT00039741|523712378|FG000|Overall Study|Non-compliance with protocol|1|||
145236976|NCT00039741|523712379|FG001|Overall Study|Non-compliance with protocol|0|||
145236977|NCT00039741|523712380|FG002|Overall Study|Non-compliance with protocol|1|||
145236978|NCT00039741|523712381|FG003|Overall Study|Non-compliance with protocol|0|||
145236979|NCT00039741|523712378|FG000|Overall Study|Withdrew consent|0|||
145236980|NCT00039741|523712379|FG001|Overall Study|Withdrew consent|5|||
145236981|NCT00039741|523712380|FG002|Overall Study|Withdrew consent|0|||
145236982|NCT00039741|523712381|FG003|Overall Study|Withdrew consent|1|||
145236983|NCT00039741|523712378|FG000|Overall Study|Missed final visit|2|||
145236984|NCT00039741|523712379|FG001|Overall Study|Missed final visit|1|||
145236985|NCT00039741|523712380|FG002|Overall Study|Missed final visit|2|||
145236986|NCT00039741|523712381|FG003|Overall Study|Missed final visit|2|||
145236987|NCT00946881|523712382|FG000|First Treatment|Withdrawal by Subject|1|||
145236988|NCT00946881|523712382|FG000|First Treatment|Patient relocated to another state|1|||
145236989|NCT00946881|523712382|FG000|Retreatment|Withdrawal by Subject|1|||
145236990|NCT00293423|523712383|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
145236991|NCT00293423|523712384|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
145236992|NCT00293423|523712383|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
145236993|NCT00293423|523712384|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
145236994|NCT00293423|523712383|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
145236995|NCT00293423|523712384|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
145236996|NCT00293423|523712383|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
145236997|NCT00293423|523712384|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
145236998|NCT00293423|523712383|FG000|Surgical Resection|processing error during surgical resection|1|||
145236999|NCT00293423|523712384|FG001|Surgical Resection|processing error during surgical resection|0|||
145237000|NCT00293423|523712383|FG000|Surgical Resection|Withdrawal by Subject|4|||
145237001|NCT00293423|523712384|FG001|Surgical Resection|Withdrawal by Subject|0|||
145237002|NCT00293423|523712383|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
145237003|NCT00293423|523712384|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
145237004|NCT00964158|523712385|FG000|Overall Study|Lost to Follow-up|0|||
145237005|NCT00964158|523712386|FG001|Overall Study|Lost to Follow-up|1|||
145237006|NCT00964158|523712387|FG002|Overall Study|Lost to Follow-up|2|||
145237007|NCT00964158|523712385|FG000|Overall Study|Withdrawal by Subject|0|||
145237008|NCT00964158|523712386|FG001|Overall Study|Withdrawal by Subject|0|||
145237009|NCT00964158|523712387|FG002|Overall Study|Withdrawal by Subject|6|||
145237010|NCT00507416|523712388|FG000|Overall Study|Adverse Event|58|||
145237011|NCT00507416|523712389|FG001|Overall Study|Adverse Event|67|||
145237012|NCT00507416|523712390|FG002|Overall Study|Adverse Event|65|||
145237013|NCT00507416|523712388|FG000|Overall Study|Protocol Violation|1|||
145237014|NCT00507416|523712389|FG001|Overall Study|Protocol Violation|2|||
145237015|NCT00507416|523712390|FG002|Overall Study|Protocol Violation|0|||
145237016|NCT00507416|523712388|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
145237017|NCT00507416|523712389|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
145237018|NCT00507416|523712390|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
145237019|NCT00507416|523712388|FG000|Overall Study|Progressive Disease|20|||
145237020|NCT00507416|523712389|FG001|Overall Study|Progressive Disease|10|||
145408692|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
145237021|NCT00507416|523712390|FG002|Overall Study|Progressive Disease|13|||
145237022|NCT00507416|523712388|FG000|Overall Study|Patient declined further treatment|18|||
145237023|NCT00507416|523712389|FG001|Overall Study|Patient declined further treatment|14|||
145237024|NCT00507416|523712390|FG002|Overall Study|Patient declined further treatment|11|||
145237025|NCT00507416|523712388|FG000|Overall Study|Other|11|||
145237026|NCT00507416|523712389|FG001|Overall Study|Other|16|||
145408693|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
145408694|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
145408695|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145408696|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145408697|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
145408698|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145408699|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
145408700|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145408701|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
145408702|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Physician Decision|0|||
145408703|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Physician Decision|0|||
145408704|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Physician Decision|0|||
145408705|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Physician Decision|0|||
145408706|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Physician Decision|1|||
145408707|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Physician Decision|0|||
145408708|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Physician Decision|0|||
145408709|NCT01995201|524351884|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
145408710|NCT01995201|524351885|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
145408711|NCT01995201|524351886|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
145408712|NCT01995201|524351887|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
145408713|NCT01995201|524351888|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
145408714|NCT01995201|524351889|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
145408715|NCT01995201|524351890|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
145408716|NCT03329001|524351891|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408717|NCT03329001|524351892|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408718|NCT03329001|524351893|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
145408719|NCT03329001|524351894|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
145408720|NCT03329001|524351895|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408721|NCT03329001|524351896|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408722|NCT03329001|524351897|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408723|NCT03329001|524351898|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
145408724|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145408725|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145408726|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145408727|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
145562568|NCT02419742|524920077|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
145562569|NCT00507442|524920082|FG000|Overall Study|Adverse Event|8|||
145562570|NCT00507442|524920083|FG001|Overall Study|Adverse Event|11|||
145562571|NCT00507442|524920084|FG002|Overall Study|Adverse Event|4|||
145562572|NCT00507442|524920085|FG003|Overall Study|Adverse Event|1|||
145562573|NCT00507442|524920082|FG000|Overall Study|Protocol Violation|0|||
145562574|NCT00507442|524920083|FG001|Overall Study|Protocol Violation|1|||
145562575|NCT00507442|524920084|FG002|Overall Study|Protocol Violation|0|||
145237027|NCT00507416|523712390|FG002|Overall Study|Other|13|||
145237028|NCT00507416|523712388|FG000|Overall Study|Did not Receive Study Treatment|3|||
145237029|NCT00507416|523712389|FG001|Overall Study|Did not Receive Study Treatment|9|||
145237030|NCT00507416|523712390|FG002|Overall Study|Did not Receive Study Treatment|4|||
145237031|NCT01182337|523712391|FG000|Overall Study|Withdrawal by Subject|3|||
145237032|NCT01182337|523712392|FG001|Overall Study|Withdrawal by Subject|1|||
145237033|NCT01182337|523712391|FG000|Overall Study|Lost to Follow-up|0|||
145237034|NCT01182337|523712392|FG001|Overall Study|Lost to Follow-up|1|||
145237035|NCT01021813|523712393|FG000|DB Treatment Phase|Adverse Event|60|||
145237036|NCT01021813|523712394|FG001|DB Treatment Phase|Adverse Event|22|||
145237037|NCT01021813|523712395|FG002|DB Treatment Phase|Adverse Event|0|||
145237038|NCT01021813|523712396|FG003|DB Treatment Phase|Adverse Event|0|||
145237039|NCT01021813|523712397|FG004|DB Treatment Phase|Adverse Event|0|||
145237040|NCT01021813|523712393|FG000|DB Treatment Phase|Lack of Efficacy|44|||
145237041|NCT01021813|523712394|FG001|DB Treatment Phase|Lack of Efficacy|28|||
145237042|NCT01021813|523712395|FG002|DB Treatment Phase|Lack of Efficacy|0|||
145237043|NCT01021813|523712396|FG003|DB Treatment Phase|Lack of Efficacy|0|||
145237044|NCT01021813|523712397|FG004|DB Treatment Phase|Lack of Efficacy|0|||
145237045|NCT01021813|523712393|FG000|DB Treatment Phase|Lost to Follow-up|14|||
145562576|NCT00507442|524920085|FG003|Overall Study|Protocol Violation|0|||
145562577|NCT00507442|524920082|FG000|Overall Study|Lost to Follow-up|0|||
145562578|NCT00507442|524920083|FG001|Overall Study|Lost to Follow-up|0|||
145562579|NCT00507442|524920084|FG002|Overall Study|Lost to Follow-up|1|||
145237046|NCT01021813|523712394|FG001|DB Treatment Phase|Lost to Follow-up|12|||
145237047|NCT01021813|523712395|FG002|DB Treatment Phase|Lost to Follow-up|0|||
145237048|NCT01021813|523712396|FG003|DB Treatment Phase|Lost to Follow-up|0|||
145237049|NCT01021813|523712397|FG004|DB Treatment Phase|Lost to Follow-up|0|||
145619957|NCT01625338|525123639|FG001|Overall Study|Lost to Follow-up|3|||
145237050|NCT01021813|523712393|FG000|DB Treatment Phase|Physician Decision|17|||
145237051|NCT01021813|523712394|FG001|DB Treatment Phase|Physician Decision|8|||
145237052|NCT01021813|523712395|FG002|DB Treatment Phase|Physician Decision|0|||
145237053|NCT01021813|523712396|FG003|DB Treatment Phase|Physician Decision|0|||
145237054|NCT01021813|523712397|FG004|DB Treatment Phase|Physician Decision|0|||
145237055|NCT01021813|523712393|FG000|DB Treatment Phase|Pregnancy|1|||
145237056|NCT01021813|523712394|FG001|DB Treatment Phase|Pregnancy|0|||
145237057|NCT01021813|523712395|FG002|DB Treatment Phase|Pregnancy|0|||
145237058|NCT01021813|523712396|FG003|DB Treatment Phase|Pregnancy|0|||
145237059|NCT01021813|523712397|FG004|DB Treatment Phase|Pregnancy|0|||
145237060|NCT01021813|523712393|FG000|DB Treatment Phase|Protocol Violation|4|||
145237061|NCT01021813|523712394|FG001|DB Treatment Phase|Protocol Violation|3|||
145237062|NCT01021813|523712395|FG002|DB Treatment Phase|Protocol Violation|0|||
145237063|NCT01021813|523712396|FG003|DB Treatment Phase|Protocol Violation|0|||
145237064|NCT01021813|523712397|FG004|DB Treatment Phase|Protocol Violation|0|||
145237065|NCT01021813|523712393|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
145237066|NCT01021813|523712394|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
145237067|NCT01021813|523712395|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
145237068|NCT01021813|523712396|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
145237069|NCT01021813|523712397|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
145237070|NCT01021813|523712393|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
145237071|NCT01021813|523712394|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
145237072|NCT01021813|523712395|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
145237073|NCT01021813|523712396|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
145237074|NCT01021813|523712397|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
145237075|NCT01021813|523712393|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
145237076|NCT01021813|523712394|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
145237077|NCT01021813|523712395|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
145237078|NCT01021813|523712396|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
145237079|NCT01021813|523712397|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
145237080|NCT01021813|523712393|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
145237081|NCT01021813|523712394|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
145237082|NCT01021813|523712395|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
145237083|NCT01021813|523712396|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
145237084|NCT01021813|523712397|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
145237085|NCT01021813|523712393|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
145237086|NCT01021813|523712394|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
145237087|NCT01021813|523712395|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
145237088|NCT01021813|523712396|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
145237089|NCT01021813|523712397|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
145237090|NCT01021813|523712393|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
145237091|NCT01021813|523712394|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
145237092|NCT01021813|523712395|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
145237093|NCT01021813|523712396|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
145237094|NCT01021813|523712397|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
145237095|NCT02270684|523712398|FG000|Overall Study|Lost to Follow-up|0|||
145237096|NCT02270684|523712399|FG001|Overall Study|Lost to Follow-up|3|||
145237097|NCT02270684|523712398|FG000|Overall Study|Study terminated|1|||
145237098|NCT02270684|523712399|FG001|Overall Study|Study terminated|0|||
145237099|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
145237100|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
145619958|NCT01625338|525123640|FG002|Overall Study|Lost to Follow-up|2|||
145237101|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
145237102|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
145237103|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
145237104|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
145237105|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
145237106|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
145237107|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
145237108|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
145237109|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
145237110|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
145619959|NCT01625338|525123638|FG000|Overall Study|Investigator Decision|0|||
145237111|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
145237112|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
145237113|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
145619960|NCT01625338|525123639|FG001|Overall Study|Investigator Decision|2|||
145619961|NCT01625338|525123640|FG002|Overall Study|Investigator Decision|1|||
145237114|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
145237115|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
145237116|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
145237117|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
145295578|NCT00849901|523932522|FG002|Extension Phase|Parent or Caregiver Decision|4|||
145295579|NCT00849901|523932520|FG000|Extension Phase|Physician Decision|1|||
145295580|NCT00849901|523932521|FG001|Extension Phase|Physician Decision|2|||
145295581|NCT00849901|523932522|FG002|Extension Phase|Physician Decision|0|||
145295582|NCT00849901|523932520|FG000|Extension Phase|Lack of Efficacy|2|||
145295583|NCT00849901|523932521|FG001|Extension Phase|Lack of Efficacy|4|||
145295584|NCT00849901|523932522|FG002|Extension Phase|Lack of Efficacy|1|||
145295585|NCT00537030|523932534|FG000|Overall Study|Physician Decision|2|||
145295586|NCT00537030|523932534|FG000|Overall Study|Withdrawal by Subject|2|||
145295587|NCT00537030|523932534|FG000|Overall Study|≥ Grade 2 allergy|7|||
145295588|NCT00537030|523932534|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
145295589|NCT00537030|523932534|FG000|Overall Study|Ineligible|2|||
145295590|NCT00537030|523932534|FG000|Overall Study|Inevaluable|2|||
145295591|NCT01496183|523932536|FG000|Overall Study|Physician Decision|3|||
145295592|NCT01496183|523932537|FG001|Overall Study|Physician Decision|1|||
145295593|NCT01496183|523932536|FG000|Overall Study|Withdrawal by Subject|0|||
145408728|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145408729|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145237118|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
145237119|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
145237120|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
145237121|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
145237122|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
145237123|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
145237124|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
145237125|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
145237126|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
145237127|NCT00476996|523712404|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
145237128|NCT00476996|523712405|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
145237129|NCT00476996|523712406|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
145237130|NCT00476996|523712407|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
145237131|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
145237132|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
145237133|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
145237134|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
145237135|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
145237136|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
145237137|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
145237138|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
145237139|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Death|0|||
145237140|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Death|0|||
145237141|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Death|0|||
145237142|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Death|7|||
145237143|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
145237144|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
145237145|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
145237146|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
145237147|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
145237148|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
145237149|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
145237150|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
145237151|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
145237152|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
145237153|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
145237154|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
145237155|NCT00476996|523712404|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
145237156|NCT00476996|523712405|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
145237157|NCT00476996|523712406|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
145237158|NCT00476996|523712407|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
145237159|NCT01769469|523712412|FG000|Overall Study|Consent Withdrawn|5|||
145237160|NCT01769469|523712412|FG000|Overall Study|Moved Out Of Area|3|||
145237161|NCT01769469|523712412|FG000|Overall Study|Lost to Follow-up|17|||
145237162|NCT01769469|523712412|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
145237163|NCT01769469|523712412|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
145295594|NCT01496183|523932537|FG001|Overall Study|Withdrawal by Subject|1|||
145295595|NCT03130699|523932538|FG000|Overall Study|Lost to Follow-up|34|||
145295596|NCT03130699|523932539|FG001|Overall Study|Lost to Follow-up|37|||
145408730|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145562580|NCT00507442|524920085|FG003|Overall Study|Lost to Follow-up|0|||
145562581|NCT00507442|524920082|FG000|Overall Study|Physician Decision|0|||
145562582|NCT00507442|524920083|FG001|Overall Study|Physician Decision|2|||
145562583|NCT00507442|524920084|FG002|Overall Study|Physician Decision|4|||
145562584|NCT00507442|524920085|FG003|Overall Study|Physician Decision|1|||
145562585|NCT00507442|524920082|FG000|Overall Study|Progressive Disease|2|||
145237164|NCT02447458|523712418|FG000|Overall Study|Other|0|||
145237165|NCT02447458|523712419|FG001|Overall Study|Other|0|||
145237166|NCT02447458|523712420|FG002|Overall Study|Other|1|||
145237167|NCT02447458|523712421|FG003|Overall Study|Other|0|||
145237168|NCT02447458|523712422|FG004|Overall Study|Other|0|||
145237169|NCT02447458|523712423|FG005|Overall Study|Other|0|||
145237170|NCT02674685|523712426|FG000|Overall Study|Withdrawal by Subject|4|||
145237171|NCT03148756|523712427|FG000|Overall Study|Study Terminated|0|||
145237172|NCT03148756|523712428|FG001|Overall Study|Study Terminated|1|||
145237173|NCT05406440|523714192|FG000|Overall Study|Lost to Follow-up|0|||
145237174|NCT05406440|523714193|FG001|Overall Study|Lost to Follow-up|0|||
145237175|NCT05406440|523714194|FG002|Overall Study|Lost to Follow-up|0|||
145237176|NCT05406440|523714195|FG003|Overall Study|Lost to Follow-up|0|||
145237177|NCT05406440|523714196|FG004|Overall Study|Lost to Follow-up|2|||
145237178|NCT05406440|523714197|FG005|Overall Study|Lost to Follow-up|0|||
145237179|NCT05406440|523714198|FG006|Overall Study|Lost to Follow-up|0|||
145237180|NCT05406440|523714192|FG000|Overall Study|Physician Decision|0|||
145237181|NCT05406440|523714193|FG001|Overall Study|Physician Decision|0|||
145237182|NCT05406440|523714194|FG002|Overall Study|Physician Decision|0|||
145237183|NCT05406440|523714195|FG003|Overall Study|Physician Decision|0|||
145237184|NCT05406440|523714196|FG004|Overall Study|Physician Decision|1|||
145237185|NCT05406440|523714197|FG005|Overall Study|Physician Decision|0|||
145237186|NCT05406440|523714198|FG006|Overall Study|Physician Decision|0|||
145237187|NCT05406440|523714192|FG000|Overall Study|Withdrawal by Subject|0|||
145237188|NCT05406440|523714193|FG001|Overall Study|Withdrawal by Subject|0|||
145237189|NCT05406440|523714194|FG002|Overall Study|Withdrawal by Subject|0|||
145237190|NCT05406440|523714195|FG003|Overall Study|Withdrawal by Subject|0|||
145237191|NCT05406440|523714196|FG004|Overall Study|Withdrawal by Subject|0|||
145237192|NCT05406440|523714197|FG005|Overall Study|Withdrawal by Subject|2|||
145237193|NCT05406440|523714198|FG006|Overall Study|Withdrawal by Subject|0|||
145237194|NCT04507776|523714211|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
145237195|NCT01711541|523714214|FG000|Overall Study|Cancel prior to treatment|0|||
145237196|NCT01711541|523714215|FG001|Overall Study|Cancel prior to treatment|0|||
145237197|NCT01711541|523714216|FG002|Overall Study|Cancel prior to treatment|0|||
145237198|NCT01711541|523714217|FG003|Overall Study|Cancel prior to treatment|1|||
145237199|NCT01711541|523714218|FG004|Overall Study|Cancel prior to treatment|0|||
145237200|NCT01711541|523714214|FG000|Overall Study|Ineligible|0|||
145237201|NCT01711541|523714215|FG001|Overall Study|Ineligible|1|||
145237202|NCT01711541|523714216|FG002|Overall Study|Ineligible|0|||
145237203|NCT01711541|523714217|FG003|Overall Study|Ineligible|0|||
145237204|NCT01711541|523714218|FG004|Overall Study|Ineligible|0|||
145237205|NCT03943446|523714219|FG000|Overall Study|Lost to Follow-up|0|||
145295597|NCT03130699|523932540|FG002|Overall Study|Lost to Follow-up|26|||
145295598|NCT03130699|523932538|FG000|Overall Study|Withdrawal by Subject|5|||
145295599|NCT03130699|523932539|FG001|Overall Study|Withdrawal by Subject|1|||
145295600|NCT03130699|523932540|FG002|Overall Study|Withdrawal by Subject|0|||
145295601|NCT03130699|523932538|FG000|Overall Study|Withdrawal by PI|1|||
145295602|NCT03130699|523932539|FG001|Overall Study|Withdrawal by PI|2|||
145295603|NCT03130699|523932540|FG002|Overall Study|Withdrawal by PI|5|||
145295604|NCT03130699|523932538|FG000|Overall Study|Death|0|||
145295605|NCT03130699|523932539|FG001|Overall Study|Death|0|||
145295606|NCT03130699|523932540|FG002|Overall Study|Death|1|||
145295607|NCT00669864|523932543|FG000|Overall Study|Lost to Follow-up|2|||
145295608|NCT00669864|523932543|FG000|Overall Study|Protocol Violation|2|||
145295609|NCT00669864|523932543|FG000|Overall Study|Withdrawal by Subject|3|||
145295610|NCT00669864|523932543|FG000|Overall Study|Other|2|||
145295611|NCT06354270|523932546|FG000|Overall Study|Withdrawal by Subject|1|||
145295612|NCT06354270|523932547|FG001|Overall Study|Withdrawal by Subject|0|||
145295613|NCT00680121|523932548|FG000|Overall Study|Lost to Follow-up|27|||
145619962|NCT01625338|525123638|FG000|Overall Study|Subject Withdrew Consent|1|||
145237206|NCT03943446|523714220|FG001|Overall Study|Lost to Follow-up|0|||
145237207|NCT03943446|523714221|FG002|Overall Study|Lost to Follow-up|1|||
145237208|NCT03943446|523714219|FG000|Overall Study|Withdrawal by Subject|1|||
145237209|NCT03943446|523714220|FG001|Overall Study|Withdrawal by Subject|1|||
145237210|NCT03943446|523714221|FG002|Overall Study|Withdrawal by Subject|2|||
145237211|NCT03943446|523714219|FG000|Overall Study|Study Terminated by Sponsor|1|||
145237212|NCT03943446|523714220|FG001|Overall Study|Study Terminated by Sponsor|2|||
145237213|NCT03943446|523714221|FG002|Overall Study|Study Terminated by Sponsor|1|||
145295614|NCT00680121|523932549|FG001|Overall Study|Lost to Follow-up|23|||
145295615|NCT00162123|523932550|FG000|Overall Study|Disease progression|27|||
145295616|NCT00162123|523932551|FG001|Overall Study|Disease progression|19|||
145295617|NCT00162123|523932552|FG002|Overall Study|Disease progression|10|||
145562586|NCT00507442|524920083|FG001|Overall Study|Progressive Disease|4|||
145562587|NCT00507442|524920084|FG002|Overall Study|Progressive Disease|2|||
145237214|NCT03943446|523714219|FG000|Overall Study|Reason not Specified|5|||
145237215|NCT03943446|523714220|FG001|Overall Study|Reason not Specified|1|||
145237216|NCT03943446|523714221|FG002|Overall Study|Reason not Specified|3|||
145237217|NCT01281189|523714227|FG000|Overall Study|Adverse Event|7|||
145237218|NCT01281189|523714228|FG001|Overall Study|Adverse Event|9|||
145237219|NCT01281189|523714227|FG000|Overall Study|Lost to Follow-up|6|||
145237220|NCT01281189|523714228|FG001|Overall Study|Lost to Follow-up|4|||
145237221|NCT01281189|523714227|FG000|Overall Study|Withdrawal by Subject|21|||
145237222|NCT01281189|523714228|FG001|Overall Study|Withdrawal by Subject|24|||
145237223|NCT01281189|523714227|FG000|Overall Study|Physician Decision|2|||
145237224|NCT01281189|523714228|FG001|Overall Study|Physician Decision|3|||
145237225|NCT01281189|523714227|FG000|Overall Study|Death|103|||
145237226|NCT01281189|523714228|FG001|Overall Study|Death|91|||
145237227|NCT01281189|523714227|FG000|Overall Study|Other|8|||
145237228|NCT01281189|523714228|FG001|Overall Study|Other|12|||
145237229|NCT05355818|523714229|FG000|Overall Study|Adverse Event|1|||
145237230|NCT05355818|523714230|FG001|Overall Study|Adverse Event|1|||
145237231|NCT05355818|523714229|FG000|Overall Study|Lack of Efficacy|2|||
145237232|NCT05355818|523714230|FG001|Overall Study|Lack of Efficacy|1|||
145237233|NCT05355818|523714229|FG000|Overall Study|Lost to Follow-up|0|||
145237234|NCT05355818|523714230|FG001|Overall Study|Lost to Follow-up|1|||
145237235|NCT01136746|523714231|FG000|Overall Study|Lost to Follow-up|0|||
145408731|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
145408732|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145237236|NCT01136746|523714232|FG001|Overall Study|Lost to Follow-up|2|||
145237237|NCT01136746|523714231|FG000|Overall Study|Protocol Violation|2|||
145237238|NCT01136746|523714232|FG001|Overall Study|Protocol Violation|1|||
145237239|NCT01136746|523714231|FG000|Overall Study|Death|1|||
145237240|NCT01136746|523714232|FG001|Overall Study|Death|0|||
145237241|NCT01175590|523714233|FG000|Overall Study|Lost to Follow-up|1|||
145237242|NCT01175590|523714234|FG001|Overall Study|Lost to Follow-up|0|||
145237243|NCT01175590|523714233|FG000|Overall Study|Withdrawal by Subject|0|||
145237244|NCT01175590|523714234|FG001|Overall Study|Withdrawal by Subject|2|||
145237245|NCT01175590|523714233|FG000|Overall Study|Adverse Event|4|||
145237246|NCT01175590|523714234|FG001|Overall Study|Adverse Event|0|||
145237247|NCT01175590|523714233|FG000|Overall Study|Physician Decision|1|||
145237248|NCT01175590|523714234|FG001|Overall Study|Physician Decision|4|||
145237249|NCT01175590|523714233|FG000|Overall Study|Lack of Efficacy|1|||
145237250|NCT01175590|523714234|FG001|Overall Study|Lack of Efficacy|1|||
145237251|NCT01175590|523714233|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
145237252|NCT01175590|523714234|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
145237253|NCT01175590|523714233|FG000|Overall Study|Treated not as randomized|3|||
145237254|NCT01175590|523714234|FG001|Overall Study|Treated not as randomized|2|||
145237255|NCT01175590|523714233|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
145237256|NCT01175590|523714234|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
145237257|NCT01175590|523714233|FG000|Overall Study|Protocol Violation|0|||
145237258|NCT01175590|523714234|FG001|Overall Study|Protocol Violation|1|||
145237259|NCT00092677|523714240|FG000|Overall Study|Lost to Follow-up|0|||
145237260|NCT00092677|523714241|FG001|Overall Study|Lost to Follow-up|2|||
145237261|NCT00092677|523714240|FG000|Overall Study|Adminstrative|5|||
145237262|NCT00092677|523714241|FG001|Overall Study|Adminstrative|9|||
145237263|NCT02141217|523714242|FG000|Overall Study|Adverse Event|1|||
145237264|NCT02141217|523714243|FG001|Overall Study|Adverse Event|2|||
145237265|NCT02141217|523714242|FG000|Overall Study|Protocol Violation|1|||
145237266|NCT02141217|523714243|FG001|Overall Study|Protocol Violation|4|||
145237267|NCT02141217|523714242|FG000|Overall Study|Withdrawal by Subject|6|||
145237268|NCT02141217|523714243|FG001|Overall Study|Withdrawal by Subject|0|||
145408733|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145408734|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145408735|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
145408736|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145408737|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145237269|NCT02141217|523714242|FG000|Overall Study|Lost to Follow-up|1|||
145237270|NCT02141217|523714243|FG001|Overall Study|Lost to Follow-up|1|||
145237271|NCT02141217|523714242|FG000|Overall Study|Physician Decision|1|||
145237272|NCT02141217|523714243|FG001|Overall Study|Physician Decision|0|||
145237273|NCT02141217|523714242|FG000|Overall Study|Surgical Intervention|1|||
145237274|NCT02141217|523714243|FG001|Overall Study|Surgical Intervention|1|||
145237275|NCT04603391|523714244|FG000|First Intervention (4 Days)|Adverse Event|1|||
145237276|NCT04603391|523714245|FG001|First Intervention (4 Days)|Adverse Event|0|||
145237277|NCT04603391|523714244|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
145237278|NCT04603391|523714245|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
145237279|NCT02759861|523714248|FG000|Overall Study|Death|1|||
145237280|NCT00618995|523714249|FG000|Period 1|Adverse Event|0|||
145237281|NCT00618995|523714250|FG001|Period 1|Adverse Event|0|||
145237282|NCT00618995|523714251|FG002|Period 1|Adverse Event|1|||
145237283|NCT00618995|523714252|FG003|Period 1|Adverse Event|0|||
145237284|NCT00618995|523714249|FG000|Period 1|Protocol Violation|0|||
145237285|NCT00618995|523714250|FG001|Period 1|Protocol Violation|1|||
145237286|NCT00618995|523714251|FG002|Period 1|Protocol Violation|1|||
145237287|NCT00618995|523714252|FG003|Period 1|Protocol Violation|0|||
145237288|NCT00618995|523714249|FG000|Period 2|Protocol Violation|0|||
145237289|NCT00618995|523714250|FG001|Period 2|Protocol Violation|0|||
145237290|NCT00618995|523714251|FG002|Period 2|Protocol Violation|1|||
145237291|NCT00618995|523714252|FG003|Period 2|Protocol Violation|0|||
145237292|NCT00618995|523714249|FG000|Period 4|Adverse Event|1|||
145237293|NCT00618995|523714250|FG001|Period 4|Adverse Event|0|||
145237294|NCT00618995|523714251|FG002|Period 4|Adverse Event|0|||
145237295|NCT00618995|523714252|FG003|Period 4|Adverse Event|0|||
145237296|NCT02988219|523714255|FG000|Overall Study|Lack of Efficacy|1|||
145237297|NCT02988219|523714256|FG001|Overall Study|Lack of Efficacy|1|||
145237298|NCT02988219|523714255|FG000|Overall Study|Withdrawal by Subject|0|||
145237299|NCT02988219|523714256|FG001|Overall Study|Withdrawal by Subject|2|||
145237300|NCT01306032|523714257|FG000|First Intervention|Adverse Event|1|||
145237301|NCT01306032|523714258|FG001|First Intervention|Adverse Event|0|||
145237302|NCT01306032|523714259|FG002|First Intervention|Adverse Event|1|||
145237303|NCT01306032|523714260|FG003|First Intervention|Adverse Event|0|||
145237304|NCT01306032|523714261|FG004|First Intervention|Adverse Event|0|||
145237305|NCT01306032|523714262|FG005|First Intervention|Adverse Event|1|||
145237306|NCT01306032|523714257|FG000|First Intervention|Withdrawal by Subject|0|||
145237307|NCT01306032|523714258|FG001|First Intervention|Withdrawal by Subject|2|||
145237308|NCT01306032|523714259|FG002|First Intervention|Withdrawal by Subject|0|||
145237309|NCT01306032|523714260|FG003|First Intervention|Withdrawal by Subject|1|||
145237310|NCT01306032|523714261|FG004|First Intervention|Withdrawal by Subject|0|||
145237311|NCT01306032|523714262|FG005|First Intervention|Withdrawal by Subject|0|||
145237312|NCT01306032|523714257|FG000|First Intervention|Death|0|||
145237313|NCT01306032|523714258|FG001|First Intervention|Death|0|||
145237314|NCT01306032|523714259|FG002|First Intervention|Death|1|||
145237315|NCT01306032|523714260|FG003|First Intervention|Death|0|||
145237316|NCT01306032|523714261|FG004|First Intervention|Death|0|||
145237317|NCT01306032|523714262|FG005|First Intervention|Death|0|||
145237318|NCT01306032|523714257|FG000|First Intervention|Ineligible|0|||
145237319|NCT01306032|523714258|FG001|First Intervention|Ineligible|0|||
145237320|NCT01306032|523714259|FG002|First Intervention|Ineligible|0|||
145237321|NCT01306032|523714260|FG003|First Intervention|Ineligible|0|||
145237322|NCT01306032|523714261|FG004|First Intervention|Ineligible|0|||
145237323|NCT01306032|523714262|FG005|First Intervention|Ineligible|1|||
145237324|NCT01306032|523714257|FG000|First Intervention|Progressive disease|0|||
145237325|NCT01306032|523714258|FG001|First Intervention|Progressive disease|0|||
145237326|NCT01306032|523714259|FG002|First Intervention|Progressive disease|0|||
145237327|NCT01306032|523714260|FG003|First Intervention|Progressive disease|0|||
145237328|NCT01306032|523714261|FG004|First Intervention|Progressive disease|2|||
145237329|NCT01306032|523714262|FG005|First Intervention|Progressive disease|0|||
145237330|NCT01306032|523714257|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
145237331|NCT01306032|523714258|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
145237332|NCT01306032|523714259|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
145237333|NCT01306032|523714260|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
145237334|NCT01306032|523714261|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
145237335|NCT01306032|523714262|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
145237336|NCT01306032|523714257|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
145237337|NCT01306032|523714258|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
145237338|NCT01306032|523714259|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
145237339|NCT01306032|523714260|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
145237340|NCT01306032|523714261|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
145237341|NCT01306032|523714262|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
145237342|NCT01213264|523714263|FG000|Overall Study|Adverse Event|1|||
145237343|NCT01213264|523714264|FG001|Overall Study|Adverse Event|0|||
145237344|NCT01213264|523714265|FG002|Overall Study|Adverse Event|0|||
145237345|NCT01213264|523714263|FG000|Overall Study|Lost to Follow-up|1|||
145237346|NCT01213264|523714264|FG001|Overall Study|Lost to Follow-up|2|||
145237347|NCT01213264|523714265|FG002|Overall Study|Lost to Follow-up|6|||
145408738|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145237348|NCT01522443|523714267|FG000|Overall Study|No longer receiving clinical benefit|36|||
145237349|NCT01522443|523714268|FG001|Overall Study|No longer receiving clinical benefit|28|||
145237350|NCT01522443|523714267|FG000|Overall Study|Adverse Event|10|||
145237351|NCT01522443|523714268|FG001|Overall Study|Adverse Event|15|||
145237352|NCT01522443|523714267|FG000|Overall Study|Withdrawal by Subject|5|||
145237353|NCT01522443|523714268|FG001|Overall Study|Withdrawal by Subject|8|||
145237354|NCT01522443|523714267|FG000|Overall Study|No study treatment given|1|||
145237355|NCT01522443|523714268|FG001|Overall Study|No study treatment given|1|||
145237356|NCT01522443|523714267|FG000|Overall Study|Other|1|||
145237357|NCT01522443|523714268|FG001|Overall Study|Other|3|||
145237358|NCT00555568|523714270|FG000|Overall Study|Lost to Follow-up|26|||
145619963|NCT01625338|525123639|FG001|Overall Study|Subject Withdrew Consent|0|||
145619964|NCT01625338|525123640|FG002|Overall Study|Subject Withdrew Consent|2|||
145619965|NCT01625338|525123638|FG000|Overall Study|Adverse Event|1|||
145619966|NCT01625338|525123639|FG001|Overall Study|Adverse Event|0|||
145619967|NCT01625338|525123640|FG002|Overall Study|Adverse Event|1|||
145619968|NCT01625338|525123638|FG000|Overall Study|Study Discontinued by Sponsor|0|||
145619969|NCT01625338|525123639|FG001|Overall Study|Study Discontinued by Sponsor|0|||
145619970|NCT01625338|525123640|FG002|Overall Study|Study Discontinued by Sponsor|1|||
145237359|NCT00555568|523714271|FG001|Overall Study|Lost to Follow-up|16|||
145237360|NCT00555568|523714272|FG002|Overall Study|Lost to Follow-up|16|||
145237361|NCT00318565|523714273|FG000|Overall Study|Excluded per protocol|24|||
145237362|NCT00691093|523714274|FG000|Overall Study|Adverse Event|1|||
145237363|NCT00691093|523714274|FG000|Overall Study|Lost to Follow-up|1|||
145237364|NCT00691093|523714274|FG000|Overall Study|Lack of Efficacy|1|||
145237365|NCT00691093|523714274|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
145237366|NCT01588353|523714275|FG000|Step2|Withdrawal by Subject|0|||
145237367|NCT01588353|523714276|FG001|Step2|Withdrawal by Subject|1|||
145237368|NCT01588353|523714277|FG002|Step2|Withdrawal by Subject|0|||
145237369|NCT01588353|523714275|FG000|Step3|Adverse Event|0|||
145237370|NCT01588353|523714276|FG001|Step3|Adverse Event|0|||
145237371|NCT01588353|523714277|FG002|Step3|Adverse Event|2|||
145237372|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
145237373|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
145237374|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
145237375|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
145237376|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
145237377|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
145237378|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
145237379|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
145237380|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
145237381|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
145237382|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
145237383|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
145237384|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
145237385|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
145237386|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
145237387|NCT03814005|523714278|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
145237388|NCT03814005|523714279|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
145237389|NCT03814005|523714280|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
145237390|NCT00810810|523714281|FG000|Overall Study|Withdrawal by Subject|0|||
145237391|NCT00810810|523714282|FG001|Overall Study|Withdrawal by Subject|8|||
145237392|NCT00810810|523714283|FG002|Overall Study|Withdrawal by Subject|10|||
145237393|NCT00810810|523714284|FG003|Overall Study|Withdrawal by Subject|8|||
145237394|NCT00810810|523714281|FG000|Overall Study|Physician Decision|0|||
145237395|NCT00810810|523714282|FG001|Overall Study|Physician Decision|3|||
145237396|NCT00810810|523714283|FG002|Overall Study|Physician Decision|1|||
145237397|NCT00810810|523714284|FG003|Overall Study|Physician Decision|5|||
145237398|NCT01896856|523714285|FG000|Overall Study|Transportation issues / Non-compliance|0|||
145237399|NCT01896856|523714286|FG001|Overall Study|Transportation issues / Non-compliance|0|||
145237400|NCT01896856|523714287|FG002|Overall Study|Transportation issues / Non-compliance|1|||
145237401|NCT01896856|523714288|FG003|Overall Study|Transportation issues / Non-compliance|0|||
145237402|NCT01896856|523714289|FG004|Overall Study|Transportation issues / Non-compliance|0|||
145237403|NCT01896856|523714290|FG005|Overall Study|Transportation issues / Non-compliance|0|||
145237404|NCT02563925|523714293|FG000|Overall Study|Withdrawal by Subject|2|||
145237405|NCT00282867|523714294|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
145237406|NCT00282867|523714295|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
145237407|NCT00282867|523714296|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
145237408|NCT01700985|523714297|FG000|Overall Study|Incarcerated|0|||
145237409|NCT01700985|523714298|FG001|Overall Study|Incarcerated|1|||
145237410|NCT01409993|523714299|FG000|Overall Study|Adverse Event|4|||
145237411|NCT01409993|523714300|FG001|Overall Study|Adverse Event|4|||
145237412|NCT01409993|523714301|FG002|Overall Study|Adverse Event|3|||
145237413|NCT01409993|523714302|FG003|Overall Study|Adverse Event|1|||
145237414|NCT01409993|523714299|FG000|Overall Study|Withdrawal by Subject|0|||
145237415|NCT01409993|523714300|FG001|Overall Study|Withdrawal by Subject|0|||
145237416|NCT01409993|523714301|FG002|Overall Study|Withdrawal by Subject|0|||
145237417|NCT01409993|523714302|FG003|Overall Study|Withdrawal by Subject|4|||
145237418|NCT01409993|523714299|FG000|Overall Study|Lost to Follow-up|0|||
145237419|NCT01409993|523714300|FG001|Overall Study|Lost to Follow-up|1|||
145237420|NCT01409993|523714301|FG002|Overall Study|Lost to Follow-up|0|||
145237421|NCT01409993|523714302|FG003|Overall Study|Lost to Follow-up|0|||
145237422|NCT00965146|523714303|FG000|Overall Study|Death|7|||
145619971|NCT03639675|525123641|FG000|Overall Study|Withdrawal by Subject|1|||
145619972|NCT02459587|525123642|FG000|3-Month Follow-up Assessment|Death|0|||
145237423|NCT00965146|523714303|FG000|Overall Study|Lost to Follow-up|22|||
145237424|NCT00965146|523714303|FG000|Overall Study|Withdrawal by Subject|17|||
145237425|NCT00965146|523714303|FG000|Overall Study|Unable to return|1|||
145237426|NCT00965146|523714303|FG000|Overall Study|Unwilling to return|11|||
145237427|NCT00965146|523714303|FG000|Overall Study|Intercurrent illness|1|||
145237428|NCT00965146|523714303|FG000|Overall Study|Revision / Removal of Study Implant|6|||
145237429|NCT00965146|523714303|FG000|Overall Study|Overall Study Termination|145|||
145237430|NCT05067452|523714304|FG000|Overall Study|Lost to Follow-up|0|||
145237431|NCT05067452|523714305|FG001|Overall Study|Lost to Follow-up|4|||
145237432|NCT00067470|523714306|FG000|Overall Study|Withdrawal by Subject|0|||
145237433|NCT00067470|523714307|FG001|Overall Study|Withdrawal by Subject|1|||
145237434|NCT01148693|523714308|FG000|Overall Study|Attempts for cannulation were failed|13|||
145237435|NCT01148693|523714309|FG001|Overall Study|Attempts for cannulation were failed|10|||
145237436|NCT01135017|523714310|FG000|Overall Study|Adverse Event|3|||
145237437|NCT01135017|523714311|FG001|Overall Study|Adverse Event|8|||
145237438|NCT01135017|523714310|FG000|Overall Study|Other than above|3|||
145237439|NCT01135017|523714311|FG001|Overall Study|Other than above|4|||
145237440|NCT00936117|523714314|FG000|Overall Study|Adverse Event|7|||
145237441|NCT00936117|523714314|FG000|Overall Study|Unable to continue oral medication|3|||
145237442|NCT00426556|523714315|FG000|Phase I - Core Phase|Disease Progression|0|||
145237443|NCT00426556|523714316|FG001|Phase I - Core Phase|Disease Progression|6|||
145237444|NCT00426556|523714317|FG002|Phase I - Core Phase|Disease Progression|2|||
145237445|NCT00426556|523714318|FG003|Phase I - Core Phase|Disease Progression|0|||
145237446|NCT00426556|523714315|FG000|Phase I - Core Phase|Adverse Event|1|||
145237447|NCT00426556|523714316|FG001|Phase I - Core Phase|Adverse Event|3|||
145237448|NCT00426556|523714317|FG002|Phase I - Core Phase|Adverse Event|1|||
145237449|NCT00426556|523714318|FG003|Phase I - Core Phase|Adverse Event|0|||
145237450|NCT00426556|523714315|FG000|Phase I - Core Phase|Death|0|||
145237451|NCT00426556|523714316|FG001|Phase I - Core Phase|Death|1|||
145237452|NCT00426556|523714317|FG002|Phase I - Core Phase|Death|0|||
145237453|NCT00426556|523714318|FG003|Phase I - Core Phase|Death|0|||
145237454|NCT00426556|523714315|FG000|Phase I - Extension Phase|Adverse Event|0|||
145237455|NCT00426556|523714316|FG001|Phase I - Extension Phase|Adverse Event|1|||
145237456|NCT00426556|523714317|FG002|Phase I - Extension Phase|Adverse Event|1|||
145237457|NCT00426556|523714318|FG003|Phase I - Extension Phase|Adverse Event|0|||
145237458|NCT00426556|523714315|FG000|Phase I - Extension Phase|Disease Progression|5|||
145237459|NCT00426556|523714316|FG001|Phase I - Extension Phase|Disease Progression|5|||
145237460|NCT00426556|523714317|FG002|Phase I - Extension Phase|Disease Progression|6|||
145237461|NCT00426556|523714318|FG003|Phase I - Extension Phase|Disease Progression|0|||
145237462|NCT00426556|523714315|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
145237463|NCT00426556|523714316|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
145237464|NCT00426556|523714317|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
145237465|NCT00426556|523714318|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
145237466|NCT00426556|523714315|FG000|Phase II - Core Phase|Disease Progression|0|||
145237467|NCT00426556|523714316|FG001|Phase II - Core Phase|Disease Progression|0|||
145237468|NCT00426556|523714317|FG002|Phase II - Core Phase|Disease Progression|0|||
145237469|NCT00426556|523714318|FG003|Phase II - Core Phase|Disease Progression|16|||
145237470|NCT00426556|523714315|FG000|Phase II - Core Phase|Adverse Event|0|||
145237471|NCT00426556|523714316|FG001|Phase II - Core Phase|Adverse Event|0|||
145237472|NCT00426556|523714317|FG002|Phase II - Core Phase|Adverse Event|0|||
145237473|NCT00426556|523714318|FG003|Phase II - Core Phase|Adverse Event|8|||
145237474|NCT00426556|523714315|FG000|Phase II - Extension Phase|Disease Progression|0|||
145237475|NCT00426556|523714316|FG001|Phase II - Extension Phase|Disease Progression|0|||
145237476|NCT00426556|523714317|FG002|Phase II - Extension Phase|Disease Progression|0|||
145237477|NCT00426556|523714318|FG003|Phase II - Extension Phase|Disease Progression|21|||
145237478|NCT00426556|523714315|FG000|Phase II - Extension Phase|Adverse Event|0|||
145237479|NCT00426556|523714316|FG001|Phase II - Extension Phase|Adverse Event|0|||
145237480|NCT00426556|523714317|FG002|Phase II - Extension Phase|Adverse Event|0|||
145237481|NCT00426556|523714318|FG003|Phase II - Extension Phase|Adverse Event|2|||
145237482|NCT01192204|523714321|FG000|Overall Study|could not keep recall appointments|1|||
145237483|NCT01192204|523714322|FG001|Overall Study|could not keep recall appointments|0|||
145237484|NCT03699631|523714325|FG000|Overall Study|Adverse Event|3|||
145237485|NCT01767519|523714326|FG000|Overall Study|Other Reasons|4|||
145237486|NCT01767519|523714327|FG001|Overall Study|Other Reasons|4|||
145237487|NCT01767519|523714328|FG002|Overall Study|Other Reasons|2|||
145237488|NCT01767519|523714326|FG000|Overall Study|Protocol Violation|0|||
145237489|NCT01767519|523714327|FG001|Overall Study|Protocol Violation|3|||
145237490|NCT01767519|523714328|FG002|Overall Study|Protocol Violation|0|||
145237491|NCT01767519|523714326|FG000|Overall Study|Personal Reasons|1|||
145237492|NCT01767519|523714327|FG001|Overall Study|Personal Reasons|0|||
145237493|NCT01767519|523714328|FG002|Overall Study|Personal Reasons|0|||
145237494|NCT01767519|523714326|FG000|Overall Study|Lost to Follow-up|3|||
145237495|NCT01767519|523714327|FG001|Overall Study|Lost to Follow-up|1|||
145237496|NCT01767519|523714328|FG002|Overall Study|Lost to Follow-up|2|||
145237497|NCT01767519|523714326|FG000|Overall Study|Lack of Efficacy|1|||
145237498|NCT01767519|523714327|FG001|Overall Study|Lack of Efficacy|0|||
145237499|NCT01767519|523714328|FG002|Overall Study|Lack of Efficacy|0|||
145237500|NCT01767519|523714326|FG000|Overall Study|Adverse Event|5|||
145237501|NCT01767519|523714327|FG001|Overall Study|Adverse Event|5|||
145237502|NCT01767519|523714328|FG002|Overall Study|Adverse Event|1|||
145237503|NCT03101514|523714331|FG000|Overall Study|Withdrawal by Subject|4|||
145237504|NCT03101514|523714331|FG000|Overall Study|Protocol Violation|2|||
145237505|NCT03101514|523714331|FG000|Overall Study|patient's information was incomplete|1|||
145237506|NCT02247401|523714332|FG000|Overall Study|Adverse Event|1|||
145237507|NCT02247401|523714333|FG001|Overall Study|Adverse Event|0|||
145237508|NCT02247401|523714334|FG002|Overall Study|Adverse Event|0|||
145237509|NCT02247401|523714332|FG000|Overall Study|Withdrawal by Subject|4|||
145237510|NCT02247401|523714333|FG001|Overall Study|Withdrawal by Subject|1|||
145237511|NCT02247401|523714334|FG002|Overall Study|Withdrawal by Subject|1|||
145237512|NCT02247401|523714332|FG000|Overall Study|Lost to Follow-up|1|||
145237513|NCT02247401|523714333|FG001|Overall Study|Lost to Follow-up|1|||
145237514|NCT02247401|523714334|FG002|Overall Study|Lost to Follow-up|1|||
145237515|NCT04169061|523714337|FG000|Overall Study|Adverse Event|2|||
145237516|NCT04169061|523714337|FG000|Overall Study|Death|1|||
145237517|NCT04169061|523714337|FG000|Overall Study|Withdrawal by Subject|1|||
145237518|NCT04169061|523714337|FG000|Overall Study|Protocol Violation|1|||
145237519|NCT03695393|523714338|FG000|Overall Study|Death|3|||
145237520|NCT03695393|523714339|FG001|Overall Study|Death|1|||
145237521|NCT03695393|523714338|FG000|Overall Study|Lost to Follow-up|0|||
145237522|NCT03695393|523714339|FG001|Overall Study|Lost to Follow-up|1|||
145237523|NCT04585451|523714342|FG000|Overall Study|Withdrawal by Subject|26|||
145237524|NCT04585451|523714343|FG001|Overall Study|Withdrawal by Subject|0|||
145237525|NCT00673894|523714344|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
145237526|NCT00673894|523714345|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
145237527|NCT00673894|523714344|FG000|First Intervention 4 Weeks|Adverse Event|1|||
145237528|NCT00673894|523714345|FG001|First Intervention 4 Weeks|Adverse Event|0|||
145237529|NCT00493974|523714346|FG000|Overall Study|Death|1|||
145237530|NCT00493974|523714347|FG001|Overall Study|Death|2|||
145237531|NCT00493974|523714346|FG000|Overall Study|Withdrawal by Subject|8|||
145237532|NCT00493974|523714347|FG001|Overall Study|Withdrawal by Subject|6|||
145237533|NCT00493974|523714346|FG000|Overall Study|Lost to Follow-up|4|||
145237534|NCT00493974|523714347|FG001|Overall Study|Lost to Follow-up|6|||
145237535|NCT02807363|523714348|FG000|Dosing Period|Adverse Event|0|||
145237536|NCT02807363|523714349|FG001|Dosing Period|Adverse Event|1|||
145237537|NCT02807363|523714350|FG002|Dosing Period|Adverse Event|0|||
145237538|NCT02807363|523714351|FG003|Dosing Period|Adverse Event|0|||
145237539|NCT02188719|523714352|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
145237540|NCT02188719|523714353|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
145237541|NCT02188719|523714354|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
145237542|NCT02188719|523714355|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
145237543|NCT00966693|523714356|FG000|Overall Study|Adverse Event|0|||
145237544|NCT00966693|523714357|FG001|Overall Study|Adverse Event|0|||
145237545|NCT00966693|523714358|FG002|Overall Study|Adverse Event|1|||
145237546|NCT00966693|523714359|FG003|Overall Study|Adverse Event|2|||
145237547|NCT00966693|523714356|FG000|Overall Study|Death|0|||
145237548|NCT00966693|523714357|FG001|Overall Study|Death|0|||
145237549|NCT00966693|523714358|FG002|Overall Study|Death|1|||
145237550|NCT00966693|523714359|FG003|Overall Study|Death|0|||
145237551|NCT00966693|523714356|FG000|Overall Study|Withdrawal by Subject|1|||
145237552|NCT00966693|523714357|FG001|Overall Study|Withdrawal by Subject|0|||
145237553|NCT00966693|523714358|FG002|Overall Study|Withdrawal by Subject|0|||
145237554|NCT00966693|523714359|FG003|Overall Study|Withdrawal by Subject|5|||
145237555|NCT00966693|523714356|FG000|Overall Study|Disease Progression|0|||
145237556|NCT00966693|523714357|FG001|Overall Study|Disease Progression|0|||
145237557|NCT00966693|523714358|FG002|Overall Study|Disease Progression|1|||
145237558|NCT00966693|523714359|FG003|Overall Study|Disease Progression|16|||
145237559|NCT00192036|523714360|FG000|Overall Study|Protocol Violation|3|||
145237560|NCT00192036|523714360|FG000|Overall Study|Adverse Event|6|||
145237561|NCT00192036|523714360|FG000|Overall Study|Patient/Physician Perception|1|||
145237562|NCT00192036|523714360|FG000|Overall Study|Objective Tumor Progression|4|||
145237563|NCT00192036|523714360|FG000|Overall Study|Clinical Disease Progression|1|||
145237564|NCT00192036|523714360|FG000|Overall Study|Death|1|||
145237565|NCT00192036|523714360|FG000|Overall Study|Unknown or Not Specified|5|||
145237566|NCT03371732|523714361|FG000|Overall Study|Withdrawal by Subject|9|||
145237567|NCT03371732|523714362|FG001|Overall Study|Withdrawal by Subject|3|||
145295618|NCT00162123|523932553|FG003|Overall Study|Disease progression|4|||
145237568|NCT03371732|523714361|FG000|Overall Study|Refusal to continue|3|||
145237569|NCT03371732|523714362|FG001|Overall Study|Refusal to continue|4|||
145237570|NCT02581982|523714365|FG000|Overall Study|Lack of Efficacy|12|||
145237571|NCT02581982|523714365|FG000|Overall Study|Adverse Event|3|||
145237572|NCT02581982|523714365|FG000|Overall Study|Physician Decision|1|||
145237573|NCT00405821|523714366|FG000|Overall Study|Death|5|||
145237574|NCT00405821|523714367|FG001|Overall Study|Death|7|||
145237575|NCT00405821|523714366|FG000|Overall Study|Lost to Follow-up|7|||
145237576|NCT00405821|523714367|FG001|Overall Study|Lost to Follow-up|7|||
145237577|NCT00405821|523714366|FG000|Overall Study|Protocol Violation|1|||
145237578|NCT00405821|523714367|FG001|Overall Study|Protocol Violation|0|||
145237579|NCT00405821|523714366|FG000|Overall Study|initiated ART|9|||
145237580|NCT00405821|523714367|FG001|Overall Study|initiated ART|8|||
145237581|NCT01033487|523714369|FG000|Fourth Intervention Period|Adverse Event|0|||
145237582|NCT01033487|523714370|FG001|Fourth Intervention Period|Adverse Event|0|||
145237583|NCT01033487|523714371|FG002|Fourth Intervention Period|Adverse Event|0|||
145237584|NCT01033487|523714372|FG003|Fourth Intervention Period|Adverse Event|0|||
145237585|NCT01033487|523714373|FG004|Fourth Intervention Period|Adverse Event|0|||
145237586|NCT01033487|523714374|FG005|Fourth Intervention Period|Adverse Event|0|||
145237587|NCT01033487|523714375|FG006|Fourth Intervention Period|Adverse Event|0|||
145237588|NCT01033487|523714376|FG007|Fourth Intervention Period|Adverse Event|0|||
145237589|NCT01033487|523714377|FG008|Fourth Intervention Period|Adverse Event|1|||
145237590|NCT01033487|523714378|FG009|Fourth Intervention Period|Adverse Event|0|||
145237591|NCT03094832|523714379|FG000|Overall Study|Lost to Follow-up|0|||
145237592|NCT03094832|523714380|FG001|Overall Study|Lost to Follow-up|0|||
145237593|NCT03094832|523714381|FG002|Overall Study|Lost to Follow-up|0|||
145237594|NCT03094832|523714382|FG003|Overall Study|Lost to Follow-up|1|||
145237595|NCT03094832|523714383|FG004|Overall Study|Lost to Follow-up|1|||
145237596|NCT03094832|523714379|FG000|Overall Study|Death|1|||
145237597|NCT03094832|523714380|FG001|Overall Study|Death|0|||
145237598|NCT03094832|523714381|FG002|Overall Study|Death|0|||
145237599|NCT03094832|523714382|FG003|Overall Study|Death|0|||
145237600|NCT03094832|523714383|FG004|Overall Study|Death|0|||
145237601|NCT03094832|523714379|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145237602|NCT03094832|523714380|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145237603|NCT03094832|523714381|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145237604|NCT03094832|523714382|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145237605|NCT03094832|523714383|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145237606|NCT03094832|523714379|FG000|Overall Study|Other|13|||
145237607|NCT03094832|523714380|FG001|Overall Study|Other|20|||
145237608|NCT03094832|523714381|FG002|Overall Study|Other|1|||
145237609|NCT03094832|523714382|FG003|Overall Study|Other|7|||
145237610|NCT03094832|523714383|FG004|Overall Study|Other|1|||
145237611|NCT01770145|523716589|FG000|Baseline|Adverse Event|20|||
145237612|NCT01770145|523716589|FG000|Baseline|Withdrawal by Subject|1|||
145237613|NCT01770145|523716589|FG000|Baseline|Lost to Follow-up|1|||
145237614|NCT01770145|523716589|FG000|Baseline|Unable to define optimal dose|4|||
145237615|NCT01770145|523716589|FG000|Treatment|Adverse Event|3|||
145237616|NCT01770145|523716589|FG000|Treatment|Withdrawal by Subject|1|||
145237617|NCT04268303|523716590|FG000|Overall Study|Lost to Follow-up|1|||
145237618|NCT04268303|523716591|FG001|Overall Study|Lost to Follow-up|1|||
145237619|NCT04268303|523716592|FG002|Overall Study|Lost to Follow-up|2|||
145237620|NCT04268303|523716590|FG000|Overall Study|Withdrawal by Subject|0|||
145237621|NCT04268303|523716591|FG001|Overall Study|Withdrawal by Subject|1|||
145237622|NCT04268303|523716592|FG002|Overall Study|Withdrawal by Subject|1|||
145237623|NCT04268303|523716590|FG000|Overall Study|Adverse Event|2|||
145237624|NCT04268303|523716591|FG001|Overall Study|Adverse Event|0|||
145237625|NCT04268303|523716592|FG002|Overall Study|Adverse Event|0|||
145237626|NCT00355134|523716593|FG000|Core Phase|Withdrawal by Subject|35|||
145237627|NCT00355134|523716594|FG001|Core Phase|Withdrawal by Subject|24|||
145237628|NCT00355134|523716595|FG002|Core Phase|Withdrawal by Subject|35|||
145237629|NCT00355134|523716596|FG003|Core Phase|Withdrawal by Subject|0|||
145237630|NCT00355134|523716597|FG004|Core Phase|Withdrawal by Subject|0|||
145237631|NCT00355134|523716593|FG000|Core Phase|Adverse Event|28|||
145237632|NCT00355134|523716594|FG001|Core Phase|Adverse Event|22|||
145237633|NCT00355134|523716595|FG002|Core Phase|Adverse Event|16|||
145237634|NCT00355134|523716596|FG003|Core Phase|Adverse Event|0|||
145237635|NCT00355134|523716597|FG004|Core Phase|Adverse Event|0|||
145237636|NCT00355134|523716593|FG000|Core Phase|Lost to Follow-up|17|||
145237637|NCT00355134|523716594|FG001|Core Phase|Lost to Follow-up|13|||
145237638|NCT00355134|523716595|FG002|Core Phase|Lost to Follow-up|21|||
145237639|NCT00355134|523716596|FG003|Core Phase|Lost to Follow-up|0|||
145237640|NCT00355134|523716597|FG004|Core Phase|Lost to Follow-up|0|||
145237641|NCT00355134|523716593|FG000|Core Phase|Abnormal laboratory value(s)|19|||
145237642|NCT00355134|523716594|FG001|Core Phase|Abnormal laboratory value(s)|14|||
145237643|NCT00355134|523716595|FG002|Core Phase|Abnormal laboratory value(s)|2|||
145237644|NCT00355134|523716596|FG003|Core Phase|Abnormal laboratory value(s)|0|||
145237645|NCT00355134|523716597|FG004|Core Phase|Abnormal laboratory value(s)|0|||
145237646|NCT00355134|523716593|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
145237647|NCT00355134|523716594|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
145237648|NCT00355134|523716595|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
145237649|NCT00355134|523716596|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
145237650|NCT00355134|523716597|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
145237651|NCT00355134|523716593|FG000|Core Phase|Administrative problems|5|||
145237652|NCT00355134|523716594|FG001|Core Phase|Administrative problems|3|||
145237653|NCT00355134|523716595|FG002|Core Phase|Administrative problems|5|||
145237654|NCT00355134|523716596|FG003|Core Phase|Administrative problems|0|||
145237655|NCT00355134|523716597|FG004|Core Phase|Administrative problems|0|||
145562588|NCT00507442|524920085|FG003|Overall Study|Progressive Disease|0|||
145562589|NCT00507442|524920082|FG000|Overall Study|Withdrawal by Subject|4|||
145237656|NCT00355134|523716593|FG000|Core Phase|Protocol Violation|3|||
145237657|NCT00355134|523716594|FG001|Core Phase|Protocol Violation|2|||
145237658|NCT00355134|523716595|FG002|Core Phase|Protocol Violation|2|||
145562590|NCT00507442|524920083|FG001|Overall Study|Withdrawal by Subject|4|||
145562591|NCT00507442|524920084|FG002|Overall Study|Withdrawal by Subject|2|||
145562592|NCT00507442|524920085|FG003|Overall Study|Withdrawal by Subject|1|||
145562593|NCT00507442|524920082|FG000|Overall Study|Other|2|||
145562594|NCT00507442|524920083|FG001|Overall Study|Other|5|||
145562595|NCT00507442|524920084|FG002|Overall Study|Other|2|||
145562596|NCT00507442|524920085|FG003|Overall Study|Other|2|||
145562597|NCT02672423|524920087|FG000|Period 1|Adverse Event|0|||
145562598|NCT02672423|524920088|FG001|Period 1|Adverse Event|0|||
145562599|NCT02672423|524920089|FG002|Period 1|Adverse Event|0|||
145562600|NCT02672423|524920090|FG003|Period 1|Adverse Event|0|||
145562601|NCT02672423|524920091|FG004|Period 1|Adverse Event|1|||
145562602|NCT02672423|524920092|FG005|Period 1|Adverse Event|0|||
145562603|NCT02672423|524920093|FG006|Period 1|Adverse Event|0|||
145562604|NCT02672423|524920094|FG007|Period 1|Adverse Event|0|||
145562605|NCT02672423|524920095|FG008|Period 1|Adverse Event|0|||
145562606|NCT02672423|524920096|FG009|Period 1|Adverse Event|0|||
145562607|NCT02672423|524920087|FG000|Period 2|Withdrawal by Subject|0|||
145562608|NCT02672423|524920088|FG001|Period 2|Withdrawal by Subject|0|||
145562609|NCT02672423|524920089|FG002|Period 2|Withdrawal by Subject|1|||
145562610|NCT02672423|524920090|FG003|Period 2|Withdrawal by Subject|0|||
145562611|NCT02672423|524920091|FG004|Period 2|Withdrawal by Subject|0|||
145562612|NCT02672423|524920092|FG005|Period 2|Withdrawal by Subject|0|||
145562613|NCT02672423|524920093|FG006|Period 2|Withdrawal by Subject|0|||
145562614|NCT02672423|524920094|FG007|Period 2|Withdrawal by Subject|0|||
145562615|NCT02672423|524920095|FG008|Period 2|Withdrawal by Subject|0|||
145562616|NCT02672423|524920096|FG009|Period 2|Withdrawal by Subject|0|||
145562617|NCT02672423|524920087|FG000|Period 3|Withdrawal by Subject|0|||
145562618|NCT02672423|524920088|FG001|Period 3|Withdrawal by Subject|0|||
145562619|NCT02672423|524920089|FG002|Period 3|Withdrawal by Subject|0|||
145237659|NCT00355134|523716596|FG003|Core Phase|Protocol Violation|0|||
145237660|NCT00355134|523716597|FG004|Core Phase|Protocol Violation|0|||
145237661|NCT00355134|523716593|FG000|Core Phase|Abnormal test procedure result(s)|1|||
145237662|NCT00355134|523716594|FG001|Core Phase|Abnormal test procedure result(s)|2|||
145237663|NCT00355134|523716595|FG002|Core Phase|Abnormal test procedure result(s)|1|||
145237664|NCT00355134|523716596|FG003|Core Phase|Abnormal test procedure result(s)|0|||
145237665|NCT00355134|523716597|FG004|Core Phase|Abnormal test procedure result(s)|0|||
145237666|NCT00355134|523716593|FG000|Core Phase|Condition no longer requires study drug|1|||
145237667|NCT00355134|523716594|FG001|Core Phase|Condition no longer requires study drug|0|||
145237668|NCT00355134|523716595|FG002|Core Phase|Condition no longer requires study drug|1|||
145408739|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
145408740|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408741|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408742|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408743|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
145237669|NCT00355134|523716596|FG003|Core Phase|Condition no longer requires study drug|0|||
145237670|NCT00355134|523716597|FG004|Core Phase|Condition no longer requires study drug|0|||
145237671|NCT00355134|523716593|FG000|Extension Phase|Withdrawal by Subject|7|||
145237672|NCT00355134|523716594|FG001|Extension Phase|Withdrawal by Subject|11|||
145237673|NCT00355134|523716595|FG002|Extension Phase|Withdrawal by Subject|0|||
145237674|NCT00355134|523716596|FG003|Extension Phase|Withdrawal by Subject|7|||
145237675|NCT00355134|523716597|FG004|Extension Phase|Withdrawal by Subject|5|||
145237676|NCT00355134|523716593|FG000|Extension Phase|Adverse Event|13|||
145237677|NCT00355134|523716594|FG001|Extension Phase|Adverse Event|9|||
145237678|NCT00355134|523716595|FG002|Extension Phase|Adverse Event|0|||
145237679|NCT00355134|523716596|FG003|Extension Phase|Adverse Event|3|||
145237680|NCT00355134|523716597|FG004|Extension Phase|Adverse Event|5|||
145237681|NCT00355134|523716593|FG000|Extension Phase|Lost to Follow-up|2|||
145237682|NCT00355134|523716594|FG001|Extension Phase|Lost to Follow-up|6|||
145237683|NCT00355134|523716595|FG002|Extension Phase|Lost to Follow-up|0|||
145237684|NCT00355134|523716596|FG003|Extension Phase|Lost to Follow-up|2|||
145562620|NCT02672423|524920090|FG003|Period 3|Withdrawal by Subject|0|||
145562621|NCT02672423|524920091|FG004|Period 3|Withdrawal by Subject|0|||
145562622|NCT02672423|524920092|FG005|Period 3|Withdrawal by Subject|0|||
145562623|NCT02672423|524920093|FG006|Period 3|Withdrawal by Subject|0|||
145237685|NCT00355134|523716597|FG004|Extension Phase|Lost to Follow-up|4|||
145562624|NCT02672423|524920094|FG007|Period 3|Withdrawal by Subject|1|||
145562625|NCT02672423|524920095|FG008|Period 3|Withdrawal by Subject|0|||
145562626|NCT02672423|524920096|FG009|Period 3|Withdrawal by Subject|0|||
145562627|NCT02672423|524920087|FG000|Period 3|Physician Decision|0|||
145562628|NCT02672423|524920088|FG001|Period 3|Physician Decision|0|||
145562629|NCT02672423|524920089|FG002|Period 3|Physician Decision|0|||
145562630|NCT02672423|524920090|FG003|Period 3|Physician Decision|0|||
145562631|NCT02672423|524920091|FG004|Period 3|Physician Decision|0|||
145562632|NCT02672423|524920092|FG005|Period 3|Physician Decision|1|||
145562633|NCT02672423|524920093|FG006|Period 3|Physician Decision|0|||
145562634|NCT02672423|524920094|FG007|Period 3|Physician Decision|0|||
145562635|NCT02672423|524920095|FG008|Period 3|Physician Decision|0|||
145562636|NCT02672423|524920096|FG009|Period 3|Physician Decision|0|||
145562637|NCT01852812|524920097|FG000|Overall Study|Adverse Event|0|||
145562638|NCT01852812|524920098|FG001|Overall Study|Adverse Event|0|||
145562639|NCT01852812|524920099|FG002|Overall Study|Adverse Event|1|||
145562640|NCT01852812|524920097|FG000|Overall Study|Non-compliance With Study Drug|0|||
145562641|NCT01852812|524920098|FG001|Overall Study|Non-compliance With Study Drug|1|||
145562642|NCT01852812|524920099|FG002|Overall Study|Non-compliance With Study Drug|0|||
145562643|NCT02290821|524920100|FG000|Overall Study|Withdrawal by Subject|1|||
145619973|NCT02459587|525123643|FG001|3-Month Follow-up Assessment|Death|2|||
145619974|NCT02459587|525123642|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
145237686|NCT00355134|523716593|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
145237687|NCT00355134|523716594|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
145237688|NCT00355134|523716595|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
145237689|NCT00355134|523716596|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
145237690|NCT00355134|523716597|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
145237691|NCT00355134|523716593|FG000|Extension Phase|Administrative problems|2|||
145237692|NCT00355134|523716594|FG001|Extension Phase|Administrative problems|4|||
145237693|NCT00355134|523716595|FG002|Extension Phase|Administrative problems|0|||
145237694|NCT00355134|523716596|FG003|Extension Phase|Administrative problems|1|||
145237695|NCT00355134|523716597|FG004|Extension Phase|Administrative problems|1|||
145237696|NCT00355134|523716593|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
145237697|NCT00355134|523716594|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
145237698|NCT00355134|523716595|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
145237699|NCT00355134|523716596|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
145237700|NCT00355134|523716597|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
145237701|NCT00355134|523716593|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
145237702|NCT00355134|523716594|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
145237703|NCT00355134|523716595|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
145237704|NCT00355134|523716596|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
145237705|NCT00355134|523716597|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
145237706|NCT00355134|523716593|FG000|Extension Phase|Protocol Violation|0|||
145237707|NCT00355134|523716594|FG001|Extension Phase|Protocol Violation|0|||
145237708|NCT00355134|523716595|FG002|Extension Phase|Protocol Violation|0|||
145237709|NCT00355134|523716596|FG003|Extension Phase|Protocol Violation|1|||
145237710|NCT00355134|523716597|FG004|Extension Phase|Protocol Violation|0|||
145237711|NCT03621189|523716602|FG000|Overall Study|Withdrawal by Subject|0|||
145237712|NCT03621189|523716603|FG001|Overall Study|Withdrawal by Subject|3|||
145237713|NCT03621189|523716602|FG000|Overall Study|Physician Decision|0|||
145237714|NCT03621189|523716603|FG001|Overall Study|Physician Decision|2|||
145237715|NCT01135394|523716604|FG000|Screening|Lost to Follow-up|2|||
145237716|NCT01135394|523716604|FG000|Screening|Withdrawal by Subject|10|||
145295619|NCT00162123|523932554|FG004|Overall Study|Disease progression|8|||
145295620|NCT00162123|523932555|FG005|Overall Study|Disease progression|3|||
145295621|NCT00162123|523932556|FG006|Overall Study|Disease progression|1|||
145295622|NCT00162123|523932557|FG007|Overall Study|Disease progression|0|||
145295623|NCT00162123|523932550|FG000|Overall Study|Study drug toxicity|6|||
145295624|NCT00162123|523932551|FG001|Overall Study|Study drug toxicity|1|||
145237717|NCT01135394|523716604|FG000|Screening|Screening failure|16|||
145237718|NCT01135394|523716604|FG000|Screening|Physician Decision|5|||
145237719|NCT01135394|523716604|FG000|Baseline Assessment|Withdrawal by Subject|9|||
145237720|NCT01135394|523716604|FG000|Baseline Assessment|Physician Decision|3|||
145237721|NCT01135394|523716604|FG000|Baseline Assessment|Lost to Follow-up|2|||
145237722|NCT01135394|523716604|FG000|Baseline Assessment|Adverse Event|1|||
145237723|NCT01135394|523716604|FG000|Study Treatment|Withdrawal by Subject|1|||
145237724|NCT01135394|523716604|FG000|Study Treatment|Physician Decision|1|||
145237725|NCT01135394|523716604|FG000|Study Treatment|Adverse Event|2|||
145237726|NCT04432376|523716605|FG000|Double-blind Treatment Period|Adverse Event|2|||
145237727|NCT04432376|523716606|FG001|Double-blind Treatment Period|Adverse Event|6|||
145237728|NCT04432376|523716607|FG002|Double-blind Treatment Period|Adverse Event|0|||
145237729|NCT04432376|523716605|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
145237730|NCT04432376|523716606|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
145237731|NCT04432376|523716607|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145237732|NCT04432376|523716605|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145237733|NCT04432376|523716606|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145562644|NCT02290821|524920101|FG001|Overall Study|Withdrawal by Subject|1|||
145562645|NCT02290821|524920100|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
145295625|NCT00162123|523932552|FG002|Overall Study|Study drug toxicity|5|||
145562646|NCT02290821|524920101|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
145562647|NCT02290821|524920100|FG000|Overall Study|Lost to Follow-up|3|||
145237734|NCT04432376|523716607|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145237735|NCT04432376|523716605|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145237736|NCT04432376|523716606|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145237737|NCT04432376|523716607|FG002|Double-blind Treatment Period|Protocol Violation|0|||
145237738|NCT04432376|523716605|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
145237739|NCT04432376|523716606|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
145237740|NCT04432376|523716607|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
145237741|NCT02088541|523716608|FG000|Overall Study|Adverse Event|3|||
145237742|NCT02088541|523716609|FG001|Overall Study|Adverse Event|0|||
145237743|NCT02088541|523716610|FG002|Overall Study|Adverse Event|3|||
145237744|NCT02088541|523716611|FG003|Overall Study|Adverse Event|3|||
145237745|NCT02088541|523716612|FG004|Overall Study|Adverse Event|0|||
145237746|NCT02088541|523716608|FG000|Overall Study|Death|51|||
145237747|NCT02088541|523716609|FG001|Overall Study|Death|21|||
145237748|NCT02088541|523716610|FG002|Overall Study|Death|85|||
145237749|NCT02088541|523716611|FG003|Overall Study|Death|28|||
145237750|NCT02088541|523716612|FG004|Overall Study|Death|38|||
145237751|NCT02088541|523716608|FG000|Overall Study|Lost to Follow-up|2|||
145237752|NCT02088541|523716609|FG001|Overall Study|Lost to Follow-up|0|||
145237753|NCT02088541|523716610|FG002|Overall Study|Lost to Follow-up|1|||
145237754|NCT02088541|523716611|FG003|Overall Study|Lost to Follow-up|0|||
145237755|NCT02088541|523716612|FG004|Overall Study|Lost to Follow-up|0|||
145237756|NCT02088541|523716608|FG000|Overall Study|Physician Decision|2|||
145237757|NCT02088541|523716609|FG001|Overall Study|Physician Decision|1|||
145237758|NCT02088541|523716610|FG002|Overall Study|Physician Decision|2|||
145237759|NCT02088541|523716611|FG003|Overall Study|Physician Decision|0|||
145237760|NCT02088541|523716612|FG004|Overall Study|Physician Decision|2|||
145237761|NCT02088541|523716608|FG000|Overall Study|Disease progression|7|||
145237762|NCT02088541|523716609|FG001|Overall Study|Disease progression|1|||
145237763|NCT02088541|523716610|FG002|Overall Study|Disease progression|2|||
145237764|NCT02088541|523716611|FG003|Overall Study|Disease progression|3|||
145237765|NCT02088541|523716612|FG004|Overall Study|Disease progression|1|||
145237766|NCT02088541|523716608|FG000|Overall Study|Study terminated by sponsor|1|||
145237767|NCT02088541|523716609|FG001|Overall Study|Study terminated by sponsor|1|||
145237768|NCT02088541|523716610|FG002|Overall Study|Study terminated by sponsor|12|||
145237769|NCT02088541|523716611|FG003|Overall Study|Study terminated by sponsor|2|||
145237770|NCT02088541|523716612|FG004|Overall Study|Study terminated by sponsor|6|||
145237771|NCT02088541|523716608|FG000|Overall Study|Withdrawal by Subject|3|||
145237772|NCT02088541|523716609|FG001|Overall Study|Withdrawal by Subject|2|||
145237773|NCT02088541|523716610|FG002|Overall Study|Withdrawal by Subject|9|||
145237774|NCT02088541|523716611|FG003|Overall Study|Withdrawal by Subject|7|||
145237775|NCT02088541|523716612|FG004|Overall Study|Withdrawal by Subject|10|||
145237776|NCT02088541|523716608|FG000|Overall Study|Other|2|||
145237777|NCT02088541|523716609|FG001|Overall Study|Other|1|||
145237778|NCT02088541|523716610|FG002|Overall Study|Other|3|||
145237779|NCT02088541|523716611|FG003|Overall Study|Other|1|||
145237780|NCT02088541|523716612|FG004|Overall Study|Other|1|||
145237781|NCT05742841|523716613|FG000|Overall Study|Withdrawal by Subject|1|||
145237782|NCT05742841|523716613|FG000|Overall Study|Lost to Follow-up|1|||
145237783|NCT04134728|523716614|FG000|Overall Study|Adverse Event|3|||
145237784|NCT04134728|523716615|FG001|Overall Study|Adverse Event|2|||
145237785|NCT04134728|523716616|FG002|Overall Study|Adverse Event|9|||
145237786|NCT04134728|523716617|FG003|Overall Study|Adverse Event|0|||
145237787|NCT04134728|523716618|FG004|Overall Study|Adverse Event|0|||
145237788|NCT04134728|523716619|FG005|Overall Study|Adverse Event|0|||
145562648|NCT02290821|524920101|FG001|Overall Study|Lost to Follow-up|2|||
145562649|NCT02438722|524920102|FG000|Overall Study|Adverse Event|12|||
145562650|NCT02438722|524920103|FG001|Overall Study|Adverse Event|9|||
145562651|NCT02438722|524920102|FG000|Overall Study|Refusal unrelated to AE|2|||
145562652|NCT02438722|524920103|FG001|Overall Study|Refusal unrelated to AE|5|||
145562653|NCT02438722|524920102|FG000|Overall Study|Disease progression/relapse|46|||
145562654|NCT02438722|524920103|FG001|Overall Study|Disease progression/relapse|51|||
145562655|NCT02438722|524920102|FG000|Overall Study|Death|0|||
145237789|NCT04134728|523716614|FG000|Overall Study|Lack of Efficacy|3|||
145237790|NCT04134728|523716615|FG001|Overall Study|Lack of Efficacy|3|||
145237791|NCT04134728|523716616|FG002|Overall Study|Lack of Efficacy|1|||
145237792|NCT04134728|523716617|FG003|Overall Study|Lack of Efficacy|2|||
145237793|NCT04134728|523716618|FG004|Overall Study|Lack of Efficacy|0|||
145237794|NCT04134728|523716619|FG005|Overall Study|Lack of Efficacy|0|||
145562656|NCT02438722|524920103|FG001|Overall Study|Death|3|||
145237795|NCT04134728|523716614|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145237796|NCT04134728|523716615|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145237797|NCT04134728|523716616|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
145237798|NCT04134728|523716617|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145237799|NCT04134728|523716618|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145237800|NCT04134728|523716619|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145562657|NCT02438722|524920102|FG000|Overall Study|Physician Decision|2|||
145408744|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408745|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408746|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408747|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
145408748|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145408749|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145408750|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
145408751|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145237801|NCT04134728|523716614|FG000|Overall Study|Protocol Deviation|0|||
145237802|NCT04134728|523716615|FG001|Overall Study|Protocol Deviation|0|||
145237803|NCT04134728|523716616|FG002|Overall Study|Protocol Deviation|1|||
145237804|NCT04134728|523716617|FG003|Overall Study|Protocol Deviation|0|||
145237805|NCT04134728|523716618|FG004|Overall Study|Protocol Deviation|0|||
145237806|NCT04134728|523716619|FG005|Overall Study|Protocol Deviation|0|||
145237807|NCT04134728|523716614|FG000|Overall Study|Informed Consent Withdrawn|3|||
145237808|NCT04134728|523716615|FG001|Overall Study|Informed Consent Withdrawn|6|||
145237809|NCT04134728|523716616|FG002|Overall Study|Informed Consent Withdrawn|8|||
145237810|NCT04134728|523716617|FG003|Overall Study|Informed Consent Withdrawn|1|||
145237811|NCT04134728|523716618|FG004|Overall Study|Informed Consent Withdrawn|1|||
145237812|NCT04134728|523716619|FG005|Overall Study|Informed Consent Withdrawn|0|||
145237813|NCT04134728|523716614|FG000|Overall Study|Physician Decision|2|||
145237814|NCT04134728|523716615|FG001|Overall Study|Physician Decision|0|||
145237815|NCT04134728|523716616|FG002|Overall Study|Physician Decision|0|||
145237816|NCT04134728|523716617|FG003|Overall Study|Physician Decision|0|||
145237817|NCT04134728|523716618|FG004|Overall Study|Physician Decision|0|||
145237818|NCT04134728|523716619|FG005|Overall Study|Physician Decision|0|||
145237819|NCT04134728|523716614|FG000|Overall Study|Lost to Follow-up|1|||
145237820|NCT04134728|523716615|FG001|Overall Study|Lost to Follow-up|2|||
145237821|NCT04134728|523716616|FG002|Overall Study|Lost to Follow-up|1|||
145237822|NCT04134728|523716617|FG003|Overall Study|Lost to Follow-up|0|||
145237823|NCT04134728|523716618|FG004|Overall Study|Lost to Follow-up|0|||
145237824|NCT04134728|523716619|FG005|Overall Study|Lost to Follow-up|1|||
145237825|NCT04134728|523716614|FG000|Overall Study|Investigator Site Closed|0|||
145237826|NCT04134728|523716615|FG001|Overall Study|Investigator Site Closed|1|||
145237827|NCT04134728|523716616|FG002|Overall Study|Investigator Site Closed|1|||
145237828|NCT04134728|523716617|FG003|Overall Study|Investigator Site Closed|0|||
145237829|NCT04134728|523716618|FG004|Overall Study|Investigator Site Closed|0|||
145237830|NCT04134728|523716619|FG005|Overall Study|Investigator Site Closed|0|||
145237831|NCT01601704|523716629|FG000|Overall Study|Randomized but not dispensed study med|1|||
145237832|NCT01601704|523716630|FG001|Overall Study|Randomized but not dispensed study med|4|||
145619975|NCT02459587|525123643|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
145237833|NCT01090102|523716631|FG000|First 12 Weeks|Withdrawal by Subject|1|||
145237834|NCT01090102|523716632|FG001|First 12 Weeks|Withdrawal by Subject|1|||
145237835|NCT01090102|523716631|FG000|First 12 Weeks|Adverse Event|2|||
145237836|NCT01090102|523716632|FG001|First 12 Weeks|Adverse Event|0|||
145237837|NCT01090102|523716631|FG000|First 12 Weeks|Death|1|||
145237838|NCT01090102|523716632|FG001|First 12 Weeks|Death|1|||
145237839|NCT01090102|523716631|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
145237840|NCT01090102|523716632|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
145237841|NCT03518034|523716635|FG000|Overall Study|Not Treated|5|||
145237842|NCT03518034|523716636|FG001|Overall Study|Not Treated|1|||
145237843|NCT03518034|523716635|FG000|Overall Study|Withdrawal by Subject|309|||
145237844|NCT03518034|523716636|FG001|Overall Study|Withdrawal by Subject|351|||
145237845|NCT03518034|523716635|FG000|Overall Study|Lost to Follow-up|446|||
145237846|NCT03518034|523716636|FG001|Overall Study|Lost to Follow-up|458|||
145237847|NCT03518034|523716635|FG000|Overall Study|Adverse Event|138|||
145237848|NCT03518034|523716636|FG001|Overall Study|Adverse Event|130|||
145237849|NCT03518034|523716635|FG000|Overall Study|Lack of Efficacy|11|||
145237850|NCT03518034|523716636|FG001|Overall Study|Lack of Efficacy|23|||
145237851|NCT03518034|523716635|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
145237852|NCT03518034|523716636|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
145237853|NCT03518034|523716635|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
145237854|NCT03518034|523716636|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
145237855|NCT03518034|523716635|FG000|Overall Study|Other, Not Specified|84|||
145237856|NCT03518034|523716636|FG001|Overall Study|Other, Not Specified|53|||
145237857|NCT03518034|523716635|FG000|Overall Study|Reason Missing|2|||
145237858|NCT03518034|523716636|FG001|Overall Study|Reason Missing|3|||
145237859|NCT00010803|523716642|FG000|Overall Study|Withdrawal by Subject|97|||
145237860|NCT00010803|523716643|FG001|Overall Study|Withdrawal by Subject|98|||
145237861|NCT01019252|523716644|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
145237862|NCT01019252|523716645|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
145237863|NCT01019252|523716644|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
145237864|NCT01019252|523716645|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
145237865|NCT01019252|523716644|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
145237866|NCT01019252|523716645|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
145237867|NCT01019252|523716644|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
145237868|NCT01019252|523716645|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
145237869|NCT04671342|523716646|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
145237870|NCT04671342|523716646|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
145237871|NCT04671342|523716646|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
145237872|NCT04671342|523716646|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
145237873|NCT04671342|523716646|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
145237874|NCT04671342|523716646|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
145237875|NCT02273037|523716648|FG000|Overall Study|Lost to Follow-up|1|||
145237876|NCT02273037|523716649|FG001|Overall Study|Lost to Follow-up|0|||
145237877|NCT02273037|523716648|FG000|Overall Study|Delivered before monitoring initiated|1|||
145237878|NCT02273037|523716649|FG001|Overall Study|Delivered before monitoring initiated|3|||
145237879|NCT02273037|523716648|FG000|Overall Study|Breech delivery|2|||
145237880|NCT02273037|523716649|FG001|Overall Study|Breech delivery|3|||
145237881|NCT02273037|523716648|FG000|Overall Study|Multiple delivery|2|||
145237882|NCT02273037|523716649|FG001|Overall Study|Multiple delivery|2|||
145237883|NCT02273037|523716648|FG000|Overall Study|Other complication|2|||
145237884|NCT02273037|523716649|FG001|Overall Study|Other complication|0|||
145237885|NCT02062398|523716650|FG000|Overall Study|Implant removal|1|||
145237886|NCT00415519|523716653|FG000|Overall Study|Adverse Event|1|||
145237887|NCT00415519|523716654|FG001|Overall Study|Adverse Event|0|||
145237888|NCT00415519|523716653|FG000|Overall Study|Withdrawal by Subject|2|||
145237889|NCT00415519|523716654|FG001|Overall Study|Withdrawal by Subject|0|||
145237890|NCT00415519|523716653|FG000|Overall Study|Patient's convenience|1|||
145237891|NCT00415519|523716654|FG001|Overall Study|Patient's convenience|0|||
145237892|NCT03351478|523716655|FG000|Overall Study|At the subject's own request|11|||
145237893|NCT03351478|523716656|FG001|Overall Study|At the subject's own request|12|||
145237894|NCT03351478|523716657|FG002|Overall Study|At the subject's own request|5|||
145237895|NCT03351478|523716655|FG000|Overall Study|Adverse Event|1|||
145237896|NCT03351478|523716656|FG001|Overall Study|Adverse Event|2|||
145237897|NCT03351478|523716657|FG002|Overall Study|Adverse Event|1|||
145237898|NCT03351478|523716655|FG000|Overall Study|Poor compliance to protocol|1|||
145237899|NCT03351478|523716656|FG001|Overall Study|Poor compliance to protocol|0|||
145237900|NCT03351478|523716657|FG002|Overall Study|Poor compliance to protocol|0|||
145237901|NCT03351478|523716655|FG000|Overall Study|Reason not Specified|1|||
145237902|NCT03351478|523716656|FG001|Overall Study|Reason not Specified|3|||
145237903|NCT03351478|523716657|FG002|Overall Study|Reason not Specified|0|||
145237904|NCT03351478|523716655|FG000|Overall Study|Lost to Follow-up|0|||
145237905|NCT03351478|523716656|FG001|Overall Study|Lost to Follow-up|0|||
145237906|NCT03351478|523716657|FG002|Overall Study|Lost to Follow-up|1|||
145237907|NCT03657810|523716662|FG000|Overall Study|Adverse Event|0|||
145237908|NCT03657810|523716663|FG001|Overall Study|Adverse Event|1|||
145237909|NCT03657810|523716664|FG002|Overall Study|Adverse Event|0|||
145237910|NCT03657810|523716662|FG000|Overall Study|Lack of Efficacy|4|||
145237911|NCT03657810|523716663|FG001|Overall Study|Lack of Efficacy|1|||
145237912|NCT03657810|523716664|FG002|Overall Study|Lack of Efficacy|3|||
145237913|NCT03657810|523716662|FG000|Overall Study|Protocol Violation|1|||
145237914|NCT03657810|523716663|FG001|Overall Study|Protocol Violation|0|||
145237915|NCT03657810|523716664|FG002|Overall Study|Protocol Violation|0|||
145237916|NCT03657810|523716662|FG000|Overall Study|Lost to Follow-up|0|||
145237917|NCT03657810|523716663|FG001|Overall Study|Lost to Follow-up|1|||
145237918|NCT03657810|523716664|FG002|Overall Study|Lost to Follow-up|0|||
145237919|NCT03657810|523716662|FG000|Overall Study|Not provided|0|||
145237920|NCT03657810|523716663|FG001|Overall Study|Not provided|1|||
145237921|NCT03657810|523716664|FG002|Overall Study|Not provided|0|||
145237922|NCT03911869|523716665|FG000|Safety Lead-in Phase|Death|7|||
145237923|NCT03911869|523716666|FG001|Safety Lead-in Phase|Death|0|||
145237924|NCT03911869|523716667|FG002|Safety Lead-in Phase|Death|0|||
145237925|NCT03911869|523716665|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
145237926|NCT03911869|523716666|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
145237927|NCT03911869|523716667|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
145237928|NCT03911869|523716665|FG000|Safety Lead-in Phase|Other|1|||
145237929|NCT03911869|523716666|FG001|Safety Lead-in Phase|Other|0|||
145237930|NCT03911869|523716667|FG002|Safety Lead-in Phase|Other|0|||
145237931|NCT03911869|523716665|FG000|Phase 2|Death|0|||
145237932|NCT03911869|523716666|FG001|Phase 2|Death|3|||
145237933|NCT03911869|523716667|FG002|Phase 2|Death|0|||
145237934|NCT00985738|523716671|FG000|Overall Study|Study closed prematurely|8|||
145237935|NCT00985738|523716672|FG001|Overall Study|Study closed prematurely|8|||
145237936|NCT03325556|523716673|FG000|Open-label Period|Lack of Response in OL period|70|||
145237937|NCT03325556|523716674|FG001|Open-label Period|Lack of Response in OL period|0|||
145237938|NCT03325556|523716675|FG002|Open-label Period|Lack of Response in OL period|0|||
145237939|NCT03325556|523716673|FG000|Open-label Period|Adverse Event|27|||
145489782|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
145562658|NCT02438722|524920103|FG001|Overall Study|Physician Decision|2|||
145237940|NCT03325556|523716674|FG001|Open-label Period|Adverse Event|0|||
145237941|NCT03325556|523716675|FG002|Open-label Period|Adverse Event|0|||
145237942|NCT03325556|523716673|FG000|Open-label Period|Death|1|||
145237943|NCT03325556|523716674|FG001|Open-label Period|Death|0|||
145237944|NCT03325556|523716675|FG002|Open-label Period|Death|0|||
145237945|NCT03325556|523716673|FG000|Open-label Period|Lost to Follow-up|1|||
145237946|NCT03325556|523716674|FG001|Open-label Period|Lost to Follow-up|0|||
145237947|NCT03325556|523716675|FG002|Open-label Period|Lost to Follow-up|0|||
145237948|NCT03325556|523716673|FG000|Open-label Period|Non-compliance with study drug|5|||
145237949|NCT03325556|523716674|FG001|Open-label Period|Non-compliance with study drug|0|||
145562659|NCT02438722|524920102|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
145562660|NCT02438722|524920103|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
145562661|NCT02438722|524920102|FG000|Overall Study|Withdrawal by Subject|0|||
145562662|NCT02438722|524920103|FG001|Overall Study|Withdrawal by Subject|1|||
145237950|NCT03325556|523716675|FG002|Open-label Period|Non-compliance with study drug|0|||
145562663|NCT02438722|524920102|FG000|Overall Study|On protocol treatment|15|||
145562664|NCT02438722|524920103|FG001|Overall Study|On protocol treatment|14|||
145562665|NCT02438722|524920102|FG000|Overall Study|Did not receive protocol treatment|5|||
145562666|NCT02438722|524920103|FG001|Overall Study|Did not receive protocol treatment|0|||
145562667|NCT01520363|524920104|FG000|Overall Study|Withdrawal by Subject|2|||
145562668|NCT01520363|524920105|FG001|Overall Study|Withdrawal by Subject|0|||
145562669|NCT01154218|524920107|FG000|Third Intervention Period|Adverse Event|0|||
145562670|NCT01154218|524920108|FG001|Third Intervention Period|Adverse Event|1|||
145562671|NCT01154218|524920109|FG002|Third Intervention Period|Adverse Event|0|||
145562672|NCT01154218|524920110|FG003|Third Intervention Period|Adverse Event|0|||
145562673|NCT01154218|524920107|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145562674|NCT01154218|524920108|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145562675|NCT01154218|524920109|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145562676|NCT01154218|524920110|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
145562677|NCT01154218|524920107|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
145562678|NCT01154218|524920108|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
145562679|NCT01154218|524920109|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
145562680|NCT01154218|524920110|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
145562681|NCT00362115|524920113|FG000|Overall Study|Adverse Event|0|||
145562682|NCT00362115|524920114|FG001|Overall Study|Adverse Event|1|||
145562683|NCT00362115|524920115|FG002|Overall Study|Adverse Event|1|||
145562684|NCT00362115|524920116|FG003|Overall Study|Adverse Event|1|||
145562685|NCT00362115|524920117|FG004|Overall Study|Adverse Event|2|||
145562686|NCT00362115|524920118|FG005|Overall Study|Adverse Event|2|||
145562687|NCT00362115|524920119|FG006|Overall Study|Adverse Event|1|||
145562688|NCT00362115|524920113|FG000|Overall Study|Protocol Violation|0|||
145562689|NCT00362115|524920114|FG001|Overall Study|Protocol Violation|0|||
145562690|NCT00362115|524920115|FG002|Overall Study|Protocol Violation|0|||
145562691|NCT00362115|524920116|FG003|Overall Study|Protocol Violation|0|||
145562692|NCT00362115|524920117|FG004|Overall Study|Protocol Violation|0|||
145562693|NCT00362115|524920118|FG005|Overall Study|Protocol Violation|1|||
145562694|NCT00362115|524920119|FG006|Overall Study|Protocol Violation|0|||
145562695|NCT00362115|524920113|FG000|Overall Study|Lost to Follow-up|0|||
145237951|NCT03325556|523716673|FG000|Open-label Period|Use of prohibited medication|1|||
145237952|NCT03325556|523716674|FG001|Open-label Period|Use of prohibited medication|0|||
145237953|NCT03325556|523716675|FG002|Open-label Period|Use of prohibited medication|0|||
145237954|NCT03325556|523716673|FG000|Open-label Period|Protocol Violation|4|||
145237955|NCT03325556|523716674|FG001|Open-label Period|Protocol Violation|0|||
145237956|NCT03325556|523716675|FG002|Open-label Period|Protocol Violation|0|||
145237957|NCT03325556|523716673|FG000|Open-label Period|Withdrawal by Subject|17|||
145237958|NCT03325556|523716674|FG001|Open-label Period|Withdrawal by Subject|0|||
145237959|NCT03325556|523716675|FG002|Open-label Period|Withdrawal by Subject|0|||
145237960|NCT03325556|523716673|FG000|Open-label Period|Not otherwise specified|8|||
145237961|NCT03325556|523716674|FG001|Open-label Period|Not otherwise specified|0|||
145237962|NCT03325556|523716675|FG002|Open-label Period|Not otherwise specified|0|||
145237963|NCT03325556|523716673|FG000|Open-label Period|Administrative discont. at study termination|41|||
145237964|NCT03325556|523716674|FG001|Open-label Period|Administrative discont. at study termination|0|||
145562696|NCT00362115|524920114|FG001|Overall Study|Lost to Follow-up|1|||
145562697|NCT00362115|524920115|FG002|Overall Study|Lost to Follow-up|0|||
145562698|NCT00362115|524920116|FG003|Overall Study|Lost to Follow-up|0|||
145237965|NCT03325556|523716675|FG002|Open-label Period|Administrative discont. at study termination|0|||
145408752|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145562699|NCT00362115|524920117|FG004|Overall Study|Lost to Follow-up|2|||
145562700|NCT00362115|524920118|FG005|Overall Study|Lost to Follow-up|0|||
145562701|NCT00362115|524920119|FG006|Overall Study|Lost to Follow-up|1|||
145562702|NCT00362115|524920113|FG000|Overall Study|Withdrawal by Subject|1|||
145562703|NCT00362115|524920114|FG001|Overall Study|Withdrawal by Subject|3|||
145562704|NCT00362115|524920115|FG002|Overall Study|Withdrawal by Subject|1|||
145237966|NCT03325556|523716673|FG000|Double-blind Period|Relapse|0|||
145237967|NCT03325556|523716674|FG001|Double-blind Period|Relapse|15|||
145237968|NCT03325556|523716675|FG002|Double-blind Period|Relapse|34|||
145237969|NCT03325556|523716673|FG000|Double-blind Period|Adverse Event|0|||
145237970|NCT03325556|523716674|FG001|Double-blind Period|Adverse Event|3|||
145237971|NCT03325556|523716675|FG002|Double-blind Period|Adverse Event|1|||
145237972|NCT03325556|523716673|FG000|Double-blind Period|Noncompliance with study drug|0|||
145237973|NCT03325556|523716674|FG001|Double-blind Period|Noncompliance with study drug|0|||
145237974|NCT03325556|523716675|FG002|Double-blind Period|Noncompliance with study drug|1|||
145237975|NCT03325556|523716673|FG000|Double-blind Period|Use of prohibited medication|0|||
145237976|NCT03325556|523716674|FG001|Double-blind Period|Use of prohibited medication|1|||
145237977|NCT03325556|523716675|FG002|Double-blind Period|Use of prohibited medication|0|||
145237978|NCT03325556|523716673|FG000|Double-blind Period|Physician Decision|0|||
145237979|NCT03325556|523716674|FG001|Double-blind Period|Physician Decision|0|||
145237980|NCT03325556|523716675|FG002|Double-blind Period|Physician Decision|1|||
145237981|NCT03325556|523716673|FG000|Double-blind Period|Withdrawal by Subject|0|||
145237982|NCT03325556|523716674|FG001|Double-blind Period|Withdrawal by Subject|6|||
145237983|NCT03325556|523716675|FG002|Double-blind Period|Withdrawal by Subject|4|||
145237984|NCT03325556|523716673|FG000|Double-blind Period|Not otherwise specified|0|||
145237985|NCT03325556|523716674|FG001|Double-blind Period|Not otherwise specified|1|||
145237986|NCT03325556|523716675|FG002|Double-blind Period|Not otherwise specified|5|||
145237987|NCT03325556|523716673|FG000|Double-blind Period|Administrative discont. at study termination|0|||
145237988|NCT03325556|523716674|FG001|Double-blind Period|Administrative discont. at study termination|35|||
145237989|NCT03325556|523716675|FG002|Double-blind Period|Administrative discont. at study termination|31|||
145237990|NCT01705587|523716676|FG000|Overall Study|Withdrawal by Subject|0|||
145237991|NCT01705587|523716677|FG001|Overall Study|Withdrawal by Subject|1|||
145237992|NCT02227849|523716678|FG000|Overall Study|Adverse Event|4|||
145237993|NCT02227849|523716678|FG000|Overall Study|Physician Decision|1|||
145237994|NCT02227849|523716678|FG000|Overall Study|Withdrawal by Subject|3|||
145237995|NCT01590212|523716681|FG000|Overall Study|Withdrawal by Subject|2|||
145237996|NCT01590212|523716682|FG001|Overall Study|Withdrawal by Subject|2|||
145237997|NCT01590212|523716683|FG002|Overall Study|Withdrawal by Subject|2|||
145237998|NCT01590212|523716681|FG000|Overall Study|Lost to Follow-up|1|||
145237999|NCT01590212|523716682|FG001|Overall Study|Lost to Follow-up|2|||
145238000|NCT01590212|523716683|FG002|Overall Study|Lost to Follow-up|3|||
145238001|NCT00762268|523716684|FG000|Overall Study|Withdrawal by Subject|3|||
145238002|NCT00762268|523716685|FG001|Overall Study|Withdrawal by Subject|3|||
145238003|NCT02533401|523716686|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
145238004|NCT02533401|523716686|FG000|Overall Study|Death|5|||
145238005|NCT02533401|523716686|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
145238006|NCT02533401|523716686|FG000|Overall Study|Lost to Follow-up|1|||
145238007|NCT02533401|523716686|FG000|Overall Study|Violation of Selection Criteria|1|||
145238008|NCT04897594|523716689|FG000|Overall Study|Lost to Follow-up|0|||
145238009|NCT04897594|523716690|FG001|Overall Study|Lost to Follow-up|1|||
145238010|NCT04897594|523716691|FG002|Overall Study|Lost to Follow-up|1|||
145238011|NCT04897594|523716689|FG000|Overall Study|Sponsor Decision|0|||
145238012|NCT04897594|523716690|FG001|Overall Study|Sponsor Decision|0|||
145238013|NCT04897594|523716691|FG002|Overall Study|Sponsor Decision|1|||
145238014|NCT04897594|523716689|FG000|Overall Study|Withdrawal by Subject|1|||
145238015|NCT04897594|523716690|FG001|Overall Study|Withdrawal by Subject|0|||
145238016|NCT04897594|523716691|FG002|Overall Study|Withdrawal by Subject|1|||
145238017|NCT00881361|523716696|FG000|Overall Study|Terminated prior to surgery|27|||
145238018|NCT00881361|523716697|FG001|Overall Study|Terminated prior to surgery|7|||
145238019|NCT00881361|523716698|FG002|Overall Study|Terminated prior to surgery|0|||
145238020|NCT00881361|523716696|FG000|Overall Study|Ineligible|17|||
145238021|NCT00881361|523716697|FG001|Overall Study|Ineligible|2|||
145238022|NCT00881361|523716698|FG002|Overall Study|Ineligible|2|||
145238023|NCT02137837|523716699|FG000|Overall Study|Adverse Event|0|||
145238024|NCT02137837|523716700|FG001|Overall Study|Adverse Event|2|||
145238025|NCT02137837|523716701|FG002|Overall Study|Adverse Event|1|||
145238026|NCT02137837|523716699|FG000|Overall Study|Refusal unrelated to adverse event|2|||
145238027|NCT02137837|523716700|FG001|Overall Study|Refusal unrelated to adverse event|2|||
145238028|NCT02137837|523716701|FG002|Overall Study|Refusal unrelated to adverse event|1|||
145238029|NCT02137837|523716699|FG000|Overall Study|Progression/relapse|9|||
145238030|NCT02137837|523716700|FG001|Overall Study|Progression/relapse|7|||
145238031|NCT02137837|523716701|FG002|Overall Study|Progression/relapse|7|||
145238032|NCT02137837|523716699|FG000|Overall Study|Not protocol specified|2|||
145238033|NCT02137837|523716700|FG001|Overall Study|Not protocol specified|1|||
145238034|NCT02137837|523716701|FG002|Overall Study|Not protocol specified|3|||
145238035|NCT01181141|523716706|FG000|Overall Study|Adverse Event|2|||
145238036|NCT01181141|523716707|FG001|Overall Study|Adverse Event|1|||
145238037|NCT01181141|523716706|FG000|Overall Study|Lack of Efficacy|1|||
145238038|NCT01181141|523716707|FG001|Overall Study|Lack of Efficacy|0|||
145238039|NCT01181141|523716706|FG000|Overall Study|Lost to Follow-up|1|||
145238040|NCT01181141|523716707|FG001|Overall Study|Lost to Follow-up|1|||
145238041|NCT01181141|523716706|FG000|Overall Study|Physician Decision|2|||
145238042|NCT01181141|523716707|FG001|Overall Study|Physician Decision|0|||
145238043|NCT01181141|523716706|FG000|Overall Study|Protocol Violation|3|||
145238044|NCT01181141|523716707|FG001|Overall Study|Protocol Violation|1|||
145238045|NCT01181141|523716706|FG000|Overall Study|Withdrawal by Subject|3|||
145238046|NCT01181141|523716707|FG001|Overall Study|Withdrawal by Subject|1|||
145238047|NCT01329341|523716708|FG000|Overall Study|Withdrawal by Subject|44|||
145238048|NCT03017846|523716711|FG000|Overall Study|Lost to Follow-up|3|||
145238049|NCT03017846|523716711|FG000|Overall Study|Adverse Event|2|||
145238050|NCT05014542|523716713|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
145238051|NCT05014542|523716714|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
145238052|NCT05014542|523716713|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
145238053|NCT05014542|523716714|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
145238054|NCT05014542|523716713|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
145238055|NCT05014542|523716714|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
145238056|NCT05014542|523716713|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
145238057|NCT05014542|523716714|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
145238058|NCT01438307|523716715|FG000|Overall Study|Death|1|||
145238059|NCT01438307|523716716|FG001|Overall Study|Death|1|||
145238060|NCT01342952|523716717|FG000|Overall Study|Adverse Event|0|||
145238061|NCT01342952|523716718|FG001|Overall Study|Adverse Event|5|||
145238062|NCT01342952|523716719|FG002|Overall Study|Adverse Event|1|||
145238063|NCT01342952|523716720|FG003|Overall Study|Adverse Event|0|||
145238064|NCT01342952|523716717|FG000|Overall Study|Lost to Follow-up|0|||
145238065|NCT01342952|523716718|FG001|Overall Study|Lost to Follow-up|2|||
145238066|NCT01342952|523716719|FG002|Overall Study|Lost to Follow-up|0|||
145238067|NCT01342952|523716720|FG003|Overall Study|Lost to Follow-up|0|||
145238068|NCT01342952|523716717|FG000|Overall Study|Withdrawal by Subject|1|||
145238069|NCT01342952|523716718|FG001|Overall Study|Withdrawal by Subject|1|||
145238070|NCT01342952|523716719|FG002|Overall Study|Withdrawal by Subject|0|||
145238071|NCT01342952|523716720|FG003|Overall Study|Withdrawal by Subject|0|||
145238072|NCT01342952|523716717|FG000|Overall Study|Physician Decision|3|||
145238073|NCT01342952|523716718|FG001|Overall Study|Physician Decision|3|||
145238074|NCT01342952|523716719|FG002|Overall Study|Physician Decision|1|||
145238075|NCT01342952|523716720|FG003|Overall Study|Physician Decision|0|||
145238076|NCT03970824|523716724|FG000|Overall Study|Withdrawal by Subject|1|||
145238077|NCT03970824|523716725|FG001|Overall Study|Withdrawal by Subject|1|||
145238078|NCT03970824|523716726|FG002|Overall Study|Withdrawal by Subject|3|||
145238079|NCT03970824|523716724|FG000|Overall Study|Lost to Follow-up|0|||
145238080|NCT03970824|523716725|FG001|Overall Study|Lost to Follow-up|2|||
145238081|NCT03970824|523716726|FG002|Overall Study|Lost to Follow-up|1|||
145238082|NCT03970824|523716724|FG000|Overall Study|Adverse Event|1|||
145238083|NCT03970824|523716725|FG001|Overall Study|Adverse Event|0|||
145238084|NCT03970824|523716726|FG002|Overall Study|Adverse Event|0|||
145238085|NCT00416312|523716727|FG000|Overall Study|tumors not visible on imaging|2|||
145238086|NCT00105560|523716730|FG000|Overall Study|Lost to Follow-up|1|||
145238087|NCT02146248|523716732|FG000|Overall Study|Withdrawal by Subject|2|||
145238088|NCT01315847|523716733|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
145238089|NCT01315847|523716734|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
145238090|NCT01315847|523716733|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
145238091|NCT01315847|523716734|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
145238092|NCT00862654|523716740|FG000|Overall Study|Lack of Efficacy|1|||
145238093|NCT00862654|523716741|FG001|Overall Study|Lack of Efficacy|0|||
145238094|NCT00862654|523716742|FG002|Overall Study|Lack of Efficacy|1|||
145238095|NCT00862654|523716743|FG003|Overall Study|Lack of Efficacy|0|||
145238096|NCT00862654|523716740|FG000|Overall Study|Lost to Follow-up|1|||
145238097|NCT00862654|523716741|FG001|Overall Study|Lost to Follow-up|2|||
145238098|NCT00862654|523716742|FG002|Overall Study|Lost to Follow-up|1|||
145238099|NCT00862654|523716743|FG003|Overall Study|Lost to Follow-up|3|||
145238100|NCT00862654|523716740|FG000|Overall Study|Adverse Event|0|||
145238101|NCT00862654|523716741|FG001|Overall Study|Adverse Event|1|||
145238102|NCT00862654|523716742|FG002|Overall Study|Adverse Event|1|||
145238103|NCT00862654|523716743|FG003|Overall Study|Adverse Event|0|||
145238104|NCT00862654|523716740|FG000|Overall Study|Pregnancy|1|||
145562705|NCT00362115|524920116|FG003|Overall Study|Withdrawal by Subject|0|||
145562706|NCT00362115|524920117|FG004|Overall Study|Withdrawal by Subject|1|||
145238105|NCT00862654|523716741|FG001|Overall Study|Pregnancy|1|||
145238106|NCT00862654|523716742|FG002|Overall Study|Pregnancy|0|||
145238107|NCT00862654|523716743|FG003|Overall Study|Pregnancy|0|||
145238108|NCT00862654|523716740|FG000|Overall Study|Withdrawal by Subject|2|||
145238109|NCT00862654|523716741|FG001|Overall Study|Withdrawal by Subject|2|||
145238110|NCT00862654|523716742|FG002|Overall Study|Withdrawal by Subject|2|||
145238111|NCT00862654|523716743|FG003|Overall Study|Withdrawal by Subject|3|||
145238112|NCT00862654|523716740|FG000|Overall Study|Subject mistake|0|||
145238113|NCT00862654|523716741|FG001|Overall Study|Subject mistake|1|||
145238114|NCT00862654|523716742|FG002|Overall Study|Subject mistake|0|||
145238115|NCT00862654|523716743|FG003|Overall Study|Subject mistake|0|||
145238116|NCT00862654|523716740|FG000|Overall Study|Familly constraint|0|||
145562707|NCT00362115|524920118|FG005|Overall Study|Withdrawal by Subject|3|||
145238117|NCT00862654|523716741|FG001|Overall Study|Familly constraint|1|||
145238118|NCT00862654|523716742|FG002|Overall Study|Familly constraint|0|||
145238119|NCT00862654|523716743|FG003|Overall Study|Familly constraint|0|||
145238120|NCT00862654|523716740|FG000|Overall Study|Never used study drugs|1|||
145238121|NCT00862654|523716741|FG001|Overall Study|Never used study drugs|0|||
145238122|NCT00862654|523716742|FG002|Overall Study|Never used study drugs|0|||
145238123|NCT00862654|523716743|FG003|Overall Study|Never used study drugs|0|||
145238124|NCT00862654|523716740|FG000|Overall Study|Included after end of inclusions|0|||
145238125|NCT00862654|523716741|FG001|Overall Study|Included after end of inclusions|0|||
145238126|NCT00862654|523716742|FG002|Overall Study|Included after end of inclusions|1|||
145238127|NCT00862654|523716743|FG003|Overall Study|Included after end of inclusions|0|||
145238128|NCT03954444|523716744|FG000|Overall Study|Withdrawal by Subject|5|||
145238129|NCT03954444|523716745|FG001|Overall Study|Withdrawal by Subject|5|||
145238130|NCT03954444|523716746|FG002|Overall Study|Withdrawal by Subject|5|||
145238131|NCT03954444|523716744|FG000|Overall Study|Adverse Event|1|||
145238132|NCT03954444|523716745|FG001|Overall Study|Adverse Event|3|||
145238133|NCT03954444|523716746|FG002|Overall Study|Adverse Event|2|||
145238134|NCT03954444|523716744|FG000|Overall Study|Protocol Violation|0|||
145238135|NCT03954444|523716745|FG001|Overall Study|Protocol Violation|3|||
145238136|NCT03954444|523716746|FG002|Overall Study|Protocol Violation|5|||
145238137|NCT03954444|523716744|FG000|Overall Study|Use of prohibited therapy|1|||
145238138|NCT03954444|523716745|FG001|Overall Study|Use of prohibited therapy|1|||
145238139|NCT03954444|523716746|FG002|Overall Study|Use of prohibited therapy|2|||
145238140|NCT03954444|523716744|FG000|Overall Study|Lost to Follow-up|1|||
145238141|NCT03954444|523716745|FG001|Overall Study|Lost to Follow-up|0|||
145238142|NCT03954444|523716746|FG002|Overall Study|Lost to Follow-up|1|||
145238143|NCT03954444|523716744|FG000|Overall Study|Non-compliant with study drug application|2|||
145238144|NCT03954444|523716745|FG001|Overall Study|Non-compliant with study drug application|2|||
145238145|NCT03954444|523716746|FG002|Overall Study|Non-compliant with study drug application|0|||
145238146|NCT03954444|523716744|FG000|Overall Study|Administrative reasons|0|||
145238147|NCT03954444|523716745|FG001|Overall Study|Administrative reasons|0|||
145238148|NCT03954444|523716746|FG002|Overall Study|Administrative reasons|1|||
145238149|NCT03954444|523716744|FG000|Overall Study|Miscellaneous|3|||
145238150|NCT03954444|523716745|FG001|Overall Study|Miscellaneous|2|||
145238151|NCT03954444|523716746|FG002|Overall Study|Miscellaneous|1|||
145238152|NCT00903370|523716748|FG000|Overall Study|Death|13|||
145238153|NCT00903370|523716749|FG001|Overall Study|Death|10|||
145238154|NCT00903370|523716748|FG000|Overall Study|Withdrawal by Subject|9|||
145238155|NCT00903370|523716749|FG001|Overall Study|Withdrawal by Subject|6|||
145238156|NCT00903370|523716748|FG000|Overall Study|Lost to Follow-up|6|||
145238157|NCT00903370|523716749|FG001|Overall Study|Lost to Follow-up|8|||
145238158|NCT04186663|523716750|FG000|Overall Study|Lost to Follow-up|1|||
145238159|NCT04186663|523716750|FG000|Overall Study|Unable to complete blood draw|3|||
145238160|NCT00719862|523716755|FG000|Overall Study|Adverse Event|1|||
145238161|NCT00719862|523716756|FG001|Overall Study|Adverse Event|2|||
145238162|NCT00719862|523716755|FG000|Overall Study|Lack of Efficacy|3|||
145238163|NCT00719862|523716756|FG001|Overall Study|Lack of Efficacy|0|||
145238164|NCT00719862|523716755|FG000|Overall Study|Non-Compliance|1|||
145238165|NCT00719862|523716756|FG001|Overall Study|Non-Compliance|0|||
145238166|NCT00719862|523716755|FG000|Overall Study|Withdrawal by Subject|1|||
145238167|NCT00719862|523716756|FG001|Overall Study|Withdrawal by Subject|0|||
145238168|NCT00719862|523716755|FG000|Overall Study|Lost to Follow-up|0|||
145238169|NCT00719862|523716756|FG001|Overall Study|Lost to Follow-up|1|||
145238170|NCT00719862|523716755|FG000|Overall Study|Other|2|||
145238171|NCT00719862|523716756|FG001|Overall Study|Other|3|||
145238172|NCT01184846|523716757|FG000|Overall Study|Adverse Event|2|||
145238173|NCT01184846|523716757|FG000|Overall Study|Insufficient response|1|||
145238174|NCT01999946|523716758|FG000|Overall Study|Participant not released from jail|2|||
145238175|NCT01999946|523716759|FG001|Overall Study|Participant not released from jail|2|||
145238176|NCT01999946|523716760|FG002|Overall Study|Participant not released from jail|0|||
145238177|NCT01999946|523716758|FG000|Overall Study|Not included in primary outcome analysis|0|||
145562708|NCT00362115|524920119|FG006|Overall Study|Withdrawal by Subject|4|||
145562709|NCT00362115|524920113|FG000|Overall Study|Lack of Efficacy|1|||
145238178|NCT01999946|523716759|FG001|Overall Study|Not included in primary outcome analysis|0|||
145238179|NCT01999946|523716760|FG002|Overall Study|Not included in primary outcome analysis|79|||
145238180|NCT00719953|523716763|FG000|Overall Study|Adverse Event|4|||
145238181|NCT01626989|523716764|FG000|Screening Period|Screen Failure|15|||
145238182|NCT01626989|523716765|FG001|Screening Period|Screen Failure|0|||
145238183|NCT01626989|523716766|FG002|Screening Period|Screen Failure|0|||
145238184|NCT01626989|523716764|FG000|Screening Period|Withdrawal by Subject|2|||
145238185|NCT01626989|523716765|FG001|Screening Period|Withdrawal by Subject|0|||
145238186|NCT01626989|523716766|FG002|Screening Period|Withdrawal by Subject|0|||
145238187|NCT02947022|523716769|FG000|Overall Study|Study Stopped|1|||
145265334|NCT00953017|523819296|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
145265335|NCT00953017|523819297|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
145238188|NCT00379236|523718193|FG000|Double-blind|Adverse Event|11|||
145238189|NCT00379236|523718194|FG001|Double-blind|Adverse Event|6|||
145238190|NCT00379236|523718195|FG002|Double-blind|Adverse Event|0|||
145238191|NCT00379236|523718193|FG000|Double-blind|Protocol Violation|3|||
145238192|NCT00379236|523718194|FG001|Double-blind|Protocol Violation|3|||
145238193|NCT00379236|523718195|FG002|Double-blind|Protocol Violation|0|||
145238194|NCT00379236|523718193|FG000|Double-blind|Withdrawal by Subject|12|||
145238195|NCT00379236|523718194|FG001|Double-blind|Withdrawal by Subject|13|||
145238196|NCT00379236|523718195|FG002|Double-blind|Withdrawal by Subject|0|||
145238197|NCT00379236|523718193|FG000|Double-blind|Lost to Follow-up|4|||
145238198|NCT00379236|523718194|FG001|Double-blind|Lost to Follow-up|3|||
145238199|NCT00379236|523718195|FG002|Double-blind|Lost to Follow-up|0|||
145238200|NCT00379236|523718193|FG000|Double-blind|Use of exclusionary medication|1|||
145238201|NCT00379236|523718194|FG001|Double-blind|Use of exclusionary medication|2|||
145238202|NCT00379236|523718195|FG002|Double-blind|Use of exclusionary medication|0|||
145238203|NCT00379236|523718193|FG000|Double-blind|Other|3|||
145238204|NCT00379236|523718194|FG001|Double-blind|Other|7|||
145238205|NCT00379236|523718195|FG002|Double-blind|Other|0|||
145238206|NCT00379236|523718193|FG000|Double-blind|Data could not be retrieved|2|||
145238207|NCT00379236|523718194|FG001|Double-blind|Data could not be retrieved|2|||
145238208|NCT00379236|523718195|FG002|Double-blind|Data could not be retrieved|0|||
145238209|NCT00379236|523718193|FG000|Open-label Extension|Adverse Event|0|||
145238210|NCT00379236|523718194|FG001|Open-label Extension|Adverse Event|0|||
145238211|NCT00379236|523718195|FG002|Open-label Extension|Adverse Event|13|||
145238212|NCT00379236|523718193|FG000|Open-label Extension|Protocol Violation|0|||
145238213|NCT00379236|523718194|FG001|Open-label Extension|Protocol Violation|0|||
145408753|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145408754|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145408755|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
145408756|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408757|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408758|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
145408759|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408760|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408761|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408762|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408763|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
145408764|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408765|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408766|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
145408767|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408768|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408769|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408770|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408771|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
145408772|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408773|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145562710|NCT00362115|524920114|FG001|Overall Study|Lack of Efficacy|0|||
145562711|NCT00362115|524920115|FG002|Overall Study|Lack of Efficacy|5|||
145562712|NCT00362115|524920116|FG003|Overall Study|Lack of Efficacy|2|||
145562713|NCT00362115|524920117|FG004|Overall Study|Lack of Efficacy|2|||
145238214|NCT00379236|523718195|FG002|Open-label Extension|Protocol Violation|7|||
145238215|NCT00379236|523718193|FG000|Open-label Extension|Withdrawal by Subject|0|||
145238216|NCT00379236|523718194|FG001|Open-label Extension|Withdrawal by Subject|0|||
145238217|NCT00379236|523718195|FG002|Open-label Extension|Withdrawal by Subject|13|||
145238218|NCT00379236|523718193|FG000|Open-label Extension|Lost to Follow-up|0|||
145238219|NCT00379236|523718194|FG001|Open-label Extension|Lost to Follow-up|0|||
145238220|NCT00379236|523718195|FG002|Open-label Extension|Lost to Follow-up|12|||
145238221|NCT00379236|523718193|FG000|Open-label Extension|Use of exclusionary medication|0|||
145238222|NCT00379236|523718194|FG001|Open-label Extension|Use of exclusionary medication|0|||
145238223|NCT00379236|523718195|FG002|Open-label Extension|Use of exclusionary medication|3|||
145238224|NCT00379236|523718193|FG000|Open-label Extension|Other|0|||
145238225|NCT00379236|523718194|FG001|Open-label Extension|Other|0|||
145238226|NCT00379236|523718195|FG002|Open-label Extension|Other|7|||
145562714|NCT00362115|524920118|FG005|Overall Study|Lack of Efficacy|0|||
145562715|NCT00362115|524920119|FG006|Overall Study|Lack of Efficacy|3|||
145562716|NCT00362115|524920113|FG000|Overall Study|Physician Decision|0|||
145562717|NCT00362115|524920114|FG001|Overall Study|Physician Decision|0|||
145562718|NCT00362115|524920115|FG002|Overall Study|Physician Decision|0|||
145562719|NCT00362115|524920116|FG003|Overall Study|Physician Decision|0|||
145562720|NCT00362115|524920117|FG004|Overall Study|Physician Decision|0|||
145562721|NCT00362115|524920118|FG005|Overall Study|Physician Decision|0|||
145562722|NCT00362115|524920119|FG006|Overall Study|Physician Decision|3|||
145562723|NCT00362115|524920113|FG000|Overall Study|Other|0|||
145562724|NCT00362115|524920114|FG001|Overall Study|Other|1|||
145562725|NCT00362115|524920115|FG002|Overall Study|Other|0|||
145562726|NCT00362115|524920116|FG003|Overall Study|Other|1|||
145238227|NCT00801892|523718196|FG000|Main Study Period|Withdrawal by Subject|0|||
145238228|NCT00801892|523718197|FG001|Main Study Period|Withdrawal by Subject|1|||
145238229|NCT00801892|523718196|FG000|Sham Crossover Period|Lost to Follow-up|0|||
145238230|NCT00801892|523718197|FG001|Sham Crossover Period|Lost to Follow-up|2|||
145238231|NCT00438464|523718198|FG000|Overall Study|Terminated Early|14|||
145238232|NCT00438464|523718199|FG001|Overall Study|Terminated Early|5|||
145238233|NCT00438464|523718198|FG000|Overall Study|Incomplete data submission|0|||
145238234|NCT00438464|523718199|FG001|Overall Study|Incomplete data submission|2|||
145238235|NCT00728936|523718200|FG000|Overall Study|Withdrawal by Subject|0|||
145238236|NCT00728936|523718201|FG001|Overall Study|Withdrawal by Subject|0|||
145238237|NCT00728936|523718202|FG002|Overall Study|Withdrawal by Subject|0|||
145238238|NCT00728936|523718203|FG003|Overall Study|Withdrawal by Subject|0|||
145238239|NCT00728936|523718204|FG004|Overall Study|Withdrawal by Subject|0|||
145238240|NCT00728936|523718205|FG005|Overall Study|Withdrawal by Subject|1|||
145238241|NCT00728936|523718206|FG006|Overall Study|Withdrawal by Subject|0|||
145238242|NCT02905825|523718207|FG000|Overall Study|Protocol Violation|11|||
145238243|NCT02905825|523718207|FG000|Overall Study|Device Malfunction|1|||
145238244|NCT00510484|523718211|FG000|Wash-out Period|Adverse Event|0|||
145238245|NCT00510484|523718212|FG001|Wash-out Period|Adverse Event|1|||
145238246|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
145238247|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
145238248|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
145238249|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
145238250|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
145238251|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
145238252|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
145238253|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
145238254|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
145238255|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
145238256|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
145238257|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
145238258|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
145238259|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
145238260|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
145238261|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
145238262|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
145238263|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
145238264|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
145238265|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
145238266|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
145238267|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
145238268|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
145238269|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
145562727|NCT00362115|524920117|FG004|Overall Study|Other|0|||
145562728|NCT00362115|524920118|FG005|Overall Study|Other|1|||
145562729|NCT00362115|524920119|FG006|Overall Study|Other|0|||
145562730|NCT00768144|524920121|FG000|Overall Study|Adverse Event|13|||
145562731|NCT00768144|524920121|FG000|Overall Study|Progressive Disease|21|||
145562732|NCT00768144|524920121|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
145562733|NCT00768144|524920121|FG000|Overall Study|Pt Withdrew Consent|1|||
145562734|NCT00832585|524920132|FG000|Overall Study|Withdrawal by Subject|1|||
145562735|NCT00832585|524920132|FG000|Overall Study|Lost to Follow-up|1|||
145562736|NCT02677987|524920135|FG000|Overall Study|Withdrawal by Subject|3|||
145562737|NCT02677987|524920136|FG001|Overall Study|Withdrawal by Subject|0|||
145562738|NCT02677987|524920135|FG000|Overall Study|Lost to Follow-up|1|||
145562739|NCT02677987|524920136|FG001|Overall Study|Lost to Follow-up|0|||
145238270|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
145238271|NCT01457924|523718217|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
145238272|NCT01457924|523718218|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
145238273|NCT01457924|523718219|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
145295626|NCT00162123|523932553|FG003|Overall Study|Study drug toxicity|0|||
145562740|NCT00673179|524920137|FG000|Overall Study|Toxicity/Complications|3|||
145238274|NCT01457924|523718220|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
145238275|NCT01457924|523718221|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
145238276|NCT01457924|523718217|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
145295627|NCT00162123|523932554|FG004|Overall Study|Study drug toxicity|4|||
145295628|NCT00162123|523932555|FG005|Overall Study|Study drug toxicity|1|||
145295629|NCT00162123|523932556|FG006|Overall Study|Study drug toxicity|1|||
145295630|NCT00162123|523932557|FG007|Overall Study|Study drug toxicity|0|||
145295631|NCT00162123|523932550|FG000|Overall Study|Death|3|||
145295632|NCT00162123|523932551|FG001|Overall Study|Death|3|||
145295633|NCT00162123|523932552|FG002|Overall Study|Death|1|||
145295634|NCT00162123|523932553|FG003|Overall Study|Death|1|||
145295635|NCT00162123|523932554|FG004|Overall Study|Death|1|||
145295636|NCT00162123|523932555|FG005|Overall Study|Death|1|||
145295637|NCT00162123|523932556|FG006|Overall Study|Death|0|||
145295638|NCT00162123|523932557|FG007|Overall Study|Death|0|||
145295639|NCT00162123|523932550|FG000|Overall Study|Withdrawal by Subject|2|||
145295640|NCT00162123|523932551|FG001|Overall Study|Withdrawal by Subject|0|||
145295641|NCT00162123|523932552|FG002|Overall Study|Withdrawal by Subject|2|||
145295642|NCT00162123|523932553|FG003|Overall Study|Withdrawal by Subject|1|||
145295643|NCT00162123|523932554|FG004|Overall Study|Withdrawal by Subject|1|||
145295644|NCT00162123|523932555|FG005|Overall Study|Withdrawal by Subject|2|||
145295645|NCT00162123|523932556|FG006|Overall Study|Withdrawal by Subject|1|||
145295646|NCT00162123|523932557|FG007|Overall Study|Withdrawal by Subject|0|||
145295647|NCT00162123|523932550|FG000|Overall Study|Deterioration without progression|2|||
145295648|NCT00162123|523932551|FG001|Overall Study|Deterioration without progression|2|||
145295649|NCT00162123|523932552|FG002|Overall Study|Deterioration without progression|3|||
145295650|NCT00162123|523932553|FG003|Overall Study|Deterioration without progression|0|||
145295651|NCT00162123|523932554|FG004|Overall Study|Deterioration without progression|1|||
145295652|NCT00162123|523932555|FG005|Overall Study|Deterioration without progression|0|||
145295653|NCT00162123|523932556|FG006|Overall Study|Deterioration without progression|0|||
145295654|NCT00162123|523932557|FG007|Overall Study|Deterioration without progression|0|||
145295655|NCT00162123|523932550|FG000|Overall Study|Adverse Event|1|||
145295656|NCT00162123|523932551|FG001|Overall Study|Adverse Event|2|||
145295657|NCT00162123|523932552|FG002|Overall Study|Adverse Event|0|||
145295658|NCT00162123|523932553|FG003|Overall Study|Adverse Event|2|||
145295659|NCT00162123|523932554|FG004|Overall Study|Adverse Event|1|||
145295660|NCT00162123|523932555|FG005|Overall Study|Adverse Event|0|||
145295661|NCT00162123|523932556|FG006|Overall Study|Adverse Event|0|||
145295662|NCT00162123|523932557|FG007|Overall Study|Adverse Event|0|||
145295663|NCT00162123|523932550|FG000|Overall Study|Not specified (before treatment)|2|||
145295664|NCT00162123|523932551|FG001|Overall Study|Not specified (before treatment)|0|||
145295665|NCT00162123|523932552|FG002|Overall Study|Not specified (before treatment)|0|||
145295666|NCT00162123|523932553|FG003|Overall Study|Not specified (before treatment)|0|||
145408774|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
145408775|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408776|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408777|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408778|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408779|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
145408780|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145238277|NCT01457924|523718218|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
145238278|NCT01457924|523718219|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
145238279|NCT01457924|523718220|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
145238280|NCT01457924|523718221|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
145238281|NCT01457924|523718217|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
145238282|NCT01457924|523718218|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
145238283|NCT01457924|523718219|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
145238284|NCT01457924|523718220|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
145238285|NCT01457924|523718221|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
145238286|NCT01457924|523718217|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
145238287|NCT01457924|523718218|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
145238288|NCT01457924|523718219|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
145238289|NCT01457924|523718220|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
145238290|NCT01457924|523718221|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
145238291|NCT01457924|523718217|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
145238292|NCT01457924|523718218|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
145238293|NCT01457924|523718219|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
145238294|NCT01457924|523718220|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
145238295|NCT01457924|523718221|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
145295667|NCT00162123|523932554|FG004|Overall Study|Not specified (before treatment)|12|||
145295668|NCT00162123|523932555|FG005|Overall Study|Not specified (before treatment)|1|||
145295669|NCT00162123|523932556|FG006|Overall Study|Not specified (before treatment)|0|||
145295670|NCT00162123|523932557|FG007|Overall Study|Not specified (before treatment)|0|||
145295671|NCT00162123|523932550|FG000|Overall Study|Not specified (after start of treatment)|0|||
145238296|NCT01457924|523718217|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
145238297|NCT01457924|523718218|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
145238298|NCT01457924|523718219|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
145238299|NCT01457924|523718220|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
145238300|NCT01457924|523718221|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
145238301|NCT01457924|523718217|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
145238302|NCT01457924|523718218|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
145238303|NCT01457924|523718219|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
145238304|NCT01457924|523718220|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
145238305|NCT01457924|523718221|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
145238306|NCT01457924|523718217|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
145238307|NCT01457924|523718218|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
145238308|NCT01457924|523718219|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
145238309|NCT01457924|523718220|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
145238310|NCT01457924|523718221|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
145238311|NCT00448760|523718222|FG000|Overall Study|Death|3|||
145238312|NCT00118911|523718223|FG000|Overall Study|Withdrawal by Subject|2|||
145238313|NCT00118911|523718224|FG001|Overall Study|Withdrawal by Subject|5|||
145238314|NCT05507580|523718225|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145238315|NCT05507580|523718226|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145238316|NCT05507580|523718227|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
145238317|NCT05507580|523718228|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
145238318|NCT05507580|523718229|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
145238319|NCT05507580|523718230|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
145238320|NCT05507580|523718225|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
145238321|NCT05507580|523718226|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145238322|NCT05507580|523718227|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145238323|NCT05507580|523718228|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145238324|NCT05507580|523718229|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145238325|NCT05507580|523718230|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145238326|NCT05507580|523718225|FG000|Double-Blind Treatment Period|Other, not specified|5|||
145238327|NCT05507580|523718226|FG001|Double-Blind Treatment Period|Other, not specified|4|||
145238328|NCT05507580|523718227|FG002|Double-Blind Treatment Period|Other, not specified|0|||
145238329|NCT05507580|523718228|FG003|Double-Blind Treatment Period|Other, not specified|0|||
145238330|NCT05507580|523718229|FG004|Double-Blind Treatment Period|Other, not specified|0|||
145238331|NCT05507580|523718230|FG005|Double-Blind Treatment Period|Other, not specified|0|||
145238332|NCT05507580|523718225|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
145238333|NCT05507580|523718226|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
145238334|NCT05507580|523718227|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
145238335|NCT05507580|523718228|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
145238336|NCT05507580|523718229|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
145238337|NCT05507580|523718230|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
145238338|NCT05507580|523718225|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
145238339|NCT05507580|523718226|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
145238340|NCT05507580|523718227|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
145238341|NCT05507580|523718228|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
145238342|NCT05507580|523718229|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
145238343|NCT05507580|523718230|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
145238344|NCT05507580|523718225|FG000|Single-Blind Treatment Period|Other, not specified|0|||
145238345|NCT05507580|523718226|FG001|Single-Blind Treatment Period|Other, not specified|0|||
145238346|NCT05507580|523718227|FG002|Single-Blind Treatment Period|Other, not specified|2|||
145238347|NCT05507580|523718228|FG003|Single-Blind Treatment Period|Other, not specified|7|||
145238348|NCT05507580|523718229|FG004|Single-Blind Treatment Period|Other, not specified|3|||
145238349|NCT05507580|523718230|FG005|Single-Blind Treatment Period|Other, not specified|5|||
145619976|NCT02459587|525123642|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
145619977|NCT02459587|525123643|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
145619978|NCT02459587|525123642|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
145619979|NCT02459587|525123643|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
145619980|NCT02459587|525123642|FG000|6-month Follow-up Assessment|Death|2|||
145619981|NCT02459587|525123643|FG001|6-month Follow-up Assessment|Death|1|||
145619982|NCT02459587|525123642|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
145619983|NCT02459587|525123643|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
145619984|NCT02459587|525123642|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
145619985|NCT02459587|525123643|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
145619986|NCT02459587|525123642|FG000|12-month Follow-up Assessment|Death|2|||
145619987|NCT02459587|525123643|FG001|12-month Follow-up Assessment|Death|0|||
145238350|NCT03496662|523718232|FG000|Overall Study|Adverse Event|0|||
145238351|NCT03496662|523718233|FG001|Overall Study|Adverse Event|0|||
145238352|NCT03496662|523718234|FG002|Overall Study|Adverse Event|4|||
145238353|NCT03496662|523718232|FG000|Overall Study|Withdrawal by Subject|1|||
145238354|NCT03496662|523718233|FG001|Overall Study|Withdrawal by Subject|0|||
145238355|NCT03496662|523718234|FG002|Overall Study|Withdrawal by Subject|2|||
145238356|NCT03496662|523718232|FG000|Overall Study|Death|0|||
145238357|NCT03496662|523718233|FG001|Overall Study|Death|0|||
145238358|NCT03496662|523718234|FG002|Overall Study|Death|2|||
145238359|NCT03496662|523718232|FG000|Overall Study|Noncompliance|0|||
145238360|NCT03496662|523718233|FG001|Overall Study|Noncompliance|0|||
145238361|NCT03496662|523718234|FG002|Overall Study|Noncompliance|1|||
145238362|NCT00270998|523718235|FG000|3 Month Follow-up|Adverse Event|1|||
145238363|NCT00270998|523718236|FG001|3 Month Follow-up|Adverse Event|0|||
145238364|NCT00270998|523718237|FG002|3 Month Follow-up|Adverse Event|0|||
145238365|NCT00270998|523718235|FG000|3 Month Follow-up|Lack of Efficacy|1|||
145238366|NCT00270998|523718236|FG001|3 Month Follow-up|Lack of Efficacy|2|||
145238367|NCT00270998|523718237|FG002|3 Month Follow-up|Lack of Efficacy|1|||
145238368|NCT00270998|523718235|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
145238369|NCT00270998|523718236|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
145238370|NCT00270998|523718237|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
145238371|NCT00270998|523718235|FG000|3 Month Follow-up|Pessary did not fit|12|||
145238372|NCT00270998|523718236|FG001|3 Month Follow-up|Pessary did not fit|0|||
145238373|NCT00270998|523718237|FG002|3 Month Follow-up|Pessary did not fit|0|||
145238374|NCT00270998|523718235|FG000|3 Month Follow-up|Personal/family health|1|||
145238375|NCT00270998|523718236|FG001|3 Month Follow-up|Personal/family health|1|||
145238376|NCT00270998|523718237|FG002|3 Month Follow-up|Personal/family health|0|||
145238377|NCT00270998|523718235|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
145238378|NCT00270998|523718236|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
145238379|NCT00270998|523718237|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
145238380|NCT00270998|523718235|FG000|12 Month Follow-up|Lack of Efficacy|5|||
145238381|NCT00270998|523718236|FG001|12 Month Follow-up|Lack of Efficacy|4|||
145238382|NCT00270998|523718237|FG002|12 Month Follow-up|Lack of Efficacy|3|||
145238383|NCT00270998|523718235|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
145238384|NCT00270998|523718236|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
145238385|NCT00270998|523718237|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
145238386|NCT00270998|523718235|FG000|12 Month Follow-up|Pessary did not fit|1|||
145238387|NCT00270998|523718236|FG001|12 Month Follow-up|Pessary did not fit|0|||
145238388|NCT00270998|523718237|FG002|12 Month Follow-up|Pessary did not fit|0|||
145238389|NCT00270998|523718235|FG000|12 Month Follow-up|Personal/family health|0|||
145238390|NCT00270998|523718236|FG001|12 Month Follow-up|Personal/family health|5|||
145238391|NCT00270998|523718237|FG002|12 Month Follow-up|Personal/family health|1|||
145238392|NCT00270998|523718235|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
145238393|NCT00270998|523718236|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
145238394|NCT00270998|523718237|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
145238395|NCT00493467|523718238|FG000|Overall Study|Death|1|||
145238396|NCT03395223|523718239|FG000|Overall Study|Lost to Follow-up|3|||
145238397|NCT03395223|523718239|FG000|Overall Study|Other|1|||
145238398|NCT01074658|523718243|FG000|Overall Study|No implant attempted|19|||
145238399|NCT00432562|523718247|FG000|Overall Study|Death|3|||
145238400|NCT00432562|523718248|FG001|Overall Study|Death|0|||
145238401|NCT00425100|523718252|FG000|Overall Study|Adverse Event|36|||
145238402|NCT00425100|523718252|FG000|Overall Study|Lack of Efficacy|4|||
145238403|NCT00425100|523718252|FG000|Overall Study|Lost to Follow-up|2|||
145238404|NCT00425100|523718252|FG000|Overall Study|Protocol Violation|4|||
145238405|NCT00425100|523718252|FG000|Overall Study|Withdrawal by Subject|7|||
145238406|NCT02559713|523718255|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
145238407|NCT05425719|523718258|FG000|Overall Study|Lost to Follow-up|4|||
145295672|NCT00162123|523932551|FG001|Overall Study|Not specified (after start of treatment)|0|||
145295673|NCT00162123|523932552|FG002|Overall Study|Not specified (after start of treatment)|0|||
145295674|NCT00162123|523932553|FG003|Overall Study|Not specified (after start of treatment)|0|||
145295675|NCT00162123|523932554|FG004|Overall Study|Not specified (after start of treatment)|3|||
145295676|NCT00162123|523932555|FG005|Overall Study|Not specified (after start of treatment)|0|||
145238408|NCT05425719|523718259|FG001|Overall Study|Lost to Follow-up|0|||
145562741|NCT00673179|524920138|FG001|Overall Study|Toxicity/Complications|0|||
145238409|NCT05425719|523718258|FG000|Overall Study|Withdrew consent|1|||
145238410|NCT05425719|523718259|FG001|Overall Study|Withdrew consent|1|||
145238411|NCT00555906|523718262|FG000|Phase 1|Objective Progression or Relapse|3|||
145238412|NCT00555906|523718263|FG001|Phase 1|Objective Progression or Relapse|5|||
145238413|NCT00555906|523718264|FG002|Phase 1|Objective Progression or Relapse|3|||
145238414|NCT00555906|523718265|FG003|Phase 1|Objective Progression or Relapse|1|||
145238415|NCT00555906|523718266|FG004|Phase 1|Objective Progression or Relapse|0|||
145238416|NCT00555906|523718262|FG000|Phase 1|Global Deterioration of Health Status|0|||
145238417|NCT00555906|523718263|FG001|Phase 1|Global Deterioration of Health Status|1|||
145238418|NCT00555906|523718264|FG002|Phase 1|Global Deterioration of Health Status|1|||
145238419|NCT00555906|523718265|FG003|Phase 1|Global Deterioration of Health Status|1|||
145238420|NCT00555906|523718266|FG004|Phase 1|Global Deterioration of Health Status|0|||
145238421|NCT00555906|523718262|FG000|Phase 1|Adverse Event|0|||
145238422|NCT00555906|523718263|FG001|Phase 1|Adverse Event|0|||
145238423|NCT00555906|523718264|FG002|Phase 1|Adverse Event|3|||
145238424|NCT00555906|523718265|FG003|Phase 1|Adverse Event|2|||
145238425|NCT00555906|523718266|FG004|Phase 1|Adverse Event|0|||
145238426|NCT00555906|523718262|FG000|Phase 1|Withdrawal by Subject|0|||
145238427|NCT00555906|523718263|FG001|Phase 1|Withdrawal by Subject|0|||
145238428|NCT00555906|523718264|FG002|Phase 1|Withdrawal by Subject|0|||
145238429|NCT00555906|523718265|FG003|Phase 1|Withdrawal by Subject|1|||
145238430|NCT00555906|523718266|FG004|Phase 1|Withdrawal by Subject|0|||
145238431|NCT00555906|523718262|FG000|Phase 2|Adverse Event|0|||
145238432|NCT00555906|523718263|FG001|Phase 2|Adverse Event|0|||
145238433|NCT00555906|523718264|FG002|Phase 2|Adverse Event|0|||
145238434|NCT00555906|523718265|FG003|Phase 2|Adverse Event|0|||
145238435|NCT00555906|523718266|FG004|Phase 2|Adverse Event|4|||
145238436|NCT00555906|523718262|FG000|Phase 2|Global Deterioration of Health Status|0|||
145238437|NCT00555906|523718263|FG001|Phase 2|Global Deterioration of Health Status|0|||
145295677|NCT00162123|523932556|FG006|Overall Study|Not specified (after start of treatment)|0|||
145295678|NCT00162123|523932557|FG007|Overall Study|Not specified (after start of treatment)|0|||
145295679|NCT00162123|523932550|FG000|Overall Study|Physician Decision|1|||
145295680|NCT00162123|523932551|FG001|Overall Study|Physician Decision|2|||
145295681|NCT00162123|523932552|FG002|Overall Study|Physician Decision|0|||
145295682|NCT00162123|523932553|FG003|Overall Study|Physician Decision|0|||
145295683|NCT00162123|523932554|FG004|Overall Study|Physician Decision|0|||
145295684|NCT00162123|523932555|FG005|Overall Study|Physician Decision|1|||
145295685|NCT00162123|523932556|FG006|Overall Study|Physician Decision|1|||
145295686|NCT00162123|523932557|FG007|Overall Study|Physician Decision|0|||
145295687|NCT00162123|523932550|FG000|Overall Study|Tumor assessment only (not treated)|0|||
145295688|NCT00162123|523932551|FG001|Overall Study|Tumor assessment only (not treated)|0|||
145295689|NCT00162123|523932552|FG002|Overall Study|Tumor assessment only (not treated)|0|||
145295690|NCT00162123|523932553|FG003|Overall Study|Tumor assessment only (not treated)|0|||
145295691|NCT00162123|523932554|FG004|Overall Study|Tumor assessment only (not treated)|0|||
145295692|NCT00162123|523932555|FG005|Overall Study|Tumor assessment only (not treated)|0|||
145295693|NCT00162123|523932556|FG006|Overall Study|Tumor assessment only (not treated)|0|||
145295694|NCT00162123|523932557|FG007|Overall Study|Tumor assessment only (not treated)|1|||
145295695|NCT00162123|523932550|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
145295696|NCT00162123|523932551|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
145295697|NCT00162123|523932552|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
145295698|NCT00162123|523932553|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
145295699|NCT00162123|523932554|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
145295700|NCT00162123|523932555|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
145295701|NCT00162123|523932556|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
145295702|NCT00162123|523932557|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
145295703|NCT02016170|523932558|FG000|Overall Study|Adverse Event|1|||
145295704|NCT02016170|523932559|FG001|Overall Study|Adverse Event|1|||
145295705|NCT02016170|523932560|FG002|Overall Study|Adverse Event|0|||
145295706|NCT02016170|523932558|FG000|Overall Study|Protocol Violation|1|||
145295707|NCT02016170|523932559|FG001|Overall Study|Protocol Violation|0|||
145295708|NCT02016170|523932560|FG002|Overall Study|Protocol Violation|0|||
145295709|NCT01936948|523932564|FG000|Overall Study|no 30-day follow-up data|0|||
145295710|NCT01936948|523932565|FG001|Overall Study|no 30-day follow-up data|3|||
145295711|NCT01936948|523932566|FG002|Overall Study|no 30-day follow-up data|3|||
145295712|NCT01936948|523932567|FG003|Overall Study|no 30-day follow-up data|3|||
145295713|NCT01395030|523932568|FG000|Overall Study|Did not complete FCH PET/CT|7|||
145295714|NCT02327130|523932569|FG000|Overall Study|Discharged in less than 5 days|5|||
145295715|NCT02327130|523932569|FG000|Overall Study|Physician Decision|2|||
145562742|NCT01531387|524920139|FG000|Overall Study|Early termination of study|11|||
145562743|NCT01531387|524920140|FG001|Overall Study|Early termination of study|11|||
145562744|NCT00567892|524920141|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
145295716|NCT02327130|523932569|FG000|Overall Study|Unable to provide breath sample|1|||
145295717|NCT02327130|523932569|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
145295718|NCT02327130|523932569|FG000|Overall Study|Met exclusion criteria|3|||
145295719|NCT05214560|523932571|FG000|Overall Study|Screening Failure|1|||
145295720|NCT05214560|523932571|FG000|Overall Study|Physician Decision|4|||
145295721|NCT05214560|523932571|FG000|Overall Study|Withdrawal by Subject|1|||
145295722|NCT05214560|523932571|FG000|Overall Study|Lost to Follow-up|2|||
145295723|NCT05214560|523932571|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
145295724|NCT05214560|523932571|FG000|Overall Study|Study physician not available for the anesthesia|3|||
145562745|NCT00567892|524920142|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
145238438|NCT00555906|523718264|FG002|Phase 2|Global Deterioration of Health Status|0|||
145238439|NCT00555906|523718265|FG003|Phase 2|Global Deterioration of Health Status|0|||
145238440|NCT00555906|523718266|FG004|Phase 2|Global Deterioration of Health Status|2|||
145238441|NCT00555906|523718262|FG000|Phase 2|Objective Progression or Relapse|0|||
145238442|NCT00555906|523718263|FG001|Phase 2|Objective Progression or Relapse|0|||
145238443|NCT00555906|523718264|FG002|Phase 2|Objective Progression or Relapse|0|||
145238444|NCT00555906|523718265|FG003|Phase 2|Objective Progression or Relapse|0|||
145238445|NCT00555906|523718266|FG004|Phase 2|Objective Progression or Relapse|16|||
145238446|NCT00555906|523718262|FG000|Phase 2|Withdrawal by Subject|0|||
145238447|NCT00555906|523718263|FG001|Phase 2|Withdrawal by Subject|0|||
145238448|NCT00555906|523718264|FG002|Phase 2|Withdrawal by Subject|0|||
145238449|NCT00555906|523718265|FG003|Phase 2|Withdrawal by Subject|0|||
145238450|NCT00555906|523718266|FG004|Phase 2|Withdrawal by Subject|2|||
145238451|NCT00555906|523718262|FG000|Phase 2|Other|0|||
145238452|NCT00555906|523718263|FG001|Phase 2|Other|0|||
145238453|NCT00555906|523718264|FG002|Phase 2|Other|0|||
145238454|NCT00555906|523718265|FG003|Phase 2|Other|0|||
145238455|NCT00555906|523718266|FG004|Phase 2|Other|6|||
145238456|NCT00555906|523718262|FG000|Phase 2|Randomized but not Treated|0|||
145238457|NCT00555906|523718263|FG001|Phase 2|Randomized but not Treated|0|||
145238458|NCT00555906|523718264|FG002|Phase 2|Randomized but not Treated|0|||
145238459|NCT00555906|523718265|FG003|Phase 2|Randomized but not Treated|0|||
145238460|NCT00555906|523718266|FG004|Phase 2|Randomized but not Treated|2|||
145238461|NCT02193828|523718267|FG000|Overall Study|Withdrawal by Subject|0|||
145238462|NCT02193828|523718268|FG001|Overall Study|Withdrawal by Subject|0|||
145238463|NCT02193828|523718269|FG002|Overall Study|Withdrawal by Subject|1|||
145238464|NCT02193828|523718270|FG003|Overall Study|Withdrawal by Subject|1|||
145238465|NCT03219567|523718271|FG000|Overall Study|Withdrawal by Subject|0|||
145238466|NCT03219567|523718272|FG001|Overall Study|Withdrawal by Subject|1|||
145238467|NCT00889681|523718273|FG000|Overall Study|Not meeting qualification Criteria|2|||
145238468|NCT00889681|523718273|FG000|Overall Study|Insurance disapproval|1|||
145238469|NCT01313208|523718274|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
145238470|NCT01313208|523718275|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
145238471|NCT01313208|523718274|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
145238472|NCT01313208|523718275|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
145238473|NCT01313208|523718274|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
145238474|NCT01313208|523718275|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
145238475|NCT01313208|523718274|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
145238476|NCT01313208|523718275|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
145238477|NCT01313208|523718274|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
145238478|NCT01313208|523718275|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
145238479|NCT01313208|523718274|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
145238480|NCT01313208|523718275|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
145238481|NCT01313208|523718274|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
145238482|NCT01313208|523718275|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
145238483|NCT01313208|523718274|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
145238484|NCT01313208|523718275|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
145238485|NCT01313208|523718274|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
145238486|NCT01313208|523718275|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
145238487|NCT01957787|523718276|FG000|Overall Study|Death|18|||
145238488|NCT01957787|523718276|FG000|Overall Study|Lost to Follow-up|3|||
145238489|NCT01957787|523718276|FG000|Overall Study|Withdrawal by Subject|3|||
145238490|NCT01957787|523718276|FG000|Overall Study|Entered Hospice or Similar Program|2|||
145238491|NCT01957787|523718276|FG000|Overall Study|Index Tumor(s) Resected|2|||
145238492|NCT01957787|523718276|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
145238493|NCT01957787|523718276|FG000|Overall Study|Local therapy, not cryoablation|6|||
145238494|NCT05109702|523718277|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
145238495|NCT05109702|523718278|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
145238496|NCT05109702|523718279|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
145238497|NCT05109702|523718277|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
145238498|NCT05109702|523718278|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
145238499|NCT05109702|523718279|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
145238500|NCT05109702|523718277|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
145238501|NCT05109702|523718278|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
145238502|NCT05109702|523718279|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
145238503|NCT05109702|523718277|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
145238504|NCT05109702|523718278|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
145238505|NCT05109702|523718279|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
145238506|NCT05109702|523718277|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
145238507|NCT05109702|523718278|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
145238508|NCT05109702|523718279|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
145238509|NCT01392378|523718280|FG000|Infant Series|Adverse Event|0|||
145238510|NCT01392378|523718281|FG001|Infant Series|Adverse Event|0|||
145238511|NCT01392378|523718282|FG002|Infant Series|Adverse Event|0|||
145238512|NCT01392378|523718283|FG003|Infant Series|Adverse Event|1|||
145238513|NCT01392378|523718284|FG004|Infant Series|Adverse Event|0|||
145238514|NCT01392378|523718280|FG000|Infant Series|Lost to Follow-up|0|||
145238515|NCT01392378|523718281|FG001|Infant Series|Lost to Follow-up|0|||
145562746|NCT00567892|524920143|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
145562747|NCT00567892|524920144|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
145562748|NCT00567892|524920141|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
145562749|NCT00567892|524920142|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
145562750|NCT00567892|524920143|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
145562751|NCT00567892|524920144|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
145562752|NCT01344161|524920146|FG000|Overall Study|Lost to Follow-up|4|||
145562753|NCT01344161|524920147|FG001|Overall Study|Lost to Follow-up|1|||
145562754|NCT01344161|524920146|FG000|Overall Study|Pregnancy|0|||
145562755|NCT01344161|524920147|FG001|Overall Study|Pregnancy|1|||
145562756|NCT01344161|524920146|FG000|Overall Study|Protocol Violation|1|||
145562757|NCT01344161|524920147|FG001|Overall Study|Protocol Violation|1|||
145562758|NCT04690751|524920148|FG000|Overall Study|Protocol Violation|0|||
145562759|NCT04690751|524920149|FG001|Overall Study|Protocol Violation|1|||
145562760|NCT04690751|524920150|FG002|Overall Study|Protocol Violation|0|||
145562761|NCT04690751|524920151|FG003|Overall Study|Protocol Violation|1|||
145562762|NCT04690751|524920152|FG004|Overall Study|Protocol Violation|2|||
145562763|NCT04690751|524920153|FG005|Overall Study|Protocol Violation|0|||
145562764|NCT04690751|524920148|FG000|Overall Study|Adverse Event|0|||
145562765|NCT04690751|524920149|FG001|Overall Study|Adverse Event|0|||
145562766|NCT04690751|524920150|FG002|Overall Study|Adverse Event|1|||
145562767|NCT04690751|524920151|FG003|Overall Study|Adverse Event|0|||
145562768|NCT04690751|524920152|FG004|Overall Study|Adverse Event|0|||
145562769|NCT04690751|524920153|FG005|Overall Study|Adverse Event|0|||
145562770|NCT04690751|524920148|FG000|Overall Study|Positive urine drug screen test|0|||
145562771|NCT04690751|524920149|FG001|Overall Study|Positive urine drug screen test|0|||
145238516|NCT01392378|523718282|FG002|Infant Series|Lost to Follow-up|0|||
145238517|NCT01392378|523718283|FG003|Infant Series|Lost to Follow-up|1|||
145238518|NCT01392378|523718284|FG004|Infant Series|Lost to Follow-up|0|||
145238519|NCT01392378|523718280|FG000|Infant Series|Protocol Violation|0|||
145238520|NCT01392378|523718281|FG001|Infant Series|Protocol Violation|1|||
145562772|NCT04690751|524920150|FG002|Overall Study|Positive urine drug screen test|0|||
145562773|NCT04690751|524920151|FG003|Overall Study|Positive urine drug screen test|0|||
145562774|NCT04690751|524920152|FG004|Overall Study|Positive urine drug screen test|1|||
145562775|NCT04690751|524920153|FG005|Overall Study|Positive urine drug screen test|0|||
145562776|NCT04364620|524920154|FG000|Overall Study|Disease Progression|20|||
145562777|NCT04364620|524920154|FG000|Overall Study|Adverse Event|5|||
145562778|NCT04364620|524920154|FG000|Overall Study|Physician Decision|4|||
145562779|NCT04364620|524920154|FG000|Overall Study|Death|3|||
145562780|NCT04364620|524920154|FG000|Overall Study|Other|2|||
145562781|NCT04364620|524920154|FG000|Overall Study|Withdrawal by Subject|1|||
145562782|NCT00699972|524921672|FG000|Overall Study|Adverse Event|7|||
145562783|NCT00699972|524921673|FG001|Overall Study|Adverse Event|9|||
145562784|NCT00699972|524921674|FG002|Overall Study|Adverse Event|24|||
145562785|NCT00699972|524921672|FG000|Overall Study|Lost to Follow-up|0|||
145562786|NCT00699972|524921673|FG001|Overall Study|Lost to Follow-up|2|||
145562787|NCT00699972|524921674|FG002|Overall Study|Lost to Follow-up|0|||
145562788|NCT00699972|524921672|FG000|Overall Study|Withdrawal by Subject|3|||
145238521|NCT01392378|523718282|FG002|Infant Series|Protocol Violation|0|||
145562789|NCT00699972|524921673|FG001|Overall Study|Withdrawal by Subject|7|||
145562790|NCT00699972|524921674|FG002|Overall Study|Withdrawal by Subject|4|||
145562791|NCT00699972|524921672|FG000|Overall Study|Lack of Efficacy|2|||
145562792|NCT00699972|524921673|FG001|Overall Study|Lack of Efficacy|0|||
145619988|NCT02459587|525123642|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
145619989|NCT02459587|525123643|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
145619990|NCT02459587|525123642|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
145619991|NCT02459587|525123643|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
145619992|NCT02459587|525123642|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
145619993|NCT02459587|525123643|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
145238522|NCT01392378|523718283|FG003|Infant Series|Protocol Violation|0|||
145238523|NCT01392378|523718284|FG004|Infant Series|Protocol Violation|0|||
145238524|NCT01392378|523718280|FG000|Infant Series|Withdrawal by Parent|4|||
145238525|NCT01392378|523718281|FG001|Infant Series|Withdrawal by Parent|1|||
145238526|NCT01392378|523718282|FG002|Infant Series|Withdrawal by Parent|0|||
145238527|NCT01392378|523718283|FG003|Infant Series|Withdrawal by Parent|0|||
145238528|NCT01392378|523718284|FG004|Infant Series|Withdrawal by Parent|0|||
145238529|NCT01392378|523718280|FG000|After Infant Series|Lost to Follow-up|0|||
145238530|NCT01392378|523718281|FG001|After Infant Series|Lost to Follow-up|0|||
145562793|NCT00699972|524921674|FG002|Overall Study|Lack of Efficacy|2|||
145562794|NCT00699972|524921672|FG000|Overall Study|Administrative/Other|3|||
145562795|NCT00699972|524921673|FG001|Overall Study|Administrative/Other|1|||
145562796|NCT00699972|524921674|FG002|Overall Study|Administrative/Other|4|||
145562797|NCT00699972|524921672|FG000|Overall Study|Randomized, Not Treated|1|||
145562798|NCT00699972|524921673|FG001|Overall Study|Randomized, Not Treated|0|||
145562799|NCT00699972|524921674|FG002|Overall Study|Randomized, Not Treated|1|||
145562800|NCT01365507|524921675|FG000|Overall Study|Withdrawal Criteria|8|||
145562801|NCT01365507|524921676|FG001|Overall Study|Withdrawal Criteria|5|||
145238531|NCT01392378|523718282|FG002|After Infant Series|Lost to Follow-up|1|||
145238532|NCT01392378|523718283|FG003|After Infant Series|Lost to Follow-up|0|||
145238533|NCT01392378|523718284|FG004|After Infant Series|Lost to Follow-up|0|||
145238534|NCT01392378|523718280|FG000|After Infant Series|Withdrawal by Parent|0|||
145238535|NCT01392378|523718281|FG001|After Infant Series|Withdrawal by Parent|1|||
145238536|NCT01392378|523718282|FG002|After Infant Series|Withdrawal by Parent|1|||
145238537|NCT01392378|523718283|FG003|After Infant Series|Withdrawal by Parent|0|||
145238538|NCT01392378|523718284|FG004|After Infant Series|Withdrawal by Parent|1|||
145238539|NCT01392378|523718280|FG000|Toddler Dose|Lost to Follow-up|0|||
145238540|NCT01392378|523718281|FG001|Toddler Dose|Lost to Follow-up|0|||
145238541|NCT01392378|523718282|FG002|Toddler Dose|Lost to Follow-up|0|||
145238542|NCT01392378|523718283|FG003|Toddler Dose|Lost to Follow-up|1|||
145238543|NCT01392378|523718284|FG004|Toddler Dose|Lost to Follow-up|0|||
145238544|NCT01392378|523718280|FG000|Toddler Dose|Withdrawal by Parent|0|||
145238545|NCT01392378|523718281|FG001|Toddler Dose|Withdrawal by Parent|1|||
145238546|NCT01392378|523718282|FG002|Toddler Dose|Withdrawal by Parent|0|||
145238547|NCT01392378|523718283|FG003|Toddler Dose|Withdrawal by Parent|1|||
145238548|NCT01392378|523718284|FG004|Toddler Dose|Withdrawal by Parent|1|||
145238549|NCT00788697|523718290|FG000|Overall Study|No study drug administered|12|||
145238550|NCT00788697|523718290|FG000|Overall Study|Training Patients|74|||
145238551|NCT00788697|523718290|FG000|Overall Study|no truth standard procedure available|5|||
145238552|NCT00788697|523718290|FG000|Overall Study|Technically inadequate truth standard|1|||
145238553|NCT00788697|523718290|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
145238554|NCT01998880|523718291|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
145238555|NCT01998880|523718292|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
145238556|NCT01998880|523718291|FG000|Overall Study|Disease Progression|1|||
145238557|NCT01998880|523718292|FG001|Overall Study|Disease Progression|8|||
145238558|NCT01998880|523718291|FG000|Overall Study|Withdrew Consent|2|||
145238559|NCT01998880|523718292|FG001|Overall Study|Withdrew Consent|1|||
145238560|NCT01998880|523718291|FG000|Overall Study|Death|3|||
145238561|NCT01998880|523718292|FG001|Overall Study|Death|6|||
145238562|NCT01998880|523718291|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145238563|NCT01998880|523718292|FG001|Overall Study|Insufficient Therapeutic Response|5|||
145238564|NCT01998880|523718291|FG000|Overall Study|Administrative/Other|1|||
145238565|NCT01998880|523718292|FG001|Overall Study|Administrative/Other|1|||
145238566|NCT01998880|523718291|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
145238567|NCT01998880|523718292|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
145238568|NCT01998880|523718291|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
145238569|NCT01998880|523718292|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145238570|NCT01998880|523718291|FG000|Overall Study|Did Not Receive Treatment|3|||
145238571|NCT01998880|523718292|FG001|Overall Study|Did Not Receive Treatment|2|||
145238572|NCT00004732|523718293|FG000|Overall Study|Withdrawal by Subject|36|||
145238573|NCT00004732|523718294|FG001|Overall Study|Withdrawal by Subject|64|||
145238574|NCT00004732|523718293|FG000|Overall Study|Lost to Follow-up|33|||
145238575|NCT00004732|523718294|FG001|Overall Study|Lost to Follow-up|47|||
145238576|NCT01688635|523718295|FG000|Washout 1|Withdrawal by Subject|1|||
145238577|NCT01688635|523718296|FG001|Washout 1|Withdrawal by Subject|0|||
145238578|NCT01688635|523718295|FG000|Washout 1|Adverse Event|0|||
145238579|NCT01688635|523718296|FG001|Washout 1|Adverse Event|1|||
145238580|NCT01688635|523718295|FG000|Washout 1|Physician Decision|0|||
145238581|NCT01688635|523718296|FG001|Washout 1|Physician Decision|1|||
145238582|NCT01688635|523718295|FG000|Washout 2|Physician Decision|1|||
145238583|NCT01688635|523718296|FG001|Washout 2|Physician Decision|0|||
145238584|NCT01688635|523718295|FG000|Washout 2|Withdrawal by Subject|1|||
145238585|NCT01688635|523718296|FG001|Washout 2|Withdrawal by Subject|0|||
145238586|NCT01688635|523718295|FG000|Washout 2|Sponsor Decision|1|||
145238587|NCT01688635|523718296|FG001|Washout 2|Sponsor Decision|2|||
145238588|NCT01688635|523718295|FG000|Washout 3|Withdrawal by Subject|1|||
145238589|NCT01688635|523718296|FG001|Washout 3|Withdrawal by Subject|0|||
145238590|NCT02713789|523718297|FG000|Overall Study|Lost to Follow-up|0|||
145238591|NCT02713789|523718298|FG001|Overall Study|Lost to Follow-up|1|||
145238592|NCT02713789|523718299|FG002|Overall Study|Lost to Follow-up|1|||
145238593|NCT02661464|523718302|FG000|Overall Study|Lost to Follow-up|28|||
145238594|NCT02661464|523718303|FG001|Overall Study|Lost to Follow-up|0|||
145238595|NCT02661464|523718304|FG002|Overall Study|Lost to Follow-up|0|||
145238596|NCT02661464|523718305|FG003|Overall Study|Lost to Follow-up|0|||
145238597|NCT02661464|523718302|FG000|Overall Study|Withdrawal by Subject|3|||
145238598|NCT02661464|523718303|FG001|Overall Study|Withdrawal by Subject|1|||
145295725|NCT05214560|523932571|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
145295726|NCT05214560|523932571|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
145238599|NCT02661464|523718304|FG002|Overall Study|Withdrawal by Subject|0|||
145238600|NCT02661464|523718305|FG003|Overall Study|Withdrawal by Subject|0|||
145238601|NCT02661464|523718302|FG000|Overall Study|Participants terminated prematurely|288|||
145238602|NCT02661464|523718303|FG001|Overall Study|Participants terminated prematurely|52|||
145238603|NCT02661464|523718304|FG002|Overall Study|Participants terminated prematurely|1|||
145238604|NCT02661464|523718305|FG003|Overall Study|Participants terminated prematurely|1|||
145238605|NCT02661464|523718302|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
145238606|NCT02661464|523718303|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
145562802|NCT01365507|524921675|FG000|Overall Study|Unclassified|1|||
145562803|NCT01365507|524921676|FG001|Overall Study|Unclassified|4|||
145562804|NCT01012622|524921677|FG000|Overall Study|Withdrawal by Subject|6|||
145238607|NCT02661464|523718304|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
145238608|NCT02661464|523718305|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
145238609|NCT00014911|523718306|FG000|Overall Study|Adverse Event|1|||
145238610|NCT00014911|523718306|FG000|Overall Study|Lost to Follow-up|1|||
145238611|NCT00014911|523718306|FG000|Overall Study|Withdrawal by Subject|6|||
145238612|NCT00014911|523718306|FG000|Overall Study|Unknown Reasons|2|||
145238613|NCT00014911|523718306|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
145238614|NCT01924299|523718310|FG000|Period 2|Withdrawal by Subject|1|||
145238615|NCT01924299|523718311|FG001|Period 2|Withdrawal by Subject|0|||
145238616|NCT01924299|523718310|FG000|Period 2|Adverse Event|0|||
145238617|NCT01924299|523718311|FG001|Period 2|Adverse Event|1|||
145238618|NCT00141037|523718313|FG000|Overall Study|Physician Decision|1|||
145238619|NCT00141037|523718314|FG001|Overall Study|Physician Decision|2|||
145238620|NCT00141037|523718313|FG000|Overall Study|Lost to Follow-up|3|||
145238621|NCT00141037|523718314|FG001|Overall Study|Lost to Follow-up|1|||
145238622|NCT00141037|523718313|FG000|Overall Study|Protocol Violation|0|||
145238623|NCT00141037|523718314|FG001|Overall Study|Protocol Violation|2|||
145238624|NCT00141037|523718313|FG000|Overall Study|Withdrawal by Subject|2|||
145238625|NCT00141037|523718314|FG001|Overall Study|Withdrawal by Subject|1|||
145238626|NCT00141037|523718313|FG000|Overall Study|Other|0|||
145238627|NCT00141037|523718314|FG001|Overall Study|Other|1|||
145238628|NCT00141037|523718313|FG000|Overall Study|Moved from area|1|||
145238629|NCT00141037|523718314|FG001|Overall Study|Moved from area|7|||
145238630|NCT00141037|523718313|FG000|Overall Study|Graft Failure|3|||
145238631|NCT00141037|523718314|FG001|Overall Study|Graft Failure|4|||
145238632|NCT00888615|523718315|FG000|Overall Study|No treatment|2|||
145238633|NCT00637377|523718316|FG000|Overall Study|Adverse Event|2|||
145238634|NCT00637377|523718317|FG001|Overall Study|Adverse Event|6|||
145238635|NCT00637377|523718318|FG002|Overall Study|Adverse Event|8|||
145238636|NCT00637377|523718319|FG003|Overall Study|Adverse Event|9|||
145238637|NCT00637377|523718316|FG000|Overall Study|Death|1|||
145238638|NCT00637377|523718317|FG001|Overall Study|Death|3|||
145238639|NCT00637377|523718318|FG002|Overall Study|Death|2|||
145238640|NCT00637377|523718319|FG003|Overall Study|Death|1|||
145238641|NCT00637377|523718316|FG000|Overall Study|Lack of Efficacy|0|||
145238642|NCT00637377|523718317|FG001|Overall Study|Lack of Efficacy|0|||
145238643|NCT00637377|523718318|FG002|Overall Study|Lack of Efficacy|1|||
145238644|NCT00637377|523718319|FG003|Overall Study|Lack of Efficacy|1|||
145238645|NCT00637377|523718316|FG000|Overall Study|Lost to Follow-up|4|||
145238646|NCT00637377|523718317|FG001|Overall Study|Lost to Follow-up|1|||
145238647|NCT00637377|523718318|FG002|Overall Study|Lost to Follow-up|2|||
145238648|NCT00637377|523718319|FG003|Overall Study|Lost to Follow-up|2|||
145238649|NCT00637377|523718316|FG000|Overall Study|Protocol Violation|2|||
145238650|NCT00637377|523718317|FG001|Overall Study|Protocol Violation|1|||
145238651|NCT00637377|523718318|FG002|Overall Study|Protocol Violation|1|||
145238652|NCT00637377|523718319|FG003|Overall Study|Protocol Violation|0|||
145238653|NCT00637377|523718316|FG000|Overall Study|Withdrawal by Subject|11|||
145238654|NCT00637377|523718317|FG001|Overall Study|Withdrawal by Subject|15|||
145238655|NCT00637377|523718318|FG002|Overall Study|Withdrawal by Subject|13|||
145238656|NCT00637377|523718319|FG003|Overall Study|Withdrawal by Subject|11|||
145238657|NCT00637377|523718316|FG000|Overall Study|Other (no further information available)|7|||
145238658|NCT00637377|523718317|FG001|Overall Study|Other (no further information available)|6|||
145238659|NCT00637377|523718318|FG002|Overall Study|Other (no further information available)|10|||
145238660|NCT00637377|523718319|FG003|Overall Study|Other (no further information available)|5|||
145238661|NCT01293084|523718322|FG000|Overall Study|Physician Decision|3|||
145238662|NCT01293084|523718322|FG000|Overall Study|Withdrawal by Subject|2|||
145238663|NCT01742091|523720142|FG000|Overall Study|Adverse Event|0|||
145238664|NCT01742091|523720143|FG001|Overall Study|Adverse Event|0|||
145562805|NCT01012622|524921677|FG000|Overall Study|Lost to Follow-up|5|||
145562806|NCT01012622|524921677|FG000|Overall Study|Adverse Event|7|||
145238665|NCT01742091|523720144|FG002|Overall Study|Adverse Event|0|||
145238666|NCT01742091|523720145|FG003|Overall Study|Adverse Event|0|||
145238667|NCT01742091|523720146|FG004|Overall Study|Adverse Event|1|||
145238668|NCT01742091|523720147|FG005|Overall Study|Adverse Event|0|||
145238669|NCT01742091|523720142|FG000|Overall Study|Physician Decision|0|||
145562807|NCT01012622|524921677|FG000|Overall Study|non-compliance with the drug|9|||
145238670|NCT01742091|523720143|FG001|Overall Study|Physician Decision|0|||
145238671|NCT01742091|523720144|FG002|Overall Study|Physician Decision|0|||
145238672|NCT01742091|523720145|FG003|Overall Study|Physician Decision|0|||
145238673|NCT01742091|523720146|FG004|Overall Study|Physician Decision|0|||
145238674|NCT01742091|523720147|FG005|Overall Study|Physician Decision|1|||
145238675|NCT01742091|523720142|FG000|Overall Study|Withdrawal by Subject|0|||
145238676|NCT01742091|523720143|FG001|Overall Study|Withdrawal by Subject|0|||
145238677|NCT01742091|523720144|FG002|Overall Study|Withdrawal by Subject|0|||
145238678|NCT01742091|523720145|FG003|Overall Study|Withdrawal by Subject|1|||
145238679|NCT01742091|523720146|FG004|Overall Study|Withdrawal by Subject|0|||
145238680|NCT01742091|523720147|FG005|Overall Study|Withdrawal by Subject|0|||
145238681|NCT01742091|523720142|FG000|Overall Study|Lost to Follow-up|0|||
145238682|NCT01742091|523720143|FG001|Overall Study|Lost to Follow-up|0|||
145238683|NCT01742091|523720144|FG002|Overall Study|Lost to Follow-up|0|||
145238684|NCT01742091|523720145|FG003|Overall Study|Lost to Follow-up|0|||
145238685|NCT01742091|523720146|FG004|Overall Study|Lost to Follow-up|0|||
145238686|NCT01742091|523720147|FG005|Overall Study|Lost to Follow-up|1|||
145238687|NCT00212758|523720150|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
145238688|NCT00212758|523720151|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
145238689|NCT00212758|523720150|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
145238690|NCT00212758|523720151|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
145238691|NCT02574481|523720152|FG000|Overall Study|Withdrawal by Subject|29|||
145238692|NCT02574481|523720153|FG001|Overall Study|Withdrawal by Subject|15|||
145238693|NCT02574481|523720154|FG002|Overall Study|Withdrawal by Subject|4|||
145238694|NCT02574481|523720155|FG003|Overall Study|Withdrawal by Subject|1|||
145238695|NCT02574481|523720152|FG000|Overall Study|Adverse Event|5|||
145238696|NCT02574481|523720153|FG001|Overall Study|Adverse Event|1|||
145238697|NCT02574481|523720154|FG002|Overall Study|Adverse Event|1|||
145238698|NCT02574481|523720155|FG003|Overall Study|Adverse Event|0|||
145238699|NCT02574481|523720152|FG000|Overall Study|Visit Missed|15|||
145238700|NCT02574481|523720153|FG001|Overall Study|Visit Missed|7|||
145238701|NCT02574481|523720154|FG002|Overall Study|Visit Missed|5|||
145238702|NCT02574481|523720155|FG003|Overall Study|Visit Missed|0|||
145238703|NCT02574481|523720152|FG000|Overall Study|Other|7|||
145238704|NCT02574481|523720153|FG001|Overall Study|Other|2|||
145238705|NCT02574481|523720154|FG002|Overall Study|Other|0|||
145238706|NCT02574481|523720155|FG003|Overall Study|Other|0|||
145238707|NCT02574481|523720152|FG000|Overall Study|Death|48|||
145238708|NCT02574481|523720153|FG001|Overall Study|Death|26|||
145238709|NCT02574481|523720154|FG002|Overall Study|Death|12|||
145408781|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145408782|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
145238710|NCT02574481|523720155|FG003|Overall Study|Death|4|||
145238711|NCT02574481|523720152|FG000|Overall Study|Physician Decision|5|||
145238712|NCT02574481|523720153|FG001|Overall Study|Physician Decision|2|||
145238713|NCT02574481|523720154|FG002|Overall Study|Physician Decision|0|||
145238714|NCT02574481|523720155|FG003|Overall Study|Physician Decision|0|||
145238715|NCT02574481|523720152|FG000|Overall Study|Lost to Follow-up|5|||
145238716|NCT02574481|523720153|FG001|Overall Study|Lost to Follow-up|1|||
145238717|NCT02574481|523720154|FG002|Overall Study|Lost to Follow-up|3|||
145238718|NCT02574481|523720155|FG003|Overall Study|Lost to Follow-up|0|||
145238719|NCT01105936|523720156|FG000|Period 1|Adverse Event|0|||
145238720|NCT01105936|523720157|FG001|Period 1|Adverse Event|0|||
145238721|NCT01105936|523720158|FG002|Period 1|Adverse Event|0|||
145238722|NCT01105936|523720159|FG003|Period 1|Adverse Event|1|||
145238723|NCT01105936|523720156|FG000|Period 2|Adverse Event|1|||
145238724|NCT01105936|523720157|FG001|Period 2|Adverse Event|0|||
145238725|NCT01105936|523720158|FG002|Period 2|Adverse Event|0|||
145238726|NCT01105936|523720159|FG003|Period 2|Adverse Event|0|||
145238727|NCT01105936|523720156|FG000|Period 3|Protocol Violation|0|||
145238728|NCT01105936|523720157|FG001|Period 3|Protocol Violation|2|||
145238729|NCT01105936|523720158|FG002|Period 3|Protocol Violation|0|||
145238730|NCT01105936|523720159|FG003|Period 3|Protocol Violation|0|||
145238731|NCT03382262|523720162|FG000|Overall Study|Physician Decision|0|||
145238732|NCT03382262|523720163|FG001|Overall Study|Physician Decision|0|||
145238733|NCT03382262|523720164|FG002|Overall Study|Physician Decision|1|||
145238734|NCT03382262|523720165|FG003|Overall Study|Physician Decision|0|||
145408783|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
145238735|NCT03382262|523720162|FG000|Overall Study|Withdrawal by Subject|0|||
145238736|NCT03382262|523720163|FG001|Overall Study|Withdrawal by Subject|0|||
145238737|NCT03382262|523720164|FG002|Overall Study|Withdrawal by Subject|0|||
145238738|NCT03382262|523720165|FG003|Overall Study|Withdrawal by Subject|1|||
145238739|NCT02940860|523720166|FG000|Overall Study|Non-serious AE|1|||
145238740|NCT02940860|523720167|FG001|Overall Study|Non-serious AE|2|||
145238741|NCT02940860|523720166|FG000|Overall Study|Serious AE|7|||
145238742|NCT02940860|523720167|FG001|Overall Study|Serious AE|3|||
145238743|NCT02940860|523720166|FG000|Overall Study|Withdrawal by Subject|19|||
145238744|NCT02940860|523720167|FG001|Overall Study|Withdrawal by Subject|9|||
145238745|NCT02940860|523720166|FG000|Overall Study|Lost to Follow-up|13|||
145238746|NCT02940860|523720167|FG001|Overall Study|Lost to Follow-up|7|||
145238747|NCT02940860|523720166|FG000|Overall Study|Physician Decision|5|||
145238748|NCT02940860|523720167|FG001|Overall Study|Physician Decision|3|||
145238749|NCT02940860|523720166|FG000|Overall Study|Sponsor Decision|0|||
145238750|NCT02940860|523720167|FG001|Overall Study|Sponsor Decision|1|||
145238751|NCT02940860|523720166|FG000|Overall Study|Protocol Violation|0|||
145238752|NCT02940860|523720167|FG001|Overall Study|Protocol Violation|2|||
145238753|NCT02940860|523720166|FG000|Overall Study|Death|3|||
145238754|NCT02940860|523720167|FG001|Overall Study|Death|2|||
145238755|NCT02940860|523720166|FG000|Overall Study|Moved, poor venous access, transport|6|||
145238756|NCT02940860|523720167|FG001|Overall Study|Moved, poor venous access, transport|4|||
145238757|NCT02940860|523720166|FG000|Overall Study|Not treated|2|||
145238758|NCT02940860|523720167|FG001|Overall Study|Not treated|2|||
145238759|NCT00608881|523720170|FG000|Overall Study|Death|22|||
145238760|NCT00608881|523720171|FG001|Overall Study|Death|13|||
145238761|NCT00608881|523720170|FG000|Overall Study|Adverse Event|5|||
145238762|NCT00608881|523720171|FG001|Overall Study|Adverse Event|3|||
145238763|NCT00608881|523720170|FG000|Overall Study|Lost to Follow-up|28|||
145238764|NCT00608881|523720171|FG001|Overall Study|Lost to Follow-up|14|||
145238765|NCT00608881|523720170|FG000|Overall Study|Withdrawal by Subject|18|||
145238766|NCT00608881|523720171|FG001|Overall Study|Withdrawal by Subject|29|||
145238767|NCT00608881|523720170|FG000|Overall Study|Physician Decision|5|||
145238768|NCT00608881|523720171|FG001|Overall Study|Physician Decision|5|||
145238769|NCT00608881|523720170|FG000|Overall Study|Institutionalized|1|||
145238770|NCT00608881|523720171|FG001|Overall Study|Institutionalized|2|||
145238771|NCT04702984|523720172|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
145238772|NCT06000501|523720175|FG000|Overall Study|Screen failure|3|||
145238773|NCT06000501|523720175|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
145238774|NCT06000501|523720175|FG000|Overall Study|Physician Decision|4|||
145238775|NCT06000501|523720175|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
145238776|NCT06000501|523720175|FG000|Overall Study|Scheduling issues|2|||
145238777|NCT01248364|523720176|FG000|Overall Study|Adverse Event|0|||
145238778|NCT01248364|523720177|FG001|Overall Study|Adverse Event|1|||
145238779|NCT01248364|523720178|FG002|Overall Study|Adverse Event|0|||
145238780|NCT01248364|523720179|FG003|Overall Study|Adverse Event|0|||
145238781|NCT01374217|523720182|FG000|Overall Study|Lack of Efficacy|13|||
145238782|NCT03495817|523720183|FG000|26 Week Open Label|Adverse Event|3|||
145238783|NCT03495817|523720183|FG000|26 Week Open Label|Withdrawal by Subject|4|||
145238784|NCT03495817|523720183|FG000|26 Week Open Label|Lost to Follow-up|1|||
145238785|NCT03495817|523720183|FG000|26 Week Extension|Lost to Follow-up|2|||
145238786|NCT01117012|523720188|FG000|Overall Study|Adverse Event|0|||
145238787|NCT01117012|523720189|FG001|Overall Study|Adverse Event|1|||
145238788|NCT01117012|523720188|FG000|Overall Study|Death|1|||
145238789|NCT01117012|523720189|FG001|Overall Study|Death|1|||
145238790|NCT01117012|523720188|FG000|Overall Study|Withdrawal by Subject|3|||
145238791|NCT01117012|523720189|FG001|Overall Study|Withdrawal by Subject|0|||
145238792|NCT01117012|523720188|FG000|Overall Study|Undefined|4|||
145238793|NCT01117012|523720189|FG001|Overall Study|Undefined|3|||
145238794|NCT04682353|523720193|FG000|Overall Study|Lost to Follow-up|0|||
145238795|NCT04682353|523720194|FG001|Overall Study|Lost to Follow-up|1|||
145238796|NCT04682353|523720195|FG002|Overall Study|Lost to Follow-up|0|||
145238797|NCT04682353|523720196|FG003|Overall Study|Lost to Follow-up|1|||
145295727|NCT05214560|523932571|FG000|Overall Study|Surgery not performed|3|||
145295728|NCT02672553|523932572|FG000|Overall Study|Death|3|||
145295729|NCT02672553|523932573|FG001|Overall Study|Death|5|||
145295730|NCT02672553|523932572|FG000|Overall Study|Valve Explant|1|||
145295731|NCT02672553|523932573|FG001|Overall Study|Valve Explant|0|||
145295732|NCT02672553|523932572|FG000|Overall Study|Conversion to Commercial Valve|3|||
145295733|NCT02672553|523932573|FG001|Overall Study|Conversion to Commercial Valve|0|||
145295734|NCT02672553|523932572|FG000|Overall Study|Withdrawal by Subject|3|||
145295735|NCT02672553|523932573|FG001|Overall Study|Withdrawal by Subject|3|||
145295736|NCT02672553|523932572|FG000|Overall Study|Intraoperative screen failure|2|||
145295737|NCT02672553|523932573|FG001|Overall Study|Intraoperative screen failure|0|||
145295738|NCT01606306|523932574|FG000|Overall Study|Lack of Efficacy|2|||
145295739|NCT01606306|523932575|FG001|Overall Study|Lack of Efficacy|1|||
145295740|NCT01606306|523932576|FG002|Overall Study|Lack of Efficacy|4|||
145295741|NCT01606306|523932577|FG003|Overall Study|Lack of Efficacy|4|||
145295742|NCT01606306|523932578|FG004|Overall Study|Lack of Efficacy|1|||
145295743|NCT01606306|523932579|FG005|Overall Study|Lack of Efficacy|2|||
145295744|NCT01606306|523932574|FG000|Overall Study|Adverse Event|1|||
145295745|NCT01606306|523932575|FG001|Overall Study|Adverse Event|0|||
145295746|NCT01606306|523932576|FG002|Overall Study|Adverse Event|1|||
145295747|NCT01606306|523932577|FG003|Overall Study|Adverse Event|1|||
145295748|NCT01606306|523932578|FG004|Overall Study|Adverse Event|2|||
145295749|NCT01606306|523932579|FG005|Overall Study|Adverse Event|0|||
145295750|NCT01606306|523932574|FG000|Overall Study|Lost to Follow-up|7|||
145295751|NCT01606306|523932575|FG001|Overall Study|Lost to Follow-up|4|||
145295752|NCT01606306|523932576|FG002|Overall Study|Lost to Follow-up|5|||
145295753|NCT01606306|523932577|FG003|Overall Study|Lost to Follow-up|4|||
145295754|NCT01606306|523932578|FG004|Overall Study|Lost to Follow-up|3|||
145295755|NCT01606306|523932579|FG005|Overall Study|Lost to Follow-up|5|||
145295756|NCT01606306|523932574|FG000|Overall Study|Withdrawal by Subject|4|||
145295757|NCT01606306|523932575|FG001|Overall Study|Withdrawal by Subject|3|||
145295758|NCT01606306|523932576|FG002|Overall Study|Withdrawal by Subject|4|||
145295759|NCT01606306|523932577|FG003|Overall Study|Withdrawal by Subject|4|||
145238798|NCT04682353|523720193|FG000|Overall Study|Personal reasons|0|||
145238799|NCT04682353|523720194|FG001|Overall Study|Personal reasons|1|||
145238800|NCT04682353|523720195|FG002|Overall Study|Personal reasons|0|||
145238801|NCT04682353|523720196|FG003|Overall Study|Personal reasons|0|||
145238802|NCT01586806|523720197|FG000|Overall Study|Protocol Violation|0|||
145238803|NCT01586806|523720198|FG001|Overall Study|Protocol Violation|1|||
145238804|NCT01586806|523720199|FG002|Overall Study|Protocol Violation|0|||
145238805|NCT01586806|523720197|FG000|Overall Study|Withdrawal by Subject|1|||
145238806|NCT01586806|523720198|FG001|Overall Study|Withdrawal by Subject|0|||
145238807|NCT01586806|523720199|FG002|Overall Study|Withdrawal by Subject|0|||
145238808|NCT01586806|523720197|FG000|Overall Study|Lost to Follow-up|2|||
145238809|NCT01586806|523720198|FG001|Overall Study|Lost to Follow-up|3|||
145238810|NCT01586806|523720199|FG002|Overall Study|Lost to Follow-up|2|||
145238811|NCT02849626|523720200|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
145238812|NCT02849626|523720201|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
145238813|NCT02849626|523720202|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
145238814|NCT02849626|523720203|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
145238815|NCT02849626|523720200|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
145238816|NCT02849626|523720201|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
145238817|NCT02849626|523720202|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
145238818|NCT02849626|523720203|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
145238819|NCT02849626|523720200|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
145238820|NCT02849626|523720201|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
145238821|NCT02849626|523720202|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
145238822|NCT02849626|523720203|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
145238823|NCT02849626|523720200|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
145238824|NCT02849626|523720201|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
145238825|NCT02849626|523720202|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
145238826|NCT02849626|523720203|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
145238827|NCT02849626|523720200|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
145295760|NCT01606306|523932578|FG004|Overall Study|Withdrawal by Subject|5|||
145295761|NCT01606306|523932579|FG005|Overall Study|Withdrawal by Subject|4|||
145295762|NCT01606306|523932574|FG000|Overall Study|Physician Decision|1|||
145295763|NCT01606306|523932575|FG001|Overall Study|Physician Decision|2|||
145295764|NCT01606306|523932576|FG002|Overall Study|Physician Decision|0|||
145295765|NCT01606306|523932577|FG003|Overall Study|Physician Decision|0|||
145295766|NCT01606306|523932578|FG004|Overall Study|Physician Decision|0|||
145295767|NCT01606306|523932579|FG005|Overall Study|Physician Decision|0|||
145295768|NCT00950872|523932580|FG000|Overall Study|Withdrawal by Subject|1|||
145295769|NCT00950872|523932580|FG000|Overall Study|Did not have surgery|2|||
145295770|NCT00970281|523932583|FG000|Overall Study|Lack of Efficacy|1|||
145295771|NCT00970281|523932584|FG001|Overall Study|Lack of Efficacy|14|||
145295772|NCT00970281|523932583|FG000|Overall Study|Withdrawal by Subject|0|||
145295773|NCT00970281|523932584|FG001|Overall Study|Withdrawal by Subject|1|||
145295774|NCT00970281|523932583|FG000|Overall Study|Physician Decision|1|||
145295775|NCT00970281|523932584|FG001|Overall Study|Physician Decision|1|||
145295776|NCT02003183|523932585|FG000|Overall Study|Lost to Follow-up|0|||
145295777|NCT02003183|523932586|FG001|Overall Study|Lost to Follow-up|2|||
145295778|NCT02534493|523932589|FG000|Overall Study|Lost to Follow-up|1|||
145295779|NCT02534493|523932589|FG000|Overall Study|Withdrawal by Subject|1|||
145295780|NCT01054599|523932595|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
145295781|NCT01054599|523932596|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
145295782|NCT01054599|523932595|FG000|Overall Study|Protocol Violation|1|||
145295783|NCT01054599|523932596|FG001|Overall Study|Protocol Violation|0|||
145295784|NCT01054599|523932595|FG000|Overall Study|Spells/seizure-like episodes|1|||
145295785|NCT01054599|523932596|FG001|Overall Study|Spells/seizure-like episodes|1|||
145295786|NCT01054599|523932595|FG000|Overall Study|Timing/scheduling difficulties|1|||
145295787|NCT01054599|523932596|FG001|Overall Study|Timing/scheduling difficulties|1|||
145295788|NCT01054599|523932595|FG000|Overall Study|Visual impairment, WTAR <80|0|||
145295789|NCT01054599|523932596|FG001|Overall Study|Visual impairment, WTAR <80|1|||
145295790|NCT01054599|523932595|FG000|Overall Study|Lost to Follow-up|0|||
145295791|NCT01054599|523932596|FG001|Overall Study|Lost to Follow-up|2|||
145295792|NCT01054599|523932595|FG000|Overall Study|Adverse Event|0|||
145295793|NCT01054599|523932596|FG001|Overall Study|Adverse Event|1|||
145295794|NCT01054599|523932595|FG000|Overall Study|Withdrawal by Subject|0|||
145238828|NCT02849626|523720201|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
145238829|NCT02849626|523720202|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
145238830|NCT02849626|523720203|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
145238831|NCT02849626|523720200|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
145295795|NCT01054599|523932596|FG001|Overall Study|Withdrawal by Subject|1|||
145295796|NCT01104662|523932597|FG000|Overall Study|Adverse Event|2|||
145295797|NCT01104662|523932598|FG001|Overall Study|Adverse Event|2|||
145295798|NCT01104662|523932599|FG002|Overall Study|Adverse Event|0|||
145295799|NCT01104662|523932600|FG003|Overall Study|Adverse Event|1|||
145295800|NCT01104662|523932601|FG004|Overall Study|Adverse Event|1|||
145295801|NCT01104662|523932602|FG005|Overall Study|Adverse Event|1|||
145238832|NCT02849626|523720201|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
145238833|NCT02849626|523720202|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
145238834|NCT02849626|523720203|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
145238835|NCT02849626|523720200|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
145238836|NCT02849626|523720201|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
145238837|NCT02849626|523720202|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
145238838|NCT02849626|523720203|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
145238839|NCT02849626|523720200|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
145238840|NCT02849626|523720201|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
145238841|NCT02849626|523720202|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
145238842|NCT02849626|523720203|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
145238843|NCT02849626|523720200|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
145238844|NCT02849626|523720201|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
145238845|NCT02849626|523720202|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
145238846|NCT02849626|523720203|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
145238847|NCT02849626|523720200|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
145238848|NCT02849626|523720201|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
145238849|NCT02849626|523720202|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
145238850|NCT02849626|523720203|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
145238851|NCT02849626|523720200|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
145238852|NCT02849626|523720201|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
145238853|NCT02849626|523720202|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
145238854|NCT02849626|523720203|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
145238855|NCT01185704|523720204|FG000|Overall Study|Randomized but not treated|3|||
145238856|NCT01185704|523720205|FG001|Overall Study|Randomized but not treated|3|||
145238857|NCT01185704|523720204|FG000|Overall Study|Lack of ovarian response|5|||
145238858|NCT01185704|523720205|FG001|Overall Study|Lack of ovarian response|1|||
145238859|NCT01185704|523720204|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
145238860|NCT01185704|523720205|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
145238861|NCT01185704|523720204|FG000|Overall Study|Ectopic pregnancy|0|||
145238862|NCT01185704|523720205|FG001|Overall Study|Ectopic pregnancy|1|||
145238863|NCT04176445|523720208|FG000|Overall Study|Adverse Event|0|||
145238864|NCT04176445|523720209|FG001|Overall Study|Adverse Event|1|||
145238865|NCT04176445|523720208|FG000|Overall Study|change plans weaning after first intervention|0|||
145238866|NCT04176445|523720209|FG001|Overall Study|change plans weaning after first intervention|1|||
145238867|NCT00187889|523720210|FG000|Overall Study|Withdrawal by Subject|6|||
145238868|NCT00187889|523720211|FG001|Overall Study|Withdrawal by Subject|4|||
145238869|NCT04046341|523720212|FG000|Overall Study|Lost to Follow-up|2|||
145238870|NCT04046341|523720212|FG000|Overall Study|Withdrawal by Subject|1|||
145238871|NCT04377672|523720214|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
145238872|NCT00405652|523720217|FG000|Overall Study|Adverse Event|4|||
145238873|NCT03505749|523720220|FG000|Overall Study|Lost to Follow-up|7|||
145238874|NCT03505749|523720221|FG001|Overall Study|Lost to Follow-up|11|||
145238875|NCT03505749|523720220|FG000|Overall Study|Withdrawal by Subject|6|||
145238876|NCT03505749|523720221|FG001|Overall Study|Withdrawal by Subject|0|||
145238877|NCT03505749|523720220|FG000|Overall Study|Discharged from treatment|3|||
145238878|NCT03505749|523720221|FG001|Overall Study|Discharged from treatment|6|||
145238879|NCT00435994|523720222|FG000|Overall Study|Lost to Follow-up|7|||
145238880|NCT00435994|523720223|FG001|Overall Study|Lost to Follow-up|0|||
145238881|NCT00435994|523720224|FG002|Overall Study|Lost to Follow-up|0|||
145238882|NCT01151540|523720225|FG000|Overall Study|Other|2|||
145238883|NCT01151540|523720225|FG000|Overall Study|Adverse event, non-fatal|4|||
145238884|NCT01151540|523720225|FG000|Overall Study|Withdrawal by Subject|7|||
145238885|NCT03846219|523720227|FG000|Overall Study|Withdrawal by Subject|3|||
145238886|NCT03846219|523720228|FG001|Overall Study|Withdrawal by Subject|2|||
145238887|NCT03846219|523720229|FG002|Overall Study|Withdrawal by Subject|2|||
145238888|NCT03846219|523720227|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
145238889|NCT03846219|523720228|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
145238890|NCT03846219|523720229|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
145238891|NCT03846219|523720227|FG000|Overall Study|Physician Decision|0|||
145238892|NCT03846219|523720228|FG001|Overall Study|Physician Decision|0|||
145238893|NCT03846219|523720229|FG002|Overall Study|Physician Decision|2|||
145238894|NCT02322411|523720230|FG000|Overall Study|Lost to Follow-up|4|||
145238895|NCT02322411|523720231|FG001|Overall Study|Lost to Follow-up|7|||
145238896|NCT02322411|523720230|FG000|Overall Study|Withdrawal by Subject|1|||
145238897|NCT02322411|523720231|FG001|Overall Study|Withdrawal by Subject|0|||
145238898|NCT02248857|523720235|FG000|3 Month|Withdrawal by Subject|9|||
145238899|NCT02248857|523720236|FG001|3 Month|Withdrawal by Subject|3|||
145238900|NCT02248857|523720237|FG002|3 Month|Withdrawal by Subject|4|||
145238901|NCT02248857|523720235|FG000|3 Month|Unable to reach for 3 month|35|||
145238902|NCT02248857|523720236|FG001|3 Month|Unable to reach for 3 month|29|||
145238903|NCT02248857|523720237|FG002|3 Month|Unable to reach for 3 month|26|||
145238904|NCT02248857|523720235|FG000|3 Month|Partially completed, unable to finish|2|||
145238905|NCT02248857|523720236|FG001|3 Month|Partially completed, unable to finish|2|||
145238906|NCT02248857|523720237|FG002|3 Month|Partially completed, unable to finish|1|||
145238907|NCT02248857|523720235|FG000|6 Month|Lost to Follow-up|27|||
145238908|NCT02248857|523720236|FG001|6 Month|Lost to Follow-up|26|||
145238909|NCT02248857|523720237|FG002|6 Month|Lost to Follow-up|15|||
145238910|NCT02248857|523720235|FG000|6 Month|Partially completed, unable to finish|0|||
145238911|NCT02248857|523720236|FG001|6 Month|Partially completed, unable to finish|1|||
145238912|NCT02248857|523720237|FG002|6 Month|Partially completed, unable to finish|0|||
145238913|NCT02248857|523720235|FG000|6 Month|Withdrawal by Subject|0|||
145238914|NCT02248857|523720236|FG001|6 Month|Withdrawal by Subject|2|||
145238915|NCT02248857|523720237|FG002|6 Month|Withdrawal by Subject|2|||
145238916|NCT02248857|523720235|FG000|6 Month|Death|1|||
145238917|NCT02248857|523720236|FG001|6 Month|Death|0|||
145238918|NCT02248857|523720237|FG002|6 Month|Death|0|||
145238919|NCT02671461|523720238|FG000|Treatment|Adverse Event|0|||
145238920|NCT02671461|523720239|FG001|Treatment|Adverse Event|0|||
145238921|NCT02671461|523720240|FG002|Treatment|Adverse Event|1|||
145238922|NCT02671461|523720238|FG000|Treatment|Administrative Reason by Sponsor|1|||
145238923|NCT02671461|523720239|FG001|Treatment|Administrative Reason by Sponsor|3|||
145238924|NCT02671461|523720240|FG002|Treatment|Administrative Reason by Sponsor|4|||
145238925|NCT02671461|523720238|FG000|Treatment|Randomized, not treated|1|||
145238926|NCT02671461|523720239|FG001|Treatment|Randomized, not treated|0|||
145238927|NCT02671461|523720240|FG002|Treatment|Randomized, not treated|0|||
145238928|NCT02671461|523720238|FG000|Follow-up|Withdrawal by Subject|1|||
145238929|NCT02671461|523720239|FG001|Follow-up|Withdrawal by Subject|0|||
145238930|NCT02671461|523720240|FG002|Follow-up|Withdrawal by Subject|0|||
145238931|NCT02671461|523720238|FG000|Follow-up|Lost to Follow-up|0|||
145238932|NCT02671461|523720239|FG001|Follow-up|Lost to Follow-up|0|||
145238933|NCT02671461|523720240|FG002|Follow-up|Lost to Follow-up|1|||
145238934|NCT02671461|523720238|FG000|Follow-up|Administrative Reason by Sponsor|0|||
145238935|NCT02671461|523720239|FG001|Follow-up|Administrative Reason by Sponsor|1|||
145238936|NCT02671461|523720240|FG002|Follow-up|Administrative Reason by Sponsor|0|||
145238937|NCT02261883|523720241|FG000|Overall Study|Death|3|||
145238938|NCT02261883|523720242|FG001|Overall Study|Death|2|||
145238939|NCT02261883|523720241|FG000|Overall Study|Physician Decision|1|||
145238940|NCT02261883|523720242|FG001|Overall Study|Physician Decision|0|||
145238941|NCT02261883|523720241|FG000|Overall Study|Protocol Violation|1|||
145238942|NCT02261883|523720242|FG001|Overall Study|Protocol Violation|0|||
145238943|NCT02261883|523720241|FG000|Overall Study|Withdrawal by Subject|0|||
145238944|NCT02261883|523720242|FG001|Overall Study|Withdrawal by Subject|1|||
145238945|NCT02261883|523720241|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
145238946|NCT02261883|523720242|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
145238947|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
145238948|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
145238949|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
145238950|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
145238951|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
145238952|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
145238953|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
145238954|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
145238955|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
145238956|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
145295802|NCT01104662|523932603|FG006|Overall Study|Adverse Event|0|||
145295803|NCT01104662|523932604|FG007|Overall Study|Adverse Event|0|||
145295804|NCT01104662|523932597|FG000|Overall Study|Clinical Failure|1|||
145295805|NCT01104662|523932598|FG001|Overall Study|Clinical Failure|0|||
145295806|NCT01104662|523932599|FG002|Overall Study|Clinical Failure|0|||
145238957|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
145238958|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
145238959|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
145238960|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
145238961|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
145238962|NCT01412060|523720243|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
145238963|NCT01412060|523720244|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
145238964|NCT01412060|523720245|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
145238965|NCT01412060|523720243|FG000|Period Between RIP and SP|Adverse Event|4|||
145295807|NCT01104662|523932600|FG003|Overall Study|Clinical Failure|0|||
145295808|NCT01104662|523932601|FG004|Overall Study|Clinical Failure|0|||
145238966|NCT01412060|523720244|FG001|Period Between RIP and SP|Adverse Event|0|||
145238967|NCT01412060|523720245|FG002|Period Between RIP and SP|Adverse Event|0|||
145238968|NCT01412060|523720243|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
145238969|NCT01412060|523720244|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
145295809|NCT01104662|523932602|FG005|Overall Study|Clinical Failure|1|||
145295810|NCT01104662|523932603|FG006|Overall Study|Clinical Failure|0|||
145619994|NCT05343455|525123646|FG000|Overall Study|Withdrawal by Subject|4|||
145238970|NCT01412060|523720245|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
145238971|NCT01412060|523720243|FG000|Period Between RIP and SP|Protocol Violation|2|||
145238972|NCT01412060|523720244|FG001|Period Between RIP and SP|Protocol Violation|0|||
145619995|NCT05343455|525123647|FG001|Overall Study|Withdrawal by Subject|9|||
145619996|NCT05343455|525123648|FG002|Overall Study|Withdrawal by Subject|7|||
145619997|NCT05343455|525123646|FG000|Overall Study|Adverse Event|2|||
145619998|NCT05343455|525123647|FG001|Overall Study|Adverse Event|1|||
145619999|NCT05343455|525123648|FG002|Overall Study|Adverse Event|2|||
145620000|NCT05343455|525123646|FG000|Overall Study|Lost to Follow-up|1|||
145620001|NCT05343455|525123647|FG001|Overall Study|Lost to Follow-up|1|||
145620002|NCT05343455|525123648|FG002|Overall Study|Lost to Follow-up|3|||
145620003|NCT05343455|525123646|FG000|Overall Study|Pregnancy|1|||
145620004|NCT05343455|525123647|FG001|Overall Study|Pregnancy|0|||
145620005|NCT05343455|525123648|FG002|Overall Study|Pregnancy|0|||
145620006|NCT05343455|525123646|FG000|Overall Study|Physician Decision|0|||
145620007|NCT05343455|525123647|FG001|Overall Study|Physician Decision|0|||
145238973|NCT01412060|523720245|FG002|Period Between RIP and SP|Protocol Violation|0|||
145238974|NCT01412060|523720243|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
145238975|NCT01412060|523720244|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
145238976|NCT01412060|523720245|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
145238977|NCT01412060|523720243|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
145238978|NCT01412060|523720244|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
145238979|NCT01412060|523720245|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
145238980|NCT01412060|523720243|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
145238981|NCT01412060|523720244|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
145238982|NCT01412060|523720245|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
145238983|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
145238984|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
145238985|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
145238986|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
145238987|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
145238988|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
145238989|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
145238990|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
145238991|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
145238992|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
145295811|NCT01104662|523932604|FG007|Overall Study|Clinical Failure|0|||
145295812|NCT01104662|523932597|FG000|Overall Study|Participant left investigator's care|1|||
145295813|NCT01104662|523932598|FG001|Overall Study|Participant left investigator's care|1|||
145295814|NCT01104662|523932599|FG002|Overall Study|Participant left investigator's care|0|||
145295815|NCT01104662|523932600|FG003|Overall Study|Participant left investigator's care|0|||
145295816|NCT01104662|523932601|FG004|Overall Study|Participant left investigator's care|0|||
145295817|NCT01104662|523932602|FG005|Overall Study|Participant left investigator's care|0|||
145295818|NCT01104662|523932603|FG006|Overall Study|Participant left investigator's care|0|||
145295819|NCT01104662|523932604|FG007|Overall Study|Participant left investigator's care|0|||
145295820|NCT01104662|523932597|FG000|Overall Study|Reason not specified|3|||
145408784|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145408785|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145408786|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145562808|NCT01012622|524921677|FG000|Overall Study|Other|1|||
145562809|NCT01012622|524921677|FG000|Overall Study|screening failure|1|||
145562810|NCT01012622|524921677|FG000|Overall Study|withdrawal of consent by a parent|2|||
145562811|NCT04254978|524921678|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
145562812|NCT04254978|524921678|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
145562813|NCT04254978|524921678|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
145562814|NCT04254978|524921678|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
145562815|NCT04254978|524921678|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
145562816|NCT04254978|524921678|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
145562817|NCT02515942|524921679|FG000|Overall Study|Adverse Event|5|||
145562818|NCT02515942|524921680|FG001|Overall Study|Adverse Event|0|||
145562819|NCT02515942|524921681|FG002|Overall Study|Adverse Event|0|||
145562820|NCT02515942|524921679|FG000|Overall Study|Death|0|||
145238993|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
145295821|NCT01104662|523932598|FG001|Overall Study|Reason not specified|3|||
145620008|NCT05343455|525123648|FG002|Overall Study|Physician Decision|1|||
145620009|NCT05343455|525123646|FG000|Overall Study|Protocol Violation|0|||
145620010|NCT05343455|525123647|FG001|Overall Study|Protocol Violation|1|||
145620011|NCT05343455|525123648|FG002|Overall Study|Protocol Violation|1|||
145620012|NCT03468426|525123649|FG000|Overall Study|Progressive disease|3|||
145562821|NCT02515942|524921680|FG001|Overall Study|Death|0|||
145562822|NCT02515942|524921681|FG002|Overall Study|Death|1|||
145562823|NCT02515942|524921679|FG000|Overall Study|Lack of Efficacy|0|||
145562824|NCT02515942|524921680|FG001|Overall Study|Lack of Efficacy|0|||
145562825|NCT02515942|524921681|FG002|Overall Study|Lack of Efficacy|1|||
145562826|NCT02515942|524921679|FG000|Overall Study|Lost to Follow-up|2|||
145562827|NCT02515942|524921680|FG001|Overall Study|Lost to Follow-up|0|||
145562828|NCT02515942|524921681|FG002|Overall Study|Lost to Follow-up|0|||
145562829|NCT02515942|524921679|FG000|Overall Study|Withdrawal by Subject|0|||
145562830|NCT02515942|524921680|FG001|Overall Study|Withdrawal by Subject|3|||
145562831|NCT02515942|524921681|FG002|Overall Study|Withdrawal by Subject|2|||
145562832|NCT00902564|524921682|FG000|Overall Study|Withdrawal by Subject|2|||
145562833|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
145562834|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
145562835|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
145562836|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
145562837|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
145562838|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
145562839|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
145562840|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
145562841|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
145238994|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
145238995|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
145238996|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
145238997|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
145238998|NCT01412060|523720243|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
145238999|NCT01412060|523720244|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
145239000|NCT01412060|523720245|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
145239001|NCT01412060|523720243|FG000|Period Between SP and DBP|Protocol Violation|2|||
145562842|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
145562843|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
145562844|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
145562845|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
145562846|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
145562847|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
145562848|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
145562849|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
145562850|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
145562851|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
145562852|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
145562853|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
145562854|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
145562855|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
145562856|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
145562857|NCT00277212|524921683|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
145562858|NCT00277212|524921684|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
145239002|NCT01412060|523720244|FG001|Period Between SP and DBP|Protocol Violation|0|||
145239003|NCT01412060|523720245|FG002|Period Between SP and DBP|Protocol Violation|0|||
145295822|NCT01104662|523932599|FG002|Overall Study|Reason not specified|0|||
145295823|NCT01104662|523932600|FG003|Overall Study|Reason not specified|0|||
145295824|NCT01104662|523932601|FG004|Overall Study|Reason not specified|0|||
145295825|NCT01104662|523932602|FG005|Overall Study|Reason not specified|1|||
145295826|NCT01104662|523932603|FG006|Overall Study|Reason not specified|0|||
145295827|NCT01104662|523932604|FG007|Overall Study|Reason not specified|0|||
145295828|NCT01104662|523932597|FG000|Overall Study|Randomized but not treated|3|||
145295829|NCT01104662|523932598|FG001|Overall Study|Randomized but not treated|4|||
145295830|NCT01104662|523932599|FG002|Overall Study|Randomized but not treated|1|||
145295831|NCT01104662|523932600|FG003|Overall Study|Randomized but not treated|0|||
145295832|NCT01104662|523932601|FG004|Overall Study|Randomized but not treated|0|||
145295833|NCT01104662|523932602|FG005|Overall Study|Randomized but not treated|1|||
145295834|NCT01104662|523932603|FG006|Overall Study|Randomized but not treated|0|||
145295835|NCT01104662|523932604|FG007|Overall Study|Randomized but not treated|0|||
145295836|NCT00743197|523932605|FG000|Overall Study|Study terminated due to departure of PI.|1|||
145295837|NCT00743197|523932606|FG001|Overall Study|Study terminated due to departure of PI.|2|||
145295838|NCT01478620|523932607|FG000|Overall Study|Lost to Follow-up|6|||
145562859|NCT00277212|524921685|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
145562860|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
145562861|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
145295839|NCT02170688|523932610|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
145295840|NCT02170688|523932611|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
145239004|NCT01412060|523720243|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
145239005|NCT01412060|523720244|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
145239006|NCT01412060|523720245|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
145239007|NCT01412060|523720243|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
145239008|NCT01412060|523720244|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
145239009|NCT01412060|523720245|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
145239010|NCT01412060|523720243|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
145239011|NCT01412060|523720244|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
145239012|NCT01412060|523720245|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
145239013|NCT01412060|523720243|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
145239014|NCT01412060|523720244|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
145239015|NCT01412060|523720245|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
145239016|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
145239017|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
145239018|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
145239019|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
145239020|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
145239021|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
145239022|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
145239023|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
145239024|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
145239025|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
145239026|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
145239027|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
145239028|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
145239029|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
145239030|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
145239031|NCT01412060|523720243|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
145239032|NCT01412060|523720244|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
145239033|NCT01412060|523720245|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
145239034|NCT03549117|523720255|FG000|Overall Study|Withdrawal by Subject|1|||
145239035|NCT03549117|523720256|FG001|Overall Study|Withdrawal by Subject|0|||
145239036|NCT00367432|523720257|FG000|First Period (16 Weeks)|Adverse Event|6|||
145239037|NCT00367432|523720258|FG001|First Period (16 Weeks)|Adverse Event|0|||
145562862|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
145562863|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
145562864|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
145562865|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
145562866|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
145562867|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
145562868|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
145562869|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
145562870|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
145562871|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
145562872|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
145562873|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
145562874|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
145562875|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
145562876|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
145562877|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
145562878|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
145562879|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
145562880|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
145562881|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
145562882|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
145562883|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
145562884|NCT00277212|524921683|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
145562885|NCT00277212|524921684|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
145562886|NCT00277212|524921685|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
145562887|NCT03336216|524921686|FG000|Randomization|Not reported|2|||
145562888|NCT03336216|524921687|FG001|Randomization|Not reported|0|||
145620013|NCT03468426|525123650|FG001|Overall Study|Progressive disease|0|||
145239038|NCT00367432|523720257|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
145239039|NCT00367432|523720258|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
145562889|NCT03336216|524921688|FG002|Randomization|Not reported|1|||
145562890|NCT03336216|524921689|FG003|Randomization|Not reported|0|||
145562891|NCT03336216|524921686|FG000|Randomization|Other reasons|1|||
145620014|NCT03468426|525123651|FG002|Overall Study|Progressive disease|4|||
145239040|NCT00367432|523720257|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
145562892|NCT03336216|524921687|FG001|Randomization|Other reasons|1|||
145562893|NCT03336216|524921688|FG002|Randomization|Other reasons|1|||
145562894|NCT03336216|524921689|FG003|Randomization|Other reasons|0|||
145562895|NCT03336216|524921686|FG000|Randomization|Participant no longer meets study criteria|0|||
145562896|NCT03336216|524921687|FG001|Randomization|Participant no longer meets study criteria|2|||
145562897|NCT03336216|524921688|FG002|Randomization|Participant no longer meets study criteria|4|||
145562898|NCT03336216|524921689|FG003|Randomization|Participant no longer meets study criteria|1|||
145562899|NCT03336216|524921686|FG000|Randomization|Lost to Follow-up|1|||
145562900|NCT03336216|524921687|FG001|Randomization|Lost to Follow-up|0|||
145562901|NCT03336216|524921688|FG002|Randomization|Lost to Follow-up|0|||
145562902|NCT03336216|524921689|FG003|Randomization|Lost to Follow-up|0|||
145562903|NCT03336216|524921686|FG000|Randomization|Participant withdrew consent|9|||
145562904|NCT03336216|524921687|FG001|Randomization|Participant withdrew consent|1|||
145562905|NCT03336216|524921688|FG002|Randomization|Participant withdrew consent|0|||
145562906|NCT03336216|524921689|FG003|Randomization|Participant withdrew consent|0|||
145562907|NCT03336216|524921686|FG000|Randomization|Adverse Event|1|||
145562908|NCT03336216|524921687|FG001|Randomization|Adverse Event|1|||
145562909|NCT03336216|524921688|FG002|Randomization|Adverse Event|0|||
145562910|NCT03336216|524921689|FG003|Randomization|Adverse Event|0|||
145562911|NCT03336216|524921686|FG000|Treatment|Adverse Event|2|||
145562912|NCT03336216|524921687|FG001|Treatment|Adverse Event|3|||
145562913|NCT03336216|524921688|FG002|Treatment|Adverse Event|4|||
145562914|NCT03336216|524921689|FG003|Treatment|Adverse Event|4|||
145562915|NCT03336216|524921686|FG000|Treatment|Participant request to discontinue treatment|2|||
145562916|NCT03336216|524921687|FG001|Treatment|Participant request to discontinue treatment|1|||
145562917|NCT03336216|524921688|FG002|Treatment|Participant request to discontinue treatment|2|||
145562918|NCT03336216|524921689|FG003|Treatment|Participant request to discontinue treatment|2|||
145562919|NCT03336216|524921686|FG000|Treatment|Participant withdrew consent|7|||
145562920|NCT03336216|524921687|FG001|Treatment|Participant withdrew consent|2|||
145562921|NCT03336216|524921688|FG002|Treatment|Participant withdrew consent|3|||
145562922|NCT03336216|524921689|FG003|Treatment|Participant withdrew consent|2|||
145562923|NCT03336216|524921686|FG000|Treatment|Death|2|||
145562924|NCT03336216|524921687|FG001|Treatment|Death|3|||
145562925|NCT03336216|524921688|FG002|Treatment|Death|3|||
145562926|NCT03336216|524921689|FG003|Treatment|Death|4|||
145562927|NCT03336216|524921686|FG000|Treatment|Participant no longer meets study criteria|0|||
145562928|NCT03336216|524921687|FG001|Treatment|Participant no longer meets study criteria|1|||
145620015|NCT03468426|525123652|FG003|Overall Study|Progressive disease|20|||
145239041|NCT00367432|523720258|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
145239042|NCT00367432|523720257|FG000|First Period (16 Weeks)|Other Reason|2|||
145239043|NCT00367432|523720258|FG001|First Period (16 Weeks)|Other Reason|0|||
145239044|NCT00367432|523720257|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
145239045|NCT00367432|523720258|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
145239046|NCT00367432|523720257|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
145239047|NCT00367432|523720258|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
145239048|NCT00367432|523720257|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
145239049|NCT00367432|523720258|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
145239050|NCT00367432|523720257|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
145239051|NCT00367432|523720258|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
145239052|NCT00367432|523720257|FG000|Second Period (up to 54 Months)|Other Reason|6|||
145239053|NCT00367432|523720258|FG001|Second Period (up to 54 Months)|Other Reason|2|||
145239054|NCT05567393|523720259|FG000|Overall Study|Voluntary Withdrawal|0|||
145239055|NCT05567393|523720260|FG001|Overall Study|Voluntary Withdrawal|0|||
145239056|NCT05567393|523720261|FG002|Overall Study|Voluntary Withdrawal|0|||
145239057|NCT05567393|523720262|FG003|Overall Study|Voluntary Withdrawal|0|||
145239058|NCT05567393|523720263|FG004|Overall Study|Voluntary Withdrawal|0|||
145239059|NCT05567393|523720264|FG005|Overall Study|Voluntary Withdrawal|0|||
145239060|NCT05567393|523720265|FG006|Overall Study|Voluntary Withdrawal|0|||
145239061|NCT05567393|523720266|FG007|Overall Study|Voluntary Withdrawal|0|||
145239062|NCT05567393|523720267|FG008|Overall Study|Voluntary Withdrawal|0|||
145239063|NCT05567393|523720268|FG009|Overall Study|Voluntary Withdrawal|0|||
145239064|NCT05567393|523720269|FG010|Overall Study|Voluntary Withdrawal|0|||
145239065|NCT05567393|523720270|FG011|Overall Study|Voluntary Withdrawal|0|||
145239066|NCT05567393|523720271|FG012|Overall Study|Voluntary Withdrawal|0|||
145239067|NCT05567393|523720272|FG013|Overall Study|Voluntary Withdrawal|1|||
145239068|NCT05567393|523720273|FG014|Overall Study|Voluntary Withdrawal|0|||
145239069|NCT05567393|523720274|FG015|Overall Study|Voluntary Withdrawal|0|||
145562929|NCT03336216|524921688|FG002|Treatment|Participant no longer meets study criteria|0|||
145562930|NCT03336216|524921689|FG003|Treatment|Participant no longer meets study criteria|0|||
145562931|NCT03336216|524921686|FG000|Treatment|Other reasons|2|||
145562932|NCT03336216|524921687|FG001|Treatment|Other reasons|0|||
145562933|NCT03336216|524921688|FG002|Treatment|Other reasons|0|||
145562934|NCT03336216|524921689|FG003|Treatment|Other reasons|3|||
145239070|NCT05567393|523720275|FG016|Overall Study|Voluntary Withdrawal|0|||
145295841|NCT02170688|523932612|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
145295842|NCT02170688|523932613|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
145295843|NCT02170688|523932614|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
145295844|NCT02170688|523932610|FG000|Overall Study|Full dose not received|0|||
145295845|NCT02170688|523932611|FG001|Overall Study|Full dose not received|1|||
145295846|NCT02170688|523932612|FG002|Overall Study|Full dose not received|0|||
145295847|NCT02170688|523932613|FG003|Overall Study|Full dose not received|0|||
145295848|NCT02170688|523932614|FG004|Overall Study|Full dose not received|0|||
145295849|NCT02170688|523932610|FG000|Overall Study|Physician Decision|0|||
145295850|NCT02170688|523932611|FG001|Overall Study|Physician Decision|0|||
145295851|NCT02170688|523932612|FG002|Overall Study|Physician Decision|1|||
145295852|NCT02170688|523932613|FG003|Overall Study|Physician Decision|0|||
145295853|NCT02170688|523932614|FG004|Overall Study|Physician Decision|0|||
145295854|NCT02079532|523932617|FG000|Overall Study|Adverse Event|7|||
145295855|NCT02079532|523932617|FG000|Overall Study|Additional or changed therapy|2|||
145295856|NCT02079532|523932617|FG000|Overall Study|Lack of Efficacy|9|||
145295857|NCT02079532|523932617|FG000|Overall Study|Protocol Violation|3|||
145295858|NCT02079532|523932617|FG000|Overall Study|Withdrawal by Subject|1|||
145295859|NCT02079532|523932617|FG000|Overall Study|Administrative problems|1|||
145295860|NCT02079532|523932617|FG000|Overall Study|Inclusion into ReFIRST|3|||
145295861|NCT02079532|523932617|FG000|Overall Study|Other|3|||
145295862|NCT00745420|523934336|FG000|Overall Study|Ineligible|1|||
145295863|NCT04455633|523934337|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
145295864|NCT04455633|523934338|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
145295865|NCT04455633|523934339|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
145295866|NCT04455633|523934337|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
145295867|NCT04455633|523934338|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
145295868|NCT04455633|523934339|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
145295869|NCT04455633|523934337|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
145295870|NCT04455633|523934338|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
145295871|NCT04455633|523934339|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
145295872|NCT04455633|523934337|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
145295873|NCT04455633|523934338|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
145562935|NCT03336216|524921686|FG000|Treatment|Disease progression|23|||
145562936|NCT03336216|524921687|FG001|Treatment|Disease progression|34|||
145562937|NCT03336216|524921688|FG002|Treatment|Disease progression|33|||
145562938|NCT03336216|524921689|FG003|Treatment|Disease progression|26|||
145562939|NCT03336216|524921686|FG000|Treatment|Study drug toxicity|0|||
145562940|NCT03336216|524921687|FG001|Treatment|Study drug toxicity|3|||
145562941|NCT03336216|524921688|FG002|Treatment|Study drug toxicity|2|||
145562942|NCT03336216|524921689|FG003|Treatment|Study drug toxicity|0|||
145562943|NCT03336216|524921686|FG000|Treatment|Adverse Event unrelated to study drug|1|||
145562944|NCT03336216|524921687|FG001|Treatment|Adverse Event unrelated to study drug|1|||
145562945|NCT03336216|524921688|FG002|Treatment|Adverse Event unrelated to study drug|1|||
145562946|NCT03336216|524921689|FG003|Treatment|Adverse Event unrelated to study drug|0|||
145562947|NCT03336216|524921686|FG000|Treatment|Disease Recurrence|1|||
145562948|NCT03336216|524921687|FG001|Treatment|Disease Recurrence|0|||
145562949|NCT03336216|524921688|FG002|Treatment|Disease Recurrence|0|||
145562950|NCT03336216|524921689|FG003|Treatment|Disease Recurrence|0|||
145562951|NCT00922766|524921697|FG000|Overall Study|Death|3|||
145562952|NCT00922766|524921697|FG000|Overall Study|Withdrawal by Subject|2|||
145562953|NCT00922766|524921697|FG000|Overall Study|Other|1|||
145562954|NCT00922766|524921697|FG000|Overall Study|Adverse Event|1|||
145562955|NCT00666757|524921703|FG000|Overall Study|Lost to Follow-up|39|||
145562956|NCT00666757|524921704|FG001|Overall Study|Lost to Follow-up|35|||
145562957|NCT00666757|524921703|FG000|Overall Study|Protocol Violation|23|||
145562958|NCT00666757|524921704|FG001|Overall Study|Protocol Violation|24|||
145562959|NCT00666757|524921703|FG000|Overall Study|Adverse Event|22|||
145562960|NCT00666757|524921704|FG001|Overall Study|Adverse Event|12|||
145562961|NCT00666757|524921703|FG000|Overall Study|Withdrawal by Subject|13|||
145562962|NCT00666757|524921704|FG001|Overall Study|Withdrawal by Subject|17|||
145562963|NCT00666757|524921703|FG000|Overall Study|Lack of Efficacy|3|||
145562964|NCT00666757|524921704|FG001|Overall Study|Lack of Efficacy|6|||
145562965|NCT00666757|524921703|FG000|Overall Study|Physician Decision|0|||
145562966|NCT00666757|524921704|FG001|Overall Study|Physician Decision|2|||
145562967|NCT00666757|524921703|FG000|Overall Study|Sponsor decision|0|||
145562968|NCT00666757|524921704|FG001|Overall Study|Sponsor decision|1|||
145620016|NCT03468426|525123653|FG004|Overall Study|Progressive disease|23|||
145295874|NCT04455633|523934339|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
145295875|NCT03527745|523934340|FG000|Overall Study|Lost to Follow-up|3|||
145295876|NCT03527745|523934341|FG001|Overall Study|Lost to Follow-up|6|||
145295877|NCT03527745|523934342|FG002|Overall Study|Lost to Follow-up|7|||
145562969|NCT01231581|524921705|FG000|Overall Study|Lost to Follow-up|2|||
145562970|NCT01231581|524921706|FG001|Overall Study|Lost to Follow-up|2|||
145562971|NCT01231581|524921705|FG000|Overall Study|Withdrawal by Subject|6|||
145562972|NCT01231581|524921706|FG001|Overall Study|Withdrawal by Subject|9|||
145562973|NCT01231581|524921705|FG000|Overall Study|Study Closed/Terminated|6|||
145562974|NCT01231581|524921706|FG001|Overall Study|Study Closed/Terminated|5|||
145562975|NCT01231581|524921705|FG000|Overall Study|Death|65|||
145562976|NCT01231581|524921706|FG001|Overall Study|Death|64|||
145562977|NCT01231581|524921705|FG000|Overall Study|Ongoing|1|||
145562978|NCT01231581|524921706|FG001|Overall Study|Ongoing|0|||
145562979|NCT05954052|524921707|FG000|Overall Study|Adverse Event|1|||
145562980|NCT01723163|524921708|FG000|Treatment Phase|Withdrawal by Subject|14|||
145562981|NCT01723163|524921709|FG001|Treatment Phase|Withdrawal by Subject|6|||
145562982|NCT01723163|524921708|FG000|Treatment Phase|Withdrawal by PI|5|||
145562983|NCT01723163|524921709|FG001|Treatment Phase|Withdrawal by PI|1|||
145562984|NCT01723163|524921708|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
145562985|NCT01723163|524921709|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
145562986|NCT01723163|524921708|FG000|3-Month Follow-up|Unable to Contact|12|||
145562987|NCT01723163|524921709|FG001|3-Month Follow-up|Unable to Contact|19|||
145562988|NCT01723163|524921708|FG000|6-Month Follow-up|Death|1|||
145562989|NCT01723163|524921709|FG001|6-Month Follow-up|Death|0|||
145562990|NCT01723163|524921708|FG000|6-Month Follow-up|Unable to Contact|17|||
145562991|NCT01723163|524921709|FG001|6-Month Follow-up|Unable to Contact|15|||
145562992|NCT01723163|524921708|FG000|12-Month Follow-up|Death|1|||
145562993|NCT01723163|524921709|FG001|12-Month Follow-up|Death|0|||
145562994|NCT01723163|524921708|FG000|12-Month Follow-up|Unable to Contact|23|||
145562995|NCT01723163|524921709|FG001|12-Month Follow-up|Unable to Contact|28|||
145562996|NCT02510794|524921710|FG000|Overall Study|Adverse Event|0|||
145562997|NCT02510794|524921711|FG001|Overall Study|Adverse Event|1|||
145562998|NCT02510794|524921712|FG002|Overall Study|Adverse Event|0|||
145562999|NCT02510794|524921713|FG003|Overall Study|Adverse Event|0|||
145563000|NCT02510794|524921710|FG000|Overall Study|Death|1|||
145563001|NCT02510794|524921711|FG001|Overall Study|Death|2|||
145563002|NCT02510794|524921712|FG002|Overall Study|Death|1|||
145563003|NCT02510794|524921713|FG003|Overall Study|Death|1|||
145563004|NCT02510794|524921710|FG000|Overall Study|Lack of Efficacy|3|||
145563005|NCT02510794|524921711|FG001|Overall Study|Lack of Efficacy|1|||
145563006|NCT02510794|524921712|FG002|Overall Study|Lack of Efficacy|1|||
145563007|NCT02510794|524921713|FG003|Overall Study|Lack of Efficacy|0|||
145620017|NCT03468426|525123654|FG005|Overall Study|Progressive disease|15|||
145620018|NCT03468426|525123655|FG006|Overall Study|Progressive disease|24|||
145295878|NCT03527745|523934343|FG003|Overall Study|Lost to Follow-up|9|||
145295879|NCT03527745|523934344|FG004|Overall Study|Lost to Follow-up|0|||
145295880|NCT03527745|523934345|FG005|Overall Study|Lost to Follow-up|2|||
145295881|NCT03527745|523934346|FG006|Overall Study|Lost to Follow-up|3|||
145295882|NCT03527745|523934347|FG007|Overall Study|Lost to Follow-up|2|||
145295883|NCT03527745|523934348|FG008|Overall Study|Lost to Follow-up|3|||
145295884|NCT03527745|523934349|FG009|Overall Study|Lost to Follow-up|2|||
145295885|NCT03527745|523934350|FG010|Overall Study|Lost to Follow-up|1|||
145295886|NCT03527745|523934351|FG011|Overall Study|Lost to Follow-up|1|||
145295887|NCT03527745|523934352|FG012|Overall Study|Lost to Follow-up|0|||
145295888|NCT03527745|523934353|FG013|Overall Study|Lost to Follow-up|0|||
145295889|NCT03527745|523934354|FG014|Overall Study|Lost to Follow-up|0|||
145295890|NCT03527745|523934355|FG015|Overall Study|Lost to Follow-up|0|||
145295891|NCT03527745|523934356|FG016|Overall Study|Lost to Follow-up|1|||
145295892|NCT03527745|523934357|FG017|Overall Study|Lost to Follow-up|0|||
145295893|NCT03527745|523934358|FG018|Overall Study|Lost to Follow-up|0|||
145295894|NCT03527745|523934359|FG019|Overall Study|Lost to Follow-up|1|||
145295895|NCT03527745|523934360|FG020|Overall Study|Lost to Follow-up|1|||
145295896|NCT03527745|523934361|FG021|Overall Study|Lost to Follow-up|5|||
145295897|NCT03527745|523934362|FG022|Overall Study|Lost to Follow-up|6|||
145295898|NCT03527745|523934363|FG023|Overall Study|Lost to Follow-up|8|||
145295899|NCT03527745|523934364|FG024|Overall Study|Lost to Follow-up|1|||
145295900|NCT03527745|523934365|FG025|Overall Study|Lost to Follow-up|3|||
145295901|NCT02152566|523934366|FG000|Overall Study|Lost to Follow-up|1|||
145295902|NCT02152566|523934366|FG000|Overall Study|Withdrawal by Subject|2|||
145295903|NCT02942264|523934368|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295904|NCT02942264|523934369|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
145295905|NCT02942264|523934370|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295906|NCT02942264|523934371|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295907|NCT02942264|523934372|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145563008|NCT02510794|524921710|FG000|Overall Study|Participant moved out of the area|0|||
145563009|NCT02510794|524921711|FG001|Overall Study|Participant moved out of the area|0|||
145563010|NCT02510794|524921712|FG002|Overall Study|Participant moved out of the area|0|||
145563011|NCT02510794|524921713|FG003|Overall Study|Participant moved out of the area|1|||
145563012|NCT02510794|524921710|FG000|Overall Study|Physician Decision|3|||
145563013|NCT02510794|524921711|FG001|Overall Study|Physician Decision|0|||
145563014|NCT02510794|524921712|FG002|Overall Study|Physician Decision|0|||
145563015|NCT02510794|524921713|FG003|Overall Study|Physician Decision|0|||
145563016|NCT02510794|524921710|FG000|Overall Study|Protocol Violation|0|||
145563017|NCT02510794|524921711|FG001|Overall Study|Protocol Violation|0|||
145563018|NCT02510794|524921712|FG002|Overall Study|Protocol Violation|1|||
145620019|NCT03468426|525123656|FG007|Overall Study|Progressive disease|27|||
145239071|NCT05567393|523720276|FG017|Overall Study|Voluntary Withdrawal|0|||
145239072|NCT02177175|523720281|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
145239073|NCT02177175|523720282|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
145239074|NCT04199793|523720283|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
145239075|NCT04199793|523720284|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
145239076|NCT04199793|523720283|FG000|Overall Study|Withdrawal by Subject|1|||
145239077|NCT04199793|523720284|FG001|Overall Study|Withdrawal by Subject|1|||
145239078|NCT03820726|523720289|FG000|Overall Study|Other than listed|23|||
145239079|NCT03820726|523720289|FG000|Overall Study|Withdrawal by Subject|37|||
145239080|NCT03820726|523720289|FG000|Overall Study|Lost to Follow-up|3|||
145239081|NCT03820726|523720289|FG000|Overall Study|Protocol deviation|1|||
145239082|NCT03820726|523720289|FG000|Overall Study|Adverse Event|146|||
145239083|NCT03820726|523720289|FG000|Overall Study|Not treated|1|||
145239084|NCT01938001|523720293|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
145239085|NCT01938001|523720294|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
145295908|NCT02942264|523934373|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295909|NCT02942264|523934374|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
145295910|NCT02942264|523934375|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295911|NCT02942264|523934376|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
145295912|NCT02942264|523934368|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295913|NCT02942264|523934369|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295914|NCT02942264|523934370|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295915|NCT02942264|523934371|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295916|NCT02942264|523934372|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295917|NCT02942264|523934373|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295918|NCT02942264|523934374|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295919|NCT02942264|523934375|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
145295920|NCT02942264|523934376|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
145295921|NCT01328093|523934377|FG000|Double-Blind Phase|Adverse Event|78|||
145295922|NCT01328093|523934378|FG001|Double-Blind Phase|Adverse Event|15|||
145295923|NCT01328093|523934377|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
145295924|NCT01328093|523934378|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
145295925|NCT01328093|523934377|FG000|Double-Blind Phase|Lost to Follow-up|39|||
145295926|NCT01328093|523934378|FG001|Double-Blind Phase|Lost to Follow-up|14|||
145295927|NCT01328093|523934377|FG000|Double-Blind Phase|Protocol Violation|30|||
145295928|NCT01328093|523934378|FG001|Double-Blind Phase|Protocol Violation|10|||
145295929|NCT01328093|523934377|FG000|Double-Blind Phase|Lack of Efficacy|55|||
145295930|NCT01328093|523934378|FG001|Double-Blind Phase|Lack of Efficacy|13|||
145295931|NCT01328093|523934377|FG000|Double-Blind Phase|Sponsor Decision|17|||
145295932|NCT01328093|523934378|FG001|Double-Blind Phase|Sponsor Decision|3|||
145563019|NCT02510794|524921713|FG003|Overall Study|Protocol Violation|0|||
145563020|NCT02510794|524921710|FG000|Overall Study|Withdrawal by Subject|1|||
145563021|NCT02510794|524921711|FG001|Overall Study|Withdrawal by Subject|2|||
145295933|NCT01328093|523934377|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
145563022|NCT02510794|524921712|FG002|Overall Study|Withdrawal by Subject|4|||
145563023|NCT02510794|524921713|FG003|Overall Study|Withdrawal by Subject|3|||
145563024|NCT02731729|524921716|FG000|Overall Study|Death|2|||
145563025|NCT02731729|524921717|FG001|Overall Study|Death|2|||
145563026|NCT02731729|524921716|FG000|Overall Study|Study terminated by Sponsor|6|||
145563027|NCT02731729|524921717|FG001|Overall Study|Study terminated by Sponsor|6|||
145563028|NCT02731729|524921716|FG000|Overall Study|Withdrawal by Subject|1|||
145563029|NCT02731729|524921717|FG001|Overall Study|Withdrawal by Subject|0|||
145563030|NCT01344447|524921718|FG000|Overall Study|Adverse Event|1|||
145563031|NCT01344447|524921718|FG000|Overall Study|Protocol Violation|1|||
145563032|NCT01344447|524921718|FG000|Overall Study|Withdrawal by Subject|1|||
145563033|NCT01344447|524921718|FG000|Overall Study|The contrast was not seen|1|||
145563034|NCT01344447|524921718|FG000|Overall Study|Physician Decision|1|||
145563035|NCT01344447|524921718|FG000|Overall Study|MRA unsuccessful|1|||
145563036|NCT01344447|524921718|FG000|Overall Study|Bolus tracking failed|1|||
145563037|NCT01344447|524921718|FG000|Overall Study|Error of power injector|1|||
145563038|NCT01660711|524921719|FG000|Overall Study|Adverse Event|7|||
145563039|NCT01660711|524921719|FG000|Overall Study|Withdrawal by Subject|1|||
145563040|NCT01316276|524921720|FG000|Overall Study|Death|1|||
145563041|NCT01316276|524921720|FG000|Overall Study|Adverse Event|19|||
145563042|NCT01316276|524921720|FG000|Overall Study|Withdrawal of consent|24|||
145563043|NCT01316276|524921720|FG000|Overall Study|Lost to Follow-up|1|||
145239086|NCT01938001|523720293|FG000|Pre-Treatment|Death|1|||
145239087|NCT01938001|523720294|FG001|Pre-Treatment|Death|0|||
145295934|NCT01328093|523934378|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
145563044|NCT01316276|524921720|FG000|Overall Study|Other|22|||
145563045|NCT06027866|524921721|FG000|Overall Study|Withdrawal by Subject|2|||
145563046|NCT04343521|524921726|FG000|Overall Study|Adverse Event|0|||
145563047|NCT04343521|524921727|FG001|Overall Study|Adverse Event|2|||
145563048|NCT04343521|524921726|FG000|Overall Study|Death|1|||
145563049|NCT04343521|524921727|FG001|Overall Study|Death|2|||
145239088|NCT01938001|523720293|FG000|Treatment|Death|2|||
145239089|NCT01938001|523720294|FG001|Treatment|Death|0|||
145239090|NCT01938001|523720293|FG000|Treatment|Adverse Event|14|||
145239091|NCT01938001|523720294|FG001|Treatment|Adverse Event|8|||
145239092|NCT01938001|523720293|FG000|Treatment|Progressive Disease|21|||
145239093|NCT01938001|523720294|FG001|Treatment|Progressive Disease|54|||
145239094|NCT01938001|523720293|FG000|Treatment|Withdrawal by Subject|13|||
145239095|NCT01938001|523720294|FG001|Treatment|Withdrawal by Subject|7|||
145295935|NCT01328093|523934377|FG000|Double-Blind Phase|Scheduling conflict|8|||
145295936|NCT01328093|523934378|FG001|Double-Blind Phase|Scheduling conflict|3|||
145295937|NCT01328093|523934377|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
145295938|NCT01328093|523934378|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
145295939|NCT01328093|523934377|FG000|Double-Blind Phase|Death|1|||
145295940|NCT01328093|523934378|FG001|Double-Blind Phase|Death|0|||
145295941|NCT01328093|523934377|FG000|Open-Label Phase|Sponsor Decision|98|||
145563050|NCT04343521|524921726|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
145563051|NCT04343521|524921727|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
145563052|NCT04343521|524921726|FG000|Overall Study|Withdrawal by Subject|70|||
145563053|NCT04343521|524921727|FG001|Overall Study|Withdrawal by Subject|95|||
145563054|NCT04343521|524921726|FG000|Overall Study|Withdrawal by study team|6|||
145563055|NCT04343521|524921727|FG001|Overall Study|Withdrawal by study team|12|||
145563056|NCT02939560|524921730|FG000|Overall Study|Withdrawal by Subject|2|||
145563057|NCT02939560|524921730|FG000|Overall Study|Protocol Violation|1|||
145563058|NCT03340025|524921731|FG000|Overall Study|Lost to Follow-up|2|||
145563059|NCT03340025|524921732|FG001|Overall Study|Lost to Follow-up|2|||
145563060|NCT02420691|524921735|FG000|Overall Study|Adverse Event|3|||
145563061|NCT02420691|524921735|FG000|Overall Study|Withdrawal by Subject|3|||
145563062|NCT03897179|524921738|FG000|Overall Study|Withdrawal by Subject|1|||
145563063|NCT00704535|524921739|FG000|Overall Study|Adverse Event|2|||
145563064|NCT00704535|524921739|FG000|Overall Study|Death|2|||
145563065|NCT00704535|524921739|FG000|Overall Study|Lost to Follow-up|8|||
145563066|NCT00704535|524921739|FG000|Overall Study|Protocol Violation|10|||
145563067|NCT00704535|524921739|FG000|Overall Study|Completed status not on Case Report Form|124|||
145563068|NCT05694546|524921741|FG000|Overall Study|Lost to Follow-up|11|||
145563069|NCT02424383|524921742|FG000|Overall Study|Withdrawal by Subject|32|||
145563070|NCT02424383|524921742|FG000|Overall Study|Death|170|||
145563071|NCT02424383|524921742|FG000|Overall Study|Sponsor's decision|3|||
145563072|NCT02424383|524921742|FG000|Overall Study|Investigator's decision|44|||
145563073|NCT02424383|524921742|FG000|Overall Study|Lost to Follow-up|81|||
145563074|NCT02424383|524921742|FG000|Overall Study|Other|7|||
145563075|NCT02424383|524921742|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
145563076|NCT01251380|524921748|FG000|Overall Study|Other (Not otherwise specified)|12|||
145563077|NCT01251380|524921748|FG000|Overall Study|Withdrawal by Subject|6|||
145563078|NCT01251380|524921748|FG000|Overall Study|Lack of Efficacy|1|||
145563079|NCT01251380|524921748|FG000|Overall Study|Adverse Event|1|||
145563080|NCT01251380|524921748|FG000|Overall Study|Lost to Follow-up|2|||
145563081|NCT01150123|524921749|FG000|Overall Study|Withdrawal by Subject|1|||
145239096|NCT01938001|523720293|FG000|Treatment|Other reasons|2|||
145239097|NCT01938001|523720294|FG001|Treatment|Other reasons|1|||
145239098|NCT02293902|523720298|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
145239099|NCT02293902|523720299|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
145239100|NCT02293902|523720300|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
145239101|NCT02293902|523720301|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
145239102|NCT02293902|523720302|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
145239103|NCT02293902|523720298|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
145239104|NCT02293902|523720299|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
145239105|NCT02293902|523720300|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
145239106|NCT02293902|523720301|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
145239107|NCT02293902|523720302|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
145563082|NCT01150123|524921750|FG001|Overall Study|Withdrawal by Subject|1|||
145239108|NCT02293902|523720298|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
145239109|NCT02293902|523720299|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
145239110|NCT02293902|523720300|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
145239111|NCT02293902|523720301|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
145563083|NCT01150123|524921751|FG002|Overall Study|Withdrawal by Subject|2|||
145563084|NCT01150123|524921752|FG003|Overall Study|Withdrawal by Subject|1|||
145563085|NCT01150123|524921753|FG004|Overall Study|Withdrawal by Subject|1|||
145563086|NCT01150123|524921754|FG005|Overall Study|Withdrawal by Subject|1|||
145563087|NCT01150123|524921755|FG006|Overall Study|Withdrawal by Subject|0|||
145563088|NCT01150123|524921756|FG007|Overall Study|Withdrawal by Subject|3|||
145239112|NCT02293902|523720302|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
145295942|NCT01328093|523934378|FG001|Open-Label Phase|Sponsor Decision|34|||
145295943|NCT01328093|523934377|FG000|Open-Label Phase|Protocol Violation|8|||
145563089|NCT01150123|524921757|FG008|Overall Study|Withdrawal by Subject|2|||
145563090|NCT01150123|524921758|FG009|Overall Study|Withdrawal by Subject|0|||
145239113|NCT02293902|523720298|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
145239114|NCT02293902|523720299|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
145239115|NCT02293902|523720300|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
145239116|NCT02293902|523720301|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
145239117|NCT02293902|523720302|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
145239118|NCT02293902|523720298|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
145239119|NCT02293902|523720299|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
145239120|NCT02293902|523720300|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
145239121|NCT02293902|523720301|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
145239122|NCT02293902|523720302|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
145239123|NCT04021706|523722245|FG000|Overall Study|Adverse Event|2|||
145239124|NCT04021706|523722246|FG001|Overall Study|Adverse Event|0|||
145239125|NCT04021706|523722245|FG000|Overall Study|Withdrawal by Subject|1|||
145239126|NCT04021706|523722246|FG001|Overall Study|Withdrawal by Subject|2|||
145239127|NCT04021706|523722245|FG000|Overall Study|Physician Decision|1|||
145239128|NCT04021706|523722246|FG001|Overall Study|Physician Decision|0|||
145239129|NCT01375647|523722247|FG000|Overall Study|Lost to Follow-up|3|||
145239130|NCT01375647|523722248|FG001|Overall Study|Lost to Follow-up|3|||
145239131|NCT01375647|523722249|FG002|Overall Study|Lost to Follow-up|7|||
145239132|NCT01375647|523722250|FG003|Overall Study|Lost to Follow-up|10|||
145239133|NCT01375647|523722247|FG000|Overall Study|Death|1|||
145239134|NCT01375647|523722248|FG001|Overall Study|Death|2|||
145239135|NCT01375647|523722249|FG002|Overall Study|Death|1|||
145239136|NCT01375647|523722250|FG003|Overall Study|Death|0|||
145239137|NCT01375647|523722247|FG000|Overall Study|Withdrawal by Subject|17|||
145239138|NCT01375647|523722248|FG001|Overall Study|Withdrawal by Subject|20|||
145239139|NCT01375647|523722249|FG002|Overall Study|Withdrawal by Subject|26|||
145239140|NCT01375647|523722250|FG003|Overall Study|Withdrawal by Subject|14|||
145239141|NCT01375647|523722247|FG000|Overall Study|Physician Decision|1|||
145239142|NCT01375647|523722248|FG001|Overall Study|Physician Decision|0|||
145239143|NCT01375647|523722249|FG002|Overall Study|Physician Decision|0|||
145239144|NCT01375647|523722250|FG003|Overall Study|Physician Decision|0|||
145239145|NCT02332798|523722251|FG000|Overall Study|Unwilling to Participate in Study|0|||
145239146|NCT02332798|523722252|FG001|Overall Study|Unwilling to Participate in Study|1|||
145239147|NCT02332798|523722253|FG002|Overall Study|Unwilling to Participate in Study|1|||
145239148|NCT02332798|523722251|FG000|Overall Study|Positive Urine Drug Test|0|||
145239149|NCT02332798|523722252|FG001|Overall Study|Positive Urine Drug Test|1|||
145239150|NCT02332798|523722253|FG002|Overall Study|Positive Urine Drug Test|0|||
145239151|NCT02332798|523722251|FG000|Overall Study|Abnormal Laboratory Findings|1|||
145239152|NCT02332798|523722252|FG001|Overall Study|Abnormal Laboratory Findings|0|||
145239153|NCT02332798|523722253|FG002|Overall Study|Abnormal Laboratory Findings|0|||
145239154|NCT00595868|523722254|FG000|Overall Study|Lost to Follow-up|45|||
145239155|NCT00595868|523722255|FG001|Overall Study|Lost to Follow-up|50|||
145239156|NCT01102140|523722256|FG000|Overall Study|Lost to Follow-up|1|||
145239157|NCT01102140|523722257|FG001|Overall Study|Lost to Follow-up|0|||
145239158|NCT01102140|523722256|FG000|Overall Study|Investigator terminated study|2|||
145239159|NCT01102140|523722257|FG001|Overall Study|Investigator terminated study|2|||
145239160|NCT03788967|523722260|FG000|Overall Study|Lost to Follow-up|14|||
145239161|NCT03788967|523722261|FG001|Overall Study|Lost to Follow-up|10|||
145239162|NCT03788967|523722260|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
145239163|NCT03788967|523722261|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
145239164|NCT03788967|523722260|FG000|Overall Study|Participant Withdrawal of Consent|13|||
145239165|NCT03788967|523722261|FG001|Overall Study|Participant Withdrawal of Consent|5|||
145239166|NCT03788967|523722260|FG000|Overall Study|Adverse Event|1|||
145239167|NCT03788967|523722261|FG001|Overall Study|Adverse Event|1|||
145239168|NCT03788967|523722260|FG000|Overall Study|COVID-19|1|||
145239169|NCT03788967|523722261|FG001|Overall Study|COVID-19|2|||
145239170|NCT00462488|523722262|FG000|Overall Study|Protocol Violation|1|||
145239171|NCT00462488|523722263|FG001|Overall Study|Protocol Violation|0|||
145239172|NCT00462488|523722262|FG000|Overall Study|Lack of Efficacy|19|||
145239173|NCT00462488|523722263|FG001|Overall Study|Lack of Efficacy|17|||
145239174|NCT02848313|523722268|FG000|Overall Study|Adverse Event|1|||
145239175|NCT02848313|523722269|FG001|Overall Study|Adverse Event|2|||
145239176|NCT02848313|523722268|FG000|Overall Study|Lack of Efficacy|0|||
145239177|NCT02848313|523722269|FG001|Overall Study|Lack of Efficacy|1|||
145239178|NCT02848313|523722268|FG000|Overall Study|Withdrawal by Subject|1|||
145239179|NCT02848313|523722269|FG001|Overall Study|Withdrawal by Subject|1|||
145239180|NCT02848313|523722268|FG000|Overall Study|Lost to follow up|1|||
145239181|NCT02848313|523722269|FG001|Overall Study|Lost to follow up|0|||
145239182|NCT03510910|523722270|FG000|Overall Study|Incomplete Survey|2|||
145239183|NCT03510910|523722271|FG001|Overall Study|Incomplete Survey|3|||
145295944|NCT01328093|523934378|FG001|Open-Label Phase|Protocol Violation|3|||
145239184|NCT01673490|523722275|FG000|Overall Study|Lost to Follow-up|1|||
145239185|NCT01673490|523722275|FG000|Overall Study|Adverse Event|3|||
145239186|NCT01673490|523722275|FG000|Overall Study|Withdrawal by Subject|3|||
145295945|NCT01328093|523934377|FG000|Open-Label Phase|Lost to Follow-up|10|||
145295946|NCT01328093|523934378|FG001|Open-Label Phase|Lost to Follow-up|1|||
145295947|NCT01328093|523934377|FG000|Open-Label Phase|Adverse Event|10|||
145295948|NCT01328093|523934378|FG001|Open-Label Phase|Adverse Event|4|||
145295949|NCT01328093|523934377|FG000|Open-Label Phase|Lack of Efficacy|5|||
145295950|NCT01328093|523934378|FG001|Open-Label Phase|Lack of Efficacy|6|||
145295951|NCT01328093|523934377|FG000|Open-Label Phase|Withdrawal by Subject|4|||
145295952|NCT01328093|523934378|FG001|Open-Label Phase|Withdrawal by Subject|1|||
145295953|NCT01328093|523934377|FG000|Open-Label Phase|Scheduling conflict|2|||
145295954|NCT01328093|523934378|FG001|Open-Label Phase|Scheduling conflict|1|||
145295955|NCT01328093|523934377|FG000|Open-Label Phase|Subject is moving or has moved|2|||
145295956|NCT01328093|523934378|FG001|Open-Label Phase|Subject is moving or has moved|0|||
145295957|NCT01328093|523934377|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
145408787|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
145408788|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145563091|NCT01150123|524921759|FG010|Overall Study|Withdrawal by Subject|1|||
145563092|NCT01150123|524921760|FG011|Overall Study|Withdrawal by Subject|0|||
145563093|NCT01150123|524921761|FG012|Overall Study|Withdrawal by Subject|1|||
145563094|NCT01150123|524921762|FG013|Overall Study|Withdrawal by Subject|0|||
145563095|NCT01150123|524921763|FG014|Overall Study|Withdrawal by Subject|0|||
145563096|NCT01150123|524921764|FG015|Overall Study|Withdrawal by Subject|1|||
145563097|NCT01150123|524921765|FG016|Overall Study|Withdrawal by Subject|0|||
145563098|NCT01150123|524921766|FG017|Overall Study|Withdrawal by Subject|1|||
145563099|NCT01150123|524921749|FG000|Overall Study|Lost to Follow-up|2|||
145563100|NCT01150123|524921750|FG001|Overall Study|Lost to Follow-up|1|||
145563101|NCT01150123|524921751|FG002|Overall Study|Lost to Follow-up|2|||
145563102|NCT01150123|524921752|FG003|Overall Study|Lost to Follow-up|2|||
145563103|NCT01150123|524921753|FG004|Overall Study|Lost to Follow-up|2|||
145563104|NCT01150123|524921754|FG005|Overall Study|Lost to Follow-up|5|||
145563105|NCT01150123|524921755|FG006|Overall Study|Lost to Follow-up|0|||
145563106|NCT01150123|524921756|FG007|Overall Study|Lost to Follow-up|0|||
145563107|NCT01150123|524921757|FG008|Overall Study|Lost to Follow-up|3|||
145563108|NCT01150123|524921758|FG009|Overall Study|Lost to Follow-up|1|||
145563109|NCT01150123|524921759|FG010|Overall Study|Lost to Follow-up|1|||
145563110|NCT01150123|524921760|FG011|Overall Study|Lost to Follow-up|1|||
145563111|NCT01150123|524921761|FG012|Overall Study|Lost to Follow-up|2|||
145563112|NCT01150123|524921762|FG013|Overall Study|Lost to Follow-up|0|||
145563113|NCT01150123|524921763|FG014|Overall Study|Lost to Follow-up|0|||
145563114|NCT01150123|524921764|FG015|Overall Study|Lost to Follow-up|0|||
145563115|NCT01150123|524921765|FG016|Overall Study|Lost to Follow-up|0|||
145563116|NCT01150123|524921766|FG017|Overall Study|Lost to Follow-up|0|||
145563117|NCT02171260|524921771|FG000|Overall Study|Death|0|||
145563118|NCT02171260|524921772|FG001|Overall Study|Death|0|||
145563119|NCT02171260|524921773|FG002|Overall Study|Death|0|||
145563120|NCT02171260|524921774|FG003|Overall Study|Death|1|||
145563121|NCT02171260|524921771|FG000|Overall Study|Physician Decision|1|||
145563122|NCT02171260|524921772|FG001|Overall Study|Physician Decision|0|||
145563123|NCT02171260|524921773|FG002|Overall Study|Physician Decision|1|||
145563124|NCT02171260|524921774|FG003|Overall Study|Physician Decision|0|||
145563125|NCT02171260|524921771|FG000|Overall Study|Withdrawal by Subject|1|||
145563126|NCT02171260|524921772|FG001|Overall Study|Withdrawal by Subject|0|||
145563127|NCT02171260|524921773|FG002|Overall Study|Withdrawal by Subject|0|||
145563128|NCT02171260|524921774|FG003|Overall Study|Withdrawal by Subject|0|||
145563129|NCT02171260|524921771|FG000|Overall Study|Evidence of progressive disease|4|||
145563130|NCT02171260|524921772|FG001|Overall Study|Evidence of progressive disease|6|||
145295958|NCT01328093|523934378|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
145295959|NCT02731157|523934381|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
145295960|NCT03980483|523934382|FG000|Overall Study|Adverse Event|13|||
145295961|NCT03980483|523934383|FG001|Overall Study|Adverse Event|29|||
145295962|NCT03980483|523934384|FG002|Overall Study|Adverse Event|11|||
145295963|NCT03980483|523934385|FG003|Overall Study|Adverse Event|2|||
145295964|NCT03980483|523934386|FG004|Overall Study|Adverse Event|2|||
145295965|NCT03980483|523934387|FG005|Overall Study|Adverse Event|2|||
145295966|NCT03980483|523934382|FG000|Overall Study|Lack of Efficacy|7|||
145408789|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408790|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
145563131|NCT02171260|524921773|FG002|Overall Study|Evidence of progressive disease|4|||
145563132|NCT02171260|524921774|FG003|Overall Study|Evidence of progressive disease|4|||
145563133|NCT00323492|524921781|FG000|Study Phase 1|Adverse Event|2|||
145563134|NCT00323492|524921782|FG001|Study Phase 1|Adverse Event|0|||
145563135|NCT00323492|524921783|FG002|Study Phase 1|Adverse Event|0|||
145563136|NCT00323492|524921781|FG000|Study Phase 2|Adverse Event|1|||
145563137|NCT00323492|524921782|FG001|Study Phase 2|Adverse Event|0|||
145563138|NCT00323492|524921783|FG002|Study Phase 2|Adverse Event|0|||
145563139|NCT00323492|524921781|FG000|Study Phase 2|Physician Decision|1|||
145295967|NCT03980483|523934383|FG001|Overall Study|Lack of Efficacy|6|||
145295968|NCT03980483|523934384|FG002|Overall Study|Lack of Efficacy|0|||
145295969|NCT03980483|523934385|FG003|Overall Study|Lack of Efficacy|3|||
145239187|NCT04914819|523722276|FG000|Overall Study|Pregnancy|3|||
145239188|NCT04914819|523722277|FG001|Overall Study|Pregnancy|1|||
145239189|NCT04914819|523722276|FG000|Overall Study|Discontinued study|4|||
145239190|NCT04914819|523722277|FG001|Overall Study|Discontinued study|1|||
145239191|NCT04914819|523722276|FG000|Overall Study|Lost to Follow-up|7|||
145239192|NCT04914819|523722277|FG001|Overall Study|Lost to Follow-up|0|||
145239193|NCT02715804|523722279|FG000|Overall Study|Death|222|||
145239194|NCT02715804|523722280|FG001|Overall Study|Death|106|||
145239195|NCT02715804|523722279|FG000|Overall Study|Withdrawal by Subject|5|||
145239196|NCT02715804|523722280|FG001|Overall Study|Withdrawal by Subject|4|||
145295970|NCT03980483|523934386|FG004|Overall Study|Lack of Efficacy|1|||
145295971|NCT03980483|523934387|FG005|Overall Study|Lack of Efficacy|1|||
145295972|NCT03980483|523934382|FG000|Overall Study|Lost to Follow-up|2|||
145295973|NCT03980483|523934383|FG001|Overall Study|Lost to Follow-up|4|||
145295974|NCT03980483|523934384|FG002|Overall Study|Lost to Follow-up|2|||
145295975|NCT03980483|523934385|FG003|Overall Study|Lost to Follow-up|1|||
145295976|NCT03980483|523934386|FG004|Overall Study|Lost to Follow-up|2|||
145295977|NCT03980483|523934387|FG005|Overall Study|Lost to Follow-up|0|||
145295978|NCT03980483|523934382|FG000|Overall Study|Protocol Violation|4|||
145295979|NCT03980483|523934383|FG001|Overall Study|Protocol Violation|2|||
145295980|NCT03980483|523934384|FG002|Overall Study|Protocol Violation|1|||
145295981|NCT03980483|523934385|FG003|Overall Study|Protocol Violation|1|||
145295982|NCT03980483|523934386|FG004|Overall Study|Protocol Violation|0|||
145295983|NCT03980483|523934387|FG005|Overall Study|Protocol Violation|0|||
145295984|NCT03980483|523934382|FG000|Overall Study|Physician Decision|14|||
145295985|NCT03980483|523934383|FG001|Overall Study|Physician Decision|10|||
145295986|NCT03980483|523934384|FG002|Overall Study|Physician Decision|7|||
145295987|NCT03980483|523934385|FG003|Overall Study|Physician Decision|4|||
145295988|NCT03980483|523934386|FG004|Overall Study|Physician Decision|4|||
145295989|NCT03980483|523934387|FG005|Overall Study|Physician Decision|2|||
145295990|NCT03980483|523934382|FG000|Overall Study|Withdrawal by Subject|38|||
145295991|NCT03980483|523934383|FG001|Overall Study|Withdrawal by Subject|21|||
145295992|NCT03980483|523934384|FG002|Overall Study|Withdrawal by Subject|15|||
145295993|NCT03980483|523934385|FG003|Overall Study|Withdrawal by Subject|5|||
145295994|NCT03980483|523934386|FG004|Overall Study|Withdrawal by Subject|3|||
145295995|NCT03980483|523934387|FG005|Overall Study|Withdrawal by Subject|4|||
145295996|NCT03980483|523934382|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
145295997|NCT03980483|523934383|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145295998|NCT03980483|523934384|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145295999|NCT03980483|523934385|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145296000|NCT03980483|523934386|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145296001|NCT03980483|523934387|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145296002|NCT03980483|523934382|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
145296003|NCT03980483|523934383|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
145296004|NCT03980483|523934384|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
145296005|NCT03980483|523934385|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
145296006|NCT03980483|523934386|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
145296007|NCT03980483|523934387|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
145296008|NCT03980483|523934382|FG000|Overall Study|Other|0|||
145296009|NCT03980483|523934383|FG001|Overall Study|Other|1|||
145296010|NCT03980483|523934384|FG002|Overall Study|Other|0|||
145296011|NCT03980483|523934385|FG003|Overall Study|Other|0|||
145296012|NCT03980483|523934386|FG004|Overall Study|Other|0|||
145296013|NCT03980483|523934387|FG005|Overall Study|Other|0|||
145296014|NCT00760266|523934390|FG000|Overall Study|Adverse Event|13|||
145296015|NCT00760266|523934391|FG001|Overall Study|Adverse Event|7|||
145296016|NCT00760266|523934390|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145296017|NCT00760266|523934391|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145296018|NCT00760266|523934390|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145296019|NCT00760266|523934391|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145296020|NCT00760266|523934390|FG000|Overall Study|Lack of Efficacy|2|||
145296021|NCT00760266|523934391|FG001|Overall Study|Lack of Efficacy|2|||
145563140|NCT00323492|524921782|FG001|Study Phase 2|Physician Decision|0|||
145563141|NCT00323492|524921783|FG002|Study Phase 2|Physician Decision|0|||
145239197|NCT02715804|523722279|FG000|Overall Study|Other than specified|2|||
145296022|NCT00760266|523934390|FG000|Overall Study|Protocol deviation|2|||
145296023|NCT00760266|523934391|FG001|Overall Study|Protocol deviation|4|||
145296024|NCT00760266|523934390|FG000|Overall Study|Patient withdrew consent|3|||
145296025|NCT00760266|523934391|FG001|Overall Study|Patient withdrew consent|3|||
145296026|NCT00760266|523934390|FG000|Overall Study|Lost to Follow-up|2|||
145239198|NCT02715804|523722280|FG001|Overall Study|Other than specified|3|||
145296027|NCT00760266|523934391|FG001|Overall Study|Lost to Follow-up|1|||
145239199|NCT01625611|523722283|FG000|Overall Study|No adlib drinks Lab 1|3|||
145296028|NCT00760266|523934390|FG000|Overall Study|Administrative Problems|0|||
145296029|NCT00760266|523934391|FG001|Overall Study|Administrative Problems|1|||
145296030|NCT01239121|523934392|FG000|Overall Study|Withdrawal by Subject|2|||
145296031|NCT01239121|523934393|FG001|Overall Study|Withdrawal by Subject|4|||
145296032|NCT01239121|523934394|FG002|Overall Study|Withdrawal by Subject|0|||
145239200|NCT01625611|523722284|FG001|Overall Study|No adlib drinks Lab 1|0|||
145239201|NCT01625611|523722283|FG000|Overall Study|Technical issues with PET|1|||
145239202|NCT01625611|523722284|FG001|Overall Study|Technical issues with PET|0|||
145239203|NCT01625611|523722283|FG000|Overall Study|Unable to complete study procedures|1|||
145239204|NCT01625611|523722284|FG001|Overall Study|Unable to complete study procedures|0|||
145239205|NCT01625611|523722283|FG000|Overall Study|Withdrawal by Subject|3|||
145239206|NCT01625611|523722284|FG001|Overall Study|Withdrawal by Subject|0|||
145239207|NCT00948194|523722285|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
145239208|NCT00948194|523722286|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
145239209|NCT00233324|523722287|FG000|Main Study|Death|68|||
145239210|NCT00233324|523722288|FG001|Main Study|Death|60|||
145239211|NCT00233324|523722289|FG002|Main Study|Death|62|||
145239212|NCT00233324|523722290|FG003|Main Study|Death|47|||
145239213|NCT00233324|523722287|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
145239214|NCT00233324|523722288|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
145239215|NCT00233324|523722289|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
145239216|NCT00233324|523722290|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
145239217|NCT00233324|523722287|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
145239218|NCT00233324|523722288|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
145296033|NCT03657160|523934395|FG000|Overall Study|Adverse Event|5|||
145296034|NCT03657160|523934396|FG001|Overall Study|Adverse Event|6|||
145563142|NCT00323492|524921781|FG000|Study Phase 2|Lost to Follow-up|1|||
145563143|NCT00323492|524921782|FG001|Study Phase 2|Lost to Follow-up|0|||
145563144|NCT00323492|524921783|FG002|Study Phase 2|Lost to Follow-up|0|||
145563145|NCT00323492|524921781|FG000|Study Phase 2|Withdrawal by Subject|0|||
145563146|NCT00323492|524921782|FG001|Study Phase 2|Withdrawal by Subject|1|||
145563147|NCT00323492|524921783|FG002|Study Phase 2|Withdrawal by Subject|0|||
145563148|NCT00323492|524921781|FG000|Study Phase 2|Noncompliance with study schedule|0|||
145563149|NCT00323492|524921782|FG001|Study Phase 2|Noncompliance with study schedule|0|||
145563150|NCT00323492|524921783|FG002|Study Phase 2|Noncompliance with study schedule|1|||
145563151|NCT00323492|524921781|FG000|Study Phase 2|Protocol Violation|1|||
145563152|NCT00323492|524921782|FG001|Study Phase 2|Protocol Violation|0|||
145563153|NCT00323492|524921783|FG002|Study Phase 2|Protocol Violation|0|||
145563154|NCT02486042|524921784|FG000|Overall Study|Physician Decision|1|||
145563155|NCT02486042|524921785|FG001|Overall Study|Physician Decision|7|||
145563156|NCT02486042|524921784|FG000|Overall Study|Hospital transfer|2|||
145563157|NCT02486042|524921785|FG001|Overall Study|Hospital transfer|2|||
145563158|NCT02486042|524921784|FG000|Overall Study|Withdrawal by Subject|0|||
145563159|NCT02486042|524921785|FG001|Overall Study|Withdrawal by Subject|2|||
145563160|NCT01466387|524921786|FG000|Overall Study|Adverse Event|0|||
145563161|NCT01466387|524921787|FG001|Overall Study|Adverse Event|0|||
145563162|NCT01466387|524921788|FG002|Overall Study|Adverse Event|1|||
145563163|NCT01466387|524921789|FG003|Overall Study|Adverse Event|1|||
145563164|NCT01466387|524921790|FG004|Overall Study|Adverse Event|0|||
145563165|NCT01466387|524921791|FG005|Overall Study|Adverse Event|0|||
145563166|NCT01466387|524921786|FG000|Overall Study|Lost to Follow-up|0|||
145563167|NCT01466387|524921787|FG001|Overall Study|Lost to Follow-up|0|||
145563168|NCT01466387|524921788|FG002|Overall Study|Lost to Follow-up|0|||
145563169|NCT01466387|524921789|FG003|Overall Study|Lost to Follow-up|0|||
145563170|NCT01466387|524921790|FG004|Overall Study|Lost to Follow-up|0|||
145563171|NCT01466387|524921791|FG005|Overall Study|Lost to Follow-up|1|||
145563172|NCT01466387|524921786|FG000|Overall Study|Protocol Violation|1|||
145563173|NCT01466387|524921787|FG001|Overall Study|Protocol Violation|0|||
145563174|NCT01466387|524921788|FG002|Overall Study|Protocol Violation|0|||
145563175|NCT01466387|524921789|FG003|Overall Study|Protocol Violation|1|||
145563176|NCT01466387|524921790|FG004|Overall Study|Protocol Violation|0|||
145563177|NCT01466387|524921791|FG005|Overall Study|Protocol Violation|0|||
145563178|NCT01319877|524921792|FG000|Overall Study|Lost to Follow-up|100|||
145563179|NCT01319877|524921793|FG001|Overall Study|Lost to Follow-up|37|||
145563180|NCT01319877|524921792|FG000|Overall Study|Physician Decision|2|||
145563181|NCT01319877|524921793|FG001|Overall Study|Physician Decision|0|||
145563182|NCT01319877|524921792|FG000|Overall Study|Disease Progression|2|||
145563183|NCT01319877|524921793|FG001|Overall Study|Disease Progression|2|||
145563184|NCT01319877|524921792|FG000|Overall Study|Withdrawal by Subject|0|||
145563185|NCT01319877|524921793|FG001|Overall Study|Withdrawal by Subject|1|||
145563186|NCT01319877|524921792|FG000|Overall Study|Reason Not Specified|4|||
145563187|NCT01319877|524921793|FG001|Overall Study|Reason Not Specified|5|||
145563188|NCT02347189|524921796|FG000|Overall Study|No implant attempted of study device|9|||
145563189|NCT02347189|524921796|FG000|Overall Study|No primary outcome data available|2|||
145563190|NCT04404855|524921797|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
145563191|NCT04404855|524921798|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
145563192|NCT00735878|524921799|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
145563193|NCT00735878|524921800|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
145563194|NCT00735878|524921801|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
145239219|NCT00233324|523722289|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
145620020|NCT03468426|525123657|FG008|Overall Study|Progressive disease|13|||
145620021|NCT03468426|525123658|FG009|Overall Study|Progressive disease|13|||
145620022|NCT03468426|525123659|FG010|Overall Study|Progressive disease|0|||
145620023|NCT03468426|525123649|FG000|Overall Study|Other adverse event or clinical progression|0|||
145620024|NCT03468426|525123650|FG001|Overall Study|Other adverse event or clinical progression|1|||
145620025|NCT03468426|525123651|FG002|Overall Study|Other adverse event or clinical progression|3|||
145620026|NCT03468426|525123652|FG003|Overall Study|Other adverse event or clinical progression|14|||
145620027|NCT03468426|525123653|FG004|Overall Study|Other adverse event or clinical progression|10|||
145620028|NCT03468426|525123654|FG005|Overall Study|Other adverse event or clinical progression|8|||
145296035|NCT03657160|523934395|FG000|Overall Study|Protocol Deviation|3|||
145296036|NCT03657160|523934396|FG001|Overall Study|Protocol Deviation|0|||
145296037|NCT03657160|523934395|FG000|Overall Study|Withdrawal by Subject|18|||
145296038|NCT03657160|523934396|FG001|Overall Study|Withdrawal by Subject|16|||
145296039|NCT03657160|523934395|FG000|Overall Study|Site Termination|1|||
145296040|NCT03657160|523934396|FG001|Overall Study|Site Termination|0|||
145296041|NCT03657160|523934395|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
145296042|NCT03657160|523934396|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
145296043|NCT03657160|523934395|FG000|Overall Study|Death|33|||
145296044|NCT03657160|523934396|FG001|Overall Study|Death|26|||
145563195|NCT03320564|524921802|FG000|Overall Study|Protocol Violation|1|||
145563196|NCT04248933|524921808|FG000|Overall Study|Lost to Follow-up|9|||
145563197|NCT04248933|524921808|FG000|Overall Study|Withdrawal by Subject|2|||
145563198|NCT00578942|524921809|FG000|Overall Study|Lost to Follow-up|1|||
145563199|NCT00600938|524921810|FG000|Core Study|Abnormal test procedure result(s)|3|||
145563200|NCT00600938|524921811|FG001|Core Study|Abnormal test procedure result(s)|2|||
145563201|NCT00600938|524921812|FG002|Core Study|Abnormal test procedure result(s)|0|||
145563202|NCT00600938|524921813|FG003|Core Study|Abnormal test procedure result(s)|0|||
145563203|NCT00600938|524921810|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
145563204|NCT00600938|524921811|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
145563205|NCT00600938|524921812|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
145563206|NCT00600938|524921813|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
145563207|NCT00600938|524921810|FG000|Core Study|Patient withdrew consent|7|||
145563208|NCT00600938|524921811|FG001|Core Study|Patient withdrew consent|12|||
145563209|NCT00600938|524921812|FG002|Core Study|Patient withdrew consent|0|||
145563210|NCT00600938|524921813|FG003|Core Study|Patient withdrew consent|0|||
145563211|NCT00600938|524921810|FG000|Core Study|Lost to Follow-up|3|||
145563212|NCT00600938|524921811|FG001|Core Study|Lost to Follow-up|2|||
145563213|NCT00600938|524921812|FG002|Core Study|Lost to Follow-up|0|||
145563214|NCT00600938|524921813|FG003|Core Study|Lost to Follow-up|0|||
145563215|NCT00600938|524921810|FG000|Core Study|Death|1|||
145563216|NCT00600938|524921811|FG001|Core Study|Death|1|||
145563217|NCT00600938|524921812|FG002|Core Study|Death|0|||
145563218|NCT00600938|524921813|FG003|Core Study|Death|0|||
145563219|NCT00600938|524921810|FG000|Core Study|Protocol Violation|1|||
145563220|NCT00600938|524921811|FG001|Core Study|Protocol Violation|2|||
145563221|NCT00600938|524921812|FG002|Core Study|Protocol Violation|0|||
145563222|NCT00600938|524921813|FG003|Core Study|Protocol Violation|0|||
145563223|NCT00600938|524921810|FG000|Extension Study|Adverse Event|1|||
145563224|NCT00600938|524921811|FG001|Extension Study|Adverse Event|0|||
145563225|NCT00600938|524921812|FG002|Extension Study|Adverse Event|2|||
145563226|NCT00600938|524921813|FG003|Extension Study|Adverse Event|0|||
145563227|NCT00600938|524921810|FG000|Extension Study|Abnormal test procedure results|0|||
145563228|NCT00600938|524921811|FG001|Extension Study|Abnormal test procedure results|1|||
145563229|NCT00600938|524921812|FG002|Extension Study|Abnormal test procedure results|1|||
145296045|NCT03657160|523934395|FG000|Overall Study|Death (COVID-19-Related)|1|||
145296046|NCT03657160|523934396|FG001|Overall Study|Death (COVID-19-Related)|0|||
145296047|NCT03657160|523934395|FG000|Overall Study|Reason Not Specified|5|||
145296048|NCT03657160|523934396|FG001|Overall Study|Reason Not Specified|5|||
145296049|NCT03657160|523934395|FG000|Overall Study|Other (COVID-19-Related)|0|||
145296050|NCT03657160|523934396|FG001|Overall Study|Other (COVID-19-Related)|1|||
145296051|NCT00686959|523934398|FG000|Overall Study|Participants censored (no death events)|124|||
145296052|NCT00686959|523934399|FG001|Overall Study|Participants censored (no death events)|117|||
145563230|NCT00600938|524921813|FG003|Extension Study|Abnormal test procedure results|1|||
145563231|NCT00600938|524921810|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
145296053|NCT01449630|523934401|FG000|Period 1|Physician Decision|1|||
145296054|NCT01449630|523934402|FG001|Period 1|Physician Decision|0|||
145563232|NCT00600938|524921811|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
145563233|NCT00600938|524921812|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
145563234|NCT00600938|524921813|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
145563235|NCT00600938|524921810|FG000|Extension Study|Withdrawal by Subject|2|||
145620029|NCT03468426|525123655|FG006|Overall Study|Other adverse event or clinical progression|5|||
145296055|NCT01449630|523934403|FG002|Period 1|Physician Decision|0|||
145296056|NCT01449630|523934404|FG003|Period 1|Physician Decision|1|||
145563236|NCT00600938|524921811|FG001|Extension Study|Withdrawal by Subject|2|||
145563237|NCT00600938|524921812|FG002|Extension Study|Withdrawal by Subject|3|||
145563238|NCT00600938|524921813|FG003|Extension Study|Withdrawal by Subject|0|||
145563239|NCT00600938|524921810|FG000|Extension Study|Lost to Follow-up|1|||
145239220|NCT00233324|523722290|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
145239221|NCT03170258|523722301|FG000|Overall Study|Physician Decision|4|||
145239222|NCT03170258|523722302|FG001|Overall Study|Physician Decision|0|||
145239223|NCT03170258|523722301|FG000|Overall Study|Equipment issues|1|||
145239224|NCT03170258|523722302|FG001|Overall Study|Equipment issues|0|||
145239225|NCT03170258|523722301|FG000|Overall Study|Medication|1|||
145239226|NCT03170258|523722302|FG001|Overall Study|Medication|0|||
145239227|NCT03170258|523722301|FG000|Overall Study|Sleep issues|1|||
145239228|NCT03170258|523722302|FG001|Overall Study|Sleep issues|0|||
145239229|NCT01563107|523722303|FG000|Overall Study|Physician Decision|0|||
145239230|NCT01563107|523722304|FG001|Overall Study|Physician Decision|1|||
145239231|NCT01563107|523722305|FG002|Overall Study|Physician Decision|1|||
145239232|NCT01563107|523722306|FG003|Overall Study|Physician Decision|3|||
145239233|NCT01563107|523722303|FG000|Overall Study|Withdrawal by Subject|1|||
145239234|NCT01563107|523722304|FG001|Overall Study|Withdrawal by Subject|2|||
145239235|NCT01563107|523722305|FG002|Overall Study|Withdrawal by Subject|1|||
145239236|NCT01563107|523722306|FG003|Overall Study|Withdrawal by Subject|2|||
145239237|NCT02707601|523722307|FG000|Overall Study|Death|0|||
145239238|NCT02707601|523722308|FG001|Overall Study|Death|1|||
145239239|NCT02707601|523722307|FG000|Overall Study|Lack of Efficacy|0|||
145239240|NCT02707601|523722308|FG001|Overall Study|Lack of Efficacy|1|||
145239241|NCT02707601|523722307|FG000|Overall Study|Investigator's Discretion|1|||
145239242|NCT02707601|523722308|FG001|Overall Study|Investigator's Discretion|0|||
145239243|NCT02707601|523722307|FG000|Overall Study|Withdrew Consent|0|||
145239244|NCT02707601|523722308|FG001|Overall Study|Withdrew Consent|1|||
145239245|NCT02707601|523722307|FG000|Overall Study|Lost to Follow-up|1|||
145239246|NCT02707601|523722308|FG001|Overall Study|Lost to Follow-up|1|||
145239247|NCT02707601|523722307|FG000|Overall Study|Participants Randomized but Not Treated|2|||
145239248|NCT02707601|523722308|FG001|Overall Study|Participants Randomized but Not Treated|0|||
145239249|NCT03907969|523722310|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
145239250|NCT03907969|523722311|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
145239251|NCT03907969|523722312|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
145239252|NCT03907969|523722313|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
145239253|NCT03907969|523722314|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
145239254|NCT03907969|523722315|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
145239255|NCT03907969|523722316|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
145239256|NCT03907969|523722317|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
145239257|NCT03907969|523722318|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
145239258|NCT03907969|523722319|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
145239259|NCT03907969|523722320|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
145239260|NCT03907969|523722310|FG000|Monotherapy Part A|Progressive Disease|0|||
145239261|NCT03907969|523722311|FG001|Monotherapy Part A|Progressive Disease|1|||
145239262|NCT03907969|523722312|FG002|Monotherapy Part A|Progressive Disease|0|||
145239263|NCT03907969|523722313|FG003|Monotherapy Part A|Progressive Disease|0|||
145239264|NCT03907969|523722314|FG004|Monotherapy Part A|Progressive Disease|0|||
145239265|NCT03907969|523722315|FG005|Monotherapy Part A|Progressive Disease|1|||
145239266|NCT03907969|523722316|FG006|Monotherapy Part A|Progressive Disease|2|||
145239267|NCT03907969|523722317|FG007|Monotherapy Part A|Progressive Disease|0|||
145239268|NCT03907969|523722318|FG008|Monotherapy Part A|Progressive Disease|0|||
145239269|NCT03907969|523722319|FG009|Monotherapy Part A|Progressive Disease|0|||
145239270|NCT03907969|523722320|FG010|Monotherapy Part A|Progressive Disease|0|||
145239271|NCT03907969|523722310|FG000|Monotherapy Part A|Death|0|||
145239272|NCT03907969|523722311|FG001|Monotherapy Part A|Death|0|||
145239273|NCT03907969|523722312|FG002|Monotherapy Part A|Death|1|||
145239274|NCT03907969|523722313|FG003|Monotherapy Part A|Death|1|||
145239275|NCT03907969|523722314|FG004|Monotherapy Part A|Death|0|||
145239276|NCT03907969|523722315|FG005|Monotherapy Part A|Death|1|||
145239277|NCT03907969|523722316|FG006|Monotherapy Part A|Death|0|||
145239278|NCT03907969|523722317|FG007|Monotherapy Part A|Death|0|||
145239279|NCT03907969|523722318|FG008|Monotherapy Part A|Death|0|||
145239280|NCT03907969|523722319|FG009|Monotherapy Part A|Death|0|||
145239281|NCT03907969|523722320|FG010|Monotherapy Part A|Death|0|||
145563240|NCT00600938|524921811|FG001|Extension Study|Lost to Follow-up|1|||
145239282|NCT03907969|523722310|FG000|Combination Therapy Part A|Adverse Event|0|||
145239283|NCT03907969|523722311|FG001|Combination Therapy Part A|Adverse Event|0|||
145239284|NCT03907969|523722312|FG002|Combination Therapy Part A|Adverse Event|0|||
145239285|NCT03907969|523722313|FG003|Combination Therapy Part A|Adverse Event|0|||
145239286|NCT03907969|523722314|FG004|Combination Therapy Part A|Adverse Event|0|||
145239287|NCT03907969|523722315|FG005|Combination Therapy Part A|Adverse Event|0|||
145239288|NCT03907969|523722316|FG006|Combination Therapy Part A|Adverse Event|0|||
145239289|NCT03907969|523722317|FG007|Combination Therapy Part A|Adverse Event|0|||
145239290|NCT03907969|523722318|FG008|Combination Therapy Part A|Adverse Event|0|||
145239291|NCT03907969|523722319|FG009|Combination Therapy Part A|Adverse Event|1|||
145239292|NCT03907969|523722320|FG010|Combination Therapy Part A|Adverse Event|1|||
145239293|NCT03907969|523722310|FG000|Combination Therapy Part A|Progressive disease|0|||
145239294|NCT03907969|523722311|FG001|Combination Therapy Part A|Progressive disease|0|||
145563241|NCT00600938|524921812|FG002|Extension Study|Lost to Follow-up|2|||
145239295|NCT03907969|523722312|FG002|Combination Therapy Part A|Progressive disease|0|||
145239296|NCT03907969|523722313|FG003|Combination Therapy Part A|Progressive disease|0|||
145239297|NCT03907969|523722314|FG004|Combination Therapy Part A|Progressive disease|0|||
145239298|NCT03907969|523722315|FG005|Combination Therapy Part A|Progressive disease|0|||
145239299|NCT03907969|523722316|FG006|Combination Therapy Part A|Progressive disease|0|||
145239300|NCT03907969|523722317|FG007|Combination Therapy Part A|Progressive disease|1|||
145239301|NCT03907969|523722318|FG008|Combination Therapy Part A|Progressive disease|0|||
145239302|NCT03907969|523722319|FG009|Combination Therapy Part A|Progressive disease|2|||
145239303|NCT03907969|523722320|FG010|Combination Therapy Part A|Progressive disease|3|||
145239304|NCT03907969|523722310|FG000|Combination Therapy Part A|Death|0|||
145239305|NCT03907969|523722311|FG001|Combination Therapy Part A|Death|0|||
145239306|NCT03907969|523722312|FG002|Combination Therapy Part A|Death|0|||
145239307|NCT03907969|523722313|FG003|Combination Therapy Part A|Death|0|||
145239308|NCT03907969|523722314|FG004|Combination Therapy Part A|Death|0|||
145239309|NCT03907969|523722315|FG005|Combination Therapy Part A|Death|0|||
145239310|NCT03907969|523722316|FG006|Combination Therapy Part A|Death|0|||
145239311|NCT03907969|523722317|FG007|Combination Therapy Part A|Death|0|||
145239312|NCT03907969|523722318|FG008|Combination Therapy Part A|Death|1|||
145239313|NCT03907969|523722319|FG009|Combination Therapy Part A|Death|0|||
145239314|NCT03907969|523722320|FG010|Combination Therapy Part A|Death|1|||
145239315|NCT03907969|523722310|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
145239316|NCT03907969|523722311|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
145239317|NCT03907969|523722312|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
145239318|NCT03907969|523722313|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
145239319|NCT03907969|523722314|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
145239320|NCT03907969|523722315|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
145239321|NCT03907969|523722316|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
145239322|NCT03907969|523722317|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
145239323|NCT03907969|523722318|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
145239324|NCT03907969|523722319|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
145239325|NCT03907969|523722320|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
145239326|NCT03907969|523722310|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
145239327|NCT03907969|523722311|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
145239328|NCT03907969|523722312|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
145239329|NCT03907969|523722313|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
145239330|NCT03907969|523722314|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
145239331|NCT03907969|523722315|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
145239332|NCT03907969|523722316|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
145239333|NCT03907969|523722317|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
145239334|NCT03907969|523722318|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
145239335|NCT03907969|523722319|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
145239336|NCT03907969|523722320|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
145239337|NCT03907969|523722310|FG000|Combination Therapy Part A|Physician Decision|0|||
145239338|NCT03907969|523722311|FG001|Combination Therapy Part A|Physician Decision|0|||
145239339|NCT03907969|523722312|FG002|Combination Therapy Part A|Physician Decision|0|||
145239340|NCT03907969|523722313|FG003|Combination Therapy Part A|Physician Decision|0|||
145239341|NCT03907969|523722314|FG004|Combination Therapy Part A|Physician Decision|0|||
145239342|NCT03907969|523722315|FG005|Combination Therapy Part A|Physician Decision|0|||
145239343|NCT03907969|523722316|FG006|Combination Therapy Part A|Physician Decision|0|||
145239344|NCT03907969|523722317|FG007|Combination Therapy Part A|Physician Decision|1|||
145239345|NCT03907969|523722318|FG008|Combination Therapy Part A|Physician Decision|0|||
145239346|NCT03907969|523722319|FG009|Combination Therapy Part A|Physician Decision|0|||
145239347|NCT03907969|523722320|FG010|Combination Therapy Part A|Physician Decision|1|||
145239348|NCT04209530|523722324|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
145239349|NCT04209530|523722325|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
145239350|NCT04209530|523722324|FG000|Overall Study|Withdrawal by Subject|0|||
145239351|NCT04209530|523722325|FG001|Overall Study|Withdrawal by Subject|1|||
145239352|NCT00607919|523722326|FG000|Acute Phase|Adverse Event|9|||
145239353|NCT00607919|523722327|FG001|Acute Phase|Adverse Event|2|||
145239354|NCT00607919|523722326|FG000|Acute Phase|Entry Criteria Not Met|1|||
145239355|NCT00607919|523722327|FG001|Acute Phase|Entry Criteria Not Met|1|||
145239356|NCT00607919|523722326|FG000|Acute Phase|Lack of Efficacy|1|||
145239357|NCT00607919|523722327|FG001|Acute Phase|Lack of Efficacy|2|||
145239358|NCT00607919|523722326|FG000|Acute Phase|Lost to Follow-up|9|||
145239359|NCT00607919|523722327|FG001|Acute Phase|Lost to Follow-up|3|||
145239360|NCT00607919|523722326|FG000|Acute Phase|Parent/Caregiver Decision|6|||
145239361|NCT00607919|523722327|FG001|Acute Phase|Parent/Caregiver Decision|4|||
145239362|NCT00607919|523722326|FG000|Acute Phase|Protocol Violation|5|||
145239363|NCT00607919|523722327|FG001|Acute Phase|Protocol Violation|1|||
145239364|NCT00607919|523722326|FG000|Acute Phase|Withdrawal by Subject|3|||
145239365|NCT00607919|523722327|FG001|Acute Phase|Withdrawal by Subject|3|||
145239366|NCT00607919|523722326|FG000|Open-Label Phase|Adverse Event|1|||
145239367|NCT00607919|523722327|FG001|Open-Label Phase|Adverse Event|5|||
145239368|NCT00607919|523722326|FG000|Open-Label Phase|Lost to Follow-up|4|||
145239369|NCT00607919|523722327|FG001|Open-Label Phase|Lost to Follow-up|1|||
145239370|NCT00607919|523722326|FG000|Open-Label Phase|Protocol Violation|2|||
145239371|NCT00607919|523722327|FG001|Open-Label Phase|Protocol Violation|2|||
145239372|NCT00607919|523722326|FG000|Open-Label Phase|Withdrawal by Subject|2|||
145239373|NCT00607919|523722327|FG001|Open-Label Phase|Withdrawal by Subject|2|||
145239374|NCT00607919|523722326|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
145239375|NCT00607919|523722327|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
145563242|NCT00600938|524921813|FG003|Extension Study|Lost to Follow-up|0|||
145563243|NCT00600938|524921810|FG000|Extension Study|Death|1|||
145563244|NCT00600938|524921811|FG001|Extension Study|Death|0|||
145563245|NCT00600938|524921812|FG002|Extension Study|Death|0|||
145563246|NCT00600938|524921813|FG003|Extension Study|Death|0|||
145563247|NCT02680639|524921814|FG000|Screening Period|Screen Failure|7|||
145563248|NCT02680639|524921815|FG001|Screening Period|Screen Failure|0|||
145296057|NCT01449630|523934405|FG004|Period 1|Physician Decision|0|||
145296058|NCT01449630|523934406|FG005|Period 1|Physician Decision|0|||
145296059|NCT01449630|523934407|FG006|Period 1|Physician Decision|0|||
145296060|NCT01449630|523934408|FG007|Period 1|Physician Decision|0|||
145563249|NCT02680639|524921816|FG002|Screening Period|Screen Failure|0|||
145563250|NCT02946047|524921820|FG000|Overall Study|Adverse Event|1|||
145239376|NCT01709708|523722328|FG000|Overall Study|Protocol Violation|1|||
145239377|NCT01709708|523722329|FG001|Overall Study|Protocol Violation|2|||
145239378|NCT01527110|523722330|FG000|Overall Study|Adverse Event|1|||
145239379|NCT02007252|523722333|FG000|Overall Study|Administrative problems|3|||
145239380|NCT02007252|523722334|FG001|Overall Study|Administrative problems|7|||
145239381|NCT02007252|523722333|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145239382|NCT02007252|523722334|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145239383|NCT02007252|523722333|FG000|Overall Study|Adverse Event|7|||
145239384|NCT02007252|523722334|FG001|Overall Study|Adverse Event|4|||
145296061|NCT01449630|523934409|FG008|Period 1|Physician Decision|0|||
145296062|NCT01449630|523934401|FG000|Period 1|Sponsor Decision|0|||
145296063|NCT01449630|523934402|FG001|Period 1|Sponsor Decision|0|||
145296064|NCT01449630|523934403|FG002|Period 1|Sponsor Decision|0|||
145296065|NCT01449630|523934404|FG003|Period 1|Sponsor Decision|0|||
145296066|NCT01449630|523934405|FG004|Period 1|Sponsor Decision|0|||
145408791|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408792|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408793|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408794|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408795|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
145408796|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408797|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408798|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
145408799|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
145408800|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408801|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408802|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408803|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
145408804|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408805|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408806|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
145408807|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
145408808|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408809|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408810|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408811|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
145408812|NCT03329001|524351891|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408813|NCT03329001|524351892|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408814|NCT03329001|524351893|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
145408815|NCT03329001|524351894|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
145563251|NCT02946047|524921821|FG001|Overall Study|Adverse Event|0|||
145563252|NCT02946047|524921822|FG002|Overall Study|Adverse Event|0|||
145563253|NCT02946047|524921823|FG003|Overall Study|Adverse Event|0|||
145563254|NCT04439318|524921824|FG000|Overall Study|Ineligible|1|||
145563255|NCT04439318|524921824|FG000|Overall Study|Never Started Treatment|3|||
145239385|NCT00527072|523722335|FG000|Overall Study|Adverse Event|13|||
145239386|NCT00527072|523722335|FG000|Overall Study|Lack of Efficacy|11|||
145239387|NCT00527072|523722335|FG000|Overall Study|Lost to Follow-up|3|||
145296067|NCT01449630|523934406|FG005|Period 1|Sponsor Decision|1|||
145296068|NCT01449630|523934407|FG006|Period 1|Sponsor Decision|0|||
145296069|NCT01449630|523934408|FG007|Period 1|Sponsor Decision|0|||
145239388|NCT00527072|523722335|FG000|Overall Study|Protocol Violation|2|||
145239389|NCT00527072|523722335|FG000|Overall Study|Withdrawal by Subject|7|||
145239390|NCT00511108|523722338|FG000|Overall Study|Adverse Event|2|||
145239391|NCT00511108|523722339|FG001|Overall Study|Adverse Event|0|||
145239392|NCT00511108|523722340|FG002|Overall Study|Adverse Event|1|||
145239393|NCT00511108|523722341|FG003|Overall Study|Adverse Event|2|||
145239394|NCT00511108|523722338|FG000|Overall Study|Lost to Follow-up|0|||
145239395|NCT00511108|523722339|FG001|Overall Study|Lost to Follow-up|2|||
145239396|NCT00511108|523722340|FG002|Overall Study|Lost to Follow-up|1|||
145239397|NCT00511108|523722341|FG003|Overall Study|Lost to Follow-up|0|||
145239398|NCT00511108|523722338|FG000|Overall Study|Physician Decision|0|||
145239399|NCT00511108|523722339|FG001|Overall Study|Physician Decision|0|||
145239400|NCT00511108|523722340|FG002|Overall Study|Physician Decision|0|||
145239401|NCT00511108|523722341|FG003|Overall Study|Physician Decision|1|||
145239402|NCT00511108|523722338|FG000|Overall Study|Withdrawal by Subject|4|||
145239403|NCT00511108|523722339|FG001|Overall Study|Withdrawal by Subject|0|||
145239404|NCT00511108|523722340|FG002|Overall Study|Withdrawal by Subject|3|||
145239405|NCT00511108|523722341|FG003|Overall Study|Withdrawal by Subject|2|||
145239406|NCT02147691|523722342|FG000|Overall Study|Withdrawal by Subject|2|||
145239407|NCT02147691|523722343|FG001|Overall Study|Withdrawal by Subject|0|||
145239408|NCT02147691|523722342|FG000|Overall Study|Adverse Event|2|||
145239409|NCT02147691|523722343|FG001|Overall Study|Adverse Event|0|||
145239410|NCT02147691|523722342|FG000|Overall Study|Lost to Follow-up|0|||
145239411|NCT02147691|523722343|FG001|Overall Study|Lost to Follow-up|1|||
145239412|NCT01998958|523722346|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239413|NCT01998958|523722347|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
145239414|NCT01998958|523722348|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239415|NCT01998958|523722349|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239416|NCT01998958|523722350|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239417|NCT01998958|523722351|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239418|NCT01998958|523722352|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239419|NCT01998958|523722353|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239420|NCT01998958|523722354|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239421|NCT01998958|523722355|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239422|NCT01998958|523722356|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239423|NCT01998958|523722357|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239424|NCT01998958|523722358|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239425|NCT01998958|523722359|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239426|NCT01998958|523722360|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239427|NCT01998958|523722361|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239428|NCT01998958|523722362|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239429|NCT01998958|523722363|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239430|NCT01998958|523722364|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239431|NCT01998958|523722365|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239432|NCT01998958|523722366|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239433|NCT01998958|523722367|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239434|NCT01998958|523722368|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239435|NCT01998958|523722369|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239436|NCT01998958|523722370|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239437|NCT01998958|523722371|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239438|NCT01998958|523722372|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239439|NCT01998958|523722373|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239440|NCT01998958|523722374|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239441|NCT01998958|523722375|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239442|NCT01998958|523722376|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239443|NCT01998958|523722377|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
145239444|NCT01998958|523722346|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239445|NCT01998958|523722347|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
145239446|NCT01998958|523722348|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239447|NCT01998958|523722349|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239448|NCT01998958|523722350|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239449|NCT01998958|523722351|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239450|NCT01998958|523722352|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239451|NCT01998958|523722353|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239452|NCT01998958|523722354|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239453|NCT01998958|523722355|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239454|NCT01998958|523722356|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239455|NCT01998958|523722357|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239456|NCT01998958|523722358|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239457|NCT01998958|523722359|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239458|NCT01998958|523722360|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239459|NCT01998958|523722361|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239460|NCT01998958|523722362|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239461|NCT01998958|523722363|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239462|NCT01998958|523722364|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239463|NCT01998958|523722365|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239464|NCT01998958|523722366|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239465|NCT01998958|523722367|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239466|NCT01998958|523722368|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239467|NCT01998958|523722369|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239468|NCT01998958|523722370|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239469|NCT01998958|523722371|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239470|NCT01998958|523722372|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145563256|NCT04439318|524921824|FG000|Overall Study|Adverse Event|10|||
145563257|NCT04439318|524921824|FG000|Overall Study|Death|2|||
145563258|NCT04439318|524921824|FG000|Overall Study|Disease Progression|25|||
145563259|NCT04439318|524921824|FG000|Overall Study|Other Complicating Disease|2|||
145563260|NCT04439318|524921824|FG000|Overall Study|Withdrawal by Subject|4|||
145563261|NCT04439318|524921824|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
145563262|NCT04439318|524921824|FG000|Overall Study|Non-Compliance|1|||
145563263|NCT04439318|524921824|FG000|Overall Study|Still on Treatment|1|||
145563264|NCT02268409|524923967|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
145563265|NCT02268409|524923967|FG000|Overall Study|Death|1|||
145563266|NCT02268409|524923967|FG000|Overall Study|Lost to Follow-up|1|||
145563267|NCT02268409|524923967|FG000|Overall Study|Protocol Violation|3|||
145563268|NCT02268409|524923967|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
145563269|NCT02268409|524923967|FG000|Overall Study|Withdrawal by Subject|5|||
145563270|NCT04865354|524923968|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
145563271|NCT04865354|524923969|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
145563272|NCT04865354|524923968|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
145563273|NCT04865354|524923969|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
145563274|NCT04865354|524923968|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
145563275|NCT04865354|524923969|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
145563276|NCT03873987|524923970|FG000|Overall Study|Adverse Event|1|||
145563277|NCT03873987|524923971|FG001|Overall Study|Adverse Event|0|||
145563278|NCT03873987|524923970|FG000|Overall Study|staff was unable to start a new IV line|1|||
145563279|NCT03873987|524923971|FG001|Overall Study|staff was unable to start a new IV line|0|||
145563280|NCT03873987|524923970|FG000|Overall Study|Lost to Follow-up|0|||
145563281|NCT03873987|524923971|FG001|Overall Study|Lost to Follow-up|1|||
145563282|NCT01465022|524923972|FG000|Overall Study|Lost to Follow-up|15|||
145563283|NCT01465022|524923973|FG001|Overall Study|Lost to Follow-up|14|||
145563284|NCT01465022|524923974|FG002|Overall Study|Lost to Follow-up|0|||
145563285|NCT01465022|524923972|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
145563286|NCT01465022|524923973|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
145563287|NCT01465022|524923974|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
145563288|NCT01465022|524923972|FG000|Overall Study|Not Randomized|0|||
145563289|NCT01465022|524923973|FG001|Overall Study|Not Randomized|0|||
145563290|NCT01465022|524923974|FG002|Overall Study|Not Randomized|70|||
145563291|NCT02520011|524923975|FG000|Overall Study|Adverse Event|0|||
145563292|NCT02520011|524923976|FG001|Overall Study|Adverse Event|1|||
145563293|NCT02520011|524923977|FG002|Overall Study|Adverse Event|2|||
145563294|NCT02520011|524923975|FG000|Overall Study|Death|0|||
145563295|NCT02520011|524923976|FG001|Overall Study|Death|8|||
145563296|NCT02520011|524923977|FG002|Overall Study|Death|1|||
145563297|NCT02520011|524923975|FG000|Overall Study|Lack of Efficacy|4|||
145563298|NCT02520011|524923976|FG001|Overall Study|Lack of Efficacy|26|||
145563299|NCT02520011|524923977|FG002|Overall Study|Lack of Efficacy|4|||
145563300|NCT02520011|524923975|FG000|Overall Study|Physician Decision|0|||
145563301|NCT02520011|524923976|FG001|Overall Study|Physician Decision|2|||
145563302|NCT02520011|524923977|FG002|Overall Study|Physician Decision|0|||
145563303|NCT02520011|524923975|FG000|Overall Study|Withdrawal by Subject|1|||
145563304|NCT02520011|524923976|FG001|Overall Study|Withdrawal by Subject|3|||
145563305|NCT02520011|524923977|FG002|Overall Study|Withdrawal by Subject|0|||
145563306|NCT02520011|524923975|FG000|Overall Study|Protocol Deviation|0|||
145563307|NCT02520011|524923976|FG001|Overall Study|Protocol Deviation|1|||
145563308|NCT02520011|524923977|FG002|Overall Study|Protocol Deviation|0|||
145239471|NCT01998958|523722373|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239472|NCT01998958|523722374|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239473|NCT01998958|523722375|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145563309|NCT02520011|524923975|FG000|Overall Study|Patient went to hospice|0|||
145563310|NCT02520011|524923976|FG001|Overall Study|Patient went to hospice|1|||
145563311|NCT02520011|524923977|FG002|Overall Study|Patient went to hospice|0|||
145563312|NCT02520011|524923975|FG000|Overall Study|Progressive disease following response|0|||
145563313|NCT02520011|524923976|FG001|Overall Study|Progressive disease following response|4|||
145563314|NCT02520011|524923977|FG002|Overall Study|Progressive disease following response|2|||
145563315|NCT03239470|524923981|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
145563316|NCT03239470|524923982|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
145563317|NCT01957462|524923983|FG000|Test Period 1|Withdrawal by Subject|1|||
145563318|NCT01957462|524923984|FG001|Test Period 1|Withdrawal by Subject|0|||
145563319|NCT01957462|524923983|FG000|Test Period 1|Adverse Event|1|||
145563320|NCT01957462|524923984|FG001|Test Period 1|Adverse Event|0|||
145563321|NCT03616912|524923985|FG000|Overall Study|Adverse Event|17|||
145563322|NCT03616912|524923986|FG001|Overall Study|Adverse Event|21|||
145563323|NCT03616912|524923987|FG002|Overall Study|Adverse Event|9|||
145563324|NCT03616912|524923988|FG003|Overall Study|Adverse Event|0|||
145563325|NCT03616912|524923989|FG004|Overall Study|Adverse Event|0|||
145563326|NCT03616912|524923990|FG005|Overall Study|Adverse Event|0|||
145563327|NCT03616912|524923985|FG000|Overall Study|Death|1|||
145563328|NCT03616912|524923986|FG001|Overall Study|Death|1|||
145563329|NCT03616912|524923987|FG002|Overall Study|Death|0|||
145563330|NCT03616912|524923988|FG003|Overall Study|Death|0|||
145563331|NCT03616912|524923989|FG004|Overall Study|Death|0|||
145563332|NCT03616912|524923990|FG005|Overall Study|Death|0|||
145563333|NCT03616912|524923985|FG000|Overall Study|Lack of Efficacy|13|||
145563334|NCT03616912|524923986|FG001|Overall Study|Lack of Efficacy|6|||
145563335|NCT03616912|524923987|FG002|Overall Study|Lack of Efficacy|8|||
145563336|NCT03616912|524923988|FG003|Overall Study|Lack of Efficacy|4|||
145563337|NCT03616912|524923989|FG004|Overall Study|Lack of Efficacy|5|||
145563338|NCT03616912|524923990|FG005|Overall Study|Lack of Efficacy|1|||
145563339|NCT03616912|524923985|FG000|Overall Study|Lost to Follow-up|1|||
145563340|NCT03616912|524923986|FG001|Overall Study|Lost to Follow-up|2|||
145563341|NCT03616912|524923987|FG002|Overall Study|Lost to Follow-up|3|||
145563342|NCT03616912|524923988|FG003|Overall Study|Lost to Follow-up|0|||
145563343|NCT03616912|524923989|FG004|Overall Study|Lost to Follow-up|0|||
145563344|NCT03616912|524923990|FG005|Overall Study|Lost to Follow-up|0|||
145563345|NCT03616912|524923985|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
145563346|NCT03616912|524923986|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
145563347|NCT03616912|524923987|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
145563348|NCT03616912|524923988|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
145563349|NCT03616912|524923989|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
145563350|NCT03616912|524923990|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
145563351|NCT03616912|524923985|FG000|Overall Study|Withdrawal by Subject|12|||
145563352|NCT03616912|524923986|FG001|Overall Study|Withdrawal by Subject|12|||
145563353|NCT03616912|524923987|FG002|Overall Study|Withdrawal by Subject|15|||
145239474|NCT01998958|523722376|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239475|NCT01998958|523722377|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
145239476|NCT01998958|523722346|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
145239477|NCT01998958|523722347|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
145239478|NCT01998958|523722348|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
145239479|NCT01998958|523722349|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
145239480|NCT01998958|523722350|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
145239481|NCT01998958|523722351|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
145239482|NCT01998958|523722352|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
145239483|NCT01998958|523722353|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
145239484|NCT01998958|523722354|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
145239485|NCT01998958|523722355|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
145239486|NCT01998958|523722356|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
145239487|NCT01998958|523722357|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
145239488|NCT01998958|523722358|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
145239489|NCT01998958|523722359|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
145239490|NCT01998958|523722360|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
145239491|NCT01998958|523722361|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
145239492|NCT01998958|523722362|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
145239493|NCT01998958|523722363|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
145239494|NCT01998958|523722364|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
145239495|NCT01998958|523722365|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
145239496|NCT01998958|523722366|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
145296070|NCT01449630|523934409|FG008|Period 1|Sponsor Decision|0|||
145563354|NCT03616912|524923988|FG003|Overall Study|Withdrawal by Subject|2|||
145563355|NCT03616912|524923989|FG004|Overall Study|Withdrawal by Subject|0|||
145296071|NCT01449630|523934401|FG000|Period 2|Sponsor Decision|0|||
145563356|NCT03616912|524923990|FG005|Overall Study|Withdrawal by Subject|2|||
145563357|NCT03616912|524923985|FG000|Overall Study|Study Terminated by Sponsor|0|||
145563358|NCT03616912|524923986|FG001|Overall Study|Study Terminated by Sponsor|0|||
145563359|NCT03616912|524923987|FG002|Overall Study|Study Terminated by Sponsor|0|||
145563360|NCT03616912|524923988|FG003|Overall Study|Study Terminated by Sponsor|10|||
145563361|NCT03616912|524923989|FG004|Overall Study|Study Terminated by Sponsor|9|||
145239497|NCT01998958|523722367|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
145239498|NCT01998958|523722368|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
145239499|NCT01998958|523722369|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
145296072|NCT01449630|523934402|FG001|Period 2|Sponsor Decision|0|||
145563362|NCT03616912|524923990|FG005|Overall Study|Study Terminated by Sponsor|11|||
145563363|NCT03616912|524923985|FG000|Overall Study|Protocol Deviation|1|||
145563364|NCT03616912|524923986|FG001|Overall Study|Protocol Deviation|1|||
145563365|NCT03616912|524923987|FG002|Overall Study|Protocol Deviation|0|||
145563366|NCT03616912|524923988|FG003|Overall Study|Protocol Deviation|0|||
145563367|NCT03616912|524923989|FG004|Overall Study|Protocol Deviation|0|||
145563368|NCT03616912|524923990|FG005|Overall Study|Protocol Deviation|0|||
145563369|NCT03616912|524923985|FG000|Overall Study|Pregnancy|1|||
145563370|NCT03616912|524923986|FG001|Overall Study|Pregnancy|0|||
145563371|NCT03616912|524923987|FG002|Overall Study|Pregnancy|4|||
145563372|NCT03616912|524923988|FG003|Overall Study|Pregnancy|0|||
145563373|NCT03616912|524923989|FG004|Overall Study|Pregnancy|0|||
145563374|NCT03616912|524923990|FG005|Overall Study|Pregnancy|0|||
145563375|NCT03616912|524923985|FG000|Overall Study|Protocol Violation|1|||
145563376|NCT03616912|524923986|FG001|Overall Study|Protocol Violation|0|||
145563377|NCT03616912|524923987|FG002|Overall Study|Protocol Violation|2|||
145563378|NCT03616912|524923988|FG003|Overall Study|Protocol Violation|0|||
145563379|NCT03616912|524923989|FG004|Overall Study|Protocol Violation|0|||
145563380|NCT03616912|524923990|FG005|Overall Study|Protocol Violation|0|||
145563381|NCT03616912|524923985|FG000|Overall Study|Physician Decision|2|||
145563382|NCT03616912|524923986|FG001|Overall Study|Physician Decision|0|||
145239500|NCT01998958|523722370|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
145239501|NCT01998958|523722371|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
145239502|NCT01998958|523722372|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
145239503|NCT01998958|523722373|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
145239504|NCT01998958|523722374|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
145239505|NCT01998958|523722375|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
145239506|NCT01998958|523722376|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
145239507|NCT01998958|523722377|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
145239508|NCT01998958|523722346|FG000|Period 1 (Panel A and B)|Other|1|||
145239509|NCT01998958|523722347|FG001|Period 1 (Panel A and B)|Other|0|||
145239510|NCT01998958|523722348|FG002|Period 1 (Panel A and B)|Other|0|||
145239511|NCT01998958|523722349|FG003|Period 1 (Panel A and B)|Other|0|||
145239512|NCT01998958|523722350|FG004|Period 1 (Panel A and B)|Other|0|||
145239513|NCT01998958|523722351|FG005|Period 1 (Panel A and B)|Other|0|||
145239514|NCT01998958|523722352|FG006|Period 1 (Panel A and B)|Other|0|||
145239515|NCT01998958|523722353|FG007|Period 1 (Panel A and B)|Other|0|||
145239516|NCT01998958|523722354|FG008|Period 1 (Panel A and B)|Other|0|||
145239517|NCT01998958|523722355|FG009|Period 1 (Panel A and B)|Other|0|||
145239518|NCT01998958|523722356|FG010|Period 1 (Panel A and B)|Other|0|||
145239519|NCT01998958|523722357|FG011|Period 1 (Panel A and B)|Other|0|||
145239520|NCT01998958|523722358|FG012|Period 1 (Panel A and B)|Other|0|||
145239521|NCT01998958|523722359|FG013|Period 1 (Panel A and B)|Other|0|||
145239522|NCT01998958|523722360|FG014|Period 1 (Panel A and B)|Other|0|||
145239523|NCT01998958|523722361|FG015|Period 1 (Panel A and B)|Other|0|||
145239524|NCT01998958|523722362|FG016|Period 1 (Panel A and B)|Other|0|||
145239525|NCT01998958|523722363|FG017|Period 1 (Panel A and B)|Other|0|||
145239526|NCT01998958|523722364|FG018|Period 1 (Panel A and B)|Other|0|||
145239527|NCT01998958|523722365|FG019|Period 1 (Panel A and B)|Other|0|||
145239528|NCT01998958|523722366|FG020|Period 1 (Panel A and B)|Other|0|||
145239529|NCT01998958|523722367|FG021|Period 1 (Panel A and B)|Other|0|||
145239530|NCT01998958|523722368|FG022|Period 1 (Panel A and B)|Other|0|||
145239531|NCT01998958|523722369|FG023|Period 1 (Panel A and B)|Other|0|||
145239532|NCT01998958|523722370|FG024|Period 1 (Panel A and B)|Other|0|||
145239533|NCT01998958|523722371|FG025|Period 1 (Panel A and B)|Other|0|||
145239534|NCT01998958|523722372|FG026|Period 1 (Panel A and B)|Other|0|||
145239535|NCT01998958|523722373|FG027|Period 1 (Panel A and B)|Other|0|||
145239536|NCT01998958|523722374|FG028|Period 1 (Panel A and B)|Other|0|||
145239537|NCT01998958|523722375|FG029|Period 1 (Panel A and B)|Other|0|||
145239538|NCT01998958|523722376|FG030|Period 1 (Panel A and B)|Other|0|||
145239539|NCT01998958|523722377|FG031|Period 1 (Panel A and B)|Other|0|||
145239540|NCT01998958|523722346|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
145239541|NCT01998958|523722347|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
145239542|NCT01998958|523722348|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
145239543|NCT01998958|523722349|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
145296073|NCT01449630|523934403|FG002|Period 2|Sponsor Decision|0|||
145296074|NCT01449630|523934404|FG003|Period 2|Sponsor Decision|0|||
145296075|NCT01449630|523934405|FG004|Period 2|Sponsor Decision|0|||
145296076|NCT01449630|523934406|FG005|Period 2|Sponsor Decision|0|||
145296077|NCT01449630|523934407|FG006|Period 2|Sponsor Decision|1|||
145563383|NCT03616912|524923987|FG002|Overall Study|Physician Decision|0|||
145563384|NCT03616912|524923988|FG003|Overall Study|Physician Decision|0|||
145563385|NCT03616912|524923989|FG004|Overall Study|Physician Decision|1|||
145563386|NCT03616912|524923990|FG005|Overall Study|Physician Decision|0|||
145239544|NCT01998958|523722350|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
145239545|NCT01998958|523722351|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
145239546|NCT01998958|523722352|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
145239547|NCT01998958|523722353|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
145239548|NCT01998958|523722354|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
145239549|NCT01998958|523722355|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
145239550|NCT01998958|523722356|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
145239551|NCT01998958|523722357|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
145239552|NCT01998958|523722358|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
145296078|NCT01449630|523934408|FG007|Period 2|Sponsor Decision|0|||
145296079|NCT01449630|523934409|FG008|Period 2|Sponsor Decision|0|||
145239553|NCT01998958|523722359|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
145239554|NCT01998958|523722360|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
145239555|NCT01998958|523722361|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
145239556|NCT01998958|523722362|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
145239557|NCT01998958|523722363|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
145239558|NCT01998958|523722364|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
145239559|NCT01998958|523722365|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
145239560|NCT01998958|523722366|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
145239561|NCT01998958|523722367|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
145239562|NCT01998958|523722368|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
145563387|NCT03616912|524923985|FG000|Overall Study|Randomized But Never Treated|0|||
145563388|NCT03616912|524923986|FG001|Overall Study|Randomized But Never Treated|2|||
145563389|NCT03616912|524923987|FG002|Overall Study|Randomized But Never Treated|0|||
145563390|NCT03616912|524923988|FG003|Overall Study|Randomized But Never Treated|0|||
145563391|NCT03616912|524923989|FG004|Overall Study|Randomized But Never Treated|0|||
145563392|NCT03616912|524923990|FG005|Overall Study|Randomized But Never Treated|0|||
145563393|NCT01856790|524923993|FG000|Closed Loop Control|Withdrawal by Subject|2|||
145563394|NCT01856790|524923993|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
145563395|NCT01921829|524923994|FG000|Overall Study|Withdrawal by Subject|0|||
145563396|NCT01921829|524923995|FG001|Overall Study|Withdrawal by Subject|1|||
145563397|NCT01762943|524923997|FG000|Overall Study|Physician Decision|1|||
145563398|NCT01762943|524923998|FG001|Overall Study|Physician Decision|1|||
145563399|NCT01762943|524923997|FG000|Overall Study|Protocol Violation|1|||
145563400|NCT01762943|524923998|FG001|Overall Study|Protocol Violation|0|||
145563401|NCT01762943|524923997|FG000|Overall Study|Withdrawal by Subject|2|||
145563402|NCT01762943|524923998|FG001|Overall Study|Withdrawal by Subject|1|||
145563403|NCT00539838|524923999|FG000|Overall Study|Fail to return|2|||
145563404|NCT00539838|524924000|FG001|Overall Study|Fail to return|0|||
145563405|NCT00539838|524924001|FG002|Overall Study|Fail to return|0|||
145563406|NCT00539838|524923999|FG000|Overall Study|Withdrawal by Subject|0|||
145563407|NCT00539838|524924000|FG001|Overall Study|Withdrawal by Subject|4|||
145563408|NCT00539838|524924001|FG002|Overall Study|Withdrawal by Subject|0|||
145563409|NCT00539838|524923999|FG000|Overall Study|Death|0|||
145563410|NCT00539838|524924000|FG001|Overall Study|Death|2|||
145563411|NCT00539838|524924001|FG002|Overall Study|Death|0|||
145563412|NCT00539838|524923999|FG000|Overall Study|Did not cooperate|1|||
145563413|NCT00539838|524924000|FG001|Overall Study|Did not cooperate|0|||
145563414|NCT00539838|524924001|FG002|Overall Study|Did not cooperate|1|||
145563415|NCT00539838|524923999|FG000|Overall Study|Administrative|4|||
145563416|NCT00539838|524924000|FG001|Overall Study|Administrative|0|||
145563417|NCT00539838|524924001|FG002|Overall Study|Administrative|8|||
145563418|NCT02658890|524924004|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563419|NCT02658890|524924005|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563420|NCT02658890|524924006|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563421|NCT02658890|524924007|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563422|NCT02658890|524924008|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563423|NCT02658890|524924009|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563424|NCT02658890|524924010|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563425|NCT02658890|524924011|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563426|NCT02658890|524924012|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
145563427|NCT02658890|524924013|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563428|NCT02658890|524924014|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563429|NCT02658890|524924015|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563430|NCT02658890|524924016|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563431|NCT02658890|524924017|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563432|NCT02658890|524924018|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563433|NCT02658890|524924019|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563434|NCT02658890|524924020|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563435|NCT02658890|524924021|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563436|NCT02658890|524924022|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563437|NCT02658890|524924023|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563438|NCT02658890|524924024|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563439|NCT02658890|524924025|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563440|NCT02658890|524924026|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145296080|NCT01735630|523934410|FG000|Overall Study|Adverse Event|8|||
145563441|NCT02658890|524924027|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563442|NCT02658890|524924028|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563443|NCT02658890|524924029|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145239563|NCT01998958|523722369|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
145239564|NCT01998958|523722370|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
145239565|NCT01998958|523722371|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
145563444|NCT02658890|524924030|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563445|NCT02658890|524924004|FG000|Treatment Phase|Adverse Event|0|||
145563446|NCT02658890|524924005|FG001|Treatment Phase|Adverse Event|1|||
145563447|NCT02658890|524924006|FG002|Treatment Phase|Adverse Event|2|||
145563448|NCT02658890|524924007|FG003|Treatment Phase|Adverse Event|2|||
145563449|NCT02658890|524924008|FG004|Treatment Phase|Adverse Event|1|||
145563450|NCT02658890|524924009|FG005|Treatment Phase|Adverse Event|0|||
145563451|NCT02658890|524924010|FG006|Treatment Phase|Adverse Event|0|||
145563452|NCT02658890|524924011|FG007|Treatment Phase|Adverse Event|2|||
145563453|NCT02658890|524924012|FG008|Treatment Phase|Adverse Event|1|||
145563454|NCT02658890|524924013|FG009|Treatment Phase|Adverse Event|2|||
145563455|NCT02658890|524924014|FG010|Treatment Phase|Adverse Event|3|||
145563456|NCT02658890|524924015|FG011|Treatment Phase|Adverse Event|0|||
145563457|NCT02658890|524924016|FG012|Treatment Phase|Adverse Event|1|||
145563458|NCT02658890|524924017|FG013|Treatment Phase|Adverse Event|4|||
145563459|NCT02658890|524924018|FG014|Treatment Phase|Adverse Event|0|||
145563460|NCT02658890|524924019|FG015|Treatment Phase|Adverse Event|0|||
145563461|NCT02658890|524924020|FG016|Treatment Phase|Adverse Event|0|||
145563462|NCT02658890|524924021|FG017|Treatment Phase|Adverse Event|0|||
145563463|NCT02658890|524924022|FG018|Treatment Phase|Adverse Event|5|||
145563464|NCT02658890|524924023|FG019|Treatment Phase|Adverse Event|1|||
145563465|NCT02658890|524924024|FG020|Treatment Phase|Adverse Event|3|||
145563466|NCT02658890|524924025|FG021|Treatment Phase|Adverse Event|0|||
145563467|NCT02658890|524924026|FG022|Treatment Phase|Adverse Event|5|||
145563468|NCT02658890|524924027|FG023|Treatment Phase|Adverse Event|0|||
145563469|NCT02658890|524924028|FG024|Treatment Phase|Adverse Event|0|||
145563470|NCT02658890|524924029|FG025|Treatment Phase|Adverse Event|2|||
145563471|NCT02658890|524924030|FG026|Treatment Phase|Adverse Event|1|||
145563472|NCT02658890|524924004|FG000|Treatment Phase|Death|0|||
145563473|NCT02658890|524924005|FG001|Treatment Phase|Death|0|||
145563474|NCT02658890|524924006|FG002|Treatment Phase|Death|0|||
145563475|NCT02658890|524924007|FG003|Treatment Phase|Death|0|||
145563476|NCT02658890|524924008|FG004|Treatment Phase|Death|0|||
145563477|NCT02658890|524924009|FG005|Treatment Phase|Death|0|||
145563478|NCT02658890|524924010|FG006|Treatment Phase|Death|0|||
145563479|NCT02658890|524924011|FG007|Treatment Phase|Death|0|||
145563480|NCT02658890|524924012|FG008|Treatment Phase|Death|0|||
145563481|NCT02658890|524924013|FG009|Treatment Phase|Death|0|||
145563482|NCT02658890|524924014|FG010|Treatment Phase|Death|0|||
145563483|NCT02658890|524924015|FG011|Treatment Phase|Death|0|||
145563484|NCT02658890|524924016|FG012|Treatment Phase|Death|0|||
145563485|NCT02658890|524924017|FG013|Treatment Phase|Death|0|||
145563486|NCT02658890|524924018|FG014|Treatment Phase|Death|0|||
145563487|NCT02658890|524924019|FG015|Treatment Phase|Death|0|||
145563488|NCT02658890|524924020|FG016|Treatment Phase|Death|0|||
145563489|NCT02658890|524924021|FG017|Treatment Phase|Death|0|||
145563490|NCT02658890|524924022|FG018|Treatment Phase|Death|1|||
145563491|NCT02658890|524924023|FG019|Treatment Phase|Death|0|||
145563492|NCT02658890|524924024|FG020|Treatment Phase|Death|0|||
145563493|NCT02658890|524924025|FG021|Treatment Phase|Death|0|||
145563494|NCT02658890|524924026|FG022|Treatment Phase|Death|0|||
145563495|NCT02658890|524924027|FG023|Treatment Phase|Death|0|||
145563496|NCT02658890|524924028|FG024|Treatment Phase|Death|0|||
145563497|NCT02658890|524924029|FG025|Treatment Phase|Death|0|||
145563498|NCT02658890|524924030|FG026|Treatment Phase|Death|0|||
145563499|NCT02658890|524924004|FG000|Treatment Phase|Lost to Follow-up|0|||
145563500|NCT02658890|524924005|FG001|Treatment Phase|Lost to Follow-up|0|||
145563501|NCT02658890|524924006|FG002|Treatment Phase|Lost to Follow-up|0|||
145563502|NCT02658890|524924007|FG003|Treatment Phase|Lost to Follow-up|0|||
145563503|NCT02658890|524924008|FG004|Treatment Phase|Lost to Follow-up|0|||
145563504|NCT02658890|524924009|FG005|Treatment Phase|Lost to Follow-up|0|||
145239566|NCT01998958|523722372|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
145239567|NCT01998958|523722373|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
145563505|NCT02658890|524924010|FG006|Treatment Phase|Lost to Follow-up|1|||
145563506|NCT02658890|524924011|FG007|Treatment Phase|Lost to Follow-up|0|||
145563507|NCT02658890|524924012|FG008|Treatment Phase|Lost to Follow-up|0|||
145563508|NCT02658890|524924013|FG009|Treatment Phase|Lost to Follow-up|0|||
145563509|NCT02658890|524924014|FG010|Treatment Phase|Lost to Follow-up|0|||
145563510|NCT02658890|524924015|FG011|Treatment Phase|Lost to Follow-up|0|||
145563511|NCT02658890|524924016|FG012|Treatment Phase|Lost to Follow-up|0|||
145563512|NCT02658890|524924017|FG013|Treatment Phase|Lost to Follow-up|0|||
145239568|NCT01998958|523722374|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
145563513|NCT02658890|524924018|FG014|Treatment Phase|Lost to Follow-up|0|||
145563514|NCT02658890|524924019|FG015|Treatment Phase|Lost to Follow-up|0|||
145563515|NCT02658890|524924020|FG016|Treatment Phase|Lost to Follow-up|0|||
145563516|NCT02658890|524924021|FG017|Treatment Phase|Lost to Follow-up|0|||
145563517|NCT02658890|524924022|FG018|Treatment Phase|Lost to Follow-up|0|||
145563518|NCT02658890|524924023|FG019|Treatment Phase|Lost to Follow-up|0|||
145563519|NCT02658890|524924024|FG020|Treatment Phase|Lost to Follow-up|0|||
145563520|NCT02658890|524924025|FG021|Treatment Phase|Lost to Follow-up|0|||
145563521|NCT02658890|524924026|FG022|Treatment Phase|Lost to Follow-up|0|||
145239569|NCT01998958|523722375|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
145239570|NCT01998958|523722376|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
145296081|NCT01735630|523934411|FG001|Overall Study|Adverse Event|7|||
145296082|NCT01735630|523934410|FG000|Overall Study|Lost to Follow-up|1|||
145296083|NCT01735630|523934411|FG001|Overall Study|Lost to Follow-up|0|||
145296084|NCT01735630|523934410|FG000|Overall Study|Physician Decision|0|||
145296085|NCT01735630|523934411|FG001|Overall Study|Physician Decision|1|||
145296086|NCT01735630|523934410|FG000|Overall Study|Sponsor Decision|2|||
145296087|NCT01735630|523934411|FG001|Overall Study|Sponsor Decision|1|||
145296088|NCT01735630|523934410|FG000|Overall Study|Withdrawal by Subject|7|||
145296089|NCT01735630|523934411|FG001|Overall Study|Withdrawal by Subject|9|||
145239571|NCT01998958|523722377|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
145239572|NCT01998958|523722346|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239573|NCT01998958|523722347|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239574|NCT01998958|523722348|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239575|NCT01998958|523722349|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239576|NCT01998958|523722350|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239577|NCT01998958|523722351|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239578|NCT01998958|523722352|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239579|NCT01998958|523722353|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239580|NCT01998958|523722354|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239581|NCT01998958|523722355|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239582|NCT01998958|523722356|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145296090|NCT01572948|523934412|FG000|Overall Study|Lost to Follow-up|1|||
145296091|NCT01572948|523934413|FG001|Overall Study|Lost to Follow-up|0|||
145296092|NCT01572948|523934412|FG000|Overall Study|unable to contact|0|||
145408816|NCT03329001|524351895|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408817|NCT03329001|524351896|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408818|NCT03329001|524351897|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408819|NCT03329001|524351898|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
145408820|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408821|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408822|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408823|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
145408824|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408825|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408826|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408827|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
145408828|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408829|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408830|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408831|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
145408832|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408833|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408834|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408835|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
145408836|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408837|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408838|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
145408839|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408840|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408841|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408842|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408843|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
145408844|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145408845|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145408846|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
145408847|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
145408848|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145408849|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145408850|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145239583|NCT01998958|523722357|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239584|NCT01998958|523722358|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145296093|NCT01572948|523934413|FG001|Overall Study|unable to contact|1|||
145296094|NCT01126736|523934418|FG000|Overall Study|Death|2|||
145296095|NCT01126736|523934419|FG001|Overall Study|Death|2|||
145296096|NCT01126736|523934420|FG002|Overall Study|Death|1|||
145296097|NCT01126736|523934421|FG003|Overall Study|Death|19|||
145296098|NCT01126736|523934422|FG004|Overall Study|Death|19|||
145296099|NCT01126736|523934418|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
145296100|NCT01126736|523934419|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
145296101|NCT01126736|523934420|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
145296102|NCT01126736|523934421|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
145296103|NCT01126736|523934422|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
145296104|NCT01126736|523934418|FG000|Overall Study|Lost to Follow-up|0|||
145563522|NCT02658890|524924027|FG023|Treatment Phase|Lost to Follow-up|0|||
145563523|NCT02658890|524924028|FG024|Treatment Phase|Lost to Follow-up|0|||
145563524|NCT02658890|524924029|FG025|Treatment Phase|Lost to Follow-up|0|||
145563525|NCT02658890|524924030|FG026|Treatment Phase|Lost to Follow-up|0|||
145563526|NCT02658890|524924004|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
145563527|NCT02658890|524924005|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
145563528|NCT02658890|524924006|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
145563529|NCT02658890|524924007|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
145563530|NCT02658890|524924008|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
145563531|NCT02658890|524924009|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
145563532|NCT02658890|524924010|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
145563533|NCT02658890|524924011|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
145563534|NCT02658890|524924012|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
145563535|NCT02658890|524924013|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
145563536|NCT02658890|524924014|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
145239585|NCT01998958|523722359|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239586|NCT01998958|523722360|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
145239587|NCT01998958|523722361|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239588|NCT01998958|523722362|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239589|NCT01998958|523722363|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239590|NCT01998958|523722364|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
145239591|NCT01998958|523722365|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239592|NCT01998958|523722366|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239593|NCT01998958|523722367|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239594|NCT01998958|523722368|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239595|NCT01998958|523722369|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239596|NCT01998958|523722370|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239597|NCT01998958|523722371|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239598|NCT01998958|523722372|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239599|NCT01998958|523722373|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239600|NCT01998958|523722374|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239601|NCT01998958|523722375|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239602|NCT01998958|523722376|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239603|NCT01998958|523722377|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
145239604|NCT01998958|523722346|FG000|Open Label Phase (Optional)|Adverse Event|0|||
145239605|NCT01998958|523722347|FG001|Open Label Phase (Optional)|Adverse Event|0|||
145239606|NCT01998958|523722348|FG002|Open Label Phase (Optional)|Adverse Event|0|||
145239607|NCT01998958|523722349|FG003|Open Label Phase (Optional)|Adverse Event|0|||
145239608|NCT01998958|523722350|FG004|Open Label Phase (Optional)|Adverse Event|0|||
145239609|NCT01998958|523722351|FG005|Open Label Phase (Optional)|Adverse Event|0|||
145239610|NCT01998958|523722352|FG006|Open Label Phase (Optional)|Adverse Event|0|||
145239611|NCT01998958|523722353|FG007|Open Label Phase (Optional)|Adverse Event|0|||
145239612|NCT01998958|523722354|FG008|Open Label Phase (Optional)|Adverse Event|0|||
145239613|NCT01998958|523722355|FG009|Open Label Phase (Optional)|Adverse Event|0|||
145239614|NCT01998958|523722356|FG010|Open Label Phase (Optional)|Adverse Event|0|||
145239615|NCT01998958|523722357|FG011|Open Label Phase (Optional)|Adverse Event|0|||
145239616|NCT01998958|523722358|FG012|Open Label Phase (Optional)|Adverse Event|0|||
145239617|NCT01998958|523722359|FG013|Open Label Phase (Optional)|Adverse Event|0|||
145239618|NCT01998958|523722360|FG014|Open Label Phase (Optional)|Adverse Event|0|||
145239619|NCT01998958|523722361|FG015|Open Label Phase (Optional)|Adverse Event|0|||
145239620|NCT01998958|523722362|FG016|Open Label Phase (Optional)|Adverse Event|0|||
145239621|NCT01998958|523722363|FG017|Open Label Phase (Optional)|Adverse Event|0|||
145239622|NCT01998958|523722364|FG018|Open Label Phase (Optional)|Adverse Event|0|||
145239623|NCT01998958|523722365|FG019|Open Label Phase (Optional)|Adverse Event|0|||
145239624|NCT01998958|523722366|FG020|Open Label Phase (Optional)|Adverse Event|0|||
145239625|NCT01998958|523722367|FG021|Open Label Phase (Optional)|Adverse Event|0|||
145239626|NCT01998958|523722368|FG022|Open Label Phase (Optional)|Adverse Event|0|||
145239627|NCT01998958|523722369|FG023|Open Label Phase (Optional)|Adverse Event|1|||
145239628|NCT01998958|523722370|FG024|Open Label Phase (Optional)|Adverse Event|0|||
145239629|NCT01998958|523722371|FG025|Open Label Phase (Optional)|Adverse Event|0|||
145239630|NCT01998958|523722372|FG026|Open Label Phase (Optional)|Adverse Event|0|||
145296105|NCT01126736|523934419|FG001|Overall Study|Lost to Follow-up|0|||
145563537|NCT02658890|524924015|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
145563538|NCT02658890|524924016|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
145563539|NCT02658890|524924017|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
145239631|NCT01998958|523722373|FG027|Open Label Phase (Optional)|Adverse Event|0|||
145239632|NCT01998958|523722374|FG028|Open Label Phase (Optional)|Adverse Event|0|||
145239633|NCT01998958|523722375|FG029|Open Label Phase (Optional)|Adverse Event|0|||
145239634|NCT01998958|523722376|FG030|Open Label Phase (Optional)|Adverse Event|0|||
145239635|NCT01998958|523722377|FG031|Open Label Phase (Optional)|Adverse Event|0|||
145239636|NCT01998958|523722346|FG000|Open Label Phase (Optional)|Other|0|||
145239637|NCT01998958|523722347|FG001|Open Label Phase (Optional)|Other|0|||
145239638|NCT01998958|523722348|FG002|Open Label Phase (Optional)|Other|0|||
145239639|NCT01998958|523722349|FG003|Open Label Phase (Optional)|Other|0|||
145239640|NCT01998958|523722350|FG004|Open Label Phase (Optional)|Other|0|||
145239641|NCT01998958|523722351|FG005|Open Label Phase (Optional)|Other|0|||
145239642|NCT01998958|523722352|FG006|Open Label Phase (Optional)|Other|0|||
145239643|NCT01998958|523722353|FG007|Open Label Phase (Optional)|Other|0|||
145239644|NCT01998958|523722354|FG008|Open Label Phase (Optional)|Other|0|||
145239645|NCT01998958|523722355|FG009|Open Label Phase (Optional)|Other|0|||
145239646|NCT01998958|523722356|FG010|Open Label Phase (Optional)|Other|0|||
145239647|NCT01998958|523722357|FG011|Open Label Phase (Optional)|Other|0|||
145239648|NCT01998958|523722358|FG012|Open Label Phase (Optional)|Other|0|||
145239649|NCT01998958|523722359|FG013|Open Label Phase (Optional)|Other|0|||
145239650|NCT01998958|523722360|FG014|Open Label Phase (Optional)|Other|0|||
145239651|NCT01998958|523722361|FG015|Open Label Phase (Optional)|Other|0|||
145239652|NCT01998958|523722362|FG016|Open Label Phase (Optional)|Other|0|||
145239653|NCT01998958|523722363|FG017|Open Label Phase (Optional)|Other|0|||
145239654|NCT01998958|523722364|FG018|Open Label Phase (Optional)|Other|0|||
145239655|NCT01998958|523722365|FG019|Open Label Phase (Optional)|Other|0|||
145239656|NCT01998958|523722366|FG020|Open Label Phase (Optional)|Other|0|||
145239657|NCT01998958|523722367|FG021|Open Label Phase (Optional)|Other|0|||
145239658|NCT01998958|523722368|FG022|Open Label Phase (Optional)|Other|5|||
145239659|NCT01998958|523722369|FG023|Open Label Phase (Optional)|Other|1|||
145239660|NCT01998958|523722370|FG024|Open Label Phase (Optional)|Other|0|||
145239661|NCT01998958|523722371|FG025|Open Label Phase (Optional)|Other|0|||
145239662|NCT01998958|523722372|FG026|Open Label Phase (Optional)|Other|0|||
145239663|NCT01998958|523722373|FG027|Open Label Phase (Optional)|Other|0|||
145239664|NCT01998958|523722374|FG028|Open Label Phase (Optional)|Other|0|||
145239665|NCT01998958|523722375|FG029|Open Label Phase (Optional)|Other|0|||
145239666|NCT01998958|523722376|FG030|Open Label Phase (Optional)|Other|0|||
145239667|NCT01998958|523722377|FG031|Open Label Phase (Optional)|Other|0|||
145563540|NCT02658890|524924018|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
145563541|NCT02658890|524924019|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
145563542|NCT02658890|524924020|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
145563543|NCT02658890|524924021|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
145563544|NCT02658890|524924022|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
145563545|NCT02658890|524924023|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
145563546|NCT02658890|524924024|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
145563547|NCT02658890|524924025|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
145563548|NCT02658890|524924026|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
145563549|NCT02658890|524924027|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
145563550|NCT02658890|524924028|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
145563551|NCT02658890|524924029|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
145563552|NCT02658890|524924030|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
145563553|NCT02658890|524924004|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
145563554|NCT02658890|524924005|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
145563555|NCT02658890|524924006|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
145563556|NCT02658890|524924007|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
145563557|NCT02658890|524924008|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
145563558|NCT02658890|524924009|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
145563559|NCT02658890|524924010|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
145563560|NCT02658890|524924011|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
145563561|NCT02658890|524924012|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
145563562|NCT02658890|524924013|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
145239668|NCT01998958|523722346|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239669|NCT01998958|523722347|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
145563563|NCT02658890|524924014|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
145563564|NCT02658890|524924015|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
145563565|NCT02658890|524924016|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
145563566|NCT02658890|524924017|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
145239670|NCT01998958|523722348|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239671|NCT01998958|523722349|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239672|NCT01998958|523722350|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239673|NCT01998958|523722351|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239674|NCT01998958|523722352|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239675|NCT01998958|523722353|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239676|NCT01998958|523722354|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239677|NCT01998958|523722355|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239678|NCT01998958|523722356|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
145296106|NCT01126736|523934420|FG002|Overall Study|Lost to Follow-up|0|||
145239679|NCT01998958|523722357|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239680|NCT01998958|523722358|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239681|NCT01998958|523722359|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
145563567|NCT02658890|524924018|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
145563568|NCT02658890|524924019|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
145563569|NCT02658890|524924020|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
145563570|NCT02658890|524924021|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
145239682|NCT01998958|523722360|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239683|NCT01998958|523722361|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239684|NCT01998958|523722362|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239685|NCT01998958|523722363|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239686|NCT01998958|523722364|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239687|NCT01998958|523722365|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239688|NCT01998958|523722366|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239689|NCT01998958|523722367|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239690|NCT01998958|523722368|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
145239691|NCT01998958|523722369|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239692|NCT01998958|523722370|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239693|NCT01998958|523722371|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239694|NCT01998958|523722372|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239695|NCT01998958|523722373|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239696|NCT01998958|523722374|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239697|NCT01998958|523722375|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239698|NCT01998958|523722376|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239699|NCT01998958|523722377|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
145239700|NCT01998958|523722346|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239701|NCT01998958|523722347|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239702|NCT01998958|523722348|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239703|NCT01998958|523722349|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239704|NCT01998958|523722350|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239705|NCT01998958|523722351|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239706|NCT01998958|523722352|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239707|NCT01998958|523722353|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239708|NCT01998958|523722354|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239709|NCT01998958|523722355|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239710|NCT01998958|523722356|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239711|NCT01998958|523722357|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239712|NCT01998958|523722358|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239713|NCT01998958|523722359|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239714|NCT01998958|523722360|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239715|NCT01998958|523722361|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239716|NCT01998958|523722362|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239717|NCT01998958|523722363|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239718|NCT01998958|523722364|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239719|NCT01998958|523722365|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239720|NCT01998958|523722366|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239721|NCT01998958|523722367|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
145239722|NCT01998958|523722368|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
145239723|NCT01998958|523722369|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239724|NCT01998958|523722370|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239725|NCT01998958|523722371|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239726|NCT01998958|523722372|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239727|NCT01998958|523722373|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239728|NCT01998958|523722374|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239729|NCT01998958|523722375|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239730|NCT01998958|523722376|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
145563571|NCT02658890|524924022|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
145563572|NCT02658890|524924023|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
145563573|NCT02658890|524924024|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
145563574|NCT02658890|524924025|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
145239731|NCT01998958|523722377|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
145239732|NCT01998958|523722346|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239733|NCT01998958|523722347|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239734|NCT01998958|523722348|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239735|NCT01998958|523722349|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239736|NCT01998958|523722350|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239737|NCT01998958|523722351|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239738|NCT01998958|523722352|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239739|NCT01998958|523722353|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239740|NCT01998958|523722354|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145563575|NCT02658890|524924026|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
145563576|NCT02658890|524924027|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
145563577|NCT02658890|524924028|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
145563578|NCT02658890|524924029|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
145563579|NCT02658890|524924030|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
145563580|NCT02658890|524924004|FG000|Treatment Phase|Other Reasons|0|||
145563581|NCT02658890|524924005|FG001|Treatment Phase|Other Reasons|0|||
145563582|NCT02658890|524924006|FG002|Treatment Phase|Other Reasons|0|||
145563583|NCT02658890|524924007|FG003|Treatment Phase|Other Reasons|0|||
145563584|NCT02658890|524924008|FG004|Treatment Phase|Other Reasons|0|||
145563585|NCT02658890|524924009|FG005|Treatment Phase|Other Reasons|0|||
145563586|NCT02658890|524924010|FG006|Treatment Phase|Other Reasons|1|||
145563587|NCT02658890|524924011|FG007|Treatment Phase|Other Reasons|0|||
145563588|NCT02658890|524924012|FG008|Treatment Phase|Other Reasons|1|||
145563589|NCT02658890|524924013|FG009|Treatment Phase|Other Reasons|0|||
145563590|NCT02658890|524924014|FG010|Treatment Phase|Other Reasons|0|||
145563591|NCT02658890|524924015|FG011|Treatment Phase|Other Reasons|0|||
145563592|NCT02658890|524924016|FG012|Treatment Phase|Other Reasons|0|||
145563593|NCT02658890|524924017|FG013|Treatment Phase|Other Reasons|2|||
145563594|NCT02658890|524924018|FG014|Treatment Phase|Other Reasons|0|||
145563595|NCT02658890|524924019|FG015|Treatment Phase|Other Reasons|0|||
145563596|NCT02658890|524924020|FG016|Treatment Phase|Other Reasons|0|||
145563597|NCT02658890|524924021|FG017|Treatment Phase|Other Reasons|0|||
145563598|NCT02658890|524924022|FG018|Treatment Phase|Other Reasons|1|||
145563599|NCT02658890|524924023|FG019|Treatment Phase|Other Reasons|0|||
145563600|NCT02658890|524924024|FG020|Treatment Phase|Other Reasons|0|||
145563601|NCT02658890|524924025|FG021|Treatment Phase|Other Reasons|0|||
145239741|NCT01998958|523722355|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239742|NCT01998958|523722356|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239743|NCT01998958|523722357|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239744|NCT01998958|523722358|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239745|NCT01998958|523722359|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239746|NCT01998958|523722360|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239747|NCT01998958|523722361|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239748|NCT01998958|523722362|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239749|NCT01998958|523722363|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239750|NCT01998958|523722364|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239751|NCT01998958|523722365|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239752|NCT01998958|523722366|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239753|NCT01998958|523722367|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
145239754|NCT01998958|523722368|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
145239755|NCT01998958|523722369|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
145239756|NCT01998958|523722370|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239757|NCT01998958|523722371|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239758|NCT01998958|523722372|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239759|NCT01998958|523722373|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239760|NCT01998958|523722374|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239761|NCT01998958|523722375|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239762|NCT01998958|523722376|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239763|NCT01998958|523722377|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
145239764|NCT01628393|523722378|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
145239765|NCT01628393|523722379|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145239766|NCT01628393|523722380|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145239767|NCT01628393|523722381|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145239768|NCT01628393|523722382|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
145239769|NCT01628393|523722378|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
145239770|NCT01628393|523722379|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
145239771|NCT01628393|523722380|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
145239772|NCT01628393|523722381|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
145239773|NCT01628393|523722382|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
145239774|NCT01628393|523722378|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
145239775|NCT01628393|523722379|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
145239776|NCT01628393|523722380|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
145239777|NCT01628393|523722381|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
145239778|NCT01628393|523722382|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
145239779|NCT01628393|523722378|FG000|Blinded Active Extension Period|Adverse Event|0|||
145296107|NCT01126736|523934421|FG003|Overall Study|Lost to Follow-up|1|||
145563602|NCT02658890|524924026|FG022|Treatment Phase|Other Reasons|0|||
145563603|NCT02658890|524924027|FG023|Treatment Phase|Other Reasons|0|||
145563604|NCT02658890|524924028|FG024|Treatment Phase|Other Reasons|1|||
145563605|NCT02658890|524924029|FG025|Treatment Phase|Other Reasons|0|||
145563606|NCT02658890|524924030|FG026|Treatment Phase|Other Reasons|1|||
145563607|NCT02658890|524924004|FG000|Treatment Phase|Progressive Disease|6|||
145239780|NCT01628393|523722379|FG001|Blinded Active Extension Period|Adverse Event|1|||
145239781|NCT01628393|523722380|FG002|Blinded Active Extension Period|Adverse Event|0|||
145239782|NCT01628393|523722381|FG003|Blinded Active Extension Period|Adverse Event|2|||
145239783|NCT01628393|523722382|FG004|Blinded Active Extension Period|Adverse Event|2|||
145239784|NCT01628393|523722378|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
145239785|NCT01628393|523722379|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
145239786|NCT01628393|523722380|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
145239787|NCT01628393|523722381|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
145239788|NCT01628393|523722382|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
145239789|NCT01628393|523722378|FG000|Blinded Active Extension Period|Physician Decision|0|||
145239790|NCT01628393|523722379|FG001|Blinded Active Extension Period|Physician Decision|3|||
145239791|NCT01628393|523722380|FG002|Blinded Active Extension Period|Physician Decision|0|||
145239792|NCT01628393|523722381|FG003|Blinded Active Extension Period|Physician Decision|1|||
145239793|NCT01628393|523722382|FG004|Blinded Active Extension Period|Physician Decision|0|||
145239794|NCT01628393|523722378|FG000|Blinded Active Extension Period|Protocol Violation|0|||
145239795|NCT01628393|523722379|FG001|Blinded Active Extension Period|Protocol Violation|0|||
145239796|NCT01628393|523722380|FG002|Blinded Active Extension Period|Protocol Violation|2|||
145239797|NCT01628393|523722381|FG003|Blinded Active Extension Period|Protocol Violation|1|||
145239798|NCT01628393|523722382|FG004|Blinded Active Extension Period|Protocol Violation|0|||
145239799|NCT01628393|523722378|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
145239800|NCT01628393|523722379|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
145239801|NCT01628393|523722380|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
145239802|NCT01628393|523722381|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
145239803|NCT01628393|523722382|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
145239804|NCT00561340|523722383|FG000|Overall Study|refused to drink pediasure|6|||
145239805|NCT00561340|523722384|FG001|Overall Study|refused to drink pediasure|0|||
145239806|NCT01989754|523722385|FG000|Overall Study|Withdrawal by Subject|10|||
145239807|NCT01989754|523722386|FG001|Overall Study|Withdrawal by Subject|14|||
145239808|NCT01989754|523722385|FG000|Overall Study|Lost to Follow-up|28|||
145239809|NCT01989754|523722386|FG001|Overall Study|Lost to Follow-up|20|||
145239810|NCT01989754|523722385|FG000|Overall Study|Closed Site|1|||
145239811|NCT01989754|523722386|FG001|Overall Study|Closed Site|1|||
145239812|NCT01369225|523722389|FG000|Overall Study|Withdrawal by Subject|1|||
145239813|NCT01369225|523722390|FG001|Overall Study|Withdrawal by Subject|0|||
145239814|NCT01369225|523722391|FG002|Overall Study|Withdrawal by Subject|2|||
145239815|NCT01369225|523722392|FG003|Overall Study|Withdrawal by Subject|1|||
145239816|NCT01369225|523722393|FG004|Overall Study|Withdrawal by Subject|0|||
145239817|NCT01369225|523722394|FG005|Overall Study|Withdrawal by Subject|0|||
145239818|NCT01369225|523722389|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
145239819|NCT01369225|523722390|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
145239820|NCT01369225|523722391|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
145239821|NCT01369225|523722392|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
145239822|NCT01369225|523722393|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
145239823|NCT01369225|523722394|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
145239824|NCT01369225|523722389|FG000|Overall Study|Other|1|||
145239825|NCT01369225|523722390|FG001|Overall Study|Other|0|||
145239826|NCT01369225|523722391|FG002|Overall Study|Other|0|||
145239827|NCT01369225|523722392|FG003|Overall Study|Other|0|||
145239828|NCT01369225|523722393|FG004|Overall Study|Other|1|||
145296108|NCT01126736|523934422|FG004|Overall Study|Lost to Follow-up|1|||
145296109|NCT01126736|523934418|FG000|Overall Study|Administrative reasons|0|||
145296110|NCT01126736|523934419|FG001|Overall Study|Administrative reasons|0|||
145296111|NCT01126736|523934420|FG002|Overall Study|Administrative reasons|0|||
145296112|NCT01126736|523934421|FG003|Overall Study|Administrative reasons|0|||
145296113|NCT01126736|523934422|FG004|Overall Study|Administrative reasons|1|||
145296114|NCT01126736|523934418|FG000|Overall Study|Progressive disease|0|||
145296115|NCT01126736|523934419|FG001|Overall Study|Progressive disease|0|||
145296116|NCT01126736|523934420|FG002|Overall Study|Progressive disease|0|||
145296117|NCT01126736|523934421|FG003|Overall Study|Progressive disease|2|||
145296118|NCT01126736|523934422|FG004|Overall Study|Progressive disease|1|||
145296119|NCT01126736|523934418|FG000|Overall Study|Withdrawal by Subject|0|||
145296120|NCT01126736|523934419|FG001|Overall Study|Withdrawal by Subject|0|||
145296121|NCT01126736|523934420|FG002|Overall Study|Withdrawal by Subject|0|||
145296122|NCT01126736|523934421|FG003|Overall Study|Withdrawal by Subject|1|||
145239829|NCT01369225|523722394|FG005|Overall Study|Other|0|||
145239830|NCT01369225|523722389|FG000|Overall Study|Adverse Event|0|||
145239831|NCT01369225|523722390|FG001|Overall Study|Adverse Event|0|||
145239832|NCT01369225|523722391|FG002|Overall Study|Adverse Event|0|||
145296123|NCT01126736|523934422|FG004|Overall Study|Withdrawal by Subject|1|||
145239833|NCT01369225|523722392|FG003|Overall Study|Adverse Event|1|||
145239834|NCT01369225|523722393|FG004|Overall Study|Adverse Event|1|||
145296124|NCT01126736|523934418|FG000|Overall Study|Other|2|||
145296125|NCT01126736|523934419|FG001|Overall Study|Other|4|||
145296126|NCT01126736|523934420|FG002|Overall Study|Other|4|||
145296127|NCT01126736|523934421|FG003|Overall Study|Other|16|||
145563608|NCT02658890|524924005|FG001|Treatment Phase|Progressive Disease|7|||
145563609|NCT02658890|524924006|FG002|Treatment Phase|Progressive Disease|6|||
145563610|NCT02658890|524924007|FG003|Treatment Phase|Progressive Disease|12|||
145563611|NCT02658890|524924008|FG004|Treatment Phase|Progressive Disease|6|||
145563612|NCT02658890|524924009|FG005|Treatment Phase|Progressive Disease|18|||
145563613|NCT02658890|524924010|FG006|Treatment Phase|Progressive Disease|12|||
145563614|NCT02658890|524924011|FG007|Treatment Phase|Progressive Disease|19|||
145239835|NCT01369225|523722394|FG005|Overall Study|Adverse Event|0|||
145239836|NCT00105183|523722398|FG000|Overall Study|Death|19|||
145239837|NCT00105183|523722399|FG001|Overall Study|Death|13|||
145239838|NCT00105183|523722400|FG002|Overall Study|Death|15|||
145239839|NCT00105183|523722398|FG000|Overall Study|Withdrawal by Subject|1|||
145239840|NCT00105183|523722399|FG001|Overall Study|Withdrawal by Subject|1|||
145239841|NCT00105183|523722400|FG002|Overall Study|Withdrawal by Subject|4|||
145239842|NCT00105183|523722398|FG000|Overall Study|Physician Decision|1|||
145239843|NCT00105183|523722399|FG001|Overall Study|Physician Decision|2|||
145239844|NCT00105183|523722400|FG002|Overall Study|Physician Decision|3|||
145239845|NCT00105183|523722398|FG000|Overall Study|Lost to Follow-up|0|||
145239846|NCT00105183|523722399|FG001|Overall Study|Lost to Follow-up|1|||
145239847|NCT00105183|523722400|FG002|Overall Study|Lost to Follow-up|1|||
145239848|NCT00105183|523722398|FG000|Overall Study|Other reason|1|||
145239849|NCT00105183|523722399|FG001|Overall Study|Other reason|2|||
145239850|NCT00105183|523722400|FG002|Overall Study|Other reason|0|||
145239851|NCT01467661|523722402|FG000|Overall Study|Adverse Event|16|||
145239852|NCT01467661|523722402|FG000|Overall Study|Withdrawal by Subject|1|||
145239853|NCT01467661|523722402|FG000|Overall Study|Lack of Efficacy|3|||
145239854|NCT01467661|523722402|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
145239855|NCT03037307|523722403|FG000|Period 1|Did Not Meet Study Criteria|0|||
145239856|NCT03037307|523722404|FG001|Period 1|Did Not Meet Study Criteria|0|||
145239857|NCT03037307|523722405|FG002|Period 1|Did Not Meet Study Criteria|0|||
145239858|NCT03037307|523722406|FG003|Period 1|Did Not Meet Study Criteria|1|||
145239859|NCT03037307|523722407|FG004|Period 1|Did Not Meet Study Criteria|0|||
145239860|NCT03037307|523722408|FG005|Period 1|Did Not Meet Study Criteria|0|||
145239861|NCT01855945|523722411|FG000|Overall Study|Adverse Event|0|||
145239862|NCT01855945|523722412|FG001|Overall Study|Adverse Event|0|||
145239863|NCT01855945|523722413|FG002|Overall Study|Adverse Event|0|||
145239864|NCT01855945|523722414|FG003|Overall Study|Adverse Event|0|||
145239865|NCT01855945|523722415|FG004|Overall Study|Adverse Event|0|||
145239866|NCT01855945|523722416|FG005|Overall Study|Adverse Event|0|||
145239867|NCT01855945|523722417|FG006|Overall Study|Adverse Event|1|||
145239868|NCT01855945|523722418|FG007|Overall Study|Adverse Event|0|||
145239869|NCT01855945|523722419|FG008|Overall Study|Adverse Event|0|||
145239870|NCT01855945|523722420|FG009|Overall Study|Adverse Event|0|||
145239871|NCT01855945|523722421|FG010|Overall Study|Adverse Event|0|||
145239872|NCT01855945|523722422|FG011|Overall Study|Adverse Event|0|||
145239873|NCT01855945|523722411|FG000|Overall Study|Death|0|||
145239874|NCT01855945|523722412|FG001|Overall Study|Death|0|||
145239875|NCT01855945|523722413|FG002|Overall Study|Death|0|||
145239876|NCT01855945|523722414|FG003|Overall Study|Death|0|||
145239877|NCT01855945|523722415|FG004|Overall Study|Death|0|||
145239878|NCT01855945|523722416|FG005|Overall Study|Death|0|||
145239879|NCT01855945|523722417|FG006|Overall Study|Death|2|||
145239880|NCT01855945|523722418|FG007|Overall Study|Death|0|||
145239881|NCT01855945|523722419|FG008|Overall Study|Death|0|||
145239882|NCT01855945|523722420|FG009|Overall Study|Death|0|||
145239883|NCT01855945|523722421|FG010|Overall Study|Death|0|||
145239884|NCT01855945|523722422|FG011|Overall Study|Death|0|||
145239885|NCT01855945|523722411|FG000|Overall Study|Lost to Follow-up|11|||
145239886|NCT01855945|523722412|FG001|Overall Study|Lost to Follow-up|10|||
145239887|NCT01855945|523722413|FG002|Overall Study|Lost to Follow-up|7|||
145239888|NCT01855945|523722414|FG003|Overall Study|Lost to Follow-up|3|||
145239889|NCT01855945|523722415|FG004|Overall Study|Lost to Follow-up|0|||
145239890|NCT01855945|523722416|FG005|Overall Study|Lost to Follow-up|3|||
145563615|NCT02658890|524924012|FG008|Treatment Phase|Progressive Disease|26|||
145239891|NCT01855945|523722417|FG006|Overall Study|Lost to Follow-up|4|||
145239892|NCT01855945|523722418|FG007|Overall Study|Lost to Follow-up|7|||
145239893|NCT01855945|523722419|FG008|Overall Study|Lost to Follow-up|2|||
145239894|NCT01855945|523722420|FG009|Overall Study|Lost to Follow-up|0|||
145239895|NCT01855945|523722421|FG010|Overall Study|Lost to Follow-up|0|||
145239896|NCT01855945|523722422|FG011|Overall Study|Lost to Follow-up|2|||
145239897|NCT01855945|523722411|FG000|Overall Study|Other - Unclassified|1|||
145239898|NCT01855945|523722412|FG001|Overall Study|Other - Unclassified|1|||
145239899|NCT01855945|523722413|FG002|Overall Study|Other - Unclassified|1|||
145296128|NCT01126736|523934422|FG004|Overall Study|Other|15|||
145296129|NCT01720264|523934428|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
145239900|NCT01855945|523722414|FG003|Overall Study|Other - Unclassified|0|||
145239901|NCT01855945|523722415|FG004|Overall Study|Other - Unclassified|0|||
145239902|NCT01855945|523722416|FG005|Overall Study|Other - Unclassified|0|||
145563616|NCT02658890|524924013|FG009|Treatment Phase|Progressive Disease|8|||
145239903|NCT01855945|523722417|FG006|Overall Study|Other - Unclassified|2|||
145239904|NCT01855945|523722418|FG007|Overall Study|Other - Unclassified|1|||
145239905|NCT01855945|523722419|FG008|Overall Study|Other - Unclassified|0|||
145239906|NCT01855945|523722420|FG009|Overall Study|Other - Unclassified|0|||
145239907|NCT01855945|523722421|FG010|Overall Study|Other - Unclassified|1|||
145239908|NCT01855945|523722422|FG011|Overall Study|Other - Unclassified|0|||
145239909|NCT01855945|523722411|FG000|Overall Study|Withdrawal by Subject|4|||
145239910|NCT01855945|523722412|FG001|Overall Study|Withdrawal by Subject|0|||
145239911|NCT01855945|523722413|FG002|Overall Study|Withdrawal by Subject|4|||
145239912|NCT01855945|523722414|FG003|Overall Study|Withdrawal by Subject|1|||
145239913|NCT01855945|523722415|FG004|Overall Study|Withdrawal by Subject|1|||
145239914|NCT01855945|523722416|FG005|Overall Study|Withdrawal by Subject|0|||
145239915|NCT01855945|523722417|FG006|Overall Study|Withdrawal by Subject|1|||
145239916|NCT01855945|523722418|FG007|Overall Study|Withdrawal by Subject|0|||
145239917|NCT01855945|523722419|FG008|Overall Study|Withdrawal by Subject|0|||
145408851|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
145239918|NCT01855945|523722420|FG009|Overall Study|Withdrawal by Subject|2|||
145239919|NCT01855945|523722421|FG010|Overall Study|Withdrawal by Subject|4|||
145239920|NCT01855945|523722422|FG011|Overall Study|Withdrawal by Subject|1|||
145239921|NCT02156804|523722423|FG000|Overall Study|Withdrawal by Subject|1|||
145239922|NCT00389441|523722426|FG000|Overall Study|Adverse Event|7|||
145239923|NCT00389441|523722426|FG000|Overall Study|Death|4|||
145239924|NCT00389441|523722426|FG000|Overall Study|Lost to Follow-up|2|||
145239925|NCT00389441|523722426|FG000|Overall Study|Withdrawal by Subject|4|||
145239926|NCT00389441|523722426|FG000|Overall Study|Physician Decision|1|||
145239927|NCT00389441|523722426|FG000|Overall Study|Protocol Violation|1|||
145239928|NCT00389441|523722426|FG000|Overall Study|Global deterioration of health status|4|||
145239929|NCT00389441|523722426|FG000|Overall Study|Objective progression or relapse|26|||
145239930|NCT00389441|523722426|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
145239931|NCT00389441|523722426|FG000|Overall Study|Clinical progression|1|||
145239932|NCT02260388|523722427|FG000|Overall Study|Lost to Follow-up|2|||
145239933|NCT02260388|523722428|FG001|Overall Study|Lost to Follow-up|8|||
145239934|NCT02260388|523722429|FG002|Overall Study|Lost to Follow-up|3|||
145239935|NCT02260388|523722430|FG003|Overall Study|Lost to Follow-up|4|||
145239936|NCT00636441|523722432|FG000|Overall Study|Adverse Event|0|||
145239937|NCT00636441|523722433|FG001|Overall Study|Adverse Event|1|||
145239938|NCT00636441|523722434|FG002|Overall Study|Adverse Event|1|||
145239939|NCT00636441|523722435|FG003|Overall Study|Adverse Event|0|||
145239940|NCT00636441|523722436|FG004|Overall Study|Adverse Event|0|||
145239941|NCT00636441|523722437|FG005|Overall Study|Adverse Event|1|||
145239942|NCT00636441|523722438|FG006|Overall Study|Adverse Event|0|||
145239943|NCT00636441|523722432|FG000|Overall Study|Late, ineligible|0|||
145239944|NCT00636441|523722433|FG001|Overall Study|Late, ineligible|0|||
145239945|NCT00636441|523722434|FG002|Overall Study|Late, ineligible|0|||
145239946|NCT00636441|523722435|FG003|Overall Study|Late, ineligible|0|||
145239947|NCT00636441|523722436|FG004|Overall Study|Late, ineligible|0|||
145239948|NCT00636441|523722437|FG005|Overall Study|Late, ineligible|0|||
145239949|NCT00636441|523722438|FG006|Overall Study|Late, ineligible|1|||
145239950|NCT00636441|523722432|FG000|Overall Study|Screen Failure|0|||
145239951|NCT00636441|523722433|FG001|Overall Study|Screen Failure|0|||
145239952|NCT00636441|523722434|FG002|Overall Study|Screen Failure|0|||
145239953|NCT00636441|523722435|FG003|Overall Study|Screen Failure|0|||
145239954|NCT00636441|523722436|FG004|Overall Study|Screen Failure|0|||
145239955|NCT00636441|523722437|FG005|Overall Study|Screen Failure|0|||
145239956|NCT00636441|523722438|FG006|Overall Study|Screen Failure|17|||
145239957|NCT00305604|523722439|FG000|Overall Study|Adverse Event|6|||
145239958|NCT00305604|523722440|FG001|Overall Study|Adverse Event|3|||
145239959|NCT00305604|523722439|FG000|Overall Study|Lack of Efficacy|11|||
145239960|NCT00305604|523722440|FG001|Overall Study|Lack of Efficacy|18|||
145239961|NCT00305604|523722439|FG000|Overall Study|Lost to Follow-up|0|||
145239962|NCT00305604|523722440|FG001|Overall Study|Lost to Follow-up|4|||
145239963|NCT00305604|523722439|FG000|Overall Study|Protocol Violation|2|||
145239964|NCT00305604|523722440|FG001|Overall Study|Protocol Violation|1|||
145239965|NCT00305604|523722439|FG000|Overall Study|Withdrawal by Subject|12|||
145239966|NCT00305604|523722440|FG001|Overall Study|Withdrawal by Subject|21|||
145239967|NCT00305604|523722439|FG000|Overall Study|Patient moved|1|||
145239968|NCT00305604|523722440|FG001|Overall Study|Patient moved|0|||
145239969|NCT00753623|523722442|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
145239970|NCT00753623|523722443|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
145239971|NCT00753623|523722442|FG000|Phase I (14 Days)|Physician Decision|1|||
145563617|NCT02658890|524924014|FG010|Treatment Phase|Progressive Disease|7|||
145239972|NCT00753623|523722443|FG001|Phase I (14 Days)|Physician Decision|2|||
145239973|NCT00753623|523722442|FG000|Phase I (14 Days)|Adverse Event|0|||
145239974|NCT00753623|523722443|FG001|Phase I (14 Days)|Adverse Event|1|||
145239975|NCT00753623|523722442|FG000|Washout (7 Days)|Physician Decision|1|||
145239976|NCT00753623|523722443|FG001|Washout (7 Days)|Physician Decision|0|||
145239977|NCT00753623|523722442|FG000|Phase II (14 Days)|Physician Decision|0|||
145239978|NCT00753623|523722443|FG001|Phase II (14 Days)|Physician Decision|1|||
145239979|NCT03332303|523722444|FG000|Overall Study|Participant did not dose|1|||
145239980|NCT03332303|523722445|FG001|Overall Study|Participant did not dose|2|||
145239981|NCT03332303|523722446|FG002|Overall Study|Participant did not dose|0|||
145239982|NCT03332303|523722444|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
145239983|NCT03332303|523722445|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
145239984|NCT03332303|523722446|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
145239985|NCT03332303|523722444|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
145239986|NCT03332303|523722445|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
145239987|NCT03332303|523722446|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
145239988|NCT03332303|523722444|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
145239989|NCT03332303|523722445|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
145239990|NCT03332303|523722446|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
145239991|NCT03332303|523722444|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
145239992|NCT03332303|523722445|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
145239993|NCT03332303|523722446|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
145239994|NCT03332303|523722444|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
145239995|NCT03332303|523722445|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
145239996|NCT03332303|523722446|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
145239997|NCT03332303|523722444|FG000|Overall Study|Participant had a significant protocol deviation|0|||
145239998|NCT03332303|523722445|FG001|Overall Study|Participant had a significant protocol deviation|1|||
145239999|NCT03332303|523722446|FG002|Overall Study|Participant had a significant protocol deviation|0|||
145240000|NCT00326417|523722448|FG000|Overall Study|Withdrawal by Subject|0|||
145240001|NCT00326417|523722449|FG001|Overall Study|Withdrawal by Subject|0|||
145240002|NCT00326417|523722450|FG002|Overall Study|Withdrawal by Subject|1|||
145240003|NCT00326417|523722451|FG003|Overall Study|Withdrawal by Subject|0|||
145240004|NCT00326417|523722448|FG000|Overall Study|Arm Closed|7|||
145240005|NCT00326417|523722449|FG001|Overall Study|Arm Closed|0|||
145240006|NCT00326417|523722450|FG002|Overall Study|Arm Closed|0|||
145240007|NCT00326417|523722451|FG003|Overall Study|Arm Closed|3|||
145240008|NCT00326417|523722448|FG000|Overall Study|Death|7|||
145240009|NCT00326417|523722449|FG001|Overall Study|Death|0|||
145240010|NCT00326417|523722450|FG002|Overall Study|Death|0|||
145240011|NCT00326417|523722451|FG003|Overall Study|Death|0|||
145240012|NCT00844285|523722452|FG000|Overall Study|Other|0|||
145240013|NCT00844285|523722453|FG001|Overall Study|Other|1|||
145240014|NCT00844285|523722454|FG002|Overall Study|Other|0|||
145240015|NCT00844285|523722452|FG000|Overall Study|Other than specified|95|||
145240016|NCT00844285|523722453|FG001|Overall Study|Other than specified|129|||
145240017|NCT00844285|523722454|FG002|Overall Study|Other than specified|12|||
145240018|NCT00844285|523722452|FG000|Overall Study|Site closure|256|||
145240019|NCT00844285|523722453|FG001|Overall Study|Site closure|450|||
145240020|NCT00844285|523722454|FG002|Overall Study|Site closure|50|||
145240021|NCT00844285|523722452|FG000|Overall Study|Follow-up < 8 years|16|||
145240022|NCT00844285|523722453|FG001|Overall Study|Follow-up < 8 years|23|||
145240023|NCT00844285|523722454|FG002|Overall Study|Follow-up < 8 years|4|||
145240024|NCT00844285|523722452|FG000|Overall Study|Protocol Violation|26|||
145240025|NCT00844285|523722453|FG001|Overall Study|Protocol Violation|28|||
145240026|NCT00844285|523722454|FG002|Overall Study|Protocol Violation|54|||
145240027|NCT00844285|523722452|FG000|Overall Study|Death|22|||
145240028|NCT00844285|523722453|FG001|Overall Study|Death|21|||
145240029|NCT00844285|523722454|FG002|Overall Study|Death|8|||
145240030|NCT00844285|523722452|FG000|Overall Study|Withdrew Consent|344|||
145240031|NCT00844285|523722453|FG001|Overall Study|Withdrew Consent|466|||
145240032|NCT00844285|523722454|FG002|Overall Study|Withdrew Consent|70|||
145240033|NCT00844285|523722452|FG000|Overall Study|Lost to Follow-up|330|||
145240034|NCT00844285|523722453|FG001|Overall Study|Lost to Follow-up|486|||
145240035|NCT00844285|523722454|FG002|Overall Study|Lost to Follow-up|74|||
145240036|NCT00345540|523722455|FG000|Overall Study|Withdrawal by Subject|1|||
145240037|NCT01406652|523722456|FG000|Overall Study|Lost-to-follow-up|3|||
145240038|NCT01406652|523722457|FG001|Overall Study|Lost-to-follow-up|4|||
145240039|NCT01406652|523722456|FG000|Overall Study|Withdrawal by Subject|2|||
145240040|NCT01406652|523722457|FG001|Overall Study|Withdrawal by Subject|2|||
145240041|NCT01406652|523722456|FG000|Overall Study|Insufficient follow-up|5|||
145240042|NCT01406652|523722457|FG001|Overall Study|Insufficient follow-up|4|||
145240043|NCT01406652|523722456|FG000|Overall Study|Infection not sure|10|||
145240044|NCT01406652|523722457|FG001|Overall Study|Infection not sure|10|||
145240045|NCT00628758|523722458|FG000|Overall Study|Adverse Event|2|||
145240046|NCT00628758|523722459|FG001|Overall Study|Adverse Event|3|||
145240047|NCT00628758|523722458|FG000|Overall Study|Withdrawal by Subject|6|||
145240048|NCT00628758|523722459|FG001|Overall Study|Withdrawal by Subject|3|||
145240049|NCT00628758|523722458|FG000|Overall Study|Death|1|||
145240050|NCT00628758|523722459|FG001|Overall Study|Death|0|||
145240051|NCT00628758|523722458|FG000|Overall Study|Protocol Violation|5|||
145240052|NCT00628758|523722459|FG001|Overall Study|Protocol Violation|1|||
145240053|NCT00628758|523722458|FG000|Overall Study|Lost to Follow-up|25|||
145240054|NCT00628758|523722459|FG001|Overall Study|Lost to Follow-up|31|||
145240055|NCT00628758|523722458|FG000|Overall Study|Pregnancy|2|||
145240056|NCT00628758|523722459|FG001|Overall Study|Pregnancy|2|||
145240057|NCT00628758|523722458|FG000|Overall Study|Investigator Moved|3|||
145240058|NCT00628758|523722459|FG001|Overall Study|Investigator Moved|0|||
145240059|NCT00628758|523722458|FG000|Overall Study|Treatment Failure|0|||
145240060|NCT00628758|523722459|FG001|Overall Study|Treatment Failure|2|||
145240061|NCT04179786|523722460|FG000|Overall Study|Withdrawal by Subject|8|||
145240062|NCT03310580|523722461|FG000|Overall Study|Adverse Event|0|||
145240063|NCT03310580|523722462|FG001|Overall Study|Adverse Event|1|||
145240064|NCT03310580|523722463|FG002|Overall Study|Adverse Event|0|||
145240065|NCT03175562|523722464|FG000|Overall Study|Adverse Event|1|||
145240066|NCT03175562|523722464|FG000|Overall Study|Lost to Follow-up|3|||
145240067|NCT03175562|523722464|FG000|Overall Study|Withdrawal by Subject|7|||
145240068|NCT03175562|523722464|FG000|Overall Study|Other (Not Specified)|5|||
145240069|NCT01230749|523722465|FG000|Overall Study|Adverse Event|0|||
145240070|NCT01230749|523722466|FG001|Overall Study|Adverse Event|0|||
145240071|NCT01230749|523722467|FG002|Overall Study|Adverse Event|0|||
145240072|NCT01230749|523722468|FG003|Overall Study|Adverse Event|1|||
145240073|NCT01230749|523722465|FG000|Overall Study|Physician Decision|0|||
145240074|NCT01230749|523722466|FG001|Overall Study|Physician Decision|0|||
145240075|NCT01230749|523722467|FG002|Overall Study|Physician Decision|1|||
145240076|NCT01230749|523722468|FG003|Overall Study|Physician Decision|0|||
145240077|NCT01230749|523722465|FG000|Overall Study|Withdrawal by Subject|0|||
145240078|NCT01230749|523722466|FG001|Overall Study|Withdrawal by Subject|1|||
145240079|NCT01230749|523722467|FG002|Overall Study|Withdrawal by Subject|0|||
145240080|NCT01230749|523722468|FG003|Overall Study|Withdrawal by Subject|0|||
145240081|NCT01230749|523722465|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
145240082|NCT01230749|523722466|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
145240083|NCT01230749|523722467|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
145240084|NCT01230749|523722468|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
145240085|NCT02688153|523724702|FG000|Overall Study|Death|7|||
145240086|NCT02688153|523724703|FG001|Overall Study|Death|5|||
145240087|NCT02688153|523724702|FG000|Overall Study|Withdrawal by Subject|4|||
145240088|NCT02688153|523724703|FG001|Overall Study|Withdrawal by Subject|2|||
145240089|NCT02688153|523724702|FG000|Overall Study|Valve Explant|1|||
145240090|NCT02688153|523724703|FG001|Overall Study|Valve Explant|0|||
145240091|NCT02688153|523724702|FG000|Overall Study|Conversion to Commercial Valve|3|||
145240092|NCT02688153|523724703|FG001|Overall Study|Conversion to Commercial Valve|0|||
145240093|NCT00107172|523724704|FG000|Overall Study|Withdrawal by Subject|1|||
145240094|NCT00107172|523724705|FG001|Overall Study|Withdrawal by Subject|0|||
145240095|NCT00107172|523724704|FG000|Overall Study|Death|0|||
145240096|NCT00107172|523724705|FG001|Overall Study|Death|2|||
145240097|NCT00107172|523724704|FG000|Overall Study|Other Reason|4|||
145240098|NCT00107172|523724705|FG001|Overall Study|Other Reason|3|||
145240099|NCT03750240|523724707|FG000|Overall Study|Technical Difficulties|2|||
145240100|NCT03706040|523724708|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
145240101|NCT03706040|523724709|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
145240102|NCT03706040|523724710|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
145240103|NCT03706040|523724711|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
145240104|NCT03706040|523724712|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
145240105|NCT03706040|523724713|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
145240106|NCT03706040|523724714|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
145240107|NCT03706040|523724708|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
145296130|NCT01720264|523934428|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
145296131|NCT01720264|523934428|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
145296132|NCT03018249|523934440|FG000|Overall Study|Withdrawal by Subject|2|||
145563618|NCT02658890|524924015|FG011|Treatment Phase|Progressive Disease|9|||
145240108|NCT03706040|523724709|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
145240109|NCT03706040|523724710|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
145296133|NCT03018249|523934441|FG001|Overall Study|Withdrawal by Subject|2|||
145563619|NCT02658890|524924016|FG012|Treatment Phase|Progressive Disease|8|||
145296134|NCT02343120|523934442|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
145296135|NCT02343120|523934443|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
145296136|NCT02343120|523934444|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
145296137|NCT02343120|523934445|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
145240110|NCT03706040|523724711|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
145240111|NCT03706040|523724712|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
145240112|NCT03706040|523724713|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
145240113|NCT03706040|523724714|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
145240114|NCT03706040|523724708|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
145240115|NCT03706040|523724709|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
145240116|NCT03706040|523724710|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
145563620|NCT02658890|524924017|FG013|Treatment Phase|Progressive Disease|29|||
145240117|NCT03706040|523724711|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
145240118|NCT03706040|523724712|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
145240119|NCT03706040|523724713|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
145240120|NCT03706040|523724714|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
145240121|NCT03706040|523724708|FG000|Period A (Week 0 to Week 16)|Other|2|||
145240122|NCT03706040|523724709|FG001|Period A (Week 0 to Week 16)|Other|0|||
145240123|NCT03706040|523724710|FG002|Period A (Week 0 to Week 16)|Other|2|||
145240124|NCT03706040|523724711|FG003|Period A (Week 0 to Week 16)|Other|0|||
145240125|NCT03706040|523724712|FG004|Period A (Week 0 to Week 16)|Other|0|||
145240126|NCT03706040|523724713|FG005|Period A (Week 0 to Week 16)|Other|0|||
145240127|NCT03706040|523724714|FG006|Period A (Week 0 to Week 16)|Other|0|||
145240128|NCT03706040|523724708|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
145240129|NCT03706040|523724709|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
145240130|NCT03706040|523724710|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
145240131|NCT03706040|523724711|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
145240132|NCT03706040|523724712|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
145240133|NCT03706040|523724713|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
145240134|NCT03706040|523724714|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
145240135|NCT03706040|523724708|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
145240136|NCT03706040|523724709|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
145240137|NCT03706040|523724710|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
145240138|NCT03706040|523724711|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
145240139|NCT03706040|523724712|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
145240140|NCT03706040|523724713|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
145240141|NCT03706040|523724714|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
145240142|NCT03706040|523724708|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145240143|NCT03706040|523724709|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145240144|NCT03706040|523724710|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145240145|NCT03706040|523724711|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145240146|NCT03706040|523724712|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
145240147|NCT03706040|523724713|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
145240148|NCT03706040|523724714|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
145240149|NCT03706040|523724708|FG000|Period B (Week 16 to Week 52)|Other|0|||
145240150|NCT03706040|523724709|FG001|Period B (Week 16 to Week 52)|Other|0|||
145240151|NCT03706040|523724710|FG002|Period B (Week 16 to Week 52)|Other|0|||
145240152|NCT03706040|523724711|FG003|Period B (Week 16 to Week 52)|Other|4|||
145240153|NCT03706040|523724712|FG004|Period B (Week 16 to Week 52)|Other|5|||
145240154|NCT03706040|523724713|FG005|Period B (Week 16 to Week 52)|Other|23|||
145240155|NCT03706040|523724714|FG006|Period B (Week 16 to Week 52)|Other|17|||
145240156|NCT00927758|523724715|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
145296138|NCT02343120|523934446|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
145296139|NCT02343120|523934442|FG000|Part 1: Dose Escalation|Death|1|||
145296140|NCT02343120|523934443|FG001|Part 1: Dose Escalation|Death|2|||
145296141|NCT02343120|523934444|FG002|Part 1: Dose Escalation|Death|2|||
145296142|NCT02343120|523934445|FG003|Part 1: Dose Escalation|Death|2|||
145296143|NCT02343120|523934446|FG004|Part 1: Dose Escalation|Death|1|||
145296144|NCT02343120|523934442|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
145296145|NCT02343120|523934443|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
145296146|NCT02343120|523934444|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
145296147|NCT02343120|523934445|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
145296148|NCT02343120|523934446|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
145296149|NCT02343120|523934442|FG000|Part 2: Expansion|Sponsor decision|0|||
145296150|NCT02343120|523934443|FG001|Part 2: Expansion|Sponsor decision|0|||
145296151|NCT02343120|523934444|FG002|Part 2: Expansion|Sponsor decision|0|||
145296152|NCT02343120|523934445|FG003|Part 2: Expansion|Sponsor decision|165|||
145296153|NCT02343120|523934446|FG004|Part 2: Expansion|Sponsor decision|67|||
145296154|NCT02343120|523934442|FG000|Part 2: Expansion|Death|0|||
145296155|NCT02343120|523934443|FG001|Part 2: Expansion|Death|0|||
145296156|NCT02343120|523934444|FG002|Part 2: Expansion|Death|0|||
145296157|NCT02343120|523934445|FG003|Part 2: Expansion|Death|74|||
145296158|NCT02343120|523934446|FG004|Part 2: Expansion|Death|17|||
145296159|NCT02343120|523934442|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
145240157|NCT00927758|523724716|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
145240158|NCT00927758|523724717|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
145296160|NCT02343120|523934443|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
145296161|NCT02343120|523934444|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
145296162|NCT02343120|523934445|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
145296163|NCT02343120|523934446|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
145296164|NCT02343120|523934442|FG000|Part 2: Expansion|Lost to Follow-up|0|||
145296165|NCT02343120|523934443|FG001|Part 2: Expansion|Lost to Follow-up|0|||
145296166|NCT02343120|523934444|FG002|Part 2: Expansion|Lost to Follow-up|0|||
145296167|NCT02343120|523934445|FG003|Part 2: Expansion|Lost to Follow-up|5|||
145296168|NCT02343120|523934446|FG004|Part 2: Expansion|Lost to Follow-up|2|||
145296169|NCT02343120|523934442|FG000|Part 2: Expansion|Other|0|||
145296170|NCT02343120|523934443|FG001|Part 2: Expansion|Other|0|||
145296171|NCT02343120|523934444|FG002|Part 2: Expansion|Other|0|||
145296172|NCT02343120|523934445|FG003|Part 2: Expansion|Other|1|||
145240159|NCT00927758|523724718|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
145240160|NCT00927758|523724719|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
145240161|NCT00927758|523724720|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
145240162|NCT00927758|523724715|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
145240163|NCT00927758|523724716|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
145240164|NCT00927758|523724717|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
145240165|NCT00927758|523724718|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
145240166|NCT00927758|523724719|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
145240167|NCT00927758|523724720|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
145240168|NCT00439725|523724722|FG000|Treatment Period|Withdrawal by Subject|22|||
145240169|NCT00439725|523724723|FG001|Treatment Period|Withdrawal by Subject|19|||
145240170|NCT00439725|523724722|FG000|Treatment Period|Study terminated by sponsor|156|||
145240171|NCT00439725|523724723|FG001|Treatment Period|Study terminated by sponsor|148|||
145240172|NCT00439725|523724722|FG000|Treatment Period|Site closed by investigator|1|||
145240173|NCT00439725|523724723|FG001|Treatment Period|Site closed by investigator|2|||
145240174|NCT00439725|523724722|FG000|Treatment Period|Adverse Event|39|||
145240175|NCT00439725|523724723|FG001|Treatment Period|Adverse Event|18|||
145240176|NCT00439725|523724722|FG000|Treatment Period|Physician Decision|1|||
145240177|NCT00439725|523724723|FG001|Treatment Period|Physician Decision|1|||
145240178|NCT00439725|523724722|FG000|Treatment Period|Protocol Violation|2|||
145240179|NCT00439725|523724723|FG001|Treatment Period|Protocol Violation|1|||
145240180|NCT00439725|523724722|FG000|Treatment Period|Clinical endpoint reached|6|||
145240181|NCT00439725|523724723|FG001|Treatment Period|Clinical endpoint reached|50|||
145240182|NCT00439725|523724722|FG000|Treatment Period|Technical problems|1|||
145240183|NCT00439725|523724723|FG001|Treatment Period|Technical problems|0|||
145240184|NCT00439725|523724722|FG000|Treatment Period|Lost to Follow-up|1|||
145240185|NCT00439725|523724723|FG001|Treatment Period|Lost to Follow-up|1|||
145240186|NCT00439725|523724722|FG000|Treatment Period|Participant convenience|1|||
145240187|NCT00439725|523724723|FG001|Treatment Period|Participant convenience|0|||
145240188|NCT00439725|523724722|FG000|Treatment Period|Protocol driven decision point|1|||
145240189|NCT00439725|523724723|FG001|Treatment Period|Protocol driven decision point|1|||
145240190|NCT00439725|523724722|FG000|Treatment Period|Death|1|||
145240191|NCT00439725|523724723|FG001|Treatment Period|Death|1|||
145240192|NCT00439725|523724722|FG000|Treatment Period|Participant did not receive treatment|4|||
145240193|NCT00439725|523724723|FG001|Treatment Period|Participant did not receive treatment|4|||
145240194|NCT00439725|523724722|FG000|Observational Period|Withdrawal by Subject|2|||
145240195|NCT00439725|523724723|FG001|Observational Period|Withdrawal by Subject|2|||
145240196|NCT00439725|523724722|FG000|Observational Period|Lost to Follow-up|0|||
145240197|NCT00439725|523724723|FG001|Observational Period|Lost to Follow-up|1|||
145240198|NCT00439725|523724722|FG000|Observational Period|Death|0|||
145240199|NCT00439725|523724723|FG001|Observational Period|Death|2|||
145240200|NCT00439725|523724722|FG000|Observational Period|Study termination by sponsor|1|||
145240201|NCT00439725|523724723|FG001|Observational Period|Study termination by sponsor|1|||
145240202|NCT00439725|523724722|FG000|Observational Period|Clinical endpoint reached|3|||
145240203|NCT00439725|523724723|FG001|Observational Period|Clinical endpoint reached|1|||
145240204|NCT00439725|523724722|FG000|Observational Period|Technical problems|1|||
145240205|NCT00439725|523724723|FG001|Observational Period|Technical problems|0|||
145240206|NCT00439725|523724722|FG000|Observational Period|Participant convenience|1|||
145240207|NCT00439725|523724723|FG001|Observational Period|Participant convenience|0|||
145240208|NCT01544478|523724724|FG000|Overall Study|Adverse Event|1|||
145240209|NCT01544478|523724724|FG000|Overall Study|Death|1|||
145240210|NCT01544478|523724724|FG000|Overall Study|Lost to Follow-up|48|||
145240211|NCT01544478|523724724|FG000|Overall Study|Physician Decision|15|||
145240212|NCT01544478|523724724|FG000|Overall Study|Pregnancy|1|||
145240213|NCT01544478|523724724|FG000|Overall Study|Withdrawal by Subject|52|||
145240214|NCT04038385|523724726|FG000|Overall Study|Completed baseline assessment only|7|||
145240215|NCT04038385|523724727|FG001|Overall Study|Completed baseline assessment only|4|||
145240216|NCT04038385|523724726|FG000|Overall Study|Moved out of area|4|||
145240217|NCT04038385|523724727|FG001|Overall Study|Moved out of area|2|||
145240218|NCT04038385|523724726|FG000|Overall Study|Discontinued study involvement|6|||
145240219|NCT04038385|523724727|FG001|Overall Study|Discontinued study involvement|1|||
145240220|NCT02038790|523724728|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
145240221|NCT02038790|523724729|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
145240222|NCT02431793|523724730|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
145240223|NCT02431793|523724731|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
145240224|NCT02431793|523724732|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
145240225|NCT02431793|523724730|FG000|Overall Study|Withdrawal by Subject|7|||
145240226|NCT02431793|523724731|FG001|Overall Study|Withdrawal by Subject|5|||
145296173|NCT02343120|523934446|FG004|Part 2: Expansion|Other|5|||
145296174|NCT02343120|523934442|FG000|Part 2: Expansion|Adverse Event|0|||
145296175|NCT02343120|523934443|FG001|Part 2: Expansion|Adverse Event|0|||
145296176|NCT02343120|523934444|FG002|Part 2: Expansion|Adverse Event|0|||
145296177|NCT02343120|523934445|FG003|Part 2: Expansion|Adverse Event|1|||
145620030|NCT03468426|525123656|FG007|Overall Study|Other adverse event or clinical progression|4|||
145620031|NCT03468426|525123657|FG008|Overall Study|Other adverse event or clinical progression|6|||
145620032|NCT03468426|525123658|FG009|Overall Study|Other adverse event or clinical progression|11|||
145620033|NCT03468426|525123659|FG010|Overall Study|Other adverse event or clinical progression|0|||
145620034|NCT03468426|525123649|FG000|Overall Study|Refused to continue taking trial medication|0|||
145620035|NCT03468426|525123650|FG001|Overall Study|Refused to continue taking trial medication|0|||
145620036|NCT03468426|525123651|FG002|Overall Study|Refused to continue taking trial medication|0|||
145620037|NCT03468426|525123652|FG003|Overall Study|Refused to continue taking trial medication|2|||
145620038|NCT03468426|525123653|FG004|Overall Study|Refused to continue taking trial medication|0|||
145620039|NCT03468426|525123654|FG005|Overall Study|Refused to continue taking trial medication|3|||
145620040|NCT03468426|525123655|FG006|Overall Study|Refused to continue taking trial medication|0|||
145620041|NCT03468426|525123656|FG007|Overall Study|Refused to continue taking trial medication|0|||
145620042|NCT03468426|525123657|FG008|Overall Study|Refused to continue taking trial medication|1|||
145620043|NCT03468426|525123658|FG009|Overall Study|Refused to continue taking trial medication|0|||
145620044|NCT03468426|525123659|FG010|Overall Study|Refused to continue taking trial medication|0|||
145620045|NCT03468426|525123649|FG000|Overall Study|Other than listed|0|||
145620046|NCT03468426|525123650|FG001|Overall Study|Other than listed|1|||
145620047|NCT03468426|525123651|FG002|Overall Study|Other than listed|0|||
145620048|NCT03468426|525123652|FG003|Overall Study|Other than listed|0|||
145620049|NCT03468426|525123653|FG004|Overall Study|Other than listed|2|||
145620050|NCT03468426|525123654|FG005|Overall Study|Other than listed|2|||
145620051|NCT03468426|525123655|FG006|Overall Study|Other than listed|0|||
145620052|NCT03468426|525123656|FG007|Overall Study|Other than listed|0|||
145620053|NCT03468426|525123657|FG008|Overall Study|Other than listed|4|||
145620054|NCT03468426|525123658|FG009|Overall Study|Other than listed|4|||
145620055|NCT03468426|525123659|FG010|Overall Study|Other than listed|1|||
145620056|NCT03468426|525123649|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145240227|NCT02431793|523724732|FG002|Overall Study|Withdrawal by Subject|5|||
145240228|NCT02431793|523724730|FG000|Overall Study|Lost to Follow-up|101|||
145240229|NCT02431793|523724731|FG001|Overall Study|Lost to Follow-up|122|||
145240230|NCT02431793|523724732|FG002|Overall Study|Lost to Follow-up|104|||
145240231|NCT00063986|523724736|FG000|Overall Study|Withdrawal by Subject|1|||
145240232|NCT00063986|523724736|FG000|Overall Study|Ineligible|1|||
145240233|NCT00063986|523724736|FG000|Overall Study|Intra-operatively ineligible|4|||
145240234|NCT00247273|523724744|FG000|Overall Study|Adverse Event|85|||
145240235|NCT00247273|523724745|FG001|Overall Study|Adverse Event|80|||
145240236|NCT00247273|523724744|FG000|Overall Study|Physician Decision|6|||
145240237|NCT00247273|523724745|FG001|Overall Study|Physician Decision|3|||
145240238|NCT00247273|523724744|FG000|Overall Study|Lost to Follow-up|7|||
145240239|NCT00247273|523724745|FG001|Overall Study|Lost to Follow-up|7|||
145240240|NCT00247273|523724744|FG000|Overall Study|Withdrawal by Subject|46|||
145240241|NCT00247273|523724745|FG001|Overall Study|Withdrawal by Subject|47|||
145240242|NCT00247273|523724744|FG000|Overall Study|Did not take any study drug|2|||
145240243|NCT00247273|523724745|FG001|Overall Study|Did not take any study drug|0|||
145240244|NCT01419015|523724746|FG000|Overall Study|Death|2|||
145240245|NCT03276572|523724747|FG000|Overall Study|In follow-up|0|||
145240246|NCT03276572|523724748|FG001|Overall Study|In follow-up|0|||
145240247|NCT03276572|523724749|FG002|Overall Study|In follow-up|0|||
145240248|NCT03276572|523724750|FG003|Overall Study|In follow-up|0|||
145240249|NCT03276572|523724751|FG004|Overall Study|In follow-up|0|||
145240250|NCT03276572|523724752|FG005|Overall Study|In follow-up|1|||
145240251|NCT03276572|523724753|FG006|Overall Study|In follow-up|1|||
145240252|NCT03276572|523724747|FG000|Overall Study|Lost to Follow-up|0|||
145240253|NCT03276572|523724748|FG001|Overall Study|Lost to Follow-up|0|||
145240254|NCT03276572|523724749|FG002|Overall Study|Lost to Follow-up|0|||
145240255|NCT03276572|523724750|FG003|Overall Study|Lost to Follow-up|0|||
145240256|NCT03276572|523724751|FG004|Overall Study|Lost to Follow-up|0|||
145240257|NCT03276572|523724752|FG005|Overall Study|Lost to Follow-up|0|||
145240258|NCT03276572|523724753|FG006|Overall Study|Lost to Follow-up|1|||
145240259|NCT02657434|523724766|FG000|Overall Study|Study Terminated By Sponsor|64|||
145240260|NCT02657434|523724767|FG001|Overall Study|Study Terminated By Sponsor|82|||
145240261|NCT02657434|523724766|FG000|Overall Study|Death|189|||
145240262|NCT02657434|523724767|FG001|Overall Study|Death|190|||
145240263|NCT02657434|523724766|FG000|Overall Study|Lost to Follow-up|2|||
145240264|NCT02657434|523724767|FG001|Overall Study|Lost to Follow-up|2|||
145296178|NCT02343120|523934446|FG004|Part 2: Expansion|Adverse Event|1|||
145296179|NCT01030965|523934448|FG000|Overall Study|Lack of Efficacy|3|||
145296180|NCT01030965|523934449|FG001|Overall Study|Lack of Efficacy|2|||
145296181|NCT01030965|523934450|FG002|Overall Study|Lack of Efficacy|0|||
145296182|NCT01030965|523934451|FG003|Overall Study|Lack of Efficacy|3|||
145296183|NCT01030965|523934448|FG000|Overall Study|Protocol Violation|1|||
145296184|NCT01030965|523934449|FG001|Overall Study|Protocol Violation|1|||
145240265|NCT02657434|523724766|FG000|Overall Study|Randomization by Error|2|||
145240266|NCT02657434|523724767|FG001|Overall Study|Randomization by Error|0|||
145240267|NCT02657434|523724766|FG000|Overall Study|Withdrawal by Subject|28|||
145296185|NCT01030965|523934450|FG002|Overall Study|Protocol Violation|1|||
145240268|NCT02657434|523724767|FG001|Overall Study|Withdrawal by Subject|17|||
145240269|NCT02657434|523724766|FG000|Overall Study|Protocol Violation|1|||
145240270|NCT02657434|523724767|FG001|Overall Study|Protocol Violation|0|||
145240271|NCT02657434|523724766|FG000|Overall Study|Physician Decision|0|||
145240272|NCT02657434|523724767|FG001|Overall Study|Physician Decision|1|||
145240273|NCT01392742|523724770|FG000|Overall Study|Premature study termination|42|||
145240274|NCT01392742|523724770|FG000|Overall Study|Failure to return|35|||
145240275|NCT01392742|523724770|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
145240276|NCT01392742|523724770|FG000|Overall Study|Lost to Follow-up|34|||
145240277|NCT01392742|523724770|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
145240278|NCT01392742|523724770|FG000|Overall Study|ITR and Protocol deviation|1|||
145240279|NCT01392742|523724770|FG000|Overall Study|Adverse event/intercurrent illness|17|||
145240280|NCT01392742|523724770|FG000|Overall Study|Protocol Violation|14|||
145240281|NCT01392742|523724770|FG000|Overall Study|Other|3|||
145240282|NCT01392742|523724770|FG000|Overall Study|Missing information|13|||
145240283|NCT02432703|523724771|FG000|Overall Study|Adverse Event|1|||
145240284|NCT02432703|523724772|FG001|Overall Study|Adverse Event|4|||
145240285|NCT02432703|523724771|FG000|Overall Study|Lack of Efficacy|1|||
145240286|NCT02432703|523724772|FG001|Overall Study|Lack of Efficacy|0|||
145240287|NCT02432703|523724771|FG000|Overall Study|Lost to Follow-up|5|||
145240288|NCT02432703|523724772|FG001|Overall Study|Lost to Follow-up|3|||
145240289|NCT02432703|523724771|FG000|Overall Study|Withdrawal by Subject|9|||
145240290|NCT02432703|523724772|FG001|Overall Study|Withdrawal by Subject|6|||
145240291|NCT02432703|523724771|FG000|Overall Study|Other|6|||
145240292|NCT02432703|523724772|FG001|Overall Study|Other|5|||
145240293|NCT00724815|523724775|FG000|Overall Study|Randomized, not treated|31|||
145240294|NCT00724815|523724776|FG001|Overall Study|Randomized, not treated|30|||
145240295|NCT00724815|523724775|FG000|Overall Study|Adverse Event|5|||
145240296|NCT00724815|523724776|FG001|Overall Study|Adverse Event|3|||
145240297|NCT00724815|523724775|FG000|Overall Study|Lost to Follow-up|4|||
145240298|NCT00724815|523724776|FG001|Overall Study|Lost to Follow-up|1|||
145240299|NCT00724815|523724775|FG000|Overall Study|Other Various|3|||
145240300|NCT00724815|523724776|FG001|Overall Study|Other Various|5|||
145240301|NCT00810043|523724777|FG000|Overall Study|Withdrawal by Subject|1|||
145240302|NCT00810043|523724778|FG001|Overall Study|Withdrawal by Subject|0|||
145240303|NCT00810043|523724779|FG002|Overall Study|Withdrawal by Subject|2|||
145240304|NCT00810043|523724777|FG000|Overall Study|Lost to Follow-up|1|||
145240305|NCT00810043|523724778|FG001|Overall Study|Lost to Follow-up|0|||
145240306|NCT00810043|523724779|FG002|Overall Study|Lost to Follow-up|0|||
145240307|NCT00810043|523724777|FG000|Overall Study|Physician Decision|0|||
145240308|NCT00810043|523724778|FG001|Overall Study|Physician Decision|0|||
145240309|NCT00810043|523724779|FG002|Overall Study|Physician Decision|2|||
145240310|NCT00810043|523724777|FG000|Overall Study|Death|2|||
145240311|NCT00810043|523724778|FG001|Overall Study|Death|0|||
145240312|NCT00810043|523724779|FG002|Overall Study|Death|0|||
145240313|NCT00810043|523724777|FG000|Overall Study|Unrelated medical problem|0|||
145240314|NCT00810043|523724778|FG001|Overall Study|Unrelated medical problem|1|||
145240315|NCT00810043|523724779|FG002|Overall Study|Unrelated medical problem|0|||
145240316|NCT00810043|523724777|FG000|Overall Study|Non-medical problem|0|||
145240317|NCT00810043|523724778|FG001|Overall Study|Non-medical problem|0|||
145240318|NCT00810043|523724779|FG002|Overall Study|Non-medical problem|1|||
145240319|NCT00810043|523724777|FG000|Overall Study|No longer met enrollment criteria|0|||
145240320|NCT00810043|523724778|FG001|Overall Study|No longer met enrollment criteria|0|||
145240321|NCT00810043|523724779|FG002|Overall Study|No longer met enrollment criteria|3|||
145240322|NCT02001688|523724780|FG000|Overall Study|Withdrawal by Subject|0|||
145240323|NCT02001688|523724781|FG001|Overall Study|Withdrawal by Subject|0|||
145240324|NCT02001688|523724782|FG002|Overall Study|Withdrawal by Subject|1|||
145240325|NCT02001688|523724780|FG000|Overall Study|Adverse Event|0|||
145240326|NCT02001688|523724781|FG001|Overall Study|Adverse Event|1|||
145240327|NCT02001688|523724782|FG002|Overall Study|Adverse Event|0|||
145240328|NCT00445341|523724783|FG000|Overall Study|refused further treatment|1|||
145240329|NCT00445341|523724783|FG000|Overall Study|taken off treatment too early|1|||
145240330|NCT03051217|523724786|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
145240331|NCT03051217|523724787|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145240332|NCT03051217|523724788|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
145240333|NCT03051217|523724789|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145240334|NCT03051217|523724790|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145240335|NCT03051217|523724791|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145240336|NCT03051217|523724792|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145240337|NCT03051217|523724786|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145240338|NCT03051217|523724787|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
145240339|NCT03051217|523724788|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145240340|NCT03051217|523724789|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145240341|NCT03051217|523724790|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145296186|NCT01030965|523934451|FG003|Overall Study|Protocol Violation|1|||
145296187|NCT01030965|523934448|FG000|Overall Study|Adverse Event|0|||
145296188|NCT01030965|523934449|FG001|Overall Study|Adverse Event|1|||
145240342|NCT03051217|523724791|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145240343|NCT03051217|523724792|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
145240344|NCT03051217|523724786|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
145240345|NCT03051217|523724787|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
145240346|NCT03051217|523724788|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
145240347|NCT03051217|523724789|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145240348|NCT03051217|523724790|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145240349|NCT03051217|523724791|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145240350|NCT03051217|523724792|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145240351|NCT03051217|523724786|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
145240352|NCT03051217|523724787|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
145240353|NCT03051217|523724788|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
145240354|NCT03051217|523724789|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
145240355|NCT03051217|523724790|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
145240356|NCT03051217|523724791|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
145240357|NCT03051217|523724792|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
145240358|NCT03051217|523724786|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240359|NCT03051217|523724787|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240360|NCT03051217|523724788|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240361|NCT03051217|523724789|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
145240362|NCT03051217|523724790|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240363|NCT03051217|523724791|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240364|NCT03051217|523724792|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
145240365|NCT03051217|523724786|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240366|NCT03051217|523724787|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240367|NCT03051217|523724788|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240368|NCT03051217|523724789|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
145240369|NCT03051217|523724790|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240370|NCT03051217|523724791|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240371|NCT03051217|523724792|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
145240372|NCT03051217|523724786|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240373|NCT03051217|523724787|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240374|NCT03051217|523724788|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240375|NCT03051217|523724789|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240376|NCT03051217|523724790|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
145240377|NCT03051217|523724791|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240378|NCT03051217|523724792|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
145240379|NCT03051217|523724786|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240380|NCT03051217|523724787|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240381|NCT03051217|523724788|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240382|NCT03051217|523724789|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240383|NCT03051217|523724790|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240384|NCT03051217|523724791|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
145240385|NCT03051217|523724792|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
145240386|NCT00641706|523724793|FG000|Overall Study|Adverse Event|2|||
145240387|NCT00641706|523724794|FG001|Overall Study|Adverse Event|1|||
145240388|NCT00641706|523724793|FG000|Overall Study|Withdrawal by Subject|6|||
145240389|NCT00641706|523724794|FG001|Overall Study|Withdrawal by Subject|1|||
145240390|NCT00641706|523724793|FG000|Overall Study|Clinical Decline|1|||
145240391|NCT00641706|523724794|FG001|Overall Study|Clinical Decline|0|||
145240392|NCT00641706|523724793|FG000|Overall Study|Lead Investigator Decision|0|||
145240393|NCT00641706|523724794|FG001|Overall Study|Lead Investigator Decision|1|||
145240394|NCT01675141|523724795|FG000|Overall Study|Lenalidomide outside NIH|3|||
145240395|NCT01675141|523724795|FG000|Overall Study|Withdrawal by Subject|3|||
145240396|NCT01675141|523724795|FG000|Overall Study|Physician Decision|4|||
145240397|NCT01675141|523724795|FG000|Overall Study|No treatment, per protocol|1|||
145240398|NCT00109772|523724796|FG000|Double-blind Treatment|Adverse Event|14|||
145240399|NCT00109772|523724797|FG001|Double-blind Treatment|Adverse Event|5|||
145240400|NCT00109772|523724796|FG000|Double-blind Treatment|Lack of Efficacy|1|||
145240401|NCT00109772|523724797|FG001|Double-blind Treatment|Lack of Efficacy|0|||
145240402|NCT00109772|523724796|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
145240403|NCT00109772|523724797|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
145240404|NCT00109772|523724796|FG000|Double-blind Treatment|Lost to Follow-up|2|||
145240405|NCT00109772|523724797|FG001|Double-blind Treatment|Lost to Follow-up|3|||
145240406|NCT00109772|523724796|FG000|Double-blind Treatment|Protocol Violation|0|||
145240407|NCT00109772|523724797|FG001|Double-blind Treatment|Protocol Violation|1|||
145296189|NCT01030965|523934450|FG002|Overall Study|Adverse Event|2|||
145240408|NCT00109772|523724796|FG000|Double-blind Treatment|Other|0|||
145240409|NCT00109772|523724797|FG001|Double-blind Treatment|Other|4|||
145240410|NCT00109772|523724796|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
145240411|NCT00109772|523724797|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
145240412|NCT00109772|523724796|FG000|Open-label Extension|Adverse Event|10|||
145240413|NCT00109772|523724797|FG001|Open-label Extension|Adverse Event|19|||
145240414|NCT00109772|523724796|FG000|Open-label Extension|Lack of Efficacy|19|||
145240415|NCT00109772|523724797|FG001|Open-label Extension|Lack of Efficacy|11|||
145240416|NCT00109772|523724796|FG000|Open-label Extension|Withdrawal by Subject|9|||
145240417|NCT00109772|523724797|FG001|Open-label Extension|Withdrawal by Subject|6|||
145240418|NCT00109772|523724796|FG000|Open-label Extension|Lost to Follow-up|1|||
145240419|NCT00109772|523724797|FG001|Open-label Extension|Lost to Follow-up|0|||
145240420|NCT00109772|523724796|FG000|Open-label Extension|Death|0|||
145240421|NCT00109772|523724797|FG001|Open-label Extension|Death|1|||
145240422|NCT00109772|523724796|FG000|Open-label Extension|Protocol Violation|2|||
145240423|NCT00109772|523724797|FG001|Open-label Extension|Protocol Violation|2|||
145240424|NCT00109772|523724796|FG000|Open-label Extension|Other|4|||
145240425|NCT00109772|523724797|FG001|Open-label Extension|Other|10|||
145240426|NCT05441540|523724800|FG000|Overall Study|Withdrawal by Subject|2|||
145240427|NCT04539262|523724806|FG000|Overall Study|Adverse Event|0|||
145240428|NCT04539262|523724807|FG001|Overall Study|Adverse Event|0|||
145240429|NCT04539262|523724808|FG002|Overall Study|Adverse Event|1|||
145240430|NCT04539262|523724809|FG003|Overall Study|Adverse Event|0|||
145240431|NCT04539262|523724810|FG004|Overall Study|Adverse Event|0|||
145240432|NCT04539262|523724811|FG005|Overall Study|Adverse Event|0|||
145240433|NCT04539262|523724812|FG006|Overall Study|Adverse Event|0|||
145240434|NCT04539262|523724813|FG007|Overall Study|Adverse Event|0|||
145240435|NCT04539262|523724806|FG000|Overall Study|Withdrew Consent|0|||
145240436|NCT04539262|523724807|FG001|Overall Study|Withdrew Consent|0|||
145240437|NCT04539262|523724808|FG002|Overall Study|Withdrew Consent|0|||
145240438|NCT04539262|523724809|FG003|Overall Study|Withdrew Consent|1|||
145240439|NCT04539262|523724810|FG004|Overall Study|Withdrew Consent|0|||
145240440|NCT04539262|523724811|FG005|Overall Study|Withdrew Consent|0|||
145240441|NCT04539262|523724812|FG006|Overall Study|Withdrew Consent|0|||
145240442|NCT04539262|523724813|FG007|Overall Study|Withdrew Consent|0|||
145240443|NCT04539262|523724806|FG000|Overall Study|Randomized, Not treated|0|||
145240444|NCT04539262|523724807|FG001|Overall Study|Randomized, Not treated|1|||
145240445|NCT04539262|523724808|FG002|Overall Study|Randomized, Not treated|0|||
145240446|NCT04539262|523724809|FG003|Overall Study|Randomized, Not treated|0|||
145240447|NCT04539262|523724810|FG004|Overall Study|Randomized, Not treated|0|||
145240448|NCT04539262|523724811|FG005|Overall Study|Randomized, Not treated|0|||
145240449|NCT04539262|523724812|FG006|Overall Study|Randomized, Not treated|1|||
145240450|NCT04539262|523724813|FG007|Overall Study|Randomized, Not treated|0|||
145240451|NCT03673956|523724816|FG000|Overall Study|Lost to Follow-up|1|||
145240452|NCT03673956|523724817|FG001|Overall Study|Lost to Follow-up|0|||
145240453|NCT03673956|523724818|FG002|Overall Study|Lost to Follow-up|0|||
145240454|NCT03673956|523724819|FG003|Overall Study|Lost to Follow-up|0|||
145240455|NCT03673956|523724816|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
145240456|NCT03673956|523724817|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
145240457|NCT03673956|523724818|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
145240458|NCT03673956|523724819|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
145240459|NCT03228394|523724822|FG000|Overall Study|Lost to Follow-up|0|||
145240460|NCT03228394|523724823|FG001|Overall Study|Lost to Follow-up|0|||
145240461|NCT03228394|523724824|FG002|Overall Study|Lost to Follow-up|1|||
145240462|NCT03228394|523724825|FG003|Overall Study|Lost to Follow-up|1|||
145240463|NCT03228394|523724826|FG004|Overall Study|Lost to Follow-up|0|||
145240464|NCT03228394|523724827|FG005|Overall Study|Lost to Follow-up|0|||
145240465|NCT03228394|523724828|FG006|Overall Study|Lost to Follow-up|2|||
145240466|NCT03228394|523724829|FG007|Overall Study|Lost to Follow-up|0|||
145240467|NCT03228394|523724822|FG000|Overall Study|Withdrawal by Subject|0|||
145240468|NCT03228394|523724823|FG001|Overall Study|Withdrawal by Subject|0|||
145240469|NCT03228394|523724824|FG002|Overall Study|Withdrawal by Subject|1|||
145240470|NCT03228394|523724825|FG003|Overall Study|Withdrawal by Subject|0|||
145240471|NCT03228394|523724826|FG004|Overall Study|Withdrawal by Subject|0|||
145240472|NCT03228394|523724827|FG005|Overall Study|Withdrawal by Subject|0|||
145240473|NCT03228394|523724828|FG006|Overall Study|Withdrawal by Subject|1|||
145240474|NCT03228394|523724829|FG007|Overall Study|Withdrawal by Subject|3|||
145240475|NCT03228394|523724822|FG000|Overall Study|Protocol Violation|0|||
145240476|NCT03228394|523724823|FG001|Overall Study|Protocol Violation|0|||
145240477|NCT03228394|523724824|FG002|Overall Study|Protocol Violation|0|||
145240478|NCT03228394|523724825|FG003|Overall Study|Protocol Violation|1|||
145240479|NCT03228394|523724826|FG004|Overall Study|Protocol Violation|0|||
145240480|NCT03228394|523724827|FG005|Overall Study|Protocol Violation|0|||
145240481|NCT03228394|523724828|FG006|Overall Study|Protocol Violation|0|||
145240482|NCT03228394|523724829|FG007|Overall Study|Protocol Violation|0|||
145240483|NCT03228394|523724822|FG000|Overall Study|Physician Decision|0|||
145240484|NCT03228394|523724823|FG001|Overall Study|Physician Decision|0|||
145296190|NCT01030965|523934451|FG003|Overall Study|Adverse Event|1|||
145296191|NCT01030965|523934448|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
145296192|NCT01030965|523934449|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
145563621|NCT02658890|524924018|FG014|Treatment Phase|Progressive Disease|6|||
145563622|NCT02658890|524924019|FG015|Treatment Phase|Progressive Disease|2|||
145563623|NCT02658890|524924020|FG016|Treatment Phase|Progressive Disease|32|||
145563624|NCT02658890|524924021|FG017|Treatment Phase|Progressive Disease|14|||
145563625|NCT02658890|524924022|FG018|Treatment Phase|Progressive Disease|40|||
145563626|NCT02658890|524924023|FG019|Treatment Phase|Progressive Disease|32|||
145240485|NCT03228394|523724824|FG002|Overall Study|Physician Decision|0|||
145240486|NCT03228394|523724825|FG003|Overall Study|Physician Decision|0|||
145240487|NCT03228394|523724826|FG004|Overall Study|Physician Decision|0|||
145240488|NCT03228394|523724827|FG005|Overall Study|Physician Decision|0|||
145240489|NCT03228394|523724828|FG006|Overall Study|Physician Decision|1|||
145240490|NCT03228394|523724829|FG007|Overall Study|Physician Decision|0|||
145240491|NCT03228394|523724822|FG000|Overall Study|Noncompliance|0|||
145240492|NCT03228394|523724823|FG001|Overall Study|Noncompliance|0|||
145240493|NCT03228394|523724824|FG002|Overall Study|Noncompliance|0|||
145240494|NCT03228394|523724825|FG003|Overall Study|Noncompliance|0|||
145240495|NCT03228394|523724826|FG004|Overall Study|Noncompliance|0|||
145240496|NCT03228394|523724827|FG005|Overall Study|Noncompliance|0|||
145240497|NCT03228394|523724828|FG006|Overall Study|Noncompliance|1|||
145240498|NCT03228394|523724829|FG007|Overall Study|Noncompliance|0|||
145240499|NCT00294684|523724830|FG000|Overall Study|Lost to Follow-up|5|||
145240500|NCT00294684|523724831|FG001|Overall Study|Lost to Follow-up|8|||
145240501|NCT02443805|523724832|FG000|Overall Study|Adverse Event|100|||
145240502|NCT02443805|523724833|FG001|Overall Study|Adverse Event|18|||
145240503|NCT02443805|523724832|FG000|Overall Study|Withdrawal by Subject|73|||
145240504|NCT02443805|523724833|FG001|Overall Study|Withdrawal by Subject|74|||
145240505|NCT02443805|523724832|FG000|Overall Study|Lost to Follow-up|19|||
145240506|NCT02443805|523724833|FG001|Overall Study|Lost to Follow-up|14|||
145240507|NCT02443805|523724832|FG000|Overall Study|Pregnancy|6|||
145240508|NCT02443805|523724833|FG001|Overall Study|Pregnancy|5|||
145240509|NCT02443805|523724832|FG000|Overall Study|Protocol Violation|2|||
145240510|NCT02443805|523724833|FG001|Overall Study|Protocol Violation|4|||
145240511|NCT02443805|523724832|FG000|Overall Study|Lack of Efficacy|1|||
145240512|NCT02443805|523724833|FG001|Overall Study|Lack of Efficacy|1|||
145240513|NCT02443805|523724832|FG000|Overall Study|Non-compliance with study drug|6|||
145240514|NCT02443805|523724833|FG001|Overall Study|Non-compliance with study drug|4|||
145240515|NCT02443805|523724832|FG000|Overall Study|Withdrawal by parent/guardian|3|||
145240516|NCT02443805|523724833|FG001|Overall Study|Withdrawal by parent/guardian|5|||
145240517|NCT02443805|523724832|FG000|Overall Study|Any other reason not above-mentioned|3|||
145240518|NCT02443805|523724833|FG001|Overall Study|Any other reason not above-mentioned|2|||
145240519|NCT00968708|523724834|FG000|Overall Study|Adverse Event|169|||
145240520|NCT00968708|523724835|FG001|Overall Study|Adverse Event|150|||
145240521|NCT00968708|523724834|FG000|Overall Study|Major Protocol Deviation|0|||
145240522|NCT00968708|523724835|FG001|Overall Study|Major Protocol Deviation|1|||
145240523|NCT00968708|523724834|FG000|Overall Study|Lost to Follow-up|19|||
145240524|NCT00968708|523724835|FG001|Overall Study|Lost to Follow-up|11|||
145240525|NCT00968708|523724834|FG000|Overall Study|Voluntary Withdrawal|104|||
145240526|NCT00968708|523724835|FG001|Overall Study|Voluntary Withdrawal|101|||
145240527|NCT00968708|523724834|FG000|Overall Study|Investigator Discretion|0|||
145240528|NCT00968708|523724835|FG001|Overall Study|Investigator Discretion|1|||
145240529|NCT00968708|523724834|FG000|Overall Study|Other|26|||
145240530|NCT00968708|523724835|FG001|Overall Study|Other|34|||
145240531|NCT02708966|523724836|FG000|Overall Study|Lost to Follow-up|2|||
145240532|NCT02708966|523724837|FG001|Overall Study|Lost to Follow-up|2|||
145240533|NCT01851863|523724842|FG000|Overall Study|Did not receive study medication|2|||
145240534|NCT01851863|523724843|FG001|Overall Study|Did not receive study medication|5|||
145240535|NCT01851863|523724844|FG002|Overall Study|Did not receive study medication|3|||
145240536|NCT01851863|523724845|FG003|Overall Study|Did not receive study medication|0|||
145240537|NCT01851863|523724842|FG000|Overall Study|Lost to Follow-up|3|||
145240538|NCT01851863|523724843|FG001|Overall Study|Lost to Follow-up|4|||
145563627|NCT02658890|524924024|FG020|Treatment Phase|Progressive Disease|19|||
145563628|NCT02658890|524924025|FG021|Treatment Phase|Progressive Disease|30|||
145563629|NCT02658890|524924026|FG022|Treatment Phase|Progressive Disease|15|||
145563630|NCT02658890|524924027|FG023|Treatment Phase|Progressive Disease|0|||
145240539|NCT01851863|523724844|FG002|Overall Study|Lost to Follow-up|2|||
145240540|NCT01851863|523724845|FG003|Overall Study|Lost to Follow-up|3|||
145240541|NCT02076334|523724846|FG000|Overall Study|Protocol Violation|1|||
145563631|NCT02658890|524924028|FG024|Treatment Phase|Progressive Disease|0|||
145240542|NCT02076334|523724847|FG001|Overall Study|Protocol Violation|0|||
145240543|NCT02076334|523724848|FG002|Overall Study|Protocol Violation|0|||
145240544|NCT02076334|523724849|FG003|Overall Study|Protocol Violation|0|||
145240545|NCT02076334|523724846|FG000|Overall Study|Lost to Follow-up|0|||
145296193|NCT01030965|523934450|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
145563632|NCT02658890|524924029|FG025|Treatment Phase|Progressive Disease|14|||
145563633|NCT02658890|524924030|FG026|Treatment Phase|Progressive Disease|11|||
145240546|NCT02076334|523724847|FG001|Overall Study|Lost to Follow-up|1|||
145240547|NCT02076334|523724848|FG002|Overall Study|Lost to Follow-up|1|||
145240548|NCT02076334|523724849|FG003|Overall Study|Lost to Follow-up|0|||
145240549|NCT02076334|523724846|FG000|Overall Study|muscle soreness|0|||
145240550|NCT02076334|523724847|FG001|Overall Study|muscle soreness|0|||
145240551|NCT02076334|523724848|FG002|Overall Study|muscle soreness|0|||
145240552|NCT02076334|523724849|FG003|Overall Study|muscle soreness|1|||
145240553|NCT02224638|523724852|FG000|Overall Study|Adverse Event|1|||
145240554|NCT02224638|523724853|FG001|Overall Study|Adverse Event|1|||
145240555|NCT00861380|523724854|FG000|Overall Study|Withdrawal Information not recorded|8427|||
145240556|NCT00861380|523724855|FG001|Overall Study|Withdrawal Information not recorded|9112|||
145240557|NCT00861380|523724856|FG002|Overall Study|Withdrawal Information not recorded|8872|||
145240558|NCT00861380|523724857|FG003|Overall Study|Withdrawal Information not recorded|3689|||
145240559|NCT00861380|523724858|FG004|Overall Study|Withdrawal Information not recorded|1812|||
145240560|NCT00861380|523724859|FG005|Overall Study|Withdrawal Information not recorded|6249|||
145240561|NCT00861380|523724860|FG006|Overall Study|Withdrawal Information not recorded|3020|||
145240562|NCT00376246|523724862|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
145240563|NCT00376246|523724863|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
145240564|NCT00376246|523724862|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145240565|NCT00376246|523724863|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
145240566|NCT00376246|523724862|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
145240567|NCT00376246|523724863|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145296194|NCT01030965|523934451|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
145296195|NCT01030965|523934448|FG000|Overall Study|Withdrawal by Subject|0|||
145296196|NCT01030965|523934449|FG001|Overall Study|Withdrawal by Subject|1|||
145296197|NCT01030965|523934450|FG002|Overall Study|Withdrawal by Subject|0|||
145296198|NCT01030965|523934451|FG003|Overall Study|Withdrawal by Subject|2|||
145296199|NCT02097290|523934452|FG000|Overall Study|Death|6|||
145620057|NCT03468426|525123650|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145620058|NCT03468426|525123651|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145296200|NCT02097290|523934452|FG000|Overall Study|Total Withdrawals|3|||
145296201|NCT02097290|523934452|FG000|Overall Study|Attempt|8|||
145296202|NCT00824265|523934455|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
145296203|NCT00824265|523934456|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
145296204|NCT00824265|523934455|FG000|Treatment Phase|Protocol Violation|1|||
145296205|NCT00824265|523934456|FG001|Treatment Phase|Protocol Violation|0|||
145563634|NCT02658890|524924004|FG000|Treatment Phase|Study Drug Toxicity|0|||
145563635|NCT02658890|524924005|FG001|Treatment Phase|Study Drug Toxicity|0|||
145563636|NCT02658890|524924006|FG002|Treatment Phase|Study Drug Toxicity|2|||
145563637|NCT02658890|524924007|FG003|Treatment Phase|Study Drug Toxicity|0|||
145563638|NCT02658890|524924008|FG004|Treatment Phase|Study Drug Toxicity|0|||
145563639|NCT02658890|524924009|FG005|Treatment Phase|Study Drug Toxicity|0|||
145563640|NCT02658890|524924010|FG006|Treatment Phase|Study Drug Toxicity|0|||
145563641|NCT02658890|524924011|FG007|Treatment Phase|Study Drug Toxicity|0|||
145563642|NCT02658890|524924012|FG008|Treatment Phase|Study Drug Toxicity|3|||
145563643|NCT02658890|524924013|FG009|Treatment Phase|Study Drug Toxicity|0|||
145296206|NCT00824265|523934455|FG000|Treatment Phase|Lost to Follow-up|1|||
145296207|NCT00824265|523934456|FG001|Treatment Phase|Lost to Follow-up|1|||
145296208|NCT00824265|523934455|FG000|Treatment Phase|Physician Decision|6|||
145296209|NCT00824265|523934456|FG001|Treatment Phase|Physician Decision|12|||
145296210|NCT00824265|523934455|FG000|Treatment Phase|Withdrawal by Subject|6|||
145296211|NCT00824265|523934456|FG001|Treatment Phase|Withdrawal by Subject|15|||
145296212|NCT00824265|523934455|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
145296213|NCT00824265|523934456|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
145296214|NCT00824265|523934455|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
145296215|NCT00824265|523934456|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
145563644|NCT02658890|524924014|FG010|Treatment Phase|Study Drug Toxicity|1|||
145240568|NCT03205982|523724864|FG000|Overall Study|Lost to Follow-up|20|||
145240569|NCT03205982|523724865|FG001|Overall Study|Lost to Follow-up|19|||
145563645|NCT02658890|524924015|FG011|Treatment Phase|Study Drug Toxicity|1|||
145240570|NCT03205982|523724864|FG000|Overall Study|Withdrawal by Subject|4|||
145240571|NCT03205982|523724865|FG001|Overall Study|Withdrawal by Subject|3|||
145240572|NCT03205982|523724864|FG000|Overall Study|Withdrawal by PI|0|||
145240573|NCT03205982|523724865|FG001|Overall Study|Withdrawal by PI|1|||
145240574|NCT00994162|523724868|FG000|Overall Study|Withdrawal by Subject|1|||
145240575|NCT00994162|523724868|FG000|Overall Study|Lost to Follow-up|2|||
145240576|NCT00994162|523724868|FG000|Overall Study|Product Complaint|1|||
145296216|NCT02888171|523934459|FG000|Overall Study|Lost to Follow-up|2|||
145296217|NCT02888171|523934460|FG001|Overall Study|Lost to Follow-up|1|||
145296218|NCT02888171|523934459|FG000|Overall Study|Withdrawal by Subject|3|||
145296219|NCT02888171|523934460|FG001|Overall Study|Withdrawal by Subject|2|||
145296220|NCT02888171|523934459|FG000|Overall Study|Adverse Event|0|||
145296221|NCT02888171|523934460|FG001|Overall Study|Adverse Event|1|||
145563646|NCT02658890|524924016|FG012|Treatment Phase|Study Drug Toxicity|2|||
145563647|NCT02658890|524924017|FG013|Treatment Phase|Study Drug Toxicity|9|||
145240577|NCT00994162|523724868|FG000|Overall Study|Poor Compliance|5|||
145240578|NCT00994162|523724868|FG000|Overall Study|Lack of Response|3|||
145240579|NCT00994162|523724868|FG000|Overall Study|Discharged from Hospital|4|||
145240580|NCT00994162|523724868|FG000|Overall Study|Death|2|||
145240581|NCT00994162|523724868|FG000|Overall Study|Care Transferred to Another Physician|2|||
145240582|NCT00994162|523724868|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
145240583|NCT00994162|523724868|FG000|Overall Study|Physician Decision|2|||
145240584|NCT00994162|523724868|FG000|Overall Study|Surrounding Wound Erythematous|1|||
145240585|NCT00994162|523724868|FG000|Overall Study|Machine Losing Vaccum|1|||
145240586|NCT00994162|523724868|FG000|Overall Study|Patient Lived Too Far Away|1|||
145240587|NCT00994162|523724868|FG000|Overall Study|Above Knee Amputation|1|||
145240588|NCT00994162|523724868|FG000|Overall Study|Reason Not Reported By Site|1|||
145240589|NCT02983799|523724869|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
145240590|NCT02983799|523724870|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
145240591|NCT02983799|523724871|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
145240592|NCT02983799|523724872|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
145240593|NCT02983799|523724873|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
145240594|NCT02983799|523724869|FG000|Overall Study|Death|20|||
145240595|NCT02983799|523724870|FG001|Overall Study|Death|5|||
145240596|NCT02983799|523724871|FG002|Overall Study|Death|23|||
145240597|NCT02983799|523724872|FG003|Overall Study|Death|47|||
145240598|NCT02983799|523724873|FG004|Overall Study|Death|7|||
145240599|NCT02983799|523724869|FG000|Overall Study|Withdrawal by Subject|1|||
145240600|NCT02983799|523724870|FG001|Overall Study|Withdrawal by Subject|0|||
145240601|NCT02983799|523724871|FG002|Overall Study|Withdrawal by Subject|3|||
145240602|NCT02983799|523724872|FG003|Overall Study|Withdrawal by Subject|4|||
145240603|NCT02983799|523724873|FG004|Overall Study|Withdrawal by Subject|1|||
145240604|NCT02983799|523724869|FG000|Overall Study|Protocol Violation|0|||
145240605|NCT02983799|523724870|FG001|Overall Study|Protocol Violation|1|||
145240606|NCT02983799|523724871|FG002|Overall Study|Protocol Violation|0|||
145240607|NCT02983799|523724872|FG003|Overall Study|Protocol Violation|0|||
145240608|NCT02983799|523724873|FG004|Overall Study|Protocol Violation|1|||
145240609|NCT02983799|523724869|FG000|Overall Study|Lost to Follow-up|1|||
145240610|NCT02983799|523724870|FG001|Overall Study|Lost to Follow-up|0|||
145240611|NCT02983799|523724871|FG002|Overall Study|Lost to Follow-up|1|||
145240612|NCT02983799|523724872|FG003|Overall Study|Lost to Follow-up|0|||
145240613|NCT02983799|523724873|FG004|Overall Study|Lost to Follow-up|0|||
145240614|NCT03136367|523724884|FG000|T1 Consultation|discontinued mistakenly included|2|||
145240615|NCT03136367|523724885|FG001|T1 Consultation|discontinued mistakenly included|6|||
145240616|NCT03136367|523724886|FG002|T1 Consultation|discontinued mistakenly included|1|||
145240617|NCT03136367|523724884|FG000|T1 Consultation|Discontinued other|0|||
145240618|NCT03136367|523724885|FG001|T1 Consultation|Discontinued other|1|||
145240619|NCT03136367|523724886|FG002|T1 Consultation|Discontinued other|0|||
145240620|NCT03136367|523724884|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
145240621|NCT03136367|523724885|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
145240622|NCT03136367|523724886|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
145240623|NCT03136367|523724884|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
145240624|NCT03136367|523724885|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
145240625|NCT03136367|523724886|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
145240626|NCT03136367|523724884|FG000|T2 Post-consultation|Discontinued other|0|||
145240627|NCT03136367|523724885|FG001|T2 Post-consultation|Discontinued other|2|||
145240628|NCT03136367|523724886|FG002|T2 Post-consultation|Discontinued other|6|||
145240629|NCT03136367|523724884|FG000|T2 Post-consultation|Discontinued transferred care|0|||
145240630|NCT03136367|523724885|FG001|T2 Post-consultation|Discontinued transferred care|0|||
145240631|NCT03136367|523724886|FG002|T2 Post-consultation|Discontinued transferred care|3|||
145240632|NCT03136367|523724884|FG000|T2 Post-consultation|Discontinued lost contact|0|||
145240633|NCT03136367|523724885|FG001|T2 Post-consultation|Discontinued lost contact|1|||
145240634|NCT03136367|523724886|FG002|T2 Post-consultation|Discontinued lost contact|0|||
145240635|NCT03136367|523724884|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
145240636|NCT03136367|523724885|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
145240637|NCT03136367|523724886|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
145240638|NCT03136367|523724884|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
145240639|NCT03136367|523724885|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
145240640|NCT03136367|523724886|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
145296222|NCT02920996|523934461|FG000|Overall Study|Adverse Event|8|||
145240641|NCT03136367|523724884|FG000|T3 1 Week After Surgery|other discontinued|2|||
145240642|NCT03136367|523724885|FG001|T3 1 Week After Surgery|other discontinued|4|||
145240643|NCT03136367|523724886|FG002|T3 1 Week After Surgery|other discontinued|3|||
145240644|NCT03136367|523724884|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
145240645|NCT03136367|523724885|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
145240646|NCT03136367|523724886|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
145240647|NCT03136367|523724884|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
145240648|NCT03136367|523724885|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
145240649|NCT03136367|523724886|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
145240650|NCT03136367|523724884|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
145240651|NCT03136367|523724885|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
145240652|NCT03136367|523724886|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
145240653|NCT03136367|523724884|FG000|T4 12 Weeks After Surgery|Death|0|||
145240654|NCT03136367|523724885|FG001|T4 12 Weeks After Surgery|Death|1|||
145240655|NCT03136367|523724886|FG002|T4 12 Weeks After Surgery|Death|3|||
145240656|NCT03136367|523724884|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
145240657|NCT03136367|523724885|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
145240658|NCT03136367|523724886|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
145240659|NCT03136367|523724884|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
145240660|NCT03136367|523724885|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
145240661|NCT03136367|523724886|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
145240662|NCT03136367|523724884|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
145240663|NCT03136367|523724885|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
145240664|NCT03136367|523724886|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
145240665|NCT03136367|523724884|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
145240666|NCT03136367|523724885|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
145240667|NCT03136367|523724886|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
145240668|NCT03136367|523724884|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
145240669|NCT03136367|523724885|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
145240670|NCT03136367|523724886|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
145240671|NCT03136367|523724884|FG000|T5 1 Year After Surgery|Death|0|||
145240672|NCT03136367|523724885|FG001|T5 1 Year After Surgery|Death|0|||
145240673|NCT03136367|523724886|FG002|T5 1 Year After Surgery|Death|1|||
145240674|NCT03136367|523724884|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
145240675|NCT03136367|523724885|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
145240676|NCT03136367|523724886|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
145240677|NCT03136367|523724884|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
145240678|NCT03136367|523724885|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
145240679|NCT03136367|523724886|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
145240680|NCT03136367|523724884|FG000|T5 1 Year After Surgery|study ended before due|31|||
145240681|NCT03136367|523724885|FG001|T5 1 Year After Surgery|study ended before due|103|||
145240682|NCT03136367|523724886|FG002|T5 1 Year After Surgery|study ended before due|110|||
145240683|NCT03136367|523724884|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
145240684|NCT03136367|523724885|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
145240685|NCT03136367|523724886|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
145240686|NCT03307629|523724890|FG000|Overall Study|Withdrawal by Subject|0|||
145240687|NCT03307629|523724891|FG001|Overall Study|Withdrawal by Subject|0|||
145240688|NCT03307629|523724892|FG002|Overall Study|Withdrawal by Subject|0|||
145240689|NCT03307629|523724893|FG003|Overall Study|Withdrawal by Subject|2|||
145240690|NCT03307629|523724890|FG000|Overall Study|Disease Progression|0|||
145240691|NCT03307629|523724891|FG001|Overall Study|Disease Progression|0|||
145240692|NCT03307629|523724892|FG002|Overall Study|Disease Progression|0|||
145240693|NCT03307629|523724893|FG003|Overall Study|Disease Progression|3|||
145240694|NCT03307629|523724890|FG000|Overall Study|Death|0|||
145240695|NCT03307629|523724891|FG001|Overall Study|Death|3|||
145240696|NCT03307629|523724892|FG002|Overall Study|Death|0|||
145240697|NCT03307629|523724893|FG003|Overall Study|Death|1|||
145240698|NCT02853032|523724894|FG000|Overall Study|Adverse Event|4|||
145240699|NCT02853032|523724895|FG001|Overall Study|Adverse Event|0|||
145240700|NCT02853032|523724894|FG000|Overall Study|Withdrawal by Subject|3|||
145240701|NCT02853032|523724895|FG001|Overall Study|Withdrawal by Subject|1|||
145240702|NCT02853032|523724894|FG000|Overall Study|Requested to withdraw from all treatment|2|||
145240703|NCT02853032|523724895|FG001|Overall Study|Requested to withdraw from all treatment|2|||
145240704|NCT02146833|523724896|FG000|Overall Study|Death|10|||
145240705|NCT02146833|523724896|FG000|Overall Study|No longer consented to study treatment|1|||
145240706|NCT03726333|523724897|FG000|Overall Study|Progressive Disease|0|||
145240707|NCT03726333|523724898|FG001|Overall Study|Progressive Disease|0|||
145620059|NCT03468426|525123652|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145240708|NCT03726333|523724899|FG002|Overall Study|Progressive Disease|1|||
145240709|NCT03726333|523724900|FG003|Overall Study|Progressive Disease|0|||
145240710|NCT03726333|523724901|FG004|Overall Study|Progressive Disease|0|||
145240711|NCT03366844|523726411|FG000|Overall Study|Physician Decision|1|||
145240712|NCT03366844|523726411|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
145240713|NCT03682055|523726417|FG000|Overall Study|Lack of Efficacy|1|||
145240714|NCT03682055|523726418|FG001|Overall Study|Lack of Efficacy|2|||
145240715|NCT03682055|523726419|FG002|Overall Study|Lack of Efficacy|1|||
145240716|NCT03682055|523726420|FG003|Overall Study|Lack of Efficacy|2|||
145240717|NCT03682055|523726421|FG004|Overall Study|Lack of Efficacy|1|||
145240718|NCT03682055|523726422|FG005|Overall Study|Lack of Efficacy|3|||
145240719|NCT03682055|523726417|FG000|Overall Study|Withdrawal by Subject|0|||
145240720|NCT03682055|523726418|FG001|Overall Study|Withdrawal by Subject|0|||
145240721|NCT03682055|523726419|FG002|Overall Study|Withdrawal by Subject|0|||
145240722|NCT03682055|523726420|FG003|Overall Study|Withdrawal by Subject|0|||
145240723|NCT03682055|523726421|FG004|Overall Study|Withdrawal by Subject|0|||
145240724|NCT03682055|523726422|FG005|Overall Study|Withdrawal by Subject|1|||
145240725|NCT03682055|523726417|FG000|Overall Study|Termination of Study by Sponsor|0|||
145240726|NCT03682055|523726418|FG001|Overall Study|Termination of Study by Sponsor|0|||
145240727|NCT03682055|523726419|FG002|Overall Study|Termination of Study by Sponsor|0|||
145240728|NCT03682055|523726420|FG003|Overall Study|Termination of Study by Sponsor|0|||
145240729|NCT03682055|523726421|FG004|Overall Study|Termination of Study by Sponsor|0|||
145240730|NCT03682055|523726422|FG005|Overall Study|Termination of Study by Sponsor|3|||
145240731|NCT02687711|523726423|FG000|Overall Study|Adverse Event|89|||
145240732|NCT02687711|523726423|FG000|Overall Study|Lack of Efficacy|70|||
145240733|NCT02687711|523726423|FG000|Overall Study|Lost to Follow-up|20|||
145240734|NCT02687711|523726423|FG000|Overall Study|Consent withdrawn|15|||
145240735|NCT02687711|523726423|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
145240736|NCT02687711|523726423|FG000|Overall Study|Too expensive|4|||
145240737|NCT02687711|523726423|FG000|Overall Study|Participant moved abroad|1|||
145240738|NCT02687711|523726423|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
145240739|NCT02687711|523726423|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
145240740|NCT02687711|523726423|FG000|Overall Study|Disliked taste|1|||
145240741|NCT02687711|523726423|FG000|Overall Study|Low mood|1|||
145240742|NCT02687711|523726423|FG000|Overall Study|Side effects|1|||
145240743|NCT02687711|523726423|FG000|Overall Study|Change of Hospital|1|||
145240744|NCT02687711|523726423|FG000|Overall Study|Liver Encephalopathy|1|||
145240745|NCT02687711|523726423|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
145240746|NCT02687711|523726423|FG000|Overall Study|Withdrawn due to intake interruption|1|||
145240747|NCT02687711|523726423|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
145240748|NCT02687711|523726423|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
145240749|NCT02687711|523726423|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
145240750|NCT00191386|523726424|FG000|Overall Study|Adverse Event|16|||
145240751|NCT00191386|523726424|FG000|Overall Study|Lost to Follow-up|1|||
145240752|NCT00191386|523726424|FG000|Overall Study|Entry Criteria Exclusion|3|||
145240753|NCT00191386|523726424|FG000|Overall Study|Protocol Violation|18|||
145240754|NCT00191386|523726424|FG000|Overall Study|Withdrawal by Subject|96|||
145240755|NCT00191386|523726424|FG000|Overall Study|Physician Decision|11|||
145240756|NCT00191386|523726424|FG000|Overall Study|Lack of Efficacy|15|||
145296223|NCT02920996|523934462|FG001|Overall Study|Adverse Event|0|||
145296224|NCT02920996|523934461|FG000|Overall Study|Physician Decision|1|||
145296225|NCT02920996|523934462|FG001|Overall Study|Physician Decision|0|||
145296226|NCT02920996|523934461|FG000|Overall Study|Death|1|||
145296227|NCT02920996|523934462|FG001|Overall Study|Death|0|||
145563648|NCT02658890|524924018|FG014|Treatment Phase|Study Drug Toxicity|0|||
145563649|NCT02658890|524924019|FG015|Treatment Phase|Study Drug Toxicity|1|||
145563650|NCT02658890|524924020|FG016|Treatment Phase|Study Drug Toxicity|1|||
145563651|NCT02658890|524924021|FG017|Treatment Phase|Study Drug Toxicity|0|||
145563652|NCT02658890|524924022|FG018|Treatment Phase|Study Drug Toxicity|8|||
145563653|NCT02658890|524924023|FG019|Treatment Phase|Study Drug Toxicity|3|||
145563654|NCT02658890|524924024|FG020|Treatment Phase|Study Drug Toxicity|2|||
145240757|NCT03077243|523726425|FG000|Overall Study|Death|1|||
145240758|NCT03077243|523726426|FG001|Overall Study|Death|2|||
145240759|NCT03077243|523726427|FG002|Overall Study|Death|0|||
145296228|NCT02920996|523934461|FG000|Overall Study|Missing|1|||
145296229|NCT02920996|523934462|FG001|Overall Study|Missing|0|||
145296230|NCT02920996|523934461|FG000|Overall Study|Subject Non-Compliance|1|||
145296231|NCT02920996|523934462|FG001|Overall Study|Subject Non-Compliance|0|||
145296232|NCT01402947|523934463|FG000|First Intervention|Adverse Event|0|||
145296233|NCT01402947|523934464|FG001|First Intervention|Adverse Event|1|||
145296234|NCT00591630|523934465|FG000|Overall Study|Death|0|||
145296235|NCT00591630|523934466|FG001|Overall Study|Death|0|||
145296236|NCT00591630|523934467|FG002|Overall Study|Death|1|||
145296237|NCT00591630|523934468|FG003|Overall Study|Death|0|||
145563655|NCT02658890|524924025|FG021|Treatment Phase|Study Drug Toxicity|0|||
145240760|NCT03077243|523726428|FG003|Overall Study|Death|0|||
145240761|NCT03077243|523726425|FG000|Overall Study|Withdrawal by Subject|1|||
145240762|NCT03077243|523726426|FG001|Overall Study|Withdrawal by Subject|3|||
145240763|NCT03077243|523726427|FG002|Overall Study|Withdrawal by Subject|0|||
145240764|NCT03077243|523726428|FG003|Overall Study|Withdrawal by Subject|0|||
145296238|NCT02158936|523934473|FG000|Overall Study|Study closed/ terminated|57|||
145296239|NCT02158936|523934474|FG001|Overall Study|Study closed/ terminated|77|||
145296240|NCT02158936|523934473|FG000|Overall Study|Azacitidine tx discontinued|53|||
145296241|NCT02158936|523934474|FG001|Overall Study|Azacitidine tx discontinued|46|||
145296242|NCT02158936|523934473|FG000|Overall Study|Adverse Event|39|||
145563656|NCT02658890|524924026|FG022|Treatment Phase|Study Drug Toxicity|8|||
145563657|NCT02658890|524924027|FG023|Treatment Phase|Study Drug Toxicity|0|||
145563658|NCT02658890|524924028|FG024|Treatment Phase|Study Drug Toxicity|0|||
145563659|NCT02658890|524924029|FG025|Treatment Phase|Study Drug Toxicity|2|||
145563660|NCT02658890|524924030|FG026|Treatment Phase|Study Drug Toxicity|0|||
145563661|NCT02658890|524924004|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145240765|NCT03077243|523726425|FG000|Overall Study|Physician Decision|1|||
145240766|NCT03077243|523726426|FG001|Overall Study|Physician Decision|0|||
145240767|NCT03077243|523726427|FG002|Overall Study|Physician Decision|0|||
145240768|NCT03077243|523726428|FG003|Overall Study|Physician Decision|0|||
145240769|NCT03077243|523726425|FG000|Overall Study|Research at two study sites terminated early|0|||
145240770|NCT03077243|523726426|FG001|Overall Study|Research at two study sites terminated early|0|||
145240771|NCT03077243|523726427|FG002|Overall Study|Research at two study sites terminated early|0|||
145240772|NCT03077243|523726428|FG003|Overall Study|Research at two study sites terminated early|69|||
145240773|NCT03984812|523726429|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240774|NCT03984812|523726430|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240775|NCT03984812|523726431|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
145240776|NCT03984812|523726432|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240777|NCT03984812|523726433|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240778|NCT03984812|523726434|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240779|NCT03984812|523726435|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240780|NCT03984812|523726436|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240781|NCT03984812|523726437|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240782|NCT03984812|523726438|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240783|NCT03984812|523726439|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
145240784|NCT02580240|523726440|FG000|Overall Study|Physician Decision|2|||
145240785|NCT02580240|523726441|FG001|Overall Study|Physician Decision|0|||
145240786|NCT02954952|523726442|FG000|Overall Study|Withdrawal by Subject|1|||
145240787|NCT02954952|523726443|FG001|Overall Study|Withdrawal by Subject|0|||
145240788|NCT02954952|523726444|FG002|Overall Study|Withdrawal by Subject|0|||
145240789|NCT02954952|523726442|FG000|Overall Study|No data collected|0|||
145240790|NCT02954952|523726443|FG001|Overall Study|No data collected|1|||
145240791|NCT02954952|523726444|FG002|Overall Study|No data collected|0|||
145240792|NCT02911519|523726445|FG000|Overall Study|Lost to Follow-up|2|||
145240793|NCT02911519|523726446|FG001|Overall Study|Lost to Follow-up|2|||
145240794|NCT02911519|523726445|FG000|Overall Study|Death|0|||
145240795|NCT02911519|523726446|FG001|Overall Study|Death|2|||
145240796|NCT00653328|523726447|FG000|Overall Study|Withdrawal by Subject|1|||
145240797|NCT00653328|523726447|FG000|Overall Study|Adverse Event|2|||
145240798|NCT00653328|523726447|FG000|Overall Study|Disease progression|10|||
145240799|NCT00653328|523726447|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
145240800|NCT01237223|523726454|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
145240801|NCT01237223|523726455|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
145240802|NCT01237223|523726456|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
145240803|NCT01237223|523726457|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
145240804|NCT01237223|523726458|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
145240805|NCT01237223|523726459|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
145240806|NCT01237223|523726454|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
145240807|NCT01237223|523726455|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
145240808|NCT01237223|523726456|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
145240809|NCT01237223|523726457|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
145240810|NCT01237223|523726458|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
145240811|NCT01237223|523726459|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
145240812|NCT01237223|523726454|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
145240813|NCT01237223|523726455|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
145240814|NCT01237223|523726456|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
145240815|NCT01237223|523726457|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
145240816|NCT01237223|523726458|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
145240817|NCT01237223|523726459|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
145240818|NCT01237223|523726454|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
145240819|NCT01237223|523726455|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
145240820|NCT01237223|523726456|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
145240821|NCT01237223|523726457|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
145563662|NCT02658890|524924005|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563663|NCT02658890|524924006|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145240822|NCT01237223|523726458|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
145240823|NCT01237223|523726459|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
145240824|NCT01237223|523726454|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
145240825|NCT01237223|523726455|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
145240826|NCT01237223|523726456|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
145563664|NCT02658890|524924007|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
145240827|NCT01237223|523726457|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
145240828|NCT01237223|523726458|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
145296243|NCT02158936|523934474|FG001|Overall Study|Adverse Event|24|||
145296244|NCT02158936|523934473|FG000|Overall Study|Withdrawal by Subject|15|||
145296245|NCT02158936|523934474|FG001|Overall Study|Withdrawal by Subject|16|||
145296246|NCT02158936|523934473|FG000|Overall Study|Physician Decision|15|||
145296247|NCT02158936|523934474|FG001|Overall Study|Physician Decision|13|||
145296248|NCT02158936|523934473|FG000|Overall Study|Lost to Follow-up|0|||
145296249|NCT02158936|523934474|FG001|Overall Study|Lost to Follow-up|1|||
145296250|NCT00522457|523934475|FG000|Overall Study|Due to disease progression|16|||
145296251|NCT00522457|523934475|FG000|Overall Study|Adverse Event|2|||
145296252|NCT01706926|523934476|FG000|Overall Study|Lost to Follow-up|0|||
145296253|NCT01706926|523934477|FG001|Overall Study|Lost to Follow-up|0|||
145296254|NCT01706926|523934478|FG002|Overall Study|Lost to Follow-up|1|||
145296255|NCT01706926|523934479|FG003|Overall Study|Lost to Follow-up|0|||
145296256|NCT01706926|523934476|FG000|Overall Study|Withdrawal by Subject|2|||
145296257|NCT01706926|523934477|FG001|Overall Study|Withdrawal by Subject|0|||
145296258|NCT01706926|523934478|FG002|Overall Study|Withdrawal by Subject|1|||
145296259|NCT01706926|523934479|FG003|Overall Study|Withdrawal by Subject|2|||
145296260|NCT01706926|523934476|FG000|Overall Study|Other|4|||
145296261|NCT01706926|523934477|FG001|Overall Study|Other|4|||
145296262|NCT01706926|523934478|FG002|Overall Study|Other|4|||
145296263|NCT01706926|523934479|FG003|Overall Study|Other|3|||
145296264|NCT04349917|523935735|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
145296265|NCT04349917|523935736|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
145296266|NCT04349917|523935735|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
145296267|NCT04349917|523935736|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
145296268|NCT04188106|523935737|FG000|Overall Study|Lost to Follow-up|5|||
145296269|NCT04188106|523935737|FG000|Overall Study|Non-Compliance|1|||
145296270|NCT00441467|523935738|FG000|Overall Study|Adverse Event|6|||
145240829|NCT01237223|523726459|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
145240830|NCT01237223|523726454|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
145240831|NCT01237223|523726455|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
145240832|NCT01237223|523726456|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
145240833|NCT01237223|523726457|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
145240834|NCT01237223|523726458|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
145240835|NCT01237223|523726459|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
145240836|NCT01237223|523726454|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
145240837|NCT01237223|523726455|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
145240838|NCT01237223|523726456|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
145240839|NCT01237223|523726457|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
145240840|NCT01237223|523726458|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
145240841|NCT01237223|523726459|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
145240842|NCT01237223|523726454|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
145240843|NCT01237223|523726455|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
145240844|NCT01237223|523726456|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
145240845|NCT01237223|523726457|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
145240846|NCT01237223|523726458|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
145240847|NCT01237223|523726459|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
145240848|NCT01237223|523726454|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
145240849|NCT01237223|523726455|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
145240850|NCT01237223|523726456|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
145240851|NCT01237223|523726457|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
145240852|NCT01237223|523726458|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
145240853|NCT01237223|523726459|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
145240854|NCT01237223|523726454|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
145240855|NCT01237223|523726455|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
145240856|NCT01237223|523726456|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
145240857|NCT01237223|523726457|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
145240858|NCT01237223|523726458|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
145296271|NCT00441467|523935738|FG000|Overall Study|Withdrawal by Subject|3|||
145296272|NCT00441467|523935738|FG000|Overall Study|Progressive disease|9|||
145296273|NCT02289963|523935739|FG000|Overall Study|Adverse Event|1|||
145296274|NCT02289963|523935740|FG001|Overall Study|Adverse Event|2|||
145296275|NCT02289963|523935739|FG000|Overall Study|Poor compliance to protocol|1|||
145296276|NCT02289963|523935740|FG001|Overall Study|Poor compliance to protocol|0|||
145296277|NCT02289963|523935739|FG000|Overall Study|Withdrawal by Subject|1|||
145296278|NCT02289963|523935740|FG001|Overall Study|Withdrawal by Subject|0|||
145296279|NCT02289963|523935739|FG000|Overall Study|Last injection missed|2|||
145240859|NCT01237223|523726459|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
145240860|NCT00813917|523726466|FG000|Overall Study|Adverse Event|0|||
145240861|NCT00813917|523726467|FG001|Overall Study|Adverse Event|1|||
145240862|NCT00813917|523726466|FG000|Overall Study|Withdrawal by Subject|3|||
145240863|NCT00813917|523726467|FG001|Overall Study|Withdrawal by Subject|4|||
145240864|NCT00813917|523726466|FG000|Overall Study|Lost to Follow-up|3|||
145240865|NCT00813917|523726467|FG001|Overall Study|Lost to Follow-up|1|||
145240866|NCT01359046|523726468|FG000|Overall Study|Did not receive allocated intervention|6|||
145240867|NCT01359046|523726469|FG001|Overall Study|Did not receive allocated intervention|6|||
145240868|NCT01359046|523726468|FG000|Overall Study|Physician Decision|1|||
145240869|NCT01359046|523726469|FG001|Overall Study|Physician Decision|11|||
145240870|NCT00792701|523726472|FG000|Overall Study|Adverse Event|0|||
145240871|NCT00792701|523726473|FG001|Overall Study|Adverse Event|22|||
145240872|NCT00792701|523726472|FG000|Overall Study|Ineligible|1|||
145240873|NCT00792701|523726473|FG001|Overall Study|Ineligible|3|||
145240874|NCT00792701|523726472|FG000|Overall Study|Withdrawal by Subject|1|||
145240875|NCT00792701|523726473|FG001|Overall Study|Withdrawal by Subject|19|||
145240876|NCT00792701|523726472|FG000|Overall Study|Not protocol specified|17|||
145240877|NCT00792701|523726473|FG001|Overall Study|Not protocol specified|0|||
145240878|NCT00064077|523726478|FG000|Overall Study|Improper prior treatment|1|||
145240879|NCT00064077|523726479|FG001|Overall Study|Improper prior treatment|0|||
145240880|NCT00064077|523726480|FG002|Overall Study|Improper prior treatment|0|||
145240881|NCT00064077|523726481|FG003|Overall Study|Improper prior treatment|0|||
145240882|NCT00064077|523726478|FG000|Overall Study|Poor risk|2|||
145240883|NCT00064077|523726479|FG001|Overall Study|Poor risk|0|||
145240884|NCT00064077|523726480|FG002|Overall Study|Poor risk|1|||
145240885|NCT00064077|523726481|FG003|Overall Study|Poor risk|1|||
145240886|NCT00064077|523726478|FG000|Overall Study|Pathology|10|||
145240887|NCT00064077|523726479|FG001|Overall Study|Pathology|7|||
145240888|NCT00064077|523726480|FG002|Overall Study|Pathology|3|||
145240889|NCT00064077|523726481|FG003|Overall Study|Pathology|4|||
145240890|NCT00064077|523726478|FG000|Overall Study|No surgery|0|||
145240891|NCT00064077|523726479|FG001|Overall Study|No surgery|0|||
145240892|NCT00064077|523726480|FG002|Overall Study|No surgery|1|||
145240893|NCT00064077|523726481|FG003|Overall Study|No surgery|0|||
145240894|NCT00064077|523726478|FG000|Overall Study|No tumor|0|||
145240895|NCT00064077|523726479|FG001|Overall Study|No tumor|0|||
145240896|NCT00064077|523726480|FG002|Overall Study|No tumor|1|||
145240897|NCT00064077|523726481|FG003|Overall Study|No tumor|0|||
145240898|NCT00064077|523726478|FG000|Overall Study|Other reasons|2|||
145240899|NCT00064077|523726479|FG001|Overall Study|Other reasons|2|||
145240900|NCT00064077|523726480|FG002|Overall Study|Other reasons|1|||
145240901|NCT00064077|523726481|FG003|Overall Study|Other reasons|2|||
145240902|NCT00615914|523726482|FG000|Overall Study|Adverse Event|274|||
145240903|NCT00615914|523726482|FG000|Overall Study|Death|20|||
145240904|NCT00615914|523726482|FG000|Overall Study|Lack of Efficacy|59|||
145240905|NCT00615914|523726482|FG000|Overall Study|Lost to Follow-up|187|||
145240906|NCT00615914|523726482|FG000|Overall Study|Withdrawal by Subject|16|||
145240907|NCT00615914|523726482|FG000|Overall Study|Physician Decision|4|||
145240908|NCT00615914|523726482|FG000|Overall Study|No data was collected.|65|||
145240909|NCT00615914|523726482|FG000|Overall Study|No treatment|2|||
145240910|NCT00615914|523726482|FG000|Overall Study|Irregularly enrolled patients|10|||
145240911|NCT00802867|523726485|FG000|Overall Study|Lost to Follow-up|6|||
145240912|NCT00802867|523726485|FG000|Overall Study|Protocol Violation|6|||
145240913|NCT00802867|523726485|FG000|Overall Study|Withdrawal by Subject|1|||
145240914|NCT04075396|523726486|FG000|Overall Study|Death|11|||
145240915|NCT04075396|523726487|FG001|Overall Study|Death|9|||
145240916|NCT04075396|523726486|FG000|Overall Study|Withdrawal by Subject|1|||
145240917|NCT04075396|523726487|FG001|Overall Study|Withdrawal by Subject|2|||
145240918|NCT04075396|523726486|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
145240919|NCT04075396|523726487|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
145240920|NCT04075396|523726486|FG000|Overall Study|Enrolled but not-treated|0|||
145240921|NCT04075396|523726487|FG001|Overall Study|Enrolled but not-treated|1|||
145240922|NCT01156532|523726488|FG000|Overall Study|Family Reasons|1|||
145240923|NCT01156532|523726488|FG000|Overall Study|Lost to Follow-up|1|||
145240924|NCT01809197|523726489|FG000|Overall Study|Lost to Follow-up|4|||
145240925|NCT01809197|523726490|FG001|Overall Study|Lost to Follow-up|2|||
145240926|NCT01809197|523726489|FG000|Overall Study|Adverse Event|2|||
145296280|NCT02289963|523935740|FG001|Overall Study|Last injection missed|2|||
145240927|NCT01809197|523726490|FG001|Overall Study|Adverse Event|3|||
145240928|NCT01809197|523726489|FG000|Overall Study|Failed slit lamp exam|1|||
145240929|NCT01809197|523726490|FG001|Overall Study|Failed slit lamp exam|0|||
145240930|NCT01809197|523726489|FG000|Overall Study|Non-Compliance|1|||
145240931|NCT01809197|523726490|FG001|Overall Study|Non-Compliance|1|||
145240932|NCT01809197|523726489|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
145240933|NCT01809197|523726490|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
145240934|NCT01809197|523726489|FG000|Overall Study|Withdrawal by Subject|1|||
145240935|NCT01809197|523726490|FG001|Overall Study|Withdrawal by Subject|1|||
145563665|NCT02658890|524924008|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563666|NCT02658890|524924009|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563667|NCT02658890|524924010|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563668|NCT02658890|524924011|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563669|NCT02658890|524924012|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563670|NCT02658890|524924013|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
145240936|NCT01809197|523726489|FG000|Overall Study|Product not available|0|||
145240937|NCT01809197|523726490|FG001|Overall Study|Product not available|1|||
145240938|NCT03379376|523726495|FG000|Overall Study|Lost to Follow-up|2|||
145240939|NCT03379376|523726495|FG000|Overall Study|Did not wish to complete follow up|1|||
145240940|NCT03379376|523726495|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
145240941|NCT03379376|523726495|FG000|Overall Study|Death|1|||
145240942|NCT01611298|523726496|FG000|Overall Study|Relapsed|2|||
145240943|NCT01296698|523726497|FG000|Overall Study|Adverse Event|1|||
145240944|NCT01296698|523726498|FG001|Overall Study|Adverse Event|0|||
145240945|NCT01296698|523726497|FG000|Overall Study|Death|1|||
145240946|NCT01296698|523726498|FG001|Overall Study|Death|0|||
145240947|NCT01296698|523726497|FG000|Overall Study|Lost to Follow-up|19|||
145240948|NCT01296698|523726498|FG001|Overall Study|Lost to Follow-up|1|||
145240949|NCT01296698|523726497|FG000|Overall Study|Withdrawal by Subject|12|||
145240950|NCT01296698|523726498|FG001|Overall Study|Withdrawal by Subject|0|||
145240951|NCT01296698|523726497|FG000|Overall Study|Difficulty Contacting Subject|2|||
145240952|NCT01296698|523726498|FG001|Overall Study|Difficulty Contacting Subject|0|||
145240953|NCT01296698|523726497|FG000|Overall Study|Study Terminated by Sponsor|209|||
145240954|NCT01296698|523726498|FG001|Overall Study|Study Terminated by Sponsor|12|||
145240955|NCT03639987|523726501|FG000|Overall Study|Study terminated by sponsor|26|||
145240956|NCT03639987|523726502|FG001|Overall Study|Study terminated by sponsor|25|||
145240957|NCT03639987|523726501|FG000|Overall Study|Lost to Follow-up|0|||
145240958|NCT03639987|523726502|FG001|Overall Study|Lost to Follow-up|1|||
145240959|NCT04294095|523726514|FG000|Overall Study|Adverse Event|1|||
145240960|NCT04294095|523726515|FG001|Overall Study|Adverse Event|0|||
145240961|NCT01998399|523726517|FG000|Overall Study|Lost to Follow-up|1|||
145240962|NCT01998399|523726518|FG001|Overall Study|Lost to Follow-up|3|||
145240963|NCT01998399|523726517|FG000|Overall Study|Death|4|||
145240964|NCT01998399|523726518|FG001|Overall Study|Death|2|||
145240965|NCT01998399|523726517|FG000|Overall Study|Study stopped before dosing completed|3|||
145240966|NCT01998399|523726518|FG001|Overall Study|Study stopped before dosing completed|3|||
145240967|NCT01998399|523726517|FG000|Overall Study|Withdrawal by Subject|0|||
145240968|NCT01998399|523726518|FG001|Overall Study|Withdrawal by Subject|1|||
145240969|NCT01455415|523726533|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
145240970|NCT01455415|523726534|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
145240971|NCT01455415|523726533|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
145240972|NCT01455415|523726534|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
145240973|NCT01455415|523726533|FG000|Period 1|Drug Error not Associated to AE|0|||
145240974|NCT01455415|523726534|FG001|Period 1|Drug Error not Associated to AE|1|||
145240975|NCT01455415|523726533|FG000|Period 1|AE Not Related to Study Drug|2|||
145240976|NCT01455415|523726534|FG001|Period 1|AE Not Related to Study Drug|6|||
145240977|NCT01455415|523726533|FG000|Period 1|Withdrawal by Subject|4|||
145240978|NCT01455415|523726534|FG001|Period 1|Withdrawal by Subject|5|||
145240979|NCT01455415|523726533|FG000|Period 1|Unspecified Reason|1|||
145240980|NCT01455415|523726534|FG001|Period 1|Unspecified Reason|1|||
145240981|NCT01455415|523726533|FG000|Period 1|Protocol Violation|0|||
145240982|NCT01455415|523726534|FG001|Period 1|Protocol Violation|2|||
145240983|NCT01455415|523726533|FG000|Washout|AE Related to Study Drug|2|||
145240984|NCT01455415|523726534|FG001|Washout|AE Related to Study Drug|0|||
145240985|NCT01455415|523726533|FG000|Washout|Lost to Follow-up|1|||
145240986|NCT01455415|523726534|FG001|Washout|Lost to Follow-up|0|||
145240987|NCT01455415|523726533|FG000|Washout|Drug Error not Associated to AE|2|||
145240988|NCT01455415|523726534|FG001|Washout|Drug Error not Associated to AE|1|||
145296281|NCT02289963|523935739|FG000|Overall Study|End treatment visit outside visit window|0|||
145296282|NCT02289963|523935740|FG001|Overall Study|End treatment visit outside visit window|4|||
145296283|NCT02289963|523935739|FG000|Overall Study|Other than specified above|0|||
145563671|NCT02658890|524924014|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145296284|NCT02289963|523935740|FG001|Overall Study|Other than specified above|2|||
145240989|NCT01455415|523726533|FG000|Washout|AE Not Related to Study Drug|2|||
145240990|NCT01455415|523726534|FG001|Washout|AE Not Related to Study Drug|3|||
145240991|NCT01455415|523726533|FG000|Washout|Unspecified Reason|1|||
145240992|NCT01455415|523726534|FG001|Washout|Unspecified Reason|2|||
145240993|NCT01455415|523726533|FG000|Washout|Protocol Violation|0|||
145240994|NCT01455415|523726534|FG001|Washout|Protocol Violation|1|||
145240995|NCT01455415|523726533|FG000|Period 2|AE Related to Study Drug|1|||
145240996|NCT01455415|523726534|FG001|Period 2|AE Related to Study Drug|2|||
145240997|NCT01455415|523726533|FG000|Period 2|Lost to Follow-up|2|||
145240998|NCT01455415|523726534|FG001|Period 2|Lost to Follow-up|1|||
145240999|NCT01455415|523726533|FG000|Period 2|AE Not Related to Study Drug|2|||
145241000|NCT01455415|523726534|FG001|Period 2|AE Not Related to Study Drug|1|||
145241001|NCT01455415|523726533|FG000|Period 2|Lack of Efficacy|2|||
145241002|NCT01455415|523726534|FG001|Period 2|Lack of Efficacy|0|||
145241003|NCT01455415|523726533|FG000|Period 2|Withdrawal by Subject|2|||
145241004|NCT01455415|523726534|FG001|Period 2|Withdrawal by Subject|3|||
145241005|NCT01455415|523726533|FG000|Period 2|Unspecified Reason|2|||
145241006|NCT01455415|523726534|FG001|Period 2|Unspecified Reason|3|||
145241007|NCT01455415|523726533|FG000|Period 2|Protocol Violation|2|||
145241008|NCT01455415|523726534|FG001|Period 2|Protocol Violation|0|||
145241009|NCT01455415|523726533|FG000|Follow-up|AE Related to Study Drug|0|||
145241010|NCT01455415|523726534|FG001|Follow-up|AE Related to Study Drug|1|||
145241011|NCT01455415|523726533|FG000|Follow-up|Lack of Efficacy|0|||
145241012|NCT01455415|523726534|FG001|Follow-up|Lack of Efficacy|1|||
145241013|NCT01455415|523726533|FG000|Follow-up|Withdrawal by Subject|2|||
145241014|NCT01455415|523726534|FG001|Follow-up|Withdrawal by Subject|0|||
145241015|NCT01455415|523726533|FG000|Follow-up|Unspecified Reason|1|||
145241016|NCT01455415|523726534|FG001|Follow-up|Unspecified Reason|0|||
145241017|NCT02762708|523726535|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
145241018|NCT02762708|523726536|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
145241019|NCT02762708|523726537|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
145241020|NCT02762708|523726538|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
145241021|NCT01468701|523726543|FG000|Overall Study|Not eligible|91|||
145241022|NCT01468701|523726544|FG001|Overall Study|Not eligible|140|||
145241023|NCT01468701|523726545|FG002|Overall Study|Not eligible|29|||
145241024|NCT01468701|523726546|FG003|Overall Study|Not eligible|12|||
145241025|NCT01468701|523726547|FG004|Overall Study|Not eligible|22|||
145241026|NCT01468701|523726548|FG005|Overall Study|Not eligible|2|||
145241027|NCT01468701|523726549|FG006|Overall Study|Not eligible|39|||
145241028|NCT01468701|523726550|FG007|Overall Study|Not eligible|1|||
145241029|NCT01468701|523726551|FG008|Overall Study|Not eligible|40|||
145241030|NCT01468701|523726552|FG009|Overall Study|Not eligible|126|||
145241031|NCT01468701|523726553|FG010|Overall Study|Not eligible|39|||
145241032|NCT01468701|523726554|FG011|Overall Study|Not eligible|33|||
145241033|NCT01468701|523726555|FG012|Overall Study|Not eligible|1|||
145241034|NCT01468701|523726556|FG013|Overall Study|Not eligible|19|||
145241035|NCT01468701|523726557|FG014|Overall Study|Not eligible|1|||
145241036|NCT01468701|523726558|FG015|Overall Study|Not eligible|32|||
145241037|NCT01468701|523726559|FG016|Overall Study|Not eligible|0|||
145241038|NCT01468701|523726543|FG000|Overall Study|Lost to Follow-up|306|||
145241039|NCT01468701|523726544|FG001|Overall Study|Lost to Follow-up|0|||
145241040|NCT01468701|523726545|FG002|Overall Study|Lost to Follow-up|0|||
145241041|NCT01468701|523726546|FG003|Overall Study|Lost to Follow-up|0|||
145241042|NCT01468701|523726547|FG004|Overall Study|Lost to Follow-up|0|||
145241043|NCT01468701|523726548|FG005|Overall Study|Lost to Follow-up|0|||
145241044|NCT01468701|523726549|FG006|Overall Study|Lost to Follow-up|0|||
145241045|NCT01468701|523726550|FG007|Overall Study|Lost to Follow-up|0|||
145241046|NCT01468701|523726551|FG008|Overall Study|Lost to Follow-up|215|||
145241047|NCT01468701|523726552|FG009|Overall Study|Lost to Follow-up|309|||
145241048|NCT01468701|523726553|FG010|Overall Study|Lost to Follow-up|224|||
145241049|NCT01468701|523726554|FG011|Overall Study|Lost to Follow-up|212|||
145241050|NCT01468701|523726555|FG012|Overall Study|Lost to Follow-up|11|||
145241051|NCT01468701|523726556|FG013|Overall Study|Lost to Follow-up|164|||
145241052|NCT01468701|523726557|FG014|Overall Study|Lost to Follow-up|17|||
145241053|NCT01468701|523726558|FG015|Overall Study|Lost to Follow-up|127|||
145241054|NCT01468701|523726559|FG016|Overall Study|Lost to Follow-up|1|||
145241055|NCT01468701|523726543|FG000|Overall Study|Withdrawal by Subject|165|||
145241056|NCT01468701|523726544|FG001|Overall Study|Withdrawal by Subject|0|||
145241057|NCT01468701|523726545|FG002|Overall Study|Withdrawal by Subject|0|||
145241058|NCT01468701|523726546|FG003|Overall Study|Withdrawal by Subject|0|||
145241059|NCT01468701|523726547|FG004|Overall Study|Withdrawal by Subject|0|||
145241060|NCT01468701|523726548|FG005|Overall Study|Withdrawal by Subject|0|||
145296285|NCT01042522|523935741|FG000|Overall Study|Adverse Event|1|||
145620060|NCT03468426|525123653|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145620061|NCT03468426|525123654|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145620062|NCT03468426|525123655|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145620063|NCT03468426|525123656|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145241061|NCT01468701|523726549|FG006|Overall Study|Withdrawal by Subject|0|||
145241062|NCT01468701|523726550|FG007|Overall Study|Withdrawal by Subject|0|||
145241063|NCT01468701|523726551|FG008|Overall Study|Withdrawal by Subject|83|||
145241064|NCT01468701|523726552|FG009|Overall Study|Withdrawal by Subject|88|||
145241065|NCT01468701|523726553|FG010|Overall Study|Withdrawal by Subject|100|||
145241066|NCT01468701|523726554|FG011|Overall Study|Withdrawal by Subject|114|||
145241067|NCT01468701|523726555|FG012|Overall Study|Withdrawal by Subject|9|||
145241068|NCT01468701|523726556|FG013|Overall Study|Withdrawal by Subject|47|||
145241069|NCT01468701|523726557|FG014|Overall Study|Withdrawal by Subject|6|||
145241070|NCT01468701|523726558|FG015|Overall Study|Withdrawal by Subject|31|||
145241071|NCT01468701|523726559|FG016|Overall Study|Withdrawal by Subject|0|||
145241072|NCT01468701|523726543|FG000|Overall Study|Other reasons than listed|437|||
145241073|NCT01468701|523726544|FG001|Overall Study|Other reasons than listed|0|||
145241074|NCT01468701|523726545|FG002|Overall Study|Other reasons than listed|0|||
145241075|NCT01468701|523726546|FG003|Overall Study|Other reasons than listed|0|||
145241076|NCT01468701|523726547|FG004|Overall Study|Other reasons than listed|0|||
145241077|NCT01468701|523726548|FG005|Overall Study|Other reasons than listed|0|||
145241078|NCT01468701|523726549|FG006|Overall Study|Other reasons than listed|0|||
145241079|NCT01468701|523726550|FG007|Overall Study|Other reasons than listed|0|||
145241080|NCT01468701|523726551|FG008|Overall Study|Other reasons than listed|318|||
145241081|NCT01468701|523726552|FG009|Overall Study|Other reasons than listed|658|||
145241082|NCT01468701|523726553|FG010|Overall Study|Other reasons than listed|433|||
145241083|NCT01468701|523726554|FG011|Overall Study|Other reasons than listed|504|||
145241084|NCT01468701|523726555|FG012|Overall Study|Other reasons than listed|28|||
145241085|NCT01468701|523726556|FG013|Overall Study|Other reasons than listed|239|||
145241086|NCT01468701|523726557|FG014|Overall Study|Other reasons than listed|39|||
145241087|NCT01468701|523726558|FG015|Overall Study|Other reasons than listed|172|||
145241088|NCT01468701|523726559|FG016|Overall Study|Other reasons than listed|0|||
145241089|NCT01468701|523726543|FG000|Overall Study|No end of study case report form|0|||
145241090|NCT01468701|523726544|FG001|Overall Study|No end of study case report form|0|||
145241091|NCT01468701|523726545|FG002|Overall Study|No end of study case report form|0|||
145241092|NCT01468701|523726546|FG003|Overall Study|No end of study case report form|0|||
145241093|NCT01468701|523726547|FG004|Overall Study|No end of study case report form|0|||
145241094|NCT01468701|523726548|FG005|Overall Study|No end of study case report form|0|||
145241095|NCT01468701|523726549|FG006|Overall Study|No end of study case report form|0|||
145241096|NCT01468701|523726550|FG007|Overall Study|No end of study case report form|0|||
145241097|NCT01468701|523726551|FG008|Overall Study|No end of study case report form|4|||
145241098|NCT01468701|523726552|FG009|Overall Study|No end of study case report form|1|||
145241099|NCT01468701|523726553|FG010|Overall Study|No end of study case report form|2|||
145241100|NCT01468701|523726554|FG011|Overall Study|No end of study case report form|3|||
145241101|NCT01468701|523726555|FG012|Overall Study|No end of study case report form|0|||
145241102|NCT01468701|523726556|FG013|Overall Study|No end of study case report form|1|||
145241103|NCT01468701|523726557|FG014|Overall Study|No end of study case report form|0|||
145241104|NCT01468701|523726558|FG015|Overall Study|No end of study case report form|0|||
145241105|NCT01468701|523726559|FG016|Overall Study|No end of study case report form|0|||
145241106|NCT01468701|523726543|FG000|Overall Study|Not being followed up|0|||
145241107|NCT01468701|523726544|FG001|Overall Study|Not being followed up|4963|||
145241108|NCT01468701|523726545|FG002|Overall Study|Not being followed up|1755|||
145241109|NCT01468701|523726546|FG003|Overall Study|Not being followed up|703|||
145241110|NCT01468701|523726547|FG004|Overall Study|Not being followed up|1714|||
145241111|NCT01468701|523726548|FG005|Overall Study|Not being followed up|126|||
145241112|NCT01468701|523726549|FG006|Overall Study|Not being followed up|1170|||
145241113|NCT01468701|523726550|FG007|Overall Study|Not being followed up|4|||
145241114|NCT01468701|523726551|FG008|Overall Study|Not being followed up|0|||
145241115|NCT01468701|523726552|FG009|Overall Study|Not being followed up|0|||
145241116|NCT01468701|523726553|FG010|Overall Study|Not being followed up|0|||
145241117|NCT01468701|523726554|FG011|Overall Study|Not being followed up|0|||
145241118|NCT01468701|523726555|FG012|Overall Study|Not being followed up|0|||
145241119|NCT01468701|523726556|FG013|Overall Study|Not being followed up|0|||
145241120|NCT01468701|523726557|FG014|Overall Study|Not being followed up|0|||
145241121|NCT01468701|523726558|FG015|Overall Study|Not being followed up|0|||
145241122|NCT01468701|523726559|FG016|Overall Study|Not being followed up|0|||
145241123|NCT02679781|523726560|FG000|Overall Study|Lost to Follow-up|1|||
145563672|NCT02658890|524924015|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563673|NCT02658890|524924016|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145241124|NCT02679781|523726561|FG001|Overall Study|Lost to Follow-up|2|||
145241125|NCT02679781|523726560|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
145241126|NCT02679781|523726561|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
145241127|NCT01822223|523726562|FG000|Overall Study|Death|0|||
145241128|NCT01822223|523726563|FG001|Overall Study|Death|1|||
145241129|NCT00631540|523726569|FG000|Overall Study|Withdrawal by Subject|5|||
145563674|NCT02658890|524924017|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563675|NCT02658890|524924018|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563676|NCT02658890|524924019|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563677|NCT02658890|524924020|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145241130|NCT00631540|523726569|FG000|Overall Study|Death|4|||
145241131|NCT00631540|523726569|FG000|Overall Study|Lost to Follow-up|2|||
145241132|NCT00631540|523726569|FG000|Overall Study|Core Lab Data Unavailable|3|||
145241133|NCT00970268|523726575|FG000|Overall Study|Withdrawal by Subject|12|||
145241134|NCT00970268|523726576|FG001|Overall Study|Withdrawal by Subject|19|||
145241135|NCT00970268|523726575|FG000|Overall Study|Adverse Event|15|||
145241136|NCT00970268|523726576|FG001|Overall Study|Adverse Event|12|||
145241137|NCT00970268|523726575|FG000|Overall Study|Lack of Efficacy|3|||
145241138|NCT00970268|523726576|FG001|Overall Study|Lack of Efficacy|6|||
145241139|NCT00970268|523726575|FG000|Overall Study|Protocol Violation|4|||
145241140|NCT00970268|523726576|FG001|Overall Study|Protocol Violation|7|||
145241141|NCT00970268|523726575|FG000|Overall Study|Other Reason|3|||
145241142|NCT00970268|523726576|FG001|Overall Study|Other Reason|1|||
145241143|NCT00970268|523726575|FG000|Overall Study|COPD Exacerbation|4|||
145241144|NCT00970268|523726576|FG001|Overall Study|COPD Exacerbation|2|||
145241145|NCT00970268|523726575|FG000|Overall Study|Lost to Follow-up|1|||
145241146|NCT00970268|523726576|FG001|Overall Study|Lost to Follow-up|2|||
145241147|NCT00970268|523726575|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
145241148|NCT00970268|523726576|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
145241149|NCT02091921|523726581|FG000|Overall Study|Adverse Event|3|||
145241150|NCT02483078|523726582|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
145241151|NCT02483078|523726583|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
145241152|NCT02483078|523726582|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
145241153|NCT02483078|523726583|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
145241154|NCT02483078|523726582|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
145241155|NCT02483078|523726583|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
145241156|NCT02483078|523726582|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
145241157|NCT02483078|523726583|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
145241158|NCT02483078|523726582|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
145241159|NCT02483078|523726583|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
145241160|NCT02483078|523726582|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
145241161|NCT02483078|523726583|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
145241162|NCT04876599|523726588|FG000|Overall Study|Missed|2|||
145241163|NCT04876599|523726589|FG001|Overall Study|Missed|0|||
145241164|NCT04876599|523726588|FG000|Overall Study|Declined|2|||
145241165|NCT04876599|523726589|FG001|Overall Study|Declined|3|||
145241166|NCT03000686|523728803|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
145241167|NCT03000686|523728804|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
145241168|NCT03000686|523728805|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
145241169|NCT03000686|523728806|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
145241170|NCT02920450|523728807|FG000|Overall Study|Death|1|||
145241171|NCT02920450|523728808|FG001|Overall Study|Death|0|||
145241172|NCT02920450|523728809|FG002|Overall Study|Death|0|||
145241173|NCT02920450|523728810|FG003|Overall Study|Death|0|||
145241174|NCT02920450|523728807|FG000|Overall Study|Withdrawal by Subject|1|||
145241175|NCT02920450|523728808|FG001|Overall Study|Withdrawal by Subject|0|||
145241176|NCT02920450|523728809|FG002|Overall Study|Withdrawal by Subject|0|||
145241177|NCT02920450|523728810|FG003|Overall Study|Withdrawal by Subject|0|||
145241178|NCT01112982|523728818|FG000|Overall Study|Withdrawal by Subject|1|||
145241179|NCT01112982|523728818|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
145241180|NCT01981109|523728821|FG000|Overall Study|Death|36|||
145241181|NCT01981109|523728821|FG000|Overall Study|Withdrawal by Subject|40|||
145241182|NCT01981109|523728821|FG000|Overall Study|Lost to Follow-up|9|||
145241183|NCT01981109|523728821|FG000|Overall Study|No Discontinuation Documentation|37|||
145241184|NCT01981109|523728821|FG000|Overall Study|Study Termination|100|||
145241185|NCT01981109|523728821|FG000|Overall Study|No data available|2|||
145241186|NCT02023268|523728822|FG000|Overall Study|Lack of Efficacy|0|||
145241187|NCT02023268|523728823|FG001|Overall Study|Lack of Efficacy|1|||
145241188|NCT02023268|523728822|FG000|Overall Study|Adverse Event|0|||
145241189|NCT02023268|523728823|FG001|Overall Study|Adverse Event|2|||
145241190|NCT02023268|523728822|FG000|Overall Study|Withdrawal by Subject|0|||
145241191|NCT02023268|523728823|FG001|Overall Study|Withdrawal by Subject|1|||
145241192|NCT03407170|523728824|FG000|Overall Study|Adverse Event|1|||
145241193|NCT00126672|523728827|FG000|Overall Study|Adverse Event|4|||
145241194|NCT00126672|523728827|FG000|Overall Study|Lost to Follow-up|4|||
145241195|NCT01001234|523728828|FG000|Overall Study|Withdrawal by Subject|2|||
145241196|NCT01001234|523728829|FG001|Overall Study|Withdrawal by Subject|0|||
145241197|NCT01001234|523728830|FG002|Overall Study|Withdrawal by Subject|3|||
145241198|NCT01001234|523728831|FG003|Overall Study|Withdrawal by Subject|0|||
145241199|NCT01001234|523728832|FG004|Overall Study|Withdrawal by Subject|0|||
145241200|NCT01001234|523728828|FG000|Overall Study|Protocol Violation|34|||
145241201|NCT01001234|523728829|FG001|Overall Study|Protocol Violation|3|||
145241202|NCT01001234|523728830|FG002|Overall Study|Protocol Violation|19|||
145241203|NCT01001234|523728831|FG003|Overall Study|Protocol Violation|18|||
145241204|NCT01001234|523728832|FG004|Overall Study|Protocol Violation|0|||
145241205|NCT01001234|523728828|FG000|Overall Study|Lost to Follow-up|0|||
145241206|NCT01001234|523728829|FG001|Overall Study|Lost to Follow-up|0|||
145241207|NCT01001234|523728830|FG002|Overall Study|Lost to Follow-up|1|||
145241208|NCT01001234|523728831|FG003|Overall Study|Lost to Follow-up|2|||
145241209|NCT01001234|523728832|FG004|Overall Study|Lost to Follow-up|0|||
145241210|NCT01001234|523728828|FG000|Overall Study|Physician Decision|1|||
145241211|NCT01001234|523728829|FG001|Overall Study|Physician Decision|0|||
145241212|NCT01001234|523728830|FG002|Overall Study|Physician Decision|0|||
145241213|NCT01001234|523728831|FG003|Overall Study|Physician Decision|0|||
145241214|NCT01001234|523728832|FG004|Overall Study|Physician Decision|0|||
145241215|NCT01001234|523728828|FG000|Overall Study|Not Treated: Adverse Event|1|||
145563678|NCT02658890|524924021|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563679|NCT02658890|524924022|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
145563680|NCT02658890|524924023|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563681|NCT02658890|524924024|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145241216|NCT01001234|523728829|FG001|Overall Study|Not Treated: Adverse Event|0|||
145241217|NCT01001234|523728830|FG002|Overall Study|Not Treated: Adverse Event|0|||
145241218|NCT01001234|523728831|FG003|Overall Study|Not Treated: Adverse Event|0|||
145241219|NCT01001234|523728832|FG004|Overall Study|Not Treated: Adverse Event|0|||
145241220|NCT01001234|523728828|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
145241221|NCT01001234|523728829|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
145241222|NCT01001234|523728830|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
145241223|NCT01001234|523728831|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
145241224|NCT01001234|523728832|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
145241225|NCT01001234|523728828|FG000|Overall Study|Not Treated: Protocol Violation|3|||
145241226|NCT01001234|523728829|FG001|Overall Study|Not Treated: Protocol Violation|0|||
145241227|NCT01001234|523728830|FG002|Overall Study|Not Treated: Protocol Violation|0|||
145241228|NCT01001234|523728831|FG003|Overall Study|Not Treated: Protocol Violation|0|||
145241229|NCT01001234|523728832|FG004|Overall Study|Not Treated: Protocol Violation|0|||
145241230|NCT01001234|523728828|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
145241231|NCT01001234|523728829|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
145241232|NCT01001234|523728830|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
145241233|NCT01001234|523728831|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
145241234|NCT01001234|523728832|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
145241235|NCT01001234|523728828|FG000|Overall Study|Not Treated: Pregnancy|3|||
145241236|NCT01001234|523728829|FG001|Overall Study|Not Treated: Pregnancy|0|||
145241237|NCT01001234|523728830|FG002|Overall Study|Not Treated: Pregnancy|0|||
145241238|NCT01001234|523728831|FG003|Overall Study|Not Treated: Pregnancy|0|||
145241239|NCT01001234|523728832|FG004|Overall Study|Not Treated: Pregnancy|0|||
145241240|NCT01001234|523728828|FG000|Overall Study|Not Treated: Physician Decision|37|||
145241241|NCT01001234|523728829|FG001|Overall Study|Not Treated: Physician Decision|4|||
145241242|NCT01001234|523728830|FG002|Overall Study|Not Treated: Physician Decision|0|||
145241243|NCT01001234|523728831|FG003|Overall Study|Not Treated: Physician Decision|0|||
145241244|NCT01001234|523728832|FG004|Overall Study|Not Treated: Physician Decision|0|||
145241245|NCT01001234|523728828|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
145241246|NCT01001234|523728829|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
145241247|NCT01001234|523728830|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
145241248|NCT01001234|523728831|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
145241249|NCT01001234|523728832|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
145241250|NCT00928512|523728835|FG000|Overall Study|Adverse Event|4|||
145241251|NCT00928512|523728836|FG001|Overall Study|Adverse Event|3|||
145241252|NCT00928512|523728837|FG002|Overall Study|Adverse Event|2|||
145241253|NCT00928512|523728838|FG003|Overall Study|Adverse Event|8|||
145241254|NCT00928512|523728839|FG004|Overall Study|Adverse Event|6|||
145241255|NCT00928512|523728835|FG000|Overall Study|Lack of Efficacy|2|||
145241256|NCT00928512|523728836|FG001|Overall Study|Lack of Efficacy|0|||
145241257|NCT00928512|523728837|FG002|Overall Study|Lack of Efficacy|4|||
145241258|NCT00928512|523728838|FG003|Overall Study|Lack of Efficacy|7|||
145241259|NCT00928512|523728839|FG004|Overall Study|Lack of Efficacy|3|||
145241260|NCT00928512|523728835|FG000|Overall Study|Protocol Violation|0|||
145241261|NCT00928512|523728836|FG001|Overall Study|Protocol Violation|1|||
145241262|NCT00928512|523728837|FG002|Overall Study|Protocol Violation|0|||
145241263|NCT00928512|523728838|FG003|Overall Study|Protocol Violation|1|||
145241264|NCT00928512|523728839|FG004|Overall Study|Protocol Violation|3|||
145241265|NCT00928512|523728835|FG000|Overall Study|Withdrawal by Subject|3|||
145241266|NCT00928512|523728836|FG001|Overall Study|Withdrawal by Subject|0|||
145241267|NCT00928512|523728837|FG002|Overall Study|Withdrawal by Subject|3|||
145241268|NCT00928512|523728838|FG003|Overall Study|Withdrawal by Subject|4|||
145241269|NCT00928512|523728839|FG004|Overall Study|Withdrawal by Subject|0|||
145241270|NCT00928512|523728835|FG000|Overall Study|Lost to Follow-up|1|||
145241271|NCT00928512|523728836|FG001|Overall Study|Lost to Follow-up|1|||
145241272|NCT00928512|523728837|FG002|Overall Study|Lost to Follow-up|2|||
145241273|NCT00928512|523728838|FG003|Overall Study|Lost to Follow-up|1|||
145241274|NCT00928512|523728839|FG004|Overall Study|Lost to Follow-up|3|||
145241275|NCT00928512|523728835|FG000|Overall Study|Administrative Problems|0|||
145241276|NCT00928512|523728836|FG001|Overall Study|Administrative Problems|1|||
145241277|NCT00928512|523728837|FG002|Overall Study|Administrative Problems|0|||
145241278|NCT00928512|523728838|FG003|Overall Study|Administrative Problems|0|||
145241279|NCT00928512|523728839|FG004|Overall Study|Administrative Problems|0|||
145241280|NCT04153929|523728840|FG000|Overall Study|Other than listed|2|||
145241281|NCT04153929|523728841|FG001|Overall Study|Other than listed|2|||
145241282|NCT04153929|523728842|FG002|Overall Study|Other than listed|0|||
145241283|NCT04153929|523728843|FG003|Overall Study|Other than listed|1|||
145241284|NCT04153929|523728844|FG004|Overall Study|Other than listed|0|||
145241285|NCT04153929|523728845|FG005|Overall Study|Other than listed|2|||
145620064|NCT03468426|525123657|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145241286|NCT04153929|523728846|FG006|Overall Study|Other than listed|2|||
145241287|NCT04153929|523728847|FG007|Overall Study|Other than listed|1|||
145241288|NCT04153929|523728840|FG000|Overall Study|Lost to Follow-up|2|||
145241289|NCT04153929|523728841|FG001|Overall Study|Lost to Follow-up|1|||
145241290|NCT04153929|523728842|FG002|Overall Study|Lost to Follow-up|0|||
145241291|NCT04153929|523728843|FG003|Overall Study|Lost to Follow-up|1|||
145241292|NCT04153929|523728844|FG004|Overall Study|Lost to Follow-up|1|||
145241293|NCT04153929|523728845|FG005|Overall Study|Lost to Follow-up|0|||
145241294|NCT04153929|523728846|FG006|Overall Study|Lost to Follow-up|0|||
145241295|NCT04153929|523728847|FG007|Overall Study|Lost to Follow-up|0|||
145241296|NCT04153929|523728840|FG000|Overall Study|Withdrawal by Subject|3|||
145241297|NCT04153929|523728841|FG001|Overall Study|Withdrawal by Subject|1|||
145241298|NCT04153929|523728842|FG002|Overall Study|Withdrawal by Subject|0|||
145241299|NCT04153929|523728843|FG003|Overall Study|Withdrawal by Subject|3|||
145241300|NCT04153929|523728844|FG004|Overall Study|Withdrawal by Subject|1|||
145241301|NCT04153929|523728845|FG005|Overall Study|Withdrawal by Subject|0|||
145241302|NCT04153929|523728846|FG006|Overall Study|Withdrawal by Subject|1|||
145241303|NCT04153929|523728847|FG007|Overall Study|Withdrawal by Subject|0|||
145241304|NCT04153929|523728840|FG000|Overall Study|Protocol Violation|0|||
145241305|NCT04153929|523728841|FG001|Overall Study|Protocol Violation|0|||
145241306|NCT04153929|523728842|FG002|Overall Study|Protocol Violation|0|||
145241307|NCT04153929|523728843|FG003|Overall Study|Protocol Violation|0|||
145241308|NCT04153929|523728844|FG004|Overall Study|Protocol Violation|0|||
145241309|NCT04153929|523728845|FG005|Overall Study|Protocol Violation|0|||
145241310|NCT04153929|523728846|FG006|Overall Study|Protocol Violation|1|||
145241311|NCT04153929|523728847|FG007|Overall Study|Protocol Violation|2|||
145241312|NCT04153929|523728840|FG000|Overall Study|Adverse Event|3|||
145241313|NCT04153929|523728841|FG001|Overall Study|Adverse Event|5|||
145241314|NCT04153929|523728842|FG002|Overall Study|Adverse Event|5|||
145241315|NCT04153929|523728843|FG003|Overall Study|Adverse Event|11|||
145241316|NCT04153929|523728844|FG004|Overall Study|Adverse Event|15|||
145241317|NCT04153929|523728845|FG005|Overall Study|Adverse Event|4|||
145241318|NCT04153929|523728846|FG006|Overall Study|Adverse Event|8|||
145241319|NCT04153929|523728847|FG007|Overall Study|Adverse Event|2|||
145241320|NCT04153929|523728840|FG000|Overall Study|Not treated|1|||
145241321|NCT04153929|523728841|FG001|Overall Study|Not treated|0|||
145241322|NCT04153929|523728842|FG002|Overall Study|Not treated|0|||
145241323|NCT04153929|523728843|FG003|Overall Study|Not treated|0|||
145241324|NCT04153929|523728844|FG004|Overall Study|Not treated|0|||
145241325|NCT04153929|523728845|FG005|Overall Study|Not treated|0|||
145241326|NCT04153929|523728846|FG006|Overall Study|Not treated|1|||
145241327|NCT04153929|523728847|FG007|Overall Study|Not treated|0|||
145241328|NCT04083794|523728848|FG000|Overall Study|Lost to Follow-up|9|||
145241329|NCT01975675|523728851|FG000|Overall Study|Death|0|||
145241330|NCT01975675|523728852|FG001|Overall Study|Death|1|||
145241331|NCT01975675|523728853|FG002|Overall Study|Death|0|||
145241332|NCT01975675|523728854|FG003|Overall Study|Death|0|||
145241333|NCT00224003|523728855|FG000|Overall Study|Adverse Event|1|||
145241334|NCT00224003|523728855|FG000|Overall Study|Protocol Violation|2|||
145241335|NCT00224003|523728855|FG000|Overall Study|Withdrawal by Subject|1|||
145241336|NCT00224003|523728855|FG000|Overall Study|unk|3|||
145241337|NCT00729326|523728862|FG000|Overall Study|Lost to Follow-up|2|||
145241338|NCT00729326|523728863|FG001|Overall Study|Lost to Follow-up|0|||
145241339|NCT00729326|523728862|FG000|Overall Study|Physician Decision|0|||
145241340|NCT00729326|523728863|FG001|Overall Study|Physician Decision|1|||
145241341|NCT00729326|523728862|FG000|Overall Study|Protocol Violation|3|||
145241342|NCT00729326|523728863|FG001|Overall Study|Protocol Violation|2|||
145241343|NCT00729326|523728862|FG000|Overall Study|Subject Decision|4|||
145241344|NCT00729326|523728863|FG001|Overall Study|Subject Decision|4|||
145241345|NCT00729326|523728862|FG000|Overall Study|Sponsor Decision|1|||
145241346|NCT00729326|523728863|FG001|Overall Study|Sponsor Decision|2|||
145241347|NCT01235728|523728864|FG000|Overall Study|Protocol Violation|0|||
145241348|NCT01235728|523728865|FG001|Overall Study|Protocol Violation|0|||
145241349|NCT01235728|523728866|FG002|Overall Study|Protocol Violation|0|||
145241350|NCT01235728|523728867|FG003|Overall Study|Protocol Violation|1|||
145241351|NCT01235728|523728868|FG004|Overall Study|Protocol Violation|0|||
145241352|NCT01235728|523728869|FG005|Overall Study|Protocol Violation|0|||
145241353|NCT01235728|523728870|FG006|Overall Study|Protocol Violation|0|||
145241354|NCT01235728|523728871|FG007|Overall Study|Protocol Violation|0|||
145241355|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
145241356|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
145241357|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
145241358|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
145241359|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
145241360|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
145241361|NCT00996593|523728872|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
145241362|NCT00996593|523728872|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
145241363|NCT00996593|523728872|FG000|Long-Term Follow-Up|Site Closed|1|||
145241364|NCT01202760|523728873|FG000|Overall Study|Entry Criteria Not Met|0|||
145241365|NCT01202760|523728874|FG001|Overall Study|Entry Criteria Not Met|3|||
145241366|NCT01202760|523728875|FG002|Overall Study|Entry Criteria Not Met|1|||
145241367|NCT01202760|523728873|FG000|Overall Study|Adverse Event|11|||
145241368|NCT01202760|523728874|FG001|Overall Study|Adverse Event|9|||
145241369|NCT01202760|523728875|FG002|Overall Study|Adverse Event|10|||
145241370|NCT01202760|523728873|FG000|Overall Study|Death|2|||
145241371|NCT01202760|523728874|FG001|Overall Study|Death|1|||
145241372|NCT01202760|523728875|FG002|Overall Study|Death|0|||
145241373|NCT01202760|523728873|FG000|Overall Study|Lack of Efficacy|6|||
145241374|NCT01202760|523728874|FG001|Overall Study|Lack of Efficacy|8|||
145241375|NCT01202760|523728875|FG002|Overall Study|Lack of Efficacy|7|||
145241376|NCT01202760|523728873|FG000|Overall Study|Lost to Follow-up|0|||
145241377|NCT01202760|523728874|FG001|Overall Study|Lost to Follow-up|2|||
145241378|NCT01202760|523728875|FG002|Overall Study|Lost to Follow-up|1|||
145241379|NCT01202760|523728873|FG000|Overall Study|Parent / Caregiver Decision|0|||
145241380|NCT01202760|523728874|FG001|Overall Study|Parent / Caregiver Decision|1|||
145241381|NCT01202760|523728875|FG002|Overall Study|Parent / Caregiver Decision|0|||
145241382|NCT01202760|523728873|FG000|Overall Study|Withdrawal by Subject|17|||
145241383|NCT01202760|523728874|FG001|Overall Study|Withdrawal by Subject|18|||
145563682|NCT02658890|524924025|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563683|NCT02658890|524924026|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
145241384|NCT01202760|523728875|FG002|Overall Study|Withdrawal by Subject|14|||
145241385|NCT01202760|523728873|FG000|Overall Study|Physician Decision|0|||
145241386|NCT01202760|523728874|FG001|Overall Study|Physician Decision|1|||
145241387|NCT01202760|523728875|FG002|Overall Study|Physician Decision|0|||
145241388|NCT01202760|523728873|FG000|Overall Study|Protocol Violation|7|||
145241389|NCT01202760|523728874|FG001|Overall Study|Protocol Violation|5|||
145241390|NCT01202760|523728875|FG002|Overall Study|Protocol Violation|2|||
145241391|NCT01202760|523728873|FG000|Overall Study|Sponsor Decision|4|||
145241392|NCT01202760|523728874|FG001|Overall Study|Sponsor Decision|4|||
145241393|NCT01202760|523728875|FG002|Overall Study|Sponsor Decision|0|||
145241394|NCT00871572|523728876|FG000|Overall Study|Adverse Event|0|||
145241395|NCT00871572|523728877|FG001|Overall Study|Adverse Event|2|||
145241396|NCT00871572|523728878|FG002|Overall Study|Adverse Event|0|||
145241397|NCT00871572|523728879|FG003|Overall Study|Adverse Event|3|||
145296286|NCT01042522|523935742|FG001|Overall Study|Adverse Event|2|||
145296287|NCT01042522|523935741|FG000|Overall Study|Disease Progression|5|||
145296288|NCT01042522|523935742|FG001|Overall Study|Disease Progression|0|||
145296289|NCT01042522|523935741|FG000|Overall Study|Death|1|||
145296290|NCT01042522|523935742|FG001|Overall Study|Death|0|||
145296291|NCT01042522|523935741|FG000|Overall Study|Patient Refused|0|||
145296292|NCT01042522|523935742|FG001|Overall Study|Patient Refused|3|||
145296293|NCT01042522|523935741|FG000|Overall Study|Withdrawal by Subject|1|||
145296294|NCT01042522|523935742|FG001|Overall Study|Withdrawal by Subject|1|||
145296295|NCT01746017|523935745|FG000|Period 1|Withdrawal by Subject|0|||
145296296|NCT01746017|523935746|FG001|Period 1|Withdrawal by Subject|0|||
145296297|NCT01746017|523935747|FG002|Period 1|Withdrawal by Subject|0|||
145296298|NCT01746017|523935748|FG003|Period 1|Withdrawal by Subject|0|||
145296299|NCT01746017|523935749|FG004|Period 1|Withdrawal by Subject|0|||
145296300|NCT01746017|523935750|FG005|Period 1|Withdrawal by Subject|0|||
145296301|NCT01746017|523935751|FG006|Period 1|Withdrawal by Subject|1|||
145296302|NCT01746017|523935752|FG007|Period 1|Withdrawal by Subject|0|||
145296303|NCT01746017|523935753|FG008|Period 1|Withdrawal by Subject|0|||
145296304|NCT01746017|523935754|FG009|Period 1|Withdrawal by Subject|0|||
145296305|NCT01746017|523935755|FG010|Period 1|Withdrawal by Subject|0|||
145296306|NCT01746017|523935745|FG000|Period 3|Withdrawal by Subject|0|||
145296307|NCT01746017|523935746|FG001|Period 3|Withdrawal by Subject|0|||
145296308|NCT01746017|523935747|FG002|Period 3|Withdrawal by Subject|0|||
145296309|NCT01746017|523935748|FG003|Period 3|Withdrawal by Subject|0|||
145296310|NCT01746017|523935749|FG004|Period 3|Withdrawal by Subject|0|||
145296311|NCT01746017|523935750|FG005|Period 3|Withdrawal by Subject|1|||
145296312|NCT01746017|523935751|FG006|Period 3|Withdrawal by Subject|0|||
145296313|NCT01746017|523935752|FG007|Period 3|Withdrawal by Subject|0|||
145241398|NCT00871572|523728876|FG000|Overall Study|Investigator Decision|0|||
145241399|NCT00871572|523728877|FG001|Overall Study|Investigator Decision|1|||
145241400|NCT00871572|523728878|FG002|Overall Study|Investigator Decision|0|||
145241401|NCT00871572|523728879|FG003|Overall Study|Investigator Decision|1|||
145241402|NCT00871572|523728876|FG000|Overall Study|Lost to Follow-up|0|||
145296314|NCT01746017|523935753|FG008|Period 3|Withdrawal by Subject|0|||
145296315|NCT01746017|523935754|FG009|Period 3|Withdrawal by Subject|0|||
145296316|NCT01746017|523935755|FG010|Period 3|Withdrawal by Subject|0|||
145296317|NCT01507051|523935756|FG000|Overall Study|Withdrawal by Subject|1|||
145296318|NCT01507051|523935757|FG001|Overall Study|Withdrawal by Subject|3|||
145296319|NCT01507051|523935758|FG002|Overall Study|Withdrawal by Subject|1|||
145296320|NCT01507051|523935759|FG003|Overall Study|Withdrawal by Subject|6|||
145296321|NCT01507051|523935756|FG000|Overall Study|Physician Decision|0|||
145296322|NCT01507051|523935757|FG001|Overall Study|Physician Decision|0|||
145296323|NCT01507051|523935758|FG002|Overall Study|Physician Decision|0|||
145241403|NCT00871572|523728877|FG001|Overall Study|Lost to Follow-up|1|||
145241404|NCT00871572|523728878|FG002|Overall Study|Lost to Follow-up|0|||
145241405|NCT00871572|523728879|FG003|Overall Study|Lost to Follow-up|1|||
145241406|NCT00871572|523728876|FG000|Overall Study|Protocol Violation|0|||
145241407|NCT00871572|523728877|FG001|Overall Study|Protocol Violation|0|||
145241408|NCT00871572|523728878|FG002|Overall Study|Protocol Violation|1|||
145241409|NCT00871572|523728879|FG003|Overall Study|Protocol Violation|1|||
145241410|NCT00871572|523728876|FG000|Overall Study|Sponsor Decision|1|||
145241411|NCT00871572|523728877|FG001|Overall Study|Sponsor Decision|0|||
145241412|NCT00871572|523728878|FG002|Overall Study|Sponsor Decision|0|||
145241413|NCT00871572|523728879|FG003|Overall Study|Sponsor Decision|0|||
145241414|NCT00871572|523728876|FG000|Overall Study|Withdrawal by Subject|1|||
145241415|NCT00871572|523728877|FG001|Overall Study|Withdrawal by Subject|2|||
145241416|NCT00871572|523728878|FG002|Overall Study|Withdrawal by Subject|3|||
145241417|NCT00871572|523728879|FG003|Overall Study|Withdrawal by Subject|1|||
145241418|NCT01654523|523728880|FG000|Overall Study|Withdrawal by Subject|1|||
145241419|NCT04354155|523728883|FG000|Overall Study|Withdrawal by Subject|1|||
145241420|NCT04354155|523728883|FG000|Overall Study|Did not meet criteria for study intervention|1|||
145408852|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145408853|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145241421|NCT01686958|523728884|FG000|Overall Study|Withdrawal by Subject|1|||
145241422|NCT02810951|523728887|FG000|Overall Study|Adverse Event|1|||
145241423|NCT03199638|523728888|FG000|Overall Study|inability to drink glutamine during regularly|0|||
145241424|NCT03199638|523728889|FG001|Overall Study|inability to drink glutamine during regularly|2|||
145241425|NCT01575899|523728890|FG000|Overall Study|Lost to Follow-up|3|||
145241426|NCT01575899|523728891|FG001|Overall Study|Lost to Follow-up|4|||
145241427|NCT01575899|523728892|FG002|Overall Study|Lost to Follow-up|2|||
145241428|NCT01575899|523728890|FG000|Overall Study|Protocol Violation|2|||
145241429|NCT01575899|523728891|FG001|Overall Study|Protocol Violation|1|||
145241430|NCT01575899|523728892|FG002|Overall Study|Protocol Violation|0|||
145241431|NCT03097029|523728893|FG000|Overall Study|Withdrawal by Subject|1|||
145241432|NCT02807844|523728894|FG000|Overall Study|Physician Decision|0|||
145241433|NCT02807844|523728895|FG001|Overall Study|Physician Decision|0|||
145241434|NCT02807844|523728896|FG002|Overall Study|Physician Decision|0|||
145241435|NCT02807844|523728897|FG003|Overall Study|Physician Decision|0|||
145241436|NCT02807844|523728898|FG004|Overall Study|Physician Decision|0|||
145241437|NCT02807844|523728899|FG005|Overall Study|Physician Decision|0|||
145241438|NCT02807844|523728900|FG006|Overall Study|Physician Decision|3|||
145241439|NCT02807844|523728901|FG007|Overall Study|Physician Decision|0|||
145241440|NCT02807844|523728902|FG008|Overall Study|Physician Decision|1|||
145241441|NCT02807844|523728903|FG009|Overall Study|Physician Decision|2|||
145241442|NCT02807844|523728894|FG000|Overall Study|Death|0|||
145241443|NCT02807844|523728895|FG001|Overall Study|Death|0|||
145241444|NCT02807844|523728896|FG002|Overall Study|Death|2|||
145241445|NCT02807844|523728897|FG003|Overall Study|Death|4|||
145241446|NCT02807844|523728898|FG004|Overall Study|Death|1|||
145241447|NCT02807844|523728899|FG005|Overall Study|Death|2|||
145241448|NCT02807844|523728900|FG006|Overall Study|Death|1|||
145241449|NCT02807844|523728901|FG007|Overall Study|Death|2|||
145241450|NCT02807844|523728902|FG008|Overall Study|Death|0|||
145241451|NCT02807844|523728903|FG009|Overall Study|Death|1|||
145241452|NCT02807844|523728894|FG000|Overall Study|Withdrawal by Subject|0|||
145241453|NCT02807844|523728895|FG001|Overall Study|Withdrawal by Subject|0|||
145241454|NCT02807844|523728896|FG002|Overall Study|Withdrawal by Subject|2|||
145241455|NCT02807844|523728897|FG003|Overall Study|Withdrawal by Subject|1|||
145241456|NCT02807844|523728898|FG004|Overall Study|Withdrawal by Subject|1|||
145241457|NCT02807844|523728899|FG005|Overall Study|Withdrawal by Subject|0|||
145241458|NCT02807844|523728900|FG006|Overall Study|Withdrawal by Subject|1|||
145241459|NCT02807844|523728901|FG007|Overall Study|Withdrawal by Subject|0|||
145241460|NCT02807844|523728902|FG008|Overall Study|Withdrawal by Subject|0|||
145241461|NCT02807844|523728903|FG009|Overall Study|Withdrawal by Subject|0|||
145241462|NCT02807844|523728894|FG000|Overall Study|Progressive disease|5|||
145241463|NCT02807844|523728895|FG001|Overall Study|Progressive disease|12|||
145241464|NCT02807844|523728896|FG002|Overall Study|Progressive disease|8|||
145241465|NCT02807844|523728897|FG003|Overall Study|Progressive disease|8|||
145241466|NCT02807844|523728898|FG004|Overall Study|Progressive disease|3|||
145241467|NCT02807844|523728899|FG005|Overall Study|Progressive disease|8|||
145408854|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
145241468|NCT02807844|523728900|FG006|Overall Study|Progressive disease|14|||
145241469|NCT02807844|523728901|FG007|Overall Study|Progressive disease|17|||
145241470|NCT02807844|523728902|FG008|Overall Study|Progressive disease|19|||
145241471|NCT02807844|523728903|FG009|Overall Study|Progressive disease|15|||
145241472|NCT02807844|523728894|FG000|Overall Study|Adverse Event|1|||
145241473|NCT02807844|523728895|FG001|Overall Study|Adverse Event|0|||
145241474|NCT02807844|523728896|FG002|Overall Study|Adverse Event|0|||
145241475|NCT02807844|523728897|FG003|Overall Study|Adverse Event|0|||
145241476|NCT02807844|523728898|FG004|Overall Study|Adverse Event|1|||
145241477|NCT02807844|523728899|FG005|Overall Study|Adverse Event|1|||
145241478|NCT02807844|523728900|FG006|Overall Study|Adverse Event|1|||
145241479|NCT02807844|523728901|FG007|Overall Study|Adverse Event|1|||
145241480|NCT02807844|523728902|FG008|Overall Study|Adverse Event|1|||
145241481|NCT02807844|523728903|FG009|Overall Study|Adverse Event|2|||
145241482|NCT00373490|523728904|FG000|Overall Study|Adverse Event|0|||
145241483|NCT00373490|523728905|FG001|Overall Study|Adverse Event|1|||
145241484|NCT00373490|523728904|FG000|Overall Study|Lack of Efficacy|9|||
145241485|NCT00373490|523728905|FG001|Overall Study|Lack of Efficacy|4|||
145241486|NCT00373490|523728904|FG000|Overall Study|Withdrawal by Subject|0|||
145241487|NCT00373490|523728905|FG001|Overall Study|Withdrawal by Subject|1|||
145241488|NCT00108953|523728906|FG000|Follow-up|Death|18|||
145241489|NCT00108953|523728907|FG001|Follow-up|Death|26|||
145241490|NCT00108953|523728906|FG000|Follow-up|Lost to Follow-up|1|||
145241491|NCT00108953|523728907|FG001|Follow-up|Lost to Follow-up|1|||
145241492|NCT00108953|523728906|FG000|Follow-up|Study terminated by sponsor|10|||
145241493|NCT00108953|523728907|FG001|Follow-up|Study terminated by sponsor|6|||
145241494|NCT00587301|523728914|FG000|Overall Study|Screen Failure|9|||
145241495|NCT00587301|523728914|FG000|Overall Study|Lost to Follow-up|22|||
145241496|NCT00587301|523728914|FG000|Overall Study|Withdrawal by Subject|7|||
145241497|NCT00587301|523728914|FG000|Overall Study|Protocol Violation|7|||
145241498|NCT02758613|523728915|FG000|Treatment|Physician and Sponsor Decision|1|||
145241499|NCT02758613|523728916|FG001|Treatment|Physician and Sponsor Decision|0|||
145241500|NCT02758613|523728917|FG002|Treatment|Physician and Sponsor Decision|0|||
145241501|NCT02758613|523728918|FG003|Treatment|Physician and Sponsor Decision|0|||
145241502|NCT02758613|523728915|FG000|Treatment|Withdrawal by Subject|1|||
145241503|NCT02758613|523728916|FG001|Treatment|Withdrawal by Subject|0|||
145241504|NCT02758613|523728917|FG002|Treatment|Withdrawal by Subject|1|||
145241505|NCT02758613|523728918|FG003|Treatment|Withdrawal by Subject|0|||
145241506|NCT01496274|523728920|FG000|Overall Study|Protocol Violation|0|||
145241507|NCT01496274|523728921|FG001|Overall Study|Protocol Violation|1|||
145241508|NCT01496274|523728920|FG000|Overall Study|Adverse Event|1|||
145241509|NCT01496274|523728921|FG001|Overall Study|Adverse Event|1|||
145241510|NCT01496274|523728920|FG000|Overall Study|Withdrawal by Subject|2|||
145241511|NCT01496274|523728921|FG001|Overall Study|Withdrawal by Subject|0|||
145241512|NCT01496274|523728920|FG000|Overall Study|Lost to Follow-up|0|||
145241513|NCT01496274|523728921|FG001|Overall Study|Lost to Follow-up|3|||
145241514|NCT00351819|523728922|FG000|Overall Study|Lost to Follow-up|4|||
145241515|NCT00351819|523728923|FG001|Overall Study|Lost to Follow-up|4|||
145241516|NCT00351819|523728922|FG000|Overall Study|Withdrawal by Subject|0|||
145241517|NCT00351819|523728923|FG001|Overall Study|Withdrawal by Subject|4|||
145241518|NCT00351819|523728922|FG000|Overall Study|Elevated PSA|1|||
145241519|NCT00351819|523728923|FG001|Overall Study|Elevated PSA|1|||
145241520|NCT00351819|523728922|FG000|Overall Study|Traumatic ankle fracture|1|||
145241521|NCT00351819|523728923|FG001|Overall Study|Traumatic ankle fracture|0|||
145241522|NCT00351819|523728922|FG000|Overall Study|Unprofessional behavior|1|||
145296324|NCT01507051|523935759|FG003|Overall Study|Physician Decision|1|||
145296325|NCT01507051|523935756|FG000|Overall Study|Adverse Event|1|||
145296326|NCT01507051|523935757|FG001|Overall Study|Adverse Event|0|||
145296327|NCT01507051|523935758|FG002|Overall Study|Adverse Event|0|||
145296328|NCT01507051|523935759|FG003|Overall Study|Adverse Event|0|||
145296329|NCT01675622|523935760|FG000|Overall Study|Withdrawal by Subject|2|||
145296330|NCT01675622|523935761|FG001|Overall Study|Withdrawal by Subject|2|||
145296331|NCT01675622|523935760|FG000|Overall Study|Adverse Event|12|||
145296332|NCT01675622|523935761|FG001|Overall Study|Adverse Event|10|||
145296333|NCT01675622|523935760|FG000|Overall Study|Protocol Violation|4|||
145296334|NCT01675622|523935761|FG001|Overall Study|Protocol Violation|1|||
145296335|NCT01675622|523935760|FG000|Overall Study|Lack of Efficacy|2|||
145296336|NCT01675622|523935761|FG001|Overall Study|Lack of Efficacy|4|||
145296337|NCT01675622|523935760|FG000|Overall Study|Lost to Follow-up|1|||
145296338|NCT01675622|523935761|FG001|Overall Study|Lost to Follow-up|3|||
145296339|NCT01675622|523935760|FG000|Overall Study|Other|5|||
145296340|NCT01675622|523935761|FG001|Overall Study|Other|4|||
145296341|NCT02311361|523935762|FG000|Overall Study|Did not receive treatment|0|||
145296342|NCT02311361|523935763|FG001|Overall Study|Did not receive treatment|1|||
145296343|NCT02311361|523935764|FG002|Overall Study|Did not receive treatment|0|||
145241523|NCT00351819|523728923|FG001|Overall Study|Unprofessional behavior|0|||
145241524|NCT00351819|523728922|FG000|Overall Study|Non-compliance|0|||
145241525|NCT00351819|523728923|FG001|Overall Study|Non-compliance|1|||
145241526|NCT00351819|523728922|FG000|Overall Study|Incarcerated|0|||
145241527|NCT00351819|523728923|FG001|Overall Study|Incarcerated|1|||
145241528|NCT00351819|523728922|FG000|Overall Study|Enrolled in another trial|0|||
145241529|NCT00351819|523728923|FG001|Overall Study|Enrolled in another trial|1|||
145296344|NCT02311361|523935765|FG003|Overall Study|Did not receive treatment|1|||
145296345|NCT00485472|523935767|FG000|Overall Study|Adverse Event|8|||
145296346|NCT00485472|523935768|FG001|Overall Study|Adverse Event|5|||
145296347|NCT00485472|523935767|FG000|Overall Study|Lack of Efficacy|5|||
145296348|NCT00485472|523935768|FG001|Overall Study|Lack of Efficacy|4|||
145296349|NCT00485472|523935767|FG000|Overall Study|Withdrawal by Subject|1|||
145241530|NCT01400139|523728925|FG000|HYD Core Study|Adverse Event|210|||
145241531|NCT01400139|523728925|FG000|HYD Core Study|Lack of Efficacy|59|||
145241532|NCT01400139|523728925|FG000|HYD Core Study|Withdrawal by Subject|114|||
145241533|NCT01400139|523728925|FG000|HYD Core Study|Lost to Follow-up|39|||
145241534|NCT01400139|523728925|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
145241535|NCT01400139|523728925|FG000|HYD Core Study|Administrative|56|||
145241536|NCT01400139|523728925|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
145241537|NCT01400139|523728925|FG000|HYD Extension Period|Adverse Event|8|||
145241538|NCT01400139|523728925|FG000|HYD Extension Period|Withdrawal by Subject|5|||
145241539|NCT01400139|523728925|FG000|HYD Extension Period|Administrative|10|||
145241540|NCT00418717|523728927|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
145241541|NCT00418717|523728927|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
145241542|NCT00249795|523728928|FG000|Overall Study|Not treated|16|||
145241543|NCT00249795|523728929|FG001|Overall Study|Not treated|14|||
145241544|NCT00249795|523728928|FG000|Overall Study|Symptomatic hypotension|127|||
145241545|NCT00249795|523728929|FG001|Overall Study|Symptomatic hypotension|64|||
145241546|NCT00249795|523728928|FG000|Overall Study|Other Serious Adverse Event|84|||
145241547|NCT00249795|523728929|FG001|Overall Study|Other Serious Adverse Event|93|||
145241548|NCT00249795|523728928|FG000|Overall Study|Qualifying condition not present|26|||
145241549|NCT00249795|523728929|FG001|Overall Study|Qualifying condition not present|29|||
145241550|NCT00249795|523728928|FG000|Overall Study|Withdrawal by Subject|678|||
145241551|NCT00249795|523728929|FG001|Overall Study|Withdrawal by Subject|742|||
145241552|NCT00249795|523728928|FG000|Overall Study|Thromboembolic / outcome event|39|||
145241553|NCT00249795|523728929|FG001|Overall Study|Thromboembolic / outcome event|45|||
145241554|NCT00249795|523728928|FG000|Overall Study|Oral anticoagulant required|2|||
145241555|NCT00249795|523728929|FG001|Overall Study|Oral anticoagulant required|0|||
145241556|NCT00249795|523728928|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
145241557|NCT00249795|523728929|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
145241558|NCT00249795|523728928|FG000|Overall Study|Non-compliance|71|||
145241559|NCT00249795|523728929|FG001|Overall Study|Non-compliance|69|||
145241560|NCT00249795|523728928|FG000|Overall Study|Study drug intolerance|3|||
145241561|NCT00249795|523728929|FG001|Overall Study|Study drug intolerance|3|||
145241562|NCT00249795|523728928|FG000|Overall Study|Other adverse events (non-serious)|188|||
145241563|NCT00249795|523728929|FG001|Overall Study|Other adverse events (non-serious)|159|||
145241564|NCT00249795|523728928|FG000|Overall Study|Physician withdrew consent|71|||
145241565|NCT00249795|523728929|FG001|Overall Study|Physician withdrew consent|63|||
145241566|NCT00249795|523728928|FG000|Overall Study|Surgery / procedure|4|||
145241567|NCT00249795|523728929|FG001|Overall Study|Surgery / procedure|5|||
145241568|NCT00249795|523728928|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
145241569|NCT00249795|523728929|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
145241570|NCT00249795|523728928|FG000|Overall Study|Lightheadedness / dizziness|15|||
145241571|NCT00249795|523728929|FG001|Overall Study|Lightheadedness / dizziness|11|||
145241572|NCT00249795|523728928|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
145241573|NCT00249795|523728929|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
145241574|NCT00249795|523728928|FG000|Overall Study|Other contraindicated medication|1|||
145241575|NCT00249795|523728929|FG001|Overall Study|Other contraindicated medication|1|||
145241576|NCT00249795|523728928|FG000|Overall Study|Event related to cardiac condition|17|||
145241577|NCT00249795|523728929|FG001|Overall Study|Event related to cardiac condition|16|||
145241578|NCT00249795|523728928|FG000|Overall Study|Patient not wish to continue after May08|4|||
145241579|NCT00249795|523728929|FG001|Overall Study|Patient not wish to continue after May08|6|||
145241580|NCT00249795|523728928|FG000|Overall Study|Site not agree to continue after May08|1|||
145241581|NCT00249795|523728929|FG001|Overall Study|Site not agree to continue after May08|1|||
145241582|NCT00249795|523728928|FG000|Overall Study|Lost to Follow-up|0|||
145241583|NCT00249795|523728929|FG001|Overall Study|Lost to Follow-up|2|||
145241584|NCT00249795|523728928|FG000|Overall Study|Missing|0|||
145241585|NCT00249795|523728929|FG001|Overall Study|Missing|1|||
145241586|NCT00719537|523728932|FG000|Overall Study|Withdrawal by Subject|1|||
145241587|NCT00719537|523728933|FG001|Overall Study|Withdrawal by Subject|0|||
145241588|NCT00719537|523728932|FG000|Overall Study|Lost to Follow-up|0|||
145241589|NCT00719537|523728933|FG001|Overall Study|Lost to Follow-up|1|||
145241590|NCT01142193|523728936|FG000|Overall Study|Adverse Event|12|||
145241591|NCT01142193|523728937|FG001|Overall Study|Adverse Event|4|||
145241592|NCT01142193|523728936|FG000|Overall Study|Lack of Efficacy|2|||
145241593|NCT01142193|523728937|FG001|Overall Study|Lack of Efficacy|1|||
145241594|NCT01142193|523728936|FG000|Overall Study|Physician Decision|1|||
145241595|NCT01142193|523728937|FG001|Overall Study|Physician Decision|1|||
145241596|NCT01142193|523728936|FG000|Overall Study|Withdrawal by Subject|4|||
145241597|NCT01142193|523728937|FG001|Overall Study|Withdrawal by Subject|3|||
145241598|NCT01142193|523728936|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
145241599|NCT01142193|523728937|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
145241600|NCT01142193|523728936|FG000|Overall Study|Other|1|||
145241601|NCT01142193|523728937|FG001|Overall Study|Other|2|||
145241602|NCT03549429|523728938|FG000|Overall Study|Protocol Violation|5|||
145241603|NCT03549429|523728939|FG001|Overall Study|Protocol Violation|3|||
145241604|NCT01425749|523728940|FG000|Overall Study|progression of melanoma|0|||
145241605|NCT01425749|523728941|FG001|Overall Study|progression of melanoma|1|||
145241606|NCT02910219|523728942|FG000|Overall Study|Withdrawal by Subject|1|||
145241607|NCT02910219|523728943|FG001|Overall Study|Withdrawal by Subject|1|||
145241608|NCT02096042|523728944|FG000|Overall Study|Disease Progression|1|||
145241609|NCT02096042|523728945|FG001|Overall Study|Disease Progression|0|||
145241610|NCT02096042|523728946|FG002|Overall Study|Disease Progression|0|||
145241611|NCT00701441|523728950|FG000|Overall Study|failure in cpap compliance|0|||
145241612|NCT00701441|523728951|FG001|Overall Study|failure in cpap compliance|4|||
145241613|NCT01068717|523728954|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
145241614|NCT01068717|523728955|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
145241615|NCT01068717|523728956|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
145241616|NCT01068717|523728957|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
145241617|NCT04209400|523728958|FG000|Overall Study|Withdrawal by Subject|0|||
145241618|NCT04209400|523728959|FG001|Overall Study|Withdrawal by Subject|1|||
145241619|NCT00795509|523728961|FG000|Overall Study|Protocol Violation|31|||
145241620|NCT01079195|523728962|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
145241621|NCT01079195|523728962|FG000|Overall Study|No Documentation Available|437|||
145241622|NCT01079195|523728962|FG000|Overall Study|Adverse Event|157|||
145241623|NCT01079195|523728962|FG000|Overall Study|Reason Unknown|39|||
145241624|NCT01079195|523728962|FG000|Overall Study|Withdrawal by Subject|18|||
145241625|NCT01079195|523728962|FG000|Overall Study|Financial Reasons|15|||
145241626|NCT01079195|523728962|FG000|Overall Study|Lack of Effectiveness|12|||
145241627|NCT01079195|523728962|FG000|Overall Study|Physician Decision|4|||
145241628|NCT01079195|523728962|FG000|Overall Study|Improved Status of Participant|4|||
145241629|NCT01079195|523728962|FG000|Overall Study|No Follow-up Documentation Available|4|||
145241630|NCT01079195|523728962|FG000|Overall Study|Non-compliance|2|||
145241631|NCT05200455|523728966|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
145241632|NCT01602549|523728967|FG000|Overall Study|Protocol Violation|0|||
145241633|NCT01602549|523728968|FG001|Overall Study|Protocol Violation|1|||
145241634|NCT01602549|523728967|FG000|Overall Study|Withdrawal by Subject|1|||
145241635|NCT01602549|523728968|FG001|Overall Study|Withdrawal by Subject|0|||
145241636|NCT00807014|523728969|FG000|Overall Study|Participant Considered Disease Cured|13|||
145241637|NCT00807014|523728970|FG001|Overall Study|Participant Considered Disease Cured|2|||
145241638|NCT00807014|523728969|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
145241639|NCT00807014|523728970|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
145241640|NCT00807014|523728969|FG000|Overall Study|Protocol Violation|2|||
145241641|NCT00807014|523728970|FG001|Overall Study|Protocol Violation|8|||
145241642|NCT00807014|523728969|FG000|Overall Study|Adverse Event|0|||
145241643|NCT00807014|523728970|FG001|Overall Study|Adverse Event|2|||
145241644|NCT00807014|523728969|FG000|Overall Study|Lost to Follow-up|9|||
145241645|NCT00807014|523728970|FG001|Overall Study|Lost to Follow-up|7|||
145241646|NCT00807014|523728969|FG000|Overall Study|Recovery|1|||
145241647|NCT00807014|523728970|FG001|Overall Study|Recovery|0|||
145241648|NCT00807014|523728969|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
145241649|NCT00807014|523728970|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
145241650|NCT03700736|523728973|FG000|Overall Study|Pregnancy|1|||
145241651|NCT03700736|523728974|FG001|Overall Study|Pregnancy|1|||
145241652|NCT03700736|523728973|FG000|Overall Study|Withdrawal by Subject|2|||
145241653|NCT03700736|523728974|FG001|Overall Study|Withdrawal by Subject|6|||
145241654|NCT01410799|523728976|FG000|Overall Study|PI decision|13|||
145241655|NCT04126031|523728978|FG000|Part A|Withdrawal by Subject|0|||
145241656|NCT04126031|523728979|FG001|Part A|Withdrawal by Subject|0|||
145241657|NCT04126031|523728980|FG002|Part A|Withdrawal by Subject|1|||
145241658|NCT04126031|523728981|FG003|Part A|Withdrawal by Subject|0|||
145241659|NCT04126031|523728982|FG004|Part A|Withdrawal by Subject|0|||
145241660|NCT04126031|523728983|FG005|Part A|Withdrawal by Subject|0|||
145241661|NCT04126031|523728978|FG000|Part A|Other|1|||
145241662|NCT04126031|523728979|FG001|Part A|Other|0|||
145241663|NCT04126031|523728980|FG002|Part A|Other|0|||
145241664|NCT04126031|523728981|FG003|Part A|Other|0|||
145241665|NCT04126031|523728982|FG004|Part A|Other|0|||
145241666|NCT04126031|523728983|FG005|Part A|Other|0|||
145241667|NCT04126031|523728978|FG000|Part B|Adverse Event|0|||
145241668|NCT04126031|523728979|FG001|Part B|Adverse Event|0|||
145241669|NCT04126031|523728980|FG002|Part B|Adverse Event|0|||
145241670|NCT04126031|523728981|FG003|Part B|Adverse Event|0|||
145241671|NCT04126031|523728982|FG004|Part B|Adverse Event|0|||
145241672|NCT04126031|523728983|FG005|Part B|Adverse Event|2|||
145241673|NCT04126031|523728978|FG000|Part B|Pre-existing hypertransaminasemia|0|||
145241674|NCT04126031|523728979|FG001|Part B|Pre-existing hypertransaminasemia|0|||
145241675|NCT04126031|523728980|FG002|Part B|Pre-existing hypertransaminasemia|0|||
145241676|NCT04126031|523728981|FG003|Part B|Pre-existing hypertransaminasemia|0|||
145241677|NCT04126031|523728982|FG004|Part B|Pre-existing hypertransaminasemia|1|||
145241678|NCT04126031|523728983|FG005|Part B|Pre-existing hypertransaminasemia|0|||
145241679|NCT00617656|523728984|FG000|Overall Study|Inclusion error|4|||
145241680|NCT00617656|523728985|FG001|Overall Study|Inclusion error|4|||
145241681|NCT00617656|523728986|FG002|Overall Study|Inclusion error|0|||
145241682|NCT00617656|523728987|FG003|Overall Study|Inclusion error|0|||
145241683|NCT00617656|523728984|FG000|Overall Study|Missing data|44|||
145241684|NCT00617656|523728985|FG001|Overall Study|Missing data|30|||
145241685|NCT00617656|523728986|FG002|Overall Study|Missing data|13|||
145241686|NCT00617656|523728987|FG003|Overall Study|Missing data|6|||
145241687|NCT00617656|523728984|FG000|Overall Study|Withdrawal by Subject|0|||
145241688|NCT00617656|523728985|FG001|Overall Study|Withdrawal by Subject|2|||
145241689|NCT00617656|523728986|FG002|Overall Study|Withdrawal by Subject|0|||
145241690|NCT00617656|523728987|FG003|Overall Study|Withdrawal by Subject|0|||
145241691|NCT01826448|523731088|FG000|Overall Study|Adverse Event|1|||
145241692|NCT01826448|523731089|FG001|Overall Study|Adverse Event|3|||
145241693|NCT01826448|523731088|FG000|Overall Study|Disease progression|2|||
145241694|NCT01826448|523731089|FG001|Overall Study|Disease progression|4|||
145241695|NCT01826448|523731088|FG000|Overall Study|Withdrawal by Subject|1|||
145241696|NCT01826448|523731089|FG001|Overall Study|Withdrawal by Subject|0|||
145241697|NCT01826448|523731088|FG000|Overall Study|Physician Decision|0|||
145241698|NCT01826448|523731089|FG001|Overall Study|Physician Decision|1|||
145241699|NCT01826448|523731088|FG000|Overall Study|2 active cancers|0|||
145241700|NCT01826448|523731089|FG001|Overall Study|2 active cancers|1|||
145241701|NCT00880100|523731090|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
145241702|NCT00880100|523731090|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
145241703|NCT00880100|523731090|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
145241704|NCT02971007|523731094|FG000|Overall Study|Adverse Event|1|||
145241705|NCT02971007|523731095|FG001|Overall Study|Adverse Event|0|||
145241706|NCT02971007|523731096|FG002|Overall Study|Adverse Event|0|||
145241707|NCT02971007|523731094|FG000|Overall Study|Lost to Follow-up|0|||
145241708|NCT02971007|523731095|FG001|Overall Study|Lost to Follow-up|1|||
145241709|NCT02971007|523731096|FG002|Overall Study|Lost to Follow-up|1|||
145241710|NCT02971007|523731094|FG000|Overall Study|Withdrawal by Subject|0|||
145241711|NCT02971007|523731095|FG001|Overall Study|Withdrawal by Subject|1|||
145241712|NCT02971007|523731096|FG002|Overall Study|Withdrawal by Subject|0|||
145296350|NCT00485472|523935768|FG001|Overall Study|Withdrawal by Subject|0|||
145296351|NCT00485472|523935767|FG000|Overall Study|Protocol Violation|0|||
145296352|NCT00485472|523935768|FG001|Overall Study|Protocol Violation|1|||
145296353|NCT00485472|523935767|FG000|Overall Study|Other|2|||
145296354|NCT00485472|523935768|FG001|Overall Study|Other|1|||
145296355|NCT00485472|523935767|FG000|Overall Study|Lost to Follow-up|0|||
145296356|NCT00485472|523935768|FG001|Overall Study|Lost to Follow-up|1|||
145296357|NCT01492361|523935769|FG000|Overall Study|Withdrawal by Subject|281|||
145296358|NCT01492361|523935770|FG001|Overall Study|Withdrawal by Subject|297|||
145296359|NCT01492361|523935769|FG000|Overall Study|Physician Decision|12|||
145296360|NCT01492361|523935770|FG001|Overall Study|Physician Decision|12|||
145296361|NCT01492361|523935769|FG000|Overall Study|Lost to Follow-up|6|||
145296362|NCT01492361|523935770|FG001|Overall Study|Lost to Follow-up|13|||
145296363|NCT01492361|523935769|FG000|Overall Study|Other than specified above|106|||
145296364|NCT01492361|523935770|FG001|Overall Study|Other than specified above|138|||
145296365|NCT04015232|523935774|FG000|Overall Study|Withdrawal by Subject|7|||
145296366|NCT04015232|523935775|FG001|Overall Study|Withdrawal by Subject|4|||
145296367|NCT04015232|523935774|FG000|Overall Study|Protocol Violation|1|||
145296368|NCT04015232|523935775|FG001|Overall Study|Protocol Violation|0|||
145296369|NCT04015232|523935774|FG000|Overall Study|Medical Grounds|3|||
145296370|NCT04015232|523935775|FG001|Overall Study|Medical Grounds|3|||
145296371|NCT05150964|523935780|FG000|Overall Study|Lost to Follow-up|2|||
145296372|NCT02107092|523935783|FG000|Overall Study|Miscellaneous|3|||
145296373|NCT02107092|523935783|FG000|Overall Study|Subject compliance|3|||
145296374|NCT02107092|523935783|FG000|Overall Study|Hypo-or hyperkalemia|2|||
145296375|NCT02107092|523935783|FG000|Overall Study|Met ECG withdrawal criteria|3|||
145296376|NCT02107092|523935783|FG000|Overall Study|Physician Decision|3|||
145296377|NCT02107092|523935783|FG000|Overall Study|Lost to Follow-up|2|||
145296378|NCT02107092|523935783|FG000|Overall Study|Withdrawal by Subject|9|||
145296379|NCT02107092|523935783|FG000|Overall Study|Adverse Event|7|||
145241713|NCT02971007|523731094|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
145241714|NCT02971007|523731095|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
145241715|NCT02971007|523731096|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
145241716|NCT02971007|523731094|FG000|Overall Study|Patient discontinued study drug|0|||
145241717|NCT02971007|523731095|FG001|Overall Study|Patient discontinued study drug|1|||
145241718|NCT02971007|523731096|FG002|Overall Study|Patient discontinued study drug|0|||
145296380|NCT02107092|523935783|FG000|Overall Study|Expected progression of CKD|12|||
145296381|NCT04213326|523935788|FG000|Overall Study|Consent withdrawn|51|||
145296382|NCT04213326|523935789|FG001|Overall Study|Consent withdrawn|241|||
145296383|NCT04213326|523935788|FG000|Overall Study|Lost to Follow-up|50|||
145296384|NCT04213326|523935789|FG001|Overall Study|Lost to Follow-up|902|||
145296385|NCT04213326|523935788|FG000|Overall Study|Protocol Violation|3|||
145241719|NCT00784459|523731101|FG000|Overall Study|Adverse Event|0|||
145296386|NCT04213326|523935789|FG001|Overall Study|Protocol Violation|25|||
145296387|NCT04213326|523935788|FG000|Overall Study|Participant eligibility changed|106|||
145296388|NCT04213326|523935789|FG001|Overall Study|Participant eligibility changed|19|||
145241720|NCT00784459|523731102|FG001|Overall Study|Adverse Event|2|||
145241721|NCT02431702|523731103|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
145241722|NCT02431702|523731104|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241723|NCT02431702|523731105|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241724|NCT02431702|523731106|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241725|NCT02431702|523731107|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241726|NCT02431702|523731108|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241727|NCT02431702|523731109|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
145241728|NCT02431702|523731103|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
145241729|NCT02431702|523731104|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
145241730|NCT02431702|523731105|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
145241731|NCT02431702|523731106|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
145241732|NCT02431702|523731107|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
145241733|NCT02431702|523731108|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
145563684|NCT02658890|524924027|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145241734|NCT02431702|523731109|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
145241735|NCT02431702|523731103|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
145241736|NCT02431702|523731104|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
145241737|NCT02431702|523731105|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
145241738|NCT02431702|523731106|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
145241739|NCT02431702|523731107|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
145241740|NCT02431702|523731108|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
145241741|NCT02431702|523731109|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
145241742|NCT02431702|523731103|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
145241743|NCT02431702|523731104|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
145241744|NCT02431702|523731105|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
145241745|NCT02431702|523731106|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
145241746|NCT02431702|523731107|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
145241747|NCT02431702|523731108|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
145241748|NCT02431702|523731109|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
145241749|NCT02431702|523731103|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
145241750|NCT02431702|523731104|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145241751|NCT02431702|523731105|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145241752|NCT02431702|523731106|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145241753|NCT02431702|523731107|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145241754|NCT02431702|523731108|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145296389|NCT04213326|523935788|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
145296390|NCT04213326|523935789|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
145296391|NCT04213326|523935788|FG000|Overall Study|Incomplete study visit|0|||
145296392|NCT04213326|523935789|FG001|Overall Study|Incomplete study visit|367|||
145296393|NCT02549092|523935790|FG000|Treatment Period|Adverse Event|2|||
145296394|NCT02549092|523935791|FG001|Treatment Period|Adverse Event|2|||
145296395|NCT02549092|523935790|FG000|Treatment Period|Withdrawal by Subject|1|||
145296396|NCT02549092|523935791|FG001|Treatment Period|Withdrawal by Subject|3|||
145296397|NCT02549092|523935790|FG000|Treatment Period|Lack of Efficacy|0|||
145296398|NCT02549092|523935791|FG001|Treatment Period|Lack of Efficacy|2|||
145296399|NCT02549092|523935790|FG000|Extension/Transition Period|Adverse Event|1|||
145296400|NCT02549092|523935791|FG001|Extension/Transition Period|Adverse Event|1|||
145296401|NCT02549092|523935790|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
145296402|NCT02549092|523935791|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
145296403|NCT02549092|523935790|FG000|Extension/Transition Period|Other, Not Specified|4|||
145296404|NCT02549092|523935791|FG001|Extension/Transition Period|Other, Not Specified|2|||
145296405|NCT00906347|523935802|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
145296406|NCT00906347|523935803|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
145296407|NCT00906347|523935802|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
145296408|NCT00906347|523935803|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
145296409|NCT00906347|523935802|FG000|Received Study Drug|Refused study drug|1|||
145563685|NCT02658890|524924028|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563686|NCT02658890|524924029|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145241755|NCT02431702|523731109|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
145241756|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
145241757|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
145241758|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
145296410|NCT00906347|523935803|FG001|Received Study Drug|Refused study drug|0|||
145296411|NCT00906347|523935802|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
145296412|NCT00906347|523935803|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
145296413|NCT00472290|523935808|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
145296414|NCT00472290|523935808|FG000|Overall Study|Protocol Specified Criteria|7|||
145241759|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
145241760|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
145241761|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
145241762|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
145241763|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
145241764|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
145241765|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
145241766|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
145241767|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
145241768|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
145241769|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
145241770|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
145241771|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
145241772|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
145241773|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
145241774|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
145241775|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
145241776|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
145241777|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241778|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
145241779|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241780|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241781|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241782|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241783|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
145241784|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
145241785|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
145241786|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
145241787|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
145241788|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
145241789|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
145241790|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
145241791|NCT02431702|523731103|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145241792|NCT02431702|523731104|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145241793|NCT02431702|523731105|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
145241794|NCT02431702|523731106|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145241795|NCT02431702|523731107|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145241796|NCT02431702|523731108|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145241797|NCT02431702|523731109|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
145296415|NCT00472290|523935808|FG000|Overall Study|Administrative Decision|37|||
145296416|NCT00472290|523935808|FG000|Overall Study|Death|3|||
145296417|NCT00472290|523935808|FG000|Overall Study|Lost to Follow-up|1|||
145296418|NCT00472290|523935808|FG000|Overall Study|Lack of Efficacy|1|||
145296419|NCT00472290|523935808|FG000|Overall Study|Disease Progression|4|||
145296420|NCT00472290|523935808|FG000|Overall Study|Withdrawal by Subject|5|||
145296421|NCT00472290|523935808|FG000|Overall Study|Adverse Event|6|||
145296422|NCT00472290|523935808|FG000|Overall Study|Requirement for alternative therapy|7|||
145296423|NCT00777829|523935809|FG000|Overall Study|Withdrawal by Subject|0|||
145296424|NCT00777829|523935810|FG001|Overall Study|Withdrawal by Subject|2|||
145296425|NCT00745095|523935819|FG000|Overall Study|Declined to participate|1|||
145296426|NCT00745095|523935820|FG001|Overall Study|Declined to participate|0|||
145296427|NCT00745095|523935821|FG002|Overall Study|Declined to participate|0|||
145296428|NCT00745095|523935822|FG003|Overall Study|Declined to participate|0|||
145296429|NCT00745095|523935823|FG004|Overall Study|Declined to participate|92|||
145296430|NCT00745095|523935824|FG005|Overall Study|Declined to participate|95|||
145296431|NCT00745095|523935819|FG000|Overall Study|Ineligible due to GFR criteria|0|||
145296432|NCT00745095|523935820|FG001|Overall Study|Ineligible due to GFR criteria|2|||
145296433|NCT00745095|523935821|FG002|Overall Study|Ineligible due to GFR criteria|3|||
145296434|NCT00745095|523935822|FG003|Overall Study|Ineligible due to GFR criteria|3|||
145296435|NCT00745095|523935823|FG004|Overall Study|Ineligible due to GFR criteria|30|||
145296436|NCT00745095|523935824|FG005|Overall Study|Ineligible due to GFR criteria|28|||
145296437|NCT01479439|523935825|FG000|Overall Study|Adverse Event|1|||
145296438|NCT01479439|523935826|FG001|Overall Study|Adverse Event|0|||
145296439|NCT01479439|523935827|FG002|Overall Study|Adverse Event|0|||
145296440|NCT01479439|523935825|FG000|Overall Study|Lost to Follow-up|0|||
145620065|NCT03468426|525123658|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145620066|NCT03468426|525123659|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145563687|NCT02658890|524924030|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
145563688|NCT02658890|524924004|FG000|Treatment Phase|Withdrawal by Subject|0|||
145563689|NCT02658890|524924005|FG001|Treatment Phase|Withdrawal by Subject|1|||
145563690|NCT02658890|524924006|FG002|Treatment Phase|Withdrawal by Subject|0|||
145563691|NCT02658890|524924007|FG003|Treatment Phase|Withdrawal by Subject|0|||
145563692|NCT02658890|524924008|FG004|Treatment Phase|Withdrawal by Subject|0|||
145563693|NCT02658890|524924009|FG005|Treatment Phase|Withdrawal by Subject|0|||
145563694|NCT02658890|524924010|FG006|Treatment Phase|Withdrawal by Subject|1|||
145563695|NCT02658890|524924011|FG007|Treatment Phase|Withdrawal by Subject|0|||
145563696|NCT02658890|524924012|FG008|Treatment Phase|Withdrawal by Subject|0|||
145563697|NCT02658890|524924013|FG009|Treatment Phase|Withdrawal by Subject|1|||
145563698|NCT02658890|524924014|FG010|Treatment Phase|Withdrawal by Subject|0|||
145563699|NCT02658890|524924015|FG011|Treatment Phase|Withdrawal by Subject|0|||
145563700|NCT02658890|524924016|FG012|Treatment Phase|Withdrawal by Subject|1|||
145563701|NCT02658890|524924017|FG013|Treatment Phase|Withdrawal by Subject|3|||
145563702|NCT02658890|524924018|FG014|Treatment Phase|Withdrawal by Subject|0|||
145563703|NCT02658890|524924019|FG015|Treatment Phase|Withdrawal by Subject|0|||
145563704|NCT02658890|524924020|FG016|Treatment Phase|Withdrawal by Subject|1|||
145563705|NCT02658890|524924021|FG017|Treatment Phase|Withdrawal by Subject|0|||
145563706|NCT02658890|524924022|FG018|Treatment Phase|Withdrawal by Subject|4|||
145563707|NCT02658890|524924023|FG019|Treatment Phase|Withdrawal by Subject|3|||
145563708|NCT02658890|524924024|FG020|Treatment Phase|Withdrawal by Subject|0|||
145563709|NCT02658890|524924025|FG021|Treatment Phase|Withdrawal by Subject|4|||
145563710|NCT02658890|524924026|FG022|Treatment Phase|Withdrawal by Subject|1|||
145563711|NCT02658890|524924027|FG023|Treatment Phase|Withdrawal by Subject|1|||
145563712|NCT02658890|524924028|FG024|Treatment Phase|Withdrawal by Subject|0|||
145563713|NCT02658890|524924029|FG025|Treatment Phase|Withdrawal by Subject|0|||
145563714|NCT02658890|524924030|FG026|Treatment Phase|Withdrawal by Subject|0|||
145563715|NCT02474199|524924034|FG000|Overall Study|Lost to Follow-up|1|||
145563716|NCT02474199|524924035|FG001|Overall Study|Lost to Follow-up|0|||
145563717|NCT02474199|524924036|FG002|Overall Study|Lost to Follow-up|0|||
145563718|NCT02474199|524924037|FG003|Overall Study|Lost to Follow-up|0|||
145563719|NCT02474199|524924034|FG000|Overall Study|Withdrawal by Subject|1|||
145563720|NCT02474199|524924035|FG001|Overall Study|Withdrawal by Subject|2|||
145563721|NCT02474199|524924036|FG002|Overall Study|Withdrawal by Subject|0|||
145563722|NCT02474199|524924037|FG003|Overall Study|Withdrawal by Subject|1|||
145563723|NCT02474199|524924034|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
145563724|NCT02474199|524924035|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
145563725|NCT02474199|524924036|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
145563726|NCT02474199|524924037|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
145563727|NCT02474199|524924034|FG000|Overall Study|Did not meet eligibility criteria|0|||
145241798|NCT02431702|523731103|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
145241799|NCT02431702|523731104|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
145241800|NCT02431702|523731105|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
145241801|NCT02431702|523731106|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
145241802|NCT02431702|523731107|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
145241803|NCT02431702|523731108|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
145241804|NCT02431702|523731109|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
145241805|NCT02431702|523731103|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
145241806|NCT02431702|523731104|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
145241807|NCT02431702|523731105|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
145241808|NCT02431702|523731106|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
145241809|NCT02431702|523731107|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
145241810|NCT02431702|523731108|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
145241811|NCT02431702|523731109|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
145241812|NCT02431702|523731103|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
145241813|NCT02431702|523731104|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
145563728|NCT02474199|524924035|FG001|Overall Study|Did not meet eligibility criteria|0|||
145563729|NCT02474199|524924036|FG002|Overall Study|Did not meet eligibility criteria|2|||
145563730|NCT02474199|524924037|FG003|Overall Study|Did not meet eligibility criteria|2|||
145563731|NCT03090100|524924038|FG000|Overall Study|Adverse Event|9|||
145241814|NCT02431702|523731105|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
145563732|NCT03090100|524924039|FG001|Overall Study|Adverse Event|11|||
145563733|NCT03090100|524924038|FG000|Overall Study|Pregnancy|1|||
145563734|NCT03090100|524924039|FG001|Overall Study|Pregnancy|1|||
145563735|NCT03090100|524924038|FG000|Overall Study|Lack of Efficacy|2|||
145563736|NCT03090100|524924039|FG001|Overall Study|Lack of Efficacy|7|||
145563737|NCT03090100|524924038|FG000|Overall Study|Lost to Follow-up|2|||
145563738|NCT03090100|524924039|FG001|Overall Study|Lost to Follow-up|2|||
145563739|NCT03090100|524924038|FG000|Overall Study|Withdrawal by Subject|7|||
145241815|NCT02431702|523731106|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
145241816|NCT02431702|523731107|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
145241817|NCT02431702|523731108|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
145563740|NCT03090100|524924039|FG001|Overall Study|Withdrawal by Subject|19|||
145563741|NCT03090100|524924038|FG000|Overall Study|Protocol Violation|2|||
145563742|NCT03090100|524924039|FG001|Overall Study|Protocol Violation|6|||
145241818|NCT02431702|523731109|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
145241819|NCT02431702|523731103|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
145241820|NCT02431702|523731104|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
145241821|NCT02431702|523731105|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
145241822|NCT02431702|523731106|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
145241823|NCT02431702|523731107|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
145241824|NCT02431702|523731108|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
145241825|NCT02431702|523731109|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
145241826|NCT03551626|523731110|FG000|Overall Study|Adverse Event|88|||
145241827|NCT03551626|523731110|FG000|Overall Study|Disease relapse|18|||
145241828|NCT03551626|523731110|FG000|Overall Study|Withdrawal of informed consent|6|||
145241829|NCT03551626|523731110|FG000|Overall Study|Patient decision|5|||
145241830|NCT03551626|523731110|FG000|Overall Study|Physician Decision|4|||
145241831|NCT03551626|523731110|FG000|Overall Study|Lost to Follow-up|3|||
145241832|NCT03551626|523731110|FG000|Overall Study|Pregnancy|1|||
145241833|NCT03551626|523731110|FG000|Overall Study|Protocol deviation|1|||
145241834|NCT03551626|523731110|FG000|Overall Study|Technical problems|1|||
145241835|NCT01017549|523731113|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
145241836|NCT01017549|523731113|FG000|One-year Follow-up|Lost to Follow-up|2|||
145241837|NCT01017549|523731113|FG000|One-year Follow-up|Withdrawal by Subject|5|||
145241838|NCT01017549|523731113|FG000|5 Year Follow-up|Lost to Follow-up|9|||
145241839|NCT01017549|523731113|FG000|5 Year Follow-up|Mastectomy|3|||
145241840|NCT00443846|523731114|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
145241841|NCT00443846|523731115|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
145563743|NCT03090100|524924038|FG000|Overall Study|Non-compliance|2|||
145563744|NCT03090100|524924039|FG001|Overall Study|Non-compliance|0|||
145563745|NCT03090100|524924038|FG000|Overall Study|Other|2|||
145563746|NCT03090100|524924039|FG001|Overall Study|Other|2|||
145563747|NCT00159588|524924040|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
145241842|NCT00443846|523731114|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
145241843|NCT00443846|523731115|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
145241844|NCT00443846|523731114|FG000|Overall Study|Adverse Event|0|||
145241845|NCT00443846|523731115|FG001|Overall Study|Adverse Event|1|||
145241846|NCT00443846|523731114|FG000|Overall Study|Personal reason|8|||
145241847|NCT00443846|523731115|FG001|Overall Study|Personal reason|3|||
145241848|NCT00443846|523731114|FG000|Overall Study|Lost to Follow-up|1|||
145241849|NCT00443846|523731115|FG001|Overall Study|Lost to Follow-up|2|||
145241850|NCT00391807|523731122|FG000|Overall Study|Did not receive study medication|23|||
145241851|NCT00391807|523731122|FG000|Overall Study|Adverse Event|177|||
145241852|NCT00391807|523731122|FG000|Overall Study|Pregnancy|25|||
145241853|NCT00391807|523731122|FG000|Overall Study|Lost to Follow-up|227|||
145241854|NCT00391807|523731122|FG000|Overall Study|Withdrawal by Subject|147|||
145241855|NCT00391807|523731122|FG000|Overall Study|Protocol Violation|20|||
145241856|NCT00391807|523731122|FG000|Overall Study|Various|96|||
145241857|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
145241858|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
145241859|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
145241860|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
145241861|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
145563748|NCT00159588|524924041|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
145241862|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
145241863|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
145241864|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
145241865|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
145241866|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
145241867|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
145563749|NCT00159588|524924042|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
145563750|NCT03446040|524924043|FG000|Overall Study|Disease progression|3|||
145563751|NCT03446040|524924044|FG001|Overall Study|Disease progression|3|||
145563752|NCT03446040|524924045|FG002|Overall Study|Disease progression|3|||
145563753|NCT03446040|524924046|FG003|Overall Study|Disease progression|4|||
145241868|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
145241869|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
145241870|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
145241871|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
145241872|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
145241873|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
145563754|NCT03446040|524924047|FG004|Overall Study|Disease progression|4|||
145241874|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
145241875|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
145241876|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
145241877|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
145241878|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
145241879|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
145241880|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
145241881|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
145241882|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Other|1|||
145241883|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Other|0|||
145241884|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Other|0|||
145241885|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Other|0|||
145241886|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Other|1|||
145241887|NCT02980692|523731125|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
145241888|NCT02980692|523731126|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
145241889|NCT02980692|523731127|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
145241890|NCT02980692|523731128|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
145241891|NCT02980692|523731129|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
145241892|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Adverse Event|0|||
145241893|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Adverse Event|0|||
145241894|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Adverse Event|0|||
145241895|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Adverse Event|1|||
145241896|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Adverse Event|1|||
145241897|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
145241898|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
145241899|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
145241900|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
145241901|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
145241902|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
145241903|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
145241904|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
145241905|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
145241906|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
145241907|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Pregnancy|0|||
145241908|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Pregnancy|0|||
145241909|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Pregnancy|1|||
145241910|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Pregnancy|1|||
145241911|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Pregnancy|0|||
145241912|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
145241913|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
145241914|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
145241915|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
145241916|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
145241917|NCT02980692|523731125|FG000|Double-blind Follow-up Period|Other|0|||
145241918|NCT02980692|523731126|FG001|Double-blind Follow-up Period|Other|0|||
145241919|NCT02980692|523731127|FG002|Double-blind Follow-up Period|Other|1|||
145241920|NCT02980692|523731128|FG003|Double-blind Follow-up Period|Other|1|||
145241921|NCT02980692|523731129|FG004|Double-blind Follow-up Period|Other|3|||
145241922|NCT03725293|523731133|FG000|Overall Study|Physician Decision|9|||
145241923|NCT03725293|523731134|FG001|Overall Study|Physician Decision|6|||
145241924|NCT03725293|523731133|FG000|Overall Study|alternative vascular access needs|1|||
145241925|NCT03725293|523731134|FG001|Overall Study|alternative vascular access needs|2|||
145241926|NCT03725293|523731133|FG000|Overall Study|venous anatomy screen failures|2|||
145241927|NCT03725293|523731134|FG001|Overall Study|venous anatomy screen failures|1|||
145241928|NCT02143141|523731135|FG000|Overall Study|pain scores at 24 hours not collected|1|||
145241929|NCT02143141|523731136|FG001|Overall Study|pain scores at 24 hours not collected|0|||
145241930|NCT04583969|523731137|FG000|Overall Study|Death|31|||
145408855|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145408856|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145408857|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145408858|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145408859|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
145620067|NCT03468426|525123649|FG000|Overall Study|missing reason|0|||
145241931|NCT04583969|523731138|FG001|Overall Study|Death|38|||
145241932|NCT04583969|523731137|FG000|Overall Study|Lost to Follow-up|16|||
145241933|NCT04583969|523731138|FG001|Overall Study|Lost to Follow-up|13|||
145241934|NCT04583969|523731137|FG000|Overall Study|Protocol Violation|1|||
145241935|NCT04583969|523731138|FG001|Overall Study|Protocol Violation|0|||
145241936|NCT04583969|523731137|FG000|Overall Study|Withdrawal by Subject|3|||
145241937|NCT04583969|523731138|FG001|Overall Study|Withdrawal by Subject|3|||
145241938|NCT04583969|523731137|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
145241939|NCT04583969|523731138|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
145241940|NCT04583969|523731137|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
145241941|NCT04583969|523731138|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
145241942|NCT04583969|523731137|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
145241943|NCT04583969|523731138|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
145241944|NCT04583969|523731137|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
145241945|NCT04583969|523731138|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
145241946|NCT04583969|523731137|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
145241947|NCT04583969|523731138|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
145241948|NCT03862495|523731141|FG000|Overall Study|Lost to Follow-up|37|||
145241949|NCT03862495|523731142|FG001|Overall Study|Lost to Follow-up|35|||
145241950|NCT04397796|523731143|FG000|Overall Study|Death|3|||
145241951|NCT04397796|523731144|FG001|Overall Study|Death|1|||
145241952|NCT01057862|523731145|FG000|Overall Study|Withdrawal by Subject|1|||
145241953|NCT01057862|523731146|FG001|Overall Study|Withdrawal by Subject|2|||
145241954|NCT03363165|523731149|FG000|3-month Follow-up|Death|0|||
145241955|NCT03363165|523731150|FG001|3-month Follow-up|Death|1|||
145241956|NCT03363165|523731149|FG000|6-month Follow-up|Death|0|||
145241957|NCT03363165|523731150|FG001|6-month Follow-up|Death|1|||
145241958|NCT03363165|523731149|FG000|6-month Follow-up|Withdrawal by Subject|1|||
145241959|NCT03363165|523731150|FG001|6-month Follow-up|Withdrawal by Subject|1|||
145241960|NCT03363165|523731149|FG000|12-month Follow-up|Death|1|||
145241961|NCT03363165|523731150|FG001|12-month Follow-up|Death|1|||
145241962|NCT03363165|523731149|FG000|12-month Follow-up|Withdrawal by Subject|1|||
145241963|NCT03363165|523731150|FG001|12-month Follow-up|Withdrawal by Subject|1|||
145241964|NCT02255760|523731151|FG000|Overall Study|Lost to Follow-up|0|||
145241965|NCT02255760|523731152|FG001|Overall Study|Lost to Follow-up|1|||
145241966|NCT02255760|523731153|FG002|Overall Study|Lost to Follow-up|0|||
145241967|NCT02255760|523731154|FG003|Overall Study|Lost to Follow-up|0|||
145241968|NCT02255760|523731155|FG004|Overall Study|Lost to Follow-up|0|||
145241969|NCT00618813|523731156|FG000|Overall Study|Lack of Efficacy|1|||
145241970|NCT00618813|523731156|FG000|Overall Study|Physician Decision|2|||
145241971|NCT00618813|523731156|FG000|Overall Study|Withdrawal by Subject|1|||
145241972|NCT00003838|523731157|FG000|Overall Study|Death|0|||
145241973|NCT00003838|523731158|FG001|Overall Study|Death|12|||
145241974|NCT00003838|523731159|FG002|Overall Study|Death|7|||
145241975|NCT00003838|523731157|FG000|Overall Study|Lost to Follow-up|0|||
145241976|NCT00003838|523731158|FG001|Overall Study|Lost to Follow-up|1|||
145241977|NCT00003838|523731159|FG002|Overall Study|Lost to Follow-up|1|||
145241978|NCT00003838|523731157|FG000|Overall Study|Disease Progression|0|||
145241979|NCT00003838|523731158|FG001|Overall Study|Disease Progression|12|||
145241980|NCT00003838|523731159|FG002|Overall Study|Disease Progression|0|||
145241981|NCT00425113|523731160|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
145241982|NCT00425113|523731161|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
145241983|NCT00425113|523731160|FG000|Overall Study|diagnosis of abdominal TB|0|||
145241984|NCT00425113|523731161|FG001|Overall Study|diagnosis of abdominal TB|1|||
145241985|NCT00425113|523731160|FG000|Overall Study|missing study drug more than 14 days|0|||
145241986|NCT00425113|523731161|FG001|Overall Study|missing study drug more than 14 days|1|||
145241987|NCT00425113|523731160|FG000|Overall Study|Withdrawal by Subject|1|||
145241988|NCT00425113|523731161|FG001|Overall Study|Withdrawal by Subject|0|||
145241989|NCT00879437|523731164|FG000|Overall Study|Protocol Violation|0|||
145241990|NCT00879437|523731165|FG001|Overall Study|Protocol Violation|1|||
145241991|NCT00879437|523731164|FG000|Overall Study|Death|1|||
145241992|NCT00879437|523731165|FG001|Overall Study|Death|0|||
145241993|NCT00268463|523731166|FG000|Overall Study|study terminated due to low accrual|10|||
145241994|NCT00268463|523731167|FG001|Overall Study|study terminated due to low accrual|12|||
145241995|NCT00770224|523731168|FG000|Step 1: Induction|Adverse Event|3|||
145241996|NCT00770224|523731169|FG001|Step 1: Induction|Adverse Event|0|||
145241997|NCT00770224|523731168|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
145241998|NCT00770224|523731169|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
145241999|NCT00770224|523731168|FG000|Step 1: Induction|Other reason not protocol specified|2|||
145242000|NCT00770224|523731169|FG001|Step 1: Induction|Other reason not protocol specified|0|||
145242001|NCT00770224|523731168|FG000|Step 1: Induction|Ineligible|2|||
145242002|NCT00770224|523731169|FG001|Step 1: Induction|Ineligible|0|||
145242003|NCT00770224|523731168|FG000|Step 1: Induction|No protocol treatment given|1|||
145242004|NCT00770224|523731169|FG001|Step 1: Induction|No protocol treatment given|0|||
145242005|NCT00770224|523731168|FG000|Step 2: Maintenance|Adverse Event|0|||
145242006|NCT00770224|523731169|FG001|Step 2: Maintenance|Adverse Event|10|||
145242007|NCT00770224|523731168|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
145242008|NCT00770224|523731169|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
145242009|NCT00770224|523731168|FG000|Step 2: Maintenance|Progression/relapse|0|||
145242010|NCT00770224|523731169|FG001|Step 2: Maintenance|Progression/relapse|1|||
145242011|NCT00770224|523731168|FG000|Step 2: Maintenance|Death|0|||
145242012|NCT00770224|523731169|FG001|Step 2: Maintenance|Death|2|||
145242013|NCT00770224|523731168|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
145242014|NCT00770224|523731169|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
145242015|NCT00770224|523731168|FG000|Step 2: Maintenance|Ineligible|0|||
145242016|NCT00770224|523731169|FG001|Step 2: Maintenance|Ineligible|2|||
145242017|NCT04737759|523731170|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
145242018|NCT04737759|523731171|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
145242019|NCT04737759|523731170|FG000|Overall Study|Death|2|||
145242020|NCT04737759|523731171|FG001|Overall Study|Death|0|||
145242021|NCT04737759|523731170|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
145242022|NCT04737759|523731171|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
145242023|NCT04737759|523731170|FG000|Overall Study|Lost to Follow-up|4|||
145242024|NCT04737759|523731171|FG001|Overall Study|Lost to Follow-up|12|||
145242025|NCT01484561|523731172|FG000|Overall Study|Lack of Efficacy|3|||
145242026|NCT01484561|523731173|FG001|Overall Study|Lack of Efficacy|1|||
145242027|NCT01484561|523731172|FG000|Overall Study|Lost to Follow-up|1|||
145242028|NCT01484561|523731173|FG001|Overall Study|Lost to Follow-up|0|||
145242029|NCT01484561|523731172|FG000|Overall Study|Withdrawal by Subject|3|||
145242030|NCT01484561|523731173|FG001|Overall Study|Withdrawal by Subject|0|||
145242031|NCT01484561|523731172|FG000|Overall Study|Other|1|||
145242032|NCT01484561|523731173|FG001|Overall Study|Other|1|||
145242033|NCT01484561|523731172|FG000|Overall Study|Adverse Event|1|||
145242034|NCT01484561|523731173|FG001|Overall Study|Adverse Event|4|||
145242035|NCT03371251|523731174|FG000|Overall Study|Withdrawal by Subject|1|||
145242036|NCT03371251|523731175|FG001|Overall Study|Withdrawal by Subject|0|||
145242037|NCT03371251|523731176|FG002|Overall Study|Withdrawal by Subject|1|||
145242038|NCT03371251|523731177|FG003|Overall Study|Withdrawal by Subject|0|||
145242039|NCT03371251|523731178|FG004|Overall Study|Withdrawal by Subject|2|||
145242040|NCT03371251|523731179|FG005|Overall Study|Withdrawal by Subject|2|||
145242041|NCT03371251|523731174|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
145242042|NCT03371251|523731175|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
145242043|NCT03371251|523731176|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
145242044|NCT03371251|523731177|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
145242045|NCT03371251|523731178|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
145242046|NCT03371251|523731179|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
145242047|NCT03371251|523731174|FG000|Overall Study|Adverse Event|0|||
145242048|NCT03371251|523731175|FG001|Overall Study|Adverse Event|0|||
145242049|NCT03371251|523731176|FG002|Overall Study|Adverse Event|0|||
145242050|NCT03371251|523731177|FG003|Overall Study|Adverse Event|0|||
145242051|NCT03371251|523731178|FG004|Overall Study|Adverse Event|1|||
145242052|NCT03371251|523731179|FG005|Overall Study|Adverse Event|0|||
145242053|NCT03371251|523731174|FG000|Overall Study|Decision by Sponsor|0|||
145242054|NCT03371251|523731175|FG001|Overall Study|Decision by Sponsor|0|||
145242055|NCT03371251|523731176|FG002|Overall Study|Decision by Sponsor|0|||
145242056|NCT03371251|523731177|FG003|Overall Study|Decision by Sponsor|0|||
145242057|NCT03371251|523731178|FG004|Overall Study|Decision by Sponsor|2|||
145242058|NCT03371251|523731179|FG005|Overall Study|Decision by Sponsor|0|||
145242059|NCT00291187|523731180|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
145242060|NCT00291187|523731181|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
145242061|NCT00291187|523731182|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
145242062|NCT00291187|523731183|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
145242063|NCT04362813|523731184|FG000|Overall Study|Death|12|||
145563755|NCT03446040|524924048|FG005|Overall Study|Disease progression|6|||
145563756|NCT03446040|524924049|FG006|Overall Study|Disease progression|3|||
145563757|NCT03446040|524924050|FG007|Overall Study|Disease progression|4|||
145563758|NCT03446040|524924051|FG008|Overall Study|Disease progression|2|||
145563759|NCT03446040|524924052|FG009|Overall Study|Disease progression|4|||
145563760|NCT03446040|524924053|FG010|Overall Study|Disease progression|9|||
145563761|NCT03446040|524924054|FG011|Overall Study|Disease progression|3|||
145242064|NCT04362813|523731185|FG001|Overall Study|Death|16|||
145242065|NCT04362813|523731184|FG000|Overall Study|Withdrawal by Subject|3|||
145242066|NCT04362813|523731185|FG001|Overall Study|Withdrawal by Subject|1|||
145242067|NCT04362813|523731184|FG000|Overall Study|Protocol Violation|0|||
145242068|NCT04362813|523731185|FG001|Overall Study|Protocol Violation|3|||
145242069|NCT04362813|523731184|FG000|Overall Study|Lost to Follow-up|1|||
145242070|NCT04362813|523731185|FG001|Overall Study|Lost to Follow-up|1|||
145296441|NCT01479439|523935826|FG001|Overall Study|Lost to Follow-up|1|||
145563762|NCT03446040|524924055|FG012|Overall Study|Disease progression|7|||
145563763|NCT03446040|524924056|FG013|Overall Study|Disease progression|7|||
145242071|NCT04362813|523731184|FG000|Overall Study|Enrolled but did not receive treatment|2|||
145242072|NCT04362813|523731185|FG001|Overall Study|Enrolled but did not receive treatment|4|||
145242073|NCT00961116|523731186|FG000|Washout Period of 7 Days|Adverse Event|1|||
145242074|NCT00961116|523731187|FG001|Washout Period of 7 Days|Adverse Event|1|||
145242075|NCT00961116|523731186|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
145242076|NCT00961116|523731187|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145242077|NCT00961116|523731186|FG000|Washout Period of 7 Days|Protocol Violation|0|||
145242078|NCT00961116|523731187|FG001|Washout Period of 7 Days|Protocol Violation|1|||
145242079|NCT00615459|523731191|FG000|Period I|Adverse Event|2|||
145242080|NCT00615459|523731192|FG001|Period I|Adverse Event|0|||
145242081|NCT00615459|523731193|FG002|Period I|Adverse Event|1|||
145242082|NCT00615459|523731194|FG003|Period I|Adverse Event|0|||
145242083|NCT00615459|523731191|FG000|Period I|Subject withdrew consent|1|||
145242084|NCT00615459|523731192|FG001|Period I|Subject withdrew consent|0|||
145242085|NCT00615459|523731193|FG002|Period I|Subject withdrew consent|0|||
145242086|NCT00615459|523731194|FG003|Period I|Subject withdrew consent|1|||
145242087|NCT00615459|523731191|FG000|Period I|Abnormal test procedure results|1|||
145242088|NCT00615459|523731192|FG001|Period I|Abnormal test procedure results|1|||
145242089|NCT00615459|523731193|FG002|Period I|Abnormal test procedure results|1|||
145242090|NCT00615459|523731194|FG003|Period I|Abnormal test procedure results|0|||
145242091|NCT00615459|523731191|FG000|Period II|Adverse Event|1|||
145242092|NCT00615459|523731192|FG001|Period II|Adverse Event|0|||
145242093|NCT00615459|523731193|FG002|Period II|Adverse Event|0|||
145242094|NCT00615459|523731194|FG003|Period II|Adverse Event|0|||
145242095|NCT00615459|523731191|FG000|Period II|Lost to Follow-up|0|||
145242096|NCT00615459|523731192|FG001|Period II|Lost to Follow-up|0|||
145242097|NCT00615459|523731193|FG002|Period II|Lost to Follow-up|0|||
145242098|NCT00615459|523731194|FG003|Period II|Lost to Follow-up|1|||
145242099|NCT00615459|523731191|FG000|Period III|Adverse Event|0|||
145242100|NCT00615459|523731192|FG001|Period III|Adverse Event|1|||
145242101|NCT00615459|523731193|FG002|Period III|Adverse Event|0|||
145242102|NCT00615459|523731194|FG003|Period III|Adverse Event|0|||
145242103|NCT00615459|523731191|FG000|Period III|Administrative problems|0|||
145242104|NCT00615459|523731192|FG001|Period III|Administrative problems|1|||
145242105|NCT00615459|523731193|FG002|Period III|Administrative problems|1|||
145242106|NCT00615459|523731194|FG003|Period III|Administrative problems|0|||
145242107|NCT00615459|523731191|FG000|Period III|Unsatisfactory therapeutic effect|0|||
145242108|NCT00615459|523731192|FG001|Period III|Unsatisfactory therapeutic effect|1|||
145242109|NCT00615459|523731193|FG002|Period III|Unsatisfactory therapeutic effect|0|||
145242110|NCT00615459|523731194|FG003|Period III|Unsatisfactory therapeutic effect|0|||
145242111|NCT00918346|523731197|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
145242112|NCT00918346|523731198|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
145242113|NCT03238352|523731199|FG000|Overall Study|Lost to Follow-up|0|||
145242114|NCT03238352|523731200|FG001|Overall Study|Lost to Follow-up|2|||
145242115|NCT03238352|523731201|FG002|Overall Study|Lost to Follow-up|1|||
145242116|NCT03238352|523731199|FG000|Overall Study|Withdrawal by Subject|0|||
145242117|NCT03238352|523731200|FG001|Overall Study|Withdrawal by Subject|1|||
145242118|NCT03238352|523731201|FG002|Overall Study|Withdrawal by Subject|0|||
145242119|NCT00709124|523731202|FG000|Overall Study|Death|3|||
145242120|NCT00709124|523731203|FG001|Overall Study|Death|1|||
145242121|NCT00709124|523731202|FG000|Overall Study|encephalopathy; can't do assessment|1|||
145242122|NCT00709124|523731203|FG001|Overall Study|encephalopathy; can't do assessment|0|||
145242123|NCT00753688|523731210|FG000|Overall Study|Death|102|||
145242124|NCT00753688|523731211|FG001|Overall Study|Death|203|||
145242125|NCT00753688|523731210|FG000|Overall Study|Missing|4|||
145242126|NCT00753688|523731211|FG001|Overall Study|Missing|9|||
145242127|NCT00753688|523731210|FG000|Overall Study|Participant Withdrew Consent|2|||
145242128|NCT00753688|523731211|FG001|Overall Study|Participant Withdrew Consent|2|||
145242129|NCT00753688|523731210|FG000|Overall Study|Ongoing - in Follow-up|15|||
145242130|NCT00753688|523731211|FG001|Overall Study|Ongoing - in Follow-up|31|||
145242131|NCT00753688|523731210|FG000|Overall Study|Adverse Event|0|||
145242132|NCT00753688|523731211|FG001|Overall Study|Adverse Event|1|||
145242133|NCT03803202|523731215|FG000|Overall Study|Other|0|||
145242134|NCT03803202|523731216|FG001|Overall Study|Other|1|||
145242135|NCT03803202|523731217|FG002|Overall Study|Other|0|||
145242136|NCT03803202|523731218|FG003|Overall Study|Other|0|||
145242137|NCT03803202|523731219|FG004|Overall Study|Other|0|||
145242138|NCT03803202|523731220|FG005|Overall Study|Other|0|||
145242139|NCT03803202|523731221|FG006|Overall Study|Other|0|||
145242140|NCT03803202|523731222|FG007|Overall Study|Other|0|||
145242141|NCT03803202|523731223|FG008|Overall Study|Other|0|||
145242142|NCT03803202|523731215|FG000|Overall Study|Death|0|||
145242143|NCT03803202|523731216|FG001|Overall Study|Death|0|||
145242144|NCT03803202|523731217|FG002|Overall Study|Death|0|||
145242145|NCT03803202|523731218|FG003|Overall Study|Death|0|||
145242146|NCT03803202|523731219|FG004|Overall Study|Death|0|||
145242147|NCT03803202|523731220|FG005|Overall Study|Death|1|||
145242148|NCT03803202|523731221|FG006|Overall Study|Death|0|||
145242149|NCT03803202|523731222|FG007|Overall Study|Death|0|||
145242150|NCT03803202|523731223|FG008|Overall Study|Death|0|||
145242151|NCT03803202|523731215|FG000|Overall Study|Withdrawal by Subject|0|||
145242152|NCT03803202|523731216|FG001|Overall Study|Withdrawal by Subject|0|||
145242153|NCT03803202|523731217|FG002|Overall Study|Withdrawal by Subject|1|||
145242154|NCT03803202|523731218|FG003|Overall Study|Withdrawal by Subject|0|||
145242155|NCT03803202|523731219|FG004|Overall Study|Withdrawal by Subject|0|||
145242156|NCT03803202|523731220|FG005|Overall Study|Withdrawal by Subject|0|||
145242157|NCT03803202|523731221|FG006|Overall Study|Withdrawal by Subject|0|||
145242158|NCT03803202|523731222|FG007|Overall Study|Withdrawal by Subject|1|||
145242159|NCT03803202|523731223|FG008|Overall Study|Withdrawal by Subject|0|||
145242160|NCT03803202|523731215|FG000|Overall Study|Lost to Follow-up|0|||
145242161|NCT03803202|523731216|FG001|Overall Study|Lost to Follow-up|0|||
145242162|NCT03803202|523731217|FG002|Overall Study|Lost to Follow-up|0|||
145242163|NCT03803202|523731218|FG003|Overall Study|Lost to Follow-up|1|||
145242164|NCT03803202|523731219|FG004|Overall Study|Lost to Follow-up|1|||
145242165|NCT03803202|523731220|FG005|Overall Study|Lost to Follow-up|0|||
145242166|NCT03803202|523731221|FG006|Overall Study|Lost to Follow-up|1|||
145242167|NCT03803202|523731222|FG007|Overall Study|Lost to Follow-up|0|||
145242168|NCT03803202|523731223|FG008|Overall Study|Lost to Follow-up|0|||
145242169|NCT01125293|523731224|FG000|Overall Study|Disease Progression|1|||
145242170|NCT01125293|523731225|FG001|Overall Study|Disease Progression|3|||
145242171|NCT01125293|523731226|FG002|Overall Study|Disease Progression|4|||
145242172|NCT01125293|523731227|FG003|Overall Study|Disease Progression|3|||
145242173|NCT01125293|523731228|FG004|Overall Study|Disease Progression|5|||
145242174|NCT01125293|523731229|FG005|Overall Study|Disease Progression|12|||
145242175|NCT01125293|523731224|FG000|Overall Study|Adverse Event|1|||
145242176|NCT01125293|523731225|FG001|Overall Study|Adverse Event|0|||
145242177|NCT01125293|523731226|FG002|Overall Study|Adverse Event|0|||
145242178|NCT01125293|523731227|FG003|Overall Study|Adverse Event|0|||
145242179|NCT01125293|523731228|FG004|Overall Study|Adverse Event|2|||
145242180|NCT01125293|523731229|FG005|Overall Study|Adverse Event|8|||
145242181|NCT01125293|523731224|FG000|Overall Study|Symptomatic Deterioration|1|||
145242182|NCT01125293|523731225|FG001|Overall Study|Symptomatic Deterioration|0|||
145242183|NCT01125293|523731226|FG002|Overall Study|Symptomatic Deterioration|0|||
145242184|NCT01125293|523731227|FG003|Overall Study|Symptomatic Deterioration|0|||
145242185|NCT01125293|523731228|FG004|Overall Study|Symptomatic Deterioration|0|||
145242186|NCT01125293|523731229|FG005|Overall Study|Symptomatic Deterioration|0|||
145242187|NCT01125293|523731224|FG000|Overall Study|Death|0|||
145242188|NCT01125293|523731225|FG001|Overall Study|Death|0|||
145242189|NCT01125293|523731226|FG002|Overall Study|Death|0|||
145242190|NCT01125293|523731227|FG003|Overall Study|Death|0|||
145242191|NCT01125293|523731228|FG004|Overall Study|Death|1|||
145242192|NCT01125293|523731229|FG005|Overall Study|Death|0|||
145242193|NCT01125293|523731224|FG000|Overall Study|Withdrawal by Subject|0|||
145242194|NCT01125293|523731225|FG001|Overall Study|Withdrawal by Subject|0|||
145242195|NCT01125293|523731226|FG002|Overall Study|Withdrawal by Subject|0|||
145242196|NCT01125293|523731227|FG003|Overall Study|Withdrawal by Subject|0|||
145242197|NCT01125293|523731228|FG004|Overall Study|Withdrawal by Subject|2|||
145242198|NCT01125293|523731229|FG005|Overall Study|Withdrawal by Subject|1|||
145242199|NCT01125293|523731224|FG000|Overall Study|Physician Decision|0|||
145242200|NCT01125293|523731225|FG001|Overall Study|Physician Decision|0|||
145242201|NCT01125293|523731226|FG002|Overall Study|Physician Decision|0|||
145242202|NCT01125293|523731227|FG003|Overall Study|Physician Decision|0|||
145242203|NCT01125293|523731228|FG004|Overall Study|Physician Decision|0|||
145242204|NCT01125293|523731229|FG005|Overall Study|Physician Decision|2|||
145296442|NCT01479439|523935827|FG002|Overall Study|Lost to Follow-up|0|||
145563764|NCT03446040|524924043|FG000|Overall Study|Study drug toxicity|0|||
145563765|NCT03446040|524924044|FG001|Overall Study|Study drug toxicity|0|||
145563766|NCT03446040|524924045|FG002|Overall Study|Study drug toxicity|0|||
145563767|NCT03446040|524924046|FG003|Overall Study|Study drug toxicity|0|||
145563768|NCT03446040|524924047|FG004|Overall Study|Study drug toxicity|0|||
145563769|NCT03446040|524924048|FG005|Overall Study|Study drug toxicity|0|||
145563770|NCT03446040|524924049|FG006|Overall Study|Study drug toxicity|0|||
145563771|NCT03446040|524924050|FG007|Overall Study|Study drug toxicity|0|||
145563772|NCT03446040|524924051|FG008|Overall Study|Study drug toxicity|1|||
145242205|NCT00260429|523731234|FG000|Overall Study|failure to follow appointments|1|||
145242206|NCT00260429|523731235|FG001|Overall Study|failure to follow appointments|0|||
145242207|NCT00260429|523731234|FG000|Overall Study|scheduled hand surgery|1|||
145242208|NCT00260429|523731235|FG001|Overall Study|scheduled hand surgery|0|||
145242209|NCT00659126|523731236|FG000|Overall Study|Adverse Event|2|||
145242210|NCT00659126|523731237|FG001|Overall Study|Adverse Event|2|||
145242211|NCT00659126|523731236|FG000|Overall Study|Screen failure|1|||
145242212|NCT00659126|523731237|FG001|Overall Study|Screen failure|1|||
145242213|NCT00659126|523731236|FG000|Overall Study|Technical problems with MRI|0|||
145242214|NCT00659126|523731237|FG001|Overall Study|Technical problems with MRI|1|||
145242215|NCT02633046|523731238|FG000|Overall Study|Adverse Event|8|||
145242216|NCT02633046|523731238|FG000|Overall Study|Physician Decision|7|||
145242217|NCT02633046|523731238|FG000|Overall Study|Withdrawal by Subject|8|||
145242218|NCT02633046|523731238|FG000|Overall Study|Increased proteinuria|2|||
145296443|NCT01479439|523935825|FG000|Overall Study|Protocol Violation|0|||
145242219|NCT02633046|523731238|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
145242220|NCT02633046|523731238|FG000|Overall Study|Mutual decision patient and physician|1|||
145242221|NCT00617591|523731242|FG000|Overall Study|Withdrew consent during Induction|4|||
145242222|NCT00617591|523731242|FG000|Overall Study|Withdrew consent during Maintenance|6|||
145242223|NCT01203787|523731249|FG000|Overall Study|Death|12|||
145242224|NCT01203787|523731250|FG001|Overall Study|Death|10|||
145242225|NCT01203787|523731249|FG000|Overall Study|Withdrawal by Subject|6|||
145242226|NCT01203787|523731250|FG001|Overall Study|Withdrawal by Subject|2|||
145242227|NCT01203787|523731249|FG000|Overall Study|Lost to Follow-up|2|||
145242228|NCT01203787|523731250|FG001|Overall Study|Lost to Follow-up|0|||
145242229|NCT01203787|523731249|FG000|Overall Study|Adverse Event|11|||
145242230|NCT01203787|523731250|FG001|Overall Study|Adverse Event|15|||
145242231|NCT03693404|523731252|FG000|Overall Study|Withdrawal by Subject|1|||
145242232|NCT03693404|523731253|FG001|Overall Study|Withdrawal by Subject|0|||
145242233|NCT03693404|523731252|FG000|Overall Study|Lost to Follow-up|0|||
145242234|NCT03693404|523731253|FG001|Overall Study|Lost to Follow-up|5|||
145242235|NCT03693404|523731252|FG000|Overall Study|Excluded from Analysis|0|||
145242236|NCT03693404|523731253|FG001|Overall Study|Excluded from Analysis|1|||
145242237|NCT00651313|523731254|FG000|Overall Study|Adverse Event|0|||
145242238|NCT00651313|523731255|FG001|Overall Study|Adverse Event|1|||
145242239|NCT00651313|523731254|FG000|Overall Study|Withdrawal by Subject|3|||
145242240|NCT00651313|523731255|FG001|Overall Study|Withdrawal by Subject|1|||
145242241|NCT00651313|523731254|FG000|Overall Study|Lost to Follow-up|1|||
145242242|NCT00651313|523731255|FG001|Overall Study|Lost to Follow-up|1|||
145242243|NCT00651313|523731254|FG000|Overall Study|Adminstrative Discontinuation|2|||
145242244|NCT00651313|523731255|FG001|Overall Study|Adminstrative Discontinuation|3|||
145242245|NCT00892957|523731257|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
145242246|NCT00892957|523731258|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
145242247|NCT00892957|523731257|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
145242248|NCT00892957|523731258|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
145242249|NCT00676208|523731272|FG000|Overall Study|Lost to Follow-up|0|||
145242250|NCT00676208|523731273|FG001|Overall Study|Lost to Follow-up|2|||
145242251|NCT00676208|523731272|FG000|Overall Study|Incomplete data|2|||
145242252|NCT00676208|523731273|FG001|Overall Study|Incomplete data|4|||
145242253|NCT00669032|523731274|FG000|Overall Study|Lost to Follow-up|6|||
145242254|NCT00669032|523731275|FG001|Overall Study|Lost to Follow-up|5|||
145242255|NCT00669032|523731274|FG000|Overall Study|Lack of Efficacy|8|||
145242256|NCT00669032|523731275|FG001|Overall Study|Lack of Efficacy|19|||
145242257|NCT00669032|523731274|FG000|Overall Study|Withdrawal by Subject|12|||
145242258|NCT00669032|523731275|FG001|Overall Study|Withdrawal by Subject|13|||
145242259|NCT00669032|523731274|FG000|Overall Study|Adverse Event|12|||
145242260|NCT00669032|523731275|FG001|Overall Study|Adverse Event|16|||
145242261|NCT00669032|523731274|FG000|Overall Study|Physician Decision|1|||
145242262|NCT00669032|523731275|FG001|Overall Study|Physician Decision|1|||
145242263|NCT00669032|523731274|FG000|Overall Study|No fulfilment of the selection criteria|5|||
145242264|NCT00669032|523731275|FG001|Overall Study|No fulfilment of the selection criteria|5|||
145242265|NCT01946412|523731276|FG000|Overall Study|Adverse Event|1|||
145242266|NCT01946412|523731276|FG000|Overall Study|Non-Compliance|1|||
145242267|NCT01946412|523731276|FG000|Overall Study|Continued with commercial Kalydeco|2|||
145242268|NCT01946412|523731276|FG000|Overall Study|Difficulty in swallowing|1|||
145242269|NCT00323310|523733396|FG000|Overall Study|Withdrawal by Subject|1|||
145242270|NCT00323310|523733396|FG000|Overall Study|a parent refused blood draw|1|||
145242271|NCT00323310|523733396|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
145242272|NCT00446641|523733397|FG000|Overall Study|Withdrawal by Subject|8|||
145242273|NCT00446641|523733398|FG001|Overall Study|Withdrawal by Subject|3|||
145242274|NCT00446641|523733397|FG000|Overall Study|poor compliance|8|||
145242275|NCT00446641|523733398|FG001|Overall Study|poor compliance|6|||
145242276|NCT00446641|523733397|FG000|Overall Study|Lost to Follow-up|1|||
145242277|NCT00446641|523733398|FG001|Overall Study|Lost to Follow-up|1|||
145242278|NCT03565991|523733400|FG000|Overall Study|Other|11|||
145242279|NCT03565991|523733401|FG001|Overall Study|Other|0|||
145242280|NCT03565991|523733400|FG000|Overall Study|Global deterioration of health status|14|||
145242281|NCT03565991|523733401|FG001|Overall Study|Global deterioration of health status|4|||
145242282|NCT03565991|523733400|FG000|Overall Study|Withdrawal by Subject|2|||
145408860|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408861|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145242283|NCT03565991|523733401|FG001|Overall Study|Withdrawal by Subject|6|||
145242284|NCT03565991|523733400|FG000|Overall Study|Progressive disease|121|||
145242285|NCT03565991|523733401|FG001|Overall Study|Progressive disease|29|||
145242286|NCT03565991|523733400|FG000|Overall Study|Death|3|||
145242287|NCT03565991|523733401|FG001|Overall Study|Death|0|||
145242288|NCT03565991|523733400|FG000|Overall Study|Adverse Event|7|||
145242289|NCT03565991|523733401|FG001|Overall Study|Adverse Event|2|||
145242290|NCT00086385|523733404|FG000|Overall Study|Death|2|||
145242291|NCT00086385|523733405|FG001|Overall Study|Death|2|||
145242292|NCT00086385|523733406|FG002|Overall Study|Death|1|||
145242293|NCT00086385|523733407|FG003|Overall Study|Death|1|||
145242294|NCT03424044|523733412|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242295|NCT03424044|523733413|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242296|NCT03424044|523733414|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
145242297|NCT03424044|523733415|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242298|NCT03424044|523733416|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242299|NCT03424044|523733417|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242300|NCT03424044|523733418|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242301|NCT03424044|523733419|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242302|NCT03424044|523733420|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
145242303|NCT03424044|523733412|FG000|First Intervention (76 Hours)|Adverse Event|0|||
145242304|NCT03424044|523733413|FG001|First Intervention (76 Hours)|Adverse Event|0|||
145242305|NCT03424044|523733414|FG002|First Intervention (76 Hours)|Adverse Event|0|||
145242306|NCT03424044|523733415|FG003|First Intervention (76 Hours)|Adverse Event|0|||
145242307|NCT03424044|523733416|FG004|First Intervention (76 Hours)|Adverse Event|1|||
145242308|NCT03424044|523733417|FG005|First Intervention (76 Hours)|Adverse Event|0|||
145242309|NCT03424044|523733418|FG006|First Intervention (76 Hours)|Adverse Event|0|||
145242310|NCT03424044|523733419|FG007|First Intervention (76 Hours)|Adverse Event|0|||
145242311|NCT03424044|523733420|FG008|First Intervention (76 Hours)|Adverse Event|0|||
145242312|NCT03424044|523733412|FG000|First Intervention (76 Hours)|device issues|0|||
145242313|NCT03424044|523733413|FG001|First Intervention (76 Hours)|device issues|0|||
145242314|NCT03424044|523733414|FG002|First Intervention (76 Hours)|device issues|0|||
145242315|NCT03424044|523733415|FG003|First Intervention (76 Hours)|device issues|0|||
145242316|NCT03424044|523733416|FG004|First Intervention (76 Hours)|device issues|0|||
145242317|NCT03424044|523733417|FG005|First Intervention (76 Hours)|device issues|0|||
145242318|NCT03424044|523733418|FG006|First Intervention (76 Hours)|device issues|1|||
145242319|NCT03424044|523733419|FG007|First Intervention (76 Hours)|device issues|1|||
145242320|NCT03424044|523733420|FG008|First Intervention (76 Hours)|device issues|1|||
145242321|NCT03424044|523733412|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
145242322|NCT03424044|523733413|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
145620068|NCT03468426|525123650|FG001|Overall Study|missing reason|0|||
145620069|NCT03468426|525123651|FG002|Overall Study|missing reason|0|||
145620070|NCT03468426|525123652|FG003|Overall Study|missing reason|0|||
145620071|NCT03468426|525123653|FG004|Overall Study|missing reason|0|||
145620072|NCT03468426|525123654|FG005|Overall Study|missing reason|0|||
145620073|NCT03468426|525123655|FG006|Overall Study|missing reason|0|||
145620074|NCT03468426|525123656|FG007|Overall Study|missing reason|0|||
145620075|NCT03468426|525123657|FG008|Overall Study|missing reason|0|||
145620076|NCT03468426|525123658|FG009|Overall Study|missing reason|1|||
145620077|NCT03468426|525123659|FG010|Overall Study|missing reason|0|||
145620078|NCT01349907|525123663|FG000|Overall Study|Adverse Event|37|||
145620079|NCT01349907|525123664|FG001|Overall Study|Adverse Event|11|||
145620080|NCT01349907|525123663|FG000|Overall Study|Treatment failure|13|||
145296444|NCT01479439|523935826|FG001|Overall Study|Protocol Violation|0|||
145296445|NCT01479439|523935827|FG002|Overall Study|Protocol Violation|2|||
145296446|NCT02079766|523935828|FG000|Overall Study|Physician Decision|1|||
145620081|NCT01349907|525123664|FG001|Overall Study|Treatment failure|4|||
145620082|NCT01349907|525123663|FG000|Overall Study|Lost to Follow-up|25|||
145242323|NCT03424044|523733414|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
145242324|NCT03424044|523733415|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
145242325|NCT03424044|523733416|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
145242326|NCT03424044|523733417|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
145242327|NCT03424044|523733418|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
145242328|NCT03424044|523733419|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
145242329|NCT03424044|523733420|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
145242330|NCT03424044|523733412|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242331|NCT03424044|523733413|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242332|NCT03424044|523733414|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242333|NCT03424044|523733415|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
145296447|NCT02079766|523935829|FG001|Overall Study|Physician Decision|0|||
145296448|NCT02079766|523935828|FG000|Overall Study|Withdrawal by Subject|1|||
145296449|NCT02079766|523935829|FG001|Overall Study|Withdrawal by Subject|0|||
145242334|NCT03424044|523733416|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242335|NCT03424044|523733417|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145296450|NCT01044732|523935832|FG000|Overall Study|Lost to Follow-up|2|||
145620083|NCT01349907|525123664|FG001|Overall Study|Lost to Follow-up|6|||
145242336|NCT03424044|523733418|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242337|NCT03424044|523733419|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242338|NCT03424044|523733420|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
145242339|NCT00402285|523733421|FG000|Overall Study|insufficient RNA quality|7|||
145296451|NCT01044732|523935833|FG001|Overall Study|Lost to Follow-up|1|||
145296452|NCT01044732|523935832|FG000|Overall Study|Physician Decision|5|||
145242340|NCT00402285|523733422|FG001|Overall Study|insufficient RNA quality|6|||
145242341|NCT00402285|523733423|FG002|Overall Study|insufficient RNA quality|2|||
145242342|NCT02471586|523733432|FG000|Overall Study|Lost to Follow-up|3|||
145242343|NCT02471586|523733433|FG001|Overall Study|Lost to Follow-up|8|||
145242344|NCT02471586|523733434|FG002|Overall Study|Lost to Follow-up|4|||
145242345|NCT02471586|523733432|FG000|Overall Study|Death|2|||
145242346|NCT02471586|523733433|FG001|Overall Study|Death|2|||
145242347|NCT02471586|523733434|FG002|Overall Study|Death|0|||
145242348|NCT04839393|523733445|FG000|Overall Study|Adverse Event|0|||
145242349|NCT04839393|523733446|FG001|Overall Study|Adverse Event|0|||
145242350|NCT04839393|523733447|FG002|Overall Study|Adverse Event|2|||
145242351|NCT04839393|523733445|FG000|Overall Study|Withdrawal by participant|0|||
145242352|NCT04839393|523733446|FG001|Overall Study|Withdrawal by participant|0|||
145242353|NCT04839393|523733447|FG002|Overall Study|Withdrawal by participant|1|||
145242354|NCT00254163|523733454|FG000|Overall Study|Adverse Event|29|||
145242355|NCT00254163|523733455|FG001|Overall Study|Adverse Event|26|||
145242356|NCT00254163|523733454|FG000|Overall Study|Patient request/withdrew consent|6|||
145242357|NCT00254163|523733455|FG001|Overall Study|Patient request/withdrew consent|4|||
145242358|NCT00254163|523733454|FG000|Overall Study|Investigator request|1|||
145242359|NCT00254163|523733455|FG001|Overall Study|Investigator request|3|||
145242360|NCT00254163|523733454|FG000|Overall Study|Failed entry|1|||
145242361|NCT00254163|523733455|FG001|Overall Study|Failed entry|3|||
145242362|NCT00254163|523733454|FG000|Overall Study|Progressive disease|0|||
145242363|NCT00254163|523733455|FG001|Overall Study|Progressive disease|1|||
145242364|NCT00254163|523733454|FG000|Overall Study|Death|0|||
145242365|NCT00254163|523733455|FG001|Overall Study|Death|1|||
145242366|NCT00254163|523733454|FG000|Overall Study|Other|8|||
145242367|NCT00254163|523733455|FG001|Overall Study|Other|8|||
145563773|NCT03446040|524924052|FG009|Overall Study|Study drug toxicity|0|||
145563774|NCT03446040|524924053|FG010|Overall Study|Study drug toxicity|0|||
145563775|NCT03446040|524924054|FG011|Overall Study|Study drug toxicity|0|||
145563776|NCT03446040|524924055|FG012|Overall Study|Study drug toxicity|0|||
145242368|NCT00633893|523733456|FG000|Overall Study|Death|1|||
145242369|NCT00633893|523733457|FG001|Overall Study|Death|3|||
145242370|NCT00633893|523733458|FG002|Overall Study|Death|9|||
145242371|NCT00633893|523733456|FG000|Overall Study|Adverse Event|65|||
145242372|NCT00633893|523733457|FG001|Overall Study|Adverse Event|58|||
145242373|NCT00633893|523733458|FG002|Overall Study|Adverse Event|126|||
145242374|NCT00633893|523733456|FG000|Overall Study|Withdrawal by Subject|7|||
145242375|NCT00633893|523733457|FG001|Overall Study|Withdrawal by Subject|12|||
145242376|NCT00633893|523733458|FG002|Overall Study|Withdrawal by Subject|6|||
145242377|NCT00633893|523733456|FG000|Overall Study|Lost to Follow-up|2|||
145242378|NCT00633893|523733457|FG001|Overall Study|Lost to Follow-up|4|||
145242379|NCT00633893|523733458|FG002|Overall Study|Lost to Follow-up|8|||
145242380|NCT00633893|523733456|FG000|Overall Study|Poor/non-compliance|5|||
145242381|NCT00633893|523733457|FG001|Overall Study|Poor/non-compliance|12|||
145242382|NCT00633893|523733458|FG002|Overall Study|Poor/non-compliance|3|||
145242383|NCT00633893|523733456|FG000|Overall Study|Pregnancy|2|||
145242384|NCT00633893|523733457|FG001|Overall Study|Pregnancy|1|||
145242385|NCT00633893|523733458|FG002|Overall Study|Pregnancy|1|||
145242386|NCT00633893|523733456|FG000|Overall Study|Not meet/no longer meets criteria|4|||
145242387|NCT00633893|523733457|FG001|Overall Study|Not meet/no longer meets criteria|6|||
145242388|NCT00633893|523733458|FG002|Overall Study|Not meet/no longer meets criteria|4|||
145242389|NCT00633893|523733456|FG000|Overall Study|Other|28|||
145242390|NCT00633893|523733457|FG001|Overall Study|Other|33|||
145242391|NCT00633893|523733458|FG002|Overall Study|Other|31|||
145242392|NCT00239356|523733459|FG000|Overall Study|Lack of Efficacy|1|||
145242393|NCT00239356|523733460|FG001|Overall Study|Lack of Efficacy|0|||
145242394|NCT00239356|523733459|FG000|Overall Study|Adverse Event|6|||
145242395|NCT00239356|523733460|FG001|Overall Study|Adverse Event|0|||
145242396|NCT00239356|523733459|FG000|Overall Study|Withdrawal by Subject|15|||
145563777|NCT03446040|524924056|FG013|Overall Study|Study drug toxicity|0|||
145563778|NCT03446040|524924043|FG000|Overall Study|Adverse Event|0|||
145563779|NCT03446040|524924044|FG001|Overall Study|Adverse Event|0|||
145242397|NCT00239356|523733460|FG001|Overall Study|Withdrawal by Subject|6|||
145242398|NCT00239356|523733459|FG000|Overall Study|Lost to Follow-up|3|||
145242399|NCT00239356|523733460|FG001|Overall Study|Lost to Follow-up|0|||
145242400|NCT00239356|523733459|FG000|Overall Study|poor/non-compliance|2|||
145242401|NCT00239356|523733460|FG001|Overall Study|poor/non-compliance|0|||
145242402|NCT00239356|523733459|FG000|Overall Study|Pregnancy|1|||
145242403|NCT00239356|523733460|FG001|Overall Study|Pregnancy|0|||
145242404|NCT00239356|523733459|FG000|Overall Study|Administrative reason|0|||
145242405|NCT00239356|523733460|FG001|Overall Study|Administrative reason|1|||
145242406|NCT00239356|523733459|FG000|Overall Study|Drug available on market|11|||
145242407|NCT00239356|523733460|FG001|Overall Study|Drug available on market|2|||
145242408|NCT00369278|523733461|FG000|Overall Study|Adverse Event|14|||
145242409|NCT00369278|523733462|FG001|Overall Study|Adverse Event|11|||
145563780|NCT03446040|524924045|FG002|Overall Study|Adverse Event|0|||
145242410|NCT00369278|523733461|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145242411|NCT00369278|523733462|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
145296453|NCT01044732|523935833|FG001|Overall Study|Physician Decision|3|||
145563781|NCT03446040|524924046|FG003|Overall Study|Adverse Event|0|||
145563782|NCT03446040|524924047|FG004|Overall Study|Adverse Event|0|||
145563783|NCT03446040|524924048|FG005|Overall Study|Adverse Event|2|||
145563784|NCT03446040|524924049|FG006|Overall Study|Adverse Event|0|||
145563785|NCT03446040|524924050|FG007|Overall Study|Adverse Event|0|||
145563786|NCT03446040|524924051|FG008|Overall Study|Adverse Event|1|||
145563787|NCT03446040|524924052|FG009|Overall Study|Adverse Event|0|||
145563788|NCT03446040|524924053|FG010|Overall Study|Adverse Event|0|||
145563789|NCT03446040|524924054|FG011|Overall Study|Adverse Event|0|||
145242412|NCT00369278|523733461|FG000|Overall Study|Protocol Violation|2|||
145242413|NCT00369278|523733462|FG001|Overall Study|Protocol Violation|1|||
145242414|NCT00369278|523733461|FG000|Overall Study|Withdrawal by Subject|2|||
145242415|NCT00369278|523733462|FG001|Overall Study|Withdrawal by Subject|2|||
145242416|NCT00369278|523733461|FG000|Overall Study|Lost to Follow-up|1|||
145242417|NCT00369278|523733462|FG001|Overall Study|Lost to Follow-up|0|||
145242418|NCT00369278|523733461|FG000|Overall Study|Graft loss|1|||
145242419|NCT00369278|523733462|FG001|Overall Study|Graft loss|2|||
145242420|NCT02044822|523733463|FG000|Overall Study|Study Terminated by Sponsor|77|||
145242421|NCT02044822|523733463|FG000|Overall Study|Investigator's Discretion|10|||
145242422|NCT02044822|523733463|FG000|Overall Study|Withdrew Consent|3|||
145242423|NCT02044822|523733463|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
145242424|NCT02044822|523733463|FG000|Overall Study|Lost to Follow-up|1|||
145242425|NCT02025530|523733466|FG000|Overall Study|No longer met elligibility criteria|5|||
145242426|NCT02025530|523733467|FG001|Overall Study|No longer met elligibility criteria|1|||
145242427|NCT03417505|523733468|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
145242428|NCT03417505|523733469|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
145242429|NCT01444898|523733481|FG000|Overall Study|Withdrawal by Subject|1|||
145242430|NCT03235726|523733482|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242431|NCT03235726|523733483|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242432|NCT03235726|523733484|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242433|NCT03235726|523733485|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242434|NCT03235726|523733486|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
145242435|NCT03235726|523733487|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242436|NCT03235726|523733488|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242437|NCT03235726|523733489|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242438|NCT03235726|523733490|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242439|NCT03235726|523733491|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
145242440|NCT03235726|523733482|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242441|NCT03235726|523733483|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242442|NCT03235726|523733484|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242443|NCT03235726|523733485|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242444|NCT03235726|523733486|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
145242445|NCT03235726|523733487|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242446|NCT03235726|523733488|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242447|NCT03235726|523733489|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242448|NCT03235726|523733490|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242449|NCT03235726|523733491|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
145242450|NCT01819506|523733492|FG000|Overall Study|Physician Decision|5|||
145242451|NCT01819506|523733493|FG001|Overall Study|Physician Decision|2|||
145242452|NCT01819506|523733492|FG000|Overall Study|Withdrawal by Subject|3|||
145242453|NCT01819506|523733493|FG001|Overall Study|Withdrawal by Subject|3|||
145242454|NCT00114218|523733504|FG000|Overall Study|Wrong Cell Type|2|||
145242455|NCT00114218|523733504|FG000|Overall Study|Wrong Primary|1|||
145242456|NCT00114218|523733504|FG000|Overall Study|Never Treated|1|||
145242457|NCT01505114|523733506|FG000|Overall Study|Withdrawal by Subject|5|||
145242458|NCT01505114|523733507|FG001|Overall Study|Withdrawal by Subject|4|||
145242459|NCT01505114|523733508|FG002|Overall Study|Withdrawal by Subject|4|||
145242460|NCT01505114|523733509|FG003|Overall Study|Withdrawal by Subject|7|||
145563790|NCT03446040|524924055|FG012|Overall Study|Adverse Event|0|||
145242461|NCT01505114|523733506|FG000|Overall Study|Death|1|||
145242462|NCT01505114|523733507|FG001|Overall Study|Death|0|||
145242463|NCT01505114|523733508|FG002|Overall Study|Death|0|||
145242464|NCT01505114|523733509|FG003|Overall Study|Death|1|||
145296454|NCT01044732|523935832|FG000|Overall Study|Protocol Violation|11|||
145296455|NCT01044732|523935833|FG001|Overall Study|Protocol Violation|12|||
145296456|NCT01044732|523935832|FG000|Overall Study|Withdrawal by Subject|0|||
145242465|NCT01505114|523733506|FG000|Overall Study|unable to adhere to visit schedule|3|||
145296457|NCT01044732|523935833|FG001|Overall Study|Withdrawal by Subject|1|||
145296458|NCT01044732|523935832|FG000|Overall Study|Inadequate bowel preparation|11|||
145563791|NCT03446040|524924056|FG013|Overall Study|Adverse Event|0|||
145563792|NCT03446040|524924043|FG000|Overall Study|Death|0|||
145563793|NCT03446040|524924044|FG001|Overall Study|Death|0|||
145563794|NCT03446040|524924045|FG002|Overall Study|Death|0|||
145563795|NCT03446040|524924046|FG003|Overall Study|Death|0|||
145563796|NCT03446040|524924047|FG004|Overall Study|Death|0|||
145563797|NCT03446040|524924048|FG005|Overall Study|Death|0|||
145563798|NCT03446040|524924049|FG006|Overall Study|Death|0|||
145563799|NCT03446040|524924050|FG007|Overall Study|Death|0|||
145563800|NCT03446040|524924051|FG008|Overall Study|Death|0|||
145563801|NCT03446040|524924052|FG009|Overall Study|Death|0|||
145563802|NCT03446040|524924053|FG010|Overall Study|Death|1|||
145563803|NCT03446040|524924054|FG011|Overall Study|Death|0|||
145563804|NCT03446040|524924055|FG012|Overall Study|Death|0|||
145563805|NCT03446040|524924056|FG013|Overall Study|Death|2|||
145563806|NCT03446040|524924043|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
145563807|NCT03446040|524924044|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
145563808|NCT03446040|524924045|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
145563809|NCT03446040|524924046|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
145563810|NCT03446040|524924047|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
145563811|NCT03446040|524924048|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
145563812|NCT03446040|524924049|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
145563813|NCT03446040|524924050|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
145563814|NCT03446040|524924051|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
145563815|NCT03446040|524924052|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
145563816|NCT03446040|524924053|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
145563817|NCT03446040|524924054|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
145563818|NCT03446040|524924055|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
145563819|NCT03446040|524924056|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
145563820|NCT03446040|524924043|FG000|Overall Study|Participant withdrew consent|0|||
145563821|NCT03446040|524924044|FG001|Overall Study|Participant withdrew consent|0|||
145563822|NCT03446040|524924045|FG002|Overall Study|Participant withdrew consent|0|||
145563823|NCT03446040|524924046|FG003|Overall Study|Participant withdrew consent|0|||
145563824|NCT03446040|524924047|FG004|Overall Study|Participant withdrew consent|0|||
145563825|NCT03446040|524924048|FG005|Overall Study|Participant withdrew consent|1|||
145563826|NCT03446040|524924049|FG006|Overall Study|Participant withdrew consent|0|||
145563827|NCT03446040|524924050|FG007|Overall Study|Participant withdrew consent|1|||
145563828|NCT03446040|524924051|FG008|Overall Study|Participant withdrew consent|0|||
145563829|NCT03446040|524924052|FG009|Overall Study|Participant withdrew consent|0|||
145563830|NCT03446040|524924053|FG010|Overall Study|Participant withdrew consent|0|||
145563831|NCT03446040|524924054|FG011|Overall Study|Participant withdrew consent|0|||
145563832|NCT03446040|524924055|FG012|Overall Study|Participant withdrew consent|0|||
145563833|NCT03446040|524924056|FG013|Overall Study|Participant withdrew consent|0|||
145563834|NCT03446040|524924043|FG000|Overall Study|Not reported|0|||
145563835|NCT03446040|524924044|FG001|Overall Study|Not reported|0|||
145563836|NCT03446040|524924045|FG002|Overall Study|Not reported|1|||
145563837|NCT03446040|524924046|FG003|Overall Study|Not reported|0|||
145563838|NCT03446040|524924047|FG004|Overall Study|Not reported|0|||
145563839|NCT03446040|524924048|FG005|Overall Study|Not reported|0|||
145563840|NCT03446040|524924049|FG006|Overall Study|Not reported|0|||
145563841|NCT03446040|524924050|FG007|Overall Study|Not reported|0|||
145563842|NCT03446040|524924051|FG008|Overall Study|Not reported|0|||
145563843|NCT03446040|524924052|FG009|Overall Study|Not reported|0|||
145563844|NCT03446040|524924053|FG010|Overall Study|Not reported|0|||
145563845|NCT03446040|524924054|FG011|Overall Study|Not reported|0|||
145563846|NCT03446040|524924055|FG012|Overall Study|Not reported|0|||
145563847|NCT03446040|524924056|FG013|Overall Study|Not reported|0|||
145563848|NCT00456521|524924057|FG000|Overall Study|Adverse Event|150|||
145563849|NCT00456521|524924058|FG001|Overall Study|Adverse Event|25|||
145563850|NCT00456521|524924057|FG000|Overall Study|Withdrawal by Subject|43|||
145563851|NCT00456521|524924058|FG001|Overall Study|Withdrawal by Subject|24|||
145563852|NCT00456521|524924057|FG000|Overall Study|Lost to Follow-up|22|||
145563853|NCT00456521|524924058|FG001|Overall Study|Lost to Follow-up|17|||
145563854|NCT00456521|524924057|FG000|Overall Study|Lack of Efficacy|3|||
145563855|NCT00456521|524924058|FG001|Overall Study|Lack of Efficacy|6|||
145563856|NCT00456521|524924057|FG000|Overall Study|Protocol Violation|4|||
145563857|NCT00456521|524924058|FG001|Overall Study|Protocol Violation|0|||
145563858|NCT00456521|524924057|FG000|Overall Study|Pregnancy|1|||
145563859|NCT00456521|524924058|FG001|Overall Study|Pregnancy|1|||
145563860|NCT00456521|524924057|FG000|Overall Study|Drug non-compliance, moved, other|26|||
145563861|NCT00456521|524924058|FG001|Overall Study|Drug non-compliance, moved, other|11|||
145563862|NCT00605475|524924059|FG000|Overall Study|Abnormal Laboratory Values|0|||
145563863|NCT00605475|524924060|FG001|Overall Study|Abnormal Laboratory Values|0|||
145563864|NCT00605475|524924061|FG002|Overall Study|Abnormal Laboratory Values|0|||
145563865|NCT00605475|524924062|FG003|Overall Study|Abnormal Laboratory Values|0|||
145563866|NCT00605475|524924063|FG004|Overall Study|Abnormal Laboratory Values|0|||
145408862|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
145408863|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408864|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408865|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408866|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408867|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
145408868|NCT03329001|524351891|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408869|NCT03329001|524351892|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408870|NCT03329001|524351893|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408871|NCT03329001|524351894|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
145408872|NCT03329001|524351895|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408873|NCT03329001|524351896|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408874|NCT03329001|524351897|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408875|NCT03329001|524351898|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
145408876|NCT03329001|524351891|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408877|NCT03329001|524351892|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408878|NCT03329001|524351893|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408879|NCT03329001|524351894|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408880|NCT03329001|524351895|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408881|NCT03329001|524351896|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
145408882|NCT03329001|524351897|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145408883|NCT03329001|524351898|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
145563867|NCT00605475|524924064|FG005|Overall Study|Abnormal Laboratory Values|0|||
145563868|NCT00605475|524924065|FG006|Overall Study|Abnormal Laboratory Values|0|||
145242466|NCT01505114|523733507|FG001|Overall Study|unable to adhere to visit schedule|2|||
145242467|NCT01505114|523733508|FG002|Overall Study|unable to adhere to visit schedule|3|||
145242468|NCT01505114|523733509|FG003|Overall Study|unable to adhere to visit schedule|3|||
145242469|NCT01505114|523733506|FG000|Overall Study|Lost to Follow-up|11|||
145242470|NCT01505114|523733507|FG001|Overall Study|Lost to Follow-up|5|||
145242471|NCT01505114|523733508|FG002|Overall Study|Lost to Follow-up|8|||
145242472|NCT01505114|523733509|FG003|Overall Study|Lost to Follow-up|7|||
145242473|NCT01505114|523733506|FG000|Overall Study|relocated|4|||
145242474|NCT01505114|523733507|FG001|Overall Study|relocated|2|||
145242475|NCT01505114|523733508|FG002|Overall Study|relocated|2|||
145242476|NCT01505114|523733509|FG003|Overall Study|relocated|3|||
145242477|NCT01505114|523733506|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
145242478|NCT01505114|523733507|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
145242479|NCT01505114|523733508|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
145242480|NCT01505114|523733509|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
145242481|NCT01505114|523733506|FG000|Overall Study|staff safety concerns|0|||
145242482|NCT01505114|523733507|FG001|Overall Study|staff safety concerns|0|||
145242483|NCT01505114|523733508|FG002|Overall Study|staff safety concerns|0|||
145242484|NCT01505114|523733509|FG003|Overall Study|staff safety concerns|1|||
145242485|NCT01505114|523733506|FG000|Overall Study|investigator decision|1|||
145242486|NCT01505114|523733507|FG001|Overall Study|investigator decision|0|||
145242487|NCT01505114|523733508|FG002|Overall Study|investigator decision|1|||
145242488|NCT01505114|523733509|FG003|Overall Study|investigator decision|0|||
145242489|NCT01040845|523733510|FG000|Overall Study|Withdrawal by Subject|1|||
145242490|NCT01040845|523733511|FG001|Overall Study|Withdrawal by Subject|1|||
145242491|NCT01040845|523733510|FG000|Overall Study|Physician Decision|1|||
145242492|NCT01040845|523733511|FG001|Overall Study|Physician Decision|0|||
145242493|NCT01963780|523733512|FG000|Overall Study|Death|7|||
145296459|NCT01044732|523935833|FG001|Overall Study|Inadequate bowel preparation|17|||
145296460|NCT01044732|523935832|FG000|Overall Study|Inability to reach cecum|5|||
145296461|NCT01044732|523935833|FG001|Overall Study|Inability to reach cecum|2|||
145296462|NCT01044732|523935832|FG000|Overall Study|Technical error or malfunction|15|||
145296463|NCT01044732|523935833|FG001|Overall Study|Technical error or malfunction|14|||
145296464|NCT03991494|523935836|FG000|Overall Study|Progressive Disease|4|||
145296465|NCT00683293|523935847|FG000|Overall Study|Withdrawal by Subject|2|||
145296466|NCT00683293|523935848|FG001|Overall Study|Withdrawal by Subject|3|||
145296467|NCT02507375|523935855|FG000|Overall Study|Progressive Disease|4|||
145296468|NCT02507375|523935856|FG001|Overall Study|Progressive Disease|5|||
145563869|NCT00605475|524924066|FG007|Overall Study|Abnormal Laboratory Values|0|||
145563870|NCT00605475|524924067|FG008|Overall Study|Abnormal Laboratory Values|1|||
145563871|NCT00605475|524924068|FG009|Overall Study|Abnormal Laboratory Values|0|||
145242494|NCT01000025|523733516|FG000|Overall Study|Adverse Event|43|||
145242495|NCT01000025|523733517|FG001|Overall Study|Adverse Event|2|||
145242496|NCT01000025|523733516|FG000|Overall Study|Withdrawal by Subject|13|||
145242497|NCT01000025|523733517|FG001|Overall Study|Withdrawal by Subject|8|||
145242498|NCT01000025|523733516|FG000|Overall Study|Death|23|||
145242499|NCT01000025|523733517|FG001|Overall Study|Death|13|||
145242500|NCT01000025|523733516|FG000|Overall Study|Lack of Efficacy|363|||
145296469|NCT02507375|523935855|FG000|Overall Study|Death|0|||
145242501|NCT01000025|523733517|FG001|Overall Study|Lack of Efficacy|208|||
145242502|NCT01000025|523733516|FG000|Overall Study|Intercurrent Illness|26|||
145242503|NCT01000025|523733517|FG001|Overall Study|Intercurrent Illness|7|||
145242504|NCT04423757|523733518|FG000|Overall Study|Adverse Event|2|||
145242505|NCT04423757|523733519|FG001|Overall Study|Adverse Event|0|||
145242506|NCT04423757|523733518|FG000|Overall Study|Not treated|1|||
145242507|NCT04423757|523733519|FG001|Overall Study|Not treated|1|||
145296470|NCT02507375|523935856|FG001|Overall Study|Death|1|||
145296471|NCT02507375|523935855|FG000|Overall Study|Refused treatment|0|||
145296472|NCT02507375|523935856|FG001|Overall Study|Refused treatment|1|||
145296473|NCT02507375|523935855|FG000|Overall Study|Adverse Event|0|||
145296474|NCT02507375|523935856|FG001|Overall Study|Adverse Event|1|||
145296475|NCT01387737|523937781|FG000|Overall Study|Adverse Event|20|||
145296476|NCT01387737|523937782|FG001|Overall Study|Adverse Event|30|||
145296477|NCT01387737|523937781|FG000|Overall Study|Lack of Efficacy|1|||
145296478|NCT01387737|523937782|FG001|Overall Study|Lack of Efficacy|0|||
145296479|NCT01387737|523937781|FG000|Overall Study|Physician Decision|3|||
145296480|NCT01387737|523937782|FG001|Overall Study|Physician Decision|10|||
145296481|NCT01387737|523937781|FG000|Overall Study|Withdrawal by Subject|27|||
145296482|NCT01387737|523937782|FG001|Overall Study|Withdrawal by Subject|31|||
145296483|NCT01387737|523937781|FG000|Overall Study|Clearly not eligible for the study|1|||
145296484|NCT01387737|523937782|FG001|Overall Study|Clearly not eligible for the study|3|||
145296485|NCT01248247|523937784|FG000|Overall Study|Adverse Event|2|||
145296486|NCT01248247|523937785|FG001|Overall Study|Adverse Event|4|||
145296487|NCT01248247|523937786|FG002|Overall Study|Adverse Event|4|||
145296488|NCT01248247|523937787|FG003|Overall Study|Adverse Event|2|||
145296489|NCT01248247|523937784|FG000|Overall Study|Death|0|||
145296490|NCT01248247|523937785|FG001|Overall Study|Death|1|||
145296491|NCT01248247|523937786|FG002|Overall Study|Death|4|||
145296492|NCT01248247|523937787|FG003|Overall Study|Death|7|||
145296493|NCT01248247|523937784|FG000|Overall Study|Lost to Follow-up|0|||
145296494|NCT01248247|523937785|FG001|Overall Study|Lost to Follow-up|1|||
145296495|NCT01248247|523937786|FG002|Overall Study|Lost to Follow-up|1|||
145296496|NCT01248247|523937787|FG003|Overall Study|Lost to Follow-up|0|||
145296497|NCT01248247|523937784|FG000|Overall Study|Alternative treatment|0|||
145296498|NCT01248247|523937785|FG001|Overall Study|Alternative treatment|1|||
145242508|NCT02738580|523733520|FG000|Overall Study|Adverse Event|1|||
145242509|NCT02738580|523733521|FG001|Overall Study|Adverse Event|0|||
145242510|NCT02738580|523733520|FG000|Overall Study|Lack of Efficacy|3|||
145242511|NCT02738580|523733521|FG001|Overall Study|Lack of Efficacy|2|||
145242512|NCT02738580|523733520|FG000|Overall Study|Withdrawal by Subject|0|||
145242513|NCT02738580|523733521|FG001|Overall Study|Withdrawal by Subject|1|||
145296499|NCT01248247|523937786|FG002|Overall Study|Alternative treatment|0|||
145296500|NCT01248247|523937787|FG003|Overall Study|Alternative treatment|0|||
145296501|NCT01248247|523937784|FG000|Overall Study|Other|2|||
145296502|NCT01248247|523937785|FG001|Overall Study|Other|8|||
145296503|NCT01248247|523937786|FG002|Overall Study|Other|8|||
145296504|NCT01248247|523937787|FG003|Overall Study|Other|5|||
145296505|NCT01248247|523937784|FG000|Overall Study|Progression|18|||
145296506|NCT01248247|523937785|FG001|Overall Study|Progression|27|||
145296507|NCT01248247|523937786|FG002|Overall Study|Progression|56|||
145296508|NCT01248247|523937787|FG003|Overall Study|Progression|44|||
145296509|NCT01248247|523937784|FG000|Overall Study|Refuse further treatment|0|||
145296510|NCT01248247|523937785|FG001|Overall Study|Refuse further treatment|0|||
145296511|NCT01248247|523937786|FG002|Overall Study|Refuse further treatment|1|||
145296512|NCT01248247|523937787|FG003|Overall Study|Refuse further treatment|2|||
145296513|NCT01248247|523937784|FG000|Overall Study|Complicating disease|0|||
145296514|NCT01248247|523937785|FG001|Overall Study|Complicating disease|0|||
145296515|NCT01248247|523937786|FG002|Overall Study|Complicating disease|1|||
145296516|NCT01248247|523937787|FG003|Overall Study|Complicating disease|1|||
145296517|NCT00705536|523937788|FG000|Start Period 1|Withdrawal by Subject|0|||
145296518|NCT00705536|523937789|FG001|Start Period 1|Withdrawal by Subject|0|||
145296519|NCT00705536|523937790|FG002|Start Period 1|Withdrawal by Subject|0|||
145296520|NCT00705536|523937791|FG003|Start Period 1|Withdrawal by Subject|1|||
145296521|NCT00549718|523937792|FG000|Overall Study|Insufficient clinical response|20|||
145296522|NCT00549718|523937793|FG001|Overall Study|Insufficient clinical response|7|||
145296523|NCT00549718|523937794|FG002|Overall Study|Insufficient clinical response|18|||
145408884|NCT03329001|524351891|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408885|NCT03329001|524351892|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408886|NCT03329001|524351893|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145242514|NCT02738580|523733520|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
145242515|NCT02738580|523733521|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
145296524|NCT00549718|523937795|FG003|Overall Study|Insufficient clinical response|32|||
145296525|NCT00549718|523937792|FG000|Overall Study|Adverse Event|6|||
145296526|NCT00549718|523937793|FG001|Overall Study|Adverse Event|8|||
145296527|NCT00549718|523937794|FG002|Overall Study|Adverse Event|7|||
145296528|NCT00549718|523937795|FG003|Overall Study|Adverse Event|3|||
145296529|NCT00549718|523937792|FG000|Overall Study|Lost to Follow-up|4|||
145242516|NCT01250756|523733524|FG000|Infant Series|Withdrawal by Subject|4|||
145242517|NCT01250756|523733525|FG001|Infant Series|Withdrawal by Subject|5|||
145242518|NCT01250756|523733524|FG000|Infant Series|Randomized, Not Vaccinated|2|||
145242519|NCT01250756|523733525|FG001|Infant Series|Randomized, Not Vaccinated|2|||
145242520|NCT01250756|523733524|FG000|Infant Series|Other|22|||
145242521|NCT01250756|523733525|FG001|Infant Series|Other|0|||
145242522|NCT01250756|523733524|FG000|After Infant Series|Adverse Event|5|||
145242523|NCT01250756|523733525|FG001|After Infant Series|Adverse Event|2|||
145242524|NCT01250756|523733524|FG000|After Infant Series|Withdrawal by Subject|4|||
145242525|NCT01250756|523733525|FG001|After Infant Series|Withdrawal by Subject|1|||
145242526|NCT01250756|523733524|FG000|After Infant Series|Other|2|||
145242527|NCT01250756|523733525|FG001|After Infant Series|Other|1|||
145242528|NCT01250756|523733524|FG000|Toddler Dose|Adverse Event|0|||
145242529|NCT01250756|523733525|FG001|Toddler Dose|Adverse Event|1|||
145242530|NCT01250756|523733524|FG000|After Toddler Dose|Adverse Event|0|||
145242531|NCT01250756|523733525|FG001|After Toddler Dose|Adverse Event|1|||
145242532|NCT02999100|523733526|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
145242533|NCT02999100|523733527|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
145242534|NCT02999100|523733528|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
145242535|NCT02999100|523733529|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
145242536|NCT02999100|523733530|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
145242537|NCT02999100|523733531|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
145242538|NCT02999100|523733526|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
145242539|NCT02999100|523733527|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
145296530|NCT00549718|523937793|FG001|Overall Study|Lost to Follow-up|2|||
145296531|NCT00549718|523937794|FG002|Overall Study|Lost to Follow-up|0|||
145563872|NCT00605475|524924059|FG000|Overall Study|Administrative problems|0|||
145296532|NCT00549718|523937795|FG003|Overall Study|Lost to Follow-up|6|||
145296533|NCT00549718|523937792|FG000|Overall Study|Withdrawal by Subject|9|||
145563873|NCT00605475|524924060|FG001|Overall Study|Administrative problems|0|||
145563874|NCT00605475|524924061|FG002|Overall Study|Administrative problems|0|||
145563875|NCT00605475|524924062|FG003|Overall Study|Administrative problems|0|||
145563876|NCT00605475|524924063|FG004|Overall Study|Administrative problems|0|||
145563877|NCT00605475|524924064|FG005|Overall Study|Administrative problems|0|||
145563878|NCT00605475|524924065|FG006|Overall Study|Administrative problems|1|||
145563879|NCT00605475|524924066|FG007|Overall Study|Administrative problems|0|||
145563880|NCT00605475|524924067|FG008|Overall Study|Administrative problems|0|||
145563881|NCT00605475|524924068|FG009|Overall Study|Administrative problems|0|||
145563882|NCT00605475|524924059|FG000|Overall Study|Lost to Follow-up|0|||
145563883|NCT00605475|524924060|FG001|Overall Study|Lost to Follow-up|0|||
145563884|NCT00605475|524924061|FG002|Overall Study|Lost to Follow-up|0|||
145563885|NCT00605475|524924062|FG003|Overall Study|Lost to Follow-up|0|||
145563886|NCT00605475|524924063|FG004|Overall Study|Lost to Follow-up|0|||
145563887|NCT00605475|524924064|FG005|Overall Study|Lost to Follow-up|0|||
145563888|NCT00605475|524924065|FG006|Overall Study|Lost to Follow-up|0|||
145563889|NCT00605475|524924066|FG007|Overall Study|Lost to Follow-up|0|||
145563890|NCT00605475|524924067|FG008|Overall Study|Lost to Follow-up|1|||
145563891|NCT00605475|524924068|FG009|Overall Study|Lost to Follow-up|1|||
145563892|NCT00605475|524924059|FG000|Overall Study|Protocol Violation|0|||
145563893|NCT00605475|524924060|FG001|Overall Study|Protocol Violation|0|||
145563894|NCT00605475|524924061|FG002|Overall Study|Protocol Violation|0|||
145563895|NCT00605475|524924062|FG003|Overall Study|Protocol Violation|0|||
145563896|NCT00605475|524924063|FG004|Overall Study|Protocol Violation|1|||
145563897|NCT00605475|524924064|FG005|Overall Study|Protocol Violation|0|||
145563898|NCT00605475|524924065|FG006|Overall Study|Protocol Violation|0|||
145563899|NCT00605475|524924066|FG007|Overall Study|Protocol Violation|0|||
145563900|NCT00605475|524924067|FG008|Overall Study|Protocol Violation|0|||
145563901|NCT00605475|524924068|FG009|Overall Study|Protocol Violation|0|||
145563902|NCT00605475|524924059|FG000|Overall Study|Withdrawal by Subject|0|||
145563903|NCT00605475|524924060|FG001|Overall Study|Withdrawal by Subject|0|||
145563904|NCT00605475|524924061|FG002|Overall Study|Withdrawal by Subject|0|||
145563905|NCT00605475|524924062|FG003|Overall Study|Withdrawal by Subject|0|||
145620084|NCT01349907|525123663|FG000|Overall Study|Withdrawal by Subject|30|||
145242540|NCT02999100|523733528|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
145242541|NCT02999100|523733529|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
145242542|NCT02999100|523733530|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
145242543|NCT02999100|523733531|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
145242544|NCT02999100|523733526|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
145242545|NCT02999100|523733527|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
145242546|NCT02999100|523733528|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
145242547|NCT02999100|523733529|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
145563906|NCT00605475|524924063|FG004|Overall Study|Withdrawal by Subject|0|||
145563907|NCT00605475|524924064|FG005|Overall Study|Withdrawal by Subject|2|||
145563908|NCT00605475|524924065|FG006|Overall Study|Withdrawal by Subject|0|||
145563909|NCT00605475|524924066|FG007|Overall Study|Withdrawal by Subject|0|||
145563910|NCT00605475|524924067|FG008|Overall Study|Withdrawal by Subject|0|||
145242548|NCT02999100|523733530|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
145242549|NCT02999100|523733531|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
145242550|NCT00293241|523733532|FG000|Overall Study|Lost to Follow-up|9|||
145242551|NCT00293241|523733533|FG001|Overall Study|Lost to Follow-up|16|||
145242552|NCT00293241|523733532|FG000|Overall Study|Physician Decision|23|||
145242553|NCT00293241|523733533|FG001|Overall Study|Physician Decision|17|||
145242554|NCT00293241|523733532|FG000|Overall Study|Withdrawal by Subject|4|||
145242555|NCT00293241|523733533|FG001|Overall Study|Withdrawal by Subject|8|||
145242556|NCT03595384|523733534|FG000|Overall Study|Other time commitments|8|||
145242557|NCT03595384|523733534|FG000|Overall Study|Changes to session time|7|||
145242558|NCT03595384|523733534|FG000|Overall Study|Relocation out of country|1|||
145242559|NCT01270958|523733536|FG000|Overall Study|Lost to Follow-up|2|||
145242560|NCT01270958|523733536|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
145242561|NCT02228564|523733537|FG000|Overall Study|Withdrawal by Subject|10|||
145242562|NCT02228564|523733537|FG000|Overall Study|Death|11|||
145242563|NCT02228564|523733537|FG000|Overall Study|Physician Decision|5|||
145242564|NCT02228564|523733537|FG000|Overall Study|Lost to Follow-up|17|||
145242565|NCT02228564|523733537|FG000|Overall Study|Other|6|||
145242566|NCT02142504|523733541|FG000|Overall Study|Protocol Violation|2|||
145242567|NCT02142504|523733542|FG001|Overall Study|Protocol Violation|1|||
145242568|NCT02142504|523733543|FG002|Overall Study|Protocol Violation|2|||
145242569|NCT02142504|523733541|FG000|Overall Study|Adverse Event|2|||
145242570|NCT02142504|523733542|FG001|Overall Study|Adverse Event|3|||
145242571|NCT02142504|523733543|FG002|Overall Study|Adverse Event|4|||
145242572|NCT02142504|523733541|FG000|Overall Study|Lost to Follow-up|12|||
145242573|NCT02142504|523733542|FG001|Overall Study|Lost to Follow-up|19|||
145242574|NCT02142504|523733543|FG002|Overall Study|Lost to Follow-up|17|||
145242575|NCT02142504|523733541|FG000|Overall Study|Withdrawal by Subject|7|||
145242576|NCT02142504|523733542|FG001|Overall Study|Withdrawal by Subject|9|||
145242577|NCT02142504|523733543|FG002|Overall Study|Withdrawal by Subject|11|||
145242578|NCT02142504|523733541|FG000|Overall Study|Pregnancy|4|||
145242579|NCT02142504|523733542|FG001|Overall Study|Pregnancy|4|||
145242580|NCT02142504|523733543|FG002|Overall Study|Pregnancy|2|||
145242581|NCT02142504|523733541|FG000|Overall Study|Physician Decision|0|||
145242582|NCT02142504|523733542|FG001|Overall Study|Physician Decision|1|||
145242583|NCT02142504|523733543|FG002|Overall Study|Physician Decision|3|||
145242584|NCT02142504|523733541|FG000|Overall Study|Reason Not Specified|4|||
145242585|NCT02142504|523733542|FG001|Overall Study|Reason Not Specified|5|||
145242586|NCT02142504|523733543|FG002|Overall Study|Reason Not Specified|4|||
145242587|NCT02925312|523733544|FG000|Overall Study|Lost to Follow-up|25|||
145242588|NCT02925312|523733545|FG001|Overall Study|Lost to Follow-up|0|||
145242589|NCT02925312|523733544|FG000|Overall Study|Adverse Event|2|||
145242590|NCT02925312|523733545|FG001|Overall Study|Adverse Event|0|||
145242591|NCT04114539|523733546|FG000|Overall Study|Adverse Event|14|||
145242592|NCT04114539|523733546|FG000|Overall Study|Lost to Follow-up|2|||
145242593|NCT04114539|523733546|FG000|Overall Study|Non-compliance with Protocol|2|||
145242594|NCT04114539|523733546|FG000|Overall Study|Non-compliance with Study Drug|1|||
145242595|NCT04114539|523733546|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
145242596|NCT04114539|523733546|FG000|Overall Study|Withdrew consent|10|||
145242597|NCT04114539|523733546|FG000|Overall Study|Others not specified|5|||
145242598|NCT04114539|523733546|FG000|Overall Study|Investigator Decision|2|||
145242599|NCT04285853|523733547|FG000|Overall Study|Withdrawal by Subject|1|||
145242600|NCT04285853|523733548|FG001|Overall Study|Withdrawal by Subject|0|||
145242601|NCT04285853|523733547|FG000|Overall Study|Lost to Follow-up|9|||
145242602|NCT04285853|523733548|FG001|Overall Study|Lost to Follow-up|5|||
145242603|NCT01072448|523733549|FG000|Overall Study|Adverse Event|9|||
145242604|NCT01072448|523733550|FG001|Overall Study|Adverse Event|10|||
145242605|NCT01072448|523733549|FG000|Overall Study|Subject withdrew consent|4|||
145242606|NCT01072448|523733550|FG001|Overall Study|Subject withdrew consent|9|||
145242607|NCT01072448|523733549|FG000|Overall Study|Protocol deviation|3|||
145242608|NCT01072448|523733550|FG001|Overall Study|Protocol deviation|4|||
145242609|NCT01072448|523733549|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145242610|NCT01072448|523733550|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145242611|NCT01072448|523733549|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145242612|NCT01072448|523733550|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145242613|NCT01072448|523733549|FG000|Overall Study|Lost to Follow-up|1|||
145242614|NCT01072448|523733550|FG001|Overall Study|Lost to Follow-up|1|||
145242615|NCT01072448|523733549|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145242616|NCT01072448|523733550|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145242617|NCT01072448|523733549|FG000|Overall Study|Death|0|||
145242618|NCT01072448|523733550|FG001|Overall Study|Death|2|||
145242619|NCT01225172|523733557|FG000|Overall Study|Subject decision to stop|1|||
145242620|NCT01225172|523733558|FG001|Overall Study|Subject decision to stop|0|||
145242621|NCT01225172|523733557|FG000|Overall Study|Subject request to discontinue treatment|3|||
145242622|NCT01225172|523733558|FG001|Overall Study|Subject request to discontinue treatment|1|||
145242623|NCT01225172|523733557|FG000|Overall Study|Subject no longer meets study criteria|1|||
145242624|NCT01225172|523733558|FG001|Overall Study|Subject no longer meets study criteria|0|||
145408887|NCT03329001|524351894|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408888|NCT03329001|524351895|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
145408889|NCT03329001|524351896|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408890|NCT03329001|524351897|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408891|NCT03329001|524351898|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
145408892|NCT03329001|524351891|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145408893|NCT03329001|524351892|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145242625|NCT01225172|523733557|FG000|Overall Study|Withdrawal by Subject|1|||
145408894|NCT03329001|524351893|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145408895|NCT03329001|524351894|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145408896|NCT03329001|524351895|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
145408897|NCT03329001|524351896|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
145408898|NCT03329001|524351897|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145242626|NCT01225172|523733558|FG001|Overall Study|Withdrawal by Subject|0|||
145242627|NCT03404518|523733559|FG000|Overall Study|Lost to Follow-up|28|||
145242628|NCT03404518|523733560|FG001|Overall Study|Lost to Follow-up|30|||
145242629|NCT03404518|523733559|FG000|Overall Study|Protocol Violation|13|||
145242630|NCT03404518|523733560|FG001|Overall Study|Protocol Violation|6|||
145242631|NCT02079519|523733561|FG000|Overall Study|Disease Progression|9|||
145242632|NCT02079519|523733561|FG000|Overall Study|Adverse Event|1|||
145242633|NCT01576406|523733562|FG000|Overall Study|Lost to Follow-up|1|||
145242634|NCT01576406|523733563|FG001|Overall Study|Lost to Follow-up|2|||
145242635|NCT01576406|523733564|FG002|Overall Study|Lost to Follow-up|0|||
145242636|NCT01576406|523733565|FG003|Overall Study|Lost to Follow-up|0|||
145242637|NCT01576406|523733566|FG004|Overall Study|Lost to Follow-up|0|||
145242638|NCT01576406|523733567|FG005|Overall Study|Lost to Follow-up|0|||
145242639|NCT01576406|523733562|FG000|Overall Study|Death|3|||
145242640|NCT01576406|523733563|FG001|Overall Study|Death|4|||
145408899|NCT03329001|524351898|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
145408900|NCT03329001|524351891|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408901|NCT03329001|524351892|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408902|NCT03329001|524351893|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408903|NCT03329001|524351894|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408904|NCT03329001|524351895|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
145408905|NCT03329001|524351896|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408906|NCT03329001|524351897|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408907|NCT03329001|524351898|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
145408908|NCT03329001|524351891|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408909|NCT03329001|524351892|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408910|NCT03329001|524351893|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408911|NCT03329001|524351894|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408912|NCT03329001|524351895|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
145408913|NCT03329001|524351896|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
145563911|NCT00605475|524924068|FG009|Overall Study|Withdrawal by Subject|1|||
145563912|NCT02596854|524924069|FG000|Overall Study|Withdrawn|8|||
145563913|NCT00076011|524924073|FG000|Overall Study|Death|1|||
145563914|NCT00076011|524924073|FG000|Overall Study|Adverse Event|10|||
145563915|NCT00076011|524924073|FG000|Overall Study|Lack of Efficacy|25|||
145563916|NCT00076011|524924073|FG000|Overall Study|Withdrawal by Subject|1|||
145242641|NCT01576406|523733564|FG002|Overall Study|Death|8|||
145242642|NCT01576406|523733565|FG003|Overall Study|Death|5|||
145242643|NCT01576406|523733566|FG004|Overall Study|Death|7|||
145242644|NCT01576406|523733567|FG005|Overall Study|Death|9|||
145242645|NCT01576406|523733562|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
145242646|NCT01576406|523733563|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
145242647|NCT01576406|523733564|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
145563917|NCT00076011|524924073|FG000|Overall Study|Study terminated by sponsor|3|||
145563918|NCT00076011|524924073|FG000|Overall Study|Other|11|||
145242648|NCT01576406|523733565|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
145242649|NCT01576406|523733566|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
145242650|NCT01576406|523733567|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
145242651|NCT01576406|523733562|FG000|Overall Study|Withdrawal the consent|2|||
145242652|NCT01576406|523733563|FG001|Overall Study|Withdrawal the consent|2|||
145242653|NCT01576406|523733564|FG002|Overall Study|Withdrawal the consent|5|||
145242654|NCT01576406|523733565|FG003|Overall Study|Withdrawal the consent|1|||
145242655|NCT01576406|523733566|FG004|Overall Study|Withdrawal the consent|1|||
145242656|NCT01576406|523733567|FG005|Overall Study|Withdrawal the consent|3|||
145242657|NCT01576406|523733562|FG000|Overall Study|Other|0|||
145242658|NCT01576406|523733563|FG001|Overall Study|Other|0|||
145242659|NCT01576406|523733564|FG002|Overall Study|Other|2|||
145242660|NCT01576406|523733565|FG003|Overall Study|Other|2|||
145242661|NCT01576406|523733566|FG004|Overall Study|Other|0|||
145242662|NCT01576406|523733567|FG005|Overall Study|Other|0|||
145242663|NCT00642018|523733568|FG000|Overall Study|Adverse Event|11|||
145242664|NCT00642018|523733569|FG001|Overall Study|Adverse Event|36|||
145242665|NCT00642018|523733568|FG000|Overall Study|Withdrawal by Subject|4|||
145242666|NCT00642018|523733569|FG001|Overall Study|Withdrawal by Subject|10|||
145242667|NCT00642018|523733568|FG000|Overall Study|Progressive Disease|13|||
145242668|NCT00642018|523733569|FG001|Overall Study|Progressive Disease|18|||
145242669|NCT00642018|523733568|FG000|Overall Study|Physician Decision|0|||
145242670|NCT00642018|523733569|FG001|Overall Study|Physician Decision|10|||
145242671|NCT00642018|523733568|FG000|Overall Study|Protocol Violation|0|||
145242672|NCT00642018|523733569|FG001|Overall Study|Protocol Violation|1|||
145242673|NCT00642018|523733568|FG000|Overall Study|Death|0|||
145242674|NCT00642018|523733569|FG001|Overall Study|Death|3|||
145242675|NCT00642018|523733568|FG000|Overall Study|Entry Criteria Not Met|0|||
145242676|NCT00642018|523733569|FG001|Overall Study|Entry Criteria Not Met|1|||
145242677|NCT01607073|523733570|FG000|Overall Study|Adverse Event|1|||
145242678|NCT00131664|523733571|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
145242679|NCT00131664|523733572|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
145242680|NCT00131664|523733573|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
145242681|NCT00131664|523733574|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
145242682|NCT00131664|523733575|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
145242683|NCT00131664|523733576|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
145242684|NCT00131664|523733571|FG000|First Period (First 6 Months)|Death|0|||
145242685|NCT00131664|523733572|FG001|First Period (First 6 Months)|Death|1|||
145242686|NCT00131664|523733573|FG002|First Period (First 6 Months)|Death|0|||
145242687|NCT00131664|523733574|FG003|First Period (First 6 Months)|Death|0|||
145242688|NCT00131664|523733575|FG004|First Period (First 6 Months)|Death|0|||
145242689|NCT00131664|523733576|FG005|First Period (First 6 Months)|Death|0|||
145242690|NCT00131664|523733571|FG000|First Period (First 6 Months)|Protocol Violation|2|||
145242691|NCT00131664|523733572|FG001|First Period (First 6 Months)|Protocol Violation|2|||
145242692|NCT00131664|523733573|FG002|First Period (First 6 Months)|Protocol Violation|1|||
145242693|NCT00131664|523733574|FG003|First Period (First 6 Months)|Protocol Violation|0|||
145242694|NCT00131664|523733575|FG004|First Period (First 6 Months)|Protocol Violation|0|||
145242695|NCT00131664|523733576|FG005|First Period (First 6 Months)|Protocol Violation|0|||
145242696|NCT00131664|523733571|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
145242697|NCT00131664|523733572|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
145242698|NCT00131664|523733573|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
145242699|NCT00131664|523733574|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
145242700|NCT00131664|523733575|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
145242701|NCT00131664|523733576|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
145242702|NCT00131664|523733571|FG000|First Period (First 6 Months)|Adverse Event|9|||
145242703|NCT00131664|523733572|FG001|First Period (First 6 Months)|Adverse Event|4|||
145242704|NCT00131664|523733573|FG002|First Period (First 6 Months)|Adverse Event|5|||
145242705|NCT00131664|523733574|FG003|First Period (First 6 Months)|Adverse Event|0|||
145242706|NCT00131664|523733575|FG004|First Period (First 6 Months)|Adverse Event|0|||
145242707|NCT00131664|523733576|FG005|First Period (First 6 Months)|Adverse Event|0|||
145242708|NCT00131664|523733571|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
145242709|NCT00131664|523733572|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
145296534|NCT00549718|523937793|FG001|Overall Study|Withdrawal by Subject|18|||
145296535|NCT00549718|523937794|FG002|Overall Study|Withdrawal by Subject|12|||
145296536|NCT00549718|523937795|FG003|Overall Study|Withdrawal by Subject|13|||
145296537|NCT00549718|523937792|FG000|Overall Study|Administrative|2|||
145296538|NCT00549718|523937793|FG001|Overall Study|Administrative|2|||
145296539|NCT00549718|523937794|FG002|Overall Study|Administrative|2|||
145296540|NCT00549718|523937795|FG003|Overall Study|Administrative|1|||
145296541|NCT04032977|523937796|FG000|Overall Study|Withdrawal by Subject|6|||
145296542|NCT04032977|523937797|FG001|Overall Study|Withdrawal by Subject|1|||
145242710|NCT00131664|523733573|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
145242711|NCT00131664|523733574|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
145242712|NCT00131664|523733575|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
145242713|NCT00131664|523733576|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
145242714|NCT00131664|523733571|FG000|First Period (First 6 Months)|Administrative reasons|2|||
145242715|NCT00131664|523733572|FG001|First Period (First 6 Months)|Administrative reasons|0|||
145242716|NCT00131664|523733573|FG002|First Period (First 6 Months)|Administrative reasons|5|||
145242717|NCT00131664|523733574|FG003|First Period (First 6 Months)|Administrative reasons|0|||
145242718|NCT00131664|523733575|FG004|First Period (First 6 Months)|Administrative reasons|0|||
145242719|NCT00131664|523733576|FG005|First Period (First 6 Months)|Administrative reasons|0|||
145242720|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
145296543|NCT04032977|523937796|FG000|Overall Study|Lost to Follow-up|2|||
145296544|NCT04032977|523937797|FG001|Overall Study|Lost to Follow-up|7|||
145242721|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
145242722|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
145242723|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
145242724|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
145242725|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
145242726|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
145242727|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
145242728|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
145242729|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
145242730|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
145242731|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
145242732|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
145242733|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
145242734|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
145242735|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
145242736|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
145242737|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
145242738|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
145242739|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
145242740|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
145242741|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
145242742|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
145242743|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
145242744|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
145242745|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
145242746|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
145242747|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
145242748|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
145242749|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
145242750|NCT00131664|523733571|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
145242751|NCT00131664|523733572|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
145242752|NCT00131664|523733573|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
145242753|NCT00131664|523733574|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
145242754|NCT00131664|523733575|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
145242755|NCT00131664|523733576|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
145242756|NCT01280812|523735431|FG000|Overall Study|Withdrawal by Subject|2|||
145242757|NCT01280812|523735432|FG001|Overall Study|Withdrawal by Subject|1|||
145242758|NCT01280812|523735433|FG002|Overall Study|Withdrawal by Subject|0|||
145242759|NCT01280812|523735431|FG000|Overall Study|Lost to Follow-up|1|||
145242760|NCT01280812|523735432|FG001|Overall Study|Lost to Follow-up|1|||
145242761|NCT01280812|523735433|FG002|Overall Study|Lost to Follow-up|1|||
145242762|NCT00959894|523735436|FG000|Overall Study|Lost to Follow-up|10|||
145242763|NCT00959894|523735436|FG000|Overall Study|Adverse Event|3|||
145242764|NCT00959894|523735436|FG000|Overall Study|Withdrawal by Subject|1|||
145242765|NCT00959894|523735436|FG000|Overall Study|Need for contraindicated medication|1|||
145242766|NCT00959894|523735436|FG000|Overall Study|Subject moved out of town|1|||
145242767|NCT01376388|523735437|FG000|Overall Study|Adverse Event|13|||
145242768|NCT01376388|523735437|FG000|Overall Study|Lack of Efficacy|2|||
145242769|NCT01376388|523735437|FG000|Overall Study|Withdrawal by Subject|3|||
145242770|NCT02009930|523735445|FG000|Overall Study|withdrawn|5|||
145242771|NCT02959970|523735448|FG000|Overall Study|Adverse Event|1|||
145242772|NCT02959970|523735449|FG001|Overall Study|Adverse Event|0|||
145242773|NCT02959970|523735448|FG000|Overall Study|Withdrawal by Subject|0|||
145242774|NCT02959970|523735449|FG001|Overall Study|Withdrawal by Subject|2|||
145242775|NCT02959970|523735448|FG000|Overall Study|Lost to Follow-up|1|||
145242776|NCT02959970|523735449|FG001|Overall Study|Lost to Follow-up|5|||
145242777|NCT00666536|523735450|FG000|Overall Study|Adverse Event|9|||
145242778|NCT00666536|523735451|FG001|Overall Study|Adverse Event|19|||
145242779|NCT00666536|523735450|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145242780|NCT00666536|523735451|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145242781|NCT00666536|523735450|FG000|Overall Study|Protocol deviation(s)|8|||
145296545|NCT04032977|523937796|FG000|Overall Study|Pregnancy|1|||
145296546|NCT04032977|523937797|FG001|Overall Study|Pregnancy|0|||
145296547|NCT03075761|523937799|FG000|Overall Study|Lost to Follow-up|1|||
145296548|NCT03075761|523937800|FG001|Overall Study|Lost to Follow-up|6|||
145242782|NCT00666536|523735451|FG001|Overall Study|Protocol deviation(s)|6|||
145242783|NCT00666536|523735450|FG000|Overall Study|Withdrawal by Subject|10|||
145242784|NCT00666536|523735451|FG001|Overall Study|Withdrawal by Subject|9|||
145296549|NCT02880761|523937801|FG000|Overall Study|Death|6|||
145242785|NCT00666536|523735450|FG000|Overall Study|Lost to Follow-up|4|||
145242786|NCT00666536|523735451|FG001|Overall Study|Lost to Follow-up|3|||
145242787|NCT03805971|523735452|FG000|Overall Study|Withdrawal by Subject|1|||
145242788|NCT03805971|523735452|FG000|Overall Study|Protocol Violation|2|||
145242789|NCT01510028|523735458|FG000|Overall Study|Lack of Efficacy|1|||
145242790|NCT01510028|523735459|FG001|Overall Study|Lack of Efficacy|0|||
145242791|NCT01510028|523735460|FG002|Overall Study|Lack of Efficacy|0|||
145242792|NCT01510028|523735461|FG003|Overall Study|Lack of Efficacy|0|||
145242793|NCT02741310|523735462|FG000|Overall Study|Sponsor Decision|2|||
145242794|NCT02741310|523735463|FG001|Overall Study|Sponsor Decision|2|||
145242795|NCT05091918|523735464|FG000|Overall Study|Adverse Event|1|||
145242796|NCT05091918|523735464|FG000|Overall Study|Withdrawal by Subject|81|||
145242797|NCT01100658|523735465|FG000|Overall Study|Withdrawal by Subject|1|||
145242798|NCT01784211|523735469|FG000|Part A (Days 1-15)|Adverse Event|1|||
145242799|NCT01784211|523735470|FG001|Part A (Days 1-15)|Adverse Event|1|||
145242800|NCT01784211|523735471|FG002|Part A (Days 1-15)|Adverse Event|0|||
145242801|NCT01784211|523735472|FG003|Part A (Days 1-15)|Adverse Event|0|||
145242802|NCT01784211|523735473|FG004|Part A (Days 1-15)|Adverse Event|0|||
145242803|NCT01784211|523735474|FG005|Part A (Days 1-15)|Adverse Event|0|||
145242804|NCT01784211|523735469|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
145242805|NCT01784211|523735470|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
145242806|NCT01784211|523735471|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
145242807|NCT01784211|523735472|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
145242808|NCT01784211|523735473|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
145242809|NCT01784211|523735474|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
145242810|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
145242811|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
145242812|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
145242813|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
145242814|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
145242815|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
145242816|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
145242817|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
145242818|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
145242819|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
145242820|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
145242821|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
145242822|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
145242823|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
145242824|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
145242825|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
145242826|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
145242827|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
145242828|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
145242829|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
145563919|NCT00076011|524924073|FG000|Overall Study|Ongoing|1|||
145242830|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
145242831|NCT01001572|523735477|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
145242832|NCT01001572|523735478|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
145242833|NCT01001572|523735479|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
145242834|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145242835|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
145242836|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
145242837|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145242838|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
145242839|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
145242840|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
145242841|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
145296550|NCT02880761|523937802|FG001|Overall Study|Death|8|||
145563920|NCT05071183|524924078|FG000|Overall Study|Death|1|||
145563921|NCT05071183|524924079|FG001|Overall Study|Death|2|||
145563922|NCT05071183|524924080|FG002|Overall Study|Death|0|||
145242842|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
145242843|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
145242844|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
145242845|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
145242846|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
145242847|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
145242848|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
145563923|NCT05071183|524924078|FG000|Overall Study|Other Reasons|1|||
145563924|NCT05071183|524924079|FG001|Overall Study|Other Reasons|3|||
145242849|NCT01001572|523735477|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145242850|NCT01001572|523735478|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145242851|NCT01001572|523735479|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145242852|NCT01094808|523735480|FG000|Overall Study|Withdrawal by Subject|1|||
145242853|NCT01094808|523735481|FG001|Overall Study|Withdrawal by Subject|1|||
145242854|NCT01094808|523735482|FG002|Overall Study|Withdrawal by Subject|0|||
145242855|NCT00282568|523735491|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
145296551|NCT02880761|523937801|FG000|Overall Study|Withdrawal by Subject|3|||
145242856|NCT00282568|523735491|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
145242857|NCT00282568|523735491|FG000|Extended Treatment Period|Adverse Event|17|||
145242858|NCT00282568|523735491|FG000|Extended Treatment Period|Non-compliance|4|||
145242859|NCT00282568|523735491|FG000|Extended Treatment Period|Physician Decision|1|||
145242860|NCT00282568|523735491|FG000|Extended Treatment Period|Lost to Follow-up|2|||
145242861|NCT00990249|523735496|FG000|Overall Study|Disease Progression|8|||
145242862|NCT00990249|523735496|FG000|Overall Study|Non-Compliance|1|||
145296552|NCT02880761|523937802|FG001|Overall Study|Withdrawal by Subject|6|||
145296553|NCT02880761|523937801|FG000|Overall Study|Protocol Violation|4|||
145296554|NCT02880761|523937802|FG001|Overall Study|Protocol Violation|3|||
145296555|NCT02880761|523937801|FG000|Overall Study|Lost to Follow-up|3|||
145296556|NCT02880761|523937802|FG001|Overall Study|Lost to Follow-up|4|||
145296557|NCT03597256|523937803|FG000|Overall Study|Lost to Follow-up|3|||
145296558|NCT03597256|523937804|FG001|Overall Study|Lost to Follow-up|1|||
145296559|NCT03597256|523937803|FG000|Overall Study|Withdrawal by Subject|0|||
145296560|NCT03597256|523937804|FG001|Overall Study|Withdrawal by Subject|1|||
145296561|NCT03597256|523937803|FG000|Overall Study|Could not return for treatment|0|||
145296562|NCT03597256|523937804|FG001|Overall Study|Could not return for treatment|1|||
145296563|NCT03597256|523937803|FG000|Overall Study|Moved from location|0|||
145296564|NCT03597256|523937804|FG001|Overall Study|Moved from location|1|||
145296565|NCT03597256|523937803|FG000|Overall Study|Not accepted the treatment|0|||
145296566|NCT03597256|523937804|FG001|Overall Study|Not accepted the treatment|1|||
145296567|NCT02106156|523937805|FG000|Overall Study|Patient Died|19|||
145296568|NCT02106156|523937806|FG001|Overall Study|Patient Died|0|||
145296569|NCT02106156|523937807|FG002|Overall Study|Patient Died|0|||
145296570|NCT02106156|523937805|FG000|Overall Study|Lack of Tolerability|305|||
145296571|NCT02106156|523937806|FG001|Overall Study|Lack of Tolerability|3|||
145296572|NCT02106156|523937807|FG002|Overall Study|Lack of Tolerability|0|||
145296573|NCT02106156|523937805|FG000|Overall Study|Lack of Virological Response|1044|||
145296574|NCT02106156|523937806|FG001|Overall Study|Lack of Virological Response|8|||
145296575|NCT02106156|523937807|FG002|Overall Study|Lack of Virological Response|0|||
145296576|NCT02106156|523937805|FG000|Overall Study|Concomitant Disease|74|||
145296577|NCT02106156|523937806|FG001|Overall Study|Concomitant Disease|2|||
145296578|NCT02106156|523937807|FG002|Overall Study|Concomitant Disease|0|||
145296579|NCT02106156|523937805|FG000|Overall Study|Lack of Compliance|211|||
145296580|NCT02106156|523937806|FG001|Overall Study|Lack of Compliance|7|||
145296581|NCT02106156|523937807|FG002|Overall Study|Lack of Compliance|0|||
145296582|NCT02106156|523937805|FG000|Overall Study|Patients Request|307|||
145296583|NCT02106156|523937806|FG001|Overall Study|Patients Request|9|||
145296584|NCT02106156|523937807|FG002|Overall Study|Patients Request|0|||
145296585|NCT02106156|523937805|FG000|Overall Study|Lost to Follow-up|451|||
145296586|NCT02106156|523937806|FG001|Overall Study|Lost to Follow-up|8|||
145296587|NCT02106156|523937807|FG002|Overall Study|Lost to Follow-up|0|||
145296588|NCT02106156|523937805|FG000|Overall Study|Unplanned Event|82|||
145296589|NCT02106156|523937806|FG001|Overall Study|Unplanned Event|2|||
145296590|NCT02106156|523937807|FG002|Overall Study|Unplanned Event|0|||
145296591|NCT02106156|523937805|FG000|Overall Study|Change of Laboratory Parameter|10|||
145296592|NCT02106156|523937806|FG001|Overall Study|Change of Laboratory Parameter|0|||
145296593|NCT02106156|523937807|FG002|Overall Study|Change of Laboratory Parameter|0|||
145296594|NCT02106156|523937805|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
145296595|NCT02106156|523937806|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
145296596|NCT02106156|523937807|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
145296597|NCT02106156|523937805|FG000|Overall Study|Relocation/Change of Physician|40|||
145296598|NCT02106156|523937806|FG001|Overall Study|Relocation/Change of Physician|1|||
145296599|NCT02106156|523937807|FG002|Overall Study|Relocation/Change of Physician|0|||
145242863|NCT00990249|523735496|FG000|Overall Study|Death|2|||
145242864|NCT00990249|523735496|FG000|Overall Study|Not treated|2|||
145242865|NCT02873208|523735497|FG000|Overall Study|Withdrawal by Subject|36|||
145242866|NCT02873208|523735497|FG000|Overall Study|Lost to Follow-up|22|||
145296600|NCT00560235|523937817|FG000|Phase 1|Discontinued|8|||
145296601|NCT00560235|523937818|FG001|Phase 1|Discontinued|0|||
145296602|NCT00560235|523937819|FG002|Phase 1|Discontinued|0|||
145296603|NCT00560235|523937817|FG000|Phase 1B|Discontinued|0|||
145296604|NCT00560235|523937818|FG001|Phase 1B|Discontinued|19|||
145296605|NCT00560235|523937819|FG002|Phase 1B|Discontinued|0|||
145242867|NCT02873208|523735497|FG000|Overall Study|Adverse Event|15|||
145296606|NCT00560235|523937817|FG000|Phase 2|Discontinued|0|||
145296607|NCT00560235|523937818|FG001|Phase 2|Discontinued|0|||
145296608|NCT00560235|523937819|FG002|Phase 2|Discontinued|96|||
145296609|NCT00560235|523937817|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
145242868|NCT02873208|523735497|FG000|Overall Study|Non-compliance with study drug|12|||
145242869|NCT02873208|523735497|FG000|Overall Study|Protocol Violation|8|||
145242870|NCT02873208|523735497|FG000|Overall Study|Pregnancy|2|||
145242871|NCT02873208|523735497|FG000|Overall Study|Incarceration|1|||
145242872|NCT02873208|523735497|FG000|Overall Study|Lack of Efficacy|1|||
145242873|NCT02873208|523735497|FG000|Overall Study|Physician Decision|1|||
145242874|NCT00415584|523735498|FG000|Overall Study|Withdrawal by Subject|1|||
145242875|NCT01831804|523735499|FG000|Overall Study|Adverse Event|0|||
145242876|NCT01831804|523735500|FG001|Overall Study|Adverse Event|0|||
145242877|NCT01831804|523735501|FG002|Overall Study|Adverse Event|0|||
145242878|NCT01831804|523735502|FG003|Overall Study|Adverse Event|0|||
145242879|NCT01831804|523735503|FG004|Overall Study|Adverse Event|0|||
145242880|NCT01831804|523735504|FG005|Overall Study|Adverse Event|0|||
145242881|NCT01831804|523735505|FG006|Overall Study|Adverse Event|1|||
145296610|NCT00560235|523937818|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
145296611|NCT00560235|523937819|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
145296612|NCT00051025|523937821|FG000|Overall Study|Progressive Disease|1|||
145296613|NCT00051025|523937822|FG001|Overall Study|Progressive Disease|1|||
145296614|NCT00051025|523937821|FG000|Overall Study|Adverse Event|1|||
145296615|NCT00051025|523937822|FG001|Overall Study|Adverse Event|1|||
145296616|NCT00051025|523937821|FG000|Overall Study|Withdrawal by Subject|0|||
145296617|NCT00051025|523937822|FG001|Overall Study|Withdrawal by Subject|1|||
145296618|NCT00051025|523937821|FG000|Overall Study|Death|0|||
145296619|NCT00051025|523937822|FG001|Overall Study|Death|1|||
145296620|NCT02017964|523937826|FG000|Overall Study|Patient deemed ineligible|1|||
145296621|NCT00150462|523937830|FG000|Overall Study|Disease Progression or Relapse|3|||
145296622|NCT00150462|523937831|FG001|Overall Study|Disease Progression or Relapse|1|||
145296623|NCT00150462|523937832|FG002|Overall Study|Disease Progression or Relapse|2|||
145296624|NCT00150462|523937833|FG003|Overall Study|Disease Progression or Relapse|1|||
145296625|NCT00150462|523937834|FG004|Overall Study|Disease Progression or Relapse|2|||
145296626|NCT00150462|523937835|FG005|Overall Study|Disease Progression or Relapse|2|||
145296627|NCT00150462|523937836|FG006|Overall Study|Disease Progression or Relapse|3|||
145296628|NCT00150462|523937837|FG007|Overall Study|Disease Progression or Relapse|5|||
145296629|NCT00150462|523937838|FG008|Overall Study|Disease Progression or Relapse|5|||
145296630|NCT00150462|523937839|FG009|Overall Study|Disease Progression or Relapse|3|||
145296631|NCT00150462|523937840|FG010|Overall Study|Disease Progression or Relapse|2|||
145296632|NCT00150462|523937830|FG000|Overall Study|Withdrawal by Subject|0|||
145296633|NCT00150462|523937831|FG001|Overall Study|Withdrawal by Subject|1|||
145296634|NCT00150462|523937832|FG002|Overall Study|Withdrawal by Subject|1|||
145296635|NCT00150462|523937833|FG003|Overall Study|Withdrawal by Subject|0|||
145296636|NCT00150462|523937834|FG004|Overall Study|Withdrawal by Subject|1|||
145296637|NCT00150462|523937835|FG005|Overall Study|Withdrawal by Subject|2|||
145296638|NCT00150462|523937836|FG006|Overall Study|Withdrawal by Subject|0|||
145296639|NCT00150462|523937837|FG007|Overall Study|Withdrawal by Subject|1|||
145296640|NCT00150462|523937838|FG008|Overall Study|Withdrawal by Subject|0|||
145296641|NCT00150462|523937839|FG009|Overall Study|Withdrawal by Subject|1|||
145296642|NCT00150462|523937840|FG010|Overall Study|Withdrawal by Subject|0|||
145296643|NCT00150462|523937830|FG000|Overall Study|Death|0|||
145296644|NCT00150462|523937831|FG001|Overall Study|Death|1|||
145296645|NCT00150462|523937832|FG002|Overall Study|Death|0|||
145296646|NCT00150462|523937833|FG003|Overall Study|Death|0|||
145296647|NCT00150462|523937834|FG004|Overall Study|Death|0|||
145296648|NCT00150462|523937835|FG005|Overall Study|Death|0|||
145296649|NCT00150462|523937836|FG006|Overall Study|Death|0|||
145296650|NCT00150462|523937837|FG007|Overall Study|Death|0|||
145296651|NCT00150462|523937838|FG008|Overall Study|Death|1|||
145296652|NCT00150462|523937839|FG009|Overall Study|Death|0|||
145296653|NCT00150462|523937840|FG010|Overall Study|Death|0|||
145296654|NCT00150462|523937830|FG000|Overall Study|Adverse Event|0|||
145296655|NCT00150462|523937831|FG001|Overall Study|Adverse Event|0|||
145296656|NCT00150462|523937832|FG002|Overall Study|Adverse Event|0|||
145242882|NCT01831804|523735506|FG007|Overall Study|Adverse Event|0|||
145242883|NCT01831804|523735507|FG008|Overall Study|Adverse Event|1|||
145242884|NCT01831804|523735499|FG000|Overall Study|Protocol Violation|0|||
145242885|NCT01831804|523735500|FG001|Overall Study|Protocol Violation|0|||
145242886|NCT01831804|523735501|FG002|Overall Study|Protocol Violation|2|||
145242887|NCT01831804|523735502|FG003|Overall Study|Protocol Violation|0|||
145242888|NCT01831804|523735503|FG004|Overall Study|Protocol Violation|0|||
145242889|NCT01831804|523735504|FG005|Overall Study|Protocol Violation|0|||
145296657|NCT00150462|523937833|FG003|Overall Study|Adverse Event|1|||
145296658|NCT00150462|523937834|FG004|Overall Study|Adverse Event|0|||
145296659|NCT00150462|523937835|FG005|Overall Study|Adverse Event|0|||
145563925|NCT05071183|524924080|FG002|Overall Study|Other Reasons|2|||
145296660|NCT00150462|523937836|FG006|Overall Study|Adverse Event|0|||
145296661|NCT00150462|523937837|FG007|Overall Study|Adverse Event|2|||
145296662|NCT00150462|523937838|FG008|Overall Study|Adverse Event|0|||
145296663|NCT00150462|523937839|FG009|Overall Study|Adverse Event|1|||
145296664|NCT00150462|523937840|FG010|Overall Study|Adverse Event|0|||
145242890|NCT01831804|523735505|FG006|Overall Study|Protocol Violation|0|||
145242891|NCT01831804|523735506|FG007|Overall Study|Protocol Violation|0|||
145242892|NCT01831804|523735507|FG008|Overall Study|Protocol Violation|0|||
145242893|NCT01831804|523735499|FG000|Overall Study|Protocol defined stopping criteria|1|||
145242894|NCT01831804|523735500|FG001|Overall Study|Protocol defined stopping criteria|1|||
145242895|NCT01831804|523735501|FG002|Overall Study|Protocol defined stopping criteria|3|||
145242896|NCT01831804|523735502|FG003|Overall Study|Protocol defined stopping criteria|0|||
145242897|NCT01831804|523735503|FG004|Overall Study|Protocol defined stopping criteria|1|||
145242898|NCT01831804|523735504|FG005|Overall Study|Protocol defined stopping criteria|0|||
145242899|NCT01831804|523735505|FG006|Overall Study|Protocol defined stopping criteria|0|||
145242900|NCT01831804|523735506|FG007|Overall Study|Protocol defined stopping criteria|0|||
145242901|NCT01831804|523735507|FG008|Overall Study|Protocol defined stopping criteria|0|||
145242902|NCT01831804|523735499|FG000|Overall Study|Lost to Follow-up|0|||
145242903|NCT01831804|523735500|FG001|Overall Study|Lost to Follow-up|0|||
145242904|NCT01831804|523735501|FG002|Overall Study|Lost to Follow-up|1|||
145242905|NCT01831804|523735502|FG003|Overall Study|Lost to Follow-up|0|||
145242906|NCT01831804|523735503|FG004|Overall Study|Lost to Follow-up|0|||
145242907|NCT01831804|523735504|FG005|Overall Study|Lost to Follow-up|0|||
145242908|NCT01831804|523735505|FG006|Overall Study|Lost to Follow-up|0|||
145242909|NCT01831804|523735506|FG007|Overall Study|Lost to Follow-up|0|||
145242910|NCT01831804|523735507|FG008|Overall Study|Lost to Follow-up|1|||
145242911|NCT01831804|523735499|FG000|Overall Study|Investigator discretion|0|||
145242912|NCT01831804|523735500|FG001|Overall Study|Investigator discretion|0|||
145242913|NCT01831804|523735501|FG002|Overall Study|Investigator discretion|0|||
145242914|NCT01831804|523735502|FG003|Overall Study|Investigator discretion|0|||
145242915|NCT01831804|523735503|FG004|Overall Study|Investigator discretion|1|||
145242916|NCT01831804|523735504|FG005|Overall Study|Investigator discretion|0|||
145242917|NCT01831804|523735505|FG006|Overall Study|Investigator discretion|0|||
145242918|NCT01831804|523735506|FG007|Overall Study|Investigator discretion|1|||
145242919|NCT01831804|523735507|FG008|Overall Study|Investigator discretion|0|||
145242920|NCT01831804|523735499|FG000|Overall Study|Withdrew Consent|0|||
145242921|NCT01831804|523735500|FG001|Overall Study|Withdrew Consent|1|||
145242922|NCT01831804|523735501|FG002|Overall Study|Withdrew Consent|0|||
145242923|NCT01831804|523735502|FG003|Overall Study|Withdrew Consent|0|||
145242924|NCT01831804|523735503|FG004|Overall Study|Withdrew Consent|0|||
145242925|NCT01831804|523735504|FG005|Overall Study|Withdrew Consent|0|||
145242926|NCT01831804|523735505|FG006|Overall Study|Withdrew Consent|0|||
145242927|NCT01831804|523735506|FG007|Overall Study|Withdrew Consent|2|||
145242928|NCT01831804|523735507|FG008|Overall Study|Withdrew Consent|0|||
145242929|NCT00563368|523735508|FG000|Overall Study|Lost to Follow-up|14|||
145242930|NCT00563368|523735509|FG001|Overall Study|Lost to Follow-up|14|||
145242931|NCT00563368|523735510|FG002|Overall Study|Lost to Follow-up|12|||
145242932|NCT00563368|523735511|FG003|Overall Study|Lost to Follow-up|6|||
145242933|NCT00563368|523735512|FG004|Overall Study|Lost to Follow-up|9|||
145242934|NCT00563368|523735513|FG005|Overall Study|Lost to Follow-up|8|||
145242935|NCT00563368|523735514|FG006|Overall Study|Lost to Follow-up|9|||
145242936|NCT00563368|523735508|FG000|Overall Study|Adverse Event|3|||
145242937|NCT00563368|523735509|FG001|Overall Study|Adverse Event|4|||
145242938|NCT00563368|523735510|FG002|Overall Study|Adverse Event|5|||
145242939|NCT00563368|523735511|FG003|Overall Study|Adverse Event|9|||
145242940|NCT00563368|523735512|FG004|Overall Study|Adverse Event|6|||
145242941|NCT00563368|523735513|FG005|Overall Study|Adverse Event|10|||
145242942|NCT00563368|523735514|FG006|Overall Study|Adverse Event|17|||
145242943|NCT00563368|523735508|FG000|Overall Study|Withdrawal by Subject|11|||
145242944|NCT00563368|523735509|FG001|Overall Study|Withdrawal by Subject|6|||
145242945|NCT00563368|523735510|FG002|Overall Study|Withdrawal by Subject|5|||
145242946|NCT00563368|523735511|FG003|Overall Study|Withdrawal by Subject|7|||
145242947|NCT00563368|523735512|FG004|Overall Study|Withdrawal by Subject|8|||
145242948|NCT00563368|523735513|FG005|Overall Study|Withdrawal by Subject|5|||
145242949|NCT00563368|523735514|FG006|Overall Study|Withdrawal by Subject|4|||
145242950|NCT00563368|523735508|FG000|Overall Study|protocol non-compliance|1|||
145242951|NCT00563368|523735509|FG001|Overall Study|protocol non-compliance|1|||
145242952|NCT00563368|523735510|FG002|Overall Study|protocol non-compliance|2|||
145242953|NCT00563368|523735511|FG003|Overall Study|protocol non-compliance|1|||
145242954|NCT00563368|523735512|FG004|Overall Study|protocol non-compliance|0|||
145242955|NCT00563368|523735513|FG005|Overall Study|protocol non-compliance|1|||
145242956|NCT00563368|523735514|FG006|Overall Study|protocol non-compliance|3|||
145242957|NCT00563368|523735508|FG000|Overall Study|Pregnancy|1|||
145242958|NCT00563368|523735509|FG001|Overall Study|Pregnancy|0|||
145242959|NCT00563368|523735510|FG002|Overall Study|Pregnancy|1|||
145242960|NCT00563368|523735511|FG003|Overall Study|Pregnancy|2|||
145242961|NCT00563368|523735512|FG004|Overall Study|Pregnancy|1|||
145242962|NCT00563368|523735513|FG005|Overall Study|Pregnancy|2|||
145242963|NCT00563368|523735514|FG006|Overall Study|Pregnancy|0|||
145242964|NCT00563368|523735508|FG000|Overall Study|requirement for restricted medication|0|||
145242965|NCT00563368|523735509|FG001|Overall Study|requirement for restricted medication|0|||
145242966|NCT00563368|523735510|FG002|Overall Study|requirement for restricted medication|2|||
145242967|NCT00563368|523735511|FG003|Overall Study|requirement for restricted medication|0|||
145296665|NCT00150462|523937830|FG000|Overall Study|Physician Decision|0|||
145296666|NCT00150462|523937831|FG001|Overall Study|Physician Decision|0|||
145296667|NCT00150462|523937832|FG002|Overall Study|Physician Decision|1|||
145296668|NCT00150462|523937833|FG003|Overall Study|Physician Decision|1|||
145296669|NCT00150462|523937834|FG004|Overall Study|Physician Decision|0|||
145296670|NCT00150462|523937835|FG005|Overall Study|Physician Decision|0|||
145296671|NCT00150462|523937836|FG006|Overall Study|Physician Decision|0|||
145296672|NCT00150462|523937837|FG007|Overall Study|Physician Decision|0|||
145242968|NCT00563368|523735512|FG004|Overall Study|requirement for restricted medication|0|||
145242969|NCT00563368|523735513|FG005|Overall Study|requirement for restricted medication|0|||
145242970|NCT00563368|523735514|FG006|Overall Study|requirement for restricted medication|0|||
145242971|NCT00563368|523735508|FG000|Overall Study|Other|5|||
145242972|NCT00563368|523735509|FG001|Overall Study|Other|5|||
145242973|NCT00563368|523735510|FG002|Overall Study|Other|3|||
145242974|NCT00563368|523735511|FG003|Overall Study|Other|4|||
145242975|NCT00563368|523735512|FG004|Overall Study|Other|4|||
145242976|NCT00563368|523735513|FG005|Overall Study|Other|4|||
145242977|NCT00563368|523735514|FG006|Overall Study|Other|0|||
145242978|NCT01061567|523735515|FG000|Overall Study|Adverse Event|32|||
145242979|NCT01061567|523735515|FG000|Overall Study|Death|2|||
145242980|NCT01061567|523735515|FG000|Overall Study|Lack of Efficacy|3|||
145242981|NCT01061567|523735515|FG000|Overall Study|Lost to Follow-up|24|||
145242982|NCT01061567|523735515|FG000|Overall Study|Protocol Violation|1|||
145242983|NCT01061567|523735515|FG000|Overall Study|Withdrawal by Subject|11|||
145242984|NCT01061567|523735515|FG000|Overall Study|Other reason than stated above|3|||
145242985|NCT02640755|523735516|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
145242986|NCT02640755|523735517|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
145242987|NCT02640755|523735516|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
145242988|NCT02640755|523735517|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
145242989|NCT02640755|523735516|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
145242990|NCT02640755|523735517|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
145242991|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
145242992|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
145296673|NCT00150462|523937838|FG008|Overall Study|Physician Decision|0|||
145296674|NCT00150462|523937839|FG009|Overall Study|Physician Decision|0|||
145296675|NCT00150462|523937840|FG010|Overall Study|Physician Decision|0|||
145296676|NCT00150462|523937830|FG000|Overall Study|Other|0|||
145296677|NCT00150462|523937831|FG001|Overall Study|Other|0|||
145296678|NCT00150462|523937832|FG002|Overall Study|Other|0|||
145296679|NCT00150462|523937833|FG003|Overall Study|Other|0|||
145296680|NCT00150462|523937834|FG004|Overall Study|Other|0|||
145296681|NCT00150462|523937835|FG005|Overall Study|Other|0|||
145296682|NCT00150462|523937836|FG006|Overall Study|Other|0|||
145296683|NCT00150462|523937837|FG007|Overall Study|Other|0|||
145296684|NCT00150462|523937838|FG008|Overall Study|Other|0|||
145296685|NCT00150462|523937839|FG009|Overall Study|Other|1|||
145296686|NCT00150462|523937840|FG010|Overall Study|Other|1|||
145296687|NCT00569374|523937843|FG000|Overall Study|Withdrawal by Subject|4|||
145296688|NCT04638153|523937844|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145296689|NCT04638153|523937845|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145296690|NCT04638153|523937846|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145296691|NCT04638153|523937844|FG000|Overall Study|Study terminated by sponsor|4|||
145296692|NCT04638153|523937845|FG001|Overall Study|Study terminated by sponsor|2|||
145296693|NCT04638153|523937846|FG002|Overall Study|Study terminated by sponsor|14|||
145296694|NCT01434693|523937849|FG000|Overall Study|Adverse Event|1|||
145296695|NCT01434693|523937850|FG001|Overall Study|Adverse Event|0|||
145296696|NCT01434693|523937851|FG002|Overall Study|Adverse Event|0|||
145296697|NCT01434693|523937852|FG003|Overall Study|Adverse Event|0|||
145296698|NCT01434693|523937849|FG000|Overall Study|Withdrawal by Subject|1|||
145296699|NCT01434693|523937850|FG001|Overall Study|Withdrawal by Subject|0|||
145296700|NCT01434693|523937851|FG002|Overall Study|Withdrawal by Subject|1|||
145296701|NCT01434693|523937852|FG003|Overall Study|Withdrawal by Subject|1|||
145242993|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
145242994|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
145242995|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
145242996|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
145296702|NCT01434693|523937849|FG000|Overall Study|Lost to Follow-up|1|||
145296703|NCT01434693|523937850|FG001|Overall Study|Lost to Follow-up|0|||
145296704|NCT01434693|523937851|FG002|Overall Study|Lost to Follow-up|0|||
145242997|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
145242998|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
145242999|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
145296705|NCT01434693|523937852|FG003|Overall Study|Lost to Follow-up|0|||
145296706|NCT04006171|523937853|FG000|Overall Study|Withdrawal by Subject|8|||
145296707|NCT04006171|523937854|FG001|Overall Study|Withdrawal by Subject|7|||
145296708|NCT04006171|523937853|FG000|Overall Study|missing serum samples|2|||
145243000|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
145243001|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
145243002|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
145243003|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
145243004|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
145243005|NCT03434041|523735518|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
145243006|NCT03434041|523735519|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
145243007|NCT03434041|523735518|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
145243008|NCT03434041|523735519|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
145243009|NCT03434041|523735518|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
145243010|NCT03434041|523735519|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
145243011|NCT03434041|523735518|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
145243012|NCT03434041|523735519|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
145243013|NCT03447821|523735520|FG000|Overall Study|Withdrawal by Subject|1|||
145243014|NCT03447821|523735521|FG001|Overall Study|Withdrawal by Subject|1|||
145243015|NCT03447821|523735522|FG002|Overall Study|Withdrawal by Subject|0|||
145243016|NCT03447821|523735520|FG000|Overall Study|Lost to Follow-up|0|||
145243017|NCT03447821|523735521|FG001|Overall Study|Lost to Follow-up|0|||
145243018|NCT03447821|523735522|FG002|Overall Study|Lost to Follow-up|1|||
145243019|NCT01732107|523735525|FG000|Overall Study|Adverse Event|2|||
145243020|NCT01732107|523735525|FG000|Overall Study|Disease Progression|8|||
145243021|NCT01732107|523735525|FG000|Overall Study|Physician Decision|1|||
145243022|NCT01732107|523735525|FG000|Overall Study|Withdrawal by Subject|2|||
145243023|NCT02959190|523735526|FG000|Open Label|Adverse Event|5|||
145243024|NCT02959190|523735527|FG001|Open Label|Adverse Event|7|||
145243025|NCT02959190|523735528|FG002|Open Label|Adverse Event|3|||
145243026|NCT02959190|523735529|FG003|Open Label|Adverse Event|4|||
145243027|NCT02959190|523735526|FG000|Open Label|Pregnancy|0|||
145243028|NCT02959190|523735527|FG001|Open Label|Pregnancy|1|||
145243029|NCT02959190|523735528|FG002|Open Label|Pregnancy|0|||
145243030|NCT02959190|523735529|FG003|Open Label|Pregnancy|0|||
145243031|NCT02959190|523735526|FG000|Open Label|Withdrawal by Subject|2|||
145243032|NCT02959190|523735527|FG001|Open Label|Withdrawal by Subject|8|||
145243033|NCT02959190|523735528|FG002|Open Label|Withdrawal by Subject|0|||
145243034|NCT02959190|523735529|FG003|Open Label|Withdrawal by Subject|0|||
145243035|NCT02959190|523735526|FG000|Open Label|Physician Decision|0|||
145243036|NCT02959190|523735527|FG001|Open Label|Physician Decision|0|||
145243037|NCT02959190|523735528|FG002|Open Label|Physician Decision|1|||
145243038|NCT02959190|523735529|FG003|Open Label|Physician Decision|0|||
145243039|NCT02959190|523735526|FG000|Open Label|Protocol Violation|0|||
145243040|NCT02959190|523735527|FG001|Open Label|Protocol Violation|0|||
145243041|NCT02959190|523735528|FG002|Open Label|Protocol Violation|0|||
145243042|NCT02959190|523735529|FG003|Open Label|Protocol Violation|2|||
145243043|NCT02959190|523735526|FG000|Post Treatment Follow Up|Adverse Event|1|||
145243044|NCT02959190|523735527|FG001|Post Treatment Follow Up|Adverse Event|1|||
145243045|NCT02959190|523735528|FG002|Post Treatment Follow Up|Adverse Event|0|||
145243046|NCT02959190|523735529|FG003|Post Treatment Follow Up|Adverse Event|0|||
145243047|NCT02959190|523735526|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
145243048|NCT02959190|523735527|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
145243049|NCT02959190|523735528|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
145243050|NCT02959190|523735529|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
145243051|NCT04445688|523735530|FG000|Washout (One Week)|Adverse Event|2|||
145243052|NCT04445688|523735530|FG000|Washout (One Week)|Withdrawal by Subject|1|||
145243053|NCT01235507|523735533|FG000|Overall Study|Adverse Event|1|||
145243054|NCT01235507|523735533|FG000|Overall Study|Withdrawal by Subject|1|||
145243055|NCT02017704|523735539|FG000|Overall Study|Withdrawal by Subject|2|||
145243056|NCT02017704|523735540|FG001|Overall Study|Withdrawal by Subject|0|||
145243057|NCT01928082|523735542|FG000|Overall Study|Study terminated.|1|||
145243058|NCT01815580|523735543|FG000|Overall Study|Lost to Follow-up|4|||
145243059|NCT01815580|523735544|FG001|Overall Study|Lost to Follow-up|7|||
145243060|NCT01815580|523735543|FG000|Overall Study|Withdrawal by Subject|3|||
145243061|NCT01815580|523735544|FG001|Overall Study|Withdrawal by Subject|4|||
145243062|NCT01815580|523735543|FG000|Overall Study|Excluded from analysis|5|||
145243063|NCT01815580|523735544|FG001|Overall Study|Excluded from analysis|4|||
145243064|NCT00166517|523735548|FG000|Overall Study|Lost to Follow-up|1|||
145243065|NCT00166517|523735549|FG001|Overall Study|Lost to Follow-up|0|||
145243066|NCT00166517|523735548|FG000|Overall Study|Protocol Violation|4|||
145243067|NCT00166517|523735549|FG001|Overall Study|Protocol Violation|1|||
145243068|NCT00166517|523735548|FG000|Overall Study|Withdrawal by Subject|0|||
145243069|NCT00166517|523735549|FG001|Overall Study|Withdrawal by Subject|1|||
145243070|NCT03094611|523735553|FG000|Overall Study|Lack of Efficacy|1|||
145243071|NCT03094611|523735553|FG000|Overall Study|Stem Cell Transplant|1|||
145296709|NCT04006171|523937854|FG001|Overall Study|missing serum samples|2|||
145243072|NCT00842361|523735554|FG000|Overall Study|Protocol Violation|1|||
145243073|NCT00842361|523735555|FG001|Overall Study|Protocol Violation|0|||
145243074|NCT00842361|523735554|FG000|Overall Study|Unclassified|0|||
145243075|NCT00842361|523735555|FG001|Overall Study|Unclassified|2|||
145243076|NCT02186561|523735556|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
145243077|NCT02186561|523735556|FG000|Enrollment|Enrollment Cap Reached|5|||
145243078|NCT02186561|523735556|FG000|Enrollment|Insurance Denial|2|||
145243079|NCT02186561|523735556|FG000|Enrollment|Withdrawal by Subject|2|||
145243080|NCT02186561|523735556|FG000|Enrollment|Investigator Withdrew Consent|1|||
145243081|NCT02186561|523735556|FG000|30-Day Post Index Procedure Visit|Death|1|||
145243082|NCT02186561|523735556|FG000|1- Year Post Index Procedure Visit|Death|1|||
145243083|NCT02186561|523735556|FG000|1- Year Post Index Procedure Visit|Missed|1|||
145243084|NCT02460978|523735558|FG000|Overall Study|Adverse Event|17|||
145243085|NCT02460978|523735559|FG001|Overall Study|Adverse Event|11|||
145243086|NCT02460978|523735560|FG002|Overall Study|Adverse Event|11|||
145243087|NCT02460978|523735558|FG000|Overall Study|Withdrawal by Subject|5|||
145243088|NCT02460978|523735559|FG001|Overall Study|Withdrawal by Subject|5|||
145243089|NCT02460978|523735560|FG002|Overall Study|Withdrawal by Subject|14|||
145243090|NCT02460978|523735558|FG000|Overall Study|Lost to Follow-up|2|||
145243091|NCT02460978|523735559|FG001|Overall Study|Lost to Follow-up|3|||
145243092|NCT02460978|523735560|FG002|Overall Study|Lost to Follow-up|1|||
145243093|NCT02460978|523735558|FG000|Overall Study|Protocol Violation|1|||
145243094|NCT02460978|523735559|FG001|Overall Study|Protocol Violation|1|||
145243095|NCT02460978|523735560|FG002|Overall Study|Protocol Violation|1|||
145243096|NCT02460978|523735558|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
145243097|NCT02460978|523735559|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
145243098|NCT02460978|523735560|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
145243099|NCT02460978|523735558|FG000|Overall Study|Pregnancy|0|||
145243100|NCT02460978|523735559|FG001|Overall Study|Pregnancy|0|||
145243101|NCT02460978|523735560|FG002|Overall Study|Pregnancy|2|||
145243102|NCT00588523|523735564|FG000|Overall Study|Not treated|3|||
145243103|NCT01459068|523735569|FG000|Overall Study|Withdrawal by Subject|8|||
145243104|NCT01459068|523735570|FG001|Overall Study|Withdrawal by Subject|18|||
145243105|NCT01459068|523735569|FG000|Overall Study|Lost to Follow-up|31|||
145243106|NCT01459068|523735570|FG001|Overall Study|Lost to Follow-up|15|||
145243107|NCT01459068|523735569|FG000|Overall Study|Death|0|||
145243108|NCT01459068|523735570|FG001|Overall Study|Death|1|||
145243109|NCT02023112|523735571|FG000|Overall Study|Withdrawal by Subject|2|||
145243110|NCT02023112|523735572|FG001|Overall Study|Withdrawal by Subject|1|||
145243111|NCT01015820|523735573|FG000|Overall Study|Suboptimal measurements|1|||
145243112|NCT01015820|523735574|FG001|Overall Study|Suboptimal measurements|0|||
145243113|NCT01313078|523735575|FG000|Overall Study|Death|1|||
145243114|NCT01313078|523735575|FG000|Overall Study|Discontinued study drug|1|||
145243115|NCT01313078|523735575|FG000|Overall Study|Withdrawal by Subject|1|||
145243116|NCT03136484|523735576|FG000|Overall Study|Withdrawal by Subject|19|||
145243117|NCT03136484|523735577|FG001|Overall Study|Withdrawal by Subject|14|||
145243118|NCT03136484|523735576|FG000|Overall Study|Lost to Follow-up|7|||
145243119|NCT03136484|523735577|FG001|Overall Study|Lost to Follow-up|8|||
145243120|NCT03136484|523735576|FG000|Overall Study|Death|1|||
145243121|NCT03136484|523735577|FG001|Overall Study|Death|0|||
145243122|NCT01449955|523735582|FG000|Overall Study|Withdrawal by Subject|1|||
145243123|NCT01449955|523735583|FG001|Overall Study|Withdrawal by Subject|2|||
145243124|NCT01601470|523735584|FG000|Period 2 - LCZ696|Physician Decision|1|||
145243125|NCT01176240|523735589|FG000|Study 306A|Lack of Efficacy|2|||
145243126|NCT01176240|523735590|FG001|Study 306A|Lack of Efficacy|1|||
145243127|NCT01176240|523735589|FG000|Study 306A|Protocol Violation|0|||
145243128|NCT01176240|523735590|FG001|Study 306A|Protocol Violation|1|||
145243129|NCT01176240|523735589|FG000|Study 306A|Withdrawal by Subject|0|||
145243130|NCT01176240|523735590|FG001|Study 306A|Withdrawal by Subject|1|||
145243131|NCT01176240|523735589|FG000|Study 306A|Stop due to diverse problems|1|||
145243132|NCT01176240|523735590|FG001|Study 306A|Stop due to diverse problems|0|||
145243133|NCT01176240|523735589|FG000|Study 306B|Lack of Efficacy|5|||
145243134|NCT01176240|523735590|FG001|Study 306B|Lack of Efficacy|3|||
145243135|NCT01176240|523735589|FG000|Study 306B|Adverse Event|10|||
145243136|NCT01176240|523735590|FG001|Study 306B|Adverse Event|5|||
145243137|NCT01176240|523735589|FG000|Study 306B|Protocol Violation|2|||
145243138|NCT01176240|523735590|FG001|Study 306B|Protocol Violation|3|||
145243139|NCT01176240|523735589|FG000|Study 306B|Withdrawal by Subject|4|||
145296710|NCT04006171|523937853|FG000|Overall Study|insufficient sample volume|2|||
145296711|NCT04006171|523937854|FG001|Overall Study|insufficient sample volume|3|||
145296712|NCT00912288|523937855|FG000|Overall Study|Death|0|||
145296713|NCT00912288|523937856|FG001|Overall Study|Death|1|||
145296714|NCT00912288|523937855|FG000|Overall Study|Adverse Event|1|||
145296715|NCT00912288|523937856|FG001|Overall Study|Adverse Event|1|||
145296716|NCT00912288|523937855|FG000|Overall Study|Lost to Follow-up|1|||
145296717|NCT00912288|523937856|FG001|Overall Study|Lost to Follow-up|0|||
145296718|NCT00912288|523937855|FG000|Overall Study|Protocol Violation|1|||
145296719|NCT00912288|523937856|FG001|Overall Study|Protocol Violation|0|||
145296720|NCT00912288|523937855|FG000|Overall Study|Withdrawal by Subject|3|||
145296721|NCT00912288|523937856|FG001|Overall Study|Withdrawal by Subject|3|||
145296722|NCT00912288|523937855|FG000|Overall Study|Study terminated by sponsor|34|||
145620085|NCT01349907|525123664|FG001|Overall Study|Withdrawal by Subject|8|||
145620086|NCT01349907|525123663|FG000|Overall Study|Protocol Violation|33|||
145620087|NCT01349907|525123664|FG001|Overall Study|Protocol Violation|13|||
145620088|NCT01349907|525123663|FG000|Overall Study|Administrative|1|||
145296723|NCT00912288|523937856|FG001|Overall Study|Study terminated by sponsor|35|||
145296724|NCT00912288|523937855|FG000|Overall Study|Other|1|||
145296725|NCT00912288|523937856|FG001|Overall Study|Other|0|||
145296726|NCT01440283|523937857|FG000|Overall Study|Death|3|||
145296727|NCT01440283|523937857|FG000|Overall Study|Withdrawal by Subject|4|||
145296728|NCT01440283|523937857|FG000|Overall Study|Physician Decision|3|||
145296729|NCT02087904|523937866|FG000|Overall Study|Did Not Receive Study Drug|0|||
145296730|NCT02087904|523937867|FG001|Overall Study|Did Not Receive Study Drug|0|||
145296731|NCT02087904|523937868|FG002|Overall Study|Did Not Receive Study Drug|2|||
145296732|NCT02087904|523937869|FG003|Overall Study|Did Not Receive Study Drug|1|||
145296733|NCT02087904|523937866|FG000|Overall Study|Adverse Event|8|||
145296734|NCT02087904|523937867|FG001|Overall Study|Adverse Event|4|||
145296735|NCT02087904|523937868|FG002|Overall Study|Adverse Event|4|||
145296736|NCT02087904|523937869|FG003|Overall Study|Adverse Event|12|||
145296737|NCT02087904|523937866|FG000|Overall Study|Lack of Efficacy|3|||
145296738|NCT02087904|523937867|FG001|Overall Study|Lack of Efficacy|6|||
145296739|NCT02087904|523937868|FG002|Overall Study|Lack of Efficacy|3|||
145296740|NCT02087904|523937869|FG003|Overall Study|Lack of Efficacy|2|||
145296741|NCT02087904|523937866|FG000|Overall Study|Other|6|||
145296742|NCT02087904|523937867|FG001|Overall Study|Other|2|||
145296743|NCT02087904|523937868|FG002|Overall Study|Other|4|||
145296744|NCT02087904|523937869|FG003|Overall Study|Other|4|||
145296745|NCT02087904|523937866|FG000|Overall Study|Withdrawal by Subject|8|||
145296746|NCT02087904|523937867|FG001|Overall Study|Withdrawal by Subject|3|||
145296747|NCT02087904|523937868|FG002|Overall Study|Withdrawal by Subject|7|||
145296748|NCT02087904|523937869|FG003|Overall Study|Withdrawal by Subject|4|||
145296749|NCT02087904|523937866|FG000|Overall Study|Lost to Follow-up|0|||
145296750|NCT02087904|523937867|FG001|Overall Study|Lost to Follow-up|4|||
145296751|NCT02087904|523937868|FG002|Overall Study|Lost to Follow-up|2|||
145296752|NCT02087904|523937869|FG003|Overall Study|Lost to Follow-up|2|||
145296753|NCT03099538|523937871|FG000|Overall Study|Lack of Efficacy|3|||
145296754|NCT01196052|523937872|FG000|Overall Study|Adverse Event|9|||
145296755|NCT01196052|523937872|FG000|Overall Study|Lost to Follow-up|1|||
145296756|NCT01196052|523937872|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
145296757|NCT01196052|523937872|FG000|Overall Study|Reason not Specified|5|||
145296758|NCT01196052|523937872|FG000|Overall Study|Withdrawal by Subject|6|||
145620089|NCT01349907|525123664|FG001|Overall Study|Administrative|1|||
145620090|NCT04004208|525123667|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145620091|NCT04004208|525123668|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145620092|NCT04004208|525123667|FG000|Overall Study|Death|3|||
145296759|NCT02178722|523937873|FG000|Overall Study|Withdrawal by Subject|0|||
145296760|NCT02178722|523937874|FG001|Overall Study|Withdrawal by Subject|0|||
145296761|NCT02178722|523937875|FG002|Overall Study|Withdrawal by Subject|0|||
145296762|NCT02178722|523937876|FG003|Overall Study|Withdrawal by Subject|2|||
145296763|NCT02178722|523937877|FG004|Overall Study|Withdrawal by Subject|33|||
145296764|NCT02178722|523937873|FG000|Overall Study|Death|2|||
145296765|NCT02178722|523937874|FG001|Overall Study|Death|13|||
145296766|NCT02178722|523937875|FG002|Overall Study|Death|12|||
145296767|NCT02178722|523937876|FG003|Overall Study|Death|12|||
145296768|NCT02178722|523937877|FG004|Overall Study|Death|205|||
145296769|NCT02178722|523937873|FG000|Overall Study|Lost to Follow-up|0|||
145296770|NCT02178722|523937874|FG001|Overall Study|Lost to Follow-up|0|||
145296771|NCT02178722|523937875|FG002|Overall Study|Lost to Follow-up|0|||
145296772|NCT02178722|523937876|FG003|Overall Study|Lost to Follow-up|2|||
145296773|NCT02178722|523937877|FG004|Overall Study|Lost to Follow-up|11|||
145296774|NCT02178722|523937873|FG000|Overall Study|Study terminated by Sponsor|2|||
145296775|NCT02178722|523937874|FG001|Overall Study|Study terminated by Sponsor|7|||
145296776|NCT02178722|523937875|FG002|Overall Study|Study terminated by Sponsor|6|||
145296777|NCT02178722|523937876|FG003|Overall Study|Study terminated by Sponsor|4|||
145296778|NCT02178722|523937877|FG004|Overall Study|Study terminated by Sponsor|128|||
145296779|NCT02178722|523937873|FG000|Overall Study|Physician Decision|0|||
145296780|NCT02178722|523937874|FG001|Overall Study|Physician Decision|0|||
145296781|NCT02178722|523937875|FG002|Overall Study|Physician Decision|0|||
145563926|NCT01480076|524924081|FG000|Overall Study|Run-in Failure|52|||
145563927|NCT01480076|524924081|FG000|Overall Study|Adverse Event|39|||
145563928|NCT01480076|524924081|FG000|Overall Study|Death|2|||
145563929|NCT01480076|524924081|FG000|Overall Study|Disease Progression|5|||
145563930|NCT01480076|524924081|FG000|Overall Study|Non-compliance With Study Protocol|15|||
145563931|NCT01480076|524924081|FG000|Overall Study|Withdrawal by Subject|105|||
145563932|NCT01480076|524924081|FG000|Overall Study|Lost to Follow-up|7|||
145563933|NCT01480076|524924081|FG000|Overall Study|Investigator Decision|13|||
145563934|NCT01480076|524924081|FG000|Overall Study|Other|52|||
145563935|NCT02503332|524924082|FG000|Overall Study|Adverse Event|17|||
145563936|NCT02503332|524924083|FG001|Overall Study|Adverse Event|5|||
145563937|NCT02503332|524924084|FG002|Overall Study|Adverse Event|3|||
145620093|NCT04004208|525123668|FG001|Overall Study|Death|0|||
145296782|NCT02178722|523937876|FG003|Overall Study|Physician Decision|0|||
145296783|NCT02178722|523937877|FG004|Overall Study|Physician Decision|3|||
145296784|NCT02178722|523937873|FG000|Overall Study|Other|0|||
145296785|NCT02178722|523937874|FG001|Overall Study|Other|0|||
145296786|NCT02178722|523937875|FG002|Overall Study|Other|0|||
145296787|NCT02178722|523937876|FG003|Overall Study|Other|0|||
145296788|NCT02178722|523937877|FG004|Overall Study|Other|2|||
145296789|NCT00440557|523937878|FG000|Overall Study|Withdrawal by Subject|10|||
145296790|NCT00440557|523937879|FG001|Overall Study|Withdrawal by Subject|5|||
145563938|NCT02503332|524924085|FG003|Overall Study|Adverse Event|1|||
145563939|NCT02503332|524924082|FG000|Overall Study|Investigator's Decision|5|||
145563940|NCT02503332|524924083|FG001|Overall Study|Investigator's Decision|1|||
145243140|NCT01176240|523735590|FG001|Study 306B|Withdrawal by Subject|1|||
145243141|NCT01176240|523735589|FG000|Study 306B|Physician Decision|2|||
145243142|NCT01176240|523735590|FG001|Study 306B|Physician Decision|1|||
145243143|NCT01176240|523735589|FG000|Study 306B|Supine Hypertension|1|||
145243144|NCT01176240|523735590|FG001|Study 306B|Supine Hypertension|2|||
145243145|NCT01176240|523735589|FG000|Study 306B|Lost to Follow-up|0|||
145243146|NCT01176240|523735590|FG001|Study 306B|Lost to Follow-up|1|||
145243147|NCT01176240|523735589|FG000|Study 306B|withdrew prior to dosing|2|||
145243148|NCT01176240|523735590|FG001|Study 306B|withdrew prior to dosing|1|||
145243149|NCT03627494|523735591|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
145243150|NCT03627494|523735592|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243151|NCT03627494|523735593|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
145243152|NCT03627494|523735594|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243153|NCT03627494|523735595|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243154|NCT03627494|523735596|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243155|NCT03627494|523735597|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243156|NCT03627494|523735598|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243157|NCT03627494|523735599|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243158|NCT03627494|523735600|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243159|NCT03627494|523735601|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243160|NCT03627494|523735602|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
145243161|NCT03627494|523735591|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243162|NCT03627494|523735592|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243163|NCT03627494|523735593|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243164|NCT03627494|523735594|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243165|NCT03627494|523735595|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243166|NCT03627494|523735596|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243167|NCT03627494|523735597|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243168|NCT03627494|523735598|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243169|NCT03627494|523735599|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
145243170|NCT03627494|523735600|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243171|NCT03627494|523735601|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243172|NCT03627494|523735602|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
145243173|NCT03627494|523735591|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243174|NCT03627494|523735592|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243175|NCT03627494|523735593|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243176|NCT03627494|523735594|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243177|NCT03627494|523735595|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243178|NCT03627494|523735596|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243179|NCT03627494|523735597|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243180|NCT03627494|523735598|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243181|NCT03627494|523735599|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
145243182|NCT03627494|523735600|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
145296791|NCT00440557|523937880|FG002|Overall Study|Withdrawal by Subject|11|||
145563941|NCT02503332|524924084|FG002|Overall Study|Investigator's Decision|0|||
145243183|NCT03627494|523735601|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
145243184|NCT03627494|523735602|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
145563942|NCT02503332|524924085|FG003|Overall Study|Investigator's Decision|0|||
145563943|NCT02503332|524924082|FG000|Overall Study|Sponsor's Decision|1|||
145563944|NCT02503332|524924083|FG001|Overall Study|Sponsor's Decision|0|||
145563945|NCT02503332|524924084|FG002|Overall Study|Sponsor's Decision|0|||
145563946|NCT02503332|524924085|FG003|Overall Study|Sponsor's Decision|1|||
145243185|NCT03906136|523737623|FG000|Overall Study|Adverse Event|1|||
145243186|NCT03906136|523737624|FG001|Overall Study|Adverse Event|0|||
145243187|NCT03906136|523737623|FG000|Overall Study|Lost to Follow-up|7|||
145243188|NCT03906136|523737624|FG001|Overall Study|Lost to Follow-up|4|||
145243189|NCT03906136|523737623|FG000|Overall Study|Physician Decision|1|||
145243190|NCT03906136|523737624|FG001|Overall Study|Physician Decision|0|||
145243191|NCT03906136|523737623|FG000|Overall Study|Withdrawal by Subject|3|||
145243192|NCT03906136|523737624|FG001|Overall Study|Withdrawal by Subject|7|||
145563947|NCT02503332|524924082|FG000|Overall Study|Subject Request|6|||
145243193|NCT00937326|523737626|FG000|Overall Study|Adverse Event|0|||
145243194|NCT00937326|523737627|FG001|Overall Study|Adverse Event|3|||
145243195|NCT00937326|523737628|FG002|Overall Study|Adverse Event|1|||
145243196|NCT00937326|523737629|FG003|Overall Study|Adverse Event|1|||
145296792|NCT00440557|523937878|FG000|Overall Study|Lost to Follow-up|1|||
145243197|NCT00937326|523737630|FG004|Overall Study|Adverse Event|2|||
145243198|NCT00937326|523737626|FG000|Overall Study|Death|0|||
145243199|NCT00937326|523737627|FG001|Overall Study|Death|0|||
145243200|NCT00937326|523737628|FG002|Overall Study|Death|1|||
145243201|NCT00937326|523737629|FG003|Overall Study|Death|0|||
145243202|NCT00937326|523737630|FG004|Overall Study|Death|0|||
145243203|NCT00937326|523737626|FG000|Overall Study|Withdrawal by Subject|3|||
145243204|NCT00937326|523737627|FG001|Overall Study|Withdrawal by Subject|4|||
145243205|NCT00937326|523737628|FG002|Overall Study|Withdrawal by Subject|1|||
145243206|NCT00937326|523737629|FG003|Overall Study|Withdrawal by Subject|4|||
145243207|NCT00937326|523737630|FG004|Overall Study|Withdrawal by Subject|3|||
145243208|NCT00937326|523737626|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
145243209|NCT00937326|523737627|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
145243210|NCT00937326|523737628|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
145243211|NCT00937326|523737629|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
145243212|NCT00937326|523737630|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
145243213|NCT02578992|523737631|FG000|Overall Study|equipment not available or malfunction|3|||
145243214|NCT02578992|523737632|FG001|Overall Study|equipment not available or malfunction|3|||
145243215|NCT00790218|523737633|FG000|Overall Study|Death|1|||
145243216|NCT00790218|523737634|FG001|Overall Study|Death|0|||
145243217|NCT00790218|523737635|FG002|Overall Study|Death|0|||
145243218|NCT02443155|523737636|FG000|Overall Study|Adverse Event|3|||
145243219|NCT02443155|523737637|FG001|Overall Study|Adverse Event|4|||
145243220|NCT02443155|523737638|FG002|Overall Study|Adverse Event|1|||
145243221|NCT02443155|523737639|FG003|Overall Study|Adverse Event|2|||
145243222|NCT02443155|523737636|FG000|Overall Study|Unclassified|0|||
145243223|NCT02443155|523737637|FG001|Overall Study|Unclassified|0|||
145243224|NCT02443155|523737638|FG002|Overall Study|Unclassified|2|||
145243225|NCT02443155|523737639|FG003|Overall Study|Unclassified|1|||
145243226|NCT02443155|523737636|FG000|Overall Study|Withdrawal by Subject|4|||
145243227|NCT02443155|523737637|FG001|Overall Study|Withdrawal by Subject|7|||
145243228|NCT02443155|523737638|FG002|Overall Study|Withdrawal by Subject|3|||
145243229|NCT02443155|523737639|FG003|Overall Study|Withdrawal by Subject|9|||
145243230|NCT02443155|523737636|FG000|Overall Study|Pregnancy|3|||
145243231|NCT02443155|523737637|FG001|Overall Study|Pregnancy|1|||
145243232|NCT02443155|523737638|FG002|Overall Study|Pregnancy|1|||
145243233|NCT02443155|523737639|FG003|Overall Study|Pregnancy|2|||
145243234|NCT02443155|523737636|FG000|Overall Study|Lost to Follow-up|1|||
145243235|NCT02443155|523737637|FG001|Overall Study|Lost to Follow-up|2|||
145243236|NCT02443155|523737638|FG002|Overall Study|Lost to Follow-up|0|||
145243237|NCT02443155|523737639|FG003|Overall Study|Lost to Follow-up|1|||
145243238|NCT02443155|523737636|FG000|Overall Study|Protocol Violation|1|||
145243239|NCT02443155|523737637|FG001|Overall Study|Protocol Violation|0|||
145243240|NCT02443155|523737638|FG002|Overall Study|Protocol Violation|1|||
145243241|NCT02443155|523737639|FG003|Overall Study|Protocol Violation|1|||
145243242|NCT02443155|523737636|FG000|Overall Study|Death|0|||
145243243|NCT02443155|523737637|FG001|Overall Study|Death|0|||
145243244|NCT02443155|523737638|FG002|Overall Study|Death|1|||
145243245|NCT02443155|523737639|FG003|Overall Study|Death|0|||
145243246|NCT00405275|523737645|FG000|Overall Study|Death|1|||
145243247|NCT00405275|523737646|FG001|Overall Study|Death|0|||
145243248|NCT00405275|523737645|FG000|Overall Study|Lost to Follow-up|5|||
145243249|NCT00405275|523737646|FG001|Overall Study|Lost to Follow-up|1|||
145243250|NCT00405275|523737645|FG000|Overall Study|Withdrawal by Subject|7|||
145243251|NCT00405275|523737646|FG001|Overall Study|Withdrawal by Subject|9|||
145243252|NCT00405275|523737645|FG000|Overall Study|Unwilling to continue|10|||
145243253|NCT00405275|523737646|FG001|Overall Study|Unwilling to continue|9|||
145243254|NCT01308853|523737647|FG000|Overall Study|Adverse Event|1|||
145243255|NCT01308853|523737647|FG000|Overall Study|Lost to Follow-up|2|||
145243256|NCT01308853|523737647|FG000|Overall Study|Insertion of permanent implants|1|||
145243257|NCT00693420|523737652|FG000|Overall Study|Adverse Event|4|||
145243258|NCT00693420|523737653|FG001|Overall Study|Adverse Event|4|||
145243259|NCT00693420|523737652|FG000|Overall Study|Lost to Follow-up|0|||
145243260|NCT00693420|523737653|FG001|Overall Study|Lost to Follow-up|3|||
145243261|NCT00693420|523737652|FG000|Overall Study|Withdrawal by Subject|1|||
145243262|NCT00693420|523737653|FG001|Overall Study|Withdrawal by Subject|0|||
145243263|NCT00693420|523737652|FG000|Overall Study|Protocol Violation|0|||
145243264|NCT00693420|523737653|FG001|Overall Study|Protocol Violation|2|||
145243265|NCT00693420|523737652|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
145243266|NCT00693420|523737653|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
145243267|NCT00693420|523737652|FG000|Overall Study|Personal Reasons|1|||
145243268|NCT00693420|523737653|FG001|Overall Study|Personal Reasons|4|||
145243269|NCT02853123|523737654|FG000|Treatment Period 1|Adverse Event|0|||
145243270|NCT02853123|523737655|FG001|Treatment Period 1|Adverse Event|3|||
145243271|NCT02853123|523737654|FG000|Washout Period|Worsening of COPD|0|||
145243272|NCT02853123|523737655|FG001|Washout Period|Worsening of COPD|3|||
145243273|NCT02853123|523737654|FG000|Washout Period|Adverse Event|1|||
145243274|NCT02853123|523737655|FG001|Washout Period|Adverse Event|0|||
145243275|NCT03250624|523737656|FG000|Overall Study|Lack of Efficacy|1|||
145563948|NCT02503332|524924083|FG001|Overall Study|Subject Request|5|||
145563949|NCT02503332|524924084|FG002|Overall Study|Subject Request|2|||
145563950|NCT02503332|524924085|FG003|Overall Study|Subject Request|1|||
145563951|NCT02503332|524924082|FG000|Overall Study|Death|0|||
145563952|NCT02503332|524924083|FG001|Overall Study|Death|2|||
145563953|NCT02503332|524924084|FG002|Overall Study|Death|2|||
145563954|NCT02503332|524924085|FG003|Overall Study|Death|0|||
145563955|NCT02503332|524924082|FG000|Overall Study|Other|5|||
145563956|NCT02503332|524924083|FG001|Overall Study|Other|6|||
145563957|NCT02503332|524924084|FG002|Overall Study|Other|1|||
145243276|NCT03250624|523737657|FG001|Overall Study|Lack of Efficacy|4|||
145243277|NCT03250624|523737656|FG000|Overall Study|Adverse Event|0|||
145243278|NCT03250624|523737657|FG001|Overall Study|Adverse Event|1|||
145243279|NCT03250624|523737656|FG000|Overall Study|Other|1|||
145243280|NCT03250624|523737657|FG001|Overall Study|Other|2|||
145243281|NCT00106249|523737659|FG000|Overall Study|Lost to Follow-up|3|||
145243282|NCT00106249|523737660|FG001|Overall Study|Lost to Follow-up|2|||
145243283|NCT00509028|523737663|FG000|Overall Study|Adverse Event|2|||
145243284|NCT00509028|523737664|FG001|Overall Study|Adverse Event|0|||
145243285|NCT00509028|523737663|FG000|Overall Study|Withdrawal by Subject|4|||
145243286|NCT00509028|523737664|FG001|Overall Study|Withdrawal by Subject|3|||
145243287|NCT00509028|523737663|FG000|Overall Study|Lost to Follow-up|0|||
145243288|NCT00509028|523737664|FG001|Overall Study|Lost to Follow-up|1|||
145243289|NCT00509028|523737663|FG000|Overall Study|Protocol Violation|4|||
145243290|NCT00509028|523737664|FG001|Overall Study|Protocol Violation|2|||
145243291|NCT00509028|523737663|FG000|Overall Study|Non-compliance|2|||
145243292|NCT00509028|523737664|FG001|Overall Study|Non-compliance|1|||
145243293|NCT00948428|523737665|FG000|Overall Study|Withdrawal by Subject|6|||
145243294|NCT00948428|523737666|FG001|Overall Study|Withdrawal by Subject|12|||
145243295|NCT00948428|523737667|FG002|Overall Study|Withdrawal by Subject|7|||
145243296|NCT00948428|523737665|FG000|Overall Study|Adverse Event|6|||
145243297|NCT00948428|523737666|FG001|Overall Study|Adverse Event|3|||
145243298|NCT00948428|523737667|FG002|Overall Study|Adverse Event|0|||
145243299|NCT00948428|523737665|FG000|Overall Study|Lost to Follow-up|2|||
145243300|NCT00948428|523737666|FG001|Overall Study|Lost to Follow-up|1|||
145243301|NCT00948428|523737667|FG002|Overall Study|Lost to Follow-up|1|||
145243302|NCT00948428|523737665|FG000|Overall Study|Death|2|||
145243303|NCT00948428|523737666|FG001|Overall Study|Death|0|||
145243304|NCT00948428|523737667|FG002|Overall Study|Death|0|||
145243305|NCT00948428|523737665|FG000|Overall Study|Intercurrent Illness|1|||
145243306|NCT00948428|523737666|FG001|Overall Study|Intercurrent Illness|0|||
145243307|NCT00948428|523737667|FG002|Overall Study|Intercurrent Illness|0|||
145243308|NCT00948428|523737665|FG000|Overall Study|Non-compliance|1|||
145243309|NCT00948428|523737666|FG001|Overall Study|Non-compliance|2|||
145243310|NCT00948428|523737667|FG002|Overall Study|Non-compliance|0|||
145243311|NCT05283499|523737670|FG000|Overall Study|Did not receive intervention|1|||
145243312|NCT05283499|523737671|FG001|Overall Study|Did not receive intervention|2|||
145296793|NCT00440557|523937879|FG001|Overall Study|Lost to Follow-up|2|||
145296794|NCT00440557|523937880|FG002|Overall Study|Lost to Follow-up|6|||
145296795|NCT00440557|523937878|FG000|Overall Study|Adverse Event|3|||
145296796|NCT00440557|523937879|FG001|Overall Study|Adverse Event|3|||
145296797|NCT00440557|523937880|FG002|Overall Study|Adverse Event|5|||
145296798|NCT00440557|523937878|FG000|Overall Study|Death|2|||
145296799|NCT00440557|523937879|FG001|Overall Study|Death|6|||
145563958|NCT02503332|524924085|FG003|Overall Study|Other|1|||
145243313|NCT02408484|523737672|FG000|Overall Study|Withdrawal by Subject|3|||
145243314|NCT02408484|523737672|FG000|Overall Study|Not treated during study period|1|||
145243315|NCT01117181|523737674|FG000|Overall Study|Lost to Follow-up|1|||
145243316|NCT01117181|523737675|FG001|Overall Study|Lost to Follow-up|0|||
145243317|NCT01117181|523737674|FG000|Overall Study|Withdrawal by Subject|0|||
145243318|NCT01117181|523737675|FG001|Overall Study|Withdrawal by Subject|2|||
145296800|NCT00440557|523937880|FG002|Overall Study|Death|3|||
145296801|NCT00440557|523937878|FG000|Overall Study|Began Dialysis|4|||
145296802|NCT00440557|523937879|FG001|Overall Study|Began Dialysis|1|||
145296803|NCT00440557|523937880|FG002|Overall Study|Began Dialysis|4|||
145296804|NCT00440557|523937878|FG000|Overall Study|Principal Investigator decision|0|||
145563959|NCT01589445|524924088|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
145296805|NCT00440557|523937879|FG001|Overall Study|Principal Investigator decision|3|||
145563960|NCT01589445|524924088|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
145563961|NCT01589445|524924088|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
145243319|NCT01495689|523737680|FG000|Overall Study|Death|0|||
145243320|NCT01495689|523737681|FG001|Overall Study|Death|1|||
145243321|NCT01495689|523737680|FG000|Overall Study|Withdrawal by Subject|3|||
145243322|NCT01495689|523737681|FG001|Overall Study|Withdrawal by Subject|0|||
145243323|NCT01495689|523737680|FG000|Overall Study|Lost to Follow-up|7|||
145243324|NCT01495689|523737681|FG001|Overall Study|Lost to Follow-up|6|||
145243325|NCT05516134|523737682|FG000|Overall Study|Lost to Follow-up|1|||
145243326|NCT05516134|523737683|FG001|Overall Study|Lost to Follow-up|0|||
145243327|NCT05516134|523737684|FG002|Overall Study|Lost to Follow-up|0|||
145296806|NCT00440557|523937880|FG002|Overall Study|Principal Investigator decision|1|||
145243328|NCT00517413|523737691|FG000|Overall Study|Adverse Event|7|||
145243329|NCT00517413|523737691|FG000|Overall Study|Death|13|||
145243330|NCT00517413|523737691|FG000|Overall Study|Protocol Violation|15|||
145243331|NCT00517413|523737691|FG000|Overall Study|Withdrawal by Subject|2|||
145243332|NCT00517413|523737691|FG000|Overall Study|Failure to return|1|||
145243333|NCT00517413|523737691|FG000|Overall Study|Other-Reasons|23|||
145243334|NCT00606177|523737692|FG000|Overall Study|Adverse Event|9|||
145243335|NCT00606177|523737693|FG001|Overall Study|Adverse Event|5|||
145243336|NCT00606177|523737692|FG000|Overall Study|Lack of Efficacy|3|||
145243337|NCT00606177|523737693|FG001|Overall Study|Lack of Efficacy|7|||
145243338|NCT00606177|523737692|FG000|Overall Study|Physician Decision|1|||
145243339|NCT00606177|523737693|FG001|Overall Study|Physician Decision|0|||
145243340|NCT00606177|523737692|FG000|Overall Study|Protocol Violation|1|||
145243341|NCT00606177|523737693|FG001|Overall Study|Protocol Violation|4|||
145243342|NCT00606177|523737692|FG000|Overall Study|Withdrawal by Subject|5|||
145243343|NCT00606177|523737693|FG001|Overall Study|Withdrawal by Subject|6|||
145243344|NCT00606177|523737692|FG000|Overall Study|Progression to depressive phase|6|||
145243345|NCT00606177|523737693|FG001|Overall Study|Progression to depressive phase|1|||
145243346|NCT00606177|523737692|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
145243347|NCT00606177|523737693|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
145243348|NCT00606177|523737692|FG000|Overall Study|Change of residence or other commitments|1|||
145243349|NCT00606177|523737693|FG001|Overall Study|Change of residence or other commitments|1|||
145243350|NCT00136357|523737694|FG000|Overall Study|Withdrawal by Subject|3|||
145243351|NCT00136357|523737695|FG001|Overall Study|Withdrawal by Subject|2|||
145243352|NCT01355497|523737696|FG000|Overall Study|Death|19|||
145243353|NCT01355497|523737697|FG001|Overall Study|Death|18|||
145243354|NCT01355497|523737696|FG000|Overall Study|Lost to Follow-up|3|||
145243355|NCT01355497|523737697|FG001|Overall Study|Lost to Follow-up|0|||
145243356|NCT01355497|523737696|FG000|Overall Study|Protocol Violation|0|||
145243357|NCT01355497|523737697|FG001|Overall Study|Protocol Violation|1|||
145243358|NCT01355497|523737696|FG000|Overall Study|other-not provided|9|||
145243359|NCT01355497|523737697|FG001|Overall Study|other-not provided|4|||
145243360|NCT01355497|523737696|FG000|Overall Study|Withdrawal by Subject|12|||
145243361|NCT01355497|523737697|FG001|Overall Study|Withdrawal by Subject|20|||
145243362|NCT01355497|523737696|FG000|Overall Study|noncompliance|1|||
145243363|NCT01355497|523737697|FG001|Overall Study|noncompliance|2|||
145243364|NCT01355497|523737696|FG000|Overall Study|progressive disease|11|||
145243365|NCT01355497|523737697|FG001|Overall Study|progressive disease|8|||
145243366|NCT01355497|523737696|FG000|Overall Study|Adverse Event|11|||
145243367|NCT01355497|523737697|FG001|Overall Study|Adverse Event|10|||
145243368|NCT01548417|523737699|FG000|Overall Study|Withdrawal by Subject|0|||
145243369|NCT01548417|523737700|FG001|Overall Study|Withdrawal by Subject|2|||
145243370|NCT02057068|523737709|FG000|Overall Study|Withdrawal by Subject|2|||
145243371|NCT02057068|523737710|FG001|Overall Study|Withdrawal by Subject|2|||
145243372|NCT02057068|523737709|FG000|Overall Study|Caregiver (CG) Health|0|||
145243373|NCT02057068|523737710|FG001|Overall Study|Caregiver (CG) Health|2|||
145243374|NCT02057068|523737709|FG000|Overall Study|Carepartner (CP) Health|4|||
145243375|NCT02057068|523737710|FG001|Overall Study|Carepartner (CP) Health|2|||
145243376|NCT02057068|523737709|FG000|Overall Study|Lost to Follow-up|2|||
145243377|NCT02057068|523737710|FG001|Overall Study|Lost to Follow-up|2|||
145243378|NCT00865046|523737713|FG000|Overall Study|Lost to Follow-up|1|||
145243379|NCT00865046|523737714|FG001|Overall Study|Lost to Follow-up|4|||
145243380|NCT00865046|523737715|FG002|Overall Study|Lost to Follow-up|0|||
145243381|NCT00865046|523737713|FG000|Overall Study|Death|0|||
145296807|NCT00440557|523937878|FG000|Overall Study|Patient moved|1|||
145296808|NCT00440557|523937879|FG001|Overall Study|Patient moved|2|||
145296809|NCT00440557|523937880|FG002|Overall Study|Patient moved|1|||
145296810|NCT00440557|523937878|FG000|Overall Study|Principal Investigator's office closed|3|||
145296811|NCT00440557|523937879|FG001|Overall Study|Principal Investigator's office closed|6|||
145243382|NCT00865046|523737714|FG001|Overall Study|Death|1|||
145243383|NCT00865046|523737715|FG002|Overall Study|Death|1|||
145243384|NCT00865046|523737713|FG000|Overall Study|Withdrawal by Subject|5|||
145296812|NCT00440557|523937880|FG002|Overall Study|Principal Investigator's office closed|4|||
145296813|NCT00440557|523937878|FG000|Overall Study|Patient transferred to nursing home|0|||
145296814|NCT00440557|523937879|FG001|Overall Study|Patient transferred to nursing home|1|||
145243385|NCT00865046|523737714|FG001|Overall Study|Withdrawal by Subject|0|||
145243386|NCT00865046|523737715|FG002|Overall Study|Withdrawal by Subject|0|||
145243387|NCT04685538|523737717|FG000|Overall Study|Adverse Event|0|||
145243388|NCT04685538|523737718|FG001|Overall Study|Adverse Event|1|||
145243389|NCT04685538|523737717|FG000|Overall Study|Lost to Follow-up|0|||
145243390|NCT04685538|523737718|FG001|Overall Study|Lost to Follow-up|2|||
145243391|NCT03168555|523737720|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
145243392|NCT03168555|523737720|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
145243393|NCT03168555|523737720|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
145243394|NCT03168555|523737720|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
145243395|NCT01587274|523737723|FG000|Overall Study|Lost to Follow-up|4|||
145243396|NCT01587274|523737724|FG001|Overall Study|Lost to Follow-up|5|||
145563962|NCT01589445|524924088|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
145563963|NCT01589445|524924088|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
145563964|NCT01589445|524924088|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
145563965|NCT01589445|524924088|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
145563966|NCT01589445|524924088|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
145563967|NCT01589445|524924088|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
145563968|NCT01589445|524924088|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
145563969|NCT00325754|524924089|FG000|Overall Study|Adverse Event|4|||
145563970|NCT00325754|524924090|FG001|Overall Study|Adverse Event|1|||
145563971|NCT00600756|524924092|FG000|Analysis After 6 Months|Adverse Event|43|||
145563972|NCT00600756|524924093|FG001|Analysis After 6 Months|Adverse Event|33|||
145563973|NCT00600756|524924092|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
145563974|NCT00600756|524924093|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
145563975|NCT00600756|524924092|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
145563976|NCT00600756|524924093|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
145563977|NCT00600756|524924092|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
145563978|NCT00600756|524924093|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
145563979|NCT00600756|524924092|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
145563980|NCT00600756|524924093|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
145563981|NCT00600756|524924092|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
145563982|NCT00600756|524924093|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
145563983|NCT00600756|524924092|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
145563984|NCT00600756|524924093|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
145563985|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
145563986|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
145563987|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
145563988|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
145563989|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
145563990|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
145563991|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
145563992|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
145563993|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
145563994|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
145563995|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
145563996|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
145563997|NCT00600756|524924092|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
145563998|NCT00600756|524924093|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
145563999|NCT01826487|524924098|FG000|Overall Study|Adverse Event|1|||
145564000|NCT01826487|524924099|FG001|Overall Study|Adverse Event|1|||
145564001|NCT01826487|524924098|FG000|Overall Study|Lost to Follow-up|1|||
145564002|NCT01826487|524924099|FG001|Overall Study|Lost to Follow-up|0|||
145564003|NCT01826487|524924098|FG000|Overall Study|Withdrawal by Subject|1|||
145564004|NCT01826487|524924099|FG001|Overall Study|Withdrawal by Subject|3|||
145564005|NCT01826487|524924098|FG000|Overall Study|Protocol Violation|1|||
145564006|NCT01826487|524924099|FG001|Overall Study|Protocol Violation|1|||
145564007|NCT01358357|524924100|FG000|Open Label Phase|Adverse Event|0|||
145564008|NCT01358357|524924101|FG001|Open Label Phase|Adverse Event|0|||
145564009|NCT01358357|524924102|FG002|Open Label Phase|Adverse Event|59|||
145564010|NCT01358357|524924100|FG000|Open Label Phase|Lack of Efficacy|0|||
145564011|NCT01358357|524924101|FG001|Open Label Phase|Lack of Efficacy|0|||
145564012|NCT01358357|524924102|FG002|Open Label Phase|Lack of Efficacy|107|||
145564013|NCT01358357|524924100|FG000|Open Label Phase|Lost to Follow-up|0|||
145564014|NCT01358357|524924101|FG001|Open Label Phase|Lost to Follow-up|0|||
145564015|NCT01358357|524924102|FG002|Open Label Phase|Lost to Follow-up|76|||
145564016|NCT01358357|524924100|FG000|Open Label Phase|Protocol Violation|0|||
145564017|NCT01358357|524924101|FG001|Open Label Phase|Protocol Violation|0|||
145564018|NCT01358357|524924102|FG002|Open Label Phase|Protocol Violation|45|||
145564019|NCT01358357|524924100|FG000|Open Label Phase|Withdrawal by Subject|0|||
145564020|NCT01358357|524924101|FG001|Open Label Phase|Withdrawal by Subject|0|||
145564021|NCT01358357|524924102|FG002|Open Label Phase|Withdrawal by Subject|112|||
145564022|NCT01358357|524924100|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
145564023|NCT01358357|524924101|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
145564024|NCT01358357|524924102|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
145564025|NCT01358357|524924100|FG000|Open Label Phase|Terminated at study completion|0|||
145564026|NCT01358357|524924101|FG001|Open Label Phase|Terminated at study completion|0|||
145564027|NCT01358357|524924102|FG002|Open Label Phase|Terminated at study completion|5|||
145564028|NCT01358357|524924100|FG000|Open Label Phase|Mood episode|0|||
145564029|NCT01358357|524924101|FG001|Open Label Phase|Mood episode|0|||
145564030|NCT01358357|524924102|FG002|Open Label Phase|Mood episode|42|||
145296815|NCT00440557|523937880|FG002|Overall Study|Patient transferred to nursing home|0|||
145243397|NCT01587274|523737725|FG002|Overall Study|Lost to Follow-up|3|||
145243398|NCT01421069|523737726|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
145243399|NCT01421069|523737726|FG000|Parent Study|Failed to return|3|||
145243400|NCT01421069|523737726|FG000|Parent Study|Withdrawal by Subject|1|||
145243401|NCT01421069|523737726|FG000|Parent Study|Lost to Follow-up|2|||
145243402|NCT01421069|523737726|FG000|Parent Study|Lack of Efficacy|1|||
145243403|NCT01421069|523737726|FG000|Overall Period for Extension Study|Other|2|||
145243404|NCT01421069|523737726|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
145243405|NCT01421069|523737726|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
145243406|NCT01421069|523737726|FG000|Overall Period for Extension Study|Pregnancy|1|||
145243407|NCT01421069|523737726|FG000|Overall Period for Extension Study|Adverse Event|1|||
145243408|NCT01421069|523737726|FG000|Overall Period for Extension Study|Protocol Violation|1|||
145243409|NCT01421069|523737726|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
145243410|NCT01421069|523737726|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
145243411|NCT01421069|523737726|FG000|Active Treatment Period|Other|1|||
145243412|NCT01421069|523737726|FG000|Active Treatment Period|No longer willing to participate in study|8|||
145243413|NCT01421069|523737726|FG000|Active Treatment Period|Insufficient clinical response|1|||
145243414|NCT01421069|523737726|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
145243415|NCT01421069|523737726|FG000|Active Treatment Period|Pregnancy|1|||
145243416|NCT01421069|523737726|FG000|Active Treatment Period|Adverse Event|1|||
145243417|NCT01421069|523737726|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
145243418|NCT01421069|523737726|FG000|Active Treatment Period|Enrolled in observational period|29|||
145243419|NCT01421069|523737726|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
145243420|NCT01421069|523737726|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
145243421|NCT01421069|523737726|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
145243422|NCT01421069|523737726|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
145243423|NCT01421069|523737726|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
145243424|NCT01421069|523737726|FG000|2b. Retreatment Period|Protocol Violation|1|||
145243425|NCT01421069|523737726|FG000|Observational Period|Other|1|||
145243426|NCT01421069|523737726|FG000|Observational Period|No longer willing to participate in study|4|||
145243427|NCT01421069|523737726|FG000|Observational Period|Lost to Follow-up|3|||
145243428|NCT01641081|523737727|FG000|Period 1|Sponsor request (potential unblinding)|0|||
145243429|NCT01641081|523737728|FG001|Period 1|Sponsor request (potential unblinding)|0|||
145243430|NCT01641081|523737729|FG002|Period 1|Sponsor request (potential unblinding)|0|||
145243431|NCT01641081|523737730|FG003|Period 1|Sponsor request (potential unblinding)|0|||
145243432|NCT01641081|523737731|FG004|Period 1|Sponsor request (potential unblinding)|0|||
145243433|NCT01641081|523737732|FG005|Period 1|Sponsor request (potential unblinding)|0|||
145296816|NCT00440557|523937878|FG000|Overall Study|Patient had surgery|1|||
145296817|NCT00440557|523937879|FG001|Overall Study|Patient had surgery|0|||
145296818|NCT00440557|523937880|FG002|Overall Study|Patient had surgery|0|||
145243434|NCT01641081|523737733|FG006|Period 1|Sponsor request (potential unblinding)|1|||
145243435|NCT01641081|523737734|FG007|Period 1|Sponsor request (potential unblinding)|0|||
145243436|NCT01641081|523737735|FG008|Period 1|Sponsor request (potential unblinding)|0|||
145296819|NCT03340727|523937881|FG000|Overall Study|Death|1|||
145296820|NCT03340727|523937882|FG001|Overall Study|Death|0|||
145296821|NCT03340727|523937881|FG000|Overall Study|Lost to Follow-up|31|||
145296822|NCT03340727|523937882|FG001|Overall Study|Lost to Follow-up|35|||
145243437|NCT01641081|523737736|FG009|Period 1|Sponsor request (potential unblinding)|0|||
145243438|NCT01641081|523737727|FG000|Period 1|Protocol Violation|0|||
145296823|NCT03340727|523937881|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
145564031|NCT01358357|524924100|FG000|Double-Blind Phase|Adverse Event|8|||
145564032|NCT01358357|524924101|FG001|Double-Blind Phase|Adverse Event|5|||
145564033|NCT01358357|524924102|FG002|Double-Blind Phase|Adverse Event|0|||
145564034|NCT01358357|524924100|FG000|Double-Blind Phase|Lost to Follow-up|5|||
145564035|NCT01358357|524924101|FG001|Double-Blind Phase|Lost to Follow-up|7|||
145564036|NCT01358357|524924102|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145564037|NCT01358357|524924100|FG000|Double-Blind Phase|Protocol Violation|1|||
145564038|NCT01358357|524924101|FG001|Double-Blind Phase|Protocol Violation|11|||
145564039|NCT01358357|524924102|FG002|Double-Blind Phase|Protocol Violation|0|||
145564040|NCT01358357|524924100|FG000|Double-Blind Phase|Protocol Violation|16|||
145564041|NCT01358357|524924101|FG001|Double-Blind Phase|Protocol Violation|12|||
145564042|NCT01358357|524924102|FG002|Double-Blind Phase|Protocol Violation|0|||
145564043|NCT01358357|524924100|FG000|Double-Blind Phase|Terminated at study completion|2|||
145564044|NCT01358357|524924101|FG001|Double-Blind Phase|Terminated at study completion|0|||
145564045|NCT01358357|524924102|FG002|Double-Blind Phase|Terminated at study completion|0|||
145564046|NCT01358357|524924100|FG000|Double-Blind Phase|Recurrence of mood event|48|||
145564047|NCT01358357|524924101|FG001|Double-Blind Phase|Recurrence of mood event|64|||
145564048|NCT01358357|524924102|FG002|Double-Blind Phase|Recurrence of mood event|0|||
145564049|NCT01358357|524924100|FG000|Double-Blind Phase|Administrative|0|||
145564050|NCT01358357|524924101|FG001|Double-Blind Phase|Administrative|1|||
145564051|NCT01358357|524924102|FG002|Double-Blind Phase|Administrative|0|||
145564052|NCT00352846|524924109|FG000|Overall Study|Disease progression|0|||
145564053|NCT00352846|524924110|FG001|Overall Study|Disease progression|2|||
145564054|NCT00352846|524924109|FG000|Overall Study|Withdrawal by Subject|3|||
145564055|NCT00352846|524924110|FG001|Overall Study|Withdrawal by Subject|8|||
145564056|NCT00352846|524924109|FG000|Overall Study|Ineligible|3|||
145564057|NCT00352846|524924110|FG001|Overall Study|Ineligible|2|||
145564058|NCT00352846|524924109|FG000|Overall Study|Non-compliance|2|||
145564059|NCT00352846|524924110|FG001|Overall Study|Non-compliance|0|||
145564060|NCT00352846|524924109|FG000|Overall Study|Death|0|||
145243439|NCT01641081|523737728|FG001|Period 1|Protocol Violation|0|||
145243440|NCT01641081|523737729|FG002|Period 1|Protocol Violation|0|||
145243441|NCT01641081|523737730|FG003|Period 1|Protocol Violation|0|||
145243442|NCT01641081|523737731|FG004|Period 1|Protocol Violation|1|||
145243443|NCT01641081|523737732|FG005|Period 1|Protocol Violation|0|||
145243444|NCT01641081|523737733|FG006|Period 1|Protocol Violation|0|||
145243445|NCT01641081|523737734|FG007|Period 1|Protocol Violation|1|||
145243446|NCT01641081|523737735|FG008|Period 1|Protocol Violation|0|||
145243447|NCT01641081|523737736|FG009|Period 1|Protocol Violation|0|||
145243448|NCT01641081|523737727|FG000|Period 1|Adverse Event|1|||
145243449|NCT01641081|523737728|FG001|Period 1|Adverse Event|0|||
145243450|NCT01641081|523737729|FG002|Period 1|Adverse Event|0|||
145243451|NCT01641081|523737730|FG003|Period 1|Adverse Event|0|||
145243452|NCT01641081|523737731|FG004|Period 1|Adverse Event|0|||
145243453|NCT01641081|523737732|FG005|Period 1|Adverse Event|0|||
145243454|NCT01641081|523737733|FG006|Period 1|Adverse Event|0|||
145243455|NCT01641081|523737734|FG007|Period 1|Adverse Event|2|||
145243456|NCT01641081|523737735|FG008|Period 1|Adverse Event|0|||
145243457|NCT01641081|523737736|FG009|Period 1|Adverse Event|0|||
145243458|NCT01641081|523737727|FG000|Period 2|Adverse Event|0|||
145243459|NCT01641081|523737728|FG001|Period 2|Adverse Event|0|||
145243460|NCT01641081|523737729|FG002|Period 2|Adverse Event|0|||
145243461|NCT01641081|523737730|FG003|Period 2|Adverse Event|0|||
145243462|NCT01641081|523737731|FG004|Period 2|Adverse Event|0|||
145243463|NCT01641081|523737732|FG005|Period 2|Adverse Event|1|||
145243464|NCT01641081|523737733|FG006|Period 2|Adverse Event|0|||
145243465|NCT01641081|523737734|FG007|Period 2|Adverse Event|0|||
145243466|NCT01641081|523737735|FG008|Period 2|Adverse Event|0|||
145243467|NCT01641081|523737736|FG009|Period 2|Adverse Event|0|||
145243468|NCT01641081|523737727|FG000|Period 2|Withdrawal by Subject|0|||
145243469|NCT01641081|523737728|FG001|Period 2|Withdrawal by Subject|0|||
145243470|NCT01641081|523737729|FG002|Period 2|Withdrawal by Subject|0|||
145243471|NCT01641081|523737730|FG003|Period 2|Withdrawal by Subject|1|||
145243472|NCT01641081|523737731|FG004|Period 2|Withdrawal by Subject|0|||
145243473|NCT01641081|523737732|FG005|Period 2|Withdrawal by Subject|0|||
145243474|NCT01641081|523737733|FG006|Period 2|Withdrawal by Subject|2|||
145243475|NCT01641081|523737734|FG007|Period 2|Withdrawal by Subject|0|||
145243476|NCT01641081|523737735|FG008|Period 2|Withdrawal by Subject|0|||
145243477|NCT01641081|523737736|FG009|Period 2|Withdrawal by Subject|0|||
145243478|NCT01641081|523737727|FG000|Period 2|Protocol Violation|1|||
145243479|NCT01641081|523737728|FG001|Period 2|Protocol Violation|0|||
145243480|NCT01641081|523737729|FG002|Period 2|Protocol Violation|0|||
145243481|NCT01641081|523737730|FG003|Period 2|Protocol Violation|0|||
145243482|NCT01641081|523737731|FG004|Period 2|Protocol Violation|0|||
145243483|NCT01641081|523737732|FG005|Period 2|Protocol Violation|0|||
145243484|NCT01641081|523737733|FG006|Period 2|Protocol Violation|0|||
145243485|NCT01641081|523737734|FG007|Period 2|Protocol Violation|0|||
145243486|NCT01641081|523737735|FG008|Period 2|Protocol Violation|0|||
145243487|NCT01641081|523737736|FG009|Period 2|Protocol Violation|0|||
145243488|NCT01641081|523737727|FG000|Period 3|Adverse Event|0|||
145243489|NCT01641081|523737728|FG001|Period 3|Adverse Event|0|||
145243490|NCT01641081|523737729|FG002|Period 3|Adverse Event|1|||
145243491|NCT01641081|523737730|FG003|Period 3|Adverse Event|0|||
145243492|NCT01641081|523737731|FG004|Period 3|Adverse Event|0|||
145243493|NCT01641081|523737732|FG005|Period 3|Adverse Event|0|||
145243494|NCT01641081|523737733|FG006|Period 3|Adverse Event|0|||
145243495|NCT01641081|523737734|FG007|Period 3|Adverse Event|0|||
145243496|NCT01641081|523737735|FG008|Period 3|Adverse Event|0|||
145243497|NCT01641081|523737736|FG009|Period 3|Adverse Event|0|||
145243498|NCT01641081|523737727|FG000|Period 3|Withdrawal by Subject|0|||
145243499|NCT01641081|523737728|FG001|Period 3|Withdrawal by Subject|0|||
145243500|NCT01641081|523737729|FG002|Period 3|Withdrawal by Subject|0|||
145243501|NCT01641081|523737730|FG003|Period 3|Withdrawal by Subject|0|||
145564061|NCT00352846|524924110|FG001|Overall Study|Death|1|||
145564062|NCT00788827|524924111|FG000|Overall Study|Lack of Efficacy|2|||
145243502|NCT01641081|523737731|FG004|Period 3|Withdrawal by Subject|0|||
145243503|NCT01641081|523737732|FG005|Period 3|Withdrawal by Subject|0|||
145243504|NCT01641081|523737733|FG006|Period 3|Withdrawal by Subject|0|||
145243505|NCT01641081|523737734|FG007|Period 3|Withdrawal by Subject|0|||
145243506|NCT01641081|523737735|FG008|Period 3|Withdrawal by Subject|1|||
145243507|NCT01641081|523737736|FG009|Period 3|Withdrawal by Subject|0|||
145243508|NCT01641081|523737727|FG000|Period 4|Adverse Event|0|||
145243509|NCT01641081|523737728|FG001|Period 4|Adverse Event|1|||
145243510|NCT01641081|523737729|FG002|Period 4|Adverse Event|0|||
145564063|NCT01527682|524924112|FG000|Overall Study|Protocol Violation|8|||
145408914|NCT03329001|524351897|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408915|NCT03329001|524351898|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
145408916|NCT03329001|524351891|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408917|NCT03329001|524351892|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408918|NCT03329001|524351893|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408919|NCT03329001|524351894|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408920|NCT03329001|524351895|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408921|NCT03329001|524351896|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
145408922|NCT03329001|524351897|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
145408923|NCT03329001|524351898|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
145408924|NCT03329001|524351891|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408925|NCT03329001|524351892|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408926|NCT03329001|524351893|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408927|NCT03329001|524351894|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408928|NCT03329001|524351895|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408929|NCT03329001|524351896|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408930|NCT03329001|524351897|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
145408931|NCT03329001|524351898|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
145408932|NCT03329001|524351891|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408933|NCT03329001|524351892|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408934|NCT03329001|524351893|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408935|NCT03329001|524351894|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408936|NCT03329001|524351895|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408937|NCT03329001|524351896|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
145408938|NCT03329001|524351897|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
145408939|NCT03329001|524351898|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
145408940|NCT03329001|524351891|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408941|NCT03329001|524351892|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408942|NCT03329001|524351893|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408943|NCT03329001|524351894|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408944|NCT03329001|524351895|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408945|NCT03329001|524351896|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
145408946|NCT03329001|524351897|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
145408947|NCT03329001|524351898|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
145408948|NCT00963235|524351903|FG000|Overall Study|Withdrawal by Subject|22|||
145408949|NCT00963235|524351903|FG000|Overall Study|Lost to Follow-up|14|||
145408950|NCT00963235|524351903|FG000|Overall Study|Failed to return|9|||
145408951|NCT00963235|524351903|FG000|Overall Study|Protocol Violation|7|||
145408952|NCT00963235|524351903|FG000|Overall Study|Adverse Event|5|||
145408953|NCT00963235|524351903|FG000|Overall Study|Physician Decision|2|||
145408954|NCT00963235|524351903|FG000|Overall Study|Other|1|||
145408955|NCT01341470|524351905|FG000|Overall Study|Sponsor decision|0|||
145408956|NCT01341470|524351906|FG001|Overall Study|Sponsor decision|0|||
145408957|NCT01341470|524351907|FG002|Overall Study|Sponsor decision|1|||
145408958|NCT01341470|524351908|FG003|Overall Study|Sponsor decision|1|||
145408959|NCT01341470|524351909|FG004|Overall Study|Sponsor decision|0|||
145408960|NCT01341470|524351910|FG005|Overall Study|Sponsor decision|1|||
145408961|NCT05376358|524351914|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
145408962|NCT05376358|524351915|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
145408963|NCT05376358|524351914|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
145408964|NCT05376358|524351915|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
145408965|NCT05376358|524351914|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
145408966|NCT05376358|524351915|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
145408967|NCT05376358|524351914|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
145408968|NCT05376358|524351915|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
145408969|NCT05376358|524351914|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
145408970|NCT05376358|524351915|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
145408971|NCT05376358|524351914|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
145408972|NCT05376358|524351915|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
145408973|NCT04225832|524351916|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
145620094|NCT04004208|525123667|FG000|Overall Study|COVID-19 pandemic|1|||
145620095|NCT04004208|525123668|FG001|Overall Study|COVID-19 pandemic|0|||
145620096|NCT04004208|525123667|FG000|Overall Study|Physician Decision|1|||
145243511|NCT01641081|523737730|FG003|Period 4|Adverse Event|1|||
145243512|NCT01641081|523737731|FG004|Period 4|Adverse Event|0|||
145243513|NCT01641081|523737732|FG005|Period 4|Adverse Event|0|||
145243514|NCT01641081|523737733|FG006|Period 4|Adverse Event|0|||
145243515|NCT01641081|523737734|FG007|Period 4|Adverse Event|0|||
145243516|NCT01641081|523737735|FG008|Period 4|Adverse Event|0|||
145243517|NCT01641081|523737736|FG009|Period 4|Adverse Event|0|||
145243518|NCT01641081|523737727|FG000|Period 5|Adverse Event|0|||
145243519|NCT01641081|523737728|FG001|Period 5|Adverse Event|0|||
145243520|NCT01641081|523737729|FG002|Period 5|Adverse Event|2|||
145296824|NCT03340727|523937882|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
145296825|NCT03340727|523937881|FG000|Overall Study|Transferred to another facility|10|||
145296826|NCT03340727|523937882|FG001|Overall Study|Transferred to another facility|7|||
145296827|NCT03340727|523937881|FG000|Overall Study|Withdrawal by Subject|28|||
145296828|NCT03340727|523937882|FG001|Overall Study|Withdrawal by Subject|17|||
145296829|NCT02015390|523937883|FG000|Overall Study|Lost to Follow-up|1|||
145296830|NCT02015390|523937884|FG001|Overall Study|Lost to Follow-up|0|||
145296831|NCT02015390|523937883|FG000|Overall Study|Adverse Event|0|||
145296832|NCT02015390|523937884|FG001|Overall Study|Adverse Event|3|||
145296833|NCT02015390|523937883|FG000|Overall Study|Physician Decision|0|||
145296834|NCT02015390|523937884|FG001|Overall Study|Physician Decision|1|||
145296835|NCT00877032|523937885|FG000|Overall Study|Did not meet entrance criteria|0|||
145296836|NCT00877032|523937886|FG001|Overall Study|Did not meet entrance criteria|0|||
145296837|NCT00877032|523937887|FG002|Overall Study|Did not meet entrance criteria|0|||
145296838|NCT00877032|523937888|FG003|Overall Study|Did not meet entrance criteria|1|||
145296839|NCT00877032|523937889|FG004|Overall Study|Did not meet entrance criteria|0|||
145296840|NCT00877032|523937890|FG005|Overall Study|Did not meet entrance criteria|0|||
145296841|NCT00877032|523937891|FG006|Overall Study|Did not meet entrance criteria|2|||
145296842|NCT00669942|523937892|FG000|Parts 2 and 3|Adverse Event|0|||
145296843|NCT00669942|523937893|FG001|Parts 2 and 3|Adverse Event|0|||
145296844|NCT00669942|523937894|FG002|Parts 2 and 3|Adverse Event|0|||
145296845|NCT00669942|523937895|FG003|Parts 2 and 3|Adverse Event|0|||
145296846|NCT00669942|523937896|FG004|Parts 2 and 3|Adverse Event|0|||
145296847|NCT00669942|523937897|FG005|Parts 2 and 3|Adverse Event|0|||
145296848|NCT00669942|523937898|FG006|Parts 2 and 3|Adverse Event|0|||
145296849|NCT00669942|523937899|FG007|Parts 2 and 3|Adverse Event|2|||
145296850|NCT00669942|523937900|FG008|Parts 2 and 3|Adverse Event|1|||
145296851|NCT00669942|523937901|FG009|Parts 2 and 3|Adverse Event|0|||
145296852|NCT00669942|523937902|FG010|Parts 2 and 3|Adverse Event|0|||
145296853|NCT00669942|523937903|FG011|Parts 2 and 3|Adverse Event|0|||
145296854|NCT00669942|523937892|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
145296855|NCT00669942|523937893|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
145296856|NCT00669942|523937894|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
145296857|NCT00669942|523937895|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
145296858|NCT00669942|523937896|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
145296859|NCT00669942|523937897|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
145296860|NCT00669942|523937898|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
145296861|NCT00669942|523937899|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
145296862|NCT00669942|523937900|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
145296863|NCT00669942|523937901|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
145296864|NCT00669942|523937902|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
145296865|NCT00669942|523937903|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
145296866|NCT00669942|523937892|FG000|Parts 2 and 3|Protocol Violation|0|||
145296867|NCT00669942|523937893|FG001|Parts 2 and 3|Protocol Violation|0|||
145296868|NCT00669942|523937894|FG002|Parts 2 and 3|Protocol Violation|0|||
145296869|NCT00669942|523937895|FG003|Parts 2 and 3|Protocol Violation|0|||
145296870|NCT00669942|523937896|FG004|Parts 2 and 3|Protocol Violation|0|||
145296871|NCT00669942|523937897|FG005|Parts 2 and 3|Protocol Violation|1|||
145296872|NCT00669942|523937898|FG006|Parts 2 and 3|Protocol Violation|0|||
145296873|NCT00669942|523937899|FG007|Parts 2 and 3|Protocol Violation|0|||
145408974|NCT04225832|524351917|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
145408975|NCT04225832|524351916|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
145243521|NCT01641081|523737730|FG003|Period 5|Adverse Event|0|||
145243522|NCT01641081|523737731|FG004|Period 5|Adverse Event|0|||
145243523|NCT01641081|523737732|FG005|Period 5|Adverse Event|0|||
145243524|NCT01641081|523737733|FG006|Period 5|Adverse Event|0|||
145243525|NCT01641081|523737734|FG007|Period 5|Adverse Event|0|||
145243526|NCT01641081|523737735|FG008|Period 5|Adverse Event|0|||
145243527|NCT01641081|523737736|FG009|Period 5|Adverse Event|0|||
145243528|NCT03383614|523737741|FG000|Overall Study|Withdrawal by Subject|0|||
145296874|NCT00669942|523937900|FG008|Parts 2 and 3|Protocol Violation|0|||
145296875|NCT00669942|523937901|FG009|Parts 2 and 3|Protocol Violation|0|||
145296876|NCT00669942|523937902|FG010|Parts 2 and 3|Protocol Violation|0|||
145296877|NCT00669942|523937903|FG011|Parts 2 and 3|Protocol Violation|0|||
145296878|NCT03752528|523937904|FG000|Part A|Lost to Follow-up|1|||
145296879|NCT03752528|523937904|FG000|Part A|Protocol Violation|1|||
145296880|NCT03752528|523937904|FG000|Part B|Protocol Violation|1|||
145296881|NCT03752528|523937904|FG000|Part B|Study terminated by sponsor|3|||
145296882|NCT00259012|523937906|FG000|Overall Study|Adverse Event|0|||
145564064|NCT04668950|524924116|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
145564065|NCT04668950|524924117|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
145243529|NCT03383614|523737742|FG001|Overall Study|Withdrawal by Subject|1|||
145243530|NCT03383614|523737743|FG002|Overall Study|Withdrawal by Subject|0|||
145243531|NCT03383614|523737744|FG003|Overall Study|Withdrawal by Subject|0|||
145243532|NCT01749800|523737745|FG000|Overall Study|not meeting inclusion criteria|3|||
145243533|NCT01749800|523737746|FG001|Overall Study|not meeting inclusion criteria|0|||
145243534|NCT01749800|523737747|FG002|Overall Study|not meeting inclusion criteria|0|||
145243535|NCT01749800|523737745|FG000|Overall Study|Withdrawal by Subject|0|||
145243536|NCT01749800|523737746|FG001|Overall Study|Withdrawal by Subject|1|||
145243537|NCT01749800|523737747|FG002|Overall Study|Withdrawal by Subject|0|||
145243538|NCT00841672|523737749|FG000|Overall Study|Adverse Event|7|||
145296883|NCT00259012|523937907|FG001|Overall Study|Adverse Event|1|||
145296884|NCT00259012|523937906|FG000|Overall Study|Withdrawal by Subject|1|||
145296885|NCT00259012|523937907|FG001|Overall Study|Withdrawal by Subject|0|||
145296886|NCT00259012|523937906|FG000|Overall Study|Physician Decision|0|||
145296887|NCT00259012|523937907|FG001|Overall Study|Physician Decision|1|||
145296888|NCT00259012|523937906|FG000|Overall Study|Lost to Follow-up|0|||
145296889|NCT00259012|523937907|FG001|Overall Study|Lost to Follow-up|1|||
145296890|NCT00259012|523937906|FG000|Overall Study|Protocol Violation|1|||
145296891|NCT00259012|523937907|FG001|Overall Study|Protocol Violation|1|||
145296892|NCT03002077|523937908|FG000|Overall Study|Non-compliance with Study Drug|4|||
145296893|NCT03002077|523937908|FG000|Overall Study|Non-compliance w/Background ADT|1|||
145296894|NCT03002077|523937908|FG000|Overall Study|Study Terminated by Sponsor|257|||
145296895|NCT03002077|523937908|FG000|Overall Study|Site Terminated by Sponsor|5|||
145296896|NCT03002077|523937908|FG000|Overall Study|Miscellaneous Reasons|10|||
145296897|NCT03002077|523937908|FG000|Overall Study|Adverse Event|23|||
145296898|NCT03002077|523937908|FG000|Overall Study|Lack of Efficacy|20|||
145564066|NCT04668950|524924116|FG000|Overall Study|Could not confirm started study medication|15|||
145564067|NCT04668950|524924117|FG001|Overall Study|Could not confirm started study medication|15|||
145564068|NCT04668950|524924116|FG000|Overall Study|Could not confirm baseline status|6|||
145564069|NCT04668950|524924117|FG001|Overall Study|Could not confirm baseline status|2|||
145564070|NCT04668950|524924116|FG000|Overall Study|Drop out and did not start medication|15|||
145564071|NCT04668950|524924117|FG001|Overall Study|Drop out and did not start medication|17|||
145564072|NCT04668950|524924116|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
145564073|NCT04668950|524924117|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
145564074|NCT04668950|524924116|FG000|Overall Study|Other|2|||
145564075|NCT04668950|524924117|FG001|Overall Study|Other|4|||
145564076|NCT03979638|524924118|FG000|Period 1|Physician Decision|1|||
145564077|NCT03979638|524924119|FG001|Period 1|Physician Decision|1|||
145564078|NCT03979638|524924118|FG000|Period 1|Withdrawal by Subject|4|||
145564079|NCT03979638|524924119|FG001|Period 1|Withdrawal by Subject|3|||
145564080|NCT03979638|524924118|FG000|Period 1|Study terminated by Sponsor|1|||
145564081|NCT03979638|524924119|FG001|Period 1|Study terminated by Sponsor|3|||
145564082|NCT03979638|524924118|FG000|Period 1|Protocol Violation|1|||
145564083|NCT03979638|524924119|FG001|Period 1|Protocol Violation|0|||
145564084|NCT03979638|524924118|FG000|Period 2|Study terminated by Sponsor|1|||
145564085|NCT03979638|524924119|FG001|Period 2|Study terminated by Sponsor|1|||
145564086|NCT04220411|524924124|FG000|Overall Study|Adverse Event|0|||
145564087|NCT04220411|524924125|FG001|Overall Study|Adverse Event|0|||
145564088|NCT04220411|524924126|FG002|Overall Study|Adverse Event|0|||
145564089|NCT04220411|524924127|FG003|Overall Study|Adverse Event|1|||
145564090|NCT03200899|524924128|FG000|Overall Study|Lost to Follow-up|10|||
145564091|NCT03200899|524924129|FG001|Overall Study|Lost to Follow-up|23|||
145564092|NCT01400516|524924141|FG000|Primary Trial|Withdrawal by Subject|0|||
145564093|NCT01400516|524924142|FG001|Primary Trial|Withdrawal by Subject|2|||
145564094|NCT00549562|524924143|FG000|Overall Study|Adverse Event|1|||
145564095|NCT00549562|524924143|FG000|Overall Study|Lack of Efficacy|1|||
145296899|NCT03002077|523937908|FG000|Overall Study|Withdrawal by Subject|72|||
145564096|NCT00323115|524924149|FG000|Vaccine Administration|Adverse Event|1|||
145564097|NCT00323115|524924149|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
145564098|NCT02496533|524924150|FG000|Overall Study|Lack of data on outcome|3|||
145620097|NCT04004208|525123668|FG001|Overall Study|Physician Decision|0|||
145564099|NCT02496533|524924151|FG001|Overall Study|Lack of data on outcome|0|||
145620098|NCT04004208|525123667|FG000|Overall Study|Adverse Event|1|||
145620099|NCT04004208|525123668|FG001|Overall Study|Adverse Event|1|||
145243539|NCT00841672|523737750|FG001|Overall Study|Adverse Event|16|||
145243540|NCT00841672|523737749|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145296900|NCT03002077|523937908|FG000|Overall Study|Lost to Follow-up|21|||
145296901|NCT03002077|523937908|FG000|Overall Study|Pregnancy|4|||
145296902|NCT03002077|523937908|FG000|Overall Study|Protocol Violation|21|||
145296903|NCT04625114|523937915|FG000|Overall Study|Adverse Event|3|||
145296904|NCT04625114|523937916|FG001|Overall Study|Adverse Event|1|||
145296905|NCT04625114|523937915|FG000|Overall Study|Withdrawal by Subject|2|||
145296906|NCT04625114|523937916|FG001|Overall Study|Withdrawal by Subject|0|||
145296907|NCT01629381|523937917|FG000|Overall Study|Withdrawal by Subject|2|||
145243541|NCT00841672|523737750|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145243542|NCT00841672|523737749|FG000|Overall Study|Subject withdrew consent|2|||
145243543|NCT00841672|523737750|FG001|Overall Study|Subject withdrew consent|4|||
145243544|NCT00841672|523737749|FG000|Overall Study|Lost to Follow-up|1|||
145243545|NCT00841672|523737750|FG001|Overall Study|Lost to Follow-up|1|||
145243546|NCT00841672|523737749|FG000|Overall Study|Administrative problems|9|||
145243547|NCT00841672|523737750|FG001|Overall Study|Administrative problems|9|||
145243548|NCT00841672|523737749|FG000|Overall Study|Misrandomized|1|||
145243549|NCT00841672|523737750|FG001|Overall Study|Misrandomized|0|||
145243550|NCT00841672|523737749|FG000|Overall Study|Protocol Deviation|0|||
145243551|NCT00841672|523737750|FG001|Overall Study|Protocol Deviation|1|||
145243552|NCT01451398|523737751|FG000|Overall Study|Adverse Event|7|||
145243553|NCT01451398|523737752|FG001|Overall Study|Adverse Event|9|||
145243554|NCT01451398|523737751|FG000|Overall Study|Protocol Violation|1|||
145243555|NCT01451398|523737752|FG001|Overall Study|Protocol Violation|2|||
145243556|NCT01451398|523737751|FG000|Overall Study|Physician Decision|1|||
145620100|NCT01310868|525123674|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
145243557|NCT01451398|523737752|FG001|Overall Study|Physician Decision|1|||
145243558|NCT01451398|523737751|FG000|Overall Study|Withdrawal by Subject|10|||
145243559|NCT01451398|523737752|FG001|Overall Study|Withdrawal by Subject|14|||
145243560|NCT01451398|523737751|FG000|Overall Study|Lost to Follow-up|6|||
145243561|NCT01451398|523737752|FG001|Overall Study|Lost to Follow-up|4|||
145243562|NCT01451398|523737751|FG000|Overall Study|Non-compliance with study drug|1|||
145243563|NCT01451398|523737752|FG001|Overall Study|Non-compliance with study drug|3|||
145243564|NCT01451398|523737751|FG000|Overall Study|Non-compliance with protocol|1|||
145243565|NCT01451398|523737752|FG001|Overall Study|Non-compliance with protocol|1|||
145243566|NCT01451398|523737751|FG000|Overall Study|Moved out of country|0|||
145243567|NCT01451398|523737752|FG001|Overall Study|Moved out of country|1|||
145243568|NCT01451398|523737751|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
145243569|NCT01451398|523737752|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
145243570|NCT01451398|523737751|FG000|Overall Study|Lack of Efficacy|0|||
145243571|NCT01451398|523737752|FG001|Overall Study|Lack of Efficacy|1|||
145243572|NCT00422669|523737753|FG000|Overall Study|The study was terminated early.|98|||
145243573|NCT00422669|523737754|FG001|Overall Study|The study was terminated early.|100|||
145243574|NCT00422669|523737755|FG002|Overall Study|The study was terminated early.|7|||
145243575|NCT02709109|523737756|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
145243576|NCT02709109|523737757|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
145243577|NCT02709109|523737758|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
145243578|NCT02709109|523737759|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
145243579|NCT02709109|523737756|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
145243580|NCT02709109|523737757|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
145243581|NCT02709109|523737758|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
145243582|NCT02709109|523737759|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
145243583|NCT02709109|523737756|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
145243584|NCT02709109|523737757|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
145243585|NCT02709109|523737758|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
145243586|NCT02709109|523737759|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
145243587|NCT02709109|523737756|FG000|Washout Period (28 Days)|Other|2|||
145243588|NCT02709109|523737757|FG001|Washout Period (28 Days)|Other|2|||
145243589|NCT02709109|523737758|FG002|Washout Period (28 Days)|Other|3|||
145243590|NCT02709109|523737759|FG003|Washout Period (28 Days)|Other|0|||
145243591|NCT02709109|523737756|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
145243592|NCT02709109|523737757|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
145243593|NCT02709109|523737758|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
145243594|NCT02709109|523737759|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
145243595|NCT02709109|523737756|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
145243596|NCT02709109|523737757|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
145243597|NCT02709109|523737758|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
145243598|NCT02709109|523737759|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
145243599|NCT02709109|523737756|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
145243600|NCT02709109|523737757|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
145243601|NCT02709109|523737758|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
145243602|NCT02709109|523737759|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
145243603|NCT02709109|523737756|FG000|Treatment Period 2 (28 Days)|Other|0|||
145243604|NCT02709109|523737757|FG001|Treatment Period 2 (28 Days)|Other|0|||
145243605|NCT02709109|523737758|FG002|Treatment Period 2 (28 Days)|Other|1|||
145243606|NCT02709109|523737759|FG003|Treatment Period 2 (28 Days)|Other|0|||
145243607|NCT02650895|523737769|FG000|Overall Study|Withdrawal by Subject|0|||
145243608|NCT02650895|523737770|FG001|Overall Study|Withdrawal by Subject|1|||
145243609|NCT02650895|523737771|FG002|Overall Study|Withdrawal by Subject|0|||
145243610|NCT02650895|523737772|FG003|Overall Study|Withdrawal by Subject|0|||
145243611|NCT02650895|523737773|FG004|Overall Study|Withdrawal by Subject|0|||
145564100|NCT02496533|524924150|FG000|Overall Study|Patient did not complete all measures|0|||
145564101|NCT02496533|524924151|FG001|Overall Study|Patient did not complete all measures|4|||
145564102|NCT02496533|524924150|FG000|Overall Study|Late for radiologic testing|0|||
145564103|NCT02496533|524924151|FG001|Overall Study|Late for radiologic testing|2|||
145243612|NCT02650895|523737774|FG005|Overall Study|Withdrawal by Subject|0|||
145243613|NCT00922974|523739941|FG000|Phase II Component|Protocol Violation|2|||
145243614|NCT00922974|523739942|FG001|Phase II Component|Protocol Violation|0|||
145243615|NCT00922974|523739941|FG000|Phase II Component|Not evaluable for treatment review|5|||
145243616|NCT00922974|523739942|FG001|Phase II Component|Not evaluable for treatment review|0|||
145243617|NCT00922974|523739941|FG000|Phase III Component|Protocol Violation|8|||
145243618|NCT00922974|523739942|FG001|Phase III Component|Protocol Violation|6|||
145243619|NCT02944513|523739943|FG000|Overall Study|Withdrawal by Subject|4|||
145243620|NCT02944513|523739944|FG001|Overall Study|Withdrawal by Subject|1|||
145243621|NCT00731666|523739947|FG000|Overall Study|Adverse Event|2|||
145243622|NCT00731666|523739947|FG000|Overall Study|Lost to Follow-up|8|||
145243623|NCT00731666|523739947|FG000|Overall Study|Withdrawal by Subject|2|||
145243624|NCT00088595|523739948|FG000|Overall Study|Adverse Event|11|||
145243625|NCT00088595|523739948|FG000|Overall Study|Withdrawal by Subject|8|||
145243626|NCT00088595|523739948|FG000|Overall Study|Ongoing (After Core)|7|||
145243627|NCT00088595|523739948|FG000|Overall Study|New Cancer Therapy|2|||
145243628|NCT00608894|523739949|FG000|Overall Study|Withdrawal by Subject|0|||
145243629|NCT00608894|523739950|FG001|Overall Study|Withdrawal by Subject|2|||
145243630|NCT01473355|523739962|FG000|Overall Study|Protocol Violation|2|||
145243631|NCT01473355|523739962|FG000|Overall Study|Adverse Event|2|||
145243632|NCT01473355|523739962|FG000|Overall Study|Lost to Follow-up|2|||
145243633|NCT02809118|523739963|FG000|Overall Study|Withdrawal by Subject|0|||
145243634|NCT02809118|523739964|FG001|Overall Study|Withdrawal by Subject|1|||
145243635|NCT02809118|523739965|FG002|Overall Study|Withdrawal by Subject|1|||
145243636|NCT01235338|523739966|FG000|Overall Study|Adverse Event|3|||
145243637|NCT01235338|523739967|FG001|Overall Study|Adverse Event|2|||
145243638|NCT01235338|523739966|FG000|Overall Study|Protocol Violation|1|||
145243639|NCT01235338|523739967|FG001|Overall Study|Protocol Violation|1|||
145243640|NCT01235338|523739966|FG000|Overall Study|Withdrawal by Subject|5|||
145243641|NCT01235338|523739967|FG001|Overall Study|Withdrawal by Subject|0|||
145243642|NCT01235338|523739966|FG000|Overall Study|Exclusion criteria violations|1|||
145243643|NCT01235338|523739967|FG001|Overall Study|Exclusion criteria violations|1|||
145243644|NCT01235338|523739966|FG000|Overall Study|Positive drug screen|0|||
145243645|NCT01235338|523739967|FG001|Overall Study|Positive drug screen|1|||
145243646|NCT01235338|523739966|FG000|Overall Study|Prohibited meds|1|||
145243647|NCT01235338|523739967|FG001|Overall Study|Prohibited meds|0|||
145243648|NCT02436915|523739971|FG000|Overall Study|Withdrawal by Subject|0|||
145243649|NCT02436915|523739972|FG001|Overall Study|Withdrawal by Subject|1|||
145243650|NCT01843205|523739975|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
145243651|NCT01843205|523739976|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
145243652|NCT02603172|523739982|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243653|NCT02603172|523739983|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243654|NCT02603172|523739984|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
145243655|NCT02603172|523739985|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243656|NCT02603172|523739986|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145564104|NCT00489853|524925520|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
145564105|NCT00489853|524925521|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
145243657|NCT02603172|523739987|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243658|NCT02603172|523739988|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243659|NCT02603172|523739989|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
145243660|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Death|3|||
145243661|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Death|0|||
145243662|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Death|0|||
145243663|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Death|0|||
145243664|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Death|0|||
145243665|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
145243666|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
145243667|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
145243668|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
145243669|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
145296908|NCT01629381|523937918|FG001|Overall Study|Withdrawal by Subject|5|||
145296909|NCT02849652|523937924|FG000|Overall Study|Lost to Follow-up|104|||
145564106|NCT00489853|524925522|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
145243670|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145243671|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
145243672|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
145243673|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145243674|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
145243675|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Other|0|||
145243676|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Other|0|||
145243677|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Other|1|||
145243678|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Other|0|||
145243679|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Other|0|||
145243680|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
145243681|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
145243682|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
145243683|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
145243684|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
145243685|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
145243686|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
145243687|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
145243688|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
145243689|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
145243690|NCT01224106|523739992|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145243691|NCT01224106|523739993|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145243692|NCT01224106|523739994|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145243693|NCT01224106|523739995|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145243694|NCT01224106|523739996|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145243695|NCT01224106|523739992|FG000|Open-Label Extension (OLE) Phase|Death|0|||
145243696|NCT01224106|523739993|FG001|Open-Label Extension (OLE) Phase|Death|0|||
145243697|NCT01224106|523739994|FG002|Open-Label Extension (OLE) Phase|Death|0|||
145243698|NCT01224106|523739995|FG003|Open-Label Extension (OLE) Phase|Death|1|||
145243699|NCT01224106|523739996|FG004|Open-Label Extension (OLE) Phase|Death|3|||
145243700|NCT01224106|523739992|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
145243701|NCT01224106|523739993|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
145243702|NCT01224106|523739994|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
145243703|NCT01224106|523739995|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
145243704|NCT01224106|523739996|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
145243705|NCT01224106|523739992|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
145243706|NCT01224106|523739993|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
145243707|NCT01224106|523739994|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
145243708|NCT01224106|523739995|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
145243709|NCT01224106|523739996|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
145243710|NCT01224106|523739992|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
145243711|NCT01224106|523739993|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
145243712|NCT01224106|523739994|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
145243713|NCT01224106|523739995|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
145243714|NCT01224106|523739996|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
145243715|NCT01224106|523739992|FG000|Open-Label Extension (OLE) Phase|Other|0|||
145243716|NCT01224106|523739993|FG001|Open-Label Extension (OLE) Phase|Other|0|||
145243717|NCT01224106|523739994|FG002|Open-Label Extension (OLE) Phase|Other|0|||
145243718|NCT01224106|523739995|FG003|Open-Label Extension (OLE) Phase|Other|5|||
145243719|NCT01224106|523739996|FG004|Open-Label Extension (OLE) Phase|Other|3|||
145243720|NCT00441727|523739997|FG000|Overall Study|Protocol Violation|19|||
145243721|NCT00441727|523739998|FG001|Overall Study|Protocol Violation|28|||
145243722|NCT00441727|523739999|FG002|Overall Study|Protocol Violation|32|||
145243723|NCT00441727|523739997|FG000|Overall Study|Adverse Event|26|||
145243724|NCT00441727|523739998|FG001|Overall Study|Adverse Event|33|||
145243725|NCT00441727|523739999|FG002|Overall Study|Adverse Event|28|||
145243726|NCT00441727|523739997|FG000|Overall Study|Lack of Efficacy|7|||
145243727|NCT00441727|523739998|FG001|Overall Study|Lack of Efficacy|8|||
145243728|NCT00441727|523739999|FG002|Overall Study|Lack of Efficacy|48|||
145243729|NCT00441727|523739997|FG000|Overall Study|Withdrawal by Subject|40|||
145296910|NCT02849652|523937925|FG001|Overall Study|Lost to Follow-up|35|||
145296911|NCT02849652|523937926|FG002|Overall Study|Lost to Follow-up|116|||
145296912|NCT02849652|523937927|FG003|Overall Study|Lost to Follow-up|22|||
145296913|NCT02849652|523937924|FG000|Overall Study|Withdrawal by Subject|10|||
145296914|NCT02849652|523937925|FG001|Overall Study|Withdrawal by Subject|2|||
145296915|NCT02849652|523937926|FG002|Overall Study|Withdrawal by Subject|8|||
145296916|NCT02849652|523937927|FG003|Overall Study|Withdrawal by Subject|4|||
145296917|NCT00854308|523937928|FG000|Overall Study|Disease progression|42|||
145243730|NCT00441727|523739998|FG001|Overall Study|Withdrawal by Subject|34|||
145243731|NCT00441727|523739999|FG002|Overall Study|Withdrawal by Subject|47|||
145243732|NCT00441727|523739997|FG000|Overall Study|Lost to Follow-up|5|||
145243733|NCT00441727|523739998|FG001|Overall Study|Lost to Follow-up|6|||
145243734|NCT00441727|523739999|FG002|Overall Study|Lost to Follow-up|5|||
145296918|NCT00854308|523937929|FG001|Overall Study|Disease progression|50|||
145296919|NCT00854308|523937928|FG000|Overall Study|Adverse Event|8|||
145620101|NCT01628874|525123681|FG000|Overall Study|Physician Decision|1|||
145243735|NCT00441727|523739997|FG000|Overall Study|Safety Reasons|3|||
145243736|NCT00441727|523739998|FG001|Overall Study|Safety Reasons|1|||
145243737|NCT00441727|523739999|FG002|Overall Study|Safety Reasons|3|||
145564107|NCT00489853|524925520|FG000|Wash-out Period 1|Adverse Event|0|||
145564108|NCT00489853|524925521|FG001|Wash-out Period 1|Adverse Event|1|||
145564109|NCT00489853|524925522|FG002|Wash-out Period 1|Adverse Event|1|||
145564110|NCT00489853|524925520|FG000|Wash-out Period 1|Protocol Violation|0|||
145564111|NCT00489853|524925521|FG001|Wash-out Period 1|Protocol Violation|1|||
145564112|NCT00489853|524925522|FG002|Wash-out Period 1|Protocol Violation|1|||
145564113|NCT00489853|524925520|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
145564114|NCT00489853|524925521|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
145564115|NCT00489853|524925522|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
145564116|NCT00489853|524925520|FG000|Wash-out Period 2|Adverse Event|1|||
145243738|NCT00441727|523739997|FG000|Overall Study|Various reason specified|6|||
145564117|NCT00489853|524925521|FG001|Wash-out Period 2|Adverse Event|1|||
145564118|NCT00489853|524925522|FG002|Wash-out Period 2|Adverse Event|0|||
145564119|NCT00489853|524925520|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
145564120|NCT00489853|524925521|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
145564121|NCT00489853|524925522|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
145564122|NCT00489853|524925520|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
145564123|NCT00489853|524925521|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
145564124|NCT00489853|524925522|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
145564125|NCT00004888|524925528|FG000|Overall Study|Adverse Event|5|||
145564126|NCT00004888|524925529|FG001|Overall Study|Adverse Event|10|||
145564127|NCT00004888|524925528|FG000|Overall Study|Withdrawal by Subject|0|||
145564128|NCT00004888|524925529|FG001|Overall Study|Withdrawal by Subject|3|||
145564129|NCT00004888|524925528|FG000|Overall Study|Physician Decision|1|||
145564130|NCT00004888|524925529|FG001|Overall Study|Physician Decision|1|||
145564131|NCT00004888|524925528|FG000|Overall Study|Progressive Disease|4|||
145564132|NCT00004888|524925529|FG001|Overall Study|Progressive Disease|9|||
145564133|NCT00004888|524925528|FG000|Overall Study|Death without progressive disease|0|||
145564134|NCT00004888|524925529|FG001|Overall Study|Death without progressive disease|1|||
145564135|NCT00004888|524925528|FG000|Overall Study|Toxic death|1|||
145564136|NCT00004888|524925529|FG001|Overall Study|Toxic death|0|||
145564137|NCT02579265|524925530|FG000|Overall Study|Weaned off earlier than 28 days|44|||
145564138|NCT02579265|524925531|FG001|Overall Study|Weaned off earlier than 28 days|43|||
145564139|NCT02579265|524925530|FG000|Overall Study|Adverse Event|2|||
145564140|NCT02579265|524925531|FG001|Overall Study|Adverse Event|0|||
145564141|NCT02579265|524925530|FG000|Overall Study|Any other reason not specified|0|||
145564142|NCT02579265|524925531|FG001|Overall Study|Any other reason not specified|2|||
145564143|NCT02579265|524925530|FG000|Overall Study|Withdrawal by Subject|2|||
145564144|NCT02579265|524925531|FG001|Overall Study|Withdrawal by Subject|0|||
145564145|NCT02579265|524925530|FG000|Overall Study|Physician Decision|1|||
145564146|NCT02579265|524925531|FG001|Overall Study|Physician Decision|0|||
145564147|NCT02579265|524925530|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
145564148|NCT02579265|524925531|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
145564149|NCT02174848|524925532|FG000|Overall Study|Adverse Event|2|||
145564150|NCT02174848|524925533|FG001|Overall Study|Adverse Event|1|||
145243739|NCT00441727|523739998|FG001|Overall Study|Various reason specified|8|||
145243740|NCT00441727|523739999|FG002|Overall Study|Various reason specified|5|||
145243741|NCT02133001|523740000|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
145564151|NCT02174848|524925532|FG000|Overall Study|Withdrawal by Subject|3|||
145564152|NCT02174848|524925533|FG001|Overall Study|Withdrawal by Subject|3|||
145564153|NCT02174848|524925532|FG000|Overall Study|Lost to Follow-up|0|||
145564154|NCT02174848|524925533|FG001|Overall Study|Lost to Follow-up|1|||
145564155|NCT02174848|524925532|FG000|Overall Study|Worsening of disease|1|||
145243742|NCT02133001|523740001|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
145243743|NCT02133001|523740000|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
145243744|NCT02133001|523740001|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
145243745|NCT02133001|523740000|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
145243746|NCT02133001|523740001|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
145243747|NCT02133001|523740000|FG000|Double Blind (Day 1-25)|Other|2|||
145243748|NCT02133001|523740001|FG001|Double Blind (Day 1-25)|Other|2|||
145296920|NCT00854308|523937929|FG001|Overall Study|Adverse Event|3|||
145296921|NCT00854308|523937928|FG000|Overall Study|Death|2|||
145296922|NCT00854308|523937929|FG001|Overall Study|Death|5|||
145296923|NCT00854308|523937928|FG000|Overall Study|Physician Decision|6|||
145243749|NCT02133001|523740000|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
145243750|NCT02133001|523740001|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
145296924|NCT00854308|523937929|FG001|Overall Study|Physician Decision|6|||
145296925|NCT00854308|523937928|FG000|Overall Study|Withdrawal by Subject|4|||
145296926|NCT00854308|523937929|FG001|Overall Study|Withdrawal by Subject|2|||
145296927|NCT00854308|523937928|FG000|Overall Study|Sponsor's decision to terminate study|0|||
145564156|NCT02174848|524925533|FG001|Overall Study|Worsening of disease|1|||
145620102|NCT01628874|525123682|FG001|Overall Study|Physician Decision|1|||
145243751|NCT02133001|523740000|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
145296928|NCT00854308|523937929|FG001|Overall Study|Sponsor's decision to terminate study|1|||
145243752|NCT02133001|523740001|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
145243753|NCT02133001|523740000|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
145243754|NCT02133001|523740001|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
145243755|NCT02133001|523740000|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
145243756|NCT02133001|523740001|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
145243757|NCT04211961|523740002|FG000|Overall Study|Death|0|||
145243758|NCT04211961|523740003|FG001|Overall Study|Death|1|||
145243759|NCT04211961|523740002|FG000|Overall Study|Lost to Follow-up|0|||
145243760|NCT04211961|523740003|FG001|Overall Study|Lost to Follow-up|1|||
145243761|NCT04211961|523740002|FG000|Overall Study|Withdrawal by Subject|0|||
145243762|NCT04211961|523740003|FG001|Overall Study|Withdrawal by Subject|1|||
145243763|NCT03210220|523740006|FG000|Overall Study|Physician Decision|1|||
145243764|NCT03210220|523740007|FG001|Overall Study|Physician Decision|0|||
145243765|NCT00420342|523740008|FG000|Overall Study|Lost to Follow-up|1|||
145243766|NCT00420342|523740009|FG001|Overall Study|Lost to Follow-up|0|||
145564157|NCT02174848|524925532|FG000|Overall Study|Unable to comply with study requirements|1|||
145564158|NCT02174848|524925533|FG001|Overall Study|Unable to comply with study requirements|0|||
145564159|NCT04091646|524925537|FG000|Overall Study|Adverse Event|2|||
145564160|NCT04091646|524925538|FG001|Overall Study|Adverse Event|1|||
145564161|NCT04091646|524925537|FG000|Overall Study|Lost to Follow-up|6|||
145564162|NCT04091646|524925538|FG001|Overall Study|Lost to Follow-up|2|||
145564163|NCT04091646|524925537|FG000|Overall Study|Protocol Violation|0|||
145564164|NCT04091646|524925538|FG001|Overall Study|Protocol Violation|1|||
145564165|NCT04091646|524925537|FG000|Overall Study|Withdrawal by Subject|4|||
145564166|NCT04091646|524925538|FG001|Overall Study|Withdrawal by Subject|1|||
145564167|NCT04091646|524925537|FG000|Overall Study|Participant Incarcerated|1|||
145564168|NCT04091646|524925538|FG001|Overall Study|Participant Incarcerated|0|||
145564169|NCT03314584|524925541|FG000|Overall Study|Withdrawal by Subject|3|||
145564170|NCT03314584|524925542|FG001|Overall Study|Withdrawal by Subject|3|||
145564171|NCT03314584|524925541|FG000|Overall Study|Lost to Follow-up|4|||
145564172|NCT03314584|524925542|FG001|Overall Study|Lost to Follow-up|0|||
145564173|NCT03615326|524925550|FG000|Overall Study|Death|266|||
145564174|NCT03615326|524925551|FG001|Overall Study|Death|286|||
145564175|NCT03615326|524925552|FG002|Overall Study|Death|14|||
145564176|NCT03615326|524925553|FG003|Overall Study|Death|17|||
145564177|NCT03615326|524925550|FG000|Overall Study|Lost to Follow-up|0|||
145564178|NCT03615326|524925551|FG001|Overall Study|Lost to Follow-up|1|||
145564179|NCT03615326|524925552|FG002|Overall Study|Lost to Follow-up|0|||
145564180|NCT03615326|524925553|FG003|Overall Study|Lost to Follow-up|0|||
145564181|NCT03615326|524925550|FG000|Overall Study|Withdrawal by Subject|1|||
145564182|NCT03615326|524925551|FG001|Overall Study|Withdrawal by Subject|3|||
145564183|NCT03615326|524925552|FG002|Overall Study|Withdrawal by Subject|0|||
145564184|NCT03615326|524925553|FG003|Overall Study|Withdrawal by Subject|0|||
145564185|NCT03615326|524925550|FG000|Overall Study|Participants Ongoing|83|||
145564186|NCT03615326|524925551|FG001|Overall Study|Participants Ongoing|58|||
145564187|NCT03615326|524925552|FG002|Overall Study|Participants Ongoing|6|||
145564188|NCT03615326|524925553|FG003|Overall Study|Participants Ongoing|3|||
145564189|NCT02532647|524925554|FG000|Overall Study|Did not receive trial medication|1|||
145564190|NCT02532647|524925555|FG001|Overall Study|Did not receive trial medication|0|||
145564191|NCT02532647|524925556|FG002|Overall Study|Did not receive trial medication|1|||
145564192|NCT03168464|524925561|FG000|Overall Study|Death|9|||
145564193|NCT03168464|524925561|FG000|Overall Study|Progression of disease|6|||
145564194|NCT04649164|524925562|FG000|Overall Study|Withdrawal by Subject|1|||
145564195|NCT04649164|524925563|FG001|Overall Study|Withdrawal by Subject|1|||
145564196|NCT04649164|524925564|FG002|Overall Study|Withdrawal by Subject|2|||
145564197|NCT04649164|524925562|FG000|Overall Study|Participant's care recipient expired|0|||
145564198|NCT04649164|524925563|FG001|Overall Study|Participant's care recipient expired|0|||
145564199|NCT04649164|524925564|FG002|Overall Study|Participant's care recipient expired|2|||
145243767|NCT00420342|523740010|FG002|Overall Study|Lost to Follow-up|1|||
145243768|NCT00420342|523740008|FG000|Overall Study|Withdrawal by Subject|0|||
145243769|NCT00420342|523740009|FG001|Overall Study|Withdrawal by Subject|2|||
145243770|NCT00420342|523740010|FG002|Overall Study|Withdrawal by Subject|0|||
145243771|NCT00839436|523740011|FG000|Overall Study|Developed exclusionary condition|1|||
145243772|NCT00839436|523740012|FG001|Overall Study|Developed exclusionary condition|0|||
145243773|NCT00839436|523740013|FG002|Overall Study|Developed exclusionary condition|0|||
145243774|NCT00839436|523740011|FG000|Overall Study|Withdrawal by Subject|0|||
145243775|NCT00839436|523740012|FG001|Overall Study|Withdrawal by Subject|1|||
145243776|NCT00839436|523740013|FG002|Overall Study|Withdrawal by Subject|0|||
145243777|NCT00839436|523740011|FG000|Overall Study|Study drug no longer available|0|||
145243778|NCT00839436|523740012|FG001|Overall Study|Study drug no longer available|0|||
145243779|NCT00839436|523740013|FG002|Overall Study|Study drug no longer available|1|||
145243780|NCT05784129|523740014|FG000|Overall Study|Study terminated by sponsor|2|||
145243781|NCT05784129|523740015|FG001|Overall Study|Study terminated by sponsor|2|||
145243782|NCT02580591|523740017|FG000|Overall Study|Adverse Event|0|||
145243783|NCT02580591|523740018|FG001|Overall Study|Adverse Event|1|||
145243784|NCT02580591|523740019|FG002|Overall Study|Adverse Event|2|||
145243785|NCT02580591|523740020|FG003|Overall Study|Adverse Event|5|||
145243786|NCT02580591|523740017|FG000|Overall Study|Protocol Violation|3|||
145408976|NCT04225832|524351917|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
145408977|NCT00311168|524351918|FG000|First Intervention|Withdrawal by Subject|2|||
145408978|NCT00311168|524351919|FG001|First Intervention|Withdrawal by Subject|2|||
145408979|NCT00311168|524351918|FG000|First Intervention|Lost to Follow-up|1|||
145408980|NCT00311168|524351919|FG001|First Intervention|Lost to Follow-up|1|||
145408981|NCT00311168|524351918|FG000|First Intervention|Protocol Violation|1|||
145408982|NCT00311168|524351919|FG001|First Intervention|Protocol Violation|1|||
145408983|NCT00311168|524351918|FG000|First Intervention|Adverse Event|1|||
145408984|NCT00311168|524351919|FG001|First Intervention|Adverse Event|0|||
145408985|NCT00311168|524351918|FG000|First Intervention|Other|2|||
145408986|NCT00311168|524351919|FG001|First Intervention|Other|2|||
145408987|NCT00311168|524351918|FG000|Second Intervention|Lost to Follow-up|9|||
145408988|NCT00311168|524351919|FG001|Second Intervention|Lost to Follow-up|2|||
145408989|NCT00311168|524351918|FG000|Second Intervention|Withdrawal by Subject|0|||
145408990|NCT00311168|524351919|FG001|Second Intervention|Withdrawal by Subject|1|||
145408991|NCT00311168|524351918|FG000|Second Intervention|Other|1|||
145408992|NCT00311168|524351919|FG001|Second Intervention|Other|1|||
145408993|NCT03323502|524351922|FG000|Overall Study|Resident could not be linked to CMS data|594|||
145243787|NCT02580591|523740018|FG001|Overall Study|Protocol Violation|2|||
145243788|NCT02580591|523740019|FG002|Overall Study|Protocol Violation|1|||
145243789|NCT02580591|523740020|FG003|Overall Study|Protocol Violation|1|||
145243790|NCT02580591|523740017|FG000|Overall Study|Lost to Follow-up|5|||
145243791|NCT02580591|523740018|FG001|Overall Study|Lost to Follow-up|3|||
145243792|NCT02580591|523740019|FG002|Overall Study|Lost to Follow-up|3|||
145243793|NCT02580591|523740020|FG003|Overall Study|Lost to Follow-up|1|||
145243794|NCT02580591|523740017|FG000|Overall Study|Withdrawal by Subject|6|||
145243795|NCT02580591|523740018|FG001|Overall Study|Withdrawal by Subject|1|||
145243796|NCT02580591|523740019|FG002|Overall Study|Withdrawal by Subject|2|||
145243797|NCT02580591|523740020|FG003|Overall Study|Withdrawal by Subject|3|||
145243798|NCT02580591|523740017|FG000|Overall Study|Not treated|1|||
145408994|NCT03323502|524351923|FG001|Overall Study|Resident could not be linked to CMS data|435|||
145408995|NCT03323502|524351922|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
145243799|NCT02580591|523740018|FG001|Overall Study|Not treated|1|||
145243800|NCT02580591|523740019|FG002|Overall Study|Not treated|0|||
145243801|NCT02580591|523740020|FG003|Overall Study|Not treated|0|||
145243802|NCT02580591|523740017|FG000|Overall Study|Other than specified|3|||
145243803|NCT02580591|523740018|FG001|Overall Study|Other than specified|2|||
145243804|NCT02580591|523740019|FG002|Overall Study|Other than specified|5|||
145243805|NCT02580591|523740020|FG003|Overall Study|Other than specified|2|||
145408996|NCT03323502|524351923|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
145408997|NCT03323502|524351922|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
145408998|NCT03323502|524351923|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
145408999|NCT03323502|524351922|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
145409000|NCT03323502|524351923|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
145409001|NCT03323502|524351922|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
145409002|NCT03323502|524351923|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
145409003|NCT06001021|524351926|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
145409004|NCT06001021|524351927|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145409005|NCT06001021|524351928|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145409006|NCT06001021|524351929|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
145409007|NCT06001021|524351930|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
145409008|NCT06001021|524351931|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
145409009|NCT06001021|524351932|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
145409010|NCT06001021|524351926|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
145409011|NCT06001021|524351927|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145409012|NCT06001021|524351928|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145409013|NCT06001021|524351929|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
145409014|NCT06001021|524351930|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
145409015|NCT06001021|524351931|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145409016|NCT06001021|524351932|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
145409017|NCT02337829|524351933|FG000|Overall Study|Death|0|||
145409018|NCT02337829|524351934|FG001|Overall Study|Death|1|||
145243806|NCT01599806|523740024|FG000|Overall Study|Lost to Follow-up|20|||
145243807|NCT01599806|523740025|FG001|Overall Study|Lost to Follow-up|20|||
145243808|NCT01599806|523740024|FG000|Overall Study|Withdrawal by Subject|12|||
145243809|NCT01599806|523740025|FG001|Overall Study|Withdrawal by Subject|12|||
145409019|NCT02337829|524351935|FG002|Overall Study|Death|0|||
145409020|NCT02337829|524351936|FG003|Overall Study|Death|0|||
145409021|NCT02337829|524351933|FG000|Overall Study|Study terminated by sponsor|12|||
145243810|NCT01599806|523740024|FG000|Overall Study|Other Eligibility criteria|11|||
145243811|NCT01599806|523740025|FG001|Overall Study|Other Eligibility criteria|9|||
145243812|NCT03006926|523740029|FG000|Overall Study|Adverse Event|0|||
145243813|NCT03006926|523740030|FG001|Overall Study|Adverse Event|27|||
145243814|NCT03006926|523740029|FG000|Overall Study|Withdrawal by Subject|0|||
145243815|NCT03006926|523740030|FG001|Overall Study|Withdrawal by Subject|1|||
145243816|NCT03006926|523740029|FG000|Overall Study|Radiological Disease Progression|0|||
145243817|NCT03006926|523740030|FG001|Overall Study|Radiological Disease Progression|52|||
145243818|NCT03006926|523740029|FG000|Overall Study|Clinical Disease Progression|0|||
145243819|NCT03006926|523740030|FG001|Overall Study|Clinical Disease Progression|10|||
145243820|NCT03006926|523740029|FG000|Overall Study|Other|0|||
145243821|NCT03006926|523740030|FG001|Overall Study|Other|8|||
145243822|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
145243823|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
145296929|NCT01390844|523937930|FG000|Treatment Phase|Adverse Event|12|||
145296930|NCT01390844|523937931|FG001|Treatment Phase|Adverse Event|2|||
145296931|NCT01390844|523937932|FG002|Treatment Phase|Adverse Event|3|||
145296932|NCT01390844|523937933|FG003|Treatment Phase|Adverse Event|2|||
145296933|NCT01390844|523937930|FG000|Treatment Phase|Treatment Failure|23|||
145296934|NCT01390844|523937931|FG001|Treatment Phase|Treatment Failure|25|||
145296935|NCT01390844|523937932|FG002|Treatment Phase|Treatment Failure|10|||
145296936|NCT01390844|523937933|FG003|Treatment Phase|Treatment Failure|13|||
145296937|NCT01390844|523937930|FG000|Treatment Phase|Non-Medical Reasons|5|||
145296938|NCT01390844|523937931|FG001|Treatment Phase|Non-Medical Reasons|1|||
145296939|NCT01390844|523937932|FG002|Treatment Phase|Non-Medical Reasons|8|||
145296940|NCT01390844|523937933|FG003|Treatment Phase|Non-Medical Reasons|1|||
145296941|NCT01390844|523937930|FG000|Treatment Phase|Non-GCP Compliant|0|||
145296942|NCT01390844|523937931|FG001|Treatment Phase|Non-GCP Compliant|0|||
145296943|NCT01390844|523937932|FG002|Treatment Phase|Non-GCP Compliant|10|||
145296944|NCT01390844|523937933|FG003|Treatment Phase|Non-GCP Compliant|3|||
145296945|NCT01390844|523937930|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
145296946|NCT01390844|523937931|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
145296947|NCT01390844|523937932|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
145296948|NCT01390844|523937933|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
145296949|NCT02781727|523937936|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
145296950|NCT02781727|523937937|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
145296951|NCT02781727|523937936|FG000|Treatment Period|Withdrawal by Subject|1|||
145296952|NCT02781727|523937937|FG001|Treatment Period|Withdrawal by Subject|0|||
145296953|NCT02781727|523937936|FG000|Treatment Period|Lost to Follow-up|0|||
145296954|NCT02781727|523937937|FG001|Treatment Period|Lost to Follow-up|1|||
145296955|NCT00304083|523937939|FG000|Overall Study|Withdrawal by Subject|4|||
145296956|NCT00304083|523937940|FG001|Overall Study|Withdrawal by Subject|2|||
145296957|NCT00304083|523937939|FG000|Overall Study|Physician Decision|8|||
145296958|NCT00304083|523937940|FG001|Overall Study|Physician Decision|3|||
145564200|NCT00634088|524925567|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
145564201|NCT00634088|524925568|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
145564202|NCT00634088|524925569|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
145564203|NCT00634088|524925570|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
145564204|NCT00634088|524925567|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
145243824|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
145243825|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
145243826|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
145243827|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
145243828|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
145296959|NCT00304083|523937939|FG000|Overall Study|Disease Progression|5|||
145564205|NCT00634088|524925568|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
145296960|NCT00304083|523937940|FG001|Overall Study|Disease Progression|1|||
145296961|NCT00304083|523937939|FG000|Overall Study|Other|5|||
145296962|NCT00304083|523937940|FG001|Overall Study|Other|2|||
145296963|NCT01378975|523937941|FG000|Overall Study|Death|77|||
145564206|NCT00634088|524925569|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
145564207|NCT00634088|524925570|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
145564208|NCT00634088|524925567|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
145564209|NCT00634088|524925568|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
145564210|NCT00634088|524925569|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
145243829|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
145243830|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
145243831|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
145564211|NCT00634088|524925570|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
145243832|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
145296964|NCT01378975|523937942|FG001|Overall Study|Death|46|||
145296965|NCT01378975|523937941|FG000|Overall Study|Investigator Request|1|||
145296966|NCT01378975|523937942|FG001|Overall Study|Investigator Request|0|||
145296967|NCT01378975|523937941|FG000|Overall Study|Lost to Follow-up|4|||
145296968|NCT01378975|523937942|FG001|Overall Study|Lost to Follow-up|1|||
145296969|NCT01378975|523937941|FG000|Overall Study|Withdrew Consent|4|||
145296970|NCT01378975|523937942|FG001|Overall Study|Withdrew Consent|3|||
145296971|NCT03125200|523937947|FG000|Overall Study|Study Termination|0|||
145564212|NCT00634088|524925567|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
145564213|NCT00634088|524925568|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
145564214|NCT00634088|524925569|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
145564215|NCT00634088|524925570|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
145564216|NCT00634088|524925567|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
145564217|NCT00634088|524925568|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
145564218|NCT00634088|524925569|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
145564219|NCT00634088|524925570|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
145564220|NCT00634088|524925567|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
145564221|NCT00634088|524925568|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
145564222|NCT00634088|524925569|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
145564223|NCT00634088|524925570|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
145564224|NCT02439320|524925579|FG000|Overall Study|Adverse Event|0|||
145564225|NCT02439320|524925580|FG001|Overall Study|Adverse Event|2|||
145564226|NCT02439320|524925581|FG002|Overall Study|Adverse Event|0|||
145564227|NCT02439320|524925579|FG000|Overall Study|Lost to Follow-up|37|||
145564228|NCT02439320|524925580|FG001|Overall Study|Lost to Follow-up|34|||
145564229|NCT02439320|524925581|FG002|Overall Study|Lost to Follow-up|42|||
145564230|NCT02439320|524925579|FG000|Overall Study|Death|0|||
145564231|NCT02439320|524925580|FG001|Overall Study|Death|1|||
145564232|NCT02439320|524925581|FG002|Overall Study|Death|0|||
145564233|NCT02439320|524925579|FG000|Overall Study|Noncompliance with Protocol|10|||
145564234|NCT02439320|524925580|FG001|Overall Study|Noncompliance with Protocol|11|||
145564235|NCT02439320|524925581|FG002|Overall Study|Noncompliance with Protocol|7|||
145564236|NCT02439320|524925579|FG000|Overall Study|Pregnancy|0|||
145564237|NCT02439320|524925580|FG001|Overall Study|Pregnancy|1|||
145564238|NCT02439320|524925581|FG002|Overall Study|Pregnancy|1|||
145564239|NCT02439320|524925579|FG000|Overall Study|Withdrawal by Subject|12|||
145564240|NCT02439320|524925580|FG001|Overall Study|Withdrawal by Subject|16|||
145564241|NCT02439320|524925581|FG002|Overall Study|Withdrawal by Subject|14|||
145564242|NCT02439320|524925579|FG000|Overall Study|Physician Decision|2|||
145564243|NCT02439320|524925580|FG001|Overall Study|Physician Decision|1|||
145564244|NCT02439320|524925581|FG002|Overall Study|Physician Decision|0|||
145564245|NCT02439320|524925579|FG000|Overall Study|Sponsor Request|0|||
145564246|NCT02439320|524925580|FG001|Overall Study|Sponsor Request|2|||
145564247|NCT02439320|524925581|FG002|Overall Study|Sponsor Request|1|||
145564248|NCT02439320|524925579|FG000|Overall Study|Randomization Failure|35|||
145564249|NCT02439320|524925580|FG001|Overall Study|Randomization Failure|46|||
145564250|NCT02439320|524925581|FG002|Overall Study|Randomization Failure|34|||
145564251|NCT03343483|524925587|FG000|Overall Study|Death|0|||
145564252|NCT03343483|524925588|FG001|Overall Study|Death|3|||
145564253|NCT03343483|524925587|FG000|Overall Study|Lost to Follow-up|9|||
145564254|NCT03343483|524925588|FG001|Overall Study|Lost to Follow-up|13|||
145564255|NCT03343483|524925587|FG000|Overall Study|Withdrawal by Subject|8|||
145564256|NCT03343483|524925588|FG001|Overall Study|Withdrawal by Subject|17|||
145564257|NCT01505608|524925589|FG000|Phase I|Lack of Efficacy|0|||
145564258|NCT01505608|524925590|FG001|Phase I|Lack of Efficacy|4|||
145564259|NCT01505608|524925589|FG000|Phase I|Adverse Event|0|||
145564260|NCT01505608|524925590|FG001|Phase I|Adverse Event|1|||
145564261|NCT01505608|524925589|FG000|Phase I|Withdrawal by Subject|0|||
145564262|NCT01505608|524925590|FG001|Phase I|Withdrawal by Subject|1|||
145564263|NCT01505608|524925589|FG000|Phase II|Lack of Efficacy|2|||
145564264|NCT01505608|524925590|FG001|Phase II|Lack of Efficacy|1|||
145564265|NCT01505608|524925589|FG000|Phase II|Protocol Violation|0|||
145564266|NCT01505608|524925590|FG001|Phase II|Protocol Violation|1|||
145564267|NCT03969992|524925595|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
145243833|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
145243834|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
145564268|NCT03969992|524925596|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
145564269|NCT03969992|524925597|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
145564270|NCT03969992|524925595|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
145564271|NCT03969992|524925596|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
145564272|NCT03969992|524925597|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
145564273|NCT03969992|524925595|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
145564274|NCT03969992|524925596|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
145564275|NCT03969992|524925597|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
145564276|NCT03969992|524925595|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
145243835|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
145243836|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
145564277|NCT03969992|524925596|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
145564278|NCT03969992|524925597|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
145564279|NCT03969992|524925595|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
145564280|NCT03969992|524925596|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
145564281|NCT03969992|524925597|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
145564282|NCT02063737|524925598|FG000|Overall Study|Lost to Follow-up|11|||
145296972|NCT03125200|523937948|FG001|Overall Study|Study Termination|0|||
145296973|NCT03125200|523937949|FG002|Overall Study|Study Termination|0|||
145296974|NCT03125200|523937950|FG003|Overall Study|Study Termination|1|||
145296975|NCT03125200|523937951|FG004|Overall Study|Study Termination|1|||
145296976|NCT03125200|523937952|FG005|Overall Study|Study Termination|2|||
145296977|NCT03125200|523937953|FG006|Overall Study|Study Termination|1|||
145296978|NCT03125200|523937947|FG000|Overall Study|Clinical Progression|0|||
145296979|NCT03125200|523937948|FG001|Overall Study|Clinical Progression|0|||
145296980|NCT03125200|523937949|FG002|Overall Study|Clinical Progression|0|||
145296981|NCT03125200|523937950|FG003|Overall Study|Clinical Progression|1|||
145296982|NCT03125200|523937951|FG004|Overall Study|Clinical Progression|0|||
145296983|NCT03125200|523937952|FG005|Overall Study|Clinical Progression|1|||
145296984|NCT03125200|523937953|FG006|Overall Study|Clinical Progression|0|||
145296985|NCT03125200|523937947|FG000|Overall Study|Progressive Disease|2|||
145296986|NCT03125200|523937948|FG001|Overall Study|Progressive Disease|1|||
145296987|NCT03125200|523937949|FG002|Overall Study|Progressive Disease|2|||
145296988|NCT03125200|523937950|FG003|Overall Study|Progressive Disease|1|||
145296989|NCT03125200|523937951|FG004|Overall Study|Progressive Disease|2|||
145296990|NCT03125200|523937952|FG005|Overall Study|Progressive Disease|0|||
145296991|NCT03125200|523937953|FG006|Overall Study|Progressive Disease|1|||
145296992|NCT03125200|523937947|FG000|Overall Study|Lack of Efficacy|0|||
145296993|NCT03125200|523937948|FG001|Overall Study|Lack of Efficacy|0|||
145296994|NCT03125200|523937949|FG002|Overall Study|Lack of Efficacy|0|||
145296995|NCT03125200|523937950|FG003|Overall Study|Lack of Efficacy|1|||
145296996|NCT03125200|523937951|FG004|Overall Study|Lack of Efficacy|0|||
145296997|NCT03125200|523937952|FG005|Overall Study|Lack of Efficacy|0|||
145296998|NCT03125200|523937953|FG006|Overall Study|Lack of Efficacy|0|||
145296999|NCT03125200|523937947|FG000|Overall Study|Toxicity|0|||
145297000|NCT03125200|523937948|FG001|Overall Study|Toxicity|0|||
145297001|NCT03125200|523937949|FG002|Overall Study|Toxicity|0|||
145297002|NCT03125200|523937950|FG003|Overall Study|Toxicity|1|||
145297003|NCT03125200|523937951|FG004|Overall Study|Toxicity|0|||
145297004|NCT03125200|523937952|FG005|Overall Study|Toxicity|0|||
145243837|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
145297005|NCT03125200|523937953|FG006|Overall Study|Toxicity|0|||
145297006|NCT03125200|523937947|FG000|Overall Study|Consent Withdrawn by Subject|0|||
145297007|NCT03125200|523937948|FG001|Overall Study|Consent Withdrawn by Subject|1|||
145297008|NCT03125200|523937949|FG002|Overall Study|Consent Withdrawn by Subject|0|||
145243838|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
145243839|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
145243840|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
145243841|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
145243842|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
145243843|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
145243844|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
145243845|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
145243846|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
145243847|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
145243848|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
145243849|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
145297009|NCT03125200|523937950|FG003|Overall Study|Consent Withdrawn by Subject|0|||
145297010|NCT03125200|523937951|FG004|Overall Study|Consent Withdrawn by Subject|1|||
145297011|NCT03125200|523937952|FG005|Overall Study|Consent Withdrawn by Subject|0|||
145297012|NCT03125200|523937953|FG006|Overall Study|Consent Withdrawn by Subject|1|||
145297013|NCT01937390|523937957|FG000|Overall Study|Death|2|||
145297014|NCT01937390|523937957|FG000|Overall Study|Lost to Follow-up|7|||
145297015|NCT01937390|523937957|FG000|Overall Study|Withdrawal by Subject|5|||
145297016|NCT01937390|523937957|FG000|Overall Study|Fail to return|21|||
145297017|NCT03144687|523937960|FG000|Overall Study|Death|0|||
145297018|NCT03144687|523937961|FG001|Overall Study|Death|2|||
145297019|NCT03144687|523937960|FG000|Overall Study|Lost to Follow-up|0|||
145297020|NCT03144687|523937961|FG001|Overall Study|Lost to Follow-up|1|||
145297021|NCT03144687|523937960|FG000|Overall Study|Physician Decision|0|||
145297022|NCT03144687|523937961|FG001|Overall Study|Physician Decision|1|||
145297023|NCT03144687|523937960|FG000|Overall Study|Withdrawal by Subject|1|||
145297024|NCT03144687|523937961|FG001|Overall Study|Withdrawal by Subject|3|||
145297025|NCT03144687|523937960|FG000|Overall Study|Not Reported|2|||
145297026|NCT03144687|523937961|FG001|Overall Study|Not Reported|0|||
145297027|NCT05017480|523939358|FG000|Stage 1 Study|Withdrawal by Subject|8|||
145297028|NCT05017480|523939359|FG001|Stage 1 Study|Withdrawal by Subject|6|||
145297029|NCT05017480|523939360|FG002|Stage 1 Study|Withdrawal by Subject|0|||
145297030|NCT05017480|523939361|FG003|Stage 1 Study|Withdrawal by Subject|0|||
145297031|NCT05017480|523939362|FG004|Stage 1 Study|Withdrawal by Subject|0|||
145297032|NCT05017480|523939358|FG000|Stage 1 Study|Adverse Event|1|||
145297033|NCT05017480|523939359|FG001|Stage 1 Study|Adverse Event|1|||
145297034|NCT05017480|523939360|FG002|Stage 1 Study|Adverse Event|0|||
145564283|NCT02063737|524925599|FG001|Overall Study|Lost to Follow-up|4|||
145564284|NCT00439556|524925600|FG000|Overall Study|Patient was taken off study for non-comp|0|||
145564285|NCT00439556|524925601|FG001|Overall Study|Patient was taken off study for non-comp|1|||
145564286|NCT00439556|524925602|FG002|Overall Study|Patient was taken off study for non-comp|0|||
145564287|NCT01324388|524925605|FG000|Part 1 of Study|Adverse Event|2|||
145564288|NCT01324388|524925606|FG001|Part 1 of Study|Adverse Event|0|||
145564289|NCT01324388|524925607|FG002|Part 1 of Study|Adverse Event|0|||
145564290|NCT01324388|524925608|FG003|Part 1 of Study|Adverse Event|0|||
145564291|NCT01324388|524925605|FG000|Part 1 of Study|Protocol Violation|1|||
145564292|NCT01324388|524925606|FG001|Part 1 of Study|Protocol Violation|2|||
145564293|NCT01324388|524925607|FG002|Part 1 of Study|Protocol Violation|0|||
145564294|NCT01324388|524925608|FG003|Part 1 of Study|Protocol Violation|0|||
145564295|NCT01324388|524925605|FG000|Part 1 of Study|Physician Decision|1|||
145564296|NCT01324388|524925606|FG001|Part 1 of Study|Physician Decision|0|||
145564297|NCT01324388|524925607|FG002|Part 1 of Study|Physician Decision|0|||
145564298|NCT01324388|524925608|FG003|Part 1 of Study|Physician Decision|0|||
145564299|NCT01324388|524925605|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
145564300|NCT01324388|524925606|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
145564301|NCT01324388|524925607|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
145564302|NCT01324388|524925608|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
145564303|NCT01324388|524925605|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
145564304|NCT01324388|524925606|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
145564305|NCT01324388|524925607|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
145564306|NCT01324388|524925608|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
145564307|NCT01405963|524925609|FG000|Overall Study|Moved Away|2|||
145564308|NCT01405963|524925610|FG001|Overall Study|Moved Away|0|||
145564309|NCT01405963|524925609|FG000|Overall Study|Adverse Event|0|||
145564310|NCT01405963|524925610|FG001|Overall Study|Adverse Event|1|||
145564311|NCT01405963|524925609|FG000|Overall Study|Lost to Follow-up|0|||
145564312|NCT01405963|524925610|FG001|Overall Study|Lost to Follow-up|1|||
145564313|NCT01498640|524925611|FG000|Overall Study|Lost to Follow-up|1|||
145564314|NCT01498640|524925611|FG000|Overall Study|Death|1|||
145564315|NCT01498640|524925611|FG000|Overall Study|Other|3|||
145564316|NCT01737047|524925612|FG000|Overall Study|Death|10|||
145564317|NCT01737047|524925613|FG001|Overall Study|Death|0|||
145564318|NCT01737047|524925614|FG002|Overall Study|Death|1|||
145564319|NCT01737047|524925612|FG000|Overall Study|Withdrawal by Subject|17|||
145564320|NCT01737047|524925613|FG001|Overall Study|Withdrawal by Subject|11|||
145564321|NCT01737047|524925614|FG002|Overall Study|Withdrawal by Subject|4|||
145620103|NCT01628874|525123681|FG000|Overall Study|Age >4 months|4|||
145620104|NCT01628874|525123682|FG001|Overall Study|Age >4 months|2|||
145620105|NCT00873093|525123683|FG000|Overall Study|Adverse Event|0|||
145243850|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
145243851|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
145243852|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
145243853|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
145243854|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
145243855|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
145243856|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
145243857|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
145243858|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
145243859|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
145243860|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
145243861|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
145243862|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
145243863|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
145243864|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
145243865|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
145564322|NCT00129129|524925615|FG000|Primary Phase|Adverse Event|2|||
145243866|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
145243867|NCT03689972|523740031|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
145243868|NCT03689972|523740032|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
145243869|NCT03689972|523740033|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
145564323|NCT00129129|524925616|FG001|Primary Phase|Adverse Event|1|||
145564324|NCT00129129|524925617|FG002|Primary Phase|Adverse Event|0|||
145564325|NCT00129129|524925618|FG003|Primary Phase|Adverse Event|0|||
145564326|NCT00129129|524925619|FG004|Primary Phase|Adverse Event|0|||
145564327|NCT00129129|524925615|FG000|Primary Phase|Withdrawal by Subject|12|||
145564328|NCT00129129|524925616|FG001|Primary Phase|Withdrawal by Subject|10|||
145564329|NCT00129129|524925617|FG002|Primary Phase|Withdrawal by Subject|0|||
145564330|NCT00129129|524925618|FG003|Primary Phase|Withdrawal by Subject|0|||
145620106|NCT00873093|525123684|FG001|Overall Study|Adverse Event|2|||
145620107|NCT00873093|525123685|FG002|Overall Study|Adverse Event|0|||
145564331|NCT00129129|524925619|FG004|Primary Phase|Withdrawal by Subject|0|||
145564332|NCT00129129|524925615|FG000|Primary Phase|Migration from study area|1|||
145564333|NCT00129129|524925616|FG001|Primary Phase|Migration from study area|3|||
145564334|NCT00129129|524925617|FG002|Primary Phase|Migration from study area|0|||
145564335|NCT00129129|524925618|FG003|Primary Phase|Migration from study area|0|||
145564336|NCT00129129|524925619|FG004|Primary Phase|Migration from study area|0|||
145564337|NCT00129129|524925615|FG000|Primary Phase|Lost to Follow-up|8|||
145564338|NCT00129129|524925616|FG001|Primary Phase|Lost to Follow-up|6|||
145564339|NCT00129129|524925617|FG002|Primary Phase|Lost to Follow-up|0|||
145564340|NCT00129129|524925618|FG003|Primary Phase|Lost to Follow-up|0|||
145564341|NCT00129129|524925619|FG004|Primary Phase|Lost to Follow-up|0|||
145564342|NCT00129129|524925615|FG000|Primary Phase|Other|2|||
145620108|NCT00873093|525123686|FG003|Overall Study|Adverse Event|0|||
145620109|NCT00873093|525123687|FG004|Overall Study|Adverse Event|0|||
145243870|NCT03689972|523740034|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
145243871|NCT03689972|523740035|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
145243872|NCT03689972|523740031|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
145243873|NCT03689972|523740032|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
145243874|NCT03689972|523740033|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
145243875|NCT03689972|523740034|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
145243876|NCT03689972|523740035|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
145243877|NCT03689972|523740031|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
145243878|NCT03689972|523740032|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
145243879|NCT03689972|523740033|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
145243880|NCT03689972|523740034|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
145243881|NCT03689972|523740035|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
145243882|NCT03689972|523740031|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
145243883|NCT03689972|523740032|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
145243884|NCT03689972|523740033|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
145243885|NCT03689972|523740034|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
145243886|NCT03689972|523740035|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
145243887|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
145243888|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
145243889|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
145243890|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
145243891|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
145243892|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
145243893|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
145243894|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
145243895|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
145243896|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
145243897|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
145243898|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
145243899|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
145243900|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
145243901|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
145243902|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
145243903|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
145243904|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
145243905|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
145243906|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
145243907|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
145243908|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
145243909|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
145297035|NCT05017480|523939361|FG003|Stage 1 Study|Adverse Event|0|||
145297036|NCT05017480|523939362|FG004|Stage 1 Study|Adverse Event|0|||
145297037|NCT05017480|523939358|FG000|Stage 1 Study|Poor Compliance|1|||
145297038|NCT05017480|523939359|FG001|Stage 1 Study|Poor Compliance|1|||
145297039|NCT05017480|523939360|FG002|Stage 1 Study|Poor Compliance|0|||
145297040|NCT05017480|523939361|FG003|Stage 1 Study|Poor Compliance|0|||
145297041|NCT05017480|523939362|FG004|Stage 1 Study|Poor Compliance|0|||
145297042|NCT05017480|523939358|FG000|Stage 1 Study|Physician Decision|0|||
145243910|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
145243911|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
145297043|NCT05017480|523939359|FG001|Stage 1 Study|Physician Decision|1|||
145564343|NCT00129129|524925616|FG001|Primary Phase|Other|5|||
145564344|NCT00129129|524925617|FG002|Primary Phase|Other|0|||
145564345|NCT00129129|524925618|FG003|Primary Phase|Other|0|||
145620110|NCT00873093|525123683|FG000|Overall Study|Death|0|||
145297044|NCT05017480|523939360|FG002|Stage 1 Study|Physician Decision|0|||
145297045|NCT05017480|523939361|FG003|Stage 1 Study|Physician Decision|0|||
145297046|NCT05017480|523939362|FG004|Stage 1 Study|Physician Decision|0|||
145297047|NCT05017480|523939358|FG000|Stage 2 Study|Withdrawal by Subject|0|||
145297048|NCT05017480|523939359|FG001|Stage 2 Study|Withdrawal by Subject|0|||
145297049|NCT05017480|523939360|FG002|Stage 2 Study|Withdrawal by Subject|6|||
145297050|NCT05017480|523939361|FG003|Stage 2 Study|Withdrawal by Subject|9|||
145297051|NCT05017480|523939362|FG004|Stage 2 Study|Withdrawal by Subject|11|||
145297052|NCT05017480|523939358|FG000|Stage 2 Study|Lost to Follow-up|0|||
145297053|NCT05017480|523939359|FG001|Stage 2 Study|Lost to Follow-up|0|||
145297054|NCT05017480|523939360|FG002|Stage 2 Study|Lost to Follow-up|0|||
145297055|NCT05017480|523939361|FG003|Stage 2 Study|Lost to Follow-up|2|||
145297056|NCT05017480|523939362|FG004|Stage 2 Study|Lost to Follow-up|1|||
145297057|NCT05017480|523939358|FG000|Stage 2 Study|Adverse Event|0|||
145297058|NCT05017480|523939359|FG001|Stage 2 Study|Adverse Event|0|||
145297059|NCT05017480|523939360|FG002|Stage 2 Study|Adverse Event|0|||
145297060|NCT05017480|523939361|FG003|Stage 2 Study|Adverse Event|1|||
145297061|NCT05017480|523939362|FG004|Stage 2 Study|Adverse Event|0|||
145297062|NCT05017480|523939358|FG000|Stage 2 Study|COVID-19|0|||
145297063|NCT05017480|523939359|FG001|Stage 2 Study|COVID-19|0|||
145297064|NCT05017480|523939360|FG002|Stage 2 Study|COVID-19|0|||
145297065|NCT05017480|523939361|FG003|Stage 2 Study|COVID-19|1|||
145297066|NCT05017480|523939362|FG004|Stage 2 Study|COVID-19|0|||
145297067|NCT05017480|523939358|FG000|Stage 2 Study|Pregnancy|0|||
145297068|NCT05017480|523939359|FG001|Stage 2 Study|Pregnancy|0|||
145297069|NCT05017480|523939360|FG002|Stage 2 Study|Pregnancy|0|||
145297070|NCT05017480|523939361|FG003|Stage 2 Study|Pregnancy|0|||
145243912|NCT03689972|523740031|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
145243913|NCT03689972|523740032|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
145243914|NCT03689972|523740033|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
145243915|NCT03689972|523740034|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
145243916|NCT03689972|523740035|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
145243917|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
145243918|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
145243919|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
145243920|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
145243921|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
145243922|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
145243923|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
145297071|NCT05017480|523939362|FG004|Stage 2 Study|Pregnancy|1|||
145297072|NCT01136382|523939363|FG000|Overall Study|Other|8|||
145297073|NCT01136382|523939364|FG001|Overall Study|Other|3|||
145297074|NCT01136382|523939363|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
145297075|NCT01136382|523939364|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
145297076|NCT01136382|523939363|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
145297077|NCT01136382|523939364|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
145297078|NCT01136382|523939363|FG000|Overall Study|Withdrawal by Subject|4|||
145297079|NCT01136382|523939364|FG001|Overall Study|Withdrawal by Subject|1|||
145297080|NCT02653664|523939372|FG000|Post-Treatment|Withdrawal by Subject|6|||
145564346|NCT00129129|524925619|FG004|Primary Phase|Other|0|||
145564347|NCT00129129|524925615|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
145564348|NCT00129129|524925616|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
145564349|NCT00129129|524925617|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
145564350|NCT00129129|524925618|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
145564351|NCT00129129|524925619|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
145564352|NCT00129129|524925615|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
145564353|NCT00129129|524925616|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
145564354|NCT00129129|524925617|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
145564355|NCT00129129|524925618|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
145564356|NCT00129129|524925619|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
145564357|NCT00129129|524925615|FG000|Fourth Dose Phase|Migration from study area|0|||
145564358|NCT00129129|524925616|FG001|Fourth Dose Phase|Migration from study area|0|||
145564359|NCT00129129|524925617|FG002|Fourth Dose Phase|Migration from study area|0|||
145564360|NCT00129129|524925618|FG003|Fourth Dose Phase|Migration from study area|0|||
145564361|NCT00129129|524925619|FG004|Fourth Dose Phase|Migration from study area|2|||
145564362|NCT00129129|524925615|FG000|Fourth Dose Phase|Other|0|||
145564363|NCT00129129|524925616|FG001|Fourth Dose Phase|Other|0|||
145564364|NCT00129129|524925617|FG002|Fourth Dose Phase|Other|0|||
145564365|NCT00129129|524925618|FG003|Fourth Dose Phase|Other|1|||
145564366|NCT00129129|524925619|FG004|Fourth Dose Phase|Other|1|||
145564367|NCT00129129|524925615|FG000|Fourth Dose Phase|Protocol Violation|0|||
145564368|NCT00129129|524925616|FG001|Fourth Dose Phase|Protocol Violation|0|||
145297081|NCT02653664|523939373|FG001|Post-Treatment|Withdrawal by Subject|5|||
145297082|NCT02653664|523939374|FG002|Post-Treatment|Withdrawal by Subject|7|||
145297083|NCT02653664|523939372|FG000|Post-Treatment|Lost to Follow-up|8|||
145297084|NCT02653664|523939373|FG001|Post-Treatment|Lost to Follow-up|1|||
145243924|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
145243925|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
145243926|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
145243927|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
145243928|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
145243929|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
145243930|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
145243931|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
145243932|NCT02417064|523740036|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
145243933|NCT02417064|523740037|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
145243934|NCT02417064|523740038|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
145243935|NCT02417064|523740036|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
145243936|NCT02417064|523740037|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
145243937|NCT02417064|523740038|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
145243938|NCT02417064|523740036|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
145243939|NCT02417064|523740037|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
145243940|NCT02417064|523740038|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
145243941|NCT02417064|523740036|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
145243942|NCT02417064|523740037|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
145243943|NCT02417064|523740038|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
145243944|NCT02417064|523740036|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
145243945|NCT02417064|523740037|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
145243946|NCT02417064|523740038|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
145243947|NCT02417064|523740036|FG000|Follow-up Phase (24 Weeks)|Other|2|||
145243948|NCT02417064|523740037|FG001|Follow-up Phase (24 Weeks)|Other|2|||
145243949|NCT02417064|523740038|FG002|Follow-up Phase (24 Weeks)|Other|3|||
145243950|NCT04882072|523740039|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
145243951|NCT04882072|523740040|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
145243952|NCT04882072|523740039|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
145243953|NCT04882072|523740040|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
145243954|NCT04882072|523740039|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
145243955|NCT04882072|523740040|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
145243956|NCT00732641|523740041|FG000|Overall Study|Relapse or Progressive Disease|65|||
145243957|NCT00732641|523740042|FG001|Overall Study|Relapse or Progressive Disease|101|||
145243958|NCT00732641|523740041|FG000|Overall Study|Serious Adverse Events|12|||
145243959|NCT00732641|523740042|FG001|Overall Study|Serious Adverse Events|3|||
145243960|NCT00732641|523740041|FG000|Overall Study|Physician Decision|6|||
145243961|NCT00732641|523740042|FG001|Overall Study|Physician Decision|0|||
145243962|NCT00732641|523740041|FG000|Overall Study|Withdrawal by Subject|4|||
145243963|NCT00732641|523740042|FG001|Overall Study|Withdrawal by Subject|2|||
145243964|NCT00732641|523740041|FG000|Overall Study|Unable to Complete|1|||
145243965|NCT00732641|523740042|FG001|Overall Study|Unable to Complete|1|||
145243966|NCT00732641|523740041|FG000|Overall Study|Other|18|||
145243967|NCT00732641|523740042|FG001|Overall Study|Other|5|||
145243968|NCT01192100|523740043|FG000|Overall Study|Withdrawal by Subject|0|||
145243969|NCT01192100|523740044|FG001|Overall Study|Withdrawal by Subject|0|||
145243970|NCT01192100|523740045|FG002|Overall Study|Withdrawal by Subject|0|||
145243971|NCT01192100|523740046|FG003|Overall Study|Withdrawal by Subject|0|||
145243972|NCT01192100|523740047|FG004|Overall Study|Withdrawal by Subject|1|||
145243973|NCT01192100|523740048|FG005|Overall Study|Withdrawal by Subject|0|||
145243974|NCT01192100|523740043|FG000|Overall Study|Protocol Violation|0|||
145243975|NCT01192100|523740044|FG001|Overall Study|Protocol Violation|0|||
145243976|NCT01192100|523740045|FG002|Overall Study|Protocol Violation|0|||
145243977|NCT01192100|523740046|FG003|Overall Study|Protocol Violation|1|||
145243978|NCT01192100|523740047|FG004|Overall Study|Protocol Violation|0|||
145243979|NCT01192100|523740048|FG005|Overall Study|Protocol Violation|0|||
145243980|NCT02475629|523740049|FG000|Overall Study|Adverse Event|1|||
145243981|NCT02475629|523740049|FG000|Overall Study|Death|4|||
145243982|NCT02475629|523740049|FG000|Overall Study|Physician Decision|1|||
145243983|NCT02475629|523740049|FG000|Overall Study|Withdrawal by Subject|1|||
145243984|NCT02475629|523740049|FG000|Overall Study|Lost to Follow-up|1|||
145243985|NCT02475629|523740049|FG000|Overall Study|Subject non-compliance|1|||
145243986|NCT01095666|523740050|FG000|Overall Study|Lack of Efficacy|0|||
145243987|NCT01095666|523740051|FG001|Overall Study|Lack of Efficacy|0|||
145243988|NCT01095666|523740052|FG002|Overall Study|Lack of Efficacy|1|||
145243989|NCT01095666|523740050|FG000|Overall Study|Adverse Event|2|||
145243990|NCT01095666|523740051|FG001|Overall Study|Adverse Event|1|||
145243991|NCT01095666|523740052|FG002|Overall Study|Adverse Event|3|||
145243992|NCT01095666|523740050|FG000|Overall Study|Lost to Follow-up|2|||
145243993|NCT01095666|523740051|FG001|Overall Study|Lost to Follow-up|2|||
145243994|NCT01095666|523740052|FG002|Overall Study|Lost to Follow-up|0|||
145243995|NCT01095666|523740050|FG000|Overall Study|Withdrawal by Subject|6|||
145243996|NCT01095666|523740051|FG001|Overall Study|Withdrawal by Subject|6|||
145243997|NCT01095666|523740052|FG002|Overall Study|Withdrawal by Subject|1|||
145564369|NCT00129129|524925617|FG002|Fourth Dose Phase|Protocol Violation|0|||
145564370|NCT00129129|524925618|FG003|Fourth Dose Phase|Protocol Violation|1|||
145243998|NCT01095666|523740050|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
145243999|NCT01095666|523740051|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
145244000|NCT01095666|523740052|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
145244001|NCT00924729|523740065|FG000|Overall Study|insufficient volume for analysis|1|||
145244002|NCT00924729|523740066|FG001|Overall Study|insufficient volume for analysis|0|||
145244003|NCT00924729|523740065|FG000|Overall Study|Protocol Violation|1|||
145244004|NCT00924729|523740066|FG001|Overall Study|Protocol Violation|0|||
145244005|NCT01814826|523740069|FG000|Overall Study|Other|3|||
145244006|NCT01814826|523740070|FG001|Overall Study|Other|5|||
145244007|NCT01814826|523740071|FG002|Overall Study|Other|0|||
145244008|NCT01814826|523740069|FG000|Overall Study|Death|29|||
145244009|NCT01814826|523740070|FG001|Overall Study|Death|24|||
145244010|NCT01814826|523740071|FG002|Overall Study|Death|3|||
145244011|NCT02917629|523740072|FG000|Overall Study|Withdrawal by Subject|0|||
145244012|NCT02917629|523740073|FG001|Overall Study|Withdrawal by Subject|1|||
145244013|NCT03339401|523740074|FG000|Overall Study|Death|2|||
145244014|NCT03339401|523740075|FG001|Overall Study|Death|1|||
145244015|NCT03339401|523740074|FG000|Overall Study|Withdrawal by Subject|2|||
145244016|NCT03339401|523740075|FG001|Overall Study|Withdrawal by Subject|0|||
145244017|NCT03339401|523740074|FG000|Overall Study|Study terminated|4|||
145244018|NCT03339401|523740075|FG001|Overall Study|Study terminated|3|||
145244019|NCT03339401|523740074|FG000|Overall Study|Investigator Decision|1|||
145244020|NCT03339401|523740075|FG001|Overall Study|Investigator Decision|0|||
145244021|NCT00718523|523740076|FG000|Overall Study|Withdrawal by Subject|5|||
145244022|NCT00718523|523740077|FG001|Overall Study|Withdrawal by Subject|7|||
145244023|NCT00718523|523740076|FG000|Overall Study|Death|13|||
145244024|NCT00718523|523740077|FG001|Overall Study|Death|17|||
145244025|NCT01042938|523740078|FG000|Overall Study|Withdrawal by Subject|1|||
145244026|NCT01042938|523740079|FG001|Overall Study|Withdrawal by Subject|1|||
145244027|NCT01042938|523740078|FG000|Overall Study|Protocol Violation|1|||
145244028|NCT01042938|523740079|FG001|Overall Study|Protocol Violation|1|||
145244029|NCT01042938|523740078|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
145244030|NCT01042938|523740079|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
145244031|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
145244032|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
145244033|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
145244034|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
145244035|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
145244036|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
145244037|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
145244038|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
145244039|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
145244040|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
145244041|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
145244042|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
145244043|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
145244044|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
145244045|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
145244046|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
145244047|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
145244048|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
145244049|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
145244050|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
145244051|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
145244052|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
145244053|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
145244054|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
145244055|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
145244056|NCT00856986|523740080|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
145244057|NCT00856986|523740081|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
145297085|NCT02653664|523939374|FG002|Post-Treatment|Lost to Follow-up|7|||
145297086|NCT02653664|523939372|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
145297087|NCT02653664|523939373|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
145297088|NCT02653664|523939374|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
145297089|NCT02653664|523939372|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
145297090|NCT02653664|523939373|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
145297091|NCT02653664|523939374|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
145297092|NCT02653664|523939372|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
145297093|NCT02653664|523939373|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
145297094|NCT02653664|523939374|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
145297095|NCT02653664|523939372|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
145377813|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145244058|NCT00856986|523740082|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
145244059|NCT00856986|523740083|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
145244060|NCT00856986|523740084|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
145244061|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
145244062|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
145244063|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
145244064|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
145244065|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
145244066|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
145244067|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
145244068|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
145244069|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
145244070|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
145244071|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
145244072|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
145244073|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
145244074|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
145244075|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
145244076|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
145244077|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
145244078|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
145244079|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
145244080|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
145244081|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
145244082|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
145244083|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
145244084|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
145244085|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
145244086|NCT00856986|523740080|FG000|Main Period, Weeks 0-26|Unclassified|7|||
145244087|NCT00856986|523740081|FG001|Main Period, Weeks 0-26|Unclassified|6|||
145244088|NCT00856986|523740082|FG002|Main Period, Weeks 0-26|Unclassified|7|||
145244089|NCT00856986|523740083|FG003|Main Period, Weeks 0-26|Unclassified|0|||
145244090|NCT00856986|523740084|FG004|Main Period, Weeks 0-26|Unclassified|0|||
145244091|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
145244092|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
145244093|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
145244094|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
145244095|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
145244096|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
145244097|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
145244098|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
145244099|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
145244100|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
145244101|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
145244102|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
145244103|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
145244104|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
145297096|NCT02653664|523939373|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
145297097|NCT02653664|523939374|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
145297098|NCT02653664|523939372|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
145297099|NCT02653664|523939373|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
145297100|NCT02653664|523939374|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
145297101|NCT02653664|523939372|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
145297102|NCT02653664|523939373|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
145297103|NCT02653664|523939374|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
145297104|NCT02653664|523939372|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
145297105|NCT02653664|523939373|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
145297106|NCT02653664|523939374|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
145297107|NCT02653664|523939372|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
145297108|NCT02653664|523939373|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
145297109|NCT02653664|523939374|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
145297110|NCT04657770|523939375|FG000|Overall Study|Withdrawal by Subject|3|||
145297111|NCT04657770|523939375|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
145297112|NCT00746798|523939376|FG000|Overall Study|Protocol Violation|0|||
145297113|NCT00746798|523939377|FG001|Overall Study|Protocol Violation|1|||
145297114|NCT00746798|523939378|FG002|Overall Study|Protocol Violation|0|||
145409022|NCT02337829|524351934|FG001|Overall Study|Study terminated by sponsor|10|||
145409023|NCT02337829|524351935|FG002|Overall Study|Study terminated by sponsor|5|||
145244105|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
145244106|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
145244107|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
145244108|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
145244109|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
145244110|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
145244111|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
145244112|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
145244113|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
145244114|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
145244115|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
145244116|NCT00856986|523740080|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
145244117|NCT00856986|523740081|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
145244118|NCT00856986|523740082|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
145244119|NCT00856986|523740083|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
145244120|NCT00856986|523740084|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
145244121|NCT03032510|523740085|FG000|Overall Study|Adverse Event|5|||
145244122|NCT03032510|523740086|FG001|Overall Study|Adverse Event|2|||
145244123|NCT03032510|523740085|FG000|Overall Study|Lost to Follow-up|8|||
145244124|NCT03032510|523740086|FG001|Overall Study|Lost to Follow-up|7|||
145564371|NCT00129129|524925619|FG004|Fourth Dose Phase|Protocol Violation|0|||
145564372|NCT03089606|524925620|FG000|Overall Study|Progression after Cycle 1|1|||
145564373|NCT00335972|524925621|FG000|Overall Study|not given treatments|0|||
145564374|NCT00335972|524925622|FG001|Overall Study|not given treatments|3|||
145564375|NCT02802592|524925626|FG000|Overall Study|Study terminated due to loss of funding|4|||
145564376|NCT02882854|524925627|FG000|Overall Study|Lost to Follow-up|1|||
145564377|NCT02882854|524925628|FG001|Overall Study|Lost to Follow-up|2|||
145564378|NCT02882854|524925627|FG000|Overall Study|Physician Decision|0|||
145564379|NCT02882854|524925628|FG001|Overall Study|Physician Decision|1|||
145564380|NCT01408030|524925629|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
145564381|NCT01408030|524925630|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
145564382|NCT01408030|524925631|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
145564383|NCT01408030|524925632|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
145564384|NCT01408030|524925629|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
145564385|NCT01408030|524925630|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
145564386|NCT01408030|524925631|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
145564387|NCT01408030|524925632|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
145564388|NCT01408030|524925629|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
145564389|NCT01408030|524925630|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
145564390|NCT01408030|524925631|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
145564391|NCT01408030|524925632|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
145564392|NCT01408030|524925629|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
145564393|NCT01408030|524925630|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
145564394|NCT01408030|524925631|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
145564395|NCT01408030|524925632|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
145564396|NCT01408030|524925629|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
145564397|NCT01408030|524925630|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
145564398|NCT01408030|524925631|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
145564399|NCT01408030|524925632|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
145564400|NCT01408030|524925629|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
145564401|NCT01408030|524925630|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
145564402|NCT01408030|524925631|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
145564403|NCT01408030|524925632|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
145564404|NCT01408030|524925629|FG000|Observation Phase (Off Drug)|Other|1|||
145564405|NCT01408030|524925630|FG001|Observation Phase (Off Drug)|Other|1|||
145564406|NCT01408030|524925631|FG002|Observation Phase (Off Drug)|Other|1|||
145564407|NCT01408030|524925632|FG003|Observation Phase (Off Drug)|Other|1|||
145564408|NCT02590939|524925633|FG000|Overall Study|Withdrawal by Subject|3|||
145564409|NCT02590939|524925634|FG001|Overall Study|Withdrawal by Subject|1|||
145564410|NCT02590939|524925633|FG000|Overall Study|Failed the nociceptive test|2|||
145564411|NCT02590939|524925634|FG001|Overall Study|Failed the nociceptive test|1|||
145564412|NCT02081079|524925635|FG000|Overall Study|Lack of Efficacy|3|||
145564413|NCT02081079|524925636|FG001|Overall Study|Lack of Efficacy|2|||
145564414|NCT02081079|524925635|FG000|Overall Study|Lost to Follow-up|1|||
145564415|NCT02081079|524925636|FG001|Overall Study|Lost to Follow-up|0|||
145564416|NCT04365556|524925637|FG000|Overall Study|No longer eligible due to treatment plan|1|||
145244125|NCT03032510|523740085|FG000|Overall Study|Withdrawal by Subject|8|||
145564417|NCT04365556|524925638|FG001|Overall Study|No longer eligible due to treatment plan|0|||
145564418|NCT04365556|524925637|FG000|Overall Study|Lost to Follow-up|3|||
145244126|NCT03032510|523740086|FG001|Overall Study|Withdrawal by Subject|7|||
145564419|NCT04365556|524925638|FG001|Overall Study|Lost to Follow-up|2|||
145564420|NCT04837131|524925639|FG000|Overall Study|Death|1|||
145564421|NCT04837131|524925639|FG000|Overall Study|Withdrawal by Subject|1|||
145564422|NCT04837131|524925639|FG000|Overall Study|Adverse Event|1|||
145564423|NCT04837131|524925639|FG000|Overall Study|Protocol Violation|1|||
145297115|NCT00746798|523939379|FG003|Overall Study|Protocol Violation|0|||
145564424|NCT00502697|524927225|FG000|Overall Study|Withdrawal by Subject|3|||
145564425|NCT00502697|524927226|FG001|Overall Study|Withdrawal by Subject|1|||
145564426|NCT00502697|524927225|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
145564427|NCT00502697|524927226|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
145564428|NCT00502697|524927225|FG000|Overall Study|found not to meet eligibility criteria|3|||
145564429|NCT00502697|524927226|FG001|Overall Study|found not to meet eligibility criteria|4|||
145564430|NCT00502697|524927225|FG000|Overall Study|did not meet assignment criteria|4|||
145564431|NCT00502697|524927226|FG001|Overall Study|did not meet assignment criteria|2|||
145564432|NCT05083442|524927232|FG000|Overall Study|Lost to Follow-up|1|||
145564433|NCT05083442|524927233|FG001|Overall Study|Lost to Follow-up|0|||
145564434|NCT05083442|524927232|FG000|Overall Study|Lack of Efficacy|0|||
145564435|NCT05083442|524927233|FG001|Overall Study|Lack of Efficacy|1|||
145564436|NCT05083442|524927232|FG000|Overall Study|Withdrawal by Subject|1|||
145564437|NCT05083442|524927233|FG001|Overall Study|Withdrawal by Subject|3|||
145564438|NCT05083442|524927232|FG000|Overall Study|scheduling difficulties|1|||
145564439|NCT05083442|524927233|FG001|Overall Study|scheduling difficulties|2|||
145564440|NCT00136084|524927237|FG000|Overall Study|Death|12|||
145564441|NCT00136084|524927238|FG001|Overall Study|Death|5|||
145564442|NCT00136084|524927237|FG000|Overall Study|Unacceptable toxicity|8|||
145564443|NCT00136084|524927238|FG001|Overall Study|Unacceptable toxicity|11|||
145564444|NCT00136084|524927237|FG000|Overall Study|Relapse|20|||
145564445|NCT00136084|524927238|FG001|Overall Study|Relapse|23|||
145564446|NCT00136084|524927237|FG000|Overall Study|Lost to Follow-up|2|||
145564447|NCT00136084|524927238|FG001|Overall Study|Lost to Follow-up|0|||
145564448|NCT00136084|524927237|FG000|Overall Study|No Response|1|||
145564449|NCT00136084|524927238|FG001|Overall Study|No Response|2|||
145564450|NCT00136084|524927237|FG000|Overall Study|Withdrawal by Subject|5|||
145564451|NCT00136084|524927238|FG001|Overall Study|Withdrawal by Subject|1|||
145564452|NCT00644969|524927239|FG000|Treatment Phase|Randomized, not treated|1|||
145564453|NCT00644969|524927240|FG001|Treatment Phase|Randomized, not treated|0|||
145564454|NCT00644969|524927239|FG000|Treatment Phase|Adverse Event|3|||
145564455|NCT00644969|524927240|FG001|Treatment Phase|Adverse Event|0|||
145564456|NCT00644969|524927239|FG000|Treatment Phase|Withdrawal by Subject|4|||
145564457|NCT00644969|524927240|FG001|Treatment Phase|Withdrawal by Subject|0|||
145564458|NCT00644969|524927239|FG000|Treatment Phase|Lost to Follow-up|2|||
145564459|NCT00644969|524927240|FG001|Treatment Phase|Lost to Follow-up|2|||
145564460|NCT00644969|524927239|FG000|Treatment Phase|Other|4|||
145564461|NCT00644969|524927240|FG001|Treatment Phase|Other|1|||
145564462|NCT00644969|524927239|FG000|Post Treatment Phase|Death|1|||
145564463|NCT00644969|524927240|FG001|Post Treatment Phase|Death|0|||
145564464|NCT00644969|524927239|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
145564465|NCT00644969|524927240|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
145297116|NCT00746798|523939376|FG000|Overall Study|Withdrawal by Subject|0|||
145297117|NCT00746798|523939377|FG001|Overall Study|Withdrawal by Subject|1|||
145297118|NCT00746798|523939378|FG002|Overall Study|Withdrawal by Subject|1|||
145297119|NCT00746798|523939379|FG003|Overall Study|Withdrawal by Subject|0|||
145297120|NCT00746798|523939376|FG000|Overall Study|Death|0|||
145297121|NCT00746798|523939377|FG001|Overall Study|Death|0|||
145297122|NCT00746798|523939378|FG002|Overall Study|Death|2|||
145564466|NCT00644969|524927239|FG000|Post Treatment Phase|Lost to Follow-up|4|||
145564467|NCT00644969|524927240|FG001|Post Treatment Phase|Lost to Follow-up|1|||
145564468|NCT00644969|524927239|FG000|Post Treatment Phase|Other|1|||
145564469|NCT00644969|524927240|FG001|Post Treatment Phase|Other|0|||
145564470|NCT02449239|524927241|FG000|Induction Phase|Lack of Efficacy|64|||
145564471|NCT02449239|524927241|FG000|Induction Phase|Adverse Event|1|||
145564472|NCT02449239|524927241|FG000|Induction Phase|Lost to Follow-up|1|||
145564473|NCT02449239|524927241|FG000|Induction Phase|Protocol Violation|1|||
145564474|NCT02449239|524927241|FG000|Induction Phase|Physician Decision|1|||
145564475|NCT02449239|524927241|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
145297123|NCT00746798|523939379|FG003|Overall Study|Death|0|||
145297124|NCT00746798|523939376|FG000|Overall Study|Participant unable to return for visit|1|||
145564476|NCT02449239|524927241|FG000|Induction Phase|Withdrawal by Subject|1|||
145564477|NCT02449239|524927241|FG000|Maintenance Month 3|Lack of Efficacy|14|||
145564478|NCT02449239|524927241|FG000|Maintenance Month 6|Lack of Efficacy|10|||
145564479|NCT02449239|524927241|FG000|Maintenance Month 6|Adverse Event|2|||
145564480|NCT02449239|524927241|FG000|Maintenance Month 6|Physician Decision|1|||
145564481|NCT02449239|524927241|FG000|Maintenance Month 9|Lack of Efficacy|2|||
145564482|NCT02449239|524927241|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
145564483|NCT02449239|524927241|FG000|Maintenance Month 12|Lack of Efficacy|5|||
145564484|NCT02449239|524927241|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
145564485|NCT02449239|524927241|FG000|Maintenance Month 12|Subject moved from area|1|||
145564486|NCT02449239|524927241|FG000|Maintenance Month 15|Lack of Efficacy|1|||
145564487|NCT02449239|524927241|FG000|Maintenance Month 21|Lack of Efficacy|1|||
145297125|NCT00746798|523939377|FG001|Overall Study|Participant unable to return for visit|0|||
145564488|NCT02449239|524927241|FG000|Maintenance Month 21|Sponsor decision|1|||
145297126|NCT00746798|523939378|FG002|Overall Study|Participant unable to return for visit|0|||
145244127|NCT03032510|523740085|FG000|Overall Study|Subject noncompliance|4|||
145244128|NCT03032510|523740086|FG001|Overall Study|Subject noncompliance|2|||
145244129|NCT03032510|523740085|FG000|Overall Study|Physician Decision|2|||
145244130|NCT03032510|523740086|FG001|Overall Study|Physician Decision|0|||
145244131|NCT05041062|523740087|FG000|Overall Study|Adverse Event|2|||
145244132|NCT04018612|523740088|FG000|Overall Study|Withdrawal by Subject|1|||
145244133|NCT04018612|523740089|FG001|Overall Study|Withdrawal by Subject|0|||
145244134|NCT04018612|523740090|FG002|Overall Study|Withdrawal by Subject|1|||
145244135|NCT02999191|523740092|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
145244136|NCT02999191|523740093|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
145244137|NCT02999191|523740094|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
145244138|NCT01802515|523740104|FG000|Overall Study|Withdrawal by Subject|3|||
145244139|NCT01802515|523740105|FG001|Overall Study|Withdrawal by Subject|0|||
145564489|NCT03509675|524927242|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
145564490|NCT03509675|524927243|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
145564491|NCT03509675|524927242|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
145564492|NCT03509675|524927243|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
145564493|NCT03509675|524927242|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
145244140|NCT01802515|523740106|FG002|Overall Study|Withdrawal by Subject|0|||
145244141|NCT01906476|523740107|FG000|Overall Study|Lost to Follow-up|17|||
145244142|NCT01906476|523740108|FG001|Overall Study|Lost to Follow-up|16|||
145244143|NCT01993667|523740112|FG000|Overall Study|Insufficient data to analyze|16|||
145244144|NCT01993667|523740113|FG001|Overall Study|Insufficient data to analyze|16|||
145244145|NCT01993667|523740112|FG000|Overall Study|Insufficient altitude reached|3|||
145244146|NCT01993667|523740113|FG001|Overall Study|Insufficient altitude reached|1|||
145244147|NCT01993667|523740112|FG000|Overall Study|Lost to Follow-up|2|||
145244148|NCT01993667|523740113|FG001|Overall Study|Lost to Follow-up|2|||
145244149|NCT01931150|523740114|FG000|Overall Study|Withdrawal by Subject|1|||
145244150|NCT01931150|523740115|FG001|Overall Study|Withdrawal by Subject|2|||
145244151|NCT01696396|523741868|FG000|Overall Study|Withdrawal by Subject|19|||
145244152|NCT01696396|523741869|FG001|Overall Study|Withdrawal by Subject|5|||
145244153|NCT01696396|523741870|FG002|Overall Study|Withdrawal by Subject|19|||
145244154|NCT01696396|523741871|FG003|Overall Study|Withdrawal by Subject|11|||
145244155|NCT01696396|523741868|FG000|Overall Study|Decision by Sponsor|3|||
145244156|NCT01696396|523741869|FG001|Overall Study|Decision by Sponsor|1|||
145244157|NCT01696396|523741870|FG002|Overall Study|Decision by Sponsor|2|||
145244158|NCT01696396|523741871|FG003|Overall Study|Decision by Sponsor|2|||
145244159|NCT01696396|523741868|FG000|Overall Study|Lost to Follow-up|9|||
145244160|NCT01696396|523741869|FG001|Overall Study|Lost to Follow-up|1|||
145244161|NCT01696396|523741870|FG002|Overall Study|Lost to Follow-up|4|||
145244162|NCT01696396|523741871|FG003|Overall Study|Lost to Follow-up|1|||
145244163|NCT01696396|523741868|FG000|Overall Study|Death|0|||
145244164|NCT01696396|523741869|FG001|Overall Study|Death|0|||
145244165|NCT01696396|523741870|FG002|Overall Study|Death|1|||
145244166|NCT01696396|523741871|FG003|Overall Study|Death|0|||
145244167|NCT02371980|523741877|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
145244168|NCT02371980|523741878|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
145244169|NCT02371980|523741879|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
145244170|NCT02371980|523741880|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
145244171|NCT02371980|523741881|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
145244172|NCT02371980|523741877|FG000|Open-label Period|Significant Protocol Deviation|19|||
145244173|NCT02371980|523741878|FG001|Open-label Period|Significant Protocol Deviation|0|||
145244174|NCT02371980|523741879|FG002|Open-label Period|Significant Protocol Deviation|0|||
145244175|NCT02371980|523741880|FG003|Open-label Period|Significant Protocol Deviation|0|||
145244176|NCT02371980|523741881|FG004|Open-label Period|Significant Protocol Deviation|0|||
145244177|NCT02371980|523741877|FG000|Open-label Period|Noncompliance with Study Drug|10|||
145244178|NCT02371980|523741878|FG001|Open-label Period|Noncompliance with Study Drug|0|||
145244179|NCT02371980|523741879|FG002|Open-label Period|Noncompliance with Study Drug|0|||
145244180|NCT02371980|523741880|FG003|Open-label Period|Noncompliance with Study Drug|0|||
145244181|NCT02371980|523741881|FG004|Open-label Period|Noncompliance with Study Drug|0|||
145244182|NCT02371980|523741877|FG000|Open-label Period|Lost to Follow-up|55|||
145244183|NCT02371980|523741878|FG001|Open-label Period|Lost to Follow-up|0|||
145244184|NCT02371980|523741879|FG002|Open-label Period|Lost to Follow-up|0|||
145244185|NCT02371980|523741880|FG003|Open-label Period|Lost to Follow-up|0|||
145244186|NCT02371980|523741881|FG004|Open-label Period|Lost to Follow-up|0|||
145244187|NCT02371980|523741877|FG000|Open-label Period|Voluntary Withdrawal|91|||
145244188|NCT02371980|523741878|FG001|Open-label Period|Voluntary Withdrawal|0|||
145244189|NCT02371980|523741879|FG002|Open-label Period|Voluntary Withdrawal|0|||
145244190|NCT02371980|523741880|FG003|Open-label Period|Voluntary Withdrawal|0|||
145244191|NCT02371980|523741881|FG004|Open-label Period|Voluntary Withdrawal|0|||
145244192|NCT02371980|523741877|FG000|Open-label Period|Pregnancy|1|||
145244193|NCT02371980|523741878|FG001|Open-label Period|Pregnancy|0|||
145244194|NCT02371980|523741879|FG002|Open-label Period|Pregnancy|0|||
145244195|NCT02371980|523741880|FG003|Open-label Period|Pregnancy|0|||
145244196|NCT02371980|523741881|FG004|Open-label Period|Pregnancy|0|||
145564494|NCT03509675|524927243|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
145564495|NCT03509675|524927242|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
145564496|NCT03509675|524927243|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
145564497|NCT05620576|524927246|FG000|Overall Study|Adverse Event|1|||
145564498|NCT05620576|524927247|FG001|Overall Study|Adverse Event|1|||
145564499|NCT05620576|524927246|FG000|Overall Study|Lost to Follow-up|3|||
145564500|NCT05620576|524927247|FG001|Overall Study|Lost to Follow-up|1|||
145564501|NCT05620576|524927246|FG000|Overall Study|Physician Decision|0|||
145564502|NCT05620576|524927247|FG001|Overall Study|Physician Decision|1|||
145564503|NCT05620576|524927246|FG000|Overall Study|Protocol Deviation|1|||
145564504|NCT05620576|524927247|FG001|Overall Study|Protocol Deviation|1|||
145564505|NCT05620576|524927246|FG000|Overall Study|Withdrawal by Subject|2|||
145564506|NCT05620576|524927247|FG001|Overall Study|Withdrawal by Subject|3|||
145564507|NCT02622828|524927248|FG000|Overall Study|participant withdrew|3|||
145564508|NCT02780804|524927249|FG000|Overall Study|Death|1|||
145564509|NCT02780804|524927250|FG001|Overall Study|Death|0|||
145564510|NCT02780804|524927251|FG002|Overall Study|Death|0|||
145564511|NCT02780804|524927249|FG000|Overall Study|Lack of Efficacy|5|||
145564512|NCT02780804|524927250|FG001|Overall Study|Lack of Efficacy|8|||
145564513|NCT02780804|524927251|FG002|Overall Study|Lack of Efficacy|4|||
145564514|NCT02780804|524927249|FG000|Overall Study|Physician Decision|0|||
145564515|NCT02780804|524927250|FG001|Overall Study|Physician Decision|0|||
145564516|NCT02780804|524927251|FG002|Overall Study|Physician Decision|2|||
145564517|NCT02780804|524927249|FG000|Overall Study|Withdrawal by Subject|0|||
145564518|NCT02780804|524927250|FG001|Overall Study|Withdrawal by Subject|1|||
145564519|NCT02780804|524927251|FG002|Overall Study|Withdrawal by Subject|0|||
145244197|NCT02371980|523741877|FG000|Open-label Period|Lack of Efficacy|116|||
145244198|NCT02371980|523741878|FG001|Open-label Period|Lack of Efficacy|0|||
145244199|NCT02371980|523741879|FG002|Open-label Period|Lack of Efficacy|0|||
145244200|NCT02371980|523741880|FG003|Open-label Period|Lack of Efficacy|0|||
145297127|NCT00746798|523939379|FG003|Overall Study|Participant unable to return for visit|0|||
145297128|NCT00633594|523939382|FG000|Overall Study|Adverse Event|0|||
145297129|NCT00633594|523939383|FG001|Overall Study|Adverse Event|4|||
145297130|NCT00633594|523939384|FG002|Overall Study|Adverse Event|7|||
145297131|NCT00633594|523939382|FG000|Overall Study|Death|0|||
145297132|NCT00633594|523939383|FG001|Overall Study|Death|1|||
145297133|NCT00633594|523939384|FG002|Overall Study|Death|2|||
145297134|NCT00633594|523939382|FG000|Overall Study|Disease Progression|0|||
145409024|NCT02337829|524351936|FG003|Overall Study|Study terminated by sponsor|6|||
145244201|NCT02371980|523741881|FG004|Open-label Period|Lack of Efficacy|0|||
145244202|NCT02371980|523741877|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
145244203|NCT02371980|523741878|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
145244204|NCT02371980|523741879|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
145244205|NCT02371980|523741880|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
145244206|NCT02371980|523741881|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
145244207|NCT02371980|523741877|FG000|Open-label Period|Reason not Specified|9|||
145244208|NCT02371980|523741878|FG001|Open-label Period|Reason not Specified|0|||
145244209|NCT02371980|523741879|FG002|Open-label Period|Reason not Specified|0|||
145409025|NCT02337829|524351933|FG000|Overall Study|discontinued for other reasons|6|||
145409026|NCT02337829|524351934|FG001|Overall Study|discontinued for other reasons|3|||
145409027|NCT02337829|524351935|FG002|Overall Study|discontinued for other reasons|1|||
145409028|NCT02337829|524351936|FG003|Overall Study|discontinued for other reasons|4|||
145409029|NCT00390013|524351938|FG000|Phase 1|tired|0|||
145409030|NCT00390013|524351939|FG001|Phase 1|tired|0|||
145409031|NCT00390013|524351940|FG002|Phase 1|tired|0|||
145409032|NCT00390013|524351941|FG003|Phase 1|tired|1|||
145409033|NCT00390013|524351938|FG000|Phase 2 First Treatment|tired|1|||
145409034|NCT00390013|524351939|FG001|Phase 2 First Treatment|tired|0|||
145564520|NCT04920123|524927258|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
145564521|NCT04920123|524927259|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145564522|NCT04920123|524927260|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
145564523|NCT02586493|524927270|FG000|Overall Study|Adverse Event|4|||
145564524|NCT02586493|524927270|FG000|Overall Study|Protocol Violation|6|||
145564525|NCT02586493|524927270|FG000|Overall Study|Lost to Follow-up|1|||
145564526|NCT02586493|524927270|FG000|Overall Study|Withdrawal by Subject|1|||
145564527|NCT06134817|524927274|FG000|Overall Study|Physician Departure - termination of study|1|||
145564528|NCT00278954|524927275|FG000|Overall Study|Adverse Event|3|||
145564529|NCT00278954|524927275|FG000|Overall Study|Lost to Follow-up|1|||
145244210|NCT02371980|523741880|FG003|Open-label Period|Reason not Specified|0|||
145244211|NCT02371980|523741881|FG004|Open-label Period|Reason not Specified|0|||
145244212|NCT02371980|523741877|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
145297135|NCT00633594|523939383|FG001|Overall Study|Disease Progression|0|||
145409035|NCT00390013|524351940|FG002|Phase 2 First Treatment|tired|0|||
145409036|NCT00390013|524351941|FG003|Phase 2 First Treatment|tired|0|||
145409037|NCT00390013|524351938|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
145564530|NCT00278954|524927275|FG000|Overall Study|Withdrawal by Subject|1|||
145564531|NCT02046148|524927281|FG000|Overall Study|Lost to Follow-up|1|||
145297136|NCT00633594|523939384|FG002|Overall Study|Disease Progression|1|||
145244213|NCT02371980|523741878|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
145244214|NCT02371980|523741879|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
145244215|NCT02371980|523741880|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
145244216|NCT02371980|523741881|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
145244217|NCT02371980|523741877|FG000|Double-blind Period|Significant Protocol Deviation|0|||
145244218|NCT02371980|523741878|FG001|Double-blind Period|Significant Protocol Deviation|2|||
145244219|NCT02371980|523741879|FG002|Double-blind Period|Significant Protocol Deviation|7|||
145244220|NCT02371980|523741880|FG003|Double-blind Period|Significant Protocol Deviation|3|||
145244221|NCT02371980|523741881|FG004|Double-blind Period|Significant Protocol Deviation|3|||
145244222|NCT02371980|523741877|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
145244223|NCT02371980|523741878|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
145244224|NCT02371980|523741879|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
145244225|NCT02371980|523741880|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
145244226|NCT02371980|523741881|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
145244227|NCT02371980|523741877|FG000|Double-blind Period|Lost to Follow-up|0|||
145244228|NCT02371980|523741878|FG001|Double-blind Period|Lost to Follow-up|8|||
145244229|NCT02371980|523741879|FG002|Double-blind Period|Lost to Follow-up|8|||
145244230|NCT02371980|523741880|FG003|Double-blind Period|Lost to Follow-up|6|||
145244231|NCT02371980|523741881|FG004|Double-blind Period|Lost to Follow-up|5|||
145244232|NCT02371980|523741877|FG000|Double-blind Period|Voluntary Withdrawal|0|||
145244233|NCT02371980|523741878|FG001|Double-blind Period|Voluntary Withdrawal|12|||
145244234|NCT02371980|523741879|FG002|Double-blind Period|Voluntary Withdrawal|8|||
145244235|NCT02371980|523741880|FG003|Double-blind Period|Voluntary Withdrawal|9|||
145244236|NCT02371980|523741881|FG004|Double-blind Period|Voluntary Withdrawal|11|||
145244237|NCT02371980|523741877|FG000|Double-blind Period|Relapse|0|||
145244238|NCT02371980|523741878|FG001|Double-blind Period|Relapse|50|||
145244239|NCT02371980|523741879|FG002|Double-blind Period|Relapse|25|||
145244240|NCT02371980|523741880|FG003|Double-blind Period|Relapse|25|||
145244241|NCT02371980|523741881|FG004|Double-blind Period|Relapse|26|||
145244242|NCT02371980|523741877|FG000|Double-blind Period|Reason not Specified|0|||
145244243|NCT02371980|523741878|FG001|Double-blind Period|Reason not Specified|3|||
145244244|NCT02371980|523741879|FG002|Double-blind Period|Reason not Specified|3|||
145244245|NCT02371980|523741880|FG003|Double-blind Period|Reason not Specified|2|||
145244246|NCT02371980|523741881|FG004|Double-blind Period|Reason not Specified|1|||
145244247|NCT02371980|523741877|FG000|Double-blind Period|Missing|0|||
145244248|NCT02371980|523741878|FG001|Double-blind Period|Missing|1|||
145244249|NCT02371980|523741879|FG002|Double-blind Period|Missing|0|||
145244250|NCT02371980|523741880|FG003|Double-blind Period|Missing|0|||
145244251|NCT02371980|523741881|FG004|Double-blind Period|Missing|0|||
145244252|NCT03938636|523741884|FG000|Overall Study|Protocol Violation|0|||
145244253|NCT03938636|523741885|FG001|Overall Study|Protocol Violation|1|||
145244254|NCT03938636|523741886|FG002|Overall Study|Protocol Violation|1|||
145244255|NCT03938636|523741884|FG000|Overall Study|Subject withdrew due to death in family|0|||
145297137|NCT00727571|523939386|FG000|Overall Study|Ineligibility determined|1|||
145297138|NCT00727571|523939387|FG001|Overall Study|Ineligibility determined|1|||
145297139|NCT00727571|523939388|FG002|Overall Study|Ineligibility determined|1|||
145297140|NCT00727571|523939389|FG003|Overall Study|Ineligibility determined|0|||
145297141|NCT00727571|523939386|FG000|Overall Study|Death|0|||
145297142|NCT00727571|523939387|FG001|Overall Study|Death|19|||
145297143|NCT00727571|523939388|FG002|Overall Study|Death|5|||
145297144|NCT00727571|523939389|FG003|Overall Study|Death|1|||
145297145|NCT00727571|523939386|FG000|Overall Study|Physician Decision|0|||
145297146|NCT00727571|523939387|FG001|Overall Study|Physician Decision|5|||
145297147|NCT00727571|523939388|FG002|Overall Study|Physician Decision|0|||
145297148|NCT00727571|523939389|FG003|Overall Study|Physician Decision|0|||
145564532|NCT02046148|524927282|FG001|Overall Study|Lost to Follow-up|1|||
145564533|NCT02046148|524927281|FG000|Overall Study|Withdrawal by Subject|0|||
145564534|NCT02046148|524927282|FG001|Overall Study|Withdrawal by Subject|2|||
145244256|NCT03938636|523741885|FG001|Overall Study|Subject withdrew due to death in family|1|||
145244257|NCT03938636|523741886|FG002|Overall Study|Subject withdrew due to death in family|0|||
145244258|NCT03938636|523741884|FG000|Overall Study|Missed visit|0|||
145244259|NCT03938636|523741885|FG001|Overall Study|Missed visit|1|||
145244260|NCT03938636|523741886|FG002|Overall Study|Missed visit|0|||
145244261|NCT03938636|523741884|FG000|Overall Study|Adverse Event|0|||
145244262|NCT03938636|523741885|FG001|Overall Study|Adverse Event|0|||
145564535|NCT02211131|524927294|FG000|Overall Study|Death|26|||
145244263|NCT03938636|523741886|FG002|Overall Study|Adverse Event|1|||
145244264|NCT03938636|523741884|FG000|Overall Study|Lost to Follow-up|0|||
145244265|NCT03938636|523741885|FG001|Overall Study|Lost to Follow-up|0|||
145244266|NCT03938636|523741886|FG002|Overall Study|Lost to Follow-up|1|||
145244267|NCT01518309|523741887|FG000|Overall Study|Adverse Event|6|||
145297149|NCT00727571|523939386|FG000|Overall Study|Withdrawal by Subject|0|||
145297150|NCT00727571|523939387|FG001|Overall Study|Withdrawal by Subject|10|||
145297151|NCT00727571|523939388|FG002|Overall Study|Withdrawal by Subject|11|||
145297152|NCT00727571|523939389|FG003|Overall Study|Withdrawal by Subject|0|||
145620111|NCT00873093|525123684|FG001|Overall Study|Death|3|||
145244268|NCT01518309|523741887|FG000|Overall Study|Death|6|||
145244269|NCT01518309|523741887|FG000|Overall Study|Lack of Efficacy|7|||
145244270|NCT01518309|523741887|FG000|Overall Study|Withdrawal by Subject|6|||
145244271|NCT01518309|523741887|FG000|Overall Study|Physician Decision|3|||
145244272|NCT01518309|523741887|FG000|Overall Study|Sponsor Decision|2|||
145244273|NCT01518309|523741887|FG000|Overall Study|Not in Predefined Categories|9|||
145244274|NCT00863317|523741888|FG000|Overall Study|Lost to Follow-up|8|||
145244275|NCT00863317|523741889|FG001|Overall Study|Lost to Follow-up|9|||
145244276|NCT02579863|523741890|FG000|Overall Study|Final Disposition Unknown|2|||
145244277|NCT02579863|523741891|FG001|Overall Study|Final Disposition Unknown|1|||
145244278|NCT02579863|523741890|FG000|Overall Study|Adverse Event|18|||
145244279|NCT02579863|523741891|FG001|Overall Study|Adverse Event|11|||
145244280|NCT02579863|523741890|FG000|Overall Study|Death|31|||
145244281|NCT02579863|523741891|FG001|Overall Study|Death|29|||
145244282|NCT02579863|523741890|FG000|Overall Study|Lost to Follow-up|2|||
145244283|NCT02579863|523741891|FG001|Overall Study|Lost to Follow-up|1|||
145244284|NCT02579863|523741890|FG000|Overall Study|Physician Decision|1|||
145244285|NCT02579863|523741891|FG001|Overall Study|Physician Decision|2|||
145244286|NCT02579863|523741890|FG000|Overall Study|Screen Failure|0|||
145244287|NCT02579863|523741891|FG001|Overall Study|Screen Failure|2|||
145244288|NCT02579863|523741890|FG000|Overall Study|Study Terminated at Selected Sites|82|||
145244289|NCT02579863|523741891|FG001|Overall Study|Study Terminated at Selected Sites|88|||
145244290|NCT02579863|523741890|FG000|Overall Study|Withdrawal by Subject|20|||
145244291|NCT02579863|523741891|FG001|Overall Study|Withdrawal by Subject|20|||
145244292|NCT00216086|523741894|FG000|Overall Study|Protocol Violation|1|||
145244293|NCT00216086|523741894|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
145244294|NCT00216086|523741894|FG000|Overall Study|Social Reasons|2|||
145244295|NCT00038142|523741895|FG000|Overall Study|Ineligible|1|||
145244296|NCT00038142|523741896|FG001|Overall Study|Ineligible|0|||
145244297|NCT00038142|523741895|FG000|Overall Study|Progressive Disease|11|||
145244298|NCT00038142|523741896|FG001|Overall Study|Progressive Disease|7|||
145244299|NCT00038142|523741895|FG000|Overall Study|Death|1|||
145244300|NCT00038142|523741896|FG001|Overall Study|Death|0|||
145244301|NCT00038142|523741895|FG000|Overall Study|Adverse Event|1|||
145244302|NCT00038142|523741896|FG001|Overall Study|Adverse Event|0|||
145244303|NCT00038142|523741895|FG000|Overall Study|Unknown Reason|8|||
145244304|NCT00038142|523741896|FG001|Overall Study|Unknown Reason|0|||
145244305|NCT00809614|523741897|FG000|Overall Study|Lack of Efficacy|2|||
145244306|NCT00809614|523741898|FG001|Overall Study|Lack of Efficacy|3|||
145244307|NCT00809614|523741897|FG000|Overall Study|Withdrawal by Subject|1|||
145244308|NCT00809614|523741898|FG001|Overall Study|Withdrawal by Subject|1|||
145244309|NCT01080625|523741899|FG000|Overall Study|Physician Decision|0|||
145244310|NCT01080625|523741900|FG001|Overall Study|Physician Decision|2|||
145244311|NCT01080625|523741901|FG002|Overall Study|Physician Decision|1|||
145244312|NCT00446797|523741904|FG000|Overall Study|Lack of Efficacy|0|||
145244313|NCT00446797|523741905|FG001|Overall Study|Lack of Efficacy|2|||
145244314|NCT00446797|523741904|FG000|Overall Study|Lost to Follow-up|5|||
145244315|NCT00446797|523741905|FG001|Overall Study|Lost to Follow-up|3|||
145244316|NCT00446797|523741904|FG000|Overall Study|Withdrawal by Subject|2|||
145244317|NCT00446797|523741905|FG001|Overall Study|Withdrawal by Subject|2|||
145244318|NCT00446797|523741904|FG000|Overall Study|Protocol Violation|1|||
145244319|NCT00446797|523741905|FG001|Overall Study|Protocol Violation|3|||
145244320|NCT00446797|523741904|FG000|Overall Study|subject entered at another site|0|||
145244321|NCT00446797|523741905|FG001|Overall Study|subject entered at another site|1|||
145244322|NCT00446797|523741904|FG000|Overall Study|did not meet entrance criteria|0|||
145244323|NCT00446797|523741905|FG001|Overall Study|did not meet entrance criteria|1|||
145244324|NCT00364832|523741906|FG000|Core Period|Early Withdrawals|2|||
145244325|NCT00364832|523741907|FG001|Core Period|Early Withdrawals|2|||
145244326|NCT00364832|523741908|FG002|Core Period|Early Withdrawals|1|||
145244327|NCT00364832|523741909|FG003|Core Period|Early Withdrawals|1|||
145244328|NCT00364832|523741910|FG004|Core Period|Early Withdrawals|0|||
145620112|NCT00873093|525123685|FG002|Overall Study|Death|2|||
145244329|NCT00364832|523741911|FG005|Core Period|Early Withdrawals|0|||
145244330|NCT00364832|523741912|FG006|Core Period|Early Withdrawals|4|||
145244331|NCT00364832|523741913|FG007|Core Period|Early Withdrawals|1|||
145244332|NCT00364832|523741914|FG008|Core Period|Early Withdrawals|0|||
145244333|NCT00364832|523741915|FG009|Core Period|Early Withdrawals|0|||
145244334|NCT00364832|523741916|FG010|Core Period|Early Withdrawals|0|||
145244335|NCT00364832|523741917|FG011|Core Period|Early Withdrawals|0|||
145244336|NCT00364832|523741906|FG000|Extension Year 1|Early Withdrawals|0|||
145244337|NCT00364832|523741907|FG001|Extension Year 1|Early Withdrawals|0|||
145244338|NCT00364832|523741908|FG002|Extension Year 1|Early Withdrawals|0|||
145620113|NCT00873093|525123686|FG003|Overall Study|Death|0|||
145244339|NCT00364832|523741909|FG003|Extension Year 1|Early Withdrawals|0|||
145244340|NCT00364832|523741910|FG004|Extension Year 1|Early Withdrawals|0|||
145244341|NCT00364832|523741911|FG005|Extension Year 1|Early Withdrawals|0|||
145244342|NCT00364832|523741912|FG006|Extension Year 1|Early Withdrawals|0|||
145244343|NCT00364832|523741913|FG007|Extension Year 1|Early Withdrawals|0|||
145244344|NCT00364832|523741914|FG008|Extension Year 1|Early Withdrawals|0|||
145244345|NCT00364832|523741915|FG009|Extension Year 1|Early Withdrawals|4|||
145244346|NCT00364832|523741916|FG010|Extension Year 1|Early Withdrawals|2|||
145244347|NCT00364832|523741917|FG011|Extension Year 1|Early Withdrawals|10|||
145244348|NCT00364832|523741906|FG000|Extension Year 2|Early Withdrawals|0|||
145244349|NCT00364832|523741907|FG001|Extension Year 2|Early Withdrawals|0|||
145244350|NCT00364832|523741908|FG002|Extension Year 2|Early Withdrawals|0|||
145244351|NCT00364832|523741909|FG003|Extension Year 2|Early Withdrawals|0|||
145244352|NCT00364832|523741910|FG004|Extension Year 2|Early Withdrawals|0|||
145244353|NCT00364832|523741911|FG005|Extension Year 2|Early Withdrawals|0|||
145244354|NCT00364832|523741912|FG006|Extension Year 2|Early Withdrawals|0|||
145244355|NCT00364832|523741913|FG007|Extension Year 2|Early Withdrawals|0|||
145244356|NCT00364832|523741914|FG008|Extension Year 2|Early Withdrawals|0|||
145244357|NCT00364832|523741915|FG009|Extension Year 2|Early Withdrawals|5|||
145244358|NCT00364832|523741916|FG010|Extension Year 2|Early Withdrawals|5|||
145244359|NCT00364832|523741917|FG011|Extension Year 2|Early Withdrawals|3|||
145244360|NCT01440972|523741926|FG000|Overall Study|Withdrawal by Subject|3|||
145244361|NCT01440972|523741927|FG001|Overall Study|Withdrawal by Subject|2|||
145244362|NCT03933215|523741928|FG000|Overall Study|Other|6|||
145244363|NCT03933215|523741928|FG000|Overall Study|Sponsor decision|5|||
145244364|NCT03933215|523741928|FG000|Overall Study|Protocol Violation|5|||
145244365|NCT03933215|523741928|FG000|Overall Study|Withdrawal by Subject|6|||
145244366|NCT03933215|523741928|FG000|Overall Study|Lost to Follow-up|6|||
145244367|NCT03933215|523741928|FG000|Overall Study|Enrolled but not treated|38|||
145244368|NCT02473289|523741929|FG000|Overall Study|Adverse Event|2|||
145244369|NCT02473289|523741930|FG001|Overall Study|Adverse Event|3|||
145244370|NCT02473289|523741929|FG000|Overall Study|Lost to Follow-up|1|||
145244371|NCT02473289|523741930|FG001|Overall Study|Lost to Follow-up|1|||
145244372|NCT02473289|523741929|FG000|Overall Study|Protocol Violation|0|||
145244373|NCT02473289|523741930|FG001|Overall Study|Protocol Violation|1|||
145244374|NCT02473289|523741929|FG000|Overall Study|Withdrawal of consent|6|||
145244375|NCT02473289|523741930|FG001|Overall Study|Withdrawal of consent|7|||
145244376|NCT02473289|523741929|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
145244377|NCT02473289|523741930|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
145244378|NCT02473289|523741929|FG000|Overall Study|Other|2|||
145244379|NCT02473289|523741930|FG001|Overall Study|Other|0|||
145297153|NCT00727571|523939386|FG000|Overall Study|Subject Non Compliance|0|||
145297154|NCT00727571|523939387|FG001|Overall Study|Subject Non Compliance|6|||
145297155|NCT00727571|523939388|FG002|Overall Study|Subject Non Compliance|0|||
145297156|NCT00727571|523939389|FG003|Overall Study|Subject Non Compliance|4|||
145297157|NCT00727571|523939386|FG000|Overall Study|Dismissed from nursing home|0|||
145297158|NCT00727571|523939387|FG001|Overall Study|Dismissed from nursing home|9|||
145297159|NCT00727571|523939388|FG002|Overall Study|Dismissed from nursing home|5|||
145297160|NCT00727571|523939389|FG003|Overall Study|Dismissed from nursing home|0|||
145297161|NCT00727571|523939386|FG000|Overall Study|Hospitalization|0|||
145297162|NCT00727571|523939387|FG001|Overall Study|Hospitalization|1|||
145297163|NCT00727571|523939388|FG002|Overall Study|Hospitalization|0|||
145409038|NCT00390013|524351939|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
145564536|NCT02211131|524927295|FG001|Overall Study|Death|16|||
145564537|NCT02211131|524927294|FG000|Overall Study|Lost to Follow-up|4|||
145564538|NCT02211131|524927295|FG001|Overall Study|Lost to Follow-up|3|||
145564539|NCT02211131|524927294|FG000|Overall Study|Decision by Sponsor|1|||
145564540|NCT02211131|524927295|FG001|Overall Study|Decision by Sponsor|1|||
145564541|NCT02211131|524927294|FG000|Overall Study|Withdrawal by Subject|3|||
145564542|NCT02211131|524927295|FG001|Overall Study|Withdrawal by Subject|8|||
145564543|NCT05664490|524927297|FG000|Overall Study|Withdrawal by Subject|0|||
145564544|NCT05664490|524927298|FG001|Overall Study|Withdrawal by Subject|1|||
145564545|NCT05664490|524927297|FG000|Overall Study|Lost to Follow-up|14|||
145564546|NCT05664490|524927298|FG001|Overall Study|Lost to Follow-up|22|||
145564547|NCT05442554|524927299|FG000|Overall Study|Adverse Event|1|||
145564548|NCT01990495|524927303|FG000|Overall Study|Physician Decision|5|||
145564549|NCT01990495|524927304|FG001|Overall Study|Physician Decision|4|||
145244380|NCT00407550|523741931|FG000|Overall Study|Adverse Event|0|||
145244381|NCT00407550|523741932|FG001|Overall Study|Adverse Event|1|||
145620114|NCT00873093|525123687|FG004|Overall Study|Death|0|||
145620115|NCT00873093|525123683|FG000|Overall Study|Physician Decision|0|||
145620116|NCT00873093|525123684|FG001|Overall Study|Physician Decision|17|||
145244382|NCT00407550|523741931|FG000|Overall Study|Withdrawal by Subject|0|||
145297164|NCT00727571|523939389|FG003|Overall Study|Hospitalization|1|||
145297165|NCT00727571|523939386|FG000|Overall Study|AE not leading to hospitalization|0|||
145409039|NCT00390013|524351940|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
145244383|NCT00407550|523741932|FG001|Overall Study|Withdrawal by Subject|2|||
145244384|NCT00407550|523741931|FG000|Overall Study|Death|1|||
145564550|NCT01752855|524927307|FG000|Overall Study|Adverse Event|1|||
145564551|NCT01752855|524927308|FG001|Overall Study|Adverse Event|0|||
145564552|NCT01752855|524927307|FG000|Overall Study|Withdrew Consent|0|||
145564553|NCT01752855|524927308|FG001|Overall Study|Withdrew Consent|2|||
145564554|NCT01752855|524927307|FG000|Overall Study|Lack of Efficacy|0|||
145244385|NCT00407550|523741932|FG001|Overall Study|Death|0|||
145244386|NCT00407550|523741931|FG000|Overall Study|Insurance or Other medical condition|2|||
145244387|NCT00407550|523741932|FG001|Overall Study|Insurance or Other medical condition|1|||
145244388|NCT01266070|523741933|FG000|Overall Study|Adverse Event|3|||
145409040|NCT00390013|524351941|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
145409041|NCT04221490|524351942|FG000|At 30 Days Follow-up|Death|7|||
145409042|NCT04221490|524351942|FG000|At 30 Days Follow-up|Missed Visit|4|||
145409043|NCT04221490|524351942|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
145409044|NCT04221490|524351942|FG000|At 6 Months Follow-up|Death|9|||
145409045|NCT04221490|524351942|FG000|At 6 Months Follow-up|Physician Decision|1|||
145409046|NCT04221490|524351942|FG000|At 6 Months Follow-up|Missed Visit|8|||
145409047|NCT04221490|524351942|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
145409048|NCT02550795|524351947|FG000|Overall Study|Physician Decision|0|||
145409049|NCT02550795|524351948|FG001|Overall Study|Physician Decision|1|||
145409050|NCT02550795|524351949|FG002|Overall Study|Physician Decision|0|||
145409051|NCT02802228|524351950|FG000|Overall Study|Withdrawal by Subject|2|||
145409052|NCT02802228|524351951|FG001|Overall Study|Withdrawal by Subject|0|||
145409053|NCT02802228|524351950|FG000|Overall Study|Lost to Follow-up|1|||
145409054|NCT02802228|524351951|FG001|Overall Study|Lost to Follow-up|0|||
145409055|NCT02802228|524351950|FG000|Overall Study|Adverse Event|1|||
145409056|NCT02802228|524351951|FG001|Overall Study|Adverse Event|0|||
145409057|NCT02802228|524351950|FG000|Overall Study|Physician Decision|1|||
145409058|NCT02802228|524351951|FG001|Overall Study|Physician Decision|0|||
145409059|NCT00695019|524351952|FG000|Overall Study|Withdrawal by Subject|8|||
145409060|NCT00695019|524351953|FG001|Overall Study|Withdrawal by Subject|6|||
145409061|NCT00695019|524351954|FG002|Overall Study|Withdrawal by Subject|4|||
145409062|NCT00695019|524351952|FG000|Overall Study|Protocol Violation|1|||
145409063|NCT00695019|524351953|FG001|Overall Study|Protocol Violation|3|||
145409064|NCT00695019|524351954|FG002|Overall Study|Protocol Violation|1|||
145409065|NCT00695019|524351952|FG000|Overall Study|Lack of Efficacy|0|||
145409066|NCT00695019|524351953|FG001|Overall Study|Lack of Efficacy|0|||
145409067|NCT00695019|524351954|FG002|Overall Study|Lack of Efficacy|1|||
145409068|NCT00695019|524351952|FG000|Overall Study|Various|4|||
145409069|NCT00695019|524351953|FG001|Overall Study|Various|5|||
145409070|NCT00695019|524351954|FG002|Overall Study|Various|4|||
145409071|NCT02225587|524351955|FG000|Overall Study|Adverse Event|5|||
145409072|NCT02225587|524351956|FG001|Overall Study|Adverse Event|5|||
145409073|NCT02225587|524351955|FG000|Overall Study|Lost to Follow-up|5|||
145409074|NCT02225587|524351956|FG001|Overall Study|Lost to Follow-up|5|||
145409075|NCT02225587|524351955|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145409076|NCT02225587|524351956|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145409077|NCT02225587|524351955|FG000|Overall Study|Physician Decision|2|||
145409078|NCT02225587|524351956|FG001|Overall Study|Physician Decision|0|||
145409079|NCT02225587|524351955|FG000|Overall Study|Protocol Violation|1|||
145409080|NCT02225587|524351956|FG001|Overall Study|Protocol Violation|0|||
145564555|NCT01752855|524927308|FG001|Overall Study|Lack of Efficacy|2|||
145564556|NCT01478321|524927309|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
145564557|NCT01478321|524927309|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
145564558|NCT01478321|524927309|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
145564559|NCT01478321|524927309|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
145564560|NCT01478321|524927309|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
145564561|NCT01478321|524927309|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
145564562|NCT01478321|524927309|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
145564563|NCT01478321|524927309|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
145564564|NCT01488097|524927311|FG000|Overall Study|Lost to Follow-up|1|||
145564565|NCT01577758|524927312|FG000|Dose Escalation Phase|Adverse Event|0|||
145564566|NCT01577758|524927313|FG001|Dose Escalation Phase|Adverse Event|0|||
145564567|NCT01577758|524927314|FG002|Dose Escalation Phase|Adverse Event|0|||
145564568|NCT01577758|524927315|FG003|Dose Escalation Phase|Adverse Event|0|||
145564569|NCT01577758|524927316|FG004|Dose Escalation Phase|Adverse Event|0|||
145564570|NCT01577758|524927317|FG005|Dose Escalation Phase|Adverse Event|2|||
145564571|NCT01577758|524927318|FG006|Dose Escalation Phase|Adverse Event|1|||
145564572|NCT01577758|524927319|FG007|Dose Escalation Phase|Adverse Event|0|||
145564573|NCT01577758|524927312|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
145409081|NCT02225587|524351955|FG000|Overall Study|Participant Moved|1|||
145409082|NCT02225587|524351956|FG001|Overall Study|Participant Moved|0|||
145409083|NCT02225587|524351955|FG000|Overall Study|Withdrawal by Subject|13|||
145244389|NCT01266070|523741933|FG000|Overall Study|Protocol Violation|1|||
145244390|NCT01838213|523741934|FG000|Overall Study|Ineligible|166|||
145409084|NCT02225587|524351956|FG001|Overall Study|Withdrawal by Subject|28|||
145409085|NCT00924898|524351957|FG000|Overall Study|Withdrawal by Subject|2|||
145409086|NCT05291689|524351963|FG000|Overall Study|Adverse Event|3|||
145409087|NCT05291689|524351963|FG000|Overall Study|Lack of Efficacy|10|||
145564574|NCT01577758|524927313|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
145564575|NCT01577758|524927314|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
145564576|NCT01577758|524927315|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
145564577|NCT01577758|524927316|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
145564578|NCT01577758|524927317|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
145564579|NCT01577758|524927318|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
145564580|NCT01577758|524927319|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
145564581|NCT01577758|524927312|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145564582|NCT01577758|524927313|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
145564583|NCT01577758|524927314|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
145564584|NCT01577758|524927315|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145564585|NCT01577758|524927316|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
145564586|NCT01577758|524927317|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
145564587|NCT01577758|524927318|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
145564588|NCT01577758|524927319|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
145564589|NCT01577758|524927312|FG000|Dose Escalation Phase|Progression Disease|2|||
145564590|NCT01577758|524927313|FG001|Dose Escalation Phase|Progression Disease|2|||
145564591|NCT01577758|524927314|FG002|Dose Escalation Phase|Progression Disease|1|||
145564592|NCT01577758|524927315|FG003|Dose Escalation Phase|Progression Disease|2|||
145297166|NCT00727571|523939387|FG001|Overall Study|AE not leading to hospitalization|0|||
145297167|NCT00727571|523939388|FG002|Overall Study|AE not leading to hospitalization|2|||
145297168|NCT00727571|523939389|FG003|Overall Study|AE not leading to hospitalization|0|||
145297169|NCT00727571|523939386|FG000|Overall Study|Other|0|||
145297170|NCT00727571|523939387|FG001|Overall Study|Other|4|||
145297171|NCT00727571|523939388|FG002|Overall Study|Other|6|||
145564593|NCT01577758|524927316|FG004|Dose Escalation Phase|Progression Disease|5|||
145564594|NCT01577758|524927317|FG005|Dose Escalation Phase|Progression Disease|0|||
145564595|NCT01577758|524927318|FG006|Dose Escalation Phase|Progression Disease|0|||
145564596|NCT01577758|524927319|FG007|Dose Escalation Phase|Progression Disease|0|||
145564597|NCT01577758|524927312|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145564598|NCT01577758|524927313|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145564599|NCT01577758|524927314|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145564600|NCT01577758|524927315|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145297172|NCT00727571|523939389|FG003|Overall Study|Other|0|||
145297173|NCT01287013|523939390|FG000|Overall Study|Non-evaluable|3|||
145297174|NCT01287013|523939391|FG001|Overall Study|Non-evaluable|5|||
145297175|NCT01287013|523939392|FG002|Overall Study|Non-evaluable|21|||
145297176|NCT03247556|523939395|FG000|Overall Study|Adverse Event|1|||
145297177|NCT03247556|523939396|FG001|Overall Study|Adverse Event|4|||
145297178|NCT03247556|523939397|FG002|Overall Study|Adverse Event|5|||
145297179|NCT03247556|523939395|FG000|Overall Study|Lost to Follow-up|5|||
145297180|NCT03247556|523939396|FG001|Overall Study|Lost to Follow-up|5|||
145297181|NCT03247556|523939397|FG002|Overall Study|Lost to Follow-up|4|||
145297182|NCT03247556|523939395|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
145297183|NCT03247556|523939396|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
145297184|NCT03247556|523939397|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
145297185|NCT03247556|523939395|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
145297186|NCT03247556|523939396|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
145297187|NCT03247556|523939397|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
145297188|NCT03247556|523939395|FG000|Overall Study|Protocol Violation|2|||
145297189|NCT03247556|523939396|FG001|Overall Study|Protocol Violation|0|||
145297190|NCT03247556|523939397|FG002|Overall Study|Protocol Violation|1|||
145297191|NCT03247556|523939395|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
145297192|NCT03247556|523939396|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
145297193|NCT03247556|523939397|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
145297194|NCT00274937|523939399|FG000|Overall Study|Physician Decision|10|||
145297195|NCT00274937|523939399|FG000|Overall Study|Withdrawal by Subject|6|||
145297196|NCT00274937|523939399|FG000|Overall Study|Progressive Disease|4|||
145297197|NCT02189941|523939400|FG000|Overall Study|Non-compliance|0|||
145297198|NCT02189941|523939401|FG001|Overall Study|Non-compliance|0|||
145297199|NCT02189941|523939402|FG002|Overall Study|Non-compliance|1|||
145297200|NCT00445003|523939403|FG000|Overall Study|Death|1|||
145297201|NCT00445003|523939404|FG001|Overall Study|Death|2|||
145297202|NCT00445003|523939405|FG002|Overall Study|Death|1|||
145297203|NCT00445003|523939403|FG000|Overall Study|Missed Visit|3|||
145297204|NCT00445003|523939404|FG001|Overall Study|Missed Visit|5|||
145297205|NCT00445003|523939405|FG002|Overall Study|Missed Visit|1|||
145297206|NCT00445003|523939403|FG000|Overall Study|Dropped|1|||
145564601|NCT01577758|524927316|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145297207|NCT00445003|523939404|FG001|Overall Study|Dropped|3|||
145297208|NCT00445003|523939405|FG002|Overall Study|Dropped|2|||
145297209|NCT00528606|523939406|FG000|Overall Study|Withdrew consent|4|||
145297210|NCT00528606|523939407|FG001|Overall Study|Withdrew consent|3|||
145297211|NCT00528606|523939406|FG000|Overall Study|Lost to Follow-up|4|||
145297212|NCT00528606|523939407|FG001|Overall Study|Lost to Follow-up|1|||
145297213|NCT00528606|523939406|FG000|Overall Study|Adverse Event|3|||
145297214|NCT00528606|523939407|FG001|Overall Study|Adverse Event|0|||
145564602|NCT01577758|524927317|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145564603|NCT01577758|524927318|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
145564604|NCT01577758|524927319|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
145297215|NCT00528606|523939406|FG000|Overall Study|Other|2|||
145297216|NCT00528606|523939407|FG001|Overall Study|Other|0|||
145297217|NCT01471093|523939408|FG000|Overall Study|Adverse Event|1|||
145297218|NCT01471093|523939409|FG001|Overall Study|Adverse Event|0|||
145297219|NCT01471093|523939410|FG002|Overall Study|Adverse Event|0|||
145297220|NCT01471093|523939411|FG003|Overall Study|Adverse Event|0|||
145297221|NCT02475954|523939412|FG000|Overall Study|Withdrawal by Subject|2|||
145297222|NCT02475954|523939413|FG001|Overall Study|Withdrawal by Subject|2|||
145297223|NCT02475954|523939412|FG000|Overall Study|Lost to Follow-up|11|||
145297224|NCT02475954|523939413|FG001|Overall Study|Lost to Follow-up|9|||
145297225|NCT02475954|523939412|FG000|Overall Study|Death|1|||
145297226|NCT02475954|523939413|FG001|Overall Study|Death|1|||
145297227|NCT01918397|523939418|FG000|Overall Study|Never started treatment|2|||
145297228|NCT01918397|523939419|FG001|Overall Study|Never started treatment|1|||
145297229|NCT01918397|523939420|FG002|Overall Study|Never started treatment|0|||
145297230|NCT01918397|523939421|FG003|Overall Study|Never started treatment|0|||
145297231|NCT01918397|523939418|FG000|Overall Study|Adverse Event|1|||
145297232|NCT01918397|523939419|FG001|Overall Study|Adverse Event|1|||
145297233|NCT01918397|523939420|FG002|Overall Study|Adverse Event|1|||
145297234|NCT01918397|523939421|FG003|Overall Study|Adverse Event|0|||
145297235|NCT01918397|523939418|FG000|Overall Study|Lack of compliance|2|||
145297236|NCT01918397|523939419|FG001|Overall Study|Lack of compliance|2|||
145297237|NCT01918397|523939420|FG002|Overall Study|Lack of compliance|3|||
145297238|NCT01918397|523939421|FG003|Overall Study|Lack of compliance|0|||
145297239|NCT01918397|523939418|FG000|Overall Study|Pregnancy|0|||
145297240|NCT01918397|523939419|FG001|Overall Study|Pregnancy|1|||
145297241|NCT01918397|523939420|FG002|Overall Study|Pregnancy|0|||
145297242|NCT01918397|523939421|FG003|Overall Study|Pregnancy|0|||
145297243|NCT01918397|523939418|FG000|Overall Study|Rifampin susceptible|0|||
145297244|NCT01918397|523939419|FG001|Overall Study|Rifampin susceptible|0|||
145297245|NCT01918397|523939420|FG002|Overall Study|Rifampin susceptible|0|||
145297246|NCT01918397|523939421|FG003|Overall Study|Rifampin susceptible|2|||
145297247|NCT01918397|523939418|FG000|Overall Study|Treatment failure|0|||
145297248|NCT01918397|523939419|FG001|Overall Study|Treatment failure|0|||
145297249|NCT01918397|523939420|FG002|Overall Study|Treatment failure|0|||
145297250|NCT01918397|523939421|FG003|Overall Study|Treatment failure|1|||
145564605|NCT01577758|524927312|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564606|NCT01577758|524927313|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564607|NCT01577758|524927314|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564608|NCT01577758|524927315|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564609|NCT01577758|524927316|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564610|NCT01577758|524927317|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564611|NCT01577758|524927318|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
145564612|NCT01577758|524927319|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
145564613|NCT01577758|524927312|FG000|mCRC Expansion Phase|Progression Disease|0|||
145564614|NCT01577758|524927313|FG001|mCRC Expansion Phase|Progression Disease|0|||
145564615|NCT01577758|524927314|FG002|mCRC Expansion Phase|Progression Disease|0|||
145564616|NCT01577758|524927315|FG003|mCRC Expansion Phase|Progression Disease|0|||
145564617|NCT01577758|524927316|FG004|mCRC Expansion Phase|Progression Disease|0|||
145564618|NCT01577758|524927317|FG005|mCRC Expansion Phase|Progression Disease|0|||
145564619|NCT01577758|524927318|FG006|mCRC Expansion Phase|Progression Disease|0|||
145564620|NCT01577758|524927319|FG007|mCRC Expansion Phase|Progression Disease|19|||
145564621|NCT01293240|524927320|FG000|Overall Study|Noncompliance|2|||
145564622|NCT02404350|524927324|FG000|Overall Study|Adverse Event|2|||
145564623|NCT02404350|524927325|FG001|Overall Study|Adverse Event|2|||
145564624|NCT02404350|524927326|FG002|Overall Study|Adverse Event|3|||
145564625|NCT02404350|524927327|FG003|Overall Study|Adverse Event|9|||
145564626|NCT02404350|524927324|FG000|Overall Study|Lack of Efficacy|3|||
145564627|NCT02404350|524927325|FG001|Overall Study|Lack of Efficacy|1|||
145297251|NCT01918397|523939418|FG000|Overall Study|Withdrawal by Subject|3|||
145297252|NCT01918397|523939419|FG001|Overall Study|Withdrawal by Subject|2|||
145297253|NCT01918397|523939420|FG002|Overall Study|Withdrawal by Subject|1|||
145297254|NCT01918397|523939421|FG003|Overall Study|Withdrawal by Subject|1|||
145297255|NCT01918397|523939418|FG000|Overall Study|XDR at baseline|0|||
145297256|NCT01918397|523939419|FG001|Overall Study|XDR at baseline|0|||
145297257|NCT01918397|523939420|FG002|Overall Study|XDR at baseline|1|||
145297258|NCT01918397|523939421|FG003|Overall Study|XDR at baseline|0|||
145297259|NCT01918397|523939418|FG000|Overall Study|Lost to Follow-up|2|||
145564628|NCT02404350|524927326|FG002|Overall Study|Lack of Efficacy|0|||
145564629|NCT02404350|524927327|FG003|Overall Study|Lack of Efficacy|3|||
145297260|NCT01918397|523939419|FG001|Overall Study|Lost to Follow-up|1|||
145297261|NCT01918397|523939420|FG002|Overall Study|Lost to Follow-up|1|||
145297262|NCT01918397|523939421|FG003|Overall Study|Lost to Follow-up|1|||
145297263|NCT01918397|523939418|FG000|Overall Study|Increased QTc|1|||
145297264|NCT01918397|523939419|FG001|Overall Study|Increased QTc|0|||
145564630|NCT02404350|524927324|FG000|Overall Study|Lost to Follow-up|2|||
145564631|NCT02404350|524927325|FG001|Overall Study|Lost to Follow-up|0|||
145564632|NCT02404350|524927326|FG002|Overall Study|Lost to Follow-up|0|||
145564633|NCT02404350|524927327|FG003|Overall Study|Lost to Follow-up|1|||
145244391|NCT01838213|523741935|FG001|Overall Study|Ineligible|191|||
145244392|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
145244393|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
145244394|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
145244395|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
145244396|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
145244397|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
145244398|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
145244399|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
145244400|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
145297265|NCT01918397|523939420|FG002|Overall Study|Increased QTc|0|||
145297266|NCT01918397|523939421|FG003|Overall Study|Increased QTc|1|||
145297267|NCT01918397|523939418|FG000|Overall Study|Death|0|||
145297268|NCT01918397|523939419|FG001|Overall Study|Death|0|||
145297269|NCT01918397|523939420|FG002|Overall Study|Death|1|||
145297270|NCT01918397|523939421|FG003|Overall Study|Death|0|||
145297271|NCT01918397|523939418|FG000|Overall Study|Involved in another investigative trial|0|||
145297272|NCT01918397|523939419|FG001|Overall Study|Involved in another investigative trial|0|||
145297273|NCT01918397|523939420|FG002|Overall Study|Involved in another investigative trial|0|||
145409088|NCT05291689|524351963|FG000|Overall Study|Withdrawal by Subject|4|||
145564634|NCT02404350|524927324|FG000|Overall Study|Physician Decision|1|||
145564635|NCT02404350|524927325|FG001|Overall Study|Physician Decision|0|||
145564636|NCT02404350|524927326|FG002|Overall Study|Physician Decision|0|||
145564637|NCT02404350|524927327|FG003|Overall Study|Physician Decision|2|||
145564638|NCT02404350|524927324|FG000|Overall Study|Pregnancy|0|||
145564639|NCT02404350|524927325|FG001|Overall Study|Pregnancy|0|||
145564640|NCT02404350|524927326|FG002|Overall Study|Pregnancy|0|||
145564641|NCT02404350|524927327|FG003|Overall Study|Pregnancy|1|||
145564642|NCT02404350|524927324|FG000|Overall Study|Withdrawal by Subject|7|||
145564643|NCT02404350|524927325|FG001|Overall Study|Withdrawal by Subject|3|||
145564644|NCT02404350|524927326|FG002|Overall Study|Withdrawal by Subject|3|||
145564645|NCT02404350|524927327|FG003|Overall Study|Withdrawal by Subject|19|||
145564646|NCT02404350|524927324|FG000|Overall Study|Due to Non-compliance with treatment|0|||
145564647|NCT02404350|524927325|FG001|Overall Study|Due to Non-compliance with treatment|0|||
145564648|NCT02404350|524927326|FG002|Overall Study|Due to Non-compliance with treatment|0|||
145564649|NCT02404350|524927327|FG003|Overall Study|Due to Non-compliance with treatment|1|||
145564650|NCT02404350|524927324|FG000|Overall Study|Due to Technical problems|0|||
145564651|NCT02404350|524927325|FG001|Overall Study|Due to Technical problems|0|||
145564652|NCT02404350|524927326|FG002|Overall Study|Due to Technical problems|0|||
145564653|NCT02404350|524927327|FG003|Overall Study|Due to Technical problems|1|||
145564654|NCT05389657|524927328|FG000|Overall Study|Lost to Follow-up|7|||
145564655|NCT05389657|524927329|FG001|Overall Study|Lost to Follow-up|8|||
145564656|NCT03261947|524927333|FG000|Overall Study|Death|10|||
145564657|NCT03261947|524927334|FG001|Overall Study|Death|13|||
145564658|NCT03261947|524927335|FG002|Overall Study|Death|17|||
145564659|NCT03261947|524927336|FG003|Overall Study|Death|12|||
145564660|NCT03261947|524927337|FG004|Overall Study|Death|8|||
145564661|NCT03261947|524927333|FG000|Overall Study|Lost to Follow-up|0|||
145564662|NCT03261947|524927334|FG001|Overall Study|Lost to Follow-up|0|||
145564663|NCT03261947|524927335|FG002|Overall Study|Lost to Follow-up|2|||
145564664|NCT03261947|524927336|FG003|Overall Study|Lost to Follow-up|1|||
145564665|NCT03261947|524927337|FG004|Overall Study|Lost to Follow-up|0|||
145564666|NCT03261947|524927333|FG000|Overall Study|Withdrawal by Subject|0|||
145564667|NCT03261947|524927334|FG001|Overall Study|Withdrawal by Subject|0|||
145564668|NCT03261947|524927335|FG002|Overall Study|Withdrawal by Subject|3|||
145564669|NCT03261947|524927336|FG003|Overall Study|Withdrawal by Subject|0|||
145564670|NCT03261947|524927337|FG004|Overall Study|Withdrawal by Subject|1|||
145564671|NCT03261947|524927333|FG000|Overall Study|Site Terminated by Sponsor|0|||
145564672|NCT03261947|524927334|FG001|Overall Study|Site Terminated by Sponsor|0|||
145564673|NCT03261947|524927335|FG002|Overall Study|Site Terminated by Sponsor|4|||
145564674|NCT03261947|524927336|FG003|Overall Study|Site Terminated by Sponsor|7|||
145564675|NCT03261947|524927337|FG004|Overall Study|Site Terminated by Sponsor|5|||
145564676|NCT03261947|524927333|FG000|Overall Study|Reason not Specified|2|||
145564677|NCT03261947|524927334|FG001|Overall Study|Reason not Specified|0|||
145564678|NCT03261947|524927335|FG002|Overall Study|Reason not Specified|4|||
145564679|NCT03261947|524927336|FG003|Overall Study|Reason not Specified|1|||
145244401|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
145409089|NCT01931098|524351964|FG000|Overall Study|Withdrawal by Subject|0|||
145564680|NCT03261947|524927337|FG004|Overall Study|Reason not Specified|3|||
145564681|NCT02140567|524927339|FG000|Overall Study|Problems with recording equipment|6|||
145564682|NCT02039674|524927341|FG000|Overall Study|Adverse Event|0|||
145564683|NCT02039674|524927342|FG001|Overall Study|Adverse Event|0|||
145564684|NCT02039674|524927343|FG002|Overall Study|Adverse Event|0|||
145564685|NCT02039674|524927344|FG003|Overall Study|Adverse Event|1|||
145564686|NCT02039674|524927345|FG004|Overall Study|Adverse Event|0|||
145564687|NCT02039674|524927346|FG005|Overall Study|Adverse Event|0|||
145244402|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
145244403|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
145244404|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
145244405|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
145244406|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
145244407|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
145244408|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
145244409|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
145244410|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
145244411|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
145244412|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
145244413|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
145244414|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
145244415|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
145244416|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
145244417|NCT02918318|523741936|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
145244418|NCT02918318|523741937|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
145244419|NCT02918318|523741938|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
145244420|NCT02918318|523741939|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
145244421|NCT02918318|523741940|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
145244422|NCT02918318|523741936|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
145244423|NCT02918318|523741937|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
145244424|NCT02918318|523741938|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
145244425|NCT02918318|523741939|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
145244426|NCT02918318|523741940|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
145244427|NCT02918318|523741936|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
145244428|NCT02918318|523741937|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244429|NCT02918318|523741938|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
145244430|NCT02918318|523741939|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
145244431|NCT02918318|523741940|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244432|NCT02918318|523741936|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
145244433|NCT02918318|523741937|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
145244434|NCT02918318|523741938|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
145244435|NCT02918318|523741939|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
145244436|NCT02918318|523741940|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
145244437|NCT02918318|523741936|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
145244438|NCT02918318|523741937|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
145244439|NCT02918318|523741938|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
145244440|NCT02918318|523741939|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
145244441|NCT02918318|523741940|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
145244442|NCT02918318|523741936|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
145244443|NCT02918318|523741937|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
145244444|NCT02918318|523741938|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
145244445|NCT02918318|523741939|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
145244446|NCT02918318|523741940|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
145244447|NCT02918318|523741936|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244448|NCT02918318|523741937|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244449|NCT02918318|523741938|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244450|NCT02918318|523741939|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
145244451|NCT02918318|523741940|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
145244452|NCT03185819|523741941|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
145244453|NCT03185819|523741942|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
145244454|NCT03185819|523741943|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
145244455|NCT03185819|523741944|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
145244456|NCT03185819|523741941|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
145244457|NCT03185819|523741942|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
145409090|NCT01931098|524351965|FG001|Overall Study|Withdrawal by Subject|1|||
145244458|NCT03185819|523741943|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
145244459|NCT03185819|523741944|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
145244460|NCT03185819|523741941|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
145244461|NCT03185819|523741942|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
145244462|NCT03185819|523741943|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
145244463|NCT03185819|523741944|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
145244464|NCT03185819|523741941|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
145409091|NCT01931098|524351964|FG000|Overall Study|Enrolled in different protocol|0|||
145409092|NCT01931098|524351965|FG001|Overall Study|Enrolled in different protocol|1|||
145409093|NCT01931098|524351964|FG000|Overall Study|Unable to begin trmt:active infection|0|||
145244465|NCT03185819|523741942|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
145244466|NCT03185819|523741943|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
145244467|NCT03185819|523741944|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
145244468|NCT03185819|523741941|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
145244469|NCT03185819|523741942|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
145244470|NCT03185819|523741943|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
145244471|NCT03185819|523741944|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
145564688|NCT02039674|524927347|FG006|Overall Study|Adverse Event|0|||
145564689|NCT02039674|524927348|FG007|Overall Study|Adverse Event|0|||
145564690|NCT02039674|524927349|FG008|Overall Study|Adverse Event|2|||
145564691|NCT02039674|524927350|FG009|Overall Study|Adverse Event|1|||
145564692|NCT02039674|524927351|FG010|Overall Study|Adverse Event|0|||
145564693|NCT02039674|524927352|FG011|Overall Study|Adverse Event|2|||
145564694|NCT02039674|524927353|FG012|Overall Study|Adverse Event|3|||
145564695|NCT02039674|524927354|FG013|Overall Study|Adverse Event|1|||
145564696|NCT02039674|524927341|FG000|Overall Study|Death|2|||
145564697|NCT02039674|524927342|FG001|Overall Study|Death|0|||
145564698|NCT02039674|524927343|FG002|Overall Study|Death|2|||
145564699|NCT02039674|524927344|FG003|Overall Study|Death|3|||
145564700|NCT02039674|524927345|FG004|Overall Study|Death|0|||
145564701|NCT02039674|524927346|FG005|Overall Study|Death|0|||
145564702|NCT02039674|524927347|FG006|Overall Study|Death|1|||
145564703|NCT02039674|524927348|FG007|Overall Study|Death|0|||
145564704|NCT02039674|524927349|FG008|Overall Study|Death|2|||
145564705|NCT02039674|524927350|FG009|Overall Study|Death|0|||
145564706|NCT02039674|524927351|FG010|Overall Study|Death|1|||
145564707|NCT02039674|524927352|FG011|Overall Study|Death|3|||
145564708|NCT02039674|524927353|FG012|Overall Study|Death|2|||
145564709|NCT02039674|524927354|FG013|Overall Study|Death|8|||
145564710|NCT02039674|524927341|FG000|Overall Study|Excluded Medication|1|||
145564711|NCT02039674|524927342|FG001|Overall Study|Excluded Medication|1|||
145564712|NCT02039674|524927343|FG002|Overall Study|Excluded Medication|0|||
145564713|NCT02039674|524927344|FG003|Overall Study|Excluded Medication|1|||
145564714|NCT02039674|524927345|FG004|Overall Study|Excluded Medication|0|||
145564715|NCT02039674|524927346|FG005|Overall Study|Excluded Medication|1|||
145564716|NCT02039674|524927347|FG006|Overall Study|Excluded Medication|0|||
145564717|NCT02039674|524927348|FG007|Overall Study|Excluded Medication|0|||
145564718|NCT02039674|524927349|FG008|Overall Study|Excluded Medication|2|||
145564719|NCT02039674|524927350|FG009|Overall Study|Excluded Medication|3|||
145564720|NCT02039674|524927351|FG010|Overall Study|Excluded Medication|5|||
145564721|NCT02039674|524927352|FG011|Overall Study|Excluded Medication|6|||
145564722|NCT02039674|524927353|FG012|Overall Study|Excluded Medication|8|||
145564723|NCT02039674|524927354|FG013|Overall Study|Excluded Medication|3|||
145564724|NCT02039674|524927341|FG000|Overall Study|Lost to Follow-up|0|||
145564725|NCT02039674|524927342|FG001|Overall Study|Lost to Follow-up|0|||
145564726|NCT02039674|524927343|FG002|Overall Study|Lost to Follow-up|0|||
145564727|NCT02039674|524927344|FG003|Overall Study|Lost to Follow-up|0|||
145564728|NCT02039674|524927345|FG004|Overall Study|Lost to Follow-up|1|||
145564729|NCT02039674|524927346|FG005|Overall Study|Lost to Follow-up|1|||
145564730|NCT02039674|524927347|FG006|Overall Study|Lost to Follow-up|0|||
145564731|NCT02039674|524927348|FG007|Overall Study|Lost to Follow-up|0|||
145564732|NCT02039674|524927349|FG008|Overall Study|Lost to Follow-up|0|||
145564733|NCT02039674|524927350|FG009|Overall Study|Lost to Follow-up|0|||
145564734|NCT02039674|524927351|FG010|Overall Study|Lost to Follow-up|0|||
145564735|NCT02039674|524927352|FG011|Overall Study|Lost to Follow-up|2|||
145564736|NCT02039674|524927353|FG012|Overall Study|Lost to Follow-up|2|||
145564737|NCT02039674|524927354|FG013|Overall Study|Lost to Follow-up|1|||
145564738|NCT02039674|524927341|FG000|Overall Study|Physician Decision|0|||
145564739|NCT02039674|524927342|FG001|Overall Study|Physician Decision|0|||
145564740|NCT02039674|524927343|FG002|Overall Study|Physician Decision|0|||
145564741|NCT02039674|524927344|FG003|Overall Study|Physician Decision|0|||
145564742|NCT02039674|524927345|FG004|Overall Study|Physician Decision|0|||
145564743|NCT02039674|524927346|FG005|Overall Study|Physician Decision|0|||
145620117|NCT00873093|525123685|FG002|Overall Study|Physician Decision|10|||
145564744|NCT02039674|524927347|FG006|Overall Study|Physician Decision|0|||
145564745|NCT02039674|524927348|FG007|Overall Study|Physician Decision|0|||
145564746|NCT02039674|524927349|FG008|Overall Study|Physician Decision|0|||
145564747|NCT02039674|524927350|FG009|Overall Study|Physician Decision|0|||
145564748|NCT02039674|524927351|FG010|Overall Study|Physician Decision|0|||
145564749|NCT02039674|524927352|FG011|Overall Study|Physician Decision|1|||
145564750|NCT02039674|524927353|FG012|Overall Study|Physician Decision|1|||
145564751|NCT02039674|524927354|FG013|Overall Study|Physician Decision|0|||
145564752|NCT02039674|524927341|FG000|Overall Study|Progressive Disease|8|||
145564753|NCT02039674|524927342|FG001|Overall Study|Progressive Disease|8|||
145564754|NCT02039674|524927343|FG002|Overall Study|Progressive Disease|6|||
145564755|NCT02039674|524927344|FG003|Overall Study|Progressive Disease|7|||
145564756|NCT02039674|524927345|FG004|Overall Study|Progressive Disease|9|||
145564757|NCT02039674|524927346|FG005|Overall Study|Progressive Disease|10|||
145564758|NCT02039674|524927347|FG006|Overall Study|Progressive Disease|1|||
145564759|NCT02039674|524927348|FG007|Overall Study|Progressive Disease|3|||
145244472|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
145244473|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
145244474|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
145244475|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
145244476|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
145244477|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
145244478|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
145244479|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
145244480|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
145244481|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
145244482|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
145244483|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
145244484|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
145244485|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
145244486|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
145244487|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
145244488|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
145244489|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
145244490|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
145244491|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
145244492|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
145244493|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
145564760|NCT02039674|524927349|FG008|Overall Study|Progressive Disease|6|||
145244494|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
145244495|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
145244496|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
145244497|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
145244498|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
145244499|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
145244500|NCT03185819|523741941|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
145244501|NCT03185819|523741942|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
145564761|NCT02039674|524927350|FG009|Overall Study|Progressive Disease|4|||
145244502|NCT03185819|523741943|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
145244503|NCT03185819|523741944|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
145244504|NCT03097133|523741945|FG000|Overall Study|Lost to Follow-up|3|||
145244505|NCT03097133|523741946|FG001|Overall Study|Lost to Follow-up|2|||
145244506|NCT03097133|523741945|FG000|Overall Study|Withdrawal by Subject|2|||
145244507|NCT03097133|523741946|FG001|Overall Study|Withdrawal by Subject|5|||
145244508|NCT03097133|523741945|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
145564762|NCT02039674|524927351|FG010|Overall Study|Progressive Disease|0|||
145564763|NCT02039674|524927352|FG011|Overall Study|Progressive Disease|34|||
145564764|NCT02039674|524927353|FG012|Overall Study|Progressive Disease|34|||
145564765|NCT02039674|524927354|FG013|Overall Study|Progressive Disease|18|||
145564766|NCT02039674|524927341|FG000|Overall Study|Withdrawal by Subject|1|||
145564767|NCT02039674|524927342|FG001|Overall Study|Withdrawal by Subject|2|||
145564768|NCT02039674|524927343|FG002|Overall Study|Withdrawal by Subject|3|||
145564769|NCT02039674|524927344|FG003|Overall Study|Withdrawal by Subject|0|||
145564770|NCT02039674|524927345|FG004|Overall Study|Withdrawal by Subject|1|||
145564771|NCT02039674|524927346|FG005|Overall Study|Withdrawal by Subject|0|||
145564772|NCT02039674|524927347|FG006|Overall Study|Withdrawal by Subject|0|||
145564773|NCT02039674|524927348|FG007|Overall Study|Withdrawal by Subject|0|||
145564774|NCT02039674|524927349|FG008|Overall Study|Withdrawal by Subject|0|||
145564775|NCT02039674|524927350|FG009|Overall Study|Withdrawal by Subject|1|||
145564776|NCT02039674|524927351|FG010|Overall Study|Withdrawal by Subject|1|||
145564777|NCT02039674|524927352|FG011|Overall Study|Withdrawal by Subject|4|||
145564778|NCT02039674|524927353|FG012|Overall Study|Withdrawal by Subject|6|||
145564779|NCT02039674|524927354|FG013|Overall Study|Withdrawal by Subject|2|||
145564780|NCT02039674|524927341|FG000|Overall Study|Clinical Progression|0|||
145564781|NCT02039674|524927342|FG001|Overall Study|Clinical Progression|0|||
145564782|NCT02039674|524927343|FG002|Overall Study|Clinical Progression|0|||
145564783|NCT02039674|524927344|FG003|Overall Study|Clinical Progression|0|||
145564784|NCT02039674|524927345|FG004|Overall Study|Clinical Progression|0|||
145564785|NCT02039674|524927346|FG005|Overall Study|Clinical Progression|0|||
145564786|NCT02039674|524927347|FG006|Overall Study|Clinical Progression|1|||
145564787|NCT02039674|524927348|FG007|Overall Study|Clinical Progression|0|||
145564788|NCT02039674|524927349|FG008|Overall Study|Clinical Progression|0|||
145564789|NCT02039674|524927350|FG009|Overall Study|Clinical Progression|0|||
145244509|NCT03097133|523741946|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
145244510|NCT03097133|523741945|FG000|Overall Study|Other|3|||
145244511|NCT03097133|523741946|FG001|Overall Study|Other|2|||
145244512|NCT03097133|523741945|FG000|Overall Study|Adverse Event|1|||
145244513|NCT03097133|523741946|FG001|Overall Study|Adverse Event|0|||
145244514|NCT00732238|523741949|FG000|Overall Study|Bacteremia|4|||
145244515|NCT00732238|523741950|FG001|Overall Study|Bacteremia|1|||
145244516|NCT00732238|523741949|FG000|Overall Study|Asymptomatic bacteriuria|1|||
145244517|NCT00732238|523741950|FG001|Overall Study|Asymptomatic bacteriuria|0|||
145244518|NCT02910089|523741951|FG000|Overall Study|Lost insurance eligibility|22|||
145244519|NCT02910089|523741952|FG001|Overall Study|Lost insurance eligibility|16|||
145244520|NCT02939976|523741953|FG000|Overall Study|Lost to Follow-up|7|||
145244521|NCT02939976|523741954|FG001|Overall Study|Lost to Follow-up|1|||
145244522|NCT02939976|523741955|FG002|Overall Study|Lost to Follow-up|1|||
145244523|NCT02939976|523741956|FG003|Overall Study|Lost to Follow-up|2|||
145244524|NCT02939976|523741953|FG000|Overall Study|Withdrawal by Subject|4|||
145244525|NCT02939976|523741954|FG001|Overall Study|Withdrawal by Subject|0|||
145244526|NCT02939976|523741955|FG002|Overall Study|Withdrawal by Subject|2|||
145244527|NCT02939976|523741956|FG003|Overall Study|Withdrawal by Subject|4|||
145244528|NCT02939976|523741953|FG000|Overall Study|Due to early study closure|4|||
145244529|NCT02939976|523741954|FG001|Overall Study|Due to early study closure|3|||
145244530|NCT02939976|523741955|FG002|Overall Study|Due to early study closure|2|||
145244531|NCT02939976|523741956|FG003|Overall Study|Due to early study closure|3|||
145244532|NCT04080752|523741957|FG000|Overall Study|Adverse Event|2|||
145244533|NCT04080752|523741958|FG001|Overall Study|Adverse Event|3|||
145564790|NCT02039674|524927351|FG010|Overall Study|Clinical Progression|0|||
145564791|NCT02039674|524927352|FG011|Overall Study|Clinical Progression|0|||
145564792|NCT02039674|524927353|FG012|Overall Study|Clinical Progression|1|||
145564793|NCT02039674|524927354|FG013|Overall Study|Clinical Progression|0|||
145564794|NCT02039674|524927341|FG000|Overall Study|Sponsor Decision|1|||
145564795|NCT02039674|524927342|FG001|Overall Study|Sponsor Decision|1|||
145564796|NCT02039674|524927343|FG002|Overall Study|Sponsor Decision|1|||
145564797|NCT02039674|524927344|FG003|Overall Study|Sponsor Decision|1|||
145564798|NCT02039674|524927345|FG004|Overall Study|Sponsor Decision|1|||
145564799|NCT02039674|524927346|FG005|Overall Study|Sponsor Decision|0|||
145564800|NCT02039674|524927347|FG006|Overall Study|Sponsor Decision|0|||
145564801|NCT02039674|524927348|FG007|Overall Study|Sponsor Decision|0|||
145564802|NCT02039674|524927349|FG008|Overall Study|Sponsor Decision|0|||
145564803|NCT02039674|524927350|FG009|Overall Study|Sponsor Decision|3|||
145564804|NCT02039674|524927351|FG010|Overall Study|Sponsor Decision|0|||
145564805|NCT02039674|524927352|FG011|Overall Study|Sponsor Decision|8|||
145564806|NCT02039674|524927353|FG012|Overall Study|Sponsor Decision|5|||
145564807|NCT02039674|524927354|FG013|Overall Study|Sponsor Decision|0|||
145564808|NCT02039674|524927341|FG000|Overall Study|Other|0|||
145564809|NCT02039674|524927342|FG001|Overall Study|Other|0|||
145564810|NCT02039674|524927343|FG002|Overall Study|Other|0|||
145564811|NCT02039674|524927344|FG003|Overall Study|Other|0|||
145564812|NCT02039674|524927345|FG004|Overall Study|Other|0|||
145564813|NCT02039674|524927346|FG005|Overall Study|Other|0|||
145564814|NCT02039674|524927347|FG006|Overall Study|Other|0|||
145564815|NCT02039674|524927348|FG007|Overall Study|Other|0|||
145564816|NCT02039674|524927349|FG008|Overall Study|Other|0|||
145564817|NCT02039674|524927350|FG009|Overall Study|Other|0|||
145564818|NCT02039674|524927351|FG010|Overall Study|Other|0|||
145564819|NCT02039674|524927352|FG011|Overall Study|Other|0|||
145564820|NCT02039674|524927353|FG012|Overall Study|Other|1|||
145564821|NCT02039674|524927354|FG013|Overall Study|Other|0|||
145244534|NCT04080752|523741957|FG000|Overall Study|Lack of Efficacy|1|||
145244535|NCT04080752|523741958|FG001|Overall Study|Lack of Efficacy|0|||
145244536|NCT04080752|523741957|FG000|Overall Study|Lost to Follow-up|1|||
145244537|NCT04080752|523741958|FG001|Overall Study|Lost to Follow-up|0|||
145244538|NCT04080752|523741957|FG000|Overall Study|Pregnancy|0|||
145244539|NCT04080752|523741958|FG001|Overall Study|Pregnancy|1|||
145244540|NCT04080752|523741957|FG000|Overall Study|Withdrawal by Subject|7|||
145244541|NCT04080752|523741958|FG001|Overall Study|Withdrawal by Subject|0|||
145244542|NCT04080752|523741957|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145244543|NCT04080752|523741958|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145244544|NCT04080752|523741957|FG000|Overall Study|Other|2|||
145244545|NCT04080752|523741958|FG001|Overall Study|Other|1|||
145244546|NCT01585168|523741959|FG000|Overall Study|Lost to Follow-up|3|||
145409094|NCT01931098|524351965|FG001|Overall Study|Unable to begin trmt:active infection|1|||
145564822|NCT03774433|524927356|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
145564823|NCT00108160|524927357|FG000|Overall Study|Lost to Follow-up|25|||
145564824|NCT00108160|524927358|FG001|Overall Study|Lost to Follow-up|12|||
145564825|NCT00108160|524927357|FG000|Overall Study|Death|1|||
145564826|NCT00108160|524927358|FG001|Overall Study|Death|2|||
145564827|NCT00108160|524927357|FG000|Overall Study|Withdrawal by Subject|4|||
145564828|NCT00108160|524927358|FG001|Overall Study|Withdrawal by Subject|2|||
145564829|NCT00108160|524927357|FG000|Overall Study|Protocol Violation|9|||
145564830|NCT00108160|524927358|FG001|Overall Study|Protocol Violation|5|||
145564831|NCT05045144|524927360|FG000|Overall Study|Lost to Follow-up|3|||
145564832|NCT05045144|524927361|FG001|Overall Study|Lost to Follow-up|2|||
145564833|NCT05045144|524927362|FG002|Overall Study|Lost to Follow-up|3|||
145564834|NCT05045144|524927363|FG003|Overall Study|Lost to Follow-up|5|||
145564835|NCT05045144|524927364|FG004|Overall Study|Lost to Follow-up|13|||
145564836|NCT05045144|524927360|FG000|Overall Study|Withdrawal by Subject|0|||
145564837|NCT05045144|524927361|FG001|Overall Study|Withdrawal by Subject|1|||
145564838|NCT05045144|524927362|FG002|Overall Study|Withdrawal by Subject|0|||
145564839|NCT05045144|524927363|FG003|Overall Study|Withdrawal by Subject|0|||
145564840|NCT05045144|524927364|FG004|Overall Study|Withdrawal by Subject|0|||
145564841|NCT05045144|524927360|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145564842|NCT05045144|524927361|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145564843|NCT05045144|524927362|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145564844|NCT05045144|524927363|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145564845|NCT05045144|524927364|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145564846|NCT02385084|524927365|FG000|Period 2|Protocol Violation|0|||
145564847|NCT02385084|524927366|FG001|Period 2|Protocol Violation|0|||
145564848|NCT02385084|524927367|FG002|Period 2|Protocol Violation|1|||
145564849|NCT02385084|524927368|FG003|Period 2|Protocol Violation|0|||
145564850|NCT02385084|524927369|FG004|Period 2|Protocol Violation|0|||
145564851|NCT02385084|524927370|FG005|Period 2|Protocol Violation|0|||
145564852|NCT02965703|524927372|FG000|Overall Study|Withdrawal by Subject|6|||
145564853|NCT02965703|524927373|FG001|Overall Study|Withdrawal by Subject|3|||
145564854|NCT02965703|524927374|FG002|Overall Study|Withdrawal by Subject|1|||
145564855|NCT02965703|524927372|FG000|Overall Study|Protocol Violation|1|||
145564856|NCT02965703|524927373|FG001|Overall Study|Protocol Violation|0|||
145564857|NCT02965703|524927374|FG002|Overall Study|Protocol Violation|0|||
145564858|NCT02965703|524927372|FG000|Overall Study|Adverse Event|1|||
145564859|NCT02965703|524927373|FG001|Overall Study|Adverse Event|1|||
145564860|NCT02965703|524927374|FG002|Overall Study|Adverse Event|0|||
145564861|NCT02965703|524927372|FG000|Overall Study|Lost to Follow-up|2|||
145564862|NCT02965703|524927373|FG001|Overall Study|Lost to Follow-up|1|||
145564863|NCT02965703|524927374|FG002|Overall Study|Lost to Follow-up|1|||
145564864|NCT02968979|524927375|FG000|Overall Study|Protocol Violation|7|||
145564865|NCT02968979|524927375|FG000|Overall Study|Withdrawal by Subject|1|||
145564866|NCT00729183|524927376|FG000|Overall Study|Adverse Event|11|||
145564867|NCT00729183|524927377|FG001|Overall Study|Adverse Event|5|||
145564868|NCT00729183|524927376|FG000|Overall Study|Lack of Efficacy|0|||
145564869|NCT00729183|524927377|FG001|Overall Study|Lack of Efficacy|1|||
145564870|NCT00729183|524927376|FG000|Overall Study|Lost to Follow-up|3|||
145564871|NCT00729183|524927377|FG001|Overall Study|Lost to Follow-up|1|||
145564872|NCT00729183|524927376|FG000|Overall Study|Physician Decision|1|||
145564873|NCT00729183|524927377|FG001|Overall Study|Physician Decision|1|||
145564874|NCT00729183|524927376|FG000|Overall Study|Protocol Violation|1|||
145564875|NCT00729183|524927377|FG001|Overall Study|Protocol Violation|0|||
145564876|NCT00729183|524927376|FG000|Overall Study|Withdrawal by Subject|9|||
145564877|NCT00729183|524927377|FG001|Overall Study|Withdrawal by Subject|7|||
145564878|NCT03745144|524927384|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
145564879|NCT03745144|524927385|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
145564880|NCT03745144|524927386|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
145564881|NCT03745144|524927384|FG000|Period 1|Other|0|||
145564882|NCT03745144|524927385|FG001|Period 1|Other|0|||
145564883|NCT03745144|524927386|FG002|Period 1|Other|1|||
145564884|NCT01359254|524927387|FG000|Overall Study|Death|1|||
145564885|NCT01359254|524927388|FG001|Overall Study|Death|0|||
145564886|NCT01124643|524927399|FG000|Overall Study|Death|1|||
145564887|NCT02678676|524927402|FG000|Overall Study|Death|619|||
145564888|NCT02678676|524927403|FG001|Overall Study|Death|649|||
145564889|NCT02678676|524927402|FG000|Overall Study|Withdrawal by Subject|13|||
145564890|NCT02678676|524927403|FG001|Overall Study|Withdrawal by Subject|5|||
145564891|NCT02678676|524927402|FG000|Overall Study|Lost to Follow-up|171|||
145564892|NCT02678676|524927403|FG001|Overall Study|Lost to Follow-up|151|||
145564893|NCT02678676|524927402|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
145564894|NCT02678676|524927403|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
145564895|NCT00851799|524927404|FG000|Overall Study|Death|1|||
145564896|NCT00851799|524927405|FG001|Overall Study|Death|0|||
145564897|NCT00851799|524927406|FG002|Overall Study|Death|1|||
145564898|NCT00851799|524927404|FG000|Overall Study|Lost to Follow-up|5|||
145564899|NCT00851799|524927405|FG001|Overall Study|Lost to Follow-up|3|||
145564900|NCT00851799|524927406|FG002|Overall Study|Lost to Follow-up|10|||
145564901|NCT00851799|524927404|FG000|Overall Study|Not able to get to clinic|8|||
145564902|NCT00851799|524927405|FG001|Overall Study|Not able to get to clinic|5|||
145564903|NCT00851799|524927406|FG002|Overall Study|Not able to get to clinic|9|||
145564904|NCT00851799|524927404|FG000|Overall Study|Not willing to adhere to requirements|1|||
145564905|NCT00851799|524927405|FG001|Overall Study|Not willing to adhere to requirements|2|||
145564906|NCT00851799|524927406|FG002|Overall Study|Not willing to adhere to requirements|2|||
145564907|NCT00851799|524927404|FG000|Overall Study|Withdrew consent prior study completion|1|||
145564908|NCT00851799|524927405|FG001|Overall Study|Withdrew consent prior study completion|2|||
145297274|NCT01918397|523939421|FG003|Overall Study|Involved in another investigative trial|1|||
145297275|NCT00880568|523939422|FG000|Overall Study|Disease progression|3|||
145297276|NCT00880568|523939423|FG001|Overall Study|Disease progression|3|||
145297277|NCT00880568|523939424|FG002|Overall Study|Disease progression|3|||
145297278|NCT00880568|523939425|FG003|Overall Study|Disease progression|1|||
145297279|NCT00880568|523939426|FG004|Overall Study|Disease progression|3|||
145297280|NCT00880568|523939427|FG005|Overall Study|Disease progression|3|||
145297281|NCT00880568|523939428|FG006|Overall Study|Disease progression|5|||
145297282|NCT00880568|523939429|FG007|Overall Study|Disease progression|0|||
145297283|NCT00880568|523939430|FG008|Overall Study|Disease progression|3|||
145297284|NCT00880568|523939422|FG000|Overall Study|Adverse Event|0|||
145297285|NCT00880568|523939423|FG001|Overall Study|Adverse Event|0|||
145297286|NCT00880568|523939424|FG002|Overall Study|Adverse Event|0|||
145297287|NCT00880568|523939425|FG003|Overall Study|Adverse Event|0|||
145297288|NCT00880568|523939426|FG004|Overall Study|Adverse Event|0|||
145297289|NCT00880568|523939427|FG005|Overall Study|Adverse Event|0|||
145297290|NCT00880568|523939428|FG006|Overall Study|Adverse Event|1|||
145297291|NCT00880568|523939429|FG007|Overall Study|Adverse Event|1|||
145297292|NCT00880568|523939430|FG008|Overall Study|Adverse Event|0|||
145297293|NCT00880568|523939422|FG000|Overall Study|Withdrawal by Subject|0|||
145297294|NCT00880568|523939423|FG001|Overall Study|Withdrawal by Subject|0|||
145297295|NCT00880568|523939424|FG002|Overall Study|Withdrawal by Subject|0|||
145297296|NCT00880568|523939425|FG003|Overall Study|Withdrawal by Subject|0|||
145297297|NCT00880568|523939426|FG004|Overall Study|Withdrawal by Subject|0|||
145297298|NCT00880568|523939427|FG005|Overall Study|Withdrawal by Subject|0|||
145297299|NCT00880568|523939428|FG006|Overall Study|Withdrawal by Subject|0|||
145297300|NCT00880568|523939429|FG007|Overall Study|Withdrawal by Subject|1|||
145297301|NCT00880568|523939430|FG008|Overall Study|Withdrawal by Subject|0|||
145297302|NCT00620022|523939431|FG000|Treatment Period 1|Adverse Event|4|||
145297303|NCT00620022|523939432|FG001|Treatment Period 1|Adverse Event|6|||
145297304|NCT00620022|523939431|FG000|Treatment Period 1|Subject withdrew consent|1|||
145297305|NCT00620022|523939432|FG001|Treatment Period 1|Subject withdrew consent|0|||
145297306|NCT00620022|523939431|FG000|Treatment Period 2|Adverse Event|2|||
145297307|NCT00620022|523939432|FG001|Treatment Period 2|Adverse Event|2|||
145297308|NCT00358449|523939439|FG000|Overall Study|Adverse Event|1|||
145297309|NCT00358449|523939440|FG001|Overall Study|Adverse Event|0|||
145297310|NCT00358449|523939441|FG002|Overall Study|Adverse Event|1|||
145297311|NCT00358449|523939439|FG000|Overall Study|Lost to Follow-up|1|||
145297312|NCT00358449|523939440|FG001|Overall Study|Lost to Follow-up|0|||
145297313|NCT00358449|523939441|FG002|Overall Study|Lost to Follow-up|0|||
145297314|NCT00358449|523939439|FG000|Overall Study|Withdrawal by Subject|2|||
145297315|NCT00358449|523939440|FG001|Overall Study|Withdrawal by Subject|0|||
145297316|NCT00358449|523939441|FG002|Overall Study|Withdrawal by Subject|0|||
145297317|NCT00358449|523939439|FG000|Overall Study|Lack of Efficacy|0|||
145297318|NCT00358449|523939440|FG001|Overall Study|Lack of Efficacy|1|||
145297319|NCT00358449|523939441|FG002|Overall Study|Lack of Efficacy|0|||
145297320|NCT00358449|523939439|FG000|Overall Study|Steriod Inhaler was Increased|0|||
145297321|NCT00358449|523939440|FG001|Overall Study|Steriod Inhaler was Increased|0|||
145297322|NCT00358449|523939441|FG002|Overall Study|Steriod Inhaler was Increased|1|||
145297323|NCT01804270|523939442|FG000|Overall Study|Withdrawal by Subject|1|||
145297324|NCT01804270|523939443|FG001|Overall Study|Withdrawal by Subject|1|||
145297325|NCT00496964|523939447|FG000|Overall Study|Withdrawal by Subject|0|||
145297326|NCT00496964|523939448|FG001|Overall Study|Withdrawal by Subject|1|||
145297327|NCT03478397|523939449|FG000|Overall Study|Refused to participate|31|||
145297328|NCT03478397|523939450|FG001|Overall Study|Refused to participate|7|||
145297329|NCT01661686|523939456|FG000|Overall Study|Lost to Follow-up|2|||
145297330|NCT01661686|523939457|FG001|Overall Study|Lost to Follow-up|1|||
145297331|NCT01661686|523939456|FG000|Overall Study|did not receive allocated intervention|0|||
145297332|NCT01661686|523939457|FG001|Overall Study|did not receive allocated intervention|1|||
145297333|NCT04869787|523939460|FG000|Screening|Physician Decision|1|||
145297334|NCT04869787|523939460|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
145297335|NCT00813293|523939461|FG000|Overall Study|Intercurrent illness|1|||
145297336|NCT00813293|523939462|FG001|Overall Study|Intercurrent illness|0|||
145620118|NCT00873093|525123686|FG003|Overall Study|Physician Decision|10|||
145297337|NCT00813293|523939461|FG000|Overall Study|Adverse Event|0|||
145297338|NCT00813293|523939462|FG001|Overall Study|Adverse Event|1|||
145297339|NCT02794974|523939463|FG000|Overall Study|Physician Decision|0|||
145297340|NCT02794974|523939464|FG001|Overall Study|Physician Decision|1|||
145297341|NCT00533273|523939465|FG000|Double-blind|Withdrew consent|0|||
145297342|NCT00533273|523939466|FG001|Double-blind|Withdrew consent|2|||
145297343|NCT00533273|523939465|FG000|Open-label|Withdrawal by Subject|6|||
145297344|NCT00533273|523939466|FG001|Open-label|Withdrawal by Subject|0|||
145297345|NCT01873586|523939468|FG000|Overall Study|Lost to Follow-up|3|||
145620119|NCT00873093|525123687|FG004|Overall Study|Physician Decision|2|||
145297346|NCT02202850|523939469|FG000|Overall Study|Other|2|||
145297347|NCT02202850|523939470|FG001|Overall Study|Other|2|||
145297348|NCT02202850|523939469|FG000|Overall Study|Enbrel treatment discontinued|15|||
145297349|NCT02202850|523939470|FG001|Overall Study|Enbrel treatment discontinued|3|||
145244547|NCT01585168|523741960|FG001|Overall Study|Lost to Follow-up|1|||
145244548|NCT01585168|523741961|FG002|Overall Study|Lost to Follow-up|1|||
145244549|NCT01585168|523741962|FG003|Overall Study|Lost to Follow-up|1|||
145244550|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
145244551|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
145244552|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
145244553|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
145244554|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
145244555|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
145244556|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
145244557|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
145244558|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
145244559|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
145244560|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
145244561|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
145244562|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
145244563|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
145244564|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
145564909|NCT00851799|524927406|FG002|Overall Study|Withdrew consent prior study completion|1|||
145564910|NCT00851799|524927404|FG000|Overall Study|Severe Debilitation|0|||
145564911|NCT00851799|524927405|FG001|Overall Study|Severe Debilitation|1|||
145564912|NCT00851799|524927406|FG002|Overall Study|Severe Debilitation|0|||
145564913|NCT00851799|524927404|FG000|Overall Study|Completed protocol due to pregnancy|0|||
145564914|NCT00851799|524927405|FG001|Overall Study|Completed protocol due to pregnancy|0|||
145564915|NCT00851799|524927406|FG002|Overall Study|Completed protocol due to pregnancy|1|||
145564916|NCT01342510|524927407|FG000|Overall Study|Protocol Violation|12|||
145564917|NCT01342510|524927408|FG001|Overall Study|Protocol Violation|6|||
145564918|NCT01342510|524927409|FG002|Overall Study|Protocol Violation|13|||
145564919|NCT01342510|524927410|FG003|Overall Study|Protocol Violation|11|||
145564920|NCT01449526|524927411|FG000|Overall Study|Lost to Follow-up|1|||
145564921|NCT01449526|524927412|FG001|Overall Study|Lost to Follow-up|2|||
145564922|NCT01449526|524927411|FG000|Overall Study|Withdrawal by Subject|1|||
145564923|NCT01449526|524927412|FG001|Overall Study|Withdrawal by Subject|1|||
145564924|NCT01449526|524927411|FG000|Overall Study|Symptoms/complaints|0|||
145564925|NCT01449526|524927412|FG001|Overall Study|Symptoms/complaints|1|||
145564926|NCT01449526|524927411|FG000|Overall Study|Lack of Motivation|0|||
145564927|NCT01449526|524927412|FG001|Overall Study|Lack of Motivation|1|||
145564928|NCT01449526|524927411|FG000|Overall Study|Cannot maintain visits|0|||
145564929|NCT01449526|524927412|FG001|Overall Study|Cannot maintain visits|1|||
145564930|NCT00589108|524928979|FG000|Overall Study|Lost to Follow-up|1|||
145564931|NCT00589108|524928980|FG001|Overall Study|Lost to Follow-up|1|||
145564932|NCT00589108|524928981|FG002|Overall Study|Lost to Follow-up|1|||
145564933|NCT00589108|524928979|FG000|Overall Study|Death|3|||
145564934|NCT00589108|524928980|FG001|Overall Study|Death|3|||
145564935|NCT00589108|524928981|FG002|Overall Study|Death|4|||
145564936|NCT03256552|524928982|FG000|Overall Study|Protocol Violation|1|||
145564937|NCT03256552|524928982|FG000|Overall Study|Physician Decision|1|||
145564938|NCT03256552|524928982|FG000|Overall Study|Adverse Event|1|||
145564939|NCT03256552|524928982|FG000|Overall Study|Withdrawal by Subject|2|||
145564940|NCT01933048|524928990|FG000|Overall Study|Lost to Follow-up|15|||
145564941|NCT01933048|524928991|FG001|Overall Study|Lost to Follow-up|18|||
145564942|NCT01933048|524928990|FG000|Overall Study|personal reasons|1|||
145564943|NCT01933048|524928991|FG001|Overall Study|personal reasons|1|||
145564944|NCT01933048|524928990|FG000|Overall Study|Protocol Violation|7|||
145564945|NCT01933048|524928991|FG001|Overall Study|Protocol Violation|8|||
145564946|NCT01933048|524928990|FG000|Overall Study|Physician Decision|1|||
145564947|NCT01933048|524928991|FG001|Overall Study|Physician Decision|0|||
145564948|NCT01933048|524928990|FG000|Overall Study|unknown reasons|1|||
145564949|NCT01933048|524928991|FG001|Overall Study|unknown reasons|1|||
145564950|NCT02476968|524928992|FG000|Overall Study|Other|0|||
145564951|NCT02476968|524928993|FG001|Overall Study|Other|2|||
145564952|NCT02476968|524928994|FG002|Overall Study|Other|0|||
145564953|NCT02476968|524928992|FG000|Overall Study|Lost to Follow-up|10|||
145564954|NCT02476968|524928993|FG001|Overall Study|Lost to Follow-up|0|||
145564955|NCT02476968|524928994|FG002|Overall Study|Lost to Follow-up|1|||
145564956|NCT02476968|524928992|FG000|Overall Study|Death|48|||
145564957|NCT02476968|524928993|FG001|Overall Study|Death|8|||
145564958|NCT02476968|524928994|FG002|Overall Study|Death|1|||
145564959|NCT02476968|524928992|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145564960|NCT02476968|524928993|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145564961|NCT02476968|524928994|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145564962|NCT02476968|524928992|FG000|Overall Study|Patient decision|37|||
145564963|NCT02476968|524928993|FG001|Overall Study|Patient decision|8|||
145564964|NCT02476968|524928994|FG002|Overall Study|Patient decision|0|||
145297350|NCT02202850|523939469|FG000|Overall Study|Lost to Follow-up|7|||
145297351|NCT02202850|523939470|FG001|Overall Study|Lost to Follow-up|1|||
145297352|NCT00615069|523939471|FG000|Overall Study|Death|10|||
145297353|NCT00615069|523939471|FG000|Overall Study|Physician Decision|2|||
145297354|NCT00615069|523939471|FG000|Overall Study|Withdrawal by Subject|4|||
145297355|NCT00454909|523939472|FG000|Overall Study|Withdrawal by Subject|1|||
145297356|NCT00454909|523939473|FG001|Overall Study|Withdrawal by Subject|0|||
145297357|NCT00454909|523939474|FG002|Overall Study|Withdrawal by Subject|0|||
145297358|NCT00454909|523939472|FG000|Overall Study|Migrated/moved from study area|0|||
145297359|NCT00454909|523939473|FG001|Overall Study|Migrated/moved from study area|0|||
145297360|NCT00454909|523939474|FG002|Overall Study|Migrated/moved from study area|1|||
145297361|NCT00454909|523939472|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
145297362|NCT00454909|523939473|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
145297363|NCT00454909|523939474|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
145297364|NCT00454909|523939472|FG000|Overall Study|Others|1|||
145297365|NCT00454909|523939473|FG001|Overall Study|Others|0|||
145564965|NCT03412084|524929003|FG000|Overall Study|Withdrawal by Subject|2|||
145564966|NCT03412084|524929004|FG001|Overall Study|Withdrawal by Subject|0|||
145564967|NCT03412084|524929003|FG000|Overall Study|Participant moved|1|||
145564968|NCT03412084|524929004|FG001|Overall Study|Participant moved|0|||
145564969|NCT03412084|524929003|FG000|Overall Study|Lost to Follow-up|1|||
145564970|NCT03412084|524929004|FG001|Overall Study|Lost to Follow-up|1|||
145564971|NCT01928862|524929005|FG000|Overall Study|Lost to Follow-up|1|||
145564972|NCT01928862|524929006|FG001|Overall Study|Lost to Follow-up|0|||
145564973|NCT01928862|524929007|FG002|Overall Study|Lost to Follow-up|0|||
145564974|NCT01928862|524929008|FG003|Overall Study|Lost to Follow-up|0|||
145564975|NCT01928862|524929009|FG004|Overall Study|Lost to Follow-up|1|||
145564976|NCT02053753|524929017|FG000|Overall Study|Withdrawal by Subject|2|||
145564977|NCT02053753|524929018|FG001|Overall Study|Withdrawal by Subject|4|||
145564978|NCT02053753|524929017|FG000|Overall Study|Decision by Sponsor|1|||
145564979|NCT02053753|524929018|FG001|Overall Study|Decision by Sponsor|1|||
145564980|NCT02053753|524929017|FG000|Overall Study|Lost to Follow-up|4|||
145564981|NCT02053753|524929018|FG001|Overall Study|Lost to Follow-up|3|||
145564982|NCT02972632|524929019|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
145564983|NCT02972632|524929019|FG000|Overall Study|Lost to Follow-up|4|||
145564984|NCT02972632|524929019|FG000|Overall Study|Voluntary Withdrawal|10|||
145564985|NCT02023151|524929020|FG000|Overall Study|Lost to Follow-up|4|||
145564986|NCT04064294|524929021|FG000|Overall Study|Adverse Event|1|||
145564987|NCT04064294|524929022|FG001|Overall Study|Adverse Event|0|||
145564988|NCT04064294|524929023|FG002|Overall Study|Adverse Event|0|||
145564989|NCT03450707|524929024|FG000|Overall Study|Outside enrollment window|4|||
145564990|NCT03450707|524929025|FG001|Overall Study|Outside enrollment window|1|||
145564991|NCT03450707|524929024|FG000|Overall Study|Death|1|||
145564992|NCT03450707|524929025|FG001|Overall Study|Death|0|||
145564993|NCT03450707|524929024|FG000|Overall Study|Indication for thiamine|1|||
145564994|NCT03450707|524929025|FG001|Overall Study|Indication for thiamine|1|||
145564995|NCT03450707|524929024|FG000|Overall Study|Evidence of traumatic brain injury|1|||
145564996|NCT03450707|524929025|FG001|Overall Study|Evidence of traumatic brain injury|0|||
145564997|NCT03450707|524929024|FG000|Overall Study|Following commands|0|||
145564998|NCT03450707|524929025|FG001|Overall Study|Following commands|3|||
145564999|NCT03450707|524929024|FG000|Overall Study|Lactate < 3.5|0|||
145565000|NCT03450707|524929025|FG001|Overall Study|Lactate < 3.5|2|||
145565001|NCT03450707|524929024|FG000|Overall Study|Rearrest with ECMO|0|||
145565002|NCT03450707|524929025|FG001|Overall Study|Rearrest with ECMO|1|||
145565003|NCT03450707|524929024|FG000|Overall Study|Indication for thiamine + head CT results|0|||
145565004|NCT03450707|524929025|FG001|Overall Study|Indication for thiamine + head CT results|1|||
145565005|NCT03450707|524929024|FG000|Overall Study|Family/patient goals of care|0|||
145565006|NCT03450707|524929025|FG001|Overall Study|Family/patient goals of care|1|||
145565007|NCT03975647|524929029|FG000|Overall Study|Death|71|||
145565008|NCT03975647|524929030|FG001|Overall Study|Death|63|||
145565009|NCT03975647|524929029|FG000|Overall Study|Lost to Follow-up|2|||
145565010|NCT03975647|524929030|FG001|Overall Study|Lost to Follow-up|2|||
145620120|NCT00873093|525123683|FG000|Overall Study|Withdrawal by Subject|1|||
145620121|NCT00873093|525123684|FG001|Overall Study|Withdrawal by Subject|4|||
145620122|NCT00873093|525123685|FG002|Overall Study|Withdrawal by Subject|4|||
145297366|NCT00454909|523939474|FG002|Overall Study|Others|0|||
145297367|NCT02996682|523939475|FG000|Overall Study|Death|0|||
145297368|NCT02996682|523939476|FG001|Overall Study|Death|3|||
145565011|NCT03975647|524929029|FG000|Overall Study|Subject withdrawal of consent|7|||
145565012|NCT03975647|524929030|FG001|Overall Study|Subject withdrawal of consent|11|||
145565013|NCT00228917|524929033|FG000|Overall Study|Migrated/moved from study area|0|||
145565014|NCT00228917|524929034|FG001|Overall Study|Migrated/moved from study area|0|||
145565015|NCT00228917|524929035|FG002|Overall Study|Migrated/moved from study area|0|||
145565016|NCT00228917|524929036|FG003|Overall Study|Migrated/moved from study area|0|||
145565017|NCT00228917|524929037|FG004|Overall Study|Migrated/moved from study area|0|||
145565018|NCT00228917|524929038|FG005|Overall Study|Migrated/moved from study area|2|||
145620123|NCT00873093|525123686|FG003|Overall Study|Withdrawal by Subject|0|||
145297369|NCT01981720|523939477|FG000|Overall Study|Adverse Event|1|||
145297370|NCT01981720|523939477|FG000|Overall Study|Withdrawal by Subject|3|||
145297371|NCT01981720|523939477|FG000|Overall Study|Pregnancy|1|||
145297372|NCT00282048|523939478|FG000|Overall Study|Lack of Efficacy|30|||
145297373|NCT00282048|523939478|FG000|Overall Study|Adverse Event|22|||
145297374|NCT00282048|523939478|FG000|Overall Study|Withdrawal by Subject|1|||
145297375|NCT00282048|523939478|FG000|Overall Study|Other|8|||
145297376|NCT00282048|523939478|FG000|Overall Study|Ongoing|1|||
145297377|NCT03048500|523939480|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
145297378|NCT03048500|523939480|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
145297379|NCT03048500|523939480|FG000|Reached 1st Response/Continued Treatment|Death|1|||
145297380|NCT03048500|523939480|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
145297381|NCT03048500|523939480|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
145297382|NCT03048500|523939480|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
145297383|NCT03048500|523939480|FG000|Follow up for 3 Years|Death|12|||
145297384|NCT01941030|523939483|FG000|Overall Study|Death|3|||
145297385|NCT01941030|523939484|FG001|Overall Study|Death|2|||
145297386|NCT01941030|523939483|FG000|Overall Study|Lost to Follow-up|6|||
145297387|NCT01941030|523939484|FG001|Overall Study|Lost to Follow-up|5|||
145297388|NCT01941030|523939483|FG000|Overall Study|Withdrawal by Subject|4|||
145297389|NCT01941030|523939484|FG001|Overall Study|Withdrawal by Subject|6|||
145297390|NCT00870870|523939487|FG000|Overall Study|Withdrawal by Subject|0|||
145297391|NCT00870870|523939488|FG001|Overall Study|Withdrawal by Subject|1|||
145297392|NCT00870870|523939489|FG002|Overall Study|Withdrawal by Subject|1|||
145297393|NCT00870870|523939490|FG003|Overall Study|Withdrawal by Subject|3|||
145297394|NCT00870870|523939487|FG000|Overall Study|Adverse Event|0|||
145297395|NCT00870870|523939488|FG001|Overall Study|Adverse Event|0|||
145297396|NCT00870870|523939489|FG002|Overall Study|Adverse Event|2|||
145297397|NCT00870870|523939490|FG003|Overall Study|Adverse Event|2|||
145297398|NCT03639311|523939495|FG000|Maintenance Phase|Lost to Follow-up|1|||
145297399|NCT03639311|523939496|FG001|Maintenance Phase|Lost to Follow-up|0|||
145297400|NCT03639311|523939497|FG002|Maintenance Phase|Lost to Follow-up|0|||
145297401|NCT03639311|523939495|FG000|Maintenance Phase|Adverse Event|1|||
145297402|NCT03639311|523939496|FG001|Maintenance Phase|Adverse Event|0|||
145297403|NCT03639311|523939497|FG002|Maintenance Phase|Adverse Event|0|||
145297404|NCT03639311|523939495|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
145297405|NCT03639311|523939496|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
145297406|NCT03639311|523939497|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
145297407|NCT03639311|523939495|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
145297408|NCT03639311|523939496|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
145297409|NCT03639311|523939497|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
145297410|NCT03639311|523939495|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
145297411|NCT03639311|523939496|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
145297412|NCT03639311|523939497|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
145297413|NCT03639311|523939495|FG000|Maintenance Phase|Lack of Efficacy|1|||
145297414|NCT03639311|523939496|FG001|Maintenance Phase|Lack of Efficacy|0|||
145297415|NCT03639311|523939497|FG002|Maintenance Phase|Lack of Efficacy|0|||
145297416|NCT00822926|523939498|FG000|Second Injection Visit|Lost to Follow-up|1|||
145297417|NCT00822926|523939499|FG001|Second Injection Visit|Lost to Follow-up|0|||
145297418|NCT00822926|523939498|FG000|Second Injection Visit|Withdrawal by Subject|0|||
145297419|NCT00822926|523939499|FG001|Second Injection Visit|Withdrawal by Subject|1|||
145297420|NCT00694551|523939501|FG000|Overall Study|Disease Progression|1|||
145297421|NCT00694551|523939502|FG001|Overall Study|Disease Progression|0|||
145297422|NCT00694551|523939503|FG002|Overall Study|Disease Progression|1|||
145297423|NCT03544138|523939508|FG000|Overall Study|Lost to Follow-up|29|||
145297424|NCT02817841|523940782|FG000|Overall Study|Lost to Follow-up|287|||
145565019|NCT00228917|524929039|FG006|Overall Study|Migrated/moved from study area|0|||
145565020|NCT00228917|524929040|FG007|Overall Study|Migrated/moved from study area|0|||
145565021|NCT00409617|524929041|FG000|Overall Study|Adverse Event|57|||
145565022|NCT00409617|524929041|FG000|Overall Study|Lack of Efficacy|54|||
145565023|NCT00409617|524929041|FG000|Overall Study|Lost to Follow-up|2|||
145565024|NCT00409617|524929041|FG000|Overall Study|Protocol Violation|24|||
145565025|NCT00409617|524929041|FG000|Overall Study|Withdrawal by Subject|8|||
145565026|NCT00409617|524929041|FG000|Overall Study|Administrative reasons|1|||
145565027|NCT00409617|524929041|FG000|Overall Study|Not described|14|||
145565028|NCT01354496|524929055|FG000|Period 1|Adverse Event|0|||
145565029|NCT01354496|524929056|FG001|Period 1|Adverse Event|0|||
145565030|NCT01354496|524929057|FG002|Period 1|Adverse Event|1|||
145297425|NCT02817841|523940782|FG000|Overall Study|Withdrawal by Subject|183|||
145297426|NCT02817841|523940782|FG000|Overall Study|Adverse event not related to bleeding|131|||
145297427|NCT02817841|523940782|FG000|Overall Study|Adverse event related to bleeding|51|||
145565031|NCT01354496|524929058|FG003|Period 1|Adverse Event|0|||
145565032|NCT01354496|524929059|FG004|Period 1|Adverse Event|0|||
145565033|NCT01354496|524929060|FG005|Period 1|Adverse Event|0|||
145565034|NCT01354496|524929055|FG000|Period 1|Physician Decision|0|||
145565035|NCT01354496|524929056|FG001|Period 1|Physician Decision|0|||
145565036|NCT01354496|524929057|FG002|Period 1|Physician Decision|1|||
145565037|NCT01354496|524929058|FG003|Period 1|Physician Decision|0|||
145565038|NCT01354496|524929059|FG004|Period 1|Physician Decision|0|||
145565039|NCT01354496|524929060|FG005|Period 1|Physician Decision|0|||
145565040|NCT01354496|524929055|FG000|Period 2|Adverse Event|0|||
145565041|NCT01354496|524929056|FG001|Period 2|Adverse Event|0|||
145565042|NCT01354496|524929057|FG002|Period 2|Adverse Event|0|||
145565043|NCT01354496|524929058|FG003|Period 2|Adverse Event|1|||
145565044|NCT01354496|524929059|FG004|Period 2|Adverse Event|0|||
145565045|NCT01354496|524929060|FG005|Period 2|Adverse Event|0|||
145565046|NCT01354496|524929055|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
145565047|NCT01354496|524929056|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
145565048|NCT01354496|524929057|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
145565049|NCT01354496|524929058|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
145565050|NCT01354496|524929059|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
145565051|NCT01354496|524929060|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
145565052|NCT01524692|524929063|FG000|Overall Study|Withdrawal by Subject|3|||
145565053|NCT03190889|524929064|FG000|Overall Study|Lost to Follow-up|7|||
145565054|NCT03190889|524929065|FG001|Overall Study|Lost to Follow-up|7|||
145565055|NCT03190889|524929066|FG002|Overall Study|Lost to Follow-up|3|||
145565056|NCT03190889|524929064|FG000|Overall Study|Withdrawal by Subject|1|||
145565057|NCT03190889|524929065|FG001|Overall Study|Withdrawal by Subject|1|||
145565058|NCT03190889|524929066|FG002|Overall Study|Withdrawal by Subject|2|||
145565059|NCT03190889|524929064|FG000|Overall Study|Did not complete protocol|4|||
145565060|NCT03190889|524929065|FG001|Overall Study|Did not complete protocol|9|||
145565061|NCT03190889|524929066|FG002|Overall Study|Did not complete protocol|0|||
145565062|NCT03190889|524929064|FG000|Overall Study|COVID-19|1|||
145565063|NCT03190889|524929065|FG001|Overall Study|COVID-19|0|||
145565064|NCT03190889|524929066|FG002|Overall Study|COVID-19|2|||
145565065|NCT04007523|524929067|FG000|Overall Study|Withdrawal by Subject|0|||
145565066|NCT04007523|524929068|FG001|Overall Study|Withdrawal by Subject|1|||
145565067|NCT04007523|524929069|FG002|Overall Study|Withdrawal by Subject|1|||
145565068|NCT04007523|524929070|FG003|Overall Study|Withdrawal by Subject|0|||
145565069|NCT04007523|524929067|FG000|Overall Study|ICU Transfer|0|||
145565070|NCT04007523|524929068|FG001|Overall Study|ICU Transfer|1|||
145565071|NCT04007523|524929069|FG002|Overall Study|ICU Transfer|0|||
145565072|NCT04007523|524929070|FG003|Overall Study|ICU Transfer|0|||
145565073|NCT04007523|524929067|FG000|Overall Study|COVID hospital closure|0|||
145565074|NCT04007523|524929068|FG001|Overall Study|COVID hospital closure|0|||
145565075|NCT04007523|524929069|FG002|Overall Study|COVID hospital closure|1|||
145565076|NCT04007523|524929070|FG003|Overall Study|COVID hospital closure|2|||
145565077|NCT04007523|524929067|FG000|Overall Study|Surgery cancelled|0|||
145565078|NCT04007523|524929068|FG001|Overall Study|Surgery cancelled|0|||
145565079|NCT04007523|524929069|FG002|Overall Study|Surgery cancelled|1|||
145565080|NCT04007523|524929070|FG003|Overall Study|Surgery cancelled|1|||
145565081|NCT02136576|524929071|FG000|Overall Study|Lost to Follow-up|2|||
145565082|NCT02136576|524929072|FG001|Overall Study|Lost to Follow-up|0|||
145565083|NCT02136576|524929073|FG002|Overall Study|Lost to Follow-up|0|||
145565084|NCT02197806|524929075|FG000|Overall Study|Adverse Event|0|||
145565085|NCT02197806|524929076|FG001|Overall Study|Adverse Event|1|||
145565086|NCT02197806|524929077|FG002|Overall Study|Adverse Event|0|||
145565087|NCT02197806|524929078|FG003|Overall Study|Adverse Event|1|||
145565088|NCT00537381|524929079|FG000|Overall Study|Adverse Event|13|||
145565089|NCT00537381|524929080|FG001|Overall Study|Adverse Event|9|||
145565090|NCT00537381|524929079|FG000|Overall Study|Death|3|||
145565091|NCT00537381|524929080|FG001|Overall Study|Death|3|||
145565092|NCT00537381|524929079|FG000|Overall Study|Withdrawal by Subject|5|||
145565093|NCT00537381|524929080|FG001|Overall Study|Withdrawal by Subject|14|||
145244565|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
145244566|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
145244567|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
145297428|NCT02817841|523940782|FG000|Overall Study|Pregnancy|32|||
145565094|NCT00537381|524929079|FG000|Overall Study|Physician Decision|7|||
145565095|NCT00537381|524929080|FG001|Overall Study|Physician Decision|6|||
145565096|NCT00537381|524929079|FG000|Overall Study|Disease Progression|9|||
145565097|NCT00537381|524929080|FG001|Overall Study|Disease Progression|18|||
145565098|NCT00537381|524929079|FG000|Overall Study|Sponsor decision|14|||
145565099|NCT00537381|524929080|FG001|Overall Study|Sponsor decision|9|||
145565100|NCT00537381|524929079|FG000|Overall Study|Other|5|||
145565101|NCT00537381|524929080|FG001|Overall Study|Other|3|||
145565102|NCT03065244|524929087|FG000|Overall Study|Lost to Follow-up|1|||
145565103|NCT03065244|524929088|FG001|Overall Study|Lost to Follow-up|1|||
145565104|NCT03065244|524929087|FG000|Overall Study|Diagnosed with a different disease|1|||
145565105|NCT03065244|524929088|FG001|Overall Study|Diagnosed with a different disease|1|||
145565106|NCT03065244|524929087|FG000|Overall Study|Protocol Violation|0|||
145565107|NCT03065244|524929088|FG001|Overall Study|Protocol Violation|1|||
145565108|NCT03065244|524929087|FG000|Overall Study|Withdrawal by Subject|1|||
145565109|NCT03065244|524929088|FG001|Overall Study|Withdrawal by Subject|1|||
145565110|NCT00500292|524929089|FG000|Overall Study|Adverse Event|3|||
145297429|NCT02817841|523940782|FG000|Overall Study|Pregnancy wish|17|||
145297430|NCT02817841|523940782|FG000|Overall Study|Other reasons|53|||
145297431|NCT02817841|523940782|FG000|Overall Study|Protocol Violation|94|||
145297432|NCT00397488|523940783|FG000|Overall Study|Withdrawal by Subject|3|||
145297433|NCT00397488|523940783|FG000|Overall Study|Adverse Event|3|||
145297434|NCT00397488|523940783|FG000|Overall Study|Death|1|||
145297435|NCT02424097|523940786|FG000|Overall Study|Lost to Follow-up|1|||
145297436|NCT02424097|523940787|FG001|Overall Study|Lost to Follow-up|2|||
145297437|NCT01215981|523940790|FG000|Overall Study|Physician Decision|0|||
145297438|NCT01215981|523940791|FG001|Overall Study|Physician Decision|1|||
145565111|NCT00500292|524929090|FG001|Overall Study|Adverse Event|6|||
145565112|NCT00500292|524929091|FG002|Overall Study|Adverse Event|4|||
145565113|NCT00500292|524929089|FG000|Overall Study|Condition under investigation worsened|21|||
145565114|NCT00500292|524929090|FG001|Overall Study|Condition under investigation worsened|23|||
145565115|NCT00500292|524929091|FG002|Overall Study|Condition under investigation worsened|19|||
145565116|NCT00500292|524929089|FG000|Overall Study|Withdrawal by Subject|0|||
145565117|NCT00500292|524929090|FG001|Overall Study|Withdrawal by Subject|1|||
145565118|NCT00500292|524929091|FG002|Overall Study|Withdrawal by Subject|0|||
145565119|NCT00500292|524929089|FG000|Overall Study|Other|1|||
145565120|NCT00500292|524929090|FG001|Overall Study|Other|1|||
145565121|NCT00500292|524929091|FG002|Overall Study|Other|4|||
145565122|NCT03717480|524929092|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
145565123|NCT01894152|524929093|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
145565124|NCT01708174|524929094|FG000|Treatment Period|Withdrawal by Subject|1|||
145565125|NCT01708174|524929095|FG001|Treatment Period|Withdrawal by Subject|0|||
145565126|NCT01708174|524929096|FG002|Treatment Period|Withdrawal by Subject|0|||
145565127|NCT01708174|524929094|FG000|Treatment Period|Progressive disease|0|||
145565128|NCT01708174|524929095|FG001|Treatment Period|Progressive disease|1|||
145565129|NCT01708174|524929096|FG002|Treatment Period|Progressive disease|0|||
145565130|NCT01708174|524929094|FG000|Treatment Period|Death|0|||
145565131|NCT01708174|524929095|FG001|Treatment Period|Death|0|||
145565132|NCT01708174|524929096|FG002|Treatment Period|Death|1|||
145565133|NCT01708174|524929094|FG000|Treatment Period|Adverse Event|0|||
145565134|NCT01708174|524929095|FG001|Treatment Period|Adverse Event|1|||
145565135|NCT01708174|524929096|FG002|Treatment Period|Adverse Event|0|||
145565136|NCT00923559|524929097|FG000|Overall Study|Lost to Follow-up|2|||
145565137|NCT00923559|524929098|FG001|Overall Study|Lost to Follow-up|3|||
145565138|NCT00744627|524929103|FG000|Overall Study|Adverse Event|6|||
145565139|NCT00744627|524929104|FG001|Overall Study|Adverse Event|9|||
145565140|NCT00744627|524929103|FG000|Overall Study|Lack of Efficacy|7|||
145565141|NCT00744627|524929104|FG001|Overall Study|Lack of Efficacy|3|||
145565142|NCT00744627|524929103|FG000|Overall Study|Noncompliance|0|||
145565143|NCT00744627|524929104|FG001|Overall Study|Noncompliance|1|||
145565144|NCT00744627|524929103|FG000|Overall Study|Protocol Deviations|0|||
145565145|NCT00744627|524929104|FG001|Overall Study|Protocol Deviations|2|||
145565146|NCT00744627|524929103|FG000|Overall Study|Voluntary Withdrawal|9|||
145565147|NCT00744627|524929104|FG001|Overall Study|Voluntary Withdrawal|6|||
145565148|NCT00744627|524929103|FG000|Overall Study|Lost to Follow-up|2|||
145565149|NCT00744627|524929104|FG001|Overall Study|Lost to Follow-up|1|||
145565150|NCT00744627|524929103|FG000|Overall Study|Other|1|||
145565151|NCT00744627|524929104|FG001|Overall Study|Other|0|||
145565152|NCT01062555|524929106|FG000|Phase 1|Death|10|||
145565153|NCT01062555|524929107|FG001|Phase 1|Death|17|||
145565154|NCT01062555|524929108|FG002|Phase 1|Death|0|||
145565155|NCT01062555|524929109|FG003|Phase 1|Death|0|||
145565156|NCT01062555|524929106|FG000|Phase 1|Graft Failure|12|||
145297439|NCT01215981|523940790|FG000|Overall Study|Protocol Violation|1|||
145297440|NCT01215981|523940791|FG001|Overall Study|Protocol Violation|0|||
145297441|NCT01215981|523940790|FG000|Overall Study|Withdrawal by Subject|1|||
145297442|NCT01215981|523940791|FG001|Overall Study|Withdrawal by Subject|0|||
145409095|NCT01931098|524351964|FG000|Overall Study|Refused further treatment|0|||
145565157|NCT01062555|524929107|FG001|Phase 1|Graft Failure|8|||
145565158|NCT01062555|524929108|FG002|Phase 1|Graft Failure|0|||
145565159|NCT01062555|524929109|FG003|Phase 1|Graft Failure|0|||
145620124|NCT00873093|525123687|FG004|Overall Study|Withdrawal by Subject|0|||
145620125|NCT00873093|525123683|FG000|Overall Study|Ineligible|0|||
145409096|NCT01931098|524351965|FG001|Overall Study|Refused further treatment|1|||
145565160|NCT01062555|524929106|FG000|Phase 1|Withdrawal by Subject|1|||
145565161|NCT01062555|524929107|FG001|Phase 1|Withdrawal by Subject|1|||
145565162|NCT01062555|524929108|FG002|Phase 1|Withdrawal by Subject|0|||
145565163|NCT01062555|524929109|FG003|Phase 1|Withdrawal by Subject|0|||
145565164|NCT01062555|524929106|FG000|Phase 2|Death|0|||
145565165|NCT01062555|524929107|FG001|Phase 2|Death|0|||
145565166|NCT01062555|524929108|FG002|Phase 2|Death|8|||
145565167|NCT01062555|524929109|FG003|Phase 2|Death|3|||
145565168|NCT01062555|524929106|FG000|Phase 2|Graft failure|0|||
145565169|NCT01062555|524929107|FG001|Phase 2|Graft failure|0|||
145565170|NCT01062555|524929108|FG002|Phase 2|Graft failure|7|||
145565171|NCT01062555|524929109|FG003|Phase 2|Graft failure|4|||
145565172|NCT01062555|524929106|FG000|Phase 2|Withdrawal by Subject|0|||
145565173|NCT01062555|524929107|FG001|Phase 2|Withdrawal by Subject|0|||
145244568|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
145244569|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
145244570|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
145244571|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
145409097|NCT02278354|524351969|FG000|Overall Study|Lost to Follow-up|2|||
145409098|NCT02278354|524351970|FG001|Overall Study|Lost to Follow-up|2|||
145409099|NCT02278354|524351969|FG000|Overall Study|Withdrawal by Subject|0|||
145565174|NCT01062555|524929108|FG002|Phase 2|Withdrawal by Subject|0|||
145244572|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
145244573|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
145244574|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Other|0|||
145244575|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Other|1|||
145244576|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Other|0|||
145244577|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Other|0|||
145244578|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
145244579|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
145244580|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
145244581|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
145244582|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
145244583|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
145244584|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
145244585|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
145244586|NCT01194414|523741963|FG000|24 Weeks Double Blind Period|Death|0|||
145244587|NCT01194414|523741964|FG001|24 Weeks Double Blind Period|Death|1|||
145244588|NCT01194414|523741965|FG002|24 Weeks Double Blind Period|Death|0|||
145244589|NCT01194414|523741966|FG003|24 Weeks Double Blind Period|Death|0|||
145244590|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
145244591|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
145244592|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
145244593|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
145244594|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
145244595|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
145244596|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
145244597|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
145244598|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
145244599|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
145244600|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
145244601|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
145244602|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
145244603|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
145244604|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
145244605|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
145244606|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
145244607|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
145244608|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
145244609|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
145244610|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
145244611|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
145244612|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
145244613|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
145409100|NCT02278354|524351970|FG001|Overall Study|Withdrawal by Subject|1|||
145409101|NCT02278354|524351969|FG000|Overall Study|<10 professional fights|2|||
145565175|NCT01062555|524929109|FG003|Phase 2|Withdrawal by Subject|7|||
145565176|NCT01062555|524929106|FG000|Phase 2|Protocol Violation|0|||
145565177|NCT01062555|524929107|FG001|Phase 2|Protocol Violation|0|||
145565178|NCT01062555|524929108|FG002|Phase 2|Protocol Violation|0|||
145565179|NCT01062555|524929109|FG003|Phase 2|Protocol Violation|3|||
145565180|NCT01062555|524929106|FG000|Phase 2|Physician Decision|0|||
145565181|NCT01062555|524929107|FG001|Phase 2|Physician Decision|0|||
145565182|NCT01062555|524929108|FG002|Phase 2|Physician Decision|0|||
145565183|NCT01062555|524929109|FG003|Phase 2|Physician Decision|17|||
145565184|NCT03560531|524929110|FG000|Overall Study|Death|4|||
145565185|NCT03560531|524929111|FG001|Overall Study|Death|1|||
145565186|NCT03560531|524929112|FG002|Overall Study|Death|1|||
145565187|NCT03560531|524929113|FG003|Overall Study|Death|2|||
145565188|NCT03560531|524929114|FG004|Overall Study|Death|6|||
145565189|NCT03560531|524929115|FG005|Overall Study|Death|1|||
145409102|NCT02278354|524351970|FG001|Overall Study|<10 professional fights|0|||
145565190|NCT03560531|524929116|FG006|Overall Study|Death|4|||
145620126|NCT00873093|525123684|FG001|Overall Study|Ineligible|1|||
145244614|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Other|2|||
145565191|NCT03560531|524929117|FG007|Overall Study|Death|8|||
145409103|NCT01901562|524351972|FG000|Overall Study|Protocol Violation|5|||
145409104|NCT01901562|524351972|FG000|Overall Study|Excluded intraoperatively|4|||
145409105|NCT01925794|524351973|FG000|180 Days|Death|2|||
145409106|NCT01925794|524351973|FG000|180 Days|Withdrawal by Subject|2|||
145409107|NCT01925794|524351973|FG000|270 Days|Death|2|||
145409108|NCT01925794|524351973|FG000|270 Days|Protocol Violation|3|||
145409109|NCT02612155|524351974|FG000|Overall Study|Death|1|||
145409110|NCT02612155|524351975|FG001|Overall Study|Death|1|||
145409111|NCT02612155|524351974|FG000|Overall Study|Lost to Follow-up|2|||
145244615|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Other|1|||
145244616|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Other|0|||
145244617|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Other|0|||
145244618|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
145244619|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
145244620|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
145244621|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
145244622|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
145244623|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
145244624|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
145244625|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
145244626|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
145244627|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
145409112|NCT02612155|524351975|FG001|Overall Study|Lost to Follow-up|2|||
145409113|NCT02879695|524351979|FG000|Overall Study|Did not start study treatment|2|||
145409114|NCT02879695|524351980|FG001|Overall Study|Did not start study treatment|0|||
145409115|NCT02879695|524351981|FG002|Overall Study|Did not start study treatment|3|||
145409116|NCT02879695|524351982|FG003|Overall Study|Did not start study treatment|0|||
145409117|NCT03126110|524351984|FG000|Phase 1|Death|2|||
145409118|NCT03126110|524351985|FG001|Phase 1|Death|2|||
145409119|NCT03126110|524351986|FG002|Phase 1|Death|4|||
145409120|NCT03126110|524351987|FG003|Phase 1|Death|3|||
145409121|NCT03126110|524351988|FG004|Phase 1|Death|4|||
145409122|NCT03126110|524351989|FG005|Phase 1|Death|4|||
145244628|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
145244629|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
145244630|NCT01194414|523741963|FG000|72 Weeks Open Label Extension|Death|1|||
145244631|NCT01194414|523741964|FG001|72 Weeks Open Label Extension|Death|2|||
145244632|NCT01194414|523741965|FG002|72 Weeks Open Label Extension|Death|0|||
145244633|NCT01194414|523741966|FG003|72 Weeks Open Label Extension|Death|2|||
145244634|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
145244635|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
145244636|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
145244637|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
145244638|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
145244639|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
145244640|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
145244641|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
145244642|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
145244643|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
145244644|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
145244645|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
145244646|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
145244647|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
145244648|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
145244649|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
145244650|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
145244651|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
145244652|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
145244653|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
145244654|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
145244655|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
145244656|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
145244657|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
145409123|NCT03126110|524351990|FG006|Phase 1|Death|3|||
145409124|NCT03126110|524351991|FG007|Phase 1|Death|4|||
145409125|NCT03126110|524351992|FG008|Phase 1|Death|5|||
145620127|NCT00873093|525123685|FG002|Overall Study|Ineligible|0|||
145244658|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
145244659|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
145409126|NCT03126110|524351993|FG009|Phase 1|Death|2|||
145409127|NCT03126110|524351994|FG010|Phase 1|Death|6|||
145409128|NCT03126110|524351995|FG011|Phase 1|Death|0|||
145409129|NCT03126110|524351996|FG012|Phase 1|Death|0|||
145565192|NCT03560531|524929118|FG008|Overall Study|Death|1|||
145565193|NCT03560531|524929119|FG009|Overall Study|Death|3|||
145565194|NCT03560531|524929120|FG010|Overall Study|Death|2|||
145565195|NCT03560531|524929121|FG011|Overall Study|Death|0|||
145565196|NCT03560531|524929122|FG012|Overall Study|Death|4|||
145565197|NCT03560531|524929123|FG013|Overall Study|Death|1|||
145565198|NCT03560531|524929110|FG000|Overall Study|Lost to Follow-up|1|||
145565199|NCT03560531|524929111|FG001|Overall Study|Lost to Follow-up|1|||
145565200|NCT03560531|524929112|FG002|Overall Study|Lost to Follow-up|0|||
145565201|NCT03560531|524929113|FG003|Overall Study|Lost to Follow-up|0|||
145565202|NCT03560531|524929114|FG004|Overall Study|Lost to Follow-up|0|||
145565203|NCT03560531|524929115|FG005|Overall Study|Lost to Follow-up|0|||
145565204|NCT03560531|524929116|FG006|Overall Study|Lost to Follow-up|1|||
145565205|NCT03560531|524929117|FG007|Overall Study|Lost to Follow-up|0|||
145565206|NCT03560531|524929118|FG008|Overall Study|Lost to Follow-up|0|||
145565207|NCT03560531|524929119|FG009|Overall Study|Lost to Follow-up|0|||
145565208|NCT03560531|524929120|FG010|Overall Study|Lost to Follow-up|0|||
145565209|NCT03560531|524929121|FG011|Overall Study|Lost to Follow-up|0|||
145565210|NCT03560531|524929122|FG012|Overall Study|Lost to Follow-up|0|||
145565211|NCT03560531|524929123|FG013|Overall Study|Lost to Follow-up|0|||
145565212|NCT03560531|524929110|FG000|Overall Study|Withdrawal by Subject|1|||
145565213|NCT03560531|524929111|FG001|Overall Study|Withdrawal by Subject|0|||
145565214|NCT03560531|524929112|FG002|Overall Study|Withdrawal by Subject|0|||
145565215|NCT03560531|524929113|FG003|Overall Study|Withdrawal by Subject|0|||
145565216|NCT03560531|524929114|FG004|Overall Study|Withdrawal by Subject|0|||
145565217|NCT03560531|524929115|FG005|Overall Study|Withdrawal by Subject|0|||
145565218|NCT03560531|524929116|FG006|Overall Study|Withdrawal by Subject|0|||
145565219|NCT03560531|524929117|FG007|Overall Study|Withdrawal by Subject|3|||
145244660|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
145244661|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
145244662|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
145244663|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
145244664|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
145244665|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
145244666|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
145244667|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
145244668|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
145244669|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
145244670|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
145244671|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
145244672|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
145244673|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
145244674|NCT03605836|523741967|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
145244675|NCT03605836|523741968|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
145244676|NCT03605836|523741969|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
145244677|NCT03605836|523741970|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
145244678|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
145244679|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
145244680|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
145244681|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
145244682|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
145244683|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
145244684|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
145244685|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
145244686|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
145297443|NCT02943447|523940792|FG000|Blinded Study Phase|Withdrew Consent|1|||
145297444|NCT02943447|523940793|FG001|Blinded Study Phase|Withdrew Consent|2|||
145297445|NCT02943447|523940794|FG002|Blinded Study Phase|Withdrew Consent|1|||
145297446|NCT02943447|523940792|FG000|Blinded Study Phase|Adverse Event|3|||
145297447|NCT02943447|523940793|FG001|Blinded Study Phase|Adverse Event|0|||
145297448|NCT02943447|523940794|FG002|Blinded Study Phase|Adverse Event|0|||
145297449|NCT02943447|523940792|FG000|Blinded Study Phase|Investigator's discretion|1|||
145565220|NCT03560531|524929118|FG008|Overall Study|Withdrawal by Subject|2|||
145565221|NCT03560531|524929119|FG009|Overall Study|Withdrawal by Subject|0|||
145565222|NCT03560531|524929120|FG010|Overall Study|Withdrawal by Subject|0|||
145565223|NCT03560531|524929121|FG011|Overall Study|Withdrawal by Subject|0|||
145565224|NCT03560531|524929122|FG012|Overall Study|Withdrawal by Subject|2|||
145565225|NCT03560531|524929123|FG013|Overall Study|Withdrawal by Subject|0|||
145565226|NCT03560531|524929110|FG000|Overall Study|Study end per-protocol|1|||
145565227|NCT03560531|524929111|FG001|Overall Study|Study end per-protocol|1|||
145297450|NCT02943447|523940793|FG001|Blinded Study Phase|Investigator's discretion|0|||
145297451|NCT02943447|523940794|FG002|Blinded Study Phase|Investigator's discretion|0|||
145297452|NCT02943447|523940792|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
145297453|NCT02943447|523940793|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
145297454|NCT02943447|523940794|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
145297455|NCT02943447|523940792|FG000|Open-Label Extension Phase|Adverse Event|4|||
145297456|NCT02943447|523940793|FG001|Open-Label Extension Phase|Adverse Event|7|||
145297457|NCT02943447|523940794|FG002|Open-Label Extension Phase|Adverse Event|3|||
145297458|NCT02943447|523940792|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
145297459|NCT02943447|523940793|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
145297460|NCT02943447|523940794|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
145297461|NCT02943447|523940792|FG000|Open-Label Extension Phase|Withdrew consent|1|||
145297462|NCT02943447|523940793|FG001|Open-Label Extension Phase|Withdrew consent|1|||
145297463|NCT02943447|523940794|FG002|Open-Label Extension Phase|Withdrew consent|1|||
145297464|NCT02943447|523940792|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145297465|NCT02943447|523940793|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
145297466|NCT02943447|523940794|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145297467|NCT00840632|523940796|FG000|First Intervention|Withdrawal by Subject|0|||
145297468|NCT00840632|523940797|FG001|First Intervention|Withdrawal by Subject|1|||
145297469|NCT00840632|523940796|FG000|Washout|Withdrawal by Subject|1|||
145297470|NCT00840632|523940797|FG001|Washout|Withdrawal by Subject|1|||
145297471|NCT01725529|523940804|FG000|Overall Study|Adverse Event|1|||
145297472|NCT01725529|523940805|FG001|Overall Study|Adverse Event|0|||
145297473|NCT01725529|523940806|FG002|Overall Study|Adverse Event|0|||
145297474|NCT01725529|523940804|FG000|Overall Study|Lost to Follow-up|2|||
145297475|NCT01725529|523940805|FG001|Overall Study|Lost to Follow-up|1|||
145297476|NCT01725529|523940806|FG002|Overall Study|Lost to Follow-up|1|||
145297477|NCT01725529|523940804|FG000|Overall Study|Protocol Violation|0|||
145297478|NCT01725529|523940805|FG001|Overall Study|Protocol Violation|1|||
145297479|NCT01725529|523940806|FG002|Overall Study|Protocol Violation|1|||
145297480|NCT01725529|523940804|FG000|Overall Study|Withdrawal by Subject|12|||
145297481|NCT01725529|523940805|FG001|Overall Study|Withdrawal by Subject|14|||
145297482|NCT01725529|523940806|FG002|Overall Study|Withdrawal by Subject|8|||
145297483|NCT01900730|523940808|FG000|Overall Study|Withdrawal by Subject|1|||
145297484|NCT01900730|523940809|FG001|Overall Study|Withdrawal by Subject|0|||
145297485|NCT01900730|523940808|FG000|Overall Study|Screen Failure|1|||
145297486|NCT01900730|523940809|FG001|Overall Study|Screen Failure|0|||
145297487|NCT01179048|523940810|FG000|Overall Study|Withdrawn - does not allow contact|4|||
145297488|NCT01179048|523940811|FG001|Overall Study|Withdrawn - does not allow contact|8|||
145297489|NCT01179048|523940810|FG000|Overall Study|Lost to Follow-up|8|||
145297490|NCT01179048|523940811|FG001|Overall Study|Lost to Follow-up|9|||
145297491|NCT01179048|523940810|FG000|Overall Study|Alive|127|||
145297492|NCT01179048|523940811|FG001|Overall Study|Alive|142|||
145297493|NCT02109042|523940812|FG000|Overall Study|Sponsor Decision|15|||
145297494|NCT03203447|523940813|FG000|Overall Study|Withdrawal by Subject|2|||
145297495|NCT03203447|523940814|FG001|Overall Study|Withdrawal by Subject|1|||
145297496|NCT03203447|523940813|FG000|Overall Study|Lost to Follow-up|1|||
145297497|NCT03203447|523940814|FG001|Overall Study|Lost to Follow-up|10|||
145297498|NCT03203447|523940813|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
145297499|NCT03203447|523940814|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
145297500|NCT00324168|523940819|FG000|Overall Study|Lost to Follow-up|19|||
145297501|NCT00324168|523940820|FG001|Overall Study|Lost to Follow-up|18|||
145297502|NCT00324168|523940819|FG000|Overall Study|Death|3|||
145297503|NCT00324168|523940820|FG001|Overall Study|Death|3|||
145297504|NCT00324168|523940819|FG000|Overall Study|Patient did not visit in f/u window|6|||
145297505|NCT00324168|523940820|FG001|Overall Study|Patient did not visit in f/u window|9|||
145297506|NCT01203878|523940821|FG000|Overall Study|Withdrawal by Subject|0|||
145297507|NCT01203878|523940822|FG001|Overall Study|Withdrawal by Subject|0|||
145297508|NCT01203878|523940823|FG002|Overall Study|Withdrawal by Subject|1|||
145297509|NCT01203878|523940821|FG000|Overall Study|Adverse Event|0|||
145297510|NCT01203878|523940822|FG001|Overall Study|Adverse Event|0|||
145297511|NCT01203878|523940823|FG002|Overall Study|Adverse Event|2|||
145297512|NCT04407806|523940825|FG000|Overall Study|Withdrawal by Subject|1|||
145297513|NCT04407806|523940826|FG001|Overall Study|Withdrawal by Subject|2|||
145297514|NCT05327491|523940829|FG000|Periods 1 & 2|Miscellaneous|0|||
145297515|NCT05327491|523940830|FG001|Periods 1 & 2|Miscellaneous|1|||
145297516|NCT05327491|523940831|FG002|Periods 1 & 2|Miscellaneous|0|||
145297517|NCT05327491|523940832|FG003|Periods 1 & 2|Miscellaneous|0|||
145297518|NCT05327491|523940829|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
145297519|NCT05327491|523940830|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
145297520|NCT05327491|523940831|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
145297521|NCT05327491|523940832|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
145297522|NCT02188303|523940833|FG000|Overall Study|Adverse Event|0|||
145297523|NCT02188303|523940834|FG001|Overall Study|Adverse Event|0|||
145409130|NCT03126110|524351997|FG013|Phase 1|Death|0|||
145297524|NCT02188303|523940835|FG002|Overall Study|Adverse Event|0|||
145244687|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
145244688|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
145244689|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
145244690|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
145244691|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
145244692|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
145244693|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
145244694|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
145244695|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
145244696|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
145297525|NCT02188303|523940836|FG003|Overall Study|Adverse Event|0|||
145297526|NCT02188303|523940837|FG004|Overall Study|Adverse Event|0|||
145297527|NCT02188303|523940838|FG005|Overall Study|Adverse Event|2|||
145565228|NCT03560531|524929112|FG002|Overall Study|Study end per-protocol|2|||
145565229|NCT03560531|524929113|FG003|Overall Study|Study end per-protocol|0|||
145565230|NCT03560531|524929114|FG004|Overall Study|Study end per-protocol|1|||
145565231|NCT03560531|524929115|FG005|Overall Study|Study end per-protocol|0|||
145565232|NCT03560531|524929116|FG006|Overall Study|Study end per-protocol|0|||
145565233|NCT03560531|524929117|FG007|Overall Study|Study end per-protocol|0|||
145565234|NCT03560531|524929118|FG008|Overall Study|Study end per-protocol|0|||
145565235|NCT03560531|524929119|FG009|Overall Study|Study end per-protocol|0|||
145565236|NCT03560531|524929120|FG010|Overall Study|Study end per-protocol|0|||
145565237|NCT03560531|524929121|FG011|Overall Study|Study end per-protocol|0|||
145565238|NCT03560531|524929122|FG012|Overall Study|Study end per-protocol|0|||
145565239|NCT03560531|524929123|FG013|Overall Study|Study end per-protocol|0|||
145565240|NCT03560531|524929110|FG000|Overall Study|Early study termination by sponsor|9|||
145565241|NCT03560531|524929111|FG001|Overall Study|Early study termination by sponsor|0|||
145565242|NCT03560531|524929112|FG002|Overall Study|Early study termination by sponsor|0|||
145565243|NCT03560531|524929113|FG003|Overall Study|Early study termination by sponsor|4|||
145565244|NCT03560531|524929114|FG004|Overall Study|Early study termination by sponsor|8|||
145565245|NCT03560531|524929115|FG005|Overall Study|Early study termination by sponsor|2|||
145565246|NCT03560531|524929116|FG006|Overall Study|Early study termination by sponsor|5|||
145565247|NCT03560531|524929117|FG007|Overall Study|Early study termination by sponsor|64|||
145565248|NCT03560531|524929118|FG008|Overall Study|Early study termination by sponsor|7|||
145565249|NCT03560531|524929119|FG009|Overall Study|Early study termination by sponsor|2|||
145565250|NCT03560531|524929120|FG010|Overall Study|Early study termination by sponsor|16|||
145565251|NCT03560531|524929121|FG011|Overall Study|Early study termination by sponsor|2|||
145565252|NCT03560531|524929122|FG012|Overall Study|Early study termination by sponsor|6|||
145565253|NCT03560531|524929123|FG013|Overall Study|Early study termination by sponsor|2|||
145565254|NCT01471379|524929124|FG000|Overall Study|Adverse Event|1|||
145565255|NCT01471379|524929125|FG001|Overall Study|Adverse Event|0|||
145565256|NCT01471379|524929126|FG002|Overall Study|Adverse Event|0|||
145565257|NCT01471379|524929124|FG000|Overall Study|Study terminated|0|||
145565258|NCT01471379|524929125|FG001|Overall Study|Study terminated|1|||
145565259|NCT01471379|524929126|FG002|Overall Study|Study terminated|0|||
145565260|NCT02028988|524929127|FG000|Overall Study|Withdrawal by Subject|2|||
145565261|NCT01063595|524929128|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
145565262|NCT01063595|524929129|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
145565263|NCT01063595|524929128|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
145565264|NCT01063595|524929129|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
145565265|NCT01063595|524929128|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
145565266|NCT01063595|524929129|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
145565267|NCT01063595|524929128|FG000|First Intervention|Adverse Event|1|||
145565268|NCT01063595|524929129|FG001|First Intervention|Adverse Event|4|||
145565269|NCT01063595|524929128|FG000|First Intervention|Withdrawal by Subject|1|||
145565270|NCT01063595|524929129|FG001|First Intervention|Withdrawal by Subject|0|||
145565271|NCT01063595|524929128|FG000|First Intervention|Reason not Specified|0|||
145565272|NCT01063595|524929129|FG001|First Intervention|Reason not Specified|1|||
145565273|NCT00747435|524929130|FG000|Overall Study|Lost to Follow-up|2|||
145565274|NCT00747435|524929130|FG000|Overall Study|Withdrawal by Subject|3|||
145244697|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
145244698|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
145244699|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
145244700|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
145244701|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
145297528|NCT02188303|523940839|FG006|Overall Study|Adverse Event|0|||
145297529|NCT02188303|523940840|FG007|Overall Study|Adverse Event|2|||
145565275|NCT00747435|524929130|FG000|Overall Study|Still undergoing follow up|1|||
145565276|NCT05756790|524929143|FG000|Overall Study|Withdrawal by Subject|1|||
145565277|NCT05756790|524929144|FG001|Overall Study|Withdrawal by Subject|1|||
145565278|NCT05756790|524929145|FG002|Overall Study|Withdrawal by Subject|1|||
145620128|NCT00873093|525123686|FG003|Overall Study|Ineligible|1|||
145297530|NCT02188303|523940833|FG000|Overall Study|Dose Termination Criteria Met|0|||
145297531|NCT02188303|523940834|FG001|Overall Study|Dose Termination Criteria Met|0|||
145297532|NCT02188303|523940835|FG002|Overall Study|Dose Termination Criteria Met|0|||
145297533|NCT02188303|523940836|FG003|Overall Study|Dose Termination Criteria Met|0|||
145297534|NCT02188303|523940837|FG004|Overall Study|Dose Termination Criteria Met|0|||
145297535|NCT02188303|523940838|FG005|Overall Study|Dose Termination Criteria Met|0|||
145297536|NCT02188303|523940839|FG006|Overall Study|Dose Termination Criteria Met|2|||
145297537|NCT02188303|523940840|FG007|Overall Study|Dose Termination Criteria Met|4|||
145297538|NCT04206332|523940842|FG000|Part A|Lost to Follow-up|0|||
145297539|NCT04206332|523940843|FG001|Part A|Lost to Follow-up|1|||
145297540|NCT04206332|523940844|FG002|Part A|Lost to Follow-up|0|||
145297541|NCT04206332|523940845|FG003|Part A|Lost to Follow-up|0|||
145297542|NCT04206332|523940846|FG004|Part A|Lost to Follow-up|0|||
145297543|NCT04206332|523940847|FG005|Part A|Lost to Follow-up|0|||
145297544|NCT04206332|523940848|FG006|Part A|Lost to Follow-up|0|||
145297545|NCT04206332|523940849|FG007|Part A|Lost to Follow-up|0|||
145297546|NCT04206332|523940850|FG008|Part A|Lost to Follow-up|0|||
145297547|NCT04206332|523940851|FG009|Part A|Lost to Follow-up|0|||
145297548|NCT04206332|523940852|FG010|Part A|Lost to Follow-up|0|||
145297549|NCT04206332|523940853|FG011|Part A|Lost to Follow-up|0|||
145297550|NCT04206332|523940854|FG012|Part A|Lost to Follow-up|0|||
145297551|NCT04206332|523940855|FG013|Part A|Lost to Follow-up|0|||
145297552|NCT04206332|523940856|FG014|Part A|Lost to Follow-up|0|||
145297553|NCT04206332|523940857|FG015|Part A|Lost to Follow-up|0|||
145297554|NCT04206332|523940858|FG016|Part A|Lost to Follow-up|0|||
145297555|NCT04206332|523940842|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297556|NCT04206332|523940843|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297557|NCT04206332|523940844|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297558|NCT04206332|523940845|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297559|NCT04206332|523940846|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297560|NCT04206332|523940847|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
145297561|NCT04206332|523940848|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297562|NCT04206332|523940849|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297563|NCT04206332|523940850|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297564|NCT04206332|523940851|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297565|NCT04206332|523940852|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297566|NCT04206332|523940853|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297567|NCT04206332|523940854|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297568|NCT04206332|523940855|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297569|NCT04206332|523940856|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297570|NCT04206332|523940857|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297571|NCT04206332|523940858|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
145297572|NCT04206332|523940842|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297573|NCT04206332|523940843|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145565279|NCT05756790|524929146|FG003|Overall Study|Withdrawal by Subject|1|||
145565280|NCT05756790|524929147|FG004|Overall Study|Withdrawal by Subject|0|||
145244702|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
145244703|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
145244704|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
145244705|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
145244706|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
145244707|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
145244708|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
145244709|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
145244710|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
145244711|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
145297574|NCT04206332|523940844|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145409131|NCT03126110|524351998|FG014|Phase 1|Death|0|||
145565281|NCT05756790|524929148|FG005|Overall Study|Withdrawal by Subject|0|||
145565282|NCT05756790|524929143|FG000|Overall Study|Protocol Violation|0|||
145565283|NCT05756790|524929144|FG001|Overall Study|Protocol Violation|0|||
145244712|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
145244713|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
145244714|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
145244715|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
145244716|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
145244717|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
145244718|NCT03605836|523741967|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
145244719|NCT03605836|523741968|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
145244720|NCT03605836|523741969|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
145244721|NCT03605836|523741970|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
145244722|NCT02977507|523741972|FG000|Overall Study|Protocol Deviation|1|||
145244723|NCT02977507|523741973|FG001|Overall Study|Protocol Deviation|0|||
145244724|NCT02977507|523741972|FG000|Overall Study|Lost to Follow-up|1|||
145244725|NCT02977507|523741973|FG001|Overall Study|Lost to Follow-up|0|||
145244726|NCT00654420|523741974|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
145244727|NCT00654420|523741975|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
145244728|NCT00654420|523741976|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
145244729|NCT00654420|523741977|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
145244730|NCT00654420|523741974|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
145244731|NCT00654420|523741975|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
145244732|NCT00654420|523741976|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
145244733|NCT00654420|523741977|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
145244734|NCT00654420|523741974|FG000|Phase II|Adverse Event|0|||
145244735|NCT00654420|523741975|FG001|Phase II|Adverse Event|0|||
145244736|NCT00654420|523741976|FG002|Phase II|Adverse Event|3|||
145244737|NCT00654420|523741977|FG003|Phase II|Adverse Event|3|||
145244738|NCT00654420|523741974|FG000|Phase II|Lost to Follow-up|0|||
145244739|NCT00654420|523741975|FG001|Phase II|Lost to Follow-up|0|||
145244740|NCT00654420|523741976|FG002|Phase II|Lost to Follow-up|0|||
145244741|NCT00654420|523741977|FG003|Phase II|Lost to Follow-up|1|||
145244742|NCT00654420|523741974|FG000|Phase II|Physician Decision|0|||
145244743|NCT00654420|523741975|FG001|Phase II|Physician Decision|0|||
145244744|NCT00654420|523741976|FG002|Phase II|Physician Decision|0|||
145244745|NCT00654420|523741977|FG003|Phase II|Physician Decision|4|||
145244746|NCT00654420|523741974|FG000|Phase II|Progressive Disease|0|||
145244747|NCT00654420|523741975|FG001|Phase II|Progressive Disease|0|||
145244748|NCT00654420|523741976|FG002|Phase II|Progressive Disease|29|||
145244749|NCT00654420|523741977|FG003|Phase II|Progressive Disease|29|||
145244750|NCT00654420|523741974|FG000|Phase II|Withdrawal by Subject|0|||
145244751|NCT00654420|523741975|FG001|Phase II|Withdrawal by Subject|0|||
145244752|NCT00654420|523741976|FG002|Phase II|Withdrawal by Subject|4|||
145244753|NCT00654420|523741977|FG003|Phase II|Withdrawal by Subject|1|||
145244754|NCT00654420|523741974|FG000|Phase II|Missing Disposition Record|0|||
145244755|NCT00654420|523741975|FG001|Phase II|Missing Disposition Record|0|||
145244756|NCT00654420|523741976|FG002|Phase II|Missing Disposition Record|1|||
145244757|NCT00654420|523741977|FG003|Phase II|Missing Disposition Record|0|||
145244758|NCT00741260|523741986|FG000|Overall Study|Disease Progression|3|||
145244759|NCT00741260|523741987|FG001|Overall Study|Disease Progression|5|||
145244760|NCT00741260|523741988|FG002|Overall Study|Disease Progression|3|||
145244761|NCT00741260|523741989|FG003|Overall Study|Disease Progression|3|||
145244762|NCT00741260|523741990|FG004|Overall Study|Disease Progression|5|||
145244763|NCT00741260|523741991|FG005|Overall Study|Disease Progression|37|||
145244764|NCT00741260|523741992|FG006|Overall Study|Disease Progression|4|||
145244765|NCT00741260|523741986|FG000|Overall Study|Death|0|||
145244766|NCT00741260|523741987|FG001|Overall Study|Death|1|||
145244767|NCT00741260|523741988|FG002|Overall Study|Death|0|||
145244768|NCT00741260|523741989|FG003|Overall Study|Death|1|||
145244769|NCT00741260|523741990|FG004|Overall Study|Death|2|||
145244770|NCT00741260|523741991|FG005|Overall Study|Death|2|||
145244771|NCT00741260|523741992|FG006|Overall Study|Death|1|||
145297575|NCT04206332|523940845|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297576|NCT04206332|523940846|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297577|NCT04206332|523940847|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297578|NCT04206332|523940848|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297579|NCT04206332|523940849|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
145297580|NCT04206332|523940850|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297581|NCT04206332|523940851|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145244772|NCT00741260|523741986|FG000|Overall Study|Withdrawal by Subject|0|||
145244773|NCT00741260|523741987|FG001|Overall Study|Withdrawal by Subject|0|||
145244774|NCT00741260|523741988|FG002|Overall Study|Withdrawal by Subject|0|||
145244775|NCT00741260|523741989|FG003|Overall Study|Withdrawal by Subject|0|||
145244776|NCT00741260|523741990|FG004|Overall Study|Withdrawal by Subject|1|||
145244777|NCT00741260|523741991|FG005|Overall Study|Withdrawal by Subject|3|||
145244778|NCT00741260|523741992|FG006|Overall Study|Withdrawal by Subject|1|||
145244779|NCT00741260|523741986|FG000|Overall Study|Physician Decision|1|||
145244780|NCT00741260|523741987|FG001|Overall Study|Physician Decision|1|||
145244781|NCT00741260|523741988|FG002|Overall Study|Physician Decision|0|||
145244782|NCT00741260|523741989|FG003|Overall Study|Physician Decision|0|||
145244783|NCT00741260|523741990|FG004|Overall Study|Physician Decision|0|||
145244784|NCT00741260|523741991|FG005|Overall Study|Physician Decision|0|||
145244785|NCT00741260|523741992|FG006|Overall Study|Physician Decision|0|||
145244786|NCT00741260|523741986|FG000|Overall Study|Other|2|||
145244787|NCT00741260|523741987|FG001|Overall Study|Other|1|||
145244788|NCT00741260|523741988|FG002|Overall Study|Other|1|||
145244789|NCT00741260|523741989|FG003|Overall Study|Other|2|||
145244790|NCT00741260|523741990|FG004|Overall Study|Other|1|||
145244791|NCT00741260|523741991|FG005|Overall Study|Other|3|||
145244792|NCT00741260|523741992|FG006|Overall Study|Other|1|||
145244793|NCT02565615|523741993|FG000|Overall Study|Death|0|||
145244794|NCT02565615|523741994|FG001|Overall Study|Death|1|||
145244795|NCT02565615|523741995|FG002|Overall Study|Death|0|||
145244796|NCT02565615|523741996|FG003|Overall Study|Death|0|||
145244797|NCT02565615|523741997|FG004|Overall Study|Death|4|||
145244798|NCT02565615|523741993|FG000|Overall Study|Not willing to participate in study|2|||
145244799|NCT02565615|523741994|FG001|Overall Study|Not willing to participate in study|21|||
145244800|NCT02565615|523741995|FG002|Overall Study|Not willing to participate in study|0|||
145244801|NCT02565615|523741996|FG003|Overall Study|Not willing to participate in study|1|||
145244802|NCT02565615|523741997|FG004|Overall Study|Not willing to participate in study|169|||
145244803|NCT02565615|523741993|FG000|Overall Study|Lost to Follow-up|0|||
145244804|NCT02565615|523741994|FG001|Overall Study|Lost to Follow-up|4|||
145244805|NCT02565615|523741995|FG002|Overall Study|Lost to Follow-up|0|||
145244806|NCT02565615|523741996|FG003|Overall Study|Lost to Follow-up|1|||
145244807|NCT02565615|523741997|FG004|Overall Study|Lost to Follow-up|765|||
145244808|NCT02565615|523741993|FG000|Overall Study|Not meeting eligibility criteria|0|||
145244809|NCT02565615|523741994|FG001|Overall Study|Not meeting eligibility criteria|7|||
145244810|NCT02565615|523741995|FG002|Overall Study|Not meeting eligibility criteria|0|||
145244811|NCT02565615|523741996|FG003|Overall Study|Not meeting eligibility criteria|0|||
145244812|NCT02565615|523741997|FG004|Overall Study|Not meeting eligibility criteria|25|||
145244813|NCT02565615|523741993|FG000|Overall Study|Reason not defined|0|||
145244814|NCT02565615|523741994|FG001|Overall Study|Reason not defined|2|||
145244815|NCT02565615|523741995|FG002|Overall Study|Reason not defined|0|||
145244816|NCT02565615|523741996|FG003|Overall Study|Reason not defined|1|||
145297582|NCT04206332|523940852|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
145297583|NCT04206332|523940853|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297584|NCT04206332|523940854|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145377814|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145565284|NCT05756790|524929145|FG002|Overall Study|Protocol Violation|1|||
145565285|NCT05756790|524929146|FG003|Overall Study|Protocol Violation|1|||
145565286|NCT05756790|524929147|FG004|Overall Study|Protocol Violation|0|||
145565287|NCT05756790|524929148|FG005|Overall Study|Protocol Violation|0|||
145620129|NCT00873093|525123687|FG004|Overall Study|Ineligible|0|||
145620130|NCT01152554|525123688|FG000|Overall Study|Withdrawal by Subject|73|||
145620131|NCT01152554|525123689|FG001|Overall Study|Withdrawal by Subject|28|||
145620132|NCT01152554|525123688|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
145565288|NCT05756790|524929143|FG000|Overall Study|Ineligible|0|||
145565289|NCT05756790|524929144|FG001|Overall Study|Ineligible|0|||
145565290|NCT05756790|524929145|FG002|Overall Study|Ineligible|0|||
145565291|NCT05756790|524929146|FG003|Overall Study|Ineligible|0|||
145565292|NCT05756790|524929147|FG004|Overall Study|Ineligible|2|||
145565293|NCT05756790|524929148|FG005|Overall Study|Ineligible|2|||
145565294|NCT01023581|524930603|FG000|Overall Study|Adverse Event|4|||
145565295|NCT01023581|524930604|FG001|Overall Study|Adverse Event|4|||
145565296|NCT01023581|524930605|FG002|Overall Study|Adverse Event|7|||
145565297|NCT01023581|524930606|FG003|Overall Study|Adverse Event|3|||
145565298|NCT01023581|524930607|FG004|Overall Study|Adverse Event|2|||
145565299|NCT01023581|524930608|FG005|Overall Study|Adverse Event|5|||
145565300|NCT01023581|524930609|FG006|Overall Study|Adverse Event|11|||
145565301|NCT01023581|524930603|FG000|Overall Study|Major protocol deviation|2|||
145565302|NCT01023581|524930604|FG001|Overall Study|Major protocol deviation|0|||
145244817|NCT02565615|523741997|FG004|Overall Study|Reason not defined|62|||
145244818|NCT02565615|523741993|FG000|Overall Study|Adverse Event|1|||
145244819|NCT02565615|523741994|FG001|Overall Study|Adverse Event|1|||
145244820|NCT02565615|523741995|FG002|Overall Study|Adverse Event|0|||
145244821|NCT02565615|523741996|FG003|Overall Study|Adverse Event|0|||
145244822|NCT02565615|523741997|FG004|Overall Study|Adverse Event|9|||
145244823|NCT02565615|523741993|FG000|Overall Study|Untreated|0|||
145244824|NCT02565615|523741994|FG001|Overall Study|Untreated|0|||
145244825|NCT02565615|523741995|FG002|Overall Study|Untreated|0|||
145244826|NCT02565615|523741996|FG003|Overall Study|Untreated|0|||
145565303|NCT01023581|524930605|FG002|Overall Study|Major protocol deviation|3|||
145565304|NCT01023581|524930606|FG003|Overall Study|Major protocol deviation|0|||
145565305|NCT01023581|524930607|FG004|Overall Study|Major protocol deviation|0|||
145244827|NCT02565615|523741997|FG004|Overall Study|Untreated|567|||
145244828|NCT05563714|523741998|FG000|Overall Study|Death|2|||
145244829|NCT05563714|523741999|FG001|Overall Study|Death|2|||
145244830|NCT05563714|523742000|FG002|Overall Study|Death|0|||
145244831|NCT05563714|523742001|FG003|Overall Study|Death|0|||
145244832|NCT05563714|523741998|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
145244833|NCT05563714|523741999|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
145244834|NCT05563714|523742000|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
145244835|NCT05563714|523742001|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
145244836|NCT05563714|523741998|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
145244837|NCT05563714|523741999|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
145244838|NCT05563714|523742000|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
145244839|NCT05563714|523742001|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
145244840|NCT05563714|523741998|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
145244841|NCT05563714|523741999|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
145244842|NCT05563714|523742000|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
145244843|NCT05563714|523742001|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
145244844|NCT05563714|523741998|FG000|Overall Study|Lost to Follow-up|22|||
145244845|NCT05563714|523741999|FG001|Overall Study|Lost to Follow-up|19|||
145244846|NCT05563714|523742000|FG002|Overall Study|Lost to Follow-up|0|||
145244847|NCT05563714|523742001|FG003|Overall Study|Lost to Follow-up|0|||
145244848|NCT02427100|523742005|FG000|Overall Study|Lost to Follow-up|0|||
145244849|NCT02427100|523742006|FG001|Overall Study|Lost to Follow-up|2|||
145244850|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
145244851|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
145244852|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
145244853|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
145244854|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
145244855|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
145244856|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
145244857|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
145244858|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145244859|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145244860|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145297585|NCT04206332|523940855|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145409132|NCT03126110|524351999|FG015|Phase 1|Death|0|||
145565306|NCT01023581|524930608|FG005|Overall Study|Major protocol deviation|0|||
145565307|NCT01023581|524930609|FG006|Overall Study|Major protocol deviation|0|||
145565308|NCT01023581|524930603|FG000|Overall Study|Lost to Follow-up|4|||
145565309|NCT01023581|524930604|FG001|Overall Study|Lost to Follow-up|8|||
145565310|NCT01023581|524930605|FG002|Overall Study|Lost to Follow-up|7|||
145565311|NCT01023581|524930606|FG003|Overall Study|Lost to Follow-up|2|||
145565312|NCT01023581|524930607|FG004|Overall Study|Lost to Follow-up|5|||
145565313|NCT01023581|524930608|FG005|Overall Study|Lost to Follow-up|2|||
145565314|NCT01023581|524930609|FG006|Overall Study|Lost to Follow-up|2|||
145565315|NCT01023581|524930603|FG000|Overall Study|Withdrawal by Subject|13|||
145565316|NCT01023581|524930604|FG001|Overall Study|Withdrawal by Subject|8|||
145565317|NCT01023581|524930605|FG002|Overall Study|Withdrawal by Subject|16|||
145565318|NCT01023581|524930606|FG003|Overall Study|Withdrawal by Subject|10|||
145565319|NCT01023581|524930607|FG004|Overall Study|Withdrawal by Subject|6|||
145565320|NCT01023581|524930608|FG005|Overall Study|Withdrawal by Subject|8|||
145565321|NCT01023581|524930609|FG006|Overall Study|Withdrawal by Subject|5|||
145565322|NCT01023581|524930603|FG000|Overall Study|Pregnancy|0|||
145565323|NCT01023581|524930604|FG001|Overall Study|Pregnancy|0|||
145565324|NCT01023581|524930605|FG002|Overall Study|Pregnancy|0|||
145565325|NCT01023581|524930606|FG003|Overall Study|Pregnancy|2|||
145565326|NCT01023581|524930607|FG004|Overall Study|Pregnancy|0|||
145565327|NCT01023581|524930608|FG005|Overall Study|Pregnancy|1|||
145565328|NCT01023581|524930609|FG006|Overall Study|Pregnancy|0|||
145565329|NCT01023581|524930603|FG000|Overall Study|Lack of Efficacy|9|||
145565330|NCT01023581|524930604|FG001|Overall Study|Lack of Efficacy|3|||
145565331|NCT01023581|524930605|FG002|Overall Study|Lack of Efficacy|6|||
145565332|NCT01023581|524930606|FG003|Overall Study|Lack of Efficacy|2|||
145565333|NCT01023581|524930607|FG004|Overall Study|Lack of Efficacy|1|||
145565334|NCT01023581|524930608|FG005|Overall Study|Lack of Efficacy|2|||
145565335|NCT01023581|524930609|FG006|Overall Study|Lack of Efficacy|1|||
145565336|NCT01023581|524930603|FG000|Overall Study|Physician Decision|2|||
145565337|NCT01023581|524930604|FG001|Overall Study|Physician Decision|0|||
145565338|NCT01023581|524930605|FG002|Overall Study|Physician Decision|2|||
145565339|NCT01023581|524930606|FG003|Overall Study|Physician Decision|1|||
145565340|NCT01023581|524930607|FG004|Overall Study|Physician Decision|1|||
145565341|NCT01023581|524930608|FG005|Overall Study|Physician Decision|1|||
145565342|NCT01023581|524930609|FG006|Overall Study|Physician Decision|1|||
145565343|NCT01023581|524930603|FG000|Overall Study|Other|1|||
145565344|NCT01023581|524930604|FG001|Overall Study|Other|0|||
145244861|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145244862|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145244863|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
145244864|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
145244865|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
145244866|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
145244867|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
145244868|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
145244869|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
145244870|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
145244871|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
145244872|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244873|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244874|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244875|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244876|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244877|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
145244878|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
145244879|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244880|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244881|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244882|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244883|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244884|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
145244885|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
145244886|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145409133|NCT03126110|524352000|FG016|Phase 1|Death|0|||
145409134|NCT03126110|524351984|FG000|Phase 1|Lost to Follow-up|0|||
145409135|NCT03126110|524351985|FG001|Phase 1|Lost to Follow-up|1|||
145409136|NCT03126110|524351986|FG002|Phase 1|Lost to Follow-up|0|||
145409137|NCT03126110|524351987|FG003|Phase 1|Lost to Follow-up|0|||
145409138|NCT03126110|524351988|FG004|Phase 1|Lost to Follow-up|0|||
145409139|NCT03126110|524351989|FG005|Phase 1|Lost to Follow-up|0|||
145409140|NCT03126110|524351990|FG006|Phase 1|Lost to Follow-up|0|||
145409141|NCT03126110|524351991|FG007|Phase 1|Lost to Follow-up|0|||
145409142|NCT03126110|524351992|FG008|Phase 1|Lost to Follow-up|1|||
145409143|NCT03126110|524351993|FG009|Phase 1|Lost to Follow-up|0|||
145409144|NCT03126110|524351994|FG010|Phase 1|Lost to Follow-up|0|||
145244887|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145409145|NCT03126110|524351995|FG011|Phase 1|Lost to Follow-up|0|||
145409146|NCT03126110|524351996|FG012|Phase 1|Lost to Follow-up|0|||
145409147|NCT03126110|524351997|FG013|Phase 1|Lost to Follow-up|0|||
145409148|NCT03126110|524351998|FG014|Phase 1|Lost to Follow-up|0|||
145409149|NCT03126110|524351999|FG015|Phase 1|Lost to Follow-up|0|||
145409150|NCT03126110|524352000|FG016|Phase 1|Lost to Follow-up|0|||
145409151|NCT03126110|524351984|FG000|Phase 1|Withdrawal by Subject|1|||
145409152|NCT03126110|524351985|FG001|Phase 1|Withdrawal by Subject|0|||
145409153|NCT03126110|524351986|FG002|Phase 1|Withdrawal by Subject|0|||
145409154|NCT03126110|524351987|FG003|Phase 1|Withdrawal by Subject|1|||
145409155|NCT03126110|524351988|FG004|Phase 1|Withdrawal by Subject|1|||
145409156|NCT03126110|524351989|FG005|Phase 1|Withdrawal by Subject|0|||
145409157|NCT03126110|524351990|FG006|Phase 1|Withdrawal by Subject|0|||
145409158|NCT03126110|524351991|FG007|Phase 1|Withdrawal by Subject|0|||
145409159|NCT03126110|524351992|FG008|Phase 1|Withdrawal by Subject|2|||
145409160|NCT03126110|524351993|FG009|Phase 1|Withdrawal by Subject|1|||
145409161|NCT03126110|524351994|FG010|Phase 1|Withdrawal by Subject|0|||
145409162|NCT03126110|524351995|FG011|Phase 1|Withdrawal by Subject|0|||
145409163|NCT03126110|524351996|FG012|Phase 1|Withdrawal by Subject|0|||
145409164|NCT03126110|524351997|FG013|Phase 1|Withdrawal by Subject|0|||
145409165|NCT03126110|524351998|FG014|Phase 1|Withdrawal by Subject|0|||
145409166|NCT03126110|524351999|FG015|Phase 1|Withdrawal by Subject|0|||
145409167|NCT03126110|524352000|FG016|Phase 1|Withdrawal by Subject|0|||
145565345|NCT01023581|524930605|FG002|Overall Study|Other|1|||
145565346|NCT01023581|524930606|FG003|Overall Study|Other|0|||
145565347|NCT01023581|524930607|FG004|Overall Study|Other|1|||
145244888|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145244889|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145244890|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145409168|NCT03126110|524351984|FG000|Phase 1|Safety follow-up no longer necessary|1|||
145409169|NCT03126110|524351985|FG001|Phase 1|Safety follow-up no longer necessary|0|||
145409170|NCT03126110|524351986|FG002|Phase 1|Safety follow-up no longer necessary|0|||
145409171|NCT03126110|524351987|FG003|Phase 1|Safety follow-up no longer necessary|0|||
145409172|NCT03126110|524351988|FG004|Phase 1|Safety follow-up no longer necessary|0|||
145409173|NCT03126110|524351989|FG005|Phase 1|Safety follow-up no longer necessary|0|||
145565348|NCT01023581|524930608|FG005|Overall Study|Other|0|||
145565349|NCT01023581|524930609|FG006|Overall Study|Other|0|||
145565350|NCT01176292|524930610|FG000|Overall Study|Lost to Follow-up|2|||
145565351|NCT01176292|524930611|FG001|Overall Study|Lost to Follow-up|4|||
145565352|NCT01176292|524930610|FG000|Overall Study|Adverse Event|1|||
145565353|NCT01176292|524930611|FG001|Overall Study|Adverse Event|1|||
145565354|NCT01176292|524930610|FG000|Overall Study|Physician Decision|0|||
145565355|NCT01176292|524930611|FG001|Overall Study|Physician Decision|2|||
145565356|NCT01176292|524930610|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
145565357|NCT01176292|524930611|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
145565358|NCT00997503|524930612|FG000|Overall Study|Death|53|||
145565359|NCT00997503|524930612|FG000|Overall Study|Withdrawal by Subject|76|||
145565360|NCT00997503|524930612|FG000|Overall Study|Lost to Follow-up|33|||
145565361|NCT00997503|524930612|FG000|Overall Study|Adverse Event|3|||
145565362|NCT00997503|524930612|FG000|Overall Study|Physician Decision|10|||
145565363|NCT00997503|524930612|FG000|Overall Study|Missed 12-month follow-up|85|||
145565364|NCT00997503|524930612|FG000|Overall Study|Other reason|13|||
145565365|NCT00380393|524930613|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
145565366|NCT00380393|524930614|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
145244891|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
145244892|NCT02120352|523742007|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
145244893|NCT02120352|523742008|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
145244894|NCT02120352|523742009|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
145244895|NCT02120352|523742010|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
145565367|NCT00380393|524930613|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
145565368|NCT00380393|524930614|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
145565369|NCT00380393|524930613|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
145565370|NCT00380393|524930614|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
145565371|NCT00380393|524930613|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
145565372|NCT00380393|524930614|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
145565373|NCT00380393|524930613|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
145565374|NCT00380393|524930614|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
145565375|NCT00380393|524930613|FG000|Month 14|Withdrawal by Subject|9|||
145244896|NCT02120352|523742011|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
145244897|NCT02120352|523742012|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
145244898|NCT02120352|523742013|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
145244899|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
145244900|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
145244901|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
145244902|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
145244903|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
145244904|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
145244905|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
145244906|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
145244907|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
145244908|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
145244909|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
145244910|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
145244911|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
145297586|NCT04206332|523940856|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297587|NCT04206332|523940857|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297588|NCT04206332|523940858|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297589|NCT04206332|523940842|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297590|NCT04206332|523940843|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297591|NCT04206332|523940844|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297592|NCT04206332|523940845|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297593|NCT04206332|523940846|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145565376|NCT00380393|524930614|FG001|Month 14|Withdrawal by Subject|7|||
145244912|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
145244913|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
145244914|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
145244915|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
145244916|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
145565377|NCT00380393|524930613|FG000|Month 14|Death|1|||
145565378|NCT00380393|524930614|FG001|Month 14|Death|0|||
145565379|NCT00380393|524930613|FG000|Month 14|Lost to Follow-up|0|||
145565380|NCT00380393|524930614|FG001|Month 14|Lost to Follow-up|1|||
145244917|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
145244918|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
145244919|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
145565381|NCT00380393|524930613|FG000|Month 14|Migrated/moved from study area|39|||
145565382|NCT00380393|524930614|FG001|Month 14|Migrated/moved from study area|42|||
145565383|NCT00380393|524930613|FG000|Month 14|Protocol Violation|2|||
145565384|NCT00380393|524930614|FG001|Month 14|Protocol Violation|0|||
145565385|NCT00380393|524930613|FG000|Month 14|Others|6|||
145565386|NCT00380393|524930614|FG001|Month 14|Others|6|||
145565387|NCT01859507|524930615|FG000|Overall Study|left the country|4|||
145565388|NCT04476030|524930616|FG000|Overall Study|Withdrawal by Subject|20|||
145565389|NCT04476030|524930617|FG001|Overall Study|Withdrawal by Subject|16|||
145565390|NCT04476030|524930616|FG000|Overall Study|Adverse Event|10|||
145565391|NCT04476030|524930617|FG001|Overall Study|Adverse Event|11|||
145565392|NCT04476030|524930616|FG000|Overall Study|Lost to Follow-up|7|||
145565393|NCT04476030|524930617|FG001|Overall Study|Lost to Follow-up|4|||
145565394|NCT04476030|524930616|FG000|Overall Study|Physician Decision|1|||
145565395|NCT04476030|524930617|FG001|Overall Study|Physician Decision|1|||
145565396|NCT04476030|524930616|FG000|Overall Study|Protocol Deviation|2|||
145565397|NCT04476030|524930617|FG001|Overall Study|Protocol Deviation|0|||
145565398|NCT04476030|524930616|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
145565399|NCT04476030|524930617|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
145565400|NCT04476030|524930616|FG000|Overall Study|Randomized but not Dosed|2|||
145565401|NCT04476030|524930617|FG001|Overall Study|Randomized but not Dosed|8|||
145565402|NCT02404311|524930618|FG000|Part A: Month 0-18|Death|2|||
145565403|NCT02404311|524930619|FG001|Part A: Month 0-18|Death|0|||
145565404|NCT02404311|524930620|FG002|Part A: Month 0-18|Death|0|||
145565405|NCT02404311|524930621|FG003|Part A: Month 0-18|Death|0|||
145565406|NCT02404311|524930622|FG004|Part A: Month 0-18|Death|0|||
145565407|NCT02404311|524930618|FG000|Part A: Month 0-18|Physician Decision|1|||
145565408|NCT02404311|524930619|FG001|Part A: Month 0-18|Physician Decision|0|||
145565409|NCT02404311|524930620|FG002|Part A: Month 0-18|Physician Decision|0|||
145565410|NCT02404311|524930621|FG003|Part A: Month 0-18|Physician Decision|0|||
145565411|NCT02404311|524930622|FG004|Part A: Month 0-18|Physician Decision|0|||
145565412|NCT02404311|524930618|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
145565413|NCT02404311|524930619|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
145565414|NCT02404311|524930620|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
145565415|NCT02404311|524930621|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
145244920|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
145244921|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
145244922|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
145244923|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
145244924|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
145244925|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
145244926|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
145244927|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244928|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244929|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244930|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
145244931|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244932|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244933|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
145244934|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
145244935|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
145244936|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
145244937|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
145244938|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
145244939|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
145244940|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
145244941|NCT02120352|523742007|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244942|NCT02120352|523742008|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
145244943|NCT02120352|523742009|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244944|NCT02120352|523742010|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244945|NCT02120352|523742011|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244946|NCT02120352|523742012|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244947|NCT02120352|523742013|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
145244948|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
145565416|NCT02404311|524930622|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
145565417|NCT02404311|524930618|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
145565418|NCT02404311|524930619|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
145244949|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
145565419|NCT02404311|524930620|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
145565420|NCT02404311|524930621|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
145565421|NCT02404311|524930622|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
145565422|NCT02404311|524930618|FG000|Part A: Month 0-18|HIV Infection|6|||
145565423|NCT02404311|524930619|FG001|Part A: Month 0-18|HIV Infection|2|||
145565424|NCT02404311|524930620|FG002|Part A: Month 0-18|HIV Infection|0|||
145620133|NCT01152554|525123689|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
145620134|NCT01152554|525123688|FG000|Overall Study|Adverse Event|67|||
145620135|NCT01152554|525123689|FG001|Overall Study|Adverse Event|14|||
145620136|NCT01152554|525123688|FG000|Overall Study|Severe non-compliance to protocol|36|||
145620137|NCT01152554|525123689|FG001|Overall Study|Severe non-compliance to protocol|14|||
145620138|NCT01152554|525123688|FG000|Overall Study|Condition under investigation worsened|5|||
145620139|NCT01152554|525123689|FG001|Overall Study|Condition under investigation worsened|2|||
145620140|NCT01152554|525123688|FG000|Overall Study|Lack of Efficacy|20|||
145620141|NCT01152554|525123689|FG001|Overall Study|Lack of Efficacy|3|||
145620142|NCT01152554|525123688|FG000|Overall Study|Study-specific withdrawal criteria|17|||
145620143|NCT01152554|525123689|FG001|Overall Study|Study-specific withdrawal criteria|8|||
145620144|NCT01152554|525123688|FG000|Overall Study|Lost to Follow-up|87|||
145620145|NCT01152554|525123689|FG001|Overall Study|Lost to Follow-up|32|||
145620146|NCT01152554|525123688|FG000|Overall Study|Other|28|||
145620147|NCT01152554|525123689|FG001|Overall Study|Other|8|||
145620148|NCT01152554|525123688|FG000|Overall Study|Death|1|||
145620149|NCT01152554|525123689|FG001|Overall Study|Death|1|||
145620150|NCT02117544|525123690|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
145620151|NCT02117544|525123691|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
145620152|NCT03486899|525123692|FG000|Overall Study|Lost to Follow-up|4|||
145620153|NCT03486899|525123693|FG001|Overall Study|Lost to Follow-up|1|||
145565425|NCT02404311|524930621|FG003|Part A: Month 0-18|HIV Infection|0|||
145565426|NCT02404311|524930622|FG004|Part A: Month 0-18|HIV Infection|0|||
145565427|NCT02404311|524930618|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
145565428|NCT02404311|524930619|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
145565429|NCT02404311|524930620|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
145565430|NCT02404311|524930621|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
145565431|NCT02404311|524930622|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
145565432|NCT02256891|524930627|FG000|Overall Study|Death|0|||
145565433|NCT02256891|524930628|FG001|Overall Study|Death|2|||
145565434|NCT02256891|524930627|FG000|Overall Study|Lost to Follow-up|0|||
145565435|NCT02256891|524930628|FG001|Overall Study|Lost to Follow-up|3|||
145565436|NCT02256891|524930627|FG000|Overall Study|Physician Decision|7|||
145565437|NCT02256891|524930628|FG001|Overall Study|Physician Decision|3|||
145565438|NCT02256891|524930627|FG000|Overall Study|Screen Fail|5|||
145565439|NCT02256891|524930628|FG001|Overall Study|Screen Fail|4|||
145565440|NCT02256891|524930627|FG000|Overall Study|Equipment Malfunction|0|||
145565441|NCT02256891|524930628|FG001|Overall Study|Equipment Malfunction|1|||
145565442|NCT04171414|524930637|FG000|Overall Study|Death|1|||
145565443|NCT04171414|524930637|FG000|Overall Study|Withdrawal by Subject|1|||
145565444|NCT00218296|524930638|FG000|Overall Study|Lost to Follow-up|9|||
145565445|NCT00218296|524930639|FG001|Overall Study|Lost to Follow-up|7|||
145565446|NCT00218296|524930638|FG000|Overall Study|Withdrawal by Subject|36|||
145565447|NCT00218296|524930639|FG001|Overall Study|Withdrawal by Subject|47|||
145565448|NCT00218296|524930638|FG000|Overall Study|Randomized but did not enter treatment|66|||
145565449|NCT00218296|524930639|FG001|Overall Study|Randomized but did not enter treatment|67|||
145565450|NCT00481195|524930642|FG000|Overall Study|Adverse Event|16|||
145565451|NCT00481195|524930643|FG001|Overall Study|Adverse Event|11|||
145565452|NCT00481195|524930642|FG000|Overall Study|Lack of Efficacy|1|||
145565453|NCT00481195|524930643|FG001|Overall Study|Lack of Efficacy|3|||
145565454|NCT00481195|524930642|FG000|Overall Study|Lost to Follow-up|4|||
145565455|NCT00481195|524930643|FG001|Overall Study|Lost to Follow-up|6|||
145565456|NCT00481195|524930642|FG000|Overall Study|Physician Decision|3|||
145565457|NCT00481195|524930643|FG001|Overall Study|Physician Decision|1|||
145565458|NCT00481195|524930642|FG000|Overall Study|Protocol Violation|10|||
145565459|NCT00481195|524930643|FG001|Overall Study|Protocol Violation|7|||
145620154|NCT03486899|525123694|FG002|Overall Study|Lost to Follow-up|4|||
145620155|NCT03486899|525123695|FG003|Overall Study|Lost to Follow-up|3|||
145620156|NCT03486899|525123692|FG000|Overall Study|Death|1|||
145244950|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
145565460|NCT00481195|524930642|FG000|Overall Study|Withdrawal by Subject|3|||
145565461|NCT00481195|524930643|FG001|Overall Study|Withdrawal by Subject|9|||
145565462|NCT00481195|524930642|FG000|Overall Study|Miscellaneous|2|||
145565463|NCT00481195|524930643|FG001|Overall Study|Miscellaneous|2|||
145620157|NCT03486899|525123693|FG001|Overall Study|Death|0|||
145620158|NCT03486899|525123694|FG002|Overall Study|Death|0|||
145620159|NCT03486899|525123695|FG003|Overall Study|Death|1|||
145620160|NCT03486899|525123692|FG000|Overall Study|Adverse Event|0|||
145620161|NCT03486899|525123693|FG001|Overall Study|Adverse Event|2|||
145565464|NCT00337103|524930650|FG000|Overall Study|Progressive Disease|414|||
145565465|NCT00337103|524930651|FG001|Overall Study|Progressive Disease|410|||
145565466|NCT00337103|524930650|FG000|Overall Study|Adverse Event|45|||
145565467|NCT00337103|524930651|FG001|Overall Study|Adverse Event|59|||
145565468|NCT00337103|524930650|FG000|Overall Study|Subject Choice|34|||
145565469|NCT00337103|524930651|FG001|Overall Study|Subject Choice|27|||
145620162|NCT03486899|525123694|FG002|Overall Study|Adverse Event|0|||
145565470|NCT00337103|524930650|FG000|Overall Study|Clinical Progression|27|||
145565471|NCT00337103|524930651|FG001|Overall Study|Clinical Progression|24|||
145565472|NCT00337103|524930650|FG000|Overall Study|Physician Decision|15|||
145565473|NCT00337103|524930651|FG001|Overall Study|Physician Decision|14|||
145565474|NCT00337103|524930650|FG000|Overall Study|Withdrawal by Subject|8|||
145565475|NCT00337103|524930651|FG001|Overall Study|Withdrawal by Subject|5|||
145244951|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
145244952|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
145244953|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
145244954|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
145244955|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145244956|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145565476|NCT00337103|524930650|FG000|Overall Study|Other|5|||
145565477|NCT00337103|524930651|FG001|Overall Study|Other|6|||
145565478|NCT00337103|524930650|FG000|Overall Study|Entry Criteria Not Met|4|||
145565479|NCT00337103|524930651|FG001|Overall Study|Entry Criteria Not Met|1|||
145565480|NCT00337103|524930650|FG000|Overall Study|Lost to Follow-up|1|||
145565481|NCT00337103|524930651|FG001|Overall Study|Lost to Follow-up|2|||
145565482|NCT00337103|524930650|FG000|Overall Study|Death|1|||
145565483|NCT00337103|524930651|FG001|Overall Study|Death|0|||
145565484|NCT01289847|524930652|FG000|Overall Study|Patient could not comply with visits|1|||
145565485|NCT02871739|524930671|FG000|Overall Study|Lost to Follow-up|3|||
145565486|NCT02871739|524930672|FG001|Overall Study|Lost to Follow-up|2|||
145565487|NCT02871739|524930673|FG002|Overall Study|Lost to Follow-up|0|||
145565488|NCT02871739|524930674|FG003|Overall Study|Lost to Follow-up|2|||
145565489|NCT04372602|524930675|FG000|Overall Study|Withdrawal by Subject|1|||
145565490|NCT04372602|524930676|FG001|Overall Study|Withdrawal by Subject|1|||
145565491|NCT04372602|524930675|FG000|Overall Study|Adverse Event|0|||
145565492|NCT04372602|524930676|FG001|Overall Study|Adverse Event|1|||
145565493|NCT04372602|524930675|FG000|Overall Study|Transitioned to comfort care|0|||
145565494|NCT04372602|524930676|FG001|Overall Study|Transitioned to comfort care|1|||
145565495|NCT00594464|524930677|FG000|Overall Study|Withdrawal by Subject|1|||
145565496|NCT00594464|524930677|FG000|Overall Study|Delay in operation|2|||
145565497|NCT02907359|524930678|FG000|Overall Study|Death|234|||
145565498|NCT02907359|524930679|FG001|Overall Study|Death|117|||
145565499|NCT02907359|524930678|FG000|Overall Study|Withdrawal by Subject|6|||
145565500|NCT02907359|524930679|FG001|Overall Study|Withdrawal by Subject|11|||
145565501|NCT02907359|524930678|FG000|Overall Study|Lost to Follow-up|1|||
145565502|NCT02907359|524930679|FG001|Overall Study|Lost to Follow-up|0|||
145565503|NCT01085097|524930680|FG000|Overall Study|Adverse Event|0|||
145565504|NCT01085097|524930681|FG001|Overall Study|Adverse Event|0|||
145565505|NCT01085097|524930682|FG002|Overall Study|Adverse Event|2|||
145565506|NCT01085097|524930680|FG000|Overall Study|Treatment failure|2|||
145565507|NCT01085097|524930681|FG001|Overall Study|Treatment failure|0|||
145565508|NCT01085097|524930682|FG002|Overall Study|Treatment failure|0|||
145565509|NCT06049043|524930691|FG000|Overall Study|Lost to Follow-up|11|||
145565510|NCT06049043|524930692|FG001|Overall Study|Lost to Follow-up|9|||
145565511|NCT02741700|524930694|FG000|Overall Study|Lost to Follow-up|17|||
145565512|NCT02741700|524930695|FG001|Overall Study|Lost to Follow-up|8|||
145565513|NCT02741700|524930694|FG000|Overall Study|Withdrawal by Subject|2|||
145565514|NCT02741700|524930695|FG001|Overall Study|Withdrawal by Subject|5|||
145565515|NCT02741700|524930694|FG000|Overall Study|Physician Decision|3|||
145565516|NCT02741700|524930695|FG001|Overall Study|Physician Decision|0|||
145565517|NCT02741700|524930694|FG000|Overall Study|Moved out of State|0|||
145565518|NCT02741700|524930695|FG001|Overall Study|Moved out of State|1|||
145565519|NCT02741700|524930694|FG000|Overall Study|Death|4|||
145565520|NCT02741700|524930695|FG001|Overall Study|Death|5|||
145565521|NCT01774786|524930696|FG000|Overall Study|Death|300|||
145565522|NCT01774786|524930697|FG001|Overall Study|Death|319|||
145244957|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145244958|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145565523|NCT01774786|524930696|FG000|Overall Study|Lost to Follow-up|6|||
145565524|NCT01774786|524930697|FG001|Overall Study|Lost to Follow-up|7|||
145565525|NCT01774786|524930696|FG000|Overall Study|Withdrawal by Subject|18|||
145565526|NCT01774786|524930697|FG001|Overall Study|Withdrawal by Subject|14|||
145565527|NCT01774786|524930696|FG000|Overall Study|Physician Decision|2|||
145565528|NCT01774786|524930697|FG001|Overall Study|Physician Decision|0|||
145565529|NCT01774786|524930696|FG000|Overall Study|Non-compliance|0|||
145565530|NCT01774786|524930697|FG001|Overall Study|Non-compliance|1|||
145565531|NCT01774786|524930696|FG000|Overall Study|Reason Not Specified|2|||
145565532|NCT01774786|524930697|FG001|Overall Study|Reason Not Specified|5|||
145565533|NCT02268812|524930698|FG000|Overall Study|Adverse Event|8|||
145565534|NCT02268812|524930699|FG001|Overall Study|Adverse Event|26|||
145565535|NCT02268812|524930700|FG002|Overall Study|Adverse Event|7|||
145565536|NCT02268812|524930701|FG003|Overall Study|Adverse Event|10|||
145565537|NCT02268812|524930698|FG000|Overall Study|Protocol deviation|0|||
145565538|NCT02268812|524930699|FG001|Overall Study|Protocol deviation|0|||
145565539|NCT02268812|524930700|FG002|Overall Study|Protocol deviation|1|||
145565540|NCT02268812|524930701|FG003|Overall Study|Protocol deviation|0|||
145244959|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
145244960|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145244961|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
145244962|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
145244963|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
145244964|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
145244965|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
145244966|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
145244967|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
145565541|NCT02268812|524930698|FG000|Overall Study|Withdrawal by Subject|0|||
145565542|NCT02268812|524930699|FG001|Overall Study|Withdrawal by Subject|1|||
145565543|NCT02268812|524930700|FG002|Overall Study|Withdrawal by Subject|0|||
145565544|NCT02268812|524930701|FG003|Overall Study|Withdrawal by Subject|0|||
145565545|NCT02268812|524930698|FG000|Overall Study|Physician Decision|3|||
145565546|NCT02268812|524930699|FG001|Overall Study|Physician Decision|1|||
145565547|NCT02268812|524930700|FG002|Overall Study|Physician Decision|0|||
145565548|NCT02268812|524930701|FG003|Overall Study|Physician Decision|1|||
145565549|NCT02268812|524930698|FG000|Overall Study|Other|5|||
145565550|NCT02268812|524930699|FG001|Overall Study|Other|4|||
145565551|NCT02268812|524930700|FG002|Overall Study|Other|1|||
145565552|NCT02268812|524930701|FG003|Overall Study|Other|3|||
145565553|NCT04544293|524930702|FG000|Double-blind|Adverse Event|2|||
145565554|NCT04544293|524930703|FG001|Double-blind|Adverse Event|1|||
145565555|NCT04544293|524930702|FG000|Double-blind|Pregnancy|0|||
145565556|NCT04544293|524930703|FG001|Double-blind|Pregnancy|1|||
145565557|NCT04544293|524930702|FG000|Double-blind|Lost to Follow-up|0|||
145565558|NCT04544293|524930703|FG001|Double-blind|Lost to Follow-up|1|||
145565559|NCT04544293|524930702|FG000|Open-Label Extension|Study ongoing|79|||
145565560|NCT04544293|524930703|FG001|Open-Label Extension|Study ongoing|81|||
145565561|NCT01951157|524930705|FG000|Overall Study|Progressive Disease|12|||
145565562|NCT01951157|524930706|FG001|Overall Study|Progressive Disease|13|||
145565563|NCT01951157|524930707|FG002|Overall Study|Progressive Disease|10|||
145565564|NCT01951157|524930705|FG000|Overall Study|Treatment-unrelated AE|1|||
145565565|NCT01951157|524930706|FG001|Overall Study|Treatment-unrelated AE|0|||
145565566|NCT01951157|524930707|FG002|Overall Study|Treatment-unrelated AE|3|||
145565567|NCT01951157|524930705|FG000|Overall Study|Study Termination|0|||
145565568|NCT01951157|524930706|FG001|Overall Study|Study Termination|0|||
145565569|NCT01951157|524930707|FG002|Overall Study|Study Termination|1|||
145565570|NCT01951157|524930705|FG000|Overall Study|Physician Decision|5|||
145565571|NCT01951157|524930706|FG001|Overall Study|Physician Decision|3|||
145565572|NCT01951157|524930707|FG002|Overall Study|Physician Decision|2|||
145565573|NCT01951157|524930705|FG000|Overall Study|Non-treatmentrelated death|2|||
145565574|NCT01951157|524930706|FG001|Overall Study|Non-treatmentrelated death|2|||
145565575|NCT01951157|524930707|FG002|Overall Study|Non-treatmentrelated death|2|||
145565576|NCT01951157|524930705|FG000|Overall Study|No treated|0|||
145565577|NCT01951157|524930706|FG001|Overall Study|No treated|1|||
145565578|NCT01951157|524930707|FG002|Overall Study|No treated|0|||
145565579|NCT01951157|524930705|FG000|Overall Study|Treatment-related AE|2|||
145565580|NCT01951157|524930706|FG001|Overall Study|Treatment-related AE|0|||
145565581|NCT01951157|524930707|FG002|Overall Study|Treatment-related AE|4|||
145565582|NCT01951157|524930705|FG000|Overall Study|Consent withdrawn by subject|0|||
145565583|NCT01951157|524930706|FG001|Overall Study|Consent withdrawn by subject|1|||
145565584|NCT01951157|524930707|FG002|Overall Study|Consent withdrawn by subject|3|||
145565585|NCT01951157|524930705|FG000|Overall Study|Treatment-related death|0|||
145565586|NCT01951157|524930706|FG001|Overall Study|Treatment-related death|2|||
145565587|NCT01951157|524930707|FG002|Overall Study|Treatment-related death|0|||
145565588|NCT02268786|524930708|FG000|Overall Study|No Euploid Embryos available|42|||
145565589|NCT02268786|524930709|FG001|Overall Study|No Euploid Embryos available|0|||
145565590|NCT02268786|524930708|FG000|Overall Study|Withdrawal by Subject|7|||
145565591|NCT02268786|524930709|FG001|Overall Study|Withdrawal by Subject|14|||
145565592|NCT02268786|524930708|FG000|Overall Study|Thaw Failure|6|||
145565593|NCT02268786|524930709|FG001|Overall Study|Thaw Failure|4|||
145565594|NCT02268786|524930708|FG000|Overall Study|Protocol Violation|1|||
145565595|NCT02268786|524930709|FG001|Overall Study|Protocol Violation|0|||
145565596|NCT04809220|524930712|FG000|Overall Study|Adverse Event|4|||
145565597|NCT04809220|524930713|FG001|Overall Study|Adverse Event|0|||
145565598|NCT04809220|524930712|FG000|Overall Study|Death|1|||
145565599|NCT04809220|524930713|FG001|Overall Study|Death|0|||
145565600|NCT04809220|524930712|FG000|Overall Study|Lost to Follow-up|3|||
145565601|NCT04809220|524930713|FG001|Overall Study|Lost to Follow-up|0|||
145565602|NCT04809220|524930712|FG000|Overall Study|Physician Decision|0|||
145565603|NCT04809220|524930713|FG001|Overall Study|Physician Decision|1|||
145565604|NCT04809220|524930712|FG000|Overall Study|Withdrawal by Subject|9|||
145565605|NCT04809220|524930713|FG001|Overall Study|Withdrawal by Subject|5|||
145565606|NCT04809220|524930712|FG000|Overall Study|Due to long-term overseas business trips|1|||
145620163|NCT03486899|525123695|FG003|Overall Study|Adverse Event|2|||
145409174|NCT03126110|524351990|FG006|Phase 1|Safety follow-up no longer necessary|0|||
145409175|NCT03126110|524351991|FG007|Phase 1|Safety follow-up no longer necessary|0|||
145244968|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
145244969|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
145244970|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
145244971|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
145244972|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
145244973|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
145244974|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
145244975|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
145244976|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
145244977|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
145244978|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
145244979|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
145244980|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
145244981|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
145244982|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
145244983|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145244984|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
145244985|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
145244986|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145409176|NCT03126110|524351992|FG008|Phase 1|Safety follow-up no longer necessary|0|||
145409177|NCT03126110|524351993|FG009|Phase 1|Safety follow-up no longer necessary|0|||
145565607|NCT04809220|524930713|FG001|Overall Study|Due to long-term overseas business trips|0|||
145565608|NCT02120794|524930717|FG000|Overall Study|Withdrawal by Subject|43|||
145565609|NCT02120794|524930717|FG000|Overall Study|Adverse Event|10|||
145565610|NCT02120794|524930717|FG000|Overall Study|Physician Decision|4|||
145565611|NCT02120794|524930717|FG000|Overall Study|Due to insurance coverage|1|||
145565612|NCT00994240|524930719|FG000|Overall Study|Lost to Follow-up|3|||
145565613|NCT00994240|524930720|FG001|Overall Study|Lost to Follow-up|2|||
145565614|NCT00994240|524930719|FG000|Overall Study|Withdrawal by Subject|1|||
145565615|NCT00994240|524930720|FG001|Overall Study|Withdrawal by Subject|0|||
145565616|NCT00994240|524930719|FG000|Overall Study|study termination|2|||
145565617|NCT00994240|524930720|FG001|Overall Study|study termination|3|||
145565618|NCT01200797|524930721|FG000|Overall Study|symptomatic deterioration|2|||
145565619|NCT01200797|524930721|FG000|Overall Study|Adverse Event|4|||
145565620|NCT01200797|524930721|FG000|Overall Study|Disease Progression|13|||
145565621|NCT00642668|524930726|FG000|Overall Study|Lost to Follow-up|1|||
145565622|NCT00642668|524930726|FG000|Overall Study|Adverse Event|2|||
145565623|NCT00642668|524930726|FG000|Overall Study|Death|2|||
145565624|NCT00642668|524930726|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145565625|NCT00642668|524930726|FG000|Overall Study|Failure to Return|1|||
145565626|NCT00642668|524930726|FG000|Overall Study|Dialysis Initiation|5|||
145565627|NCT00642668|524930726|FG000|Overall Study|Blood Transfusion|2|||
145244987|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145244988|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145244989|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
145565628|NCT03608774|524930727|FG000|Overall Study|Lost to Follow-up|5|||
145565629|NCT03608774|524930728|FG001|Overall Study|Lost to Follow-up|5|||
145565630|NCT03608774|524930727|FG000|Overall Study|Withdrawal by Subject|1|||
145565631|NCT03608774|524930728|FG001|Overall Study|Withdrawal by Subject|0|||
145565632|NCT03608774|524930727|FG000|Overall Study|Protocol Violation|1|||
145565633|NCT03608774|524930728|FG001|Overall Study|Protocol Violation|0|||
145565634|NCT03608774|524930727|FG000|Overall Study|Not eligible at enrollment|0|||
145565635|NCT03608774|524930728|FG001|Overall Study|Not eligible at enrollment|1|||
145565636|NCT03608774|524930727|FG000|Overall Study|Health related event|0|||
145565637|NCT03608774|524930728|FG001|Overall Study|Health related event|1|||
145565638|NCT01586819|524930729|FG000|Overall Study|Withdrawal by Subject|1|||
145565639|NCT01586819|524930730|FG001|Overall Study|Withdrawal by Subject|0|||
145565640|NCT00896337|524930731|FG000|Overall Study|Death|7|||
145565641|NCT00896337|524930731|FG000|Overall Study|Withdrawal by Subject|7|||
145565642|NCT00896337|524930731|FG000|Overall Study|Lost to Follow-up|11|||
145565643|NCT02910167|524930739|FG000|Overall Study|Adverse Event|1|||
145565644|NCT02910167|524930739|FG000|Overall Study|Lost to Follow-up|18|||
145565645|NCT04059146|524930740|FG000|Overall Study|Withdrawal by Subject|0|||
145565646|NCT04059146|524930741|FG001|Overall Study|Withdrawal by Subject|1|||
145620164|NCT03486899|525123692|FG000|Overall Study|Withdrawal by Subject|3|||
145565647|NCT00748215|524930742|FG000|Overall Study|Withdrawal by Subject|7|||
145565648|NCT00748215|524930743|FG001|Overall Study|Withdrawal by Subject|7|||
145565649|NCT00748215|524930742|FG000|Overall Study|Treatment change|2|||
145565650|NCT00748215|524930743|FG001|Overall Study|Treatment change|1|||
145565651|NCT00748215|524930742|FG000|Overall Study|Change in patient condition|0|||
145244990|NCT02120352|523742007|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
145244991|NCT02120352|523742008|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
145244992|NCT02120352|523742009|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
145244993|NCT02120352|523742010|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
145244994|NCT02120352|523742011|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
145244995|NCT02120352|523742012|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
145244996|NCT02120352|523742013|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
145244997|NCT02120352|523742007|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145244998|NCT02120352|523742008|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145297594|NCT04206332|523940847|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297595|NCT04206332|523940848|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297596|NCT04206332|523940849|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297597|NCT04206332|523940850|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145565652|NCT00748215|524930743|FG001|Overall Study|Change in patient condition|3|||
145565653|NCT00748215|524930742|FG000|Overall Study|Non-compliant|0|||
145565654|NCT00748215|524930743|FG001|Overall Study|Non-compliant|2|||
145565655|NCT00748215|524930742|FG000|Overall Study|Adverse Event|0|||
145565656|NCT00748215|524930743|FG001|Overall Study|Adverse Event|5|||
145565657|NCT03026257|524932100|FG000|Overall Study|Adverse Event|3|||
145565658|NCT03026257|524932101|FG001|Overall Study|Adverse Event|0|||
145565659|NCT03026257|524932102|FG002|Overall Study|Adverse Event|0|||
145565660|NCT03026257|524932103|FG003|Overall Study|Adverse Event|0|||
145565661|NCT03026257|524932104|FG004|Overall Study|Adverse Event|0|||
145565662|NCT03026257|524932105|FG005|Overall Study|Adverse Event|0|||
145565663|NCT03026257|524932100|FG000|Overall Study|Lost to Follow-up|1|||
145565664|NCT03026257|524932101|FG001|Overall Study|Lost to Follow-up|0|||
145565665|NCT03026257|524932102|FG002|Overall Study|Lost to Follow-up|0|||
145565666|NCT03026257|524932103|FG003|Overall Study|Lost to Follow-up|0|||
145565667|NCT03026257|524932104|FG004|Overall Study|Lost to Follow-up|0|||
145565668|NCT03026257|524932105|FG005|Overall Study|Lost to Follow-up|0|||
145565669|NCT03026257|524932100|FG000|Overall Study|Protocol Violation|1|||
145565670|NCT03026257|524932101|FG001|Overall Study|Protocol Violation|0|||
145565671|NCT03026257|524932102|FG002|Overall Study|Protocol Violation|0|||
145565672|NCT03026257|524932103|FG003|Overall Study|Protocol Violation|1|||
145565673|NCT03026257|524932104|FG004|Overall Study|Protocol Violation|1|||
145565674|NCT03026257|524932105|FG005|Overall Study|Protocol Violation|0|||
145565675|NCT03026257|524932100|FG000|Overall Study|Withdrawal by Subject|1|||
145565676|NCT03026257|524932101|FG001|Overall Study|Withdrawal by Subject|1|||
145565677|NCT03026257|524932102|FG002|Overall Study|Withdrawal by Subject|0|||
145565678|NCT03026257|524932103|FG003|Overall Study|Withdrawal by Subject|0|||
145565679|NCT03026257|524932104|FG004|Overall Study|Withdrawal by Subject|0|||
145244999|NCT02120352|523742009|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145245000|NCT02120352|523742010|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145297598|NCT04206332|523940851|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297599|NCT04206332|523940852|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297600|NCT04206332|523940853|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297601|NCT04206332|523940854|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297602|NCT04206332|523940855|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297603|NCT04206332|523940856|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297604|NCT04206332|523940857|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
145297605|NCT04206332|523940858|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
145297606|NCT04206332|523940842|FG000|Part C|Withdrawal by Subject|0|||
145297607|NCT04206332|523940843|FG001|Part C|Withdrawal by Subject|0|||
145297608|NCT04206332|523940844|FG002|Part C|Withdrawal by Subject|0|||
145297609|NCT04206332|523940845|FG003|Part C|Withdrawal by Subject|0|||
145297610|NCT04206332|523940846|FG004|Part C|Withdrawal by Subject|0|||
145297611|NCT04206332|523940847|FG005|Part C|Withdrawal by Subject|0|||
145297612|NCT04206332|523940848|FG006|Part C|Withdrawal by Subject|0|||
145297613|NCT04206332|523940849|FG007|Part C|Withdrawal by Subject|0|||
145297614|NCT04206332|523940850|FG008|Part C|Withdrawal by Subject|0|||
145297615|NCT04206332|523940851|FG009|Part C|Withdrawal by Subject|0|||
145565680|NCT03026257|524932105|FG005|Overall Study|Withdrawal by Subject|0|||
145565681|NCT02181556|524932106|FG000|Overall Study|Withdrawal by Subject|1|||
145565682|NCT00427635|524932107|FG000|Treatment Phase|Withdrawal by Subject|1|||
145565683|NCT00427635|524932108|FG001|Treatment Phase|Withdrawal by Subject|0|||
145565684|NCT00427635|524932107|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
145565685|NCT00427635|524932108|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
145565686|NCT00838201|524932109|FG000|Overall Study|Investigator decision, or other reasons|2|||
145620165|NCT03486899|525123693|FG001|Overall Study|Withdrawal by Subject|7|||
145620166|NCT03486899|525123694|FG002|Overall Study|Withdrawal by Subject|4|||
145245001|NCT02120352|523742011|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145245002|NCT02120352|523742012|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
145245003|NCT02120352|523742013|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
145245004|NCT01610206|523742016|FG000|Overall Study|Adverse Event|10|||
145245005|NCT01610206|523742017|FG001|Overall Study|Adverse Event|30|||
145245006|NCT00196196|523742018|FG000|Overall Study|Withdrawal by Subject|2|||
145245007|NCT00196196|523742018|FG000|Overall Study|Did not have required condition (hydroce|5|||
145245008|NCT03034057|523742021|FG000|Overall Study|Withdrawal by Subject|10|||
145245009|NCT03034057|523742021|FG000|Overall Study|Protocol Violation|1|||
145245010|NCT03034057|523742021|FG000|Overall Study|Not defined|2|||
145245011|NCT03034057|523742021|FG000|Overall Study|Lost to Follow-up|19|||
145245012|NCT03034057|523742021|FG000|Overall Study|Adverse Event|22|||
145245013|NCT03034057|523742021|FG000|Overall Study|Medication error without associated AE|1|||
145245014|NCT03271307|523742022|FG000|Overall Study|Lost to Follow-up|0|||
145245015|NCT03271307|523742023|FG001|Overall Study|Lost to Follow-up|0|||
145245016|NCT03271307|523742024|FG002|Overall Study|Lost to Follow-up|0|||
145245017|NCT03271307|523742025|FG003|Overall Study|Lost to Follow-up|28|||
145245018|NCT03271307|523742026|FG004|Overall Study|Lost to Follow-up|91|||
145245019|NCT02671760|523742029|FG000|Overall Study|Lost to Follow-up|0|||
145245020|NCT02671760|523742030|FG001|Overall Study|Lost to Follow-up|1|||
145245021|NCT02671760|523742031|FG002|Overall Study|Lost to Follow-up|0|||
145245022|NCT02566109|523742032|FG000|Overall Study|Withdrawal by Subject|1|||
145245023|NCT01041404|523742035|FG000|Overall Study|Adverse Event|45|||
145245024|NCT01041404|523742036|FG001|Overall Study|Adverse Event|35|||
145245025|NCT01041404|523742035|FG000|Overall Study|Lack of Efficacy|200|||
145245026|NCT01041404|523742036|FG001|Overall Study|Lack of Efficacy|210|||
145245027|NCT01041404|523742035|FG000|Overall Study|Violation of Selection Criteria|0|||
145245028|NCT01041404|523742036|FG001|Overall Study|Violation of Selection Criteria|1|||
145245029|NCT01041404|523742035|FG000|Overall Study|Protocol Violation|4|||
145245030|NCT01041404|523742036|FG001|Overall Study|Protocol Violation|0|||
145245031|NCT01041404|523742035|FG000|Overall Study|Withdrawal by Subject|29|||
145245032|NCT01041404|523742036|FG001|Overall Study|Withdrawal by Subject|23|||
145245033|NCT01041404|523742035|FG000|Overall Study|Failure to Return|1|||
145245034|NCT01041404|523742036|FG001|Overall Study|Failure to Return|2|||
145245035|NCT01041404|523742035|FG000|Overall Study|Other|11|||
145245036|NCT01041404|523742036|FG001|Overall Study|Other|23|||
145245037|NCT01685203|523742037|FG000|Overall Study|Lost to Follow-up|3|||
145245038|NCT01685203|523742038|FG001|Overall Study|Lost to Follow-up|3|||
145245039|NCT01685203|523742039|FG002|Overall Study|Lost to Follow-up|0|||
145245040|NCT01685203|523742040|FG003|Overall Study|Lost to Follow-up|1|||
145297616|NCT04206332|523940852|FG010|Part C|Withdrawal by Subject|0|||
145297617|NCT04206332|523940853|FG011|Part C|Withdrawal by Subject|0|||
145297618|NCT04206332|523940854|FG012|Part C|Withdrawal by Subject|0|||
145297619|NCT04206332|523940855|FG013|Part C|Withdrawal by Subject|0|||
145297620|NCT04206332|523940856|FG014|Part C|Withdrawal by Subject|2|||
145297621|NCT04206332|523940857|FG015|Part C|Withdrawal by Subject|0|||
145565687|NCT00838201|524932110|FG001|Overall Study|Investigator decision, or other reasons|3|||
145565688|NCT00838201|524932109|FG000|Overall Study|Noncompliance|0|||
145565689|NCT00838201|524932110|FG001|Overall Study|Noncompliance|1|||
145565690|NCT00838201|524932109|FG000|Overall Study|Administrative decision|1|||
145565691|NCT00838201|524932110|FG001|Overall Study|Administrative decision|2|||
145565692|NCT00838201|524932109|FG000|Overall Study|Disease progression|3|||
145565693|NCT00838201|524932110|FG001|Overall Study|Disease progression|3|||
145565694|NCT00838201|524932109|FG000|Overall Study|Consent withdrawn|16|||
145565695|NCT00838201|524932110|FG001|Overall Study|Consent withdrawn|19|||
145565696|NCT00838201|524932109|FG000|Overall Study|Lost to Follow-up|4|||
145565697|NCT00838201|524932110|FG001|Overall Study|Lost to Follow-up|3|||
145565698|NCT00838201|524932109|FG000|Overall Study|Adverse Event|5|||
145565699|NCT00838201|524932110|FG001|Overall Study|Adverse Event|9|||
145565700|NCT00838201|524932109|FG000|Overall Study|Death|11|||
145565701|NCT00838201|524932110|FG001|Overall Study|Death|13|||
145565702|NCT02042924|524932114|FG000|Overall Study|Early Death|1|||
145565703|NCT04033003|524932115|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
145565704|NCT04033003|524932116|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
145565705|NCT04033003|524932115|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
145245041|NCT01685203|523742041|FG004|Overall Study|Lost to Follow-up|0|||
145245042|NCT01685203|523742042|FG005|Overall Study|Lost to Follow-up|0|||
145297622|NCT04206332|523940858|FG016|Part C|Withdrawal by Subject|0|||
145297623|NCT02334722|523940859|FG000|Overall Study|Lost to Follow-up|4|||
145565706|NCT04033003|524932116|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
145565707|NCT04033003|524932115|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
145245043|NCT01685203|523742043|FG006|Overall Study|Lost to Follow-up|0|||
145245044|NCT01685203|523742037|FG000|Overall Study|Adverse Event|0|||
145245045|NCT01685203|523742038|FG001|Overall Study|Adverse Event|0|||
145245046|NCT01685203|523742039|FG002|Overall Study|Adverse Event|0|||
145245047|NCT01685203|523742040|FG003|Overall Study|Adverse Event|0|||
145565708|NCT04033003|524932116|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
145297624|NCT02334722|523940860|FG001|Overall Study|Lost to Follow-up|0|||
145565709|NCT04033003|524932115|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
145565710|NCT04033003|524932116|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
145565711|NCT04033003|524932115|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
145565712|NCT04033003|524932116|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
145565713|NCT04033003|524932115|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
145565714|NCT04033003|524932116|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
145565715|NCT04033003|524932115|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
145565716|NCT04033003|524932116|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
145565717|NCT04033003|524932115|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
145565718|NCT04033003|524932116|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
145565719|NCT04033003|524932115|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
145565720|NCT04033003|524932116|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
145565721|NCT04033003|524932115|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
145565722|NCT04033003|524932116|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
145565723|NCT04033003|524932115|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
145565724|NCT04033003|524932116|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
145245048|NCT01685203|523742041|FG004|Overall Study|Adverse Event|0|||
145245049|NCT01685203|523742042|FG005|Overall Study|Adverse Event|2|||
145245050|NCT01685203|523742043|FG006|Overall Study|Adverse Event|0|||
145245051|NCT01685203|523742037|FG000|Overall Study|Adverse event and withdrew consent|1|||
145245052|NCT01685203|523742038|FG001|Overall Study|Adverse event and withdrew consent|0|||
145245053|NCT01685203|523742039|FG002|Overall Study|Adverse event and withdrew consent|0|||
145245054|NCT01685203|523742040|FG003|Overall Study|Adverse event and withdrew consent|0|||
145245055|NCT01685203|523742041|FG004|Overall Study|Adverse event and withdrew consent|0|||
145245056|NCT01685203|523742042|FG005|Overall Study|Adverse event and withdrew consent|0|||
145245057|NCT01685203|523742043|FG006|Overall Study|Adverse event and withdrew consent|0|||
145245058|NCT01685203|523742037|FG000|Overall Study|Patient's decision|0|||
145245059|NCT01685203|523742038|FG001|Overall Study|Patient's decision|0|||
145245060|NCT01685203|523742039|FG002|Overall Study|Patient's decision|0|||
145245061|NCT01685203|523742040|FG003|Overall Study|Patient's decision|0|||
145245062|NCT01685203|523742041|FG004|Overall Study|Patient's decision|0|||
145245063|NCT01685203|523742042|FG005|Overall Study|Patient's decision|1|||
145245064|NCT01685203|523742043|FG006|Overall Study|Patient's decision|0|||
145245065|NCT00383708|523742044|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
145245066|NCT00383708|523742044|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
145245067|NCT00383708|523742044|FG000|Run-in Period|Protocol Violation|4|||
145245068|NCT00383708|523742044|FG000|Run-in Period|Adverse Event|2|||
145245069|NCT00383708|523742044|FG000|Run-in Period|Claustrophobia|1|||
145245070|NCT00383708|523742044|FG000|Co-administration Period|Adverse Event|5|||
145245071|NCT00318370|523742045|FG000|Period 1|Lack of Efficacy|5|||
145245072|NCT00318370|523742046|FG001|Period 1|Lack of Efficacy|0|||
145245073|NCT00318370|523742047|FG002|Period 1|Lack of Efficacy|0|||
145245074|NCT00318370|523742045|FG000|Period 1|Physician Decision|1|||
145245075|NCT00318370|523742046|FG001|Period 1|Physician Decision|0|||
145245076|NCT00318370|523742047|FG002|Period 1|Physician Decision|0|||
145245077|NCT00318370|523742045|FG000|Period 1|Withdrawal by Subject|1|||
145245078|NCT00318370|523742046|FG001|Period 1|Withdrawal by Subject|0|||
145245079|NCT00318370|523742047|FG002|Period 1|Withdrawal by Subject|0|||
145245080|NCT00318370|523742045|FG000|Period 2|Adverse Event|0|||
145245081|NCT00318370|523742046|FG001|Period 2|Adverse Event|3|||
145245082|NCT00318370|523742047|FG002|Period 2|Adverse Event|0|||
145245083|NCT00318370|523742045|FG000|Period 2|Lack of Efficacy|0|||
145245084|NCT00318370|523742046|FG001|Period 2|Lack of Efficacy|5|||
145245085|NCT00318370|523742047|FG002|Period 2|Lack of Efficacy|0|||
145245086|NCT00318370|523742045|FG000|Period 2|Physician Decision|0|||
145245087|NCT00318370|523742046|FG001|Period 2|Physician Decision|1|||
145245088|NCT00318370|523742047|FG002|Period 2|Physician Decision|0|||
145245089|NCT00318370|523742045|FG000|Period 2|Withdrawal by Subject|0|||
145245090|NCT00318370|523742046|FG001|Period 2|Withdrawal by Subject|1|||
145245091|NCT00318370|523742047|FG002|Period 2|Withdrawal by Subject|0|||
145245092|NCT00318370|523742045|FG000|Period 2|Other|0|||
145245093|NCT00318370|523742046|FG001|Period 2|Other|1|||
145565725|NCT04033003|524932115|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
145245094|NCT00318370|523742047|FG002|Period 2|Other|0|||
145245095|NCT00318370|523742045|FG000|Period 3|Adverse Event|0|||
145245096|NCT00318370|523742046|FG001|Period 3|Adverse Event|0|||
145245097|NCT00318370|523742047|FG002|Period 3|Adverse Event|1|||
145245098|NCT00318370|523742045|FG000|Period 3|Lack of Efficacy|0|||
145245099|NCT00318370|523742046|FG001|Period 3|Lack of Efficacy|0|||
145245100|NCT00318370|523742047|FG002|Period 3|Lack of Efficacy|24|||
145245101|NCT00318370|523742045|FG000|Period 3|Death|0|||
145245102|NCT00318370|523742046|FG001|Period 3|Death|0|||
145565726|NCT04033003|524932116|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
145565727|NCT04033003|524932115|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
145565728|NCT04033003|524932116|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
145245103|NCT00318370|523742047|FG002|Period 3|Death|1|||
145245104|NCT00318370|523742045|FG000|Period 3|Physician Decision|0|||
145245105|NCT00318370|523742046|FG001|Period 3|Physician Decision|0|||
145565729|NCT01714310|524932117|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
145565730|NCT01714310|524932118|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
145565731|NCT01714310|524932119|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
145565732|NCT01714310|524932117|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
145565733|NCT01714310|524932118|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
145565734|NCT01714310|524932119|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
145565735|NCT01714310|524932117|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
145565736|NCT01714310|524932118|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
145565737|NCT01714310|524932119|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
145565738|NCT01714310|524932117|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
145565739|NCT01714310|524932118|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
145565740|NCT01714310|524932119|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
145565741|NCT02487394|524932120|FG000|Phase 1|Withdrawal by Subject|0|||
145565742|NCT02487394|524932121|FG001|Phase 1|Withdrawal by Subject|1|||
145245106|NCT00318370|523742047|FG002|Period 3|Physician Decision|1|||
145245107|NCT00318370|523742045|FG000|Period 3|Withdrawal by Subject|0|||
145245108|NCT00318370|523742046|FG001|Period 3|Withdrawal by Subject|0|||
145245109|NCT00318370|523742047|FG002|Period 3|Withdrawal by Subject|3|||
145245110|NCT00318370|523742045|FG000|Period 3|Other|0|||
145245111|NCT00318370|523742046|FG001|Period 3|Other|0|||
145245112|NCT00318370|523742047|FG002|Period 3|Other|3|||
145245113|NCT01750840|523742050|FG000|Overall Study|Lost to Follow-up|4|||
145245114|NCT01997281|523742053|FG000|Overall Study|Withdrawal by Subject|1|||
145245115|NCT01997281|523742054|FG001|Overall Study|Withdrawal by Subject|0|||
145245116|NCT03619837|523742055|FG000|Screening|received organs from HCV-negative donors|47|||
145245117|NCT03619837|523742055|FG000|Screening|died on the wait-list|2|||
145245118|NCT03619837|523742055|FG000|Screening|remained on the wait list|40|||
145245119|NCT03619837|523742055|FG000|Screening|didn't meet eligibility criteria|3|||
145245120|NCT03619837|523742055|FG000|Screening|withdrew consent|2|||
145245121|NCT03619837|523742055|FG000|Screening|never listed for HCV-viremic donor|1|||
145245122|NCT03619837|523742055|FG000|Screening|developed exclusion criteria|2|||
145245123|NCT03619837|523742055|FG000|Screening|excluded by the investigator due to non-compliance|1|||
145245124|NCT00880607|523742056|FG000|Overall Study|Physician Decision|2|||
145245125|NCT00880607|523742057|FG001|Overall Study|Physician Decision|2|||
145245126|NCT00880607|523742056|FG000|Overall Study|Protocol Violation|2|||
145245127|NCT00880607|523742057|FG001|Overall Study|Protocol Violation|1|||
145245128|NCT00880607|523742056|FG000|Overall Study|surgery did not extend past L1 level|3|||
145245129|NCT00880607|523742057|FG001|Overall Study|surgery did not extend past L1 level|0|||
145245130|NCT00981682|523742065|FG000|Overall Study|Adverse Event|48|||
145245131|NCT00981682|523742065|FG000|Overall Study|Withdrawal by Subject|52|||
145245132|NCT00981682|523742065|FG000|Overall Study|Lost to Follow-up|14|||
145245133|NCT00981682|523742065|FG000|Overall Study|Lack of Efficacy|13|||
145245134|NCT00981682|523742065|FG000|Overall Study|Protocol Violation|6|||
145245135|NCT00981682|523742065|FG000|Overall Study|administrative|9|||
145245136|NCT02712008|523743887|FG000|Baseline (Day 1) up to Week 12|Death|3|||
145245137|NCT02712008|523743888|FG001|Baseline (Day 1) up to Week 12|Death|0|||
145245138|NCT02712008|523743889|FG002|Baseline (Day 1) up to Week 12|Death|0|||
145245139|NCT02712008|523743890|FG003|Baseline (Day 1) up to Week 12|Death|0|||
145245140|NCT02712008|523743891|FG004|Baseline (Day 1) up to Week 12|Death|0|||
145245141|NCT02712008|523743892|FG005|Baseline (Day 1) up to Week 12|Death|0|||
145245142|NCT02712008|523743893|FG006|Baseline (Day 1) up to Week 12|Death|0|||
145245143|NCT02712008|523743894|FG007|Baseline (Day 1) up to Week 12|Death|0|||
145245144|NCT02712008|523743887|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245145|NCT02712008|523743888|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
145245146|NCT02712008|523743889|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
145245147|NCT02712008|523743890|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245148|NCT02712008|523743891|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245149|NCT02712008|523743892|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245150|NCT02712008|523743893|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245151|NCT02712008|523743894|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
145245152|NCT02712008|523743887|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
145245153|NCT02712008|523743888|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145245154|NCT02712008|523743889|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
145245155|NCT02712008|523743890|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145245156|NCT02712008|523743891|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145565743|NCT00826267|524932126|FG000|Overall Study|Other Adverse Event|1|||
145565744|NCT00826267|524932127|FG001|Overall Study|Other Adverse Event|0|||
145245157|NCT02712008|523743892|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145245158|NCT02712008|523743893|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145565745|NCT00826267|524932128|FG002|Overall Study|Other Adverse Event|0|||
145565746|NCT01675882|524932145|FG000|Overall Study|Adverse Event|0|||
145245159|NCT02712008|523743894|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
145245160|NCT02712008|523743887|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245161|NCT02712008|523743888|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245162|NCT02712008|523743889|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
145565747|NCT01675882|524932146|FG001|Overall Study|Adverse Event|2|||
145565748|NCT01675882|524932147|FG002|Overall Study|Adverse Event|1|||
145565749|NCT01675882|524932148|FG003|Overall Study|Adverse Event|0|||
145565750|NCT01675882|524932145|FG000|Overall Study|Participant unwilling to continue|2|||
145565751|NCT01675882|524932146|FG001|Overall Study|Participant unwilling to continue|4|||
145565752|NCT01675882|524932147|FG002|Overall Study|Participant unwilling to continue|2|||
145565753|NCT01675882|524932148|FG003|Overall Study|Participant unwilling to continue|1|||
145565754|NCT01675882|524932145|FG000|Overall Study|Lost to Follow-up|0|||
145565755|NCT01675882|524932146|FG001|Overall Study|Lost to Follow-up|1|||
145565756|NCT01675882|524932147|FG002|Overall Study|Lost to Follow-up|0|||
145565757|NCT01675882|524932148|FG003|Overall Study|Lost to Follow-up|0|||
145565758|NCT01675882|524932145|FG000|Overall Study|Non-compliance|0|||
145565759|NCT01675882|524932146|FG001|Overall Study|Non-compliance|0|||
145565760|NCT01675882|524932147|FG002|Overall Study|Non-compliance|0|||
145565761|NCT01675882|524932148|FG003|Overall Study|Non-compliance|1|||
145565762|NCT02711800|524932152|FG000|Overall Study|Lost to Follow-up|1|||
145565763|NCT02711800|524932152|FG000|Overall Study|Withdrawal by Subject|1|||
145565764|NCT02932904|524932161|FG000|Overall Study|Reason not Specified|1|||
145565765|NCT02932904|524932162|FG001|Overall Study|Reason not Specified|0|||
145565766|NCT02932904|524932163|FG002|Overall Study|Reason not Specified|2|||
145565767|NCT02932904|524932164|FG003|Overall Study|Reason not Specified|2|||
145565768|NCT02932904|524932161|FG000|Overall Study|Noncompliance with Study Drug|2|||
145565769|NCT02932904|524932162|FG001|Overall Study|Noncompliance with Study Drug|3|||
145565770|NCT02932904|524932163|FG002|Overall Study|Noncompliance with Study Drug|3|||
145565771|NCT02932904|524932164|FG003|Overall Study|Noncompliance with Study Drug|4|||
145565772|NCT02932904|524932161|FG000|Overall Study|Pregnancy|0|||
145565773|NCT02932904|524932162|FG001|Overall Study|Pregnancy|1|||
145565774|NCT02932904|524932163|FG002|Overall Study|Pregnancy|1|||
145565775|NCT02932904|524932164|FG003|Overall Study|Pregnancy|0|||
145245163|NCT02712008|523743890|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245164|NCT02712008|523743891|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245165|NCT02712008|523743892|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245166|NCT02712008|523743893|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245167|NCT02712008|523743894|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
145245168|NCT02712008|523743887|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245169|NCT02712008|523743888|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
145245170|NCT02712008|523743889|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245171|NCT02712008|523743890|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245172|NCT02712008|523743891|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245173|NCT02712008|523743892|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245174|NCT02712008|523743893|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245175|NCT02712008|523743894|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
145245176|NCT02712008|523743887|FG000|From Week 12 up to Week 36|Adverse Event|0|||
145245177|NCT02712008|523743888|FG001|From Week 12 up to Week 36|Adverse Event|0|||
145245178|NCT02712008|523743889|FG002|From Week 12 up to Week 36|Adverse Event|0|||
145245179|NCT02712008|523743890|FG003|From Week 12 up to Week 36|Adverse Event|0|||
145245180|NCT02712008|523743891|FG004|From Week 12 up to Week 36|Adverse Event|1|||
145245181|NCT02712008|523743892|FG005|From Week 12 up to Week 36|Adverse Event|0|||
145245182|NCT02712008|523743893|FG006|From Week 12 up to Week 36|Adverse Event|0|||
145245183|NCT02712008|523743894|FG007|From Week 12 up to Week 36|Adverse Event|2|||
145245184|NCT02712008|523743887|FG000|From Week 12 up to Week 36|Death|1|||
145245185|NCT02712008|523743888|FG001|From Week 12 up to Week 36|Death|0|||
145245186|NCT02712008|523743889|FG002|From Week 12 up to Week 36|Death|0|||
145297625|NCT02334722|523940859|FG000|Overall Study|6 week questionnaire not completed|2|||
145297626|NCT02334722|523940860|FG001|Overall Study|6 week questionnaire not completed|0|||
145297627|NCT02334722|523940859|FG000|Overall Study|Unable to obtain medication|1|||
145297628|NCT02334722|523940860|FG001|Overall Study|Unable to obtain medication|1|||
145297629|NCT02334722|523940859|FG000|Overall Study|Withdrawal by Subject|0|||
145565776|NCT02932904|524932161|FG000|Overall Study|Study Termination|0|||
145565777|NCT02932904|524932162|FG001|Overall Study|Study Termination|1|||
145565778|NCT02932904|524932163|FG002|Overall Study|Study Termination|0|||
145245187|NCT02712008|523743890|FG003|From Week 12 up to Week 36|Death|0|||
145245188|NCT02712008|523743891|FG004|From Week 12 up to Week 36|Death|0|||
145245189|NCT02712008|523743892|FG005|From Week 12 up to Week 36|Death|0|||
145297630|NCT02334722|523940860|FG001|Overall Study|Withdrawal by Subject|3|||
145297631|NCT02334722|523940859|FG000|Overall Study|Adverse Event|0|||
145565779|NCT02932904|524932164|FG003|Overall Study|Study Termination|0|||
145245190|NCT02712008|523743893|FG006|From Week 12 up to Week 36|Death|1|||
145245191|NCT02712008|523743894|FG007|From Week 12 up to Week 36|Death|0|||
145565780|NCT02932904|524932161|FG000|Overall Study|Voluntary Withdrawal|2|||
145565781|NCT02932904|524932162|FG001|Overall Study|Voluntary Withdrawal|1|||
145565782|NCT02932904|524932163|FG002|Overall Study|Voluntary Withdrawal|4|||
145565783|NCT02932904|524932164|FG003|Overall Study|Voluntary Withdrawal|2|||
145565784|NCT02932904|524932161|FG000|Overall Study|Lost to Follow-up|5|||
145565785|NCT02932904|524932162|FG001|Overall Study|Lost to Follow-up|3|||
145565786|NCT02932904|524932163|FG002|Overall Study|Lost to Follow-up|6|||
145565787|NCT02932904|524932164|FG003|Overall Study|Lost to Follow-up|0|||
145565788|NCT02932904|524932161|FG000|Overall Study|Significant Protocol Deviation|2|||
145565789|NCT02932904|524932162|FG001|Overall Study|Significant Protocol Deviation|3|||
145565790|NCT02932904|524932163|FG002|Overall Study|Significant Protocol Deviation|6|||
145565791|NCT02932904|524932164|FG003|Overall Study|Significant Protocol Deviation|1|||
145565792|NCT02932904|524932161|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
145565793|NCT02932904|524932162|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
145565794|NCT02932904|524932163|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
145565795|NCT02932904|524932164|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
145565796|NCT02932904|524932161|FG000|Overall Study|Randomized But Not Treated|1|||
145565797|NCT02932904|524932162|FG001|Overall Study|Randomized But Not Treated|1|||
145565798|NCT02932904|524932163|FG002|Overall Study|Randomized But Not Treated|0|||
145565799|NCT02932904|524932164|FG003|Overall Study|Randomized But Not Treated|2|||
145565800|NCT02016482|524932165|FG000|Period A|Adverse Event|3|||
145565801|NCT02016482|524932166|FG001|Period A|Adverse Event|5|||
145565802|NCT02016482|524932165|FG000|Period A|Withdrawal by Subject|3|||
145565803|NCT02016482|524932166|FG001|Period A|Withdrawal by Subject|4|||
145565804|NCT02016482|524932165|FG000|Period A|Lost to Follow-up|3|||
145565805|NCT02016482|524932166|FG001|Period A|Lost to Follow-up|3|||
145565806|NCT02016482|524932165|FG000|Period A|Lack of Efficacy|2|||
145565807|NCT02016482|524932166|FG001|Period A|Lack of Efficacy|1|||
145565808|NCT02016482|524932165|FG000|Period A|Other|3|||
145565809|NCT02016482|524932166|FG001|Period A|Other|0|||
145565810|NCT02016482|524932165|FG000|Period A|Protocol Violation|0|||
145565811|NCT02016482|524932166|FG001|Period A|Protocol Violation|1|||
145565812|NCT02016482|524932165|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
145565813|NCT02016482|524932166|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
145565814|NCT02016482|524932165|FG000|Period B|Withdrawal by Subject|1|||
145565815|NCT02016482|524932166|FG001|Period B|Withdrawal by Subject|1|||
145565816|NCT02016482|524932165|FG000|Period B|Lost to Follow-up|2|||
145565817|NCT02016482|524932166|FG001|Period B|Lost to Follow-up|0|||
145565818|NCT02016482|524932165|FG000|Period B|Lack of Efficacy|6|||
145565819|NCT02016482|524932166|FG001|Period B|Lack of Efficacy|4|||
145565820|NCT02016482|524932165|FG000|Period B|Other|4|||
145565821|NCT02016482|524932166|FG001|Period B|Other|0|||
145565822|NCT02016482|524932165|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
145565823|NCT02016482|524932166|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
145565824|NCT03161483|524932172|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
145565825|NCT03161483|524932173|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
145565826|NCT03161483|524932174|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
145565827|NCT03161483|524932175|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
145565828|NCT03161483|524932172|FG000|Treatment Period|Death|1|||
145565829|NCT03161483|524932173|FG001|Treatment Period|Death|0|||
145565830|NCT03161483|524932174|FG002|Treatment Period|Death|0|||
145565831|NCT03161483|524932175|FG003|Treatment Period|Death|0|||
145565832|NCT03161483|524932172|FG000|Treatment Period|Adverse Event|5|||
145565833|NCT03161483|524932173|FG001|Treatment Period|Adverse Event|2|||
145565834|NCT03161483|524932174|FG002|Treatment Period|Adverse Event|1|||
145565835|NCT03161483|524932175|FG003|Treatment Period|Adverse Event|11|||
145565836|NCT03161483|524932172|FG000|Treatment Period|Pregnancy|1|||
145565837|NCT03161483|524932173|FG001|Treatment Period|Pregnancy|0|||
145565838|NCT03161483|524932174|FG002|Treatment Period|Pregnancy|0|||
145565839|NCT03161483|524932175|FG003|Treatment Period|Pregnancy|0|||
145565840|NCT03161483|524932172|FG000|Treatment Period|Lack of Efficacy|0|||
145565841|NCT03161483|524932173|FG001|Treatment Period|Lack of Efficacy|0|||
145565842|NCT03161483|524932174|FG002|Treatment Period|Lack of Efficacy|0|||
145565843|NCT03161483|524932175|FG003|Treatment Period|Lack of Efficacy|1|||
145620167|NCT03486899|525123695|FG003|Overall Study|Withdrawal by Subject|3|||
145620168|NCT03486899|525123692|FG000|Overall Study|Other Reasons|0|||
145620169|NCT03486899|525123693|FG001|Overall Study|Other Reasons|1|||
145245192|NCT02712008|523743887|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
145245193|NCT02712008|523743888|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
145245194|NCT02712008|523743889|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
145620170|NCT03486899|525123694|FG002|Overall Study|Other Reasons|0|||
145245195|NCT02712008|523743890|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
145245196|NCT02712008|523743891|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
145565844|NCT03161483|524932172|FG000|Treatment Period|Withdrawal by Subject|2|||
145565845|NCT03161483|524932173|FG001|Treatment Period|Withdrawal by Subject|5|||
145565846|NCT03161483|524932174|FG002|Treatment Period|Withdrawal by Subject|2|||
145565847|NCT03161483|524932175|FG003|Treatment Period|Withdrawal by Subject|6|||
145565848|NCT03161483|524932172|FG000|Treatment Period|Lost to Follow-up|0|||
145565849|NCT03161483|524932173|FG001|Treatment Period|Lost to Follow-up|0|||
145565850|NCT03161483|524932174|FG002|Treatment Period|Lost to Follow-up|0|||
145565851|NCT03161483|524932175|FG003|Treatment Period|Lost to Follow-up|1|||
145620171|NCT03486899|525123695|FG003|Overall Study|Other Reasons|1|||
145565852|NCT03161483|524932172|FG000|Treatment Period|Protocol Violation|0|||
145620172|NCT02408549|525123696|FG000|Overall Study|Adverse Event|15|||
145620173|NCT02408549|525123696|FG000|Overall Study|Death|4|||
145620174|NCT02408549|525123696|FG000|Overall Study|Lack of Efficacy|17|||
145620175|NCT02408549|525123696|FG000|Overall Study|Protocol Violation|4|||
145620176|NCT02408549|525123696|FG000|Overall Study|Lost to Follow-up|6|||
145620177|NCT02408549|525123696|FG000|Overall Study|Consent withdrawn|30|||
145620178|NCT02408549|525123696|FG000|Overall Study|Neurology research program closing at site|1|||
145620179|NCT02408549|525123696|FG000|Overall Study|Site closure|1|||
145620180|NCT02408549|525123696|FG000|Overall Study|Pregnancy|1|||
145620181|NCT02408549|525123696|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
145620182|NCT02408549|525123696|FG000|Overall Study|Subject moved to another place, far from site|1|||
145620183|NCT02408549|525123696|FG000|Overall Study|Study terminated at site|1|||
145620184|NCT01232556|525123699|FG000|Overall Study|Withdrawal by Subject|21|||
145620185|NCT01232556|525123700|FG001|Overall Study|Withdrawal by Subject|17|||
145620186|NCT01232556|525123699|FG000|Overall Study|Death|97|||
145245197|NCT02712008|523743892|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
145245198|NCT02712008|523743893|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
145245199|NCT02712008|523743894|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
145245200|NCT02712008|523743887|FG000|From Week 12 up to Week 36|Physician Decision|0|||
145245201|NCT02712008|523743888|FG001|From Week 12 up to Week 36|Physician Decision|0|||
145245202|NCT02712008|523743889|FG002|From Week 12 up to Week 36|Physician Decision|0|||
145245203|NCT02712008|523743890|FG003|From Week 12 up to Week 36|Physician Decision|1|||
145245204|NCT02712008|523743891|FG004|From Week 12 up to Week 36|Physician Decision|1|||
145245205|NCT02712008|523743892|FG005|From Week 12 up to Week 36|Physician Decision|0|||
145245206|NCT02712008|523743893|FG006|From Week 12 up to Week 36|Physician Decision|0|||
145245207|NCT02712008|523743894|FG007|From Week 12 up to Week 36|Physician Decision|0|||
145245208|NCT02712008|523743887|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245209|NCT02712008|523743888|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245210|NCT02712008|523743889|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245211|NCT02712008|523743890|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245212|NCT02712008|523743891|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245213|NCT02712008|523743892|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
145245214|NCT02712008|523743893|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
145245215|NCT02712008|523743894|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
145245216|NCT01731990|523743895|FG000|Overall Study|Adverse Event|1|||
145245217|NCT01731990|523743896|FG001|Overall Study|Adverse Event|5|||
145245218|NCT01731990|523743895|FG000|Overall Study|Withdrawal by Subject|1|||
145245219|NCT01731990|523743896|FG001|Overall Study|Withdrawal by Subject|1|||
145245220|NCT01731990|523743895|FG000|Overall Study|Protocol deviation|1|||
145245221|NCT01731990|523743896|FG001|Overall Study|Protocol deviation|2|||
145245222|NCT01731990|523743895|FG000|Overall Study|Death|1|||
145245223|NCT01731990|523743896|FG001|Overall Study|Death|0|||
145620187|NCT01232556|525123700|FG001|Overall Study|Death|97|||
145245224|NCT01131078|523743905|FG000|Overall Study|Adverse Event|22|||
145245225|NCT01131078|523743906|FG001|Overall Study|Adverse Event|12|||
145245226|NCT01131078|523743907|FG002|Overall Study|Adverse Event|17|||
145245227|NCT01131078|523743905|FG000|Overall Study|Progressive Disease|58|||
145245228|NCT01131078|523743906|FG001|Overall Study|Progressive Disease|77|||
145245229|NCT01131078|523743907|FG002|Overall Study|Progressive Disease|71|||
145245230|NCT01131078|523743905|FG000|Overall Study|Protocol Violation|1|||
145245231|NCT01131078|523743906|FG001|Overall Study|Protocol Violation|0|||
145245232|NCT01131078|523743907|FG002|Overall Study|Protocol Violation|0|||
145245233|NCT01131078|523743905|FG000|Overall Study|Lost to Follow-up|1|||
145245234|NCT01131078|523743906|FG001|Overall Study|Lost to Follow-up|1|||
145245235|NCT01131078|523743907|FG002|Overall Study|Lost to Follow-up|1|||
145245236|NCT01131078|523743905|FG000|Overall Study|Withdrawal by Subject|2|||
145245237|NCT01131078|523743906|FG001|Overall Study|Withdrawal by Subject|4|||
145245238|NCT01131078|523743907|FG002|Overall Study|Withdrawal by Subject|3|||
145245239|NCT01131078|523743905|FG000|Overall Study|Non-compliance|3|||
145245240|NCT01131078|523743906|FG001|Overall Study|Non-compliance|0|||
145245241|NCT01131078|523743907|FG002|Overall Study|Non-compliance|0|||
145245242|NCT01131078|523743905|FG000|Overall Study|Physician Decision|10|||
145245243|NCT01131078|523743906|FG001|Overall Study|Physician Decision|6|||
145245244|NCT01131078|523743907|FG002|Overall Study|Physician Decision|8|||
145245245|NCT01131078|523743905|FG000|Overall Study|Death|4|||
145409178|NCT03126110|524351994|FG010|Phase 1|Safety follow-up no longer necessary|0|||
145620188|NCT01232556|525123699|FG000|Overall Study|Lost to Follow-up|0|||
145245246|NCT01131078|523743906|FG001|Overall Study|Death|0|||
145245247|NCT01131078|523743907|FG002|Overall Study|Death|2|||
145245248|NCT01131078|523743905|FG000|Overall Study|Other|0|||
145245249|NCT01131078|523743906|FG001|Overall Study|Other|1|||
145409179|NCT03126110|524351995|FG011|Phase 1|Safety follow-up no longer necessary|0|||
145620189|NCT01232556|525123700|FG001|Overall Study|Lost to Follow-up|2|||
145620190|NCT01232556|525123699|FG000|Overall Study|Terminated by Sponsor|35|||
145245250|NCT01131078|523743907|FG002|Overall Study|Other|0|||
145245251|NCT01199198|523743908|FG000|Overall Study|Adverse Event|3|||
145245252|NCT01199198|523743909|FG001|Overall Study|Adverse Event|0|||
145245253|NCT01199198|523743908|FG000|Overall Study|Lost to Follow-up|1|||
145245254|NCT01199198|523743909|FG001|Overall Study|Lost to Follow-up|5|||
145245255|NCT01199198|523743908|FG000|Overall Study|Withdrawal by Subject|1|||
145245256|NCT01199198|523743909|FG001|Overall Study|Withdrawal by Subject|2|||
145245257|NCT01199198|523743908|FG000|Overall Study|ICU Transfer|1|||
145245258|NCT01199198|523743909|FG001|Overall Study|ICU Transfer|2|||
145245259|NCT01199198|523743908|FG000|Overall Study|Hospice-care transfer|1|||
145245260|NCT01199198|523743909|FG001|Overall Study|Hospice-care transfer|2|||
145245261|NCT04315298|523743910|FG000|Overall Study|Withdrawal by Subject|0|||
145245262|NCT04315298|523743911|FG001|Overall Study|Withdrawal by Subject|0|||
145245263|NCT04315298|523743912|FG002|Overall Study|Withdrawal by Subject|0|||
145245264|NCT04315298|523743913|FG003|Overall Study|Withdrawal by Subject|2|||
145245265|NCT04315298|523743914|FG004|Overall Study|Withdrawal by Subject|2|||
145245266|NCT04315298|523743915|FG005|Overall Study|Withdrawal by Subject|2|||
145245267|NCT04315298|523743916|FG006|Overall Study|Withdrawal by Subject|0|||
145245268|NCT04315298|523743917|FG007|Overall Study|Withdrawal by Subject|1|||
145245269|NCT04315298|523743918|FG008|Overall Study|Withdrawal by Subject|1|||
145245270|NCT04315298|523743919|FG009|Overall Study|Withdrawal by Subject|1|||
145245271|NCT04315298|523743920|FG010|Overall Study|Withdrawal by Subject|0|||
145245272|NCT04315298|523743921|FG011|Overall Study|Withdrawal by Subject|0|||
145245273|NCT04315298|523743922|FG012|Overall Study|Withdrawal by Subject|0|||
145245274|NCT04315298|523743923|FG013|Overall Study|Withdrawal by Subject|0|||
145245275|NCT04315298|523743924|FG014|Overall Study|Withdrawal by Subject|0|||
145245276|NCT04315298|523743925|FG015|Overall Study|Withdrawal by Subject|0|||
145245277|NCT04315298|523743926|FG016|Overall Study|Withdrawal by Subject|0|||
145245278|NCT04315298|523743927|FG017|Overall Study|Withdrawal by Subject|0|||
145245279|NCT04315298|523743928|FG018|Overall Study|Withdrawal by Subject|0|||
145245280|NCT04315298|523743910|FG000|Overall Study|Physician Decision|0|||
145245281|NCT04315298|523743911|FG001|Overall Study|Physician Decision|0|||
145245282|NCT04315298|523743912|FG002|Overall Study|Physician Decision|0|||
145245283|NCT04315298|523743913|FG003|Overall Study|Physician Decision|0|||
145245284|NCT04315298|523743914|FG004|Overall Study|Physician Decision|1|||
145245285|NCT04315298|523743915|FG005|Overall Study|Physician Decision|0|||
145245286|NCT04315298|523743916|FG006|Overall Study|Physician Decision|0|||
145245287|NCT04315298|523743917|FG007|Overall Study|Physician Decision|0|||
145245288|NCT04315298|523743918|FG008|Overall Study|Physician Decision|0|||
145245289|NCT04315298|523743919|FG009|Overall Study|Physician Decision|0|||
145245290|NCT04315298|523743920|FG010|Overall Study|Physician Decision|0|||
145245291|NCT04315298|523743921|FG011|Overall Study|Physician Decision|0|||
145245292|NCT04315298|523743922|FG012|Overall Study|Physician Decision|0|||
145245293|NCT04315298|523743923|FG013|Overall Study|Physician Decision|0|||
145245294|NCT04315298|523743924|FG014|Overall Study|Physician Decision|0|||
145245295|NCT04315298|523743925|FG015|Overall Study|Physician Decision|0|||
145245296|NCT04315298|523743926|FG016|Overall Study|Physician Decision|0|||
145245297|NCT04315298|523743927|FG017|Overall Study|Physician Decision|0|||
145245298|NCT04315298|523743928|FG018|Overall Study|Physician Decision|0|||
145245299|NCT04315298|523743910|FG000|Overall Study|Lost to Follow-up|5|||
145245300|NCT04315298|523743911|FG001|Overall Study|Lost to Follow-up|10|||
145245301|NCT04315298|523743912|FG002|Overall Study|Lost to Follow-up|6|||
145245302|NCT04315298|523743913|FG003|Overall Study|Lost to Follow-up|8|||
145245303|NCT04315298|523743914|FG004|Overall Study|Lost to Follow-up|12|||
145565853|NCT03161483|524932173|FG001|Treatment Period|Protocol Violation|0|||
145565854|NCT03161483|524932174|FG002|Treatment Period|Protocol Violation|0|||
145565855|NCT03161483|524932175|FG003|Treatment Period|Protocol Violation|1|||
145245304|NCT04315298|523743915|FG005|Overall Study|Lost to Follow-up|13|||
145245305|NCT04315298|523743916|FG006|Overall Study|Lost to Follow-up|9|||
145245306|NCT04315298|523743917|FG007|Overall Study|Lost to Follow-up|16|||
145245307|NCT04315298|523743918|FG008|Overall Study|Lost to Follow-up|14|||
145245308|NCT04315298|523743919|FG009|Overall Study|Lost to Follow-up|0|||
145245309|NCT04315298|523743920|FG010|Overall Study|Lost to Follow-up|2|||
145245310|NCT04315298|523743921|FG011|Overall Study|Lost to Follow-up|1|||
145245311|NCT04315298|523743922|FG012|Overall Study|Lost to Follow-up|0|||
145245312|NCT04315298|523743923|FG013|Overall Study|Lost to Follow-up|0|||
145245313|NCT04315298|523743924|FG014|Overall Study|Lost to Follow-up|0|||
145565856|NCT03161483|524932172|FG000|Treatment Period|Other reasons|1|||
145565857|NCT03161483|524932173|FG001|Treatment Period|Other reasons|1|||
145245314|NCT04315298|523743925|FG015|Overall Study|Lost to Follow-up|2|||
145245315|NCT04315298|523743926|FG016|Overall Study|Lost to Follow-up|0|||
145245316|NCT04315298|523743927|FG017|Overall Study|Lost to Follow-up|0|||
145245317|NCT04315298|523743928|FG018|Overall Study|Lost to Follow-up|0|||
145245318|NCT04315298|523743910|FG000|Overall Study|Death|24|||
145245319|NCT04315298|523743911|FG001|Overall Study|Death|60|||
145245320|NCT04315298|523743912|FG002|Overall Study|Death|49|||
145245321|NCT04315298|523743913|FG003|Overall Study|Death|59|||
145245322|NCT04315298|523743914|FG004|Overall Study|Death|70|||
145245323|NCT04315298|523743915|FG005|Overall Study|Death|114|||
145245324|NCT04315298|523743916|FG006|Overall Study|Death|9|||
145565858|NCT03161483|524932174|FG002|Treatment Period|Other reasons|0|||
145565859|NCT03161483|524932175|FG003|Treatment Period|Other reasons|0|||
145245325|NCT04315298|523743917|FG007|Overall Study|Death|12|||
145565860|NCT00743652|524932179|FG000|Overall Study|Parent/Legal Guardian Request|3|||
145565861|NCT00743652|524932180|FG001|Overall Study|Parent/Legal Guardian Request|2|||
145565862|NCT00743652|524932181|FG002|Overall Study|Parent/Legal Guardian Request|2|||
145565863|NCT00743652|524932182|FG003|Overall Study|Parent/Legal Guardian Request|2|||
145565864|NCT00743652|524932183|FG004|Overall Study|Parent/Legal Guardian Request|0|||
145565865|NCT00743652|524932179|FG000|Overall Study|Adverse Event|3|||
145565866|NCT00743652|524932180|FG001|Overall Study|Adverse Event|0|||
145565867|NCT00743652|524932181|FG002|Overall Study|Adverse Event|0|||
145565868|NCT00743652|524932182|FG003|Overall Study|Adverse Event|0|||
145565869|NCT00743652|524932183|FG004|Overall Study|Adverse Event|0|||
145565870|NCT00743652|524932179|FG000|Overall Study|Death|2|||
145565871|NCT00743652|524932180|FG001|Overall Study|Death|0|||
145245326|NCT04315298|523743918|FG008|Overall Study|Death|21|||
145245327|NCT04315298|523743919|FG009|Overall Study|Death|16|||
145245328|NCT04315298|523743920|FG010|Overall Study|Death|40|||
145245329|NCT04315298|523743921|FG011|Overall Study|Death|40|||
145245330|NCT04315298|523743922|FG012|Overall Study|Death|3|||
145245331|NCT04315298|523743923|FG013|Overall Study|Death|4|||
145245332|NCT04315298|523743924|FG014|Overall Study|Death|6|||
145245333|NCT04315298|523743925|FG015|Overall Study|Death|4|||
145245334|NCT04315298|523743926|FG016|Overall Study|Death|3|||
145245335|NCT04315298|523743927|FG017|Overall Study|Death|1|||
145245336|NCT04315298|523743928|FG018|Overall Study|Death|0|||
145245337|NCT00736385|523743929|FG000|Overall Study|Withdrawal by Subject|2|||
145245338|NCT00736385|523743930|FG001|Overall Study|Withdrawal by Subject|2|||
145245339|NCT00736385|523743929|FG000|Overall Study|Adverse Event|0|||
145245340|NCT00736385|523743930|FG001|Overall Study|Adverse Event|1|||
145245341|NCT01183104|523743931|FG000|Overall Study|Adverse Event|8|||
145245342|NCT01183104|523743932|FG001|Overall Study|Adverse Event|6|||
145245343|NCT01183104|523743931|FG000|Overall Study|Death|0|||
145245344|NCT01183104|523743932|FG001|Overall Study|Death|1|||
145245345|NCT01183104|523743931|FG000|Overall Study|Lost to Follow-up|14|||
145245346|NCT01183104|523743932|FG001|Overall Study|Lost to Follow-up|7|||
145245347|NCT01183104|523743931|FG000|Overall Study|Physician Decision|5|||
145245348|NCT01183104|523743932|FG001|Overall Study|Physician Decision|8|||
145245349|NCT01183104|523743931|FG000|Overall Study|Withdrawal by Subject|6|||
145245350|NCT01183104|523743932|FG001|Overall Study|Withdrawal by Subject|11|||
145245351|NCT01183104|523743931|FG000|Overall Study|Nonparticipation in Extension Study|39|||
145245352|NCT01183104|523743932|FG001|Overall Study|Nonparticipation in Extension Study|50|||
145245353|NCT01183104|523743931|FG000|Overall Study|Did not receive study drug|5|||
145245354|NCT01183104|523743932|FG001|Overall Study|Did not receive study drug|9|||
145565872|NCT00743652|524932181|FG002|Overall Study|Death|0|||
145565873|NCT00743652|524932182|FG003|Overall Study|Death|0|||
145565874|NCT00743652|524932183|FG004|Overall Study|Death|0|||
145565875|NCT00743652|524932179|FG000|Overall Study|Investigator Request|0|||
145565876|NCT00743652|524932180|FG001|Overall Study|Investigator Request|0|||
145565877|NCT00743652|524932181|FG002|Overall Study|Investigator Request|0|||
145565878|NCT00743652|524932182|FG003|Overall Study|Investigator Request|2|||
145565879|NCT00743652|524932183|FG004|Overall Study|Investigator Request|0|||
145565880|NCT00743652|524932179|FG000|Overall Study|Other|1|||
145565881|NCT00743652|524932180|FG001|Overall Study|Other|1|||
145565882|NCT00743652|524932181|FG002|Overall Study|Other|0|||
145245355|NCT03267511|523743933|FG000|Overall Study|Lost to Follow-up|0|||
145245356|NCT03267511|523743934|FG001|Overall Study|Lost to Follow-up|0|||
145245357|NCT03267511|523743935|FG002|Overall Study|Lost to Follow-up|0|||
145245358|NCT03267511|523743936|FG003|Overall Study|Lost to Follow-up|1|||
145245359|NCT01594749|523743937|FG000|Overall Study|Adverse Event|2|||
145245360|NCT01594749|523743938|FG001|Overall Study|Adverse Event|1|||
145245361|NCT01594749|523743937|FG000|Overall Study|Withdrawal by Subject|2|||
145245362|NCT01594749|523743938|FG001|Overall Study|Withdrawal by Subject|2|||
145245363|NCT01594749|523743937|FG000|Overall Study|Protocol Violation|2|||
145245364|NCT01594749|523743938|FG001|Overall Study|Protocol Violation|0|||
145245365|NCT01594749|523743937|FG000|Overall Study|Physician Decision|1|||
145245366|NCT01594749|523743938|FG001|Overall Study|Physician Decision|1|||
145565883|NCT00743652|524932182|FG003|Overall Study|Other|0|||
145245367|NCT01594749|523743937|FG000|Overall Study|Non-compliance with Protocol|0|||
145245368|NCT01594749|523743938|FG001|Overall Study|Non-compliance with Protocol|1|||
145297632|NCT02334722|523940860|FG001|Overall Study|Adverse Event|2|||
145245369|NCT01594749|523743937|FG000|Overall Study|Lost to Follow-up|1|||
145245370|NCT01594749|523743938|FG001|Overall Study|Lost to Follow-up|0|||
145245371|NCT01594749|523743937|FG000|Overall Study|Death|9|||
145245372|NCT01594749|523743938|FG001|Overall Study|Death|3|||
145565884|NCT00743652|524932183|FG004|Overall Study|Other|0|||
145565885|NCT00743652|524932179|FG000|Overall Study|Lost to Follow-up|1|||
145565886|NCT00743652|524932180|FG001|Overall Study|Lost to Follow-up|0|||
145565887|NCT00743652|524932181|FG002|Overall Study|Lost to Follow-up|0|||
145565888|NCT00743652|524932182|FG003|Overall Study|Lost to Follow-up|0|||
145565889|NCT00743652|524932183|FG004|Overall Study|Lost to Follow-up|0|||
145245373|NCT01594749|523743937|FG000|Overall Study|Not Treated|4|||
145565890|NCT02547129|524932184|FG000|Overall Study|Difficulty with ongoing infection|1|||
145245374|NCT01594749|523743938|FG001|Overall Study|Not Treated|10|||
145245375|NCT01594749|523743937|FG000|Overall Study|Lost Source Documentation|1|||
145245376|NCT01594749|523743938|FG001|Overall Study|Lost Source Documentation|0|||
145245377|NCT00364351|523743939|FG000|Overall Study|Adverse Event|90|||
145245378|NCT00364351|523743940|FG001|Overall Study|Adverse Event|44|||
145245379|NCT00364351|523743939|FG000|Overall Study|Condition under investigation worsened|469|||
145245380|NCT00364351|523743940|FG001|Overall Study|Condition under investigation worsened|497|||
145245381|NCT00364351|523743939|FG000|Overall Study|Prohibited concomitant medication|0|||
145245382|NCT00364351|523743940|FG001|Overall Study|Prohibited concomitant medication|2|||
145245383|NCT00364351|523743939|FG000|Overall Study|Lost to Follow-up|1|||
145245384|NCT00364351|523743940|FG001|Overall Study|Lost to Follow-up|1|||
145245385|NCT00364351|523743939|FG000|Overall Study|Withdrawal by Subject|30|||
145245386|NCT00364351|523743940|FG001|Overall Study|Withdrawal by Subject|29|||
145245387|NCT00364351|523743939|FG000|Overall Study|Incorrect enrollment|1|||
145245388|NCT00364351|523743940|FG001|Overall Study|Incorrect enrollment|1|||
145245389|NCT00364351|523743939|FG000|Overall Study|Sponsor decision|1|||
145245390|NCT00364351|523743940|FG001|Overall Study|Sponsor decision|0|||
145245391|NCT00364351|523743939|FG000|Overall Study|Poor treatment compliance|0|||
145245392|NCT00364351|523743940|FG001|Overall Study|Poor treatment compliance|3|||
145245393|NCT00364351|523743939|FG000|Overall Study|Investigator error|0|||
145245394|NCT00364351|523743940|FG001|Overall Study|Investigator error|2|||
145245395|NCT00364351|523743939|FG000|Overall Study|Patient could not travel to site|0|||
145245396|NCT00364351|523743940|FG001|Overall Study|Patient could not travel to site|1|||
145245397|NCT00364351|523743939|FG000|Overall Study|Randomised treatment not started|0|||
145245398|NCT00364351|523743940|FG001|Overall Study|Randomised treatment not started|3|||
145245399|NCT00653068|523743941|FG000|Overall Study|Death|9|||
145245400|NCT00653068|523743941|FG000|Overall Study|Lack of Efficacy|34|||
145245401|NCT00653068|523743941|FG000|Overall Study|Physician Decision|4|||
145245402|NCT00653068|523743941|FG000|Overall Study|Withdrawal by Subject|1|||
145245403|NCT00653068|523743941|FG000|Overall Study|Ineligible|2|||
145245404|NCT02177786|523743942|FG000|Overall Study|Withdrew Consent|2|||
145245405|NCT02177786|523743943|FG001|Overall Study|Withdrew Consent|6|||
145245406|NCT02177786|523743944|FG002|Overall Study|Withdrew Consent|9|||
145245407|NCT02177786|523743945|FG003|Overall Study|Withdrew Consent|5|||
145245408|NCT02177786|523743942|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
145245409|NCT02177786|523743943|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
145245410|NCT02177786|523743944|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
145245411|NCT02177786|523743945|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
145245412|NCT02177786|523743942|FG000|Overall Study|Adverse Event|1|||
145245413|NCT02177786|523743943|FG001|Overall Study|Adverse Event|1|||
145245414|NCT02177786|523743944|FG002|Overall Study|Adverse Event|2|||
145245415|NCT02177786|523743945|FG003|Overall Study|Adverse Event|3|||
145245416|NCT02177786|523743942|FG000|Overall Study|Death|1|||
145245417|NCT02177786|523743943|FG001|Overall Study|Death|1|||
145245418|NCT02177786|523743944|FG002|Overall Study|Death|1|||
145245419|NCT02177786|523743945|FG003|Overall Study|Death|1|||
145245420|NCT02177786|523743942|FG000|Overall Study|Lost to Follow-up|0|||
145245421|NCT02177786|523743943|FG001|Overall Study|Lost to Follow-up|0|||
145245422|NCT02177786|523743944|FG002|Overall Study|Lost to Follow-up|2|||
145245423|NCT02177786|523743945|FG003|Overall Study|Lost to Follow-up|2|||
145245424|NCT02177786|523743942|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145245425|NCT02177786|523743943|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145245426|NCT02177786|523743944|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145245427|NCT02177786|523743945|FG003|Overall Study|Non-Compliance with Study Drug|1|||
145245428|NCT02177786|523743942|FG000|Overall Study|Protocol Violation|0|||
145245429|NCT02177786|523743943|FG001|Overall Study|Protocol Violation|0|||
145245430|NCT02177786|523743944|FG002|Overall Study|Protocol Violation|2|||
145245431|NCT02177786|523743945|FG003|Overall Study|Protocol Violation|0|||
145245432|NCT02177786|523743942|FG000|Overall Study|Progressive Disease|0|||
145245433|NCT02177786|523743943|FG001|Overall Study|Progressive Disease|1|||
145297633|NCT02334722|523940859|FG000|Overall Study|Physician Decision|0|||
145297634|NCT02334722|523940860|FG001|Overall Study|Physician Decision|1|||
145297635|NCT05612724|523940862|FG000|Overall Study|Lost to Follow-up|4|||
145297636|NCT04000815|523940869|FG000|Overall Study|Lost to Follow-up|9|||
145297637|NCT04000815|523940870|FG001|Overall Study|Lost to Follow-up|2|||
145297638|NCT04000815|523940871|FG002|Overall Study|Lost to Follow-up|3|||
145297639|NCT04000815|523940869|FG000|Overall Study|Withdrawal by Subject|4|||
145297640|NCT04000815|523940870|FG001|Overall Study|Withdrawal by Subject|3|||
145297641|NCT04000815|523940871|FG002|Overall Study|Withdrawal by Subject|2|||
145297642|NCT04000815|523940869|FG000|Overall Study|Right ovarian cyst occured|1|||
145409180|NCT03126110|524351996|FG012|Phase 1|Safety follow-up no longer necessary|0|||
145409181|NCT03126110|524351997|FG013|Phase 1|Safety follow-up no longer necessary|0|||
145245434|NCT02177786|523743944|FG002|Overall Study|Progressive Disease|0|||
145245435|NCT02177786|523743945|FG003|Overall Study|Progressive Disease|0|||
145245436|NCT02177786|523743942|FG000|Overall Study|Missing study completion status|0|||
145245437|NCT02177786|523743943|FG001|Overall Study|Missing study completion status|1|||
145245438|NCT02177786|523743944|FG002|Overall Study|Missing study completion status|0|||
145245439|NCT02177786|523743945|FG003|Overall Study|Missing study completion status|0|||
145297643|NCT04000815|523940870|FG001|Overall Study|Right ovarian cyst occured|0|||
145297644|NCT04000815|523940871|FG002|Overall Study|Right ovarian cyst occured|0|||
145297645|NCT04000815|523940869|FG000|Overall Study|Hypertension occured on follow up|0|||
145297646|NCT04000815|523940870|FG001|Overall Study|Hypertension occured on follow up|0|||
145297647|NCT04000815|523940871|FG002|Overall Study|Hypertension occured on follow up|2|||
145297648|NCT00239577|523940872|FG000|Primary Phase|Adverse Event|0|||
145245440|NCT01305941|523743946|FG000|Overall Study|Adverse Event|6|||
145245441|NCT01305941|523743946|FG000|Overall Study|Clinical decline|2|||
145245442|NCT01305941|523743946|FG000|Overall Study|Withdrawal by Subject|1|||
145245443|NCT01305941|523743946|FG000|Overall Study|Death|1|||
145245444|NCT03950440|523743947|FG000|Overall Study|Death|8|||
145245445|NCT03950440|523743948|FG001|Overall Study|Death|2|||
145245446|NCT03950440|523743949|FG002|Overall Study|Death|1|||
145245447|NCT02892734|523743950|FG000|Treatment on Study|Progressive Disease|2|||
145245448|NCT02892734|523743950|FG000|Follow up for 2 Years|Death|2|||
145245449|NCT02892734|523743950|FG000|Follow up for 2 Years|Study closed early|1|||
145245450|NCT02043509|523743951|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
145245451|NCT02043509|523743952|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
145245452|NCT02043509|523743951|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
145245453|NCT02043509|523743952|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
145245454|NCT02043509|523743951|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
145245455|NCT02043509|523743952|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
145245456|NCT02043509|523743951|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
145245457|NCT02043509|523743952|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
145245458|NCT00608244|523743957|FG000|Overall Study|Adverse Event|1|||
145245459|NCT00608244|523743957|FG000|Overall Study|Low trough levels|1|||
145245460|NCT01957215|523743962|FG000|Overall Study|Adverse Event|2|||
145245461|NCT01957215|523743963|FG001|Overall Study|Adverse Event|2|||
145245462|NCT01957215|523743962|FG000|Overall Study|Lost to Follow-up|3|||
145245463|NCT01957215|523743963|FG001|Overall Study|Lost to Follow-up|3|||
145245464|NCT01957215|523743962|FG000|Overall Study|Protocol Violation|1|||
145245465|NCT01957215|523743963|FG001|Overall Study|Protocol Violation|2|||
145245466|NCT01957215|523743962|FG000|Overall Study|Withdrawal by Subject|7|||
145245467|NCT01957215|523743963|FG001|Overall Study|Withdrawal by Subject|5|||
145245468|NCT01977040|523743968|FG000|Overall Study|Vasa previa not confirmed|2|||
145245469|NCT01685060|523743972|FG000|Overall Study|Rollover patients|16|||
145245470|NCT01685060|523743972|FG000|Overall Study|Adverse Event|12|||
145245471|NCT01685060|523743972|FG000|Overall Study|Progressive disease|69|||
145245472|NCT01685060|523743972|FG000|Overall Study|Physician Decision|14|||
145245473|NCT01685060|523743972|FG000|Overall Study|Subject/guardian decision|20|||
145245474|NCT01685060|523743972|FG000|Overall Study|Lost to Follow-up|1|||
145245475|NCT01685060|523743972|FG000|Overall Study|Death|8|||
145245476|NCT03597503|523743973|FG000|Overall Study|Withdrawal by Subject|0|||
145245477|NCT03597503|523743974|FG001|Overall Study|Withdrawal by Subject|2|||
145245478|NCT03597503|523743973|FG000|Overall Study|Lost to Follow-up|1|||
145245479|NCT03597503|523743974|FG001|Overall Study|Lost to Follow-up|2|||
145245480|NCT03597503|523743973|FG000|Overall Study|Protocol Violation|1|||
145245481|NCT03597503|523743974|FG001|Overall Study|Protocol Violation|0|||
145245482|NCT00688623|523743979|FG000|Overall Study|Adverse Event|22|||
145245483|NCT00688623|523743979|FG000|Overall Study|abnormal lab value|1|||
145245484|NCT00688623|523743979|FG000|Overall Study|Withdrawal by Subject|4|||
145245485|NCT00688623|523743979|FG000|Overall Study|Death|3|||
145245486|NCT00688623|523743979|FG000|Overall Study|disease progression|23|||
145245487|NCT00688623|523743979|FG000|Overall Study|Protocol Violation|2|||
145245488|NCT02000219|523743980|FG000|14-Week Study Period|Physician Decision|1|||
145245489|NCT02000219|523743980|FG000|14-Week Study Period|Adverse Event|1|||
145245490|NCT02000219|523743980|FG000|14-Week Study Period|Underwent transplantation|1|||
145245491|NCT02000219|523743980|FG000|Continuation Period|Withdrawal by Subject|1|||
145245492|NCT02000219|523743980|FG000|Continuation Period|Had liver transplant|2|||
145245493|NCT02000219|523743980|FG000|Continuation Period|Non-compliance with study drug|2|||
145297649|NCT00239577|523940873|FG001|Primary Phase|Adverse Event|0|||
145297650|NCT00239577|523940874|FG002|Primary Phase|Adverse Event|1|||
145297651|NCT00239577|523940875|FG003|Primary Phase|Adverse Event|0|||
145297652|NCT00239577|523940872|FG000|Primary Phase|Other|5|||
145297653|NCT00239577|523940873|FG001|Primary Phase|Other|3|||
145297654|NCT00239577|523940874|FG002|Primary Phase|Other|2|||
145245494|NCT02667236|523743982|FG000|Overall Study|Adverse Event|1|||
145245495|NCT02667236|523743983|FG001|Overall Study|Adverse Event|1|||
145245496|NCT02667236|523743982|FG000|Overall Study|Withdrawal by Subject|2|||
145409182|NCT03126110|524351998|FG014|Phase 1|Safety follow-up no longer necessary|0|||
145245497|NCT02667236|523743983|FG001|Overall Study|Withdrawal by Subject|0|||
145245498|NCT00634751|523743987|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
145245499|NCT00634751|523743988|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
145245500|NCT00634751|523743989|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
145245501|NCT00634751|523743990|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
145245502|NCT00634751|523743987|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
145245503|NCT00634751|523743988|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
145297655|NCT00239577|523940875|FG003|Primary Phase|Other|0|||
145245504|NCT00634751|523743989|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
145245505|NCT00634751|523743990|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
145245506|NCT00634751|523743987|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
145245507|NCT00634751|523743988|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
145245508|NCT00634751|523743989|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
145245509|NCT00634751|523743990|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
145245510|NCT04402385|523743991|FG000|Overall Study|Withdrawal by Subject|4|||
145297656|NCT02422264|523940878|FG000|Overall Study|Serious Adverse Event|1|||
145297657|NCT02422264|523940879|FG001|Overall Study|Serious Adverse Event|0|||
145297658|NCT02422264|523940878|FG000|Overall Study|Withdrawal by Subject|1|||
145297659|NCT02422264|523940879|FG001|Overall Study|Withdrawal by Subject|2|||
145297660|NCT02422264|523940878|FG000|Overall Study|Migrated/moved from study area|3|||
145297661|NCT02422264|523940879|FG001|Overall Study|Migrated/moved from study area|1|||
145297662|NCT02422264|523940878|FG000|Overall Study|Subject vaccinated outside of the study|0|||
145297663|NCT02422264|523940879|FG001|Overall Study|Subject vaccinated outside of the study|1|||
145297664|NCT03021018|523940880|FG000|Overall Study|Adverse Event|1|||
145297665|NCT03021018|523940881|FG001|Overall Study|Adverse Event|0|||
145297666|NCT03021018|523940882|FG002|Overall Study|Adverse Event|0|||
145297667|NCT03021018|523940880|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
145297668|NCT03021018|523940881|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
145297669|NCT03021018|523940882|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
145297670|NCT00856388|523940885|FG000|Overall Study|Other|1|||
145297671|NCT01617668|523940887|FG000|Overall Study|Adverse Event|7|||
145297672|NCT01617668|523940888|FG001|Overall Study|Adverse Event|0|||
145297673|NCT01617668|523940889|FG002|Overall Study|Adverse Event|12|||
145297674|NCT01617668|523940890|FG003|Overall Study|Adverse Event|5|||
145297675|NCT01617668|523940887|FG000|Overall Study|Physician Decision|1|||
145297676|NCT01617668|523940888|FG001|Overall Study|Physician Decision|2|||
145297677|NCT01617668|523940889|FG002|Overall Study|Physician Decision|3|||
145297678|NCT01617668|523940890|FG003|Overall Study|Physician Decision|0|||
145297679|NCT01617668|523940887|FG000|Overall Study|Progressive Disease|4|||
145297680|NCT01617668|523940888|FG001|Overall Study|Progressive Disease|4|||
145297681|NCT01617668|523940889|FG002|Overall Study|Progressive Disease|6|||
145297682|NCT01617668|523940890|FG003|Overall Study|Progressive Disease|9|||
145297683|NCT01617668|523940887|FG000|Overall Study|Subject/guardian decision|1|||
145297684|NCT01617668|523940888|FG001|Overall Study|Subject/guardian decision|3|||
145297685|NCT01617668|523940889|FG002|Overall Study|Subject/guardian decision|2|||
145297686|NCT01617668|523940890|FG003|Overall Study|Subject/guardian decision|1|||
145297687|NCT00925769|523940891|FG000|Overall Study|Major toxicity|1|||
145297688|NCT00925769|523940892|FG001|Overall Study|Major toxicity|0|||
145297689|NCT00925769|523940893|FG002|Overall Study|Major toxicity|1|||
145297690|NCT00925769|523940894|FG003|Overall Study|Major toxicity|1|||
145297691|NCT00925769|523940895|FG004|Overall Study|Major toxicity|0|||
145297692|NCT00925769|523940896|FG005|Overall Study|Major toxicity|0|||
145297693|NCT00925769|523940891|FG000|Overall Study|Disease progression|4|||
145297694|NCT00925769|523940892|FG001|Overall Study|Disease progression|5|||
145297695|NCT00925769|523940893|FG002|Overall Study|Disease progression|3|||
145297696|NCT00925769|523940894|FG003|Overall Study|Disease progression|4|||
145245511|NCT04402385|523743992|FG001|Overall Study|Withdrawal by Subject|4|||
145297697|NCT00925769|523940895|FG004|Overall Study|Disease progression|2|||
145297698|NCT00925769|523940896|FG005|Overall Study|Disease progression|3|||
145297699|NCT00925769|523940891|FG000|Overall Study|Death|0|||
145297700|NCT00925769|523940892|FG001|Overall Study|Death|0|||
145297701|NCT00925769|523940893|FG002|Overall Study|Death|1|||
145297702|NCT00925769|523940894|FG003|Overall Study|Death|0|||
145297703|NCT00925769|523940895|FG004|Overall Study|Death|0|||
145297704|NCT00925769|523940896|FG005|Overall Study|Death|0|||
145297705|NCT00925769|523940891|FG000|Overall Study|Physician Decision|1|||
145297706|NCT00925769|523940892|FG001|Overall Study|Physician Decision|0|||
145297707|NCT00925769|523940893|FG002|Overall Study|Physician Decision|0|||
145297708|NCT00925769|523940894|FG003|Overall Study|Physician Decision|0|||
145297709|NCT00925769|523940895|FG004|Overall Study|Physician Decision|0|||
145245512|NCT04402385|523743991|FG000|Overall Study|Lost to Follow-up|1|||
145297710|NCT00925769|523940896|FG005|Overall Study|Physician Decision|0|||
145297711|NCT00925769|523940891|FG000|Overall Study|Missing documentation|0|||
145297712|NCT00925769|523940892|FG001|Overall Study|Missing documentation|1|||
145297713|NCT00925769|523940893|FG002|Overall Study|Missing documentation|0|||
145297714|NCT00925769|523940894|FG003|Overall Study|Missing documentation|0|||
145245513|NCT04402385|523743992|FG001|Overall Study|Lost to Follow-up|1|||
145245514|NCT04402385|523743991|FG000|Overall Study|Physician Decision|0|||
145297715|NCT00925769|523940895|FG004|Overall Study|Missing documentation|0|||
145297716|NCT00925769|523940896|FG005|Overall Study|Missing documentation|0|||
145297717|NCT00925769|523940891|FG000|Overall Study|End of study visit not done|0|||
145297718|NCT00925769|523940892|FG001|Overall Study|End of study visit not done|0|||
145297719|NCT00925769|523940893|FG002|Overall Study|End of study visit not done|1|||
145297720|NCT00925769|523940894|FG003|Overall Study|End of study visit not done|0|||
145620191|NCT01232556|525123700|FG001|Overall Study|Terminated by Sponsor|51|||
145297721|NCT00925769|523940895|FG004|Overall Study|End of study visit not done|0|||
145297722|NCT00925769|523940896|FG005|Overall Study|End of study visit not done|0|||
145297723|NCT00925769|523940891|FG000|Overall Study|Participant is unable to swallow drug|0|||
145297724|NCT00925769|523940892|FG001|Overall Study|Participant is unable to swallow drug|0|||
145297725|NCT00925769|523940893|FG002|Overall Study|Participant is unable to swallow drug|0|||
145297726|NCT00925769|523940894|FG003|Overall Study|Participant is unable to swallow drug|1|||
145297727|NCT00925769|523940895|FG004|Overall Study|Participant is unable to swallow drug|0|||
145297728|NCT00925769|523940896|FG005|Overall Study|Participant is unable to swallow drug|0|||
145297729|NCT00925769|523940891|FG000|Overall Study|Adverse Event|0|||
145297730|NCT00925769|523940892|FG001|Overall Study|Adverse Event|0|||
145297731|NCT00925769|523940893|FG002|Overall Study|Adverse Event|0|||
145409183|NCT03126110|524351999|FG015|Phase 1|Safety follow-up no longer necessary|0|||
145409184|NCT03126110|524352000|FG016|Phase 1|Safety follow-up no longer necessary|0|||
145409185|NCT03126110|524351984|FG000|Phase 1|Survival follow-up no longer necessary|0|||
145409186|NCT03126110|524351985|FG001|Phase 1|Survival follow-up no longer necessary|0|||
145409187|NCT03126110|524351986|FG002|Phase 1|Survival follow-up no longer necessary|1|||
145409188|NCT03126110|524351987|FG003|Phase 1|Survival follow-up no longer necessary|0|||
145409189|NCT03126110|524351988|FG004|Phase 1|Survival follow-up no longer necessary|0|||
145409190|NCT03126110|524351989|FG005|Phase 1|Survival follow-up no longer necessary|0|||
145409191|NCT03126110|524351990|FG006|Phase 1|Survival follow-up no longer necessary|0|||
145409192|NCT03126110|524351991|FG007|Phase 1|Survival follow-up no longer necessary|0|||
145409193|NCT03126110|524351992|FG008|Phase 1|Survival follow-up no longer necessary|0|||
145409194|NCT03126110|524351993|FG009|Phase 1|Survival follow-up no longer necessary|0|||
145409195|NCT03126110|524351994|FG010|Phase 1|Survival follow-up no longer necessary|0|||
145409196|NCT03126110|524351995|FG011|Phase 1|Survival follow-up no longer necessary|0|||
145409197|NCT03126110|524351996|FG012|Phase 1|Survival follow-up no longer necessary|0|||
145245515|NCT04402385|523743992|FG001|Overall Study|Physician Decision|1|||
145297732|NCT00925769|523940894|FG003|Overall Study|Adverse Event|0|||
145297733|NCT00925769|523940895|FG004|Overall Study|Adverse Event|1|||
145297734|NCT00925769|523940896|FG005|Overall Study|Adverse Event|0|||
145297735|NCT01038856|523940899|FG000|Overall Study|Adverse Event|2|||
145297736|NCT02300103|523940900|FG000|Overall Study|Lack of Efficacy|3|||
145297737|NCT02300103|523940900|FG000|Overall Study|Protocol Violation|1|||
145297738|NCT02300103|523940900|FG000|Overall Study|Withdrew Consent|2|||
145297739|NCT04091971|523940901|FG000|Overall Study|Withdrawal by Subject|1|||
145297740|NCT04091971|523940901|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
145297741|NCT04091971|523940901|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
145297742|NCT01666730|523940903|FG000|Overall Study|Adverse Event|16|||
145297743|NCT01666730|523940903|FG000|Overall Study|Death|2|||
145297744|NCT01666730|523940903|FG000|Overall Study|Physician Decision|5|||
145297745|NCT01666730|523940903|FG000|Overall Study|Withdrawal by Subject|9|||
145297746|NCT01666730|523940903|FG000|Overall Study|Disease progression/relapse|18|||
145297747|NCT04466111|523940904|FG000|Prior to Trial Phase|Physician Decision|1|||
145297748|NCT03553823|523940905|FG000|Overall Study|Physician Decision|0|||
145297749|NCT03553823|523940906|FG001|Overall Study|Physician Decision|1|||
145245516|NCT03654560|523743993|FG000|Overall Study|Death|3|||
145245517|NCT03654560|523743994|FG001|Overall Study|Death|1|||
145245518|NCT03654560|523743993|FG000|Overall Study|Lost to Follow-up|1|||
145245519|NCT03654560|523743994|FG001|Overall Study|Lost to Follow-up|0|||
145245520|NCT03745989|523743996|FG000|Overall Study|Death|3|||
145245521|NCT03745989|523743997|FG001|Overall Study|Death|7|||
145245522|NCT03745989|523743998|FG002|Overall Study|Death|4|||
145245523|NCT03745989|523743996|FG000|Overall Study|Lost to Follow-up|0|||
145245524|NCT03745989|523743997|FG001|Overall Study|Lost to Follow-up|2|||
145245525|NCT03745989|523743998|FG002|Overall Study|Lost to Follow-up|0|||
145245526|NCT03745989|523743996|FG000|Overall Study|Sponsor Decision|0|||
145245527|NCT03745989|523743997|FG001|Overall Study|Sponsor Decision|2|||
145245528|NCT03745989|523743998|FG002|Overall Study|Sponsor Decision|8|||
145245529|NCT03745989|523743996|FG000|Overall Study|Withdrawal by Subject|0|||
145245530|NCT03745989|523743997|FG001|Overall Study|Withdrawal by Subject|1|||
145245531|NCT03745989|523743998|FG002|Overall Study|Withdrawal by Subject|3|||
145297750|NCT03603314|523940907|FG000|Overall Study|Lost to Follow-up|0|||
145297751|NCT03603314|523940908|FG001|Overall Study|Lost to Follow-up|3|||
145297752|NCT03603314|523940909|FG002|Overall Study|Lost to Follow-up|0|||
145297753|NCT03603314|523940907|FG000|Overall Study|Protocol Violation|0|||
145297754|NCT03603314|523940908|FG001|Overall Study|Protocol Violation|1|||
145297755|NCT03603314|523940909|FG002|Overall Study|Protocol Violation|0|||
145245532|NCT00481988|523744005|FG000|Overall Study|Withdrawal by Subject|1|||
145297756|NCT03603314|523940907|FG000|Overall Study|Adverse Event|2|||
145297757|NCT03603314|523940908|FG001|Overall Study|Adverse Event|0|||
145297758|NCT03603314|523940909|FG002|Overall Study|Adverse Event|0|||
145245533|NCT00481988|523744006|FG001|Overall Study|Withdrawal by Subject|1|||
145245534|NCT00910728|523744020|FG000|Overall Study|Lack of Efficacy|2|||
145297759|NCT03603314|523940907|FG000|Overall Study|Physician Decision|1|||
145297760|NCT03603314|523940908|FG001|Overall Study|Physician Decision|1|||
145409198|NCT03126110|524351997|FG013|Phase 1|Survival follow-up no longer necessary|0|||
145409199|NCT03126110|524351998|FG014|Phase 1|Survival follow-up no longer necessary|0|||
145565891|NCT02547129|524932185|FG001|Overall Study|Difficulty with ongoing infection|0|||
145565892|NCT03925324|524932186|FG000|Overall Study|Death|1|||
145565893|NCT03925324|524932187|FG001|Overall Study|Death|1|||
145565894|NCT00805766|524932188|FG000|Screening Period|Adverse Event|1|||
145565895|NCT00805766|524932188|FG000|Screening Period|Lack of Efficacy|2|||
145565896|NCT00805766|524932188|FG000|Screening Period|Pregnancy|1|||
145565897|NCT00805766|524932188|FG000|Screening Period|Responder|2|||
145565898|NCT00805766|524932188|FG000|Increased Dose Period|Adverse Event|4|||
145565899|NCT00805766|524932188|FG000|Increased Dose Period|Lack of Efficacy|7|||
145565900|NCT00805766|524932188|FG000|Increased Dose Period|Pregnancy|1|||
145565901|NCT00805766|524932188|FG000|Increased Dose Period|Withdrawal by Subject|1|||
145565902|NCT00794196|524932189|FG000|Overall Study|Lost to Follow-up|5|||
145565903|NCT00794196|524932190|FG001|Overall Study|Lost to Follow-up|23|||
145565904|NCT02129803|524932194|FG000|Overall Study|Protocol Violation|4|||
145565905|NCT02129803|524932195|FG001|Overall Study|Protocol Violation|0|||
145565906|NCT02129803|524932194|FG000|Overall Study|Physician Decision|0|||
145565907|NCT02129803|524932195|FG001|Overall Study|Physician Decision|1|||
145565908|NCT02129803|524932194|FG000|Overall Study|Difficulty sleeping|1|||
145565909|NCT02129803|524932195|FG001|Overall Study|Difficulty sleeping|0|||
145565910|NCT02129803|524932194|FG000|Overall Study|Morning headache|0|||
145565911|NCT02129803|524932195|FG001|Overall Study|Morning headache|1|||
145565912|NCT02129803|524932194|FG000|Overall Study|Withdrawal by Subject|1|||
145565913|NCT02129803|524932195|FG001|Overall Study|Withdrawal by Subject|1|||
145565914|NCT00149747|524932202|FG000|Overall Study|Death|1|||
145565915|NCT00149747|524932203|FG001|Overall Study|Death|0|||
145565916|NCT00149747|524932202|FG000|Overall Study|Withdrawal by Subject|3|||
145565917|NCT00149747|524932203|FG001|Overall Study|Withdrawal by Subject|3|||
145565918|NCT03818516|524932204|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
145565919|NCT03742141|524932209|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
145565920|NCT00850395|524932210|FG000|Overall Study|Death|1|||
145565921|NCT00850395|524932210|FG000|Overall Study|Adverse Event|1|||
145565922|NCT00850395|524932210|FG000|Overall Study|Insufficient clinical response|3|||
145565923|NCT00850395|524932210|FG000|Overall Study|Other|5|||
145565924|NCT04371380|524932211|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
145565925|NCT04371380|524932212|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
145565926|NCT04371380|524932213|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
145565927|NCT02739269|524932214|FG000|Overall Study|Protocol Violation|5|||
145565928|NCT02739269|524932215|FG001|Overall Study|Protocol Violation|0|||
145565929|NCT02739269|524932214|FG000|Overall Study|Cycle cancellation|2|||
145565930|NCT02739269|524932215|FG001|Overall Study|Cycle cancellation|2|||
145565931|NCT02739269|524932214|FG000|Overall Study|Withdrawal by Subject|0|||
145565932|NCT02739269|524932215|FG001|Overall Study|Withdrawal by Subject|2|||
145565933|NCT00405548|524932218|FG000|Overall Study|Cognitive Memory problems on study day|1|||
145565934|NCT00405548|524932219|FG001|Overall Study|Cognitive Memory problems on study day|0|||
145565935|NCT00405548|524932218|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
145565936|NCT00405548|524932219|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
145245535|NCT00910728|523744021|FG001|Overall Study|Lack of Efficacy|3|||
145245536|NCT00910728|523744022|FG002|Overall Study|Lack of Efficacy|1|||
145245537|NCT00910728|523744023|FG003|Overall Study|Lack of Efficacy|2|||
145245538|NCT00910728|523744024|FG004|Overall Study|Lack of Efficacy|1|||
145245539|NCT00910728|523744025|FG005|Overall Study|Lack of Efficacy|0|||
145245540|NCT00910728|523744026|FG006|Overall Study|Lack of Efficacy|2|||
145245541|NCT00910728|523744027|FG007|Overall Study|Lack of Efficacy|2|||
145245542|NCT00910728|523744028|FG008|Overall Study|Lack of Efficacy|2|||
145245543|NCT00910728|523744020|FG000|Overall Study|Withdrawal by Subject|0|||
145245544|NCT00910728|523744021|FG001|Overall Study|Withdrawal by Subject|0|||
145245545|NCT00910728|523744022|FG002|Overall Study|Withdrawal by Subject|0|||
145245546|NCT00910728|523744023|FG003|Overall Study|Withdrawal by Subject|0|||
145245547|NCT00910728|523744024|FG004|Overall Study|Withdrawal by Subject|3|||
145565937|NCT00405548|524932218|FG000|Overall Study|Unable to self-administer shots|1|||
145620192|NCT01232556|525123699|FG000|Overall Study|Other|6|||
145565938|NCT00405548|524932219|FG001|Overall Study|Unable to self-administer shots|0|||
145620193|NCT01232556|525123700|FG001|Overall Study|Other|4|||
145620194|NCT02448719|525123701|FG000|Overall Study|Withdrawal by Subject|0|||
145245548|NCT00910728|523744025|FG005|Overall Study|Withdrawal by Subject|1|||
145245549|NCT00910728|523744026|FG006|Overall Study|Withdrawal by Subject|2|||
145565939|NCT00405548|524932218|FG000|Overall Study|Venous access failed during study day|1|||
145565940|NCT00405548|524932219|FG001|Overall Study|Venous access failed during study day|0|||
145565941|NCT00405548|524932218|FG000|Overall Study|Withdrawal by Subject|1|||
145565942|NCT00405548|524932219|FG001|Overall Study|Withdrawal by Subject|0|||
145565943|NCT01709695|524932220|FG000|Overall Study|Withdrawal by Subject|1|||
145565944|NCT01709695|524932221|FG001|Overall Study|Withdrawal by Subject|1|||
145565945|NCT00680901|524932225|FG000|Overall Study|Ongoing: On Study Treatment|1|||
145565946|NCT00680901|524932226|FG001|Overall Study|Ongoing: On Study Treatment|0|||
145565947|NCT00680901|524932225|FG000|Overall Study|Ongoing: In Follow Up|1|||
145565948|NCT00680901|524932226|FG001|Overall Study|Ongoing: In Follow Up|0|||
145245550|NCT00910728|523744027|FG007|Overall Study|Withdrawal by Subject|0|||
145245551|NCT00910728|523744028|FG008|Overall Study|Withdrawal by Subject|0|||
145245552|NCT00910728|523744020|FG000|Overall Study|(not specified)|2|||
145245553|NCT00910728|523744021|FG001|Overall Study|(not specified)|0|||
145245554|NCT00910728|523744022|FG002|Overall Study|(not specified)|1|||
145245555|NCT00910728|523744023|FG003|Overall Study|(not specified)|0|||
145245556|NCT00910728|523744024|FG004|Overall Study|(not specified)|1|||
145245557|NCT00910728|523744025|FG005|Overall Study|(not specified)|0|||
145245558|NCT00910728|523744026|FG006|Overall Study|(not specified)|0|||
145245559|NCT00910728|523744027|FG007|Overall Study|(not specified)|0|||
145245560|NCT00910728|523744028|FG008|Overall Study|(not specified)|0|||
145245561|NCT00910728|523744020|FG000|Overall Study|Adverse Event|2|||
145245562|NCT00910728|523744021|FG001|Overall Study|Adverse Event|0|||
145245563|NCT00910728|523744022|FG002|Overall Study|Adverse Event|1|||
145245564|NCT00910728|523744023|FG003|Overall Study|Adverse Event|1|||
145245565|NCT00910728|523744024|FG004|Overall Study|Adverse Event|0|||
145245566|NCT00910728|523744025|FG005|Overall Study|Adverse Event|0|||
145245567|NCT00910728|523744026|FG006|Overall Study|Adverse Event|2|||
145245568|NCT00910728|523744027|FG007|Overall Study|Adverse Event|1|||
145245569|NCT00910728|523744028|FG008|Overall Study|Adverse Event|1|||
145245570|NCT03997760|523744029|FG000|Overall Study|Protocol Deviation|0|||
145245571|NCT03997760|523744030|FG001|Overall Study|Protocol Deviation|1|||
145245572|NCT03997760|523744031|FG002|Overall Study|Protocol Deviation|0|||
145245573|NCT03997760|523744032|FG003|Overall Study|Protocol Deviation|0|||
145245574|NCT01915095|523744033|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
145245575|NCT01915095|523744034|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
145245576|NCT01915095|523744035|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
145245577|NCT01915095|523744036|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
145245578|NCT01915095|523744037|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
145245579|NCT00361218|523744038|FG000|Overall Study|Lost to Follow-up|11|||
145245580|NCT00361218|523744038|FG000|Overall Study|Personal Reasons|7|||
145245581|NCT00361218|523744038|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
145245582|NCT04968353|523744041|FG000|Overall Study|Non-compliance|1|||
145245583|NCT04968353|523744042|FG001|Overall Study|Non-compliance|0|||
145245584|NCT04968353|523744043|FG002|Overall Study|Non-compliance|2|||
145565949|NCT00680901|524932225|FG000|Overall Study|Adverse Event|1|||
145565950|NCT00680901|524932226|FG001|Overall Study|Adverse Event|1|||
145565951|NCT00680901|524932225|FG000|Overall Study|Lost to Follow-up|3|||
145565952|NCT00680901|524932226|FG001|Overall Study|Lost to Follow-up|5|||
145565953|NCT00680901|524932225|FG000|Overall Study|Subject decided to withdraw from the study|4|||
145565954|NCT00680901|524932226|FG001|Overall Study|Subject decided to withdraw from the study|15|||
145565955|NCT00680901|524932225|FG000|Overall Study|Sponsor decision|1|||
145565956|NCT00680901|524932226|FG001|Overall Study|Sponsor decision|0|||
145565957|NCT00680901|524932225|FG000|Overall Study|Physician Decision|0|||
145565958|NCT00680901|524932226|FG001|Overall Study|Physician Decision|2|||
145565959|NCT00680901|524932225|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
145565960|NCT00680901|524932226|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
145565961|NCT00680901|524932225|FG000|Overall Study|Other protocol defined stopping criteria|17|||
145565962|NCT00680901|524932226|FG001|Overall Study|Other protocol defined stopping criteria|17|||
145565963|NCT00075582|524932227|FG000|Overall Study|Adverse Event|3|||
145565964|NCT00075582|524932228|FG001|Overall Study|Adverse Event|1|||
145565965|NCT00075582|524932227|FG000|Overall Study|Lack of Efficacy|4|||
145565966|NCT00075582|524932228|FG001|Overall Study|Lack of Efficacy|8|||
145565967|NCT00075582|524932227|FG000|Overall Study|Physician Decision|5|||
145565968|NCT00075582|524932228|FG001|Overall Study|Physician Decision|8|||
145565969|NCT00075582|524932227|FG000|Overall Study|Withdrawal by Subject|2|||
145565970|NCT00075582|524932228|FG001|Overall Study|Withdrawal by Subject|2|||
145565971|NCT00075582|524932227|FG000|Overall Study|Ineligible for study|36|||
145565972|NCT00075582|524932228|FG001|Overall Study|Ineligible for study|16|||
145245585|NCT04968353|523744044|FG003|Overall Study|Non-compliance|0|||
145245586|NCT02896192|523744045|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
145245587|NCT02896192|523744045|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
145245588|NCT02896192|523744045|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
145245589|NCT00368472|523744049|FG000|Overall Study|Adverse Event|22|||
145245590|NCT00368472|523744049|FG000|Overall Study|Medication non-compliance|4|||
145565973|NCT01177540|524932229|FG000|Overall Study|Adverse Event|1|||
145245591|NCT00368472|523744049|FG000|Overall Study|Protocol Violation|2|||
145245592|NCT00368472|523744049|FG000|Overall Study|Request of Investigator or Sponsor|3|||
145245593|NCT00368472|523744049|FG000|Overall Study|Withdrawal by Subject|40|||
145245594|NCT00368472|523744049|FG000|Overall Study|Diary non-compliance|1|||
145245595|NCT00368472|523744049|FG000|Overall Study|Other|32|||
145245596|NCT00368472|523744049|FG000|Overall Study|Missing Final Disposition Date|1|||
145245597|NCT04507360|523745746|FG000|Week 1|Lost to Follow-up|0|||
145245598|NCT04507360|523745747|FG001|Week 1|Lost to Follow-up|0|||
145565974|NCT01177540|524932230|FG001|Overall Study|Adverse Event|0|||
145565975|NCT01418937|524932234|FG000|Overall Study|Lost to Follow-up|5|||
145565976|NCT01418937|524932234|FG000|Overall Study|Protocol Violation|1|||
145565977|NCT01418937|524932234|FG000|Overall Study|Pregnancy|1|||
145565978|NCT01418937|524932234|FG000|Overall Study|Withdrawal by Subject|1|||
145565979|NCT01623596|524932235|FG000|Overall Study|Abnormal laboratory values|2|||
145565980|NCT01623596|524932236|FG001|Overall Study|Abnormal laboratory values|0|||
145565981|NCT01623596|524932235|FG000|Overall Study|Administrative problems|9|||
145565982|NCT01623596|524932236|FG001|Overall Study|Administrative problems|13|||
145565983|NCT01623596|524932235|FG000|Overall Study|Adverse Event|20|||
145565984|NCT01623596|524932236|FG001|Overall Study|Adverse Event|29|||
145565985|NCT01623596|524932235|FG000|Overall Study|Death|0|||
145565986|NCT01623596|524932236|FG001|Overall Study|Death|2|||
145565987|NCT01623596|524932235|FG000|Overall Study|Lost to Follow-up|12|||
145565988|NCT01623596|524932236|FG001|Overall Study|Lost to Follow-up|16|||
145565989|NCT01623596|524932235|FG000|Overall Study|Withdrawal by Subject|13|||
145565990|NCT01623596|524932236|FG001|Overall Study|Withdrawal by Subject|31|||
145565991|NCT01623596|524932235|FG000|Overall Study|Patient no longer requires study drug|1|||
145565992|NCT01623596|524932236|FG001|Overall Study|Patient no longer requires study drug|0|||
145565993|NCT01623596|524932235|FG000|Overall Study|Protocol Violation|0|||
145565994|NCT01623596|524932236|FG001|Overall Study|Protocol Violation|6|||
145565995|NCT01623596|524932235|FG000|Overall Study|Lack of Efficacy|5|||
145565996|NCT01623596|524932236|FG001|Overall Study|Lack of Efficacy|3|||
145565997|NCT01324349|524932237|FG000|Overall Study|Death|1|||
145565998|NCT01324349|524932238|FG001|Overall Study|Death|1|||
145565999|NCT01324349|524932237|FG000|Overall Study|Withdrawal by Subject|0|||
145566000|NCT01324349|524932238|FG001|Overall Study|Withdrawal by Subject|1|||
145566001|NCT01070316|524932239|FG000|Extension Phase|Lack of Efficacy|3|||
145566002|NCT01070316|524932239|FG000|Extension Phase|Withdrawal by Subject|1|||
145566003|NCT01132495|524932242|FG000|Overall Study|Various reasons|40|||
145566004|NCT01132495|524932243|FG001|Overall Study|Various reasons|38|||
145566005|NCT01132495|524932244|FG002|Overall Study|Various reasons|20|||
145245599|NCT04507360|523745748|FG002|Week 1|Lost to Follow-up|0|||
145245600|NCT04507360|523745749|FG003|Week 1|Lost to Follow-up|0|||
145245601|NCT04507360|523745750|FG004|Week 1|Lost to Follow-up|0|||
145245602|NCT04507360|523745751|FG005|Week 1|Lost to Follow-up|0|||
145245603|NCT04507360|523745752|FG006|Week 1|Lost to Follow-up|0|||
145245604|NCT04507360|523745753|FG007|Week 1|Lost to Follow-up|0|||
145245605|NCT04507360|523745754|FG008|Week 1|Lost to Follow-up|72|||
145245606|NCT04507360|523745755|FG009|Week 1|Lost to Follow-up|22|||
145245607|NCT04507360|523745756|FG010|Week 1|Lost to Follow-up|10|||
145245608|NCT04507360|523745746|FG000|Week 2|Lost to Follow-up|0|||
145245609|NCT04507360|523745747|FG001|Week 2|Lost to Follow-up|0|||
145245610|NCT04507360|523745748|FG002|Week 2|Lost to Follow-up|0|||
145245611|NCT04507360|523745749|FG003|Week 2|Lost to Follow-up|0|||
145245612|NCT04507360|523745750|FG004|Week 2|Lost to Follow-up|0|||
145245613|NCT04507360|523745751|FG005|Week 2|Lost to Follow-up|0|||
145245614|NCT04507360|523745752|FG006|Week 2|Lost to Follow-up|0|||
145245615|NCT04507360|523745753|FG007|Week 2|Lost to Follow-up|0|||
145245616|NCT04507360|523745754|FG008|Week 2|Lost to Follow-up|121|||
145245617|NCT04507360|523745755|FG009|Week 2|Lost to Follow-up|85|||
145245618|NCT04507360|523745756|FG010|Week 2|Lost to Follow-up|82|||
145245619|NCT04507360|523745746|FG000|Week 3|Lost to Follow-up|0|||
145566006|NCT01132495|524932245|FG003|Overall Study|Various reasons|12|||
145566007|NCT00082433|524932246|FG000|Overall Study|Adverse Event|12|||
145566008|NCT00082433|524932247|FG001|Overall Study|Adverse Event|17|||
145566009|NCT00082433|524932246|FG000|Overall Study|Death|8|||
145566010|NCT00082433|524932247|FG001|Overall Study|Death|18|||
145566011|NCT00082433|524932246|FG000|Overall Study|Disease Progression/Relapse|270|||
145566012|NCT00082433|524932247|FG001|Overall Study|Disease Progression/Relapse|388|||
145566013|NCT00082433|524932246|FG000|Overall Study|Physician Decision|50|||
145245620|NCT04507360|523745747|FG001|Week 3|Lost to Follow-up|0|||
145245621|NCT04507360|523745748|FG002|Week 3|Lost to Follow-up|0|||
145245622|NCT04507360|523745749|FG003|Week 3|Lost to Follow-up|0|||
145566014|NCT00082433|524932247|FG001|Overall Study|Physician Decision|61|||
145566015|NCT00082433|524932246|FG000|Overall Study|Lost to Follow-up|1|||
145566016|NCT00082433|524932247|FG001|Overall Study|Lost to Follow-up|2|||
145566017|NCT00082433|524932246|FG000|Overall Study|Study Drug Toxicity|179|||
145245623|NCT04507360|523745750|FG004|Week 3|Lost to Follow-up|0|||
145566018|NCT00082433|524932247|FG001|Overall Study|Study Drug Toxicity|66|||
145566019|NCT00082433|524932246|FG000|Overall Study|Withdrawal by Subject|55|||
145620195|NCT02448719|525123702|FG001|Overall Study|Withdrawal by Subject|0|||
145245624|NCT04507360|523745751|FG005|Week 3|Lost to Follow-up|0|||
145245625|NCT04507360|523745752|FG006|Week 3|Lost to Follow-up|0|||
145245626|NCT04507360|523745753|FG007|Week 3|Lost to Follow-up|0|||
145245627|NCT04507360|523745754|FG008|Week 3|Lost to Follow-up|123|||
145245628|NCT04507360|523745755|FG009|Week 3|Lost to Follow-up|92|||
145566020|NCT00082433|524932247|FG001|Overall Study|Withdrawal by Subject|30|||
145566021|NCT00082433|524932246|FG000|Overall Study|Still On Treatment|2|||
145566022|NCT00082433|524932247|FG001|Overall Study|Still On Treatment|1|||
145245629|NCT04507360|523745756|FG010|Week 3|Lost to Follow-up|84|||
145245630|NCT04507360|523745746|FG000|Week 4|Lost to Follow-up|0|||
145566023|NCT00082433|524932246|FG000|Overall Study|Not Treated|12|||
145245631|NCT04507360|523745747|FG001|Week 4|Lost to Follow-up|0|||
145245632|NCT04507360|523745748|FG002|Week 4|Lost to Follow-up|0|||
145245633|NCT04507360|523745749|FG003|Week 4|Lost to Follow-up|0|||
145245634|NCT04507360|523745750|FG004|Week 4|Lost to Follow-up|0|||
145245635|NCT04507360|523745751|FG005|Week 4|Lost to Follow-up|0|||
145245636|NCT04507360|523745752|FG006|Week 4|Lost to Follow-up|0|||
145245637|NCT04507360|523745753|FG007|Week 4|Lost to Follow-up|0|||
145245638|NCT04507360|523745754|FG008|Week 4|Lost to Follow-up|131|||
145245639|NCT04507360|523745755|FG009|Week 4|Lost to Follow-up|115|||
145245640|NCT04507360|523745756|FG010|Week 4|Lost to Follow-up|102|||
145245641|NCT04507360|523745746|FG000|Week 5|Lost to Follow-up|0|||
145245642|NCT04507360|523745747|FG001|Week 5|Lost to Follow-up|0|||
145245643|NCT04507360|523745748|FG002|Week 5|Lost to Follow-up|0|||
145245644|NCT04507360|523745749|FG003|Week 5|Lost to Follow-up|0|||
145245645|NCT04507360|523745750|FG004|Week 5|Lost to Follow-up|0|||
145245646|NCT04507360|523745751|FG005|Week 5|Lost to Follow-up|0|||
145245647|NCT04507360|523745752|FG006|Week 5|Lost to Follow-up|0|||
145245648|NCT04507360|523745753|FG007|Week 5|Lost to Follow-up|0|||
145245649|NCT04507360|523745754|FG008|Week 5|Lost to Follow-up|103|||
145245650|NCT04507360|523745755|FG009|Week 5|Lost to Follow-up|135|||
145245651|NCT04507360|523745756|FG010|Week 5|Lost to Follow-up|143|||
145245652|NCT04507360|523745746|FG000|Week 8|Lost to Follow-up|0|||
145245653|NCT04507360|523745747|FG001|Week 8|Lost to Follow-up|0|||
145245654|NCT04507360|523745748|FG002|Week 8|Lost to Follow-up|0|||
145245655|NCT04507360|523745749|FG003|Week 8|Lost to Follow-up|0|||
145245656|NCT04507360|523745750|FG004|Week 8|Lost to Follow-up|0|||
145245657|NCT04507360|523745751|FG005|Week 8|Lost to Follow-up|0|||
145245658|NCT04507360|523745752|FG006|Week 8|Lost to Follow-up|0|||
145245659|NCT04507360|523745753|FG007|Week 8|Lost to Follow-up|0|||
145245660|NCT04507360|523745754|FG008|Week 8|Lost to Follow-up|139|||
145245661|NCT04507360|523745755|FG009|Week 8|Lost to Follow-up|145|||
145245662|NCT04507360|523745756|FG010|Week 8|Lost to Follow-up|152|||
145245663|NCT01004159|523745757|FG000|Overall Study|Adverse Event|2|||
145245664|NCT01004159|523745757|FG000|Overall Study|Disease Progression|18|||
145245665|NCT04483544|523745759|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
145245666|NCT04483544|523745759|FG000|Post-Treatment|Admitted to hospice|2|||
145245667|NCT04483544|523745759|FG000|Post-Treatment|Study terminated|3|||
145245668|NCT01119963|523745764|FG000|Overall Study|Lost to Follow-up|1|||
145245669|NCT01119963|523745765|FG001|Overall Study|Lost to Follow-up|1|||
145245670|NCT04072575|523745777|FG000|Overall Study|Physician Decision|1|||
145245671|NCT04072575|523745777|FG000|Overall Study|Adverse Event|7|||
145245672|NCT04072575|523745777|FG000|Overall Study|Withdrawal by Subject|14|||
145245673|NCT04072575|523745777|FG000|Overall Study|Other|2|||
145245674|NCT02498392|523745778|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
145245675|NCT02498392|523745779|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
145245676|NCT02498392|523745778|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
145245677|NCT02498392|523745779|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
145245678|NCT02498392|523745778|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
145245679|NCT02498392|523745779|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
145245680|NCT02498392|523745778|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
145245681|NCT02498392|523745779|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
145245682|NCT02498392|523745778|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
145245683|NCT02498392|523745779|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
145566024|NCT00082433|524932247|FG001|Overall Study|Not Treated|11|||
145566025|NCT00082433|524932246|FG000|Overall Study|Ineligible|2|||
145566026|NCT00082433|524932247|FG001|Overall Study|Ineligible|1|||
145566027|NCT00082433|524932246|FG000|Overall Study|Noncompliance|2|||
145245684|NCT02498392|523745778|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
145245685|NCT02498392|523745779|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
145245686|NCT02244619|523745780|FG000|Overall Study|Did not receive study intervention|8|||
145245687|NCT02244619|523745781|FG001|Overall Study|Did not receive study intervention|21|||
145566028|NCT00082433|524932247|FG001|Overall Study|Noncompliance|1|||
145566029|NCT00082433|524932246|FG000|Overall Study|New primary cancer|1|||
145566030|NCT00082433|524932247|FG001|Overall Study|New primary cancer|0|||
145245688|NCT01156363|523745782|FG000|Overall Study|Adverse Event|6|||
145245689|NCT01156363|523745782|FG000|Overall Study|Insufficient Therapeutic Response|5|||
145245690|NCT01156363|523745782|FG000|Overall Study|Failure to Return|1|||
145245691|NCT01156363|523745782|FG000|Overall Study|Refused Treatment|4|||
145245692|NCT01156363|523745782|FG000|Overall Study|Other|6|||
145245693|NCT03135262|523745783|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
145245694|NCT03135262|523745784|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
145245695|NCT03135262|523745785|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
145245696|NCT03135262|523745786|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
145245697|NCT03135262|523745787|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
145245698|NCT03135262|523745783|FG000|Overall Study|Progression of disease|0|||
145245699|NCT03135262|523745784|FG001|Overall Study|Progression of disease|0|||
145245700|NCT03135262|523745785|FG002|Overall Study|Progression of disease|0|||
145245701|NCT03135262|523745786|FG003|Overall Study|Progression of disease|1|||
145566031|NCT00082433|524932246|FG000|Overall Study|Impending surgery|0|||
145245702|NCT03135262|523745787|FG004|Overall Study|Progression of disease|0|||
145245703|NCT03135262|523745783|FG000|Overall Study|Death|6|||
145245704|NCT03135262|523745784|FG001|Overall Study|Death|2|||
145245705|NCT03135262|523745785|FG002|Overall Study|Death|2|||
145245706|NCT03135262|523745786|FG003|Overall Study|Death|2|||
145245707|NCT03135262|523745787|FG004|Overall Study|Death|0|||
145245708|NCT03135262|523745783|FG000|Overall Study|Withdrawal by Subject|0|||
145245709|NCT03135262|523745784|FG001|Overall Study|Withdrawal by Subject|0|||
145245710|NCT03135262|523745785|FG002|Overall Study|Withdrawal by Subject|1|||
145245711|NCT03135262|523745786|FG003|Overall Study|Withdrawal by Subject|0|||
145245712|NCT03135262|523745787|FG004|Overall Study|Withdrawal by Subject|1|||
145245713|NCT03135262|523745783|FG000|Overall Study|Study terminated by sponsor|2|||
145245714|NCT03135262|523745784|FG001|Overall Study|Study terminated by sponsor|4|||
145245715|NCT03135262|523745785|FG002|Overall Study|Study terminated by sponsor|4|||
145245716|NCT03135262|523745786|FG003|Overall Study|Study terminated by sponsor|3|||
145245717|NCT03135262|523745787|FG004|Overall Study|Study terminated by sponsor|0|||
145245718|NCT03285490|523745788|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
145245719|NCT03285490|523745789|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
145245720|NCT03285490|523745788|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
145245721|NCT03285490|523745789|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
145245722|NCT02728206|523745790|FG000|Overall Study|Death|1|||
145245723|NCT04159701|523745796|FG000|Period 1: Treatment Period|Pregnancy|1|||
145245724|NCT04159701|523745797|FG001|Period 1: Treatment Period|Pregnancy|0|||
145245725|NCT04159701|523745796|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
145245726|NCT04159701|523745797|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
145245727|NCT04159701|523745796|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
145245728|NCT04159701|523745797|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
145245729|NCT04159701|523745796|FG000|Washout Period|site terminated by sponsor|0|||
145245730|NCT04159701|523745797|FG001|Washout Period|site terminated by sponsor|1|||
145245731|NCT04159701|523745796|FG000|Washout Period|study terminated by sponsor|10|||
145245732|NCT04159701|523745797|FG001|Washout Period|study terminated by sponsor|3|||
145245733|NCT04159701|523745796|FG000|Washout Period|Withdrawal by Subject|1|||
145245734|NCT04159701|523745797|FG001|Washout Period|Withdrawal by Subject|0|||
145245735|NCT04159701|523745796|FG000|Washout Period|Inadvertent Enrollment|1|||
145245736|NCT04159701|523745797|FG001|Washout Period|Inadvertent Enrollment|0|||
145245737|NCT04159701|523745796|FG000|Washout Period|Miscellaneous|1|||
145245738|NCT04159701|523745797|FG001|Washout Period|Miscellaneous|0|||
145245739|NCT04159701|523745796|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
145245740|NCT04159701|523745797|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
145245741|NCT04159701|523745796|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
145245742|NCT04159701|523745797|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
145245743|NCT04159701|523745796|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
145245744|NCT04159701|523745797|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
145245745|NCT04159701|523745796|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
145245746|NCT04159701|523745797|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
145245747|NCT04159701|523745796|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
145245748|NCT04159701|523745797|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
145245749|NCT01782885|523745803|FG000|Overall Study|Lost to Follow-up|4|||
145245750|NCT01782885|523745804|FG001|Overall Study|Lost to Follow-up|6|||
145245751|NCT01849562|523745805|FG000|Overall Study|Lost to Follow-up|1|||
145245752|NCT01849562|523745806|FG001|Overall Study|Lost to Follow-up|0|||
145245753|NCT01849562|523745807|FG002|Overall Study|Lost to Follow-up|0|||
145245754|NCT01849562|523745805|FG000|Overall Study|Non-compliance with Study Drug|1|||
145245755|NCT01849562|523745806|FG001|Overall Study|Non-compliance with Study Drug|0|||
145245756|NCT01849562|523745807|FG002|Overall Study|Non-compliance with Study Drug|0|||
145245757|NCT01024920|523745810|FG000|Overall Study|Progressive disease|47|||
145245758|NCT01024920|523745811|FG001|Overall Study|Progressive disease|25|||
145409200|NCT03126110|524351999|FG015|Phase 1|Survival follow-up no longer necessary|0|||
145409201|NCT03126110|524352000|FG016|Phase 1|Survival follow-up no longer necessary|0|||
145245759|NCT01024920|523745810|FG000|Overall Study|Adverse Event|8|||
145409202|NCT03126110|524351984|FG000|Phase 2|Study terminated by the sponsor|0|||
145409203|NCT03126110|524351985|FG001|Phase 2|Study terminated by the sponsor|0|||
145245760|NCT01024920|523745811|FG001|Overall Study|Adverse Event|4|||
145245761|NCT01024920|523745810|FG000|Overall Study|Lost to Follow-up|0|||
145245762|NCT01024920|523745811|FG001|Overall Study|Lost to Follow-up|1|||
145245763|NCT01024920|523745810|FG000|Overall Study|Patient refusal to continue|4|||
145245764|NCT01024920|523745811|FG001|Overall Study|Patient refusal to continue|0|||
145245765|NCT01024920|523745810|FG000|Overall Study|Other than listed|5|||
145245766|NCT01024920|523745811|FG001|Overall Study|Other than listed|1|||
145245767|NCT01024920|523745810|FG000|Overall Study|Not treated|3|||
145245768|NCT01024920|523745811|FG001|Overall Study|Not treated|0|||
145245769|NCT01024920|523745810|FG000|Overall Study|Protocol Violation|0|||
145245770|NCT01024920|523745811|FG001|Overall Study|Protocol Violation|1|||
145409204|NCT03126110|524351986|FG002|Phase 2|Study terminated by the sponsor|0|||
145245771|NCT00633360|523745812|FG000|Overall Study|Lost to Follow-up|1|||
145245772|NCT00633360|523745813|FG001|Overall Study|Lost to Follow-up|1|||
145245773|NCT00633360|523745812|FG000|Overall Study|Adverse Event|3|||
145245774|NCT00633360|523745813|FG001|Overall Study|Adverse Event|1|||
145245775|NCT00633360|523745812|FG000|Overall Study|Protocol Violation|0|||
145245776|NCT00633360|523745813|FG001|Overall Study|Protocol Violation|1|||
145245777|NCT00610207|523745814|FG000|Overall Study|Lost to Follow-up|3|||
145245778|NCT03236506|523745823|FG000|Overall Study|Death|1|||
145245779|NCT03236506|523745824|FG001|Overall Study|Death|1|||
145245780|NCT03236506|523745825|FG002|Overall Study|Death|1|||
145245781|NCT03236506|523745823|FG000|Overall Study|Withdrawal by Subject|3|||
145245782|NCT03236506|523745824|FG001|Overall Study|Withdrawal by Subject|3|||
145245783|NCT03236506|523745825|FG002|Overall Study|Withdrawal by Subject|4|||
145245784|NCT03236506|523745823|FG000|Overall Study|Did not initiate treatment|2|||
145245785|NCT03236506|523745824|FG001|Overall Study|Did not initiate treatment|1|||
145245786|NCT03236506|523745825|FG002|Overall Study|Did not initiate treatment|2|||
145245787|NCT01594411|523745834|FG000|Overall Study|Lost to Follow-up|2|||
145245788|NCT01929707|523745838|FG000|Intervention Period 1|Lost to Follow-up|0|||
145245789|NCT01929707|523745839|FG001|Intervention Period 1|Lost to Follow-up|0|||
145245790|NCT01929707|523745840|FG002|Intervention Period 1|Lost to Follow-up|0|||
145245791|NCT01929707|523745841|FG003|Intervention Period 1|Lost to Follow-up|1|||
145245792|NCT01929707|523745842|FG004|Intervention Period 1|Lost to Follow-up|0|||
145245793|NCT01929707|523745843|FG005|Intervention Period 1|Lost to Follow-up|0|||
145245794|NCT01929707|523745844|FG006|Intervention Period 1|Lost to Follow-up|0|||
145245795|NCT01929707|523745845|FG007|Intervention Period 1|Lost to Follow-up|0|||
145245796|NCT01929707|523745838|FG000|Intervention Period 1|Withdrawal by Subject|0|||
145245797|NCT01929707|523745839|FG001|Intervention Period 1|Withdrawal by Subject|0|||
145245798|NCT01929707|523745840|FG002|Intervention Period 1|Withdrawal by Subject|0|||
145245799|NCT01929707|523745841|FG003|Intervention Period 1|Withdrawal by Subject|2|||
145245800|NCT01929707|523745842|FG004|Intervention Period 1|Withdrawal by Subject|0|||
145245801|NCT01929707|523745843|FG005|Intervention Period 1|Withdrawal by Subject|0|||
145245802|NCT01929707|523745844|FG006|Intervention Period 1|Withdrawal by Subject|0|||
145245803|NCT01929707|523745845|FG007|Intervention Period 1|Withdrawal by Subject|0|||
145245804|NCT01929707|523745838|FG000|Intervention Period 2|Withdrawal by Subject|0|||
145245805|NCT01929707|523745839|FG001|Intervention Period 2|Withdrawal by Subject|0|||
145245806|NCT01929707|523745840|FG002|Intervention Period 2|Withdrawal by Subject|0|||
145245807|NCT01929707|523745841|FG003|Intervention Period 2|Withdrawal by Subject|0|||
145245808|NCT01929707|523745842|FG004|Intervention Period 2|Withdrawal by Subject|0|||
145245809|NCT01929707|523745843|FG005|Intervention Period 2|Withdrawal by Subject|2|||
145245810|NCT01929707|523745844|FG006|Intervention Period 2|Withdrawal by Subject|0|||
145245811|NCT01929707|523745845|FG007|Intervention Period 2|Withdrawal by Subject|0|||
145245812|NCT00437203|523745846|FG000|Overall Study|Death|0|||
145245813|NCT00437203|523745847|FG001|Overall Study|Death|0|||
145245814|NCT00437203|523745848|FG002|Overall Study|Death|1|||
145245815|NCT00437203|523745849|FG003|Overall Study|Death|0|||
145245816|NCT00437203|523745850|FG004|Overall Study|Death|0|||
145245817|NCT00437203|523745851|FG005|Overall Study|Death|0|||
145245818|NCT00437203|523745852|FG006|Overall Study|Death|0|||
145245819|NCT00437203|523745853|FG007|Overall Study|Death|1|||
145245820|NCT00437203|523745854|FG008|Overall Study|Death|0|||
145245821|NCT00437203|523745855|FG009|Overall Study|Death|1|||
145245822|NCT00437203|523745846|FG000|Overall Study|Adverse Event|1|||
145245823|NCT00437203|523745847|FG001|Overall Study|Adverse Event|1|||
145245824|NCT00437203|523745848|FG002|Overall Study|Adverse Event|0|||
145245825|NCT00437203|523745849|FG003|Overall Study|Adverse Event|0|||
145245826|NCT00437203|523745850|FG004|Overall Study|Adverse Event|0|||
145566032|NCT00082433|524932247|FG001|Overall Study|Impending surgery|1|||
145566033|NCT01796197|524932250|FG000|Overall Study|Lost to Follow-up|1|||
145566034|NCT01796197|524932250|FG000|Overall Study|Lack of Efficacy|1|||
145566035|NCT00574405|524934086|FG000|Overall Study|Withdrawal by Subject|3|||
145245827|NCT00437203|523745851|FG005|Overall Study|Adverse Event|0|||
145245828|NCT00437203|523745852|FG006|Overall Study|Adverse Event|0|||
145297761|NCT03603314|523940909|FG002|Overall Study|Physician Decision|0|||
145245829|NCT00437203|523745853|FG007|Overall Study|Adverse Event|1|||
145297762|NCT03603314|523940907|FG000|Overall Study|Withdrawal by Subject|4|||
145245830|NCT00437203|523745854|FG008|Overall Study|Adverse Event|0|||
145245831|NCT00437203|523745855|FG009|Overall Study|Adverse Event|1|||
145245832|NCT00437203|523745846|FG000|Overall Study|Study terminated by sponsor|0|||
145245833|NCT00437203|523745847|FG001|Overall Study|Study terminated by sponsor|0|||
145245834|NCT00437203|523745848|FG002|Overall Study|Study terminated by sponsor|0|||
145245835|NCT00437203|523745849|FG003|Overall Study|Study terminated by sponsor|0|||
145245836|NCT00437203|523745850|FG004|Overall Study|Study terminated by sponsor|0|||
145245837|NCT00437203|523745851|FG005|Overall Study|Study terminated by sponsor|0|||
145245838|NCT00437203|523745852|FG006|Overall Study|Study terminated by sponsor|0|||
145245839|NCT00437203|523745853|FG007|Overall Study|Study terminated by sponsor|0|||
145245840|NCT00437203|523745854|FG008|Overall Study|Study terminated by sponsor|1|||
145245841|NCT00437203|523745855|FG009|Overall Study|Study terminated by sponsor|0|||
145566036|NCT00574405|524934087|FG001|Overall Study|Withdrawal by Subject|2|||
145245842|NCT00437203|523745846|FG000|Overall Study|Objective progression or relapse|5|||
145245843|NCT00437203|523745847|FG001|Overall Study|Objective progression or relapse|6|||
145245844|NCT00437203|523745848|FG002|Overall Study|Objective progression or relapse|2|||
145245845|NCT00437203|523745849|FG003|Overall Study|Objective progression or relapse|3|||
145245846|NCT00437203|523745850|FG004|Overall Study|Objective progression or relapse|3|||
145245847|NCT00437203|523745851|FG005|Overall Study|Objective progression or relapse|3|||
145245848|NCT00437203|523745852|FG006|Overall Study|Objective progression or relapse|6|||
145245849|NCT00437203|523745853|FG007|Overall Study|Objective progression or relapse|1|||
145245850|NCT00437203|523745854|FG008|Overall Study|Objective progression or relapse|2|||
145245851|NCT00437203|523745855|FG009|Overall Study|Objective progression or relapse|2|||
145245852|NCT00437203|523745846|FG000|Overall Study|Other|0|||
145245853|NCT00437203|523745847|FG001|Overall Study|Other|1|||
145245854|NCT00437203|523745848|FG002|Overall Study|Other|0|||
145245855|NCT00437203|523745849|FG003|Overall Study|Other|0|||
145245856|NCT00437203|523745850|FG004|Overall Study|Other|0|||
145245857|NCT00437203|523745851|FG005|Overall Study|Other|0|||
145245858|NCT00437203|523745852|FG006|Overall Study|Other|1|||
145245859|NCT00437203|523745853|FG007|Overall Study|Other|0|||
145245860|NCT00437203|523745854|FG008|Overall Study|Other|0|||
145245861|NCT00437203|523745855|FG009|Overall Study|Other|0|||
145245862|NCT00431496|523745862|FG000|Overall Study|Adverse Event|3|||
145245863|NCT00431496|523745862|FG000|Overall Study|Lost to Follow-up|1|||
145245864|NCT00431496|523745862|FG000|Overall Study|Withdrawal by Subject|2|||
145245865|NCT00431496|523745862|FG000|Overall Study|Protocol-specified criteria|5|||
145245866|NCT02343952|523745863|FG000|Study Treatment|Disease Progression|23|||
145245867|NCT02343952|523745863|FG000|Study Treatment|Death|3|||
145245868|NCT02343952|523745863|FG000|Study Treatment|Adverse Event|19|||
145245869|NCT02343952|523745863|FG000|Study Treatment|Withdrawal by Subject|7|||
145245870|NCT02343952|523745863|FG000|Study Treatment|other complicating Diseases|1|||
145245871|NCT02343952|523745863|FG000|Follow up|Withdrawal by Subject|3|||
145245872|NCT02343952|523745863|FG000|Follow up|Death|33|||
145245873|NCT02343952|523745863|FG000|Follow up|Patient does not meet eligibility for study.|1|||
145245874|NCT02343952|523745863|FG000|Follow up|Research department closed by the practice.|5|||
145245875|NCT02343952|523745863|FG000|Follow up|Patient went home to Russia|1|||
145245876|NCT02343952|523745863|FG000|Follow up|Disease Progression|1|||
145245877|NCT02343952|523745863|FG000|Follow up|study terminated|1|||
145245878|NCT02067533|523745864|FG000|Overall Study|Lost to Follow-up|4|||
145245879|NCT02067533|523745865|FG001|Overall Study|Lost to Follow-up|2|||
145245880|NCT00565812|523745866|FG000|Overall Study|Death|2|||
145245881|NCT00565812|523745867|FG001|Overall Study|Death|1|||
145245882|NCT00565812|523745868|FG002|Overall Study|Death|3|||
145245883|NCT00565812|523745866|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
145245884|NCT00565812|523745867|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
145245885|NCT00565812|523745868|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
145245886|NCT00565812|523745866|FG000|Overall Study|Lost to Follow-up|10|||
145245887|NCT00565812|523745867|FG001|Overall Study|Lost to Follow-up|8|||
145566037|NCT04380857|524934089|FG000|Overall Study|Lost to Follow-up|3|||
145245888|NCT00565812|523745868|FG002|Overall Study|Lost to Follow-up|8|||
145245889|NCT00565812|523745866|FG000|Overall Study|Withdrawal by Subject|58|||
145245890|NCT00565812|523745867|FG001|Overall Study|Withdrawal by Subject|47|||
145245891|NCT00565812|523745868|FG002|Overall Study|Withdrawal by Subject|48|||
145245892|NCT00565812|523745866|FG000|Overall Study|Work Schedule|5|||
145245893|NCT00565812|523745867|FG001|Overall Study|Work Schedule|3|||
145245894|NCT00565812|523745868|FG002|Overall Study|Work Schedule|1|||
145245895|NCT00565812|523745866|FG000|Overall Study|Protocol Violation|2|||
145245896|NCT00565812|523745867|FG001|Overall Study|Protocol Violation|6|||
145245897|NCT00565812|523745868|FG002|Overall Study|Protocol Violation|4|||
145245898|NCT00565812|523745866|FG000|Overall Study|Adverse Event|41|||
145245899|NCT00565812|523745867|FG001|Overall Study|Adverse Event|54|||
145245900|NCT00565812|523745868|FG002|Overall Study|Adverse Event|40|||
145245901|NCT00565812|523745866|FG000|Overall Study|Jury Duty|1|||
145566038|NCT04380857|524934090|FG001|Overall Study|Lost to Follow-up|3|||
145566039|NCT02558790|524934091|FG000|Overall Study|Lost to Follow-up|2|||
145566040|NCT02558790|524934091|FG000|Overall Study|Physician Decision|1|||
145245902|NCT00565812|523745867|FG001|Overall Study|Jury Duty|0|||
145245903|NCT00565812|523745868|FG002|Overall Study|Jury Duty|0|||
145245904|NCT00565812|523745866|FG000|Overall Study|Relocated Out of Area|5|||
145245905|NCT00565812|523745867|FG001|Overall Study|Relocated Out of Area|8|||
145245906|NCT00565812|523745868|FG002|Overall Study|Relocated Out of Area|9|||
145245907|NCT00565812|523745866|FG000|Overall Study|Sponsor Decision|1|||
145245908|NCT00565812|523745867|FG001|Overall Study|Sponsor Decision|5|||
145245909|NCT00565812|523745868|FG002|Overall Study|Sponsor Decision|1|||
145245910|NCT00565812|523745866|FG000|Overall Study|Domestic Reasons|7|||
145245911|NCT00565812|523745867|FG001|Overall Study|Domestic Reasons|1|||
145245912|NCT00565812|523745868|FG002|Overall Study|Domestic Reasons|3|||
145245913|NCT00565812|523745866|FG000|Overall Study|Research Site Closure|6|||
145245914|NCT00565812|523745867|FG001|Overall Study|Research Site Closure|1|||
145245915|NCT00565812|523745868|FG002|Overall Study|Research Site Closure|8|||
145566041|NCT02558790|524934091|FG000|Overall Study|Withdrawal by Subject|1|||
145245916|NCT00565812|523745866|FG000|Overall Study|Surgical Intervention|0|||
145245917|NCT00565812|523745867|FG001|Overall Study|Surgical Intervention|1|||
145245918|NCT00565812|523745868|FG002|Overall Study|Surgical Intervention|2|||
145245919|NCT00565812|523745866|FG000|Overall Study|Low Compliance|1|||
145245920|NCT00565812|523745867|FG001|Overall Study|Low Compliance|0|||
145245921|NCT00565812|523745868|FG002|Overall Study|Low Compliance|1|||
145245922|NCT00565812|523745866|FG000|Overall Study|Follow-up Visit Not Completed|2|||
145245923|NCT00565812|523745867|FG001|Overall Study|Follow-up Visit Not Completed|0|||
145245924|NCT00565812|523745868|FG002|Overall Study|Follow-up Visit Not Completed|1|||
145245925|NCT00565812|523745866|FG000|Overall Study|Physician Decision|2|||
145245926|NCT00565812|523745867|FG001|Overall Study|Physician Decision|0|||
145245927|NCT00565812|523745868|FG002|Overall Study|Physician Decision|0|||
145245928|NCT00845845|523745869|FG000|Overall Study|Lost to Follow-up|0|||
145245929|NCT00845845|523745870|FG001|Overall Study|Lost to Follow-up|4|||
145245930|NCT00479167|523745871|FG000|Overall Study|Withdrawal by Subject|1|||
145245931|NCT01570309|523745874|FG000|Overall Study|Withdrawal by Subject|3|||
145245932|NCT01570309|523745875|FG001|Overall Study|Withdrawal by Subject|3|||
145245933|NCT00560794|523745876|FG000|Overall Study|Adverse Event|2|||
145245934|NCT00560794|523745876|FG000|Overall Study|Patient was not Compliant|1|||
145245935|NCT00560794|523745876|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
145245936|NCT00560794|523745876|FG000|Overall Study|Hematological Relapse|1|||
145245937|NCT00560794|523745876|FG000|Overall Study|Received Bone Marrow Transplant|6|||
145245938|NCT04857892|523745877|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
145245939|NCT04857892|523745878|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
145245940|NCT04857892|523745879|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
145245941|NCT04857892|523745880|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
145245942|NCT04857892|523745881|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
145245943|NCT04857892|523745877|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
145245944|NCT04857892|523745878|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
145245945|NCT04857892|523745879|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
145245946|NCT04857892|523745880|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
145245947|NCT04857892|523745881|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
145245948|NCT04857892|523745877|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
145245949|NCT04857892|523745878|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
145245950|NCT04857892|523745879|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
145245951|NCT04857892|523745880|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
145245952|NCT04857892|523745881|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
145245953|NCT02384993|523745886|FG000|Overall Study|Adverse Event|0|||
145245954|NCT02384993|523745887|FG001|Overall Study|Adverse Event|1|||
145245955|NCT04095793|523745888|FG000|Overall Study|Adverse Event|3|||
145245956|NCT04095793|523745888|FG000|Overall Study|Study Terminated by Sponsor|103|||
145245957|NCT04095793|523745888|FG000|Overall Study|Withdrawal by Subject|4|||
145245958|NCT00209092|523748019|FG000|Overall Study|Progression of disease|7|||
145245959|NCT00209092|523748020|FG001|Overall Study|Progression of disease|1|||
145245960|NCT00209092|523748019|FG000|Overall Study|Adverse Event|0|||
145245961|NCT00209092|523748020|FG001|Overall Study|Adverse Event|1|||
145245962|NCT00209092|523748019|FG000|Overall Study|Withdrawal by Subject|1|||
145245963|NCT00209092|523748020|FG001|Overall Study|Withdrawal by Subject|0|||
145245964|NCT02828644|523748021|FG000|Overall Study|Lost to Follow-up|23|||
145245965|NCT02828644|523748022|FG001|Overall Study|Lost to Follow-up|22|||
145245966|NCT02996110|523748023|FG000|Pre-Treatment|Other Reasons|0|||
145245967|NCT02996110|523748024|FG001|Pre-Treatment|Other Reasons|1|||
145245968|NCT02996110|523748025|FG002|Pre-Treatment|Other Reasons|0|||
145245969|NCT02996110|523748026|FG003|Pre-Treatment|Other Reasons|0|||
145245970|NCT02996110|523748027|FG004|Pre-Treatment|Other Reasons|1|||
145245971|NCT02996110|523748023|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
145245972|NCT02996110|523748024|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
145245973|NCT02996110|523748025|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
145245974|NCT02996110|523748026|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
145245975|NCT02996110|523748027|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
145245976|NCT02996110|523748023|FG000|Track 1|Disease Progression|15|||
145245977|NCT02996110|523748024|FG001|Track 1|Disease Progression|17|||
145245978|NCT02996110|523748025|FG002|Track 1|Disease Progression|0|||
145245979|NCT02996110|523748026|FG003|Track 1|Disease Progression|0|||
145566042|NCT02558790|524934091|FG000|Overall Study|Screen Fail|3|||
145245980|NCT02996110|523748027|FG004|Track 1|Disease Progression|0|||
145245981|NCT02996110|523748023|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
145245982|NCT02996110|523748024|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
145245983|NCT02996110|523748025|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
145245984|NCT02996110|523748026|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
145245985|NCT02996110|523748027|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
145566043|NCT01572038|524934093|FG000|Overall Study|Death|648|||
145566044|NCT01572038|524934093|FG000|Overall Study|Withdrawal by Subject|204|||
145566045|NCT01572038|524934093|FG000|Overall Study|Lost to Follow-up|81|||
145409205|NCT03126110|524351987|FG003|Phase 2|Study terminated by the sponsor|0|||
145409206|NCT03126110|524351988|FG004|Phase 2|Study terminated by the sponsor|0|||
145566046|NCT01572038|524934093|FG000|Overall Study|Physician Decision|20|||
145245986|NCT02996110|523748023|FG000|Track 1|Study Drug Toxicity|5|||
145245987|NCT02996110|523748024|FG001|Track 1|Study Drug Toxicity|3|||
145245988|NCT02996110|523748025|FG002|Track 1|Study Drug Toxicity|0|||
145245989|NCT02996110|523748026|FG003|Track 1|Study Drug Toxicity|0|||
145245990|NCT02996110|523748027|FG004|Track 1|Study Drug Toxicity|0|||
145245991|NCT02996110|523748023|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
145245992|NCT02996110|523748024|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
145245993|NCT02996110|523748025|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
145245994|NCT02996110|523748026|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
145245995|NCT02996110|523748027|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
145245996|NCT02996110|523748023|FG000|Track 1|Administrative Reason by Sponsor|0|||
145245997|NCT02996110|523748024|FG001|Track 1|Administrative Reason by Sponsor|1|||
145245998|NCT02996110|523748025|FG002|Track 1|Administrative Reason by Sponsor|0|||
145245999|NCT02996110|523748026|FG003|Track 1|Administrative Reason by Sponsor|0|||
145246000|NCT02996110|523748027|FG004|Track 1|Administrative Reason by Sponsor|0|||
145246001|NCT02996110|523748023|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
145246002|NCT02996110|523748024|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
145246003|NCT02996110|523748025|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
145246004|NCT02996110|523748026|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
145246005|NCT02996110|523748027|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
145246006|NCT02996110|523748023|FG000|Track 2|Disease Progression|33|||
145246007|NCT02996110|523748024|FG001|Track 2|Disease Progression|26|||
145246008|NCT02996110|523748025|FG002|Track 2|Disease Progression|19|||
145246009|NCT02996110|523748026|FG003|Track 2|Disease Progression|16|||
145246010|NCT02996110|523748027|FG004|Track 2|Disease Progression|15|||
145246011|NCT02996110|523748023|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
145246012|NCT02996110|523748024|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
145246013|NCT02996110|523748025|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
145246014|NCT02996110|523748026|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
145246015|NCT02996110|523748027|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
145246016|NCT02996110|523748023|FG000|Track 2|Death|0|||
145246017|NCT02996110|523748024|FG001|Track 2|Death|0|||
145246018|NCT02996110|523748025|FG002|Track 2|Death|1|||
145246019|NCT02996110|523748026|FG003|Track 2|Death|0|||
145246020|NCT02996110|523748027|FG004|Track 2|Death|1|||
145246021|NCT02996110|523748023|FG000|Track 2|Study Drug Toxicity|4|||
145246022|NCT02996110|523748024|FG001|Track 2|Study Drug Toxicity|1|||
145246023|NCT02996110|523748025|FG002|Track 2|Study Drug Toxicity|4|||
145246024|NCT02996110|523748026|FG003|Track 2|Study Drug Toxicity|1|||
145246025|NCT02996110|523748027|FG004|Track 2|Study Drug Toxicity|0|||
145246026|NCT02996110|523748023|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
145246027|NCT02996110|523748024|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
145246028|NCT02996110|523748025|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
145246029|NCT02996110|523748026|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
145246030|NCT02996110|523748027|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
145246031|NCT02996110|523748023|FG000|Track 2|Participant Withdrew Consent|1|||
145246032|NCT02996110|523748024|FG001|Track 2|Participant Withdrew Consent|2|||
145246033|NCT02996110|523748025|FG002|Track 2|Participant Withdrew Consent|3|||
145246034|NCT02996110|523748026|FG003|Track 2|Participant Withdrew Consent|1|||
145246035|NCT02996110|523748027|FG004|Track 2|Participant Withdrew Consent|1|||
145246036|NCT02996110|523748023|FG000|Track 2|Other Reasons|0|||
145246037|NCT02996110|523748024|FG001|Track 2|Other Reasons|0|||
145246038|NCT02996110|523748025|FG002|Track 2|Other Reasons|1|||
145246039|NCT02996110|523748026|FG003|Track 2|Other Reasons|0|||
145246040|NCT02996110|523748027|FG004|Track 2|Other Reasons|1|||
145246041|NCT00524043|523748028|FG000|Overall Study|Lack of Efficacy|15|||
145246042|NCT00524043|523748029|FG001|Overall Study|Lack of Efficacy|13|||
145246043|NCT00524043|523748030|FG002|Overall Study|Lack of Efficacy|14|||
145246044|NCT00524043|523748028|FG000|Overall Study|Withdrawal by Subject|5|||
145246045|NCT00524043|523748029|FG001|Overall Study|Withdrawal by Subject|7|||
145246046|NCT00524043|523748030|FG002|Overall Study|Withdrawal by Subject|7|||
145246047|NCT00524043|523748028|FG000|Overall Study|Adverse Event|5|||
145246048|NCT00524043|523748029|FG001|Overall Study|Adverse Event|2|||
145246049|NCT00524043|523748030|FG002|Overall Study|Adverse Event|7|||
145246050|NCT00524043|523748028|FG000|Overall Study|Lost to Follow-up|3|||
145409207|NCT03126110|524351989|FG005|Phase 2|Study terminated by the sponsor|0|||
145246051|NCT00524043|523748029|FG001|Overall Study|Lost to Follow-up|5|||
145246052|NCT00524043|523748030|FG002|Overall Study|Lost to Follow-up|3|||
145246053|NCT00524043|523748028|FG000|Overall Study|Various (eg, incarceration)|2|||
145246054|NCT00524043|523748029|FG001|Overall Study|Various (eg, incarceration)|1|||
145246055|NCT00524043|523748030|FG002|Overall Study|Various (eg, incarceration)|0|||
145246056|NCT01536418|523748037|FG000|Overall Study|Protocol Violation|2|||
145409208|NCT03126110|524351990|FG006|Phase 2|Study terminated by the sponsor|0|||
145246057|NCT01536418|523748038|FG001|Overall Study|Protocol Violation|3|||
145246058|NCT01536418|523748037|FG000|Overall Study|Physician Decision|1|||
145246059|NCT01536418|523748038|FG001|Overall Study|Physician Decision|3|||
145246060|NCT01536418|523748037|FG000|Overall Study|Study closed/terminated|41|||
145246061|NCT01536418|523748038|FG001|Overall Study|Study closed/terminated|37|||
145246062|NCT01536418|523748037|FG000|Overall Study|Lack of Efficacy|10|||
145246063|NCT01536418|523748038|FG001|Overall Study|Lack of Efficacy|16|||
145246064|NCT01536418|523748037|FG000|Overall Study|Adverse Event|9|||
145246065|NCT01536418|523748038|FG001|Overall Study|Adverse Event|4|||
145246066|NCT01536418|523748037|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
145246067|NCT01536418|523748038|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
145246068|NCT01536418|523748037|FG000|Overall Study|Withdrawal by Subject|5|||
145246069|NCT01536418|523748038|FG001|Overall Study|Withdrawal by Subject|3|||
145246070|NCT02658149|523748043|FG000|Overall Study|Physician Decision|1|||
145246071|NCT02658149|523748044|FG001|Overall Study|Physician Decision|0|||
145246072|NCT00711412|523748045|FG000|Induction Treatment|Death|2|||
145246073|NCT00711412|523748045|FG000|Induction Treatment|Adverse Event|1|||
145246074|NCT00711412|523748045|FG000|Induction Treatment|Other|1|||
145246075|NCT00711412|523748045|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
145246076|NCT00711412|523748045|FG000|Evaluated for Combination Treatment|Death|1|||
145246077|NCT00711412|523748045|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
145246078|NCT00711412|523748045|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
145246079|NCT00711412|523748045|FG000|Combination Treatment|Progressive Disease|1|||
145246080|NCT00711412|523748045|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
145246081|NCT00711412|523748045|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
145246082|NCT00711412|523748045|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
145246083|NCT00711412|523748045|FG000|Evaluation for Response and Surgery|Death|1|||
145246084|NCT00711412|523748045|FG000|Survival Follow up Until Death|Other|12|||
145246085|NCT04097028|523748052|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
145246086|NCT04097028|523748052|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
145246087|NCT04097028|523748052|FG000|Overall Study|Disease Progression prior to Surgery|2|||
145297763|NCT03603314|523940908|FG001|Overall Study|Withdrawal by Subject|5|||
145297764|NCT03603314|523940909|FG002|Overall Study|Withdrawal by Subject|3|||
145297765|NCT03603314|523940907|FG000|Overall Study|Other|0|||
145297766|NCT03603314|523940908|FG001|Overall Study|Other|1|||
145297767|NCT03603314|523940909|FG002|Overall Study|Other|0|||
145297768|NCT01389102|523940910|FG000|Overall Study|Adverse Event|1|||
145297769|NCT01389102|523940911|FG001|Overall Study|Adverse Event|3|||
145297770|NCT01389102|523940912|FG002|Overall Study|Adverse Event|2|||
145297771|NCT01389102|523940913|FG003|Overall Study|Adverse Event|2|||
145297772|NCT01389102|523940914|FG004|Overall Study|Adverse Event|2|||
145297773|NCT01389102|523940915|FG005|Overall Study|Adverse Event|2|||
145297774|NCT01389102|523940910|FG000|Overall Study|Hurricane Katrina|4|||
145297775|NCT01389102|523940911|FG001|Overall Study|Hurricane Katrina|2|||
145297776|NCT01389102|523940912|FG002|Overall Study|Hurricane Katrina|3|||
145297777|NCT01389102|523940913|FG003|Overall Study|Hurricane Katrina|0|||
145297778|NCT01389102|523940914|FG004|Overall Study|Hurricane Katrina|3|||
145297779|NCT01389102|523940915|FG005|Overall Study|Hurricane Katrina|1|||
145297780|NCT01389102|523940910|FG000|Overall Study|Lost to Follow-up|4|||
145297781|NCT01389102|523940911|FG001|Overall Study|Lost to Follow-up|1|||
145297782|NCT01389102|523940912|FG002|Overall Study|Lost to Follow-up|1|||
145297783|NCT01389102|523940913|FG003|Overall Study|Lost to Follow-up|2|||
145297784|NCT01389102|523940914|FG004|Overall Study|Lost to Follow-up|4|||
145297785|NCT01389102|523940915|FG005|Overall Study|Lost to Follow-up|1|||
145297786|NCT01389102|523940910|FG000|Overall Study|Protocol Violation|0|||
145297787|NCT01389102|523940911|FG001|Overall Study|Protocol Violation|0|||
145297788|NCT01389102|523940912|FG002|Overall Study|Protocol Violation|3|||
145297789|NCT01389102|523940913|FG003|Overall Study|Protocol Violation|0|||
145297790|NCT01389102|523940914|FG004|Overall Study|Protocol Violation|1|||
145297791|NCT01389102|523940915|FG005|Overall Study|Protocol Violation|1|||
145297792|NCT01389102|523940910|FG000|Overall Study|Withdrawal by Subject|7|||
145297793|NCT01389102|523940911|FG001|Overall Study|Withdrawal by Subject|4|||
145246088|NCT04097028|523748052|FG000|Overall Study|Adverse Event prior to Surgery|1|||
145246089|NCT03687827|523748053|FG000|Treatment Period 1|Death|0|||
145297794|NCT01389102|523940912|FG002|Overall Study|Withdrawal by Subject|9|||
145297795|NCT01389102|523940913|FG003|Overall Study|Withdrawal by Subject|2|||
145297796|NCT01389102|523940914|FG004|Overall Study|Withdrawal by Subject|3|||
145566047|NCT01572038|524934093|FG000|Overall Study|Patient Decision|14|||
145297797|NCT01389102|523940915|FG005|Overall Study|Withdrawal by Subject|3|||
145297798|NCT01389102|523940910|FG000|Overall Study|Subject Traveling Out of Country|0|||
145297799|NCT01389102|523940911|FG001|Overall Study|Subject Traveling Out of Country|0|||
145297800|NCT01389102|523940912|FG002|Overall Study|Subject Traveling Out of Country|0|||
145297801|NCT01389102|523940913|FG003|Overall Study|Subject Traveling Out of Country|1|||
145297802|NCT01389102|523940914|FG004|Overall Study|Subject Traveling Out of Country|0|||
145297803|NCT01389102|523940915|FG005|Overall Study|Subject Traveling Out of Country|0|||
145297804|NCT01389102|523940910|FG000|Overall Study|Subject Moved|2|||
145297805|NCT01389102|523940911|FG001|Overall Study|Subject Moved|0|||
145297806|NCT01389102|523940912|FG002|Overall Study|Subject Moved|1|||
145297807|NCT01389102|523940913|FG003|Overall Study|Subject Moved|0|||
145297808|NCT01389102|523940914|FG004|Overall Study|Subject Moved|0|||
145297809|NCT01389102|523940915|FG005|Overall Study|Subject Moved|0|||
145297810|NCT01389102|523940910|FG000|Overall Study|Unavailable due to husband's illness|0|||
145297811|NCT01389102|523940911|FG001|Overall Study|Unavailable due to husband's illness|1|||
145297812|NCT01389102|523940912|FG002|Overall Study|Unavailable due to husband's illness|0|||
145297813|NCT01389102|523940913|FG003|Overall Study|Unavailable due to husband's illness|0|||
145297814|NCT01389102|523940914|FG004|Overall Study|Unavailable due to husband's illness|0|||
145297815|NCT01389102|523940915|FG005|Overall Study|Unavailable due to husband's illness|0|||
145297816|NCT01389102|523940910|FG000|Overall Study|Investigator Judgement|0|||
145297817|NCT01389102|523940911|FG001|Overall Study|Investigator Judgement|1|||
145297818|NCT01389102|523940912|FG002|Overall Study|Investigator Judgement|0|||
145297819|NCT01389102|523940913|FG003|Overall Study|Investigator Judgement|0|||
145297820|NCT01389102|523940914|FG004|Overall Study|Investigator Judgement|0|||
145297821|NCT01389102|523940915|FG005|Overall Study|Investigator Judgement|0|||
145297822|NCT03450070|523940916|FG000|Overall Study|Withdrawal by Subject|8|||
145297823|NCT00050778|523940917|FG000|Overall Study|Adverse Event|13|||
145297824|NCT00050778|523940918|FG001|Overall Study|Adverse Event|3|||
145297825|NCT00050778|523940919|FG002|Overall Study|Adverse Event|2|||
145297826|NCT00050778|523940917|FG000|Overall Study|Death|0|||
145297827|NCT00050778|523940918|FG001|Overall Study|Death|1|||
145297828|NCT00050778|523940919|FG002|Overall Study|Death|1|||
145297829|NCT00050778|523940917|FG000|Overall Study|Lack of Efficacy|16|||
145297830|NCT00050778|523940918|FG001|Overall Study|Lack of Efficacy|2|||
145297831|NCT00050778|523940919|FG002|Overall Study|Lack of Efficacy|2|||
145297832|NCT00050778|523940917|FG000|Overall Study|Lost to Follow-up|0|||
145297833|NCT00050778|523940918|FG001|Overall Study|Lost to Follow-up|2|||
145297834|NCT00050778|523940919|FG002|Overall Study|Lost to Follow-up|4|||
145297835|NCT00050778|523940917|FG000|Overall Study|Physician Decision|3|||
145297836|NCT00050778|523940918|FG001|Overall Study|Physician Decision|0|||
145297837|NCT00050778|523940919|FG002|Overall Study|Physician Decision|2|||
145297838|NCT00050778|523940917|FG000|Overall Study|Protocol Violation|2|||
145297839|NCT00050778|523940918|FG001|Overall Study|Protocol Violation|0|||
145297840|NCT00050778|523940919|FG002|Overall Study|Protocol Violation|1|||
145297841|NCT00050778|523940917|FG000|Overall Study|Withdrawal by Subject|6|||
145297842|NCT00050778|523940918|FG001|Overall Study|Withdrawal by Subject|8|||
145297843|NCT00050778|523940919|FG002|Overall Study|Withdrawal by Subject|4|||
145297844|NCT00050778|523940917|FG000|Overall Study|Randomized but not treated|4|||
145297845|NCT00050778|523940918|FG001|Overall Study|Randomized but not treated|5|||
145297846|NCT00050778|523940919|FG002|Overall Study|Randomized but not treated|2|||
145297847|NCT00050778|523940917|FG000|Overall Study|Familial and personal reasons|1|||
145297848|NCT00050778|523940918|FG001|Overall Study|Familial and personal reasons|0|||
145297849|NCT00050778|523940919|FG002|Overall Study|Familial and personal reasons|0|||
145297850|NCT02910037|523940922|FG000|Overall Study|Withdrawal by Subject|4|||
145297851|NCT02910037|523940922|FG000|Overall Study|Lost to Follow-up|6|||
145297852|NCT00436553|523940923|FG000|Overall Study|Adverse Event|4|||
145297853|NCT00436553|523940924|FG001|Overall Study|Adverse Event|3|||
145297854|NCT00436553|523940925|FG002|Overall Study|Adverse Event|4|||
145297855|NCT00436553|523940923|FG000|Overall Study|Death|3|||
145297856|NCT00436553|523940924|FG001|Overall Study|Death|1|||
145297857|NCT00436553|523940925|FG002|Overall Study|Death|3|||
145297858|NCT00436553|523940923|FG000|Overall Study|Lost to Follow-up|0|||
145297859|NCT00436553|523940924|FG001|Overall Study|Lost to Follow-up|2|||
145297860|NCT00436553|523940925|FG002|Overall Study|Lost to Follow-up|0|||
145297861|NCT00436553|523940923|FG000|Overall Study|Protocol Violation|1|||
145297862|NCT00436553|523940924|FG001|Overall Study|Protocol Violation|0|||
145297863|NCT00436553|523940925|FG002|Overall Study|Protocol Violation|0|||
145297864|NCT00436553|523940923|FG000|Overall Study|Withdrawal by Subject|5|||
145566048|NCT01572038|524934093|FG000|Overall Study|Progressive Disease|8|||
145566049|NCT01572038|524934093|FG000|Overall Study|Site Closed Before Completing Form|6|||
145297865|NCT00436553|523940924|FG001|Overall Study|Withdrawal by Subject|6|||
145297866|NCT00436553|523940925|FG002|Overall Study|Withdrawal by Subject|3|||
145297867|NCT01035060|523940926|FG000|Overall Study|Lost to Follow-up|0|||
145297868|NCT01035060|523940927|FG001|Overall Study|Lost to Follow-up|7|||
145297869|NCT01035060|523940926|FG000|Overall Study|Did not quality after 2nd screening|14|||
145297870|NCT01035060|523940927|FG001|Overall Study|Did not quality after 2nd screening|1|||
145297871|NCT01035060|523940926|FG000|Overall Study|Withdrawal by Subject|8|||
145297872|NCT01035060|523940927|FG001|Overall Study|Withdrawal by Subject|6|||
145297873|NCT01035060|523940926|FG000|Overall Study|Physician Decision|2|||
145297874|NCT01035060|523940927|FG001|Overall Study|Physician Decision|0|||
145297875|NCT00064753|523940931|FG000|Overall Study|Death|251|||
145297876|NCT00064753|523940932|FG001|Overall Study|Death|242|||
145566050|NCT01572038|524934093|FG000|Overall Study|Enrolled into Another Trial|3|||
145297877|NCT00064753|523940931|FG000|Overall Study|Withdrawal by Subject|198|||
145297878|NCT00064753|523940932|FG001|Overall Study|Withdrawal by Subject|171|||
145297879|NCT00064753|523940931|FG000|Overall Study|Lost to Follow-up|225|||
145246090|NCT03687827|523748054|FG001|Treatment Period 1|Death|1|||
145246091|NCT03687827|523748053|FG000|Treatment Period 1|Lost to Follow-up|2|||
145246092|NCT03687827|523748054|FG001|Treatment Period 1|Lost to Follow-up|2|||
145246093|NCT03687827|523748053|FG000|Treatment Period 1|Physician Decision|5|||
145246094|NCT03687827|523748054|FG001|Treatment Period 1|Physician Decision|2|||
145246095|NCT03687827|523748053|FG000|Treatment Period 1|Withdrawal by Subject|7|||
145246096|NCT03687827|523748054|FG001|Treatment Period 1|Withdrawal by Subject|3|||
145246097|NCT03687827|523748053|FG000|Treatment Period 2|Physician Decision|4|||
145246098|NCT03687827|523748054|FG001|Treatment Period 2|Physician Decision|1|||
145246099|NCT03687827|523748053|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145246100|NCT03687827|523748054|FG001|Treatment Period 2|Withdrawal by Subject|2|||
145246101|NCT00735072|523748057|FG000|Overall Study|interrupted study med during ARV change|1|||
145246102|NCT00735072|523748058|FG001|Overall Study|interrupted study med during ARV change|0|||
145246103|NCT00735072|523748057|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
145246104|NCT00735072|523748058|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
145246105|NCT00911144|523748059|FG000|Overall Study|Withdrawal by Subject|16|||
145566051|NCT01572038|524934093|FG000|Overall Study|Participated in Another Trial|3|||
145566052|NCT01572038|524934093|FG000|Overall Study|Termination by Sponsor|2|||
145566053|NCT01572038|524934093|FG000|Overall Study|Patient Deterioration|1|||
145566054|NCT01572038|524934093|FG000|Overall Study|Sponsor Decision|1|||
145246106|NCT00911144|523748060|FG001|Overall Study|Withdrawal by Subject|5|||
145246107|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
145246108|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
145246109|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
145566055|NCT01888497|524934094|FG000|Washout Period 1|Withdrawal by Subject|0|||
145566056|NCT01888497|524934095|FG001|Washout Period 1|Withdrawal by Subject|0|||
145566057|NCT01888497|524934096|FG002|Washout Period 1|Withdrawal by Subject|1|||
145566058|NCT01888497|524934097|FG003|Washout Period 1|Withdrawal by Subject|1|||
145566059|NCT01888497|524934094|FG000|Washout Period 2|Adverse Event|0|||
145566060|NCT01888497|524934095|FG001|Washout Period 2|Adverse Event|0|||
145566061|NCT01888497|524934096|FG002|Washout Period 2|Adverse Event|0|||
145566062|NCT01888497|524934097|FG003|Washout Period 2|Adverse Event|1|||
145566063|NCT01888497|524934094|FG000|Washout Period 2|Withdrawal by Subject|0|||
145620196|NCT02448719|525123703|FG002|Overall Study|Withdrawal by Subject|0|||
145620197|NCT02448719|525123704|FG003|Overall Study|Withdrawal by Subject|0|||
145246110|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
145246111|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
145246112|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
145246113|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
145246114|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
145246115|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
145246116|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
145246117|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
145246118|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
145246119|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
145246120|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
145246121|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
145246122|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
145246123|NCT01291511|523748061|FG000|Cross-Titration and Stabilization Phase|Death|1|||
145246124|NCT01291511|523748062|FG001|Cross-Titration and Stabilization Phase|Death|0|||
145246125|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
145246126|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
145246127|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
145246128|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
145246129|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
145246130|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
145246131|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
145246132|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
145246133|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
145246134|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
145246135|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
145246136|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
145566064|NCT01888497|524934095|FG001|Washout Period 2|Withdrawal by Subject|0|||
145620198|NCT02448719|525123705|FG004|Overall Study|Withdrawal by Subject|1|||
145246137|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
145246138|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
145246139|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
145246140|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
145297880|NCT00064753|523940932|FG001|Overall Study|Lost to Follow-up|235|||
145409209|NCT03126110|524351991|FG007|Phase 2|Study terminated by the sponsor|0|||
145409210|NCT03126110|524351992|FG008|Phase 2|Study terminated by the sponsor|0|||
145409211|NCT03126110|524351993|FG009|Phase 2|Study terminated by the sponsor|0|||
145409212|NCT03126110|524351994|FG010|Phase 2|Study terminated by the sponsor|0|||
145409213|NCT03126110|524351995|FG011|Phase 2|Study terminated by the sponsor|0|||
145409214|NCT03126110|524351996|FG012|Phase 2|Study terminated by the sponsor|0|||
145409215|NCT03126110|524351997|FG013|Phase 2|Study terminated by the sponsor|4|||
145409216|NCT03126110|524351998|FG014|Phase 2|Study terminated by the sponsor|0|||
145409217|NCT03126110|524351999|FG015|Phase 2|Study terminated by the sponsor|0|||
145409218|NCT03126110|524352000|FG016|Phase 2|Study terminated by the sponsor|0|||
145409219|NCT03126110|524351984|FG000|Phase 2|Withdrawal by Subject|0|||
145409220|NCT03126110|524351985|FG001|Phase 2|Withdrawal by Subject|0|||
145409221|NCT03126110|524351986|FG002|Phase 2|Withdrawal by Subject|0|||
145409222|NCT03126110|524351987|FG003|Phase 2|Withdrawal by Subject|0|||
145409223|NCT03126110|524351988|FG004|Phase 2|Withdrawal by Subject|0|||
145409224|NCT03126110|524351989|FG005|Phase 2|Withdrawal by Subject|0|||
145409225|NCT03126110|524351990|FG006|Phase 2|Withdrawal by Subject|0|||
145409226|NCT03126110|524351991|FG007|Phase 2|Withdrawal by Subject|0|||
145409227|NCT03126110|524351992|FG008|Phase 2|Withdrawal by Subject|0|||
145409228|NCT03126110|524351993|FG009|Phase 2|Withdrawal by Subject|0|||
145409229|NCT03126110|524351994|FG010|Phase 2|Withdrawal by Subject|0|||
145409230|NCT03126110|524351995|FG011|Phase 2|Withdrawal by Subject|1|||
145409231|NCT03126110|524351996|FG012|Phase 2|Withdrawal by Subject|3|||
145409232|NCT03126110|524351997|FG013|Phase 2|Withdrawal by Subject|3|||
145409233|NCT03126110|524351998|FG014|Phase 2|Withdrawal by Subject|2|||
145409234|NCT03126110|524351999|FG015|Phase 2|Withdrawal by Subject|1|||
145409235|NCT03126110|524352000|FG016|Phase 2|Withdrawal by Subject|0|||
145297881|NCT02193880|523940933|FG000|Overall Study|patients did not collect enough HPC|3|||
145297882|NCT03522675|523940934|FG000|Overall Study|Screen fail|1|||
145297883|NCT03522675|523940934|FG000|Overall Study|Non-reactive to histamine|1|||
145297884|NCT00707161|523940935|FG000|Overall Study|Physician Decision|6|||
145297885|NCT02674477|523940936|FG000|Overall Study|Protocol Violation|8|||
145297886|NCT02674477|523940937|FG001|Overall Study|Protocol Violation|2|||
145297887|NCT00296647|523940938|FG000|Overall Study|Death|4|||
145297888|NCT00296647|523940939|FG001|Overall Study|Death|1|||
145297889|NCT00296647|523940940|FG002|Overall Study|Death|2|||
145297890|NCT00296647|523940941|FG003|Overall Study|Death|1|||
145297891|NCT00296647|523940942|FG004|Overall Study|Death|1|||
145297892|NCT00296647|523940938|FG000|Overall Study|Withdrawal by Subject|28|||
145297893|NCT00296647|523940939|FG001|Overall Study|Withdrawal by Subject|27|||
145297894|NCT00296647|523940940|FG002|Overall Study|Withdrawal by Subject|32|||
145297895|NCT00296647|523940941|FG003|Overall Study|Withdrawal by Subject|16|||
145297896|NCT00296647|523940942|FG004|Overall Study|Withdrawal by Subject|19|||
145409236|NCT03126110|524351984|FG000|Phase 2|Lost to Follow-up|0|||
145409237|NCT03126110|524351985|FG001|Phase 2|Lost to Follow-up|0|||
145409238|NCT03126110|524351986|FG002|Phase 2|Lost to Follow-up|0|||
145409239|NCT03126110|524351987|FG003|Phase 2|Lost to Follow-up|0|||
145409240|NCT03126110|524351988|FG004|Phase 2|Lost to Follow-up|0|||
145409241|NCT03126110|524351989|FG005|Phase 2|Lost to Follow-up|0|||
145409242|NCT03126110|524351990|FG006|Phase 2|Lost to Follow-up|0|||
145409243|NCT03126110|524351991|FG007|Phase 2|Lost to Follow-up|0|||
145409244|NCT03126110|524351992|FG008|Phase 2|Lost to Follow-up|0|||
145409245|NCT03126110|524351993|FG009|Phase 2|Lost to Follow-up|0|||
145409246|NCT03126110|524351994|FG010|Phase 2|Lost to Follow-up|0|||
145409247|NCT03126110|524351995|FG011|Phase 2|Lost to Follow-up|1|||
145409248|NCT03126110|524351996|FG012|Phase 2|Lost to Follow-up|1|||
145409249|NCT03126110|524351997|FG013|Phase 2|Lost to Follow-up|1|||
145409250|NCT03126110|524351998|FG014|Phase 2|Lost to Follow-up|2|||
145409251|NCT03126110|524351999|FG015|Phase 2|Lost to Follow-up|0|||
145297897|NCT00565448|523940943|FG000|Overall Study|Adverse Event|1|||
145409252|NCT03126110|524352000|FG016|Phase 2|Lost to Follow-up|0|||
145409253|NCT03126110|524351984|FG000|Phase 2|Death|0|||
145409254|NCT03126110|524351985|FG001|Phase 2|Death|0|||
145409255|NCT03126110|524351986|FG002|Phase 2|Death|0|||
145409256|NCT03126110|524351987|FG003|Phase 2|Death|0|||
145409257|NCT03126110|524351988|FG004|Phase 2|Death|0|||
145409258|NCT03126110|524351989|FG005|Phase 2|Death|0|||
145409259|NCT03126110|524351990|FG006|Phase 2|Death|0|||
145409260|NCT03126110|524351991|FG007|Phase 2|Death|0|||
145409261|NCT03126110|524351992|FG008|Phase 2|Death|0|||
145409262|NCT03126110|524351993|FG009|Phase 2|Death|0|||
145566065|NCT01888497|524934096|FG002|Washout Period 2|Withdrawal by Subject|0|||
145566066|NCT01888497|524934097|FG003|Washout Period 2|Withdrawal by Subject|1|||
145297898|NCT00565448|523940944|FG001|Overall Study|Adverse Event|2|||
145297899|NCT00565448|523940943|FG000|Overall Study|Disease progression|1|||
145297900|NCT00565448|523940944|FG001|Overall Study|Disease progression|0|||
145297901|NCT00565448|523940943|FG000|Overall Study|Withdrawal by Subject|1|||
145409263|NCT03126110|524351994|FG010|Phase 2|Death|0|||
145409264|NCT03126110|524351995|FG011|Phase 2|Death|6|||
145409265|NCT03126110|524351996|FG012|Phase 2|Death|12|||
145409266|NCT03126110|524351997|FG013|Phase 2|Death|25|||
145409267|NCT03126110|524351998|FG014|Phase 2|Death|11|||
145409268|NCT03126110|524351999|FG015|Phase 2|Death|3|||
145409269|NCT03126110|524352000|FG016|Phase 2|Death|2|||
145566067|NCT04152447|524934098|FG000|Overall Study|Lost to Follow-up|1|||
145566068|NCT04152447|524934099|FG001|Overall Study|Lost to Follow-up|0|||
145566069|NCT04152447|524934098|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
145566070|NCT04152447|524934099|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
145566071|NCT04152447|524934098|FG000|Overall Study|Withdrawal by Subject|0|||
145566072|NCT04152447|524934099|FG001|Overall Study|Withdrawal by Subject|1|||
145566073|NCT04152447|524934098|FG000|Overall Study|Found ineligible after enrolling|1|||
145566074|NCT04152447|524934099|FG001|Overall Study|Found ineligible after enrolling|1|||
145566075|NCT04152447|524934098|FG000|Overall Study|Did not receive VR headset in time.|0|||
145566076|NCT04152447|524934099|FG001|Overall Study|Did not receive VR headset in time.|2|||
145566077|NCT03240133|524934102|FG000|Overall Study|Withdrawal by Subject|0|||
145566078|NCT03240133|524934103|FG001|Overall Study|Withdrawal by Subject|1|||
145566079|NCT03240133|524934104|FG002|Overall Study|Withdrawal by Subject|0|||
145566080|NCT03240133|524934102|FG000|Overall Study|Adverse Event|1|||
145566081|NCT03240133|524934103|FG001|Overall Study|Adverse Event|1|||
145566082|NCT03240133|524934104|FG002|Overall Study|Adverse Event|0|||
145566083|NCT03240133|524934102|FG000|Overall Study|Rash|1|||
145566084|NCT03240133|524934103|FG001|Overall Study|Rash|0|||
145566085|NCT03240133|524934104|FG002|Overall Study|Rash|0|||
145566086|NCT03240133|524934102|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
145566087|NCT03240133|524934103|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
145566088|NCT03240133|524934104|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
145566089|NCT03240133|524934102|FG000|Overall Study|Intercurrent illness.|0|||
145566090|NCT03240133|524934103|FG001|Overall Study|Intercurrent illness.|1|||
145566091|NCT03240133|524934104|FG002|Overall Study|Intercurrent illness.|0|||
145566092|NCT03240133|524934102|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
145566093|NCT03240133|524934103|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
145566094|NCT03240133|524934104|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
145566095|NCT00097721|524934106|FG000|Overall Study|Adverse Event|8|||
145566096|NCT00097721|524934107|FG001|Overall Study|Adverse Event|1|||
145566097|NCT00097721|524934106|FG000|Overall Study|Withdrawal by Subject|6|||
145566098|NCT00097721|524934107|FG001|Overall Study|Withdrawal by Subject|1|||
145566099|NCT00097721|524934106|FG000|Overall Study|Progressive Disease|55|||
145566100|NCT00097721|524934107|FG001|Overall Study|Progressive Disease|27|||
145566101|NCT00097721|524934106|FG000|Overall Study|Physician Decision|1|||
145566102|NCT00097721|524934107|FG001|Overall Study|Physician Decision|3|||
145566103|NCT00097721|524934106|FG000|Overall Study|Reason not given|1|||
145566104|NCT00097721|524934107|FG001|Overall Study|Reason not given|1|||
145566105|NCT00314574|524934111|FG000|Overall Study|Death|3|||
145566106|NCT00314574|524934112|FG001|Overall Study|Death|0|||
145566107|NCT00314574|524934111|FG000|Overall Study|Adverse Event|11|||
145566108|NCT00314574|524934112|FG001|Overall Study|Adverse Event|16|||
145566109|NCT00314574|524934111|FG000|Overall Study|Lost to Follow-up|19|||
145566110|NCT00314574|524934112|FG001|Overall Study|Lost to Follow-up|25|||
145566111|NCT00314574|524934111|FG000|Overall Study|Withdrawal by Subject|33|||
145566112|NCT00314574|524934112|FG001|Overall Study|Withdrawal by Subject|22|||
145566113|NCT00314574|524934111|FG000|Overall Study|Physician Decision|22|||
145566114|NCT00314574|524934112|FG001|Overall Study|Physician Decision|15|||
145566115|NCT00314574|524934111|FG000|Overall Study|Pregnancy|6|||
145566116|NCT00314574|524934112|FG001|Overall Study|Pregnancy|4|||
145566117|NCT00314574|524934111|FG000|Overall Study|Data unknown at database lock|0|||
145566118|NCT00314574|524934112|FG001|Overall Study|Data unknown at database lock|1|||
145566119|NCT00449956|524934113|FG000|Overall Study|Adverse Event|7|||
145566120|NCT00449956|524934114|FG001|Overall Study|Adverse Event|1|||
145566121|NCT00449956|524934115|FG002|Overall Study|Adverse Event|6|||
145566122|NCT00449956|524934113|FG000|Overall Study|Lack of Efficacy|0|||
145566123|NCT00449956|524934114|FG001|Overall Study|Lack of Efficacy|0|||
145566124|NCT00449956|524934115|FG002|Overall Study|Lack of Efficacy|1|||
145566125|NCT00449956|524934113|FG000|Overall Study|Protocol Violation|1|||
145566126|NCT00449956|524934114|FG001|Overall Study|Protocol Violation|1|||
145566127|NCT00449956|524934115|FG002|Overall Study|Protocol Violation|1|||
145566128|NCT00449956|524934113|FG000|Overall Study|Withdrawal by Subject|0|||
145566129|NCT00449956|524934114|FG001|Overall Study|Withdrawal by Subject|1|||
145566130|NCT00449956|524934115|FG002|Overall Study|Withdrawal by Subject|0|||
145566131|NCT00449956|524934113|FG000|Overall Study|Physician Decision|2|||
145566132|NCT00449956|524934114|FG001|Overall Study|Physician Decision|1|||
145566133|NCT00449956|524934115|FG002|Overall Study|Physician Decision|1|||
145566134|NCT01446965|524934120|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
145566135|NCT01446965|524934121|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
145566136|NCT01446965|524934120|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
145566137|NCT01446965|524934121|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
145566138|NCT00004412|524934124|FG000|Randomized Period|Moved to Crossover Period|3|||
145566139|NCT00004412|524934125|FG001|Randomized Period|Moved to Crossover Period|0|||
145620199|NCT02448719|525123706|FG005|Overall Study|Withdrawal by Subject|0|||
145620200|NCT02448719|525123707|FG006|Overall Study|Withdrawal by Subject|0|||
145566140|NCT00004412|524934126|FG002|Randomized Period|Moved to Crossover Period|0|||
145566141|NCT03144180|524934132|FG000|Overall Study|STAT Delivery|1|||
145566142|NCT03144180|524934133|FG001|Overall Study|STAT Delivery|1|||
145566143|NCT03144180|524934132|FG000|Overall Study|Provider forgot to fill out forms|1|||
145566144|NCT03144180|524934133|FG001|Overall Study|Provider forgot to fill out forms|3|||
145566145|NCT03144180|524934132|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
145566146|NCT03144180|524934133|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
145566147|NCT03144180|524934132|FG000|Overall Study|Scrub tech removed tube cap|0|||
145246141|NCT01291511|523748061|FG000|Double-blind Relapse Prevention Phase|Death|1|||
145246142|NCT01291511|523748062|FG001|Double-blind Relapse Prevention Phase|Death|0|||
145246143|NCT00047008|523748065|FG000|Overall Study|Withdrawn consent|2|||
145246144|NCT00047008|523748066|FG001|Overall Study|Withdrawn consent|3|||
145246145|NCT00047008|523748065|FG000|Overall Study|Ineligible|9|||
145246146|NCT00047008|523748066|FG001|Overall Study|Ineligible|8|||
145246147|NCT00429572|523748067|FG000|Overall Study|Disease progression|1|||
145246148|NCT02773368|523748068|FG000|Overall Study|Lost to Follow-up|4|||
145246149|NCT02773368|523748069|FG001|Overall Study|Lost to Follow-up|1|||
145566148|NCT03144180|524934133|FG001|Overall Study|Scrub tech removed tube cap|1|||
145566149|NCT03387813|524934136|FG000|Overall Study|Death|40|||
145566150|NCT03387813|524934137|FG001|Overall Study|Death|37|||
145566151|NCT03387813|524934138|FG002|Overall Study|Death|190|||
145566152|NCT03387813|524934136|FG000|Overall Study|Withdrawal by Subject|9|||
145566153|NCT03387813|524934137|FG001|Overall Study|Withdrawal by Subject|19|||
145566154|NCT03387813|524934138|FG002|Overall Study|Withdrawal by Subject|32|||
145566155|NCT03387813|524934136|FG000|Overall Study|Lost to Follow-up|3|||
145566156|NCT03387813|524934137|FG001|Overall Study|Lost to Follow-up|9|||
145566157|NCT03387813|524934138|FG002|Overall Study|Lost to Follow-up|15|||
145566158|NCT03387813|524934136|FG000|Overall Study|Non-Compliance|6|||
145566159|NCT03387813|524934137|FG001|Overall Study|Non-Compliance|6|||
145246150|NCT02773368|523748068|FG000|Overall Study|Withdrawal by Subject|5|||
145246151|NCT02773368|523748069|FG001|Overall Study|Withdrawal by Subject|1|||
145246152|NCT02773368|523748068|FG000|Overall Study|Unclassified|1|||
145246153|NCT02773368|523748069|FG001|Overall Study|Unclassified|1|||
145246154|NCT02773368|523748068|FG000|Overall Study|Missing|0|||
145246155|NCT02773368|523748069|FG001|Overall Study|Missing|1|||
145246156|NCT01366534|523748070|FG000|Overall Study|Lost to Follow-up|1|||
145246157|NCT01366534|523748071|FG001|Overall Study|Lost to Follow-up|0|||
145246158|NCT01366534|523748072|FG002|Overall Study|Lost to Follow-up|0|||
145246159|NCT01366534|523748070|FG000|Overall Study|Migrated|1|||
145246160|NCT01366534|523748071|FG001|Overall Study|Migrated|1|||
145246161|NCT01366534|523748072|FG002|Overall Study|Migrated|0|||
145566160|NCT03387813|524934138|FG002|Overall Study|Non-Compliance|31|||
145566161|NCT03387813|524934136|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
145566162|NCT03387813|524934137|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
145566163|NCT03387813|524934138|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
145566164|NCT04327999|524934143|FG000|Overall Study|Protocol Violation|1|||
145566165|NCT02872116|524934148|FG000|Pre-Treatment|Disease Progression|0|||
145566166|NCT02872116|524934149|FG001|Pre-Treatment|Disease Progression|1|||
145566167|NCT02872116|524934150|FG002|Pre-Treatment|Disease Progression|0|||
145566168|NCT02872116|524934148|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
145566169|NCT02872116|524934149|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
145566170|NCT02872116|524934150|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
145566171|NCT02872116|524934148|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
145566172|NCT02872116|524934149|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
145566173|NCT02872116|524934150|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
145566174|NCT02872116|524934148|FG000|Pre-Treatment|Participant withdrew consent|2|||
145566175|NCT02872116|524934149|FG001|Pre-Treatment|Participant withdrew consent|20|||
145566176|NCT02872116|524934150|FG002|Pre-Treatment|Participant withdrew consent|3|||
145246162|NCT01366534|523748070|FG000|Overall Study|Declined challenged|0|||
145246163|NCT01366534|523748071|FG001|Overall Study|Declined challenged|1|||
145246164|NCT01366534|523748072|FG002|Overall Study|Declined challenged|0|||
145246165|NCT01929018|523748075|FG000|Overall Study|Lost to Follow-up|1|||
145246166|NCT01929018|523748076|FG001|Overall Study|Lost to Follow-up|0|||
145409270|NCT03126110|524351984|FG000|Phase 2|Progressive Disease|0|||
145566177|NCT02872116|524934148|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
145566178|NCT02872116|524934149|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
145566179|NCT02872116|524934150|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
145566180|NCT02872116|524934148|FG000|Pre-Treatment|Other reasons|1|||
145566181|NCT02872116|524934149|FG001|Pre-Treatment|Other reasons|2|||
145246167|NCT01929018|523748075|FG000|Overall Study|Hospitalization|0|||
145246168|NCT01929018|523748076|FG001|Overall Study|Hospitalization|1|||
145246169|NCT01047436|523748078|FG000|Overall Study|Protocol Violation|1|||
145246170|NCT01047436|523748079|FG001|Overall Study|Protocol Violation|0|||
145409271|NCT03126110|524351985|FG001|Phase 2|Progressive Disease|0|||
145566182|NCT02872116|524934150|FG002|Pre-Treatment|Other reasons|2|||
145620201|NCT02448719|525123708|FG007|Overall Study|Withdrawal by Subject|0|||
145620202|NCT02448719|525123709|FG008|Overall Study|Withdrawal by Subject|0|||
145620203|NCT02448719|525123710|FG009|Overall Study|Withdrawal by Subject|0|||
145620204|NCT02448719|525123711|FG010|Overall Study|Withdrawal by Subject|0|||
145620205|NCT01473420|525123712|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
145620206|NCT01473420|525123713|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
145620207|NCT01473420|525123712|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
145246171|NCT01678313|523748082|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
145246172|NCT01678313|523748083|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
145246173|NCT01678313|523748082|FG000|Completed the 3-month Therapy|Physician Decision|3|||
145246174|NCT01678313|523748083|FG001|Completed the 3-month Therapy|Physician Decision|4|||
145246175|NCT01678313|523748082|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
145246176|NCT01678313|523748083|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
145246177|NCT01678313|523748082|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
145246178|NCT01678313|523748083|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
145246179|NCT02635867|523748086|FG000|Overall Study|Lost to Follow-up|4|||
145246180|NCT02635867|523748087|FG001|Overall Study|Lost to Follow-up|3|||
145246181|NCT02635867|523748088|FG002|Overall Study|Lost to Follow-up|3|||
145246182|NCT02635867|523748089|FG003|Overall Study|Lost to Follow-up|4|||
145246183|NCT02635867|523748090|FG004|Overall Study|Lost to Follow-up|1|||
145246184|NCT02565576|523748093|FG000|Overall Study|abnormal lab value|2|||
145246185|NCT02565576|523748094|FG001|Overall Study|abnormal lab value|0|||
145246186|NCT02565576|523748093|FG000|Overall Study|subject / guardian decision|1|||
145246187|NCT02565576|523748094|FG001|Overall Study|subject / guardian decision|3|||
145246188|NCT02565576|523748093|FG000|Overall Study|Lost to Follow-up|1|||
145246189|NCT02565576|523748094|FG001|Overall Study|Lost to Follow-up|0|||
145246190|NCT02565576|523748093|FG000|Overall Study|Death|0|||
145246191|NCT02565576|523748094|FG001|Overall Study|Death|2|||
145246192|NCT02565576|523748093|FG000|Overall Study|Adverse Event|1|||
145246193|NCT02565576|523748094|FG001|Overall Study|Adverse Event|0|||
145246194|NCT00939341|523748095|FG000|Overall Study|Adverse Event|15|||
145246195|NCT00939341|523748095|FG000|Overall Study|Pregnancy|1|||
145246196|NCT00939341|523748095|FG000|Overall Study|Lost to Follow-up|23|||
145246197|NCT00939341|523748095|FG000|Overall Study|Withdrawal by Subject|13|||
145246198|NCT00939341|523748095|FG000|Overall Study|Protocol Violation|6|||
145246199|NCT00939341|523748095|FG000|Overall Study|Incorrect enrolment|8|||
145246200|NCT01131130|523748098|FG000|Period 1 - Baseline|Pregnancy|1|||
145246201|NCT01131130|523748098|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
145246202|NCT02437162|523748103|FG000|Overall Study|Protocol Violation|0|||
145246203|NCT02437162|523748104|FG001|Overall Study|Protocol Violation|1|||
145246204|NCT02437162|523748105|FG002|Overall Study|Protocol Violation|0|||
145246205|NCT02437162|523748103|FG000|Overall Study|Randomized but not treated|0|||
145246206|NCT02437162|523748104|FG001|Overall Study|Randomized but not treated|0|||
145246207|NCT02437162|523748105|FG002|Overall Study|Randomized but not treated|1|||
145246208|NCT02437162|523748103|FG000|Overall Study|Study discontinued by Sponsor|93|||
145246209|NCT02437162|523748104|FG001|Overall Study|Study discontinued by Sponsor|98|||
145246210|NCT02437162|523748105|FG002|Overall Study|Study discontinued by Sponsor|97|||
145246211|NCT02437162|523748103|FG000|Overall Study|Withdrawal by Subject|13|||
145246212|NCT02437162|523748104|FG001|Overall Study|Withdrawal by Subject|7|||
145246213|NCT02437162|523748105|FG002|Overall Study|Withdrawal by Subject|9|||
145246214|NCT02437162|523748103|FG000|Overall Study|Adverse Event|0|||
145246215|NCT02437162|523748104|FG001|Overall Study|Adverse Event|1|||
145246216|NCT02437162|523748105|FG002|Overall Study|Adverse Event|0|||
145246217|NCT02437162|523748103|FG000|Overall Study|Lost to Follow-up|1|||
145246218|NCT02437162|523748104|FG001|Overall Study|Lost to Follow-up|0|||
145246219|NCT02437162|523748105|FG002|Overall Study|Lost to Follow-up|1|||
145246220|NCT02437162|523748103|FG000|Overall Study|Death|0|||
145246221|NCT02437162|523748104|FG001|Overall Study|Death|1|||
145246222|NCT02437162|523748105|FG002|Overall Study|Death|0|||
145246223|NCT02437162|523748103|FG000|Overall Study|Other|0|||
145246224|NCT02437162|523748104|FG001|Overall Study|Other|0|||
145246225|NCT02437162|523748105|FG002|Overall Study|Other|1|||
145246226|NCT03981744|523748106|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
145246227|NCT03981744|523748107|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
145297902|NCT00565448|523940944|FG001|Overall Study|Withdrawal by Subject|0|||
145246228|NCT03981744|523748108|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
145246229|NCT03981744|523748109|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
145246230|NCT03981744|523748106|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
145246231|NCT03981744|523748107|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
145246232|NCT03981744|523748108|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
145246233|NCT03981744|523748109|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
145246234|NCT03981744|523748106|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
145246235|NCT03981744|523748107|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
145620208|NCT01473420|525123713|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
145620209|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
145566183|NCT02872116|524934148|FG000|Treatment|Death|121|||
145566184|NCT02872116|524934149|FG001|Treatment|Death|94|||
145566185|NCT02872116|524934150|FG002|Treatment|Death|68|||
145566186|NCT02872116|524934148|FG000|Treatment|Lost to Follow-up|5|||
145566187|NCT02872116|524934149|FG001|Treatment|Lost to Follow-up|7|||
145566188|NCT02872116|524934150|FG002|Treatment|Lost to Follow-up|3|||
145566189|NCT02872116|524934148|FG000|Treatment|Participant withdrew consent|20|||
145566190|NCT02872116|524934149|FG001|Treatment|Participant withdrew consent|40|||
145566191|NCT02872116|524934150|FG002|Treatment|Participant withdrew consent|8|||
145566192|NCT02872116|524934148|FG000|Treatment|Other reasons|13|||
145566193|NCT02872116|524934149|FG001|Treatment|Other reasons|12|||
145566194|NCT02872116|524934150|FG002|Treatment|Other reasons|5|||
145566195|NCT02346136|524934151|FG000|Overall Study|Withdrawal by Subject|7|||
145566196|NCT02346136|524934152|FG001|Overall Study|Withdrawal by Subject|5|||
145566197|NCT02346136|524934151|FG000|Overall Study|Death|1|||
145566198|NCT02346136|524934152|FG001|Overall Study|Death|0|||
145566199|NCT02346136|524934151|FG000|Overall Study|Study termination|14|||
145566200|NCT02346136|524934152|FG001|Overall Study|Study termination|18|||
145566201|NCT02308735|524934153|FG000|Overall Study|Physician Decision|2|||
145566202|NCT02308735|524934154|FG001|Overall Study|Physician Decision|0|||
145566203|NCT02308735|524934155|FG002|Overall Study|Physician Decision|0|||
145566204|NCT02308735|524934156|FG003|Overall Study|Physician Decision|2|||
145566205|NCT00006478|524934164|FG000|Overall Study|Vaccine could not be produced|1|||
145566206|NCT00006478|524934164|FG000|Overall Study|Physician Decision|6|||
145566207|NCT04238728|524934170|FG000|Overall Study|Withdrawal by Subject|1|||
145566208|NCT04238728|524934170|FG000|Overall Study|Lost to Follow-up|2|||
145566209|NCT01907828|524934171|FG000|Overall Study|Exclusion criteria not met|0|||
145566210|NCT01907828|524934172|FG001|Overall Study|Exclusion criteria not met|1|||
145566211|NCT01907828|524934171|FG000|Overall Study|Withdrawal by Subject|3|||
145566212|NCT01907828|524934172|FG001|Overall Study|Withdrawal by Subject|4|||
145566213|NCT01907828|524934171|FG000|Overall Study|Lost to Follow-up|3|||
145246236|NCT03981744|523748108|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
145246237|NCT03981744|523748109|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
145246238|NCT02782104|523748110|FG000|Overall Study|Other|215|||
145246239|NCT02782104|523748110|FG000|Overall Study|Induction Day 28 Non Responder|9|||
145246240|NCT02782104|523748110|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145246241|NCT02782104|523748110|FG000|Overall Study|Death|8|||
145246242|NCT02782104|523748110|FG000|Overall Study|Pregnancy|6|||
145246243|NCT02782104|523748110|FG000|Overall Study|Withdrawal by Subject|63|||
145246244|NCT02782104|523748110|FG000|Overall Study|Protocol Violation|7|||
145246245|NCT02782104|523748110|FG000|Overall Study|Lack of Efficacy|61|||
145246246|NCT02782104|523748110|FG000|Overall Study|Lost to Follow-up|23|||
145246247|NCT02782104|523748110|FG000|Overall Study|Adverse Event|74|||
145246248|NCT04338321|523748111|FG000|Overall Study|Adverse Event|4|||
145246249|NCT04338321|523748112|FG001|Overall Study|Adverse Event|10|||
145246250|NCT04338321|523748111|FG000|Overall Study|Death|1|||
145246251|NCT04338321|523748112|FG001|Overall Study|Death|1|||
145246252|NCT04338321|523748111|FG000|Overall Study|Lost to Follow-up|4|||
145246253|NCT04338321|523748112|FG001|Overall Study|Lost to Follow-up|9|||
145246254|NCT04338321|523748111|FG000|Overall Study|Withdrawal by Subject|45|||
145246255|NCT04338321|523748112|FG001|Overall Study|Withdrawal by Subject|69|||
145246256|NCT04338321|523748111|FG000|Overall Study|Physician Decision|5|||
145246257|NCT04338321|523748112|FG001|Overall Study|Physician Decision|9|||
145246258|NCT04338321|523748111|FG000|Overall Study|Other|3|||
145246259|NCT04338321|523748112|FG001|Overall Study|Other|10|||
145246260|NCT03464136|523748113|FG000|Overall Study|Lost to Follow-up|5|||
145246261|NCT03464136|523748114|FG001|Overall Study|Lost to Follow-up|8|||
145246262|NCT03464136|523748113|FG000|Overall Study|Withdrawal by Subject|16|||
145246263|NCT03464136|523748114|FG001|Overall Study|Withdrawal by Subject|13|||
145246264|NCT03464136|523748113|FG000|Overall Study|Death|1|||
145246265|NCT03464136|523748114|FG001|Overall Study|Death|0|||
145246266|NCT03464136|523748113|FG000|Overall Study|Other|8|||
145246267|NCT03464136|523748114|FG001|Overall Study|Other|4|||
145246268|NCT02438787|523748115|FG000|Overall Study|Adverse Event|1|||
145566214|NCT01907828|524934172|FG001|Overall Study|Lost to Follow-up|0|||
145246269|NCT02438787|523748116|FG001|Overall Study|Adverse Event|0|||
145246270|NCT02438787|523748117|FG002|Overall Study|Adverse Event|2|||
145246271|NCT02438787|523748115|FG000|Overall Study|Lack of Efficacy|1|||
145246272|NCT02438787|523748116|FG001|Overall Study|Lack of Efficacy|2|||
145246273|NCT02438787|523748117|FG002|Overall Study|Lack of Efficacy|0|||
145566215|NCT01907828|524934171|FG000|Overall Study|Participant refused 24-month follow-up|1|||
145566216|NCT01907828|524934172|FG001|Overall Study|Participant refused 24-month follow-up|0|||
145246274|NCT02438787|523748115|FG000|Overall Study|Lost to Follow-up|0|||
145246275|NCT02438787|523748116|FG001|Overall Study|Lost to Follow-up|1|||
145246276|NCT02438787|523748117|FG002|Overall Study|Lost to Follow-up|0|||
145566217|NCT01907828|524934171|FG000|Overall Study|Participant met exclusion criteria|0|||
145566218|NCT01907828|524934172|FG001|Overall Study|Participant met exclusion criteria|1|||
145566219|NCT01364428|524934177|FG000|Overall Study|Adverse Event|1|||
145566220|NCT01364428|524934178|FG001|Overall Study|Adverse Event|2|||
145566221|NCT01364428|524934177|FG000|Overall Study|Protocol Violation|2|||
145297903|NCT01863745|523940945|FG000|Overall Study|Disease Progression|9|||
145297904|NCT01863745|523940945|FG000|Overall Study|Adverse Event|2|||
145297905|NCT01863745|523940945|FG000|Overall Study|Death|1|||
145297906|NCT01863745|523940945|FG000|Overall Study|Withdrawal by Subject|1|||
145297907|NCT00193609|523940946|FG000|Overall Study|Lack of Efficacy|2|||
145297908|NCT00193609|523940946|FG000|Overall Study|Adverse Event|2|||
145566222|NCT01364428|524934178|FG001|Overall Study|Protocol Violation|0|||
145566223|NCT01364428|524934177|FG000|Overall Study|Withdrawal Criteria|14|||
145566224|NCT01364428|524934178|FG001|Overall Study|Withdrawal Criteria|10|||
145566225|NCT01364428|524934177|FG000|Overall Study|Other|3|||
145566226|NCT01364428|524934178|FG001|Overall Study|Other|3|||
145566227|NCT01073865|524934179|FG000|Overall Study|Reasons other than below|19|||
145566228|NCT01073865|524934180|FG001|Overall Study|Reasons other than below|31|||
145566229|NCT01073865|524934179|FG000|Overall Study|Lost to Follow-up|1|||
145566230|NCT01073865|524934180|FG001|Overall Study|Lost to Follow-up|1|||
145566231|NCT01073865|524934179|FG000|Overall Study|Death|3|||
145566232|NCT01073865|524934180|FG001|Overall Study|Death|2|||
145566233|NCT01073865|524934179|FG000|Overall Study|Withdrawal by Subject|5|||
145566234|NCT01073865|524934180|FG001|Overall Study|Withdrawal by Subject|5|||
145566235|NCT01256593|524934185|FG000|Overall Study|Protocol Violation|26|||
145566236|NCT01256593|524934185|FG000|Overall Study|No Drug Administration Information|2|||
145566237|NCT01256593|524934185|FG000|Overall Study|No Visit After Treatment|186|||
145566238|NCT04414553|524934186|FG000|Overall Study|Lost to Follow-up|20|||
145566239|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
145566240|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
145566241|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
145566242|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
145566243|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
145566244|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
145566245|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
145566246|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
145566247|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
145566248|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
145566249|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
145566250|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
145566251|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
145566252|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
145566253|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
145566254|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
145566255|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
145566256|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
145566257|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
145566258|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
145566259|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
145566260|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
145566261|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
145566262|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
145566263|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
145566264|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
145566265|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
145566266|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
145566267|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
145566268|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
145566269|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
145566270|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
145566271|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
145566272|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
145566273|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
145566274|NCT03373383|524934189|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
145566275|NCT03373383|524934190|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
145566276|NCT03373383|524934191|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
145566277|NCT03373383|524934192|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
145566278|NCT03373383|524934193|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
145566279|NCT03373383|524934189|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
145566280|NCT03373383|524934190|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
145566281|NCT03373383|524934191|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
145566282|NCT03373383|524934192|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
145566283|NCT03373383|524934193|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
145566284|NCT03131440|524934198|FG000|Overall Study|Withdrawal by Subject|1|||
145566285|NCT03131440|524934199|FG001|Overall Study|Withdrawal by Subject|3|||
145566286|NCT03131440|524934200|FG002|Overall Study|Withdrawal by Subject|0|||
145297909|NCT00735904|523940947|FG000|Overall Study|Adverse Event|3|||
145297910|NCT00735904|523940947|FG000|Overall Study|Death|20|||
145246277|NCT02438787|523748115|FG000|Overall Study|Protocol Violation|0|||
145246278|NCT02438787|523748116|FG001|Overall Study|Protocol Violation|0|||
145246279|NCT02438787|523748117|FG002|Overall Study|Protocol Violation|1|||
145246280|NCT02438787|523748115|FG000|Overall Study|Withdrawal by Subject|15|||
145246281|NCT02438787|523748116|FG001|Overall Study|Withdrawal by Subject|7|||
145246282|NCT02438787|523748117|FG002|Overall Study|Withdrawal by Subject|10|||
145246283|NCT02438787|523748115|FG000|Overall Study|Study discontinued by sponsor|64|||
145246284|NCT02438787|523748116|FG001|Overall Study|Study discontinued by sponsor|72|||
145246285|NCT02438787|523748117|FG002|Overall Study|Study discontinued by sponsor|69|||
145246286|NCT02438787|523748115|FG000|Overall Study|Other|0|||
145246287|NCT02438787|523748116|FG001|Overall Study|Other|1|||
145246288|NCT02438787|523748117|FG002|Overall Study|Other|0|||
145246289|NCT02438787|523748115|FG000|Overall Study|Site terminated by sponsor|0|||
145246290|NCT02438787|523748116|FG001|Overall Study|Site terminated by sponsor|0|||
145246291|NCT02438787|523748117|FG002|Overall Study|Site terminated by sponsor|1|||
145246292|NCT03412565|523748118|FG000|Overall Study|Lost to Follow-up|0|||
145297911|NCT00735904|523940947|FG000|Overall Study|Protocol Violation|1|||
145297912|NCT00735904|523940947|FG000|Overall Study|Withdrawal by Subject|1|||
145297913|NCT00735904|523940947|FG000|Overall Study|Study Terminated by Sponsor|5|||
145297914|NCT00735904|523940947|FG000|Overall Study|Other|8|||
145297915|NCT02028715|523942517|FG000|Overall Study|Adverse Event|2|||
145297916|NCT02028715|523942518|FG001|Overall Study|Adverse Event|2|||
145297917|NCT02028715|523942517|FG000|Overall Study|Physician Decision|1|||
145297918|NCT02028715|523942518|FG001|Overall Study|Physician Decision|0|||
145297919|NCT02028715|523942517|FG000|Overall Study|Did not complete satisfaction surveys|2|||
145297920|NCT02028715|523942518|FG001|Overall Study|Did not complete satisfaction surveys|2|||
145297921|NCT02533258|523942519|FG000|Overall Study|Adverse Event|1|||
145297922|NCT02533258|523942519|FG000|Overall Study|Death|2|||
145297923|NCT02533258|523942519|FG000|Overall Study|Other|1|||
145297924|NCT02533258|523942519|FG000|Overall Study|Economic factor|1|||
145297925|NCT02533258|523942519|FG000|Overall Study|Progression of pleural effusion|1|||
145297926|NCT02533258|523942519|FG000|Overall Study|Lack of Efficacy|2|||
145297927|NCT01710657|523942520|FG000|Overall Study|Lost to Follow-up|2|||
145297928|NCT01710657|523942521|FG001|Overall Study|Lost to Follow-up|0|||
145297929|NCT01710657|523942522|FG002|Overall Study|Lost to Follow-up|1|||
145297930|NCT01710657|523942520|FG000|Overall Study|Protocol Violation|2|||
145297931|NCT01710657|523942521|FG001|Overall Study|Protocol Violation|2|||
145297932|NCT01710657|523942522|FG002|Overall Study|Protocol Violation|0|||
145297933|NCT01710657|523942520|FG000|Overall Study|Adverse Event|14|||
145297934|NCT01710657|523942521|FG001|Overall Study|Adverse Event|8|||
145297935|NCT01710657|523942522|FG002|Overall Study|Adverse Event|28|||
145297936|NCT01710657|523942520|FG000|Overall Study|Withdrawal by Subject|0|||
145297937|NCT01710657|523942521|FG001|Overall Study|Withdrawal by Subject|1|||
145297938|NCT01710657|523942522|FG002|Overall Study|Withdrawal by Subject|2|||
145297939|NCT01710657|523942520|FG000|Overall Study|Lack of Efficacy|0|||
145297940|NCT01710657|523942521|FG001|Overall Study|Lack of Efficacy|1|||
145297941|NCT01710657|523942522|FG002|Overall Study|Lack of Efficacy|1|||
145297942|NCT01367457|523942526|FG000|Overall Study|Death|2|||
145297943|NCT01367457|523942527|FG001|Overall Study|Death|0|||
145297944|NCT01367457|523942528|FG002|Overall Study|Death|0|||
145297945|NCT01367457|523942526|FG000|Overall Study|Investigator's decision|2|||
145246293|NCT03412565|523748119|FG001|Overall Study|Lost to Follow-up|0|||
145297946|NCT01367457|523942527|FG001|Overall Study|Investigator's decision|0|||
145297947|NCT01367457|523942528|FG002|Overall Study|Investigator's decision|0|||
145246294|NCT03412565|523748120|FG002|Overall Study|Lost to Follow-up|1|||
145246295|NCT03412565|523748121|FG003|Overall Study|Lost to Follow-up|0|||
145246296|NCT03412565|523748118|FG000|Overall Study|Physician Decision|0|||
145246297|NCT03412565|523748119|FG001|Overall Study|Physician Decision|0|||
145246298|NCT03412565|523748120|FG002|Overall Study|Physician Decision|0|||
145297948|NCT01367457|523942526|FG000|Overall Study|Clinical decline (CD)|2|||
145297949|NCT01367457|523942527|FG001|Overall Study|Clinical decline (CD)|0|||
145297950|NCT01367457|523942528|FG002|Overall Study|Clinical decline (CD)|0|||
145297951|NCT01367457|523942526|FG000|Overall Study|Progression and death|8|||
145566287|NCT03131440|524934201|FG003|Overall Study|Withdrawal by Subject|0|||
145246299|NCT03412565|523748121|FG003|Overall Study|Physician Decision|1|||
145246300|NCT03412565|523748118|FG000|Overall Study|Withdrawal by Subject|0|||
145246301|NCT03412565|523748119|FG001|Overall Study|Withdrawal by Subject|4|||
145297952|NCT01367457|523942527|FG001|Overall Study|Progression and death|0|||
145297953|NCT01367457|523942528|FG002|Overall Study|Progression and death|0|||
145297954|NCT01367457|523942526|FG000|Overall Study|Toxicity|16|||
145297955|NCT01367457|523942527|FG001|Overall Study|Toxicity|0|||
145297956|NCT01367457|523942528|FG002|Overall Study|Toxicity|0|||
145297957|NCT01367457|523942526|FG000|Overall Study|Progression|137|||
145297958|NCT01367457|523942527|FG001|Overall Study|Progression|0|||
145246302|NCT03412565|523748120|FG002|Overall Study|Withdrawal by Subject|5|||
145246303|NCT03412565|523748121|FG003|Overall Study|Withdrawal by Subject|5|||
145246304|NCT03412565|523748118|FG000|Overall Study|Death|1|||
145297959|NCT01367457|523942528|FG002|Overall Study|Progression|0|||
145409272|NCT03126110|524351986|FG002|Phase 2|Progressive Disease|0|||
145620210|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
145620211|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
145620212|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
145620213|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
145620214|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
145620215|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
145620216|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
145620217|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
145620218|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
145620219|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
145620220|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
145297960|NCT01367457|523942526|FG000|Overall Study|Patient asks for rest + slow progression|1|||
145297961|NCT01367457|523942527|FG001|Overall Study|Patient asks for rest + slow progression|0|||
145297962|NCT01367457|523942528|FG002|Overall Study|Patient asks for rest + slow progression|0|||
145297963|NCT01367457|523942526|FG000|Overall Study|Investigator's opinion, stable disease|1|||
145297964|NCT01367457|523942527|FG001|Overall Study|Investigator's opinion, stable disease|0|||
145297965|NCT01367457|523942528|FG002|Overall Study|Investigator's opinion, stable disease|0|||
145297966|NCT01367457|523942526|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
145297967|NCT01367457|523942527|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
145297968|NCT01367457|523942528|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
145297969|NCT01367457|523942526|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
145297970|NCT01367457|523942527|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
145297971|NCT01367457|523942528|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
145297972|NCT01367457|523942526|FG000|Overall Study|low grade toxicities + stable disease|1|||
145297973|NCT01367457|523942527|FG001|Overall Study|low grade toxicities + stable disease|0|||
145297974|NCT01367457|523942528|FG002|Overall Study|low grade toxicities + stable disease|0|||
145297975|NCT01367457|523942526|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
145297976|NCT01367457|523942527|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
145297977|NCT01367457|523942528|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
145297978|NCT01367457|523942526|FG000|Overall Study|Withdrawal by Subject|1|||
145297979|NCT01367457|523942527|FG001|Overall Study|Withdrawal by Subject|0|||
145297980|NCT01367457|523942528|FG002|Overall Study|Withdrawal by Subject|0|||
145297981|NCT01367457|523942526|FG000|Overall Study|CD, associated leukaemia|1|||
145297982|NCT01367457|523942527|FG001|Overall Study|CD, associated leukaemia|0|||
145297983|NCT01367457|523942528|FG002|Overall Study|CD, associated leukaemia|0|||
145297984|NCT01367457|523942526|FG000|Overall Study|Uncontrolled pain|1|||
145297985|NCT01367457|523942527|FG001|Overall Study|Uncontrolled pain|0|||
145297986|NCT01367457|523942528|FG002|Overall Study|Uncontrolled pain|0|||
145297987|NCT01367457|523942526|FG000|Overall Study|Overall status worsens to grade 4|1|||
145297988|NCT01367457|523942527|FG001|Overall Study|Overall status worsens to grade 4|0|||
145297989|NCT01367457|523942528|FG002|Overall Study|Overall status worsens to grade 4|0|||
145297990|NCT01367457|523942526|FG000|Overall Study|Stabilisation + frequent infections|1|||
145297991|NCT01367457|523942527|FG001|Overall Study|Stabilisation + frequent infections|0|||
145297992|NCT01367457|523942528|FG002|Overall Study|Stabilisation + frequent infections|0|||
145297993|NCT01367457|523942526|FG000|Overall Study|No clinical benefit|1|||
145297994|NCT01367457|523942527|FG001|Overall Study|No clinical benefit|0|||
145297995|NCT01367457|523942528|FG002|Overall Study|No clinical benefit|0|||
145297996|NCT01367457|523942526|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
145297997|NCT01367457|523942527|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
145297998|NCT01367457|523942528|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
145297999|NCT01367457|523942526|FG000|Overall Study|Overall decline|1|||
145620221|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
145246305|NCT03412565|523748119|FG001|Overall Study|Death|3|||
145246306|NCT03412565|523748120|FG002|Overall Study|Death|4|||
145246307|NCT03412565|523748121|FG003|Overall Study|Death|5|||
145246308|NCT03412565|523748118|FG000|Overall Study|Data collection ended|0|||
145246309|NCT03412565|523748119|FG001|Overall Study|Data collection ended|41|||
145246310|NCT03412565|523748120|FG002|Overall Study|Data collection ended|41|||
145246311|NCT03412565|523748121|FG003|Overall Study|Data collection ended|40|||
145246312|NCT03375203|523748122|FG000|Overall Study|Protocol Violation|0|||
145246313|NCT03375203|523748123|FG001|Overall Study|Protocol Violation|0|||
145246314|NCT03375203|523748124|FG002|Overall Study|Protocol Violation|1|||
145246315|NCT03375203|523748125|FG003|Overall Study|Protocol Violation|0|||
145246316|NCT03375203|523748126|FG004|Overall Study|Protocol Violation|0|||
145246317|NCT03375203|523748122|FG000|Overall Study|Adverse Event|2|||
145246318|NCT03375203|523748123|FG001|Overall Study|Adverse Event|3|||
145246319|NCT03375203|523748124|FG002|Overall Study|Adverse Event|0|||
145298000|NCT01367457|523942527|FG001|Overall Study|Overall decline|0|||
145298001|NCT01367457|523942528|FG002|Overall Study|Overall decline|0|||
145298002|NCT01367457|523942526|FG000|Overall Study|Rejection of treatment|1|||
145298003|NCT01367457|523942527|FG001|Overall Study|Rejection of treatment|0|||
145246320|NCT03375203|523748125|FG003|Overall Study|Adverse Event|2|||
145409273|NCT03126110|524351987|FG003|Phase 2|Progressive Disease|0|||
145409274|NCT03126110|524351988|FG004|Phase 2|Progressive Disease|0|||
145409275|NCT03126110|524351989|FG005|Phase 2|Progressive Disease|0|||
145409276|NCT03126110|524351990|FG006|Phase 2|Progressive Disease|0|||
145409277|NCT03126110|524351991|FG007|Phase 2|Progressive Disease|0|||
145409278|NCT03126110|524351992|FG008|Phase 2|Progressive Disease|0|||
145409279|NCT03126110|524351993|FG009|Phase 2|Progressive Disease|0|||
145409280|NCT03126110|524351994|FG010|Phase 2|Progressive Disease|0|||
145409281|NCT03126110|524351995|FG011|Phase 2|Progressive Disease|0|||
145409282|NCT03126110|524351996|FG012|Phase 2|Progressive Disease|0|||
145409283|NCT03126110|524351997|FG013|Phase 2|Progressive Disease|1|||
145409284|NCT03126110|524351998|FG014|Phase 2|Progressive Disease|0|||
145409285|NCT03126110|524351999|FG015|Phase 2|Progressive Disease|0|||
145409286|NCT03126110|524352000|FG016|Phase 2|Progressive Disease|0|||
145409287|NCT03126110|524351984|FG000|Phase 2|Started new treatment|0|||
145409288|NCT03126110|524351985|FG001|Phase 2|Started new treatment|0|||
145409289|NCT03126110|524351986|FG002|Phase 2|Started new treatment|0|||
145409290|NCT03126110|524351987|FG003|Phase 2|Started new treatment|0|||
145409291|NCT03126110|524351988|FG004|Phase 2|Started new treatment|0|||
145409292|NCT03126110|524351989|FG005|Phase 2|Started new treatment|0|||
145409293|NCT03126110|524351990|FG006|Phase 2|Started new treatment|0|||
145409294|NCT03126110|524351991|FG007|Phase 2|Started new treatment|0|||
145409295|NCT03126110|524351992|FG008|Phase 2|Started new treatment|0|||
145409296|NCT03126110|524351993|FG009|Phase 2|Started new treatment|0|||
145409297|NCT03126110|524351994|FG010|Phase 2|Started new treatment|0|||
145409298|NCT03126110|524351995|FG011|Phase 2|Started new treatment|0|||
145409299|NCT03126110|524351996|FG012|Phase 2|Started new treatment|0|||
145409300|NCT03126110|524351997|FG013|Phase 2|Started new treatment|0|||
145409301|NCT03126110|524351998|FG014|Phase 2|Started new treatment|1|||
145409302|NCT03126110|524351999|FG015|Phase 2|Started new treatment|0|||
145409303|NCT03126110|524352000|FG016|Phase 2|Started new treatment|0|||
145409304|NCT00294658|524352001|FG000|Overall Study|Death|0|||
145409305|NCT00294658|524352002|FG001|Overall Study|Death|1|||
145409306|NCT00294658|524352001|FG000|Overall Study|Lost to Follow-up|4|||
145409307|NCT00294658|524352002|FG001|Overall Study|Lost to Follow-up|0|||
145409308|NCT00294658|524352001|FG000|Overall Study|Physician Decision|1|||
145409309|NCT00294658|524352002|FG001|Overall Study|Physician Decision|2|||
145409310|NCT00294658|524352001|FG000|Overall Study|Pregnancy|0|||
145409311|NCT00294658|524352002|FG001|Overall Study|Pregnancy|1|||
145409312|NCT00294658|524352001|FG000|Overall Study|Withdrawal by Subject|0|||
145409313|NCT00294658|524352002|FG001|Overall Study|Withdrawal by Subject|4|||
145409314|NCT00294658|524352001|FG000|Overall Study|Found to have invasive thymoma|1|||
145409315|NCT00294658|524352002|FG001|Overall Study|Found to have invasive thymoma|0|||
145409316|NCT00294658|524352001|FG000|Overall Study|Patient and family were not satisfied|0|||
145409317|NCT00294658|524352002|FG001|Overall Study|Patient and family were not satisfied|1|||
145409318|NCT00580840|524352003|FG000|Run-in|Adverse Event|17|||
145409319|NCT00580840|524352004|FG001|Run-in|Adverse Event|0|||
145409320|NCT00580840|524352005|FG002|Run-in|Adverse Event|0|||
145409321|NCT00580840|524352006|FG003|Run-in|Adverse Event|0|||
145409322|NCT00580840|524352003|FG000|Run-in|Lack of Efficacy|93|||
145409323|NCT00580840|524352004|FG001|Run-in|Lack of Efficacy|0|||
145409324|NCT00580840|524352005|FG002|Run-in|Lack of Efficacy|0|||
145409325|NCT00580840|524352006|FG003|Run-in|Lack of Efficacy|0|||
145409326|NCT00580840|524352003|FG000|Run-in|Loss of Efficacy|1|||
145409327|NCT00580840|524352004|FG001|Run-in|Loss of Efficacy|0|||
145409328|NCT00580840|524352005|FG002|Run-in|Loss of Efficacy|0|||
145409329|NCT00580840|524352006|FG003|Run-in|Loss of Efficacy|0|||
145409330|NCT00580840|524352003|FG000|Run-in|Lost to Follow-up|4|||
145409331|NCT00580840|524352004|FG001|Run-in|Lost to Follow-up|0|||
145409332|NCT00580840|524352005|FG002|Run-in|Lost to Follow-up|0|||
145409333|NCT00580840|524352006|FG003|Run-in|Lost to Follow-up|0|||
145409334|NCT00580840|524352003|FG000|Run-in|Withdrawal by Subject|5|||
145409335|NCT00580840|524352004|FG001|Run-in|Withdrawal by Subject|0|||
145409336|NCT00580840|524352005|FG002|Run-in|Withdrawal by Subject|0|||
145566288|NCT03131440|524934202|FG004|Overall Study|Withdrawal by Subject|1|||
145566289|NCT03131440|524934203|FG005|Overall Study|Withdrawal by Subject|0|||
145566290|NCT03131440|524934204|FG006|Overall Study|Withdrawal by Subject|0|||
145566291|NCT03131440|524934205|FG007|Overall Study|Withdrawal by Subject|1|||
145409337|NCT00580840|524352006|FG003|Run-in|Withdrawal by Subject|0|||
145409338|NCT00580840|524352003|FG000|Run-in|Other: Per Sponsor Request|2|||
145409339|NCT00580840|524352004|FG001|Run-in|Other: Per Sponsor Request|0|||
145409340|NCT00580840|524352005|FG002|Run-in|Other: Per Sponsor Request|0|||
145566292|NCT03131440|524934206|FG008|Overall Study|Withdrawal by Subject|1|||
145409341|NCT00580840|524352006|FG003|Run-in|Other: Per Sponsor Request|0|||
145409342|NCT00580840|524352003|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
145409343|NCT00580840|524352004|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145409344|NCT00580840|524352005|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145409345|NCT00580840|524352006|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
145409346|NCT00580840|524352003|FG000|Run-in|Other: Exclusionary Lab Value|1|||
145409347|NCT00580840|524352004|FG001|Run-in|Other: Exclusionary Lab Value|0|||
145409348|NCT00580840|524352005|FG002|Run-in|Other: Exclusionary Lab Value|0|||
145298004|NCT01367457|523942528|FG002|Overall Study|Rejection of treatment|0|||
145298005|NCT01367457|523942526|FG000|Overall Study|Lost to Follow-up|1|||
145298006|NCT01367457|523942527|FG001|Overall Study|Lost to Follow-up|0|||
145298007|NCT01367457|523942528|FG002|Overall Study|Lost to Follow-up|0|||
145298008|NCT01367457|523942526|FG000|Overall Study|Death from septic shock|1|||
145298009|NCT01367457|523942527|FG001|Overall Study|Death from septic shock|0|||
145298010|NCT01367457|523942528|FG002|Overall Study|Death from septic shock|0|||
145298011|NCT01367457|523942526|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
145298012|NCT01367457|523942527|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
145298013|NCT01367457|523942528|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
145298014|NCT01367457|523942526|FG000|Overall Study|Patient's Wish|1|||
145298015|NCT01367457|523942527|FG001|Overall Study|Patient's Wish|0|||
145298016|NCT01367457|523942528|FG002|Overall Study|Patient's Wish|0|||
145298017|NCT01367457|523942526|FG000|Overall Study|Palliative. Overall decline|1|||
145298018|NCT01367457|523942527|FG001|Overall Study|Palliative. Overall decline|0|||
145298019|NCT01367457|523942528|FG002|Overall Study|Palliative. Overall decline|0|||
145298020|NCT01367457|523942526|FG000|Overall Study|Suspected DP/suspected active infection|1|||
145298021|NCT01367457|523942527|FG001|Overall Study|Suspected DP/suspected active infection|0|||
145298022|NCT01367457|523942528|FG002|Overall Study|Suspected DP/suspected active infection|0|||
145298023|NCT03447262|523942529|FG000|Overall Study|Adverse Event|7|||
145298024|NCT03447262|523942529|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
145298025|NCT03447262|523942529|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
145298026|NCT03447262|523942529|FG000|Overall Study|Death|2|||
145298027|NCT03447262|523942529|FG000|Overall Study|Study Termination by Sponsor|455|||
145298028|NCT03447262|523942529|FG000|Overall Study|Other|4|||
145298029|NCT02058498|523942530|FG000|Overall Study|Withdrawal by Subject|4|||
145298030|NCT02511782|523942537|FG000|Overall Study|Withdrawal by Subject|1|||
145298031|NCT02511782|523942538|FG001|Overall Study|Withdrawal by Subject|0|||
145298032|NCT02511782|523942539|FG002|Overall Study|Withdrawal by Subject|0|||
145298033|NCT00112463|523942542|FG000|Overall Study|Physician Decision|1|||
145298034|NCT00112463|523942542|FG000|Overall Study|Progression|30|||
145298035|NCT00112463|523942542|FG000|Overall Study|Second Primary|1|||
145298036|NCT00112463|523942542|FG000|Overall Study|Toxicity|3|||
145298037|NCT00112463|523942542|FG000|Overall Study|Withdrawal by Subject|2|||
145298038|NCT00112463|523942542|FG000|Overall Study|Never started treatment|2|||
145298039|NCT01171963|523942543|FG000|Overall Study|Adverse Event|10|||
145298040|NCT01171963|523942544|FG001|Overall Study|Adverse Event|15|||
145298041|NCT01171963|523942543|FG000|Overall Study|Lost to Follow-up|23|||
145298042|NCT01171963|523942544|FG001|Overall Study|Lost to Follow-up|24|||
145298043|NCT01171963|523942543|FG000|Overall Study|Other - diarrhoea|1|||
145298044|NCT01171963|523942544|FG001|Overall Study|Other - diarrhoea|0|||
145298045|NCT01171963|523942543|FG000|Overall Study|Withdrawal by Subject|114|||
145298046|NCT01171963|523942544|FG001|Overall Study|Withdrawal by Subject|129|||
145298047|NCT05093205|523942545|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
145298048|NCT05093205|523942546|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
145246321|NCT03375203|523748126|FG004|Overall Study|Adverse Event|2|||
145246322|NCT03375203|523748122|FG000|Overall Study|Withdrawal by Subject|3|||
145246323|NCT03375203|523748123|FG001|Overall Study|Withdrawal by Subject|0|||
145246324|NCT03375203|523748124|FG002|Overall Study|Withdrawal by Subject|1|||
145409349|NCT00580840|524352006|FG003|Run-in|Other: Exclusionary Lab Value|0|||
145409350|NCT00580840|524352003|FG000|Double-Blind|Adverse Event|0|||
145409351|NCT00580840|524352004|FG001|Double-Blind|Adverse Event|3|||
145246325|NCT03375203|523748125|FG003|Overall Study|Withdrawal by Subject|0|||
145246326|NCT03375203|523748126|FG004|Overall Study|Withdrawal by Subject|2|||
145246327|NCT03375203|523748122|FG000|Overall Study|Non-compliance with study drug|1|||
145246328|NCT03375203|523748123|FG001|Overall Study|Non-compliance with study drug|0|||
145246329|NCT03375203|523748124|FG002|Overall Study|Non-compliance with study drug|0|||
145246330|NCT03375203|523748125|FG003|Overall Study|Non-compliance with study drug|0|||
145246331|NCT03375203|523748126|FG004|Overall Study|Non-compliance with study drug|0|||
145246332|NCT03375203|523748122|FG000|Overall Study|Randomized, not treated.|0|||
145246333|NCT03375203|523748123|FG001|Overall Study|Randomized, not treated.|1|||
145246334|NCT03375203|523748124|FG002|Overall Study|Randomized, not treated.|0|||
145246335|NCT03375203|523748125|FG003|Overall Study|Randomized, not treated.|0|||
145246336|NCT03375203|523748126|FG004|Overall Study|Randomized, not treated.|0|||
145246337|NCT03107793|523748127|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
145246338|NCT03107793|523748128|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
145246339|NCT03107793|523748129|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
145246340|NCT03107793|523748130|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
145246341|NCT03107793|523748131|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
145246342|NCT03107793|523748127|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
145246343|NCT03107793|523748128|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
145246344|NCT03107793|523748129|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
145246345|NCT03107793|523748130|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
145298049|NCT05093205|523942547|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
145298050|NCT05093205|523942548|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
145298051|NCT05093205|523942549|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
145298052|NCT05093205|523942550|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
145298053|NCT05093205|523942551|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
145298054|NCT05093205|523942552|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
145298055|NCT05093205|523942553|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
145298056|NCT05093205|523942554|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
145298057|NCT05093205|523942555|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
145298058|NCT05093205|523942556|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
145298059|NCT05093205|523942557|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
145298060|NCT05093205|523942545|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298061|NCT05093205|523942546|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298062|NCT05093205|523942547|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
145298063|NCT05093205|523942548|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298064|NCT05093205|523942549|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298065|NCT05093205|523942550|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298066|NCT05093205|523942551|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298067|NCT05093205|523942552|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298068|NCT05093205|523942553|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298069|NCT05093205|523942554|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298070|NCT05093205|523942555|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298071|NCT05093205|523942556|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298072|NCT05093205|523942557|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
145298073|NCT05093205|523942545|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
145298074|NCT05093205|523942546|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
145298075|NCT05093205|523942547|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
145298076|NCT05093205|523942548|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
145298077|NCT05093205|523942549|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
145298078|NCT05093205|523942550|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
145298079|NCT05093205|523942551|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
145298080|NCT05093205|523942552|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
145298081|NCT05093205|523942553|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
145298082|NCT05093205|523942554|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
145298083|NCT05093205|523942555|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
145298084|NCT05093205|523942556|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
145298085|NCT05093205|523942557|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
145298086|NCT05093205|523942545|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
145298087|NCT05093205|523942546|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
145298088|NCT05093205|523942547|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
145298089|NCT05093205|523942548|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
145298090|NCT05093205|523942549|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
145298091|NCT05093205|523942550|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
145298092|NCT05093205|523942551|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
145298093|NCT05093205|523942552|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
145298094|NCT05093205|523942553|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
145298095|NCT05093205|523942554|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
145298096|NCT05093205|523942555|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
145298097|NCT05093205|523942556|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
145298098|NCT05093205|523942557|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
145298099|NCT05093205|523942545|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
145298100|NCT05093205|523942546|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
145409352|NCT00580840|524352005|FG002|Double-Blind|Adverse Event|4|||
145409353|NCT00580840|524352006|FG003|Double-Blind|Adverse Event|1|||
145566293|NCT03131440|524934207|FG009|Overall Study|Withdrawal by Subject|1|||
145566294|NCT03131440|524934208|FG010|Overall Study|Withdrawal by Subject|0|||
145566295|NCT03131440|524934209|FG011|Overall Study|Withdrawal by Subject|1|||
145298101|NCT05093205|523942547|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
145298102|NCT05093205|523942548|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
145298103|NCT05093205|523942549|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
145566296|NCT03131440|524934210|FG012|Overall Study|Withdrawal by Subject|1|||
145566297|NCT03131440|524934211|FG013|Overall Study|Withdrawal by Subject|0|||
145566298|NCT03131440|524934212|FG014|Overall Study|Withdrawal by Subject|1|||
145566299|NCT03131440|524934213|FG015|Overall Study|Withdrawal by Subject|0|||
145566300|NCT03131440|524934214|FG016|Overall Study|Withdrawal by Subject|0|||
145298104|NCT05093205|523942550|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
145298105|NCT05093205|523942551|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
145298106|NCT05093205|523942552|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
145298107|NCT05093205|523942553|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
145298108|NCT05093205|523942554|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
145298109|NCT05093205|523942555|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
145298110|NCT05093205|523942556|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
145298111|NCT05093205|523942557|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
145298112|NCT05093205|523942545|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
145566301|NCT03131440|524934215|FG017|Overall Study|Withdrawal by Subject|0|||
145298113|NCT05093205|523942546|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
145298114|NCT05093205|523942547|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
145298115|NCT05093205|523942548|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
145298116|NCT05093205|523942549|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
145298117|NCT05093205|523942550|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
145298118|NCT05093205|523942551|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
145246346|NCT03107793|523748131|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
145246347|NCT03107793|523748127|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
145246348|NCT03107793|523748128|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
145246349|NCT03107793|523748129|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
145246350|NCT03107793|523748130|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
145246351|NCT03107793|523748131|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
145246352|NCT03107793|523748127|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
145246353|NCT03107793|523748128|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145298119|NCT05093205|523942552|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
145298120|NCT05093205|523942553|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
145298121|NCT05093205|523942554|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
145298122|NCT05093205|523942555|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
145298123|NCT05093205|523942556|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
145298124|NCT05093205|523942557|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
145298125|NCT05093205|523942545|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
145298126|NCT05093205|523942546|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
145298127|NCT05093205|523942547|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
145298128|NCT05093205|523942548|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
145298129|NCT05093205|523942549|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
145298130|NCT05093205|523942550|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
145298131|NCT05093205|523942551|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
145298132|NCT05093205|523942552|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
145298133|NCT05093205|523942553|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
145298134|NCT05093205|523942554|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
145298135|NCT05093205|523942555|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
145298136|NCT05093205|523942556|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
145298137|NCT05093205|523942557|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
145298138|NCT05093205|523942545|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
145298139|NCT05093205|523942546|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
145298140|NCT05093205|523942547|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
145298141|NCT05093205|523942548|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
145298142|NCT05093205|523942549|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
145298143|NCT05093205|523942550|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
145298144|NCT05093205|523942551|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
145298145|NCT05093205|523942552|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
145298146|NCT05093205|523942553|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
145298147|NCT05093205|523942554|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
145298148|NCT05093205|523942555|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
145298149|NCT05093205|523942556|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
145298150|NCT05093205|523942557|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
145298151|NCT05093205|523942545|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298152|NCT05093205|523942546|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298153|NCT05093205|523942547|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298154|NCT05093205|523942548|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298155|NCT05093205|523942549|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298156|NCT05093205|523942550|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298157|NCT05093205|523942551|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298158|NCT05093205|523942552|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298159|NCT05093205|523942553|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298160|NCT05093205|523942554|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
145298161|NCT05093205|523942555|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298162|NCT05093205|523942556|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298163|NCT05093205|523942557|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
145298164|NCT05093205|523942545|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
145298165|NCT05093205|523942546|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
145298166|NCT05093205|523942547|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
145298167|NCT05093205|523942548|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
145298168|NCT05093205|523942549|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
145298169|NCT05093205|523942550|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
145298170|NCT05093205|523942551|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
145298171|NCT05093205|523942552|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
145298172|NCT05093205|523942553|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
145298173|NCT05093205|523942554|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
145298174|NCT05093205|523942555|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
145298175|NCT05093205|523942556|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
145298176|NCT05093205|523942557|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
145298177|NCT05093205|523942545|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145246354|NCT03107793|523748129|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145246355|NCT03107793|523748130|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145246356|NCT03107793|523748131|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145246357|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145246358|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
145246359|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
145246360|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145246361|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145246362|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145246363|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
145298178|NCT05093205|523942546|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298179|NCT05093205|523942547|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298180|NCT05093205|523942548|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298181|NCT05093205|523942549|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298182|NCT05093205|523942550|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298183|NCT05093205|523942551|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298184|NCT05093205|523942552|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298185|NCT05093205|523942553|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298186|NCT05093205|523942554|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298187|NCT05093205|523942555|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
145298188|NCT05093205|523942556|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298189|NCT05093205|523942557|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
145298190|NCT05093205|523942545|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298191|NCT05093205|523942546|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298192|NCT05093205|523942547|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298193|NCT05093205|523942548|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298194|NCT05093205|523942549|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298195|NCT05093205|523942550|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298196|NCT05093205|523942551|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298197|NCT05093205|523942552|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298198|NCT05093205|523942553|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298199|NCT05093205|523942554|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298200|NCT05093205|523942555|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298201|NCT05093205|523942556|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
145298202|NCT05093205|523942557|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
145298203|NCT05093205|523942545|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
145298204|NCT05093205|523942546|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
145298205|NCT05093205|523942547|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
145298206|NCT05093205|523942548|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
145298207|NCT05093205|523942549|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
145298208|NCT05093205|523942550|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
145298209|NCT05093205|523942551|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
145298210|NCT05093205|523942552|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
145298211|NCT05093205|523942553|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
145298212|NCT05093205|523942554|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
145298213|NCT05093205|523942555|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
145298214|NCT05093205|523942556|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
145298215|NCT05093205|523942557|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
145298216|NCT05093205|523942545|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298217|NCT05093205|523942546|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298218|NCT05093205|523942547|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298219|NCT05093205|523942548|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298220|NCT05093205|523942549|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298221|NCT05093205|523942550|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298222|NCT05093205|523942551|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298223|NCT05093205|523942552|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298224|NCT05093205|523942553|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298225|NCT05093205|523942554|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298226|NCT05093205|523942555|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298227|NCT05093205|523942556|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
145409354|NCT00580840|524352003|FG000|Double-Blind|Loss of Efficacy|0|||
145246364|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
145246365|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145298228|NCT05093205|523942557|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
145298229|NCT03361228|523942558|FG000|Overall Study|Other|1|||
145298230|NCT03361228|523942559|FG001|Overall Study|Other|1|||
145298231|NCT03361228|523942558|FG000|Overall Study|Death|3|||
145298232|NCT03361228|523942559|FG001|Overall Study|Death|0|||
145298233|NCT02979353|523942568|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
145298234|NCT02979353|523942569|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
145298235|NCT02979353|523942568|FG000|Overall Study|Withdrawal by Subject|16|||
145298236|NCT02979353|523942569|FG001|Overall Study|Withdrawal by Subject|12|||
145298237|NCT02979353|523942568|FG000|Overall Study|Death|10|||
145298238|NCT02979353|523942569|FG001|Overall Study|Death|11|||
145298239|NCT02979353|523942568|FG000|Overall Study|Transfer to Hospice Care|19|||
145298240|NCT02979353|523942569|FG001|Overall Study|Transfer to Hospice Care|14|||
145298241|NCT02979353|523942568|FG000|Overall Study|Lost to Follow-up|1|||
145298242|NCT02979353|523942569|FG001|Overall Study|Lost to Follow-up|5|||
145298243|NCT01722877|523942575|FG000|Overall Study|Death|1|||
145298244|NCT01722877|523942575|FG000|Overall Study|Lost to Follow-up|1|||
145298245|NCT03693430|523942576|FG000|Overall Study|Lost to Follow-up|3|||
145298246|NCT03693430|523942577|FG001|Overall Study|Lost to Follow-up|14|||
145298247|NCT03693430|523942576|FG000|Overall Study|Death|1|||
145298248|NCT03693430|523942577|FG001|Overall Study|Death|0|||
145298249|NCT03693430|523942576|FG000|Overall Study|Withdrawal by Subject|0|||
145298250|NCT03693430|523942577|FG001|Overall Study|Withdrawal by Subject|4|||
145298251|NCT00585689|523942578|FG000|Overall Study|Received different ABI-007 schedule|3|||
145298252|NCT00585689|523942578|FG000|Overall Study|Adverse Event|1|||
145298253|NCT00585689|523942578|FG000|Overall Study|Patient Declined Surgery|1|||
145298254|NCT00585689|523942578|FG000|Overall Study|Patient had unresectable disease|1|||
145298255|NCT00585689|523942578|FG000|Overall Study|Death|1|||
145298256|NCT02930005|523942579|FG000|Overall Study|Lost to Follow-up|1|||
145298257|NCT02930005|523942580|FG001|Overall Study|Lost to Follow-up|5|||
145298258|NCT02373098|523942582|FG000|Overall Study|Lost to Follow-up|1|||
145298259|NCT02373098|523942583|FG001|Overall Study|Lost to Follow-up|0|||
145298260|NCT02373098|523942582|FG000|Overall Study|Protocol Violation|3|||
145298261|NCT02373098|523942583|FG001|Overall Study|Protocol Violation|0|||
145298262|NCT02373098|523942582|FG000|Overall Study|Withdrawal by Subject|5|||
145298263|NCT02373098|523942583|FG001|Overall Study|Withdrawal by Subject|0|||
145298264|NCT02373098|523942582|FG000|Overall Study|Adverse Event|3|||
145298265|NCT02373098|523942583|FG001|Overall Study|Adverse Event|0|||
145298266|NCT05067647|523942589|FG000|Overall Study|Lost to Follow-up|1|||
145298267|NCT03897088|523942592|FG000|Overall Study|Withdrawal by Subject|12|||
145298268|NCT03897088|523942593|FG001|Overall Study|Withdrawal by Subject|12|||
145298269|NCT03897088|523942592|FG000|Overall Study|Lost to Follow-up|7|||
145298270|NCT03897088|523942593|FG001|Overall Study|Lost to Follow-up|15|||
145298271|NCT03897088|523942592|FG000|Overall Study|Sponsor Decision|1|||
145298272|NCT03897088|523942593|FG001|Overall Study|Sponsor Decision|2|||
145298273|NCT03897088|523942592|FG000|Overall Study|COVID-19|2|||
145298274|NCT03897088|523942593|FG001|Overall Study|COVID-19|0|||
145298275|NCT03897088|523942592|FG000|Overall Study|Other|3|||
145298276|NCT03897088|523942593|FG001|Overall Study|Other|0|||
145298277|NCT03897088|523942592|FG000|Overall Study|Non-compliance with Study Drug|1|||
145298278|NCT03897088|523942593|FG001|Overall Study|Non-compliance with Study Drug|1|||
145298279|NCT03897088|523942592|FG000|Overall Study|Pregnancy|0|||
145246366|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145246367|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
145246368|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
145246369|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
145246370|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
145246371|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
145246372|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145246373|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
145246374|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
145246375|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145246376|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145246377|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
145246378|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
145298280|NCT03897088|523942593|FG001|Overall Study|Pregnancy|1|||
145298281|NCT00855738|523942598|FG000|Overall Study|Lost to Follow-up|2|||
145298282|NCT00855738|523942598|FG000|Overall Study|Adverse Event|1|||
145246379|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
145246380|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
145246381|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
145246382|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
145298283|NCT00855738|523942598|FG000|Overall Study|Subject Defaulted|1|||
145298284|NCT00855738|523942598|FG000|Overall Study|Death|1|||
145298285|NCT04320849|523942609|FG000|Overall Study|Withdrawal by Subject|4|||
145298286|NCT04320849|523942609|FG000|Overall Study|Imaging data unavailable|2|||
145298287|NCT04320849|523942609|FG000|Overall Study|Incomplete imaging|2|||
145298288|NCT00319735|523942614|FG000|Overall Study|Death|2|||
145298289|NCT03929393|523942615|FG000|Overall Study|Death|1|||
145298290|NCT03929393|523942616|FG001|Overall Study|Death|0|||
145298291|NCT03929393|523942615|FG000|Overall Study|Time Commitment|2|||
145298292|NCT03929393|523942616|FG001|Overall Study|Time Commitment|5|||
145298293|NCT03929393|523942615|FG000|Overall Study|Motor Vehicle Accident|0|||
145298294|NCT03929393|523942616|FG001|Overall Study|Motor Vehicle Accident|1|||
145298295|NCT03929393|523942615|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
145246383|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
145246384|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
145246385|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
145246386|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
145246387|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145246388|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
145246389|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145298296|NCT03929393|523942616|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
145298297|NCT03929393|523942615|FG000|Overall Study|Other|1|||
145298298|NCT03929393|523942616|FG001|Overall Study|Other|3|||
145298299|NCT00119379|523942626|FG000|Overall Study|Adverse Event|4|||
145298300|NCT00119379|523942627|FG001|Overall Study|Adverse Event|1|||
145298301|NCT01569152|523942630|FG000|Phase IIa, Period 1|Early Escape|5|||
145298302|NCT01569152|523942631|FG001|Phase IIa, Period 1|Early Escape|22|||
145298303|NCT01569152|523942632|FG002|Phase IIa, Period 1|Early Escape|0|||
145298304|NCT01569152|523942630|FG000|Phase IIa, Period 1|Adverse Event|4|||
145298305|NCT01569152|523942631|FG001|Phase IIa, Period 1|Adverse Event|0|||
145298306|NCT01569152|523942632|FG002|Phase IIa, Period 1|Adverse Event|0|||
145298307|NCT01569152|523942630|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
145298308|NCT01569152|523942631|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
145298309|NCT01569152|523942632|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
145298310|NCT01569152|523942630|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
145298311|NCT01569152|523942631|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
145298312|NCT01569152|523942632|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
145298313|NCT01569152|523942630|FG000|Phase IIa, Period 1|Protocol Violation|0|||
145298314|NCT01569152|523942631|FG001|Phase IIa, Period 1|Protocol Violation|1|||
145298315|NCT01569152|523942632|FG002|Phase IIa, Period 1|Protocol Violation|0|||
145298316|NCT01569152|523942630|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
145298317|NCT01569152|523942631|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
145298318|NCT01569152|523942632|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
145298319|NCT01569152|523942630|FG000|Safety Extension, Period 3|Adverse Event|0|||
145298320|NCT01569152|523942631|FG001|Safety Extension, Period 3|Adverse Event|0|||
145298321|NCT01569152|523942632|FG002|Safety Extension, Period 3|Adverse Event|4|||
145298322|NCT01569152|523942630|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
145298323|NCT01569152|523942631|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
145298324|NCT01569152|523942632|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
145298325|NCT01569152|523942630|FG000|Safety Extension, Period 3|Physician Decision|0|||
145298326|NCT01569152|523942631|FG001|Safety Extension, Period 3|Physician Decision|0|||
145298327|NCT01569152|523942632|FG002|Safety Extension, Period 3|Physician Decision|2|||
145298328|NCT01569152|523942630|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
145298329|NCT01569152|523942631|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
145298330|NCT01569152|523942632|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
145298331|NCT01706536|523942633|FG000|Overall Study|Withdrawal by Subject|1|||
145298332|NCT01706536|523942634|FG001|Overall Study|Withdrawal by Subject|0|||
145298333|NCT01706536|523942635|FG002|Overall Study|Withdrawal by Subject|1|||
145298334|NCT01706536|523942636|FG003|Overall Study|Withdrawal by Subject|0|||
145298335|NCT01706536|523942637|FG004|Overall Study|Withdrawal by Subject|0|||
145298336|NCT01706536|523942633|FG000|Overall Study|Adverse Event|2|||
145298337|NCT01706536|523942634|FG001|Overall Study|Adverse Event|3|||
145298338|NCT01706536|523942635|FG002|Overall Study|Adverse Event|4|||
145298339|NCT01706536|523942636|FG003|Overall Study|Adverse Event|3|||
145298340|NCT01706536|523942637|FG004|Overall Study|Adverse Event|2|||
145298341|NCT01706536|523942633|FG000|Overall Study|Lack of Efficacy|1|||
145298342|NCT01706536|523942634|FG001|Overall Study|Lack of Efficacy|0|||
145298343|NCT01706536|523942635|FG002|Overall Study|Lack of Efficacy|0|||
145298344|NCT01706536|523942636|FG003|Overall Study|Lack of Efficacy|1|||
145298345|NCT01706536|523942637|FG004|Overall Study|Lack of Efficacy|0|||
145298346|NCT01706536|523942633|FG000|Overall Study|non compliance|0|||
145298347|NCT01706536|523942634|FG001|Overall Study|non compliance|1|||
145298348|NCT01706536|523942635|FG002|Overall Study|non compliance|0|||
145298349|NCT01706536|523942636|FG003|Overall Study|non compliance|0|||
145298350|NCT01706536|523942637|FG004|Overall Study|non compliance|0|||
145409355|NCT00580840|524352004|FG001|Double-Blind|Loss of Efficacy|1|||
145409356|NCT00580840|524352005|FG002|Double-Blind|Loss of Efficacy|2|||
145409357|NCT00580840|524352006|FG003|Double-Blind|Loss of Efficacy|10|||
145246390|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145298351|NCT03262012|523942638|FG000|Overall Study|Withdrawal by Subject|15|||
145298352|NCT03262012|523942639|FG001|Overall Study|Withdrawal by Subject|13|||
145298353|NCT03262012|523942640|FG002|Overall Study|Withdrawal by Subject|8|||
145298354|NCT03262012|523942641|FG003|Overall Study|Withdrawal by Subject|7|||
145298355|NCT03262012|523942638|FG000|Overall Study|Adverse Event|10|||
145298356|NCT03262012|523942639|FG001|Overall Study|Adverse Event|12|||
145298357|NCT03262012|523942640|FG002|Overall Study|Adverse Event|4|||
145298358|NCT03262012|523942641|FG003|Overall Study|Adverse Event|6|||
145298359|NCT03262012|523942638|FG000|Overall Study|Physician Decision|2|||
145409358|NCT00580840|524352003|FG000|Double-Blind|Lost to Follow-up|0|||
145409359|NCT00580840|524352004|FG001|Double-Blind|Lost to Follow-up|1|||
145409360|NCT00580840|524352005|FG002|Double-Blind|Lost to Follow-up|0|||
145409361|NCT00580840|524352006|FG003|Double-Blind|Lost to Follow-up|2|||
145409362|NCT00580840|524352003|FG000|Double-Blind|Withdrawal by Subject|0|||
145409363|NCT00580840|524352004|FG001|Double-Blind|Withdrawal by Subject|1|||
145409364|NCT00580840|524352005|FG002|Double-Blind|Withdrawal by Subject|2|||
145409365|NCT00580840|524352006|FG003|Double-Blind|Withdrawal by Subject|2|||
145409366|NCT00580840|524352003|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
145409367|NCT00580840|524352004|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
145409368|NCT00580840|524352005|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
145409369|NCT00580840|524352006|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
145409370|NCT00580840|524352003|FG000|Double-Blind|Other: Forbidden Medication|0|||
145409371|NCT00580840|524352004|FG001|Double-Blind|Other: Forbidden Medication|0|||
145409372|NCT00580840|524352005|FG002|Double-Blind|Other: Forbidden Medication|1|||
145409373|NCT00580840|524352006|FG003|Double-Blind|Other: Forbidden Medication|0|||
145409374|NCT01402700|524352007|FG000|Overall Study|Death|3|||
145409375|NCT01402700|524352007|FG000|Overall Study|Withdrawal by Subject|3|||
145409376|NCT01402700|524352007|FG000|Overall Study|Missed Visit|1|||
145409377|NCT03805841|524352008|FG000|Overall Study|Clinical Progression|2|||
145409378|NCT03805841|524352009|FG001|Overall Study|Clinical Progression|0|||
145409379|NCT03805841|524352010|FG002|Overall Study|Clinical Progression|0|||
145409380|NCT03805841|524352008|FG000|Overall Study|Death|0|||
145409381|NCT03805841|524352009|FG001|Overall Study|Death|3|||
145409382|NCT03805841|524352010|FG002|Overall Study|Death|1|||
145409383|NCT03805841|524352008|FG000|Overall Study|Lost to Follow-up|0|||
145409384|NCT03805841|524352009|FG001|Overall Study|Lost to Follow-up|0|||
145409385|NCT03805841|524352010|FG002|Overall Study|Lost to Follow-up|1|||
145409386|NCT03805841|524352008|FG000|Overall Study|Withdrawal by Subject|2|||
145409387|NCT03805841|524352009|FG001|Overall Study|Withdrawal by Subject|3|||
145409388|NCT03805841|524352010|FG002|Overall Study|Withdrawal by Subject|0|||
145409389|NCT03805841|524352008|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
145409390|NCT03805841|524352009|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
145409391|NCT03805841|524352010|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
145409392|NCT01910441|524352011|FG000|Overall Study|Sponsor decision|0|||
145409393|NCT01910441|524352012|FG001|Overall Study|Sponsor decision|2|||
145409394|NCT01910441|524352011|FG000|Overall Study|Lost to Follow-up|6|||
145409395|NCT01910441|524352012|FG001|Overall Study|Lost to Follow-up|5|||
145409396|NCT01910441|524352011|FG000|Overall Study|Withdrawal by Subject|0|||
145409397|NCT01910441|524352012|FG001|Overall Study|Withdrawal by Subject|1|||
145409398|NCT01910441|524352011|FG000|Overall Study|Non-compliance|0|||
145409399|NCT01910441|524352012|FG001|Overall Study|Non-compliance|1|||
145409400|NCT01910441|524352011|FG000|Overall Study|Adverse Event|1|||
145409401|NCT01910441|524352012|FG001|Overall Study|Adverse Event|0|||
145409402|NCT01910441|524352011|FG000|Overall Study|Physician Decision|0|||
145409403|NCT01910441|524352012|FG001|Overall Study|Physician Decision|1|||
145409404|NCT00141817|524352013|FG000|Overall Study|Protocol Violation|0|||
145409405|NCT00141817|524352014|FG001|Overall Study|Protocol Violation|0|||
145409406|NCT00141817|524352015|FG002|Overall Study|Protocol Violation|1|||
145409407|NCT00141817|524352016|FG003|Overall Study|Protocol Violation|0|||
145409408|NCT00141817|524352013|FG000|Overall Study|Parent request|1|||
145409409|NCT00141817|524352014|FG001|Overall Study|Parent request|0|||
145409410|NCT00141817|524352015|FG002|Overall Study|Parent request|0|||
145409411|NCT00141817|524352016|FG003|Overall Study|Parent request|0|||
145409412|NCT01126424|524353746|FG000|Overall Study|Adverse Event|0|||
145409413|NCT01126424|524353747|FG001|Overall Study|Adverse Event|0|||
145409414|NCT01126424|524353748|FG002|Overall Study|Adverse Event|0|||
145409415|NCT01126424|524353749|FG003|Overall Study|Adverse Event|0|||
145409416|NCT01126424|524353750|FG004|Overall Study|Adverse Event|1|||
145409417|NCT01126424|524353751|FG005|Overall Study|Adverse Event|0|||
145409418|NCT01126424|524353746|FG000|Overall Study|Withdrawal by Subject|0|||
145409419|NCT01126424|524353747|FG001|Overall Study|Withdrawal by Subject|0|||
145409420|NCT01126424|524353748|FG002|Overall Study|Withdrawal by Subject|1|||
145409421|NCT01126424|524353749|FG003|Overall Study|Withdrawal by Subject|3|||
145409422|NCT01126424|524353750|FG004|Overall Study|Withdrawal by Subject|1|||
145409423|NCT01126424|524353751|FG005|Overall Study|Withdrawal by Subject|0|||
145409424|NCT02127671|524353752|FG000|Overall Study|Death|2|||
145620222|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
145620223|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
145409425|NCT02127671|524353753|FG001|Overall Study|Death|2|||
145409426|NCT02127671|524353752|FG000|Overall Study|Lost to Follow-up|4|||
145409427|NCT02127671|524353753|FG001|Overall Study|Lost to Follow-up|2|||
145409428|NCT02127671|524353752|FG000|Overall Study|Physician Decision|1|||
145409429|NCT02127671|524353753|FG001|Overall Study|Physician Decision|0|||
145409430|NCT02127671|524353752|FG000|Overall Study|incarceration|0|||
145409431|NCT02127671|524353753|FG001|Overall Study|incarceration|1|||
145409432|NCT02127671|524353752|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
145246391|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145246392|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
145246393|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
145246394|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
145246395|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
145246396|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
145246397|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
145246398|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
145246399|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
145246400|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
145246401|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
145246402|NCT03107793|523748127|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
145246403|NCT03107793|523748128|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
145246404|NCT03107793|523748129|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
145246405|NCT03107793|523748130|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
145246406|NCT03107793|523748131|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
145246407|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
145246408|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
145246409|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
145246410|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
145246411|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
145246412|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
145246413|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
145246414|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
145246415|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
145246416|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
145246417|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
145246418|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
145246419|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
145246420|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
145246421|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
145246422|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Death|0|||
145246423|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Death|0|||
145246424|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Death|0|||
145246425|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Death|0|||
145246426|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Death|1|||
145246427|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
145246428|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
145246429|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
145246430|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
145246431|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
145246432|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
145246433|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
145246434|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
145246435|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
145246436|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
145246437|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
145246438|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
145246439|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
145246440|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
145246441|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
145246442|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
145246443|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
145246444|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
145246445|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
145246446|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
145246447|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
145246448|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
145246449|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
145246450|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
145246451|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
145246452|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Other|0|||
145246453|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Other|0|||
145246454|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Other|0|||
145566302|NCT03131440|524934216|FG018|Overall Study|Withdrawal by Subject|1|||
145246455|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Other|1|||
145246456|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Other|3|||
145246457|NCT03107793|523748127|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
145246458|NCT03107793|523748128|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
145246459|NCT03107793|523748129|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
145246460|NCT03107793|523748130|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
145246461|NCT03107793|523748131|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
145246462|NCT00246376|523748141|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
145246463|NCT00246376|523748142|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
145246464|NCT00246376|523748143|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
145246465|NCT00246376|523748144|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
145246466|NCT00246376|523748145|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
145246467|NCT00246376|523748141|FG000|Overall Study|Adverse Event|2|||
145246468|NCT00246376|523748142|FG001|Overall Study|Adverse Event|3|||
145246469|NCT00246376|523748143|FG002|Overall Study|Adverse Event|1|||
145246470|NCT00246376|523748144|FG003|Overall Study|Adverse Event|3|||
145246471|NCT00246376|523748145|FG004|Overall Study|Adverse Event|1|||
145246472|NCT00246376|523748141|FG000|Overall Study|Lost to Follow-up|2|||
145246473|NCT00246376|523748142|FG001|Overall Study|Lost to Follow-up|11|||
145246474|NCT00246376|523748143|FG002|Overall Study|Lost to Follow-up|11|||
145246475|NCT00246376|523748144|FG003|Overall Study|Lost to Follow-up|16|||
145246476|NCT00246376|523748145|FG004|Overall Study|Lost to Follow-up|13|||
145246477|NCT01872897|523748146|FG000|Overall Study|Withdrawal by Subject|1|||
145246478|NCT01872897|523748147|FG001|Overall Study|Withdrawal by Subject|0|||
145246479|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
145246480|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
145246481|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
145246482|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
145246483|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
145246484|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
145246485|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
145246486|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
145246487|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
145246488|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
145246489|NCT02418585|523748152|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
145246490|NCT02418585|523748153|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
145246491|NCT02418585|523748152|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
145246492|NCT02418585|523748153|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
145566303|NCT03131440|524934217|FG019|Overall Study|Withdrawal by Subject|0|||
145246493|NCT02418585|523748152|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
145246494|NCT02418585|523748153|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
145246495|NCT02418585|523748152|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
145246496|NCT02418585|523748153|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
145246497|NCT02418585|523748152|FG000|Follow-up Phase (24 Weeks)|Other|3|||
145246498|NCT02418585|523748153|FG001|Follow-up Phase (24 Weeks)|Other|2|||
145246499|NCT02040857|523748154|FG000|Overall Study|Adverse Event|14|||
145246500|NCT02040857|523748154|FG000|Overall Study|Physician Decision|5|||
145246501|NCT02040857|523748154|FG000|Overall Study|Withdrawal by Subject|31|||
145246502|NCT02040857|523748154|FG000|Overall Study|patient non-compliance|3|||
145246503|NCT02040857|523748154|FG000|Overall Study|Lost to Follow-up|2|||
145246504|NCT02040857|523748154|FG000|Overall Study|recurrence|4|||
145246505|NCT02040857|523748154|FG000|Overall Study|ineligible|1|||
145246506|NCT00329784|523748157|FG000|Overall Study|Lost to Follow-up|0|||
145246507|NCT00329784|523748158|FG001|Overall Study|Lost to Follow-up|1|||
145246508|NCT00329784|523748159|FG002|Overall Study|Lost to Follow-up|0|||
145246509|NCT00329784|523748160|FG003|Overall Study|Lost to Follow-up|0|||
145246510|NCT00329784|523748157|FG000|Overall Study|Withdrawal by Subject|4|||
145246511|NCT00329784|523748158|FG001|Overall Study|Withdrawal by Subject|2|||
145246512|NCT00329784|523748159|FG002|Overall Study|Withdrawal by Subject|0|||
145246513|NCT00329784|523748160|FG003|Overall Study|Withdrawal by Subject|0|||
145246514|NCT00329784|523748157|FG000|Overall Study|Other|1|||
145246515|NCT00329784|523748158|FG001|Overall Study|Other|2|||
145246516|NCT00329784|523748159|FG002|Overall Study|Other|0|||
145246517|NCT00329784|523748160|FG003|Overall Study|Other|0|||
145246518|NCT01098032|523748161|FG000|Overall Study|Withdrawal by Subject|1|||
145246519|NCT01098032|523748162|FG001|Overall Study|Withdrawal by Subject|1|||
145246520|NCT03152110|523748185|FG000|Overall Study|Withdrawal by Subject|3|||
145246521|NCT00552344|523748188|FG000|Overall Study|Lack of Efficacy|55|||
145246522|NCT00552344|523748188|FG000|Overall Study|Loss of efficacy|75|||
145246523|NCT00552344|523748188|FG000|Overall Study|Lost to Follow-up|8|||
145246524|NCT00552344|523748188|FG000|Overall Study|Withdrawal by Subject|48|||
145246525|NCT00552344|523748188|FG000|Overall Study|SAE, non-fatal|6|||
145298360|NCT03262012|523942639|FG001|Overall Study|Physician Decision|5|||
145409433|NCT02127671|524353753|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
145409434|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
145409435|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
145246526|NCT00552344|523748188|FG000|Overall Study|AE, non-serious non-fatal|38|||
145246527|NCT00552344|523748188|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
145246528|NCT00552344|523748188|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
145246529|NCT00552344|523748188|FG000|Overall Study|Other Reason|22|||
145246530|NCT01634100|523748189|FG000|Overall Study|Withdrawal by Subject|1|||
145409436|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
145409437|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
145409438|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
145409439|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
145409440|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145409441|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145409442|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
145409443|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
145409444|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
145409445|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
145409446|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
145409447|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
145409448|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
145409449|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
145409450|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145409451|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
145409452|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145409453|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
145409454|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145409455|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
145409456|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145409457|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
145409458|NCT00620542|524353763|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
145409459|NCT00620542|524353764|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
145409460|NCT00620542|524353765|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
145409461|NCT00620542|524353766|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
145409462|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
145409463|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
145409464|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
145409465|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
145409466|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
145409467|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
145409468|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
145409469|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
145409470|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
145409471|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
145409472|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
145409473|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
145409474|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
145409475|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
145409476|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
145409477|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
145409478|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
145409479|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
145409480|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
145409481|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
145409482|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
145409483|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
145409484|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
145409485|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
145409486|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
145409487|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
145409488|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
145409489|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
145409490|NCT00620542|524353763|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
145409491|NCT00620542|524353764|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
145409492|NCT00620542|524353765|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
145246531|NCT01634100|523748190|FG001|Overall Study|Withdrawal by Subject|0|||
145409493|NCT00620542|524353766|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
145409494|NCT01970371|524353767|FG000|Overall Study|Death|8|||
145409495|NCT01970371|524353768|FG001|Overall Study|Death|13|||
145409496|NCT01970371|524353769|FG002|Overall Study|Death|12|||
145246532|NCT01634100|523748191|FG002|Overall Study|Withdrawal by Subject|1|||
145246533|NCT01634100|523748192|FG003|Overall Study|Withdrawal by Subject|0|||
145246534|NCT01634100|523748193|FG004|Overall Study|Withdrawal by Subject|0|||
145566304|NCT03131440|524934218|FG020|Overall Study|Withdrawal by Subject|1|||
145566305|NCT03131440|524934219|FG021|Overall Study|Withdrawal by Subject|1|||
145566306|NCT03131440|524934220|FG022|Overall Study|Withdrawal by Subject|1|||
145246535|NCT01634100|523748194|FG005|Overall Study|Withdrawal by Subject|0|||
145246536|NCT00471276|523748195|FG000|Overall Study|Death|2|||
145246537|NCT00471276|523748195|FG000|Overall Study|Adverse Event|16|||
145246538|NCT00471276|523748195|FG000|Overall Study|Protocol Violation|1|||
145246539|NCT00471276|523748195|FG000|Overall Study|Objective progression or relapse|54|||
145246540|NCT00471276|523748195|FG000|Overall Study|Global deterioration of health status|1|||
145246541|NCT00471276|523748195|FG000|Overall Study|Other|3|||
145246542|NCT00471276|523748195|FG000|Overall Study|Refused treatment|6|||
145246543|NCT00744991|523748196|FG000|Overall Study|Progressive Disease|11|||
145298361|NCT03262012|523942640|FG002|Overall Study|Physician Decision|1|||
145298362|NCT03262012|523942641|FG003|Overall Study|Physician Decision|0|||
145620224|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
145298363|NCT03262012|523942638|FG000|Overall Study|Lack of Efficacy|0|||
145566307|NCT03131440|524934221|FG023|Overall Study|Withdrawal by Subject|0|||
145566308|NCT03131440|524934222|FG024|Overall Study|Withdrawal by Subject|0|||
145566309|NCT03131440|524934223|FG025|Overall Study|Withdrawal by Subject|0|||
145566310|NCT03131440|524934224|FG026|Overall Study|Withdrawal by Subject|0|||
145566311|NCT03131440|524934225|FG027|Overall Study|Withdrawal by Subject|0|||
145566312|NCT03131440|524934226|FG028|Overall Study|Withdrawal by Subject|0|||
145566313|NCT03131440|524934227|FG029|Overall Study|Withdrawal by Subject|0|||
145566314|NCT03131440|524934228|FG030|Overall Study|Withdrawal by Subject|1|||
145566315|NCT03131440|524934229|FG031|Overall Study|Withdrawal by Subject|0|||
145566316|NCT03131440|524934198|FG000|Overall Study|Lost to Follow-up|0|||
145566317|NCT03131440|524934199|FG001|Overall Study|Lost to Follow-up|0|||
145566318|NCT03131440|524934200|FG002|Overall Study|Lost to Follow-up|0|||
145566319|NCT03131440|524934201|FG003|Overall Study|Lost to Follow-up|0|||
145566320|NCT03131440|524934202|FG004|Overall Study|Lost to Follow-up|0|||
145566321|NCT03131440|524934203|FG005|Overall Study|Lost to Follow-up|1|||
145620225|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
145620226|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
145620227|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
145620228|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
145620229|NCT01473420|525123712|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
145298364|NCT03262012|523942639|FG001|Overall Study|Lack of Efficacy|5|||
145298365|NCT03262012|523942640|FG002|Overall Study|Lack of Efficacy|1|||
145298366|NCT03262012|523942641|FG003|Overall Study|Lack of Efficacy|2|||
145298367|NCT03262012|523942638|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
145298368|NCT03262012|523942639|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
145298369|NCT03262012|523942640|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
145298370|NCT03262012|523942641|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
145298371|NCT01469546|523942644|FG000|Received 5 mg Dose|Adverse Event|13|||
145298372|NCT01469546|523942644|FG000|Received 5 mg Dose|Death|2|||
145298373|NCT01469546|523942644|FG000|Received 5 mg Dose|Protocol Violation|2|||
145298374|NCT01469546|523942644|FG000|Received 5 mg Dose|Progressive Disease|3|||
145298375|NCT01469546|523942644|FG000|Received 5 mg Dose|Physician Decision|3|||
145298376|NCT00385684|523942645|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
145298377|NCT00385684|523942646|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
145298378|NCT00385684|523942645|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
145298379|NCT00385684|523942646|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
145298380|NCT00385684|523942645|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
145298381|NCT00385684|523942646|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
145298382|NCT01811953|523944887|FG000|Overall Study|Adverse Event|0|||
145298383|NCT01811953|523944888|FG001|Overall Study|Adverse Event|0|||
145298384|NCT01811953|523944889|FG002|Overall Study|Adverse Event|0|||
145298385|NCT01811953|523944890|FG003|Overall Study|Adverse Event|1|||
145298386|NCT01811953|523944891|FG004|Overall Study|Adverse Event|0|||
145298387|NCT01811953|523944892|FG005|Overall Study|Adverse Event|1|||
145298388|NCT01811953|523944887|FG000|Overall Study|Protocol Violation|0|||
145298389|NCT01811953|523944888|FG001|Overall Study|Protocol Violation|0|||
145298390|NCT01811953|523944889|FG002|Overall Study|Protocol Violation|0|||
145298391|NCT01811953|523944890|FG003|Overall Study|Protocol Violation|0|||
145298392|NCT01811953|523944891|FG004|Overall Study|Protocol Violation|1|||
145298393|NCT01811953|523944892|FG005|Overall Study|Protocol Violation|0|||
145246544|NCT00744991|523748196|FG000|Overall Study|Withdrawal by Subject|8|||
145246545|NCT00744991|523748196|FG000|Overall Study|Physician Decision|3|||
145298394|NCT03655106|523944894|FG000|Overall Study|Withdrawal by Subject|3|||
145298395|NCT03655106|523944895|FG001|Overall Study|Withdrawal by Subject|2|||
145298396|NCT03655106|523944894|FG000|Overall Study|Lost to Follow-up|2|||
145298397|NCT03655106|523944895|FG001|Overall Study|Lost to Follow-up|1|||
145298398|NCT03655106|523944894|FG000|Overall Study|Duplicate Enrollment|1|||
145566322|NCT03131440|524934204|FG006|Overall Study|Lost to Follow-up|0|||
145246546|NCT00744991|523748196|FG000|Overall Study|Adverse Event|2|||
145246547|NCT00744991|523748196|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
145246548|NCT01662986|523748197|FG000|Overall Study|Adverse Event|5|||
145246549|NCT01662986|523748198|FG001|Overall Study|Adverse Event|4|||
145246550|NCT01662986|523748197|FG000|Overall Study|Protocol Violation|2|||
145246551|NCT01662986|523748198|FG001|Overall Study|Protocol Violation|3|||
145246552|NCT01662986|523748197|FG000|Overall Study|Lost to Follow-up|5|||
145246553|NCT01662986|523748198|FG001|Overall Study|Lost to Follow-up|4|||
145246554|NCT01662986|523748197|FG000|Overall Study|Withdrawal by Subject|2|||
145246555|NCT01662986|523748198|FG001|Overall Study|Withdrawal by Subject|2|||
145246556|NCT01662986|523748197|FG000|Overall Study|Not Treated|1|||
145246557|NCT01662986|523748198|FG001|Overall Study|Not Treated|0|||
145246558|NCT01662986|523748197|FG000|Overall Study|Other than stated above|3|||
145246559|NCT01662986|523748198|FG001|Overall Study|Other than stated above|0|||
145246560|NCT01487863|523748199|FG000|Overall Study|Death|19|||
145246561|NCT01487863|523748200|FG001|Overall Study|Death|19|||
145246562|NCT01975376|523748201|FG000|Overall Study|Adverse Event|5|||
145246563|NCT01975376|523748202|FG001|Overall Study|Adverse Event|5|||
145246564|NCT01975376|523748201|FG000|Overall Study|Death|65|||
145246565|NCT01975376|523748202|FG001|Overall Study|Death|72|||
145246566|NCT01975376|523748201|FG000|Overall Study|Lost to Follow-up|70|||
145246567|NCT01975376|523748202|FG001|Overall Study|Lost to Follow-up|66|||
145246568|NCT01975376|523748201|FG000|Overall Study|Withdrew consent|68|||
145246569|NCT01975376|523748202|FG001|Overall Study|Withdrew consent|62|||
145246570|NCT01975376|523748201|FG000|Overall Study|Other|2|||
145246571|NCT01975376|523748202|FG001|Overall Study|Other|4|||
145246572|NCT01975376|523748201|FG000|Overall Study|Randomized, Not Treated|16|||
145246573|NCT01975376|523748202|FG001|Overall Study|Randomized, Not Treated|8|||
145246574|NCT04449276|523748203|FG000|Overall Study|Adverse Event|1|||
145246575|NCT04449276|523748204|FG001|Overall Study|Adverse Event|2|||
145246576|NCT04449276|523748205|FG002|Overall Study|Adverse Event|0|||
145246577|NCT04449276|523748206|FG003|Overall Study|Adverse Event|0|||
145246578|NCT04449276|523748207|FG004|Overall Study|Adverse Event|2|||
145246579|NCT04449276|523748208|FG005|Overall Study|Adverse Event|0|||
145246580|NCT04449276|523748209|FG006|Overall Study|Adverse Event|0|||
145246581|NCT04449276|523748210|FG007|Overall Study|Adverse Event|1|||
145246582|NCT04449276|523748203|FG000|Overall Study|Withdrawal by Subject|2|||
145246583|NCT04449276|523748204|FG001|Overall Study|Withdrawal by Subject|0|||
145246584|NCT04449276|523748205|FG002|Overall Study|Withdrawal by Subject|0|||
145246585|NCT04449276|523748206|FG003|Overall Study|Withdrawal by Subject|1|||
145246586|NCT04449276|523748207|FG004|Overall Study|Withdrawal by Subject|0|||
145246587|NCT04449276|523748208|FG005|Overall Study|Withdrawal by Subject|0|||
145246588|NCT04449276|523748209|FG006|Overall Study|Withdrawal by Subject|0|||
145246589|NCT04449276|523748210|FG007|Overall Study|Withdrawal by Subject|0|||
145246590|NCT04449276|523748203|FG000|Overall Study|Other|0|||
145246591|NCT04449276|523748204|FG001|Overall Study|Other|2|||
145246592|NCT04449276|523748205|FG002|Overall Study|Other|3|||
145246593|NCT04449276|523748206|FG003|Overall Study|Other|2|||
145246594|NCT04449276|523748207|FG004|Overall Study|Other|0|||
145246595|NCT04449276|523748208|FG005|Overall Study|Other|0|||
145246596|NCT04449276|523748209|FG006|Overall Study|Other|0|||
145246597|NCT04449276|523748210|FG007|Overall Study|Other|1|||
145246598|NCT01614795|523748213|FG000|Overall Study|Adverse Event|0|||
145246599|NCT01614795|523748214|FG001|Overall Study|Adverse Event|0|||
145246600|NCT01614795|523748215|FG002|Overall Study|Adverse Event|1|||
145246601|NCT01614795|523748216|FG003|Overall Study|Adverse Event|1|||
145246602|NCT01614795|523748213|FG000|Overall Study|Lack of Efficacy|10|||
145246603|NCT01614795|523748214|FG001|Overall Study|Lack of Efficacy|10|||
145246604|NCT01614795|523748215|FG002|Overall Study|Lack of Efficacy|9|||
145246605|NCT01614795|523748216|FG003|Overall Study|Lack of Efficacy|8|||
145246606|NCT01614795|523748213|FG000|Overall Study|Physician Decision|1|||
145246607|NCT01614795|523748214|FG001|Overall Study|Physician Decision|0|||
145246608|NCT01614795|523748215|FG002|Overall Study|Physician Decision|1|||
145298399|NCT03655106|523944895|FG001|Overall Study|Duplicate Enrollment|1|||
145246609|NCT01614795|523748216|FG003|Overall Study|Physician Decision|1|||
145246610|NCT01614795|523748213|FG000|Overall Study|Withdrawal by Subject|0|||
145246611|NCT01614795|523748214|FG001|Overall Study|Withdrawal by Subject|1|||
145246612|NCT01614795|523748215|FG002|Overall Study|Withdrawal by Subject|0|||
145246613|NCT01614795|523748216|FG003|Overall Study|Withdrawal by Subject|2|||
145246614|NCT01614795|523748213|FG000|Overall Study|Ineligible|0|||
145246615|NCT01614795|523748214|FG001|Overall Study|Ineligible|1|||
145246616|NCT01614795|523748215|FG002|Overall Study|Ineligible|0|||
145246617|NCT01614795|523748216|FG003|Overall Study|Ineligible|0|||
145246618|NCT00044213|523748217|FG000|Overall Study|Withdrawal by Subject|50|||
145246619|NCT00044213|523748218|FG001|Overall Study|Withdrawal by Subject|65|||
145246620|NCT00044213|523748219|FG002|Overall Study|Withdrawal by Subject|91|||
145246621|NCT00044213|523748220|FG003|Overall Study|Withdrawal by Subject|83|||
145246622|NCT00044213|523748217|FG000|Overall Study|Death|42|||
145246623|NCT00044213|523748218|FG001|Overall Study|Death|42|||
145246624|NCT00044213|523748219|FG002|Overall Study|Death|42|||
145246625|NCT00044213|523748220|FG003|Overall Study|Death|49|||
145246626|NCT00044213|523748217|FG000|Overall Study|Lost to Follow-up|8|||
145566323|NCT03131440|524934205|FG007|Overall Study|Lost to Follow-up|0|||
145566324|NCT03131440|524934206|FG008|Overall Study|Lost to Follow-up|0|||
145566325|NCT03131440|524934207|FG009|Overall Study|Lost to Follow-up|0|||
145566326|NCT03131440|524934208|FG010|Overall Study|Lost to Follow-up|0|||
145566327|NCT03131440|524934209|FG011|Overall Study|Lost to Follow-up|0|||
145566328|NCT03131440|524934210|FG012|Overall Study|Lost to Follow-up|0|||
145566329|NCT03131440|524934211|FG013|Overall Study|Lost to Follow-up|0|||
145566330|NCT03131440|524934212|FG014|Overall Study|Lost to Follow-up|0|||
145566331|NCT03131440|524934213|FG015|Overall Study|Lost to Follow-up|0|||
145566332|NCT03131440|524934214|FG016|Overall Study|Lost to Follow-up|0|||
145566333|NCT03131440|524934215|FG017|Overall Study|Lost to Follow-up|0|||
145566334|NCT03131440|524934216|FG018|Overall Study|Lost to Follow-up|0|||
145566335|NCT03131440|524934217|FG019|Overall Study|Lost to Follow-up|2|||
145566336|NCT03131440|524934218|FG020|Overall Study|Lost to Follow-up|1|||
145566337|NCT03131440|524934219|FG021|Overall Study|Lost to Follow-up|0|||
145566338|NCT03131440|524934220|FG022|Overall Study|Lost to Follow-up|1|||
145246627|NCT00044213|523748218|FG001|Overall Study|Lost to Follow-up|5|||
145246628|NCT00044213|523748219|FG002|Overall Study|Lost to Follow-up|5|||
145246629|NCT00044213|523748220|FG003|Overall Study|Lost to Follow-up|4|||
145246630|NCT00098865|523750341|FG000|Overall Study|Progressive Disease|6|||
145246631|NCT00098865|523750341|FG000|Overall Study|Adverse Event|2|||
145246632|NCT00098865|523750341|FG000|Overall Study|Alternative Therapy|1|||
145246633|NCT03050307|523750342|FG000|Overall Study|Adverse Event|4|||
145246634|NCT03050307|523750343|FG001|Overall Study|Adverse Event|2|||
145246635|NCT03050307|523750342|FG000|Overall Study|Significant Protocol Deviation|0|||
145246636|NCT03050307|523750343|FG001|Overall Study|Significant Protocol Deviation|1|||
145246637|NCT03050307|523750342|FG000|Overall Study|Lost to Follow-up|0|||
145298400|NCT03655106|523944894|FG000|Overall Study|Protocol Violation|3|||
145566339|NCT03131440|524934221|FG023|Overall Study|Lost to Follow-up|0|||
145566340|NCT03131440|524934222|FG024|Overall Study|Lost to Follow-up|1|||
145566341|NCT03131440|524934223|FG025|Overall Study|Lost to Follow-up|0|||
145566342|NCT03131440|524934224|FG026|Overall Study|Lost to Follow-up|0|||
145566343|NCT03131440|524934225|FG027|Overall Study|Lost to Follow-up|2|||
145566344|NCT03131440|524934226|FG028|Overall Study|Lost to Follow-up|0|||
145566345|NCT03131440|524934227|FG029|Overall Study|Lost to Follow-up|2|||
145566346|NCT03131440|524934228|FG030|Overall Study|Lost to Follow-up|0|||
145566347|NCT03131440|524934229|FG031|Overall Study|Lost to Follow-up|0|||
145566348|NCT03131440|524934198|FG000|Overall Study|Death|0|||
145566349|NCT03131440|524934199|FG001|Overall Study|Death|0|||
145566350|NCT03131440|524934200|FG002|Overall Study|Death|0|||
145566351|NCT03131440|524934201|FG003|Overall Study|Death|0|||
145566352|NCT03131440|524934202|FG004|Overall Study|Death|0|||
145566353|NCT03131440|524934203|FG005|Overall Study|Death|0|||
145566354|NCT03131440|524934204|FG006|Overall Study|Death|0|||
145566355|NCT03131440|524934205|FG007|Overall Study|Death|0|||
145566356|NCT03131440|524934206|FG008|Overall Study|Death|0|||
145566357|NCT03131440|524934207|FG009|Overall Study|Death|0|||
145566358|NCT03131440|524934208|FG010|Overall Study|Death|0|||
145566359|NCT03131440|524934209|FG011|Overall Study|Death|0|||
145566360|NCT03131440|524934210|FG012|Overall Study|Death|0|||
145566361|NCT03131440|524934211|FG013|Overall Study|Death|0|||
145566362|NCT03131440|524934212|FG014|Overall Study|Death|0|||
145566363|NCT03131440|524934213|FG015|Overall Study|Death|0|||
145566364|NCT03131440|524934214|FG016|Overall Study|Death|0|||
145566365|NCT03131440|524934215|FG017|Overall Study|Death|0|||
145566366|NCT03131440|524934216|FG018|Overall Study|Death|0|||
145566367|NCT03131440|524934217|FG019|Overall Study|Death|0|||
145566368|NCT03131440|524934218|FG020|Overall Study|Death|0|||
145566369|NCT03131440|524934219|FG021|Overall Study|Death|0|||
145566370|NCT03131440|524934220|FG022|Overall Study|Death|0|||
145566371|NCT03131440|524934221|FG023|Overall Study|Death|0|||
145566372|NCT03131440|524934222|FG024|Overall Study|Death|0|||
145298401|NCT03655106|523944895|FG001|Overall Study|Protocol Violation|0|||
145298402|NCT01993030|523944899|FG000|Overall Study|Adverse Event|0|||
145298403|NCT01993030|523944900|FG001|Overall Study|Adverse Event|4|||
145298404|NCT01049334|523944901|FG000|Overall Study|Withdrawal by Subject|5|||
145298405|NCT01049334|523944902|FG001|Overall Study|Withdrawal by Subject|3|||
145298406|NCT01049334|523944901|FG000|Overall Study|Adverse Event|2|||
145298407|NCT01049334|523944902|FG001|Overall Study|Adverse Event|3|||
145298408|NCT01049334|523944901|FG000|Overall Study|Physician Decision|2|||
145298409|NCT01049334|523944902|FG001|Overall Study|Physician Decision|0|||
145298410|NCT01049334|523944901|FG000|Overall Study|Protocol Violation|0|||
145298411|NCT01049334|523944902|FG001|Overall Study|Protocol Violation|1|||
145298412|NCT02736721|523944905|FG000|Overall Study|Adverse Event|8|||
145298413|NCT02736721|523944905|FG000|Overall Study|Lost to Follow-up|3|||
145566373|NCT03131440|524934223|FG025|Overall Study|Death|1|||
145566374|NCT03131440|524934224|FG026|Overall Study|Death|0|||
145566375|NCT03131440|524934225|FG027|Overall Study|Death|0|||
145566376|NCT03131440|524934226|FG028|Overall Study|Death|0|||
145298414|NCT02736721|523944905|FG000|Overall Study|Other|5|||
145566377|NCT03131440|524934227|FG029|Overall Study|Death|0|||
145566378|NCT03131440|524934228|FG030|Overall Study|Death|0|||
145566379|NCT03131440|524934229|FG031|Overall Study|Death|0|||
145566380|NCT00746941|524934232|FG000|Overall Study|Death|2|||
145566381|NCT00746941|524934233|FG001|Overall Study|Death|0|||
145566382|NCT00746941|524934234|FG002|Overall Study|Death|0|||
145246638|NCT03050307|523750343|FG001|Overall Study|Lost to Follow-up|1|||
145246639|NCT03050307|523750342|FG000|Overall Study|Voluntary Withdrawal|3|||
145246640|NCT03050307|523750343|FG001|Overall Study|Voluntary Withdrawal|4|||
145246641|NCT03050307|523750342|FG000|Overall Study|Reason not Specified|1|||
145246642|NCT03050307|523750343|FG001|Overall Study|Reason not Specified|1|||
145246643|NCT00439309|523750344|FG000|Follow-Up|Death|1|||
145246644|NCT00439309|523750345|FG001|Follow-Up|Death|0|||
145246645|NCT00439309|523750344|FG000|Follow-Up|Lost to Follow-up|2|||
145246646|NCT00439309|523750345|FG001|Follow-Up|Lost to Follow-up|0|||
145246647|NCT00439309|523750344|FG000|Follow-Up|Withdrawal by Subject|0|||
145246648|NCT00439309|523750345|FG001|Follow-Up|Withdrawal by Subject|1|||
145246649|NCT00439309|523750344|FG000|Follow-Up|Late response by subject|0|||
145246650|NCT00439309|523750345|FG001|Follow-Up|Late response by subject|1|||
145246651|NCT00430027|523750347|FG000|Overall Study|Study terminated|8|||
145246652|NCT00464620|523750348|FG000|Overall Study|Physician Decision|1|||
145246653|NCT00464620|523750349|FG001|Overall Study|Physician Decision|0|||
145246654|NCT00464620|523750350|FG002|Overall Study|Physician Decision|0|||
145246655|NCT00464620|523750348|FG000|Overall Study|Withdrawal by Subject|1|||
145246656|NCT00464620|523750349|FG001|Overall Study|Withdrawal by Subject|0|||
145246657|NCT00464620|523750350|FG002|Overall Study|Withdrawal by Subject|3|||
145246658|NCT00464620|523750348|FG000|Overall Study|Ineligible sarcoma subtype|0|||
145246659|NCT00464620|523750349|FG001|Overall Study|Ineligible sarcoma subtype|2|||
145246660|NCT00464620|523750350|FG002|Overall Study|Ineligible sarcoma subtype|2|||
145246661|NCT00464620|523750348|FG000|Overall Study|Use of prohibited concomitant medication|0|||
145246662|NCT00464620|523750349|FG001|Overall Study|Use of prohibited concomitant medication|0|||
145246663|NCT00464620|523750350|FG002|Overall Study|Use of prohibited concomitant medication|2|||
145246664|NCT01998906|523750351|FG000|Overall Study|Participants ongoing in follow-up|77|||
145246665|NCT01998906|523750352|FG001|Overall Study|Participants ongoing in follow-up|60|||
145246666|NCT01998906|523750353|FG002|Overall Study|Participants ongoing in follow-up|58|||
145246667|NCT01998906|523750351|FG000|Overall Study|Death|21|||
145298415|NCT03988803|523944906|FG000|Period 2|Prematurely discontinued from medication|2|||
145298416|NCT03988803|523944906|FG000|Period 2|Adverse Event|1|||
145298417|NCT05038293|523944910|FG000|Overall Study|device was not operating properly for one subject.|1|||
145298418|NCT05038293|523944911|FG001|Overall Study|device was not operating properly for one subject.|0|||
145298419|NCT05038293|523944910|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
145298420|NCT05038293|523944911|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
145298421|NCT01171989|523944912|FG000|Overall Study|Lost to Follow-up|0|||
145298422|NCT01171989|523944913|FG001|Overall Study|Lost to Follow-up|0|||
145298423|NCT01171989|523944914|FG002|Overall Study|Lost to Follow-up|1|||
145298424|NCT03136380|523944923|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145298425|NCT03136380|523944924|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
145298426|NCT03136380|523944925|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145298427|NCT03136380|523944926|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145298428|NCT03136380|523944927|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
145298429|NCT02419937|523944931|FG000|Overall Study|Lost to Follow-up|1|||
145298430|NCT02419937|523944932|FG001|Overall Study|Lost to Follow-up|0|||
145298431|NCT00910663|523944933|FG000|Period 1|Withdrawal by Subject|0|||
145298432|NCT00910663|523944934|FG001|Period 1|Withdrawal by Subject|1|||
145298433|NCT02865850|523944935|FG000|Overall Study|Death|15|||
145298434|NCT02865850|523944936|FG001|Overall Study|Death|19|||
145298435|NCT02865850|523944935|FG000|Overall Study|Withdrawal by Subject|3|||
145298436|NCT02865850|523944936|FG001|Overall Study|Withdrawal by Subject|2|||
145298437|NCT02865850|523944935|FG000|Overall Study|Lost to Follow-up|3|||
145298438|NCT02865850|523944936|FG001|Overall Study|Lost to Follow-up|2|||
145298439|NCT02726581|523944937|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
145298440|NCT02726581|523944938|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
145298441|NCT02726581|523944939|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
145246668|NCT01998906|523750352|FG001|Overall Study|Death|30|||
145246669|NCT01998906|523750353|FG002|Overall Study|Death|17|||
145246670|NCT01998906|523750351|FG000|Overall Study|Lack of Efficacy|10|||
145246671|NCT01998906|523750352|FG001|Overall Study|Lack of Efficacy|9|||
145246672|NCT01998906|523750353|FG002|Overall Study|Lack of Efficacy|8|||
145246673|NCT01998906|523750351|FG000|Overall Study|Failure to return|0|||
145246674|NCT01998906|523750352|FG001|Overall Study|Failure to return|2|||
145246675|NCT01998906|523750353|FG002|Overall Study|Failure to return|4|||
145298442|NCT02726581|523944937|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
145298443|NCT02726581|523944938|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
145566383|NCT00746941|524934235|FG003|Overall Study|Death|6|||
145566384|NCT00746941|524934232|FG000|Overall Study|Physician Decision|0|||
145246676|NCT01998906|523750351|FG000|Overall Study|Violation of Selection Criteria|0|||
145298444|NCT02726581|523944939|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
145409497|NCT01970371|524353767|FG000|Overall Study|Lost to Follow-up|0|||
145409498|NCT01970371|524353768|FG001|Overall Study|Lost to Follow-up|0|||
145409499|NCT01970371|524353769|FG002|Overall Study|Lost to Follow-up|1|||
145409500|NCT01481779|524353770|FG000|Overall Study|Adverse Event|23|||
145409501|NCT01481779|524353771|FG001|Overall Study|Adverse Event|5|||
145409502|NCT01481779|524353770|FG000|Overall Study|Lost to Follow-up|3|||
145409503|NCT01481779|524353771|FG001|Overall Study|Lost to Follow-up|2|||
145409504|NCT01481779|524353770|FG000|Overall Study|Protocol Violation|2|||
145409505|NCT01481779|524353771|FG001|Overall Study|Protocol Violation|3|||
145409506|NCT01481779|524353770|FG000|Overall Study|Withdrawal by Subject|26|||
145409507|NCT01481779|524353771|FG001|Overall Study|Withdrawal by Subject|13|||
145409508|NCT01481779|524353770|FG000|Overall Study|Physician Decision|13|||
145409509|NCT01481779|524353771|FG001|Overall Study|Physician Decision|4|||
145409510|NCT01481779|524353770|FG000|Overall Study|Sponsor Decision|3|||
145409511|NCT01481779|524353771|FG001|Overall Study|Sponsor Decision|1|||
145409512|NCT04115059|524353775|FG000|Overall Study|Withdrawal by Subject|1|||
145409513|NCT04115059|524353775|FG000|Overall Study|Lack of Efficacy|2|||
145409514|NCT03575364|524353783|FG000|Overall Study|Death|45|||
145409515|NCT03575364|524353783|FG000|Overall Study|Lost to Follow-up|114|||
145409516|NCT03575364|524353783|FG000|Overall Study|Withdrawal by Subject|21|||
145409517|NCT03575364|524353783|FG000|Overall Study|Physician Decision|11|||
145409518|NCT03575364|524353783|FG000|Overall Study|Subject Refused Follow-up|13|||
145409519|NCT03575364|524353783|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
145409520|NCT03575364|524353783|FG000|Overall Study|Patient moved out of the state|1|||
145409521|NCT03575364|524353783|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
145409522|NCT03575364|524353783|FG000|Overall Study|Patient is lost to follow up|1|||
145409523|NCT03575364|524353783|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
145409524|NCT05522751|524353784|FG000|Overall Study|Adverse Event|1|||
145409525|NCT06420232|524353785|FG000|Overall Study|Withdrawal by Subject|3|||
145409526|NCT01582451|524353791|FG000|Overall Study|Adverse Event|1|||
145409527|NCT01582451|524353792|FG001|Overall Study|Adverse Event|3|||
145409528|NCT01582451|524353791|FG000|Overall Study|Death|3|||
145409529|NCT01582451|524353792|FG001|Overall Study|Death|3|||
145409530|NCT01582451|524353791|FG000|Overall Study|Lost to Follow-up|0|||
145409531|NCT01582451|524353792|FG001|Overall Study|Lost to Follow-up|2|||
145409532|NCT01582451|524353791|FG000|Overall Study|Protocol Violation|11|||
145409533|NCT01582451|524353792|FG001|Overall Study|Protocol Violation|3|||
145409534|NCT01582451|524353791|FG000|Overall Study|Withdrawal by Subject|13|||
145409535|NCT01582451|524353792|FG001|Overall Study|Withdrawal by Subject|9|||
145409536|NCT01582451|524353791|FG000|Overall Study|Physician Decision|3|||
145409537|NCT01582451|524353792|FG001|Overall Study|Physician Decision|0|||
145409538|NCT01582451|524353791|FG000|Overall Study|Sponsor Decision|1|||
145409539|NCT01582451|524353792|FG001|Overall Study|Sponsor Decision|0|||
145409540|NCT01369433|524353793|FG000|Overall Study|Adverse Event|31|||
145409541|NCT01369433|524353794|FG001|Overall Study|Adverse Event|1|||
145409542|NCT01369433|524353793|FG000|Overall Study|Required significant surgical procedure|1|||
145409543|NCT01369433|524353794|FG001|Overall Study|Required significant surgical procedure|0|||
145409544|NCT01369433|524353793|FG000|Overall Study|Non-compliance|1|||
145409545|NCT01369433|524353794|FG001|Overall Study|Non-compliance|0|||
145409546|NCT01369433|524353793|FG000|Overall Study|Withdrawal by Subject|5|||
145409547|NCT01369433|524353794|FG001|Overall Study|Withdrawal by Subject|2|||
145409548|NCT01369433|524353793|FG000|Overall Study|Study terminated by Sponsor|67|||
145409549|NCT01369433|524353794|FG001|Overall Study|Study terminated by Sponsor|0|||
145409550|NCT01369433|524353793|FG000|Overall Study|Lost to Follow-up|1|||
145409551|NCT01369433|524353794|FG001|Overall Study|Lost to Follow-up|0|||
145409552|NCT01369433|524353793|FG000|Overall Study|Death|5|||
145409553|NCT01369433|524353794|FG001|Overall Study|Death|0|||
145409554|NCT01369433|524353793|FG000|Overall Study|Investigator discretion|6|||
145409555|NCT01369433|524353794|FG001|Overall Study|Investigator discretion|1|||
145409556|NCT01369433|524353793|FG000|Overall Study|Progressive Disease|92|||
145409557|NCT01369433|524353794|FG001|Overall Study|Progressive Disease|12|||
145566385|NCT00746941|524934233|FG001|Overall Study|Physician Decision|0|||
145409558|NCT01838876|524353795|FG000|Overall Study|Adverse Event|49|||
145409559|NCT01838876|524353795|FG000|Overall Study|Insufficient Therapeutic Response|10|||
145409560|NCT01838876|524353795|FG000|Overall Study|Protocol Violation|34|||
145409561|NCT01838876|524353795|FG000|Overall Study|Withdrawal of Consent|33|||
145409562|NCT01838876|524353795|FG000|Overall Study|Lost to Follow-up|21|||
145409563|NCT01838876|524353795|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
145409564|NCT01838876|524353795|FG000|Overall Study|Reason not Specified|7|||
145409565|NCT01838876|524353795|FG000|Overall Study|Did not meet eligibility criteria|78|||
145409566|NCT00689936|524353796|FG000|Active Treatment Phase|Adverse Event|68|||
145409567|NCT00689936|524353797|FG001|Active Treatment Phase|Adverse Event|71|||
145409568|NCT00689936|524353798|FG002|Active Treatment Phase|Adverse Event|76|||
145409569|NCT00689936|524353796|FG000|Active Treatment Phase|Disease Progression|273|||
145409570|NCT00689936|524353797|FG001|Active Treatment Phase|Disease Progression|362|||
145409571|NCT00689936|524353798|FG002|Active Treatment Phase|Disease Progression|339|||
145566386|NCT00746941|524934234|FG002|Overall Study|Physician Decision|2|||
145566387|NCT00746941|524934235|FG003|Overall Study|Physician Decision|0|||
145409572|NCT00689936|524353796|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
145409573|NCT00689936|524353797|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
145409574|NCT00689936|524353798|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
145409575|NCT00689936|524353796|FG000|Active Treatment Phase|Death|60|||
145409576|NCT00689936|524353797|FG001|Active Treatment Phase|Death|28|||
145409577|NCT00689936|524353798|FG002|Active Treatment Phase|Death|37|||
145409578|NCT00689936|524353796|FG000|Active Treatment Phase|Lost to Follow-up|0|||
145409579|NCT00689936|524353797|FG001|Active Treatment Phase|Lost to Follow-up|2|||
145409580|NCT00689936|524353798|FG002|Active Treatment Phase|Lost to Follow-up|2|||
145409581|NCT00689936|524353796|FG000|Active Treatment Phase|Protocol Violation|2|||
145409582|NCT00689936|524353797|FG001|Active Treatment Phase|Protocol Violation|2|||
145409583|NCT00689936|524353798|FG002|Active Treatment Phase|Protocol Violation|4|||
145409584|NCT00689936|524353796|FG000|Active Treatment Phase|Study Close Out|64|||
145409585|NCT00689936|524353797|FG001|Active Treatment Phase|Study Close Out|26|||
145409586|NCT00689936|524353798|FG002|Active Treatment Phase|Study Close Out|21|||
145409587|NCT00689936|524353796|FG000|Active Treatment Phase|Miscellaneous|52|||
145409588|NCT00689936|524353797|FG001|Active Treatment Phase|Miscellaneous|34|||
145409589|NCT00689936|524353798|FG002|Active Treatment Phase|Miscellaneous|47|||
145409590|NCT00689936|524353796|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
145409591|NCT00689936|524353797|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
145409592|NCT00689936|524353798|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
145409593|NCT01682031|524353799|FG000|Overall Study|Withdrawal by Subject|0|||
145409594|NCT01682031|524353800|FG001|Overall Study|Withdrawal by Subject|1|||
145409595|NCT01682031|524353799|FG000|Overall Study|Adverse Event|0|||
145409596|NCT01682031|524353800|FG001|Overall Study|Adverse Event|2|||
145409597|NCT01682031|524353799|FG000|Overall Study|MRI results indicate increased nodul|0|||
145409598|NCT01682031|524353800|FG001|Overall Study|MRI results indicate increased nodul|1|||
145409599|NCT01682031|524353799|FG000|Overall Study|Patient could not swallow tablets|1|||
145409600|NCT01682031|524353800|FG001|Overall Study|Patient could not swallow tablets|0|||
145409601|NCT01682031|524353799|FG000|Overall Study|Patient stopped selenium on his own|0|||
145409602|NCT01682031|524353800|FG001|Overall Study|Patient stopped selenium on his own|1|||
145409603|NCT03965923|524353803|FG000|Overall Study|Withdrawal by Subject|1|||
145409604|NCT03965923|524353804|FG001|Overall Study|Withdrawal by Subject|2|||
145409605|NCT03965923|524353805|FG002|Overall Study|Withdrawal by Subject|3|||
145409606|NCT03965923|524353806|FG003|Overall Study|Withdrawal by Subject|1|||
145409607|NCT03965923|524353807|FG004|Overall Study|Withdrawal by Subject|2|||
145409608|NCT03965923|524353808|FG005|Overall Study|Withdrawal by Subject|0|||
145409609|NCT03965923|524353809|FG006|Overall Study|Withdrawal by Subject|4|||
145409610|NCT03965923|524353810|FG007|Overall Study|Withdrawal by Subject|3|||
145409611|NCT03965923|524353811|FG008|Overall Study|Withdrawal by Subject|4|||
145409612|NCT03965923|524353812|FG009|Overall Study|Withdrawal by Subject|0|||
145409613|NCT03965923|524353813|FG010|Overall Study|Withdrawal by Subject|2|||
145409614|NCT03965923|524353814|FG011|Overall Study|Withdrawal by Subject|0|||
145409615|NCT03965923|524353803|FG000|Overall Study|Lost to Follow-up|2|||
145409616|NCT03965923|524353804|FG001|Overall Study|Lost to Follow-up|1|||
145409617|NCT03965923|524353805|FG002|Overall Study|Lost to Follow-up|1|||
145409618|NCT03965923|524353806|FG003|Overall Study|Lost to Follow-up|0|||
145409619|NCT03965923|524353807|FG004|Overall Study|Lost to Follow-up|2|||
145409620|NCT03965923|524353808|FG005|Overall Study|Lost to Follow-up|1|||
145409621|NCT03965923|524353809|FG006|Overall Study|Lost to Follow-up|2|||
145409622|NCT03965923|524353810|FG007|Overall Study|Lost to Follow-up|1|||
145409623|NCT03965923|524353811|FG008|Overall Study|Lost to Follow-up|0|||
145409624|NCT03965923|524353812|FG009|Overall Study|Lost to Follow-up|2|||
145409625|NCT03965923|524353813|FG010|Overall Study|Lost to Follow-up|0|||
145409626|NCT03965923|524353814|FG011|Overall Study|Lost to Follow-up|0|||
145409627|NCT03965923|524353803|FG000|Overall Study|Death|0|||
145409628|NCT03965923|524353804|FG001|Overall Study|Death|0|||
145409629|NCT03965923|524353805|FG002|Overall Study|Death|0|||
145409630|NCT03965923|524353806|FG003|Overall Study|Death|0|||
145409631|NCT03965923|524353807|FG004|Overall Study|Death|0|||
145409632|NCT03965923|524353808|FG005|Overall Study|Death|0|||
145409633|NCT03965923|524353809|FG006|Overall Study|Death|0|||
145409634|NCT03965923|524353810|FG007|Overall Study|Death|1|||
145409635|NCT03965923|524353811|FG008|Overall Study|Death|4|||
145409636|NCT03965923|524353812|FG009|Overall Study|Death|0|||
145409637|NCT03965923|524353813|FG010|Overall Study|Death|4|||
145409638|NCT03965923|524353814|FG011|Overall Study|Death|0|||
145409639|NCT03965923|524353803|FG000|Overall Study|Other reason|0|||
145409640|NCT03965923|524353804|FG001|Overall Study|Other reason|0|||
145409641|NCT03965923|524353805|FG002|Overall Study|Other reason|0|||
145409642|NCT03965923|524353806|FG003|Overall Study|Other reason|1|||
145409643|NCT03965923|524353807|FG004|Overall Study|Other reason|0|||
145409644|NCT03965923|524353808|FG005|Overall Study|Other reason|0|||
145409645|NCT03965923|524353809|FG006|Overall Study|Other reason|0|||
145409646|NCT03965923|524353810|FG007|Overall Study|Other reason|0|||
145409647|NCT03965923|524353811|FG008|Overall Study|Other reason|0|||
145409648|NCT03965923|524353812|FG009|Overall Study|Other reason|0|||
145409649|NCT03965923|524353813|FG010|Overall Study|Other reason|2|||
145246677|NCT01998906|523750352|FG001|Overall Study|Violation of Selection Criteria|0|||
145246678|NCT01998906|523750353|FG002|Overall Study|Violation of Selection Criteria|1|||
145246679|NCT01998906|523750351|FG000|Overall Study|Withdrawal by Subject|1|||
145246680|NCT01998906|523750352|FG001|Overall Study|Withdrawal by Subject|4|||
145246681|NCT01998906|523750353|FG002|Overall Study|Withdrawal by Subject|3|||
145246682|NCT01998906|523750351|FG000|Overall Study|Administrative/Other|2|||
145246683|NCT01998906|523750352|FG001|Overall Study|Administrative/Other|1|||
145246684|NCT01998906|523750353|FG002|Overall Study|Administrative/Other|3|||
145246685|NCT01998906|523750351|FG000|Overall Study|Other|3|||
145246686|NCT01998906|523750352|FG001|Overall Study|Other|8|||
145246687|NCT01998906|523750353|FG002|Overall Study|Other|4|||
145246688|NCT01572844|523750354|FG000|Overall Study|Physician Decision|1|||
145246689|NCT01572844|523750355|FG001|Overall Study|Physician Decision|1|||
145246690|NCT04984876|523750360|FG000|Overall Study|Subject decision|2|||
145246691|NCT04984876|523750361|FG001|Overall Study|Subject decision|10|||
145298445|NCT02726581|523944937|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145298446|NCT02726581|523944938|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145298447|NCT02726581|523944939|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145298448|NCT02726581|523944937|FG000|Treatment Period|Disease progression|47|||
145298449|NCT02726581|523944938|FG001|Treatment Period|Disease progression|50|||
145298450|NCT02726581|523944939|FG002|Treatment Period|Disease progression|16|||
145298451|NCT02726581|523944937|FG000|Treatment Period|Other reasons|9|||
145298452|NCT02726581|523944938|FG001|Treatment Period|Other reasons|8|||
145298453|NCT02726581|523944939|FG002|Treatment Period|Other reasons|2|||
145298454|NCT02726581|523944937|FG000|Treatment Period|Study drug toxicity|6|||
145298455|NCT02726581|523944938|FG001|Treatment Period|Study drug toxicity|3|||
145298456|NCT02726581|523944939|FG002|Treatment Period|Study drug toxicity|2|||
145298457|NCT02726581|523944937|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
145298458|NCT02726581|523944938|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
145298459|NCT02726581|523944939|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
145298460|NCT02726581|523944937|FG000|Treatment Period|Participant withdrew consent|3|||
145298461|NCT02726581|523944938|FG001|Treatment Period|Participant withdrew consent|1|||
145298462|NCT02726581|523944939|FG002|Treatment Period|Participant withdrew consent|1|||
145298463|NCT02726581|523944937|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
145298464|NCT02726581|523944938|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
145298465|NCT02726581|523944939|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
145298466|NCT02726581|523944937|FG000|Treatment Period|Maximum clinical benefit|0|||
145298467|NCT02726581|523944938|FG001|Treatment Period|Maximum clinical benefit|2|||
145298468|NCT02726581|523944939|FG002|Treatment Period|Maximum clinical benefit|0|||
145298469|NCT02726581|523944937|FG000|Treatment Period|Death|1|||
145298470|NCT02726581|523944938|FG001|Treatment Period|Death|0|||
145298471|NCT02726581|523944939|FG002|Treatment Period|Death|0|||
145298472|NCT02726581|523944937|FG000|Treatment Period|Poor/non-compliance|1|||
145298473|NCT02726581|523944938|FG001|Treatment Period|Poor/non-compliance|0|||
145298474|NCT02726581|523944939|FG002|Treatment Period|Poor/non-compliance|0|||
145298475|NCT02726581|523944937|FG000|Treatment Period|Participant no longer meets study criteria|0|||
145298476|NCT02726581|523944938|FG001|Treatment Period|Participant no longer meets study criteria|1|||
145298477|NCT02726581|523944939|FG002|Treatment Period|Participant no longer meets study criteria|0|||
145298478|NCT01844375|523944943|FG000|Overall Study|Protocol Violation|1|||
145298479|NCT01844375|523944944|FG001|Overall Study|Protocol Violation|1|||
145298480|NCT01772537|523944946|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
145298481|NCT01772537|523944947|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
145298482|NCT01772537|523944948|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
145298483|NCT03627091|523944949|FG000|Overall Study|Adverse Event|0|||
145298484|NCT03627091|523944950|FG001|Overall Study|Adverse Event|0|||
145298485|NCT03627091|523944951|FG002|Overall Study|Adverse Event|2|||
145298486|NCT03627091|523944949|FG000|Overall Study|Withdrawal by Subject|2|||
145298487|NCT03627091|523944950|FG001|Overall Study|Withdrawal by Subject|0|||
145246692|NCT04984876|523750362|FG002|Overall Study|Subject decision|3|||
145246693|NCT04984876|523750363|FG003|Overall Study|Subject decision|3|||
145246694|NCT04984876|523750364|FG004|Overall Study|Subject decision|3|||
145246695|NCT04984876|523750365|FG005|Overall Study|Subject decision|0|||
145298488|NCT03627091|523944951|FG002|Overall Study|Withdrawal by Subject|2|||
145298489|NCT03627091|523944949|FG000|Overall Study|Physician Decision|2|||
145246696|NCT04984876|523750360|FG000|Overall Study|Guardian decision|0|||
145246697|NCT04984876|523750361|FG001|Overall Study|Guardian decision|1|||
145298490|NCT03627091|523944950|FG001|Overall Study|Physician Decision|0|||
145298491|NCT03627091|523944951|FG002|Overall Study|Physician Decision|0|||
145298492|NCT03627091|523944949|FG000|Overall Study|Site terminated by sponsor|0|||
145298493|NCT03627091|523944950|FG001|Overall Study|Site terminated by sponsor|1|||
145298494|NCT03627091|523944951|FG002|Overall Study|Site terminated by sponsor|0|||
145246698|NCT04984876|523750362|FG002|Overall Study|Guardian decision|0|||
145246699|NCT04984876|523750363|FG003|Overall Study|Guardian decision|2|||
145246700|NCT04984876|523750364|FG004|Overall Study|Guardian decision|0|||
145298495|NCT03627091|523944949|FG000|Overall Study|Disease relapse|7|||
145409650|NCT03965923|524353814|FG011|Overall Study|Other reason|0|||
145620230|NCT01473420|525123713|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
145620231|NCT04172987|525123714|FG000|Lead In Period|Adverse Event|1|||
145620232|NCT04172987|525123714|FG000|Lead In Period|Protocol Violation|1|||
145246701|NCT04984876|523750365|FG005|Overall Study|Guardian decision|1|||
145246702|NCT04984876|523750360|FG000|Overall Study|Lost to Follow-up|0|||
145246703|NCT04984876|523750361|FG001|Overall Study|Lost to Follow-up|0|||
145246704|NCT04984876|523750362|FG002|Overall Study|Lost to Follow-up|1|||
145246705|NCT04984876|523750363|FG003|Overall Study|Lost to Follow-up|1|||
145246706|NCT04984876|523750364|FG004|Overall Study|Lost to Follow-up|0|||
145246707|NCT04984876|523750365|FG005|Overall Study|Lost to Follow-up|0|||
145246708|NCT04984876|523750360|FG000|Overall Study|Physician Decision|1|||
145246709|NCT04984876|523750361|FG001|Overall Study|Physician Decision|0|||
145246710|NCT04984876|523750362|FG002|Overall Study|Physician Decision|0|||
145246711|NCT04984876|523750363|FG003|Overall Study|Physician Decision|1|||
145246712|NCT04984876|523750364|FG004|Overall Study|Physician Decision|0|||
145246713|NCT04984876|523750365|FG005|Overall Study|Physician Decision|0|||
145246714|NCT04984876|523750360|FG000|Overall Study|Adverse Event|0|||
145246715|NCT04984876|523750361|FG001|Overall Study|Adverse Event|0|||
145298496|NCT03627091|523944950|FG001|Overall Study|Disease relapse|5|||
145298497|NCT03627091|523944951|FG002|Overall Study|Disease relapse|1|||
145298498|NCT03627091|523944949|FG000|Overall Study|Other|1|||
145298499|NCT03627091|523944950|FG001|Overall Study|Other|0|||
145298500|NCT03627091|523944951|FG002|Overall Study|Other|0|||
145298501|NCT00450190|523944952|FG000|Overall Study|Withdrawal by Subject|2|||
145298502|NCT01536574|523944953|FG000|Overall Study|Adverse Event|4|||
145298503|NCT01536574|523944954|FG001|Overall Study|Adverse Event|5|||
145298504|NCT01536574|523944953|FG000|Overall Study|Withdrawal by Subject|1|||
145298505|NCT01536574|523944954|FG001|Overall Study|Withdrawal by Subject|2|||
145298506|NCT01536574|523944953|FG000|Overall Study|Lack of Efficacy|1|||
145298507|NCT01536574|523944954|FG001|Overall Study|Lack of Efficacy|0|||
145298508|NCT01376167|523944955|FG000|Overall Study|Lost to Follow-up|2|||
145298509|NCT01376167|523944956|FG001|Overall Study|Lost to Follow-up|4|||
145298510|NCT01376167|523944957|FG002|Overall Study|Lost to Follow-up|2|||
145298511|NCT01376167|523944955|FG000|Overall Study|Physician Decision|1|||
145298512|NCT01376167|523944956|FG001|Overall Study|Physician Decision|1|||
145298513|NCT01376167|523944957|FG002|Overall Study|Physician Decision|0|||
145298514|NCT01376167|523944955|FG000|Overall Study|Withdrawal by Subject|1|||
145298515|NCT01376167|523944956|FG001|Overall Study|Withdrawal by Subject|5|||
145298516|NCT01376167|523944957|FG002|Overall Study|Withdrawal by Subject|4|||
145298517|NCT00834756|523944958|FG000|First Intervention|Adverse Event|1|||
145298518|NCT00834756|523944959|FG001|First Intervention|Adverse Event|0|||
145298519|NCT00834756|523944958|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
145298520|NCT00834756|523944959|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
145298521|NCT02193165|523944962|FG000|4 Week Product Use|Lost to Follow-up|1|||
145298522|NCT02193165|523944963|FG001|4 Week Product Use|Lost to Follow-up|1|||
145298523|NCT02193165|523944964|FG002|4 Week Product Use|Lost to Follow-up|1|||
145298524|NCT02193165|523944962|FG000|6 Week Product Use|Lost to Follow-up|0|||
145298525|NCT02193165|523944963|FG001|6 Week Product Use|Lost to Follow-up|1|||
145298526|NCT02193165|523944964|FG002|6 Week Product Use|Lost to Follow-up|0|||
145298527|NCT04239872|523944965|FG000|Overall Study|Lost to Follow-up|0|||
145298528|NCT04239872|523944966|FG001|Overall Study|Lost to Follow-up|1|||
145298529|NCT01498120|523944970|FG000|Overall Study|Lost to Follow-up|1|||
145298530|NCT01498120|523944970|FG000|Overall Study|Withdrawal by Subject|5|||
145298531|NCT01498120|523944970|FG000|Overall Study|AE, non-serious non-fatal|3|||
145298532|NCT01498120|523944970|FG000|Overall Study|Other|4|||
145298533|NCT01173692|523944971|FG000|Overall Study|Adverse Event|1|||
145298534|NCT01173692|523944972|FG001|Overall Study|Adverse Event|2|||
145298535|NCT01173692|523944971|FG000|Overall Study|Withdrawal by Subject|1|||
145298536|NCT01173692|523944972|FG001|Overall Study|Withdrawal by Subject|3|||
145298537|NCT01472341|523944973|FG000|Overall Study|Started insulin therapy|55|||
145298538|NCT01472341|523944973|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
145298539|NCT01472341|523944973|FG000|Overall Study|Withdrawal by Subject|39|||
145298540|NCT01472341|523944973|FG000|Overall Study|Lost to Follow-up|52|||
145298541|NCT01472341|523944973|FG000|Overall Study|Laboratory parameters unavailable|25|||
145298542|NCT01472341|523944973|FG000|Overall Study|Death|9|||
145298543|NCT00579670|523944974|FG000|Overall Study|Death|1|||
145298544|NCT00579670|523944975|FG001|Overall Study|Death|0|||
145298545|NCT00579670|523944976|FG002|Overall Study|Death|0|||
145298546|NCT00579670|523944977|FG003|Overall Study|Death|0|||
145298547|NCT00579670|523944978|FG004|Overall Study|Death|0|||
145298548|NCT00579670|523944974|FG000|Overall Study|Adverse Event|1|||
145298549|NCT00579670|523944975|FG001|Overall Study|Adverse Event|0|||
145298550|NCT00579670|523944976|FG002|Overall Study|Adverse Event|1|||
145298551|NCT00579670|523944977|FG003|Overall Study|Adverse Event|2|||
145298552|NCT00579670|523944978|FG004|Overall Study|Adverse Event|0|||
145298553|NCT00579670|523944974|FG000|Overall Study|Lack of Efficacy|0|||
145246716|NCT04984876|523750362|FG002|Overall Study|Adverse Event|1|||
145246717|NCT04984876|523750363|FG003|Overall Study|Adverse Event|0|||
145298554|NCT00579670|523944975|FG001|Overall Study|Lack of Efficacy|0|||
145246718|NCT04984876|523750364|FG004|Overall Study|Adverse Event|0|||
145246719|NCT04984876|523750365|FG005|Overall Study|Adverse Event|0|||
145246720|NCT02204410|523750366|FG000|Overall Study|Lost to Follow-up|5|||
145246721|NCT02204410|523750366|FG000|Overall Study|Physician Decision|2|||
145246722|NCT02204410|523750366|FG000|Overall Study|Protocol Violation|1|||
145246723|NCT02204410|523750366|FG000|Overall Study|Withdrawal by Subject|3|||
145246724|NCT01462045|523750371|FG000|Overall Study|Family matter|0|||
145246725|NCT01462045|523750372|FG001|Overall Study|Family matter|1|||
145246726|NCT01462045|523750373|FG002|Overall Study|Family matter|0|||
145246727|NCT06073054|523750382|FG000|Overall Study|Withdrawal by Subject|2|||
145246728|NCT03149029|523750383|FG000|Overall Study|Adverse Event|2|||
145246729|NCT03149029|523750384|FG001|Overall Study|Adverse Event|0|||
145246730|NCT00068822|523750385|FG000|First Randomized Intervention|Lost to Follow-up|1|||
145246731|NCT00068822|523750386|FG001|First Randomized Intervention|Lost to Follow-up|2|||
145246732|NCT00981292|523750387|FG000|Day 1|Protocol Violation|1|||
145246733|NCT00981292|523750388|FG001|Day 1|Protocol Violation|0|||
145246734|NCT00981292|523750389|FG002|Day 1|Protocol Violation|0|||
145246735|NCT00981292|523750390|FG003|Day 1|Protocol Violation|0|||
145246736|NCT00981292|523750391|FG004|Day 1|Protocol Violation|0|||
145246737|NCT00981292|523750392|FG005|Day 1|Protocol Violation|2|||
145246738|NCT00981292|523750387|FG000|Day 2|Protocol Violation|2|||
145246739|NCT00981292|523750388|FG001|Day 2|Protocol Violation|0|||
145246740|NCT00981292|523750389|FG002|Day 2|Protocol Violation|0|||
145246741|NCT00981292|523750390|FG003|Day 2|Protocol Violation|0|||
145246742|NCT00981292|523750391|FG004|Day 2|Protocol Violation|0|||
145246743|NCT00981292|523750392|FG005|Day 2|Protocol Violation|0|||
145246744|NCT00981292|523750387|FG000|Day 3|Protocol Violation|0|||
145246745|NCT00981292|523750388|FG001|Day 3|Protocol Violation|0|||
145246746|NCT00981292|523750389|FG002|Day 3|Protocol Violation|0|||
145246747|NCT00981292|523750390|FG003|Day 3|Protocol Violation|0|||
145246748|NCT00981292|523750391|FG004|Day 3|Protocol Violation|0|||
145246749|NCT00981292|523750392|FG005|Day 3|Protocol Violation|1|||
145246750|NCT00424099|523750393|FG000|Overall Study|Adverse Event|0|||
145246751|NCT00424099|523750394|FG001|Overall Study|Adverse Event|1|||
145246752|NCT00424099|523750395|FG002|Overall Study|Adverse Event|1|||
145246753|NCT00424099|523750396|FG003|Overall Study|Adverse Event|0|||
145246754|NCT00424099|523750393|FG000|Overall Study|Death|0|||
145246755|NCT00424099|523750394|FG001|Overall Study|Death|1|||
145246756|NCT00424099|523750395|FG002|Overall Study|Death|0|||
145246757|NCT00424099|523750396|FG003|Overall Study|Death|0|||
145246758|NCT00424099|523750393|FG000|Overall Study|Illness|2|||
145246759|NCT00424099|523750394|FG001|Overall Study|Illness|0|||
145246760|NCT00424099|523750395|FG002|Overall Study|Illness|1|||
145246761|NCT00424099|523750396|FG003|Overall Study|Illness|4|||
145246762|NCT00424099|523750393|FG000|Overall Study|Lost to Follow-up|0|||
145246763|NCT00424099|523750394|FG001|Overall Study|Lost to Follow-up|0|||
145246764|NCT00424099|523750395|FG002|Overall Study|Lost to Follow-up|3|||
145246765|NCT00424099|523750396|FG003|Overall Study|Lost to Follow-up|0|||
145246766|NCT00424099|523750393|FG000|Overall Study|Hospitalized|1|||
145246767|NCT00424099|523750394|FG001|Overall Study|Hospitalized|2|||
145246768|NCT00424099|523750395|FG002|Overall Study|Hospitalized|1|||
145246769|NCT00424099|523750396|FG003|Overall Study|Hospitalized|3|||
145246770|NCT00424099|523750393|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
145246771|NCT00424099|523750394|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
145246772|NCT00424099|523750395|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
145246773|NCT00424099|523750396|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
145246774|NCT00424099|523750393|FG000|Overall Study|Withdrawal by Subject|1|||
145246775|NCT00424099|523750394|FG001|Overall Study|Withdrawal by Subject|9|||
145246776|NCT00424099|523750395|FG002|Overall Study|Withdrawal by Subject|4|||
145246777|NCT00424099|523750396|FG003|Overall Study|Withdrawal by Subject|6|||
145246778|NCT00424099|523750393|FG000|Overall Study|Physician Decision|0|||
145246779|NCT00424099|523750394|FG001|Overall Study|Physician Decision|0|||
145246780|NCT00424099|523750395|FG002|Overall Study|Physician Decision|1|||
145246781|NCT00424099|523750396|FG003|Overall Study|Physician Decision|0|||
145246782|NCT00424099|523750393|FG000|Overall Study|Missing|0|||
145246783|NCT00424099|523750394|FG001|Overall Study|Missing|0|||
145246784|NCT00424099|523750395|FG002|Overall Study|Missing|1|||
145246785|NCT00424099|523750396|FG003|Overall Study|Missing|0|||
145246786|NCT00764322|523750397|FG000|Overall Study|Withdrawal by Subject|11|||
145246787|NCT00764322|523750397|FG000|Overall Study|No CYP2D6 genotyping|9|||
145246788|NCT03345342|523750398|FG000|Open-Label Phase|Adverse Event|30|||
145246789|NCT03345342|523750399|FG001|Open-Label Phase|Adverse Event|0|||
145246790|NCT03345342|523750400|FG002|Open-Label Phase|Adverse Event|0|||
145246791|NCT03345342|523750401|FG003|Open-Label Phase|Adverse Event|0|||
145620233|NCT04172987|525123714|FG000|Period 1|Physician Decision|1|||
145246792|NCT03345342|523750402|FG004|Open-Label Phase|Adverse Event|0|||
145246793|NCT03345342|523750398|FG000|Open-Label Phase|Death|1|||
145246794|NCT03345342|523750399|FG001|Open-Label Phase|Death|0|||
145246795|NCT03345342|523750400|FG002|Open-Label Phase|Death|0|||
145246796|NCT03345342|523750401|FG003|Open-Label Phase|Death|0|||
145246797|NCT03345342|523750402|FG004|Open-Label Phase|Death|0|||
145246798|NCT03345342|523750398|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
145566388|NCT00746941|524934232|FG000|Overall Study|Withdrawal by Subject|3|||
145566389|NCT00746941|524934233|FG001|Overall Study|Withdrawal by Subject|0|||
145246799|NCT03345342|523750399|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
145246800|NCT03345342|523750400|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
145246801|NCT03345342|523750401|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
145246802|NCT03345342|523750402|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
145246803|NCT03345342|523750398|FG000|Open-Label Phase|Lack of Efficacy|6|||
145246804|NCT03345342|523750399|FG001|Open-Label Phase|Lack of Efficacy|0|||
145246805|NCT03345342|523750400|FG002|Open-Label Phase|Lack of Efficacy|0|||
145246806|NCT03345342|523750401|FG003|Open-Label Phase|Lack of Efficacy|0|||
145246807|NCT03345342|523750402|FG004|Open-Label Phase|Lack of Efficacy|0|||
145246808|NCT03345342|523750398|FG000|Open-Label Phase|Lost to Follow-up|9|||
145246809|NCT03345342|523750399|FG001|Open-Label Phase|Lost to Follow-up|0|||
145246810|NCT03345342|523750400|FG002|Open-Label Phase|Lost to Follow-up|0|||
145246811|NCT03345342|523750401|FG003|Open-Label Phase|Lost to Follow-up|0|||
145246812|NCT03345342|523750402|FG004|Open-Label Phase|Lost to Follow-up|0|||
145246813|NCT03345342|523750398|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
145246814|NCT03345342|523750399|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
145246815|NCT03345342|523750400|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
145246816|NCT03345342|523750401|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
145246817|NCT03345342|523750402|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
145246818|NCT03345342|523750398|FG000|Open-Label Phase|Physician Decision|4|||
145246819|NCT03345342|523750399|FG001|Open-Label Phase|Physician Decision|0|||
145246820|NCT03345342|523750400|FG002|Open-Label Phase|Physician Decision|0|||
145246821|NCT03345342|523750401|FG003|Open-Label Phase|Physician Decision|0|||
145246822|NCT03345342|523750402|FG004|Open-Label Phase|Physician Decision|0|||
145246823|NCT03345342|523750398|FG000|Open-Label Phase|Protocol Violation|8|||
145246824|NCT03345342|523750399|FG001|Open-Label Phase|Protocol Violation|0|||
145246825|NCT03345342|523750400|FG002|Open-Label Phase|Protocol Violation|0|||
145246826|NCT03345342|523750401|FG003|Open-Label Phase|Protocol Violation|0|||
145246827|NCT03345342|523750402|FG004|Open-Label Phase|Protocol Violation|0|||
145246828|NCT03345342|523750398|FG000|Open-Label Phase|Withdrawal by Subject|57|||
145246829|NCT03345342|523750399|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145246830|NCT03345342|523750400|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145246831|NCT03345342|523750401|FG003|Open-Label Phase|Withdrawal by Subject|0|||
145246832|NCT03345342|523750402|FG004|Open-Label Phase|Withdrawal by Subject|0|||
145246833|NCT03345342|523750398|FG000|Open-Label Phase|Other|15|||
145246834|NCT03345342|523750399|FG001|Open-Label Phase|Other|0|||
145246835|NCT03345342|523750400|FG002|Open-Label Phase|Other|0|||
145246836|NCT03345342|523750401|FG003|Open-Label Phase|Other|0|||
145246837|NCT03345342|523750402|FG004|Open-Label Phase|Other|0|||
145298555|NCT00579670|523944976|FG002|Overall Study|Lack of Efficacy|1|||
145298556|NCT00579670|523944977|FG003|Overall Study|Lack of Efficacy|14|||
145298557|NCT00579670|523944978|FG004|Overall Study|Lack of Efficacy|0|||
145298558|NCT00579670|523944974|FG000|Overall Study|Lost to Follow-up|0|||
145298559|NCT00579670|523944975|FG001|Overall Study|Lost to Follow-up|1|||
145298560|NCT00579670|523944976|FG002|Overall Study|Lost to Follow-up|0|||
145298561|NCT00579670|523944977|FG003|Overall Study|Lost to Follow-up|4|||
145298562|NCT00579670|523944978|FG004|Overall Study|Lost to Follow-up|0|||
145298563|NCT00579670|523944974|FG000|Overall Study|Other|0|||
145298564|NCT00579670|523944975|FG001|Overall Study|Other|0|||
145298565|NCT00579670|523944976|FG002|Overall Study|Other|1|||
145298566|NCT00579670|523944977|FG003|Overall Study|Other|2|||
145298567|NCT00579670|523944978|FG004|Overall Study|Other|0|||
145298568|NCT00579670|523944974|FG000|Overall Study|Withdrawal by Subject|0|||
145298569|NCT00579670|523944975|FG001|Overall Study|Withdrawal by Subject|0|||
145298570|NCT00579670|523944976|FG002|Overall Study|Withdrawal by Subject|1|||
145298571|NCT00579670|523944977|FG003|Overall Study|Withdrawal by Subject|0|||
145298572|NCT00579670|523944978|FG004|Overall Study|Withdrawal by Subject|0|||
145298573|NCT01118312|523944982|FG000|Overall Study|Lost to Follow-up|33|||
145298574|NCT01118312|523944983|FG001|Overall Study|Lost to Follow-up|32|||
145298575|NCT01118312|523944982|FG000|Overall Study|Withdrawal by Subject|1|||
145298576|NCT01118312|523944983|FG001|Overall Study|Withdrawal by Subject|3|||
145298577|NCT00678639|523944984|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
145298578|NCT00678639|523944985|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
145298579|NCT01546545|523944988|FG000|Overall Study|Withdrawal by Subject|1|||
145298580|NCT04060147|523944989|FG000|Overall Study|Withdrew consent|1|||
145298581|NCT00986245|523944990|FG000|First Intervention|Poor compliance|8|||
145566390|NCT00746941|524934234|FG002|Overall Study|Withdrawal by Subject|0|||
145246838|NCT03345342|523750398|FG000|Double-Blind Phase|Adverse Event|0|||
145246839|NCT03345342|523750399|FG001|Double-Blind Phase|Adverse Event|1|||
145246840|NCT03345342|523750400|FG002|Double-Blind Phase|Adverse Event|6|||
145246841|NCT03345342|523750401|FG003|Double-Blind Phase|Adverse Event|0|||
145298582|NCT00986245|523944991|FG001|First Intervention|Poor compliance|4|||
145566391|NCT00746941|524934235|FG003|Overall Study|Withdrawal by Subject|2|||
145620234|NCT04172987|525123714|FG000|Period 2|Adverse Event|5|||
145246842|NCT03345342|523750402|FG004|Double-Blind Phase|Adverse Event|0|||
145246843|NCT03345342|523750398|FG000|Double-Blind Phase|Death|0|||
145566392|NCT00746941|524934232|FG000|Overall Study|Other, reason not provided|2|||
145566393|NCT00746941|524934233|FG001|Overall Study|Other, reason not provided|4|||
145566394|NCT00746941|524934234|FG002|Overall Study|Other, reason not provided|0|||
145566395|NCT00746941|524934235|FG003|Overall Study|Other, reason not provided|4|||
145566396|NCT00746941|524934232|FG000|Overall Study|Adverse Event|0|||
145566397|NCT00746941|524934233|FG001|Overall Study|Adverse Event|0|||
145566398|NCT00746941|524934234|FG002|Overall Study|Adverse Event|0|||
145566399|NCT00746941|524934235|FG003|Overall Study|Adverse Event|1|||
145566400|NCT01640366|524934242|FG000|Overall Study|Withdrawal by Subject|1|||
145566401|NCT01640366|524934242|FG000|Overall Study|Protocol Violation|16|||
145620235|NCT04172987|525123714|FG000|Period 2|Dosing Termination by Sponsor|4|||
145620236|NCT00738530|525123719|FG000|Overall Study|Death|220|||
145246844|NCT03345342|523750399|FG001|Double-Blind Phase|Death|2|||
145246845|NCT03345342|523750400|FG002|Double-Blind Phase|Death|1|||
145246846|NCT03345342|523750401|FG003|Double-Blind Phase|Death|0|||
145246847|NCT03345342|523750402|FG004|Double-Blind Phase|Death|0|||
145246848|NCT03345342|523750398|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
145246849|NCT03345342|523750399|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
145246850|NCT03345342|523750400|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
145246851|NCT03345342|523750401|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
145246852|NCT03345342|523750402|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
145246853|NCT03345342|523750398|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145246854|NCT03345342|523750399|FG001|Double-Blind Phase|Lost to Follow-up|1|||
145246855|NCT03345342|523750400|FG002|Double-Blind Phase|Lost to Follow-up|7|||
145246856|NCT03345342|523750401|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145246857|NCT03345342|523750402|FG004|Double-Blind Phase|Lost to Follow-up|0|||
145246858|NCT03345342|523750398|FG000|Double-Blind Phase|Physician Decision|0|||
145246859|NCT03345342|523750399|FG001|Double-Blind Phase|Physician Decision|1|||
145246860|NCT03345342|523750400|FG002|Double-Blind Phase|Physician Decision|4|||
145246861|NCT03345342|523750401|FG003|Double-Blind Phase|Physician Decision|0|||
145246862|NCT03345342|523750402|FG004|Double-Blind Phase|Physician Decision|0|||
145246863|NCT03345342|523750398|FG000|Double-Blind Phase|Protocol Violation|0|||
145246864|NCT03345342|523750399|FG001|Double-Blind Phase|Protocol Violation|0|||
145246865|NCT03345342|523750400|FG002|Double-Blind Phase|Protocol Violation|1|||
145246866|NCT03345342|523750401|FG003|Double-Blind Phase|Protocol Violation|0|||
145246867|NCT03345342|523750402|FG004|Double-Blind Phase|Protocol Violation|0|||
145246868|NCT03345342|523750398|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145246869|NCT03345342|523750399|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
145298583|NCT00986245|523944990|FG000|First Intervention|Lack of Efficacy|1|||
145298584|NCT00986245|523944991|FG001|First Intervention|Lack of Efficacy|2|||
145298585|NCT00986245|523944990|FG000|First Intervention|Withdrawal by Subject|0|||
145298586|NCT00986245|523944991|FG001|First Intervention|Withdrawal by Subject|1|||
145298587|NCT00986245|523944990|FG000|First Intervention|Protocol Violation|0|||
145298588|NCT00986245|523944991|FG001|First Intervention|Protocol Violation|1|||
145298589|NCT00986245|523944990|FG000|First Intervention|Out of indication|1|||
145298590|NCT00986245|523944991|FG001|First Intervention|Out of indication|0|||
145298591|NCT00986245|523944990|FG000|Second Intervention|Poor compliance|1|||
145298592|NCT00986245|523944991|FG001|Second Intervention|Poor compliance|0|||
145298593|NCT00986245|523944990|FG000|Second Intervention|Lost to Follow-up|1|||
145298594|NCT00986245|523944991|FG001|Second Intervention|Lost to Follow-up|0|||
145298595|NCT00986245|523944990|FG000|Second Intervention|Protocol Violation|0|||
145298596|NCT00986245|523944991|FG001|Second Intervention|Protocol Violation|1|||
145298597|NCT01214850|523944992|FG000|Overall Study|Withdrawal by Subject|38|||
145298598|NCT01214850|523944993|FG001|Overall Study|Withdrawal by Subject|31|||
145298599|NCT01214850|523944994|FG002|Overall Study|Withdrawal by Subject|28|||
145298600|NCT01214850|523944992|FG000|Overall Study|Lost to Follow-up|124|||
145298601|NCT01214850|523944993|FG001|Overall Study|Lost to Follow-up|98|||
145298602|NCT01214850|523944994|FG002|Overall Study|Lost to Follow-up|123|||
145298603|NCT01214850|523944992|FG000|Overall Study|Protocol Violation|5|||
145298604|NCT01214850|523944993|FG001|Overall Study|Protocol Violation|5|||
145566402|NCT01640366|524934242|FG000|Overall Study|Lost to Follow-up|5|||
145246870|NCT03345342|523750400|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
145246871|NCT03345342|523750401|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145246872|NCT03345342|523750402|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145246873|NCT03345342|523750398|FG000|Double-Blind Phase|Other|0|||
145246874|NCT03345342|523750399|FG001|Double-Blind Phase|Other|1|||
145246875|NCT03345342|523750400|FG002|Double-Blind Phase|Other|3|||
145298605|NCT01214850|523944994|FG002|Overall Study|Protocol Violation|6|||
145298606|NCT01214850|523944992|FG000|Overall Study|Adverse event or death|11|||
145298607|NCT01214850|523944993|FG001|Overall Study|Adverse event or death|8|||
145298608|NCT01214850|523944994|FG002|Overall Study|Adverse event or death|3|||
145298609|NCT01214850|523944992|FG000|Overall Study|Inappropriate enrollment|2|||
145298610|NCT01214850|523944993|FG001|Overall Study|Inappropriate enrollment|1|||
145566403|NCT02818777|524934246|FG000|Overall Study|Adverse Event|3|||
145246876|NCT03345342|523750401|FG003|Double-Blind Phase|Other|0|||
145246877|NCT03345342|523750402|FG004|Double-Blind Phase|Other|0|||
145566404|NCT00856908|524934247|FG000|Overall Study|Lost to Follow-up|1|||
145409651|NCT02452190|524353815|FG000|Overall Study|Withdrawal by Sponsor|1|||
145409652|NCT02452190|524353816|FG001|Overall Study|Withdrawal by Sponsor|3|||
145409653|NCT02452190|524353815|FG000|Overall Study|Pregnancy|1|||
145409654|NCT02452190|524353816|FG001|Overall Study|Pregnancy|0|||
145409655|NCT02452190|524353815|FG000|Overall Study|Investigator's Decision|2|||
145409656|NCT02452190|524353816|FG001|Overall Study|Investigator's Decision|0|||
145409657|NCT02452190|524353815|FG000|Overall Study|Lack of Efficacy|3|||
145409658|NCT02452190|524353816|FG001|Overall Study|Lack of Efficacy|1|||
145409659|NCT02452190|524353815|FG000|Overall Study|Lost to Follow-up|4|||
145409660|NCT02452190|524353816|FG001|Overall Study|Lost to Follow-up|3|||
145409661|NCT02452190|524353815|FG000|Overall Study|Adverse Event|2|||
145409662|NCT02452190|524353816|FG001|Overall Study|Adverse Event|5|||
145409663|NCT02452190|524353815|FG000|Overall Study|Withdrawal by Subject|20|||
145566405|NCT00856908|524934248|FG001|Overall Study|Lost to Follow-up|0|||
145566406|NCT01712256|524934255|FG000|Overall Study|Lost to Follow-up|1|||
145246878|NCT03345342|523750398|FG000|Follow-Up Phase|Adverse Event|0|||
145246879|NCT03345342|523750399|FG001|Follow-Up Phase|Adverse Event|0|||
145246880|NCT03345342|523750400|FG002|Follow-Up Phase|Adverse Event|0|||
145246881|NCT03345342|523750401|FG003|Follow-Up Phase|Adverse Event|0|||
145246882|NCT03345342|523750402|FG004|Follow-Up Phase|Adverse Event|4|||
145246883|NCT03345342|523750398|FG000|Follow-Up Phase|Lost to Follow-up|0|||
145246884|NCT03345342|523750399|FG001|Follow-Up Phase|Lost to Follow-up|0|||
145246885|NCT03345342|523750400|FG002|Follow-Up Phase|Lost to Follow-up|0|||
145246886|NCT03345342|523750401|FG003|Follow-Up Phase|Lost to Follow-up|0|||
145246887|NCT03345342|523750402|FG004|Follow-Up Phase|Lost to Follow-up|6|||
145246888|NCT03345342|523750398|FG000|Follow-Up Phase|Physician Decision|0|||
145246889|NCT03345342|523750399|FG001|Follow-Up Phase|Physician Decision|0|||
145246890|NCT03345342|523750400|FG002|Follow-Up Phase|Physician Decision|0|||
145246891|NCT03345342|523750401|FG003|Follow-Up Phase|Physician Decision|0|||
145246892|NCT03345342|523750402|FG004|Follow-Up Phase|Physician Decision|5|||
145246893|NCT03345342|523750398|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
145246894|NCT03345342|523750399|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
145246895|NCT03345342|523750400|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
145246896|NCT03345342|523750401|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
145246897|NCT03345342|523750402|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
145246898|NCT03345342|523750398|FG000|Follow-Up Phase|Other|0|||
145246899|NCT03345342|523750399|FG001|Follow-Up Phase|Other|0|||
145246900|NCT03345342|523750400|FG002|Follow-Up Phase|Other|0|||
145246901|NCT03345342|523750401|FG003|Follow-Up Phase|Other|3|||
145246902|NCT03345342|523750402|FG004|Follow-Up Phase|Other|1|||
145246903|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
145246904|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
145246905|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
145246906|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
145246907|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
145246908|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
145246909|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
145246910|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
145246911|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
145246912|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
145246913|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
145246914|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
145246915|NCT03321526|523750403|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
145246916|NCT03321526|523750404|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
145246917|NCT03321526|523750403|FG000|Follow-up Phase (2 Weeks)|Other|24|||
145246918|NCT03321526|523750404|FG001|Follow-up Phase (2 Weeks)|Other|24|||
145246919|NCT01989572|523750405|FG000|Overall Study|Lack of Efficacy|35|||
145246920|NCT01989572|523750406|FG001|Overall Study|Lack of Efficacy|48|||
145246921|NCT01989572|523750407|FG002|Overall Study|Lack of Efficacy|48|||
145246922|NCT01989572|523750408|FG003|Overall Study|Lack of Efficacy|43|||
145409664|NCT02452190|524353816|FG001|Overall Study|Withdrawal by Subject|11|||
145409665|NCT02452190|524353815|FG000|Overall Study|Noncompliance with study drug|1|||
145409666|NCT02452190|524353816|FG001|Overall Study|Noncompliance with study drug|0|||
145409667|NCT02452190|524353815|FG000|Overall Study|Participant traveled abroad|1|||
145246923|NCT01989572|523750409|FG004|Overall Study|Lack of Efficacy|71|||
145246924|NCT01989572|523750410|FG005|Overall Study|Lack of Efficacy|79|||
145246925|NCT01989572|523750405|FG000|Overall Study|Adverse Event|2|||
145246926|NCT01989572|523750406|FG001|Overall Study|Adverse Event|1|||
145246927|NCT01989572|523750407|FG002|Overall Study|Adverse Event|3|||
145566407|NCT02276612|524934261|FG000|Overall Study|Death|1|||
145566408|NCT02276612|524934262|FG001|Overall Study|Death|0|||
145246928|NCT01989572|523750408|FG003|Overall Study|Adverse Event|0|||
145246929|NCT01989572|523750409|FG004|Overall Study|Adverse Event|3|||
145246930|NCT01989572|523750410|FG005|Overall Study|Adverse Event|0|||
145246931|NCT01989572|523750405|FG000|Overall Study|Death|0|||
145246932|NCT01989572|523750406|FG001|Overall Study|Death|0|||
145566409|NCT02276612|524934261|FG000|Overall Study|Pregnancy|1|||
145298611|NCT01214850|523944994|FG002|Overall Study|Inappropriate enrollment|0|||
145298612|NCT01214850|523944992|FG000|Overall Study|Administrative reason|1|||
145298613|NCT01214850|523944993|FG001|Overall Study|Administrative reason|0|||
145298614|NCT01214850|523944994|FG002|Overall Study|Administrative reason|0|||
145298615|NCT01214850|523944992|FG000|Overall Study|Unable to classify|2|||
145298616|NCT01214850|523944993|FG001|Overall Study|Unable to classify|1|||
145298617|NCT01214850|523944994|FG002|Overall Study|Unable to classify|1|||
145298618|NCT00610363|523944995|FG000|Overall Study|Non-compliance with protocol|0|||
145298619|NCT00610363|523944996|FG001|Overall Study|Non-compliance with protocol|1|||
145298620|NCT00610363|523944995|FG000|Overall Study|Adverse Event|3|||
145298621|NCT00610363|523944996|FG001|Overall Study|Adverse Event|1|||
145298622|NCT00610363|523944995|FG000|Overall Study|Lack of Efficacy|2|||
145298623|NCT00610363|523944996|FG001|Overall Study|Lack of Efficacy|0|||
145298624|NCT00610363|523944995|FG000|Overall Study|Lost to Follow-up|4|||
145298625|NCT00610363|523944996|FG001|Overall Study|Lost to Follow-up|0|||
145298626|NCT00610363|523944995|FG000|Overall Study|Withdrawal by Subject|1|||
145298627|NCT00610363|523944996|FG001|Overall Study|Withdrawal by Subject|0|||
145298628|NCT00610363|523944995|FG000|Overall Study|Other than specified above|1|||
145298629|NCT00610363|523944996|FG001|Overall Study|Other than specified above|1|||
145298630|NCT03204539|523944997|FG000|Overall Study|Loss of funding|0|||
145298631|NCT03204539|523944998|FG001|Overall Study|Loss of funding|1|||
145298632|NCT00302952|523945012|FG000|Overall Study|Physician Decision|1|||
145298633|NCT00302952|523945013|FG001|Overall Study|Physician Decision|1|||
145298634|NCT00302952|523945012|FG000|Overall Study|Withdrawal by Subject|2|||
145298635|NCT00302952|523945013|FG001|Overall Study|Withdrawal by Subject|3|||
145298636|NCT00302952|523945012|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
145298637|NCT00302952|523945013|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
145298638|NCT00336479|523945014|FG000|Overall Study|Adverse Event|8|||
145298639|NCT00336479|523945015|FG001|Overall Study|Adverse Event|11|||
145298640|NCT00336479|523945016|FG002|Overall Study|Adverse Event|18|||
145298641|NCT00336479|523945017|FG003|Overall Study|Adverse Event|4|||
145298642|NCT00336479|523945014|FG000|Overall Study|Noncompliant|1|||
145298643|NCT00336479|523945015|FG001|Overall Study|Noncompliant|7|||
145298644|NCT00336479|523945016|FG002|Overall Study|Noncompliant|3|||
145298645|NCT00336479|523945017|FG003|Overall Study|Noncompliant|0|||
145409668|NCT02452190|524353816|FG001|Overall Study|Participant traveled abroad|0|||
145409669|NCT02452190|524353815|FG000|Overall Study|Death|0|||
145246933|NCT01989572|523750407|FG002|Overall Study|Death|0|||
145246934|NCT01989572|523750408|FG003|Overall Study|Death|0|||
145246935|NCT01989572|523750409|FG004|Overall Study|Death|1|||
145246936|NCT01989572|523750410|FG005|Overall Study|Death|0|||
145246937|NCT01989572|523750405|FG000|Overall Study|Withdrawal by Subject|4|||
145246938|NCT01989572|523750406|FG001|Overall Study|Withdrawal by Subject|1|||
145246939|NCT01989572|523750407|FG002|Overall Study|Withdrawal by Subject|5|||
145246940|NCT01989572|523750408|FG003|Overall Study|Withdrawal by Subject|1|||
145246941|NCT01989572|523750409|FG004|Overall Study|Withdrawal by Subject|12|||
145246942|NCT01989572|523750410|FG005|Overall Study|Withdrawal by Subject|4|||
145246943|NCT01989572|523750405|FG000|Overall Study|complicating disease|1|||
145246944|NCT01989572|523750406|FG001|Overall Study|complicating disease|1|||
145246945|NCT01989572|523750407|FG002|Overall Study|complicating disease|2|||
145246946|NCT01989572|523750408|FG003|Overall Study|complicating disease|0|||
145246947|NCT01989572|523750409|FG004|Overall Study|complicating disease|1|||
145246948|NCT01989572|523750410|FG005|Overall Study|complicating disease|0|||
145246949|NCT01989572|523750405|FG000|Overall Study|error|2|||
145246950|NCT01989572|523750406|FG001|Overall Study|error|1|||
145246951|NCT01989572|523750407|FG002|Overall Study|error|1|||
145246952|NCT01989572|523750408|FG003|Overall Study|error|1|||
145246953|NCT01989572|523750409|FG004|Overall Study|error|1|||
145246954|NCT01989572|523750410|FG005|Overall Study|error|1|||
145246955|NCT01989572|523750405|FG000|Overall Study|maximum dose reached|0|||
145246956|NCT01989572|523750406|FG001|Overall Study|maximum dose reached|1|||
145246957|NCT01989572|523750407|FG002|Overall Study|maximum dose reached|0|||
145246958|NCT01989572|523750408|FG003|Overall Study|maximum dose reached|0|||
145246959|NCT01989572|523750409|FG004|Overall Study|maximum dose reached|1|||
145246960|NCT01989572|523750410|FG005|Overall Study|maximum dose reached|0|||
145246961|NCT01989572|523750405|FG000|Overall Study|unknown/not specify|3|||
145298646|NCT00336479|523945014|FG000|Overall Study|Physician Decision|2|||
145298647|NCT00336479|523945015|FG001|Overall Study|Physician Decision|3|||
145298648|NCT00336479|523945016|FG002|Overall Study|Physician Decision|1|||
145298649|NCT00336479|523945017|FG003|Overall Study|Physician Decision|0|||
145298650|NCT00336479|523945014|FG000|Overall Study|Lost to Follow-up|3|||
145298651|NCT00336479|523945015|FG001|Overall Study|Lost to Follow-up|2|||
145298652|NCT00336479|523945016|FG002|Overall Study|Lost to Follow-up|0|||
145298653|NCT00336479|523945017|FG003|Overall Study|Lost to Follow-up|0|||
145298654|NCT00336479|523945014|FG000|Overall Study|Withdrawal by Subject|3|||
145298655|NCT00336479|523945015|FG001|Overall Study|Withdrawal by Subject|2|||
145246962|NCT01989572|523750406|FG001|Overall Study|unknown/not specify|4|||
145246963|NCT01989572|523750407|FG002|Overall Study|unknown/not specify|1|||
145298656|NCT00336479|523945016|FG002|Overall Study|Withdrawal by Subject|3|||
145298657|NCT00336479|523945017|FG003|Overall Study|Withdrawal by Subject|0|||
145298658|NCT00336479|523945014|FG000|Overall Study|Other|0|||
145298659|NCT00336479|523945015|FG001|Overall Study|Other|0|||
145298660|NCT00336479|523945016|FG002|Overall Study|Other|1|||
145298661|NCT00336479|523945017|FG003|Overall Study|Other|0|||
145298662|NCT00336479|523945014|FG000|Overall Study|Virologic Stopping Rule|20|||
145298663|NCT00336479|523945015|FG001|Overall Study|Virologic Stopping Rule|0|||
145298664|NCT00336479|523945016|FG002|Overall Study|Virologic Stopping Rule|0|||
145298665|NCT00336479|523945017|FG003|Overall Study|Virologic Stopping Rule|0|||
145298666|NCT00550537|523945018|FG000|Overall Study|Death|18|||
145298667|NCT00550537|523945018|FG000|Overall Study|Adverse Event|20|||
145298668|NCT00550537|523945018|FG000|Overall Study|Disease progression before|46|||
145298669|NCT00550537|523945018|FG000|Overall Study|Withdrawal by Subject|7|||
145298670|NCT00550537|523945018|FG000|Overall Study|Change in treatment plan|4|||
145298671|NCT00550537|523945018|FG000|Overall Study|Other complicating ilness|3|||
145298672|NCT00550537|523945018|FG000|Overall Study|Declining performance status|2|||
145298673|NCT00550537|523945018|FG000|Overall Study|Treated closer to home|4|||
145298674|NCT02008565|523945019|FG000|Overall Study|Protocol Violation|1|||
145298675|NCT02008565|523945020|FG001|Overall Study|Protocol Violation|1|||
145298676|NCT02008565|523945021|FG002|Overall Study|Protocol Violation|2|||
145298677|NCT02008565|523945022|FG003|Overall Study|Protocol Violation|0|||
145298678|NCT00268905|523945023|FG000|Overall Study|Adverse Event|3|||
145298679|NCT00268905|523945024|FG001|Overall Study|Adverse Event|0|||
145298680|NCT00268905|523945025|FG002|Overall Study|Adverse Event|4|||
145298681|NCT00268905|523945023|FG000|Overall Study|Lost to Follow-up|0|||
145298682|NCT00268905|523945024|FG001|Overall Study|Lost to Follow-up|1|||
145298683|NCT00268905|523945025|FG002|Overall Study|Lost to Follow-up|0|||
145298684|NCT00268905|523945023|FG000|Overall Study|Withdrawal by Subject|0|||
145298685|NCT00268905|523945024|FG001|Overall Study|Withdrawal by Subject|0|||
145298686|NCT00268905|523945025|FG002|Overall Study|Withdrawal by Subject|3|||
145298687|NCT00268905|523945023|FG000|Overall Study|Progressive Disease|28|||
145298688|NCT00268905|523945024|FG001|Overall Study|Progressive Disease|4|||
145298689|NCT00268905|523945025|FG002|Overall Study|Progressive Disease|3|||
145298690|NCT00268905|523945023|FG000|Overall Study|Physician Decision|3|||
145298691|NCT00268905|523945024|FG001|Overall Study|Physician Decision|0|||
145298692|NCT00268905|523945025|FG002|Overall Study|Physician Decision|1|||
145298693|NCT00268905|523945023|FG000|Overall Study|Clinical Progression|9|||
145298694|NCT00268905|523945024|FG001|Overall Study|Clinical Progression|4|||
145298695|NCT00268905|523945025|FG002|Overall Study|Clinical Progression|1|||
145298696|NCT00617305|523945026|FG000|Overall Study|Adverse Event|4|||
145298697|NCT00617305|523945027|FG001|Overall Study|Adverse Event|0|||
145298698|NCT00617305|523945028|FG002|Overall Study|Adverse Event|0|||
145298699|NCT00617305|523945026|FG000|Overall Study|Death|1|||
145298700|NCT00617305|523945027|FG001|Overall Study|Death|0|||
145298701|NCT00617305|523945028|FG002|Overall Study|Death|0|||
145298702|NCT00617305|523945026|FG000|Overall Study|Physician Decision|1|||
145298703|NCT00617305|523945027|FG001|Overall Study|Physician Decision|0|||
145298704|NCT00617305|523945028|FG002|Overall Study|Physician Decision|0|||
145298705|NCT00617305|523945026|FG000|Overall Study|Protocol Violation|1|||
145298706|NCT00617305|523945027|FG001|Overall Study|Protocol Violation|0|||
145298707|NCT00617305|523945028|FG002|Overall Study|Protocol Violation|1|||
145298708|NCT00617305|523945026|FG000|Overall Study|Withdrawal by Subject|1|||
145298709|NCT00617305|523945027|FG001|Overall Study|Withdrawal by Subject|0|||
145298710|NCT00617305|523945028|FG002|Overall Study|Withdrawal by Subject|0|||
145298711|NCT02193178|523945029|FG000|Overall Study|Lost to Follow-up|1|||
145298712|NCT02193178|523945029|FG000|Overall Study|Dry eyes|1|||
145298713|NCT03435081|523945030|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
145298714|NCT03435081|523945031|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
145298715|NCT03435081|523945032|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
145298716|NCT03435081|523945030|FG000|Week 0 to Week 16|Adverse Event|2|||
145298717|NCT03435081|523945031|FG001|Week 0 to Week 16|Adverse Event|2|||
145298718|NCT03435081|523945032|FG002|Week 0 to Week 16|Adverse Event|2|||
145298719|NCT03435081|523945030|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
145298720|NCT03435081|523945031|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
145298721|NCT03435081|523945032|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
145298722|NCT03435081|523945030|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
145298723|NCT03435081|523945031|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
145298724|NCT03435081|523945032|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
145298725|NCT03435081|523945030|FG000|Week 0 to Week 16|Pregnancy|1|||
145298726|NCT03435081|523945031|FG001|Week 0 to Week 16|Pregnancy|0|||
145298727|NCT03435081|523945032|FG002|Week 0 to Week 16|Pregnancy|0|||
145298728|NCT03435081|523945030|FG000|Week 0 to Week 16|Non-compliance|1|||
145298729|NCT03435081|523945031|FG001|Week 0 to Week 16|Non-compliance|0|||
145298730|NCT03435081|523945032|FG002|Week 0 to Week 16|Non-compliance|2|||
145298731|NCT03435081|523945030|FG000|Week 0 to Week 16|Inadequate Response|0|||
145298732|NCT03435081|523945031|FG001|Week 0 to Week 16|Inadequate Response|1|||
145298733|NCT03435081|523945032|FG002|Week 0 to Week 16|Inadequate Response|0|||
145298734|NCT03435081|523945030|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
145298735|NCT03435081|523945031|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
145246964|NCT01989572|523750408|FG003|Overall Study|unknown/not specify|3|||
145246965|NCT01989572|523750409|FG004|Overall Study|unknown/not specify|3|||
145246966|NCT01989572|523750410|FG005|Overall Study|unknown/not specify|5|||
145246967|NCT01989572|523750405|FG000|Overall Study|not start protocol therapy|5|||
145246968|NCT01989572|523750406|FG001|Overall Study|not start protocol therapy|1|||
145246969|NCT01989572|523750407|FG002|Overall Study|not start protocol therapy|2|||
145246970|NCT01989572|523750408|FG003|Overall Study|not start protocol therapy|3|||
145246971|NCT01989572|523750409|FG004|Overall Study|not start protocol therapy|4|||
145246972|NCT01989572|523750410|FG005|Overall Study|not start protocol therapy|18|||
145246973|NCT01989572|523750405|FG000|Overall Study|alternative therapy|3|||
145246974|NCT01989572|523750406|FG001|Overall Study|alternative therapy|0|||
145246975|NCT01989572|523750407|FG002|Overall Study|alternative therapy|0|||
145246976|NCT01989572|523750408|FG003|Overall Study|alternative therapy|0|||
145246977|NCT01989572|523750409|FG004|Overall Study|alternative therapy|1|||
145246978|NCT01989572|523750410|FG005|Overall Study|alternative therapy|3|||
145246979|NCT04599972|523750414|FG000|Overall Study|Withdrawal by Subject|6|||
145246980|NCT04599972|523750415|FG001|Overall Study|Withdrawal by Subject|1|||
145246981|NCT04599972|523750414|FG000|Overall Study|Adverse Event|1|||
145246982|NCT04599972|523750415|FG001|Overall Study|Adverse Event|1|||
145246983|NCT04599972|523750414|FG000|Overall Study|Lost to Follow-up|1|||
145246984|NCT04599972|523750415|FG001|Overall Study|Lost to Follow-up|6|||
145246985|NCT04599972|523750414|FG000|Overall Study|Protocol Violation|1|||
145246986|NCT04599972|523750415|FG001|Overall Study|Protocol Violation|0|||
145246987|NCT04599972|523750414|FG000|Overall Study|Other reason|1|||
145246988|NCT04599972|523750415|FG001|Overall Study|Other reason|0|||
145246989|NCT00638690|523750416|FG000|Overall Study|Death|655|||
145246990|NCT00638690|523750417|FG001|Overall Study|Death|335|||
145246991|NCT00638690|523750416|FG000|Overall Study|Withdrawal by Subject|22|||
145246992|NCT00638690|523750417|FG001|Overall Study|Withdrawal by Subject|5|||
145246993|NCT00638690|523750416|FG000|Overall Study|Lost to Follow-up|4|||
145246994|NCT00638690|523750417|FG001|Overall Study|Lost to Follow-up|2|||
145246995|NCT02348840|523750418|FG000|Overall Study|Withdrawal by Subject|2|||
145246996|NCT02348840|523750419|FG001|Overall Study|Withdrawal by Subject|1|||
145246997|NCT02348840|523750420|FG002|Overall Study|Withdrawal by Subject|0|||
145246998|NCT02348840|523750421|FG003|Overall Study|Withdrawal by Subject|0|||
145246999|NCT00373880|523750422|FG000|Overall Study|Physician Decision|3|||
145247000|NCT00373880|523750422|FG000|Overall Study|Arrested|1|||
145247001|NCT00373880|523750422|FG000|Overall Study|Protocol Violation|14|||
145566410|NCT02276612|524934262|FG001|Overall Study|Pregnancy|0|||
145566411|NCT02276612|524934261|FG000|Overall Study|Withdrew Consent|1|||
145566412|NCT02276612|524934262|FG001|Overall Study|Withdrew Consent|0|||
145247002|NCT01347073|523750423|FG000|Overall Study|Adverse Event|1|||
145247003|NCT01347073|523750423|FG000|Overall Study|Liver Transplant|1|||
145247004|NCT00621244|523750424|FG000|Overall Study|Withdrawal by Subject|7|||
145247005|NCT00621244|523750425|FG001|Overall Study|Withdrawal by Subject|3|||
145247006|NCT00621244|523750426|FG002|Overall Study|Withdrawal by Subject|3|||
145247007|NCT00621244|523750427|FG003|Overall Study|Withdrawal by Subject|3|||
145247008|NCT00621244|523750424|FG000|Overall Study|Disease progression|44|||
145247009|NCT00621244|523750425|FG001|Overall Study|Disease progression|20|||
145247010|NCT00621244|523750426|FG002|Overall Study|Disease progression|20|||
145247011|NCT00621244|523750427|FG003|Overall Study|Disease progression|15|||
145247012|NCT00621244|523750424|FG000|Overall Study|Death|3|||
145247013|NCT00621244|523750425|FG001|Overall Study|Death|3|||
145247014|NCT00621244|523750426|FG002|Overall Study|Death|1|||
145247015|NCT00621244|523750427|FG003|Overall Study|Death|1|||
145247016|NCT00621244|523750424|FG000|Overall Study|Adverse Event|27|||
145247017|NCT00621244|523750425|FG001|Overall Study|Adverse Event|7|||
145247018|NCT00621244|523750426|FG002|Overall Study|Adverse Event|9|||
145247019|NCT00621244|523750427|FG003|Overall Study|Adverse Event|2|||
145247020|NCT00621244|523750424|FG000|Overall Study|Administrative problems|5|||
145247021|NCT00621244|523750425|FG001|Overall Study|Administrative problems|1|||
145247022|NCT00621244|523750426|FG002|Overall Study|Administrative problems|0|||
145247023|NCT00621244|523750427|FG003|Overall Study|Administrative problems|2|||
145247024|NCT01466062|523750428|FG000|Overall Study|Adverse Event|1|||
145247025|NCT01466062|523750428|FG000|Overall Study|Withdrawal by Subject|1|||
145247026|NCT02865928|523750429|FG000|Overall Study|Withdrawal by Subject|1|||
145247027|NCT02865928|523750430|FG001|Overall Study|Withdrawal by Subject|0|||
145247028|NCT02865928|523750429|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
145247029|NCT02865928|523750430|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
145247030|NCT02865928|523750429|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
145298736|NCT03435081|523945032|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
145298737|NCT03435081|523945030|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
145247031|NCT02865928|523750430|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
145247032|NCT01925014|523750431|FG000|Overall Study|Inappropriate enrollment|4|||
145247033|NCT01925014|523750432|FG001|Overall Study|Inappropriate enrollment|6|||
145247034|NCT01925014|523750431|FG000|Overall Study|Withdrawal by Subject|5|||
145409670|NCT02452190|524353816|FG001|Overall Study|Death|1|||
145409671|NCT06001866|524353819|FG000|Overall Study|Withdrawal by Subject|0|||
145409672|NCT06001866|524353820|FG001|Overall Study|Withdrawal by Subject|2|||
145409673|NCT06001866|524353819|FG000|Overall Study|Protocol Violation|0|||
145409674|NCT06001866|524353820|FG001|Overall Study|Protocol Violation|2|||
145409675|NCT03330197|524353821|FG000|Overall Study|Adverse Event|0|||
145409676|NCT03330197|524353822|FG001|Overall Study|Adverse Event|1|||
145409677|NCT03330197|524353821|FG000|Overall Study|Withdrawal by Subject|0|||
145409678|NCT03330197|524353822|FG001|Overall Study|Withdrawal by Subject|1|||
145409679|NCT04235374|524353823|FG000|Overall Study|Death|91|||
145409680|NCT04235374|524353824|FG001|Overall Study|Death|91|||
145409681|NCT04235374|524353823|FG000|Overall Study|Refused|2|||
145409682|NCT04235374|524353824|FG001|Overall Study|Refused|2|||
145409683|NCT04235374|524353823|FG000|Overall Study|Unavailable|12|||
145409684|NCT04235374|524353824|FG001|Overall Study|Unavailable|3|||
145298738|NCT03435081|523945031|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
145298739|NCT03435081|523945032|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
145298740|NCT03435081|523945030|FG000|Week 16 to Week 104|Adverse Event|1|||
145298741|NCT03435081|523945031|FG001|Week 16 to Week 104|Adverse Event|0|||
145298742|NCT03435081|523945032|FG002|Week 16 to Week 104|Adverse Event|2|||
145298743|NCT03435081|523945030|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
145566413|NCT02276612|524934261|FG000|Overall Study|Lost to Follow-up|1|||
145298744|NCT03435081|523945031|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
145298745|NCT03435081|523945032|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
145298746|NCT03435081|523945030|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
145298747|NCT03435081|523945031|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
145298748|NCT03435081|523945032|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
145298749|NCT03435081|523945030|FG000|Week 16 to Week 104|Non--Compliance|0|||
145298750|NCT03435081|523945031|FG001|Week 16 to Week 104|Non--Compliance|0|||
145298751|NCT03435081|523945032|FG002|Week 16 to Week 104|Non--Compliance|1|||
145298752|NCT00420238|523945033|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
145298753|NCT00420238|523945034|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
145298754|NCT00420238|523945033|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
145298755|NCT00420238|523945034|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
145298756|NCT00420238|523945033|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
145298757|NCT00420238|523945034|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
145298758|NCT00420238|523945033|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
145298759|NCT00420238|523945034|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
145298760|NCT00420238|523945033|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
145298761|NCT00420238|523945034|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
145298762|NCT00420238|523945033|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
145409685|NCT04235374|524353823|FG000|Overall Study|Withdrawal by Subject|0|||
145409686|NCT04235374|524353824|FG001|Overall Study|Withdrawal by Subject|1|||
145409687|NCT04235374|524353823|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
145409688|NCT04235374|524353824|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
145409689|NCT00314145|524353825|FG000|Overall Study|Withdrawal by Subject|8|||
145409690|NCT00314145|524353826|FG001|Overall Study|Withdrawal by Subject|10|||
145566414|NCT02276612|524934262|FG001|Overall Study|Lost to Follow-up|0|||
145566415|NCT04097821|524934263|FG000|Overall Study|Subject Decision|0|||
145566416|NCT04097821|524934264|FG001|Overall Study|Subject Decision|0|||
145566417|NCT04097821|524934265|FG002|Overall Study|Subject Decision|0|||
145247035|NCT01925014|523750432|FG001|Overall Study|Withdrawal by Subject|13|||
145247036|NCT01690988|523750433|FG000|Overall Study|Withdrawal by Subject|2|||
145247037|NCT01690988|523750434|FG001|Overall Study|Withdrawal by Subject|2|||
145247038|NCT01690988|523750435|FG002|Overall Study|Withdrawal by Subject|3|||
145247039|NCT01690988|523750433|FG000|Overall Study|Physician Decision|0|||
145247040|NCT01690988|523750434|FG001|Overall Study|Physician Decision|0|||
145247041|NCT01690988|523750435|FG002|Overall Study|Physician Decision|1|||
145247042|NCT01690988|523750433|FG000|Overall Study|Operation Cancelled|1|||
145247043|NCT01690988|523750434|FG001|Overall Study|Operation Cancelled|1|||
145247044|NCT01690988|523750435|FG002|Overall Study|Operation Cancelled|0|||
145247045|NCT01690988|523750433|FG000|Overall Study|Determined ineligible|1|||
145247046|NCT01690988|523750434|FG001|Overall Study|Determined ineligible|0|||
145247047|NCT01690988|523750435|FG002|Overall Study|Determined ineligible|0|||
145247048|NCT01690988|523750433|FG000|Overall Study|Death|1|||
145409691|NCT00314145|524353825|FG000|Overall Study|Lost to Follow-up|5|||
145409692|NCT00314145|524353826|FG001|Overall Study|Lost to Follow-up|12|||
145409693|NCT00314145|524353825|FG000|Overall Study|Physician Decision|3|||
145247049|NCT01690988|523750434|FG001|Overall Study|Death|1|||
145298763|NCT00420238|523945034|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
145298764|NCT00048581|523945035|FG000|Double-Blind Period|Adverse Event|9|||
145298765|NCT00048581|523945036|FG001|Double-Blind Period|Adverse Event|5|||
145409694|NCT00314145|524353826|FG001|Overall Study|Physician Decision|4|||
145247050|NCT01690988|523750435|FG002|Overall Study|Death|1|||
145247051|NCT01690988|523750433|FG000|Overall Study|Sedated|1|||
145247052|NCT01690988|523750434|FG001|Overall Study|Sedated|1|||
145247053|NCT01690988|523750435|FG002|Overall Study|Sedated|2|||
145247054|NCT00312728|523750445|FG000|Overall Study|Progressive disease|53|||
145247055|NCT00312728|523750445|FG000|Overall Study|Adverse Event|32|||
145247056|NCT00312728|523750445|FG000|Overall Study|Withdrawal by Subject|10|||
145247057|NCT00312728|523750445|FG000|Overall Study|Required non-protocol cancer treatment|2|||
145247058|NCT00312728|523750445|FG000|Overall Study|Protocol Violation|2|||
145247059|NCT00312728|523750445|FG000|Overall Study|Other|10|||
145247060|NCT00312728|523750445|FG000|Overall Study|Other|1|||
145247061|NCT03696576|523750446|FG000|Overall Study|Soreness of throat after therapy|1|||
145247062|NCT03696576|523750447|FG001|Overall Study|Soreness of throat after therapy|1|||
145247063|NCT03696576|523750446|FG000|Overall Study|Lost to Follow-up|2|||
145247064|NCT03696576|523750447|FG001|Overall Study|Lost to Follow-up|4|||
145247065|NCT00338806|523750448|FG000|Acute Phase|Withdrawal by Subject|0|||
145247066|NCT00338806|523750449|FG001|Acute Phase|Withdrawal by Subject|1|||
145247067|NCT00338806|523750448|FG000|Follow-up|Lost to Follow-up|1|||
145247068|NCT00338806|523750449|FG001|Follow-up|Lost to Follow-up|3|||
145247069|NCT00179517|523750457|FG000|Overall Study|Withdrawal by Subject|2|||
145247070|NCT00179517|523750458|FG001|Overall Study|Withdrawal by Subject|1|||
145298766|NCT00048581|523945037|FG002|Double-Blind Period|Adverse Event|0|||
145298767|NCT00048581|523945035|FG000|Double-Blind Period|Lack of Efficacy|14|||
145298768|NCT00048581|523945036|FG001|Double-Blind Period|Lack of Efficacy|27|||
145298769|NCT00048581|523945037|FG002|Double-Blind Period|Lack of Efficacy|0|||
145298770|NCT00048581|523945035|FG000|Double-Blind Period|Lost to Follow-up|5|||
145298771|NCT00048581|523945036|FG001|Double-Blind Period|Lost to Follow-up|0|||
145298772|NCT00048581|523945037|FG002|Double-Blind Period|Lost to Follow-up|0|||
145298773|NCT00048581|523945035|FG000|Double-Blind Period|Withdrawal by Subject|5|||
145298774|NCT00048581|523945036|FG001|Double-Blind Period|Withdrawal by Subject|2|||
145298775|NCT00048581|523945037|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145298776|NCT00048581|523945035|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
145298777|NCT00048581|523945036|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
145298778|NCT00048581|523945037|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
145298779|NCT00048581|523945035|FG000|Double-Blind Period|Investigator Decision|1|||
145298780|NCT00048581|523945036|FG001|Double-Blind Period|Investigator Decision|0|||
145298781|NCT00048581|523945037|FG002|Double-Blind Period|Investigator Decision|0|||
145298782|NCT00048581|523945035|FG000|Open-Label Period|Death|0|||
145298783|NCT00048581|523945036|FG001|Open-Label Period|Death|0|||
145298784|NCT00048581|523945037|FG002|Open-Label Period|Death|4|||
145298785|NCT00048581|523945035|FG000|Open-Label Period|Adverse Event|0|||
145298786|NCT00048581|523945036|FG001|Open-Label Period|Adverse Event|0|||
145298787|NCT00048581|523945037|FG002|Open-Label Period|Adverse Event|37|||
145298788|NCT00048581|523945035|FG000|Open-Label Period|Lack of Efficacy|0|||
145298789|NCT00048581|523945036|FG001|Open-Label Period|Lack of Efficacy|0|||
145298790|NCT00048581|523945037|FG002|Open-Label Period|Lack of Efficacy|69|||
145298791|NCT00048581|523945035|FG000|Open-Label Period|Lost to Follow-up|0|||
145298792|NCT00048581|523945036|FG001|Open-Label Period|Lost to Follow-up|0|||
145298793|NCT00048581|523945037|FG002|Open-Label Period|Lost to Follow-up|14|||
145298794|NCT00048581|523945035|FG000|Open-Label Period|Withdrawal by Subject|0|||
145298795|NCT00048581|523945036|FG001|Open-Label Period|Withdrawal by Subject|0|||
145298796|NCT00048581|523945037|FG002|Open-Label Period|Withdrawal by Subject|20|||
145298797|NCT00048581|523945035|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
145298798|NCT00048581|523945036|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
145298799|NCT00048581|523945037|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
145298800|NCT00048581|523945035|FG000|Open-Label Period|Poor/Non-compliance|0|||
145298801|NCT00048581|523945036|FG001|Open-Label Period|Poor/Non-compliance|0|||
145298802|NCT00048581|523945037|FG002|Open-Label Period|Poor/Non-compliance|5|||
145298803|NCT00048581|523945035|FG000|Open-Label Period|Pregnancy|0|||
145298804|NCT00048581|523945036|FG001|Open-Label Period|Pregnancy|0|||
145298805|NCT00048581|523945037|FG002|Open-Label Period|Pregnancy|7|||
145298806|NCT00048581|523945035|FG000|Open-Label Period|Study Site Closure|0|||
145298807|NCT00048581|523945036|FG001|Open-Label Period|Study Site Closure|0|||
145298808|NCT00048581|523945037|FG002|Open-Label Period|Study Site Closure|2|||
145298809|NCT00048581|523945035|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
145298810|NCT00048581|523945036|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
145298811|NCT00048581|523945037|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
145298812|NCT00048581|523945035|FG000|Open-Label Period|Problem With Transportation To Site|0|||
145298813|NCT00048581|523945036|FG001|Open-Label Period|Problem With Transportation To Site|0|||
145298814|NCT00048581|523945037|FG002|Open-Label Period|Problem With Transportation To Site|1|||
145298815|NCT00048581|523945035|FG000|Open-Label Period|Primary Investigator Retired|0|||
145298816|NCT00048581|523945036|FG001|Open-Label Period|Primary Investigator Retired|0|||
145298817|NCT00048581|523945037|FG002|Open-Label Period|Primary Investigator Retired|2|||
145298818|NCT00048581|523945035|FG000|Open-Label Period|Study Ended By Sponsor|0|||
145298819|NCT00048581|523945036|FG001|Open-Label Period|Study Ended By Sponsor|0|||
145298820|NCT00048581|523945037|FG002|Open-Label Period|Study Ended By Sponsor|1|||
145298821|NCT01406795|523945038|FG000|Overall Study|Withdrawal by Subject|1|||
145247071|NCT00023712|523750459|FG000|Overall Study|Not platinum sensitive|1|||
145247072|NCT00023712|523750460|FG001|Overall Study|Not platinum sensitive|0|||
145247073|NCT00023712|523750459|FG000|Overall Study|Never treated|1|||
145247074|NCT00023712|523750460|FG001|Overall Study|Never treated|1|||
145247075|NCT02963766|523750467|FG000|Double-Blind Period|Adverse Event|1|||
145247076|NCT02963766|523750468|FG001|Double-Blind Period|Adverse Event|0|||
145247077|NCT02963766|523750469|FG002|Double-Blind Period|Adverse Event|1|||
145247078|NCT02963766|523750467|FG000|Double-Blind Period|Physician Decision|1|||
145247079|NCT02963766|523750468|FG001|Double-Blind Period|Physician Decision|0|||
145247080|NCT02963766|523750469|FG002|Double-Blind Period|Physician Decision|0|||
145247081|NCT02963766|523750467|FG000|Double-Blind Period|Withdrawal by Subject|1|||
145247082|NCT02963766|523750468|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145247083|NCT02963766|523750469|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145247084|NCT02963766|523750467|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
145247085|NCT02963766|523750468|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
145247086|NCT02963766|523750469|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
145247087|NCT02963766|523750467|FG000|Double-Blind Period|Protocol Violation|1|||
145247088|NCT02963766|523750468|FG001|Double-Blind Period|Protocol Violation|0|||
145247089|NCT02963766|523750469|FG002|Double-Blind Period|Protocol Violation|0|||
145247090|NCT02963766|523750467|FG000|Double-Blind Period|Lost to Follow-up|0|||
145247091|NCT02963766|523750468|FG001|Double-Blind Period|Lost to Follow-up|1|||
145247092|NCT02963766|523750469|FG002|Double-Blind Period|Lost to Follow-up|0|||
145247093|NCT02963766|523750467|FG000|Open Label Extension (OLE)|Physician Decision|1|||
145247094|NCT02963766|523750468|FG001|Open Label Extension (OLE)|Physician Decision|2|||
145247095|NCT02963766|523750469|FG002|Open Label Extension (OLE)|Physician Decision|2|||
145247096|NCT02963766|523750467|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
145247097|NCT02963766|523750468|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
145247098|NCT02963766|523750469|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
145247099|NCT00499460|523750473|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
145247100|NCT00499460|523750474|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
145247101|NCT00499460|523750473|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
145247102|NCT00499460|523750474|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
145247103|NCT00499460|523750473|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
145247104|NCT00499460|523750474|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
145247105|NCT03209362|523750476|FG000|Overall Study|Adverse Event|0|||
145247106|NCT03209362|523750477|FG001|Overall Study|Adverse Event|1|||
145247107|NCT03209362|523750476|FG000|Overall Study|Lost to Follow-up|0|||
145247108|NCT03209362|523750477|FG001|Overall Study|Lost to Follow-up|1|||
145247109|NCT03209362|523750476|FG000|Overall Study|Withdrawal by Subject|2|||
145247110|NCT03209362|523750477|FG001|Overall Study|Withdrawal by Subject|0|||
145247111|NCT03209362|523750476|FG000|Overall Study|Other|0|||
145247112|NCT03209362|523750477|FG001|Overall Study|Other|1|||
145247113|NCT00251589|523750478|FG000|Overall Study|Adverse Event|5|||
145247114|NCT00251589|523750479|FG001|Overall Study|Adverse Event|1|||
145247115|NCT00251589|523750480|FG002|Overall Study|Adverse Event|2|||
145247116|NCT00251589|523750481|FG003|Overall Study|Adverse Event|1|||
145247117|NCT00251589|523750478|FG000|Overall Study|Withdrawal by Subject|1|||
145247118|NCT00251589|523750479|FG001|Overall Study|Withdrawal by Subject|1|||
145247119|NCT00251589|523750480|FG002|Overall Study|Withdrawal by Subject|0|||
145247120|NCT00251589|523750481|FG003|Overall Study|Withdrawal by Subject|0|||
145247121|NCT00251589|523750478|FG000|Overall Study|Discontinued due to progressive disease|9|||
145247122|NCT00251589|523750479|FG001|Overall Study|Discontinued due to progressive disease|1|||
145247123|NCT00251589|523750480|FG002|Overall Study|Discontinued due to progressive disease|0|||
145247124|NCT00251589|523750481|FG003|Overall Study|Discontinued due to progressive disease|1|||
145247125|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Adverse Event|22|||
145247126|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Adverse Event|0|||
145247127|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
145247128|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
145247129|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
145247130|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
145247131|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
145247132|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
145247133|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
145247134|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
145247135|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
145247136|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
145409695|NCT00314145|524353825|FG000|Overall Study|Adverse Event|0|||
145247137|NCT02493868|523750484|FG000|Induction Phase: DE Participants|Other|8|||
145247138|NCT02493868|523750485|FG001|Induction Phase: DE Participants|Other|0|||
145247139|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
145247140|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
145247141|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
145566418|NCT04097821|524934266|FG003|Overall Study|Subject Decision|1|||
145298822|NCT03966365|523945039|FG000|Overall Study|Protocol Violation|1|||
145298823|NCT03966365|523945040|FG001|Overall Study|Protocol Violation|0|||
145298824|NCT02801877|523945043|FG000|Overall Study|Lost to Follow-up|1|||
145298825|NCT02801877|523945044|FG001|Overall Study|Lost to Follow-up|1|||
145298826|NCT02801877|523945045|FG002|Overall Study|Lost to Follow-up|2|||
145247142|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
145247143|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
145298827|NCT02801877|523945046|FG003|Overall Study|Lost to Follow-up|0|||
145298828|NCT02801877|523945043|FG000|Overall Study|Never Started Treatment|2|||
145298829|NCT02801877|523945044|FG001|Overall Study|Never Started Treatment|0|||
145298830|NCT02801877|523945045|FG002|Overall Study|Never Started Treatment|4|||
145298831|NCT02801877|523945046|FG003|Overall Study|Never Started Treatment|0|||
145298832|NCT00154102|523945047|FG000|Overall Study|investigational study phase ongoing|7|||
145247144|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
145247145|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
145247146|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
145247147|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
145247148|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
145247149|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
145247150|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
145247151|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
145247152|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
145247153|NCT02493868|523750484|FG000|Optimization Phase: DE+TE Participants|Other|10|||
145247154|NCT02493868|523750485|FG001|Optimization Phase: DE+TE Participants|Other|2|||
145247155|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
145247156|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
145247157|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
145247158|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
145247159|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
145247160|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
145247161|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
145247162|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
145247163|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
145247164|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
145247165|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
145247166|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
145247167|NCT02493868|523750484|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
145247168|NCT02493868|523750485|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
145247169|NCT02493868|523750484|FG000|Follow-up Phase|Lost to Follow-up|1|||
145247170|NCT02493868|523750485|FG001|Follow-up Phase|Lost to Follow-up|0|||
145247171|NCT02493868|523750484|FG000|Follow-up Phase|Withdrawal by Subject|3|||
145247172|NCT02493868|523750485|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145247173|NCT02493868|523750484|FG000|Follow-up Phase|Investigator Decision|5|||
145247174|NCT02493868|523750485|FG001|Follow-up Phase|Investigator Decision|1|||
145247175|NCT02493868|523750484|FG000|Follow-up Phase|Other|2|||
145247176|NCT02493868|523750485|FG001|Follow-up Phase|Other|1|||
145247177|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
145247178|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
145247179|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
145247180|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
145247181|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
145247182|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
145247183|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
145247184|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
145247185|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
145247186|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
145247187|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
145247188|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
145247189|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
145298833|NCT00154102|523945048|FG001|Overall Study|investigational study phase ongoing|2|||
145298834|NCT00463606|523945049|FG000|Overall Study|Adverse Event|21|||
145298835|NCT00463606|523945050|FG001|Overall Study|Adverse Event|18|||
145298836|NCT00463606|523945051|FG002|Overall Study|Adverse Event|11|||
145298837|NCT00463606|523945049|FG000|Overall Study|Withdrawal by Subject|11|||
145409696|NCT00314145|524353826|FG001|Overall Study|Adverse Event|3|||
145247190|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Death|0|||
145247191|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Death|0|||
145298838|NCT00463606|523945050|FG001|Overall Study|Withdrawal by Subject|11|||
145298839|NCT00463606|523945051|FG002|Overall Study|Withdrawal by Subject|5|||
145298840|NCT00463606|523945049|FG000|Overall Study|Lost to Follow-up|2|||
145409697|NCT00314145|524353825|FG000|Overall Study|Protocol Violation|3|||
145409698|NCT00314145|524353826|FG001|Overall Study|Protocol Violation|0|||
145247192|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Death|1|||
145247193|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Death|0|||
145247194|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Death|0|||
145247195|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Death|0|||
145247196|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Death|0|||
145247197|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Death|0|||
145247198|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Death|0|||
145247199|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Death|0|||
145247200|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Death|0|||
145247201|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Death|0|||
145247202|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Death|0|||
145247203|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
145247204|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
145247205|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
145247206|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247207|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247208|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247209|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247210|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247211|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247212|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247213|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247214|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247215|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
145247216|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247217|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247218|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
145247219|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247220|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247221|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247222|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247223|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247224|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247225|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247226|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247227|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247228|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
145247229|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
145247230|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
145247231|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
145247232|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
145247233|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
145247234|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
145247235|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
145247236|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
145247237|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
145247238|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
145247239|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
145247240|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
145247241|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
145247242|NCT02407236|523750486|FG000|Induction Study (8 Weeks)|Other|2|||
145247243|NCT02407236|523750487|FG001|Induction Study (8 Weeks)|Other|1|||
145247244|NCT02407236|523750488|FG002|Induction Study (8 Weeks)|Other|5|||
145247245|NCT02407236|523750489|FG003|Induction Study (8 Weeks)|Other|0|||
145247246|NCT02407236|523750490|FG004|Induction Study (8 Weeks)|Other|0|||
145247247|NCT02407236|523750491|FG005|Induction Study (8 Weeks)|Other|0|||
145247248|NCT02407236|523750492|FG006|Induction Study (8 Weeks)|Other|0|||
145247249|NCT02407236|523750493|FG007|Induction Study (8 Weeks)|Other|0|||
145247250|NCT02407236|523750494|FG008|Induction Study (8 Weeks)|Other|0|||
145247251|NCT02407236|523750495|FG009|Induction Study (8 Weeks)|Other|0|||
145247252|NCT02407236|523750496|FG010|Induction Study (8 Weeks)|Other|0|||
145247253|NCT02407236|523750497|FG011|Induction Study (8 Weeks)|Other|0|||
145247254|NCT02407236|523750498|FG012|Induction Study (8 Weeks)|Other|0|||
145247255|NCT02407236|523750486|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247256|NCT02407236|523750487|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247257|NCT02407236|523750488|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
145298841|NCT00463606|523945050|FG001|Overall Study|Lost to Follow-up|2|||
145247258|NCT02407236|523750489|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
145247259|NCT02407236|523750490|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
145247260|NCT02407236|523750491|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
145247261|NCT02407236|523750492|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
145247262|NCT02407236|523750493|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
145620237|NCT00738530|525123720|FG001|Overall Study|Death|224|||
145620238|NCT00738530|525123719|FG000|Overall Study|Lost to Follow-up|8|||
145409699|NCT00314145|524353825|FG000|Overall Study|Sponsor Decision|2|||
145409700|NCT00314145|524353826|FG001|Overall Study|Sponsor Decision|0|||
145409701|NCT02572167|524353829|FG000|Overall Study|Withdrawal by Subject|0|||
145409702|NCT02572167|524353830|FG001|Overall Study|Withdrawal by Subject|3|||
145409703|NCT02572167|524353831|FG002|Overall Study|Withdrawal by Subject|0|||
145409704|NCT02572167|524353829|FG000|Overall Study|Lost to Follow-up|2|||
145409705|NCT02572167|524353830|FG001|Overall Study|Lost to Follow-up|5|||
145409706|NCT02572167|524353831|FG002|Overall Study|Lost to Follow-up|3|||
145409707|NCT02572167|524353829|FG000|Overall Study|Death|0|||
145409708|NCT02572167|524353830|FG001|Overall Study|Death|8|||
145409709|NCT02572167|524353831|FG002|Overall Study|Death|3|||
145409710|NCT02572167|524353829|FG000|Overall Study|Did not meet inclusion criteria|0|||
145409711|NCT02572167|524353830|FG001|Overall Study|Did not meet inclusion criteria|0|||
145409712|NCT02572167|524353831|FG002|Overall Study|Did not meet inclusion criteria|1|||
145409713|NCT02572167|524353829|FG000|Overall Study|Study closure by Sponsor|4|||
145409714|NCT02572167|524353830|FG001|Overall Study|Study closure by Sponsor|40|||
145409715|NCT02572167|524353831|FG002|Overall Study|Study closure by Sponsor|24|||
145409716|NCT00976027|524353832|FG000|Overall Study|Serious Adverse Event|36|||
145409717|NCT00976027|524353833|FG001|Overall Study|Serious Adverse Event|17|||
145409718|NCT00976027|524353832|FG000|Overall Study|Adverse Event|0|||
145409719|NCT00976027|524353833|FG001|Overall Study|Adverse Event|2|||
145409720|NCT00976027|524353832|FG000|Overall Study|Protocol Violation|60|||
145247263|NCT02407236|523750494|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247264|NCT02407236|523750495|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247265|NCT02407236|523750496|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247266|NCT02407236|523750497|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247267|NCT02407236|523750498|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
145247268|NCT02407236|523750486|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247269|NCT02407236|523750487|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247270|NCT02407236|523750488|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247271|NCT02407236|523750489|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
145247272|NCT02407236|523750490|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
145247273|NCT02407236|523750491|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
145247274|NCT02407236|523750492|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
145247275|NCT02407236|523750493|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
145247276|NCT02407236|523750494|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247277|NCT02407236|523750495|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247278|NCT02407236|523750496|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247279|NCT02407236|523750497|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247280|NCT02407236|523750498|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
145247281|NCT02407236|523750486|FG000|Maintenance Study (44 Weeks)|Other|0|||
145247282|NCT02407236|523750487|FG001|Maintenance Study (44 Weeks)|Other|0|||
145247283|NCT02407236|523750488|FG002|Maintenance Study (44 Weeks)|Other|0|||
145247284|NCT02407236|523750489|FG003|Maintenance Study (44 Weeks)|Other|5|||
145247285|NCT02407236|523750490|FG004|Maintenance Study (44 Weeks)|Other|7|||
145247286|NCT02407236|523750491|FG005|Maintenance Study (44 Weeks)|Other|8|||
145247287|NCT02407236|523750492|FG006|Maintenance Study (44 Weeks)|Other|4|||
145247288|NCT02407236|523750493|FG007|Maintenance Study (44 Weeks)|Other|6|||
145247289|NCT02407236|523750494|FG008|Maintenance Study (44 Weeks)|Other|0|||
145247290|NCT02407236|523750495|FG009|Maintenance Study (44 Weeks)|Other|0|||
145247291|NCT02407236|523750496|FG010|Maintenance Study (44 Weeks)|Other|0|||
145247292|NCT02407236|523750497|FG011|Maintenance Study (44 Weeks)|Other|0|||
145247293|NCT02407236|523750498|FG012|Maintenance Study (44 Weeks)|Other|0|||
145247294|NCT02407236|523750486|FG000|Maintenance Study (44 Weeks)|Death|0|||
145247295|NCT02407236|523750487|FG001|Maintenance Study (44 Weeks)|Death|0|||
145247296|NCT02407236|523750488|FG002|Maintenance Study (44 Weeks)|Death|0|||
145247297|NCT02407236|523750489|FG003|Maintenance Study (44 Weeks)|Death|0|||
145247298|NCT02407236|523750490|FG004|Maintenance Study (44 Weeks)|Death|0|||
145247299|NCT02407236|523750491|FG005|Maintenance Study (44 Weeks)|Death|0|||
145247300|NCT02407236|523750492|FG006|Maintenance Study (44 Weeks)|Death|0|||
145247301|NCT02407236|523750493|FG007|Maintenance Study (44 Weeks)|Death|1|||
145247302|NCT02407236|523750494|FG008|Maintenance Study (44 Weeks)|Death|0|||
145247303|NCT02407236|523750495|FG009|Maintenance Study (44 Weeks)|Death|0|||
145247304|NCT02407236|523750496|FG010|Maintenance Study (44 Weeks)|Death|0|||
145247305|NCT02407236|523750497|FG011|Maintenance Study (44 Weeks)|Death|0|||
145247306|NCT02407236|523750498|FG012|Maintenance Study (44 Weeks)|Death|0|||
145247307|NCT02407236|523750486|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247308|NCT02407236|523750487|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145409721|NCT00976027|524353833|FG001|Overall Study|Protocol Violation|27|||
145247309|NCT02407236|523750488|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247310|NCT02407236|523750489|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145409722|NCT00976027|524353832|FG000|Overall Study|Lost to Follow-up|208|||
145409723|NCT00976027|524353833|FG001|Overall Study|Lost to Follow-up|103|||
145409724|NCT00976027|524353832|FG000|Overall Study|Withdrawal by Subject|107|||
145247311|NCT02407236|523750490|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247312|NCT02407236|523750491|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247313|NCT02407236|523750492|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247314|NCT02407236|523750493|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
145247315|NCT02407236|523750494|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
145247316|NCT02407236|523750495|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
145247317|NCT02407236|523750496|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
145247318|NCT02407236|523750497|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
145247319|NCT02407236|523750498|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
145247320|NCT02407236|523750486|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247321|NCT02407236|523750487|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247322|NCT02407236|523750488|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247323|NCT02407236|523750489|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247324|NCT02407236|523750490|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247325|NCT02407236|523750491|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247326|NCT02407236|523750492|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247327|NCT02407236|523750493|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247328|NCT02407236|523750494|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247329|NCT02407236|523750495|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247330|NCT02407236|523750496|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
145247331|NCT02407236|523750497|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247332|NCT02407236|523750498|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
145247333|NCT02407236|523750486|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247334|NCT02407236|523750487|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247335|NCT02407236|523750488|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247336|NCT02407236|523750489|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247337|NCT02407236|523750490|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247338|NCT02407236|523750491|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247339|NCT02407236|523750492|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247340|NCT02407236|523750493|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
145247341|NCT02407236|523750494|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
145247342|NCT02407236|523750495|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
145247343|NCT02407236|523750496|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
145247344|NCT02407236|523750497|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
145247345|NCT02407236|523750498|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
145247346|NCT02407236|523750486|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
145247347|NCT02407236|523750487|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
145247348|NCT02407236|523750488|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
145247349|NCT02407236|523750489|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
145247350|NCT02407236|523750490|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
145247351|NCT02407236|523750491|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
145247352|NCT02407236|523750492|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
145247353|NCT02407236|523750493|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
145247354|NCT02407236|523750494|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
145247355|NCT02407236|523750495|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
145247356|NCT02407236|523750496|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
145247357|NCT02407236|523750497|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
145247358|NCT02407236|523750498|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
145247359|NCT01627782|523750503|FG000|Overall Study|Adverse Event|1|||
145247360|NCT01627782|523750504|FG001|Overall Study|Adverse Event|2|||
145247361|NCT01627782|523750505|FG002|Overall Study|Adverse Event|0|||
145247362|NCT01627782|523750506|FG003|Overall Study|Adverse Event|1|||
145247363|NCT01627782|523750503|FG000|Overall Study|Lack of Efficacy|11|||
145247364|NCT01627782|523750504|FG001|Overall Study|Lack of Efficacy|1|||
145247365|NCT01627782|523750505|FG002|Overall Study|Lack of Efficacy|15|||
145247366|NCT01627782|523750506|FG003|Overall Study|Lack of Efficacy|2|||
145247367|NCT01627782|523750503|FG000|Overall Study|Protocol Violation|1|||
145247368|NCT01627782|523750504|FG001|Overall Study|Protocol Violation|0|||
145247369|NCT01627782|523750505|FG002|Overall Study|Protocol Violation|0|||
145247370|NCT01627782|523750506|FG003|Overall Study|Protocol Violation|0|||
145247371|NCT01627782|523750503|FG000|Overall Study|Withdrawal by Subject|2|||
145247372|NCT01627782|523750504|FG001|Overall Study|Withdrawal by Subject|1|||
145298842|NCT00463606|523945051|FG002|Overall Study|Lost to Follow-up|3|||
145298843|NCT00463606|523945049|FG000|Overall Study|Subject noncompliance|1|||
145247373|NCT01627782|523750505|FG002|Overall Study|Withdrawal by Subject|0|||
145247374|NCT01627782|523750506|FG003|Overall Study|Withdrawal by Subject|0|||
145247375|NCT01627782|523750503|FG000|Overall Study|Other|0|||
145247376|NCT01627782|523750504|FG001|Overall Study|Other|2|||
145247377|NCT01627782|523750505|FG002|Overall Study|Other|0|||
145298844|NCT00463606|523945050|FG001|Overall Study|Subject noncompliance|1|||
145298845|NCT00463606|523945051|FG002|Overall Study|Subject noncompliance|0|||
145247378|NCT01627782|523750506|FG003|Overall Study|Other|3|||
145247379|NCT01627782|523750503|FG000|Overall Study|Randomized But Not Treated|1|||
145247380|NCT01627782|523750504|FG001|Overall Study|Randomized But Not Treated|0|||
145247381|NCT01627782|523750505|FG002|Overall Study|Randomized But Not Treated|0|||
145247382|NCT01627782|523750506|FG003|Overall Study|Randomized But Not Treated|0|||
145247383|NCT00643448|523750507|FG000|Overall Study|Lack of Efficacy|2|||
145247384|NCT00643448|523750508|FG001|Overall Study|Lack of Efficacy|0|||
145247385|NCT00643448|523750509|FG002|Overall Study|Lack of Efficacy|4|||
145247386|NCT00643448|523750507|FG000|Overall Study|Adverse Event|2|||
145247387|NCT00643448|523750508|FG001|Overall Study|Adverse Event|2|||
145247388|NCT00643448|523750509|FG002|Overall Study|Adverse Event|2|||
145247389|NCT00643448|523750507|FG000|Overall Study|QTcF>550 ms|0|||
145247390|NCT00643448|523750508|FG001|Overall Study|QTcF>550 ms|3|||
145247391|NCT00643448|523750509|FG002|Overall Study|QTcF>550 ms|0|||
145247392|NCT02177812|523750513|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247393|NCT02177812|523750514|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247394|NCT02177812|523750515|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247395|NCT02177812|523750516|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247396|NCT02177812|523750517|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247397|NCT02177812|523750518|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
145247398|NCT02177812|523750519|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
145247399|NCT02177812|523750520|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
145247400|NCT02177812|523750521|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
145247401|NCT02177812|523750513|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247402|NCT02177812|523750514|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247403|NCT02177812|523750515|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247404|NCT02177812|523750516|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247405|NCT02177812|523750517|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247406|NCT02177812|523750518|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
145247407|NCT02177812|523750519|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
145247408|NCT02177812|523750520|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247409|NCT02177812|523750521|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
145247410|NCT02177812|523750513|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
145247411|NCT02177812|523750514|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
145247412|NCT02177812|523750515|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
145247413|NCT02177812|523750516|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
145247414|NCT02177812|523750517|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
145247415|NCT02177812|523750518|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
145247416|NCT02177812|523750519|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
145247417|NCT02177812|523750520|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
145247418|NCT02177812|523750521|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
145247419|NCT00089999|523750522|FG000|Overall Study|Adverse Event|4|||
145247420|NCT00089999|523750523|FG001|Overall Study|Adverse Event|7|||
145247421|NCT00089999|523750522|FG000|Overall Study|Withdrawal by Subject|0|||
145247422|NCT00089999|523750523|FG001|Overall Study|Withdrawal by Subject|4|||
145247423|NCT00089999|523750522|FG000|Overall Study|Lost to Follow-up|2|||
145247424|NCT00089999|523750523|FG001|Overall Study|Lost to Follow-up|1|||
145247425|NCT00089999|523750522|FG000|Overall Study|Radiological Progression of Cancer|52|||
145247426|NCT00089999|523750523|FG001|Overall Study|Radiological Progression of Cancer|44|||
145247427|NCT00089999|523750522|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
145247428|NCT00089999|523750523|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
145247429|NCT00089999|523750522|FG000|Overall Study|Death|3|||
145247430|NCT00089999|523750523|FG001|Overall Study|Death|3|||
145247431|NCT00089999|523750522|FG000|Overall Study|Poor General Condition|1|||
145247432|NCT00089999|523750523|FG001|Overall Study|Poor General Condition|0|||
145247433|NCT00089999|523750522|FG000|Overall Study|Clinical Progression|1|||
145247434|NCT00089999|523750523|FG001|Overall Study|Clinical Progression|2|||
145247435|NCT00089999|523750522|FG000|Overall Study|Physician Decision|2|||
145247436|NCT00089999|523750523|FG001|Overall Study|Physician Decision|2|||
145247437|NCT00089999|523750522|FG000|Overall Study|Patient Underwent Surgery|2|||
145247438|NCT00089999|523750523|FG001|Overall Study|Patient Underwent Surgery|0|||
145247439|NCT00089999|523750522|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
145247440|NCT00089999|523750523|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
145247441|NCT03039569|523750527|FG000|Overall Study|Lost to Follow-up|5|||
145247442|NCT03039569|523750528|FG001|Overall Study|Lost to Follow-up|4|||
145298846|NCT00463606|523945049|FG000|Overall Study|Subject moved out of town|1|||
145247443|NCT01167153|523750529|FG000|Overall Study|Non-effective therapy|1|||
145247444|NCT01167153|523750530|FG001|Overall Study|Non-effective therapy|4|||
145247445|NCT01167153|523750529|FG000|Overall Study|AE including clinical laboratory AE|2|||
145247446|NCT01167153|523750530|FG001|Overall Study|AE including clinical laboratory AE|8|||
145247447|NCT01167153|523750529|FG000|Overall Study|Hypotension|1|||
145247448|NCT01167153|523750530|FG001|Overall Study|Hypotension|0|||
145247449|NCT01167153|523750529|FG000|Overall Study|Lost to Follow-up|7|||
145247450|NCT01167153|523750530|FG001|Overall Study|Lost to Follow-up|9|||
145298847|NCT00463606|523945050|FG001|Overall Study|Subject moved out of town|0|||
145566419|NCT04097821|524934267|FG004|Overall Study|Subject Decision|2|||
145247451|NCT01167153|523750529|FG000|Overall Study|Non-compliance to concomitant medication|0|||
145247452|NCT01167153|523750530|FG001|Overall Study|Non-compliance to concomitant medication|2|||
145247453|NCT01167153|523750529|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
145247454|NCT01167153|523750530|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
145247455|NCT01167153|523750529|FG000|Overall Study|Withdrawal consent|1|||
145247456|NCT01167153|523750530|FG001|Overall Study|Withdrawal consent|1|||
145247457|NCT01167153|523750529|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
145247458|NCT01167153|523750530|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
145247459|NCT03695471|523752466|FG000|Overall Study|Cancellation|1|||
145247460|NCT02859558|523752467|FG000|Step 1|Not Eligible|0|||
145247461|NCT02859558|523752468|FG001|Step 1|Not Eligible|0|||
145247462|NCT02859558|523752469|FG002|Step 1|Not Eligible|0|||
145247463|NCT02859558|523752470|FG003|Step 1|Not Eligible|0|||
145247464|NCT02859558|523752471|FG004|Step 1|Not Eligible|3|||
145247465|NCT02859558|523752467|FG000|Step 1|Lost to Follow-up|1|||
145247466|NCT02859558|523752468|FG001|Step 1|Lost to Follow-up|3|||
145247467|NCT02859558|523752469|FG002|Step 1|Lost to Follow-up|3|||
145247468|NCT02859558|523752470|FG003|Step 1|Lost to Follow-up|0|||
145247469|NCT02859558|523752471|FG004|Step 1|Lost to Follow-up|0|||
145247470|NCT02859558|523752467|FG000|Step 1|Did Not Return to Clinic|2|||
145298848|NCT00463606|523945051|FG002|Overall Study|Subject moved out of town|0|||
145298849|NCT00463606|523945049|FG000|Overall Study|Physician Decision|0|||
145298850|NCT00463606|523945050|FG001|Overall Study|Physician Decision|1|||
145298851|NCT00463606|523945051|FG002|Overall Study|Physician Decision|0|||
145298852|NCT00463606|523945049|FG000|Overall Study|Sponsor request|0|||
145298853|NCT00463606|523945050|FG001|Overall Study|Sponsor request|1|||
145298854|NCT00463606|523945051|FG002|Overall Study|Sponsor request|0|||
145298855|NCT00463606|523945049|FG000|Overall Study|Exclusion criteria violation|2|||
145298856|NCT00463606|523945050|FG001|Overall Study|Exclusion criteria violation|0|||
145298857|NCT00463606|523945051|FG002|Overall Study|Exclusion criteria violation|0|||
145298858|NCT00463606|523945049|FG000|Overall Study|Coordinator error|1|||
145298859|NCT00463606|523945050|FG001|Overall Study|Coordinator error|0|||
145298860|NCT00463606|523945051|FG002|Overall Study|Coordinator error|0|||
145298861|NCT00463606|523945049|FG000|Overall Study|Patient randomized in error|1|||
145298862|NCT00463606|523945050|FG001|Overall Study|Patient randomized in error|0|||
145298863|NCT00463606|523945051|FG002|Overall Study|Patient randomized in error|0|||
145298864|NCT00463606|523945049|FG000|Overall Study|Participation in another ABT-335 trial|1|||
145298865|NCT00463606|523945050|FG001|Overall Study|Participation in another ABT-335 trial|0|||
145298866|NCT00463606|523945051|FG002|Overall Study|Participation in another ABT-335 trial|0|||
145298867|NCT00463606|523945049|FG000|Overall Study|Protocol Violation|0|||
145298868|NCT00463606|523945050|FG001|Overall Study|Protocol Violation|0|||
145298869|NCT00463606|523945051|FG002|Overall Study|Protocol Violation|1|||
145298870|NCT01223365|523945053|FG000|Open-label Titration Period|Enrolled but not treated|1|||
145298871|NCT01223365|523945053|FG000|Open-label Titration Period|Adverse Event|23|||
145298872|NCT01223365|523945053|FG000|Open-label Titration Period|Lack of Efficacy|3|||
145298873|NCT01223365|523945053|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
145298874|NCT01223365|523945053|FG000|Open-label Titration Period|Protocol Violation|1|||
145298875|NCT01223365|523945053|FG000|Open-label Titration Period|Lost to Follow-up|2|||
145298876|NCT01223365|523945053|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
145298877|NCT01223365|523945053|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
145298878|NCT01223365|523945053|FG000|Open-label Titration Period|Starting physical therapy|1|||
145298879|NCT01223365|523945053|FG000|Open-label Treatment Period|Adverse Event|39|||
145298880|NCT01223365|523945053|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
145298881|NCT01223365|523945053|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
145298882|NCT01223365|523945053|FG000|Open-label Treatment Period|Protocol Violation|15|||
145298883|NCT01223365|523945053|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
145298884|NCT01223365|523945053|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
145298885|NCT01223365|523945053|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
145298886|NCT01223365|523945053|FG000|Open-label Treatment Period|Moved out of area|2|||
145298887|NCT01223365|523945053|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
145298888|NCT01223365|523945053|FG000|Open-label Treatment Period|"Out of window"|1|||
145298889|NCT01223365|523945053|FG000|Open-label Treatment Period|Starting physical therapy|1|||
145566420|NCT04097821|524934268|FG005|Overall Study|Subject Decision|2|||
145298890|NCT01223365|523945053|FG000|Open-label Treatment Period|Physician Decision|2|||
145566421|NCT04097821|524934269|FG006|Overall Study|Subject Decision|0|||
145566422|NCT04097821|524934270|FG007|Overall Study|Subject Decision|1|||
145566423|NCT04097821|524934263|FG000|Overall Study|Death|0|||
145566424|NCT04097821|524934264|FG001|Overall Study|Death|0|||
145566425|NCT04097821|524934265|FG002|Overall Study|Death|3|||
145247471|NCT02859558|523752468|FG001|Step 1|Did Not Return to Clinic|3|||
145247472|NCT02859558|523752469|FG002|Step 1|Did Not Return to Clinic|4|||
145247473|NCT02859558|523752470|FG003|Step 1|Did Not Return to Clinic|0|||
145247474|NCT02859558|523752471|FG004|Step 1|Did Not Return to Clinic|0|||
145247475|NCT02859558|523752467|FG000|Step 1|Moved|0|||
145409725|NCT00976027|524353833|FG001|Overall Study|Withdrawal by Subject|66|||
145409726|NCT04435626|524353836|FG000|Overall Study|Lost to Follow-up|1|||
145409727|NCT04435626|524353837|FG001|Overall Study|Lost to Follow-up|5|||
145409728|NCT04435626|524353836|FG000|Overall Study|Withdrawal by Subject|6|||
145409729|NCT04435626|524353837|FG001|Overall Study|Withdrawal by Subject|7|||
145409730|NCT04435626|524353836|FG000|Overall Study|major GCP violations|8|||
145409731|NCT04435626|524353837|FG001|Overall Study|major GCP violations|7|||
145409732|NCT01771107|524353845|FG000|Overall Study|Adverse Event|1|||
145409733|NCT01771107|524353846|FG001|Overall Study|Adverse Event|3|||
145409734|NCT01771107|524353845|FG000|Overall Study|Withdrawal by Subject|0|||
145409735|NCT01771107|524353846|FG001|Overall Study|Withdrawal by Subject|2|||
145409736|NCT01771107|524353845|FG000|Overall Study|Lost to Follow-up|0|||
145409737|NCT01771107|524353846|FG001|Overall Study|Lost to Follow-up|1|||
145409738|NCT01771107|524353845|FG000|Overall Study|participant moved|0|||
145409739|NCT01771107|524353846|FG001|Overall Study|participant moved|1|||
145409740|NCT01771107|524353845|FG000|Overall Study|Other|0|||
145409741|NCT01771107|524353846|FG001|Overall Study|Other|1|||
145409742|NCT02296125|524353851|FG000|Overall Study|Withdrawal by Subject|18|||
145409743|NCT02296125|524353852|FG001|Overall Study|Withdrawal by Subject|8|||
145409744|NCT02296125|524353853|FG002|Overall Study|Withdrawal by Subject|6|||
145409745|NCT02296125|524353854|FG003|Overall Study|Withdrawal by Subject|2|||
145409746|NCT02296125|524353851|FG000|Overall Study|Adverse Event|41|||
145409747|NCT02296125|524353852|FG001|Overall Study|Adverse Event|52|||
145409748|NCT02296125|524353853|FG002|Overall Study|Adverse Event|9|||
145409749|NCT02296125|524353854|FG003|Overall Study|Adverse Event|4|||
145409750|NCT02296125|524353851|FG000|Overall Study|Severe non-compliance to protocol|0|||
145409751|NCT02296125|524353852|FG001|Overall Study|Severe non-compliance to protocol|1|||
145409752|NCT02296125|524353853|FG002|Overall Study|Severe non-compliance to protocol|0|||
145409753|NCT02296125|524353854|FG003|Overall Study|Severe non-compliance to protocol|0|||
145409754|NCT02296125|524353851|FG000|Overall Study|Condition under investigation worsened|153|||
145409755|NCT02296125|524353852|FG001|Overall Study|Condition under investigation worsened|199|||
145409756|NCT02296125|524353853|FG002|Overall Study|Condition under investigation worsened|39|||
145409757|NCT02296125|524353854|FG003|Overall Study|Condition under investigation worsened|56|||
145409758|NCT02296125|524353851|FG000|Overall Study|Any reason not specifically recorded|6|||
145409759|NCT02296125|524353852|FG001|Overall Study|Any reason not specifically recorded|4|||
145409760|NCT02296125|524353853|FG002|Overall Study|Any reason not specifically recorded|2|||
145409761|NCT02296125|524353854|FG003|Overall Study|Any reason not specifically recorded|0|||
145409762|NCT01160614|524353855|FG000|Overall Study|Withdrawal by Subject|0|||
145409763|NCT01160614|524353856|FG001|Overall Study|Withdrawal by Subject|2|||
145409764|NCT05248386|524353857|FG000|Overall Study|Technical problems|0|||
145409765|NCT05248386|524353858|FG001|Overall Study|Technical problems|1|||
145409766|NCT05248386|524353857|FG000|Overall Study|Withdrawal by Subject|15|||
145409767|NCT05248386|524353858|FG001|Overall Study|Withdrawal by Subject|10|||
145409768|NCT05248386|524353857|FG000|Overall Study|Physician Decision|0|||
145409769|NCT05248386|524353858|FG001|Overall Study|Physician Decision|1|||
145409770|NCT05248386|524353857|FG000|Overall Study|Adverse Event|2|||
145409771|NCT05248386|524353858|FG001|Overall Study|Adverse Event|4|||
145409772|NCT05248386|524353857|FG000|Overall Study|Other|1|||
145409773|NCT05248386|524353858|FG001|Overall Study|Other|0|||
145409774|NCT05248386|524353857|FG000|Overall Study|Lack of Efficacy|14|||
145409775|NCT05248386|524353858|FG001|Overall Study|Lack of Efficacy|12|||
145409776|NCT02864992|524353859|FG000|Overall Study|still on treatment|15|||
145409777|NCT02864992|524353860|FG001|Overall Study|still on treatment|1|||
145409778|NCT02864992|524353861|FG002|Overall Study|still on treatment|33|||
145409779|NCT03621592|524353862|FG000|Overall Study|Lost to Follow-up|1|||
145409780|NCT03621592|524353863|FG001|Overall Study|Lost to Follow-up|0|||
145409781|NCT03621592|524353862|FG000|Overall Study|Lack of Improvement|1|||
145409782|NCT03621592|524353863|FG001|Overall Study|Lack of Improvement|0|||
145409783|NCT03621592|524353862|FG000|Overall Study|Preference to receive wound care closer to home|1|||
145409784|NCT03621592|524353863|FG001|Overall Study|Preference to receive wound care closer to home|0|||
145409785|NCT03621592|524353862|FG000|Overall Study|Lack of healing|0|||
145409786|NCT03621592|524353863|FG001|Overall Study|Lack of healing|2|||
145409787|NCT04967222|524353865|FG000|Randomized|Lost to Follow-up|0|||
145409788|NCT04967222|524353866|FG001|Randomized|Lost to Follow-up|1|||
145409789|NCT04967222|524353867|FG002|Randomized|Lost to Follow-up|1|||
145409790|NCT04967222|524353865|FG000|Randomized|Physician Decision|0|||
145409791|NCT04967222|524353866|FG001|Randomized|Physician Decision|0|||
145409792|NCT04967222|524353867|FG002|Randomized|Physician Decision|1|||
145409793|NCT04967222|524353865|FG000|Randomized|Withdrawal by Subject|0|||
145409794|NCT04967222|524353866|FG001|Randomized|Withdrawal by Subject|0|||
145409795|NCT04967222|524353867|FG002|Randomized|Withdrawal by Subject|2|||
145409796|NCT04967222|524353865|FG000|Randomized|abnormal finding in MRI|0|||
145409797|NCT04967222|524353866|FG001|Randomized|abnormal finding in MRI|2|||
145409798|NCT04967222|524353867|FG002|Randomized|abnormal finding in MRI|0|||
145409799|NCT02382380|524353868|FG000|Overall Study|Withdrawal by Subject|2|||
145409800|NCT02382380|524353869|FG001|Overall Study|Withdrawal by Subject|2|||
145409801|NCT02382380|524353868|FG000|Overall Study|Lost to Follow-up|0|||
145247476|NCT02859558|523752468|FG001|Step 1|Moved|1|||
145247477|NCT02859558|523752469|FG002|Step 1|Moved|1|||
145247478|NCT02859558|523752470|FG003|Step 1|Moved|0|||
145247479|NCT02859558|523752471|FG004|Step 1|Moved|0|||
145247480|NCT02859558|523752467|FG000|Step 1|Withdrawal By Participant|1|||
145247481|NCT02859558|523752468|FG001|Step 1|Withdrawal By Participant|2|||
145247482|NCT02859558|523752469|FG002|Step 1|Withdrawal By Participant|1|||
145247483|NCT02859558|523752470|FG003|Step 1|Withdrawal By Participant|0|||
145247484|NCT02859558|523752471|FG004|Step 1|Withdrawal By Participant|0|||
145247485|NCT02859558|523752467|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
145247486|NCT02859558|523752468|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
145247487|NCT02859558|523752469|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
145247488|NCT02859558|523752470|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
145247489|NCT02859558|523752471|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
145247490|NCT02859558|523752467|FG000|Step 1|Incarceration|0|||
145247491|NCT02859558|523752468|FG001|Step 1|Incarceration|1|||
145247492|NCT02859558|523752469|FG002|Step 1|Incarceration|0|||
145247493|NCT02859558|523752470|FG003|Step 1|Incarceration|0|||
145247494|NCT02859558|523752471|FG004|Step 1|Incarceration|0|||
145247495|NCT02859558|523752467|FG000|Step 1|Non-Adherence to Study Drug|2|||
145247496|NCT02859558|523752468|FG001|Step 1|Non-Adherence to Study Drug|0|||
145247497|NCT02859558|523752469|FG002|Step 1|Non-Adherence to Study Drug|1|||
145247498|NCT02859558|523752470|FG003|Step 1|Non-Adherence to Study Drug|0|||
145247499|NCT02859558|523752471|FG004|Step 1|Non-Adherence to Study Drug|0|||
145247500|NCT02859558|523752467|FG000|Step 1|Non-Adherence to Study Requirements|3|||
145247501|NCT02859558|523752468|FG001|Step 1|Non-Adherence to Study Requirements|1|||
145247502|NCT02859558|523752469|FG002|Step 1|Non-Adherence to Study Requirements|0|||
145247503|NCT02859558|523752470|FG003|Step 1|Non-Adherence to Study Requirements|0|||
145247504|NCT02859558|523752471|FG004|Step 1|Non-Adherence to Study Requirements|0|||
145247505|NCT02859558|523752467|FG000|Step 1|Virologic Failure|2|||
145247506|NCT02859558|523752468|FG001|Step 1|Virologic Failure|1|||
145247507|NCT02859558|523752469|FG002|Step 1|Virologic Failure|1|||
145247508|NCT02859558|523752470|FG003|Step 1|Virologic Failure|0|||
145247509|NCT02859558|523752471|FG004|Step 1|Virologic Failure|0|||
145247510|NCT02859558|523752467|FG000|Step 2|Lost to Follow-up|3|||
145247511|NCT02859558|523752468|FG001|Step 2|Lost to Follow-up|3|||
145247512|NCT02859558|523752469|FG002|Step 2|Lost to Follow-up|1|||
145247513|NCT02859558|523752470|FG003|Step 2|Lost to Follow-up|0|||
145247514|NCT02859558|523752471|FG004|Step 2|Lost to Follow-up|0|||
145247515|NCT02859558|523752467|FG000|Step 2|Withdrawal by Subject|0|||
145247516|NCT02859558|523752468|FG001|Step 2|Withdrawal by Subject|1|||
145247517|NCT02859558|523752469|FG002|Step 2|Withdrawal by Subject|1|||
145247518|NCT02859558|523752470|FG003|Step 2|Withdrawal by Subject|0|||
145247519|NCT02859558|523752471|FG004|Step 2|Withdrawal by Subject|0|||
145247520|NCT02859558|523752467|FG000|Step 2|Unexpected Closure of Site|0|||
145247521|NCT02859558|523752468|FG001|Step 2|Unexpected Closure of Site|1|||
145247522|NCT02859558|523752469|FG002|Step 2|Unexpected Closure of Site|1|||
145247523|NCT02859558|523752470|FG003|Step 2|Unexpected Closure of Site|0|||
145247524|NCT02859558|523752471|FG004|Step 2|Unexpected Closure of Site|0|||
145247525|NCT02859558|523752467|FG000|Step 2|Death|1|||
145247526|NCT02859558|523752468|FG001|Step 2|Death|0|||
145247527|NCT02859558|523752469|FG002|Step 2|Death|0|||
145247528|NCT02859558|523752470|FG003|Step 2|Death|0|||
145247529|NCT02859558|523752471|FG004|Step 2|Death|0|||
145247530|NCT02859558|523752467|FG000|Step 2|Incarceration|0|||
145247531|NCT02859558|523752468|FG001|Step 2|Incarceration|0|||
145247532|NCT02859558|523752469|FG002|Step 2|Incarceration|1|||
145247533|NCT02859558|523752470|FG003|Step 2|Incarceration|0|||
145247534|NCT02859558|523752471|FG004|Step 2|Incarceration|0|||
145247535|NCT01938391|523752474|FG000|6 Month Follow up|Withdrawal by Subject|1|||
145247536|NCT01938391|523752474|FG000|12 Month Follow up|Physician Decision|1|||
145247537|NCT01938391|523752474|FG000|12 Month Follow up|Withdrawal by Subject|1|||
145247538|NCT01077193|523752475|FG000|Overall Study|Lost to Follow-up|1|||
145247539|NCT01077193|523752475|FG000|Overall Study|Withdrawal by Subject|2|||
145247540|NCT01077193|523752475|FG000|Overall Study|Lack of Efficacy|1|||
145247541|NCT01077193|523752475|FG000|Overall Study|Study Terminated by Sponsor|40|||
145247542|NCT02234050|523752487|FG000|Overall Study|Lack of Efficacy|38|||
145247543|NCT02234050|523752488|FG001|Overall Study|Lack of Efficacy|22|||
145247544|NCT02234050|523752487|FG000|Overall Study|Adverse Event|13|||
145247545|NCT02234050|523752488|FG001|Overall Study|Adverse Event|1|||
145247546|NCT02234050|523752487|FG000|Overall Study|Withdrawal by Subject|4|||
145247547|NCT02234050|523752488|FG001|Overall Study|Withdrawal by Subject|2|||
145298891|NCT02682602|523945054|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
145247548|NCT02234050|523752487|FG000|Overall Study|Sponsor's decision|6|||
145298892|NCT02682602|523945055|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
145298893|NCT02682602|523945054|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
145247549|NCT02234050|523752488|FG001|Overall Study|Sponsor's decision|0|||
145247550|NCT01680991|523752489|FG000|Overall Study|Adverse Event|1|||
145247551|NCT01680991|523752490|FG001|Overall Study|Adverse Event|0|||
145247552|NCT01680991|523752491|FG002|Overall Study|Adverse Event|0|||
145247553|NCT01680991|523752489|FG000|Overall Study|Death|1|||
145409802|NCT02382380|524353869|FG001|Overall Study|Lost to Follow-up|1|||
145409803|NCT01295944|524353870|FG000|Overall Study|Switched to alternative treatment|1|||
145409804|NCT01295944|524353870|FG000|Overall Study|Ineligible|9|||
145409805|NCT01295944|524353870|FG000|Overall Study|Withdrawal by Subject|1|||
145409806|NCT01295944|524353870|FG000|Overall Study|Participant chose to be treated in Peru|1|||
145409807|NCT01295944|524353870|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
145409808|NCT01295944|524353870|FG000|Overall Study|Physician Decision|1|||
145409809|NCT01295944|524353870|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
145409810|NCT01295944|524353870|FG000|Overall Study|Disease progression|4|||
145409811|NCT01295944|524353870|FG000|Overall Study|Transferred care before starting new treatment|1|||
145409812|NCT03785366|524353878|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
145409813|NCT03785366|524353879|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
145409814|NCT03785366|524353878|FG000|Overall Study|Lost to Follow-up|1|||
145409815|NCT03785366|524353879|FG001|Overall Study|Lost to Follow-up|0|||
145409816|NCT03785366|524353878|FG000|Overall Study|Partial IUD Expulsion|0|||
145409817|NCT03785366|524353879|FG001|Overall Study|Partial IUD Expulsion|2|||
145409818|NCT03785366|524353878|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
145409819|NCT03785366|524353879|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
145409820|NCT03240874|524353880|FG000|Overall Study|Lost to Follow-up|0|||
145409821|NCT03240874|524353881|FG001|Overall Study|Lost to Follow-up|2|||
145409822|NCT03240874|524353882|FG002|Overall Study|Lost to Follow-up|4|||
145409823|NCT03240874|524353883|FG003|Overall Study|Lost to Follow-up|1|||
145409824|NCT05252702|524353884|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
145409825|NCT05252702|524353884|FG000|Overall Study|Death|16|||
145409826|NCT05252702|524353884|FG000|Overall Study|System explant|5|||
145409827|NCT05252702|524353884|FG000|Overall Study|Lost to Follow-up|1|||
145409828|NCT05252702|524353884|FG000|Overall Study|Withdrawn by investigator|1|||
145409829|NCT05252702|524353884|FG000|Overall Study|Visit not due|306|||
145409830|NCT05252702|524353884|FG000|Overall Study|Visit within window but not completed|92|||
145409831|NCT05252702|524353884|FG000|Overall Study|Unsuccessful implant|1|||
145409832|NCT04153864|524353885|FG000|Overall Study|Withdrawal by Subject|21|||
145409833|NCT04153864|524353886|FG001|Overall Study|Withdrawal by Subject|7|||
145409834|NCT04153864|524353887|FG002|Overall Study|Withdrawal by Subject|23|||
145409835|NCT04153864|524353888|FG003|Overall Study|Withdrawal by Subject|2|||
145409836|NCT04153864|524353885|FG000|Overall Study|Lost to Follow-up|4|||
145409837|NCT04153864|524353886|FG001|Overall Study|Lost to Follow-up|0|||
145409838|NCT04153864|524353887|FG002|Overall Study|Lost to Follow-up|3|||
145409839|NCT04153864|524353888|FG003|Overall Study|Lost to Follow-up|0|||
145409840|NCT04153864|524353885|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
145409841|NCT04153864|524353886|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
145409842|NCT04153864|524353887|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
145409843|NCT04153864|524353888|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
145409844|NCT03036254|524353889|FG000|Overall Study|Adverse Event|6|||
145409845|NCT03036254|524353890|FG001|Overall Study|Adverse Event|4|||
145409846|NCT03036254|524353889|FG000|Overall Study|Death|3|||
145409847|NCT03036254|524353890|FG001|Overall Study|Death|1|||
145409848|NCT03036254|524353889|FG000|Overall Study|Lack of Efficacy|5|||
145409849|NCT03036254|524353890|FG001|Overall Study|Lack of Efficacy|1|||
145409850|NCT03036254|524353889|FG000|Overall Study|Withdrawal by Subject|3|||
145409851|NCT03036254|524353890|FG001|Overall Study|Withdrawal by Subject|5|||
145409852|NCT02783274|524353892|FG000|Overall Study|Withdrawal by Subject|16|||
145409853|NCT02783274|524353892|FG000|Overall Study|Physician Decision|6|||
145409854|NCT02783274|524353892|FG000|Overall Study|Death|9|||
145409855|NCT02783274|524353892|FG000|Overall Study|Lost to Follow-up|22|||
145409856|NCT02783274|524353892|FG000|Overall Study|Other|22|||
145409857|NCT01802281|524353894|FG000|Overall Study|Death|1|||
145409858|NCT01802281|524353895|FG001|Overall Study|Death|2|||
145409859|NCT01802281|524353894|FG000|Overall Study|Withdrawal by Subject|2|||
145566426|NCT04097821|524934266|FG003|Overall Study|Death|1|||
145566427|NCT04097821|524934267|FG004|Overall Study|Death|0|||
145566428|NCT04097821|524934268|FG005|Overall Study|Death|0|||
145566429|NCT04097821|524934269|FG006|Overall Study|Death|0|||
145566430|NCT04097821|524934270|FG007|Overall Study|Death|0|||
145566431|NCT04097821|524934263|FG000|Overall Study|Physician Decision|1|||
145566432|NCT04097821|524934264|FG001|Overall Study|Physician Decision|2|||
145566433|NCT04097821|524934265|FG002|Overall Study|Physician Decision|0|||
145409860|NCT01802281|524353895|FG001|Overall Study|Withdrawal by Subject|1|||
145409861|NCT01802281|524353894|FG000|Overall Study|Ineligible|5|||
145409862|NCT01802281|524353895|FG001|Overall Study|Ineligible|3|||
145409863|NCT04133909|524353901|FG000|Overall Study|Death|11|||
145409864|NCT04133909|524353902|FG001|Overall Study|Death|11|||
145409865|NCT04133909|524353901|FG000|Overall Study|Adverse Event|4|||
145409866|NCT04133909|524353902|FG001|Overall Study|Adverse Event|5|||
145409867|NCT04133909|524353901|FG000|Overall Study|Lost to Follow-up|3|||
145409868|NCT04133909|524353902|FG001|Overall Study|Lost to Follow-up|5|||
145566434|NCT04097821|524934266|FG003|Overall Study|Physician Decision|0|||
145566435|NCT04097821|524934267|FG004|Overall Study|Physician Decision|0|||
145409869|NCT04133909|524353901|FG000|Overall Study|Physician Decision|4|||
145409870|NCT04133909|524353902|FG001|Overall Study|Physician Decision|7|||
145409871|NCT04133909|524353901|FG000|Overall Study|Withdrawal by Subject|40|||
145409872|NCT04133909|524353902|FG001|Overall Study|Withdrawal by Subject|35|||
145409873|NCT04133909|524353901|FG000|Overall Study|Lack of Efficacy|2|||
145409874|NCT04133909|524353902|FG001|Overall Study|Lack of Efficacy|7|||
145409875|NCT04133909|524353901|FG000|Overall Study|Randomized in error|1|||
145409876|NCT04133909|524353902|FG001|Overall Study|Randomized in error|1|||
145409877|NCT01811238|524353903|FG000|Overall Study|Withdrawal by Subject|42|||
145409878|NCT01811238|524353903|FG000|Overall Study|Adverse Event|25|||
145409879|NCT01811238|524353903|FG000|Overall Study|Protocol Violation|4|||
145409880|NCT01811238|524353903|FG000|Overall Study|Lack of Efficacy|4|||
145409881|NCT01811238|524353903|FG000|Overall Study|subject refused study medication|6|||
145409882|NCT02916927|524353907|FG000|Overall Study|Discharged prior to study drug receipt|0|||
145409883|NCT02916927|524353908|FG001|Overall Study|Discharged prior to study drug receipt|2|||
145409884|NCT02916927|524353907|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
145409885|NCT02916927|524353908|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
145409886|NCT02916927|524353907|FG000|Overall Study|Withdrawal before first time point|1|||
145409887|NCT02916927|524353908|FG001|Overall Study|Withdrawal before first time point|0|||
145409888|NCT00858988|524353918|FG000|Analysis|Lactulose unable to be detected in urine|2|||
145409889|NCT00858988|524353919|FG001|Analysis|Lactulose unable to be detected in urine|1|||
145409890|NCT01706328|524353920|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
145409891|NCT01706328|524353921|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145409892|NCT01706328|524353922|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145566436|NCT04097821|524934268|FG005|Overall Study|Physician Decision|0|||
145566437|NCT04097821|524934269|FG006|Overall Study|Physician Decision|0|||
145566438|NCT04097821|524934270|FG007|Overall Study|Physician Decision|0|||
145566439|NCT04097821|524934263|FG000|Overall Study|Adverse Event|0|||
145566440|NCT04097821|524934264|FG001|Overall Study|Adverse Event|0|||
145566441|NCT04097821|524934265|FG002|Overall Study|Adverse Event|1|||
145566442|NCT04097821|524934266|FG003|Overall Study|Adverse Event|1|||
145566443|NCT04097821|524934267|FG004|Overall Study|Adverse Event|0|||
145409893|NCT01706328|524353920|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
145409894|NCT01706328|524353921|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145409895|NCT01706328|524353922|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145409896|NCT01706328|524353920|FG000|2-week Run-in Period|Physician Decision|4|||
145409897|NCT01706328|524353921|FG001|2-week Run-in Period|Physician Decision|0|||
145409898|NCT01706328|524353922|FG002|2-week Run-in Period|Physician Decision|0|||
145409899|NCT01706328|524353920|FG000|2-week Run-in Period|Adverse Event|4|||
145409900|NCT01706328|524353921|FG001|2-week Run-in Period|Adverse Event|0|||
145409901|NCT01706328|524353922|FG002|2-week Run-in Period|Adverse Event|0|||
145409902|NCT01706328|524353920|FG000|2-week Run-in Period|Lost to Follow-up|2|||
145409903|NCT01706328|524353921|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145409904|NCT01706328|524353922|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145409905|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
145409906|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
145409907|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
145409908|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
145409909|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
145409910|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
145409911|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
145409912|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
145409913|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
145409914|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
145409915|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
145409916|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
145409917|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
145409918|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
145409919|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
145409920|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
145566444|NCT04097821|524934268|FG005|Overall Study|Adverse Event|0|||
145566445|NCT04097821|524934269|FG006|Overall Study|Adverse Event|0|||
145566446|NCT04097821|524934270|FG007|Overall Study|Adverse Event|0|||
145620239|NCT00738530|525123720|FG001|Overall Study|Lost to Follow-up|6|||
145620240|NCT00738530|525123719|FG000|Overall Study|Withdrawal by Subject|6|||
145620241|NCT00738530|525123720|FG001|Overall Study|Withdrawal by Subject|8|||
145409921|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
145409922|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
145409923|NCT01706328|524353920|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145566447|NCT04097821|524934263|FG000|Overall Study|New Therapy For Study Indication|0|||
145566448|NCT04097821|524934264|FG001|Overall Study|New Therapy For Study Indication|0|||
145409924|NCT01706328|524353921|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
145409925|NCT01706328|524353922|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
145409926|NCT02924376|524353923|FG000|Overall Study|Progressive Disease|4|||
145409927|NCT02924376|524353924|FG001|Overall Study|Progressive Disease|0|||
145409928|NCT02924376|524353925|FG002|Overall Study|Progressive Disease|1|||
145409929|NCT02924376|524353926|FG003|Overall Study|Progressive Disease|0|||
145409930|NCT02924376|524353923|FG000|Overall Study|Death|73|||
145409931|NCT02924376|524353924|FG001|Overall Study|Death|18|||
145409932|NCT02924376|524353925|FG002|Overall Study|Death|15|||
145409933|NCT02924376|524353926|FG003|Overall Study|Death|2|||
145409934|NCT02924376|524353923|FG000|Overall Study|Lost to Follow-up|3|||
145409935|NCT02924376|524353924|FG001|Overall Study|Lost to Follow-up|0|||
145409936|NCT02924376|524353925|FG002|Overall Study|Lost to Follow-up|0|||
145409937|NCT02924376|524353926|FG003|Overall Study|Lost to Follow-up|0|||
145409938|NCT02924376|524353923|FG000|Overall Study|Study Terminated by Sponsor|19|||
145409939|NCT02924376|524353924|FG001|Overall Study|Study Terminated by Sponsor|0|||
145409940|NCT02924376|524353925|FG002|Overall Study|Study Terminated by Sponsor|0|||
145409941|NCT02924376|524353926|FG003|Overall Study|Study Terminated by Sponsor|0|||
145409942|NCT02924376|524353923|FG000|Overall Study|Physician Decision|1|||
145409943|NCT02924376|524353924|FG001|Overall Study|Physician Decision|0|||
145409944|NCT02924376|524353925|FG002|Overall Study|Physician Decision|0|||
145409945|NCT02924376|524353926|FG003|Overall Study|Physician Decision|0|||
145409946|NCT02924376|524353923|FG000|Overall Study|Withdrawal by Subject|7|||
145409947|NCT02924376|524353924|FG001|Overall Study|Withdrawal by Subject|2|||
145409948|NCT02924376|524353925|FG002|Overall Study|Withdrawal by Subject|1|||
145409949|NCT02924376|524353926|FG003|Overall Study|Withdrawal by Subject|0|||
145409950|NCT02924376|524353923|FG000|Overall Study|Rolled Over to Another Study|1|||
145409951|NCT02924376|524353924|FG001|Overall Study|Rolled Over to Another Study|0|||
145409952|NCT02924376|524353925|FG002|Overall Study|Rolled Over to Another Study|0|||
145409953|NCT02924376|524353926|FG003|Overall Study|Rolled Over to Another Study|0|||
145409954|NCT03595748|524355064|FG000|Overall Study|Death|11|||
145409955|NCT03595748|524355065|FG001|Overall Study|Death|12|||
145409956|NCT03595748|524355064|FG000|Overall Study|Withdrawal by Subject|28|||
145409957|NCT03595748|524355065|FG001|Overall Study|Withdrawal by Subject|29|||
145409958|NCT03595748|524355064|FG000|Overall Study|Protocol Violation|0|||
145409959|NCT03595748|524355065|FG001|Overall Study|Protocol Violation|1|||
145409960|NCT04809974|524355066|FG000|Lead-in Phase|Withdrawal by Subject|3|||
145409961|NCT04809974|524355067|FG001|Lead-in Phase|Withdrawal by Subject|0|||
145409962|NCT04809974|524355068|FG002|Lead-in Phase|Withdrawal by Subject|0|||
145409963|NCT04809974|524355066|FG000|Lead-in Phase|No longer eligible|11|||
145409964|NCT04809974|524355067|FG001|Lead-in Phase|No longer eligible|0|||
145409965|NCT04809974|524355068|FG002|Lead-in Phase|No longer eligible|0|||
145409966|NCT04809974|524355066|FG000|Randomized Phase|Lost to Follow-up|0|||
145409967|NCT04809974|524355067|FG001|Randomized Phase|Lost to Follow-up|1|||
145409968|NCT04809974|524355068|FG002|Randomized Phase|Lost to Follow-up|5|||
145409969|NCT04809974|524355066|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
145409970|NCT04809974|524355067|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
145566449|NCT04097821|524934265|FG002|Overall Study|New Therapy For Study Indication|0|||
145566450|NCT04097821|524934266|FG003|Overall Study|New Therapy For Study Indication|0|||
145566451|NCT04097821|524934267|FG004|Overall Study|New Therapy For Study Indication|0|||
145566452|NCT04097821|524934268|FG005|Overall Study|New Therapy For Study Indication|0|||
145566453|NCT04097821|524934269|FG006|Overall Study|New Therapy For Study Indication|1|||
145566454|NCT04097821|524934270|FG007|Overall Study|New Therapy For Study Indication|0|||
145566455|NCT00244712|524934271|FG000|Overall Study|Adverse Event|20|||
145566456|NCT00244712|524934272|FG001|Overall Study|Adverse Event|21|||
145566457|NCT00244712|524934271|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
145566458|NCT00244712|524934272|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
145566459|NCT00244712|524934271|FG000|Overall Study|Lack of Compliance|10|||
145566460|NCT00244712|524934272|FG001|Overall Study|Lack of Compliance|11|||
145566461|NCT00244712|524934271|FG000|Overall Study|Lost to Follow-up|45|||
145566462|NCT00244712|524934272|FG001|Overall Study|Lost to Follow-up|52|||
145566463|NCT00244712|524934271|FG000|Overall Study|Withdrawal by Subject|13|||
145566464|NCT00244712|524934272|FG001|Overall Study|Withdrawal by Subject|23|||
145409971|NCT04809974|524355068|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
145409972|NCT04809974|524355066|FG000|Randomized Phase|Adverse Event|0|||
145409973|NCT04809974|524355067|FG001|Randomized Phase|Adverse Event|1|||
145409974|NCT04809974|524355068|FG002|Randomized Phase|Adverse Event|4|||
145409975|NCT04809974|524355066|FG000|Randomized Phase|Withdrawal by Subject|0|||
145409976|NCT04809974|524355067|FG001|Randomized Phase|Withdrawal by Subject|0|||
145409977|NCT04809974|524355068|FG002|Randomized Phase|Withdrawal by Subject|5|||
145409978|NCT00770809|524355069|FG000|Overall Study|Adverse Event|9|||
145409979|NCT00770809|524355070|FG001|Overall Study|Adverse Event|1|||
145409980|NCT00770809|524355071|FG002|Overall Study|Adverse Event|12|||
145409981|NCT00770809|524355069|FG000|Overall Study|Death|1|||
145566465|NCT00244712|524934271|FG000|Overall Study|Protocol Violation, disease progression|13|||
145247554|NCT01680991|523752490|FG001|Overall Study|Death|0|||
145247555|NCT01680991|523752491|FG002|Overall Study|Death|1|||
145247556|NCT01680991|523752489|FG000|Overall Study|Protocol Violation|0|||
145247557|NCT01680991|523752490|FG001|Overall Study|Protocol Violation|1|||
145247558|NCT01680991|523752491|FG002|Overall Study|Protocol Violation|0|||
145247559|NCT01680991|523752489|FG000|Overall Study|Withdrawal by Subject|5|||
145247560|NCT01680991|523752490|FG001|Overall Study|Withdrawal by Subject|1|||
145247561|NCT01680991|523752491|FG002|Overall Study|Withdrawal by Subject|0|||
145247562|NCT01680991|523752489|FG000|Overall Study|Progressive disease (PD)|0|||
145247563|NCT01680991|523752490|FG001|Overall Study|Progressive disease (PD)|10|||
145247564|NCT01680991|523752491|FG002|Overall Study|Progressive disease (PD)|0|||
145247565|NCT01680991|523752489|FG000|Overall Study|Physician Decision|0|||
145247566|NCT01680991|523752490|FG001|Overall Study|Physician Decision|7|||
145247567|NCT01680991|523752491|FG002|Overall Study|Physician Decision|2|||
145247568|NCT01680991|523752489|FG000|Overall Study|Bad physical condition|0|||
145247569|NCT01680991|523752490|FG001|Overall Study|Bad physical condition|0|||
145247570|NCT01680991|523752491|FG002|Overall Study|Bad physical condition|1|||
145247571|NCT01680991|523752489|FG000|Overall Study|PD confirmed in other hospital|1|||
145247572|NCT01680991|523752490|FG001|Overall Study|PD confirmed in other hospital|0|||
145247573|NCT01680991|523752491|FG002|Overall Study|PD confirmed in other hospital|0|||
145247574|NCT03377452|523752492|FG000|Overall Study|Refused assessment|0|||
145247575|NCT03377452|523752493|FG001|Overall Study|Refused assessment|2|||
145247576|NCT03377452|523752492|FG000|Overall Study|Lost to Follow-up|5|||
145247577|NCT03377452|523752493|FG001|Overall Study|Lost to Follow-up|4|||
145247578|NCT01408732|523752494|FG000|Overall Study|Withdrawal by Subject|2|||
145247579|NCT01408732|523752495|FG001|Overall Study|Withdrawal by Subject|2|||
145247580|NCT00796003|523752496|FG000|Overall Study|Disease Progression|2|||
145247581|NCT00796003|523752497|FG001|Overall Study|Disease Progression|13|||
145247582|NCT00796003|523752496|FG000|Overall Study|Adverse Event|1|||
145247583|NCT00796003|523752497|FG001|Overall Study|Adverse Event|7|||
145298894|NCT02682602|523945055|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
145298895|NCT03567174|523945056|FG000|Overall Study|Death|24|||
145247584|NCT00796003|523752496|FG000|Overall Study|Specified organ function not met|0|||
145247585|NCT00796003|523752497|FG001|Overall Study|Specified organ function not met|1|||
145247586|NCT00796003|523752496|FG000|Overall Study|Physician Decision|0|||
145247587|NCT00796003|523752497|FG001|Overall Study|Physician Decision|4|||
145247588|NCT00796003|523752496|FG000|Overall Study|Withdrawal by Subject|0|||
145247589|NCT00796003|523752497|FG001|Overall Study|Withdrawal by Subject|1|||
145247590|NCT00796003|523752496|FG000|Overall Study|Other|0|||
145247591|NCT00796003|523752497|FG001|Overall Study|Other|1|||
145247592|NCT00796003|523752496|FG000|Overall Study|Participants Not treated|0|||
145247593|NCT00796003|523752497|FG001|Overall Study|Participants Not treated|2|||
145247594|NCT03277105|523752498|FG000|Overall Study|Death|129|||
145247595|NCT03277105|523752499|FG001|Overall Study|Death|124|||
145298896|NCT03567174|523945057|FG001|Overall Study|Death|31|||
145298897|NCT03567174|523945056|FG000|Overall Study|Lost to Follow-up|165|||
145298898|NCT03567174|523945057|FG001|Overall Study|Lost to Follow-up|174|||
145298899|NCT02140060|523945058|FG000|Overall Study|Adverse Event|0|||
145298900|NCT02140060|523945059|FG001|Overall Study|Adverse Event|0|||
145298901|NCT02140060|523945060|FG002|Overall Study|Adverse Event|0|||
145298902|NCT02140060|523945061|FG003|Overall Study|Adverse Event|1|||
145298903|NCT02140060|523945062|FG004|Overall Study|Adverse Event|1|||
145298904|NCT02140060|523945063|FG005|Overall Study|Adverse Event|1|||
145298905|NCT02140060|523945058|FG000|Overall Study|Lack of Efficacy|0|||
145298906|NCT02140060|523945059|FG001|Overall Study|Lack of Efficacy|0|||
145298907|NCT02140060|523945060|FG002|Overall Study|Lack of Efficacy|0|||
145298908|NCT02140060|523945061|FG003|Overall Study|Lack of Efficacy|1|||
145298909|NCT02140060|523945062|FG004|Overall Study|Lack of Efficacy|0|||
145298910|NCT02140060|523945063|FG005|Overall Study|Lack of Efficacy|0|||
145298911|NCT06358820|523946840|FG000|Overall Study|Adverse Event|11|||
145298912|NCT06358820|523946840|FG000|Overall Study|kidney transplantation|3|||
145298913|NCT06358820|523946840|FG000|Overall Study|patient voluntary withdrawal|6|||
145298914|NCT06358820|523946840|FG000|Overall Study|Physician Decision|1|||
145298915|NCT01124175|523946845|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
145298916|NCT01124175|523946846|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
145298917|NCT00942968|523946847|FG000|Overall Study|Adverse Event|60|||
145298918|NCT00942968|523946847|FG000|Overall Study|Death|76|||
145298919|NCT00942968|523946847|FG000|Overall Study|Protocol Violation|9|||
145298920|NCT00942968|523946847|FG000|Overall Study|Lost to Follow-up|4|||
145298921|NCT00942968|523946847|FG000|Overall Study|Withdrawal by Subject|44|||
145298922|NCT00942968|523946847|FG000|Overall Study|Sponsor request|5|||
145298923|NCT00942968|523946847|FG000|Overall Study|Physician Decision|11|||
145247596|NCT03277105|523752498|FG000|Overall Study|Lost to Follow-up|2|||
145247597|NCT03277105|523752499|FG001|Overall Study|Lost to Follow-up|4|||
145247598|NCT03277105|523752498|FG000|Overall Study|Withdrawal by Subject|10|||
145247599|NCT03277105|523752499|FG001|Overall Study|Withdrawal by Subject|10|||
145298924|NCT00942968|523946847|FG000|Overall Study|Progression of disease|12|||
145298925|NCT00942968|523946847|FG000|Overall Study|Inferior vena cava filter placement|4|||
145298926|NCT00942968|523946847|FG000|Overall Study|Pulmonary embolism (PE)|1|||
145298927|NCT00942968|523946847|FG000|Overall Study|Participant required pancreatic biopsy|1|||
145298928|NCT00942968|523946847|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
145298929|NCT00520130|523946848|FG000|Overall Study|Disease progression on study|4|||
145298930|NCT00520130|523946849|FG001|Overall Study|Disease progression on study|0|||
145298931|NCT00520130|523946848|FG000|Overall Study|Physician Decision|1|||
145298932|NCT00520130|523946849|FG001|Overall Study|Physician Decision|1|||
145298933|NCT01045096|523946850|FG000|Overall Study|Withdrawal by Subject|2|||
145298934|NCT01045096|523946851|FG001|Overall Study|Withdrawal by Subject|0|||
145298935|NCT01045096|523946852|FG002|Overall Study|Withdrawal by Subject|0|||
145298936|NCT01045096|523946850|FG000|Overall Study|Other|1|||
145298937|NCT01045096|523946851|FG001|Overall Study|Other|0|||
145298938|NCT01045096|523946852|FG002|Overall Study|Other|0|||
145298939|NCT01511939|523946854|FG000|Overall Study|Withdrawal by Subject|2|||
145247600|NCT03277105|523752498|FG000|Overall Study|Other|118|||
145247601|NCT03277105|523752499|FG001|Overall Study|Other|125|||
145247602|NCT02280096|523752500|FG000|Overall Study|Pregnancy|1|||
145247603|NCT02280096|523752501|FG001|Overall Study|Pregnancy|0|||
145247604|NCT02280096|523752500|FG000|Overall Study|Functional neurological disorder|1|||
145247605|NCT02280096|523752501|FG001|Overall Study|Functional neurological disorder|0|||
145247606|NCT02280096|523752500|FG000|Overall Study|Lack of attachment|0|||
145247607|NCT02280096|523752501|FG001|Overall Study|Lack of attachment|1|||
145247608|NCT00414973|523752509|FG000|Overall Study|Withdrawal by Subject|14|||
145247609|NCT00414973|523752510|FG001|Overall Study|Withdrawal by Subject|4|||
145247610|NCT00414973|523752511|FG002|Overall Study|Withdrawal by Subject|1|||
145247611|NCT00414973|523752512|FG003|Overall Study|Withdrawal by Subject|0|||
145247612|NCT00414973|523752509|FG000|Overall Study|Adverse Event|10|||
145247613|NCT00414973|523752510|FG001|Overall Study|Adverse Event|0|||
145298940|NCT01511939|523946855|FG001|Overall Study|Withdrawal by Subject|1|||
145298941|NCT01511939|523946856|FG002|Overall Study|Withdrawal by Subject|0|||
145298942|NCT03497897|523946860|FG000|Overall Study|Adverse Event|1|||
145298943|NCT03497897|523946861|FG001|Overall Study|Adverse Event|1|||
145298944|NCT03497897|523946862|FG002|Overall Study|Adverse Event|1|||
145298945|NCT03497897|523946860|FG000|Overall Study|Lost to Follow-up|2|||
145298946|NCT03497897|523946861|FG001|Overall Study|Lost to Follow-up|0|||
145298947|NCT03497897|523946862|FG002|Overall Study|Lost to Follow-up|2|||
145298948|NCT03497897|523946860|FG000|Overall Study|Physician Decision|1|||
145298949|NCT03497897|523946861|FG001|Overall Study|Physician Decision|0|||
145298950|NCT03497897|523946862|FG002|Overall Study|Physician Decision|0|||
145298951|NCT03497897|523946860|FG000|Overall Study|Subject/Guardian Decision|2|||
145298952|NCT03497897|523946861|FG001|Overall Study|Subject/Guardian Decision|1|||
145298953|NCT03497897|523946862|FG002|Overall Study|Subject/Guardian Decision|3|||
145298954|NCT00723528|523946865|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298955|NCT00723528|523946866|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298956|NCT00723528|523946867|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
145298957|NCT00723528|523946868|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298958|NCT00723528|523946869|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298959|NCT00723528|523946870|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298960|NCT00723528|523946871|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
145298961|NCT00723528|523946865|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
145298962|NCT00723528|523946866|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298963|NCT00723528|523946867|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298964|NCT00723528|523946868|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298965|NCT00723528|523946869|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298966|NCT00723528|523946870|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298967|NCT00723528|523946871|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
145298968|NCT00723528|523946865|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
145298969|NCT00723528|523946866|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
145298970|NCT00723528|523946867|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
145298971|NCT00723528|523946868|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
145409982|NCT00770809|524355070|FG001|Overall Study|Death|0|||
145566466|NCT00244712|524934272|FG001|Overall Study|Protocol Violation, disease progression|11|||
145566467|NCT01077804|524934273|FG000|Overall Study|Unreachable|102|||
145247614|NCT00414973|523752511|FG002|Overall Study|Adverse Event|1|||
145247615|NCT00414973|523752512|FG003|Overall Study|Adverse Event|0|||
145247616|NCT00414973|523752509|FG000|Overall Study|Protocol Violation|3|||
145247617|NCT00414973|523752510|FG001|Overall Study|Protocol Violation|4|||
145247618|NCT00414973|523752511|FG002|Overall Study|Protocol Violation|0|||
145247619|NCT00414973|523752512|FG003|Overall Study|Protocol Violation|0|||
145247620|NCT00414973|523752509|FG000|Overall Study|Lost to Follow-up|0|||
145247621|NCT00414973|523752510|FG001|Overall Study|Lost to Follow-up|2|||
145298972|NCT00723528|523946869|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
145298973|NCT00723528|523946870|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
145298974|NCT00723528|523946871|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
145247622|NCT00414973|523752511|FG002|Overall Study|Lost to Follow-up|0|||
145409983|NCT00770809|524355071|FG002|Overall Study|Death|0|||
145298975|NCT00723528|523946865|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298976|NCT00723528|523946866|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298977|NCT00723528|523946867|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
145298978|NCT00723528|523946868|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298979|NCT00723528|523946869|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298980|NCT00723528|523946870|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298981|NCT00723528|523946871|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
145298982|NCT00723528|523946865|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
145298983|NCT00723528|523946866|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
145298984|NCT00723528|523946867|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
145298985|NCT00723528|523946868|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
145298986|NCT00723528|523946869|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
145298987|NCT00723528|523946870|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
145298988|NCT00723528|523946871|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
145298989|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
145298990|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
145298991|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
145298992|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
145298993|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
145298994|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
145298995|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
145298996|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145298997|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145298998|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145298999|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145299000|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145299001|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
145299002|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
145299003|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Other|0|||
145299004|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Other|0|||
145299005|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Other|0|||
145299006|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Other|0|||
145299007|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Other|1|||
145299008|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Other|4|||
145299009|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Other|0|||
145299010|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Adverse Event|0|||
145299011|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Adverse Event|0|||
145299012|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Adverse Event|0|||
145299013|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Adverse Event|0|||
145299014|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Adverse Event|1|||
145299015|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Adverse Event|0|||
145299016|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Adverse Event|1|||
145299017|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299018|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299019|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299020|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299021|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299022|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
145299023|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
145299024|NCT00723528|523946865|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299025|NCT00723528|523946866|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299026|NCT00723528|523946867|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299027|NCT00723528|523946868|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299028|NCT00723528|523946869|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299029|NCT00723528|523946870|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
145299030|NCT00723528|523946871|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
145299031|NCT03785548|523946875|FG000|Overall Study|age > 80|1|||
145299032|NCT03785548|523946876|FG001|Overall Study|age > 80|0|||
145299033|NCT03785548|523946875|FG000|Overall Study|no Postop queries|1|||
145299034|NCT03785548|523946876|FG001|Overall Study|no Postop queries|0|||
145299035|NCT00667862|523946878|FG000|Overall Study|Adverse Event|9|||
145299036|NCT00667862|523946878|FG000|Overall Study|Death|1|||
145299037|NCT00667862|523946878|FG000|Overall Study|Disease Progression|22|||
145299038|NCT00667862|523946878|FG000|Overall Study|Withdrawal by Subject|3|||
145299039|NCT02495857|523946884|FG000|Overall Study|Adverse Event|5|||
145409984|NCT00770809|524355069|FG000|Overall Study|Withdrawal by Subject|3|||
145409985|NCT00770809|524355070|FG001|Overall Study|Withdrawal by Subject|3|||
145409986|NCT00770809|524355071|FG002|Overall Study|Withdrawal by Subject|7|||
145409987|NCT00770809|524355069|FG000|Overall Study|Progression|2|||
145409988|NCT00770809|524355070|FG001|Overall Study|Progression|2|||
145409989|NCT00770809|524355071|FG002|Overall Study|Progression|0|||
145409990|NCT00770809|524355069|FG000|Overall Study|Complicating illness|0|||
145409991|NCT00770809|524355070|FG001|Overall Study|Complicating illness|0|||
145409992|NCT00770809|524355071|FG002|Overall Study|Complicating illness|1|||
145409993|NCT00770809|524355069|FG000|Overall Study|Other Medical Reasons|2|||
145409994|NCT00770809|524355070|FG001|Overall Study|Other Medical Reasons|4|||
145409995|NCT00770809|524355071|FG002|Overall Study|Other Medical Reasons|3|||
145409996|NCT00690898|524355072|FG000|SCREENING|Screen failure|18|||
145409997|NCT00690898|524355072|FG000|TREATMENT|Adverse Event|3|||
145409998|NCT00690898|524355072|FG000|TREATMENT|Lack of Efficacy|18|||
145409999|NCT00690898|524355072|FG000|TREATMENT|Withdrawal by Subject|4|||
145410000|NCT00690898|524355072|FG000|TREATMENT|Other (not otherwise specified)|1|||
145410001|NCT05977868|524355073|FG000|Overall Study|Withdrawal by Subject|1|||
145410002|NCT05977868|524355074|FG001|Overall Study|Withdrawal by Subject|2|||
145410003|NCT05977868|524355073|FG000|Overall Study|Transitioned to comfort care|1|||
145410004|NCT05977868|524355074|FG001|Overall Study|Transitioned to comfort care|0|||
145410005|NCT00487188|524355087|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
145410006|NCT00487188|524355088|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
145410007|NCT00487188|524355089|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
145410008|NCT00487188|524355087|FG000|Induction Phase|Adverse Event|5|||
145410009|NCT00487188|524355088|FG001|Induction Phase|Adverse Event|0|||
145410010|NCT00487188|524355089|FG002|Induction Phase|Adverse Event|0|||
145410011|NCT00487188|524355087|FG000|Induction Phase|Lack of Efficacy|0|||
145410012|NCT00487188|524355088|FG001|Induction Phase|Lack of Efficacy|1|||
145410013|NCT00487188|524355089|FG002|Induction Phase|Lack of Efficacy|0|||
145410014|NCT00487188|524355087|FG000|Induction Phase|Protocol Violation|1|||
145410015|NCT00487188|524355088|FG001|Induction Phase|Protocol Violation|0|||
145410016|NCT00487188|524355089|FG002|Induction Phase|Protocol Violation|0|||
145410017|NCT00487188|524355087|FG000|Induction Phase|Refused Treatment|1|||
145247623|NCT00414973|523752512|FG003|Overall Study|Lost to Follow-up|0|||
145247624|NCT00414973|523752509|FG000|Overall Study|Sponsor Decision|1|||
145247625|NCT00414973|523752510|FG001|Overall Study|Sponsor Decision|0|||
145410018|NCT00487188|524355088|FG001|Induction Phase|Refused Treatment|2|||
145410019|NCT00487188|524355089|FG002|Induction Phase|Refused Treatment|0|||
145410020|NCT00487188|524355087|FG000|Induction Phase|Lost to Follow-up|2|||
145410021|NCT00487188|524355088|FG001|Induction Phase|Lost to Follow-up|2|||
145410022|NCT00487188|524355089|FG002|Induction Phase|Lost to Follow-up|0|||
145410023|NCT00487188|524355087|FG000|Induction Phase|Administrative|0|||
145410024|NCT00487188|524355088|FG001|Induction Phase|Administrative|1|||
145410025|NCT00487188|524355089|FG002|Induction Phase|Administrative|0|||
145410026|NCT00487188|524355087|FG000|Maintenance Phase|Adverse Event|1|||
145410027|NCT00487188|524355088|FG001|Maintenance Phase|Adverse Event|0|||
145410028|NCT00487188|524355089|FG002|Maintenance Phase|Adverse Event|0|||
145410029|NCT00487188|524355087|FG000|Maintenance Phase|Death|1|||
145410030|NCT00487188|524355088|FG001|Maintenance Phase|Death|0|||
145410031|NCT00487188|524355089|FG002|Maintenance Phase|Death|0|||
145410032|NCT00487188|524355087|FG000|Maintenance Phase|Lost to Follow-up|1|||
145410033|NCT00487188|524355088|FG001|Maintenance Phase|Lost to Follow-up|0|||
145410034|NCT00487188|524355089|FG002|Maintenance Phase|Lost to Follow-up|0|||
145410035|NCT00487188|524355087|FG000|Maintenance Phase|Administrative|0|||
145410036|NCT00487188|524355088|FG001|Maintenance Phase|Administrative|0|||
145410037|NCT00487188|524355089|FG002|Maintenance Phase|Administrative|1|||
145410038|NCT05696847|524355091|FG000|Overall Study|Withdrawal by Subject|1|||
145566468|NCT01077804|524934273|FG000|Overall Study|Refused to continue|79|||
145566469|NCT01077804|524934273|FG000|Overall Study|Other|18|||
145566470|NCT00403273|524936122|FG000|Overall Study|Lost to Follow-up|3|||
145566471|NCT00403273|524936123|FG001|Overall Study|Lost to Follow-up|2|||
145247626|NCT00414973|523752511|FG002|Overall Study|Sponsor Decision|0|||
145410039|NCT05696847|524355092|FG001|Overall Study|Withdrawal by Subject|0|||
145410040|NCT05696847|524355093|FG002|Overall Study|Withdrawal by Subject|0|||
145410041|NCT05696847|524355094|FG003|Overall Study|Withdrawal by Subject|0|||
145410042|NCT05696847|524355095|FG004|Overall Study|Withdrawal by Subject|0|||
145410043|NCT05696847|524355096|FG005|Overall Study|Withdrawal by Subject|0|||
145410044|NCT05696847|524355091|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145410045|NCT05696847|524355092|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145410046|NCT05696847|524355093|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145410047|NCT05696847|524355094|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145410048|NCT05696847|524355095|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145566472|NCT00403273|524936122|FG000|Overall Study|Physician Decision|0|||
145247627|NCT00414973|523752512|FG003|Overall Study|Sponsor Decision|0|||
145410049|NCT05696847|524355096|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145410050|NCT05696847|524355091|FG000|Overall Study|Adverse Event|0|||
145566473|NCT00403273|524936123|FG001|Overall Study|Physician Decision|1|||
145566474|NCT00403273|524936122|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
145566475|NCT00403273|524936123|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
145247628|NCT00414973|523752509|FG000|Overall Study|Death|0|||
145247629|NCT00414973|523752510|FG001|Overall Study|Death|0|||
145247630|NCT00414973|523752511|FG002|Overall Study|Death|1|||
145247631|NCT00414973|523752512|FG003|Overall Study|Death|0|||
145247632|NCT01512693|523752521|FG000|Overall Study|Withdrawal by Subject|0|||
145247633|NCT01512693|523752522|FG001|Overall Study|Withdrawal by Subject|1|||
145247634|NCT04731922|523752532|FG000|Overall Study|Adverse Event|0|||
145247635|NCT04731922|523752533|FG001|Overall Study|Adverse Event|0|||
145247636|NCT04731922|523752534|FG002|Overall Study|Adverse Event|0|||
145247637|NCT04731922|523752535|FG003|Overall Study|Adverse Event|0|||
145247638|NCT04731922|523752536|FG004|Overall Study|Adverse Event|0|||
145247639|NCT04731922|523752537|FG005|Overall Study|Adverse Event|0|||
145247640|NCT04731922|523752538|FG006|Overall Study|Adverse Event|0|||
145247641|NCT04731922|523752539|FG007|Overall Study|Adverse Event|0|||
145247642|NCT04731922|523752540|FG008|Overall Study|Adverse Event|0|||
145247643|NCT04731922|523752541|FG009|Overall Study|Adverse Event|0|||
145247644|NCT04731922|523752542|FG010|Overall Study|Adverse Event|1|||
145247645|NCT04731922|523752543|FG011|Overall Study|Adverse Event|0|||
145247646|NCT04731922|523752544|FG012|Overall Study|Adverse Event|0|||
145247647|NCT04731922|523752545|FG013|Overall Study|Adverse Event|0|||
145247648|NCT04731922|523752546|FG014|Overall Study|Adverse Event|0|||
145247649|NCT04731922|523752547|FG015|Overall Study|Adverse Event|0|||
145247650|NCT04731922|523752548|FG016|Overall Study|Adverse Event|0|||
145247651|NCT04731922|523752532|FG000|Overall Study|Lost to Follow-up|0|||
145247652|NCT04731922|523752533|FG001|Overall Study|Lost to Follow-up|0|||
145247653|NCT04731922|523752534|FG002|Overall Study|Lost to Follow-up|0|||
145247654|NCT04731922|523752535|FG003|Overall Study|Lost to Follow-up|1|||
145247655|NCT04731922|523752536|FG004|Overall Study|Lost to Follow-up|0|||
145247656|NCT04731922|523752537|FG005|Overall Study|Lost to Follow-up|1|||
145247657|NCT04731922|523752538|FG006|Overall Study|Lost to Follow-up|0|||
145247658|NCT04731922|523752539|FG007|Overall Study|Lost to Follow-up|0|||
145247659|NCT04731922|523752540|FG008|Overall Study|Lost to Follow-up|0|||
145247660|NCT04731922|523752541|FG009|Overall Study|Lost to Follow-up|0|||
145247661|NCT04731922|523752542|FG010|Overall Study|Lost to Follow-up|0|||
145247662|NCT04731922|523752543|FG011|Overall Study|Lost to Follow-up|0|||
145247663|NCT04731922|523752544|FG012|Overall Study|Lost to Follow-up|0|||
145247664|NCT04731922|523752545|FG013|Overall Study|Lost to Follow-up|0|||
145566476|NCT01083433|524936124|FG000|Overall Study|Lost to Follow-up|2|||
145247665|NCT04731922|523752546|FG014|Overall Study|Lost to Follow-up|0|||
145247666|NCT04731922|523752547|FG015|Overall Study|Lost to Follow-up|0|||
145247667|NCT04731922|523752548|FG016|Overall Study|Lost to Follow-up|0|||
145247668|NCT04731922|523752532|FG000|Overall Study|Withdrawal by Subject|1|||
145247669|NCT04731922|523752533|FG001|Overall Study|Withdrawal by Subject|0|||
145247670|NCT04731922|523752534|FG002|Overall Study|Withdrawal by Subject|0|||
145247671|NCT04731922|523752535|FG003|Overall Study|Withdrawal by Subject|0|||
145247672|NCT04731922|523752536|FG004|Overall Study|Withdrawal by Subject|1|||
145247673|NCT04731922|523752537|FG005|Overall Study|Withdrawal by Subject|0|||
145247674|NCT04731922|523752538|FG006|Overall Study|Withdrawal by Subject|1|||
145247675|NCT04731922|523752539|FG007|Overall Study|Withdrawal by Subject|0|||
145247676|NCT04731922|523752540|FG008|Overall Study|Withdrawal by Subject|0|||
145247677|NCT04731922|523752541|FG009|Overall Study|Withdrawal by Subject|0|||
145247678|NCT04731922|523752542|FG010|Overall Study|Withdrawal by Subject|0|||
145247679|NCT04731922|523752543|FG011|Overall Study|Withdrawal by Subject|0|||
145247680|NCT04731922|523752544|FG012|Overall Study|Withdrawal by Subject|0|||
145247681|NCT04731922|523752545|FG013|Overall Study|Withdrawal by Subject|1|||
145247682|NCT04731922|523752546|FG014|Overall Study|Withdrawal by Subject|0|||
145247683|NCT04731922|523752547|FG015|Overall Study|Withdrawal by Subject|0|||
145247684|NCT04731922|523752548|FG016|Overall Study|Withdrawal by Subject|0|||
145247685|NCT04731922|523752532|FG000|Overall Study|Other|0|||
145247686|NCT04731922|523752533|FG001|Overall Study|Other|0|||
145247687|NCT04731922|523752534|FG002|Overall Study|Other|0|||
145299040|NCT02495857|523946885|FG001|Overall Study|Adverse Event|0|||
145299041|NCT02495857|523946886|FG002|Overall Study|Adverse Event|1|||
145247688|NCT04731922|523752535|FG003|Overall Study|Other|0|||
145247689|NCT04731922|523752536|FG004|Overall Study|Other|0|||
145247690|NCT04731922|523752537|FG005|Overall Study|Other|0|||
145247691|NCT04731922|523752538|FG006|Overall Study|Other|1|||
145247692|NCT04731922|523752539|FG007|Overall Study|Other|0|||
145247693|NCT04731922|523752540|FG008|Overall Study|Other|0|||
145247694|NCT04731922|523752541|FG009|Overall Study|Other|0|||
145247695|NCT04731922|523752542|FG010|Overall Study|Other|0|||
145247696|NCT04731922|523752543|FG011|Overall Study|Other|0|||
145247697|NCT04731922|523752544|FG012|Overall Study|Other|0|||
145247698|NCT04731922|523752545|FG013|Overall Study|Other|0|||
145247699|NCT04731922|523752546|FG014|Overall Study|Other|0|||
145247700|NCT04731922|523752547|FG015|Overall Study|Other|0|||
145247701|NCT04731922|523752548|FG016|Overall Study|Other|0|||
145247702|NCT01819194|523752550|FG000|Overall Study|Loss of study articles|2|||
145410051|NCT05696847|524355092|FG001|Overall Study|Adverse Event|0|||
145410052|NCT05696847|524355093|FG002|Overall Study|Adverse Event|0|||
145410053|NCT05696847|524355094|FG003|Overall Study|Adverse Event|0|||
145410054|NCT05696847|524355095|FG004|Overall Study|Adverse Event|0|||
145410055|NCT05696847|524355096|FG005|Overall Study|Adverse Event|1|||
145410056|NCT05696847|524355091|FG000|Overall Study|Sponsor Decision|0|||
145410057|NCT05696847|524355092|FG001|Overall Study|Sponsor Decision|0|||
145410058|NCT05696847|524355093|FG002|Overall Study|Sponsor Decision|0|||
145566477|NCT01083433|524936125|FG001|Overall Study|Lost to Follow-up|1|||
145566478|NCT01083433|524936126|FG002|Overall Study|Lost to Follow-up|1|||
145247703|NCT00045630|523752556|FG000|Overall Study|Adverse Event|1|||
145247704|NCT00045630|523752556|FG000|Overall Study|Refusal unrelated to adverse event|1|||
145410059|NCT05696847|524355094|FG003|Overall Study|Sponsor Decision|1|||
145410060|NCT05696847|524355095|FG004|Overall Study|Sponsor Decision|0|||
145410061|NCT05696847|524355096|FG005|Overall Study|Sponsor Decision|0|||
145410062|NCT03112603|524355099|FG000|End of Randomization Period|Lost to Follow-up|3|||
145410063|NCT03112603|524355100|FG001|End of Randomization Period|Lost to Follow-up|0|||
145410064|NCT03112603|524355101|FG002|End of Randomization Period|Lost to Follow-up|0|||
145410065|NCT03112603|524355099|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
145410066|NCT03112603|524355100|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
145410067|NCT03112603|524355101|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
145410068|NCT03112603|524355099|FG000|End of Randomization Period|Physician Decision|43|||
145410069|NCT03112603|524355100|FG001|End of Randomization Period|Physician Decision|18|||
145410070|NCT03112603|524355101|FG002|End of Randomization Period|Physician Decision|0|||
145410071|NCT03112603|524355099|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
145410072|NCT03112603|524355100|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
145410073|NCT03112603|524355101|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
145410074|NCT03112603|524355099|FG000|End of Randomization Period|Death|10|||
145410075|NCT03112603|524355100|FG001|End of Randomization Period|Death|7|||
145410076|NCT03112603|524355101|FG002|End of Randomization Period|Death|0|||
145410077|NCT03112603|524355099|FG000|End of Randomization Period|Disease Relapse|12|||
145410078|NCT03112603|524355100|FG001|End of Randomization Period|Disease Relapse|7|||
145410079|NCT03112603|524355101|FG002|End of Randomization Period|Disease Relapse|0|||
145410080|NCT03112603|524355099|FG000|End of Randomization Period|Lack of Efficacy|25|||
145410081|NCT03112603|524355100|FG001|End of Randomization Period|Lack of Efficacy|77|||
145410082|NCT03112603|524355101|FG002|End of Randomization Period|Lack of Efficacy|0|||
145410083|NCT03112603|524355099|FG000|End of Randomization Period|Adverse Event|32|||
145410084|NCT03112603|524355100|FG001|End of Randomization Period|Adverse Event|12|||
145410085|NCT03112603|524355101|FG002|End of Randomization Period|Adverse Event|0|||
145410086|NCT03112603|524355099|FG000|End of Cross Over Period|Death|0|||
145410087|NCT03112603|524355100|FG001|End of Cross Over Period|Death|0|||
145410088|NCT03112603|524355101|FG002|End of Cross Over Period|Death|2|||
145410089|NCT03112603|524355099|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
145410090|NCT03112603|524355100|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
145410091|NCT03112603|524355101|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
145410092|NCT03112603|524355099|FG000|End of Cross Over Period|Physician Decision|0|||
145410093|NCT03112603|524355100|FG001|End of Cross Over Period|Physician Decision|0|||
145410094|NCT03112603|524355101|FG002|End of Cross Over Period|Physician Decision|29|||
145410095|NCT03112603|524355099|FG000|End of Cross Over Period|Lack of Efficacy|0|||
145410096|NCT03112603|524355100|FG001|End of Cross Over Period|Lack of Efficacy|0|||
145410097|NCT03112603|524355101|FG002|End of Cross Over Period|Lack of Efficacy|8|||
145410098|NCT03112603|524355099|FG000|End of Cross Over Period|Adverse Event|0|||
145410099|NCT03112603|524355100|FG001|End of Cross Over Period|Adverse Event|0|||
145410100|NCT03112603|524355101|FG002|End of Cross Over Period|Adverse Event|6|||
145410101|NCT03112603|524355099|FG000|End of Cross Over Period|Disease Relapse|0|||
145410102|NCT03112603|524355100|FG001|End of Cross Over Period|Disease Relapse|0|||
145410103|NCT03112603|524355101|FG002|End of Cross Over Period|Disease Relapse|2|||
145410104|NCT00207740|524355102|FG000|Overall Study|Adverse Event|4|||
145410105|NCT00207740|524355103|FG001|Overall Study|Adverse Event|14|||
145247705|NCT00045630|523752556|FG000|Overall Study|Progression/relapse|1|||
145247706|NCT00045630|523752556|FG000|Overall Study|Death|1|||
145247707|NCT00045630|523752556|FG000|Overall Study|Ineligible|2|||
145247708|NCT00981747|523752557|FG000|Losartan|Withdrawal by Subject|1|||
145247709|NCT00981747|523752557|FG000|Losartan|Death|1|||
145247710|NCT00981747|523752557|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
145410106|NCT00207740|524355104|FG002|Overall Study|Adverse Event|14|||
145247711|NCT00701103|523752558|FG000|Overall Study|Adverse Event|0|||
145247712|NCT00701103|523752559|FG001|Overall Study|Adverse Event|0|||
145247713|NCT00701103|523752560|FG002|Overall Study|Adverse Event|1|||
145247714|NCT00701103|523752561|FG003|Overall Study|Adverse Event|1|||
145410107|NCT00207740|524355105|FG003|Overall Study|Adverse Event|11|||
145410108|NCT00207740|524355102|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145247715|NCT00701103|523752562|FG004|Overall Study|Adverse Event|0|||
145247716|NCT00701103|523752563|FG005|Overall Study|Adverse Event|1|||
145566479|NCT01083433|524936124|FG000|Overall Study|Withdrawal by Subject|0|||
145247717|NCT00701103|523752564|FG006|Overall Study|Adverse Event|1|||
145247718|NCT00701103|523752565|FG007|Overall Study|Adverse Event|0|||
145247719|NCT00701103|523752566|FG008|Overall Study|Adverse Event|0|||
145247720|NCT00701103|523752567|FG009|Overall Study|Adverse Event|2|||
145247721|NCT00701103|523752568|FG010|Overall Study|Adverse Event|0|||
145247722|NCT00701103|523752558|FG000|Overall Study|Progressive Disease|5|||
145247723|NCT00701103|523752559|FG001|Overall Study|Progressive Disease|2|||
145247724|NCT00701103|523752560|FG002|Overall Study|Progressive Disease|6|||
145247725|NCT00701103|523752561|FG003|Overall Study|Progressive Disease|5|||
145247726|NCT00701103|523752562|FG004|Overall Study|Progressive Disease|6|||
145247727|NCT00701103|523752563|FG005|Overall Study|Progressive Disease|5|||
145247728|NCT00701103|523752564|FG006|Overall Study|Progressive Disease|7|||
145247729|NCT00701103|523752565|FG007|Overall Study|Progressive Disease|7|||
145247730|NCT00701103|523752566|FG008|Overall Study|Progressive Disease|8|||
145247731|NCT00701103|523752567|FG009|Overall Study|Progressive Disease|8|||
145247732|NCT00701103|523752568|FG010|Overall Study|Progressive Disease|11|||
145247733|NCT00701103|523752558|FG000|Overall Study|Withdrawal by Subject|0|||
145247734|NCT00701103|523752559|FG001|Overall Study|Withdrawal by Subject|1|||
145247735|NCT00701103|523752560|FG002|Overall Study|Withdrawal by Subject|1|||
145247736|NCT00701103|523752561|FG003|Overall Study|Withdrawal by Subject|0|||
145247737|NCT00701103|523752562|FG004|Overall Study|Withdrawal by Subject|0|||
145247738|NCT00701103|523752563|FG005|Overall Study|Withdrawal by Subject|0|||
145247739|NCT00701103|523752564|FG006|Overall Study|Withdrawal by Subject|0|||
145247740|NCT00701103|523752565|FG007|Overall Study|Withdrawal by Subject|0|||
145247741|NCT00701103|523752566|FG008|Overall Study|Withdrawal by Subject|0|||
145247742|NCT00701103|523752567|FG009|Overall Study|Withdrawal by Subject|0|||
145247743|NCT00701103|523752568|FG010|Overall Study|Withdrawal by Subject|0|||
145247744|NCT00701103|523752558|FG000|Overall Study|Other|0|||
145247745|NCT00701103|523752559|FG001|Overall Study|Other|0|||
145247746|NCT00701103|523752560|FG002|Overall Study|Other|0|||
145247747|NCT00701103|523752561|FG003|Overall Study|Other|0|||
145247748|NCT00701103|523752562|FG004|Overall Study|Other|0|||
145247749|NCT00701103|523752563|FG005|Overall Study|Other|0|||
145247750|NCT00701103|523752564|FG006|Overall Study|Other|0|||
145247751|NCT00701103|523752565|FG007|Overall Study|Other|0|||
145247752|NCT00701103|523752566|FG008|Overall Study|Other|1|||
145247753|NCT00701103|523752567|FG009|Overall Study|Other|1|||
145247754|NCT00701103|523752568|FG010|Overall Study|Other|0|||
145247755|NCT01448707|523752574|FG000|Overall Study|Adverse Event|3|||
145247756|NCT01448707|523752575|FG001|Overall Study|Adverse Event|1|||
145247757|NCT01448707|523752574|FG000|Overall Study|Lost to Follow-up|2|||
145247758|NCT01448707|523752575|FG001|Overall Study|Lost to Follow-up|6|||
145247759|NCT01448707|523752574|FG000|Overall Study|Withdrawal by Subject|6|||
145247760|NCT01448707|523752575|FG001|Overall Study|Withdrawal by Subject|7|||
145247761|NCT01448707|523752574|FG000|Overall Study|Other|7|||
145247762|NCT01448707|523752575|FG001|Overall Study|Other|4|||
145247763|NCT02033850|523752580|FG000|Overall Study|Death|1|||
145247764|NCT02033850|523752581|FG001|Overall Study|Death|0|||
145247765|NCT02033850|523752580|FG000|Overall Study|unrelated medical reason|1|||
145247766|NCT02033850|523752581|FG001|Overall Study|unrelated medical reason|1|||
145247767|NCT02820038|523752585|FG000|Overall Study|Lost to Follow-up|7|||
145247768|NCT02820038|523752586|FG001|Overall Study|Lost to Follow-up|11|||
145247769|NCT02820038|523752587|FG002|Overall Study|Lost to Follow-up|2|||
145247770|NCT02820038|523752588|FG003|Overall Study|Lost to Follow-up|9|||
145247771|NCT02820038|523752585|FG000|Overall Study|Withdrawal by Subject|3|||
145247772|NCT02820038|523752586|FG001|Overall Study|Withdrawal by Subject|14|||
145247773|NCT02820038|523752587|FG002|Overall Study|Withdrawal by Subject|3|||
145247774|NCT02820038|523752588|FG003|Overall Study|Withdrawal by Subject|13|||
145247775|NCT00441480|523752593|FG000|Overall Study|Protocol Violation|1|||
145247776|NCT00441480|523752594|FG001|Overall Study|Protocol Violation|1|||
145247777|NCT00441480|523752593|FG000|Overall Study|Withdrawal by Subject|2|||
145247778|NCT00441480|523752594|FG001|Overall Study|Withdrawal by Subject|3|||
145247779|NCT00614991|523752595|FG000|Overall Study|Adverse Event|3|||
145247780|NCT00614991|523752596|FG001|Overall Study|Adverse Event|3|||
145299042|NCT02495857|523946884|FG000|Overall Study|Withdrawal by Subject|9|||
145299043|NCT02495857|523946885|FG001|Overall Study|Withdrawal by Subject|6|||
145299044|NCT02495857|523946886|FG002|Overall Study|Withdrawal by Subject|10|||
145299045|NCT02495857|523946884|FG000|Overall Study|Physician Decision|0|||
145247781|NCT00614991|523752597|FG002|Overall Study|Adverse Event|0|||
145247782|NCT00614991|523752598|FG003|Overall Study|Adverse Event|0|||
145247783|NCT00614991|523752599|FG004|Overall Study|Adverse Event|1|||
145247784|NCT00614991|523752600|FG005|Overall Study|Adverse Event|0|||
145247785|NCT02623699|523752601|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247786|NCT02623699|523752602|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
145247787|NCT02623699|523752603|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247788|NCT02623699|523752604|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247789|NCT02623699|523752605|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247790|NCT02623699|523752606|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247791|NCT02623699|523752607|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247792|NCT02623699|523752608|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247793|NCT02623699|523752609|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247794|NCT02623699|523752610|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247795|NCT02623699|523752611|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247796|NCT02623699|523752612|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
145247797|NCT02623699|523752601|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247798|NCT02623699|523752602|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247799|NCT02623699|523752603|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247800|NCT02623699|523752604|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247801|NCT02623699|523752605|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145410109|NCT00207740|524355103|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145410110|NCT00207740|524355104|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145410111|NCT00207740|524355105|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
145410112|NCT00207740|524355102|FG000|Overall Study|Lost to Follow-up|0|||
145410113|NCT00207740|524355103|FG001|Overall Study|Lost to Follow-up|2|||
145410114|NCT00207740|524355104|FG002|Overall Study|Lost to Follow-up|1|||
145410115|NCT00207740|524355105|FG003|Overall Study|Lost to Follow-up|1|||
145410116|NCT00207740|524355102|FG000|Overall Study|Death|0|||
145410117|NCT00207740|524355103|FG001|Overall Study|Death|0|||
145410118|NCT00207740|524355104|FG002|Overall Study|Death|0|||
145410119|NCT00207740|524355105|FG003|Overall Study|Death|1|||
145410120|NCT00207740|524355102|FG000|Overall Study|Sponsor Directive|22|||
145410121|NCT00207740|524355103|FG001|Overall Study|Sponsor Directive|15|||
145410122|NCT00207740|524355104|FG002|Overall Study|Sponsor Directive|16|||
145410123|NCT00207740|524355105|FG003|Overall Study|Sponsor Directive|21|||
145410124|NCT00207740|524355102|FG000|Overall Study|Other|2|||
145410125|NCT00207740|524355103|FG001|Overall Study|Other|10|||
145410126|NCT00207740|524355104|FG002|Overall Study|Other|7|||
145410127|NCT00207740|524355105|FG003|Overall Study|Other|5|||
145410128|NCT03916926|524355106|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
145410129|NCT03916926|524355107|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
145410130|NCT03916926|524355106|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
145410131|NCT03916926|524355107|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
145410132|NCT03916926|524355106|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
145410133|NCT03916926|524355107|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
145410134|NCT03916926|524355106|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
145410135|NCT03916926|524355107|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
145410136|NCT04725188|524355108|FG000|Overall Study|Death|72|||
145410137|NCT04725188|524355109|FG001|Overall Study|Death|69|||
145410138|NCT04725188|524355110|FG002|Overall Study|Death|76|||
145410139|NCT04725188|524355108|FG000|Overall Study|Lost to Follow-up|1|||
145410140|NCT04725188|524355109|FG001|Overall Study|Lost to Follow-up|0|||
145410141|NCT04725188|524355110|FG002|Overall Study|Lost to Follow-up|1|||
145410142|NCT04725188|524355108|FG000|Overall Study|Withdrawal by Subject|2|||
145410143|NCT04725188|524355109|FG001|Overall Study|Withdrawal by Subject|2|||
145410144|NCT04725188|524355110|FG002|Overall Study|Withdrawal by Subject|1|||
145410145|NCT04725188|524355108|FG000|Overall Study|Sponsor Decision|12|||
145410146|NCT04725188|524355109|FG001|Overall Study|Sponsor Decision|12|||
145410147|NCT04725188|524355110|FG002|Overall Study|Sponsor Decision|7|||
145410148|NCT00088153|524355111|FG000|Overall Study|Physician Decision|3|||
145410149|NCT00088153|524355112|FG001|Overall Study|Physician Decision|3|||
145410150|NCT00088153|524355111|FG000|Overall Study|Withdrawal by Subject|10|||
145410151|NCT00088153|524355112|FG001|Overall Study|Withdrawal by Subject|10|||
145410152|NCT00088153|524355111|FG000|Overall Study|Lost to Follow-up|11|||
145410153|NCT00088153|524355112|FG001|Overall Study|Lost to Follow-up|12|||
145410154|NCT02246777|524355121|FG000|Overall Study|Adverse Event|2|||
145410155|NCT02246777|524355121|FG000|Overall Study|Change of residence|1|||
145410156|NCT01063114|524355122|FG000|Overall Study|Lost to Follow-up|1|||
145410157|NCT04635423|524355123|FG000|Overall Study|Ongoing|493|||
145410158|NCT04635423|524355124|FG001|Overall Study|Ongoing|501|||
145410159|NCT04635423|524355123|FG000|Overall Study|Withdrawal by Subject|36|||
145410160|NCT04635423|524355124|FG001|Overall Study|Withdrawal by Subject|29|||
145410161|NCT05556057|524355125|FG000|Overall Study|Lost to Follow-up|5|||
145410162|NCT05556057|524355126|FG001|Overall Study|Lost to Follow-up|4|||
145410163|NCT05556057|524355125|FG000|Overall Study|Withdrawal by Subject|0|||
145410164|NCT05556057|524355126|FG001|Overall Study|Withdrawal by Subject|2|||
145410165|NCT05020743|524355136|FG000|Overall Study|Enrollment in Interventional Study|2|||
145410166|NCT05020743|524355137|FG001|Overall Study|Enrollment in Interventional Study|9|||
145410167|NCT05020743|524355138|FG002|Overall Study|Enrollment in Interventional Study|0|||
145410168|NCT05020743|524355136|FG000|Overall Study|Withdrawal by Subject|0|||
145410169|NCT05020743|524355137|FG001|Overall Study|Withdrawal by Subject|3|||
145410170|NCT05020743|524355138|FG002|Overall Study|Withdrawal by Subject|1|||
145410171|NCT05020743|524355136|FG000|Overall Study|Lost to Follow-up|1|||
145410172|NCT05020743|524355137|FG001|Overall Study|Lost to Follow-up|0|||
145410173|NCT05020743|524355138|FG002|Overall Study|Lost to Follow-up|0|||
145410174|NCT05020743|524355136|FG000|Overall Study|Study Termination by Sponsor|10|||
145410175|NCT05020743|524355137|FG001|Overall Study|Study Termination by Sponsor|11|||
145410176|NCT05020743|524355138|FG002|Overall Study|Study Termination by Sponsor|10|||
145620242|NCT04179461|525123721|FG000|Overall Study|Lost to Follow-up|4|||
145299046|NCT02495857|523946885|FG001|Overall Study|Physician Decision|1|||
145299047|NCT02495857|523946886|FG002|Overall Study|Physician Decision|0|||
145299048|NCT02495857|523946884|FG000|Overall Study|Protocol Violation|1|||
145299049|NCT02495857|523946885|FG001|Overall Study|Protocol Violation|1|||
145299050|NCT02495857|523946886|FG002|Overall Study|Protocol Violation|2|||
145299051|NCT02495857|523946884|FG000|Overall Study|Lost to Follow-up|4|||
145299052|NCT02495857|523946885|FG001|Overall Study|Lost to Follow-up|5|||
145299053|NCT02495857|523946886|FG002|Overall Study|Lost to Follow-up|3|||
145299054|NCT02495857|523946884|FG000|Overall Study|Other|3|||
145299055|NCT02495857|523946885|FG001|Overall Study|Other|3|||
145299056|NCT02495857|523946886|FG002|Overall Study|Other|2|||
145299057|NCT02883452|523946888|FG000|Overall Study|Withdrawal by Subject|1|||
145299058|NCT02883452|523946889|FG001|Overall Study|Withdrawal by Subject|1|||
145299059|NCT02883452|523946890|FG002|Overall Study|Withdrawal by Subject|3|||
145299060|NCT02883452|523946891|FG003|Overall Study|Withdrawal by Subject|0|||
145299061|NCT02883452|523946892|FG004|Overall Study|Withdrawal by Subject|2|||
145299062|NCT02883452|523946893|FG005|Overall Study|Withdrawal by Subject|5|||
145299063|NCT02883452|523946888|FG000|Overall Study|Disease progression|1|||
145299064|NCT02883452|523946889|FG001|Overall Study|Disease progression|0|||
145299065|NCT02883452|523946890|FG002|Overall Study|Disease progression|0|||
145299066|NCT02883452|523946891|FG003|Overall Study|Disease progression|1|||
145299067|NCT02883452|523946892|FG004|Overall Study|Disease progression|4|||
145299068|NCT02883452|523946893|FG005|Overall Study|Disease progression|5|||
145299069|NCT02883452|523946888|FG000|Overall Study|Adverse Event|2|||
145299070|NCT02883452|523946889|FG001|Overall Study|Adverse Event|1|||
145299071|NCT02883452|523946890|FG002|Overall Study|Adverse Event|1|||
145299072|NCT02883452|523946891|FG003|Overall Study|Adverse Event|1|||
145410177|NCT03488524|524355139|FG000|Overall Study|Withdrawal by Subject|51|||
145410178|NCT03488524|524355139|FG000|Overall Study|Death|19|||
145410179|NCT03488524|524355139|FG000|Overall Study|Study Sponsor|11|||
145299073|NCT02883452|523946892|FG004|Overall Study|Adverse Event|1|||
145299074|NCT02883452|523946893|FG005|Overall Study|Adverse Event|3|||
145299075|NCT02883452|523946888|FG000|Overall Study|Physician Decision|0|||
145299076|NCT02883452|523946889|FG001|Overall Study|Physician Decision|0|||
145299077|NCT02883452|523946890|FG002|Overall Study|Physician Decision|0|||
145299078|NCT02883452|523946891|FG003|Overall Study|Physician Decision|0|||
145299079|NCT02883452|523946892|FG004|Overall Study|Physician Decision|4|||
145299080|NCT02883452|523946893|FG005|Overall Study|Physician Decision|1|||
145299081|NCT02883452|523946888|FG000|Overall Study|Death|1|||
145299082|NCT02883452|523946889|FG001|Overall Study|Death|0|||
145299083|NCT02883452|523946890|FG002|Overall Study|Death|1|||
145410180|NCT03488524|524355139|FG000|Overall Study|Physician Decision|4|||
145410181|NCT03488524|524355139|FG000|Overall Study|Lost to Follow-up|3|||
145410182|NCT02390284|524355140|FG000|Overall Study|Physician Decision|0|||
145410183|NCT02390284|524355141|FG001|Overall Study|Physician Decision|0|||
145410184|NCT02390284|524355142|FG002|Overall Study|Physician Decision|9|||
145410185|NCT03980223|524355143|FG000|Overall Study|Lost to Follow-up|3|||
145410186|NCT03980223|524355144|FG001|Overall Study|Lost to Follow-up|7|||
145410187|NCT03980223|524355145|FG002|Overall Study|Lost to Follow-up|10|||
145410188|NCT03980223|524355146|FG003|Overall Study|Lost to Follow-up|8|||
145410189|NCT03980223|524355143|FG000|Overall Study|Withdrawal by Subject|0|||
145410190|NCT03980223|524355144|FG001|Overall Study|Withdrawal by Subject|0|||
145410191|NCT03980223|524355145|FG002|Overall Study|Withdrawal by Subject|1|||
145410192|NCT03980223|524355146|FG003|Overall Study|Withdrawal by Subject|2|||
145410193|NCT03980223|524355143|FG000|Overall Study|Physician Decision|0|||
145299084|NCT02883452|523946891|FG003|Overall Study|Death|0|||
145299085|NCT02883452|523946892|FG004|Overall Study|Death|0|||
145299086|NCT02883452|523946893|FG005|Overall Study|Death|0|||
145299087|NCT02883452|523946888|FG000|Overall Study|Other|0|||
145299088|NCT02883452|523946889|FG001|Overall Study|Other|0|||
145299089|NCT02883452|523946890|FG002|Overall Study|Other|0|||
145299090|NCT02883452|523946891|FG003|Overall Study|Other|0|||
145299091|NCT02883452|523946892|FG004|Overall Study|Other|0|||
145299092|NCT02883452|523946893|FG005|Overall Study|Other|1|||
145299093|NCT00667095|523946903|FG000|Overall Study|Withdrawal by Subject|0|||
145299094|NCT00667095|523946904|FG001|Overall Study|Withdrawal by Subject|1|||
145299095|NCT01520909|523946905|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
145299096|NCT01520909|523946906|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
145299097|NCT01520909|523946907|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
145299098|NCT01520909|523946905|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
145299099|NCT01520909|523946906|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
145299100|NCT01520909|523946907|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
145299101|NCT01520909|523946905|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
145410194|NCT03980223|524355144|FG001|Overall Study|Physician Decision|0|||
145410195|NCT03980223|524355145|FG002|Overall Study|Physician Decision|1|||
145410196|NCT03980223|524355146|FG003|Overall Study|Physician Decision|0|||
145410197|NCT03980223|524355143|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
145299102|NCT01520909|523946906|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
145410198|NCT03980223|524355144|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
145566480|NCT01083433|524936125|FG001|Overall Study|Withdrawal by Subject|5|||
145566481|NCT01083433|524936126|FG002|Overall Study|Withdrawal by Subject|3|||
145566482|NCT01083433|524936124|FG000|Overall Study|Pregnancy|0|||
145566483|NCT01083433|524936125|FG001|Overall Study|Pregnancy|0|||
145566484|NCT01083433|524936126|FG002|Overall Study|Pregnancy|1|||
145247802|NCT02623699|523752606|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247803|NCT02623699|523752607|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
145247804|NCT02623699|523752608|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247805|NCT02623699|523752609|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247806|NCT02623699|523752610|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247807|NCT02623699|523752611|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247808|NCT02623699|523752612|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
145247809|NCT02623699|523752601|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247810|NCT02623699|523752602|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247811|NCT02623699|523752603|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247812|NCT02623699|523752604|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247813|NCT02623699|523752605|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247814|NCT02623699|523752606|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
145247815|NCT02623699|523752607|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247816|NCT02623699|523752608|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247817|NCT02623699|523752609|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247818|NCT02623699|523752610|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145566485|NCT04615949|524936132|FG000|Overall Study|Withdrawal by Subject|2|||
145566486|NCT04615949|524936133|FG001|Overall Study|Withdrawal by Subject|4|||
145566487|NCT04615949|524936132|FG000|Overall Study|Lost to Follow-up|2|||
145247819|NCT02623699|523752611|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247820|NCT02623699|523752612|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
145247821|NCT02623699|523752601|FG000|Part B (Up to 289 Days)|Death|0|||
145247822|NCT02623699|523752602|FG001|Part B (Up to 289 Days)|Death|0|||
145247823|NCT02623699|523752603|FG002|Part B (Up to 289 Days)|Death|0|||
145247824|NCT02623699|523752604|FG003|Part B (Up to 289 Days)|Death|0|||
145247825|NCT02623699|523752605|FG004|Part B (Up to 289 Days)|Death|0|||
145247826|NCT02623699|523752606|FG005|Part B (Up to 289 Days)|Death|1|||
145247827|NCT02623699|523752607|FG006|Part B (Up to 289 Days)|Death|1|||
145247828|NCT02623699|523752608|FG007|Part B (Up to 289 Days)|Death|0|||
145247829|NCT02623699|523752609|FG008|Part B (Up to 289 Days)|Death|1|||
145247830|NCT02623699|523752610|FG009|Part B (Up to 289 Days)|Death|0|||
145247831|NCT02623699|523752611|FG010|Part B (Up to 289 Days)|Death|0|||
145247832|NCT02623699|523752612|FG011|Part B (Up to 289 Days)|Death|0|||
145247833|NCT02623699|523752601|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
145247834|NCT02623699|523752602|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
145247835|NCT02623699|523752603|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
145247836|NCT02623699|523752604|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
145247837|NCT02623699|523752605|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
145247838|NCT02623699|523752606|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
145247839|NCT02623699|523752607|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
145247840|NCT02623699|523752608|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
145247841|NCT02623699|523752609|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
145247842|NCT02623699|523752610|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
145247843|NCT02623699|523752611|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
145247844|NCT02623699|523752612|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
145247845|NCT02623699|523752601|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247846|NCT02623699|523752602|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247847|NCT02623699|523752603|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247848|NCT02623699|523752604|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247849|NCT02623699|523752605|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247850|NCT02623699|523752606|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247851|NCT02623699|523752607|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247852|NCT02623699|523752608|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247853|NCT02623699|523752609|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247854|NCT02623699|523752610|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
145247855|NCT02623699|523752611|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
145247856|NCT02623699|523752612|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
145247857|NCT02623699|523752601|FG000|Part C (Up to 236 Days)|Death|0|||
145247858|NCT02623699|523752602|FG001|Part C (Up to 236 Days)|Death|0|||
145247859|NCT02623699|523752603|FG002|Part C (Up to 236 Days)|Death|0|||
145247860|NCT02623699|523752604|FG003|Part C (Up to 236 Days)|Death|0|||
145247861|NCT02623699|523752605|FG004|Part C (Up to 236 Days)|Death|0|||
145247862|NCT02623699|523752606|FG005|Part C (Up to 236 Days)|Death|0|||
145247863|NCT02623699|523752607|FG006|Part C (Up to 236 Days)|Death|0|||
145247864|NCT02623699|523752608|FG007|Part C (Up to 236 Days)|Death|0|||
145247865|NCT02623699|523752609|FG008|Part C (Up to 236 Days)|Death|0|||
145247866|NCT02623699|523752610|FG009|Part C (Up to 236 Days)|Death|0|||
145247867|NCT02623699|523752611|FG010|Part C (Up to 236 Days)|Death|0|||
145247868|NCT02623699|523752612|FG011|Part C (Up to 236 Days)|Death|1|||
145247869|NCT02623699|523752601|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
145566488|NCT04615949|524936133|FG001|Overall Study|Lost to Follow-up|2|||
145566489|NCT04615949|524936132|FG000|Overall Study|Death|0|||
145247870|NCT02623699|523752602|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
145247871|NCT02623699|523752603|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
145247872|NCT02623699|523752604|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
145247873|NCT02623699|523752605|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
145247874|NCT02623699|523752606|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
145247875|NCT02623699|523752607|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
145247876|NCT02623699|523752608|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
145247877|NCT02623699|523752609|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
145247878|NCT02623699|523752610|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
145247879|NCT02623699|523752611|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
145247880|NCT02623699|523752612|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
145247881|NCT00033371|523752613|FG000|Overall Study|Adverse Event|1|||
145247882|NCT00033371|523752614|FG001|Overall Study|Adverse Event|5|||
145247883|NCT00033371|523752613|FG000|Overall Study|Lost to Follow-up|2|||
145247884|NCT00033371|523752614|FG001|Overall Study|Lost to Follow-up|1|||
145247885|NCT00033371|523752613|FG000|Overall Study|Withdrawal by Subject|3|||
145247886|NCT00033371|523752614|FG001|Overall Study|Withdrawal by Subject|3|||
145247887|NCT00033371|523752613|FG000|Overall Study|Disease Progression|0|||
145299103|NCT01520909|523946907|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
145299104|NCT01520909|523946905|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
145299105|NCT01520909|523946906|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
145299106|NCT01520909|523946907|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
145247888|NCT00033371|523752614|FG001|Overall Study|Disease Progression|1|||
145247889|NCT01390038|523752615|FG000|Overall Study|Death|1|||
145247890|NCT01390038|523752615|FG000|Overall Study|Lost to Follow-up|1|||
145247891|NCT01390038|523752615|FG000|Overall Study|Withdrawal by Subject|4|||
145247892|NCT01390038|523752615|FG000|Overall Study|Simpliciti System Removal|2|||
145247893|NCT01922739|523752616|FG000|Titration/Adjustment Period|Adverse Event|3|||
145247894|NCT01922739|523752616|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
145247895|NCT01922739|523752616|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
145247896|NCT01922739|523752616|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
145247897|NCT01922739|523752616|FG000|Open-label Treatment Period|Adverse Event|6|||
145247898|NCT01922739|523752616|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
145247899|NCT01922739|523752616|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
145247900|NCT01922739|523752616|FG000|Open-label Treatment Period|Protocol Violation|5|||
145247901|NCT01922739|523752616|FG000|Open-label Treatment Period|Pregnancy|1|||
145247902|NCT01922739|523752616|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
145247903|NCT01922739|523752616|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
145247904|NCT01922739|523752616|FG000|Open-label Treatment Period|Physician Decision|1|||
145247905|NCT01922739|523752616|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
145247906|NCT00422240|523752617|FG000|Overall Study|Lack of Efficacy|1|||
145247907|NCT00422240|523752618|FG001|Overall Study|Lack of Efficacy|2|||
145247908|NCT00422240|523752619|FG002|Overall Study|Lack of Efficacy|0|||
145247909|NCT00422240|523752620|FG003|Overall Study|Lack of Efficacy|1|||
145247910|NCT00422240|523752617|FG000|Overall Study|Adverse Event|11|||
145247911|NCT00422240|523752618|FG001|Overall Study|Adverse Event|4|||
145247912|NCT00422240|523752619|FG002|Overall Study|Adverse Event|5|||
145299107|NCT00830206|523946910|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
145299108|NCT00830206|523946911|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
145299109|NCT00905346|523946914|FG000|Period 1|Withdrawal by Subject|1|||
145299110|NCT00905346|523946915|FG001|Period 1|Withdrawal by Subject|0|||
145299111|NCT01435265|523946916|FG000|Overall Study|Lost to Follow-up|0|||
145299112|NCT01435265|523946917|FG001|Overall Study|Lost to Follow-up|1|||
145299113|NCT00909610|523946920|FG000|Period: First Intervention|Adverse Event|0|||
145299114|NCT00909610|523946921|FG001|Period: First Intervention|Adverse Event|1|||
145299115|NCT00909610|523946920|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
145299116|NCT00909610|523946921|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
145299117|NCT00909610|523946920|FG000|Period: Second Intervention|Adverse Event|1|||
145299118|NCT00909610|523946921|FG001|Period: Second Intervention|Adverse Event|0|||
145299119|NCT04123548|523946925|FG000|Overall Study|Withdrawal by Subject|1|||
145299120|NCT04123548|523946925|FG000|Overall Study|Lost to Follow-up|8|||
145299121|NCT04123548|523946925|FG000|Overall Study|Death|4|||
145299122|NCT04123548|523946925|FG000|Overall Study|Reason Not Specified|1|||
145299123|NCT04166630|523946927|FG000|Overall Study|Withdrawal by Subject|0|||
145299124|NCT04166630|523946928|FG001|Overall Study|Withdrawal by Subject|1|||
145247913|NCT00422240|523752620|FG003|Overall Study|Adverse Event|2|||
145247914|NCT00422240|523752617|FG000|Overall Study|Subject request|21|||
145247915|NCT00422240|523752618|FG001|Overall Study|Subject request|17|||
145247916|NCT00422240|523752619|FG002|Overall Study|Subject request|18|||
145247917|NCT00422240|523752620|FG003|Overall Study|Subject request|30|||
145247918|NCT00422240|523752617|FG000|Overall Study|Protocol Violation|0|||
145247919|NCT00422240|523752618|FG001|Overall Study|Protocol Violation|1|||
145299125|NCT01034358|523946929|FG000|Overall Study|Withdrawal by Subject|1|||
145299126|NCT01034358|523946929|FG000|Overall Study|Protocol Violation|1|||
145247920|NCT00422240|523752619|FG002|Overall Study|Protocol Violation|0|||
145247921|NCT00422240|523752620|FG003|Overall Study|Protocol Violation|1|||
145247922|NCT00422240|523752617|FG000|Overall Study|Lost to Follow-up|31|||
145247923|NCT00422240|523752618|FG001|Overall Study|Lost to Follow-up|32|||
145247924|NCT00422240|523752619|FG002|Overall Study|Lost to Follow-up|19|||
145247925|NCT00422240|523752620|FG003|Overall Study|Lost to Follow-up|34|||
145247926|NCT00422240|523752617|FG000|Overall Study|Other|1|||
145247927|NCT00422240|523752618|FG001|Overall Study|Other|0|||
145299127|NCT01838941|523946930|FG000|Overall Study|Adverse Event|1|||
145299128|NCT01838941|523946930|FG000|Overall Study|Withdrawal by Subject|1|||
145299129|NCT02822235|523946931|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
145299130|NCT02822235|523946932|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
145299131|NCT02822235|523946931|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
145299132|NCT02822235|523946932|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
145299133|NCT02822235|523946931|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
145299134|NCT02822235|523946932|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
145299135|NCT02822235|523946931|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
145299136|NCT02822235|523946932|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
145299137|NCT02822235|523946931|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
145299138|NCT02822235|523946932|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
145299139|NCT02822235|523946931|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
145299140|NCT02822235|523946932|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
145299141|NCT00627016|523946935|FG000|Overall Study|Adverse Event|1|||
145299142|NCT00627016|523946936|FG001|Overall Study|Adverse Event|1|||
145299143|NCT00627016|523946935|FG000|Overall Study|Protocol Violation|0|||
145299144|NCT00627016|523946936|FG001|Overall Study|Protocol Violation|2|||
145299145|NCT00627016|523946935|FG000|Overall Study|Lost to Follow-up|0|||
145299146|NCT00627016|523946936|FG001|Overall Study|Lost to Follow-up|1|||
145299147|NCT00627016|523946935|FG000|Overall Study|Withdrawal by Subject|2|||
145299148|NCT00627016|523946936|FG001|Overall Study|Withdrawal by Subject|1|||
145299149|NCT00627016|523946935|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145299150|NCT00627016|523946936|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
145299151|NCT00627016|523946935|FG000|Overall Study|Lack of Efficacy|1|||
145299152|NCT00627016|523946936|FG001|Overall Study|Lack of Efficacy|0|||
145299153|NCT00627016|523946935|FG000|Overall Study|Placed on Excluded Drugs|1|||
145299154|NCT00627016|523946936|FG001|Overall Study|Placed on Excluded Drugs|0|||
145299155|NCT00627016|523946935|FG000|Overall Study|Pregnancy|1|||
145299156|NCT00627016|523946936|FG001|Overall Study|Pregnancy|0|||
145299157|NCT01534663|523946937|FG000|Overall Study|Lost to Follow-up|0|||
145299158|NCT01534663|523946938|FG001|Overall Study|Lost to Follow-up|2|||
145299159|NCT01534663|523946937|FG000|Overall Study|Adverse Event|2|||
145299160|NCT01534663|523946938|FG001|Overall Study|Adverse Event|1|||
145299161|NCT04088760|523946941|FG000|Overall Study|Physician Decision|1|||
145299162|NCT00377260|523946942|FG000|Overall Study|Lost to Follow-up|0|||
145299163|NCT00377260|523946943|FG001|Overall Study|Lost to Follow-up|1|||
145299164|NCT00377260|523946942|FG000|Overall Study|Withdrawal by Subject|2|||
145299165|NCT00377260|523946943|FG001|Overall Study|Withdrawal by Subject|4|||
145299166|NCT00829530|523946944|FG000|First Intervention|Adverse Event|0|||
145299167|NCT00829530|523946945|FG001|First Intervention|Adverse Event|1|||
145299168|NCT00829530|523946944|FG000|First Intervention|Intolerance to Venopuncture|0|||
145299169|NCT00829530|523946945|FG001|First Intervention|Intolerance to Venopuncture|1|||
145299170|NCT00829530|523946944|FG000|Second Intervention|Intolerance to Venopuncture|1|||
145299171|NCT00829530|523946945|FG001|Second Intervention|Intolerance to Venopuncture|0|||
145299172|NCT01391793|523946946|FG000|Overall Study|Ineligible|3|||
145299173|NCT01391793|523946947|FG001|Overall Study|Ineligible|0|||
145299174|NCT01391793|523946946|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
145299175|NCT01391793|523946947|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
145299176|NCT01391793|523946946|FG000|Overall Study|No DMSA|73|||
145299177|NCT01391793|523946947|FG001|Overall Study|No DMSA|57|||
145299178|NCT01015625|523946948|FG000|Overall Study|Lost to Follow-up|3|||
145299179|NCT01015625|523946949|FG001|Overall Study|Lost to Follow-up|1|||
145299180|NCT01015625|523946948|FG000|Overall Study|Withdrawal by Subject|2|||
145299181|NCT01015625|523946949|FG001|Overall Study|Withdrawal by Subject|3|||
145299182|NCT01015625|523946948|FG000|Overall Study|Physician Decision|2|||
145299183|NCT01015625|523946949|FG001|Overall Study|Physician Decision|0|||
145299184|NCT01015625|523946948|FG000|Overall Study|Death|30|||
145299185|NCT01015625|523946949|FG001|Overall Study|Death|22|||
145299186|NCT03107091|523946951|FG000|Overall Study|Physician Decision|1|||
145299187|NCT00105196|523946956|FG000|Overall Study|Lack of Efficacy|2|||
145247928|NCT00422240|523752619|FG002|Overall Study|Other|0|||
145299188|NCT00105196|523946957|FG001|Overall Study|Lack of Efficacy|3|||
145299189|NCT00105196|523946956|FG000|Overall Study|Adverse Event|11|||
145299190|NCT00105196|523946957|FG001|Overall Study|Adverse Event|3|||
145299191|NCT00105196|523946956|FG000|Overall Study|Withdrawal by Subject|6|||
145299192|NCT00105196|523946957|FG001|Overall Study|Withdrawal by Subject|6|||
145299193|NCT00105196|523946956|FG000|Overall Study|Lost to Follow-up|3|||
145247929|NCT00422240|523752620|FG003|Overall Study|Other|1|||
145247930|NCT00422240|523752617|FG000|Overall Study|Pregnancy|3|||
145247931|NCT00422240|523752618|FG001|Overall Study|Pregnancy|1|||
145247932|NCT00422240|523752619|FG002|Overall Study|Pregnancy|1|||
145247933|NCT00422240|523752620|FG003|Overall Study|Pregnancy|2|||
145247934|NCT01927068|523752621|FG000|Overall Study|Death|37|||
145247935|NCT01927068|523752622|FG001|Overall Study|Death|3|||
145247936|NCT01927068|523752621|FG000|Overall Study|Withdrawal by Subject|50|||
145247937|NCT01927068|523752622|FG001|Overall Study|Withdrawal by Subject|3|||
145247938|NCT01927068|523752621|FG000|Overall Study|Lost to Follow-up|10|||
145247939|NCT01927068|523752622|FG001|Overall Study|Lost to Follow-up|2|||
145247940|NCT01927068|523752621|FG000|Overall Study|Physician Decision|9|||
145247941|NCT01927068|523752622|FG001|Overall Study|Physician Decision|0|||
145247942|NCT01927068|523752621|FG000|Overall Study|Missed last follow-up visit|2|||
145247943|NCT01927068|523752622|FG001|Overall Study|Missed last follow-up visit|0|||
145247944|NCT00441012|523752623|FG000|Overall Study|Adverse Event|0|||
145247945|NCT00441012|523752624|FG001|Overall Study|Adverse Event|1|||
145247946|NCT00441012|523752623|FG000|Overall Study|Lost to Follow-up|3|||
145247947|NCT00441012|523752624|FG001|Overall Study|Lost to Follow-up|3|||
145247948|NCT00441012|523752623|FG000|Overall Study|Protocol Violation|10|||
145247949|NCT00441012|523752624|FG001|Overall Study|Protocol Violation|9|||
145247950|NCT00441012|523752623|FG000|Overall Study|Withdrawal by Subject|4|||
145247951|NCT00441012|523752624|FG001|Overall Study|Withdrawal by Subject|0|||
145247952|NCT00441012|523752623|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
145247953|NCT00441012|523752624|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
145247954|NCT04489940|523752625|FG000|Overall Study|Other|2|||
145247955|NCT04489940|523752625|FG000|Overall Study|Withdrawal by Subject|2|||
145247956|NCT04489940|523752625|FG000|Overall Study|Death|5|||
145247957|NCT04489940|523752625|FG000|Overall Study|Lost to Follow-up|1|||
145247958|NCT01624467|523752626|FG000|Overall Study|Withdrawal by Subject|2|||
145247959|NCT01624467|523752626|FG000|Overall Study|Lost to Follow-up|1|||
145247960|NCT01624467|523752626|FG000|Overall Study|Adverse Event|7|||
145247961|NCT01624467|523752626|FG000|Overall Study|Progressive Disease|19|||
145247962|NCT01624467|523752626|FG000|Overall Study|Per Sponsor Requirement|1|||
145247963|NCT01624467|523752626|FG000|Overall Study|Subject Withdrew from Treatment|1|||
145247964|NCT04498468|523752627|FG000|Overall Study|Lost to Follow-up|3|||
145247965|NCT02725268|523752628|FG000|Overall Study|Death|58|||
145247966|NCT02725268|523752629|FG001|Overall Study|Death|59|||
145247967|NCT02725268|523752630|FG002|Overall Study|Death|30|||
145247968|NCT02725268|523752631|FG003|Overall Study|Death|16|||
145247969|NCT02725268|523752628|FG000|Overall Study|Lost to Follow-up|4|||
145247970|NCT02725268|523752629|FG001|Overall Study|Lost to Follow-up|3|||
145247971|NCT02725268|523752630|FG002|Overall Study|Lost to Follow-up|0|||
145247972|NCT02725268|523752631|FG003|Overall Study|Lost to Follow-up|1|||
145247973|NCT02725268|523752628|FG000|Overall Study|Site Terminated by Sponsor|0|||
145247974|NCT02725268|523752629|FG001|Overall Study|Site Terminated by Sponsor|1|||
145247975|NCT02725268|523752630|FG002|Overall Study|Site Terminated by Sponsor|0|||
145247976|NCT02725268|523752631|FG003|Overall Study|Site Terminated by Sponsor|0|||
145247977|NCT02725268|523752628|FG000|Overall Study|Withdrawal by Subject|8|||
145247978|NCT02725268|523752629|FG001|Overall Study|Withdrawal by Subject|6|||
145247979|NCT02725268|523752630|FG002|Overall Study|Withdrawal by Subject|8|||
145247980|NCT02725268|523752631|FG003|Overall Study|Withdrawal by Subject|1|||
145247981|NCT02725268|523752628|FG000|Overall Study|Reason not Specified|2|||
145247982|NCT02725268|523752629|FG001|Overall Study|Reason not Specified|1|||
145247983|NCT02725268|523752630|FG002|Overall Study|Reason not Specified|0|||
145247984|NCT02725268|523752631|FG003|Overall Study|Reason not Specified|0|||
145247985|NCT00262314|523752637|FG000|Overall Study|Changing physicians|38|||
145247986|NCT00262314|523752637|FG000|Overall Study|Death|12|||
145247987|NCT00262314|523752637|FG000|Overall Study|Patient's decision|92|||
145247988|NCT00262314|523752637|FG000|Overall Study|Other|95|||
145247989|NCT00262314|523752637|FG000|Overall Study|Lost to Follow-up|70|||
145247990|NCT00262314|523752637|FG000|Overall Study|Administrative withdrawal|30|||
145247991|NCT02224274|523752638|FG000|Overall Study|Death|1|||
145247992|NCT02224274|523752639|FG001|Overall Study|Death|0|||
145247993|NCT00887068|523752640|FG000|Overall Study|Withdrawal by Subject|2|||
145247994|NCT00887068|523752641|FG001|Overall Study|Withdrawal by Subject|0|||
145247995|NCT00887068|523752640|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
145247996|NCT00887068|523752641|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
145247997|NCT00814307|523752642|FG000|Overall Study|Randomized but not treated|1|||
145247998|NCT00814307|523752643|FG001|Overall Study|Randomized but not treated|0|||
145247999|NCT00814307|523752644|FG002|Overall Study|Randomized but not treated|0|||
145248000|NCT00814307|523752645|FG003|Overall Study|Randomized but not treated|0|||
145248001|NCT00814307|523752642|FG000|Overall Study|Adverse Event|3|||
145248002|NCT00814307|523752643|FG001|Overall Study|Adverse Event|9|||
145248003|NCT00814307|523752644|FG002|Overall Study|Adverse Event|3|||
145248004|NCT00814307|523752645|FG003|Overall Study|Adverse Event|2|||
145248005|NCT00814307|523752642|FG000|Overall Study|Lack of Efficacy|1|||
145248006|NCT00814307|523752643|FG001|Overall Study|Lack of Efficacy|1|||
145248007|NCT00814307|523752644|FG002|Overall Study|Lack of Efficacy|3|||
145248008|NCT00814307|523752645|FG003|Overall Study|Lack of Efficacy|4|||
145248009|NCT00814307|523752642|FG000|Overall Study|Other|1|||
145248010|NCT00814307|523752643|FG001|Overall Study|Other|2|||
145248011|NCT00814307|523752644|FG002|Overall Study|Other|0|||
145248012|NCT00814307|523752645|FG003|Overall Study|Other|1|||
145248013|NCT00814307|523752642|FG000|Overall Study|Protocol Violation|2|||
145248014|NCT00814307|523752643|FG001|Overall Study|Protocol Violation|8|||
145248015|NCT00814307|523752644|FG002|Overall Study|Protocol Violation|1|||
145248016|NCT00814307|523752645|FG003|Overall Study|Protocol Violation|1|||
145248017|NCT00814307|523752642|FG000|Overall Study|Withdrawal by Subject|4|||
145248018|NCT00814307|523752643|FG001|Overall Study|Withdrawal by Subject|6|||
145248019|NCT00814307|523752644|FG002|Overall Study|Withdrawal by Subject|0|||
145248020|NCT00814307|523752645|FG003|Overall Study|Withdrawal by Subject|2|||
145248021|NCT00814307|523752642|FG000|Overall Study|Death|0|||
145248022|NCT00814307|523752643|FG001|Overall Study|Death|1|||
145248023|NCT00814307|523752644|FG002|Overall Study|Death|0|||
145248024|NCT00814307|523752645|FG003|Overall Study|Death|0|||
145248025|NCT03073200|523752654|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145248026|NCT03073200|523752655|FG001|Double Blind Treatment Period|Protocol Violation|0|||
145248027|NCT03073200|523752656|FG002|Double Blind Treatment Period|Protocol Violation|0|||
145248028|NCT03073200|523752657|FG003|Double Blind Treatment Period|Protocol Violation|0|||
145248029|NCT03073200|523752658|FG004|Double Blind Treatment Period|Protocol Violation|0|||
145248030|NCT03073200|523752659|FG005|Double Blind Treatment Period|Protocol Violation|0|||
145248031|NCT03073200|523752660|FG006|Double Blind Treatment Period|Protocol Violation|0|||
145248032|NCT03073200|523752661|FG007|Double Blind Treatment Period|Protocol Violation|0|||
145248033|NCT03073200|523752662|FG008|Double Blind Treatment Period|Protocol Violation|0|||
145248034|NCT03073200|523752663|FG009|Double Blind Treatment Period|Protocol Violation|0|||
145248035|NCT03073200|523752664|FG010|Double Blind Treatment Period|Protocol Violation|0|||
145248036|NCT03073200|523752665|FG011|Double Blind Treatment Period|Protocol Violation|0|||
145248037|NCT03073200|523752666|FG012|Double Blind Treatment Period|Protocol Violation|0|||
145248038|NCT03073200|523752667|FG013|Double Blind Treatment Period|Protocol Violation|0|||
145248039|NCT03073200|523752668|FG014|Double Blind Treatment Period|Protocol Violation|0|||
145248040|NCT03073200|523752654|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248041|NCT03073200|523752655|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
145248042|NCT03073200|523752656|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248043|NCT03073200|523752657|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248044|NCT03073200|523752658|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248045|NCT03073200|523752659|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248046|NCT03073200|523752660|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248047|NCT03073200|523752661|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248048|NCT03073200|523752662|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248049|NCT03073200|523752663|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248050|NCT03073200|523752664|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248051|NCT03073200|523752665|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248052|NCT03073200|523752666|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248053|NCT03073200|523752667|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248054|NCT03073200|523752668|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
145248055|NCT03073200|523752654|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
145248056|NCT03073200|523752655|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248057|NCT03073200|523752656|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
145299194|NCT00105196|523946957|FG001|Overall Study|Lost to Follow-up|2|||
145299195|NCT00105196|523946956|FG000|Overall Study|Poor/noncompliance|3|||
145299196|NCT00105196|523946957|FG001|Overall Study|Poor/noncompliance|4|||
145299197|NCT00105196|523946956|FG000|Overall Study|Protocol Violation|5|||
145299198|NCT00105196|523946957|FG001|Overall Study|Protocol Violation|2|||
145248058|NCT03073200|523752657|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248059|NCT03073200|523752658|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248060|NCT03073200|523752659|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248061|NCT03073200|523752660|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248062|NCT03073200|523752661|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248063|NCT03073200|523752662|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248064|NCT03073200|523752663|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248065|NCT03073200|523752664|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248066|NCT03073200|523752665|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248067|NCT03073200|523752666|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
145620243|NCT03100838|525123722|FG000|Overall Study|Adverse Event|1|||
145248068|NCT03073200|523752667|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248069|NCT03073200|523752668|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
145248070|NCT03073200|523752654|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
145299199|NCT00105196|523946956|FG000|Overall Study|pending surgery|0|||
145299200|NCT00105196|523946957|FG001|Overall Study|pending surgery|1|||
145248071|NCT03073200|523752655|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248072|NCT03073200|523752656|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248073|NCT03073200|523752657|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
145248074|NCT03073200|523752658|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
145248075|NCT03073200|523752659|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248076|NCT03073200|523752660|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248077|NCT03073200|523752661|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248078|NCT03073200|523752662|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248079|NCT03073200|523752663|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248080|NCT03073200|523752664|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248081|NCT03073200|523752665|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248082|NCT03073200|523752666|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248083|NCT03073200|523752667|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248084|NCT03073200|523752668|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
145248085|NCT03073200|523752654|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
145248086|NCT03073200|523752655|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
145248087|NCT03073200|523752656|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
145248088|NCT03073200|523752657|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
145248089|NCT03073200|523752658|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
145248090|NCT03073200|523752659|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
145248091|NCT03073200|523752660|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
145248092|NCT03073200|523752661|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
145248093|NCT03073200|523752662|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
145248094|NCT03073200|523752663|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
145248095|NCT03073200|523752664|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
145248096|NCT03073200|523752665|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
145248097|NCT03073200|523752666|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
145248098|NCT03073200|523752667|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
145248099|NCT03073200|523752668|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
145248100|NCT03073200|523752654|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248101|NCT03073200|523752655|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248102|NCT03073200|523752656|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248103|NCT03073200|523752657|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248104|NCT03073200|523752658|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
145248105|NCT03073200|523752659|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248106|NCT03073200|523752660|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248107|NCT03073200|523752661|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248108|NCT03073200|523752662|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248109|NCT03073200|523752663|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248110|NCT03073200|523752664|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248111|NCT03073200|523752665|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248112|NCT03073200|523752666|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248113|NCT03073200|523752667|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248114|NCT03073200|523752668|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
145248115|NCT03073200|523752654|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248116|NCT03073200|523752655|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248117|NCT03073200|523752656|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248118|NCT03073200|523752657|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
145248119|NCT03073200|523752658|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
145248120|NCT03073200|523752659|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248121|NCT03073200|523752660|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248122|NCT03073200|523752661|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248123|NCT03073200|523752662|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248124|NCT03073200|523752663|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248125|NCT03073200|523752664|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248126|NCT03073200|523752665|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248127|NCT03073200|523752666|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248128|NCT03073200|523752667|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248129|NCT03073200|523752668|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
145248130|NCT03073200|523752654|FG000|Extension Period|Lost to Follow-up|0|||
145248131|NCT03073200|523752655|FG001|Extension Period|Lost to Follow-up|0|||
145248132|NCT03073200|523752656|FG002|Extension Period|Lost to Follow-up|0|||
145299201|NCT00105196|523946956|FG000|Overall Study|marijuana use|0|||
145299202|NCT00105196|523946957|FG001|Overall Study|marijuana use|1|||
145299203|NCT00105196|523946956|FG000|Overall Study|Subject became unblinded|0|||
145566490|NCT04615949|524936133|FG001|Overall Study|Death|2|||
145566491|NCT03036566|524936134|FG000|Overall Study|Lost to Follow-up|3|||
145566492|NCT01852292|524936135|FG000|Overall Study|Untreated - did not receive study drug|3|||
145248133|NCT03073200|523752657|FG003|Extension Period|Lost to Follow-up|0|||
145248134|NCT03073200|523752658|FG004|Extension Period|Lost to Follow-up|0|||
145248135|NCT03073200|523752659|FG005|Extension Period|Lost to Follow-up|0|||
145248136|NCT03073200|523752660|FG006|Extension Period|Lost to Follow-up|1|||
145248137|NCT03073200|523752661|FG007|Extension Period|Lost to Follow-up|1|||
145248138|NCT03073200|523752662|FG008|Extension Period|Lost to Follow-up|0|||
145248139|NCT03073200|523752663|FG009|Extension Period|Lost to Follow-up|0|||
145248140|NCT03073200|523752664|FG010|Extension Period|Lost to Follow-up|0|||
145248141|NCT03073200|523752665|FG011|Extension Period|Lost to Follow-up|0|||
145248142|NCT03073200|523752666|FG012|Extension Period|Lost to Follow-up|0|||
145248143|NCT03073200|523752667|FG013|Extension Period|Lost to Follow-up|0|||
145248144|NCT03073200|523752668|FG014|Extension Period|Lost to Follow-up|0|||
145248145|NCT03073200|523752654|FG000|Extension Period|Sponsor Decision|0|||
145248146|NCT03073200|523752655|FG001|Extension Period|Sponsor Decision|0|||
145248147|NCT03073200|523752656|FG002|Extension Period|Sponsor Decision|0|||
145248148|NCT03073200|523752657|FG003|Extension Period|Sponsor Decision|0|||
145248149|NCT03073200|523752658|FG004|Extension Period|Sponsor Decision|0|||
145248150|NCT03073200|523752659|FG005|Extension Period|Sponsor Decision|0|||
145248151|NCT03073200|523752660|FG006|Extension Period|Sponsor Decision|0|||
145248152|NCT03073200|523752661|FG007|Extension Period|Sponsor Decision|0|||
145248153|NCT03073200|523752662|FG008|Extension Period|Sponsor Decision|1|||
145248154|NCT03073200|523752663|FG009|Extension Period|Sponsor Decision|0|||
145248155|NCT03073200|523752664|FG010|Extension Period|Sponsor Decision|0|||
145248156|NCT03073200|523752665|FG011|Extension Period|Sponsor Decision|0|||
145248157|NCT03073200|523752666|FG012|Extension Period|Sponsor Decision|0|||
145248158|NCT03073200|523752667|FG013|Extension Period|Sponsor Decision|0|||
145248159|NCT03073200|523752668|FG014|Extension Period|Sponsor Decision|0|||
145248160|NCT03073200|523752654|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
145248161|NCT03073200|523752655|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
145248162|NCT03073200|523752656|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
145248163|NCT03073200|523752657|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
145248164|NCT03073200|523752658|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
145248165|NCT03073200|523752659|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
145248166|NCT03073200|523752660|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
145248167|NCT03073200|523752661|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
145248168|NCT03073200|523752662|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
145248169|NCT03073200|523752663|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
145248170|NCT03073200|523752664|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
145248171|NCT03073200|523752665|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
145248172|NCT03073200|523752666|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
145248173|NCT03073200|523752667|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
145248174|NCT03073200|523752668|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
145248175|NCT03073200|523752654|FG000|Extension Period|Withdrawal by Subject|0|||
145248176|NCT03073200|523752655|FG001|Extension Period|Withdrawal by Subject|0|||
145248177|NCT03073200|523752656|FG002|Extension Period|Withdrawal by Subject|0|||
145248178|NCT03073200|523752657|FG003|Extension Period|Withdrawal by Subject|0|||
145248179|NCT03073200|523752658|FG004|Extension Period|Withdrawal by Subject|0|||
145248180|NCT03073200|523752659|FG005|Extension Period|Withdrawal by Subject|0|||
145248181|NCT03073200|523752660|FG006|Extension Period|Withdrawal by Subject|1|||
145248182|NCT03073200|523752661|FG007|Extension Period|Withdrawal by Subject|2|||
145248183|NCT03073200|523752662|FG008|Extension Period|Withdrawal by Subject|0|||
145248184|NCT03073200|523752663|FG009|Extension Period|Withdrawal by Subject|0|||
145248185|NCT03073200|523752664|FG010|Extension Period|Withdrawal by Subject|0|||
145248186|NCT03073200|523752665|FG011|Extension Period|Withdrawal by Subject|0|||
145248187|NCT03073200|523752666|FG012|Extension Period|Withdrawal by Subject|0|||
145248188|NCT03073200|523752667|FG013|Extension Period|Withdrawal by Subject|0|||
145248189|NCT03073200|523752668|FG014|Extension Period|Withdrawal by Subject|0|||
145248190|NCT03073200|523752654|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248191|NCT03073200|523752655|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248192|NCT03073200|523752656|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248193|NCT03073200|523752657|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248194|NCT03073200|523752658|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248195|NCT03073200|523752659|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248196|NCT03073200|523752660|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248197|NCT03073200|523752661|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
145299204|NCT00105196|523946957|FG001|Overall Study|Subject became unblinded|1|||
145248198|NCT03073200|523752662|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248199|NCT03073200|523752663|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248200|NCT03073200|523752664|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248201|NCT03073200|523752665|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
145248202|NCT03073200|523752666|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248203|NCT03073200|523752667|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
145248204|NCT03073200|523752668|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
145299205|NCT00893464|523946958|FG000|Overall Study|Did not complete therapy/experience PD|0|||
145299206|NCT00893464|523946959|FG001|Overall Study|Did not complete therapy/experience PD|0|||
145299207|NCT00893464|523946960|FG002|Overall Study|Did not complete therapy/experience PD|0|||
145299208|NCT00893464|523946961|FG003|Overall Study|Did not complete therapy/experience PD|0|||
145299209|NCT00893464|523946962|FG004|Overall Study|Did not complete therapy/experience PD|0|||
145299210|NCT00893464|523946963|FG005|Overall Study|Did not complete therapy/experience PD|0|||
145299211|NCT00893464|523946964|FG006|Overall Study|Did not complete therapy/experience PD|2|||
145299212|NCT00893464|523946965|FG007|Overall Study|Did not complete therapy/experience PD|2|||
145299213|NCT01544127|523946966|FG000|Overall Study|Lost to Follow-up|4|||
145299214|NCT01544127|523946967|FG001|Overall Study|Lost to Follow-up|2|||
145299215|NCT01544127|523946968|FG002|Overall Study|Lost to Follow-up|9|||
145299216|NCT01544127|523946966|FG000|Overall Study|Withdrawal by Subject|2|||
145410199|NCT03980223|524355145|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
145248205|NCT03073200|523752654|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248206|NCT03073200|523752655|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248207|NCT03073200|523752656|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248208|NCT03073200|523752657|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248209|NCT03073200|523752658|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248210|NCT03073200|523752659|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248211|NCT03073200|523752660|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248212|NCT03073200|523752661|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248213|NCT03073200|523752662|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248214|NCT03073200|523752663|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248215|NCT03073200|523752664|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248216|NCT03073200|523752665|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
145248217|NCT03073200|523752666|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248218|NCT03073200|523752667|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248219|NCT03073200|523752668|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
145248220|NCT03073200|523752654|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248221|NCT03073200|523752655|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248222|NCT03073200|523752656|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248223|NCT03073200|523752657|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248224|NCT03073200|523752658|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248225|NCT03073200|523752659|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248226|NCT03073200|523752660|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248227|NCT03073200|523752661|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248228|NCT03073200|523752662|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248229|NCT03073200|523752663|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248230|NCT03073200|523752664|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
145248231|NCT03073200|523752665|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
145248232|NCT03073200|523752666|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248233|NCT03073200|523752667|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145248234|NCT03073200|523752668|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
145299217|NCT01544127|523946967|FG001|Overall Study|Withdrawal by Subject|2|||
145299218|NCT01544127|523946968|FG002|Overall Study|Withdrawal by Subject|1|||
145299219|NCT01544127|523946966|FG000|Overall Study|Discharged out of catchment area|1|||
145410200|NCT03980223|524355146|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
145410201|NCT01922934|524355150|FG000|Eligible Patients|Death|0|||
145410202|NCT01922934|524355151|FG001|Eligible Patients|Death|7|||
145410203|NCT01922934|524355150|FG000|Eligible Patients|Physician Decision|17|||
145410204|NCT01922934|524355151|FG001|Eligible Patients|Physician Decision|0|||
145410205|NCT01922934|524355150|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
145410206|NCT01922934|524355151|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
145410207|NCT01922934|524355150|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
145410208|NCT01922934|524355151|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
145410209|NCT01922934|524355150|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
145410210|NCT01922934|524355151|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
145410211|NCT01922934|524355150|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
145410212|NCT01922934|524355151|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
145566493|NCT01852292|524936136|FG001|Overall Study|Untreated - did not receive study drug|1|||
145566494|NCT01852292|524936135|FG000|Overall Study|Death|9|||
145566495|NCT01852292|524936136|FG001|Overall Study|Death|8|||
145566496|NCT01852292|524936135|FG000|Overall Study|Patient/guardian decision|8|||
145248235|NCT03073200|523752654|FG000|Randomized Withdrawal Period|Adverse Event|0|||
145299220|NCT01544127|523946967|FG001|Overall Study|Discharged out of catchment area|1|||
145299221|NCT01544127|523946968|FG002|Overall Study|Discharged out of catchment area|1|||
145299222|NCT01544127|523946966|FG000|Overall Study|Death|1|||
145248236|NCT03073200|523752655|FG001|Randomized Withdrawal Period|Adverse Event|0|||
145248237|NCT03073200|523752656|FG002|Randomized Withdrawal Period|Adverse Event|0|||
145248238|NCT03073200|523752657|FG003|Randomized Withdrawal Period|Adverse Event|0|||
145248239|NCT03073200|523752658|FG004|Randomized Withdrawal Period|Adverse Event|0|||
145248240|NCT03073200|523752659|FG005|Randomized Withdrawal Period|Adverse Event|0|||
145248241|NCT03073200|523752660|FG006|Randomized Withdrawal Period|Adverse Event|0|||
145248242|NCT03073200|523752661|FG007|Randomized Withdrawal Period|Adverse Event|0|||
145248243|NCT03073200|523752662|FG008|Randomized Withdrawal Period|Adverse Event|0|||
145248244|NCT03073200|523752663|FG009|Randomized Withdrawal Period|Adverse Event|0|||
145248245|NCT03073200|523752664|FG010|Randomized Withdrawal Period|Adverse Event|1|||
145248246|NCT03073200|523752665|FG011|Randomized Withdrawal Period|Adverse Event|0|||
145248247|NCT03073200|523752666|FG012|Randomized Withdrawal Period|Adverse Event|0|||
145248248|NCT03073200|523752667|FG013|Randomized Withdrawal Period|Adverse Event|0|||
145248249|NCT03073200|523752668|FG014|Randomized Withdrawal Period|Adverse Event|0|||
145248250|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248251|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248252|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248253|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248254|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248255|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248256|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248257|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248258|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248259|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248260|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248261|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248262|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248263|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
145248264|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
145248265|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248266|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145299223|NCT01544127|523946967|FG001|Overall Study|Death|0|||
145299224|NCT01544127|523946968|FG002|Overall Study|Death|0|||
145299225|NCT01544127|523946966|FG000|Overall Study|Jail or Prison|1|||
145299226|NCT01544127|523946967|FG001|Overall Study|Jail or Prison|1|||
145299227|NCT01544127|523946968|FG002|Overall Study|Jail or Prison|2|||
145299228|NCT01544127|523946966|FG000|Overall Study|Became Psychotic|1|||
145299229|NCT01544127|523946967|FG001|Overall Study|Became Psychotic|0|||
145299230|NCT01544127|523946968|FG002|Overall Study|Became Psychotic|0|||
145299231|NCT01544127|523946966|FG000|Overall Study|Researcher withdrew|1|||
145299232|NCT01544127|523946967|FG001|Overall Study|Researcher withdrew|0|||
145299233|NCT01544127|523946968|FG002|Overall Study|Researcher withdrew|0|||
145299234|NCT01544127|523946966|FG000|Overall Study|Went active duty|0|||
145299235|NCT01544127|523946967|FG001|Overall Study|Went active duty|0|||
145299236|NCT01544127|523946968|FG002|Overall Study|Went active duty|1|||
145299237|NCT01256684|523946969|FG000|Overall Study|Adverse Event|1|||
145299238|NCT01256684|523946970|FG001|Overall Study|Adverse Event|4|||
145299239|NCT01256684|523946971|FG002|Overall Study|Adverse Event|2|||
145299240|NCT01256684|523946969|FG000|Overall Study|Withdrawal by Subject|4|||
145299241|NCT01256684|523946970|FG001|Overall Study|Withdrawal by Subject|0|||
145299242|NCT01256684|523946971|FG002|Overall Study|Withdrawal by Subject|2|||
145410213|NCT00724945|524355156|FG000|Period 1|non-compliance|1|||
145410214|NCT00724945|524355157|FG001|Period 1|non-compliance|0|||
145410215|NCT00724945|524355156|FG000|Period 1|Adverse Event|1|||
145410216|NCT00724945|524355157|FG001|Period 1|Adverse Event|1|||
145299243|NCT01256684|523946969|FG000|Overall Study|Physician Decision|0|||
145299244|NCT01256684|523946970|FG001|Overall Study|Physician Decision|1|||
145299245|NCT01256684|523946971|FG002|Overall Study|Physician Decision|0|||
145410217|NCT00724945|524355156|FG000|Period 1|Lost to Follow-up|1|||
145410218|NCT00724945|524355157|FG001|Period 1|Lost to Follow-up|0|||
145410219|NCT00724945|524355156|FG000|Period 2|lens comfort issue|3|||
145410220|NCT00724945|524355157|FG001|Period 2|lens comfort issue|0|||
145566497|NCT01852292|524936136|FG001|Overall Study|Patient/guardian decision|4|||
145248267|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248268|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248269|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248270|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248271|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248272|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145299246|NCT01256684|523946969|FG000|Overall Study|Lack of Efficacy|0|||
145299247|NCT01256684|523946970|FG001|Overall Study|Lack of Efficacy|1|||
145410221|NCT00724945|524355156|FG000|Period 2|lens physiology issue|1|||
145410222|NCT00724945|524355157|FG001|Period 2|lens physiology issue|0|||
145410223|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
145410224|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
145566498|NCT01852292|524936135|FG000|Overall Study|Adverse Event|8|||
145248273|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248274|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248275|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248276|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248277|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248278|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
145248279|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145248280|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248281|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248282|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248283|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248284|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248285|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248286|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248287|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248288|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248289|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248290|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248291|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248292|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248293|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
145248294|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
145248295|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248296|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248297|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248298|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248299|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248300|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248301|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248302|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248303|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248304|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248305|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145299248|NCT01256684|523946971|FG002|Overall Study|Lack of Efficacy|1|||
145299249|NCT01256684|523946969|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
145299250|NCT01256684|523946970|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
145299251|NCT01256684|523946971|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
145299252|NCT02914600|523946972|FG000|Overall Study|Adverse Event|298|||
145299253|NCT02914600|523946973|FG001|Overall Study|Adverse Event|35|||
145299254|NCT02914600|523946974|FG002|Overall Study|Adverse Event|25|||
145299255|NCT02914600|523946972|FG000|Overall Study|Sponsors decision|287|||
145299256|NCT02914600|523946973|FG001|Overall Study|Sponsors decision|41|||
145299257|NCT02914600|523946974|FG002|Overall Study|Sponsors decision|12|||
145299258|NCT02914600|523946972|FG000|Overall Study|Withdrawal by Subject|158|||
145299259|NCT02914600|523946973|FG001|Overall Study|Withdrawal by Subject|20|||
145299260|NCT02914600|523946974|FG002|Overall Study|Withdrawal by Subject|18|||
145299261|NCT02914600|523946972|FG000|Overall Study|Investigators discretion|169|||
145299262|NCT02914600|523946973|FG001|Overall Study|Investigators discretion|14|||
145299263|NCT02914600|523946974|FG002|Overall Study|Investigators discretion|13|||
145299264|NCT02914600|523946972|FG000|Overall Study|Lost to Follow-up|10|||
145299265|NCT02914600|523946973|FG001|Overall Study|Lost to Follow-up|4|||
145299266|NCT02914600|523946974|FG002|Overall Study|Lost to Follow-up|0|||
145299267|NCT02914600|523946972|FG000|Overall Study|Pregnancy|8|||
145299268|NCT02914600|523946973|FG001|Overall Study|Pregnancy|0|||
145299269|NCT02914600|523946974|FG002|Overall Study|Pregnancy|0|||
145299270|NCT02914600|523946972|FG000|Overall Study|Protocol Violation|5|||
145299271|NCT02914600|523946973|FG001|Overall Study|Protocol Violation|3|||
145299272|NCT02914600|523946974|FG002|Overall Study|Protocol Violation|0|||
145299273|NCT02914600|523946972|FG000|Overall Study|Non-compliance with study drug|6|||
145299274|NCT02914600|523946973|FG001|Overall Study|Non-compliance with study drug|1|||
145299275|NCT02914600|523946974|FG002|Overall Study|Non-compliance with study drug|0|||
145299276|NCT02914600|523946972|FG000|Overall Study|Death|3|||
145299277|NCT02914600|523946973|FG001|Overall Study|Death|1|||
145299278|NCT02914600|523946974|FG002|Overall Study|Death|1|||
145299279|NCT02914600|523946972|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
145299280|NCT02914600|523946973|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
145299281|NCT02914600|523946974|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
145299282|NCT02914600|523946972|FG000|Overall Study|Enrolled but not treated|1|||
145299283|NCT02914600|523946973|FG001|Overall Study|Enrolled but not treated|0|||
145248306|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248307|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248308|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
145248309|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145248310|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248311|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248312|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248313|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248314|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248315|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248316|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248317|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248318|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248319|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248320|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248321|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248322|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248323|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
145248324|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
145248325|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248326|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248327|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248328|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248329|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248330|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248331|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248332|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248333|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248334|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248335|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248336|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248337|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248338|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
145248339|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
145248340|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248341|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248342|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248343|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248344|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248345|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248346|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248347|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248348|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145299284|NCT02914600|523946974|FG002|Overall Study|Enrolled but not treated|0|||
145299285|NCT02457520|523946975|FG000|Active Treatment Phase|Adverse Event|10|||
145299286|NCT02457520|523946975|FG000|Active Treatment Phase|Lost to Follow-up|8|||
145299287|NCT02457520|523946975|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
145299288|NCT02457520|523946975|FG000|Active Treatment Phase|other|4|||
145299289|NCT02457520|523946975|FG000|Active Treatment Phase|Physician Decision|1|||
145248349|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145299290|NCT02457520|523946975|FG000|Active Treatment Phase|Protocol Violation|1|||
145299291|NCT02457520|523946975|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
145299292|NCT02457520|523946975|FG000|Post-treatment Period|Other: Retreatment Required|7|||
145299293|NCT02457520|523946975|FG000|Post-treatment Period|Lost to Follow-up|23|||
145299294|NCT02457520|523946975|FG000|Post-treatment Period|Other|3|||
145299295|NCT02457520|523946975|FG000|Post-treatment Period|Physician Decision|1|||
145299296|NCT02457520|523946975|FG000|Post-treatment Period|Withdrawal by Subject|14|||
145299297|NCT00184600|523946976|FG000|Overall Study|Adverse Event|9|||
145299298|NCT00184600|523946977|FG001|Overall Study|Adverse Event|0|||
145299299|NCT00184600|523946978|FG002|Overall Study|Adverse Event|5|||
145299300|NCT00184600|523946976|FG000|Overall Study|Death|3|||
145299301|NCT00184600|523946977|FG001|Overall Study|Death|9|||
145299302|NCT00184600|523946978|FG002|Overall Study|Death|7|||
145299303|NCT00184600|523946976|FG000|Overall Study|Lack of Efficacy|3|||
145299304|NCT00184600|523946977|FG001|Overall Study|Lack of Efficacy|1|||
145299305|NCT00184600|523946978|FG002|Overall Study|Lack of Efficacy|3|||
145299306|NCT00184600|523946976|FG000|Overall Study|Lost to Follow-up|4|||
145248350|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248351|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248352|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248353|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
145248354|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145248355|NCT03073200|523752654|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248356|NCT03073200|523752655|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248357|NCT03073200|523752656|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248358|NCT03073200|523752657|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248359|NCT03073200|523752658|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248360|NCT03073200|523752659|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248361|NCT03073200|523752660|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248362|NCT03073200|523752661|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248363|NCT03073200|523752662|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248364|NCT03073200|523752663|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248365|NCT03073200|523752664|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248366|NCT03073200|523752665|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248367|NCT03073200|523752666|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248368|NCT03073200|523752667|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
145248369|NCT03073200|523752668|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
145248370|NCT02290340|523752670|FG000|Overall Study|Lost to Follow-up|0|||
145248371|NCT02290340|523752671|FG001|Overall Study|Lost to Follow-up|0|||
145248372|NCT02290340|523752672|FG002|Overall Study|Lost to Follow-up|0|||
145248373|NCT02290340|523752673|FG003|Overall Study|Lost to Follow-up|1|||
145248374|NCT02290340|523752670|FG000|Overall Study|Withdrawal by Subject|1|||
145248375|NCT02290340|523752671|FG001|Overall Study|Withdrawal by Subject|0|||
145248376|NCT02290340|523752672|FG002|Overall Study|Withdrawal by Subject|0|||
145248377|NCT02290340|523752673|FG003|Overall Study|Withdrawal by Subject|0|||
145248378|NCT02290340|523752670|FG000|Overall Study|Other|1|||
145248379|NCT02290340|523752671|FG001|Overall Study|Other|0|||
145248380|NCT02290340|523752672|FG002|Overall Study|Other|0|||
145248381|NCT02290340|523752673|FG003|Overall Study|Other|1|||
145248382|NCT02571972|523752676|FG000|Overall Study|Protocol Violation|2|||
145248383|NCT02571972|523752676|FG000|Overall Study|Withdrawal by Subject|2|||
145248384|NCT03039192|523752679|FG000|Overall Study|Lost to Follow-up|4|||
145248385|NCT03039192|523752680|FG001|Overall Study|Lost to Follow-up|4|||
145248386|NCT03039192|523752679|FG000|Overall Study|Adverse event, serious fatal|0|||
145248387|NCT03039192|523752680|FG001|Overall Study|Adverse event, serious fatal|1|||
145248388|NCT03039192|523752679|FG000|Overall Study|Adverse event, non-fatal|0|||
145248389|NCT03039192|523752680|FG001|Overall Study|Adverse event, non-fatal|2|||
145248390|NCT03039192|523752679|FG000|Overall Study|Withdrawal by Subject|6|||
145248391|NCT03039192|523752680|FG001|Overall Study|Withdrawal by Subject|9|||
145248392|NCT03039192|523752679|FG000|Overall Study|Discontinued from treatment phase|19|||
145248393|NCT03039192|523752680|FG001|Overall Study|Discontinued from treatment phase|12|||
145248394|NCT03039192|523752679|FG000|Overall Study|Other|3|||
145248395|NCT03039192|523752680|FG001|Overall Study|Other|2|||
145248396|NCT00766142|523754426|FG000|Overall Study|Protocol Violation|4|||
145248397|NCT01432756|523754427|FG000|Overall Study|Lost to Follow-up|1|||
145248398|NCT01432756|523754428|FG001|Overall Study|Lost to Follow-up|0|||
145248399|NCT01432756|523754429|FG002|Overall Study|Lost to Follow-up|2|||
145248400|NCT01432756|523754430|FG003|Overall Study|Lost to Follow-up|1|||
145248401|NCT00777257|523754444|FG000|Overall Study|Adverse Event|3|||
145248402|NCT00777257|523754445|FG001|Overall Study|Adverse Event|1|||
145248403|NCT00777257|523754446|FG002|Overall Study|Adverse Event|0|||
145248404|NCT00777257|523754444|FG000|Overall Study|Lost to Follow-up|3|||
145248405|NCT00777257|523754445|FG001|Overall Study|Lost to Follow-up|3|||
145248406|NCT00777257|523754446|FG002|Overall Study|Lost to Follow-up|2|||
145248407|NCT00777257|523754444|FG000|Overall Study|Protocol Violation|2|||
145248408|NCT00777257|523754445|FG001|Overall Study|Protocol Violation|2|||
145248409|NCT00777257|523754446|FG002|Overall Study|Protocol Violation|2|||
145248410|NCT00777257|523754444|FG000|Overall Study|Withdrawal by Subject|3|||
145299307|NCT00184600|523946977|FG001|Overall Study|Lost to Follow-up|6|||
145299308|NCT00184600|523946978|FG002|Overall Study|Lost to Follow-up|1|||
145299309|NCT00184600|523946976|FG000|Overall Study|Protocol Violation|2|||
145248411|NCT00777257|523754445|FG001|Overall Study|Withdrawal by Subject|6|||
145248412|NCT00777257|523754446|FG002|Overall Study|Withdrawal by Subject|5|||
145248413|NCT02973997|523754451|FG000|Overall Study|Withdrawal by Subject|4|||
145248414|NCT02973997|523754452|FG001|Overall Study|Withdrawal by Subject|0|||
145248415|NCT02973997|523754451|FG000|Overall Study|Adverse Event|4|||
145248416|NCT02973997|523754452|FG001|Overall Study|Adverse Event|1|||
145248417|NCT02973997|523754451|FG000|Overall Study|Disease Progression|11|||
145248418|NCT02973997|523754452|FG001|Overall Study|Disease Progression|20|||
145248419|NCT02973997|523754451|FG000|Overall Study|Alternative Therapy|3|||
145248420|NCT02973997|523754452|FG001|Overall Study|Alternative Therapy|0|||
145248421|NCT02973997|523754451|FG000|Overall Study|Other complicating disease|0|||
145248422|NCT02973997|523754452|FG001|Overall Study|Other complicating disease|1|||
145248423|NCT02973997|523754451|FG000|Overall Study|Death|0|||
145248424|NCT02973997|523754452|FG001|Overall Study|Death|1|||
145248425|NCT01431521|523754453|FG000|Overall Study|Withdrawal by Subject|0|||
145248426|NCT01431521|523754454|FG001|Overall Study|Withdrawal by Subject|0|||
145248427|NCT01431521|523754455|FG002|Overall Study|Withdrawal by Subject|1|||
145248428|NCT01431521|523754456|FG003|Overall Study|Withdrawal by Subject|0|||
145248429|NCT00444951|523754457|FG000|Overall Study|Lost to Follow-up|1|||
145248430|NCT00444951|523754458|FG001|Overall Study|Lost to Follow-up|1|||
145248431|NCT00444951|523754459|FG002|Overall Study|Lost to Follow-up|0|||
145248432|NCT00444951|523754457|FG000|Overall Study|Withdrawal by Subject|4|||
145248433|NCT00444951|523754458|FG001|Overall Study|Withdrawal by Subject|5|||
145248434|NCT00444951|523754459|FG002|Overall Study|Withdrawal by Subject|3|||
145248435|NCT00366444|523754461|FG000|Overall Study|Withdrawal by Subject|1|||
145248436|NCT00366444|523754462|FG001|Overall Study|Withdrawal by Subject|1|||
145248437|NCT00366444|523754461|FG000|Overall Study|Lack of Efficacy|0|||
145248438|NCT00366444|523754462|FG001|Overall Study|Lack of Efficacy|1|||
145248439|NCT06048809|523754470|FG000|Overall Study|Adverse Event|2|||
145248440|NCT06048809|523754471|FG001|Overall Study|Adverse Event|0|||
145248441|NCT06048809|523754470|FG000|Overall Study|Withdrawal by Subject|1|||
145248442|NCT06048809|523754471|FG001|Overall Study|Withdrawal by Subject|1|||
145248443|NCT04960202|523754473|FG000|Overall Study|Other|5|||
145248444|NCT04960202|523754474|FG001|Overall Study|Other|0|||
145248445|NCT04960202|523754473|FG000|Overall Study|Withdrawal by Subject|37|||
145248446|NCT04960202|523754474|FG001|Overall Study|Withdrawal by Subject|43|||
145248447|NCT04960202|523754473|FG000|Overall Study|Lost to Follow-up|20|||
145248448|NCT04960202|523754474|FG001|Overall Study|Lost to Follow-up|16|||
145248449|NCT04960202|523754473|FG000|Overall Study|Death|0|||
145248450|NCT04960202|523754474|FG001|Overall Study|Death|15|||
145248451|NCT02158728|523754475|FG000|Overall Study|no procedure according to CIP done|3|||
145248452|NCT02158728|523754475|FG000|Overall Study|no qualified dataset|24|||
145248453|NCT03558828|523754476|FG000|Overall Study|Lost to Follow-up|4|||
145248454|NCT03558828|523754477|FG001|Overall Study|Lost to Follow-up|3|||
145248455|NCT03558828|523754478|FG002|Overall Study|Lost to Follow-up|3|||
145248456|NCT03558828|523754479|FG003|Overall Study|Lost to Follow-up|5|||
145248457|NCT03558828|523754480|FG004|Overall Study|Lost to Follow-up|2|||
145248458|NCT03558828|523754481|FG005|Overall Study|Lost to Follow-up|3|||
145248459|NCT03558828|523754476|FG000|Overall Study|dropped before the intervention|1|||
145248460|NCT03558828|523754477|FG001|Overall Study|dropped before the intervention|1|||
145248461|NCT03558828|523754478|FG002|Overall Study|dropped before the intervention|0|||
145248462|NCT03558828|523754479|FG003|Overall Study|dropped before the intervention|0|||
145248463|NCT03558828|523754480|FG004|Overall Study|dropped before the intervention|0|||
145248464|NCT03558828|523754481|FG005|Overall Study|dropped before the intervention|0|||
145248465|NCT00673816|523754486|FG000|Overall Study|Adverse Event|1|||
145248466|NCT00673816|523754486|FG000|Overall Study|Withdrawal by Subject|1|||
145248467|NCT01804842|523754487|FG000|Overall Study|Adverse Event|1|||
145248468|NCT01804842|523754488|FG001|Overall Study|Adverse Event|1|||
145248469|NCT01804842|523754489|FG002|Overall Study|Adverse Event|0|||
145248470|NCT01804842|523754487|FG000|Overall Study|Lost to Follow-up|1|||
145248471|NCT01804842|523754488|FG001|Overall Study|Lost to Follow-up|0|||
145248472|NCT01804842|523754489|FG002|Overall Study|Lost to Follow-up|0|||
145248473|NCT01804842|523754487|FG000|Overall Study|Non-Compliance|1|||
145248474|NCT01804842|523754488|FG001|Overall Study|Non-Compliance|1|||
145248475|NCT01804842|523754489|FG002|Overall Study|Non-Compliance|0|||
145248476|NCT01804842|523754487|FG000|Overall Study|Personal Reason|0|||
145248477|NCT01804842|523754488|FG001|Overall Study|Personal Reason|0|||
145248478|NCT01804842|523754489|FG002|Overall Study|Personal Reason|1|||
145248479|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
145248480|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
145248481|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
145248482|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
145248483|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
145248484|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
145248485|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
145299310|NCT00184600|523946977|FG001|Overall Study|Protocol Violation|2|||
145566499|NCT01852292|524936136|FG001|Overall Study|Adverse Event|11|||
145566500|NCT01852292|524936135|FG000|Overall Study|Physician Decision|6|||
145566501|NCT01852292|524936136|FG001|Overall Study|Physician Decision|2|||
145248486|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
145248487|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
145248488|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
145248489|NCT03774875|523754490|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
145248490|NCT03774875|523754491|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
145248491|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
145566502|NCT01852292|524936135|FG000|Overall Study|Protocol Violation|2|||
145248492|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
145248493|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
145248494|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
145248495|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
145248496|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
145248497|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
145248498|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
145248499|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
145248500|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
145248501|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
145248502|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
145248503|NCT03774875|523754490|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
145248504|NCT03774875|523754491|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
145248505|NCT02352090|523754492|FG000|Overall Study|general malaise|1|||
145248506|NCT02352090|523754493|FG001|Overall Study|general malaise|0|||
145248507|NCT02352090|523754494|FG002|Overall Study|general malaise|0|||
145248508|NCT02352090|523754492|FG000|Overall Study|non-specified mild side-effects|0|||
145248509|NCT02352090|523754493|FG001|Overall Study|non-specified mild side-effects|0|||
145248510|NCT02352090|523754494|FG002|Overall Study|non-specified mild side-effects|2|||
145248511|NCT05179057|523754495|FG000|Overall Study|Adverse Event|3|||
145248512|NCT05179057|523754496|FG001|Overall Study|Adverse Event|2|||
145248513|NCT05179057|523754495|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
145248514|NCT05179057|523754496|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
145248515|NCT05179057|523754495|FG000|Overall Study|Study terminated|13|||
145248516|NCT05179057|523754496|FG001|Overall Study|Study terminated|7|||
145248517|NCT05179057|523754495|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
145248518|NCT05179057|523754496|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
145248519|NCT05179057|523754495|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
145248520|NCT05179057|523754496|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
145248521|NCT03146403|523754506|FG000|Overall Study|Withdrawal by Subject|0|||
145248522|NCT03146403|523754507|FG001|Overall Study|Withdrawal by Subject|3|||
145248523|NCT03146403|523754506|FG000|Overall Study|Lost to Follow-up|2|||
145248524|NCT03146403|523754507|FG001|Overall Study|Lost to Follow-up|0|||
145248525|NCT02182999|523754509|FG000|Overall Study|Adverse Event|4|||
145248526|NCT02182999|523754510|FG001|Overall Study|Adverse Event|3|||
145248527|NCT02182999|523754509|FG000|Overall Study|Physician Decision|1|||
145248528|NCT02182999|523754510|FG001|Overall Study|Physician Decision|0|||
145248529|NCT02252588|523754511|FG000|Overall Study|Withdrawal by Subject|4|||
145248530|NCT02252588|523754512|FG001|Overall Study|Withdrawal by Subject|0|||
145248531|NCT03039790|523754515|FG000|Overall Study|Lost to Follow-up|2|||
145248532|NCT03039790|523754516|FG001|Overall Study|Lost to Follow-up|0|||
145248533|NCT03039790|523754517|FG002|Overall Study|Lost to Follow-up|1|||
145248534|NCT03039790|523754518|FG003|Overall Study|Lost to Follow-up|1|||
145248535|NCT03039790|523754519|FG004|Overall Study|Lost to Follow-up|0|||
145248536|NCT03039790|523754520|FG005|Overall Study|Lost to Follow-up|1|||
145248537|NCT03039790|523754521|FG006|Overall Study|Lost to Follow-up|1|||
145248538|NCT03039790|523754522|FG007|Overall Study|Lost to Follow-up|1|||
145248539|NCT03039790|523754523|FG008|Overall Study|Lost to Follow-up|0|||
145248540|NCT03039790|523754524|FG009|Overall Study|Lost to Follow-up|1|||
145248541|NCT03039790|523754525|FG010|Overall Study|Lost to Follow-up|1|||
145248542|NCT03039790|523754526|FG011|Overall Study|Lost to Follow-up|0|||
145248543|NCT03039790|523754527|FG012|Overall Study|Lost to Follow-up|1|||
145299311|NCT00184600|523946978|FG002|Overall Study|Protocol Violation|3|||
145299312|NCT00184600|523946976|FG000|Overall Study|Withdrawal by Subject|20|||
145299313|NCT00184600|523946977|FG001|Overall Study|Withdrawal by Subject|28|||
145299314|NCT00184600|523946978|FG002|Overall Study|Withdrawal by Subject|12|||
145299315|NCT00184600|523946976|FG000|Overall Study|Unclassified|4|||
145299316|NCT00184600|523946977|FG001|Overall Study|Unclassified|5|||
145299317|NCT00184600|523946978|FG002|Overall Study|Unclassified|3|||
145299318|NCT00696020|523946981|FG000|Overall Study|Adverse Event|3|||
145299319|NCT00696020|523946982|FG001|Overall Study|Adverse Event|1|||
145410225|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
145248544|NCT03039790|523754528|FG013|Overall Study|Lost to Follow-up|0|||
145299320|NCT00696020|523946983|FG002|Overall Study|Adverse Event|2|||
145248545|NCT03039790|523754529|FG014|Overall Study|Lost to Follow-up|3|||
145248546|NCT03039790|523754530|FG015|Overall Study|Lost to Follow-up|1|||
145248547|NCT03039790|523754531|FG016|Overall Study|Lost to Follow-up|2|||
145248548|NCT03039790|523754532|FG017|Overall Study|Lost to Follow-up|2|||
145248549|NCT03039790|523754533|FG018|Overall Study|Lost to Follow-up|1|||
145248550|NCT03039790|523754534|FG019|Overall Study|Lost to Follow-up|3|||
145299321|NCT00696020|523946984|FG003|Overall Study|Adverse Event|1|||
145410226|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
145620244|NCT03100838|525123723|FG001|Overall Study|Adverse Event|0|||
145248551|NCT03039790|523754515|FG000|Overall Study|Withdrawal of Consent|1|||
145248552|NCT03039790|523754516|FG001|Overall Study|Withdrawal of Consent|0|||
145248553|NCT03039790|523754517|FG002|Overall Study|Withdrawal of Consent|0|||
145248554|NCT03039790|523754518|FG003|Overall Study|Withdrawal of Consent|1|||
145248555|NCT03039790|523754519|FG004|Overall Study|Withdrawal of Consent|0|||
145248556|NCT03039790|523754520|FG005|Overall Study|Withdrawal of Consent|0|||
145248557|NCT03039790|523754521|FG006|Overall Study|Withdrawal of Consent|0|||
145248558|NCT03039790|523754522|FG007|Overall Study|Withdrawal of Consent|0|||
145248559|NCT03039790|523754523|FG008|Overall Study|Withdrawal of Consent|0|||
145248560|NCT03039790|523754524|FG009|Overall Study|Withdrawal of Consent|1|||
145248561|NCT03039790|523754525|FG010|Overall Study|Withdrawal of Consent|0|||
145248562|NCT03039790|523754526|FG011|Overall Study|Withdrawal of Consent|0|||
145248563|NCT03039790|523754527|FG012|Overall Study|Withdrawal of Consent|2|||
145248564|NCT03039790|523754528|FG013|Overall Study|Withdrawal of Consent|0|||
145248565|NCT03039790|523754529|FG014|Overall Study|Withdrawal of Consent|1|||
145248566|NCT03039790|523754530|FG015|Overall Study|Withdrawal of Consent|5|||
145248567|NCT03039790|523754531|FG016|Overall Study|Withdrawal of Consent|3|||
145248568|NCT03039790|523754532|FG017|Overall Study|Withdrawal of Consent|0|||
145248569|NCT03039790|523754533|FG018|Overall Study|Withdrawal of Consent|2|||
145248570|NCT03039790|523754534|FG019|Overall Study|Withdrawal of Consent|5|||
145248571|NCT03039790|523754515|FG000|Overall Study|Death|0|||
145248572|NCT03039790|523754516|FG001|Overall Study|Death|0|||
145248573|NCT03039790|523754517|FG002|Overall Study|Death|0|||
145248574|NCT03039790|523754518|FG003|Overall Study|Death|0|||
145248575|NCT03039790|523754519|FG004|Overall Study|Death|0|||
145248576|NCT03039790|523754520|FG005|Overall Study|Death|0|||
145248577|NCT03039790|523754521|FG006|Overall Study|Death|0|||
145248578|NCT03039790|523754522|FG007|Overall Study|Death|0|||
145248579|NCT03039790|523754523|FG008|Overall Study|Death|0|||
145248580|NCT03039790|523754524|FG009|Overall Study|Death|0|||
145248581|NCT03039790|523754525|FG010|Overall Study|Death|0|||
145248582|NCT03039790|523754526|FG011|Overall Study|Death|0|||
145248583|NCT03039790|523754527|FG012|Overall Study|Death|0|||
145248584|NCT03039790|523754528|FG013|Overall Study|Death|0|||
145248585|NCT03039790|523754529|FG014|Overall Study|Death|0|||
145248586|NCT03039790|523754530|FG015|Overall Study|Death|1|||
145248587|NCT03039790|523754531|FG016|Overall Study|Death|3|||
145248588|NCT03039790|523754532|FG017|Overall Study|Death|0|||
145248589|NCT03039790|523754533|FG018|Overall Study|Death|2|||
145248590|NCT03039790|523754534|FG019|Overall Study|Death|0|||
145248591|NCT03039790|523754515|FG000|Overall Study|Reason, not Specified|1|||
145248592|NCT03039790|523754516|FG001|Overall Study|Reason, not Specified|0|||
145248593|NCT03039790|523754517|FG002|Overall Study|Reason, not Specified|0|||
145248594|NCT03039790|523754518|FG003|Overall Study|Reason, not Specified|0|||
145248595|NCT03039790|523754519|FG004|Overall Study|Reason, not Specified|0|||
145248596|NCT03039790|523754520|FG005|Overall Study|Reason, not Specified|0|||
145248597|NCT03039790|523754521|FG006|Overall Study|Reason, not Specified|0|||
145248598|NCT03039790|523754522|FG007|Overall Study|Reason, not Specified|0|||
145248599|NCT03039790|523754523|FG008|Overall Study|Reason, not Specified|0|||
145248600|NCT03039790|523754524|FG009|Overall Study|Reason, not Specified|0|||
145248601|NCT03039790|523754525|FG010|Overall Study|Reason, not Specified|0|||
145248602|NCT03039790|523754526|FG011|Overall Study|Reason, not Specified|0|||
145248603|NCT03039790|523754527|FG012|Overall Study|Reason, not Specified|0|||
145299322|NCT00696020|523946981|FG000|Overall Study|Lack of Efficacy|1|||
145299323|NCT00696020|523946982|FG001|Overall Study|Lack of Efficacy|0|||
145299324|NCT00696020|523946983|FG002|Overall Study|Lack of Efficacy|0|||
145299325|NCT00696020|523946984|FG003|Overall Study|Lack of Efficacy|0|||
145299326|NCT00696020|523946981|FG000|Overall Study|Protocol Violation|0|||
145299327|NCT00696020|523946982|FG001|Overall Study|Protocol Violation|0|||
145299328|NCT00696020|523946983|FG002|Overall Study|Protocol Violation|0|||
145299329|NCT00696020|523946984|FG003|Overall Study|Protocol Violation|1|||
145299330|NCT00696020|523946981|FG000|Overall Study|Withdrawal by Subject|0|||
145299331|NCT00696020|523946982|FG001|Overall Study|Withdrawal by Subject|1|||
145248604|NCT03039790|523754528|FG013|Overall Study|Reason, not Specified|0|||
145248605|NCT03039790|523754529|FG014|Overall Study|Reason, not Specified|0|||
145299332|NCT00696020|523946983|FG002|Overall Study|Withdrawal by Subject|0|||
145299333|NCT00696020|523946984|FG003|Overall Study|Withdrawal by Subject|1|||
145299334|NCT00696020|523946981|FG000|Overall Study|Other not stated above|0|||
145299335|NCT00696020|523946982|FG001|Overall Study|Other not stated above|0|||
145248606|NCT03039790|523754530|FG015|Overall Study|Reason, not Specified|0|||
145248607|NCT03039790|523754531|FG016|Overall Study|Reason, not Specified|2|||
145248608|NCT03039790|523754532|FG017|Overall Study|Reason, not Specified|0|||
145248609|NCT03039790|523754533|FG018|Overall Study|Reason, not Specified|1|||
145248610|NCT03039790|523754534|FG019|Overall Study|Reason, not Specified|0|||
145248611|NCT00498368|523754544|FG000|Overall Study|Withdrawal by Subject|3|||
145248612|NCT00498368|523754545|FG001|Overall Study|Withdrawal by Subject|2|||
145248613|NCT02266004|523754546|FG000|Overall Study|unrelated adverse event|1|||
145248614|NCT02266004|523754546|FG000|Overall Study|Physician Decision|1|||
145299336|NCT00696020|523946983|FG002|Overall Study|Other not stated above|1|||
145248615|NCT00537771|523754551|FG000|Overall Study|Withdrawal by Subject|6|||
145248616|NCT00537771|523754552|FG001|Overall Study|Withdrawal by Subject|23|||
145248617|NCT00537771|523754551|FG000|Overall Study|Adverse Event|8|||
145248618|NCT00537771|523754552|FG001|Overall Study|Adverse Event|15|||
145248619|NCT00537771|523754551|FG000|Overall Study|Lost to Follow-up|9|||
145410227|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
145248620|NCT00537771|523754552|FG001|Overall Study|Lost to Follow-up|15|||
145248621|NCT00537771|523754551|FG000|Overall Study|Protocol Violation|2|||
145248622|NCT00537771|523754552|FG001|Overall Study|Protocol Violation|6|||
145248623|NCT00537771|523754551|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
145248624|NCT00537771|523754552|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
145248625|NCT02736929|523754556|FG000|Main Study|Lost to Follow-up|7|||
145248626|NCT02736929|523754557|FG001|Main Study|Lost to Follow-up|1|||
145248627|NCT02736929|523754558|FG002|Main Study|Lost to Follow-up|0|||
145248628|NCT02736929|523754556|FG000|Main Study|Withdrawal by Subject|1|||
145248629|NCT02736929|523754557|FG001|Main Study|Withdrawal by Subject|1|||
145248630|NCT02736929|523754558|FG002|Main Study|Withdrawal by Subject|0|||
145248631|NCT02736929|523754556|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
145248632|NCT02736929|523754557|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
145248633|NCT02736929|523754558|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
145248634|NCT02972593|523754561|FG000|Overall Study|Lost to Follow-up|19|||
145248635|NCT02972593|523754562|FG001|Overall Study|Lost to Follow-up|15|||
145248636|NCT02972593|523754561|FG000|Overall Study|Protocol Violation|1|||
145248637|NCT02972593|523754562|FG001|Overall Study|Protocol Violation|0|||
145248638|NCT00693693|523754563|FG000|Overall Study|Lost to Follow-up|1|||
145248639|NCT00693693|523754564|FG001|Overall Study|Lost to Follow-up|1|||
145248640|NCT00693693|523754565|FG002|Overall Study|Lost to Follow-up|2|||
145248641|NCT00285649|523754566|FG000|Overall Study|Lost to Follow-up|6|||
145248642|NCT00285649|523754567|FG001|Overall Study|Lost to Follow-up|4|||
145248643|NCT00285649|523754568|FG002|Overall Study|Lost to Follow-up|4|||
145248644|NCT00285649|523754566|FG000|Overall Study|Withdrawal by Subject|3|||
145248645|NCT00285649|523754567|FG001|Overall Study|Withdrawal by Subject|2|||
145248646|NCT00285649|523754568|FG002|Overall Study|Withdrawal by Subject|2|||
145248647|NCT02465489|523754569|FG000|Overall Study|Adverse Event|5|||
145248648|NCT01764022|523754574|FG000|Overall Study|Death|3|||
145248649|NCT01764022|523754575|FG001|Overall Study|Death|5|||
145410228|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
145410229|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
145410230|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
145410231|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
145410232|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
145566503|NCT01852292|524936136|FG001|Overall Study|Protocol Violation|0|||
145566504|NCT01852292|524936135|FG000|Overall Study|Non-compliance with study treatment|1|||
145566505|NCT01852292|524936136|FG001|Overall Study|Non-compliance with study treatment|0|||
145248650|NCT01764022|523754574|FG000|Overall Study|Withdrawal by Subject|2|||
145248651|NCT01764022|523754575|FG001|Overall Study|Withdrawal by Subject|6|||
145248652|NCT01764022|523754574|FG000|Overall Study|Lack of Efficacy|0|||
145248653|NCT01764022|523754575|FG001|Overall Study|Lack of Efficacy|1|||
145248654|NCT01764022|523754574|FG000|Overall Study|Physician Decision|0|||
145248655|NCT01764022|523754575|FG001|Overall Study|Physician Decision|2|||
145248656|NCT01764022|523754574|FG000|Overall Study|Lost to Follow-up|2|||
145248657|NCT01764022|523754575|FG001|Overall Study|Lost to Follow-up|0|||
145248658|NCT01764022|523754574|FG000|Overall Study|Protocol Violation|1|||
145248659|NCT01764022|523754575|FG001|Overall Study|Protocol Violation|0|||
145248660|NCT02203916|523754576|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145248661|NCT02203916|523754577|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
145248662|NCT02203916|523754578|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
145248663|NCT02203916|523754576|FG000|Overall Study|Major Protocol Deviation|1|||
145248664|NCT02203916|523754577|FG001|Overall Study|Major Protocol Deviation|1|||
145248665|NCT02203916|523754578|FG002|Overall Study|Major Protocol Deviation|0|||
145248666|NCT02203916|523754576|FG000|Overall Study|Lost to Follow-up|0|||
145248667|NCT02203916|523754577|FG001|Overall Study|Lost to Follow-up|1|||
145248668|NCT02203916|523754578|FG002|Overall Study|Lost to Follow-up|0|||
145248669|NCT02203916|523754576|FG000|Overall Study|Voluntary Withdrawal|3|||
145248670|NCT02203916|523754577|FG001|Overall Study|Voluntary Withdrawal|3|||
145248671|NCT02203916|523754578|FG002|Overall Study|Voluntary Withdrawal|8|||
145248672|NCT02203916|523754576|FG000|Overall Study|Lack of Efficacy|3|||
145566506|NCT01852292|524936135|FG000|Overall Study|Study terminated by Sponsor|0|||
145248673|NCT02203916|523754577|FG001|Overall Study|Lack of Efficacy|0|||
145248674|NCT02203916|523754578|FG002|Overall Study|Lack of Efficacy|0|||
145248675|NCT02203916|523754576|FG000|Overall Study|Reason Not Specified|0|||
145248676|NCT02203916|523754577|FG001|Overall Study|Reason Not Specified|2|||
145248677|NCT02203916|523754578|FG002|Overall Study|Reason Not Specified|1|||
145248678|NCT04247828|523754582|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
145248679|NCT03215667|523754584|FG000|Overall Study|Physician Decision|4|||
145248680|NCT03934203|523754585|FG000|Overall Study|Adverse Event|0|||
145248681|NCT03934203|523754586|FG001|Overall Study|Adverse Event|0|||
145299337|NCT00696020|523946984|FG003|Overall Study|Other not stated above|1|||
145299338|NCT00624065|523946985|FG000|Overall Study|Adverse Event|5|||
145299339|NCT00624065|523946986|FG001|Overall Study|Adverse Event|6|||
145299340|NCT00624065|523946985|FG000|Overall Study|Lost to Follow-up|4|||
145299341|NCT00624065|523946986|FG001|Overall Study|Lost to Follow-up|1|||
145299342|NCT00624065|523946985|FG000|Overall Study|Consent withdrawn|6|||
145299343|NCT00624065|523946986|FG001|Overall Study|Consent withdrawn|5|||
145299344|NCT00624065|523946985|FG000|Overall Study|Lack of Efficacy|0|||
145299345|NCT00624065|523946986|FG001|Overall Study|Lack of Efficacy|3|||
145248682|NCT03934203|523754587|FG002|Overall Study|Adverse Event|1|||
145248683|NCT03934203|523754588|FG003|Overall Study|Adverse Event|0|||
145248684|NCT03934203|523754589|FG004|Overall Study|Adverse Event|1|||
145248685|NCT03934203|523754590|FG005|Overall Study|Adverse Event|0|||
145248686|NCT03934203|523754591|FG006|Overall Study|Adverse Event|2|||
145248687|NCT03934203|523754592|FG007|Overall Study|Adverse Event|0|||
145248688|NCT03934203|523754593|FG008|Overall Study|Adverse Event|0|||
145248689|NCT03934203|523754594|FG009|Overall Study|Adverse Event|0|||
145248690|NCT03934203|523754595|FG010|Overall Study|Adverse Event|0|||
145248691|NCT03934203|523754596|FG011|Overall Study|Adverse Event|0|||
145248692|NCT03934203|523754597|FG012|Overall Study|Adverse Event|0|||
145248693|NCT03934203|523754598|FG013|Overall Study|Adverse Event|1|||
145248694|NCT03934203|523754599|FG014|Overall Study|Adverse Event|0|||
145248695|NCT01810380|523754600|FG000|Overall Study|Randomised not treated|2|||
145248696|NCT01810380|523754601|FG001|Overall Study|Randomised not treated|1|||
145248697|NCT01810380|523754602|FG002|Overall Study|Randomised not treated|1|||
145248698|NCT01810380|523754600|FG000|Overall Study|Adverse Event|11|||
145248699|NCT01810380|523754601|FG001|Overall Study|Adverse Event|14|||
145248700|NCT01810380|523754602|FG002|Overall Study|Adverse Event|4|||
145248701|NCT01810380|523754600|FG000|Overall Study|Lack of Efficacy|24|||
145248702|NCT01810380|523754601|FG001|Overall Study|Lack of Efficacy|10|||
145248703|NCT01810380|523754602|FG002|Overall Study|Lack of Efficacy|11|||
145248704|NCT01810380|523754600|FG000|Overall Study|Protocol Violation|1|||
145248705|NCT01810380|523754601|FG001|Overall Study|Protocol Violation|0|||
145248706|NCT01810380|523754602|FG002|Overall Study|Protocol Violation|1|||
145248707|NCT01810380|523754600|FG000|Overall Study|Withdrawal by Subject|6|||
145248708|NCT01810380|523754601|FG001|Overall Study|Withdrawal by Subject|0|||
145248709|NCT01810380|523754602|FG002|Overall Study|Withdrawal by Subject|6|||
145248710|NCT01810380|523754600|FG000|Overall Study|Administrative or other reasons|11|||
145248711|NCT01810380|523754601|FG001|Overall Study|Administrative or other reasons|13|||
145248712|NCT01810380|523754602|FG002|Overall Study|Administrative or other reasons|9|||
145248713|NCT03799627|523754603|FG000|Overall Study|Adverse Event|1|||
145248714|NCT03799627|523754604|FG001|Overall Study|Adverse Event|2|||
145248715|NCT03799627|523754605|FG002|Overall Study|Adverse Event|0|||
145248716|NCT03799627|523754606|FG003|Overall Study|Adverse Event|0|||
145248717|NCT03799627|523754607|FG004|Overall Study|Adverse Event|2|||
145248718|NCT03799627|523754608|FG005|Overall Study|Adverse Event|5|||
145248719|NCT03799627|523754609|FG006|Overall Study|Adverse Event|0|||
145248720|NCT03799627|523754610|FG007|Overall Study|Adverse Event|2|||
145248721|NCT03799627|523754611|FG008|Overall Study|Adverse Event|0|||
145566507|NCT01852292|524936136|FG001|Overall Study|Study terminated by Sponsor|1|||
145566508|NCT01852292|524936135|FG000|Overall Study|Progressive disease|42|||
145566509|NCT01852292|524936136|FG001|Overall Study|Progressive disease|52|||
145566510|NCT04013191|524936139|FG000|Overall Study|Adverse Event|1|||
145566511|NCT04013191|524936140|FG001|Overall Study|Adverse Event|0|||
145566512|NCT03711162|524936147|FG000|Overall Study|Adverse Event|5|||
145566513|NCT03711162|524936148|FG001|Overall Study|Adverse Event|2|||
145566514|NCT03711162|524936149|FG002|Overall Study|Adverse Event|4|||
145566515|NCT03711162|524936147|FG000|Overall Study|Death|11|||
145566516|NCT03711162|524936148|FG001|Overall Study|Death|7|||
145566517|NCT03711162|524936149|FG002|Overall Study|Death|8|||
145620245|NCT03100838|525123724|FG002|Overall Study|Adverse Event|0|||
145248722|NCT03799627|523754603|FG000|Overall Study|Physician Decision|2|||
145248723|NCT03799627|523754604|FG001|Overall Study|Physician Decision|2|||
145248724|NCT03799627|523754605|FG002|Overall Study|Physician Decision|0|||
145248725|NCT03799627|523754606|FG003|Overall Study|Physician Decision|0|||
145248726|NCT03799627|523754607|FG004|Overall Study|Physician Decision|2|||
145248727|NCT03799627|523754608|FG005|Overall Study|Physician Decision|2|||
145248728|NCT03799627|523754609|FG006|Overall Study|Physician Decision|0|||
145248729|NCT03799627|523754610|FG007|Overall Study|Physician Decision|0|||
145248730|NCT03799627|523754611|FG008|Overall Study|Physician Decision|0|||
145248731|NCT03799627|523754603|FG000|Overall Study|Withdrawal by Subject|1|||
145299346|NCT00624065|523946985|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
145299347|NCT00624065|523946986|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
145299348|NCT01387022|523946988|FG000|Overall Study|Death|1|||
145248732|NCT03799627|523754604|FG001|Overall Study|Withdrawal by Subject|1|||
145299349|NCT01387022|523946989|FG001|Overall Study|Death|1|||
145299350|NCT01387022|523946988|FG000|Overall Study|Lost to Follow-up|0|||
145566518|NCT03711162|524936147|FG000|Overall Study|Lost to Follow-up|1|||
145566519|NCT03711162|524936148|FG001|Overall Study|Lost to Follow-up|0|||
145566520|NCT03711162|524936149|FG002|Overall Study|Lost to Follow-up|1|||
145566521|NCT03711162|524936147|FG000|Overall Study|Study Terminated by Sponsor|139|||
145566522|NCT03711162|524936148|FG001|Overall Study|Study Terminated by Sponsor|152|||
145566523|NCT03711162|524936149|FG002|Overall Study|Study Terminated by Sponsor|146|||
145566524|NCT03711162|524936147|FG000|Overall Study|Withdrawal by Subject|17|||
145566525|NCT03711162|524936148|FG001|Overall Study|Withdrawal by Subject|10|||
145566526|NCT03711162|524936149|FG002|Overall Study|Withdrawal by Subject|10|||
145566527|NCT03711162|524936147|FG000|Overall Study|Miscellaneous|1|||
145566528|NCT03711162|524936148|FG001|Overall Study|Miscellaneous|2|||
145566529|NCT03711162|524936149|FG002|Overall Study|Miscellaneous|2|||
145248733|NCT03799627|523754605|FG002|Overall Study|Withdrawal by Subject|0|||
145248734|NCT03799627|523754606|FG003|Overall Study|Withdrawal by Subject|2|||
145248735|NCT03799627|523754607|FG004|Overall Study|Withdrawal by Subject|0|||
145248736|NCT03799627|523754608|FG005|Overall Study|Withdrawal by Subject|3|||
145248737|NCT03799627|523754609|FG006|Overall Study|Withdrawal by Subject|0|||
145248738|NCT03799627|523754610|FG007|Overall Study|Withdrawal by Subject|0|||
145248739|NCT03799627|523754611|FG008|Overall Study|Withdrawal by Subject|0|||
145248740|NCT03799627|523754603|FG000|Overall Study|Lack of Efficacy|0|||
145248741|NCT03799627|523754604|FG001|Overall Study|Lack of Efficacy|0|||
145248742|NCT03799627|523754605|FG002|Overall Study|Lack of Efficacy|0|||
145248743|NCT03799627|523754606|FG003|Overall Study|Lack of Efficacy|1|||
145248744|NCT03799627|523754607|FG004|Overall Study|Lack of Efficacy|0|||
145248745|NCT03799627|523754608|FG005|Overall Study|Lack of Efficacy|0|||
145248746|NCT03799627|523754609|FG006|Overall Study|Lack of Efficacy|0|||
145248747|NCT03799627|523754610|FG007|Overall Study|Lack of Efficacy|0|||
145248748|NCT03799627|523754611|FG008|Overall Study|Lack of Efficacy|0|||
145248749|NCT03799627|523754603|FG000|Overall Study|Lost to Follow-up|0|||
145248750|NCT03799627|523754604|FG001|Overall Study|Lost to Follow-up|0|||
145248751|NCT03799627|523754605|FG002|Overall Study|Lost to Follow-up|0|||
145248752|NCT03799627|523754606|FG003|Overall Study|Lost to Follow-up|0|||
145248753|NCT03799627|523754607|FG004|Overall Study|Lost to Follow-up|0|||
145248754|NCT03799627|523754608|FG005|Overall Study|Lost to Follow-up|0|||
145248755|NCT03799627|523754609|FG006|Overall Study|Lost to Follow-up|1|||
145248756|NCT03799627|523754610|FG007|Overall Study|Lost to Follow-up|0|||
145248757|NCT03799627|523754611|FG008|Overall Study|Lost to Follow-up|1|||
145248758|NCT03799627|523754603|FG000|Overall Study|Death|0|||
145248759|NCT03799627|523754604|FG001|Overall Study|Death|0|||
145248760|NCT03799627|523754605|FG002|Overall Study|Death|0|||
145248761|NCT03799627|523754606|FG003|Overall Study|Death|1|||
145248762|NCT03799627|523754607|FG004|Overall Study|Death|0|||
145248763|NCT03799627|523754608|FG005|Overall Study|Death|0|||
145248764|NCT03799627|523754609|FG006|Overall Study|Death|0|||
145248765|NCT03799627|523754610|FG007|Overall Study|Death|0|||
145248766|NCT03799627|523754611|FG008|Overall Study|Death|0|||
145248767|NCT03799627|523754603|FG000|Overall Study|Study Drug Put on Hold|1|||
145248768|NCT03799627|523754604|FG001|Overall Study|Study Drug Put on Hold|0|||
145248769|NCT03799627|523754605|FG002|Overall Study|Study Drug Put on Hold|0|||
145248770|NCT03799627|523754606|FG003|Overall Study|Study Drug Put on Hold|0|||
145248771|NCT03799627|523754607|FG004|Overall Study|Study Drug Put on Hold|0|||
145248772|NCT03799627|523754608|FG005|Overall Study|Study Drug Put on Hold|0|||
145248773|NCT03799627|523754609|FG006|Overall Study|Study Drug Put on Hold|0|||
145248774|NCT03799627|523754610|FG007|Overall Study|Study Drug Put on Hold|0|||
145248775|NCT03799627|523754611|FG008|Overall Study|Study Drug Put on Hold|0|||
145248776|NCT03799627|523754603|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
145248777|NCT03799627|523754604|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
145248778|NCT03799627|523754605|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
145248779|NCT03799627|523754606|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
145248780|NCT03799627|523754607|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
145248781|NCT03799627|523754608|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
145248782|NCT03799627|523754609|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
145248783|NCT03799627|523754610|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
145248784|NCT03799627|523754611|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
145248785|NCT03799627|523754603|FG000|Overall Study|Kidney Transplantation|1|||
145248786|NCT03799627|523754604|FG001|Overall Study|Kidney Transplantation|0|||
145248787|NCT03799627|523754605|FG002|Overall Study|Kidney Transplantation|0|||
145248788|NCT03799627|523754606|FG003|Overall Study|Kidney Transplantation|1|||
145248789|NCT03799627|523754607|FG004|Overall Study|Kidney Transplantation|1|||
145248790|NCT03799627|523754608|FG005|Overall Study|Kidney Transplantation|0|||
145248791|NCT03799627|523754609|FG006|Overall Study|Kidney Transplantation|0|||
145248792|NCT03799627|523754610|FG007|Overall Study|Kidney Transplantation|0|||
145248793|NCT03799627|523754611|FG008|Overall Study|Kidney Transplantation|0|||
145248794|NCT03799627|523754603|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
145248795|NCT03799627|523754604|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
145248796|NCT03799627|523754605|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
145248797|NCT03799627|523754606|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
145248798|NCT03799627|523754607|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
145566530|NCT03711162|524936147|FG000|Overall Study|Not Treated|1|||
145566531|NCT03711162|524936148|FG001|Overall Study|Not Treated|0|||
145248799|NCT03799627|523754608|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
145248800|NCT03799627|523754609|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
145248801|NCT03799627|523754610|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
145248802|NCT03799627|523754611|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
145248803|NCT03799627|523754603|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248804|NCT03799627|523754604|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
145248805|NCT03799627|523754605|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248806|NCT03799627|523754606|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248807|NCT03799627|523754607|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248808|NCT03799627|523754608|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248809|NCT03799627|523754609|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248810|NCT03799627|523754610|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248811|NCT03799627|523754611|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
145248812|NCT03799627|523754603|FG000|Overall Study|Met Exclusion Criteria|0|||
145248813|NCT03799627|523754604|FG001|Overall Study|Met Exclusion Criteria|0|||
145248814|NCT03799627|523754605|FG002|Overall Study|Met Exclusion Criteria|0|||
145248815|NCT03799627|523754606|FG003|Overall Study|Met Exclusion Criteria|1|||
145248816|NCT03799627|523754607|FG004|Overall Study|Met Exclusion Criteria|0|||
145248817|NCT03799627|523754608|FG005|Overall Study|Met Exclusion Criteria|0|||
145248818|NCT03799627|523754609|FG006|Overall Study|Met Exclusion Criteria|0|||
145248819|NCT03799627|523754610|FG007|Overall Study|Met Exclusion Criteria|0|||
145248820|NCT03799627|523754611|FG008|Overall Study|Met Exclusion Criteria|0|||
145248821|NCT03799627|523754603|FG000|Overall Study|Investigational Product Noncompliance|0|||
145248822|NCT03799627|523754604|FG001|Overall Study|Investigational Product Noncompliance|0|||
145248823|NCT03799627|523754605|FG002|Overall Study|Investigational Product Noncompliance|0|||
145248824|NCT03799627|523754606|FG003|Overall Study|Investigational Product Noncompliance|1|||
145248825|NCT03799627|523754607|FG004|Overall Study|Investigational Product Noncompliance|0|||
145248826|NCT03799627|523754608|FG005|Overall Study|Investigational Product Noncompliance|0|||
145248827|NCT03799627|523754609|FG006|Overall Study|Investigational Product Noncompliance|0|||
145248828|NCT03799627|523754610|FG007|Overall Study|Investigational Product Noncompliance|0|||
145248829|NCT03799627|523754611|FG008|Overall Study|Investigational Product Noncompliance|0|||
145248830|NCT03799627|523754603|FG000|Overall Study|Participant Relocation|0|||
145248831|NCT03799627|523754604|FG001|Overall Study|Participant Relocation|0|||
145248832|NCT03799627|523754605|FG002|Overall Study|Participant Relocation|0|||
145248833|NCT03799627|523754606|FG003|Overall Study|Participant Relocation|1|||
145248834|NCT03799627|523754607|FG004|Overall Study|Participant Relocation|0|||
145248835|NCT03799627|523754608|FG005|Overall Study|Participant Relocation|1|||
145248836|NCT03799627|523754609|FG006|Overall Study|Participant Relocation|0|||
145248837|NCT03799627|523754610|FG007|Overall Study|Participant Relocation|0|||
145248838|NCT03799627|523754611|FG008|Overall Study|Participant Relocation|0|||
145248839|NCT03799627|523754603|FG000|Overall Study|Eurofin Issue|0|||
145248840|NCT03799627|523754604|FG001|Overall Study|Eurofin Issue|0|||
145248841|NCT03799627|523754605|FG002|Overall Study|Eurofin Issue|0|||
145248842|NCT03799627|523754606|FG003|Overall Study|Eurofin Issue|0|||
145248843|NCT03799627|523754607|FG004|Overall Study|Eurofin Issue|1|||
145248844|NCT03799627|523754608|FG005|Overall Study|Eurofin Issue|0|||
145248845|NCT03799627|523754609|FG006|Overall Study|Eurofin Issue|0|||
145248846|NCT03799627|523754610|FG007|Overall Study|Eurofin Issue|0|||
145248847|NCT03799627|523754611|FG008|Overall Study|Eurofin Issue|0|||
145248848|NCT03799627|523754603|FG000|Overall Study|Noncompliance with Site Instructions|0|||
145248849|NCT03799627|523754604|FG001|Overall Study|Noncompliance with Site Instructions|0|||
145248850|NCT03799627|523754605|FG002|Overall Study|Noncompliance with Site Instructions|0|||
145248851|NCT03799627|523754606|FG003|Overall Study|Noncompliance with Site Instructions|0|||
145248852|NCT03799627|523754607|FG004|Overall Study|Noncompliance with Site Instructions|1|||
145248853|NCT03799627|523754608|FG005|Overall Study|Noncompliance with Site Instructions|0|||
145248854|NCT03799627|523754609|FG006|Overall Study|Noncompliance with Site Instructions|0|||
145248855|NCT03799627|523754610|FG007|Overall Study|Noncompliance with Site Instructions|0|||
145248856|NCT03799627|523754611|FG008|Overall Study|Noncompliance with Site Instructions|0|||
145248857|NCT03799627|523754603|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248858|NCT03799627|523754604|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248859|NCT03799627|523754605|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248860|NCT03799627|523754606|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248861|NCT03799627|523754607|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
145248862|NCT03799627|523754608|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248863|NCT03799627|523754609|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248864|NCT03799627|523754610|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248865|NCT03799627|523754611|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
145248866|NCT03799627|523754603|FG000|Overall Study|Changes In Hemoglobin Values|1|||
145248867|NCT03799627|523754604|FG001|Overall Study|Changes In Hemoglobin Values|2|||
145248868|NCT03799627|523754605|FG002|Overall Study|Changes In Hemoglobin Values|1|||
145248869|NCT03799627|523754606|FG003|Overall Study|Changes In Hemoglobin Values|0|||
145248870|NCT03799627|523754607|FG004|Overall Study|Changes In Hemoglobin Values|0|||
145248871|NCT03799627|523754608|FG005|Overall Study|Changes In Hemoglobin Values|2|||
145248872|NCT03799627|523754609|FG006|Overall Study|Changes In Hemoglobin Values|1|||
145248873|NCT03799627|523754610|FG007|Overall Study|Changes In Hemoglobin Values|0|||
145248874|NCT03799627|523754611|FG008|Overall Study|Changes In Hemoglobin Values|1|||
145248875|NCT05104749|523754616|FG000|Overall Study|Lost to Follow-up|2|||
145248876|NCT05104749|523754617|FG001|Overall Study|Lost to Follow-up|3|||
145248877|NCT03964493|523754618|FG000|Overall Study|Withdrawal by Subject|4|||
145248878|NCT03964493|523754619|FG001|Overall Study|Withdrawal by Subject|1|||
145248879|NCT03964493|523754618|FG000|Overall Study|Lost to Follow-up|13|||
145248880|NCT03964493|523754619|FG001|Overall Study|Lost to Follow-up|4|||
145248881|NCT01474889|523754620|FG000|Overall Study|Physician Decision|1|||
145248882|NCT01474889|523754621|FG001|Overall Study|Physician Decision|0|||
145248883|NCT01474889|523754622|FG002|Overall Study|Physician Decision|0|||
145248884|NCT01474889|523754620|FG000|Overall Study|Did not meet inclusion|1|||
145248885|NCT01474889|523754621|FG001|Overall Study|Did not meet inclusion|0|||
145248886|NCT01474889|523754622|FG002|Overall Study|Did not meet inclusion|0|||
145248887|NCT01474889|523754620|FG000|Overall Study|Withdrawal by Subject|0|||
145248888|NCT01474889|523754621|FG001|Overall Study|Withdrawal by Subject|1|||
145248889|NCT01474889|523754622|FG002|Overall Study|Withdrawal by Subject|0|||
145248890|NCT00901394|523754623|FG000|Overall Study|Physician Decision|1|||
145248891|NCT00901394|523754624|FG001|Overall Study|Physician Decision|1|||
145248892|NCT00901394|523754625|FG002|Overall Study|Physician Decision|2|||
145248893|NCT02569398|523754629|FG000|Overall Study|Adverse Event|0|||
145248894|NCT02569398|523754630|FG001|Overall Study|Adverse Event|1|||
145248895|NCT02569398|523754631|FG002|Overall Study|Adverse Event|6|||
145248896|NCT02569398|523754629|FG000|Overall Study|Withdrawal by Subject|43|||
145248897|NCT02569398|523754630|FG001|Overall Study|Withdrawal by Subject|43|||
145248898|NCT02569398|523754631|FG002|Overall Study|Withdrawal by Subject|30|||
145248899|NCT02569398|523754629|FG000|Overall Study|Study terminated by sponsor|130|||
145248900|NCT02569398|523754630|FG001|Overall Study|Study terminated by sponsor|131|||
145248901|NCT02569398|523754631|FG002|Overall Study|Study terminated by sponsor|134|||
145248902|NCT02569398|523754629|FG000|Overall Study|Other|12|||
145248903|NCT02569398|523754630|FG001|Overall Study|Other|14|||
145248904|NCT02569398|523754631|FG002|Overall Study|Other|13|||
145248905|NCT03559192|523754632|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
145248906|NCT03559192|523754633|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
145248907|NCT03559192|523754634|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
145248908|NCT03559192|523754632|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
145248909|NCT03559192|523754633|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
145248910|NCT03559192|523754634|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
145248911|NCT03559192|523754632|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
145248912|NCT03559192|523754633|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
145248913|NCT03559192|523754634|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
145248914|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
145248915|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
145248916|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
145248917|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
145248918|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
145248919|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
145248920|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
145248921|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
145248922|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
145248923|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
145248924|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
145248925|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
145248926|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
145248927|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
145248928|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
145248929|NCT03559192|523754632|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
145248930|NCT03559192|523754633|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
145248931|NCT03559192|523754634|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
145248932|NCT04888507|523756205|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
145248933|NCT00636155|523756206|FG000|Overall Study|Adverse Event|8|||
145248934|NCT00636155|523756206|FG000|Overall Study|Lack of Efficacy|1|||
145248935|NCT00636155|523756206|FG000|Overall Study|Withdrawal by Subject|3|||
145248936|NCT00636155|523756206|FG000|Overall Study|Stem cell transplant|1|||
145248937|NCT00636155|523756206|FG000|Overall Study|Physician Decision|5|||
145248938|NCT00400946|523756207|FG000|Overall Study|Ineligible|0|||
145248939|NCT00400946|523756208|FG001|Overall Study|Ineligible|0|||
145248940|NCT00400946|523756209|FG002|Overall Study|Ineligible|0|||
145248941|NCT00400946|523756210|FG003|Overall Study|Ineligible|5|||
145248942|NCT00400946|523756211|FG004|Overall Study|Ineligible|1|||
145248943|NCT00400946|523756207|FG000|Overall Study|Induction Failure|0|||
145248944|NCT00400946|523756208|FG001|Overall Study|Induction Failure|0|||
145248945|NCT00400946|523756209|FG002|Overall Study|Induction Failure|0|||
145248946|NCT00400946|523756210|FG003|Overall Study|Induction Failure|11|||
145248947|NCT00400946|523756211|FG004|Overall Study|Induction Failure|8|||
145248948|NCT00400946|523756207|FG000|Overall Study|Induction Death|0|||
145248949|NCT00400946|523756208|FG001|Overall Study|Induction Death|0|||
145248950|NCT00400946|523756209|FG002|Overall Study|Induction Death|0|||
145248951|NCT00400946|523756210|FG003|Overall Study|Induction Death|13|||
145248952|NCT00400946|523756211|FG004|Overall Study|Induction Death|3|||
145248953|NCT00400946|523756207|FG000|Overall Study|Lost to Follow-up|1|||
145248954|NCT00400946|523756208|FG001|Overall Study|Lost to Follow-up|1|||
145248955|NCT00400946|523756209|FG002|Overall Study|Lost to Follow-up|0|||
145248956|NCT00400946|523756210|FG003|Overall Study|Lost to Follow-up|0|||
145248957|NCT00400946|523756211|FG004|Overall Study|Lost to Follow-up|1|||
145248958|NCT00400946|523756207|FG000|Overall Study|Remission Death|1|||
145248959|NCT00400946|523756208|FG001|Overall Study|Remission Death|1|||
145248960|NCT00400946|523756209|FG002|Overall Study|Remission Death|0|||
145248961|NCT00400946|523756210|FG003|Overall Study|Remission Death|0|||
145248962|NCT00400946|523756211|FG004|Overall Study|Remission Death|1|||
145248963|NCT00400946|523756207|FG000|Overall Study|Relapse|9|||
145248964|NCT00400946|523756208|FG001|Overall Study|Relapse|2|||
145248965|NCT00400946|523756209|FG002|Overall Study|Relapse|1|||
145248966|NCT00400946|523756210|FG003|Overall Study|Relapse|1|||
145248967|NCT00400946|523756211|FG004|Overall Study|Relapse|5|||
145248968|NCT00400946|523756207|FG000|Overall Study|Transplant in CR1|0|||
145248969|NCT00400946|523756208|FG001|Overall Study|Transplant in CR1|0|||
145248970|NCT00400946|523756209|FG002|Overall Study|Transplant in CR1|0|||
145248971|NCT00400946|523756210|FG003|Overall Study|Transplant in CR1|10|||
145248972|NCT00400946|523756211|FG004|Overall Study|Transplant in CR1|1|||
145248973|NCT00400946|523756207|FG000|Overall Study|Withdrawal by Subject|2|||
145248974|NCT00400946|523756208|FG001|Overall Study|Withdrawal by Subject|5|||
145248975|NCT00400946|523756209|FG002|Overall Study|Withdrawal by Subject|1|||
145248976|NCT00400946|523756210|FG003|Overall Study|Withdrawal by Subject|5|||
145248977|NCT00400946|523756211|FG004|Overall Study|Withdrawal by Subject|8|||
145248978|NCT00400946|523756207|FG000|Overall Study|Clinical|1|||
145248979|NCT00400946|523756208|FG001|Overall Study|Clinical|2|||
145248980|NCT00400946|523756209|FG002|Overall Study|Clinical|0|||
145248981|NCT00400946|523756210|FG003|Overall Study|Clinical|2|||
145248982|NCT00400946|523756211|FG004|Overall Study|Clinical|9|||
145248983|NCT00400946|523756207|FG000|Overall Study|Other|0|||
145248984|NCT00400946|523756208|FG001|Overall Study|Other|0|||
145248985|NCT00400946|523756209|FG002|Overall Study|Other|0|||
145248986|NCT00400946|523756210|FG003|Overall Study|Other|0|||
145248987|NCT00400946|523756211|FG004|Overall Study|Other|1|||
145248988|NCT05643170|523756212|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
145248989|NCT05643170|523756212|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
145248990|NCT02358863|523756213|FG000|Overall Study|Physician Decision|3|||
145248991|NCT01673373|523756219|FG000|Overall Study|Death|2|||
145248992|NCT02632344|523756220|FG000|Overall Study|Adverse Event|3|||
145248993|NCT02632344|523756220|FG000|Overall Study|Lack of Efficacy|3|||
145248994|NCT02632344|523756220|FG000|Overall Study|Withdrawal by Subject|2|||
145299351|NCT01387022|523946989|FG001|Overall Study|Lost to Follow-up|3|||
145299352|NCT02076022|523946990|FG000|Overall Study|Withdrawal by Subject|2|||
145299353|NCT02076022|523946991|FG001|Overall Study|Withdrawal by Subject|0|||
145248995|NCT05426460|523756225|FG000|Overall Study|Protocol Violation|1|||
145248996|NCT05426460|523756226|FG001|Overall Study|Protocol Violation|1|||
145248997|NCT05426460|523756227|FG002|Overall Study|Protocol Violation|1|||
145248998|NCT05426460|523756228|FG003|Overall Study|Protocol Violation|0|||
145248999|NCT02000622|523756229|FG000|Overall Study|Withdrawal by Subject|5|||
145249000|NCT02000622|523756230|FG001|Overall Study|Withdrawal by Subject|7|||
145249001|NCT02000622|523756229|FG000|Overall Study|Lost to Follow-up|4|||
145299354|NCT00312663|523946994|FG000|Immunization Phase|Adverse Event|0|||
145299355|NCT00312663|523946995|FG001|Immunization Phase|Adverse Event|1|||
145299356|NCT00312663|523946996|FG002|Immunization Phase|Adverse Event|0|||
145249002|NCT02000622|523756230|FG001|Overall Study|Lost to Follow-up|0|||
145249003|NCT02000622|523756229|FG000|Overall Study|Death|159|||
145249004|NCT02000622|523756230|FG001|Overall Study|Death|73|||
145249005|NCT02000622|523756229|FG000|Overall Study|Withdrawn due to site closure|1|||
145249006|NCT02000622|523756230|FG001|Overall Study|Withdrawn due to site closure|0|||
145249007|NCT01405027|523756234|FG000|Overall Study|Withdrawn consent|3|||
145299357|NCT00286754|523947000|FG000|Overall Study|Adverse Event|2|||
145299358|NCT00286754|523947001|FG001|Overall Study|Adverse Event|2|||
145249008|NCT01405027|523756235|FG001|Overall Study|Withdrawn consent|0|||
145249009|NCT01405027|523756234|FG000|Overall Study|Lost to Follow-up|16|||
145249010|NCT01405027|523756235|FG001|Overall Study|Lost to Follow-up|24|||
145249011|NCT01405027|523756234|FG000|Overall Study|Investigator judgement|0|||
145249012|NCT01405027|523756235|FG001|Overall Study|Investigator judgement|2|||
145299359|NCT00286754|523947002|FG002|Overall Study|Adverse Event|3|||
145249013|NCT01405027|523756234|FG000|Overall Study|Death|1|||
145249014|NCT01405027|523756235|FG001|Overall Study|Death|0|||
145249015|NCT01405027|523756234|FG000|Overall Study|Other or Unknown|12|||
145249016|NCT01405027|523756235|FG001|Overall Study|Other or Unknown|25|||
145249017|NCT00589602|523756241|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
145249018|NCT03887052|523756242|FG000|Overall Study|Adverse Event|2|||
145249019|NCT03887052|523756242|FG000|Overall Study|Physician Decision|2|||
145249020|NCT03887052|523756242|FG000|Overall Study|Withdrawal by Subject|3|||
145249021|NCT03887052|523756242|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
145249022|NCT03887052|523756242|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
145249023|NCT02365506|523756243|FG000|Overall Study|Investigator's Discretion|0|||
145249024|NCT02365506|523756244|FG001|Overall Study|Investigator's Discretion|0|||
145249025|NCT02365506|523756245|FG002|Overall Study|Investigator's Discretion|1|||
145249026|NCT01266876|523756248|FG000|Overall Study|Adverse Event|0|||
145249027|NCT01266876|523756249|FG001|Overall Study|Adverse Event|0|||
145249028|NCT01266876|523756250|FG002|Overall Study|Adverse Event|0|||
145249029|NCT01266876|523756251|FG003|Overall Study|Adverse Event|1|||
145249030|NCT01266876|523756252|FG004|Overall Study|Adverse Event|0|||
145249031|NCT01058395|523756253|FG000|Overall Study|Death|2|||
145249032|NCT01058395|523756254|FG001|Overall Study|Death|1|||
145249033|NCT01058395|523756253|FG000|Overall Study|Lost to Follow-up|1|||
145249034|NCT01058395|523756254|FG001|Overall Study|Lost to Follow-up|0|||
145249035|NCT04288089|523756255|FG000|Overall Study|Ongoing Treatment|2|||
145249036|NCT04288089|523756256|FG001|Overall Study|Ongoing Treatment|1|||
145249037|NCT04288089|523756257|FG002|Overall Study|Ongoing Treatment|1|||
145249038|NCT04288089|523756258|FG003|Overall Study|Ongoing Treatment|4|||
145249039|NCT00976963|523756259|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
145249040|NCT00976963|523756260|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
145249041|NCT00976963|523756259|FG000|Overall Study|administrative error|1|||
145249042|NCT00976963|523756260|FG001|Overall Study|administrative error|0|||
145249043|NCT00976963|523756259|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
145249044|NCT00976963|523756260|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
145249045|NCT02768103|523756263|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
145249046|NCT00557323|523756264|FG000|Overall Study|Death|3|||
145249047|NCT00557323|523756264|FG000|Overall Study|Withdrawal by Subject|2|||
145249048|NCT00557323|523756264|FG000|Overall Study|Administrative change|2|||
145249049|NCT02148952|523756265|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
145249050|NCT02148952|523756266|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
145249051|NCT02148952|523756265|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
145249052|NCT02148952|523756266|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
145299360|NCT00286754|523947000|FG000|Overall Study|Withdrawal by Subject|6|||
145299361|NCT00286754|523947001|FG001|Overall Study|Withdrawal by Subject|2|||
145299362|NCT00286754|523947002|FG002|Overall Study|Withdrawal by Subject|0|||
145299363|NCT00286754|523947000|FG000|Overall Study|Lost to Follow-up|12|||
145299364|NCT00286754|523947001|FG001|Overall Study|Lost to Follow-up|14|||
145299365|NCT00286754|523947002|FG002|Overall Study|Lost to Follow-up|6|||
145299366|NCT00286754|523947000|FG000|Overall Study|Moved out of state|0|||
145299367|NCT00286754|523947001|FG001|Overall Study|Moved out of state|0|||
145299368|NCT00286754|523947002|FG002|Overall Study|Moved out of state|1|||
145299369|NCT02661295|523947003|FG000|Overall Study|Death|1|||
145299370|NCT02661295|523947003|FG000|Overall Study|Transferred Out|1|||
145299371|NCT02661295|523947003|FG000|Overall Study|Kidney Transplant|1|||
145299372|NCT02661295|523947003|FG000|Overall Study|Withdrawn due to side effects|8|||
145299373|NCT02661295|523947003|FG000|Overall Study|Withdrawn due to access type|1|||
145299374|NCT02661295|523947003|FG000|Overall Study|Withdrawn due to allergies|1|||
145299375|NCT02661295|523947003|FG000|Overall Study|Withdrawn due to non-compliance|1|||
145299376|NCT02661295|523947003|FG000|Overall Study|Withdrawal by Subject|3|||
145299377|NCT02661295|523947003|FG000|Overall Study|Failed screening|2|||
145299378|NCT02336165|523947004|FG000|Overall Study|Death|3|||
145299379|NCT02336165|523947005|FG001|Overall Study|Death|0|||
145299380|NCT02336165|523947006|FG002|Overall Study|Death|0|||
145249053|NCT02148952|523756265|FG000|Follow-Up|Lost to Follow-up|219|||
145249054|NCT02148952|523756266|FG001|Follow-Up|Lost to Follow-up|231|||
145249055|NCT02148952|523756265|FG000|Follow-Up|Withdrawal by Subject|46|||
145299381|NCT02336165|523947007|FG003|Overall Study|Death|0|||
145249056|NCT02148952|523756266|FG001|Follow-Up|Withdrawal by Subject|48|||
145249057|NCT03748420|523756267|FG000|Overall Study|No 12 month medication adherence data available|0|||
145249058|NCT03748420|523756268|FG001|Overall Study|No 12 month medication adherence data available|1|||
145299382|NCT02336165|523947008|FG004|Overall Study|Death|1|||
145299383|NCT02336165|523947004|FG000|Overall Study|Physician Decision|2|||
145299384|NCT02336165|523947005|FG001|Overall Study|Physician Decision|2|||
145299385|NCT02336165|523947006|FG002|Overall Study|Physician Decision|1|||
145299386|NCT02336165|523947007|FG003|Overall Study|Physician Decision|1|||
145299387|NCT02336165|523947008|FG004|Overall Study|Physician Decision|0|||
145299388|NCT02336165|523947004|FG000|Overall Study|Withdrawal by Subject|0|||
145249059|NCT03748420|523756267|FG000|Overall Study|Death|24|||
145299389|NCT02336165|523947005|FG001|Overall Study|Withdrawal by Subject|0|||
145299390|NCT02336165|523947006|FG002|Overall Study|Withdrawal by Subject|1|||
145299391|NCT02336165|523947007|FG003|Overall Study|Withdrawal by Subject|0|||
145299392|NCT02336165|523947008|FG004|Overall Study|Withdrawal by Subject|1|||
145299393|NCT02336165|523947004|FG000|Overall Study|Adverse Event|4|||
145299394|NCT02336165|523947005|FG001|Overall Study|Adverse Event|1|||
145299395|NCT02336165|523947006|FG002|Overall Study|Adverse Event|2|||
145299396|NCT02336165|523947007|FG003|Overall Study|Adverse Event|4|||
145299397|NCT02336165|523947008|FG004|Overall Study|Adverse Event|1|||
145299398|NCT02336165|523947004|FG000|Overall Study|Progressive disease|23|||
145299399|NCT02336165|523947005|FG001|Overall Study|Progressive disease|22|||
145299400|NCT02336165|523947006|FG002|Overall Study|Progressive disease|27|||
145299401|NCT02336165|523947007|FG003|Overall Study|Progressive disease|24|||
145299402|NCT02336165|523947008|FG004|Overall Study|Progressive disease|19|||
145299403|NCT02336165|523947004|FG000|Overall Study|Non-compliance|1|||
145299404|NCT02336165|523947005|FG001|Overall Study|Non-compliance|0|||
145299405|NCT02336165|523947006|FG002|Overall Study|Non-compliance|0|||
145299406|NCT02336165|523947007|FG003|Overall Study|Non-compliance|1|||
145299407|NCT02336165|523947008|FG004|Overall Study|Non-compliance|0|||
145299408|NCT02336165|523947004|FG000|Overall Study|Other|1|||
145299409|NCT02336165|523947005|FG001|Overall Study|Other|0|||
145299410|NCT02336165|523947006|FG002|Overall Study|Other|0|||
145299411|NCT02336165|523947007|FG003|Overall Study|Other|1|||
145299412|NCT02336165|523947008|FG004|Overall Study|Other|0|||
145299413|NCT04185909|523947013|FG000|Overall Study|Lost to Follow-up|1|||
145299414|NCT00857623|523947014|FG000|Overall Study|Adverse Event|5|||
145299415|NCT00857623|523947015|FG001|Overall Study|Adverse Event|2|||
145299416|NCT00857623|523947014|FG000|Overall Study|Study-specific discontinuation criteria|5|||
145299417|NCT00857623|523947015|FG001|Overall Study|Study-specific discontinuation criteria|3|||
145299418|NCT00857623|523947014|FG000|Overall Study|Withdrawal by Subject|2|||
145299419|NCT00857623|523947015|FG001|Overall Study|Withdrawal by Subject|1|||
145299420|NCT00857623|523947014|FG000|Overall Study|Lack of Efficacy|1|||
145299421|NCT00857623|523947015|FG001|Overall Study|Lack of Efficacy|1|||
145299422|NCT00857623|523947014|FG000|Overall Study|Severe non-compliance to protocol|1|||
145299423|NCT00857623|523947015|FG001|Overall Study|Severe non-compliance to protocol|1|||
145249060|NCT03748420|523756268|FG001|Overall Study|Death|28|||
145249061|NCT03748420|523756267|FG000|Overall Study|Lost to Follow-up|231|||
145249062|NCT03748420|523756268|FG001|Overall Study|Lost to Follow-up|230|||
145249063|NCT04007367|523756269|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
145249064|NCT04007367|523756270|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
145249065|NCT04007367|523756271|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
145249066|NCT04007367|523756269|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
145249067|NCT04007367|523756270|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
145249068|NCT04007367|523756271|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
145249069|NCT04007367|523756269|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
145249070|NCT04007367|523756270|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
145249071|NCT04007367|523756271|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
145249072|NCT04007367|523756269|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
145249073|NCT04007367|523756270|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
145249074|NCT04007367|523756271|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
145249075|NCT04007367|523756269|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
145249076|NCT04007367|523756270|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
145299424|NCT00857623|523947014|FG000|Overall Study|Intake of prohibited medication|0|||
145299425|NCT00857623|523947015|FG001|Overall Study|Intake of prohibited medication|1|||
145299426|NCT00857623|523947014|FG000|Overall Study|Positive for HEP C|0|||
145299427|NCT00857623|523947015|FG001|Overall Study|Positive for HEP C|1|||
145299428|NCT04510285|523947018|FG000|Overall Study|Death|1|||
145299429|NCT00626548|523947019|FG000|Overall Study|Adverse Event|164|||
145299430|NCT00626548|523947020|FG001|Overall Study|Adverse Event|44|||
145249077|NCT04007367|523756271|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
145249078|NCT00372489|523756276|FG000|Overall Study|Adverse Event|18|||
145299431|NCT00626548|523947019|FG000|Overall Study|Withdrawal by Subject|42|||
145299432|NCT00626548|523947020|FG001|Overall Study|Withdrawal by Subject|46|||
145299433|NCT00626548|523947019|FG000|Overall Study|Protocol Violation|4|||
145299434|NCT00626548|523947020|FG001|Overall Study|Protocol Violation|11|||
145299435|NCT00626548|523947019|FG000|Overall Study|Lost to Follow-up|2|||
145299436|NCT00626548|523947020|FG001|Overall Study|Lost to Follow-up|2|||
145249079|NCT00372489|523756276|FG000|Overall Study|Lack of Efficacy|1|||
145299437|NCT00626548|523947019|FG000|Overall Study|Other termination reason|493|||
145249080|NCT00372489|523756276|FG000|Overall Study|Lost to Follow-up|3|||
145299438|NCT00626548|523947020|FG001|Overall Study|Other termination reason|613|||
145299439|NCT05376319|523948729|FG000|Overall Study|Funding termination|2|||
145299440|NCT05376319|523948730|FG001|Overall Study|Funding termination|4|||
145299441|NCT01340495|523948735|FG000|Overall Study|Withdrawal by Subject|1|||
145299442|NCT00070291|523948736|FG000|Step 1|Withdrawal by Subject|1|||
145299443|NCT00070291|523948736|FG000|Step 1|Adverse Event|1|||
145249081|NCT00372489|523756276|FG000|Overall Study|Physician Decision|3|||
145249082|NCT00372489|523756276|FG000|Overall Study|Withdrawal by Subject|5|||
145249083|NCT00372489|523756276|FG000|Overall Study|Patient Relocation|2|||
145249084|NCT00372489|523756276|FG000|Overall Study|Renal transplant|6|||
145249085|NCT00372489|523756276|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
145249086|NCT04476108|523756277|FG000|Overall Study|Adverse Event|4|||
145249087|NCT04476108|523756278|FG001|Overall Study|Adverse Event|1|||
145249088|NCT04476108|523756277|FG000|Overall Study|Lost to Follow-up|1|||
145249089|NCT04476108|523756278|FG001|Overall Study|Lost to Follow-up|0|||
145249090|NCT04476108|523756277|FG000|Overall Study|Inadvertent Enrollment|1|||
145249091|NCT04476108|523756278|FG001|Overall Study|Inadvertent Enrollment|0|||
145249092|NCT04476108|523756277|FG000|Overall Study|Protocol Violation|1|||
145249093|NCT04476108|523756278|FG001|Overall Study|Protocol Violation|1|||
145249094|NCT04476108|523756277|FG000|Overall Study|Withdrawal by Subject|1|||
145249095|NCT04476108|523756278|FG001|Overall Study|Withdrawal by Subject|1|||
145249096|NCT04259346|523756279|FG000|Overall Study|Lost to Follow-up|1|||
145249097|NCT04259346|523756280|FG001|Overall Study|Lost to Follow-up|3|||
145249098|NCT04259346|523756279|FG000|Overall Study|Protocol Violation|1|||
145249099|NCT04259346|523756280|FG001|Overall Study|Protocol Violation|0|||
145249100|NCT04259346|523756279|FG000|Overall Study|Withdrawal by Subject|1|||
145249101|NCT04259346|523756280|FG001|Overall Study|Withdrawal by Subject|0|||
145249102|NCT04259346|523756279|FG000|Overall Study|Adverse Event|1|||
145249103|NCT04259346|523756280|FG001|Overall Study|Adverse Event|1|||
145249104|NCT00085644|523756281|FG000|Double-Blind Period|Adverse Event|5|||
145249105|NCT00085644|523756282|FG001|Double-Blind Period|Adverse Event|2|||
145249106|NCT00085644|523756283|FG002|Double-Blind Period|Adverse Event|0|||
145249107|NCT00085644|523756281|FG000|Double-Blind Period|Withdrawal by Subject|3|||
145249108|NCT00085644|523756282|FG001|Double-Blind Period|Withdrawal by Subject|0|||
145249109|NCT00085644|523756283|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145249110|NCT00085644|523756281|FG000|Double-Blind Period|Lost to Follow-up|2|||
145249111|NCT00085644|523756282|FG001|Double-Blind Period|Lost to Follow-up|1|||
145249112|NCT00085644|523756283|FG002|Double-Blind Period|Lost to Follow-up|0|||
145249113|NCT00085644|523756281|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
145249114|NCT00085644|523756282|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
145249115|NCT00085644|523756283|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
145249116|NCT00085644|523756281|FG000|Double-Blind Period|Contemplating pregnancy|1|||
145249117|NCT00085644|523756282|FG001|Double-Blind Period|Contemplating pregnancy|0|||
145249118|NCT00085644|523756283|FG002|Double-Blind Period|Contemplating pregnancy|0|||
145249119|NCT00085644|523756281|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
145249120|NCT00085644|523756282|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
145249121|NCT00085644|523756283|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
145249122|NCT00085644|523756281|FG000|Open-Label Period|Adverse Event|0|||
145249123|NCT00085644|523756282|FG001|Open-Label Period|Adverse Event|0|||
145249124|NCT00085644|523756283|FG002|Open-Label Period|Adverse Event|38|||
145249125|NCT00085644|523756281|FG000|Open-Label Period|Withdrawal by Subject|0|||
145249126|NCT00085644|523756282|FG001|Open-Label Period|Withdrawal by Subject|0|||
145249127|NCT00085644|523756283|FG002|Open-Label Period|Withdrawal by Subject|29|||
145249128|NCT00085644|523756281|FG000|Open-Label Period|Lost to Follow-up|0|||
145249129|NCT00085644|523756282|FG001|Open-Label Period|Lost to Follow-up|0|||
145249130|NCT00085644|523756283|FG002|Open-Label Period|Lost to Follow-up|13|||
145249131|NCT00085644|523756281|FG000|Open-Label Period|Lack of Efficacy|0|||
145249132|NCT00085644|523756282|FG001|Open-Label Period|Lack of Efficacy|0|||
145249133|NCT00085644|523756283|FG002|Open-Label Period|Lack of Efficacy|15|||
145249134|NCT00085644|523756281|FG000|Open-Label Period|Pregnancy|0|||
145566532|NCT03711162|524936149|FG002|Overall Study|Not Treated|1|||
145249135|NCT00085644|523756282|FG001|Open-Label Period|Pregnancy|0|||
145249136|NCT00085644|523756283|FG002|Open-Label Period|Pregnancy|3|||
145249137|NCT00085644|523756281|FG000|Open-Label Period|Contemplating pregnancy|0|||
145249138|NCT00085644|523756282|FG001|Open-Label Period|Contemplating pregnancy|0|||
145249139|NCT00085644|523756283|FG002|Open-Label Period|Contemplating pregnancy|3|||
145249140|NCT00085644|523756281|FG000|Open-Label Period|Protocol Violation|0|||
145249141|NCT00085644|523756282|FG001|Open-Label Period|Protocol Violation|0|||
145249142|NCT00085644|523756283|FG002|Open-Label Period|Protocol Violation|4|||
145249143|NCT00085644|523756281|FG000|Open-Label Period|Personal reason|0|||
145249144|NCT00085644|523756282|FG001|Open-Label Period|Personal reason|0|||
145249145|NCT00085644|523756283|FG002|Open-Label Period|Personal reason|4|||
145249146|NCT03330106|523756284|FG000|Part A|Withdrawal by Subject|1|||
145566533|NCT03711162|524936147|FG000|Overall Study|Physician Decision|0|||
145566534|NCT03711162|524936148|FG001|Overall Study|Physician Decision|2|||
145249147|NCT03330106|523756285|FG001|Part A|Withdrawal by Subject|1|||
145249148|NCT03330106|523756286|FG002|Part A|Withdrawal by Subject|0|||
145249149|NCT03330106|523756287|FG003|Part A|Withdrawal by Subject|0|||
145249150|NCT03330106|523756284|FG000|Part A|Death|2|||
145249151|NCT03330106|523756285|FG001|Part A|Death|1|||
145249152|NCT03330106|523756286|FG002|Part A|Death|0|||
145249153|NCT03330106|523756287|FG003|Part A|Death|0|||
145566535|NCT03711162|524936149|FG002|Overall Study|Physician Decision|0|||
145566536|NCT03711162|524936147|FG000|Overall Study|Lack of Efficacy|0|||
145249154|NCT03330106|523756284|FG000|Part A|Adverse Event|0|||
145410233|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
145249155|NCT03330106|523756285|FG001|Part A|Adverse Event|1|||
145249156|NCT03330106|523756286|FG002|Part A|Adverse Event|0|||
145249157|NCT03330106|523756287|FG003|Part A|Adverse Event|0|||
145249158|NCT03330106|523756284|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
145249159|NCT03330106|523756285|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
145249160|NCT03330106|523756286|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
145249161|NCT03330106|523756287|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
145249162|NCT03330106|523756284|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
145249163|NCT03330106|523756285|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
145249164|NCT03330106|523756286|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
145249165|NCT03330106|523756287|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
145249166|NCT03330106|523756284|FG000|Part A|Progressive Disease|0|||
145249167|NCT03330106|523756285|FG001|Part A|Progressive Disease|1|||
145249168|NCT03330106|523756286|FG002|Part A|Progressive Disease|0|||
145249169|NCT03330106|523756287|FG003|Part A|Progressive Disease|0|||
145249170|NCT03330106|523756284|FG000|Part B|Lost to Follow-up|0|||
145249171|NCT03330106|523756285|FG001|Part B|Lost to Follow-up|0|||
145249172|NCT03330106|523756286|FG002|Part B|Lost to Follow-up|0|||
145249173|NCT03330106|523756287|FG003|Part B|Lost to Follow-up|1|||
145249174|NCT03330106|523756284|FG000|Part B|Withdrawal by Subject|0|||
145249175|NCT03330106|523756285|FG001|Part B|Withdrawal by Subject|0|||
145249176|NCT03330106|523756286|FG002|Part B|Withdrawal by Subject|4|||
145249177|NCT03330106|523756287|FG003|Part B|Withdrawal by Subject|0|||
145249178|NCT03330106|523756284|FG000|Part B|Death|0|||
145249179|NCT03330106|523756285|FG001|Part B|Death|0|||
145249180|NCT03330106|523756286|FG002|Part B|Death|2|||
145249181|NCT03330106|523756287|FG003|Part B|Death|0|||
145249182|NCT03330106|523756284|FG000|Part B|Clinical Progression|0|||
145249183|NCT03330106|523756285|FG001|Part B|Clinical Progression|0|||
145249184|NCT03330106|523756286|FG002|Part B|Clinical Progression|1|||
145249185|NCT03330106|523756287|FG003|Part B|Clinical Progression|1|||
145249186|NCT03330106|523756284|FG000|Part B|Symptomatic Deterioration|0|||
145249187|NCT03330106|523756285|FG001|Part B|Symptomatic Deterioration|0|||
145249188|NCT03330106|523756286|FG002|Part B|Symptomatic Deterioration|0|||
145249189|NCT03330106|523756287|FG003|Part B|Symptomatic Deterioration|1|||
145249190|NCT03330106|523756284|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
145249191|NCT03330106|523756285|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
145249192|NCT03330106|523756286|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
145249193|NCT03330106|523756287|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
145410234|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
145410235|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
145410236|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
145410237|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
145410238|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
145566537|NCT03711162|524936148|FG001|Overall Study|Lack of Efficacy|0|||
145249194|NCT03330106|523756284|FG000|Part B|Progressive Disease|0|||
145410239|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
145249195|NCT03330106|523756285|FG001|Part B|Progressive Disease|0|||
145249196|NCT03330106|523756286|FG002|Part B|Progressive Disease|11|||
145249197|NCT03330106|523756287|FG003|Part B|Progressive Disease|4|||
145249198|NCT00623766|523756288|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
145249199|NCT00623766|523756289|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
145249200|NCT00623766|523756288|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
145249201|NCT00623766|523756289|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
145249202|NCT00623766|523756288|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
145249203|NCT00623766|523756289|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
145249204|NCT00623766|523756288|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
145410240|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
145249205|NCT00623766|523756289|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
145249206|NCT00623766|523756288|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
145249207|NCT00623766|523756289|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
145249208|NCT00486889|523756290|FG000|Overall Study|Death|3|||
145249209|NCT00486889|523756290|FG000|Overall Study|Non-compliant|2|||
145249210|NCT00486889|523756290|FG000|Overall Study|Withdrawal by Subject|6|||
145249211|NCT00893763|523756291|FG000|Overall Study|extubated|110|||
145249212|NCT00893763|523756292|FG001|Overall Study|extubated|110|||
145410241|NCT01069939|524355158|FG000|Randomised and Included in the Analyses|Removal|1|||
145410242|NCT01069939|524355159|FG001|Randomised and Included in the Analyses|Removal|0|||
145249213|NCT01437267|523756297|FG000|Overall Study|Withdrawal by Subject|0|||
145249214|NCT01437267|523756298|FG001|Overall Study|Withdrawal by Subject|0|||
145249215|NCT01437267|523756299|FG002|Overall Study|Withdrawal by Subject|0|||
145249216|NCT01437267|523756300|FG003|Overall Study|Withdrawal by Subject|1|||
145249217|NCT01437267|523756301|FG004|Overall Study|Withdrawal by Subject|0|||
145249218|NCT01437267|523756302|FG005|Overall Study|Withdrawal by Subject|0|||
145249219|NCT01437267|523756297|FG000|Overall Study|Protocol Violation|0|||
145249220|NCT01437267|523756298|FG001|Overall Study|Protocol Violation|1|||
145249221|NCT01437267|523756299|FG002|Overall Study|Protocol Violation|0|||
145249222|NCT01437267|523756300|FG003|Overall Study|Protocol Violation|0|||
145249223|NCT01437267|523756301|FG004|Overall Study|Protocol Violation|0|||
145249224|NCT01437267|523756302|FG005|Overall Study|Protocol Violation|0|||
145249225|NCT00608842|523756305|FG000|Overall Study|Participant's Request|0|||
145249226|NCT00608842|523756306|FG001|Overall Study|Participant's Request|1|||
145249227|NCT00608842|523756307|FG002|Overall Study|Participant's Request|2|||
145249228|NCT00608842|523756308|FG003|Overall Study|Participant's Request|1|||
145249229|NCT00608842|523756305|FG000|Overall Study|Lost to Follow-up|1|||
145249230|NCT00608842|523756306|FG001|Overall Study|Lost to Follow-up|0|||
145249231|NCT00608842|523756307|FG002|Overall Study|Lost to Follow-up|0|||
145249232|NCT00608842|523756308|FG003|Overall Study|Lost to Follow-up|0|||
145249233|NCT00899678|523756309|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
145249234|NCT00899678|523756310|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
145249235|NCT00899678|523756311|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
145249236|NCT00899678|523756309|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
145249237|NCT00899678|523756310|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
145249238|NCT00899678|523756311|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
145249239|NCT00899678|523756309|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
145249240|NCT00899678|523756310|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
145249241|NCT00899678|523756311|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
145249242|NCT00899678|523756309|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
145249243|NCT00899678|523756310|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
145249244|NCT00899678|523756311|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
145249245|NCT00899678|523756309|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
145249246|NCT00899678|523756310|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
145249247|NCT00899678|523756311|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
145249248|NCT00899678|523756309|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
145249249|NCT00899678|523756310|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
145249250|NCT00899678|523756311|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
145249251|NCT00899678|523756309|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
145249252|NCT00899678|523756310|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
145249253|NCT00899678|523756311|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
145249254|NCT00899678|523756309|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
145249255|NCT00899678|523756310|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
145249256|NCT00899678|523756311|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
145249257|NCT00899678|523756309|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
145249258|NCT00899678|523756310|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
145249259|NCT00899678|523756311|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
145249260|NCT02699125|523756314|FG000|Placebo|Lost to Follow-up|2|||
145249261|NCT02699125|523756315|FG001|Placebo|Lost to Follow-up|0|||
145249262|NCT02699125|523756314|FG000|Placebo|Protocol Violation|1|||
145249263|NCT02699125|523756315|FG001|Placebo|Protocol Violation|0|||
145249264|NCT02699125|523756314|FG000|Placebo|Withdrawal by Subject|0|||
145249265|NCT02699125|523756315|FG001|Placebo|Withdrawal by Subject|4|||
145249266|NCT02699125|523756314|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
145249267|NCT02699125|523756315|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
145249268|NCT04445051|523756322|FG000|Overall Study|Adverse Event|0|||
145249269|NCT04445051|523756323|FG001|Overall Study|Adverse Event|0|||
145249270|NCT04445051|523756324|FG002|Overall Study|Adverse Event|1|||
145249271|NCT04445051|523756325|FG003|Overall Study|Adverse Event|0|||
145249272|NCT04445051|523756326|FG004|Overall Study|Adverse Event|0|||
145249273|NCT04445051|523756327|FG005|Overall Study|Adverse Event|0|||
145249274|NCT02092324|523756331|FG000|Overall Study|Adverse Event|1|||
145249275|NCT02092324|523756331|FG000|Overall Study|Lack of Efficacy|6|||
145249276|NCT02092324|523756331|FG000|Overall Study|Proceed to Transplant|3|||
145249277|NCT02092324|523756331|FG000|Overall Study|Physician Decision|7|||
145299444|NCT00070291|523948736|FG000|Step 2|Adverse Event|1|||
145299445|NCT02262377|523948737|FG000|Overall Study|Lost to Follow-up|5|||
145299446|NCT02262377|523948738|FG001|Overall Study|Lost to Follow-up|6|||
145249278|NCT02092324|523756331|FG000|Overall Study|Misdiagnosis|2|||
145249279|NCT00398138|523756334|FG000|Overall Study|Adverse Event|2|||
145249280|NCT04973085|523756339|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
145249281|NCT04973085|523756340|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
145249282|NCT03924427|523756346|FG000|Overall Study|Adverse Event|4|||
145249283|NCT03924427|523756346|FG000|Overall Study|Lack of Efficacy|1|||
145249284|NCT03924427|523756346|FG000|Overall Study|Withdrawal by Subject|1|||
145249285|NCT01316380|523756351|FG000|Overall Study|Adverse Event|0|||
145249286|NCT01316380|523756352|FG001|Overall Study|Adverse Event|2|||
145249287|NCT01316380|523756353|FG002|Overall Study|Adverse Event|1|||
145249288|NCT01316380|523756351|FG000|Overall Study|Protocol Violation|0|||
145249289|NCT01316380|523756352|FG001|Overall Study|Protocol Violation|0|||
145249290|NCT01316380|523756353|FG002|Overall Study|Protocol Violation|1|||
145249291|NCT01316380|523756351|FG000|Overall Study|Withdrawal by Subject|1|||
145249292|NCT01316380|523756352|FG001|Overall Study|Withdrawal by Subject|2|||
145249293|NCT01316380|523756353|FG002|Overall Study|Withdrawal by Subject|0|||
145249294|NCT01316380|523756351|FG000|Overall Study|Other|0|||
145249295|NCT01316380|523756352|FG001|Overall Study|Other|1|||
145249296|NCT01316380|523756353|FG002|Overall Study|Other|1|||
145249297|NCT01316380|523756351|FG000|Overall Study|Not treated|1|||
145249298|NCT01316380|523756352|FG001|Overall Study|Not treated|0|||
145249299|NCT01316380|523756353|FG002|Overall Study|Not treated|0|||
145249300|NCT00149890|523756357|FG000|Overall Study|Adverse Event|1|||
145249301|NCT00149890|523756358|FG001|Overall Study|Adverse Event|8|||
145249302|NCT00149890|523756357|FG000|Overall Study|Lack of Efficacy|8|||
145249303|NCT00149890|523756358|FG001|Overall Study|Lack of Efficacy|9|||
145249304|NCT00149890|523756357|FG000|Overall Study|Protocol Violation|1|||
145249305|NCT00149890|523756358|FG001|Overall Study|Protocol Violation|0|||
145249306|NCT00149890|523756357|FG000|Overall Study|Lost to Follow-up|1|||
145249307|NCT00149890|523756358|FG001|Overall Study|Lost to Follow-up|0|||
145249308|NCT00149890|523756357|FG000|Overall Study|Graft Loss|2|||
145249309|NCT00149890|523756358|FG001|Overall Study|Graft Loss|1|||
145249310|NCT01387594|523756359|FG000|Overall Study|Withdrawal by Subject|0|||
145249311|NCT01387594|523756360|FG001|Overall Study|Withdrawal by Subject|2|||
145249312|NCT01387594|523756359|FG000|Overall Study|Lost to Follow-up|0|||
145249313|NCT01387594|523756360|FG001|Overall Study|Lost to Follow-up|1|||
145249314|NCT01365091|523756361|FG000|Period 1|Adverse Event|1|||
145249315|NCT01365091|523756362|FG001|Period 1|Adverse Event|0|||
145249316|NCT01365091|523756363|FG002|Period 1|Adverse Event|2|||
145249317|NCT01365091|523756364|FG003|Period 1|Adverse Event|3|||
145249318|NCT01365091|523756361|FG000|Period 1|Positive test result for drugs of abuse|1|||
145249319|NCT01365091|523756362|FG001|Period 1|Positive test result for drugs of abuse|0|||
145249320|NCT01365091|523756363|FG002|Period 1|Positive test result for drugs of abuse|0|||
145249321|NCT01365091|523756364|FG003|Period 1|Positive test result for drugs of abuse|0|||
145249322|NCT01365091|523756361|FG000|Period 1|No longer met study criteria|0|||
145249323|NCT01365091|523756362|FG001|Period 1|No longer met study criteria|1|||
145249324|NCT01365091|523756363|FG002|Period 1|No longer met study criteria|0|||
145249325|NCT01365091|523756364|FG003|Period 1|No longer met study criteria|0|||
145249326|NCT01365091|523756361|FG000|Period 1|Withdrawal by Subject|0|||
145249327|NCT01365091|523756362|FG001|Period 1|Withdrawal by Subject|1|||
145249328|NCT01365091|523756363|FG002|Period 1|Withdrawal by Subject|0|||
145249329|NCT01365091|523756364|FG003|Period 1|Withdrawal by Subject|0|||
145249330|NCT01365091|523756361|FG000|Period 1|Personal reasons|0|||
145249331|NCT01365091|523756362|FG001|Period 1|Personal reasons|0|||
145249332|NCT01365091|523756363|FG002|Period 1|Personal reasons|1|||
145249333|NCT01365091|523756364|FG003|Period 1|Personal reasons|0|||
145249334|NCT01365091|523756361|FG000|Period 2|Withdrawal by Subject|1|||
145249335|NCT01365091|523756362|FG001|Period 2|Withdrawal by Subject|0|||
145249336|NCT01365091|523756363|FG002|Period 2|Withdrawal by Subject|0|||
145249337|NCT01365091|523756364|FG003|Period 2|Withdrawal by Subject|0|||
145249338|NCT01365091|523756361|FG000|Period 2|Adverse Event|0|||
145249339|NCT01365091|523756362|FG001|Period 2|Adverse Event|0|||
145249340|NCT01365091|523756363|FG002|Period 2|Adverse Event|1|||
145249341|NCT01365091|523756364|FG003|Period 2|Adverse Event|0|||
145249342|NCT05116683|523756365|FG000|Overall Study|Physician Decision|4|||
145249343|NCT04964557|523756367|FG000|Overall Study|Withdrawal by Subject|3|||
145249344|NCT04964557|523756368|FG001|Overall Study|Withdrawal by Subject|2|||
145249345|NCT04964557|523756367|FG000|Overall Study|Lost to Follow-up|1|||
145249346|NCT04964557|523756368|FG001|Overall Study|Lost to Follow-up|2|||
145249347|NCT04964557|523756367|FG000|Overall Study|Physician Decision|2|||
145249348|NCT04964557|523756368|FG001|Overall Study|Physician Decision|0|||
145249349|NCT04964557|523756367|FG000|Overall Study|Death|3|||
145249350|NCT04964557|523756368|FG001|Overall Study|Death|0|||
145410243|NCT05166876|524355160|FG000|Overall Study|Withdrawal by Subject|1|||
145410244|NCT05166876|524355161|FG001|Overall Study|Withdrawal by Subject|0|||
145249351|NCT04964557|523756367|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
145249352|NCT04964557|523756368|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
145249353|NCT05166603|523756369|FG000|Overall Study|Withdrawal by Subject|68|||
145249354|NCT05166603|523756370|FG001|Overall Study|Withdrawal by Subject|0|||
145249355|NCT04924114|523758548|FG000|Overall Study|Withdrawal by Subject|0|||
145249356|NCT04924114|523758549|FG001|Overall Study|Withdrawal by Subject|2|||
145249357|NCT04924114|523758550|FG002|Overall Study|Withdrawal by Subject|2|||
145249358|NCT04924114|523758551|FG003|Overall Study|Withdrawal by Subject|0|||
145249359|NCT04924114|523758552|FG004|Overall Study|Withdrawal by Subject|2|||
145249360|NCT03671148|523758554|FG000|Overall Study|Adverse Event|3|||
145249361|NCT03671148|523758555|FG001|Overall Study|Adverse Event|2|||
145249362|NCT03671148|523758554|FG000|Overall Study|Withdrawal by Subject|8|||
145249363|NCT03671148|523758555|FG001|Overall Study|Withdrawal by Subject|2|||
145249364|NCT03671148|523758554|FG000|Overall Study|Lost to Follow-up|1|||
145249365|NCT03671148|523758555|FG001|Overall Study|Lost to Follow-up|2|||
145249366|NCT03671148|523758554|FG000|Overall Study|Lack of Efficacy|7|||
145249367|NCT03671148|523758555|FG001|Overall Study|Lack of Efficacy|2|||
145249368|NCT03671148|523758554|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
145249369|NCT03671148|523758555|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
145249370|NCT03671148|523758554|FG000|Overall Study|Other|1|||
145249371|NCT03671148|523758555|FG001|Overall Study|Other|0|||
145249372|NCT03671148|523758554|FG000|Overall Study|Incomplete Randomization Visit|1|||
145249373|NCT03671148|523758555|FG001|Overall Study|Incomplete Randomization Visit|0|||
145249374|NCT03878160|523758559|FG000|Overall Study|Lost to Follow-up|1|||
145249375|NCT03878160|523758560|FG001|Overall Study|Lost to Follow-up|1|||
145249376|NCT03878160|523758561|FG002|Overall Study|Lost to Follow-up|1|||
145249377|NCT03878160|523758559|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
145249378|NCT03878160|523758560|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
145249379|NCT03878160|523758561|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
145249380|NCT00413777|523758567|FG000|Fixed-dose Period|Lost to Follow-up|1|||
145249381|NCT00413777|523758568|FG001|Fixed-dose Period|Lost to Follow-up|1|||
145249382|NCT00413777|523758567|FG000|Fixed-dose Period|Adverse Event|2|||
145249383|NCT00413777|523758568|FG001|Fixed-dose Period|Adverse Event|1|||
145249384|NCT00413777|523758567|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
145249385|NCT00413777|523758568|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
145249386|NCT00413777|523758567|FG000|Fixed-dose Period|Withdrew Consent|0|||
145249387|NCT00413777|523758568|FG001|Fixed-dose Period|Withdrew Consent|1|||
145249388|NCT03287830|523758569|FG000|Overall Study|Withdrawal by Subject|1|||
145249389|NCT03287830|523758570|FG001|Overall Study|Withdrawal by Subject|1|||
145249390|NCT03287830|523758569|FG000|Overall Study|not meeting inclusion criteria|5|||
145249391|NCT03287830|523758570|FG001|Overall Study|not meeting inclusion criteria|12|||
145249392|NCT05505734|523758571|FG000|Overall Study|Withdrawal by Subject|51|||
145249393|NCT05505734|523758572|FG001|Overall Study|Withdrawal by Subject|64|||
145249394|NCT05505734|523758571|FG000|Overall Study|Adverse Event|6|||
145249395|NCT05505734|523758572|FG001|Overall Study|Adverse Event|20|||
145249396|NCT05505734|523758571|FG000|Overall Study|Protocol Violation|8|||
145249397|NCT05505734|523758572|FG001|Overall Study|Protocol Violation|15|||
145249398|NCT05505734|523758571|FG000|Overall Study|Lack of therapeutic response|0|||
145249399|NCT05505734|523758572|FG001|Overall Study|Lack of therapeutic response|1|||
145249400|NCT05505734|523758571|FG000|Overall Study|Lost to Follow-up|247|||
145249401|NCT05505734|523758572|FG001|Overall Study|Lost to Follow-up|237|||
145249402|NCT05505734|523758571|FG000|Overall Study|Physician Decision|22|||
145249403|NCT05505734|523758572|FG001|Overall Study|Physician Decision|13|||
145249404|NCT05505734|523758571|FG000|Overall Study|Death|2|||
145249405|NCT05505734|523758572|FG001|Overall Study|Death|1|||
145249406|NCT05505734|523758571|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145299447|NCT02262377|523948737|FG000|Overall Study|Found ineligible after enrollment|3|||
145299448|NCT02262377|523948738|FG001|Overall Study|Found ineligible after enrollment|0|||
145299449|NCT02262377|523948737|FG000|Overall Study|Withdrawal by Subject|4|||
145299450|NCT02262377|523948738|FG001|Overall Study|Withdrawal by Subject|0|||
145299451|NCT04915755|523948739|FG000|Overall Study|Physician Decision|3|||
145299452|NCT04915755|523948740|FG001|Overall Study|Physician Decision|2|||
145299453|NCT04915755|523948739|FG000|Overall Study|Withdrawal by Subject|1|||
145299454|NCT04915755|523948740|FG001|Overall Study|Withdrawal by Subject|1|||
145299455|NCT04915755|523948739|FG000|Overall Study|Ongoing for PACT|3|||
145299456|NCT04915755|523948740|FG001|Overall Study|Ongoing for PACT|2|||
145299457|NCT04915755|523948739|FG000|Overall Study|Other|7|||
145299458|NCT04915755|523948740|FG001|Overall Study|Other|11|||
145299459|NCT01591785|523948741|FG000|Overall Study|worsening condition|1|||
145299460|NCT01591785|523948742|FG001|Overall Study|worsening condition|2|||
145299461|NCT01591785|523948741|FG000|Overall Study|Protocol Violation|2|||
145299462|NCT01591785|523948742|FG001|Overall Study|Protocol Violation|0|||
145249407|NCT05505734|523758572|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145249408|NCT05505734|523758571|FG000|Overall Study|Pregnancy|1|||
145249409|NCT05505734|523758572|FG001|Overall Study|Pregnancy|0|||
145249410|NCT05505734|523758571|FG000|Overall Study|Other|17|||
145249411|NCT05505734|523758572|FG001|Overall Study|Other|13|||
145299463|NCT01591785|523948741|FG000|Overall Study|Lost to Follow-up|1|||
145299464|NCT01591785|523948742|FG001|Overall Study|Lost to Follow-up|0|||
145299465|NCT00396279|523948744|FG000|Overall Study|Ongoing in study|26|||
145249412|NCT02136134|523758578|FG000|Overall Study|Death|170|||
145249413|NCT02136134|523758579|FG001|Overall Study|Death|148|||
145249414|NCT02136134|523758578|FG000|Overall Study|Withdrawal by Subject|19|||
145249415|NCT02136134|523758579|FG001|Overall Study|Withdrawal by Subject|10|||
145249416|NCT02136134|523758578|FG000|Overall Study|Lost to Follow-up|3|||
145299466|NCT00396279|523948744|FG000|Overall Study|Disease progression|2|||
145299467|NCT00396279|523948744|FG000|Overall Study|Withdrawal by Subject|1|||
145299468|NCT00396279|523948744|FG000|Overall Study|Physician Decision|1|||
145566538|NCT03711162|524936149|FG002|Overall Study|Lack of Efficacy|2|||
145249417|NCT02136134|523758579|FG001|Overall Study|Lost to Follow-up|3|||
145249418|NCT02136134|523758578|FG000|Overall Study|Uspecified|55|||
145249419|NCT02136134|523758579|FG001|Overall Study|Uspecified|90|||
145249420|NCT03070119|523758582|FG000|Overall Study|Adverse Event|0|||
145249421|NCT03070119|523758583|FG001|Overall Study|Adverse Event|0|||
145249422|NCT03070119|523758584|FG002|Overall Study|Adverse Event|1|||
145249423|NCT03070119|523758582|FG000|Overall Study|Lost to Follow-up|0|||
145249424|NCT03070119|523758583|FG001|Overall Study|Lost to Follow-up|1|||
145249425|NCT03070119|523758584|FG002|Overall Study|Lost to Follow-up|0|||
145249426|NCT03070119|523758582|FG000|Overall Study|Consent Withdrawn|6|||
145249427|NCT03070119|523758583|FG001|Overall Study|Consent Withdrawn|5|||
145249428|NCT03070119|523758584|FG002|Overall Study|Consent Withdrawn|3|||
145249429|NCT03070119|523758582|FG000|Overall Study|Investigator Decision|0|||
145249430|NCT03070119|523758583|FG001|Overall Study|Investigator Decision|0|||
145249431|NCT03070119|523758584|FG002|Overall Study|Investigator Decision|1|||
145249432|NCT03070119|523758582|FG000|Overall Study|Death|7|||
145249433|NCT03070119|523758583|FG001|Overall Study|Death|14|||
145249434|NCT03070119|523758584|FG002|Overall Study|Death|5|||
145249435|NCT03070119|523758582|FG000|Overall Study|Disease Progression|5|||
145249436|NCT03070119|523758583|FG001|Overall Study|Disease Progression|7|||
145249437|NCT03070119|523758584|FG002|Overall Study|Disease Progression|7|||
145249438|NCT03070119|523758582|FG000|Overall Study|Reason not Specified|2|||
145249439|NCT03070119|523758583|FG001|Overall Study|Reason not Specified|2|||
145249440|NCT03070119|523758584|FG002|Overall Study|Reason not Specified|1|||
145249441|NCT02974621|523758586|FG000|Overall Study|Didn't receive study treatment|1|||
145249442|NCT02974621|523758587|FG001|Overall Study|Didn't receive study treatment|10|||
145249443|NCT00732472|523758588|FG000|Overall Study|Adverse Event|0|||
145249444|NCT00732472|523758589|FG001|Overall Study|Adverse Event|1|||
145249445|NCT00732472|523758590|FG002|Overall Study|Adverse Event|1|||
145249446|NCT00732472|523758591|FG003|Overall Study|Adverse Event|1|||
145249447|NCT00732472|523758588|FG000|Overall Study|Protocol Violation|0|||
145249448|NCT00732472|523758589|FG001|Overall Study|Protocol Violation|0|||
145249449|NCT00732472|523758590|FG002|Overall Study|Protocol Violation|0|||
145249450|NCT00732472|523758591|FG003|Overall Study|Protocol Violation|1|||
145249451|NCT00732472|523758588|FG000|Overall Study|Withdrawal by Subject|0|||
145249452|NCT00732472|523758589|FG001|Overall Study|Withdrawal by Subject|2|||
145249453|NCT00732472|523758590|FG002|Overall Study|Withdrawal by Subject|0|||
145249454|NCT00732472|523758591|FG003|Overall Study|Withdrawal by Subject|1|||
145249455|NCT02155712|523758593|FG000|Overall Study|Death|12|||
145249456|NCT02155712|523758594|FG001|Overall Study|Death|0|||
145249457|NCT02155712|523758593|FG000|Overall Study|Lost to Follow-up|37|||
145249458|NCT02155712|523758594|FG001|Overall Study|Lost to Follow-up|22|||
145249459|NCT02155712|523758593|FG000|Overall Study|Revision of device|4|||
145249460|NCT02155712|523758594|FG001|Overall Study|Revision of device|3|||
145249461|NCT02155712|523758593|FG000|Overall Study|Withdrawal by Subject|39|||
145249462|NCT02155712|523758594|FG001|Overall Study|Withdrawal by Subject|21|||
145249463|NCT02155712|523758593|FG000|Overall Study|Site termination|77|||
145249464|NCT02155712|523758594|FG001|Overall Study|Site termination|19|||
145249465|NCT02155712|523758593|FG000|Overall Study|Sponsor terminated study early|150|||
145249466|NCT02155712|523758594|FG001|Overall Study|Sponsor terminated study early|0|||
145249467|NCT02155712|523758593|FG000|Overall Study|Missed final 5-year protocol visit|0|||
145249468|NCT02155712|523758594|FG001|Overall Study|Missed final 5-year protocol visit|32|||
145249469|NCT02155712|523758593|FG000|Overall Study|Censored because surgery cancelled|6|||
145249470|NCT02155712|523758594|FG001|Overall Study|Censored because surgery cancelled|10|||
145249471|NCT02155712|523758593|FG000|Overall Study|Censored because study device was not implanted|61|||
145249472|NCT02155712|523758594|FG001|Overall Study|Censored because study device was not implanted|66|||
145249473|NCT02155712|523758593|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
145249474|NCT02155712|523758594|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
145249475|NCT05180721|523758595|FG000|Overall Study|Lost to Follow-up|4|||
145249476|NCT03575351|523758596|FG000|Overall Study|Adverse Event|1|||
145249477|NCT03575351|523758597|FG001|Overall Study|Adverse Event|0|||
145249478|NCT03575351|523758596|FG000|Overall Study|Death|2|||
145249479|NCT03575351|523758597|FG001|Overall Study|Death|2|||
145249480|NCT03575351|523758596|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
145249481|NCT03575351|523758597|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
145249482|NCT03575351|523758596|FG000|Overall Study|Lack of Efficacy|28|||
145249483|NCT03575351|523758597|FG001|Overall Study|Lack of Efficacy|0|||
145249484|NCT03575351|523758596|FG000|Overall Study|Withdrawal by Subject|1|||
145249485|NCT03575351|523758597|FG001|Overall Study|Withdrawal by Subject|1|||
145249486|NCT03575351|523758596|FG000|Overall Study|Physician Decision|3|||
145249487|NCT03575351|523758597|FG001|Overall Study|Physician Decision|0|||
145249488|NCT03575351|523758596|FG000|Overall Study|Disease relapse|15|||
145620246|NCT03100838|525123725|FG003|Overall Study|Adverse Event|0|||
145249489|NCT03575351|523758597|FG001|Overall Study|Disease relapse|6|||
145410245|NCT05166876|524355162|FG002|Overall Study|Withdrawal by Subject|0|||
145249490|NCT03575351|523758596|FG000|Overall Study|Study drug manufacturing failure|0|||
145249491|NCT03575351|523758597|FG001|Overall Study|Study drug manufacturing failure|1|||
145620247|NCT03100838|525123722|FG000|Overall Study|Physician Decision|1|||
145249492|NCT03575351|523758596|FG000|Overall Study|other reasons|5|||
145249493|NCT03575351|523758597|FG001|Overall Study|other reasons|0|||
145249494|NCT01688999|523758598|FG000|Overall Study|Withdrawal by Subject|5|||
145249495|NCT01688999|523758599|FG001|Overall Study|Withdrawal by Subject|1|||
145249496|NCT01688999|523758600|FG002|Overall Study|Withdrawal by Subject|1|||
145249497|NCT01688999|523758598|FG000|Overall Study|Adverse Event|2|||
145249498|NCT01688999|523758599|FG001|Overall Study|Adverse Event|0|||
145249499|NCT01688999|523758600|FG002|Overall Study|Adverse Event|2|||
145249500|NCT01688999|523758598|FG000|Overall Study|Ineligible/Not treated|1|||
145249501|NCT01688999|523758599|FG001|Overall Study|Ineligible/Not treated|0|||
145249502|NCT01688999|523758600|FG002|Overall Study|Ineligible/Not treated|0|||
145249503|NCT01855425|523758619|FG000|Overall Study|Physician Decision|20|||
145249504|NCT01600105|523758623|FG000|Total Participants|Withdrawal by Subject|1|||
145249505|NCT01600105|523758624|FG001|Total Participants|Withdrawal by Subject|0|||
145249506|NCT01600105|523758623|FG000|Total Participants|No images in PACS|10|||
145249507|NCT01600105|523758624|FG001|Total Participants|No images in PACS|0|||
145249508|NCT01600105|523758623|FG000|Total Participants|Insufficient image quality|30|||
145249509|NCT01600105|523758624|FG001|Total Participants|Insufficient image quality|10|||
145249510|NCT01600105|523758623|FG000|Sub Study I|Insufficient image quality|0|||
145249511|NCT01600105|523758624|FG001|Sub Study I|Insufficient image quality|10|||
145249512|NCT01600105|523758623|FG000|Sub Study II|Withdrawal by Subject|1|||
145249513|NCT01600105|523758624|FG001|Sub Study II|Withdrawal by Subject|0|||
145249514|NCT01600105|523758623|FG000|Sub Study II|No images in PACS|1|||
145249515|NCT01600105|523758624|FG001|Sub Study II|No images in PACS|0|||
145249516|NCT01600105|523758623|FG000|Sub Study II|Insufficient image quality|3|||
145249517|NCT01600105|523758624|FG001|Sub Study II|Insufficient image quality|0|||
145249518|NCT01600105|523758623|FG000|Sub Study III|Insufficient image quality|5|||
145249519|NCT01600105|523758624|FG001|Sub Study III|Insufficient image quality|0|||
145249520|NCT01600105|523758623|FG000|Sub Study V|Poor Image Quality|2|||
145249521|NCT01600105|523758624|FG001|Sub Study V|Poor Image Quality|0|||
145249522|NCT01025232|523758625|FG000|Overall Study|Study drug no longer available|3|||
145249523|NCT01025232|523758626|FG001|Overall Study|Study drug no longer available|6|||
145249524|NCT01263444|523758627|FG000|Overall Study|Adverse Event|8|||
145249525|NCT01263444|523758627|FG000|Overall Study|Withdrawal by Subject|1|||
145249526|NCT01263444|523758627|FG000|Overall Study|Protocol Violation|1|||
145249527|NCT01899768|523758629|FG000|Part A|Adverse Event|2|||
145249528|NCT01899768|523758629|FG000|Part A|Withdrawal by Subject|1|||
145249529|NCT01899768|523758629|FG000|Part B|Adverse Event|1|||
145249530|NCT01899768|523758629|FG000|Part B|Withdrawal by Subject|1|||
145249531|NCT04043416|523758630|FG000|Washout|Change in health condition|0|||
145249532|NCT04043416|523758631|FG001|Washout|Change in health condition|1|||
145249533|NCT01196091|523758632|FG000|Overall Study|Adverse Event|22|||
145249534|NCT01196091|523758633|FG001|Overall Study|Adverse Event|27|||
145249535|NCT01196091|523758634|FG002|Overall Study|Adverse Event|26|||
145249536|NCT01196091|523758632|FG000|Overall Study|Death|3|||
145249537|NCT01196091|523758633|FG001|Overall Study|Death|2|||
145249538|NCT01196091|523758634|FG002|Overall Study|Death|2|||
145249539|NCT01196091|523758632|FG000|Overall Study|Entry Criteria Not Met|11|||
145249540|NCT01196091|523758633|FG001|Overall Study|Entry Criteria Not Met|11|||
145249541|NCT01196091|523758634|FG002|Overall Study|Entry Criteria Not Met|10|||
145249542|NCT01196091|523758632|FG000|Overall Study|Lack of Efficacy|15|||
145299469|NCT01882257|523948745|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
145299470|NCT01882257|523948746|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
145299471|NCT01882257|523948747|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
145299472|NCT01882257|523948745|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
145299473|NCT01882257|523948746|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
145299474|NCT01882257|523948747|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
145299475|NCT03351335|523948752|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
145299476|NCT03351335|523948753|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
145299477|NCT03351335|523948754|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
145299478|NCT04605094|523948755|FG000|Overall Study|Adverse Event|2|||
145410246|NCT00658528|524355163|FG000|Overall Study|Adverse Event|5|||
145410247|NCT00658528|524355164|FG001|Overall Study|Adverse Event|7|||
145249543|NCT01196091|523758633|FG001|Overall Study|Lack of Efficacy|12|||
145249544|NCT01196091|523758634|FG002|Overall Study|Lack of Efficacy|17|||
145249545|NCT01196091|523758632|FG000|Overall Study|Lost to Follow-up|5|||
145249546|NCT01196091|523758633|FG001|Overall Study|Lost to Follow-up|5|||
145249547|NCT01196091|523758634|FG002|Overall Study|Lost to Follow-up|6|||
145249548|NCT01196091|523758632|FG000|Overall Study|Parent/Caregiver Decision|0|||
145249549|NCT01196091|523758633|FG001|Overall Study|Parent/Caregiver Decision|0|||
145249550|NCT01196091|523758634|FG002|Overall Study|Parent/Caregiver Decision|1|||
145249551|NCT01196091|523758632|FG000|Overall Study|Withdrawal by Subject|16|||
145249552|NCT01196091|523758633|FG001|Overall Study|Withdrawal by Subject|19|||
145249553|NCT01196091|523758634|FG002|Overall Study|Withdrawal by Subject|22|||
145249554|NCT01196091|523758632|FG000|Overall Study|Physician Decision|3|||
145249555|NCT01196091|523758633|FG001|Overall Study|Physician Decision|3|||
145249556|NCT01196091|523758634|FG002|Overall Study|Physician Decision|4|||
145249557|NCT01196091|523758632|FG000|Overall Study|Protocol Violation|1|||
145249558|NCT01196091|523758633|FG001|Overall Study|Protocol Violation|3|||
145249559|NCT01196091|523758634|FG002|Overall Study|Protocol Violation|3|||
145249560|NCT01196091|523758632|FG000|Overall Study|Sponsor Decision|6|||
145249561|NCT01196091|523758633|FG001|Overall Study|Sponsor Decision|5|||
145249562|NCT01196091|523758634|FG002|Overall Study|Sponsor Decision|4|||
145249563|NCT01196091|523758632|FG000|Overall Study|Excluded Site|5|||
145249564|NCT01196091|523758633|FG001|Overall Study|Excluded Site|11|||
145249565|NCT01196091|523758634|FG002|Overall Study|Excluded Site|8|||
145249566|NCT01196091|523758632|FG000|Overall Study|Randomized, No Study Drug Received|1|||
145249567|NCT01196091|523758633|FG001|Overall Study|Randomized, No Study Drug Received|0|||
145249568|NCT01196091|523758634|FG002|Overall Study|Randomized, No Study Drug Received|1|||
145249569|NCT00355615|523758636|FG000|Randomized Double Blind Period|Adverse Event|1|||
145249570|NCT00355615|523758637|FG001|Randomized Double Blind Period|Adverse Event|0|||
145249571|NCT00355615|523758638|FG002|Randomized Double Blind Period|Adverse Event|0|||
145249572|NCT00355615|523758639|FG003|Randomized Double Blind Period|Adverse Event|0|||
145249573|NCT00355615|523758640|FG004|Randomized Double Blind Period|Adverse Event|0|||
145249574|NCT00355615|523758636|FG000|Randomized Double Blind Period|Protocol Violation|0|||
145249575|NCT00355615|523758637|FG001|Randomized Double Blind Period|Protocol Violation|0|||
145249576|NCT00355615|523758638|FG002|Randomized Double Blind Period|Protocol Violation|1|||
145249577|NCT00355615|523758639|FG003|Randomized Double Blind Period|Protocol Violation|1|||
145249578|NCT00355615|523758640|FG004|Randomized Double Blind Period|Protocol Violation|0|||
145249579|NCT00355615|523758636|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
145249580|NCT00355615|523758637|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
145249581|NCT00355615|523758638|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
145249582|NCT00355615|523758639|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
145249583|NCT00355615|523758640|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
145249584|NCT00355615|523758636|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
145249585|NCT00355615|523758637|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
145249586|NCT00355615|523758638|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
145249587|NCT00355615|523758639|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
145249588|NCT00355615|523758640|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
145249589|NCT00355615|523758636|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
145249590|NCT00355615|523758637|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
145249591|NCT00355615|523758638|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
145249592|NCT00355615|523758639|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
145249593|NCT00355615|523758640|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
145249594|NCT00355615|523758636|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
145249595|NCT00355615|523758637|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
145249596|NCT00355615|523758638|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
145249597|NCT00355615|523758639|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
145249598|NCT00355615|523758640|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
145249599|NCT03198728|523758649|FG000|Overall Study|Adverse Event|10|||
145249600|NCT03198728|523758650|FG001|Overall Study|Adverse Event|5|||
145249601|NCT03198728|523758649|FG000|Overall Study|Lost to Follow-up|21|||
145249602|NCT03198728|523758650|FG001|Overall Study|Lost to Follow-up|7|||
145249603|NCT03198728|523758649|FG000|Overall Study|Physician Decision|7|||
145249604|NCT03198728|523758650|FG001|Overall Study|Physician Decision|2|||
145249605|NCT03198728|523758649|FG000|Overall Study|Withdrawal by Subject|14|||
145249606|NCT03198728|523758650|FG001|Overall Study|Withdrawal by Subject|10|||
145249607|NCT03446612|523758651|FG000|Overall Study|Protocol defined stopping criteria|0|||
145249608|NCT03446612|523758652|FG001|Overall Study|Protocol defined stopping criteria|1|||
145249609|NCT00333970|523758653|FG000|Overall Study|Withdrawal by Subject|13|||
145249610|NCT00333970|523758654|FG001|Overall Study|Withdrawal by Subject|7|||
145566539|NCT03711162|524936147|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
145249611|NCT03148795|523758658|FG000|Overall Study|Progressive Disease|1|||
145249612|NCT04228445|523758666|FG000|Overall Study|Lost to Follow-up|1|||
145249613|NCT04228445|523758667|FG001|Overall Study|Lost to Follow-up|1|||
145249614|NCT04228445|523758666|FG000|Overall Study|Physician Decision|1|||
145249615|NCT04228445|523758667|FG001|Overall Study|Physician Decision|2|||
145249616|NCT04228445|523758666|FG000|Overall Study|Withdrawal by Subject|0|||
145249617|NCT04228445|523758667|FG001|Overall Study|Withdrawal by Subject|1|||
145249618|NCT04228445|523758666|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
145249619|NCT04228445|523758667|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
145249620|NCT03418376|523758668|FG000|Overall Study|Musculoskeletal injury|1|||
145249621|NCT03418376|523758669|FG001|Overall Study|Musculoskeletal injury|2|||
145249622|NCT03418376|523758670|FG002|Overall Study|Musculoskeletal injury|1|||
145566540|NCT03711162|524936148|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
145566541|NCT03711162|524936149|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
145249623|NCT03418376|523758671|FG003|Overall Study|Musculoskeletal injury|0|||
145249624|NCT03418376|523758668|FG000|Overall Study|Personal reasons|0|||
145249625|NCT03418376|523758669|FG001|Overall Study|Personal reasons|2|||
145249626|NCT03418376|523758670|FG002|Overall Study|Personal reasons|2|||
145249627|NCT03418376|523758671|FG003|Overall Study|Personal reasons|1|||
145249628|NCT03418376|523758668|FG000|Overall Study|Exacerbation|0|||
145249629|NCT03418376|523758669|FG001|Overall Study|Exacerbation|1|||
145249630|NCT03418376|523758670|FG002|Overall Study|Exacerbation|0|||
145249631|NCT03418376|523758671|FG003|Overall Study|Exacerbation|0|||
145249632|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
145249633|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
145249634|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
145249635|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
145249636|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
145249637|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
145249638|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
145249639|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
145249640|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
145249641|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
145249642|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
145249643|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
145249644|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
145249645|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
145249646|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
145249647|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
145249648|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
145249649|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
145249650|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
145249651|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
145249652|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
145249653|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
145249654|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
145249655|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
145249656|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
145249657|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
145249658|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
145249659|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
145249660|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
145249661|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
145249662|NCT04757376|523758674|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
145249663|NCT04757376|523758675|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
145249664|NCT04757376|523758676|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
145249665|NCT04757376|523758677|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
145249666|NCT04757376|523758678|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
145249667|NCT04757376|523758674|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
145249668|NCT04757376|523758675|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
145249669|NCT04757376|523758676|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
145249670|NCT04757376|523758677|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
145249671|NCT04757376|523758678|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
145249672|NCT01307046|523758679|FG000|Overall Study|Adverse Event|3|||
145249673|NCT01307046|523758680|FG001|Overall Study|Adverse Event|3|||
145249674|NCT01307046|523758679|FG000|Overall Study|Lack of Efficacy|0|||
145249675|NCT01307046|523758680|FG001|Overall Study|Lack of Efficacy|2|||
145249676|NCT01307046|523758679|FG000|Overall Study|Physician Decision|2|||
145249677|NCT01307046|523758680|FG001|Overall Study|Physician Decision|0|||
145249678|NCT01307046|523758679|FG000|Overall Study|Withdrawal by Subject|1|||
145249679|NCT01307046|523758680|FG001|Overall Study|Withdrawal by Subject|1|||
145249680|NCT01307046|523758679|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
145249681|NCT01307046|523758680|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
145249682|NCT01307046|523758679|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
145299479|NCT04605094|523948756|FG001|Overall Study|Adverse Event|2|||
145299480|NCT04605094|523948755|FG000|Overall Study|Lost to Follow-up|1|||
145299481|NCT04605094|523948756|FG001|Overall Study|Lost to Follow-up|4|||
145249683|NCT01307046|523758680|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
145249684|NCT02574520|523758681|FG000|Overall Study|Not dosed|2|||
145249685|NCT02574520|523758682|FG001|Overall Study|Not dosed|0|||
145249686|NCT02574520|523758683|FG002|Overall Study|Not dosed|5|||
145249687|NCT02574520|523758684|FG003|Overall Study|Not dosed|4|||
145249688|NCT02574520|523758681|FG000|Overall Study|Adverse Event|0|||
145249689|NCT02574520|523758682|FG001|Overall Study|Adverse Event|0|||
145249690|NCT02574520|523758683|FG002|Overall Study|Adverse Event|0|||
145249691|NCT02574520|523758684|FG003|Overall Study|Adverse Event|1|||
145249692|NCT02574520|523758681|FG000|Overall Study|Withdrawal by Subject|0|||
145249693|NCT02574520|523758682|FG001|Overall Study|Withdrawal by Subject|0|||
145249694|NCT02574520|523758683|FG002|Overall Study|Withdrawal by Subject|0|||
145249695|NCT02574520|523758684|FG003|Overall Study|Withdrawal by Subject|1|||
145249696|NCT02574520|523758681|FG000|Overall Study|Other|0|||
145249697|NCT02574520|523758682|FG001|Overall Study|Other|0|||
145249698|NCT02574520|523758683|FG002|Overall Study|Other|0|||
145249699|NCT02574520|523758684|FG003|Overall Study|Other|2|||
145249700|NCT03935594|523758696|FG000|Overall Study|Physician Decision|3|||
145249701|NCT01435122|523758697|FG000|Overall Study|Early withdrawal due to toxicity|8|||
145249702|NCT01190020|523758698|FG000|Overall Study|Adverse Event|2|||
145249703|NCT01190020|523758699|FG001|Overall Study|Adverse Event|0|||
145249704|NCT01190020|523758698|FG000|Overall Study|Lost to Follow-up|2|||
145249705|NCT01190020|523758699|FG001|Overall Study|Lost to Follow-up|0|||
145249706|NCT01190020|523758698|FG000|Overall Study|Withdrawal by Subject|3|||
145249707|NCT01190020|523758699|FG001|Overall Study|Withdrawal by Subject|0|||
145249708|NCT00796224|523758700|FG000|Overall Study|Adverse Event|1|||
145249709|NCT00796224|523758701|FG001|Overall Study|Adverse Event|0|||
145249710|NCT00796224|523758700|FG000|Overall Study|Protocol Violation|0|||
145249711|NCT00796224|523758701|FG001|Overall Study|Protocol Violation|1|||
145249712|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
145249713|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
145249714|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
145249715|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
145249716|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
145249717|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
145249718|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145249719|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145249720|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
145249721|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
145249722|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
145249723|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
145249724|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
145249725|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145249726|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145249727|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145249728|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
145249729|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
145249730|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
145249731|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
145249732|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
145249733|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
145249734|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
145249735|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
145249736|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
145249737|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145249738|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
145249739|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145249740|NCT03227224|523758704|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
145249741|NCT03227224|523758705|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
145249742|NCT03227224|523758706|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
145249743|NCT03227224|523758707|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
145299482|NCT04605094|523948755|FG000|Overall Study|Physician Decision|2|||
145299483|NCT04605094|523948756|FG001|Overall Study|Physician Decision|2|||
145249744|NCT03227224|523758704|FG000|Follow-up Phase (2 Weeks)|Other|4|||
145249745|NCT03227224|523758705|FG001|Follow-up Phase (2 Weeks)|Other|4|||
145249746|NCT03227224|523758706|FG002|Follow-up Phase (2 Weeks)|Other|6|||
145249747|NCT03227224|523758707|FG003|Follow-up Phase (2 Weeks)|Other|3|||
145249748|NCT04195750|523758708|FG000|Overall Study|Death|245|||
145249749|NCT04195750|523758709|FG001|Overall Study|Death|253|||
145249750|NCT04195750|523758710|FG002|Overall Study|Death|5|||
145249751|NCT04195750|523758708|FG000|Overall Study|Physician Decision|0|||
145249752|NCT04195750|523758709|FG001|Overall Study|Physician Decision|1|||
145249753|NCT04195750|523758710|FG002|Overall Study|Physician Decision|0|||
145249754|NCT04195750|523758708|FG000|Overall Study|Withdrawal by Subject|9|||
145249755|NCT04195750|523758709|FG001|Overall Study|Withdrawal by Subject|8|||
145249756|NCT04195750|523758710|FG002|Overall Study|Withdrawal by Subject|0|||
145249757|NCT04195750|523758708|FG000|Overall Study|Ongoing|120|||
145249758|NCT04195750|523758709|FG001|Overall Study|Ongoing|110|||
145249759|NCT04195750|523758710|FG002|Overall Study|Ongoing|4|||
145249760|NCT02406027|523758711|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
145249761|NCT02406027|523758712|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
145249762|NCT02406027|523758713|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
145249763|NCT02406027|523758714|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
145249764|NCT02406027|523758715|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
145249765|NCT02406027|523758716|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
145249766|NCT02406027|523758717|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
145249767|NCT02406027|523758711|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
145249768|NCT02406027|523758712|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
145249769|NCT02406027|523758713|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
145249770|NCT02406027|523758714|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
145249771|NCT02406027|523758715|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
145249772|NCT02406027|523758716|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
145249773|NCT02406027|523758717|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
145249774|NCT02406027|523758711|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
145249775|NCT02406027|523758712|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
145249776|NCT02406027|523758713|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
145249777|NCT02406027|523758714|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
145249778|NCT02406027|523758715|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
145249779|NCT02406027|523758716|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
145249780|NCT02406027|523758717|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
145249781|NCT02406027|523758711|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
145249782|NCT02406027|523758712|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
145249783|NCT02406027|523758713|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
145249784|NCT02406027|523758714|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
145249785|NCT02406027|523758715|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
145249786|NCT02406027|523758716|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
145249787|NCT02406027|523758717|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
145249788|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
145249789|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
145249790|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
145249791|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
145249792|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
145249793|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
145249794|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
145249795|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
145249796|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
145249797|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
145249798|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
145249799|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
145249800|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
145249801|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
145249802|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
145249803|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
145249804|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
145249805|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
145249806|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
145249807|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
145249808|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
145249809|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
145249810|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
145249811|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
145249812|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
145249813|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
145249814|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
145249815|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
145249816|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145249817|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145410248|NCT00658528|524355163|FG000|Overall Study|Lost to Follow-up|14|||
145249818|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145249819|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145249820|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145249821|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
145249822|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
145249823|NCT02406027|523758711|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249824|NCT02406027|523758712|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249825|NCT02406027|523758713|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249826|NCT02406027|523758714|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249827|NCT02406027|523758715|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
145249828|NCT02406027|523758716|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249829|NCT02406027|523758717|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
145249830|NCT03782376|523758718|FG000|Overall Study|Lost to Follow-up|2|||
145249831|NCT03782376|523758719|FG001|Overall Study|Lost to Follow-up|2|||
145249832|NCT03782376|523758718|FG000|Overall Study|Withdrawal by Subject|7|||
145249833|NCT03782376|523758719|FG001|Overall Study|Withdrawal by Subject|11|||
145249834|NCT03782376|523758718|FG000|Overall Study|Death|1|||
145249835|NCT03782376|523758719|FG001|Overall Study|Death|0|||
145249836|NCT03782376|523758718|FG000|Overall Study|Other|16|||
145249837|NCT03782376|523758719|FG001|Overall Study|Other|17|||
145249838|NCT03277794|523758722|FG000|Overall Study|Lost to Follow-up|2|||
145249839|NCT03277794|523758723|FG001|Overall Study|Lost to Follow-up|4|||
145249840|NCT03277794|523758722|FG000|Overall Study|Withdrew due to high acuity|1|||
145249841|NCT03277794|523758723|FG001|Overall Study|Withdrew due to high acuity|0|||
145249842|NCT02254304|523758725|FG000|Overall Study|Adverse Event|2|||
145249843|NCT02254304|523758726|FG001|Overall Study|Adverse Event|1|||
145249844|NCT02254304|523758725|FG000|Overall Study|Lost to Follow-up|2|||
145249845|NCT02254304|523758726|FG001|Overall Study|Lost to Follow-up|2|||
145249846|NCT02254304|523758725|FG000|Overall Study|Protocol Violation|1|||
145249847|NCT02254304|523758726|FG001|Overall Study|Protocol Violation|0|||
145249848|NCT02254304|523758725|FG000|Overall Study|Withdrawal by Subject|3|||
145249849|NCT02254304|523758726|FG001|Overall Study|Withdrawal by Subject|0|||
145249850|NCT02254304|523758725|FG000|Overall Study|Injection site pain and Injection fear|1|||
145249851|NCT02254304|523758726|FG001|Overall Study|Injection site pain and Injection fear|0|||
145249852|NCT02254304|523758725|FG000|Overall Study|Personal causes|4|||
145249853|NCT02254304|523758726|FG001|Overall Study|Personal causes|1|||
145249854|NCT02254304|523758725|FG000|Overall Study|Personal decision|1|||
145249855|NCT02254304|523758726|FG001|Overall Study|Personal decision|0|||
145249856|NCT02531633|523760724|FG000|Part A (52 Weeks)|Sponsor request|24|||
145249857|NCT02531633|523760725|FG001|Part A (52 Weeks)|Sponsor request|24|||
145249858|NCT02531633|523760726|FG002|Part A (52 Weeks)|Sponsor request|18|||
145249859|NCT02531633|523760727|FG003|Part A (52 Weeks)|Sponsor request|18|||
145249860|NCT02531633|523760728|FG004|Part A (52 Weeks)|Sponsor request|19|||
145249861|NCT02531633|523760729|FG005|Part A (52 Weeks)|Sponsor request|0|||
145249862|NCT02531633|523760730|FG006|Part A (52 Weeks)|Sponsor request|0|||
145249863|NCT02531633|523760731|FG007|Part A (52 Weeks)|Sponsor request|0|||
145249864|NCT02531633|523760732|FG008|Part A (52 Weeks)|Sponsor request|0|||
145249865|NCT02531633|523760733|FG009|Part A (52 Weeks)|Sponsor request|0|||
145249866|NCT02531633|523760724|FG000|Part A (52 Weeks)|Protocol Violation|1|||
145249867|NCT02531633|523760725|FG001|Part A (52 Weeks)|Protocol Violation|0|||
145249868|NCT02531633|523760726|FG002|Part A (52 Weeks)|Protocol Violation|0|||
145249869|NCT02531633|523760727|FG003|Part A (52 Weeks)|Protocol Violation|0|||
145249870|NCT02531633|523760728|FG004|Part A (52 Weeks)|Protocol Violation|0|||
145249871|NCT02531633|523760729|FG005|Part A (52 Weeks)|Protocol Violation|0|||
145249872|NCT02531633|523760730|FG006|Part A (52 Weeks)|Protocol Violation|0|||
145249873|NCT02531633|523760731|FG007|Part A (52 Weeks)|Protocol Violation|0|||
145299484|NCT04605094|523948755|FG000|Overall Study|Study terminated by Sponsor|31|||
145299485|NCT04605094|523948756|FG001|Overall Study|Study terminated by Sponsor|33|||
145299486|NCT04605094|523948755|FG000|Overall Study|Withdrawal by Subject|22|||
145299487|NCT04605094|523948756|FG001|Overall Study|Withdrawal by Subject|19|||
145299488|NCT04605094|523948755|FG000|Overall Study|Other|1|||
145299489|NCT04605094|523948756|FG001|Overall Study|Other|1|||
145249874|NCT02531633|523760732|FG008|Part A (52 Weeks)|Protocol Violation|0|||
145299490|NCT01900691|523948757|FG000|Overall Study|Death|7|||
145299491|NCT01900691|523948757|FG000|Overall Study|Lost to Follow-up|4|||
145299492|NCT01900691|523948757|FG000|Overall Study|Study Device Not Placed|3|||
145249875|NCT02531633|523760733|FG009|Part A (52 Weeks)|Protocol Violation|0|||
145249876|NCT02531633|523760724|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
145249877|NCT02531633|523760725|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
145249878|NCT02531633|523760726|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
145249879|NCT02531633|523760727|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
145249880|NCT02531633|523760728|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
145249881|NCT02531633|523760729|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
145299493|NCT01900691|523948757|FG000|Overall Study|Non study stent placed|2|||
145410249|NCT00658528|524355164|FG001|Overall Study|Lost to Follow-up|22|||
145410250|NCT00658528|524355163|FG000|Overall Study|Withdrawal by Subject|8|||
145249882|NCT02531633|523760730|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
145249883|NCT02531633|523760731|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
145249884|NCT02531633|523760732|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
145249885|NCT02531633|523760733|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
145249886|NCT02531633|523760724|FG000|Part A (52 Weeks)|Physician Decision|1|||
145249887|NCT02531633|523760725|FG001|Part A (52 Weeks)|Physician Decision|4|||
145249888|NCT02531633|523760726|FG002|Part A (52 Weeks)|Physician Decision|3|||
145249889|NCT02531633|523760727|FG003|Part A (52 Weeks)|Physician Decision|1|||
145249890|NCT02531633|523760728|FG004|Part A (52 Weeks)|Physician Decision|0|||
145249891|NCT02531633|523760729|FG005|Part A (52 Weeks)|Physician Decision|0|||
145249892|NCT02531633|523760730|FG006|Part A (52 Weeks)|Physician Decision|0|||
145249893|NCT02531633|523760731|FG007|Part A (52 Weeks)|Physician Decision|0|||
145249894|NCT02531633|523760732|FG008|Part A (52 Weeks)|Physician Decision|0|||
145249895|NCT02531633|523760733|FG009|Part A (52 Weeks)|Physician Decision|0|||
145249896|NCT02531633|523760724|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
145249897|NCT02531633|523760725|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
145249898|NCT02531633|523760726|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
145249899|NCT02531633|523760727|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
145249900|NCT02531633|523760728|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
145249901|NCT02531633|523760729|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
145249902|NCT02531633|523760730|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
145249903|NCT02531633|523760731|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
145249904|NCT02531633|523760732|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
145249905|NCT02531633|523760733|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
145249906|NCT02531633|523760724|FG000|Part A (52 Weeks)|Other|2|||
145410251|NCT00658528|524355164|FG001|Overall Study|Withdrawal by Subject|6|||
145249907|NCT02531633|523760725|FG001|Part A (52 Weeks)|Other|0|||
145249908|NCT02531633|523760726|FG002|Part A (52 Weeks)|Other|0|||
145249909|NCT02531633|523760727|FG003|Part A (52 Weeks)|Other|0|||
145249910|NCT02531633|523760728|FG004|Part A (52 Weeks)|Other|0|||
145249911|NCT02531633|523760729|FG005|Part A (52 Weeks)|Other|0|||
145249912|NCT02531633|523760730|FG006|Part A (52 Weeks)|Other|0|||
145249913|NCT02531633|523760731|FG007|Part A (52 Weeks)|Other|0|||
145249914|NCT02531633|523760732|FG008|Part A (52 Weeks)|Other|0|||
145249915|NCT02531633|523760733|FG009|Part A (52 Weeks)|Other|0|||
145249916|NCT02531633|523760724|FG000|Part B (104 Weeks)|Sponsor request|0|||
145249917|NCT02531633|523760725|FG001|Part B (104 Weeks)|Sponsor request|0|||
145249918|NCT02531633|523760726|FG002|Part B (104 Weeks)|Sponsor request|0|||
145249919|NCT02531633|523760727|FG003|Part B (104 Weeks)|Sponsor request|0|||
145249920|NCT02531633|523760728|FG004|Part B (104 Weeks)|Sponsor request|0|||
145249921|NCT02531633|523760729|FG005|Part B (104 Weeks)|Sponsor request|8|||
145249922|NCT02531633|523760730|FG006|Part B (104 Weeks)|Sponsor request|5|||
145249923|NCT02531633|523760731|FG007|Part B (104 Weeks)|Sponsor request|3|||
145249924|NCT02531633|523760732|FG008|Part B (104 Weeks)|Sponsor request|5|||
145249925|NCT02531633|523760733|FG009|Part B (104 Weeks)|Sponsor request|4|||
145249926|NCT02531633|523760724|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
145249927|NCT02531633|523760725|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
145249928|NCT02531633|523760726|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
145249929|NCT02531633|523760727|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
145249930|NCT02531633|523760728|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
145249931|NCT02531633|523760729|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
145249932|NCT02531633|523760730|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
145249933|NCT02531633|523760731|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
145249934|NCT02531633|523760732|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
145249935|NCT02531633|523760733|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
145249936|NCT04517253|523760734|FG000|Primary Treatment Period|Adverse Event|1|||
145249937|NCT04517253|523760735|FG001|Primary Treatment Period|Adverse Event|0|||
145249938|NCT04517253|523760736|FG002|Primary Treatment Period|Adverse Event|0|||
145249939|NCT04517253|523760734|FG000|Primary Treatment Period|Death|0|||
145249940|NCT04517253|523760735|FG001|Primary Treatment Period|Death|1|||
145249941|NCT04517253|523760736|FG002|Primary Treatment Period|Death|0|||
145249942|NCT04517253|523760734|FG000|Maintenance Period|Withdrawal by Subject|1|||
145249943|NCT04517253|523760735|FG001|Maintenance Period|Withdrawal by Subject|0|||
145249944|NCT04517253|523760736|FG002|Maintenance Period|Withdrawal by Subject|0|||
145249945|NCT04517253|523760734|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
145249946|NCT04517253|523760735|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
145249947|NCT04517253|523760736|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
145620248|NCT03100838|525123723|FG001|Overall Study|Physician Decision|1|||
145249948|NCT05016037|523760741|FG000|Overall Study|Lost to Follow-up|2|||
145249949|NCT02324049|523760745|FG000|Part C|Study terminated|11|||
145249950|NCT02159365|523760746|FG000|Overall Study|Disease Progression|23|||
145249951|NCT02159365|523760746|FG000|Overall Study|Other reasons|11|||
145249952|NCT02159365|523760746|FG000|Overall Study|Administrative reason by Sponsor|9|||
145249953|NCT02159365|523760746|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
145249954|NCT02159365|523760746|FG000|Overall Study|Study drug toxicity|7|||
145249955|NCT02159365|523760746|FG000|Overall Study|Maximum clinical benefit|3|||
145249956|NCT02159365|523760746|FG000|Overall Study|Subject request to discontinue treatment|3|||
145249957|NCT02159365|523760746|FG000|Overall Study|Subject withdrew consent|3|||
145249958|NCT02159365|523760746|FG000|Overall Study|Death|1|||
145249959|NCT02159365|523760746|FG000|Overall Study|Lost to Follow-up|1|||
145249960|NCT00796549|523760748|FG000|Overall Study|Adverse Event|11|||
145249961|NCT00796549|523760748|FG000|Overall Study|not entered|149|||
145249962|NCT00796549|523760748|FG000|Overall Study|Other|2|||
145249963|NCT00796549|523760748|FG000|Overall Study|Progressive disease|56|||
145249964|NCT04051944|523760752|FG000|Overall Study|Study ending|1|||
145249965|NCT04051944|523760753|FG001|Overall Study|Study ending|1|||
145249966|NCT04051944|523760752|FG000|Overall Study|Early study termination by participant|1|||
145249967|NCT04051944|523760753|FG001|Overall Study|Early study termination by participant|0|||
145249968|NCT04051944|523760752|FG000|Overall Study|Withdrawal by Subject|2|||
145249969|NCT04051944|523760753|FG001|Overall Study|Withdrawal by Subject|2|||
145249970|NCT04051944|523760752|FG000|Overall Study|Lack of Efficacy|3|||
145249971|NCT04051944|523760753|FG001|Overall Study|Lack of Efficacy|0|||
145249972|NCT04051944|523760752|FG000|Overall Study|Adverse event, non- fatal|1|||
145249973|NCT04051944|523760753|FG001|Overall Study|Adverse event, non- fatal|1|||
145249974|NCT03083470|523760754|FG000|Overall Study|Lost to Follow-up|0|||
145249975|NCT03083470|523760755|FG001|Overall Study|Lost to Follow-up|0|||
145249976|NCT03083470|523760756|FG002|Overall Study|Lost to Follow-up|0|||
145249977|NCT03083470|523760757|FG003|Overall Study|Lost to Follow-up|0|||
145249978|NCT03083470|523760758|FG004|Overall Study|Lost to Follow-up|1|||
145249979|NCT03083470|523760754|FG000|Overall Study|Withdrawal by Subject|0|||
145249980|NCT03083470|523760755|FG001|Overall Study|Withdrawal by Subject|0|||
145249981|NCT03083470|523760756|FG002|Overall Study|Withdrawal by Subject|0|||
145249982|NCT03083470|523760757|FG003|Overall Study|Withdrawal by Subject|0|||
145249983|NCT03083470|523760758|FG004|Overall Study|Withdrawal by Subject|1|||
145249984|NCT03077711|523760759|FG000|Overall Study|Lost to Follow-up|2|||
145249985|NCT03077711|523760760|FG001|Overall Study|Lost to Follow-up|2|||
145249986|NCT03077711|523760759|FG000|Overall Study|noncompliant taking medication|2|||
145249987|NCT03077711|523760760|FG001|Overall Study|noncompliant taking medication|0|||
145249988|NCT01526928|523760761|FG000|Overall Study|Progressive Disease|35|||
145249989|NCT01526928|523760762|FG001|Overall Study|Progressive Disease|17|||
145249990|NCT01526928|523760763|FG002|Overall Study|Progressive Disease|150|||
145249991|NCT01526928|523760764|FG003|Overall Study|Progressive Disease|182|||
145249992|NCT01526928|523760765|FG004|Overall Study|Progressive Disease|76|||
145249993|NCT01526928|523760766|FG005|Overall Study|Progressive Disease|4|||
145249994|NCT01526928|523760761|FG000|Overall Study|Adverse Event|2|||
145249995|NCT01526928|523760762|FG001|Overall Study|Adverse Event|1|||
145249996|NCT01526928|523760763|FG002|Overall Study|Adverse Event|29|||
145249997|NCT01526928|523760764|FG003|Overall Study|Adverse Event|40|||
145249998|NCT01526928|523760765|FG004|Overall Study|Adverse Event|13|||
145249999|NCT01526928|523760766|FG005|Overall Study|Adverse Event|2|||
145250000|NCT01526928|523760761|FG000|Overall Study|Death|0|||
145250001|NCT01526928|523760762|FG001|Overall Study|Death|0|||
145250002|NCT01526928|523760763|FG002|Overall Study|Death|3|||
145620249|NCT03100838|525123724|FG002|Overall Study|Physician Decision|1|||
145620250|NCT03100838|525123725|FG003|Overall Study|Physician Decision|1|||
145250003|NCT01526928|523760764|FG003|Overall Study|Death|0|||
145250004|NCT01526928|523760765|FG004|Overall Study|Death|0|||
145250005|NCT01526928|523760766|FG005|Overall Study|Death|0|||
145250006|NCT01526928|523760761|FG000|Overall Study|Withdrawal by Subject|1|||
145250007|NCT01526928|523760762|FG001|Overall Study|Withdrawal by Subject|0|||
145250008|NCT01526928|523760763|FG002|Overall Study|Withdrawal by Subject|13|||
145250009|NCT01526928|523760764|FG003|Overall Study|Withdrawal by Subject|11|||
145250010|NCT01526928|523760765|FG004|Overall Study|Withdrawal by Subject|3|||
145250011|NCT01526928|523760766|FG005|Overall Study|Withdrawal by Subject|0|||
145250012|NCT01526928|523760761|FG000|Overall Study|Physician Decision|0|||
145250013|NCT01526928|523760762|FG001|Overall Study|Physician Decision|0|||
145250014|NCT01526928|523760763|FG002|Overall Study|Physician Decision|2|||
145250015|NCT01526928|523760764|FG003|Overall Study|Physician Decision|5|||
145250016|NCT01526928|523760765|FG004|Overall Study|Physician Decision|0|||
145250017|NCT01526928|523760766|FG005|Overall Study|Physician Decision|0|||
145250018|NCT01526928|523760761|FG000|Overall Study|Other Reason|0|||
145250019|NCT01526928|523760762|FG001|Overall Study|Other Reason|1|||
145250020|NCT01526928|523760763|FG002|Overall Study|Other Reason|11|||
145250021|NCT01526928|523760764|FG003|Overall Study|Other Reason|4|||
145250022|NCT01526928|523760765|FG004|Overall Study|Other Reason|1|||
145250023|NCT01526928|523760766|FG005|Overall Study|Other Reason|0|||
145250024|NCT01526928|523760761|FG000|Overall Study|Lost to Follow-up|0|||
145250025|NCT01526928|523760762|FG001|Overall Study|Lost to Follow-up|0|||
145250026|NCT01526928|523760763|FG002|Overall Study|Lost to Follow-up|0|||
145250027|NCT01526928|523760764|FG003|Overall Study|Lost to Follow-up|1|||
145250028|NCT01526928|523760765|FG004|Overall Study|Lost to Follow-up|0|||
145250029|NCT01526928|523760766|FG005|Overall Study|Lost to Follow-up|0|||
145250030|NCT01526928|523760761|FG000|Overall Study|Protocol Deviation|0|||
145250031|NCT01526928|523760762|FG001|Overall Study|Protocol Deviation|0|||
145250032|NCT01526928|523760763|FG002|Overall Study|Protocol Deviation|0|||
145620251|NCT03100838|525123722|FG000|Overall Study|Pregnancy|0|||
145250033|NCT01526928|523760764|FG003|Overall Study|Protocol Deviation|2|||
145250034|NCT01526928|523760765|FG004|Overall Study|Protocol Deviation|0|||
145250035|NCT01526928|523760766|FG005|Overall Study|Protocol Deviation|0|||
145250036|NCT01526928|523760761|FG000|Overall Study|Missing|0|||
145250037|NCT01526928|523760762|FG001|Overall Study|Missing|0|||
145250038|NCT01526928|523760763|FG002|Overall Study|Missing|1|||
145250039|NCT01526928|523760764|FG003|Overall Study|Missing|0|||
145250040|NCT01526928|523760765|FG004|Overall Study|Missing|2|||
145250041|NCT01526928|523760766|FG005|Overall Study|Missing|0|||
145250042|NCT00736450|523760767|FG000|Overall Study|Not ABC gene eligible|19|||
145250043|NCT00736450|523760767|FG000|Overall Study|Withdrawal by Subject|5|||
145250044|NCT00736450|523760767|FG000|Overall Study|Physician Decision|1|||
145250045|NCT04157751|523760768|FG000|Overall Study|Withdrawal by Subject|12|||
145250046|NCT04157751|523760769|FG001|Overall Study|Withdrawal by Subject|17|||
145250047|NCT04157751|523760768|FG000|Overall Study|Lost to Follow-up|6|||
145250048|NCT04157751|523760769|FG001|Overall Study|Lost to Follow-up|2|||
145250049|NCT04157751|523760768|FG000|Overall Study|Adverse Event|34|||
145250050|NCT04157751|523760769|FG001|Overall Study|Adverse Event|23|||
145250051|NCT04157751|523760768|FG000|Overall Study|Not treated|1|||
145250052|NCT04157751|523760769|FG001|Overall Study|Not treated|5|||
145250053|NCT04157751|523760768|FG000|Overall Study|Other reason not stated above|10|||
145250054|NCT04157751|523760769|FG001|Overall Study|Other reason not stated above|10|||
145250055|NCT01332851|523760772|FG000|Overall Study|Withdrawal by Subject|4|||
145250056|NCT01332851|523760773|FG001|Overall Study|Withdrawal by Subject|2|||
145250057|NCT01332851|523760772|FG000|Overall Study|Lost to Follow-up|7|||
145250058|NCT01332851|523760773|FG001|Overall Study|Lost to Follow-up|11|||
145250059|NCT03299166|523760774|FG000|Overall Study|Adverse Event|9|||
145250060|NCT03299166|523760775|FG001|Overall Study|Adverse Event|4|||
145250061|NCT03299166|523760774|FG000|Overall Study|Withdrawal by Subject|6|||
145250062|NCT03299166|523760775|FG001|Overall Study|Withdrawal by Subject|5|||
145250063|NCT03299166|523760774|FG000|Overall Study|Physician Decision|1|||
145250064|NCT03299166|523760775|FG001|Overall Study|Physician Decision|1|||
145250065|NCT03299166|523760774|FG000|Overall Study|Sponsor Decision|3|||
145250066|NCT03299166|523760775|FG001|Overall Study|Sponsor Decision|0|||
145250067|NCT03299166|523760774|FG000|Overall Study|Lost to Follow-up|2|||
145250068|NCT03299166|523760775|FG001|Overall Study|Lost to Follow-up|4|||
145250069|NCT03299166|523760774|FG000|Overall Study|Randomization Error|0|||
145250070|NCT03299166|523760775|FG001|Overall Study|Randomization Error|1|||
145250071|NCT03299166|523760774|FG000|Overall Study|Subject unable to return due to COVID|1|||
145250072|NCT03299166|523760775|FG001|Overall Study|Subject unable to return due to COVID|0|||
145250073|NCT03299166|523760774|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
145250074|NCT03299166|523760775|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
145250075|NCT01302691|523760778|FG000|Overall Study|Adverse Event|2|||
145250076|NCT01302691|523760779|FG001|Overall Study|Adverse Event|0|||
145250077|NCT01302691|523760778|FG000|Overall Study|Death|0|||
145250078|NCT01302691|523760779|FG001|Overall Study|Death|1|||
145250079|NCT01302691|523760778|FG000|Overall Study|Lost to Follow-up|1|||
145250080|NCT01302691|523760779|FG001|Overall Study|Lost to Follow-up|0|||
145250081|NCT01302691|523760778|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
145250082|NCT01302691|523760779|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
145250083|NCT01302691|523760778|FG000|Overall Study|Physician Decision|0|||
145250084|NCT01302691|523760779|FG001|Overall Study|Physician Decision|1|||
145250085|NCT01302691|523760778|FG000|Overall Study|Protocol Violation|1|||
145250086|NCT01302691|523760779|FG001|Overall Study|Protocol Violation|0|||
145250087|NCT02829775|523760780|FG000|Overall Study|Death|1|||
145250088|NCT02829775|523760780|FG000|Overall Study|Withdrawal by Subject|3|||
145250089|NCT02829775|523760780|FG000|Overall Study|Disease remission|1|||
145250090|NCT03796195|523760781|FG000|Overall Study|Study closed early|1|||
145250091|NCT00062647|523760782|FG000|Overall Study|Death|2|||
145250092|NCT00062647|523760783|FG001|Overall Study|Death|2|||
145250093|NCT00062647|523760782|FG000|Overall Study|Adverse Event|1|||
145250094|NCT00062647|523760783|FG001|Overall Study|Adverse Event|1|||
145250095|NCT00062647|523760782|FG000|Overall Study|Withdrawal by Subject|2|||
145250096|NCT00062647|523760783|FG001|Overall Study|Withdrawal by Subject|1|||
145250097|NCT00062647|523760782|FG000|Overall Study|Protocol Violation|1|||
145250098|NCT00062647|523760783|FG001|Overall Study|Protocol Violation|0|||
145620252|NCT03100838|525123723|FG001|Overall Study|Pregnancy|1|||
145250099|NCT00062647|523760782|FG000|Overall Study|Lost to Follow-up|1|||
145250100|NCT00062647|523760783|FG001|Overall Study|Lost to Follow-up|2|||
145250101|NCT00062647|523760782|FG000|Overall Study|Failed continuation criteria|4|||
145250102|NCT00062647|523760783|FG001|Overall Study|Failed continuation criteria|2|||
145250103|NCT00062647|523760782|FG000|Overall Study|Other|4|||
145250104|NCT00062647|523760783|FG001|Overall Study|Other|4|||
145250105|NCT00062647|523760782|FG000|Overall Study|Never received study treatment|1|||
145250106|NCT00062647|523760783|FG001|Overall Study|Never received study treatment|1|||
145250107|NCT02392468|523760789|FG000|Overall Study|Adverse Event|0|||
145250108|NCT02392468|523760790|FG001|Overall Study|Adverse Event|1|||
145250109|NCT02392468|523760791|FG002|Overall Study|Adverse Event|0|||
145250110|NCT02392468|523760792|FG003|Overall Study|Adverse Event|0|||
145250111|NCT02392468|523760793|FG004|Overall Study|Adverse Event|0|||
145250112|NCT02392468|523760794|FG005|Overall Study|Adverse Event|1|||
145250113|NCT01039428|523760795|FG000|Overall Study|Protocol Violation|1|||
145250114|NCT01039428|523760796|FG001|Overall Study|Protocol Violation|0|||
145250115|NCT01039428|523760795|FG000|Overall Study|Withdrawal by Subject|1|||
145250116|NCT01039428|523760796|FG001|Overall Study|Withdrawal by Subject|0|||
145250117|NCT01313039|523760797|FG000|Overall Study|Physician Decision|1|||
145250118|NCT01313039|523760797|FG000|Overall Study|Adverse Event|1|||
145250119|NCT01678560|523760800|FG000|Overall Study|Physician Decision|4|||
145250120|NCT01678560|523760801|FG001|Overall Study|Physician Decision|4|||
145299494|NCT01900691|523948757|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
145299495|NCT01900691|523948757|FG000|Overall Study|Complete stent migration through digestive tract|1|||
145299496|NCT02724462|523948758|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
145299497|NCT02724462|523948759|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
145299498|NCT02724462|523948758|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
145299499|NCT02724462|523948759|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
145299500|NCT02724462|523948758|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
145299501|NCT02724462|523948759|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
145299502|NCT02724462|523948758|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
145299503|NCT02724462|523948759|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
145250121|NCT01678560|523760800|FG000|Overall Study|Death|0|||
145250122|NCT01678560|523760801|FG001|Overall Study|Death|1|||
145250123|NCT01678560|523760800|FG000|Overall Study|Withdrawal by Subject|0|||
145250124|NCT01678560|523760801|FG001|Overall Study|Withdrawal by Subject|1|||
145250125|NCT02201472|523760802|FG000|Overall Study|Lack of Efficacy|2|||
145250126|NCT02470429|523760803|FG000|Overall Study|Adverse Event|1|||
145250127|NCT02470429|523760804|FG001|Overall Study|Adverse Event|0|||
145250128|NCT02470429|523760803|FG000|Overall Study|Withdrawal by Subject|1|||
145250129|NCT02470429|523760804|FG001|Overall Study|Withdrawal by Subject|0|||
145250130|NCT01300767|523760805|FG000|Overall Study|Discomfort|2|||
145250131|NCT01300767|523760805|FG000|Overall Study|Biomicroscopy|1|||
145250132|NCT01300767|523760805|FG000|Overall Study|Unacceptable fit|1|||
145250133|NCT00117572|523760806|FG000|Overall Study|Site withdrew before starting treatment|2|||
145410252|NCT00658528|524355163|FG000|Overall Study|Withdrawal of consent|5|||
145410253|NCT00658528|524355164|FG001|Overall Study|Withdrawal of consent|6|||
145410254|NCT00658528|524355163|FG000|Overall Study|Other|8|||
145410255|NCT00658528|524355164|FG001|Overall Study|Other|4|||
145410256|NCT01147458|524355165|FG000|First Intervention|Study terminated by sponsor|8|||
145250134|NCT00117572|523760807|FG001|Overall Study|Site withdrew before starting treatment|3|||
145250135|NCT00117572|523760806|FG000|Overall Study|Withdrawal by Subject|3|||
145250136|NCT00117572|523760807|FG001|Overall Study|Withdrawal by Subject|3|||
145250137|NCT00117572|523760806|FG000|Overall Study|Protocol Violation|1|||
145250138|NCT00117572|523760807|FG001|Overall Study|Protocol Violation|0|||
145250139|NCT01188811|523760810|FG000|Overall Study|Withdrawal by Subject|0|||
145250140|NCT01188811|523760811|FG001|Overall Study|Withdrawal by Subject|2|||
145250141|NCT01188811|523760810|FG000|Overall Study|Adverse Event|6|||
145250142|NCT01188811|523760811|FG001|Overall Study|Adverse Event|0|||
145250143|NCT00654368|523760812|FG000|Overall Study|Ineligibility determined|6|||
145250144|NCT00654368|523760813|FG001|Overall Study|Ineligibility determined|0|||
145250145|NCT00654368|523760814|FG002|Overall Study|Ineligibility determined|0|||
145250146|NCT00654368|523760812|FG000|Overall Study|Protocol deviation|3|||
145250147|NCT00654368|523760813|FG001|Overall Study|Protocol deviation|2|||
145250148|NCT00654368|523760814|FG002|Overall Study|Protocol deviation|1|||
145250149|NCT00654368|523760812|FG000|Overall Study|Non-compliance|2|||
145250150|NCT00654368|523760813|FG001|Overall Study|Non-compliance|1|||
145250151|NCT00654368|523760814|FG002|Overall Study|Non-compliance|2|||
145250152|NCT00654368|523760812|FG000|Overall Study|Withdrawal by Subject|5|||
145250153|NCT00654368|523760813|FG001|Overall Study|Withdrawal by Subject|2|||
145250154|NCT00654368|523760814|FG002|Overall Study|Withdrawal by Subject|2|||
145299504|NCT02724462|523948758|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
145299505|NCT02724462|523948759|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
145299506|NCT02724462|523948758|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
145250155|NCT00654368|523760812|FG000|Overall Study|Disease progression|21|||
145299507|NCT02724462|523948759|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
145410257|NCT01147458|524355166|FG001|First Intervention|Study terminated by sponsor|8|||
145410258|NCT01147458|524355167|FG002|First Intervention|Study terminated by sponsor|7|||
145250156|NCT00654368|523760813|FG001|Overall Study|Disease progression|31|||
145250157|NCT00654368|523760814|FG002|Overall Study|Disease progression|13|||
145250158|NCT00654368|523760812|FG000|Overall Study|Requirement for alternative therapy|1|||
145250159|NCT00654368|523760813|FG001|Overall Study|Requirement for alternative therapy|1|||
145250160|NCT00654368|523760814|FG002|Overall Study|Requirement for alternative therapy|1|||
145250161|NCT00654368|523760812|FG000|Overall Study|Physician Decision|0|||
145250162|NCT00654368|523760813|FG001|Overall Study|Physician Decision|0|||
145250163|NCT00654368|523760814|FG002|Overall Study|Physician Decision|2|||
145250164|NCT00654368|523760812|FG000|Overall Study|Death|1|||
145250165|NCT00654368|523760813|FG001|Overall Study|Death|0|||
145250166|NCT00654368|523760814|FG002|Overall Study|Death|0|||
145250167|NCT00654368|523760812|FG000|Overall Study|Pregnancy|0|||
145250168|NCT00654368|523760813|FG001|Overall Study|Pregnancy|0|||
145250169|NCT00654368|523760814|FG002|Overall Study|Pregnancy|2|||
145250170|NCT00654368|523760812|FG000|Overall Study|Other|0|||
145250171|NCT00654368|523760813|FG001|Overall Study|Other|2|||
145250172|NCT00654368|523760814|FG002|Overall Study|Other|3|||
145250173|NCT00654368|523760812|FG000|Overall Study|Adverse Event|14|||
145250174|NCT00654368|523760813|FG001|Overall Study|Adverse Event|9|||
145250175|NCT00654368|523760814|FG002|Overall Study|Adverse Event|6|||
145250176|NCT01602744|523760815|FG000|Overall Study|Death|17|||
145250177|NCT01602744|523760816|FG001|Overall Study|Death|15|||
145250178|NCT01602744|523760815|FG000|Overall Study|Lost to Follow-up|13|||
145250179|NCT01602744|523760816|FG001|Overall Study|Lost to Follow-up|8|||
145250180|NCT00804986|523760817|FG000|Overall Study|Adverse Event|0|||
145250181|NCT00804986|523760818|FG001|Overall Study|Adverse Event|1|||
145250182|NCT00804986|523760819|FG002|Overall Study|Adverse Event|2|||
145250183|NCT00804986|523760820|FG003|Overall Study|Adverse Event|1|||
145250184|NCT00804986|523760821|FG004|Overall Study|Adverse Event|3|||
145250185|NCT00804986|523760822|FG005|Overall Study|Adverse Event|0|||
145250186|NCT00804986|523760817|FG000|Overall Study|Lack of Efficacy|0|||
145250187|NCT00804986|523760818|FG001|Overall Study|Lack of Efficacy|0|||
145250188|NCT00804986|523760819|FG002|Overall Study|Lack of Efficacy|0|||
145250189|NCT00804986|523760820|FG003|Overall Study|Lack of Efficacy|1|||
145250190|NCT00804986|523760821|FG004|Overall Study|Lack of Efficacy|0|||
145250191|NCT00804986|523760822|FG005|Overall Study|Lack of Efficacy|3|||
145250192|NCT00804986|523760817|FG000|Overall Study|Lost to Follow-up|0|||
145250193|NCT00804986|523760818|FG001|Overall Study|Lost to Follow-up|0|||
145250194|NCT00804986|523760819|FG002|Overall Study|Lost to Follow-up|0|||
145250195|NCT00804986|523760820|FG003|Overall Study|Lost to Follow-up|1|||
145410259|NCT01147458|524355168|FG003|First Intervention|Study terminated by sponsor|8|||
145410260|NCT01147458|524355165|FG000|First Intervention|Protocol Violation|2|||
145410261|NCT01147458|524355166|FG001|First Intervention|Protocol Violation|3|||
145250196|NCT00804986|523760821|FG004|Overall Study|Lost to Follow-up|1|||
145250197|NCT00804986|523760822|FG005|Overall Study|Lost to Follow-up|3|||
145250198|NCT00804986|523760817|FG000|Overall Study|Protocol Violation|0|||
145250199|NCT00804986|523760818|FG001|Overall Study|Protocol Violation|1|||
145250200|NCT00804986|523760819|FG002|Overall Study|Protocol Violation|0|||
145250201|NCT00804986|523760820|FG003|Overall Study|Protocol Violation|1|||
145250202|NCT00804986|523760821|FG004|Overall Study|Protocol Violation|0|||
145250203|NCT00804986|523760822|FG005|Overall Study|Protocol Violation|0|||
145250204|NCT00804986|523760817|FG000|Overall Study|Withdrawal by Subject|0|||
145250205|NCT00804986|523760818|FG001|Overall Study|Withdrawal by Subject|3|||
145250206|NCT00804986|523760819|FG002|Overall Study|Withdrawal by Subject|0|||
145250207|NCT00804986|523760820|FG003|Overall Study|Withdrawal by Subject|3|||
145250208|NCT00804986|523760821|FG004|Overall Study|Withdrawal by Subject|5|||
145250209|NCT00804986|523760822|FG005|Overall Study|Withdrawal by Subject|3|||
145250210|NCT00804986|523760817|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
145250211|NCT00804986|523760818|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
145250212|NCT00804986|523760819|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
145250213|NCT00804986|523760820|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
145410262|NCT01147458|524355167|FG002|First Intervention|Protocol Violation|2|||
145250214|NCT00804986|523760821|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
145250215|NCT00804986|523760822|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
145250216|NCT00804986|523760817|FG000|Overall Study|Sponsor Decision|0|||
145250217|NCT00804986|523760818|FG001|Overall Study|Sponsor Decision|1|||
145250218|NCT00804986|523760819|FG002|Overall Study|Sponsor Decision|0|||
145250219|NCT00804986|523760820|FG003|Overall Study|Sponsor Decision|0|||
145250220|NCT00804986|523760821|FG004|Overall Study|Sponsor Decision|0|||
145250221|NCT00804986|523760822|FG005|Overall Study|Sponsor Decision|0|||
145250222|NCT00804986|523760817|FG000|Overall Study|Physician Decision|1|||
145250223|NCT00804986|523760818|FG001|Overall Study|Physician Decision|0|||
145250224|NCT00804986|523760819|FG002|Overall Study|Physician Decision|0|||
145250225|NCT00804986|523760820|FG003|Overall Study|Physician Decision|0|||
145410263|NCT01147458|524355168|FG003|First Intervention|Protocol Violation|3|||
145250226|NCT00804986|523760821|FG004|Overall Study|Physician Decision|0|||
145250227|NCT00804986|523760822|FG005|Overall Study|Physician Decision|0|||
145250228|NCT00959699|523760824|FG000|Treatment Period|Adverse Event|3|||
145250229|NCT00959699|523760825|FG001|Treatment Period|Adverse Event|13|||
145250230|NCT00959699|523760824|FG000|Treatment Period|Lack of Efficacy|15|||
145250231|NCT00959699|523760825|FG001|Treatment Period|Lack of Efficacy|6|||
145250232|NCT00959699|523760824|FG000|Treatment Period|Lost to Follow-up|0|||
145250233|NCT00959699|523760825|FG001|Treatment Period|Lost to Follow-up|1|||
145250234|NCT00959699|523760824|FG000|Treatment Period|Withdrawal by Subject|1|||
145250235|NCT00959699|523760825|FG001|Treatment Period|Withdrawal by Subject|3|||
145250236|NCT00959699|523760824|FG000|Treatment Period|Non-Compliance with Protocol|0|||
145410264|NCT01147458|524355165|FG000|First Intervention|Withdrawal by Subject|3|||
145250237|NCT00959699|523760825|FG001|Treatment Period|Non-Compliance with Protocol|1|||
145250238|NCT00959699|523760824|FG000|Treatment Period|Did not receive treatment|0|||
145250239|NCT00959699|523760825|FG001|Treatment Period|Did not receive treatment|1|||
145250240|NCT00959699|523760824|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
145250241|NCT00959699|523760825|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
145250242|NCT00959699|523760824|FG000|Follow-up Period|Lost to Follow-up|3|||
145250243|NCT00959699|523760825|FG001|Follow-up Period|Lost to Follow-up|2|||
145250244|NCT00959699|523760824|FG000|Follow-up Period|Withdrawal by Subject|3|||
145250245|NCT00959699|523760825|FG001|Follow-up Period|Withdrawal by Subject|4|||
145250246|NCT00606294|523760828|FG000|Overall Study|Withdrawal by Subject|36|||
145250247|NCT00606294|523760829|FG001|Overall Study|Withdrawal by Subject|0|||
145250248|NCT01976624|523760830|FG000|Overall Study|Participants contraindicated|2|||
145250249|NCT01976624|523760830|FG000|Overall Study|Participants age less than 19 years|12|||
145250250|NCT02774291|523760831|FG000|Overall Study|Lost to Follow-up|1|||
145250251|NCT00113555|523760835|FG000|Overall Study|Baseline Failure|59|||
145250252|NCT00113555|523760835|FG000|Overall Study|Permanently Explanted|7|||
145250253|NCT00113555|523760835|FG000|Overall Study|Death|1|||
145250254|NCT00113555|523760835|FG000|Overall Study|Missed Followup|4|||
145250255|NCT00113555|523760835|FG000|Overall Study|Lost to Follow-up|8|||
145250256|NCT00609167|523760836|FG000|Overall Study|Withdrawal by Subject|1|||
145250257|NCT00609167|523760837|FG001|Overall Study|Withdrawal by Subject|0|||
145250258|NCT00609167|523760836|FG000|Overall Study|Lack of Efficacy|1|||
145250259|NCT00609167|523760837|FG001|Overall Study|Lack of Efficacy|0|||
145250260|NCT00609167|523760836|FG000|Overall Study|Adverse Event|5|||
145250261|NCT00609167|523760837|FG001|Overall Study|Adverse Event|1|||
145250262|NCT00609167|523760836|FG000|Overall Study|Disease Progression|1|||
145250263|NCT00609167|523760837|FG001|Overall Study|Disease Progression|0|||
145250264|NCT00609167|523760836|FG000|Overall Study|Stem Cell Transplant|0|||
145250265|NCT00609167|523760837|FG001|Overall Study|Stem Cell Transplant|6|||
145250266|NCT03898323|523760838|FG000|Overall Study|Physician Decision|1|||
145250267|NCT00712270|523760839|FG000|Overall Study|Withdrawal by Subject|11|||
145250268|NCT00712270|523760839|FG000|Overall Study|Screen Failure|3|||
145250269|NCT03954704|523760850|FG000|Overall Study|Death|1|||
145250270|NCT03954704|523760851|FG001|Overall Study|Death|1|||
145250271|NCT03954704|523760852|FG002|Overall Study|Death|1|||
145250272|NCT03954704|523760853|FG003|Overall Study|Death|3|||
145250273|NCT03954704|523760854|FG004|Overall Study|Death|2|||
145250274|NCT03954704|523760855|FG005|Overall Study|Death|2|||
145250275|NCT03954704|523760856|FG006|Overall Study|Death|0|||
145250276|NCT03954704|523760850|FG000|Overall Study|Withdrew Consent|0|||
145250277|NCT03954704|523760851|FG001|Overall Study|Withdrew Consent|0|||
145250278|NCT03954704|523760852|FG002|Overall Study|Withdrew Consent|1|||
145250279|NCT03954704|523760853|FG003|Overall Study|Withdrew Consent|0|||
145250280|NCT03954704|523760854|FG004|Overall Study|Withdrew Consent|0|||
145250281|NCT03954704|523760855|FG005|Overall Study|Withdrew Consent|1|||
145566542|NCT03034954|524936150|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
145566543|NCT03034954|524936151|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
145566544|NCT01275066|524936158|FG000|Overall Study|Withdrawal by Subject|0|||
145566545|NCT01275066|524936159|FG001|Overall Study|Withdrawal by Subject|0|||
145566546|NCT01275066|524936160|FG002|Overall Study|Withdrawal by Subject|1|||
145566547|NCT01275066|524936158|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
145566548|NCT01275066|524936159|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
145566549|NCT01275066|524936160|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
145566550|NCT00394212|524936163|FG000|Overall Study|Lost to Follow-up|3|||
145566551|NCT00394212|524936164|FG001|Overall Study|Lost to Follow-up|0|||
145250282|NCT03954704|523760856|FG006|Overall Study|Withdrew Consent|0|||
145250283|NCT03954704|523760850|FG000|Overall Study|Lost to Follow-up|0|||
145250284|NCT03954704|523760851|FG001|Overall Study|Lost to Follow-up|0|||
145250285|NCT03954704|523760852|FG002|Overall Study|Lost to Follow-up|0|||
145250286|NCT03954704|523760853|FG003|Overall Study|Lost to Follow-up|0|||
145250287|NCT03954704|523760854|FG004|Overall Study|Lost to Follow-up|0|||
145250288|NCT03954704|523760855|FG005|Overall Study|Lost to Follow-up|0|||
145250289|NCT03954704|523760856|FG006|Overall Study|Lost to Follow-up|1|||
145250290|NCT03954704|523760850|FG000|Overall Study|Study Terminated by Sponsor|0|||
145250291|NCT03954704|523760851|FG001|Overall Study|Study Terminated by Sponsor|0|||
145299508|NCT00469417|523948760|FG000|Overall Study|Treatment failure all lesions|18|||
145299509|NCT00469417|523948761|FG001|Overall Study|Treatment failure all lesions|11|||
145566552|NCT00394212|524936163|FG000|Overall Study|Withdrawal by Subject|4|||
145250292|NCT03954704|523760852|FG002|Overall Study|Study Terminated by Sponsor|1|||
145250293|NCT03954704|523760853|FG003|Overall Study|Study Terminated by Sponsor|0|||
145250294|NCT03954704|523760854|FG004|Overall Study|Study Terminated by Sponsor|1|||
145250295|NCT03954704|523760855|FG005|Overall Study|Study Terminated by Sponsor|4|||
145250296|NCT03954704|523760856|FG006|Overall Study|Study Terminated by Sponsor|2|||
145250297|NCT03954704|523760850|FG000|Overall Study|Enrolled but not Treated|0|||
145566553|NCT00394212|524936164|FG001|Overall Study|Withdrawal by Subject|1|||
145250298|NCT03954704|523760851|FG001|Overall Study|Enrolled but not Treated|0|||
145250299|NCT03954704|523760852|FG002|Overall Study|Enrolled but not Treated|0|||
145250300|NCT03954704|523760853|FG003|Overall Study|Enrolled but not Treated|0|||
145299510|NCT00469417|523948760|FG000|Overall Study|Consent withdrawn|1|||
145566554|NCT00588445|524936165|FG000|Overall Study|Protocol Violation|1|||
145566555|NCT00588445|524936165|FG000|Overall Study|Withdrawal by Subject|3|||
145566556|NCT00588445|524936165|FG000|Overall Study|Disease Progression|1|||
145566557|NCT00588445|524936165|FG000|Overall Study|Not Treated|10|||
145566558|NCT00116831|524936168|FG000|Overall Study|Adverse Event|14|||
145566559|NCT00116831|524936169|FG001|Overall Study|Adverse Event|16|||
145566560|NCT00116831|524936168|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
145566561|NCT00116831|524936169|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
145566562|NCT00116831|524936168|FG000|Overall Study|Lost to Follow-up|8|||
145566563|NCT00116831|524936169|FG001|Overall Study|Lost to Follow-up|6|||
145566564|NCT00116831|524936168|FG000|Overall Study|Protocol Violation|3|||
145566565|NCT00116831|524936169|FG001|Overall Study|Protocol Violation|6|||
145566566|NCT00116831|524936168|FG000|Overall Study|Hypoglycaemic events|1|||
145566567|NCT00116831|524936169|FG001|Overall Study|Hypoglycaemic events|0|||
145566568|NCT00116831|524936168|FG000|Overall Study|Low haemoglobin on screening|1|||
145566569|NCT00116831|524936169|FG001|Overall Study|Low haemoglobin on screening|0|||
145566570|NCT00116831|524936168|FG000|Overall Study|Withdrawn investigational product|1|||
145566571|NCT00116831|524936169|FG001|Overall Study|Withdrawn investigational product|0|||
145250301|NCT03954704|523760854|FG004|Overall Study|Enrolled but not Treated|0|||
145250302|NCT03954704|523760855|FG005|Overall Study|Enrolled but not Treated|1|||
145250303|NCT03954704|523760856|FG006|Overall Study|Enrolled but not Treated|0|||
145250304|NCT03864627|523760858|FG000|Overall Study|Adverse Event|0|||
145250305|NCT03864627|523760859|FG001|Overall Study|Adverse Event|1|||
145250306|NCT03864627|523760858|FG000|Overall Study|Lack of Efficacy|0|||
145250307|NCT03864627|523760859|FG001|Overall Study|Lack of Efficacy|1|||
145250308|NCT03864627|523760858|FG000|Overall Study|Lost to Follow-up|0|||
145250309|NCT03864627|523760859|FG001|Overall Study|Lost to Follow-up|1|||
145250310|NCT03864627|523760858|FG000|Overall Study|Withdrawal by Subject|4|||
145250311|NCT03864627|523760859|FG001|Overall Study|Withdrawal by Subject|8|||
145250312|NCT03864627|523760858|FG000|Overall Study|Study terminated by sponsor|0|||
145250313|NCT03864627|523760859|FG001|Overall Study|Study terminated by sponsor|1|||
145250314|NCT01388491|523760860|FG000|Overall Study|Adverse Event|10|||
145250315|NCT01388491|523760861|FG001|Overall Study|Adverse Event|9|||
145250316|NCT01388491|523760860|FG000|Overall Study|Sponsor Request|9|||
145250317|NCT01388491|523760861|FG001|Overall Study|Sponsor Request|7|||
145250318|NCT01388491|523760860|FG000|Overall Study|Withdrawal by Subject|6|||
145250319|NCT01388491|523760861|FG001|Overall Study|Withdrawal by Subject|10|||
145250320|NCT01388491|523760860|FG000|Overall Study|Lost to Follow-up|4|||
145250321|NCT01388491|523760861|FG001|Overall Study|Lost to Follow-up|3|||
145250322|NCT01388491|523760860|FG000|Overall Study|Protocol Violation|2|||
145250323|NCT01388491|523760861|FG001|Overall Study|Protocol Violation|0|||
145250324|NCT01388491|523760860|FG000|Overall Study|Noncompliance|2|||
145250325|NCT01388491|523760861|FG001|Overall Study|Noncompliance|0|||
145250326|NCT01388491|523760860|FG000|Overall Study|Pregnancy|1|||
145250327|NCT01388491|523760861|FG001|Overall Study|Pregnancy|0|||
145250328|NCT04035473|523760862|FG000|Screening/Baseline|Death|0|||
145250329|NCT04035473|523760863|FG001|Screening/Baseline|Death|1|||
145250330|NCT04035473|523760862|FG000|Screening/Baseline|Adverse Event|0|||
145250331|NCT04035473|523760863|FG001|Screening/Baseline|Adverse Event|1|||
145250332|NCT04035473|523760862|FG000|Follow-up Period|Adverse Event|2|||
145250333|NCT04035473|523760863|FG001|Follow-up Period|Adverse Event|0|||
145250334|NCT00112840|523760864|FG000|Overall Study|Physician Decision|1|||
145250335|NCT00112840|523760865|FG001|Overall Study|Physician Decision|0|||
145250336|NCT00112840|523760866|FG002|Overall Study|Physician Decision|0|||
145299511|NCT00469417|523948761|FG001|Overall Study|Consent withdrawn|1|||
145299512|NCT00469417|523948760|FG000|Overall Study|Adverse Event|8|||
145299513|NCT00469417|523948761|FG001|Overall Study|Adverse Event|2|||
145299514|NCT00469417|523948760|FG000|Overall Study|Lost to Follow-up|1|||
145299515|NCT00469417|523948761|FG001|Overall Study|Lost to Follow-up|2|||
145250337|NCT00112840|523760864|FG000|Overall Study|Withdrawal by Subject|1|||
145299516|NCT00469417|523948760|FG000|Overall Study|Intercurrent disease|0|||
145566572|NCT00116831|524936168|FG000|Overall Study|Withdrawal by Subject|32|||
145566573|NCT00116831|524936169|FG001|Overall Study|Withdrawal by Subject|32|||
145566574|NCT00116831|524936168|FG000|Overall Study|Insufficient therapeutic effect|0|||
145250338|NCT00112840|523760865|FG001|Overall Study|Withdrawal by Subject|0|||
145250339|NCT00112840|523760866|FG002|Overall Study|Withdrawal by Subject|1|||
145250340|NCT00112840|523760864|FG000|Overall Study|Protocol Violation|0|||
145250341|NCT00112840|523760865|FG001|Overall Study|Protocol Violation|0|||
145250342|NCT00112840|523760866|FG002|Overall Study|Protocol Violation|5|||
145250343|NCT03595176|523760867|FG000|Overall Study|Death|0|||
145250344|NCT03595176|523760868|FG001|Overall Study|Death|2|||
145250345|NCT03595176|523760867|FG000|Overall Study|Lost to Follow-up|0|||
145250346|NCT03595176|523760868|FG001|Overall Study|Lost to Follow-up|1|||
145299517|NCT00469417|523948761|FG001|Overall Study|Intercurrent disease|1|||
145250347|NCT02735044|523760870|FG000|Overall Study|Adverse Event|3|||
145250348|NCT02735044|523760871|FG001|Overall Study|Adverse Event|3|||
145250349|NCT02735044|523760870|FG000|Overall Study|Lack of Efficacy|1|||
145250350|NCT02735044|523760871|FG001|Overall Study|Lack of Efficacy|0|||
145299518|NCT00469417|523948760|FG000|Overall Study|Randomized but not treated|2|||
145250351|NCT02735044|523760870|FG000|Overall Study|Poor compliance to protocol|7|||
145250352|NCT02735044|523760871|FG001|Overall Study|Poor compliance to protocol|7|||
145250353|NCT02735044|523760870|FG000|Overall Study|Randomized and not treated|0|||
145250354|NCT02735044|523760871|FG001|Overall Study|Randomized and not treated|2|||
145250355|NCT02735044|523760870|FG000|Overall Study|Other, not specified above|5|||
145250356|NCT02735044|523760871|FG001|Overall Study|Other, not specified above|11|||
145250357|NCT01682759|523760872|FG000|Overall Study|Death|2|||
145250358|NCT01682759|523760873|FG001|Overall Study|Death|1|||
145250359|NCT01682759|523760872|FG000|Overall Study|Lost to Follow-up|10|||
145250360|NCT01682759|523760873|FG001|Overall Study|Lost to Follow-up|13|||
145250361|NCT01682759|523760872|FG000|Overall Study|Physician Decision|1|||
145250362|NCT01682759|523760873|FG001|Overall Study|Physician Decision|1|||
145250363|NCT01682759|523760872|FG000|Overall Study|Withdrawal by Subject|56|||
145250364|NCT01682759|523760873|FG001|Overall Study|Withdrawal by Subject|55|||
145250365|NCT00397891|523760875|FG000|Overall Study|Withdrawal by Subject|1|||
145250366|NCT00397891|523760876|FG001|Overall Study|Withdrawal by Subject|0|||
145250367|NCT00397891|523760877|FG002|Overall Study|Withdrawal by Subject|0|||
145250368|NCT00397891|523760878|FG003|Overall Study|Withdrawal by Subject|0|||
145250369|NCT00397891|523760879|FG004|Overall Study|Withdrawal by Subject|1|||
145250370|NCT00412113|523760880|FG000|Overall Study|Adverse Event|11|||
145250371|NCT00412113|523760881|FG001|Overall Study|Adverse Event|15|||
145250372|NCT00412113|523760880|FG000|Overall Study|did not receive treatment|1|||
145250373|NCT00412113|523760881|FG001|Overall Study|did not receive treatment|0|||
145250374|NCT01226472|523760889|FG000|Overall Study|Progressive Disease|1|||
145250375|NCT02903966|523762977|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
145250376|NCT02903966|523762978|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
145250377|NCT02903966|523762977|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
145250378|NCT02903966|523762978|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
145250379|NCT02903966|523762977|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
145250380|NCT02903966|523762978|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
145250381|NCT01320033|523762979|FG000|Overall Study|Lack of Efficacy|0|||
145250382|NCT01320033|523762980|FG001|Overall Study|Lack of Efficacy|0|||
145250383|NCT01320033|523762981|FG002|Overall Study|Lack of Efficacy|1|||
145250384|NCT01320033|523762979|FG000|Overall Study|Adverse Event|9|||
145250385|NCT01320033|523762980|FG001|Overall Study|Adverse Event|7|||
145250386|NCT01320033|523762981|FG002|Overall Study|Adverse Event|8|||
145250387|NCT01320033|523762979|FG000|Overall Study|Withdrawal by Subject|22|||
145250388|NCT01320033|523762980|FG001|Overall Study|Withdrawal by Subject|23|||
145250389|NCT01320033|523762981|FG002|Overall Study|Withdrawal by Subject|23|||
145250390|NCT01320033|523762979|FG000|Overall Study|Protocol Violation|3|||
145250391|NCT01320033|523762980|FG001|Overall Study|Protocol Violation|5|||
145250392|NCT01320033|523762981|FG002|Overall Study|Protocol Violation|3|||
145250393|NCT01320033|523762979|FG000|Overall Study|Lost to Follow-up|22|||
145250394|NCT01320033|523762980|FG001|Overall Study|Lost to Follow-up|26|||
145250395|NCT01320033|523762981|FG002|Overall Study|Lost to Follow-up|17|||
145250396|NCT01320033|523762979|FG000|Overall Study|Other|2|||
145299519|NCT00469417|523948761|FG001|Overall Study|Randomized but not treated|0|||
145299520|NCT01954394|523948764|FG000|Overall Study|Enrolled but not treated|1|||
145299521|NCT01954394|523948765|FG001|Overall Study|Enrolled but not treated|0|||
145299522|NCT01954394|523948764|FG000|Overall Study|Adverse Event|10|||
145299523|NCT01954394|523948765|FG001|Overall Study|Adverse Event|23|||
145299524|NCT01954394|523948764|FG000|Overall Study|Poor compliance to protocol|7|||
145299525|NCT01954394|523948765|FG001|Overall Study|Poor compliance to protocol|7|||
145299526|NCT01954394|523948764|FG000|Overall Study|Participant Moved|0|||
145299527|NCT01954394|523948765|FG001|Overall Study|Participant Moved|4|||
145299528|NCT01954394|523948764|FG000|Overall Study|Related to Study Drug administration|2|||
145299529|NCT01954394|523948765|FG001|Overall Study|Related to Study Drug administration|2|||
145299530|NCT01954394|523948764|FG000|Overall Study|Other than specified above|10|||
145299531|NCT01954394|523948765|FG001|Overall Study|Other than specified above|21|||
145299532|NCT04089735|523948770|FG000|Overall Study|Adverse Event|1|||
145299533|NCT04089735|523948771|FG001|Overall Study|Adverse Event|0|||
145299534|NCT04089735|523948772|FG002|Overall Study|Adverse Event|1|||
145566575|NCT00116831|524936169|FG001|Overall Study|Insufficient therapeutic effect|1|||
145299535|NCT04089735|523948773|FG003|Overall Study|Adverse Event|1|||
145299536|NCT04089735|523948774|FG004|Overall Study|Adverse Event|0|||
145566576|NCT00116831|524936168|FG000|Overall Study|Missing data for participant|1|||
145566577|NCT00116831|524936169|FG001|Overall Study|Missing data for participant|0|||
145250397|NCT01320033|523762980|FG001|Overall Study|Other|3|||
145250398|NCT01320033|523762981|FG002|Overall Study|Other|1|||
145250399|NCT00963469|523762982|FG000|Overall Study|Adverse Event|15|||
145250400|NCT00963469|523762983|FG001|Overall Study|Adverse Event|11|||
145250401|NCT00963469|523762984|FG002|Overall Study|Adverse Event|1|||
145250402|NCT00963469|523762982|FG000|Overall Study|Lack of Efficacy|10|||
145299537|NCT04089735|523948775|FG005|Overall Study|Adverse Event|0|||
145299538|NCT04089735|523948770|FG000|Overall Study|Physician Decision|0|||
145299539|NCT04089735|523948771|FG001|Overall Study|Physician Decision|3|||
145299540|NCT04089735|523948772|FG002|Overall Study|Physician Decision|0|||
145299541|NCT04089735|523948773|FG003|Overall Study|Physician Decision|0|||
145250403|NCT00963469|523762983|FG001|Overall Study|Lack of Efficacy|7|||
145250404|NCT00963469|523762984|FG002|Overall Study|Lack of Efficacy|2|||
145250405|NCT00963469|523762982|FG000|Overall Study|Lost to Follow-up|1|||
145250406|NCT00963469|523762983|FG001|Overall Study|Lost to Follow-up|1|||
145250407|NCT00963469|523762984|FG002|Overall Study|Lost to Follow-up|0|||
145250408|NCT00963469|523762982|FG000|Overall Study|Protocol Violation|5|||
145250409|NCT00963469|523762983|FG001|Overall Study|Protocol Violation|5|||
145250410|NCT00963469|523762984|FG002|Overall Study|Protocol Violation|3|||
145250411|NCT00963469|523762982|FG000|Overall Study|Withdrawal by Subject|4|||
145250412|NCT00963469|523762983|FG001|Overall Study|Withdrawal by Subject|1|||
145250413|NCT00963469|523762984|FG002|Overall Study|Withdrawal by Subject|1|||
145250414|NCT00963469|523762982|FG000|Overall Study|Pre-randomization Adverse Event|1|||
145250415|NCT00963469|523762983|FG001|Overall Study|Pre-randomization Adverse Event|2|||
145250416|NCT00963469|523762984|FG002|Overall Study|Pre-randomization Adverse Event|0|||
145250417|NCT00963469|523762982|FG000|Overall Study|Moved|1|||
145250418|NCT00963469|523762983|FG001|Overall Study|Moved|0|||
145250419|NCT00963469|523762984|FG002|Overall Study|Moved|0|||
145250420|NCT00963469|523762982|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
145250421|NCT00963469|523762983|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
145250422|NCT00963469|523762984|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
145250423|NCT04969900|523762993|FG000|Overall Study|Physician Decision|1|||
145250424|NCT04969900|523762994|FG001|Overall Study|Physician Decision|1|||
145250425|NCT04969900|523762993|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
145250426|NCT04969900|523762994|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
145250427|NCT05618808|523762998|FG000|Overall Study|Withdrawal by Subject|3|||
145250428|NCT05618808|523762999|FG001|Overall Study|Withdrawal by Subject|1|||
145250429|NCT05618808|523763000|FG002|Overall Study|Withdrawal by Subject|3|||
145250430|NCT03381274|523763001|FG000|Overall Study|Death|2|||
145250431|NCT03381274|523763002|FG001|Overall Study|Death|9|||
145250432|NCT03381274|523763003|FG002|Overall Study|Death|3|||
145250433|NCT03381274|523763004|FG003|Overall Study|Death|2|||
145250434|NCT03381274|523763005|FG004|Overall Study|Death|3|||
145250435|NCT03381274|523763001|FG000|Overall Study|Lost to Follow-up|0|||
145250436|NCT03381274|523763002|FG001|Overall Study|Lost to Follow-up|0|||
145250437|NCT03381274|523763003|FG002|Overall Study|Lost to Follow-up|0|||
145250438|NCT03381274|523763004|FG003|Overall Study|Lost to Follow-up|1|||
145250439|NCT03381274|523763005|FG004|Overall Study|Lost to Follow-up|0|||
145250440|NCT03381274|523763001|FG000|Overall Study|Withdrawal by Subject|2|||
145250441|NCT03381274|523763002|FG001|Overall Study|Withdrawal by Subject|1|||
145250442|NCT03381274|523763003|FG002|Overall Study|Withdrawal by Subject|3|||
145250443|NCT03381274|523763004|FG003|Overall Study|Withdrawal by Subject|1|||
145250444|NCT03381274|523763005|FG004|Overall Study|Withdrawal by Subject|0|||
145250445|NCT03381274|523763001|FG000|Overall Study|Other|1|||
145250446|NCT03381274|523763002|FG001|Overall Study|Other|11|||
145250447|NCT03381274|523763003|FG002|Overall Study|Other|0|||
145250448|NCT03381274|523763004|FG003|Overall Study|Other|2|||
145250449|NCT03381274|523763005|FG004|Overall Study|Other|2|||
145250450|NCT01874353|523763006|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
145250451|NCT01874353|523763007|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
145250452|NCT01874353|523763008|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
145250453|NCT01874353|523763009|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
145250454|NCT01874353|523763006|FG000|Overall Study|Lost to Follow-up|2|||
145250455|NCT01874353|523763007|FG001|Overall Study|Lost to Follow-up|2|||
145250456|NCT01874353|523763008|FG002|Overall Study|Lost to Follow-up|2|||
145250457|NCT01874353|523763009|FG003|Overall Study|Lost to Follow-up|0|||
145250458|NCT01874353|523763006|FG000|Overall Study|Death|110|||
145299542|NCT04089735|523948774|FG004|Overall Study|Physician Decision|0|||
145299543|NCT04089735|523948775|FG005|Overall Study|Physician Decision|0|||
145299544|NCT04089735|523948770|FG000|Overall Study|Withdrawal by Subject|0|||
145299545|NCT04089735|523948771|FG001|Overall Study|Withdrawal by Subject|0|||
145566578|NCT04904185|524936170|FG000|Overall Study|Expansion failure|1|||
145250459|NCT01874353|523763007|FG001|Overall Study|Death|60|||
145250460|NCT01874353|523763008|FG002|Overall Study|Death|13|||
145250461|NCT01874353|523763009|FG003|Overall Study|Death|7|||
145250462|NCT01874353|523763006|FG000|Overall Study|Withdrawal by Subject|13|||
145250463|NCT01874353|523763007|FG001|Overall Study|Withdrawal by Subject|11|||
145250464|NCT01874353|523763008|FG002|Overall Study|Withdrawal by Subject|0|||
145250465|NCT01874353|523763009|FG003|Overall Study|Withdrawal by Subject|0|||
145250466|NCT04992507|523763018|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
145250467|NCT04992507|523763019|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
145250468|NCT04992507|523763018|FG000|Overall Study|Death|0|||
145250469|NCT04992507|523763019|FG001|Overall Study|Death|1|||
145250470|NCT01852591|523763020|FG000|Overall Study|Withdrawal by Subject|2|||
145250471|NCT01852591|523763020|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
145299546|NCT04089735|523948772|FG002|Overall Study|Withdrawal by Subject|1|||
145410265|NCT01147458|524355166|FG001|First Intervention|Withdrawal by Subject|0|||
145410266|NCT01147458|524355167|FG002|First Intervention|Withdrawal by Subject|1|||
145410267|NCT01147458|524355168|FG003|First Intervention|Withdrawal by Subject|0|||
145410268|NCT01147458|524355165|FG000|First Intervention|Adverse Event|0|||
145410269|NCT01147458|524355166|FG001|First Intervention|Adverse Event|3|||
145410270|NCT01147458|524355167|FG002|First Intervention|Adverse Event|2|||
145410271|NCT01147458|524355168|FG003|First Intervention|Adverse Event|3|||
145410272|NCT01147458|524355165|FG000|First Intervention|Other|1|||
145410273|NCT01147458|524355166|FG001|First Intervention|Other|2|||
145410274|NCT01147458|524355167|FG002|First Intervention|Other|0|||
145410275|NCT01147458|524355168|FG003|First Intervention|Other|0|||
145410276|NCT01147458|524355165|FG000|Second Intervention|Study terminated by sponsor|7|||
145410277|NCT01147458|524355166|FG001|Second Intervention|Study terminated by sponsor|5|||
145410278|NCT01147458|524355167|FG002|Second Intervention|Study terminated by sponsor|5|||
145410279|NCT01147458|524355168|FG003|Second Intervention|Study terminated by sponsor|3|||
145410280|NCT01147458|524355165|FG000|Second Intervention|Protocol Violation|0|||
145410281|NCT01147458|524355166|FG001|Second Intervention|Protocol Violation|1|||
145566579|NCT04904185|524936171|FG001|Overall Study|Expansion failure|0|||
145250472|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
145250473|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
145250474|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Death|1|||
145250475|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Death|1|||
145250476|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
145250477|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
145250478|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
145250479|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
145250480|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
145250481|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
145250482|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
145250483|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
145250484|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
145250485|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
145250486|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
145250487|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
145250488|NCT03728881|523763023|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
145250489|NCT03728881|523763024|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
145250490|NCT03728881|523763023|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
145250491|NCT03728881|523763024|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
145250492|NCT03728881|523763023|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
145250493|NCT03728881|523763024|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
145250494|NCT04651777|523763029|FG000|Overall Study|Adverse Event|1|||
145250495|NCT04651777|523763029|FG000|Overall Study|Withdrawal by Subject|2|||
145250496|NCT06048367|523763030|FG000|Overall Study|Withdrawal by Subject|0|||
145250497|NCT06048367|523763031|FG001|Overall Study|Withdrawal by Subject|1|||
145250498|NCT06048367|523763032|FG002|Overall Study|Withdrawal by Subject|0|||
145250499|NCT06048367|523763033|FG003|Overall Study|Withdrawal by Subject|0|||
145250500|NCT06048367|523763034|FG004|Overall Study|Withdrawal by Subject|0|||
145250501|NCT06048367|523763030|FG000|Overall Study|Withdrawal by Subject|0|||
145250502|NCT06048367|523763031|FG001|Overall Study|Withdrawal by Subject|0|||
145250503|NCT06048367|523763032|FG002|Overall Study|Withdrawal by Subject|1|||
145250504|NCT06048367|523763033|FG003|Overall Study|Withdrawal by Subject|0|||
145250505|NCT06048367|523763034|FG004|Overall Study|Withdrawal by Subject|0|||
145250506|NCT06048367|523763030|FG000|Overall Study|Withdrawal by Subject|0|||
145250507|NCT06048367|523763031|FG001|Overall Study|Withdrawal by Subject|0|||
145250508|NCT06048367|523763032|FG002|Overall Study|Withdrawal by Subject|0|||
145250509|NCT06048367|523763033|FG003|Overall Study|Withdrawal by Subject|1|||
145250510|NCT06048367|523763034|FG004|Overall Study|Withdrawal by Subject|0|||
145250511|NCT06048367|523763030|FG000|Overall Study|Withdrawal by Subject|0|||
145250512|NCT06048367|523763031|FG001|Overall Study|Withdrawal by Subject|0|||
145410282|NCT01147458|524355167|FG002|Second Intervention|Protocol Violation|1|||
145410283|NCT01147458|524355168|FG003|Second Intervention|Protocol Violation|0|||
145410284|NCT01147458|524355165|FG000|Second Intervention|Withdrawal by Subject|0|||
145410285|NCT01147458|524355166|FG001|Second Intervention|Withdrawal by Subject|1|||
145410286|NCT01147458|524355167|FG002|Second Intervention|Withdrawal by Subject|0|||
145410287|NCT01147458|524355168|FG003|Second Intervention|Withdrawal by Subject|0|||
145250513|NCT06048367|523763032|FG002|Overall Study|Withdrawal by Subject|0|||
145250514|NCT06048367|523763033|FG003|Overall Study|Withdrawal by Subject|1|||
145410288|NCT01147458|524355165|FG000|Second Intervention|Adverse Event|2|||
145410289|NCT01147458|524355166|FG001|Second Intervention|Adverse Event|0|||
145410290|NCT01147458|524355167|FG002|Second Intervention|Adverse Event|1|||
145410291|NCT01147458|524355168|FG003|Second Intervention|Adverse Event|1|||
145410292|NCT01147458|524355165|FG000|Second Intervention|Other|0|||
145250515|NCT06048367|523763034|FG004|Overall Study|Withdrawal by Subject|0|||
145250516|NCT04088331|523763035|FG000|Overall Study|Lost to Follow-up|3|||
145250517|NCT04088331|523763035|FG000|Overall Study|Withdrawal by Subject|7|||
145250518|NCT04088331|523763035|FG000|Overall Study|Adverse Event|4|||
145250519|NCT03233308|523763036|FG000|Overall Study|Adverse Event|1|||
145250520|NCT03233308|523763036|FG000|Overall Study|Protocol Violation|1|||
145250521|NCT03715205|523763038|FG000|Overall Study|Death|13|||
145250522|NCT03715205|523763038|FG000|Overall Study|Lost to Follow-up|2|||
145250523|NCT03715205|523763038|FG000|Overall Study|Physician Decision|93|||
145250524|NCT03715205|523763038|FG000|Overall Study|Withdrawal by Subject|26|||
145250525|NCT02756845|523763039|FG000|Overall Study|Death|12|||
145250526|NCT02756845|523763040|FG001|Overall Study|Death|2|||
145250527|NCT02756845|523763039|FG000|Overall Study|Withdrawal by Subject|1|||
145250528|NCT02756845|523763040|FG001|Overall Study|Withdrawal by Subject|0|||
145250529|NCT03342404|523763041|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
145250530|NCT03342404|523763042|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
145250531|NCT03342404|523763041|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
145250532|NCT03342404|523763042|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
145250533|NCT03342404|523763041|FG000|Blinded Treatment Phase|Adverse Event|5|||
145250534|NCT03342404|523763042|FG001|Blinded Treatment Phase|Adverse Event|4|||
145250535|NCT03342404|523763041|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
145250536|NCT03342404|523763042|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
145250537|NCT03342404|523763041|FG000|Blinded Treatment Phase|Other reasons|1|||
145250538|NCT03342404|523763042|FG001|Blinded Treatment Phase|Other reasons|0|||
145250539|NCT03342404|523763041|FG000|Blinded Treatment Phase|Physician Decision|1|||
145250540|NCT03342404|523763042|FG001|Blinded Treatment Phase|Physician Decision|0|||
145250541|NCT03342404|523763041|FG000|Blinded Treatment Phase|Death|1|||
145250542|NCT03342404|523763042|FG001|Blinded Treatment Phase|Death|0|||
145250543|NCT03342404|523763041|FG000|Open-Label Phase|Lost to Follow-up|0|||
145250544|NCT03342404|523763042|FG001|Open-Label Phase|Lost to Follow-up|1|||
145250545|NCT03342404|523763041|FG000|Open-Label Phase|Other reasons|0|||
145250546|NCT03342404|523763042|FG001|Open-Label Phase|Other reasons|1|||
145250547|NCT03342404|523763041|FG000|Open-Label Phase|Adverse Event|0|||
145250548|NCT03342404|523763042|FG001|Open-Label Phase|Adverse Event|3|||
145250549|NCT03342404|523763041|FG000|Open-Label Phase|Withdrawal by Subject|0|||
145250550|NCT03342404|523763042|FG001|Open-Label Phase|Withdrawal by Subject|6|||
145250551|NCT03733249|523763044|FG000|Overall Study|Death|7|||
145250552|NCT03733249|523763044|FG000|Overall Study|Disease relapse|16|||
145250553|NCT03733249|523763044|FG000|Overall Study|Lost to Follow-up|4|||
145250554|NCT03733249|523763044|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
145250555|NCT03733249|523763044|FG000|Overall Study|Withdrawal by Subject|1|||
145250556|NCT00850135|523763045|FG000|Overall Study|Physician Decision|1|||
145250557|NCT02253992|523763046|FG000|Overall Study|Study drug toxicity|1|||
145250558|NCT02253992|523763047|FG001|Overall Study|Study drug toxicity|0|||
145250559|NCT02253992|523763048|FG002|Overall Study|Study drug toxicity|10|||
145250560|NCT02253992|523763046|FG000|Overall Study|Disease progression|4|||
145250561|NCT02253992|523763047|FG001|Overall Study|Disease progression|3|||
145250562|NCT02253992|523763048|FG002|Overall Study|Disease progression|98|||
145250563|NCT02253992|523763046|FG000|Overall Study|Withdrawal by Subject|0|||
145250564|NCT02253992|523763047|FG001|Overall Study|Withdrawal by Subject|0|||
145250565|NCT02253992|523763048|FG002|Overall Study|Withdrawal by Subject|3|||
145299547|NCT04089735|523948773|FG003|Overall Study|Withdrawal by Subject|0|||
145299548|NCT04089735|523948774|FG004|Overall Study|Withdrawal by Subject|0|||
145299549|NCT04089735|523948775|FG005|Overall Study|Withdrawal by Subject|0|||
145299550|NCT04089735|523948770|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
145299551|NCT04089735|523948771|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
145299552|NCT04089735|523948772|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
145299553|NCT04089735|523948773|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
145299554|NCT04089735|523948774|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
145299555|NCT04089735|523948775|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
145250566|NCT02253992|523763046|FG000|Overall Study|Adverse Event|0|||
145250567|NCT02253992|523763047|FG001|Overall Study|Adverse Event|0|||
145250568|NCT02253992|523763048|FG002|Overall Study|Adverse Event|8|||
145250569|NCT02253992|523763046|FG000|Overall Study|Death|0|||
145250570|NCT02253992|523763047|FG001|Overall Study|Death|0|||
145250571|NCT02253992|523763048|FG002|Overall Study|Death|1|||
145250572|NCT02253992|523763046|FG000|Overall Study|Subject discontinued study drug|1|||
145250573|NCT02253992|523763047|FG001|Overall Study|Subject discontinued study drug|0|||
145250574|NCT02253992|523763048|FG002|Overall Study|Subject discontinued study drug|1|||
145250575|NCT02253992|523763046|FG000|Overall Study|Completed treatment as per protocol|0|||
145250576|NCT02253992|523763047|FG001|Overall Study|Completed treatment as per protocol|1|||
145250577|NCT02253992|523763048|FG002|Overall Study|Completed treatment as per protocol|22|||
145250578|NCT02253992|523763046|FG000|Overall Study|Other|0|||
145299556|NCT02128997|523948777|FG000|Overall Study|Lost to Follow-up|6|||
145299557|NCT02128997|523948778|FG001|Overall Study|Lost to Follow-up|11|||
145299558|NCT00418184|523948785|FG000|Double-blind Phase|Withdrawal by Subject|22|||
145299559|NCT00418184|523948786|FG001|Double-blind Phase|Withdrawal by Subject|9|||
145299560|NCT00418184|523948785|FG000|Double-blind Phase|Adverse Event|2|||
145299561|NCT00418184|523948786|FG001|Double-blind Phase|Adverse Event|1|||
145299562|NCT00418184|523948785|FG000|Double-blind Phase|Poor compliance|3|||
145299563|NCT00418184|523948786|FG001|Double-blind Phase|Poor compliance|1|||
145410293|NCT01147458|524355166|FG001|Second Intervention|Other|0|||
145410294|NCT01147458|524355167|FG002|Second Intervention|Other|1|||
145410295|NCT01147458|524355168|FG003|Second Intervention|Other|0|||
145410296|NCT00832975|524355176|FG000|Overall Study|Lost to Follow-up|7|||
145410297|NCT00832975|524355176|FG000|Overall Study|Protocol Violation|6|||
145410298|NCT00832975|524355176|FG000|Overall Study|Death|5|||
145410299|NCT00832975|524355176|FG000|Overall Study|Physician Decision|4|||
145410300|NCT00832975|524355176|FG000|Overall Study|Withdrawal by Subject|3|||
145410301|NCT00832975|524355176|FG000|Overall Study|Other reasons|14|||
145410302|NCT04603066|524355181|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
145410303|NCT04603066|524355182|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
145410304|NCT05759338|524355183|FG000|Overall Study|Withdrawal by Subject|3|||
145410305|NCT04409002|524355184|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
145250579|NCT02253992|523763047|FG001|Overall Study|Other|0|||
145410306|NCT04835441|524355185|FG000|Overall Study|Physician Decision|4|||
145410307|NCT04835441|524355186|FG001|Overall Study|Physician Decision|4|||
145410308|NCT04835441|524355185|FG000|Overall Study|Other|1|||
145410309|NCT04835441|524355186|FG001|Overall Study|Other|1|||
145410310|NCT04835441|524355185|FG000|Overall Study|Lost to Follow-up|0|||
145410311|NCT04835441|524355186|FG001|Overall Study|Lost to Follow-up|1|||
145410312|NCT06481579|524355187|FG000|Overall Study|Death|1|||
145410313|NCT06481579|524355188|FG001|Overall Study|Death|0|||
145410314|NCT06481579|524355187|FG000|Overall Study|Withdrawal by Subject|3|||
145410315|NCT06481579|524355188|FG001|Overall Study|Withdrawal by Subject|0|||
145410316|NCT06481579|524355187|FG000|Overall Study|Other|1|||
145410317|NCT06481579|524355188|FG001|Overall Study|Other|1|||
145410318|NCT05253807|524355189|FG000|Overall Study|Death|1|||
145410319|NCT05253807|524355190|FG001|Overall Study|Death|4|||
145410320|NCT05253807|524355189|FG000|Overall Study|Withdrawal by Subject|1|||
145410321|NCT05253807|524355190|FG001|Overall Study|Withdrawal by Subject|0|||
145410322|NCT05253807|524355189|FG000|Overall Study|Study Terminated by Sponsor|1|||
145410323|NCT05253807|524355190|FG001|Overall Study|Study Terminated by Sponsor|1|||
145410324|NCT00177671|524356770|FG000|Overall Study|Withdrawal by Subject|5|||
145566580|NCT04904185|524936170|FG000|Overall Study|Late response on prior treatment|1|||
145566581|NCT04904185|524936171|FG001|Overall Study|Late response on prior treatment|0|||
145250580|NCT02253992|523763048|FG002|Overall Study|Other|1|||
145250581|NCT00772889|523763049|FG000|Overall Study|Adverse Event|7|||
145250582|NCT00772889|523763050|FG001|Overall Study|Adverse Event|4|||
145250583|NCT00772889|523763051|FG002|Overall Study|Adverse Event|0|||
145250584|NCT00772889|523763049|FG000|Overall Study|Withdrawal by Subject|9|||
145250585|NCT00772889|523763050|FG001|Overall Study|Withdrawal by Subject|8|||
145250586|NCT00772889|523763051|FG002|Overall Study|Withdrawal by Subject|9|||
145250587|NCT00772889|523763049|FG000|Overall Study|Lost to Follow-up|6|||
145250588|NCT00772889|523763050|FG001|Overall Study|Lost to Follow-up|6|||
145250589|NCT00772889|523763051|FG002|Overall Study|Lost to Follow-up|7|||
145250590|NCT03323086|523763052|FG000|Overall Study|Lost to Follow-up|3|||
145250591|NCT03323086|523763053|FG001|Overall Study|Lost to Follow-up|2|||
145299564|NCT01247701|523948788|FG000|Overall Study|Death|2|||
145299565|NCT01247701|523948788|FG000|Overall Study|Relapsed|8|||
145299566|NCT00096447|523948789|FG000|Overall Study|Never treated|1|||
145299567|NCT00834743|523948790|FG000|Second Intervention|Withdrawal by Subject|1|||
145410325|NCT00177671|524356771|FG001|Overall Study|Withdrawal by Subject|6|||
145410326|NCT00177671|524356770|FG000|Overall Study|medical complications|2|||
145410327|NCT00177671|524356771|FG001|Overall Study|medical complications|0|||
145410328|NCT00177671|524356770|FG000|Overall Study|Adverse Event|6|||
145566582|NCT02945410|524936172|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145566583|NCT02945410|524936173|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
145566584|NCT02945410|524936174|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145250592|NCT00606229|523763058|FG000|Overall Study|Adverse Event|11|||
145250593|NCT00606229|523763058|FG000|Overall Study|Lack of Efficacy|1|||
145410329|NCT00177671|524356771|FG001|Overall Study|Adverse Event|0|||
145410330|NCT00177671|524356770|FG000|Overall Study|Physician Decision|12|||
145410331|NCT00177671|524356771|FG001|Overall Study|Physician Decision|8|||
145410332|NCT02293499|524356772|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
145410333|NCT02293499|524356773|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
145410334|NCT02293499|524356774|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
145250594|NCT00606229|523763058|FG000|Overall Study|Withdrawal by Subject|4|||
145299568|NCT00834743|523948791|FG001|Second Intervention|Withdrawal by Subject|0|||
145299569|NCT03025880|523948792|FG000|Overall Study|Adverse Event|1|||
145410335|NCT02293499|524356772|FG000|Intervention - Camp|Withdrawal by Subject|3|||
145410336|NCT02293499|524356773|FG001|Intervention - Camp|Withdrawal by Subject|6|||
145410337|NCT02293499|524356774|FG002|Intervention - Camp|Withdrawal by Subject|2|||
145410338|NCT02293499|524356772|FG000|Intervention - Camp|these are those not showing up at camp|24|||
145410339|NCT02293499|524356773|FG001|Intervention - Camp|these are those not showing up at camp|28|||
145250595|NCT00606229|523763058|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
145250596|NCT00606229|523763058|FG000|Overall Study|change of residence or other commitments|2|||
145250597|NCT03523715|523763059|FG000|Overall Study|Lost to Follow-up|11|||
145250598|NCT03523715|523763060|FG001|Overall Study|Lost to Follow-up|14|||
145250599|NCT03523715|523763059|FG000|Overall Study|Did not meet inclusion criteria|1|||
145250600|NCT03523715|523763060|FG001|Overall Study|Did not meet inclusion criteria|0|||
145250601|NCT03523715|523763059|FG000|Overall Study|Internally inconsistent reporting|0|||
145250602|NCT03523715|523763060|FG001|Overall Study|Internally inconsistent reporting|2|||
145250603|NCT02139280|523763061|FG000|Overall Study|No longer eligible|2|||
145250604|NCT02139280|523763062|FG001|Overall Study|No longer eligible|0|||
145250605|NCT05559203|523763063|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
145250606|NCT00422903|523763065|FG000|Overall Study|Disease Progression|3|||
145250607|NCT00422903|523763066|FG001|Overall Study|Disease Progression|1|||
145250608|NCT00422903|523763065|FG000|Overall Study|Adverse Event|0|||
145250609|NCT00422903|523763066|FG001|Overall Study|Adverse Event|2|||
145250610|NCT00422903|523763065|FG000|Overall Study|Informed Consent Withdrawn|1|||
145250611|NCT00422903|523763066|FG001|Overall Study|Informed Consent Withdrawn|2|||
145250612|NCT01947894|523763071|FG000|Overall Study|Other|3|||
145250613|NCT01947894|523763072|FG001|Overall Study|Other|4|||
145250614|NCT01947894|523763073|FG002|Overall Study|Other|3|||
145410340|NCT02293499|524356774|FG002|Intervention - Camp|these are those not showing up at camp|4|||
145410341|NCT02293499|524356772|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
145410342|NCT02293499|524356773|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
145410343|NCT02293499|524356774|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
145566585|NCT02945410|524936175|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145566586|NCT02945410|524936176|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145566587|NCT02945410|524936177|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
145566588|NCT02945410|524936172|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
145566589|NCT02945410|524936173|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
145566590|NCT02945410|524936174|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
145566591|NCT02945410|524936175|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
145566592|NCT02945410|524936176|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
145566593|NCT02945410|524936177|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
145566594|NCT02945410|524936172|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
145566595|NCT02945410|524936173|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
145566596|NCT02945410|524936174|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
145566597|NCT02945410|524936175|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
145566598|NCT02945410|524936176|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
145566599|NCT02945410|524936177|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
145566600|NCT00110812|524936180|FG000|Main Study|Death|0|||
145566601|NCT00110812|524936181|FG001|Main Study|Death|0|||
145566602|NCT00110812|524936182|FG002|Main Study|Death|2|||
145566603|NCT00110812|524936180|FG000|Main Study|Withdrawal by Subject|0|||
145566604|NCT00110812|524936181|FG001|Main Study|Withdrawal by Subject|0|||
145566605|NCT00110812|524936182|FG002|Main Study|Withdrawal by Subject|1|||
145566606|NCT00110812|524936180|FG000|Main Study|Lost to Follow-up|8|||
145566607|NCT00110812|524936181|FG001|Main Study|Lost to Follow-up|11|||
145566608|NCT00110812|524936182|FG002|Main Study|Lost to Follow-up|10|||
145566609|NCT00110812|524936180|FG000|Extended Follow-up|Death|1|||
145566610|NCT00110812|524936181|FG001|Extended Follow-up|Death|0|||
145566611|NCT00110812|524936182|FG002|Extended Follow-up|Death|3|||
145566612|NCT00110812|524936180|FG000|Extended Follow-up|Withdrawal by Subject|0|||
145566613|NCT00110812|524936181|FG001|Extended Follow-up|Withdrawal by Subject|1|||
145566614|NCT00110812|524936182|FG002|Extended Follow-up|Withdrawal by Subject|0|||
145566615|NCT00110812|524936180|FG000|Extended Follow-up|Lost to Follow-up|1|||
145566616|NCT00110812|524936181|FG001|Extended Follow-up|Lost to Follow-up|3|||
145566617|NCT00110812|524936182|FG002|Extended Follow-up|Lost to Follow-up|1|||
145566618|NCT00735371|524936185|FG000|Overall Study|Adverse Event|3|||
145566619|NCT00735371|524936186|FG001|Overall Study|Adverse Event|3|||
145566620|NCT00735371|524936187|FG002|Overall Study|Adverse Event|4|||
145250615|NCT01947894|523763071|FG000|Overall Study|Withdrawal by Subject|12|||
145250616|NCT01947894|523763072|FG001|Overall Study|Withdrawal by Subject|4|||
145250617|NCT01947894|523763073|FG002|Overall Study|Withdrawal by Subject|1|||
145250618|NCT01947894|523763071|FG000|Overall Study|Death|12|||
145250619|NCT01947894|523763072|FG001|Overall Study|Death|1|||
145250620|NCT01947894|523763073|FG002|Overall Study|Death|0|||
145250621|NCT01947894|523763071|FG000|Overall Study|Physician Decision|2|||
145410344|NCT02293499|524356772|FG000|3 Month Follow Up|Lost to Follow-up|14|||
145566621|NCT00735371|524936188|FG003|Overall Study|Adverse Event|1|||
145566622|NCT00735371|524936185|FG000|Overall Study|Protocol Violation|2|||
145250622|NCT01947894|523763072|FG001|Overall Study|Physician Decision|0|||
145566623|NCT00735371|524936186|FG001|Overall Study|Protocol Violation|2|||
145250623|NCT01947894|523763073|FG002|Overall Study|Physician Decision|0|||
145250624|NCT01947894|523763071|FG000|Overall Study|Adverse Event|5|||
145250625|NCT01947894|523763072|FG001|Overall Study|Adverse Event|1|||
145250626|NCT01947894|523763073|FG002|Overall Study|Adverse Event|0|||
145250627|NCT01947894|523763071|FG000|Overall Study|Switched to other growth hormone brand|53|||
145250628|NCT01947894|523763072|FG001|Overall Study|Switched to other growth hormone brand|8|||
145250629|NCT01947894|523763073|FG002|Overall Study|Switched to other growth hormone brand|23|||
145250630|NCT01249157|523763074|FG000|Overall Study|Withdrawal by Subject|1|||
145250631|NCT03630016|523763075|FG000|Overall Study|Poor Sensor Placement|1|||
145250632|NCT00090766|523763076|FG000|Overall Study|Nephrectomy Planned|0|||
145250633|NCT00090766|523763077|FG001|Overall Study|Nephrectomy Planned|0|||
145250634|NCT00090766|523763078|FG002|Overall Study|Nephrectomy Planned|1|||
145250635|NCT00090766|523763076|FG000|Overall Study|Death|1|||
145250636|NCT00090766|523763077|FG001|Overall Study|Death|0|||
145250637|NCT00090766|523763078|FG002|Overall Study|Death|0|||
145250638|NCT00090766|523763076|FG000|Overall Study|Admin|0|||
145250639|NCT00090766|523763077|FG001|Overall Study|Admin|2|||
145250640|NCT00090766|523763078|FG002|Overall Study|Admin|0|||
145250641|NCT00090766|523763076|FG000|Overall Study|Lost to Follow-up|2|||
145250642|NCT00090766|523763077|FG001|Overall Study|Lost to Follow-up|0|||
145250643|NCT00090766|523763078|FG002|Overall Study|Lost to Follow-up|2|||
145250644|NCT01894776|523763079|FG000|Overall Study|Withdrawal by Subject|1|||
145250645|NCT02485860|523763080|FG000|Overall Study|Lost to Follow-up|4|||
145250646|NCT02485860|523763081|FG001|Overall Study|Lost to Follow-up|1|||
145250647|NCT02485860|523763080|FG000|Overall Study|Physician Decision|1|||
145250648|NCT02485860|523763081|FG001|Overall Study|Physician Decision|2|||
145250649|NCT02485860|523763080|FG000|Overall Study|Health context (COVID-19)|1|||
145250650|NCT02485860|523763081|FG001|Overall Study|Health context (COVID-19)|0|||
145250651|NCT03325010|523763082|FG000|Overall Study|Adverse Event|3|||
145250652|NCT03325010|523763083|FG001|Overall Study|Adverse Event|8|||
145299570|NCT03025880|523948793|FG001|Overall Study|Adverse Event|0|||
145299571|NCT03025880|523948792|FG000|Overall Study|Death|1|||
145299572|NCT03025880|523948793|FG001|Overall Study|Death|1|||
145299573|NCT03025880|523948792|FG000|Overall Study|Withdrawal by Subject|0|||
145299574|NCT03025880|523948793|FG001|Overall Study|Withdrawal by Subject|1|||
145299575|NCT03025880|523948792|FG000|Overall Study|Physician Decision|0|||
145299576|NCT03025880|523948793|FG001|Overall Study|Physician Decision|1|||
145299577|NCT03025880|523948792|FG000|Overall Study|Progressive Disease|12|||
145299578|NCT03025880|523948793|FG001|Overall Study|Progressive Disease|19|||
145299579|NCT02728102|523948794|FG000|Overall Study|Death|3|||
145299580|NCT02728102|523948795|FG001|Overall Study|Death|0|||
145299581|NCT02728102|523948796|FG002|Overall Study|Death|1|||
145299582|NCT02728102|523948794|FG000|Overall Study|Withdrawal by Subject|0|||
145299583|NCT02728102|523948795|FG001|Overall Study|Withdrawal by Subject|2|||
145299584|NCT02728102|523948796|FG002|Overall Study|Withdrawal by Subject|3|||
145299585|NCT02728102|523948794|FG000|Overall Study|Physician Decision|1|||
145299586|NCT02728102|523948795|FG001|Overall Study|Physician Decision|1|||
145299587|NCT02728102|523948796|FG002|Overall Study|Physician Decision|0|||
145299588|NCT02728102|523948794|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
145299589|NCT02728102|523948795|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
145299590|NCT02728102|523948796|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
145299591|NCT02728102|523948794|FG000|Overall Study|Covid|0|||
145299592|NCT02728102|523948795|FG001|Overall Study|Covid|0|||
145299593|NCT02728102|523948796|FG002|Overall Study|Covid|1|||
145299594|NCT00553280|523948798|FG000|Overall Study|Adverse Event|19|||
145299595|NCT00553280|523948798|FG000|Overall Study|Lack of Efficacy|3|||
145299596|NCT00553280|523948798|FG000|Overall Study|Withdrawal by Subject|3|||
145299597|NCT00553280|523948798|FG000|Overall Study|Physician Decision|1|||
145299598|NCT01536405|523948799|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
145299599|NCT01536405|523948800|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
145410345|NCT02293499|524356773|FG001|3 Month Follow Up|Lost to Follow-up|15|||
145250653|NCT03325010|523763082|FG000|Overall Study|Protocol Violation|1|||
145250654|NCT03325010|523763083|FG001|Overall Study|Protocol Violation|8|||
145299600|NCT01536405|523948799|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
145299601|NCT01536405|523948800|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
145299602|NCT01536405|523948799|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
145299603|NCT01536405|523948800|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
145299604|NCT01536405|523948799|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
145299605|NCT01536405|523948800|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
145250655|NCT03325010|523763082|FG000|Overall Study|Withdrawal by Subject|1|||
145250656|NCT03325010|523763083|FG001|Overall Study|Withdrawal by Subject|3|||
145250657|NCT03325010|523763082|FG000|Overall Study|Lost to Follow-up|1|||
145250658|NCT03325010|523763083|FG001|Overall Study|Lost to Follow-up|0|||
145250659|NCT03325010|523763082|FG000|Overall Study|Physician Decision|1|||
145250660|NCT03325010|523763083|FG001|Overall Study|Physician Decision|1|||
145566624|NCT00735371|524936187|FG002|Overall Study|Protocol Violation|0|||
145250661|NCT03325010|523763082|FG000|Overall Study|Lack of Efficacy|2|||
145250662|NCT03325010|523763083|FG001|Overall Study|Lack of Efficacy|0|||
145250663|NCT00471315|523763086|FG000|Overall Study|Adverse Event|7|||
145250664|NCT00471315|523763086|FG000|Overall Study|Withdrawal by Subject|1|||
145250665|NCT03858686|523763091|FG000|Period 1|Adverse Event|1|||
145250666|NCT03858686|523763092|FG001|Period 1|Adverse Event|1|||
145250667|NCT03858686|523763091|FG000|Period 1|Lack of compliance|0|||
145250668|NCT03858686|523763092|FG001|Period 1|Lack of compliance|1|||
145250669|NCT03858686|523763091|FG000|Period 1|Adverse Event|0|||
145250670|NCT03858686|523763092|FG001|Period 1|Adverse Event|1|||
145250671|NCT03858686|523763091|FG000|Period 2|Adverse Event|0|||
145250672|NCT03858686|523763092|FG001|Period 2|Adverse Event|1|||
145250673|NCT02875366|523763095|FG000|Overall Study|Adverse Event|0|||
145250674|NCT02875366|523763096|FG001|Overall Study|Adverse Event|2|||
145250675|NCT02875366|523763095|FG000|Overall Study|Noncompliance|0|||
145250676|NCT02875366|523763096|FG001|Overall Study|Noncompliance|1|||
145250677|NCT00683774|523763097|FG000|Overall Study|Withdrawal by Subject|0|||
145250678|NCT00683774|523763098|FG001|Overall Study|Withdrawal by Subject|1|||
145250679|NCT00683774|523763097|FG000|Overall Study|Physician Decision|3|||
145250680|NCT00683774|523763098|FG001|Overall Study|Physician Decision|0|||
145250681|NCT00691054|523763099|FG000|Overall Study|Withdrawal by Subject|1|||
145250682|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
145250683|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145250684|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145250685|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145250686|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145250687|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145250688|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
145250689|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145250690|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145250691|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145250692|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145250693|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145250694|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
145250695|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145250696|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145250697|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145250698|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145250699|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145250700|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Other|14|||
145250701|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Other|0|||
145250702|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Other|0|||
145250703|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Other|0|||
145250704|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Other|0|||
145250705|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Other|0|||
145250706|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
145250707|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
145250708|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
145250709|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
145250710|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
145250711|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
145250712|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
145250713|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145250714|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145250715|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145250716|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145250717|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145250718|NCT02141854|523763101|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
145250719|NCT02141854|523763102|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145250720|NCT02141854|523763103|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145250721|NCT02141854|523763104|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145250722|NCT02141854|523763105|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145250723|NCT02141854|523763106|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145250724|NCT02141854|523763101|FG000|Treatment Period|Protocol Violation|0|||
145250725|NCT02141854|523763102|FG001|Treatment Period|Protocol Violation|1|||
145566625|NCT00735371|524936188|FG003|Overall Study|Protocol Violation|3|||
145566626|NCT00735371|524936185|FG000|Overall Study|Withdrawal by Subject|0|||
145566627|NCT00735371|524936186|FG001|Overall Study|Withdrawal by Subject|2|||
145566628|NCT00735371|524936187|FG002|Overall Study|Withdrawal by Subject|2|||
145566629|NCT00735371|524936188|FG003|Overall Study|Withdrawal by Subject|0|||
145250726|NCT02141854|523763103|FG002|Treatment Period|Protocol Violation|0|||
145250727|NCT02141854|523763104|FG003|Treatment Period|Protocol Violation|2|||
145250728|NCT02141854|523763105|FG004|Treatment Period|Protocol Violation|2|||
145250729|NCT02141854|523763106|FG005|Treatment Period|Protocol Violation|1|||
145410346|NCT02293499|524356774|FG002|3 Month Follow Up|Lost to Follow-up|6|||
145410347|NCT02293499|524356772|FG000|6 Month Follow Up|Lost to Follow-up|17|||
145410348|NCT02293499|524356773|FG001|6 Month Follow Up|Lost to Follow-up|27|||
145410349|NCT02293499|524356774|FG002|6 Month Follow Up|Lost to Follow-up|6|||
145410350|NCT02293499|524356772|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
145410351|NCT02293499|524356773|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
145410352|NCT02293499|524356774|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
145410353|NCT02293499|524356772|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
145410354|NCT02293499|524356773|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
145250730|NCT02141854|523763101|FG000|Treatment Period|Noncompliance|0|||
145250731|NCT02141854|523763102|FG001|Treatment Period|Noncompliance|0|||
145250732|NCT02141854|523763103|FG002|Treatment Period|Noncompliance|0|||
145250733|NCT02141854|523763104|FG003|Treatment Period|Noncompliance|1|||
145250734|NCT02141854|523763105|FG004|Treatment Period|Noncompliance|0|||
145250735|NCT02141854|523763106|FG005|Treatment Period|Noncompliance|0|||
145250736|NCT02141854|523763101|FG000|Treatment Period|Lack of Efficacy|0|||
145250737|NCT02141854|523763102|FG001|Treatment Period|Lack of Efficacy|0|||
145250738|NCT02141854|523763103|FG002|Treatment Period|Lack of Efficacy|0|||
145250739|NCT02141854|523763104|FG003|Treatment Period|Lack of Efficacy|1|||
145250740|NCT02141854|523763105|FG004|Treatment Period|Lack of Efficacy|1|||
145250741|NCT02141854|523763106|FG005|Treatment Period|Lack of Efficacy|7|||
145250742|NCT02141854|523763101|FG000|Treatment Period|Pregnancy|0|||
145250743|NCT02141854|523763102|FG001|Treatment Period|Pregnancy|1|||
145250744|NCT02141854|523763103|FG002|Treatment Period|Pregnancy|0|||
145250745|NCT02141854|523763104|FG003|Treatment Period|Pregnancy|0|||
145250746|NCT02141854|523763105|FG004|Treatment Period|Pregnancy|0|||
145250747|NCT02141854|523763106|FG005|Treatment Period|Pregnancy|0|||
145250748|NCT02141854|523763101|FG000|Treatment Period|Other|0|||
145250749|NCT02141854|523763102|FG001|Treatment Period|Other|1|||
145250750|NCT02141854|523763103|FG002|Treatment Period|Other|2|||
145250751|NCT02141854|523763104|FG003|Treatment Period|Other|0|||
145250752|NCT02141854|523763105|FG004|Treatment Period|Other|1|||
145250753|NCT02141854|523763106|FG005|Treatment Period|Other|2|||
145250754|NCT02141854|523763101|FG000|Treatment Period|Adverse Event|0|||
145250755|NCT02141854|523763102|FG001|Treatment Period|Adverse Event|2|||
145250756|NCT02141854|523763103|FG002|Treatment Period|Adverse Event|2|||
145250757|NCT02141854|523763104|FG003|Treatment Period|Adverse Event|0|||
145250758|NCT02141854|523763105|FG004|Treatment Period|Adverse Event|2|||
145250759|NCT02141854|523763106|FG005|Treatment Period|Adverse Event|2|||
145250760|NCT02141854|523763101|FG000|Treatment Period|Withdrawal by Subject|0|||
145250761|NCT02141854|523763102|FG001|Treatment Period|Withdrawal by Subject|2|||
145250762|NCT02141854|523763103|FG002|Treatment Period|Withdrawal by Subject|3|||
145250763|NCT02141854|523763104|FG003|Treatment Period|Withdrawal by Subject|3|||
145250764|NCT02141854|523763105|FG004|Treatment Period|Withdrawal by Subject|4|||
145250765|NCT02141854|523763106|FG005|Treatment Period|Withdrawal by Subject|7|||
145250766|NCT02141854|523763101|FG000|Treatment Period|Disease progression|0|||
145250767|NCT02141854|523763102|FG001|Treatment Period|Disease progression|2|||
145250768|NCT02141854|523763103|FG002|Treatment Period|Disease progression|1|||
145250769|NCT02141854|523763104|FG003|Treatment Period|Disease progression|3|||
145250770|NCT02141854|523763105|FG004|Treatment Period|Disease progression|0|||
145250771|NCT02141854|523763106|FG005|Treatment Period|Disease progression|18|||
145250772|NCT02141854|523763101|FG000|Treatment Period|Lost to Follow-up|0|||
145250773|NCT02141854|523763102|FG001|Treatment Period|Lost to Follow-up|1|||
145250774|NCT02141854|523763103|FG002|Treatment Period|Lost to Follow-up|1|||
145250775|NCT02141854|523763104|FG003|Treatment Period|Lost to Follow-up|1|||
145250776|NCT02141854|523763105|FG004|Treatment Period|Lost to Follow-up|0|||
145250777|NCT02141854|523763106|FG005|Treatment Period|Lost to Follow-up|1|||
145250778|NCT01868594|523763109|FG000|Overall Study|Do not meet inclusion criteria|4|||
145250779|NCT01868594|523763110|FG001|Overall Study|Do not meet inclusion criteria|3|||
145250780|NCT01201967|523763113|FG000|Overall Study|Lost to Follow-up|6|||
145250781|NCT01201967|523763114|FG001|Overall Study|Lost to Follow-up|5|||
145250782|NCT02116361|523763117|FG000|Overall Study|Pregnancy|0|||
145250783|NCT02116361|523763118|FG001|Overall Study|Pregnancy|0|||
145250784|NCT02116361|523763119|FG002|Overall Study|Pregnancy|0|||
145250785|NCT02116361|523763120|FG003|Overall Study|Pregnancy|1|||
145250786|NCT02116361|523763117|FG000|Overall Study|Protocol Violation|1|||
145410355|NCT02293499|524356774|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
145250787|NCT02116361|523763118|FG001|Overall Study|Protocol Violation|0|||
145250788|NCT02116361|523763119|FG002|Overall Study|Protocol Violation|0|||
145250789|NCT02116361|523763120|FG003|Overall Study|Protocol Violation|2|||
145250790|NCT02116361|523763117|FG000|Overall Study|Physician Decision|2|||
145250791|NCT02116361|523763118|FG001|Overall Study|Physician Decision|3|||
145250792|NCT02116361|523763119|FG002|Overall Study|Physician Decision|0|||
145250793|NCT02116361|523763120|FG003|Overall Study|Physician Decision|0|||
145250794|NCT02116361|523763117|FG000|Overall Study|Adverse Event|1|||
145566630|NCT00735371|524936185|FG000|Overall Study|Lost to Follow-up|1|||
145250795|NCT02116361|523763118|FG001|Overall Study|Adverse Event|0|||
145250796|NCT02116361|523763119|FG002|Overall Study|Adverse Event|0|||
145250797|NCT02116361|523763120|FG003|Overall Study|Adverse Event|3|||
145250798|NCT02116361|523763117|FG000|Overall Study|Other Reasons|3|||
145250799|NCT02116361|523763118|FG001|Overall Study|Other Reasons|3|||
145250800|NCT02116361|523763119|FG002|Overall Study|Other Reasons|3|||
145250801|NCT02116361|523763120|FG003|Overall Study|Other Reasons|3|||
145250802|NCT02116361|523763117|FG000|Overall Study|Lack of Efficacy|5|||
145250803|NCT02116361|523763118|FG001|Overall Study|Lack of Efficacy|7|||
145250804|NCT02116361|523763119|FG002|Overall Study|Lack of Efficacy|4|||
145250805|NCT02116361|523763120|FG003|Overall Study|Lack of Efficacy|3|||
145250806|NCT02116361|523763117|FG000|Overall Study|Lost to Follow-up|4|||
145250807|NCT02116361|523763118|FG001|Overall Study|Lost to Follow-up|5|||
145250808|NCT02116361|523763119|FG002|Overall Study|Lost to Follow-up|7|||
145250809|NCT02116361|523763120|FG003|Overall Study|Lost to Follow-up|5|||
145250810|NCT02116361|523763117|FG000|Overall Study|Personal Reasons|6|||
145250811|NCT02116361|523763118|FG001|Overall Study|Personal Reasons|6|||
145250812|NCT02116361|523763119|FG002|Overall Study|Personal Reasons|4|||
145250813|NCT02116361|523763120|FG003|Overall Study|Personal Reasons|9|||
145250814|NCT02116361|523763117|FG000|Overall Study|Investigator Decision - Relapse|9|||
145250815|NCT02116361|523763118|FG001|Overall Study|Investigator Decision - Relapse|7|||
145250816|NCT02116361|523763119|FG002|Overall Study|Investigator Decision - Relapse|8|||
145250817|NCT02116361|523763120|FG003|Overall Study|Investigator Decision - Relapse|5|||
145250818|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
145250819|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
145250820|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
145250821|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
145250822|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Other|13|||
145250823|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
145250824|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
145250825|NCT02497287|523763121|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
145250826|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
145250827|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
145250828|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
145250829|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
145250830|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
145250831|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
145250832|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
145250833|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
145250834|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
145250835|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
145250836|NCT02497287|523763121|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
145250837|NCT02497287|523763121|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
145250838|NCT02497287|523763121|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
145250839|NCT02497287|523763121|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
145250840|NCT02497287|523763121|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
145250841|NCT02497287|523763121|FG000|Follow-up Phase (4 Week)|Other|1|||
145250842|NCT02659098|523763122|FG000|Overall Study|Withdrawal by Subject|7|||
145250843|NCT04363944|523763123|FG000|Overall Study|Withdrawal by Subject|2|||
145250844|NCT04363944|523763124|FG001|Overall Study|Withdrawal by Subject|0|||
145250845|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
145250846|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
145250847|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Death|0|||
145250848|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Death|4|||
145250849|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
145250850|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
145250851|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
145250852|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
145250853|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
145250854|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
145250855|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
145250856|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
145250857|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
145250858|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
145250859|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Other|4|||
145566631|NCT00735371|524936186|FG001|Overall Study|Lost to Follow-up|1|||
145250860|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Other|3|||
145250861|NCT03517722|523763125|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
145250862|NCT03517722|523763126|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
145250863|NCT03517722|523763125|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
145250864|NCT03517722|523763126|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
145250865|NCT03517722|523763125|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
145250866|NCT03517722|523763126|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
145250867|NCT03517722|523763125|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
145250868|NCT03517722|523763126|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
145250869|NCT03517722|523763125|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
145250870|NCT03517722|523763126|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
145250871|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
145250872|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
145250873|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
145250874|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
145250875|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
145250876|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
145250877|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
145250878|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
145250879|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
145250880|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
145250881|NCT02422186|523763127|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
145250882|NCT02422186|523763128|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
145250883|NCT02422186|523763127|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
145250884|NCT02422186|523763128|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
145250885|NCT02422186|523763127|FG000|Follow-up Phase (2 Weeks)|Other|3|||
145250886|NCT02422186|523763128|FG001|Follow-up Phase (2 Weeks)|Other|0|||
145250887|NCT03074318|523763129|FG000|Overall Study|Adverse Event|0|||
145250888|NCT03074318|523763130|FG001|Overall Study|Adverse Event|1|||
145250889|NCT03074318|523763131|FG002|Overall Study|Adverse Event|1|||
145250890|NCT03074318|523763132|FG003|Overall Study|Adverse Event|1|||
145250891|NCT03074318|523763129|FG000|Overall Study|Death|1|||
145250892|NCT03074318|523763130|FG001|Overall Study|Death|0|||
145250893|NCT03074318|523763131|FG002|Overall Study|Death|0|||
145250894|NCT03074318|523763132|FG003|Overall Study|Death|0|||
145250895|NCT03074318|523763129|FG000|Overall Study|Withdrawal by Subject|1|||
145250896|NCT03074318|523763130|FG001|Overall Study|Withdrawal by Subject|2|||
145250897|NCT03074318|523763131|FG002|Overall Study|Withdrawal by Subject|2|||
145250898|NCT03074318|523763132|FG003|Overall Study|Withdrawal by Subject|4|||
145250899|NCT03074318|523763129|FG000|Overall Study|Trial Closure|2|||
145250900|NCT03074318|523763130|FG001|Overall Study|Trial Closure|2|||
145250901|NCT03074318|523763131|FG002|Overall Study|Trial Closure|3|||
145250902|NCT03074318|523763132|FG003|Overall Study|Trial Closure|11|||
145250903|NCT00952419|523763133|FG000|Overall Study|Adverse Event|2|||
145250904|NCT00952419|523763134|FG001|Overall Study|Adverse Event|0|||
145250905|NCT00952419|523763135|FG002|Overall Study|Adverse Event|0|||
145250906|NCT00952419|523763133|FG000|Overall Study|Protocol Violation|3|||
145250907|NCT00952419|523763134|FG001|Overall Study|Protocol Violation|7|||
145250908|NCT00952419|523763135|FG002|Overall Study|Protocol Violation|0|||
145250909|NCT00952419|523763133|FG000|Overall Study|Withdrawal by Subject|1|||
145250910|NCT00952419|523763134|FG001|Overall Study|Withdrawal by Subject|3|||
145250911|NCT00952419|523763135|FG002|Overall Study|Withdrawal by Subject|0|||
145250912|NCT03573804|523763136|FG000|Overall Study|claustrophobia or MRI table problems|10|||
145250913|NCT03661983|523764556|FG000|Open Label Stabilization Phase|Adverse Event|5|||
145250914|NCT03661983|523764557|FG001|Open Label Stabilization Phase|Adverse Event|0|||
145250915|NCT03661983|523764558|FG002|Open Label Stabilization Phase|Adverse Event|0|||
145250916|NCT03661983|523764559|FG003|Open Label Stabilization Phase|Adverse Event|0|||
145250917|NCT03661983|523764556|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
145250918|NCT03661983|523764557|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
145250919|NCT03661983|523764558|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
145250920|NCT03661983|523764559|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
145250921|NCT03661983|523764556|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
145250922|NCT03661983|523764557|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
145250923|NCT03661983|523764558|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
145250924|NCT03661983|523764559|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
145250925|NCT03661983|523764556|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
145250926|NCT03661983|523764557|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
145250927|NCT03661983|523764558|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
145250928|NCT03661983|523764559|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
145250929|NCT03661983|523764556|FG000|Double-blind Randomized Phase|Adverse Event|0|||
145250930|NCT03661983|523764557|FG001|Double-blind Randomized Phase|Adverse Event|1|||
145250931|NCT03661983|523764558|FG002|Double-blind Randomized Phase|Adverse Event|0|||
145250932|NCT03661983|523764559|FG003|Double-blind Randomized Phase|Adverse Event|0|||
145250933|NCT03661983|523764556|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
145250934|NCT03661983|523764557|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
145250935|NCT03661983|523764558|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
145250936|NCT03661983|523764559|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
145250937|NCT03661983|523764556|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
145250938|NCT03661983|523764557|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
145250939|NCT03661983|523764558|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
145250940|NCT03661983|523764559|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
145250941|NCT03661983|523764556|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
145250942|NCT03661983|523764557|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
145250943|NCT03661983|523764558|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
145250944|NCT03661983|523764559|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
145250945|NCT02045979|523764560|FG000|Overall Study|Informed Consent Withdrawn|2|||
145250946|NCT02045979|523764561|FG001|Overall Study|Informed Consent Withdrawn|0|||
145250947|NCT02045979|523764562|FG002|Overall Study|Informed Consent Withdrawn|1|||
145250948|NCT02045979|523764560|FG000|Overall Study|not specified above|0|||
145250949|NCT02045979|523764561|FG001|Overall Study|not specified above|1|||
145250950|NCT02045979|523764562|FG002|Overall Study|not specified above|0|||
145250951|NCT00378534|523764563|FG000|Overall Study|Participants did not receive transplant|3|||
145250952|NCT00378534|523764564|FG001|Overall Study|Participants did not receive transplant|0|||
145250953|NCT04423718|523764567|FG000|Main Study|Adverse Event|9|||
145250954|NCT04423718|523764568|FG001|Main Study|Adverse Event|5|||
145250955|NCT04423718|523764569|FG002|Main Study|Adverse Event|8|||
145250956|NCT04423718|523764567|FG000|Main Study|Physician Decision|3|||
145250957|NCT04423718|523764568|FG001|Main Study|Physician Decision|3|||
145250958|NCT04423718|523764569|FG002|Main Study|Physician Decision|2|||
145250959|NCT04423718|523764567|FG000|Main Study|Protocol Violation|0|||
145250960|NCT04423718|523764568|FG001|Main Study|Protocol Violation|0|||
145250961|NCT04423718|523764569|FG002|Main Study|Protocol Violation|1|||
145250962|NCT04423718|523764567|FG000|Main Study|Lost to Follow-up|3|||
145250963|NCT04423718|523764568|FG001|Main Study|Lost to Follow-up|3|||
145250964|NCT04423718|523764569|FG002|Main Study|Lost to Follow-up|4|||
145250965|NCT04423718|523764567|FG000|Main Study|Lack of Efficacy|2|||
145250966|NCT04423718|523764568|FG001|Main Study|Lack of Efficacy|1|||
145250967|NCT04423718|523764569|FG002|Main Study|Lack of Efficacy|0|||
145250968|NCT04423718|523764567|FG000|Main Study|Withdrawal by Subject|14|||
145250969|NCT04423718|523764568|FG001|Main Study|Withdrawal by Subject|20|||
145250970|NCT04423718|523764569|FG002|Main Study|Withdrawal by Subject|20|||
145250971|NCT04423718|523764567|FG000|Main Study|Death|10|||
145250972|NCT04423718|523764568|FG001|Main Study|Death|7|||
145250973|NCT04423718|523764569|FG002|Main Study|Death|7|||
145250974|NCT04423718|523764567|FG000|Main Study|COVID-19 pandemic|2|||
145250975|NCT04423718|523764568|FG001|Main Study|COVID-19 pandemic|2|||
145250976|NCT04423718|523764569|FG002|Main Study|COVID-19 pandemic|2|||
145250977|NCT04423718|523764567|FG000|Main Study|Other|7|||
145250978|NCT04423718|523764568|FG001|Main Study|Other|3|||
145250979|NCT04423718|523764569|FG002|Main Study|Other|2|||
145250980|NCT04423718|523764567|FG000|Extension Phase|Other|1|||
145250981|NCT04423718|523764568|FG001|Extension Phase|Other|0|||
145250982|NCT04423718|523764569|FG002|Extension Phase|Other|0|||
145250983|NCT04423718|523764567|FG000|Extension Phase|Logistical problems|0|||
145250984|NCT04423718|523764568|FG001|Extension Phase|Logistical problems|1|||
145250985|NCT04423718|523764569|FG002|Extension Phase|Logistical problems|1|||
145250986|NCT04423718|523764567|FG000|Extension Phase|Physician Decision|1|||
145250987|NCT04423718|523764568|FG001|Extension Phase|Physician Decision|0|||
145250988|NCT04423718|523764569|FG002|Extension Phase|Physician Decision|1|||
145250989|NCT04423718|523764567|FG000|Extension Phase|Lack of Efficacy|2|||
145299606|NCT01536405|523948799|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
145299607|NCT01536405|523948800|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
145299608|NCT01536405|523948799|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
145299609|NCT01536405|523948800|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
145299610|NCT01536405|523948799|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
145299611|NCT01536405|523948800|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
145299612|NCT01536405|523948799|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
145299613|NCT01536405|523948800|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
145299614|NCT01536405|523948799|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
145299615|NCT01536405|523948800|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
145299616|NCT01536405|523948799|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
145250990|NCT04423718|523764568|FG001|Extension Phase|Lack of Efficacy|0|||
145299617|NCT01536405|523948800|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
145250991|NCT04423718|523764569|FG002|Extension Phase|Lack of Efficacy|1|||
145250992|NCT04423718|523764567|FG000|Extension Phase|Lost to Follow-up|0|||
145250993|NCT04423718|523764568|FG001|Extension Phase|Lost to Follow-up|2|||
145250994|NCT04423718|523764569|FG002|Extension Phase|Lost to Follow-up|3|||
145250995|NCT04423718|523764567|FG000|Extension Phase|Adverse Event|2|||
145250996|NCT04423718|523764568|FG001|Extension Phase|Adverse Event|3|||
145250997|NCT04423718|523764569|FG002|Extension Phase|Adverse Event|1|||
145250998|NCT04423718|523764567|FG000|Extension Phase|Death|4|||
145250999|NCT04423718|523764568|FG001|Extension Phase|Death|7|||
145251000|NCT04423718|523764569|FG002|Extension Phase|Death|2|||
145251001|NCT04423718|523764567|FG000|Extension Phase|Withdrawal by Subject|11|||
145299618|NCT01536405|523948799|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
145251002|NCT04423718|523764568|FG001|Extension Phase|Withdrawal by Subject|11|||
145251003|NCT04423718|523764569|FG002|Extension Phase|Withdrawal by Subject|7|||
145251004|NCT00425945|523764570|FG000|Overall Study|Concern about Supplement|2|||
145251005|NCT00425945|523764571|FG001|Overall Study|Concern about Supplement|0|||
145251006|NCT00425945|523764570|FG000|Overall Study|Inconvenience|0|||
145251007|NCT00425945|523764571|FG001|Overall Study|Inconvenience|2|||
145251008|NCT00425945|523764570|FG000|Overall Study|Lost to Follow-up|0|||
145251009|NCT00425945|523764571|FG001|Overall Study|Lost to Follow-up|2|||
145251010|NCT00425945|523764570|FG000|Overall Study|Began hypertension medication|1|||
145251011|NCT00425945|523764571|FG001|Overall Study|Began hypertension medication|0|||
145251012|NCT00425945|523764570|FG000|Overall Study|Began cancer treatments|1|||
145251013|NCT00425945|523764571|FG001|Overall Study|Began cancer treatments|0|||
145251014|NCT00425945|523764570|FG000|Overall Study|Moved from area|0|||
145251015|NCT00425945|523764571|FG001|Overall Study|Moved from area|1|||
145251016|NCT02881151|523764572|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
145251017|NCT01222767|523764574|FG000|Overall Study|Progressive disease|13|||
145251018|NCT01222767|523764574|FG000|Overall Study|Adverse Event|2|||
145251019|NCT01222767|523764574|FG000|Overall Study|Surgical resection|1|||
145251020|NCT01222767|523764574|FG000|Overall Study|Never treated|1|||
145251021|NCT03258593|523764575|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
145251022|NCT03258593|523764576|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
145251023|NCT03258593|523764577|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
145251024|NCT03258593|523764578|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
145251025|NCT03258593|523764575|FG000|Run-In Maintenance Phase|Disease progression|3|||
145251026|NCT03258593|523764576|FG001|Run-In Maintenance Phase|Disease progression|0|||
145251027|NCT03258593|523764577|FG002|Run-In Maintenance Phase|Disease progression|0|||
145251028|NCT03258593|523764578|FG003|Run-In Maintenance Phase|Disease progression|0|||
145251029|NCT03258593|523764575|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
145251030|NCT03258593|523764576|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
145251031|NCT03258593|523764577|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
145251032|NCT03258593|523764578|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
145251033|NCT03258593|523764575|FG000|Expansion Maintenance Phase|Physician Decision|0|||
145251034|NCT03258593|523764576|FG001|Expansion Maintenance Phase|Physician Decision|1|||
145251035|NCT03258593|523764577|FG002|Expansion Maintenance Phase|Physician Decision|0|||
145251036|NCT03258593|523764578|FG003|Expansion Maintenance Phase|Physician Decision|0|||
145251037|NCT00723489|523764579|FG000|Overall Study|Physician Decision|0|||
145251038|NCT00723489|523764580|FG001|Overall Study|Physician Decision|1|||
145251039|NCT00723489|523764581|FG002|Overall Study|Physician Decision|0|||
145251040|NCT00723489|523764582|FG003|Overall Study|Physician Decision|0|||
145251041|NCT00723489|523764579|FG000|Overall Study|Pregnancy|0|||
145251042|NCT00723489|523764580|FG001|Overall Study|Pregnancy|0|||
145251043|NCT00723489|523764581|FG002|Overall Study|Pregnancy|0|||
145251044|NCT00723489|523764582|FG003|Overall Study|Pregnancy|1|||
145251045|NCT00723489|523764579|FG000|Overall Study|Withdrawal by Subject|0|||
145251046|NCT00723489|523764580|FG001|Overall Study|Withdrawal by Subject|0|||
145251047|NCT00723489|523764581|FG002|Overall Study|Withdrawal by Subject|0|||
145251048|NCT00723489|523764582|FG003|Overall Study|Withdrawal by Subject|1|||
145251049|NCT00723489|523764579|FG000|Overall Study|Seropositive at baseline|1|||
145251050|NCT00723489|523764580|FG001|Overall Study|Seropositive at baseline|0|||
145251051|NCT00723489|523764581|FG002|Overall Study|Seropositive at baseline|0|||
145251052|NCT00723489|523764582|FG003|Overall Study|Seropositive at baseline|0|||
145251053|NCT00723489|523764579|FG000|Overall Study|Prohibited Medication|0|||
145251054|NCT00723489|523764580|FG001|Overall Study|Prohibited Medication|0|||
145251055|NCT00723489|523764581|FG002|Overall Study|Prohibited Medication|0|||
145251056|NCT00723489|523764582|FG003|Overall Study|Prohibited Medication|1|||
145251057|NCT00723489|523764579|FG000|Overall Study|Samples Collected Out of Window|0|||
145251058|NCT00723489|523764580|FG001|Overall Study|Samples Collected Out of Window|3|||
145251059|NCT00723489|523764581|FG002|Overall Study|Samples Collected Out of Window|0|||
145251060|NCT00723489|523764582|FG003|Overall Study|Samples Collected Out of Window|0|||
145251061|NCT03657576|523764586|FG000|Overall Study|Death|0|||
145251062|NCT03657576|523764587|FG001|Overall Study|Death|1|||
145251063|NCT03657576|523764588|FG002|Overall Study|Death|1|||
145251064|NCT03657576|523764589|FG003|Overall Study|Death|0|||
145251065|NCT03657576|523764590|FG004|Overall Study|Death|0|||
145251066|NCT03657576|523764591|FG005|Overall Study|Death|0|||
145251067|NCT03657576|523764586|FG000|Overall Study|Withdrawal by Subject|0|||
145251068|NCT03657576|523764587|FG001|Overall Study|Withdrawal by Subject|0|||
145251069|NCT03657576|523764588|FG002|Overall Study|Withdrawal by Subject|0|||
145251070|NCT03657576|523764589|FG003|Overall Study|Withdrawal by Subject|1|||
145251071|NCT03657576|523764590|FG004|Overall Study|Withdrawal by Subject|0|||
145251072|NCT03657576|523764591|FG005|Overall Study|Withdrawal by Subject|0|||
145251073|NCT03657576|523764586|FG000|Overall Study|Screen Fail|0|||
145251074|NCT03657576|523764587|FG001|Overall Study|Screen Fail|0|||
145251075|NCT03657576|523764588|FG002|Overall Study|Screen Fail|0|||
145251076|NCT03657576|523764589|FG003|Overall Study|Screen Fail|0|||
145251077|NCT03657576|523764590|FG004|Overall Study|Screen Fail|0|||
145251078|NCT03657576|523764591|FG005|Overall Study|Screen Fail|5|||
145251079|NCT03657576|523764586|FG000|Overall Study|Disease Progression|1|||
145251080|NCT03657576|523764587|FG001|Overall Study|Disease Progression|1|||
145251081|NCT03657576|523764588|FG002|Overall Study|Disease Progression|0|||
145251082|NCT03657576|523764589|FG003|Overall Study|Disease Progression|5|||
145251083|NCT03657576|523764590|FG004|Overall Study|Disease Progression|0|||
145251084|NCT03657576|523764591|FG005|Overall Study|Disease Progression|0|||
145251085|NCT03657576|523764586|FG000|Overall Study|Insurance Coverage|0|||
145251086|NCT03657576|523764587|FG001|Overall Study|Insurance Coverage|0|||
145251087|NCT03657576|523764588|FG002|Overall Study|Insurance Coverage|0|||
145251088|NCT03657576|523764589|FG003|Overall Study|Insurance Coverage|1|||
145251089|NCT03657576|523764590|FG004|Overall Study|Insurance Coverage|0|||
145251090|NCT03657576|523764591|FG005|Overall Study|Insurance Coverage|0|||
145251091|NCT04437511|523764592|FG000|Overall Study|Adverse Event|50|||
145251092|NCT04437511|523764593|FG001|Overall Study|Adverse Event|21|||
145251093|NCT04437511|523764592|FG000|Overall Study|Death|15|||
145251094|NCT04437511|523764593|FG001|Overall Study|Death|10|||
145251095|NCT04437511|523764592|FG000|Overall Study|Lost to Follow-up|11|||
145251096|NCT04437511|523764593|FG001|Overall Study|Lost to Follow-up|11|||
145251097|NCT04437511|523764592|FG000|Overall Study|Physician Decision|19|||
145251098|NCT04437511|523764593|FG001|Overall Study|Physician Decision|10|||
145251099|NCT04437511|523764592|FG000|Overall Study|Progressive Disease|4|||
145251100|NCT04437511|523764593|FG001|Overall Study|Progressive Disease|7|||
145251101|NCT04437511|523764592|FG000|Overall Study|Withdrawal by Subject|111|||
145251102|NCT04437511|523764593|FG001|Overall Study|Withdrawal by Subject|94|||
145251103|NCT04437511|523764592|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
145251104|NCT04437511|523764593|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
145251105|NCT04437511|523764592|FG000|Overall Study|Continuing Study|7|||
145251106|NCT04437511|523764593|FG001|Overall Study|Continuing Study|5|||
145251107|NCT04284787|523764596|FG000|Overall Study|Disease Progression|9|||
145251108|NCT04284787|523764597|FG001|Overall Study|Disease Progression|12|||
145251109|NCT04284787|523764596|FG000|Overall Study|Physician Decision|12|||
145251110|NCT04284787|523764597|FG001|Overall Study|Physician Decision|7|||
145251111|NCT04284787|523764596|FG000|Overall Study|Transplant|5|||
145251112|NCT04284787|523764597|FG001|Overall Study|Transplant|4|||
145251113|NCT04284787|523764596|FG000|Overall Study|Death|1|||
145251114|NCT04284787|523764597|FG001|Overall Study|Death|2|||
145251115|NCT04284787|523764596|FG000|Overall Study|Adverse Event|0|||
145251116|NCT04284787|523764597|FG001|Overall Study|Adverse Event|4|||
145251117|NCT04284787|523764596|FG000|Overall Study|Non-adherence|2|||
145251118|NCT04284787|523764597|FG001|Overall Study|Non-adherence|0|||
145251119|NCT04284787|523764596|FG000|Overall Study|Lack of Efficacy|2|||
145251120|NCT04284787|523764597|FG001|Overall Study|Lack of Efficacy|0|||
145251121|NCT02559115|523764598|FG000|Overall Study|Withdrawal by Subject|3|||
145251122|NCT01996865|523764599|FG000|Induction Period|Protocol Violation|1|||
145251123|NCT01996865|523764600|FG001|Induction Period|Protocol Violation|0|||
145251124|NCT01996865|523764601|FG002|Induction Period|Protocol Violation|0|||
145251125|NCT01996865|523764599|FG000|Induction Period|Progressive Disease|4|||
145251126|NCT01996865|523764600|FG001|Induction Period|Progressive Disease|0|||
145251127|NCT01996865|523764601|FG002|Induction Period|Progressive Disease|0|||
145251128|NCT01996865|523764599|FG000|Induction Period|Lost to Follow-up|10|||
145251129|NCT01996865|523764600|FG001|Induction Period|Lost to Follow-up|0|||
145251130|NCT01996865|523764601|FG002|Induction Period|Lost to Follow-up|0|||
145251131|NCT01996865|523764599|FG000|Induction Period|Other Reasons|13|||
145251132|NCT01996865|523764600|FG001|Induction Period|Other Reasons|0|||
145251133|NCT01996865|523764601|FG002|Induction Period|Other Reasons|0|||
145251134|NCT01996865|523764599|FG000|Induction Period|Adverse Event|20|||
145251135|NCT01996865|523764600|FG001|Induction Period|Adverse Event|0|||
145251136|NCT01996865|523764601|FG002|Induction Period|Adverse Event|0|||
145251137|NCT01996865|523764599|FG000|Induction Period|Withdrawal by Subject|60|||
145251138|NCT01996865|523764600|FG001|Induction Period|Withdrawal by Subject|0|||
145251139|NCT01996865|523764601|FG002|Induction Period|Withdrawal by Subject|0|||
145251140|NCT01996865|523764599|FG000|Induction Period|Death|111|||
145251141|NCT01996865|523764600|FG001|Induction Period|Death|0|||
145251142|NCT01996865|523764601|FG002|Induction Period|Death|0|||
145251143|NCT01996865|523764599|FG000|Maintenance Period|Protocol Violation|0|||
145251144|NCT01996865|523764600|FG001|Maintenance Period|Protocol Violation|1|||
145251145|NCT01996865|523764601|FG002|Maintenance Period|Protocol Violation|1|||
145251146|NCT01996865|523764599|FG000|Maintenance Period|Other reasons|0|||
145251147|NCT01996865|523764600|FG001|Maintenance Period|Other reasons|8|||
145251148|NCT01996865|523764601|FG002|Maintenance Period|Other reasons|5|||
145251149|NCT01996865|523764599|FG000|Maintenance Period|Progressive Disease|0|||
145251150|NCT01996865|523764600|FG001|Maintenance Period|Progressive Disease|6|||
145251151|NCT01996865|523764601|FG002|Maintenance Period|Progressive Disease|23|||
145251152|NCT01996865|523764599|FG000|Maintenance Period|Withdrawal by Subject|0|||
145251153|NCT01996865|523764600|FG001|Maintenance Period|Withdrawal by Subject|18|||
145251154|NCT01996865|523764601|FG002|Maintenance Period|Withdrawal by Subject|4|||
145251155|NCT01996865|523764599|FG000|Maintenance Period|Adverse Event|0|||
145251156|NCT01996865|523764600|FG001|Maintenance Period|Adverse Event|7|||
145251157|NCT01996865|523764601|FG002|Maintenance Period|Adverse Event|7|||
145251158|NCT01996865|523764599|FG000|Maintenance Period|Death|0|||
145251159|NCT01996865|523764600|FG001|Maintenance Period|Death|15|||
145299619|NCT01536405|523948800|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
145299620|NCT01536405|523948799|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
145299621|NCT01536405|523948800|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
145299622|NCT01536405|523948799|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
145251160|NCT01996865|523764601|FG002|Maintenance Period|Death|3|||
145251161|NCT01996865|523764599|FG000|Maintenance Period|Lost to Follow-up|0|||
145251162|NCT01996865|523764600|FG001|Maintenance Period|Lost to Follow-up|2|||
145251163|NCT01996865|523764601|FG002|Maintenance Period|Lost to Follow-up|0|||
145251164|NCT02354690|523764608|FG000|Overall Study|Physician Decision|1|||
145251165|NCT00515099|523764613|FG000|Overall Study|Lost to Follow-up|0|||
145251166|NCT00515099|523764614|FG001|Overall Study|Lost to Follow-up|4|||
145251167|NCT00515099|523764613|FG000|Overall Study|Withdrawal by Subject|2|||
145251168|NCT00515099|523764614|FG001|Overall Study|Withdrawal by Subject|0|||
145251169|NCT00515099|523764613|FG000|Overall Study|IRB Recommendation|1|||
145251170|NCT00515099|523764614|FG001|Overall Study|IRB Recommendation|0|||
145251171|NCT00592072|523764615|FG000|Wash Out Period|Lost to Follow-up|1|||
145251172|NCT00592072|523764616|FG001|Wash Out Period|Lost to Follow-up|1|||
145251173|NCT03369704|523764617|FG000|Treatment Epoch|technical problems|1|||
145251174|NCT03369704|523764618|FG001|Treatment Epoch|technical problems|0|||
145251175|NCT03369704|523764617|FG000|Treatment Epoch|Protocol Violation|1|||
145251176|NCT03369704|523764618|FG001|Treatment Epoch|Protocol Violation|0|||
145251177|NCT03369704|523764617|FG000|Treatment Epoch|Lost to Follow-up|0|||
145251178|NCT03369704|523764618|FG001|Treatment Epoch|Lost to Follow-up|1|||
145251179|NCT03369704|523764617|FG000|Treatment Epoch|Lack of Efficacy|0|||
145251180|NCT03369704|523764618|FG001|Treatment Epoch|Lack of Efficacy|2|||
145251181|NCT03369704|523764617|FG000|Treatment Epoch|Adverse Event|2|||
145251182|NCT03369704|523764618|FG001|Treatment Epoch|Adverse Event|0|||
145251183|NCT03369704|523764617|FG000|Follow-up Epoch|Lost to Follow-up|1|||
145251184|NCT03369704|523764618|FG001|Follow-up Epoch|Lost to Follow-up|0|||
145251185|NCT05333289|523764620|FG000|Overall Study|Other|1|||
145251186|NCT05333289|523764621|FG001|Overall Study|Other|0|||
145251187|NCT05333289|523764622|FG002|Overall Study|Other|0|||
145251188|NCT05333289|523764623|FG003|Overall Study|Other|1|||
145251189|NCT05333289|523764624|FG004|Overall Study|Other|1|||
145251190|NCT05333289|523764625|FG005|Overall Study|Other|2|||
145251191|NCT05333289|523764626|FG006|Overall Study|Other|2|||
145251192|NCT05333289|523764627|FG007|Overall Study|Other|0|||
145251193|NCT05333289|523764620|FG000|Overall Study|Withdrawal by Subject|1|||
145251194|NCT05333289|523764621|FG001|Overall Study|Withdrawal by Subject|2|||
145251195|NCT05333289|523764622|FG002|Overall Study|Withdrawal by Subject|2|||
145251196|NCT05333289|523764623|FG003|Overall Study|Withdrawal by Subject|1|||
145251197|NCT05333289|523764624|FG004|Overall Study|Withdrawal by Subject|1|||
145251198|NCT05333289|523764625|FG005|Overall Study|Withdrawal by Subject|2|||
145251199|NCT05333289|523764626|FG006|Overall Study|Withdrawal by Subject|1|||
145251200|NCT05333289|523764627|FG007|Overall Study|Withdrawal by Subject|3|||
145251201|NCT05333289|523764620|FG000|Overall Study|Protocol Violation|1|||
145251202|NCT05333289|523764621|FG001|Overall Study|Protocol Violation|0|||
145251203|NCT05333289|523764622|FG002|Overall Study|Protocol Violation|0|||
145251204|NCT05333289|523764623|FG003|Overall Study|Protocol Violation|0|||
145299623|NCT01536405|523948800|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
145299624|NCT02255097|523948803|FG000|Overall Study|Death|151|||
145251205|NCT05333289|523764624|FG004|Overall Study|Protocol Violation|0|||
145251206|NCT05333289|523764625|FG005|Overall Study|Protocol Violation|0|||
145251207|NCT05333289|523764626|FG006|Overall Study|Protocol Violation|0|||
145251208|NCT05333289|523764627|FG007|Overall Study|Protocol Violation|0|||
145251209|NCT05333289|523764620|FG000|Overall Study|Physician Decision|0|||
145251210|NCT05333289|523764621|FG001|Overall Study|Physician Decision|0|||
145251211|NCT05333289|523764622|FG002|Overall Study|Physician Decision|1|||
145251212|NCT05333289|523764623|FG003|Overall Study|Physician Decision|0|||
145251213|NCT05333289|523764624|FG004|Overall Study|Physician Decision|0|||
145251214|NCT05333289|523764625|FG005|Overall Study|Physician Decision|2|||
145251215|NCT05333289|523764626|FG006|Overall Study|Physician Decision|0|||
145251216|NCT05333289|523764627|FG007|Overall Study|Physician Decision|0|||
145251217|NCT05333289|523764620|FG000|Overall Study|Lost to Follow-up|6|||
145251218|NCT05333289|523764621|FG001|Overall Study|Lost to Follow-up|0|||
145251219|NCT05333289|523764622|FG002|Overall Study|Lost to Follow-up|1|||
145251220|NCT05333289|523764623|FG003|Overall Study|Lost to Follow-up|6|||
145251221|NCT05333289|523764624|FG004|Overall Study|Lost to Follow-up|3|||
145251222|NCT05333289|523764625|FG005|Overall Study|Lost to Follow-up|3|||
145251223|NCT05333289|523764626|FG006|Overall Study|Lost to Follow-up|2|||
145251224|NCT05333289|523764627|FG007|Overall Study|Lost to Follow-up|1|||
145251225|NCT05333289|523764620|FG000|Overall Study|Death|1|||
145251226|NCT05333289|523764621|FG001|Overall Study|Death|0|||
145251227|NCT05333289|523764622|FG002|Overall Study|Death|0|||
145299625|NCT02255097|523948803|FG000|Overall Study|Lost to Follow-up|5|||
145251228|NCT05333289|523764623|FG003|Overall Study|Death|0|||
145251229|NCT05333289|523764624|FG004|Overall Study|Death|0|||
145251230|NCT05333289|523764625|FG005|Overall Study|Death|0|||
145251231|NCT05333289|523764626|FG006|Overall Study|Death|0|||
145251232|NCT05333289|523764627|FG007|Overall Study|Death|0|||
145251233|NCT02750501|523764628|FG000|Overall Study|Adverse Event|4|||
145251234|NCT02750501|523764628|FG000|Overall Study|Physician Decision|1|||
145251235|NCT02750501|523764628|FG000|Overall Study|Protocol Violation|1|||
145251236|NCT02750501|523764628|FG000|Overall Study|G-tube came out|1|||
145251237|NCT02750501|523764628|FG000|Overall Study|Non-compliant use of PERT|1|||
145251238|NCT03685643|523764629|FG000|Overall Study|Lost to Follow-up|14|||
145251239|NCT03685643|523764630|FG001|Overall Study|Lost to Follow-up|22|||
145251240|NCT03797144|523764631|FG000|Enrollment|Protocol Violation|4|||
145251241|NCT03797144|523764632|FG001|Enrollment|Protocol Violation|1|||
145251242|NCT03797144|523764631|FG000|Surgery|Protocol Violation|1|||
145251243|NCT03797144|523764632|FG001|Surgery|Protocol Violation|0|||
145251244|NCT03797144|523764631|FG000|3 Month|Early termination cut-off date|2|||
145251245|NCT03797144|523764632|FG001|3 Month|Early termination cut-off date|0|||
145251246|NCT03797144|523764631|FG000|12 Month|Early termination cut-off date|8|||
145251247|NCT03797144|523764632|FG001|12 Month|Early termination cut-off date|9|||
145251248|NCT03797144|523764631|FG000|24 Month|Early termination cut-off date|1|||
145251249|NCT03797144|523764632|FG001|24 Month|Early termination cut-off date|1|||
145251250|NCT04430036|523764633|FG000|Safety Run in Phase|Progression of disease|2|||
145251251|NCT00376675|523764634|FG000|Overall Study|Withdrawal by Subject|9|||
145251252|NCT00376675|523764635|FG001|Overall Study|Withdrawal by Subject|2|||
145251253|NCT00376675|523764634|FG000|Overall Study|Adverse Event|10|||
145251254|NCT00376675|523764635|FG001|Overall Study|Adverse Event|5|||
145251255|NCT00376675|523764634|FG000|Overall Study|Other Reason|1|||
145251256|NCT00376675|523764635|FG001|Overall Study|Other Reason|7|||
145251257|NCT00423592|523764643|FG000|Overall Study|Adverse Event (through Week 12)|2|||
145251258|NCT00423592|523764643|FG000|Overall Study|Adverse Event (post Week 12)|5|||
145251259|NCT00002981|523764648|FG000|Overall Study|Inevaluable|6|||
145251260|NCT00255008|523764649|FG000|Overall Study|Adverse Event|1|||
145251261|NCT00255008|523764650|FG001|Overall Study|Adverse Event|1|||
145251262|NCT00255008|523764651|FG002|Overall Study|Adverse Event|2|||
145251263|NCT00255008|523764652|FG003|Overall Study|Adverse Event|0|||
145251264|NCT00255008|523764649|FG000|Overall Study|Lost to Follow-up|1|||
145251265|NCT00255008|523764650|FG001|Overall Study|Lost to Follow-up|0|||
145251266|NCT00255008|523764651|FG002|Overall Study|Lost to Follow-up|1|||
145251267|NCT00255008|523764652|FG003|Overall Study|Lost to Follow-up|2|||
145251268|NCT00255008|523764649|FG000|Overall Study|Did not meet viral reduction criteria|4|||
145251269|NCT00255008|523764650|FG001|Overall Study|Did not meet viral reduction criteria|5|||
145251270|NCT00255008|523764651|FG002|Overall Study|Did not meet viral reduction criteria|0|||
145251271|NCT00255008|523764652|FG003|Overall Study|Did not meet viral reduction criteria|1|||
145251272|NCT00255008|523764649|FG000|Overall Study|Withdrew consent|0|||
145251273|NCT00255008|523764650|FG001|Overall Study|Withdrew consent|0|||
145251274|NCT00255008|523764651|FG002|Overall Study|Withdrew consent|2|||
145251275|NCT00255008|523764652|FG003|Overall Study|Withdrew consent|0|||
145251276|NCT00255008|523764649|FG000|Overall Study|Sponsor request|18|||
145251277|NCT00255008|523764650|FG001|Overall Study|Sponsor request|3|||
145251278|NCT00255008|523764651|FG002|Overall Study|Sponsor request|8|||
145251279|NCT00255008|523764652|FG003|Overall Study|Sponsor request|17|||
145251280|NCT00255008|523764649|FG000|Overall Study|Adverse lab experience|1|||
145251281|NCT00255008|523764650|FG001|Overall Study|Adverse lab experience|0|||
145251282|NCT00255008|523764651|FG002|Overall Study|Adverse lab experience|0|||
145251283|NCT00255008|523764652|FG003|Overall Study|Adverse lab experience|0|||
145251284|NCT00255008|523764649|FG000|Overall Study|Other|7|||
145251285|NCT00255008|523764650|FG001|Overall Study|Other|0|||
145251286|NCT00255008|523764651|FG002|Overall Study|Other|3|||
145251287|NCT00255008|523764652|FG003|Overall Study|Other|2|||
145251288|NCT05083949|523764653|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
145251289|NCT05083949|523764654|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
145251290|NCT05083949|523764653|FG000|Period 1|Adverse Event|1|||
145251291|NCT05083949|523764654|FG001|Period 1|Adverse Event|1|||
145251292|NCT05083949|523764653|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
145251293|NCT05083949|523764654|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
145251294|NCT05083949|523764653|FG000|Period 2|Adverse Event|0|||
145251295|NCT05083949|523764654|FG001|Period 2|Adverse Event|2|||
145251296|NCT03457636|523764658|FG000|Overall Study|Lost to Follow-up|2|||
145566632|NCT00735371|524936187|FG002|Overall Study|Lost to Follow-up|3|||
145566633|NCT00735371|524936188|FG003|Overall Study|Lost to Follow-up|1|||
145566634|NCT00735371|524936185|FG000|Overall Study|Lack of Efficacy|4|||
145566635|NCT00735371|524936186|FG001|Overall Study|Lack of Efficacy|2|||
145251297|NCT01833806|523764659|FG000|Overall Study|Alternative treatment|2|||
145251298|NCT01833806|523764659|FG000|Overall Study|Death|5|||
145251299|NCT01833806|523764659|FG000|Overall Study|Physician Decision|1|||
145251300|NCT01833806|523764659|FG000|Overall Study|Lost to Follow-up|1|||
145251301|NCT00707486|523764666|FG000|Overall Study|Withdrawal by Subject|1|||
145251302|NCT01885104|523764677|FG000|Overall Study|Withdrawal of Consent|1|||
145251303|NCT01885104|523764678|FG001|Overall Study|Withdrawal of Consent|0|||
145251304|NCT01885104|523764677|FG000|Overall Study|Lost to Follow-up|0|||
145251305|NCT01885104|523764678|FG001|Overall Study|Lost to Follow-up|1|||
145566636|NCT00735371|524936187|FG002|Overall Study|Lack of Efficacy|0|||
145251306|NCT01885104|523764677|FG000|Overall Study|Physician Decision|1|||
145251307|NCT01885104|523764678|FG001|Overall Study|Physician Decision|0|||
145251308|NCT00126425|523764682|FG000|Overall Study|Withdrawal by Subject|17|||
145251309|NCT00126425|523764683|FG001|Overall Study|Withdrawal by Subject|1|||
145251310|NCT00126425|523764682|FG000|Overall Study|Lost to Follow-up|8|||
145251311|NCT00126425|523764683|FG001|Overall Study|Lost to Follow-up|4|||
145251312|NCT00126425|523764682|FG000|Overall Study|Protocol Violation|9|||
145251313|NCT00126425|523764683|FG001|Overall Study|Protocol Violation|6|||
145251314|NCT00126425|523764682|FG000|Overall Study|Adverse Event|1|||
145251315|NCT00126425|523764683|FG001|Overall Study|Adverse Event|0|||
145251316|NCT00126425|523764682|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
145251317|NCT00126425|523764683|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
145251318|NCT00126425|523764682|FG000|Overall Study|Other|5|||
145251319|NCT00126425|523764683|FG001|Overall Study|Other|0|||
145251320|NCT04350372|523764685|FG000|Overall Study|Death|1|||
145251321|NCT04474366|523764686|FG000|Overall Study|Lost to Follow-up|2|||
145251322|NCT04474366|523764687|FG001|Overall Study|Lost to Follow-up|5|||
145251323|NCT00320190|523764688|FG000|First 12 Months|Completed but did not enter extension|5|||
145251324|NCT00320190|523764689|FG001|First 12 Months|Completed but did not enter extension|3|||
145251325|NCT00320190|523764688|FG000|First 12 Months|Sponsor terminated study|2|||
145251326|NCT00320190|523764689|FG001|First 12 Months|Sponsor terminated study|2|||
145251327|NCT00320190|523764688|FG000|First 12 Months|Lost to Follow-up|0|||
145251328|NCT00320190|523764689|FG001|First 12 Months|Lost to Follow-up|1|||
145251329|NCT00320190|523764688|FG000|First 12 Months|Enrollment failure|0|||
145251330|NCT00320190|523764689|FG001|First 12 Months|Enrollment failure|1|||
145251331|NCT00320190|523764688|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
145251332|NCT00320190|523764689|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
145251333|NCT00320190|523764688|FG000|First 12 Months|Investigator request|0|||
145251334|NCT00320190|523764689|FG001|First 12 Months|Investigator request|1|||
145251335|NCT00320190|523764688|FG000|First 12 Months|Study drug toxicity|0|||
145251336|NCT00320190|523764689|FG001|First 12 Months|Study drug toxicity|1|||
145251337|NCT00320190|523764688|FG000|First 12 Months|Withdrawal by Subject|0|||
145251338|NCT00320190|523764689|FG001|First 12 Months|Withdrawal by Subject|1|||
145251339|NCT00320190|523764688|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
145251340|NCT00320190|523764689|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
145251341|NCT00320190|523764688|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
145251342|NCT00320190|523764689|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
145251343|NCT00320190|523764688|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
145251344|NCT00320190|523764689|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
145251345|NCT05307523|523764691|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
145251346|NCT05307523|523764692|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
145251347|NCT05307523|523764691|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
145251348|NCT05307523|523764692|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
145251349|NCT04412668|523764695|FG000|Overall Study|Death - multiple comorbidities|2|||
145251350|NCT04412668|523764696|FG001|Overall Study|Death - multiple comorbidities|0|||
145251351|NCT04412668|523764697|FG002|Overall Study|Death - multiple comorbidities|0|||
145251352|NCT04412668|523764695|FG000|Overall Study|Withdrawal by Subject|3|||
145299626|NCT02255097|523948803|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
145299627|NCT02255097|523948803|FG000|Overall Study|Withdrawal by Subject|7|||
145251353|NCT04412668|523764696|FG001|Overall Study|Withdrawal by Subject|0|||
145251354|NCT04412668|523764697|FG002|Overall Study|Withdrawal by Subject|0|||
145251355|NCT04412668|523764695|FG000|Overall Study|Other than Specified|2|||
145251356|NCT04412668|523764696|FG001|Overall Study|Other than Specified|0|||
145251357|NCT04412668|523764697|FG002|Overall Study|Other than Specified|0|||
145251358|NCT00102804|523764698|FG000|Overall Study|Progressive Disease (PD)|307|||
145251359|NCT00102804|523764699|FG001|Overall Study|Progressive Disease (PD)|196|||
145251360|NCT00102804|523764698|FG000|Overall Study|Withdrawal by Subject|46|||
145251361|NCT00102804|523764699|FG001|Overall Study|Withdrawal by Subject|7|||
145299628|NCT02255097|523948803|FG000|Overall Study|Allocated but not treated|1|||
145299629|NCT02514122|523948804|FG000|Overall Study|Withdrawal by Subject|2|||
145299630|NCT02514122|523948805|FG001|Overall Study|Withdrawal by Subject|0|||
145299631|NCT01010542|523948806|FG000|Overall Study|Adverse Event|0|||
145251362|NCT00102804|523764698|FG000|Overall Study|Adverse Event|37|||
145299632|NCT01010542|523948807|FG001|Overall Study|Adverse Event|1|||
145299633|NCT01010542|523948808|FG002|Overall Study|Adverse Event|0|||
145251363|NCT00102804|523764699|FG001|Overall Study|Adverse Event|3|||
145299634|NCT01010542|523948806|FG000|Overall Study|Lost to Follow-up|0|||
145251364|NCT00102804|523764698|FG000|Overall Study|Physician Decision|24|||
145299635|NCT01010542|523948807|FG001|Overall Study|Lost to Follow-up|1|||
145251365|NCT00102804|523764699|FG001|Overall Study|Physician Decision|6|||
145251366|NCT00102804|523764698|FG000|Overall Study|Death|5|||
145251367|NCT00102804|523764699|FG001|Overall Study|Death|6|||
145251368|NCT00102804|523764698|FG000|Overall Study|Enrollment Criteria Not Met|6|||
145251369|NCT00102804|523764699|FG001|Overall Study|Enrollment Criteria Not Met|0|||
145299636|NCT01010542|523948808|FG002|Overall Study|Lost to Follow-up|0|||
145251370|NCT00102804|523764698|FG000|Overall Study|Lost to Follow-up|4|||
145251371|NCT00102804|523764699|FG001|Overall Study|Lost to Follow-up|1|||
145251372|NCT00102804|523764698|FG000|Overall Study|Protocol Violation|2|||
145251373|NCT00102804|523764699|FG001|Overall Study|Protocol Violation|1|||
145251374|NCT00102804|523764698|FG000|Overall Study|Satisfactory Response|2|||
145251375|NCT00102804|523764699|FG001|Overall Study|Satisfactory Response|0|||
145251376|NCT00102804|523764698|FG000|Overall Study|Sponsor Decision|1|||
145251377|NCT00102804|523764699|FG001|Overall Study|Sponsor Decision|0|||
145251378|NCT00102804|523764698|FG000|Overall Study|Alive, Receiving Treatment|7|||
145251379|NCT00102804|523764699|FG001|Overall Study|Alive, Receiving Treatment|2|||
145251380|NCT02299206|523764704|FG000|Overall Study|Lost to Follow-up|1|||
145251381|NCT02299206|523764704|FG000|Overall Study|Withdrawal by Subject|1|||
145251382|NCT01592773|523766075|FG000|Overall Study|Study Terminated by Sponsor|582|||
145251383|NCT01592773|523766075|FG000|Overall Study|Withdrawal by Subject|35|||
145251384|NCT01592773|523766075|FG000|Overall Study|Lost to Follow-up|19|||
145251385|NCT01592773|523766075|FG000|Overall Study|Adverse Event|17|||
145251386|NCT01592773|523766075|FG000|Overall Study|Lack of Efficacy|9|||
145251387|NCT01592773|523766075|FG000|Overall Study|Protocol Violation|2|||
145251388|NCT01592773|523766075|FG000|Overall Study|Inclusion/exclusion not meet|1|||
145251389|NCT01592773|523766075|FG000|Overall Study|Other Reason|1|||
145251390|NCT04418427|523766077|FG000|Overall Study|Death|0|||
145251391|NCT04418427|523766078|FG001|Overall Study|Death|1|||
145251392|NCT04418427|523766079|FG002|Overall Study|Death|0|||
145251393|NCT04418427|523766077|FG000|Overall Study|Lost to Follow-up|0|||
145251394|NCT04418427|523766078|FG001|Overall Study|Lost to Follow-up|2|||
145251395|NCT04418427|523766079|FG002|Overall Study|Lost to Follow-up|2|||
145251396|NCT04418427|523766077|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
145251397|NCT04418427|523766078|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
145251398|NCT04418427|523766079|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
145251399|NCT04418427|523766077|FG000|Overall Study|Pre-existing medical condition|0|||
145251400|NCT04418427|523766078|FG001|Overall Study|Pre-existing medical condition|1|||
145251401|NCT04418427|523766079|FG002|Overall Study|Pre-existing medical condition|0|||
145251402|NCT04076579|523766086|FG000|Overall Study|Adverse Event|2|||
145251403|NCT04076579|523766087|FG001|Overall Study|Adverse Event|0|||
145251404|NCT04076579|523766086|FG000|Overall Study|discontinued due to toxicity|1|||
145251405|NCT04076579|523766087|FG001|Overall Study|discontinued due to toxicity|0|||
145251406|NCT04076579|523766086|FG000|Overall Study|Physician Decision|1|||
145251407|NCT04076579|523766087|FG001|Overall Study|Physician Decision|0|||
145251408|NCT04076579|523766086|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
145251409|NCT04076579|523766087|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
145251410|NCT04076579|523766086|FG000|Overall Study|Noncompliance|0|||
145251411|NCT04076579|523766087|FG001|Overall Study|Noncompliance|1|||
145251412|NCT04076579|523766086|FG000|Overall Study|Withdrawal by Subject|0|||
145251413|NCT04076579|523766087|FG001|Overall Study|Withdrawal by Subject|2|||
145251414|NCT03793010|523766088|FG000|Overall Study|Withdrawal by Subject|5|||
145251415|NCT03793010|523766089|FG001|Overall Study|Withdrawal by Subject|7|||
145251416|NCT03793010|523766088|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
145251417|NCT03793010|523766089|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
145251418|NCT03793010|523766088|FG000|Overall Study|Lost to Follow-up|1|||
145251419|NCT03793010|523766089|FG001|Overall Study|Lost to Follow-up|2|||
145251420|NCT03793010|523766088|FG000|Overall Study|Patient couldn't sit still for injection|1|||
145299637|NCT01010542|523948806|FG000|Overall Study|Withdrawal by Subject|0|||
145299638|NCT01010542|523948807|FG001|Overall Study|Withdrawal by Subject|3|||
145299639|NCT01010542|523948808|FG002|Overall Study|Withdrawal by Subject|2|||
145299640|NCT01675765|523948809|FG000|Overall Study|Progressive disease|4|||
145299641|NCT01675765|523948810|FG001|Overall Study|Progressive disease|4|||
145299642|NCT01675765|523948809|FG000|Overall Study|Adverse Event|1|||
145299643|NCT01675765|523948810|FG001|Overall Study|Adverse Event|2|||
145299644|NCT01675765|523948809|FG000|Overall Study|Withdrawal by Subject|2|||
145299645|NCT01675765|523948810|FG001|Overall Study|Withdrawal by Subject|0|||
145299646|NCT01675765|523948809|FG000|Overall Study|Death|1|||
145299647|NCT01675765|523948810|FG001|Overall Study|Death|0|||
145299648|NCT01675765|523948809|FG000|Overall Study|Clinical progression|3|||
145299649|NCT01675765|523948810|FG001|Overall Study|Clinical progression|2|||
145251421|NCT03793010|523766089|FG001|Overall Study|Patient couldn't sit still for injection|0|||
145299650|NCT03965091|523948811|FG000|Overall Study|Adverse Event|0|||
145299651|NCT03965091|523948812|FG001|Overall Study|Adverse Event|2|||
145299652|NCT03965091|523948813|FG002|Overall Study|Adverse Event|3|||
145299653|NCT03965091|523948811|FG000|Overall Study|Withdrawal by Subject|11|||
145251422|NCT03793010|523766088|FG000|Overall Study|Withdrew to pursue other treatment|1|||
145251423|NCT03793010|523766089|FG001|Overall Study|Withdrew to pursue other treatment|0|||
145251424|NCT03793010|523766088|FG000|Overall Study|Did not meet eligibility criteria|1|||
145251425|NCT03793010|523766089|FG001|Overall Study|Did not meet eligibility criteria|0|||
145251426|NCT01952041|523766095|FG000|Overall Study|Lost to Follow-up|9|||
145251427|NCT01952041|523766096|FG001|Overall Study|Lost to Follow-up|16|||
145251428|NCT01952041|523766095|FG000|Overall Study|Withdrawal by Subject|7|||
145251429|NCT01952041|523766096|FG001|Overall Study|Withdrawal by Subject|5|||
145251430|NCT01952041|523766095|FG000|Overall Study|Death|1|||
145251431|NCT01952041|523766096|FG001|Overall Study|Death|0|||
145251432|NCT01736176|523766097|FG000|Overall Study|Adverse Event|3|||
145251433|NCT01736176|523766097|FG000|Overall Study|Withdrawal by Subject|4|||
145251434|NCT01736176|523766097|FG000|Overall Study|Lack of Efficacy|3|||
145251435|NCT01736176|523766097|FG000|Overall Study|Unable to Complete PEG Placement|1|||
145251436|NCT00186121|523766098|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
145251437|NCT00186121|523766098|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
145251438|NCT00186121|523766098|FG000|Overall Study|Not eligible (no treatment)|1|||
145251439|NCT03650387|523766099|FG000|Overall Study|Withdrawal by Subject|13|||
145251440|NCT03650387|523766099|FG000|Overall Study|Lost to Follow-up|12|||
145251441|NCT03650387|523766099|FG000|Overall Study|Adverse Event (Not related)|1|||
145251442|NCT03650387|523766099|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
145251443|NCT01370499|523766100|FG000|Overall Study|Adverse Event|38|||
145251444|NCT01370499|523766101|FG001|Overall Study|Adverse Event|12|||
145251445|NCT01370499|523766100|FG000|Overall Study|Lack of Efficacy|4|||
145251446|NCT01370499|523766101|FG001|Overall Study|Lack of Efficacy|2|||
145251447|NCT01370499|523766100|FG000|Overall Study|Lost to Follow-up|2|||
145251448|NCT01370499|523766101|FG001|Overall Study|Lost to Follow-up|1|||
145251449|NCT01370499|523766100|FG000|Overall Study|Physician Decision|3|||
145251450|NCT01370499|523766101|FG001|Overall Study|Physician Decision|3|||
145251451|NCT01370499|523766100|FG000|Overall Study|Protocol Violation|5|||
145251452|NCT01370499|523766101|FG001|Overall Study|Protocol Violation|4|||
145251453|NCT01370499|523766100|FG000|Overall Study|Withdrawal by Subject|18|||
145251454|NCT01370499|523766101|FG001|Overall Study|Withdrawal by Subject|7|||
145251455|NCT01370499|523766100|FG000|Overall Study|Sponsor Decision|41|||
145251456|NCT01370499|523766101|FG001|Overall Study|Sponsor Decision|15|||
145251457|NCT00887822|523766102|FG000|Overall Study|Insufficient therapeutic response|53|||
145251458|NCT00887822|523766103|FG001|Overall Study|Insufficient therapeutic response|55|||
145251459|NCT00887822|523766102|FG000|Overall Study|Adverse Event|14|||
145251460|NCT00887822|523766103|FG001|Overall Study|Adverse Event|17|||
145251461|NCT00887822|523766102|FG000|Overall Study|Failure to return|11|||
145251462|NCT00887822|523766103|FG001|Overall Study|Failure to return|11|||
145251463|NCT00887822|523766102|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
145251464|NCT00887822|523766103|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
145251465|NCT00887822|523766102|FG000|Overall Study|Administrative/Other than specified|5|||
145251466|NCT00887822|523766103|FG001|Overall Study|Administrative/Other than specified|4|||
145251467|NCT00887822|523766102|FG000|Overall Study|Death|2|||
145251468|NCT00887822|523766103|FG001|Overall Study|Death|3|||
145251469|NCT00887822|523766102|FG000|Overall Study|Protocol Violation|0|||
145251470|NCT00887822|523766103|FG001|Overall Study|Protocol Violation|1|||
145251471|NCT00887822|523766102|FG000|Overall Study|Randomized but not treated|0|||
145251472|NCT00887822|523766103|FG001|Overall Study|Randomized but not treated|1|||
145251473|NCT05815758|523766104|FG000|Overall Study|Adverse Event|6|||
145251474|NCT05815758|523766105|FG001|Overall Study|Adverse Event|2|||
145251475|NCT05815758|523766104|FG000|Overall Study|Lost to Follow-up|14|||
145251476|NCT05815758|523766105|FG001|Overall Study|Lost to Follow-up|1|||
145251477|NCT05815758|523766104|FG000|Overall Study|Withdrawal by Subject|6|||
145251478|NCT05815758|523766105|FG001|Overall Study|Withdrawal by Subject|6|||
145251479|NCT05815758|523766104|FG000|Overall Study|Protocol Violation|1|||
145251480|NCT05815758|523766105|FG001|Overall Study|Protocol Violation|1|||
145251481|NCT05815758|523766104|FG000|Overall Study|Discontinued|4|||
145251482|NCT05815758|523766105|FG001|Overall Study|Discontinued|4|||
145251483|NCT00934791|523766106|FG000|Overall Study|Withdrawal by Subject|1|||
145251484|NCT00934791|523766107|FG001|Overall Study|Withdrawal by Subject|0|||
145251485|NCT04124952|523766109|FG000|Overall Study|Lost to Follow-up|1|||
145299654|NCT03965091|523948812|FG001|Overall Study|Withdrawal by Subject|3|||
145299655|NCT03965091|523948813|FG002|Overall Study|Withdrawal by Subject|5|||
145299656|NCT03965091|523948811|FG000|Overall Study|Non-compliance with study drug|0|||
145299657|NCT03965091|523948812|FG001|Overall Study|Non-compliance with study drug|0|||
145299658|NCT03965091|523948813|FG002|Overall Study|Non-compliance with study drug|1|||
145251486|NCT00166504|523766111|FG000|Overall Study|Adverse Event|3|||
145251487|NCT00166504|523766112|FG001|Overall Study|Adverse Event|3|||
145620253|NCT03100838|525123724|FG002|Overall Study|Pregnancy|0|||
145251488|NCT00166504|523766111|FG000|Overall Study|Lost to Follow-up|1|||
145251489|NCT00166504|523766112|FG001|Overall Study|Lost to Follow-up|1|||
145251490|NCT00166504|523766111|FG000|Overall Study|Withdrawal by Subject|1|||
145299659|NCT03965091|523948811|FG000|Overall Study|Lost to Follow-up|1|||
145251491|NCT00166504|523766112|FG001|Overall Study|Withdrawal by Subject|0|||
145251492|NCT03261037|523766115|FG000|Overall Study|Withdrawal by Subject|2|||
145251493|NCT03261037|523766116|FG001|Overall Study|Withdrawal by Subject|13|||
145251494|NCT03261037|523766117|FG002|Overall Study|Withdrawal by Subject|0|||
145251495|NCT03261037|523766118|FG003|Overall Study|Withdrawal by Subject|18|||
145251496|NCT03261037|523766115|FG000|Overall Study|Non-compliance with study procedures|0|||
145251497|NCT03261037|523766116|FG001|Overall Study|Non-compliance with study procedures|2|||
145299660|NCT03965091|523948812|FG001|Overall Study|Lost to Follow-up|1|||
145251498|NCT03261037|523766117|FG002|Overall Study|Non-compliance with study procedures|0|||
145251499|NCT03261037|523766118|FG003|Overall Study|Non-compliance with study procedures|6|||
145251500|NCT03261037|523766115|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
145251501|NCT03261037|523766116|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
145251502|NCT03261037|523766117|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
145251503|NCT03261037|523766118|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
145251504|NCT03261037|523766115|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
145251505|NCT03261037|523766116|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
145251506|NCT03261037|523766117|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
145251507|NCT03261037|523766118|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
145251508|NCT03261037|523766115|FG000|Overall Study|Diagnosed but protocol deviation|1|||
145251509|NCT03261037|523766116|FG001|Overall Study|Diagnosed but protocol deviation|0|||
145251510|NCT03261037|523766117|FG002|Overall Study|Diagnosed but protocol deviation|0|||
145251511|NCT03261037|523766118|FG003|Overall Study|Diagnosed but protocol deviation|0|||
145251512|NCT03261037|523766115|FG000|Overall Study|Participant did not want to continue the study|0|||
145251513|NCT03261037|523766116|FG001|Overall Study|Participant did not want to continue the study|1|||
145251514|NCT03261037|523766117|FG002|Overall Study|Participant did not want to continue the study|0|||
145251515|NCT03261037|523766118|FG003|Overall Study|Participant did not want to continue the study|0|||
145251516|NCT03261037|523766115|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
145251517|NCT03261037|523766116|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
145251518|NCT03261037|523766117|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
145251519|NCT03261037|523766118|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
145251520|NCT03261037|523766115|FG000|Overall Study|Participant presented clinical improvement|0|||
145251521|NCT03261037|523766116|FG001|Overall Study|Participant presented clinical improvement|2|||
145251522|NCT03261037|523766117|FG002|Overall Study|Participant presented clinical improvement|0|||
145251523|NCT03261037|523766118|FG003|Overall Study|Participant presented clinical improvement|0|||
145251524|NCT03261037|523766115|FG000|Overall Study|Technical difficulties|0|||
145251525|NCT03261037|523766116|FG001|Overall Study|Technical difficulties|0|||
145251526|NCT03261037|523766117|FG002|Overall Study|Technical difficulties|0|||
145251527|NCT03261037|523766118|FG003|Overall Study|Technical difficulties|1|||
145299661|NCT03965091|523948813|FG002|Overall Study|Lost to Follow-up|1|||
145299662|NCT03965091|523948811|FG000|Overall Study|Lack of Efficacy|2|||
145299663|NCT03965091|523948812|FG001|Overall Study|Lack of Efficacy|0|||
145299664|NCT03965091|523948813|FG002|Overall Study|Lack of Efficacy|0|||
145299665|NCT03965091|523948811|FG000|Overall Study|Other than specified|9|||
145299666|NCT03965091|523948812|FG001|Overall Study|Other than specified|11|||
145299667|NCT03965091|523948813|FG002|Overall Study|Other than specified|8|||
145299668|NCT01534520|523948816|FG000|Overall Study|Adverse Event|0|||
145299669|NCT01534520|523948817|FG001|Overall Study|Adverse Event|1|||
145299670|NCT01417078|523948818|FG000|Overall Study|Withdrawal by Subject|1|||
145299671|NCT01059903|523948820|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
145299672|NCT01059903|523948821|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
145299673|NCT03725605|523948822|FG000|Overall Study|Unsuccessful TIL expansion|2|||
145299674|NCT03555305|523948823|FG000|Period 1|Physician Decision|0|||
145299675|NCT03555305|523948824|FG001|Period 1|Physician Decision|1|||
145299676|NCT03555305|523948823|FG000|Period 1|Adverse Event|0|||
145299677|NCT03555305|523948824|FG001|Period 1|Adverse Event|1|||
145299678|NCT03135834|523948830|FG000|Stage 1|Adverse Event|1|||
145299679|NCT03135834|523948831|FG001|Stage 1|Adverse Event|2|||
145299680|NCT03135834|523948832|FG002|Stage 1|Adverse Event|2|||
145299681|NCT03135834|523948833|FG003|Stage 1|Adverse Event|1|||
145299682|NCT03135834|523948830|FG000|Stage 1|Death|1|||
145299683|NCT03135834|523948831|FG001|Stage 1|Death|0|||
145299684|NCT03135834|523948832|FG002|Stage 1|Death|0|||
145299685|NCT03135834|523948833|FG003|Stage 1|Death|0|||
145299686|NCT03135834|523948830|FG000|Stage 1|Lost to Follow-up|17|||
145299687|NCT03135834|523948831|FG001|Stage 1|Lost to Follow-up|24|||
145299688|NCT03135834|523948832|FG002|Stage 1|Lost to Follow-up|21|||
145566637|NCT00735371|524936188|FG003|Overall Study|Lack of Efficacy|4|||
145566638|NCT00735371|524936185|FG000|Overall Study|Sponsor Decision|3|||
145566639|NCT00735371|524936186|FG001|Overall Study|Sponsor Decision|1|||
145299689|NCT03135834|523948833|FG003|Stage 1|Lost to Follow-up|38|||
145299690|NCT03135834|523948830|FG000|Stage 1|No longer met eligibility criteria|1|||
145299691|NCT03135834|523948831|FG001|Stage 1|No longer met eligibility criteria|6|||
145299692|NCT03135834|523948832|FG002|Stage 1|No longer met eligibility criteria|2|||
145299693|NCT03135834|523948833|FG003|Stage 1|No longer met eligibility criteria|5|||
145299694|NCT03135834|523948830|FG000|Stage 1|Other|0|||
145299695|NCT03135834|523948831|FG001|Stage 1|Other|2|||
145299696|NCT03135834|523948832|FG002|Stage 1|Other|1|||
145299697|NCT03135834|523948833|FG003|Stage 1|Other|0|||
145299698|NCT03135834|523948830|FG000|Stage 1|Physician Decision|0|||
145299699|NCT03135834|523948831|FG001|Stage 1|Physician Decision|1|||
145566640|NCT00735371|524936187|FG002|Overall Study|Sponsor Decision|0|||
145410356|NCT02293499|524356772|FG000|9 Month Follow Up|Lost to Follow-up|24|||
145251528|NCT03261037|523766115|FG000|Overall Study|Equipment failed to work|0|||
145251529|NCT03261037|523766116|FG001|Overall Study|Equipment failed to work|0|||
145251530|NCT03261037|523766117|FG002|Overall Study|Equipment failed to work|0|||
145251531|NCT03261037|523766118|FG003|Overall Study|Equipment failed to work|1|||
145251532|NCT03261037|523766115|FG000|Overall Study|End of study for participant and no follow up|0|||
145251533|NCT03261037|523766116|FG001|Overall Study|End of study for participant and no follow up|0|||
145251534|NCT03261037|523766117|FG002|Overall Study|End of study for participant and no follow up|0|||
145251535|NCT03261037|523766118|FG003|Overall Study|End of study for participant and no follow up|1|||
145251536|NCT03261037|523766115|FG000|Overall Study|Participant was too weak to continue in study|1|||
145251537|NCT03261037|523766116|FG001|Overall Study|Participant was too weak to continue in study|0|||
145251538|NCT03261037|523766117|FG002|Overall Study|Participant was too weak to continue in study|0|||
145251539|NCT03261037|523766118|FG003|Overall Study|Participant was too weak to continue in study|0|||
145251540|NCT01944462|523766123|FG000|PPPP Educational Program|Lost to Follow-up|60|||
145251541|NCT05298774|523766126|FG000|Overall Study|Physician Decision|3|||
145251542|NCT05298774|523766126|FG000|Overall Study|Withdrawal by Subject|2|||
145251543|NCT05298774|523766126|FG000|Overall Study|Lost to Follow-up|3|||
145251544|NCT05298774|523766126|FG000|Overall Study|Screen failure|1|||
145251545|NCT01267955|523766127|FG000|Stage 1 (6 Months)|Death|3|||
145251546|NCT01267955|523766127|FG000|Stage 2 (6 Months)|Death|5|||
145251547|NCT01267955|523766127|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
145251548|NCT03662789|523766128|FG000|Overall Study|Lost to Follow-up|1|||
145251549|NCT03662789|523766129|FG001|Overall Study|Lost to Follow-up|2|||
145251550|NCT03662789|523766128|FG000|Overall Study|Could not perform treadmill test|4|||
145251551|NCT03662789|523766129|FG001|Overall Study|Could not perform treadmill test|4|||
145251552|NCT03662789|523766128|FG000|Overall Study|Death|0|||
145251553|NCT03662789|523766129|FG001|Overall Study|Death|1|||
145251554|NCT03598140|523766130|FG000|Overall Study|enrolled but didn't start|1|||
145251555|NCT03598140|523766131|FG001|Overall Study|enrolled but didn't start|0|||
145251556|NCT05304611|523766132|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251557|NCT05304611|523766133|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251558|NCT05304611|523766134|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251559|NCT05304611|523766135|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251560|NCT05304611|523766136|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251561|NCT05304611|523766137|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251562|NCT05304611|523766138|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
145251563|NCT05304611|523766139|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251564|NCT05304611|523766140|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
145251565|NCT05304611|523766141|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251566|NCT05304611|523766142|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251567|NCT05304611|523766143|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
145251568|NCT05304611|523766132|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
145251569|NCT05304611|523766133|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
145251570|NCT05304611|523766134|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
145251571|NCT05304611|523766135|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
145251572|NCT05304611|523766136|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
145251573|NCT05304611|523766137|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
145251574|NCT05304611|523766138|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
145251575|NCT05304611|523766139|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
145251576|NCT05304611|523766140|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
145251577|NCT05304611|523766141|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
145251578|NCT05304611|523766142|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
145251579|NCT05304611|523766143|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
145410357|NCT02293499|524356773|FG001|9 Month Follow Up|Lost to Follow-up|28|||
145620254|NCT03100838|525123725|FG003|Overall Study|Pregnancy|0|||
145251580|NCT05304611|523766132|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
145251581|NCT05304611|523766133|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
145251582|NCT05304611|523766134|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
145251583|NCT05304611|523766135|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
145251584|NCT05304611|523766136|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
145251585|NCT05304611|523766137|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
145251586|NCT05304611|523766138|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
145251587|NCT05304611|523766139|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
145251588|NCT05304611|523766140|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
145251589|NCT05304611|523766141|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
145251590|NCT05304611|523766142|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
145251591|NCT05304611|523766143|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
145251592|NCT00963820|523766144|FG000|Dose Escalation Phase|Progressive Disease|3|||
145251593|NCT00963820|523766145|FG001|Dose Escalation Phase|Progressive Disease|3|||
145251594|NCT00963820|523766146|FG002|Dose Escalation Phase|Progressive Disease|3|||
145251595|NCT00963820|523766147|FG003|Dose Escalation Phase|Progressive Disease|3|||
145251596|NCT00963820|523766148|FG004|Dose Escalation Phase|Progressive Disease|4|||
145620255|NCT03100838|525123722|FG000|Overall Study|Lost to Follow-up|0|||
145251597|NCT00963820|523766149|FG005|Dose Escalation Phase|Progressive Disease|3|||
145251598|NCT00963820|523766150|FG006|Dose Escalation Phase|Progressive Disease|3|||
145251599|NCT00963820|523766151|FG007|Dose Escalation Phase|Progressive Disease|2|||
145251600|NCT00963820|523766152|FG008|Dose Escalation Phase|Progressive Disease|0|||
145251601|NCT00963820|523766153|FG009|Dose Escalation Phase|Progressive Disease|0|||
145251602|NCT00963820|523766154|FG010|Dose Escalation Phase|Progressive Disease|0|||
145251603|NCT00963820|523766155|FG011|Dose Escalation Phase|Progressive Disease|0|||
145251604|NCT00963820|523766144|FG000|Dose Escalation Phase|Adverse Event|0|||
145251605|NCT00963820|523766145|FG001|Dose Escalation Phase|Adverse Event|0|||
145251606|NCT00963820|523766146|FG002|Dose Escalation Phase|Adverse Event|0|||
145251607|NCT00963820|523766147|FG003|Dose Escalation Phase|Adverse Event|0|||
145251608|NCT00963820|523766148|FG004|Dose Escalation Phase|Adverse Event|0|||
145251609|NCT00963820|523766149|FG005|Dose Escalation Phase|Adverse Event|0|||
145251610|NCT00963820|523766150|FG006|Dose Escalation Phase|Adverse Event|3|||
145251611|NCT00963820|523766151|FG007|Dose Escalation Phase|Adverse Event|1|||
145251612|NCT00963820|523766152|FG008|Dose Escalation Phase|Adverse Event|0|||
145251613|NCT00963820|523766153|FG009|Dose Escalation Phase|Adverse Event|0|||
145251614|NCT00963820|523766154|FG010|Dose Escalation Phase|Adverse Event|0|||
145251615|NCT00963820|523766155|FG011|Dose Escalation Phase|Adverse Event|0|||
145251616|NCT00963820|523766144|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145251617|NCT00963820|523766145|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
145251618|NCT00963820|523766146|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
145251619|NCT00963820|523766147|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145251620|NCT00963820|523766148|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
145251621|NCT00963820|523766149|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
145251622|NCT00963820|523766150|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
145251623|NCT00963820|523766151|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
145251624|NCT00963820|523766152|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
145251625|NCT00963820|523766153|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
145251626|NCT00963820|523766154|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
145251627|NCT00963820|523766155|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
145251628|NCT00963820|523766144|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251629|NCT00963820|523766145|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251630|NCT00963820|523766146|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251631|NCT00963820|523766147|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251632|NCT00963820|523766148|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251633|NCT00963820|523766149|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251634|NCT00963820|523766150|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
145251635|NCT00963820|523766151|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251636|NCT00963820|523766152|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251637|NCT00963820|523766153|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251638|NCT00963820|523766154|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251639|NCT00963820|523766155|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
145251640|NCT00963820|523766144|FG000|Expansion Phase|Progressive Disease|0|||
145251641|NCT00963820|523766145|FG001|Expansion Phase|Progressive Disease|0|||
145251642|NCT00963820|523766146|FG002|Expansion Phase|Progressive Disease|0|||
145251643|NCT00963820|523766147|FG003|Expansion Phase|Progressive Disease|0|||
145251644|NCT00963820|523766148|FG004|Expansion Phase|Progressive Disease|0|||
145251645|NCT00963820|523766149|FG005|Expansion Phase|Progressive Disease|0|||
145251646|NCT00963820|523766150|FG006|Expansion Phase|Progressive Disease|0|||
145251647|NCT00963820|523766151|FG007|Expansion Phase|Progressive Disease|0|||
145251648|NCT00963820|523766152|FG008|Expansion Phase|Progressive Disease|8|||
145251649|NCT00963820|523766153|FG009|Expansion Phase|Progressive Disease|6|||
145251650|NCT00963820|523766154|FG010|Expansion Phase|Progressive Disease|4|||
145251651|NCT00963820|523766155|FG011|Expansion Phase|Progressive Disease|2|||
145251652|NCT00963820|523766144|FG000|Expansion Phase|Adverse Event|0|||
145251653|NCT00963820|523766145|FG001|Expansion Phase|Adverse Event|0|||
145251654|NCT00963820|523766146|FG002|Expansion Phase|Adverse Event|0|||
145251655|NCT00963820|523766147|FG003|Expansion Phase|Adverse Event|0|||
145299700|NCT03135834|523948832|FG002|Stage 1|Physician Decision|0|||
145299701|NCT03135834|523948833|FG003|Stage 1|Physician Decision|0|||
145299702|NCT03135834|523948830|FG000|Stage 1|Pregnancy|0|||
145299703|NCT03135834|523948831|FG001|Stage 1|Pregnancy|4|||
145251656|NCT00963820|523766148|FG004|Expansion Phase|Adverse Event|0|||
145251657|NCT00963820|523766149|FG005|Expansion Phase|Adverse Event|0|||
145251658|NCT00963820|523766150|FG006|Expansion Phase|Adverse Event|0|||
145251659|NCT00963820|523766151|FG007|Expansion Phase|Adverse Event|0|||
145251660|NCT00963820|523766152|FG008|Expansion Phase|Adverse Event|1|||
145251661|NCT00963820|523766153|FG009|Expansion Phase|Adverse Event|3|||
145251662|NCT00963820|523766154|FG010|Expansion Phase|Adverse Event|0|||
145251663|NCT00963820|523766155|FG011|Expansion Phase|Adverse Event|0|||
145251664|NCT00963820|523766144|FG000|Expansion Phase|Withdrawal by Subject|0|||
145299704|NCT03135834|523948832|FG002|Stage 1|Pregnancy|2|||
145299705|NCT03135834|523948833|FG003|Stage 1|Pregnancy|4|||
145251665|NCT00963820|523766145|FG001|Expansion Phase|Withdrawal by Subject|0|||
145251666|NCT00963820|523766146|FG002|Expansion Phase|Withdrawal by Subject|0|||
145251667|NCT00963820|523766147|FG003|Expansion Phase|Withdrawal by Subject|0|||
145251668|NCT00963820|523766148|FG004|Expansion Phase|Withdrawal by Subject|0|||
145251669|NCT00963820|523766149|FG005|Expansion Phase|Withdrawal by Subject|0|||
145251670|NCT00963820|523766150|FG006|Expansion Phase|Withdrawal by Subject|0|||
145251671|NCT00963820|523766151|FG007|Expansion Phase|Withdrawal by Subject|0|||
145251672|NCT00963820|523766152|FG008|Expansion Phase|Withdrawal by Subject|1|||
145251673|NCT00963820|523766153|FG009|Expansion Phase|Withdrawal by Subject|0|||
145251674|NCT00963820|523766154|FG010|Expansion Phase|Withdrawal by Subject|1|||
145251675|NCT00963820|523766155|FG011|Expansion Phase|Withdrawal by Subject|1|||
145251676|NCT00963820|523766144|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251677|NCT00963820|523766145|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251678|NCT00963820|523766146|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251679|NCT00963820|523766147|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251680|NCT00963820|523766148|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251681|NCT00963820|523766149|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251682|NCT00963820|523766150|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251683|NCT00963820|523766151|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251684|NCT00963820|523766152|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251685|NCT00963820|523766153|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251686|NCT00963820|523766154|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
145251687|NCT00963820|523766155|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
145251688|NCT04556175|523766159|FG000|Overall Study|Study terminated due to COVID-19|8|||
145251689|NCT04556175|523766160|FG001|Overall Study|Study terminated due to COVID-19|8|||
145251690|NCT05549505|523766162|FG000|Overall Study|Lost to Follow-up|2|||
145251691|NCT05549505|523766163|FG001|Overall Study|Lost to Follow-up|0|||
145251692|NCT05549505|523766162|FG000|Overall Study|Withdrawal by Subject|3|||
145251693|NCT05549505|523766163|FG001|Overall Study|Withdrawal by Subject|3|||
145251694|NCT05549505|523766162|FG000|Overall Study|Other: Miscellaneous|3|||
145251695|NCT05549505|523766163|FG001|Overall Study|Other: Miscellaneous|6|||
145251696|NCT05492877|523766166|FG000|Overall Study|Adverse Event|11|||
145251697|NCT05492877|523766167|FG001|Overall Study|Adverse Event|7|||
145251698|NCT05492877|523766166|FG000|Overall Study|Death|1|||
145251699|NCT05492877|523766167|FG001|Overall Study|Death|0|||
145251700|NCT05492877|523766166|FG000|Overall Study|Lost to Follow-up|1|||
145251701|NCT05492877|523766167|FG001|Overall Study|Lost to Follow-up|1|||
145251702|NCT05492877|523766166|FG000|Overall Study|Physician Decision|1|||
145251703|NCT05492877|523766167|FG001|Overall Study|Physician Decision|2|||
145251704|NCT05492877|523766166|FG000|Overall Study|Protocol Violation|1|||
145251705|NCT05492877|523766167|FG001|Overall Study|Protocol Violation|1|||
145251706|NCT05492877|523766166|FG000|Overall Study|Withdrawal by Subject|3|||
145251707|NCT05492877|523766167|FG001|Overall Study|Withdrawal by Subject|7|||
145251708|NCT05492877|523766166|FG000|Overall Study|Reason not specified|6|||
145251709|NCT05492877|523766167|FG001|Overall Study|Reason not specified|4|||
145251710|NCT01842334|523766169|FG000|Overall Study|Withdrawal by Subject|3|||
145251711|NCT01842334|523766170|FG001|Overall Study|Withdrawal by Subject|3|||
145251712|NCT01842334|523766169|FG000|Overall Study|Moved away mid-study|0|||
145251713|NCT01842334|523766170|FG001|Overall Study|Moved away mid-study|1|||
145251714|NCT00942422|523766171|FG000|Overall Study|Withdrawal by Subject|1|||
145251715|NCT00942422|523766171|FG000|Overall Study|Death|1|||
145251716|NCT00942422|523766171|FG000|Overall Study|Progressive diease|1|||
145251717|NCT02943668|523766172|FG000|Overall Study|Disease Progression|1|||
145251718|NCT00572728|523766177|FG000|Overall Study|Withdrawal by Subject|10|||
145251719|NCT00572728|523766177|FG000|Overall Study|Ineligible|3|||
145251720|NCT00572728|523766177|FG000|Overall Study|Enrolled under Amendment 4|5|||
145251721|NCT00572728|523766177|FG000|Overall Study|Offstudy due to complicating disease|1|||
145251722|NCT00572728|523766177|FG000|Overall Study|FLT1 not completed|4|||
145251723|NCT00572728|523766177|FG000|Overall Study|First Chemotherapy not initiated|2|||
145251724|NCT00572728|523766177|FG000|Overall Study|FLT2 not completed|5|||
145251725|NCT00572728|523766177|FG000|Overall Study|Second chemotherapy not initiated|1|||
145251726|NCT00572728|523766177|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
145299706|NCT03135834|523948830|FG000|Stage 1|Protocol Violation|1|||
145299707|NCT03135834|523948831|FG001|Stage 1|Protocol Violation|1|||
145299708|NCT03135834|523948832|FG002|Stage 1|Protocol Violation|2|||
145566641|NCT00735371|524936188|FG003|Overall Study|Sponsor Decision|1|||
145566642|NCT00735371|524936185|FG000|Overall Study|Protocol Violation|0|||
145566643|NCT00735371|524936186|FG001|Overall Study|Protocol Violation|1|||
145566644|NCT00735371|524936187|FG002|Overall Study|Protocol Violation|2|||
145251727|NCT00572728|523766177|FG000|Overall Study|Pathology missing|1|||
145251728|NCT02724111|523766178|FG000|Overall Study|Protocol Violation|2|||
145251729|NCT02724111|523766179|FG001|Overall Study|Protocol Violation|5|||
145251730|NCT02996500|523766180|FG000|Overall Study|Adverse Event|1|||
145251731|NCT02996500|523766181|FG001|Overall Study|Adverse Event|1|||
145299709|NCT03135834|523948833|FG003|Stage 1|Protocol Violation|1|||
145251732|NCT02996500|523766182|FG002|Overall Study|Adverse Event|4|||
145251733|NCT02996500|523766183|FG003|Overall Study|Adverse Event|3|||
145251734|NCT02996500|523766184|FG004|Overall Study|Adverse Event|1|||
145251735|NCT02996500|523766185|FG005|Overall Study|Adverse Event|2|||
145251736|NCT02996500|523766180|FG000|Overall Study|Lack of Efficacy|0|||
145251737|NCT02996500|523766181|FG001|Overall Study|Lack of Efficacy|0|||
145251738|NCT02996500|523766182|FG002|Overall Study|Lack of Efficacy|0|||
145251739|NCT02996500|523766183|FG003|Overall Study|Lack of Efficacy|0|||
145251740|NCT02996500|523766184|FG004|Overall Study|Lack of Efficacy|2|||
145251741|NCT02996500|523766185|FG005|Overall Study|Lack of Efficacy|0|||
145251742|NCT02996500|523766180|FG000|Overall Study|Lost to Follow-up|1|||
145251743|NCT02996500|523766181|FG001|Overall Study|Lost to Follow-up|0|||
145251744|NCT02996500|523766182|FG002|Overall Study|Lost to Follow-up|0|||
145251745|NCT02996500|523766183|FG003|Overall Study|Lost to Follow-up|0|||
145251746|NCT02996500|523766184|FG004|Overall Study|Lost to Follow-up|0|||
145251747|NCT02996500|523766185|FG005|Overall Study|Lost to Follow-up|1|||
145251748|NCT02996500|523766180|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145251749|NCT02996500|523766181|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145251750|NCT02996500|523766182|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
145251751|NCT02996500|523766183|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145251752|NCT02996500|523766184|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
145251753|NCT02996500|523766185|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
145251754|NCT02996500|523766180|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145251755|NCT02996500|523766181|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145251756|NCT02996500|523766182|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145251757|NCT02996500|523766183|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145251758|NCT02996500|523766184|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145251759|NCT02996500|523766185|FG005|Overall Study|Non-Compliance With Study Drug|1|||
145251760|NCT02996500|523766180|FG000|Overall Study|Progressive Disease|1|||
145251761|NCT02996500|523766181|FG001|Overall Study|Progressive Disease|0|||
145251762|NCT02996500|523766182|FG002|Overall Study|Progressive Disease|0|||
145251763|NCT02996500|523766183|FG003|Overall Study|Progressive Disease|0|||
145251764|NCT02996500|523766184|FG004|Overall Study|Progressive Disease|0|||
145251765|NCT02996500|523766185|FG005|Overall Study|Progressive Disease|0|||
145251766|NCT02996500|523766180|FG000|Overall Study|Other|2|||
145251767|NCT02996500|523766181|FG001|Overall Study|Other|0|||
145251768|NCT02996500|523766182|FG002|Overall Study|Other|2|||
145251769|NCT02996500|523766183|FG003|Overall Study|Other|0|||
145251770|NCT02996500|523766184|FG004|Overall Study|Other|0|||
145251771|NCT02996500|523766185|FG005|Overall Study|Other|0|||
145251772|NCT02996500|523766180|FG000|Overall Study|Protocol Violation|0|||
145251773|NCT02996500|523766181|FG001|Overall Study|Protocol Violation|0|||
145251774|NCT02996500|523766182|FG002|Overall Study|Protocol Violation|0|||
145251775|NCT02996500|523766183|FG003|Overall Study|Protocol Violation|1|||
145251776|NCT02996500|523766184|FG004|Overall Study|Protocol Violation|0|||
145251777|NCT02996500|523766185|FG005|Overall Study|Protocol Violation|0|||
145251778|NCT02996500|523766180|FG000|Overall Study|Withdrawal by Subject|3|||
145251779|NCT02996500|523766181|FG001|Overall Study|Withdrawal by Subject|0|||
145251780|NCT02996500|523766182|FG002|Overall Study|Withdrawal by Subject|3|||
145251781|NCT02996500|523766183|FG003|Overall Study|Withdrawal by Subject|0|||
145251782|NCT02996500|523766184|FG004|Overall Study|Withdrawal by Subject|2|||
145299710|NCT03135834|523948830|FG000|Stage 1|Withdrawal by parent/guardian|2|||
145299711|NCT03135834|523948831|FG001|Stage 1|Withdrawal by parent/guardian|10|||
145299712|NCT03135834|523948832|FG002|Stage 1|Withdrawal by parent/guardian|2|||
145299713|NCT03135834|523948833|FG003|Stage 1|Withdrawal by parent/guardian|1|||
145299714|NCT03135834|523948830|FG000|Stage 1|Withdrawal by Subject|16|||
145299715|NCT03135834|523948831|FG001|Stage 1|Withdrawal by Subject|22|||
145299716|NCT03135834|523948832|FG002|Stage 1|Withdrawal by Subject|7|||
145299717|NCT03135834|523948833|FG003|Stage 1|Withdrawal by Subject|10|||
145299718|NCT03135834|523948830|FG000|Stage 1|Randomized but not Vaccinated|0|||
145299719|NCT03135834|523948831|FG001|Stage 1|Randomized but not Vaccinated|3|||
145299720|NCT03135834|523948832|FG002|Stage 1|Randomized but not Vaccinated|1|||
145299721|NCT03135834|523948833|FG003|Stage 1|Randomized but not Vaccinated|6|||
145299722|NCT03135834|523948830|FG000|Stage 2|Lost to Follow-up|0|||
145299723|NCT03135834|523948831|FG001|Stage 2|Lost to Follow-up|1|||
145299724|NCT03135834|523948832|FG002|Stage 2|Lost to Follow-up|0|||
145299725|NCT03135834|523948833|FG003|Stage 2|Lost to Follow-up|0|||
145410358|NCT02293499|524356774|FG002|9 Month Follow Up|Lost to Follow-up|4|||
145251783|NCT02996500|523766185|FG005|Overall Study|Withdrawal by Subject|0|||
145299726|NCT03135834|523948830|FG000|Stage 2|Withdrawal by Subject|0|||
145251784|NCT00322387|523766187|FG000|Treatment Period|Adverse Event|0|||
145251785|NCT00322387|523766188|FG001|Treatment Period|Adverse Event|1|||
145251786|NCT00322387|523766187|FG000|Follow-up Period|Final assessment not done|1|||
145251787|NCT00322387|523766188|FG001|Follow-up Period|Final assessment not done|3|||
145251788|NCT00322387|523766187|FG000|Follow-up Period|Death|1|||
145251789|NCT00322387|523766188|FG001|Follow-up Period|Death|0|||
145251790|NCT03128307|523766190|FG000|Overall Study|Lost to Follow-up|29|||
145299727|NCT03135834|523948831|FG001|Stage 2|Withdrawal by Subject|1|||
145251791|NCT03128307|523766190|FG000|Overall Study|Withdrawal by Subject|5|||
145251792|NCT01855919|523767860|FG000|Overall Study|Adverse Event|16|||
145251793|NCT01855919|523767861|FG001|Overall Study|Adverse Event|8|||
145251794|NCT01855919|523767860|FG000|Overall Study|Lack of Efficacy|1|||
145251795|NCT01855919|523767861|FG001|Overall Study|Lack of Efficacy|3|||
145251796|NCT01855919|523767860|FG000|Overall Study|Withdrawal by Subject|4|||
145251797|NCT01855919|523767861|FG001|Overall Study|Withdrawal by Subject|10|||
145251798|NCT01855919|523767860|FG000|Overall Study|Entry Criteria Not Met|1|||
145251799|NCT01855919|523767861|FG001|Overall Study|Entry Criteria Not Met|1|||
145251800|NCT01855919|523767860|FG000|Overall Study|Protocol Violation|1|||
145251801|NCT01855919|523767861|FG001|Overall Study|Protocol Violation|4|||
145251802|NCT03455530|523767862|FG000|Overall Study|Withdrawal by Subject|9|||
145251803|NCT03455530|523767863|FG001|Overall Study|Withdrawal by Subject|1|||
145299728|NCT03135834|523948832|FG002|Stage 2|Withdrawal by Subject|0|||
145299729|NCT03135834|523948833|FG003|Stage 2|Withdrawal by Subject|0|||
145299730|NCT03135834|523948830|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
145299731|NCT03135834|523948831|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
145299732|NCT03135834|523948832|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
145410359|NCT02293499|524356772|FG000|12 Month Follow Up|Lost to Follow-up|26|||
145410360|NCT02293499|524356773|FG001|12 Month Follow Up|Lost to Follow-up|25|||
145410361|NCT02293499|524356774|FG002|12 Month Follow Up|Lost to Follow-up|6|||
145410362|NCT02293499|524356772|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
145410363|NCT02293499|524356773|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
145410364|NCT02293499|524356774|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
145410365|NCT02293499|524356772|FG000|15 Month Follow Up|Lost to Follow-up|22|||
145410366|NCT02293499|524356773|FG001|15 Month Follow Up|Lost to Follow-up|22|||
145410367|NCT02293499|524356774|FG002|15 Month Follow Up|Lost to Follow-up|7|||
145410368|NCT01991314|524356777|FG000|Overall Study|Adverse Event|5|||
145410369|NCT01991314|524356778|FG001|Overall Study|Adverse Event|1|||
145410370|NCT01991314|524356777|FG000|Overall Study|Lost to Follow-up|6|||
145410371|NCT01991314|524356778|FG001|Overall Study|Lost to Follow-up|10|||
145410372|NCT01136954|524356779|FG000|Overall Study|Adverse Event|3|||
145410373|NCT01136954|524356780|FG001|Overall Study|Adverse Event|2|||
145410374|NCT01136954|524356779|FG000|Overall Study|Withdrawal by Subject|6|||
145410375|NCT01136954|524356780|FG001|Overall Study|Withdrawal by Subject|2|||
145410376|NCT01136954|524356779|FG000|Overall Study|Lack of Efficacy|14|||
145410377|NCT01136954|524356780|FG001|Overall Study|Lack of Efficacy|13|||
145410378|NCT01136954|524356779|FG000|Overall Study|Physician Decision|0|||
145410379|NCT01136954|524356780|FG001|Overall Study|Physician Decision|1|||
145410380|NCT01136954|524356779|FG000|Overall Study|Other|1|||
145410381|NCT01136954|524356780|FG001|Overall Study|Other|3|||
145410382|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
145410383|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
145410384|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
145410385|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
145410386|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
145410387|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145410388|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
145410389|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145410390|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145410391|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
145410392|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Death|0|||
145410393|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Death|0|||
145410394|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Death|1|||
145410395|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Death|0|||
145410396|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Death|0|||
145299733|NCT03135834|523948833|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
145299734|NCT03135834|523948830|FG000|Stage 2|Did not receive Booster Vaccination|1|||
145299735|NCT03135834|523948831|FG001|Stage 2|Did not receive Booster Vaccination|1|||
145299736|NCT03135834|523948832|FG002|Stage 2|Did not receive Booster Vaccination|0|||
145299737|NCT03135834|523948833|FG003|Stage 2|Did not receive Booster Vaccination|0|||
145620256|NCT03100838|525123723|FG001|Overall Study|Lost to Follow-up|0|||
145251804|NCT03455530|523767864|FG002|Overall Study|Withdrawal by Subject|3|||
145410397|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
145410398|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
145410399|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
145410400|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
145410401|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
145410402|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Other|2|||
145410403|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Other|1|||
145410404|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Other|0|||
145299738|NCT02100228|523948834|FG000|Overall Study|Other|19|||
145299739|NCT02100228|523948835|FG001|Overall Study|Other|19|||
145299740|NCT02100228|523948834|FG000|Overall Study|Administrative reason|0|||
145410405|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Other|0|||
145299741|NCT02100228|523948835|FG001|Overall Study|Administrative reason|1|||
145620257|NCT03100838|525123724|FG002|Overall Study|Lost to Follow-up|1|||
145251805|NCT03455530|523767865|FG003|Overall Study|Withdrawal by Subject|3|||
145251806|NCT00740116|523767870|FG000|Overall Study|Withdrawal by Subject|1|||
145251807|NCT00740116|523767871|FG001|Overall Study|Withdrawal by Subject|1|||
145251808|NCT00740116|523767870|FG000|Overall Study|Protocol Violation|1|||
145251809|NCT00740116|523767871|FG001|Overall Study|Protocol Violation|4|||
145251810|NCT01293123|523767872|FG000|Overall Study|Lost to Follow-up|0|||
145251811|NCT01293123|523767873|FG001|Overall Study|Lost to Follow-up|1|||
145251812|NCT00121485|523767874|FG000|Overall Study|Not implanted|1|||
145251813|NCT00121485|523767875|FG001|Overall Study|Not implanted|5|||
145251814|NCT00121485|523767874|FG000|Overall Study|Crossover|0|||
145251815|NCT00121485|523767875|FG001|Overall Study|Crossover|2|||
145251816|NCT01888965|523767876|FG000|Overall Study|Adverse Event|5|||
145251817|NCT01888965|523767876|FG000|Overall Study|Lack of Efficacy|4|||
145251818|NCT00908895|523767877|FG000|Overall Study|Lost to Follow-up|1|||
145251819|NCT00908895|523767878|FG001|Overall Study|Lost to Follow-up|3|||
145251820|NCT00908895|523767877|FG000|Overall Study|algodystrophy|2|||
145251821|NCT00908895|523767878|FG001|Overall Study|algodystrophy|2|||
145251822|NCT00908895|523767877|FG000|Overall Study|Adverse Event|1|||
145251823|NCT00908895|523767878|FG001|Overall Study|Adverse Event|1|||
145251824|NCT02608099|523767881|FG000|Overall Study|Ablation procedure not initiated|3|||
145251825|NCT02608099|523767882|FG001|Overall Study|Ablation procedure not initiated|2|||
145251826|NCT00417248|523767886|FG000|Overall Study|Study Terminated|6|||
145251827|NCT00417248|523767886|FG000|Overall Study|Death|1|||
145251828|NCT00417248|523767886|FG000|Overall Study|Lack of Efficacy|1|||
145251829|NCT01569568|523767887|FG000|Overall Study|Physician Decision|0|||
145251830|NCT01569568|523767888|FG001|Overall Study|Physician Decision|2|||
145251831|NCT02425891|523767889|FG000|Overall Study|Death|333|||
145251832|NCT02425891|523767890|FG001|Overall Study|Death|314|||
145251833|NCT02425891|523767889|FG000|Overall Study|Lost to Follow-up|4|||
145251834|NCT02425891|523767890|FG001|Overall Study|Lost to Follow-up|6|||
145251835|NCT02425891|523767889|FG000|Overall Study|Non-Compliance|1|||
145251836|NCT02425891|523767890|FG001|Overall Study|Non-Compliance|1|||
145251837|NCT02425891|523767889|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
145251838|NCT02425891|523767890|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
145410406|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Other|0|||
145410407|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145410408|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145410409|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
145410410|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145410411|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
145410412|NCT03317496|524356781|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145410413|NCT03317496|524356782|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
145410414|NCT03317496|524356783|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145251839|NCT02425891|523767889|FG000|Overall Study|Physician Decision|0|||
145251840|NCT02425891|523767890|FG001|Overall Study|Physician Decision|1|||
145299742|NCT02100228|523948834|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
145299743|NCT02100228|523948835|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
145299744|NCT02100228|523948834|FG000|Overall Study|Non-compliance|0|||
145299745|NCT02100228|523948835|FG001|Overall Study|Non-compliance|3|||
145299746|NCT02100228|523948834|FG000|Overall Study|Lost to Follow-up|0|||
145299747|NCT02100228|523948835|FG001|Overall Study|Lost to Follow-up|1|||
145299748|NCT02100228|523948834|FG000|Overall Study|Withdrawal by Subject|27|||
145299749|NCT02100228|523948835|FG001|Overall Study|Withdrawal by Subject|37|||
145299750|NCT02100228|523948834|FG000|Overall Study|Adverse Event|16|||
145299751|NCT02100228|523948835|FG001|Overall Study|Adverse Event|12|||
145299752|NCT02100228|523948834|FG000|Overall Study|Death|1|||
145299753|NCT02100228|523948835|FG001|Overall Study|Death|1|||
145299754|NCT00214422|523948836|FG000|Overall Study|Physician Decision|2|||
145299755|NCT00214422|523948837|FG001|Overall Study|Physician Decision|0|||
145299756|NCT00214422|523948838|FG002|Overall Study|Physician Decision|0|||
145299757|NCT00214422|523948836|FG000|Overall Study|Developed esophageal ca|1|||
145251841|NCT02425891|523767889|FG000|Overall Study|Protocol Violation|1|||
145299758|NCT00214422|523948837|FG001|Overall Study|Developed esophageal ca|0|||
145299759|NCT00214422|523948838|FG002|Overall Study|Developed esophageal ca|0|||
145299760|NCT00214422|523948836|FG000|Overall Study|Pt taken off study|1|||
145410415|NCT03317496|524356784|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
145251842|NCT02425891|523767890|FG001|Overall Study|Protocol Violation|1|||
145251843|NCT02425891|523767889|FG000|Overall Study|Study Terminated By Sponsor|85|||
145566645|NCT00735371|524936188|FG003|Overall Study|Protocol Violation|0|||
145251844|NCT02425891|523767890|FG001|Overall Study|Study Terminated By Sponsor|95|||
145251845|NCT02425891|523767889|FG000|Overall Study|Withdrawal by Subject|27|||
145251846|NCT02425891|523767890|FG001|Overall Study|Withdrawal by Subject|32|||
145299761|NCT00214422|523948837|FG001|Overall Study|Pt taken off study|1|||
145299762|NCT00214422|523948838|FG002|Overall Study|Pt taken off study|0|||
145251847|NCT02145429|523767894|FG000|Overall Study|Death|4|||
145251848|NCT02145429|523767895|FG001|Overall Study|Death|5|||
145251849|NCT02145429|523767894|FG000|Overall Study|Lost to Follow-up|4|||
145410416|NCT03317496|524356785|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
145410417|NCT03317496|524356781|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
145410418|NCT03317496|524356782|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
145410419|NCT03317496|524356783|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
145410420|NCT03317496|524356784|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
145410421|NCT03317496|524356785|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
145251850|NCT02145429|523767895|FG001|Overall Study|Lost to Follow-up|3|||
145251851|NCT02145429|523767894|FG000|Overall Study|Withdrawal by Subject|8|||
145251852|NCT02145429|523767895|FG001|Overall Study|Withdrawal by Subject|3|||
145251853|NCT03345849|523767896|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
145251854|NCT03345849|523767897|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
145251855|NCT03345849|523767898|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
145251856|NCT03345849|523767899|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
145251857|NCT03345849|523767896|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
145251858|NCT03345849|523767897|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
145251859|NCT03345849|523767898|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
145251860|NCT03345849|523767899|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
145251861|NCT03345849|523767896|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
145251862|NCT03345849|523767897|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
145251863|NCT03345849|523767898|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
145251864|NCT03345849|523767899|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
145251865|NCT03345849|523767896|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
145251866|NCT03345849|523767897|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
145251867|NCT03345849|523767898|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
145251868|NCT03345849|523767899|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
145251869|NCT03345849|523767896|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
145251870|NCT03345849|523767897|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
145251871|NCT03345849|523767898|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
145251872|NCT03345849|523767899|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
145251873|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
145251874|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
145251875|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
145251876|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
145251877|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
145251878|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
145251879|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
145251880|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
145251881|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
145251882|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
145251883|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
145251884|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
145251885|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
145251886|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
145251887|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
145251888|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
145251889|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
145251890|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
145251891|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
145251892|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
145251893|NCT03345849|523767896|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
145251894|NCT03345849|523767897|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
145251895|NCT03345849|523767898|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
145251896|NCT03345849|523767899|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
145251897|NCT02943577|523767900|FG000|Overall Study|Protocol Violation|0|||
145251898|NCT02943577|523767901|FG001|Overall Study|Protocol Violation|1|||
145251899|NCT02943577|523767900|FG000|Overall Study|Adverse Event|3|||
145251900|NCT02943577|523767901|FG001|Overall Study|Adverse Event|2|||
145251901|NCT02943577|523767900|FG000|Overall Study|Lost to Follow-up|0|||
145251902|NCT02943577|523767901|FG001|Overall Study|Lost to Follow-up|1|||
145251903|NCT02943577|523767900|FG000|Overall Study|Withdrawal by Subject|1|||
145251904|NCT02943577|523767901|FG001|Overall Study|Withdrawal by Subject|1|||
145251905|NCT02943577|523767900|FG000|Overall Study|Pregnancy|1|||
145251906|NCT02943577|523767901|FG001|Overall Study|Pregnancy|0|||
145251907|NCT00081263|523767907|FG000|Overall Study|clerical error|1|||
145251908|NCT00081263|523767908|FG001|Overall Study|clerical error|0|||
145410422|NCT03317496|524356781|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
145410423|NCT03317496|524356782|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145410424|NCT03317496|524356783|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145251909|NCT00081263|523767907|FG000|Overall Study|wrong cell type|7|||
145251910|NCT00081263|523767908|FG001|Overall Study|wrong cell type|5|||
145251911|NCT00081263|523767907|FG000|Overall Study|improper pre-protocol therapy|0|||
145251912|NCT00081263|523767908|FG001|Overall Study|improper pre-protocol therapy|1|||
145251913|NCT00081263|523767907|FG000|Overall Study|Inadequate pathology|0|||
145251914|NCT00081263|523767908|FG001|Overall Study|Inadequate pathology|1|||
145251915|NCT00081263|523767907|FG000|Overall Study|Never treated|4|||
145251916|NCT00081263|523767908|FG001|Overall Study|Never treated|5|||
145251917|NCT00081263|523767907|FG000|Overall Study|Inadequate data|5|||
145251918|NCT00081263|523767908|FG001|Overall Study|Inadequate data|10|||
145251919|NCT05564039|523767915|FG000|Overall Study|Adverse Event|1|||
145251920|NCT05564039|523767916|FG001|Overall Study|Adverse Event|0|||
145251921|NCT05564039|523767915|FG000|Overall Study|Death|1|||
145251922|NCT05564039|523767916|FG001|Overall Study|Death|1|||
145251923|NCT05564039|523767915|FG000|Overall Study|Lost to Follow-up|3|||
145251924|NCT05564039|523767916|FG001|Overall Study|Lost to Follow-up|2|||
145299763|NCT00214422|523948836|FG000|Overall Study|Disease progression on study|1|||
145299764|NCT00214422|523948837|FG001|Overall Study|Disease progression on study|0|||
145299765|NCT00214422|523948838|FG002|Overall Study|Disease progression on study|0|||
145299766|NCT00214422|523948836|FG000|Overall Study|Unable to make a radiation treatment|0|||
145566646|NCT00735371|524936185|FG000|Overall Study|Prior Vyvanse Exposure|1|||
145566647|NCT00735371|524936186|FG001|Overall Study|Prior Vyvanse Exposure|1|||
145566648|NCT00735371|524936187|FG002|Overall Study|Prior Vyvanse Exposure|0|||
145566649|NCT00735371|524936188|FG003|Overall Study|Prior Vyvanse Exposure|0|||
145566650|NCT00735371|524936185|FG000|Overall Study|Exclusion criteria|1|||
145566651|NCT00735371|524936186|FG001|Overall Study|Exclusion criteria|0|||
145566652|NCT00735371|524936187|FG002|Overall Study|Exclusion criteria|0|||
145566653|NCT00735371|524936188|FG003|Overall Study|Exclusion criteria|0|||
145566654|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
145251925|NCT05564039|523767915|FG000|Overall Study|Withdrawal by Subject|2|||
145251926|NCT05564039|523767916|FG001|Overall Study|Withdrawal by Subject|0|||
145251927|NCT05564039|523767915|FG000|Overall Study|Inadvertent enrollment|3|||
145251928|NCT05564039|523767916|FG001|Overall Study|Inadvertent enrollment|6|||
145299767|NCT00214422|523948837|FG001|Overall Study|Unable to make a radiation treatment|0|||
145299768|NCT00214422|523948838|FG002|Overall Study|Unable to make a radiation treatment|1|||
145299769|NCT02612337|523948840|FG000|Overall Study|Lack of Efficacy|1|||
145299770|NCT02612337|523948841|FG001|Overall Study|Lack of Efficacy|0|||
145299771|NCT02612337|523948840|FG000|Overall Study|Withdrawal by Subject|2|||
145299772|NCT02612337|523948841|FG001|Overall Study|Withdrawal by Subject|2|||
145299773|NCT02612337|523948840|FG000|Overall Study|Did not receive study drug|0|||
145299774|NCT02612337|523948841|FG001|Overall Study|Did not receive study drug|1|||
145299775|NCT02421952|523948844|FG000|Overall Study|Diary Not Returned|93|||
145299776|NCT02421952|523948844|FG000|Overall Study|Failed seriation task|13|||
145299777|NCT02421952|523948844|FG000|Overall Study|Subject uncooperative for baseline test|2|||
145299778|NCT02421952|523948844|FG000|Overall Study|Surgery cancelled|1|||
145299779|NCT00854100|523948845|FG000|Overall Study|Inability to complete the study visits|0|||
145299780|NCT00854100|523948846|FG001|Overall Study|Inability to complete the study visits|0|||
145299781|NCT00854100|523948847|FG002|Overall Study|Inability to complete the study visits|1|||
145299782|NCT00854100|523948845|FG000|Overall Study|Lost to Follow-up|2|||
145299783|NCT00854100|523948846|FG001|Overall Study|Lost to Follow-up|0|||
145299784|NCT00854100|523948847|FG002|Overall Study|Lost to Follow-up|3|||
145299785|NCT00854100|523948845|FG000|Overall Study|Withdrawal by Subject|3|||
145299786|NCT00854100|523948846|FG001|Overall Study|Withdrawal by Subject|1|||
145299787|NCT00854100|523948847|FG002|Overall Study|Withdrawal by Subject|2|||
145299788|NCT00854100|523948845|FG000|Overall Study|Protocol Violation|2|||
145299789|NCT00854100|523948846|FG001|Overall Study|Protocol Violation|4|||
145299790|NCT00854100|523948847|FG002|Overall Study|Protocol Violation|3|||
145299791|NCT00854100|523948845|FG000|Overall Study|Adverse Event|2|||
145299792|NCT00854100|523948846|FG001|Overall Study|Adverse Event|1|||
145299793|NCT00854100|523948847|FG002|Overall Study|Adverse Event|2|||
145299794|NCT02216071|523948859|FG000|Overall Study|Withdrawal by Subject|7|||
145299795|NCT02216071|523948860|FG001|Overall Study|Withdrawal by Subject|2|||
145299796|NCT02216071|523948859|FG000|Overall Study|Lost to Follow-up|3|||
145299797|NCT02216071|523948860|FG001|Overall Study|Lost to Follow-up|3|||
145299798|NCT02216071|523948859|FG000|Overall Study|Protocol Violation|3|||
145299799|NCT02216071|523948860|FG001|Overall Study|Protocol Violation|5|||
145299800|NCT02216071|523948859|FG000|Overall Study|Other|2|||
145299801|NCT02216071|523948860|FG001|Overall Study|Other|2|||
145299802|NCT04753437|523948861|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145566655|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
145566656|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
145566657|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
145620258|NCT03100838|525123725|FG003|Overall Study|Lost to Follow-up|0|||
145251929|NCT04785144|523767917|FG000|Overall Study|Withdrawal by Subject|4|||
145251930|NCT04785144|523767918|FG001|Overall Study|Withdrawal by Subject|1|||
145251931|NCT04785144|523767919|FG002|Overall Study|Withdrawal by Subject|0|||
145251932|NCT04785144|523767920|FG003|Overall Study|Withdrawal by Subject|0|||
145251933|NCT04785144|523767921|FG004|Overall Study|Withdrawal by Subject|0|||
145251934|NCT04785144|523767922|FG005|Overall Study|Withdrawal by Subject|2|||
145251935|NCT04785144|523767923|FG006|Overall Study|Withdrawal by Subject|2|||
145251936|NCT04785144|523767924|FG007|Overall Study|Withdrawal by Subject|0|||
145251937|NCT04785144|523767925|FG008|Overall Study|Withdrawal by Subject|1|||
145251938|NCT04785144|523767926|FG009|Overall Study|Withdrawal by Subject|0|||
145251939|NCT04785144|523767917|FG000|Overall Study|Lost to Follow-up|1|||
145251940|NCT04785144|523767918|FG001|Overall Study|Lost to Follow-up|0|||
145251941|NCT04785144|523767919|FG002|Overall Study|Lost to Follow-up|0|||
145251942|NCT04785144|523767920|FG003|Overall Study|Lost to Follow-up|0|||
145251943|NCT04785144|523767921|FG004|Overall Study|Lost to Follow-up|1|||
145251944|NCT04785144|523767922|FG005|Overall Study|Lost to Follow-up|2|||
145251945|NCT04785144|523767923|FG006|Overall Study|Lost to Follow-up|1|||
145251946|NCT04785144|523767924|FG007|Overall Study|Lost to Follow-up|2|||
145251947|NCT04785144|523767925|FG008|Overall Study|Lost to Follow-up|4|||
145251948|NCT04785144|523767926|FG009|Overall Study|Lost to Follow-up|1|||
145251949|NCT04785144|523767917|FG000|Overall Study|Protocol Violation|0|||
145251950|NCT04785144|523767918|FG001|Overall Study|Protocol Violation|0|||
145251951|NCT04785144|523767919|FG002|Overall Study|Protocol Violation|0|||
145251952|NCT04785144|523767920|FG003|Overall Study|Protocol Violation|0|||
145251953|NCT04785144|523767921|FG004|Overall Study|Protocol Violation|0|||
145251954|NCT04785144|523767922|FG005|Overall Study|Protocol Violation|0|||
145251955|NCT04785144|523767923|FG006|Overall Study|Protocol Violation|1|||
145251956|NCT04785144|523767924|FG007|Overall Study|Protocol Violation|0|||
145251957|NCT04785144|523767925|FG008|Overall Study|Protocol Violation|0|||
145251958|NCT04785144|523767926|FG009|Overall Study|Protocol Violation|0|||
145251959|NCT04785144|523767917|FG000|Overall Study|Physician Decision|0|||
145251960|NCT04785144|523767918|FG001|Overall Study|Physician Decision|0|||
145251961|NCT04785144|523767919|FG002|Overall Study|Physician Decision|0|||
145251962|NCT04785144|523767920|FG003|Overall Study|Physician Decision|0|||
145251963|NCT04785144|523767921|FG004|Overall Study|Physician Decision|0|||
145251964|NCT04785144|523767922|FG005|Overall Study|Physician Decision|0|||
145251965|NCT04785144|523767923|FG006|Overall Study|Physician Decision|0|||
145251966|NCT04785144|523767924|FG007|Overall Study|Physician Decision|0|||
145251967|NCT04785144|523767925|FG008|Overall Study|Physician Decision|0|||
145251968|NCT04785144|523767926|FG009|Overall Study|Physician Decision|1|||
145251969|NCT04785144|523767917|FG000|Overall Study|Unable to continue due to work schedule|0|||
145251970|NCT04785144|523767918|FG001|Overall Study|Unable to continue due to work schedule|0|||
145251971|NCT04785144|523767919|FG002|Overall Study|Unable to continue due to work schedule|0|||
145251972|NCT04785144|523767920|FG003|Overall Study|Unable to continue due to work schedule|0|||
145251973|NCT04785144|523767921|FG004|Overall Study|Unable to continue due to work schedule|0|||
145251974|NCT04785144|523767922|FG005|Overall Study|Unable to continue due to work schedule|0|||
145251975|NCT04785144|523767923|FG006|Overall Study|Unable to continue due to work schedule|0|||
145251976|NCT04785144|523767924|FG007|Overall Study|Unable to continue due to work schedule|0|||
145251977|NCT04785144|523767925|FG008|Overall Study|Unable to continue due to work schedule|0|||
145251978|NCT04785144|523767926|FG009|Overall Study|Unable to continue due to work schedule|1|||
145251979|NCT01263470|523767927|FG000|Overall Study|Adverse Event|2|||
145251980|NCT01263470|523767928|FG001|Overall Study|Adverse Event|2|||
145251981|NCT01263470|523767929|FG002|Overall Study|Adverse Event|1|||
145251982|NCT01263470|523767930|FG003|Overall Study|Adverse Event|1|||
145251983|NCT01263470|523767931|FG004|Overall Study|Adverse Event|2|||
145251984|NCT01263470|523767932|FG005|Overall Study|Adverse Event|2|||
145251985|NCT01263470|523767927|FG000|Overall Study|Protocol Violation|0|||
145251986|NCT01263470|523767928|FG001|Overall Study|Protocol Violation|1|||
145251987|NCT01263470|523767929|FG002|Overall Study|Protocol Violation|0|||
145251988|NCT01263470|523767930|FG003|Overall Study|Protocol Violation|0|||
145251989|NCT01263470|523767931|FG004|Overall Study|Protocol Violation|0|||
145251990|NCT01263470|523767932|FG005|Overall Study|Protocol Violation|1|||
145251991|NCT01263470|523767927|FG000|Overall Study|Withdrawal by Subject|0|||
145251992|NCT01263470|523767928|FG001|Overall Study|Withdrawal by Subject|1|||
145251993|NCT01263470|523767929|FG002|Overall Study|Withdrawal by Subject|1|||
145251994|NCT01263470|523767930|FG003|Overall Study|Withdrawal by Subject|2|||
145251995|NCT01263470|523767931|FG004|Overall Study|Withdrawal by Subject|0|||
145251996|NCT01263470|523767932|FG005|Overall Study|Withdrawal by Subject|2|||
145251997|NCT01263470|523767927|FG000|Overall Study|Lack of Efficacy|0|||
145251998|NCT01263470|523767928|FG001|Overall Study|Lack of Efficacy|0|||
145251999|NCT01263470|523767929|FG002|Overall Study|Lack of Efficacy|2|||
145252000|NCT01263470|523767930|FG003|Overall Study|Lack of Efficacy|0|||
145252001|NCT01263470|523767931|FG004|Overall Study|Lack of Efficacy|0|||
145252002|NCT01263470|523767932|FG005|Overall Study|Lack of Efficacy|0|||
145252003|NCT01263470|523767927|FG000|Overall Study|Participant Unavailability|0|||
145252004|NCT01263470|523767928|FG001|Overall Study|Participant Unavailability|1|||
145252005|NCT01263470|523767929|FG002|Overall Study|Participant Unavailability|0|||
145252006|NCT01263470|523767930|FG003|Overall Study|Participant Unavailability|0|||
145252007|NCT01263470|523767931|FG004|Overall Study|Participant Unavailability|0|||
145252008|NCT01263470|523767932|FG005|Overall Study|Participant Unavailability|0|||
145252009|NCT01263470|523767927|FG000|Overall Study|Study Drug Non-compliance|0|||
145252010|NCT01263470|523767928|FG001|Overall Study|Study Drug Non-compliance|0|||
145252011|NCT01263470|523767929|FG002|Overall Study|Study Drug Non-compliance|0|||
145252012|NCT01263470|523767930|FG003|Overall Study|Study Drug Non-compliance|0|||
145252013|NCT01263470|523767931|FG004|Overall Study|Study Drug Non-compliance|1|||
145252014|NCT01263470|523767932|FG005|Overall Study|Study Drug Non-compliance|0|||
145252015|NCT00712712|523767933|FG000|Overall Study|Protocol Violation|11|||
145252016|NCT00712712|523767933|FG000|Overall Study|Radiofrequency not done|3|||
145252017|NCT00712712|523767933|FG000|Overall Study|Death|8|||
145252018|NCT00712712|523767933|FG000|Overall Study|Withdrawal by Subject|1|||
145252019|NCT02060903|523767936|FG000|Overall Study|Lost to Follow-up|4|||
145252020|NCT02060903|523767937|FG001|Overall Study|Lost to Follow-up|0|||
145252021|NCT02060903|523767936|FG000|Overall Study|Withdrawal by Subject|0|||
145252022|NCT02060903|523767937|FG001|Overall Study|Withdrawal by Subject|7|||
145252023|NCT00137267|523767938|FG000|Overall Study|Lost to Follow-up|15|||
145252024|NCT00137267|523767939|FG001|Overall Study|Lost to Follow-up|21|||
145252025|NCT01602822|523767942|FG000|Overall Study|Adverse Event|11|||
145252026|NCT02871791|523767946|FG000|Phase 1b|Death|0|||
145252027|NCT02871791|523767947|FG001|Phase 1b|Death|1|||
145252028|NCT02871791|523767946|FG000|Phase 1b|progressive disease|6|||
145252029|NCT02871791|523767947|FG001|Phase 1b|progressive disease|2|||
145252030|NCT02871791|523767946|FG000|Phase 2|Death|1|||
145252031|NCT02871791|523767947|FG001|Phase 2|Death|0|||
145252032|NCT02871791|523767946|FG000|Phase 2|Lost to Follow-up|2|||
145252033|NCT02871791|523767947|FG001|Phase 2|Lost to Follow-up|0|||
145252034|NCT02010567|523767961|FG000|Overall Study|Adverse Event|0|||
145252035|NCT02010567|523767962|FG001|Overall Study|Adverse Event|0|||
145252036|NCT02010567|523767963|FG002|Overall Study|Adverse Event|1|||
145252037|NCT02010567|523767964|FG003|Overall Study|Adverse Event|0|||
145252038|NCT02010567|523767965|FG004|Overall Study|Adverse Event|1|||
145252039|NCT00118040|523767970|FG000|Overall Study|Adverse Event|0|||
145252040|NCT00118040|523767971|FG001|Overall Study|Adverse Event|1|||
145252041|NCT00118040|523767972|FG002|Overall Study|Adverse Event|0|||
145252042|NCT00118040|523767970|FG000|Overall Study|Withdrawal by Subject|0|||
145252043|NCT00118040|523767971|FG001|Overall Study|Withdrawal by Subject|0|||
145252044|NCT00118040|523767972|FG002|Overall Study|Withdrawal by Subject|2|||
145252045|NCT00118040|523767970|FG000|Overall Study|Medical Contraindication|0|||
145252046|NCT00118040|523767971|FG001|Overall Study|Medical Contraindication|0|||
145252047|NCT00118040|523767972|FG002|Overall Study|Medical Contraindication|1|||
145252048|NCT00118040|523767970|FG000|Overall Study|Non-Compliant Participant|1|||
145252049|NCT00118040|523767971|FG001|Overall Study|Non-Compliant Participant|1|||
145252050|NCT00118040|523767972|FG002|Overall Study|Non-Compliant Participant|2|||
145252051|NCT00118040|523767970|FG000|Overall Study|Other|0|||
145252052|NCT00118040|523767971|FG001|Overall Study|Other|0|||
145252053|NCT00118040|523767972|FG002|Overall Study|Other|1|||
145299803|NCT04753437|523948862|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
145299804|NCT04753437|523948861|FG000|Overall Study|Liver Function Test Abnormalities|2|||
145299805|NCT04753437|523948862|FG001|Overall Study|Liver Function Test Abnormalities|4|||
145299806|NCT01066143|523950204|FG000|Overall Study|ineligible for the study|8|||
145299807|NCT01294787|523950205|FG000|Period 1|Adverse Event|0|||
145299808|NCT01294787|523950206|FG001|Period 1|Adverse Event|0|||
145299809|NCT01294787|523950207|FG002|Period 1|Adverse Event|0|||
145299810|NCT01294787|523950208|FG003|Period 1|Adverse Event|0|||
145299811|NCT01294787|523950209|FG004|Period 1|Adverse Event|1|||
145299812|NCT01294787|523950210|FG005|Period 1|Adverse Event|0|||
145299813|NCT01294787|523950205|FG000|Period 1|Withdrawal by Subject|0|||
145299814|NCT01294787|523950206|FG001|Period 1|Withdrawal by Subject|0|||
145299815|NCT01294787|523950207|FG002|Period 1|Withdrawal by Subject|0|||
145299816|NCT01294787|523950208|FG003|Period 1|Withdrawal by Subject|1|||
145299817|NCT01294787|523950209|FG004|Period 1|Withdrawal by Subject|1|||
145299818|NCT01294787|523950210|FG005|Period 1|Withdrawal by Subject|1|||
145299819|NCT01294787|523950205|FG000|Period 1|Administrative problem|0|||
145299820|NCT01294787|523950206|FG001|Period 1|Administrative problem|0|||
145299821|NCT01294787|523950207|FG002|Period 1|Administrative problem|1|||
145252054|NCT00397631|523767973|FG000|Overall Study|Adverse Event|5|||
145252055|NCT00397631|523767974|FG001|Overall Study|Adverse Event|6|||
145252056|NCT00397631|523767973|FG000|Overall Study|Lack of Efficacy|7|||
145252057|NCT00397631|523767974|FG001|Overall Study|Lack of Efficacy|10|||
145299822|NCT01294787|523950208|FG003|Period 1|Administrative problem|0|||
145299823|NCT01294787|523950209|FG004|Period 1|Administrative problem|0|||
145299824|NCT01294787|523950210|FG005|Period 1|Administrative problem|1|||
145299825|NCT01294787|523950205|FG000|Period 2|Adverse Event|0|||
145299826|NCT01294787|523950206|FG001|Period 2|Adverse Event|3|||
145252058|NCT00397631|523767973|FG000|Overall Study|Lost to Follow-up|8|||
145252059|NCT00397631|523767974|FG001|Overall Study|Lost to Follow-up|9|||
145252060|NCT00397631|523767973|FG000|Overall Study|Physician Decision|2|||
145252061|NCT00397631|523767974|FG001|Overall Study|Physician Decision|0|||
145252062|NCT00397631|523767973|FG000|Overall Study|Protocol Violation|0|||
145252063|NCT00397631|523767974|FG001|Overall Study|Protocol Violation|1|||
145299827|NCT01294787|523950207|FG002|Period 2|Adverse Event|0|||
145299828|NCT01294787|523950208|FG003|Period 2|Adverse Event|1|||
145252064|NCT00397631|523767973|FG000|Overall Study|Withdrawal by Subject|7|||
145252065|NCT00397631|523767974|FG001|Overall Study|Withdrawal by Subject|14|||
145252066|NCT00397631|523767973|FG000|Overall Study|protocol discontinuation criteria|1|||
145252067|NCT00397631|523767974|FG001|Overall Study|protocol discontinuation criteria|4|||
145252068|NCT01738594|523767975|FG000|Registration and Treatment Start|Adverse Event|0|||
145252069|NCT01738594|523767976|FG001|Registration and Treatment Start|Adverse Event|1|||
145252070|NCT01738594|523767977|FG002|Registration and Treatment Start|Adverse Event|0|||
145252071|NCT01738594|523767978|FG003|Registration and Treatment Start|Adverse Event|0|||
145252072|NCT01738594|523767979|FG004|Registration and Treatment Start|Adverse Event|0|||
145252073|NCT01738594|523767980|FG005|Registration and Treatment Start|Adverse Event|0|||
145252074|NCT01738594|523767981|FG006|Registration and Treatment Start|Adverse Event|0|||
145252075|NCT01738594|523767982|FG007|Registration and Treatment Start|Adverse Event|0|||
145252076|NCT01738594|523767975|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252077|NCT01738594|523767976|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252078|NCT01738594|523767977|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252079|NCT01738594|523767978|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252080|NCT01738594|523767979|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252081|NCT01738594|523767980|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
145252082|NCT01738594|523767981|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252083|NCT01738594|523767982|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
145252084|NCT01738594|523767975|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252085|NCT01738594|523767976|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
145252086|NCT01738594|523767977|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252087|NCT01738594|523767978|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252088|NCT01738594|523767979|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252089|NCT01738594|523767980|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
145299829|NCT01294787|523950209|FG004|Period 2|Adverse Event|0|||
145299830|NCT01294787|523950210|FG005|Period 2|Adverse Event|0|||
145299831|NCT01294787|523950205|FG000|Period 2|No longer needs study drug|0|||
145252090|NCT01738594|523767981|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252091|NCT01738594|523767982|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
145252092|NCT01738594|523767975|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252093|NCT01738594|523767976|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252094|NCT01738594|523767977|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252095|NCT01738594|523767978|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252096|NCT01738594|523767979|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252097|NCT01738594|523767980|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
145252098|NCT01738594|523767981|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252099|NCT01738594|523767982|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
145252100|NCT01738594|523767975|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252101|NCT01738594|523767976|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252102|NCT01738594|523767977|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252103|NCT01738594|523767978|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252104|NCT01738594|523767979|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252105|NCT01738594|523767980|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
145252106|NCT01738594|523767981|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252107|NCT01738594|523767982|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
145252108|NCT01738594|523767975|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252109|NCT01738594|523767976|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252110|NCT01738594|523767977|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252111|NCT01738594|523767978|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252112|NCT01738594|523767979|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
145252113|NCT01738594|523767980|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252114|NCT01738594|523767981|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145299832|NCT01294787|523950206|FG001|Period 2|No longer needs study drug|0|||
145299833|NCT01294787|523950207|FG002|Period 2|No longer needs study drug|0|||
145299834|NCT01294787|523950208|FG003|Period 2|No longer needs study drug|1|||
145299835|NCT01294787|523950209|FG004|Period 2|No longer needs study drug|0|||
145299836|NCT01294787|523950210|FG005|Period 2|No longer needs study drug|0|||
145299837|NCT01294787|523950205|FG000|Period 3|Adverse Event|0|||
145299838|NCT01294787|523950206|FG001|Period 3|Adverse Event|0|||
145299839|NCT01294787|523950207|FG002|Period 3|Adverse Event|0|||
145299840|NCT01294787|523950208|FG003|Period 3|Adverse Event|0|||
145299841|NCT01294787|523950209|FG004|Period 3|Adverse Event|1|||
145299842|NCT01294787|523950210|FG005|Period 3|Adverse Event|0|||
145299843|NCT01948258|523950213|FG000|Overall Study|Pregnancy|41|||
145410425|NCT03317496|524356784|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145410426|NCT03317496|524356785|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
145410427|NCT03317496|524356781|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145410428|NCT03317496|524356782|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145410429|NCT03317496|524356783|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
145410430|NCT03317496|524356784|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145410431|NCT03317496|524356785|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
145410432|NCT03317496|524356781|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
145410433|NCT03317496|524356782|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
145410434|NCT03317496|524356783|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
145252115|NCT01738594|523767982|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
145252116|NCT01738594|523767975|FG000|Follow up for 1 Year|Death|0|||
145252117|NCT01738594|523767976|FG001|Follow up for 1 Year|Death|0|||
145252118|NCT01738594|523767977|FG002|Follow up for 1 Year|Death|0|||
145252119|NCT01738594|523767978|FG003|Follow up for 1 Year|Death|0|||
145252120|NCT01738594|523767979|FG004|Follow up for 1 Year|Death|0|||
145252121|NCT01738594|523767980|FG005|Follow up for 1 Year|Death|1|||
145252122|NCT01738594|523767981|FG006|Follow up for 1 Year|Death|0|||
145252123|NCT01738594|523767982|FG007|Follow up for 1 Year|Death|0|||
145252124|NCT01738594|523767975|FG000|Follow up for 1 Year|Other|0|||
145252125|NCT01738594|523767976|FG001|Follow up for 1 Year|Other|0|||
145252126|NCT01738594|523767977|FG002|Follow up for 1 Year|Other|0|||
145252127|NCT01738594|523767978|FG003|Follow up for 1 Year|Other|0|||
145252128|NCT01738594|523767979|FG004|Follow up for 1 Year|Other|0|||
145252129|NCT01738594|523767980|FG005|Follow up for 1 Year|Other|2|||
145252130|NCT01738594|523767981|FG006|Follow up for 1 Year|Other|0|||
145252131|NCT01738594|523767982|FG007|Follow up for 1 Year|Other|0|||
145252132|NCT00403390|523767984|FG000|Overall Study|Withdrawal by Subject|1|||
145252133|NCT00403390|523767985|FG001|Overall Study|Withdrawal by Subject|0|||
145252134|NCT00403390|523767984|FG000|Overall Study|samples lost|1|||
145252135|NCT00403390|523767985|FG001|Overall Study|samples lost|0|||
145252136|NCT00403390|523767984|FG000|Overall Study|non-compliant|1|||
145252137|NCT00403390|523767985|FG001|Overall Study|non-compliant|0|||
145252138|NCT01878175|523767986|FG000|Overall Study|Developed contraindicated health problem|2|||
145252139|NCT01796106|523767987|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
145252140|NCT01796106|523767988|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
145252141|NCT01108068|523767989|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
145252142|NCT01108068|523767990|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
145252143|NCT00836953|523767991|FG000|Overall Study|Withdrawal by Subject|1|||
145252144|NCT00836953|523767991|FG000|Overall Study|Lost to Follow-up|1|||
145252145|NCT02201251|523767992|FG000|Overall Study|Adverse Event|1|||
145252146|NCT02201251|523767993|FG001|Overall Study|Adverse Event|1|||
145252147|NCT02201251|523767992|FG000|Overall Study|Protocol Violation|1|||
145252148|NCT02201251|523767993|FG001|Overall Study|Protocol Violation|0|||
145252149|NCT02201251|523767992|FG000|Overall Study|Noncompliance with Study Drug|0|||
145252150|NCT02201251|523767993|FG001|Overall Study|Noncompliance with Study Drug|1|||
145252151|NCT02201251|523767992|FG000|Overall Study|Withdrawal by Subject|2|||
145252152|NCT02201251|523767993|FG001|Overall Study|Withdrawal by Subject|1|||
145252153|NCT02711553|523767994|FG000|Overall Study|Withdrawal by Subject|2|||
145252154|NCT02711553|523767995|FG001|Overall Study|Withdrawal by Subject|1|||
145252155|NCT02711553|523767996|FG002|Overall Study|Withdrawal by Subject|1|||
145252156|NCT02711553|523767997|FG003|Overall Study|Withdrawal by Subject|0|||
145252157|NCT02711553|523767994|FG000|Overall Study|Lost to Follow-up|3|||
145252158|NCT02711553|523767995|FG001|Overall Study|Lost to Follow-up|3|||
145299844|NCT01948258|523950213|FG000|Overall Study|Did not complete by cut-off date|35|||
145299845|NCT01948258|523950213|FG000|Overall Study|Lost to Follow-up|27|||
145299846|NCT01948258|523950213|FG000|Overall Study|Withdrawal by SPD|8|||
145299847|NCT01948258|523950213|FG000|Overall Study|Withdrawal by Subject|6|||
145299848|NCT01948258|523950213|FG000|Overall Study|Health Care Professional|43|||
145299849|NCT01948258|523950213|FG000|Overall Study|Removed from statistical analysis|2|||
145299850|NCT01466166|523950217|FG000|Overall Study|Death|1|||
145299851|NCT01466166|523950217|FG000|Overall Study|Lost to Follow-up|7|||
145410435|NCT03317496|524356784|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
145410436|NCT03317496|524356785|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
145410437|NCT03317496|524356781|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
145566658|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
145252159|NCT02711553|523767996|FG002|Overall Study|Lost to Follow-up|6|||
145299852|NCT01466166|523950217|FG000|Overall Study|Infusion Reaction (IR)|27|||
145299853|NCT01466166|523950217|FG000|Overall Study|Adverse Event (Other than IR)|11|||
145299854|NCT01466166|523950217|FG000|Overall Study|Elevated Serum Uric Acid|78|||
145410438|NCT03317496|524356782|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
145410439|NCT03317496|524356783|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
145252160|NCT02711553|523767997|FG003|Overall Study|Lost to Follow-up|3|||
145252161|NCT02711553|523767994|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
145252162|NCT02711553|523767995|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
145252163|NCT02711553|523767996|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
145252164|NCT02711553|523767997|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
145252165|NCT01828567|523768000|FG000|Overall Study|Lost to Follow-up|27|||
145252166|NCT01828567|523768001|FG001|Overall Study|Lost to Follow-up|9|||
145252167|NCT01828567|523768000|FG000|Overall Study|Excluded - did not meet criteria|4|||
145252168|NCT01828567|523768001|FG001|Overall Study|Excluded - did not meet criteria|1|||
145252169|NCT02332876|523768002|FG000|Overall Study|Lost to Follow-up|1|||
145252170|NCT02332876|523768003|FG001|Overall Study|Lost to Follow-up|1|||
145410440|NCT03317496|524356784|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
145410441|NCT03317496|524356785|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
145410442|NCT03317496|524356781|FG000|Phase 2: Treatment|Adverse Event|0|||
145410443|NCT03317496|524356782|FG001|Phase 2: Treatment|Adverse Event|0|||
145410444|NCT03317496|524356783|FG002|Phase 2: Treatment|Adverse Event|0|||
145410445|NCT03317496|524356784|FG003|Phase 2: Treatment|Adverse Event|0|||
145410446|NCT03317496|524356785|FG004|Phase 2: Treatment|Adverse Event|6|||
145410447|NCT03317496|524356781|FG000|Phase 2: Treatment|Progressive disease|0|||
145410448|NCT03317496|524356782|FG001|Phase 2: Treatment|Progressive disease|0|||
145410449|NCT03317496|524356783|FG002|Phase 2: Treatment|Progressive disease|0|||
145410450|NCT03317496|524356784|FG003|Phase 2: Treatment|Progressive disease|0|||
145410451|NCT03317496|524356785|FG004|Phase 2: Treatment|Progressive disease|22|||
145410452|NCT03317496|524356781|FG000|Phase 2: Treatment|Other|0|||
145410453|NCT03317496|524356782|FG001|Phase 2: Treatment|Other|0|||
145410454|NCT03317496|524356783|FG002|Phase 2: Treatment|Other|0|||
145410455|NCT03317496|524356784|FG003|Phase 2: Treatment|Other|0|||
145410456|NCT03317496|524356785|FG004|Phase 2: Treatment|Other|4|||
145410457|NCT03317496|524356781|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
145252171|NCT02415595|523768004|FG000|Overall Study|Administrative reason by sponsor|39|||
145252172|NCT02415595|523768005|FG001|Overall Study|Administrative reason by sponsor|40|||
145410458|NCT03317496|524356782|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
145252173|NCT02415595|523768006|FG002|Overall Study|Administrative reason by sponsor|41|||
145252174|NCT02415595|523768007|FG003|Overall Study|Administrative reason by sponsor|39|||
145252175|NCT02415595|523768004|FG000|Overall Study|Adverse Event|1|||
145252176|NCT02415595|523768005|FG001|Overall Study|Adverse Event|3|||
145252177|NCT02415595|523768006|FG002|Overall Study|Adverse Event|5|||
145252178|NCT02415595|523768007|FG003|Overall Study|Adverse Event|10|||
145252179|NCT02415595|523768004|FG000|Overall Study|Lack of Efficacy|4|||
145252180|NCT02415595|523768005|FG001|Overall Study|Lack of Efficacy|4|||
145252181|NCT02415595|523768006|FG002|Overall Study|Lack of Efficacy|0|||
145252182|NCT02415595|523768007|FG003|Overall Study|Lack of Efficacy|0|||
145252183|NCT02415595|523768004|FG000|Overall Study|Lost to Follow-up|1|||
145252184|NCT02415595|523768005|FG001|Overall Study|Lost to Follow-up|3|||
145252185|NCT02415595|523768006|FG002|Overall Study|Lost to Follow-up|1|||
145252186|NCT02415595|523768007|FG003|Overall Study|Lost to Follow-up|1|||
145252187|NCT02415595|523768004|FG000|Overall Study|Poor/Non-compliance|1|||
145252188|NCT02415595|523768005|FG001|Overall Study|Poor/Non-compliance|0|||
145252189|NCT02415595|523768006|FG002|Overall Study|Poor/Non-compliance|1|||
145252190|NCT02415595|523768007|FG003|Overall Study|Poor/Non-compliance|0|||
145252191|NCT02415595|523768004|FG000|Overall Study|Reached stopping criteria|0|||
145252192|NCT02415595|523768005|FG001|Overall Study|Reached stopping criteria|1|||
145252193|NCT02415595|523768006|FG002|Overall Study|Reached stopping criteria|1|||
145252194|NCT02415595|523768007|FG003|Overall Study|Reached stopping criteria|0|||
145252195|NCT02415595|523768004|FG000|Overall Study|Withdrawal by Subject|4|||
145252196|NCT02415595|523768005|FG001|Overall Study|Withdrawal by Subject|0|||
145252197|NCT02415595|523768006|FG002|Overall Study|Withdrawal by Subject|1|||
145252198|NCT02415595|523768007|FG003|Overall Study|Withdrawal by Subject|3|||
145252199|NCT02415595|523768004|FG000|Overall Study|Other|0|||
145252200|NCT02415595|523768005|FG001|Overall Study|Other|1|||
145252201|NCT02415595|523768006|FG002|Overall Study|Other|1|||
145252202|NCT02415595|523768007|FG003|Overall Study|Other|0|||
145252203|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
145410459|NCT03317496|524356783|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
145410460|NCT03317496|524356784|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
145410461|NCT03317496|524356785|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
145410462|NCT03317496|524356781|FG000|Phase 2: Treatment|Physician Decision|0|||
145252204|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
145252205|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
145252206|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145252207|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
145252208|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145252209|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145252210|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145252211|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
145252212|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
145252213|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145410463|NCT03317496|524356782|FG001|Phase 2: Treatment|Physician Decision|0|||
145410464|NCT03317496|524356783|FG002|Phase 2: Treatment|Physician Decision|0|||
145410465|NCT03317496|524356784|FG003|Phase 2: Treatment|Physician Decision|0|||
145252214|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145252215|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
145252216|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
145252217|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
145252218|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
145252219|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
145252220|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
145252221|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
145252222|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
145252223|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
145252224|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145252225|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145252226|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
145252227|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Screen failure|0|||
145252228|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Screen failure|1|||
145252229|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Screen failure|2|||
145252230|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Screen failure|0|||
145252231|NCT02614261|523768008|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
145252232|NCT02614261|523768009|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
145252233|NCT02614261|523768010|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
145252234|NCT02614261|523768011|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145252235|NCT02614261|523768008|FG000|Open-Label Extension Phase|Adverse Event|23|||
145252236|NCT02614261|523768009|FG001|Open-Label Extension Phase|Adverse Event|12|||
145252237|NCT02614261|523768010|FG002|Open-Label Extension Phase|Adverse Event|11|||
145252238|NCT02614261|523768011|FG003|Open-Label Extension Phase|Adverse Event|0|||
145252239|NCT02614261|523768008|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
145252240|NCT02614261|523768009|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
145252241|NCT02614261|523768010|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
145252242|NCT02614261|523768011|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
145252243|NCT02614261|523768008|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
145252244|NCT02614261|523768009|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
145252245|NCT02614261|523768010|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
145252246|NCT02614261|523768011|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
145252247|NCT02614261|523768008|FG000|Open-Label Extension Phase|Physician Decision|2|||
145252248|NCT02614261|523768009|FG001|Open-Label Extension Phase|Physician Decision|0|||
145252249|NCT02614261|523768010|FG002|Open-Label Extension Phase|Physician Decision|0|||
145252250|NCT02614261|523768011|FG003|Open-Label Extension Phase|Physician Decision|0|||
145252251|NCT02614261|523768008|FG000|Open-Label Extension Phase|Pregnancy|1|||
145252252|NCT02614261|523768009|FG001|Open-Label Extension Phase|Pregnancy|2|||
145252253|NCT02614261|523768010|FG002|Open-Label Extension Phase|Pregnancy|1|||
145252254|NCT02614261|523768011|FG003|Open-Label Extension Phase|Pregnancy|0|||
145252255|NCT02614261|523768008|FG000|Open-Label Extension Phase|Protocol Violation|3|||
145252256|NCT02614261|523768009|FG001|Open-Label Extension Phase|Protocol Violation|4|||
145252257|NCT02614261|523768010|FG002|Open-Label Extension Phase|Protocol Violation|1|||
145252258|NCT02614261|523768011|FG003|Open-Label Extension Phase|Protocol Violation|0|||
145252259|NCT02614261|523768008|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
145252260|NCT02614261|523768009|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
145252261|NCT02614261|523768010|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
145252262|NCT02614261|523768011|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
145252263|NCT02614261|523768008|FG000|Follow-up Phase|Adverse Event|2|||
145252264|NCT02614261|523768009|FG001|Follow-up Phase|Adverse Event|0|||
145252265|NCT02614261|523768010|FG002|Follow-up Phase|Adverse Event|1|||
145252266|NCT02614261|523768011|FG003|Follow-up Phase|Adverse Event|0|||
145252267|NCT02614261|523768008|FG000|Follow-up Phase|Lost to Follow-up|12|||
145252268|NCT02614261|523768009|FG001|Follow-up Phase|Lost to Follow-up|5|||
145252269|NCT02614261|523768010|FG002|Follow-up Phase|Lost to Follow-up|2|||
145252270|NCT02614261|523768011|FG003|Follow-up Phase|Lost to Follow-up|0|||
145252271|NCT02614261|523768008|FG000|Follow-up Phase|Physician Decision|5|||
145252272|NCT02614261|523768009|FG001|Follow-up Phase|Physician Decision|1|||
145252273|NCT02614261|523768010|FG002|Follow-up Phase|Physician Decision|0|||
145252274|NCT02614261|523768011|FG003|Follow-up Phase|Physician Decision|0|||
145252275|NCT02614261|523768008|FG000|Follow-up Phase|Pregnancy|0|||
145252276|NCT02614261|523768009|FG001|Follow-up Phase|Pregnancy|1|||
145252277|NCT02614261|523768010|FG002|Follow-up Phase|Pregnancy|0|||
145252278|NCT02614261|523768011|FG003|Follow-up Phase|Pregnancy|0|||
145252279|NCT02614261|523768008|FG000|Follow-up Phase|Protocol Violation|1|||
145252280|NCT02614261|523768009|FG001|Follow-up Phase|Protocol Violation|0|||
145252281|NCT02614261|523768010|FG002|Follow-up Phase|Protocol Violation|0|||
145252282|NCT02614261|523768011|FG003|Follow-up Phase|Protocol Violation|0|||
145252283|NCT02614261|523768008|FG000|Follow-up Phase|Withdrawal by Subject|12|||
145252284|NCT02614261|523768009|FG001|Follow-up Phase|Withdrawal by Subject|4|||
145252285|NCT02614261|523768010|FG002|Follow-up Phase|Withdrawal by Subject|11|||
145252286|NCT02614261|523768011|FG003|Follow-up Phase|Withdrawal by Subject|0|||
145252287|NCT02614261|523768008|FG000|Israel Addendum|Withdrawal by Subject|0|||
145252288|NCT02614261|523768009|FG001|Israel Addendum|Withdrawal by Subject|0|||
145252289|NCT02614261|523768010|FG002|Israel Addendum|Withdrawal by Subject|0|||
145252290|NCT02614261|523768011|FG003|Israel Addendum|Withdrawal by Subject|4|||
145252291|NCT03231228|523768015|FG000|Overall Study|Lost to Follow-up|2|||
145252292|NCT03231228|523768016|FG001|Overall Study|Lost to Follow-up|0|||
145252293|NCT03231228|523768015|FG000|Overall Study|Physician Decision|1|||
145252294|NCT03231228|523768016|FG001|Overall Study|Physician Decision|0|||
145252295|NCT03399786|523768022|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
145252296|NCT03399786|523768023|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145252297|NCT03399786|523768024|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145252298|NCT03399786|523768025|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145252299|NCT03399786|523768022|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
145252300|NCT03399786|523768023|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
145252301|NCT03399786|523768024|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
145252302|NCT03399786|523768025|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
145252303|NCT03399786|523768022|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
145252304|NCT03399786|523768023|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
145252305|NCT03399786|523768024|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
145252306|NCT03399786|523768025|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
145252307|NCT03037489|523769923|FG000|Overall Study|Adverse Event|4|||
145252308|NCT03037489|523769924|FG001|Overall Study|Adverse Event|0|||
145252309|NCT03037489|523769923|FG000|Overall Study|Withdrawal by Subject|3|||
145252310|NCT03037489|523769924|FG001|Overall Study|Withdrawal by Subject|0|||
145252311|NCT02499172|523769925|FG000|Overall Study|Financial reason|0|||
145252312|NCT02499172|523769926|FG001|Overall Study|Financial reason|0|||
145252313|NCT02499172|523769927|FG002|Overall Study|Financial reason|523|||
145252314|NCT02499172|523769928|FG003|Overall Study|Financial reason|436|||
145252315|NCT02499172|523769925|FG000|Overall Study|Lost to Follow-up|65|||
145252316|NCT02499172|523769926|FG001|Overall Study|Lost to Follow-up|64|||
145252317|NCT02499172|523769927|FG002|Overall Study|Lost to Follow-up|0|||
145252318|NCT02499172|523769928|FG003|Overall Study|Lost to Follow-up|0|||
145252319|NCT00724243|523769931|FG000|Overall Study|Lack of Efficacy|10|||
145252320|NCT00724243|523769931|FG000|Overall Study|Adverse Event|5|||
145252321|NCT04610827|523769933|FG000|Overall Study|Withdrawal by Subject|1|||
145252322|NCT04610827|523769934|FG001|Overall Study|Withdrawal by Subject|1|||
145252323|NCT04610827|523769935|FG002|Overall Study|Withdrawal by Subject|0|||
145252324|NCT01997892|523769936|FG000|Overall Study|Physician Decision|2|||
145252325|NCT01997892|523769936|FG000|Overall Study|Lost to Follow-up|6|||
145252326|NCT01997892|523769936|FG000|Overall Study|Death|14|||
145252327|NCT01997892|523769936|FG000|Overall Study|Renal transplant|8|||
145252328|NCT01997892|523769936|FG000|Overall Study|Other|3|||
145252329|NCT01997892|523769936|FG000|Overall Study|Study completion data not recorded|35|||
145252330|NCT02710422|523769937|FG000|Overall Study|Termination of study|9|||
145252331|NCT02710422|523769938|FG001|Overall Study|Termination of study|9|||
145252332|NCT01654224|523769963|FG000|Overall Study|Lost to Follow-up|2|||
145252333|NCT01654224|523769964|FG001|Overall Study|Lost to Follow-up|2|||
145252334|NCT01654224|523769963|FG000|Overall Study|Did not receive allocation|1|||
145252335|NCT01654224|523769964|FG001|Overall Study|Did not receive allocation|8|||
145252336|NCT01654224|523769963|FG000|Overall Study|Insufficient blood sample|3|||
145252337|NCT01654224|523769964|FG001|Overall Study|Insufficient blood sample|2|||
145252338|NCT03763942|523769965|FG000|Overall Study|Lost to Follow-up|114|||
145252339|NCT03763942|523769966|FG001|Overall Study|Lost to Follow-up|54|||
145252340|NCT03763942|523769965|FG000|Overall Study|Protocol Violation|1|||
145252341|NCT03763942|523769966|FG001|Overall Study|Protocol Violation|0|||
145252342|NCT03763942|523769965|FG000|Overall Study|Withdrawal by Subject|2|||
145252343|NCT03763942|523769966|FG001|Overall Study|Withdrawal by Subject|0|||
145252344|NCT03763942|523769965|FG000|Overall Study|Other|2|||
145252345|NCT03763942|523769966|FG001|Overall Study|Other|3|||
145252346|NCT02200510|523769967|FG000|Overall Study|Death|1|||
145252347|NCT02200510|523769968|FG001|Overall Study|Death|1|||
145252348|NCT02200510|523769967|FG000|Overall Study|Protocol Violation|0|||
145252349|NCT02200510|523769968|FG001|Overall Study|Protocol Violation|1|||
145252350|NCT02200510|523769967|FG000|Overall Study|Lost to Follow-up|7|||
145252351|NCT02200510|523769968|FG001|Overall Study|Lost to Follow-up|1|||
145252352|NCT02200510|523769967|FG000|Overall Study|potential COI - joined study team|1|||
145252353|NCT02200510|523769968|FG001|Overall Study|potential COI - joined study team|0|||
145252354|NCT00939055|523769969|FG000|Overall Study|Discontinuation prior to procedure|4|||
145252355|NCT00939055|523769970|FG001|Overall Study|Discontinuation prior to procedure|0|||
145252356|NCT00584987|523769971|FG000|Overall Study|Protocol Violation|1|||
145252357|NCT00584987|523769972|FG001|Overall Study|Protocol Violation|1|||
145252358|NCT00584987|523769973|FG002|Overall Study|Protocol Violation|1|||
145252359|NCT00584987|523769974|FG003|Overall Study|Protocol Violation|0|||
145252360|NCT00584987|523769971|FG000|Overall Study|Adverse Event|0|||
145252361|NCT00584987|523769972|FG001|Overall Study|Adverse Event|0|||
145252362|NCT00584987|523769973|FG002|Overall Study|Adverse Event|0|||
145252363|NCT00584987|523769974|FG003|Overall Study|Adverse Event|1|||
145252364|NCT02274311|523769978|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
145252365|NCT04564027|523769981|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
145252366|NCT04564027|523769982|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
145252367|NCT04564027|523769983|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
145252368|NCT04564027|523769984|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
145252369|NCT05827978|523769985|FG000|Overall Study|Adverse Event|1|||
145252370|NCT05827978|523769986|FG001|Overall Study|Adverse Event|0|||
145252371|NCT05827978|523769987|FG002|Overall Study|Adverse Event|0|||
145252372|NCT05827978|523769988|FG003|Overall Study|Adverse Event|1|||
145252373|NCT05827978|523769989|FG004|Overall Study|Adverse Event|0|||
145252374|NCT05827978|523769990|FG005|Overall Study|Adverse Event|0|||
145252375|NCT05827978|523769985|FG000|Overall Study|Death|1|||
145252376|NCT05827978|523769986|FG001|Overall Study|Death|5|||
145252377|NCT05827978|523769987|FG002|Overall Study|Death|2|||
145252378|NCT05827978|523769988|FG003|Overall Study|Death|3|||
145252379|NCT05827978|523769989|FG004|Overall Study|Death|1|||
145252380|NCT05827978|523769990|FG005|Overall Study|Death|3|||
145252381|NCT05827978|523769985|FG000|Overall Study|Lost to Follow-up|57|||
145252382|NCT05827978|523769986|FG001|Overall Study|Lost to Follow-up|88|||
145252383|NCT05827978|523769987|FG002|Overall Study|Lost to Follow-up|54|||
145252384|NCT05827978|523769988|FG003|Overall Study|Lost to Follow-up|47|||
145252385|NCT05827978|523769989|FG004|Overall Study|Lost to Follow-up|25|||
145252386|NCT05827978|523769990|FG005|Overall Study|Lost to Follow-up|10|||
145252387|NCT05827978|523769985|FG000|Overall Study|Noncompliance with Study Procedures|0|||
145252388|NCT05827978|523769986|FG001|Overall Study|Noncompliance with Study Procedures|1|||
145252389|NCT05827978|523769987|FG002|Overall Study|Noncompliance with Study Procedures|1|||
145252390|NCT05827978|523769988|FG003|Overall Study|Noncompliance with Study Procedures|1|||
145252391|NCT05827978|523769989|FG004|Overall Study|Noncompliance with Study Procedures|1|||
145252392|NCT05827978|523769990|FG005|Overall Study|Noncompliance with Study Procedures|0|||
145252393|NCT05827978|523769985|FG000|Overall Study|Physician Decision|2|||
145252394|NCT05827978|523769986|FG001|Overall Study|Physician Decision|0|||
145252395|NCT05827978|523769987|FG002|Overall Study|Physician Decision|1|||
145252396|NCT05827978|523769988|FG003|Overall Study|Physician Decision|2|||
145252397|NCT05827978|523769989|FG004|Overall Study|Physician Decision|1|||
145252398|NCT05827978|523769990|FG005|Overall Study|Physician Decision|1|||
145252399|NCT05827978|523769985|FG000|Overall Study|Protocol Violation|5|||
145252400|NCT05827978|523769986|FG001|Overall Study|Protocol Violation|2|||
145252401|NCT05827978|523769987|FG002|Overall Study|Protocol Violation|0|||
145252402|NCT05827978|523769988|FG003|Overall Study|Protocol Violation|0|||
145252403|NCT05827978|523769989|FG004|Overall Study|Protocol Violation|0|||
145252404|NCT05827978|523769990|FG005|Overall Study|Protocol Violation|0|||
145252405|NCT05827978|523769985|FG000|Overall Study|Withdrawal by Subject|17|||
145252406|NCT05827978|523769986|FG001|Overall Study|Withdrawal by Subject|16|||
145252407|NCT05827978|523769987|FG002|Overall Study|Withdrawal by Subject|10|||
145252408|NCT05827978|523769988|FG003|Overall Study|Withdrawal by Subject|12|||
145252409|NCT05827978|523769989|FG004|Overall Study|Withdrawal by Subject|10|||
145252410|NCT05827978|523769990|FG005|Overall Study|Withdrawal by Subject|9|||
145252411|NCT05827978|523769985|FG000|Overall Study|Other Than Specified|0|||
145252412|NCT05827978|523769986|FG001|Overall Study|Other Than Specified|0|||
145252413|NCT05827978|523769987|FG002|Overall Study|Other Than Specified|1|||
145252414|NCT05827978|523769988|FG003|Overall Study|Other Than Specified|0|||
145252415|NCT05827978|523769989|FG004|Overall Study|Other Than Specified|2|||
145252416|NCT05827978|523769990|FG005|Overall Study|Other Than Specified|0|||
145252417|NCT04566445|523769991|FG000|Overall Study|Death|4|||
145252418|NCT04566445|523769992|FG001|Overall Study|Death|1|||
145252419|NCT04566445|523769993|FG002|Overall Study|Death|1|||
145252420|NCT04566445|523769991|FG000|Overall Study|Lost to Follow-up|3|||
145252421|NCT04566445|523769992|FG001|Overall Study|Lost to Follow-up|1|||
145252422|NCT04566445|523769993|FG002|Overall Study|Lost to Follow-up|1|||
145252423|NCT04566445|523769991|FG000|Overall Study|Study terminated by sponsor|11|||
145252424|NCT04566445|523769992|FG001|Overall Study|Study terminated by sponsor|17|||
145252425|NCT04566445|523769993|FG002|Overall Study|Study terminated by sponsor|32|||
145252426|NCT04566445|523769991|FG000|Overall Study|Withdrawal by Subject|12|||
145252427|NCT04566445|523769992|FG001|Overall Study|Withdrawal by Subject|14|||
145252428|NCT04566445|523769993|FG002|Overall Study|Withdrawal by Subject|13|||
145252429|NCT04566445|523769991|FG000|Overall Study|Randomized but not treated due to AE|2|||
145252430|NCT04566445|523769992|FG001|Overall Study|Randomized but not treated due to AE|1|||
145252431|NCT04566445|523769993|FG002|Overall Study|Randomized but not treated due to AE|0|||
145252432|NCT04566445|523769991|FG000|Overall Study|Adverse Event|1|||
145252433|NCT04566445|523769992|FG001|Overall Study|Adverse Event|1|||
145252434|NCT04566445|523769993|FG002|Overall Study|Adverse Event|0|||
145252435|NCT00610714|523769996|FG000|Overall Study|Adverse Event|3|||
145252436|NCT00610714|523769997|FG001|Overall Study|Adverse Event|1|||
145252437|NCT00610714|523769996|FG000|Overall Study|Death|12|||
145252438|NCT00610714|523769997|FG001|Overall Study|Death|18|||
145252439|NCT00610714|523769996|FG000|Overall Study|Withdrawal by Subject|9|||
145252440|NCT00610714|523769997|FG001|Overall Study|Withdrawal by Subject|3|||
145299855|NCT01466166|523950217|FG000|Overall Study|Withdrawal by Subject|13|||
145299856|NCT01466166|523950217|FG000|Overall Study|Sponsor Decision|4|||
145299857|NCT01466166|523950217|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
145299858|NCT01466166|523950217|FG000|Overall Study|Other|20|||
145299859|NCT00851877|523950225|FG000|Phase I-1|Death|1|||
145299860|NCT00851877|523950226|FG001|Phase I-1|Death|0|||
145299861|NCT00851877|523950227|FG002|Phase I-1|Death|0|||
145299862|NCT00851877|523950225|FG000|Phase II|Withdrawal by Subject|0|||
145299863|NCT00851877|523950226|FG001|Phase II|Withdrawal by Subject|0|||
145252441|NCT00610714|523769996|FG000|Overall Study|Study completion at 120 PFS events|2|||
145252442|NCT00610714|523769997|FG001|Overall Study|Study completion at 120 PFS events|2|||
145252443|NCT01327573|523769998|FG000|Overall Study|Physician Decision|3|||
145252444|NCT01327573|523769999|FG001|Overall Study|Physician Decision|1|||
145252445|NCT01108263|523770000|FG000|Overall Study|Adverse Event|0|||
145252446|NCT01108263|523770001|FG001|Overall Study|Adverse Event|1|||
145252447|NCT00729560|523770002|FG000|Overall Study|Withdrawal by Subject|3|||
145252448|NCT00829010|523770005|FG000|Overall Study|Adverse Event|1|||
145252449|NCT00829010|523770006|FG001|Overall Study|Adverse Event|0|||
145252450|NCT00829010|523770007|FG002|Overall Study|Adverse Event|0|||
145252451|NCT00829010|523770008|FG003|Overall Study|Adverse Event|0|||
145252452|NCT00829010|523770009|FG004|Overall Study|Adverse Event|0|||
145252453|NCT00829010|523770005|FG000|Overall Study|Withdrawal by Subject|0|||
145252454|NCT00829010|523770006|FG001|Overall Study|Withdrawal by Subject|1|||
145252455|NCT00829010|523770007|FG002|Overall Study|Withdrawal by Subject|1|||
145252456|NCT00829010|523770008|FG003|Overall Study|Withdrawal by Subject|0|||
145252457|NCT00829010|523770009|FG004|Overall Study|Withdrawal by Subject|2|||
145252458|NCT00829010|523770005|FG000|Overall Study|Lost to Follow-up|1|||
145252459|NCT00829010|523770006|FG001|Overall Study|Lost to Follow-up|0|||
145252460|NCT00829010|523770007|FG002|Overall Study|Lost to Follow-up|2|||
145252461|NCT00829010|523770008|FG003|Overall Study|Lost to Follow-up|0|||
145252462|NCT00829010|523770009|FG004|Overall Study|Lost to Follow-up|0|||
145252463|NCT00829010|523770005|FG000|Overall Study|Fatality|5|||
145252464|NCT00829010|523770006|FG001|Overall Study|Fatality|4|||
145252465|NCT00829010|523770007|FG002|Overall Study|Fatality|0|||
145252466|NCT00829010|523770008|FG003|Overall Study|Fatality|3|||
145252467|NCT00829010|523770009|FG004|Overall Study|Fatality|0|||
145252468|NCT00829010|523770005|FG000|Overall Study|Migrated/Moved from study area|3|||
145252469|NCT00829010|523770006|FG001|Overall Study|Migrated/Moved from study area|4|||
145252470|NCT00829010|523770007|FG002|Overall Study|Migrated/Moved from study area|0|||
145252471|NCT00829010|523770008|FG003|Overall Study|Migrated/Moved from study area|5|||
145252472|NCT00829010|523770009|FG004|Overall Study|Migrated/Moved from study area|0|||
145252473|NCT01029691|523770010|FG000|Continued APAP to Delivery|Death|0|||
145252474|NCT01029691|523770011|FG001|Continued APAP to Delivery|Death|0|||
145252475|NCT01029691|523770012|FG002|Continued APAP to Delivery|Death|1|||
145252476|NCT01023516|523770014|FG000|Overall Study|Voluntary discontinuation|7|||
145252477|NCT01023516|523770015|FG001|Overall Study|Voluntary discontinuation|5|||
145252478|NCT01023516|523770014|FG000|Overall Study|Adverse Event|9|||
145252479|NCT01023516|523770015|FG001|Overall Study|Adverse Event|6|||
145252480|NCT01023516|523770014|FG000|Overall Study|Safety reason|0|||
145252481|NCT01023516|523770015|FG001|Overall Study|Safety reason|3|||
145252482|NCT01023516|523770014|FG000|Overall Study|Study-specific criteria|4|||
145252483|NCT01023516|523770015|FG001|Overall Study|Study-specific criteria|2|||
145252484|NCT01023516|523770014|FG000|Overall Study|Incorrect enrolment|4|||
145252485|NCT01023516|523770015|FG001|Overall Study|Incorrect enrolment|2|||
145252486|NCT00638989|523770018|FG000|Overall Study|Lost to Follow-up|0|||
145252487|NCT00638989|523770019|FG001|Overall Study|Lost to Follow-up|0|||
145252488|NCT00638989|523770020|FG002|Overall Study|Lost to Follow-up|1|||
145252489|NCT05245071|523770021|FG000|Overall Study|Progressive disease|18|||
145252490|NCT05245071|523770021|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
145252491|NCT05245071|523770021|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
145252492|NCT00853112|523770022|FG000|Overall Study|Randomized but not treated|0|||
145252493|NCT00853112|523770023|FG001|Overall Study|Randomized but not treated|1|||
145252494|NCT00853112|523770024|FG002|Overall Study|Randomized but not treated|0|||
145252495|NCT00853112|523770025|FG003|Overall Study|Randomized but not treated|2|||
145252496|NCT00853112|523770026|FG004|Overall Study|Randomized but not treated|0|||
145252497|NCT00853112|523770027|FG005|Overall Study|Randomized but not treated|0|||
145252498|NCT00853112|523770028|FG006|Overall Study|Randomized but not treated|1|||
145252499|NCT02477800|523770031|FG000|Placebo-Controlled Period|Adverse Event|16|||
145252500|NCT02477800|523770032|FG001|Placebo-Controlled Period|Adverse Event|25|||
145252501|NCT02477800|523770033|FG002|Placebo-Controlled Period|Adverse Event|28|||
145252502|NCT02477800|523770034|FG003|Placebo-Controlled Period|Adverse Event|0|||
145252503|NCT02477800|523770035|FG004|Placebo-Controlled Period|Adverse Event|0|||
145252504|NCT02477800|523770036|FG005|Placebo-Controlled Period|Adverse Event|0|||
145252505|NCT02477800|523770037|FG006|Placebo-Controlled Period|Adverse Event|0|||
145252506|NCT02477800|523770031|FG000|Placebo-Controlled Period|Change of Treatment|1|||
145299864|NCT00851877|523950227|FG002|Phase II|Withdrawal by Subject|3|||
145299865|NCT00620074|523950228|FG000|Overall Study|Adverse Event|1|||
145299866|NCT00829673|523950229|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145252507|NCT02477800|523770032|FG001|Placebo-Controlled Period|Change of Treatment|2|||
145252508|NCT02477800|523770033|FG002|Placebo-Controlled Period|Change of Treatment|1|||
145252509|NCT02477800|523770034|FG003|Placebo-Controlled Period|Change of Treatment|0|||
145252510|NCT02477800|523770035|FG004|Placebo-Controlled Period|Change of Treatment|0|||
145252511|NCT02477800|523770036|FG005|Placebo-Controlled Period|Change of Treatment|0|||
145252512|NCT02477800|523770037|FG006|Placebo-Controlled Period|Change of Treatment|0|||
145252513|NCT02477800|523770031|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
145252514|NCT02477800|523770032|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
145252515|NCT02477800|523770033|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
145252516|NCT02477800|523770034|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
145252517|NCT02477800|523770035|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
145252518|NCT02477800|523770036|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
145252519|NCT02477800|523770037|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
145252520|NCT02477800|523770031|FG000|Placebo-Controlled Period|Death|0|||
145252521|NCT02477800|523770032|FG001|Placebo-Controlled Period|Death|3|||
145252522|NCT02477800|523770033|FG002|Placebo-Controlled Period|Death|2|||
145252523|NCT02477800|523770034|FG003|Placebo-Controlled Period|Death|0|||
145252524|NCT02477800|523770035|FG004|Placebo-Controlled Period|Death|0|||
145252525|NCT02477800|523770036|FG005|Placebo-Controlled Period|Death|0|||
145252526|NCT02477800|523770037|FG006|Placebo-Controlled Period|Death|0|||
145252527|NCT02477800|523770031|FG000|Placebo-Controlled Period|Disease Progression|1|||
145252528|NCT02477800|523770032|FG001|Placebo-Controlled Period|Disease Progression|0|||
145252529|NCT02477800|523770033|FG002|Placebo-Controlled Period|Disease Progression|1|||
145252530|NCT02477800|523770034|FG003|Placebo-Controlled Period|Disease Progression|0|||
145299867|NCT00829673|523950230|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145299868|NCT00829790|523950233|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
145299869|NCT00829790|523950234|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
145299870|NCT03214952|523950235|FG000|Overall Study|Protocol Deviation|45|||
145299871|NCT03214952|523950235|FG000|Overall Study|Case Report Forms Uncollected|13|||
145299872|NCT02246166|523950236|FG000|Overall Study|Protocol Violation|1|||
145299873|NCT02246166|523950237|FG001|Overall Study|Protocol Violation|0|||
145299874|NCT03769896|523950238|FG000|Open-label Phase|Lack of Efficacy|5|||
145299875|NCT03769896|523950239|FG001|Open-label Phase|Lack of Efficacy|0|||
145299876|NCT03769896|523950238|FG000|Open-label Phase|Adverse Event|3|||
145299877|NCT03769896|523950239|FG001|Open-label Phase|Adverse Event|0|||
145299878|NCT03769896|523950238|FG000|Open-label Phase|Withdrawal by Subject|1|||
145299879|NCT03769896|523950239|FG001|Open-label Phase|Withdrawal by Subject|0|||
145299880|NCT04112823|523950244|FG000|Overall Study|Lost to Follow-up|2|||
145299881|NCT04112823|523950245|FG001|Overall Study|Lost to Follow-up|3|||
145299882|NCT00625443|523950249|FG000|Overall Study|Adverse Event|1|||
145299883|NCT00625443|523950250|FG001|Overall Study|Adverse Event|4|||
145299884|NCT00625443|523950251|FG002|Overall Study|Adverse Event|0|||
145299885|NCT00625443|523950249|FG000|Overall Study|Non-compliance with protocol|0|||
145299886|NCT00625443|523950250|FG001|Overall Study|Non-compliance with protocol|1|||
145299887|NCT00625443|523950251|FG002|Overall Study|Non-compliance with protocol|0|||
145299888|NCT00625443|523950249|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
145299889|NCT00625443|523950250|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
145299890|NCT00625443|523950251|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
145299891|NCT00625443|523950249|FG000|Overall Study|Withdrawal by Subject|0|||
145299892|NCT00625443|523950250|FG001|Overall Study|Withdrawal by Subject|1|||
145299893|NCT00625443|523950251|FG002|Overall Study|Withdrawal by Subject|2|||
145299894|NCT00625443|523950249|FG000|Overall Study|Physician Decision|0|||
145299895|NCT00625443|523950250|FG001|Overall Study|Physician Decision|4|||
145299896|NCT00625443|523950251|FG002|Overall Study|Physician Decision|2|||
145299897|NCT00625443|523950249|FG000|Overall Study|Other|0|||
145299898|NCT00625443|523950250|FG001|Overall Study|Other|1|||
145299899|NCT00625443|523950251|FG002|Overall Study|Other|1|||
145299900|NCT02924883|523950252|FG000|Overall Study|Death|39|||
145299901|NCT02924883|523950253|FG001|Overall Study|Death|20|||
145299902|NCT02924883|523950252|FG000|Overall Study|Lost to Follow-up|1|||
145566659|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
145252531|NCT02477800|523770035|FG004|Placebo-Controlled Period|Disease Progression|0|||
145252532|NCT02477800|523770036|FG005|Placebo-Controlled Period|Disease Progression|0|||
145252533|NCT02477800|523770037|FG006|Placebo-Controlled Period|Disease Progression|0|||
145252534|NCT02477800|523770031|FG000|Placebo-Controlled Period|Investigator Decision|3|||
145252535|NCT02477800|523770032|FG001|Placebo-Controlled Period|Investigator Decision|2|||
145299903|NCT02924883|523950253|FG001|Overall Study|Lost to Follow-up|0|||
145299904|NCT02924883|523950252|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
145299905|NCT02924883|523950253|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
145299906|NCT02924883|523950252|FG000|Overall Study|Protocol Violation|1|||
145299907|NCT02924883|523950253|FG001|Overall Study|Protocol Violation|0|||
145299908|NCT02924883|523950252|FG000|Overall Study|Withdrawal by Subject|22|||
145299909|NCT02924883|523950253|FG001|Overall Study|Withdrawal by Subject|16|||
145566660|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
145299910|NCT02924883|523950252|FG000|Overall Study|Progressive Disease|1|||
145252536|NCT02477800|523770033|FG002|Placebo-Controlled Period|Investigator Decision|1|||
145252537|NCT02477800|523770034|FG003|Placebo-Controlled Period|Investigator Decision|0|||
145252538|NCT02477800|523770035|FG004|Placebo-Controlled Period|Investigator Decision|0|||
145252539|NCT02477800|523770036|FG005|Placebo-Controlled Period|Investigator Decision|0|||
145252540|NCT02477800|523770037|FG006|Placebo-Controlled Period|Investigator Decision|0|||
145252541|NCT02477800|523770031|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
145252542|NCT02477800|523770032|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
145252543|NCT02477800|523770033|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
145252544|NCT02477800|523770034|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
145252545|NCT02477800|523770035|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
145252546|NCT02477800|523770036|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
145252547|NCT02477800|523770037|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
145252548|NCT02477800|523770031|FG000|Placebo-Controlled Period|Relocation|2|||
145252549|NCT02477800|523770032|FG001|Placebo-Controlled Period|Relocation|0|||
145252550|NCT02477800|523770033|FG002|Placebo-Controlled Period|Relocation|0|||
145252551|NCT02477800|523770034|FG003|Placebo-Controlled Period|Relocation|0|||
145252552|NCT02477800|523770035|FG004|Placebo-Controlled Period|Relocation|0|||
145252553|NCT02477800|523770036|FG005|Placebo-Controlled Period|Relocation|0|||
145252554|NCT02477800|523770037|FG006|Placebo-Controlled Period|Relocation|0|||
145252555|NCT02477800|523770031|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
145252556|NCT02477800|523770032|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
145252557|NCT02477800|523770033|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
145252558|NCT02477800|523770034|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
145252559|NCT02477800|523770035|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
145252560|NCT02477800|523770036|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
145252561|NCT02477800|523770037|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
145252562|NCT02477800|523770031|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
145252563|NCT02477800|523770032|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
145252564|NCT02477800|523770033|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
145252565|NCT02477800|523770034|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
145252566|NCT02477800|523770035|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
145252567|NCT02477800|523770036|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
145252568|NCT02477800|523770037|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
145252569|NCT02477800|523770031|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
145299911|NCT02924883|523950253|FG001|Overall Study|Progressive Disease|0|||
145299912|NCT02924883|523950252|FG000|Overall Study|Study Terminated by Sponsor|69|||
145299913|NCT02924883|523950253|FG001|Overall Study|Study Terminated by Sponsor|32|||
145299914|NCT01182415|523950254|FG000|Overall Study|Lost to Follow-up|1|||
145299915|NCT02587962|523950260|FG000|Overall Study|Adverse Event|0|||
145299916|NCT02587962|523950261|FG001|Overall Study|Adverse Event|0|||
145299917|NCT02587962|523950262|FG002|Overall Study|Adverse Event|1|||
145299918|NCT02587962|523950263|FG003|Overall Study|Adverse Event|0|||
145299919|NCT02587962|523950264|FG004|Overall Study|Adverse Event|0|||
145299920|NCT02587962|523950260|FG000|Overall Study|Withdrawal by Subject|0|||
145299921|NCT02587962|523950261|FG001|Overall Study|Withdrawal by Subject|0|||
145299922|NCT02587962|523950262|FG002|Overall Study|Withdrawal by Subject|1|||
145299923|NCT02587962|523950263|FG003|Overall Study|Withdrawal by Subject|1|||
145299924|NCT02587962|523950264|FG004|Overall Study|Withdrawal by Subject|4|||
145299925|NCT02587962|523950260|FG000|Overall Study|Radiological progression|2|||
145299926|NCT02587962|523950261|FG001|Overall Study|Radiological progression|2|||
145299927|NCT02587962|523950262|FG002|Overall Study|Radiological progression|2|||
145299928|NCT02587962|523950263|FG003|Overall Study|Radiological progression|5|||
145299929|NCT02587962|523950264|FG004|Overall Study|Radiological progression|10|||
145299930|NCT02587962|523950260|FG000|Overall Study|Clinical progression|0|||
145299931|NCT02587962|523950261|FG001|Overall Study|Clinical progression|1|||
145299932|NCT02587962|523950262|FG002|Overall Study|Clinical progression|2|||
145299933|NCT02587962|523950263|FG003|Overall Study|Clinical progression|0|||
145410466|NCT03317496|524356785|FG004|Phase 2: Treatment|Physician Decision|1|||
145410467|NCT03317496|524356781|FG000|Phase 2: Treatment|Death|0|||
145410468|NCT03317496|524356782|FG001|Phase 2: Treatment|Death|0|||
145410469|NCT03317496|524356783|FG002|Phase 2: Treatment|Death|0|||
145410470|NCT03317496|524356784|FG003|Phase 2: Treatment|Death|0|||
145252570|NCT02477800|523770032|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
145252571|NCT02477800|523770033|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
145252572|NCT02477800|523770034|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
145410471|NCT03317496|524356785|FG004|Phase 2: Treatment|Death|1|||
145410472|NCT03317496|524356781|FG000|Phase 2: Follow-up|Death|0|||
145299934|NCT02587962|523950264|FG004|Overall Study|Clinical progression|1|||
145299935|NCT01185548|523950265|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
145299936|NCT00086996|523950267|FG000|Overall Study|Adverse Event|29|||
145299937|NCT00086996|523950267|FG000|Overall Study|Death|4|||
145410473|NCT03317496|524356782|FG001|Phase 2: Follow-up|Death|0|||
145410474|NCT03317496|524356783|FG002|Phase 2: Follow-up|Death|0|||
145252573|NCT02477800|523770035|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
145252574|NCT02477800|523770036|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
145252575|NCT02477800|523770037|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
145252576|NCT02477800|523770031|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
145252577|NCT02477800|523770032|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
145252578|NCT02477800|523770033|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
145252579|NCT02477800|523770034|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145252580|NCT02477800|523770035|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145252581|NCT02477800|523770036|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145252582|NCT02477800|523770037|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145252583|NCT02477800|523770031|FG000|Placebo-Controlled Period|Reason not Specified|161|||
145252584|NCT02477800|523770032|FG001|Placebo-Controlled Period|Reason not Specified|161|||
145252585|NCT02477800|523770033|FG002|Placebo-Controlled Period|Reason not Specified|189|||
145252586|NCT02477800|523770034|FG003|Placebo-Controlled Period|Reason not Specified|0|||
145252587|NCT02477800|523770035|FG004|Placebo-Controlled Period|Reason not Specified|0|||
145252588|NCT02477800|523770036|FG005|Placebo-Controlled Period|Reason not Specified|0|||
145252589|NCT02477800|523770037|FG006|Placebo-Controlled Period|Reason not Specified|0|||
145252590|NCT02477800|523770031|FG000|Long Term Extension Period|Adverse Event|0|||
145252591|NCT02477800|523770032|FG001|Long Term Extension Period|Adverse Event|0|||
145252592|NCT02477800|523770033|FG002|Long Term Extension Period|Adverse Event|0|||
145252593|NCT02477800|523770034|FG003|Long Term Extension Period|Adverse Event|6|||
145252594|NCT02477800|523770035|FG004|Long Term Extension Period|Adverse Event|2|||
145252595|NCT02477800|523770036|FG005|Long Term Extension Period|Adverse Event|4|||
145252596|NCT02477800|523770037|FG006|Long Term Extension Period|Adverse Event|3|||
145252597|NCT02477800|523770031|FG000|Long Term Extension Period|Death|0|||
145252598|NCT02477800|523770032|FG001|Long Term Extension Period|Death|0|||
145252599|NCT02477800|523770033|FG002|Long Term Extension Period|Death|0|||
145252600|NCT02477800|523770034|FG003|Long Term Extension Period|Death|1|||
145252601|NCT02477800|523770035|FG004|Long Term Extension Period|Death|1|||
145252602|NCT02477800|523770036|FG005|Long Term Extension Period|Death|1|||
145252603|NCT02477800|523770037|FG006|Long Term Extension Period|Death|2|||
145252604|NCT02477800|523770031|FG000|Long Term Extension Period|Consent Withdrawn|0|||
145252605|NCT02477800|523770032|FG001|Long Term Extension Period|Consent Withdrawn|0|||
145252606|NCT02477800|523770033|FG002|Long Term Extension Period|Consent Withdrawn|0|||
145252607|NCT02477800|523770034|FG003|Long Term Extension Period|Consent Withdrawn|10|||
145252608|NCT02477800|523770035|FG004|Long Term Extension Period|Consent Withdrawn|4|||
145252609|NCT02477800|523770036|FG005|Long Term Extension Period|Consent Withdrawn|13|||
145252610|NCT02477800|523770037|FG006|Long Term Extension Period|Consent Withdrawn|16|||
145252611|NCT02477800|523770031|FG000|Long Term Extension Period|Disease Progression|0|||
145252612|NCT02477800|523770032|FG001|Long Term Extension Period|Disease Progression|0|||
145252613|NCT02477800|523770033|FG002|Long Term Extension Period|Disease Progression|0|||
145252614|NCT02477800|523770034|FG003|Long Term Extension Period|Disease Progression|3|||
145252615|NCT02477800|523770035|FG004|Long Term Extension Period|Disease Progression|1|||
145252616|NCT02477800|523770036|FG005|Long Term Extension Period|Disease Progression|1|||
145252617|NCT02477800|523770037|FG006|Long Term Extension Period|Disease Progression|0|||
145252618|NCT02477800|523770031|FG000|Long Term Extension Period|Investigator Decision|0|||
145252619|NCT02477800|523770032|FG001|Long Term Extension Period|Investigator Decision|0|||
145252620|NCT02477800|523770033|FG002|Long Term Extension Period|Investigator Decision|0|||
145252621|NCT02477800|523770034|FG003|Long Term Extension Period|Investigator Decision|0|||
145252622|NCT02477800|523770035|FG004|Long Term Extension Period|Investigator Decision|0|||
145252623|NCT02477800|523770036|FG005|Long Term Extension Period|Investigator Decision|0|||
145252624|NCT02477800|523770037|FG006|Long Term Extension Period|Investigator Decision|2|||
145252625|NCT02477800|523770031|FG000|Long Term Extension Period|Lost to Follow-up|0|||
145252626|NCT02477800|523770032|FG001|Long Term Extension Period|Lost to Follow-up|0|||
145252627|NCT02477800|523770033|FG002|Long Term Extension Period|Lost to Follow-up|0|||
145252628|NCT02477800|523770034|FG003|Long Term Extension Period|Lost to Follow-up|0|||
145252629|NCT02477800|523770035|FG004|Long Term Extension Period|Lost to Follow-up|1|||
145252630|NCT02477800|523770036|FG005|Long Term Extension Period|Lost to Follow-up|3|||
145252631|NCT02477800|523770037|FG006|Long Term Extension Period|Lost to Follow-up|0|||
145252632|NCT02477800|523770031|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
145252633|NCT02477800|523770032|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
145252634|NCT02477800|523770033|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
145252635|NCT02477800|523770034|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
145566661|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
145566662|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
145566663|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
145252636|NCT02477800|523770035|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
145252637|NCT02477800|523770036|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
145252638|NCT02477800|523770037|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
145252639|NCT02477800|523770031|FG000|Long Term Extension Period|Study Visit Burden|0|||
145252640|NCT02477800|523770032|FG001|Long Term Extension Period|Study Visit Burden|0|||
145252641|NCT02477800|523770033|FG002|Long Term Extension Period|Study Visit Burden|0|||
145252642|NCT02477800|523770034|FG003|Long Term Extension Period|Study Visit Burden|3|||
145252643|NCT02477800|523770035|FG004|Long Term Extension Period|Study Visit Burden|0|||
145252644|NCT02477800|523770036|FG005|Long Term Extension Period|Study Visit Burden|2|||
145252645|NCT02477800|523770037|FG006|Long Term Extension Period|Study Visit Burden|2|||
145252646|NCT02477800|523770031|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
145252647|NCT02477800|523770032|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
145252648|NCT02477800|523770033|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
145252649|NCT02477800|523770034|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
145252650|NCT02477800|523770035|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
145252651|NCT02477800|523770036|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
145252652|NCT02477800|523770037|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
145252653|NCT02477800|523770031|FG000|Long Term Extension Period|Reason not Specified|0|||
145252654|NCT02477800|523770032|FG001|Long Term Extension Period|Reason not Specified|0|||
145252655|NCT02477800|523770033|FG002|Long Term Extension Period|Reason not Specified|0|||
145252656|NCT02477800|523770034|FG003|Long Term Extension Period|Reason not Specified|126|||
145252657|NCT02477800|523770035|FG004|Long Term Extension Period|Reason not Specified|140|||
145252658|NCT02477800|523770036|FG005|Long Term Extension Period|Reason not Specified|270|||
145252659|NCT02477800|523770037|FG006|Long Term Extension Period|Reason not Specified|224|||
145252660|NCT01426009|523770038|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
145252661|NCT01426009|523770038|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
145252662|NCT01426009|523770038|FG000|Washout 1|Withdrawal by Subject|1|||
145252663|NCT01426009|523770038|FG000|Washout 1|Personal Reasons|1|||
145252664|NCT01426009|523770038|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
145252665|NCT01426009|523770038|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
145252666|NCT01426009|523770038|FG000|Washout 2|electrive surgery|1|||
145252667|NCT01426009|523770038|FG000|Washout 3|personal reasons|1|||
145252668|NCT01426009|523770038|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
145252669|NCT01426009|523770038|FG000|Washout 4|Lost to Follow-up|1|||
145252670|NCT04107935|523770039|FG000|Overall Study|Death|1|||
145252671|NCT04107935|523770040|FG001|Overall Study|Death|0|||
145252672|NCT01021553|523770042|FG000|Overall Study|Adverse Event|1|||
145252673|NCT01021553|523770043|FG001|Overall Study|Adverse Event|0|||
145252674|NCT01021553|523770044|FG002|Overall Study|Adverse Event|0|||
145252675|NCT01021553|523770042|FG000|Overall Study|Lack of Efficacy|2|||
145252676|NCT01021553|523770043|FG001|Overall Study|Lack of Efficacy|2|||
145252677|NCT01021553|523770044|FG002|Overall Study|Lack of Efficacy|0|||
145252678|NCT01021553|523770042|FG000|Overall Study|Protocol Violation|0|||
145252679|NCT01021553|523770043|FG001|Overall Study|Protocol Violation|2|||
145252680|NCT01021553|523770044|FG002|Overall Study|Protocol Violation|2|||
145252681|NCT01021553|523770042|FG000|Overall Study|Lost to Follow-up|0|||
145252682|NCT01021553|523770043|FG001|Overall Study|Lost to Follow-up|0|||
145252683|NCT01021553|523770044|FG002|Overall Study|Lost to Follow-up|1|||
145252684|NCT01021553|523770042|FG000|Overall Study|Withdrawal by Subject|1|||
145252685|NCT01021553|523770043|FG001|Overall Study|Withdrawal by Subject|1|||
145252686|NCT01021553|523770044|FG002|Overall Study|Withdrawal by Subject|0|||
145252687|NCT01950364|523770045|FG000|Overall Study|Adverse Event|3|||
145252688|NCT01950364|523770046|FG001|Overall Study|Adverse Event|0|||
145252689|NCT01950364|523770045|FG000|Overall Study|Stem Cell Transplant|2|||
145252690|NCT01950364|523770046|FG001|Overall Study|Stem Cell Transplant|6|||
145252691|NCT01950364|523770045|FG000|Overall Study|Disease Progression|5|||
145252692|NCT01950364|523770046|FG001|Overall Study|Disease Progression|2|||
145252693|NCT01950364|523770045|FG000|Overall Study|Withdrawal by Subject|0|||
145252694|NCT01950364|523770046|FG001|Overall Study|Withdrawal by Subject|1|||
145252695|NCT01950364|523770045|FG000|Overall Study|Protocol Violation|0|||
145252696|NCT01950364|523770046|FG001|Overall Study|Protocol Violation|1|||
145252697|NCT02877134|523770050|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252698|NCT02877134|523770051|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
145252699|NCT02877134|523770052|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252700|NCT02877134|523770053|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252701|NCT02877134|523770054|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252702|NCT02877134|523770055|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
145252703|NCT02877134|523770056|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252704|NCT02877134|523770057|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252705|NCT02877134|523770058|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252706|NCT02877134|523770059|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252707|NCT02877134|523770060|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252708|NCT02877134|523770061|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
145252709|NCT02877134|523770050|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252710|NCT02877134|523770051|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
145252711|NCT02877134|523770052|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145299938|NCT00086996|523950267|FG000|Overall Study|progression/relapse|7|||
145252712|NCT02877134|523770053|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
145252713|NCT02877134|523770054|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252714|NCT02877134|523770055|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252715|NCT02877134|523770056|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
145252716|NCT02877134|523770057|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252717|NCT02877134|523770058|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252718|NCT02877134|523770059|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252719|NCT02877134|523770060|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252720|NCT02877134|523770061|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
145252721|NCT02877134|523770050|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
145252722|NCT02877134|523770051|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
145252723|NCT02877134|523770052|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
145252724|NCT02877134|523770053|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
145252725|NCT02877134|523770054|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
145252726|NCT02877134|523770055|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
145252727|NCT02877134|523770056|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
145252728|NCT02877134|523770057|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
145252729|NCT02877134|523770058|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
145252730|NCT02877134|523770059|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
145252731|NCT02877134|523770060|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
145252732|NCT02877134|523770061|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
145252733|NCT02877134|523770050|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
145252734|NCT02877134|523770051|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
145252735|NCT02877134|523770052|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
145252736|NCT02877134|523770053|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
145252737|NCT02877134|523770054|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
145252738|NCT02877134|523770055|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
145252739|NCT02877134|523770056|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
145252740|NCT02877134|523770057|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
145252741|NCT02877134|523770058|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
145252742|NCT02877134|523770059|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
145252743|NCT02877134|523770060|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
145252744|NCT02877134|523770061|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
145252745|NCT02877134|523770050|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252746|NCT02877134|523770051|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252747|NCT02877134|523770052|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252748|NCT02877134|523770053|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252749|NCT02877134|523770054|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252750|NCT02877134|523770055|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252751|NCT02877134|523770056|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252752|NCT02877134|523770057|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252753|NCT02877134|523770058|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
145252754|NCT02877134|523770059|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252755|NCT02877134|523770060|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252756|NCT02877134|523770061|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
145252757|NCT02877134|523770050|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252758|NCT02877134|523770051|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252759|NCT02877134|523770052|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252760|NCT02877134|523770053|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252761|NCT02877134|523770054|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252762|NCT02877134|523770055|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252763|NCT02877134|523770056|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
145252764|NCT02877134|523770057|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
145252765|NCT02877134|523770058|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
145252766|NCT02877134|523770059|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
145252767|NCT02877134|523770060|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
145252768|NCT02877134|523770061|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
145252769|NCT02877134|523770050|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252770|NCT02877134|523770051|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252771|NCT02877134|523770052|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252772|NCT02877134|523770053|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252773|NCT02877134|523770054|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252774|NCT02877134|523770055|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252775|NCT02877134|523770056|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145299939|NCT00086996|523950267|FG000|Overall Study|Withdrawal by Subject|13|||
145252776|NCT02877134|523770057|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
145252777|NCT02877134|523770058|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
145252778|NCT02877134|523770059|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
145252779|NCT02877134|523770060|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252780|NCT02877134|523770061|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
145252781|NCT02877134|523770050|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
145252782|NCT02877134|523770051|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
145252783|NCT02877134|523770052|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
145252784|NCT02877134|523770053|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
145252785|NCT02877134|523770054|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
145252786|NCT02877134|523770055|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
145252787|NCT02877134|523770056|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
145252788|NCT02877134|523770057|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
145252789|NCT02877134|523770058|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
145252790|NCT02877134|523770059|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
145252791|NCT02877134|523770060|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
145252792|NCT02877134|523770061|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
145252793|NCT04048876|523770064|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
145252794|NCT04048876|523770065|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
145252795|NCT04048876|523770066|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
145252796|NCT04048876|523770067|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
145252797|NCT04048876|523770064|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
145252798|NCT04048876|523770065|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
145252799|NCT04048876|523770066|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
145252800|NCT04048876|523770067|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
145252801|NCT04048876|523770064|FG000|Placebo Controlled Phase|Adverse Event|0|||
145252802|NCT04048876|523770065|FG001|Placebo Controlled Phase|Adverse Event|1|||
145252803|NCT04048876|523770066|FG002|Placebo Controlled Phase|Adverse Event|0|||
145252804|NCT04048876|523770067|FG003|Placebo Controlled Phase|Adverse Event|0|||
145252805|NCT04048876|523770064|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
145252806|NCT04048876|523770065|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
145252807|NCT04048876|523770066|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
145252808|NCT04048876|523770067|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
145252809|NCT01347840|523770072|FG000|Overall Study|Withdrawal by Subject|1|||
145252810|NCT03512275|523770075|FG000|Overall Study|Withdrawal by Subject|1|||
145252811|NCT03512275|523770076|FG001|Overall Study|Withdrawal by Subject|3|||
145252812|NCT03512275|523770075|FG000|Overall Study|Physician Decision|0|||
145252813|NCT03512275|523770076|FG001|Overall Study|Physician Decision|1|||
145252814|NCT03512275|523770075|FG000|Overall Study|Lost to Follow-up|0|||
145252815|NCT03512275|523770076|FG001|Overall Study|Lost to Follow-up|3|||
145252816|NCT03512275|523770075|FG000|Overall Study|Other|1|||
145252817|NCT03512275|523770076|FG001|Overall Study|Other|0|||
145252818|NCT04063865|523770077|FG000|Overall Study|Physician Decision|1|||
145252819|NCT04063865|523770078|FG001|Overall Study|Physician Decision|3|||
145252820|NCT04063865|523770077|FG000|Overall Study|Study Closed Prior to Completion|4|||
145252821|NCT04063865|523770078|FG001|Overall Study|Study Closed Prior to Completion|4|||
145252822|NCT04063865|523770077|FG000|Overall Study|Withdrawal by Subject|1|||
145252823|NCT04063865|523770078|FG001|Overall Study|Withdrawal by Subject|1|||
145252824|NCT01700140|523770079|FG000|Overall Study|Use of rescue drugs|3|||
145252825|NCT01700140|523770080|FG001|Overall Study|Use of rescue drugs|3|||
145252826|NCT01700140|523770081|FG002|Overall Study|Use of rescue drugs|1|||
145252827|NCT01700140|523770079|FG000|Overall Study|Discontinuation of radiotherapy|1|||
145252828|NCT01700140|523770080|FG001|Overall Study|Discontinuation of radiotherapy|0|||
145252829|NCT01700140|523770081|FG002|Overall Study|Discontinuation of radiotherapy|0|||
145252830|NCT01700140|523770079|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
145252831|NCT01700140|523770080|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
145252832|NCT01700140|523770081|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
145252833|NCT01700140|523770079|FG000|Overall Study|Aggravation of symptoms|1|||
145252834|NCT01700140|523770080|FG001|Overall Study|Aggravation of symptoms|0|||
145252835|NCT01700140|523770081|FG002|Overall Study|Aggravation of symptoms|0|||
145252836|NCT01700140|523770079|FG000|Overall Study|Adverse Event|0|||
145252837|NCT01700140|523770080|FG001|Overall Study|Adverse Event|1|||
145252838|NCT01700140|523770081|FG002|Overall Study|Adverse Event|0|||
145252839|NCT01700140|523770079|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
145252840|NCT01700140|523770080|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
145252841|NCT01700140|523770081|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
145252842|NCT01060124|523770082|FG000|Overall Study|Other|16|||
145252843|NCT01060124|523770082|FG000|Overall Study|Adverse Event|14|||
145252844|NCT01060124|523770082|FG000|Overall Study|Withdrawal by Subject|7|||
145252845|NCT01708915|523770088|FG000|Overall Study|Adverse Event|1|||
145252846|NCT01708915|523770089|FG001|Overall Study|Adverse Event|0|||
145252847|NCT01708915|523770090|FG002|Overall Study|Adverse Event|9|||
145252848|NCT01708915|523770091|FG003|Overall Study|Adverse Event|13|||
145252849|NCT01708915|523770088|FG000|Overall Study|Lack of Efficacy|84|||
145252850|NCT01708915|523770089|FG001|Overall Study|Lack of Efficacy|60|||
145252851|NCT01708915|523770090|FG002|Overall Study|Lack of Efficacy|35|||
145252852|NCT01708915|523770091|FG003|Overall Study|Lack of Efficacy|15|||
145252853|NCT01708915|523770088|FG000|Overall Study|Protocol Violation|0|||
145252854|NCT01708915|523770089|FG001|Overall Study|Protocol Violation|0|||
145252855|NCT01708915|523770090|FG002|Overall Study|Protocol Violation|0|||
145252856|NCT01708915|523770091|FG003|Overall Study|Protocol Violation|1|||
145252857|NCT01708915|523770088|FG000|Overall Study|Withdrawal by Subject|0|||
145252858|NCT01708915|523770089|FG001|Overall Study|Withdrawal by Subject|1|||
145252859|NCT01708915|523770090|FG002|Overall Study|Withdrawal by Subject|2|||
145252860|NCT01708915|523770091|FG003|Overall Study|Withdrawal by Subject|2|||
145252861|NCT01708915|523770088|FG000|Overall Study|Other reasons than stated above|1|||
145252862|NCT01708915|523770089|FG001|Overall Study|Other reasons than stated above|1|||
145252863|NCT01708915|523770090|FG002|Overall Study|Other reasons than stated above|0|||
145252864|NCT01708915|523770091|FG003|Overall Study|Other reasons than stated above|2|||
145252865|NCT00374127|523770094|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
145252866|NCT00374127|523770094|FG000|Overall Study|Blood could not be drawn.|2|||
145252867|NCT00374127|523770094|FG000|Overall Study|Protocol Violation|5|||
145252868|NCT00374127|523770094|FG000|Overall Study|Pregnancy|1|||
145252869|NCT01222416|523770095|FG000|Overall Study|ineligible;metastasis|3|||
145252870|NCT01222416|523770096|FG001|Overall Study|ineligible;metastasis|0|||
145252871|NCT01222416|523770095|FG000|Overall Study|Adverse Event|4|||
145252872|NCT01222416|523770096|FG001|Overall Study|Adverse Event|0|||
145252873|NCT01222416|523770095|FG000|Overall Study|Withdrawal by Subject|5|||
145252874|NCT01222416|523770096|FG001|Overall Study|Withdrawal by Subject|0|||
145252875|NCT01222416|523770095|FG000|Overall Study|scheduling|6|||
145252876|NCT01222416|523770096|FG001|Overall Study|scheduling|0|||
145252877|NCT01222416|523770095|FG000|Overall Study|missed view/scan|1|||
145252878|NCT01222416|523770096|FG001|Overall Study|missed view/scan|0|||
145252879|NCT01222416|523770095|FG000|Overall Study|Death|1|||
145252880|NCT01222416|523770096|FG001|Overall Study|Death|0|||
145252881|NCT00518336|523770097|FG000|Year 7|Lost to Follow-up|2|||
145252882|NCT00518336|523770098|FG001|Year 7|Lost to Follow-up|0|||
145252883|NCT00518336|523770097|FG000|Year 7|Could not attend in time|0|||
145252884|NCT00518336|523770098|FG001|Year 7|Could not attend in time|3|||
145252885|NCT00518336|523770097|FG000|Year 8|Lost to Follow-up|1|||
145252886|NCT00518336|523770098|FG001|Year 8|Lost to Follow-up|1|||
145252887|NCT00518336|523770097|FG000|Year 8|Could not attend in time|0|||
145252888|NCT00518336|523770098|FG001|Year 8|Could not attend in time|1|||
145252889|NCT00518336|523770097|FG000|Year 9|Migrated/moved from study area|1|||
145252890|NCT00518336|523770098|FG001|Year 9|Migrated/moved from study area|1|||
145252891|NCT00518336|523770097|FG000|Year 9|Lost to Follow-up|3|||
145252892|NCT00518336|523770098|FG001|Year 9|Lost to Follow-up|0|||
145252893|NCT00518336|523770097|FG000|Year 9|Personal reasons|1|||
145252894|NCT00518336|523770098|FG001|Year 9|Personal reasons|0|||
145252895|NCT04223778|523770099|FG000|Overall Study|Death|1|||
145252896|NCT04223778|523770100|FG001|Overall Study|Death|1|||
145252897|NCT04223778|523770099|FG000|Overall Study|Lost to Follow-up|4|||
145299940|NCT00086996|523950267|FG000|Overall Study|Other|6|||
145299941|NCT00086996|523950267|FG000|Overall Study|not eligible|5|||
145299942|NCT01422538|523950271|FG000|Overall Study|Lost to Follow-up|0|||
145252898|NCT04223778|523770100|FG001|Overall Study|Lost to Follow-up|5|||
145252899|NCT04223778|523770099|FG000|Overall Study|Physician Decision|10|||
145252900|NCT04223778|523770100|FG001|Overall Study|Physician Decision|6|||
145252901|NCT04223778|523770099|FG000|Overall Study|Withdrawal by Subject|35|||
145252902|NCT04223778|523770100|FG001|Overall Study|Withdrawal by Subject|17|||
145299943|NCT01422538|523950272|FG001|Overall Study|Lost to Follow-up|1|||
145252903|NCT04223778|523770099|FG000|Overall Study|Not Reported|7|||
145252904|NCT04223778|523770100|FG001|Overall Study|Not Reported|8|||
145252905|NCT02059174|523771715|FG000|Period 1|Withdrawal by Subject|0|||
145252906|NCT02059174|523771716|FG001|Period 1|Withdrawal by Subject|2|||
145252907|NCT02059174|523771715|FG000|Period 2|Withdrawal by Subject|0|||
145252908|NCT02059174|523771716|FG001|Period 2|Withdrawal by Subject|2|||
145252909|NCT02059174|523771715|FG000|Period 2|Protocol Violation|1|||
145252910|NCT02059174|523771716|FG001|Period 2|Protocol Violation|0|||
145252911|NCT02059174|523771715|FG000|Period 3|Physician Decision|1|||
145299944|NCT01422538|523950273|FG002|Overall Study|Lost to Follow-up|1|||
145252912|NCT02059174|523771716|FG001|Period 3|Physician Decision|0|||
145252913|NCT02306148|523771717|FG000|Overall Study|Adverse Event|12|||
145252914|NCT02306148|523771718|FG001|Overall Study|Adverse Event|6|||
145252915|NCT02306148|523771717|FG000|Overall Study|Lost to Follow-up|1|||
145252916|NCT02306148|523771718|FG001|Overall Study|Lost to Follow-up|4|||
145252917|NCT04167514|523771725|FG000|Overall Study|Adverse event, not serious|0|||
145252918|NCT04167514|523771726|FG001|Overall Study|Adverse event, not serious|1|||
145252919|NCT04167514|523771725|FG000|Overall Study|Lost to Follow-up|1|||
145252920|NCT04167514|523771726|FG001|Overall Study|Lost to Follow-up|0|||
145252921|NCT04167514|523771725|FG000|Overall Study|Participant Decision|2|||
145252922|NCT04167514|523771726|FG001|Overall Study|Participant Decision|4|||
145299945|NCT01422538|523950271|FG000|Overall Study|Missed visit|0|||
145252923|NCT04167514|523771725|FG000|Overall Study|Physician Decision|3|||
145252924|NCT04167514|523771726|FG001|Overall Study|Physician Decision|2|||
145252925|NCT04167514|523771725|FG000|Overall Study|Death|14|||
145252926|NCT04167514|523771726|FG001|Overall Study|Death|18|||
145252927|NCT04167514|523771725|FG000|Overall Study|Enrolled but treatment not administered|2|||
145252928|NCT04167514|523771726|FG001|Overall Study|Enrolled but treatment not administered|0|||
145252929|NCT04167514|523771725|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
145252930|NCT04167514|523771726|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
145252931|NCT04167514|523771725|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
145252932|NCT04167514|523771726|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
145252933|NCT00290355|523771727|FG000|Overall Study|Serious adverse event|7|||
145252934|NCT00290355|523771728|FG001|Overall Study|Serious adverse event|4|||
145252935|NCT00290355|523771727|FG000|Overall Study|Study product reactogenicity|1|||
145252936|NCT00290355|523771728|FG001|Overall Study|Study product reactogenicity|0|||
145252937|NCT00290355|523771727|FG000|Overall Study|Protocol Violation|1|||
145252938|NCT00290355|523771728|FG001|Overall Study|Protocol Violation|0|||
145252939|NCT00290355|523771727|FG000|Overall Study|Withdrawal by Subject|2|||
145252940|NCT00290355|523771728|FG001|Overall Study|Withdrawal by Subject|0|||
145252941|NCT00290355|523771727|FG000|Overall Study|Migrated / moved from the study area|1|||
145252942|NCT00290355|523771728|FG001|Overall Study|Migrated / moved from the study area|0|||
145252943|NCT00290355|523771727|FG000|Overall Study|Lost to Follow-up|3|||
145252944|NCT00290355|523771728|FG001|Overall Study|Lost to Follow-up|1|||
145252945|NCT00290355|523771727|FG000|Overall Study|Other|2|||
145252946|NCT00290355|523771728|FG001|Overall Study|Other|0|||
145252947|NCT00033514|523771729|FG000|Overall Study|Lost to Follow-up|1|||
145252948|NCT00033514|523771730|FG001|Overall Study|Lost to Follow-up|1|||
145252949|NCT00033514|523771729|FG000|Overall Study|Withdrawal by Subject|0|||
145252950|NCT00033514|523771730|FG001|Overall Study|Withdrawal by Subject|3|||
145252951|NCT03225833|523771733|FG000|Overall Study|Adverse Event|0|||
145252952|NCT03225833|523771734|FG001|Overall Study|Adverse Event|1|||
145252953|NCT03225833|523771735|FG002|Overall Study|Adverse Event|2|||
145252954|NCT03225833|523771736|FG003|Overall Study|Adverse Event|0|||
145252955|NCT03225833|523771737|FG004|Overall Study|Adverse Event|0|||
145252956|NCT03225833|523771738|FG005|Overall Study|Adverse Event|2|||
145252957|NCT03225833|523771733|FG000|Overall Study|Withdrawal by Subject|1|||
145252958|NCT03225833|523771734|FG001|Overall Study|Withdrawal by Subject|0|||
145252959|NCT03225833|523771735|FG002|Overall Study|Withdrawal by Subject|0|||
145252960|NCT03225833|523771736|FG003|Overall Study|Withdrawal by Subject|0|||
145252961|NCT03225833|523771737|FG004|Overall Study|Withdrawal by Subject|1|||
145252962|NCT03225833|523771738|FG005|Overall Study|Withdrawal by Subject|0|||
145252963|NCT03225833|523771733|FG000|Overall Study|Termination of Study by Sponsor|4|||
145252964|NCT03225833|523771734|FG001|Overall Study|Termination of Study by Sponsor|0|||
145252965|NCT03225833|523771735|FG002|Overall Study|Termination of Study by Sponsor|0|||
145252966|NCT03225833|523771736|FG003|Overall Study|Termination of Study by Sponsor|0|||
145252967|NCT03225833|523771737|FG004|Overall Study|Termination of Study by Sponsor|0|||
145252968|NCT03225833|523771738|FG005|Overall Study|Termination of Study by Sponsor|7|||
145252969|NCT03225833|523771733|FG000|Overall Study|Sponsor Decision|0|||
145252970|NCT03225833|523771734|FG001|Overall Study|Sponsor Decision|0|||
145252971|NCT03225833|523771735|FG002|Overall Study|Sponsor Decision|0|||
145252972|NCT03225833|523771736|FG003|Overall Study|Sponsor Decision|0|||
145252973|NCT03225833|523771737|FG004|Overall Study|Sponsor Decision|0|||
145252974|NCT03225833|523771738|FG005|Overall Study|Sponsor Decision|1|||
145252975|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
145252976|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
145252977|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
145252978|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
145252979|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Other|1|||
145252980|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Other|0|||
145252981|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Other|2|||
145252982|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Other|4|||
145252983|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
145252984|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
145252985|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
145252986|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
145252987|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Adverse Event|0|||
145252988|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Adverse Event|0|||
145252989|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Adverse Event|1|||
145252990|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Adverse Event|2|||
145252991|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
145252992|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
145252993|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
145252994|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
145252995|NCT00808028|523771739|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
145252996|NCT00808028|523771740|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
145252997|NCT00808028|523771741|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
145252998|NCT00808028|523771742|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
145252999|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
145253000|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
145253001|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
145253002|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
145253003|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
145253004|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
145253005|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
145253006|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
145253007|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
145253008|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
145253009|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
145253010|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
145253011|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
145253012|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
145253013|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
145253014|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
145253015|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
145253016|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
145253017|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
145253018|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
145253019|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
145253020|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
145253021|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
145253022|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
145253023|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
145253024|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
145253025|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
145253026|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
145566664|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
145566665|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
145253027|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
145253028|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
145253029|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
145253030|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
145253031|NCT00808028|523771739|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
145253032|NCT00808028|523771740|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
145253033|NCT00808028|523771741|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
145253034|NCT00808028|523771742|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
145253035|NCT00508001|523771752|FG000|Overall Study|Adverse Event|2|||
145253036|NCT00508001|523771753|FG001|Overall Study|Adverse Event|0|||
145253037|NCT00508001|523771754|FG002|Overall Study|Adverse Event|4|||
145253038|NCT00508001|523771752|FG000|Overall Study|condition under investigation worsened|13|||
145253039|NCT00508001|523771753|FG001|Overall Study|condition under investigation worsened|7|||
145253040|NCT00508001|523771754|FG002|Overall Study|condition under investigation worsened|1|||
145253041|NCT00508001|523771752|FG000|Overall Study|Death|0|||
145253042|NCT00508001|523771753|FG001|Overall Study|Death|1|||
145253043|NCT00508001|523771754|FG002|Overall Study|Death|1|||
145253044|NCT00508001|523771752|FG000|Overall Study|Withdrawal by Subject|4|||
145253045|NCT00508001|523771753|FG001|Overall Study|Withdrawal by Subject|4|||
145253046|NCT00508001|523771754|FG002|Overall Study|Withdrawal by Subject|1|||
145253047|NCT01599585|523771755|FG000|Overall Study|Withdrawal by Subject|16|||
145253048|NCT01599585|523771756|FG001|Overall Study|Withdrawal by Subject|9|||
145253049|NCT01599585|523771755|FG000|Overall Study|Lost to Follow-up|3|||
145253050|NCT01599585|523771756|FG001|Overall Study|Lost to Follow-up|5|||
145253051|NCT01599585|523771755|FG000|Overall Study|randomized did not start treatment|3|||
145253052|NCT01599585|523771756|FG001|Overall Study|randomized did not start treatment|3|||
145253053|NCT03093350|523771757|FG000|Overall Study|Death|1|||
145253054|NCT03093350|523771757|FG000|Overall Study|Signed consent, never began treartment|1|||
145253055|NCT00777036|523771758|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
145253056|NCT00777036|523771759|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
145253057|NCT00777036|523771760|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
145253058|NCT00777036|523771761|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
145253059|NCT00777036|523771758|FG000|On Treatment|Administrative Reason By Sponsor|1|||
145253060|NCT00777036|523771759|FG001|On Treatment|Administrative Reason By Sponsor|0|||
145253061|NCT00777036|523771760|FG002|On Treatment|Administrative Reason By Sponsor|9|||
145253062|NCT00777036|523771761|FG003|On Treatment|Administrative Reason By Sponsor|0|||
145253063|NCT00777036|523771758|FG000|On Treatment|Failure to Meet Study Criteria|0|||
145253064|NCT00777036|523771759|FG001|On Treatment|Failure to Meet Study Criteria|1|||
145253065|NCT00777036|523771760|FG002|On Treatment|Failure to Meet Study Criteria|4|||
145253066|NCT00777036|523771761|FG003|On Treatment|Failure to Meet Study Criteria|0|||
145253067|NCT00777036|523771758|FG000|On Treatment|Pregnancy|1|||
145253068|NCT00777036|523771759|FG001|On Treatment|Pregnancy|0|||
145253069|NCT00777036|523771760|FG002|On Treatment|Pregnancy|1|||
145253070|NCT00777036|523771761|FG003|On Treatment|Pregnancy|0|||
145253071|NCT00777036|523771758|FG000|On Treatment|Non-compliance with Study Drug|1|||
145253072|NCT00777036|523771759|FG001|On Treatment|Non-compliance with Study Drug|0|||
145253073|NCT00777036|523771760|FG002|On Treatment|Non-compliance with Study Drug|1|||
145253074|NCT00777036|523771761|FG003|On Treatment|Non-compliance with Study Drug|0|||
145253075|NCT00777036|523771758|FG000|On Treatment|Maximum Clinical Benefit|2|||
145253076|NCT00777036|523771759|FG001|On Treatment|Maximum Clinical Benefit|0|||
145253077|NCT00777036|523771760|FG002|On Treatment|Maximum Clinical Benefit|5|||
145299946|NCT01422538|523950272|FG001|Overall Study|Missed visit|1|||
145253078|NCT00777036|523771761|FG003|On Treatment|Maximum Clinical Benefit|0|||
145253079|NCT00777036|523771758|FG000|On Treatment|Withdrawal by Subject|0|||
145253080|NCT00777036|523771759|FG001|On Treatment|Withdrawal by Subject|2|||
145253081|NCT00777036|523771760|FG002|On Treatment|Withdrawal by Subject|2|||
145253082|NCT00777036|523771761|FG003|On Treatment|Withdrawal by Subject|0|||
145253083|NCT00777036|523771758|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
145253084|NCT00777036|523771759|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
145253085|NCT00777036|523771760|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
145253086|NCT00777036|523771761|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
145253087|NCT00777036|523771758|FG000|On Treatment|Death|0|||
145253088|NCT00777036|523771759|FG001|On Treatment|Death|2|||
145253089|NCT00777036|523771760|FG002|On Treatment|Death|0|||
145253090|NCT00777036|523771761|FG003|On Treatment|Death|0|||
145253091|NCT00777036|523771758|FG000|On Treatment|Study Drug Toxicity|1|||
145253092|NCT00777036|523771759|FG001|On Treatment|Study Drug Toxicity|0|||
145253093|NCT00777036|523771760|FG002|On Treatment|Study Drug Toxicity|4|||
145253094|NCT00777036|523771761|FG003|On Treatment|Study Drug Toxicity|0|||
145253095|NCT00777036|523771758|FG000|On Treatment|Progressive Disease|6|||
145253096|NCT00777036|523771759|FG001|On Treatment|Progressive Disease|4|||
145253097|NCT00777036|523771760|FG002|On Treatment|Progressive Disease|7|||
145253098|NCT00777036|523771761|FG003|On Treatment|Progressive Disease|0|||
145253099|NCT00777036|523771758|FG000|On Treatment|Not Reported|0|||
145253100|NCT00777036|523771759|FG001|On Treatment|Not Reported|0|||
145253101|NCT00777036|523771760|FG002|On Treatment|Not Reported|2|||
145253102|NCT00777036|523771761|FG003|On Treatment|Not Reported|0|||
145253103|NCT00777036|523771758|FG000|On Treatment|Site Closed|0|||
145253104|NCT00777036|523771759|FG001|On Treatment|Site Closed|1|||
145253105|NCT00777036|523771760|FG002|On Treatment|Site Closed|1|||
145253106|NCT00777036|523771761|FG003|On Treatment|Site Closed|0|||
145253107|NCT00777036|523771758|FG000|Follow-Up|Withdrawal by Subject|0|||
145253108|NCT00777036|523771759|FG001|Follow-Up|Withdrawal by Subject|0|||
145253109|NCT00777036|523771760|FG002|Follow-Up|Withdrawal by Subject|5|||
145253110|NCT00777036|523771761|FG003|Follow-Up|Withdrawal by Subject|0|||
145253111|NCT00777036|523771758|FG000|Follow-Up|Death|1|||
145253112|NCT00777036|523771759|FG001|Follow-Up|Death|9|||
145299947|NCT01422538|523950273|FG002|Overall Study|Missed visit|1|||
145299948|NCT00004562|523950274|FG000|Overall Study|Lost to Follow-up|102|||
145299949|NCT00004562|523950275|FG001|Overall Study|Lost to Follow-up|91|||
145299950|NCT02770820|523950276|FG000|Overall Study|Death|1|||
145299951|NCT02770820|523950276|FG000|Overall Study|Physician Decision|2|||
145299952|NCT00301366|523950277|FG000|Overall Study|Adverse Event|1|||
145299953|NCT00552669|523950280|FG000|Overall Study|Death|3|||
145253113|NCT00777036|523771760|FG002|Follow-Up|Death|0|||
145253114|NCT00777036|523771761|FG003|Follow-Up|Death|0|||
145253115|NCT00777036|523771758|FG000|Follow-Up|Lost to Follow-up|3|||
145253116|NCT00777036|523771759|FG001|Follow-Up|Lost to Follow-up|0|||
145299954|NCT00552669|523950281|FG001|Overall Study|Death|7|||
145299955|NCT03195491|523950282|FG000|Overall Study|Study drug toxicity|25|||
145299956|NCT03195491|523950283|FG001|Overall Study|Study drug toxicity|3|||
145299957|NCT03195491|523950282|FG000|Overall Study|Maximum clinical benefit|5|||
145299958|NCT03195491|523950283|FG001|Overall Study|Maximum clinical benefit|0|||
145253117|NCT00777036|523771760|FG002|Follow-Up|Lost to Follow-up|0|||
145253118|NCT00777036|523771761|FG003|Follow-Up|Lost to Follow-up|0|||
145253119|NCT00777036|523771758|FG000|Follow-Up|Reason Not Specified|4|||
145253120|NCT00777036|523771759|FG001|Follow-Up|Reason Not Specified|0|||
145253121|NCT00777036|523771760|FG002|Follow-Up|Reason Not Specified|13|||
145253122|NCT00777036|523771761|FG003|Follow-Up|Reason Not Specified|0|||
145253123|NCT00777036|523771758|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
145253124|NCT00777036|523771759|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
145253125|NCT00777036|523771760|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
145253126|NCT00777036|523771761|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
145253127|NCT01553591|523771762|FG000|Overall Study|Voluntarily withdrew|94|||
145299959|NCT03195491|523950282|FG000|Overall Study|Lost to Follow-up|1|||
145299960|NCT03195491|523950283|FG001|Overall Study|Lost to Follow-up|0|||
145620259|NCT03259373|525123726|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
145620260|NCT03259373|525123727|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
145620261|NCT03259373|525123726|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
145620262|NCT03259373|525123727|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
145620263|NCT03259373|525123726|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
145253128|NCT01553591|523771763|FG001|Overall Study|Voluntarily withdrew|79|||
145253129|NCT01553591|523771764|FG002|Overall Study|Voluntarily withdrew|96|||
145253130|NCT01553591|523771762|FG000|Overall Study|Adverse Event|36|||
145253131|NCT01553591|523771763|FG001|Overall Study|Adverse Event|45|||
145253132|NCT01553591|523771764|FG002|Overall Study|Adverse Event|16|||
145253133|NCT01553591|523771762|FG000|Overall Study|Lost to Follow-up|25|||
145253134|NCT01553591|523771763|FG001|Overall Study|Lost to Follow-up|23|||
145253135|NCT01553591|523771764|FG002|Overall Study|Lost to Follow-up|16|||
145253136|NCT01553591|523771762|FG000|Overall Study|Physician decision: other|11|||
145253137|NCT01553591|523771763|FG001|Overall Study|Physician decision: other|14|||
145253138|NCT01553591|523771764|FG002|Overall Study|Physician decision: other|16|||
145253139|NCT01553591|523771762|FG000|Overall Study|Physician decision: lack of efficacy|2|||
145253140|NCT01553591|523771763|FG001|Overall Study|Physician decision: lack of efficacy|3|||
145253141|NCT01553591|523771764|FG002|Overall Study|Physician decision: lack of efficacy|7|||
145253142|NCT01553591|523771762|FG000|Overall Study|Protocol Violation|3|||
145253143|NCT01553591|523771763|FG001|Overall Study|Protocol Violation|4|||
145253144|NCT01553591|523771764|FG002|Overall Study|Protocol Violation|4|||
145253145|NCT01553591|523771762|FG000|Overall Study|Sponsor decision|1|||
145253146|NCT01553591|523771763|FG001|Overall Study|Sponsor decision|0|||
145253147|NCT01553591|523771764|FG002|Overall Study|Sponsor decision|3|||
145253148|NCT01553591|523771762|FG000|Overall Study|Randomized and never dispensed drug|0|||
145253149|NCT01553591|523771763|FG001|Overall Study|Randomized and never dispensed drug|1|||
145253150|NCT01553591|523771764|FG002|Overall Study|Randomized and never dispensed drug|0|||
145253151|NCT04005755|523771774|FG000|Overall Study|Adverse Event|6|||
145253152|NCT04005755|523771774|FG000|Overall Study|Physician Decision|3|||
145253153|NCT04005755|523771774|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
145253154|NCT04005755|523771774|FG000|Overall Study|Withdrawal by Subject|3|||
145253155|NCT04005755|523771774|FG000|Overall Study|Lost to Follow-up|1|||
145253156|NCT02289833|523771775|FG000|Overall Study|Study discontinuation|0|||
145253157|NCT02289833|523771776|FG001|Overall Study|Study discontinuation|1|||
145253158|NCT02289833|523771775|FG000|Overall Study|Lost to Follow-up|4|||
145253159|NCT02289833|523771776|FG001|Overall Study|Lost to Follow-up|0|||
145253160|NCT02289833|523771775|FG000|Overall Study|Death|23|||
145253161|NCT02289833|523771776|FG001|Overall Study|Death|16|||
145253162|NCT02723019|523771777|FG000|Overall Study|Death|17|||
145253163|NCT02723019|523771778|FG001|Overall Study|Death|13|||
145253164|NCT02723019|523771777|FG000|Overall Study|Withdrawal by Subject|11|||
145253165|NCT02723019|523771778|FG001|Overall Study|Withdrawal by Subject|7|||
145253166|NCT02723019|523771777|FG000|Overall Study|Lost to Follow-up|57|||
145253167|NCT02723019|523771778|FG001|Overall Study|Lost to Follow-up|70|||
145253168|NCT00958191|523771779|FG000|Overall Study|Death|4|||
145253169|NCT00958191|523771779|FG000|Overall Study|Lost to Follow-up|5|||
145253170|NCT00958191|523771779|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
145253171|NCT00958191|523771779|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
145253172|NCT00958191|523771779|FG000|Overall Study|Revision of study device|4|||
145253173|NCT00958191|523771779|FG000|Overall Study|Site termination|11|||
145253174|NCT00958191|523771779|FG000|Overall Study|No 5 yr x-rays|56|||
145253175|NCT00611767|523771780|FG000|Overall Study|Withdrawal by Subject|4|||
145253176|NCT00611767|523771781|FG001|Overall Study|Withdrawal by Subject|1|||
145253177|NCT00611767|523771780|FG000|Overall Study|Thiopental not available|3|||
145253178|NCT00611767|523771781|FG001|Overall Study|Thiopental not available|0|||
145253179|NCT00611767|523771780|FG000|Overall Study|didn't like the medication|1|||
145253180|NCT00611767|523771781|FG001|Overall Study|didn't like the medication|1|||
145253181|NCT00611767|523771780|FG000|Overall Study|Physician Decision|1|||
145253182|NCT00611767|523771781|FG001|Overall Study|Physician Decision|0|||
145253183|NCT01642004|523771782|FG000|Randomization|Adverse Event unrelated to study drug|1|||
145253184|NCT01642004|523771783|FG001|Randomization|Adverse Event unrelated to study drug|0|||
145253185|NCT01642004|523771782|FG000|Randomization|Participant withdrew consent|1|||
145253186|NCT01642004|523771783|FG001|Randomization|Participant withdrew consent|6|||
145253187|NCT01642004|523771782|FG000|Randomization|No longer meets study criteria|2|||
145253188|NCT01642004|523771783|FG001|Randomization|No longer meets study criteria|2|||
145253189|NCT01642004|523771782|FG000|Treatment|Disease progression|95|||
145253190|NCT01642004|523771783|FG001|Treatment|Disease progression|79|||
145253191|NCT01642004|523771782|FG000|Treatment|Study drug toxicity|10|||
145253192|NCT01642004|523771783|FG001|Treatment|Study drug toxicity|13|||
145253193|NCT01642004|523771782|FG000|Treatment|Death|1|||
145253194|NCT01642004|523771783|FG001|Treatment|Death|1|||
145253195|NCT01642004|523771782|FG000|Treatment|Adverse event unrelated to study drug|9|||
145253196|NCT01642004|523771783|FG001|Treatment|Adverse event unrelated to study drug|13|||
145253197|NCT01642004|523771782|FG000|Treatment|Maximum clinical benefit|1|||
145253198|NCT01642004|523771783|FG001|Treatment|Maximum clinical benefit|9|||
145253199|NCT01642004|523771782|FG000|Treatment|Poor/non-compliance|1|||
145253200|NCT01642004|523771783|FG001|Treatment|Poor/non-compliance|0|||
145253201|NCT01642004|523771782|FG000|Treatment|No longer meets study criteria|1|||
145253202|NCT01642004|523771783|FG001|Treatment|No longer meets study criteria|2|||
145253203|NCT01642004|523771782|FG000|Treatment|Other reasons|2|||
145253204|NCT01642004|523771783|FG001|Treatment|Other reasons|0|||
145253205|NCT01642004|523771782|FG000|Treatment|Not reported|0|||
145253206|NCT01642004|523771783|FG001|Treatment|Not reported|3|||
145253207|NCT01642004|523771782|FG000|Treatment|Participant request to discontinue study treatment|6|||
145253208|NCT01642004|523771783|FG001|Treatment|Participant request to discontinue study treatment|4|||
145253209|NCT01642004|523771782|FG000|Treatment|Participant withdrew consent|5|||
145253210|NCT01642004|523771783|FG001|Treatment|Participant withdrew consent|5|||
145253211|NCT01818765|523771784|FG000|Overall Study|Death|2|||
145253212|NCT02005211|523771787|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253213|NCT02005211|523771788|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253214|NCT02005211|523771789|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253215|NCT02005211|523771790|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253216|NCT02005211|523771791|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
145253217|NCT02005211|523771792|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253218|NCT02005211|523771793|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
145253219|NCT02202161|523771796|FG000|Overall Study|Adverse Event|1|||
145253220|NCT02202161|523771797|FG001|Overall Study|Adverse Event|1|||
145253221|NCT02202161|523771798|FG002|Overall Study|Adverse Event|0|||
145253222|NCT02202161|523771799|FG003|Overall Study|Adverse Event|0|||
145253223|NCT02202161|523771800|FG004|Overall Study|Adverse Event|0|||
145253224|NCT02202161|523771801|FG005|Overall Study|Adverse Event|1|||
145253225|NCT02202161|523771802|FG006|Overall Study|Adverse Event|0|||
145253226|NCT02202161|523771803|FG007|Overall Study|Adverse Event|0|||
145253227|NCT02202161|523771796|FG000|Overall Study|Did not meet continuation criteria|0|||
145253228|NCT02202161|523771797|FG001|Overall Study|Did not meet continuation criteria|0|||
145253229|NCT02202161|523771798|FG002|Overall Study|Did not meet continuation criteria|0|||
145253230|NCT02202161|523771799|FG003|Overall Study|Did not meet continuation criteria|0|||
145253231|NCT02202161|523771800|FG004|Overall Study|Did not meet continuation criteria|0|||
145253232|NCT02202161|523771801|FG005|Overall Study|Did not meet continuation criteria|0|||
145253233|NCT02202161|523771802|FG006|Overall Study|Did not meet continuation criteria|0|||
145253234|NCT02202161|523771803|FG007|Overall Study|Did not meet continuation criteria|3|||
145253235|NCT02202161|523771796|FG000|Overall Study|Physician Decision|0|||
145299961|NCT03195491|523950282|FG000|Overall Study|Death|3|||
145299962|NCT03195491|523950283|FG001|Overall Study|Death|0|||
145299963|NCT03195491|523950282|FG000|Overall Study|Adverse event unrelated to study drug|19|||
145299964|NCT03195491|523950283|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145299965|NCT03195491|523950282|FG000|Overall Study|Disease progression|266|||
145299966|NCT03195491|523950283|FG001|Overall Study|Disease progression|8|||
145299967|NCT03195491|523950282|FG000|Overall Study|Other reasons|10|||
145299968|NCT03195491|523950283|FG001|Overall Study|Other reasons|0|||
145299969|NCT03195491|523950282|FG000|Overall Study|Participant withdrew consent|8|||
145299970|NCT03195491|523950283|FG001|Overall Study|Participant withdrew consent|1|||
145299971|NCT03195491|523950282|FG000|Overall Study|Participant no longer meets study criteria|0|||
145299972|NCT03195491|523950283|FG001|Overall Study|Participant no longer meets study criteria|1|||
145299973|NCT03195491|523950282|FG000|Overall Study|Participant request to discontinue study treatment|10|||
145299974|NCT03195491|523950283|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145299975|NCT01263704|523950284|FG000|Overall Study|Progressive disease|18|||
145299976|NCT01263704|523950284|FG000|Overall Study|Adverse Event|3|||
145299977|NCT01263704|523950284|FG000|Overall Study|Death|2|||
145299978|NCT01263704|523950284|FG000|Overall Study|Patient withdrew consent|2|||
145299979|NCT01263704|523950284|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
145299980|NCT01263704|523950284|FG000|Overall Study|Lost to Follow-up|1|||
145566666|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
145566667|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
145566668|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
145566669|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Death|5|||
145566670|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Death|0|||
145253236|NCT02202161|523771797|FG001|Overall Study|Physician Decision|0|||
145299981|NCT01263704|523950284|FG000|Overall Study|Colon metastases|1|||
145299982|NCT01263704|523950284|FG000|Overall Study|Principal Investigator (PI) decision|1|||
145299983|NCT01061866|523950285|FG000|Overall Study|Adverse Event|2|||
145253237|NCT02202161|523771798|FG002|Overall Study|Physician Decision|0|||
145253238|NCT02202161|523771799|FG003|Overall Study|Physician Decision|0|||
145253239|NCT02202161|523771800|FG004|Overall Study|Physician Decision|0|||
145253240|NCT02202161|523771801|FG005|Overall Study|Physician Decision|0|||
145253241|NCT02202161|523771802|FG006|Overall Study|Physician Decision|0|||
145253242|NCT02202161|523771803|FG007|Overall Study|Physician Decision|3|||
145253243|NCT02202161|523771796|FG000|Overall Study|Withdrawal by Subject|0|||
145253244|NCT02202161|523771797|FG001|Overall Study|Withdrawal by Subject|0|||
145253245|NCT02202161|523771798|FG002|Overall Study|Withdrawal by Subject|0|||
145253246|NCT02202161|523771799|FG003|Overall Study|Withdrawal by Subject|0|||
145253247|NCT02202161|523771800|FG004|Overall Study|Withdrawal by Subject|1|||
145253248|NCT02202161|523771801|FG005|Overall Study|Withdrawal by Subject|0|||
145253249|NCT02202161|523771802|FG006|Overall Study|Withdrawal by Subject|0|||
145253250|NCT02202161|523771803|FG007|Overall Study|Withdrawal by Subject|0|||
145253251|NCT00832091|523771804|FG000|Overall Study|Adverse Event|1|||
145253252|NCT00832091|523771805|FG001|Overall Study|Adverse Event|1|||
145253253|NCT00832091|523771804|FG000|Overall Study|Protocol Violation|1|||
145253254|NCT00832091|523771805|FG001|Overall Study|Protocol Violation|0|||
145253255|NCT00832091|523771804|FG000|Overall Study|Withdrawal by Subject|2|||
145253256|NCT00832091|523771805|FG001|Overall Study|Withdrawal by Subject|1|||
145253257|NCT00832091|523771804|FG000|Overall Study|Prohibited Medication|1|||
145253258|NCT00832091|523771805|FG001|Overall Study|Prohibited Medication|0|||
145253259|NCT00952588|523771806|FG000|Overall Study|Death|28|||
145253260|NCT00952588|523771807|FG001|Overall Study|Death|13|||
145253261|NCT00952588|523771806|FG000|Overall Study|Withdrawal by Subject|2|||
145253262|NCT00952588|523771807|FG001|Overall Study|Withdrawal by Subject|5|||
145253263|NCT00952588|523771806|FG000|Overall Study|Adverse Event|2|||
145253264|NCT00952588|523771807|FG001|Overall Study|Adverse Event|3|||
145253265|NCT00952588|523771806|FG000|Overall Study|Lost to Follow-up|2|||
145253266|NCT00952588|523771807|FG001|Overall Study|Lost to Follow-up|0|||
145253267|NCT00952588|523771806|FG000|Overall Study|Physician Decision|0|||
145253268|NCT00952588|523771807|FG001|Overall Study|Physician Decision|1|||
145253269|NCT00952588|523771806|FG000|Overall Study|Lack of Efficacy|2|||
145253270|NCT00952588|523771807|FG001|Overall Study|Lack of Efficacy|2|||
145253271|NCT04554394|523771808|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
145253272|NCT04554394|523771809|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
145253273|NCT04554394|523771808|FG000|Overall Study|Withdrawal by Subject|2|||
145253274|NCT04554394|523771809|FG001|Overall Study|Withdrawal by Subject|2|||
145253275|NCT04554394|523771808|FG000|Overall Study|Lost to Follow-up|2|||
145253276|NCT04554394|523771809|FG001|Overall Study|Lost to Follow-up|2|||
145253277|NCT04554394|523771808|FG000|Overall Study|Physician Decision|1|||
145253278|NCT04554394|523771809|FG001|Overall Study|Physician Decision|1|||
145253279|NCT01766401|523771810|FG000|Overall Study|Adverse Event|7|||
145253280|NCT01766401|523771811|FG001|Overall Study|Adverse Event|22|||
145253281|NCT01766401|523771810|FG000|Overall Study|Lack of Efficacy|1|||
145253282|NCT01766401|523771811|FG001|Overall Study|Lack of Efficacy|2|||
145253283|NCT01766401|523771810|FG000|Overall Study|Protocol Violation|3|||
145253284|NCT01766401|523771811|FG001|Overall Study|Protocol Violation|8|||
145253285|NCT01766401|523771810|FG000|Overall Study|Withdrawal by Subject|15|||
145253286|NCT01766401|523771811|FG001|Overall Study|Withdrawal by Subject|12|||
145253287|NCT01766401|523771810|FG000|Overall Study|Lost to Follow-up|10|||
145253288|NCT01766401|523771811|FG001|Overall Study|Lost to Follow-up|11|||
145253289|NCT01766401|523771810|FG000|Overall Study|Pregnancy|1|||
145253290|NCT01766401|523771811|FG001|Overall Study|Pregnancy|1|||
145253291|NCT00935701|523771812|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
145253292|NCT01197794|523771813|FG000|Overall Study|Adverse Event|3|||
145253293|NCT01197794|523771814|FG001|Overall Study|Adverse Event|2|||
145253294|NCT01197794|523771815|FG002|Overall Study|Adverse Event|4|||
145253295|NCT01197794|523771816|FG003|Overall Study|Adverse Event|4|||
145253296|NCT01197794|523771817|FG004|Overall Study|Adverse Event|4|||
145253297|NCT01197794|523771818|FG005|Overall Study|Adverse Event|2|||
145253298|NCT01197794|523771819|FG006|Overall Study|Adverse Event|3|||
145253299|NCT01197794|523771813|FG000|Overall Study|Protocol Violation|0|||
145253300|NCT01197794|523771814|FG001|Overall Study|Protocol Violation|0|||
145253301|NCT01197794|523771815|FG002|Overall Study|Protocol Violation|0|||
145253302|NCT01197794|523771816|FG003|Overall Study|Protocol Violation|0|||
145620264|NCT03259373|525123727|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
145253303|NCT01197794|523771817|FG004|Overall Study|Protocol Violation|2|||
145253304|NCT01197794|523771818|FG005|Overall Study|Protocol Violation|0|||
145253305|NCT01197794|523771819|FG006|Overall Study|Protocol Violation|1|||
145253306|NCT01197794|523771813|FG000|Overall Study|Development of study withdrawal criteria|3|||
145253307|NCT01197794|523771814|FG001|Overall Study|Development of study withdrawal criteria|0|||
145253308|NCT01197794|523771815|FG002|Overall Study|Development of study withdrawal criteria|0|||
145253309|NCT01197794|523771816|FG003|Overall Study|Development of study withdrawal criteria|1|||
145253310|NCT01197794|523771817|FG004|Overall Study|Development of study withdrawal criteria|0|||
145253311|NCT01197794|523771818|FG005|Overall Study|Development of study withdrawal criteria|0|||
145253312|NCT01197794|523771819|FG006|Overall Study|Development of study withdrawal criteria|1|||
145253313|NCT01197794|523771813|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
145253314|NCT01197794|523771814|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
145253315|NCT01197794|523771815|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
145253316|NCT01197794|523771816|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
145253317|NCT01197794|523771817|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
145299984|NCT01270503|523950286|FG000|Overall Study|Lost to Follow-up|1|||
145299985|NCT02459951|523950287|FG000|Overall Study|Unable to meet holding requirement|1|||
145299986|NCT00252720|523950289|FG000|Overall Study|Withdrawal by Subject|95|||
145299987|NCT00252720|523950290|FG001|Overall Study|Withdrawal by Subject|97|||
145299988|NCT00252720|523950289|FG000|Overall Study|Death|7|||
145299989|NCT00252720|523950290|FG001|Overall Study|Death|8|||
145253318|NCT01197794|523771818|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
145253319|NCT01197794|523771819|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
145253320|NCT01197794|523771813|FG000|Overall Study|Withdrawal by Subject|3|||
145253321|NCT01197794|523771814|FG001|Overall Study|Withdrawal by Subject|3|||
145253322|NCT01197794|523771815|FG002|Overall Study|Withdrawal by Subject|4|||
145253323|NCT01197794|523771816|FG003|Overall Study|Withdrawal by Subject|1|||
145253324|NCT01197794|523771817|FG004|Overall Study|Withdrawal by Subject|1|||
145253325|NCT01197794|523771818|FG005|Overall Study|Withdrawal by Subject|5|||
145253326|NCT01197794|523771819|FG006|Overall Study|Withdrawal by Subject|6|||
145253327|NCT01197794|523771813|FG000|Overall Study|Lost to Follow-up|1|||
145253328|NCT01197794|523771814|FG001|Overall Study|Lost to Follow-up|1|||
145253329|NCT01197794|523771815|FG002|Overall Study|Lost to Follow-up|0|||
145253330|NCT01197794|523771816|FG003|Overall Study|Lost to Follow-up|1|||
145253331|NCT01197794|523771817|FG004|Overall Study|Lost to Follow-up|0|||
145253332|NCT01197794|523771818|FG005|Overall Study|Lost to Follow-up|1|||
145253333|NCT01197794|523771819|FG006|Overall Study|Lost to Follow-up|0|||
145253334|NCT01197794|523771813|FG000|Overall Study|Other|1|||
145253335|NCT01197794|523771814|FG001|Overall Study|Other|1|||
145253336|NCT01197794|523771815|FG002|Overall Study|Other|3|||
145253337|NCT01197794|523771816|FG003|Overall Study|Other|0|||
145253338|NCT01197794|523771817|FG004|Overall Study|Other|2|||
145299990|NCT00252720|523950289|FG000|Overall Study|Moving|23|||
145299991|NCT00252720|523950290|FG001|Overall Study|Moving|42|||
145299992|NCT00252720|523950289|FG000|Overall Study|Mainly patients lost to follow-up|7|||
145299993|NCT00252720|523950290|FG001|Overall Study|Mainly patients lost to follow-up|18|||
145299994|NCT00102440|523950291|FG000|Overall Study|Lost to Follow-up|25|||
145299995|NCT00102440|523950292|FG001|Overall Study|Lost to Follow-up|18|||
145299996|NCT00102440|523950293|FG002|Overall Study|Lost to Follow-up|21|||
145299997|NCT00102440|523950291|FG000|Overall Study|Adverse Event|16|||
145299998|NCT00102440|523950292|FG001|Overall Study|Adverse Event|23|||
145299999|NCT00102440|523950293|FG002|Overall Study|Adverse Event|8|||
145300000|NCT00102440|523950291|FG000|Overall Study|Gout Flare|10|||
145300001|NCT00102440|523950292|FG001|Overall Study|Gout Flare|28|||
145300002|NCT00102440|523950293|FG002|Overall Study|Gout Flare|9|||
145300003|NCT00102440|523950291|FG000|Overall Study|Personal Reason(s)|19|||
145300004|NCT00102440|523950292|FG001|Overall Study|Personal Reason(s)|13|||
145300005|NCT00102440|523950293|FG002|Overall Study|Personal Reason(s)|13|||
145300006|NCT00102440|523950291|FG000|Overall Study|Other|11|||
145300007|NCT00102440|523950292|FG001|Overall Study|Other|14|||
145300008|NCT00102440|523950293|FG002|Overall Study|Other|14|||
145300009|NCT00102440|523950291|FG000|Overall Study|Protocol Violation|7|||
145300010|NCT00102440|523950292|FG001|Overall Study|Protocol Violation|2|||
145300011|NCT00102440|523950293|FG002|Overall Study|Protocol Violation|1|||
145300012|NCT00772941|523950294|FG000|Overall Study|CRFs not available|195|||
145300013|NCT00772941|523950294|FG000|Overall Study|Study not completed|16|||
145300014|NCT00772941|523950294|FG000|Overall Study|Missed Visits|374|||
145300015|NCT00772941|523950294|FG000|Overall Study|Poor Compliance|7|||
145300016|NCT00772941|523950294|FG000|Overall Study|GPSP Violation|90|||
145300017|NCT04786184|523950296|FG000|Overall Study|Adverse Event|4|||
145300018|NCT04786184|523950297|FG001|Overall Study|Adverse Event|0|||
145300019|NCT04786184|523950296|FG000|Overall Study|Withdrawal by Subject|3|||
145300020|NCT04786184|523950297|FG001|Overall Study|Withdrawal by Subject|1|||
145300021|NCT04786184|523950296|FG000|Overall Study|Lost to Follow-up|4|||
145300022|NCT04786184|523950297|FG001|Overall Study|Lost to Follow-up|2|||
145300023|NCT01745120|523950298|FG000|Overall Study|Investigator decision|1|||
145300024|NCT01745120|523950299|FG001|Overall Study|Investigator decision|0|||
145300025|NCT01185821|523950300|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145300026|NCT01185821|523950301|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145300027|NCT01185821|523950302|FG002|Overall Study|Abnormal laboratory value(s)|1|||
145300028|NCT01185821|523950303|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145300029|NCT01185821|523950304|FG004|Overall Study|Abnormal laboratory value(s)|0|||
145300030|NCT01185821|523950300|FG000|Overall Study|Protocol Violation|0|||
145300031|NCT01185821|523950301|FG001|Overall Study|Protocol Violation|0|||
145410475|NCT03317496|524356784|FG003|Phase 2: Follow-up|Death|0|||
145410476|NCT03317496|524356785|FG004|Phase 2: Follow-up|Death|24|||
145253339|NCT01197794|523771818|FG005|Overall Study|Other|2|||
145253340|NCT01197794|523771819|FG006|Overall Study|Other|4|||
145253341|NCT01055457|523771820|FG000|Overall Study|Lost to Follow-up|0|||
145253342|NCT01055457|523771821|FG001|Overall Study|Lost to Follow-up|1|||
145300032|NCT01185821|523950302|FG002|Overall Study|Protocol Violation|0|||
145300033|NCT01185821|523950303|FG003|Overall Study|Protocol Violation|1|||
145300034|NCT01185821|523950304|FG004|Overall Study|Protocol Violation|1|||
145300035|NCT01185821|523950300|FG000|Overall Study|Abnormal test procedure result|0|||
145253343|NCT01055457|523771822|FG002|Overall Study|Lost to Follow-up|0|||
145253344|NCT01055457|523771823|FG003|Overall Study|Lost to Follow-up|0|||
145253345|NCT01055457|523771824|FG004|Overall Study|Lost to Follow-up|0|||
145253346|NCT01055457|523771825|FG005|Overall Study|Lost to Follow-up|1|||
145253347|NCT01055457|523771826|FG006|Overall Study|Lost to Follow-up|0|||
145253348|NCT01055457|523771827|FG007|Overall Study|Lost to Follow-up|0|||
145253349|NCT01055457|523771828|FG008|Overall Study|Lost to Follow-up|0|||
145253350|NCT01055457|523771829|FG009|Overall Study|Lost to Follow-up|0|||
145253351|NCT01055457|523771820|FG000|Overall Study|Protocol Violation|0|||
145253352|NCT01055457|523771821|FG001|Overall Study|Protocol Violation|0|||
145253353|NCT01055457|523771822|FG002|Overall Study|Protocol Violation|1|||
145253354|NCT01055457|523771823|FG003|Overall Study|Protocol Violation|1|||
145253355|NCT01055457|523771824|FG004|Overall Study|Protocol Violation|1|||
145253356|NCT01055457|523771825|FG005|Overall Study|Protocol Violation|2|||
145253357|NCT01055457|523771826|FG006|Overall Study|Protocol Violation|1|||
145253358|NCT01055457|523771827|FG007|Overall Study|Protocol Violation|0|||
145253359|NCT01055457|523771828|FG008|Overall Study|Protocol Violation|0|||
145253360|NCT01055457|523771829|FG009|Overall Study|Protocol Violation|1|||
145253361|NCT01055457|523771820|FG000|Overall Study|Subject Disinterest|0|||
145253362|NCT01055457|523771821|FG001|Overall Study|Subject Disinterest|0|||
145253363|NCT01055457|523771822|FG002|Overall Study|Subject Disinterest|0|||
145253364|NCT01055457|523771823|FG003|Overall Study|Subject Disinterest|0|||
145253365|NCT01055457|523771824|FG004|Overall Study|Subject Disinterest|0|||
145253366|NCT01055457|523771825|FG005|Overall Study|Subject Disinterest|0|||
145410477|NCT03317496|524356781|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
145410478|NCT03317496|524356782|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
145410479|NCT03317496|524356783|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
145410480|NCT03317496|524356784|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
145410481|NCT03317496|524356785|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
145410482|NCT03317496|524356781|FG000|Phase 2: Follow-up|Other|0|||
145410483|NCT03317496|524356782|FG001|Phase 2: Follow-up|Other|0|||
145410484|NCT03317496|524356783|FG002|Phase 2: Follow-up|Other|0|||
145410485|NCT03317496|524356784|FG003|Phase 2: Follow-up|Other|0|||
145410486|NCT03317496|524356785|FG004|Phase 2: Follow-up|Other|1|||
145410487|NCT03317496|524356781|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
145410488|NCT03317496|524356782|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
145410489|NCT03317496|524356783|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
145410490|NCT03317496|524356784|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
145410491|NCT03317496|524356785|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
145410492|NCT02034591|524356794|FG000|Overall Study|Withdrawal by Subject|0|||
145410493|NCT02034591|524356795|FG001|Overall Study|Withdrawal by Subject|0|||
145410494|NCT02034591|524356796|FG002|Overall Study|Withdrawal by Subject|0|||
145253367|NCT01055457|523771826|FG006|Overall Study|Subject Disinterest|0|||
145253368|NCT01055457|523771827|FG007|Overall Study|Subject Disinterest|1|||
145253369|NCT01055457|523771828|FG008|Overall Study|Subject Disinterest|0|||
145253370|NCT01055457|523771829|FG009|Overall Study|Subject Disinterest|0|||
145253371|NCT01055457|523771820|FG000|Overall Study|Subject Ineligible|1|||
145253372|NCT01055457|523771821|FG001|Overall Study|Subject Ineligible|0|||
145253373|NCT01055457|523771822|FG002|Overall Study|Subject Ineligible|1|||
145253374|NCT01055457|523771823|FG003|Overall Study|Subject Ineligible|0|||
145253375|NCT01055457|523771824|FG004|Overall Study|Subject Ineligible|1|||
145253376|NCT01055457|523771825|FG005|Overall Study|Subject Ineligible|0|||
145253377|NCT01055457|523771826|FG006|Overall Study|Subject Ineligible|0|||
145253378|NCT01055457|523771827|FG007|Overall Study|Subject Ineligible|0|||
145253379|NCT01055457|523771828|FG008|Overall Study|Subject Ineligible|0|||
145253380|NCT01055457|523771829|FG009|Overall Study|Subject Ineligible|0|||
145253381|NCT01055457|523771820|FG000|Overall Study|Discomfort|0|||
145253382|NCT01055457|523771821|FG001|Overall Study|Discomfort|0|||
145253383|NCT01055457|523771822|FG002|Overall Study|Discomfort|0|||
145253384|NCT01055457|523771823|FG003|Overall Study|Discomfort|0|||
145253385|NCT01055457|523771824|FG004|Overall Study|Discomfort|1|||
145253386|NCT01055457|523771825|FG005|Overall Study|Discomfort|0|||
145253387|NCT01055457|523771826|FG006|Overall Study|Discomfort|0|||
145253388|NCT01055457|523771827|FG007|Overall Study|Discomfort|0|||
145410495|NCT02034591|524356797|FG003|Overall Study|Withdrawal by Subject|0|||
145410496|NCT02034591|524356798|FG004|Overall Study|Withdrawal by Subject|1|||
145410497|NCT02034591|524356799|FG005|Overall Study|Withdrawal by Subject|0|||
145410498|NCT00817063|524356800|FG000|Overall Study|Adverse Event|32|||
145410499|NCT00817063|524356801|FG001|Overall Study|Adverse Event|13|||
145410500|NCT00817063|524356800|FG000|Overall Study|Death|1|||
145253389|NCT01055457|523771828|FG008|Overall Study|Discomfort|0|||
145253390|NCT01055457|523771829|FG009|Overall Study|Discomfort|0|||
145253391|NCT01055457|523771820|FG000|Overall Study|Pregnancy|0|||
145253392|NCT01055457|523771821|FG001|Overall Study|Pregnancy|0|||
145253393|NCT01055457|523771822|FG002|Overall Study|Pregnancy|0|||
145253394|NCT01055457|523771823|FG003|Overall Study|Pregnancy|1|||
145253395|NCT01055457|523771824|FG004|Overall Study|Pregnancy|0|||
145253396|NCT01055457|523771825|FG005|Overall Study|Pregnancy|0|||
145253397|NCT01055457|523771826|FG006|Overall Study|Pregnancy|0|||
145253398|NCT01055457|523771827|FG007|Overall Study|Pregnancy|0|||
145253399|NCT01055457|523771828|FG008|Overall Study|Pregnancy|0|||
145253400|NCT01055457|523771829|FG009|Overall Study|Pregnancy|0|||
145253401|NCT01055457|523771820|FG000|Overall Study|Adverse Event|0|||
145253402|NCT01055457|523771821|FG001|Overall Study|Adverse Event|0|||
145253403|NCT01055457|523771822|FG002|Overall Study|Adverse Event|0|||
145253404|NCT01055457|523771823|FG003|Overall Study|Adverse Event|1|||
145253405|NCT01055457|523771824|FG004|Overall Study|Adverse Event|0|||
145253406|NCT01055457|523771825|FG005|Overall Study|Adverse Event|0|||
145253407|NCT01055457|523771826|FG006|Overall Study|Adverse Event|0|||
145253408|NCT01055457|523771827|FG007|Overall Study|Adverse Event|0|||
145253409|NCT01055457|523771828|FG008|Overall Study|Adverse Event|0|||
145253410|NCT01055457|523771829|FG009|Overall Study|Adverse Event|0|||
145253411|NCT04055844|523771830|FG000|Overall Study|Adverse Event|12|||
145253412|NCT04055844|523771830|FG000|Overall Study|Poor Performance|1|||
145253413|NCT04055844|523771830|FG000|Overall Study|Death|1|||
145253414|NCT00703781|523771839|FG000|Overall Study|Withdrawal by Subject|1|||
145253415|NCT00703781|523771840|FG001|Overall Study|Withdrawal by Subject|2|||
145253416|NCT00703781|523771839|FG000|Overall Study|Cancelled surgery|1|||
145253417|NCT00703781|523771840|FG001|Overall Study|Cancelled surgery|0|||
145253418|NCT02683668|523771844|FG000|Period 2|Withdrawal by Subject|0|||
145253419|NCT02683668|523771845|FG001|Period 2|Withdrawal by Subject|1|||
145253420|NCT02683668|523771846|FG002|Period 2|Withdrawal by Subject|0|||
145253421|NCT03893630|523771849|FG000|Overall Study|Lost to Follow-up|5|||
145253422|NCT03893630|523771850|FG001|Overall Study|Lost to Follow-up|4|||
145253423|NCT03893630|523771851|FG002|Overall Study|Lost to Follow-up|2|||
145253424|NCT03893630|523771849|FG000|Overall Study|Withdrawal by Subject|3|||
145253425|NCT03893630|523771850|FG001|Overall Study|Withdrawal by Subject|6|||
145253426|NCT03893630|523771851|FG002|Overall Study|Withdrawal by Subject|3|||
145253427|NCT03893630|523771849|FG000|Overall Study|Discontinued Intervention|0|||
145253428|NCT03893630|523771850|FG001|Overall Study|Discontinued Intervention|4|||
145253429|NCT03893630|523771851|FG002|Overall Study|Discontinued Intervention|2|||
145253430|NCT03053180|523773881|FG000|Overall Study|Failure to Return|1|||
145253431|NCT02972658|523773887|FG000|Overall Study|Adverse Event|0|||
145253432|NCT02972658|523773888|FG001|Overall Study|Adverse Event|3|||
145253433|NCT02972658|523773889|FG002|Overall Study|Adverse Event|0|||
145253434|NCT02972658|523773890|FG003|Overall Study|Adverse Event|2|||
145253435|NCT02972658|523773887|FG000|Overall Study|Other-determined by Investigator|1|||
145253436|NCT02972658|523773888|FG001|Overall Study|Other-determined by Investigator|1|||
145253437|NCT02972658|523773889|FG002|Overall Study|Other-determined by Investigator|0|||
145253438|NCT02972658|523773890|FG003|Overall Study|Other-determined by Investigator|0|||
145253439|NCT02972658|523773887|FG000|Overall Study|Death|0|||
145253440|NCT02972658|523773888|FG001|Overall Study|Death|0|||
145253441|NCT02972658|523773889|FG002|Overall Study|Death|0|||
145253442|NCT02972658|523773890|FG003|Overall Study|Death|1|||
145253443|NCT02972658|523773887|FG000|Overall Study|Lost to Follow-up|0|||
145253444|NCT02972658|523773888|FG001|Overall Study|Lost to Follow-up|1|||
145253445|NCT02972658|523773889|FG002|Overall Study|Lost to Follow-up|1|||
145253446|NCT02972658|523773890|FG003|Overall Study|Lost to Follow-up|2|||
145253447|NCT02972658|523773887|FG000|Overall Study|Progressive Disease|0|||
145253448|NCT02972658|523773888|FG001|Overall Study|Progressive Disease|1|||
145253449|NCT02972658|523773889|FG002|Overall Study|Progressive Disease|0|||
145253450|NCT02972658|523773890|FG003|Overall Study|Progressive Disease|1|||
145253451|NCT02972658|523773887|FG000|Overall Study|Withdrawal by Subject|4|||
145253452|NCT02972658|523773888|FG001|Overall Study|Withdrawal by Subject|4|||
145253453|NCT02972658|523773889|FG002|Overall Study|Withdrawal by Subject|1|||
145253454|NCT02972658|523773890|FG003|Overall Study|Withdrawal by Subject|6|||
145253455|NCT02972658|523773887|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
145253456|NCT02972658|523773888|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
145253457|NCT02972658|523773889|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
145253458|NCT02972658|523773890|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
145253459|NCT02972658|523773887|FG000|Overall Study|Sponsor Decision|70|||
145253460|NCT02972658|523773888|FG001|Overall Study|Sponsor Decision|127|||
145253461|NCT02972658|523773889|FG002|Overall Study|Sponsor Decision|72|||
145253462|NCT02972658|523773890|FG003|Overall Study|Sponsor Decision|119|||
145253463|NCT03958149|523773891|FG000|Overall Study|Withdrawal by Subject|0|||
145253464|NCT03958149|523773892|FG001|Overall Study|Withdrawal by Subject|1|||
145253465|NCT02785588|523773893|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
145253466|NCT02785588|523773893|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
145253467|NCT00621764|523773895|FG000|Overall Study|Protocol Violation|0|||
145253468|NCT00621764|523773896|FG001|Overall Study|Protocol Violation|0|||
145253469|NCT00621764|523773897|FG002|Overall Study|Protocol Violation|0|||
145253470|NCT00621764|523773898|FG003|Overall Study|Protocol Violation|1|||
145253471|NCT03031327|523773905|FG000|Overall Study|Withdrawal by Subject|0|||
145253472|NCT03031327|523773906|FG001|Overall Study|Withdrawal by Subject|1|||
145253473|NCT03031327|523773907|FG002|Overall Study|Withdrawal by Subject|1|||
145253474|NCT00211536|523773908|FG000|Overall Study|Withdrawal by Subject|2|||
145253475|NCT00211536|523773909|FG001|Overall Study|Withdrawal by Subject|2|||
145253476|NCT00211536|523773908|FG000|Overall Study|Physician Decision|0|||
145253477|NCT00211536|523773909|FG001|Overall Study|Physician Decision|5|||
145253478|NCT00211536|523773908|FG000|Overall Study|Adverse Event|2|||
145253479|NCT00211536|523773909|FG001|Overall Study|Adverse Event|0|||
145253480|NCT00669240|523773910|FG000|Overall Study|Lack of Efficacy|33|||
145253481|NCT00669240|523773910|FG000|Overall Study|Withdrawal by Subject|42|||
145253482|NCT00669240|523773910|FG000|Overall Study|Lost to Follow-up|34|||
145253483|NCT00669240|523773910|FG000|Overall Study|Adverse Event|21|||
145253484|NCT00669240|523773910|FG000|Overall Study|Other|19|||
145253485|NCT00669240|523773910|FG000|Overall Study|Enrolled but not treated|15|||
145253486|NCT00669240|523773910|FG000|Overall Study|Enrolled but no dosing record|1|||
145253487|NCT02583399|523773911|FG000|Overall Study|Able to be discharged|3|||
145253488|NCT02583399|523773911|FG000|Overall Study|Wanted to use a restricted medication|3|||
145253489|NCT01004861|523773912|FG000|Overall Study|Disease progression|3|||
145253490|NCT01004861|523773913|FG001|Overall Study|Disease progression|4|||
145253491|NCT01004861|523773914|FG002|Overall Study|Disease progression|5|||
145253492|NCT01004861|523773915|FG003|Overall Study|Disease progression|4|||
145253493|NCT01004861|523773916|FG004|Overall Study|Disease progression|4|||
145253494|NCT01004861|523773917|FG005|Overall Study|Disease progression|4|||
145253495|NCT01004861|523773918|FG006|Overall Study|Disease progression|5|||
145253496|NCT01004861|523773919|FG007|Overall Study|Disease progression|1|||
145253497|NCT01004861|523773920|FG008|Overall Study|Disease progression|4|||
145253498|NCT01004861|523773921|FG009|Overall Study|Disease progression|7|||
145253499|NCT01004861|523773922|FG010|Overall Study|Disease progression|6|||
145253500|NCT01004861|523773923|FG011|Overall Study|Disease progression|3|||
145253501|NCT01004861|523773924|FG012|Overall Study|Disease progression|8|||
145253502|NCT01004861|523773912|FG000|Overall Study|Physician Decision|0|||
145253503|NCT01004861|523773913|FG001|Overall Study|Physician Decision|2|||
145253504|NCT01004861|523773914|FG002|Overall Study|Physician Decision|1|||
145253505|NCT01004861|523773915|FG003|Overall Study|Physician Decision|1|||
145253506|NCT01004861|523773916|FG004|Overall Study|Physician Decision|1|||
145253507|NCT01004861|523773917|FG005|Overall Study|Physician Decision|0|||
145253508|NCT01004861|523773918|FG006|Overall Study|Physician Decision|0|||
145253509|NCT01004861|523773919|FG007|Overall Study|Physician Decision|1|||
145253510|NCT01004861|523773920|FG008|Overall Study|Physician Decision|0|||
145253511|NCT01004861|523773921|FG009|Overall Study|Physician Decision|0|||
145253512|NCT01004861|523773922|FG010|Overall Study|Physician Decision|0|||
145253513|NCT01004861|523773923|FG011|Overall Study|Physician Decision|0|||
145253514|NCT01004861|523773924|FG012|Overall Study|Physician Decision|3|||
145253515|NCT01004861|523773912|FG000|Overall Study|Adverse Event|0|||
145253516|NCT01004861|523773913|FG001|Overall Study|Adverse Event|0|||
145253517|NCT01004861|523773914|FG002|Overall Study|Adverse Event|0|||
145253518|NCT01004861|523773915|FG003|Overall Study|Adverse Event|1|||
145253519|NCT01004861|523773916|FG004|Overall Study|Adverse Event|0|||
145253520|NCT01004861|523773917|FG005|Overall Study|Adverse Event|2|||
145253521|NCT01004861|523773918|FG006|Overall Study|Adverse Event|1|||
145253522|NCT01004861|523773919|FG007|Overall Study|Adverse Event|1|||
145253523|NCT01004861|523773920|FG008|Overall Study|Adverse Event|13|||
145253524|NCT01004861|523773921|FG009|Overall Study|Adverse Event|1|||
145253525|NCT01004861|523773922|FG010|Overall Study|Adverse Event|1|||
145253526|NCT01004861|523773923|FG011|Overall Study|Adverse Event|0|||
145253527|NCT01004861|523773924|FG012|Overall Study|Adverse Event|2|||
145253528|NCT01004861|523773912|FG000|Overall Study|Protocol Violation|0|||
145253529|NCT01004861|523773913|FG001|Overall Study|Protocol Violation|0|||
145253530|NCT01004861|523773914|FG002|Overall Study|Protocol Violation|0|||
145253531|NCT01004861|523773915|FG003|Overall Study|Protocol Violation|0|||
145253532|NCT01004861|523773916|FG004|Overall Study|Protocol Violation|1|||
145253533|NCT01004861|523773917|FG005|Overall Study|Protocol Violation|0|||
145253534|NCT01004861|523773918|FG006|Overall Study|Protocol Violation|0|||
145253535|NCT01004861|523773919|FG007|Overall Study|Protocol Violation|0|||
145253536|NCT01004861|523773920|FG008|Overall Study|Protocol Violation|0|||
145253537|NCT01004861|523773921|FG009|Overall Study|Protocol Violation|0|||
145253538|NCT01004861|523773922|FG010|Overall Study|Protocol Violation|0|||
145253539|NCT01004861|523773923|FG011|Overall Study|Protocol Violation|0|||
145300036|NCT01185821|523950301|FG001|Overall Study|Abnormal test procedure result|0|||
145300037|NCT01185821|523950302|FG002|Overall Study|Abnormal test procedure result|0|||
145300038|NCT01185821|523950303|FG003|Overall Study|Abnormal test procedure result|0|||
145300039|NCT01185821|523950304|FG004|Overall Study|Abnormal test procedure result|1|||
145253540|NCT01004861|523773924|FG012|Overall Study|Protocol Violation|0|||
145253541|NCT01004861|523773912|FG000|Overall Study|Lost to Follow-up|0|||
145253542|NCT01004861|523773913|FG001|Overall Study|Lost to Follow-up|0|||
145253543|NCT01004861|523773914|FG002|Overall Study|Lost to Follow-up|0|||
145253544|NCT01004861|523773915|FG003|Overall Study|Lost to Follow-up|0|||
145253545|NCT01004861|523773916|FG004|Overall Study|Lost to Follow-up|0|||
145300040|NCT01185821|523950300|FG000|Overall Study|Death|0|||
145253546|NCT01004861|523773917|FG005|Overall Study|Lost to Follow-up|0|||
145253547|NCT01004861|523773918|FG006|Overall Study|Lost to Follow-up|0|||
145300041|NCT01185821|523950301|FG001|Overall Study|Death|1|||
145253548|NCT01004861|523773919|FG007|Overall Study|Lost to Follow-up|1|||
145253549|NCT01004861|523773920|FG008|Overall Study|Lost to Follow-up|3|||
145253550|NCT01004861|523773921|FG009|Overall Study|Lost to Follow-up|0|||
145253551|NCT01004861|523773922|FG010|Overall Study|Lost to Follow-up|0|||
145253552|NCT01004861|523773923|FG011|Overall Study|Lost to Follow-up|1|||
145300042|NCT01185821|523950302|FG002|Overall Study|Death|0|||
145300043|NCT01185821|523950303|FG003|Overall Study|Death|0|||
145300044|NCT01185821|523950304|FG004|Overall Study|Death|0|||
145300045|NCT01185821|523950300|FG000|Overall Study|Condition no longer required study drug|0|||
145300046|NCT01185821|523950301|FG001|Overall Study|Condition no longer required study drug|0|||
145300047|NCT01185821|523950302|FG002|Overall Study|Condition no longer required study drug|0|||
145300048|NCT01185821|523950303|FG003|Overall Study|Condition no longer required study drug|0|||
145300049|NCT01185821|523950304|FG004|Overall Study|Condition no longer required study drug|1|||
145300050|NCT01185821|523950300|FG000|Overall Study|Adverse Event|2|||
145253553|NCT01004861|523773924|FG012|Overall Study|Lost to Follow-up|0|||
145253554|NCT01004861|523773912|FG000|Overall Study|Non-compliance|0|||
145253555|NCT01004861|523773913|FG001|Overall Study|Non-compliance|0|||
145253556|NCT01004861|523773914|FG002|Overall Study|Non-compliance|0|||
145253557|NCT01004861|523773915|FG003|Overall Study|Non-compliance|0|||
145253558|NCT01004861|523773916|FG004|Overall Study|Non-compliance|0|||
145253559|NCT01004861|523773917|FG005|Overall Study|Non-compliance|0|||
145253560|NCT01004861|523773918|FG006|Overall Study|Non-compliance|0|||
145253561|NCT01004861|523773919|FG007|Overall Study|Non-compliance|0|||
145253562|NCT01004861|523773920|FG008|Overall Study|Non-compliance|5|||
145253563|NCT01004861|523773921|FG009|Overall Study|Non-compliance|0|||
145253564|NCT01004861|523773922|FG010|Overall Study|Non-compliance|0|||
145253565|NCT01004861|523773923|FG011|Overall Study|Non-compliance|0|||
145253566|NCT01004861|523773924|FG012|Overall Study|Non-compliance|1|||
145253567|NCT01004861|523773912|FG000|Overall Study|Other|0|||
145253568|NCT01004861|523773913|FG001|Overall Study|Other|0|||
145253569|NCT01004861|523773914|FG002|Overall Study|Other|0|||
145253570|NCT01004861|523773915|FG003|Overall Study|Other|0|||
145253571|NCT01004861|523773916|FG004|Overall Study|Other|0|||
145253572|NCT01004861|523773917|FG005|Overall Study|Other|0|||
145253573|NCT01004861|523773918|FG006|Overall Study|Other|0|||
145253574|NCT01004861|523773919|FG007|Overall Study|Other|0|||
145253575|NCT01004861|523773920|FG008|Overall Study|Other|0|||
145253576|NCT01004861|523773921|FG009|Overall Study|Other|2|||
145253577|NCT01004861|523773922|FG010|Overall Study|Other|1|||
145253578|NCT01004861|523773923|FG011|Overall Study|Other|2|||
145253579|NCT01004861|523773924|FG012|Overall Study|Other|3|||
145253580|NCT01004861|523773912|FG000|Overall Study|Patient decision|0|||
145253581|NCT01004861|523773913|FG001|Overall Study|Patient decision|0|||
145253582|NCT01004861|523773914|FG002|Overall Study|Patient decision|0|||
145253583|NCT01004861|523773915|FG003|Overall Study|Patient decision|0|||
145253584|NCT01004861|523773916|FG004|Overall Study|Patient decision|1|||
145253585|NCT01004861|523773917|FG005|Overall Study|Patient decision|0|||
145253586|NCT01004861|523773918|FG006|Overall Study|Patient decision|1|||
145253587|NCT01004861|523773919|FG007|Overall Study|Patient decision|0|||
145253588|NCT01004861|523773920|FG008|Overall Study|Patient decision|7|||
145253589|NCT01004861|523773921|FG009|Overall Study|Patient decision|1|||
145253590|NCT01004861|523773922|FG010|Overall Study|Patient decision|1|||
145253591|NCT01004861|523773923|FG011|Overall Study|Patient decision|2|||
145253592|NCT01004861|523773924|FG012|Overall Study|Patient decision|3|||
145253593|NCT01004861|523773912|FG000|Overall Study|Transitioned to Phase 4 study|0|||
145253594|NCT01004861|523773913|FG001|Overall Study|Transitioned to Phase 4 study|0|||
145253595|NCT01004861|523773914|FG002|Overall Study|Transitioned to Phase 4 study|0|||
145253596|NCT01004861|523773915|FG003|Overall Study|Transitioned to Phase 4 study|0|||
145253597|NCT01004861|523773916|FG004|Overall Study|Transitioned to Phase 4 study|0|||
145300051|NCT01185821|523950301|FG001|Overall Study|Adverse Event|3|||
145300052|NCT01185821|523950302|FG002|Overall Study|Adverse Event|1|||
145300053|NCT01185821|523950303|FG003|Overall Study|Adverse Event|2|||
145300054|NCT01185821|523950304|FG004|Overall Study|Adverse Event|5|||
145300055|NCT01185821|523950300|FG000|Overall Study|Lack of Efficacy|0|||
145300056|NCT01185821|523950301|FG001|Overall Study|Lack of Efficacy|0|||
145253598|NCT01004861|523773917|FG005|Overall Study|Transitioned to Phase 4 study|0|||
145253599|NCT01004861|523773918|FG006|Overall Study|Transitioned to Phase 4 study|0|||
145253600|NCT01004861|523773919|FG007|Overall Study|Transitioned to Phase 4 study|0|||
145253601|NCT01004861|523773920|FG008|Overall Study|Transitioned to Phase 4 study|2|||
145253602|NCT01004861|523773921|FG009|Overall Study|Transitioned to Phase 4 study|0|||
145253603|NCT01004861|523773922|FG010|Overall Study|Transitioned to Phase 4 study|0|||
145300057|NCT01185821|523950302|FG002|Overall Study|Lack of Efficacy|3|||
145253604|NCT01004861|523773923|FG011|Overall Study|Transitioned to Phase 4 study|0|||
145253605|NCT01004861|523773924|FG012|Overall Study|Transitioned to Phase 4 study|0|||
145253606|NCT01004861|523773912|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253607|NCT01004861|523773913|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253608|NCT01004861|523773914|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145300058|NCT01185821|523950303|FG003|Overall Study|Lack of Efficacy|0|||
145300059|NCT01185821|523950304|FG004|Overall Study|Lack of Efficacy|9|||
145566671|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Death|2|||
145566672|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Death|0|||
145566673|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Death|4|||
145253609|NCT01004861|523773915|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253610|NCT01004861|523773916|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253611|NCT01004861|523773917|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253612|NCT01004861|523773918|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253613|NCT01004861|523773919|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253614|NCT01004861|523773920|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
145253615|NCT01004861|523773921|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253616|NCT01004861|523773922|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253617|NCT01004861|523773923|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253618|NCT01004861|523773924|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
145253619|NCT01004861|523773912|FG000|Overall Study|Patient withdrew|0|||
145253620|NCT01004861|523773913|FG001|Overall Study|Patient withdrew|0|||
145253621|NCT01004861|523773914|FG002|Overall Study|Patient withdrew|0|||
145253622|NCT01004861|523773915|FG003|Overall Study|Patient withdrew|0|||
145253623|NCT01004861|523773916|FG004|Overall Study|Patient withdrew|0|||
145253624|NCT01004861|523773917|FG005|Overall Study|Patient withdrew|0|||
145253625|NCT01004861|523773918|FG006|Overall Study|Patient withdrew|0|||
145253626|NCT01004861|523773919|FG007|Overall Study|Patient withdrew|0|||
145253627|NCT01004861|523773920|FG008|Overall Study|Patient withdrew|1|||
145253628|NCT01004861|523773921|FG009|Overall Study|Patient withdrew|0|||
145253629|NCT01004861|523773922|FG010|Overall Study|Patient withdrew|0|||
145253630|NCT01004861|523773923|FG011|Overall Study|Patient withdrew|0|||
145253631|NCT01004861|523773924|FG012|Overall Study|Patient withdrew|0|||
145253632|NCT01004861|523773912|FG000|Overall Study|Surgical resection|0|||
145253633|NCT01004861|523773913|FG001|Overall Study|Surgical resection|0|||
145253634|NCT01004861|523773914|FG002|Overall Study|Surgical resection|0|||
145253635|NCT01004861|523773915|FG003|Overall Study|Surgical resection|0|||
145253636|NCT01004861|523773916|FG004|Overall Study|Surgical resection|0|||
145253637|NCT01004861|523773917|FG005|Overall Study|Surgical resection|0|||
145253638|NCT01004861|523773918|FG006|Overall Study|Surgical resection|0|||
145253639|NCT01004861|523773919|FG007|Overall Study|Surgical resection|0|||
145253640|NCT01004861|523773920|FG008|Overall Study|Surgical resection|1|||
145253641|NCT01004861|523773921|FG009|Overall Study|Surgical resection|0|||
145253642|NCT01004861|523773922|FG010|Overall Study|Surgical resection|0|||
145253643|NCT01004861|523773923|FG011|Overall Study|Surgical resection|0|||
145253644|NCT01004861|523773924|FG012|Overall Study|Surgical resection|0|||
145253645|NCT01004861|523773912|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253646|NCT01004861|523773913|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253647|NCT01004861|523773914|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253648|NCT01004861|523773915|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253649|NCT01004861|523773916|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253650|NCT01004861|523773917|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145300060|NCT01185821|523950300|FG000|Overall Study|Withdrawal by Subject|3|||
145300061|NCT01185821|523950301|FG001|Overall Study|Withdrawal by Subject|2|||
145300062|NCT01185821|523950302|FG002|Overall Study|Withdrawal by Subject|2|||
145300063|NCT01185821|523950303|FG003|Overall Study|Withdrawal by Subject|1|||
145300064|NCT01185821|523950304|FG004|Overall Study|Withdrawal by Subject|3|||
145300065|NCT01185821|523950300|FG000|Overall Study|Lost to Follow-up|1|||
145300066|NCT01185821|523950301|FG001|Overall Study|Lost to Follow-up|1|||
145300067|NCT01185821|523950302|FG002|Overall Study|Lost to Follow-up|2|||
145300068|NCT01185821|523950303|FG003|Overall Study|Lost to Follow-up|1|||
145300069|NCT01185821|523950304|FG004|Overall Study|Lost to Follow-up|2|||
145300070|NCT01185821|523950300|FG000|Overall Study|Administrative problems|0|||
145300071|NCT01185821|523950301|FG001|Overall Study|Administrative problems|0|||
145300072|NCT01185821|523950302|FG002|Overall Study|Administrative problems|1|||
145300073|NCT01185821|523950303|FG003|Overall Study|Administrative problems|1|||
145300074|NCT01185821|523950304|FG004|Overall Study|Administrative problems|2|||
145300075|NCT00385593|523950313|FG000|Overall Study|Adverse Event|3|||
145300076|NCT00385593|523950314|FG001|Overall Study|Adverse Event|2|||
145300077|NCT00385593|523950313|FG000|Overall Study|Withdrawal by Subject|17|||
145410501|NCT00817063|524356801|FG001|Overall Study|Death|1|||
145300078|NCT00385593|523950314|FG001|Overall Study|Withdrawal by Subject|7|||
145410502|NCT00817063|524356800|FG000|Overall Study|Lack of Efficacy|33|||
145300079|NCT00385593|523950313|FG000|Overall Study|Lost to Follow-up|12|||
145410503|NCT00817063|524356801|FG001|Overall Study|Lack of Efficacy|86|||
145253651|NCT01004861|523773918|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145300080|NCT00385593|523950314|FG001|Overall Study|Lost to Follow-up|8|||
145300081|NCT00385593|523950313|FG000|Overall Study|Protocol Violation|7|||
145300082|NCT00385593|523950314|FG001|Overall Study|Protocol Violation|4|||
145300083|NCT00385593|523950313|FG000|Overall Study|Several reasons|17|||
145300084|NCT00385593|523950314|FG001|Overall Study|Several reasons|15|||
145253652|NCT01004861|523773919|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253653|NCT01004861|523773920|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
145253654|NCT01004861|523773921|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253655|NCT01004861|523773922|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253656|NCT01004861|523773923|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253657|NCT01004861|523773924|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
145253658|NCT01004861|523773912|FG000|Overall Study|Study termination by Sponsor|0|||
145253659|NCT01004861|523773913|FG001|Overall Study|Study termination by Sponsor|0|||
145253660|NCT01004861|523773914|FG002|Overall Study|Study termination by Sponsor|0|||
145253661|NCT01004861|523773915|FG003|Overall Study|Study termination by Sponsor|0|||
145253662|NCT01004861|523773916|FG004|Overall Study|Study termination by Sponsor|0|||
145253663|NCT01004861|523773917|FG005|Overall Study|Study termination by Sponsor|0|||
145253664|NCT01004861|523773918|FG006|Overall Study|Study termination by Sponsor|0|||
145566674|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
145566675|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
145566676|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
145253665|NCT01004861|523773919|FG007|Overall Study|Study termination by Sponsor|0|||
145253666|NCT01004861|523773920|FG008|Overall Study|Study termination by Sponsor|1|||
145253667|NCT01004861|523773921|FG009|Overall Study|Study termination by Sponsor|0|||
145253668|NCT01004861|523773922|FG010|Overall Study|Study termination by Sponsor|0|||
145253669|NCT01004861|523773923|FG011|Overall Study|Study termination by Sponsor|0|||
145253670|NCT01004861|523773924|FG012|Overall Study|Study termination by Sponsor|0|||
145253671|NCT00003389|523773925|FG000|Overall Study|Disease progression|6|||
145253672|NCT00003389|523773926|FG001|Overall Study|Disease progression|1|||
145253673|NCT00003389|523773925|FG000|Overall Study|Adverse Event|13|||
145253674|NCT00003389|523773926|FG001|Overall Study|Adverse Event|2|||
145253675|NCT00003389|523773925|FG000|Overall Study|Death|0|||
145253676|NCT00003389|523773926|FG001|Overall Study|Death|3|||
145253677|NCT00003389|523773925|FG000|Overall Study|Withdrawal by Subject|12|||
145253678|NCT00003389|523773926|FG001|Overall Study|Withdrawal by Subject|5|||
145253679|NCT00003389|523773925|FG000|Overall Study|Alternative therapy|2|||
145253680|NCT00003389|523773926|FG001|Overall Study|Alternative therapy|1|||
145253681|NCT00003389|523773925|FG000|Overall Study|Complicating disease|1|||
145253682|NCT00003389|523773926|FG001|Overall Study|Complicating disease|0|||
145253683|NCT00003389|523773925|FG000|Overall Study|Off-treatment reason missing|31|||
145253684|NCT00003389|523773926|FG001|Overall Study|Off-treatment reason missing|21|||
145253685|NCT00003389|523773925|FG000|Overall Study|Ineligible|33|||
145253686|NCT00003389|523773926|FG001|Overall Study|Ineligible|27|||
145253687|NCT02554721|523773927|FG000|Overall Study|Adverse Event|1|||
145253688|NCT02554721|523773928|FG001|Overall Study|Adverse Event|0|||
145253689|NCT02554721|523773929|FG002|Overall Study|Adverse Event|0|||
145253690|NCT02554721|523773930|FG003|Overall Study|Adverse Event|0|||
145253691|NCT02554721|523773931|FG004|Overall Study|Adverse Event|1|||
145253692|NCT02554721|523773927|FG000|Overall Study|Noncompliance|0|||
145253693|NCT02554721|523773928|FG001|Overall Study|Noncompliance|0|||
145253694|NCT02554721|523773929|FG002|Overall Study|Noncompliance|0|||
145253695|NCT02554721|523773930|FG003|Overall Study|Noncompliance|0|||
145253696|NCT02554721|523773931|FG004|Overall Study|Noncompliance|1|||
145253697|NCT00686699|523773932|FG000|Treatment Period 1|Adverse Event|0|||
145253698|NCT00686699|523773933|FG001|Treatment Period 1|Adverse Event|2|||
145253699|NCT01693562|523773936|FG000|Escalation Phase|Withdrawal by Subject|0|||
145253700|NCT01693562|523773937|FG001|Escalation Phase|Withdrawal by Subject|1|||
145253701|NCT01693562|523773938|FG002|Escalation Phase|Withdrawal by Subject|0|||
145253702|NCT01693562|523773939|FG003|Escalation Phase|Withdrawal by Subject|0|||
145253703|NCT01693562|523773940|FG004|Escalation Phase|Withdrawal by Subject|0|||
145253704|NCT01693562|523773941|FG005|Escalation Phase|Withdrawal by Subject|2|||
145253705|NCT01693562|523773942|FG006|Escalation Phase|Withdrawal by Subject|0|||
145253706|NCT01693562|523773943|FG007|Escalation Phase|Withdrawal by Subject|0|||
145253707|NCT01693562|523773944|FG008|Escalation Phase|Withdrawal by Subject|0|||
145566677|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
145566678|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
145253708|NCT01693562|523773945|FG009|Escalation Phase|Withdrawal by Subject|0|||
145253709|NCT01693562|523773946|FG010|Escalation Phase|Withdrawal by Subject|0|||
145253710|NCT01693562|523773947|FG011|Escalation Phase|Withdrawal by Subject|0|||
145253711|NCT01693562|523773948|FG012|Escalation Phase|Withdrawal by Subject|0|||
145253712|NCT01693562|523773949|FG013|Escalation Phase|Withdrawal by Subject|0|||
145253713|NCT01693562|523773950|FG014|Escalation Phase|Withdrawal by Subject|0|||
145300085|NCT00385593|523950313|FG000|Overall Study|Incorrect inclusion|2|||
145300086|NCT00385593|523950314|FG001|Overall Study|Incorrect inclusion|0|||
145253714|NCT01693562|523773951|FG015|Escalation Phase|Withdrawal by Subject|0|||
145253715|NCT01693562|523773952|FG016|Escalation Phase|Withdrawal by Subject|0|||
145253716|NCT01693562|523773953|FG017|Escalation Phase|Withdrawal by Subject|0|||
145300087|NCT00385593|523950313|FG000|Overall Study|Incorrect randomization|0|||
145300088|NCT00385593|523950314|FG001|Overall Study|Incorrect randomization|1|||
145253717|NCT01693562|523773954|FG018|Escalation Phase|Withdrawal by Subject|0|||
145253718|NCT01693562|523773955|FG019|Escalation Phase|Withdrawal by Subject|0|||
145253719|NCT01693562|523773956|FG020|Escalation Phase|Withdrawal by Subject|0|||
145253720|NCT01693562|523773957|FG021|Escalation Phase|Withdrawal by Subject|0|||
145253721|NCT01693562|523773958|FG022|Escalation Phase|Withdrawal by Subject|0|||
145253722|NCT01693562|523773936|FG000|Escalation Phase|Death|4|||
145253723|NCT01693562|523773937|FG001|Escalation Phase|Death|2|||
145253724|NCT01693562|523773938|FG002|Escalation Phase|Death|0|||
145253725|NCT01693562|523773939|FG003|Escalation Phase|Death|3|||
145253726|NCT01693562|523773940|FG004|Escalation Phase|Death|6|||
145253727|NCT01693562|523773941|FG005|Escalation Phase|Death|4|||
145253728|NCT01693562|523773942|FG006|Escalation Phase|Death|0|||
145253729|NCT01693562|523773943|FG007|Escalation Phase|Death|0|||
145253730|NCT01693562|523773944|FG008|Escalation Phase|Death|0|||
145253731|NCT01693562|523773945|FG009|Escalation Phase|Death|0|||
145253732|NCT01693562|523773946|FG010|Escalation Phase|Death|0|||
145253733|NCT01693562|523773947|FG011|Escalation Phase|Death|0|||
145253734|NCT01693562|523773948|FG012|Escalation Phase|Death|0|||
145253735|NCT01693562|523773949|FG013|Escalation Phase|Death|0|||
145253736|NCT01693562|523773950|FG014|Escalation Phase|Death|0|||
145253737|NCT01693562|523773951|FG015|Escalation Phase|Death|0|||
145253738|NCT01693562|523773952|FG016|Escalation Phase|Death|0|||
145253739|NCT01693562|523773953|FG017|Escalation Phase|Death|0|||
145253740|NCT01693562|523773954|FG018|Escalation Phase|Death|0|||
145253741|NCT01693562|523773955|FG019|Escalation Phase|Death|0|||
145253742|NCT01693562|523773956|FG020|Escalation Phase|Death|0|||
145253743|NCT01693562|523773957|FG021|Escalation Phase|Death|0|||
145253744|NCT01693562|523773958|FG022|Escalation Phase|Death|0|||
145253745|NCT01693562|523773936|FG000|Escalation Phase|Lost to Follow-up|0|||
145253746|NCT01693562|523773937|FG001|Escalation Phase|Lost to Follow-up|1|||
145253747|NCT01693562|523773938|FG002|Escalation Phase|Lost to Follow-up|1|||
145253748|NCT01693562|523773939|FG003|Escalation Phase|Lost to Follow-up|0|||
145253749|NCT01693562|523773940|FG004|Escalation Phase|Lost to Follow-up|0|||
145253750|NCT01693562|523773941|FG005|Escalation Phase|Lost to Follow-up|0|||
145253751|NCT01693562|523773942|FG006|Escalation Phase|Lost to Follow-up|0|||
145300089|NCT03586726|523950317|FG000|Overall Study|Withdrawal by Subject|1|||
145300090|NCT00965185|523950318|FG000|Overall Study|Lost to Follow-up|2|||
145300091|NCT00965185|523950319|FG001|Overall Study|Lost to Follow-up|0|||
145300092|NCT00965185|523950318|FG000|Overall Study|Withdrawal by Subject|0|||
145300093|NCT00965185|523950319|FG001|Overall Study|Withdrawal by Subject|1|||
145300094|NCT05275205|523950320|FG000|Overall Study|Adverse Event|1|||
145300095|NCT05275205|523950321|FG001|Overall Study|Adverse Event|2|||
145300096|NCT05275205|523950320|FG000|Overall Study|Physician Decision|1|||
145300097|NCT05275205|523950321|FG001|Overall Study|Physician Decision|1|||
145300098|NCT05275205|523950320|FG000|Overall Study|Withdrawal by Subject|2|||
145300099|NCT05275205|523950321|FG001|Overall Study|Withdrawal by Subject|3|||
145300100|NCT05275205|523950320|FG000|Overall Study|Death|1|||
145300101|NCT05275205|523950321|FG001|Overall Study|Death|0|||
145300102|NCT05275205|523950320|FG000|Overall Study|Patient unable to attend visits|1|||
145300103|NCT05275205|523950321|FG001|Overall Study|Patient unable to attend visits|0|||
145300104|NCT02963259|523950324|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
145300105|NCT02963259|523950324|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
145300106|NCT02963259|523950324|FG000|Overall Study|Death|1|||
145300107|NCT02963259|523950324|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
145300108|NCT03243630|523950326|FG000|Overall Study|Protocol Violation|1|||
145300109|NCT03243630|523950326|FG000|Overall Study|Physician Decision|1|||
145300110|NCT00939003|523950327|FG000|Double-blind Treatment Period|Adverse Event|1|||
145300111|NCT00939003|523950328|FG001|Double-blind Treatment Period|Adverse Event|1|||
145300112|NCT00939003|523950327|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145253752|NCT01693562|523773943|FG007|Escalation Phase|Lost to Follow-up|0|||
145253753|NCT01693562|523773944|FG008|Escalation Phase|Lost to Follow-up|0|||
145300113|NCT00939003|523950328|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
145300114|NCT00939003|523950327|FG000|Double-blind Treatment Period|Pregnancy|0|||
145300115|NCT00939003|523950328|FG001|Double-blind Treatment Period|Pregnancy|1|||
145300116|NCT00939003|523950327|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
145253754|NCT01693562|523773945|FG009|Escalation Phase|Lost to Follow-up|0|||
145300117|NCT00939003|523950328|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
145410504|NCT00817063|524356800|FG000|Overall Study|Failure to Return|13|||
145253755|NCT01693562|523773946|FG010|Escalation Phase|Lost to Follow-up|0|||
145253756|NCT01693562|523773947|FG011|Escalation Phase|Lost to Follow-up|0|||
145253757|NCT01693562|523773948|FG012|Escalation Phase|Lost to Follow-up|0|||
145253758|NCT01693562|523773949|FG013|Escalation Phase|Lost to Follow-up|0|||
145253759|NCT01693562|523773950|FG014|Escalation Phase|Lost to Follow-up|0|||
145253760|NCT01693562|523773951|FG015|Escalation Phase|Lost to Follow-up|0|||
145300118|NCT00939003|523950327|FG000|Open-label Treatment Period|Adverse Event|4|||
145300119|NCT00939003|523950328|FG001|Open-label Treatment Period|Adverse Event|8|||
145300120|NCT00939003|523950327|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
145253761|NCT01693562|523773952|FG016|Escalation Phase|Lost to Follow-up|0|||
145253762|NCT01693562|523773953|FG017|Escalation Phase|Lost to Follow-up|0|||
145253763|NCT01693562|523773954|FG018|Escalation Phase|Lost to Follow-up|0|||
145253764|NCT01693562|523773955|FG019|Escalation Phase|Lost to Follow-up|0|||
145253765|NCT01693562|523773956|FG020|Escalation Phase|Lost to Follow-up|0|||
145253766|NCT01693562|523773957|FG021|Escalation Phase|Lost to Follow-up|0|||
145253767|NCT01693562|523773958|FG022|Escalation Phase|Lost to Follow-up|0|||
145253768|NCT01693562|523773936|FG000|Escalation Phase|Other|0|||
145253769|NCT01693562|523773937|FG001|Escalation Phase|Other|0|||
145253770|NCT01693562|523773938|FG002|Escalation Phase|Other|2|||
145253771|NCT01693562|523773939|FG003|Escalation Phase|Other|0|||
145253772|NCT01693562|523773940|FG004|Escalation Phase|Other|0|||
145253773|NCT01693562|523773941|FG005|Escalation Phase|Other|1|||
145253774|NCT01693562|523773942|FG006|Escalation Phase|Other|0|||
145253775|NCT01693562|523773943|FG007|Escalation Phase|Other|0|||
145253776|NCT01693562|523773944|FG008|Escalation Phase|Other|0|||
145253777|NCT01693562|523773945|FG009|Escalation Phase|Other|0|||
145253778|NCT01693562|523773946|FG010|Escalation Phase|Other|0|||
145253779|NCT01693562|523773947|FG011|Escalation Phase|Other|0|||
145253780|NCT01693562|523773948|FG012|Escalation Phase|Other|0|||
145253781|NCT01693562|523773949|FG013|Escalation Phase|Other|0|||
145253782|NCT01693562|523773950|FG014|Escalation Phase|Other|0|||
145253783|NCT01693562|523773951|FG015|Escalation Phase|Other|0|||
145253784|NCT01693562|523773952|FG016|Escalation Phase|Other|0|||
145253785|NCT01693562|523773953|FG017|Escalation Phase|Other|0|||
145253786|NCT01693562|523773954|FG018|Escalation Phase|Other|0|||
145253787|NCT01693562|523773955|FG019|Escalation Phase|Other|0|||
145253788|NCT01693562|523773956|FG020|Escalation Phase|Other|0|||
145253789|NCT01693562|523773957|FG021|Escalation Phase|Other|0|||
145253790|NCT01693562|523773958|FG022|Escalation Phase|Other|0|||
145253791|NCT01693562|523773936|FG000|Exploration Phase|Withdrawal by Subject|0|||
145253792|NCT01693562|523773937|FG001|Exploration Phase|Withdrawal by Subject|0|||
145253793|NCT01693562|523773938|FG002|Exploration Phase|Withdrawal by Subject|0|||
145253794|NCT01693562|523773939|FG003|Exploration Phase|Withdrawal by Subject|0|||
145253795|NCT01693562|523773940|FG004|Exploration Phase|Withdrawal by Subject|0|||
145253796|NCT01693562|523773941|FG005|Exploration Phase|Withdrawal by Subject|0|||
145253797|NCT01693562|523773942|FG006|Exploration Phase|Withdrawal by Subject|2|||
145253798|NCT01693562|523773943|FG007|Exploration Phase|Withdrawal by Subject|0|||
145253799|NCT01693562|523773944|FG008|Exploration Phase|Withdrawal by Subject|0|||
145253800|NCT01693562|523773945|FG009|Exploration Phase|Withdrawal by Subject|0|||
145253801|NCT01693562|523773946|FG010|Exploration Phase|Withdrawal by Subject|0|||
145253802|NCT01693562|523773947|FG011|Exploration Phase|Withdrawal by Subject|0|||
145253803|NCT01693562|523773948|FG012|Exploration Phase|Withdrawal by Subject|0|||
145253804|NCT01693562|523773949|FG013|Exploration Phase|Withdrawal by Subject|0|||
145253805|NCT01693562|523773950|FG014|Exploration Phase|Withdrawal by Subject|0|||
145253806|NCT01693562|523773951|FG015|Exploration Phase|Withdrawal by Subject|0|||
145253807|NCT01693562|523773952|FG016|Exploration Phase|Withdrawal by Subject|0|||
145253808|NCT01693562|523773953|FG017|Exploration Phase|Withdrawal by Subject|0|||
145253809|NCT01693562|523773954|FG018|Exploration Phase|Withdrawal by Subject|0|||
145253810|NCT01693562|523773955|FG019|Exploration Phase|Withdrawal by Subject|0|||
145253811|NCT01693562|523773956|FG020|Exploration Phase|Withdrawal by Subject|0|||
145253812|NCT01693562|523773957|FG021|Exploration Phase|Withdrawal by Subject|0|||
145253813|NCT01693562|523773958|FG022|Exploration Phase|Withdrawal by Subject|0|||
145253814|NCT01693562|523773936|FG000|Exploration Phase|Death|0|||
145253815|NCT01693562|523773937|FG001|Exploration Phase|Death|0|||
145253816|NCT01693562|523773938|FG002|Exploration Phase|Death|0|||
145253817|NCT01693562|523773939|FG003|Exploration Phase|Death|0|||
145253818|NCT01693562|523773940|FG004|Exploration Phase|Death|0|||
145253819|NCT01693562|523773941|FG005|Exploration Phase|Death|0|||
145253820|NCT01693562|523773942|FG006|Exploration Phase|Death|17|||
145253821|NCT01693562|523773943|FG007|Exploration Phase|Death|0|||
145253822|NCT01693562|523773944|FG008|Exploration Phase|Death|0|||
145253823|NCT01693562|523773945|FG009|Exploration Phase|Death|0|||
145566679|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
145253824|NCT01693562|523773946|FG010|Exploration Phase|Death|0|||
145253825|NCT01693562|523773947|FG011|Exploration Phase|Death|0|||
145253826|NCT01693562|523773948|FG012|Exploration Phase|Death|0|||
145253827|NCT01693562|523773949|FG013|Exploration Phase|Death|0|||
145253828|NCT01693562|523773950|FG014|Exploration Phase|Death|0|||
145253829|NCT01693562|523773951|FG015|Exploration Phase|Death|0|||
145253830|NCT01693562|523773952|FG016|Exploration Phase|Death|0|||
145253831|NCT01693562|523773953|FG017|Exploration Phase|Death|0|||
145253832|NCT01693562|523773954|FG018|Exploration Phase|Death|0|||
145253833|NCT01693562|523773955|FG019|Exploration Phase|Death|0|||
145253834|NCT01693562|523773956|FG020|Exploration Phase|Death|0|||
145253835|NCT01693562|523773957|FG021|Exploration Phase|Death|0|||
145253836|NCT01693562|523773958|FG022|Exploration Phase|Death|0|||
145253837|NCT01693562|523773936|FG000|Exploration Phase|Other|0|||
145253838|NCT01693562|523773937|FG001|Exploration Phase|Other|0|||
145253839|NCT01693562|523773938|FG002|Exploration Phase|Other|0|||
145253840|NCT01693562|523773939|FG003|Exploration Phase|Other|0|||
145253841|NCT01693562|523773940|FG004|Exploration Phase|Other|0|||
145253842|NCT01693562|523773941|FG005|Exploration Phase|Other|0|||
145253843|NCT01693562|523773942|FG006|Exploration Phase|Other|2|||
145253844|NCT01693562|523773943|FG007|Exploration Phase|Other|0|||
145253845|NCT01693562|523773944|FG008|Exploration Phase|Other|0|||
145253846|NCT01693562|523773945|FG009|Exploration Phase|Other|0|||
145253847|NCT01693562|523773946|FG010|Exploration Phase|Other|0|||
145253848|NCT01693562|523773947|FG011|Exploration Phase|Other|0|||
145253849|NCT01693562|523773948|FG012|Exploration Phase|Other|0|||
145253850|NCT01693562|523773949|FG013|Exploration Phase|Other|0|||
145253851|NCT01693562|523773950|FG014|Exploration Phase|Other|0|||
145253852|NCT01693562|523773951|FG015|Exploration Phase|Other|0|||
145253853|NCT01693562|523773952|FG016|Exploration Phase|Other|0|||
145253854|NCT01693562|523773953|FG017|Exploration Phase|Other|0|||
145253855|NCT01693562|523773954|FG018|Exploration Phase|Other|0|||
145253856|NCT01693562|523773955|FG019|Exploration Phase|Other|0|||
145253857|NCT01693562|523773956|FG020|Exploration Phase|Other|0|||
145253858|NCT01693562|523773957|FG021|Exploration Phase|Other|0|||
145253859|NCT01693562|523773958|FG022|Exploration Phase|Other|0|||
145253860|NCT01693562|523773936|FG000|Expansion Phase|Withdrawal by Subject|0|||
145253861|NCT01693562|523773937|FG001|Expansion Phase|Withdrawal by Subject|0|||
145253862|NCT01693562|523773938|FG002|Expansion Phase|Withdrawal by Subject|0|||
145253863|NCT01693562|523773939|FG003|Expansion Phase|Withdrawal by Subject|0|||
145253864|NCT01693562|523773940|FG004|Expansion Phase|Withdrawal by Subject|0|||
145253865|NCT01693562|523773941|FG005|Expansion Phase|Withdrawal by Subject|0|||
145253866|NCT01693562|523773942|FG006|Expansion Phase|Withdrawal by Subject|0|||
145253867|NCT01693562|523773943|FG007|Expansion Phase|Withdrawal by Subject|16|||
145253868|NCT01693562|523773944|FG008|Expansion Phase|Withdrawal by Subject|2|||
145253869|NCT01693562|523773945|FG009|Expansion Phase|Withdrawal by Subject|54|||
145253870|NCT01693562|523773946|FG010|Expansion Phase|Withdrawal by Subject|2|||
145253871|NCT01693562|523773947|FG011|Expansion Phase|Withdrawal by Subject|2|||
145253872|NCT01693562|523773948|FG012|Expansion Phase|Withdrawal by Subject|3|||
145253873|NCT01693562|523773949|FG013|Expansion Phase|Withdrawal by Subject|5|||
145253874|NCT01693562|523773950|FG014|Expansion Phase|Withdrawal by Subject|16|||
145253875|NCT01693562|523773951|FG015|Expansion Phase|Withdrawal by Subject|7|||
145253876|NCT01693562|523773952|FG016|Expansion Phase|Withdrawal by Subject|40|||
145253877|NCT01693562|523773953|FG017|Expansion Phase|Withdrawal by Subject|4|||
145253878|NCT01693562|523773954|FG018|Expansion Phase|Withdrawal by Subject|8|||
145253879|NCT01693562|523773955|FG019|Expansion Phase|Withdrawal by Subject|3|||
145253880|NCT01693562|523773956|FG020|Expansion Phase|Withdrawal by Subject|1|||
145253881|NCT01693562|523773957|FG021|Expansion Phase|Withdrawal by Subject|8|||
145253882|NCT01693562|523773958|FG022|Expansion Phase|Withdrawal by Subject|1|||
145253883|NCT01693562|523773936|FG000|Expansion Phase|Death|0|||
145253884|NCT01693562|523773937|FG001|Expansion Phase|Death|0|||
145253885|NCT01693562|523773938|FG002|Expansion Phase|Death|0|||
145253886|NCT01693562|523773939|FG003|Expansion Phase|Death|0|||
145253887|NCT01693562|523773940|FG004|Expansion Phase|Death|0|||
145253888|NCT01693562|523773941|FG005|Expansion Phase|Death|0|||
145253889|NCT01693562|523773942|FG006|Expansion Phase|Death|0|||
145253890|NCT01693562|523773943|FG007|Expansion Phase|Death|42|||
145253891|NCT01693562|523773944|FG008|Expansion Phase|Death|17|||
145253892|NCT01693562|523773945|FG009|Expansion Phase|Death|208|||
145253893|NCT01693562|523773946|FG010|Expansion Phase|Death|30|||
145410505|NCT00817063|524356801|FG001|Overall Study|Failure to Return|12|||
145253894|NCT01693562|523773947|FG011|Expansion Phase|Death|8|||
145253895|NCT01693562|523773948|FG012|Expansion Phase|Death|19|||
145253896|NCT01693562|523773949|FG013|Expansion Phase|Death|42|||
145253897|NCT01693562|523773950|FG014|Expansion Phase|Death|23|||
145253898|NCT01693562|523773951|FG015|Expansion Phase|Death|23|||
145253899|NCT01693562|523773952|FG016|Expansion Phase|Death|128|||
145253900|NCT01693562|523773953|FG017|Expansion Phase|Death|16|||
145253901|NCT01693562|523773954|FG018|Expansion Phase|Death|36|||
145253902|NCT01693562|523773955|FG019|Expansion Phase|Death|16|||
145253903|NCT01693562|523773956|FG020|Expansion Phase|Death|17|||
145253904|NCT01693562|523773957|FG021|Expansion Phase|Death|35|||
145253905|NCT01693562|523773958|FG022|Expansion Phase|Death|7|||
145253906|NCT01693562|523773936|FG000|Expansion Phase|Lost to Follow-up|0|||
145253907|NCT01693562|523773937|FG001|Expansion Phase|Lost to Follow-up|0|||
145253908|NCT01693562|523773938|FG002|Expansion Phase|Lost to Follow-up|0|||
145253909|NCT01693562|523773939|FG003|Expansion Phase|Lost to Follow-up|0|||
145253910|NCT01693562|523773940|FG004|Expansion Phase|Lost to Follow-up|0|||
145253911|NCT01693562|523773941|FG005|Expansion Phase|Lost to Follow-up|0|||
145253912|NCT01693562|523773942|FG006|Expansion Phase|Lost to Follow-up|0|||
145253913|NCT01693562|523773943|FG007|Expansion Phase|Lost to Follow-up|1|||
145253914|NCT01693562|523773944|FG008|Expansion Phase|Lost to Follow-up|2|||
145253915|NCT01693562|523773945|FG009|Expansion Phase|Lost to Follow-up|10|||
145253916|NCT01693562|523773946|FG010|Expansion Phase|Lost to Follow-up|4|||
145253917|NCT01693562|523773947|FG011|Expansion Phase|Lost to Follow-up|4|||
145253918|NCT01693562|523773948|FG012|Expansion Phase|Lost to Follow-up|1|||
145253919|NCT01693562|523773949|FG013|Expansion Phase|Lost to Follow-up|3|||
145253920|NCT01693562|523773950|FG014|Expansion Phase|Lost to Follow-up|0|||
145253921|NCT01693562|523773951|FG015|Expansion Phase|Lost to Follow-up|1|||
145253922|NCT01693562|523773952|FG016|Expansion Phase|Lost to Follow-up|1|||
145253923|NCT01693562|523773953|FG017|Expansion Phase|Lost to Follow-up|0|||
145253924|NCT01693562|523773954|FG018|Expansion Phase|Lost to Follow-up|2|||
145253925|NCT01693562|523773955|FG019|Expansion Phase|Lost to Follow-up|1|||
145253926|NCT01693562|523773956|FG020|Expansion Phase|Lost to Follow-up|2|||
145253927|NCT01693562|523773957|FG021|Expansion Phase|Lost to Follow-up|2|||
145253928|NCT01693562|523773958|FG022|Expansion Phase|Lost to Follow-up|1|||
145253929|NCT01693562|523773936|FG000|Expansion Phase|Other|0|||
145253930|NCT01693562|523773937|FG001|Expansion Phase|Other|0|||
145253931|NCT01693562|523773938|FG002|Expansion Phase|Other|0|||
145253932|NCT01693562|523773939|FG003|Expansion Phase|Other|0|||
145253933|NCT01693562|523773940|FG004|Expansion Phase|Other|0|||
145253934|NCT01693562|523773941|FG005|Expansion Phase|Other|0|||
145253935|NCT01693562|523773942|FG006|Expansion Phase|Other|0|||
145253936|NCT01693562|523773943|FG007|Expansion Phase|Other|3|||
145253937|NCT01693562|523773944|FG008|Expansion Phase|Other|1|||
145253938|NCT01693562|523773945|FG009|Expansion Phase|Other|28|||
145253939|NCT01693562|523773946|FG010|Expansion Phase|Other|4|||
145253940|NCT01693562|523773947|FG011|Expansion Phase|Other|7|||
145253941|NCT01693562|523773948|FG012|Expansion Phase|Other|0|||
145253942|NCT01693562|523773949|FG013|Expansion Phase|Other|1|||
145253943|NCT01693562|523773950|FG014|Expansion Phase|Other|1|||
145253944|NCT01693562|523773951|FG015|Expansion Phase|Other|0|||
145253945|NCT01693562|523773952|FG016|Expansion Phase|Other|28|||
145253946|NCT01693562|523773953|FG017|Expansion Phase|Other|0|||
145253947|NCT01693562|523773954|FG018|Expansion Phase|Other|1|||
145253948|NCT01693562|523773955|FG019|Expansion Phase|Other|0|||
145253949|NCT01693562|523773956|FG020|Expansion Phase|Other|1|||
145253950|NCT01693562|523773957|FG021|Expansion Phase|Other|17|||
145253951|NCT01693562|523773958|FG022|Expansion Phase|Other|1|||
145253952|NCT00364611|523773959|FG000|Overall Study|Did not receive study medication|0|||
145253953|NCT00364611|523773960|FG001|Overall Study|Did not receive study medication|1|||
145253954|NCT00364611|523773959|FG000|Overall Study|Adverse Event|7|||
145253955|NCT00364611|523773960|FG001|Overall Study|Adverse Event|4|||
145253956|NCT00364611|523773959|FG000|Overall Study|Participant's Request|3|||
145253957|NCT00364611|523773960|FG001|Overall Study|Participant's Request|4|||
145253958|NCT00364611|523773959|FG000|Overall Study|Disease Progression|38|||
145253959|NCT00364611|523773960|FG001|Overall Study|Disease Progression|8|||
145253960|NCT00364611|523773959|FG000|Overall Study|Investigator decision|2|||
145253961|NCT00364611|523773960|FG001|Overall Study|Investigator decision|2|||
145253962|NCT00364611|523773959|FG000|Overall Study|Found Ineligible|1|||
145253963|NCT00364611|523773960|FG001|Overall Study|Found Ineligible|0|||
145253964|NCT00364611|523773959|FG000|Overall Study|Presumed CR on Study|0|||
145253965|NCT00364611|523773960|FG001|Overall Study|Presumed CR on Study|1|||
145253966|NCT00364611|523773959|FG000|Overall Study|Receiving Liver Ablation|0|||
145253967|NCT00364611|523773960|FG001|Overall Study|Receiving Liver Ablation|1|||
145253968|NCT02759939|523773965|FG000|Overall Study|Missing data on first outcome assessed|11|||
145253969|NCT02759939|523773966|FG001|Overall Study|Missing data on first outcome assessed|2|||
145253970|NCT02759939|523773967|FG002|Overall Study|Missing data on first outcome assessed|5|||
145253971|NCT02759939|523773968|FG003|Overall Study|Missing data on first outcome assessed|2|||
145253972|NCT02759939|523773965|FG000|Overall Study|Ineligible for T2 and T3|310|||
145253973|NCT02759939|523773966|FG001|Overall Study|Ineligible for T2 and T3|179|||
145253974|NCT02759939|523773967|FG002|Overall Study|Ineligible for T2 and T3|366|||
145253975|NCT02759939|523773968|FG003|Overall Study|Ineligible for T2 and T3|391|||
145253976|NCT02759939|523773965|FG000|Overall Study|Lost to Follow-up|735|||
145253977|NCT02759939|523773966|FG001|Overall Study|Lost to Follow-up|791|||
145253978|NCT02759939|523773967|FG002|Overall Study|Lost to Follow-up|783|||
145253979|NCT02759939|523773968|FG003|Overall Study|Lost to Follow-up|650|||
145253980|NCT04097925|523773969|FG000|Overall Study|Withdrawal by Subject|1|||
145253981|NCT04397757|523773972|FG000|Overall Study|Death|3|||
145253982|NCT04397757|523773973|FG001|Overall Study|Death|11|||
145300121|NCT00939003|523950328|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
145300122|NCT00939003|523950327|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
145253983|NCT04397757|523773972|FG000|Overall Study|Withdrawal by Subject|2|||
145253984|NCT04397757|523773973|FG001|Overall Study|Withdrawal by Subject|0|||
145253985|NCT04397757|523773972|FG000|Overall Study|Lost to Follow-up|4|||
145253986|NCT04397757|523773973|FG001|Overall Study|Lost to Follow-up|3|||
145253987|NCT00087594|523773974|FG000|Overall Study|Adverse Event|2|||
145253988|NCT00087594|523773975|FG001|Overall Study|Adverse Event|3|||
145253989|NCT00087594|523773974|FG000|Overall Study|Lost to Follow-up|0|||
145253990|NCT00087594|523773975|FG001|Overall Study|Lost to Follow-up|2|||
145253991|NCT00087594|523773974|FG000|Overall Study|Withdrawal by Subject|4|||
145253992|NCT00087594|523773975|FG001|Overall Study|Withdrawal by Subject|2|||
145300123|NCT00939003|523950328|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
145300124|NCT00939003|523950327|FG000|Open-label Treatment Period|Pregnancy|1|||
145253993|NCT00087594|523773974|FG000|Overall Study|Lack of Efficacy|2|||
145253994|NCT00087594|523773975|FG001|Overall Study|Lack of Efficacy|5|||
145253995|NCT04657003|523773976|FG000|Overall Study|Adverse Event|5|||
145253996|NCT04657003|523773977|FG001|Overall Study|Adverse Event|1|||
145253997|NCT04657003|523773978|FG002|Overall Study|Adverse Event|5|||
145300125|NCT00939003|523950328|FG001|Open-label Treatment Period|Pregnancy|1|||
145253998|NCT04657003|523773976|FG000|Overall Study|Death|0|||
145253999|NCT04657003|523773977|FG001|Overall Study|Death|2|||
145254000|NCT04657003|523773978|FG002|Overall Study|Death|0|||
145254001|NCT04657003|523773976|FG000|Overall Study|Lost to Follow-up|8|||
145254002|NCT04657003|523773977|FG001|Overall Study|Lost to Follow-up|4|||
145254003|NCT04657003|523773978|FG002|Overall Study|Lost to Follow-up|10|||
145254004|NCT04657003|523773976|FG000|Overall Study|Other - As Reported by Investigator|3|||
145254005|NCT04657003|523773977|FG001|Overall Study|Other - As Reported by Investigator|2|||
145254006|NCT04657003|523773978|FG002|Overall Study|Other - As Reported by Investigator|2|||
145254007|NCT04657003|523773976|FG000|Overall Study|Pregnancy|2|||
145254008|NCT04657003|523773977|FG001|Overall Study|Pregnancy|0|||
145254009|NCT04657003|523773978|FG002|Overall Study|Pregnancy|2|||
145254010|NCT04657003|523773976|FG000|Overall Study|Withdrawal by Subject|16|||
145254011|NCT04657003|523773977|FG001|Overall Study|Withdrawal by Subject|7|||
145254012|NCT04657003|523773978|FG002|Overall Study|Withdrawal by Subject|10|||
145254013|NCT01823991|523773981|FG000|Overall Study|Withdrawal by Subject|8|||
145254014|NCT01823991|523773982|FG001|Overall Study|Withdrawal by Subject|5|||
145254015|NCT00768040|523773983|FG000|Overall Study|Adverse Event|3|||
145254016|NCT00768040|523773984|FG001|Overall Study|Adverse Event|2|||
145254017|NCT00768040|523773983|FG000|Overall Study|Abnormal laboratory value|1|||
145254018|NCT00768040|523773984|FG001|Overall Study|Abnormal laboratory value|1|||
145254019|NCT02185040|523773988|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
145254020|NCT02185040|523773989|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
145254021|NCT02185040|523773990|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
145254022|NCT02185040|523773991|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
145254023|NCT02185040|523773992|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
145254024|NCT02185040|523773993|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
145254025|NCT02185040|523773994|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
145254026|NCT02185040|523773988|FG000|Part 1 Treatment Phase|Adverse Event|1|||
145254027|NCT02185040|523773989|FG001|Part 1 Treatment Phase|Adverse Event|0|||
145254028|NCT02185040|523773990|FG002|Part 1 Treatment Phase|Adverse Event|0|||
145254029|NCT02185040|523773991|FG003|Part 1 Treatment Phase|Adverse Event|2|||
145254030|NCT02185040|523773992|FG004|Part 1 Treatment Phase|Adverse Event|3|||
145254031|NCT02185040|523773993|FG005|Part 1 Treatment Phase|Adverse Event|0|||
145254032|NCT02185040|523773994|FG006|Part 1 Treatment Phase|Adverse Event|0|||
145254033|NCT02185040|523773988|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254034|NCT02185040|523773989|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
145254035|NCT02185040|523773990|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254036|NCT02185040|523773991|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254037|NCT02185040|523773992|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254038|NCT02185040|523773993|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254039|NCT02185040|523773994|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
145254040|NCT02185040|523773988|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254041|NCT02185040|523773989|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
145254042|NCT02185040|523773990|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254043|NCT02185040|523773991|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254044|NCT02185040|523773992|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254045|NCT02185040|523773993|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254046|NCT02185040|523773994|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
145254047|NCT02185040|523773988|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
145254048|NCT02185040|523773989|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
145254049|NCT02185040|523773990|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
145254050|NCT02185040|523773991|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
145254051|NCT02185040|523773992|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
145300126|NCT00939003|523950327|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
145300127|NCT00939003|523950328|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
145300128|NCT00939003|523950327|FG000|Open-label Treatment Period|Site Closure|3|||
145300129|NCT00939003|523950328|FG001|Open-label Treatment Period|Site Closure|4|||
145300130|NCT03707912|523950329|FG000|Overall Study|Violation of inclusion criteria|1|||
145300131|NCT03707912|523950330|FG001|Overall Study|Violation of inclusion criteria|0|||
145300132|NCT02131129|523950331|FG000|Overall Study|Withdrawal by Subject|1|||
145300133|NCT02131129|523950332|FG001|Overall Study|Withdrawal by Subject|0|||
145300134|NCT02865122|523950333|FG000|Overall Study|Adverse Event|1|||
145300135|NCT02865122|523950334|FG001|Overall Study|Adverse Event|0|||
145254052|NCT02185040|523773993|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
145254053|NCT02185040|523773994|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
145254054|NCT02185040|523773988|FG000|Active Treatment Extension Phase|Adverse Event|0|||
145254055|NCT02185040|523773989|FG001|Active Treatment Extension Phase|Adverse Event|0|||
145300136|NCT02865122|523950335|FG002|Overall Study|Adverse Event|0|||
145254056|NCT02185040|523773990|FG002|Active Treatment Extension Phase|Adverse Event|0|||
145254057|NCT02185040|523773991|FG003|Active Treatment Extension Phase|Adverse Event|0|||
145254058|NCT02185040|523773992|FG004|Active Treatment Extension Phase|Adverse Event|0|||
145254059|NCT02185040|523773993|FG005|Active Treatment Extension Phase|Adverse Event|1|||
145300137|NCT03880266|523950336|FG000|Overall Study|Withdrawal by Subject|0|||
145300138|NCT03880266|523950337|FG001|Overall Study|Withdrawal by Subject|1|||
145254060|NCT02185040|523773994|FG006|Active Treatment Extension Phase|Adverse Event|4|||
145254061|NCT02185040|523773988|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
145254062|NCT02185040|523773989|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
145254063|NCT02185040|523773990|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
145254064|NCT02185040|523773991|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
145254065|NCT02185040|523773992|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
145254066|NCT02185040|523773993|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
145254067|NCT02185040|523773994|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
145254068|NCT02185040|523773988|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254069|NCT02185040|523773989|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254070|NCT02185040|523773990|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254071|NCT02185040|523773991|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254072|NCT02185040|523773992|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254073|NCT02185040|523773993|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
145254074|NCT02185040|523773994|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
145254075|NCT03347279|523773995|FG000|Overall Study|Withdrawal by Subject|8|||
145254076|NCT03347279|523773996|FG001|Overall Study|Withdrawal by Subject|15|||
145254077|NCT03347279|523773995|FG000|Overall Study|Death|0|||
145254078|NCT03347279|523773996|FG001|Overall Study|Death|2|||
145254079|NCT03347279|523773995|FG000|Overall Study|Lost to Follow-up|5|||
145254080|NCT03347279|523773996|FG001|Overall Study|Lost to Follow-up|2|||
145254081|NCT03347279|523773995|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
145254082|NCT03347279|523773996|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
145254083|NCT02987205|523774000|FG000|Overall Study|Adverse Event|1|||
145254084|NCT02987205|523774000|FG000|Overall Study|Withdrawal by Subject|3|||
145254085|NCT03558503|523774001|FG000|Overall Study|Adverse Event|1|||
145254086|NCT03558503|523774001|FG000|Overall Study|Death|1|||
145254087|NCT03558503|523774001|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
145254088|NCT02094612|523774002|FG000|Overall Study|Lost to Follow-up|47|||
145254089|NCT02094612|523774003|FG001|Overall Study|Lost to Follow-up|47|||
145254090|NCT02094612|523774002|FG000|Overall Study|Never started ADHD medication|32|||
145254091|NCT02094612|523774003|FG001|Overall Study|Never started ADHD medication|23|||
145254092|NCT02646891|523774004|FG000|Overall Study|Adverse Event|0|||
145254093|NCT02646891|523774005|FG001|Overall Study|Adverse Event|1|||
145254094|NCT02646891|523774006|FG002|Overall Study|Adverse Event|0|||
145254095|NCT02646891|523774007|FG003|Overall Study|Adverse Event|0|||
145254096|NCT02646891|523774008|FG004|Overall Study|Adverse Event|0|||
145254097|NCT02646891|523774009|FG005|Overall Study|Adverse Event|0|||
145254098|NCT02646891|523774010|FG006|Overall Study|Adverse Event|0|||
145254099|NCT02646891|523774011|FG007|Overall Study|Adverse Event|0|||
145254100|NCT02646891|523774012|FG008|Overall Study|Adverse Event|0|||
145254101|NCT02646891|523774013|FG009|Overall Study|Adverse Event|0|||
145254102|NCT02646891|523774004|FG000|Overall Study|Lost to Follow-up|0|||
145254103|NCT02646891|523774005|FG001|Overall Study|Lost to Follow-up|0|||
145254104|NCT02646891|523774006|FG002|Overall Study|Lost to Follow-up|0|||
145254105|NCT02646891|523774007|FG003|Overall Study|Lost to Follow-up|0|||
145254106|NCT02646891|523774008|FG004|Overall Study|Lost to Follow-up|0|||
145254107|NCT02646891|523774009|FG005|Overall Study|Lost to Follow-up|0|||
145254108|NCT02646891|523774010|FG006|Overall Study|Lost to Follow-up|2|||
145254109|NCT02646891|523774011|FG007|Overall Study|Lost to Follow-up|2|||
145254110|NCT02646891|523774012|FG008|Overall Study|Lost to Follow-up|2|||
145254111|NCT02646891|523774013|FG009|Overall Study|Lost to Follow-up|2|||
145254112|NCT02646891|523774004|FG000|Overall Study|Protocol Violation|0|||
145254113|NCT02646891|523774005|FG001|Overall Study|Protocol Violation|0|||
145254114|NCT02646891|523774006|FG002|Overall Study|Protocol Violation|0|||
145300139|NCT03880266|523950338|FG002|Overall Study|Withdrawal by Subject|1|||
145300140|NCT03880266|523950339|FG003|Overall Study|Withdrawal by Subject|0|||
145300141|NCT03880266|523950340|FG004|Overall Study|Withdrawal by Subject|0|||
145300142|NCT03880266|523950341|FG005|Overall Study|Withdrawal by Subject|0|||
145300143|NCT03880266|523950342|FG006|Overall Study|Withdrawal by Subject|0|||
145300144|NCT03880266|523950343|FG007|Overall Study|Withdrawal by Subject|0|||
145254115|NCT02646891|523774007|FG003|Overall Study|Protocol Violation|0|||
145254116|NCT02646891|523774008|FG004|Overall Study|Protocol Violation|0|||
145254117|NCT02646891|523774009|FG005|Overall Study|Protocol Violation|0|||
145254118|NCT02646891|523774010|FG006|Overall Study|Protocol Violation|1|||
145254119|NCT02646891|523774011|FG007|Overall Study|Protocol Violation|1|||
145254120|NCT02646891|523774012|FG008|Overall Study|Protocol Violation|0|||
145254121|NCT02646891|523774013|FG009|Overall Study|Protocol Violation|0|||
145254122|NCT02646891|523774004|FG000|Overall Study|Withdrawal by Subject|2|||
145254123|NCT02646891|523774005|FG001|Overall Study|Withdrawal by Subject|0|||
145300145|NCT05369208|523951526|FG000|Core Phase|Prohibited Medication Required|2|||
145254124|NCT02646891|523774006|FG002|Overall Study|Withdrawal by Subject|1|||
145254125|NCT02646891|523774007|FG003|Overall Study|Withdrawal by Subject|0|||
145254126|NCT02646891|523774008|FG004|Overall Study|Withdrawal by Subject|0|||
145254127|NCT02646891|523774009|FG005|Overall Study|Withdrawal by Subject|0|||
145254128|NCT02646891|523774010|FG006|Overall Study|Withdrawal by Subject|5|||
145254129|NCT02646891|523774011|FG007|Overall Study|Withdrawal by Subject|9|||
145254130|NCT02646891|523774012|FG008|Overall Study|Withdrawal by Subject|7|||
145254131|NCT02646891|523774013|FG009|Overall Study|Withdrawal by Subject|3|||
145254132|NCT02646891|523774004|FG000|Overall Study|Death|0|||
145254133|NCT02646891|523774005|FG001|Overall Study|Death|0|||
145254134|NCT02646891|523774006|FG002|Overall Study|Death|0|||
145254135|NCT02646891|523774007|FG003|Overall Study|Death|0|||
145254136|NCT02646891|523774008|FG004|Overall Study|Death|0|||
145254137|NCT02646891|523774009|FG005|Overall Study|Death|0|||
145254138|NCT02646891|523774010|FG006|Overall Study|Death|1|||
145254139|NCT02646891|523774011|FG007|Overall Study|Death|1|||
145254140|NCT02646891|523774012|FG008|Overall Study|Death|1|||
145254141|NCT02646891|523774013|FG009|Overall Study|Death|0|||
145254142|NCT01542632|523774014|FG000|Overall Study|Withdrawal of Consent|0|||
145254143|NCT01542632|523774015|FG001|Overall Study|Withdrawal of Consent|0|||
145254144|NCT01542632|523774016|FG002|Overall Study|Withdrawal of Consent|0|||
145254145|NCT01542632|523774017|FG003|Overall Study|Withdrawal of Consent|2|||
145254146|NCT01542632|523774018|FG004|Overall Study|Withdrawal of Consent|3|||
145254147|NCT01542632|523774019|FG005|Overall Study|Withdrawal of Consent|0|||
145254148|NCT01542632|523774014|FG000|Overall Study|Adverse Event|0|||
145254149|NCT01542632|523774015|FG001|Overall Study|Adverse Event|0|||
145254150|NCT01542632|523774016|FG002|Overall Study|Adverse Event|1|||
145254151|NCT01542632|523774017|FG003|Overall Study|Adverse Event|0|||
145254152|NCT01542632|523774018|FG004|Overall Study|Adverse Event|0|||
145254153|NCT01542632|523774019|FG005|Overall Study|Adverse Event|0|||
145254154|NCT01542632|523774014|FG000|Overall Study|Lost to Follow-up|0|||
145254155|NCT01542632|523774015|FG001|Overall Study|Lost to Follow-up|1|||
145254156|NCT01542632|523774016|FG002|Overall Study|Lost to Follow-up|0|||
145254157|NCT01542632|523774017|FG003|Overall Study|Lost to Follow-up|0|||
145254158|NCT01542632|523774018|FG004|Overall Study|Lost to Follow-up|0|||
145254159|NCT01542632|523774019|FG005|Overall Study|Lost to Follow-up|0|||
145254160|NCT01542632|523774014|FG000|Overall Study|Sponsor/Investigator Decision|0|||
145254161|NCT01542632|523774015|FG001|Overall Study|Sponsor/Investigator Decision|0|||
145254162|NCT01542632|523774016|FG002|Overall Study|Sponsor/Investigator Decision|0|||
145254163|NCT01542632|523774017|FG003|Overall Study|Sponsor/Investigator Decision|0|||
145254164|NCT01542632|523774018|FG004|Overall Study|Sponsor/Investigator Decision|1|||
145254165|NCT01542632|523774019|FG005|Overall Study|Sponsor/Investigator Decision|0|||
145254166|NCT03991936|523774020|FG000|Overall Study|Lost to Follow-up|1|||
145254167|NCT03991936|523774021|FG001|Overall Study|Lost to Follow-up|1|||
145254168|NCT03991936|523774022|FG002|Overall Study|Lost to Follow-up|1|||
145254169|NCT03991936|523774023|FG003|Overall Study|Lost to Follow-up|1|||
145254170|NCT03991936|523774024|FG004|Overall Study|Lost to Follow-up|1|||
145254171|NCT02773849|523774026|FG000|Overall Study|Lost to Follow-up|11|||
145254172|NCT02773849|523774026|FG000|Overall Study|Death|26|||
145254173|NCT02773849|523774026|FG000|Overall Study|Withdrawal by Subject|5|||
145300146|NCT05369208|523951526|FG000|Core Phase|Adverse Event|1|||
145300147|NCT05369208|523951526|FG000|Core Phase|Lack of Efficacy|1|||
145300148|NCT04934722|523951527|FG000|Overall Study|Death|4|||
145300149|NCT04934722|523951528|FG001|Overall Study|Death|3|||
145300150|NCT04934722|523951527|FG000|Overall Study|Participants Ongoing|88|||
145300151|NCT04934722|523951528|FG001|Overall Study|Participants Ongoing|91|||
145300152|NCT00371839|523951529|FG000|Overall Study|Death|4|||
145300153|NCT00371839|523951530|FG001|Overall Study|Death|0|||
145300154|NCT00371839|523951531|FG002|Overall Study|Death|0|||
145300155|NCT00371839|523951529|FG000|Overall Study|Withdrawal by Subject|7|||
145300156|NCT00371839|523951530|FG001|Overall Study|Withdrawal by Subject|4|||
145300157|NCT00371839|523951531|FG002|Overall Study|Withdrawal by Subject|0|||
145300158|NCT00371839|523951529|FG000|Overall Study|Lost to Follow-up|6|||
145300159|NCT00371839|523951530|FG001|Overall Study|Lost to Follow-up|3|||
145254174|NCT02773849|523774026|FG000|Overall Study|Withdrawal of Consent|9|||
145254175|NCT02773849|523774026|FG000|Overall Study|Other: not due to lack of tolerability|11|||
145254176|NCT03442595|523774039|FG000|Overall Study|Lost to Follow-up|94|||
145254177|NCT03442595|523774040|FG001|Overall Study|Lost to Follow-up|0|||
145254178|NCT02187224|523774043|FG000|Overall Study|Did not show up for test day|1|||
145300160|NCT00371839|523951531|FG002|Overall Study|Lost to Follow-up|2|||
145300161|NCT01149473|523951532|FG000|First Intervention|Adverse Event|1|||
145300162|NCT01149473|523951533|FG001|First Intervention|Adverse Event|1|||
145254179|NCT02187224|523774044|FG001|Overall Study|Did not show up for test day|0|||
145254180|NCT01010776|523774048|FG000|Main Phase|Withdrawal by Subject|14|||
145254181|NCT01010776|523774048|FG000|Main Phase|Lack of Efficacy|8|||
145254182|NCT01010776|523774048|FG000|Main Phase|Adverse Event|7|||
145254183|NCT01010776|523774048|FG000|Main Phase|Lost to Follow-up|6|||
145254184|NCT01010776|523774048|FG000|Main Phase|Non-compliance to study medication|5|||
145254185|NCT01010776|523774048|FG000|Main Phase|Selection failure|2|||
145300163|NCT01149473|523951532|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145300164|NCT01149473|523951533|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145300165|NCT02331394|523951537|FG000|Overall Study|Disease progression|1|||
145254186|NCT01010776|523774048|FG000|Main Phase|Inform consent withdrawal|1|||
145254187|NCT01010776|523774048|FG000|Main Phase|Other|1|||
145254188|NCT01010776|523774048|FG000|Main Phase|Did not received study medication|5|||
145254189|NCT01010776|523774048|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
145254190|NCT01010776|523774048|FG000|Extension Phase|Other|3|||
145254191|NCT03267576|523774054|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
145254192|NCT03267576|523774055|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
145254193|NCT03267576|523774054|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
145254194|NCT03267576|523774055|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
145254195|NCT01268514|523774056|FG000|Overall Study|Adverse Event|20|||
145254196|NCT01268514|523774056|FG000|Overall Study|Death|8|||
145254197|NCT01268514|523774056|FG000|Overall Study|Lost to Follow-up|5|||
145254198|NCT01268514|523774056|FG000|Overall Study|Withdrawal by Subject|3|||
145254199|NCT01268514|523774056|FG000|Overall Study|Withdrawal by Surgeon|5|||
145254200|NCT01846208|523774057|FG000|Overall Study|Withdrew prior to treatment|1|||
145254201|NCT01846208|523774058|FG001|Overall Study|Withdrew prior to treatment|1|||
145254202|NCT01846208|523774059|FG002|Overall Study|Withdrew prior to treatment|1|||
145254203|NCT01846208|523774057|FG000|Overall Study|Dosing Symptoms|1|||
145254204|NCT01846208|523774058|FG001|Overall Study|Dosing Symptoms|2|||
145254205|NCT01846208|523774059|FG002|Overall Study|Dosing Symptoms|6|||
145254206|NCT01846208|523774057|FG000|Overall Study|Withdrawal by Subject|5|||
145254207|NCT01846208|523774058|FG001|Overall Study|Withdrawal by Subject|0|||
145254208|NCT01846208|523774059|FG002|Overall Study|Withdrawal by Subject|0|||
145254209|NCT01846208|523774057|FG000|Overall Study|Non-compliance|1|||
145254210|NCT01846208|523774058|FG001|Overall Study|Non-compliance|1|||
145254211|NCT01846208|523774059|FG002|Overall Study|Non-compliance|0|||
145254212|NCT01846208|523774057|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
145254213|NCT01846208|523774058|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
145254214|NCT01846208|523774059|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
145254215|NCT01846208|523774057|FG000|Overall Study|Refused SU OFC|0|||
145254216|NCT01846208|523774058|FG001|Overall Study|Refused SU OFC|0|||
145254217|NCT01846208|523774059|FG002|Overall Study|Refused SU OFC|1|||
145254218|NCT01432938|523774060|FG000|First Intervention|Protocol Violation|1|||
145254219|NCT01432938|523774061|FG001|First Intervention|Protocol Violation|0|||
145254220|NCT01432938|523774060|FG000|First Intervention|Physician Decision|1|||
145254221|NCT01432938|523774061|FG001|First Intervention|Physician Decision|0|||
145254222|NCT01432938|523774060|FG000|Second Intervention|Adverse Event|1|||
145254223|NCT01432938|523774061|FG001|Second Intervention|Adverse Event|0|||
145254224|NCT01424306|523774062|FG000|Overall Study|Protocol Violation|0|||
145254225|NCT01424306|523774063|FG001|Overall Study|Protocol Violation|0|||
145254226|NCT01424306|523774064|FG002|Overall Study|Protocol Violation|0|||
145254227|NCT01424306|523774065|FG003|Overall Study|Protocol Violation|0|||
145254228|NCT01424306|523774066|FG004|Overall Study|Protocol Violation|1|||
145254229|NCT01424306|523774067|FG005|Overall Study|Protocol Violation|0|||
145254230|NCT01875874|523774071|FG000|Overall Study|Death|3|||
145254231|NCT03344562|523774074|FG000|Overall Study|Withdrawal by Subject|2|||
145254232|NCT03344562|523774075|FG001|Overall Study|Withdrawal by Subject|0|||
145254233|NCT02736474|523774076|FG000|Overall Study|Lost to Follow-up|0|||
145254234|NCT02736474|523774077|FG001|Overall Study|Lost to Follow-up|1|||
145254235|NCT02463331|523774078|FG000|Overall Study|Adverse Event|4|||
145254236|NCT02463331|523774079|FG001|Overall Study|Adverse Event|2|||
145254237|NCT02463331|523774078|FG000|Overall Study|Lost to Follow-up|1|||
145254238|NCT02463331|523774079|FG001|Overall Study|Lost to Follow-up|1|||
145254239|NCT02463331|523774078|FG000|Overall Study|Pregnancy|2|||
145254240|NCT02463331|523774079|FG001|Overall Study|Pregnancy|3|||
145254241|NCT02463331|523774078|FG000|Overall Study|Lack of Efficacy|6|||
145254242|NCT02463331|523774079|FG001|Overall Study|Lack of Efficacy|0|||
145254243|NCT02463331|523774078|FG000|Overall Study|Physician Decision|3|||
145254244|NCT02463331|523774079|FG001|Overall Study|Physician Decision|0|||
145254245|NCT02382276|523774080|FG000|Overall Study|Withdrawal by Subject|4|||
145254246|NCT02382276|523774081|FG001|Overall Study|Withdrawal by Subject|8|||
145254247|NCT02382276|523774082|FG002|Overall Study|Withdrawal by Subject|5|||
145254248|NCT02382276|523774080|FG000|Overall Study|Adverse Event|7|||
145254249|NCT02382276|523774081|FG001|Overall Study|Adverse Event|2|||
145254250|NCT02382276|523774082|FG002|Overall Study|Adverse Event|32|||
145254251|NCT02382276|523774080|FG000|Overall Study|Physician Decision|0|||
145254252|NCT02382276|523774081|FG001|Overall Study|Physician Decision|0|||
145254253|NCT02382276|523774082|FG002|Overall Study|Physician Decision|2|||
145254254|NCT04191096|523774087|FG000|Overall Study|Death|102|||
145254255|NCT04191096|523774088|FG001|Overall Study|Death|89|||
145254256|NCT04191096|523774087|FG000|Overall Study|Lost to Follow-up|1|||
145254257|NCT04191096|523774088|FG001|Overall Study|Lost to Follow-up|1|||
145254258|NCT04191096|523774087|FG000|Overall Study|Withdrawal by Subject|5|||
145254259|NCT04191096|523774088|FG001|Overall Study|Withdrawal by Subject|5|||
145254260|NCT04191096|523774087|FG000|Overall Study|Participants Ongoing|518|||
145254261|NCT04191096|523774088|FG001|Overall Study|Participants Ongoing|530|||
145254262|NCT01465958|523775403|FG000|Run-in Phase|Protocol Violation|1|||
145254263|NCT01465958|523775404|FG001|Run-in Phase|Protocol Violation|0|||
145254264|NCT01465958|523775403|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
145254265|NCT01465958|523775404|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
145254266|NCT03818399|523775408|FG000|Overall Study|Lost to Follow-up|11|||
145254267|NCT03818399|523775408|FG000|Overall Study|Withdrawal by Subject|1|||
145254268|NCT03818399|523775408|FG000|Overall Study|Protocol Violation|2|||
145254269|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
145254270|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
145254271|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
145254272|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
145254273|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Death|38|||
145254274|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Death|10|||
145254275|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
145254276|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
145254277|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
145254278|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
145254279|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
145254280|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
145254281|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
145254282|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
145254283|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
145254284|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
145254285|NCT02421939|523775409|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
145254286|NCT02421939|523775410|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
145254287|NCT02421939|523775409|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
145254288|NCT02421939|523775410|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
145254289|NCT02421939|523775409|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
145254290|NCT02421939|523775410|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
145410506|NCT00817063|524356800|FG000|Overall Study|Violation of Selection at Entry|7|||
145410507|NCT00817063|524356801|FG001|Overall Study|Violation of Selection at Entry|4|||
145410508|NCT00817063|524356800|FG000|Overall Study|Protocol Violation|3|||
145410509|NCT00817063|524356801|FG001|Overall Study|Protocol Violation|8|||
145410510|NCT00817063|524356800|FG000|Overall Study|Withdrawal by Subject|17|||
145410511|NCT00817063|524356801|FG001|Overall Study|Withdrawal by Subject|37|||
145410512|NCT00817063|524356800|FG000|Overall Study|Early Improvement|19|||
145410513|NCT00817063|524356801|FG001|Overall Study|Early Improvement|4|||
145410514|NCT00817063|524356800|FG000|Overall Study|Administrative|10|||
145410515|NCT00817063|524356801|FG001|Overall Study|Administrative|4|||
145410516|NCT00817063|524356800|FG000|Overall Study|Abnormality of Laboratory Test|2|||
145410517|NCT00817063|524356801|FG001|Overall Study|Abnormality of Laboratory Test|1|||
145410518|NCT01496456|524356802|FG000|Overall Study|Protocol Violation|1|||
145410519|NCT01496456|524356802|FG000|Overall Study|Lost to Follow-up|7|||
145410520|NCT04919161|524356803|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
145410521|NCT04919161|524356804|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
145410522|NCT04919161|524356803|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
145410523|NCT04919161|524356804|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
145410524|NCT04919161|524356803|FG000|Overall Study|Acute ankle sprain after session 1|0|||
145410525|NCT04919161|524356804|FG001|Overall Study|Acute ankle sprain after session 1|1|||
145410526|NCT02489773|524356805|FG000|Overall Study|Lost to Follow-up|4|||
145410527|NCT02489773|524356806|FG001|Overall Study|Lost to Follow-up|1|||
145410528|NCT02489773|524356805|FG000|Overall Study|Physician Decision|1|||
145410529|NCT02489773|524356806|FG001|Overall Study|Physician Decision|0|||
145410530|NCT02489773|524356805|FG000|Overall Study|Withdrawal by Subject|1|||
145410531|NCT02489773|524356806|FG001|Overall Study|Withdrawal by Subject|0|||
145410532|NCT02489773|524356805|FG000|Overall Study|Leave the country or the state|1|||
145410533|NCT02489773|524356806|FG001|Overall Study|Leave the country or the state|1|||
145410534|NCT00712920|524356807|FG000|Overall Study|Adverse Event|3|||
145410535|NCT00712920|524356808|FG001|Overall Study|Adverse Event|4|||
145410536|NCT00712920|524356809|FG002|Overall Study|Adverse Event|7|||
145254291|NCT02421939|523775409|FG000|Long Term Follow up: up to 3 Years|Death|118|||
145254292|NCT02421939|523775410|FG001|Long Term Follow up: up to 3 Years|Death|65|||
145254293|NCT02421939|523775409|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
145254294|NCT02421939|523775410|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
145254295|NCT01685372|523775411|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
145254296|NCT01685372|523775412|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
145254297|NCT00103207|523775413|FG000|Overall Study|Adverse Event|3|||
145410537|NCT00712920|524356807|FG000|Overall Study|Withdrawal by Subject|4|||
145254298|NCT00103207|523775413|FG000|Overall Study|Death|1|||
145254299|NCT00103207|523775413|FG000|Overall Study|Withdrawal by Subject|2|||
145410538|NCT00712920|524356808|FG001|Overall Study|Withdrawal by Subject|2|||
145410539|NCT00712920|524356809|FG002|Overall Study|Withdrawal by Subject|1|||
145410540|NCT00712920|524356807|FG000|Overall Study|Lost to Follow-up|1|||
145410541|NCT00712920|524356808|FG001|Overall Study|Lost to Follow-up|4|||
145254300|NCT00103207|523775413|FG000|Overall Study|Other complicating disease|1|||
145254301|NCT00103207|523775413|FG000|Overall Study|Ineligible|4|||
145254302|NCT00103207|523775413|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
145254303|NCT00129376|523775414|FG000|Overall Study|Adverse Event|1|||
145254304|NCT00129376|523775414|FG000|Overall Study|Lack of Efficacy|1|||
145254305|NCT02061540|523775415|FG000|Overall Study|Adverse Event|2|||
145254306|NCT02061540|523775415|FG000|Overall Study|Withdrawal by Subject|2|||
145254307|NCT02561273|523775422|FG000|Overall Study|Protocol Violation|1|||
145254308|NCT02561273|523775423|FG001|Overall Study|Protocol Violation|0|||
145254309|NCT02718625|523775425|FG000|Overall Study|Adverse Event|0|||
145254310|NCT02718625|523775426|FG001|Overall Study|Adverse Event|1|||
145254311|NCT02718625|523775425|FG000|Overall Study|Termination of Study by Sponsor|0|||
145254312|NCT02718625|523775426|FG001|Overall Study|Termination of Study by Sponsor|1|||
145254313|NCT00811395|523775427|FG000|Extension Treatment|Adverse Event|1|||
145254314|NCT00811395|523775428|FG001|Extension Treatment|Adverse Event|2|||
145254315|NCT00811395|523775429|FG002|Extension Treatment|Adverse Event|2|||
145254316|NCT00811395|523775430|FG003|Extension Treatment|Adverse Event|2|||
145254317|NCT00811395|523775431|FG004|Extension Treatment|Adverse Event|0|||
145254318|NCT00811395|523775432|FG005|Extension Treatment|Adverse Event|1|||
145254319|NCT00811395|523775427|FG000|Extension Treatment|Progressive disease|1|||
145254320|NCT00811395|523775428|FG001|Extension Treatment|Progressive disease|1|||
145254321|NCT00811395|523775429|FG002|Extension Treatment|Progressive disease|0|||
145254322|NCT00811395|523775430|FG003|Extension Treatment|Progressive disease|0|||
145254323|NCT00811395|523775431|FG004|Extension Treatment|Progressive disease|0|||
145254324|NCT00811395|523775432|FG005|Extension Treatment|Progressive disease|0|||
145254325|NCT00811395|523775427|FG000|Extension Treatment|Participant did not wish to continue|0|||
145254326|NCT00811395|523775428|FG001|Extension Treatment|Participant did not wish to continue|3|||
145254327|NCT00811395|523775429|FG002|Extension Treatment|Participant did not wish to continue|0|||
145254328|NCT00811395|523775430|FG003|Extension Treatment|Participant did not wish to continue|1|||
145254329|NCT00811395|523775431|FG004|Extension Treatment|Participant did not wish to continue|0|||
145254330|NCT00811395|523775432|FG005|Extension Treatment|Participant did not wish to continue|1|||
145254331|NCT00811395|523775427|FG000|Extension Treatment|Other than above|0|||
145254332|NCT00811395|523775428|FG001|Extension Treatment|Other than above|0|||
145254333|NCT00811395|523775429|FG002|Extension Treatment|Other than above|1|||
145254334|NCT00811395|523775430|FG003|Extension Treatment|Other than above|0|||
145254335|NCT00811395|523775431|FG004|Extension Treatment|Other than above|0|||
145254336|NCT00811395|523775432|FG005|Extension Treatment|Other than above|0|||
145254337|NCT01562327|523775437|FG000|Overall Study|Adverse Event|2|||
145254338|NCT01562327|523775437|FG000|Overall Study|Lack of Efficacy|1|||
145254339|NCT01562327|523775437|FG000|Overall Study|Participant drop-out|1|||
145254340|NCT01562327|523775437|FG000|Overall Study|Infusion not received at 6 month window|4|||
145254341|NCT01947127|523775438|FG000|Overall Study|Protocol Violation|18|||
145300166|NCT02098876|523951540|FG000|Overall Study|Withdrawal by Subject|5|||
145300167|NCT02098876|523951541|FG001|Overall Study|Withdrawal by Subject|5|||
145300168|NCT01602419|523951544|FG000|Overall Study|Not treated with Wilate|9|||
145300169|NCT01602419|523951544|FG000|Overall Study|Adverse Drug Reaction|4|||
145300170|NCT01602419|523951544|FG000|Overall Study|Insurance issues|3|||
145300171|NCT01602419|523951544|FG000|Overall Study|Changed treatment centre|1|||
145300172|NCT01602419|523951544|FG000|Overall Study|Treatment centre closed|1|||
145300173|NCT01602419|523951544|FG000|Overall Study|Withdrawal by Subject|5|||
145300174|NCT01602419|523951544|FG000|Overall Study|Lost to Follow-up|6|||
145300175|NCT01792635|523951545|FG000|Part B|Adverse Event|0|||
145300176|NCT01792635|523951546|FG001|Part B|Adverse Event|0|||
145300177|NCT01792635|523951547|FG002|Part B|Adverse Event|1|||
145300178|NCT01792635|523951545|FG000|Part B|Study terminated|0|||
145300179|NCT01792635|523951546|FG001|Part B|Study terminated|4|||
145300180|NCT01792635|523951547|FG002|Part B|Study terminated|3|||
145300181|NCT03956862|523951551|FG000|Overall Study|Lost to Follow-up|1|||
145300182|NCT03956862|523951552|FG001|Overall Study|Lost to Follow-up|1|||
145300183|NCT03956862|523951551|FG000|Overall Study|Withdrawal by Subject|1|||
145254342|NCT01947127|523775439|FG001|Overall Study|Protocol Violation|38|||
145254343|NCT01947127|523775438|FG000|Overall Study|Withdrawal by Subject|1|||
145254344|NCT01947127|523775439|FG001|Overall Study|Withdrawal by Subject|1|||
145254345|NCT01947127|523775438|FG000|Overall Study|Data loss|4|||
145254346|NCT01947127|523775439|FG001|Overall Study|Data loss|4|||
145254347|NCT00170846|523775440|FG000|Overall Study|Subject withdrew Informed Consent|5|||
145254348|NCT00170846|523775441|FG001|Overall Study|Subject withdrew Informed Consent|12|||
145254349|NCT00170846|523775442|FG002|Overall Study|Subject withdrew Informed Consent|8|||
145254350|NCT00170846|523775440|FG000|Overall Study|Lost to Follow-up|6|||
145254351|NCT00170846|523775441|FG001|Overall Study|Lost to Follow-up|3|||
145254352|NCT00170846|523775442|FG002|Overall Study|Lost to Follow-up|2|||
145254353|NCT00170846|523775440|FG000|Overall Study|Death|0|||
145254354|NCT00170846|523775441|FG001|Overall Study|Death|3|||
145300184|NCT03956862|523951552|FG001|Overall Study|Withdrawal by Subject|1|||
145300185|NCT02714062|523951553|FG000|Overall Study|Adverse Event|0|||
145300186|NCT02714062|523951554|FG001|Overall Study|Adverse Event|0|||
145300187|NCT02714062|523951555|FG002|Overall Study|Adverse Event|2|||
145410542|NCT00712920|524356809|FG002|Overall Study|Lost to Follow-up|0|||
145410543|NCT00712920|524356807|FG000|Overall Study|Lack of Efficacy|1|||
145410544|NCT00712920|524356808|FG001|Overall Study|Lack of Efficacy|0|||
145410545|NCT00712920|524356809|FG002|Overall Study|Lack of Efficacy|1|||
145410546|NCT00712920|524356807|FG000|Overall Study|Other|5|||
145410547|NCT00712920|524356808|FG001|Overall Study|Other|7|||
145410548|NCT00712920|524356809|FG002|Overall Study|Other|3|||
145410549|NCT00712920|524356807|FG000|Overall Study|Non-compliance|3|||
145566680|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
145566681|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
145566682|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
145566683|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
145254355|NCT00170846|523775442|FG002|Overall Study|Death|3|||
145254356|NCT00170846|523775440|FG000|Overall Study|Reason Missing|0|||
145254357|NCT00170846|523775441|FG001|Overall Study|Reason Missing|1|||
145254358|NCT00170846|523775442|FG002|Overall Study|Reason Missing|0|||
145254359|NCT00528840|523775445|FG000|Overall Study|Lost to Follow-up|10|||
145254360|NCT00528840|523775445|FG000|Overall Study|Adverse Event|1|||
145254361|NCT00528840|523775445|FG000|Overall Study|Withdrawal by Subject|17|||
145254362|NCT00528840|523775445|FG000|Overall Study|Death|2|||
145254363|NCT00528840|523775445|FG000|Overall Study|Administrative Reasons|1|||
145254364|NCT00528840|523775445|FG000|Overall Study|Other|2|||
145254365|NCT01603628|523775452|FG000|Overall Study|Personal Reasons|1|||
145254366|NCT01603628|523775453|FG001|Overall Study|Personal Reasons|1|||
145254367|NCT01603628|523775454|FG002|Overall Study|Personal Reasons|2|||
145254368|NCT01603628|523775452|FG000|Overall Study|Protocol Violation|1|||
145254369|NCT01603628|523775453|FG001|Overall Study|Protocol Violation|1|||
145254370|NCT01603628|523775454|FG002|Overall Study|Protocol Violation|0|||
145566684|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
145566685|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
145254371|NCT01603628|523775452|FG000|Overall Study|Lost to Follow-up|0|||
145254372|NCT01603628|523775453|FG001|Overall Study|Lost to Follow-up|1|||
145254373|NCT01603628|523775454|FG002|Overall Study|Lost to Follow-up|0|||
145254374|NCT01603628|523775452|FG000|Overall Study|Other Miscellaneous Reason|1|||
145254375|NCT01603628|523775453|FG001|Overall Study|Other Miscellaneous Reason|0|||
145254376|NCT01603628|523775454|FG002|Overall Study|Other Miscellaneous Reason|0|||
145254377|NCT01969565|523775455|FG000|Overall Study|Withdrawal by Subject|1|||
145254378|NCT01756833|523775461|FG000|Overall Study|Withdrawal by Subject|4|||
145254379|NCT01756833|523775462|FG001|Overall Study|Withdrawal by Subject|3|||
145254380|NCT02795182|523775466|FG000|Overall Study|Death|5|||
145254381|NCT02795182|523775467|FG001|Overall Study|Death|4|||
145254382|NCT02795182|523775468|FG002|Overall Study|Death|4|||
145254383|NCT02795182|523775469|FG003|Overall Study|Death|18|||
145254384|NCT02795182|523775466|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
145254385|NCT02795182|523775467|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
145254386|NCT02795182|523775468|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
145254387|NCT02795182|523775469|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
145254388|NCT02795182|523775466|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
145254389|NCT02795182|523775467|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
145254390|NCT02795182|523775468|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
145254391|NCT02795182|523775469|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
145254392|NCT02795182|523775466|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
145254393|NCT02795182|523775467|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
145254394|NCT02795182|523775468|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
145254395|NCT02795182|523775469|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
145566686|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
145566687|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
145566688|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
145254396|NCT02795182|523775466|FG000|Overall Study|Withdrawal by Subject|4|||
145254397|NCT02795182|523775467|FG001|Overall Study|Withdrawal by Subject|0|||
145254398|NCT02795182|523775468|FG002|Overall Study|Withdrawal by Subject|0|||
145254399|NCT02795182|523775469|FG003|Overall Study|Withdrawal by Subject|3|||
145254400|NCT02795182|523775466|FG000|Overall Study|Lost to Follow-up|0|||
145254401|NCT02795182|523775467|FG001|Overall Study|Lost to Follow-up|0|||
145254402|NCT02795182|523775468|FG002|Overall Study|Lost to Follow-up|1|||
145410550|NCT00712920|524356808|FG001|Overall Study|Non-compliance|0|||
145566689|NCT01604343|524936189|FG000|Prior to W52 Administration(Through W52)|Other|15|||
145254403|NCT02795182|523775469|FG003|Overall Study|Lost to Follow-up|1|||
145254404|NCT02795182|523775466|FG000|Overall Study|Roll Over to Long Term Extension|3|||
145254405|NCT02795182|523775467|FG001|Overall Study|Roll Over to Long Term Extension|3|||
145254406|NCT02795182|523775468|FG002|Overall Study|Roll Over to Long Term Extension|2|||
145410551|NCT00712920|524356809|FG002|Overall Study|Non-compliance|0|||
145566690|NCT01604343|524936190|FG001|Prior to W52 Administration(Through W52)|Other|0|||
145566691|NCT01604343|524936191|FG002|Prior to W52 Administration(Through W52)|Other|10|||
145566692|NCT01604343|524936192|FG003|Prior to W52 Administration(Through W52)|Other|0|||
145566693|NCT01604343|524936193|FG004|Prior to W52 Administration(Through W52)|Other|6|||
145566694|NCT01604343|524936189|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
145566695|NCT01604343|524936190|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
145566696|NCT01604343|524936191|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
145254407|NCT02795182|523775469|FG003|Overall Study|Roll Over to Long Term Extension|5|||
145254408|NCT02795182|523775466|FG000|Overall Study|Progressive Disease|0|||
145254409|NCT02795182|523775467|FG001|Overall Study|Progressive Disease|1|||
145254410|NCT02795182|523775468|FG002|Overall Study|Progressive Disease|0|||
145254411|NCT02795182|523775469|FG003|Overall Study|Progressive Disease|4|||
145254412|NCT02795182|523775466|FG000|Overall Study|Physician Decision|0|||
145254413|NCT02795182|523775467|FG001|Overall Study|Physician Decision|0|||
145254414|NCT02795182|523775468|FG002|Overall Study|Physician Decision|0|||
145254415|NCT02795182|523775469|FG003|Overall Study|Physician Decision|1|||
145254416|NCT00398086|523775472|FG000|Overall Study|Unacceptable Toxicity|2|||
145254417|NCT00398086|523775473|FG001|Overall Study|Unacceptable Toxicity|8|||
145254418|NCT00398086|523775474|FG002|Overall Study|Unacceptable Toxicity|2|||
145254419|NCT00398086|523775472|FG000|Overall Study|Adverse Event|1|||
145254420|NCT00398086|523775473|FG001|Overall Study|Adverse Event|4|||
145254421|NCT00398086|523775474|FG002|Overall Study|Adverse Event|0|||
145254422|NCT00398086|523775472|FG000|Overall Study|Physician Decision|1|||
145254423|NCT00398086|523775473|FG001|Overall Study|Physician Decision|4|||
145254424|NCT00398086|523775474|FG002|Overall Study|Physician Decision|0|||
145254425|NCT00398086|523775472|FG000|Overall Study|Withdrawal by Subject|5|||
145254426|NCT00398086|523775473|FG001|Overall Study|Withdrawal by Subject|7|||
145254427|NCT00398086|523775474|FG002|Overall Study|Withdrawal by Subject|0|||
145254428|NCT00696774|523775475|FG000|Period II|Adverse Event|0|||
145254429|NCT00696774|523775476|FG001|Period II|Adverse Event|0|||
145254430|NCT00696774|523775477|FG002|Period II|Adverse Event|15|||
145254431|NCT00696774|523775475|FG000|Period II|Lost to Follow-up|0|||
145254432|NCT00696774|523775476|FG001|Period II|Lost to Follow-up|0|||
145254433|NCT00696774|523775477|FG002|Period II|Lost to Follow-up|4|||
145254434|NCT00696774|523775475|FG000|Period II|Protocol Violation|0|||
145254435|NCT00696774|523775476|FG001|Period II|Protocol Violation|0|||
145254436|NCT00696774|523775477|FG002|Period II|Protocol Violation|11|||
145254437|NCT00696774|523775475|FG000|Period II|Withdrawal by Subject|0|||
145254438|NCT00696774|523775476|FG001|Period II|Withdrawal by Subject|0|||
145254439|NCT00696774|523775477|FG002|Period II|Withdrawal by Subject|4|||
145254440|NCT00696774|523775475|FG000|Period II|Sponsor Decision|0|||
145254441|NCT00696774|523775476|FG001|Period II|Sponsor Decision|0|||
145254442|NCT00696774|523775477|FG002|Period II|Sponsor Decision|0|||
145254443|NCT00696774|523775475|FG000|Period II|Lack of Efficacy|0|||
145254444|NCT00696774|523775476|FG001|Period II|Lack of Efficacy|0|||
145254445|NCT00696774|523775477|FG002|Period II|Lack of Efficacy|2|||
145254446|NCT00696774|523775475|FG000|Period III|Adverse Event|1|||
145254447|NCT00696774|523775476|FG001|Period III|Adverse Event|1|||
145254448|NCT00696774|523775477|FG002|Period III|Adverse Event|0|||
145254449|NCT00696774|523775475|FG000|Period III|Lost to Follow-up|2|||
145254450|NCT00696774|523775476|FG001|Period III|Lost to Follow-up|1|||
145254451|NCT00696774|523775477|FG002|Period III|Lost to Follow-up|0|||
145254452|NCT00696774|523775475|FG000|Period III|Protocol Violation|1|||
145254453|NCT00696774|523775476|FG001|Period III|Protocol Violation|1|||
145254454|NCT00696774|523775477|FG002|Period III|Protocol Violation|0|||
145254455|NCT00696774|523775475|FG000|Period III|Withdrawal by Subject|1|||
145254456|NCT00696774|523775476|FG001|Period III|Withdrawal by Subject|2|||
145254457|NCT00696774|523775477|FG002|Period III|Withdrawal by Subject|0|||
145254458|NCT00696774|523775475|FG000|Period III|Sponsor Decision|2|||
145254459|NCT00696774|523775476|FG001|Period III|Sponsor Decision|0|||
145254460|NCT00696774|523775477|FG002|Period III|Sponsor Decision|0|||
145254461|NCT00696774|523775475|FG000|Period III|Lack of Efficacy|0|||
145254462|NCT00696774|523775476|FG001|Period III|Lack of Efficacy|2|||
145254463|NCT00696774|523775477|FG002|Period III|Lack of Efficacy|0|||
145254464|NCT02087241|523775478|FG000|Overall Study|Death|2|||
145254465|NCT02087241|523775479|FG001|Overall Study|Death|1|||
145254466|NCT02087241|523775480|FG002|Overall Study|Death|1|||
145254467|NCT02087241|523775481|FG003|Overall Study|Death|1|||
145254468|NCT02087241|523775478|FG000|Overall Study|Withdrawal by Subject|1|||
145254469|NCT02087241|523775479|FG001|Overall Study|Withdrawal by Subject|0|||
145254470|NCT02087241|523775480|FG002|Overall Study|Withdrawal by Subject|0|||
145254471|NCT02087241|523775481|FG003|Overall Study|Withdrawal by Subject|1|||
145254472|NCT02087241|523775478|FG000|Overall Study|Progressive Disease|0|||
145254473|NCT02087241|523775479|FG001|Overall Study|Progressive Disease|0|||
145254474|NCT02087241|523775480|FG002|Overall Study|Progressive Disease|0|||
145254475|NCT02087241|523775481|FG003|Overall Study|Progressive Disease|1|||
145254476|NCT02087241|523775478|FG000|Overall Study|Study Terminated by Sponsor|0|||
145254477|NCT02087241|523775479|FG001|Overall Study|Study Terminated by Sponsor|2|||
145254478|NCT02087241|523775480|FG002|Overall Study|Study Terminated by Sponsor|0|||
145254479|NCT02087241|523775481|FG003|Overall Study|Study Terminated by Sponsor|4|||
145254480|NCT02181504|523775482|FG000|Overall Study|Adverse Event|1|||
145254481|NCT02181504|523775483|FG001|Overall Study|Adverse Event|1|||
145254482|NCT02181504|523775484|FG002|Overall Study|Adverse Event|1|||
145254483|NCT00461552|523775487|FG000|Overall Study|Drug Dispensing error|0|||
145254484|NCT00461552|523775488|FG001|Overall Study|Drug Dispensing error|2|||
145254485|NCT01289028|523775489|FG000|Overall Study|Progressive Disease|49|||
145254486|NCT01289028|523775489|FG000|Overall Study|Adverse Event|14|||
145254487|NCT01289028|523775489|FG000|Overall Study|Withdrawal by Subject|6|||
145254488|NCT01289028|523775489|FG000|Overall Study|Death|4|||
145254489|NCT01289028|523775489|FG000|Overall Study|Lack of Efficacy|2|||
145254490|NCT01289028|523775489|FG000|Overall Study|No longer required|2|||
145300188|NCT02714062|523951553|FG000|Overall Study|Withdrawal by Subject|1|||
145300189|NCT02714062|523951554|FG001|Overall Study|Withdrawal by Subject|0|||
145300190|NCT02714062|523951555|FG002|Overall Study|Withdrawal by Subject|1|||
145300191|NCT02714062|523951553|FG000|Overall Study|Protocol Violation|0|||
145300192|NCT02714062|523951554|FG001|Overall Study|Protocol Violation|1|||
145300193|NCT02714062|523951555|FG002|Overall Study|Protocol Violation|0|||
145300194|NCT00850174|523951558|FG000|Washout: One Week|Withdrawal by Subject|0|||
145300195|NCT00850174|523951559|FG001|Washout: One Week|Withdrawal by Subject|2|||
145300196|NCT00850174|523951558|FG000|Second Intervention|Withdrawal by Subject|1|||
145300197|NCT00850174|523951559|FG001|Second Intervention|Withdrawal by Subject|0|||
145300198|NCT01363765|523951562|FG000|Overall Study|non-diagnostic|2621|||
145300199|NCT01363765|523951563|FG001|Overall Study|non-diagnostic|1124|||
145300200|NCT01363765|523951562|FG000|Overall Study|duplicate records|736|||
145300201|NCT01363765|523951563|FG001|Overall Study|duplicate records|3177|||
145300202|NCT01363765|523951562|FG000|Overall Study|non-resident|156|||
145300203|NCT01363765|523951563|FG001|Overall Study|non-resident|76|||
145300204|NCT01363765|523951562|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
145300205|NCT01363765|523951563|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
145300206|NCT01363765|523951562|FG000|Overall Study|smear during intervention|2170|||
145300207|NCT01363765|523951563|FG001|Overall Study|smear during intervention|0|||
145300208|NCT02682784|523951571|FG000|Overall Study|Withdrawal by Subject|0|||
145300209|NCT02682784|523951572|FG001|Overall Study|Withdrawal by Subject|2|||
145300210|NCT02682784|523951573|FG002|Overall Study|Withdrawal by Subject|1|||
145300211|NCT02682784|523951574|FG003|Overall Study|Withdrawal by Subject|2|||
145300212|NCT02682784|523951571|FG000|Overall Study|Physician Decision|1|||
145300213|NCT02682784|523951572|FG001|Overall Study|Physician Decision|0|||
145300214|NCT02682784|523951573|FG002|Overall Study|Physician Decision|1|||
145300215|NCT02682784|523951574|FG003|Overall Study|Physician Decision|1|||
145300216|NCT01702987|523951575|FG000|Overall Study|Withdrawal by Subject|1|||
145300217|NCT01702987|523951576|FG001|Overall Study|Withdrawal by Subject|0|||
145300218|NCT02017223|523951577|FG000|Overall Study|Algorithm problems|2|||
145300219|NCT00365846|523951582|FG000|Overall Study|Lost to Follow-up|1|||
145300220|NCT04263649|523951588|FG000|Overall Study|Adverse Event|53|||
145300221|NCT04263649|523951588|FG000|Overall Study|Lost to Follow-up|3|||
145300222|NCT04263649|523951588|FG000|Overall Study|Death|29|||
145300223|NCT04263649|523951588|FG000|Overall Study|Device deficiency|19|||
145300224|NCT04263649|523951588|FG000|Overall Study|other reasons|11|||
145300225|NCT02057458|523951589|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
145300226|NCT02057458|523951590|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
145300227|NCT02057458|523951591|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
145300228|NCT02057458|523951589|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
145300229|NCT02057458|523951590|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
145300230|NCT02057458|523951591|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
145300231|NCT02057458|523951589|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
145300232|NCT02057458|523951590|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
145300233|NCT02057458|523951591|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
145410552|NCT02696616|524356811|FG000|Overall Study|Adverse Event|0|||
145410553|NCT02696616|524356812|FG001|Overall Study|Adverse Event|1|||
145410554|NCT02696616|524356813|FG002|Overall Study|Adverse Event|0|||
145410555|NCT02696616|524356814|FG003|Overall Study|Adverse Event|0|||
145410556|NCT02696616|524356815|FG004|Overall Study|Adverse Event|0|||
145410557|NCT02696616|524356816|FG005|Overall Study|Adverse Event|0|||
145254491|NCT01289028|523775489|FG000|Overall Study|Lost to Follow-up|2|||
145254492|NCT01289028|523775489|FG000|Overall Study|New Cancer Therapy|2|||
145300234|NCT05169710|523951594|FG000|Overall Study|Adverse Event|1|||
145300235|NCT05169710|523951595|FG001|Overall Study|Adverse Event|2|||
145300236|NCT05169710|523951596|FG002|Overall Study|Adverse Event|2|||
145300237|NCT05169710|523951594|FG000|Overall Study|Lost to Follow-up|0|||
145300238|NCT05169710|523951595|FG001|Overall Study|Lost to Follow-up|0|||
145300239|NCT05169710|523951596|FG002|Overall Study|Lost to Follow-up|1|||
145300240|NCT05169710|523951594|FG000|Overall Study|Withdrawal by Subject|2|||
145300241|NCT05169710|523951595|FG001|Overall Study|Withdrawal by Subject|1|||
145410558|NCT02696616|524356817|FG006|Overall Study|Adverse Event|0|||
145254493|NCT01289028|523775489|FG000|Overall Study|Abnormal Lab Value|1|||
145254494|NCT01289028|523775489|FG000|Overall Study|Missing reason for discon|1|||
145254495|NCT00998985|523775496|FG000|Overall Study|Withdrawal by Subject|0|||
145254496|NCT00998985|523775497|FG001|Overall Study|Withdrawal by Subject|0|||
145254497|NCT00998985|523775498|FG002|Overall Study|Withdrawal by Subject|0|||
145254498|NCT00998985|523775499|FG003|Overall Study|Withdrawal by Subject|0|||
145254499|NCT00998985|523775500|FG004|Overall Study|Withdrawal by Subject|0|||
145254500|NCT00998985|523775501|FG005|Overall Study|Withdrawal by Subject|0|||
145254501|NCT00998985|523775502|FG006|Overall Study|Withdrawal by Subject|0|||
145254502|NCT00998985|523775503|FG007|Overall Study|Withdrawal by Subject|0|||
145254503|NCT00998985|523775504|FG008|Overall Study|Withdrawal by Subject|1|||
145254504|NCT00998985|523775505|FG009|Overall Study|Withdrawal by Subject|0|||
145254505|NCT00998985|523775506|FG010|Overall Study|Withdrawal by Subject|0|||
145254506|NCT00998985|523775507|FG011|Overall Study|Withdrawal by Subject|0|||
145254507|NCT00998985|523775508|FG012|Overall Study|Withdrawal by Subject|0|||
145254508|NCT00998985|523775509|FG013|Overall Study|Withdrawal by Subject|0|||
145254509|NCT00998985|523775496|FG000|Overall Study|Protocol Violation|0|||
145254510|NCT00998985|523775497|FG001|Overall Study|Protocol Violation|0|||
145254511|NCT00998985|523775498|FG002|Overall Study|Protocol Violation|0|||
145254512|NCT00998985|523775499|FG003|Overall Study|Protocol Violation|0|||
145254513|NCT00998985|523775500|FG004|Overall Study|Protocol Violation|0|||
145254514|NCT00998985|523775501|FG005|Overall Study|Protocol Violation|1|||
145254515|NCT00998985|523775502|FG006|Overall Study|Protocol Violation|0|||
145254516|NCT00998985|523775503|FG007|Overall Study|Protocol Violation|0|||
145254517|NCT00998985|523775504|FG008|Overall Study|Protocol Violation|0|||
145254518|NCT00998985|523775505|FG009|Overall Study|Protocol Violation|0|||
145254519|NCT00998985|523775506|FG010|Overall Study|Protocol Violation|0|||
145254520|NCT00998985|523775507|FG011|Overall Study|Protocol Violation|0|||
145254521|NCT00998985|523775508|FG012|Overall Study|Protocol Violation|0|||
145254522|NCT00998985|523775509|FG013|Overall Study|Protocol Violation|0|||
145254523|NCT01040728|523775511|FG000|Overall Study|Adverse Event|4|||
145254524|NCT01040728|523775512|FG001|Overall Study|Adverse Event|8|||
145254525|NCT01040728|523775513|FG002|Overall Study|Adverse Event|0|||
145254526|NCT01040728|523775514|FG003|Overall Study|Adverse Event|4|||
145254527|NCT01040728|523775511|FG000|Overall Study|Withdrawal by Subject|0|||
145254528|NCT01040728|523775512|FG001|Overall Study|Withdrawal by Subject|1|||
145254529|NCT01040728|523775513|FG002|Overall Study|Withdrawal by Subject|1|||
145254530|NCT01040728|523775514|FG003|Overall Study|Withdrawal by Subject|0|||
145254531|NCT01040728|523775511|FG000|Overall Study|Protocol Violation|0|||
145254532|NCT01040728|523775512|FG001|Overall Study|Protocol Violation|0|||
145254533|NCT01040728|523775513|FG002|Overall Study|Protocol Violation|0|||
145254534|NCT01040728|523775514|FG003|Overall Study|Protocol Violation|1|||
145254535|NCT01040728|523775511|FG000|Overall Study|Lack of Efficacy|0|||
145254536|NCT01040728|523775512|FG001|Overall Study|Lack of Efficacy|1|||
145254537|NCT01040728|523775513|FG002|Overall Study|Lack of Efficacy|0|||
145254538|NCT01040728|523775514|FG003|Overall Study|Lack of Efficacy|1|||
145254539|NCT01040728|523775511|FG000|Overall Study|Other reasons not listed above|0|||
145254540|NCT01040728|523775512|FG001|Overall Study|Other reasons not listed above|1|||
145254541|NCT01040728|523775513|FG002|Overall Study|Other reasons not listed above|0|||
145254542|NCT01040728|523775514|FG003|Overall Study|Other reasons not listed above|0|||
145254543|NCT01012037|523775517|FG000|Overall Study|Adverse Event|0|||
145254544|NCT01012037|523775518|FG001|Overall Study|Adverse Event|8|||
145254545|NCT01012037|523775519|FG002|Overall Study|Adverse Event|3|||
145254546|NCT01012037|523775517|FG000|Overall Study|Protocol Violation|0|||
145254547|NCT01012037|523775518|FG001|Overall Study|Protocol Violation|3|||
145254548|NCT01012037|523775519|FG002|Overall Study|Protocol Violation|5|||
145254549|NCT01012037|523775517|FG000|Overall Study|Withdrawal by Subject|0|||
145254550|NCT01012037|523775518|FG001|Overall Study|Withdrawal by Subject|4|||
145254551|NCT01012037|523775519|FG002|Overall Study|Withdrawal by Subject|1|||
145254552|NCT01012037|523775517|FG000|Overall Study|Other reason (not specified)|1|||
145254553|NCT01012037|523775518|FG001|Overall Study|Other reason (not specified)|1|||
145254554|NCT01012037|523775519|FG002|Overall Study|Other reason (not specified)|1|||
145254555|NCT02583711|523775520|FG000|Overall Study|Withdrawal by Subject|0|||
145254556|NCT02583711|523775521|FG001|Overall Study|Withdrawal by Subject|10|||
145254557|NCT02583711|523775522|FG002|Overall Study|Withdrawal by Subject|0|||
145254558|NCT00415623|523775526|FG000|Overall Study|Adverse Event|3|||
145254559|NCT00415623|523775527|FG001|Overall Study|Adverse Event|4|||
145254560|NCT00415623|523775526|FG000|Overall Study|Death|1|||
145300242|NCT05169710|523951596|FG002|Overall Study|Withdrawal by Subject|0|||
145300243|NCT05169710|523951594|FG000|Overall Study|Other Study Discontinuation Reason|0|||
145254561|NCT00415623|523775527|FG001|Overall Study|Death|0|||
145254562|NCT00415623|523775526|FG000|Overall Study|Withdrawal by Subject|1|||
145254563|NCT00415623|523775527|FG001|Overall Study|Withdrawal by Subject|1|||
145254564|NCT01369069|523775528|FG000|Overall Study|Lost to Follow-up|8|||
145254565|NCT01369069|523775529|FG001|Overall Study|Lost to Follow-up|9|||
145254566|NCT01369069|523775528|FG000|Overall Study|Withdrawal by Subject|9|||
145254567|NCT01369069|523775529|FG001|Overall Study|Withdrawal by Subject|7|||
145254568|NCT02573012|523775530|FG000|Overall Study|Adverse Event|5|||
145254569|NCT02573012|523775531|FG001|Overall Study|Adverse Event|5|||
145300244|NCT05169710|523951595|FG001|Overall Study|Other Study Discontinuation Reason|2|||
145300245|NCT05169710|523951596|FG002|Overall Study|Other Study Discontinuation Reason|0|||
145254570|NCT02573012|523775530|FG000|Overall Study|Lack of Efficacy|5|||
145254571|NCT02573012|523775531|FG001|Overall Study|Lack of Efficacy|4|||
145254572|NCT02573012|523775530|FG000|Overall Study|Non-compliance|1|||
145254573|NCT02573012|523775531|FG001|Overall Study|Non-compliance|2|||
145254574|NCT02573012|523775530|FG000|Overall Study|Withdrawal by Subject|2|||
145254575|NCT02573012|523775531|FG001|Overall Study|Withdrawal by Subject|2|||
145254576|NCT02573012|523775530|FG000|Overall Study|Study Ended per Protocol|1|||
145254577|NCT02573012|523775531|FG001|Overall Study|Study Ended per Protocol|0|||
145254578|NCT02573012|523775530|FG000|Overall Study|Physician Decision|1|||
145254579|NCT02573012|523775531|FG001|Overall Study|Physician Decision|2|||
145254580|NCT00882362|523775532|FG000|Overall Study|Adverse Event|13|||
145254581|NCT00882362|523775533|FG001|Overall Study|Adverse Event|10|||
145254582|NCT00882362|523775532|FG000|Overall Study|Withdrawal by Subject|13|||
145254583|NCT00882362|523775533|FG001|Overall Study|Withdrawal by Subject|10|||
145254584|NCT00882362|523775532|FG000|Overall Study|Lack of Efficacy|3|||
145254585|NCT00882362|523775533|FG001|Overall Study|Lack of Efficacy|0|||
145254586|NCT00882362|523775532|FG000|Overall Study|Protocol Violation|7|||
145254587|NCT00882362|523775533|FG001|Overall Study|Protocol Violation|2|||
145254588|NCT00882362|523775532|FG000|Overall Study|Pregnancy|1|||
145254589|NCT00882362|523775533|FG001|Overall Study|Pregnancy|0|||
145254590|NCT00882362|523775532|FG000|Overall Study|Physician Decision|5|||
145254591|NCT00882362|523775533|FG001|Overall Study|Physician Decision|1|||
145254592|NCT00882362|523775532|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
145254593|NCT00882362|523775533|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
145254594|NCT00882362|523775532|FG000|Overall Study|change of residence or other commitments|5|||
145254595|NCT00882362|523775533|FG001|Overall Study|change of residence or other commitments|0|||
145254596|NCT02096471|523775534|FG000|Overall Study|Adverse Event|1|||
145254597|NCT02096471|523775534|FG000|Overall Study|Lack of Efficacy|7|||
145254598|NCT02096471|523775534|FG000|Overall Study|Withdrawal by Subject|3|||
145254599|NCT02096471|523775534|FG000|Overall Study|Non-Compliant|2|||
145254600|NCT01809327|523775535|FG000|Overall Study|Lost to Follow-up|5|||
145254601|NCT01809327|523775536|FG001|Overall Study|Lost to Follow-up|2|||
145254602|NCT01809327|523775537|FG002|Overall Study|Lost to Follow-up|4|||
145254603|NCT01809327|523775538|FG003|Overall Study|Lost to Follow-up|2|||
145254604|NCT01809327|523775539|FG004|Overall Study|Lost to Follow-up|3|||
145254605|NCT01809327|523775535|FG000|Overall Study|Withdrawal by Subject|6|||
145254606|NCT01809327|523775536|FG001|Overall Study|Withdrawal by Subject|4|||
145254607|NCT01809327|523775537|FG002|Overall Study|Withdrawal by Subject|4|||
145254608|NCT01809327|523775538|FG003|Overall Study|Withdrawal by Subject|2|||
145254609|NCT01809327|523775539|FG004|Overall Study|Withdrawal by Subject|5|||
145254610|NCT01809327|523775535|FG000|Overall Study|Adverse Event|4|||
145254611|NCT01809327|523775536|FG001|Overall Study|Adverse Event|3|||
145254612|NCT01809327|523775537|FG002|Overall Study|Adverse Event|7|||
145254613|NCT01809327|523775538|FG003|Overall Study|Adverse Event|4|||
145254614|NCT01809327|523775539|FG004|Overall Study|Adverse Event|8|||
145254615|NCT01809327|523775535|FG000|Overall Study|Death|1|||
145254616|NCT01809327|523775536|FG001|Overall Study|Death|0|||
145254617|NCT01809327|523775537|FG002|Overall Study|Death|0|||
145254618|NCT01809327|523775538|FG003|Overall Study|Death|0|||
145254619|NCT01809327|523775539|FG004|Overall Study|Death|0|||
145254620|NCT01809327|523775535|FG000|Overall Study|Protocol Violation|0|||
145254621|NCT01809327|523775536|FG001|Overall Study|Protocol Violation|1|||
145254622|NCT01809327|523775537|FG002|Overall Study|Protocol Violation|0|||
145254623|NCT01809327|523775538|FG003|Overall Study|Protocol Violation|0|||
145254624|NCT01809327|523775539|FG004|Overall Study|Protocol Violation|0|||
145254625|NCT01809327|523775535|FG000|Overall Study|Physician Decision|1|||
145254626|NCT01809327|523775536|FG001|Overall Study|Physician Decision|1|||
145254627|NCT01809327|523775537|FG002|Overall Study|Physician Decision|0|||
145410559|NCT01732783|524356820|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
145410560|NCT01732783|524356821|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
145254628|NCT01809327|523775538|FG003|Overall Study|Physician Decision|0|||
145254629|NCT01809327|523775539|FG004|Overall Study|Physician Decision|0|||
145254630|NCT01809327|523775535|FG000|Overall Study|Pregnancy|1|||
145254631|NCT01809327|523775536|FG001|Overall Study|Pregnancy|0|||
145254632|NCT01809327|523775537|FG002|Overall Study|Pregnancy|0|||
145254633|NCT01809327|523775538|FG003|Overall Study|Pregnancy|0|||
145254634|NCT01809327|523775539|FG004|Overall Study|Pregnancy|0|||
145254635|NCT01809327|523775535|FG000|Overall Study|Other|14|||
145254636|NCT01809327|523775536|FG001|Overall Study|Other|15|||
145254637|NCT01809327|523775537|FG002|Overall Study|Other|7|||
145410561|NCT01732783|524356822|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
145254638|NCT01809327|523775538|FG003|Overall Study|Other|4|||
145254639|NCT01809327|523775539|FG004|Overall Study|Other|9|||
145254640|NCT02545049|523775542|FG000|Overall Study|Withdrawal by Subject|1|||
145254641|NCT02545049|523775543|FG001|Overall Study|Withdrawal by Subject|7|||
145254642|NCT02545049|523775542|FG000|Overall Study|Lost to Follow-up|4|||
145254643|NCT02545049|523775543|FG001|Overall Study|Lost to Follow-up|6|||
145254644|NCT02545049|523775542|FG000|Overall Study|GCP violations|37|||
145254645|NCT02545049|523775543|FG001|Overall Study|GCP violations|48|||
145254646|NCT02985684|523775544|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
145300246|NCT04400890|523951597|FG000|Overall Study|Withdrawal by Subject|3|||
145300247|NCT04400890|523951598|FG001|Overall Study|Withdrawal by Subject|2|||
145300248|NCT02392000|523951609|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
145300249|NCT02392000|523951609|FG000|Overall Study|Withdrawal by Subject|1|||
145300250|NCT02392000|523951609|FG000|Overall Study|Lost to Follow-up|8|||
145300251|NCT04384978|523951610|FG000|Overall Study|Withdrawal by Subject|4|||
145300252|NCT04384978|523951611|FG001|Overall Study|Withdrawal by Subject|0|||
145300253|NCT03197883|523951614|FG000|Overall Study|Adverse Event|1|||
145300254|NCT03197883|523951615|FG001|Overall Study|Adverse Event|1|||
145300255|NCT03197883|523951614|FG000|Overall Study|Lost to Follow-up|1|||
145300256|NCT03197883|523951615|FG001|Overall Study|Lost to Follow-up|0|||
145300257|NCT03197883|523951614|FG000|Overall Study|Protocol Violation|1|||
145300258|NCT03197883|523951615|FG001|Overall Study|Protocol Violation|0|||
145300259|NCT03197883|523951614|FG000|Overall Study|Other (Not Specified)|0|||
145300260|NCT03197883|523951615|FG001|Overall Study|Other (Not Specified)|5|||
145300261|NCT00389064|523951622|FG000|Overall Study|Adverse Event|11|||
145300262|NCT00389064|523951623|FG001|Overall Study|Adverse Event|3|||
145300263|NCT00389064|523951622|FG000|Overall Study|Lack of Efficacy|3|||
145300264|NCT00389064|523951623|FG001|Overall Study|Lack of Efficacy|14|||
145300265|NCT00389064|523951622|FG000|Overall Study|Withdrawal by Subject|17|||
145300266|NCT00389064|523951623|FG001|Overall Study|Withdrawal by Subject|27|||
145300267|NCT00389064|523951622|FG000|Overall Study|Physician Decision|2|||
145300268|NCT00389064|523951623|FG001|Overall Study|Physician Decision|2|||
145300269|NCT00389064|523951622|FG000|Overall Study|Lost to Follow-up|1|||
145300270|NCT00389064|523951623|FG001|Overall Study|Lost to Follow-up|2|||
145300271|NCT00389064|523951622|FG000|Overall Study|Protocol Violation|2|||
145300272|NCT00389064|523951623|FG001|Overall Study|Protocol Violation|0|||
145300273|NCT00389064|523951622|FG000|Overall Study|Multiple Reasons|9|||
145300274|NCT00389064|523951623|FG001|Overall Study|Multiple Reasons|11|||
145300275|NCT03500692|523951628|FG000|Overall Study|Death|163|||
145300276|NCT03500692|523951628|FG000|Overall Study|Lost to Follow-up|75|||
145300277|NCT03500692|523951628|FG000|Overall Study|Termination Reasons|3|||
145300278|NCT04149964|523951629|FG000|Overall Study|Lost to Follow-up|19|||
145300279|NCT04149964|523951630|FG001|Overall Study|Lost to Follow-up|18|||
145300280|NCT03041025|523951637|FG000|Overall Study|Adverse Event|0|||
145300281|NCT03041025|523951638|FG001|Overall Study|Adverse Event|0|||
145410562|NCT01732783|524356820|FG000|Overall Study|Death|13|||
145410563|NCT01732783|524356821|FG001|Overall Study|Death|4|||
145410564|NCT01732783|524356822|FG002|Overall Study|Death|1|||
145410565|NCT01732783|524356820|FG000|Overall Study|Lost to Follow-up|7|||
145410566|NCT01732783|524356821|FG001|Overall Study|Lost to Follow-up|1|||
145410567|NCT01732783|524356822|FG002|Overall Study|Lost to Follow-up|1|||
145410568|NCT01732783|524356820|FG000|Overall Study|Administrative Decision|8|||
145410569|NCT01732783|524356821|FG001|Overall Study|Administrative Decision|2|||
145410570|NCT01732783|524356822|FG002|Overall Study|Administrative Decision|1|||
145410571|NCT01732783|524356820|FG000|Overall Study|Withdrawal by Subject|1|||
145254647|NCT02985684|523775544|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
145254648|NCT02985684|523775544|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
145254649|NCT05158244|523776895|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
145254650|NCT05158244|523776896|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
145254651|NCT05158244|523776897|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
145254652|NCT05158244|523776898|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
145254653|NCT05158244|523776899|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
145254654|NCT05158244|523776895|FG000|Overall Study|Withdrawal by Subject|0|||
145254655|NCT05158244|523776896|FG001|Overall Study|Withdrawal by Subject|0|||
145254656|NCT05158244|523776897|FG002|Overall Study|Withdrawal by Subject|1|||
145410572|NCT01732783|524356821|FG001|Overall Study|Withdrawal by Subject|0|||
145254657|NCT05158244|523776898|FG003|Overall Study|Withdrawal by Subject|0|||
145300282|NCT03041025|523951639|FG002|Overall Study|Adverse Event|1|||
145300283|NCT03041025|523951637|FG000|Overall Study|Lost to Follow-up|1|||
145300284|NCT03041025|523951638|FG001|Overall Study|Lost to Follow-up|0|||
145300285|NCT03041025|523951639|FG002|Overall Study|Lost to Follow-up|0|||
145300286|NCT03041025|523951637|FG000|Overall Study|Withdrawal by Subject|0|||
145410573|NCT01732783|524356822|FG002|Overall Study|Withdrawal by Subject|0|||
145566697|NCT01604343|524936192|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
145300287|NCT03041025|523951638|FG001|Overall Study|Withdrawal by Subject|0|||
145566698|NCT01604343|524936193|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
145300288|NCT03041025|523951639|FG002|Overall Study|Withdrawal by Subject|1|||
145300289|NCT01577381|523951644|FG000|Overall Study|Discontinued|2|||
145410574|NCT01500083|524356823|FG000|Overall Study|Adverse Event|4|||
145566699|NCT01604343|524936189|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
145300290|NCT01577381|523951645|FG001|Overall Study|Discontinued|1|||
145300291|NCT01577381|523951646|FG002|Overall Study|Discontinued|2|||
145300292|NCT01577381|523951647|FG003|Overall Study|Discontinued|2|||
145300293|NCT01577381|523951644|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
145410575|NCT01500083|524356824|FG001|Overall Study|Adverse Event|17|||
145254658|NCT05158244|523776899|FG004|Overall Study|Withdrawal by Subject|0|||
145254659|NCT00141297|523776901|FG000|Overall Study|Adverse Event|0|||
145254660|NCT00141297|523776902|FG001|Overall Study|Adverse Event|0|||
145254661|NCT00141297|523776903|FG002|Overall Study|Adverse Event|1|||
145254662|NCT00141297|523776904|FG003|Overall Study|Adverse Event|0|||
145254663|NCT00141297|523776905|FG004|Overall Study|Adverse Event|1|||
145254664|NCT00141297|523776906|FG005|Overall Study|Adverse Event|1|||
145254665|NCT00141297|523776907|FG006|Overall Study|Adverse Event|0|||
145254666|NCT00141297|523776908|FG007|Overall Study|Adverse Event|1|||
145254667|NCT00141297|523776909|FG008|Overall Study|Adverse Event|1|||
145254668|NCT00141297|523776910|FG009|Overall Study|Adverse Event|0|||
145254669|NCT00141297|523776901|FG000|Overall Study|Death|1|||
145254670|NCT00141297|523776902|FG001|Overall Study|Death|0|||
145254671|NCT00141297|523776903|FG002|Overall Study|Death|0|||
145254672|NCT00141297|523776904|FG003|Overall Study|Death|0|||
145254673|NCT00141297|523776905|FG004|Overall Study|Death|0|||
145254674|NCT00141297|523776906|FG005|Overall Study|Death|0|||
145254675|NCT00141297|523776907|FG006|Overall Study|Death|0|||
145254676|NCT00141297|523776908|FG007|Overall Study|Death|0|||
145254677|NCT00141297|523776909|FG008|Overall Study|Death|1|||
145254678|NCT00141297|523776910|FG009|Overall Study|Death|0|||
145254679|NCT00141297|523776901|FG000|Overall Study|Withdrawal by Subject|0|||
145254680|NCT00141297|523776902|FG001|Overall Study|Withdrawal by Subject|0|||
145254681|NCT00141297|523776903|FG002|Overall Study|Withdrawal by Subject|0|||
145254682|NCT00141297|523776904|FG003|Overall Study|Withdrawal by Subject|0|||
145254683|NCT00141297|523776905|FG004|Overall Study|Withdrawal by Subject|0|||
145254684|NCT00141297|523776906|FG005|Overall Study|Withdrawal by Subject|0|||
145254685|NCT00141297|523776907|FG006|Overall Study|Withdrawal by Subject|0|||
145254686|NCT00141297|523776908|FG007|Overall Study|Withdrawal by Subject|0|||
145254687|NCT00141297|523776909|FG008|Overall Study|Withdrawal by Subject|1|||
145254688|NCT00141297|523776910|FG009|Overall Study|Withdrawal by Subject|0|||
145254689|NCT00141297|523776901|FG000|Overall Study|Other|0|||
145254690|NCT00141297|523776902|FG001|Overall Study|Other|0|||
145254691|NCT00141297|523776903|FG002|Overall Study|Other|0|||
145254692|NCT00141297|523776904|FG003|Overall Study|Other|1|||
145254693|NCT00141297|523776905|FG004|Overall Study|Other|5|||
145254694|NCT00141297|523776906|FG005|Overall Study|Other|0|||
145254695|NCT00141297|523776907|FG006|Overall Study|Other|0|||
145254696|NCT00141297|523776908|FG007|Overall Study|Other|0|||
145254697|NCT00141297|523776909|FG008|Overall Study|Other|2|||
145254698|NCT00141297|523776910|FG009|Overall Study|Other|0|||
145254699|NCT00141297|523776901|FG000|Overall Study|Progressive Disease|2|||
145254700|NCT00141297|523776902|FG001|Overall Study|Progressive Disease|3|||
145254701|NCT00141297|523776903|FG002|Overall Study|Progressive Disease|6|||
145254702|NCT00141297|523776904|FG003|Overall Study|Progressive Disease|2|||
145254703|NCT00141297|523776905|FG004|Overall Study|Progressive Disease|15|||
145254704|NCT00141297|523776906|FG005|Overall Study|Progressive Disease|2|||
145254705|NCT00141297|523776907|FG006|Overall Study|Progressive Disease|3|||
145254706|NCT00141297|523776908|FG007|Overall Study|Progressive Disease|3|||
145254707|NCT00141297|523776909|FG008|Overall Study|Progressive Disease|15|||
145254708|NCT00141297|523776910|FG009|Overall Study|Progressive Disease|6|||
145254709|NCT00141297|523776901|FG000|Overall Study|Transitioned|0|||
145254710|NCT00141297|523776902|FG001|Overall Study|Transitioned|0|||
145254711|NCT00141297|523776903|FG002|Overall Study|Transitioned|0|||
145254712|NCT00141297|523776904|FG003|Overall Study|Transitioned|0|||
145254713|NCT00141297|523776905|FG004|Overall Study|Transitioned|1|||
145254714|NCT00141297|523776906|FG005|Overall Study|Transitioned|0|||
145254715|NCT00141297|523776907|FG006|Overall Study|Transitioned|0|||
145254716|NCT00141297|523776908|FG007|Overall Study|Transitioned|0|||
145254717|NCT00141297|523776909|FG008|Overall Study|Transitioned|0|||
145254718|NCT00141297|523776910|FG009|Overall Study|Transitioned|0|||
145254719|NCT02447952|523776911|FG000|Overall Study|Adverse Event|2|||
145254720|NCT02447952|523776911|FG000|Overall Study|Physician Decision|1|||
145254721|NCT02447952|523776911|FG000|Overall Study|Withdrawal by Subject|4|||
145254722|NCT00808132|523776912|FG000|Overall Study|Adverse Event|34|||
145254723|NCT00808132|523776913|FG001|Overall Study|Adverse Event|33|||
145254724|NCT00808132|523776914|FG002|Overall Study|Adverse Event|16|||
145254725|NCT00808132|523776915|FG003|Overall Study|Adverse Event|31|||
145254726|NCT00808132|523776916|FG004|Overall Study|Adverse Event|33|||
145254727|NCT00808132|523776912|FG000|Overall Study|Death|0|||
145254728|NCT00808132|523776913|FG001|Overall Study|Death|0|||
145254729|NCT00808132|523776914|FG002|Overall Study|Death|0|||
145254730|NCT00808132|523776915|FG003|Overall Study|Death|0|||
145254731|NCT00808132|523776916|FG004|Overall Study|Death|1|||
145254732|NCT00808132|523776912|FG000|Overall Study|Physician Decision|0|||
145254733|NCT00808132|523776913|FG001|Overall Study|Physician Decision|1|||
145254734|NCT00808132|523776914|FG002|Overall Study|Physician Decision|0|||
145566700|NCT01604343|524936190|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
145254735|NCT00808132|523776915|FG003|Overall Study|Physician Decision|0|||
145254736|NCT00808132|523776916|FG004|Overall Study|Physician Decision|0|||
145254737|NCT00808132|523776912|FG000|Overall Study|Lost to Follow-up|8|||
145254738|NCT00808132|523776913|FG001|Overall Study|Lost to Follow-up|10|||
145254739|NCT00808132|523776914|FG002|Overall Study|Lost to Follow-up|11|||
145254740|NCT00808132|523776915|FG003|Overall Study|Lost to Follow-up|8|||
145254741|NCT00808132|523776916|FG004|Overall Study|Lost to Follow-up|9|||
145254742|NCT00808132|523776912|FG000|Overall Study|Protocol Violation|8|||
145254743|NCT00808132|523776913|FG001|Overall Study|Protocol Violation|9|||
145254744|NCT00808132|523776914|FG002|Overall Study|Protocol Violation|4|||
145254745|NCT00808132|523776915|FG003|Overall Study|Protocol Violation|9|||
145254746|NCT00808132|523776916|FG004|Overall Study|Protocol Violation|5|||
145254747|NCT00808132|523776912|FG000|Overall Study|Withdrawal by Subject|27|||
145254748|NCT00808132|523776913|FG001|Overall Study|Withdrawal by Subject|18|||
145254749|NCT00808132|523776914|FG002|Overall Study|Withdrawal by Subject|2|||
145254750|NCT00808132|523776915|FG003|Overall Study|Withdrawal by Subject|7|||
145254751|NCT00808132|523776916|FG004|Overall Study|Withdrawal by Subject|16|||
145254752|NCT00808132|523776912|FG000|Overall Study|Other|6|||
145254753|NCT00808132|523776913|FG001|Overall Study|Other|4|||
145254754|NCT00808132|523776914|FG002|Overall Study|Other|6|||
145254755|NCT00808132|523776915|FG003|Overall Study|Other|2|||
145254756|NCT00808132|523776916|FG004|Overall Study|Other|15|||
145254757|NCT00808132|523776912|FG000|Overall Study|Randomized, but not treated|10|||
145254758|NCT00808132|523776913|FG001|Overall Study|Randomized, but not treated|7|||
145254759|NCT00808132|523776914|FG002|Overall Study|Randomized, but not treated|9|||
145254760|NCT00808132|523776915|FG003|Overall Study|Randomized, but not treated|8|||
145254761|NCT00808132|523776916|FG004|Overall Study|Randomized, but not treated|9|||
145254762|NCT00808132|523776912|FG000|Overall Study|Unsatisfactory response|5|||
145254763|NCT00808132|523776913|FG001|Overall Study|Unsatisfactory response|6|||
145254764|NCT00808132|523776914|FG002|Overall Study|Unsatisfactory response|6|||
145254765|NCT00808132|523776915|FG003|Overall Study|Unsatisfactory response|4|||
145254766|NCT00808132|523776916|FG004|Overall Study|Unsatisfactory response|12|||
145254767|NCT00033293|523776917|FG000|Overall Study|Death|0|||
145254768|NCT00033293|523776918|FG001|Overall Study|Death|1|||
145254769|NCT00033293|523776917|FG000|Overall Study|Lack of Efficacy|5|||
145254770|NCT00033293|523776918|FG001|Overall Study|Lack of Efficacy|8|||
145254771|NCT00033293|523776917|FG000|Overall Study|Lost to Follow-up|0|||
145254772|NCT00033293|523776918|FG001|Overall Study|Lost to Follow-up|1|||
145254773|NCT00033293|523776917|FG000|Overall Study|Physician Decision|3|||
145254774|NCT00033293|523776918|FG001|Overall Study|Physician Decision|1|||
145254775|NCT00033293|523776917|FG000|Overall Study|Withdrawal by Subject|1|||
145254776|NCT00033293|523776918|FG001|Overall Study|Withdrawal by Subject|0|||
145254777|NCT00033293|523776917|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
145254778|NCT00033293|523776918|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
145254779|NCT00033293|523776917|FG000|Overall Study|Treatment refused|0|||
145254780|NCT00033293|523776918|FG001|Overall Study|Treatment refused|6|||
145254781|NCT00890201|523776919|FG000|Overall Study|Protocol Violation|5|||
145254782|NCT00890201|523776920|FG001|Overall Study|Protocol Violation|56|||
145254783|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
145254784|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
145254785|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
145254786|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
145254787|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
145254788|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
145254789|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
145254790|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
145254791|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Death|0|||
145254792|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Death|0|||
145254793|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Death|0|||
145254794|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Death|1|||
145254795|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Death|1|||
145254796|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Death|0|||
145254797|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Death|2|||
145254798|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Death|0|||
145254799|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254800|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254801|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254802|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
145254803|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254804|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254805|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254806|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
145254807|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254808|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254809|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254810|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
145254811|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254812|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254813|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254814|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
145254815|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
145300294|NCT01577381|523951645|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
145300295|NCT01577381|523951646|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
145300296|NCT01577381|523951647|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
145300297|NCT02186821|523951648|FG000|Overall Study|Adverse Event|9|||
145300298|NCT02186821|523951648|FG000|Overall Study|Death|2|||
145300299|NCT02186821|523951648|FG000|Overall Study|Disease progression|32|||
145300300|NCT02186821|523951648|FG000|Overall Study|Protocol Violation|1|||
145300301|NCT02186821|523951648|FG000|Overall Study|Physician Decision|1|||
145300302|NCT02186821|523951648|FG000|Overall Study|Study terminated by sponsor|2|||
145300303|NCT01313780|523951649|FG000|Overall Study|Lack of Efficacy|4|||
145300304|NCT01313780|523951650|FG001|Overall Study|Lack of Efficacy|2|||
145300305|NCT01313780|523951649|FG000|Overall Study|Adverse Event|6|||
145300306|NCT01313780|523951650|FG001|Overall Study|Adverse Event|11|||
145300307|NCT01313780|523951649|FG000|Overall Study|Withdrawal by Subject|2|||
145300308|NCT01313780|523951650|FG001|Overall Study|Withdrawal by Subject|8|||
145300309|NCT01313780|523951649|FG000|Overall Study|Protocol Violation|10|||
145300310|NCT01313780|523951650|FG001|Overall Study|Protocol Violation|4|||
145300311|NCT01313780|523951649|FG000|Overall Study|missing data|3|||
145300312|NCT01313780|523951650|FG001|Overall Study|missing data|3|||
145300313|NCT00467896|523953132|FG000|Overall Study|Consent Withdrawal|18|||
145300314|NCT00467896|523953132|FG000|Overall Study|Adverse Event|7|||
145300315|NCT00467896|523953132|FG000|Overall Study|Serious Adverse Event|13|||
145300316|NCT00467896|523953132|FG000|Overall Study|Non-compliance|3|||
145300317|NCT00467896|523953132|FG000|Overall Study|Changed therapy|2|||
145254816|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
145254817|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
145254818|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
145254819|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
145254820|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
145254821|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
145254822|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
145254823|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
145254824|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
145254825|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
145254826|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
145254827|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
145254828|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
145254829|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
145254830|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
145254831|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
145254832|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
145254833|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
145254834|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
145254835|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
145254836|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
145254837|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
145254838|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
145254839|NCT02442765|523776921|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254840|NCT02442765|523776922|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254841|NCT02442765|523776923|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254842|NCT02442765|523776924|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254843|NCT02442765|523776925|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
145254844|NCT02442765|523776926|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254845|NCT02442765|523776927|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
145254846|NCT02442765|523776928|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
145254847|NCT00887913|523776929|FG000|Overall Study|Withdrawal by Subject|6|||
145300318|NCT00467896|523953132|FG000|Overall Study|Patient received transplant|2|||
145300319|NCT00467896|523953132|FG000|Overall Study|Patient had atrial septostomy|1|||
145300320|NCT00467896|523953132|FG000|Overall Study|Patient weaned off iloprost|1|||
145300321|NCT00467896|523953132|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
145300322|NCT00467896|523953132|FG000|Overall Study|Started intravenous prostacyclin|1|||
145300323|NCT00467896|523953132|FG000|Overall Study|Started inhaled Remodulin|1|||
145300324|NCT00467896|523953132|FG000|Overall Study|Patient had no improvement|1|||
145300325|NCT03772522|523953133|FG000|Pre-intervention|Withdrawal by Subject|3|||
145254848|NCT01200758|523776932|FG000|Stage I|Death|0|||
145300326|NCT03772522|523953134|FG001|Pre-intervention|Withdrawal by Subject|4|||
145300327|NCT03772522|523953133|FG000|Intervention|Withdrawal by Subject|1|||
145300328|NCT03772522|523953134|FG001|Intervention|Withdrawal by Subject|0|||
145300329|NCT03772522|523953133|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
145300330|NCT03772522|523953134|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
145300331|NCT03818581|523953137|FG000|Overall Study|Adverse Event|1|||
145300332|NCT03818581|523953138|FG001|Overall Study|Adverse Event|0|||
145254849|NCT01200758|523776933|FG001|Stage I|Death|1|||
145254850|NCT01200758|523776934|FG002|Stage I|Death|0|||
145254851|NCT01200758|523776935|FG003|Stage I|Death|0|||
145254852|NCT01200758|523776932|FG000|Stage I|Physician Decision|1|||
145254853|NCT01200758|523776933|FG001|Stage I|Physician Decision|1|||
145254854|NCT01200758|523776934|FG002|Stage I|Physician Decision|0|||
145254855|NCT01200758|523776935|FG003|Stage I|Physician Decision|0|||
145254856|NCT01200758|523776932|FG000|Stage I|Lack of Efficacy|2|||
145254857|NCT01200758|523776933|FG001|Stage I|Lack of Efficacy|1|||
145254858|NCT01200758|523776934|FG002|Stage I|Lack of Efficacy|0|||
145254859|NCT01200758|523776935|FG003|Stage I|Lack of Efficacy|0|||
145254860|NCT01200758|523776932|FG000|Stage I|Adverse Event|5|||
145254861|NCT01200758|523776933|FG001|Stage I|Adverse Event|5|||
145254862|NCT01200758|523776934|FG002|Stage I|Adverse Event|0|||
145254863|NCT01200758|523776935|FG003|Stage I|Adverse Event|0|||
145254864|NCT01200758|523776932|FG000|Stage I|Withdrawal by Subject|1|||
145254865|NCT01200758|523776933|FG001|Stage I|Withdrawal by Subject|2|||
145254866|NCT01200758|523776934|FG002|Stage I|Withdrawal by Subject|0|||
145254867|NCT01200758|523776935|FG003|Stage I|Withdrawal by Subject|0|||
145254868|NCT01200758|523776932|FG000|Stage I|Disease Progression|9|||
145254869|NCT01200758|523776933|FG001|Stage I|Disease Progression|7|||
145254870|NCT01200758|523776934|FG002|Stage I|Disease Progression|0|||
145254871|NCT01200758|523776935|FG003|Stage I|Disease Progression|0|||
145254872|NCT01200758|523776932|FG000|Stage 2|Disease Progression|0|||
145254873|NCT01200758|523776933|FG001|Stage 2|Disease Progression|0|||
145254874|NCT01200758|523776934|FG002|Stage 2|Disease Progression|16|||
145254875|NCT01200758|523776935|FG003|Stage 2|Disease Progression|21|||
145254876|NCT01200758|523776932|FG000|Stage 2|Lack of Efficacy|0|||
145254877|NCT01200758|523776933|FG001|Stage 2|Lack of Efficacy|0|||
145254878|NCT01200758|523776934|FG002|Stage 2|Lack of Efficacy|4|||
145254879|NCT01200758|523776935|FG003|Stage 2|Lack of Efficacy|2|||
145254880|NCT01200758|523776932|FG000|Stage 2|Physician Decision|0|||
145254881|NCT01200758|523776933|FG001|Stage 2|Physician Decision|0|||
145254882|NCT01200758|523776934|FG002|Stage 2|Physician Decision|5|||
145254883|NCT01200758|523776935|FG003|Stage 2|Physician Decision|7|||
145254884|NCT01200758|523776932|FG000|Stage 2|Adverse Event|0|||
145254885|NCT01200758|523776933|FG001|Stage 2|Adverse Event|0|||
145254886|NCT01200758|523776934|FG002|Stage 2|Adverse Event|5|||
145254887|NCT01200758|523776935|FG003|Stage 2|Adverse Event|9|||
145254888|NCT01200758|523776932|FG000|Stage 2|Withdrawal by Subject|0|||
145254889|NCT01200758|523776933|FG001|Stage 2|Withdrawal by Subject|0|||
145254890|NCT01200758|523776934|FG002|Stage 2|Withdrawal by Subject|4|||
145254891|NCT01200758|523776935|FG003|Stage 2|Withdrawal by Subject|1|||
145254892|NCT01200758|523776932|FG000|Stage 2|Lost to Follow-up|0|||
145254893|NCT01200758|523776933|FG001|Stage 2|Lost to Follow-up|0|||
145254894|NCT01200758|523776934|FG002|Stage 2|Lost to Follow-up|3|||
145254895|NCT01200758|523776935|FG003|Stage 2|Lost to Follow-up|1|||
145254896|NCT01200758|523776932|FG000|Stage 2|Protocol Violation|0|||
145254897|NCT01200758|523776933|FG001|Stage 2|Protocol Violation|0|||
145254898|NCT01200758|523776934|FG002|Stage 2|Protocol Violation|1|||
145254899|NCT01200758|523776935|FG003|Stage 2|Protocol Violation|4|||
145254900|NCT01200758|523776932|FG000|Stage 2|Death|0|||
145254901|NCT01200758|523776933|FG001|Stage 2|Death|0|||
145254902|NCT01200758|523776934|FG002|Stage 2|Death|3|||
145254903|NCT01200758|523776935|FG003|Stage 2|Death|5|||
145254904|NCT00598585|523776936|FG000|Overall Study|Lost to Follow-up|1|||
145254905|NCT00598585|523776937|FG001|Overall Study|Lost to Follow-up|0|||
145254906|NCT00545584|523776938|FG000|Overall Study|Only one reason for discontinuation|62|||
145254907|NCT00545584|523776939|FG001|Overall Study|Only one reason for discontinuation|61|||
145254908|NCT00545584|523776940|FG002|Overall Study|Only one reason for discontinuation|48|||
145254909|NCT00545584|523776938|FG000|Overall Study|Two or more reasons for discontinuation|17|||
145254910|NCT00545584|523776939|FG001|Overall Study|Two or more reasons for discontinuation|19|||
145254911|NCT00545584|523776940|FG002|Overall Study|Two or more reasons for discontinuation|8|||
145254912|NCT03525613|523776943|FG000|Overall Study|Adverse Event|11|||
145254913|NCT03525613|523776944|FG001|Overall Study|Adverse Event|8|||
145254914|NCT03525613|523776945|FG002|Overall Study|Adverse Event|3|||
145254915|NCT03525613|523776946|FG003|Overall Study|Adverse Event|3|||
145254916|NCT03525613|523776943|FG000|Overall Study|Lost to Follow-up|4|||
145254917|NCT03525613|523776944|FG001|Overall Study|Lost to Follow-up|5|||
145254918|NCT03525613|523776945|FG002|Overall Study|Lost to Follow-up|3|||
145254919|NCT03525613|523776946|FG003|Overall Study|Lost to Follow-up|2|||
145254920|NCT03525613|523776943|FG000|Overall Study|Physician Decision|0|||
145254921|NCT03525613|523776944|FG001|Overall Study|Physician Decision|1|||
145254922|NCT03525613|523776945|FG002|Overall Study|Physician Decision|0|||
145254923|NCT03525613|523776946|FG003|Overall Study|Physician Decision|1|||
145254924|NCT03525613|523776943|FG000|Overall Study|Consent Withdrawal|25|||
145300333|NCT03818581|523953139|FG002|Overall Study|Adverse Event|0|||
145300334|NCT03818581|523953140|FG003|Overall Study|Adverse Event|0|||
145254925|NCT03525613|523776944|FG001|Overall Study|Consent Withdrawal|16|||
145254926|NCT03525613|523776945|FG002|Overall Study|Consent Withdrawal|12|||
145254927|NCT03525613|523776946|FG003|Overall Study|Consent Withdrawal|9|||
145254928|NCT03525613|523776943|FG000|Overall Study|Death|20|||
145254929|NCT03525613|523776944|FG001|Overall Study|Death|9|||
145254930|NCT03525613|523776945|FG002|Overall Study|Death|7|||
145254931|NCT03525613|523776946|FG003|Overall Study|Death|1|||
145254932|NCT03525613|523776943|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
145254933|NCT03525613|523776944|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
145254934|NCT03525613|523776945|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
145254935|NCT03525613|523776946|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
145254936|NCT00135694|523776950|FG000|Overall Study|Adverse Event|17|||
145254937|NCT00135694|523776951|FG001|Overall Study|Adverse Event|4|||
145254938|NCT00135694|523776952|FG002|Overall Study|Adverse Event|0|||
145254939|NCT00135694|523776950|FG000|Overall Study|Death|14|||
145254940|NCT00135694|523776951|FG001|Overall Study|Death|1|||
145254941|NCT00135694|523776952|FG002|Overall Study|Death|2|||
145254942|NCT00135694|523776950|FG000|Overall Study|Lost to Follow-up|8|||
145254943|NCT00135694|523776951|FG001|Overall Study|Lost to Follow-up|7|||
145254944|NCT00135694|523776952|FG002|Overall Study|Lost to Follow-up|1|||
145254945|NCT00135694|523776950|FG000|Overall Study|Withdrawal by Subject|41|||
145254946|NCT00135694|523776951|FG001|Overall Study|Withdrawal by Subject|7|||
145254947|NCT00135694|523776952|FG002|Overall Study|Withdrawal by Subject|4|||
145254948|NCT00135694|523776950|FG000|Overall Study|Protocol Violation|19|||
145254949|NCT00135694|523776951|FG001|Overall Study|Protocol Violation|1|||
145254950|NCT00135694|523776952|FG002|Overall Study|Protocol Violation|0|||
145254951|NCT00135694|523776950|FG000|Overall Study|Hepatitis C related reasons|39|||
145254952|NCT00135694|523776951|FG001|Overall Study|Hepatitis C related reasons|1|||
145254953|NCT00135694|523776952|FG002|Overall Study|Hepatitis C related reasons|0|||
145254954|NCT00135694|523776950|FG000|Overall Study|Ineligible for Random assignment|42|||
145254955|NCT00135694|523776951|FG001|Overall Study|Ineligible for Random assignment|0|||
145254956|NCT00135694|523776952|FG002|Overall Study|Ineligible for Random assignment|0|||
145254957|NCT02584660|523776953|FG000|Overall Study|Adverse Event|4|||
145254958|NCT02584660|523776954|FG001|Overall Study|Adverse Event|0|||
145254959|NCT02584660|523776953|FG000|Overall Study|Lost to Follow-up|3|||
145254960|NCT02584660|523776954|FG001|Overall Study|Lost to Follow-up|4|||
145254961|NCT02584660|523776953|FG000|Overall Study|Protocol Violation|0|||
145254962|NCT02584660|523776954|FG001|Overall Study|Protocol Violation|1|||
145254963|NCT02584660|523776953|FG000|Overall Study|Withdrawal by Subject|0|||
145254964|NCT02584660|523776954|FG001|Overall Study|Withdrawal by Subject|2|||
145254965|NCT02584660|523776953|FG000|Overall Study|Other|0|||
145254966|NCT02584660|523776954|FG001|Overall Study|Other|1|||
145254967|NCT00374452|523776955|FG000|Overall Study|Left clinic before intervention started|4|||
145254968|NCT00374452|523776956|FG001|Overall Study|Left clinic before intervention started|1|||
145254969|NCT00374452|523776955|FG000|Overall Study|Change in job role before intervention|0|||
145254970|NCT00374452|523776956|FG001|Overall Study|Change in job role before intervention|1|||
145254971|NCT00374452|523776955|FG000|Overall Study|Left clinic after intervention started|1|||
145254972|NCT00374452|523776956|FG001|Overall Study|Left clinic after intervention started|1|||
145254973|NCT00374452|523776955|FG000|Overall Study|Withdrawal by Subject|0|||
145254974|NCT00374452|523776956|FG001|Overall Study|Withdrawal by Subject|2|||
145254975|NCT03117309|523776960|FG000|Overall Study|Not meeting inclusion criteria|0|||
145254976|NCT03117309|523776961|FG001|Overall Study|Not meeting inclusion criteria|1|||
145254977|NCT02120469|523776964|FG000|Overall Study|HER-2/neu-amplified|1|||
145254978|NCT02120469|523776965|FG001|Overall Study|HER-2/neu-amplified|0|||
145254979|NCT02120469|523776966|FG002|Overall Study|HER-2/neu-amplified|1|||
145254980|NCT01601873|523776967|FG000|Overall Study|Lost to Follow-up|2|||
145254981|NCT01601873|523776968|FG001|Overall Study|Lost to Follow-up|3|||
145254982|NCT03196973|523776969|FG000|Overall Study|Adverse Event|1|||
145254983|NCT03196973|523776970|FG001|Overall Study|Adverse Event|1|||
145254984|NCT03196973|523776971|FG002|Overall Study|Adverse Event|2|||
145254985|NCT03196973|523776969|FG000|Overall Study|Lack of Efficacy|2|||
145254986|NCT03196973|523776970|FG001|Overall Study|Lack of Efficacy|6|||
145254987|NCT03196973|523776971|FG002|Overall Study|Lack of Efficacy|1|||
145254988|NCT03196973|523776969|FG000|Overall Study|Lost to Follow-up|4|||
145254989|NCT03196973|523776970|FG001|Overall Study|Lost to Follow-up|3|||
145254990|NCT03196973|523776971|FG002|Overall Study|Lost to Follow-up|2|||
145254991|NCT03196973|523776969|FG000|Overall Study|Consent withdrawn|2|||
145254992|NCT03196973|523776970|FG001|Overall Study|Consent withdrawn|1|||
145254993|NCT03196973|523776971|FG002|Overall Study|Consent withdrawn|0|||
145254994|NCT03196973|523776969|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
145254995|NCT03196973|523776970|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
145254996|NCT03196973|523776971|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
145254997|NCT00805142|523776979|FG000|Titration Period|Adverse Event|3|||
145254998|NCT00805142|523776980|FG001|Titration Period|Adverse Event|3|||
145254999|NCT00805142|523776979|FG000|Titration Period|Lack of Efficacy|1|||
145255000|NCT00805142|523776980|FG001|Titration Period|Lack of Efficacy|1|||
145255001|NCT00805142|523776979|FG000|Titration Period|Lost to Follow-up|0|||
145255002|NCT00805142|523776980|FG001|Titration Period|Lost to Follow-up|1|||
145255003|NCT00805142|523776979|FG000|Titration Period|Disease Progression|2|||
145255004|NCT00805142|523776980|FG001|Titration Period|Disease Progression|1|||
145255005|NCT00805142|523776979|FG000|Titration Period|Withdrawal of consent|0|||
145255006|NCT00805142|523776980|FG001|Titration Period|Withdrawal of consent|1|||
145255007|NCT00805142|523776979|FG000|Titration Period|Other|0|||
145255008|NCT00805142|523776980|FG001|Titration Period|Other|3|||
145255009|NCT00805142|523776979|FG000|Maintenance Period|Adverse Event|0|||
145255010|NCT00805142|523776980|FG001|Maintenance Period|Adverse Event|1|||
145255011|NCT00805142|523776979|FG000|Maintenance Period|Other|0|||
145255012|NCT00805142|523776980|FG001|Maintenance Period|Other|1|||
145255013|NCT00424463|523776982|FG000|Overall Study|Adverse Event|2|||
145255014|NCT00424463|523776983|FG001|Overall Study|Adverse Event|3|||
145255015|NCT00424463|523776984|FG002|Overall Study|Adverse Event|2|||
145255016|NCT00424463|523776982|FG000|Overall Study|Physician Decision|0|||
145255017|NCT00424463|523776983|FG001|Overall Study|Physician Decision|2|||
145255018|NCT00424463|523776984|FG002|Overall Study|Physician Decision|2|||
145255019|NCT00424463|523776982|FG000|Overall Study|Withdrawal by Subject|4|||
145255020|NCT00424463|523776983|FG001|Overall Study|Withdrawal by Subject|2|||
145255021|NCT00424463|523776984|FG002|Overall Study|Withdrawal by Subject|5|||
145255022|NCT00424463|523776982|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
145255023|NCT00424463|523776983|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
145255024|NCT00424463|523776984|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
145255025|NCT00424463|523776982|FG000|Overall Study|Patient's convenience|0|||
145255026|NCT00424463|523776983|FG001|Overall Study|Patient's convenience|0|||
145255027|NCT00424463|523776984|FG002|Overall Study|Patient's convenience|1|||
145255028|NCT02449915|523776985|FG000|Overall Study|Exclusion criteria - drug use|1|||
145255029|NCT02449915|523776986|FG001|Overall Study|Exclusion criteria - drug use|0|||
145255030|NCT02449915|523776985|FG000|Overall Study|Withdrawal by Subject|0|||
145255031|NCT02449915|523776986|FG001|Overall Study|Withdrawal by Subject|2|||
145255032|NCT02449915|523776985|FG000|Overall Study|Intraoperative surgical findings|1|||
145255033|NCT02449915|523776986|FG001|Overall Study|Intraoperative surgical findings|1|||
145255034|NCT02449915|523776985|FG000|Overall Study|Abnormal preop lab|0|||
145255035|NCT02449915|523776986|FG001|Overall Study|Abnormal preop lab|1|||
145255036|NCT01436357|523776987|FG000|Overall Study|Death|5|||
145255037|NCT01436357|523776988|FG001|Overall Study|Death|1|||
145255038|NCT01436357|523776987|FG000|Overall Study|Enrolled but not vaccinated|1|||
145255039|NCT01436357|523776988|FG001|Overall Study|Enrolled but not vaccinated|1|||
145255040|NCT01436357|523776987|FG000|Overall Study|Incarceration|18|||
145255041|NCT01436357|523776988|FG001|Overall Study|Incarceration|20|||
145255042|NCT01436357|523776987|FG000|Overall Study|Lost to Follow-up|67|||
145255043|NCT01436357|523776988|FG001|Overall Study|Lost to Follow-up|61|||
145255044|NCT01436357|523776987|FG000|Overall Study|Protocol Violation|1|||
145255045|NCT01436357|523776988|FG001|Overall Study|Protocol Violation|0|||
145255046|NCT01436357|523776987|FG000|Overall Study|Withdrawal by Subject|26|||
145255047|NCT01436357|523776988|FG001|Overall Study|Withdrawal by Subject|38|||
145255048|NCT01436357|523776987|FG000|Overall Study|Physician Decision|3|||
145255049|NCT01436357|523776988|FG001|Overall Study|Physician Decision|4|||
145255050|NCT01436357|523776987|FG000|Overall Study|Moved out of area|1|||
145255051|NCT01436357|523776988|FG001|Overall Study|Moved out of area|2|||
145255052|NCT01436357|523776987|FG000|Overall Study|Subject in rehab|0|||
145255053|NCT01436357|523776988|FG001|Overall Study|Subject in rehab|1|||
145255054|NCT00656799|523776990|FG000|Overall Study|Death|2|||
145255055|NCT04144140|523778547|FG000|Overall Study|Other|0|||
145255056|NCT04144140|523778548|FG001|Overall Study|Other|0|||
145255057|NCT04144140|523778549|FG002|Overall Study|Other|0|||
145255058|NCT04144140|523778550|FG003|Overall Study|Other|0|||
145255059|NCT04144140|523778551|FG004|Overall Study|Other|0|||
145255060|NCT04144140|523778552|FG005|Overall Study|Other|1|||
145255061|NCT04144140|523778553|FG006|Overall Study|Other|0|||
145255062|NCT02408016|523778556|FG000|Overall Study|Death|6|||
145255063|NCT02408016|523778557|FG001|Overall Study|Death|1|||
145255064|NCT02408016|523778558|FG002|Overall Study|Death|0|||
145255065|NCT02408016|523778556|FG000|Overall Study|Physician Decision|0|||
145300335|NCT03818581|523953141|FG004|Overall Study|Adverse Event|0|||
145300336|NCT03818581|523953137|FG000|Overall Study|Covid-19|2|||
145255066|NCT02408016|523778557|FG001|Overall Study|Physician Decision|2|||
145255067|NCT02408016|523778558|FG002|Overall Study|Physician Decision|0|||
145255068|NCT03557801|523778560|FG000|Overall Study|Protocol Violation|1|||
145255069|NCT03557801|523778561|FG001|Overall Study|Protocol Violation|0|||
145255070|NCT03557801|523778562|FG002|Overall Study|Protocol Violation|0|||
145255071|NCT03557801|523778560|FG000|Overall Study|Withdrawal by Subject|1|||
145255072|NCT03557801|523778561|FG001|Overall Study|Withdrawal by Subject|0|||
145255073|NCT03557801|523778562|FG002|Overall Study|Withdrawal by Subject|3|||
145255074|NCT03557801|523778560|FG000|Overall Study|Lost to Follow-up|0|||
145255075|NCT03557801|523778561|FG001|Overall Study|Lost to Follow-up|1|||
145255076|NCT03557801|523778562|FG002|Overall Study|Lost to Follow-up|0|||
145255077|NCT02807376|523778565|FG000|Overall Study|Intra-operative exclusion criteria|3|||
145255078|NCT02807376|523778566|FG001|Overall Study|Intra-operative exclusion criteria|0|||
145255079|NCT02807376|523778565|FG000|Overall Study|Lost to Follow-up|0|||
145255080|NCT02807376|523778566|FG001|Overall Study|Lost to Follow-up|1|||
145255081|NCT00846027|523778567|FG000|Overall Study|Death|3|||
145255082|NCT00846027|523778567|FG000|Overall Study|Disease Progression|30|||
145255083|NCT00846027|523778567|FG000|Overall Study|Toxicity|12|||
145255084|NCT00846027|523778567|FG000|Overall Study|Patient Decision|7|||
145255085|NCT00846027|523778567|FG000|Overall Study|Investigator Discretion|29|||
145255086|NCT00846027|523778567|FG000|Overall Study|Protocol Violation|2|||
145255087|NCT00846027|523778567|FG000|Overall Study|Subject Not Treated|7|||
145255088|NCT03228836|523778572|FG000|Overall Study|Adverse Event|3|||
145255089|NCT03228836|523778572|FG000|Overall Study|Withdrawal by Subject|1|||
145255090|NCT03228836|523778572|FG000|Overall Study|Death|1|||
145255091|NCT03228836|523778572|FG000|Overall Study|Physician Decision|1|||
145255092|NCT03228836|523778572|FG000|Overall Study|Disease Progression|7|||
145255093|NCT03228836|523778572|FG000|Overall Study|Other|4|||
145255094|NCT04652102|523778575|FG000|Overall Study|Adverse Event|14|||
145255095|NCT04652102|523778576|FG001|Overall Study|Adverse Event|13|||
145255096|NCT04652102|523778575|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
145255097|NCT04652102|523778576|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
145255098|NCT04652102|523778575|FG000|Overall Study|Physician Decision|78|||
145255099|NCT04652102|523778576|FG001|Overall Study|Physician Decision|40|||
145255100|NCT04652102|523778575|FG000|Overall Study|Study Ended by Sponsor|64|||
145255101|NCT04652102|523778576|FG001|Overall Study|Study Ended by Sponsor|17|||
145255102|NCT04652102|523778575|FG000|Overall Study|Withdrawal by Subject|4625|||
145255103|NCT04652102|523778576|FG001|Overall Study|Withdrawal by Subject|5594|||
145255104|NCT04652102|523778575|FG000|Overall Study|Lost to Follow-up|2019|||
145255105|NCT04652102|523778576|FG001|Overall Study|Lost to Follow-up|1082|||
145255106|NCT04652102|523778575|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
145255107|NCT04652102|523778576|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
145255108|NCT04652102|523778575|FG000|Overall Study|Miscellaneous|80|||
145255109|NCT04652102|523778576|FG001|Overall Study|Miscellaneous|64|||
145566701|NCT01604343|524936191|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
145255110|NCT02192190|523778579|FG000|Overall Study|Adverse Event|1|||
145255111|NCT02192190|523778580|FG001|Overall Study|Adverse Event|1|||
145255112|NCT02192190|523778581|FG002|Overall Study|Adverse Event|0|||
145255113|NCT02192190|523778582|FG003|Overall Study|Adverse Event|0|||
145255114|NCT02192190|523778583|FG004|Overall Study|Adverse Event|0|||
145255115|NCT02192190|523778584|FG005|Overall Study|Adverse Event|0|||
145255116|NCT02192190|523778579|FG000|Overall Study|Lost to Follow-up|3|||
145255117|NCT02192190|523778580|FG001|Overall Study|Lost to Follow-up|3|||
145255118|NCT02192190|523778581|FG002|Overall Study|Lost to Follow-up|2|||
145255119|NCT02192190|523778582|FG003|Overall Study|Lost to Follow-up|1|||
145255120|NCT02192190|523778583|FG004|Overall Study|Lost to Follow-up|4|||
145255121|NCT02192190|523778584|FG005|Overall Study|Lost to Follow-up|3|||
145255122|NCT02192190|523778579|FG000|Overall Study|Physician Decision|2|||
145255123|NCT02192190|523778580|FG001|Overall Study|Physician Decision|0|||
145255124|NCT02192190|523778581|FG002|Overall Study|Physician Decision|0|||
145255125|NCT02192190|523778582|FG003|Overall Study|Physician Decision|0|||
145255126|NCT02192190|523778583|FG004|Overall Study|Physician Decision|0|||
145255127|NCT02192190|523778584|FG005|Overall Study|Physician Decision|0|||
145255128|NCT02192190|523778579|FG000|Overall Study|Terminated by Sponsor|43|||
145255129|NCT02192190|523778580|FG001|Overall Study|Terminated by Sponsor|23|||
145255130|NCT02192190|523778581|FG002|Overall Study|Terminated by Sponsor|20|||
145255131|NCT02192190|523778582|FG003|Overall Study|Terminated by Sponsor|23|||
145255132|NCT02192190|523778583|FG004|Overall Study|Terminated by Sponsor|21|||
145255133|NCT02192190|523778584|FG005|Overall Study|Terminated by Sponsor|23|||
145255134|NCT02192190|523778579|FG000|Overall Study|Withdrawal by Subject|4|||
145255135|NCT02192190|523778580|FG001|Overall Study|Withdrawal by Subject|1|||
145255136|NCT02192190|523778581|FG002|Overall Study|Withdrawal by Subject|2|||
145255137|NCT02192190|523778582|FG003|Overall Study|Withdrawal by Subject|1|||
145255138|NCT02192190|523778583|FG004|Overall Study|Withdrawal by Subject|5|||
145300337|NCT03818581|523953138|FG001|Overall Study|Covid-19|0|||
145300338|NCT03818581|523953139|FG002|Overall Study|Covid-19|0|||
145300339|NCT03818581|523953140|FG003|Overall Study|Covid-19|0|||
145300340|NCT03818581|523953141|FG004|Overall Study|Covid-19|1|||
145300341|NCT03818581|523953137|FG000|Overall Study|Withdrawal by Subject|0|||
145300342|NCT03818581|523953138|FG001|Overall Study|Withdrawal by Subject|0|||
145300343|NCT03818581|523953139|FG002|Overall Study|Withdrawal by Subject|0|||
145300344|NCT03818581|523953140|FG003|Overall Study|Withdrawal by Subject|0|||
145566702|NCT01604343|524936192|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
145300345|NCT03818581|523953141|FG004|Overall Study|Withdrawal by Subject|1|||
145255139|NCT02192190|523778584|FG005|Overall Study|Withdrawal by Subject|3|||
145255140|NCT02192190|523778579|FG000|Overall Study|Could not Keep Visit Schedule|1|||
145255141|NCT02192190|523778580|FG001|Overall Study|Could not Keep Visit Schedule|0|||
145255142|NCT02192190|523778581|FG002|Overall Study|Could not Keep Visit Schedule|0|||
145255143|NCT02192190|523778582|FG003|Overall Study|Could not Keep Visit Schedule|0|||
145255144|NCT02192190|523778583|FG004|Overall Study|Could not Keep Visit Schedule|0|||
145255145|NCT02192190|523778584|FG005|Overall Study|Could not Keep Visit Schedule|0|||
145255146|NCT02192190|523778579|FG000|Overall Study|Positive Drug Screen|0|||
145255147|NCT02192190|523778580|FG001|Overall Study|Positive Drug Screen|0|||
145255148|NCT02192190|523778581|FG002|Overall Study|Positive Drug Screen|0|||
145410576|NCT01500083|524356823|FG000|Overall Study|Death|0|||
145255149|NCT02192190|523778582|FG003|Overall Study|Positive Drug Screen|1|||
145255150|NCT02192190|523778583|FG004|Overall Study|Positive Drug Screen|0|||
145255151|NCT02192190|523778584|FG005|Overall Study|Positive Drug Screen|0|||
145255152|NCT02192190|523778579|FG000|Overall Study|Inadequate Pain Relief|0|||
145255153|NCT02192190|523778580|FG001|Overall Study|Inadequate Pain Relief|1|||
145255154|NCT02192190|523778581|FG002|Overall Study|Inadequate Pain Relief|1|||
145255155|NCT02192190|523778582|FG003|Overall Study|Inadequate Pain Relief|0|||
145255156|NCT02192190|523778583|FG004|Overall Study|Inadequate Pain Relief|0|||
145255157|NCT02192190|523778584|FG005|Overall Study|Inadequate Pain Relief|0|||
145255158|NCT02607865|523778585|FG000|Overall Study|Lost to Follow-up|9|||
145255159|NCT02607865|523778586|FG001|Overall Study|Lost to Follow-up|7|||
145255160|NCT02607865|523778587|FG002|Overall Study|Lost to Follow-up|7|||
145255161|NCT02607865|523778588|FG003|Overall Study|Lost to Follow-up|5|||
145255162|NCT02607865|523778585|FG000|Overall Study|Withdrawal by Subject|18|||
145255163|NCT02607865|523778586|FG001|Overall Study|Withdrawal by Subject|18|||
145255164|NCT02607865|523778587|FG002|Overall Study|Withdrawal by Subject|17|||
145255165|NCT02607865|523778588|FG003|Overall Study|Withdrawal by Subject|8|||
145255166|NCT02607865|523778585|FG000|Overall Study|Death|5|||
145255167|NCT02607865|523778586|FG001|Overall Study|Death|4|||
145255168|NCT02607865|523778587|FG002|Overall Study|Death|1|||
145255169|NCT02607865|523778588|FG003|Overall Study|Death|3|||
145255170|NCT02607865|523778585|FG000|Overall Study|Unclassified|1|||
145255171|NCT02607865|523778586|FG001|Overall Study|Unclassified|1|||
145255172|NCT02607865|523778587|FG002|Overall Study|Unclassified|2|||
145255173|NCT02607865|523778588|FG003|Overall Study|Unclassified|0|||
145255174|NCT03227692|523778589|FG000|Overall Study|Protocol Violation|1|||
145255175|NCT03227692|523778590|FG001|Overall Study|Protocol Violation|1|||
145255176|NCT03227692|523778589|FG000|Overall Study|Lost to Follow-up|4|||
145255177|NCT03227692|523778590|FG001|Overall Study|Lost to Follow-up|2|||
145255178|NCT03227692|523778589|FG000|Overall Study|Adverse Event|0|||
145255179|NCT03227692|523778590|FG001|Overall Study|Adverse Event|2|||
145255180|NCT00381706|523778591|FG000|Overall Study|Never treated|7|||
145255181|NCT00381706|523778592|FG001|Overall Study|Never treated|2|||
145255182|NCT00381706|523778593|FG002|Overall Study|Never treated|1|||
145255183|NCT00203294|523778594|FG000|Overall Study|Withdrawal by Subject|8|||
145255184|NCT00203294|523778595|FG001|Overall Study|Withdrawal by Subject|13|||
145255185|NCT00886587|523778596|FG000|Overall Study|Adverse Event|2|||
145255186|NCT00886587|523778597|FG001|Overall Study|Adverse Event|1|||
145255187|NCT00886587|523778596|FG000|Overall Study|Protocol Violation|2|||
145255188|NCT00886587|523778597|FG001|Overall Study|Protocol Violation|0|||
145255189|NCT00886587|523778596|FG000|Overall Study|Withdrawal by Subject|0|||
145255190|NCT00886587|523778597|FG001|Overall Study|Withdrawal by Subject|1|||
145255191|NCT00550615|523778601|FG000|Overall Study|Withdrawal by Subject|0|||
145255192|NCT00550615|523778602|FG001|Overall Study|Withdrawal by Subject|0|||
145255193|NCT00550615|523778603|FG002|Overall Study|Withdrawal by Subject|2|||
145255194|NCT00550615|523778604|FG003|Overall Study|Withdrawal by Subject|3|||
145255195|NCT00550615|523778601|FG000|Overall Study|Not evaluable|0|||
145255196|NCT00550615|523778602|FG001|Overall Study|Not evaluable|0|||
145255197|NCT00550615|523778603|FG002|Overall Study|Not evaluable|2|||
145255198|NCT00550615|523778604|FG003|Overall Study|Not evaluable|7|||
145255199|NCT02405091|523778607|FG000|Overall Study|Adverse Event|16|||
145255200|NCT02405091|523778608|FG001|Overall Study|Adverse Event|10|||
145255201|NCT02405091|523778609|FG002|Overall Study|Adverse Event|0|||
145255202|NCT02405091|523778607|FG000|Overall Study|Protocol Violation|1|||
145255203|NCT02405091|523778608|FG001|Overall Study|Protocol Violation|0|||
145255204|NCT02405091|523778609|FG002|Overall Study|Protocol Violation|0|||
145255205|NCT02405091|523778607|FG000|Overall Study|Noncompliance|1|||
145255206|NCT02405091|523778608|FG001|Overall Study|Noncompliance|6|||
145255207|NCT02405091|523778609|FG002|Overall Study|Noncompliance|2|||
145300346|NCT03818581|523953137|FG000|Overall Study|No longer met study criteria|0|||
145300347|NCT03818581|523953138|FG001|Overall Study|No longer met study criteria|0|||
145300348|NCT03818581|523953139|FG002|Overall Study|No longer met study criteria|0|||
145300349|NCT03818581|523953140|FG003|Overall Study|No longer met study criteria|0|||
145300350|NCT03818581|523953141|FG004|Overall Study|No longer met study criteria|1|||
145255208|NCT02405091|523778607|FG000|Overall Study|Withdrawal by Subject|4|||
145255209|NCT02405091|523778608|FG001|Overall Study|Withdrawal by Subject|8|||
145255210|NCT02405091|523778609|FG002|Overall Study|Withdrawal by Subject|0|||
145255211|NCT02405091|523778607|FG000|Overall Study|Death|0|||
145255212|NCT02405091|523778608|FG001|Overall Study|Death|1|||
145255213|NCT02405091|523778609|FG002|Overall Study|Death|0|||
145255214|NCT02405091|523778607|FG000|Overall Study|Lost to Follow-up|5|||
145255215|NCT02405091|523778608|FG001|Overall Study|Lost to Follow-up|6|||
145255216|NCT02405091|523778609|FG002|Overall Study|Lost to Follow-up|0|||
145255217|NCT02405091|523778607|FG000|Overall Study|Physician Decision|2|||
145255218|NCT02405091|523778608|FG001|Overall Study|Physician Decision|2|||
145255219|NCT02405091|523778609|FG002|Overall Study|Physician Decision|0|||
145255220|NCT01948791|523778617|FG000|Overall Study|Adverse Event|12|||
145255221|NCT01948791|523778617|FG000|Overall Study|Lack of Efficacy|3|||
145255222|NCT01948791|523778617|FG000|Overall Study|Protocol Violation|2|||
145410577|NCT01500083|524356824|FG001|Overall Study|Death|2|||
145410578|NCT01500083|524356823|FG000|Overall Study|Lost to Follow-up|1|||
145410579|NCT01500083|524356824|FG001|Overall Study|Lost to Follow-up|0|||
145410580|NCT01500083|524356823|FG000|Overall Study|Withdrawal of Consent|0|||
145410581|NCT01500083|524356824|FG001|Overall Study|Withdrawal of Consent|1|||
145410582|NCT01500083|524356823|FG000|Overall Study|Disease Progression|2|||
145410583|NCT01500083|524356824|FG001|Overall Study|Disease Progression|10|||
145410584|NCT01500083|524356823|FG000|Overall Study|Investigator Discretion|3|||
145410585|NCT01500083|524356824|FG001|Overall Study|Investigator Discretion|8|||
145410586|NCT01500083|524356823|FG000|Overall Study|Other Reasons|2|||
145410587|NCT01500083|524356824|FG001|Overall Study|Other Reasons|5|||
145410588|NCT01555931|524356825|FG000|Overall Study|Lost to Follow-up|2|||
145410589|NCT01555931|524356826|FG001|Overall Study|Lost to Follow-up|5|||
145410590|NCT01697579|524356830|FG000|Base Study-Cycle 1|Adverse Event|1|||
145410591|NCT01697579|524356831|FG001|Base Study-Cycle 1|Adverse Event|0|||
145410592|NCT01697579|524356832|FG002|Base Study-Cycle 1|Adverse Event|0|||
145410593|NCT01697579|524356833|FG003|Base Study-Cycle 1|Adverse Event|0|||
145410594|NCT01697579|524356834|FG004|Base Study-Cycle 1|Adverse Event|0|||
145410595|NCT01697579|524356835|FG005|Base Study-Cycle 1|Adverse Event|0|||
145410596|NCT01697579|524356836|FG006|Base Study-Cycle 1|Adverse Event|0|||
145410597|NCT01697579|524356830|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
145410598|NCT01697579|524356831|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410599|NCT01697579|524356832|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410600|NCT01697579|524356833|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410601|NCT01697579|524356834|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410602|NCT01697579|524356835|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410603|NCT01697579|524356836|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
145410604|NCT01697579|524356830|FG000|Base Study-Cycle 1|Protocol Violation|0|||
145410605|NCT01697579|524356831|FG001|Base Study-Cycle 1|Protocol Violation|0|||
145410606|NCT01697579|524356832|FG002|Base Study-Cycle 1|Protocol Violation|0|||
145410607|NCT01697579|524356833|FG003|Base Study-Cycle 1|Protocol Violation|0|||
145410608|NCT01697579|524356834|FG004|Base Study-Cycle 1|Protocol Violation|3|||
145410609|NCT01697579|524356835|FG005|Base Study-Cycle 1|Protocol Violation|0|||
145410610|NCT01697579|524356836|FG006|Base Study-Cycle 1|Protocol Violation|0|||
145410611|NCT01697579|524356830|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410612|NCT01697579|524356831|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
145410613|NCT01697579|524356832|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410614|NCT01697579|524356833|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410615|NCT01697579|524356834|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410616|NCT01697579|524356835|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410617|NCT01697579|524356836|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
145410618|NCT01697579|524356830|FG000|Base Study-Cycle 1|Technical Problems|0|||
145410619|NCT01697579|524356831|FG001|Base Study-Cycle 1|Technical Problems|0|||
145410620|NCT01697579|524356832|FG002|Base Study-Cycle 1|Technical Problems|1|||
145410621|NCT01697579|524356833|FG003|Base Study-Cycle 1|Technical Problems|1|||
145255223|NCT01948791|523778617|FG000|Overall Study|Withdrawal by Subject|5|||
145255224|NCT01948791|523778617|FG000|Overall Study|Lost to Follow-up|6|||
145255225|NCT01948791|523778617|FG000|Overall Study|Management issues|1|||
145255226|NCT01948791|523778617|FG000|Overall Study|Others|7|||
145255227|NCT01948791|523778617|FG000|Overall Study|Screening failure|35|||
145255228|NCT00247962|523778629|FG000|Overall Study|Adverse Event|15|||
145255229|NCT00247962|523778630|FG001|Overall Study|Adverse Event|12|||
145255230|NCT00247962|523778629|FG000|Overall Study|Lost to Follow-up|3|||
145255231|NCT00247962|523778630|FG001|Overall Study|Lost to Follow-up|1|||
145255232|NCT00247962|523778629|FG000|Overall Study|Physician Decision|0|||
145255233|NCT00247962|523778630|FG001|Overall Study|Physician Decision|1|||
145255234|NCT00247962|523778629|FG000|Overall Study|Protocol Violation|1|||
145410622|NCT01697579|524356834|FG004|Base Study-Cycle 1|Technical Problems|0|||
145410623|NCT01697579|524356835|FG005|Base Study-Cycle 1|Technical Problems|0|||
145410624|NCT01697579|524356836|FG006|Base Study-Cycle 1|Technical Problems|0|||
145566703|NCT01604343|524936193|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
145255235|NCT00247962|523778630|FG001|Overall Study|Protocol Violation|1|||
145255236|NCT00247962|523778629|FG000|Overall Study|Withdrawal by Subject|3|||
145255237|NCT00247962|523778630|FG001|Overall Study|Withdrawal by Subject|2|||
145410625|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Death|0|||
145410626|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Death|0|||
145410627|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Death|0|||
145410628|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Death|0|||
145410629|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Death|0|||
145410630|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Death|0|||
145410631|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Death|2|||
145255238|NCT00247962|523778629|FG000|Overall Study|Lack of Efficacy|4|||
145255239|NCT00247962|523778630|FG001|Overall Study|Lack of Efficacy|2|||
145255240|NCT01955005|523778631|FG000|Overall Study|Withdrawal by Subject|3|||
145255241|NCT01955005|523778632|FG001|Overall Study|Withdrawal by Subject|5|||
145255242|NCT01469637|523778637|FG000|First Intervention|Unacceptable behavior|0|||
145255243|NCT01469637|523778638|FG001|First Intervention|Unacceptable behavior|1|||
145255244|NCT01469637|523778637|FG000|Second Intervention|Incarcerated|1|||
145255245|NCT01469637|523778638|FG001|Second Intervention|Incarcerated|0|||
145255246|NCT01371721|523778639|FG000|Overall Study|Adverse Event|5|||
145255247|NCT01371721|523778640|FG001|Overall Study|Adverse Event|4|||
145255248|NCT01371721|523778641|FG002|Overall Study|Adverse Event|5|||
145255249|NCT01371721|523778639|FG000|Overall Study|Protocol Violation|6|||
145255250|NCT01371721|523778640|FG001|Overall Study|Protocol Violation|4|||
145255251|NCT01371721|523778641|FG002|Overall Study|Protocol Violation|5|||
145255252|NCT01371721|523778639|FG000|Overall Study|Lost to Follow-up|8|||
145255253|NCT01371721|523778640|FG001|Overall Study|Lost to Follow-up|2|||
145255254|NCT01371721|523778641|FG002|Overall Study|Lost to Follow-up|6|||
145255255|NCT01371721|523778639|FG000|Overall Study|Withdrawal by Subject|5|||
145255256|NCT01371721|523778640|FG001|Overall Study|Withdrawal by Subject|7|||
145255257|NCT01371721|523778641|FG002|Overall Study|Withdrawal by Subject|11|||
145255258|NCT01371721|523778639|FG000|Overall Study|Other|2|||
145255259|NCT01371721|523778640|FG001|Overall Study|Other|3|||
145255260|NCT01371721|523778641|FG002|Overall Study|Other|0|||
145255261|NCT01371721|523778639|FG000|Overall Study|Lack of Efficacy|2|||
145255262|NCT01371721|523778640|FG001|Overall Study|Lack of Efficacy|4|||
145255263|NCT01371721|523778641|FG002|Overall Study|Lack of Efficacy|3|||
145255264|NCT01371721|523778639|FG000|Overall Study|Randomized but not treated|1|||
145255265|NCT01371721|523778640|FG001|Overall Study|Randomized but not treated|0|||
145255266|NCT01371721|523778641|FG002|Overall Study|Randomized but not treated|0|||
145255267|NCT01610414|523778643|FG000|Study Start - Month 13|Serious Adverse Event|65|||
145255268|NCT01610414|523778644|FG001|Study Start - Month 13|Serious Adverse Event|67|||
145255269|NCT01610414|523778643|FG000|Study Start - Month 13|Adverse Event|14|||
145255270|NCT01610414|523778644|FG001|Study Start - Month 13|Adverse Event|14|||
145255271|NCT01610414|523778643|FG000|Study Start - Month 13|Protocol Violation|3|||
145255272|NCT01610414|523778644|FG001|Study Start - Month 13|Protocol Violation|1|||
145255273|NCT01610414|523778643|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
145255274|NCT01610414|523778644|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
145255275|NCT01610414|523778643|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
145255276|NCT01610414|523778644|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
145255277|NCT01610414|523778643|FG000|Study Start - Month 13|Lost to Follow-up|4|||
145255278|NCT01610414|523778644|FG001|Study Start - Month 13|Lost to Follow-up|6|||
145255279|NCT01610414|523778643|FG000|Study Start - Month 13|Suspected HZ episode|1|||
145255280|NCT01610414|523778644|FG001|Study Start - Month 13|Suspected HZ episode|3|||
145255281|NCT01610414|523778643|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
145255282|NCT01610414|523778644|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
145255283|NCT01610414|523778643|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
145255284|NCT01610414|523778644|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
145255285|NCT01610414|523778643|FG000|Month 13 - Month 25|Adverse Event|8|||
145255286|NCT01610414|523778644|FG001|Month 13 - Month 25|Adverse Event|4|||
145255287|NCT01610414|523778643|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
145255288|NCT01610414|523778644|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
145255289|NCT01610414|523778643|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
145255290|NCT01610414|523778644|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
145255291|NCT01610414|523778643|FG000|Month 13 - Month 25|Protocol Violation|0|||
145255292|NCT01610414|523778644|FG001|Month 13 - Month 25|Protocol Violation|2|||
145255293|NCT01610414|523778643|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
145255294|NCT01610414|523778644|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
145255295|NCT01610414|523778643|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
145255296|NCT01610414|523778644|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
145255297|NCT01610414|523778643|FG000|After Month 25|Study end not reached|48|||
145255298|NCT01610414|523778644|FG001|After Month 25|Study end not reached|53|||
145255299|NCT02483611|523778657|FG000|Overall Study|Protocol Violation|0|||
145255300|NCT02483611|523778658|FG001|Overall Study|Protocol Violation|0|||
145255301|NCT02483611|523778659|FG002|Overall Study|Protocol Violation|1|||
145255302|NCT02520141|523778666|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
145255303|NCT02036476|523778671|FG000|Overall Study|Withdrawal by Subject|2|||
145255304|NCT02036476|523778671|FG000|Overall Study|Progressive Disease|4|||
145255305|NCT02036476|523778671|FG000|Overall Study|Unacceptable Toxicity|2|||
145255306|NCT02168816|523778672|FG000|Overall Study|Lost to Follow-up|2|||
145255307|NCT02168816|523778673|FG001|Overall Study|Lost to Follow-up|2|||
145255308|NCT01984294|523778678|FG000|Overall Study|Randomized but Never Treated|0|||
145255309|NCT01984294|523778679|FG001|Overall Study|Randomized but Never Treated|0|||
145255310|NCT01984294|523778680|FG002|Overall Study|Randomized but Never Treated|1|||
145255311|NCT01984294|523778678|FG000|Overall Study|Lack of Efficacy|4|||
145255312|NCT01984294|523778679|FG001|Overall Study|Lack of Efficacy|2|||
145255313|NCT01984294|523778680|FG002|Overall Study|Lack of Efficacy|6|||
145255314|NCT01984294|523778678|FG000|Overall Study|Adverse Event|0|||
145255315|NCT01984294|523778679|FG001|Overall Study|Adverse Event|1|||
145255316|NCT01984294|523778680|FG002|Overall Study|Adverse Event|0|||
145255317|NCT01066546|523778681|FG000|Overall Study|Study terminated by sponsor|5|||
145255318|NCT03452397|523778686|FG000|Overall Study|Adverse Event|1|||
145255319|NCT03452397|523778687|FG001|Overall Study|Adverse Event|0|||
145255320|NCT03452397|523778688|FG002|Overall Study|Adverse Event|0|||
145255321|NCT03452397|523778689|FG003|Overall Study|Adverse Event|0|||
145255322|NCT03452397|523778686|FG000|Overall Study|Administrative reason|0|||
145255323|NCT03452397|523778687|FG001|Overall Study|Administrative reason|0|||
145255324|NCT03452397|523778688|FG002|Overall Study|Administrative reason|1|||
145255325|NCT03452397|523778689|FG003|Overall Study|Administrative reason|1|||
145255326|NCT03452397|523778686|FG000|Overall Study|Withdrawal by Subject|0|||
145255327|NCT03452397|523778687|FG001|Overall Study|Withdrawal by Subject|0|||
145255328|NCT03452397|523778688|FG002|Overall Study|Withdrawal by Subject|1|||
145255329|NCT03452397|523778689|FG003|Overall Study|Withdrawal by Subject|0|||
145255330|NCT03258762|523778690|FG000|Overall Study|Lost to Follow-up|0|||
145255331|NCT03258762|523778691|FG001|Overall Study|Lost to Follow-up|1|||
145255332|NCT00125268|523778692|FG000|Overall Study|Withdrawal by Subject|1|||
145255333|NCT00125268|523778693|FG001|Overall Study|Withdrawal by Subject|1|||
145255334|NCT01711359|523778694|FG000|Treatment Period|Withdrawal by Subject|18|||
145255335|NCT01711359|523778695|FG001|Treatment Period|Withdrawal by Subject|7|||
145255336|NCT01711359|523778696|FG002|Treatment Period|Withdrawal by Subject|13|||
145255337|NCT01711359|523778694|FG000|Treatment Period|Lack of Efficacy|13|||
145255338|NCT01711359|523778695|FG001|Treatment Period|Lack of Efficacy|2|||
145255339|NCT01711359|523778696|FG002|Treatment Period|Lack of Efficacy|2|||
145255340|NCT01711359|523778694|FG000|Treatment Period|Adverse Event|8|||
145255341|NCT01711359|523778695|FG001|Treatment Period|Adverse Event|10|||
145255342|NCT01711359|523778696|FG002|Treatment Period|Adverse Event|24|||
145255343|NCT01711359|523778694|FG000|Treatment Period|Physician Decision|4|||
145255344|NCT01711359|523778695|FG001|Treatment Period|Physician Decision|3|||
145255345|NCT01711359|523778696|FG002|Treatment Period|Physician Decision|2|||
145255346|NCT01711359|523778694|FG000|Treatment Period|Death|3|||
145255347|NCT01711359|523778695|FG001|Treatment Period|Death|0|||
145255348|NCT01711359|523778696|FG002|Treatment Period|Death|0|||
145255349|NCT01711359|523778694|FG000|Treatment Period|Entry Criteria Not Met|1|||
145255350|NCT01711359|523778695|FG001|Treatment Period|Entry Criteria Not Met|0|||
145255351|NCT01711359|523778696|FG002|Treatment Period|Entry Criteria Not Met|0|||
145255352|NCT01711359|523778694|FG000|Treatment Period|Sponsor Decision|1|||
145255353|NCT01711359|523778695|FG001|Treatment Period|Sponsor Decision|0|||
145255354|NCT01711359|523778696|FG002|Treatment Period|Sponsor Decision|0|||
145255355|NCT01711359|523778694|FG000|Treatment Period|Lost to Follow-up|1|||
145255356|NCT01711359|523778695|FG001|Treatment Period|Lost to Follow-up|1|||
145255357|NCT01711359|523778696|FG002|Treatment Period|Lost to Follow-up|1|||
145255358|NCT01711359|523778694|FG000|Treatment Period|Randomized, Not Treated|3|||
145255359|NCT01711359|523778695|FG001|Treatment Period|Randomized, Not Treated|1|||
145255360|NCT01711359|523778696|FG002|Treatment Period|Randomized, Not Treated|0|||
145255361|NCT02691468|523778697|FG000|Overall Study|Bronchial blocker use|2|||
145255362|NCT02691468|523778698|FG001|Overall Study|Bronchial blocker use|1|||
145255363|NCT02691468|523778697|FG000|Overall Study|Lost to Follow-up|2|||
145255364|NCT02691468|523778698|FG001|Overall Study|Lost to Follow-up|1|||
145255365|NCT02691468|523778697|FG000|Overall Study|Failure to advance FOB|2|||
145255366|NCT02691468|523778698|FG001|Overall Study|Failure to advance FOB|0|||
145255367|NCT01021423|523778702|FG000|Overall Study|Study terminated|4|||
145255368|NCT01021423|523778703|FG001|Overall Study|Study terminated|5|||
145255369|NCT03756285|523778704|FG000|Overall Study|Lost to Follow-up|0|||
145410632|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145410633|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145410634|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145410635|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145410636|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145255370|NCT03756285|523778705|FG001|Overall Study|Lost to Follow-up|1|||
145410637|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
145255371|NCT03756285|523778704|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
145255372|NCT03756285|523778705|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
145255373|NCT03756285|523778704|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
145255374|NCT03756285|523778705|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
145255375|NCT00286156|523778707|FG000|Overall Study|Missed 12 month visit|0|||
145255376|NCT00286156|523778708|FG001|Overall Study|Missed 12 month visit|0|||
145255377|NCT00286156|523778709|FG002|Overall Study|Missed 12 month visit|1|||
145255378|NCT00286156|523778707|FG000|Overall Study|AE: pulmonary embolus|0|||
145255379|NCT00286156|523778708|FG001|Overall Study|AE: pulmonary embolus|1|||
145255380|NCT00286156|523778709|FG002|Overall Study|AE: pulmonary embolus|0|||
145255381|NCT00286156|523778707|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
145255382|NCT00286156|523778708|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
145255383|NCT00286156|523778709|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
145255384|NCT00286156|523778707|FG000|Overall Study|AE: pneumonia|1|||
145255385|NCT00286156|523778708|FG001|Overall Study|AE: pneumonia|0|||
145566704|NCT01604343|524936189|FG000|Week 52 to Week 104|Adverse Event|0|||
145255386|NCT00286156|523778709|FG002|Overall Study|AE: pneumonia|0|||
145255387|NCT06334055|523778710|FG000|Overall Study|Adverse Event|4|||
145255388|NCT06334055|523778710|FG000|Overall Study|Disqualified|72|||
145255389|NCT05281094|523778711|FG000|Overall Study|Adverse Event|1|||
145255390|NCT05281094|523778712|FG001|Overall Study|Adverse Event|0|||
145255391|NCT05281094|523778711|FG000|Overall Study|Lost to Follow-up|29|||
145255392|NCT05281094|523778712|FG001|Overall Study|Lost to Follow-up|22|||
145255393|NCT05281094|523778711|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
145255394|NCT05281094|523778712|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
145255395|NCT05281094|523778711|FG000|Overall Study|Death|1|||
145255396|NCT05281094|523778712|FG001|Overall Study|Death|2|||
145255397|NCT05281094|523778711|FG000|Overall Study|Not pre-specified reason|8|||
145255398|NCT05281094|523778712|FG001|Overall Study|Not pre-specified reason|5|||
145255399|NCT00631969|523778713|FG000|Overall Study|Adverse Event|3|||
145255400|NCT00631969|523778714|FG001|Overall Study|Adverse Event|1|||
145255401|NCT00631969|523778713|FG000|Overall Study|Lack of Efficacy|2|||
145255402|NCT00631969|523778714|FG001|Overall Study|Lack of Efficacy|8|||
145255403|NCT00631969|523778713|FG000|Overall Study|Lost to Follow-up|2|||
145255404|NCT00631969|523778714|FG001|Overall Study|Lost to Follow-up|1|||
145255405|NCT00631969|523778713|FG000|Overall Study|Protocol Violation|1|||
145255406|NCT00631969|523778714|FG001|Overall Study|Protocol Violation|1|||
145255407|NCT00631969|523778713|FG000|Overall Study|Consent Withdrawn|5|||
145255408|NCT00631969|523778714|FG001|Overall Study|Consent Withdrawn|7|||
145255409|NCT00631969|523778713|FG000|Overall Study|Noncompliant With Study Medication|0|||
145255410|NCT00631969|523778714|FG001|Overall Study|Noncompliant With Study Medication|1|||
145255411|NCT00631969|523778713|FG000|Overall Study|No Drug Exposure|2|||
145255412|NCT00631969|523778714|FG001|Overall Study|No Drug Exposure|2|||
145255413|NCT02390167|523781379|FG000|Overall Study|Lost to Follow-up|1|||
145255414|NCT01265719|523781380|FG000|Overall Study|Does not meet entrance criteria|0|||
145255415|NCT01265719|523781381|FG001|Overall Study|Does not meet entrance criteria|3|||
145255416|NCT01265719|523781380|FG000|Overall Study|Other reasons|2|||
145255417|NCT01265719|523781381|FG001|Overall Study|Other reasons|0|||
145255418|NCT01265719|523781380|FG000|Overall Study|Withdrawal by Subject|8|||
145255419|NCT01265719|523781381|FG001|Overall Study|Withdrawal by Subject|3|||
145255420|NCT01265719|523781380|FG000|Overall Study|Lost to Follow-up|2|||
145255421|NCT01265719|523781381|FG001|Overall Study|Lost to Follow-up|7|||
145255422|NCT01265719|523781380|FG000|Overall Study|Adverse Event|2|||
145255423|NCT01265719|523781381|FG001|Overall Study|Adverse Event|0|||
145255424|NCT00027027|523781383|FG000|Overall Study|Adverse Event|0|||
145255425|NCT00027027|523781384|FG001|Overall Study|Adverse Event|0|||
145255426|NCT00027027|523781385|FG002|Overall Study|Adverse Event|1|||
145255427|NCT00027027|523781386|FG003|Overall Study|Adverse Event|0|||
145255428|NCT00027027|523781387|FG004|Overall Study|Adverse Event|1|||
145255429|NCT00027027|523781383|FG000|Overall Study|Admitted for Signs of PD|0|||
145255430|NCT00027027|523781384|FG001|Overall Study|Admitted for Signs of PD|0|||
145255431|NCT00027027|523781385|FG002|Overall Study|Admitted for Signs of PD|0|||
145255432|NCT00027027|523781386|FG003|Overall Study|Admitted for Signs of PD|0|||
145255433|NCT00027027|523781387|FG004|Overall Study|Admitted for Signs of PD|1|||
145255434|NCT00027027|523781383|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
145255435|NCT00027027|523781384|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
145255436|NCT00027027|523781385|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
145255437|NCT00027027|523781386|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
145255438|NCT00027027|523781387|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
145255439|NCT00027027|523781383|FG000|Overall Study|PD Requiring Surgery|0|||
145255440|NCT00027027|523781384|FG001|Overall Study|PD Requiring Surgery|0|||
145255441|NCT00027027|523781385|FG002|Overall Study|PD Requiring Surgery|1|||
145255442|NCT00027027|523781386|FG003|Overall Study|PD Requiring Surgery|0|||
145255443|NCT00027027|523781387|FG004|Overall Study|PD Requiring Surgery|0|||
145255444|NCT00027027|523781383|FG000|Overall Study|Physician Decision Due To PD|2|||
145255445|NCT00027027|523781384|FG001|Overall Study|Physician Decision Due To PD|3|||
145255446|NCT00027027|523781385|FG002|Overall Study|Physician Decision Due To PD|2|||
145255447|NCT00027027|523781386|FG003|Overall Study|Physician Decision Due To PD|3|||
145255448|NCT00027027|523781387|FG004|Overall Study|Physician Decision Due To PD|5|||
145255449|NCT00027027|523781383|FG000|Overall Study|Withdrawal by Subject|0|||
145255450|NCT00027027|523781384|FG001|Overall Study|Withdrawal by Subject|0|||
145255451|NCT00027027|523781385|FG002|Overall Study|Withdrawal by Subject|0|||
145255452|NCT00027027|523781386|FG003|Overall Study|Withdrawal by Subject|0|||
145255453|NCT00027027|523781387|FG004|Overall Study|Withdrawal by Subject|1|||
145255454|NCT01967134|523781391|FG000|Overall Study|Lost to Follow-up|0|||
145255455|NCT01967134|523781392|FG001|Overall Study|Lost to Follow-up|1|||
145255456|NCT01967134|523781393|FG002|Overall Study|Lost to Follow-up|0|||
145255457|NCT04735432|523781395|FG000|Overall Study|Other - due to personal reason|1|||
145255458|NCT04735432|523781396|FG001|Overall Study|Other - due to personal reason|0|||
145255459|NCT04735432|523781395|FG000|Overall Study|Adverse Event|2|||
145255460|NCT04735432|523781396|FG001|Overall Study|Adverse Event|0|||
145410638|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
145255461|NCT00945945|523781397|FG000|Overall Study|Adverse Event|15|||
145255462|NCT00945945|523781398|FG001|Overall Study|Adverse Event|35|||
145255463|NCT00945945|523781397|FG000|Overall Study|Withdrawal by Subject|7|||
145255464|NCT00945945|523781398|FG001|Overall Study|Withdrawal by Subject|10|||
145255465|NCT00945945|523781397|FG000|Overall Study|Lost to Follow-up|4|||
145255466|NCT00945945|523781398|FG001|Overall Study|Lost to Follow-up|5|||
145255467|NCT00945945|523781397|FG000|Overall Study|Lack of Efficacy|6|||
145255468|NCT00945945|523781398|FG001|Overall Study|Lack of Efficacy|2|||
145255469|NCT00945945|523781397|FG000|Overall Study|Protocol Violation|4|||
145255470|NCT00945945|523781398|FG001|Overall Study|Protocol Violation|2|||
145255471|NCT00945945|523781397|FG000|Overall Study|Entry Criteria Not Met|0|||
145255472|NCT00945945|523781398|FG001|Overall Study|Entry Criteria Not Met|1|||
145255473|NCT01066819|523781399|FG000|Overall Study|Adverse Event|18|||
145255474|NCT01066819|523781400|FG001|Overall Study|Adverse Event|1|||
145255475|NCT01066819|523781401|FG002|Overall Study|Adverse Event|6|||
145255476|NCT01066819|523781402|FG003|Overall Study|Adverse Event|0|||
145255477|NCT01066819|523781403|FG004|Overall Study|Adverse Event|0|||
145255478|NCT01066819|523781404|FG005|Overall Study|Adverse Event|0|||
145255479|NCT01066819|523781399|FG000|Overall Study|Death|5|||
145255480|NCT01066819|523781400|FG001|Overall Study|Death|0|||
145255481|NCT01066819|523781401|FG002|Overall Study|Death|1|||
145255482|NCT01066819|523781402|FG003|Overall Study|Death|0|||
145255483|NCT01066819|523781403|FG004|Overall Study|Death|0|||
145255484|NCT01066819|523781404|FG005|Overall Study|Death|0|||
145255485|NCT01066819|523781399|FG000|Overall Study|Lack of Efficacy|22|||
145255486|NCT01066819|523781400|FG001|Overall Study|Lack of Efficacy|1|||
145255487|NCT01066819|523781401|FG002|Overall Study|Lack of Efficacy|2|||
145255488|NCT01066819|523781402|FG003|Overall Study|Lack of Efficacy|1|||
145255489|NCT01066819|523781403|FG004|Overall Study|Lack of Efficacy|0|||
145255490|NCT01066819|523781404|FG005|Overall Study|Lack of Efficacy|0|||
145255491|NCT01066819|523781399|FG000|Overall Study|Physician Decision|6|||
145255492|NCT01066819|523781400|FG001|Overall Study|Physician Decision|2|||
145255493|NCT01066819|523781401|FG002|Overall Study|Physician Decision|3|||
145255494|NCT01066819|523781402|FG003|Overall Study|Physician Decision|0|||
145255495|NCT01066819|523781403|FG004|Overall Study|Physician Decision|0|||
145255496|NCT01066819|523781404|FG005|Overall Study|Physician Decision|0|||
145255497|NCT01066819|523781399|FG000|Overall Study|Protocol Violation|12|||
145255498|NCT01066819|523781400|FG001|Overall Study|Protocol Violation|6|||
145255499|NCT01066819|523781401|FG002|Overall Study|Protocol Violation|0|||
145255500|NCT01066819|523781402|FG003|Overall Study|Protocol Violation|0|||
145255501|NCT01066819|523781403|FG004|Overall Study|Protocol Violation|0|||
145255502|NCT01066819|523781404|FG005|Overall Study|Protocol Violation|0|||
145255503|NCT01066819|523781399|FG000|Overall Study|Withdrawal by Subject|29|||
145255504|NCT01066819|523781400|FG001|Overall Study|Withdrawal by Subject|11|||
145255505|NCT01066819|523781401|FG002|Overall Study|Withdrawal by Subject|6|||
145255506|NCT01066819|523781402|FG003|Overall Study|Withdrawal by Subject|0|||
145255507|NCT01066819|523781403|FG004|Overall Study|Withdrawal by Subject|0|||
145255508|NCT01066819|523781404|FG005|Overall Study|Withdrawal by Subject|0|||
145255509|NCT01066819|523781399|FG000|Overall Study|Administrative|6|||
145255510|NCT01066819|523781400|FG001|Overall Study|Administrative|4|||
145255511|NCT01066819|523781401|FG002|Overall Study|Administrative|2|||
145255512|NCT01066819|523781402|FG003|Overall Study|Administrative|0|||
145255513|NCT01066819|523781403|FG004|Overall Study|Administrative|0|||
145255514|NCT01066819|523781404|FG005|Overall Study|Administrative|0|||
145255515|NCT01066819|523781399|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
145255516|NCT01066819|523781400|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
145255517|NCT01066819|523781401|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
145255518|NCT01066819|523781402|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
145255519|NCT01066819|523781403|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
145255520|NCT01066819|523781404|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
145255521|NCT01066819|523781399|FG000|Overall Study|Early termination|2|||
145255522|NCT01066819|523781400|FG001|Overall Study|Early termination|0|||
145255523|NCT01066819|523781401|FG002|Overall Study|Early termination|0|||
145255524|NCT01066819|523781402|FG003|Overall Study|Early termination|0|||
145255525|NCT01066819|523781403|FG004|Overall Study|Early termination|0|||
145255526|NCT01066819|523781404|FG005|Overall Study|Early termination|0|||
145255527|NCT01066819|523781399|FG000|Overall Study|Failed to return|298|||
145255528|NCT01066819|523781400|FG001|Overall Study|Failed to return|107|||
145255529|NCT01066819|523781401|FG002|Overall Study|Failed to return|68|||
145255530|NCT01066819|523781402|FG003|Overall Study|Failed to return|7|||
145300351|NCT00218257|523953144|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
145255531|NCT01066819|523781403|FG004|Overall Study|Failed to return|2|||
145255532|NCT01066819|523781404|FG005|Overall Study|Failed to return|3|||
145255533|NCT01066819|523781399|FG000|Overall Study|Lab test not done|9|||
145255534|NCT01066819|523781400|FG001|Overall Study|Lab test not done|0|||
145255535|NCT01066819|523781401|FG002|Overall Study|Lab test not done|2|||
145255536|NCT01066819|523781402|FG003|Overall Study|Lab test not done|1|||
145255537|NCT01066819|523781403|FG004|Overall Study|Lab test not done|0|||
145255538|NCT01066819|523781404|FG005|Overall Study|Lab test not done|0|||
145410639|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
145410640|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
145410641|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
145410642|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
145410643|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
145255539|NCT01066819|523781399|FG000|Overall Study|Miscellaneous|28|||
145255540|NCT01066819|523781400|FG001|Overall Study|Miscellaneous|10|||
145255541|NCT01066819|523781401|FG002|Overall Study|Miscellaneous|18|||
145255542|NCT01066819|523781402|FG003|Overall Study|Miscellaneous|1|||
145255543|NCT01066819|523781403|FG004|Overall Study|Miscellaneous|0|||
145255544|NCT01066819|523781404|FG005|Overall Study|Miscellaneous|0|||
145255545|NCT01066819|523781399|FG000|Overall Study|Non responders|123|||
145255546|NCT01066819|523781400|FG001|Overall Study|Non responders|2|||
145255547|NCT01066819|523781401|FG002|Overall Study|Non responders|7|||
145255548|NCT01066819|523781402|FG003|Overall Study|Non responders|2|||
145255549|NCT01066819|523781403|FG004|Overall Study|Non responders|0|||
145255550|NCT01066819|523781404|FG005|Overall Study|Non responders|1|||
145255551|NCT01066819|523781399|FG000|Overall Study|Not categorised|9|||
145255552|NCT01066819|523781400|FG001|Overall Study|Not categorised|2|||
145255553|NCT01066819|523781401|FG002|Overall Study|Not categorised|6|||
145255554|NCT01066819|523781402|FG003|Overall Study|Not categorised|1|||
145255555|NCT01066819|523781403|FG004|Overall Study|Not categorised|0|||
145255556|NCT01066819|523781404|FG005|Overall Study|Not categorised|0|||
145255557|NCT01066819|523781399|FG000|Overall Study|Relapse|16|||
145255558|NCT01066819|523781400|FG001|Overall Study|Relapse|4|||
145255559|NCT01066819|523781401|FG002|Overall Study|Relapse|3|||
145255560|NCT01066819|523781402|FG003|Overall Study|Relapse|0|||
145255561|NCT01066819|523781403|FG004|Overall Study|Relapse|0|||
145255562|NCT01066819|523781404|FG005|Overall Study|Relapse|0|||
145255563|NCT01066819|523781399|FG000|Overall Study|Results not available|1|||
145255564|NCT01066819|523781400|FG001|Overall Study|Results not available|0|||
145255565|NCT01066819|523781401|FG002|Overall Study|Results not available|0|||
145255566|NCT01066819|523781402|FG003|Overall Study|Results not available|0|||
145255567|NCT01066819|523781403|FG004|Overall Study|Results not available|0|||
145255568|NCT01066819|523781404|FG005|Overall Study|Results not available|0|||
145255569|NCT01066819|523781399|FG000|Overall Study|Screen failure|1|||
145255570|NCT01066819|523781400|FG001|Overall Study|Screen failure|0|||
145255571|NCT01066819|523781401|FG002|Overall Study|Screen failure|0|||
145255572|NCT01066819|523781402|FG003|Overall Study|Screen failure|0|||
145255573|NCT01066819|523781403|FG004|Overall Study|Screen failure|0|||
145255574|NCT01066819|523781404|FG005|Overall Study|Screen failure|0|||
145255575|NCT01066819|523781399|FG000|Overall Study|Spontaneous cure|1|||
145255576|NCT01066819|523781400|FG001|Overall Study|Spontaneous cure|0|||
145255577|NCT01066819|523781401|FG002|Overall Study|Spontaneous cure|0|||
145255578|NCT01066819|523781402|FG003|Overall Study|Spontaneous cure|0|||
145255579|NCT01066819|523781403|FG004|Overall Study|Spontaneous cure|0|||
145255580|NCT01066819|523781404|FG005|Overall Study|Spontaneous cure|0|||
145255581|NCT01066819|523781399|FG000|Overall Study|Treatment never started|85|||
145255582|NCT01066819|523781400|FG001|Overall Study|Treatment never started|19|||
145255583|NCT01066819|523781401|FG002|Overall Study|Treatment never started|19|||
145255584|NCT01066819|523781402|FG003|Overall Study|Treatment never started|3|||
145255585|NCT01066819|523781403|FG004|Overall Study|Treatment never started|2|||
145255586|NCT01066819|523781404|FG005|Overall Study|Treatment never started|2|||
145255587|NCT01066819|523781399|FG000|Overall Study|Treatment stopped|12|||
145255588|NCT01066819|523781400|FG001|Overall Study|Treatment stopped|1|||
145255589|NCT01066819|523781401|FG002|Overall Study|Treatment stopped|2|||
145255590|NCT01066819|523781402|FG003|Overall Study|Treatment stopped|1|||
145255591|NCT01066819|523781403|FG004|Overall Study|Treatment stopped|0|||
145410644|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
145410645|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
145410646|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145410647|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145255592|NCT01066819|523781404|FG005|Overall Study|Treatment stopped|0|||
145255593|NCT01066819|523781399|FG000|Overall Study|Other|5|||
145255594|NCT01066819|523781400|FG001|Overall Study|Other|1|||
145255595|NCT01066819|523781401|FG002|Overall Study|Other|1|||
145255596|NCT01066819|523781402|FG003|Overall Study|Other|0|||
145255597|NCT01066819|523781403|FG004|Overall Study|Other|0|||
145255598|NCT01066819|523781404|FG005|Overall Study|Other|0|||
145255599|NCT00805194|523781405|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
145255600|NCT00805194|523781406|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
145255601|NCT00805194|523781405|FG000|Overall Study|Worsening or AE of underlying disease|64|||
145410648|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145255602|NCT00805194|523781406|FG001|Overall Study|Worsening or AE of underlying disease|70|||
145255603|NCT00805194|523781405|FG000|Overall Study|Other AE|84|||
145255604|NCT00805194|523781406|FG001|Overall Study|Other AE|73|||
145255605|NCT00805194|523781405|FG000|Overall Study|Protocol Violation|9|||
145255606|NCT00805194|523781406|FG001|Overall Study|Protocol Violation|9|||
145255607|NCT00805194|523781405|FG000|Overall Study|Lost to Follow-up|5|||
145255608|NCT00805194|523781406|FG001|Overall Study|Lost to Follow-up|5|||
145255609|NCT00805194|523781405|FG000|Overall Study|Withdrawal by Subject|60|||
145255610|NCT00805194|523781406|FG001|Overall Study|Withdrawal by Subject|42|||
145255611|NCT00805194|523781405|FG000|Overall Study|Not treated|3|||
145255612|NCT00805194|523781406|FG001|Overall Study|Not treated|4|||
145255613|NCT00805194|523781405|FG000|Overall Study|Reasons other than stated above|20|||
145255614|NCT00805194|523781406|FG001|Overall Study|Reasons other than stated above|16|||
145255615|NCT00718887|523781408|FG000|Overall Study|Withdrawal by Subject|3|||
145255616|NCT00718887|523781409|FG001|Overall Study|Withdrawal by Subject|2|||
145255617|NCT00718887|523781408|FG000|Overall Study|Not identified|2|||
145255618|NCT00718887|523781409|FG001|Overall Study|Not identified|7|||
145255619|NCT00775138|523781410|FG000|Overall Study|Withdrawal by Subject|0|||
145255620|NCT00775138|523781411|FG001|Overall Study|Withdrawal by Subject|0|||
145255621|NCT00775138|523781412|FG002|Overall Study|Withdrawal by Subject|2|||
145255622|NCT00775138|523781413|FG003|Overall Study|Withdrawal by Subject|2|||
145255623|NCT00775138|523781410|FG000|Overall Study|Adverse Event|0|||
145255624|NCT00775138|523781411|FG001|Overall Study|Adverse Event|0|||
145255625|NCT00775138|523781412|FG002|Overall Study|Adverse Event|1|||
145255626|NCT00775138|523781413|FG003|Overall Study|Adverse Event|0|||
145255627|NCT00535236|523781414|FG000|Overall Study|Adverse Event|1|||
145255628|NCT00535236|523781415|FG001|Overall Study|Adverse Event|0|||
145255629|NCT00535236|523781416|FG002|Overall Study|Adverse Event|9|||
145255630|NCT00535236|523781417|FG003|Overall Study|Adverse Event|3|||
145255631|NCT00535236|523781418|FG004|Overall Study|Adverse Event|3|||
145255632|NCT00535236|523781419|FG005|Overall Study|Adverse Event|0|||
145255633|NCT00535236|523781420|FG006|Overall Study|Adverse Event|5|||
145255634|NCT00535236|523781421|FG007|Overall Study|Adverse Event|1|||
145255635|NCT00535236|523781422|FG008|Overall Study|Adverse Event|2|||
145255636|NCT00535236|523781423|FG009|Overall Study|Adverse Event|1|||
145255637|NCT00535236|523781414|FG000|Overall Study|Lost to Follow-up|1|||
145255638|NCT00535236|523781415|FG001|Overall Study|Lost to Follow-up|2|||
145255639|NCT00535236|523781416|FG002|Overall Study|Lost to Follow-up|0|||
145255640|NCT00535236|523781417|FG003|Overall Study|Lost to Follow-up|0|||
145255641|NCT00535236|523781418|FG004|Overall Study|Lost to Follow-up|2|||
145255642|NCT00535236|523781419|FG005|Overall Study|Lost to Follow-up|0|||
145255643|NCT00535236|523781420|FG006|Overall Study|Lost to Follow-up|0|||
145255644|NCT00535236|523781421|FG007|Overall Study|Lost to Follow-up|0|||
145255645|NCT00535236|523781422|FG008|Overall Study|Lost to Follow-up|6|||
145255646|NCT00535236|523781423|FG009|Overall Study|Lost to Follow-up|1|||
145255647|NCT00535236|523781414|FG000|Overall Study|Physician Decision|0|||
145255648|NCT00535236|523781415|FG001|Overall Study|Physician Decision|0|||
145255649|NCT00535236|523781416|FG002|Overall Study|Physician Decision|0|||
145255650|NCT00535236|523781417|FG003|Overall Study|Physician Decision|0|||
145255651|NCT00535236|523781418|FG004|Overall Study|Physician Decision|1|||
145255652|NCT00535236|523781419|FG005|Overall Study|Physician Decision|0|||
145255653|NCT00535236|523781420|FG006|Overall Study|Physician Decision|1|||
145255654|NCT00535236|523781421|FG007|Overall Study|Physician Decision|0|||
145255655|NCT00535236|523781422|FG008|Overall Study|Physician Decision|0|||
145255656|NCT00535236|523781423|FG009|Overall Study|Physician Decision|0|||
145255657|NCT00535236|523781414|FG000|Overall Study|Protocol Violation|2|||
145255658|NCT00535236|523781415|FG001|Overall Study|Protocol Violation|0|||
145255659|NCT00535236|523781416|FG002|Overall Study|Protocol Violation|1|||
145255660|NCT00535236|523781417|FG003|Overall Study|Protocol Violation|0|||
145255661|NCT00535236|523781418|FG004|Overall Study|Protocol Violation|0|||
145255662|NCT00535236|523781419|FG005|Overall Study|Protocol Violation|0|||
145255663|NCT00535236|523781420|FG006|Overall Study|Protocol Violation|0|||
145255664|NCT00535236|523781421|FG007|Overall Study|Protocol Violation|0|||
145255665|NCT00535236|523781422|FG008|Overall Study|Protocol Violation|1|||
145255666|NCT00535236|523781423|FG009|Overall Study|Protocol Violation|0|||
145255667|NCT00535236|523781414|FG000|Overall Study|Withdrawal by Subject|3|||
145255668|NCT00535236|523781415|FG001|Overall Study|Withdrawal by Subject|0|||
145255669|NCT00535236|523781416|FG002|Overall Study|Withdrawal by Subject|2|||
145255670|NCT00535236|523781417|FG003|Overall Study|Withdrawal by Subject|1|||
145255671|NCT00535236|523781418|FG004|Overall Study|Withdrawal by Subject|6|||
145255672|NCT00535236|523781419|FG005|Overall Study|Withdrawal by Subject|1|||
145255673|NCT00535236|523781420|FG006|Overall Study|Withdrawal by Subject|5|||
145255674|NCT00535236|523781421|FG007|Overall Study|Withdrawal by Subject|0|||
145255675|NCT00535236|523781422|FG008|Overall Study|Withdrawal by Subject|4|||
145255676|NCT00535236|523781423|FG009|Overall Study|Withdrawal by Subject|2|||
145255677|NCT04880642|523781424|FG000|Randomization|Withdrawal by Subject|2|||
145255678|NCT04880642|523781425|FG001|Randomization|Withdrawal by Subject|3|||
145255679|NCT04880642|523781424|FG000|Treatment Period|Adverse Event|0|||
145255680|NCT04880642|523781425|FG001|Treatment Period|Adverse Event|1|||
145255681|NCT04880642|523781424|FG000|Treatment Period|Death|6|||
145255682|NCT04880642|523781425|FG001|Treatment Period|Death|6|||
145255683|NCT04880642|523781424|FG000|Treatment Period|Lost to Follow-up|1|||
145255684|NCT04880642|523781425|FG001|Treatment Period|Lost to Follow-up|0|||
145255685|NCT04880642|523781424|FG000|Treatment Period|Protocol Violation|0|||
145255686|NCT04880642|523781425|FG001|Treatment Period|Protocol Violation|1|||
145566705|NCT01604343|524936190|FG001|Week 52 to Week 104|Adverse Event|12|||
145566706|NCT01604343|524936191|FG002|Week 52 to Week 104|Adverse Event|26|||
145255687|NCT04880642|523781424|FG000|Treatment Period|Withdrawal by Subject|5|||
145255688|NCT04880642|523781425|FG001|Treatment Period|Withdrawal by Subject|3|||
145255689|NCT04880642|523781424|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
145255690|NCT04880642|523781425|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
145255691|NCT04880642|523781424|FG000|Follow-up|Death|4|||
145255692|NCT04880642|523781425|FG001|Follow-up|Death|3|||
145255693|NCT04880642|523781424|FG000|Follow-up|Withdrawal by Subject|1|||
145255694|NCT04880642|523781425|FG001|Follow-up|Withdrawal by Subject|0|||
145255695|NCT02275052|523781426|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145255696|NCT02275052|523781427|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145255697|NCT02275052|523781428|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145255698|NCT02275052|523781429|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145255699|NCT02275052|523781426|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
145255700|NCT02275052|523781427|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
145255701|NCT02275052|523781428|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
145255702|NCT02275052|523781429|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
145255703|NCT02275052|523781426|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
145255704|NCT02275052|523781427|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
145255705|NCT02275052|523781428|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145255706|NCT02275052|523781429|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145255707|NCT02275052|523781426|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
145255708|NCT02275052|523781427|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
145255709|NCT02275052|523781428|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
145300352|NCT00218257|523953145|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
145300353|NCT02096211|523953146|FG000|Overall Study|Death|2|||
145300354|NCT02096211|523953146|FG000|Overall Study|Withdrawal by Subject|8|||
145300355|NCT02096211|523953146|FG000|Overall Study|Revision of implant|7|||
145300356|NCT02096211|523953146|FG000|Overall Study|Lost to Follow-up|43|||
145300357|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
145300358|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
145300359|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Death|2|||
145300360|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Death|1|||
145300361|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
145300362|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
145300363|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
145300364|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
145300365|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Other|8|||
145300366|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Other|13|||
145300367|NCT01439880|523953151|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
145300368|NCT01439880|523953152|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
145300369|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
145300370|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
145300371|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
145300372|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
145300373|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Death|3|||
145300374|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Death|13|||
145300375|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
145300376|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
145300377|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Other|14|||
145300378|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Other|31|||
145300379|NCT01439880|523953151|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
145300380|NCT01439880|523953152|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
145300381|NCT03874715|523953155|FG000|Overall Study|Adverse Event|2|||
145300382|NCT03874715|523953156|FG001|Overall Study|Adverse Event|0|||
145300383|NCT03874715|523953155|FG000|Overall Study|Poor compliance to protocol|5|||
145300384|NCT03874715|523953156|FG001|Overall Study|Poor compliance to protocol|1|||
145300385|NCT03874715|523953155|FG000|Overall Study|Withdrawal by Subject|1|||
145300386|NCT03874715|523953156|FG001|Overall Study|Withdrawal by Subject|0|||
145300387|NCT03874715|523953155|FG000|Overall Study|Other-unspecified|1|||
145300388|NCT03874715|523953156|FG001|Overall Study|Other-unspecified|0|||
145300389|NCT00328926|523953157|FG000|Overall Study|Pregnancy|2|||
145300390|NCT00328926|523953158|FG001|Overall Study|Pregnancy|1|||
145566707|NCT01604343|524936192|FG003|Week 52 to Week 104|Adverse Event|21|||
145566708|NCT01604343|524936193|FG004|Week 52 to Week 104|Adverse Event|27|||
145255710|NCT02275052|523781429|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
145300391|NCT00328926|523953159|FG002|Overall Study|Pregnancy|0|||
145566709|NCT01604343|524936189|FG000|Week 52 to Week 104|Death|0|||
145566710|NCT01604343|524936190|FG001|Week 52 to Week 104|Death|4|||
145300392|NCT00328926|523953157|FG000|Overall Study|Lost to Follow-up|0|||
145300393|NCT00328926|523953158|FG001|Overall Study|Lost to Follow-up|1|||
145255711|NCT02275052|523781426|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
145255712|NCT02275052|523781427|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
145255713|NCT02275052|523781428|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
145255714|NCT02275052|523781429|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
145255715|NCT02275052|523781426|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
145255716|NCT02275052|523781427|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
145255717|NCT02275052|523781428|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
145255718|NCT02275052|523781429|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
145255719|NCT02275052|523781426|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
145255720|NCT02275052|523781427|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
145255721|NCT02275052|523781428|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
145255722|NCT02275052|523781429|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
145255723|NCT02275052|523781426|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145255724|NCT02275052|523781427|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145255725|NCT02275052|523781428|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
145255726|NCT02275052|523781429|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
145255727|NCT02275052|523781426|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145255728|NCT02275052|523781427|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145255729|NCT02275052|523781428|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145255730|NCT02275052|523781429|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
145255731|NCT02275052|523781426|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145255732|NCT02275052|523781427|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145255733|NCT02275052|523781428|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145255734|NCT02275052|523781429|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
145255735|NCT02275052|523781426|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145255736|NCT02275052|523781427|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145255737|NCT02275052|523781428|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145255738|NCT02275052|523781429|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
145255739|NCT00561795|523781430|FG000|Overall Study|Adverse Event|3|||
145255740|NCT00561795|523781431|FG001|Overall Study|Adverse Event|3|||
145255741|NCT00561795|523781432|FG002|Overall Study|Adverse Event|0|||
145255742|NCT00561795|523781433|FG003|Overall Study|Adverse Event|0|||
145255743|NCT00561795|523781430|FG000|Overall Study|Study Closed/Terminated|0|||
145255744|NCT00561795|523781431|FG001|Overall Study|Study Closed/Terminated|3|||
145255745|NCT00561795|523781432|FG002|Overall Study|Study Closed/Terminated|0|||
145255746|NCT00561795|523781433|FG003|Overall Study|Study Closed/Terminated|0|||
145255747|NCT00561795|523781430|FG000|Overall Study|Physician Decision|1|||
145255748|NCT00561795|523781431|FG001|Overall Study|Physician Decision|0|||
145255749|NCT00561795|523781432|FG002|Overall Study|Physician Decision|0|||
145255750|NCT00561795|523781433|FG003|Overall Study|Physician Decision|0|||
145255751|NCT00948389|523781436|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
145255752|NCT00948389|523781437|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
145255753|NCT00948389|523781438|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
145255754|NCT00948389|523781439|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
145255755|NCT00948389|523781440|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
145255756|NCT00948389|523781436|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
145255757|NCT00948389|523781437|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
145255758|NCT00948389|523781438|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
145255759|NCT00948389|523781439|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
145255760|NCT00948389|523781440|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
145255761|NCT00948389|523781436|FG000|Overall Study|Both Progression and Toxicity|1|||
145255762|NCT00948389|523781437|FG001|Overall Study|Both Progression and Toxicity|0|||
145255763|NCT00948389|523781438|FG002|Overall Study|Both Progression and Toxicity|0|||
145255764|NCT00948389|523781439|FG003|Overall Study|Both Progression and Toxicity|0|||
145255765|NCT00948389|523781440|FG004|Overall Study|Both Progression and Toxicity|0|||
145255766|NCT00568399|523781442|FG000|Overall Study|Death|2|||
145255767|NCT00568399|523781442|FG000|Overall Study|Adverse Event|5|||
145255768|NCT00568399|523781442|FG000|Overall Study|Withdrawal by Subject|8|||
145255769|NCT02967562|523781443|FG000|Overall Study|Consent not obtained|1|||
145255770|NCT02967562|523781444|FG001|Overall Study|Consent not obtained|0|||
145255771|NCT02967562|523781443|FG000|Overall Study|High leak precluding analysis|1|||
145255772|NCT02967562|523781444|FG001|Overall Study|High leak precluding analysis|1|||
145255773|NCT01488994|523781447|FG000|Overall Study|Withdrawal by Subject|0|||
145255774|NCT01488994|523781448|FG001|Overall Study|Withdrawal by Subject|1|||
145255775|NCT01072500|523781449|FG000|Overall Study|Death|2|||
145255776|NCT01072500|523781450|FG001|Overall Study|Death|2|||
145255777|NCT01072500|523781449|FG000|Overall Study|Lost to Follow-up|5|||
145410649|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145255778|NCT01072500|523781450|FG001|Overall Study|Lost to Follow-up|2|||
145255779|NCT01072500|523781449|FG000|Overall Study|Withdrawal by Subject|17|||
145255780|NCT01072500|523781450|FG001|Overall Study|Withdrawal by Subject|10|||
145255781|NCT02908841|523781451|FG000|Overall Study|Physician Decision|4|||
145255782|NCT02908841|523781452|FG001|Overall Study|Physician Decision|0|||
145255783|NCT01611558|523781453|FG000|Induction Phase|Study drug toxicity|15|||
145255784|NCT01611558|523781453|FG000|Induction Phase|Disease progression|18|||
145255785|NCT01611558|523781453|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
145255786|NCT01611558|523781453|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
145255787|NCT01611558|523781453|FG000|Induction Phase|Death|1|||
145255788|NCT01611558|523781453|FG000|Maintenance Phase|Withdrawal by Subject|1|||
145255789|NCT01611558|523781453|FG000|Maintenance Phase|Elevated Uric acid|1|||
145255790|NCT03798366|523781465|FG000|Overall Study|Lost to Follow-up|0|||
145255791|NCT03798366|523781466|FG001|Overall Study|Lost to Follow-up|1|||
145255792|NCT01412333|523781470|FG000|Overall Study|Adverse Event|40|||
145255793|NCT01412333|523781471|FG001|Overall Study|Adverse Event|42|||
145255794|NCT01412333|523781470|FG000|Overall Study|Death|5|||
145255795|NCT01412333|523781471|FG001|Overall Study|Death|6|||
145255796|NCT01412333|523781470|FG000|Overall Study|Lack of Efficacy|22|||
145255797|NCT01412333|523781471|FG001|Overall Study|Lack of Efficacy|10|||
145255798|NCT01412333|523781470|FG000|Overall Study|Lost to Follow-up|15|||
145255799|NCT01412333|523781471|FG001|Overall Study|Lost to Follow-up|12|||
145255800|NCT01412333|523781470|FG000|Overall Study|Non-Compliance|3|||
145255801|NCT01412333|523781471|FG001|Overall Study|Non-Compliance|7|||
145255802|NCT01412333|523781470|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145255803|NCT01412333|523781471|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145255804|NCT01412333|523781470|FG000|Overall Study|Other|30|||
145255805|NCT01412333|523781471|FG001|Overall Study|Other|33|||
145255806|NCT01412333|523781470|FG000|Overall Study|Physician Decision|11|||
145255807|NCT01412333|523781471|FG001|Overall Study|Physician Decision|16|||
145255808|NCT01412333|523781470|FG000|Overall Study|Pregnancy|6|||
145255809|NCT01412333|523781471|FG001|Overall Study|Pregnancy|4|||
145255810|NCT01412333|523781470|FG000|Overall Study|Protocol Violation|1|||
145255811|NCT01412333|523781471|FG001|Overall Study|Protocol Violation|2|||
145255812|NCT01412333|523781470|FG000|Overall Study|Study Terminated By Sponsor|3|||
145255813|NCT01412333|523781471|FG001|Overall Study|Study Terminated By Sponsor|2|||
145255814|NCT01412333|523781470|FG000|Overall Study|Withdrawal by Subject|51|||
145255815|NCT01412333|523781471|FG001|Overall Study|Withdrawal by Subject|54|||
145255816|NCT01412333|523781470|FG000|Overall Study|Missing|1|||
145255817|NCT01412333|523781471|FG001|Overall Study|Missing|3|||
145255818|NCT04005885|523781472|FG000|First Intervention|Withdrawal by Subject|1|||
145255819|NCT04005885|523781473|FG001|First Intervention|Withdrawal by Subject|1|||
145255820|NCT04005885|523781472|FG000|Second Intervention|Withdrawal by Subject|0|||
145255821|NCT04005885|523781473|FG001|Second Intervention|Withdrawal by Subject|2|||
145255822|NCT00750867|523781475|FG000|Overall Study|Adverse Event|2|||
145255823|NCT00474539|523781476|FG000|Infant Series|Withdrawal by Subject|3|||
145255824|NCT00474539|523781477|FG001|Infant Series|Withdrawal by Subject|4|||
145255825|NCT00474539|523781476|FG000|Infant Series|Randomization error|5|||
145255826|NCT00474539|523781477|FG001|Infant Series|Randomization error|0|||
145255827|NCT00474539|523781476|FG000|Infant Series|Lost to Follow-up|2|||
145255828|NCT00474539|523781477|FG001|Infant Series|Lost to Follow-up|1|||
145255829|NCT00474539|523781476|FG000|Infant Series|Protocol Violation|0|||
145255830|NCT00474539|523781477|FG001|Infant Series|Protocol Violation|1|||
145255831|NCT00474539|523781476|FG000|After Infant Series|Lost to Follow-up|3|||
145255832|NCT00474539|523781477|FG001|After Infant Series|Lost to Follow-up|0|||
145255833|NCT00474539|523781476|FG000|After Infant Series|Withdrawal by Subject|1|||
145255834|NCT00474539|523781477|FG001|After Infant Series|Withdrawal by Subject|0|||
145255835|NCT00474539|523781476|FG000|Toddler Dose|Protocol Violation|1|||
145255836|NCT00474539|523781477|FG001|Toddler Dose|Protocol Violation|0|||
145255837|NCT03018340|523781478|FG000|Overall Study|Adverse Event|1|||
145255838|NCT03018340|523781479|FG001|Overall Study|Adverse Event|2|||
145566711|NCT01604343|524936191|FG002|Week 52 to Week 104|Death|2|||
145255839|NCT03018340|523781478|FG000|Overall Study|Withdrawal by Subject|0|||
145255840|NCT03018340|523781479|FG001|Overall Study|Withdrawal by Subject|8|||
145255841|NCT03018340|523781478|FG000|Overall Study|Lack of Efficacy|0|||
145255842|NCT03018340|523781479|FG001|Overall Study|Lack of Efficacy|1|||
145255843|NCT03018340|523781478|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
145255844|NCT03018340|523781479|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
145255845|NCT03018340|523781478|FG000|Overall Study|Lost to Follow-up|1|||
145255846|NCT03018340|523781479|FG001|Overall Study|Lost to Follow-up|7|||
145255847|NCT03018340|523781478|FG000|Overall Study|Protocol Violation|3|||
145255848|NCT03018340|523781479|FG001|Overall Study|Protocol Violation|7|||
145255849|NCT03018340|523781478|FG000|Overall Study|Not further specified|0|||
145255850|NCT03018340|523781479|FG001|Overall Study|Not further specified|1|||
145566712|NCT01604343|524936192|FG003|Week 52 to Week 104|Death|5|||
145255851|NCT01836549|523781480|FG000|Overall Study|Did not receive study drug|0|||
145255852|NCT01836549|523781481|FG001|Overall Study|Did not receive study drug|0|||
145255853|NCT01836549|523781482|FG002|Overall Study|Did not receive study drug|1|||
145255854|NCT01836549|523781483|FG003|Overall Study|Did not receive study drug|0|||
145255855|NCT01836549|523781484|FG004|Overall Study|Did not receive study drug|0|||
145255856|NCT01836549|523781485|FG005|Overall Study|Did not receive study drug|0|||
145566713|NCT01604343|524936193|FG004|Week 52 to Week 104|Death|0|||
145255857|NCT01836549|523781486|FG006|Overall Study|Did not receive study drug|0|||
145255858|NCT01836549|523781480|FG000|Overall Study|Patient declared ineligible|0|||
145255859|NCT01836549|523781481|FG001|Overall Study|Patient declared ineligible|0|||
145255860|NCT01836549|523781482|FG002|Overall Study|Patient declared ineligible|0|||
145255861|NCT01836549|523781483|FG003|Overall Study|Patient declared ineligible|1|||
145255862|NCT01836549|523781484|FG004|Overall Study|Patient declared ineligible|0|||
145255863|NCT01836549|523781485|FG005|Overall Study|Patient declared ineligible|0|||
145255864|NCT01836549|523781486|FG006|Overall Study|Patient declared ineligible|0|||
145255865|NCT01836549|523781480|FG000|Overall Study|Patient inevaluable to start therapy|0|||
145255866|NCT01836549|523781481|FG001|Overall Study|Patient inevaluable to start therapy|0|||
145255867|NCT01836549|523781482|FG002|Overall Study|Patient inevaluable to start therapy|0|||
145255868|NCT01836549|523781483|FG003|Overall Study|Patient inevaluable to start therapy|0|||
145255869|NCT01836549|523781484|FG004|Overall Study|Patient inevaluable to start therapy|0|||
145255870|NCT01836549|523781485|FG005|Overall Study|Patient inevaluable to start therapy|0|||
145255871|NCT01836549|523781486|FG006|Overall Study|Patient inevaluable to start therapy|1|||
145255872|NCT01657253|523781489|FG000|Overall Study|Lost to Follow-up|6|||
145255873|NCT01657253|523781490|FG001|Overall Study|Lost to Follow-up|5|||
145255874|NCT01657253|523781489|FG000|Overall Study|Withdrawal by Subject|11|||
145255875|NCT01657253|523781490|FG001|Overall Study|Withdrawal by Subject|12|||
145255876|NCT01657253|523781489|FG000|Overall Study|Adverse Event|0|||
145255877|NCT01657253|523781490|FG001|Overall Study|Adverse Event|1|||
145255878|NCT01970540|523781491|FG000|Overall Study|Non-treatment-related AE|0|||
145255879|NCT01970540|523781492|FG001|Overall Study|Non-treatment-related AE|0|||
145255880|NCT01970540|523781493|FG002|Overall Study|Non-treatment-related AE|1|||
145255881|NCT01970540|523781491|FG000|Overall Study|Progressive disease|55|||
145255882|NCT01970540|523781492|FG001|Overall Study|Progressive disease|23|||
145255883|NCT01970540|523781493|FG002|Overall Study|Progressive disease|10|||
145255884|NCT01970540|523781491|FG000|Overall Study|Treatment delay over protocol|0|||
145255885|NCT01970540|523781492|FG001|Overall Study|Treatment delay over protocol|0|||
145255886|NCT01970540|523781493|FG002|Overall Study|Treatment delay over protocol|1|||
145255887|NCT01970540|523781491|FG000|Overall Study|Physician Decision|7|||
145255888|NCT01970540|523781492|FG001|Overall Study|Physician Decision|2|||
145255889|NCT01970540|523781493|FG002|Overall Study|Physician Decision|0|||
145255890|NCT01970540|523781491|FG000|Overall Study|Clinical progression|0|||
145255891|NCT01970540|523781492|FG001|Overall Study|Clinical progression|1|||
145255892|NCT01970540|523781493|FG002|Overall Study|Clinical progression|1|||
145255893|NCT01970540|523781491|FG000|Overall Study|End of study|2|||
145255894|NCT01970540|523781492|FG001|Overall Study|End of study|0|||
145255895|NCT01970540|523781493|FG002|Overall Study|End of study|2|||
145255896|NCT01970540|523781491|FG000|Overall Study|Adverse Event|0|||
145255897|NCT01970540|523781492|FG001|Overall Study|Adverse Event|2|||
145255898|NCT01970540|523781493|FG002|Overall Study|Adverse Event|1|||
145255899|NCT01970540|523781491|FG000|Overall Study|Treatment-related AE|4|||
145255900|NCT01970540|523781492|FG001|Overall Study|Treatment-related AE|0|||
145255901|NCT01970540|523781493|FG002|Overall Study|Treatment-related AE|2|||
145255902|NCT01970540|523781491|FG000|Overall Study|Withdrawal by Subject|4|||
145255903|NCT01970540|523781492|FG001|Overall Study|Withdrawal by Subject|0|||
145255904|NCT01970540|523781493|FG002|Overall Study|Withdrawal by Subject|1|||
145255905|NCT01970540|523781491|FG000|Overall Study|Clinical deterioration|1|||
145255906|NCT01970540|523781492|FG001|Overall Study|Clinical deterioration|0|||
145255907|NCT01970540|523781493|FG002|Overall Study|Clinical deterioration|0|||
145255908|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Adverse Event|30|||
145255909|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Adverse Event|25|||
145255910|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Adverse Event|23|||
145255911|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Adverse Event|14|||
145255912|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Death|0|||
145255913|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Death|0|||
145255914|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Death|1|||
145255915|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Death|0|||
145255916|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Physician Decision|0|||
145255917|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Physician Decision|1|||
145255918|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Physician Decision|0|||
145255919|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Physician Decision|1|||
145255920|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
145255921|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
145255922|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
145255923|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
145255924|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Other|6|||
145255925|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Other|1|||
145255926|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Other|0|||
145255927|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Other|2|||
145255928|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
145255929|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
145255930|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
145255931|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
145255932|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
145255933|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
145255934|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
145255935|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
145255936|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
145255937|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
145255938|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
145255939|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
145255940|NCT00242710|523781494|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
145255941|NCT00242710|523781495|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
145255942|NCT00242710|523781496|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
145255943|NCT00242710|523781497|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
145255944|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Adverse Event|2|||
145255945|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Adverse Event|3|||
145255946|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Adverse Event|5|||
145255947|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Adverse Event|2|||
145255948|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Physician Decision|1|||
145255949|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Physician Decision|1|||
145255950|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Physician Decision|0|||
145255951|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Physician Decision|0|||
145255952|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Other|24|||
145255953|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Other|24|||
145255954|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Other|9|||
145255955|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Other|11|||
145255956|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Extension not Available|17|||
145255957|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Extension not Available|21|||
145255958|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Extension not Available|8|||
145255959|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Extension not Available|7|||
145255960|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
145255961|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
145255962|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
145255963|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
145255964|NCT00242710|523781494|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
145255965|NCT00242710|523781495|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
145255966|NCT00242710|523781496|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
145255967|NCT00242710|523781497|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
145255968|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
145255969|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
145255970|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
145255971|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
145255972|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Death|0|||
145255973|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Death|0|||
145255974|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Death|0|||
145255975|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Death|1|||
145255976|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
145255977|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
145255978|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
145255979|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
145255980|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Other|3|||
145255981|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Other|5|||
145255982|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Other|4|||
145255983|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Other|3|||
145255984|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
145255985|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
145255986|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
145255987|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
145255988|NCT00242710|523781494|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
145255989|NCT00242710|523781495|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
145255990|NCT00242710|523781496|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
145566714|NCT01604343|524936189|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
145255991|NCT00242710|523781497|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
145255992|NCT00579527|523781498|FG000|Overall Study|Death|4|||
145255993|NCT02555722|523781499|FG000|Week 2|Adverse Event|0|||
145255994|NCT02555722|523781500|FG001|Week 2|Adverse Event|1|||
145255995|NCT02555722|523781499|FG000|Week 2|Withdrawal by Subject|1|||
145255996|NCT02555722|523781500|FG001|Week 2|Withdrawal by Subject|0|||
145255997|NCT02555722|523781499|FG000|Month 1|Lens Discomfort|1|||
145255998|NCT02555722|523781500|FG001|Month 1|Lens Discomfort|0|||
145255999|NCT02555722|523781499|FG000|Month 2|Withdrawal by Subject|3|||
145410650|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145410651|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
145410652|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
145410653|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145410654|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145410655|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145566715|NCT01604343|524936190|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
145566716|NCT01604343|524936191|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
145256000|NCT02555722|523781500|FG001|Month 2|Withdrawal by Subject|0|||
145256001|NCT02555722|523781499|FG000|Month 2|Lost to Follow-up|1|||
145256002|NCT02555722|523781500|FG001|Month 2|Lost to Follow-up|0|||
145256003|NCT00702949|523781501|FG000|Overall Study|Refusal|3|||
145256004|NCT00702949|523781502|FG001|Overall Study|Refusal|2|||
145256005|NCT00702949|523781503|FG002|Overall Study|Refusal|2|||
145256006|NCT00702949|523781501|FG000|Overall Study|Adverse Event|1|||
145256007|NCT00702949|523781502|FG001|Overall Study|Adverse Event|6|||
145256008|NCT00702949|523781503|FG002|Overall Study|Adverse Event|3|||
145256009|NCT00702949|523781501|FG000|Overall Study|Other Medical Reason/unknown|1|||
145256010|NCT00702949|523781502|FG001|Overall Study|Other Medical Reason/unknown|1|||
145256011|NCT00702949|523781503|FG002|Overall Study|Other Medical Reason/unknown|3|||
145256012|NCT00523744|523781507|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
145256013|NCT00523744|523781507|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
145256014|NCT00523744|523781507|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
145256015|NCT00523744|523781507|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
145256016|NCT00523744|523781507|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
145256017|NCT00523744|523781507|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
145256018|NCT00542425|523781511|FG000|Initial 24 Weeks|Administrative reasons|0|||
145256019|NCT00542425|523781512|FG001|Initial 24 Weeks|Administrative reasons|0|||
145256020|NCT00542425|523781513|FG002|Initial 24 Weeks|Administrative reasons|1|||
145256021|NCT00542425|523781514|FG003|Initial 24 Weeks|Administrative reasons|1|||
145256022|NCT00542425|523781515|FG004|Initial 24 Weeks|Administrative reasons|0|||
145256023|NCT00542425|523781511|FG000|Initial 24 Weeks|Adverse Event|0|||
145256024|NCT00542425|523781512|FG001|Initial 24 Weeks|Adverse Event|1|||
145256025|NCT00542425|523781513|FG002|Initial 24 Weeks|Adverse Event|1|||
145256026|NCT00542425|523781514|FG003|Initial 24 Weeks|Adverse Event|3|||
145256027|NCT00542425|523781515|FG004|Initial 24 Weeks|Adverse Event|2|||
145256028|NCT00542425|523781511|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
145256029|NCT00542425|523781512|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
145300394|NCT00328926|523953159|FG002|Overall Study|Lost to Follow-up|0|||
145300395|NCT00328926|523953157|FG000|Overall Study|Death|0|||
145300396|NCT00328926|523953158|FG001|Overall Study|Death|0|||
145300397|NCT00328926|523953159|FG002|Overall Study|Death|1|||
145300398|NCT00328926|523953157|FG000|Overall Study|In vitro fertilization treatment|0|||
145300399|NCT00328926|523953158|FG001|Overall Study|In vitro fertilization treatment|0|||
145300400|NCT00328926|523953159|FG002|Overall Study|In vitro fertilization treatment|1|||
145300401|NCT00328926|523953157|FG000|Overall Study|Lack of ovarian response|0|||
145300402|NCT00328926|523953158|FG001|Overall Study|Lack of ovarian response|1|||
145300403|NCT00328926|523953159|FG002|Overall Study|Lack of ovarian response|0|||
145300404|NCT02269657|523953160|FG000|Overall Study|Protocol Violation|3|||
145300405|NCT02956460|523953161|FG000|Lens 1|Lost to Follow-up|1|||
145300406|NCT02956460|523953162|FG001|Lens 1|Lost to Follow-up|0|||
145300407|NCT00834249|523953163|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145300408|NCT00834249|523953164|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
145410656|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145566717|NCT01604343|524936192|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
145566718|NCT01604343|524936193|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
145566719|NCT01604343|524936189|FG000|Week 52 to Week 104|Physician Decision|0|||
145566720|NCT01604343|524936190|FG001|Week 52 to Week 104|Physician Decision|1|||
145566721|NCT01604343|524936191|FG002|Week 52 to Week 104|Physician Decision|0|||
145566722|NCT01604343|524936192|FG003|Week 52 to Week 104|Physician Decision|0|||
145566723|NCT01604343|524936193|FG004|Week 52 to Week 104|Physician Decision|2|||
145566724|NCT01604343|524936189|FG000|Week 52 to Week 104|Pregnancy|0|||
145566725|NCT01604343|524936190|FG001|Week 52 to Week 104|Pregnancy|0|||
145566726|NCT01604343|524936191|FG002|Week 52 to Week 104|Pregnancy|1|||
145566727|NCT01604343|524936192|FG003|Week 52 to Week 104|Pregnancy|2|||
145256030|NCT00542425|523781513|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
145256031|NCT00542425|523781514|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
145256032|NCT00542425|523781515|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
145256033|NCT00542425|523781511|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
145256034|NCT00542425|523781512|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
145256035|NCT00542425|523781513|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
145256036|NCT00542425|523781514|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
145256037|NCT00542425|523781515|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
145256038|NCT00542425|523781511|FG000|Initial 24 Weeks|Non-compliance|0|||
145256039|NCT00542425|523781512|FG001|Initial 24 Weeks|Non-compliance|0|||
145300409|NCT00834249|523953163|FG000|Second Intervention|Adverse Event|1|||
145256040|NCT00542425|523781513|FG002|Initial 24 Weeks|Non-compliance|0|||
145256041|NCT00542425|523781514|FG003|Initial 24 Weeks|Non-compliance|1|||
145256042|NCT00542425|523781515|FG004|Initial 24 Weeks|Non-compliance|1|||
145256043|NCT00542425|523781511|FG000|Initial 24 Weeks|Protocol Violation|0|||
145256044|NCT00542425|523781512|FG001|Initial 24 Weeks|Protocol Violation|0|||
145256045|NCT00542425|523781513|FG002|Initial 24 Weeks|Protocol Violation|0|||
145256046|NCT00542425|523781514|FG003|Initial 24 Weeks|Protocol Violation|1|||
145256047|NCT00542425|523781515|FG004|Initial 24 Weeks|Protocol Violation|0|||
145256048|NCT00542425|523781511|FG000|Initial 24 Weeks|Refusal of treatment|2|||
145256049|NCT00542425|523781512|FG001|Initial 24 Weeks|Refusal of treatment|2|||
145256050|NCT00542425|523781513|FG002|Initial 24 Weeks|Refusal of treatment|1|||
145256051|NCT00542425|523781514|FG003|Initial 24 Weeks|Refusal of treatment|4|||
145256052|NCT00542425|523781515|FG004|Initial 24 Weeks|Refusal of treatment|1|||
145256053|NCT00542425|523781511|FG000|Initial 24 Weeks|Other|0|||
145256054|NCT00542425|523781512|FG001|Initial 24 Weeks|Other|2|||
145256055|NCT00542425|523781513|FG002|Initial 24 Weeks|Other|1|||
145256056|NCT00542425|523781514|FG003|Initial 24 Weeks|Other|0|||
145256057|NCT00542425|523781515|FG004|Initial 24 Weeks|Other|0|||
145256058|NCT00542425|523781511|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
145256059|NCT00542425|523781512|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
145256060|NCT00542425|523781513|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
145256061|NCT00542425|523781514|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
145256062|NCT00542425|523781515|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
145256063|NCT00542425|523781511|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
145256064|NCT00542425|523781512|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
145256065|NCT00542425|523781513|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
145256066|NCT00542425|523781514|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
145256067|NCT00542425|523781515|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
145256068|NCT00542425|523781511|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
145256069|NCT00542425|523781512|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
145256070|NCT00542425|523781513|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
145256071|NCT00542425|523781514|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
145256072|NCT00542425|523781515|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
145256073|NCT00542425|523781511|FG000|Extended 24 Weeks of Treatment|Other|1|||
145256074|NCT00542425|523781512|FG001|Extended 24 Weeks of Treatment|Other|1|||
145256075|NCT00542425|523781513|FG002|Extended 24 Weeks of Treatment|Other|0|||
145256076|NCT00542425|523781514|FG003|Extended 24 Weeks of Treatment|Other|0|||
145256077|NCT00542425|523781515|FG004|Extended 24 Weeks of Treatment|Other|1|||
145256078|NCT00826540|523781518|FG000|Overall Study|ineligible|3|||
145256079|NCT00826540|523781518|FG000|Overall Study|Withdrawal by Subject|1|||
145256080|NCT01166386|523781519|FG000|Overall Study|Withdrawal by Subject|3|||
145256081|NCT01166386|523781520|FG001|Overall Study|Withdrawal by Subject|5|||
145256082|NCT02802735|523781521|FG000|Overall Study|Withdrawal by Subject|0|||
145256083|NCT02802735|523781522|FG001|Overall Study|Withdrawal by Subject|1|||
145256084|NCT02802735|523781523|FG002|Overall Study|Withdrawal by Subject|0|||
145256085|NCT02802735|523781524|FG003|Overall Study|Withdrawal by Subject|0|||
145256086|NCT02802735|523781525|FG004|Overall Study|Withdrawal by Subject|0|||
145256087|NCT03922711|523781526|FG000|Overall Study|Adverse Event|3|||
145256088|NCT03922711|523781527|FG001|Overall Study|Adverse Event|2|||
145256089|NCT03922711|523781528|FG002|Overall Study|Adverse Event|2|||
145300410|NCT00834249|523953164|FG001|Second Intervention|Adverse Event|0|||
145300411|NCT03450057|523953167|FG000|Overall Study|Death|17|||
145300412|NCT03450057|523953167|FG000|Overall Study|ICF withdrawal|4|||
145300413|NCT03450057|523953167|FG000|Overall Study|Lost to Follow-up|2|||
145300414|NCT04129346|523953168|FG000|Overall Study|Death|1|||
145300415|NCT04129346|523953169|FG001|Overall Study|Death|0|||
145300416|NCT05755282|523953170|FG000|Overall Study|Protocol Violation|0|||
145300417|NCT05755282|523953171|FG001|Overall Study|Protocol Violation|1|||
145300418|NCT00573066|523953172|FG000|Overall Study|Exclusion criteria|18|||
145300419|NCT00573066|523953172|FG000|Overall Study|IV malfunction|1|||
145566728|NCT01604343|524936193|FG004|Week 52 to Week 104|Pregnancy|1|||
145566729|NCT01604343|524936189|FG000|Week 52 to Week 104|Other|0|||
145566730|NCT01604343|524936190|FG001|Week 52 to Week 104|Other|11|||
145566731|NCT01604343|524936191|FG002|Week 52 to Week 104|Other|11|||
145566732|NCT01604343|524936192|FG003|Week 52 to Week 104|Other|6|||
145256090|NCT03922711|523781526|FG000|Overall Study|Protocol Violation|1|||
145256091|NCT03922711|523781527|FG001|Overall Study|Protocol Violation|0|||
145256092|NCT03922711|523781528|FG002|Overall Study|Protocol Violation|0|||
145256093|NCT03922711|523781526|FG000|Overall Study|Withdrawal by Subject|0|||
145256094|NCT03922711|523781527|FG001|Overall Study|Withdrawal by Subject|3|||
145256095|NCT03922711|523781528|FG002|Overall Study|Withdrawal by Subject|1|||
145256096|NCT03922711|523781526|FG000|Overall Study|Not further specified|0|||
145300420|NCT00573066|523953172|FG000|Overall Study|Postoperative bleeding|1|||
145300421|NCT01015703|523953173|FG000|Overall Study|Withdrawal by Subject|0|||
145256097|NCT03922711|523781527|FG001|Overall Study|Not further specified|0|||
145256098|NCT03922711|523781528|FG002|Overall Study|Not further specified|1|||
145566733|NCT01604343|524936193|FG004|Week 52 to Week 104|Other|3|||
145410657|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
145410658|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
145410659|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
145410660|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145410661|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145410662|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145410663|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145410664|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145410665|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
145410666|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
145256099|NCT02390362|523781529|FG000|Overall Study|Withdrawal by Subject|0|||
145256100|NCT02390362|523781530|FG001|Overall Study|Withdrawal by Subject|1|||
145256101|NCT04009824|523781531|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
145256102|NCT04009824|523781532|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
145256103|NCT04009824|523781533|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
145256104|NCT04009824|523781534|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
145256105|NCT04009824|523781535|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
145256106|NCT01024946|523781536|FG000|Overall Study|Screen Failure|3|||
145256107|NCT01024946|523781536|FG000|Overall Study|Withdrawal by Subject|1|||
145256108|NCT01024946|523781536|FG000|Overall Study|Adverse Event|1|||
145256109|NCT02608892|523781546|FG000|Overall Study|Lost to Follow-up|1|||
145256110|NCT02608892|523781547|FG001|Overall Study|Lost to Follow-up|0|||
145256111|NCT02590406|523781548|FG000|Overall Study|Adverse Event|1|||
145256112|NCT02590406|523781549|FG001|Overall Study|Adverse Event|0|||
145256113|NCT02590406|523781548|FG000|Overall Study|Saturometer malfunction|0|||
145256114|NCT02590406|523781549|FG001|Overall Study|Saturometer malfunction|1|||
145256115|NCT03032523|523781552|FG000|Overall Study|Withdrawal by Subject|2|||
145256116|NCT03032523|523781553|FG001|Overall Study|Withdrawal by Subject|2|||
145256117|NCT03032523|523781552|FG000|Overall Study|Physician Decision|1|||
145256118|NCT03032523|523781553|FG001|Overall Study|Physician Decision|0|||
145256119|NCT00957723|523781554|FG000|Overall Study|Death|3|||
145256120|NCT00957723|523781554|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
145256121|NCT00957723|523781554|FG000|Overall Study|Lost to Follow-up|8|||
145256122|NCT00957723|523781554|FG000|Overall Study|Withdrawal by Subject|24|||
145256123|NCT00957723|523781554|FG000|Overall Study|Investigative Site Terminated|61|||
145256124|NCT00957723|523781554|FG000|Overall Study|Intercurrent Illness|2|||
145256125|NCT00957723|523781554|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
145256126|NCT00984009|523781555|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
145256127|NCT00281528|523781556|FG000|Overall Study|Progressive Disease|28|||
145256128|NCT00281528|523781557|FG001|Overall Study|Progressive Disease|18|||
145256129|NCT00281528|523781558|FG002|Overall Study|Progressive Disease|27|||
145256130|NCT00281528|523781556|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
145256131|NCT00281528|523781557|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
145256132|NCT00281528|523781558|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
145256133|NCT00281528|523781556|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
145256134|NCT00281528|523781557|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
145256135|NCT00281528|523781558|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
145256136|NCT00281528|523781556|FG000|Overall Study|Physician Decision|11|||
145256137|NCT00281528|523781557|FG001|Overall Study|Physician Decision|4|||
145256138|NCT00281528|523781558|FG002|Overall Study|Physician Decision|5|||
145256139|NCT00281528|523781556|FG000|Overall Study|Protocol Violation|1|||
145256140|NCT00281528|523781557|FG001|Overall Study|Protocol Violation|0|||
145256141|NCT00281528|523781558|FG002|Overall Study|Protocol Violation|1|||
145256142|NCT00281528|523781556|FG000|Overall Study|Withdrawal by Subject|5|||
145256143|NCT00281528|523781557|FG001|Overall Study|Withdrawal by Subject|5|||
145256144|NCT00281528|523781558|FG002|Overall Study|Withdrawal by Subject|7|||
145256145|NCT00281528|523781556|FG000|Overall Study|Other|6|||
145410667|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145410668|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145410669|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145410670|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145566734|NCT01604343|524936189|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
145566735|NCT01604343|524936190|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
145566736|NCT01604343|524936191|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
145256146|NCT00281528|523781557|FG001|Overall Study|Other|3|||
145566737|NCT01604343|524936192|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
145256147|NCT00281528|523781558|FG002|Overall Study|Other|5|||
145256148|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
145256149|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
145256150|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
145256151|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
145256152|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
145256153|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
145256154|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
145256155|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
145256156|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
145256157|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
145256158|NCT02178592|523781559|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
145256159|NCT02178592|523781560|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
145256160|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
145256161|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
145256162|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
145256163|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
145566738|NCT01604343|524936193|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
145566739|NCT01604343|524936189|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
145566740|NCT01604343|524936190|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
145566741|NCT01604343|524936191|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
145566742|NCT01604343|524936192|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
145566743|NCT01604343|524936193|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
145566744|NCT01604343|524936189|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
145566745|NCT01604343|524936190|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
145566746|NCT01604343|524936191|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
145566747|NCT01604343|524936192|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
145566748|NCT01604343|524936193|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
145566749|NCT02871375|524936197|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
145566750|NCT02871375|524936198|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
145566751|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
145566752|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
145566753|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
145566754|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
145566755|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
145566756|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
145566757|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
145566758|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
145566759|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
145566760|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
145566761|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
145566762|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
145566763|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
145566764|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
145566765|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
145566766|NCT03735667|524936199|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
145566767|NCT03735667|524936200|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
145566768|NCT03735667|524936201|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
145566769|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
145566770|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
145566771|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
145566772|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
145566773|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
145566774|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
145566775|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
145566776|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
145566777|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
145566778|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
145256164|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
145256165|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
145256166|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
145256167|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
145256168|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
145256169|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
145256170|NCT02178592|523781559|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
145256171|NCT02178592|523781560|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
145256172|NCT01225211|523781562|FG000|Overall Study|Adverse Event|0|||
145256173|NCT01225211|523781563|FG001|Overall Study|Adverse Event|0|||
145256174|NCT01225211|523781564|FG002|Overall Study|Adverse Event|1|||
145256175|NCT01225211|523781565|FG003|Overall Study|Adverse Event|0|||
145256176|NCT01225211|523781566|FG004|Overall Study|Adverse Event|0|||
145566779|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
145256177|NCT01225211|523781567|FG005|Overall Study|Adverse Event|0|||
145256178|NCT01225211|523781568|FG006|Overall Study|Adverse Event|0|||
145256179|NCT01225211|523781569|FG007|Overall Study|Adverse Event|0|||
145256180|NCT01225211|523781570|FG008|Overall Study|Adverse Event|0|||
145256181|NCT01225211|523781571|FG009|Overall Study|Adverse Event|1|||
145256182|NCT01225211|523781562|FG000|Overall Study|Withdrawal by Subject|0|||
145256183|NCT01225211|523781563|FG001|Overall Study|Withdrawal by Subject|0|||
145256184|NCT01225211|523781564|FG002|Overall Study|Withdrawal by Subject|0|||
145300422|NCT01015703|523953174|FG001|Overall Study|Withdrawal by Subject|1|||
145566780|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
145566781|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
145566782|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
145566783|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
145566784|NCT03735667|524936199|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
145566785|NCT03735667|524936200|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
145566786|NCT03735667|524936201|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
145566787|NCT03792672|524936203|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
145566788|NCT03792672|524936204|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
145566789|NCT03792672|524936205|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
145566790|NCT03792672|524936206|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
145566791|NCT03792672|524936207|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
145566792|NCT03792672|524936208|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
145566793|NCT03792672|524936203|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
145566794|NCT03792672|524936204|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
145566795|NCT03792672|524936205|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
145566796|NCT03792672|524936206|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
145566797|NCT03792672|524936207|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
145566798|NCT03792672|524936208|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
145566799|NCT03792672|524936203|FG000|Treatment Period 4 (2 Days)|Other|1|||
145566800|NCT03792672|524936204|FG001|Treatment Period 4 (2 Days)|Other|0|||
145566801|NCT03792672|524936205|FG002|Treatment Period 4 (2 Days)|Other|0|||
145566802|NCT03792672|524936206|FG003|Treatment Period 4 (2 Days)|Other|0|||
145566803|NCT03792672|524936207|FG004|Treatment Period 4 (2 Days)|Other|0|||
145566804|NCT03792672|524936208|FG005|Treatment Period 4 (2 Days)|Other|0|||
145566805|NCT00453999|524936209|FG000|Overall Study|Adverse Event|1|||
145566806|NCT00453999|524936210|FG001|Overall Study|Adverse Event|2|||
145566807|NCT00453999|524936211|FG002|Overall Study|Adverse Event|1|||
145566808|NCT00453999|524936209|FG000|Overall Study|Lost to Follow-up|0|||
145566809|NCT00453999|524936210|FG001|Overall Study|Lost to Follow-up|1|||
145566810|NCT00453999|524936211|FG002|Overall Study|Lost to Follow-up|1|||
145566811|NCT00453999|524936209|FG000|Overall Study|Withdrawal by Subject|2|||
145566812|NCT00453999|524936210|FG001|Overall Study|Withdrawal by Subject|1|||
145566813|NCT00453999|524936211|FG002|Overall Study|Withdrawal by Subject|1|||
145566814|NCT00453999|524936209|FG000|Overall Study|Subject Request|2|||
145566815|NCT00453999|524936210|FG001|Overall Study|Subject Request|1|||
145566816|NCT00453999|524936211|FG002|Overall Study|Subject Request|0|||
145566817|NCT04960228|524936226|FG000|Overall Study|Withdrawal by Subject|216|||
145566818|NCT04960228|524936227|FG001|Overall Study|Withdrawal by Subject|35|||
145566819|NCT04960228|524936226|FG000|Overall Study|Failed attention check|69|||
145566820|NCT04960228|524936227|FG001|Overall Study|Failed attention check|148|||
145566821|NCT04960228|524936226|FG000|Overall Study|Flagged for response quality by Dynata|3|||
145566822|NCT04960228|524936227|FG001|Overall Study|Flagged for response quality by Dynata|3|||
145566823|NCT01987427|524936228|FG000|Overall Study|Adverse Event|4|||
145566824|NCT01987427|524936229|FG001|Overall Study|Adverse Event|2|||
145566825|NCT01987427|524936230|FG002|Overall Study|Adverse Event|8|||
145566826|NCT01987427|524936228|FG000|Overall Study|Lost to Follow-up|6|||
145566827|NCT01987427|524936229|FG001|Overall Study|Lost to Follow-up|6|||
145566828|NCT01987427|524936230|FG002|Overall Study|Lost to Follow-up|9|||
145566829|NCT01987427|524936228|FG000|Overall Study|Withdrawal by Subject|2|||
145566830|NCT01987427|524936229|FG001|Overall Study|Withdrawal by Subject|1|||
145566831|NCT01987427|524936230|FG002|Overall Study|Withdrawal by Subject|3|||
145566832|NCT01987427|524936228|FG000|Overall Study|Lack of Efficacy|1|||
145566833|NCT01987427|524936229|FG001|Overall Study|Lack of Efficacy|0|||
145566834|NCT01987427|524936230|FG002|Overall Study|Lack of Efficacy|0|||
145566835|NCT01987427|524936228|FG000|Overall Study|Other|1|||
145566836|NCT01987427|524936229|FG001|Overall Study|Other|1|||
145566837|NCT01987427|524936230|FG002|Overall Study|Other|0|||
145566838|NCT02159521|524936231|FG000|Overall Study|Enrolled but not treated|3|||
145566839|NCT02159521|524936231|FG000|Overall Study|Withdrawal by Subject|7|||
145566840|NCT02159521|524936231|FG000|Overall Study|Lost to Follow-up|6|||
145256185|NCT01225211|523781565|FG003|Overall Study|Withdrawal by Subject|0|||
145566841|NCT02159521|524936231|FG000|Overall Study|Death|1|||
145256186|NCT01225211|523781566|FG004|Overall Study|Withdrawal by Subject|0|||
145566842|NCT02159521|524936231|FG000|Overall Study|Other than specified|1|||
145256187|NCT01225211|523781567|FG005|Overall Study|Withdrawal by Subject|0|||
145300423|NCT01015703|523953175|FG002|Overall Study|Withdrawal by Subject|0|||
145566843|NCT00694369|524936232|FG000|Overall Study|Adverse Event|0|||
145566844|NCT00694369|524936233|FG001|Overall Study|Adverse Event|1|||
145566845|NCT00694369|524936234|FG002|Overall Study|Adverse Event|0|||
145566846|NCT00694369|524936235|FG003|Overall Study|Adverse Event|1|||
145566847|NCT00694369|524936236|FG004|Overall Study|Adverse Event|3|||
145566848|NCT00694369|524936232|FG000|Overall Study|Lost to Follow-up|0|||
145566849|NCT00694369|524936233|FG001|Overall Study|Lost to Follow-up|0|||
145566850|NCT00694369|524936234|FG002|Overall Study|Lost to Follow-up|1|||
145566851|NCT00694369|524936235|FG003|Overall Study|Lost to Follow-up|1|||
145566852|NCT00694369|524936236|FG004|Overall Study|Lost to Follow-up|0|||
145566853|NCT00694369|524936232|FG000|Overall Study|Physician Decision|0|||
145566854|NCT00694369|524936233|FG001|Overall Study|Physician Decision|0|||
145566855|NCT00694369|524936234|FG002|Overall Study|Physician Decision|0|||
145566856|NCT00694369|524936235|FG003|Overall Study|Physician Decision|0|||
145566857|NCT00694369|524936236|FG004|Overall Study|Physician Decision|1|||
145566858|NCT00694369|524936232|FG000|Overall Study|Protocol Violation|0|||
145566859|NCT00694369|524936233|FG001|Overall Study|Protocol Violation|1|||
145566860|NCT00694369|524936234|FG002|Overall Study|Protocol Violation|0|||
145566861|NCT00694369|524936235|FG003|Overall Study|Protocol Violation|0|||
145566862|NCT00694369|524936236|FG004|Overall Study|Protocol Violation|0|||
145566863|NCT00694369|524936232|FG000|Overall Study|Withdrawal by Subject|1|||
145256188|NCT01225211|523781568|FG006|Overall Study|Withdrawal by Subject|1|||
145256189|NCT01225211|523781569|FG007|Overall Study|Withdrawal by Subject|0|||
145256190|NCT01225211|523781570|FG008|Overall Study|Withdrawal by Subject|1|||
145256191|NCT01225211|523781571|FG009|Overall Study|Withdrawal by Subject|3|||
145566864|NCT00694369|524936233|FG001|Overall Study|Withdrawal by Subject|1|||
145566865|NCT00694369|524936234|FG002|Overall Study|Withdrawal by Subject|1|||
145566866|NCT00694369|524936235|FG003|Overall Study|Withdrawal by Subject|1|||
145256192|NCT01225211|523781562|FG000|Overall Study|Other|0|||
145566867|NCT00694369|524936236|FG004|Overall Study|Withdrawal by Subject|2|||
145566868|NCT00907374|524936237|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
145566869|NCT00907374|524936238|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
145566870|NCT00785486|524936239|FG000|Midazolam Alone|Withdrawal by Subject|1|||
145566871|NCT03316885|524936240|FG000|Overall Study|Adverse Event|1|||
145566872|NCT03316885|524936240|FG000|Overall Study|Death|10|||
145566873|NCT03316885|524936240|FG000|Overall Study|Lost to Follow-up|4|||
145566874|NCT03316885|524936240|FG000|Overall Study|Withdrawal by Subject|9|||
145566875|NCT03316885|524936240|FG000|Overall Study|COVID related|8|||
145566876|NCT00978068|524936241|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
145566877|NCT00978068|524936242|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
145566878|NCT00978068|524936241|FG000|Overall Study|Death|1|||
145566879|NCT00978068|524936242|FG001|Overall Study|Death|2|||
145566880|NCT00978068|524936241|FG000|Overall Study|Lost to Follow-up|1|||
145566881|NCT00978068|524936242|FG001|Overall Study|Lost to Follow-up|2|||
145566882|NCT00978068|524936241|FG000|Overall Study|Physician Decision|0|||
145566883|NCT00978068|524936242|FG001|Overall Study|Physician Decision|1|||
145566884|NCT00978068|524936241|FG000|Overall Study|Unable to Comply with Study|0|||
145566885|NCT00978068|524936242|FG001|Overall Study|Unable to Comply with Study|2|||
145566886|NCT01148511|524936244|FG000|Exposed to Study Drug|Protocol Violation|2|||
145566887|NCT01148511|524936245|FG001|Exposed to Study Drug|Protocol Violation|0|||
145566888|NCT01148511|524936246|FG002|Exposed to Study Drug|Protocol Violation|0|||
145566889|NCT01148511|524936244|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
145566890|NCT01148511|524936245|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
145566891|NCT01148511|524936246|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
145566892|NCT01148511|524936244|FG000|Randomized|Adverse Event|0|||
145566893|NCT01148511|524936245|FG001|Randomized|Adverse Event|1|||
145566894|NCT01148511|524936246|FG002|Randomized|Adverse Event|0|||
145566895|NCT01148511|524936244|FG000|Randomized|Protocol Violation|0|||
145566896|NCT01148511|524936245|FG001|Randomized|Protocol Violation|2|||
145566897|NCT01148511|524936246|FG002|Randomized|Protocol Violation|1|||
145566898|NCT01148511|524936244|FG000|Randomized|Lost to Follow-up|0|||
145566899|NCT01148511|524936245|FG001|Randomized|Lost to Follow-up|1|||
145256193|NCT01225211|523781563|FG001|Overall Study|Other|0|||
145256194|NCT01225211|523781564|FG002|Overall Study|Other|0|||
145566900|NCT01148511|524936246|FG002|Randomized|Lost to Follow-up|1|||
145566901|NCT01148511|524936244|FG000|Randomized|Consent withdrawal|0|||
145566902|NCT01148511|524936245|FG001|Randomized|Consent withdrawal|5|||
145566903|NCT01148511|524936246|FG002|Randomized|Consent withdrawal|3|||
145566904|NCT01148511|524936244|FG000|Randomized|Other|0|||
145566905|NCT01148511|524936245|FG001|Randomized|Other|1|||
145566906|NCT01148511|524936246|FG002|Randomized|Other|1|||
145566907|NCT01644175|524936249|FG000|Overall Study|Randomized But Not Treated|0|||
145566908|NCT01644175|524936250|FG001|Overall Study|Randomized But Not Treated|2|||
145566909|NCT01644175|524936249|FG000|Overall Study|Adverse Event|8|||
145566910|NCT01644175|524936250|FG001|Overall Study|Adverse Event|13|||
145256195|NCT01225211|523781565|FG003|Overall Study|Other|0|||
145566911|NCT01644175|524936249|FG000|Overall Study|Death|1|||
145566912|NCT01644175|524936250|FG001|Overall Study|Death|2|||
145566913|NCT01644175|524936249|FG000|Overall Study|Poor compliance to protocol|9|||
145256196|NCT01225211|523781566|FG004|Overall Study|Other|0|||
145566914|NCT01644175|524936250|FG001|Overall Study|Poor compliance to protocol|10|||
145566915|NCT01644175|524936249|FG000|Overall Study|Physician Decision|1|||
145566916|NCT01644175|524936250|FG001|Overall Study|Physician Decision|2|||
145566917|NCT01644175|524936249|FG000|Overall Study|Participant Moved|1|||
145566918|NCT01644175|524936250|FG001|Overall Study|Participant Moved|2|||
145566919|NCT01644175|524936249|FG000|Overall Study|Consent withdrawn by participant|3|||
145566920|NCT01644175|524936250|FG001|Overall Study|Consent withdrawn by participant|4|||
145566921|NCT01644175|524936249|FG000|Overall Study|Related to Autoinjector Administration|2|||
145566922|NCT01644175|524936250|FG001|Overall Study|Related to Autoinjector Administration|1|||
145566923|NCT01644175|524936249|FG000|Overall Study|Last visit outside protocol visit window|4|||
145566924|NCT01644175|524936250|FG001|Overall Study|Last visit outside protocol visit window|11|||
145566925|NCT01644175|524936249|FG000|Overall Study|Selection criteria finally not met|0|||
145566926|NCT01644175|524936250|FG001|Overall Study|Selection criteria finally not met|1|||
145566927|NCT01644175|524936249|FG000|Overall Study|Site closure|2|||
145566928|NCT01644175|524936250|FG001|Overall Study|Site closure|2|||
145566929|NCT01644175|524936249|FG000|Overall Study|Lost to Follow-up|1|||
145566930|NCT01644175|524936250|FG001|Overall Study|Lost to Follow-up|0|||
145566931|NCT01644175|524936249|FG000|Overall Study|Other than specified above|0|||
145566932|NCT01644175|524936250|FG001|Overall Study|Other than specified above|3|||
145566933|NCT04258605|524936252|FG000|Overall Study|Death|1|||
145566934|NCT04258605|524936253|FG001|Overall Study|Death|0|||
145566935|NCT04258605|524936252|FG000|Overall Study|Early study termination|21|||
145566936|NCT04258605|524936253|FG001|Overall Study|Early study termination|2|||
145566937|NCT00962104|524936280|FG000|Overall Study|Adverse Event|10|||
145566938|NCT00962104|524936281|FG001|Overall Study|Adverse Event|3|||
145566939|NCT00962104|524936280|FG000|Overall Study|Entry Criteria Not Met|1|||
145566940|NCT00962104|524936281|FG001|Overall Study|Entry Criteria Not Met|2|||
145566941|NCT00962104|524936280|FG000|Overall Study|Lack of Efficacy|0|||
145566942|NCT00962104|524936281|FG001|Overall Study|Lack of Efficacy|1|||
145566943|NCT00962104|524936280|FG000|Overall Study|Lost to Follow-up|10|||
145566944|NCT00962104|524936281|FG001|Overall Study|Lost to Follow-up|4|||
145566945|NCT00962104|524936280|FG000|Overall Study|Physician Decision|1|||
145566946|NCT00962104|524936281|FG001|Overall Study|Physician Decision|0|||
145566947|NCT00962104|524936280|FG000|Overall Study|Protocol Violation|6|||
145566948|NCT00962104|524936281|FG001|Overall Study|Protocol Violation|8|||
145566949|NCT00962104|524936280|FG000|Overall Study|Sponsor Decision|0|||
145566950|NCT00962104|524936281|FG001|Overall Study|Sponsor Decision|1|||
145566951|NCT00962104|524936280|FG000|Overall Study|Withdrawal by Subject|10|||
145566952|NCT00962104|524936281|FG001|Overall Study|Withdrawal by Subject|6|||
145256197|NCT01225211|523781567|FG005|Overall Study|Other|0|||
145256198|NCT01225211|523781568|FG006|Overall Study|Other|0|||
145256199|NCT01225211|523781569|FG007|Overall Study|Other|0|||
145256200|NCT01225211|523781570|FG008|Overall Study|Other|0|||
145256201|NCT01225211|523781571|FG009|Overall Study|Other|1|||
145256202|NCT00537810|523781585|FG000|Overall Study|Withdrawal by Subject|4|||
145256203|NCT00537810|523781586|FG001|Overall Study|Withdrawal by Subject|11|||
145256204|NCT00537810|523781587|FG002|Overall Study|Withdrawal by Subject|4|||
145256205|NCT00537810|523781588|FG003|Overall Study|Withdrawal by Subject|3|||
145256206|NCT00537810|523781585|FG000|Overall Study|Medically withdrawn|2|||
145256207|NCT00537810|523781586|FG001|Overall Study|Medically withdrawn|2|||
145256208|NCT00537810|523781587|FG002|Overall Study|Medically withdrawn|0|||
145256209|NCT00537810|523781588|FG003|Overall Study|Medically withdrawn|1|||
145256210|NCT00554840|523781593|FG000|Overall Study|Physician Decision|0|||
145256211|NCT00554840|523781594|FG001|Overall Study|Physician Decision|1|||
145256212|NCT02698176|523781595|FG000|Overall Study|Progressive disease|4|||
145256213|NCT02698176|523781596|FG001|Overall Study|Progressive disease|3|||
145256214|NCT02698176|523781597|FG002|Overall Study|Progressive disease|1|||
145256215|NCT02698176|523781598|FG003|Overall Study|Progressive disease|0|||
145256216|NCT02698176|523781595|FG000|Overall Study|Adverse Event|2|||
145256217|NCT02698176|523781596|FG001|Overall Study|Adverse Event|0|||
145256218|NCT02698176|523781597|FG002|Overall Study|Adverse Event|0|||
145256219|NCT02698176|523781598|FG003|Overall Study|Adverse Event|0|||
145256220|NCT02698176|523781595|FG000|Overall Study|Clinical progression|3|||
145256221|NCT02698176|523781596|FG001|Overall Study|Clinical progression|0|||
145256222|NCT02698176|523781597|FG002|Overall Study|Clinical progression|0|||
145256223|NCT02698176|523781598|FG003|Overall Study|Clinical progression|0|||
145256224|NCT00925522|523781599|FG000|Overall Study|study closed -- business decision|20|||
145300424|NCT01015703|523953176|FG003|Overall Study|Withdrawal by Subject|0|||
145300425|NCT01015703|523953177|FG004|Overall Study|Withdrawal by Subject|0|||
145566953|NCT00962104|524936280|FG000|Overall Study|Other|2|||
145566954|NCT00962104|524936281|FG001|Overall Study|Other|0|||
145256225|NCT02561572|523781604|FG000|Overall Study|Inadequate time before surgery|2|||
145256226|NCT02561572|523781605|FG001|Overall Study|Inadequate time before surgery|1|||
145256227|NCT02561572|523781604|FG000|Overall Study|Protocol Violation|0|||
145256228|NCT02561572|523781605|FG001|Overall Study|Protocol Violation|1|||
145256229|NCT00795717|523781606|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
145566955|NCT02013167|524936282|FG000|Overall Study|Withdrawal by Subject|15|||
145300426|NCT01015703|523953173|FG000|Overall Study|Adverse Event|1|||
145566956|NCT02013167|524936283|FG001|Overall Study|Withdrawal by Subject|14|||
145566957|NCT02013167|524936282|FG000|Overall Study|Sponsor Decision|1|||
145566958|NCT02013167|524936283|FG001|Overall Study|Sponsor Decision|3|||
145566959|NCT02013167|524936282|FG000|Overall Study|Lost to Follow-up|0|||
145566960|NCT02013167|524936283|FG001|Overall Study|Lost to Follow-up|1|||
145566961|NCT02013167|524936282|FG000|Overall Study|Death|85|||
145256230|NCT00795717|523781607|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
145256231|NCT00795717|523781606|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
145256232|NCT00795717|523781607|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
145256233|NCT00795717|523781606|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
145256234|NCT00795717|523781607|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
145256235|NCT00795717|523781606|FG000|Phase II|too busy|0|||
145256236|NCT00795717|523781607|FG001|Phase II|too busy|1|||
145256237|NCT00410514|523781608|FG000|Overall Study|Adverse Event|2|||
145256238|NCT00410514|523781609|FG001|Overall Study|Adverse Event|2|||
145256239|NCT00410514|523781610|FG002|Overall Study|Adverse Event|2|||
145256240|NCT00410514|523781608|FG000|Overall Study|Protocol Violation|0|||
145256241|NCT00410514|523781609|FG001|Overall Study|Protocol Violation|1|||
145256242|NCT00410514|523781610|FG002|Overall Study|Protocol Violation|1|||
145256243|NCT00410514|523781608|FG000|Overall Study|Lost to Follow-up|0|||
145256244|NCT00410514|523781609|FG001|Overall Study|Lost to Follow-up|0|||
145256245|NCT00410514|523781610|FG002|Overall Study|Lost to Follow-up|2|||
145256246|NCT00410514|523781608|FG000|Overall Study|Non-compliant with study procedures|0|||
145256247|NCT00410514|523781609|FG001|Overall Study|Non-compliant with study procedures|0|||
145256248|NCT00410514|523781610|FG002|Overall Study|Non-compliant with study procedures|2|||
145256249|NCT00394654|523781611|FG000|Overall Study|Lost to Follow-up|1|||
145256250|NCT00394654|523781612|FG001|Overall Study|Lost to Follow-up|0|||
145256251|NCT00394654|523781611|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
145256252|NCT00394654|523781612|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
145256253|NCT02886338|523781613|FG000|Overall Study|Withdrawal by Subject|1|||
145256254|NCT00957034|523781617|FG000|Overall Study|Adverse Event|0|||
145256255|NCT00957034|523781618|FG001|Overall Study|Adverse Event|1|||
145256256|NCT00957034|523781619|FG002|Overall Study|Adverse Event|1|||
145256257|NCT00957034|523781617|FG000|Overall Study|Sponsor Terminated Study|6|||
145256258|NCT00957034|523781618|FG001|Overall Study|Sponsor Terminated Study|1|||
145256259|NCT00957034|523781619|FG002|Overall Study|Sponsor Terminated Study|5|||
145256260|NCT00957034|523781617|FG000|Overall Study|Withdrawal by Subject|0|||
145256261|NCT00957034|523781618|FG001|Overall Study|Withdrawal by Subject|2|||
145256262|NCT00957034|523781619|FG002|Overall Study|Withdrawal by Subject|0|||
145256263|NCT02039687|523783106|FG000|Overall Study|Adverse Event|0|||
145566962|NCT02013167|524936283|FG001|Overall Study|Death|160|||
145566963|NCT00842348|524936284|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
145566964|NCT00842348|524936285|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
145566965|NCT00842348|524936284|FG000|Study 729|Disease progression/death|19|||
145566966|NCT00842348|524936285|FG001|Study 729|Disease progression/death|30|||
145566967|NCT00842348|524936284|FG000|Study 729|Adverse Event|1|||
145566968|NCT00842348|524936285|FG001|Study 729|Adverse Event|1|||
145566969|NCT00842348|524936284|FG000|Study 729|Protocol Violation|1|||
145566970|NCT00842348|524936285|FG001|Study 729|Protocol Violation|1|||
145566971|NCT00842348|524936284|FG000|Study 729|Withdrawal by Subject|2|||
145566972|NCT00842348|524936285|FG001|Study 729|Withdrawal by Subject|4|||
145566973|NCT00842348|524936284|FG000|Study 729|Due to Sponsor stopping the study|1|||
145566974|NCT00842348|524936285|FG001|Study 729|Due to Sponsor stopping the study|1|||
145566975|NCT00842348|524936284|FG000|Study 729|Due to non-availability of IP|0|||
145566976|NCT00842348|524936285|FG001|Study 729|Due to non-availability of IP|1|||
145566977|NCT00842348|524936284|FG000|Study 729|Sponsor's decision|1|||
145566978|NCT00842348|524936285|FG001|Study 729|Sponsor's decision|0|||
145566979|NCT00842348|524936284|FG000|Study 729|Surgical resection|1|||
145566980|NCT00842348|524936285|FG001|Study 729|Surgical resection|0|||
145566981|NCT01113879|524936288|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
145566982|NCT01113879|524936289|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
145566983|NCT00026793|524936290|FG000|Overall Study|Death on study due to underlying disease|4|||
145566984|NCT00026793|524936290|FG000|Overall Study|Physician Decision|2|||
145566985|NCT00026793|524936290|FG000|Overall Study|Off study|2|||
145566986|NCT04151290|524936292|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
145566987|NCT02196324|524936296|FG000|Overall Study|Withdrawal by Subject|8|||
145566988|NCT02196324|524936297|FG001|Overall Study|Withdrawal by Subject|4|||
145566989|NCT02196324|524936296|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
145566990|NCT02196324|524936297|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
145256264|NCT02039687|523783107|FG001|Overall Study|Adverse Event|0|||
145256265|NCT02039687|523783108|FG002|Overall Study|Adverse Event|1|||
145256266|NCT02039687|523783109|FG003|Overall Study|Adverse Event|0|||
145256267|NCT02039687|523783106|FG000|Overall Study|Withdrawal by Subject|0|||
145256268|NCT02039687|523783107|FG001|Overall Study|Withdrawal by Subject|1|||
145256269|NCT02039687|523783108|FG002|Overall Study|Withdrawal by Subject|0|||
145256270|NCT02039687|523783109|FG003|Overall Study|Withdrawal by Subject|0|||
145566991|NCT02196324|524936296|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
145566992|NCT02196324|524936297|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
145566993|NCT02196324|524936296|FG000|Overall Study|Other|1|||
145566994|NCT02196324|524936297|FG001|Overall Study|Other|0|||
145566995|NCT01380184|524936298|FG000|Part 1 (19 Days)|Adverse Event|1|||
145566996|NCT01380184|524936298|FG000|Part 2|Adverse Event|5|||
145566997|NCT01380184|524936298|FG000|Part 2|Disease Progression|8|||
145566998|NCT01380184|524936298|FG000|Part 2|Lost to Follow-up|1|||
145566999|NCT04243538|524936299|FG000|Overall Study|Withdrawal by Subject|0|||
145567000|NCT04243538|524936300|FG001|Overall Study|Withdrawal by Subject|2|||
145567001|NCT04243538|524936299|FG000|Overall Study|Lost to Follow-up|0|||
145567002|NCT04243538|524936300|FG001|Overall Study|Lost to Follow-up|3|||
145567003|NCT00655564|524936301|FG000|Overall Study|Adverse Event|1|||
145567004|NCT00655564|524936301|FG000|Overall Study|Lost to Follow-up|1|||
145567005|NCT00655564|524936301|FG000|Overall Study|Desired Alternate Therapy|1|||
145567006|NCT00344773|524936303|FG000|Overall Study|Adverse Event|2|||
145567007|NCT00344773|524936303|FG000|Overall Study|Objective Disease Progression|16|||
145567008|NCT00344773|524936303|FG000|Overall Study|Withdrawal by Subject|1|||
145567009|NCT00344773|524936303|FG000|Overall Study|Not Eligible for the study|2|||
145567010|NCT02776917|524936304|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
145567011|NCT02620046|524936305|FG000|Overall Study|Adverse Event|22|||
145567012|NCT02620046|524936306|FG001|Overall Study|Adverse Event|42|||
145567013|NCT02620046|524936305|FG000|Overall Study|Lost to Follow-up|4|||
145567014|NCT02620046|524936306|FG001|Overall Study|Lost to Follow-up|10|||
145567015|NCT02620046|524936305|FG000|Overall Study|Withdrawal by Subject|36|||
145567016|NCT02620046|524936306|FG001|Overall Study|Withdrawal by Subject|66|||
145567017|NCT02620046|524936305|FG000|Overall Study|Site Termination|3|||
145567018|NCT02620046|524936306|FG001|Overall Study|Site Termination|3|||
145567019|NCT02620046|524936305|FG000|Overall Study|Pregnancy|3|||
145567020|NCT02620046|524936306|FG001|Overall Study|Pregnancy|7|||
145567021|NCT02620046|524936305|FG000|Overall Study|Lack of Efficacy|81|||
145567022|NCT02620046|524936306|FG001|Overall Study|Lack of Efficacy|146|||
145567023|NCT02620046|524936305|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
145567024|NCT02620046|524936306|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
145567025|NCT02620046|524936305|FG000|Overall Study|Reason Not Specified|13|||
145567026|NCT02620046|524936306|FG001|Overall Study|Reason Not Specified|21|||
145567027|NCT02620046|524936305|FG000|Overall Study|Significant Protocol Deviation|0|||
145567028|NCT02620046|524936306|FG001|Overall Study|Significant Protocol Deviation|1|||
145567029|NCT01336738|524938101|FG000|Overall Study|Adverse Event|0|||
145567030|NCT01336738|524938102|FG001|Overall Study|Adverse Event|3|||
145567031|NCT01336738|524938103|FG002|Overall Study|Adverse Event|2|||
145567032|NCT01336738|524938104|FG003|Overall Study|Adverse Event|1|||
145567033|NCT01336738|524938105|FG004|Overall Study|Adverse Event|3|||
145567034|NCT01336738|524938101|FG000|Overall Study|Lost to Follow-up|2|||
145567035|NCT01336738|524938102|FG001|Overall Study|Lost to Follow-up|1|||
145567036|NCT01336738|524938103|FG002|Overall Study|Lost to Follow-up|2|||
145567037|NCT01336738|524938104|FG003|Overall Study|Lost to Follow-up|2|||
145567038|NCT01336738|524938105|FG004|Overall Study|Lost to Follow-up|2|||
145567039|NCT01336738|524938101|FG000|Overall Study|Did not meet entrance criteria|0|||
145567040|NCT01336738|524938102|FG001|Overall Study|Did not meet entrance criteria|1|||
145567041|NCT01336738|524938103|FG002|Overall Study|Did not meet entrance criteria|0|||
145567042|NCT01336738|524938104|FG003|Overall Study|Did not meet entrance criteria|0|||
145567043|NCT01336738|524938105|FG004|Overall Study|Did not meet entrance criteria|0|||
145567044|NCT01336738|524938101|FG000|Overall Study|Protocol Violation|0|||
145567045|NCT01336738|524938102|FG001|Overall Study|Protocol Violation|1|||
145567046|NCT01336738|524938103|FG002|Overall Study|Protocol Violation|0|||
145567047|NCT01336738|524938104|FG003|Overall Study|Protocol Violation|0|||
145567048|NCT01336738|524938105|FG004|Overall Study|Protocol Violation|0|||
145567049|NCT01336738|524938101|FG000|Overall Study|Withdrawal by Subject|2|||
145567050|NCT01336738|524938102|FG001|Overall Study|Withdrawal by Subject|0|||
145620265|NCT03259373|525123726|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
145620266|NCT03259373|525123727|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
145300427|NCT01015703|523953174|FG001|Overall Study|Adverse Event|0|||
145300428|NCT01015703|523953175|FG002|Overall Study|Adverse Event|0|||
145300429|NCT01015703|523953176|FG003|Overall Study|Adverse Event|0|||
145300430|NCT01015703|523953177|FG004|Overall Study|Adverse Event|0|||
145567051|NCT01336738|524938103|FG002|Overall Study|Withdrawal by Subject|2|||
145567052|NCT01336738|524938104|FG003|Overall Study|Withdrawal by Subject|1|||
145567053|NCT01336738|524938105|FG004|Overall Study|Withdrawal by Subject|1|||
145620267|NCT03259373|525123726|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
145567054|NCT01336738|524938101|FG000|Overall Study|Other|3|||
145567055|NCT01336738|524938102|FG001|Overall Study|Other|3|||
145567056|NCT01336738|524938103|FG002|Overall Study|Other|2|||
145567057|NCT01336738|524938104|FG003|Overall Study|Other|3|||
145300431|NCT01015703|523953173|FG000|Overall Study|Protocol Violation|1|||
145567058|NCT01336738|524938105|FG004|Overall Study|Other|4|||
145410671|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
145410672|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
145410673|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
145410674|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145567059|NCT01581593|524938106|FG000|Overall Study|Withdrawal by Subject|1|||
145567060|NCT01332149|524938107|FG000|Overall Study|Adverse Event|11|||
145567061|NCT01332149|524938108|FG001|Overall Study|Adverse Event|9|||
145567062|NCT01332149|524938107|FG000|Overall Study|Other unspecified|5|||
145567063|NCT01332149|524938108|FG001|Overall Study|Other unspecified|7|||
145567064|NCT01332149|524938107|FG000|Overall Study|Protocol Violation|1|||
145567065|NCT01332149|524938108|FG001|Overall Study|Protocol Violation|3|||
145567066|NCT01332149|524938107|FG000|Overall Study|Withdrawal by Subject|4|||
145567067|NCT01332149|524938108|FG001|Overall Study|Withdrawal by Subject|5|||
145567068|NCT01332149|524938107|FG000|Overall Study|Lost to Follow-up|1|||
145567069|NCT01332149|524938108|FG001|Overall Study|Lost to Follow-up|1|||
145567070|NCT01332149|524938107|FG000|Overall Study|Insufficient clinical response|4|||
145567071|NCT01332149|524938108|FG001|Overall Study|Insufficient clinical response|7|||
145567072|NCT01332149|524938107|FG000|Overall Study|Did not meet entrance criteria|3|||
145567073|NCT01332149|524938108|FG001|Overall Study|Did not meet entrance criteria|4|||
145567074|NCT01332149|524938107|FG000|Overall Study|Randomized but not treated|1|||
145567075|NCT01332149|524938108|FG001|Overall Study|Randomized but not treated|2|||
145567076|NCT04982029|524938109|FG000|Overall Study|Lost to Follow-up|2|||
145567077|NCT04982029|524938110|FG001|Overall Study|Lost to Follow-up|3|||
145567078|NCT03264404|524938111|FG000|Overall Study|Death|2|||
145567079|NCT03264404|524938111|FG000|Overall Study|Physician Decision|1|||
145567080|NCT03264404|524938111|FG000|Overall Study|Disease Progression|28|||
145567081|NCT03264404|524938111|FG000|Overall Study|Adverse Event|1|||
145567082|NCT03264404|524938111|FG000|Overall Study|Off study prior to treatment|2|||
145410675|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145410676|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145410677|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145410678|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
145410679|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
145410680|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
145410681|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410682|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410683|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410684|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410685|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410686|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
145410687|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
145410688|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
145567083|NCT05458856|524938112|FG000|Overall Study|Withdrawal by Subject|5|||
145567084|NCT05458856|524938112|FG000|Overall Study|Death|4|||
145567085|NCT05458856|524938112|FG000|Overall Study|Protocol Deviation|3|||
145410689|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
145410690|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
145410691|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
145410692|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
145410693|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
145410694|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
145410695|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410696|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410697|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410698|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410699|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410700|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
145410701|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
145410702|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145410703|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145410704|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145567086|NCT05458856|524938112|FG000|Overall Study|Physician Decision|1|||
145567087|NCT02586012|524938113|FG000|Overall Study|Withdrawal by Subject|1|||
145567088|NCT02586012|524938114|FG001|Overall Study|Withdrawal by Subject|1|||
145567089|NCT02586012|524938115|FG002|Overall Study|Withdrawal by Subject|0|||
145567090|NCT02586012|524938116|FG003|Overall Study|Withdrawal by Subject|1|||
145567091|NCT02586012|524938117|FG004|Overall Study|Withdrawal by Subject|0|||
145567092|NCT02586012|524938118|FG005|Overall Study|Withdrawal by Subject|2|||
145567093|NCT02586012|524938113|FG000|Overall Study|Protocol Violation|0|||
145567094|NCT02586012|524938114|FG001|Overall Study|Protocol Violation|0|||
145567095|NCT02586012|524938115|FG002|Overall Study|Protocol Violation|0|||
145256271|NCT02039687|523783106|FG000|Overall Study|treatment assignment could not be confir|0|||
145256272|NCT02039687|523783107|FG001|Overall Study|treatment assignment could not be confir|0|||
145256273|NCT02039687|523783108|FG002|Overall Study|treatment assignment could not be confir|2|||
145256274|NCT02039687|523783109|FG003|Overall Study|treatment assignment could not be confir|0|||
145256275|NCT00959192|523783114|FG000|Overall Study|Adverse Event|1|||
145256276|NCT00959192|523783115|FG001|Overall Study|Adverse Event|1|||
145256277|NCT00959192|523783116|FG002|Overall Study|Adverse Event|1|||
145256278|NCT00959192|523783117|FG003|Overall Study|Adverse Event|0|||
145256279|NCT00959192|523783114|FG000|Overall Study|Investigator Request|1|||
145256280|NCT00959192|523783115|FG001|Overall Study|Investigator Request|0|||
145256281|NCT00959192|523783116|FG002|Overall Study|Investigator Request|0|||
145256282|NCT00959192|523783117|FG003|Overall Study|Investigator Request|0|||
145256283|NCT00959192|523783114|FG000|Overall Study|Caregiver Request|0|||
145256284|NCT00959192|523783115|FG001|Overall Study|Caregiver Request|0|||
145256285|NCT00959192|523783116|FG002|Overall Study|Caregiver Request|2|||
145256286|NCT00959192|523783117|FG003|Overall Study|Caregiver Request|1|||
145256287|NCT00532441|523783118|FG000|Overall Study|Death|1|||
145256288|NCT00532441|523783119|FG001|Overall Study|Death|0|||
145256289|NCT05466240|523783120|FG000|Overall Study|Adverse Event|1|||
145256290|NCT05466240|523783121|FG001|Overall Study|Adverse Event|0|||
145256291|NCT05466240|523783120|FG000|Overall Study|Withdrawal by Subject|1|||
145256292|NCT05466240|523783121|FG001|Overall Study|Withdrawal by Subject|0|||
145256293|NCT00305773|523783122|FG000|Overall Study|Death|3|||
145256294|NCT00305773|523783123|FG001|Overall Study|Death|2|||
145256295|NCT00305773|523783122|FG000|Overall Study|Adverse Event|1|||
145256296|NCT00305773|523783123|FG001|Overall Study|Adverse Event|2|||
145256297|NCT00305773|523783122|FG000|Overall Study|Alternative Treatment|4|||
145256298|NCT00305773|523783123|FG001|Overall Study|Alternative Treatment|4|||
145256299|NCT00305773|523783122|FG000|Overall Study|Physician Decision|1|||
145256300|NCT00305773|523783123|FG001|Overall Study|Physician Decision|1|||
145256301|NCT00305773|523783122|FG000|Overall Study|Withdrawal by Subject|1|||
145256302|NCT00305773|523783123|FG001|Overall Study|Withdrawal by Subject|4|||
145256303|NCT00305773|523783122|FG000|Overall Study|Disease Progression|1|||
145256304|NCT00305773|523783123|FG001|Overall Study|Disease Progression|3|||
145256305|NCT00305773|523783122|FG000|Overall Study|All other reasons|3|||
145256306|NCT00305773|523783123|FG001|Overall Study|All other reasons|2|||
145256307|NCT02679222|523783124|FG000|Overall Study|No time for project|1|||
145256308|NCT00303329|523783127|FG000|Overall Study|Adverse Event|7|||
145256309|NCT00303329|523783128|FG001|Overall Study|Adverse Event|14|||
145256310|NCT00303329|523783127|FG000|Overall Study|Abnormal Laboratory Values|0|||
145256311|NCT00303329|523783128|FG001|Overall Study|Abnormal Laboratory Values|1|||
145256312|NCT00303329|523783127|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
145256313|NCT00303329|523783128|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145256314|NCT00303329|523783127|FG000|Overall Study|Condition no longer requires study drug|0|||
145256315|NCT00303329|523783128|FG001|Overall Study|Condition no longer requires study drug|8|||
145256316|NCT00303329|523783127|FG000|Overall Study|Protocol Violation|3|||
145256317|NCT00303329|523783128|FG001|Overall Study|Protocol Violation|0|||
145256318|NCT00303329|523783127|FG000|Overall Study|Withdrawal by Subject|9|||
145256319|NCT00303329|523783128|FG001|Overall Study|Withdrawal by Subject|15|||
145256320|NCT00303329|523783127|FG000|Overall Study|Lost to Follow-up|0|||
145256321|NCT00303329|523783128|FG001|Overall Study|Lost to Follow-up|1|||
145256322|NCT00303329|523783127|FG000|Overall Study|Administrative problems|1|||
145256323|NCT00303329|523783128|FG001|Overall Study|Administrative problems|0|||
145256324|NCT00303329|523783127|FG000|Overall Study|Death|2|||
145256325|NCT00303329|523783128|FG001|Overall Study|Death|12|||
145256326|NCT00303329|523783127|FG000|Overall Study|Stopped at end of core|3|||
145256327|NCT00303329|523783128|FG001|Overall Study|Stopped at end of core|9|||
145256328|NCT00303329|523783127|FG000|Overall Study|Stopped at end of extension 1|1|||
145256329|NCT00303329|523783128|FG001|Overall Study|Stopped at end of extension 1|0|||
145256330|NCT00626327|523783129|FG000|Overall Study|Withdrawal by Subject|21|||
145256331|NCT00626327|523783130|FG001|Overall Study|Withdrawal by Subject|29|||
145256332|NCT00626327|523783131|FG002|Overall Study|Withdrawal by Subject|30|||
145256333|NCT00626327|523783129|FG000|Overall Study|Adverse Event|1|||
145256334|NCT00626327|523783130|FG001|Overall Study|Adverse Event|0|||
145256335|NCT00626327|523783131|FG002|Overall Study|Adverse Event|0|||
145256336|NCT00626327|523783129|FG000|Overall Study|Lost to Follow-up|24|||
145256337|NCT00626327|523783130|FG001|Overall Study|Lost to Follow-up|21|||
145256338|NCT00626327|523783131|FG002|Overall Study|Lost to Follow-up|23|||
145256339|NCT00626327|523783129|FG000|Overall Study|Inappropriate enrollment|4|||
145256340|NCT00626327|523783130|FG001|Overall Study|Inappropriate enrollment|5|||
145256341|NCT00626327|523783131|FG002|Overall Study|Inappropriate enrollment|3|||
145256342|NCT00626327|523783129|FG000|Overall Study|Administrative Reason|2|||
145256343|NCT00626327|523783130|FG001|Overall Study|Administrative Reason|0|||
145256344|NCT00626327|523783131|FG002|Overall Study|Administrative Reason|6|||
145567096|NCT02586012|524938116|FG003|Overall Study|Protocol Violation|0|||
145567097|NCT02586012|524938117|FG004|Overall Study|Protocol Violation|0|||
145300432|NCT01015703|523953174|FG001|Overall Study|Protocol Violation|0|||
145300433|NCT01015703|523953175|FG002|Overall Study|Protocol Violation|0|||
145300434|NCT01015703|523953176|FG003|Overall Study|Protocol Violation|0|||
145300435|NCT01015703|523953177|FG004|Overall Study|Protocol Violation|0|||
145300436|NCT02646124|523953178|FG000|Overall Study|Lost to Follow-up|0|||
145300437|NCT02646124|523953179|FG001|Overall Study|Lost to Follow-up|2|||
145300438|NCT00857454|523953180|FG000|Overall Study|Withdrawal by Subject|2|||
145300439|NCT00857454|523953180|FG000|Overall Study|Lost to Follow-up|1|||
145300440|NCT00857454|523953180|FG000|Overall Study|Adverse Event|2|||
145300441|NCT00857454|523953180|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
145300442|NCT00857454|523953180|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
145300443|NCT00857454|523953180|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
145300444|NCT03154047|523953181|FG000|Overall Study|Death|1|||
145300445|NCT03154047|523953181|FG000|Overall Study|Study terminated by sponsor|76|||
145300446|NCT03154047|523953181|FG000|Overall Study|Withdrawal by Subject|3|||
145300447|NCT00365365|523953182|FG000|Overall Study|Randomized but not treated|0|||
145300448|NCT00365365|523953183|FG001|Overall Study|Randomized but not treated|2|||
145300449|NCT00365365|523953184|FG002|Overall Study|Randomized but not treated|0|||
145300450|NCT00365365|523953182|FG000|Overall Study|Poor compliance to protocol|0|||
145300451|NCT00365365|523953183|FG001|Overall Study|Poor compliance to protocol|1|||
145300452|NCT00365365|523953184|FG002|Overall Study|Poor compliance to protocol|0|||
145300453|NCT00365365|523953182|FG000|Overall Study|Lost to Follow-up|3|||
145300454|NCT00365365|523953183|FG001|Overall Study|Lost to Follow-up|3|||
145300455|NCT00365365|523953184|FG002|Overall Study|Lost to Follow-up|3|||
145300456|NCT00365365|523953182|FG000|Overall Study|Death|1|||
145300457|NCT00365365|523953183|FG001|Overall Study|Death|3|||
145300458|NCT00365365|523953184|FG002|Overall Study|Death|0|||
145300459|NCT00365365|523953182|FG000|Overall Study|Subject's request|11|||
145300460|NCT00365365|523953183|FG001|Overall Study|Subject's request|13|||
145300461|NCT00365365|523953184|FG002|Overall Study|Subject's request|1|||
145300462|NCT00365365|523953182|FG000|Overall Study|Disease progression/relapse|9|||
145300463|NCT00365365|523953183|FG001|Overall Study|Disease progression/relapse|6|||
145300464|NCT00365365|523953184|FG002|Overall Study|Disease progression/relapse|7|||
145300465|NCT00365365|523953182|FG000|Overall Study|Adverse Event|6|||
145300466|NCT00365365|523953183|FG001|Overall Study|Adverse Event|6|||
145300467|NCT00365365|523953184|FG002|Overall Study|Adverse Event|3|||
145300468|NCT00365365|523953182|FG000|Overall Study|Moved|2|||
145300469|NCT00365365|523953183|FG001|Overall Study|Moved|0|||
145300470|NCT00365365|523953184|FG002|Overall Study|Moved|0|||
145300471|NCT00365365|523953182|FG000|Overall Study|New cancer|1|||
145300472|NCT00365365|523953183|FG001|Overall Study|New cancer|0|||
145300473|NCT00365365|523953184|FG002|Overall Study|New cancer|0|||
145300474|NCT00365365|523953182|FG000|Overall Study|Withdrew consent|1|||
145300475|NCT00365365|523953183|FG001|Overall Study|Withdrew consent|1|||
145300476|NCT00365365|523953184|FG002|Overall Study|Withdrew consent|0|||
145300477|NCT00365365|523953182|FG000|Overall Study|Second malignancy|0|||
145300478|NCT00365365|523953183|FG001|Overall Study|Second malignancy|1|||
145300479|NCT00365365|523953184|FG002|Overall Study|Second malignancy|0|||
145300480|NCT00365365|523953182|FG000|Overall Study|Patient/physician decision|0|||
145300481|NCT00365365|523953183|FG001|Overall Study|Patient/physician decision|0|||
145300482|NCT00365365|523953184|FG002|Overall Study|Patient/physician decision|1|||
145300483|NCT01083693|523953187|FG000|Overall Study|Adverse Event|1|||
145300484|NCT01083693|523953188|FG001|Overall Study|Adverse Event|1|||
145300485|NCT01083693|523953189|FG002|Overall Study|Adverse Event|0|||
145300486|NCT01083693|523953187|FG000|Overall Study|Lost to Follow-up|2|||
145300487|NCT01083693|523953188|FG001|Overall Study|Lost to Follow-up|0|||
145300488|NCT01083693|523953189|FG002|Overall Study|Lost to Follow-up|2|||
145300489|NCT01083693|523953187|FG000|Overall Study|Lack of effectiveness|13|||
145300490|NCT01083693|523953188|FG001|Overall Study|Lack of effectiveness|2|||
145300491|NCT01083693|523953189|FG002|Overall Study|Lack of effectiveness|2|||
145300492|NCT01083693|523953187|FG000|Overall Study|Patient Moved|0|||
145300493|NCT01083693|523953188|FG001|Overall Study|Patient Moved|1|||
145300494|NCT01083693|523953189|FG002|Overall Study|Patient Moved|0|||
145300495|NCT01083693|523953187|FG000|Overall Study|Complete remission|0|||
145300496|NCT01083693|523953188|FG001|Overall Study|Complete remission|1|||
145300497|NCT01083693|523953189|FG002|Overall Study|Complete remission|0|||
145300498|NCT01083693|523953187|FG000|Overall Study|Other medical condition/surgery|1|||
145300499|NCT01083693|523953188|FG001|Overall Study|Other medical condition/surgery|1|||
145300500|NCT01083693|523953189|FG002|Overall Study|Other medical condition/surgery|0|||
145300501|NCT01083693|523953187|FG000|Overall Study|Withdrawal by Subject|3|||
145300502|NCT01083693|523953188|FG001|Overall Study|Withdrawal by Subject|0|||
145300503|NCT01083693|523953189|FG002|Overall Study|Withdrawal by Subject|2|||
145300504|NCT01083693|523953187|FG000|Overall Study|Reason unknown|0|||
145300505|NCT01083693|523953188|FG001|Overall Study|Reason unknown|0|||
145300506|NCT01083693|523953189|FG002|Overall Study|Reason unknown|1|||
145300507|NCT01693523|523953190|FG000|Overall Study|Adverse Event|2|||
145300508|NCT01693523|523953191|FG001|Overall Study|Adverse Event|1|||
145300509|NCT01693523|523953192|FG002|Overall Study|Adverse Event|0|||
145300510|NCT01693523|523953190|FG000|Overall Study|Death|0|||
145300511|NCT01693523|523953191|FG001|Overall Study|Death|1|||
145567098|NCT02586012|524938118|FG005|Overall Study|Protocol Violation|1|||
145567099|NCT02586012|524938113|FG000|Overall Study|study terminated|0|||
145567100|NCT02586012|524938114|FG001|Overall Study|study terminated|2|||
145567101|NCT02586012|524938115|FG002|Overall Study|study terminated|1|||
145567102|NCT02586012|524938116|FG003|Overall Study|study terminated|1|||
145567103|NCT02586012|524938117|FG004|Overall Study|study terminated|1|||
145567104|NCT02586012|524938118|FG005|Overall Study|study terminated|0|||
145567105|NCT02388737|524938120|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
145567106|NCT02388737|524938121|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
145567107|NCT02388737|524938122|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
145567108|NCT02388737|524938120|FG000|Overall Study|Major Protocol Deviation|18|||
145567109|NCT02388737|524938121|FG001|Overall Study|Major Protocol Deviation|25|||
145567110|NCT02388737|524938122|FG002|Overall Study|Major Protocol Deviation|22|||
145567111|NCT02388737|524938120|FG000|Overall Study|Lost to Follow-up|5|||
145567112|NCT02388737|524938121|FG001|Overall Study|Lost to Follow-up|1|||
145567113|NCT02388737|524938122|FG002|Overall Study|Lost to Follow-up|4|||
145567114|NCT02388737|524938120|FG000|Overall Study|Voluntary Withdrawal|10|||
145567115|NCT02388737|524938121|FG001|Overall Study|Voluntary Withdrawal|18|||
145567116|NCT02388737|524938122|FG002|Overall Study|Voluntary Withdrawal|17|||
145256345|NCT00626327|523783129|FG000|Overall Study|Protocol Violation|26|||
145256346|NCT00626327|523783130|FG001|Overall Study|Protocol Violation|4|||
145256347|NCT00626327|523783131|FG002|Overall Study|Protocol Violation|26|||
145256348|NCT01716585|523783134|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
145256349|NCT01716585|523783135|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
145256350|NCT01716585|523783134|FG000|Double-blind Treatment|Adverse Event|2|||
145256351|NCT01716585|523783135|FG001|Double-blind Treatment|Adverse Event|1|||
145567117|NCT02388737|524938120|FG000|Overall Study|Lack of Efficacy|3|||
145567118|NCT02388737|524938121|FG001|Overall Study|Lack of Efficacy|0|||
145567119|NCT02388737|524938122|FG002|Overall Study|Lack of Efficacy|3|||
145567120|NCT02388737|524938120|FG000|Overall Study|Reason Not Specified|5|||
145567121|NCT02388737|524938121|FG001|Overall Study|Reason Not Specified|5|||
145567122|NCT02388737|524938122|FG002|Overall Study|Reason Not Specified|4|||
145567123|NCT01920932|524938123|FG000|Overall Study|Death|1|||
145567124|NCT01920932|524938123|FG000|Overall Study|Withdrawal of consent|1|||
145567125|NCT03299842|524938124|FG000|Overall Study|Caregiver withdrew consent|2|||
145567126|NCT03299842|524938124|FG000|Overall Study|Child would not keep the watch on|3|||
145567127|NCT00071812|524938125|FG000|24-Week Double-Blind Period|Adverse Event|2|||
145567128|NCT00071812|524938126|FG001|24-Week Double-Blind Period|Adverse Event|3|||
145567129|NCT00071812|524938127|FG002|24-Week Double-Blind Period|Adverse Event|4|||
145567130|NCT00071812|524938128|FG003|24-Week Double-Blind Period|Adverse Event|4|||
145567131|NCT00071812|524938125|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
145567132|NCT00071812|524938126|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
145567133|NCT00071812|524938127|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
145567134|NCT00071812|524938128|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
145567135|NCT00071812|524938125|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
145567136|NCT00071812|524938126|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
145567137|NCT00071812|524938127|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
145567138|NCT00071812|524938128|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
145567139|NCT00071812|524938125|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
145567140|NCT00071812|524938126|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
145567141|NCT00071812|524938127|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
145567142|NCT00071812|524938128|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
145567143|NCT00071812|524938125|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
145567144|NCT00071812|524938126|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
145567145|NCT00071812|524938127|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
145567146|NCT00071812|524938128|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
145567147|NCT00071812|524938125|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
145567148|NCT00071812|524938126|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
145567149|NCT00071812|524938127|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
145567150|NCT00071812|524938128|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
145567151|NCT00071812|524938125|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145567152|NCT00071812|524938126|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145256352|NCT01716585|523783134|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
145256353|NCT01716585|523783135|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
145256354|NCT01716585|523783134|FG000|Double-blind Treatment|Lost to Follow-up|2|||
145256355|NCT01716585|523783135|FG001|Double-blind Treatment|Lost to Follow-up|0|||
145256356|NCT01716585|523783134|FG000|Double-blind Treatment|Subject Noncompliant|1|||
145567153|NCT00071812|524938127|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145567154|NCT00071812|524938128|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
145567155|NCT00071812|524938125|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145256357|NCT01716585|523783135|FG001|Double-blind Treatment|Subject Noncompliant|0|||
145567156|NCT00071812|524938126|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145567157|NCT00071812|524938127|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145256358|NCT01716585|523783134|FG000|Double-blind Treatment|Other|1|||
145256359|NCT01716585|523783135|FG001|Double-blind Treatment|Other|0|||
145256360|NCT01716585|523783134|FG000|Open-label Treatment|Adverse Event|0|||
145256361|NCT01716585|523783135|FG001|Open-label Treatment|Adverse Event|2|||
145256362|NCT01716585|523783134|FG000|Open-label Treatment|Virologic Failure|0|||
145256363|NCT01716585|523783135|FG001|Open-label Treatment|Virologic Failure|2|||
145256364|NCT01716585|523783134|FG000|Open-label Treatment|Withdrawal by Subject|0|||
145256365|NCT01716585|523783135|FG001|Open-label Treatment|Withdrawal by Subject|3|||
145256366|NCT05102734|523783138|FG000|Overall Study|Did not require vasopressors|1|||
145256367|NCT05102734|523783139|FG001|Overall Study|Did not require vasopressors|0|||
145256368|NCT05102734|523783138|FG000|Overall Study|Did not have functioning PA catheter|1|||
145256369|NCT05102734|523783139|FG001|Overall Study|Did not have functioning PA catheter|0|||
145300512|NCT01693523|523953192|FG002|Overall Study|Death|1|||
145300513|NCT01693523|523953190|FG000|Overall Study|Lost to Follow-up|0|||
145300514|NCT01693523|523953191|FG001|Overall Study|Lost to Follow-up|0|||
145300515|NCT01693523|523953192|FG002|Overall Study|Lost to Follow-up|4|||
145300516|NCT01693523|523953190|FG000|Overall Study|Physician Decision|0|||
145300517|NCT01693523|523953191|FG001|Overall Study|Physician Decision|0|||
145300518|NCT01693523|523953192|FG002|Overall Study|Physician Decision|1|||
145300519|NCT01693523|523953190|FG000|Overall Study|Withdrawal by Subject|1|||
145300520|NCT01693523|523953191|FG001|Overall Study|Withdrawal by Subject|2|||
145300521|NCT01693523|523953192|FG002|Overall Study|Withdrawal by Subject|2|||
145300522|NCT01693523|523953190|FG000|Overall Study|Lack of compliance study medication|1|||
145300523|NCT01693523|523953191|FG001|Overall Study|Lack of compliance study medication|2|||
145300524|NCT01693523|523953192|FG002|Overall Study|Lack of compliance study medication|0|||
145300525|NCT01693523|523953190|FG000|Overall Study|Chemotherapy was held|1|||
145300526|NCT01693523|523953191|FG001|Overall Study|Chemotherapy was held|2|||
145300527|NCT01693523|523953192|FG002|Overall Study|Chemotherapy was held|0|||
145300528|NCT00834418|523953193|FG000|Overall Study|Adverse Event|0|||
145300529|NCT00834418|523953194|FG001|Overall Study|Adverse Event|2|||
145300530|NCT04567186|523953196|FG000|Period 1|COVID-19 related|1|||
145300531|NCT04567186|523953197|FG001|Period 1|COVID-19 related|0|||
145300532|NCT04567186|523953196|FG000|Period 1|Protocol Violation|0|||
145300533|NCT04567186|523953197|FG001|Period 1|Protocol Violation|1|||
145300534|NCT04567186|523953196|FG000|Period 1|Adverse Event|0|||
145300535|NCT04567186|523953197|FG001|Period 1|Adverse Event|2|||
145300536|NCT04567186|523953196|FG000|Period 2|COVID-19 Related|0|||
145300537|NCT04567186|523953197|FG001|Period 2|COVID-19 Related|1|||
145300538|NCT04567186|523953196|FG000|Period 2|Protocol Violation|0|||
145300539|NCT04567186|523953197|FG001|Period 2|Protocol Violation|1|||
145300540|NCT04567186|523953196|FG000|Period 2|Lost to Follow-up|0|||
145300541|NCT04567186|523953197|FG001|Period 2|Lost to Follow-up|1|||
145300542|NCT04567186|523953196|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
145300543|NCT04567186|523953197|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
145300544|NCT04274686|523953198|FG000|Overall Study|Physician Decision|1|||
145300545|NCT04274686|523953199|FG001|Overall Study|Physician Decision|0|||
145300546|NCT00376623|523953200|FG000|Overall Study|Progressive disease|35|||
145300547|NCT00376623|523953201|FG001|Overall Study|Progressive disease|22|||
145300548|NCT00376623|523953202|FG002|Overall Study|Progressive disease|17|||
145300549|NCT00376623|523953200|FG000|Overall Study|Lost to Follow-up|0|||
145300550|NCT00376623|523953201|FG001|Overall Study|Lost to Follow-up|1|||
145300551|NCT00376623|523953202|FG002|Overall Study|Lost to Follow-up|0|||
145300552|NCT00376623|523953200|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
145300553|NCT00376623|523953201|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
145300554|NCT00376623|523953202|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
145300555|NCT00376623|523953200|FG000|Overall Study|Not treated with BI 2536|1|||
145300556|NCT00376623|523953201|FG001|Overall Study|Not treated with BI 2536|0|||
145300557|NCT00376623|523953202|FG002|Overall Study|Not treated with BI 2536|0|||
145300558|NCT00376623|523953200|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
145300559|NCT00376623|523953201|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
145300560|NCT00376623|523953202|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
145300561|NCT00376623|523953200|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
145300562|NCT00376623|523953201|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
145300563|NCT00376623|523953202|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
145300564|NCT00376623|523953200|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
145300565|NCT00376623|523953201|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
145256370|NCT05102734|523783138|FG000|Overall Study|Inadequate video quality|2|||
145300566|NCT00376623|523953202|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
145256371|NCT05102734|523783139|FG001|Overall Study|Inadequate video quality|0|||
145256372|NCT04235959|523783140|FG000|Overall Study|Protocol Violation|0|||
145256373|NCT04235959|523783141|FG001|Overall Study|Protocol Violation|1|||
145567158|NCT00071812|524938128|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
145567159|NCT00071812|524938125|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145567160|NCT00071812|524938126|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145567161|NCT00071812|524938127|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145567162|NCT00071812|524938128|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
145567163|NCT00071812|524938125|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
145567164|NCT00071812|524938126|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
145567165|NCT00071812|524938127|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
145567166|NCT00071812|524938128|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
145567167|NCT01816139|524938129|FG000|Overall Study|Adverse Event|6|||
145567168|NCT01816139|524938130|FG001|Overall Study|Adverse Event|8|||
145567169|NCT01816139|524938129|FG000|Overall Study|Lack of Efficacy|1|||
145567170|NCT01816139|524938130|FG001|Overall Study|Lack of Efficacy|2|||
145567171|NCT01816139|524938129|FG000|Overall Study|Lost to Follow-up|5|||
145300567|NCT00376623|523953200|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
145300568|NCT00376623|523953201|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
145300569|NCT00376623|523953202|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
145300570|NCT00376623|523953200|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
145300571|NCT00376623|523953201|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
145300572|NCT00376623|523953202|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
145300573|NCT00376623|523953200|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
145300574|NCT00376623|523953201|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
145300575|NCT00376623|523953202|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
145300576|NCT00376623|523953200|FG000|Overall Study|Increase of tumour markers|0|||
145300577|NCT00376623|523953201|FG001|Overall Study|Increase of tumour markers|1|||
145300578|NCT00376623|523953202|FG002|Overall Study|Increase of tumour markers|0|||
145300579|NCT00376623|523953200|FG000|Overall Study|Bone metastasis|1|||
145300580|NCT00376623|523953201|FG001|Overall Study|Bone metastasis|0|||
145300581|NCT00376623|523953202|FG002|Overall Study|Bone metastasis|0|||
145300582|NCT04247282|523953203|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
145300583|NCT04247282|523953204|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
145300584|NCT04247282|523953205|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
145300585|NCT04247282|523953206|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
145300586|NCT04247282|523953203|FG000|Overall Study|Refused further treatment|0|||
145300587|NCT04247282|523953204|FG001|Overall Study|Refused further treatment|1|||
145300588|NCT04247282|523953205|FG002|Overall Study|Refused further treatment|0|||
145300589|NCT04247282|523953206|FG003|Overall Study|Refused further treatment|0|||
145300590|NCT01313273|523953207|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
145300591|NCT01313273|523953208|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
145300592|NCT01313273|523953207|FG000|Overall Study|Withdrawal by Subject|1|||
145300593|NCT01313273|523953208|FG001|Overall Study|Withdrawal by Subject|0|||
145300594|NCT01313273|523953207|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
145300595|NCT01313273|523953208|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
145300596|NCT03687736|523953209|FG000|Overall Study|Lost to Follow-up|7|||
145300597|NCT03687736|523953209|FG000|Overall Study|Withdrawal by Subject|3|||
145300598|NCT03496623|523953212|FG000|Run-In Period (2 Weeks)|Death|1|||
145300599|NCT03496623|523953213|FG001|Run-In Period (2 Weeks)|Death|0|||
145300600|NCT03496623|523953214|FG002|Run-In Period (2 Weeks)|Death|0|||
145300601|NCT03496623|523953215|FG003|Run-In Period (2 Weeks)|Death|0|||
145300602|NCT03496623|523953216|FG004|Run-In Period (2 Weeks)|Death|0|||
145300603|NCT03496623|523953212|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
145300604|NCT03496623|523953213|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
145300605|NCT03496623|523953214|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
145300606|NCT03496623|523953215|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
145300607|NCT03496623|523953216|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
145300608|NCT03496623|523953212|FG000|Period 1 (12 Weeks)|Death|0|||
145300609|NCT03496623|523953213|FG001|Period 1 (12 Weeks)|Death|3|||
145300610|NCT03496623|523953214|FG002|Period 1 (12 Weeks)|Death|0|||
145300611|NCT03496623|523953215|FG003|Period 1 (12 Weeks)|Death|0|||
145300612|NCT03496623|523953216|FG004|Period 1 (12 Weeks)|Death|0|||
145300613|NCT03496623|523953212|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
145300614|NCT03496623|523953213|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
145300615|NCT03496623|523953214|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
145300616|NCT03496623|523953215|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
145300617|NCT03496623|523953216|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
145300618|NCT03496623|523953212|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145300619|NCT03496623|523953213|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
145300620|NCT03496623|523953214|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
145567172|NCT01816139|524938130|FG001|Overall Study|Lost to Follow-up|3|||
145256374|NCT04235959|523783142|FG002|Overall Study|Protocol Violation|0|||
145256375|NCT04235959|523783140|FG000|Overall Study|Adverse Event|1|||
145256376|NCT04235959|523783141|FG001|Overall Study|Adverse Event|0|||
145256377|NCT04235959|523783142|FG002|Overall Study|Adverse Event|0|||
145256378|NCT03288987|523783143|FG000|Overall Study|Protocol Violation|10|||
145256379|NCT03288987|523783144|FG001|Overall Study|Protocol Violation|4|||
145256380|NCT03055806|523783147|FG000|Overall Study|Adverse Event|0|||
145256381|NCT03055806|523783148|FG001|Overall Study|Adverse Event|0|||
145256382|NCT03055806|523783149|FG002|Overall Study|Adverse Event|1|||
145300621|NCT03496623|523953215|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145300622|NCT03496623|523953216|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145300623|NCT03496623|523953212|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
145300624|NCT03496623|523953213|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
145300625|NCT03496623|523953214|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
145567173|NCT01816139|524938129|FG000|Overall Study|Withdrew Consent|6|||
145567174|NCT01816139|524938130|FG001|Overall Study|Withdrew Consent|4|||
145567175|NCT01816139|524938129|FG000|Overall Study|Protocol Violation|6|||
145567176|NCT01816139|524938130|FG001|Overall Study|Protocol Violation|3|||
145567177|NCT01816139|524938129|FG000|Overall Study|Reason not Specified|4|||
145567178|NCT01816139|524938130|FG001|Overall Study|Reason not Specified|2|||
145567179|NCT02919670|524938132|FG000|Overall Study|Only 17 participants met compliance|43|||
145567180|NCT02919670|524938133|FG001|Overall Study|Only 17 participants met compliance|39|||
145567181|NCT00436748|524938136|FG000|Overall Study|Ineligibility Determined|1|||
145567182|NCT00436748|524938137|FG001|Overall Study|Ineligibility Determined|1|||
145567183|NCT00436748|524938136|FG000|Overall Study|Adverse Event|0|||
145567184|NCT00436748|524938137|FG001|Overall Study|Adverse Event|2|||
145567185|NCT00436748|524938136|FG000|Overall Study|Consent Withdrawn|1|||
145567186|NCT00436748|524938137|FG001|Overall Study|Consent Withdrawn|4|||
145567187|NCT00436748|524938136|FG000|Overall Study|Administrative Decision|1|||
145567188|NCT00436748|524938137|FG001|Overall Study|Administrative Decision|0|||
145567189|NCT00436748|524938136|FG000|Overall Study|Lost to Follow-up|0|||
145567190|NCT00436748|524938137|FG001|Overall Study|Lost to Follow-up|1|||
145567191|NCT00436748|524938136|FG000|Overall Study|Protocol-specified Criteria|5|||
145567192|NCT00436748|524938137|FG001|Overall Study|Protocol-specified Criteria|4|||
145567193|NCT00436748|524938136|FG000|Overall Study|Other|3|||
145567194|NCT00436748|524938137|FG001|Overall Study|Other|0|||
145567195|NCT02086110|524938151|FG000|Overall Study|Withdrawal by Subject|1|||
145567196|NCT02086110|524938152|FG001|Overall Study|Withdrawal by Subject|1|||
145567197|NCT01203072|524938153|FG000|Overall Study|Adverse Event|5|||
145567198|NCT01203072|524938154|FG001|Overall Study|Adverse Event|3|||
145567199|NCT01203072|524938155|FG002|Overall Study|Adverse Event|2|||
145567200|NCT01203072|524938156|FG003|Overall Study|Adverse Event|4|||
145567201|NCT01203072|524938157|FG004|Overall Study|Adverse Event|2|||
145567202|NCT01203072|524938153|FG000|Overall Study|Lack of Efficacy|1|||
145567203|NCT01203072|524938154|FG001|Overall Study|Lack of Efficacy|0|||
145567204|NCT01203072|524938155|FG002|Overall Study|Lack of Efficacy|0|||
145567205|NCT01203072|524938156|FG003|Overall Study|Lack of Efficacy|0|||
145567206|NCT01203072|524938157|FG004|Overall Study|Lack of Efficacy|0|||
145567207|NCT01203072|524938153|FG000|Overall Study|Lost to Follow-up|0|||
145567208|NCT01203072|524938154|FG001|Overall Study|Lost to Follow-up|1|||
145567209|NCT01203072|524938155|FG002|Overall Study|Lost to Follow-up|0|||
145567210|NCT01203072|524938156|FG003|Overall Study|Lost to Follow-up|0|||
145567211|NCT01203072|524938157|FG004|Overall Study|Lost to Follow-up|0|||
145567212|NCT01203072|524938153|FG000|Overall Study|Protocol Violation|2|||
145567213|NCT01203072|524938154|FG001|Overall Study|Protocol Violation|0|||
145567214|NCT01203072|524938155|FG002|Overall Study|Protocol Violation|0|||
145567215|NCT01203072|524938156|FG003|Overall Study|Protocol Violation|0|||
145567216|NCT01203072|524938157|FG004|Overall Study|Protocol Violation|1|||
145567217|NCT01203072|524938153|FG000|Overall Study|Withdrawal by Subject|2|||
145567218|NCT01203072|524938154|FG001|Overall Study|Withdrawal by Subject|2|||
145567219|NCT01203072|524938155|FG002|Overall Study|Withdrawal by Subject|1|||
145567220|NCT01203072|524938156|FG003|Overall Study|Withdrawal by Subject|2|||
145567221|NCT01203072|524938157|FG004|Overall Study|Withdrawal by Subject|3|||
145567222|NCT02272413|524938159|FG000|Randomized Through Treatment Start|Not treated|3|||
145567223|NCT02272413|524938160|FG001|Randomized Through Treatment Start|Not treated|5|||
145256383|NCT03055806|523783150|FG003|Overall Study|Adverse Event|1|||
145256384|NCT03055806|523783147|FG000|Overall Study|Lost to Follow-up|0|||
145256385|NCT03055806|523783148|FG001|Overall Study|Lost to Follow-up|3|||
145256386|NCT03055806|523783149|FG002|Overall Study|Lost to Follow-up|6|||
145567224|NCT02272413|524938159|FG000|Pre-switch Period|Adverse Event|38|||
145567225|NCT02272413|524938160|FG001|Pre-switch Period|Adverse Event|37|||
145567226|NCT02272413|524938159|FG000|Pre-switch Period|Death|26|||
145300626|NCT03496623|523953215|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
145567227|NCT02272413|524938160|FG001|Pre-switch Period|Death|26|||
145567228|NCT02272413|524938159|FG000|Pre-switch Period|Withdrawal by Subject|27|||
145567229|NCT02272413|524938160|FG001|Pre-switch Period|Withdrawal by Subject|15|||
145567230|NCT02272413|524938159|FG000|Pre-switch Period|Physician Decision|6|||
145567231|NCT02272413|524938160|FG001|Pre-switch Period|Physician Decision|18|||
145567232|NCT02272413|524938159|FG000|Pre-switch Period|Progressive disease|185|||
145567233|NCT02272413|524938160|FG001|Pre-switch Period|Progressive disease|173|||
145567234|NCT02272413|524938159|FG000|Pre-switch Period|Lost to Follow-up|0|||
145567235|NCT02272413|524938160|FG001|Pre-switch Period|Lost to Follow-up|2|||
145567236|NCT02272413|524938159|FG000|Pre-switch Period|Protocol Violation|1|||
145300627|NCT03496623|523953216|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
145300628|NCT03496623|523953212|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145300629|NCT03496623|523953213|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145300630|NCT03496623|523953214|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
145300631|NCT03496623|523953215|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145300632|NCT03496623|523953216|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145300633|NCT03496623|523953212|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
145300634|NCT03496623|523953213|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
145300635|NCT03496623|523953214|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
145300636|NCT03496623|523953215|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
145300637|NCT03496623|523953216|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
145300638|NCT03496623|523953212|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145300639|NCT03496623|523953213|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
145300640|NCT03496623|523953214|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145300641|NCT03496623|523953215|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145300642|NCT03496623|523953216|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145300643|NCT02543203|523953217|FG000|Overall Study|Unpalatable Fragrance|2|||
145300644|NCT02543203|523953218|FG001|Overall Study|Unpalatable Fragrance|2|||
145300645|NCT02543203|523953217|FG000|Overall Study|Lost to Follow-up|1|||
145300646|NCT02543203|523953218|FG001|Overall Study|Lost to Follow-up|0|||
145300647|NCT02543203|523953217|FG000|Overall Study|Increased Irritability|1|||
145300648|NCT02543203|523953218|FG001|Overall Study|Increased Irritability|0|||
145300649|NCT02543203|523953217|FG000|Overall Study|Family|1|||
145300650|NCT02543203|523953218|FG001|Overall Study|Family|2|||
145300651|NCT02543203|523953217|FG000|Overall Study|Negative Behavior|1|||
145300652|NCT02543203|523953218|FG001|Overall Study|Negative Behavior|0|||
145300653|NCT02543203|523953217|FG000|Overall Study|Withdrawal by Subject|0|||
145300654|NCT02543203|523953218|FG001|Overall Study|Withdrawal by Subject|1|||
145300655|NCT03020615|523953219|FG000|Overall Study|Physician Decision|3|||
145300656|NCT03020615|523953220|FG001|Overall Study|Physician Decision|1|||
145300657|NCT03020615|523953221|FG002|Overall Study|Physician Decision|2|||
145300658|NCT03020615|523953219|FG000|Overall Study|Parent/guardian/patient choice|3|||
145300659|NCT03020615|523953220|FG001|Overall Study|Parent/guardian/patient choice|0|||
145300660|NCT03020615|523953221|FG002|Overall Study|Parent/guardian/patient choice|4|||
145300661|NCT03020615|523953219|FG000|Overall Study|Screen failure|0|||
145300662|NCT03020615|523953220|FG001|Overall Study|Screen failure|0|||
145300663|NCT03020615|523953221|FG002|Overall Study|Screen failure|1|||
145300664|NCT03020615|523953219|FG000|Overall Study|Death|1|||
145300665|NCT03020615|523953220|FG001|Overall Study|Death|0|||
145300666|NCT03020615|523953221|FG002|Overall Study|Death|0|||
145300667|NCT03020615|523953219|FG000|Overall Study|Lost to Follow-up|0|||
145300668|NCT03020615|523953220|FG001|Overall Study|Lost to Follow-up|1|||
145300669|NCT03020615|523953221|FG002|Overall Study|Lost to Follow-up|0|||
145300670|NCT00089661|523953222|FG000|Overall Study|Adverse Event|0|||
145300671|NCT00089661|523953223|FG001|Overall Study|Adverse Event|2|||
145300672|NCT00089661|523953222|FG000|Overall Study|Death|1|||
145300673|NCT00089661|523953223|FG001|Overall Study|Death|0|||
145300674|NCT00089661|523953222|FG000|Overall Study|Lost to Follow-up|0|||
145300675|NCT00089661|523953223|FG001|Overall Study|Lost to Follow-up|3|||
145300676|NCT00089661|523953222|FG000|Overall Study|Withdrawal by Subject|11|||
145300677|NCT00089661|523953223|FG001|Overall Study|Withdrawal by Subject|9|||
145300678|NCT00089661|523953222|FG000|Overall Study|Disease progression|1|||
145300679|NCT00089661|523953223|FG001|Overall Study|Disease progression|3|||
145300680|NCT00089661|523953222|FG000|Overall Study|Ineligibility determined|4|||
145300681|NCT00089661|523953223|FG001|Overall Study|Ineligibility determined|4|||
145567237|NCT02272413|524938160|FG001|Pre-switch Period|Protocol Violation|0|||
145567238|NCT02272413|524938159|FG000|Pre-switch Period|Other than listed|10|||
145567239|NCT02272413|524938160|FG001|Pre-switch Period|Other than listed|11|||
145300682|NCT00089661|523953222|FG000|Overall Study|Noncompliance|2|||
145300683|NCT00089661|523953223|FG001|Overall Study|Noncompliance|4|||
145300684|NCT00089661|523953222|FG000|Overall Study|Other|2|||
145300685|NCT00089661|523953223|FG001|Overall Study|Other|1|||
145300686|NCT02077465|523953227|FG000|Overall Study|Withdrew Consent|0|||
145300687|NCT02077465|523953228|FG001|Overall Study|Withdrew Consent|1|||
145300688|NCT02077465|523953227|FG000|Overall Study|Lost to Follow-up|1|||
145300689|NCT02077465|523953228|FG001|Overall Study|Lost to Follow-up|0|||
145300690|NCT02481830|523953230|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
145300691|NCT02481830|523953231|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
145300692|NCT02481830|523953230|FG000|Pre-treatment|Withdrawal by Subject|0|||
145300693|NCT02481830|523953231|FG001|Pre-treatment|Withdrawal by Subject|10|||
145300694|NCT02481830|523953230|FG000|Pre-treatment|Disease Progression|1|||
145300695|NCT02481830|523953231|FG001|Pre-treatment|Disease Progression|1|||
145300696|NCT02481830|523953230|FG000|Pre-treatment|Other reasons|0|||
145567240|NCT02272413|524938159|FG000|Post-switch Period|Adverse Event|4|||
145567241|NCT02272413|524938160|FG001|Post-switch Period|Adverse Event|4|||
145567242|NCT02272413|524938159|FG000|Post-switch Period|Death|3|||
145567243|NCT02272413|524938160|FG001|Post-switch Period|Death|2|||
145567244|NCT02272413|524938159|FG000|Post-switch Period|Withdrawal by Subject|1|||
145567245|NCT02272413|524938160|FG001|Post-switch Period|Withdrawal by Subject|2|||
145567246|NCT02272413|524938159|FG000|Post-switch Period|Physician Decision|1|||
145567247|NCT02272413|524938160|FG001|Post-switch Period|Physician Decision|1|||
145567248|NCT02272413|524938159|FG000|Post-switch Period|Progressive disease|21|||
145567249|NCT02272413|524938160|FG001|Post-switch Period|Progressive disease|21|||
145567250|NCT02272413|524938159|FG000|Post-switch Period|Study terminated by sponsor|8|||
145567251|NCT02272413|524938160|FG001|Post-switch Period|Study terminated by sponsor|11|||
145567252|NCT02272413|524938159|FG000|Post-switch Period|Other than listed|4|||
145567253|NCT02272413|524938160|FG001|Post-switch Period|Other than listed|5|||
145567254|NCT02286193|524938163|FG000|Overall Study|Referred: CRS unable to make contact|62|||
145567255|NCT02286193|524938163|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
145567256|NCT02286193|524938163|FG000|Overall Study|Referred: Declined service|38|||
145567257|NCT00423891|524938164|FG000|Enrolled|Withdrawal by Subject|0|||
145256387|NCT03055806|523783150|FG003|Overall Study|Lost to Follow-up|7|||
145567258|NCT00423891|524938165|FG001|Enrolled|Withdrawal by Subject|0|||
145567259|NCT00423891|524938166|FG002|Enrolled|Withdrawal by Subject|1|||
145567260|NCT00423891|524938164|FG000|Enrolled|Lost to Follow-up|0|||
145567261|NCT00423891|524938165|FG001|Enrolled|Lost to Follow-up|0|||
145567262|NCT00423891|524938166|FG002|Enrolled|Lost to Follow-up|1|||
145567263|NCT00423891|524938164|FG000|Enrolled|No longer met criteria|11|||
145567264|NCT00423891|524938165|FG001|Enrolled|No longer met criteria|2|||
145567265|NCT00423891|524938166|FG002|Enrolled|No longer met criteria|1|||
145567266|NCT00423891|524938164|FG000|Treatment|Withdrawal by Subject|1|||
145567267|NCT00423891|524938165|FG001|Treatment|Withdrawal by Subject|0|||
145567268|NCT00423891|524938166|FG002|Treatment|Withdrawal by Subject|0|||
145567269|NCT00423891|524938164|FG000|Treatment|Lost to Follow-up|1|||
145567270|NCT00423891|524938165|FG001|Treatment|Lost to Follow-up|0|||
145567271|NCT00423891|524938166|FG002|Treatment|Lost to Follow-up|0|||
145567272|NCT00423891|524938164|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
145567273|NCT00423891|524938165|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
145567274|NCT00423891|524938166|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
145567275|NCT00423891|524938164|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
145567276|NCT00423891|524938165|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
145567277|NCT00423891|524938166|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
145567278|NCT02852265|524938167|FG000|3-month Follow-up|Lost to Follow-up|1|||
145567279|NCT02852265|524938168|FG001|3-month Follow-up|Lost to Follow-up|1|||
145567280|NCT01828034|524938169|FG000|Overall Study|Withdrawal by Subject|0|||
145567281|NCT01828034|524938170|FG001|Overall Study|Withdrawal by Subject|0|||
145567282|NCT01828034|524938171|FG002|Overall Study|Withdrawal by Subject|0|||
145567283|NCT01828034|524938172|FG003|Overall Study|Withdrawal by Subject|1|||
145567284|NCT01988571|524938173|FG000|Overall Study|Death|3|||
145567285|NCT01988571|524938174|FG001|Overall Study|Death|1|||
145567286|NCT01988571|524938173|FG000|Overall Study|Physician Decision|2|||
145567287|NCT01988571|524938174|FG001|Overall Study|Physician Decision|1|||
145567288|NCT01988571|524938173|FG000|Overall Study|Lost to Follow-up|3|||
145567289|NCT01988571|524938174|FG001|Overall Study|Lost to Follow-up|0|||
145567290|NCT01988571|524938173|FG000|Overall Study|Withdrawal by Subject|31|||
145567291|NCT01988571|524938174|FG001|Overall Study|Withdrawal by Subject|33|||
145567292|NCT01417481|524938177|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
145567293|NCT01417481|524938178|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145567294|NCT00829296|524938179|FG000|Overall Study|Adverse Event|5|||
145567295|NCT00829296|524938180|FG001|Overall Study|Adverse Event|4|||
145567296|NCT03029624|524938181|FG000|Overall Study|Adverse Event|1|||
145567297|NCT03029624|524938181|FG000|Overall Study|Withdrawal by Subject|1|||
145567298|NCT03029624|524938181|FG000|Overall Study|Lack of Efficacy|1|||
145567299|NCT03029624|524938181|FG000|Overall Study|MRI need|2|||
145567300|NCT00775437|524938197|FG000|Overall Study|Loss of efficacy|2|||
145567301|NCT00775437|524938197|FG000|Overall Study|Withdrawal by Subject|3|||
145567302|NCT00775437|524938197|FG000|Overall Study|Lost to Follow-up|1|||
145567303|NCT01183975|524938198|FG000|Overall Study|Lost to Follow-up|73|||
145567304|NCT02376166|524938201|FG000|Overall Study|Adverse Event|1|||
145567305|NCT02376166|524938201|FG000|Overall Study|Discontinued metformin early|2|||
145567306|NCT04180020|524938202|FG000|Overall Study|missed visit|18|||
145567307|NCT04180020|524938203|FG001|Overall Study|missed visit|16|||
145567308|NCT04180020|524938202|FG000|Overall Study|Death|2|||
145567309|NCT04180020|524938203|FG001|Overall Study|Death|3|||
145567310|NCT04180020|524938202|FG000|Overall Study|Withdrawal by Subject|1|||
145256388|NCT03055806|523783147|FG000|Overall Study|Physician Decision|1|||
145256389|NCT03055806|523783148|FG001|Overall Study|Physician Decision|0|||
145256390|NCT03055806|523783149|FG002|Overall Study|Physician Decision|0|||
145567311|NCT04180020|524938203|FG001|Overall Study|Withdrawal by Subject|5|||
145567312|NCT04180020|524938202|FG000|Overall Study|incarcerated|1|||
145567313|NCT04180020|524938203|FG001|Overall Study|incarcerated|1|||
145410705|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145567314|NCT04180020|524938202|FG000|Overall Study|Physician Decision|0|||
145256391|NCT03055806|523783150|FG003|Overall Study|Physician Decision|1|||
145256392|NCT03055806|523783147|FG000|Overall Study|Protocol Violation|1|||
145256393|NCT03055806|523783148|FG001|Overall Study|Protocol Violation|0|||
145256394|NCT03055806|523783149|FG002|Overall Study|Protocol Violation|0|||
145256395|NCT03055806|523783150|FG003|Overall Study|Protocol Violation|0|||
145256396|NCT03055806|523783147|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
145256397|NCT03055806|523783148|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
145256398|NCT03055806|523783149|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
145256399|NCT03055806|523783150|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
145256400|NCT03055806|523783147|FG000|Overall Study|Withdrawal of consent to continue study|2|||
145567315|NCT04180020|524938203|FG001|Overall Study|Physician Decision|2|||
145567316|NCT02244580|524938210|FG000|Overall Study|No cancer tissues available|241|||
145567317|NCT00811577|524938213|FG000|Overall Study|Lost to Follow-up|7|||
145567318|NCT00811577|524938214|FG001|Overall Study|Lost to Follow-up|1|||
145567319|NCT00811577|524938213|FG000|Overall Study|Withdrawal by Subject|3|||
145567320|NCT00811577|524938214|FG001|Overall Study|Withdrawal by Subject|0|||
145567321|NCT04251221|524938215|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
145567322|NCT04251221|524938216|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
145567323|NCT00329407|524938217|FG000|Overall Study|Withdrawal by Subject|1|||
145567324|NCT02357940|524938218|FG000|Overall Study|Adverse Event|0|||
145567325|NCT02357940|524938219|FG001|Overall Study|Adverse Event|1|||
145567326|NCT02357940|524938218|FG000|Overall Study|Investigator's judgement|0|||
145567327|NCT02357940|524938219|FG001|Overall Study|Investigator's judgement|1|||
145567328|NCT02442778|524938220|FG000|Overall Study|Adverse Event|2|||
145567329|NCT02442778|524938221|FG001|Overall Study|Adverse Event|6|||
145567330|NCT02442778|524938222|FG002|Overall Study|Adverse Event|6|||
145567331|NCT02442778|524938220|FG000|Overall Study|Death|0|||
145567332|NCT02442778|524938221|FG001|Overall Study|Death|2|||
145567333|NCT02442778|524938222|FG002|Overall Study|Death|0|||
145567334|NCT02442778|524938220|FG000|Overall Study|Lack of Efficacy|1|||
145567335|NCT02442778|524938221|FG001|Overall Study|Lack of Efficacy|0|||
145567336|NCT02442778|524938222|FG002|Overall Study|Lack of Efficacy|0|||
145567337|NCT02442778|524938220|FG000|Overall Study|Lost to Follow-up|1|||
145567338|NCT02442778|524938221|FG001|Overall Study|Lost to Follow-up|1|||
145567339|NCT02442778|524938222|FG002|Overall Study|Lost to Follow-up|1|||
145567340|NCT02442778|524938220|FG000|Overall Study|Non-compliance with study drug|2|||
145567341|NCT02442778|524938221|FG001|Overall Study|Non-compliance with study drug|0|||
145567342|NCT02442778|524938222|FG002|Overall Study|Non-compliance with study drug|1|||
145256401|NCT03055806|523783148|FG001|Overall Study|Withdrawal of consent to continue study|3|||
145256402|NCT03055806|523783149|FG002|Overall Study|Withdrawal of consent to continue study|4|||
145256403|NCT03055806|523783150|FG003|Overall Study|Withdrawal of consent to continue study|6|||
145256404|NCT03055806|523783147|FG000|Overall Study|Partner not willing to try intercourse|1|||
145256405|NCT03055806|523783148|FG001|Overall Study|Partner not willing to try intercourse|0|||
145256406|NCT03055806|523783149|FG002|Overall Study|Partner not willing to try intercourse|0|||
145256407|NCT03055806|523783150|FG003|Overall Study|Partner not willing to try intercourse|0|||
145256408|NCT04601194|523783151|FG000|Overall Study|Lost to Follow-up|7|||
145256409|NCT04905563|523783152|FG000|Overall Study|Withdrawal by Subject|1|||
145256410|NCT04905563|523783153|FG001|Overall Study|Withdrawal by Subject|0|||
145256411|NCT04905563|523783152|FG000|Overall Study|Standard of care orders entered by resident|1|||
145256412|NCT04905563|523783153|FG001|Overall Study|Standard of care orders entered by resident|0|||
145256413|NCT04905563|523783152|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
145256414|NCT04905563|523783153|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
145410706|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
145410707|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
145567343|NCT02442778|524938220|FG000|Overall Study|Physician Decision|1|||
145567344|NCT02442778|524938221|FG001|Overall Study|Physician Decision|1|||
145256415|NCT04905563|523783152|FG000|Overall Study|Withdrawal by Subject|0|||
145256416|NCT04905563|523783153|FG001|Overall Study|Withdrawal by Subject|1|||
145256417|NCT01797302|523783154|FG000|Overall Study|Lost to Follow-up|16|||
145256418|NCT01797302|523783155|FG001|Overall Study|Lost to Follow-up|23|||
145256419|NCT01797302|523783156|FG002|Overall Study|Lost to Follow-up|22|||
145256420|NCT01797302|523783154|FG000|Overall Study|Withdrawal by Subject|1|||
145256421|NCT01797302|523783155|FG001|Overall Study|Withdrawal by Subject|3|||
145256422|NCT01797302|523783156|FG002|Overall Study|Withdrawal by Subject|4|||
145256423|NCT00672139|523783161|FG000|Overall Study|Death|14|||
145256424|NCT00672139|523783162|FG001|Overall Study|Death|23|||
145567345|NCT02442778|524938222|FG002|Overall Study|Physician Decision|1|||
145567346|NCT02442778|524938220|FG000|Overall Study|Protocol Deviation|3|||
145567347|NCT02442778|524938221|FG001|Overall Study|Protocol Deviation|0|||
145256425|NCT00672139|523783161|FG000|Overall Study|Withdrawal by Subject|2|||
145256426|NCT00672139|523783162|FG001|Overall Study|Withdrawal by Subject|11|||
145567348|NCT02442778|524938222|FG002|Overall Study|Protocol Deviation|1|||
145256427|NCT00672139|523783161|FG000|Overall Study|Adverse Event|4|||
145256428|NCT00672139|523783162|FG001|Overall Study|Adverse Event|7|||
145256429|NCT00672139|523783161|FG000|Overall Study|Physician Decision|2|||
145256430|NCT00672139|523783162|FG001|Overall Study|Physician Decision|0|||
145567349|NCT02442778|524938220|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
145567350|NCT02442778|524938221|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
145567351|NCT02442778|524938222|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
145567352|NCT02442778|524938220|FG000|Overall Study|Withdrawal by Subject|4|||
145567353|NCT02442778|524938221|FG001|Overall Study|Withdrawal by Subject|4|||
145567354|NCT02442778|524938222|FG002|Overall Study|Withdrawal by Subject|3|||
145567355|NCT02442778|524938220|FG000|Overall Study|Reason not specified|1|||
145567356|NCT02442778|524938221|FG001|Overall Study|Reason not specified|4|||
145567357|NCT02442778|524938222|FG002|Overall Study|Reason not specified|0|||
145567358|NCT04964128|524938225|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
145567359|NCT04964128|524938225|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
145567360|NCT03913091|524938228|FG000|Overall Study|Lost to Follow-up|18|||
145567361|NCT03913091|524938229|FG001|Overall Study|Lost to Follow-up|11|||
145567362|NCT03913091|524938228|FG000|Overall Study|Required additional meds/surgery|1|||
145567363|NCT03913091|524938229|FG001|Overall Study|Required additional meds/surgery|2|||
145567364|NCT03913091|524938228|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
145567365|NCT03913091|524938229|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
145567366|NCT00500370|524938239|FG000|Overall Study|Adverse Event|9|||
145567367|NCT00500370|524938240|FG001|Overall Study|Adverse Event|3|||
145567368|NCT00500370|524938239|FG000|Overall Study|Lost to Follow-up|10|||
145567369|NCT00500370|524938240|FG001|Overall Study|Lost to Follow-up|10|||
145567370|NCT00500370|524938239|FG000|Overall Study|Protocol Violation|2|||
145567371|NCT00500370|524938240|FG001|Overall Study|Protocol Violation|4|||
145567372|NCT00500370|524938239|FG000|Overall Study|Sponsor Decision|2|||
145567373|NCT00500370|524938240|FG001|Overall Study|Sponsor Decision|0|||
145410708|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
145410709|NCT01697579|524356830|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145410710|NCT01697579|524356831|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145567374|NCT00500370|524938239|FG000|Overall Study|Subject Decision|10|||
145567375|NCT00500370|524938240|FG001|Overall Study|Subject Decision|17|||
145567376|NCT05627518|524938241|FG000|Treatment Period 1|Adverse Event|0|||
145567377|NCT05627518|524938242|FG001|Treatment Period 1|Adverse Event|0|||
145567378|NCT05627518|524938243|FG002|Treatment Period 1|Adverse Event|1|||
145567379|NCT05627518|524938244|FG003|Treatment Period 1|Adverse Event|0|||
145567380|NCT05627518|524938245|FG004|Treatment Period 1|Adverse Event|0|||
145567381|NCT05627518|524938246|FG005|Treatment Period 1|Adverse Event|0|||
145567382|NCT05627518|524938247|FG006|Treatment Period 1|Adverse Event|0|||
145567383|NCT05627518|524938248|FG007|Treatment Period 1|Adverse Event|1|||
145567384|NCT05627518|524938241|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145567385|NCT05627518|524938242|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145567386|NCT05627518|524938243|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145567387|NCT05627518|524938244|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145567388|NCT05627518|524938245|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145567389|NCT05627518|524938246|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145567390|NCT05627518|524938247|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145567391|NCT05627518|524938248|FG007|Treatment Period 1|Withdrawal by Subject|0|||
145620268|NCT03259373|525123727|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
145620269|NCT03259373|525123726|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
145256431|NCT00672139|523783161|FG000|Overall Study|Lack of Efficacy|4|||
145256432|NCT00672139|523783162|FG001|Overall Study|Lack of Efficacy|1|||
145256433|NCT00672139|523783161|FG000|Overall Study|Protocol Violation|1|||
145256434|NCT00672139|523783162|FG001|Overall Study|Protocol Violation|1|||
145256435|NCT00672139|523783161|FG000|Overall Study|hospice discharge, caregiver requests|3|||
145256436|NCT00672139|523783162|FG001|Overall Study|hospice discharge, caregiver requests|2|||
145256437|NCT01051856|523783163|FG000|Overall Study|Withdrawal by Subject|1|||
145256438|NCT01051856|523783164|FG001|Overall Study|Withdrawal by Subject|0|||
145256439|NCT02381795|523783165|FG000|Overall Study|Withdrawal by Subject|1|||
145256440|NCT02381795|523783165|FG000|Overall Study|Study Terminated|2|||
145567392|NCT05627518|524938241|FG000|Treatment Period 1|Protocol Violation|0|||
145567393|NCT05627518|524938242|FG001|Treatment Period 1|Protocol Violation|0|||
145567394|NCT05627518|524938243|FG002|Treatment Period 1|Protocol Violation|0|||
145567395|NCT05627518|524938244|FG003|Treatment Period 1|Protocol Violation|0|||
145567396|NCT05627518|524938245|FG004|Treatment Period 1|Protocol Violation|0|||
145256441|NCT02176226|523783166|FG000|Overall Study|Lost to Follow-up|3|||
145256442|NCT02176226|523783166|FG000|Overall Study|Withdrew prior to treatment|6|||
145256443|NCT01034709|523783171|FG000|Overall Study|Protocol Violation|9|||
145256444|NCT01034709|523783172|FG001|Overall Study|Protocol Violation|16|||
145567397|NCT05627518|524938246|FG005|Treatment Period 1|Protocol Violation|0|||
145567398|NCT05627518|524938247|FG006|Treatment Period 1|Protocol Violation|6|||
145567399|NCT05627518|524938248|FG007|Treatment Period 1|Protocol Violation|6|||
145567400|NCT05627518|524938241|FG000|Treatment Period 2|Adverse Event|1|||
145567401|NCT05627518|524938242|FG001|Treatment Period 2|Adverse Event|0|||
145567402|NCT05627518|524938243|FG002|Treatment Period 2|Adverse Event|0|||
145567403|NCT05627518|524938244|FG003|Treatment Period 2|Adverse Event|0|||
145256445|NCT02516306|523783175|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
145256446|NCT02516306|523783176|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
145567404|NCT05627518|524938245|FG004|Treatment Period 2|Adverse Event|0|||
145567405|NCT05627518|524938246|FG005|Treatment Period 2|Adverse Event|0|||
145567406|NCT05627518|524938247|FG006|Treatment Period 2|Adverse Event|0|||
145567407|NCT05627518|524938248|FG007|Treatment Period 2|Adverse Event|0|||
145567408|NCT05627518|524938241|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145567409|NCT05627518|524938242|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145567410|NCT05627518|524938243|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145567411|NCT05627518|524938244|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145567412|NCT05627518|524938245|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145567413|NCT05627518|524938246|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145567414|NCT05627518|524938247|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145567415|NCT05627518|524938248|FG007|Treatment Period 2|Withdrawal by Subject|0|||
145567416|NCT04804813|524938249|FG000|Overall Study|Protocol Violation|2|||
145567417|NCT04804813|524938250|FG001|Overall Study|Protocol Violation|0|||
145567418|NCT04804813|524938249|FG000|Overall Study|Withdrawal by Subject|1|||
145256447|NCT02364999|523783178|FG000|Overall Study|Death|136|||
145256448|NCT02364999|523783179|FG001|Overall Study|Death|138|||
145256449|NCT02364999|523783178|FG000|Overall Study|Lost to Follow-up|10|||
145256450|NCT02364999|523783179|FG001|Overall Study|Lost to Follow-up|15|||
145256451|NCT02364999|523783178|FG000|Overall Study|Protocol Violation|3|||
145256452|NCT02364999|523783179|FG001|Overall Study|Protocol Violation|2|||
145256453|NCT02364999|523783178|FG000|Overall Study|Withdrawal by Subject|14|||
145256454|NCT02364999|523783179|FG001|Overall Study|Withdrawal by Subject|14|||
145567419|NCT04804813|524938250|FG001|Overall Study|Withdrawal by Subject|0|||
145567420|NCT02917031|524938254|FG000|Overall Study|Reason not specified|7|||
145567421|NCT02917031|524938255|FG001|Overall Study|Reason not specified|5|||
145567422|NCT02917031|524938256|FG002|Overall Study|Reason not specified|6|||
145567423|NCT02917031|524938254|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
145567424|NCT02917031|524938255|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
145567425|NCT02917031|524938256|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
145567426|NCT02917031|524938254|FG000|Overall Study|Withdrawal by Subject|3|||
145567427|NCT02917031|524938255|FG001|Overall Study|Withdrawal by Subject|3|||
145567428|NCT02917031|524938256|FG002|Overall Study|Withdrawal by Subject|0|||
145567429|NCT02917031|524938254|FG000|Overall Study|Physician Decision|1|||
145567430|NCT02917031|524938255|FG001|Overall Study|Physician Decision|0|||
145567431|NCT02917031|524938256|FG002|Overall Study|Physician Decision|0|||
145567432|NCT02917031|524938254|FG000|Overall Study|Adverse Event|4|||
145567433|NCT02917031|524938255|FG001|Overall Study|Adverse Event|1|||
145567434|NCT02917031|524938256|FG002|Overall Study|Adverse Event|5|||
145567435|NCT02917031|524938254|FG000|Overall Study|Death|2|||
145567436|NCT02917031|524938255|FG001|Overall Study|Death|3|||
145567437|NCT02917031|524938256|FG002|Overall Study|Death|4|||
145567438|NCT03003520|524940413|FG000|Overall Study|Adverse Event|9|||
145567439|NCT03003520|524940414|FG001|Overall Study|Adverse Event|0|||
145567440|NCT03003520|524940413|FG000|Overall Study|Death|1|||
145567441|NCT03003520|524940414|FG001|Overall Study|Death|0|||
145567442|NCT03003520|524940413|FG000|Overall Study|Other reasons|4|||
145567443|NCT03003520|524940414|FG001|Overall Study|Other reasons|0|||
145567444|NCT03003520|524940413|FG000|Overall Study|Withdrawal by Subject|6|||
145567445|NCT03003520|524940414|FG001|Overall Study|Withdrawal by Subject|0|||
145256455|NCT02364999|523783178|FG000|Overall Study|Other|0|||
145256456|NCT02364999|523783179|FG001|Overall Study|Other|1|||
145256457|NCT02364999|523783178|FG000|Overall Study|Randomized but did not receive treatment|2|||
145256458|NCT02364999|523783179|FG001|Overall Study|Randomized but did not receive treatment|3|||
145256459|NCT01351415|523783180|FG000|Overall Study|Withdrawal by Subject|15|||
145256460|NCT01351415|523783181|FG001|Overall Study|Withdrawal by Subject|17|||
145300697|NCT02481830|523953231|FG001|Pre-treatment|Other reasons|1|||
145567446|NCT03003520|524940413|FG000|Overall Study|Progressive disease|9|||
145567447|NCT03003520|524940414|FG001|Overall Study|Progressive disease|1|||
145256461|NCT01351415|523783180|FG000|Overall Study|Trial termination by the Sponsor|28|||
145256462|NCT01351415|523783181|FG001|Overall Study|Trial termination by the Sponsor|19|||
145256463|NCT01351415|523783180|FG000|Overall Study|Lost to Follow-up|5|||
145256464|NCT01351415|523783181|FG001|Overall Study|Lost to Follow-up|7|||
145300698|NCT02481830|523953230|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
145567448|NCT01914666|524940420|FG000|Treatment Period|Lack of Efficacy|0|||
145567449|NCT01914666|524940421|FG001|Treatment Period|Lack of Efficacy|0|||
145567450|NCT01914666|524940422|FG002|Treatment Period|Lack of Efficacy|2|||
145567451|NCT01914666|524940420|FG000|Treatment Period|Adverse Event|10|||
145567452|NCT01914666|524940421|FG001|Treatment Period|Adverse Event|4|||
145567453|NCT01914666|524940422|FG002|Treatment Period|Adverse Event|2|||
145567454|NCT01914666|524940420|FG000|Treatment Period|Withdrawal by Subject|3|||
145567455|NCT01914666|524940421|FG001|Treatment Period|Withdrawal by Subject|2|||
145567456|NCT01914666|524940422|FG002|Treatment Period|Withdrawal by Subject|2|||
145256465|NCT01351415|523783180|FG000|Overall Study|Death|190|||
145256466|NCT01351415|523783181|FG001|Overall Study|Death|187|||
145256467|NCT01351415|523783180|FG000|Overall Study|Physician Decision|2|||
145256468|NCT01351415|523783181|FG001|Overall Study|Physician Decision|3|||
145256469|NCT01351415|523783180|FG000|Overall Study|Reason unknown|0|||
145256470|NCT01351415|523783181|FG001|Overall Study|Reason unknown|2|||
145256471|NCT01351415|523783180|FG000|Overall Study|Never Started|5|||
145256472|NCT01351415|523783181|FG001|Overall Study|Never Started|5|||
145256473|NCT00590031|523783185|FG000|Overall Study|Adverse Event|3|||
145410711|NCT01697579|524356832|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145410712|NCT01697579|524356833|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145410713|NCT01697579|524356834|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145410714|NCT01697579|524356835|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
145410715|NCT01697579|524356836|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
145410716|NCT01044498|524356837|FG000|Overall Study|Withdrew consent|1|||
145410717|NCT01044498|524356838|FG001|Overall Study|Withdrew consent|1|||
145410718|NCT01044498|524356837|FG000|Overall Study|Adverse Event|1|||
145256474|NCT00590031|523783185|FG000|Overall Study|Withdrawal by Subject|1|||
145256475|NCT00590031|523783185|FG000|Overall Study|Metastatic Disease|1|||
145256476|NCT00590031|523783185|FG000|Overall Study|Admin Hold|1|||
145256477|NCT00472043|523783186|FG000|Overall Study|Withdrawal by Subject|1|||
145256478|NCT00472043|523783187|FG001|Overall Study|Withdrawal by Subject|0|||
145256479|NCT00472043|523783186|FG000|Overall Study|Death|1|||
145256480|NCT00472043|523783187|FG001|Overall Study|Death|0|||
145256481|NCT03147495|523783193|FG000|Overall Study|Physician Decision|0|||
145256482|NCT03147495|523783194|FG001|Overall Study|Physician Decision|6|||
145256483|NCT01142791|523783195|FG000|Overall Study|Alternative Treatment|1|||
145256484|NCT01142791|523783196|FG001|Overall Study|Alternative Treatment|0|||
145256485|NCT01142791|523783195|FG000|Overall Study|Lost to Follow-up|1|||
145256486|NCT01142791|523783196|FG001|Overall Study|Lost to Follow-up|0|||
145256487|NCT01142791|523783195|FG000|Overall Study|Withdrawal by Subject|5|||
145256488|NCT01142791|523783196|FG001|Overall Study|Withdrawal by Subject|0|||
145256489|NCT01142791|523783195|FG000|Overall Study|Received only 1 sonication|0|||
145256490|NCT01142791|523783196|FG001|Overall Study|Received only 1 sonication|6|||
145256491|NCT00877890|523783199|FG000|Overall Study|Adverse Event|6|||
145256492|NCT00877890|523783200|FG001|Overall Study|Adverse Event|6|||
145256493|NCT00877890|523783199|FG000|Overall Study|Lost to Follow-up|5|||
145256494|NCT00877890|523783200|FG001|Overall Study|Lost to Follow-up|5|||
145256495|NCT00877890|523783199|FG000|Overall Study|Protocol Violation|0|||
145256496|NCT00877890|523783200|FG001|Overall Study|Protocol Violation|1|||
145256497|NCT00877890|523783199|FG000|Overall Study|Withdrawal of Consent|6|||
145256498|NCT00877890|523783200|FG001|Overall Study|Withdrawal of Consent|12|||
145256499|NCT00877890|523783199|FG000|Overall Study|Investigator Decision|0|||
145256500|NCT00877890|523783200|FG001|Overall Study|Investigator Decision|2|||
145256501|NCT00877890|523783199|FG000|Overall Study|Loss of Glucose Control|3|||
145256502|NCT00877890|523783200|FG001|Overall Study|Loss of Glucose Control|4|||
145256503|NCT02975206|523783201|FG000|Overall Study|Withdrawal by Subject|14|||
145256504|NCT02975206|523783202|FG001|Overall Study|Withdrawal by Subject|11|||
145256505|NCT02975206|523783203|FG002|Overall Study|Withdrawal by Subject|11|||
145256506|NCT02975206|523783201|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
145256507|NCT02975206|523783202|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
145256508|NCT02975206|523783203|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
145256509|NCT01981096|523783204|FG000|Overall Study|Parent illness|1|||
145256510|NCT01981096|523783205|FG001|Overall Study|Parent illness|0|||
145256511|NCT01981096|523783204|FG000|Overall Study|Withdrawal by Subject|0|||
145256512|NCT01981096|523783205|FG001|Overall Study|Withdrawal by Subject|1|||
145256513|NCT01981096|523783204|FG000|Overall Study|Lost to Follow-up|2|||
145256514|NCT01981096|523783205|FG001|Overall Study|Lost to Follow-up|0|||
145256515|NCT00866606|523783206|FG000|Overall Study|Lost to Follow-up|3|||
145256516|NCT00866606|523783206|FG000|Overall Study|Adverse Event|1|||
145256517|NCT00392210|523783223|FG000|First Voiding Trial|Physician Decision|2|||
145256518|NCT00392210|523783224|FG001|First Voiding Trial|Physician Decision|2|||
145256519|NCT03049852|523783225|FG000|Overall Study|Lost to Follow-up|0|||
145256520|NCT03049852|523783226|FG001|Overall Study|Lost to Follow-up|1|||
145256521|NCT03049852|523783227|FG002|Overall Study|Lost to Follow-up|0|||
145256522|NCT02067104|523783228|FG000|Overall Study|Study termination due to low accrual|4|||
145256523|NCT02067104|523783229|FG001|Overall Study|Study termination due to low accrual|5|||
145256524|NCT01987609|523783230|FG000|Overall Study|Adverse Event|1|||
145256525|NCT02610231|523783231|FG000|Overall Study|Withdrawal by Subject|27|||
145256526|NCT02610231|523783231|FG000|Overall Study|Adverse Event|20|||
145256527|NCT02610231|523783231|FG000|Overall Study|Death|5|||
145256528|NCT02610231|523783231|FG000|Overall Study|Surgery|2|||
145256529|NCT02610231|523783231|FG000|Overall Study|Physician Decision|1|||
145256530|NCT02610231|523783231|FG000|Overall Study|Non Compliance|2|||
145256531|NCT02610231|523783231|FG000|Overall Study|Other|3|||
145256532|NCT00806494|523783237|FG000|Overall Study|Adverse Event|29|||
145256533|NCT00806494|523783237|FG000|Overall Study|Lack of Efficacy|6|||
145256534|NCT00806494|523783237|FG000|Overall Study|Lost to Follow-up|10|||
145256535|NCT00806494|523783237|FG000|Overall Study|Other|30|||
145256536|NCT00806494|523783237|FG000|Overall Study|Withdrawal by Subject|5|||
145256537|NCT01279954|523783240|FG000|Overall Study|Lack of Efficacy|3|||
145256538|NCT01279954|523783241|FG001|Overall Study|Lack of Efficacy|4|||
145256539|NCT02140762|523783242|FG000|Overall Study|Adverse Event|1|||
145256540|NCT02140762|523783243|FG001|Overall Study|Adverse Event|1|||
145256541|NCT02140762|523783242|FG000|Overall Study|Lost to Follow-up|9|||
145256542|NCT02140762|523783243|FG001|Overall Study|Lost to Follow-up|5|||
145256543|NCT02140762|523783242|FG000|Overall Study|Protocol Violation|1|||
145256544|NCT02140762|523783243|FG001|Overall Study|Protocol Violation|1|||
145256545|NCT02140762|523783242|FG000|Overall Study|Withdrawal by Subject|6|||
145256546|NCT02140762|523783243|FG001|Overall Study|Withdrawal by Subject|4|||
145256547|NCT02140762|523783242|FG000|Overall Study|Other|0|||
145256548|NCT02140762|523783243|FG001|Overall Study|Other|1|||
145256549|NCT02709889|523783244|FG000|Overall Study|Withdrawal by Subject|11|||
145256550|NCT02709889|523783245|FG001|Overall Study|Withdrawal by Subject|10|||
145256551|NCT02709889|523783246|FG002|Overall Study|Withdrawal by Subject|2|||
145256552|NCT02709889|523783247|FG003|Overall Study|Withdrawal by Subject|12|||
145256553|NCT02709889|523783244|FG000|Overall Study|Death|25|||
145256554|NCT02709889|523783245|FG001|Overall Study|Death|38|||
145256555|NCT02709889|523783246|FG002|Overall Study|Death|4|||
145256556|NCT02709889|523783247|FG003|Overall Study|Death|44|||
145256557|NCT02709889|523783244|FG000|Overall Study|Physician Decision|1|||
145256558|NCT02709889|523783245|FG001|Overall Study|Physician Decision|2|||
145256559|NCT02709889|523783246|FG002|Overall Study|Physician Decision|3|||
145256560|NCT02709889|523783247|FG003|Overall Study|Physician Decision|5|||
145256561|NCT02709889|523783244|FG000|Overall Study|Lost to Follow-up|2|||
145256562|NCT02709889|523783245|FG001|Overall Study|Lost to Follow-up|0|||
145256563|NCT02709889|523783246|FG002|Overall Study|Lost to Follow-up|0|||
145256564|NCT02709889|523783247|FG003|Overall Study|Lost to Follow-up|4|||
145256565|NCT02709889|523783244|FG000|Overall Study|Study Terminated by Sponsor|4|||
145256566|NCT02709889|523783245|FG001|Overall Study|Study Terminated by Sponsor|6|||
145256567|NCT02709889|523783246|FG002|Overall Study|Study Terminated by Sponsor|2|||
145256568|NCT02709889|523783247|FG003|Overall Study|Study Terminated by Sponsor|17|||
145256569|NCT02709889|523783244|FG000|Overall Study|Other, Not Specified|0|||
145256570|NCT02709889|523783245|FG001|Overall Study|Other, Not Specified|1|||
145256571|NCT02709889|523783246|FG002|Overall Study|Other, Not Specified|1|||
145256572|NCT02709889|523783247|FG003|Overall Study|Other, Not Specified|6|||
145256573|NCT00122317|523783253|FG000|Overall Study|Death|3|||
145256574|NCT00122317|523783253|FG000|Overall Study|Adverse Event|4|||
145256575|NCT00122317|523783253|FG000|Overall Study|Physician Decision|2|||
145410719|NCT01044498|524356838|FG001|Overall Study|Adverse Event|1|||
145256576|NCT00122317|523783253|FG000|Overall Study|patient non-compliance|1|||
145256577|NCT00122317|523783253|FG000|Overall Study|Withdrawal by Subject|1|||
145256578|NCT03458234|523783254|FG000|Overall Study|Withdrawal by Subject|1|||
145256579|NCT01021293|523783261|FG000|Overall Study|Serious Adverse Event|2|||
145256580|NCT01021293|523783262|FG001|Overall Study|Serious Adverse Event|1|||
145256581|NCT01021293|523783261|FG000|Overall Study|Adverse Event|2|||
145256582|NCT01021293|523783262|FG001|Overall Study|Adverse Event|1|||
145256583|NCT01021293|523783261|FG000|Overall Study|Withdrawal by Subject|1|||
145256584|NCT01021293|523783262|FG001|Overall Study|Withdrawal by Subject|3|||
145256585|NCT01021293|523783261|FG000|Overall Study|Migrated/moved from study area|6|||
145256586|NCT01021293|523783262|FG001|Overall Study|Migrated/moved from study area|18|||
145256587|NCT01021293|523783261|FG000|Overall Study|Lost to Follow-up|1|||
145256588|NCT01021293|523783262|FG001|Overall Study|Lost to Follow-up|1|||
145256589|NCT04728815|523783263|FG000|Overall Study|Lost to Follow-up|3|||
145256590|NCT04728815|523783264|FG001|Overall Study|Lost to Follow-up|0|||
145256591|NCT04728815|523783265|FG002|Overall Study|Lost to Follow-up|0|||
145256592|NCT04728815|523783266|FG003|Overall Study|Lost to Follow-up|1|||
145256593|NCT04728815|523783267|FG004|Overall Study|Lost to Follow-up|1|||
145256594|NCT04728815|523783268|FG005|Overall Study|Lost to Follow-up|0|||
145256595|NCT04728815|523783269|FG006|Overall Study|Lost to Follow-up|2|||
145256596|NCT04728815|523783270|FG007|Overall Study|Lost to Follow-up|0|||
145256597|NCT04728815|523783263|FG000|Overall Study|Physician Decision|0|||
145256598|NCT04728815|523783264|FG001|Overall Study|Physician Decision|0|||
145256599|NCT04728815|523783265|FG002|Overall Study|Physician Decision|1|||
145256600|NCT04728815|523783266|FG003|Overall Study|Physician Decision|0|||
145256601|NCT04728815|523783267|FG004|Overall Study|Physician Decision|0|||
145256602|NCT04728815|523783268|FG005|Overall Study|Physician Decision|0|||
145256603|NCT04728815|523783269|FG006|Overall Study|Physician Decision|0|||
145256604|NCT04728815|523783270|FG007|Overall Study|Physician Decision|0|||
145256605|NCT04728815|523783263|FG000|Overall Study|Treatment drop|0|||
145256606|NCT04728815|523783264|FG001|Overall Study|Treatment drop|2|||
145256607|NCT04728815|523783265|FG002|Overall Study|Treatment drop|1|||
145256608|NCT04728815|523783266|FG003|Overall Study|Treatment drop|0|||
145256609|NCT04728815|523783267|FG004|Overall Study|Treatment drop|3|||
145256610|NCT04728815|523783268|FG005|Overall Study|Treatment drop|1|||
145256611|NCT04728815|523783269|FG006|Overall Study|Treatment drop|3|||
145256612|NCT04728815|523783270|FG007|Overall Study|Treatment drop|0|||
145256613|NCT04728815|523783263|FG000|Overall Study|Study drop|0|||
145256614|NCT04728815|523783264|FG001|Overall Study|Study drop|3|||
145256615|NCT04728815|523783265|FG002|Overall Study|Study drop|3|||
145256616|NCT04728815|523783266|FG003|Overall Study|Study drop|0|||
145256617|NCT04728815|523783267|FG004|Overall Study|Study drop|0|||
145256618|NCT04728815|523783268|FG005|Overall Study|Study drop|0|||
145256619|NCT04728815|523783269|FG006|Overall Study|Study drop|7|||
145256620|NCT04728815|523783270|FG007|Overall Study|Study drop|0|||
145256621|NCT05315297|523783271|FG000|Overall Study|Lost to Follow-up|6|||
145256622|NCT05315297|523783272|FG001|Overall Study|Lost to Follow-up|4|||
145256623|NCT05315297|523783271|FG000|Overall Study|Withdrawal by Subject|0|||
145256624|NCT05315297|523783272|FG001|Overall Study|Withdrawal by Subject|1|||
145567457|NCT01914666|524940420|FG000|Treatment Period|Physician Decision|0|||
145567458|NCT01914666|524940421|FG001|Treatment Period|Physician Decision|0|||
145567459|NCT01914666|524940422|FG002|Treatment Period|Physician Decision|2|||
145256625|NCT00027846|523785100|FG000|Overall Study|Lost to Follow-up|0|||
145256626|NCT00027846|523785101|FG001|Overall Study|Lost to Follow-up|41|||
145256627|NCT00027846|523785102|FG002|Overall Study|Lost to Follow-up|9|||
145256628|NCT00027846|523785100|FG000|Overall Study|Withdrawal by Subject|0|||
145256629|NCT00027846|523785101|FG001|Overall Study|Withdrawal by Subject|14|||
145256630|NCT00027846|523785102|FG002|Overall Study|Withdrawal by Subject|7|||
145256631|NCT00027846|523785100|FG000|Overall Study|Ineligible for study|2|||
145256632|NCT00027846|523785101|FG001|Overall Study|Ineligible for study|6|||
145256633|NCT00027846|523785102|FG002|Overall Study|Ineligible for study|14|||
145256634|NCT00027846|523785100|FG000|Overall Study|Entry into another COG therapeutic study|0|||
145256635|NCT00027846|523785101|FG001|Overall Study|Entry into another COG therapeutic study|5|||
145256636|NCT00027846|523785102|FG002|Overall Study|Entry into another COG therapeutic study|2|||
145256637|NCT00027846|523785100|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
145256638|NCT00027846|523785101|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
145256639|NCT00027846|523785102|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
145256640|NCT04335929|523785103|FG000|Overall Study|Lost to Follow-up|10|||
145256641|NCT02889861|523785120|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
145256642|NCT01864746|523785121|FG000|Overall Study|Disease recurrence|25|||
145256643|NCT01864746|523785122|FG001|Overall Study|Disease recurrence|40|||
145256644|NCT01864746|523785121|FG000|Overall Study|Second primary invasive nonbreast|2|||
145256645|NCT01864746|523785122|FG001|Overall Study|Second primary invasive nonbreast|3|||
145256646|NCT01864746|523785121|FG000|Overall Study|Death|2|||
145256647|NCT01864746|523785122|FG001|Overall Study|Death|1|||
145256648|NCT01864746|523785121|FG000|Overall Study|Adverse Event|33|||
145256649|NCT01864746|523785122|FG001|Overall Study|Adverse Event|5|||
145256650|NCT01864746|523785121|FG000|Overall Study|Withdrawal by Subject|56|||
145256651|NCT01864746|523785122|FG001|Overall Study|Withdrawal by Subject|41|||
145256652|NCT01864746|523785121|FG000|Overall Study|Physician Decision|5|||
145256653|NCT01864746|523785122|FG001|Overall Study|Physician Decision|6|||
145256654|NCT01005966|523785123|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
145256655|NCT01005966|523785124|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145256656|NCT01005966|523785125|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
145256657|NCT01005966|523785126|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
145256658|NCT01005966|523785127|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
145256659|NCT01005966|523785123|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145256660|NCT01005966|523785124|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
145256661|NCT01005966|523785125|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145256662|NCT01005966|523785126|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
145256663|NCT01005966|523785127|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
145256664|NCT01005966|523785123|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
145567460|NCT00358527|524940427|FG000|Overall Study|Adverse Event|4|||
145567461|NCT00358527|524940428|FG001|Overall Study|Adverse Event|0|||
145567462|NCT00358527|524940427|FG000|Overall Study|Withdrawal by Subject|1|||
145567463|NCT00358527|524940428|FG001|Overall Study|Withdrawal by Subject|1|||
145567464|NCT00358527|524940427|FG000|Overall Study|Non-compliance with protocol|6|||
145567465|NCT00358527|524940428|FG001|Overall Study|Non-compliance with protocol|1|||
145567466|NCT00358527|524940427|FG000|Overall Study|Administrative|2|||
145567467|NCT00358527|524940428|FG001|Overall Study|Administrative|1|||
145567468|NCT00749463|524940429|FG000|Overall Study|Adverse Event|0|||
145567469|NCT00749463|524940430|FG001|Overall Study|Adverse Event|4|||
145567470|NCT00749463|524940431|FG002|Overall Study|Adverse Event|1|||
145567471|NCT00749463|524940429|FG000|Overall Study|Withdrawal by Subject|1|||
145256665|NCT01005966|523785124|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
145256666|NCT01005966|523785125|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
145256667|NCT01005966|523785126|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
145256668|NCT01005966|523785127|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
145256669|NCT01005966|523785123|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
145256670|NCT01005966|523785124|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
145256671|NCT01005966|523785125|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
145567472|NCT00749463|524940430|FG001|Overall Study|Withdrawal by Subject|0|||
145567473|NCT00749463|524940431|FG002|Overall Study|Withdrawal by Subject|0|||
145567474|NCT00913744|524940433|FG000|Overall Study|Adverse Event|2|||
145567475|NCT00913744|524940434|FG001|Overall Study|Adverse Event|0|||
145567476|NCT00913744|524940433|FG000|Overall Study|Withdrawal by Subject|2|||
145567477|NCT00913744|524940434|FG001|Overall Study|Withdrawal by Subject|1|||
145567478|NCT00913744|524940433|FG000|Overall Study|Death|1|||
145567479|NCT00913744|524940434|FG001|Overall Study|Death|0|||
145567480|NCT01344369|524940435|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
145567481|NCT01344369|524940436|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
145567482|NCT01344369|524940435|FG000|Washout of 28 Days|Physician Decision|0|||
145567483|NCT01344369|524940436|FG001|Washout of 28 Days|Physician Decision|1|||
145567484|NCT01344369|524940435|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
145567485|NCT01344369|524940436|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
145567486|NCT01454726|524940439|FG000|Overall Study|Withdrawal by Subject|0|||
145567487|NCT01454726|524940440|FG001|Overall Study|Withdrawal by Subject|1|||
145567488|NCT04200248|524940441|FG000|Overall Study|Personal reasons|0|||
145567489|NCT04200248|524940442|FG001|Overall Study|Personal reasons|0|||
145567490|NCT04200248|524940443|FG002|Overall Study|Personal reasons|1|||
145567491|NCT04200248|524940441|FG000|Overall Study|Discontinued prior to treatment|3|||
145567492|NCT04200248|524940442|FG001|Overall Study|Discontinued prior to treatment|3|||
145567493|NCT04200248|524940443|FG002|Overall Study|Discontinued prior to treatment|2|||
145567494|NCT01886833|524940446|FG000|Overall Study|IgA not available from both periods|204|||
145567495|NCT02342704|524940449|FG000|Overall Study|Physician Decision|0|||
145567496|NCT02342704|524940450|FG001|Overall Study|Physician Decision|3|||
145567497|NCT02342704|524940449|FG000|Overall Study|Sponsor Termination|49|||
145567498|NCT02342704|524940450|FG001|Overall Study|Sponsor Termination|43|||
145567499|NCT02342704|524940449|FG000|Overall Study|Other|0|||
145567500|NCT02342704|524940450|FG001|Overall Study|Other|1|||
145567501|NCT02342704|524940449|FG000|Overall Study|Withdrawal by Subject|1|||
145567502|NCT02342704|524940450|FG001|Overall Study|Withdrawal by Subject|0|||
145567503|NCT02342704|524940449|FG000|Overall Study|Lost to Follow-up|2|||
145567504|NCT02342704|524940450|FG001|Overall Study|Lost to Follow-up|1|||
145256672|NCT01005966|523785126|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
145256673|NCT01005966|523785127|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
145256674|NCT01005966|523785123|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145256675|NCT01005966|523785124|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145256676|NCT01005966|523785125|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145256677|NCT01005966|523785126|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145256678|NCT01005966|523785127|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145256679|NCT01005966|523785123|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145567505|NCT02342704|524940449|FG000|Overall Study|Adverse Event|1|||
145567506|NCT02342704|524940450|FG001|Overall Study|Adverse Event|3|||
145567507|NCT00302003|524940452|FG000|Overall Study|Lack of Efficacy|62|||
145567508|NCT00302003|524940452|FG000|Overall Study|Lost to Follow-up|1|||
145567509|NCT00302003|524940452|FG000|Overall Study|Physician Decision|2|||
145567510|NCT00302003|524940452|FG000|Overall Study|Withdrawal by Subject|5|||
145567511|NCT00302003|524940452|FG000|Overall Study|Ineligible|9|||
145567512|NCT00302003|524940452|FG000|Overall Study|Protocol Violation|1|||
145567513|NCT01539226|524940453|FG000|Overall Study|Withdrawal by Subject|24|||
145567514|NCT01539226|524940454|FG001|Overall Study|Withdrawal by Subject|54|||
145567515|NCT01539226|524940453|FG000|Overall Study|Lost to Follow-up|20|||
145567516|NCT01539226|524940454|FG001|Overall Study|Lost to Follow-up|54|||
145567517|NCT01539226|524940453|FG000|Overall Study|Death|1|||
145567518|NCT01539226|524940454|FG001|Overall Study|Death|2|||
145567519|NCT01539226|524940453|FG000|Overall Study|Adverse Event|2|||
145567520|NCT01539226|524940454|FG001|Overall Study|Adverse Event|0|||
145567521|NCT01539226|524940453|FG000|Overall Study|Pregnancy|13|||
145567522|NCT01539226|524940454|FG001|Overall Study|Pregnancy|29|||
145567523|NCT01539226|524940453|FG000|Overall Study|inappropriate enrollment|0|||
145567524|NCT01539226|524940454|FG001|Overall Study|inappropriate enrollment|1|||
145567525|NCT01539226|524940453|FG000|Overall Study|Multiple Reasons|3|||
145300699|NCT02481830|523953231|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
145300700|NCT02481830|523953230|FG000|Treatment|Disease Progression|233|||
145300701|NCT02481830|523953231|FG001|Treatment|Disease Progression|171|||
145300702|NCT02481830|523953230|FG000|Treatment|Study drug toxicity|18|||
145300703|NCT02481830|523953231|FG001|Treatment|Study drug toxicity|38|||
145300704|NCT02481830|523953230|FG000|Treatment|Death|1|||
145567526|NCT01539226|524940454|FG001|Overall Study|Multiple Reasons|1|||
145567527|NCT01539226|524940453|FG000|Overall Study|not HIV seroconversion-related|93|||
145567528|NCT01539226|524940454|FG001|Overall Study|not HIV seroconversion-related|176|||
145567529|NCT01539226|524940453|FG000|Overall Study|HIV seroconversion-related|55|||
145567530|NCT01539226|524940454|FG001|Overall Study|HIV seroconversion-related|80|||
145567531|NCT01539226|524940453|FG000|Overall Study|Non-compliance|6|||
145567532|NCT01539226|524940454|FG001|Overall Study|Non-compliance|8|||
145567533|NCT00283439|524940455|FG000|Overall Study|Adverse Event|0|||
145567534|NCT00283439|524940456|FG001|Overall Study|Adverse Event|0|||
145256680|NCT01005966|523785124|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145300705|NCT02481830|523953231|FG001|Treatment|Death|1|||
145567535|NCT00283439|524940457|FG002|Overall Study|Adverse Event|0|||
145410720|NCT01044498|524356837|FG000|Overall Study|Other|1|||
145410721|NCT01044498|524356838|FG001|Overall Study|Other|0|||
145410722|NCT05513950|524356841|FG000|Overall Study|Not treated due to technical reasons|0|||
145410723|NCT05513950|524356842|FG001|Overall Study|Not treated due to technical reasons|0|||
145410724|NCT05513950|524356843|FG002|Overall Study|Not treated due to technical reasons|1|||
145410725|NCT05513950|524356844|FG003|Overall Study|Not treated due to technical reasons|0|||
145410726|NCT02903914|524356845|FG000|Overall Study|Adverse Event|0|||
145567536|NCT00283439|524940458|FG003|Overall Study|Adverse Event|1|||
145567537|NCT00283439|524940455|FG000|Overall Study|Death|0|||
145567538|NCT00283439|524940456|FG001|Overall Study|Death|0|||
145567539|NCT00283439|524940457|FG002|Overall Study|Death|1|||
145567540|NCT00283439|524940458|FG003|Overall Study|Death|0|||
145567541|NCT00283439|524940455|FG000|Overall Study|Disease progression|0|||
145567542|NCT00283439|524940456|FG001|Overall Study|Disease progression|1|||
145567543|NCT00283439|524940457|FG002|Overall Study|Disease progression|0|||
145567544|NCT00283439|524940458|FG003|Overall Study|Disease progression|0|||
145567545|NCT00283439|524940455|FG000|Overall Study|Requirement for alternative therapy|1|||
145567546|NCT00283439|524940456|FG001|Overall Study|Requirement for alternative therapy|2|||
145567547|NCT00283439|524940457|FG002|Overall Study|Requirement for alternative therapy|5|||
145567548|NCT00283439|524940458|FG003|Overall Study|Requirement for alternative therapy|2|||
145567549|NCT00283439|524940455|FG000|Overall Study|Stem cell transplant|6|||
145567550|NCT00283439|524940456|FG001|Overall Study|Stem cell transplant|6|||
145567551|NCT00283439|524940457|FG002|Overall Study|Stem cell transplant|4|||
145567552|NCT00283439|524940458|FG003|Overall Study|Stem cell transplant|3|||
145256681|NCT01005966|523785125|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
145256682|NCT01005966|523785126|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145256683|NCT01005966|523785127|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145256684|NCT01005966|523785123|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
145256685|NCT01005966|523785124|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
145256686|NCT01005966|523785125|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
145256687|NCT01005966|523785126|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
145256688|NCT01005966|523785127|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
145256689|NCT01005966|523785123|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
145256690|NCT01005966|523785124|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
145256691|NCT01005966|523785125|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
145256692|NCT01005966|523785126|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
145567553|NCT00283439|524940455|FG000|Overall Study|Treatment discontinued|0|||
145567554|NCT00283439|524940456|FG001|Overall Study|Treatment discontinued|2|||
145410727|NCT02903914|524356846|FG001|Overall Study|Adverse Event|0|||
145410728|NCT02903914|524356847|FG002|Overall Study|Adverse Event|1|||
145410729|NCT02903914|524356848|FG003|Overall Study|Adverse Event|0|||
145410730|NCT02903914|524356849|FG004|Overall Study|Adverse Event|0|||
145410731|NCT02903914|524356850|FG005|Overall Study|Adverse Event|0|||
145410732|NCT02903914|524356851|FG006|Overall Study|Adverse Event|2|||
145410733|NCT02903914|524356852|FG007|Overall Study|Adverse Event|0|||
145410734|NCT02903914|524356845|FG000|Overall Study|Withdrawal by Subject|3|||
145410735|NCT02903914|524356846|FG001|Overall Study|Withdrawal by Subject|1|||
145410736|NCT02903914|524356847|FG002|Overall Study|Withdrawal by Subject|28|||
145410737|NCT02903914|524356848|FG003|Overall Study|Withdrawal by Subject|0|||
145410738|NCT02903914|524356849|FG004|Overall Study|Withdrawal by Subject|1|||
145567555|NCT00283439|524940457|FG002|Overall Study|Treatment discontinued|1|||
145567556|NCT00283439|524940458|FG003|Overall Study|Treatment discontinued|3|||
145567557|NCT00283439|524940455|FG000|Overall Study|Other|1|||
145567558|NCT00283439|524940456|FG001|Overall Study|Other|0|||
145567559|NCT00283439|524940457|FG002|Overall Study|Other|0|||
145567560|NCT00283439|524940458|FG003|Overall Study|Other|0|||
145567561|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
145567562|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
145567563|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
145567564|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
145256693|NCT01005966|523785127|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
145256694|NCT01005966|523785123|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
145256695|NCT01005966|523785124|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
145256696|NCT01005966|523785125|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
145256697|NCT01005966|523785126|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
145410739|NCT02903914|524356850|FG005|Overall Study|Withdrawal by Subject|2|||
145256698|NCT01005966|523785127|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
145410740|NCT02903914|524356851|FG006|Overall Study|Withdrawal by Subject|12|||
145410741|NCT02903914|524356852|FG007|Overall Study|Withdrawal by Subject|0|||
145567565|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
145567566|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
145567567|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
145567568|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
145567569|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
145256699|NCT01451203|523785128|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
145256700|NCT01451203|523785129|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
145256701|NCT01451203|523785128|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
145567570|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
145567571|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
145567572|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
145567573|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
145567574|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
145567575|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
145567576|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
145567577|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
145567578|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
145567579|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
145567580|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
145567581|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
145567582|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
145567583|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
145567584|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
145567585|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
145567586|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
145567587|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
145567588|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
145567589|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
145567590|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
145567591|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
145567592|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
145567593|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
145567594|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
145567595|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
145567596|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
145567597|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
145567598|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
145567599|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
145567600|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
145567601|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
145567602|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
145567603|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
145567604|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
145567605|NCT01218516|524940459|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
145567606|NCT01218516|524940460|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
145567607|NCT01218516|524940461|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
145567608|NCT01218516|524940462|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
145567609|NCT00333229|524940465|FG000|Overall Study|Lack of Efficacy|0|||
145567610|NCT00333229|524940466|FG001|Overall Study|Lack of Efficacy|1|||
145567611|NCT01632891|524940467|FG000|Overall Study|Lost to Follow-up|0|||
145567612|NCT01632891|524940468|FG001|Overall Study|Lost to Follow-up|1|||
145567613|NCT01632891|524940467|FG000|Overall Study|Withdrawal by Subject|1|||
145567614|NCT01632891|524940468|FG001|Overall Study|Withdrawal by Subject|0|||
145567615|NCT00240071|524940470|FG000|Overall Study|Withdrawal by Subject|3|||
145567616|NCT01641367|524940486|FG000|Cohorts|Death|18|||
145567617|NCT01641367|524940487|FG001|Cohorts|Death|1|||
145567618|NCT01641367|524940488|FG002|Cohorts|Death|2|||
145567619|NCT01641367|524940489|FG003|Cohorts|Death|0|||
145567620|NCT01641367|524940490|FG004|Cohorts|Death|1|||
145567621|NCT01641367|524940491|FG005|Cohorts|Death|1|||
145567622|NCT01641367|524940492|FG006|Cohorts|Death|0|||
145256702|NCT01451203|523785129|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
145256703|NCT01451203|523785128|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
145410742|NCT02903914|524356845|FG000|Overall Study|Progressive Disease|1|||
145567623|NCT01641367|524940493|FG007|Cohorts|Death|0|||
145567624|NCT01641367|524940486|FG000|Cohorts|Lost to Follow-up|16|||
145256704|NCT01451203|523785129|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
145410743|NCT02903914|524356846|FG001|Overall Study|Progressive Disease|0|||
145567625|NCT01641367|524940487|FG001|Cohorts|Lost to Follow-up|0|||
145567626|NCT01641367|524940488|FG002|Cohorts|Lost to Follow-up|2|||
145567627|NCT01641367|524940489|FG003|Cohorts|Lost to Follow-up|0|||
145256705|NCT01451203|523785128|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
145410744|NCT02903914|524356847|FG002|Overall Study|Progressive Disease|4|||
145567628|NCT01641367|524940490|FG004|Cohorts|Lost to Follow-up|2|||
145256706|NCT01451203|523785129|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
145256707|NCT01451203|523785128|FG000|Double-blind Treatment Period|Adverse Event|6|||
145567629|NCT01641367|524940491|FG005|Cohorts|Lost to Follow-up|0|||
145567630|NCT01641367|524940492|FG006|Cohorts|Lost to Follow-up|0|||
145567631|NCT01641367|524940493|FG007|Cohorts|Lost to Follow-up|0|||
145567632|NCT01641367|524940486|FG000|Randomized Adherence Intervention|Death|0|||
145256708|NCT01451203|523785129|FG001|Double-blind Treatment Period|Adverse Event|9|||
145256709|NCT01451203|523785128|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
145256710|NCT01451203|523785129|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
145256711|NCT01451203|523785128|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
145256712|NCT01451203|523785129|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
145256713|NCT01451203|523785128|FG000|Double-blind Treatment Period|Investigator decision|2|||
145256714|NCT01451203|523785129|FG001|Double-blind Treatment Period|Investigator decision|0|||
145256715|NCT01451203|523785128|FG000|Post-treatment Period|Consent withdrawn|2|||
145256716|NCT01451203|523785129|FG001|Post-treatment Period|Consent withdrawn|4|||
145256717|NCT01451203|523785128|FG000|Post-treatment Period|Lack of Efficacy|12|||
145256718|NCT01451203|523785129|FG001|Post-treatment Period|Lack of Efficacy|28|||
145256719|NCT01451203|523785128|FG000|Post-treatment Period|Adverse Event|0|||
145256720|NCT01451203|523785129|FG001|Post-treatment Period|Adverse Event|1|||
145256721|NCT01451203|523785128|FG000|Post-treatment Period|Investigator decision|0|||
145256722|NCT01451203|523785129|FG001|Post-treatment Period|Investigator decision|1|||
145256723|NCT02146274|523785130|FG000|Overall Study|Protocol Violation|73|||
145256724|NCT00443534|523785141|FG000|Overall Study|Lack of Efficacy|67|||
145256725|NCT00443534|523785141|FG000|Overall Study|Adverse Event|16|||
145256726|NCT00443534|523785141|FG000|Overall Study|Death|9|||
145256727|NCT00443534|523785141|FG000|Overall Study|Withdrawal by Subject|8|||
145256728|NCT00443534|523785141|FG000|Overall Study|Study Terminated by Sponsor|12|||
145256729|NCT00443534|523785141|FG000|Overall Study|Other|10|||
145256730|NCT00443534|523785141|FG000|Overall Study|Enrolled, Not Treated|1|||
145256731|NCT00413231|523785142|FG000|0 to 30-day Post Treatment|Death|5|||
145256732|NCT00413231|523785142|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
145256733|NCT00413231|523785142|FG000|30-day to 365-day Post Treatment|Death|13|||
145256734|NCT00413231|523785142|FG000|365-day to 60-month Post Treatment|Death|36|||
145256735|NCT00413231|523785142|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
145256736|NCT00413231|523785142|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
145256737|NCT00413231|523785142|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
145256738|NCT04450394|523785147|FG000|Overall Study|Adverse Event|2|||
145256739|NCT04450394|523785148|FG001|Overall Study|Adverse Event|0|||
145256740|NCT04450394|523785149|FG002|Overall Study|Adverse Event|0|||
145256741|NCT04450394|523785147|FG000|Overall Study|Death|0|||
145256742|NCT04450394|523785148|FG001|Overall Study|Death|1|||
145256743|NCT04450394|523785149|FG002|Overall Study|Death|0|||
145256744|NCT04450394|523785147|FG000|Overall Study|Lost to Follow-up|0|||
145256745|NCT04450394|523785148|FG001|Overall Study|Lost to Follow-up|3|||
145256746|NCT04450394|523785149|FG002|Overall Study|Lost to Follow-up|0|||
145256747|NCT04450394|523785147|FG000|Overall Study|Physician Decision|0|||
145256748|NCT04450394|523785148|FG001|Overall Study|Physician Decision|1|||
145256749|NCT04450394|523785149|FG002|Overall Study|Physician Decision|0|||
145256750|NCT04450394|523785147|FG000|Overall Study|Protocol Violation|2|||
145256751|NCT04450394|523785148|FG001|Overall Study|Protocol Violation|0|||
145256752|NCT04450394|523785149|FG002|Overall Study|Protocol Violation|0|||
145256753|NCT04450394|523785147|FG000|Overall Study|Withdrawal by Subject|6|||
145567633|NCT01641367|524940487|FG001|Randomized Adherence Intervention|Death|0|||
145567634|NCT01641367|524940488|FG002|Randomized Adherence Intervention|Death|0|||
145567635|NCT01641367|524940489|FG003|Randomized Adherence Intervention|Death|0|||
145567636|NCT01641367|524940490|FG004|Randomized Adherence Intervention|Death|0|||
145567637|NCT01641367|524940491|FG005|Randomized Adherence Intervention|Death|0|||
145567638|NCT01641367|524940492|FG006|Randomized Adherence Intervention|Death|11|||
145256754|NCT04450394|523785148|FG001|Overall Study|Withdrawal by Subject|9|||
145256755|NCT04450394|523785149|FG002|Overall Study|Withdrawal by Subject|0|||
145256756|NCT02516605|523785151|FG000|Overall Study|Protocol Violation|0|||
145256757|NCT02516605|523785152|FG001|Overall Study|Protocol Violation|0|||
145256758|NCT02516605|523785153|FG002|Overall Study|Protocol Violation|0|||
145256759|NCT02516605|523785154|FG003|Overall Study|Protocol Violation|0|||
145256760|NCT02516605|523785155|FG004|Overall Study|Protocol Violation|1|||
145256761|NCT02516605|523785151|FG000|Overall Study|Withdrawal by Subject|0|||
145567639|NCT01641367|524940493|FG007|Randomized Adherence Intervention|Death|12|||
145567640|NCT01641367|524940486|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
145256762|NCT02516605|523785152|FG001|Overall Study|Withdrawal by Subject|0|||
145256763|NCT02516605|523785153|FG002|Overall Study|Withdrawal by Subject|0|||
145567641|NCT01641367|524940487|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
145256764|NCT02516605|523785154|FG003|Overall Study|Withdrawal by Subject|1|||
145256765|NCT02516605|523785155|FG004|Overall Study|Withdrawal by Subject|0|||
145410745|NCT02903914|524356848|FG003|Overall Study|Progressive Disease|0|||
145256766|NCT02643420|523785156|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
145256767|NCT02643420|523785157|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
145256768|NCT02643420|523785156|FG000|Overall Study|Withdrawal by Subject|25|||
145256769|NCT02643420|523785157|FG001|Overall Study|Withdrawal by Subject|19|||
145256770|NCT02643420|523785156|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
145256771|NCT02643420|523785157|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
145256772|NCT02643420|523785156|FG000|Overall Study|Lost to Follow-up|6|||
145256773|NCT02643420|523785157|FG001|Overall Study|Lost to Follow-up|10|||
145256774|NCT02643420|523785156|FG000|Overall Study|Investigator Decision|2|||
145256775|NCT02643420|523785157|FG001|Overall Study|Investigator Decision|4|||
145256776|NCT02643420|523785156|FG000|Overall Study|Sponsor decision|1|||
145256777|NCT02643420|523785157|FG001|Overall Study|Sponsor decision|1|||
145256778|NCT02643420|523785156|FG000|Overall Study|Death|0|||
145256779|NCT02643420|523785157|FG001|Overall Study|Death|2|||
145256780|NCT02643420|523785156|FG000|Overall Study|Reason not Specified|8|||
145256781|NCT02643420|523785157|FG001|Overall Study|Reason not Specified|7|||
145256782|NCT02127970|523785158|FG000|Overall Study|Adverse Event|2|||
145256783|NCT02127970|523785159|FG001|Overall Study|Adverse Event|1|||
145256784|NCT02127970|523785158|FG000|Overall Study|Death|1|||
145256785|NCT02127970|523785159|FG001|Overall Study|Death|1|||
145256786|NCT02127970|523785158|FG000|Overall Study|Lost to Follow-up|14|||
145256787|NCT02127970|523785159|FG001|Overall Study|Lost to Follow-up|14|||
145300706|NCT02481830|523953230|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
145300707|NCT02481830|523953231|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
145300708|NCT02481830|523953230|FG000|Treatment|Participants request to discontinue Study treatment|6|||
145300709|NCT02481830|523953231|FG001|Treatment|Participants request to discontinue Study treatment|34|||
145300710|NCT02481830|523953230|FG000|Treatment|Withdrawal by Subject|2|||
145300711|NCT02481830|523953231|FG001|Treatment|Withdrawal by Subject|3|||
145300712|NCT02481830|523953230|FG000|Treatment|Lost to Follow-up|1|||
145300713|NCT02481830|523953231|FG001|Treatment|Lost to Follow-up|0|||
145300714|NCT02481830|523953230|FG000|Treatment|Maximum Clinical Benefit|0|||
145300715|NCT02481830|523953231|FG001|Treatment|Maximum Clinical Benefit|5|||
145300716|NCT02481830|523953230|FG000|Treatment|Administrative reason by sponsor|1|||
145300717|NCT02481830|523953231|FG001|Treatment|Administrative reason by sponsor|1|||
145300718|NCT02481830|523953230|FG000|Treatment|Other reasons|6|||
145300719|NCT02481830|523953231|FG001|Treatment|Other reasons|1|||
145300720|NCT04627038|523953232|FG000|Overall Study|Adverse Event|36|||
145300721|NCT04627038|523953233|FG001|Overall Study|Adverse Event|8|||
145300722|NCT04627038|523953232|FG000|Overall Study|Lost to Follow-up|1|||
145300723|NCT04627038|523953233|FG001|Overall Study|Lost to Follow-up|0|||
145300724|NCT04627038|523953232|FG000|Overall Study|Physician Decision|0|||
145300725|NCT04627038|523953233|FG001|Overall Study|Physician Decision|1|||
145300726|NCT04627038|523953232|FG000|Overall Study|Protocol Violation|3|||
145300727|NCT04627038|523953233|FG001|Overall Study|Protocol Violation|1|||
145300728|NCT04627038|523953232|FG000|Overall Study|Withdrawal by Subject|13|||
145300729|NCT04627038|523953233|FG001|Overall Study|Withdrawal by Subject|3|||
145300730|NCT04627038|523953232|FG000|Overall Study|Non-compliance with study drug|0|||
145300731|NCT04627038|523953233|FG001|Overall Study|Non-compliance with study drug|1|||
145300732|NCT04627038|523953232|FG000|Overall Study|Prohibited Concomitant Medication|1|||
145300733|NCT04627038|523953233|FG001|Overall Study|Prohibited Concomitant Medication|0|||
145300734|NCT00794963|523953238|FG000|Overall Study|Withdrawal by Subject|1|||
145300735|NCT00794963|523953239|FG001|Overall Study|Withdrawal by Subject|4|||
145300736|NCT03375463|523953240|FG000|Period 1|Lost to Follow-up|0|||
145300737|NCT03375463|523953241|FG001|Period 1|Lost to Follow-up|0|||
145300738|NCT03375463|523953242|FG002|Period 1|Lost to Follow-up|1|||
145300739|NCT03375463|523953243|FG003|Period 1|Lost to Follow-up|0|||
145300740|NCT03375463|523953244|FG004|Period 1|Lost to Follow-up|0|||
145300741|NCT03375463|523953245|FG005|Period 1|Lost to Follow-up|0|||
145300742|NCT03375463|523953240|FG000|Period 1|Adverse Event|0|||
145300743|NCT03375463|523953241|FG001|Period 1|Adverse Event|0|||
145300744|NCT03375463|523953242|FG002|Period 1|Adverse Event|0|||
145300745|NCT03375463|523953243|FG003|Period 1|Adverse Event|0|||
145300746|NCT03375463|523953244|FG004|Period 1|Adverse Event|1|||
145410746|NCT02903914|524356849|FG004|Overall Study|Progressive Disease|0|||
145256788|NCT02127970|523785158|FG000|Overall Study|Reason not Specified|4|||
145256789|NCT02127970|523785159|FG001|Overall Study|Reason not Specified|7|||
145256790|NCT02127970|523785158|FG000|Overall Study|Pregnancy|0|||
145567642|NCT01641367|524940488|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
145567643|NCT01641367|524940489|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
145567644|NCT01641367|524940490|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
145256791|NCT02127970|523785159|FG001|Overall Study|Pregnancy|1|||
145256792|NCT02127970|523785158|FG000|Overall Study|Subject Withdrew Consent|5|||
145300747|NCT03375463|523953245|FG005|Period 1|Adverse Event|0|||
145410747|NCT02903914|524356850|FG005|Overall Study|Progressive Disease|0|||
145300748|NCT03375463|523953240|FG000|Period 2|Lost to Follow-up|1|||
145300749|NCT03375463|523953241|FG001|Period 2|Lost to Follow-up|1|||
145300750|NCT03375463|523953242|FG002|Period 2|Lost to Follow-up|0|||
145256793|NCT02127970|523785159|FG001|Overall Study|Subject Withdrew Consent|3|||
145256794|NCT01710709|523785160|FG000|Overall Study|Lost to Follow-up|29|||
145256795|NCT01710709|523785160|FG000|Overall Study|Adverse Event|48|||
145256796|NCT01710709|523785160|FG000|Overall Study|Participant met withdrawal criteria|33|||
145256797|NCT01710709|523785160|FG000|Overall Study|Participant withdrawn by investigator|2|||
145256798|NCT01710709|523785160|FG000|Overall Study|Withdrawal by Subject|53|||
145256799|NCT01710709|523785160|FG000|Overall Study|Protocol Violation|5|||
145256800|NCT01710709|523785160|FG000|Overall Study|Lack of Efficacy|3|||
145256801|NCT00542321|523785162|FG000|Overall Study|Death|0|||
145256802|NCT00542321|523785163|FG001|Overall Study|Death|1|||
145256803|NCT02988115|523785170|FG000|Overall Study|Adverse Event|6|||
145256804|NCT02988115|523785171|FG001|Overall Study|Adverse Event|1|||
145256805|NCT02988115|523785170|FG000|Overall Study|Sponsor Decision|5|||
145256806|NCT02988115|523785171|FG001|Overall Study|Sponsor Decision|2|||
145256807|NCT02988115|523785170|FG000|Overall Study|Withdrawal by Subject|1|||
145256808|NCT02988115|523785171|FG001|Overall Study|Withdrawal by Subject|1|||
145256809|NCT02988115|523785170|FG000|Overall Study|Withdrawn by Mistake|1|||
145256810|NCT02988115|523785171|FG001|Overall Study|Withdrawn by Mistake|0|||
145256811|NCT02988115|523785170|FG000|Overall Study|Lost to Follow-up|1|||
145256812|NCT02988115|523785171|FG001|Overall Study|Lost to Follow-up|0|||
145256813|NCT01731951|523785172|FG000|Overall Study|Documented Disease Progression|1|||
145256814|NCT01731951|523785173|FG001|Overall Study|Documented Disease Progression|0|||
145256815|NCT01731951|523785174|FG002|Overall Study|Documented Disease Progression|0|||
145256816|NCT01731951|523785175|FG003|Overall Study|Documented Disease Progression|0|||
145256817|NCT01731951|523785176|FG004|Overall Study|Documented Disease Progression|0|||
145300751|NCT03375463|523953243|FG003|Period 2|Lost to Follow-up|0|||
145300752|NCT03375463|523953244|FG004|Period 2|Lost to Follow-up|0|||
145567645|NCT01641367|524940491|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
145567646|NCT01641367|524940492|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
145300753|NCT03375463|523953245|FG005|Period 2|Lost to Follow-up|0|||
145300754|NCT01827163|523953246|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
145300755|NCT01827163|523953246|FG000|Overall Study|Adverse Event|9|||
145300756|NCT01037114|523953247|FG000|Year 20|Others|1|||
145300757|NCT02294604|523953253|FG000|Overall Study|Did not provide samples for culture|0|||
145300758|NCT02294604|523953254|FG001|Overall Study|Did not provide samples for culture|1|||
145300759|NCT02294604|523953255|FG002|Overall Study|Did not provide samples for culture|0|||
145300760|NCT02294604|523953253|FG000|Overall Study|Culture contamination|1|||
145300761|NCT02294604|523953254|FG001|Overall Study|Culture contamination|2|||
145300762|NCT02294604|523953255|FG002|Overall Study|Culture contamination|0|||
145300763|NCT01401647|523953258|FG000|Overall Study|Withdrawal by Subject|1|||
145300764|NCT01401647|523953259|FG001|Overall Study|Withdrawal by Subject|5|||
145300765|NCT01401647|523953260|FG002|Overall Study|Withdrawal by Subject|2|||
145300766|NCT01401647|523953258|FG000|Overall Study|Lost to Follow-up|3|||
145300767|NCT01401647|523953259|FG001|Overall Study|Lost to Follow-up|3|||
145300768|NCT01401647|523953260|FG002|Overall Study|Lost to Follow-up|1|||
145300769|NCT00846495|523953267|FG000|Overall Study|Lost to Follow-up|1|||
145300770|NCT00846495|523953268|FG001|Overall Study|Lost to Follow-up|0|||
145300771|NCT00846495|523953267|FG000|Overall Study|Adverse Event|5|||
145300772|NCT00846495|523953268|FG001|Overall Study|Adverse Event|1|||
145567647|NCT01641367|524940493|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
145567648|NCT00782210|524940494|FG000|Overall Study|Adverse Event|21|||
145567649|NCT00782210|524940495|FG001|Overall Study|Adverse Event|17|||
145256818|NCT01731951|523785177|FG005|Overall Study|Documented Disease Progression|0|||
145256819|NCT01731951|523785172|FG000|Overall Study|Lost to Follow-up|2|||
145256820|NCT01731951|523785173|FG001|Overall Study|Lost to Follow-up|0|||
145256821|NCT01731951|523785174|FG002|Overall Study|Lost to Follow-up|0|||
145256822|NCT01731951|523785175|FG003|Overall Study|Lost to Follow-up|1|||
145256823|NCT01731951|523785176|FG004|Overall Study|Lost to Follow-up|3|||
145300773|NCT00846495|523953267|FG000|Overall Study|Lack of Efficacy|1|||
145300774|NCT00846495|523953268|FG001|Overall Study|Lack of Efficacy|2|||
145300775|NCT00846495|523953267|FG000|Overall Study|Physician Decision|1|||
145300776|NCT00846495|523953268|FG001|Overall Study|Physician Decision|0|||
145300777|NCT02158663|523953269|FG000|Overall Study|Withdrawal by Subject|5|||
145300778|NCT02158663|523953270|FG001|Overall Study|Withdrawal by Subject|4|||
145300779|NCT01265056|523953271|FG000|Initial Study Period|Withdrawal by Subject|1|||
145300780|NCT01265056|523953272|FG001|Initial Study Period|Withdrawal by Subject|1|||
145300781|NCT01265056|523953271|FG000|Initial Study Period|Withdrawal by Subject|1|||
145300782|NCT01265056|523953272|FG001|Initial Study Period|Withdrawal by Subject|1|||
145300783|NCT01265056|523953271|FG000|Follow up|Lost to Follow-up|7|||
145300784|NCT01265056|523953272|FG001|Follow up|Lost to Follow-up|3|||
145300785|NCT02711852|523953274|FG000|Overall Study|Death|5|||
145300786|NCT02711852|523953274|FG000|Overall Study|Lost to Follow-up|1|||
145410748|NCT02903914|524356851|FG006|Overall Study|Progressive Disease|2|||
145567650|NCT00782210|524940496|FG002|Overall Study|Adverse Event|16|||
145256824|NCT01731951|523785177|FG005|Overall Study|Lost to Follow-up|1|||
145256825|NCT01731951|523785172|FG000|Overall Study|Withdrawal of Consent|1|||
145300787|NCT02711852|523953274|FG000|Overall Study|Completed follow-up|3|||
145256826|NCT01731951|523785173|FG001|Overall Study|Withdrawal of Consent|0|||
145256827|NCT01731951|523785174|FG002|Overall Study|Withdrawal of Consent|0|||
145256828|NCT01731951|523785175|FG003|Overall Study|Withdrawal of Consent|0|||
145256829|NCT01731951|523785176|FG004|Overall Study|Withdrawal of Consent|0|||
145256830|NCT01731951|523785177|FG005|Overall Study|Withdrawal of Consent|2|||
145256831|NCT01731951|523785172|FG000|Overall Study|Death|13|||
145256832|NCT01731951|523785173|FG001|Overall Study|Death|15|||
145256833|NCT01731951|523785174|FG002|Overall Study|Death|9|||
145256834|NCT01731951|523785175|FG003|Overall Study|Death|8|||
145256835|NCT01731951|523785176|FG004|Overall Study|Death|9|||
145256836|NCT01731951|523785177|FG005|Overall Study|Death|6|||
145256837|NCT00253747|523785178|FG000|Overall Study|Lost to Follow-up|13|||
145256838|NCT00253747|523785179|FG001|Overall Study|Lost to Follow-up|14|||
145256839|NCT00253747|523785178|FG000|Overall Study|Withdrawal by Subject|10|||
145256840|NCT00253747|523785179|FG001|Overall Study|Withdrawal by Subject|11|||
145256841|NCT00253747|523785178|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
145256842|NCT00253747|523785179|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
145256843|NCT00104299|523785180|FG000|Overall Study|Adverse Event|3|||
145256844|NCT00104299|523785181|FG001|Overall Study|Adverse Event|1|||
145256845|NCT00104299|523785180|FG000|Overall Study|Death|2|||
145256846|NCT00104299|523785181|FG001|Overall Study|Death|2|||
145256847|NCT00104299|523785180|FG000|Overall Study|Withdrawal by Subject|2|||
145256848|NCT00104299|523785181|FG001|Overall Study|Withdrawal by Subject|6|||
145256849|NCT00104299|523785180|FG000|Overall Study|Physician Decision|1|||
145256850|NCT00104299|523785181|FG001|Overall Study|Physician Decision|1|||
145256851|NCT00104299|523785180|FG000|Overall Study|To have renal transplant|1|||
145256852|NCT00104299|523785181|FG001|Overall Study|To have renal transplant|0|||
145256853|NCT02452034|523785182|FG000|Overall Study|Adverse Event|0|||
145256854|NCT02452034|523785183|FG001|Overall Study|Adverse Event|0|||
145256855|NCT02452034|523785184|FG002|Overall Study|Adverse Event|0|||
145256856|NCT02452034|523785185|FG003|Overall Study|Adverse Event|0|||
145256857|NCT02452034|523785186|FG004|Overall Study|Adverse Event|0|||
145256858|NCT02452034|523785187|FG005|Overall Study|Adverse Event|1|||
145256859|NCT02452034|523785182|FG000|Overall Study|Death|0|||
145256860|NCT02452034|523785183|FG001|Overall Study|Death|0|||
145256861|NCT02452034|523785184|FG002|Overall Study|Death|0|||
145256862|NCT02452034|523785185|FG003|Overall Study|Death|0|||
145256863|NCT02452034|523785186|FG004|Overall Study|Death|1|||
145256864|NCT02452034|523785187|FG005|Overall Study|Death|1|||
145256865|NCT02452034|523785182|FG000|Overall Study|Physician Decision|0|||
145256866|NCT02452034|523785183|FG001|Overall Study|Physician Decision|1|||
145256867|NCT02452034|523785184|FG002|Overall Study|Physician Decision|1|||
145256868|NCT02452034|523785185|FG003|Overall Study|Physician Decision|0|||
145256869|NCT02452034|523785186|FG004|Overall Study|Physician Decision|0|||
145256870|NCT02452034|523785187|FG005|Overall Study|Physician Decision|0|||
145256871|NCT02452034|523785182|FG000|Overall Study|Protocol Violation|0|||
145256872|NCT02452034|523785183|FG001|Overall Study|Protocol Violation|0|||
145256873|NCT02452034|523785184|FG002|Overall Study|Protocol Violation|0|||
145256874|NCT02452034|523785185|FG003|Overall Study|Protocol Violation|0|||
145256875|NCT02452034|523785186|FG004|Overall Study|Protocol Violation|0|||
145256876|NCT02452034|523785187|FG005|Overall Study|Protocol Violation|1|||
145256877|NCT02452034|523785182|FG000|Overall Study|Screen Failure|1|||
145256878|NCT02452034|523785183|FG001|Overall Study|Screen Failure|0|||
145256879|NCT02452034|523785184|FG002|Overall Study|Screen Failure|0|||
145256880|NCT02452034|523785185|FG003|Overall Study|Screen Failure|1|||
145256881|NCT02452034|523785186|FG004|Overall Study|Screen Failure|0|||
145256882|NCT02452034|523785187|FG005|Overall Study|Screen Failure|0|||
145256883|NCT02452034|523785182|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
145256884|NCT02452034|523785183|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
145256885|NCT02452034|523785184|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
145256886|NCT02452034|523785185|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
145256887|NCT02452034|523785186|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
145256888|NCT02452034|523785187|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
145256889|NCT00125138|523785191|FG000|Overall Study|Adverse Event|1|||
145300788|NCT02711852|523953274|FG000|Overall Study|Withdrawal by Subject|1|||
145567651|NCT00782210|524940494|FG000|Overall Study|Lost to Follow-up|2|||
145567652|NCT00782210|524940495|FG001|Overall Study|Lost to Follow-up|1|||
145256890|NCT00125138|523785192|FG001|Overall Study|Adverse Event|0|||
145256891|NCT00125138|523785193|FG002|Overall Study|Adverse Event|3|||
145256892|NCT00125138|523785194|FG003|Overall Study|Adverse Event|2|||
145256893|NCT00125138|523785191|FG000|Overall Study|Withdrawal by Subject|2|||
145256894|NCT00125138|523785192|FG001|Overall Study|Withdrawal by Subject|3|||
145256895|NCT00125138|523785193|FG002|Overall Study|Withdrawal by Subject|1|||
145567653|NCT00782210|524940496|FG002|Overall Study|Lost to Follow-up|2|||
145256896|NCT00125138|523785194|FG003|Overall Study|Withdrawal by Subject|1|||
145256897|NCT00125138|523785191|FG000|Overall Study|Lack of Efficacy|0|||
145256898|NCT00125138|523785192|FG001|Overall Study|Lack of Efficacy|0|||
145256899|NCT00125138|523785193|FG002|Overall Study|Lack of Efficacy|0|||
145256900|NCT00125138|523785194|FG003|Overall Study|Lack of Efficacy|1|||
145300789|NCT00537979|523953275|FG000|Overall Study|Adverse Event|2|||
145256901|NCT00125138|523785191|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
145256902|NCT00125138|523785192|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
145256903|NCT00125138|523785193|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
145256904|NCT00125138|523785194|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
145256905|NCT02630459|523785195|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256906|NCT02630459|523785196|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
145256907|NCT02630459|523785197|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256908|NCT02630459|523785198|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
145256909|NCT02630459|523785199|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256910|NCT02630459|523785200|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256911|NCT02630459|523785201|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256912|NCT02630459|523785202|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
145256913|NCT02630459|523785195|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256914|NCT02630459|523785196|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256915|NCT02630459|523785197|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
145256916|NCT02630459|523785198|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256917|NCT02630459|523785199|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256918|NCT02630459|523785200|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256919|NCT02630459|523785201|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256920|NCT02630459|523785202|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
145256921|NCT02630459|523785195|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
145256922|NCT02630459|523785196|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
145256923|NCT02630459|523785197|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
145256924|NCT02630459|523785198|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
145256925|NCT02630459|523785199|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
145256926|NCT02630459|523785200|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
145256927|NCT02630459|523785201|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
145256928|NCT02630459|523785202|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
145256929|NCT02630459|523785195|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
145256930|NCT02630459|523785196|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256931|NCT02630459|523785197|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256932|NCT02630459|523785198|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256933|NCT02630459|523785199|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256934|NCT02630459|523785200|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256935|NCT02630459|523785201|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256936|NCT02630459|523785202|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
145256937|NCT02630459|523785195|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145256938|NCT02630459|523785196|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145256939|NCT02630459|523785197|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145256940|NCT02630459|523785198|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145256941|NCT02630459|523785199|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
145256942|NCT02630459|523785200|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
145256943|NCT02630459|523785201|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145256944|NCT02630459|523785202|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
145300790|NCT00537979|523953276|FG001|Overall Study|Adverse Event|2|||
145300791|NCT00537979|523953275|FG000|Overall Study|Withdrawal by Subject|1|||
145300792|NCT00537979|523953276|FG001|Overall Study|Withdrawal by Subject|4|||
145300793|NCT00537979|523953275|FG000|Overall Study|Lost to Follow-up|1|||
145300794|NCT00537979|523953276|FG001|Overall Study|Lost to Follow-up|4|||
145300795|NCT00537979|523953275|FG000|Overall Study|Lack of Efficacy|0|||
145300796|NCT00537979|523953276|FG001|Overall Study|Lack of Efficacy|1|||
145300797|NCT00537979|523953275|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
145300798|NCT00537979|523953276|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
145300799|NCT00537979|523953275|FG000|Overall Study|Death|0|||
145300800|NCT00537979|523953276|FG001|Overall Study|Death|3|||
145300801|NCT00537979|523953275|FG000|Overall Study|Kidney transplant|0|||
145300802|NCT00537979|523953276|FG001|Overall Study|Kidney transplant|3|||
145300803|NCT00537979|523953275|FG000|Overall Study|Heart failure|0|||
145300804|NCT00537979|523953276|FG001|Overall Study|Heart failure|1|||
145300805|NCT02601560|523953277|FG000|Overall Study|Other|0|||
145300806|NCT02601560|523953278|FG001|Overall Study|Other|0|||
145620270|NCT03259373|525123727|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
145300807|NCT02601560|523953279|FG002|Overall Study|Other|0|||
145256945|NCT02630459|523785195|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145256946|NCT02630459|523785196|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145256947|NCT02630459|523785197|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145256948|NCT02630459|523785198|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145567654|NCT00782210|524940494|FG000|Overall Study|Withdrawal by Subject|11|||
145567655|NCT00782210|524940495|FG001|Overall Study|Withdrawal by Subject|8|||
145567656|NCT00782210|524940496|FG002|Overall Study|Withdrawal by Subject|11|||
145567657|NCT00782210|524940494|FG000|Overall Study|Non compliance with protocol|0|||
145567658|NCT00782210|524940495|FG001|Overall Study|Non compliance with protocol|3|||
145567659|NCT00782210|524940496|FG002|Overall Study|Non compliance with protocol|2|||
145567660|NCT00782210|524940494|FG000|Overall Study|Lack of Efficacy|13|||
145567661|NCT00782210|524940495|FG001|Overall Study|Lack of Efficacy|4|||
145567662|NCT00782210|524940496|FG002|Overall Study|Lack of Efficacy|1|||
145567663|NCT00782210|524940494|FG000|Overall Study|Other reason not described above|3|||
145567664|NCT00782210|524940495|FG001|Overall Study|Other reason not described above|2|||
145567665|NCT00782210|524940496|FG002|Overall Study|Other reason not described above|3|||
145567666|NCT03100825|524940497|FG000|Overall Study|Participant/Guardian Decision|7|||
145567667|NCT03100825|524940497|FG000|Overall Study|Physician Decision|1|||
145567668|NCT01610791|524940501|FG000|Overall Study|Lost to Follow-up|7|||
145567669|NCT01610791|524940501|FG000|Overall Study|Adverse Event|6|||
145256949|NCT02630459|523785199|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
145256950|NCT02630459|523785200|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
145256951|NCT02630459|523785201|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145256952|NCT02630459|523785202|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
145256953|NCT02630459|523785195|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256954|NCT02630459|523785196|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256955|NCT02630459|523785197|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256956|NCT02630459|523785198|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256957|NCT02630459|523785199|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
145256958|NCT02630459|523785200|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256959|NCT02630459|523785201|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256960|NCT02630459|523785202|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
145256961|NCT00348686|523785205|FG000|Overall Study|Withdrawal by Subject|45|||
145256962|NCT00348686|523785205|FG000|Overall Study|Adverse Event|5|||
145256963|NCT00348686|523785205|FG000|Overall Study|Protocol Violation|6|||
145256964|NCT00348686|523785205|FG000|Overall Study|Lost to Follow-up|2|||
145256965|NCT00348686|523785205|FG000|Overall Study|Multiple Reasons|8|||
145256966|NCT01258738|523785208|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
145256967|NCT01258738|523785209|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
145256968|NCT01258738|523785208|FG000|Double-blind Period|Withdrawal by Subject|2|||
145256969|NCT01258738|523785209|FG001|Double-blind Period|Withdrawal by Subject|2|||
145256970|NCT01258738|523785208|FG000|Double-blind Period|Protocol Violation|1|||
145256971|NCT01258738|523785209|FG001|Double-blind Period|Protocol Violation|1|||
145256972|NCT01258738|523785208|FG000|Double-blind Period|Adverse Event|3|||
145256973|NCT01258738|523785209|FG001|Double-blind Period|Adverse Event|1|||
145256974|NCT01258738|523785208|FG000|Open-label Period|Did not meet inclusion criteria|0|||
145256975|NCT01258738|523785209|FG001|Open-label Period|Did not meet inclusion criteria|1|||
145256976|NCT01258738|523785208|FG000|Open-label Period|Insufficient clinical response|5|||
145256977|NCT01258738|523785209|FG001|Open-label Period|Insufficient clinical response|3|||
145256978|NCT01258738|523785208|FG000|Open-label Period|Lost to Follow-up|0|||
145256979|NCT01258738|523785209|FG001|Open-label Period|Lost to Follow-up|2|||
145256980|NCT01258738|523785208|FG000|Open-label Period|Withdrawal by Subject|5|||
145256981|NCT01258738|523785209|FG001|Open-label Period|Withdrawal by Subject|6|||
145256982|NCT01258738|523785208|FG000|Open-label Period|Protocol Violation|2|||
145256983|NCT01258738|523785209|FG001|Open-label Period|Protocol Violation|2|||
145256984|NCT01258738|523785208|FG000|Open-label Period|Adverse Event|4|||
145256985|NCT01258738|523785209|FG001|Open-label Period|Adverse Event|5|||
145256986|NCT01258738|523785208|FG000|Open-label Period|Other Reasons|0|||
145300808|NCT02601560|523953280|FG003|Overall Study|Other|0|||
145300809|NCT02601560|523953281|FG004|Overall Study|Other|0|||
145300810|NCT02601560|523953282|FG005|Overall Study|Other|0|||
145256987|NCT01258738|523785209|FG001|Open-label Period|Other Reasons|1|||
145256988|NCT01258738|523785208|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
145256989|NCT01258738|523785209|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
145300811|NCT02601560|523953283|FG006|Overall Study|Other|1|||
145300812|NCT02601560|523953284|FG007|Overall Study|Other|0|||
145300813|NCT03459807|523953288|FG000|Overall Study|Withdrawal due to transplant|0|||
145300814|NCT03459807|523953289|FG001|Overall Study|Withdrawal due to transplant|1|||
145567670|NCT01610791|524940501|FG000|Overall Study|Physician Decision|1|||
145567671|NCT01610791|524940501|FG000|Overall Study|Adverse event and Investigator decision|1|||
145567672|NCT01610791|524940501|FG000|Overall Study|Death|1|||
145567673|NCT01610791|524940501|FG000|Overall Study|Not determined|5|||
145256990|NCT02418000|523785210|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
145256991|NCT02418000|523785211|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
145256992|NCT02418000|523785212|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
145256993|NCT02418000|523785213|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
145300815|NCT00576056|523953290|FG000|Overall Study|Adverse Event|1|||
145567674|NCT00850200|524940502|FG000|Overall Study|Physician Decision|2|||
145567675|NCT00850200|524940502|FG000|Overall Study|Did not recieve treatment|2|||
145256994|NCT02418000|523785214|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
145256995|NCT02418000|523785210|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
145256996|NCT02418000|523785211|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
145256997|NCT02418000|523785212|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
145256998|NCT02418000|523785213|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
145256999|NCT02418000|523785214|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
145257000|NCT02418000|523785210|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
145257001|NCT02418000|523785211|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
145257002|NCT02418000|523785212|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
145257003|NCT02418000|523785213|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
145257004|NCT02418000|523785214|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
145257005|NCT02418000|523785210|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
145257006|NCT02418000|523785211|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
145257007|NCT02418000|523785212|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
145257008|NCT02418000|523785213|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
145257009|NCT02418000|523785214|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
145257010|NCT02418000|523785210|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
145257011|NCT02418000|523785211|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
145257012|NCT02418000|523785212|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
145257013|NCT02418000|523785213|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
145257014|NCT02418000|523785214|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
145257015|NCT02418000|523785210|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257016|NCT02418000|523785211|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257017|NCT02418000|523785212|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
145257018|NCT02418000|523785213|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257019|NCT02418000|523785214|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257020|NCT02418000|523785210|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257021|NCT02418000|523785211|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257022|NCT02418000|523785212|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257023|NCT02418000|523785213|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
145257024|NCT02418000|523785214|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257025|NCT02418000|523785210|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
145257026|NCT02418000|523785211|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
145257027|NCT02418000|523785212|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
145257028|NCT02418000|523785213|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
145257029|NCT02418000|523785214|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
145257030|NCT02418000|523785210|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257031|NCT02418000|523785211|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257032|NCT02418000|523785212|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257033|NCT02418000|523785213|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
145257034|NCT02418000|523785214|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
145257035|NCT00689611|523785215|FG000|Overall Study|Death|6|||
145257036|NCT00689611|523785216|FG001|Overall Study|Death|9|||
145257037|NCT00689611|523785215|FG000|Overall Study|Withdrawal by Subject|8|||
145257038|NCT00689611|523785216|FG001|Overall Study|Withdrawal by Subject|9|||
145257039|NCT00689611|523785215|FG000|Overall Study|Lost to Follow-up|27|||
145257040|NCT00689611|523785216|FG001|Overall Study|Lost to Follow-up|28|||
145257041|NCT00490815|523785217|FG000|Overall Study|Adverse Event|2|||
145257042|NCT00490815|523785218|FG001|Overall Study|Adverse Event|3|||
145257043|NCT00490815|523785217|FG000|Overall Study|Withdrawal by Subject|4|||
145257044|NCT00490815|523785218|FG001|Overall Study|Withdrawal by Subject|0|||
145257045|NCT00490815|523785217|FG000|Overall Study|Lost to Follow-up|1|||
145257046|NCT00490815|523785218|FG001|Overall Study|Lost to Follow-up|3|||
145567676|NCT00850200|524940502|FG000|Overall Study|Withdrawal by Subject|1|||
145567677|NCT00048542|524940505|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145567678|NCT00048542|524940506|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
145567679|NCT00048542|524940507|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145567680|NCT00048542|524940508|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145567681|NCT00048542|524940509|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145567682|NCT00048542|524940510|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
145567683|NCT00048542|524940511|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
145567684|NCT00048542|524940512|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
145567685|NCT00048542|524940505|FG000|Double-Blind Phase|Protocol Violation|0|||
145257047|NCT00490815|523785217|FG000|Overall Study|Death|1|||
145257048|NCT00490815|523785218|FG001|Overall Study|Death|3|||
145257049|NCT00732199|523785231|FG000|Overall Study|Withdrawal by Subject|25|||
145257050|NCT00732199|523785232|FG001|Overall Study|Withdrawal by Subject|18|||
145257051|NCT00732199|523785231|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
145257052|NCT00732199|523785232|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
145567686|NCT00048542|524940506|FG001|Double-Blind Phase|Protocol Violation|0|||
145567687|NCT00048542|524940507|FG002|Double-Blind Phase|Protocol Violation|1|||
145567688|NCT00048542|524940508|FG003|Double-Blind Phase|Protocol Violation|0|||
145567689|NCT00048542|524940509|FG004|Double-Blind Phase|Protocol Violation|0|||
145567690|NCT00048542|524940510|FG005|Double-Blind Phase|Protocol Violation|0|||
145567691|NCT00048542|524940511|FG006|Double-Blind Phase|Protocol Violation|0|||
145567692|NCT00048542|524940512|FG007|Double-Blind Phase|Protocol Violation|0|||
145567693|NCT00048542|524940505|FG000|Double-Blind Phase|Sponsor request or decision|2|||
145567694|NCT00048542|524940506|FG001|Double-Blind Phase|Sponsor request or decision|0|||
145567695|NCT00048542|524940507|FG002|Double-Blind Phase|Sponsor request or decision|0|||
145567696|NCT00048542|524940508|FG003|Double-Blind Phase|Sponsor request or decision|0|||
145567697|NCT00048542|524940509|FG004|Double-Blind Phase|Sponsor request or decision|0|||
145567698|NCT00048542|524940510|FG005|Double-Blind Phase|Sponsor request or decision|0|||
145567699|NCT00048542|524940511|FG006|Double-Blind Phase|Sponsor request or decision|0|||
145567700|NCT00048542|524940512|FG007|Double-Blind Phase|Sponsor request or decision|0|||
145567701|NCT00048542|524940505|FG000|Double-Blind Phase|Randomized in error|1|||
145567702|NCT00048542|524940506|FG001|Double-Blind Phase|Randomized in error|0|||
145567703|NCT00048542|524940507|FG002|Double-Blind Phase|Randomized in error|0|||
145567704|NCT00048542|524940508|FG003|Double-Blind Phase|Randomized in error|0|||
145567705|NCT00048542|524940509|FG004|Double-Blind Phase|Randomized in error|0|||
145567706|NCT00048542|524940510|FG005|Double-Blind Phase|Randomized in error|0|||
145567707|NCT00048542|524940511|FG006|Double-Blind Phase|Randomized in error|0|||
145567708|NCT00048542|524940512|FG007|Double-Blind Phase|Randomized in error|0|||
145567709|NCT00048542|524940505|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567710|NCT00048542|524940506|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567711|NCT00048542|524940507|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567712|NCT00048542|524940508|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567713|NCT00048542|524940509|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
145567714|NCT00048542|524940510|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
145567715|NCT00048542|524940511|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567716|NCT00048542|524940512|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
145567717|NCT00048542|524940505|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567718|NCT00048542|524940506|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567719|NCT00048542|524940507|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567720|NCT00048542|524940508|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567721|NCT00048542|524940509|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567722|NCT00048542|524940510|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
145567723|NCT00048542|524940511|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567724|NCT00048542|524940512|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
145567725|NCT00048542|524940505|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567726|NCT00048542|524940506|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567727|NCT00048542|524940507|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567728|NCT00048542|524940508|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567729|NCT00048542|524940509|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
145300816|NCT00576056|523953290|FG000|Overall Study|Death|1|||
145300817|NCT00576056|523953290|FG000|Overall Study|Lack of Efficacy|1|||
145567730|NCT00048542|524940510|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
145567731|NCT00048542|524940511|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567732|NCT00048542|524940512|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
145567733|NCT00048542|524940505|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
145567734|NCT00048542|524940506|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
145567735|NCT00048542|524940507|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
145567736|NCT00048542|524940508|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
145567737|NCT00048542|524940509|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
145567738|NCT00048542|524940510|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
145567739|NCT00048542|524940511|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
145567740|NCT00048542|524940512|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
145567741|NCT00048542|524940505|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567742|NCT00048542|524940506|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567743|NCT00048542|524940507|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567744|NCT00048542|524940508|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567745|NCT00048542|524940509|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
145567746|NCT00048542|524940510|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
145567747|NCT00048542|524940511|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567748|NCT00048542|524940512|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
145567749|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145567750|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145567751|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145300818|NCT00576056|523953290|FG000|Overall Study|Withdrawal by Subject|2|||
145567752|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145567753|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145567754|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
145567755|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
145567756|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
145567757|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567758|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567759|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567760|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567761|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567762|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
145567763|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
145567764|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
145567765|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567766|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567767|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567768|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567769|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567770|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
145567771|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
145567772|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
145567773|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567774|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567775|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567776|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567777|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567778|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
145567779|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
145567780|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
145567781|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567782|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567783|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567784|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567785|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567786|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
145567787|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
145567788|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
145567789|NCT00048542|524940505|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567790|NCT00048542|524940506|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567791|NCT00048542|524940507|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567792|NCT00048542|524940508|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567793|NCT00048542|524940509|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567794|NCT00048542|524940510|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
145567795|NCT00048542|524940511|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
145567796|NCT00048542|524940512|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
145567797|NCT04098458|524940514|FG000|Overall Study|Death|1|||
145567798|NCT04098458|524940514|FG000|Overall Study|did not meet study inclusion criteria|3|||
145567799|NCT00006489|524940515|FG000|Overall Study|Adverse Event|3|||
145567800|NCT00006489|524940516|FG001|Overall Study|Adverse Event|2|||
145567801|NCT00006489|524940517|FG002|Overall Study|Adverse Event|4|||
145567802|NCT00006489|524940518|FG003|Overall Study|Adverse Event|3|||
145567803|NCT00006489|524940515|FG000|Overall Study|Withdrawal by Subject|10|||
145567804|NCT00006489|524940516|FG001|Overall Study|Withdrawal by Subject|9|||
145567805|NCT00006489|524940517|FG002|Overall Study|Withdrawal by Subject|9|||
145567806|NCT00006489|524940518|FG003|Overall Study|Withdrawal by Subject|6|||
145567807|NCT00006489|524940515|FG000|Overall Study|Scheduling Conflict|0|||
145567808|NCT00006489|524940516|FG001|Overall Study|Scheduling Conflict|3|||
145567809|NCT00006489|524940517|FG002|Overall Study|Scheduling Conflict|2|||
145567810|NCT00006489|524940518|FG003|Overall Study|Scheduling Conflict|1|||
145567811|NCT00006489|524940515|FG000|Overall Study|Death|0|||
145567812|NCT00006489|524940516|FG001|Overall Study|Death|0|||
145567813|NCT00006489|524940517|FG002|Overall Study|Death|0|||
145567814|NCT00006489|524940518|FG003|Overall Study|Death|1|||
145567815|NCT00578175|524940519|FG000|Overall Study|Adverse Event|0|||
145300819|NCT00576056|523953290|FG000|Overall Study|did not meet eligibility criteria|8|||
145300820|NCT00576056|523953290|FG000|Overall Study|Physician Decision|1|||
145300821|NCT00858845|523953292|FG000|Overall Study|Patient underwent heart transplant.|0|||
145300822|NCT00858845|523953293|FG001|Overall Study|Patient underwent heart transplant.|1|||
145567816|NCT00578175|524940520|FG001|Overall Study|Adverse Event|1|||
145567817|NCT00578175|524940521|FG002|Overall Study|Adverse Event|1|||
145567818|NCT00578175|524940519|FG000|Overall Study|Other reasons|70|||
145567819|NCT00578175|524940520|FG001|Overall Study|Other reasons|42|||
145567820|NCT00578175|524940521|FG002|Overall Study|Other reasons|23|||
145567821|NCT01869192|524940522|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
145567822|NCT01869192|524940523|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
145567823|NCT01869192|524940522|FG000|Postoperative Chemotherapy|Physician Decision|0|||
145567824|NCT01869192|524940523|FG001|Postoperative Chemotherapy|Physician Decision|2|||
145567825|NCT01479621|524940531|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
145567826|NCT01479621|524940532|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567827|NCT01479621|524940533|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567828|NCT01479621|524940534|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567829|NCT01479621|524940535|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567830|NCT01479621|524940536|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567831|NCT01479621|524940537|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
145567832|NCT01479621|524940531|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
145567833|NCT01479621|524940532|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567834|NCT01479621|524940533|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567835|NCT01479621|524940534|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567836|NCT01479621|524940535|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567837|NCT01479621|524940536|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567838|NCT01479621|524940537|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
145567839|NCT01479621|524940531|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
145567840|NCT01479621|524940532|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567841|NCT01479621|524940533|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567842|NCT01479621|524940534|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567843|NCT01479621|524940535|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567844|NCT01479621|524940536|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567845|NCT01479621|524940537|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
145567846|NCT01479621|524940531|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
145567847|NCT01479621|524940532|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567848|NCT01479621|524940533|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567849|NCT01479621|524940534|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567850|NCT01479621|524940535|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567851|NCT01479621|524940536|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567852|NCT01479621|524940537|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
145567853|NCT01479621|524940531|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
145567854|NCT01479621|524940532|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567855|NCT01479621|524940533|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567856|NCT01479621|524940534|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567857|NCT01479621|524940535|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567858|NCT01479621|524940536|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567859|NCT01479621|524940537|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
145567860|NCT01479621|524940531|FG000|Treatment Period|Adverse Event|0|||
145567861|NCT01479621|524940532|FG001|Treatment Period|Adverse Event|0|||
145567862|NCT01479621|524940533|FG002|Treatment Period|Adverse Event|0|||
145567863|NCT01479621|524940534|FG003|Treatment Period|Adverse Event|0|||
145567864|NCT01479621|524940535|FG004|Treatment Period|Adverse Event|1|||
145567865|NCT01479621|524940536|FG005|Treatment Period|Adverse Event|2|||
145567866|NCT01479621|524940537|FG006|Treatment Period|Adverse Event|2|||
145567867|NCT01479621|524940531|FG000|Treatment Period|Withdrawal by Subject|0|||
145567868|NCT01479621|524940532|FG001|Treatment Period|Withdrawal by Subject|4|||
145567869|NCT01479621|524940533|FG002|Treatment Period|Withdrawal by Subject|2|||
145567870|NCT01479621|524940534|FG003|Treatment Period|Withdrawal by Subject|2|||
145567871|NCT01479621|524940535|FG004|Treatment Period|Withdrawal by Subject|5|||
145567872|NCT01479621|524940536|FG005|Treatment Period|Withdrawal by Subject|5|||
145567873|NCT01479621|524940537|FG006|Treatment Period|Withdrawal by Subject|1|||
145567874|NCT01479621|524940531|FG000|Treatment Period|Physician Decision|0|||
145300823|NCT03420300|523953298|FG000|Overall Study|Death|2|||
145300824|NCT05472038|523954879|FG000|Overall Study|Adverse Event|0|||
145300825|NCT05472038|523954880|FG001|Overall Study|Adverse Event|0|||
145300826|NCT05472038|523954881|FG002|Overall Study|Adverse Event|1|||
145300827|NCT05472038|523954882|FG003|Overall Study|Adverse Event|0|||
145300828|NCT05472038|523954883|FG004|Overall Study|Adverse Event|0|||
145567875|NCT01479621|524940532|FG001|Treatment Period|Physician Decision|0|||
145300829|NCT05472038|523954884|FG005|Overall Study|Adverse Event|0|||
145300830|NCT05472038|523954885|FG006|Overall Study|Adverse Event|0|||
145300831|NCT05472038|523954886|FG007|Overall Study|Adverse Event|0|||
145567876|NCT01479621|524940533|FG002|Treatment Period|Physician Decision|0|||
145567877|NCT01479621|524940534|FG003|Treatment Period|Physician Decision|0|||
145567878|NCT01479621|524940535|FG004|Treatment Period|Physician Decision|1|||
145567879|NCT01479621|524940536|FG005|Treatment Period|Physician Decision|1|||
145567880|NCT01479621|524940537|FG006|Treatment Period|Physician Decision|0|||
145567881|NCT01479621|524940531|FG000|Treatment Period|Non-compliance to study drug|0|||
145567882|NCT01479621|524940532|FG001|Treatment Period|Non-compliance to study drug|1|||
145567883|NCT01479621|524940533|FG002|Treatment Period|Non-compliance to study drug|0|||
145567884|NCT01479621|524940534|FG003|Treatment Period|Non-compliance to study drug|0|||
145567885|NCT01479621|524940535|FG004|Treatment Period|Non-compliance to study drug|0|||
145567886|NCT01479621|524940536|FG005|Treatment Period|Non-compliance to study drug|0|||
145567887|NCT01479621|524940537|FG006|Treatment Period|Non-compliance to study drug|1|||
145567888|NCT01479621|524940531|FG000|Treatment Period|Protocol Violation|0|||
145567889|NCT01479621|524940532|FG001|Treatment Period|Protocol Violation|9|||
145567890|NCT01479621|524940533|FG002|Treatment Period|Protocol Violation|6|||
145567891|NCT01479621|524940534|FG003|Treatment Period|Protocol Violation|5|||
145567892|NCT01479621|524940535|FG004|Treatment Period|Protocol Violation|2|||
145567893|NCT01479621|524940536|FG005|Treatment Period|Protocol Violation|10|||
145567894|NCT01479621|524940537|FG006|Treatment Period|Protocol Violation|6|||
145567895|NCT01479621|524940531|FG000|Treatment Period|Pregnancy|0|||
145567896|NCT01479621|524940532|FG001|Treatment Period|Pregnancy|0|||
145567897|NCT01479621|524940533|FG002|Treatment Period|Pregnancy|2|||
145567898|NCT01479621|524940534|FG003|Treatment Period|Pregnancy|0|||
145567899|NCT01479621|524940535|FG004|Treatment Period|Pregnancy|0|||
145567900|NCT01479621|524940536|FG005|Treatment Period|Pregnancy|0|||
145567901|NCT01479621|524940537|FG006|Treatment Period|Pregnancy|0|||
145567902|NCT01479621|524940531|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
145567903|NCT01479621|524940532|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
145257053|NCT02870348|523785243|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
145257054|NCT01038635|523785246|FG000|Overall Study|Disease Progression|2|||
145257055|NCT01038635|523785247|FG001|Overall Study|Disease Progression|0|||
145257056|NCT01038635|523785248|FG002|Overall Study|Disease Progression|0|||
145257057|NCT01038635|523785249|FG003|Overall Study|Disease Progression|0|||
145257058|NCT01038635|523785250|FG004|Overall Study|Disease Progression|0|||
145257059|NCT01038635|523785251|FG005|Overall Study|Disease Progression|0|||
145257060|NCT01038635|523785252|FG006|Overall Study|Disease Progression|1|||
145257061|NCT01038635|523785253|FG007|Overall Study|Disease Progression|4|||
145257062|NCT01038635|523785254|FG008|Overall Study|Disease Progression|0|||
145257063|NCT01038635|523785246|FG000|Overall Study|Death|0|||
145257064|NCT01038635|523785247|FG001|Overall Study|Death|0|||
145257065|NCT01038635|523785248|FG002|Overall Study|Death|0|||
145257066|NCT01038635|523785249|FG003|Overall Study|Death|0|||
145257067|NCT01038635|523785250|FG004|Overall Study|Death|1|||
145257068|NCT01038635|523785251|FG005|Overall Study|Death|0|||
145257069|NCT01038635|523785252|FG006|Overall Study|Death|1|||
145257070|NCT01038635|523785253|FG007|Overall Study|Death|1|||
145257071|NCT01038635|523785254|FG008|Overall Study|Death|2|||
145257072|NCT01227252|523785255|FG000|Overall Study|Sponsor Decision|0|||
145300832|NCT05472038|523954887|FG008|Overall Study|Adverse Event|0|||
145300833|NCT05472038|523954888|FG009|Overall Study|Adverse Event|0|||
145300834|NCT05472038|523954889|FG010|Overall Study|Adverse Event|0|||
145300835|NCT05472038|523954890|FG011|Overall Study|Adverse Event|0|||
145567904|NCT01479621|524940533|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
145567905|NCT01479621|524940534|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
145567906|NCT01479621|524940535|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
145567907|NCT01479621|524940536|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
145567908|NCT01479621|524940537|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
145567909|NCT01479621|524940531|FG000|Treatment Period|Lost to Follow-up|0|||
145257073|NCT01227252|523785256|FG001|Overall Study|Sponsor Decision|1|||
145257074|NCT01227252|523785257|FG002|Overall Study|Sponsor Decision|0|||
145257075|NCT01227252|523785258|FG003|Overall Study|Sponsor Decision|0|||
145257076|NCT01227252|523785255|FG000|Overall Study|Lost to Follow-up|0|||
145300836|NCT05472038|523954879|FG000|Overall Study|Death|0|||
145300837|NCT05472038|523954880|FG001|Overall Study|Death|0|||
145300838|NCT05472038|523954881|FG002|Overall Study|Death|0|||
145300839|NCT05472038|523954882|FG003|Overall Study|Death|0|||
145300840|NCT05472038|523954883|FG004|Overall Study|Death|0|||
145300841|NCT05472038|523954884|FG005|Overall Study|Death|1|||
145410749|NCT02903914|524356852|FG007|Overall Study|Progressive Disease|0|||
145257077|NCT01227252|523785256|FG001|Overall Study|Lost to Follow-up|1|||
145300842|NCT05472038|523954885|FG006|Overall Study|Death|0|||
145410750|NCT02903914|524356845|FG000|Overall Study|Death|0|||
145300843|NCT05472038|523954886|FG007|Overall Study|Death|0|||
145300844|NCT05472038|523954887|FG008|Overall Study|Death|0|||
145300845|NCT05472038|523954888|FG009|Overall Study|Death|0|||
145300846|NCT05472038|523954889|FG010|Overall Study|Death|0|||
145410751|NCT02903914|524356846|FG001|Overall Study|Death|0|||
145567910|NCT01479621|524940532|FG001|Treatment Period|Lost to Follow-up|0|||
145567911|NCT01479621|524940533|FG002|Treatment Period|Lost to Follow-up|1|||
145567912|NCT01479621|524940534|FG003|Treatment Period|Lost to Follow-up|0|||
145567913|NCT01479621|524940535|FG004|Treatment Period|Lost to Follow-up|2|||
145567914|NCT01479621|524940536|FG005|Treatment Period|Lost to Follow-up|2|||
145567915|NCT01479621|524940537|FG006|Treatment Period|Lost to Follow-up|1|||
145567916|NCT01479621|524940531|FG000|Treatment Period|Met stopping criteria|0|||
145567917|NCT01479621|524940532|FG001|Treatment Period|Met stopping criteria|8|||
145567918|NCT01479621|524940533|FG002|Treatment Period|Met stopping criteria|7|||
145567919|NCT01479621|524940534|FG003|Treatment Period|Met stopping criteria|4|||
145567920|NCT01479621|524940535|FG004|Treatment Period|Met stopping criteria|9|||
145567921|NCT01479621|524940536|FG005|Treatment Period|Met stopping criteria|20|||
145567922|NCT01479621|524940537|FG006|Treatment Period|Met stopping criteria|6|||
145567923|NCT04225923|524940542|FG000|Overall Study|Protocol Violation|1|||
145567924|NCT04225923|524940543|FG001|Overall Study|Protocol Violation|0|||
145567925|NCT04225923|524940544|FG002|Overall Study|Protocol Violation|1|||
145567926|NCT04225923|524940542|FG000|Overall Study|Withdrawal by Subject|4|||
145567927|NCT04225923|524940543|FG001|Overall Study|Withdrawal by Subject|1|||
145567928|NCT04225923|524940544|FG002|Overall Study|Withdrawal by Subject|3|||
145567929|NCT04225923|524940542|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
145567930|NCT04225923|524940543|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
145567931|NCT04225923|524940544|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
145567932|NCT00855309|524940545|FG000|Overall Study|patient never recieved drug|1|||
145567933|NCT00855309|524940546|FG001|Overall Study|patient never recieved drug|0|||
145567934|NCT01585766|524940547|FG000|Overall Study|Withdrawal by Subject|0|||
145567935|NCT01585766|524940548|FG001|Overall Study|Withdrawal by Subject|1|||
145567936|NCT01585766|524940549|FG002|Overall Study|Withdrawal by Subject|1|||
145567937|NCT01585766|524940550|FG003|Overall Study|Withdrawal by Subject|0|||
145567938|NCT01585766|524940551|FG004|Overall Study|Withdrawal by Subject|0|||
145567939|NCT01585766|524940552|FG005|Overall Study|Withdrawal by Subject|0|||
145567940|NCT01585766|524940547|FG000|Overall Study|Death|0|||
145567941|NCT01585766|524940548|FG001|Overall Study|Death|1|||
145567942|NCT01585766|524940549|FG002|Overall Study|Death|0|||
145567943|NCT01585766|524940550|FG003|Overall Study|Death|0|||
145567944|NCT01585766|524940551|FG004|Overall Study|Death|0|||
145567945|NCT01585766|524940552|FG005|Overall Study|Death|0|||
145567946|NCT01585766|524940547|FG000|Overall Study|Physician Decision|0|||
145567947|NCT01585766|524940548|FG001|Overall Study|Physician Decision|0|||
145567948|NCT01585766|524940549|FG002|Overall Study|Physician Decision|1|||
145567949|NCT01585766|524940550|FG003|Overall Study|Physician Decision|0|||
145567950|NCT01585766|524940551|FG004|Overall Study|Physician Decision|0|||
145567951|NCT01585766|524940552|FG005|Overall Study|Physician Decision|0|||
145567952|NCT04116710|524940553|FG000|Overall Study|Death|4|||
145567953|NCT04116710|524940554|FG001|Overall Study|Death|6|||
145567954|NCT04116710|524940555|FG002|Overall Study|Death|3|||
145567955|NCT04116710|524940556|FG003|Overall Study|Death|1|||
145567956|NCT04116710|524940553|FG000|Overall Study|Withdrawal by Subject|0|||
145567957|NCT04116710|524940554|FG001|Overall Study|Withdrawal by Subject|0|||
145567958|NCT04116710|524940555|FG002|Overall Study|Withdrawal by Subject|0|||
145567959|NCT04116710|524940556|FG003|Overall Study|Withdrawal by Subject|1|||
145567960|NCT00582933|524940557|FG000|Overall Study|Physician Decision|3|||
145567961|NCT02319031|524940558|FG000|Treatment Period|Death|1|||
145567962|NCT02319031|524940559|FG001|Treatment Period|Death|0|||
145567963|NCT02689258|524940563|FG000|Overall Study|Subject Non-Compliance|0|||
145567964|NCT02689258|524940564|FG001|Overall Study|Subject Non-Compliance|1|||
145567965|NCT02689258|524940565|FG002|Overall Study|Subject Non-Compliance|0|||
145567966|NCT02689258|524940566|FG003|Overall Study|Subject Non-Compliance|0|||
145567967|NCT02689258|524940567|FG004|Overall Study|Subject Non-Compliance|0|||
145567968|NCT02689258|524940568|FG005|Overall Study|Subject Non-Compliance|0|||
145567969|NCT02689258|524940569|FG006|Overall Study|Subject Non-Compliance|0|||
145257078|NCT01227252|523785257|FG002|Overall Study|Lost to Follow-up|0|||
145257079|NCT01227252|523785258|FG003|Overall Study|Lost to Follow-up|0|||
145257080|NCT01227252|523785255|FG000|Overall Study|Withdrawal by Subject|0|||
145567970|NCT02689258|524940570|FG007|Overall Study|Subject Non-Compliance|0|||
145567971|NCT02689258|524940571|FG008|Overall Study|Subject Non-Compliance|0|||
145567972|NCT02689258|524940572|FG009|Overall Study|Subject Non-Compliance|0|||
145567973|NCT02689258|524940573|FG010|Overall Study|Subject Non-Compliance|0|||
145567974|NCT02689258|524940574|FG011|Overall Study|Subject Non-Compliance|0|||
145567975|NCT02689258|524940563|FG000|Overall Study|Subject Refusal to Continue|0|||
145567976|NCT02689258|524940564|FG001|Overall Study|Subject Refusal to Continue|1|||
145257081|NCT01227252|523785256|FG001|Overall Study|Withdrawal by Subject|1|||
145257082|NCT01227252|523785257|FG002|Overall Study|Withdrawal by Subject|0|||
145567977|NCT02689258|524940565|FG002|Overall Study|Subject Refusal to Continue|0|||
145567978|NCT02689258|524940566|FG003|Overall Study|Subject Refusal to Continue|0|||
145567979|NCT02689258|524940567|FG004|Overall Study|Subject Refusal to Continue|0|||
145567980|NCT02689258|524940568|FG005|Overall Study|Subject Refusal to Continue|0|||
145567981|NCT02689258|524940569|FG006|Overall Study|Subject Refusal to Continue|0|||
145257083|NCT01227252|523785258|FG003|Overall Study|Withdrawal by Subject|0|||
145257084|NCT01060150|523785260|FG000|Overall Study|Adverse Event|6|||
145257085|NCT01060150|523785260|FG000|Overall Study|Lost to Follow-up|1|||
145257086|NCT01060150|523785260|FG000|Overall Study|Protocol Violation|6|||
145257087|NCT01060150|523785260|FG000|Overall Study|Withdrawal by Subject|8|||
145257088|NCT01060150|523785260|FG000|Overall Study|Enrolled, but not treated|2|||
145257089|NCT02177942|523785261|FG000|Overall Study|Adverse Event|1|||
145257090|NCT02177942|523785262|FG001|Overall Study|Adverse Event|0|||
145257091|NCT02177942|523785261|FG000|Overall Study|Lost to Follow-up|1|||
145257092|NCT02177942|523785262|FG001|Overall Study|Lost to Follow-up|1|||
145257093|NCT02177942|523785261|FG000|Overall Study|Protocol Violation|4|||
145257094|NCT02177942|523785262|FG001|Overall Study|Protocol Violation|6|||
145257095|NCT02177942|523785261|FG000|Overall Study|Withdrawal by Subject|71|||
145257096|NCT02177942|523785262|FG001|Overall Study|Withdrawal by Subject|81|||
145257097|NCT01566981|523785263|FG000|Overall Study|Lost to Follow-up|5|||
145257098|NCT01566981|523785264|FG001|Overall Study|Lost to Follow-up|8|||
145257099|NCT03480360|523785266|FG000|Overall Study|Death|2|||
145257100|NCT05375838|523785267|FG000|Overall Study|Other|0|||
145257101|NCT05375838|523785268|FG001|Overall Study|Other|0|||
145257102|NCT05375838|523785269|FG002|Overall Study|Other|0|||
145257103|NCT05375838|523785270|FG003|Overall Study|Other|1|||
145257104|NCT05375838|523785271|FG004|Overall Study|Other|1|||
145257105|NCT05375838|523785272|FG005|Overall Study|Other|0|||
145257106|NCT05375838|523785267|FG000|Overall Study|Withdrawal by Subject|2|||
145257107|NCT05375838|523785268|FG001|Overall Study|Withdrawal by Subject|1|||
145257108|NCT05375838|523785269|FG002|Overall Study|Withdrawal by Subject|3|||
145257109|NCT05375838|523785270|FG003|Overall Study|Withdrawal by Subject|2|||
145257110|NCT05375838|523785271|FG004|Overall Study|Withdrawal by Subject|2|||
145257111|NCT05375838|523785272|FG005|Overall Study|Withdrawal by Subject|0|||
145257112|NCT05375838|523785267|FG000|Overall Study|Protocol Violation|0|||
145257113|NCT05375838|523785268|FG001|Overall Study|Protocol Violation|0|||
145257114|NCT05375838|523785269|FG002|Overall Study|Protocol Violation|0|||
145257115|NCT05375838|523785270|FG003|Overall Study|Protocol Violation|0|||
145257116|NCT05375838|523785271|FG004|Overall Study|Protocol Violation|1|||
145257117|NCT05375838|523785272|FG005|Overall Study|Protocol Violation|0|||
145257118|NCT05375838|523785267|FG000|Overall Study|Physician Decision|0|||
145257119|NCT05375838|523785268|FG001|Overall Study|Physician Decision|1|||
145257120|NCT05375838|523785269|FG002|Overall Study|Physician Decision|0|||
145257121|NCT05375838|523785270|FG003|Overall Study|Physician Decision|0|||
145567982|NCT02689258|524940570|FG007|Overall Study|Subject Refusal to Continue|0|||
145567983|NCT02689258|524940571|FG008|Overall Study|Subject Refusal to Continue|1|||
145567984|NCT02689258|524940572|FG009|Overall Study|Subject Refusal to Continue|0|||
145567985|NCT02689258|524940573|FG010|Overall Study|Subject Refusal to Continue|0|||
145567986|NCT02689258|524940574|FG011|Overall Study|Subject Refusal to Continue|1|||
145567987|NCT02689258|524940563|FG000|Overall Study|Other|0|||
145567988|NCT02689258|524940564|FG001|Overall Study|Other|2|||
145567989|NCT02689258|524940565|FG002|Overall Study|Other|0|||
145567990|NCT02689258|524940566|FG003|Overall Study|Other|0|||
145567991|NCT02689258|524940567|FG004|Overall Study|Other|1|||
145567992|NCT02689258|524940568|FG005|Overall Study|Other|0|||
145567993|NCT02689258|524940569|FG006|Overall Study|Other|0|||
145567994|NCT02689258|524940570|FG007|Overall Study|Other|0|||
145567995|NCT02689258|524940571|FG008|Overall Study|Other|1|||
145257122|NCT05375838|523785271|FG004|Overall Study|Physician Decision|0|||
145257123|NCT05375838|523785272|FG005|Overall Study|Physician Decision|1|||
145257124|NCT05375838|523785267|FG000|Overall Study|Lost to Follow-up|2|||
145257125|NCT05375838|523785268|FG001|Overall Study|Lost to Follow-up|7|||
145257126|NCT05375838|523785269|FG002|Overall Study|Lost to Follow-up|0|||
145257127|NCT05375838|523785270|FG003|Overall Study|Lost to Follow-up|4|||
145257128|NCT05375838|523785271|FG004|Overall Study|Lost to Follow-up|2|||
145257129|NCT05375838|523785272|FG005|Overall Study|Lost to Follow-up|3|||
145300847|NCT05472038|523954890|FG011|Overall Study|Death|0|||
145300848|NCT05472038|523954879|FG000|Overall Study|Lost to Follow-up|1|||
145300849|NCT05472038|523954880|FG001|Overall Study|Lost to Follow-up|3|||
145567996|NCT02689258|524940572|FG009|Overall Study|Other|0|||
145567997|NCT02689258|524940573|FG010|Overall Study|Other|0|||
145567998|NCT02689258|524940574|FG011|Overall Study|Other|0|||
145257130|NCT01277666|523785274|FG000|Overall Study|Adverse Event|26|||
145257131|NCT01277666|523785275|FG001|Overall Study|Adverse Event|25|||
145257132|NCT01277666|523785276|FG002|Overall Study|Adverse Event|20|||
145257133|NCT01277666|523785274|FG000|Overall Study|Lack of Efficacy|8|||
145257134|NCT01277666|523785275|FG001|Overall Study|Lack of Efficacy|20|||
145567999|NCT04753164|524940576|FG000|Overall Study|Adverse Event|0|||
145568000|NCT04753164|524940577|FG001|Overall Study|Adverse Event|2|||
145568001|NCT04753164|524940576|FG000|Overall Study|Withdrawal by Subject|9|||
145568002|NCT04753164|524940577|FG001|Overall Study|Withdrawal by Subject|7|||
145257135|NCT01277666|523785276|FG002|Overall Study|Lack of Efficacy|12|||
145257136|NCT01277666|523785274|FG000|Overall Study|Protocol Violation|2|||
145257137|NCT01277666|523785275|FG001|Overall Study|Protocol Violation|3|||
145257138|NCT01277666|523785276|FG002|Overall Study|Protocol Violation|2|||
145568003|NCT04753164|524940576|FG000|Overall Study|Lost to Follow-up|6|||
145568004|NCT04753164|524940577|FG001|Overall Study|Lost to Follow-up|6|||
145568005|NCT04753164|524940576|FG000|Overall Study|Other|12|||
145568006|NCT04753164|524940577|FG001|Overall Study|Other|5|||
145568007|NCT00696137|524940579|FG000|Overall Study|Withdrawal by Subject|2|||
145568008|NCT01371656|524940580|FG000|Overall Study|Death|7|||
145568009|NCT01371656|524940581|FG001|Overall Study|Death|4|||
145568010|NCT01371656|524940580|FG000|Overall Study|Physician Decision|46|||
145568011|NCT01371656|524940581|FG001|Overall Study|Physician Decision|7|||
145568012|NCT01371656|524940580|FG000|Overall Study|Withdrawal by Subject|7|||
145568013|NCT01371656|524940581|FG001|Overall Study|Withdrawal by Subject|0|||
145568014|NCT01371656|524940580|FG000|Overall Study|Ineligible|4|||
145568015|NCT01371656|524940581|FG001|Overall Study|Ineligible|3|||
145568016|NCT01465464|524940587|FG000|Overall Study|Adverse Event|96|||
145568017|NCT01465464|524940588|FG001|Overall Study|Adverse Event|49|||
145568018|NCT01465464|524940587|FG000|Overall Study|Lack of Efficacy|139|||
145568019|NCT01465464|524940588|FG001|Overall Study|Lack of Efficacy|190|||
145568020|NCT01465464|524940587|FG000|Overall Study|Physician Decision|13|||
145568021|NCT01465464|524940588|FG001|Overall Study|Physician Decision|5|||
145568022|NCT01465464|524940587|FG000|Overall Study|Protocol Violation|1|||
145568023|NCT01465464|524940588|FG001|Overall Study|Protocol Violation|1|||
145568024|NCT01465464|524940587|FG000|Overall Study|Withdrawal by Subject|46|||
145568025|NCT01465464|524940588|FG001|Overall Study|Withdrawal by Subject|30|||
145568026|NCT01465464|524940587|FG000|Overall Study|Other|9|||
145568027|NCT01465464|524940588|FG001|Overall Study|Other|3|||
145257139|NCT01277666|523785274|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
145257140|NCT01277666|523785275|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
145257141|NCT01277666|523785276|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
145257142|NCT01277666|523785274|FG000|Overall Study|Lost to Follow-up|1|||
145257143|NCT01277666|523785275|FG001|Overall Study|Lost to Follow-up|1|||
145257144|NCT01277666|523785276|FG002|Overall Study|Lost to Follow-up|2|||
145257145|NCT01277666|523785274|FG000|Overall Study|Withdrawal by Subject|7|||
145300850|NCT05472038|523954881|FG002|Overall Study|Lost to Follow-up|3|||
145300851|NCT05472038|523954882|FG003|Overall Study|Lost to Follow-up|9|||
145300852|NCT05472038|523954883|FG004|Overall Study|Lost to Follow-up|2|||
145300853|NCT05472038|523954884|FG005|Overall Study|Lost to Follow-up|2|||
145300854|NCT05472038|523954885|FG006|Overall Study|Lost to Follow-up|1|||
145300855|NCT05472038|523954886|FG007|Overall Study|Lost to Follow-up|0|||
145300856|NCT05472038|523954887|FG008|Overall Study|Lost to Follow-up|1|||
145300857|NCT05472038|523954888|FG009|Overall Study|Lost to Follow-up|0|||
145300858|NCT05472038|523954889|FG010|Overall Study|Lost to Follow-up|2|||
145300859|NCT05472038|523954890|FG011|Overall Study|Lost to Follow-up|1|||
145300860|NCT05472038|523954879|FG000|Overall Study|Physician Decision|0|||
145300861|NCT05472038|523954880|FG001|Overall Study|Physician Decision|0|||
145300862|NCT05472038|523954881|FG002|Overall Study|Physician Decision|0|||
145300863|NCT05472038|523954882|FG003|Overall Study|Physician Decision|0|||
145300864|NCT05472038|523954883|FG004|Overall Study|Physician Decision|1|||
145300865|NCT05472038|523954884|FG005|Overall Study|Physician Decision|0|||
145300866|NCT05472038|523954885|FG006|Overall Study|Physician Decision|0|||
145300867|NCT05472038|523954886|FG007|Overall Study|Physician Decision|0|||
145300868|NCT05472038|523954887|FG008|Overall Study|Physician Decision|0|||
145300869|NCT05472038|523954888|FG009|Overall Study|Physician Decision|0|||
145300870|NCT05472038|523954889|FG010|Overall Study|Physician Decision|0|||
145300871|NCT05472038|523954890|FG011|Overall Study|Physician Decision|0|||
145300872|NCT05472038|523954879|FG000|Overall Study|Withdrawal by Subject|1|||
145300873|NCT05472038|523954880|FG001|Overall Study|Withdrawal by Subject|3|||
145300874|NCT05472038|523954881|FG002|Overall Study|Withdrawal by Subject|1|||
145300875|NCT05472038|523954882|FG003|Overall Study|Withdrawal by Subject|6|||
145300876|NCT05472038|523954883|FG004|Overall Study|Withdrawal by Subject|1|||
145300877|NCT05472038|523954884|FG005|Overall Study|Withdrawal by Subject|3|||
145300878|NCT05472038|523954885|FG006|Overall Study|Withdrawal by Subject|0|||
145300879|NCT05472038|523954886|FG007|Overall Study|Withdrawal by Subject|2|||
145300880|NCT05472038|523954887|FG008|Overall Study|Withdrawal by Subject|3|||
145300881|NCT05472038|523954888|FG009|Overall Study|Withdrawal by Subject|1|||
145300882|NCT05472038|523954889|FG010|Overall Study|Withdrawal by Subject|2|||
145300883|NCT05472038|523954890|FG011|Overall Study|Withdrawal by Subject|2|||
145300884|NCT05472038|523954879|FG000|Overall Study|Protocol Violation|0|||
145300885|NCT05472038|523954880|FG001|Overall Study|Protocol Violation|0|||
145568028|NCT01465464|524940587|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
145568029|NCT01465464|524940588|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
145257146|NCT01277666|523785275|FG001|Overall Study|Withdrawal by Subject|8|||
145300886|NCT05472038|523954881|FG002|Overall Study|Protocol Violation|0|||
145300887|NCT05472038|523954882|FG003|Overall Study|Protocol Violation|0|||
145300888|NCT05472038|523954883|FG004|Overall Study|Protocol Violation|0|||
145300889|NCT05472038|523954884|FG005|Overall Study|Protocol Violation|0|||
145568030|NCT01228747|524940593|FG000|Overall Study|Adverse Event|8|||
145568031|NCT01228747|524940594|FG001|Overall Study|Adverse Event|4|||
145300890|NCT05472038|523954885|FG006|Overall Study|Protocol Violation|0|||
145568032|NCT01228747|524940593|FG000|Overall Study|Lack of Efficacy|40|||
145568033|NCT01228747|524940594|FG001|Overall Study|Lack of Efficacy|27|||
145568034|NCT01228747|524940593|FG000|Overall Study|Protocol Violation|6|||
145257147|NCT01277666|523785276|FG002|Overall Study|Withdrawal by Subject|6|||
145568035|NCT01228747|524940594|FG001|Overall Study|Protocol Violation|5|||
145568036|NCT01228747|524940593|FG000|Overall Study|Lost to Follow-up|4|||
145568037|NCT01228747|524940594|FG001|Overall Study|Lost to Follow-up|3|||
145568038|NCT01228747|524940593|FG000|Overall Study|Withdrawal by Subject|5|||
145568039|NCT01228747|524940594|FG001|Overall Study|Withdrawal by Subject|1|||
145568040|NCT01228747|524940593|FG000|Overall Study|Other Reason|2|||
145568041|NCT01228747|524940594|FG001|Overall Study|Other Reason|5|||
145568042|NCT02036502|524940595|FG000|Part 1:Dose Determination/Escalation|Death|3|||
145568043|NCT02036502|524940596|FG001|Part 1:Dose Determination/Escalation|Death|2|||
145568044|NCT02036502|524940597|FG002|Part 1:Dose Determination/Escalation|Death|0|||
145568045|NCT02036502|524940598|FG003|Part 1:Dose Determination/Escalation|Death|0|||
145568046|NCT02036502|524940599|FG004|Part 1:Dose Determination/Escalation|Death|0|||
145568047|NCT02036502|524940600|FG005|Part 1:Dose Determination/Escalation|Death|0|||
145568048|NCT02036502|524940601|FG006|Part 1:Dose Determination/Escalation|Death|0|||
145568049|NCT02036502|524940602|FG007|Part 1:Dose Determination/Escalation|Death|0|||
145568050|NCT02036502|524940595|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
145568051|NCT02036502|524940596|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568052|NCT02036502|524940597|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568053|NCT02036502|524940598|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568054|NCT02036502|524940599|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568055|NCT02036502|524940600|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568056|NCT02036502|524940601|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568057|NCT02036502|524940602|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
145568058|NCT02036502|524940595|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568059|NCT02036502|524940596|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
145568060|NCT02036502|524940597|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568061|NCT02036502|524940598|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568062|NCT02036502|524940599|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568063|NCT02036502|524940600|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568064|NCT02036502|524940601|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568065|NCT02036502|524940602|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
145568066|NCT02036502|524940595|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
145568067|NCT02036502|524940596|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
145568068|NCT02036502|524940597|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
145568069|NCT02036502|524940598|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
145257148|NCT01277666|523785274|FG000|Overall Study|Death|0|||
145257149|NCT01277666|523785275|FG001|Overall Study|Death|0|||
145257150|NCT01277666|523785276|FG002|Overall Study|Death|1|||
145257151|NCT01385098|523785277|FG000|Overall Study|Adverse Event|10|||
145257152|NCT01385098|523785277|FG000|Overall Study|Lost to Follow-up|4|||
145257153|NCT01230827|523785278|FG000|Overall Study|Lost to Follow-up|0|||
145257154|NCT01230827|523785279|FG001|Overall Study|Lost to Follow-up|0|||
145257155|NCT01230827|523785280|FG002|Overall Study|Lost to Follow-up|1|||
145257156|NCT01230827|523785281|FG003|Overall Study|Lost to Follow-up|3|||
145257157|NCT01230827|523785278|FG000|Overall Study|Withdrawal by Subject|1|||
145257158|NCT01230827|523785279|FG001|Overall Study|Withdrawal by Subject|0|||
145257159|NCT01230827|523785280|FG002|Overall Study|Withdrawal by Subject|3|||
145257160|NCT01230827|523785281|FG003|Overall Study|Withdrawal by Subject|2|||
145257161|NCT01230827|523785278|FG000|Overall Study|Lack of Efficacy|14|||
145257162|NCT01230827|523785279|FG001|Overall Study|Lack of Efficacy|1|||
145257163|NCT01230827|523785280|FG002|Overall Study|Lack of Efficacy|2|||
145257164|NCT01230827|523785281|FG003|Overall Study|Lack of Efficacy|3|||
145257165|NCT01230827|523785278|FG000|Overall Study|Adverse Event|4|||
145257166|NCT01230827|523785279|FG001|Overall Study|Adverse Event|2|||
145257167|NCT01230827|523785280|FG002|Overall Study|Adverse Event|3|||
145257168|NCT01230827|523785281|FG003|Overall Study|Adverse Event|7|||
145257169|NCT01230827|523785278|FG000|Overall Study|Recovery|0|||
145257170|NCT01230827|523785279|FG001|Overall Study|Recovery|6|||
145257171|NCT01230827|523785280|FG002|Overall Study|Recovery|0|||
145257172|NCT01230827|523785281|FG003|Overall Study|Recovery|0|||
145568070|NCT02036502|524940599|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
145568071|NCT02036502|524940600|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
145257173|NCT01230827|523785278|FG000|Overall Study|Study terminated by Sponsor|0|||
145257174|NCT01230827|523785279|FG001|Overall Study|Study terminated by Sponsor|2|||
145257175|NCT01230827|523785280|FG002|Overall Study|Study terminated by Sponsor|56|||
145257176|NCT01230827|523785281|FG003|Overall Study|Study terminated by Sponsor|63|||
145257177|NCT01084096|523787357|FG000|Overall Study|Lost to Follow-up|1501|||
145257178|NCT01084096|523787358|FG001|Overall Study|Lost to Follow-up|1833|||
145257179|NCT01084096|523787357|FG000|Overall Study|Withdrawal by Subject|3|||
145257180|NCT01084096|523787358|FG001|Overall Study|Withdrawal by Subject|0|||
145257181|NCT01084096|523787357|FG000|Overall Study|Woman had a miscarriage|21|||
145257182|NCT01084096|523787358|FG001|Overall Study|Woman had a miscarriage|17|||
145568072|NCT02036502|524940601|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
145568073|NCT02036502|524940602|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
145568074|NCT02036502|524940595|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
145568075|NCT02036502|524940596|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
145568076|NCT02036502|524940597|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
145568077|NCT02036502|524940598|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
145568078|NCT02036502|524940599|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
145568079|NCT02036502|524940600|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
145568080|NCT02036502|524940601|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
145568081|NCT02036502|524940602|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
145568082|NCT02036502|524940595|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568083|NCT02036502|524940596|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568084|NCT02036502|524940597|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
145568085|NCT02036502|524940598|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568086|NCT02036502|524940599|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568087|NCT02036502|524940600|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568088|NCT02036502|524940601|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568089|NCT02036502|524940602|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
145568090|NCT02036502|524940595|FG000|Part 2:Dose Confirmation|Death|0|||
145568091|NCT02036502|524940596|FG001|Part 2:Dose Confirmation|Death|0|||
145568092|NCT02036502|524940597|FG002|Part 2:Dose Confirmation|Death|1|||
145568093|NCT02036502|524940598|FG003|Part 2:Dose Confirmation|Death|0|||
145568094|NCT02036502|524940599|FG004|Part 2:Dose Confirmation|Death|0|||
145568095|NCT02036502|524940600|FG005|Part 2:Dose Confirmation|Death|0|||
145568096|NCT02036502|524940601|FG006|Part 2:Dose Confirmation|Death|0|||
145568097|NCT02036502|524940602|FG007|Part 2:Dose Confirmation|Death|0|||
145568098|NCT02036502|524940595|FG000|Part 2:Dose Confirmation|Not treated|0|||
145568099|NCT02036502|524940596|FG001|Part 2:Dose Confirmation|Not treated|0|||
145300891|NCT05472038|523954886|FG007|Overall Study|Protocol Violation|1|||
145300892|NCT05472038|523954887|FG008|Overall Study|Protocol Violation|1|||
145300893|NCT05472038|523954888|FG009|Overall Study|Protocol Violation|1|||
145300894|NCT05472038|523954889|FG010|Overall Study|Protocol Violation|1|||
145300895|NCT05472038|523954890|FG011|Overall Study|Protocol Violation|1|||
145300896|NCT05472038|523954879|FG000|Overall Study|Not vaccinated|0|||
145300897|NCT05472038|523954880|FG001|Overall Study|Not vaccinated|0|||
145300898|NCT05472038|523954881|FG002|Overall Study|Not vaccinated|0|||
145300899|NCT05472038|523954882|FG003|Overall Study|Not vaccinated|1|||
145300900|NCT05472038|523954883|FG004|Overall Study|Not vaccinated|0|||
145300901|NCT05472038|523954884|FG005|Overall Study|Not vaccinated|0|||
145300902|NCT05472038|523954885|FG006|Overall Study|Not vaccinated|0|||
145300903|NCT05472038|523954886|FG007|Overall Study|Not vaccinated|0|||
145410752|NCT02903914|524356847|FG002|Overall Study|Death|9|||
145410753|NCT02903914|524356848|FG003|Overall Study|Death|0|||
145568100|NCT02036502|524940597|FG002|Part 2:Dose Confirmation|Not treated|0|||
145568101|NCT02036502|524940598|FG003|Part 2:Dose Confirmation|Not treated|1|||
145568102|NCT02036502|524940599|FG004|Part 2:Dose Confirmation|Not treated|0|||
145568103|NCT02036502|524940600|FG005|Part 2:Dose Confirmation|Not treated|0|||
145568104|NCT02036502|524940601|FG006|Part 2:Dose Confirmation|Not treated|0|||
145568105|NCT02036502|524940602|FG007|Part 2:Dose Confirmation|Not treated|0|||
145568106|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Adverse Event|0|||
145568107|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Adverse Event|0|||
145568108|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Adverse Event|0|||
145568109|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Adverse Event|0|||
145568110|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Adverse Event|0|||
145568111|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Adverse Event|4|||
145568112|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Adverse Event|0|||
145568113|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Adverse Event|2|||
145568114|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Death|0|||
145568115|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Death|0|||
145410754|NCT02903914|524356849|FG004|Overall Study|Death|1|||
145410755|NCT02903914|524356850|FG005|Overall Study|Death|3|||
145568116|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Death|0|||
145568117|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Death|0|||
145568118|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Death|0|||
145568119|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Death|24|||
145568120|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Death|0|||
145300904|NCT05472038|523954887|FG008|Overall Study|Not vaccinated|0|||
145300905|NCT05472038|523954888|FG009|Overall Study|Not vaccinated|0|||
145300906|NCT05472038|523954889|FG010|Overall Study|Not vaccinated|0|||
145410756|NCT02903914|524356851|FG006|Overall Study|Death|24|||
145410757|NCT02903914|524356852|FG007|Overall Study|Death|2|||
145568121|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Death|3|||
145568122|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568123|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568124|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568125|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
145620271|NCT00885495|525123728|FG000|Overall Study|Adverse Event|1|||
145568126|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568127|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568128|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
145568129|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
145568130|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Physician Decision|0|||
145568131|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Physician Decision|0|||
145568132|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Physician Decision|0|||
145568133|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Physician Decision|0|||
145568134|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Physician Decision|0|||
145568135|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Physician Decision|1|||
145568136|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Physician Decision|0|||
145568137|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Physician Decision|0|||
145568138|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
145568139|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
145300907|NCT05472038|523954890|FG011|Overall Study|Not vaccinated|0|||
145300908|NCT03235739|523954893|FG000|Overall Study|Withdrawal by Subject|2|||
145300909|NCT03235739|523954894|FG001|Overall Study|Withdrawal by Subject|2|||
145300910|NCT03235739|523954893|FG000|Overall Study|Physician Decision|0|||
145300911|NCT03235739|523954894|FG001|Overall Study|Physician Decision|1|||
145300912|NCT02869867|523954895|FG000|Overall Study|Protocol Violation|1|||
145300913|NCT02869867|523954896|FG001|Overall Study|Protocol Violation|0|||
145300914|NCT02869867|523954895|FG000|Overall Study|Lost to Follow-up|5|||
145300915|NCT02869867|523954896|FG001|Overall Study|Lost to Follow-up|5|||
145300916|NCT00461786|523954900|FG000|Overall Study|Entry Criteria Not Met|2|||
145300917|NCT00461786|523954900|FG000|Overall Study|Inevaluable (Never Treated)|1|||
145300918|NCT00835991|523954903|FG000|First Intervention|Adverse Event|0|||
145300919|NCT00835991|523954904|FG001|First Intervention|Adverse Event|1|||
145300920|NCT00835991|523954903|FG000|Washout|Protocol Violation|0|||
145300921|NCT00835991|523954904|FG001|Washout|Protocol Violation|2|||
145300922|NCT00835991|523954903|FG000|Washout|Withdrawal by Subject|3|||
145300923|NCT00835991|523954904|FG001|Washout|Withdrawal by Subject|1|||
145300924|NCT00272779|523954907|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
145300925|NCT00272779|523954908|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
145300926|NCT00272779|523954907|FG000|Baseline Through Week 48|Death before Week 48|4|||
145300927|NCT00272779|523954908|FG001|Baseline Through Week 48|Death before Week 48|4|||
145300928|NCT00272779|523954907|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
145300929|NCT00272779|523954908|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
145300930|NCT00272779|523954907|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
145300931|NCT00272779|523954908|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
145300932|NCT00272779|523954907|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
145300933|NCT00272779|523954908|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
145300934|NCT00272779|523954907|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
145300935|NCT00272779|523954908|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
145300936|NCT00272779|523954907|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
145300937|NCT00272779|523954908|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
145300938|NCT00272779|523954907|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
145300939|NCT00272779|523954908|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
145300940|NCT00272779|523954907|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
145300941|NCT00272779|523954908|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
145300942|NCT00272779|523954907|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
145300943|NCT00272779|523954908|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
145300944|NCT00272779|523954907|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
145300945|NCT00272779|523954908|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
145300946|NCT00272779|523954907|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
145300947|NCT00272779|523954908|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
145300948|NCT00272779|523954907|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
145300949|NCT00272779|523954908|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
145300950|NCT00272779|523954907|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
145300951|NCT00272779|523954908|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
145410758|NCT02903914|524356845|FG000|Overall Study|Lost to Follow-up|0|||
145300952|NCT00272779|523954907|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
145300953|NCT00272779|523954908|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
145300954|NCT00272779|523954907|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
145300955|NCT00272779|523954908|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
145300956|NCT00272779|523954907|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
145300957|NCT00272779|523954908|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
145410759|NCT02903914|524356846|FG001|Overall Study|Lost to Follow-up|1|||
145568140|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
145568141|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
145568142|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
145620272|NCT00885495|525123729|FG001|Overall Study|Adverse Event|2|||
145568143|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
145568144|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
145568145|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
145568146|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568147|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568148|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568149|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568150|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568151|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
145568152|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
145568153|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
145568154|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
145568155|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
145568156|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
145568157|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
145568158|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
145568159|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
145568160|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
145568161|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
145568162|NCT02036502|524940595|FG000|Part 3:Dose Expansion|Not Treated|0|||
145568163|NCT02036502|524940596|FG001|Part 3:Dose Expansion|Not Treated|0|||
145568164|NCT02036502|524940597|FG002|Part 3:Dose Expansion|Not Treated|0|||
145568165|NCT02036502|524940598|FG003|Part 3:Dose Expansion|Not Treated|0|||
145568166|NCT02036502|524940599|FG004|Part 3:Dose Expansion|Not Treated|0|||
145568167|NCT02036502|524940600|FG005|Part 3:Dose Expansion|Not Treated|2|||
145568168|NCT02036502|524940601|FG006|Part 3:Dose Expansion|Not Treated|0|||
145568169|NCT02036502|524940602|FG007|Part 3:Dose Expansion|Not Treated|0|||
145568170|NCT01068509|524940605|FG000|Overall Study|Death|0|||
145568171|NCT01068509|524940606|FG001|Overall Study|Death|0|||
145568172|NCT01068509|524940607|FG002|Overall Study|Death|1|||
145568173|NCT01068509|524940605|FG000|Overall Study|Disease Progression|5|||
145568174|NCT01068509|524940606|FG001|Overall Study|Disease Progression|20|||
145568175|NCT01068509|524940607|FG002|Overall Study|Disease Progression|18|||
145568176|NCT01068509|524940605|FG000|Overall Study|Lost to Follow-up|1|||
145568177|NCT01068509|524940606|FG001|Overall Study|Lost to Follow-up|0|||
145568178|NCT01068509|524940607|FG002|Overall Study|Lost to Follow-up|0|||
145568179|NCT01068509|524940605|FG000|Overall Study|Withdrew Consent|0|||
145568180|NCT01068509|524940606|FG001|Overall Study|Withdrew Consent|1|||
145568181|NCT01068509|524940607|FG002|Overall Study|Withdrew Consent|2|||
145568182|NCT01068509|524940605|FG000|Overall Study|Reason Not Specified|0|||
145568183|NCT01068509|524940606|FG001|Overall Study|Reason Not Specified|1|||
145568184|NCT01068509|524940607|FG002|Overall Study|Reason Not Specified|0|||
145568185|NCT02641379|524940612|FG000|Overall Study|Exclusion criterion during screening|1|||
145568186|NCT02641379|524940613|FG001|Overall Study|Exclusion criterion during screening|0|||
145568187|NCT02641379|524940614|FG002|Overall Study|Exclusion criterion during screening|0|||
145568188|NCT02641379|524940615|FG003|Overall Study|Exclusion criterion during screening|1|||
145568189|NCT02641379|524940616|FG004|Overall Study|Exclusion criterion during screening|2|||
145568190|NCT02641379|524940617|FG005|Overall Study|Exclusion criterion during screening|0|||
145568191|NCT02641379|524940618|FG006|Overall Study|Exclusion criterion during screening|0|||
145568192|NCT02641379|524940619|FG007|Overall Study|Exclusion criterion during screening|0|||
145568193|NCT02641379|524940620|FG008|Overall Study|Exclusion criterion during screening|0|||
145568194|NCT02641379|524940621|FG009|Overall Study|Exclusion criterion during screening|0|||
145568195|NCT02641379|524940622|FG010|Overall Study|Exclusion criterion during screening|0|||
145568196|NCT02641379|524940612|FG000|Overall Study|Withdrawal of informed consent|0|||
145568197|NCT02641379|524940613|FG001|Overall Study|Withdrawal of informed consent|1|||
145568198|NCT02641379|524940614|FG002|Overall Study|Withdrawal of informed consent|0|||
145568199|NCT02641379|524940615|FG003|Overall Study|Withdrawal of informed consent|0|||
145257183|NCT02033369|523787359|FG000|Overall Study|Physician Decision|1|||
145257184|NCT02033369|523787360|FG001|Overall Study|Physician Decision|2|||
145257185|NCT02033369|523787359|FG000|Overall Study|Not a good demographic match|0|||
145257186|NCT02033369|523787360|FG001|Overall Study|Not a good demographic match|2|||
145257187|NCT02033369|523787359|FG000|Overall Study|Withdrawal by Subject|1|||
145257188|NCT02033369|523787360|FG001|Overall Study|Withdrawal by Subject|1|||
145257189|NCT02033369|523787359|FG000|Overall Study|Lost to Follow-up|1|||
145257190|NCT02033369|523787360|FG001|Overall Study|Lost to Follow-up|0|||
145257191|NCT02033369|523787359|FG000|Overall Study|Protocol Violation|2|||
145257192|NCT02033369|523787360|FG001|Overall Study|Protocol Violation|0|||
145257193|NCT01503229|523787361|FG000|Overall Study|Withdrew consent|1|||
145257194|NCT01354964|523787362|FG000|Overall Study|Lost to Follow-up|2|||
145257195|NCT01354964|523787363|FG001|Overall Study|Lost to Follow-up|0|||
145257196|NCT01354964|523787362|FG000|Overall Study|IV access issues|1|||
145257197|NCT01354964|523787363|FG001|Overall Study|IV access issues|1|||
145257198|NCT01354964|523787362|FG000|Overall Study|Physician Decision|1|||
145568200|NCT02641379|524940616|FG004|Overall Study|Withdrawal of informed consent|0|||
145568201|NCT02641379|524940617|FG005|Overall Study|Withdrawal of informed consent|0|||
145568202|NCT02641379|524940618|FG006|Overall Study|Withdrawal of informed consent|0|||
145568203|NCT02641379|524940619|FG007|Overall Study|Withdrawal of informed consent|1|||
145568204|NCT02641379|524940620|FG008|Overall Study|Withdrawal of informed consent|0|||
145568205|NCT02641379|524940621|FG009|Overall Study|Withdrawal of informed consent|0|||
145568206|NCT02641379|524940622|FG010|Overall Study|Withdrawal of informed consent|0|||
145568207|NCT02641379|524940612|FG000|Overall Study|Adverse Event|7|||
145568208|NCT02641379|524940613|FG001|Overall Study|Adverse Event|8|||
145568209|NCT02641379|524940614|FG002|Overall Study|Adverse Event|2|||
145568210|NCT02641379|524940615|FG003|Overall Study|Adverse Event|2|||
145568211|NCT02641379|524940616|FG004|Overall Study|Adverse Event|5|||
145568212|NCT02641379|524940617|FG005|Overall Study|Adverse Event|1|||
145568213|NCT02641379|524940618|FG006|Overall Study|Adverse Event|5|||
145568214|NCT02641379|524940619|FG007|Overall Study|Adverse Event|0|||
145568215|NCT02641379|524940620|FG008|Overall Study|Adverse Event|1|||
145568216|NCT02641379|524940621|FG009|Overall Study|Adverse Event|1|||
145568217|NCT02641379|524940622|FG010|Overall Study|Adverse Event|5|||
145568218|NCT02641379|524940612|FG000|Overall Study|Lack of Efficacy|0|||
145568219|NCT02641379|524940613|FG001|Overall Study|Lack of Efficacy|0|||
145568220|NCT02641379|524940614|FG002|Overall Study|Lack of Efficacy|2|||
145568221|NCT02641379|524940615|FG003|Overall Study|Lack of Efficacy|0|||
145568222|NCT02641379|524940616|FG004|Overall Study|Lack of Efficacy|0|||
145568223|NCT02641379|524940617|FG005|Overall Study|Lack of Efficacy|2|||
145568224|NCT02641379|524940618|FG006|Overall Study|Lack of Efficacy|0|||
145568225|NCT02641379|524940619|FG007|Overall Study|Lack of Efficacy|5|||
145568226|NCT02641379|524940620|FG008|Overall Study|Lack of Efficacy|0|||
145568227|NCT02641379|524940621|FG009|Overall Study|Lack of Efficacy|0|||
145568228|NCT02641379|524940622|FG010|Overall Study|Lack of Efficacy|0|||
145568229|NCT02641379|524940612|FG000|Overall Study|Participant unable to attend study visit|4|||
145568230|NCT02641379|524940613|FG001|Overall Study|Participant unable to attend study visit|10|||
145568231|NCT02641379|524940614|FG002|Overall Study|Participant unable to attend study visit|1|||
145568232|NCT02641379|524940615|FG003|Overall Study|Participant unable to attend study visit|2|||
145568233|NCT02641379|524940616|FG004|Overall Study|Participant unable to attend study visit|5|||
145568234|NCT02641379|524940617|FG005|Overall Study|Participant unable to attend study visit|1|||
145568235|NCT02641379|524940618|FG006|Overall Study|Participant unable to attend study visit|1|||
145568236|NCT02641379|524940619|FG007|Overall Study|Participant unable to attend study visit|1|||
145568237|NCT02641379|524940620|FG008|Overall Study|Participant unable to attend study visit|0|||
145568238|NCT02641379|524940621|FG009|Overall Study|Participant unable to attend study visit|2|||
145568239|NCT02641379|524940622|FG010|Overall Study|Participant unable to attend study visit|0|||
145568240|NCT02641379|524940612|FG000|Overall Study|Participant's compliance|0|||
145568241|NCT02641379|524940613|FG001|Overall Study|Participant's compliance|1|||
145568242|NCT02641379|524940614|FG002|Overall Study|Participant's compliance|0|||
145568243|NCT02641379|524940615|FG003|Overall Study|Participant's compliance|1|||
145568244|NCT02641379|524940616|FG004|Overall Study|Participant's compliance|0|||
145568245|NCT02641379|524940617|FG005|Overall Study|Participant's compliance|2|||
145568246|NCT02641379|524940618|FG006|Overall Study|Participant's compliance|0|||
145568247|NCT02641379|524940619|FG007|Overall Study|Participant's compliance|0|||
145568248|NCT02641379|524940620|FG008|Overall Study|Participant's compliance|1|||
145568249|NCT02641379|524940621|FG009|Overall Study|Participant's compliance|1|||
145568250|NCT02641379|524940622|FG010|Overall Study|Participant's compliance|1|||
145568251|NCT02641379|524940612|FG000|Overall Study|Participant cannot be reached|4|||
145568252|NCT02641379|524940613|FG001|Overall Study|Participant cannot be reached|4|||
145568253|NCT02641379|524940614|FG002|Overall Study|Participant cannot be reached|0|||
145568254|NCT02641379|524940615|FG003|Overall Study|Participant cannot be reached|8|||
145568255|NCT02641379|524940616|FG004|Overall Study|Participant cannot be reached|2|||
145568256|NCT02641379|524940617|FG005|Overall Study|Participant cannot be reached|1|||
145568257|NCT02641379|524940618|FG006|Overall Study|Participant cannot be reached|0|||
145568258|NCT02641379|524940619|FG007|Overall Study|Participant cannot be reached|1|||
145568259|NCT02641379|524940620|FG008|Overall Study|Participant cannot be reached|0|||
145568260|NCT02641379|524940621|FG009|Overall Study|Participant cannot be reached|2|||
145568261|NCT02641379|524940622|FG010|Overall Study|Participant cannot be reached|1|||
145568262|NCT02641379|524940612|FG000|Overall Study|PCR positive at Week 24|15|||
145568263|NCT02641379|524940613|FG001|Overall Study|PCR positive at Week 24|21|||
145568264|NCT02641379|524940614|FG002|Overall Study|PCR positive at Week 24|62|||
145568265|NCT02641379|524940615|FG003|Overall Study|PCR positive at Week 24|0|||
145568266|NCT02641379|524940616|FG004|Overall Study|PCR positive at Week 24|0|||
145568267|NCT02641379|524940617|FG005|Overall Study|PCR positive at Week 24|6|||
145568268|NCT02641379|524940618|FG006|Overall Study|PCR positive at Week 24|3|||
145568269|NCT02641379|524940619|FG007|Overall Study|PCR positive at Week 24|8|||
145568270|NCT02641379|524940620|FG008|Overall Study|PCR positive at Week 24|0|||
145568271|NCT02641379|524940621|FG009|Overall Study|PCR positive at Week 24|1|||
145568272|NCT02641379|524940622|FG010|Overall Study|PCR positive at Week 24|0|||
145568273|NCT02641379|524940612|FG000|Overall Study|PCR positive at follow up 2|1|||
145568274|NCT02641379|524940613|FG001|Overall Study|PCR positive at follow up 2|0|||
145568275|NCT02641379|524940614|FG002|Overall Study|PCR positive at follow up 2|0|||
145568276|NCT02641379|524940615|FG003|Overall Study|PCR positive at follow up 2|0|||
145568277|NCT02641379|524940616|FG004|Overall Study|PCR positive at follow up 2|0|||
145568278|NCT02641379|524940617|FG005|Overall Study|PCR positive at follow up 2|0|||
145568279|NCT02641379|524940618|FG006|Overall Study|PCR positive at follow up 2|0|||
145568280|NCT02641379|524940619|FG007|Overall Study|PCR positive at follow up 2|0|||
145568281|NCT02641379|524940620|FG008|Overall Study|PCR positive at follow up 2|0|||
145568282|NCT02641379|524940621|FG009|Overall Study|PCR positive at follow up 2|0|||
145568283|NCT02641379|524940622|FG010|Overall Study|PCR positive at follow up 2|0|||
145568284|NCT02641379|524940612|FG000|Overall Study|Participant showed relapse|1|||
145568285|NCT02641379|524940613|FG001|Overall Study|Participant showed relapse|0|||
145568286|NCT02641379|524940614|FG002|Overall Study|Participant showed relapse|0|||
145568287|NCT02641379|524940615|FG003|Overall Study|Participant showed relapse|0|||
145568288|NCT02641379|524940616|FG004|Overall Study|Participant showed relapse|0|||
145568289|NCT02641379|524940617|FG005|Overall Study|Participant showed relapse|0|||
145568290|NCT02641379|524940618|FG006|Overall Study|Participant showed relapse|1|||
145568291|NCT02641379|524940619|FG007|Overall Study|Participant showed relapse|0|||
145568292|NCT02641379|524940620|FG008|Overall Study|Participant showed relapse|0|||
145568293|NCT02641379|524940621|FG009|Overall Study|Participant showed relapse|0|||
145568294|NCT02641379|524940622|FG010|Overall Study|Participant showed relapse|0|||
145568295|NCT02641379|524940612|FG000|Overall Study|Participant stopped study/treatment|1|||
145568296|NCT02641379|524940613|FG001|Overall Study|Participant stopped study/treatment|3|||
145568297|NCT02641379|524940614|FG002|Overall Study|Participant stopped study/treatment|1|||
145568298|NCT02641379|524940615|FG003|Overall Study|Participant stopped study/treatment|0|||
145257199|NCT01354964|523787363|FG001|Overall Study|Physician Decision|0|||
145257200|NCT02534324|523787364|FG000|Overall Study|Protocol Violation|4|||
145257201|NCT02534324|523787365|FG001|Overall Study|Protocol Violation|1|||
145257202|NCT02534324|523787364|FG000|Overall Study|Lost to Follow-up|20|||
145257203|NCT02534324|523787365|FG001|Overall Study|Lost to Follow-up|7|||
145257204|NCT02534324|523787364|FG000|Overall Study|Adverse Event|1|||
145257205|NCT02534324|523787365|FG001|Overall Study|Adverse Event|0|||
145300958|NCT00272779|523954907|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
145568299|NCT02641379|524940616|FG004|Overall Study|Participant stopped study/treatment|0|||
145568300|NCT02641379|524940617|FG005|Overall Study|Participant stopped study/treatment|1|||
145568301|NCT02641379|524940618|FG006|Overall Study|Participant stopped study/treatment|2|||
145568302|NCT02641379|524940619|FG007|Overall Study|Participant stopped study/treatment|0|||
145568303|NCT02641379|524940620|FG008|Overall Study|Participant stopped study/treatment|1|||
145568304|NCT02641379|524940621|FG009|Overall Study|Participant stopped study/treatment|0|||
145568305|NCT02641379|524940622|FG010|Overall Study|Participant stopped study/treatment|0|||
145568306|NCT02641379|524940612|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
145568307|NCT02641379|524940613|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
145568308|NCT02641379|524940614|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
145568309|NCT02641379|524940615|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
145568310|NCT02641379|524940616|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
145568311|NCT02641379|524940617|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
145568312|NCT02641379|524940618|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
145568313|NCT02641379|524940619|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
145568314|NCT02641379|524940620|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
145568315|NCT02641379|524940621|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
145568316|NCT02641379|524940622|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
145568317|NCT02641379|524940612|FG000|Overall Study|Financial problems|0|||
145568318|NCT02641379|524940613|FG001|Overall Study|Financial problems|1|||
145568319|NCT02641379|524940614|FG002|Overall Study|Financial problems|0|||
145568320|NCT02641379|524940615|FG003|Overall Study|Financial problems|0|||
145568321|NCT02641379|524940616|FG004|Overall Study|Financial problems|0|||
145568322|NCT02641379|524940617|FG005|Overall Study|Financial problems|0|||
145568323|NCT02641379|524940618|FG006|Overall Study|Financial problems|0|||
145568324|NCT02641379|524940619|FG007|Overall Study|Financial problems|0|||
145568325|NCT02641379|524940620|FG008|Overall Study|Financial problems|0|||
145568326|NCT02641379|524940621|FG009|Overall Study|Financial problems|0|||
145568327|NCT02641379|524940622|FG010|Overall Study|Financial problems|0|||
145568328|NCT02641379|524940612|FG000|Overall Study|PCR positive at Week 68|0|||
145568329|NCT02641379|524940613|FG001|Overall Study|PCR positive at Week 68|1|||
145568330|NCT02641379|524940614|FG002|Overall Study|PCR positive at Week 68|0|||
145568331|NCT02641379|524940615|FG003|Overall Study|PCR positive at Week 68|0|||
145568332|NCT02641379|524940616|FG004|Overall Study|PCR positive at Week 68|0|||
145257206|NCT05604781|523787366|FG000|Overall Study|Lost to Follow-up|3|||
145257207|NCT05604781|523787366|FG000|Overall Study|Adverse Event|1|||
145257208|NCT01041027|523787369|FG000|Overall Study|Withdrawal by Subject|2|||
145257209|NCT01041027|523787369|FG000|Overall Study|Protocol Violation|1|||
145257210|NCT01041027|523787369|FG000|Overall Study|Delayed Radiation Therapy|1|||
145257211|NCT01041027|523787369|FG000|Overall Study|Adverse Event|4|||
145257212|NCT03890731|523787370|FG000|Overall Study|Progressive disease|1|||
145257213|NCT03890731|523787370|FG000|Overall Study|Patient's decision|1|||
145568333|NCT02641379|524940617|FG005|Overall Study|PCR positive at Week 68|0|||
145568334|NCT02641379|524940618|FG006|Overall Study|PCR positive at Week 68|0|||
145568335|NCT02641379|524940619|FG007|Overall Study|PCR positive at Week 68|0|||
145568336|NCT02641379|524940620|FG008|Overall Study|PCR positive at Week 68|0|||
145568337|NCT02641379|524940621|FG009|Overall Study|PCR positive at Week 68|0|||
145568338|NCT02641379|524940622|FG010|Overall Study|PCR positive at Week 68|0|||
145568339|NCT02641379|524940612|FG000|Overall Study|PCR positive at Week 48|0|||
145568340|NCT02641379|524940613|FG001|Overall Study|PCR positive at Week 48|1|||
145568341|NCT02641379|524940614|FG002|Overall Study|PCR positive at Week 48|0|||
145568342|NCT02641379|524940615|FG003|Overall Study|PCR positive at Week 48|0|||
145568343|NCT02641379|524940616|FG004|Overall Study|PCR positive at Week 48|0|||
145568344|NCT02641379|524940617|FG005|Overall Study|PCR positive at Week 48|0|||
145568345|NCT02641379|524940618|FG006|Overall Study|PCR positive at Week 48|0|||
145568346|NCT02641379|524940619|FG007|Overall Study|PCR positive at Week 48|0|||
145568347|NCT02641379|524940620|FG008|Overall Study|PCR positive at Week 48|0|||
145568348|NCT02641379|524940621|FG009|Overall Study|PCR positive at Week 48|0|||
145300959|NCT00272779|523954908|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
145300960|NCT00272779|523954907|FG000|Baseline Through Week 48|Continuing treatment|385|||
145300961|NCT00272779|523954908|FG001|Baseline Through Week 48|Continuing treatment|368|||
145300962|NCT00272779|523954907|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
145300963|NCT00272779|523954908|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
145300964|NCT00272779|523954907|FG000|Baseline Through Week 48|Never treated|2|||
145300965|NCT00272779|523954908|FG001|Baseline Through Week 48|Never treated|3|||
145300966|NCT00272779|523954907|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
145300967|NCT00272779|523954908|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
145300968|NCT00272779|523954907|FG000|Baseline Through Week 96|Death before Week 96|6|||
145300969|NCT00272779|523954908|FG001|Baseline Through Week 96|Death before Week 96|5|||
145568349|NCT02641379|524940622|FG010|Overall Study|PCR positive at Week 48|0|||
145568350|NCT02641379|524940612|FG000|Overall Study|PCR not performed at Week 12|0|||
145568351|NCT02641379|524940613|FG001|Overall Study|PCR not performed at Week 12|0|||
145568352|NCT02641379|524940614|FG002|Overall Study|PCR not performed at Week 12|1|||
145568353|NCT02641379|524940615|FG003|Overall Study|PCR not performed at Week 12|0|||
145568354|NCT02641379|524940616|FG004|Overall Study|PCR not performed at Week 12|0|||
145568355|NCT02641379|524940617|FG005|Overall Study|PCR not performed at Week 12|0|||
145568356|NCT02641379|524940618|FG006|Overall Study|PCR not performed at Week 12|0|||
145568357|NCT02641379|524940619|FG007|Overall Study|PCR not performed at Week 12|0|||
145568358|NCT02641379|524940620|FG008|Overall Study|PCR not performed at Week 12|0|||
145568359|NCT02641379|524940621|FG009|Overall Study|PCR not performed at Week 12|0|||
145568360|NCT02641379|524940622|FG010|Overall Study|PCR not performed at Week 12|0|||
145568361|NCT02641379|524940612|FG000|Overall Study|No PCR at baseline|0|||
145568362|NCT02641379|524940613|FG001|Overall Study|No PCR at baseline|0|||
145568363|NCT02641379|524940614|FG002|Overall Study|No PCR at baseline|1|||
145568364|NCT02641379|524940615|FG003|Overall Study|No PCR at baseline|0|||
145568365|NCT02641379|524940616|FG004|Overall Study|No PCR at baseline|0|||
145568366|NCT02641379|524940617|FG005|Overall Study|No PCR at baseline|0|||
145568367|NCT02641379|524940618|FG006|Overall Study|No PCR at baseline|0|||
145568368|NCT02641379|524940619|FG007|Overall Study|No PCR at baseline|0|||
145568369|NCT02641379|524940620|FG008|Overall Study|No PCR at baseline|0|||
145300970|NCT00272779|523954907|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
145300971|NCT00272779|523954908|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
145300972|NCT00272779|523954907|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
145568370|NCT02641379|524940621|FG009|Overall Study|No PCR at baseline|0|||
145568371|NCT02641379|524940622|FG010|Overall Study|No PCR at baseline|0|||
145568372|NCT02641379|524940612|FG000|Overall Study|PCR positive at Week 28|0|||
145568373|NCT02641379|524940613|FG001|Overall Study|PCR positive at Week 28|0|||
145568374|NCT02641379|524940614|FG002|Overall Study|PCR positive at Week 28|1|||
145568375|NCT02641379|524940615|FG003|Overall Study|PCR positive at Week 28|0|||
145568376|NCT02641379|524940616|FG004|Overall Study|PCR positive at Week 28|0|||
145568377|NCT02641379|524940617|FG005|Overall Study|PCR positive at Week 28|0|||
145568378|NCT02641379|524940618|FG006|Overall Study|PCR positive at Week 28|0|||
145410760|NCT02903914|524356847|FG002|Overall Study|Lost to Follow-up|0|||
145568379|NCT02641379|524940619|FG007|Overall Study|PCR positive at Week 28|0|||
145568380|NCT02641379|524940620|FG008|Overall Study|PCR positive at Week 28|0|||
145568381|NCT02641379|524940621|FG009|Overall Study|PCR positive at Week 28|0|||
145568382|NCT02641379|524940622|FG010|Overall Study|PCR positive at Week 28|0|||
145568383|NCT02641379|524940612|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
145568384|NCT02641379|524940613|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
145300973|NCT00272779|523954908|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
145410761|NCT02903914|524356848|FG003|Overall Study|Lost to Follow-up|0|||
145410762|NCT02903914|524356849|FG004|Overall Study|Lost to Follow-up|2|||
145410763|NCT02903914|524356850|FG005|Overall Study|Lost to Follow-up|0|||
145410764|NCT02903914|524356851|FG006|Overall Study|Lost to Follow-up|1|||
145568385|NCT02641379|524940614|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
145620273|NCT00885495|525123728|FG000|Overall Study|Protocol Violation|0|||
145568386|NCT02641379|524940615|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
145568387|NCT02641379|524940616|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
145568388|NCT02641379|524940617|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
145568389|NCT02641379|524940618|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
145568390|NCT02641379|524940619|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
145568391|NCT02641379|524940620|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
145257214|NCT03890731|523787370|FG000|Overall Study|Adverse Event|4|||
145257215|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
145257216|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
145257217|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
145257218|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
145257219|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
145257220|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
145257221|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
145257222|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
145257223|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
145257224|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
145257225|NCT02528643|523787371|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
145257226|NCT02528643|523787372|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
145257227|NCT02528643|523787371|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
145257228|NCT02528643|523787372|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
145257229|NCT01640353|523787377|FG000|Overall Study|Withdrew prior to treatment|10|||
145257230|NCT01640353|523787377|FG000|Overall Study|Withdrawn from analysis at term site|12|||
145257231|NCT01640353|523787377|FG000|Overall Study|Withdrawal by Subject|5|||
145257232|NCT01640353|523787377|FG000|Overall Study|Death|2|||
145257233|NCT01640353|523787377|FG000|Overall Study|Early site termination|3|||
145257234|NCT01640353|523787377|FG000|Overall Study|Lost to Follow-up|12|||
145257235|NCT01640353|523787377|FG000|Overall Study|Physician Decision|1|||
145257236|NCT03758612|523787378|FG000|Washout Period|Withdrawal by Subject|0|||
145257237|NCT03758612|523787379|FG001|Washout Period|Withdrawal by Subject|0|||
145257238|NCT03758612|523787380|FG002|Washout Period|Withdrawal by Subject|2|||
145257239|NCT03758612|523787381|FG003|Washout Period|Withdrawal by Subject|0|||
145257240|NCT03758612|523787382|FG004|Washout Period|Withdrawal by Subject|0|||
145257241|NCT03758612|523787383|FG005|Washout Period|Withdrawal by Subject|0|||
145257242|NCT03758612|523787384|FG006|Washout Period|Withdrawal by Subject|0|||
145257243|NCT03758612|523787385|FG007|Washout Period|Withdrawal by Subject|0|||
145257244|NCT03758612|523787386|FG008|Washout Period|Withdrawal by Subject|0|||
145257245|NCT03758612|523787387|FG009|Washout Period|Withdrawal by Subject|0|||
145257246|NCT03758612|523787388|FG010|Washout Period|Withdrawal by Subject|0|||
145257247|NCT03758612|523787389|FG011|Washout Period|Withdrawal by Subject|0|||
145257248|NCT03758612|523787378|FG000|Period 2|Protocol Violation|0|||
145257249|NCT03758612|523787379|FG001|Period 2|Protocol Violation|0|||
145257250|NCT03758612|523787380|FG002|Period 2|Protocol Violation|0|||
145257251|NCT03758612|523787381|FG003|Period 2|Protocol Violation|0|||
145257252|NCT03758612|523787382|FG004|Period 2|Protocol Violation|1|||
145300974|NCT00272779|523954907|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
145300975|NCT00272779|523954908|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
145300976|NCT00272779|523954907|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
145300977|NCT00272779|523954908|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
145300978|NCT00272779|523954907|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
145300979|NCT00272779|523954908|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
145300980|NCT00272779|523954907|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
145300981|NCT00272779|523954908|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
145300982|NCT00272779|523954907|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
145410765|NCT02903914|524356852|FG007|Overall Study|Lost to Follow-up|0|||
145257253|NCT03758612|523787383|FG005|Period 2|Protocol Violation|0|||
145257254|NCT03758612|523787384|FG006|Period 2|Protocol Violation|0|||
145257255|NCT03758612|523787385|FG007|Period 2|Protocol Violation|0|||
145257256|NCT03758612|523787386|FG008|Period 2|Protocol Violation|0|||
145257257|NCT03758612|523787387|FG009|Period 2|Protocol Violation|0|||
145257258|NCT03758612|523787388|FG010|Period 2|Protocol Violation|0|||
145257259|NCT03758612|523787389|FG011|Period 2|Protocol Violation|0|||
145300983|NCT00272779|523954908|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
145300984|NCT00272779|523954907|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
145568392|NCT02641379|524940621|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
145568393|NCT02641379|524940622|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
145257260|NCT03812224|523787396|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
145257261|NCT03812224|523787397|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145257262|NCT03812224|523787396|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
145257263|NCT03812224|523787397|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
145257264|NCT03812224|523787396|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
145257265|NCT03812224|523787397|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
145257266|NCT03812224|523787396|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
145257267|NCT03812224|523787397|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
145257268|NCT00303719|523787398|FG000|Overall Study|Not evaluable, prior therapies|0|||
145257269|NCT00303719|523787399|FG001|Overall Study|Not evaluable, prior therapies|30|||
145257270|NCT00303719|523787398|FG000|Overall Study|Lost to Follow-up|0|||
145257271|NCT00303719|523787399|FG001|Overall Study|Lost to Follow-up|7|||
145257272|NCT01641952|523787400|FG000|Overall Study|Lost to Follow-up|28|||
145257273|NCT01641952|523787400|FG000|Overall Study|Adverse Event|6|||
145257274|NCT02500901|523787403|FG000|Overall Study|Disease ProgressionDD|2|||
145257275|NCT01904760|523787414|FG000|Overall Study|Protocol Violation|1|||
145257276|NCT01904760|523787415|FG001|Overall Study|Protocol Violation|0|||
145257277|NCT04249076|523787425|FG000|Overall Study|Adverse Event|1|||
145257278|NCT04249076|523787426|FG001|Overall Study|Adverse Event|1|||
145257279|NCT04249076|523787425|FG000|Overall Study|Protocol Violation|1|||
145257280|NCT04249076|523787426|FG001|Overall Study|Protocol Violation|2|||
145257281|NCT04249076|523787425|FG000|Overall Study|Lack of Efficacy|0|||
145257282|NCT04249076|523787426|FG001|Overall Study|Lack of Efficacy|1|||
145257283|NCT04249076|523787425|FG000|Overall Study|Withdrawal by Subject|0|||
145257284|NCT04249076|523787426|FG001|Overall Study|Withdrawal by Subject|1|||
145257285|NCT00783263|523787427|FG000|Overall Study|Adverse Event|3|||
145257286|NCT00783263|523787428|FG001|Overall Study|Adverse Event|0|||
145257287|NCT00783263|523787429|FG002|Overall Study|Adverse Event|2|||
145257288|NCT00783263|523787430|FG003|Overall Study|Adverse Event|1|||
145257289|NCT00783263|523787427|FG000|Overall Study|Lost to Follow-up|1|||
145257290|NCT00783263|523787428|FG001|Overall Study|Lost to Follow-up|1|||
145257291|NCT00783263|523787429|FG002|Overall Study|Lost to Follow-up|0|||
145257292|NCT00783263|523787430|FG003|Overall Study|Lost to Follow-up|0|||
145257293|NCT00783263|523787427|FG000|Overall Study|Withdrawal by Subject|0|||
145257294|NCT00783263|523787428|FG001|Overall Study|Withdrawal by Subject|1|||
145257295|NCT00783263|523787429|FG002|Overall Study|Withdrawal by Subject|1|||
145257296|NCT00783263|523787430|FG003|Overall Study|Withdrawal by Subject|2|||
145257297|NCT00106626|523787431|FG000|Overall Study|Adverse Event|5|||
145257298|NCT00106626|523787432|FG001|Overall Study|Adverse Event|4|||
145257299|NCT00106626|523787433|FG002|Overall Study|Adverse Event|3|||
145257300|NCT00106626|523787434|FG003|Overall Study|Adverse Event|3|||
145257301|NCT00106626|523787431|FG000|Overall Study|Progressive Disease|4|||
145257302|NCT00106626|523787432|FG001|Overall Study|Progressive Disease|1|||
145257303|NCT00106626|523787433|FG002|Overall Study|Progressive Disease|9|||
145257304|NCT00106626|523787434|FG003|Overall Study|Progressive Disease|10|||
145257305|NCT00106626|523787431|FG000|Overall Study|Received radiation on new therapy|1|||
145257306|NCT00106626|523787432|FG001|Overall Study|Received radiation on new therapy|0|||
145257307|NCT00106626|523787433|FG002|Overall Study|Received radiation on new therapy|0|||
145257308|NCT00106626|523787434|FG003|Overall Study|Received radiation on new therapy|0|||
145257309|NCT00106626|523787431|FG000|Overall Study|> 14 day delay in therapy start|0|||
145257310|NCT00106626|523787432|FG001|Overall Study|> 14 day delay in therapy start|1|||
145257311|NCT00106626|523787433|FG002|Overall Study|> 14 day delay in therapy start|0|||
145257312|NCT00106626|523787434|FG003|Overall Study|> 14 day delay in therapy start|0|||
145257313|NCT00405756|523787439|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
145257314|NCT00405756|523787440|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
145257315|NCT00405756|523787441|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
145257316|NCT00405756|523787439|FG000|Double-blind Treatment|Adverse Event|31|||
145257317|NCT00405756|523787440|FG001|Double-blind Treatment|Adverse Event|27|||
145257318|NCT00405756|523787441|FG002|Double-blind Treatment|Adverse Event|12|||
145257319|NCT00405756|523787439|FG000|Double-blind Treatment|Disease Progression|47|||
145257320|NCT00405756|523787440|FG001|Double-blind Treatment|Disease Progression|81|||
145257321|NCT00405756|523787441|FG002|Double-blind Treatment|Disease Progression|102|||
145257322|NCT00405756|523787439|FG000|Double-blind Treatment|Lack of Efficacy|1|||
145257323|NCT00405756|523787440|FG001|Double-blind Treatment|Lack of Efficacy|4|||
145257324|NCT00405756|523787441|FG002|Double-blind Treatment|Lack of Efficacy|2|||
145257325|NCT00405756|523787439|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
145257326|NCT00405756|523787440|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
145257327|NCT00405756|523787441|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
145257328|NCT00405756|523787439|FG000|Double-blind Treatment|Lost to Follow-up|1|||
145257329|NCT00405756|523787440|FG001|Double-blind Treatment|Lost to Follow-up|0|||
145257330|NCT00405756|523787441|FG002|Double-blind Treatment|Lost to Follow-up|0|||
145257331|NCT00405756|523787439|FG000|Double-blind Treatment|Death|4|||
145257332|NCT00405756|523787440|FG001|Double-blind Treatment|Death|4|||
145257333|NCT00405756|523787441|FG002|Double-blind Treatment|Death|4|||
145257334|NCT00405756|523787439|FG000|Double-blind Treatment|Protocol Violation|1|||
145257335|NCT00405756|523787440|FG001|Double-blind Treatment|Protocol Violation|0|||
145257336|NCT00405756|523787441|FG002|Double-blind Treatment|Protocol Violation|2|||
145257337|NCT00405756|523787439|FG000|Double-blind Treatment|Other|7|||
145257338|NCT00405756|523787440|FG001|Double-blind Treatment|Other|4|||
145257339|NCT00405756|523787441|FG002|Double-blind Treatment|Other|4|||
145257340|NCT00405756|523787439|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
145568394|NCT02641379|524940612|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
145568395|NCT02641379|524940613|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
145568396|NCT02641379|524940614|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
145568397|NCT02641379|524940615|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
145257341|NCT00405756|523787440|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
145257342|NCT00405756|523787441|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
145568398|NCT02641379|524940616|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
145257343|NCT00405756|523787439|FG000|Open-label Extension|Adverse Event|1|||
145257344|NCT00405756|523787440|FG001|Open-label Extension|Adverse Event|3|||
145257345|NCT00405756|523787441|FG002|Open-label Extension|Adverse Event|7|||
145257346|NCT00405756|523787439|FG000|Open-label Extension|Disease Progression|8|||
145257347|NCT00405756|523787440|FG001|Open-label Extension|Disease Progression|23|||
145257348|NCT00405756|523787441|FG002|Open-label Extension|Disease Progression|26|||
145257349|NCT00405756|523787439|FG000|Open-label Extension|Withdrawal by Subject|2|||
145257350|NCT00405756|523787440|FG001|Open-label Extension|Withdrawal by Subject|3|||
145257351|NCT00405756|523787441|FG002|Open-label Extension|Withdrawal by Subject|3|||
145257352|NCT00405756|523787439|FG000|Open-label Extension|Death|1|||
145257353|NCT00405756|523787440|FG001|Open-label Extension|Death|2|||
145257354|NCT00405756|523787441|FG002|Open-label Extension|Death|4|||
145257355|NCT00405756|523787439|FG000|Open-label Extension|Other|0|||
145257356|NCT00405756|523787440|FG001|Open-label Extension|Other|1|||
145257357|NCT00405756|523787441|FG002|Open-label Extension|Other|7|||
145257358|NCT00405756|523787439|FG000|Follow-up|Ongoing in Follow-up Period|52|||
145257359|NCT00405756|523787440|FG001|Follow-up|Ongoing in Follow-up Period|51|||
145257360|NCT00405756|523787441|FG002|Follow-up|Ongoing in Follow-up Period|60|||
145257361|NCT00405756|523787439|FG000|Follow-up|Death|21|||
145257362|NCT00405756|523787440|FG001|Follow-up|Death|31|||
145257363|NCT00405756|523787441|FG002|Follow-up|Death|24|||
145257364|NCT00405756|523787439|FG000|Follow-up|Lost to Follow-up|2|||
145257365|NCT00405756|523787440|FG001|Follow-up|Lost to Follow-up|8|||
145257366|NCT00405756|523787441|FG002|Follow-up|Lost to Follow-up|4|||
145257367|NCT01117428|523787443|FG000|Overall Study|Lack of Efficacy|1|||
145257368|NCT01117428|523787444|FG001|Overall Study|Lack of Efficacy|0|||
145257369|NCT01117428|523787445|FG002|Overall Study|Lack of Efficacy|0|||
145257370|NCT01117428|523787446|FG003|Overall Study|Lack of Efficacy|0|||
145257371|NCT01117428|523787447|FG004|Overall Study|Lack of Efficacy|0|||
145257372|NCT01117428|523787448|FG005|Overall Study|Lack of Efficacy|0|||
145257373|NCT01117428|523787443|FG000|Overall Study|Adverse Event|4|||
145257374|NCT01117428|523787444|FG001|Overall Study|Adverse Event|0|||
145257375|NCT01117428|523787445|FG002|Overall Study|Adverse Event|0|||
145257376|NCT01117428|523787446|FG003|Overall Study|Adverse Event|0|||
145257377|NCT01117428|523787447|FG004|Overall Study|Adverse Event|1|||
145257378|NCT01117428|523787448|FG005|Overall Study|Adverse Event|2|||
145257379|NCT01117428|523787443|FG000|Overall Study|Death|0|||
145257380|NCT01117428|523787444|FG001|Overall Study|Death|1|||
145257381|NCT01117428|523787445|FG002|Overall Study|Death|2|||
145257382|NCT01117428|523787446|FG003|Overall Study|Death|0|||
145257383|NCT01117428|523787447|FG004|Overall Study|Death|0|||
145257384|NCT01117428|523787448|FG005|Overall Study|Death|1|||
145257385|NCT01117428|523787443|FG000|Overall Study|Physician Decision|0|||
145257386|NCT01117428|523787444|FG001|Overall Study|Physician Decision|1|||
145257387|NCT01117428|523787445|FG002|Overall Study|Physician Decision|0|||
145257388|NCT01117428|523787446|FG003|Overall Study|Physician Decision|0|||
145257389|NCT01117428|523787447|FG004|Overall Study|Physician Decision|0|||
145257390|NCT01117428|523787448|FG005|Overall Study|Physician Decision|0|||
145257391|NCT01117428|523787443|FG000|Overall Study|Withdrawal by Subject|0|||
145257392|NCT01117428|523787444|FG001|Overall Study|Withdrawal by Subject|0|||
145257393|NCT01117428|523787445|FG002|Overall Study|Withdrawal by Subject|1|||
145257394|NCT01117428|523787446|FG003|Overall Study|Withdrawal by Subject|0|||
145257395|NCT01117428|523787447|FG004|Overall Study|Withdrawal by Subject|0|||
145257396|NCT01117428|523787448|FG005|Overall Study|Withdrawal by Subject|0|||
145257397|NCT01117428|523787443|FG000|Overall Study|Progressive disease|15|||
145257398|NCT01117428|523787444|FG001|Overall Study|Progressive disease|27|||
145257399|NCT01117428|523787445|FG002|Overall Study|Progressive disease|10|||
145257400|NCT01117428|523787446|FG003|Overall Study|Progressive disease|12|||
145257401|NCT01117428|523787447|FG004|Overall Study|Progressive disease|16|||
145257402|NCT01117428|523787448|FG005|Overall Study|Progressive disease|17|||
145300985|NCT00272779|523954908|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
145568399|NCT02641379|524940617|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
145568400|NCT02641379|524940618|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
145568401|NCT02641379|524940619|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
145257403|NCT02519777|523787449|FG000|Overall Study|Death|1|||
145257404|NCT02519777|523787450|FG001|Overall Study|Death|0|||
145257405|NCT02519777|523787451|FG002|Overall Study|Death|0|||
145257406|NCT02519777|523787449|FG000|Overall Study|Lost to Follow-up|0|||
145257407|NCT02519777|523787450|FG001|Overall Study|Lost to Follow-up|4|||
145257408|NCT02519777|523787451|FG002|Overall Study|Lost to Follow-up|2|||
145257409|NCT02519777|523787449|FG000|Overall Study|Withdrawal by Subject|3|||
145257410|NCT02519777|523787450|FG001|Overall Study|Withdrawal by Subject|1|||
145257411|NCT02519777|523787451|FG002|Overall Study|Withdrawal by Subject|0|||
145257412|NCT02519777|523787449|FG000|Overall Study|Severe Debilitation|1|||
145257413|NCT02519777|523787450|FG001|Overall Study|Severe Debilitation|1|||
145257414|NCT02519777|523787451|FG002|Overall Study|Severe Debilitation|1|||
145568402|NCT02641379|524940620|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
145568403|NCT02641379|524940621|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
145568404|NCT02641379|524940622|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
145568405|NCT02641379|524940612|FG000|Overall Study|Baseline viral load unavailable|0|||
145568406|NCT02641379|524940613|FG001|Overall Study|Baseline viral load unavailable|0|||
145568407|NCT02641379|524940614|FG002|Overall Study|Baseline viral load unavailable|0|||
145568408|NCT02641379|524940615|FG003|Overall Study|Baseline viral load unavailable|1|||
145568409|NCT02641379|524940616|FG004|Overall Study|Baseline viral load unavailable|0|||
145568410|NCT02641379|524940617|FG005|Overall Study|Baseline viral load unavailable|0|||
145568411|NCT02641379|524940618|FG006|Overall Study|Baseline viral load unavailable|0|||
145568412|NCT02641379|524940619|FG007|Overall Study|Baseline viral load unavailable|0|||
145568413|NCT02641379|524940620|FG008|Overall Study|Baseline viral load unavailable|0|||
145568414|NCT02641379|524940621|FG009|Overall Study|Baseline viral load unavailable|0|||
145568415|NCT02641379|524940622|FG010|Overall Study|Baseline viral load unavailable|0|||
145568416|NCT02641379|524940612|FG000|Overall Study|Blood could not be drawn|0|||
145568417|NCT02641379|524940613|FG001|Overall Study|Blood could not be drawn|0|||
145568418|NCT02641379|524940614|FG002|Overall Study|Blood could not be drawn|0|||
145568419|NCT02641379|524940615|FG003|Overall Study|Blood could not be drawn|0|||
145568420|NCT02641379|524940616|FG004|Overall Study|Blood could not be drawn|1|||
145568421|NCT02641379|524940617|FG005|Overall Study|Blood could not be drawn|0|||
145568422|NCT02641379|524940618|FG006|Overall Study|Blood could not be drawn|0|||
145568423|NCT02641379|524940619|FG007|Overall Study|Blood could not be drawn|0|||
145568424|NCT02641379|524940620|FG008|Overall Study|Blood could not be drawn|0|||
145568425|NCT02641379|524940621|FG009|Overall Study|Blood could not be drawn|0|||
145568426|NCT02641379|524940622|FG010|Overall Study|Blood could not be drawn|0|||
145568427|NCT02641379|524940612|FG000|Overall Study|Protocol Violation|0|||
145568428|NCT02641379|524940613|FG001|Overall Study|Protocol Violation|0|||
145568429|NCT02641379|524940614|FG002|Overall Study|Protocol Violation|0|||
145568430|NCT02641379|524940615|FG003|Overall Study|Protocol Violation|0|||
145568431|NCT02641379|524940616|FG004|Overall Study|Protocol Violation|2|||
145568432|NCT02641379|524940617|FG005|Overall Study|Protocol Violation|0|||
145568433|NCT02641379|524940618|FG006|Overall Study|Protocol Violation|0|||
145568434|NCT02641379|524940619|FG007|Overall Study|Protocol Violation|0|||
145568435|NCT02641379|524940620|FG008|Overall Study|Protocol Violation|1|||
145568436|NCT02641379|524940621|FG009|Overall Study|Protocol Violation|0|||
145568437|NCT02641379|524940622|FG010|Overall Study|Protocol Violation|0|||
145568438|NCT02641379|524940612|FG000|Overall Study|Participation in sili rescue study|0|||
145568439|NCT02641379|524940613|FG001|Overall Study|Participation in sili rescue study|0|||
145568440|NCT02641379|524940614|FG002|Overall Study|Participation in sili rescue study|0|||
145568441|NCT02641379|524940615|FG003|Overall Study|Participation in sili rescue study|0|||
145568442|NCT02641379|524940616|FG004|Overall Study|Participation in sili rescue study|0|||
145568443|NCT02641379|524940617|FG005|Overall Study|Participation in sili rescue study|1|||
145568444|NCT02641379|524940618|FG006|Overall Study|Participation in sili rescue study|0|||
145568445|NCT02641379|524940619|FG007|Overall Study|Participation in sili rescue study|0|||
145568446|NCT02641379|524940620|FG008|Overall Study|Participation in sili rescue study|0|||
145568447|NCT02641379|524940621|FG009|Overall Study|Participation in sili rescue study|0|||
145568448|NCT02641379|524940622|FG010|Overall Study|Participation in sili rescue study|0|||
145568449|NCT02641379|524940612|FG000|Overall Study|Lost to Follow-up|0|||
145568450|NCT02641379|524940613|FG001|Overall Study|Lost to Follow-up|0|||
145568451|NCT02641379|524940614|FG002|Overall Study|Lost to Follow-up|0|||
145568452|NCT02641379|524940615|FG003|Overall Study|Lost to Follow-up|0|||
145568453|NCT02641379|524940616|FG004|Overall Study|Lost to Follow-up|0|||
145568454|NCT02641379|524940617|FG005|Overall Study|Lost to Follow-up|0|||
145568455|NCT02641379|524940618|FG006|Overall Study|Lost to Follow-up|0|||
145568456|NCT02641379|524940619|FG007|Overall Study|Lost to Follow-up|0|||
145568457|NCT02641379|524940620|FG008|Overall Study|Lost to Follow-up|1|||
145568458|NCT02641379|524940621|FG009|Overall Study|Lost to Follow-up|0|||
145568459|NCT02641379|524940622|FG010|Overall Study|Lost to Follow-up|0|||
145568460|NCT02641379|524940612|FG000|Overall Study|Source data not found|0|||
145568461|NCT02641379|524940613|FG001|Overall Study|Source data not found|0|||
145568462|NCT02641379|524940614|FG002|Overall Study|Source data not found|0|||
145568463|NCT02641379|524940615|FG003|Overall Study|Source data not found|0|||
145568464|NCT02641379|524940616|FG004|Overall Study|Source data not found|0|||
145568465|NCT02641379|524940617|FG005|Overall Study|Source data not found|1|||
145568466|NCT02641379|524940618|FG006|Overall Study|Source data not found|0|||
145257415|NCT02519777|523787449|FG000|Overall Study|Not able to get to clinic|1|||
145257416|NCT02519777|523787450|FG001|Overall Study|Not able to get to clinic|2|||
145257417|NCT02519777|523787451|FG002|Overall Study|Not able to get to clinic|1|||
145568467|NCT02641379|524940619|FG007|Overall Study|Source data not found|0|||
145568468|NCT02641379|524940620|FG008|Overall Study|Source data not found|0|||
145568469|NCT02641379|524940621|FG009|Overall Study|Source data not found|0|||
145568470|NCT02641379|524940622|FG010|Overall Study|Source data not found|0|||
145568471|NCT02641379|524940612|FG000|Overall Study|Participant showed weight reduction|0|||
145568472|NCT02641379|524940613|FG001|Overall Study|Participant showed weight reduction|0|||
145568473|NCT02641379|524940614|FG002|Overall Study|Participant showed weight reduction|0|||
145568474|NCT02641379|524940615|FG003|Overall Study|Participant showed weight reduction|0|||
145568475|NCT02641379|524940616|FG004|Overall Study|Participant showed weight reduction|0|||
145568476|NCT02641379|524940617|FG005|Overall Study|Participant showed weight reduction|0|||
145568477|NCT02641379|524940618|FG006|Overall Study|Participant showed weight reduction|0|||
145568478|NCT02641379|524940619|FG007|Overall Study|Participant showed weight reduction|1|||
145568479|NCT02641379|524940620|FG008|Overall Study|Participant showed weight reduction|0|||
145568480|NCT02641379|524940621|FG009|Overall Study|Participant showed weight reduction|0|||
145568481|NCT02641379|524940622|FG010|Overall Study|Participant showed weight reduction|0|||
145568482|NCT02641379|524940612|FG000|Overall Study|Non-response Week 12|0|||
145568483|NCT02641379|524940613|FG001|Overall Study|Non-response Week 12|0|||
145568484|NCT02641379|524940614|FG002|Overall Study|Non-response Week 12|0|||
145568485|NCT02641379|524940615|FG003|Overall Study|Non-response Week 12|0|||
145568486|NCT02641379|524940616|FG004|Overall Study|Non-response Week 12|0|||
145568487|NCT02641379|524940617|FG005|Overall Study|Non-response Week 12|0|||
145568488|NCT02641379|524940618|FG006|Overall Study|Non-response Week 12|0|||
145568489|NCT02641379|524940619|FG007|Overall Study|Non-response Week 12|1|||
145568490|NCT02641379|524940620|FG008|Overall Study|Non-response Week 12|0|||
145568491|NCT02641379|524940621|FG009|Overall Study|Non-response Week 12|0|||
145568492|NCT02641379|524940622|FG010|Overall Study|Non-response Week 12|0|||
145568493|NCT02641379|524940612|FG000|Overall Study|No 2 Log drop at Week 12|0|||
145568494|NCT02641379|524940613|FG001|Overall Study|No 2 Log drop at Week 12|0|||
145568495|NCT02641379|524940614|FG002|Overall Study|No 2 Log drop at Week 12|0|||
145568496|NCT02641379|524940615|FG003|Overall Study|No 2 Log drop at Week 12|0|||
145568497|NCT02641379|524940616|FG004|Overall Study|No 2 Log drop at Week 12|0|||
145568498|NCT02641379|524940617|FG005|Overall Study|No 2 Log drop at Week 12|0|||
145568499|NCT02641379|524940618|FG006|Overall Study|No 2 Log drop at Week 12|0|||
145568500|NCT02641379|524940619|FG007|Overall Study|No 2 Log drop at Week 12|0|||
145568501|NCT02641379|524940620|FG008|Overall Study|No 2 Log drop at Week 12|0|||
145568502|NCT02641379|524940621|FG009|Overall Study|No 2 Log drop at Week 12|0|||
145568503|NCT02641379|524940622|FG010|Overall Study|No 2 Log drop at Week 12|1|||
145568504|NCT02641379|524940612|FG000|Overall Study|Negative PCR result|0|||
145568505|NCT02641379|524940613|FG001|Overall Study|Negative PCR result|0|||
145568506|NCT02641379|524940614|FG002|Overall Study|Negative PCR result|0|||
145568507|NCT02641379|524940615|FG003|Overall Study|Negative PCR result|0|||
145568508|NCT02641379|524940616|FG004|Overall Study|Negative PCR result|0|||
145568509|NCT02641379|524940617|FG005|Overall Study|Negative PCR result|0|||
145568510|NCT02641379|524940618|FG006|Overall Study|Negative PCR result|0|||
145568511|NCT02641379|524940619|FG007|Overall Study|Negative PCR result|0|||
145568512|NCT02641379|524940620|FG008|Overall Study|Negative PCR result|0|||
145568513|NCT02641379|524940621|FG009|Overall Study|Negative PCR result|1|||
145568514|NCT02641379|524940622|FG010|Overall Study|Negative PCR result|0|||
145568515|NCT02641379|524940612|FG000|Overall Study|Participant's PCR high|0|||
145568516|NCT02641379|524940613|FG001|Overall Study|Participant's PCR high|0|||
145568517|NCT02641379|524940614|FG002|Overall Study|Participant's PCR high|0|||
145568518|NCT02641379|524940615|FG003|Overall Study|Participant's PCR high|0|||
145568519|NCT02641379|524940616|FG004|Overall Study|Participant's PCR high|0|||
145568520|NCT02641379|524940617|FG005|Overall Study|Participant's PCR high|0|||
145568521|NCT02641379|524940618|FG006|Overall Study|Participant's PCR high|0|||
145568522|NCT02641379|524940619|FG007|Overall Study|Participant's PCR high|1|||
145568523|NCT02641379|524940620|FG008|Overall Study|Participant's PCR high|0|||
145568524|NCT02641379|524940621|FG009|Overall Study|Participant's PCR high|0|||
145568525|NCT02641379|524940622|FG010|Overall Study|Participant's PCR high|0|||
145568526|NCT02641379|524940612|FG000|Overall Study|Participant treated after Week 24|0|||
145568527|NCT02641379|524940613|FG001|Overall Study|Participant treated after Week 24|0|||
145568528|NCT02641379|524940614|FG002|Overall Study|Participant treated after Week 24|0|||
145568529|NCT02641379|524940615|FG003|Overall Study|Participant treated after Week 24|0|||
145257418|NCT02195531|523787452|FG000|Overall Study|Withdrawal by Subject|1|||
145257419|NCT02195531|523787453|FG001|Overall Study|Withdrawal by Subject|1|||
145257420|NCT02195531|523787454|FG002|Overall Study|Withdrawal by Subject|1|||
145257421|NCT01284127|523787458|FG000|Overall Study|Adverse Event|2|||
145410766|NCT02903914|524356845|FG000|Overall Study|Physician Decision|0|||
145568530|NCT02641379|524940616|FG004|Overall Study|Participant treated after Week 24|0|||
145568531|NCT02641379|524940617|FG005|Overall Study|Participant treated after Week 24|0|||
145568532|NCT02641379|524940618|FG006|Overall Study|Participant treated after Week 24|0|||
145568533|NCT02641379|524940619|FG007|Overall Study|Participant treated after Week 24|0|||
145568534|NCT02641379|524940620|FG008|Overall Study|Participant treated after Week 24|1|||
145568535|NCT02641379|524940621|FG009|Overall Study|Participant treated after Week 24|0|||
145568536|NCT02641379|524940622|FG010|Overall Study|Participant treated after Week 24|0|||
145257422|NCT01284127|523787458|FG000|Overall Study|Withdrawal by Subject|4|||
145257423|NCT01284127|523787458|FG000|Overall Study|Physician Decision|1|||
145568537|NCT02641379|524940612|FG000|Overall Study|Missing PCR result at Week 8|0|||
145568538|NCT02641379|524940613|FG001|Overall Study|Missing PCR result at Week 8|0|||
145568539|NCT02641379|524940614|FG002|Overall Study|Missing PCR result at Week 8|0|||
145568540|NCT02641379|524940615|FG003|Overall Study|Missing PCR result at Week 8|0|||
145568541|NCT02641379|524940616|FG004|Overall Study|Missing PCR result at Week 8|0|||
145568542|NCT02641379|524940617|FG005|Overall Study|Missing PCR result at Week 8|0|||
145568543|NCT02641379|524940618|FG006|Overall Study|Missing PCR result at Week 8|0|||
145568544|NCT02641379|524940619|FG007|Overall Study|Missing PCR result at Week 8|0|||
145568545|NCT02641379|524940620|FG008|Overall Study|Missing PCR result at Week 8|0|||
145568546|NCT02641379|524940621|FG009|Overall Study|Missing PCR result at Week 8|1|||
145568547|NCT02641379|524940622|FG010|Overall Study|Missing PCR result at Week 8|0|||
145568548|NCT02641379|524940612|FG000|Overall Study|PCR positive|0|||
145568549|NCT02641379|524940613|FG001|Overall Study|PCR positive|0|||
145568550|NCT02641379|524940614|FG002|Overall Study|PCR positive|0|||
145568551|NCT02641379|524940615|FG003|Overall Study|PCR positive|0|||
145568552|NCT02641379|524940616|FG004|Overall Study|PCR positive|0|||
145568553|NCT02641379|524940617|FG005|Overall Study|PCR positive|0|||
145568554|NCT02641379|524940618|FG006|Overall Study|PCR positive|1|||
145568555|NCT02641379|524940619|FG007|Overall Study|PCR positive|0|||
145568556|NCT02641379|524940620|FG008|Overall Study|PCR positive|0|||
145568557|NCT02641379|524940621|FG009|Overall Study|PCR positive|0|||
145568558|NCT02641379|524940622|FG010|Overall Study|PCR positive|0|||
145257424|NCT01683058|523787465|FG000|Overall Study|Lost to Follow-up|9|||
145257425|NCT01683058|523787465|FG000|Overall Study|Adverse Event|6|||
145257426|NCT01683058|523787465|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
145257427|NCT01683058|523787465|FG000|Overall Study|Withdrawal by Subject|7|||
145257428|NCT01683058|523787465|FG000|Overall Study|Lack of Efficacy|2|||
145257429|NCT04062240|523787466|FG000|Overall Study|equipment malfunction|1|||
145257430|NCT01957111|523787467|FG000|Overall Study|Withdrawal by Subject|1|||
145257431|NCT01957111|523787468|FG001|Overall Study|Withdrawal by Subject|1|||
145257432|NCT01057394|523787469|FG000|Overall Study|Not eligible|0|||
145257433|NCT01057394|523787470|FG001|Overall Study|Not eligible|2|||
145257434|NCT01195636|523787471|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
145257435|NCT01195636|523787472|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
145257436|NCT01195636|523787471|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
145257437|NCT01195636|523787472|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
145257438|NCT01195636|523787471|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145257439|NCT01195636|523787472|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
145257440|NCT01195636|523787471|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
145257441|NCT01195636|523787472|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
145257442|NCT01195636|523787471|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
145257443|NCT01195636|523787472|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
145257444|NCT01195636|523787471|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
145257445|NCT01195636|523787472|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
145257446|NCT01195636|523787471|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
145257447|NCT01195636|523787472|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
145257448|NCT01195636|523787471|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
145257449|NCT01195636|523787472|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
145257450|NCT03961529|523787473|FG000|Overall Study|Adverse Event|13|||
145257451|NCT03961529|523787474|FG001|Overall Study|Adverse Event|5|||
145257452|NCT03961529|523787475|FG002|Overall Study|Adverse Event|2|||
145257453|NCT03961529|523787473|FG000|Overall Study|Withdrawal by Subject|17|||
145257454|NCT03961529|523787474|FG001|Overall Study|Withdrawal by Subject|2|||
145257455|NCT03961529|523787475|FG002|Overall Study|Withdrawal by Subject|1|||
145257456|NCT03961529|523787473|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145257457|NCT03961529|523787474|FG001|Overall Study|Withdrawal by parent/guardian|7|||
145257458|NCT03961529|523787475|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145257459|NCT03961529|523787473|FG000|Overall Study|Physician Decision|2|||
145257460|NCT03961529|523787474|FG001|Overall Study|Physician Decision|1|||
145257461|NCT03961529|523787475|FG002|Overall Study|Physician Decision|1|||
145257462|NCT03961529|523787473|FG000|Overall Study|Lost to Follow-up|2|||
145257463|NCT03961529|523787474|FG001|Overall Study|Lost to Follow-up|1|||
145257464|NCT03961529|523787475|FG002|Overall Study|Lost to Follow-up|0|||
145257465|NCT03961529|523787473|FG000|Overall Study|Lack of Efficacy|2|||
145257466|NCT03961529|523787474|FG001|Overall Study|Lack of Efficacy|0|||
145257467|NCT03961529|523787475|FG002|Overall Study|Lack of Efficacy|1|||
145257468|NCT03961529|523787473|FG000|Overall Study|Other|6|||
145257469|NCT03961529|523787474|FG001|Overall Study|Other|1|||
145568559|NCT01165138|524940623|FG000|Overall Study|Adverse Event|0|||
145568560|NCT01165138|524940624|FG001|Overall Study|Adverse Event|1|||
145257470|NCT03961529|523787475|FG002|Overall Study|Other|0|||
145257471|NCT03644173|523787476|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
145410767|NCT02903914|524356846|FG001|Overall Study|Physician Decision|0|||
145568561|NCT01165138|524940625|FG002|Overall Study|Adverse Event|0|||
145568562|NCT01165138|524940626|FG003|Overall Study|Adverse Event|2|||
145257472|NCT03644173|523787476|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
145257473|NCT03644173|523787476|FG000|Participants at the 1-month Follow up|Death|2|||
145257474|NCT03644173|523787476|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
145257475|NCT03500419|523787479|FG000|Overall Study|Withdrawal by Subject|2|||
145257476|NCT03500419|523787480|FG001|Overall Study|Withdrawal by Subject|25|||
145257477|NCT00256204|523787494|FG000|Overall Study|Adverse Event|10|||
145257478|NCT00256204|523787495|FG001|Overall Study|Adverse Event|14|||
145257479|NCT00256204|523787496|FG002|Overall Study|Adverse Event|16|||
145257480|NCT00256204|523787497|FG003|Overall Study|Adverse Event|14|||
145257481|NCT00256204|523787494|FG000|Overall Study|Death|0|||
145257482|NCT00256204|523787495|FG001|Overall Study|Death|1|||
145257483|NCT00256204|523787496|FG002|Overall Study|Death|0|||
145257484|NCT00256204|523787497|FG003|Overall Study|Death|0|||
145257485|NCT00256204|523787494|FG000|Overall Study|Lost to Follow-up|1|||
145257486|NCT00256204|523787495|FG001|Overall Study|Lost to Follow-up|1|||
145257487|NCT00256204|523787496|FG002|Overall Study|Lost to Follow-up|1|||
145257488|NCT00256204|523787497|FG003|Overall Study|Lost to Follow-up|2|||
145257489|NCT00256204|523787494|FG000|Overall Study|Protocol Violation|1|||
145257490|NCT00256204|523787495|FG001|Overall Study|Protocol Violation|0|||
145257491|NCT00256204|523787496|FG002|Overall Study|Protocol Violation|2|||
145257492|NCT00256204|523787497|FG003|Overall Study|Protocol Violation|1|||
145257493|NCT00256204|523787494|FG000|Overall Study|Physician Decision|0|||
145257494|NCT00256204|523787495|FG001|Overall Study|Physician Decision|0|||
145257495|NCT00256204|523787496|FG002|Overall Study|Physician Decision|1|||
145257496|NCT00256204|523787497|FG003|Overall Study|Physician Decision|2|||
145257497|NCT00256204|523787494|FG000|Overall Study|Withdrawal by Subject|17|||
145257498|NCT00256204|523787495|FG001|Overall Study|Withdrawal by Subject|6|||
145257499|NCT00256204|523787496|FG002|Overall Study|Withdrawal by Subject|7|||
145257500|NCT00256204|523787497|FG003|Overall Study|Withdrawal by Subject|5|||
145257501|NCT00256204|523787494|FG000|Overall Study|Need for additional prohibited treatment|38|||
145257502|NCT00256204|523787495|FG001|Overall Study|Need for additional prohibited treatment|28|||
145257503|NCT00256204|523787496|FG002|Overall Study|Need for additional prohibited treatment|27|||
145257504|NCT00256204|523787497|FG003|Overall Study|Need for additional prohibited treatment|25|||
145257505|NCT00082628|523787498|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
145257506|NCT00082628|523787499|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
145257507|NCT00082628|523787500|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
145257508|NCT00082628|523787501|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
145257509|NCT00082628|523787502|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
145257510|NCT00082628|523787498|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
145257511|NCT00082628|523787499|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
145257512|NCT00082628|523787500|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
145257513|NCT00082628|523787501|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
145257514|NCT00082628|523787502|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
145257515|NCT00082628|523787498|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
145257516|NCT00082628|523787499|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
145257517|NCT00082628|523787500|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
145257518|NCT00082628|523787501|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
145257519|NCT00082628|523787502|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
145257520|NCT00082628|523787498|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
145257521|NCT00082628|523787499|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
145257522|NCT00082628|523787500|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
145257523|NCT00082628|523787501|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
145257524|NCT00082628|523787502|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
145257525|NCT00082628|523787498|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
145257526|NCT00082628|523787499|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
145257527|NCT00082628|523787500|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
145257528|NCT00082628|523787501|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
145257529|NCT00082628|523787502|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
145257530|NCT00082628|523787498|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
145257531|NCT00082628|523787499|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
145257532|NCT00082628|523787500|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
145257533|NCT00082628|523787501|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
145257534|NCT00082628|523787502|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
145257535|NCT00082628|523787498|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
145257536|NCT00082628|523787499|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
145257537|NCT00082628|523787500|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
145410768|NCT02903914|524356847|FG002|Overall Study|Physician Decision|1|||
145257538|NCT00082628|523787501|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
145257539|NCT00082628|523787502|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
145257540|NCT01234337|523787510|FG000|Overall Study|Adverse Event|58|||
145257541|NCT01234337|523787511|FG001|Overall Study|Adverse Event|21|||
145257542|NCT01234337|523787510|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
145257543|NCT01234337|523787511|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
145257544|NCT01234337|523787510|FG000|Overall Study|Investi. decision not protocol driven|5|||
145257545|NCT01234337|523787511|FG001|Overall Study|Investi. decision not protocol driven|6|||
145257546|NCT01234337|523787510|FG000|Overall Study|Non-compliant with study medication|3|||
145257547|NCT01234337|523787511|FG001|Overall Study|Non-compliant with study medication|2|||
145257548|NCT01234337|523787510|FG000|Overall Study|Randomized but not treated|6|||
145257549|NCT01234337|523787511|FG001|Overall Study|Randomized but not treated|4|||
145257550|NCT01234337|523787510|FG000|Overall Study|Lost to Follow-up|0|||
145257551|NCT01234337|523787511|FG001|Overall Study|Lost to Follow-up|1|||
145257552|NCT01234337|523787510|FG000|Overall Study|Protocol Violation|2|||
145257553|NCT01234337|523787511|FG001|Overall Study|Protocol Violation|3|||
145257554|NCT01234337|523787510|FG000|Overall Study|Withdrawal by Subject|11|||
145257555|NCT01234337|523787511|FG001|Overall Study|Withdrawal by Subject|9|||
145257556|NCT01234337|523787510|FG000|Overall Study|Death|0|||
145257557|NCT01234337|523787511|FG001|Overall Study|Death|1|||
145257558|NCT01234337|523787510|FG000|Overall Study|Switch to commercial drug|0|||
145257559|NCT01234337|523787511|FG001|Overall Study|Switch to commercial drug|1|||
145257560|NCT03481634|523787512|FG000|Overall Study|Withdrawal by Subject|16|||
145257561|NCT03481634|523787513|FG001|Overall Study|Withdrawal by Subject|19|||
145257562|NCT03481634|523787514|FG002|Overall Study|Withdrawal by Subject|14|||
145257563|NCT03481634|523787512|FG000|Overall Study|Protocol Violation|1|||
145257564|NCT03481634|523787513|FG001|Overall Study|Protocol Violation|0|||
145257565|NCT03481634|523787514|FG002|Overall Study|Protocol Violation|1|||
145257566|NCT03481634|523787512|FG000|Overall Study|Progressive disease|0|||
145257567|NCT03481634|523787513|FG001|Overall Study|Progressive disease|1|||
145257568|NCT03481634|523787514|FG002|Overall Study|Progressive disease|0|||
145257569|NCT03481634|523787512|FG000|Overall Study|Physician Decision|3|||
145257570|NCT03481634|523787513|FG001|Overall Study|Physician Decision|0|||
145257571|NCT03481634|523787514|FG002|Overall Study|Physician Decision|1|||
145257572|NCT03481634|523787512|FG000|Overall Study|Lost to Follow-up|3|||
145257573|NCT03481634|523787513|FG001|Overall Study|Lost to Follow-up|4|||
145257574|NCT03481634|523787514|FG002|Overall Study|Lost to Follow-up|4|||
145257575|NCT03481634|523787512|FG000|Overall Study|Death|4|||
145257576|NCT03481634|523787513|FG001|Overall Study|Death|8|||
145257577|NCT03481634|523787514|FG002|Overall Study|Death|7|||
145257578|NCT03481634|523787512|FG000|Overall Study|Adverse Event|6|||
145257579|NCT03481634|523787513|FG001|Overall Study|Adverse Event|3|||
145257580|NCT03481634|523787514|FG002|Overall Study|Adverse Event|7|||
145257581|NCT03490734|523787524|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
145257582|NCT03490734|523787525|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
145257583|NCT03490734|523787526|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
145257584|NCT03490734|523787527|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
145257585|NCT03490734|523787524|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
145257586|NCT03490734|523787525|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
145257587|NCT03490734|523787526|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
145257588|NCT03490734|523787527|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
145257589|NCT03490734|523787524|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
145257590|NCT03490734|523787525|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
145257591|NCT03490734|523787526|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
145257592|NCT03490734|523787527|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
145257593|NCT03490734|523787524|FG000|Post-intervention Scan Visit|Adverse Event|2|||
145257594|NCT03490734|523787525|FG001|Post-intervention Scan Visit|Adverse Event|0|||
145257595|NCT03490734|523787526|FG002|Post-intervention Scan Visit|Adverse Event|0|||
145257596|NCT03490734|523787527|FG003|Post-intervention Scan Visit|Adverse Event|0|||
145257597|NCT03490734|523787524|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
145257598|NCT03490734|523787525|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
145257599|NCT03490734|523787526|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
145257600|NCT03490734|523787527|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
145257601|NCT03490734|523787524|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
145257602|NCT03490734|523787525|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
145257603|NCT03490734|523787526|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
145257604|NCT03490734|523787527|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
145257605|NCT00994890|523787528|FG000|Overall Study|Adverse Event|13|||
145257606|NCT00994890|523787529|FG001|Overall Study|Adverse Event|9|||
145257607|NCT00994890|523787530|FG002|Overall Study|Adverse Event|11|||
145257608|NCT00994890|523787528|FG000|Overall Study|Lack of Efficacy|0|||
145257609|NCT00994890|523787529|FG001|Overall Study|Lack of Efficacy|0|||
145257610|NCT00994890|523787530|FG002|Overall Study|Lack of Efficacy|1|||
145257611|NCT00994890|523787528|FG000|Overall Study|Lost to Follow-up|6|||
145257612|NCT00994890|523787529|FG001|Overall Study|Lost to Follow-up|1|||
145257613|NCT00994890|523787530|FG002|Overall Study|Lost to Follow-up|3|||
145257614|NCT00994890|523787528|FG000|Overall Study|No longer willing to participate|8|||
145257615|NCT00994890|523787529|FG001|Overall Study|No longer willing to participate|5|||
145257616|NCT00994890|523787530|FG002|Overall Study|No longer willing to participate|13|||
145257617|NCT00994890|523787528|FG000|Overall Study|Protocol Violation|2|||
145257618|NCT00994890|523787529|FG001|Overall Study|Protocol Violation|4|||
145257619|NCT00994890|523787530|FG002|Overall Study|Protocol Violation|0|||
145257620|NCT00994890|523787528|FG000|Overall Study|Study terminated by sponsor|199|||
145257621|NCT00994890|523787529|FG001|Overall Study|Study terminated by sponsor|201|||
145257622|NCT00994890|523787530|FG002|Overall Study|Study terminated by sponsor|197|||
145257623|NCT00994890|523787528|FG000|Overall Study|Randomized, but not treated|1|||
145257624|NCT00994890|523787529|FG001|Overall Study|Randomized, but not treated|0|||
145257625|NCT00994890|523787530|FG002|Overall Study|Randomized, but not treated|0|||
145257626|NCT00994890|523787528|FG000|Overall Study|Other|2|||
145257627|NCT00994890|523787529|FG001|Overall Study|Other|2|||
145257628|NCT00994890|523787530|FG002|Overall Study|Other|1|||
145257629|NCT03323385|523787537|FG000|Overall Study|Withdrawal by Subject|1|||
145257630|NCT03323385|523787538|FG001|Overall Study|Withdrawal by Subject|2|||
145257631|NCT03323385|523787537|FG000|Overall Study|Noncompliance|0|||
145257632|NCT03323385|523787538|FG001|Overall Study|Noncompliance|1|||
145257633|NCT01849289|523787539|FG000|Overall Study|Adverse Event|3|||
145257634|NCT01849289|523787540|FG001|Overall Study|Adverse Event|3|||
145257635|NCT01849289|523787539|FG000|Overall Study|Protocol Violation|3|||
145257636|NCT01849289|523787540|FG001|Overall Study|Protocol Violation|3|||
145257637|NCT01849289|523787539|FG000|Overall Study|Withdrawal criteria|1|||
145257638|NCT01849289|523787540|FG001|Overall Study|Withdrawal criteria|0|||
145257639|NCT01849289|523787539|FG000|Overall Study|Unclassified|25|||
145257640|NCT01849289|523787540|FG001|Overall Study|Unclassified|18|||
145257641|NCT00352027|523787541|FG000|Overall Study|Progressive disease|3|||
145257642|NCT04491591|523787542|FG000|Overall Study|Accidently randomized|3|||
145257643|NCT04491591|523787543|FG001|Overall Study|Accidently randomized|1|||
145257644|NCT04491591|523787544|FG002|Overall Study|Accidently randomized|0|||
145257645|NCT04491591|523787542|FG000|Overall Study|Did not complete survey|28|||
145257646|NCT04491591|523787543|FG001|Overall Study|Did not complete survey|20|||
145257647|NCT04491591|523787544|FG002|Overall Study|Did not complete survey|3|||
145300986|NCT00272779|523954907|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
145300987|NCT00272779|523954908|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
145300988|NCT00272779|523954907|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
145300989|NCT00272779|523954908|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
145300990|NCT00272779|523954907|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
145300991|NCT00272779|523954908|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
145300992|NCT00272779|523954907|FG000|Baseline Through Week 96|Never treated|2|||
145300993|NCT00272779|523954908|FG001|Baseline Through Week 96|Never treated|3|||
145257648|NCT00660816|523787545|FG000|Overall Study|Adverse Event|1|||
145257649|NCT00660816|523787546|FG001|Overall Study|Adverse Event|2|||
145257650|NCT00660816|523787545|FG000|Overall Study|Withdrawal by Subject|1|||
145257651|NCT00660816|523787546|FG001|Overall Study|Withdrawal by Subject|0|||
145257652|NCT00660816|523787545|FG000|Overall Study|Death|0|||
145257653|NCT00660816|523787546|FG001|Overall Study|Death|2|||
145300994|NCT00272779|523954907|FG000|Baseline Through Week 96|Continuing on treatment|61|||
145300995|NCT00272779|523954908|FG001|Baseline Through Week 96|Continuing on treatment|38|||
145300996|NCT02440711|523954909|FG000|Second Intervention|Lost to Follow-up|1|||
145300997|NCT02440711|523954910|FG001|Second Intervention|Lost to Follow-up|0|||
145300998|NCT02146105|523954913|FG000|Overall Study|Adverse Event|1|||
145300999|NCT02146105|523954913|FG000|Overall Study|Withdrawal by Subject|5|||
145301000|NCT03935880|523954917|FG000|Overall Study|Lost to Follow-up|0|||
145301001|NCT03935880|523954918|FG001|Overall Study|Lost to Follow-up|1|||
145301002|NCT02476994|523954919|FG000|Overall Study|Based on feedback from FDA|1|||
145301003|NCT02476994|523954920|FG001|Overall Study|Based on feedback from FDA|0|||
145301004|NCT02563561|523954921|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
145301005|NCT02563561|523954922|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
145301006|NCT02563561|523954923|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
145410769|NCT02903914|524356848|FG003|Overall Study|Physician Decision|0|||
145257654|NCT00660816|523787545|FG000|Overall Study|Lack of Efficacy|1|||
145257655|NCT00660816|523787546|FG001|Overall Study|Lack of Efficacy|0|||
145257656|NCT00660816|523787545|FG000|Overall Study|Physician Decision|0|||
145257657|NCT00660816|523787546|FG001|Overall Study|Physician Decision|2|||
145301007|NCT02563561|523954921|FG000|Overall Study|Withdrew of Consent|1|||
145301008|NCT02563561|523954922|FG001|Overall Study|Withdrew of Consent|1|||
145301009|NCT02563561|523954923|FG002|Overall Study|Withdrew of Consent|2|||
145301010|NCT02563561|523954921|FG000|Overall Study|Lost to Follow-up|1|||
145301011|NCT02563561|523954922|FG001|Overall Study|Lost to Follow-up|1|||
145301012|NCT02563561|523954923|FG002|Overall Study|Lost to Follow-up|0|||
145301013|NCT02563561|523954921|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
145301014|NCT02563561|523954922|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
145410770|NCT02903914|524356849|FG004|Overall Study|Physician Decision|0|||
145257658|NCT00660816|523787545|FG000|Overall Study|Protocol Violation|1|||
145257659|NCT00660816|523787546|FG001|Overall Study|Protocol Violation|0|||
145257660|NCT00660816|523787545|FG000|Overall Study|Disease Progression|16|||
145257661|NCT00660816|523787546|FG001|Overall Study|Disease Progression|12|||
145257662|NCT00660816|523787545|FG000|Overall Study|Complicating Disease|0|||
145257663|NCT00660816|523787546|FG001|Overall Study|Complicating Disease|1|||
145257664|NCT02607735|523787549|FG000|Primary Study|Randomized but Never Treated|1|||
145257665|NCT02607735|523787550|FG001|Primary Study|Randomized but Never Treated|0|||
145257666|NCT02607735|523787551|FG002|Primary Study|Randomized but Never Treated|0|||
145257667|NCT02607735|523787549|FG000|Primary Study|Lost to Follow-up|4|||
145257668|NCT02607735|523787550|FG001|Primary Study|Lost to Follow-up|0|||
145257669|NCT02607735|523787551|FG002|Primary Study|Lost to Follow-up|0|||
145257670|NCT02607735|523787549|FG000|Primary Study|Withdrew Consent|2|||
145257671|NCT02607735|523787550|FG001|Primary Study|Withdrew Consent|0|||
145257672|NCT02607735|523787551|FG002|Primary Study|Withdrew Consent|0|||
145257673|NCT02607735|523787549|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
145257674|NCT02607735|523787550|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
145257675|NCT02607735|523787551|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
145568563|NCT01165138|524940623|FG000|Overall Study|Lack of Efficacy|0|||
145257676|NCT02607735|523787549|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
145257677|NCT02607735|523787550|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
145257678|NCT02607735|523787551|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
145257679|NCT01058356|523787554|FG000|Overall Study|Adverse Event|5|||
145257680|NCT01058356|523787554|FG000|Overall Study|Administration of contraindicated drugs|12|||
145257681|NCT01058356|523787554|FG000|Overall Study|Withdrawal by Subject|21|||
145257682|NCT01058356|523787554|FG000|Overall Study|Lost to Follow-up|4|||
145257683|NCT02993783|523787555|FG000|Overall Study|Reason not Specified|6|||
145257684|NCT02993783|523787556|FG001|Overall Study|Reason not Specified|9|||
145257685|NCT00606021|523787559|FG000|Induction Phase|Death|73|||
145257686|NCT00606021|523787560|FG001|Induction Phase|Death|0|||
145257687|NCT00606021|523787561|FG002|Induction Phase|Death|0|||
145257688|NCT00606021|523787559|FG000|Induction Phase|Physician Decision|2|||
145257689|NCT00606021|523787560|FG001|Induction Phase|Physician Decision|0|||
145257690|NCT00606021|523787561|FG002|Induction Phase|Physician Decision|0|||
145257691|NCT00606021|523787559|FG000|Induction Phase|Withdrawal by Subject|2|||
145257692|NCT00606021|523787560|FG001|Induction Phase|Withdrawal by Subject|0|||
145257693|NCT00606021|523787561|FG002|Induction Phase|Withdrawal by Subject|0|||
145257694|NCT00606021|523787559|FG000|Induction Phase|Lost to Follow-up|10|||
145257695|NCT00606021|523787560|FG001|Induction Phase|Lost to Follow-up|0|||
145257696|NCT00606021|523787561|FG002|Induction Phase|Lost to Follow-up|0|||
145257697|NCT00606021|523787559|FG000|Maintenance Phase|Death|0|||
145257698|NCT00606021|523787560|FG001|Maintenance Phase|Death|17|||
145257699|NCT00606021|523787561|FG002|Maintenance Phase|Death|15|||
145257700|NCT00606021|523787559|FG000|Maintenance Phase|Physician Decision|0|||
145257701|NCT00606021|523787560|FG001|Maintenance Phase|Physician Decision|1|||
145257702|NCT00606021|523787561|FG002|Maintenance Phase|Physician Decision|0|||
145257703|NCT00606021|523787559|FG000|Maintenance Phase|Lost to Follow-up|0|||
145257704|NCT00606021|523787560|FG001|Maintenance Phase|Lost to Follow-up|5|||
145257705|NCT00606021|523787561|FG002|Maintenance Phase|Lost to Follow-up|2|||
145257706|NCT00711009|523790221|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
145257707|NCT00711009|523790222|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
145257708|NCT00711009|523790221|FG000|Overall Study|Withdrawal by Subject|4|||
145257709|NCT00711009|523790222|FG001|Overall Study|Withdrawal by Subject|2|||
145257710|NCT00711009|523790221|FG000|Overall Study|Lost to Follow-up|3|||
145257711|NCT00711009|523790222|FG001|Overall Study|Lost to Follow-up|9|||
145257712|NCT00711009|523790221|FG000|Overall Study|Participant Noncompliant|0|||
145257713|NCT00711009|523790222|FG001|Overall Study|Participant Noncompliant|1|||
145257714|NCT00711009|523790221|FG000|Overall Study|Virologic Failure|2|||
145257715|NCT00711009|523790222|FG001|Overall Study|Virologic Failure|1|||
145257716|NCT00711009|523790221|FG000|Overall Study|Pregnancy|1|||
145257717|NCT00711009|523790222|FG001|Overall Study|Pregnancy|0|||
145257718|NCT00711009|523790221|FG000|Overall Study|Site closing|0|||
145257719|NCT00711009|523790222|FG001|Overall Study|Site closing|1|||
145257720|NCT00711009|523790221|FG000|Overall Study|Dose adjustment|1|||
145257721|NCT00711009|523790222|FG001|Overall Study|Dose adjustment|0|||
145257722|NCT01459016|523790224|FG000|Overall Study|Withdrawal by Subject|11|||
145301015|NCT02563561|523954923|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
145257723|NCT01459016|523790224|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
145257724|NCT00303602|523790228|FG000|Overall Study|Adverse Event|2|||
145257725|NCT00303602|523790229|FG001|Overall Study|Adverse Event|2|||
145257726|NCT00303602|523790228|FG000|Overall Study|Withdrawal by Subject|5|||
145257727|NCT00303602|523790229|FG001|Overall Study|Withdrawal by Subject|6|||
145257728|NCT00303602|523790228|FG000|Overall Study|Lost to Follow-up|5|||
145257729|NCT00303602|523790229|FG001|Overall Study|Lost to Follow-up|2|||
145257730|NCT00303602|523790228|FG000|Overall Study|Protocol entry criteria not met|2|||
145257731|NCT00303602|523790229|FG001|Overall Study|Protocol entry criteria not met|2|||
145257732|NCT00303602|523790228|FG000|Overall Study|Physician Decision|2|||
145257733|NCT00303602|523790229|FG001|Overall Study|Physician Decision|1|||
145568564|NCT01165138|524940624|FG001|Overall Study|Lack of Efficacy|32|||
145568565|NCT01165138|524940625|FG002|Overall Study|Lack of Efficacy|6|||
145568566|NCT01165138|524940626|FG003|Overall Study|Lack of Efficacy|7|||
145568567|NCT01165138|524940623|FG000|Overall Study|Protocol Violation|0|||
145568568|NCT01165138|524940624|FG001|Overall Study|Protocol Violation|7|||
145568569|NCT01165138|524940625|FG002|Overall Study|Protocol Violation|0|||
145257734|NCT00303602|523790228|FG000|Overall Study|Noncompliance|2|||
145257735|NCT00303602|523790229|FG001|Overall Study|Noncompliance|2|||
145257736|NCT00303602|523790228|FG000|Overall Study|Protocol Violation|1|||
145257737|NCT00303602|523790229|FG001|Overall Study|Protocol Violation|0|||
145257738|NCT02551874|523790236|FG000|Overall Study|Lost to Follow-up|0|||
145257739|NCT02551874|523790237|FG001|Overall Study|Lost to Follow-up|2|||
145257740|NCT02551874|523790236|FG000|Overall Study|Pregnancy|0|||
145257741|NCT02551874|523790237|FG001|Overall Study|Pregnancy|1|||
145257742|NCT02551874|523790236|FG000|Overall Study|Reason not reported|10|||
145257743|NCT02551874|523790237|FG001|Overall Study|Reason not reported|4|||
145257744|NCT02551874|523790236|FG000|Overall Study|Did not receive randomized treatment|0|||
145257745|NCT02551874|523790237|FG001|Overall Study|Did not receive randomized treatment|7|||
145257746|NCT02551874|523790236|FG000|Overall Study|Did not enter long-term study|18|||
145257747|NCT02551874|523790237|FG001|Overall Study|Did not enter long-term study|25|||
145257748|NCT00313716|523790238|FG000|Overall Study|Death|3|||
145257749|NCT00313716|523790239|FG001|Overall Study|Death|2|||
145257750|NCT00313716|523790240|FG002|Overall Study|Death|9|||
145257751|NCT00313716|523790241|FG003|Overall Study|Death|3|||
145257752|NCT00313716|523790242|FG004|Overall Study|Death|5|||
145257753|NCT00313716|523790243|FG005|Overall Study|Death|9|||
145257754|NCT00313716|523790238|FG000|Overall Study|Lost to Follow-up|2|||
145257755|NCT00313716|523790239|FG001|Overall Study|Lost to Follow-up|5|||
145257756|NCT00313716|523790240|FG002|Overall Study|Lost to Follow-up|2|||
145257757|NCT00313716|523790241|FG003|Overall Study|Lost to Follow-up|1|||
145257758|NCT00313716|523790242|FG004|Overall Study|Lost to Follow-up|0|||
145257759|NCT00313716|523790243|FG005|Overall Study|Lost to Follow-up|4|||
145257760|NCT00313716|523790238|FG000|Overall Study|Withdrawal by Subject|0|||
145257761|NCT00313716|523790239|FG001|Overall Study|Withdrawal by Subject|1|||
145257762|NCT00313716|523790240|FG002|Overall Study|Withdrawal by Subject|1|||
145257763|NCT00313716|523790241|FG003|Overall Study|Withdrawal by Subject|0|||
145257764|NCT00313716|523790242|FG004|Overall Study|Withdrawal by Subject|1|||
145257765|NCT00313716|523790243|FG005|Overall Study|Withdrawal by Subject|0|||
145257766|NCT02491463|523790244|FG000|Overall Study|Withdrawal by Subject|1|||
145257767|NCT02491463|523790245|FG001|Overall Study|Withdrawal by Subject|2|||
145257768|NCT02491463|523790246|FG002|Overall Study|Withdrawal by Subject|0|||
145257769|NCT02491463|523790247|FG003|Overall Study|Withdrawal by Subject|0|||
145257770|NCT02491463|523790244|FG000|Overall Study|Migrated/moved from study area|1|||
145257771|NCT02491463|523790245|FG001|Overall Study|Migrated/moved from study area|5|||
145257772|NCT02491463|523790246|FG002|Overall Study|Migrated/moved from study area|1|||
145257773|NCT02491463|523790247|FG003|Overall Study|Migrated/moved from study area|1|||
145257774|NCT02491463|523790244|FG000|Overall Study|Lost to Follow-up|0|||
145257775|NCT02491463|523790245|FG001|Overall Study|Lost to Follow-up|3|||
145257776|NCT02491463|523790246|FG002|Overall Study|Lost to Follow-up|3|||
145257777|NCT02491463|523790247|FG003|Overall Study|Lost to Follow-up|0|||
145257778|NCT01491802|523790248|FG000|Overall Study|Adverse Event|1|||
145257779|NCT01491802|523790249|FG001|Overall Study|Adverse Event|1|||
145257780|NCT01491802|523790248|FG000|Overall Study|Withdrawal by Subject|0|||
145568570|NCT01165138|524940626|FG003|Overall Study|Protocol Violation|2|||
145568571|NCT01165138|524940623|FG000|Overall Study|Lost to Follow-up|0|||
145568572|NCT01165138|524940624|FG001|Overall Study|Lost to Follow-up|0|||
145568573|NCT01165138|524940625|FG002|Overall Study|Lost to Follow-up|1|||
145257781|NCT01491802|523790249|FG001|Overall Study|Withdrawal by Subject|1|||
145257782|NCT00663208|523790250|FG000|Treatment Period|Lost to Follow-up|0|||
145257783|NCT00663208|523790251|FG001|Treatment Period|Lost to Follow-up|1|||
145257784|NCT00663208|523790252|FG002|Treatment Period|Lost to Follow-up|0|||
145257785|NCT00663208|523790253|FG003|Treatment Period|Lost to Follow-up|0|||
145257786|NCT00663208|523790254|FG004|Treatment Period|Lost to Follow-up|0|||
145257787|NCT00663208|523790255|FG005|Treatment Period|Lost to Follow-up|0|||
145257788|NCT00663208|523790256|FG006|Treatment Period|Lost to Follow-up|0|||
145257789|NCT00663208|523790250|FG000|Follow-up Period|Lost to Follow-up|2|||
145568574|NCT01165138|524940626|FG003|Overall Study|Lost to Follow-up|2|||
145257790|NCT00663208|523790251|FG001|Follow-up Period|Lost to Follow-up|0|||
145257791|NCT00663208|523790252|FG002|Follow-up Period|Lost to Follow-up|3|||
145257792|NCT00663208|523790253|FG003|Follow-up Period|Lost to Follow-up|2|||
145257793|NCT00663208|523790254|FG004|Follow-up Period|Lost to Follow-up|0|||
145257794|NCT00663208|523790255|FG005|Follow-up Period|Lost to Follow-up|0|||
145257795|NCT00663208|523790256|FG006|Follow-up Period|Lost to Follow-up|0|||
145257796|NCT00663208|523790250|FG000|Follow-up Period|Other reason|1|||
145257797|NCT00663208|523790251|FG001|Follow-up Period|Other reason|0|||
145257798|NCT00663208|523790252|FG002|Follow-up Period|Other reason|0|||
145257799|NCT00663208|523790253|FG003|Follow-up Period|Other reason|0|||
145257800|NCT00663208|523790254|FG004|Follow-up Period|Other reason|0|||
145257801|NCT00663208|523790255|FG005|Follow-up Period|Other reason|0|||
145257802|NCT00663208|523790256|FG006|Follow-up Period|Other reason|1|||
145257803|NCT00039377|523790259|FG000|Initial Registration|Adverse Event|2|||
145257804|NCT00039377|523790260|FG001|Initial Registration|Adverse Event|0|||
145257805|NCT00039377|523790261|FG002|Initial Registration|Adverse Event|0|||
145257806|NCT00039377|523790262|FG003|Initial Registration|Adverse Event|0|||
145257807|NCT00039377|523790259|FG000|Initial Registration|Relapsed|6|||
145257808|NCT00039377|523790260|FG001|Initial Registration|Relapsed|0|||
145257809|NCT00039377|523790261|FG002|Initial Registration|Relapsed|0|||
145257810|NCT00039377|523790262|FG003|Initial Registration|Relapsed|0|||
145257811|NCT00039377|523790259|FG000|Initial Registration|Received non-protocol therapy|11|||
145257812|NCT00039377|523790260|FG001|Initial Registration|Received non-protocol therapy|0|||
145257813|NCT00039377|523790261|FG002|Initial Registration|Received non-protocol therapy|0|||
145257814|NCT00039377|523790262|FG003|Initial Registration|Received non-protocol therapy|0|||
145257815|NCT00039377|523790259|FG000|Initial Registration|Withdrawal by Subject|3|||
145257816|NCT00039377|523790260|FG001|Initial Registration|Withdrawal by Subject|0|||
145257817|NCT00039377|523790261|FG002|Initial Registration|Withdrawal by Subject|0|||
145257818|NCT00039377|523790262|FG003|Initial Registration|Withdrawal by Subject|0|||
145257819|NCT04067310|523790266|FG000|Overall Study|Physician Decision|2|||
145257820|NCT04067310|523790267|FG001|Overall Study|Physician Decision|6|||
145257821|NCT04067310|523790266|FG000|Overall Study|Lost to Follow-up|0|||
145257822|NCT04067310|523790267|FG001|Overall Study|Lost to Follow-up|1|||
145257823|NCT04067310|523790266|FG000|Overall Study|Withdrawal by Subject|3|||
145257824|NCT04067310|523790267|FG001|Overall Study|Withdrawal by Subject|0|||
145257825|NCT01347931|523790268|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
145257826|NCT01249404|523790269|FG000|Overall Study|Study treatment not received|0|||
145257827|NCT01249404|523790270|FG001|Overall Study|Study treatment not received|1|||
145257828|NCT01249404|523790271|FG002|Overall Study|Study treatment not received|2|||
145257829|NCT01249404|523790269|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
145257830|NCT01249404|523790270|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
145257831|NCT01249404|523790271|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
145257832|NCT01249404|523790269|FG000|Overall Study|Adverse Event|2|||
145257833|NCT01249404|523790270|FG001|Overall Study|Adverse Event|2|||
145257834|NCT01249404|523790271|FG002|Overall Study|Adverse Event|2|||
145257835|NCT01249404|523790269|FG000|Overall Study|Withdrawal by Subject|2|||
145257836|NCT01249404|523790270|FG001|Overall Study|Withdrawal by Subject|2|||
145257837|NCT01249404|523790271|FG002|Overall Study|Withdrawal by Subject|0|||
145257838|NCT01249404|523790269|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
145257839|NCT01249404|523790270|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
145257840|NCT01249404|523790271|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
145257841|NCT01249404|523790269|FG000|Overall Study|Non compliance to visit schedule|0|||
145257842|NCT01249404|523790270|FG001|Overall Study|Non compliance to visit schedule|1|||
145257843|NCT01249404|523790271|FG002|Overall Study|Non compliance to visit schedule|0|||
145257844|NCT02493712|523790272|FG000|Overall Study|Withdrawal by Subject|1|||
145257845|NCT02493712|523790273|FG001|Overall Study|Withdrawal by Subject|0|||
145257846|NCT02493712|523790274|FG002|Overall Study|Withdrawal by Subject|2|||
145257847|NCT02493712|523790272|FG000|Overall Study|Protocol Violation|0|||
145257848|NCT02493712|523790273|FG001|Overall Study|Protocol Violation|0|||
145257849|NCT02493712|523790274|FG002|Overall Study|Protocol Violation|1|||
145257850|NCT02493712|523790272|FG000|Overall Study|Lost to Follow-up|1|||
145257851|NCT02493712|523790273|FG001|Overall Study|Lost to Follow-up|0|||
145257852|NCT02493712|523790274|FG002|Overall Study|Lost to Follow-up|0|||
145257853|NCT02493712|523790272|FG000|Overall Study|Physician Decision|0|||
145257854|NCT02493712|523790273|FG001|Overall Study|Physician Decision|1|||
145257855|NCT02493712|523790274|FG002|Overall Study|Physician Decision|0|||
145257856|NCT02493712|523790272|FG000|Overall Study|Lack of Efficacy|0|||
145257857|NCT02493712|523790273|FG001|Overall Study|Lack of Efficacy|5|||
145257858|NCT02493712|523790274|FG002|Overall Study|Lack of Efficacy|3|||
145257859|NCT02058940|523790275|FG000|Overall Study|Discharged from Critical Care Unit|1|||
145257860|NCT01524900|523790283|FG000|Overall Study|Lost to Follow-up|3|||
145301016|NCT02563561|523954921|FG000|Overall Study|Investigator Decision|3|||
145301017|NCT02563561|523954922|FG001|Overall Study|Investigator Decision|4|||
145257861|NCT01524900|523790284|FG001|Overall Study|Lost to Follow-up|12|||
145257862|NCT01524900|523790285|FG002|Overall Study|Lost to Follow-up|1|||
145257863|NCT01524900|523790286|FG003|Overall Study|Lost to Follow-up|0|||
145257864|NCT01524900|523790287|FG004|Overall Study|Lost to Follow-up|0|||
145257865|NCT01524900|523790283|FG000|Overall Study|Other reason than stated above|1|||
145257866|NCT01524900|523790284|FG001|Overall Study|Other reason than stated above|1|||
145257867|NCT01524900|523790285|FG002|Overall Study|Other reason than stated above|0|||
145257868|NCT01524900|523790286|FG003|Overall Study|Other reason than stated above|0|||
145257869|NCT01524900|523790287|FG004|Overall Study|Other reason than stated above|0|||
145257870|NCT01524900|523790283|FG000|Overall Study|No reason documented|2|||
145301018|NCT02563561|523954923|FG002|Overall Study|Investigator Decision|2|||
145301019|NCT02563561|523954921|FG000|Overall Study|Sponsor Decision|5|||
145257871|NCT01524900|523790284|FG001|Overall Study|No reason documented|1|||
145257872|NCT01524900|523790285|FG002|Overall Study|No reason documented|0|||
145257873|NCT01524900|523790286|FG003|Overall Study|No reason documented|1|||
145257874|NCT01524900|523790287|FG004|Overall Study|No reason documented|0|||
145257875|NCT03633461|523790295|FG000|Overall Study|Lost to Follow-up|0|||
145257876|NCT03633461|523790296|FG001|Overall Study|Lost to Follow-up|1|||
145257877|NCT03938857|523790303|FG000|Overall Study|Physician Decision|1|||
145257878|NCT03938857|523790304|FG001|Overall Study|Physician Decision|0|||
145257879|NCT03938857|523790305|FG002|Overall Study|Physician Decision|0|||
145257880|NCT03938857|523790306|FG003|Overall Study|Physician Decision|0|||
145257881|NCT02242305|523790307|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
145257882|NCT02242305|523790308|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
145257883|NCT02242305|523790307|FG000|Overall Study|Adverse Event|1|||
145257884|NCT02242305|523790308|FG001|Overall Study|Adverse Event|0|||
145257885|NCT02242305|523790307|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
145257886|NCT02242305|523790308|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
145257887|NCT02242305|523790307|FG000|Overall Study|Subject withdraws inform consent|0|||
145257888|NCT02242305|523790308|FG001|Overall Study|Subject withdraws inform consent|4|||
145257889|NCT02242305|523790307|FG000|Overall Study|Lost to Follow-up|2|||
145257890|NCT02242305|523790308|FG001|Overall Study|Lost to Follow-up|0|||
145257891|NCT03018028|523790312|FG000|Overall Study|Withdrawal by Subject|3|||
145257892|NCT03018028|523790313|FG001|Overall Study|Withdrawal by Subject|0|||
145257893|NCT03018028|523790314|FG002|Overall Study|Withdrawal by Subject|1|||
145257894|NCT03018028|523790315|FG003|Overall Study|Withdrawal by Subject|2|||
145257895|NCT03018028|523790316|FG004|Overall Study|Withdrawal by Subject|0|||
145257896|NCT00699582|523790320|FG000|Overall Study|Adverse Event|4|||
145257897|NCT00699582|523790321|FG001|Overall Study|Adverse Event|11|||
145257898|NCT00699582|523790322|FG002|Overall Study|Adverse Event|23|||
145257899|NCT00699582|523790320|FG000|Overall Study|Withdrawal by Subject|6|||
145257900|NCT00699582|523790321|FG001|Overall Study|Withdrawal by Subject|7|||
145257901|NCT00699582|523790322|FG002|Overall Study|Withdrawal by Subject|4|||
145257902|NCT00699582|523790320|FG000|Overall Study|Lack of Efficacy|1|||
145257903|NCT00699582|523790321|FG001|Overall Study|Lack of Efficacy|0|||
145257904|NCT00699582|523790322|FG002|Overall Study|Lack of Efficacy|1|||
145257905|NCT00699582|523790320|FG000|Overall Study|Progressive Disease|1|||
145257906|NCT00699582|523790321|FG001|Overall Study|Progressive Disease|0|||
145257907|NCT00699582|523790322|FG002|Overall Study|Progressive Disease|0|||
145257908|NCT00699582|523790320|FG000|Overall Study|Administrative/Other|4|||
145257909|NCT00699582|523790321|FG001|Overall Study|Administrative/Other|3|||
145257910|NCT00699582|523790322|FG002|Overall Study|Administrative/Other|0|||
145257911|NCT00699582|523790320|FG000|Overall Study|Randomized, Not Treated|2|||
145257912|NCT00699582|523790321|FG001|Overall Study|Randomized, Not Treated|1|||
145257913|NCT00699582|523790322|FG002|Overall Study|Randomized, Not Treated|0|||
145257914|NCT03099304|523790328|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
145257915|NCT03099304|523790329|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
145257916|NCT03099304|523790330|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
145257917|NCT03099304|523790331|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
145257918|NCT03099304|523790332|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
145257919|NCT03099304|523790333|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
145257920|NCT03099304|523790328|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
145257921|NCT03099304|523790329|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
145257922|NCT03099304|523790330|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
145257923|NCT03099304|523790331|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
145257924|NCT03099304|523790332|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
145568575|NCT01165138|524940623|FG000|Overall Study|Physician Decision|0|||
145568576|NCT01165138|524940624|FG001|Overall Study|Physician Decision|6|||
145568577|NCT01165138|524940625|FG002|Overall Study|Physician Decision|7|||
145568578|NCT01165138|524940626|FG003|Overall Study|Physician Decision|6|||
145568579|NCT01165138|524940623|FG000|Overall Study|Withdrawal by Subject|0|||
145568580|NCT01165138|524940624|FG001|Overall Study|Withdrawal by Subject|6|||
145257925|NCT03099304|523790333|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
145257926|NCT03099304|523790328|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
145257927|NCT03099304|523790329|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
145257928|NCT03099304|523790330|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
145257929|NCT03099304|523790331|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
145257930|NCT03099304|523790332|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
145257931|NCT03099304|523790333|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
145257932|NCT03099304|523790328|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
145257933|NCT03099304|523790329|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
145257934|NCT03099304|523790330|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
145257935|NCT03099304|523790331|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
145257936|NCT03099304|523790332|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
145257937|NCT03099304|523790333|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
145301020|NCT02563561|523954922|FG001|Overall Study|Sponsor Decision|2|||
145301021|NCT02563561|523954923|FG002|Overall Study|Sponsor Decision|4|||
145257938|NCT03099304|523790328|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
145257939|NCT03099304|523790329|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
145257940|NCT03099304|523790330|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
145257941|NCT03099304|523790331|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
145257942|NCT03099304|523790332|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
145257943|NCT03099304|523790333|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
145257944|NCT03099304|523790328|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
145257945|NCT03099304|523790329|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
145257946|NCT03099304|523790330|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
145257947|NCT03099304|523790331|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
145257948|NCT03099304|523790332|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
145257949|NCT03099304|523790333|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
145257950|NCT03099304|523790328|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
145257951|NCT03099304|523790329|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
145257952|NCT03099304|523790330|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
145257953|NCT03099304|523790331|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
145257954|NCT03099304|523790332|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
145257955|NCT03099304|523790333|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
145257956|NCT03099304|523790328|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
145257957|NCT03099304|523790329|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
145257958|NCT03099304|523790330|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
145257959|NCT03099304|523790331|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
145257960|NCT03099304|523790332|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
145257961|NCT03099304|523790333|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
145257962|NCT03099304|523790328|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
145257963|NCT03099304|523790329|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
145257964|NCT03099304|523790330|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
145257965|NCT03099304|523790331|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
145257966|NCT03099304|523790332|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
145257967|NCT03099304|523790333|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
145257968|NCT03099304|523790328|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
145257969|NCT03099304|523790329|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
145257970|NCT03099304|523790330|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
145257971|NCT03099304|523790331|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
145257972|NCT03099304|523790332|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
145257973|NCT03099304|523790333|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
145257974|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
145257975|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
145257976|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
145257977|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
145257978|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
145257979|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
145257980|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
145257981|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
145257982|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
145257983|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
145257984|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
145257985|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
145257986|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
145257987|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
145257988|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
145257989|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
145257990|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
145257991|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
145257992|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
145257993|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
145257994|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
145257995|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
145257996|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
145257997|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
145257998|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
145257999|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
145258000|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
145258001|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
145258002|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
145258003|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
145258004|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
145568581|NCT01165138|524940625|FG002|Overall Study|Withdrawal by Subject|6|||
145568582|NCT01165138|524940626|FG003|Overall Study|Withdrawal by Subject|3|||
145258005|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
145258006|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
145258007|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
145258008|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
145258009|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
145258010|NCT03099304|523790328|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
145258011|NCT03099304|523790329|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
145258012|NCT03099304|523790330|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
145258013|NCT03099304|523790331|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
145258014|NCT03099304|523790332|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
145258015|NCT03099304|523790333|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
145258016|NCT02692560|523790334|FG000|Overall Study|Withdrawal by Subject|0|||
145258017|NCT02692560|523790335|FG001|Overall Study|Withdrawal by Subject|6|||
145258018|NCT00715949|523790338|FG000|Overall Study|could not finish first test|4|||
145258019|NCT00420212|523790339|FG000|Overall Study|Adverse Event|22|||
145258020|NCT00420212|523790340|FG001|Overall Study|Adverse Event|40|||
145258021|NCT00420212|523790341|FG002|Overall Study|Adverse Event|36|||
145258022|NCT00420212|523790339|FG000|Overall Study|Lost to Follow-up|9|||
145258023|NCT00420212|523790340|FG001|Overall Study|Lost to Follow-up|11|||
145258024|NCT00420212|523790341|FG002|Overall Study|Lost to Follow-up|11|||
145258025|NCT00420212|523790339|FG000|Overall Study|Withdrawal by Subject|31|||
145258026|NCT00420212|523790340|FG001|Overall Study|Withdrawal by Subject|22|||
145258027|NCT00420212|523790341|FG002|Overall Study|Withdrawal by Subject|19|||
145258028|NCT00420212|523790339|FG000|Overall Study|Physician Decision|4|||
145258029|NCT00420212|523790340|FG001|Overall Study|Physician Decision|4|||
145258030|NCT00420212|523790341|FG002|Overall Study|Physician Decision|3|||
145258031|NCT00420212|523790339|FG000|Overall Study|Protocol Violation|4|||
145258032|NCT00420212|523790340|FG001|Overall Study|Protocol Violation|4|||
145258033|NCT00420212|523790341|FG002|Overall Study|Protocol Violation|8|||
145258034|NCT00420212|523790339|FG000|Overall Study|Death|0|||
145258035|NCT00420212|523790340|FG001|Overall Study|Death|0|||
145258036|NCT00420212|523790341|FG002|Overall Study|Death|1|||
145258037|NCT00420212|523790339|FG000|Overall Study|Other-Unspecified|21|||
145258038|NCT00420212|523790340|FG001|Overall Study|Other-Unspecified|14|||
145258039|NCT00420212|523790341|FG002|Overall Study|Other-Unspecified|18|||
145258040|NCT01326910|523790342|FG000|Overall Study|Withdrawal by Subject|3|||
145258041|NCT01326910|523790343|FG001|Overall Study|Withdrawal by Subject|2|||
145258042|NCT01326910|523790342|FG000|Overall Study|Protocol Violation|1|||
145258043|NCT01326910|523790343|FG001|Overall Study|Protocol Violation|1|||
145258044|NCT02274766|523790346|FG000|Overall Study|Withdrawal by Subject|3|||
145258045|NCT02274766|523790347|FG001|Overall Study|Withdrawal by Subject|6|||
145258046|NCT02274766|523790346|FG000|Overall Study|Did Not Receive Study Drug|1|||
145258047|NCT02274766|523790347|FG001|Overall Study|Did Not Receive Study Drug|1|||
145258048|NCT02274766|523790346|FG000|Overall Study|Subject Unwilling to Proceed|0|||
145258049|NCT02274766|523790347|FG001|Overall Study|Subject Unwilling to Proceed|1|||
145258050|NCT02274766|523790346|FG000|Overall Study|Adverse Event|0|||
145258051|NCT02274766|523790347|FG001|Overall Study|Adverse Event|1|||
145301022|NCT02563561|523954921|FG000|Overall Study|Other|1|||
145301023|NCT02563561|523954922|FG001|Overall Study|Other|5|||
145301024|NCT02563561|523954923|FG002|Overall Study|Other|2|||
145301025|NCT03122535|523954926|FG000|Overall Study|Lost to Follow-up|68|||
145301026|NCT03122535|523954927|FG001|Overall Study|Lost to Follow-up|68|||
145301027|NCT03122535|523954926|FG000|Overall Study|Physician Decision|3|||
145301028|NCT03122535|523954927|FG001|Overall Study|Physician Decision|3|||
145301029|NCT03122535|523954926|FG000|Overall Study|Withdrawal by Subject|2|||
145301030|NCT03122535|523954927|FG001|Overall Study|Withdrawal by Subject|2|||
145410771|NCT02903914|524356850|FG005|Overall Study|Physician Decision|0|||
145410772|NCT02903914|524356851|FG006|Overall Study|Physician Decision|1|||
145410773|NCT02903914|524356852|FG007|Overall Study|Physician Decision|0|||
145410774|NCT02903914|524356845|FG000|Overall Study|Symptomatic Deterioration|0|||
145410775|NCT02903914|524356846|FG001|Overall Study|Symptomatic Deterioration|0|||
145568583|NCT03323658|524940629|FG000|Overall Study|Adverse Event|0|||
145301031|NCT02718326|523954928|FG000|Overall Study|Adverse Event|4|||
145301032|NCT02718326|523954929|FG001|Overall Study|Adverse Event|9|||
145301033|NCT02718326|523954930|FG002|Overall Study|Adverse Event|0|||
145301034|NCT02718326|523954928|FG000|Overall Study|Death|8|||
145568584|NCT03323658|524940630|FG001|Overall Study|Adverse Event|1|||
145568585|NCT03323658|524940631|FG002|Overall Study|Adverse Event|0|||
145258052|NCT01681836|523790352|FG000|Second Intervention|Withdrawal by Subject|0|||
145258053|NCT01681836|523790353|FG001|Second Intervention|Withdrawal by Subject|1|||
145301035|NCT02718326|523954929|FG001|Overall Study|Death|1|||
145301036|NCT02718326|523954930|FG002|Overall Study|Death|2|||
145568586|NCT00615056|524940632|FG000|Overall Study|Death|31|||
145258054|NCT00742391|523790354|FG000|Overall Study|Adverse Event|2|||
145258055|NCT00742391|523790355|FG001|Overall Study|Adverse Event|1|||
145301037|NCT02718326|523954928|FG000|Overall Study|Withdrawal by Subject|4|||
145568587|NCT00615056|524940633|FG001|Overall Study|Death|31|||
145410776|NCT02903914|524356847|FG002|Overall Study|Symptomatic Deterioration|1|||
145410777|NCT02903914|524356848|FG003|Overall Study|Symptomatic Deterioration|0|||
145258056|NCT00742391|523790354|FG000|Overall Study|Lost to Follow-up|1|||
145258057|NCT00742391|523790355|FG001|Overall Study|Lost to Follow-up|0|||
145258058|NCT00742391|523790354|FG000|Overall Study|Protocol Violation|1|||
145258059|NCT00742391|523790355|FG001|Overall Study|Protocol Violation|0|||
145258060|NCT02394028|523790356|FG000|Induction Phase|Adverse Event|2|||
145258061|NCT02394028|523790357|FG001|Induction Phase|Adverse Event|4|||
145258062|NCT02394028|523790358|FG002|Induction Phase|Adverse Event|1|||
145258063|NCT02394028|523790359|FG003|Induction Phase|Adverse Event|2|||
145258064|NCT02394028|523790360|FG004|Induction Phase|Adverse Event|5|||
145258065|NCT02394028|523790361|FG005|Induction Phase|Adverse Event|2|||
145258066|NCT02394028|523790362|FG006|Induction Phase|Adverse Event|0|||
145258067|NCT02394028|523790363|FG007|Induction Phase|Adverse Event|0|||
145258068|NCT02394028|523790364|FG008|Induction Phase|Adverse Event|0|||
145258069|NCT02394028|523790365|FG009|Induction Phase|Adverse Event|0|||
145258070|NCT02394028|523790366|FG010|Induction Phase|Adverse Event|0|||
145258071|NCT02394028|523790356|FG000|Induction Phase|Lack of Efficacy|3|||
145258072|NCT02394028|523790357|FG001|Induction Phase|Lack of Efficacy|6|||
145258073|NCT02394028|523790358|FG002|Induction Phase|Lack of Efficacy|2|||
145258074|NCT02394028|523790359|FG003|Induction Phase|Lack of Efficacy|17|||
145258075|NCT02394028|523790360|FG004|Induction Phase|Lack of Efficacy|14|||
145258076|NCT02394028|523790361|FG005|Induction Phase|Lack of Efficacy|8|||
145258077|NCT02394028|523790362|FG006|Induction Phase|Lack of Efficacy|17|||
145258078|NCT02394028|523790363|FG007|Induction Phase|Lack of Efficacy|23|||
145258079|NCT02394028|523790364|FG008|Induction Phase|Lack of Efficacy|0|||
145258080|NCT02394028|523790365|FG009|Induction Phase|Lack of Efficacy|0|||
145258081|NCT02394028|523790366|FG010|Induction Phase|Lack of Efficacy|0|||
145258082|NCT02394028|523790356|FG000|Induction Phase|Lost to Follow-up|1|||
145258083|NCT02394028|523790357|FG001|Induction Phase|Lost to Follow-up|0|||
145258084|NCT02394028|523790358|FG002|Induction Phase|Lost to Follow-up|0|||
145258085|NCT02394028|523790359|FG003|Induction Phase|Lost to Follow-up|1|||
145258086|NCT02394028|523790360|FG004|Induction Phase|Lost to Follow-up|0|||
145258087|NCT02394028|523790361|FG005|Induction Phase|Lost to Follow-up|0|||
145258088|NCT02394028|523790362|FG006|Induction Phase|Lost to Follow-up|1|||
145258089|NCT02394028|523790363|FG007|Induction Phase|Lost to Follow-up|0|||
145258090|NCT02394028|523790364|FG008|Induction Phase|Lost to Follow-up|0|||
145258091|NCT02394028|523790365|FG009|Induction Phase|Lost to Follow-up|0|||
145258092|NCT02394028|523790366|FG010|Induction Phase|Lost to Follow-up|0|||
145258093|NCT02394028|523790356|FG000|Induction Phase|Non-compliance|0|||
145258094|NCT02394028|523790357|FG001|Induction Phase|Non-compliance|1|||
145258095|NCT02394028|523790358|FG002|Induction Phase|Non-compliance|3|||
145258096|NCT02394028|523790359|FG003|Induction Phase|Non-compliance|1|||
145258097|NCT02394028|523790360|FG004|Induction Phase|Non-compliance|3|||
145258098|NCT02394028|523790361|FG005|Induction Phase|Non-compliance|0|||
145410778|NCT02903914|524356849|FG004|Overall Study|Symptomatic Deterioration|0|||
145410779|NCT02903914|524356850|FG005|Overall Study|Symptomatic Deterioration|0|||
145410780|NCT02903914|524356851|FG006|Overall Study|Symptomatic Deterioration|0|||
145568588|NCT00615056|524940634|FG002|Overall Study|Death|21|||
145568589|NCT00615056|524940635|FG003|Overall Study|Death|23|||
145568590|NCT00615056|524940632|FG000|Overall Study|Lost to Follow-up|1|||
145568591|NCT00615056|524940633|FG001|Overall Study|Lost to Follow-up|2|||
145568592|NCT00615056|524940634|FG002|Overall Study|Lost to Follow-up|4|||
145568593|NCT00615056|524940635|FG003|Overall Study|Lost to Follow-up|5|||
145568594|NCT00615056|524940632|FG000|Overall Study|Other|13|||
145568595|NCT00615056|524940633|FG001|Overall Study|Other|15|||
145568596|NCT00615056|524940634|FG002|Overall Study|Other|10|||
145568597|NCT00615056|524940635|FG003|Overall Study|Other|7|||
145568598|NCT00615056|524940632|FG000|Overall Study|Objective progression or relapse|0|||
145568599|NCT00615056|524940633|FG001|Overall Study|Objective progression or relapse|2|||
145568600|NCT00615056|524940634|FG002|Overall Study|Objective progression or relapse|0|||
145568601|NCT00615056|524940635|FG003|Overall Study|Objective progression or relapse|0|||
145568602|NCT00615056|524940632|FG000|Overall Study|Withdrawal by Subject|0|||
145568603|NCT00615056|524940633|FG001|Overall Study|Withdrawal by Subject|1|||
145568604|NCT00615056|524940634|FG002|Overall Study|Withdrawal by Subject|1|||
145258099|NCT02394028|523790362|FG006|Induction Phase|Non-compliance|1|||
145258100|NCT02394028|523790363|FG007|Induction Phase|Non-compliance|1|||
145258101|NCT02394028|523790364|FG008|Induction Phase|Non-compliance|0|||
145258102|NCT02394028|523790365|FG009|Induction Phase|Non-compliance|0|||
145258103|NCT02394028|523790366|FG010|Induction Phase|Non-compliance|0|||
145258104|NCT02394028|523790356|FG000|Induction Phase|Physician Decision|0|||
145258105|NCT02394028|523790357|FG001|Induction Phase|Physician Decision|0|||
145258106|NCT02394028|523790358|FG002|Induction Phase|Physician Decision|1|||
145258107|NCT02394028|523790359|FG003|Induction Phase|Physician Decision|4|||
145258108|NCT02394028|523790360|FG004|Induction Phase|Physician Decision|0|||
145258109|NCT02394028|523790361|FG005|Induction Phase|Physician Decision|2|||
145258110|NCT02394028|523790362|FG006|Induction Phase|Physician Decision|1|||
145258111|NCT02394028|523790363|FG007|Induction Phase|Physician Decision|0|||
145410781|NCT02903914|524356852|FG007|Overall Study|Symptomatic Deterioration|0|||
145410782|NCT02903914|524356845|FG000|Overall Study|New Cancer Therapy|2|||
145258112|NCT02394028|523790364|FG008|Induction Phase|Physician Decision|0|||
145258113|NCT02394028|523790365|FG009|Induction Phase|Physician Decision|0|||
145258114|NCT02394028|523790366|FG010|Induction Phase|Physician Decision|0|||
145258115|NCT02394028|523790356|FG000|Induction Phase|Protocol Violation|0|||
145258116|NCT02394028|523790357|FG001|Induction Phase|Protocol Violation|2|||
145258117|NCT02394028|523790358|FG002|Induction Phase|Protocol Violation|0|||
145258118|NCT02394028|523790359|FG003|Induction Phase|Protocol Violation|3|||
145258119|NCT02394028|523790360|FG004|Induction Phase|Protocol Violation|0|||
145258120|NCT02394028|523790361|FG005|Induction Phase|Protocol Violation|1|||
145258121|NCT02394028|523790362|FG006|Induction Phase|Protocol Violation|1|||
145258122|NCT02394028|523790363|FG007|Induction Phase|Protocol Violation|0|||
145258123|NCT02394028|523790364|FG008|Induction Phase|Protocol Violation|0|||
145258124|NCT02394028|523790365|FG009|Induction Phase|Protocol Violation|0|||
145258125|NCT02394028|523790366|FG010|Induction Phase|Protocol Violation|0|||
145258126|NCT02394028|523790356|FG000|Induction Phase|Withdrawal by Subject|1|||
145258127|NCT02394028|523790357|FG001|Induction Phase|Withdrawal by Subject|2|||
145258128|NCT02394028|523790358|FG002|Induction Phase|Withdrawal by Subject|4|||
145258129|NCT02394028|523790359|FG003|Induction Phase|Withdrawal by Subject|6|||
145258130|NCT02394028|523790360|FG004|Induction Phase|Withdrawal by Subject|7|||
145258131|NCT02394028|523790361|FG005|Induction Phase|Withdrawal by Subject|4|||
145258132|NCT02394028|523790362|FG006|Induction Phase|Withdrawal by Subject|3|||
145258133|NCT02394028|523790363|FG007|Induction Phase|Withdrawal by Subject|6|||
145258134|NCT02394028|523790364|FG008|Induction Phase|Withdrawal by Subject|0|||
145258135|NCT02394028|523790365|FG009|Induction Phase|Withdrawal by Subject|0|||
145258136|NCT02394028|523790366|FG010|Induction Phase|Withdrawal by Subject|0|||
145258137|NCT02394028|523790356|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258138|NCT02394028|523790357|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258139|NCT02394028|523790358|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258140|NCT02394028|523790359|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258141|NCT02394028|523790360|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258142|NCT02394028|523790361|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258143|NCT02394028|523790362|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
145258144|NCT02394028|523790363|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258145|NCT02394028|523790364|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258146|NCT02394028|523790365|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258147|NCT02394028|523790366|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
145258148|NCT02394028|523790356|FG000|Induction Phase|Sponsor decision|0|||
145258149|NCT02394028|523790357|FG001|Induction Phase|Sponsor decision|1|||
145258150|NCT02394028|523790358|FG002|Induction Phase|Sponsor decision|2|||
145258151|NCT02394028|523790359|FG003|Induction Phase|Sponsor decision|0|||
145258152|NCT02394028|523790360|FG004|Induction Phase|Sponsor decision|0|||
145258153|NCT02394028|523790361|FG005|Induction Phase|Sponsor decision|0|||
145258154|NCT02394028|523790362|FG006|Induction Phase|Sponsor decision|0|||
145568605|NCT00615056|524940635|FG003|Overall Study|Withdrawal by Subject|0|||
145568606|NCT00615056|524940632|FG000|Overall Study|Discontinued by Sponsor|1|||
145568607|NCT00615056|524940633|FG001|Overall Study|Discontinued by Sponsor|0|||
145568608|NCT00615056|524940634|FG002|Overall Study|Discontinued by Sponsor|0|||
145568609|NCT00615056|524940635|FG003|Overall Study|Discontinued by Sponsor|0|||
145568610|NCT00615056|524940632|FG000|Overall Study|Randomized but not treated|3|||
145568611|NCT00615056|524940633|FG001|Overall Study|Randomized but not treated|0|||
145568612|NCT00615056|524940634|FG002|Overall Study|Randomized but not treated|0|||
145568613|NCT00615056|524940635|FG003|Overall Study|Randomized but not treated|0|||
145568614|NCT04536727|524940636|FG000|Overall Study|Lost to Follow-up|1|||
145568615|NCT04536727|524940637|FG001|Overall Study|Lost to Follow-up|1|||
145568616|NCT04536727|524940636|FG000|Overall Study|Death|0|||
145568617|NCT04536727|524940637|FG001|Overall Study|Death|1|||
145568618|NCT02565381|524942241|FG000|Overall Study|Lost to Follow-up|1|||
145568619|NCT02565381|524942242|FG001|Overall Study|Lost to Follow-up|0|||
145568620|NCT02565381|524942243|FG002|Overall Study|Lost to Follow-up|1|||
145568621|NCT03568942|524942248|FG000|Overall Study|Family emergency|1|||
145568622|NCT03568942|524942248|FG000|Overall Study|Lost to Follow-up|1|||
145258155|NCT02394028|523790363|FG007|Induction Phase|Sponsor decision|0|||
145258156|NCT02394028|523790364|FG008|Induction Phase|Sponsor decision|0|||
145258157|NCT02394028|523790365|FG009|Induction Phase|Sponsor decision|0|||
145258158|NCT02394028|523790366|FG010|Induction Phase|Sponsor decision|0|||
145258159|NCT02394028|523790356|FG000|Induction Phase|Technical reason|0|||
145258160|NCT02394028|523790357|FG001|Induction Phase|Technical reason|0|||
145258161|NCT02394028|523790358|FG002|Induction Phase|Technical reason|0|||
145258162|NCT02394028|523790359|FG003|Induction Phase|Technical reason|1|||
145258163|NCT02394028|523790360|FG004|Induction Phase|Technical reason|0|||
145258164|NCT02394028|523790361|FG005|Induction Phase|Technical reason|0|||
145258165|NCT02394028|523790362|FG006|Induction Phase|Technical reason|0|||
145568623|NCT02223767|524942255|FG000|Overall Study|Withdrawal by Subject|4|||
145568624|NCT02223767|524942256|FG001|Overall Study|Withdrawal by Subject|4|||
145258166|NCT02394028|523790363|FG007|Induction Phase|Technical reason|0|||
145258167|NCT02394028|523790364|FG008|Induction Phase|Technical reason|0|||
145258168|NCT02394028|523790365|FG009|Induction Phase|Technical reason|0|||
145258169|NCT02394028|523790366|FG010|Induction Phase|Technical reason|0|||
145258170|NCT02394028|523790356|FG000|Induction Phase|:ack of calculation|0|||
145258171|NCT02394028|523790357|FG001|Induction Phase|:ack of calculation|0|||
145258172|NCT02394028|523790358|FG002|Induction Phase|:ack of calculation|0|||
145258173|NCT02394028|523790359|FG003|Induction Phase|:ack of calculation|0|||
145258174|NCT02394028|523790360|FG004|Induction Phase|:ack of calculation|0|||
145258175|NCT02394028|523790361|FG005|Induction Phase|:ack of calculation|0|||
145258176|NCT02394028|523790362|FG006|Induction Phase|:ack of calculation|0|||
145258177|NCT02394028|523790363|FG007|Induction Phase|:ack of calculation|1|||
145258178|NCT02394028|523790364|FG008|Induction Phase|:ack of calculation|0|||
145258179|NCT02394028|523790365|FG009|Induction Phase|:ack of calculation|0|||
145258180|NCT02394028|523790366|FG010|Induction Phase|:ack of calculation|0|||
145258181|NCT02394028|523790356|FG000|Maintenance Phase|Protocol Violation|0|||
145258182|NCT02394028|523790357|FG001|Maintenance Phase|Protocol Violation|0|||
145258183|NCT02394028|523790358|FG002|Maintenance Phase|Protocol Violation|0|||
145258184|NCT02394028|523790359|FG003|Maintenance Phase|Protocol Violation|0|||
145258185|NCT02394028|523790360|FG004|Maintenance Phase|Protocol Violation|0|||
145258186|NCT02394028|523790361|FG005|Maintenance Phase|Protocol Violation|0|||
145258187|NCT02394028|523790362|FG006|Maintenance Phase|Protocol Violation|0|||
145258188|NCT02394028|523790363|FG007|Maintenance Phase|Protocol Violation|0|||
145258189|NCT02394028|523790364|FG008|Maintenance Phase|Protocol Violation|0|||
145258190|NCT02394028|523790365|FG009|Maintenance Phase|Protocol Violation|0|||
145258191|NCT02394028|523790366|FG010|Maintenance Phase|Protocol Violation|1|||
145258192|NCT02394028|523790356|FG000|Maintenance Phase|Physician Decision|0|||
145258193|NCT02394028|523790357|FG001|Maintenance Phase|Physician Decision|0|||
145258194|NCT02394028|523790358|FG002|Maintenance Phase|Physician Decision|0|||
145258195|NCT02394028|523790359|FG003|Maintenance Phase|Physician Decision|0|||
145258196|NCT02394028|523790360|FG004|Maintenance Phase|Physician Decision|0|||
145258197|NCT02394028|523790361|FG005|Maintenance Phase|Physician Decision|0|||
145258198|NCT02394028|523790362|FG006|Maintenance Phase|Physician Decision|0|||
145258199|NCT02394028|523790363|FG007|Maintenance Phase|Physician Decision|0|||
145258200|NCT02394028|523790364|FG008|Maintenance Phase|Physician Decision|1|||
145258201|NCT02394028|523790365|FG009|Maintenance Phase|Physician Decision|3|||
145258202|NCT02394028|523790366|FG010|Maintenance Phase|Physician Decision|2|||
145258203|NCT02394028|523790356|FG000|Maintenance Phase|Lack of Efficacy|0|||
145258204|NCT02394028|523790357|FG001|Maintenance Phase|Lack of Efficacy|0|||
145258205|NCT02394028|523790358|FG002|Maintenance Phase|Lack of Efficacy|0|||
145258206|NCT02394028|523790359|FG003|Maintenance Phase|Lack of Efficacy|0|||
145258207|NCT02394028|523790360|FG004|Maintenance Phase|Lack of Efficacy|0|||
145258208|NCT02394028|523790361|FG005|Maintenance Phase|Lack of Efficacy|0|||
145258209|NCT02394028|523790362|FG006|Maintenance Phase|Lack of Efficacy|0|||
145258210|NCT02394028|523790363|FG007|Maintenance Phase|Lack of Efficacy|0|||
145258211|NCT02394028|523790364|FG008|Maintenance Phase|Lack of Efficacy|7|||
145258212|NCT02394028|523790365|FG009|Maintenance Phase|Lack of Efficacy|25|||
145258213|NCT02394028|523790366|FG010|Maintenance Phase|Lack of Efficacy|33|||
145258214|NCT02394028|523790356|FG000|Maintenance Phase|Death|0|||
145258215|NCT02394028|523790357|FG001|Maintenance Phase|Death|0|||
145258216|NCT02394028|523790358|FG002|Maintenance Phase|Death|0|||
145258217|NCT02394028|523790359|FG003|Maintenance Phase|Death|0|||
145258218|NCT02394028|523790360|FG004|Maintenance Phase|Death|0|||
145258219|NCT02394028|523790361|FG005|Maintenance Phase|Death|0|||
145258220|NCT02394028|523790362|FG006|Maintenance Phase|Death|0|||
145258221|NCT02394028|523790363|FG007|Maintenance Phase|Death|0|||
145258222|NCT02394028|523790364|FG008|Maintenance Phase|Death|0|||
145258223|NCT02394028|523790365|FG009|Maintenance Phase|Death|0|||
145258224|NCT02394028|523790366|FG010|Maintenance Phase|Death|1|||
145258225|NCT02394028|523790356|FG000|Maintenance Phase|Adverse Event|0|||
145258226|NCT02394028|523790357|FG001|Maintenance Phase|Adverse Event|0|||
145258227|NCT02394028|523790358|FG002|Maintenance Phase|Adverse Event|0|||
145301038|NCT02718326|523954929|FG001|Overall Study|Withdrawal by Subject|9|||
145301039|NCT02718326|523954930|FG002|Overall Study|Withdrawal by Subject|6|||
145301040|NCT02718326|523954928|FG000|Overall Study|Lost to Follow-up|18|||
145301041|NCT02718326|523954929|FG001|Overall Study|Lost to Follow-up|5|||
145301042|NCT02718326|523954930|FG002|Overall Study|Lost to Follow-up|14|||
145258228|NCT02394028|523790359|FG003|Maintenance Phase|Adverse Event|0|||
145258229|NCT02394028|523790360|FG004|Maintenance Phase|Adverse Event|0|||
145258230|NCT02394028|523790361|FG005|Maintenance Phase|Adverse Event|0|||
145258231|NCT02394028|523790362|FG006|Maintenance Phase|Adverse Event|0|||
145258232|NCT02394028|523790363|FG007|Maintenance Phase|Adverse Event|0|||
145258233|NCT02394028|523790364|FG008|Maintenance Phase|Adverse Event|1|||
145301043|NCT02718326|523954928|FG000|Overall Study|Protocol Deviation|1|||
145258234|NCT02394028|523790365|FG009|Maintenance Phase|Adverse Event|1|||
145258235|NCT02394028|523790366|FG010|Maintenance Phase|Adverse Event|3|||
145258236|NCT02394028|523790356|FG000|Maintenance Phase|Site closure|0|||
145258237|NCT02394028|523790357|FG001|Maintenance Phase|Site closure|0|||
145258238|NCT02394028|523790358|FG002|Maintenance Phase|Site closure|0|||
145258239|NCT02394028|523790359|FG003|Maintenance Phase|Site closure|0|||
145258240|NCT02394028|523790360|FG004|Maintenance Phase|Site closure|0|||
145258241|NCT02394028|523790361|FG005|Maintenance Phase|Site closure|0|||
145258242|NCT02394028|523790362|FG006|Maintenance Phase|Site closure|0|||
145258243|NCT02394028|523790363|FG007|Maintenance Phase|Site closure|0|||
145258244|NCT02394028|523790364|FG008|Maintenance Phase|Site closure|0|||
145258245|NCT02394028|523790365|FG009|Maintenance Phase|Site closure|1|||
145258246|NCT02394028|523790366|FG010|Maintenance Phase|Site closure|0|||
145258247|NCT02394028|523790356|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145258248|NCT02394028|523790357|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145258249|NCT02394028|523790358|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145258250|NCT02394028|523790359|FG003|Maintenance Phase|Withdrawal by Subject|0|||
145258251|NCT02394028|523790360|FG004|Maintenance Phase|Withdrawal by Subject|0|||
145258252|NCT02394028|523790361|FG005|Maintenance Phase|Withdrawal by Subject|0|||
145258253|NCT02394028|523790362|FG006|Maintenance Phase|Withdrawal by Subject|0|||
145258254|NCT02394028|523790363|FG007|Maintenance Phase|Withdrawal by Subject|0|||
145258255|NCT02394028|523790364|FG008|Maintenance Phase|Withdrawal by Subject|3|||
145258256|NCT02394028|523790365|FG009|Maintenance Phase|Withdrawal by Subject|12|||
145258257|NCT02394028|523790366|FG010|Maintenance Phase|Withdrawal by Subject|12|||
145258258|NCT04815291|523790380|FG000|Overall Study|Lost to Follow-up|1|||
145258259|NCT04815291|523790380|FG000|Overall Study|Physician Decision|4|||
145258260|NCT04815291|523790380|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
145258261|NCT01899729|523790383|FG000|Overall Study|Adverse Event|1|||
145258262|NCT01899729|523790384|FG001|Overall Study|Adverse Event|0|||
145258263|NCT01899729|523790385|FG002|Overall Study|Adverse Event|0|||
145258264|NCT01899729|523790386|FG003|Overall Study|Adverse Event|0|||
145258265|NCT01899729|523790387|FG004|Overall Study|Adverse Event|1|||
145258266|NCT01899729|523790383|FG000|Overall Study|Withdrawal by Subject|1|||
145258267|NCT01899729|523790384|FG001|Overall Study|Withdrawal by Subject|2|||
145258268|NCT01899729|523790385|FG002|Overall Study|Withdrawal by Subject|0|||
145258269|NCT01899729|523790386|FG003|Overall Study|Withdrawal by Subject|0|||
145258270|NCT01899729|523790387|FG004|Overall Study|Withdrawal by Subject|0|||
145258271|NCT01899729|523790383|FG000|Overall Study|Lack of Efficacy|0|||
145258272|NCT01899729|523790384|FG001|Overall Study|Lack of Efficacy|0|||
145258273|NCT01899729|523790385|FG002|Overall Study|Lack of Efficacy|2|||
145258274|NCT01899729|523790386|FG003|Overall Study|Lack of Efficacy|0|||
145258275|NCT01899729|523790387|FG004|Overall Study|Lack of Efficacy|1|||
145258276|NCT01454531|523790388|FG000|Overall Study|Adverse Event|14|||
145258277|NCT01454531|523790388|FG000|Overall Study|Withdrawal by Subject|5|||
145258278|NCT01454531|523790388|FG000|Overall Study|Lost to Follow-up|1|||
145258279|NCT01454531|523790388|FG000|Overall Study|Physician Decision|1|||
145258280|NCT01454531|523790388|FG000|Overall Study|Delay in IMP administration|1|||
145258281|NCT01454531|523790388|FG000|Overall Study|Other|1|||
145258282|NCT00095836|523790389|FG000|Overall Study|Lost to Follow-up|1|||
145258283|NCT00095836|523790389|FG000|Overall Study|Adverse Event|1|||
145258284|NCT00095836|523790389|FG000|Overall Study|Death|2|||
145258285|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
145258286|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
145258287|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
145258288|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
145258289|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
145258290|NCT00989664|523790392|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
145258291|NCT00989664|523790392|FG000|Long-Term Follow-Up|Death|3|||
145301044|NCT02718326|523954929|FG001|Overall Study|Protocol Deviation|0|||
145301045|NCT02718326|523954930|FG002|Overall Study|Protocol Deviation|0|||
145568625|NCT02433834|524942257|FG000|Overall Study|Protocol-specified criteria|7|||
145568626|NCT02433834|524942257|FG000|Overall Study|Protocol Violation|3|||
145568627|NCT02433834|524942257|FG000|Overall Study|Lost to Follow-up|6|||
145568628|NCT02433834|524942257|FG000|Overall Study|Withdrawal by Subject|14|||
145568629|NCT02433834|524942257|FG000|Overall Study|Adverse Event|6|||
145568630|NCT02433834|524942257|FG000|Overall Study|Physician Decision|1|||
145568631|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
145568632|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
145301046|NCT02718326|523954928|FG000|Overall Study|Pregnancy|1|||
145258292|NCT02363322|523790394|FG000|Overall Study|Lost to Follow-up|1|||
145258293|NCT02363322|523790395|FG001|Overall Study|Lost to Follow-up|0|||
145258294|NCT00983827|523790396|FG000|Overall Study|Withdrawal by Subject|1|||
145258295|NCT01854918|523790397|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
145258296|NCT01854918|523790398|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
145258297|NCT01854918|523790397|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
145258298|NCT01854918|523790398|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
145258299|NCT01854918|523790397|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
145258300|NCT01854918|523790398|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
145568633|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
145568634|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
145258301|NCT01854918|523790397|FG000|SOC-controlled Period (Year 1)|Death|5|||
145258302|NCT01854918|523790398|FG001|SOC-controlled Period (Year 1)|Death|5|||
145258303|NCT01854918|523790397|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
145258304|NCT01854918|523790398|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
145258305|NCT01854918|523790397|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
145258306|NCT01854918|523790398|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
145258307|NCT01854918|523790397|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
145258308|NCT01854918|523790398|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
145258309|NCT01854918|523790397|FG000|All-IP Period (Years 2 and 3)|Death|5|||
145258310|NCT01854918|523790398|FG001|All-IP Period (Years 2 and 3)|Death|16|||
145258311|NCT03091920|523790405|FG000|Overall Study|Adverse Event|0|||
145258312|NCT03091920|523790406|FG001|Overall Study|Adverse Event|1|||
145258313|NCT03091920|523790407|FG002|Overall Study|Adverse Event|0|||
145258314|NCT03922945|523792347|FG000|Overall Study|Adverse Event|1|||
145258315|NCT03922945|523792348|FG001|Overall Study|Adverse Event|1|||
145258316|NCT03922945|523792349|FG002|Overall Study|Adverse Event|2|||
145258317|NCT03922945|523792347|FG000|Overall Study|Lost to Follow-up|13|||
145258318|NCT03922945|523792348|FG001|Overall Study|Lost to Follow-up|9|||
145258319|NCT03922945|523792349|FG002|Overall Study|Lost to Follow-up|20|||
145258320|NCT03922945|523792347|FG000|Overall Study|Lack of Efficacy|2|||
145258321|NCT03922945|523792348|FG001|Overall Study|Lack of Efficacy|0|||
145258322|NCT03922945|523792349|FG002|Overall Study|Lack of Efficacy|1|||
145258323|NCT03922945|523792347|FG000|Overall Study|Protocol Non-Compliance|0|||
145258324|NCT03922945|523792348|FG001|Overall Study|Protocol Non-Compliance|0|||
145258325|NCT03922945|523792349|FG002|Overall Study|Protocol Non-Compliance|1|||
145258326|NCT03922945|523792347|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
145258327|NCT03922945|523792348|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
145258328|NCT03922945|523792349|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
145258329|NCT03922945|523792347|FG000|Overall Study|All Other Personal Reasons|1|||
145258330|NCT03922945|523792348|FG001|Overall Study|All Other Personal Reasons|1|||
145258331|NCT03922945|523792349|FG002|Overall Study|All Other Personal Reasons|2|||
145258332|NCT01603615|523792360|FG000|Overall Study|Did not Receive Treatment|7|||
145258333|NCT01603615|523792360|FG000|Overall Study|Lost to Follow-up|9|||
145258334|NCT01603615|523792360|FG000|Overall Study|Personal Reasons|17|||
145258335|NCT01603615|523792360|FG000|Overall Study|Other Miscellaneous|1|||
145258336|NCT02719028|523792364|FG000|Overall Study|Adverse Event|2|||
145258337|NCT02719028|523792365|FG001|Overall Study|Adverse Event|1|||
145258338|NCT02719028|523792366|FG002|Overall Study|Adverse Event|4|||
145258339|NCT02719028|523792367|FG003|Overall Study|Adverse Event|8|||
145258340|NCT02719028|523792364|FG000|Overall Study|Physician Decision|0|||
145258341|NCT02719028|523792365|FG001|Overall Study|Physician Decision|1|||
145258342|NCT02719028|523792366|FG002|Overall Study|Physician Decision|1|||
145258343|NCT02719028|523792367|FG003|Overall Study|Physician Decision|1|||
145258344|NCT02719028|523792364|FG000|Overall Study|Use of prohibited medication|0|||
145258345|NCT02719028|523792365|FG001|Overall Study|Use of prohibited medication|0|||
145258346|NCT02719028|523792366|FG002|Overall Study|Use of prohibited medication|1|||
145258347|NCT02719028|523792367|FG003|Overall Study|Use of prohibited medication|0|||
145258348|NCT02719028|523792364|FG000|Overall Study|Protocol Violation|0|||
145258349|NCT02719028|523792365|FG001|Overall Study|Protocol Violation|0|||
145301047|NCT02718326|523954929|FG001|Overall Study|Pregnancy|0|||
145301048|NCT02718326|523954930|FG002|Overall Study|Pregnancy|0|||
145301049|NCT02472366|523954935|FG000|Overall Study|Lost to Follow-up|1|||
145301050|NCT02472366|523954936|FG001|Overall Study|Lost to Follow-up|0|||
145301051|NCT03620747|523954942|FG000|Overall Study|Participant decision|7|||
145301052|NCT03620747|523954942|FG000|Overall Study|Adverse Event|6|||
145301053|NCT03620747|523954942|FG000|Overall Study|Lack of Efficacy|1|||
145258350|NCT02719028|523792366|FG002|Overall Study|Protocol Violation|0|||
145258351|NCT02719028|523792367|FG003|Overall Study|Protocol Violation|1|||
145258352|NCT01539720|523792368|FG000|Overall Study|Screen Fail|15|||
145258353|NCT01539720|523792369|FG001|Overall Study|Screen Fail|3|||
145258354|NCT01539720|523792368|FG000|Overall Study|Lost to Follow-up|14|||
145258355|NCT01539720|523792369|FG001|Overall Study|Lost to Follow-up|7|||
145258356|NCT00298766|523792370|FG000|Overall Study|Adverse Event|18|||
145258357|NCT00298766|523792370|FG000|Overall Study|Death|2|||
145258358|NCT00298766|523792370|FG000|Overall Study|Withdrawal by Subject|9|||
145258359|NCT00298766|523792370|FG000|Overall Study|Treatment ongoing|4|||
145258360|NCT00298766|523792370|FG000|Overall Study|Progression of amyloid markers|4|||
145258361|NCT00298766|523792370|FG000|Overall Study|Deterioration in KPS and organ function|1|||
145258362|NCT00298766|523792370|FG000|Overall Study|Subjects overall condition deterioration|4|||
145301054|NCT03620747|523954942|FG000|Overall Study|Poor compliance to protocol|2|||
145258363|NCT00298766|523792370|FG000|Overall Study|Other|4|||
145301055|NCT03620747|523954942|FG000|Overall Study|Other-unspecified|3|||
145301056|NCT01513174|523954951|FG000|Overall Study|Inclusion Error|1|||
145258364|NCT03287960|523792371|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
145258365|NCT03287960|523792371|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
145301057|NCT01513174|523954952|FG001|Overall Study|Inclusion Error|7|||
145301058|NCT01513174|523954951|FG000|Overall Study|Not receive study treatment|3|||
145258366|NCT00656136|523792374|FG000|Overall Study|Progressive disease|177|||
145258367|NCT00656136|523792375|FG001|Overall Study|Progressive disease|322|||
145258368|NCT00656136|523792374|FG000|Overall Study|Other Adverse Event|5|||
145258369|NCT00656136|523792375|FG001|Overall Study|Other Adverse Event|51|||
145258370|NCT00656136|523792374|FG000|Overall Study|Protocol Violation|2|||
145258371|NCT00656136|523792375|FG001|Overall Study|Protocol Violation|3|||
145258372|NCT00656136|523792374|FG000|Overall Study|Patient refused to take study medication|7|||
145258373|NCT00656136|523792375|FG001|Overall Study|Patient refused to take study medication|10|||
145258374|NCT00656136|523792374|FG000|Overall Study|Unknown and others|4|||
145258375|NCT00656136|523792375|FG001|Overall Study|Unknown and others|4|||
145258376|NCT01191190|523792377|FG000|Overall Study|Withdrawal by Subject|1|||
145258377|NCT01345162|523792382|FG000|Overall Study|Protocol Violation|2|||
145258378|NCT01345162|523792383|FG001|Overall Study|Protocol Violation|4|||
145258379|NCT01398176|523792384|FG000|Overall Study|Lost to Follow-up|1|||
145258380|NCT01398176|523792385|FG001|Overall Study|Lost to Follow-up|3|||
145258381|NCT01398176|523792384|FG000|Overall Study|Physician Decision|2|||
145258382|NCT01398176|523792385|FG001|Overall Study|Physician Decision|3|||
145258383|NCT01871870|523792386|FG000|Overall Study|Hardware issues|7|||
145258384|NCT01871870|523792386|FG000|Overall Study|hyperglycemia|2|||
145258385|NCT01977651|523792390|FG000|4 Month Treatment Period|Adverse Event|34|||
145301059|NCT01513174|523954952|FG001|Overall Study|Not receive study treatment|1|||
145301060|NCT00635492|523954953|FG000|Overall Study|Death|12|||
145301061|NCT00635492|523954954|FG001|Overall Study|Death|40|||
145301062|NCT00635492|523954953|FG000|Overall Study|Lost to Follow-up|151|||
145301063|NCT00635492|523954954|FG001|Overall Study|Lost to Follow-up|172|||
145301064|NCT00635492|523954953|FG000|Overall Study|Physician Decision|32|||
145301065|NCT00635492|523954954|FG001|Overall Study|Physician Decision|22|||
145301066|NCT00635492|523954953|FG000|Overall Study|Sponsor decision|2|||
145301067|NCT00635492|523954954|FG001|Overall Study|Sponsor decision|3|||
145301068|NCT00635492|523954953|FG000|Overall Study|Withdrawal by Subject|82|||
145301069|NCT00635492|523954954|FG001|Overall Study|Withdrawal by Subject|45|||
145301070|NCT01900626|523954955|FG000|Overall Study|study was closed due to low enrollment|1|||
145301071|NCT01900626|523954956|FG001|Overall Study|study was closed due to low enrollment|1|||
145301072|NCT00467363|523954962|FG000|Overall Study|Lost to Follow-up|80|||
145301073|NCT00467363|523954963|FG001|Overall Study|Lost to Follow-up|70|||
145301074|NCT04533594|523954964|FG000|Overall Study|Death|26|||
145301075|NCT00473330|523954968|FG000|Core Study|Adverse Event|4|||
145301076|NCT00473330|523954969|FG001|Core Study|Adverse Event|4|||
145301077|NCT00473330|523954970|FG002|Core Study|Adverse Event|1|||
145301078|NCT00473330|523954968|FG000|Core Study|Death|6|||
145301079|NCT00473330|523954969|FG001|Core Study|Death|4|||
145301080|NCT00473330|523954970|FG002|Core Study|Death|4|||
145301081|NCT00473330|523954968|FG000|Core Study|Lost to Follow-up|5|||
145301082|NCT00473330|523954969|FG001|Core Study|Lost to Follow-up|5|||
145301083|NCT00473330|523954970|FG002|Core Study|Lost to Follow-up|10|||
145301084|NCT00473330|523954968|FG000|Core Study|Physician Decision|2|||
145301085|NCT00473330|523954969|FG001|Core Study|Physician Decision|1|||
145301086|NCT00473330|523954970|FG002|Core Study|Physician Decision|3|||
145301087|NCT00473330|523954968|FG000|Core Study|Subject Non-compliance|1|||
145301088|NCT00473330|523954969|FG001|Core Study|Subject Non-compliance|2|||
145301089|NCT00473330|523954970|FG002|Core Study|Subject Non-compliance|1|||
145301090|NCT00473330|523954968|FG000|Core Study|Subject Required Other Therapy|0|||
145301091|NCT00473330|523954969|FG001|Core Study|Subject Required Other Therapy|1|||
145301092|NCT00473330|523954970|FG002|Core Study|Subject Required Other Therapy|3|||
145301093|NCT00473330|523954968|FG000|Core Study|Subject's Decision|9|||
145301094|NCT00473330|523954969|FG001|Core Study|Subject's Decision|8|||
145301095|NCT00473330|523954970|FG002|Core Study|Subject's Decision|19|||
145301096|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
145301097|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
145301098|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
145301099|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Death|2|||
145301100|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Death|0|||
145301101|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Death|0|||
145301102|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
145301103|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
145258386|NCT01977651|523792390|FG000|4 Month Treatment Period|Death|3|||
145258387|NCT01977651|523792390|FG000|4 Month Treatment Period|Progressive Disease|43|||
145301104|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
145301105|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
145301106|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
145301107|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
145301108|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
145301109|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
145301110|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
145258388|NCT01977651|523792390|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
145258389|NCT01977651|523792390|FG000|4 Month Treatment Period|Physician Decision|4|||
145258390|NCT01977651|523792390|FG000|1 Year Extension Period|Adverse Event|14|||
145258391|NCT01977651|523792390|FG000|1 Year Extension Period|Death|10|||
145258392|NCT01977651|523792390|FG000|1 Year Extension Period|Lost to Follow-up|2|||
145258393|NCT01977651|523792390|FG000|1 Year Extension Period|Progressive Disease|86|||
145258394|NCT01977651|523792390|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
145258395|NCT01977651|523792390|FG000|1 Year Extension Period|Physician Decision|6|||
145258396|NCT01977651|523792390|FG000|1 Year Extension Period|Miscellaneous|1|||
145258397|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Adverse Event|5|||
145258398|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Death|13|||
145258399|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
145258400|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
145258401|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Physician Decision|4|||
145410783|NCT02903914|524356846|FG001|Overall Study|New Cancer Therapy|2|||
145410784|NCT02903914|524356847|FG002|Overall Study|New Cancer Therapy|21|||
145410785|NCT02903914|524356848|FG003|Overall Study|New Cancer Therapy|4|||
145410786|NCT02903914|524356849|FG004|Overall Study|New Cancer Therapy|3|||
145410787|NCT02903914|524356850|FG005|Overall Study|New Cancer Therapy|6|||
145258402|NCT01977651|523792390|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
145258403|NCT03287089|523792391|FG000|Overall Study|Lost to Follow-up|0|||
145258404|NCT03287089|523792392|FG001|Overall Study|Lost to Follow-up|2|||
145258405|NCT03287089|523792391|FG000|Overall Study|Physician Decision|0|||
145258406|NCT03287089|523792392|FG001|Overall Study|Physician Decision|2|||
145258407|NCT03287089|523792391|FG000|Overall Study|Withdrawal by Subject|0|||
145258408|NCT03287089|523792392|FG001|Overall Study|Withdrawal by Subject|2|||
145258409|NCT02543801|523792395|FG000|Overall Study|Protocol Violation|1|||
145258410|NCT02543801|523792396|FG001|Overall Study|Protocol Violation|2|||
145258411|NCT02543801|523792397|FG002|Overall Study|Protocol Violation|0|||
145258412|NCT02543801|523792398|FG003|Overall Study|Protocol Violation|0|||
145258413|NCT04118127|523792405|FG000|Overall Study|Trial terminated by sponsor|0|||
145258414|NCT04118127|523792406|FG001|Overall Study|Trial terminated by sponsor|12|||
145258415|NCT04118127|523792405|FG000|Overall Study|Adverse Event|1|||
145258416|NCT04118127|523792406|FG001|Overall Study|Adverse Event|2|||
145258417|NCT04118127|523792405|FG000|Overall Study|Physician Decision|0|||
145258418|NCT04118127|523792406|FG001|Overall Study|Physician Decision|1|||
145258419|NCT04118127|523792405|FG000|Overall Study|Withdrawal by Subject|2|||
145258420|NCT04118127|523792406|FG001|Overall Study|Withdrawal by Subject|1|||
145258421|NCT01376908|523792407|FG000|Overall Study|Protocol Violation|1|||
145258422|NCT01376908|523792408|FG001|Overall Study|Protocol Violation|1|||
145258423|NCT01376908|523792407|FG000|Overall Study|Withdrawal by Subject|1|||
145258424|NCT01376908|523792408|FG001|Overall Study|Withdrawal by Subject|2|||
145258425|NCT01646255|523792409|FG000|Overall Study|Adverse Event|7|||
145258426|NCT01646255|523792410|FG001|Overall Study|Adverse Event|8|||
145258427|NCT01646255|523792409|FG000|Overall Study|Lack of Efficacy|2|||
145258428|NCT01646255|523792410|FG001|Overall Study|Lack of Efficacy|0|||
145258429|NCT01646255|523792409|FG000|Overall Study|Withdrawal by Subject|10|||
145258430|NCT01646255|523792410|FG001|Overall Study|Withdrawal by Subject|6|||
145258431|NCT01646255|523792409|FG000|Overall Study|Compliance is not well|1|||
145258432|NCT01646255|523792410|FG001|Overall Study|Compliance is not well|0|||
145258433|NCT01646255|523792409|FG000|Overall Study|Inclusion Criteria Deviation|1|||
145258434|NCT01646255|523792410|FG001|Overall Study|Inclusion Criteria Deviation|0|||
145258435|NCT02142712|523792411|FG000|Overall Study|Lost to Follow-up|1|||
145258436|NCT02142712|523792412|FG001|Overall Study|Lost to Follow-up|1|||
145258437|NCT02142712|523792413|FG002|Overall Study|Lost to Follow-up|1|||
145258438|NCT02142712|523792414|FG003|Overall Study|Lost to Follow-up|0|||
145258439|NCT01241318|523792415|FG000|Overall Study|Woman: false pregnancies|27|||
145258440|NCT01241318|523792416|FG001|Overall Study|Woman: false pregnancies|15|||
145258441|NCT01241318|523792415|FG000|Overall Study|Woman: miscarriage/abortion|46|||
145258442|NCT01241318|523792416|FG001|Overall Study|Woman: miscarriage/abortion|38|||
145258443|NCT01241318|523792415|FG000|Overall Study|Withdrawal by Subject|175|||
145258444|NCT01241318|523792416|FG001|Overall Study|Withdrawal by Subject|46|||
145258445|NCT01241318|523792415|FG000|Overall Study|Lost to Follow-up|740|||
145410788|NCT02903914|524356851|FG006|Overall Study|New Cancer Therapy|56|||
145410789|NCT02903914|524356852|FG007|Overall Study|New Cancer Therapy|3|||
145258446|NCT01241318|523792416|FG001|Overall Study|Lost to Follow-up|455|||
145258447|NCT01241318|523792415|FG000|Overall Study|Death|2|||
145258448|NCT01241318|523792416|FG001|Overall Study|Death|4|||
145258449|NCT01241318|523792415|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
145258450|NCT01241318|523792416|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
145258451|NCT01241318|523792415|FG000|Overall Study|Woman: Stillborn infant|129|||
145258452|NCT01241318|523792416|FG001|Overall Study|Woman: Stillborn infant|146|||
145258453|NCT02355665|523792417|FG000|Overall Study|Adverse Event|16|||
145258454|NCT02355665|523792418|FG001|Overall Study|Adverse Event|24|||
145258455|NCT02355665|523792417|FG000|Overall Study|Protocol Violation|2|||
145258456|NCT02355665|523792418|FG001|Overall Study|Protocol Violation|0|||
145258457|NCT02355665|523792417|FG000|Overall Study|Withdrawal by Subject|90|||
145258458|NCT02355665|523792418|FG001|Overall Study|Withdrawal by Subject|100|||
145258459|NCT02355665|523792417|FG000|Overall Study|Lost to Follow-up|131|||
145258460|NCT02355665|523792418|FG001|Overall Study|Lost to Follow-up|103|||
145258461|NCT02355665|523792417|FG000|Overall Study|Death|4|||
145258462|NCT02355665|523792418|FG001|Overall Study|Death|2|||
145258463|NCT02355665|523792417|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
145258464|NCT02355665|523792418|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
145258465|NCT04129242|523792419|FG000|Overall Study|Physician Decision|1|||
145258466|NCT04129242|523792420|FG001|Overall Study|Physician Decision|1|||
145258467|NCT04129242|523792419|FG000|Overall Study|Protocol Violation|0|||
145258468|NCT04129242|523792420|FG001|Overall Study|Protocol Violation|1|||
145258469|NCT03480841|523792421|FG000|Overall Study|Lost to Follow-up|2|||
145258470|NCT01362049|523792422|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
145258471|NCT01362049|523792423|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
145258472|NCT01362049|523792424|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
145258473|NCT01362049|523792425|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
145258474|NCT01362049|523792422|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
145258475|NCT01362049|523792423|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
145258476|NCT01362049|523792424|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
145258477|NCT01362049|523792425|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
145258478|NCT02417935|523792428|FG000|Treatment Period|Adverse Event|12|||
145258479|NCT02417935|523792429|FG001|Treatment Period|Adverse Event|10|||
145258480|NCT02417935|523792428|FG000|Treatment Period|Lost to Follow-up|1|||
145258481|NCT02417935|523792429|FG001|Treatment Period|Lost to Follow-up|0|||
145258482|NCT02417935|523792428|FG000|Treatment Period|Entry Criteria not met|0|||
145301111|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
145301112|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
145301113|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
145301114|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
145301115|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
145301116|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
145301117|NCT00473330|523954968|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
145301118|NCT00473330|523954969|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
145301119|NCT00473330|523954970|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
145301120|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
145301121|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
145301122|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
145301123|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Death|2|||
145301124|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Death|2|||
145301125|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Death|1|||
145301126|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
145301127|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
145301128|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
145301129|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
145301130|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
145301131|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
145301132|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
145301133|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
145301134|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
145301135|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
145301136|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
145301137|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
145301138|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
145301139|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
145301140|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
145301141|NCT00473330|523954968|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
145301142|NCT00473330|523954969|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
145301143|NCT00473330|523954970|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
145301144|NCT01975948|523954971|FG000|Overall Study|Withdrawal by Subject|17|||
145301145|NCT01975948|523954972|FG001|Overall Study|Withdrawal by Subject|21|||
145301146|NCT01975948|523954973|FG002|Overall Study|Withdrawal by Subject|7|||
145301147|NCT01975948|523954974|FG003|Overall Study|Withdrawal by Subject|6|||
145301148|NCT00836056|523954975|FG000|First Intervention|Adverse Event|1|||
145301149|NCT00836056|523954976|FG001|First Intervention|Adverse Event|0|||
145258483|NCT02417935|523792429|FG001|Treatment Period|Entry Criteria not met|1|||
145258484|NCT02417935|523792428|FG000|Treatment Period|Protocol Violation|2|||
145258485|NCT02417935|523792429|FG001|Treatment Period|Protocol Violation|1|||
145258486|NCT02417935|523792428|FG000|Treatment Period|Withdrawal by Subject|3|||
145258487|NCT02417935|523792429|FG001|Treatment Period|Withdrawal by Subject|3|||
145258488|NCT02417935|523792428|FG000|Treatment Period|Physician Decision|3|||
145258489|NCT02417935|523792429|FG001|Treatment Period|Physician Decision|1|||
145258490|NCT02850276|523792430|FG000|Overall Study|screen failure|43|||
145258491|NCT02850276|523792430|FG000|Overall Study|Withdrawal by Subject|14|||
145258492|NCT02850276|523792430|FG000|Overall Study|Physician Decision|2|||
145258493|NCT02850276|523792430|FG000|Overall Study|Lost to Follow-up|2|||
145258494|NCT00962780|523792432|FG000|Overall Study|Death|0|||
145258495|NCT00962780|523792433|FG001|Overall Study|Death|1|||
145258496|NCT00962780|523792432|FG000|Overall Study|Protocol Violation|9|||
145258497|NCT00962780|523792433|FG001|Overall Study|Protocol Violation|4|||
145258498|NCT00962780|523792432|FG000|Overall Study|Withdrawal by Subject|1|||
145258499|NCT00962780|523792433|FG001|Overall Study|Withdrawal by Subject|8|||
145258500|NCT00962780|523792432|FG000|Overall Study|Other|0|||
145258501|NCT00962780|523792433|FG001|Overall Study|Other|1|||
145258502|NCT02853318|523792436|FG000|Overall Study|Withdrawal by Subject|1|||
145258503|NCT02269709|523792437|FG000|Time of Enrollment|Withdrawal by Subject|3|||
145258504|NCT02269709|523792437|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
145258505|NCT02269709|523792437|FG000|Six Month Follow-up|Lost to Follow-up|12|||
145258506|NCT02055976|523792438|FG000|Overall Study|Other|0|||
145301150|NCT01079988|523954977|FG000|Overall Study|Lost to Follow-up|0|||
145301151|NCT01079988|523954978|FG001|Overall Study|Lost to Follow-up|0|||
145301152|NCT01079988|523954979|FG002|Overall Study|Lost to Follow-up|0|||
145301153|NCT01079988|523954980|FG003|Overall Study|Lost to Follow-up|1|||
145301154|NCT01079988|523954981|FG004|Overall Study|Lost to Follow-up|0|||
145301155|NCT01079988|523954977|FG000|Overall Study|Lack of Efficacy|1|||
145301156|NCT01079988|523954978|FG001|Overall Study|Lack of Efficacy|0|||
145301157|NCT01079988|523954979|FG002|Overall Study|Lack of Efficacy|0|||
145301158|NCT01079988|523954980|FG003|Overall Study|Lack of Efficacy|0|||
145301159|NCT01079988|523954981|FG004|Overall Study|Lack of Efficacy|0|||
145301160|NCT01079988|523954977|FG000|Overall Study|Other|0|||
145301161|NCT01079988|523954978|FG001|Overall Study|Other|0|||
145301162|NCT01079988|523954979|FG002|Overall Study|Other|0|||
145301163|NCT01079988|523954980|FG003|Overall Study|Other|2|||
145301164|NCT01079988|523954981|FG004|Overall Study|Other|1|||
145301165|NCT01001208|523954982|FG000|Overall Study|Adverse Event|10|||
145301166|NCT01001208|523954983|FG001|Overall Study|Adverse Event|5|||
145301167|NCT01001208|523954982|FG000|Overall Study|Lost to Follow-up|5|||
145301168|NCT01001208|523954983|FG001|Overall Study|Lost to Follow-up|9|||
145301169|NCT01001208|523954982|FG000|Overall Study|Physician Decision|1|||
145301170|NCT01001208|523954983|FG001|Overall Study|Physician Decision|0|||
145301171|NCT01001208|523954982|FG000|Overall Study|Withdrawal by Subject|4|||
145301172|NCT01001208|523954983|FG001|Overall Study|Withdrawal by Subject|5|||
145301173|NCT01001208|523954982|FG000|Overall Study|Ineligibility Determined|4|||
145301174|NCT01001208|523954983|FG001|Overall Study|Ineligibility Determined|2|||
145301175|NCT01001208|523954982|FG000|Overall Study|Noncompliance|4|||
145301176|NCT01001208|523954983|FG001|Overall Study|Noncompliance|7|||
145301177|NCT01001208|523954982|FG000|Overall Study|Disease Progression|0|||
145301178|NCT01001208|523954983|FG001|Overall Study|Disease Progression|3|||
145301179|NCT01001208|523954982|FG000|Overall Study|Other|0|||
145301180|NCT01001208|523954983|FG001|Overall Study|Other|2|||
145301181|NCT00833937|523954984|FG000|Washout|Withdrawal by Subject|1|||
145301182|NCT00833937|523954985|FG001|Washout|Withdrawal by Subject|0|||
145301183|NCT02032888|523954988|FG000|Treatment Period|Poor compliance/noncompliance|1|||
145301184|NCT02032888|523954989|FG001|Treatment Period|Poor compliance/noncompliance|1|||
145301185|NCT02032888|523954990|FG002|Treatment Period|Poor compliance/noncompliance|0|||
145301186|NCT02032888|523954988|FG000|Treatment Period|Other|1|||
145301187|NCT02032888|523954989|FG001|Treatment Period|Other|1|||
145301188|NCT02032888|523954990|FG002|Treatment Period|Other|0|||
145301189|NCT02032888|523954988|FG000|Follow-up Period|Lost to Follow-up|1|||
145301190|NCT02032888|523954989|FG001|Follow-up Period|Lost to Follow-up|1|||
145301191|NCT02032888|523954990|FG002|Follow-up Period|Lost to Follow-up|0|||
145301192|NCT02032888|523954988|FG000|Follow-up Period|Death|1|||
145301193|NCT02032888|523954989|FG001|Follow-up Period|Death|1|||
145301194|NCT02032888|523954990|FG002|Follow-up Period|Death|0|||
145301195|NCT02032888|523954988|FG000|Follow-up Period|Other|1|||
145301196|NCT02032888|523954989|FG001|Follow-up Period|Other|0|||
145301197|NCT02032888|523954990|FG002|Follow-up Period|Other|0|||
145301198|NCT01697696|523954991|FG000|Overall Study|Study terminated by sponsor|0|||
145301199|NCT01697696|523954992|FG001|Overall Study|Study terminated by sponsor|3|||
145301200|NCT01697696|523954991|FG000|Overall Study|Protocol deviation|1|||
145301201|NCT01697696|523954992|FG001|Overall Study|Protocol deviation|0|||
145301202|NCT01697696|523954991|FG000|Overall Study|Physician Decision|1|||
145301203|NCT01697696|523954992|FG001|Overall Study|Physician Decision|0|||
145301204|NCT01697696|523954991|FG000|Overall Study|Death|4|||
145301205|NCT01697696|523954992|FG001|Overall Study|Death|2|||
145410790|NCT02903914|524356845|FG000|Overall Study|Didn't Return to Site|1|||
145301206|NCT01697696|523954991|FG000|Overall Study|Lost to Follow-up|10|||
145301207|NCT01697696|523954992|FG001|Overall Study|Lost to Follow-up|7|||
145301208|NCT01697696|523954991|FG000|Overall Study|Subject/guardian decision|31|||
145258507|NCT02055976|523792439|FG001|Overall Study|Other|0|||
145301209|NCT01697696|523954992|FG001|Overall Study|Subject/guardian decision|35|||
145301210|NCT03616106|523954993|FG000|Overall Study|Removed by PI|6|||
145258508|NCT02055976|523792440|FG002|Overall Study|Other|1|||
145258509|NCT02055976|523792441|FG003|Overall Study|Other|0|||
145258510|NCT02055976|523792442|FG004|Overall Study|Other|0|||
145258511|NCT02055976|523792443|FG005|Overall Study|Other|0|||
145258512|NCT02055976|523792444|FG006|Overall Study|Other|0|||
145258513|NCT02055976|523792445|FG007|Overall Study|Other|0|||
145258514|NCT02055976|523792446|FG008|Overall Study|Other|0|||
145258515|NCT02055976|523792438|FG000|Overall Study|Adverse Event|0|||
145258516|NCT02055976|523792439|FG001|Overall Study|Adverse Event|0|||
145258517|NCT02055976|523792440|FG002|Overall Study|Adverse Event|0|||
145258518|NCT02055976|523792441|FG003|Overall Study|Adverse Event|0|||
145258519|NCT02055976|523792442|FG004|Overall Study|Adverse Event|0|||
145258520|NCT02055976|523792443|FG005|Overall Study|Adverse Event|1|||
145258521|NCT02055976|523792444|FG006|Overall Study|Adverse Event|1|||
145258522|NCT02055976|523792445|FG007|Overall Study|Adverse Event|0|||
145258523|NCT02055976|523792446|FG008|Overall Study|Adverse Event|0|||
145258524|NCT02055976|523792438|FG000|Overall Study|Does not meet entrance criteria|0|||
145258525|NCT02055976|523792439|FG001|Overall Study|Does not meet entrance criteria|0|||
145258526|NCT02055976|523792440|FG002|Overall Study|Does not meet entrance criteria|0|||
145258527|NCT02055976|523792441|FG003|Overall Study|Does not meet entrance criteria|0|||
145258528|NCT02055976|523792442|FG004|Overall Study|Does not meet entrance criteria|0|||
145258529|NCT02055976|523792443|FG005|Overall Study|Does not meet entrance criteria|0|||
145258530|NCT02055976|523792444|FG006|Overall Study|Does not meet entrance criteria|1|||
145258531|NCT02055976|523792445|FG007|Overall Study|Does not meet entrance criteria|0|||
145258532|NCT02055976|523792446|FG008|Overall Study|Does not meet entrance criteria|0|||
145258533|NCT02055976|523792438|FG000|Overall Study|Lost to Follow-up|0|||
145258534|NCT02055976|523792439|FG001|Overall Study|Lost to Follow-up|0|||
145258535|NCT02055976|523792440|FG002|Overall Study|Lost to Follow-up|0|||
145258536|NCT02055976|523792441|FG003|Overall Study|Lost to Follow-up|1|||
145258537|NCT02055976|523792442|FG004|Overall Study|Lost to Follow-up|0|||
145258538|NCT02055976|523792443|FG005|Overall Study|Lost to Follow-up|0|||
145258539|NCT02055976|523792444|FG006|Overall Study|Lost to Follow-up|0|||
145258540|NCT02055976|523792445|FG007|Overall Study|Lost to Follow-up|0|||
145258541|NCT02055976|523792446|FG008|Overall Study|Lost to Follow-up|0|||
145258542|NCT04411472|523792447|FG000|Overall Study|Adverse Event|5|||
145258543|NCT04411472|523792448|FG001|Overall Study|Adverse Event|10|||
145258544|NCT04411472|523792449|FG002|Overall Study|Adverse Event|1|||
145258545|NCT04411472|523792450|FG003|Overall Study|Adverse Event|0|||
145258546|NCT04411472|523792451|FG004|Overall Study|Adverse Event|0|||
145258547|NCT04411472|523792452|FG005|Overall Study|Adverse Event|0|||
145258548|NCT04411472|523792447|FG000|Overall Study|Protocol Violation|1|||
145258549|NCT04411472|523792448|FG001|Overall Study|Protocol Violation|0|||
145258550|NCT04411472|523792449|FG002|Overall Study|Protocol Violation|0|||
145258551|NCT04411472|523792450|FG003|Overall Study|Protocol Violation|0|||
145258552|NCT04411472|523792451|FG004|Overall Study|Protocol Violation|0|||
145258553|NCT04411472|523792452|FG005|Overall Study|Protocol Violation|0|||
145258554|NCT04411472|523792447|FG000|Overall Study|Withdrawal by Subject|0|||
145258555|NCT04411472|523792448|FG001|Overall Study|Withdrawal by Subject|1|||
145258556|NCT04411472|523792449|FG002|Overall Study|Withdrawal by Subject|0|||
145258557|NCT04411472|523792450|FG003|Overall Study|Withdrawal by Subject|1|||
145258558|NCT04411472|523792451|FG004|Overall Study|Withdrawal by Subject|0|||
145258559|NCT04411472|523792452|FG005|Overall Study|Withdrawal by Subject|0|||
145258560|NCT04411472|523792447|FG000|Overall Study|Physician Decision|1|||
145258561|NCT04411472|523792448|FG001|Overall Study|Physician Decision|0|||
145258562|NCT04411472|523792449|FG002|Overall Study|Physician Decision|0|||
145258563|NCT04411472|523792450|FG003|Overall Study|Physician Decision|0|||
145301211|NCT03616106|523954994|FG001|Overall Study|Removed by PI|0|||
145301212|NCT03616106|523954993|FG000|Overall Study|Withdrawal by Subject|1|||
145301213|NCT03616106|523954994|FG001|Overall Study|Withdrawal by Subject|1|||
145301214|NCT03616106|523954993|FG000|Overall Study|Lost to Follow-up|7|||
145301215|NCT03616106|523954994|FG001|Overall Study|Lost to Follow-up|0|||
145568635|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
145258564|NCT04411472|523792451|FG004|Overall Study|Physician Decision|0|||
145258565|NCT04411472|523792452|FG005|Overall Study|Physician Decision|0|||
145258566|NCT04411472|523792447|FG000|Overall Study|Study terminated by sponsor|17|||
145568636|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
145568637|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
145258567|NCT04411472|523792448|FG001|Overall Study|Study terminated by sponsor|20|||
145258568|NCT04411472|523792449|FG002|Overall Study|Study terminated by sponsor|3|||
145258569|NCT04411472|523792450|FG003|Overall Study|Study terminated by sponsor|0|||
145258570|NCT04411472|523792451|FG004|Overall Study|Study terminated by sponsor|0|||
145258571|NCT04411472|523792452|FG005|Overall Study|Study terminated by sponsor|0|||
145258572|NCT00426842|523792453|FG000|Overall Study|Lost to Follow-up|1|||
145258573|NCT03769753|523792454|FG000|Overall Study|Not Treated|6|||
145258574|NCT03769753|523792454|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
145301216|NCT01880593|523954995|FG000|Overall Study|Adverse Event|1|||
145258575|NCT00684073|523792455|FG000|Selection|Selection/non-selection criteria|3|||
145258576|NCT00684073|523792455|FG000|Selection|Death|1|||
145258577|NCT00684073|523792455|FG000|Selection|noncompliance|1|||
145258578|NCT00684073|523792455|FG000|Selection|Lost to Follow-up|1|||
145258579|NCT00684073|523792455|FG000|Selection|request of the sponsor|1|||
145258580|NCT00684073|523792455|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
145258581|NCT03529162|523792458|FG000|Overall Study|Lost to Follow-up|2|||
145258582|NCT03529162|523792459|FG001|Overall Study|Lost to Follow-up|2|||
145258583|NCT02728804|523792465|FG000|Overall Study|Ineligible|3|||
145258584|NCT02728804|523792465|FG000|Overall Study|Did not complete baseline questionnaire|9|||
145258585|NCT02728804|523792465|FG000|Overall Study|Death|99|||
145258586|NCT02146352|523792466|FG000|Overall Study|Death|1|||
145258587|NCT02146352|523792466|FG000|Overall Study|Patient entered hospice care|1|||
145258588|NCT02918006|523792467|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
145258589|NCT02918006|523792468|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
145258590|NCT02918006|523792469|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
145258591|NCT02918006|523792467|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
145258592|NCT02918006|523792468|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
145258593|NCT02918006|523792469|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
145258594|NCT02918006|523792467|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
145258595|NCT02918006|523792468|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
145258596|NCT02918006|523792469|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
145258597|NCT02918006|523792467|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
145258598|NCT02918006|523792468|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
145258599|NCT02918006|523792469|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
145258600|NCT02918006|523792467|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
145258601|NCT02918006|523792468|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
145258602|NCT02918006|523792469|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
145301217|NCT01880593|523954996|FG001|Overall Study|Adverse Event|0|||
145301218|NCT01880593|523954995|FG000|Overall Study|Lack of Efficacy|1|||
145301219|NCT01880593|523954996|FG001|Overall Study|Lack of Efficacy|5|||
145301220|NCT01880593|523954995|FG000|Overall Study|Withdrawal by Subject|6|||
145301221|NCT01880593|523954996|FG001|Overall Study|Withdrawal by Subject|1|||
145301222|NCT02272777|523954997|FG000|Overall Study|Adverse Event|0|||
145301223|NCT02272777|523954998|FG001|Overall Study|Adverse Event|1|||
145301224|NCT02272777|523954997|FG000|Overall Study|Withdrawal by Subject|0|||
145301225|NCT02272777|523954998|FG001|Overall Study|Withdrawal by Subject|3|||
145301226|NCT02272777|523954997|FG000|Overall Study|Lost to Follow-up|2|||
145301227|NCT02272777|523954998|FG001|Overall Study|Lost to Follow-up|0|||
145301228|NCT02272777|523954997|FG000|Overall Study|Other|2|||
145301229|NCT02272777|523954998|FG001|Overall Study|Other|0|||
145258603|NCT02918006|523792467|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
145258604|NCT02918006|523792468|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
145258605|NCT02918006|523792469|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
145258606|NCT02918006|523792467|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
145258607|NCT02918006|523792468|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
145258608|NCT02918006|523792469|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
145258609|NCT02918006|523792467|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
145258610|NCT02918006|523792468|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
145258611|NCT02918006|523792469|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
145258612|NCT02918006|523792467|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
145258613|NCT02918006|523792468|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
145258614|NCT02918006|523792469|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
145258615|NCT00453349|523792472|FG000|Randomized|Adverse Event|12|||
145258616|NCT00453349|523792473|FG001|Randomized|Adverse Event|11|||
145301230|NCT02066922|523955002|FG000|Overall Study|Adverse Event|1|||
145258617|NCT00453349|523792472|FG000|Randomized|Lack of Efficacy|2|||
145301231|NCT00440297|523955003|FG000|Overall Study|Adverse Event|8|||
145301232|NCT00440297|523955004|FG001|Overall Study|Adverse Event|5|||
145301233|NCT00440297|523955003|FG000|Overall Study|Lost to Follow-up|1|||
145301234|NCT00440297|523955004|FG001|Overall Study|Lost to Follow-up|0|||
145301235|NCT00440297|523955003|FG000|Overall Study|Physician Decision|1|||
145301236|NCT00440297|523955004|FG001|Overall Study|Physician Decision|0|||
145301237|NCT00440297|523955003|FG000|Overall Study|Protocol Violation|11|||
145258618|NCT00453349|523792473|FG001|Randomized|Lack of Efficacy|1|||
145301238|NCT00440297|523955004|FG001|Overall Study|Protocol Violation|7|||
145301239|NCT00440297|523955003|FG000|Overall Study|Withdrawal by Subject|1|||
145410791|NCT02903914|524356846|FG001|Overall Study|Didn't Return to Site|0|||
145301240|NCT00440297|523955004|FG001|Overall Study|Withdrawal by Subject|6|||
145301241|NCT00440297|523955003|FG000|Overall Study|Randomized by mistake|1|||
145301242|NCT00440297|523955004|FG001|Overall Study|Randomized by mistake|0|||
145301243|NCT02445339|523955005|FG000|Overall Study|Physician Decision|1|||
145301244|NCT02445339|523955006|FG001|Overall Study|Physician Decision|0|||
145258619|NCT00453349|523792472|FG000|Randomized|Lost to Follow-up|7|||
145258620|NCT00453349|523792473|FG001|Randomized|Lost to Follow-up|5|||
145258621|NCT00453349|523792472|FG000|Randomized|Protocol Violation|1|||
145301245|NCT02445339|523955005|FG000|Overall Study|Lost to Follow-up|11|||
145258622|NCT00453349|523792473|FG001|Randomized|Protocol Violation|1|||
145258623|NCT00453349|523792472|FG000|Randomized|Withdrawal by Subject|3|||
145258624|NCT00453349|523792473|FG001|Randomized|Withdrawal by Subject|5|||
145258625|NCT00453349|523792472|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
145258626|NCT00453349|523792473|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
145258627|NCT00453349|523792472|FG000|Completed Study|Adverse Event|12|||
145258628|NCT00453349|523792473|FG001|Completed Study|Adverse Event|11|||
145258629|NCT00453349|523792472|FG000|Completed Study|Lack of Efficacy|2|||
145258630|NCT00453349|523792473|FG001|Completed Study|Lack of Efficacy|1|||
145258631|NCT00453349|523792472|FG000|Completed Study|Lost to Follow-up|7|||
145258632|NCT00453349|523792473|FG001|Completed Study|Lost to Follow-up|5|||
145258633|NCT00453349|523792472|FG000|Completed Study|Protocol Violation|1|||
145258634|NCT00453349|523792473|FG001|Completed Study|Protocol Violation|1|||
145258635|NCT00453349|523792472|FG000|Completed Study|Withdrawal by Subject|3|||
145258636|NCT00453349|523792473|FG001|Completed Study|Withdrawal by Subject|5|||
145258637|NCT00453349|523792472|FG000|Completed Study|Lost to follow up after study treatment|2|||
145258638|NCT00453349|523792473|FG001|Completed Study|Lost to follow up after study treatment|11|||
145258639|NCT01513460|523792478|FG000|Overall Study|Death|0|||
145258640|NCT01513460|523792479|FG001|Overall Study|Death|0|||
145258641|NCT01513460|523792480|FG002|Overall Study|Death|1|||
145258642|NCT01513460|523792478|FG000|Overall Study|Lost to Follow-up|0|||
145258643|NCT01513460|523792479|FG001|Overall Study|Lost to Follow-up|0|||
145258644|NCT01513460|523792480|FG002|Overall Study|Lost to Follow-up|2|||
145258645|NCT01513460|523792478|FG000|Overall Study|Abnormal laboratory value|1|||
145258646|NCT01513460|523792479|FG001|Overall Study|Abnormal laboratory value|0|||
145258647|NCT01513460|523792480|FG002|Overall Study|Abnormal laboratory value|1|||
145258648|NCT01513460|523792478|FG000|Overall Study|Lack of Efficacy|1|||
145258649|NCT01513460|523792479|FG001|Overall Study|Lack of Efficacy|2|||
145258650|NCT01513460|523792480|FG002|Overall Study|Lack of Efficacy|5|||
145258651|NCT01513460|523792478|FG000|Overall Study|Protocol deviations|3|||
145258652|NCT01513460|523792479|FG001|Overall Study|Protocol deviations|4|||
145258653|NCT01513460|523792480|FG002|Overall Study|Protocol deviations|3|||
145258654|NCT01513460|523792478|FG000|Overall Study|Withdrawal by Subject|7|||
145258655|NCT01513460|523792479|FG001|Overall Study|Withdrawal by Subject|8|||
145258656|NCT01513460|523792480|FG002|Overall Study|Withdrawal by Subject|21|||
145258657|NCT01513460|523792478|FG000|Overall Study|Adverse Event|16|||
145258658|NCT01513460|523792479|FG001|Overall Study|Adverse Event|18|||
145258659|NCT01513460|523792480|FG002|Overall Study|Adverse Event|23|||
145258660|NCT01513460|523792478|FG000|Overall Study|Abnormal test procedure|1|||
145258661|NCT01513460|523792479|FG001|Overall Study|Abnormal test procedure|0|||
145258662|NCT01513460|523792480|FG002|Overall Study|Abnormal test procedure|0|||
145258663|NCT00701064|523792481|FG000|Overall Study|Protocol Violation|1|||
145258664|NCT00701064|523792482|FG001|Overall Study|Protocol Violation|1|||
145258665|NCT00701064|523792481|FG000|Overall Study|Withdrawal by Subject|1|||
145258666|NCT00701064|523792482|FG001|Overall Study|Withdrawal by Subject|1|||
145258667|NCT00701064|523792481|FG000|Overall Study|initiated other PTSD treatment|2|||
145258668|NCT00701064|523792482|FG001|Overall Study|initiated other PTSD treatment|2|||
145258669|NCT02927990|523794206|FG000|Overall Study|Protocol Violation|4|||
145258670|NCT02927990|523794206|FG000|Overall Study|Physician Decision|9|||
145258671|NCT02927990|523794206|FG000|Overall Study|Room switched and therefore no study device available|15|||
145258672|NCT02927990|523794206|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
145258673|NCT00772031|523794207|FG000|Overall Study|Early termination of trial|12|||
145258674|NCT00772031|523794208|FG001|Overall Study|Early termination of trial|10|||
145258675|NCT00772031|523794207|FG000|Overall Study|Lost to Follow-up|20|||
145258676|NCT00772031|523794208|FG001|Overall Study|Lost to Follow-up|33|||
145258677|NCT03419741|523794209|FG000|Overall Study|Adverse Event|1|||
145258678|NCT03419741|523794210|FG001|Overall Study|Adverse Event|0|||
145258679|NCT03419741|523794209|FG000|Overall Study|Withdrawal by Subject|1|||
145258680|NCT03419741|523794210|FG001|Overall Study|Withdrawal by Subject|2|||
145258681|NCT04354870|523794211|FG000|Overall Study|Lost to Follow-up|32|||
145258682|NCT04354870|523794212|FG001|Overall Study|Lost to Follow-up|12|||
145258683|NCT04354870|523794211|FG000|Overall Study|Withdrawal by Subject|10|||
145258684|NCT04354870|523794212|FG001|Overall Study|Withdrawal by Subject|16|||
145258685|NCT04354870|523794211|FG000|Overall Study|Did not complete all study visits|6|||
145258686|NCT04354870|523794212|FG001|Overall Study|Did not complete all study visits|5|||
145258687|NCT03384316|523794213|FG000|Overall Study|Screen failure|0|||
145258688|NCT03384316|523794214|FG001|Overall Study|Screen failure|1|||
145258689|NCT02194699|523794219|FG000|Randomised|Did not receive treatment|1|||
145258690|NCT02194699|523794220|FG001|Randomised|Did not receive treatment|5|||
145258691|NCT02194699|523794219|FG000|Randomised|Without potential for 52 weeks of IP|5|||
145258692|NCT02194699|523794220|FG001|Randomised|Without potential for 52 weeks of IP|5|||
145258693|NCT02194699|523794219|FG000|Randomised|Duplicate patient|2|||
145258694|NCT02194699|523794220|FG001|Randomised|Duplicate patient|1|||
145258695|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
145258696|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
145258697|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
145258698|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
145258699|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
145301246|NCT02445339|523955006|FG001|Overall Study|Lost to Follow-up|15|||
145301247|NCT03206177|523955007|FG000|Overall Study|Withdrawal by Subject|1|||
145301248|NCT02024932|523955008|FG000|Overall Study|Adverse Event|2|||
145301249|NCT02024932|523955009|FG001|Overall Study|Adverse Event|3|||
145258700|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
145258701|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
145258702|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
145258703|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
145258704|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
145258705|NCT02194699|523794219|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
145258706|NCT02194699|523794220|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
145258707|NCT00561912|523794224|FG000|Overall Study|ineligible|1|||
145258708|NCT00577382|523794225|FG000|Overall Study|Adverse Event|0|||
145258709|NCT00577382|523794226|FG001|Overall Study|Adverse Event|6|||
145258710|NCT00577382|523794225|FG000|Overall Study|Withdrawal by Subject|0|||
145258711|NCT00577382|523794226|FG001|Overall Study|Withdrawal by Subject|1|||
145258712|NCT00577382|523794225|FG000|Overall Study|Progressive Disease|17|||
145258713|NCT00577382|523794226|FG001|Overall Study|Progressive Disease|19|||
145258714|NCT00577382|523794225|FG000|Overall Study|Intercurrent Illness|1|||
145258715|NCT00577382|523794226|FG001|Overall Study|Intercurrent Illness|2|||
145258716|NCT00577382|523794225|FG000|Overall Study|Death|1|||
145258717|NCT00577382|523794226|FG001|Overall Study|Death|1|||
145258718|NCT00577382|523794225|FG000|Overall Study|Lost to Follow-up|2|||
145258719|NCT00577382|523794226|FG001|Overall Study|Lost to Follow-up|2|||
145258720|NCT03007472|523794227|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
145258721|NCT03007472|523794227|FG000|Overall Study|Death|2|||
145258722|NCT03007472|523794227|FG000|Overall Study|Loss to Follow Up|1|||
145258723|NCT00649220|523794228|FG000|Overall Study|Adverse Event|2|||
145258724|NCT00649220|523794228|FG000|Overall Study|Withdrawal by Subject|1|||
145258725|NCT00525499|523794229|FG000|Overall Study|Lost to Follow-up|2|||
145258726|NCT00525499|523794230|FG001|Overall Study|Lost to Follow-up|4|||
145258727|NCT00525499|523794231|FG002|Overall Study|Lost to Follow-up|1|||
145258728|NCT00525499|523794232|FG003|Overall Study|Lost to Follow-up|4|||
145258729|NCT00525499|523794229|FG000|Overall Study|Adverse Event|0|||
145258730|NCT00525499|523794230|FG001|Overall Study|Adverse Event|1|||
145258731|NCT00525499|523794231|FG002|Overall Study|Adverse Event|0|||
145258732|NCT00525499|523794232|FG003|Overall Study|Adverse Event|1|||
145258733|NCT00525499|523794229|FG000|Overall Study|Withdrawal by Subject|5|||
145258734|NCT00525499|523794230|FG001|Overall Study|Withdrawal by Subject|1|||
145258735|NCT00525499|523794231|FG002|Overall Study|Withdrawal by Subject|5|||
145258736|NCT00525499|523794232|FG003|Overall Study|Withdrawal by Subject|2|||
145258737|NCT00525499|523794229|FG000|Overall Study|Protocol Violation|0|||
145258738|NCT00525499|523794230|FG001|Overall Study|Protocol Violation|1|||
145258739|NCT00525499|523794231|FG002|Overall Study|Protocol Violation|1|||
145258740|NCT00525499|523794232|FG003|Overall Study|Protocol Violation|0|||
145258741|NCT01729559|523794237|FG000|Overall Study|Protocol Violation|31|||
145258742|NCT01729559|523794238|FG001|Overall Study|Protocol Violation|28|||
145258743|NCT03672006|523794243|FG000|Overall Study|exclusion criteria met|0|||
145258744|NCT03672006|523794244|FG001|Overall Study|exclusion criteria met|1|||
145258745|NCT00608426|523794245|FG000|Overall Study|Death|32|||
145258746|NCT00608426|523794246|FG001|Overall Study|Death|36|||
145301250|NCT02024932|523955010|FG002|Overall Study|Adverse Event|0|||
145301251|NCT02024932|523955011|FG003|Overall Study|Adverse Event|0|||
145301252|NCT02024932|523955012|FG004|Overall Study|Adverse Event|2|||
145301253|NCT02024932|523955013|FG005|Overall Study|Adverse Event|0|||
145258747|NCT00608426|523794245|FG000|Overall Study|Lost to Follow-up|485|||
145258748|NCT00608426|523794246|FG001|Overall Study|Lost to Follow-up|521|||
145258749|NCT00608426|523794245|FG000|Overall Study|refused, health issues, wrong address|319|||
145258750|NCT00608426|523794246|FG001|Overall Study|refused, health issues, wrong address|348|||
145258751|NCT00761891|523794247|FG000|Overall Study|Withdrawal by Subject|10|||
145258752|NCT01707667|523794248|FG000|Period 1|expulsion of colonic sensor catheter|1|||
145258753|NCT01707667|523794249|FG001|Period 1|expulsion of colonic sensor catheter|0|||
145258754|NCT01453439|523794253|FG000|Treatment Phase|Withdrawal by Subject|13|||
145258755|NCT01453439|523794254|FG001|Treatment Phase|Withdrawal by Subject|10|||
145258756|NCT01453439|523794253|FG000|Treatment Phase|Suicidal Ideation|2|||
145258757|NCT01453439|523794254|FG001|Treatment Phase|Suicidal Ideation|0|||
145258758|NCT01453439|523794253|FG000|Treatment Phase|Need for higher level of care|1|||
145301254|NCT02024932|523955008|FG000|Overall Study|Abnormal laboratory value|0|||
145301255|NCT02024932|523955009|FG001|Overall Study|Abnormal laboratory value|0|||
145301256|NCT02024932|523955010|FG002|Overall Study|Abnormal laboratory value|0|||
145568638|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
145258759|NCT01453439|523794254|FG001|Treatment Phase|Need for higher level of care|1|||
145258760|NCT01453439|523794253|FG000|Treatment Phase|Therapist conflict of interest|1|||
145301257|NCT02024932|523955011|FG003|Overall Study|Abnormal laboratory value|2|||
145258761|NCT01453439|523794254|FG001|Treatment Phase|Therapist conflict of interest|0|||
145258762|NCT01453439|523794253|FG000|Follow-up|Withdrawal by Subject|0|||
145258763|NCT01453439|523794254|FG001|Follow-up|Withdrawal by Subject|1|||
145258764|NCT01453439|523794253|FG000|Follow-up|Lost to Follow-up|5|||
145258765|NCT01453439|523794254|FG001|Follow-up|Lost to Follow-up|10|||
145258766|NCT01014442|523794255|FG000|Overall Study|Adverse Event|0|||
145258767|NCT01014442|523794256|FG001|Overall Study|Adverse Event|8|||
145258768|NCT01014442|523794255|FG000|Overall Study|Withdrawal by Subject|4|||
145258769|NCT01014442|523794256|FG001|Overall Study|Withdrawal by Subject|4|||
145258770|NCT01014442|523794255|FG000|Overall Study|Protocol Violation|2|||
145258771|NCT01014442|523794256|FG001|Overall Study|Protocol Violation|5|||
145258772|NCT01014442|523794255|FG000|Overall Study|Lack of Compliance|0|||
145258773|NCT01014442|523794256|FG001|Overall Study|Lack of Compliance|1|||
145258774|NCT01014442|523794255|FG000|Overall Study|Unspecified Reason|1|||
145258775|NCT01014442|523794256|FG001|Overall Study|Unspecified Reason|1|||
145258776|NCT02074059|523794257|FG000|Overall Study|Death|0|||
145258777|NCT02074059|523794258|FG001|Overall Study|Death|0|||
145258778|NCT02074059|523794259|FG002|Overall Study|Death|0|||
145258779|NCT02074059|523794260|FG003|Overall Study|Death|0|||
145258780|NCT02074059|523794261|FG004|Overall Study|Death|1|||
145258781|NCT02074059|523794262|FG005|Overall Study|Death|1|||
145258782|NCT02764229|523794268|FG000|Overall Study|Withdrawal by Subject|15|||
145258783|NCT02764229|523794268|FG000|Overall Study|Adverse Event|9|||
145258784|NCT02764229|523794268|FG000|Overall Study|Physician Decision|5|||
145258785|NCT02764229|523794268|FG000|Overall Study|Lost to Follow-up|3|||
145258786|NCT02764229|523794268|FG000|Overall Study|Lack of Efficacy|1|||
145258787|NCT02764229|523794268|FG000|Overall Study|Study Stopped by Sponsor|69|||
145258788|NCT02135848|523794272|FG000|Overall Study|Adverse Event|2|||
145258789|NCT02135848|523794273|FG001|Overall Study|Adverse Event|0|||
145258790|NCT02135848|523794272|FG000|Overall Study|Withdrawal by Subject|1|||
145258791|NCT02135848|523794273|FG001|Overall Study|Withdrawal by Subject|1|||
145258792|NCT03258710|523794279|FG000|Overall Study|Adverse Event|1|||
145258793|NCT03258710|523794279|FG000|Overall Study|Protocol-defined stopping criteria|1|||
145258794|NCT03258710|523794279|FG000|Overall Study|Physician Decision|1|||
145258795|NCT03451630|523794280|FG000|Overall Study|Death|15|||
145258796|NCT03451630|523794281|FG001|Overall Study|Death|16|||
145258797|NCT03451630|523794282|FG002|Overall Study|Death|11|||
145258798|NCT03451630|523794280|FG000|Overall Study|Lost to Follow-up|9|||
145258799|NCT03451630|523794281|FG001|Overall Study|Lost to Follow-up|0|||
145258800|NCT03451630|523794282|FG002|Overall Study|Lost to Follow-up|4|||
145258801|NCT03451630|523794280|FG000|Overall Study|Withdrawal by Subject|0|||
145258802|NCT03451630|523794281|FG001|Overall Study|Withdrawal by Subject|3|||
145258803|NCT03451630|523794282|FG002|Overall Study|Withdrawal by Subject|0|||
145258804|NCT03451630|523794280|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
145258805|NCT03451630|523794281|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
145258806|NCT03451630|523794282|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
145258807|NCT00089505|523794283|FG000|Overall Study|Death|4|||
145258808|NCT00089505|523794284|FG001|Overall Study|Death|1|||
145258809|NCT00089505|523794285|FG002|Overall Study|Death|5|||
145258810|NCT00089505|523794286|FG003|Overall Study|Death|8|||
145258811|NCT00089505|523794283|FG000|Overall Study|Withdrawal by Subject|3|||
145258812|NCT00089505|523794284|FG001|Overall Study|Withdrawal by Subject|0|||
145258813|NCT00089505|523794285|FG002|Overall Study|Withdrawal by Subject|6|||
145258814|NCT00089505|523794286|FG003|Overall Study|Withdrawal by Subject|6|||
145258815|NCT00089505|523794283|FG000|Overall Study|Lost to Follow-up|1|||
145258816|NCT00089505|523794284|FG001|Overall Study|Lost to Follow-up|1|||
145258817|NCT00089505|523794285|FG002|Overall Study|Lost to Follow-up|9|||
145258818|NCT00089505|523794286|FG003|Overall Study|Lost to Follow-up|7|||
145258819|NCT00089505|523794283|FG000|Overall Study|Physician Decision|1|||
145258820|NCT00089505|523794284|FG001|Overall Study|Physician Decision|0|||
145258821|NCT00089505|523794285|FG002|Overall Study|Physician Decision|0|||
145568639|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
145568640|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
145568641|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
145568642|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
145568643|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
145568644|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
145568645|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
145568646|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
145568647|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
145568648|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
145568649|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
145568650|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
145568651|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
145620274|NCT00885495|525123729|FG001|Overall Study|Protocol Violation|1|||
145258822|NCT00089505|523794286|FG003|Overall Study|Physician Decision|0|||
145258823|NCT00089505|523794283|FG000|Overall Study|Protocol Violation|0|||
145258824|NCT00089505|523794284|FG001|Overall Study|Protocol Violation|0|||
145258825|NCT00089505|523794285|FG002|Overall Study|Protocol Violation|1|||
145258826|NCT00089505|523794286|FG003|Overall Study|Protocol Violation|0|||
145258827|NCT02041533|523794289|FG000|Pre-Treatment Period|Disease Progression|1|||
145258828|NCT02041533|523794290|FG001|Pre-Treatment Period|Disease Progression|1|||
145258829|NCT02041533|523794289|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
145258830|NCT02041533|523794290|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
145258831|NCT02041533|523794289|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
145258832|NCT02041533|523794290|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
145258833|NCT02041533|523794289|FG000|Treatment Period|Disease progression|189|||
145258834|NCT02041533|523794290|FG001|Treatment Period|Disease progression|146|||
145258835|NCT02041533|523794289|FG000|Treatment Period|Study drug toxicity|30|||
145258836|NCT02041533|523794290|FG001|Treatment Period|Study drug toxicity|34|||
145258837|NCT02041533|523794289|FG000|Treatment Period|Death|1|||
145258838|NCT02041533|523794290|FG001|Treatment Period|Death|0|||
145258839|NCT02041533|523794289|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
145258840|NCT02041533|523794290|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
145258841|NCT02041533|523794289|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
145258842|NCT02041533|523794290|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
145258843|NCT02041533|523794289|FG000|Treatment Period|Participant withdrew consent|2|||
145258844|NCT02041533|523794290|FG001|Treatment Period|Participant withdrew consent|2|||
145258845|NCT02041533|523794289|FG000|Treatment Period|Maximum clinical benefit|0|||
145258846|NCT02041533|523794290|FG001|Treatment Period|Maximum clinical benefit|18|||
145258847|NCT02041533|523794289|FG000|Treatment Period|Poor/Non-compliance|1|||
145258848|NCT02041533|523794290|FG001|Treatment Period|Poor/Non-compliance|0|||
145258849|NCT02041533|523794289|FG000|Treatment Period|Administrative reason by sponsor|1|||
145258850|NCT02041533|523794290|FG001|Treatment Period|Administrative reason by sponsor|0|||
145258851|NCT02041533|523794289|FG000|Treatment Period|Other reasons|9|||
145258852|NCT02041533|523794290|FG001|Treatment Period|Other reasons|2|||
145258853|NCT02041533|523794289|FG000|Treatment Period|Not Reported|0|||
145258854|NCT02041533|523794290|FG001|Treatment Period|Not Reported|1|||
145258855|NCT01756846|523794291|FG000|Overall Study|Lost to Follow-up|5|||
145258856|NCT01756846|523794292|FG001|Overall Study|Lost to Follow-up|10|||
145258857|NCT01756846|523794291|FG000|Overall Study|Withdrawal by Subject|1|||
145258858|NCT01756846|523794292|FG001|Overall Study|Withdrawal by Subject|2|||
145258859|NCT00565721|523794295|FG000|Overall Study|Screen Failure|2|||
145258860|NCT00565721|523794295|FG000|Overall Study|Lost to Follow-up|6|||
145258861|NCT00565721|523794295|FG000|Overall Study|Technical Problems|1|||
145258862|NCT00565721|523794295|FG000|Overall Study|Physician Decision|2|||
145258863|NCT00565721|523794295|FG000|Overall Study|Other reasons|6|||
145258864|NCT00529152|523794296|FG000|Overall Study|Adverse Event|2|||
145258865|NCT00529152|523794296|FG000|Overall Study|Withdrawal by Subject|2|||
145258866|NCT00529152|523794296|FG000|Overall Study|Lost to Follow-up|1|||
145258867|NCT01497899|523794297|FG000|Double-Blind Phase|Randomized but not Treated|1|||
145258868|NCT01497899|523794298|FG001|Double-Blind Phase|Randomized but not Treated|0|||
145258869|NCT01497899|523794299|FG002|Double-Blind Phase|Randomized but not Treated|0|||
145258870|NCT01497899|523794300|FG003|Double-Blind Phase|Randomized but not Treated|0|||
145258871|NCT01497899|523794297|FG000|Double-Blind Phase|Adverse Event|1|||
145258872|NCT01497899|523794298|FG001|Double-Blind Phase|Adverse Event|0|||
145258873|NCT01497899|523794299|FG002|Double-Blind Phase|Adverse Event|0|||
145258874|NCT01497899|523794300|FG003|Double-Blind Phase|Adverse Event|0|||
145258875|NCT01497899|523794297|FG000|Double-Blind Phase|Lack of Efficacy|0|||
145301258|NCT02024932|523955012|FG004|Overall Study|Abnormal laboratory value|0|||
145301259|NCT02024932|523955013|FG005|Overall Study|Abnormal laboratory value|0|||
145301260|NCT03020641|523955014|FG000|Overall Study|Lost to Follow-up|0|||
145301261|NCT03020641|523955015|FG001|Overall Study|Lost to Follow-up|1|||
145301262|NCT03020641|523955014|FG000|Overall Study|Converted to open surgery|2|||
145258876|NCT01497899|523794298|FG001|Double-Blind Phase|Lack of Efficacy|1|||
145258877|NCT01497899|523794299|FG002|Double-Blind Phase|Lack of Efficacy|0|||
145258878|NCT01497899|523794300|FG003|Double-Blind Phase|Lack of Efficacy|0|||
145258879|NCT01497899|523794297|FG000|Double-Blind Phase|Investigator's Discretion|1|||
145258880|NCT01497899|523794298|FG001|Double-Blind Phase|Investigator's Discretion|0|||
145568652|NCT00934544|524942259|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
145568653|NCT00934544|524942260|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
145258881|NCT01497899|523794299|FG002|Double-Blind Phase|Investigator's Discretion|0|||
145301263|NCT03020641|523955015|FG001|Overall Study|Converted to open surgery|1|||
145301264|NCT03020641|523955014|FG000|Overall Study|for surgery not performed|0|||
145301265|NCT03020641|523955015|FG001|Overall Study|for surgery not performed|1|||
145301266|NCT04611789|523955016|FG000|Overall Study|Lost to Follow-up|1|||
145301267|NCT04611789|523955017|FG001|Overall Study|Lost to Follow-up|0|||
145258882|NCT01497899|523794300|FG003|Double-Blind Phase|Investigator's Discretion|0|||
145258883|NCT01497899|523794297|FG000|Double-Blind Phase|Withdrew Consent|0|||
145258884|NCT01497899|523794298|FG001|Double-Blind Phase|Withdrew Consent|1|||
145258885|NCT01497899|523794299|FG002|Double-Blind Phase|Withdrew Consent|0|||
145258886|NCT01497899|523794300|FG003|Double-Blind Phase|Withdrew Consent|0|||
145258887|NCT01497899|523794297|FG000|Double-Blind Phase|Lost to Follow-up|3|||
145258888|NCT01497899|523794298|FG001|Double-Blind Phase|Lost to Follow-up|2|||
145258889|NCT01497899|523794299|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145258890|NCT01497899|523794300|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145258891|NCT01497899|523794297|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
145258892|NCT01497899|523794298|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
145258893|NCT01497899|523794299|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
145258894|NCT01497899|523794300|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
145258895|NCT01497899|523794297|FG000|Open-Label Extension Phase|Adverse Event|1|||
145258896|NCT01497899|523794298|FG001|Open-Label Extension Phase|Adverse Event|0|||
145258897|NCT01497899|523794299|FG002|Open-Label Extension Phase|Adverse Event|0|||
145258898|NCT01497899|523794300|FG003|Open-Label Extension Phase|Adverse Event|0|||
145258899|NCT01497899|523794297|FG000|Open-Label Extension Phase|Death|1|||
145258900|NCT01497899|523794298|FG001|Open-Label Extension Phase|Death|0|||
145258901|NCT01497899|523794299|FG002|Open-Label Extension Phase|Death|0|||
145258902|NCT01497899|523794300|FG003|Open-Label Extension Phase|Death|0|||
145258903|NCT01497899|523794297|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
145258904|NCT01497899|523794298|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
145258905|NCT01497899|523794299|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
145258906|NCT01497899|523794300|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
145258907|NCT01497899|523794297|FG000|Open-Label Extension Phase|Pregnancy|0|||
145258908|NCT01497899|523794298|FG001|Open-Label Extension Phase|Pregnancy|1|||
145258909|NCT01497899|523794299|FG002|Open-Label Extension Phase|Pregnancy|1|||
145258910|NCT01497899|523794300|FG003|Open-Label Extension Phase|Pregnancy|0|||
145258911|NCT01497899|523794297|FG000|Open-Label Extension Phase|Protocol Violation|0|||
145258912|NCT01497899|523794298|FG001|Open-Label Extension Phase|Protocol Violation|0|||
145258913|NCT01497899|523794299|FG002|Open-Label Extension Phase|Protocol Violation|1|||
145258914|NCT01497899|523794300|FG003|Open-Label Extension Phase|Protocol Violation|0|||
145258915|NCT01497899|523794297|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
145258916|NCT01497899|523794298|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
145258917|NCT01497899|523794299|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
145258918|NCT01497899|523794300|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
145258919|NCT02646332|523794306|FG000|Overall Study|Lost to Follow-up|0|||
145258920|NCT02646332|523794307|FG001|Overall Study|Lost to Follow-up|3|||
145258921|NCT01882439|523794308|FG000|Overall Study|Adverse event related to study drug|3|||
145258922|NCT01882439|523794309|FG001|Overall Study|Adverse event related to study drug|8|||
145258923|NCT01882439|523794310|FG002|Overall Study|Adverse event related to study drug|1|||
145258924|NCT01882439|523794311|FG003|Overall Study|Adverse event related to study drug|2|||
145258925|NCT01882439|523794308|FG000|Overall Study|Pregnancy|0|||
145258926|NCT01882439|523794309|FG001|Overall Study|Pregnancy|1|||
145258927|NCT01882439|523794310|FG002|Overall Study|Pregnancy|0|||
145258928|NCT01882439|523794311|FG003|Overall Study|Pregnancy|0|||
145258929|NCT01882439|523794308|FG000|Overall Study|Protocol Violation|2|||
145258930|NCT01882439|523794309|FG001|Overall Study|Protocol Violation|2|||
145258931|NCT01882439|523794310|FG002|Overall Study|Protocol Violation|0|||
145258932|NCT01882439|523794311|FG003|Overall Study|Protocol Violation|1|||
145258933|NCT01882439|523794308|FG000|Overall Study|No longer willing to participate|1|||
145258934|NCT01882439|523794309|FG001|Overall Study|No longer willing to participate|4|||
145258935|NCT01882439|523794310|FG002|Overall Study|No longer willing to participate|2|||
145258936|NCT01882439|523794311|FG003|Overall Study|No longer willing to participate|3|||
145258937|NCT01882439|523794308|FG000|Overall Study|Medication error with no associated AE|0|||
145258938|NCT01882439|523794309|FG001|Overall Study|Medication error with no associated AE|0|||
145258939|NCT01882439|523794310|FG002|Overall Study|Medication error with no associated AE|2|||
145258940|NCT01882439|523794311|FG003|Overall Study|Medication error with no associated AE|0|||
145258941|NCT01882439|523794308|FG000|Overall Study|Insufficient clinical response|1|||
145258942|NCT01882439|523794309|FG001|Overall Study|Insufficient clinical response|4|||
145258943|NCT01882439|523794310|FG002|Overall Study|Insufficient clinical response|4|||
145258944|NCT01882439|523794311|FG003|Overall Study|Insufficient clinical response|2|||
145258945|NCT01882439|523794308|FG000|Overall Study|Adverse event unrelated to study drug|2|||
145258946|NCT01882439|523794309|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145258947|NCT01882439|523794310|FG002|Overall Study|Adverse event unrelated to study drug|1|||
145258948|NCT01882439|523794311|FG003|Overall Study|Adverse event unrelated to study drug|1|||
145258949|NCT01775995|523794314|FG000|Overall Study|Lost to Follow-up|1|||
145258950|NCT01775995|523794315|FG001|Overall Study|Lost to Follow-up|1|||
145258951|NCT03125902|523794316|FG000|Overall Study|Adverse Event|0|||
145301268|NCT04611789|523955018|FG002|Overall Study|Lost to Follow-up|0|||
145258952|NCT03125902|523794317|FG001|Overall Study|Adverse Event|1|||
145258953|NCT03125902|523794316|FG000|Overall Study|Death|119|||
145258954|NCT03125902|523794317|FG001|Overall Study|Death|229|||
145258955|NCT03125902|523794316|FG000|Overall Study|Lost to Follow-up|4|||
145258956|NCT03125902|523794317|FG001|Overall Study|Lost to Follow-up|13|||
145301269|NCT00727961|523955020|FG000|Overall Study|Lost to Follow-up|1|||
145410792|NCT02903914|524356847|FG002|Overall Study|Didn't Return to Site|1|||
145258957|NCT03125902|523794316|FG000|Overall Study|Other|0|||
145258958|NCT03125902|523794317|FG001|Overall Study|Other|4|||
145410793|NCT02903914|524356848|FG003|Overall Study|Didn't Return to Site|1|||
145258959|NCT03125902|523794316|FG000|Overall Study|Physician Decision|2|||
145258960|NCT03125902|523794317|FG001|Overall Study|Physician Decision|1|||
145258961|NCT03125902|523794316|FG000|Overall Study|Progressive Disease|0|||
145258962|NCT03125902|523794317|FG001|Overall Study|Progressive Disease|3|||
145258963|NCT03125902|523794316|FG000|Overall Study|Study Terminated By Sponsor|74|||
145258964|NCT03125902|523794317|FG001|Overall Study|Study Terminated By Sponsor|143|||
145258965|NCT03125902|523794316|FG000|Overall Study|Withdrawal by Subject|21|||
145258966|NCT03125902|523794317|FG001|Overall Study|Withdrawal by Subject|37|||
145258967|NCT01997333|523794318|FG000|Randomization and Treatment|Disease Progression|70|||
145258968|NCT01997333|523794319|FG001|Randomization and Treatment|Disease Progression|159|||
145258969|NCT01997333|523794318|FG000|Randomization and Treatment|Adverse Event|10|||
145258970|NCT01997333|523794319|FG001|Randomization and Treatment|Adverse Event|32|||
145258971|NCT01997333|523794318|FG000|Randomization and Treatment|Physician Decision|0|||
145258972|NCT01997333|523794319|FG001|Randomization and Treatment|Physician Decision|4|||
145258973|NCT01997333|523794318|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
145258974|NCT01997333|523794319|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
145258975|NCT01997333|523794318|FG000|Randomization and Treatment|Did not receive treatment|17|||
145258976|NCT01997333|523794319|FG001|Randomization and Treatment|Did not receive treatment|5|||
145258977|NCT01997333|523794318|FG000|Survival Follow up|Withdrawal by Subject|15|||
145258978|NCT01997333|523794319|FG001|Survival Follow up|Withdrawal by Subject|6|||
145258979|NCT01997333|523794318|FG000|Survival Follow up|Lost to Follow-up|0|||
145258980|NCT01997333|523794319|FG001|Survival Follow up|Lost to Follow-up|6|||
145258981|NCT01997333|523794318|FG000|Survival Follow up|Various|1|||
145258982|NCT01997333|523794319|FG001|Survival Follow up|Various|2|||
145258983|NCT02909504|523794320|FG000|Overall Study|Adverse Event|2|||
145258984|NCT02909504|523794320|FG000|Overall Study|Lack of Efficacy|3|||
145258985|NCT02909504|523794320|FG000|Overall Study|Withdrawal by Subject|4|||
145258986|NCT02909504|523794320|FG000|Overall Study|Pregnancy|1|||
145258987|NCT02909504|523794320|FG000|Overall Study|Subject moved|1|||
145258988|NCT02909504|523794320|FG000|Overall Study|Lost to Follow-up|1|||
145258989|NCT02504424|523794321|FG000|Overall Study|Withdrawal by Subject|2|||
145258990|NCT05060003|523794327|FG000|Overall Study|ctDNA negative|7|||
145258991|NCT00440232|523794328|FG000|Overall Study|Lost to Follow-up|1|||
145258992|NCT00440232|523794329|FG001|Overall Study|Lost to Follow-up|1|||
145258993|NCT00440232|523794328|FG000|Overall Study|Unable to treat within allowed time|0|||
145258994|NCT00440232|523794329|FG001|Overall Study|Unable to treat within allowed time|1|||
145258995|NCT00440232|523794328|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
145258996|NCT00440232|523794329|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
145258997|NCT00362297|523794330|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
145258998|NCT00362297|523794331|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
145258999|NCT01747655|523794336|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
145259000|NCT01747655|523794337|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
145301270|NCT00727961|523955020|FG000|Overall Study|Adverse Event|4|||
145301271|NCT00727961|523955020|FG000|Overall Study|Patient's refusal|2|||
145301272|NCT00727961|523955020|FG000|Overall Study|Progression|30|||
145301273|NCT03238781|523955021|FG000|Overall Study|Adverse Event|1|||
145301274|NCT03238781|523955022|FG001|Overall Study|Adverse Event|1|||
145301275|NCT03238781|523955023|FG002|Overall Study|Adverse Event|2|||
145301276|NCT03238781|523955021|FG000|Overall Study|Lost to Follow-up|2|||
145301277|NCT03238781|523955022|FG001|Overall Study|Lost to Follow-up|1|||
145301278|NCT03238781|523955023|FG002|Overall Study|Lost to Follow-up|2|||
145301279|NCT03238781|523955021|FG000|Overall Study|Withdrawal by Subject|23|||
145301280|NCT03238781|523955022|FG001|Overall Study|Withdrawal by Subject|14|||
145410794|NCT02903914|524356849|FG004|Overall Study|Didn't Return to Site|0|||
145410795|NCT02903914|524356850|FG005|Overall Study|Didn't Return to Site|0|||
145410796|NCT02903914|524356851|FG006|Overall Study|Didn't Return to Site|2|||
145259001|NCT01747655|523794336|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
145410797|NCT02903914|524356852|FG007|Overall Study|Didn't Return to Site|0|||
145410798|NCT02903914|524356845|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
145568654|NCT00934544|524942261|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
145259002|NCT01747655|523794337|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
145259003|NCT01747655|523794336|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
145301281|NCT03238781|523955023|FG002|Overall Study|Withdrawal by Subject|16|||
145301282|NCT03238781|523955021|FG000|Overall Study|Decision by sponsor|0|||
145301283|NCT03238781|523955022|FG001|Overall Study|Decision by sponsor|1|||
145301284|NCT03238781|523955023|FG002|Overall Study|Decision by sponsor|0|||
145301285|NCT03161405|523955024|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
145259004|NCT01747655|523794337|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
145259005|NCT00982111|523794340|FG000|Overall Study|Adverse Event|1|||
145301286|NCT00837486|523955025|FG000|Blinded-treatment Phase|Physician Decision|1|||
145410799|NCT02903914|524356846|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
145410800|NCT02903914|524356847|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
145410801|NCT02903914|524356848|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
145410802|NCT02903914|524356849|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
145410803|NCT02903914|524356850|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
145259006|NCT00982111|523794341|FG001|Overall Study|Adverse Event|1|||
145259007|NCT00982111|523794340|FG000|Overall Study|Progressive Disease|46|||
145259008|NCT00982111|523794341|FG001|Overall Study|Progressive Disease|39|||
145259009|NCT00982111|523794340|FG000|Overall Study|Lost to Follow-up|9|||
145259010|NCT00982111|523794341|FG001|Overall Study|Lost to Follow-up|6|||
145259011|NCT00982111|523794340|FG000|Overall Study|New Anti-Cancer Therapy|5|||
145259012|NCT00982111|523794341|FG001|Overall Study|New Anti-Cancer Therapy|5|||
145259013|NCT00982111|523794340|FG000|Overall Study|Medical Decision|1|||
145259014|NCT00982111|523794341|FG001|Overall Study|Medical Decision|0|||
145259015|NCT00982111|523794340|FG000|Overall Study|Withdrawal by Subject|17|||
145259016|NCT00982111|523794341|FG001|Overall Study|Withdrawal by Subject|19|||
145259017|NCT00982111|523794340|FG000|Overall Study|Global Study End|0|||
145259018|NCT00982111|523794341|FG001|Overall Study|Global Study End|1|||
145259019|NCT00982111|523794340|FG000|Overall Study|Sponsor's Decision|0|||
145259020|NCT00982111|523794341|FG001|Overall Study|Sponsor's Decision|1|||
145259021|NCT01070381|523794342|FG000|Period 2, 1 Week of Wear|Handling|0|||
145259022|NCT01070381|523794343|FG001|Period 2, 1 Week of Wear|Handling|1|||
145259023|NCT01070381|523794342|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
145259024|NCT01070381|523794343|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
145259025|NCT01657903|523794344|FG000|Overall Study|Lost to Follow-up|1|||
145259026|NCT01657903|523794344|FG000|Overall Study|Withdrawal by Subject|1|||
145259027|NCT01259388|523794345|FG000|Overall Study|Adverse Event|3|||
145259028|NCT01259388|523794346|FG001|Overall Study|Adverse Event|0|||
145259029|NCT01259388|523794345|FG000|Overall Study|Withdrawal by Subject|1|||
145259030|NCT01259388|523794346|FG001|Overall Study|Withdrawal by Subject|1|||
145259031|NCT01259388|523794345|FG000|Overall Study|Physician Decision|1|||
145259032|NCT01259388|523794346|FG001|Overall Study|Physician Decision|0|||
145259033|NCT03512028|523794347|FG000|Overall Study|Withdrawal by Subject|2|||
145259034|NCT03512028|523794348|FG001|Overall Study|Withdrawal by Subject|0|||
145259035|NCT03512028|523794347|FG000|Overall Study|Protocol Violation|2|||
145259036|NCT03512028|523794348|FG001|Overall Study|Protocol Violation|0|||
145259037|NCT00489216|523794350|FG000|Overall Study|Adverse Event|1|||
145259038|NCT02828982|523794353|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145259039|NCT02828982|523794354|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145259040|NCT02312934|523794355|FG000|Overall Study|Lost to Follow-up|1|||
145259041|NCT02312934|523794356|FG001|Overall Study|Lost to Follow-up|0|||
145259042|NCT02312934|523794355|FG000|Overall Study|Physician Decision|1|||
145259043|NCT02312934|523794356|FG001|Overall Study|Physician Decision|0|||
145259044|NCT02098733|523794357|FG000|Overall Study|Data Not Available|5|||
145259045|NCT02098733|523794357|FG000|Overall Study|Lost to Follow-up|5|||
145259046|NCT03395704|523794358|FG000|Overall Study|Adverse Event|2|||
145259047|NCT03395704|523794359|FG001|Overall Study|Adverse Event|1|||
145259048|NCT03395704|523794358|FG000|Overall Study|Withdrawal by Subject|2|||
145259049|NCT03395704|523794359|FG001|Overall Study|Withdrawal by Subject|1|||
145259050|NCT03395704|523794358|FG000|Overall Study|Physician Decision|0|||
145259051|NCT03395704|523794359|FG001|Overall Study|Physician Decision|1|||
145259052|NCT02475564|523794360|FG000|Overall Study|Withdrawal by Subject|1|||
145259053|NCT02475564|523794361|FG001|Overall Study|Withdrawal by Subject|0|||
145259054|NCT02475564|523794360|FG000|Overall Study|Lost to Follow-up|2|||
145259055|NCT02475564|523794361|FG001|Overall Study|Lost to Follow-up|1|||
145259056|NCT02475564|523794360|FG000|Overall Study|Intense Menstrual bleeding|1|||
145259057|NCT02475564|523794361|FG001|Overall Study|Intense Menstrual bleeding|0|||
145259058|NCT01156012|523794362|FG000|Overall Study|Adverse Event|3|||
145259059|NCT01156012|523794363|FG001|Overall Study|Adverse Event|1|||
145259060|NCT01156012|523794362|FG000|Overall Study|Lost to Follow-up|1|||
145259061|NCT01156012|523794363|FG001|Overall Study|Lost to Follow-up|0|||
145259062|NCT01156012|523794362|FG000|Overall Study|Withdrawal by Subject|1|||
145259063|NCT01156012|523794363|FG001|Overall Study|Withdrawal by Subject|0|||
145259064|NCT01156012|523794362|FG000|Overall Study|use of commercial drug instead of study|0|||
145259065|NCT01156012|523794363|FG001|Overall Study|use of commercial drug instead of study|1|||
145259066|NCT01156012|523794362|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
145259067|NCT01156012|523794363|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
145259068|NCT01906489|523794364|FG000|Overall Study|Adverse Event|10|||
145259069|NCT01906489|523794365|FG001|Overall Study|Adverse Event|3|||
145259070|NCT01906489|523794364|FG000|Overall Study|Worsening of CKD|6|||
145259071|NCT01906489|523794365|FG001|Overall Study|Worsening of CKD|4|||
145259072|NCT01906489|523794364|FG000|Overall Study|Withdrawal by Subject|5|||
145259073|NCT01906489|523794365|FG001|Overall Study|Withdrawal by Subject|0|||
145259074|NCT01906489|523794364|FG000|Overall Study|Worsening of Anemia|1|||
145259075|NCT01906489|523794365|FG001|Overall Study|Worsening of Anemia|0|||
145259076|NCT01906489|523794364|FG000|Overall Study|Protocol Violation|0|||
145259077|NCT01906489|523794365|FG001|Overall Study|Protocol Violation|1|||
145259078|NCT01906489|523794364|FG000|Overall Study|Non- Compliance|1|||
145259079|NCT01906489|523794365|FG001|Overall Study|Non- Compliance|0|||
145259080|NCT01906489|523794364|FG000|Overall Study|Sponsor Decision|1|||
145259081|NCT01906489|523794365|FG001|Overall Study|Sponsor Decision|0|||
145259082|NCT01906489|523794364|FG000|Overall Study|Lost to Follow-up|1|||
145259083|NCT01906489|523794365|FG001|Overall Study|Lost to Follow-up|1|||
145259084|NCT01906489|523794364|FG000|Overall Study|Other|1|||
145259085|NCT01906489|523794365|FG001|Overall Study|Other|0|||
145259086|NCT01078389|523796370|FG000|Overall Study|Adverse Event|10|||
145259087|NCT01078389|523796371|FG001|Overall Study|Adverse Event|6|||
145259088|NCT01078389|523796370|FG000|Overall Study|Major Protocol Deviation|2|||
145259089|NCT01078389|523796371|FG001|Overall Study|Major Protocol Deviation|0|||
145259090|NCT01078389|523796370|FG000|Overall Study|Lost to Follow-up|23|||
145259091|NCT01078389|523796371|FG001|Overall Study|Lost to Follow-up|23|||
145259092|NCT01078389|523796370|FG000|Overall Study|Voluntary Withdrawal|20|||
145259093|NCT01078389|523796371|FG001|Overall Study|Voluntary Withdrawal|36|||
145259094|NCT01078389|523796370|FG000|Overall Study|Other|9|||
145259095|NCT01078389|523796371|FG001|Overall Study|Other|2|||
145259096|NCT04823494|523796372|FG000|Overall Study|Programming software malfunction.|1|||
145259097|NCT04823494|523796373|FG001|Overall Study|Programming software malfunction.|0|||
145259098|NCT04823494|523796372|FG000|Overall Study|Withdrawal by Subject|1|||
145259099|NCT04823494|523796373|FG001|Overall Study|Withdrawal by Subject|0|||
145259100|NCT04823494|523796372|FG000|Overall Study|Devices lost|0|||
145259101|NCT04823494|523796373|FG001|Overall Study|Devices lost|1|||
145259102|NCT03691831|523796374|FG000|Overall Study|Lost to Follow-up|16|||
145259103|NCT03691831|523796375|FG001|Overall Study|Lost to Follow-up|12|||
145259104|NCT03691831|523796374|FG000|Overall Study|Withdrawal by Subject|9|||
145259105|NCT03691831|523796375|FG001|Overall Study|Withdrawal by Subject|17|||
145259106|NCT03691831|523796374|FG000|Overall Study|Investigator Decision|2|||
145259107|NCT03691831|523796375|FG001|Overall Study|Investigator Decision|2|||
145259108|NCT02198040|523796376|FG000|Overall Study|Work reasons|0|||
145259109|NCT02198040|523796377|FG001|Overall Study|Work reasons|1|||
145259110|NCT02198040|523796378|FG002|Overall Study|Work reasons|0|||
145259111|NCT02198040|523796376|FG000|Overall Study|Withdrawal by Subject|0|||
145259112|NCT02198040|523796377|FG001|Overall Study|Withdrawal by Subject|0|||
145259113|NCT02198040|523796378|FG002|Overall Study|Withdrawal by Subject|1|||
145259114|NCT04524663|523796379|FG000|Overall Study|Withdrawal by Subject|0|||
145259115|NCT04524663|523796380|FG001|Overall Study|Withdrawal by Subject|2|||
145259116|NCT01884675|523796381|FG000|Overall Study|Study closed/terminated|3|||
145259117|NCT01884675|523796382|FG001|Overall Study|Study closed/terminated|2|||
145259118|NCT02361307|523796383|FG000|Overall Study|Unstable medical condition.|0|||
145259119|NCT02361307|523796384|FG001|Overall Study|Unstable medical condition.|1|||
145259120|NCT03359811|523796385|FG000|Overall Study|Protocol Violation|2|||
145259121|NCT03359811|523796386|FG001|Overall Study|Protocol Violation|0|||
145259122|NCT01189201|523796391|FG000|Overall Study|Adverse Event|1|||
145259123|NCT01682876|523796392|FG000|Overall Study|Administrative reason|4|||
145259124|NCT01682876|523796393|FG001|Overall Study|Administrative reason|4|||
145259125|NCT01682876|523796394|FG002|Overall Study|Administrative reason|0|||
145259126|NCT01682876|523796395|FG003|Overall Study|Administrative reason|3|||
145301287|NCT00837486|523955026|FG001|Blinded-treatment Phase|Physician Decision|0|||
145301288|NCT00837486|523955025|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
145301289|NCT00837486|523955026|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
145301290|NCT00837486|523955025|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
145301291|NCT00837486|523955026|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
145301292|NCT00837486|523955025|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
145301293|NCT00837486|523955026|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
145301294|NCT02655679|523955027|FG000|Overall Study|Adverse Event|0|||
145259127|NCT01682876|523796392|FG000|Overall Study|Adverse Event|0|||
145259128|NCT01682876|523796393|FG001|Overall Study|Adverse Event|0|||
145259129|NCT01682876|523796394|FG002|Overall Study|Adverse Event|0|||
145259130|NCT01682876|523796395|FG003|Overall Study|Adverse Event|1|||
145301295|NCT02655679|523955028|FG001|Overall Study|Adverse Event|1|||
145301296|NCT02655679|523955029|FG002|Overall Study|Adverse Event|0|||
145259131|NCT01682876|523796392|FG000|Overall Study|Lost to Follow-up|11|||
145259132|NCT01682876|523796393|FG001|Overall Study|Lost to Follow-up|15|||
145259133|NCT01682876|523796394|FG002|Overall Study|Lost to Follow-up|9|||
145259134|NCT01682876|523796395|FG003|Overall Study|Lost to Follow-up|11|||
145259135|NCT01682876|523796392|FG000|Overall Study|Protocol Violation|1|||
145259136|NCT01682876|523796393|FG001|Overall Study|Protocol Violation|1|||
145259137|NCT01682876|523796394|FG002|Overall Study|Protocol Violation|1|||
145259138|NCT01682876|523796395|FG003|Overall Study|Protocol Violation|1|||
145259139|NCT01682876|523796392|FG000|Overall Study|Withdrawal by Subject|4|||
145259140|NCT01682876|523796393|FG001|Overall Study|Withdrawal by Subject|0|||
145259141|NCT01682876|523796394|FG002|Overall Study|Withdrawal by Subject|0|||
145259142|NCT01682876|523796395|FG003|Overall Study|Withdrawal by Subject|2|||
145301297|NCT02655679|523955030|FG003|Overall Study|Adverse Event|0|||
145301298|NCT02655679|523955031|FG004|Overall Study|Adverse Event|0|||
145259143|NCT01682876|523796392|FG000|Overall Study|Other|1|||
145259144|NCT01682876|523796393|FG001|Overall Study|Other|0|||
145259145|NCT01682876|523796394|FG002|Overall Study|Other|1|||
145259146|NCT01682876|523796395|FG003|Overall Study|Other|1|||
145259147|NCT00911508|523796399|FG000|Overall Study|Lost to Follow-up|27|||
145259148|NCT00911508|523796400|FG001|Overall Study|Lost to Follow-up|18|||
145259149|NCT00911508|523796399|FG000|Overall Study|Withdrawal by Subject|79|||
145301299|NCT02655679|523955027|FG000|Overall Study|Withdrawal by Subject|1|||
145301300|NCT02655679|523955028|FG001|Overall Study|Withdrawal by Subject|1|||
145301301|NCT02655679|523955029|FG002|Overall Study|Withdrawal by Subject|0|||
145301302|NCT02655679|523955030|FG003|Overall Study|Withdrawal by Subject|3|||
145301303|NCT02655679|523955031|FG004|Overall Study|Withdrawal by Subject|1|||
145301304|NCT02655679|523955027|FG000|Overall Study|Inability to Comply with the Protocol|1|||
145301305|NCT02655679|523955028|FG001|Overall Study|Inability to Comply with the Protocol|0|||
145301306|NCT02655679|523955029|FG002|Overall Study|Inability to Comply with the Protocol|0|||
145301307|NCT02655679|523955030|FG003|Overall Study|Inability to Comply with the Protocol|0|||
145301308|NCT02655679|523955031|FG004|Overall Study|Inability to Comply with the Protocol|0|||
145301309|NCT02655679|523955027|FG000|Overall Study|Lost to Follow-up|0|||
145259150|NCT00911508|523796400|FG001|Overall Study|Withdrawal by Subject|112|||
145259151|NCT00240331|523796403|FG000|Overall Study|Withdrawal by Subject|125|||
145259152|NCT00240331|523796404|FG001|Overall Study|Withdrawal by Subject|132|||
145301310|NCT02655679|523955028|FG001|Overall Study|Lost to Follow-up|1|||
145301311|NCT02655679|523955029|FG002|Overall Study|Lost to Follow-up|1|||
145301312|NCT02655679|523955030|FG003|Overall Study|Lost to Follow-up|1|||
145301313|NCT02655679|523955031|FG004|Overall Study|Lost to Follow-up|0|||
145301314|NCT02655679|523955027|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145301315|NCT02655679|523955028|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145301316|NCT02655679|523955029|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145301317|NCT02655679|523955030|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145301318|NCT02655679|523955031|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145301319|NCT01421277|523955032|FG000|Overall Study|Lack of qualifying event|0|||
145301320|NCT01421277|523955033|FG001|Overall Study|Lack of qualifying event|61|||
145301321|NCT01421277|523955032|FG000|Overall Study|Incomplete baseline data|0|||
145301322|NCT01421277|523955033|FG001|Overall Study|Incomplete baseline data|31|||
145301323|NCT02039908|523955034|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
145301324|NCT02039908|523955035|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
145301325|NCT02039908|523955036|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
145301326|NCT02039908|523955037|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
145301327|NCT02039908|523955034|FG000|Phase 1-Summer|Protocol Violation|6|||
145301328|NCT02039908|523955035|FG001|Phase 1-Summer|Protocol Violation|0|||
145301329|NCT02039908|523955036|FG002|Phase 1-Summer|Protocol Violation|0|||
145301330|NCT02039908|523955037|FG003|Phase 1-Summer|Protocol Violation|0|||
145301331|NCT02039908|523955034|FG000|Phase 2-School Year|Lost to Follow-up|0|||
145301332|NCT02039908|523955035|FG001|Phase 2-School Year|Lost to Follow-up|0|||
145301333|NCT02039908|523955036|FG002|Phase 2-School Year|Lost to Follow-up|1|||
145301334|NCT02039908|523955037|FG003|Phase 2-School Year|Lost to Follow-up|3|||
145301335|NCT02039908|523955034|FG000|Phase 2-School Year|Protocol Violation|0|||
145301336|NCT02039908|523955035|FG001|Phase 2-School Year|Protocol Violation|0|||
145301337|NCT02039908|523955036|FG002|Phase 2-School Year|Protocol Violation|3|||
145301338|NCT02039908|523955037|FG003|Phase 2-School Year|Protocol Violation|0|||
145301339|NCT02039908|523955034|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
145301340|NCT02039908|523955035|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
145259153|NCT00240331|523796403|FG000|Overall Study|Option selected by investigator|1|||
145301341|NCT02039908|523955036|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
145301342|NCT02039908|523955037|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
145301343|NCT02847650|523956513|FG000|Overall Study|Adverse Event|2|||
145301344|NCT02847650|523956514|FG001|Overall Study|Adverse Event|4|||
145301345|NCT02847650|523956513|FG000|Overall Study|Lost to Follow-up|1|||
145301346|NCT02847650|523956514|FG001|Overall Study|Lost to Follow-up|0|||
145301347|NCT02847650|523956513|FG000|Overall Study|Protocol Violation|0|||
145301348|NCT02847650|523956514|FG001|Overall Study|Protocol Violation|1|||
145301349|NCT02847650|523956513|FG000|Overall Study|Withdrawal by Subject|1|||
145301350|NCT02847650|523956514|FG001|Overall Study|Withdrawal by Subject|1|||
145301351|NCT02175095|523956517|FG000|Overall Study|Withdrawal by Subject|3|||
145301352|NCT00462345|523956518|FG000|Overall Study|Withdrawal by Subject|2|||
145301353|NCT00462345|523956518|FG000|Overall Study|Did not complete second course|1|||
145301354|NCT03255733|523956519|FG000|Overall Study|Lost to Follow-up|4|||
145259154|NCT00240331|523796404|FG001|Overall Study|Option selected by investigator|2|||
145301355|NCT02378935|523956520|FG000|Overall Study|Lack of Efficacy|10|||
145301356|NCT02378935|523956521|FG001|Overall Study|Lack of Efficacy|0|||
145301357|NCT02378935|523956522|FG002|Overall Study|Lack of Efficacy|2|||
145301358|NCT02378935|523956523|FG003|Overall Study|Lack of Efficacy|6|||
145301359|NCT02378935|523956524|FG004|Overall Study|Lack of Efficacy|0|||
145301360|NCT02378935|523956525|FG005|Overall Study|Lack of Efficacy|0|||
145301361|NCT02378935|523956526|FG006|Overall Study|Lack of Efficacy|0|||
145259155|NCT01409382|523796405|FG000|Overall Study|Lost to Follow-up|1|||
145259156|NCT01409382|523796406|FG001|Overall Study|Lost to Follow-up|1|||
145259157|NCT01409382|523796405|FG000|Overall Study|Protocol Violation|0|||
145259158|NCT01409382|523796406|FG001|Overall Study|Protocol Violation|3|||
145259159|NCT01409382|523796405|FG000|Overall Study|Multiple pregnancy|2|||
145259160|NCT01409382|523796406|FG001|Overall Study|Multiple pregnancy|4|||
145259161|NCT01409382|523796405|FG000|Overall Study|Still pregnant when study ended|13|||
145259162|NCT01409382|523796406|FG001|Overall Study|Still pregnant when study ended|2|||
145259163|NCT01409382|523796405|FG000|Overall Study|Did not manage to get pregnant|64|||
145259164|NCT01409382|523796406|FG001|Overall Study|Did not manage to get pregnant|70|||
145259165|NCT01409382|523796405|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
145259166|NCT01409382|523796406|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
145259167|NCT01233076|523796407|FG000|Period 2, One Week|Lost to Follow-up|1|||
145259168|NCT01233076|523796408|FG001|Period 2, One Week|Lost to Follow-up|0|||
145259169|NCT04308668|523796409|FG000|Overall Study|Lost to Follow-up|32|||
145259170|NCT04308668|523796410|FG001|Overall Study|Lost to Follow-up|38|||
145259171|NCT04308668|523796409|FG000|Overall Study|Withdrawal by Subject|4|||
145259172|NCT04308668|523796410|FG001|Overall Study|Withdrawal by Subject|4|||
145259173|NCT01266967|523796411|FG000|Overall Study|Death|69|||
145259174|NCT01266967|523796412|FG001|Overall Study|Death|61|||
145259175|NCT01266967|523796411|FG000|Overall Study|Study Closed/Terminated|15|||
145259176|NCT01266967|523796412|FG001|Overall Study|Study Closed/Terminated|17|||
145259177|NCT01266967|523796411|FG000|Overall Study|Lost to Follow-up|2|||
145259178|NCT01266967|523796412|FG001|Overall Study|Lost to Follow-up|1|||
145259179|NCT01266967|523796411|FG000|Overall Study|Physician Decision|0|||
145259180|NCT01266967|523796412|FG001|Overall Study|Physician Decision|1|||
145259181|NCT01266967|523796411|FG000|Overall Study|Withdrawal by Subject|3|||
145259182|NCT01266967|523796412|FG001|Overall Study|Withdrawal by Subject|3|||
145259183|NCT04563845|523796413|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259184|NCT04563845|523796414|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259185|NCT04563845|523796415|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259186|NCT04563845|523796416|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259187|NCT04563845|523796417|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259188|NCT04563845|523796418|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259189|NCT04563845|523796419|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259190|NCT04563845|523796420|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
145259191|NCT04563845|523796421|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259192|NCT04563845|523796422|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259193|NCT04563845|523796423|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259194|NCT04563845|523796424|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259195|NCT04563845|523796425|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259196|NCT04563845|523796426|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
145259197|NCT04563845|523796413|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259198|NCT04563845|523796414|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259199|NCT04563845|523796415|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259200|NCT04563845|523796416|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259201|NCT04563845|523796417|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
145259202|NCT04563845|523796418|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259203|NCT04563845|523796419|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259204|NCT04563845|523796420|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259205|NCT04563845|523796421|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259206|NCT04563845|523796422|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259207|NCT04563845|523796423|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259208|NCT04563845|523796424|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259209|NCT04563845|523796425|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259210|NCT04563845|523796426|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
145259211|NCT01020812|523796427|FG000|Overall Study|Physician Decision|1|||
145259212|NCT01020812|523796427|FG000|Overall Study|Withdrawal by Subject|1|||
145259213|NCT01020812|523796427|FG000|Overall Study|Protocol Violation|1|||
145259214|NCT01519700|523796428|FG000|Overall Study|Death|1|||
145259215|NCT01519700|523796429|FG001|Overall Study|Death|0|||
145259216|NCT01519700|523796430|FG002|Overall Study|Death|0|||
145259217|NCT01519700|523796431|FG003|Overall Study|Death|0|||
145259218|NCT01519700|523796428|FG000|Overall Study|Lost to Follow-up|0|||
145259219|NCT01519700|523796429|FG001|Overall Study|Lost to Follow-up|0|||
145259220|NCT01519700|523796430|FG002|Overall Study|Lost to Follow-up|1|||
145259221|NCT01519700|523796431|FG003|Overall Study|Lost to Follow-up|1|||
145259222|NCT01519700|523796428|FG000|Overall Study|Physician Decision|1|||
145259223|NCT01519700|523796429|FG001|Overall Study|Physician Decision|1|||
145259224|NCT01519700|523796430|FG002|Overall Study|Physician Decision|3|||
145259225|NCT01519700|523796431|FG003|Overall Study|Physician Decision|0|||
145259226|NCT01519700|523796428|FG000|Overall Study|Withdrawal by Subject|5|||
145259227|NCT01519700|523796429|FG001|Overall Study|Withdrawal by Subject|3|||
145410804|NCT02903914|524356851|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
145259228|NCT01519700|523796430|FG002|Overall Study|Withdrawal by Subject|3|||
145259229|NCT01519700|523796431|FG003|Overall Study|Withdrawal by Subject|2|||
145259230|NCT01519700|523796428|FG000|Overall Study|Other Reason|2|||
145259231|NCT01519700|523796429|FG001|Overall Study|Other Reason|2|||
145259232|NCT01519700|523796430|FG002|Overall Study|Other Reason|0|||
145259233|NCT01519700|523796431|FG003|Overall Study|Other Reason|4|||
145259234|NCT00960323|523796435|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
145259235|NCT03824704|523796445|FG000|Overall Study|Study Terminated by Sponsor|1|||
145259236|NCT02155660|523796448|FG000|Overall Study|Other Reason|8|||
145259237|NCT02155660|523796449|FG001|Overall Study|Other Reason|6|||
145259238|NCT02155660|523796450|FG002|Overall Study|Other Reason|10|||
145259239|NCT02155660|523796451|FG003|Overall Study|Other Reason|10|||
145259240|NCT02155660|523796448|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145259241|NCT02155660|523796449|FG001|Overall Study|Study-specific withdrawal criteria|1|||
145259242|NCT02155660|523796450|FG002|Overall Study|Study-specific withdrawal criteria|1|||
145259243|NCT02155660|523796451|FG003|Overall Study|Study-specific withdrawal criteria|1|||
145259244|NCT02155660|523796448|FG000|Overall Study|Severe non-compliance|0|||
145259245|NCT02155660|523796449|FG001|Overall Study|Severe non-compliance|4|||
145259246|NCT02155660|523796450|FG002|Overall Study|Severe non-compliance|0|||
145259247|NCT02155660|523796451|FG003|Overall Study|Severe non-compliance|1|||
145259248|NCT02155660|523796448|FG000|Overall Study|Adverse Event|2|||
145259249|NCT02155660|523796449|FG001|Overall Study|Adverse Event|6|||
145259250|NCT02155660|523796450|FG002|Overall Study|Adverse Event|3|||
145259251|NCT02155660|523796451|FG003|Overall Study|Adverse Event|1|||
145259252|NCT02155660|523796448|FG000|Overall Study|Lost to Follow-up|3|||
145259253|NCT02155660|523796449|FG001|Overall Study|Lost to Follow-up|6|||
145259254|NCT02155660|523796450|FG002|Overall Study|Lost to Follow-up|5|||
145259255|NCT02155660|523796451|FG003|Overall Study|Lost to Follow-up|8|||
145259256|NCT02155660|523796448|FG000|Overall Study|Death|17|||
145259257|NCT02155660|523796449|FG001|Overall Study|Death|19|||
145259258|NCT02155660|523796450|FG002|Overall Study|Death|17|||
145259259|NCT02155660|523796451|FG003|Overall Study|Death|19|||
145259260|NCT02155660|523796448|FG000|Overall Study|Withdrawal by Subject|28|||
145259261|NCT02155660|523796449|FG001|Overall Study|Withdrawal by Subject|31|||
145259262|NCT02155660|523796450|FG002|Overall Study|Withdrawal by Subject|24|||
145259263|NCT02155660|523796451|FG003|Overall Study|Withdrawal by Subject|21|||
145259264|NCT03730987|523796452|FG000|Overall Study|Lost to Follow-up|2|||
145259265|NCT03730987|523796453|FG001|Overall Study|Lost to Follow-up|0|||
145259266|NCT03730987|523796454|FG002|Overall Study|Lost to Follow-up|2|||
145259267|NCT03730987|523796455|FG003|Overall Study|Lost to Follow-up|0|||
145259268|NCT02505945|523796456|FG000|Overall Study|Withdrawal by Subject|13|||
145259269|NCT02505945|523796457|FG001|Overall Study|Withdrawal by Subject|2|||
145259270|NCT02505945|523796456|FG000|Overall Study|Adverse Event|1|||
145259271|NCT02505945|523796457|FG001|Overall Study|Adverse Event|0|||
145259272|NCT02505945|523796456|FG000|Overall Study|Physician Decision|2|||
145259273|NCT02505945|523796457|FG001|Overall Study|Physician Decision|1|||
145259274|NCT02505945|523796456|FG000|Overall Study|Lost to Follow-up|6|||
145259275|NCT02505945|523796457|FG001|Overall Study|Lost to Follow-up|1|||
145259276|NCT00386152|523796458|FG000|Overall Study|Adverse Event|6|||
145259277|NCT00386152|523796459|FG001|Overall Study|Adverse Event|5|||
145259278|NCT00386152|523796460|FG002|Overall Study|Adverse Event|4|||
145259279|NCT00386152|523796458|FG000|Overall Study|Chang from original chemo stratification|4|||
145259280|NCT00386152|523796459|FG001|Overall Study|Chang from original chemo stratification|5|||
145259281|NCT00386152|523796460|FG002|Overall Study|Chang from original chemo stratification|6|||
145259282|NCT00386152|523796458|FG000|Overall Study|Death|3|||
145259283|NCT00386152|523796459|FG001|Overall Study|Death|0|||
145259284|NCT00386152|523796460|FG002|Overall Study|Death|1|||
145259285|NCT00386152|523796458|FG000|Overall Study|Disease progression|7|||
145259286|NCT00386152|523796459|FG001|Overall Study|Disease progression|4|||
145259287|NCT00386152|523796460|FG002|Overall Study|Disease progression|5|||
145259288|NCT00386152|523796458|FG000|Overall Study|Physician Decision|13|||
145259289|NCT00386152|523796459|FG001|Overall Study|Physician Decision|10|||
145259290|NCT00386152|523796460|FG002|Overall Study|Physician Decision|4|||
145259291|NCT00386152|523796458|FG000|Overall Study|Lost to Follow-up|1|||
145259292|NCT00386152|523796459|FG001|Overall Study|Lost to Follow-up|0|||
145259293|NCT00386152|523796460|FG002|Overall Study|Lost to Follow-up|0|||
145259294|NCT00386152|523796458|FG000|Overall Study|Completed chemotherapy|4|||
145259295|NCT00386152|523796459|FG001|Overall Study|Completed chemotherapy|5|||
145259296|NCT00386152|523796460|FG002|Overall Study|Completed chemotherapy|1|||
145259297|NCT00386152|523796458|FG000|Overall Study|Protocol Violation|3|||
145259298|NCT00386152|523796459|FG001|Overall Study|Protocol Violation|5|||
145259299|NCT00386152|523796460|FG002|Overall Study|Protocol Violation|2|||
145259300|NCT00386152|523796458|FG000|Overall Study|Withdrawal by Subject|3|||
145259301|NCT00386152|523796459|FG001|Overall Study|Withdrawal by Subject|6|||
145259302|NCT00386152|523796460|FG002|Overall Study|Withdrawal by Subject|10|||
145259303|NCT01667731|523796462|FG000|Overall Study|Enrolled but not treated|0|||
145259304|NCT01667731|523796463|FG001|Overall Study|Enrolled but not treated|0|||
145259305|NCT01667731|523796464|FG002|Overall Study|Enrolled but not treated|0|||
145259306|NCT01667731|523796465|FG003|Overall Study|Enrolled but not treated|0|||
145259307|NCT01667731|523796466|FG004|Overall Study|Enrolled but not treated|1|||
145259308|NCT01667731|523796462|FG000|Overall Study|Efficacy Failure|1|||
145259309|NCT01667731|523796463|FG001|Overall Study|Efficacy Failure|12|||
145259310|NCT01667731|523796464|FG002|Overall Study|Efficacy Failure|0|||
145259311|NCT01667731|523796465|FG003|Overall Study|Efficacy Failure|1|||
145259312|NCT01667731|523796466|FG004|Overall Study|Efficacy Failure|24|||
145259313|NCT01667731|523796462|FG000|Overall Study|Lost to Follow-up|2|||
145259314|NCT01667731|523796463|FG001|Overall Study|Lost to Follow-up|3|||
145259315|NCT01667731|523796464|FG002|Overall Study|Lost to Follow-up|1|||
145259316|NCT01667731|523796465|FG003|Overall Study|Lost to Follow-up|1|||
145259317|NCT01667731|523796466|FG004|Overall Study|Lost to Follow-up|2|||
145259318|NCT01667731|523796462|FG000|Overall Study|Subject Withdrew Consent|2|||
145259319|NCT01667731|523796463|FG001|Overall Study|Subject Withdrew Consent|0|||
145259320|NCT01667731|523796464|FG002|Overall Study|Subject Withdrew Consent|1|||
145259321|NCT01667731|523796465|FG003|Overall Study|Subject Withdrew Consent|0|||
145259322|NCT01667731|523796466|FG004|Overall Study|Subject Withdrew Consent|1|||
145259323|NCT01667731|523796462|FG000|Overall Study|Death|0|||
145259324|NCT01667731|523796463|FG001|Overall Study|Death|1|||
145259325|NCT01667731|523796464|FG002|Overall Study|Death|0|||
145259326|NCT01667731|523796465|FG003|Overall Study|Death|0|||
145259327|NCT01667731|523796466|FG004|Overall Study|Death|0|||
145259328|NCT02577107|523796467|FG000|Overall Study|Protocol deviation|0|||
145259329|NCT02577107|523796468|FG001|Overall Study|Protocol deviation|1|||
145259330|NCT02906644|523796469|FG000|First 2 Weeks|Withdrawal by Subject|0|||
145259331|NCT02906644|523796470|FG001|First 2 Weeks|Withdrawal by Subject|2|||
145259332|NCT02906644|523796469|FG000|First 2 Weeks|Physician Decision|1|||
145259333|NCT02906644|523796470|FG001|First 2 Weeks|Physician Decision|1|||
145259334|NCT02906644|523796469|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
145259335|NCT02906644|523796470|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
145259336|NCT02906644|523796469|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
145259337|NCT02906644|523796470|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
145259338|NCT02030067|523796473|FG000|Overall Study|Disease Progression|1|||
145259339|NCT02030067|523796474|FG001|Overall Study|Disease Progression|1|||
145259340|NCT02030067|523796475|FG002|Overall Study|Disease Progression|2|||
145259341|NCT02030067|523796476|FG003|Overall Study|Disease Progression|2|||
145259342|NCT02030067|523796477|FG004|Overall Study|Disease Progression|3|||
145259343|NCT02030067|523796478|FG005|Overall Study|Disease Progression|2|||
145259344|NCT02030067|523796479|FG006|Overall Study|Disease Progression|3|||
145259345|NCT02030067|523796480|FG007|Overall Study|Disease Progression|3|||
145259346|NCT02030067|523796481|FG008|Overall Study|Disease Progression|4|||
145259347|NCT02030067|523796482|FG009|Overall Study|Disease Progression|3|||
145259348|NCT02030067|523796483|FG010|Overall Study|Disease Progression|7|||
145259349|NCT02030067|523796484|FG011|Overall Study|Disease Progression|2|||
145259350|NCT02030067|523796485|FG012|Overall Study|Disease Progression|59|||
145259351|NCT02030067|523796473|FG000|Overall Study|Withdrawal by Subject|0|||
145259352|NCT02030067|523796474|FG001|Overall Study|Withdrawal by Subject|0|||
145259353|NCT02030067|523796475|FG002|Overall Study|Withdrawal by Subject|0|||
145259354|NCT02030067|523796476|FG003|Overall Study|Withdrawal by Subject|1|||
145259355|NCT02030067|523796477|FG004|Overall Study|Withdrawal by Subject|0|||
145259356|NCT02030067|523796478|FG005|Overall Study|Withdrawal by Subject|0|||
145259357|NCT02030067|523796479|FG006|Overall Study|Withdrawal by Subject|0|||
145259358|NCT02030067|523796480|FG007|Overall Study|Withdrawal by Subject|1|||
145259359|NCT02030067|523796481|FG008|Overall Study|Withdrawal by Subject|0|||
145259360|NCT02030067|523796482|FG009|Overall Study|Withdrawal by Subject|0|||
145259361|NCT02030067|523796483|FG010|Overall Study|Withdrawal by Subject|3|||
145259362|NCT02030067|523796484|FG011|Overall Study|Withdrawal by Subject|0|||
145259363|NCT02030067|523796485|FG012|Overall Study|Withdrawal by Subject|6|||
145259364|NCT02030067|523796473|FG000|Overall Study|Physician Decision|0|||
145259365|NCT02030067|523796474|FG001|Overall Study|Physician Decision|0|||
145259366|NCT02030067|523796475|FG002|Overall Study|Physician Decision|0|||
145259367|NCT02030067|523796476|FG003|Overall Study|Physician Decision|0|||
145259368|NCT02030067|523796477|FG004|Overall Study|Physician Decision|0|||
145259369|NCT02030067|523796478|FG005|Overall Study|Physician Decision|0|||
145259370|NCT02030067|523796479|FG006|Overall Study|Physician Decision|0|||
145259371|NCT02030067|523796480|FG007|Overall Study|Physician Decision|0|||
145259372|NCT02030067|523796481|FG008|Overall Study|Physician Decision|0|||
145259373|NCT02030067|523796482|FG009|Overall Study|Physician Decision|0|||
145259374|NCT02030067|523796483|FG010|Overall Study|Physician Decision|1|||
145259375|NCT02030067|523796484|FG011|Overall Study|Physician Decision|0|||
145259376|NCT02030067|523796485|FG012|Overall Study|Physician Decision|3|||
145259377|NCT02030067|523796473|FG000|Overall Study|other reasons|0|||
145259378|NCT02030067|523796474|FG001|Overall Study|other reasons|0|||
145259379|NCT02030067|523796475|FG002|Overall Study|other reasons|0|||
145259380|NCT02030067|523796476|FG003|Overall Study|other reasons|0|||
145259381|NCT02030067|523796477|FG004|Overall Study|other reasons|0|||
145259382|NCT02030067|523796478|FG005|Overall Study|other reasons|1|||
145259383|NCT02030067|523796479|FG006|Overall Study|other reasons|0|||
145259384|NCT02030067|523796480|FG007|Overall Study|other reasons|0|||
145259385|NCT02030067|523796481|FG008|Overall Study|other reasons|2|||
145259386|NCT02030067|523796482|FG009|Overall Study|other reasons|0|||
145259387|NCT02030067|523796483|FG010|Overall Study|other reasons|0|||
145259388|NCT02030067|523796484|FG011|Overall Study|other reasons|0|||
145259389|NCT02030067|523796485|FG012|Overall Study|other reasons|4|||
145259390|NCT02030067|523796473|FG000|Overall Study|Adverse Event|0|||
145259391|NCT02030067|523796474|FG001|Overall Study|Adverse Event|0|||
145259392|NCT02030067|523796475|FG002|Overall Study|Adverse Event|0|||
145259393|NCT02030067|523796476|FG003|Overall Study|Adverse Event|0|||
145259394|NCT02030067|523796477|FG004|Overall Study|Adverse Event|0|||
145259395|NCT02030067|523796478|FG005|Overall Study|Adverse Event|0|||
145259396|NCT02030067|523796479|FG006|Overall Study|Adverse Event|0|||
145259397|NCT02030067|523796480|FG007|Overall Study|Adverse Event|0|||
145259398|NCT02030067|523796481|FG008|Overall Study|Adverse Event|0|||
145259399|NCT02030067|523796482|FG009|Overall Study|Adverse Event|0|||
145259400|NCT02030067|523796483|FG010|Overall Study|Adverse Event|0|||
145259401|NCT02030067|523796484|FG011|Overall Study|Adverse Event|1|||
145259402|NCT02030067|523796485|FG012|Overall Study|Adverse Event|8|||
145259403|NCT00265382|523796486|FG000|Overall Study|Adverse Event|21|||
145259404|NCT00265382|523796486|FG000|Overall Study|Laboratory Abnormality|1|||
145259405|NCT00265382|523796486|FG000|Overall Study|Lost to Follow-up|3|||
145259406|NCT00265382|523796486|FG000|Overall Study|Lack of Efficacy|6|||
145259407|NCT00265382|523796486|FG000|Overall Study|Miscellaneous|6|||
145259408|NCT00265382|523796486|FG000|Overall Study|Withdrawal by Subject|13|||
145259409|NCT00265382|523796486|FG000|Overall Study|Study terminated by sponsor|94|||
145259410|NCT00265382|523796486|FG000|Overall Study|Death|1|||
145259411|NCT01724021|523796487|FG000|Overall Study|Adverse Event|11|||
145259412|NCT01724021|523796488|FG001|Overall Study|Adverse Event|6|||
145259413|NCT01724021|523796487|FG000|Overall Study|Death|46|||
145259414|NCT01724021|523796488|FG001|Overall Study|Death|58|||
145259415|NCT01724021|523796487|FG000|Overall Study|Participant request/ Withdrew consent|18|||
145259416|NCT01724021|523796488|FG001|Overall Study|Participant request/ Withdrew consent|14|||
145259417|NCT01724021|523796487|FG000|Overall Study|Lost to Follow-up|15|||
145259418|NCT01724021|523796488|FG001|Overall Study|Lost to Follow-up|15|||
145259419|NCT01724021|523796487|FG000|Overall Study|Reason Not Specified|36|||
145259420|NCT01724021|523796488|FG001|Overall Study|Reason Not Specified|39|||
145259421|NCT01724021|523796487|FG000|Overall Study|Missing|1|||
145259422|NCT01724021|523796488|FG001|Overall Study|Missing|1|||
145259423|NCT02813681|523796491|FG000|Overall Study|Physician Decision|5|||
145259424|NCT02813681|523796492|FG001|Overall Study|Physician Decision|5|||
145259425|NCT02813681|523796493|FG002|Overall Study|Physician Decision|0|||
145259426|NCT02813681|523796491|FG000|Overall Study|Lost to Follow-up|0|||
145259427|NCT02813681|523796492|FG001|Overall Study|Lost to Follow-up|1|||
145259428|NCT02813681|523796493|FG002|Overall Study|Lost to Follow-up|0|||
145259429|NCT02500706|523796494|FG000|Overall Study|Adverse Event|0|||
145259430|NCT02500706|523796495|FG001|Overall Study|Adverse Event|0|||
145259431|NCT02500706|523796496|FG002|Overall Study|Adverse Event|1|||
145259432|NCT02500706|523796494|FG000|Overall Study|Lost to Follow-up|0|||
145259433|NCT02500706|523796495|FG001|Overall Study|Lost to Follow-up|1|||
145259434|NCT02500706|523796496|FG002|Overall Study|Lost to Follow-up|1|||
145259435|NCT02500706|523796494|FG000|Overall Study|Withdrawal by Subject|4|||
145259436|NCT02500706|523796495|FG001|Overall Study|Withdrawal by Subject|6|||
145259437|NCT02500706|523796496|FG002|Overall Study|Withdrawal by Subject|4|||
145259438|NCT02500706|523796494|FG000|Overall Study|Unclassified|0|||
145259439|NCT02500706|523796495|FG001|Overall Study|Unclassified|0|||
145259440|NCT02500706|523796496|FG002|Overall Study|Unclassified|1|||
145259441|NCT04212221|523796505|FG000|Overall Study|Remained on Treatment|0|||
145259442|NCT04212221|523796506|FG001|Overall Study|Remained on Treatment|0|||
145259443|NCT04212221|523796507|FG002|Overall Study|Remained on Treatment|0|||
145259444|NCT04212221|523796508|FG003|Overall Study|Remained on Treatment|1|||
145259445|NCT04212221|523796509|FG004|Overall Study|Remained on Treatment|0|||
145259446|NCT04212221|523796510|FG005|Overall Study|Remained on Treatment|0|||
145259447|NCT04212221|523796511|FG006|Overall Study|Remained on Treatment|3|||
145259448|NCT04212221|523796512|FG007|Overall Study|Remained on Treatment|9|||
145259449|NCT04212221|523796505|FG000|Overall Study|Adverse Event|0|||
145259450|NCT04212221|523796506|FG001|Overall Study|Adverse Event|0|||
145259451|NCT04212221|523796507|FG002|Overall Study|Adverse Event|0|||
145259452|NCT04212221|523796508|FG003|Overall Study|Adverse Event|0|||
145259453|NCT04212221|523796509|FG004|Overall Study|Adverse Event|0|||
145259454|NCT04212221|523796510|FG005|Overall Study|Adverse Event|0|||
145410805|NCT02903914|524356852|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
145259455|NCT04212221|523796511|FG006|Overall Study|Adverse Event|2|||
145259456|NCT04212221|523796512|FG007|Overall Study|Adverse Event|3|||
145259457|NCT04212221|523796505|FG000|Overall Study|Death|0|||
145259458|NCT04212221|523796506|FG001|Overall Study|Death|0|||
145259459|NCT04212221|523796507|FG002|Overall Study|Death|0|||
145259460|NCT04212221|523796508|FG003|Overall Study|Death|0|||
145259461|NCT04212221|523796509|FG004|Overall Study|Death|0|||
145259462|NCT04212221|523796510|FG005|Overall Study|Death|0|||
145259463|NCT04212221|523796511|FG006|Overall Study|Death|0|||
145259464|NCT04212221|523796512|FG007|Overall Study|Death|2|||
145259465|NCT04212221|523796505|FG000|Overall Study|Disease progression according to irRECIST|1|||
145259466|NCT04212221|523796506|FG001|Overall Study|Disease progression according to irRECIST|2|||
145259467|NCT04212221|523796507|FG002|Overall Study|Disease progression according to irRECIST|3|||
145568655|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
145259468|NCT04212221|523796508|FG003|Overall Study|Disease progression according to irRECIST|3|||
145259469|NCT04212221|523796509|FG004|Overall Study|Disease progression according to irRECIST|2|||
145259470|NCT04212221|523796510|FG005|Overall Study|Disease progression according to irRECIST|2|||
145259471|NCT04212221|523796511|FG006|Overall Study|Disease progression according to irRECIST|21|||
145259472|NCT04212221|523796512|FG007|Overall Study|Disease progression according to irRECIST|17|||
145259473|NCT04212221|523796505|FG000|Overall Study|Global Deterioration of Health Status|0|||
145259474|NCT04212221|523796506|FG001|Overall Study|Global Deterioration of Health Status|0|||
145259475|NCT04212221|523796507|FG002|Overall Study|Global Deterioration of Health Status|0|||
145259476|NCT04212221|523796508|FG003|Overall Study|Global Deterioration of Health Status|0|||
145259477|NCT04212221|523796509|FG004|Overall Study|Global Deterioration of Health Status|0|||
145259478|NCT04212221|523796510|FG005|Overall Study|Global Deterioration of Health Status|0|||
145259479|NCT04212221|523796511|FG006|Overall Study|Global Deterioration of Health Status|0|||
145259480|NCT04212221|523796512|FG007|Overall Study|Global Deterioration of Health Status|2|||
145259481|NCT04212221|523796505|FG000|Overall Study|Investigator's Decision|0|||
145259482|NCT04212221|523796506|FG001|Overall Study|Investigator's Decision|0|||
145259483|NCT04212221|523796507|FG002|Overall Study|Investigator's Decision|0|||
145259484|NCT04212221|523796508|FG003|Overall Study|Investigator's Decision|1|||
145259485|NCT04212221|523796509|FG004|Overall Study|Investigator's Decision|0|||
145259486|NCT04212221|523796510|FG005|Overall Study|Investigator's Decision|0|||
145259487|NCT04212221|523796511|FG006|Overall Study|Investigator's Decision|3|||
145259488|NCT04212221|523796512|FG007|Overall Study|Investigator's Decision|0|||
145259489|NCT04212221|523796505|FG000|Overall Study|Participant refused to continue treatment|0|||
145259490|NCT04212221|523796506|FG001|Overall Study|Participant refused to continue treatment|1|||
145259491|NCT04212221|523796507|FG002|Overall Study|Participant refused to continue treatment|0|||
145259492|NCT04212221|523796508|FG003|Overall Study|Participant refused to continue treatment|1|||
145259493|NCT04212221|523796509|FG004|Overall Study|Participant refused to continue treatment|1|||
145259494|NCT04212221|523796510|FG005|Overall Study|Participant refused to continue treatment|2|||
145259495|NCT04212221|523796511|FG006|Overall Study|Participant refused to continue treatment|4|||
145259496|NCT04212221|523796512|FG007|Overall Study|Participant refused to continue treatment|2|||
145568656|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
145568657|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
145568658|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
145259497|NCT04212221|523796505|FG000|Overall Study|Protocol Violation|0|||
145259498|NCT04212221|523796506|FG001|Overall Study|Protocol Violation|0|||
145259499|NCT04212221|523796507|FG002|Overall Study|Protocol Violation|0|||
145259500|NCT04212221|523796508|FG003|Overall Study|Protocol Violation|0|||
145259501|NCT04212221|523796509|FG004|Overall Study|Protocol Violation|0|||
145259502|NCT04212221|523796510|FG005|Overall Study|Protocol Violation|0|||
145259503|NCT04212221|523796511|FG006|Overall Study|Protocol Violation|0|||
145259504|NCT04212221|523796512|FG007|Overall Study|Protocol Violation|1|||
145259505|NCT00636506|523796517|FG000|Overall Study|Lost to Follow-up|8|||
145259506|NCT00636506|523796517|FG000|Overall Study|Explanted|1|||
145259507|NCT00636506|523796517|FG000|Overall Study|Withdrawal by Subject|6|||
145259508|NCT00636506|523796517|FG000|Overall Study|Procedure aborted|1|||
145259509|NCT03742271|523796518|FG000|Overall Study|Unsatisfactory Visual Response|1|||
145259510|NCT03742271|523796518|FG000|Overall Study|Withdrawal by Subject|3|||
145259511|NCT03742271|523796518|FG000|Overall Study|Lost to Follow-up|4|||
145259512|NCT03742271|523796518|FG000|Overall Study|Failed Insertion & removal|3|||
145259513|NCT03742271|523796518|FG000|Overall Study|Protocol Violation|1|||
145259514|NCT01624974|523796519|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
145259515|NCT01624974|523796520|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
145259516|NCT01624974|523796519|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
145259517|NCT01624974|523796520|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
145259518|NCT01624974|523796519|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
145259519|NCT01624974|523796520|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
145259520|NCT01624974|523796519|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
145259521|NCT01624974|523796520|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
145259522|NCT01624974|523796519|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
145259523|NCT01624974|523796520|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
145259524|NCT01624974|523796519|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
145259525|NCT01624974|523796520|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
145259526|NCT01624974|523796519|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
145259527|NCT01624974|523796520|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
145259528|NCT01624974|523796519|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
145259529|NCT01624974|523796520|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
145301362|NCT02378935|523956520|FG000|Overall Study|Death|0|||
145301363|NCT02378935|523956521|FG001|Overall Study|Death|0|||
145301364|NCT02378935|523956522|FG002|Overall Study|Death|1|||
145301365|NCT02378935|523956523|FG003|Overall Study|Death|0|||
145301366|NCT02378935|523956524|FG004|Overall Study|Death|0|||
145301367|NCT02378935|523956525|FG005|Overall Study|Death|0|||
145301368|NCT02378935|523956526|FG006|Overall Study|Death|0|||
145301369|NCT00984022|523956529|FG000|Overall Study|Lost to Follow-up|10|||
145301370|NCT00984022|523956530|FG001|Overall Study|Lost to Follow-up|14|||
145301371|NCT00573443|523956531|FG000|Double-Blind Phase|Lost to Follow-up|1|||
145301372|NCT00573443|523956532|FG001|Double-Blind Phase|Lost to Follow-up|3|||
145259530|NCT01624974|523796519|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
145259531|NCT01624974|523796520|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
145259532|NCT01624974|523796519|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
145259533|NCT01624974|523796520|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
145259534|NCT01624974|523796519|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
145259535|NCT01624974|523796520|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
145259536|NCT01624974|523796519|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
145259537|NCT01624974|523796520|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
145259538|NCT00266695|523796521|FG000|Overall Study|Adverse Event|1|||
145259539|NCT00266695|523796521|FG000|Overall Study|Death|9|||
145259540|NCT00266695|523796521|FG000|Overall Study|Physician Decision|1|||
145259541|NCT00266695|523796521|FG000|Overall Study|Lost to Follow-up|3|||
145259542|NCT00266695|523796521|FG000|Overall Study|Withdrawal by Subject|15|||
145259543|NCT02380703|523796522|FG000|Overall Study|Withdrawal by Subject|12|||
145259544|NCT02380703|523796523|FG001|Overall Study|Withdrawal by Subject|9|||
145259545|NCT02380703|523796522|FG000|Overall Study|Lost to Follow-up|12|||
145259546|NCT02380703|523796523|FG001|Overall Study|Lost to Follow-up|12|||
145259547|NCT02380703|523796522|FG000|Overall Study|Caregiver death|1|||
145259548|NCT02380703|523796523|FG001|Overall Study|Caregiver death|0|||
145259549|NCT02380703|523796522|FG000|Overall Study|Person with dementia (PWD) death|7|||
145259550|NCT02380703|523796523|FG001|Overall Study|Person with dementia (PWD) death|8|||
145301373|NCT00573443|523956533|FG002|Double-Blind Phase|Lost to Follow-up|2|||
145301374|NCT00573443|523956531|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
145301375|NCT00573443|523956532|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
145301376|NCT00573443|523956533|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
145301377|NCT00573443|523956531|FG000|Double-Blind Phase|Adverse Event|1|||
145301378|NCT00573443|523956532|FG001|Double-Blind Phase|Adverse Event|5|||
145301379|NCT00573443|523956533|FG002|Double-Blind Phase|Adverse Event|0|||
145301380|NCT00573443|523956531|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
145301381|NCT00573443|523956532|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
145301382|NCT00573443|523956533|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
145301383|NCT00573443|523956531|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
145301384|NCT00573443|523956532|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
145301385|NCT00573443|523956533|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
145301386|NCT00573443|523956531|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
145301387|NCT00573443|523956532|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
145301388|NCT00573443|523956533|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
145301389|NCT00573443|523956531|FG000|Double-Blind Phase|Protocol Violation|0|||
145301390|NCT00573443|523956532|FG001|Double-Blind Phase|Protocol Violation|2|||
145301391|NCT00573443|523956533|FG002|Double-Blind Phase|Protocol Violation|1|||
145301392|NCT00573443|523956531|FG000|Double-Blind Phase|Other|0|||
145301393|NCT00573443|523956532|FG001|Double-Blind Phase|Other|2|||
145301394|NCT00573443|523956533|FG002|Double-Blind Phase|Other|3|||
145301395|NCT00573443|523956531|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
145301396|NCT00573443|523956532|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145301397|NCT00573443|523956533|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145301398|NCT00573443|523956531|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
145301399|NCT00573443|523956532|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
145301400|NCT00573443|523956533|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
145301401|NCT00573443|523956531|FG000|Open-Label Extension Phase|Adverse Event|3|||
145301402|NCT00573443|523956532|FG001|Open-Label Extension Phase|Adverse Event|0|||
145301403|NCT00573443|523956533|FG002|Open-Label Extension Phase|Adverse Event|0|||
145259551|NCT02380703|523796522|FG000|Overall Study|Entered Long-term Care|4|||
145259552|NCT02380703|523796523|FG001|Overall Study|Entered Long-term Care|7|||
145259553|NCT03607994|523796524|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
145259554|NCT03607994|523796525|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
145259555|NCT00620815|523796528|FG000|Overall Study|Adverse Event|1|||
145301404|NCT00573443|523956531|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
145301405|NCT00573443|523956532|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
145301406|NCT00573443|523956533|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
145301407|NCT00573443|523956531|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
145301408|NCT00573443|523956532|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
145259556|NCT00620815|523796529|FG001|Overall Study|Adverse Event|1|||
145259557|NCT00620815|523796530|FG002|Overall Study|Adverse Event|2|||
145259558|NCT00620815|523796528|FG000|Overall Study|Withdrawal by Subject|1|||
145259559|NCT00620815|523796529|FG001|Overall Study|Withdrawal by Subject|2|||
145259560|NCT00620815|523796530|FG002|Overall Study|Withdrawal by Subject|0|||
145259561|NCT00620815|523796528|FG000|Overall Study|Lost to Follow-up|1|||
145259562|NCT00620815|523796529|FG001|Overall Study|Lost to Follow-up|6|||
145259563|NCT00620815|523796530|FG002|Overall Study|Lost to Follow-up|3|||
145259564|NCT00620815|523796528|FG000|Overall Study|Inappropriate enrolment|0|||
145259565|NCT00620815|523796529|FG001|Overall Study|Inappropriate enrolment|0|||
145259566|NCT00620815|523796530|FG002|Overall Study|Inappropriate enrolment|1|||
145259567|NCT00620815|523796528|FG000|Overall Study|Protocol Violation|1|||
145259568|NCT00620815|523796529|FG001|Overall Study|Protocol Violation|2|||
145259569|NCT00620815|523796530|FG002|Overall Study|Protocol Violation|1|||
145259570|NCT01888367|523796531|FG000|Overall Study|Physician Decision|3|||
145259571|NCT01888367|523796532|FG001|Overall Study|Physician Decision|4|||
145259572|NCT01888367|523796533|FG002|Overall Study|Physician Decision|2|||
145259573|NCT01888367|523796531|FG000|Overall Study|Death|2|||
145259574|NCT01888367|523796532|FG001|Overall Study|Death|0|||
145259575|NCT01888367|523796533|FG002|Overall Study|Death|1|||
145259576|NCT01888367|523796531|FG000|Overall Study|Withdrawal by Subject|1|||
145259577|NCT01888367|523796532|FG001|Overall Study|Withdrawal by Subject|0|||
145259578|NCT01888367|523796533|FG002|Overall Study|Withdrawal by Subject|1|||
145259579|NCT01888367|523796531|FG000|Overall Study|Lost to Follow-up|1|||
145259580|NCT01888367|523796532|FG001|Overall Study|Lost to Follow-up|1|||
145259581|NCT01888367|523796533|FG002|Overall Study|Lost to Follow-up|0|||
145259582|NCT01888367|523796531|FG000|Overall Study|Protocol Violation|0|||
145259583|NCT01888367|523796532|FG001|Overall Study|Protocol Violation|0|||
145259584|NCT01888367|523796533|FG002|Overall Study|Protocol Violation|1|||
145259585|NCT01888367|523796531|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
145259586|NCT01888367|523796532|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
145259587|NCT01888367|523796533|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
145259588|NCT00591786|523796534|FG000|Overall Study|Withdrawal of Informed Consent|0|||
145259589|NCT00591786|523796535|FG001|Overall Study|Withdrawal of Informed Consent|0|||
145259590|NCT00591786|523796536|FG002|Overall Study|Withdrawal of Informed Consent|1|||
145259591|NCT00591786|523796537|FG003|Overall Study|Withdrawal of Informed Consent|0|||
145259592|NCT00591786|523796538|FG004|Overall Study|Withdrawal of Informed Consent|0|||
145259593|NCT00591786|523796539|FG005|Overall Study|Withdrawal of Informed Consent|0|||
145259594|NCT00591786|523796540|FG006|Overall Study|Withdrawal of Informed Consent|0|||
145259595|NCT00591786|523796541|FG007|Overall Study|Withdrawal of Informed Consent|0|||
145259596|NCT00591786|523796542|FG008|Overall Study|Withdrawal of Informed Consent|0|||
145259597|NCT00591786|523796543|FG009|Overall Study|Withdrawal of Informed Consent|0|||
145259598|NCT03969589|523796544|FG000|Overall Study|Lost to Follow-up|3|||
145259599|NCT03969589|523796545|FG001|Overall Study|Lost to Follow-up|2|||
145259600|NCT03969589|523796544|FG000|Overall Study|Declined Follow-Up|0|||
145259601|NCT03969589|523796545|FG001|Overall Study|Declined Follow-Up|1|||
145259602|NCT00517634|523796546|FG000|Second Treatment Period|Withdrawal by Subject|0|||
145259603|NCT00517634|523796547|FG001|Second Treatment Period|Withdrawal by Subject|0|||
145259604|NCT00517634|523796548|FG002|Second Treatment Period|Withdrawal by Subject|0|||
145259605|NCT00517634|523796549|FG003|Second Treatment Period|Withdrawal by Subject|0|||
145259606|NCT00517634|523796550|FG004|Second Treatment Period|Withdrawal by Subject|1|||
145259607|NCT00517634|523796551|FG005|Second Treatment Period|Withdrawal by Subject|0|||
145259608|NCT03143855|523796552|FG000|Overall Study|Withdrawal by Subject|4|||
145259609|NCT03143855|523796553|FG001|Overall Study|Withdrawal by Subject|3|||
145259610|NCT03143855|523796552|FG000|Overall Study|Protocol Violation|1|||
145259611|NCT03143855|523796553|FG001|Overall Study|Protocol Violation|0|||
145259612|NCT03143855|523796552|FG000|Overall Study|Participant experienced withdrawal|0|||
145259613|NCT03143855|523796553|FG001|Overall Study|Participant experienced withdrawal|1|||
145259614|NCT03417999|523796554|FG000|Overall Study|Withdrawal by Subject|1|||
145259615|NCT03417999|523796555|FG001|Overall Study|Withdrawal by Subject|0|||
145259616|NCT03417999|523796556|FG002|Overall Study|Withdrawal by Subject|0|||
145259617|NCT03417999|523796554|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
145259618|NCT03417999|523796555|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
145259619|NCT03417999|523796556|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
145259620|NCT03417999|523796554|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
145259621|NCT03417999|523796555|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
145259622|NCT03417999|523796556|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
145259623|NCT03417999|523796554|FG000|Overall Study|Inadequate study staff available to process samples|0|||
145259624|NCT03417999|523796555|FG001|Overall Study|Inadequate study staff available to process samples|0|||
145259625|NCT03417999|523796556|FG002|Overall Study|Inadequate study staff available to process samples|1|||
145259626|NCT00422942|523796561|FG000|Overall Study|Study terminated by Sponsor|3|||
145259627|NCT02539160|523796562|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
145259628|NCT02539160|523796563|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
145259629|NCT02539160|523796564|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
145259630|NCT02539160|523796565|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
145259631|NCT02539160|523796562|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
145259632|NCT02539160|523796563|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
145259633|NCT02539160|523796564|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
145259634|NCT02539160|523796565|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
145259635|NCT02539160|523796562|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
145259636|NCT02539160|523796563|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
145259637|NCT02539160|523796564|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
145259638|NCT02539160|523796565|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
145259639|NCT01681004|523796566|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
145259640|NCT01681004|523796567|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
145259641|NCT01681004|523796566|FG000|Study Completion|Lost to Follow-up|8|||
145259642|NCT01681004|523796567|FG001|Study Completion|Lost to Follow-up|3|||
145259643|NCT01681004|523796566|FG000|Study Completion|Physician Decision|1|||
145259644|NCT01681004|523796567|FG001|Study Completion|Physician Decision|3|||
145259645|NCT01681004|523796566|FG000|Study Completion|Site Termination|2|||
145259646|NCT01681004|523796567|FG001|Study Completion|Site Termination|1|||
145259647|NCT01681004|523796566|FG000|Study Completion|Death|1|||
145259648|NCT01681004|523796567|FG001|Study Completion|Death|1|||
145259649|NCT00939094|523796568|FG000|Overall Study|Adverse Event|9|||
145259650|NCT00939094|523796569|FG001|Overall Study|Adverse Event|0|||
145259651|NCT00939094|523796568|FG000|Overall Study|Withdrawal by Subject|1|||
145259652|NCT00939094|523796569|FG001|Overall Study|Withdrawal by Subject|6|||
145259653|NCT00939094|523796568|FG000|Overall Study|Lost to Follow-up|1|||
145259654|NCT00939094|523796569|FG001|Overall Study|Lost to Follow-up|1|||
145259655|NCT00939094|523796568|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145259656|NCT00939094|523796569|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145259657|NCT00939094|523796568|FG000|Overall Study|Severe non-compliance to protocol|0|||
145259658|NCT00939094|523796569|FG001|Overall Study|Severe non-compliance to protocol|1|||
145259659|NCT00939094|523796568|FG000|Overall Study|Study stopped by sponsor|0|||
145259660|NCT00939094|523796569|FG001|Overall Study|Study stopped by sponsor|2|||
145259661|NCT00939094|523796568|FG000|Overall Study|Abnormal ECG findings|1|||
145259662|NCT00939094|523796569|FG001|Overall Study|Abnormal ECG findings|0|||
145259663|NCT00134563|523798115|FG000|Overall Study|Not treated due to protocol violation|0|||
145259664|NCT00134563|523798116|FG001|Overall Study|Not treated due to protocol violation|1|||
145259665|NCT00134563|523798117|FG002|Overall Study|Not treated due to protocol violation|1|||
145259666|NCT00134563|523798115|FG000|Overall Study|Adverse Event|29|||
145259667|NCT00134563|523798116|FG001|Overall Study|Adverse Event|37|||
145259668|NCT00134563|523798117|FG002|Overall Study|Adverse Event|38|||
145259669|NCT00134563|523798115|FG000|Overall Study|Lack of Efficacy|24|||
145259670|NCT00134563|523798116|FG001|Overall Study|Lack of Efficacy|14|||
145259671|NCT00134563|523798117|FG002|Overall Study|Lack of Efficacy|17|||
145259672|NCT00134563|523798115|FG000|Overall Study|Protocol Violation|3|||
145259673|NCT00134563|523798116|FG001|Overall Study|Protocol Violation|2|||
145259674|NCT00134563|523798117|FG002|Overall Study|Protocol Violation|5|||
145259675|NCT00134563|523798115|FG000|Overall Study|Lost to Follow-up|4|||
145259676|NCT00134563|523798116|FG001|Overall Study|Lost to Follow-up|0|||
145259677|NCT00134563|523798117|FG002|Overall Study|Lost to Follow-up|2|||
145259678|NCT00134563|523798115|FG000|Overall Study|progressive disease|11|||
145259679|NCT00134563|523798116|FG001|Overall Study|progressive disease|4|||
145259680|NCT00134563|523798117|FG002|Overall Study|progressive disease|2|||
145259681|NCT00134563|523798115|FG000|Overall Study|did not wish to continue|33|||
145259682|NCT00134563|523798116|FG001|Overall Study|did not wish to continue|32|||
145259683|NCT00134563|523798117|FG002|Overall Study|did not wish to continue|26|||
145259684|NCT00134563|523798115|FG000|Overall Study|Reason other than above|0|||
145259685|NCT00134563|523798116|FG001|Overall Study|Reason other than above|2|||
145259686|NCT00134563|523798117|FG002|Overall Study|Reason other than above|5|||
145259687|NCT02406586|523798118|FG000|Overall Study|Lost to Follow-up|0|||
145259688|NCT02406586|523798119|FG001|Overall Study|Lost to Follow-up|4|||
145259689|NCT02406586|523798120|FG002|Overall Study|Lost to Follow-up|2|||
145259690|NCT02406586|523798118|FG000|Overall Study|Withdrawal by Subject|1|||
145259691|NCT02406586|523798119|FG001|Overall Study|Withdrawal by Subject|0|||
145301409|NCT00573443|523956533|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
145301410|NCT00573443|523956531|FG000|Open-Label Extension Phase|Protocol Violation|2|||
145259692|NCT02406586|523798120|FG002|Overall Study|Withdrawal by Subject|0|||
145259693|NCT02839330|523798121|FG000|Overall Study|Adverse Event|0|||
145259694|NCT02839330|523798122|FG001|Overall Study|Adverse Event|1|||
145259695|NCT02839330|523798123|FG002|Overall Study|Adverse Event|2|||
145259696|NCT02839330|523798124|FG003|Overall Study|Adverse Event|2|||
145259697|NCT02839330|523798121|FG000|Overall Study|Death|4|||
145259698|NCT02839330|523798122|FG001|Overall Study|Death|6|||
145259699|NCT02839330|523798123|FG002|Overall Study|Death|1|||
145259700|NCT02839330|523798124|FG003|Overall Study|Death|1|||
145259701|NCT02839330|523798121|FG000|Overall Study|Withdrawal by Subject|27|||
145259702|NCT02839330|523798122|FG001|Overall Study|Withdrawal by Subject|19|||
145301411|NCT00573443|523956532|FG001|Open-Label Extension Phase|Protocol Violation|0|||
145259703|NCT02839330|523798123|FG002|Overall Study|Withdrawal by Subject|11|||
145259704|NCT02839330|523798124|FG003|Overall Study|Withdrawal by Subject|13|||
145259705|NCT02839330|523798121|FG000|Overall Study|Lost to Follow-up|22|||
145259706|NCT02839330|523798122|FG001|Overall Study|Lost to Follow-up|27|||
145259707|NCT02839330|523798123|FG002|Overall Study|Lost to Follow-up|29|||
145259708|NCT02839330|523798124|FG003|Overall Study|Lost to Follow-up|25|||
145259709|NCT02839330|523798121|FG000|Overall Study|Administrative Reason|0|||
145259710|NCT02839330|523798122|FG001|Overall Study|Administrative Reason|0|||
145259711|NCT02839330|523798123|FG002|Overall Study|Administrative Reason|0|||
145259712|NCT02839330|523798124|FG003|Overall Study|Administrative Reason|1|||
145259713|NCT02839330|523798121|FG000|Overall Study|Protocol Violation|1|||
145259714|NCT02839330|523798122|FG001|Overall Study|Protocol Violation|2|||
145259715|NCT02839330|523798123|FG002|Overall Study|Protocol Violation|2|||
145259716|NCT02839330|523798124|FG003|Overall Study|Protocol Violation|3|||
145259717|NCT02839330|523798121|FG000|Overall Study|Other reason, not specified|4|||
145259718|NCT02839330|523798122|FG001|Overall Study|Other reason, not specified|3|||
145259719|NCT02839330|523798123|FG002|Overall Study|Other reason, not specified|3|||
145259720|NCT02839330|523798124|FG003|Overall Study|Other reason, not specified|6|||
145259721|NCT00883896|523798127|FG000|Overall Study|Lost to Follow-up|0|||
145259722|NCT00883896|523798128|FG001|Overall Study|Lost to Follow-up|0|||
145259723|NCT00883896|523798129|FG002|Overall Study|Lost to Follow-up|0|||
145259724|NCT00883896|523798130|FG003|Overall Study|Lost to Follow-up|2|||
145259725|NCT00883896|523798127|FG000|Overall Study|Withdrawal by Subject|5|||
145259726|NCT00883896|523798128|FG001|Overall Study|Withdrawal by Subject|0|||
145259727|NCT00883896|523798129|FG002|Overall Study|Withdrawal by Subject|1|||
145259728|NCT00883896|523798130|FG003|Overall Study|Withdrawal by Subject|3|||
145259729|NCT00883896|523798127|FG000|Overall Study|Lack of Efficacy|0|||
145259730|NCT00883896|523798128|FG001|Overall Study|Lack of Efficacy|0|||
145259731|NCT00883896|523798129|FG002|Overall Study|Lack of Efficacy|0|||
145259732|NCT00883896|523798130|FG003|Overall Study|Lack of Efficacy|2|||
145259733|NCT00883896|523798127|FG000|Overall Study|Other|1|||
145259734|NCT00883896|523798128|FG001|Overall Study|Other|0|||
145259735|NCT00883896|523798129|FG002|Overall Study|Other|0|||
145259736|NCT00883896|523798130|FG003|Overall Study|Other|0|||
145259737|NCT03380091|523798142|FG000|Overall Study|Withdrawal by Subject|2|||
145259738|NCT03380091|523798143|FG001|Overall Study|Withdrawal by Subject|1|||
145259739|NCT01980056|523798145|FG000|Overall Study|Death|1|||
145259740|NCT01980056|523798146|FG001|Overall Study|Death|1|||
145259741|NCT01980056|523798147|FG002|Overall Study|Death|0|||
145259742|NCT00661362|523798148|FG000|Overall Study|Adverse Event|5|||
145259743|NCT00661362|523798149|FG001|Overall Study|Adverse Event|4|||
145259744|NCT00661362|523798148|FG000|Overall Study|Incorrect enrollment|2|||
145259745|NCT00661362|523798149|FG001|Overall Study|Incorrect enrollment|0|||
145259746|NCT00661362|523798148|FG000|Overall Study|Study specific discontinuation criteria|4|||
145259747|NCT00661362|523798149|FG001|Overall Study|Study specific discontinuation criteria|11|||
145259748|NCT00661362|523798148|FG000|Overall Study|Withdrawal by Subject|13|||
145259749|NCT00661362|523798149|FG001|Overall Study|Withdrawal by Subject|23|||
145259750|NCT00661362|523798148|FG000|Overall Study|Lost to Follow-up|3|||
145259751|NCT00661362|523798149|FG001|Overall Study|Lost to Follow-up|1|||
145259752|NCT00661362|523798148|FG000|Overall Study|Severe non-compliance to protocol|0|||
145259753|NCT00661362|523798149|FG001|Overall Study|Severe non-compliance to protocol|1|||
145259754|NCT00661362|523798148|FG000|Overall Study|Safety reasons|1|||
145259755|NCT00661362|523798149|FG001|Overall Study|Safety reasons|0|||
145259756|NCT00661362|523798148|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
145259757|NCT00661362|523798149|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
145259758|NCT00535262|523798150|FG000|Overall Study|No funding|3|||
145259759|NCT03802331|523798152|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
145259760|NCT03802331|523798153|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
145568659|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
145568660|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
145568661|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
145568662|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
145568663|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
145259761|NCT00368069|523798155|FG000|Overall Study|Adverse Event|5|||
145568664|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
145568665|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
145568666|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
145259762|NCT00368069|523798156|FG001|Overall Study|Adverse Event|2|||
145259763|NCT00368069|523798155|FG000|Overall Study|Lack of Efficacy|0|||
145259764|NCT00368069|523798156|FG001|Overall Study|Lack of Efficacy|1|||
145259765|NCT00368069|523798155|FG000|Overall Study|Lost to Follow-up|1|||
145259766|NCT00368069|523798156|FG001|Overall Study|Lost to Follow-up|0|||
145259767|NCT00368069|523798155|FG000|Overall Study|Protocol Violation|0|||
145259768|NCT00368069|523798156|FG001|Overall Study|Protocol Violation|2|||
145259769|NCT00368069|523798155|FG000|Overall Study|Withdrawal of Consent|2|||
145259770|NCT00368069|523798156|FG001|Overall Study|Withdrawal of Consent|1|||
145259771|NCT00368069|523798155|FG000|Overall Study|no blood sampling possible|0|||
145568667|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
145568668|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
145259772|NCT00368069|523798156|FG001|Overall Study|no blood sampling possible|1|||
145259773|NCT01220024|523798162|FG000|Overall Study|Lost to Follow-up|1|||
145259774|NCT01220024|523798163|FG001|Overall Study|Lost to Follow-up|1|||
145259775|NCT00174460|523798164|FG000|Overall Study|Withdrawal by Subject|0|||
145259776|NCT00174460|523798165|FG001|Overall Study|Withdrawal by Subject|1|||
145259777|NCT00579059|523798168|FG000|Overall Study|Study Canceled at 1 Year|21|||
145259778|NCT00579059|523798169|FG001|Overall Study|Study Canceled at 1 Year|10|||
145259779|NCT00779506|523798170|FG000|Overall Study|Screening Failed|2|||
145259780|NCT00779506|523798170|FG000|Overall Study|Adverse Event|4|||
145259781|NCT00779506|523798170|FG000|Overall Study|Lack of Efficacy|11|||
145259782|NCT00779506|523798170|FG000|Overall Study|Protocol Violation|5|||
145259783|NCT00779506|523798170|FG000|Overall Study|Withdrawal by Subject|6|||
145259784|NCT00779506|523798170|FG000|Overall Study|Lost to Follow-up|1|||
145259785|NCT04047472|523798171|FG000|Overall Study|Adverse Event|3|||
145259786|NCT04047472|523798172|FG001|Overall Study|Adverse Event|3|||
145259787|NCT04047472|523798171|FG000|Overall Study|Death|0|||
145259788|NCT04047472|523798172|FG001|Overall Study|Death|1|||
145259789|NCT04047472|523798171|FG000|Overall Study|Lost to Follow-up|1|||
145259790|NCT04047472|523798172|FG001|Overall Study|Lost to Follow-up|0|||
145259791|NCT04047472|523798171|FG000|Overall Study|Physician Decision|1|||
145259792|NCT04047472|523798172|FG001|Overall Study|Physician Decision|2|||
145259793|NCT04047472|523798171|FG000|Overall Study|Protocol Violation|1|||
145259794|NCT04047472|523798172|FG001|Overall Study|Protocol Violation|0|||
145259795|NCT04047472|523798171|FG000|Overall Study|Withdrawal by Subject|10|||
145259796|NCT04047472|523798172|FG001|Overall Study|Withdrawal by Subject|10|||
145259797|NCT03982069|523798173|FG000|Overall Study|Lost to Follow-up|5|||
145259798|NCT03982069|523798174|FG001|Overall Study|Lost to Follow-up|5|||
145259799|NCT03982069|523798175|FG002|Overall Study|Lost to Follow-up|3|||
145259800|NCT03982069|523798176|FG003|Overall Study|Lost to Follow-up|5|||
145259801|NCT03982069|523798173|FG000|Overall Study|Physician Decision|0|||
145259802|NCT03982069|523798174|FG001|Overall Study|Physician Decision|1|||
145259803|NCT03982069|523798175|FG002|Overall Study|Physician Decision|0|||
145259804|NCT03982069|523798176|FG003|Overall Study|Physician Decision|0|||
145259805|NCT03982069|523798173|FG000|Overall Study|Withdrawal by Subject|2|||
145259806|NCT03982069|523798174|FG001|Overall Study|Withdrawal by Subject|1|||
145259807|NCT03982069|523798175|FG002|Overall Study|Withdrawal by Subject|5|||
145259808|NCT03982069|523798176|FG003|Overall Study|Withdrawal by Subject|2|||
145259809|NCT03982069|523798173|FG000|Overall Study|Specimen loss|3|||
145259810|NCT03982069|523798174|FG001|Overall Study|Specimen loss|3|||
145259811|NCT03982069|523798175|FG002|Overall Study|Specimen loss|1|||
145259812|NCT03982069|523798176|FG003|Overall Study|Specimen loss|1|||
145259813|NCT01218477|523798177|FG000|Overall Study|Disease progression|2|||
145259814|NCT01218477|523798178|FG001|Overall Study|Disease progression|3|||
145259815|NCT01218477|523798179|FG002|Overall Study|Disease progression|6|||
145259816|NCT01218477|523798180|FG003|Overall Study|Disease progression|2|||
145259817|NCT01218477|523798177|FG000|Overall Study|Study drug toxicity|0|||
145259818|NCT01218477|523798178|FG001|Overall Study|Study drug toxicity|2|||
145259819|NCT01218477|523798179|FG002|Overall Study|Study drug toxicity|5|||
145259820|NCT01218477|523798180|FG003|Overall Study|Study drug toxicity|0|||
145259821|NCT01218477|523798177|FG000|Overall Study|No longer meets study criteria|1|||
145259822|NCT01218477|523798178|FG001|Overall Study|No longer meets study criteria|0|||
145259823|NCT01218477|523798179|FG002|Overall Study|No longer meets study criteria|0|||
145259824|NCT01218477|523798180|FG003|Overall Study|No longer meets study criteria|0|||
145259825|NCT01218477|523798177|FG000|Overall Study|Withdrawal by Subject|0|||
145259826|NCT01218477|523798178|FG001|Overall Study|Withdrawal by Subject|0|||
145259827|NCT01218477|523798179|FG002|Overall Study|Withdrawal by Subject|1|||
145259828|NCT01218477|523798180|FG003|Overall Study|Withdrawal by Subject|0|||
145259829|NCT01218477|523798177|FG000|Overall Study|Prepared for cell transplantation|0|||
145259830|NCT01218477|523798178|FG001|Overall Study|Prepared for cell transplantation|1|||
145259831|NCT01218477|523798179|FG002|Overall Study|Prepared for cell transplantation|1|||
145259832|NCT01218477|523798180|FG003|Overall Study|Prepared for cell transplantation|0|||
145259833|NCT01218477|523798177|FG000|Overall Study|Administrative reason by sponsor|0|||
145259834|NCT01218477|523798178|FG001|Overall Study|Administrative reason by sponsor|0|||
145259835|NCT01218477|523798179|FG002|Overall Study|Administrative reason by sponsor|1|||
145259836|NCT01218477|523798180|FG003|Overall Study|Administrative reason by sponsor|0|||
145259837|NCT01218477|523798177|FG000|Overall Study|Maximum clinical benefit|0|||
145259838|NCT01218477|523798178|FG001|Overall Study|Maximum clinical benefit|2|||
145259839|NCT01218477|523798179|FG002|Overall Study|Maximum clinical benefit|0|||
145259840|NCT01218477|523798180|FG003|Overall Study|Maximum clinical benefit|0|||
145259841|NCT00787527|523798183|FG000|Overall Study|Toxicity|3|||
145259842|NCT03137433|523798184|FG000|Overall Study|Withdrawal by Subject|11|||
145259843|NCT03137433|523798185|FG001|Overall Study|Withdrawal by Subject|11|||
145259844|NCT03137433|523798184|FG000|Overall Study|Lost to Follow-up|5|||
145259845|NCT03137433|523798185|FG001|Overall Study|Lost to Follow-up|6|||
145259846|NCT03137433|523798184|FG000|Overall Study|Physician Decision|2|||
145259847|NCT03137433|523798185|FG001|Overall Study|Physician Decision|0|||
145259848|NCT03137433|523798184|FG000|Overall Study|Moved out of study area|1|||
145259849|NCT03137433|523798185|FG001|Overall Study|Moved out of study area|0|||
145259850|NCT03137433|523798184|FG000|Overall Study|Too far out of window due to COVID|0|||
145259851|NCT03137433|523798185|FG001|Overall Study|Too far out of window due to COVID|1|||
145259852|NCT00083616|523798186|FG000|Overall Study|Disease Progression|16|||
145259853|NCT00083616|523798186|FG000|Overall Study|Lost to Follow-up|1|||
145259854|NCT00083616|523798186|FG000|Overall Study|Physician Decision|2|||
145259855|NCT00083616|523798186|FG000|Overall Study|Withdrawal by Subject|3|||
145259856|NCT00083616|523798186|FG000|Overall Study|Ineligibility determined|2|||
145259857|NCT00083616|523798186|FG000|Overall Study|Non-compliance|1|||
145259858|NCT00083616|523798186|FG000|Overall Study|Other|6|||
145259859|NCT01474993|523798192|FG000|Overall Study|Lost to Follow-up|1|||
145259860|NCT01474993|523798193|FG001|Overall Study|Lost to Follow-up|2|||
145259861|NCT01474993|523798192|FG000|Overall Study|Adverse Event|0|||
145259862|NCT01474993|523798193|FG001|Overall Study|Adverse Event|1|||
145259863|NCT01853397|523798194|FG000|Overall Study|Withdrawal by Subject|0|||
145259864|NCT01853397|523798195|FG001|Overall Study|Withdrawal by Subject|0|||
145259865|NCT01853397|523798196|FG002|Overall Study|Withdrawal by Subject|0|||
145259866|NCT01853397|523798197|FG003|Overall Study|Withdrawal by Subject|1|||
145259867|NCT01853397|523798194|FG000|Overall Study|Subject Noncompliance|0|||
145259868|NCT01853397|523798195|FG001|Overall Study|Subject Noncompliance|0|||
145259869|NCT01853397|523798196|FG002|Overall Study|Subject Noncompliance|0|||
145259870|NCT01853397|523798197|FG003|Overall Study|Subject Noncompliance|1|||
145259871|NCT02132312|523798198|FG000|Overall Study|Adverse Event|2|||
145259872|NCT02132312|523798199|FG001|Overall Study|Adverse Event|0|||
145259873|NCT02132312|523798198|FG000|Overall Study|Physician Decision|1|||
145259874|NCT02132312|523798199|FG001|Overall Study|Physician Decision|1|||
145259875|NCT02132312|523798198|FG000|Overall Study|Protocol Violation|0|||
145259876|NCT02132312|523798199|FG001|Overall Study|Protocol Violation|1|||
145259877|NCT02132312|523798198|FG000|Overall Study|Withdrawal by Subject|1|||
145259878|NCT02132312|523798199|FG001|Overall Study|Withdrawal by Subject|0|||
145259879|NCT02132312|523798198|FG000|Overall Study|Lost to Follow-up|2|||
145259880|NCT02132312|523798199|FG001|Overall Study|Lost to Follow-up|1|||
145259881|NCT01632345|523798200|FG000|Treatment: Part I|Adverse Event|1|||
145259882|NCT01632345|523798201|FG001|Treatment: Part I|Adverse Event|4|||
145259883|NCT01632345|523798202|FG002|Treatment: Part I|Adverse Event|2|||
145259884|NCT01632345|523798203|FG003|Treatment: Part I|Adverse Event|1|||
145259885|NCT01632345|523798204|FG004|Treatment: Part I|Adverse Event|3|||
145259886|NCT01632345|523798205|FG005|Treatment: Part I|Adverse Event|0|||
145259887|NCT01632345|523798206|FG006|Treatment: Part I|Adverse Event|0|||
145259888|NCT01632345|523798200|FG000|Treatment: Part I|Lack of Efficacy|0|||
145259889|NCT01632345|523798201|FG001|Treatment: Part I|Lack of Efficacy|1|||
145259890|NCT01632345|523798202|FG002|Treatment: Part I|Lack of Efficacy|0|||
145259891|NCT01632345|523798203|FG003|Treatment: Part I|Lack of Efficacy|1|||
145259892|NCT01632345|523798204|FG004|Treatment: Part I|Lack of Efficacy|1|||
145259893|NCT01632345|523798205|FG005|Treatment: Part I|Lack of Efficacy|0|||
145568669|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
145259894|NCT01632345|523798206|FG006|Treatment: Part I|Lack of Efficacy|0|||
145259895|NCT01632345|523798200|FG000|Treatment: Part I|Lost to Follow-up|3|||
145259896|NCT01632345|523798201|FG001|Treatment: Part I|Lost to Follow-up|2|||
145259897|NCT01632345|523798202|FG002|Treatment: Part I|Lost to Follow-up|1|||
145259898|NCT01632345|523798203|FG003|Treatment: Part I|Lost to Follow-up|3|||
145259899|NCT01632345|523798204|FG004|Treatment: Part I|Lost to Follow-up|4|||
145259900|NCT01632345|523798205|FG005|Treatment: Part I|Lost to Follow-up|0|||
145259901|NCT01632345|523798206|FG006|Treatment: Part I|Lost to Follow-up|0|||
145259902|NCT01632345|523798200|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
145259903|NCT01632345|523798201|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
145259904|NCT01632345|523798202|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
145259905|NCT01632345|523798203|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
145259906|NCT01632345|523798204|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
145259907|NCT01632345|523798205|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
145259908|NCT01632345|523798206|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
145259909|NCT01632345|523798200|FG000|Treatment: Part I|Physician Decision|2|||
145259910|NCT01632345|523798201|FG001|Treatment: Part I|Physician Decision|1|||
145259911|NCT01632345|523798202|FG002|Treatment: Part I|Physician Decision|0|||
145259912|NCT01632345|523798203|FG003|Treatment: Part I|Physician Decision|0|||
145301412|NCT00573443|523956533|FG002|Open-Label Extension Phase|Protocol Violation|0|||
145301413|NCT00573443|523956531|FG000|Open-Label Extension Phase|Other|2|||
145301414|NCT00573443|523956532|FG001|Open-Label Extension Phase|Other|0|||
145301415|NCT00573443|523956533|FG002|Open-Label Extension Phase|Other|0|||
145301416|NCT01796171|523956536|FG000|Enrolled|Death|0|||
145301417|NCT01796171|523956537|FG001|Enrolled|Death|0|||
145301418|NCT01796171|523956538|FG002|Enrolled|Death|0|||
145301419|NCT01796171|523956539|FG003|Enrolled|Death|0|||
145301420|NCT01796171|523956540|FG004|Enrolled|Death|0|||
145301421|NCT01796171|523956541|FG005|Enrolled|Death|0|||
145259913|NCT01632345|523798204|FG004|Treatment: Part I|Physician Decision|1|||
145259914|NCT01632345|523798205|FG005|Treatment: Part I|Physician Decision|0|||
145259915|NCT01632345|523798206|FG006|Treatment: Part I|Physician Decision|0|||
145259916|NCT01632345|523798200|FG000|Treatment: Part I|Pregnancy|0|||
145259917|NCT01632345|523798201|FG001|Treatment: Part I|Pregnancy|1|||
145259918|NCT01632345|523798202|FG002|Treatment: Part I|Pregnancy|0|||
145259919|NCT01632345|523798203|FG003|Treatment: Part I|Pregnancy|0|||
145259920|NCT01632345|523798204|FG004|Treatment: Part I|Pregnancy|0|||
145259921|NCT01632345|523798205|FG005|Treatment: Part I|Pregnancy|0|||
145259922|NCT01632345|523798206|FG006|Treatment: Part I|Pregnancy|0|||
145259923|NCT01632345|523798200|FG000|Treatment: Part I|Protocol Deviation|0|||
145259924|NCT01632345|523798201|FG001|Treatment: Part I|Protocol Deviation|0|||
145259925|NCT01632345|523798202|FG002|Treatment: Part I|Protocol Deviation|1|||
145259926|NCT01632345|523798203|FG003|Treatment: Part I|Protocol Deviation|1|||
145259927|NCT01632345|523798204|FG004|Treatment: Part I|Protocol Deviation|0|||
145259928|NCT01632345|523798205|FG005|Treatment: Part I|Protocol Deviation|0|||
145259929|NCT01632345|523798206|FG006|Treatment: Part I|Protocol Deviation|0|||
145259930|NCT01632345|523798200|FG000|Treatment: Part I|Withdrawal by Subject|3|||
145259931|NCT01632345|523798201|FG001|Treatment: Part I|Withdrawal by Subject|4|||
145259932|NCT01632345|523798202|FG002|Treatment: Part I|Withdrawal by Subject|4|||
145259933|NCT01632345|523798203|FG003|Treatment: Part I|Withdrawal by Subject|1|||
145259934|NCT01632345|523798204|FG004|Treatment: Part I|Withdrawal by Subject|4|||
145259935|NCT01632345|523798205|FG005|Treatment: Part I|Withdrawal by Subject|0|||
145259936|NCT01632345|523798206|FG006|Treatment: Part I|Withdrawal by Subject|0|||
145259937|NCT01632345|523798200|FG000|Treatment: Part II|Adverse Event|0|||
145259938|NCT01632345|523798201|FG001|Treatment: Part II|Adverse Event|0|||
145259939|NCT01632345|523798202|FG002|Treatment: Part II|Adverse Event|0|||
145259940|NCT01632345|523798203|FG003|Treatment: Part II|Adverse Event|0|||
145259941|NCT01632345|523798204|FG004|Treatment: Part II|Adverse Event|0|||
145259942|NCT01632345|523798205|FG005|Treatment: Part II|Adverse Event|3|||
145259943|NCT01632345|523798206|FG006|Treatment: Part II|Adverse Event|8|||
145259944|NCT01632345|523798200|FG000|Treatment: Part II|Lost to Follow-up|0|||
145259945|NCT01632345|523798201|FG001|Treatment: Part II|Lost to Follow-up|0|||
145259946|NCT01632345|523798202|FG002|Treatment: Part II|Lost to Follow-up|0|||
145259947|NCT01632345|523798203|FG003|Treatment: Part II|Lost to Follow-up|0|||
145259948|NCT01632345|523798204|FG004|Treatment: Part II|Lost to Follow-up|0|||
145259949|NCT01632345|523798205|FG005|Treatment: Part II|Lost to Follow-up|3|||
145259950|NCT01632345|523798206|FG006|Treatment: Part II|Lost to Follow-up|1|||
145259951|NCT01632345|523798200|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259952|NCT01632345|523798201|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259953|NCT01632345|523798202|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259954|NCT01632345|523798203|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259955|NCT01632345|523798204|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259956|NCT01632345|523798205|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
145259957|NCT01632345|523798206|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
145259958|NCT01632345|523798200|FG000|Treatment: Part II|Withdrawal by Subject|0|||
145259959|NCT01632345|523798201|FG001|Treatment: Part II|Withdrawal by Subject|0|||
145259960|NCT01632345|523798202|FG002|Treatment: Part II|Withdrawal by Subject|0|||
145259961|NCT01632345|523798203|FG003|Treatment: Part II|Withdrawal by Subject|0|||
145259962|NCT01632345|523798204|FG004|Treatment: Part II|Withdrawal by Subject|0|||
145259963|NCT01632345|523798205|FG005|Treatment: Part II|Withdrawal by Subject|2|||
145259964|NCT01632345|523798206|FG006|Treatment: Part II|Withdrawal by Subject|2|||
145259965|NCT02543918|523798207|FG000|Overall Study|Never treated|0|||
145259966|NCT02543918|523798208|FG001|Overall Study|Never treated|1|||
145259967|NCT02543918|523798207|FG000|Overall Study|Lost to Follow-up|1|||
145259968|NCT02543918|523798208|FG001|Overall Study|Lost to Follow-up|1|||
145259969|NCT02543918|523798207|FG000|Overall Study|Withdrawal by Subject|1|||
145259970|NCT02543918|523798208|FG001|Overall Study|Withdrawal by Subject|1|||
145259971|NCT02543918|523798207|FG000|Overall Study|Adverse Event|1|||
145259972|NCT02543918|523798208|FG001|Overall Study|Adverse Event|1|||
145259973|NCT02452892|523798209|FG000|Week 1 Initial Randommization|Adverse Event|1|||
145259974|NCT02452892|523798210|FG001|Week 1 Initial Randommization|Adverse Event|0|||
145301422|NCT01796171|523956542|FG006|Enrolled|Death|0|||
145259975|NCT02452892|523798211|FG002|Week 1 Initial Randommization|Adverse Event|0|||
145301423|NCT01796171|523956543|FG007|Enrolled|Death|0|||
145259976|NCT02452892|523798212|FG003|Week 1 Initial Randommization|Adverse Event|0|||
145259977|NCT02452892|523798209|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
145259978|NCT02452892|523798210|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
145259979|NCT02452892|523798211|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
145259980|NCT02452892|523798212|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
145301424|NCT01796171|523956544|FG008|Enrolled|Death|0|||
145301425|NCT01796171|523956545|FG009|Enrolled|Death|0|||
145259981|NCT02452892|523798209|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
145301426|NCT01796171|523956546|FG010|Enrolled|Death|0|||
145301427|NCT01796171|523956547|FG011|Enrolled|Death|0|||
145259982|NCT02452892|523798210|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
145301428|NCT01796171|523956548|FG012|Enrolled|Death|0|||
145259983|NCT02452892|523798211|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
145259984|NCT02452892|523798212|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
145259985|NCT02452892|523798209|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
145259986|NCT02452892|523798210|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
145259987|NCT02452892|523798211|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
145259988|NCT02452892|523798212|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
145259989|NCT02452892|523798209|FG000|Follow-up|Withdrawal by Subject|0|||
145259990|NCT02452892|523798210|FG001|Follow-up|Withdrawal by Subject|0|||
145259991|NCT02452892|523798211|FG002|Follow-up|Withdrawal by Subject|0|||
145259992|NCT02452892|523798212|FG003|Follow-up|Withdrawal by Subject|1|||
145259993|NCT02452892|523798209|FG000|Follow-up|Subject left town on Day 42|1|||
145259994|NCT02452892|523798210|FG001|Follow-up|Subject left town on Day 42|0|||
145259995|NCT02452892|523798211|FG002|Follow-up|Subject left town on Day 42|0|||
145259996|NCT02452892|523798212|FG003|Follow-up|Subject left town on Day 42|0|||
145259997|NCT00545740|523798214|FG000|Overall Study|Lack of Efficacy|34|||
145259998|NCT00545740|523798215|FG001|Overall Study|Lack of Efficacy|35|||
145259999|NCT00545740|523798216|FG002|Overall Study|Lack of Efficacy|47|||
145260000|NCT00545740|523798217|FG003|Overall Study|Lack of Efficacy|36|||
145260001|NCT00545740|523798214|FG000|Overall Study|Withdrawal by Subject|17|||
145260002|NCT00545740|523798215|FG001|Overall Study|Withdrawal by Subject|15|||
145260003|NCT00545740|523798216|FG002|Overall Study|Withdrawal by Subject|16|||
145260004|NCT00545740|523798217|FG003|Overall Study|Withdrawal by Subject|18|||
145260005|NCT00545740|523798214|FG000|Overall Study|Adverse Event|10|||
145260006|NCT00545740|523798215|FG001|Overall Study|Adverse Event|18|||
145260007|NCT00545740|523798216|FG002|Overall Study|Adverse Event|19|||
145260008|NCT00545740|523798217|FG003|Overall Study|Adverse Event|9|||
145260009|NCT00545740|523798214|FG000|Overall Study|Lost to Follow-up|7|||
145260010|NCT00545740|523798215|FG001|Overall Study|Lost to Follow-up|5|||
145260011|NCT00545740|523798216|FG002|Overall Study|Lost to Follow-up|5|||
145260012|NCT00545740|523798217|FG003|Overall Study|Lost to Follow-up|6|||
145260013|NCT00545740|523798214|FG000|Overall Study|Protocol Violation|1|||
145260014|NCT00545740|523798215|FG001|Overall Study|Protocol Violation|3|||
145260015|NCT00545740|523798216|FG002|Overall Study|Protocol Violation|1|||
145260016|NCT00545740|523798217|FG003|Overall Study|Protocol Violation|0|||
145260017|NCT00545740|523798214|FG000|Overall Study|Non-compliance|0|||
145260018|NCT00545740|523798215|FG001|Overall Study|Non-compliance|2|||
145260019|NCT00545740|523798216|FG002|Overall Study|Non-compliance|1|||
145260020|NCT00545740|523798217|FG003|Overall Study|Non-compliance|0|||
145260021|NCT00545740|523798214|FG000|Overall Study|Moved|2|||
145260022|NCT00545740|523798215|FG001|Overall Study|Moved|0|||
145260023|NCT00545740|523798216|FG002|Overall Study|Moved|1|||
145260024|NCT00545740|523798217|FG003|Overall Study|Moved|0|||
145260025|NCT00545740|523798214|FG000|Overall Study|Diverticulitis attack|0|||
145260026|NCT00545740|523798215|FG001|Overall Study|Diverticulitis attack|0|||
145260027|NCT00545740|523798216|FG002|Overall Study|Diverticulitis attack|1|||
145260028|NCT00545740|523798217|FG003|Overall Study|Diverticulitis attack|1|||
145260029|NCT00545740|523798214|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
145260030|NCT00545740|523798215|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
145260031|NCT00545740|523798216|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
145260032|NCT00545740|523798217|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
145260033|NCT00545740|523798214|FG000|Overall Study|Site closure|1|||
145260034|NCT00545740|523798215|FG001|Overall Study|Site closure|0|||
145260035|NCT00545740|523798216|FG002|Overall Study|Site closure|0|||
145260036|NCT00545740|523798217|FG003|Overall Study|Site closure|0|||
145260037|NCT00545740|523798214|FG000|Overall Study|Missed visit|1|||
145260038|NCT00545740|523798215|FG001|Overall Study|Missed visit|0|||
145260039|NCT00545740|523798216|FG002|Overall Study|Missed visit|0|||
145260040|NCT00545740|523798217|FG003|Overall Study|Missed visit|0|||
145260041|NCT00545740|523798214|FG000|Overall Study|Physician Decision|0|||
145260042|NCT00545740|523798215|FG001|Overall Study|Physician Decision|0|||
145260043|NCT00545740|523798216|FG002|Overall Study|Physician Decision|3|||
145260044|NCT00545740|523798217|FG003|Overall Study|Physician Decision|0|||
145260045|NCT00545740|523798214|FG000|Overall Study|Accepted only monthly telephone calls|1|||
145260046|NCT00545740|523798215|FG001|Overall Study|Accepted only monthly telephone calls|0|||
145260047|NCT00545740|523798216|FG002|Overall Study|Accepted only monthly telephone calls|0|||
145260048|NCT00545740|523798217|FG003|Overall Study|Accepted only monthly telephone calls|0|||
145260049|NCT00545740|523798214|FG000|Overall Study|Sponsor decision|0|||
145260050|NCT00545740|523798215|FG001|Overall Study|Sponsor decision|1|||
145260051|NCT00545740|523798216|FG002|Overall Study|Sponsor decision|0|||
145260052|NCT00545740|523798217|FG003|Overall Study|Sponsor decision|0|||
145260053|NCT00545740|523798214|FG000|Overall Study|Lack of time|0|||
145260054|NCT00545740|523798215|FG001|Overall Study|Lack of time|1|||
145260055|NCT00545740|523798216|FG002|Overall Study|Lack of time|0|||
145260056|NCT00545740|523798217|FG003|Overall Study|Lack of time|0|||
145260057|NCT00545740|523798214|FG000|Overall Study|Non-adherence to visits|0|||
145260058|NCT00545740|523798215|FG001|Overall Study|Non-adherence to visits|1|||
145260059|NCT00545740|523798216|FG002|Overall Study|Non-adherence to visits|0|||
145260060|NCT00545740|523798217|FG003|Overall Study|Non-adherence to visits|0|||
145260061|NCT00545740|523798214|FG000|Overall Study|Patient difficulties|0|||
145260062|NCT00545740|523798215|FG001|Overall Study|Patient difficulties|1|||
145260063|NCT00545740|523798216|FG002|Overall Study|Patient difficulties|0|||
145260064|NCT00545740|523798217|FG003|Overall Study|Patient difficulties|0|||
145260065|NCT00545740|523798214|FG000|Overall Study|Husband against study|0|||
145260066|NCT00545740|523798215|FG001|Overall Study|Husband against study|0|||
145260067|NCT00545740|523798216|FG002|Overall Study|Husband against study|1|||
145260068|NCT00545740|523798217|FG003|Overall Study|Husband against study|0|||
145260069|NCT02117024|523798218|FG000|Overall Study|Progressive Disease|26|||
145260070|NCT02117024|523798219|FG001|Overall Study|Progressive Disease|9|||
145260071|NCT02117024|523798218|FG000|Overall Study|Significant Clinical Progression|7|||
145260072|NCT02117024|523798219|FG001|Overall Study|Significant Clinical Progression|4|||
145260073|NCT02117024|523798218|FG000|Overall Study|Death|5|||
145260074|NCT02117024|523798219|FG001|Overall Study|Death|0|||
145260075|NCT02117024|523798218|FG000|Overall Study|Withdrawal by Subject|3|||
145260076|NCT02117024|523798219|FG001|Overall Study|Withdrawal by Subject|1|||
145260077|NCT02117024|523798218|FG000|Overall Study|Protocol Violation|1|||
145260078|NCT02117024|523798219|FG001|Overall Study|Protocol Violation|0|||
145260079|NCT02117024|523798218|FG000|Overall Study|Adverse Event|1|||
145260080|NCT02117024|523798219|FG001|Overall Study|Adverse Event|2|||
145260081|NCT02117024|523798218|FG000|Overall Study|Randomized in Error|1|||
145260082|NCT02117024|523798219|FG001|Overall Study|Randomized in Error|0|||
145260083|NCT02117024|523798218|FG000|Overall Study|Patient returned to primary oncologist|0|||
145260084|NCT02117024|523798219|FG001|Overall Study|Patient returned to primary oncologist|1|||
145260085|NCT02117024|523798218|FG000|Overall Study|Patient took treatment break|0|||
145260086|NCT02117024|523798219|FG001|Overall Study|Patient took treatment break|1|||
145260087|NCT02117024|523798218|FG000|Overall Study|Physician Decision|0|||
145260088|NCT02117024|523798219|FG001|Overall Study|Physician Decision|2|||
145260089|NCT01874288|523798220|FG000|Overall Study|Withdrawal by Subject|1|||
145260090|NCT01874288|523798221|FG001|Overall Study|Withdrawal by Subject|0|||
145260091|NCT01874288|523798222|FG002|Overall Study|Withdrawal by Subject|2|||
145260092|NCT01874288|523798223|FG003|Overall Study|Withdrawal by Subject|1|||
145260093|NCT01874288|523798224|FG004|Overall Study|Withdrawal by Subject|1|||
145260094|NCT01874288|523798220|FG000|Overall Study|Physician Decision|0|||
145260095|NCT01874288|523798221|FG001|Overall Study|Physician Decision|0|||
145260096|NCT01874288|523798222|FG002|Overall Study|Physician Decision|0|||
145260097|NCT01874288|523798223|FG003|Overall Study|Physician Decision|1|||
145260098|NCT01874288|523798224|FG004|Overall Study|Physician Decision|0|||
145260099|NCT01874288|523798220|FG000|Overall Study|Progressive disease|2|||
145260100|NCT01874288|523798221|FG001|Overall Study|Progressive disease|0|||
145260101|NCT01874288|523798222|FG002|Overall Study|Progressive disease|3|||
145260102|NCT01874288|523798223|FG003|Overall Study|Progressive disease|5|||
145260103|NCT01874288|523798224|FG004|Overall Study|Progressive disease|1|||
145260104|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
145260105|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
145260106|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
145260107|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
145260108|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
145260109|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
145260110|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Death|1|||
145260111|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Death|1|||
145260112|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Death|1|||
145260113|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Death|0|||
145260114|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Death|0|||
145260115|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Death|0|||
145260116|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
145260117|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
145260118|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
145260119|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
145260120|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
145260121|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
145260122|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
145260123|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
145260124|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
145260125|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
145260126|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
145260127|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
145568670|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
145260128|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
145260129|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
145260130|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
145260131|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
145260132|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
145260133|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
145260134|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
145260135|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
145260136|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
145260137|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
145260138|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
145260139|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
145260140|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
145260141|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
145260142|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
145260143|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
145260144|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
145260145|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
145260146|NCT03370133|523798228|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
145260147|NCT03370133|523798229|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
145260148|NCT03370133|523798230|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
145260149|NCT03370133|523798231|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
145260150|NCT03370133|523798232|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
145260151|NCT03370133|523798233|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
145260152|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
145260153|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
145260154|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
145260155|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
145260156|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
145260157|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
145260158|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
145260159|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
145260160|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
145260161|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
145260162|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
145260163|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
145260164|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
145260165|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
145260166|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
145260167|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
145260168|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
145260169|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
145260170|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
145260171|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
145260172|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
145260173|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
145260174|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
145260175|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
145260176|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
145260177|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
145260178|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
145260179|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
145260180|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
145260181|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
145260182|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
145260183|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
145260184|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
145260185|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
145260186|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
145260187|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
145260188|NCT03370133|523798228|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
145620275|NCT00885495|525123728|FG000|Overall Study|Withdrawal by Subject|1|||
145260189|NCT03370133|523798229|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
145260190|NCT03370133|523798230|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
145260191|NCT03370133|523798231|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
145260192|NCT03370133|523798232|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
145260193|NCT03370133|523798233|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
145620276|NCT00885495|525123729|FG001|Overall Study|Withdrawal by Subject|0|||
145620277|NCT01563978|525123730|FG000|Overall Study|Physician Decision|1|||
145260194|NCT04490499|523798236|FG000|Overall Study|Withdrawal by Subject|2|||
145260195|NCT01843933|523798239|FG000|Overall Study|Data lost|6|||
145260196|NCT01843933|523798240|FG001|Overall Study|Data lost|4|||
145260197|NCT02612194|523798244|FG000|Overall Study|Death|5|||
145260198|NCT02612194|523798245|FG001|Overall Study|Death|0|||
145260199|NCT02612194|523798246|FG002|Overall Study|Death|2|||
145260200|NCT02612194|523798244|FG000|Overall Study|Early Study Termination|1|||
145260201|NCT02612194|523798245|FG001|Overall Study|Early Study Termination|0|||
145260202|NCT02612194|523798246|FG002|Overall Study|Early Study Termination|0|||
145260203|NCT00372905|523798247|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
145260204|NCT00372905|523798248|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
145260205|NCT00372905|523798249|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
145260206|NCT00372905|523798250|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
145260207|NCT00372905|523798247|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
145260208|NCT00372905|523798248|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
145260209|NCT00372905|523798249|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
145260210|NCT00372905|523798250|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
145260211|NCT00372905|523798247|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
145260212|NCT00372905|523798248|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
145260213|NCT00372905|523798249|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
145260214|NCT00372905|523798250|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
145260215|NCT00372905|523798247|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
145260216|NCT00372905|523798248|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
145260217|NCT00372905|523798249|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
145260218|NCT00372905|523798250|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
145260219|NCT00372905|523798247|FG000|Follow up Until Relapse or Progression|Study closed|0|||
145260220|NCT00372905|523798248|FG001|Follow up Until Relapse or Progression|Study closed|0|||
145260221|NCT00372905|523798249|FG002|Follow up Until Relapse or Progression|Study closed|0|||
145260222|NCT00372905|523798250|FG003|Follow up Until Relapse or Progression|Study closed|3|||
145260223|NCT00372905|523798247|FG000|Follow up Until Relapse or Progression|Other|0|||
145301429|NCT01796171|523956549|FG013|Enrolled|Death|0|||
145301430|NCT01796171|523956550|FG014|Enrolled|Death|1|||
145301431|NCT01796171|523956536|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
145301432|NCT01796171|523956537|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
145301433|NCT01796171|523956538|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
145301434|NCT01796171|523956539|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
145301435|NCT01796171|523956540|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
145301436|NCT01796171|523956541|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
145301437|NCT01796171|523956542|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
145301438|NCT01796171|523956543|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
145301439|NCT01796171|523956544|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
145301440|NCT01796171|523956545|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
145301441|NCT01796171|523956546|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
145301442|NCT01796171|523956547|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
145301443|NCT01796171|523956548|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
145301444|NCT01796171|523956549|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
145301445|NCT01796171|523956550|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
145301446|NCT01796171|523956536|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301447|NCT01796171|523956537|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301448|NCT01796171|523956538|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301449|NCT01796171|523956539|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301450|NCT01796171|523956540|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301451|NCT01796171|523956541|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301452|NCT01796171|523956542|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301453|NCT01796171|523956543|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145260224|NCT00372905|523798248|FG001|Follow up Until Relapse or Progression|Other|1|||
145260225|NCT00372905|523798249|FG002|Follow up Until Relapse or Progression|Other|0|||
145260226|NCT00372905|523798250|FG003|Follow up Until Relapse or Progression|Other|0|||
145260227|NCT00695318|523798252|FG000|Overall Study|Lost to Follow-up|1|||
145260228|NCT00695318|523798253|FG001|Overall Study|Lost to Follow-up|0|||
145260229|NCT00695318|523798252|FG000|Overall Study|Withdrawal by Subject|2|||
145260230|NCT00695318|523798253|FG001|Overall Study|Withdrawal by Subject|0|||
145260231|NCT00695318|523798252|FG000|Overall Study|Death|1|||
145260232|NCT00695318|523798253|FG001|Overall Study|Death|1|||
145260233|NCT00695318|523798252|FG000|Overall Study|Study Terminated|1|||
145260234|NCT00695318|523798253|FG001|Overall Study|Study Terminated|0|||
145260235|NCT02705755|523798254|FG000|Part A (6 Days)|Adverse Event|1|||
145260236|NCT02705755|523798255|FG001|Part A (6 Days)|Adverse Event|0|||
145260237|NCT02705755|523798256|FG002|Part A (6 Days)|Adverse Event|0|||
145301454|NCT01796171|523956544|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145260238|NCT02705755|523798257|FG003|Part A (6 Days)|Adverse Event|0|||
145260239|NCT02705755|523798254|FG000|Part A (6 Days)|Physician Decision|3|||
145301455|NCT01796171|523956545|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301456|NCT01796171|523956546|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301457|NCT01796171|523956547|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301458|NCT01796171|523956548|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145260240|NCT02705755|523798255|FG001|Part A (6 Days)|Physician Decision|0|||
145260241|NCT02705755|523798256|FG002|Part A (6 Days)|Physician Decision|0|||
145260242|NCT02705755|523798257|FG003|Part A (6 Days)|Physician Decision|0|||
145260243|NCT02705755|523798254|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
145260244|NCT02705755|523798255|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
145260245|NCT02705755|523798256|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
145260246|NCT02705755|523798257|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
145260247|NCT02705755|523798254|FG000|Part C (20 Weeks)|Physician Decision|0|||
145260248|NCT02705755|523798255|FG001|Part C (20 Weeks)|Physician Decision|0|||
145260249|NCT02705755|523798256|FG002|Part C (20 Weeks)|Physician Decision|0|||
145260250|NCT02705755|523798257|FG003|Part C (20 Weeks)|Physician Decision|2|||
145260251|NCT02705755|523798254|FG000|Part C (20 Weeks)|Adverse Event|0|||
145260252|NCT02705755|523798255|FG001|Part C (20 Weeks)|Adverse Event|0|||
145260253|NCT02705755|523798256|FG002|Part C (20 Weeks)|Adverse Event|0|||
145260254|NCT02705755|523798257|FG003|Part C (20 Weeks)|Adverse Event|6|||
145260255|NCT02705755|523798254|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
145260256|NCT02705755|523798255|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
145260257|NCT02705755|523798256|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
145260258|NCT02705755|523798257|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
145260259|NCT03726320|523800243|FG000|Overall Study|Lost to Follow-up|2|||
145260260|NCT03726320|523800244|FG001|Overall Study|Lost to Follow-up|4|||
145260261|NCT03726320|523800245|FG002|Overall Study|Lost to Follow-up|0|||
145260262|NCT03726320|523800243|FG000|Overall Study|Time Constraints|4|||
145260263|NCT03726320|523800244|FG001|Overall Study|Time Constraints|1|||
145260264|NCT03726320|523800245|FG002|Overall Study|Time Constraints|0|||
145260265|NCT03726320|523800243|FG000|Overall Study|Ineligible after enrollment|3|||
145260266|NCT03726320|523800244|FG001|Overall Study|Ineligible after enrollment|3|||
145260267|NCT03726320|523800245|FG002|Overall Study|Ineligible after enrollment|0|||
145260268|NCT03726320|523800243|FG000|Overall Study|Clinic / insurance issue|2|||
145260269|NCT03726320|523800244|FG001|Overall Study|Clinic / insurance issue|0|||
145260270|NCT03726320|523800245|FG002|Overall Study|Clinic / insurance issue|0|||
145260271|NCT03726320|523800243|FG000|Overall Study|Language barrier|1|||
145260272|NCT03726320|523800244|FG001|Overall Study|Language barrier|0|||
145260273|NCT03726320|523800245|FG002|Overall Study|Language barrier|0|||
145260274|NCT03726320|523800243|FG000|Overall Study|Provider left the clinic|0|||
145260275|NCT03726320|523800244|FG001|Overall Study|Provider left the clinic|0|||
145260276|NCT03726320|523800245|FG002|Overall Study|Provider left the clinic|1|||
145260277|NCT02028182|523800248|FG000|Overall Study|Protocol Violation|2|||
145260278|NCT01684930|523800251|FG000|Overall Study|Withdrawal by Subject|3|||
145260279|NCT01684930|523800252|FG001|Overall Study|Withdrawal by Subject|1|||
145260280|NCT00337935|523800253|FG000|Overall Study|Adverse Event|2|||
145260281|NCT00337935|523800254|FG001|Overall Study|Adverse Event|5|||
145260282|NCT00337935|523800253|FG000|Overall Study|Death|2|||
145260283|NCT00337935|523800254|FG001|Overall Study|Death|8|||
145260284|NCT00337935|523800253|FG000|Overall Study|Physician Decision|1|||
145260285|NCT00337935|523800254|FG001|Overall Study|Physician Decision|1|||
145260286|NCT00337935|523800253|FG000|Overall Study|Lost to Follow-up|0|||
145260287|NCT00337935|523800254|FG001|Overall Study|Lost to Follow-up|1|||
145260288|NCT00337935|523800253|FG000|Overall Study|Protocol Violation|4|||
145260289|NCT00337935|523800254|FG001|Overall Study|Protocol Violation|3|||
145260290|NCT00337935|523800253|FG000|Overall Study|Withdrawal by Subject|1|||
145301459|NCT01796171|523956549|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
145301460|NCT01796171|523956550|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
145301461|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Progressive disease|0|||
145301462|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Progressive disease|1|||
145301463|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Progressive disease|0|||
145301464|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Progressive disease|0|||
145301465|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Progressive disease|0|||
145301466|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Progressive disease|0|||
145260291|NCT00337935|523800254|FG001|Overall Study|Withdrawal by Subject|7|||
145260292|NCT00337935|523800253|FG000|Overall Study|Other|0|||
145260293|NCT00337935|523800254|FG001|Overall Study|Other|1|||
145260294|NCT00337935|523800253|FG000|Overall Study|Lack of Efficacy|0|||
145260295|NCT00337935|523800254|FG001|Overall Study|Lack of Efficacy|1|||
145260296|NCT01336647|523800257|FG000|Overall Study|Lost to Follow-up|4|||
145260297|NCT01336647|523800258|FG001|Overall Study|Lost to Follow-up|1|||
145260298|NCT01336647|523800259|FG002|Overall Study|Lost to Follow-up|3|||
145260299|NCT01786707|523800264|FG000|Overall Study|Lost to Follow-up|1|||
145260300|NCT01786707|523800265|FG001|Overall Study|Lost to Follow-up|1|||
145301467|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Progressive disease|0|||
145301468|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Progressive disease|0|||
145260301|NCT00965458|523800268|FG000|Overall Study|Adverse Event|1|||
145260302|NCT00965458|523800269|FG001|Overall Study|Adverse Event|0|||
145260303|NCT00965458|523800268|FG000|Overall Study|Lost to Follow-up|1|||
145620278|NCT01563978|525123731|FG001|Overall Study|Physician Decision|0|||
145260304|NCT00965458|523800269|FG001|Overall Study|Lost to Follow-up|3|||
145260305|NCT00965458|523800268|FG000|Overall Study|Withdrawal by Subject|0|||
145260306|NCT00965458|523800269|FG001|Overall Study|Withdrawal by Subject|1|||
145260307|NCT00594958|523800272|FG000|Overall Study|Withdrawal by Subject|1|||
145260308|NCT00594958|523800273|FG001|Overall Study|Withdrawal by Subject|0|||
145260309|NCT00594958|523800274|FG002|Overall Study|Withdrawal by Subject|1|||
145260310|NCT00594958|523800272|FG000|Overall Study|Adverse Event|4|||
145260311|NCT00594958|523800273|FG001|Overall Study|Adverse Event|1|||
145260312|NCT00594958|523800274|FG002|Overall Study|Adverse Event|2|||
145260313|NCT00594958|523800272|FG000|Overall Study|Pregnancy|0|||
145260314|NCT00594958|523800273|FG001|Overall Study|Pregnancy|2|||
145260315|NCT00594958|523800274|FG002|Overall Study|Pregnancy|0|||
145260316|NCT00594958|523800272|FG000|Overall Study|Protocol Violation|1|||
145260317|NCT00594958|523800273|FG001|Overall Study|Protocol Violation|0|||
145260318|NCT00594958|523800274|FG002|Overall Study|Protocol Violation|2|||
145260319|NCT00594958|523800272|FG000|Overall Study|Lost to Follow-up|5|||
145260320|NCT00594958|523800273|FG001|Overall Study|Lost to Follow-up|0|||
145260321|NCT00594958|523800274|FG002|Overall Study|Lost to Follow-up|3|||
145260322|NCT00594958|523800272|FG000|Overall Study|administrative|3|||
145260323|NCT00594958|523800273|FG001|Overall Study|administrative|0|||
145260324|NCT00594958|523800274|FG002|Overall Study|administrative|2|||
145260325|NCT03233009|523800275|FG000|Overall Study|Lost to Follow-up|1|||
145260326|NCT02079077|523800276|FG000|Overall Study|Lost to Follow-up|5|||
145260327|NCT02079077|523800277|FG001|Overall Study|Lost to Follow-up|7|||
145260328|NCT02079077|523800276|FG000|Overall Study|Became STIs Positive|1|||
145260329|NCT02079077|523800277|FG001|Overall Study|Became STIs Positive|2|||
145260330|NCT01425268|523800278|FG000|Overall Study|Withdrawal by Subject|2|||
145260331|NCT01425268|523800279|FG001|Overall Study|Withdrawal by Subject|0|||
145260332|NCT01425268|523800278|FG000|Overall Study|Sponsor Decision|5|||
145260333|NCT01425268|523800279|FG001|Overall Study|Sponsor Decision|0|||
145260334|NCT01425268|523800278|FG000|Overall Study|Physician Decision|1|||
145260335|NCT01425268|523800279|FG001|Overall Study|Physician Decision|0|||
145260336|NCT01101321|523800280|FG000|Period 1|Withdrawal by Subject|1|||
145260337|NCT01101321|523800281|FG001|Period 1|Withdrawal by Subject|1|||
145260338|NCT01101321|523800280|FG000|Period 1|Adverse Event|3|||
145260339|NCT01101321|523800281|FG001|Period 1|Adverse Event|3|||
145260340|NCT00682539|523800282|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
145260341|NCT00682539|523800283|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
145260342|NCT00682539|523800284|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
145260343|NCT00682539|523800282|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
145260344|NCT00682539|523800283|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
145260345|NCT00682539|523800284|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
145260346|NCT00508872|523800292|FG000|Overall Study|Lost to Follow-up|1|||
145260347|NCT00508872|523800292|FG000|Overall Study|Physician Decision|1|||
145260348|NCT03339999|523800302|FG000|Overall Study|Adverse Event|1|||
145260349|NCT03339999|523800303|FG001|Overall Study|Adverse Event|2|||
145260350|NCT03339999|523800304|FG002|Overall Study|Adverse Event|2|||
145260351|NCT03339999|523800305|FG003|Overall Study|Adverse Event|1|||
145260352|NCT03339999|523800302|FG000|Overall Study|Lack of Efficacy|0|||
145260353|NCT03339999|523800303|FG001|Overall Study|Lack of Efficacy|1|||
145260354|NCT03339999|523800304|FG002|Overall Study|Lack of Efficacy|0|||
145260355|NCT03339999|523800305|FG003|Overall Study|Lack of Efficacy|0|||
145260356|NCT03339999|523800302|FG000|Overall Study|Lost to Follow-up|0|||
145260357|NCT03339999|523800303|FG001|Overall Study|Lost to Follow-up|0|||
145260358|NCT03339999|523800304|FG002|Overall Study|Lost to Follow-up|0|||
145260359|NCT03339999|523800305|FG003|Overall Study|Lost to Follow-up|1|||
145260360|NCT03339999|523800302|FG000|Overall Study|Study Terminated by Sponsor|6|||
145260361|NCT03339999|523800303|FG001|Overall Study|Study Terminated by Sponsor|3|||
145260362|NCT03339999|523800304|FG002|Overall Study|Study Terminated by Sponsor|4|||
145410806|NCT02903914|524356845|FG000|Overall Study|Follow-up Did Not Occur|0|||
145410807|NCT02903914|524356846|FG001|Overall Study|Follow-up Did Not Occur|1|||
145410808|NCT02903914|524356847|FG002|Overall Study|Follow-up Did Not Occur|1|||
145410809|NCT02903914|524356848|FG003|Overall Study|Follow-up Did Not Occur|0|||
145410810|NCT02903914|524356849|FG004|Overall Study|Follow-up Did Not Occur|2|||
145260363|NCT03339999|523800305|FG003|Overall Study|Study Terminated by Sponsor|3|||
145260364|NCT01856920|523800306|FG000|Overall Study|Disease Progression On Study|3|||
145410811|NCT02903914|524356850|FG005|Overall Study|Follow-up Did Not Occur|0|||
145260365|NCT01856920|523800307|FG001|Overall Study|Disease Progression On Study|4|||
145260366|NCT01856920|523800306|FG000|Overall Study|Disease Progression before Treatment|1|||
145260367|NCT01856920|523800307|FG001|Overall Study|Disease Progression before Treatment|0|||
145260368|NCT01856920|523800306|FG000|Overall Study|Ineligible|0|||
145260369|NCT01856920|523800307|FG001|Overall Study|Ineligible|1|||
145260370|NCT01856920|523800306|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
145410812|NCT02903914|524356851|FG006|Overall Study|Follow-up Did Not Occur|8|||
145410813|NCT02903914|524356852|FG007|Overall Study|Follow-up Did Not Occur|0|||
145260371|NCT01856920|523800307|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
145260372|NCT01856920|523800306|FG000|Overall Study|Refused further Treatment|5|||
145260373|NCT01856920|523800307|FG001|Overall Study|Refused further Treatment|1|||
145260374|NCT01856920|523800306|FG000|Overall Study|Other Reasons|0|||
145260375|NCT01856920|523800307|FG001|Overall Study|Other Reasons|1|||
145260376|NCT01856920|523800306|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
145260377|NCT01856920|523800307|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
145260378|NCT02545270|523800309|FG000|Overall Study|technical difficulties|0|||
145260379|NCT02545270|523800310|FG001|Overall Study|technical difficulties|1|||
145260380|NCT02545270|523800311|FG002|Overall Study|technical difficulties|0|||
145260381|NCT02545270|523800309|FG000|Overall Study|Videos being too similar to other|0|||
145260382|NCT02545270|523800310|FG001|Overall Study|Videos being too similar to other|0|||
145260383|NCT02545270|523800311|FG002|Overall Study|Videos being too similar to other|2|||
145260384|NCT04594213|523800317|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
145260385|NCT04594213|523800318|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
145260386|NCT04594213|523800319|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
145260387|NCT04594213|523800320|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145260388|NCT04594213|523800321|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145260389|NCT04594213|523800322|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145260390|NCT04594213|523800317|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
145260391|NCT04594213|523800318|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
145260392|NCT04594213|523800319|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
145260393|NCT04594213|523800320|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
145260394|NCT04594213|523800321|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
145260395|NCT04594213|523800322|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
145260396|NCT04594213|523800317|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
145260397|NCT04594213|523800318|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145260398|NCT04594213|523800319|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
145260399|NCT04594213|523800320|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145260400|NCT04594213|523800321|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145260401|NCT04594213|523800322|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145260402|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145260403|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145260404|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145260405|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145260406|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
145260407|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145260408|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145260409|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145260410|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145260411|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
145260412|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
145260413|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
145260414|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145260415|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145260416|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145260417|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145260418|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145260419|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
145260420|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145260421|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145260422|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145260423|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
145260424|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145260425|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145260426|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
145260427|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
145260428|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
145260429|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
145260430|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
145260431|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
145260432|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145260433|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145260434|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145620279|NCT01563978|525123730|FG000|Overall Study|Lost to Follow-up|1|||
145620280|NCT01563978|525123731|FG001|Overall Study|Lost to Follow-up|0|||
145260435|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
145260436|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
145260437|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
145620281|NCT01563978|525123730|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
145568671|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
145568672|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
145568673|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
145568674|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
145568675|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
145260438|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145260439|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145260440|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145260441|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
145260442|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
145260443|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
145260444|NCT04594213|523800317|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
145260445|NCT04594213|523800318|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
145260446|NCT04594213|523800319|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
145260447|NCT04594213|523800320|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
145260448|NCT04594213|523800321|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
145260449|NCT04594213|523800322|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
145260450|NCT03764813|523800323|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
145260451|NCT03764813|523800324|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
145260452|NCT03764813|523800325|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
145260453|NCT03764813|523800326|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
145260454|NCT01654666|523800329|FG000|Overall Study|Protocol Violation|7|||
145260455|NCT01654666|523800330|FG001|Overall Study|Protocol Violation|4|||
145260456|NCT01654666|523800331|FG002|Overall Study|Protocol Violation|8|||
145260457|NCT01654666|523800329|FG000|Overall Study|Lost to Follow-up|4|||
145260458|NCT01654666|523800330|FG001|Overall Study|Lost to Follow-up|5|||
145260459|NCT01654666|523800331|FG002|Overall Study|Lost to Follow-up|5|||
145260460|NCT01654666|523800329|FG000|Overall Study|Withdrawal by Subject|4|||
145260461|NCT01654666|523800330|FG001|Overall Study|Withdrawal by Subject|4|||
145260462|NCT01654666|523800331|FG002|Overall Study|Withdrawal by Subject|1|||
145260463|NCT02898662|523800332|FG000|Overall Study|Adverse Event|1|||
145260464|NCT02898662|523800333|FG001|Overall Study|Adverse Event|0|||
145260465|NCT02898662|523800332|FG000|Overall Study|Loss of asthma control|23|||
145260466|NCT02898662|523800333|FG001|Overall Study|Loss of asthma control|24|||
145260467|NCT02898662|523800332|FG000|Overall Study|Withdrawal by Subject|4|||
145260468|NCT02898662|523800333|FG001|Overall Study|Withdrawal by Subject|1|||
145260469|NCT02898662|523800332|FG000|Overall Study|Technical issue|0|||
145260470|NCT02898662|523800333|FG001|Overall Study|Technical issue|1|||
145260471|NCT02898662|523800332|FG000|Overall Study|Randomized in error|0|||
145260472|NCT02898662|523800333|FG001|Overall Study|Randomized in error|1|||
145260473|NCT02898662|523800332|FG000|Overall Study|Subject decision|1|||
145260474|NCT02898662|523800333|FG001|Overall Study|Subject decision|0|||
145260475|NCT02898662|523800332|FG000|Overall Study|Other|0|||
145260476|NCT02898662|523800333|FG001|Overall Study|Other|1|||
145260477|NCT01430559|523800335|FG000|Overall Study|Adverse Event|7|||
145260478|NCT01430559|523800336|FG001|Overall Study|Adverse Event|3|||
145260479|NCT01430559|523800335|FG000|Overall Study|Entry criteria not met|1|||
145260480|NCT01430559|523800336|FG001|Overall Study|Entry criteria not met|1|||
145260481|NCT01430559|523800335|FG000|Overall Study|Lost to Follow-up|1|||
145260482|NCT01430559|523800336|FG001|Overall Study|Lost to Follow-up|0|||
145568676|NCT00934544|524942259|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
145568677|NCT00934544|524942260|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
145568678|NCT00934544|524942261|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
145568679|NCT02118428|524942268|FG000|Overall Study|Physician Decision|0|||
145260483|NCT01430559|523800335|FG000|Overall Study|Medication error|1|||
145260484|NCT01430559|523800336|FG001|Overall Study|Medication error|0|||
145260485|NCT01430559|523800335|FG000|Overall Study|Withdrawal by Subject|3|||
145260486|NCT01430559|523800336|FG001|Overall Study|Withdrawal by Subject|2|||
145260487|NCT01430559|523800335|FG000|Overall Study|Protocol Violation|1|||
145260488|NCT01430559|523800336|FG001|Overall Study|Protocol Violation|0|||
145260489|NCT01430559|523800335|FG000|Overall Study|Other|3|||
145260490|NCT01430559|523800336|FG001|Overall Study|Other|3|||
145260491|NCT01430559|523800335|FG000|Overall Study|Randomized, Not Treated|3|||
145260492|NCT01430559|523800336|FG001|Overall Study|Randomized, Not Treated|3|||
145260493|NCT04225026|523800337|FG000|Overall Study|Withdrawal by Subject|4|||
145260494|NCT04225026|523800337|FG000|Overall Study|Adverse Event|1|||
145260495|NCT04225026|523800337|FG000|Overall Study|Other|1|||
145260496|NCT04225026|523800337|FG000|Overall Study|Death|11|||
145260497|NCT04225026|523800337|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
145260498|NCT01000311|523800342|FG000|Overall Study|Adverse Event|2|||
145260499|NCT01000311|523800343|FG001|Overall Study|Adverse Event|5|||
145260500|NCT01000311|523800342|FG000|Overall Study|Withdrawal by Subject|16|||
145260501|NCT01000311|523800343|FG001|Overall Study|Withdrawal by Subject|24|||
145568680|NCT02118428|524942269|FG001|Overall Study|Physician Decision|1|||
145568681|NCT02118428|524942270|FG002|Overall Study|Physician Decision|0|||
145260502|NCT01000311|523800342|FG000|Overall Study|Lost to Follow-up|15|||
145260503|NCT01000311|523800343|FG001|Overall Study|Lost to Follow-up|24|||
145260504|NCT01000311|523800342|FG000|Overall Study|Protocol Violation|1|||
145260505|NCT01000311|523800343|FG001|Overall Study|Protocol Violation|2|||
145260506|NCT01000311|523800342|FG000|Overall Study|Inappropriate enrollment|2|||
145260507|NCT01000311|523800343|FG001|Overall Study|Inappropriate enrollment|0|||
145260508|NCT01000311|523800342|FG000|Overall Study|Administrative reason|9|||
145260509|NCT01000311|523800343|FG001|Overall Study|Administrative reason|15|||
145260510|NCT01468844|523800344|FG000|Overall Study|Adverse Event|1|||
145260511|NCT01468844|523800345|FG001|Overall Study|Adverse Event|0|||
145260512|NCT01468844|523800344|FG000|Overall Study|Withdrawal by Subject|1|||
145260513|NCT01468844|523800345|FG001|Overall Study|Withdrawal by Subject|0|||
145260514|NCT00819052|523800346|FG000|Overall Study|Adverse Event|0|||
145260515|NCT00819052|523800347|FG001|Overall Study|Adverse Event|5|||
145260516|NCT00819052|523800346|FG000|Overall Study|Protocol Violation|1|||
145260517|NCT00819052|523800347|FG001|Overall Study|Protocol Violation|2|||
145260518|NCT00819052|523800346|FG000|Overall Study|Lost to Follow-up|1|||
145260519|NCT00819052|523800347|FG001|Overall Study|Lost to Follow-up|2|||
145260520|NCT00819052|523800346|FG000|Overall Study|Withdrawal by Subject|1|||
145260521|NCT00819052|523800347|FG001|Overall Study|Withdrawal by Subject|2|||
145260522|NCT00819052|523800346|FG000|Overall Study|Lack of Efficacy|1|||
145260523|NCT00819052|523800347|FG001|Overall Study|Lack of Efficacy|1|||
145260524|NCT00819052|523800346|FG000|Overall Study|Pregnancy|1|||
145260525|NCT00819052|523800347|FG001|Overall Study|Pregnancy|2|||
145260526|NCT00819052|523800346|FG000|Overall Study|Death or events leading to death|1|||
145260527|NCT00819052|523800347|FG001|Overall Study|Death or events leading to death|0|||
145260528|NCT03524664|523800348|FG000|Overall Study|Withdrawal by Subject|1|||
145260529|NCT03524664|523800349|FG001|Overall Study|Withdrawal by Subject|2|||
145260530|NCT03524664|523800348|FG000|Overall Study|Lost to Follow-up|4|||
145260531|NCT03524664|523800349|FG001|Overall Study|Lost to Follow-up|13|||
145260532|NCT01373294|523800350|FG000|Overall Study|Adverse Event|1|||
145260533|NCT01373294|523800351|FG001|Overall Study|Adverse Event|0|||
145260534|NCT02694562|523800352|FG000|Overall Study|Death|8|||
145260535|NCT02694562|523800352|FG000|Overall Study|Protocol Violation|4|||
145260536|NCT02694562|523800352|FG000|Overall Study|Lost to Follow-up|3|||
145260537|NCT02694562|523800352|FG000|Overall Study|Screen Failure|2|||
145260538|NCT02694562|523800352|FG000|Overall Study|Physician Decision|1|||
145260539|NCT03702166|523800353|FG000|Overall Study|Lost to Follow-up|1|||
145260540|NCT03702166|523800353|FG000|Overall Study|Withdrawal by Subject|1|||
145260541|NCT01333865|523800354|FG000|Overall Study|Adverse Event|2|||
145260542|NCT01521494|523800359|FG000|Overall Study|Adverse Event|1|||
145260543|NCT01521494|523800360|FG001|Overall Study|Adverse Event|2|||
145260544|NCT01521494|523800361|FG002|Overall Study|Adverse Event|9|||
145260545|NCT01521494|523800362|FG003|Overall Study|Adverse Event|6|||
145260546|NCT01521494|523800363|FG004|Overall Study|Adverse Event|2|||
145260547|NCT01521494|523800359|FG000|Overall Study|Lack of Efficacy|0|||
145260548|NCT01521494|523800360|FG001|Overall Study|Lack of Efficacy|0|||
145260549|NCT01521494|523800361|FG002|Overall Study|Lack of Efficacy|0|||
145260550|NCT01521494|523800362|FG003|Overall Study|Lack of Efficacy|0|||
145260551|NCT01521494|523800363|FG004|Overall Study|Lack of Efficacy|2|||
145260552|NCT01521494|523800359|FG000|Overall Study|Withdrawal by Subject|1|||
145260553|NCT01521494|523800360|FG001|Overall Study|Withdrawal by Subject|1|||
145260554|NCT01521494|523800361|FG002|Overall Study|Withdrawal by Subject|0|||
145260555|NCT01521494|523800362|FG003|Overall Study|Withdrawal by Subject|2|||
145260556|NCT01521494|523800363|FG004|Overall Study|Withdrawal by Subject|0|||
145260557|NCT01521494|523800359|FG000|Overall Study|Decrease in serum phosphate|0|||
145260558|NCT01521494|523800360|FG001|Overall Study|Decrease in serum phosphate|2|||
145260559|NCT01521494|523800361|FG002|Overall Study|Decrease in serum phosphate|3|||
145260560|NCT01521494|523800362|FG003|Overall Study|Decrease in serum phosphate|12|||
145260561|NCT01521494|523800363|FG004|Overall Study|Decrease in serum phosphate|0|||
145260562|NCT01521494|523800359|FG000|Overall Study|Decrease in serum calcium|0|||
145260563|NCT01521494|523800360|FG001|Overall Study|Decrease in serum calcium|0|||
145260564|NCT01521494|523800361|FG002|Overall Study|Decrease in serum calcium|0|||
145260565|NCT01521494|523800362|FG003|Overall Study|Decrease in serum calcium|1|||
145260566|NCT01521494|523800363|FG004|Overall Study|Decrease in serum calcium|1|||
145260567|NCT01521494|523800359|FG000|Overall Study|Physician Decision|0|||
145260568|NCT01521494|523800360|FG001|Overall Study|Physician Decision|0|||
145260569|NCT01521494|523800361|FG002|Overall Study|Physician Decision|0|||
145260570|NCT01521494|523800362|FG003|Overall Study|Physician Decision|0|||
145260571|NCT01521494|523800363|FG004|Overall Study|Physician Decision|2|||
145260572|NCT01920061|523800366|FG000|Overall Study|Death|1|||
145260573|NCT01920061|523800367|FG001|Overall Study|Death|1|||
145260574|NCT01920061|523800368|FG002|Overall Study|Death|0|||
145568682|NCT02118428|524942268|FG000|Overall Study|Withdrawal by Subject|2|||
145260575|NCT01920061|523800369|FG003|Overall Study|Death|1|||
145260576|NCT01920061|523800370|FG004|Overall Study|Death|1|||
145260577|NCT01920061|523800371|FG005|Overall Study|Death|0|||
145260578|NCT01920061|523800372|FG006|Overall Study|Death|0|||
145260579|NCT01920061|523800373|FG007|Overall Study|Death|1|||
145260580|NCT01920061|523800374|FG008|Overall Study|Death|0|||
145260581|NCT01920061|523800375|FG009|Overall Study|Death|1|||
145260582|NCT01920061|523800376|FG010|Overall Study|Death|0|||
145260583|NCT01920061|523800377|FG011|Overall Study|Death|1|||
145260584|NCT01920061|523800378|FG012|Overall Study|Death|0|||
145260585|NCT01920061|523800379|FG013|Overall Study|Death|2|||
145260586|NCT01920061|523800380|FG014|Overall Study|Death|0|||
145260587|NCT01920061|523800381|FG015|Overall Study|Death|0|||
145260588|NCT01920061|523800382|FG016|Overall Study|Death|0|||
145260589|NCT01920061|523800383|FG017|Overall Study|Death|0|||
145260590|NCT01920061|523800384|FG018|Overall Study|Death|1|||
145260591|NCT01920061|523800385|FG019|Overall Study|Death|0|||
145260592|NCT01920061|523800366|FG000|Overall Study|Lost to Follow-up|0|||
145260593|NCT01920061|523800367|FG001|Overall Study|Lost to Follow-up|2|||
145260594|NCT01920061|523800368|FG002|Overall Study|Lost to Follow-up|0|||
145260595|NCT01920061|523800369|FG003|Overall Study|Lost to Follow-up|0|||
145260596|NCT01920061|523800370|FG004|Overall Study|Lost to Follow-up|0|||
145260597|NCT01920061|523800371|FG005|Overall Study|Lost to Follow-up|0|||
145260598|NCT01920061|523800372|FG006|Overall Study|Lost to Follow-up|1|||
145260599|NCT01920061|523800373|FG007|Overall Study|Lost to Follow-up|0|||
145260600|NCT01920061|523800374|FG008|Overall Study|Lost to Follow-up|0|||
145260601|NCT01920061|523800375|FG009|Overall Study|Lost to Follow-up|0|||
145260602|NCT01920061|523800376|FG010|Overall Study|Lost to Follow-up|3|||
145260603|NCT01920061|523800377|FG011|Overall Study|Lost to Follow-up|0|||
145260604|NCT01920061|523800378|FG012|Overall Study|Lost to Follow-up|0|||
145260605|NCT01920061|523800379|FG013|Overall Study|Lost to Follow-up|0|||
145260606|NCT01920061|523800380|FG014|Overall Study|Lost to Follow-up|0|||
145260607|NCT01920061|523800381|FG015|Overall Study|Lost to Follow-up|0|||
145260608|NCT01920061|523800382|FG016|Overall Study|Lost to Follow-up|0|||
145260609|NCT01920061|523800383|FG017|Overall Study|Lost to Follow-up|1|||
145260610|NCT01920061|523800384|FG018|Overall Study|Lost to Follow-up|4|||
145260611|NCT01920061|523800385|FG019|Overall Study|Lost to Follow-up|3|||
145260612|NCT01920061|523800366|FG000|Overall Study|Other|1|||
145260613|NCT01920061|523800367|FG001|Overall Study|Other|1|||
145260614|NCT01920061|523800368|FG002|Overall Study|Other|2|||
145260615|NCT01920061|523800369|FG003|Overall Study|Other|1|||
145260616|NCT01920061|523800370|FG004|Overall Study|Other|0|||
145260617|NCT01920061|523800371|FG005|Overall Study|Other|1|||
145260618|NCT01920061|523800372|FG006|Overall Study|Other|0|||
145260619|NCT01920061|523800373|FG007|Overall Study|Other|0|||
145260620|NCT01920061|523800374|FG008|Overall Study|Other|0|||
145260621|NCT01920061|523800375|FG009|Overall Study|Other|1|||
145260622|NCT01920061|523800376|FG010|Overall Study|Other|1|||
145260623|NCT01920061|523800377|FG011|Overall Study|Other|2|||
145260624|NCT01920061|523800378|FG012|Overall Study|Other|1|||
145260625|NCT01920061|523800379|FG013|Overall Study|Other|4|||
145260626|NCT01920061|523800380|FG014|Overall Study|Other|0|||
145260627|NCT01920061|523800381|FG015|Overall Study|Other|1|||
145260628|NCT01920061|523800382|FG016|Overall Study|Other|1|||
145260629|NCT01920061|523800383|FG017|Overall Study|Other|0|||
145260630|NCT01920061|523800384|FG018|Overall Study|Other|1|||
145260631|NCT01920061|523800385|FG019|Overall Study|Other|1|||
145260632|NCT01920061|523800366|FG000|Overall Study|Participant refused further follow-up|0|||
145260633|NCT01920061|523800367|FG001|Overall Study|Participant refused further follow-up|0|||
145260634|NCT01920061|523800368|FG002|Overall Study|Participant refused further follow-up|0|||
145260635|NCT01920061|523800369|FG003|Overall Study|Participant refused further follow-up|0|||
145260636|NCT01920061|523800370|FG004|Overall Study|Participant refused further follow-up|1|||
145260637|NCT01920061|523800371|FG005|Overall Study|Participant refused further follow-up|1|||
145260638|NCT01920061|523800372|FG006|Overall Study|Participant refused further follow-up|0|||
145260639|NCT01920061|523800373|FG007|Overall Study|Participant refused further follow-up|0|||
145260640|NCT01920061|523800374|FG008|Overall Study|Participant refused further follow-up|1|||
145301469|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Progressive disease|0|||
145301470|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Progressive disease|0|||
145301471|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Progressive disease|0|||
145301472|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Progressive disease|0|||
145301473|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Progressive disease|0|||
145301474|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Progressive disease|0|||
145301475|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Progressive disease|0|||
145301476|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145260641|NCT01920061|523800375|FG009|Overall Study|Participant refused further follow-up|0|||
145260642|NCT01920061|523800376|FG010|Overall Study|Participant refused further follow-up|1|||
145260643|NCT01920061|523800377|FG011|Overall Study|Participant refused further follow-up|0|||
145260644|NCT01920061|523800378|FG012|Overall Study|Participant refused further follow-up|1|||
145260645|NCT01920061|523800379|FG013|Overall Study|Participant refused further follow-up|0|||
145260646|NCT01920061|523800380|FG014|Overall Study|Participant refused further follow-up|1|||
145260647|NCT01920061|523800381|FG015|Overall Study|Participant refused further follow-up|2|||
145260648|NCT01920061|523800382|FG016|Overall Study|Participant refused further follow-up|1|||
145260649|NCT01920061|523800383|FG017|Overall Study|Participant refused further follow-up|1|||
145260650|NCT01920061|523800384|FG018|Overall Study|Participant refused further follow-up|0|||
145260651|NCT01920061|523800385|FG019|Overall Study|Participant refused further follow-up|0|||
145260652|NCT00554229|523800386|FG000|Overall Study|Lost to Follow-up|3|||
145260653|NCT00554229|523800387|FG001|Overall Study|Lost to Follow-up|6|||
145260654|NCT00554229|523800386|FG000|Overall Study|Withdrawal by Subject|29|||
145260655|NCT00554229|523800387|FG001|Overall Study|Withdrawal by Subject|37|||
145260656|NCT00554229|523800386|FG000|Overall Study|Adverse Event|71|||
145260657|NCT00554229|523800387|FG001|Overall Study|Adverse Event|39|||
145260658|NCT00554229|523800386|FG000|Overall Study|Protocol Violation|3|||
145260659|NCT00554229|523800387|FG001|Overall Study|Protocol Violation|3|||
145260660|NCT00554229|523800386|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
145260661|NCT00554229|523800387|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
145260662|NCT00554229|523800386|FG000|Overall Study|Randomised but no treatment received|1|||
145260663|NCT00554229|523800387|FG001|Overall Study|Randomised but no treatment received|0|||
145260664|NCT00877929|523800388|FG000|Overall Study|Adverse Event|11|||
145260665|NCT00877929|523800389|FG001|Overall Study|Adverse Event|20|||
145260666|NCT00877929|523800388|FG000|Overall Study|Protocol Violation|3|||
145260667|NCT00877929|523800389|FG001|Overall Study|Protocol Violation|3|||
145260668|NCT00877929|523800388|FG000|Overall Study|Lost to Follow-up|0|||
145260669|NCT00877929|523800389|FG001|Overall Study|Lost to Follow-up|1|||
145260670|NCT00877929|523800388|FG000|Overall Study|Withdrawal by Subject|4|||
145260671|NCT00877929|523800389|FG001|Overall Study|Withdrawal by Subject|4|||
145260672|NCT00877929|523800388|FG000|Overall Study|Lack of Efficacy|0|||
145260673|NCT00877929|523800389|FG001|Overall Study|Lack of Efficacy|1|||
145260674|NCT00877929|523800388|FG000|Overall Study|Other reason (not specified)|2|||
145260675|NCT00877929|523800389|FG001|Overall Study|Other reason (not specified)|6|||
145260676|NCT01140646|523800390|FG000|Overall Study|Adverse Event|4|||
145260677|NCT01140646|523800390|FG000|Overall Study|Refused Further Treatment|5|||
145260678|NCT00784836|523800398|FG000|Overall Study|Early Study Termination|3|||
145260679|NCT00689299|523800402|FG000|Overall Study|Adverse Event|2|||
145260680|NCT00689299|523800403|FG001|Overall Study|Adverse Event|1|||
145260681|NCT00689299|523800404|FG002|Overall Study|Adverse Event|1|||
145260682|NCT00689299|523800402|FG000|Overall Study|Lost to Follow-up|0|||
145260683|NCT00689299|523800403|FG001|Overall Study|Lost to Follow-up|1|||
145260684|NCT00689299|523800404|FG002|Overall Study|Lost to Follow-up|1|||
145260685|NCT00689299|523800402|FG000|Overall Study|Withdrawal by Subject|4|||
145260686|NCT00689299|523800403|FG001|Overall Study|Withdrawal by Subject|1|||
145260687|NCT00689299|523800404|FG002|Overall Study|Withdrawal by Subject|3|||
145260688|NCT00689299|523800402|FG000|Overall Study|Protocol Violation|1|||
145260689|NCT00689299|523800403|FG001|Overall Study|Protocol Violation|0|||
145260690|NCT00689299|523800404|FG002|Overall Study|Protocol Violation|0|||
145260691|NCT02613910|523800407|FG000|Overall Study|Termination of study|1|||
145260692|NCT00434876|523800412|FG000|Overall Study|Lost to Follow-up|1|||
145260693|NCT00434876|523800413|FG001|Overall Study|Lost to Follow-up|1|||
145260694|NCT00758394|523800414|FG000|2nd Intervention Order|Lost to Follow-up|0|||
145260695|NCT00758394|523800415|FG001|2nd Intervention Order|Lost to Follow-up|1|||
145260696|NCT00758394|523800416|FG002|2nd Intervention Order|Lost to Follow-up|0|||
145260697|NCT00758394|523800417|FG003|2nd Intervention Order|Lost to Follow-up|0|||
145260698|NCT00758394|523800414|FG000|3rd Intervention|Lost to Follow-up|1|||
145260699|NCT00758394|523800415|FG001|3rd Intervention|Lost to Follow-up|0|||
145260700|NCT00758394|523800416|FG002|3rd Intervention|Lost to Follow-up|0|||
145260701|NCT00758394|523800417|FG003|3rd Intervention|Lost to Follow-up|1|||
145260702|NCT01277757|523802105|FG000|Overall Study|Disease Progression|1|||
145260703|NCT01277757|523802105|FG000|Overall Study|Withdrawal by Subject|1|||
145260704|NCT03808298|523802106|FG000|Overall Study|Adverse Event|3|||
145260705|NCT03808298|523802106|FG000|Overall Study|Physician Decision|1|||
145260706|NCT03808298|523802106|FG000|Overall Study|Withdrawal by Subject|1|||
145260707|NCT03808298|523802106|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
145260708|NCT01004822|523802107|FG000|Overall Study|Objective progression or relapse|3|||
145260709|NCT01004822|523802108|FG001|Overall Study|Objective progression or relapse|3|||
145260710|NCT01004822|523802109|FG002|Overall Study|Objective progression or relapse|0|||
145260711|NCT01004822|523802110|FG003|Overall Study|Objective progression or relapse|1|||
145260712|NCT01004822|523802111|FG004|Overall Study|Objective progression or relapse|2|||
145410814|NCT02903914|524356845|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
145260713|NCT01004822|523802112|FG005|Overall Study|Objective progression or relapse|2|||
145260714|NCT01004822|523802113|FG006|Overall Study|Objective progression or relapse|1|||
145260715|NCT01004822|523802114|FG007|Overall Study|Objective progression or relapse|4|||
145260716|NCT01004822|523802107|FG000|Overall Study|Global deterioration of health status|0|||
145260717|NCT01004822|523802108|FG001|Overall Study|Global deterioration of health status|0|||
145260718|NCT01004822|523802109|FG002|Overall Study|Global deterioration of health status|0|||
145260719|NCT01004822|523802110|FG003|Overall Study|Global deterioration of health status|1|||
145410815|NCT02903914|524356846|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
145260720|NCT01004822|523802111|FG004|Overall Study|Global deterioration of health status|0|||
145260721|NCT01004822|523802112|FG005|Overall Study|Global deterioration of health status|0|||
145260722|NCT01004822|523802113|FG006|Overall Study|Global deterioration of health status|1|||
145260723|NCT01004822|523802114|FG007|Overall Study|Global deterioration of health status|0|||
145260724|NCT01004822|523802107|FG000|Overall Study|No longer willing to continue|0|||
145260725|NCT01004822|523802108|FG001|Overall Study|No longer willing to continue|0|||
145260726|NCT01004822|523802109|FG002|Overall Study|No longer willing to continue|0|||
145260727|NCT01004822|523802110|FG003|Overall Study|No longer willing to continue|1|||
145260728|NCT01004822|523802111|FG004|Overall Study|No longer willing to continue|2|||
145260729|NCT01004822|523802112|FG005|Overall Study|No longer willing to continue|1|||
145260730|NCT01004822|523802113|FG006|Overall Study|No longer willing to continue|1|||
145260731|NCT01004822|523802114|FG007|Overall Study|No longer willing to continue|0|||
145260732|NCT01004822|523802107|FG000|Overall Study|Adverse Event|0|||
145260733|NCT01004822|523802108|FG001|Overall Study|Adverse Event|0|||
145260734|NCT01004822|523802109|FG002|Overall Study|Adverse Event|0|||
145260735|NCT01004822|523802110|FG003|Overall Study|Adverse Event|0|||
145260736|NCT01004822|523802111|FG004|Overall Study|Adverse Event|0|||
145260737|NCT01004822|523802112|FG005|Overall Study|Adverse Event|0|||
145260738|NCT01004822|523802113|FG006|Overall Study|Adverse Event|1|||
145260739|NCT01004822|523802114|FG007|Overall Study|Adverse Event|1|||
145260740|NCT01004822|523802107|FG000|Overall Study|Other|0|||
145260741|NCT01004822|523802108|FG001|Overall Study|Other|0|||
145260742|NCT01004822|523802109|FG002|Overall Study|Other|4|||
145260743|NCT01004822|523802110|FG003|Overall Study|Other|1|||
145260744|NCT01004822|523802111|FG004|Overall Study|Other|0|||
145260745|NCT01004822|523802112|FG005|Overall Study|Other|1|||
145260746|NCT01004822|523802113|FG006|Overall Study|Other|0|||
145260747|NCT01004822|523802114|FG007|Overall Study|Other|0|||
145260748|NCT01858701|523802115|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
145260749|NCT01858701|523802116|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
145260750|NCT01858701|523802115|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
145260751|NCT01858701|523802116|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
145260752|NCT01858701|523802115|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
145260753|NCT01858701|523802116|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
145260754|NCT01858701|523802115|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
145260755|NCT01858701|523802116|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
145260756|NCT01801475|523802118|FG000|Overall Study|Withdrawal by Subject|0|||
145260757|NCT01801475|523802119|FG001|Overall Study|Withdrawal by Subject|0|||
145260758|NCT01801475|523802120|FG002|Overall Study|Withdrawal by Subject|0|||
145260759|NCT01801475|523802121|FG003|Overall Study|Withdrawal by Subject|0|||
145260760|NCT01801475|523802122|FG004|Overall Study|Withdrawal by Subject|1|||
145260761|NCT00421928|523802123|FG000|Overall Study|Adverse Event|61|||
145260762|NCT00421928|523802124|FG001|Overall Study|Adverse Event|140|||
145260763|NCT00421928|523802125|FG002|Overall Study|Adverse Event|22|||
145260764|NCT00421928|523802123|FG000|Overall Study|Lost to Follow-up|5|||
145260765|NCT00421928|523802124|FG001|Overall Study|Lost to Follow-up|0|||
145260766|NCT00421928|523802125|FG002|Overall Study|Lost to Follow-up|3|||
145260767|NCT00421928|523802123|FG000|Overall Study|Withdrawal by Subject|50|||
145260768|NCT00421928|523802124|FG001|Overall Study|Withdrawal by Subject|48|||
145260769|NCT00421928|523802125|FG002|Overall Study|Withdrawal by Subject|43|||
145260770|NCT00421928|523802123|FG000|Overall Study|Lack of Efficacy|15|||
145260771|NCT00421928|523802124|FG001|Overall Study|Lack of Efficacy|7|||
145260772|NCT00421928|523802125|FG002|Overall Study|Lack of Efficacy|35|||
145260773|NCT00421928|523802123|FG000|Overall Study|Study drug non-compliant|6|||
145260774|NCT00421928|523802124|FG001|Overall Study|Study drug non-compliant|7|||
145260775|NCT00421928|523802125|FG002|Overall Study|Study drug non-compliant|4|||
145260776|NCT00421928|523802123|FG000|Overall Study|All other|26|||
145260777|NCT00421928|523802124|FG001|Overall Study|All other|21|||
145260778|NCT00421928|523802125|FG002|Overall Study|All other|27|||
145260779|NCT00421928|523802123|FG000|Overall Study|Death|0|||
145260780|NCT00421928|523802124|FG001|Overall Study|Death|1|||
145260781|NCT00421928|523802125|FG002|Overall Study|Death|0|||
145260782|NCT04120116|523802137|FG000|Overall Study|Lost to Follow-up|0|||
145260783|NCT04120116|523802138|FG001|Overall Study|Lost to Follow-up|1|||
145260784|NCT04120116|523802139|FG002|Overall Study|Lost to Follow-up|0|||
145260785|NCT04120116|523802140|FG003|Overall Study|Lost to Follow-up|2|||
145260786|NCT04120116|523802137|FG000|Overall Study|Withdrawal by Subject|1|||
145260787|NCT04120116|523802138|FG001|Overall Study|Withdrawal by Subject|0|||
145260788|NCT04120116|523802139|FG002|Overall Study|Withdrawal by Subject|1|||
145260789|NCT04120116|523802140|FG003|Overall Study|Withdrawal by Subject|1|||
145260790|NCT04120116|523802137|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
145260791|NCT04120116|523802138|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
145260792|NCT04120116|523802139|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
145265336|NCT00953017|523819294|FG000|Overall Study|Brown stool prior to procedure|0|||
145410816|NCT02903914|524356847|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
145260793|NCT04120116|523802140|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
145260794|NCT05111548|523802142|FG000|Overall Study|Withdrawal by Subject|2|||
145260795|NCT05111548|523802143|FG001|Overall Study|Withdrawal by Subject|1|||
145260796|NCT05111548|523802142|FG000|Overall Study|Adverse Event|1|||
145260797|NCT05111548|523802143|FG001|Overall Study|Adverse Event|0|||
145260798|NCT02087085|523802144|FG000|Overall Study|Adverse Event|10|||
145260799|NCT02087085|523802145|FG001|Overall Study|Adverse Event|14|||
145260800|NCT02087085|523802144|FG000|Overall Study|Lack of Efficacy|4|||
145260801|NCT02087085|523802145|FG001|Overall Study|Lack of Efficacy|3|||
145260802|NCT02087085|523802144|FG000|Overall Study|Lost to Follow-up|6|||
145260803|NCT02087085|523802145|FG001|Overall Study|Lost to Follow-up|4|||
145260804|NCT02087085|523802144|FG000|Overall Study|Withdrawal by Subject|9|||
145260805|NCT02087085|523802145|FG001|Overall Study|Withdrawal by Subject|11|||
145260806|NCT02087085|523802144|FG000|Overall Study|Protocol Violation|1|||
145260807|NCT02087085|523802145|FG001|Overall Study|Protocol Violation|0|||
145260808|NCT02087085|523802144|FG000|Overall Study|Study Terminated by Sponsor|87|||
145260809|NCT02087085|523802145|FG001|Overall Study|Study Terminated by Sponsor|80|||
145260810|NCT02087085|523802144|FG000|Overall Study|Other Miscellaneous Reasons|3|||
145260811|NCT02087085|523802145|FG001|Overall Study|Other Miscellaneous Reasons|4|||
145260812|NCT00719706|523802146|FG000|Overall Study|Adverse Event|5|||
145260813|NCT00719706|523802147|FG001|Overall Study|Adverse Event|4|||
145260814|NCT00719706|523802146|FG000|Overall Study|Withdrawal by Subject|1|||
145260815|NCT00719706|523802147|FG001|Overall Study|Withdrawal by Subject|2|||
145260816|NCT00719706|523802146|FG000|Overall Study|Protocol Violation|3|||
145260817|NCT00719706|523802147|FG001|Overall Study|Protocol Violation|0|||
145260818|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
145260819|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
145260820|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
145260821|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
145260822|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
145260823|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
145260824|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
145260825|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
145260826|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
145260827|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
145260828|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
145260829|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
145260830|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
145260831|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
145260832|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
145260833|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|Other|6|||
145260834|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|Other|6|||
145260835|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|Other|7|||
145260836|NCT02681094|523802148|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
145260837|NCT02681094|523802149|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
145260838|NCT02681094|523802150|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
145260839|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Participant decision|7|||
145260840|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Participant decision|10|||
145260841|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Participant decision|9|||
145260842|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
145260843|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
145260844|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
145260845|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
145260846|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
145260847|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
145260848|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
145260849|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
145260850|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
145260851|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
145260852|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
145260853|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
145260854|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|Other|6|||
145260855|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|Other|6|||
145260856|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|Other|7|||
145260857|NCT02681094|523802148|FG000|2 - Enrolled Participants Set|No treatment given|0|||
145260858|NCT02681094|523802149|FG001|2 - Enrolled Participants Set|No treatment given|1|||
145260859|NCT02681094|523802150|FG002|2 - Enrolled Participants Set|No treatment given|1|||
145260860|NCT01270139|523802151|FG000|Overall Study|Adverse Event|8|||
145301477|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301478|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301479|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301480|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301481|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145260861|NCT01270139|523802152|FG001|Overall Study|Adverse Event|17|||
145260862|NCT01270139|523802153|FG002|Overall Study|Adverse Event|18|||
145260863|NCT01270139|523802151|FG000|Overall Study|Lost to Follow-up|10|||
145260864|NCT01270139|523802152|FG001|Overall Study|Lost to Follow-up|9|||
145260865|NCT01270139|523802153|FG002|Overall Study|Lost to Follow-up|2|||
145260866|NCT01072175|523802154|FG000|Part A (Drug-Drug Interaction)|Death|1|||
145260867|NCT01072175|523802155|FG001|Part A (Drug-Drug Interaction)|Death|0|||
145260868|NCT01072175|523802156|FG002|Part A (Drug-Drug Interaction)|Death|0|||
145260869|NCT01072175|523802157|FG003|Part A (Drug-Drug Interaction)|Death|0|||
145260870|NCT01072175|523802158|FG004|Part A (Drug-Drug Interaction)|Death|0|||
145260871|NCT01072175|523802159|FG005|Part A (Drug-Drug Interaction)|Death|0|||
145260872|NCT01072175|523802160|FG006|Part A (Drug-Drug Interaction)|Death|0|||
145260873|NCT01072175|523802161|FG007|Part A (Drug-Drug Interaction)|Death|0|||
145260874|NCT01072175|523802162|FG008|Part A (Drug-Drug Interaction)|Death|0|||
145260875|NCT01072175|523802163|FG009|Part A (Drug-Drug Interaction)|Death|0|||
145260876|NCT01072175|523802164|FG010|Part A (Drug-Drug Interaction)|Death|0|||
145260877|NCT01072175|523802165|FG011|Part A (Drug-Drug Interaction)|Death|0|||
145260878|NCT01072175|523802166|FG012|Part A (Drug-Drug Interaction)|Death|0|||
145260879|NCT01072175|523802154|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
145260880|NCT01072175|523802155|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260881|NCT01072175|523802156|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260882|NCT01072175|523802157|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260883|NCT01072175|523802158|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260884|NCT01072175|523802159|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260885|NCT01072175|523802160|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260886|NCT01072175|523802161|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260887|NCT01072175|523802162|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260888|NCT01072175|523802163|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260889|NCT01072175|523802164|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260890|NCT01072175|523802165|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260891|NCT01072175|523802166|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
145260892|NCT01072175|523802154|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
145260893|NCT01072175|523802155|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260894|NCT01072175|523802156|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260895|NCT01072175|523802157|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260896|NCT01072175|523802158|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145301482|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301483|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301484|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
145301485|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301486|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
145301487|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
145301488|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301489|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301490|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
145301491|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Physician Decision|0|||
145301492|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Physician Decision|0|||
145301493|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Physician Decision|0|||
145301494|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Physician Decision|0|||
145301495|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Physician Decision|0|||
145301496|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Physician Decision|0|||
145301497|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Physician Decision|0|||
145301498|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Physician Decision|0|||
145410817|NCT02903914|524356848|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
145410818|NCT02903914|524356849|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
145568683|NCT02118428|524942269|FG001|Overall Study|Withdrawal by Subject|2|||
145568684|NCT02118428|524942270|FG002|Overall Study|Withdrawal by Subject|0|||
145260897|NCT01072175|523802159|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260898|NCT01072175|523802160|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260899|NCT01072175|523802161|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260900|NCT01072175|523802162|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260901|NCT01072175|523802163|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145568685|NCT02118428|524942268|FG000|Overall Study|Death|7|||
145568686|NCT02118428|524942269|FG001|Overall Study|Death|5|||
145568687|NCT02118428|524942270|FG002|Overall Study|Death|0|||
145568688|NCT02118428|524942268|FG000|Overall Study|Lost to Follow-up|3|||
145568689|NCT02118428|524942269|FG001|Overall Study|Lost to Follow-up|1|||
145260902|NCT01072175|523802164|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260903|NCT01072175|523802165|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260904|NCT01072175|523802166|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
145260905|NCT01072175|523802154|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
145260906|NCT01072175|523802155|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
145260907|NCT01072175|523802156|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
145260908|NCT01072175|523802157|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
145260909|NCT01072175|523802158|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
145260910|NCT01072175|523802159|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
145260911|NCT01072175|523802160|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
145260912|NCT01072175|523802161|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
145260913|NCT01072175|523802162|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
145260914|NCT01072175|523802163|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
145260915|NCT01072175|523802164|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
145260916|NCT01072175|523802165|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
145260917|NCT01072175|523802166|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
145260918|NCT01072175|523802154|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260919|NCT01072175|523802155|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260920|NCT01072175|523802156|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
145260921|NCT01072175|523802157|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260922|NCT01072175|523802158|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
145260923|NCT01072175|523802159|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260924|NCT01072175|523802160|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260925|NCT01072175|523802161|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260926|NCT01072175|523802162|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260927|NCT01072175|523802163|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260928|NCT01072175|523802164|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260929|NCT01072175|523802165|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260930|NCT01072175|523802166|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
145260931|NCT01072175|523802154|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260932|NCT01072175|523802155|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
145260933|NCT01072175|523802156|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260934|NCT01072175|523802157|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
145260935|NCT01072175|523802158|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
145260936|NCT01072175|523802159|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260937|NCT01072175|523802160|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260938|NCT01072175|523802161|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260939|NCT01072175|523802162|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260940|NCT01072175|523802163|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260941|NCT01072175|523802164|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260942|NCT01072175|523802165|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260943|NCT01072175|523802166|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
145260944|NCT01072175|523802154|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260945|NCT01072175|523802155|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260946|NCT01072175|523802156|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
145260947|NCT01072175|523802157|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
145260948|NCT01072175|523802158|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
145260949|NCT01072175|523802159|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260950|NCT01072175|523802160|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260951|NCT01072175|523802161|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260952|NCT01072175|523802162|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260953|NCT01072175|523802163|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260954|NCT01072175|523802164|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260955|NCT01072175|523802165|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260956|NCT01072175|523802166|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
145260957|NCT01072175|523802154|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260958|NCT01072175|523802155|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
145260959|NCT01072175|523802156|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260960|NCT01072175|523802157|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
145260961|NCT01072175|523802158|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
145260962|NCT01072175|523802159|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260963|NCT01072175|523802160|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260964|NCT01072175|523802161|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260965|NCT01072175|523802162|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260966|NCT01072175|523802163|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145301499|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Physician Decision|0|||
145301500|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Physician Decision|0|||
145301501|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Physician Decision|5|||
145301502|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Physician Decision|1|||
145301503|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Physician Decision|1|||
145301504|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Physician Decision|0|||
145301505|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Physician Decision|0|||
145301506|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Death|0|||
145410819|NCT02903914|524356850|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
145410820|NCT02903914|524356851|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
145410821|NCT02903914|524356852|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
145410822|NCT02903914|524356845|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410823|NCT02903914|524356846|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410824|NCT02903914|524356847|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
145410825|NCT02903914|524356848|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410826|NCT02903914|524356849|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410827|NCT02903914|524356850|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
145410828|NCT02903914|524356851|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410829|NCT02903914|524356852|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
145410830|NCT02903914|524356845|FG000|Overall Study|Clinical Disease Progression|0|||
145410831|NCT02903914|524356846|FG001|Overall Study|Clinical Disease Progression|0|||
145410832|NCT02903914|524356847|FG002|Overall Study|Clinical Disease Progression|2|||
145410833|NCT02903914|524356848|FG003|Overall Study|Clinical Disease Progression|0|||
145410834|NCT02903914|524356849|FG004|Overall Study|Clinical Disease Progression|0|||
145410835|NCT02903914|524356850|FG005|Overall Study|Clinical Disease Progression|0|||
145410836|NCT02903914|524356851|FG006|Overall Study|Clinical Disease Progression|0|||
145410837|NCT02903914|524356852|FG007|Overall Study|Clinical Disease Progression|0|||
145410838|NCT02903914|524356845|FG000|Overall Study|Completed Follow-up Period|0|||
145410839|NCT02903914|524356846|FG001|Overall Study|Completed Follow-up Period|0|||
145410840|NCT02903914|524356847|FG002|Overall Study|Completed Follow-up Period|6|||
145410841|NCT02903914|524356848|FG003|Overall Study|Completed Follow-up Period|2|||
145410842|NCT02903914|524356849|FG004|Overall Study|Completed Follow-up Period|1|||
145410843|NCT02903914|524356850|FG005|Overall Study|Completed Follow-up Period|0|||
145410844|NCT02903914|524356851|FG006|Overall Study|Completed Follow-up Period|9|||
145410845|NCT02903914|524356852|FG007|Overall Study|Completed Follow-up Period|1|||
145410846|NCT02903914|524356845|FG000|Overall Study|Taken off Treatment per Protocol|0|||
145260967|NCT01072175|523802164|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260968|NCT01072175|523802165|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260969|NCT01072175|523802166|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
145260970|NCT01072175|523802154|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
145260971|NCT01072175|523802155|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
145260972|NCT01072175|523802156|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
145260973|NCT01072175|523802157|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
145260974|NCT01072175|523802158|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
145260975|NCT01072175|523802159|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
145260976|NCT01072175|523802160|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
145260977|NCT01072175|523802161|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
145260978|NCT01072175|523802162|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
145260979|NCT01072175|523802163|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
145260980|NCT01072175|523802164|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
145260981|NCT01072175|523802165|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
145260982|NCT01072175|523802166|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
145260983|NCT01072175|523802154|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145301507|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Death|0|||
145410847|NCT02903914|524356846|FG001|Overall Study|Taken off Treatment per Protocol|0|||
145410848|NCT02903914|524356847|FG002|Overall Study|Taken off Treatment per Protocol|0|||
145410849|NCT02903914|524356848|FG003|Overall Study|Taken off Treatment per Protocol|0|||
145301508|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Death|0|||
145410850|NCT02903914|524356849|FG004|Overall Study|Taken off Treatment per Protocol|0|||
145410851|NCT02903914|524356850|FG005|Overall Study|Taken off Treatment per Protocol|1|||
145410852|NCT02903914|524356851|FG006|Overall Study|Taken off Treatment per Protocol|0|||
145260984|NCT01072175|523802155|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260985|NCT01072175|523802156|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260986|NCT01072175|523802157|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145568690|NCT02118428|524942270|FG002|Overall Study|Lost to Follow-up|0|||
145568691|NCT02118428|524942268|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
145568692|NCT02118428|524942269|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
145568693|NCT02118428|524942270|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
145568694|NCT00654381|524942273|FG000|1st Stage|Adverse Event|3|||
145260987|NCT01072175|523802158|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260988|NCT01072175|523802159|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
145260989|NCT01072175|523802160|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
145260990|NCT01072175|523802161|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
145260991|NCT01072175|523802162|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260992|NCT01072175|523802163|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260993|NCT01072175|523802164|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260994|NCT01072175|523802165|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260995|NCT01072175|523802166|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
145260996|NCT01072175|523802154|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145260997|NCT01072175|523802155|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145260998|NCT01072175|523802156|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145260999|NCT01072175|523802157|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261000|NCT01072175|523802158|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261001|NCT01072175|523802159|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261002|NCT01072175|523802160|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
145261003|NCT01072175|523802161|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
145261004|NCT01072175|523802162|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261005|NCT01072175|523802163|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261006|NCT01072175|523802164|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261007|NCT01072175|523802165|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261008|NCT01072175|523802166|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
145261009|NCT01072175|523802154|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261010|NCT01072175|523802155|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261011|NCT01072175|523802156|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261012|NCT01072175|523802157|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261013|NCT01072175|523802158|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261014|NCT01072175|523802159|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
145261015|NCT01072175|523802160|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
145261016|NCT01072175|523802161|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
145261017|NCT01072175|523802162|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261018|NCT01072175|523802163|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261019|NCT01072175|523802164|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261020|NCT01072175|523802165|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261021|NCT01072175|523802166|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
145261022|NCT01072175|523802154|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261023|NCT01072175|523802155|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261024|NCT01072175|523802156|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261025|NCT01072175|523802157|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261026|NCT01072175|523802158|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261027|NCT01072175|523802159|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
145261028|NCT01072175|523802160|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
145261029|NCT01072175|523802161|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261030|NCT01072175|523802162|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261031|NCT01072175|523802163|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261032|NCT01072175|523802164|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261033|NCT01072175|523802165|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261034|NCT01072175|523802166|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
145261035|NCT01072175|523802154|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261036|NCT01072175|523802155|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261037|NCT01072175|523802156|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261038|NCT01072175|523802157|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261039|NCT01072175|523802158|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261040|NCT01072175|523802159|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261041|NCT01072175|523802160|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261042|NCT01072175|523802161|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261043|NCT01072175|523802162|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
145410853|NCT02903914|524356852|FG007|Overall Study|Taken off Treatment per Protocol|0|||
145410854|NCT02903914|524356845|FG000|Overall Study|Refused Further Treatment/Contact|0|||
145568695|NCT00654381|524942274|FG001|1st Stage|Adverse Event|3|||
145261044|NCT01072175|523802163|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261045|NCT01072175|523802164|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261046|NCT01072175|523802165|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261047|NCT01072175|523802166|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
145261048|NCT01072175|523802154|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261049|NCT01072175|523802155|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261050|NCT01072175|523802156|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261051|NCT01072175|523802157|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261052|NCT01072175|523802158|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261053|NCT01072175|523802159|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261054|NCT01072175|523802160|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261055|NCT01072175|523802161|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261056|NCT01072175|523802162|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
145261057|NCT01072175|523802163|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261058|NCT01072175|523802164|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261059|NCT01072175|523802165|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261060|NCT01072175|523802166|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
145261061|NCT01072175|523802154|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261062|NCT01072175|523802155|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261063|NCT01072175|523802156|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261064|NCT01072175|523802157|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261065|NCT01072175|523802158|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261066|NCT01072175|523802159|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261067|NCT01072175|523802160|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261068|NCT01072175|523802161|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261069|NCT01072175|523802162|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
145261070|NCT01072175|523802163|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261071|NCT01072175|523802164|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261072|NCT01072175|523802165|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261073|NCT01072175|523802166|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
145261074|NCT01072175|523802154|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261075|NCT01072175|523802155|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261076|NCT01072175|523802156|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261077|NCT01072175|523802157|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261078|NCT01072175|523802158|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261079|NCT01072175|523802159|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261080|NCT01072175|523802160|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261081|NCT01072175|523802161|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261082|NCT01072175|523802162|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
145261083|NCT01072175|523802163|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261084|NCT01072175|523802164|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261085|NCT01072175|523802165|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261086|NCT01072175|523802166|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
145261087|NCT01072175|523802154|FG000|Part D (HPMC Capsules)|Death|0|||
145261088|NCT01072175|523802155|FG001|Part D (HPMC Capsules)|Death|0|||
145261089|NCT01072175|523802156|FG002|Part D (HPMC Capsules)|Death|0|||
145261090|NCT01072175|523802157|FG003|Part D (HPMC Capsules)|Death|0|||
145261091|NCT01072175|523802158|FG004|Part D (HPMC Capsules)|Death|0|||
145261092|NCT01072175|523802159|FG005|Part D (HPMC Capsules)|Death|0|||
145261093|NCT01072175|523802160|FG006|Part D (HPMC Capsules)|Death|0|||
145261094|NCT01072175|523802161|FG007|Part D (HPMC Capsules)|Death|0|||
145261095|NCT01072175|523802162|FG008|Part D (HPMC Capsules)|Death|0|||
145261096|NCT01072175|523802163|FG009|Part D (HPMC Capsules)|Death|10|||
145261097|NCT01072175|523802164|FG010|Part D (HPMC Capsules)|Death|12|||
145261098|NCT01072175|523802165|FG011|Part D (HPMC Capsules)|Death|28|||
145261099|NCT01072175|523802166|FG012|Part D (HPMC Capsules)|Death|26|||
145261100|NCT01072175|523802154|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
145261101|NCT01072175|523802155|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
145261102|NCT01072175|523802156|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
145261103|NCT01072175|523802157|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
145261104|NCT01072175|523802158|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
145261105|NCT01072175|523802159|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
145261106|NCT01072175|523802160|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
145261107|NCT01072175|523802161|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
145301509|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Death|0|||
145261108|NCT01072175|523802162|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
145261109|NCT01072175|523802163|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
145261110|NCT01072175|523802164|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
145301510|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Death|0|||
145301511|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Death|0|||
145301512|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Death|0|||
145301513|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Death|0|||
145301514|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Death|0|||
145301515|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Death|0|||
145301516|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Death|2|||
145301517|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Death|0|||
145261111|NCT01072175|523802165|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
145301518|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Death|0|||
145261112|NCT01072175|523802166|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
145261113|NCT01072175|523802154|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261114|NCT01072175|523802155|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261115|NCT01072175|523802156|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261116|NCT01072175|523802157|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261117|NCT01072175|523802158|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261118|NCT01072175|523802159|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261119|NCT01072175|523802160|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261120|NCT01072175|523802161|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261121|NCT01072175|523802162|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261122|NCT01072175|523802163|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
145261123|NCT01072175|523802164|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
145261124|NCT01072175|523802165|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
145261125|NCT01072175|523802166|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
145261126|NCT01072175|523802154|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261127|NCT01072175|523802155|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261128|NCT01072175|523802156|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261129|NCT01072175|523802157|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261130|NCT01072175|523802158|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261131|NCT01072175|523802159|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261132|NCT01072175|523802160|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261133|NCT01072175|523802161|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261134|NCT01072175|523802162|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
145261135|NCT01072175|523802163|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
145261136|NCT01072175|523802164|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
145261137|NCT01072175|523802165|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
145261138|NCT01072175|523802166|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
145261139|NCT01072175|523802154|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261140|NCT01072175|523802155|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261141|NCT01072175|523802156|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261142|NCT01072175|523802157|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261143|NCT01072175|523802158|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261144|NCT01072175|523802159|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261145|NCT01072175|523802160|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261146|NCT01072175|523802161|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261147|NCT01072175|523802162|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261148|NCT01072175|523802163|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145261149|NCT01072175|523802164|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
145261150|NCT01072175|523802165|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
145261151|NCT01072175|523802166|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
145301519|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Death|0|||
145301520|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Death|0|||
145301521|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
145301522|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
145301523|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
145301524|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
145301525|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
145410855|NCT02903914|524356846|FG001|Overall Study|Refused Further Treatment/Contact|0|||
145410856|NCT02903914|524356847|FG002|Overall Study|Refused Further Treatment/Contact|0|||
145568696|NCT00654381|524942275|FG002|1st Stage|Adverse Event|3|||
145568697|NCT00654381|524942276|FG003|1st Stage|Adverse Event|3|||
145301526|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
145301527|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
145301528|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
145301529|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
145301530|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
145301531|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
145301532|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
145261152|NCT02477215|523802167|FG000|Dose Escalation Phase|Physician Decision|1|||
145261153|NCT02477215|523802168|FG001|Dose Escalation Phase|Physician Decision|2|||
145261154|NCT02477215|523802169|FG002|Dose Escalation Phase|Physician Decision|0|||
145261155|NCT02477215|523802167|FG000|Fixed Dose Phase|Physician Decision|0|||
145261156|NCT02477215|523802168|FG001|Fixed Dose Phase|Physician Decision|7|||
145261157|NCT02477215|523802169|FG002|Fixed Dose Phase|Physician Decision|0|||
145261158|NCT02210559|523802170|FG000|Overall Study|Progressive Disease|3|||
145261159|NCT02210559|523802171|FG001|Overall Study|Progressive Disease|2|||
145261160|NCT02210559|523802170|FG000|Overall Study|Adverse Event|2|||
145261161|NCT02210559|523802171|FG001|Overall Study|Adverse Event|2|||
145261162|NCT02210559|523802170|FG000|Overall Study|Physician Decision|1|||
145261163|NCT02210559|523802171|FG001|Overall Study|Physician Decision|0|||
145261164|NCT02210559|523802170|FG000|Overall Study|Withdrawal by Subject|0|||
145261165|NCT02210559|523802171|FG001|Overall Study|Withdrawal by Subject|1|||
145261166|NCT02210559|523802170|FG000|Overall Study|Other than specified|0|||
145261167|NCT02210559|523802171|FG001|Overall Study|Other than specified|1|||
145261168|NCT02546193|523802172|FG000|Overall Study|Withdrawal by Subject|2|||
145261169|NCT02546193|523802173|FG001|Overall Study|Withdrawal by Subject|0|||
145261170|NCT02546193|523802174|FG002|Overall Study|Withdrawal by Subject|1|||
145261171|NCT02546193|523802175|FG003|Overall Study|Withdrawal by Subject|0|||
145568698|NCT00654381|524942277|FG004|1st Stage|Adverse Event|2|||
145568699|NCT00654381|524942278|FG005|1st Stage|Adverse Event|1|||
145568700|NCT00654381|524942273|FG000|1st Stage|Withdrawal by Subject|0|||
145261172|NCT02546193|523802172|FG000|Overall Study|Not eligible at time of induction|4|||
145261173|NCT02546193|523802173|FG001|Overall Study|Not eligible at time of induction|6|||
145261174|NCT02546193|523802174|FG002|Overall Study|Not eligible at time of induction|1|||
145261175|NCT02546193|523802175|FG003|Overall Study|Not eligible at time of induction|0|||
145261176|NCT00917553|523802176|FG000|Overall Study|Lost to Follow-up|2|||
145261177|NCT00917553|523802177|FG001|Overall Study|Lost to Follow-up|1|||
145261178|NCT01616173|523802178|FG000|Overall Study|Lost to Follow-up|0|||
145261179|NCT01616173|523802179|FG001|Overall Study|Lost to Follow-up|2|||
145261180|NCT01616173|523802180|FG002|Overall Study|Lost to Follow-up|0|||
145261181|NCT03432819|523802182|FG000|Overall Study|Lost to Follow-up|2|||
145261182|NCT03432819|523802183|FG001|Overall Study|Lost to Follow-up|2|||
145261183|NCT03432819|523802182|FG000|Overall Study|Withdrawal by Subject|5|||
145261184|NCT03432819|523802183|FG001|Overall Study|Withdrawal by Subject|3|||
145261185|NCT04382066|523802185|FG000|Overall Study|Adverse Event|1|||
145261186|NCT04382066|523802186|FG001|Overall Study|Adverse Event|0|||
145261187|NCT04382066|523802187|FG002|Overall Study|Adverse Event|0|||
145261188|NCT04382066|523802185|FG000|Overall Study|Death|1|||
145261189|NCT04382066|523802186|FG001|Overall Study|Death|0|||
145261190|NCT04382066|523802187|FG002|Overall Study|Death|1|||
145261191|NCT01177943|523802189|FG000|First Intervention|Withdrawal by Subject|2|||
145261192|NCT01177943|523802190|FG001|First Intervention|Withdrawal by Subject|0|||
145261193|NCT00779142|523802194|FG000|Overall Study|Screen Failures|3|||
145261194|NCT00672490|523802195|FG000|Overall Study|Withdrawal by Subject|8|||
145261195|NCT00672490|523802196|FG001|Overall Study|Withdrawal by Subject|8|||
145261196|NCT00672490|523802195|FG000|Overall Study|Lack of Compliance|2|||
145261197|NCT00672490|523802196|FG001|Overall Study|Lack of Compliance|7|||
145261198|NCT00672490|523802195|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
145261199|NCT00672490|523802196|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
145261200|NCT00672490|523802195|FG000|Overall Study|Adverse Event|5|||
145261201|NCT00672490|523802196|FG001|Overall Study|Adverse Event|8|||
145301533|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
145301534|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
145301535|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
145301536|NCT01796171|523956536|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301537|NCT01796171|523956537|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301538|NCT01796171|523956538|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301539|NCT01796171|523956539|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145568701|NCT00654381|524942274|FG001|1st Stage|Withdrawal by Subject|0|||
145568702|NCT00654381|524942275|FG002|1st Stage|Withdrawal by Subject|0|||
145261202|NCT00672490|523802195|FG000|Overall Study|Violation of Concomitant Medicine|1|||
145261203|NCT00672490|523802196|FG001|Overall Study|Violation of Concomitant Medicine|0|||
145261204|NCT00672490|523802195|FG000|Overall Study|Intolerance|0|||
145261205|NCT00672490|523802196|FG001|Overall Study|Intolerance|2|||
145261206|NCT00672490|523802195|FG000|Overall Study|Lost to Follow-up|1|||
145261207|NCT00672490|523802196|FG001|Overall Study|Lost to Follow-up|5|||
145261208|NCT00672490|523802195|FG000|Overall Study|No reason was provided|6|||
145301540|NCT01796171|523956540|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301541|NCT01796171|523956541|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145261209|NCT00672490|523802196|FG001|Overall Study|No reason was provided|2|||
145261210|NCT04738123|523802200|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
145261211|NCT04738123|523802201|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
145261212|NCT04738123|523802200|FG000|Overall Study|Progressive Disease|0|||
145261213|NCT04738123|523802201|FG001|Overall Study|Progressive Disease|4|||
145261214|NCT04738123|523802200|FG000|Overall Study|Adverse Event|8|||
145261215|NCT04738123|523802201|FG001|Overall Study|Adverse Event|7|||
145568703|NCT00654381|524942276|FG003|1st Stage|Withdrawal by Subject|1|||
145261216|NCT04738123|523802200|FG000|Overall Study|Other Reasons|0|||
145261217|NCT04738123|523802201|FG001|Overall Study|Other Reasons|1|||
145261218|NCT04738123|523802200|FG000|Overall Study|Suicidal or assaultive behavior|0|||
145261219|NCT04738123|523802201|FG001|Overall Study|Suicidal or assaultive behavior|2|||
145261220|NCT04738123|523802200|FG000|Overall Study|Protocol Violation|2|||
145261221|NCT04738123|523802201|FG001|Overall Study|Protocol Violation|2|||
145261222|NCT04738123|523802200|FG000|Overall Study|Consent Withdrawn|35|||
145261223|NCT04738123|523802201|FG001|Overall Study|Consent Withdrawn|22|||
145261224|NCT01288911|523802202|FG000|Double-blind Period|Death|11|||
145261225|NCT01288911|523802203|FG001|Double-blind Period|Death|7|||
145261226|NCT01288911|523802202|FG000|Double-blind Period|Lost to Follow-up|0|||
145261227|NCT01288911|523802203|FG001|Double-blind Period|Lost to Follow-up|2|||
145261228|NCT01288911|523802202|FG000|Double-blind Period|Progressive Disease|75|||
145261229|NCT01288911|523802203|FG001|Double-blind Period|Progressive Disease|103|||
145261230|NCT01288911|523802202|FG000|Double-blind Period|Protocol Violation|1|||
145261231|NCT01288911|523802203|FG001|Double-blind Period|Protocol Violation|0|||
145261232|NCT01288911|523802202|FG000|Double-blind Period|Withdrawal by Subject|25|||
145261233|NCT01288911|523802203|FG001|Double-blind Period|Withdrawal by Subject|26|||
145261234|NCT01288911|523802202|FG000|Double-blind Period|Miscellaneous Reason|29|||
145261235|NCT01288911|523802203|FG001|Double-blind Period|Miscellaneous Reason|42|||
145261236|NCT01288911|523802202|FG000|Double-blind Period|Randomized but never received study drug|1|||
145261237|NCT01288911|523802203|FG001|Double-blind Period|Randomized but never received study drug|2|||
145261238|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Death|0|||
145261239|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Death|1|||
145261240|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
145261241|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
145261242|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
145261243|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
145261244|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
145261245|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
145261246|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
145261247|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
145261248|NCT01288911|523802202|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
145261249|NCT01288911|523802203|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
145261250|NCT00486720|523802204|FG000|Overall Study|Adverse Event|1|||
145261251|NCT00486720|523802205|FG001|Overall Study|Adverse Event|2|||
145261252|NCT00486720|523802204|FG000|Overall Study|Lack of Efficacy|4|||
145261253|NCT00486720|523802205|FG001|Overall Study|Lack of Efficacy|6|||
145261254|NCT00486720|523802204|FG000|Overall Study|Physician Decision|1|||
145261255|NCT00486720|523802205|FG001|Overall Study|Physician Decision|2|||
145261256|NCT00486720|523802204|FG000|Overall Study|Protocol Violation|1|||
145261257|NCT00486720|523802205|FG001|Overall Study|Protocol Violation|0|||
145261258|NCT00486720|523802204|FG000|Overall Study|Withdrawal by Subject|3|||
145261259|NCT00486720|523802205|FG001|Overall Study|Withdrawal by Subject|1|||
145261260|NCT00486720|523802204|FG000|Overall Study|Progressive Disease|0|||
145261261|NCT00486720|523802205|FG001|Overall Study|Progressive Disease|1|||
145261262|NCT01005875|523802206|FG000|Overall Study|Death|3|||
145261263|NCT00606931|523802209|FG000|Overall Study|Withdrawal by Subject|3|||
145261264|NCT05047601|523802211|FG000|Overall Study|Lost to Follow-up|9|||
145261265|NCT05047601|523802212|FG001|Overall Study|Lost to Follow-up|11|||
145261266|NCT05047601|523802213|FG002|Overall Study|Lost to Follow-up|7|||
145261267|NCT05047601|523802211|FG000|Overall Study|Withdrawal by Subject|25|||
145261268|NCT05047601|523802212|FG001|Overall Study|Withdrawal by Subject|36|||
145261269|NCT05047601|523802213|FG002|Overall Study|Withdrawal by Subject|23|||
145261270|NCT05047601|523802211|FG000|Overall Study|Other|10|||
145261271|NCT05047601|523802212|FG001|Overall Study|Other|6|||
145261272|NCT05047601|523802213|FG002|Overall Study|Other|5|||
145261273|NCT00286234|523802214|FG000|Overall Study|Protocol Violation|1|||
145261274|NCT00286234|523802215|FG001|Overall Study|Protocol Violation|2|||
145261275|NCT00286234|523802216|FG002|Overall Study|Protocol Violation|0|||
145261276|NCT00286234|523802217|FG003|Overall Study|Protocol Violation|1|||
145261277|NCT00286234|523802214|FG000|Overall Study|Physician Decision|1|||
145261278|NCT00286234|523802215|FG001|Overall Study|Physician Decision|0|||
145261279|NCT00286234|523802216|FG002|Overall Study|Physician Decision|0|||
145261280|NCT00286234|523802217|FG003|Overall Study|Physician Decision|1|||
145261281|NCT00286234|523802214|FG000|Overall Study|Adverse Event|0|||
145261282|NCT00286234|523802215|FG001|Overall Study|Adverse Event|0|||
145261283|NCT00286234|523802216|FG002|Overall Study|Adverse Event|0|||
145261284|NCT00286234|523802217|FG003|Overall Study|Adverse Event|1|||
145261285|NCT00286234|523802214|FG000|Overall Study|Adverse Event|0|||
145261286|NCT00286234|523802215|FG001|Overall Study|Adverse Event|0|||
145568704|NCT00654381|524942277|FG004|1st Stage|Withdrawal by Subject|0|||
145261287|NCT00286234|523802216|FG002|Overall Study|Adverse Event|0|||
145261288|NCT00286234|523802217|FG003|Overall Study|Adverse Event|1|||
145261289|NCT00302731|523802231|FG000|Overall Study|Lost to Follow-up|1|||
145568705|NCT00654381|524942278|FG005|1st Stage|Withdrawal by Subject|1|||
145568706|NCT00654381|524942273|FG000|1st Stage|Investigator's decision|0|||
145568707|NCT00654381|524942274|FG001|1st Stage|Investigator's decision|0|||
145568708|NCT00654381|524942275|FG002|1st Stage|Investigator's decision|0|||
145568709|NCT00654381|524942276|FG003|1st Stage|Investigator's decision|1|||
145568710|NCT00654381|524942277|FG004|1st Stage|Investigator's decision|0|||
145261290|NCT00302731|523802232|FG001|Overall Study|Lost to Follow-up|2|||
145261291|NCT00302731|523802233|FG002|Overall Study|Lost to Follow-up|0|||
145261292|NCT00302731|523802234|FG003|Overall Study|Lost to Follow-up|0|||
145261293|NCT00302731|523802231|FG000|Overall Study|Adverse Event|0|||
145261294|NCT00302731|523802232|FG001|Overall Study|Adverse Event|2|||
145261295|NCT00302731|523802233|FG002|Overall Study|Adverse Event|2|||
145261296|NCT00302731|523802234|FG003|Overall Study|Adverse Event|0|||
145261297|NCT00302731|523802231|FG000|Overall Study|Withdrawal by Subject|1|||
145261298|NCT00302731|523802232|FG001|Overall Study|Withdrawal by Subject|1|||
145261299|NCT00302731|523802233|FG002|Overall Study|Withdrawal by Subject|0|||
145261300|NCT00302731|523802234|FG003|Overall Study|Withdrawal by Subject|0|||
145261301|NCT00302731|523802231|FG000|Overall Study|Protocol Violation|1|||
145261302|NCT00302731|523802232|FG001|Overall Study|Protocol Violation|0|||
145261303|NCT00302731|523802233|FG002|Overall Study|Protocol Violation|0|||
145261304|NCT00302731|523802234|FG003|Overall Study|Protocol Violation|0|||
145261305|NCT00302731|523802231|FG000|Overall Study|cancer unrelated to study discovered|1|||
145261306|NCT00302731|523802232|FG001|Overall Study|cancer unrelated to study discovered|0|||
145261307|NCT00302731|523802233|FG002|Overall Study|cancer unrelated to study discovered|1|||
145261308|NCT00302731|523802234|FG003|Overall Study|cancer unrelated to study discovered|0|||
145261309|NCT01610752|523802237|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
145261310|NCT01610752|523802238|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
145261311|NCT01610752|523802239|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
145261312|NCT00283062|523802243|FG000|Overall Study|Did not receive any study medication|5|||
145261313|NCT00283062|523802244|FG001|Overall Study|Did not receive any study medication|4|||
145261314|NCT00283062|523802245|FG002|Overall Study|Did not receive any study medication|36|||
145261315|NCT00283062|523802246|FG003|Overall Study|Did not receive any study medication|45|||
145261316|NCT00283062|523802243|FG000|Overall Study|Adverse Event|2|||
145261317|NCT00283062|523802244|FG001|Overall Study|Adverse Event|0|||
145261318|NCT00283062|523802245|FG002|Overall Study|Adverse Event|1|||
145261319|NCT00283062|523802246|FG003|Overall Study|Adverse Event|0|||
145261320|NCT00283062|523802243|FG000|Overall Study|Lost to Follow-up|1|||
145261321|NCT00283062|523802244|FG001|Overall Study|Lost to Follow-up|0|||
145261322|NCT00283062|523802245|FG002|Overall Study|Lost to Follow-up|1|||
145261323|NCT00283062|523802246|FG003|Overall Study|Lost to Follow-up|0|||
145261324|NCT00283062|523802243|FG000|Overall Study|Progressive disease|0|||
145261325|NCT00283062|523802244|FG001|Overall Study|Progressive disease|0|||
145261326|NCT00283062|523802245|FG002|Overall Study|Progressive disease|1|||
145261327|NCT00283062|523802246|FG003|Overall Study|Progressive disease|0|||
145261328|NCT00283062|523802243|FG000|Overall Study|Participant did not wish to continue|3|||
145261329|NCT00283062|523802244|FG001|Overall Study|Participant did not wish to continue|2|||
145261330|NCT00283062|523802245|FG002|Overall Study|Participant did not wish to continue|1|||
145261331|NCT00283062|523802246|FG003|Overall Study|Participant did not wish to continue|0|||
145261332|NCT00283062|523802243|FG000|Overall Study|Undefined|0|||
145261333|NCT00283062|523802244|FG001|Overall Study|Undefined|1|||
145261334|NCT00283062|523802245|FG002|Overall Study|Undefined|1|||
145261335|NCT00283062|523802246|FG003|Overall Study|Undefined|4|||
145261336|NCT00283062|523802243|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
145568711|NCT00654381|524942278|FG005|1st Stage|Investigator's decision|0|||
145261337|NCT00283062|523802244|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
145261338|NCT00283062|523802245|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
145261339|NCT00283062|523802246|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
145261340|NCT00252499|523802247|FG000|Overall Study|Lost to Follow-up|1|||
145261341|NCT00252499|523802248|FG001|Overall Study|Lost to Follow-up|0|||
145261342|NCT00252499|523802249|FG002|Overall Study|Lost to Follow-up|0|||
145261343|NCT03137173|523802250|FG000|Overall Study|Withdrawal by Subject|8|||
145261344|NCT03137173|523802251|FG001|Overall Study|Withdrawal by Subject|13|||
145261345|NCT03137173|523802250|FG000|Overall Study|Death|1|||
145261346|NCT03137173|523802251|FG001|Overall Study|Death|3|||
145261347|NCT03137173|523802250|FG000|Overall Study|Physician Decision|1|||
145261348|NCT03137173|523802251|FG001|Overall Study|Physician Decision|0|||
145261349|NCT03137173|523802250|FG000|Overall Study|Lost to Follow-up|13|||
145261350|NCT03137173|523802251|FG001|Overall Study|Lost to Follow-up|18|||
145261351|NCT03137173|523802250|FG000|Overall Study|Other reasons|3|||
145261352|NCT03137173|523802251|FG001|Overall Study|Other reasons|2|||
145261353|NCT01535638|523802252|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
145261354|NCT01535638|523802253|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
145261355|NCT01535638|523802254|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
145261356|NCT01535638|523802255|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
145261357|NCT01535638|523802256|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
145568712|NCT00654381|524942273|FG000|2nd Stage|Adverse Event|2|||
145568713|NCT00654381|524942274|FG001|2nd Stage|Adverse Event|0|||
145261358|NCT01535638|523802257|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
145261359|NCT01535638|523802252|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
145261360|NCT01535638|523802253|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
145261361|NCT01535638|523802254|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
145261362|NCT01535638|523802255|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
145261363|NCT01535638|523802256|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
145261364|NCT01535638|523802257|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
145261365|NCT01365468|523802258|FG000|Overall Study|Physician Decision|1|||
145261366|NCT01365468|523802259|FG001|Overall Study|Physician Decision|0|||
145261367|NCT01365468|523802258|FG000|Overall Study|Disease progression|1|||
145261368|NCT01365468|523802259|FG001|Overall Study|Disease progression|0|||
145261369|NCT01365468|523802258|FG000|Overall Study|Lost to Follow-up|2|||
145261370|NCT01365468|523802259|FG001|Overall Study|Lost to Follow-up|0|||
145261371|NCT01482598|523802260|FG000|Overall Study|Death|7|||
145261372|NCT01482598|523802261|FG001|Overall Study|Death|10|||
145261373|NCT01482598|523802260|FG000|Overall Study|Physician Decision|0|||
145261374|NCT01482598|523802261|FG001|Overall Study|Physician Decision|3|||
145261375|NCT01482598|523802260|FG000|Overall Study|Withdrawal by Subject|4|||
145261376|NCT01482598|523802261|FG001|Overall Study|Withdrawal by Subject|5|||
145261377|NCT01482598|523802260|FG000|Overall Study|Lost to Follow-up|5|||
145261378|NCT01482598|523802261|FG001|Overall Study|Lost to Follow-up|4|||
145261379|NCT00423267|523802262|FG000|Period A|Withdrawal by Subject|0|||
145261380|NCT00423267|523802263|FG001|Period A|Withdrawal by Subject|1|||
145261381|NCT00423267|523802262|FG000|Period A|Non-compliance with protocol|1|||
145261382|NCT00423267|523802263|FG001|Period A|Non-compliance with protocol|0|||
145261383|NCT00423267|523802262|FG000|Period A|Administrative|1|||
145261384|NCT00423267|523802263|FG001|Period A|Administrative|0|||
145261385|NCT00827112|523802264|FG000|Overall Study|Adverse Event|2|||
145261386|NCT00827112|523802265|FG001|Overall Study|Adverse Event|0|||
145261387|NCT00827112|523802264|FG000|Overall Study|Lack of Efficacy|2|||
145261388|NCT00827112|523802265|FG001|Overall Study|Lack of Efficacy|0|||
145261389|NCT00827112|523802264|FG000|Overall Study|Lost to Follow-up|3|||
145261390|NCT00827112|523802265|FG001|Overall Study|Lost to Follow-up|2|||
145261391|NCT00827112|523802264|FG000|Overall Study|Pregnancy|0|||
145261392|NCT00827112|523802265|FG001|Overall Study|Pregnancy|1|||
145261393|NCT00827112|523802264|FG000|Overall Study|Protocol Violation|0|||
145261394|NCT00827112|523802265|FG001|Overall Study|Protocol Violation|2|||
145261395|NCT00827112|523802264|FG000|Overall Study|Withdrawal by Subject|2|||
145261396|NCT00827112|523802265|FG001|Overall Study|Withdrawal by Subject|1|||
145261397|NCT00827112|523802264|FG000|Overall Study|Randomized but not treated|5|||
145261398|NCT00827112|523802265|FG001|Overall Study|Randomized but not treated|3|||
145261399|NCT00827112|523802264|FG000|Overall Study|Other|1|||
145261400|NCT00827112|523802265|FG001|Overall Study|Other|3|||
145261401|NCT00689728|523802268|FG000|Double-Blind Treatment|Adverse Event|1|||
145261402|NCT00689728|523802269|FG001|Double-Blind Treatment|Adverse Event|0|||
145261403|NCT00689728|523802270|FG002|Double-Blind Treatment|Adverse Event|0|||
145261404|NCT00689728|523802268|FG000|Double-Blind Treatment|Protocol Violation|0|||
145261405|NCT00689728|523802269|FG001|Double-Blind Treatment|Protocol Violation|0|||
145261406|NCT00689728|523802270|FG002|Double-Blind Treatment|Protocol Violation|1|||
145261407|NCT00689728|523802268|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
145261408|NCT00689728|523802269|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
145261409|NCT00689728|523802270|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
145261410|NCT00689728|523802268|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
145261411|NCT00689728|523802269|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
145261412|NCT00689728|523802270|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
145261413|NCT00689728|523802268|FG000|Rescue|Adverse Event|0|||
145261414|NCT00689728|523802269|FG001|Rescue|Adverse Event|1|||
145261415|NCT00689728|523802270|FG002|Rescue|Adverse Event|0|||
145301542|NCT01796171|523956542|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301543|NCT01796171|523956543|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301544|NCT01796171|523956544|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301545|NCT01796171|523956545|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145301546|NCT01796171|523956546|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
145261416|NCT00689728|523802268|FG000|Rescue|Withdrawal by Subject|1|||
145261417|NCT00689728|523802269|FG001|Rescue|Withdrawal by Subject|1|||
145261418|NCT00689728|523802270|FG002|Rescue|Withdrawal by Subject|1|||
145261419|NCT00689728|523802268|FG000|Optional Follow-Up|Adverse Event|1|||
145261420|NCT00689728|523802269|FG001|Optional Follow-Up|Adverse Event|0|||
145301547|NCT01796171|523956547|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
145301548|NCT01796171|523956548|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145261421|NCT00689728|523802270|FG002|Optional Follow-Up|Adverse Event|0|||
145261422|NCT00689728|523802268|FG000|Optional Follow-Up|Lack of Efficacy|0|||
145261423|NCT00689728|523802269|FG001|Optional Follow-Up|Lack of Efficacy|1|||
145261424|NCT00689728|523802270|FG002|Optional Follow-Up|Lack of Efficacy|1|||
145261425|NCT00689728|523802268|FG000|Optional Follow-Up|Lost to Follow-up|0|||
145261426|NCT00689728|523802269|FG001|Optional Follow-Up|Lost to Follow-up|1|||
145261427|NCT00689728|523802270|FG002|Optional Follow-Up|Lost to Follow-up|1|||
145261428|NCT00689728|523802268|FG000|Optional Follow-Up|Protocol Violation|0|||
145568714|NCT00654381|524942275|FG002|2nd Stage|Adverse Event|2|||
145568715|NCT00654381|524942276|FG003|2nd Stage|Adverse Event|3|||
145568716|NCT00654381|524942277|FG004|2nd Stage|Adverse Event|7|||
145568717|NCT00654381|524942278|FG005|2nd Stage|Adverse Event|2|||
145568718|NCT00654381|524942273|FG000|2nd Stage|Withdrawal by Subject|0|||
145568719|NCT00654381|524942274|FG001|2nd Stage|Withdrawal by Subject|0|||
145261429|NCT00689728|523802269|FG001|Optional Follow-Up|Protocol Violation|0|||
145261430|NCT00689728|523802270|FG002|Optional Follow-Up|Protocol Violation|1|||
145261431|NCT00689728|523802268|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
145261432|NCT00689728|523802269|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
145261433|NCT00689728|523802270|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
145261434|NCT01846039|523803638|FG000|Overall Study|Protocol Violation|1|||
145261435|NCT01846039|523803638|FG000|Overall Study|Subject Withdrew Consent|1|||
145261436|NCT01855607|523803649|FG000|Overall Study|Withdrawal by Subject|1|||
145261437|NCT01855607|523803649|FG000|Overall Study|Study was terminated|11|||
145261438|NCT02181634|523803650|FG000|Overall Study|Lack of Efficacy|33|||
145261439|NCT02181634|523803650|FG000|Overall Study|Adverse Event|17|||
145261440|NCT02181634|523803650|FG000|Overall Study|Physician Decision|8|||
145261441|NCT02181634|523803650|FG000|Overall Study|Withdrawal by Subject|5|||
145261442|NCT02181634|523803650|FG000|Overall Study|Death|2|||
145261443|NCT02181634|523803650|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
145261444|NCT02181634|523803650|FG000|Overall Study|Ineligible|1|||
145261445|NCT02181634|523803650|FG000|Overall Study|Max number of dose reduction|1|||
145261446|NCT02181634|523803650|FG000|Overall Study|Symptomatic progression|1|||
145261447|NCT02181634|523803650|FG000|Overall Study|Patient opted to proceed to surgery|1|||
145261448|NCT02528331|523803651|FG000|Overall Study|Withdrawal by Subject|2|||
145301549|NCT01796171|523956549|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145261449|NCT02392078|523803652|FG000|Overall Study|Did not have procedure|32|||
145261450|NCT02392078|523803653|FG001|Overall Study|Did not have procedure|43|||
145261451|NCT02392078|523803654|FG002|Overall Study|Did not have procedure|20|||
145261452|NCT02392078|523803655|FG003|Overall Study|Did not have procedure|1|||
145261453|NCT00635804|523803662|FG000|Overall Study|Adverse Event|0|||
145261454|NCT00635804|523803663|FG001|Overall Study|Adverse Event|0|||
145261455|NCT00635804|523803664|FG002|Overall Study|Adverse Event|0|||
145261456|NCT00635804|523803665|FG003|Overall Study|Adverse Event|0|||
145261457|NCT00635804|523803666|FG004|Overall Study|Adverse Event|0|||
145261458|NCT00635804|523803667|FG005|Overall Study|Adverse Event|1|||
145261459|NCT00635804|523803668|FG006|Overall Study|Adverse Event|0|||
145261460|NCT00635804|523803669|FG007|Overall Study|Adverse Event|0|||
145261461|NCT00635804|523803662|FG000|Overall Study|Withdrawal by Subject|1|||
145261462|NCT00635804|523803663|FG001|Overall Study|Withdrawal by Subject|0|||
145261463|NCT00635804|523803664|FG002|Overall Study|Withdrawal by Subject|0|||
145261464|NCT00635804|523803665|FG003|Overall Study|Withdrawal by Subject|0|||
145261465|NCT00635804|523803666|FG004|Overall Study|Withdrawal by Subject|0|||
145261466|NCT00635804|523803667|FG005|Overall Study|Withdrawal by Subject|0|||
145261467|NCT00635804|523803668|FG006|Overall Study|Withdrawal by Subject|0|||
145261468|NCT00635804|523803669|FG007|Overall Study|Withdrawal by Subject|0|||
145261469|NCT02452320|523803679|FG000|Overall Study|Adverse Event|0|||
145261470|NCT02452320|523803680|FG001|Overall Study|Adverse Event|1|||
145261471|NCT03382639|523803681|FG000|Overall Study|Adverse Event|2|||
145261472|NCT03382639|523803682|FG001|Overall Study|Adverse Event|0|||
145261473|NCT03382639|523803683|FG002|Overall Study|Adverse Event|1|||
145261474|NCT03382639|523803684|FG003|Overall Study|Adverse Event|1|||
145261475|NCT03382639|523803681|FG000|Overall Study|Lost to Follow-up|1|||
145261476|NCT03382639|523803682|FG001|Overall Study|Lost to Follow-up|0|||
145261477|NCT03382639|523803683|FG002|Overall Study|Lost to Follow-up|0|||
145261478|NCT03382639|523803684|FG003|Overall Study|Lost to Follow-up|0|||
145261479|NCT03382639|523803681|FG000|Overall Study|Withdrawal by Subject|4|||
145301550|NCT01796171|523956550|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
145568720|NCT00654381|524942275|FG002|2nd Stage|Withdrawal by Subject|0|||
145568721|NCT00654381|524942276|FG003|2nd Stage|Withdrawal by Subject|0|||
145568722|NCT00654381|524942277|FG004|2nd Stage|Withdrawal by Subject|1|||
145568723|NCT00654381|524942278|FG005|2nd Stage|Withdrawal by Subject|1|||
145261480|NCT03382639|523803682|FG001|Overall Study|Withdrawal by Subject|3|||
145261481|NCT03382639|523803683|FG002|Overall Study|Withdrawal by Subject|2|||
145261482|NCT03382639|523803684|FG003|Overall Study|Withdrawal by Subject|3|||
145301551|NCT01796171|523956536|FG000|Follow-up Period|Start of further anticancer therapy|4|||
145568724|NCT00654381|524942273|FG000|2nd Stage|Investigator's decision|0|||
145568725|NCT00654381|524942274|FG001|2nd Stage|Investigator's decision|0|||
145261483|NCT03382639|523803681|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
145261484|NCT03382639|523803682|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
145261485|NCT03382639|523803683|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
145261486|NCT03382639|523803684|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
145261487|NCT03382639|523803681|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
145261488|NCT03382639|523803682|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
145261489|NCT03382639|523803683|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
145568726|NCT00654381|524942275|FG002|2nd Stage|Investigator's decision|1|||
145301552|NCT01796171|523956537|FG001|Follow-up Period|Start of further anticancer therapy|25|||
145301553|NCT01796171|523956538|FG002|Follow-up Period|Start of further anticancer therapy|2|||
145301554|NCT01796171|523956539|FG003|Follow-up Period|Start of further anticancer therapy|1|||
145301555|NCT01796171|523956540|FG004|Follow-up Period|Start of further anticancer therapy|2|||
145301556|NCT01796171|523956541|FG005|Follow-up Period|Start of further anticancer therapy|2|||
145301557|NCT01796171|523956542|FG006|Follow-up Period|Start of further anticancer therapy|1|||
145301558|NCT01796171|523956543|FG007|Follow-up Period|Start of further anticancer therapy|15|||
145301559|NCT01796171|523956544|FG008|Follow-up Period|Start of further anticancer therapy|2|||
145301560|NCT01796171|523956545|FG009|Follow-up Period|Start of further anticancer therapy|0|||
145301561|NCT01796171|523956546|FG010|Follow-up Period|Start of further anticancer therapy|0|||
145301562|NCT01796171|523956547|FG011|Follow-up Period|Start of further anticancer therapy|0|||
145301563|NCT01796171|523956548|FG012|Follow-up Period|Start of further anticancer therapy|0|||
145301564|NCT01796171|523956549|FG013|Follow-up Period|Start of further anticancer therapy|0|||
145301565|NCT01796171|523956550|FG014|Follow-up Period|Start of further anticancer therapy|0|||
145301566|NCT01796171|523956536|FG000|Follow-up Period|Progressive disease|0|||
145301567|NCT01796171|523956537|FG001|Follow-up Period|Progressive disease|1|||
145301568|NCT01796171|523956538|FG002|Follow-up Period|Progressive disease|0|||
145301569|NCT01796171|523956539|FG003|Follow-up Period|Progressive disease|0|||
145301570|NCT01796171|523956540|FG004|Follow-up Period|Progressive disease|0|||
145261490|NCT03382639|523803684|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
145261491|NCT03382639|523803681|FG000|Overall Study|Other|2|||
145261492|NCT03382639|523803682|FG001|Overall Study|Other|0|||
145261493|NCT03382639|523803683|FG002|Overall Study|Other|0|||
145261494|NCT03382639|523803684|FG003|Overall Study|Other|3|||
145261495|NCT00310440|523803687|FG000|Overall Study|Lost to Follow-up|17|||
145261496|NCT00310440|523803688|FG001|Overall Study|Lost to Follow-up|8|||
145261497|NCT00310440|523803687|FG000|Overall Study|Withdrawal by Subject|2|||
145261498|NCT00310440|523803688|FG001|Overall Study|Withdrawal by Subject|1|||
145261499|NCT00310440|523803687|FG000|Overall Study|Missed 12 Month Visit|7|||
145261500|NCT00310440|523803688|FG001|Overall Study|Missed 12 Month Visit|4|||
145261501|NCT01287403|523803689|FG000|1st Intervention (1 Day)|Adverse Event|1|||
145261502|NCT00148109|523803690|FG000|Overall Study|Lack of Efficacy|10|||
145261503|NCT00148109|523803691|FG001|Overall Study|Lack of Efficacy|18|||
145261504|NCT00148109|523803690|FG000|Overall Study|Adverse Event|0|||
145261505|NCT00148109|523803691|FG001|Overall Study|Adverse Event|2|||
145261506|NCT00148109|523803690|FG000|Overall Study|Withdrawal by Subject|2|||
145261507|NCT00148109|523803691|FG001|Overall Study|Withdrawal by Subject|0|||
145261508|NCT01098266|523803692|FG000|Overall Study|Physician Decision|1|||
145261509|NCT01098266|523803693|FG001|Overall Study|Physician Decision|0|||
145261510|NCT01098266|523803692|FG000|Overall Study|Death|3|||
145261511|NCT01098266|523803693|FG001|Overall Study|Death|2|||
145261512|NCT01098266|523803692|FG000|Overall Study|Withdrawal by Subject|3|||
145261513|NCT01098266|523803693|FG001|Overall Study|Withdrawal by Subject|5|||
145261514|NCT00438815|523803694|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
145261515|NCT00438815|523803694|FG000|Overall Study|3-month follow-up no longer required|12|||
145261516|NCT00438815|523803694|FG000|Overall Study|Noncompliance with protocol requirements|9|||
145261517|NCT00438815|523803694|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
145261518|NCT00438815|523803694|FG000|Overall Study|Lost to Follow-up|6|||
145261519|NCT00438815|523803694|FG000|Overall Study|Withdrawal by Subject|6|||
145261520|NCT00438815|523803694|FG000|Overall Study|Death|1|||
145261521|NCT01733758|523803695|FG000|Overall Study|Adverse Event|5|||
145261522|NCT01733758|523803696|FG001|Overall Study|Adverse Event|7|||
145261523|NCT01733758|523803697|FG002|Overall Study|Adverse Event|8|||
145261524|NCT01733758|523803698|FG003|Overall Study|Adverse Event|1|||
145261525|NCT01733758|523803695|FG000|Overall Study|Withdrawal by Subject|1|||
145261526|NCT01733758|523803696|FG001|Overall Study|Withdrawal by Subject|1|||
145261527|NCT01733758|523803697|FG002|Overall Study|Withdrawal by Subject|5|||
145261528|NCT01733758|523803698|FG003|Overall Study|Withdrawal by Subject|3|||
145301571|NCT01796171|523956541|FG005|Follow-up Period|Progressive disease|0|||
145301572|NCT01796171|523956542|FG006|Follow-up Period|Progressive disease|0|||
145301573|NCT01796171|523956543|FG007|Follow-up Period|Progressive disease|3|||
145301574|NCT01796171|523956544|FG008|Follow-up Period|Progressive disease|0|||
145301575|NCT01796171|523956545|FG009|Follow-up Period|Progressive disease|0|||
145301576|NCT01796171|523956546|FG010|Follow-up Period|Progressive disease|0|||
145301577|NCT01796171|523956547|FG011|Follow-up Period|Progressive disease|0|||
145301578|NCT01796171|523956548|FG012|Follow-up Period|Progressive disease|0|||
145261529|NCT01733758|523803695|FG000|Overall Study|Persistent Hyperglycemia|3|||
145261530|NCT01733758|523803696|FG001|Overall Study|Persistent Hyperglycemia|2|||
145301579|NCT01796171|523956549|FG013|Follow-up Period|Progressive disease|0|||
145301580|NCT01796171|523956550|FG014|Follow-up Period|Progressive disease|0|||
145261531|NCT01733758|523803697|FG002|Overall Study|Persistent Hyperglycemia|0|||
145261532|NCT01733758|523803698|FG003|Overall Study|Persistent Hyperglycemia|0|||
145261533|NCT01733758|523803695|FG000|Overall Study|Protocol Violation|0|||
145261534|NCT01733758|523803696|FG001|Overall Study|Protocol Violation|1|||
145410857|NCT02903914|524356848|FG003|Overall Study|Refused Further Treatment/Contact|0|||
145410858|NCT02903914|524356849|FG004|Overall Study|Refused Further Treatment/Contact|0|||
145410859|NCT02903914|524356850|FG005|Overall Study|Refused Further Treatment/Contact|0|||
145410860|NCT02903914|524356851|FG006|Overall Study|Refused Further Treatment/Contact|1|||
145261535|NCT01733758|523803697|FG002|Overall Study|Protocol Violation|2|||
145261536|NCT01733758|523803698|FG003|Overall Study|Protocol Violation|2|||
145261537|NCT01733758|523803695|FG000|Overall Study|Non-compliance|1|||
145261538|NCT01733758|523803696|FG001|Overall Study|Non-compliance|0|||
145261539|NCT01733758|523803697|FG002|Overall Study|Non-compliance|0|||
145261540|NCT01733758|523803698|FG003|Overall Study|Non-compliance|0|||
145261541|NCT01733758|523803695|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
145261542|NCT01733758|523803696|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
145261543|NCT01733758|523803697|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
145261544|NCT01733758|523803698|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
145261545|NCT01733758|523803695|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
145261546|NCT01733758|523803696|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
145261547|NCT01733758|523803697|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
145261548|NCT01733758|523803698|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
145261549|NCT02557308|523803701|FG000|Overall Study|Withdrawal by Subject|11|||
145261550|NCT02557308|523803702|FG001|Overall Study|Withdrawal by Subject|3|||
145261551|NCT02557308|523803703|FG002|Overall Study|Withdrawal by Subject|2|||
145261552|NCT02557308|523803704|FG003|Overall Study|Withdrawal by Subject|0|||
145261553|NCT02557308|523803705|FG004|Overall Study|Withdrawal by Subject|1|||
145261554|NCT02557308|523803706|FG005|Overall Study|Withdrawal by Subject|0|||
145261555|NCT02557308|523803707|FG006|Overall Study|Withdrawal by Subject|10|||
145261556|NCT02557308|523803708|FG007|Overall Study|Withdrawal by Subject|1|||
145261557|NCT02557308|523803701|FG000|Overall Study|Disease Progression|0|||
145261558|NCT02557308|523803702|FG001|Overall Study|Disease Progression|1|||
145261559|NCT02557308|523803703|FG002|Overall Study|Disease Progression|0|||
145261560|NCT02557308|523803704|FG003|Overall Study|Disease Progression|0|||
145261561|NCT02557308|523803705|FG004|Overall Study|Disease Progression|0|||
145261562|NCT02557308|523803706|FG005|Overall Study|Disease Progression|0|||
145261563|NCT02557308|523803707|FG006|Overall Study|Disease Progression|0|||
145261564|NCT02557308|523803708|FG007|Overall Study|Disease Progression|0|||
145261565|NCT02557308|523803701|FG000|Overall Study|Lack of Efficacy|3|||
145261566|NCT02557308|523803702|FG001|Overall Study|Lack of Efficacy|0|||
145261567|NCT02557308|523803703|FG002|Overall Study|Lack of Efficacy|0|||
145261568|NCT02557308|523803704|FG003|Overall Study|Lack of Efficacy|0|||
145261569|NCT02557308|523803705|FG004|Overall Study|Lack of Efficacy|0|||
145261570|NCT02557308|523803706|FG005|Overall Study|Lack of Efficacy|0|||
145410861|NCT02903914|524356852|FG007|Overall Study|Refused Further Treatment/Contact|0|||
145261571|NCT02557308|523803707|FG006|Overall Study|Lack of Efficacy|1|||
145261572|NCT02557308|523803708|FG007|Overall Study|Lack of Efficacy|0|||
145261573|NCT02557308|523803701|FG000|Overall Study|Adverse Event|4|||
145261574|NCT02557308|523803702|FG001|Overall Study|Adverse Event|1|||
145261575|NCT02557308|523803703|FG002|Overall Study|Adverse Event|2|||
145261576|NCT02557308|523803704|FG003|Overall Study|Adverse Event|0|||
145261577|NCT02557308|523803705|FG004|Overall Study|Adverse Event|0|||
145261578|NCT02557308|523803706|FG005|Overall Study|Adverse Event|0|||
145261579|NCT02557308|523803707|FG006|Overall Study|Adverse Event|4|||
145261580|NCT02557308|523803708|FG007|Overall Study|Adverse Event|1|||
145261581|NCT02557308|523803701|FG000|Overall Study|Lost to Follow-up|2|||
145261582|NCT02557308|523803702|FG001|Overall Study|Lost to Follow-up|0|||
145261583|NCT02557308|523803703|FG002|Overall Study|Lost to Follow-up|1|||
145261584|NCT02557308|523803704|FG003|Overall Study|Lost to Follow-up|0|||
145261585|NCT02557308|523803705|FG004|Overall Study|Lost to Follow-up|0|||
145261586|NCT02557308|523803706|FG005|Overall Study|Lost to Follow-up|0|||
145261587|NCT02557308|523803707|FG006|Overall Study|Lost to Follow-up|2|||
145261588|NCT02557308|523803708|FG007|Overall Study|Lost to Follow-up|0|||
145261589|NCT02557308|523803701|FG000|Overall Study|Death|1|||
145261590|NCT02557308|523803702|FG001|Overall Study|Death|0|||
145410862|NCT02903914|524356845|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145410863|NCT02903914|524356846|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145410864|NCT02903914|524356847|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145261591|NCT02557308|523803703|FG002|Overall Study|Death|0|||
145410865|NCT02903914|524356848|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145261592|NCT02557308|523803704|FG003|Overall Study|Death|0|||
145261593|NCT02557308|523803705|FG004|Overall Study|Death|0|||
145261594|NCT02557308|523803706|FG005|Overall Study|Death|0|||
145261595|NCT02557308|523803707|FG006|Overall Study|Death|0|||
145261596|NCT02557308|523803708|FG007|Overall Study|Death|0|||
145410866|NCT02903914|524356849|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145261597|NCT02557308|523803701|FG000|Overall Study|Study Close|98|||
145261598|NCT02557308|523803702|FG001|Overall Study|Study Close|18|||
145261599|NCT02557308|523803703|FG002|Overall Study|Study Close|5|||
145261600|NCT02557308|523803704|FG003|Overall Study|Study Close|3|||
145261601|NCT02557308|523803705|FG004|Overall Study|Study Close|1|||
145261602|NCT02557308|523803706|FG005|Overall Study|Study Close|0|||
145261603|NCT02557308|523803707|FG006|Overall Study|Study Close|123|||
145261604|NCT02557308|523803708|FG007|Overall Study|Study Close|5|||
145261605|NCT02557308|523803701|FG000|Overall Study|Except for study close|5|||
145261606|NCT02557308|523803702|FG001|Overall Study|Except for study close|0|||
145261607|NCT02557308|523803703|FG002|Overall Study|Except for study close|0|||
145261608|NCT02557308|523803704|FG003|Overall Study|Except for study close|0|||
145261609|NCT02557308|523803705|FG004|Overall Study|Except for study close|3|||
145261610|NCT02557308|523803706|FG005|Overall Study|Except for study close|0|||
145261611|NCT02557308|523803707|FG006|Overall Study|Except for study close|6|||
145261612|NCT02557308|523803708|FG007|Overall Study|Except for study close|10|||
145261613|NCT03911401|523803711|FG000|Overall Study|Adverse Event|1|||
145261614|NCT03911401|523803712|FG001|Overall Study|Adverse Event|2|||
145261615|NCT03911401|523803713|FG002|Overall Study|Adverse Event|5|||
145261616|NCT03911401|523803711|FG000|Overall Study|Lack of Efficacy|1|||
145261617|NCT03911401|523803712|FG001|Overall Study|Lack of Efficacy|1|||
145261618|NCT03911401|523803713|FG002|Overall Study|Lack of Efficacy|8|||
145261619|NCT03911401|523803711|FG000|Overall Study|Physician Decision|0|||
145261620|NCT03911401|523803712|FG001|Overall Study|Physician Decision|0|||
145261621|NCT03911401|523803713|FG002|Overall Study|Physician Decision|1|||
145261622|NCT03911401|523803711|FG000|Overall Study|Withdrawal by Subject|1|||
145261623|NCT03911401|523803712|FG001|Overall Study|Withdrawal by Subject|2|||
145261624|NCT03911401|523803713|FG002|Overall Study|Withdrawal by Subject|0|||
145261625|NCT03911401|523803711|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145261626|NCT03911401|523803712|FG001|Overall Study|Withdrawal by parent/guardian|4|||
145261627|NCT03911401|523803713|FG002|Overall Study|Withdrawal by parent/guardian|11|||
145261628|NCT06104423|523803716|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
145261629|NCT06104423|523803717|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
145261630|NCT06104423|523803718|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
145261631|NCT06104423|523803716|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
145261632|NCT06104423|523803717|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
145261633|NCT06104423|523803718|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
145261634|NCT02918968|523803719|FG000|1st Line AAT|Progressive disease|9|||
145261635|NCT02918968|523803720|FG001|1st Line AAT|Progressive disease|4|||
145261636|NCT02918968|523803719|FG000|1st Line AAT|Adverse Event|12|||
145261637|NCT02918968|523803720|FG001|1st Line AAT|Adverse Event|3|||
145261638|NCT02918968|523803719|FG000|1st Line AAT|Physician Decision|4|||
145261639|NCT02918968|523803720|FG001|1st Line AAT|Physician Decision|2|||
145261640|NCT02918968|523803719|FG000|1st Line AAT|Withdrawal by Subject|2|||
145261641|NCT02918968|523803720|FG001|1st Line AAT|Withdrawal by Subject|1|||
145261642|NCT02918968|523803719|FG000|1st Line AAT|Lost to Follow-up|0|||
145261643|NCT02918968|523803720|FG001|1st Line AAT|Lost to Follow-up|1|||
145261644|NCT02918968|523803719|FG000|1st Line AAT|Death|1|||
145261645|NCT02918968|523803720|FG001|1st Line AAT|Death|0|||
145261646|NCT02918968|523803719|FG000|1st Line AAT|Miscellaneous|1|||
145261647|NCT02918968|523803720|FG001|1st Line AAT|Miscellaneous|0|||
145261648|NCT02918968|523803719|FG000|2nd Line AAT|Progressive disease|21|||
145261649|NCT02918968|523803720|FG001|2nd Line AAT|Progressive disease|3|||
145261650|NCT02918968|523803719|FG000|2nd Line AAT|Adverse Event|2|||
145261651|NCT02918968|523803720|FG001|2nd Line AAT|Adverse Event|5|||
145261652|NCT02918968|523803719|FG000|2nd Line AAT|Physician Decision|0|||
145261653|NCT02918968|523803720|FG001|2nd Line AAT|Physician Decision|1|||
145261654|NCT02918968|523803719|FG000|2nd Line AAT|Withdrawal by Subject|2|||
145261655|NCT02918968|523803720|FG001|2nd Line AAT|Withdrawal by Subject|2|||
145261656|NCT02918968|523803719|FG000|2nd Line AAT|Death|0|||
145261657|NCT02918968|523803720|FG001|2nd Line AAT|Death|1|||
145261658|NCT01589185|523803721|FG000|Overall Study|Death|1|||
145261659|NCT01589185|523803722|FG001|Overall Study|Death|2|||
145261660|NCT01589185|523803723|FG002|Overall Study|Death|2|||
145261661|NCT01589185|523803724|FG003|Overall Study|Death|0|||
145261662|NCT01589185|523803725|FG004|Overall Study|Death|1|||
145261663|NCT01589185|523803721|FG000|Overall Study|Lost to Follow-up|1|||
145410867|NCT02903914|524356850|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145410868|NCT02903914|524356851|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
145410869|NCT02903914|524356852|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
145410870|NCT04092777|524356854|FG000|Overall Study|Lost to Follow-up|28|||
145410871|NCT04092777|524356855|FG001|Overall Study|Lost to Follow-up|46|||
145410872|NCT04092777|524356854|FG000|Overall Study|Withdrawal by Subject|8|||
145410873|NCT04092777|524356855|FG001|Overall Study|Withdrawal by Subject|5|||
145410874|NCT04225039|524356862|FG000|Overall Study|Withdrawal by Subject|1|||
145410875|NCT04225039|524356863|FG001|Overall Study|Withdrawal by Subject|0|||
145410876|NCT04225039|524356864|FG002|Overall Study|Withdrawal by Subject|0|||
145410877|NCT04225039|524356865|FG003|Overall Study|Withdrawal by Subject|1|||
145620282|NCT01563978|525123731|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
145261664|NCT01589185|523803722|FG001|Overall Study|Lost to Follow-up|0|||
145261665|NCT01589185|523803723|FG002|Overall Study|Lost to Follow-up|2|||
145261666|NCT01589185|523803724|FG003|Overall Study|Lost to Follow-up|3|||
145261667|NCT01589185|523803725|FG004|Overall Study|Lost to Follow-up|0|||
145261668|NCT00496782|523803731|FG000|Overall Study|Protocol Violation|1|||
145261669|NCT00496782|523803732|FG001|Overall Study|Protocol Violation|2|||
145261670|NCT00760994|523803733|FG000|Overall Study|Lost to Follow-up|4|||
145261671|NCT00760994|523803734|FG001|Overall Study|Lost to Follow-up|4|||
145261672|NCT00760994|523803735|FG002|Overall Study|Lost to Follow-up|3|||
145261673|NCT02431559|523803736|FG000|Overall Study|Adverse Event|0|||
145261674|NCT02431559|523803737|FG001|Overall Study|Adverse Event|1|||
145261675|NCT02431559|523803738|FG002|Overall Study|Adverse Event|0|||
145261676|NCT02431559|523803739|FG003|Overall Study|Adverse Event|4|||
145261677|NCT02431559|523803736|FG000|Overall Study|Progressive disease|2|||
145261678|NCT02431559|523803737|FG001|Overall Study|Progressive disease|1|||
145261679|NCT02431559|523803738|FG002|Overall Study|Progressive disease|4|||
145261680|NCT02431559|523803739|FG003|Overall Study|Progressive disease|22|||
145261681|NCT02431559|523803736|FG000|Overall Study|Withdrawal by Subject|0|||
145261682|NCT02431559|523803737|FG001|Overall Study|Withdrawal by Subject|1|||
145261683|NCT02431559|523803738|FG002|Overall Study|Withdrawal by Subject|0|||
145261684|NCT02431559|523803739|FG003|Overall Study|Withdrawal by Subject|4|||
145261685|NCT02431559|523803736|FG000|Overall Study|Physician Decision|0|||
145261686|NCT02431559|523803737|FG001|Overall Study|Physician Decision|0|||
145261687|NCT02431559|523803738|FG002|Overall Study|Physician Decision|0|||
145261688|NCT02431559|523803739|FG003|Overall Study|Physician Decision|1|||
145261689|NCT00955682|523803742|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
145261690|NCT00955682|523803743|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
145261691|NCT02924129|523803746|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
145261692|NCT02924129|523803747|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
145261693|NCT02924129|523803746|FG000|Overall Study|Withdrawal by Subject|2|||
145261694|NCT02924129|523803747|FG001|Overall Study|Withdrawal by Subject|2|||
145261695|NCT02924129|523803746|FG000|Overall Study|Physician Decision|1|||
145261696|NCT02924129|523803747|FG001|Overall Study|Physician Decision|0|||
145261697|NCT02924129|523803746|FG000|Overall Study|Missed Visit|0|||
145261698|NCT02924129|523803747|FG001|Overall Study|Missed Visit|1|||
145261699|NCT01348828|523803754|FG000|Overall Study|Death|20|||
145261700|NCT01348828|523803754|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
145261701|NCT01348828|523803754|FG000|Overall Study|Conversion|2|||
145261702|NCT01348828|523803754|FG000|Overall Study|missed visit|1|||
145261703|NCT02815670|523803757|FG000|Overall Study|Prematurely discontinued of the trial|1|||
145261704|NCT01002573|523806228|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
145261705|NCT01002573|523806229|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
145261706|NCT00690612|523806235|FG000|Overall Study|Adverse Event|1|||
145261707|NCT00690612|523806235|FG000|Overall Study|Withdrawal by Subject|2|||
145261708|NCT02926833|523806236|FG000|Overall Study|Death|1|||
145261709|NCT02926833|523806237|FG001|Overall Study|Death|1|||
145261710|NCT02926833|523806238|FG002|Overall Study|Death|2|||
145261711|NCT02926833|523806239|FG003|Overall Study|Death|13|||
145261712|NCT02926833|523806236|FG000|Overall Study|Lost to Follow-up|1|||
145261713|NCT02926833|523806237|FG001|Overall Study|Lost to Follow-up|2|||
145261714|NCT02926833|523806238|FG002|Overall Study|Lost to Follow-up|0|||
145261715|NCT02926833|523806239|FG003|Overall Study|Lost to Follow-up|3|||
145261716|NCT02926833|523806236|FG000|Overall Study|Full Consent Withdrawal|0|||
145261717|NCT02926833|523806237|FG001|Overall Study|Full Consent Withdrawal|0|||
145261718|NCT02926833|523806238|FG002|Overall Study|Full Consent Withdrawal|0|||
145261719|NCT02926833|523806239|FG003|Overall Study|Full Consent Withdrawal|2|||
145261720|NCT02926833|523806236|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
145261721|NCT02926833|523806237|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
145261722|NCT02926833|523806238|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
145261723|NCT02926833|523806239|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
145261724|NCT02926833|523806236|FG000|Overall Study|Investigator Decision|0|||
145261725|NCT02926833|523806237|FG001|Overall Study|Investigator Decision|1|||
145261726|NCT02926833|523806238|FG002|Overall Study|Investigator Decision|0|||
145261727|NCT02926833|523806239|FG003|Overall Study|Investigator Decision|0|||
145261728|NCT02926833|523806236|FG000|Overall Study|Adverse Event|0|||
145261729|NCT02926833|523806237|FG001|Overall Study|Adverse Event|0|||
145261730|NCT02926833|523806238|FG002|Overall Study|Adverse Event|1|||
145261731|NCT02926833|523806239|FG003|Overall Study|Adverse Event|0|||
145301581|NCT01796171|523956536|FG000|Follow-up Period|Physician Decision|0|||
145261732|NCT02926833|523806236|FG000|Overall Study|Partial Withdrawal of Consent|0|||
145261733|NCT02926833|523806237|FG001|Overall Study|Partial Withdrawal of Consent|0|||
145261734|NCT02926833|523806238|FG002|Overall Study|Partial Withdrawal of Consent|0|||
145261735|NCT02926833|523806239|FG003|Overall Study|Partial Withdrawal of Consent|1|||
145301582|NCT01796171|523956537|FG001|Follow-up Period|Physician Decision|2|||
145261736|NCT01945866|523806240|FG000|Overall Study|Eyes did not complete or were dropped|2|||
145261737|NCT01945866|523806241|FG001|Overall Study|Eyes did not complete or were dropped|0|||
145261738|NCT02946515|523806246|FG000|Overall Study|Lost to Follow-up|2|||
145261739|NCT02946515|523806247|FG001|Overall Study|Lost to Follow-up|1|||
145261740|NCT03410693|523806248|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
145261741|NCT03410693|523806249|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
145261742|NCT03410693|523806248|FG000|Overall Study|Disc trt: Lost to follow up|0|||
145261743|NCT03410693|523806249|FG001|Overall Study|Disc trt: Lost to follow up|1|||
145261744|NCT03410693|523806248|FG000|Overall Study|Disc trt: radiological progression|58|||
145261745|NCT03410693|523806249|FG001|Overall Study|Disc trt: radiological progression|50|||
145261746|NCT03410693|523806248|FG000|Overall Study|Disc trt: Other|1|||
145261747|NCT03410693|523806249|FG001|Overall Study|Disc trt: Other|0|||
145261748|NCT03410693|523806248|FG000|Overall Study|Study drug never administered|1|||
145261749|NCT03410693|523806249|FG001|Overall Study|Study drug never administered|6|||
145261750|NCT03410693|523806248|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
145261751|NCT03410693|523806249|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
145261752|NCT03410693|523806248|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
145261753|NCT03410693|523806249|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
145261754|NCT03410693|523806248|FG000|Overall Study|Disc trt: Physician decision|0|||
145261755|NCT03410693|523806249|FG001|Overall Study|Disc trt: Physician decision|5|||
145261756|NCT03410693|523806248|FG000|Overall Study|Disc trt: clinical progression|1|||
145261757|NCT03410693|523806249|FG001|Overall Study|Disc trt: clinical progression|5|||
145261758|NCT03410693|523806248|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
145261759|NCT03410693|523806249|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
145261760|NCT01789476|523806250|FG000|Overall Study|Lack of Efficacy|6|||
145261761|NCT01789476|523806251|FG001|Overall Study|Lack of Efficacy|2|||
145261762|NCT01789476|523806250|FG000|Overall Study|Adverse Event|1|||
145261763|NCT01789476|523806251|FG001|Overall Study|Adverse Event|0|||
145261764|NCT01789476|523806250|FG000|Overall Study|Unable to get IV access|1|||
145261765|NCT01789476|523806251|FG001|Overall Study|Unable to get IV access|0|||
145261766|NCT00953576|523806252|FG000|Overall Study|Adverse Event|0|||
145261767|NCT00953576|523806253|FG001|Overall Study|Adverse Event|1|||
145261768|NCT00953576|523806252|FG000|Overall Study|Ineligible after Consent|2|||
145261769|NCT00953576|523806253|FG001|Overall Study|Ineligible after Consent|0|||
145261770|NCT00501969|523806254|FG000|Overall Study|Major Protocol Violation|4|||
145261771|NCT00501969|523806254|FG000|Overall Study|Lack of Efficacy|29|||
145261772|NCT00501969|523806254|FG000|Overall Study|Adverse Event|76|||
145261773|NCT00501969|523806254|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
145261774|NCT00501969|523806254|FG000|Overall Study|Subject withdrew consent|51|||
145261775|NCT00501969|523806254|FG000|Overall Study|Lost to Follow-up|4|||
145261776|NCT00501969|523806254|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
145261777|NCT00501969|523806254|FG000|Overall Study|Other: Sponsors Request|10|||
145620283|NCT01563978|525123730|FG000|Overall Study|Adverse Event|1|||
145261778|NCT00501969|523806254|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
145261779|NCT00501969|523806254|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
145261780|NCT00501969|523806254|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
145261781|NCT00501969|523806254|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
145261782|NCT00501969|523806254|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
145261783|NCT00501969|523806254|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
145261784|NCT00501969|523806254|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
145261785|NCT00501969|523806254|FG000|Overall Study|Other: As Required by Local EC|2|||
145261786|NCT00501969|523806254|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
145261787|NCT00501969|523806254|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
145261788|NCT00665366|523806257|FG000|Overall Study|Lack of Efficacy|11|||
145261789|NCT00665366|523806258|FG001|Overall Study|Lack of Efficacy|10|||
145261790|NCT00665366|523806257|FG000|Overall Study|Adverse Event|25|||
145261791|NCT00665366|523806258|FG001|Overall Study|Adverse Event|23|||
145261792|NCT00665366|523806257|FG000|Overall Study|Withdrawal by Subject|11|||
145261793|NCT00665366|523806258|FG001|Overall Study|Withdrawal by Subject|14|||
145261794|NCT00665366|523806257|FG000|Overall Study|Lost to Follow-up|3|||
145261795|NCT00665366|523806258|FG001|Overall Study|Lost to Follow-up|5|||
145261796|NCT00665366|523806257|FG000|Overall Study|Poor compliance/noncompliance|3|||
145261797|NCT00665366|523806258|FG001|Overall Study|Poor compliance/noncompliance|5|||
145261798|NCT00665366|523806257|FG000|Overall Study|Pregnancy|1|||
145261799|NCT00665366|523806258|FG001|Overall Study|Pregnancy|0|||
145261800|NCT00665366|523806257|FG000|Overall Study|No longer meets study criteria|0|||
145261801|NCT00665366|523806258|FG001|Overall Study|No longer meets study criteria|1|||
145261802|NCT00665366|523806257|FG000|Overall Study|Other reasons|4|||
145261803|NCT00665366|523806258|FG001|Overall Study|Other reasons|1|||
145261804|NCT03039686|523806262|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
145261805|NCT03039686|523806263|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
145261806|NCT03039686|523806264|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
145261807|NCT03039686|523806262|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
145261808|NCT03039686|523806263|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
145261809|NCT03039686|523806264|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
145261810|NCT03039686|523806262|FG000|Double-blind Period|Withdrawal by Subject|2|||
145620284|NCT01563978|525123731|FG001|Overall Study|Adverse Event|2|||
145301583|NCT01796171|523956538|FG002|Follow-up Period|Physician Decision|0|||
145301584|NCT01796171|523956539|FG003|Follow-up Period|Physician Decision|0|||
145301585|NCT01796171|523956540|FG004|Follow-up Period|Physician Decision|0|||
145301586|NCT01796171|523956541|FG005|Follow-up Period|Physician Decision|0|||
145301587|NCT01796171|523956542|FG006|Follow-up Period|Physician Decision|0|||
145301588|NCT01796171|523956543|FG007|Follow-up Period|Physician Decision|0|||
145301589|NCT01796171|523956544|FG008|Follow-up Period|Physician Decision|0|||
145301590|NCT01796171|523956545|FG009|Follow-up Period|Physician Decision|0|||
145301591|NCT01796171|523956546|FG010|Follow-up Period|Physician Decision|5|||
145301592|NCT01796171|523956547|FG011|Follow-up Period|Physician Decision|0|||
145301593|NCT01796171|523956548|FG012|Follow-up Period|Physician Decision|0|||
145301594|NCT01796171|523956549|FG013|Follow-up Period|Physician Decision|0|||
145301595|NCT01796171|523956550|FG014|Follow-up Period|Physician Decision|0|||
145301596|NCT01796171|523956536|FG000|Follow-up Period|Withdrawal by Subject|0|||
145301597|NCT01796171|523956537|FG001|Follow-up Period|Withdrawal by Subject|1|||
145301598|NCT01796171|523956538|FG002|Follow-up Period|Withdrawal by Subject|0|||
145301599|NCT01796171|523956539|FG003|Follow-up Period|Withdrawal by Subject|0|||
145301600|NCT01796171|523956540|FG004|Follow-up Period|Withdrawal by Subject|0|||
145301601|NCT01796171|523956541|FG005|Follow-up Period|Withdrawal by Subject|1|||
145301602|NCT01796171|523956542|FG006|Follow-up Period|Withdrawal by Subject|0|||
145301603|NCT01796171|523956543|FG007|Follow-up Period|Withdrawal by Subject|0|||
145301604|NCT01796171|523956544|FG008|Follow-up Period|Withdrawal by Subject|0|||
145301605|NCT01796171|523956545|FG009|Follow-up Period|Withdrawal by Subject|0|||
145301606|NCT01796171|523956546|FG010|Follow-up Period|Withdrawal by Subject|3|||
145301607|NCT01796171|523956547|FG011|Follow-up Period|Withdrawal by Subject|1|||
145301608|NCT01796171|523956548|FG012|Follow-up Period|Withdrawal by Subject|0|||
145301609|NCT01796171|523956549|FG013|Follow-up Period|Withdrawal by Subject|0|||
145301610|NCT01796171|523956550|FG014|Follow-up Period|Withdrawal by Subject|0|||
145261811|NCT03039686|523806263|FG001|Double-blind Period|Withdrawal by Subject|2|||
145261812|NCT03039686|523806264|FG002|Double-blind Period|Withdrawal by Subject|1|||
145261813|NCT03039686|523806262|FG000|Double-blind Period|Death|0|||
145261814|NCT03039686|523806263|FG001|Double-blind Period|Death|0|||
145261815|NCT03039686|523806264|FG002|Double-blind Period|Death|1|||
145261816|NCT03039686|523806262|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
145261817|NCT03039686|523806263|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
145261818|NCT03039686|523806264|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
145261819|NCT03039686|523806262|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
145261820|NCT03039686|523806263|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
145261821|NCT03039686|523806264|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
145261822|NCT03039686|523806262|FG000|Open Label Period|Withdrawal by Subject|0|||
145261823|NCT03039686|523806263|FG001|Open Label Period|Withdrawal by Subject|3|||
145261824|NCT03039686|523806264|FG002|Open Label Period|Withdrawal by Subject|1|||
145261825|NCT00285857|523806268|FG000|Overall Study|Withdrawal by Subject|2|||
145261826|NCT00285857|523806268|FG000|Overall Study|Inadequate initial breast cytology|1|||
145261827|NCT00285857|523806268|FG000|Overall Study|Adverse Event|1|||
145261828|NCT05602818|523806269|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
145261829|NCT05602818|523806270|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
145261830|NCT05602818|523806271|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
145261831|NCT05602818|523806272|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
145261832|NCT05602818|523806273|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
145261833|NCT05602818|523806274|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
145261834|NCT05602818|523806275|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
145261835|NCT05602818|523806276|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
145261836|NCT05602818|523806277|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
145261837|NCT05602818|523806278|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
145261838|NCT05602818|523806279|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
145261839|NCT05602818|523806280|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
145261840|NCT05602818|523806269|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
145261841|NCT05602818|523806270|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
145261842|NCT05602818|523806271|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261843|NCT05602818|523806272|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261844|NCT05602818|523806273|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145301611|NCT01796171|523956536|FG000|Follow-up Period|Death|0|||
145301612|NCT01796171|523956537|FG001|Follow-up Period|Death|0|||
145301613|NCT01796171|523956538|FG002|Follow-up Period|Death|0|||
145301614|NCT01796171|523956539|FG003|Follow-up Period|Death|0|||
145301615|NCT01796171|523956540|FG004|Follow-up Period|Death|0|||
145301616|NCT01796171|523956541|FG005|Follow-up Period|Death|0|||
145301617|NCT01796171|523956542|FG006|Follow-up Period|Death|1|||
145301618|NCT01796171|523956543|FG007|Follow-up Period|Death|0|||
145301619|NCT01796171|523956544|FG008|Follow-up Period|Death|0|||
145301620|NCT01796171|523956545|FG009|Follow-up Period|Death|0|||
145301621|NCT01796171|523956546|FG010|Follow-up Period|Death|17|||
145301622|NCT01796171|523956547|FG011|Follow-up Period|Death|9|||
145410878|NCT04225039|524356862|FG000|Overall Study|Currently active on study treatment|0|||
145410879|NCT04225039|524356863|FG001|Overall Study|Currently active on study treatment|1|||
145410880|NCT04225039|524356864|FG002|Overall Study|Currently active on study treatment|0|||
145410881|NCT04225039|524356865|FG003|Overall Study|Currently active on study treatment|0|||
145410882|NCT04225039|524356862|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
145410883|NCT04225039|524356863|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145568727|NCT00654381|524942276|FG003|2nd Stage|Investigator's decision|1|||
145568728|NCT00654381|524942277|FG004|2nd Stage|Investigator's decision|0|||
145568729|NCT00654381|524942278|FG005|2nd Stage|Investigator's decision|0|||
145568730|NCT00654381|524942273|FG000|Extension Stage|Adverse Event|1|||
145568731|NCT00654381|524942274|FG001|Extension Stage|Adverse Event|2|||
145261845|NCT05602818|523806274|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261846|NCT05602818|523806275|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261847|NCT05602818|523806276|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261848|NCT05602818|523806277|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261849|NCT05602818|523806278|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261850|NCT05602818|523806279|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261851|NCT05602818|523806280|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
145261852|NCT05602818|523806269|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
145261853|NCT05602818|523806270|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261854|NCT05602818|523806271|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261855|NCT05602818|523806272|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261856|NCT05602818|523806273|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261857|NCT05602818|523806274|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261858|NCT05602818|523806275|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261859|NCT05602818|523806276|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261860|NCT05602818|523806277|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261861|NCT05602818|523806278|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261862|NCT05602818|523806279|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261863|NCT05602818|523806280|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
145261864|NCT05602818|523806269|FG000|Qualification Phase (3 Days)|Other|1|||
145261865|NCT05602818|523806270|FG001|Qualification Phase (3 Days)|Other|0|||
145261866|NCT05602818|523806271|FG002|Qualification Phase (3 Days)|Other|0|||
145261867|NCT05602818|523806272|FG003|Qualification Phase (3 Days)|Other|0|||
145261868|NCT05602818|523806273|FG004|Qualification Phase (3 Days)|Other|0|||
145261869|NCT05602818|523806274|FG005|Qualification Phase (3 Days)|Other|0|||
145261870|NCT05602818|523806275|FG006|Qualification Phase (3 Days)|Other|0|||
145261871|NCT05602818|523806276|FG007|Qualification Phase (3 Days)|Other|0|||
145261872|NCT05602818|523806277|FG008|Qualification Phase (3 Days)|Other|0|||
145261873|NCT05602818|523806278|FG009|Qualification Phase (3 Days)|Other|0|||
145261874|NCT05602818|523806279|FG010|Qualification Phase (3 Days)|Other|0|||
145261875|NCT05602818|523806280|FG011|Qualification Phase (3 Days)|Other|0|||
145261876|NCT05602818|523806269|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261877|NCT05602818|523806270|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
145261878|NCT05602818|523806271|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261879|NCT05602818|523806272|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261880|NCT05602818|523806273|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261881|NCT05602818|523806274|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261882|NCT05602818|523806275|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261883|NCT05602818|523806276|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261884|NCT05602818|523806277|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261885|NCT05602818|523806278|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261886|NCT05602818|523806279|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261887|NCT05602818|523806280|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
145261888|NCT05602818|523806269|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
145261889|NCT05602818|523806270|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
145261890|NCT05602818|523806271|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
145261891|NCT05602818|523806272|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
145261892|NCT05602818|523806273|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
145261893|NCT05602818|523806274|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
145261894|NCT05602818|523806275|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
145261895|NCT05602818|523806276|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
145261896|NCT05602818|523806277|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
145410884|NCT04225039|524356864|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145568732|NCT00654381|524942275|FG002|Extension Stage|Adverse Event|9|||
145568733|NCT00654381|524942276|FG003|Extension Stage|Adverse Event|7|||
145568734|NCT00654381|524942277|FG004|Extension Stage|Adverse Event|1|||
145301623|NCT01796171|523956548|FG012|Follow-up Period|Death|1|||
145301624|NCT01796171|523956549|FG013|Follow-up Period|Death|0|||
145301625|NCT01796171|523956550|FG014|Follow-up Period|Death|0|||
145301626|NCT01796171|523956536|FG000|Follow-up Period|Patient transferred to other hospital|0|||
145301627|NCT01796171|523956537|FG001|Follow-up Period|Patient transferred to other hospital|1|||
145301628|NCT01796171|523956538|FG002|Follow-up Period|Patient transferred to other hospital|0|||
145301629|NCT01796171|523956539|FG003|Follow-up Period|Patient transferred to other hospital|0|||
145301630|NCT01796171|523956540|FG004|Follow-up Period|Patient transferred to other hospital|0|||
145301631|NCT01796171|523956541|FG005|Follow-up Period|Patient transferred to other hospital|0|||
145301632|NCT01796171|523956542|FG006|Follow-up Period|Patient transferred to other hospital|0|||
145301633|NCT01796171|523956543|FG007|Follow-up Period|Patient transferred to other hospital|0|||
145410885|NCT04225039|524356865|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
145410886|NCT04225039|524356862|FG000|Overall Study|Ineligible for treatment|0|||
145410887|NCT04225039|524356863|FG001|Overall Study|Ineligible for treatment|0|||
145410888|NCT04225039|524356864|FG002|Overall Study|Ineligible for treatment|0|||
145410889|NCT04225039|524356865|FG003|Overall Study|Ineligible for treatment|4|||
145410890|NCT00876343|524356872|FG000|Overall Study|Adverse Event|7|||
145410891|NCT00876343|524356873|FG001|Overall Study|Adverse Event|8|||
145410892|NCT00876343|524356874|FG002|Overall Study|Adverse Event|2|||
145410893|NCT00876343|524356872|FG000|Overall Study|Withdrawal by Subject|4|||
145410894|NCT00876343|524356873|FG001|Overall Study|Withdrawal by Subject|4|||
145410895|NCT00876343|524356874|FG002|Overall Study|Withdrawal by Subject|3|||
145410896|NCT00876343|524356872|FG000|Overall Study|Lack of Efficacy|0|||
145410897|NCT00876343|524356873|FG001|Overall Study|Lack of Efficacy|0|||
145261897|NCT05602818|523806278|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
145261898|NCT05602818|523806279|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
145261899|NCT05602818|523806280|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
145261900|NCT05602818|523806269|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261901|NCT05602818|523806270|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261902|NCT05602818|523806271|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261903|NCT05602818|523806272|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261904|NCT05602818|523806273|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261905|NCT05602818|523806274|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261906|NCT05602818|523806275|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261907|NCT05602818|523806276|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261908|NCT05602818|523806277|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261909|NCT05602818|523806278|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
145261910|NCT05602818|523806279|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
145261911|NCT05602818|523806280|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
145261912|NCT05602818|523806269|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
145261913|NCT05602818|523806270|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
145261914|NCT05602818|523806271|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
145261915|NCT05602818|523806272|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
145261916|NCT05602818|523806273|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
145261917|NCT05602818|523806274|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
145261918|NCT05602818|523806275|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
145261919|NCT05602818|523806276|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
145261920|NCT05602818|523806277|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
145261921|NCT05602818|523806278|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
145261922|NCT05602818|523806279|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
145261923|NCT05602818|523806280|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
145261924|NCT00727246|523806281|FG000|Overall Study|could not complete MRI|0|||
145261925|NCT00727246|523806282|FG001|Overall Study|could not complete MRI|1|||
145261926|NCT00727246|523806283|FG002|Overall Study|could not complete MRI|0|||
145261927|NCT00727246|523806284|FG003|Overall Study|could not complete MRI|1|||
145261928|NCT00727246|523806281|FG000|Overall Study|incidental finding|0|||
145261929|NCT00727246|523806282|FG001|Overall Study|incidental finding|0|||
145261930|NCT00727246|523806283|FG002|Overall Study|incidental finding|0|||
145261931|NCT00727246|523806284|FG003|Overall Study|incidental finding|1|||
145261932|NCT00727246|523806281|FG000|Overall Study|withdrawn|0|||
145261933|NCT00727246|523806282|FG001|Overall Study|withdrawn|0|||
145261934|NCT00727246|523806283|FG002|Overall Study|withdrawn|1|||
145261935|NCT00727246|523806284|FG003|Overall Study|withdrawn|0|||
145261936|NCT03814499|523806285|FG000|Overall Study|Lost to Follow-up|3|||
145261937|NCT00351611|523806286|FG000|Overall Study|Adverse Event|11|||
145261938|NCT00351611|523806287|FG001|Overall Study|Adverse Event|3|||
145410898|NCT00876343|524356874|FG002|Overall Study|Lack of Efficacy|1|||
145410899|NCT00876343|524356872|FG000|Overall Study|Protocol Violation|4|||
145410900|NCT00876343|524356873|FG001|Overall Study|Protocol Violation|1|||
145568735|NCT00654381|524942278|FG005|Extension Stage|Adverse Event|1|||
145568736|NCT00654381|524942273|FG000|Extension Stage|Protocol Violation|0|||
145568737|NCT00654381|524942274|FG001|Extension Stage|Protocol Violation|0|||
145261939|NCT00351611|523806286|FG000|Overall Study|Death|1|||
145301634|NCT01796171|523956544|FG008|Follow-up Period|Patient transferred to other hospital|0|||
145261940|NCT00351611|523806287|FG001|Overall Study|Death|0|||
145261941|NCT00351611|523806286|FG000|Overall Study|Lost to Follow-up|1|||
145261942|NCT00351611|523806287|FG001|Overall Study|Lost to Follow-up|0|||
145261943|NCT00351611|523806286|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
145261944|NCT00351611|523806287|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
145261945|NCT00351611|523806286|FG000|Overall Study|Other|1|||
145261946|NCT00351611|523806287|FG001|Overall Study|Other|0|||
145261947|NCT00351611|523806286|FG000|Overall Study|Protocol Violation|0|||
145261948|NCT00351611|523806287|FG001|Overall Study|Protocol Violation|2|||
145261949|NCT02046993|523806288|FG000|Overall Study|Withdrawal by Subject|2|||
145261950|NCT02046993|523806289|FG001|Overall Study|Withdrawal by Subject|10|||
145261951|NCT02046993|523806288|FG000|Overall Study|Lost to Follow-up|1|||
145261952|NCT02046993|523806289|FG001|Overall Study|Lost to Follow-up|1|||
145261953|NCT00598442|523806290|FG000|Overall Study|Adverse Event|3|||
145261954|NCT00598442|523806291|FG001|Overall Study|Adverse Event|0|||
145261955|NCT00598442|523806292|FG002|Overall Study|Adverse Event|0|||
145261956|NCT00598442|523806290|FG000|Overall Study|Death|19|||
145261957|NCT00598442|523806291|FG001|Overall Study|Death|11|||
145261958|NCT00598442|523806292|FG002|Overall Study|Death|11|||
145261959|NCT00598442|523806290|FG000|Overall Study|Lost to Follow-up|4|||
145261960|NCT00598442|523806291|FG001|Overall Study|Lost to Follow-up|3|||
145261961|NCT00598442|523806292|FG002|Overall Study|Lost to Follow-up|3|||
145261962|NCT00598442|523806290|FG000|Overall Study|Physician Decision|2|||
145261963|NCT00598442|523806291|FG001|Overall Study|Physician Decision|1|||
145261964|NCT00598442|523806292|FG002|Overall Study|Physician Decision|1|||
145261965|NCT00598442|523806290|FG000|Overall Study|Withdrawal by Subject|8|||
145261966|NCT00598442|523806291|FG001|Overall Study|Withdrawal by Subject|16|||
145261967|NCT00598442|523806292|FG002|Overall Study|Withdrawal by Subject|6|||
145261968|NCT00598442|523806290|FG000|Overall Study|Noncompliance|0|||
145261969|NCT00598442|523806291|FG001|Overall Study|Noncompliance|2|||
145261970|NCT00598442|523806292|FG002|Overall Study|Noncompliance|1|||
145261971|NCT00598442|523806290|FG000|Overall Study|Relocation|1|||
145261972|NCT00598442|523806291|FG001|Overall Study|Relocation|4|||
145261973|NCT00598442|523806292|FG002|Overall Study|Relocation|0|||
145261974|NCT00598442|523806290|FG000|Overall Study|Renal transplant|0|||
145261975|NCT00598442|523806291|FG001|Overall Study|Renal transplant|0|||
145261976|NCT00598442|523806292|FG002|Overall Study|Renal transplant|1|||
145261977|NCT00598442|523806290|FG000|Overall Study|Site closed by sponsor|5|||
145261978|NCT00598442|523806291|FG001|Overall Study|Site closed by sponsor|2|||
145261979|NCT00598442|523806292|FG002|Overall Study|Site closed by sponsor|1|||
145261980|NCT00598442|523806290|FG000|Overall Study|Started dialysis|1|||
145261981|NCT00598442|523806291|FG001|Overall Study|Started dialysis|0|||
145261982|NCT00598442|523806292|FG002|Overall Study|Started dialysis|0|||
145261983|NCT00462501|523806303|FG000|Overall Study|Not treated|3|||
145261984|NCT00462501|523806303|FG000|Overall Study|Adverse Event|2|||
145261985|NCT00408408|523806305|FG000|Overall Study|No follow up data|2|||
145261986|NCT00408408|523806306|FG001|Overall Study|No follow up data|3|||
145261987|NCT00408408|523806307|FG002|Overall Study|No follow up data|0|||
145261988|NCT00408408|523806308|FG003|Overall Study|No follow up data|7|||
145261989|NCT00408408|523806309|FG004|Overall Study|No follow up data|5|||
145261990|NCT00408408|523806310|FG005|Overall Study|No follow up data|3|||
145261991|NCT00267202|523806319|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
145261992|NCT00267202|523806320|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
145261993|NCT00267202|523806319|FG000|Overall Study|Withdrawal by Subject|12|||
145261994|NCT00267202|523806320|FG001|Overall Study|Withdrawal by Subject|15|||
145261995|NCT00267202|523806319|FG000|Overall Study|Adverse Event|13|||
145261996|NCT00267202|523806320|FG001|Overall Study|Adverse Event|7|||
145261997|NCT00267202|523806319|FG000|Overall Study|Protocol Violation|2|||
145261998|NCT00267202|523806320|FG001|Overall Study|Protocol Violation|3|||
145261999|NCT00267202|523806319|FG000|Overall Study|Administrative problems|2|||
145262000|NCT00267202|523806320|FG001|Overall Study|Administrative problems|1|||
145262001|NCT00267202|523806319|FG000|Overall Study|Lost to Follow-up|3|||
145262002|NCT00267202|523806320|FG001|Overall Study|Lost to Follow-up|0|||
145262003|NCT00399542|523806321|FG000|Overall Study|Adverse Event|18|||
145262004|NCT00399542|523806322|FG001|Overall Study|Adverse Event|15|||
145262005|NCT00399542|523806321|FG000|Overall Study|Protocol Violation|13|||
145262006|NCT00399542|523806322|FG001|Overall Study|Protocol Violation|3|||
145262007|NCT00399542|523806321|FG000|Overall Study|Withdrawal by Subject|28|||
145262008|NCT00399542|523806322|FG001|Overall Study|Withdrawal by Subject|10|||
145262009|NCT00399542|523806321|FG000|Overall Study|Lack of Efficacy|18|||
145262010|NCT00399542|523806322|FG001|Overall Study|Lack of Efficacy|8|||
145262011|NCT00399542|523806321|FG000|Overall Study|Lost to Follow-up|6|||
145262012|NCT00399542|523806322|FG001|Overall Study|Lost to Follow-up|6|||
145262013|NCT00399542|523806321|FG000|Overall Study|Other|1|||
145262014|NCT00399542|523806322|FG001|Overall Study|Other|0|||
145262015|NCT00399542|523806321|FG000|Overall Study|Physician Decision|0|||
145262016|NCT00399542|523806322|FG001|Overall Study|Physician Decision|1|||
145262017|NCT03172026|523806323|FG000|Overall Study|Withdrawal by Subject|1|||
145262018|NCT03172026|523806324|FG001|Overall Study|Withdrawal by Subject|0|||
145262019|NCT03172026|523806323|FG000|Overall Study|COVID restrictions|1|||
145301635|NCT01796171|523956545|FG009|Follow-up Period|Patient transferred to other hospital|0|||
145301636|NCT01796171|523956546|FG010|Follow-up Period|Patient transferred to other hospital|0|||
145301637|NCT01796171|523956547|FG011|Follow-up Period|Patient transferred to other hospital|0|||
145301638|NCT01796171|523956548|FG012|Follow-up Period|Patient transferred to other hospital|0|||
145301639|NCT01796171|523956549|FG013|Follow-up Period|Patient transferred to other hospital|0|||
145301640|NCT01796171|523956550|FG014|Follow-up Period|Patient transferred to other hospital|0|||
145301641|NCT01796171|523956536|FG000|Follow-up Period|Sponsor Decision|0|||
145301642|NCT01796171|523956537|FG001|Follow-up Period|Sponsor Decision|0|||
145301643|NCT01796171|523956538|FG002|Follow-up Period|Sponsor Decision|0|||
145301644|NCT01796171|523956539|FG003|Follow-up Period|Sponsor Decision|0|||
145301645|NCT01796171|523956540|FG004|Follow-up Period|Sponsor Decision|0|||
145301646|NCT01796171|523956541|FG005|Follow-up Period|Sponsor Decision|0|||
145301647|NCT01796171|523956542|FG006|Follow-up Period|Sponsor Decision|0|||
145301648|NCT01796171|523956543|FG007|Follow-up Period|Sponsor Decision|0|||
145301649|NCT01796171|523956544|FG008|Follow-up Period|Sponsor Decision|0|||
145301650|NCT01796171|523956545|FG009|Follow-up Period|Sponsor Decision|0|||
145301651|NCT01796171|523956546|FG010|Follow-up Period|Sponsor Decision|40|||
145262020|NCT03172026|523806324|FG001|Overall Study|COVID restrictions|0|||
145262021|NCT00612456|523806325|FG000|Overall Study|Adverse Event|1|||
145262022|NCT00612456|523806326|FG001|Overall Study|Adverse Event|0|||
145262023|NCT00612456|523806327|FG002|Overall Study|Adverse Event|0|||
145262024|NCT00612456|523806325|FG000|Overall Study|Lack of Efficacy|1|||
145262025|NCT00612456|523806326|FG001|Overall Study|Lack of Efficacy|1|||
145262026|NCT00612456|523806327|FG002|Overall Study|Lack of Efficacy|0|||
145262027|NCT00612456|523806325|FG000|Overall Study|Withdrawal by Subject|0|||
145262028|NCT00612456|523806326|FG001|Overall Study|Withdrawal by Subject|1|||
145262029|NCT00612456|523806327|FG002|Overall Study|Withdrawal by Subject|0|||
145262030|NCT00504595|523806328|FG000|Overall Study|Lack of Efficacy|1|||
145262031|NCT00504595|523806329|FG001|Overall Study|Lack of Efficacy|0|||
145262032|NCT00504595|523806330|FG002|Overall Study|Lack of Efficacy|0|||
145262033|NCT00504595|523806331|FG003|Overall Study|Lack of Efficacy|0|||
145262034|NCT00504595|523806328|FG000|Overall Study|Other|0|||
145262035|NCT00504595|523806329|FG001|Overall Study|Other|0|||
145262036|NCT00504595|523806330|FG002|Overall Study|Other|2|||
145262037|NCT00504595|523806331|FG003|Overall Study|Other|0|||
145262038|NCT00334893|523806332|FG000|Overall Study|Not Treated|1|||
145262039|NCT00334893|523806333|FG001|Overall Study|Not Treated|0|||
145262040|NCT01258803|523806334|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
145262041|NCT01258803|523806335|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
145262042|NCT01258803|523806336|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
145262043|NCT01258803|523806337|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
145262044|NCT01258803|523806338|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
145262045|NCT01258803|523806339|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
145262046|NCT01258803|523806334|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
145262047|NCT01258803|523806335|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
145262048|NCT01258803|523806336|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
145262049|NCT01258803|523806337|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
145262050|NCT01258803|523806338|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
145262051|NCT01258803|523806339|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
145262052|NCT01258803|523806334|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
145262053|NCT01258803|523806335|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
145262054|NCT01258803|523806336|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
145262055|NCT01258803|523806337|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
145262056|NCT01258803|523806338|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
145262057|NCT01258803|523806339|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
145262058|NCT04652245|523806345|FG000|Wash-Out Period|Adverse Event|0|||
145262059|NCT04652245|523806346|FG001|Wash-Out Period|Adverse Event|2|||
145262060|NCT04652245|523806345|FG000|Wash-Out Period|Withdrawal by Subject|0|||
145262061|NCT04652245|523806346|FG001|Wash-Out Period|Withdrawal by Subject|2|||
145301652|NCT01796171|523956547|FG011|Follow-up Period|Sponsor Decision|15|||
145301653|NCT01796171|523956548|FG012|Follow-up Period|Sponsor Decision|7|||
145301654|NCT01796171|523956549|FG013|Follow-up Period|Sponsor Decision|0|||
145262062|NCT01552408|523806347|FG000|Overall Study|Lost to Follow-up|2|||
145262063|NCT01552408|523806348|FG001|Overall Study|Lost to Follow-up|0|||
145262064|NCT01552408|523806347|FG000|Overall Study|Relocation|0|||
145262065|NCT01552408|523806348|FG001|Overall Study|Relocation|1|||
145262066|NCT01552408|523806347|FG000|Overall Study|Withdrawal by Subject|2|||
145262067|NCT01552408|523806348|FG001|Overall Study|Withdrawal by Subject|1|||
145262068|NCT00851721|523806351|FG000|Overall Study|planned surgery|1|||
145262069|NCT00851721|523806352|FG001|Overall Study|planned surgery|0|||
145262070|NCT00851721|523806351|FG000|Overall Study|Death|1|||
145262071|NCT00851721|523806352|FG001|Overall Study|Death|0|||
145301655|NCT01796171|523956550|FG014|Follow-up Period|Sponsor Decision|0|||
145301656|NCT00418561|523956551|FG000|Overall Study|Participant's (guardian's) decision|0|||
145301657|NCT00418561|523956552|FG001|Overall Study|Participant's (guardian's) decision|1|||
145301658|NCT00418561|523956553|FG002|Overall Study|Participant's (guardian's) decision|0|||
145262072|NCT00851721|523806351|FG000|Overall Study|Adverse Event|0|||
145301659|NCT00829309|523956554|FG000|Washout: 7 Days|Protocol Violation|1|||
145301660|NCT00829309|523956555|FG001|Washout: 7 Days|Protocol Violation|0|||
145301661|NCT01705574|523956556|FG000|Double-Blind Phase|Lost to Follow-up|12|||
145301662|NCT01705574|523956557|FG001|Double-Blind Phase|Lost to Follow-up|16|||
145301663|NCT01705574|523956558|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145301664|NCT01705574|523956559|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145301665|NCT01705574|523956556|FG000|Double-Blind Phase|Adverse Event|3|||
145301666|NCT01705574|523956557|FG001|Double-Blind Phase|Adverse Event|10|||
145301667|NCT01705574|523956558|FG002|Double-Blind Phase|Adverse Event|0|||
145301668|NCT01705574|523956559|FG003|Double-Blind Phase|Adverse Event|0|||
145301669|NCT01705574|523956556|FG000|Double-Blind Phase|Withdrew Consent|8|||
145301670|NCT01705574|523956557|FG001|Double-Blind Phase|Withdrew Consent|5|||
145301671|NCT01705574|523956558|FG002|Double-Blind Phase|Withdrew Consent|0|||
145301672|NCT01705574|523956559|FG003|Double-Blind Phase|Withdrew Consent|0|||
145301673|NCT01705574|523956556|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
145301674|NCT01705574|523956557|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
145301675|NCT01705574|523956558|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
145301676|NCT01705574|523956559|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
145301677|NCT01705574|523956556|FG000|Double-Blind Phase|Pregnancy|1|||
145301678|NCT01705574|523956557|FG001|Double-Blind Phase|Pregnancy|1|||
145301679|NCT01705574|523956558|FG002|Double-Blind Phase|Pregnancy|0|||
145301680|NCT01705574|523956559|FG003|Double-Blind Phase|Pregnancy|0|||
145301681|NCT01705574|523956556|FG000|Double-Blind Phase|Protocol Violation|1|||
145301682|NCT01705574|523956557|FG001|Double-Blind Phase|Protocol Violation|0|||
145301683|NCT01705574|523956558|FG002|Double-Blind Phase|Protocol Violation|0|||
145301684|NCT01705574|523956559|FG003|Double-Blind Phase|Protocol Violation|0|||
145301685|NCT01705574|523956556|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
145301686|NCT01705574|523956557|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
145301687|NCT01705574|523956558|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
145301688|NCT01705574|523956559|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
145301689|NCT01705574|523956556|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
145301690|NCT01705574|523956557|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145301691|NCT01705574|523956558|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
145301692|NCT01705574|523956559|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
145301693|NCT01705574|523956556|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
145301694|NCT01705574|523956557|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
145301695|NCT01705574|523956558|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
145301696|NCT01705574|523956559|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
145301697|NCT01705574|523956556|FG000|Open-Label Extension Phase|Adverse Event|3|||
145301698|NCT01705574|523956557|FG001|Open-Label Extension Phase|Adverse Event|0|||
145301699|NCT01705574|523956558|FG002|Open-Label Extension Phase|Adverse Event|0|||
145301700|NCT01705574|523956559|FG003|Open-Label Extension Phase|Adverse Event|1|||
145301701|NCT01705574|523956556|FG000|Open-Label Extension Phase|Death|2|||
145301702|NCT01705574|523956557|FG001|Open-Label Extension Phase|Death|0|||
145301703|NCT01705574|523956558|FG002|Open-Label Extension Phase|Death|1|||
145301704|NCT01705574|523956559|FG003|Open-Label Extension Phase|Death|0|||
145301705|NCT01705574|523956556|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
145301706|NCT01705574|523956557|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
145301707|NCT01705574|523956558|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
145301708|NCT01705574|523956559|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
145301709|NCT01705574|523956556|FG000|Open-Label Extension Phase|Physician Decision|0|||
145301710|NCT01705574|523956557|FG001|Open-Label Extension Phase|Physician Decision|0|||
145301711|NCT01705574|523956558|FG002|Open-Label Extension Phase|Physician Decision|2|||
145301712|NCT01705574|523956559|FG003|Open-Label Extension Phase|Physician Decision|0|||
145301713|NCT01705574|523956556|FG000|Open-Label Extension Phase|Pregnancy|0|||
145301714|NCT01705574|523956557|FG001|Open-Label Extension Phase|Pregnancy|0|||
145301715|NCT01705574|523956558|FG002|Open-Label Extension Phase|Pregnancy|1|||
145301716|NCT01705574|523956559|FG003|Open-Label Extension Phase|Pregnancy|1|||
145301717|NCT00777023|523956560|FG000|Overall Study|Adverse Event|15|||
145301718|NCT00777023|523956561|FG001|Overall Study|Adverse Event|21|||
145301719|NCT00777023|523956562|FG002|Overall Study|Adverse Event|8|||
145301720|NCT00777023|523956560|FG000|Overall Study|Lack of Efficacy|1|||
145301721|NCT00777023|523956561|FG001|Overall Study|Lack of Efficacy|0|||
145301722|NCT00777023|523956562|FG002|Overall Study|Lack of Efficacy|14|||
145301723|NCT00777023|523956560|FG000|Overall Study|Protocol Violation|2|||
145301724|NCT00777023|523956561|FG001|Overall Study|Protocol Violation|1|||
145301725|NCT00777023|523956562|FG002|Overall Study|Protocol Violation|1|||
145301726|NCT00777023|523956560|FG000|Overall Study|Lost to Follow-up|2|||
145301727|NCT00777023|523956561|FG001|Overall Study|Lost to Follow-up|3|||
145301728|NCT00777023|523956562|FG002|Overall Study|Lost to Follow-up|3|||
145301729|NCT00777023|523956560|FG000|Overall Study|Death|0|||
145301730|NCT00777023|523956561|FG001|Overall Study|Death|1|||
145301731|NCT00777023|523956562|FG002|Overall Study|Death|0|||
145301732|NCT00777023|523956560|FG000|Overall Study|Withdrawal by Subject|7|||
145301733|NCT00777023|523956561|FG001|Overall Study|Withdrawal by Subject|7|||
145262073|NCT00851721|523806352|FG001|Overall Study|Adverse Event|1|||
145262074|NCT03604159|523806353|FG000|Overall Study|Lost to Follow-up|6|||
145262075|NCT03604159|523806354|FG001|Overall Study|Lost to Follow-up|7|||
145262076|NCT00383292|523806358|FG000|Overall Study|Adverse Event|4|||
145262077|NCT00383292|523806359|FG001|Overall Study|Adverse Event|1|||
145262078|NCT00383292|523806360|FG002|Overall Study|Adverse Event|2|||
145262079|NCT00383292|523806358|FG000|Overall Study|Death|3|||
145262080|NCT00383292|523806359|FG001|Overall Study|Death|3|||
145262081|NCT00383292|523806360|FG002|Overall Study|Death|3|||
145262082|NCT00383292|523806358|FG000|Overall Study|Physician Decision|4|||
145262083|NCT00383292|523806359|FG001|Overall Study|Physician Decision|0|||
145262084|NCT00383292|523806360|FG002|Overall Study|Physician Decision|1|||
145262085|NCT00383292|523806358|FG000|Overall Study|Withdrawal by Subject|3|||
145262086|NCT00383292|523806359|FG001|Overall Study|Withdrawal by Subject|2|||
145262087|NCT00383292|523806360|FG002|Overall Study|Withdrawal by Subject|2|||
145262088|NCT00383292|523806358|FG000|Overall Study|Other|1|||
145262089|NCT00383292|523806359|FG001|Overall Study|Other|0|||
145262090|NCT00383292|523806360|FG002|Overall Study|Other|0|||
145262091|NCT04533204|523806361|FG000|Overall Study|Unable to understand training instructions|1|||
145262092|NCT04533204|523806362|FG001|Overall Study|Unable to understand training instructions|1|||
145262093|NCT01303159|523806369|FG000|Overall Study|Death|16|||
145262094|NCT01303159|523806369|FG000|Overall Study|Study Termination|7|||
145262095|NCT01016912|523806370|FG000|End of Treatment Period|Lack of Efficacy|0|||
145262096|NCT01016912|523806371|FG001|End of Treatment Period|Lack of Efficacy|1|||
145262097|NCT01016912|523806372|FG002|End of Treatment Period|Lack of Efficacy|0|||
145262098|NCT01016912|523806373|FG003|End of Treatment Period|Lack of Efficacy|4|||
145262099|NCT01016912|523806374|FG004|End of Treatment Period|Lack of Efficacy|4|||
145262100|NCT01016912|523806370|FG000|End of Treatment Period|Adverse Event|0|||
145262101|NCT01016912|523806371|FG001|End of Treatment Period|Adverse Event|1|||
145262102|NCT01016912|523806372|FG002|End of Treatment Period|Adverse Event|1|||
145262103|NCT01016912|523806373|FG003|End of Treatment Period|Adverse Event|0|||
145262104|NCT01016912|523806374|FG004|End of Treatment Period|Adverse Event|0|||
145262105|NCT01016912|523806370|FG000|End of Treatment Period|Completed double-blind period only|0|||
145262106|NCT01016912|523806371|FG001|End of Treatment Period|Completed double-blind period only|1|||
145262107|NCT01016912|523806372|FG002|End of Treatment Period|Completed double-blind period only|0|||
145262108|NCT01016912|523806373|FG003|End of Treatment Period|Completed double-blind period only|0|||
145262109|NCT01016912|523806374|FG004|End of Treatment Period|Completed double-blind period only|0|||
145262110|NCT01016912|523806370|FG000|Follow-up Period|Other reason|0|||
145262111|NCT01016912|523806371|FG001|Follow-up Period|Other reason|0|||
145262112|NCT01016912|523806372|FG002|Follow-up Period|Other reason|1|||
145262113|NCT01016912|523806373|FG003|Follow-up Period|Other reason|1|||
145262114|NCT01016912|523806374|FG004|Follow-up Period|Other reason|0|||
145262115|NCT00914940|523806378|FG000|D0 to D100 Post-transplant|Death|2|||
145262116|NCT00914940|523806378|FG000|D101 to 2 Years Post-transplant|Death|8|||
145262117|NCT00914940|523806378|FG000|2 Years to 5 Years Post-transplant|Death|3|||
145262118|NCT02260791|523806390|FG000|Overall Study|Lost to Follow-up|4|||
145262119|NCT02260791|523806391|FG001|Overall Study|Lost to Follow-up|4|||
145262120|NCT02260791|523806390|FG000|Overall Study|Lack of Efficacy|2|||
145262121|NCT02260791|523806391|FG001|Overall Study|Lack of Efficacy|1|||
145262122|NCT02260791|523806390|FG000|Overall Study|Adverse Event|13|||
145262123|NCT02260791|523806391|FG001|Overall Study|Adverse Event|9|||
145262124|NCT02260791|523806390|FG000|Overall Study|Death|1|||
145262125|NCT02260791|523806391|FG001|Overall Study|Death|0|||
145262126|NCT02260791|523806390|FG000|Overall Study|Withdrawal by Subject|11|||
145262127|NCT02260791|523806391|FG001|Overall Study|Withdrawal by Subject|16|||
145262128|NCT02260791|523806390|FG000|Overall Study|Screen failure|0|||
145262129|NCT02260791|523806391|FG001|Overall Study|Screen failure|1|||
145262130|NCT02260791|523806390|FG000|Overall Study|Protocol deviation|2|||
145262131|NCT02260791|523806391|FG001|Overall Study|Protocol deviation|3|||
145262132|NCT02442284|523806392|FG000|Overall Study|Adverse Event|1|||
145262133|NCT02442284|523806392|FG000|Overall Study|Withdrew Consent|2|||
145262134|NCT02442284|523806392|FG000|Overall Study|Lost to Follow-up|3|||
145262135|NCT02442284|523806392|FG000|Overall Study|Other|1|||
145262136|NCT00842829|523806393|FG000|Dose Titration Period|Adverse Event|11|||
145262137|NCT00842829|523806394|FG001|Dose Titration Period|Adverse Event|10|||
145262138|NCT00842829|523806395|FG002|Dose Titration Period|Adverse Event|0|||
145262139|NCT00842829|523806393|FG000|Dose Titration Period|Lack of Efficacy|4|||
145262140|NCT00842829|523806394|FG001|Dose Titration Period|Lack of Efficacy|1|||
145262141|NCT00842829|523806395|FG002|Dose Titration Period|Lack of Efficacy|0|||
145262142|NCT00842829|523806393|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
145262143|NCT00842829|523806394|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
145262144|NCT00842829|523806395|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
145262145|NCT00842829|523806393|FG000|Dose Titration Period|Withdrawal by Subject|2|||
145262146|NCT00842829|523806394|FG001|Dose Titration Period|Withdrawal by Subject|6|||
145262147|NCT00842829|523806395|FG002|Dose Titration Period|Withdrawal by Subject|0|||
145262148|NCT00842829|523806393|FG000|Dose Titration Period|Other|5|||
145262149|NCT00842829|523806394|FG001|Dose Titration Period|Other|4|||
145301734|NCT00777023|523956562|FG002|Overall Study|Withdrawal by Subject|8|||
145301735|NCT00777023|523956560|FG000|Overall Study|Missing data|1|||
145301736|NCT00777023|523956561|FG001|Overall Study|Missing data|1|||
145301737|NCT00777023|523956562|FG002|Overall Study|Missing data|0|||
145301738|NCT00777023|523956560|FG000|Overall Study|Reasons not specified|4|||
145301739|NCT00777023|523956561|FG001|Overall Study|Reasons not specified|4|||
145301740|NCT00777023|523956562|FG002|Overall Study|Reasons not specified|2|||
145301741|NCT00777023|523956560|FG000|Overall Study|Last dose date unknown|3|||
145301742|NCT00777023|523956561|FG001|Overall Study|Last dose date unknown|3|||
145301743|NCT00777023|523956562|FG002|Overall Study|Last dose date unknown|1|||
145301744|NCT02659150|523956565|FG000|Subject Enrollment|Physician Decision|3|||
145301745|NCT02659150|523956565|FG000|Subject Enrollment|Withdrawal by Subject|2|||
145301746|NCT02659150|523956565|FG000|Baseline Imaging|Withdrawal by Subject|1|||
145301747|NCT02659150|523956565|FG000|Baseline Imaging|Physician Decision|1|||
145301748|NCT02659150|523956565|FG000|Study Drug Dosing|Adverse Event|1|||
145301749|NCT03699020|523956568|FG000|Overall Study|Withdrawal by Subject|3|||
145301750|NCT03699020|523956569|FG001|Overall Study|Withdrawal by Subject|2|||
145301751|NCT02246920|523956570|FG000|Overall Study|Adverse Event|3|||
145301752|NCT02246920|523956571|FG001|Overall Study|Adverse Event|1|||
145301753|NCT02246920|523956572|FG002|Overall Study|Adverse Event|1|||
145301754|NCT02246920|523956570|FG000|Overall Study|Lost to Follow-up|2|||
145301755|NCT02246920|523956571|FG001|Overall Study|Lost to Follow-up|1|||
145301756|NCT02246920|523956572|FG002|Overall Study|Lost to Follow-up|0|||
145301757|NCT02246920|523956570|FG000|Overall Study|Protocol Violation|2|||
145301758|NCT02246920|523956571|FG001|Overall Study|Protocol Violation|5|||
145301759|NCT02246920|523956572|FG002|Overall Study|Protocol Violation|1|||
145301760|NCT02246920|523956570|FG000|Overall Study|Withdrawal by Subject|0|||
145301761|NCT02246920|523956571|FG001|Overall Study|Withdrawal by Subject|0|||
145301762|NCT02246920|523956572|FG002|Overall Study|Withdrawal by Subject|1|||
145301763|NCT02678286|523956573|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
145301764|NCT02678286|523956574|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
145301765|NCT02678286|523956573|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
145301766|NCT02678286|523956574|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
145301767|NCT02678286|523956573|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
145301768|NCT02678286|523956574|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
145301769|NCT02678286|523956573|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
145301770|NCT02678286|523956574|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
145301771|NCT02678286|523956573|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
145301772|NCT02678286|523956574|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
145301773|NCT00448019|523956575|FG000|Overall Study|Withdrawal by Subject|3|||
145301774|NCT00448019|523956575|FG000|Overall Study|Disease progression|1|||
145301775|NCT00448019|523956575|FG000|Overall Study|Death|2|||
145301776|NCT00448019|523956575|FG000|Overall Study|Insurance Issues|1|||
145301777|NCT01273805|523956576|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
145301778|NCT01273805|523956577|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
145301779|NCT02647944|523956582|FG000|Overall Study|Withdrawal by Subject|0|||
145301780|NCT02647944|523956583|FG001|Overall Study|Withdrawal by Subject|3|||
145301781|NCT02647944|523956582|FG000|Overall Study|Adverse Event|2|||
145301782|NCT02647944|523956583|FG001|Overall Study|Adverse Event|0|||
145301783|NCT02760368|523956585|FG000|Overall Study|Withdrawal by Subject|8|||
145301784|NCT02760368|523956586|FG001|Overall Study|Withdrawal by Subject|12|||
145301785|NCT02760368|523956587|FG002|Overall Study|Withdrawal by Subject|9|||
145301786|NCT02760368|523956585|FG000|Overall Study|Screen Failure|0|||
145301787|NCT02760368|523956586|FG001|Overall Study|Screen Failure|0|||
145301788|NCT02760368|523956587|FG002|Overall Study|Screen Failure|1|||
145301789|NCT02760368|523956585|FG000|Overall Study|Death|0|||
145301790|NCT02760368|523956586|FG001|Overall Study|Death|1|||
145301791|NCT02760368|523956587|FG002|Overall Study|Death|0|||
145301792|NCT02760368|523956585|FG000|Overall Study|Withdrawal by Sponsor|0|||
145301793|NCT02760368|523956586|FG001|Overall Study|Withdrawal by Sponsor|0|||
145301794|NCT02760368|523956587|FG002|Overall Study|Withdrawal by Sponsor|1|||
145301795|NCT02902211|523956595|FG000|First Three Months|Withdrawal by Subject|7|||
145620285|NCT05764239|525123732|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
145620286|NCT05764239|525123732|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
145620287|NCT05764239|525123732|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
145620288|NCT05764239|525123732|FG000|DEP (Part 1)|Adverse Event|1|||
145301796|NCT02902211|523956596|FG001|First Three Months|Withdrawal by Subject|3|||
145301797|NCT01200810|523956597|FG000|Overall Study|Physician Decision|1|||
145301798|NCT01200810|523956598|FG001|Overall Study|Physician Decision|0|||
145301799|NCT01200810|523956597|FG000|Overall Study|Withdrawal by Subject|1|||
145301800|NCT01200810|523956598|FG001|Overall Study|Withdrawal by Subject|2|||
145301801|NCT01200810|523956597|FG000|Overall Study|Sponsor stopped making study drug|3|||
145301802|NCT01200810|523956598|FG001|Overall Study|Sponsor stopped making study drug|3|||
145301803|NCT00904215|523956600|FG000|Overall Study|Adverse Event|25|||
145301804|NCT00904215|523956600|FG000|Overall Study|Protocol Violation|10|||
145301805|NCT00904215|523956600|FG000|Overall Study|Lost to Follow-up|63|||
145301806|NCT00904215|523956600|FG000|Overall Study|Withdrawal by Subject|9|||
145301807|NCT00904215|523956600|FG000|Overall Study|Other|28|||
145301808|NCT00838630|523956601|FG000|First Intervention|Adverse Event|1|||
145301809|NCT00838630|523956602|FG001|First Intervention|Adverse Event|0|||
145301810|NCT00838630|523956601|FG000|Washout: 7 Days|Protocol Violation|1|||
145301811|NCT00838630|523956602|FG001|Washout: 7 Days|Protocol Violation|0|||
145301812|NCT00640562|523956603|FG000|Overall Study|Adverse Event|8|||
145301813|NCT00640562|523956604|FG001|Overall Study|Adverse Event|5|||
145301814|NCT00640562|523956603|FG000|Overall Study|Lack of Efficacy|1|||
145301815|NCT00640562|523956604|FG001|Overall Study|Lack of Efficacy|4|||
145301816|NCT00640562|523956603|FG000|Overall Study|Protocol Violation|2|||
145301817|NCT00640562|523956604|FG001|Overall Study|Protocol Violation|4|||
145301818|NCT00640562|523956603|FG000|Overall Study|Withdrawal by Subject|6|||
145301819|NCT00640562|523956604|FG001|Overall Study|Withdrawal by Subject|10|||
145301820|NCT00640562|523956603|FG000|Overall Study|Known risperidone intolerance|0|||
145301821|NCT00640562|523956604|FG001|Overall Study|Known risperidone intolerance|1|||
145301822|NCT00640562|523956603|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
145301823|NCT00640562|523956604|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
145301824|NCT00640562|523956603|FG000|Overall Study|Low study drug dose|0|||
145301825|NCT00640562|523956604|FG001|Overall Study|Low study drug dose|1|||
145301826|NCT00640562|523956603|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
145301827|NCT00640562|523956604|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
145301828|NCT00448591|523956605|FG000|Overall Study|Withdrawal by Subject|178|||
145301829|NCT00448591|523956605|FG000|Overall Study|Progressive Disease|1382|||
145301830|NCT00448591|523956605|FG000|Overall Study|Adverse Event|382|||
145301831|NCT00448591|523956605|FG000|Overall Study|Protocol Violation|41|||
145301832|NCT00448591|523956605|FG000|Overall Study|Lost to Follow-up|19|||
145301833|NCT00448591|523956605|FG000|Overall Study|Treatment Regimen Completed|70|||
145301834|NCT00448591|523956605|FG000|Overall Study|Other|154|||
145301835|NCT00448591|523956605|FG000|Overall Study|Termination of Study|70|||
145301836|NCT02937870|523956606|FG000|Overall Study|Adverse Event|1|||
145301837|NCT02937870|523956606|FG000|Overall Study|Protocol Deviation|2|||
145301838|NCT00609674|523956610|FG000|Overall Study|Adverse Event|1|||
145301839|NCT00609674|523956611|FG001|Overall Study|Adverse Event|1|||
145301840|NCT00609674|523956610|FG000|Overall Study|Protocol Violation|3|||
145301841|NCT00609674|523956611|FG001|Overall Study|Protocol Violation|5|||
145301842|NCT00609674|523956610|FG000|Overall Study|Lost to Follow-up|1|||
145301843|NCT00609674|523956611|FG001|Overall Study|Lost to Follow-up|0|||
145301844|NCT00609674|523956610|FG000|Overall Study|Withdrew consent|2|||
145301845|NCT00609674|523956611|FG001|Overall Study|Withdrew consent|1|||
145301846|NCT03098394|523956612|FG000|Overall Study|Pregnancy|0|||
145301847|NCT03098394|523956613|FG001|Overall Study|Pregnancy|1|||
145301848|NCT00244764|523956617|FG000|Overall Study|Adverse Event|37|||
145301849|NCT00244764|523956617|FG000|Overall Study|Lost to Follow-up|23|||
145301850|NCT00244764|523956617|FG000|Overall Study|Withdrawal by Subject|12|||
145301851|NCT00244764|523956617|FG000|Overall Study|Disease Progression|13|||
145301852|NCT00244764|523956617|FG000|Overall Study|Protocol Violation|2|||
145301853|NCT00244764|523956617|FG000|Overall Study|Death|1|||
145568738|NCT00654381|524942275|FG002|Extension Stage|Protocol Violation|0|||
145568739|NCT00654381|524942276|FG003|Extension Stage|Protocol Violation|1|||
145568740|NCT00654381|524942277|FG004|Extension Stage|Protocol Violation|0|||
145301854|NCT00244764|523956617|FG000|Overall Study|Off Study Medication for >21 Days|1|||
145301855|NCT00244764|523956617|FG000|Overall Study|Declining Performance Status|1|||
145301856|NCT00244764|523956617|FG000|Overall Study|Participant was Hospitalized until Death|1|||
145301857|NCT00244764|523956617|FG000|Overall Study|Primary Investigator Discretion|2|||
145301858|NCT00244764|523956617|FG000|Overall Study|Sponsor Terminated Study|2|||
145301859|NCT00244764|523956617|FG000|Overall Study|Developed Secondary Malignancy|1|||
145301860|NCT02648438|523956623|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145301861|NCT02648438|523956624|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
145301862|NCT02648438|523956625|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145301863|NCT02648438|523956623|FG000|Overall Study|Protocol Violation|2|||
145301864|NCT02648438|523956624|FG001|Overall Study|Protocol Violation|0|||
145301865|NCT02648438|523956625|FG002|Overall Study|Protocol Violation|0|||
145301866|NCT02648438|523956623|FG000|Overall Study|Withdrawal by Subject|1|||
145301867|NCT02648438|523956624|FG001|Overall Study|Withdrawal by Subject|1|||
145301868|NCT02648438|523956625|FG002|Overall Study|Withdrawal by Subject|0|||
145301869|NCT03138967|523956626|FG000|Overall Study|Death|0|||
145301870|NCT03138967|523956627|FG001|Overall Study|Death|1|||
145301871|NCT03138967|523956626|FG000|Overall Study|Physician Decision|1|||
145301872|NCT03138967|523956627|FG001|Overall Study|Physician Decision|3|||
145301873|NCT04604275|523956628|FG000|Washout-1 Week|Withdrawal by Subject|1|||
145568741|NCT00654381|524942278|FG005|Extension Stage|Protocol Violation|0|||
145568742|NCT00654381|524942273|FG000|Extension Stage|Lack of Efficacy|0|||
145568743|NCT00654381|524942274|FG001|Extension Stage|Lack of Efficacy|0|||
145568744|NCT00654381|524942275|FG002|Extension Stage|Lack of Efficacy|1|||
145301874|NCT04604275|523956629|FG001|Washout-1 Week|Withdrawal by Subject|0|||
145301875|NCT05615935|523956630|FG000|Overall Study|Lost to Follow-up|1|||
145301876|NCT05615935|523956631|FG001|Overall Study|Lost to Follow-up|1|||
145410901|NCT00876343|524356874|FG002|Overall Study|Protocol Violation|1|||
145410902|NCT00876343|524356872|FG000|Overall Study|Physician Decision|0|||
145301877|NCT03925532|523956632|FG000|Overall Study|Lost to Follow-up|1|||
145301878|NCT02689505|523956633|FG000|Overall Study|Progressive disease|2|||
145301879|NCT02689505|523956634|FG001|Overall Study|Progressive disease|2|||
145301880|NCT02689505|523956635|FG002|Overall Study|Progressive disease|3|||
145301881|NCT02689505|523956636|FG003|Overall Study|Progressive disease|9|||
145301882|NCT02689505|523956637|FG004|Overall Study|Progressive disease|1|||
145301883|NCT02689505|523956633|FG000|Overall Study|Dose Limiting Toxicity|0|||
145301884|NCT02689505|523956634|FG001|Overall Study|Dose Limiting Toxicity|1|||
145301885|NCT02689505|523956635|FG002|Overall Study|Dose Limiting Toxicity|0|||
145301886|NCT02689505|523956636|FG003|Overall Study|Dose Limiting Toxicity|0|||
145301887|NCT02689505|523956637|FG004|Overall Study|Dose Limiting Toxicity|2|||
145301888|NCT02689505|523956633|FG000|Overall Study|Other AE or clinical progression|0|||
145301889|NCT02689505|523956634|FG001|Overall Study|Other AE or clinical progression|2|||
145301890|NCT02689505|523956635|FG002|Overall Study|Other AE or clinical progression|0|||
145410903|NCT00876343|524356873|FG001|Overall Study|Physician Decision|1|||
145410904|NCT00876343|524356874|FG002|Overall Study|Physician Decision|1|||
145568745|NCT00654381|524942276|FG003|Extension Stage|Lack of Efficacy|0|||
145262150|NCT00842829|523806395|FG002|Dose Titration Period|Other|0|||
145262151|NCT00842829|523806393|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
145262152|NCT00842829|523806394|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
145262153|NCT00842829|523806395|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
145262154|NCT00842829|523806393|FG000|Dose Titration Period|Non-compliance to study drug|2|||
145262155|NCT00842829|523806394|FG001|Dose Titration Period|Non-compliance to study drug|1|||
145262156|NCT00842829|523806395|FG002|Dose Titration Period|Non-compliance to study drug|0|||
145262157|NCT00842829|523806393|FG000|Treatment Period|Adverse Event|0|||
145262158|NCT00842829|523806394|FG001|Treatment Period|Adverse Event|0|||
145262159|NCT00842829|523806395|FG002|Treatment Period|Adverse Event|15|||
145262160|NCT00842829|523806393|FG000|Treatment Period|Lack of Efficacy|0|||
145262161|NCT00842829|523806394|FG001|Treatment Period|Lack of Efficacy|0|||
145262162|NCT00842829|523806395|FG002|Treatment Period|Lack of Efficacy|6|||
145262163|NCT00842829|523806393|FG000|Treatment Period|Unstable persistent cancer pain|0|||
145262164|NCT00842829|523806394|FG001|Treatment Period|Unstable persistent cancer pain|0|||
145262165|NCT00842829|523806395|FG002|Treatment Period|Unstable persistent cancer pain|5|||
145262166|NCT00842829|523806393|FG000|Treatment Period|Withdrawal by Subject|0|||
145262167|NCT00842829|523806394|FG001|Treatment Period|Withdrawal by Subject|0|||
145262168|NCT00842829|523806395|FG002|Treatment Period|Withdrawal by Subject|11|||
145262169|NCT00842829|523806393|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
145262170|NCT00842829|523806394|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
145262171|NCT00842829|523806395|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
145262172|NCT00842829|523806393|FG000|Treatment Period|Protocol Violation|0|||
145262173|NCT00842829|523806394|FG001|Treatment Period|Protocol Violation|0|||
145262174|NCT00842829|523806395|FG002|Treatment Period|Protocol Violation|2|||
145262175|NCT00842829|523806393|FG000|Treatment Period|Other|0|||
145262176|NCT00842829|523806394|FG001|Treatment Period|Other|0|||
145262177|NCT00842829|523806395|FG002|Treatment Period|Other|18|||
145262178|NCT00842829|523806393|FG000|Treatment Period|Non-compliance to study procedures|0|||
145262179|NCT00842829|523806394|FG001|Treatment Period|Non-compliance to study procedures|0|||
145262180|NCT00842829|523806395|FG002|Treatment Period|Non-compliance to study procedures|4|||
145262181|NCT00842829|523806393|FG000|Treatment Period|Unclear completion status|0|||
145262182|NCT00842829|523806394|FG001|Treatment Period|Unclear completion status|0|||
145262183|NCT00842829|523806395|FG002|Treatment Period|Unclear completion status|1|||
145262184|NCT00842829|523806393|FG000|Continuation Period|Adverse Event|0|||
145262185|NCT00842829|523806394|FG001|Continuation Period|Adverse Event|0|||
145262186|NCT00842829|523806395|FG002|Continuation Period|Adverse Event|32|||
145262187|NCT00842829|523806393|FG000|Continuation Period|Lack of Efficacy|0|||
145262188|NCT00842829|523806394|FG001|Continuation Period|Lack of Efficacy|0|||
145262189|NCT00842829|523806395|FG002|Continuation Period|Lack of Efficacy|6|||
145262190|NCT00842829|523806393|FG000|Continuation Period|Unstable persistent cancer pain|0|||
145262191|NCT00842829|523806394|FG001|Continuation Period|Unstable persistent cancer pain|0|||
145262192|NCT00842829|523806395|FG002|Continuation Period|Unstable persistent cancer pain|3|||
145262193|NCT00842829|523806393|FG000|Continuation Period|Withdrawal by Subject|0|||
145262194|NCT00842829|523806394|FG001|Continuation Period|Withdrawal by Subject|0|||
145262195|NCT00842829|523806395|FG002|Continuation Period|Withdrawal by Subject|10|||
145262196|NCT00842829|523806393|FG000|Continuation Period|Other|0|||
145262197|NCT00842829|523806394|FG001|Continuation Period|Other|0|||
145262198|NCT00842829|523806395|FG002|Continuation Period|Other|7|||
145262199|NCT00842829|523806393|FG000|Continuation Period|Non-compliance to study procedures|0|||
145262200|NCT00842829|523806394|FG001|Continuation Period|Non-compliance to study procedures|0|||
145301891|NCT02689505|523956636|FG003|Overall Study|Other AE or clinical progression|2|||
145262201|NCT00842829|523806395|FG002|Continuation Period|Non-compliance to study procedures|2|||
145262202|NCT00842829|523806393|FG000|Continuation Period|Non-compliance to study drug|0|||
145301892|NCT02689505|523956637|FG004|Overall Study|Other AE or clinical progression|0|||
145568746|NCT00654381|524942277|FG004|Extension Stage|Lack of Efficacy|0|||
145568747|NCT00654381|524942278|FG005|Extension Stage|Lack of Efficacy|0|||
145301893|NCT00723710|523956641|FG000|Overall Study|Disease progression|48|||
145568748|NCT00654381|524942273|FG000|Extension Stage|Withdrawal by Subject|0|||
145568749|NCT00654381|524942274|FG001|Extension Stage|Withdrawal by Subject|0|||
145568750|NCT00654381|524942275|FG002|Extension Stage|Withdrawal by Subject|1|||
145568751|NCT00654381|524942276|FG003|Extension Stage|Withdrawal by Subject|1|||
145568752|NCT00654381|524942277|FG004|Extension Stage|Withdrawal by Subject|1|||
145301894|NCT00723710|523956641|FG000|Overall Study|Adverse Event|88|||
145301895|NCT00723710|523956641|FG000|Overall Study|Withdrawal by Subject|36|||
145301896|NCT00723710|523956641|FG000|Overall Study|Physician Decision|2|||
145301897|NCT04405570|523956642|FG000|Overall Study|Adverse Event|0|||
145301898|NCT04405570|523956643|FG001|Overall Study|Adverse Event|1|||
145301899|NCT04405570|523956644|FG002|Overall Study|Adverse Event|1|||
145301900|NCT04405570|523956645|FG003|Overall Study|Adverse Event|1|||
145301901|NCT04405570|523956642|FG000|Overall Study|Lost to Follow-up|0|||
145620289|NCT05764239|525123732|FG000|DEP (Part 1)|Lost to Follow-up|1|||
145620290|NCT05764239|525123732|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
145620291|NCT05764239|525123732|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
145620292|NCT05764239|525123732|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
145620293|NCT05764239|525123732|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
145620294|NCT05593211|525123733|FG000|Overall Study|Withdrawal by Subject|1|||
145620295|NCT03225846|525123734|FG000|Overall Study|Adverse Event|0|||
145620296|NCT03225846|525123735|FG001|Overall Study|Adverse Event|0|||
145620297|NCT03225846|525123736|FG002|Overall Study|Adverse Event|0|||
145301902|NCT04405570|523956643|FG001|Overall Study|Lost to Follow-up|1|||
145301903|NCT04405570|523956644|FG002|Overall Study|Lost to Follow-up|0|||
145301904|NCT04405570|523956645|FG003|Overall Study|Lost to Follow-up|0|||
145301905|NCT04405570|523956642|FG000|Overall Study|Physician Decision|0|||
145301906|NCT04405570|523956643|FG001|Overall Study|Physician Decision|0|||
145301907|NCT04405570|523956644|FG002|Overall Study|Physician Decision|1|||
145301908|NCT04405570|523956645|FG003|Overall Study|Physician Decision|0|||
145301909|NCT04405570|523956642|FG000|Overall Study|Withdrawal by Subject|0|||
145301910|NCT04405570|523956643|FG001|Overall Study|Withdrawal by Subject|1|||
145301911|NCT04405570|523956644|FG002|Overall Study|Withdrawal by Subject|1|||
145620298|NCT03225846|525123737|FG003|Overall Study|Adverse Event|0|||
145620299|NCT03225846|525123738|FG004|Overall Study|Adverse Event|0|||
145620300|NCT03225846|525123739|FG005|Overall Study|Adverse Event|0|||
145620301|NCT03225846|525123740|FG006|Overall Study|Adverse Event|6|||
145620302|NCT03225846|525123734|FG000|Overall Study|Withdrawal by Subject|0|||
145620303|NCT03225846|525123735|FG001|Overall Study|Withdrawal by Subject|1|||
145620304|NCT03225846|525123736|FG002|Overall Study|Withdrawal by Subject|0|||
145620305|NCT03225846|525123737|FG003|Overall Study|Withdrawal by Subject|0|||
145620306|NCT03225846|525123738|FG004|Overall Study|Withdrawal by Subject|0|||
145620307|NCT03225846|525123739|FG005|Overall Study|Withdrawal by Subject|0|||
145620308|NCT03225846|525123740|FG006|Overall Study|Withdrawal by Subject|0|||
145301912|NCT04405570|523956645|FG003|Overall Study|Withdrawal by Subject|0|||
145301913|NCT04405570|523956642|FG000|Overall Study|Randomized not dosed|0|||
145301914|NCT04405570|523956643|FG001|Overall Study|Randomized not dosed|2|||
145301915|NCT04405570|523956644|FG002|Overall Study|Randomized not dosed|0|||
145301916|NCT04405570|523956645|FG003|Overall Study|Randomized not dosed|0|||
145301917|NCT04499963|523956646|FG000|Overall Study|Adverse Event|3|||
145301918|NCT04499963|523956647|FG001|Overall Study|Adverse Event|0|||
145301919|NCT04499963|523956646|FG000|Overall Study|Death|3|||
145301920|NCT04499963|523956647|FG001|Overall Study|Death|0|||
145301921|NCT04499963|523956646|FG000|Overall Study|Lack of Efficacy|7|||
145301922|NCT04499963|523956647|FG001|Overall Study|Lack of Efficacy|0|||
145301923|NCT04499963|523956646|FG000|Overall Study|Lost to Follow-up|2|||
145301924|NCT04499963|523956647|FG001|Overall Study|Lost to Follow-up|0|||
145301925|NCT03546842|523956648|FG000|Overall Study|Protocol Violation|1|||
145301926|NCT03546842|523956648|FG000|Overall Study|Withdrawal by Subject|2|||
145301927|NCT02335658|523956659|FG000|Overall Study|Adverse Event|18|||
145301928|NCT02335658|523956660|FG001|Overall Study|Adverse Event|12|||
145301929|NCT02335658|523956659|FG000|Overall Study|Lack of Efficacy|4|||
145301930|NCT02335658|523956660|FG001|Overall Study|Lack of Efficacy|5|||
145301931|NCT02335658|523956659|FG000|Overall Study|Pregnancy|1|||
145301932|NCT02335658|523956660|FG001|Overall Study|Pregnancy|0|||
145568753|NCT00654381|524942278|FG005|Extension Stage|Withdrawal by Subject|1|||
145568754|NCT00654381|524942273|FG000|Extension Stage|Closure of the trial site|0|||
145620309|NCT03225846|525123734|FG000|Overall Study|Death|0|||
145620310|NCT03225846|525123735|FG001|Overall Study|Death|1|||
145620311|NCT03225846|525123736|FG002|Overall Study|Death|0|||
145620312|NCT03225846|525123737|FG003|Overall Study|Death|0|||
145301933|NCT02335658|523956659|FG000|Overall Study|Withdrawal by Subject|13|||
145301934|NCT02335658|523956660|FG001|Overall Study|Withdrawal by Subject|21|||
145301935|NCT02335658|523956659|FG000|Overall Study|non-compliance|2|||
145301936|NCT02335658|523956660|FG001|Overall Study|non-compliance|3|||
145568755|NCT00654381|524942274|FG001|Extension Stage|Closure of the trial site|0|||
145620313|NCT03225846|525123738|FG004|Overall Study|Death|0|||
145301937|NCT02335658|523956659|FG000|Overall Study|other reason|2|||
145301938|NCT02335658|523956660|FG001|Overall Study|other reason|3|||
145301939|NCT01424644|523956661|FG000|Overall Study|Adverse Event|2|||
145301940|NCT01424644|523956662|FG001|Overall Study|Adverse Event|0|||
145301941|NCT01424644|523956661|FG000|Overall Study|Withdrawal by Subject|9|||
145301942|NCT01424644|523956662|FG001|Overall Study|Withdrawal by Subject|12|||
145301943|NCT01424644|523956661|FG000|Overall Study|Lost to Follow-up|16|||
145301944|NCT01424644|523956662|FG001|Overall Study|Lost to Follow-up|12|||
145301945|NCT01424644|523956661|FG000|Overall Study|Protocol Violation|4|||
145301946|NCT01424644|523956662|FG001|Overall Study|Protocol Violation|3|||
145301947|NCT01424644|523956661|FG000|Overall Study|Administrative Reason|1|||
145301948|NCT01424644|523956662|FG001|Overall Study|Administrative Reason|0|||
145301949|NCT01424644|523956661|FG000|Overall Study|Unable to Classify|1|||
145301950|NCT01424644|523956662|FG001|Overall Study|Unable to Classify|0|||
145301951|NCT05593965|523956663|FG000|1st Intervention (1 Day)|Technical error|1|||
145301952|NCT05593965|523956664|FG001|1st Intervention (1 Day)|Technical error|0|||
145301953|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
145301954|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
145301955|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
145301956|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
145301957|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301958|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301959|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301960|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301961|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301962|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301963|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301964|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301965|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301966|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301967|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301968|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301969|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301970|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301971|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301972|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301973|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
145301974|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
145301975|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
145301976|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
145301977|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
145301978|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301979|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301980|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301981|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301982|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301983|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301984|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301985|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301986|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301987|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301988|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301989|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301990|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301991|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301992|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301993|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301994|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
145301995|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
145301996|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
145301997|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
145301998|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
145301999|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302000|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302001|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302002|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302003|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302004|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302005|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145620314|NCT03225846|525123739|FG005|Overall Study|Death|0|||
145302006|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302007|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302008|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302009|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302010|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302011|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302012|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302013|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302014|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302015|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
145302016|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
145302017|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
145302018|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
145302019|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302020|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302021|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302022|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302023|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302024|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302025|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302026|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302027|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302028|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302029|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302030|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302031|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302032|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302033|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302034|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302035|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302036|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
145302037|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
145302038|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302039|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302040|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
145302041|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302042|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302043|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302044|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302045|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302046|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302047|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302048|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302049|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302050|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302051|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302052|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302053|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302054|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302055|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302056|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302057|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
145302058|NCT01597245|523956667|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
145302059|NCT01597245|523956668|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
145302060|NCT01597245|523956669|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
145302061|NCT01597245|523956670|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302062|NCT01597245|523956671|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302063|NCT01597245|523956672|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302064|NCT01597245|523956673|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302065|NCT01597245|523956674|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145620315|NCT03225846|525123740|FG006|Overall Study|Death|0|||
145302066|NCT01597245|523956675|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302067|NCT01597245|523956676|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302068|NCT01597245|523956677|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302069|NCT01597245|523956678|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302070|NCT01597245|523956679|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145262203|NCT00842829|523806394|FG001|Continuation Period|Non-compliance to study drug|0|||
145262204|NCT00842829|523806395|FG002|Continuation Period|Non-compliance to study drug|1|||
145262205|NCT00660829|523806398|FG000|Overall Study|Adverse Event|3|||
145262206|NCT00660829|523806399|FG001|Overall Study|Adverse Event|4|||
145262207|NCT00660829|523806398|FG000|Overall Study|Lack of Efficacy|2|||
145262208|NCT00660829|523806399|FG001|Overall Study|Lack of Efficacy|3|||
145262209|NCT00660829|523806398|FG000|Overall Study|Non-Compliance|0|||
145262210|NCT00660829|523806399|FG001|Overall Study|Non-Compliance|4|||
145262211|NCT00660829|523806398|FG000|Overall Study|Withdrawal by Subject|1|||
145262212|NCT00660829|523806399|FG001|Overall Study|Withdrawal by Subject|2|||
145262213|NCT00660829|523806398|FG000|Overall Study|Lost to Follow-up|3|||
145262214|NCT00660829|523806399|FG001|Overall Study|Lost to Follow-up|2|||
145262215|NCT00660829|523806398|FG000|Overall Study|Other|9|||
145262216|NCT00660829|523806399|FG001|Overall Study|Other|4|||
145262217|NCT03590613|523806400|FG000|Period 2, 4 Days|Physician Decision|0|||
145262218|NCT03590613|523806401|FG001|Period 2, 4 Days|Physician Decision|0|||
145262219|NCT03590613|523806402|FG002|Period 2, 4 Days|Physician Decision|0|||
145262220|NCT03590613|523806403|FG003|Period 2, 4 Days|Physician Decision|1|||
145262221|NCT04369742|523806404|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
145262222|NCT04369742|523806405|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
145262223|NCT04369742|523806404|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
145262224|NCT04369742|523806405|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
145262225|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Death|2|||
145262226|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Death|0|||
145262227|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Adverse Event|33|||
145262228|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Adverse Event|31|||
145262229|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
145262230|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
145262231|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
145262232|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
145262233|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
145262234|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
145262235|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Other|7|||
145262236|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Other|8|||
145262237|NCT00280059|523806406|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
145262238|NCT00280059|523806407|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
145262239|NCT02127931|523806410|FG000|Overall Study|Glitch in Game|1|||
145262240|NCT01130831|523806411|FG000|Overall Study|Withdrawal by Subject|7|||
145262241|NCT01130831|523806411|FG000|Overall Study|Death|4|||
145262242|NCT01130831|523806411|FG000|Overall Study|Information was missing|3|||
145262243|NCT00951912|523806412|FG000|Overall Study|Lack of Efficacy|1|||
145262244|NCT00951912|523806413|FG001|Overall Study|Lack of Efficacy|0|||
145262245|NCT00951912|523806414|FG002|Overall Study|Lack of Efficacy|0|||
145262246|NCT00951912|523806412|FG000|Overall Study|Adverse Event|0|||
145262247|NCT00951912|523806413|FG001|Overall Study|Adverse Event|1|||
145262248|NCT00951912|523806414|FG002|Overall Study|Adverse Event|1|||
145262249|NCT00951912|523806412|FG000|Overall Study|Lost to Follow-up|2|||
145262250|NCT00951912|523806413|FG001|Overall Study|Lost to Follow-up|2|||
145262251|NCT00951912|523806414|FG002|Overall Study|Lost to Follow-up|0|||
145262252|NCT00951912|523806412|FG000|Overall Study|Physician Decision|1|||
145262253|NCT00951912|523806413|FG001|Overall Study|Physician Decision|0|||
145262254|NCT00951912|523806414|FG002|Overall Study|Physician Decision|1|||
145262255|NCT00951912|523806412|FG000|Overall Study|Withdrawal by Subject|1|||
145262256|NCT00951912|523806413|FG001|Overall Study|Withdrawal by Subject|1|||
145262257|NCT00951912|523806414|FG002|Overall Study|Withdrawal by Subject|0|||
145262258|NCT00951912|523806412|FG000|Overall Study|Other:Depression|1|||
145262259|NCT00951912|523806413|FG001|Overall Study|Other:Depression|0|||
145262260|NCT00951912|523806414|FG002|Overall Study|Other:Depression|0|||
145262261|NCT00951912|523806412|FG000|Overall Study|Other: Colon cancer|1|||
145262262|NCT00951912|523806413|FG001|Overall Study|Other: Colon cancer|0|||
145262263|NCT00951912|523806414|FG002|Overall Study|Other: Colon cancer|0|||
145262264|NCT00951912|523806412|FG000|Overall Study|Other: Stroke|0|||
145262265|NCT00951912|523806413|FG001|Overall Study|Other: Stroke|1|||
145262266|NCT00951912|523806414|FG002|Overall Study|Other: Stroke|0|||
145262267|NCT01377194|523806416|FG000|Overall Study|Adverse Event|3|||
145262268|NCT01377194|523806417|FG001|Overall Study|Adverse Event|12|||
145262269|NCT01377194|523806418|FG002|Overall Study|Adverse Event|19|||
145262270|NCT01377194|523806416|FG000|Overall Study|Lack of Efficacy|3|||
145262271|NCT01377194|523806417|FG001|Overall Study|Lack of Efficacy|3|||
145262272|NCT01377194|523806418|FG002|Overall Study|Lack of Efficacy|3|||
145262273|NCT01377194|523806416|FG000|Overall Study|Protocol Violation|4|||
145262274|NCT01377194|523806417|FG001|Overall Study|Protocol Violation|10|||
145262275|NCT01377194|523806418|FG002|Overall Study|Protocol Violation|6|||
145262276|NCT01377194|523806416|FG000|Overall Study|Withdrawal by Subject|8|||
145262277|NCT01377194|523806417|FG001|Overall Study|Withdrawal by Subject|10|||
145262278|NCT01377194|523806418|FG002|Overall Study|Withdrawal by Subject|7|||
145262279|NCT01377194|523806416|FG000|Overall Study|Lost to Follow-up|14|||
145262280|NCT01377194|523806417|FG001|Overall Study|Lost to Follow-up|8|||
145302071|NCT01597245|523956680|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302072|NCT01597245|523956681|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302073|NCT01597245|523956682|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302074|NCT01597245|523956683|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302075|NCT01597245|523956684|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302076|NCT01597245|523956685|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302077|NCT01597245|523956686|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302078|NCT01597245|523956687|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
145302079|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302080|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302081|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302082|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302083|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302084|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
145302085|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
145302086|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302087|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302088|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302089|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302090|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302091|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302092|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302093|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302094|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302095|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302096|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302097|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302098|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302099|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
145302100|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302101|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302102|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302103|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302104|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
145302105|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
145302106|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
145302107|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
145302108|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302109|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
145302110|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302111|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302112|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302113|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302114|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302115|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302116|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302117|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302118|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302119|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302120|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
145302121|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302122|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302123|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302124|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302125|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302126|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
145302127|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302128|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302129|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
145302130|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302131|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
145302132|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
145302133|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
145302134|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302135|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302136|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302137|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145568756|NCT00654381|524942275|FG002|Extension Stage|Closure of the trial site|0|||
145568757|NCT00654381|524942276|FG003|Extension Stage|Closure of the trial site|0|||
145568758|NCT00654381|524942277|FG004|Extension Stage|Closure of the trial site|1|||
145568759|NCT00654381|524942278|FG005|Extension Stage|Closure of the trial site|1|||
145568760|NCT00994448|524942279|FG000|Overall Study|Adverse Event|1|||
145568761|NCT00994448|524942280|FG001|Overall Study|Adverse Event|0|||
145302138|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302139|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302140|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302141|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
145302142|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302143|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302144|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302145|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302146|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
145302147|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
145302148|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
145302149|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
145302150|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
145302151|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
145302152|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
145302153|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
145302154|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
145302155|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302156|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302157|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302158|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302159|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302160|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302161|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302162|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
145302163|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302164|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302165|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302166|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302167|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
145302168|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
145302169|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
145302170|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302171|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
145302172|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
145302173|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
145302174|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
145302175|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
145302176|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302177|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302178|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302179|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302180|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302181|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302182|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302183|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
145302184|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302185|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302186|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145568762|NCT00994448|524942279|FG000|Overall Study|Lost to Follow-up|5|||
145568763|NCT00994448|524942280|FG001|Overall Study|Lost to Follow-up|1|||
145568764|NCT00994448|524942279|FG000|Overall Study|Withdrawal by Subject|1|||
145568765|NCT00994448|524942280|FG001|Overall Study|Withdrawal by Subject|1|||
145568766|NCT00994448|524942279|FG000|Overall Study|Physician Decision|1|||
145568767|NCT00994448|524942280|FG001|Overall Study|Physician Decision|0|||
145568768|NCT04164901|524942283|FG000|Overall Study|Withdrawal by Subject|4|||
145568769|NCT04164901|524942284|FG001|Overall Study|Withdrawal by Subject|4|||
145568770|NCT05358821|524942285|FG000|Overall Study|Withdrawal by Subject|0|||
145302187|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302188|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
145302189|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145568771|NCT05358821|524942286|FG001|Overall Study|Withdrawal by Subject|1|||
145568772|NCT05358821|524942287|FG002|Overall Study|Withdrawal by Subject|0|||
145568773|NCT05358821|524942285|FG000|Overall Study|Withdrawal of Consent|0|||
145568774|NCT05358821|524942286|FG001|Overall Study|Withdrawal of Consent|0|||
145302190|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302191|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302192|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
145302193|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
145302194|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
145302195|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302196|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
145302197|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302198|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302199|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302200|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302201|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302202|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302203|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302204|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
145302205|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302206|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302207|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302208|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302209|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
145302210|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
145302211|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
145302212|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302213|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
145302214|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
145302215|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
145302216|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
145302217|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
145302218|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302219|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302220|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302221|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302222|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302223|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302224|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302225|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
145302226|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302227|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302228|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302229|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302230|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302231|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
145302232|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302233|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302234|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
145302235|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
145302236|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
145302237|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
145302238|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145568775|NCT05358821|524942287|FG002|Overall Study|Withdrawal of Consent|1|||
145302239|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302240|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302241|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302242|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302243|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145568776|NCT04476017|524942291|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
145568777|NCT04476017|524942292|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
145410905|NCT00876343|524356872|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
145410906|NCT00876343|524356873|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
145568778|NCT02704364|524942293|FG000|Overall Study|Adverse Event|1|||
145568779|NCT02704364|524942294|FG001|Overall Study|Adverse Event|1|||
145568780|NCT02704364|524942295|FG002|Overall Study|Adverse Event|0|||
145568781|NCT02704364|524942293|FG000|Overall Study|Noncompliance with study drug|1|||
145568782|NCT02704364|524942294|FG001|Overall Study|Noncompliance with study drug|1|||
145568783|NCT02704364|524942295|FG002|Overall Study|Noncompliance with study drug|0|||
145568784|NCT02704364|524942293|FG000|Overall Study|Other|0|||
145568785|NCT02704364|524942294|FG001|Overall Study|Other|1|||
145568786|NCT02704364|524942295|FG002|Overall Study|Other|1|||
145568787|NCT00846742|524942296|FG000|Overall Study|Withdrawal by Subject|1|||
145568788|NCT02775344|524942298|FG000|Overall Study|No ovarian cyst identified|3|||
145568789|NCT02775344|524942299|FG001|Overall Study|No ovarian cyst identified|2|||
145568790|NCT04627064|524942300|FG000|Overall Study|Progressive disease|8|||
145568791|NCT04627064|524942301|FG001|Overall Study|Progressive disease|0|||
145262281|NCT01377194|523806418|FG002|Overall Study|Lost to Follow-up|11|||
145262282|NCT01728454|523806419|FG000|Stage 1 and 2|Pregnancy|1|||
145262283|NCT01728454|523806420|FG001|Stage 1 and 2|Pregnancy|0|||
145262284|NCT01728454|523806421|FG002|Stage 1 and 2|Pregnancy|0|||
145262285|NCT01728454|523806419|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
145262286|NCT01728454|523806420|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
145262287|NCT01728454|523806421|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
145262288|NCT01728454|523806419|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
145262289|NCT01728454|523806420|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
145262290|NCT01728454|523806421|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
145262291|NCT01728454|523806419|FG000|Stage 1 and 2|Lost to Follow-up|1|||
145262292|NCT01728454|523806420|FG001|Stage 1 and 2|Lost to Follow-up|1|||
145262293|NCT01728454|523806421|FG002|Stage 1 and 2|Lost to Follow-up|0|||
145262294|NCT01728454|523806419|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
145262295|NCT01728454|523806420|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
145262296|NCT01728454|523806421|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
145262297|NCT01728454|523806419|FG000|Stage 3|Reason Missing|0|||
145262298|NCT01728454|523806420|FG001|Stage 3|Reason Missing|0|||
145262299|NCT01728454|523806421|FG002|Stage 3|Reason Missing|1|||
145262300|NCT01728454|523806419|FG000|Stage 3|Subject Required Other Treatment|0|||
145262301|NCT01728454|523806420|FG001|Stage 3|Subject Required Other Treatment|1|||
145262302|NCT01728454|523806421|FG002|Stage 3|Subject Required Other Treatment|0|||
145262303|NCT01728454|523806419|FG000|Stage 3|Pregnancy|1|||
145262304|NCT01728454|523806420|FG001|Stage 3|Pregnancy|0|||
145262305|NCT01728454|523806421|FG002|Stage 3|Pregnancy|0|||
145262306|NCT01728454|523806419|FG000|Stage 3|Withdrew Consent|1|||
145262307|NCT01728454|523806420|FG001|Stage 3|Withdrew Consent|0|||
145262308|NCT01728454|523806421|FG002|Stage 3|Withdrew Consent|1|||
145262309|NCT01728454|523806419|FG000|Stage 3|Non-compliance with Protocol|0|||
145262310|NCT01728454|523806420|FG001|Stage 3|Non-compliance with Protocol|0|||
145262311|NCT01728454|523806421|FG002|Stage 3|Non-compliance with Protocol|1|||
145262312|NCT01728454|523806419|FG000|Stage 3|Lost to Follow-up|0|||
145262313|NCT01728454|523806420|FG001|Stage 3|Lost to Follow-up|3|||
145262314|NCT01728454|523806421|FG002|Stage 3|Lost to Follow-up|1|||
145262315|NCT01728454|523806419|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
145262316|NCT01728454|523806420|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
145262317|NCT01728454|523806421|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
145262318|NCT03077646|523806428|FG000|Overall Study|Lost to Follow-up|29|||
145262319|NCT03077646|523806429|FG001|Overall Study|Lost to Follow-up|30|||
145262320|NCT03077646|523806430|FG002|Overall Study|Lost to Follow-up|31|||
145262321|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
145262322|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
145262323|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
145262324|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
145262325|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
145262326|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
145262327|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
145262328|NCT00950755|523806431|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
145262329|NCT00950755|523806431|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
145262330|NCT00950755|523806431|FG000|Long-Term Follow-Up|Death|8|||
145262331|NCT00346775|523808411|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
145262332|NCT00346775|523808412|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
145262333|NCT00346775|523808411|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
145262334|NCT00346775|523808412|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
145262335|NCT00346775|523808411|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
145262336|NCT00346775|523808412|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
145262337|NCT01096017|523808415|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
145262338|NCT01096017|523808416|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
145302244|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302245|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302246|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
145302247|NCT01597245|523956667|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302248|NCT01597245|523956668|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302249|NCT01597245|523956669|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302250|NCT01597245|523956670|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302251|NCT01597245|523956671|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302252|NCT01597245|523956672|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302253|NCT01597245|523956673|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302254|NCT01597245|523956674|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302255|NCT01597245|523956675|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302256|NCT01597245|523956676|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302257|NCT01597245|523956677|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
145302258|NCT01597245|523956678|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302259|NCT01597245|523956679|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302260|NCT01597245|523956680|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302261|NCT01597245|523956681|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302262|NCT01597245|523956682|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302263|NCT01597245|523956683|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302264|NCT01597245|523956684|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302265|NCT01597245|523956685|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302266|NCT01597245|523956686|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302267|NCT01597245|523956687|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
145302268|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302269|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302270|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302271|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302272|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302273|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302274|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302275|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302276|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302277|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302278|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302279|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302280|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302281|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
145302282|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
145302283|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
145302284|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302285|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302286|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302287|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302288|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
145302289|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302290|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302291|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302292|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302293|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302294|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302295|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302296|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302297|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302298|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302299|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302300|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302301|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302302|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
145302303|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
145410907|NCT00876343|524356874|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
145410908|NCT00876343|524356872|FG000|Overall Study|Change of residence or other commitments|2|||
145410909|NCT00876343|524356873|FG001|Overall Study|Change of residence or other commitments|2|||
145410910|NCT00876343|524356874|FG002|Overall Study|Change of residence or other commitments|3|||
145302304|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
145302305|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302306|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302307|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302308|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302309|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
145302310|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302311|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302312|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302313|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302314|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302315|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302316|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302317|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302318|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302319|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302320|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302321|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302322|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302323|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302324|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
145302325|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
145302326|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302327|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302328|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302329|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302330|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
145302331|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302332|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302333|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302334|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302335|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302336|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302337|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302338|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302339|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302340|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302341|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302342|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302343|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302344|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302345|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
145302346|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
145302347|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145620316|NCT03225846|525123734|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
145302348|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302349|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302350|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302351|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
145302352|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302353|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302354|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302355|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302356|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302357|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302358|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302359|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302360|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302361|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302362|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302363|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145620317|NCT03225846|525123735|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
145620318|NCT03225846|525123736|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
145302364|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302365|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
145302366|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
145302367|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
145302368|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302369|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302370|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302371|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302372|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
145302373|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302374|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302375|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302376|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302377|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302378|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302379|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302380|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302381|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302382|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302383|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302384|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302385|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302386|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302387|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
145302388|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
145302389|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302390|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302391|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302392|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302393|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
145302394|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302395|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302396|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302397|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302398|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302399|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302400|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302401|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302402|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302403|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302404|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302405|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302406|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302407|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302408|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
145302409|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
145302410|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302411|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302412|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302413|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302414|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
145302415|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302416|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302417|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302418|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302419|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302420|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302421|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302422|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302423|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302424|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302425|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145568792|NCT04627064|524942300|FG000|Overall Study|Withdrawal by Subject|2|||
145568793|NCT04627064|524942301|FG001|Overall Study|Withdrawal by Subject|0|||
145568794|NCT04627064|524942300|FG000|Overall Study|Physician Decision|1|||
145568795|NCT04627064|524942301|FG001|Overall Study|Physician Decision|0|||
145568796|NCT00235872|524942304|FG000|Overall Study|Adverse Event|34|||
145568797|NCT00235872|524942304|FG000|Overall Study|Death|1|||
145568798|NCT00235872|524942304|FG000|Overall Study|Lost to Follow-up|1|||
145568799|NCT00235872|524942304|FG000|Overall Study|Withdrawal by Subject|50|||
145568800|NCT00235872|524942304|FG000|Overall Study|Administrative reason|61|||
145568801|NCT02126969|524942305|FG000|Overall Study|Withdrawal by Subject|1|||
145302426|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302427|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302428|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302429|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
145302430|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
145302431|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302432|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302433|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302434|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302435|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
145302436|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302437|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302438|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302439|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302440|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302441|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302442|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302443|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302444|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302445|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302446|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302447|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302448|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302449|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302450|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
145302451|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
145302452|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302453|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302454|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302455|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302456|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
145302457|NCT01597245|523956667|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302458|NCT01597245|523956668|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302459|NCT01597245|523956669|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302460|NCT01597245|523956670|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302461|NCT01597245|523956671|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302462|NCT01597245|523956672|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302463|NCT01597245|523956673|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302464|NCT01597245|523956674|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302465|NCT01597245|523956675|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302466|NCT01597245|523956676|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302467|NCT01597245|523956677|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302468|NCT01597245|523956678|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302469|NCT01597245|523956679|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302470|NCT01597245|523956680|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
145302471|NCT01597245|523956681|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302472|NCT01597245|523956682|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302473|NCT01597245|523956683|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302474|NCT01597245|523956684|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302475|NCT01597245|523956685|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145410911|NCT04717557|524356886|FG000|Overall Study|Withdrawal by Subject|2|||
145410912|NCT04717557|524356887|FG001|Overall Study|Withdrawal by Subject|0|||
145410913|NCT04717557|524356886|FG000|Overall Study|Death|1|||
145410914|NCT04717557|524356887|FG001|Overall Study|Death|0|||
145568802|NCT02126969|524942306|FG001|Overall Study|Withdrawal by Subject|2|||
145568803|NCT01533246|524942309|FG000|Overall Study|Adverse Event|1|||
145568804|NCT01533246|524942309|FG000|Overall Study|Withdrawal by Subject|1|||
145568805|NCT00354172|524942310|FG000|Overall Study|Did not receive transplant|1|||
145568806|NCT01800916|524942311|FG000|Test Period 1 (1 Week)|Convex product user|0|||
145568807|NCT01800916|524942312|FG001|Test Period 1 (1 Week)|Convex product user|0|||
145302476|NCT01597245|523956686|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302477|NCT01597245|523956687|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
145302478|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302479|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302480|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302481|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302482|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302483|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302484|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302485|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302486|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302487|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302488|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302489|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302490|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302491|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302492|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302493|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
145302494|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
145302495|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
145302496|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
145302497|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
145302498|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
145302499|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302500|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302501|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302502|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302503|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302504|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302505|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302506|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302507|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302508|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302509|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145568808|NCT01800916|524942313|FG002|Test Period 1 (1 Week)|Convex product user|0|||
145568809|NCT01800916|524942314|FG003|Test Period 1 (1 Week)|Convex product user|1|||
145302510|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302511|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302512|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302513|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302514|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302515|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
145302516|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
145302517|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
145302518|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
145302519|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
145302520|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302521|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302522|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302523|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302524|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302525|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302526|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302527|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302528|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302529|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302530|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145410915|NCT06354257|524356890|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145568810|NCT01800916|524942315|FG004|Test Period 1 (1 Week)|Convex product user|0|||
145568811|NCT01800916|524942316|FG005|Test Period 1 (1 Week)|Convex product user|0|||
145302531|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302532|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145568812|NCT01800916|524942317|FG006|Test Period 1 (1 Week)|Convex product user|0|||
145568813|NCT01800916|524942318|FG007|Test Period 1 (1 Week)|Convex product user|0|||
145410916|NCT06354257|524356890|FG000|Treatment Period 2|Adverse Event|1|||
145410917|NCT02685735|524356891|FG000|Overall Study|Surgery Cancelled|4|||
145410918|NCT02685735|524356892|FG001|Overall Study|Surgery Cancelled|9|||
145410919|NCT02685735|524356891|FG000|Overall Study|Adverse Event|10|||
145302533|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302534|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302535|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302536|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
145302537|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302538|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
145302539|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
145302540|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
145302541|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302542|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302543|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302544|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302545|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302546|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302547|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302548|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302549|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302550|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302551|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302552|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302553|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302554|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302555|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302556|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302557|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302558|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
145302559|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
145302560|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
145302561|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
145302562|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302563|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302564|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302565|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302566|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302567|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302568|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302569|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302570|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302571|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302572|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302573|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302574|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302575|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302576|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302577|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302578|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
145302579|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302580|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
145302581|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
145410920|NCT02685735|524356892|FG001|Overall Study|Adverse Event|3|||
145410921|NCT02685735|524356891|FG000|Overall Study|Preop testing found to be incomplete|2|||
145302582|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
145302583|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302584|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302585|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302586|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145410922|NCT02685735|524356892|FG001|Overall Study|Preop testing found to be incomplete|2|||
145568814|NCT01800916|524942319|FG008|Test Period 1 (1 Week)|Convex product user|0|||
145568815|NCT01800916|524942311|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
145568816|NCT01800916|524942312|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
145302587|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302588|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302589|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302590|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302591|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302592|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302593|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302594|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302595|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302596|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302597|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302598|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302599|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
145302600|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302601|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
145302602|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
145302603|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
145302604|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302605|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302606|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302607|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302608|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302609|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302610|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302611|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302612|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302613|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302614|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302615|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302616|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302617|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302618|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302619|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302620|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
145302621|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145410923|NCT02685735|524356891|FG000|Overall Study|Withdrawal by Subject|1|||
145410924|NCT02685735|524356892|FG001|Overall Study|Withdrawal by Subject|2|||
145410925|NCT02685735|524356891|FG000|Overall Study|Death|1|||
145302622|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302623|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
145302624|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
145302625|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302626|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302627|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302628|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302629|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302630|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302631|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302632|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302633|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302634|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302635|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302636|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302637|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302638|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302639|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302640|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302641|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
145302642|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302643|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145410926|NCT02685735|524356892|FG001|Overall Study|Death|0|||
145410927|NCT04132050|524356893|FG000|Period I (Double-blind Period)|Adverse Event|3|||
145410928|NCT04132050|524356894|FG001|Period I (Double-blind Period)|Adverse Event|0|||
145620319|NCT03225846|525123737|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
145302644|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
145302645|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
145302646|NCT01597245|523956667|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302647|NCT01597245|523956668|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302648|NCT01597245|523956669|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302649|NCT01597245|523956670|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302650|NCT01597245|523956671|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302651|NCT01597245|523956672|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302652|NCT01597245|523956673|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302653|NCT01597245|523956674|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302654|NCT01597245|523956675|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302655|NCT01597245|523956676|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302656|NCT01597245|523956677|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302657|NCT01597245|523956678|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302658|NCT01597245|523956679|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302659|NCT01597245|523956680|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302660|NCT01597245|523956681|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302661|NCT01597245|523956682|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302662|NCT01597245|523956683|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302663|NCT01597245|523956684|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302664|NCT01597245|523956685|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302665|NCT01597245|523956686|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
145302666|NCT01597245|523956687|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
145302667|NCT00731783|523956688|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
145302668|NCT00731783|523956689|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
145302669|NCT00731783|523956688|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
145302670|NCT00731783|523956689|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
145302671|NCT00731783|523956688|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
145302672|NCT00731783|523956689|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
145302673|NCT00731783|523956688|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
145302674|NCT00731783|523956689|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
145302675|NCT01802320|523956690|FG000|Overall Study|Death|1|||
145302676|NCT01802320|523956690|FG000|Overall Study|Withdrawal by Subject|1|||
145302677|NCT03181594|523958396|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
145302678|NCT03181594|523958396|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
145302679|NCT03181594|523958396|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
145302680|NCT03181594|523958396|FG000|Initial Study Protocol (12-month FU)|Death|1|||
145302681|NCT03181594|523958396|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
145302682|NCT03181594|523958396|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
145302683|NCT00960297|523958399|FG000|Overall Study|Physician Decision|1|||
145302684|NCT00960297|523958399|FG000|Overall Study|Venous port infection|1|||
145302685|NCT00960297|523958399|FG000|Overall Study|Disease progression|1|||
145302686|NCT03247972|523958409|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
145302687|NCT03247972|523958409|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
145302688|NCT03500341|523958410|FG000|Overall Study|Withdrawn prior to Completion|2|||
145302689|NCT00968812|523958411|FG000|Overall Study|Adverse Event|30|||
145302690|NCT00968812|523958412|FG001|Overall Study|Adverse Event|46|||
145302691|NCT00968812|523958413|FG002|Overall Study|Adverse Event|33|||
145302692|NCT00968812|523958411|FG000|Overall Study|Death|2|||
145302693|NCT00968812|523958412|FG001|Overall Study|Death|2|||
145302694|NCT00968812|523958413|FG002|Overall Study|Death|1|||
145302695|NCT00968812|523958411|FG000|Overall Study|Lack of Efficacy|9|||
145302696|NCT00968812|523958412|FG001|Overall Study|Lack of Efficacy|7|||
145302697|NCT00968812|523958413|FG002|Overall Study|Lack of Efficacy|16|||
145302698|NCT00968812|523958411|FG000|Overall Study|Lost to Follow-up|17|||
145302699|NCT00968812|523958412|FG001|Overall Study|Lost to Follow-up|12|||
145302700|NCT00968812|523958413|FG002|Overall Study|Lost to Follow-up|11|||
145302701|NCT00968812|523958411|FG000|Overall Study|Physician Decision|8|||
145302702|NCT00968812|523958412|FG001|Overall Study|Physician Decision|5|||
145302703|NCT00968812|523958413|FG002|Overall Study|Physician Decision|9|||
145302704|NCT00968812|523958411|FG000|Overall Study|Protocol Violation|7|||
145302705|NCT00968812|523958412|FG001|Overall Study|Protocol Violation|4|||
145302706|NCT00968812|523958413|FG002|Overall Study|Protocol Violation|3|||
145302707|NCT00968812|523958411|FG000|Overall Study|Withdrawal by Subject|17|||
145302708|NCT00968812|523958412|FG001|Overall Study|Withdrawal by Subject|23|||
145302709|NCT00968812|523958413|FG002|Overall Study|Withdrawal by Subject|25|||
145302710|NCT00968812|523958411|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
145302711|NCT00968812|523958412|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
145302712|NCT00968812|523958413|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
145302713|NCT00968812|523958411|FG000|Overall Study|Noncompliance with study drug|4|||
145620320|NCT03225846|525123738|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
145302714|NCT00968812|523958412|FG001|Overall Study|Noncompliance with study drug|1|||
145302715|NCT00968812|523958413|FG002|Overall Study|Noncompliance with study drug|6|||
145302716|NCT00968812|523958411|FG000|Overall Study|Unable to take rescue therapy|12|||
145302717|NCT00968812|523958412|FG001|Overall Study|Unable to take rescue therapy|12|||
145302718|NCT00968812|523958413|FG002|Overall Study|Unable to take rescue therapy|17|||
145302719|NCT00968812|523958411|FG000|Overall Study|Other|25|||
145302720|NCT00968812|523958412|FG001|Overall Study|Other|37|||
145302721|NCT00968812|523958413|FG002|Overall Study|Other|40|||
145302722|NCT02576938|523958416|FG000|Overall Study|Adverse Event|5|||
145302723|NCT02576938|523958417|FG001|Overall Study|Adverse Event|3|||
145302724|NCT02576938|523958418|FG002|Overall Study|Adverse Event|6|||
145302725|NCT02576938|523958416|FG000|Overall Study|Protocol Violation|1|||
145302726|NCT02576938|523958417|FG001|Overall Study|Protocol Violation|1|||
145302727|NCT02576938|523958418|FG002|Overall Study|Protocol Violation|1|||
145302728|NCT02576938|523958416|FG000|Overall Study|Withdrawal by Subject|3|||
145302729|NCT02576938|523958417|FG001|Overall Study|Withdrawal by Subject|2|||
145302730|NCT02576938|523958418|FG002|Overall Study|Withdrawal by Subject|4|||
145302731|NCT02576938|523958416|FG000|Overall Study|Lack of Efficacy|9|||
145302732|NCT02576938|523958417|FG001|Overall Study|Lack of Efficacy|4|||
145302733|NCT02576938|523958418|FG002|Overall Study|Lack of Efficacy|0|||
145302734|NCT02576938|523958416|FG000|Overall Study|Lost to Follow-up|2|||
145302735|NCT02576938|523958417|FG001|Overall Study|Lost to Follow-up|0|||
145302736|NCT02576938|523958418|FG002|Overall Study|Lost to Follow-up|1|||
145302737|NCT02576938|523958416|FG000|Overall Study|Physician Decision|0|||
145302738|NCT02576938|523958417|FG001|Overall Study|Physician Decision|1|||
145302739|NCT02576938|523958418|FG002|Overall Study|Physician Decision|0|||
145302740|NCT02576938|523958416|FG000|Overall Study|Met Exclusion Criteria|0|||
145302741|NCT02576938|523958417|FG001|Overall Study|Met Exclusion Criteria|1|||
145302742|NCT02576938|523958418|FG002|Overall Study|Met Exclusion Criteria|0|||
145302743|NCT00571064|523958421|FG000|Overall Study|Adverse Event|13|||
145302744|NCT00571064|523958421|FG000|Overall Study|Protocol Violation|4|||
145302745|NCT00571064|523958421|FG000|Overall Study|Withdrawal by Subject|2|||
145302746|NCT00571064|523958421|FG000|Overall Study|Other|2|||
145302747|NCT00003659|523958428|FG000|Overall Study|Withdrawal by Subject|3|||
145302748|NCT04022954|523958429|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
145302749|NCT04022954|523958429|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
145302750|NCT04022954|523958429|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
145302751|NCT03017885|523958430|FG000|Overall Study|Adverse Event|2|||
145302752|NCT03017885|523958431|FG001|Overall Study|Adverse Event|0|||
145302753|NCT03017885|523958432|FG002|Overall Study|Adverse Event|0|||
145302754|NCT03017885|523958433|FG003|Overall Study|Adverse Event|0|||
145302755|NCT03017885|523958434|FG004|Overall Study|Adverse Event|0|||
145302756|NCT03017885|523958435|FG005|Overall Study|Adverse Event|0|||
145302757|NCT03017885|523958430|FG000|Overall Study|Progression of disease|4|||
145302758|NCT03017885|523958431|FG001|Overall Study|Progression of disease|3|||
145302759|NCT03017885|523958432|FG002|Overall Study|Progression of disease|4|||
145302760|NCT03017885|523958433|FG003|Overall Study|Progression of disease|0|||
145302761|NCT03017885|523958434|FG004|Overall Study|Progression of disease|0|||
145302762|NCT03017885|523958435|FG005|Overall Study|Progression of disease|0|||
145302763|NCT03017885|523958430|FG000|Overall Study|Other than listed|1|||
145302764|NCT03017885|523958431|FG001|Overall Study|Other than listed|2|||
145302765|NCT03017885|523958432|FG002|Overall Study|Other than listed|1|||
145302766|NCT03017885|523958433|FG003|Overall Study|Other than listed|0|||
145302767|NCT03017885|523958434|FG004|Overall Study|Other than listed|0|||
145302768|NCT03017885|523958435|FG005|Overall Study|Other than listed|0|||
145302769|NCT03017885|523958430|FG000|Overall Study|Lost to Follow-up|2|||
145302770|NCT03017885|523958431|FG001|Overall Study|Lost to Follow-up|0|||
145302771|NCT03017885|523958432|FG002|Overall Study|Lost to Follow-up|3|||
145302772|NCT03017885|523958433|FG003|Overall Study|Lost to Follow-up|0|||
145302773|NCT03017885|523958434|FG004|Overall Study|Lost to Follow-up|0|||
145302774|NCT03017885|523958435|FG005|Overall Study|Lost to Follow-up|0|||
145302775|NCT03017885|523958430|FG000|Overall Study|Change to other anti-cancer therapy|0|||
145302776|NCT03017885|523958431|FG001|Overall Study|Change to other anti-cancer therapy|0|||
145302777|NCT03017885|523958432|FG002|Overall Study|Change to other anti-cancer therapy|1|||
145620321|NCT03225846|525123739|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
145620322|NCT03225846|525123740|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
145302778|NCT03017885|523958433|FG003|Overall Study|Change to other anti-cancer therapy|0|||
145302779|NCT03017885|523958434|FG004|Overall Study|Change to other anti-cancer therapy|0|||
145302780|NCT03017885|523958435|FG005|Overall Study|Change to other anti-cancer therapy|0|||
145302781|NCT02258074|523958437|FG000|Overall Study|Withdrawal by Subject|1|||
145302782|NCT02258074|523958438|FG001|Overall Study|Withdrawal by Subject|0|||
145302783|NCT02258074|523958439|FG002|Overall Study|Withdrawal by Subject|0|||
145302784|NCT02258074|523958440|FG003|Overall Study|Withdrawal by Subject|0|||
145302785|NCT05446870|523958441|FG000|Overall Study|Death|6|||
145410929|NCT04132050|524356893|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
145410930|NCT04132050|524356894|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
145302786|NCT05446870|523958442|FG001|Overall Study|Death|5|||
145302787|NCT05446870|523958441|FG000|Overall Study|Lost to Follow-up|0|||
145302788|NCT05446870|523958442|FG001|Overall Study|Lost to Follow-up|1|||
145302789|NCT05446870|523958441|FG000|Overall Study|Physician Decision|52|||
145302790|NCT05446870|523958442|FG001|Overall Study|Physician Decision|53|||
145302791|NCT05446870|523958441|FG000|Overall Study|Withdrawal by Subject|3|||
145302792|NCT05446870|523958442|FG001|Overall Study|Withdrawal by Subject|3|||
145302793|NCT04108858|523958444|FG000|Overall Study|Adverse Event|1|||
145302794|NCT01005745|523958445|FG000|Overall Study|No TIL growth|1|||
145302795|NCT01005745|523958445|FG000|Overall Study|Disease progressed during TIL growth|3|||
145302796|NCT01005745|523958445|FG000|Overall Study|Death prior to treatment|1|||
145302797|NCT01005745|523958445|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
145302798|NCT01208337|523958450|FG000|Overall Study|Death|3|||
145302799|NCT03663179|523958454|FG000|Overall Study|Withdrawal by Subject|2|||
145302800|NCT03663179|523958455|FG001|Overall Study|Withdrawal by Subject|0|||
145302801|NCT03663179|523958454|FG000|Overall Study|Lost to Follow-up|1|||
145302802|NCT03663179|523958455|FG001|Overall Study|Lost to Follow-up|1|||
145302803|NCT03663179|523958454|FG000|Overall Study|Revealed exclusionary condition|1|||
145302804|NCT03663179|523958455|FG001|Overall Study|Revealed exclusionary condition|0|||
145302805|NCT01615198|523958459|FG000|Overall Study|Withdrawal by Subject|5|||
145302806|NCT01615198|523958460|FG001|Overall Study|Withdrawal by Subject|5|||
145302807|NCT01615198|523958459|FG000|Overall Study|Protocol deviation|1|||
145302808|NCT01615198|523958460|FG001|Overall Study|Protocol deviation|1|||
145302809|NCT01615198|523958459|FG000|Overall Study|Physician Decision|5|||
145302810|NCT01615198|523958460|FG001|Overall Study|Physician Decision|1|||
145302811|NCT01615198|523958459|FG000|Overall Study|Lost to Follow-up|1|||
145302812|NCT01615198|523958460|FG001|Overall Study|Lost to Follow-up|1|||
145302813|NCT01615198|523958459|FG000|Overall Study|Lack of Efficacy|1|||
145302814|NCT01615198|523958460|FG001|Overall Study|Lack of Efficacy|6|||
145302815|NCT01615198|523958459|FG000|Overall Study|Adverse Event|11|||
145302816|NCT01615198|523958460|FG001|Overall Study|Adverse Event|5|||
145302817|NCT01686438|523958461|FG000|Overall Study|Lost to Follow-up|8|||
145302818|NCT01686438|523958462|FG001|Overall Study|Lost to Follow-up|9|||
145302819|NCT01686438|523958463|FG002|Overall Study|Lost to Follow-up|10|||
145302820|NCT01686438|523958461|FG000|Overall Study|Adverse Event|0|||
145302821|NCT01686438|523958462|FG001|Overall Study|Adverse Event|0|||
145302822|NCT01686438|523958463|FG002|Overall Study|Adverse Event|1|||
145302823|NCT01686438|523958461|FG000|Overall Study|Protocol Violation|0|||
145302824|NCT01686438|523958462|FG001|Overall Study|Protocol Violation|0|||
145302825|NCT01686438|523958463|FG002|Overall Study|Protocol Violation|1|||
145302826|NCT01686438|523958461|FG000|Overall Study|Withdrawal by Subject|0|||
145302827|NCT01686438|523958462|FG001|Overall Study|Withdrawal by Subject|0|||
145302828|NCT01686438|523958463|FG002|Overall Study|Withdrawal by Subject|1|||
145302829|NCT00984126|523958464|FG000|Overall Study|Protocol Violation|0|||
145302830|NCT00984126|523958465|FG001|Overall Study|Protocol Violation|0|||
145302831|NCT00984126|523958466|FG002|Overall Study|Protocol Violation|1|||
145302832|NCT00984126|523958467|FG003|Overall Study|Protocol Violation|2|||
145302833|NCT00984126|523958464|FG000|Overall Study|Adverse Event|0|||
145302834|NCT00984126|523958465|FG001|Overall Study|Adverse Event|0|||
145302835|NCT00984126|523958466|FG002|Overall Study|Adverse Event|0|||
145302836|NCT00984126|523958467|FG003|Overall Study|Adverse Event|2|||
145302837|NCT00984126|523958464|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
145302838|NCT00984126|523958465|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
145302839|NCT00984126|523958466|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
145302840|NCT00984126|523958467|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
145302841|NCT00984126|523958464|FG000|Overall Study|Withdrawal criteria|0|||
145302842|NCT00984126|523958465|FG001|Overall Study|Withdrawal criteria|1|||
145302843|NCT00984126|523958466|FG002|Overall Study|Withdrawal criteria|3|||
145302844|NCT00984126|523958467|FG003|Overall Study|Withdrawal criteria|9|||
145302845|NCT01029340|523958468|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
145302846|NCT01029340|523958469|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
145302847|NCT01029340|523958470|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
145302848|NCT01029340|523958471|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
145302849|NCT01029340|523958472|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
145302850|NCT01029340|523958473|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
145302851|NCT01029340|523958468|FG000|Part B Treatment Period|Protocol Violation|0|||
145302852|NCT01029340|523958469|FG001|Part B Treatment Period|Protocol Violation|0|||
145302853|NCT01029340|523958470|FG002|Part B Treatment Period|Protocol Violation|1|||
145302854|NCT01029340|523958471|FG003|Part B Treatment Period|Protocol Violation|0|||
145302855|NCT01029340|523958472|FG004|Part B Treatment Period|Protocol Violation|0|||
145302856|NCT01029340|523958473|FG005|Part B Treatment Period|Protocol Violation|0|||
145302857|NCT01029340|523958468|FG000|Extension Period|Adverse Event|0|||
145302858|NCT01029340|523958469|FG001|Extension Period|Adverse Event|0|||
145302859|NCT01029340|523958470|FG002|Extension Period|Adverse Event|0|||
145302860|NCT01029340|523958471|FG003|Extension Period|Adverse Event|0|||
145302861|NCT01029340|523958472|FG004|Extension Period|Adverse Event|0|||
145302862|NCT01029340|523958473|FG005|Extension Period|Adverse Event|1|||
145302863|NCT01029340|523958468|FG000|Extension Period|starting another study|0|||
145410931|NCT04132050|524356893|FG000|R788 Treatment Period|Adverse Event|5|||
145410932|NCT04132050|524356894|FG001|R788 Treatment Period|Adverse Event|0|||
145410933|NCT04132050|524356893|FG000|R788 Treatment Period|Lack of Efficacy|5|||
145410934|NCT04132050|524356894|FG001|R788 Treatment Period|Lack of Efficacy|0|||
145410935|NCT04132050|524356893|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
145568817|NCT01800916|524942313|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
145262339|NCT03778021|523808425|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
145262340|NCT03778021|523808426|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
145262341|NCT01545375|523808427|FG000|Overall Study|Adverse Event|2|||
145262342|NCT01545375|523808428|FG001|Overall Study|Adverse Event|1|||
145262343|NCT01545375|523808427|FG000|Overall Study|Lost to Follow-up|34|||
145262344|NCT01545375|523808428|FG001|Overall Study|Lost to Follow-up|31|||
145262345|NCT01545375|523808427|FG000|Overall Study|Protocol Violation|3|||
145262346|NCT01545375|523808428|FG001|Overall Study|Protocol Violation|3|||
145262347|NCT01545375|523808427|FG000|Overall Study|Withdrawal by Subject|58|||
145262348|NCT01545375|523808428|FG001|Overall Study|Withdrawal by Subject|55|||
145262349|NCT00679042|523808429|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
145262350|NCT00679042|523808429|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
145262351|NCT00679042|523808429|FG000|5-Year Follow Up|Death|1|||
145262352|NCT00679042|523808429|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
145262353|NCT00679042|523808429|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
145262354|NCT02687815|523808430|FG000|Overall Study|Lost to Follow-up|2|||
145262355|NCT02687815|523808431|FG001|Overall Study|Lost to Follow-up|4|||
145262356|NCT02687815|523808430|FG000|Overall Study|Withdrawal by Subject|2|||
145262357|NCT02687815|523808431|FG001|Overall Study|Withdrawal by Subject|4|||
145262358|NCT04177862|523808432|FG000|Overall Study|Protocol Violation|2|||
145262359|NCT04177862|523808433|FG001|Overall Study|Protocol Violation|7|||
145262360|NCT05637515|523808436|FG000|Overall Study|Withdrawal by Subject|17|||
145262361|NCT05637515|523808437|FG001|Overall Study|Withdrawal by Subject|17|||
145262362|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
145262363|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
145262364|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262365|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262366|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262367|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262368|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262369|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262370|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262371|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262372|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262373|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
145262374|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
145262375|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262376|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262377|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262378|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262379|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262380|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
145262381|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262382|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262383|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262384|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
145262385|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
145262386|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262387|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
145262388|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262389|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262390|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262391|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262392|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262393|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262394|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262395|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262396|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262397|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
145262398|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
145262399|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
145262400|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
145262401|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
145302864|NCT01029340|523958469|FG001|Extension Period|starting another study|0|||
145302865|NCT01029340|523958470|FG002|Extension Period|starting another study|0|||
145302866|NCT01029340|523958471|FG003|Extension Period|starting another study|0|||
145302867|NCT01029340|523958472|FG004|Extension Period|starting another study|0|||
145302868|NCT01029340|523958473|FG005|Extension Period|starting another study|8|||
145302869|NCT01029340|523958468|FG000|Extension Period|non-compliance|0|||
145302870|NCT01029340|523958469|FG001|Extension Period|non-compliance|0|||
145302871|NCT01029340|523958470|FG002|Extension Period|non-compliance|0|||
145302872|NCT01029340|523958471|FG003|Extension Period|non-compliance|0|||
145302873|NCT01029340|523958472|FG004|Extension Period|non-compliance|0|||
145302874|NCT01029340|523958473|FG005|Extension Period|non-compliance|1|||
145302875|NCT01029340|523958468|FG000|Extension Period|Withdrawal by Subject|0|||
145302876|NCT01029340|523958469|FG001|Extension Period|Withdrawal by Subject|0|||
145302877|NCT01029340|523958470|FG002|Extension Period|Withdrawal by Subject|0|||
145302878|NCT01029340|523958471|FG003|Extension Period|Withdrawal by Subject|0|||
145302879|NCT01029340|523958472|FG004|Extension Period|Withdrawal by Subject|0|||
145302880|NCT01029340|523958473|FG005|Extension Period|Withdrawal by Subject|1|||
145302881|NCT01029340|523958468|FG000|Extension Period|Physician Decision|0|||
145302882|NCT01029340|523958469|FG001|Extension Period|Physician Decision|0|||
145302883|NCT01029340|523958470|FG002|Extension Period|Physician Decision|0|||
145302884|NCT01029340|523958471|FG003|Extension Period|Physician Decision|0|||
145302885|NCT01029340|523958472|FG004|Extension Period|Physician Decision|0|||
145302886|NCT01029340|523958473|FG005|Extension Period|Physician Decision|1|||
145302887|NCT01864174|523958474|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
145302888|NCT01864174|523958475|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
145302889|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
145302890|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
145302891|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
145302892|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
145302893|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
145302894|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
145302895|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Death|1|||
145302896|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Death|0|||
145302897|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
145302898|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
145302899|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
145302900|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
145302901|NCT01864174|523958474|FG000|Double Blind - Compliant Randomized|Other|6|||
145302902|NCT01864174|523958475|FG001|Double Blind - Compliant Randomized|Other|10|||
145302903|NCT01864174|523958474|FG000|Off Treatment Follow-Up|Other|2|||
145302904|NCT01864174|523958475|FG001|Off Treatment Follow-Up|Other|0|||
145302905|NCT01864174|523958474|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
145302906|NCT01864174|523958475|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
145302907|NCT02648347|523958476|FG000|Overall Study|Death|174|||
145302908|NCT02648347|523958477|FG001|Overall Study|Death|167|||
145302909|NCT02648347|523958476|FG000|Overall Study|Withdrawal by Subject|16|||
145302910|NCT02648347|523958477|FG001|Overall Study|Withdrawal by Subject|9|||
145302911|NCT02648347|523958476|FG000|Overall Study|Lost to Follow-up|18|||
145302912|NCT02648347|523958477|FG001|Overall Study|Lost to Follow-up|21|||
145302913|NCT02648347|523958476|FG000|Overall Study|Missing|1|||
145302914|NCT02648347|523958477|FG001|Overall Study|Missing|0|||
145302915|NCT02739997|523958482|FG000|Overall Study|Death|1|||
145302916|NCT02739997|523958482|FG000|Overall Study|Withdrawal by Subject|1|||
145302917|NCT01723397|523958483|FG000|Study Period 1|Protocol Violation|0|||
145302918|NCT01723397|523958484|FG001|Study Period 1|Protocol Violation|1|||
145302919|NCT01723397|523958483|FG000|Study Period 2|Protocol Violation|0|||
145302920|NCT01723397|523958484|FG001|Study Period 2|Protocol Violation|1|||
145302921|NCT01474551|523958488|FG000|Overall Study|Death|1|||
145302922|NCT01854047|523958489|FG000|Overall Study|Lack of Efficacy|1|||
145302923|NCT01854047|523958490|FG001|Overall Study|Lack of Efficacy|0|||
145302924|NCT01854047|523958491|FG002|Overall Study|Lack of Efficacy|0|||
145302925|NCT01854047|523958492|FG003|Overall Study|Lack of Efficacy|0|||
145302926|NCT01854047|523958493|FG004|Overall Study|Lack of Efficacy|0|||
145302927|NCT01854047|523958489|FG000|Overall Study|Poor compliance to protocol|3|||
145302928|NCT01854047|523958490|FG001|Overall Study|Poor compliance to protocol|0|||
145302929|NCT01854047|523958491|FG002|Overall Study|Poor compliance to protocol|2|||
145302930|NCT01854047|523958492|FG003|Overall Study|Poor compliance to protocol|0|||
145302931|NCT01854047|523958493|FG004|Overall Study|Poor compliance to protocol|0|||
145302932|NCT01854047|523958489|FG000|Overall Study|Adverse Event|5|||
145302933|NCT01854047|523958490|FG001|Overall Study|Adverse Event|4|||
145302934|NCT01854047|523958491|FG002|Overall Study|Adverse Event|6|||
145302935|NCT01854047|523958492|FG003|Overall Study|Adverse Event|10|||
145302936|NCT01854047|523958493|FG004|Overall Study|Adverse Event|7|||
145302937|NCT01854047|523958489|FG000|Overall Study|Randomized but not treated|0|||
145302938|NCT01854047|523958490|FG001|Overall Study|Randomized but not treated|1|||
145302939|NCT01854047|523958491|FG002|Overall Study|Randomized but not treated|2|||
145302940|NCT01854047|523958492|FG003|Overall Study|Randomized but not treated|0|||
145302941|NCT01854047|523958493|FG004|Overall Study|Randomized but not treated|4|||
145302942|NCT01854047|523958489|FG000|Overall Study|Other than specified above|3|||
145302943|NCT01854047|523958490|FG001|Overall Study|Other than specified above|3|||
145302944|NCT01854047|523958491|FG002|Overall Study|Other than specified above|3|||
145302945|NCT01854047|523958492|FG003|Overall Study|Other than specified above|5|||
145302946|NCT01854047|523958493|FG004|Overall Study|Other than specified above|8|||
145302947|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
145302948|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
145302949|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
145302950|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
145302951|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
145302952|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
145302953|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
145302954|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
145302955|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
145302956|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
145302957|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
145302958|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
145302959|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
145302960|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
145302961|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
145302962|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
145302963|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
145302964|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
145302965|NCT01045161|523958494|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
145302966|NCT01045161|523958495|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
145302967|NCT01045161|523958496|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
145302968|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
145302969|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
145302970|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
145302971|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
145302972|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
145302973|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
145302974|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
145302975|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
145302976|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
145302977|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
145302978|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
145302979|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
145302980|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
145302981|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
145302982|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
145302983|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
145302984|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
145302985|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
145302986|NCT01045161|523958494|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
145302987|NCT01045161|523958495|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
145302988|NCT01045161|523958496|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
145302989|NCT03686033|523958497|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
145302990|NCT03686033|523958498|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
145302991|NCT03686033|523958499|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
145302992|NCT03686033|523958500|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
145302993|NCT03686033|523958501|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
145302994|NCT03686033|523958502|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
145302995|NCT03031847|523958503|FG000|Overall Study|Death|1|||
145302996|NCT03031847|523958504|FG001|Overall Study|Death|1|||
145302997|NCT03031847|523958505|FG002|Overall Study|Death|2|||
145302998|NCT03031847|523958506|FG003|Overall Study|Death|3|||
145302999|NCT03031847|523958503|FG000|Overall Study|Lost to Follow-up|1|||
145303000|NCT03031847|523958504|FG001|Overall Study|Lost to Follow-up|1|||
145303001|NCT03031847|523958505|FG002|Overall Study|Lost to Follow-up|2|||
145303002|NCT03031847|523958506|FG003|Overall Study|Lost to Follow-up|3|||
145303003|NCT01353664|523958507|FG000|Overall Study|Other|3|||
145303004|NCT01353664|523958507|FG000|Overall Study|Disease Progression|16|||
145303005|NCT03273153|523958508|FG000|Overall Study|Adverse Event|1|||
145303006|NCT03273153|523958509|FG001|Overall Study|Adverse Event|2|||
145410936|NCT04132050|524356894|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
145568818|NCT01800916|524942314|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
145568819|NCT01800916|524942315|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
145568820|NCT01800916|524942316|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
145568821|NCT01800916|524942317|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
145568822|NCT01800916|524942318|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
145568823|NCT01800916|524942319|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
145568824|NCT01232296|524942320|FG000|Overall Study|Adverse Event|24|||
145568825|NCT01232296|524942321|FG001|Overall Study|Adverse Event|12|||
145568826|NCT01232296|524942320|FG000|Overall Study|Physician Decision|1|||
145568827|NCT01232296|524942321|FG001|Overall Study|Physician Decision|1|||
145568828|NCT01232296|524942320|FG000|Overall Study|Progressive disease|43|||
145568829|NCT01232296|524942321|FG001|Overall Study|Progressive disease|61|||
145568830|NCT01232296|524942320|FG000|Overall Study|Study terminated by sponsor|0|||
145568831|NCT01232296|524942321|FG001|Overall Study|Study terminated by sponsor|1|||
145568832|NCT01232296|524942320|FG000|Overall Study|Technical problems|3|||
145568833|NCT01232296|524942321|FG001|Overall Study|Technical problems|0|||
145568834|NCT01232296|524942320|FG000|Overall Study|Subject/guardian decision|10|||
145568835|NCT01232296|524942321|FG001|Overall Study|Subject/guardian decision|2|||
145568836|NCT01232296|524942320|FG000|Overall Study|Death|1|||
145262402|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
145262403|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
145262404|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
145262405|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
145262406|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
145262407|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
145262408|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
145262409|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
145262410|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262411|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262412|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262413|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262414|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262415|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
145262416|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262417|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262418|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262419|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262420|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262421|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
145262422|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262423|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262424|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262425|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262426|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262427|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
145262428|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262429|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262430|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262431|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262432|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262433|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
145262434|NCT00151775|523808438|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262435|NCT00151775|523808439|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262436|NCT00151775|523808440|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262437|NCT00151775|523808441|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262438|NCT00151775|523808442|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262439|NCT00151775|523808443|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262440|NCT00151775|523808444|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
145262441|NCT00151775|523808445|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262442|NCT00151775|523808446|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262443|NCT00151775|523808447|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262444|NCT00151775|523808448|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262445|NCT00151775|523808449|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
145262446|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145303007|NCT03273153|523958508|FG000|Overall Study|Missing|0|||
145303008|NCT03273153|523958509|FG001|Overall Study|Missing|2|||
145303009|NCT03273153|523958508|FG000|Overall Study|Other|3|||
145568837|NCT01232296|524942321|FG001|Overall Study|Death|6|||
145568838|NCT00937547|524942328|FG000|Overall Study|misdiagnosis|1|||
145303010|NCT03273153|523958509|FG001|Overall Study|Other|2|||
145303011|NCT03273153|523958508|FG000|Overall Study|Symptomatic Deterioration|0|||
145303012|NCT03273153|523958509|FG001|Overall Study|Symptomatic Deterioration|1|||
145303013|NCT03273153|523958508|FG000|Overall Study|Progressive Disease|6|||
145303014|NCT03273153|523958509|FG001|Overall Study|Progressive Disease|5|||
145303015|NCT03273153|523958508|FG000|Overall Study|Physician Decision|1|||
145303016|NCT03273153|523958509|FG001|Overall Study|Physician Decision|3|||
145303017|NCT03273153|523958508|FG000|Overall Study|Study Terminated by Sponsor|112|||
145303018|NCT03273153|523958509|FG001|Overall Study|Study Terminated by Sponsor|102|||
145303019|NCT03273153|523958508|FG000|Overall Study|Withdrawal by Subject|26|||
145303020|NCT03273153|523958509|FG001|Overall Study|Withdrawal by Subject|25|||
145303021|NCT03273153|523958508|FG000|Overall Study|Protocol Deviation|3|||
145303022|NCT03273153|523958509|FG001|Overall Study|Protocol Deviation|0|||
145303023|NCT03273153|523958508|FG000|Overall Study|Lost to Follow-up|6|||
145303024|NCT03273153|523958509|FG001|Overall Study|Lost to Follow-up|11|||
145303025|NCT03273153|523958508|FG000|Overall Study|Death|66|||
145303026|NCT03273153|523958509|FG001|Overall Study|Death|69|||
145303027|NCT01237054|523958512|FG000|Overall Study|imaging 10C0096|1|||
145303028|NCT00838539|523958513|FG000|Overall Study|Disease Progression|2|||
145303029|NCT00838539|523958514|FG001|Overall Study|Disease Progression|4|||
145303030|NCT00838539|523958515|FG002|Overall Study|Disease Progression|3|||
145303031|NCT00838539|523958516|FG003|Overall Study|Disease Progression|2|||
145303032|NCT00838539|523958517|FG004|Overall Study|Disease Progression|4|||
145262447|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262448|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262449|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262450|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262451|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
145262452|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262453|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262454|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262455|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262456|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262457|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
145262458|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
145262459|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
145262460|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
145262461|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
145262462|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
145262463|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
145262464|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
145262465|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
145262466|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
145262467|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
145262468|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
145262469|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
145262470|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262471|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262472|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262473|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262474|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262475|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262476|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
145262477|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262478|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262479|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262480|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262481|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
145262482|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262483|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262484|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
145262485|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262486|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262487|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262488|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145303033|NCT00838539|523958518|FG005|Overall Study|Disease Progression|2|||
145303034|NCT00838539|523958519|FG006|Overall Study|Disease Progression|3|||
145303035|NCT00838539|523958520|FG007|Overall Study|Disease Progression|4|||
145303036|NCT00838539|523958521|FG008|Overall Study|Disease Progression|4|||
145303037|NCT00838539|523958522|FG009|Overall Study|Disease Progression|5|||
145303038|NCT00838539|523958523|FG010|Overall Study|Disease Progression|1|||
145303039|NCT00838539|523958524|FG011|Overall Study|Disease Progression|4|||
145303040|NCT00838539|523958513|FG000|Overall Study|Adverse Event|1|||
145303041|NCT00838539|523958514|FG001|Overall Study|Adverse Event|1|||
145303042|NCT00838539|523958515|FG002|Overall Study|Adverse Event|1|||
145303043|NCT00838539|523958516|FG003|Overall Study|Adverse Event|1|||
145303044|NCT00838539|523958517|FG004|Overall Study|Adverse Event|2|||
145303045|NCT00838539|523958518|FG005|Overall Study|Adverse Event|1|||
145303046|NCT00838539|523958519|FG006|Overall Study|Adverse Event|0|||
145303047|NCT00838539|523958520|FG007|Overall Study|Adverse Event|2|||
145303048|NCT00838539|523958521|FG008|Overall Study|Adverse Event|0|||
145303049|NCT00838539|523958522|FG009|Overall Study|Adverse Event|1|||
145303050|NCT00838539|523958523|FG010|Overall Study|Adverse Event|2|||
145303051|NCT00838539|523958524|FG011|Overall Study|Adverse Event|0|||
145303052|NCT00838539|523958513|FG000|Overall Study|Withdrawal by Subject|0|||
145303053|NCT00838539|523958514|FG001|Overall Study|Withdrawal by Subject|1|||
145303054|NCT00838539|523958515|FG002|Overall Study|Withdrawal by Subject|0|||
145303055|NCT00838539|523958516|FG003|Overall Study|Withdrawal by Subject|0|||
145303056|NCT00838539|523958517|FG004|Overall Study|Withdrawal by Subject|0|||
145303057|NCT00838539|523958518|FG005|Overall Study|Withdrawal by Subject|0|||
145303058|NCT00838539|523958519|FG006|Overall Study|Withdrawal by Subject|0|||
145303059|NCT00838539|523958520|FG007|Overall Study|Withdrawal by Subject|0|||
145303060|NCT00838539|523958521|FG008|Overall Study|Withdrawal by Subject|0|||
145303061|NCT00838539|523958522|FG009|Overall Study|Withdrawal by Subject|1|||
145303062|NCT00838539|523958523|FG010|Overall Study|Withdrawal by Subject|2|||
145303063|NCT00838539|523958524|FG011|Overall Study|Withdrawal by Subject|0|||
145303064|NCT00838539|523958513|FG000|Overall Study|Death|0|||
145303065|NCT00838539|523958514|FG001|Overall Study|Death|0|||
145303066|NCT00838539|523958515|FG002|Overall Study|Death|0|||
145303067|NCT00838539|523958516|FG003|Overall Study|Death|0|||
145303068|NCT00838539|523958517|FG004|Overall Study|Death|0|||
145303069|NCT00838539|523958518|FG005|Overall Study|Death|0|||
145303070|NCT00838539|523958519|FG006|Overall Study|Death|1|||
145303071|NCT00838539|523958520|FG007|Overall Study|Death|0|||
145303072|NCT00838539|523958521|FG008|Overall Study|Death|0|||
145303073|NCT00838539|523958522|FG009|Overall Study|Death|0|||
145303074|NCT00838539|523958523|FG010|Overall Study|Death|0|||
145303075|NCT00838539|523958524|FG011|Overall Study|Death|0|||
145303076|NCT00838539|523958513|FG000|Overall Study|Physician Decision|0|||
145303077|NCT00838539|523958514|FG001|Overall Study|Physician Decision|0|||
145303078|NCT00838539|523958515|FG002|Overall Study|Physician Decision|0|||
145303079|NCT00838539|523958516|FG003|Overall Study|Physician Decision|0|||
145303080|NCT00838539|523958517|FG004|Overall Study|Physician Decision|0|||
145303081|NCT00838539|523958518|FG005|Overall Study|Physician Decision|0|||
145303082|NCT00838539|523958519|FG006|Overall Study|Physician Decision|0|||
145303083|NCT00838539|523958520|FG007|Overall Study|Physician Decision|0|||
145303084|NCT00838539|523958521|FG008|Overall Study|Physician Decision|1|||
145303085|NCT00838539|523958522|FG009|Overall Study|Physician Decision|0|||
145303086|NCT00838539|523958523|FG010|Overall Study|Physician Decision|0|||
145303087|NCT00838539|523958524|FG011|Overall Study|Physician Decision|0|||
145303088|NCT00838539|523958513|FG000|Overall Study|Clinical Progression|0|||
145303089|NCT00838539|523958514|FG001|Overall Study|Clinical Progression|0|||
145303090|NCT00838539|523958515|FG002|Overall Study|Clinical Progression|0|||
145303091|NCT00838539|523958516|FG003|Overall Study|Clinical Progression|0|||
145303092|NCT00838539|523958517|FG004|Overall Study|Clinical Progression|0|||
145303093|NCT00838539|523958518|FG005|Overall Study|Clinical Progression|0|||
145303094|NCT00838539|523958519|FG006|Overall Study|Clinical Progression|1|||
145303095|NCT00838539|523958520|FG007|Overall Study|Clinical Progression|0|||
145303096|NCT00838539|523958521|FG008|Overall Study|Clinical Progression|0|||
145303097|NCT00838539|523958522|FG009|Overall Study|Clinical Progression|0|||
145303098|NCT00838539|523958523|FG010|Overall Study|Clinical Progression|0|||
145303099|NCT00838539|523958524|FG011|Overall Study|Clinical Progression|0|||
145620323|NCT03225846|525123734|FG000|Overall Study|Patient decision|0|||
145620324|NCT03225846|525123735|FG001|Overall Study|Patient decision|0|||
145620325|NCT03225846|525123736|FG002|Overall Study|Patient decision|0|||
145620326|NCT03225846|525123737|FG003|Overall Study|Patient decision|0|||
145303100|NCT00838539|523958513|FG000|Overall Study|Symptomatic Deterioration|0|||
145303101|NCT00838539|523958514|FG001|Overall Study|Symptomatic Deterioration|0|||
145303102|NCT00838539|523958515|FG002|Overall Study|Symptomatic Deterioration|1|||
145303103|NCT00838539|523958516|FG003|Overall Study|Symptomatic Deterioration|1|||
145303104|NCT00838539|523958517|FG004|Overall Study|Symptomatic Deterioration|0|||
145303105|NCT00838539|523958518|FG005|Overall Study|Symptomatic Deterioration|1|||
145303106|NCT00838539|523958519|FG006|Overall Study|Symptomatic Deterioration|0|||
145303107|NCT00838539|523958520|FG007|Overall Study|Symptomatic Deterioration|0|||
145303108|NCT00838539|523958521|FG008|Overall Study|Symptomatic Deterioration|0|||
145303109|NCT00838539|523958522|FG009|Overall Study|Symptomatic Deterioration|1|||
145303110|NCT00838539|523958523|FG010|Overall Study|Symptomatic Deterioration|0|||
145303111|NCT00838539|523958524|FG011|Overall Study|Symptomatic Deterioration|0|||
145303112|NCT01908205|523958525|FG000|Overall Study|Lost to Follow-up|2|||
145303113|NCT01908205|523958526|FG001|Overall Study|Lost to Follow-up|0|||
145620327|NCT03225846|525123738|FG004|Overall Study|Patient decision|0|||
145568839|NCT00937547|524942329|FG001|Overall Study|misdiagnosis|6|||
145568840|NCT00937547|524942330|FG002|Overall Study|misdiagnosis|7|||
145568841|NCT01234467|524942331|FG000|Overall Study|Adverse Event|3|||
145568842|NCT01234467|524942331|FG000|Overall Study|Death|2|||
145568843|NCT01234467|524942331|FG000|Overall Study|Withdrawal by Subject|2|||
145568844|NCT01234467|524942331|FG000|Overall Study|Disease Progression|2|||
145568845|NCT01234467|524942331|FG000|Overall Study|Clinical deterioration|1|||
145568846|NCT01234467|524942331|FG000|Overall Study|Physician Decision|1|||
145568847|NCT01234467|524942331|FG000|Overall Study|Other complicating disease (stroke)|1|||
145568848|NCT01461096|524942333|FG000|Overall Study|Death|3|||
145568849|NCT01461096|524942334|FG001|Overall Study|Death|6|||
145568850|NCT01461096|524942333|FG000|Overall Study|Severe debilitation, unable to continue|1|||
145568851|NCT01461096|524942334|FG001|Overall Study|Severe debilitation, unable to continue|1|||
145568852|NCT01461096|524942333|FG000|Overall Study|Subj not able to get to clinic|15|||
145568853|NCT01461096|524942334|FG001|Overall Study|Subj not able to get to clinic|13|||
145568854|NCT01461096|524942333|FG000|Overall Study|Site is closing|27|||
145568855|NCT01461096|524942334|FG001|Overall Study|Site is closing|30|||
145568856|NCT01461096|524942333|FG000|Overall Study|Withdrawal by Subject|5|||
145568857|NCT01461096|524942334|FG001|Overall Study|Withdrawal by Subject|3|||
145568858|NCT01461096|524942333|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
145262489|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262490|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262491|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262492|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262493|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
145262494|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262495|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262496|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
145262497|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262498|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262499|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262500|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262501|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262502|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262503|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262504|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262505|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
145262506|NCT00151775|523808438|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262507|NCT00151775|523808439|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262508|NCT00151775|523808440|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262509|NCT00151775|523808441|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262510|NCT00151775|523808442|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262511|NCT00151775|523808443|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262512|NCT00151775|523808444|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262513|NCT00151775|523808445|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262514|NCT00151775|523808446|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262515|NCT00151775|523808447|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262516|NCT00151775|523808448|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
145262517|NCT00151775|523808449|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
145262518|NCT00151775|523808438|FG000|Period 4: Open Label|Increased blood pressure|0|||
145262519|NCT00151775|523808439|FG001|Period 4: Open Label|Increased blood pressure|0|||
145262520|NCT00151775|523808440|FG002|Period 4: Open Label|Increased blood pressure|0|||
145262521|NCT00151775|523808441|FG003|Period 4: Open Label|Increased blood pressure|0|||
145262522|NCT00151775|523808442|FG004|Period 4: Open Label|Increased blood pressure|1|||
145262523|NCT00151775|523808443|FG005|Period 4: Open Label|Increased blood pressure|0|||
145262524|NCT00151775|523808444|FG006|Period 4: Open Label|Increased blood pressure|0|||
145262525|NCT00151775|523808445|FG007|Period 4: Open Label|Increased blood pressure|0|||
145262526|NCT00151775|523808446|FG008|Period 4: Open Label|Increased blood pressure|0|||
145262527|NCT00151775|523808447|FG009|Period 4: Open Label|Increased blood pressure|1|||
145262528|NCT00151775|523808448|FG010|Period 4: Open Label|Increased blood pressure|0|||
145262529|NCT00151775|523808449|FG011|Period 4: Open Label|Increased blood pressure|0|||
145262530|NCT00151775|523808438|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
145262531|NCT00151775|523808439|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
145262532|NCT00151775|523808440|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
145262533|NCT00151775|523808441|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
145262534|NCT00151775|523808442|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
145262535|NCT00151775|523808443|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
145568859|NCT01461096|524942334|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
145620328|NCT03225846|525123739|FG005|Overall Study|Patient decision|0|||
145568860|NCT01461096|524942333|FG000|Overall Study|Lost to Follow-up|8|||
145303114|NCT01908205|523958525|FG000|Overall Study|Withdrawal by Subject|3|||
145303115|NCT01908205|523958526|FG001|Overall Study|Withdrawal by Subject|1|||
145303116|NCT05323396|523958527|FG000|Overall Study|Lost to Follow-up|1|||
145303117|NCT05323396|523958528|FG001|Overall Study|Lost to Follow-up|35|||
145303118|NCT05323396|523958527|FG000|Overall Study|Pregnancy|1|||
145410937|NCT00927472|524356902|FG000|Overall Study|Withdrawal by Subject|10|||
145410938|NCT00927472|524356903|FG001|Overall Study|Withdrawal by Subject|11|||
145410939|NCT00927472|524356902|FG000|Overall Study|Lost to Follow-up|1|||
145410940|NCT00927472|524356903|FG001|Overall Study|Lost to Follow-up|6|||
145410941|NCT00927472|524356902|FG000|Overall Study|Protocol Violation|0|||
145410942|NCT00927472|524356903|FG001|Overall Study|Protocol Violation|1|||
145410943|NCT00927472|524356902|FG000|Overall Study|Post treatment Assessment out of window|0|||
145410944|NCT00927472|524356903|FG001|Overall Study|Post treatment Assessment out of window|4|||
145410945|NCT00433537|524356904|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
145410946|NCT00433537|524356905|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
145410947|NCT00433537|524356906|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
145410948|NCT00433537|524356904|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
145410949|NCT00433537|524356905|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
145410950|NCT00433537|524356906|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
145410951|NCT00433537|524356904|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
145410952|NCT00433537|524356905|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
145410953|NCT00433537|524356906|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
145410954|NCT00433537|524356904|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
145410955|NCT00433537|524356905|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
145410956|NCT00433537|524356906|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
145410957|NCT00433537|524356904|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
145410958|NCT00433537|524356905|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
145410959|NCT00433537|524356906|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
145410960|NCT00433537|524356904|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
145410961|NCT00433537|524356905|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
145410962|NCT00433537|524356906|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
145410963|NCT00433537|524356904|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
145410964|NCT00433537|524356905|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
145410965|NCT00433537|524356906|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
145568861|NCT01461096|524942334|FG001|Overall Study|Lost to Follow-up|4|||
145568862|NCT04889625|524942335|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
145568863|NCT04889625|524942336|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
145568864|NCT04889625|524942335|FG000|Period 1|Subject out of window|0|||
145568865|NCT04889625|524942336|FG001|Period 1|Subject out of window|1|||
145568866|NCT04889625|524942335|FG000|Period 1|Wrong add power dispensed|0|||
145303119|NCT05323396|523958528|FG001|Overall Study|Pregnancy|0|||
145303120|NCT04659603|523958533|FG000|Overall Study|Study terminated by sponsor|0|||
145303121|NCT04659603|523958534|FG001|Overall Study|Study terminated by sponsor|0|||
145303122|NCT04659603|523958535|FG002|Overall Study|Study terminated by sponsor|2|||
145303123|NCT04659603|523958533|FG000|Overall Study|Withdrawal by Subject|0|||
145303124|NCT04659603|523958534|FG001|Overall Study|Withdrawal by Subject|5|||
145303125|NCT04659603|523958535|FG002|Overall Study|Withdrawal by Subject|0|||
145303126|NCT04659603|523958533|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
145303127|NCT04659603|523958534|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
145303128|NCT04659603|523958535|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
145303129|NCT02089997|523958538|FG000|Overall Study|Case report forms uncollected|99|||
145303130|NCT02089997|523958538|FG000|Overall Study|Protocol Violation|147|||
145303131|NCT00095212|523958543|FG000|Overall Study|Withdrawal by Subject|1|||
145303132|NCT00095212|523958544|FG001|Overall Study|Withdrawal by Subject|3|||
145568867|NCT04889625|524942336|FG001|Period 1|Wrong add power dispensed|1|||
145568868|NCT04889625|524942335|FG000|Period 1|Discontinued due to fitting guide error|1|||
145303133|NCT02242201|523958547|FG000|Overall Study|preoperative identified neuropathy|2|||
145303134|NCT02242201|523958548|FG001|Overall Study|preoperative identified neuropathy|0|||
145303135|NCT02242201|523958549|FG002|Overall Study|preoperative identified neuropathy|0|||
145303136|NCT02242201|523958547|FG000|Overall Study|planned post-op anticoagulation|1|||
145303137|NCT02242201|523958548|FG001|Overall Study|planned post-op anticoagulation|0|||
145303138|NCT02242201|523958549|FG002|Overall Study|planned post-op anticoagulation|0|||
145303139|NCT02242201|523958547|FG000|Overall Study|changed surgical procedure|1|||
145303140|NCT02242201|523958548|FG001|Overall Study|changed surgical procedure|0|||
145303141|NCT02242201|523958549|FG002|Overall Study|changed surgical procedure|0|||
145410966|NCT00433537|524356904|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
145568869|NCT04889625|524942336|FG001|Period 1|Discontinued due to fitting guide error|1|||
145303142|NCT02242201|523958547|FG000|Overall Study|postponed surgery|0|||
145303143|NCT02242201|523958548|FG001|Overall Study|postponed surgery|0|||
145303144|NCT02242201|523958549|FG002|Overall Study|postponed surgery|1|||
145303145|NCT02242201|523958547|FG000|Overall Study|preoperative opioid consumption|0|||
145303146|NCT02242201|523958548|FG001|Overall Study|preoperative opioid consumption|1|||
145303147|NCT02242201|523958549|FG002|Overall Study|preoperative opioid consumption|0|||
145303148|NCT02374853|523958552|FG000|Overall Study|Surgery Cancelled|5|||
145303149|NCT02374853|523958553|FG001|Overall Study|Surgery Cancelled|11|||
145303150|NCT02281084|523958554|FG000|Overall Study|Death|21|||
145303151|NCT02281084|523958555|FG001|Overall Study|Death|18|||
145303152|NCT02281084|523958556|FG002|Overall Study|Death|3|||
145303153|NCT02281084|523958557|FG003|Overall Study|Death|5|||
145303154|NCT02281084|523958554|FG000|Overall Study|Adverse Event|1|||
145303155|NCT02281084|523958555|FG001|Overall Study|Adverse Event|0|||
145303156|NCT02281084|523958556|FG002|Overall Study|Adverse Event|0|||
145303157|NCT02281084|523958557|FG003|Overall Study|Adverse Event|0|||
145303158|NCT02281084|523958554|FG000|Overall Study|Withdrawal by Subject|2|||
145303159|NCT02281084|523958555|FG001|Overall Study|Withdrawal by Subject|2|||
145303160|NCT02281084|523958556|FG002|Overall Study|Withdrawal by Subject|0|||
145303161|NCT02281084|523958557|FG003|Overall Study|Withdrawal by Subject|0|||
145303162|NCT02281084|523958554|FG000|Overall Study|Site Closure by Sponsor|5|||
145303163|NCT02281084|523958555|FG001|Overall Study|Site Closure by Sponsor|1|||
145303164|NCT02281084|523958556|FG002|Overall Study|Site Closure by Sponsor|2|||
145303165|NCT02281084|523958557|FG003|Overall Study|Site Closure by Sponsor|0|||
145303166|NCT03681470|523958558|FG000|Overall Study|Lack of Efficacy|3|||
145303167|NCT03681470|523958558|FG000|Overall Study|Lost to Follow-up|1|||
145303168|NCT03681470|523958558|FG000|Overall Study|Protocol Violation|3|||
145303169|NCT03681470|523958558|FG000|Overall Study|Withdrawal by Subject|1|||
145303170|NCT02305758|523958559|FG000|Overall Study|Death|27|||
145303171|NCT02305758|523958560|FG001|Overall Study|Death|27|||
145303172|NCT02305758|523958559|FG000|Overall Study|Withdrew consent|9|||
145303173|NCT02305758|523958560|FG001|Overall Study|Withdrew consent|2|||
145303174|NCT02305758|523958559|FG000|Overall Study|Lost to Follow-up|6|||
145303175|NCT02305758|523958560|FG001|Overall Study|Lost to Follow-up|1|||
145303176|NCT02305758|523958559|FG000|Overall Study|Study Terminated by Sponsor|21|||
145303177|NCT02305758|523958560|FG001|Overall Study|Study Terminated by Sponsor|34|||
145303178|NCT02305758|523958559|FG000|Overall Study|Other, not specified|2|||
145303179|NCT02305758|523958560|FG001|Overall Study|Other, not specified|1|||
145303180|NCT02222818|523959980|FG000|Period 1|Eligibility criteria not met|0|||
145303181|NCT02222818|523959981|FG001|Period 1|Eligibility criteria not met|3|||
145303182|NCT00934050|523959982|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
145303183|NCT00934050|523959983|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
145303184|NCT00934050|523959984|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
145303185|NCT00934050|523959985|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
145303186|NCT00934050|523959986|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
145303187|NCT00934050|523959987|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
145303188|NCT00934050|523959982|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
145303189|NCT00934050|523959983|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
145303190|NCT00934050|523959984|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
145303191|NCT00934050|523959985|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
145303192|NCT00934050|523959986|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
145303193|NCT00934050|523959987|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
145303194|NCT00934050|523959982|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
145303195|NCT00934050|523959983|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
145303196|NCT00934050|523959984|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
145303197|NCT00934050|523959985|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
145303198|NCT00934050|523959986|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
145303199|NCT00934050|523959987|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
145303200|NCT00934050|523959982|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
145410967|NCT00433537|524356905|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
145410968|NCT00433537|524356906|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
145410969|NCT00433537|524356904|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
145410970|NCT00433537|524356905|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
145410971|NCT00433537|524356906|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
145303201|NCT00934050|523959983|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
145303202|NCT00934050|523959984|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
145410972|NCT01525589|524356911|FG000|Overall Study|Non-treatment-related AE|1|||
145303203|NCT00934050|523959985|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
145303204|NCT00934050|523959986|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
145410973|NCT01525589|524356912|FG001|Overall Study|Non-treatment-related AE|0|||
145410974|NCT01525589|524356913|FG002|Overall Study|Non-treatment-related AE|0|||
145410975|NCT01525589|524356911|FG000|Overall Study|Progressive disease|48|||
145410976|NCT01525589|524356912|FG001|Overall Study|Progressive disease|15|||
145568870|NCT04889625|524942335|FG000|Period 2|Test article no longer available|1|||
145303205|NCT00934050|523959987|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
145303206|NCT00934050|523959982|FG000|Enrolled After 15 Dec 2009|Death|0|||
145303207|NCT00934050|523959983|FG001|Enrolled After 15 Dec 2009|Death|0|||
145303208|NCT00934050|523959984|FG002|Enrolled After 15 Dec 2009|Death|0|||
145303209|NCT00934050|523959985|FG003|Enrolled After 15 Dec 2009|Death|0|||
145303210|NCT00934050|523959986|FG004|Enrolled After 15 Dec 2009|Death|0|||
145303211|NCT00934050|523959987|FG005|Enrolled After 15 Dec 2009|Death|1|||
145303212|NCT00934050|523959982|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
145303213|NCT00934050|523959983|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
145303214|NCT00934050|523959984|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
145303215|NCT00934050|523959985|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
145303216|NCT00934050|523959986|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
145303217|NCT00934050|523959987|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
145303218|NCT00934050|523959982|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
145303219|NCT00934050|523959983|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
145303220|NCT00934050|523959984|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
145303221|NCT00934050|523959985|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
145303222|NCT00934050|523959986|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
145303223|NCT00934050|523959987|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
145303224|NCT02149420|523959990|FG000|Core Study|Administrative problems|0|||
145303225|NCT02149420|523959991|FG001|Core Study|Administrative problems|1|||
145303226|NCT02149420|523959992|FG002|Core Study|Administrative problems|2|||
145303227|NCT02149420|523959990|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
145303228|NCT02149420|523959991|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
145303229|NCT02149420|523959992|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
145303230|NCT01111461|523959993|FG000|Overall Study|Adverse Event|32|||
145303231|NCT01111461|523959993|FG000|Overall Study|Participant choice|11|||
145303232|NCT01111461|523959993|FG000|Overall Study|Lost to Follow-up|1|||
145303233|NCT01111461|523959993|FG000|Overall Study|Withdrawal by Subject|1|||
145303234|NCT01111461|523959993|FG000|Overall Study|Other|6|||
145303235|NCT00834067|523959996|FG000|Washout of 21 Days|Protocol Violation|0|||
145303236|NCT00834067|523959997|FG001|Washout of 21 Days|Protocol Violation|1|||
145303237|NCT00440518|523959998|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
145303238|NCT00440518|523959999|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
145303239|NCT00440518|523960000|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
145303240|NCT00440518|523959998|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
145303241|NCT00440518|523959999|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
145303242|NCT00440518|523960000|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
145303243|NCT00440518|523959998|FG000|Randomized /Titration Period|Protocol Deviation|1|||
145303244|NCT00440518|523959999|FG001|Randomized /Titration Period|Protocol Deviation|0|||
145303245|NCT00440518|523960000|FG002|Randomized /Titration Period|Protocol Deviation|0|||
145303246|NCT00440518|523959998|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
145303247|NCT00440518|523959999|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
145303248|NCT00440518|523960000|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
145303249|NCT00440518|523959998|FG000|Randomized /Titration Period|Other|1|||
145303250|NCT00440518|523959999|FG001|Randomized /Titration Period|Other|0|||
145303251|NCT00440518|523960000|FG002|Randomized /Titration Period|Other|0|||
145303252|NCT00440518|523959998|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
145303253|NCT00440518|523959999|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
145303254|NCT00440518|523960000|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
145303255|NCT00440518|523959998|FG000|Randomized /Titration Period|Adverse Event|2|||
145303256|NCT00440518|523959999|FG001|Randomized /Titration Period|Adverse Event|3|||
145303257|NCT00440518|523960000|FG002|Randomized /Titration Period|Adverse Event|0|||
145303258|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
145303259|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
145303260|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
145303261|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
145303262|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
145303263|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
145303264|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
145303265|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
145303266|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
145303267|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
145303268|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
145303269|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
145303270|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
145303271|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
145303272|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
145303273|NCT00440518|523959998|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
145303274|NCT00440518|523959999|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
145303275|NCT00440518|523960000|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
145303276|NCT03570749|523960002|FG000|Overall Study|Ongoing|26|||
145410977|NCT01525589|524356913|FG002|Overall Study|Progressive disease|29|||
145410978|NCT01525589|524356911|FG000|Overall Study|Never treated|2|||
145303277|NCT03570749|523960003|FG001|Overall Study|Ongoing|25|||
145303278|NCT03570749|523960004|FG002|Overall Study|Ongoing|25|||
145303279|NCT03570749|523960005|FG003|Overall Study|Ongoing|26|||
145303280|NCT03570749|523960006|FG004|Overall Study|Ongoing|140|||
145303281|NCT03570749|523960007|FG005|Overall Study|Ongoing|142|||
145303282|NCT03570749|523960008|FG006|Overall Study|Ongoing|220|||
145303283|NCT03570749|523960002|FG000|Overall Study|Adverse Event|0|||
145303284|NCT03570749|523960003|FG001|Overall Study|Adverse Event|0|||
145303285|NCT03570749|523960004|FG002|Overall Study|Adverse Event|0|||
145303286|NCT03570749|523960005|FG003|Overall Study|Adverse Event|0|||
145303287|NCT03570749|523960006|FG004|Overall Study|Adverse Event|2|||
145303288|NCT03570749|523960007|FG005|Overall Study|Adverse Event|3|||
145303289|NCT03570749|523960008|FG006|Overall Study|Adverse Event|6|||
145303290|NCT03570749|523960002|FG000|Overall Study|Lack of Efficacy|0|||
145303291|NCT03570749|523960003|FG001|Overall Study|Lack of Efficacy|0|||
145303292|NCT03570749|523960004|FG002|Overall Study|Lack of Efficacy|0|||
145303293|NCT03570749|523960005|FG003|Overall Study|Lack of Efficacy|0|||
145303294|NCT03570749|523960006|FG004|Overall Study|Lack of Efficacy|8|||
145303295|NCT03570749|523960007|FG005|Overall Study|Lack of Efficacy|2|||
145303296|NCT03570749|523960008|FG006|Overall Study|Lack of Efficacy|7|||
145303297|NCT03570749|523960002|FG000|Overall Study|Lost to Follow-up|0|||
145303298|NCT03570749|523960003|FG001|Overall Study|Lost to Follow-up|0|||
145303299|NCT03570749|523960004|FG002|Overall Study|Lost to Follow-up|0|||
145303300|NCT03570749|523960005|FG003|Overall Study|Lost to Follow-up|0|||
145303301|NCT03570749|523960006|FG004|Overall Study|Lost to Follow-up|5|||
145303302|NCT03570749|523960007|FG005|Overall Study|Lost to Follow-up|10|||
145303303|NCT03570749|523960008|FG006|Overall Study|Lost to Follow-up|10|||
145303304|NCT03570749|523960002|FG000|Overall Study|Pregnancy|0|||
145303305|NCT03570749|523960003|FG001|Overall Study|Pregnancy|0|||
145303306|NCT03570749|523960004|FG002|Overall Study|Pregnancy|0|||
145303307|NCT03570749|523960005|FG003|Overall Study|Pregnancy|0|||
145303308|NCT03570749|523960006|FG004|Overall Study|Pregnancy|0|||
145303309|NCT03570749|523960007|FG005|Overall Study|Pregnancy|1|||
145303310|NCT03570749|523960008|FG006|Overall Study|Pregnancy|1|||
145303311|NCT03570749|523960002|FG000|Overall Study|Screen Fail|0|||
145303312|NCT03570749|523960003|FG001|Overall Study|Screen Fail|0|||
145303313|NCT03570749|523960004|FG002|Overall Study|Screen Fail|0|||
145303314|NCT03570749|523960005|FG003|Overall Study|Screen Fail|0|||
145303315|NCT03570749|523960006|FG004|Overall Study|Screen Fail|0|||
145303316|NCT03570749|523960007|FG005|Overall Study|Screen Fail|0|||
145303317|NCT03570749|523960008|FG006|Overall Study|Screen Fail|1|||
145303318|NCT03570749|523960002|FG000|Overall Study|Withdrawal by Subject|2|||
145303319|NCT03570749|523960003|FG001|Overall Study|Withdrawal by Subject|3|||
145303320|NCT03570749|523960004|FG002|Overall Study|Withdrawal by Subject|2|||
145303321|NCT03570749|523960005|FG003|Overall Study|Withdrawal by Subject|1|||
145303322|NCT03570749|523960006|FG004|Overall Study|Withdrawal by Subject|17|||
145303323|NCT03570749|523960007|FG005|Overall Study|Withdrawal by Subject|12|||
145303324|NCT03570749|523960008|FG006|Overall Study|Withdrawal by Subject|15|||
145303325|NCT03570749|523960002|FG000|Overall Study|Other|0|||
145303326|NCT03570749|523960003|FG001|Overall Study|Other|0|||
145303327|NCT03570749|523960004|FG002|Overall Study|Other|0|||
145303328|NCT03570749|523960005|FG003|Overall Study|Other|0|||
145303329|NCT03570749|523960006|FG004|Overall Study|Other|17|||
145303330|NCT03570749|523960007|FG005|Overall Study|Other|14|||
145303331|NCT03570749|523960008|FG006|Overall Study|Other|21|||
145303332|NCT03616535|523960009|FG000|Overall Study|Death|2|||
145303333|NCT03616535|523960010|FG001|Overall Study|Death|0|||
145303334|NCT03616535|523960011|FG002|Overall Study|Death|0|||
145303335|NCT03616535|523960012|FG003|Overall Study|Death|1|||
145303336|NCT03616535|523960009|FG000|Overall Study|Lost to Follow-up|2|||
145303337|NCT03616535|523960010|FG001|Overall Study|Lost to Follow-up|1|||
145303338|NCT03616535|523960011|FG002|Overall Study|Lost to Follow-up|0|||
145303339|NCT03616535|523960012|FG003|Overall Study|Lost to Follow-up|2|||
145303340|NCT03616535|523960009|FG000|Overall Study|Withdrawal by Subject|1|||
145303341|NCT03616535|523960010|FG001|Overall Study|Withdrawal by Subject|2|||
145303342|NCT03616535|523960011|FG002|Overall Study|Withdrawal by Subject|5|||
145303343|NCT03616535|523960012|FG003|Overall Study|Withdrawal by Subject|1|||
145303344|NCT03616535|523960009|FG000|Overall Study|Not specified or change in eligibility|2|||
145303345|NCT03616535|523960010|FG001|Overall Study|Not specified or change in eligibility|3|||
145303346|NCT03616535|523960011|FG002|Overall Study|Not specified or change in eligibility|3|||
145303347|NCT03616535|523960012|FG003|Overall Study|Not specified or change in eligibility|1|||
145303348|NCT00804856|523960013|FG000|Overall Study|Progressive Disease|3|||
145303349|NCT00804856|523960014|FG001|Overall Study|Progressive Disease|2|||
145303350|NCT00804856|523960015|FG002|Overall Study|Progressive Disease|4|||
145303351|NCT00804856|523960016|FG003|Overall Study|Progressive Disease|6|||
145303352|NCT00804856|523960017|FG004|Overall Study|Progressive Disease|4|||
145303353|NCT00804856|523960018|FG005|Overall Study|Progressive Disease|1|||
145303354|NCT00804856|523960019|FG006|Overall Study|Progressive Disease|8|||
145303355|NCT00804856|523960020|FG007|Overall Study|Progressive Disease|2|||
145303356|NCT00804856|523960021|FG008|Overall Study|Progressive Disease|4|||
145303357|NCT00804856|523960022|FG009|Overall Study|Progressive Disease|5|||
145303358|NCT00804856|523960023|FG010|Overall Study|Progressive Disease|12|||
145262536|NCT00151775|523808444|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
145262537|NCT00151775|523808445|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
145262538|NCT00151775|523808446|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
145262539|NCT00151775|523808447|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
145262540|NCT00151775|523808448|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
145262541|NCT00151775|523808449|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
145262542|NCT00151775|523808438|FG000|Period 4: Open Label|Adverse Event|0|||
145262543|NCT00151775|523808439|FG001|Period 4: Open Label|Adverse Event|0|||
145262544|NCT00151775|523808440|FG002|Period 4: Open Label|Adverse Event|0|||
145262545|NCT00151775|523808441|FG003|Period 4: Open Label|Adverse Event|0|||
145262546|NCT00151775|523808442|FG004|Period 4: Open Label|Adverse Event|1|||
145262547|NCT00151775|523808443|FG005|Period 4: Open Label|Adverse Event|0|||
145262548|NCT00151775|523808444|FG006|Period 4: Open Label|Adverse Event|0|||
145262549|NCT00151775|523808445|FG007|Period 4: Open Label|Adverse Event|0|||
145262550|NCT00151775|523808446|FG008|Period 4: Open Label|Adverse Event|0|||
145262551|NCT00151775|523808447|FG009|Period 4: Open Label|Adverse Event|2|||
145262552|NCT00151775|523808448|FG010|Period 4: Open Label|Adverse Event|0|||
145262553|NCT00151775|523808449|FG011|Period 4: Open Label|Adverse Event|0|||
145262554|NCT00151775|523808438|FG000|Period 4: Open Label|Lost to Follow-up|0|||
145262555|NCT00151775|523808439|FG001|Period 4: Open Label|Lost to Follow-up|0|||
145262556|NCT00151775|523808440|FG002|Period 4: Open Label|Lost to Follow-up|0|||
145262557|NCT00151775|523808441|FG003|Period 4: Open Label|Lost to Follow-up|0|||
145262558|NCT00151775|523808442|FG004|Period 4: Open Label|Lost to Follow-up|17|||
145262559|NCT00151775|523808443|FG005|Period 4: Open Label|Lost to Follow-up|0|||
145262560|NCT00151775|523808444|FG006|Period 4: Open Label|Lost to Follow-up|0|||
145262561|NCT00151775|523808445|FG007|Period 4: Open Label|Lost to Follow-up|0|||
145262562|NCT00151775|523808446|FG008|Period 4: Open Label|Lost to Follow-up|0|||
145262563|NCT00151775|523808447|FG009|Period 4: Open Label|Lost to Follow-up|7|||
145262564|NCT00151775|523808448|FG010|Period 4: Open Label|Lost to Follow-up|0|||
145262565|NCT00151775|523808449|FG011|Period 4: Open Label|Lost to Follow-up|0|||
145262566|NCT00151775|523808438|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
145262567|NCT00151775|523808439|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
145262568|NCT00151775|523808440|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
145262569|NCT00151775|523808441|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
145262570|NCT00151775|523808442|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
145262571|NCT00151775|523808443|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
145262572|NCT00151775|523808444|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
145262573|NCT00151775|523808445|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
145262574|NCT00151775|523808446|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
145262575|NCT00151775|523808447|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
145262576|NCT00151775|523808448|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
145262577|NCT00151775|523808449|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
145262578|NCT00151775|523808438|FG000|Period 4: Open Label|Other|0|||
145262579|NCT00151775|523808439|FG001|Period 4: Open Label|Other|0|||
145262580|NCT00151775|523808440|FG002|Period 4: Open Label|Other|0|||
145262581|NCT00151775|523808441|FG003|Period 4: Open Label|Other|0|||
145262582|NCT00151775|523808442|FG004|Period 4: Open Label|Other|1|||
145262583|NCT00151775|523808443|FG005|Period 4: Open Label|Other|0|||
145262584|NCT00151775|523808444|FG006|Period 4: Open Label|Other|0|||
145262585|NCT00151775|523808445|FG007|Period 4: Open Label|Other|0|||
145262586|NCT00151775|523808446|FG008|Period 4: Open Label|Other|0|||
145262587|NCT00151775|523808447|FG009|Period 4: Open Label|Other|3|||
145262588|NCT00151775|523808448|FG010|Period 4: Open Label|Other|0|||
145262589|NCT00151775|523808449|FG011|Period 4: Open Label|Other|0|||
145262590|NCT00151775|523808438|FG000|Period 4: Open Label|Physician Decision|0|||
145262591|NCT00151775|523808439|FG001|Period 4: Open Label|Physician Decision|0|||
145262592|NCT00151775|523808440|FG002|Period 4: Open Label|Physician Decision|0|||
145262593|NCT00151775|523808441|FG003|Period 4: Open Label|Physician Decision|0|||
145262594|NCT00151775|523808442|FG004|Period 4: Open Label|Physician Decision|0|||
145262595|NCT00151775|523808443|FG005|Period 4: Open Label|Physician Decision|0|||
145262596|NCT00151775|523808444|FG006|Period 4: Open Label|Physician Decision|0|||
145262597|NCT00151775|523808445|FG007|Period 4: Open Label|Physician Decision|0|||
145262598|NCT00151775|523808446|FG008|Period 4: Open Label|Physician Decision|0|||
145262599|NCT00151775|523808447|FG009|Period 4: Open Label|Physician Decision|2|||
145262600|NCT00151775|523808448|FG010|Period 4: Open Label|Physician Decision|0|||
145262601|NCT00151775|523808449|FG011|Period 4: Open Label|Physician Decision|0|||
145262602|NCT00151775|523808438|FG000|Period 4: Open Label|Protocol Violation|0|||
145262603|NCT00151775|523808439|FG001|Period 4: Open Label|Protocol Violation|0|||
145262604|NCT00151775|523808440|FG002|Period 4: Open Label|Protocol Violation|0|||
145262605|NCT00151775|523808441|FG003|Period 4: Open Label|Protocol Violation|0|||
145262606|NCT00151775|523808442|FG004|Period 4: Open Label|Protocol Violation|1|||
145262607|NCT00151775|523808443|FG005|Period 4: Open Label|Protocol Violation|0|||
145262608|NCT00151775|523808444|FG006|Period 4: Open Label|Protocol Violation|0|||
145262609|NCT00151775|523808445|FG007|Period 4: Open Label|Protocol Violation|0|||
145262610|NCT00151775|523808446|FG008|Period 4: Open Label|Protocol Violation|0|||
145568871|NCT04889625|524942336|FG001|Period 2|Test article no longer available|0|||
145568872|NCT04889625|524942335|FG000|Period 2|Incorrect lens dispensed|1|||
145568873|NCT04889625|524942336|FG001|Period 2|Incorrect lens dispensed|0|||
145568874|NCT04889625|524942335|FG000|Period 2|Wrong add power dispensed|0|||
145568875|NCT04889625|524942336|FG001|Period 2|Wrong add power dispensed|1|||
145568876|NCT04370691|524942346|FG000|Overall Study|Pending visit|48|||
145568877|NCT04370691|524942346|FG000|Overall Study|Have Not Reached Lower Window|15|||
145568878|NCT04370691|524942346|FG000|Overall Study|Termination|14|||
145262611|NCT00151775|523808447|FG009|Period 4: Open Label|Protocol Violation|0|||
145262612|NCT00151775|523808448|FG010|Period 4: Open Label|Protocol Violation|0|||
145262613|NCT00151775|523808449|FG011|Period 4: Open Label|Protocol Violation|0|||
145262614|NCT04516291|523808450|FG000|Treatment Period (24 Weeks)|Other|1|||
145262615|NCT04516291|523808451|FG001|Treatment Period (24 Weeks)|Other|0|||
145262616|NCT04516291|523808452|FG002|Treatment Period (24 Weeks)|Other|0|||
145262617|NCT04516291|523808453|FG003|Treatment Period (24 Weeks)|Other|2|||
145262618|NCT04516291|523808454|FG004|Treatment Period (24 Weeks)|Other|2|||
145262619|NCT04516291|523808455|FG005|Treatment Period (24 Weeks)|Other|4|||
145262620|NCT04516291|523808456|FG006|Treatment Period (24 Weeks)|Other|2|||
145262621|NCT04516291|523808457|FG007|Treatment Period (24 Weeks)|Other|0|||
145262622|NCT04516291|523808450|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145262623|NCT04516291|523808451|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
145262624|NCT04516291|523808452|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145262625|NCT04516291|523808453|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145262626|NCT04516291|523808454|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145262627|NCT04516291|523808455|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145262628|NCT04516291|523808456|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145262629|NCT04516291|523808457|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145262630|NCT04516291|523808450|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262631|NCT04516291|523808451|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262632|NCT04516291|523808452|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262633|NCT04516291|523808453|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
145262634|NCT04516291|523808454|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262635|NCT04516291|523808455|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262636|NCT04516291|523808456|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262637|NCT04516291|523808457|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
145262638|NCT04516291|523808450|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262639|NCT04516291|523808451|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145262640|NCT04516291|523808452|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262641|NCT04516291|523808453|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262642|NCT04516291|523808454|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262643|NCT04516291|523808455|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262644|NCT04516291|523808456|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262645|NCT04516291|523808457|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145262646|NCT04516291|523808450|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
145262647|NCT04516291|523808451|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
145262648|NCT04516291|523808452|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
145262649|NCT04516291|523808453|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
145262650|NCT04516291|523808454|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
145262651|NCT04516291|523808455|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
145262652|NCT04516291|523808456|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
145262653|NCT04516291|523808457|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
145262654|NCT04516291|523808450|FG000|Follow-up Period (12 Weeks)|Other|0|||
145262655|NCT04516291|523808451|FG001|Follow-up Period (12 Weeks)|Other|1|||
145262656|NCT04516291|523808452|FG002|Follow-up Period (12 Weeks)|Other|0|||
145262657|NCT04516291|523808453|FG003|Follow-up Period (12 Weeks)|Other|2|||
145262658|NCT04516291|523808454|FG004|Follow-up Period (12 Weeks)|Other|0|||
145262659|NCT04516291|523808455|FG005|Follow-up Period (12 Weeks)|Other|0|||
145262660|NCT04516291|523808456|FG006|Follow-up Period (12 Weeks)|Other|0|||
145262661|NCT04516291|523808457|FG007|Follow-up Period (12 Weeks)|Other|0|||
145262662|NCT04516291|523808450|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262663|NCT04516291|523808451|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262664|NCT04516291|523808452|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262665|NCT04516291|523808453|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262666|NCT04516291|523808454|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
145262667|NCT04516291|523808455|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262668|NCT04516291|523808456|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262669|NCT04516291|523808457|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145262670|NCT04516291|523808450|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
145262671|NCT04516291|523808451|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
145262672|NCT04516291|523808452|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
145262673|NCT04516291|523808453|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
145262674|NCT04516291|523808454|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
145262675|NCT04516291|523808455|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
145568879|NCT04370691|524942346|FG000|Overall Study|Missed or Overdue|10|||
145262676|NCT04516291|523808456|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
145262677|NCT04516291|523808457|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
145303359|NCT00804856|523960024|FG011|Overall Study|Progressive Disease|2|||
145262678|NCT02158949|523808458|FG000|Overall Study|Withdrawal by Subject|1|||
145262679|NCT02158949|523808459|FG001|Overall Study|Withdrawal by Subject|0|||
145262680|NCT02158949|523808458|FG000|Overall Study|Lost to Follow-up|5|||
145262681|NCT02158949|523808459|FG001|Overall Study|Lost to Follow-up|11|||
145262682|NCT01161173|523808472|FG000|Overall Study|Protocol Violation|13|||
145262683|NCT01161173|523808472|FG000|Overall Study|Lost to Follow-up|7|||
145262684|NCT01161173|523808472|FG000|Overall Study|Progressive Disease|82|||
145262685|NCT01161173|523808472|FG000|Overall Study|Withdrawal of Consent|5|||
145262686|NCT01161173|523808472|FG000|Overall Study|Unacceptable Toxicity|21|||
145262687|NCT01161173|523808472|FG000|Overall Study|Death|194|||
145262688|NCT01161173|523808472|FG000|Overall Study|End of Study|2|||
145262689|NCT01161173|523808472|FG000|Overall Study|Reasons Not Specified|23|||
145262690|NCT00792467|523808473|FG000|Overall Study|progression of disease|17|||
145262691|NCT00792467|523808473|FG000|Overall Study|Adverse Event|1|||
145262692|NCT00792467|523808473|FG000|Overall Study|patient request|1|||
145262693|NCT00792467|523808473|FG000|Overall Study|Lost to Follow-up|1|||
145262694|NCT00792467|523808473|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
145262695|NCT00792467|523808473|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
145262696|NCT03781167|523808475|FG000|Overall Study|Adverse Event|23|||
145262697|NCT03781167|523808476|FG001|Overall Study|Adverse Event|25|||
145262698|NCT03781167|523808475|FG000|Overall Study|Withdrew consent|16|||
145262699|NCT03781167|523808476|FG001|Overall Study|Withdrew consent|12|||
145262700|NCT03781167|523808475|FG000|Overall Study|Lost to Follow-up|0|||
145262701|NCT03781167|523808476|FG001|Overall Study|Lost to Follow-up|1|||
145262702|NCT03781167|523808475|FG000|Overall Study|Lack of Efficacy|4|||
145262703|NCT03781167|523808476|FG001|Overall Study|Lack of Efficacy|5|||
145262704|NCT03781167|523808475|FG000|Overall Study|Difficulty with drug delivery system|2|||
145262705|NCT03781167|523808476|FG001|Overall Study|Difficulty with drug delivery system|3|||
145262706|NCT03781167|523808475|FG000|Overall Study|Other, not specified|2|||
145262707|NCT03781167|523808476|FG001|Overall Study|Other, not specified|2|||
145262708|NCT00679354|523808478|FG000|Overall Study|Death|3|||
145262709|NCT00679354|523808478|FG000|Overall Study|Lack of Efficacy|22|||
145262710|NCT00679354|523808478|FG000|Overall Study|Physician Decision|4|||
145262711|NCT00679354|523808478|FG000|Overall Study|Ineligible|1|||
145262712|NCT01590628|523808479|FG000|Overall Study|Death|2|||
145262713|NCT01590628|523808480|FG001|Overall Study|Death|0|||
145262714|NCT03907072|523808481|FG000|Overall Study|Study Terminated by Sponsor|2|||
145262715|NCT03907072|523808482|FG001|Overall Study|Study Terminated by Sponsor|2|||
145262716|NCT03907072|523808483|FG002|Overall Study|Study Terminated by Sponsor|2|||
145262717|NCT02463097|523808484|FG000|Overall Study|Withdrawal by Subject|1|||
145262718|NCT00808665|523808485|FG000|Overall Study|Withdrawal by Subject|1|||
145262719|NCT00808665|523808486|FG001|Overall Study|Withdrawal by Subject|0|||
145262720|NCT00808665|523808485|FG000|Overall Study|only required minimally invasive surgery|1|||
145262721|NCT00808665|523808486|FG001|Overall Study|only required minimally invasive surgery|0|||
145262722|NCT00808665|523808485|FG000|Overall Study|surgery cancelled|1|||
145262723|NCT00808665|523808486|FG001|Overall Study|surgery cancelled|0|||
145262724|NCT00808665|523808485|FG000|Overall Study|required an additional procedure|0|||
145262725|NCT00808665|523808486|FG001|Overall Study|required an additional procedure|1|||
145262726|NCT00808665|523808485|FG000|Overall Study|Physician Decision|3|||
145262727|NCT00808665|523808486|FG001|Overall Study|Physician Decision|1|||
145262728|NCT00808665|523808485|FG000|Overall Study|Medication stopped by resident|0|||
145262729|NCT00808665|523808486|FG001|Overall Study|Medication stopped by resident|1|||
145262730|NCT03326323|523808487|FG000|Overall Study|Unable to receive ANH protocol|3|||
145262731|NCT01757821|523808488|FG000|Overall Study|Adverse Event|1|||
145262732|NCT03831282|523808489|FG000|Overall Study|Could not place sensor|1|||
145262733|NCT00920582|523808490|FG000|Overall Study|Lost to Follow-up|5|||
145262734|NCT00920582|523808491|FG001|Overall Study|Lost to Follow-up|1|||
145262735|NCT00920582|523808492|FG002|Overall Study|Lost to Follow-up|2|||
145262736|NCT00920582|523808493|FG003|Overall Study|Lost to Follow-up|0|||
145262737|NCT00920582|523808490|FG000|Overall Study|Withdrawal by Subject|5|||
145262738|NCT00920582|523808491|FG001|Overall Study|Withdrawal by Subject|4|||
145262739|NCT00920582|523808492|FG002|Overall Study|Withdrawal by Subject|6|||
145262740|NCT00920582|523808493|FG003|Overall Study|Withdrawal by Subject|3|||
145262741|NCT00920582|523808490|FG000|Overall Study|Protocol Violation|1|||
145262742|NCT00920582|523808491|FG001|Overall Study|Protocol Violation|0|||
145262743|NCT00920582|523808492|FG002|Overall Study|Protocol Violation|0|||
145262744|NCT00920582|523808493|FG003|Overall Study|Protocol Violation|0|||
145262745|NCT00920582|523808490|FG000|Overall Study|Other|2|||
145262746|NCT00920582|523808491|FG001|Overall Study|Other|1|||
145262747|NCT00920582|523808492|FG002|Overall Study|Other|3|||
145262748|NCT00920582|523808493|FG003|Overall Study|Other|2|||
145262749|NCT05146999|523808496|FG000|Overall Study|Withdrew consent|6|||
145303360|NCT00804856|523960025|FG012|Overall Study|Progressive Disease|2|||
145303361|NCT00804856|523960026|FG013|Overall Study|Progressive Disease|26|||
145303362|NCT00804856|523960027|FG014|Overall Study|Progressive Disease|20|||
145303363|NCT00804856|523960013|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303364|NCT00804856|523960014|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303365|NCT00804856|523960015|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303366|NCT00804856|523960016|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303367|NCT00804856|523960017|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145303368|NCT00804856|523960018|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303369|NCT00804856|523960019|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303370|NCT00804856|523960020|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303371|NCT00804856|523960021|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303372|NCT00804856|523960022|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303373|NCT00804856|523960023|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303374|NCT00804856|523960024|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303375|NCT00804856|523960025|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303376|NCT00804856|523960026|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145303377|NCT00804856|523960027|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145303378|NCT00804856|523960013|FG000|Overall Study|Other Adverse Event|1|||
145303379|NCT00804856|523960014|FG001|Overall Study|Other Adverse Event|1|||
145303380|NCT00804856|523960015|FG002|Overall Study|Other Adverse Event|1|||
145303381|NCT00804856|523960016|FG003|Overall Study|Other Adverse Event|2|||
145303382|NCT00804856|523960017|FG004|Overall Study|Other Adverse Event|2|||
145303383|NCT00804856|523960018|FG005|Overall Study|Other Adverse Event|1|||
145303384|NCT00804856|523960019|FG006|Overall Study|Other Adverse Event|3|||
145303385|NCT00804856|523960020|FG007|Overall Study|Other Adverse Event|0|||
145303386|NCT00804856|523960021|FG008|Overall Study|Other Adverse Event|0|||
145303387|NCT00804856|523960022|FG009|Overall Study|Other Adverse Event|1|||
145303388|NCT00804856|523960023|FG010|Overall Study|Other Adverse Event|5|||
145303389|NCT00804856|523960024|FG011|Overall Study|Other Adverse Event|2|||
145303390|NCT00804856|523960025|FG012|Overall Study|Other Adverse Event|0|||
145303391|NCT00804856|523960026|FG013|Overall Study|Other Adverse Event|6|||
145303392|NCT00804856|523960027|FG014|Overall Study|Other Adverse Event|13|||
145303393|NCT00804856|523960013|FG000|Overall Study|Non compliance with protocol|0|||
145303394|NCT00804856|523960014|FG001|Overall Study|Non compliance with protocol|0|||
145303395|NCT00804856|523960015|FG002|Overall Study|Non compliance with protocol|0|||
145303396|NCT00804856|523960016|FG003|Overall Study|Non compliance with protocol|0|||
145303397|NCT00804856|523960017|FG004|Overall Study|Non compliance with protocol|0|||
145303398|NCT00804856|523960018|FG005|Overall Study|Non compliance with protocol|0|||
145303399|NCT00804856|523960019|FG006|Overall Study|Non compliance with protocol|0|||
145303400|NCT00804856|523960020|FG007|Overall Study|Non compliance with protocol|0|||
145303401|NCT00804856|523960021|FG008|Overall Study|Non compliance with protocol|0|||
145303402|NCT00804856|523960022|FG009|Overall Study|Non compliance with protocol|0|||
145303403|NCT00804856|523960023|FG010|Overall Study|Non compliance with protocol|0|||
145303404|NCT00804856|523960024|FG011|Overall Study|Non compliance with protocol|0|||
145303405|NCT00804856|523960025|FG012|Overall Study|Non compliance with protocol|0|||
145303406|NCT00804856|523960026|FG013|Overall Study|Non compliance with protocol|2|||
145303407|NCT00804856|523960027|FG014|Overall Study|Non compliance with protocol|0|||
145303408|NCT00804856|523960013|FG000|Overall Study|Refused to continue medication|0|||
145303409|NCT00804856|523960014|FG001|Overall Study|Refused to continue medication|0|||
145303410|NCT00804856|523960015|FG002|Overall Study|Refused to continue medication|0|||
145303411|NCT00804856|523960016|FG003|Overall Study|Refused to continue medication|1|||
145303412|NCT00804856|523960017|FG004|Overall Study|Refused to continue medication|1|||
145303413|NCT00804856|523960018|FG005|Overall Study|Refused to continue medication|0|||
145303414|NCT00804856|523960019|FG006|Overall Study|Refused to continue medication|0|||
145303415|NCT00804856|523960020|FG007|Overall Study|Refused to continue medication|0|||
145303416|NCT00804856|523960021|FG008|Overall Study|Refused to continue medication|0|||
145303417|NCT00804856|523960022|FG009|Overall Study|Refused to continue medication|0|||
145303418|NCT00804856|523960023|FG010|Overall Study|Refused to continue medication|3|||
145303419|NCT00804856|523960024|FG011|Overall Study|Refused to continue medication|0|||
145303420|NCT00804856|523960025|FG012|Overall Study|Refused to continue medication|1|||
145303421|NCT00804856|523960026|FG013|Overall Study|Refused to continue medication|1|||
145303422|NCT00804856|523960027|FG014|Overall Study|Refused to continue medication|5|||
145303423|NCT00804856|523960013|FG000|Overall Study|Other reason than listed above|0|||
145303424|NCT00804856|523960014|FG001|Overall Study|Other reason than listed above|0|||
145303425|NCT00804856|523960015|FG002|Overall Study|Other reason than listed above|0|||
145620329|NCT03225846|525123740|FG006|Overall Study|Patient decision|1|||
145303426|NCT00804856|523960016|FG003|Overall Study|Other reason than listed above|0|||
145303427|NCT00804856|523960017|FG004|Overall Study|Other reason than listed above|0|||
145303428|NCT00804856|523960018|FG005|Overall Study|Other reason than listed above|1|||
145303429|NCT00804856|523960019|FG006|Overall Study|Other reason than listed above|0|||
145620330|NCT00996580|525123741|FG000|Overall Study|Adverse Event|466|||
145620331|NCT00996580|525123741|FG000|Overall Study|Lost to Follow-up|480|||
145303430|NCT00804856|523960020|FG007|Overall Study|Other reason than listed above|0|||
145303431|NCT00804856|523960021|FG008|Overall Study|Other reason than listed above|1|||
145303432|NCT00804856|523960022|FG009|Overall Study|Other reason than listed above|0|||
145303433|NCT00804856|523960023|FG010|Overall Study|Other reason than listed above|3|||
145303434|NCT00804856|523960024|FG011|Overall Study|Other reason than listed above|1|||
145303435|NCT00804856|523960025|FG012|Overall Study|Other reason than listed above|1|||
145303436|NCT00804856|523960026|FG013|Overall Study|Other reason than listed above|10|||
145303437|NCT00804856|523960027|FG014|Overall Study|Other reason than listed above|3|||
145303438|NCT00455312|523960028|FG000|Overall Study|Death|0|||
145303439|NCT00455312|523960029|FG001|Overall Study|Death|1|||
145303440|NCT03343535|523960030|FG000|Overall Study|Lost to Follow-up|1|||
145303441|NCT03343535|523960030|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
145303442|NCT03343535|523960030|FG000|Overall Study|Death|12|||
145303443|NCT03868891|523960031|FG000|Overall Study|Adverse Event|1|||
145303444|NCT03868891|523960032|FG001|Overall Study|Adverse Event|0|||
145303445|NCT03868891|523960031|FG000|Overall Study|Lost to Follow-up|2|||
145303446|NCT03868891|523960032|FG001|Overall Study|Lost to Follow-up|1|||
145303447|NCT03868891|523960031|FG000|Overall Study|COVID-19 Restrictions|1|||
145303448|NCT03868891|523960032|FG001|Overall Study|COVID-19 Restrictions|2|||
145303449|NCT01518972|523960033|FG000|Overall Study|Lost to Follow-up|2|||
145303450|NCT01518972|523960034|FG001|Overall Study|Lost to Follow-up|1|||
145303451|NCT01518972|523960033|FG000|Overall Study|Withdrawal by Subject|1|||
145303452|NCT01518972|523960034|FG001|Overall Study|Withdrawal by Subject|0|||
145303453|NCT01518972|523960033|FG000|Overall Study|Moved from area|1|||
145303454|NCT01518972|523960034|FG001|Overall Study|Moved from area|0|||
145303455|NCT01518972|523960033|FG000|Overall Study|Transportation problems|1|||
145303456|NCT01518972|523960034|FG001|Overall Study|Transportation problems|0|||
145303457|NCT01518972|523960033|FG000|Overall Study|Exclusionary medical condition|1|||
145303458|NCT01518972|523960034|FG001|Overall Study|Exclusionary medical condition|0|||
145303459|NCT01518972|523960033|FG000|Overall Study|Missed safety visits|0|||
145303460|NCT01518972|523960034|FG001|Overall Study|Missed safety visits|1|||
145303461|NCT01518972|523960033|FG000|Overall Study|Exclusionary medication|0|||
145303462|NCT01518972|523960034|FG001|Overall Study|Exclusionary medication|1|||
145303463|NCT01518972|523960033|FG000|Overall Study|Declined medication starting on day 12|0|||
145303464|NCT01518972|523960034|FG001|Overall Study|Declined medication starting on day 12|1|||
145303465|NCT02159950|523960039|FG000|Overall Study|Adverse Event|0|||
145303466|NCT02159950|523960040|FG001|Overall Study|Adverse Event|1|||
145303467|NCT02159950|523960039|FG000|Overall Study|Progression|0|||
145303468|NCT02159950|523960040|FG001|Overall Study|Progression|1|||
145303469|NCT00468286|523960048|FG000|Overall Study|Adverse Event|1|||
145303470|NCT00468286|523960049|FG001|Overall Study|Adverse Event|6|||
145303471|NCT00468286|523960048|FG000|Overall Study|Protocol Violation|2|||
145303472|NCT00468286|523960049|FG001|Overall Study|Protocol Violation|2|||
145303473|NCT00468286|523960048|FG000|Overall Study|Withdrawal by Subject|4|||
145303474|NCT00468286|523960049|FG001|Overall Study|Withdrawal by Subject|3|||
145303475|NCT00468286|523960048|FG000|Overall Study|Physician Decision|0|||
145303476|NCT00468286|523960049|FG001|Overall Study|Physician Decision|1|||
145303477|NCT02196675|523960050|FG000|Overall Study|Withdrawal by Subject|1|||
145303478|NCT02196675|523960051|FG001|Overall Study|Withdrawal by Subject|0|||
145303479|NCT02196675|523960052|FG002|Overall Study|Withdrawal by Subject|0|||
145303480|NCT02196675|523960050|FG000|Overall Study|Intra-operative surgical exclusion|1|||
145303481|NCT02196675|523960051|FG001|Overall Study|Intra-operative surgical exclusion|1|||
145303482|NCT02196675|523960052|FG002|Overall Study|Intra-operative surgical exclusion|0|||
145303483|NCT02196675|523960050|FG000|Overall Study|Protocol Violation|0|||
145303484|NCT02196675|523960051|FG001|Overall Study|Protocol Violation|1|||
145303485|NCT02196675|523960052|FG002|Overall Study|Protocol Violation|0|||
145303486|NCT02196675|523960050|FG000|Overall Study|Death|0|||
145303487|NCT02196675|523960051|FG001|Overall Study|Death|0|||
145303488|NCT02196675|523960052|FG002|Overall Study|Death|1|||
145303489|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
145303490|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
145303491|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
145303492|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
145303493|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
145303494|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
145303495|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
145303496|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
145303497|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
145303498|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
145303499|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
145303500|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
145303501|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
145303502|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
145303503|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
145303504|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
145303505|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
145303506|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
145303507|NCT02009163|523960056|FG000|Open-label Period (Non-randomized)|Other|13|||
145303508|NCT02009163|523960057|FG001|Open-label Period (Non-randomized)|Other|0|||
145303509|NCT02009163|523960058|FG002|Open-label Period (Non-randomized)|Other|0|||
145303510|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
145303511|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
145303512|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
145303513|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
145303514|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
145303515|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
145303516|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Adverse Event|0|||
145303517|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Adverse Event|0|||
145303518|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Adverse Event|6|||
145303519|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
145303520|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
145303521|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
145303522|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
145303523|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
145303524|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
145303525|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Pregnancy|0|||
145303526|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Pregnancy|0|||
145303527|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Pregnancy|2|||
145303528|NCT02009163|523960056|FG000|Randomized-withdrawal Period|Other|0|||
145303529|NCT02009163|523960057|FG001|Randomized-withdrawal Period|Other|9|||
145303530|NCT02009163|523960058|FG002|Randomized-withdrawal Period|Other|5|||
145303531|NCT02453386|523960061|FG000|Overall Study|Adverse Event|22|||
145303532|NCT02453386|523960062|FG001|Overall Study|Adverse Event|30|||
145303533|NCT02453386|523960063|FG002|Overall Study|Adverse Event|15|||
145303534|NCT02453386|523960061|FG000|Overall Study|Protocol Violation|1|||
145303535|NCT02453386|523960062|FG001|Overall Study|Protocol Violation|0|||
145303536|NCT02453386|523960063|FG002|Overall Study|Protocol Violation|1|||
145303537|NCT02453386|523960061|FG000|Overall Study|Withdrawal by Subject|10|||
145303538|NCT02453386|523960062|FG001|Overall Study|Withdrawal by Subject|9|||
145303539|NCT02453386|523960063|FG002|Overall Study|Withdrawal by Subject|9|||
145303540|NCT02453386|523960061|FG000|Overall Study|Sponsor Terminated Study|14|||
145303541|NCT02453386|523960062|FG001|Overall Study|Sponsor Terminated Study|8|||
145303542|NCT02453386|523960063|FG002|Overall Study|Sponsor Terminated Study|11|||
145303543|NCT02453386|523960061|FG000|Overall Study|Subject Terminated by Sponsor|1|||
145303544|NCT02453386|523960062|FG001|Overall Study|Subject Terminated by Sponsor|1|||
145303545|NCT02453386|523960063|FG002|Overall Study|Subject Terminated by Sponsor|1|||
145303546|NCT02453386|523960061|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
145303547|NCT02453386|523960062|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
145303548|NCT02453386|523960063|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
145303549|NCT02453386|523960061|FG000|Overall Study|Lost to Follow-up|0|||
145303550|NCT02453386|523960062|FG001|Overall Study|Lost to Follow-up|0|||
145303551|NCT02453386|523960063|FG002|Overall Study|Lost to Follow-up|1|||
145303552|NCT02453386|523960061|FG000|Overall Study|Other|1|||
145303553|NCT02453386|523960062|FG001|Overall Study|Other|0|||
145303554|NCT02453386|523960063|FG002|Overall Study|Other|1|||
145303555|NCT02601625|523960064|FG000|Overall Study|Lost to Follow-up|0|||
145303556|NCT02601625|523960065|FG001|Overall Study|Lost to Follow-up|0|||
145303557|NCT02601625|523960066|FG002|Overall Study|Lost to Follow-up|1|||
145303558|NCT02601625|523960067|FG003|Overall Study|Lost to Follow-up|1|||
145303559|NCT00359281|523960068|FG000|Overall Study|Adverse Event|1|||
145303560|NCT00359281|523960069|FG001|Overall Study|Adverse Event|0|||
145303561|NCT00359281|523960070|FG002|Overall Study|Adverse Event|0|||
145303562|NCT00359281|523960071|FG003|Overall Study|Adverse Event|0|||
145303563|NCT00359281|523960072|FG004|Overall Study|Adverse Event|0|||
145303564|NCT00359281|523960073|FG005|Overall Study|Adverse Event|0|||
145303565|NCT00359281|523960074|FG006|Overall Study|Adverse Event|1|||
145303566|NCT00359281|523960075|FG007|Overall Study|Adverse Event|0|||
145303567|NCT00359281|523960076|FG008|Overall Study|Adverse Event|0|||
145303568|NCT00359281|523960068|FG000|Overall Study|Withdrawal by Subject|0|||
145303569|NCT00359281|523960069|FG001|Overall Study|Withdrawal by Subject|0|||
145303570|NCT00359281|523960070|FG002|Overall Study|Withdrawal by Subject|0|||
145303571|NCT00359281|523960071|FG003|Overall Study|Withdrawal by Subject|0|||
145303572|NCT00359281|523960072|FG004|Overall Study|Withdrawal by Subject|0|||
145303573|NCT00359281|523960073|FG005|Overall Study|Withdrawal by Subject|0|||
145303574|NCT00359281|523960074|FG006|Overall Study|Withdrawal by Subject|1|||
145303575|NCT00359281|523960075|FG007|Overall Study|Withdrawal by Subject|0|||
145410979|NCT01525589|524356912|FG001|Overall Study|Never treated|0|||
145303576|NCT00359281|523960076|FG008|Overall Study|Withdrawal by Subject|0|||
145303577|NCT00838279|523960081|FG000|Washout|Protocol Violation|1|||
145303578|NCT00838279|523960082|FG001|Washout|Protocol Violation|0|||
145303579|NCT00838279|523960081|FG000|Washout|Withdrawal by Subject|0|||
145303580|NCT00838279|523960082|FG001|Washout|Withdrawal by Subject|1|||
145303581|NCT01415986|523960083|FG000|Overall Study|Lost to Follow-up|1|||
145303582|NCT03792477|523960086|FG000|Overall Study|Adverse Event|0|||
145303583|NCT03792477|523960087|FG001|Overall Study|Adverse Event|0|||
145303584|NCT03792477|523960088|FG002|Overall Study|Adverse Event|0|||
145303585|NCT03792477|523960089|FG003|Overall Study|Adverse Event|1|||
145303586|NCT03792477|523960090|FG004|Overall Study|Adverse Event|0|||
145303587|NCT03792477|523960086|FG000|Overall Study|Lost to Follow-up|0|||
145303588|NCT03792477|523960087|FG001|Overall Study|Lost to Follow-up|0|||
145303589|NCT03792477|523960088|FG002|Overall Study|Lost to Follow-up|2|||
145303590|NCT03792477|523960089|FG003|Overall Study|Lost to Follow-up|0|||
145303591|NCT03792477|523960090|FG004|Overall Study|Lost to Follow-up|0|||
145303592|NCT03792477|523960086|FG000|Overall Study|Other|0|||
145303593|NCT03792477|523960087|FG001|Overall Study|Other|0|||
145303594|NCT03792477|523960088|FG002|Overall Study|Other|0|||
145303595|NCT03792477|523960089|FG003|Overall Study|Other|0|||
145303596|NCT03792477|523960090|FG004|Overall Study|Other|1|||
145303597|NCT00840411|523960092|FG000|First Intervention|Adverse Event|1|||
145303598|NCT00840411|523960093|FG001|First Intervention|Adverse Event|0|||
145303599|NCT00840411|523960092|FG000|Washout|Withdrawal by Subject|1|||
145303600|NCT00840411|523960093|FG001|Washout|Withdrawal by Subject|0|||
145303601|NCT04419311|523960094|FG000|Overall Study|Lost to Follow-up|1|||
145303602|NCT04419311|523960095|FG001|Overall Study|Lost to Follow-up|0|||
145303603|NCT00465270|523960096|FG000|Overall Study|Death|7|||
145303604|NCT00465270|523960097|FG001|Overall Study|Death|11|||
145303605|NCT00465270|523960096|FG000|Overall Study|Withdrawal by Subject|34|||
145303606|NCT00465270|523960097|FG001|Overall Study|Withdrawal by Subject|78|||
145303607|NCT00465270|523960096|FG000|Overall Study|Lost to Follow-up|60|||
145303608|NCT00465270|523960097|FG001|Overall Study|Lost to Follow-up|67|||
145303609|NCT00465270|523960096|FG000|Overall Study|Investigator request|3|||
145303610|NCT00465270|523960097|FG001|Overall Study|Investigator request|4|||
145303611|NCT03122457|523960110|FG000|Overall Study|Withdrawal by Subject|6|||
145303612|NCT02388191|523960111|FG000|Overall Study|Patient did not receive IUD|1|||
145303613|NCT02388191|523960112|FG001|Overall Study|Patient did not receive IUD|0|||
145303614|NCT01921062|523960113|FG000|Overall Study|Withdrawal by Subject|0|||
145303615|NCT01921062|523960114|FG001|Overall Study|Withdrawal by Subject|7|||
145303616|NCT01921062|523960113|FG000|Overall Study|Adverse Event|5|||
145303617|NCT01921062|523960114|FG001|Overall Study|Adverse Event|6|||
145303618|NCT01921062|523960113|FG000|Overall Study|Protocol Violation|0|||
145303619|NCT01921062|523960114|FG001|Overall Study|Protocol Violation|1|||
145303620|NCT01921062|523960113|FG000|Overall Study|VMIQ score > 72|4|||
145303621|NCT01921062|523960114|FG001|Overall Study|VMIQ score > 72|1|||
145303622|NCT01921062|523960113|FG000|Overall Study|Logistic error|0|||
145303623|NCT01921062|523960114|FG001|Overall Study|Logistic error|1|||
145303624|NCT01911676|523960115|FG000|Period 1 of Study|Withdrawal by Subject|4|||
145303625|NCT01911676|523960116|FG001|Period 1 of Study|Withdrawal by Subject|2|||
145303626|NCT01911676|523960117|FG002|Period 1 of Study|Withdrawal by Subject|1|||
145303627|NCT01911676|523960118|FG003|Period 1 of Study|Withdrawal by Subject|2|||
145303628|NCT01911676|523960115|FG000|Period 1 of Study|Physician Decision|2|||
145303629|NCT01911676|523960116|FG001|Period 1 of Study|Physician Decision|0|||
145303630|NCT01911676|523960117|FG002|Period 1 of Study|Physician Decision|0|||
145303631|NCT01911676|523960118|FG003|Period 1 of Study|Physician Decision|1|||
145303632|NCT01911676|523960115|FG000|Period 2 of Study|Physician Decision|2|||
145303633|NCT01911676|523960116|FG001|Period 2 of Study|Physician Decision|0|||
145303634|NCT01911676|523960117|FG002|Period 2 of Study|Physician Decision|0|||
145303635|NCT01911676|523960118|FG003|Period 2 of Study|Physician Decision|1|||
145303636|NCT01911676|523960115|FG000|Period 2 of Study|Lost to Follow-up|0|||
145303637|NCT01911676|523960116|FG001|Period 2 of Study|Lost to Follow-up|0|||
145303638|NCT01911676|523960117|FG002|Period 2 of Study|Lost to Follow-up|0|||
145303639|NCT01911676|523960118|FG003|Period 2 of Study|Lost to Follow-up|1|||
145303640|NCT00657553|523960121|FG000|Overall Study|low accrual, no analysis run|5|||
145303641|NCT00657553|523960122|FG001|Overall Study|low accrual, no analysis run|5|||
145303642|NCT03173547|523960123|FG000|Overall Study|Adverse Event|2|||
145303643|NCT03173547|523960124|FG001|Overall Study|Adverse Event|0|||
145303644|NCT03173547|523960123|FG000|Overall Study|Withdrawal by Subject|2|||
145303645|NCT03173547|523960124|FG001|Overall Study|Withdrawal by Subject|2|||
145303646|NCT01169558|523960125|FG000|Overall Study|Disease progression|98|||
145303647|NCT01169558|523960125|FG000|Overall Study|Adverse Event|25|||
145410980|NCT01525589|524356913|FG002|Overall Study|Never treated|0|||
145303648|NCT01169558|523960125|FG000|Overall Study|Withdrawal of Consent|8|||
145303649|NCT01169558|523960125|FG000|Overall Study|Medical Decision|7|||
145303650|NCT01169558|523960125|FG000|Overall Study|Stable Disease|4|||
145303651|NCT01169558|523960125|FG000|Overall Study|Lost to Follow-up|4|||
145303652|NCT01169558|523960125|FG000|Overall Study|Need for Surgery|4|||
145410981|NCT01525589|524356911|FG000|Overall Study|Physician Decision|4|||
145303653|NCT01169558|523960125|FG000|Overall Study|Non-compliance|2|||
145303654|NCT01169558|523960125|FG000|Overall Study|Protocol Violation|2|||
145303655|NCT01169558|523960125|FG000|Overall Study|Partial response|2|||
145303656|NCT03134222|523960126|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
145303657|NCT03134222|523960127|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
145303658|NCT03134222|523960128|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
145303659|NCT03134222|523960129|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
145303660|NCT03134222|523960130|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
145303661|NCT03134222|523960126|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
145303662|NCT03134222|523960127|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
145303663|NCT03134222|523960128|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
145303664|NCT03134222|523960129|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
145303665|NCT03134222|523960130|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
145303666|NCT03134222|523960126|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
145303667|NCT03134222|523960127|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
145303668|NCT03134222|523960128|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
145303669|NCT03134222|523960129|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
145303670|NCT03134222|523960130|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
145303671|NCT03134222|523960126|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
145303672|NCT03134222|523960127|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
145303673|NCT03134222|523960128|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
145303674|NCT03134222|523960129|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
145303675|NCT03134222|523960130|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
145303676|NCT03134222|523960126|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
145303677|NCT03134222|523960127|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
145303678|NCT03134222|523960128|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
145303679|NCT03134222|523960129|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
145303680|NCT03134222|523960130|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
145303681|NCT03134222|523960126|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
145303682|NCT03134222|523960127|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
145303683|NCT03134222|523960128|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
145303684|NCT03134222|523960129|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
145303685|NCT03134222|523960130|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
145303686|NCT03134222|523960126|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
145303687|NCT03134222|523960127|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
145303688|NCT03134222|523960128|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
145303689|NCT03134222|523960129|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
145303690|NCT03134222|523960130|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
145303691|NCT03134222|523960126|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
145303692|NCT03134222|523960127|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
145303693|NCT03134222|523960128|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
145303694|NCT03134222|523960129|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
145303695|NCT03134222|523960130|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
145303696|NCT01136174|523960140|FG000|Overall Study|Adverse Event|0|||
145303697|NCT01136174|523960141|FG001|Overall Study|Adverse Event|0|||
145303698|NCT01136174|523960142|FG002|Overall Study|Adverse Event|0|||
145303699|NCT01136174|523960143|FG003|Overall Study|Adverse Event|4|||
145303700|NCT00811655|523960144|FG000|Overall Study|Physician Decision|1|||
145303701|NCT02820350|523960145|FG000|Overall Study|Withdrawal by Subject|3|||
145303702|NCT02820350|523960145|FG000|Overall Study|Death|4|||
145303703|NCT01754597|523960146|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
145303704|NCT01754597|523960147|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
145303705|NCT00819741|523960150|FG000|Overall Study|Adverse Event|5|||
145303706|NCT00819741|523960151|FG001|Overall Study|Adverse Event|2|||
145303707|NCT00819741|523960150|FG000|Overall Study|Lack of Efficacy|0|||
145303708|NCT00819741|523960151|FG001|Overall Study|Lack of Efficacy|2|||
145303709|NCT00819741|523960150|FG000|Overall Study|Lost to Follow-up|3|||
145303710|NCT00819741|523960151|FG001|Overall Study|Lost to Follow-up|1|||
145303711|NCT00819741|523960150|FG000|Overall Study|Protocol Violation|3|||
145303712|NCT00819741|523960151|FG001|Overall Study|Protocol Violation|4|||
145303713|NCT00819741|523960150|FG000|Overall Study|Withdrawal by Subject|2|||
145303714|NCT00819741|523960151|FG001|Overall Study|Withdrawal by Subject|2|||
145303715|NCT00819741|523960150|FG000|Overall Study|Unclassified|6|||
145303716|NCT00819741|523960151|FG001|Overall Study|Unclassified|0|||
145303717|NCT00819741|523960150|FG000|Overall Study|Reasons unknown|3|||
145303718|NCT00819741|523960151|FG001|Overall Study|Reasons unknown|3|||
145303719|NCT00119015|523960152|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
145303720|NCT00119015|523960153|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
145303721|NCT00119015|523960154|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
145303722|NCT02674152|523961671|FG000|Overall Study|Personal Reasons|1|||
145303723|NCT02674152|523961672|FG001|Overall Study|Personal Reasons|0|||
145303724|NCT02674152|523961673|FG002|Overall Study|Personal Reasons|0|||
145303725|NCT02674152|523961674|FG003|Overall Study|Personal Reasons|1|||
145303726|NCT02674152|523961675|FG004|Overall Study|Personal Reasons|1|||
145303727|NCT02674152|523961671|FG000|Overall Study|Other adverse event or clinical progression|0|||
145303728|NCT02674152|523961672|FG001|Overall Study|Other adverse event or clinical progression|1|||
145303729|NCT02674152|523961673|FG002|Overall Study|Other adverse event or clinical progression|0|||
145303730|NCT02674152|523961674|FG003|Overall Study|Other adverse event or clinical progression|3|||
145303731|NCT02674152|523961675|FG004|Overall Study|Other adverse event or clinical progression|0|||
145303732|NCT02674152|523961671|FG000|Overall Study|Dose-limiting toxicity|0|||
145303733|NCT02674152|523961672|FG001|Overall Study|Dose-limiting toxicity|0|||
145303734|NCT02674152|523961673|FG002|Overall Study|Dose-limiting toxicity|0|||
145303735|NCT02674152|523961674|FG003|Overall Study|Dose-limiting toxicity|0|||
145303736|NCT02674152|523961675|FG004|Overall Study|Dose-limiting toxicity|1|||
145303737|NCT02674152|523961671|FG000|Overall Study|Progressive Disease|2|||
145303738|NCT02674152|523961672|FG001|Overall Study|Progressive Disease|1|||
145303739|NCT02674152|523961673|FG002|Overall Study|Progressive Disease|1|||
145303740|NCT02674152|523961674|FG003|Overall Study|Progressive Disease|13|||
145303741|NCT02674152|523961675|FG004|Overall Study|Progressive Disease|2|||
145303742|NCT02674152|523961671|FG000|Overall Study|Adverse Event|0|||
145303743|NCT02674152|523961672|FG001|Overall Study|Adverse Event|0|||
145303744|NCT02674152|523961673|FG002|Overall Study|Adverse Event|1|||
145303745|NCT02674152|523961674|FG003|Overall Study|Adverse Event|0|||
145303746|NCT02674152|523961675|FG004|Overall Study|Adverse Event|1|||
145303747|NCT05265624|523961676|FG000|Overall Study|Lost to Follow-up|3|||
145303748|NCT05265624|523961677|FG001|Overall Study|Lost to Follow-up|0|||
145303749|NCT05265624|523961676|FG000|Overall Study|Withdrawal by Subject|1|||
145303750|NCT05265624|523961677|FG001|Overall Study|Withdrawal by Subject|0|||
145303751|NCT00001703|523961678|FG000|Overall Study|progressed disease|2|||
145303752|NCT00001703|523961678|FG000|Overall Study|No evidence of disease|1|||
145303753|NCT00001703|523961678|FG000|Overall Study|recurrent disease|2|||
145303754|NCT03071575|523961679|FG000|Overall Study|Death|0|||
145303755|NCT03071575|523961680|FG001|Overall Study|Death|1|||
145303756|NCT03071575|523961679|FG000|Overall Study|Lost to Follow-up|5|||
145303757|NCT03071575|523961680|FG001|Overall Study|Lost to Follow-up|11|||
145303758|NCT03071575|523961679|FG000|Overall Study|Withdrawal by Subject|4|||
145303759|NCT03071575|523961680|FG001|Overall Study|Withdrawal by Subject|2|||
145303760|NCT00834795|523961685|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
145303761|NCT00834795|523961686|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
145303762|NCT00834795|523961685|FG000|Second Intervention|Adverse Event|1|||
145303763|NCT00834795|523961686|FG001|Second Intervention|Adverse Event|0|||
145303764|NCT00579345|523961687|FG000|Overall Study|Withdrawal by Subject|2|||
145303765|NCT00579345|523961688|FG001|Overall Study|Withdrawal by Subject|0|||
145303766|NCT00579345|523961689|FG002|Overall Study|Withdrawal by Subject|0|||
145303767|NCT00579345|523961690|FG003|Overall Study|Withdrawal by Subject|0|||
145303768|NCT00579345|523961691|FG004|Overall Study|Withdrawal by Subject|0|||
145303769|NCT00579345|523961692|FG005|Overall Study|Withdrawal by Subject|0|||
145303770|NCT00579345|523961693|FG006|Overall Study|Withdrawal by Subject|0|||
145303771|NCT00579345|523961694|FG007|Overall Study|Withdrawal by Subject|1|||
145303772|NCT00579345|523961687|FG000|Overall Study|Lost to Follow-up|1|||
145303773|NCT00579345|523961688|FG001|Overall Study|Lost to Follow-up|0|||
145303774|NCT00579345|523961689|FG002|Overall Study|Lost to Follow-up|0|||
145303775|NCT00579345|523961690|FG003|Overall Study|Lost to Follow-up|0|||
145303776|NCT00579345|523961691|FG004|Overall Study|Lost to Follow-up|0|||
145303777|NCT00579345|523961692|FG005|Overall Study|Lost to Follow-up|0|||
145303778|NCT00579345|523961693|FG006|Overall Study|Lost to Follow-up|0|||
145303779|NCT00579345|523961694|FG007|Overall Study|Lost to Follow-up|0|||
145303780|NCT00579345|523961687|FG000|Overall Study|Adverse Event|0|||
145303781|NCT00579345|523961688|FG001|Overall Study|Adverse Event|0|||
145303782|NCT00579345|523961689|FG002|Overall Study|Adverse Event|1|||
145303783|NCT00579345|523961690|FG003|Overall Study|Adverse Event|0|||
145303784|NCT00579345|523961691|FG004|Overall Study|Adverse Event|0|||
145568880|NCT00606892|524942352|FG000|First Intervention|Protocol Violation|1|||
145568881|NCT00606892|524942353|FG001|First Intervention|Protocol Violation|4|||
145568882|NCT03216850|524942358|FG000|Overall Study|Pre-analytical error|6|||
145568883|NCT01116232|524942359|FG000|Overall Study|Progressive diease|4|||
145303785|NCT00579345|523961692|FG005|Overall Study|Adverse Event|0|||
145568884|NCT03554291|524942360|FG000|Overall Study|Death|2|||
145568885|NCT03554291|524942361|FG001|Overall Study|Death|1|||
145303786|NCT00579345|523961693|FG006|Overall Study|Adverse Event|0|||
145303787|NCT00579345|523961694|FG007|Overall Study|Adverse Event|0|||
145303788|NCT00579345|523961687|FG000|Overall Study|Protocol Violation|1|||
145303789|NCT00579345|523961688|FG001|Overall Study|Protocol Violation|0|||
145303790|NCT00579345|523961689|FG002|Overall Study|Protocol Violation|0|||
145303791|NCT00579345|523961690|FG003|Overall Study|Protocol Violation|0|||
145303792|NCT00579345|523961691|FG004|Overall Study|Protocol Violation|0|||
145303793|NCT00579345|523961692|FG005|Overall Study|Protocol Violation|0|||
145303794|NCT00579345|523961693|FG006|Overall Study|Protocol Violation|0|||
145303795|NCT00579345|523961694|FG007|Overall Study|Protocol Violation|1|||
145568886|NCT03554291|524942360|FG000|Overall Study|Lost to Follow-up|1|||
145568887|NCT03554291|524942361|FG001|Overall Study|Lost to Follow-up|0|||
145303796|NCT00579345|523961687|FG000|Overall Study|Death|1|||
145303797|NCT00579345|523961688|FG001|Overall Study|Death|1|||
145568888|NCT03554291|524942360|FG000|Overall Study|Withdrawal by Subject|1|||
145568889|NCT03554291|524942361|FG001|Overall Study|Withdrawal by Subject|0|||
145303798|NCT00579345|523961689|FG002|Overall Study|Death|1|||
145303799|NCT00579345|523961690|FG003|Overall Study|Death|1|||
145303800|NCT00579345|523961691|FG004|Overall Study|Death|0|||
145303801|NCT00579345|523961692|FG005|Overall Study|Death|0|||
145303802|NCT00579345|523961693|FG006|Overall Study|Death|0|||
145303803|NCT00579345|523961694|FG007|Overall Study|Death|0|||
145303804|NCT03447353|523961698|FG000|Overall Study|Failure at Screening Visit|2|||
145303805|NCT03447353|523961698|FG000|Overall Study|Lost to Follow-up|4|||
145303806|NCT03447353|523961698|FG000|Overall Study|Scheduling Conflicts|3|||
145303807|NCT03447353|523961698|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
145303808|NCT02057835|523961699|FG000|Overall Study|Withdrawal by Subject|0|||
145303809|NCT02057835|523961700|FG001|Overall Study|Withdrawal by Subject|2|||
145303810|NCT02057835|523961701|FG002|Overall Study|Withdrawal by Subject|0|||
145303811|NCT02057835|523961702|FG003|Overall Study|Withdrawal by Subject|0|||
145303812|NCT02057835|523961703|FG004|Overall Study|Withdrawal by Subject|0|||
145303813|NCT02057835|523961704|FG005|Overall Study|Withdrawal by Subject|0|||
145303814|NCT02057835|523961705|FG006|Overall Study|Withdrawal by Subject|0|||
145303815|NCT02057835|523961706|FG007|Overall Study|Withdrawal by Subject|0|||
145303816|NCT02057835|523961707|FG008|Overall Study|Withdrawal by Subject|0|||
145303817|NCT02057835|523961708|FG009|Overall Study|Withdrawal by Subject|0|||
145303818|NCT02267187|523961709|FG000|Overall Study|Physician Decision|2|||
145303819|NCT02267187|523961709|FG000|Overall Study|Screen fail|3|||
145303820|NCT04299087|523961710|FG000|Overall Study|Lost to Follow-up|2|||
145303821|NCT04299087|523961711|FG001|Overall Study|Lost to Follow-up|1|||
145303822|NCT03025087|523961712|FG000|Overall Study|Physician Decision|3|||
145303823|NCT03025087|523961713|FG001|Overall Study|Physician Decision|3|||
145303824|NCT03025087|523961714|FG002|Overall Study|Physician Decision|0|||
145303825|NCT03025087|523961715|FG003|Overall Study|Physician Decision|0|||
145303826|NCT03025087|523961716|FG004|Overall Study|Physician Decision|0|||
145303827|NCT03025087|523961712|FG000|Overall Study|Withdrawal by Subject|1|||
145303828|NCT03025087|523961713|FG001|Overall Study|Withdrawal by Subject|1|||
145303829|NCT03025087|523961714|FG002|Overall Study|Withdrawal by Subject|0|||
145303830|NCT03025087|523961715|FG003|Overall Study|Withdrawal by Subject|0|||
145303831|NCT03025087|523961716|FG004|Overall Study|Withdrawal by Subject|0|||
145303832|NCT03025087|523961712|FG000|Overall Study|Unable to complete MRI|2|||
145303833|NCT03025087|523961713|FG001|Overall Study|Unable to complete MRI|2|||
145303834|NCT03025087|523961714|FG002|Overall Study|Unable to complete MRI|0|||
145303835|NCT03025087|523961715|FG003|Overall Study|Unable to complete MRI|0|||
145303836|NCT03025087|523961716|FG004|Overall Study|Unable to complete MRI|0|||
145303837|NCT00508651|523961717|FG000|Overall Study|Lost to Follow-up|3|||
145303838|NCT00508651|523961718|FG001|Overall Study|Lost to Follow-up|1|||
145303839|NCT00508651|523961717|FG000|Overall Study|Withdrawal by Subject|1|||
145303840|NCT00508651|523961718|FG001|Overall Study|Withdrawal by Subject|1|||
145303841|NCT01376037|523961720|FG000|Overall Study|Lost to Follow-up|0|||
145303842|NCT01376037|523961721|FG001|Overall Study|Lost to Follow-up|2|||
145303843|NCT00561015|523961722|FG000|Overall Study|Adverse Event|0|||
145303844|NCT00561015|523961723|FG001|Overall Study|Adverse Event|0|||
145303845|NCT00561015|523961724|FG002|Overall Study|Adverse Event|0|||
145303846|NCT00561015|523961725|FG003|Overall Study|Adverse Event|0|||
145303847|NCT00561015|523961726|FG004|Overall Study|Adverse Event|1|||
145303848|NCT00561015|523961727|FG005|Overall Study|Adverse Event|0|||
145303849|NCT00561015|523961722|FG000|Overall Study|Lost to Follow-up|2|||
145303850|NCT00561015|523961723|FG001|Overall Study|Lost to Follow-up|0|||
145303851|NCT00561015|523961724|FG002|Overall Study|Lost to Follow-up|0|||
145303852|NCT00561015|523961725|FG003|Overall Study|Lost to Follow-up|1|||
145303853|NCT00561015|523961726|FG004|Overall Study|Lost to Follow-up|0|||
145303854|NCT00561015|523961727|FG005|Overall Study|Lost to Follow-up|3|||
145303855|NCT00561015|523961722|FG000|Overall Study|Participant non-compliance|2|||
145303856|NCT00561015|523961723|FG001|Overall Study|Participant non-compliance|0|||
145303857|NCT00561015|523961724|FG002|Overall Study|Participant non-compliance|0|||
145303858|NCT00561015|523961725|FG003|Overall Study|Participant non-compliance|0|||
145303859|NCT00561015|523961726|FG004|Overall Study|Participant non-compliance|0|||
145303860|NCT00561015|523961727|FG005|Overall Study|Participant non-compliance|0|||
145303861|NCT02545283|523961730|FG000|Overall Study|Lost to Follow-up|2|||
145303862|NCT02545283|523961731|FG001|Overall Study|Lost to Follow-up|4|||
145303863|NCT02545283|523961730|FG000|Overall Study|Withdrawal by Subject|5|||
145568890|NCT03554291|524942360|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
145568891|NCT03554291|524942361|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
145568892|NCT03274986|524942367|FG000|Overall Study|Withdrawal by Subject|0|||
145568893|NCT03274986|524942368|FG001|Overall Study|Withdrawal by Subject|1|||
145568894|NCT03274986|524942367|FG000|Overall Study|Lost to Follow-up|0|||
145568895|NCT03274986|524942368|FG001|Overall Study|Lost to Follow-up|1|||
145303864|NCT02545283|523961731|FG001|Overall Study|Withdrawal by Subject|9|||
145303865|NCT02545283|523961730|FG000|Overall Study|Death|109|||
145410982|NCT01525589|524356912|FG001|Overall Study|Physician Decision|2|||
145410983|NCT01525589|524356913|FG002|Overall Study|Physician Decision|2|||
145410984|NCT01525589|524356911|FG000|Overall Study|Death|0|||
145410985|NCT01525589|524356912|FG001|Overall Study|Death|0|||
145410986|NCT01525589|524356913|FG002|Overall Study|Death|2|||
145410987|NCT01525589|524356911|FG000|Overall Study|Treatment-related AE|1|||
145410988|NCT01525589|524356912|FG001|Overall Study|Treatment-related AE|1|||
145303866|NCT02545283|523961731|FG001|Overall Study|Death|211|||
145303867|NCT02545283|523961730|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
145303868|NCT02545283|523961731|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
145303869|NCT02545283|523961730|FG000|Overall Study|Study Terminated By Sponsor|33|||
145303870|NCT02545283|523961731|FG001|Overall Study|Study Terminated By Sponsor|71|||
145303871|NCT02436005|523961732|FG000|Second Intervention|Adverse Event|0|||
145303872|NCT02436005|523961733|FG001|Second Intervention|Adverse Event|1|||
145303873|NCT00583453|523961734|FG000|Overall Study|discontinued intervention|0|||
145303874|NCT00583453|523961735|FG001|Overall Study|discontinued intervention|2|||
145303875|NCT00905606|523961736|FG000|Period 1|Adverse Event|0|||
145303876|NCT00905606|523961737|FG001|Period 1|Adverse Event|1|||
145303877|NCT00905606|523961736|FG000|Washout|Withdrawal by Subject|1|||
145303878|NCT00905606|523961737|FG001|Washout|Withdrawal by Subject|0|||
145303879|NCT03635320|523961738|FG000|Overall Study|not implanted the device|1|||
145303880|NCT03635320|523961739|FG001|Overall Study|not implanted the device|2|||
145303881|NCT03635320|523961738|FG000|Overall Study|Withdrawal by Subject|11|||
145303882|NCT03635320|523961739|FG001|Overall Study|Withdrawal by Subject|6|||
145303883|NCT01558635|523961743|FG000|Overall Study|Death|1|||
145303884|NCT01558635|523961743|FG000|Overall Study|Withdrawal by Subject|2|||
145303885|NCT01558635|523961743|FG000|Overall Study|Physician Decision|1|||
145303886|NCT01558635|523961743|FG000|Overall Study|Subject received other treatment|1|||
145303887|NCT01558635|523961743|FG000|Overall Study|Reveal XT was explanted|1|||
145303888|NCT01158118|523961744|FG000|Overall Study|Screen failure|1|||
145303889|NCT01158118|523961745|FG001|Overall Study|Screen failure|0|||
145303890|NCT01158118|523961744|FG000|Overall Study|Donor match was a screen failure|0|||
145303891|NCT01158118|523961745|FG001|Overall Study|Donor match was a screen failure|1|||
145303892|NCT01158118|523961744|FG000|Overall Study|Suffered stroke prior to transplant|0|||
145303893|NCT01158118|523961745|FG001|Overall Study|Suffered stroke prior to transplant|1|||
145303894|NCT01158118|523961744|FG000|Overall Study|Death|0|||
145303895|NCT01158118|523961745|FG001|Overall Study|Death|1|||
145303896|NCT04994535|523961746|FG000|Overall Study|Lost to Follow-up|7|||
145303897|NCT04994535|523961747|FG001|Overall Study|Lost to Follow-up|7|||
145303898|NCT04994535|523961746|FG000|Overall Study|Withdrawal by Subject|10|||
145303899|NCT04994535|523961747|FG001|Overall Study|Withdrawal by Subject|7|||
145303900|NCT04994535|523961746|FG000|Overall Study|Other|1|||
145303901|NCT04994535|523961747|FG001|Overall Study|Other|1|||
145303902|NCT03419403|523961752|FG000|Overall Study|Withdrawal by Subject|5|||
145303903|NCT03419403|523961753|FG001|Overall Study|Withdrawal by Subject|2|||
145303904|NCT03419403|523961754|FG002|Overall Study|Withdrawal by Subject|5|||
145303905|NCT03419403|523961755|FG003|Overall Study|Withdrawal by Subject|1|||
145303906|NCT03419403|523961752|FG000|Overall Study|Progressive disease (per protocol)|0|||
145303907|NCT03419403|523961753|FG001|Overall Study|Progressive disease (per protocol)|2|||
145303908|NCT03419403|523961754|FG002|Overall Study|Progressive disease (per protocol)|2|||
145303909|NCT03419403|523961755|FG003|Overall Study|Progressive disease (per protocol)|0|||
145303910|NCT03419403|523961752|FG000|Overall Study|Other, not specified|6|||
145303911|NCT03419403|523961753|FG001|Overall Study|Other, not specified|4|||
145303912|NCT03419403|523961754|FG002|Overall Study|Other, not specified|5|||
145303913|NCT03419403|523961755|FG003|Overall Study|Other, not specified|1|||
145303914|NCT03419403|523961752|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
145303915|NCT03419403|523961753|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
145303916|NCT03419403|523961754|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
145303917|NCT03419403|523961755|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
145303918|NCT03552393|523961758|FG000|Core Period|Kidney Transplant|1|||
145303919|NCT03552393|523961758|FG000|Core Period|Prohibited Medication|1|||
145303920|NCT03552393|523961758|FG000|Safety Extension Period|Kidney Transplant|4|||
145303921|NCT01289262|523961760|FG000|Overall Study|Lost to Follow-up|29|||
145303922|NCT01289262|523961761|FG001|Overall Study|Lost to Follow-up|16|||
145303923|NCT01289262|523961760|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
145303924|NCT01289262|523961761|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
145303925|NCT04887415|523961762|FG000|Overall Study|Lost to Follow-up|2|||
145303926|NCT04608188|523961763|FG000|Overall Study|Withdrawal by Subject|4|||
145303927|NCT04608188|523961764|FG001|Overall Study|Withdrawal by Subject|8|||
145303928|NCT01250912|523961768|FG000|Overall Study|Lost to Follow-up|1|||
145303929|NCT05646251|523961771|FG000|Overall Study|Physician Decision|1|||
145303930|NCT05646251|523961772|FG001|Overall Study|Physician Decision|0|||
145303931|NCT05646251|523961773|FG002|Overall Study|Physician Decision|2|||
145410989|NCT01525589|524356913|FG002|Overall Study|Treatment-related AE|2|||
145410990|NCT01525589|524356911|FG000|Overall Study|Other reasons|0|||
145303932|NCT01218867|523961774|FG000|Overall Study|Death during treatment|0|||
145303933|NCT01218867|523961775|FG001|Overall Study|Death during treatment|0|||
145303934|NCT01218867|523961776|FG002|Overall Study|Death during treatment|0|||
145303935|NCT01218867|523961777|FG003|Overall Study|Death during treatment|0|||
145303936|NCT01218867|523961778|FG004|Overall Study|Death during treatment|0|||
145303937|NCT01218867|523961779|FG005|Overall Study|Death during treatment|0|||
145303938|NCT01218867|523961780|FG006|Overall Study|Death during treatment|1|||
145303939|NCT01218867|523961781|FG007|Overall Study|Death during treatment|0|||
145303940|NCT01218867|523961782|FG008|Overall Study|Death during treatment|0|||
145303941|NCT01218867|523961783|FG009|Overall Study|Death during treatment|0|||
145303942|NCT01218867|523961784|FG010|Overall Study|Death during treatment|0|||
145303943|NCT03233724|523961788|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
145303944|NCT03233724|523961789|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
145303945|NCT03233724|523961790|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
145303946|NCT03233724|523961791|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
145303947|NCT03233724|523961792|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
145303948|NCT03233724|523961788|FG000|Phase I Dose Escalation|Best interest of participant|1|||
145303949|NCT03233724|523961789|FG001|Phase I Dose Escalation|Best interest of participant|1|||
145303950|NCT03233724|523961790|FG002|Phase I Dose Escalation|Best interest of participant|1|||
145303951|NCT03233724|523961791|FG003|Phase I Dose Escalation|Best interest of participant|0|||
145303952|NCT03233724|523961792|FG004|Phase I Dose Escalation|Best interest of participant|0|||
145303953|NCT03233724|523961788|FG000|Phase I Dose Escalation|Physician Decision|0|||
145303954|NCT03233724|523961789|FG001|Phase I Dose Escalation|Physician Decision|0|||
145303955|NCT03233724|523961790|FG002|Phase I Dose Escalation|Physician Decision|1|||
145303956|NCT03233724|523961791|FG003|Phase I Dose Escalation|Physician Decision|0|||
145303957|NCT03233724|523961792|FG004|Phase I Dose Escalation|Physician Decision|0|||
145303958|NCT03233724|523961788|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
145303959|NCT03233724|523961789|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
145303960|NCT03233724|523961790|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
145303961|NCT03233724|523961791|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
145303962|NCT03233724|523961792|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
145303963|NCT00651820|523961795|FG000|Overall Study|Lost to Follow-up|2|||
145303964|NCT00773253|523961796|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
145303965|NCT00773253|523961797|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
145303966|NCT01566721|523961798|FG000|Treatment Period|Withdrawal by Subject|35|||
145303967|NCT01566721|523961799|FG001|Treatment Period|Withdrawal by Subject|9|||
145303968|NCT01566721|523961798|FG000|Treatment Period|Disease Progression/Recurrence|37|||
145303969|NCT01566721|523961799|FG001|Treatment Period|Disease Progression/Recurrence|13|||
145303970|NCT01566721|523961798|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
145303971|NCT01566721|523961799|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
145303972|NCT01566721|523961798|FG000|Treatment Period|Other|13|||
145303973|NCT01566721|523961799|FG001|Treatment Period|Other|2|||
145303974|NCT01566721|523961798|FG000|Treatment Period|Lack of Compliance|5|||
145303975|NCT01566721|523961799|FG001|Treatment Period|Lack of Compliance|1|||
145303976|NCT01566721|523961798|FG000|Treatment Period|Adverse Event|100|||
145303977|NCT01566721|523961799|FG001|Treatment Period|Adverse Event|30|||
145303978|NCT01566721|523961798|FG000|Treatment Period|Pregnancy|1|||
145303979|NCT01566721|523961799|FG001|Treatment Period|Pregnancy|0|||
145303980|NCT01566721|523961798|FG000|Safety Follow-up|Physician Decision|6|||
145303981|NCT01566721|523961799|FG001|Safety Follow-up|Physician Decision|4|||
145303982|NCT01566721|523961798|FG000|Safety Follow-up|Lost to Follow-up|101|||
145303983|NCT01566721|523961799|FG001|Safety Follow-up|Lost to Follow-up|48|||
145303984|NCT01566721|523961798|FG000|Safety Follow-up|Withdrawal by Subject|155|||
145303985|NCT01566721|523961799|FG001|Safety Follow-up|Withdrawal by Subject|49|||
145303986|NCT01566721|523961798|FG000|Safety Follow-up|Death|28|||
145303987|NCT01566721|523961799|FG001|Safety Follow-up|Death|4|||
145303988|NCT01566721|523961798|FG000|Safety Follow-up|Non-compliance|7|||
145303989|NCT01566721|523961799|FG001|Safety Follow-up|Non-compliance|3|||
145303990|NCT01566721|523961798|FG000|Safety Follow-up|Protocol Violation|7|||
145303991|NCT01566721|523961799|FG001|Safety Follow-up|Protocol Violation|0|||
145303992|NCT01566721|523961798|FG000|Safety Follow-up|Site closure|2|||
145303993|NCT01566721|523961799|FG001|Safety Follow-up|Site closure|3|||
145410991|NCT01525589|524356912|FG001|Overall Study|Other reasons|1|||
145410992|NCT01525589|524356913|FG002|Overall Study|Other reasons|0|||
145303994|NCT01566721|523961798|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
145303995|NCT01566721|523961799|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
145303996|NCT01566721|523961798|FG000|Safety Follow-up|Missing|7|||
145568896|NCT00603746|524942369|FG000|Overall Study|Adverse Event|2|||
145303997|NCT01566721|523961799|FG001|Safety Follow-up|Missing|2|||
145303998|NCT01566721|523961798|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
145303999|NCT01566721|523961799|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
145304000|NCT01566721|523961798|FG000|Safety Follow-up|Sponsor decision|1|||
145304001|NCT01566721|523961799|FG001|Safety Follow-up|Sponsor decision|0|||
145304002|NCT01566721|523961798|FG000|Safety Follow-up|Adverse Event|8|||
145304003|NCT01566721|523961799|FG001|Safety Follow-up|Adverse Event|4|||
145304004|NCT00446563|523961800|FG000|Overall Study|Adverse Event|4|||
145304005|NCT00446563|523961801|FG001|Overall Study|Adverse Event|3|||
145304006|NCT00446563|523961800|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145304007|NCT00446563|523961801|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145304008|NCT00446563|523961800|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145304009|NCT00446563|523961801|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145304010|NCT00446563|523961800|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145304011|NCT00446563|523961801|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145304012|NCT00446563|523961800|FG000|Overall Study|Withdrawal by Subject|2|||
145304013|NCT00446563|523961801|FG001|Overall Study|Withdrawal by Subject|1|||
145304014|NCT00446563|523961800|FG000|Overall Study|Administrative problems|0|||
145304015|NCT00446563|523961801|FG001|Overall Study|Administrative problems|1|||
145304016|NCT02409355|523961804|FG000|Overall Study|Withdrawal by Subject|1|||
145304017|NCT02409355|523961805|FG001|Overall Study|Withdrawal by Subject|0|||
145304018|NCT02409355|523961804|FG000|Overall Study|Death|1|||
145304019|NCT02409355|523961805|FG001|Overall Study|Death|1|||
145304020|NCT02409355|523961804|FG000|Overall Study|Study terminated by Sponsor|2|||
145304021|NCT02409355|523961805|FG001|Overall Study|Study terminated by Sponsor|3|||
145304022|NCT02605928|523961806|FG000|Overall Study|Model tuning phase|28|||
145304023|NCT02605928|523961806|FG000|Overall Study|Lack of Efficacy|5|||
145304024|NCT02530905|523961809|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
145304025|NCT02530905|523961810|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
145304026|NCT02530905|523961811|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
145304027|NCT01231906|523961813|FG000|Overall Study|Lack of Efficacy|75|||
145304028|NCT01231906|523961814|FG001|Overall Study|Lack of Efficacy|68|||
145304029|NCT01231906|523961813|FG000|Overall Study|Lost to Follow-up|1|||
145304030|NCT01231906|523961814|FG001|Overall Study|Lost to Follow-up|0|||
145304031|NCT01231906|523961813|FG000|Overall Study|Physician Decision|34|||
145410993|NCT01525589|524356911|FG000|Overall Study|Withdrawal by Subject|0|||
145304032|NCT01231906|523961814|FG001|Overall Study|Physician Decision|24|||
145304033|NCT01231906|523961813|FG000|Overall Study|Withdrawal by Subject|0|||
145304034|NCT01231906|523961814|FG001|Overall Study|Withdrawal by Subject|4|||
145304035|NCT01231906|523961813|FG000|Overall Study|Ineligible|10|||
145304036|NCT01231906|523961814|FG001|Overall Study|Ineligible|3|||
145304037|NCT01231906|523961813|FG000|Overall Study|No treatment|1|||
145304038|NCT01231906|523961814|FG001|Overall Study|No treatment|2|||
145304039|NCT01110005|523961815|FG000|Overall Study|ineligible|1|||
145304040|NCT01110005|523961816|FG001|Overall Study|ineligible|2|||
145304041|NCT01110005|523961815|FG000|Overall Study|missing consent|3|||
145304042|NCT01110005|523961816|FG001|Overall Study|missing consent|2|||
145304043|NCT01110005|523961815|FG000|Overall Study|Withdrawal by Subject|0|||
145304044|NCT01110005|523961816|FG001|Overall Study|Withdrawal by Subject|1|||
145304045|NCT02441309|523961819|FG000|Overall Study|Disease progression|2|||
145304046|NCT02441309|523961820|FG001|Overall Study|Disease progression|1|||
145304047|NCT02441309|523961821|FG002|Overall Study|Disease progression|2|||
145304048|NCT02441309|523961819|FG000|Overall Study|Adverse Event|0|||
145304049|NCT02441309|523961820|FG001|Overall Study|Adverse Event|1|||
145304050|NCT02441309|523961821|FG002|Overall Study|Adverse Event|0|||
145304051|NCT02441309|523961819|FG000|Overall Study|Withdrawal by Subject|1|||
145304052|NCT02441309|523961820|FG001|Overall Study|Withdrawal by Subject|0|||
145304053|NCT02441309|523961821|FG002|Overall Study|Withdrawal by Subject|1|||
145304054|NCT02658084|523961826|FG000|Overall Study|Withdrawal by Subject|1|||
145304055|NCT02658084|523961827|FG001|Overall Study|Withdrawal by Subject|0|||
145304056|NCT02658084|523961826|FG000|Overall Study|Study Termination|1|||
145304057|NCT02658084|523961827|FG001|Overall Study|Study Termination|0|||
145304058|NCT03290781|523961829|FG000|Overall Study|Adverse Event|5|||
145304059|NCT03290781|523961830|FG001|Overall Study|Adverse Event|7|||
145304060|NCT03290781|523961831|FG002|Overall Study|Adverse Event|4|||
145304061|NCT03290781|523961832|FG003|Overall Study|Adverse Event|1|||
145304062|NCT03290781|523961833|FG004|Overall Study|Adverse Event|0|||
145304063|NCT03290781|523961834|FG005|Overall Study|Adverse Event|0|||
145304064|NCT03290781|523961835|FG006|Overall Study|Adverse Event|0|||
145304065|NCT03290781|523961829|FG000|Overall Study|Death|0|||
145304066|NCT03290781|523961830|FG001|Overall Study|Death|0|||
145304067|NCT03290781|523961831|FG002|Overall Study|Death|1|||
145304068|NCT03290781|523961832|FG003|Overall Study|Death|0|||
145304069|NCT03290781|523961833|FG004|Overall Study|Death|1|||
145304070|NCT03290781|523961834|FG005|Overall Study|Death|0|||
145304071|NCT03290781|523961835|FG006|Overall Study|Death|0|||
145304072|NCT03290781|523961829|FG000|Overall Study|Withdrawal by Subject|6|||
145304073|NCT03290781|523961830|FG001|Overall Study|Withdrawal by Subject|5|||
145304074|NCT03290781|523961831|FG002|Overall Study|Withdrawal by Subject|9|||
145304075|NCT03290781|523961832|FG003|Overall Study|Withdrawal by Subject|10|||
145304076|NCT03290781|523961833|FG004|Overall Study|Withdrawal by Subject|1|||
145568897|NCT00603746|524942370|FG001|Overall Study|Adverse Event|3|||
145568898|NCT00603746|524942371|FG002|Overall Study|Adverse Event|0|||
145568899|NCT00603746|524942372|FG003|Overall Study|Adverse Event|1|||
145568900|NCT00603746|524942373|FG004|Overall Study|Adverse Event|0|||
145568901|NCT00603746|524942374|FG005|Overall Study|Adverse Event|4|||
145568902|NCT00603746|524942369|FG000|Overall Study|Lack of Efficacy|34|||
145568903|NCT00603746|524942370|FG001|Overall Study|Lack of Efficacy|11|||
145568904|NCT00603746|524942371|FG002|Overall Study|Lack of Efficacy|6|||
145304077|NCT03290781|523961834|FG005|Overall Study|Withdrawal by Subject|2|||
145304078|NCT03290781|523961835|FG006|Overall Study|Withdrawal by Subject|0|||
145304079|NCT03290781|523961829|FG000|Overall Study|Physician Decision|0|||
145304080|NCT03290781|523961830|FG001|Overall Study|Physician Decision|1|||
145304081|NCT03290781|523961831|FG002|Overall Study|Physician Decision|0|||
145304082|NCT03290781|523961832|FG003|Overall Study|Physician Decision|0|||
145304083|NCT03290781|523961833|FG004|Overall Study|Physician Decision|0|||
145304084|NCT03290781|523961834|FG005|Overall Study|Physician Decision|0|||
145304085|NCT03290781|523961835|FG006|Overall Study|Physician Decision|0|||
145304086|NCT03290781|523961829|FG000|Overall Study|Site Terminated by Sponsor|1|||
145304087|NCT03290781|523961830|FG001|Overall Study|Site Terminated by Sponsor|0|||
145304088|NCT03290781|523961831|FG002|Overall Study|Site Terminated by Sponsor|2|||
145304089|NCT03290781|523961832|FG003|Overall Study|Site Terminated by Sponsor|1|||
145304090|NCT03290781|523961833|FG004|Overall Study|Site Terminated by Sponsor|0|||
145304091|NCT03290781|523961834|FG005|Overall Study|Site Terminated by Sponsor|0|||
145304092|NCT03290781|523961835|FG006|Overall Study|Site Terminated by Sponsor|0|||
145304093|NCT03290781|523961829|FG000|Overall Study|Lost to Follow-up|0|||
145304094|NCT03290781|523961830|FG001|Overall Study|Lost to Follow-up|0|||
145304095|NCT03290781|523961831|FG002|Overall Study|Lost to Follow-up|0|||
145304096|NCT03290781|523961832|FG003|Overall Study|Lost to Follow-up|1|||
145304097|NCT03290781|523961833|FG004|Overall Study|Lost to Follow-up|0|||
145304098|NCT03290781|523961834|FG005|Overall Study|Lost to Follow-up|0|||
145304099|NCT03290781|523961835|FG006|Overall Study|Lost to Follow-up|0|||
145304100|NCT03290781|523961829|FG000|Overall Study|Protocol Deviation|2|||
145304101|NCT03290781|523961830|FG001|Overall Study|Protocol Deviation|0|||
145304102|NCT03290781|523961831|FG002|Overall Study|Protocol Deviation|0|||
145304103|NCT03290781|523961832|FG003|Overall Study|Protocol Deviation|1|||
145304104|NCT03290781|523961833|FG004|Overall Study|Protocol Deviation|0|||
145304105|NCT03290781|523961834|FG005|Overall Study|Protocol Deviation|0|||
145304106|NCT03290781|523961835|FG006|Overall Study|Protocol Deviation|0|||
145304107|NCT03290781|523961829|FG000|Overall Study|Disease Relapse|32|||
145304108|NCT03290781|523961830|FG001|Overall Study|Disease Relapse|5|||
145304109|NCT03290781|523961831|FG002|Overall Study|Disease Relapse|38|||
145304110|NCT03290781|523961832|FG003|Overall Study|Disease Relapse|7|||
145304111|NCT03290781|523961833|FG004|Overall Study|Disease Relapse|3|||
145304112|NCT03290781|523961834|FG005|Overall Study|Disease Relapse|1|||
145304113|NCT03290781|523961835|FG006|Overall Study|Disease Relapse|4|||
145304114|NCT03290781|523961829|FG000|Overall Study|Other|3|||
145304115|NCT03290781|523961830|FG001|Overall Study|Other|0|||
145304116|NCT03290781|523961831|FG002|Overall Study|Other|2|||
145304117|NCT03290781|523961832|FG003|Overall Study|Other|2|||
145304118|NCT03290781|523961833|FG004|Overall Study|Other|0|||
145304119|NCT03290781|523961834|FG005|Overall Study|Other|0|||
145304120|NCT03290781|523961835|FG006|Overall Study|Other|0|||
145304121|NCT01588236|523961840|FG000|Overall Study|Adverse Event|5|||
145304122|NCT01588236|523961841|FG001|Overall Study|Adverse Event|4|||
145304123|NCT01588236|523961842|FG002|Overall Study|Adverse Event|1|||
145304124|NCT01588236|523961840|FG000|Overall Study|Lost to Follow-up|8|||
145304125|NCT01588236|523961841|FG001|Overall Study|Lost to Follow-up|13|||
145304126|NCT01588236|523961842|FG002|Overall Study|Lost to Follow-up|6|||
145304127|NCT01588236|523961840|FG000|Overall Study|Physician Decision|1|||
145304128|NCT01588236|523961841|FG001|Overall Study|Physician Decision|2|||
145304129|NCT01588236|523961842|FG002|Overall Study|Physician Decision|0|||
145304130|NCT01588236|523961840|FG000|Overall Study|Protocol Violation|0|||
145304131|NCT01588236|523961841|FG001|Overall Study|Protocol Violation|1|||
145304132|NCT01588236|523961842|FG002|Overall Study|Protocol Violation|1|||
145304133|NCT01588236|523961840|FG000|Overall Study|Withdrawal by Subject|14|||
145304134|NCT01588236|523961841|FG001|Overall Study|Withdrawal by Subject|16|||
145304135|NCT01588236|523961842|FG002|Overall Study|Withdrawal by Subject|18|||
145304136|NCT01588236|523961840|FG000|Overall Study|Exclusion Criteria met during study|2|||
145304137|NCT01588236|523961841|FG001|Overall Study|Exclusion Criteria met during study|1|||
145304138|NCT01588236|523961842|FG002|Overall Study|Exclusion Criteria met during study|0|||
145304139|NCT01588236|523961840|FG000|Overall Study|sponsor decision|1|||
145304140|NCT01588236|523961841|FG001|Overall Study|sponsor decision|6|||
145568905|NCT00603746|524942372|FG003|Overall Study|Lack of Efficacy|11|||
145304141|NCT01588236|523961842|FG002|Overall Study|sponsor decision|2|||
145304142|NCT04115293|523963448|FG000|Overall Study|Adverse Event|0|||
145304143|NCT04115293|523963449|FG001|Overall Study|Adverse Event|2|||
145304144|NCT04115293|523963448|FG000|Overall Study|Withdrawal by Subject|2|||
145304145|NCT04115293|523963449|FG001|Overall Study|Withdrawal by Subject|1|||
145568906|NCT00603746|524942373|FG004|Overall Study|Lack of Efficacy|12|||
145568907|NCT00603746|524942374|FG005|Overall Study|Lack of Efficacy|8|||
145304146|NCT04115293|523963448|FG000|Overall Study|Physician Decision|1|||
145304147|NCT04115293|523963449|FG001|Overall Study|Physician Decision|0|||
145304148|NCT04115293|523963448|FG000|Overall Study|Death|1|||
145304149|NCT04115293|523963449|FG001|Overall Study|Death|1|||
145304150|NCT02571907|523963450|FG000|Overall Study|Death|4|||
145304151|NCT02571907|523963450|FG000|Overall Study|Lost to Follow-up|3|||
145304152|NCT02571907|523963450|FG000|Overall Study|Withdrawal by Subject|3|||
145304153|NCT02286739|523963451|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
145304154|NCT02286739|523963452|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
145304155|NCT02286739|523963451|FG000|Overall Study|No Verasense type documented|0|||
145304156|NCT02286739|523963452|FG001|Overall Study|No Verasense type documented|23|||
145304157|NCT02286739|523963451|FG000|Overall Study|Adverse Event|1|||
145304158|NCT02286739|523963452|FG001|Overall Study|Adverse Event|2|||
145304159|NCT02286739|523963451|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
145304160|NCT02286739|523963452|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
145304161|NCT02635750|523963457|FG000|Part 1, Period 2|Adverse Event|1|||
145304162|NCT02635750|523963458|FG001|Part 1, Period 2|Adverse Event|0|||
145304163|NCT02635750|523963459|FG002|Part 1, Period 2|Adverse Event|0|||
145304164|NCT02642653|523963463|FG000|Overall Study|Adverse Event|2|||
145304165|NCT02642653|523963464|FG001|Overall Study|Adverse Event|0|||
145304166|NCT02875392|523963465|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
145304167|NCT02875392|523963466|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
145304168|NCT00834717|523963472|FG000|First Intervention|Adverse Event|1|||
145304169|NCT00834717|523963473|FG001|First Intervention|Adverse Event|0|||
145568908|NCT00603746|524942369|FG000|Overall Study|Protocol Violation|0|||
145568909|NCT00603746|524942370|FG001|Overall Study|Protocol Violation|3|||
145568910|NCT00603746|524942371|FG002|Overall Study|Protocol Violation|1|||
145304170|NCT00834717|523963472|FG000|First Intervention|Withdrawal by Subject|0|||
145304171|NCT00834717|523963473|FG001|First Intervention|Withdrawal by Subject|1|||
145304172|NCT01701674|523963474|FG000|Overall Study|Unable to safely complete treatment|1|||
145304173|NCT05604170|523963475|FG000|Overall Study|Lack of Efficacy|5|||
145304174|NCT05604170|523963475|FG000|Overall Study|Adverse Event|6|||
145304175|NCT05604170|523963475|FG000|Overall Study|Physician Decision|6|||
145304176|NCT05604170|523963475|FG000|Overall Study|Lost to Follow-up|6|||
145304177|NCT05604170|523963475|FG000|Overall Study|Withdrawal by Subject|11|||
145304178|NCT05604170|523963475|FG000|Overall Study|Early study termination by sponsor|77|||
145304179|NCT05604170|523963475|FG000|Overall Study|Other|6|||
145304180|NCT03697109|523963476|FG000|Open-label (OL) Phase|Adverse Event|24|||
145304181|NCT03697109|523963477|FG001|Open-label (OL) Phase|Adverse Event|0|||
145304182|NCT03697109|523963478|FG002|Open-label (OL) Phase|Adverse Event|0|||
145304183|NCT03697109|523963476|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
145304184|NCT03697109|523963477|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
145304185|NCT03697109|523963478|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
145304186|NCT03697109|523963476|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
145304187|NCT03697109|523963477|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
145304188|NCT03697109|523963478|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
145304189|NCT03697109|523963476|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
145304190|NCT03697109|523963477|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
145304191|NCT03697109|523963478|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
145304192|NCT03697109|523963476|FG000|Open-label (OL) Phase|Physician Decision|2|||
145304193|NCT03697109|523963477|FG001|Open-label (OL) Phase|Physician Decision|0|||
145304194|NCT03697109|523963478|FG002|Open-label (OL) Phase|Physician Decision|0|||
145304195|NCT03697109|523963476|FG000|Open-label (OL) Phase|Death|2|||
145304196|NCT03697109|523963477|FG001|Open-label (OL) Phase|Death|0|||
145304197|NCT03697109|523963478|FG002|Open-label (OL) Phase|Death|0|||
145304198|NCT03697109|523963476|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
145304199|NCT03697109|523963477|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
145304200|NCT03697109|523963478|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
145568911|NCT00603746|524942372|FG003|Overall Study|Protocol Violation|0|||
145304201|NCT03697109|523963476|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
145304202|NCT03697109|523963477|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
145304203|NCT03697109|523963478|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
145304204|NCT03697109|523963476|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
145304205|NCT03697109|523963477|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
145304206|NCT03697109|523963478|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
145304207|NCT03032172|523963479|FG000|Treatment Period|Adverse Event|0|||
145304208|NCT03032172|523963480|FG001|Treatment Period|Adverse Event|1|||
145304209|NCT03032172|523963481|FG002|Treatment Period|Adverse Event|0|||
145304210|NCT03032172|523963482|FG003|Treatment Period|Adverse Event|0|||
145304211|NCT03032172|523963483|FG004|Treatment Period|Adverse Event|0|||
145304212|NCT03032172|523963484|FG005|Treatment Period|Adverse Event|0|||
145304213|NCT03032172|523963485|FG006|Treatment Period|Adverse Event|0|||
145304214|NCT03032172|523963486|FG007|Treatment Period|Adverse Event|0|||
145568912|NCT00603746|524942373|FG004|Overall Study|Protocol Violation|1|||
145304215|NCT03032172|523963479|FG000|Treatment Period|Lack of Efficacy|0|||
145304216|NCT03032172|523963480|FG001|Treatment Period|Lack of Efficacy|1|||
145304217|NCT03032172|523963481|FG002|Treatment Period|Lack of Efficacy|0|||
145304218|NCT03032172|523963482|FG003|Treatment Period|Lack of Efficacy|0|||
145304219|NCT03032172|523963483|FG004|Treatment Period|Lack of Efficacy|0|||
145304220|NCT03032172|523963484|FG005|Treatment Period|Lack of Efficacy|0|||
145304221|NCT03032172|523963485|FG006|Treatment Period|Lack of Efficacy|0|||
145304222|NCT03032172|523963486|FG007|Treatment Period|Lack of Efficacy|0|||
145304223|NCT03032172|523963479|FG000|Treatment Period|Non-compliance With Study Drug|0|||
145304224|NCT03032172|523963480|FG001|Treatment Period|Non-compliance With Study Drug|1|||
145304225|NCT03032172|523963481|FG002|Treatment Period|Non-compliance With Study Drug|0|||
145304226|NCT03032172|523963482|FG003|Treatment Period|Non-compliance With Study Drug|0|||
145304227|NCT03032172|523963483|FG004|Treatment Period|Non-compliance With Study Drug|0|||
145304228|NCT03032172|523963484|FG005|Treatment Period|Non-compliance With Study Drug|0|||
145304229|NCT03032172|523963485|FG006|Treatment Period|Non-compliance With Study Drug|0|||
145304230|NCT03032172|523963486|FG007|Treatment Period|Non-compliance With Study Drug|0|||
145304231|NCT03032172|523963479|FG000|Treatment Period|Reason Not Specified|0|||
145304232|NCT03032172|523963480|FG001|Treatment Period|Reason Not Specified|4|||
145304233|NCT03032172|523963481|FG002|Treatment Period|Reason Not Specified|1|||
145304234|NCT03032172|523963482|FG003|Treatment Period|Reason Not Specified|0|||
145304235|NCT03032172|523963483|FG004|Treatment Period|Reason Not Specified|0|||
145304236|NCT03032172|523963484|FG005|Treatment Period|Reason Not Specified|0|||
145304237|NCT03032172|523963485|FG006|Treatment Period|Reason Not Specified|0|||
145304238|NCT03032172|523963486|FG007|Treatment Period|Reason Not Specified|0|||
145304239|NCT03032172|523963479|FG000|Treatment Period|Physician Decision|0|||
145304240|NCT03032172|523963480|FG001|Treatment Period|Physician Decision|2|||
145304241|NCT03032172|523963481|FG002|Treatment Period|Physician Decision|1|||
145304242|NCT03032172|523963482|FG003|Treatment Period|Physician Decision|0|||
145304243|NCT03032172|523963483|FG004|Treatment Period|Physician Decision|0|||
145304244|NCT03032172|523963484|FG005|Treatment Period|Physician Decision|0|||
145304245|NCT03032172|523963485|FG006|Treatment Period|Physician Decision|0|||
145304246|NCT03032172|523963486|FG007|Treatment Period|Physician Decision|0|||
145304247|NCT03032172|523963479|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145304248|NCT03032172|523963480|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
145304249|NCT03032172|523963481|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
145304250|NCT03032172|523963482|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
145304251|NCT03032172|523963483|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145304252|NCT03032172|523963484|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145304253|NCT03032172|523963485|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145568913|NCT00603746|524942374|FG005|Overall Study|Protocol Violation|0|||
145568914|NCT00603746|524942369|FG000|Overall Study|Lost to Follow-up|0|||
145568915|NCT00603746|524942370|FG001|Overall Study|Lost to Follow-up|1|||
145568916|NCT00603746|524942371|FG002|Overall Study|Lost to Follow-up|1|||
145568917|NCT00603746|524942372|FG003|Overall Study|Lost to Follow-up|0|||
145568918|NCT00603746|524942373|FG004|Overall Study|Lost to Follow-up|0|||
145568919|NCT00603746|524942374|FG005|Overall Study|Lost to Follow-up|0|||
145568920|NCT00603746|524942369|FG000|Overall Study|Physician Decision|1|||
145620332|NCT00996580|525123741|FG000|Overall Study|Noncompliance with the protocol|137|||
145304254|NCT03032172|523963486|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
145304255|NCT03032172|523963479|FG000|Treatment Period|Withdrawal by Subject|2|||
145304256|NCT03032172|523963480|FG001|Treatment Period|Withdrawal by Subject|0|||
145304257|NCT03032172|523963481|FG002|Treatment Period|Withdrawal by Subject|3|||
145304258|NCT03032172|523963482|FG003|Treatment Period|Withdrawal by Subject|0|||
145304259|NCT03032172|523963483|FG004|Treatment Period|Withdrawal by Subject|0|||
145304260|NCT03032172|523963484|FG005|Treatment Period|Withdrawal by Subject|0|||
145304261|NCT03032172|523963485|FG006|Treatment Period|Withdrawal by Subject|0|||
145304262|NCT03032172|523963486|FG007|Treatment Period|Withdrawal by Subject|0|||
145304263|NCT03032172|523963479|FG000|Open-label Extension Period|Death|0|||
145304264|NCT03032172|523963480|FG001|Open-label Extension Period|Death|0|||
145304265|NCT03032172|523963481|FG002|Open-label Extension Period|Death|0|||
145304266|NCT03032172|523963482|FG003|Open-label Extension Period|Death|0|||
145304267|NCT03032172|523963483|FG004|Open-label Extension Period|Death|0|||
145304268|NCT03032172|523963484|FG005|Open-label Extension Period|Death|0|||
145304269|NCT03032172|523963485|FG006|Open-label Extension Period|Death|0|||
145304270|NCT03032172|523963486|FG007|Open-label Extension Period|Death|2|||
145304271|NCT03032172|523963479|FG000|Open-label Extension Period|Reason Not Specified|0|||
145304272|NCT03032172|523963480|FG001|Open-label Extension Period|Reason Not Specified|0|||
145304273|NCT03032172|523963481|FG002|Open-label Extension Period|Reason Not Specified|0|||
145304274|NCT03032172|523963482|FG003|Open-label Extension Period|Reason Not Specified|0|||
145304275|NCT03032172|523963483|FG004|Open-label Extension Period|Reason Not Specified|0|||
145568921|NCT00603746|524942370|FG001|Overall Study|Physician Decision|0|||
145568922|NCT00603746|524942371|FG002|Overall Study|Physician Decision|0|||
145304276|NCT03032172|523963484|FG005|Open-label Extension Period|Reason Not Specified|5|||
145304277|NCT03032172|523963485|FG006|Open-label Extension Period|Reason Not Specified|3|||
145304278|NCT03032172|523963486|FG007|Open-label Extension Period|Reason Not Specified|0|||
145304279|NCT03032172|523963479|FG000|Open-label Extension Period|Pregnancy|0|||
145304280|NCT03032172|523963480|FG001|Open-label Extension Period|Pregnancy|0|||
145304281|NCT03032172|523963481|FG002|Open-label Extension Period|Pregnancy|0|||
145304282|NCT03032172|523963482|FG003|Open-label Extension Period|Pregnancy|0|||
145304283|NCT03032172|523963483|FG004|Open-label Extension Period|Pregnancy|0|||
145304284|NCT03032172|523963484|FG005|Open-label Extension Period|Pregnancy|0|||
145304285|NCT03032172|523963485|FG006|Open-label Extension Period|Pregnancy|1|||
145304286|NCT03032172|523963486|FG007|Open-label Extension Period|Pregnancy|0|||
145304287|NCT03032172|523963479|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
145304288|NCT03032172|523963480|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
145304289|NCT03032172|523963481|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
145304290|NCT03032172|523963482|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
145304291|NCT03032172|523963483|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
145304292|NCT03032172|523963484|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
145304293|NCT03032172|523963485|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
145304294|NCT03032172|523963486|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
145304295|NCT06284525|523963489|FG000|Overall Study|Withdrawal by Subject|1|||
145304296|NCT00834522|523963490|FG000|Washout|Adverse Event|1|||
145304297|NCT00834522|523963491|FG001|Washout|Adverse Event|0|||
145304298|NCT00834522|523963490|FG000|Washout|Withdrawal by Subject|2|||
145304299|NCT00834522|523963491|FG001|Washout|Withdrawal by Subject|1|||
145304300|NCT04516967|523963492|FG000|Core Phase|Adverse Event|2|||
145304301|NCT04516967|523963493|FG001|Core Phase|Adverse Event|1|||
145304302|NCT04516967|523963494|FG002|Core Phase|Adverse Event|0|||
145304303|NCT04516967|523963492|FG000|Core Phase|Physician Decision|1|||
145304304|NCT04516967|523963493|FG001|Core Phase|Physician Decision|1|||
145304305|NCT04516967|523963494|FG002|Core Phase|Physician Decision|0|||
145304306|NCT04516967|523963492|FG000|Core Phase|Lack of Efficacy|7|||
145304307|NCT04516967|523963493|FG001|Core Phase|Lack of Efficacy|18|||
145304308|NCT04516967|523963494|FG002|Core Phase|Lack of Efficacy|0|||
145304309|NCT03165994|523963495|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
145304310|NCT03165994|523963495|FG000|Overall Study|Death|2|||
145304311|NCT03165994|523963495|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
145304312|NCT03165994|523963495|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
145304313|NCT03165994|523963495|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
145304314|NCT03165994|523963495|FG000|Overall Study|Miscellaneous|1|||
145304315|NCT00519194|523963496|FG000|Overall Study|Withdrawal by Subject|9|||
145304316|NCT00519194|523963496|FG000|Overall Study|Death|9|||
145304317|NCT00519194|523963496|FG000|Overall Study|Lost to Follow-up|3|||
145304318|NCT00905840|523963499|FG000|Overall Study|Lost to Follow-up|11|||
145304319|NCT00905840|523963499|FG000|Overall Study|Death|3|||
145304320|NCT00905840|523963499|FG000|Overall Study|Withdrawal by Subject|1|||
145304321|NCT00905840|523963499|FG000|Overall Study|Adverse Event|1|||
145304322|NCT01175018|523963500|FG000|Overall Study|Adverse Event|3|||
145304323|NCT01175018|523963501|FG001|Overall Study|Adverse Event|1|||
145304324|NCT03872128|523963505|FG000|Overall Study|Dropped out before treatment|1|||
145304325|NCT03872128|523963506|FG001|Overall Study|Dropped out before treatment|0|||
145304326|NCT03872128|523963507|FG002|Overall Study|Dropped out before treatment|4|||
145304327|NCT03872128|523963505|FG000|Overall Study|Lost to Follow-up|2|||
145304328|NCT03872128|523963506|FG001|Overall Study|Lost to Follow-up|5|||
145304329|NCT03872128|523963507|FG002|Overall Study|Lost to Follow-up|8|||
145304330|NCT03285594|523963511|FG000|Overall Study|At the Participant's Own Request|10|||
145304331|NCT03285594|523963512|FG001|Overall Study|At the Participant's Own Request|5|||
145304332|NCT03285594|523963513|FG002|Overall Study|At the Participant's Own Request|21|||
145304333|NCT03285594|523963511|FG000|Overall Study|Adverse Event|2|||
145304334|NCT03285594|523963512|FG001|Overall Study|Adverse Event|2|||
145304335|NCT03285594|523963513|FG002|Overall Study|Adverse Event|6|||
145304336|NCT03285594|523963511|FG000|Overall Study|Poor Compliance to Protocol|0|||
145304337|NCT03285594|523963512|FG001|Overall Study|Poor Compliance to Protocol|0|||
145304338|NCT03285594|523963513|FG002|Overall Study|Poor Compliance to Protocol|1|||
145304339|NCT03285594|523963511|FG000|Overall Study|Lost to Follow-up|0|||
145304340|NCT03285594|523963512|FG001|Overall Study|Lost to Follow-up|0|||
145304341|NCT03285594|523963513|FG002|Overall Study|Lost to Follow-up|1|||
145304342|NCT03285594|523963511|FG000|Overall Study|Reason Not Specified|3|||
145304343|NCT03285594|523963512|FG001|Overall Study|Reason Not Specified|4|||
145304344|NCT03285594|523963513|FG002|Overall Study|Reason Not Specified|8|||
145304345|NCT03733444|523963519|FG000|Overall Study|Adverse Event|8|||
145304346|NCT03733444|523963520|FG001|Overall Study|Adverse Event|10|||
145304347|NCT03733444|523963521|FG002|Overall Study|Adverse Event|5|||
145304348|NCT03733444|523963519|FG000|Overall Study|Death|20|||
145304349|NCT03733444|523963520|FG001|Overall Study|Death|19|||
145304350|NCT03733444|523963521|FG002|Overall Study|Death|11|||
145304351|NCT03733444|523963519|FG000|Overall Study|Lost to Follow-up|3|||
145304352|NCT03733444|523963520|FG001|Overall Study|Lost to Follow-up|0|||
145304353|NCT03733444|523963521|FG002|Overall Study|Lost to Follow-up|1|||
145304354|NCT03733444|523963519|FG000|Overall Study|Lack of Efficacy|0|||
145304355|NCT03733444|523963520|FG001|Overall Study|Lack of Efficacy|1|||
145304356|NCT03733444|523963521|FG002|Overall Study|Lack of Efficacy|1|||
145304357|NCT03733444|523963519|FG000|Overall Study|Physician Decision|2|||
145304358|NCT03733444|523963520|FG001|Overall Study|Physician Decision|1|||
145304359|NCT03733444|523963521|FG002|Overall Study|Physician Decision|0|||
145304360|NCT03733444|523963519|FG000|Overall Study|Protocol Violation|2|||
145304361|NCT03733444|523963520|FG001|Overall Study|Protocol Violation|1|||
145304362|NCT03733444|523963521|FG002|Overall Study|Protocol Violation|0|||
145304363|NCT03733444|523963519|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
145304364|NCT03733444|523963520|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
145304365|NCT03733444|523963521|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
145304366|NCT03733444|523963519|FG000|Overall Study|Study Terminated by Sponsor|203|||
145304367|NCT03733444|523963520|FG001|Overall Study|Study Terminated by Sponsor|209|||
145304368|NCT03733444|523963521|FG002|Overall Study|Study Terminated by Sponsor|221|||
145304369|NCT03733444|523963519|FG000|Overall Study|Withdrawal by Subject|19|||
145304370|NCT03733444|523963520|FG001|Overall Study|Withdrawal by Subject|18|||
145304371|NCT03733444|523963521|FG002|Overall Study|Withdrawal by Subject|16|||
145304372|NCT03733444|523963519|FG000|Overall Study|Miscellaneous|1|||
145304373|NCT03733444|523963520|FG001|Overall Study|Miscellaneous|0|||
145304374|NCT03733444|523963521|FG002|Overall Study|Miscellaneous|1|||
145304375|NCT03733444|523963519|FG000|Overall Study|Not Treated|1|||
145304376|NCT03733444|523963520|FG001|Overall Study|Not Treated|2|||
145304377|NCT03733444|523963521|FG002|Overall Study|Not Treated|1|||
145304378|NCT02838420|523963526|FG000|Overall Study|Ongoing in Study|113|||
145304379|NCT02838420|523963527|FG001|Overall Study|Ongoing in Study|45|||
145304380|NCT02838420|523963526|FG000|Overall Study|Lost to Follow-up|1|||
145304381|NCT02838420|523963527|FG001|Overall Study|Lost to Follow-up|0|||
145304382|NCT02838420|523963526|FG000|Overall Study|Withdrawal by Subject|3|||
145304383|NCT02838420|523963527|FG001|Overall Study|Withdrawal by Subject|4|||
145304384|NCT02838420|523963526|FG000|Overall Study|Death|8|||
145304385|NCT02838420|523963527|FG001|Overall Study|Death|13|||
145304386|NCT00796653|523963528|FG000|Overall Study|Adverse Event|19|||
145304387|NCT00796653|523963529|FG001|Overall Study|Adverse Event|16|||
145304388|NCT00796653|523963530|FG002|Overall Study|Adverse Event|16|||
145304389|NCT00796653|523963531|FG003|Overall Study|Adverse Event|16|||
145304390|NCT00796653|523963528|FG000|Overall Study|Lost to Follow-up|2|||
145304391|NCT00796653|523963529|FG001|Overall Study|Lost to Follow-up|1|||
145304392|NCT00796653|523963530|FG002|Overall Study|Lost to Follow-up|2|||
145304393|NCT00796653|523963531|FG003|Overall Study|Lost to Follow-up|3|||
145304394|NCT00796653|523963528|FG000|Overall Study|Withdrawal by Subject|16|||
145304395|NCT00796653|523963529|FG001|Overall Study|Withdrawal by Subject|8|||
145304396|NCT00796653|523963530|FG002|Overall Study|Withdrawal by Subject|8|||
145304397|NCT00796653|523963531|FG003|Overall Study|Withdrawal by Subject|13|||
145304398|NCT00796653|523963528|FG000|Overall Study|Lack of Efficacy|8|||
145304399|NCT00796653|523963529|FG001|Overall Study|Lack of Efficacy|1|||
145304400|NCT00796653|523963530|FG002|Overall Study|Lack of Efficacy|3|||
145304401|NCT00796653|523963531|FG003|Overall Study|Lack of Efficacy|2|||
145304402|NCT00796653|523963528|FG000|Overall Study|Non compliance with protocol|2|||
145304403|NCT00796653|523963529|FG001|Overall Study|Non compliance with protocol|2|||
145304404|NCT00796653|523963530|FG002|Overall Study|Non compliance with protocol|0|||
145304405|NCT00796653|523963531|FG003|Overall Study|Non compliance with protocol|2|||
145304406|NCT00796653|523963528|FG000|Overall Study|Other reason not described above|4|||
145304407|NCT00796653|523963529|FG001|Overall Study|Other reason not described above|9|||
145304408|NCT00796653|523963530|FG002|Overall Study|Other reason not described above|7|||
145304409|NCT00796653|523963531|FG003|Overall Study|Other reason not described above|4|||
145304410|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
145304411|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
145304412|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
145304413|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
145304414|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
145304415|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
145304416|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145304417|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145304418|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
145304419|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
145304420|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
145304421|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
145304422|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
145304423|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
145304424|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
145304425|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
145304426|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
145304427|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
145304428|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
145304429|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
145304430|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Death|0|||
145304431|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Death|1|||
145304432|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Death|0|||
145304433|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Death|0|||
145304434|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
145304435|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
145304436|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
145304437|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
145304438|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
145304439|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
145304440|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
145304441|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
145304442|NCT01940341|523963534|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
145304443|NCT01940341|523963535|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
145304444|NCT01940341|523963536|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
145304445|NCT01940341|523963537|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
145304446|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
145304447|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
145304448|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
145304449|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
145304450|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
145304451|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
145304452|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
145304453|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
145304454|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145304455|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145304456|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
145304457|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
145304458|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
145304459|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
145304460|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
145304461|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
145304462|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
145304463|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
145304464|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
145304465|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
145304466|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
145304467|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
145304468|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
145304469|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
145304470|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145304471|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145304472|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
145304473|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
145304474|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
145304475|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
145304476|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
145304477|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
145304478|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145304479|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145304480|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
145304481|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
145304482|NCT01940341|523963534|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
145304483|NCT01940341|523963535|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
145304484|NCT01940341|523963536|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
145304485|NCT01940341|523963537|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
145304486|NCT02414152|523963538|FG000|Overall Study|Withdrawal by Subject|1|||
145304487|NCT02414152|523963538|FG000|Overall Study|Lack of Efficacy|1|||
145304488|NCT02911701|523963543|FG000|Overall Study|Withdrawal by Subject|2|||
145304489|NCT02911701|523963544|FG001|Overall Study|Withdrawal by Subject|4|||
145304490|NCT02911701|523963543|FG000|Overall Study|Adverse Event|1|||
145304491|NCT02911701|523963544|FG001|Overall Study|Adverse Event|0|||
145568923|NCT00603746|524942372|FG003|Overall Study|Physician Decision|0|||
145304492|NCT01302548|523963545|FG000|Overall Study|Lost to Follow-up|2|||
145304493|NCT01302548|523963546|FG001|Overall Study|Lost to Follow-up|1|||
145304494|NCT03482882|523963551|FG000|Overall Study|Adverse Event|3|||
145304495|NCT03482882|523963551|FG000|Overall Study|Lost to Follow-up|1|||
145304496|NCT03482882|523963551|FG000|Overall Study|Protocol Violation|2|||
145304497|NCT03482882|523963551|FG000|Overall Study|Not further specified|1|||
145304498|NCT04646213|523963552|FG000|Overall Study|Physician Decision|3|||
145304499|NCT04646213|523963552|FG000|Overall Study|Withdrawal by Subject|2|||
145304500|NCT00415363|523963557|FG000|Overall Study|Withdrawal by Subject|4|||
145304501|NCT00415363|523963558|FG001|Overall Study|Withdrawal by Subject|4|||
145304502|NCT00415363|523963557|FG000|Overall Study|Adverse Event|4|||
145304503|NCT00415363|523963558|FG001|Overall Study|Adverse Event|4|||
145304504|NCT00415363|523963557|FG000|Overall Study|Lost to Follow-up|2|||
145304505|NCT00415363|523963558|FG001|Overall Study|Lost to Follow-up|1|||
145304506|NCT00415363|523963557|FG000|Overall Study|Physician Decision|3|||
145304507|NCT00415363|523963558|FG001|Overall Study|Physician Decision|1|||
145304508|NCT00415363|523963557|FG000|Overall Study|Death|16|||
145304509|NCT00415363|523963558|FG001|Overall Study|Death|12|||
145304510|NCT00415363|523963557|FG000|Overall Study|Progressive disease|26|||
145304511|NCT00415363|523963558|FG001|Overall Study|Progressive disease|32|||
145304512|NCT03801707|523963573|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
145304513|NCT00787254|523963576|FG000|Overall Study|Adverse Event|24|||
145304514|NCT00787254|523963577|FG001|Overall Study|Adverse Event|23|||
145304515|NCT00787254|523963576|FG000|Overall Study|Protocol Violation|26|||
145304516|NCT00787254|523963577|FG001|Overall Study|Protocol Violation|23|||
145304517|NCT00787254|523963576|FG000|Overall Study|Withdrawal by Subject|16|||
145304518|NCT00787254|523963577|FG001|Overall Study|Withdrawal by Subject|11|||
145304519|NCT00787254|523963576|FG000|Overall Study|Lack of Efficacy|4|||
145304520|NCT00787254|523963577|FG001|Overall Study|Lack of Efficacy|15|||
145304521|NCT00787254|523963576|FG000|Overall Study|NSAIDs discontinuation|1|||
145304522|NCT00787254|523963577|FG001|Overall Study|NSAIDs discontinuation|2|||
145304523|NCT00787254|523963576|FG000|Overall Study|Institution closed|1|||
145304524|NCT00787254|523963577|FG001|Overall Study|Institution closed|0|||
145304525|NCT00787254|523963576|FG000|Overall Study|Physician Decision|4|||
145304526|NCT00787254|523963577|FG001|Overall Study|Physician Decision|8|||
145304527|NCT03761173|523963578|FG000|Overall Study|Lost to Follow-up|93|||
145304528|NCT03761173|523963578|FG000|Overall Study|Withdrawal by Subject|74|||
145304529|NCT03761173|523963578|FG000|Overall Study|Death|45|||
145304530|NCT03761173|523963578|FG000|Overall Study|Withdrawal for Other Reasons|29|||
145304531|NCT03761173|523963578|FG000|Overall Study|Protocol Violation|1|||
145304532|NCT00316186|523963579|FG000|Overall Study|Adverse Event|6|||
145304533|NCT00316186|523963579|FG000|Overall Study|Disease Progression|4|||
145304534|NCT00316186|523963579|FG000|Overall Study|Lost to Follow-up|1|||
145304535|NCT00316186|523963579|FG000|Overall Study|Other|1|||
145304536|NCT00594035|523965332|FG000|Overall Study|Lost to Follow-up|1|||
145304537|NCT00594035|523965333|FG001|Overall Study|Lost to Follow-up|1|||
145304538|NCT00594035|523965332|FG000|Overall Study|Withdrawal by Subject|1|||
145304539|NCT00594035|523965333|FG001|Overall Study|Withdrawal by Subject|0|||
145304540|NCT00594035|523965332|FG000|Overall Study|Subject transferred to nursing home|0|||
145304541|NCT00594035|523965333|FG001|Overall Study|Subject transferred to nursing home|1|||
145304542|NCT00594035|523965332|FG000|Overall Study|Subject couldn't return due to job|0|||
145304543|NCT00594035|523965333|FG001|Overall Study|Subject couldn't return due to job|1|||
145304544|NCT00795821|523965336|FG000|Acute Treatment Phase|Adverse Event|23|||
145304545|NCT00795821|523965337|FG001|Acute Treatment Phase|Adverse Event|4|||
145304546|NCT00795821|523965336|FG000|Acute Treatment Phase|Death|1|||
145304547|NCT00795821|523965337|FG001|Acute Treatment Phase|Death|0|||
145304548|NCT00795821|523965336|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
145304549|NCT00795821|523965337|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
145304550|NCT00795821|523965336|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
145304551|NCT00795821|523965337|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
145304552|NCT00795821|523965336|FG000|Acute Treatment Phase|Physician Decision|1|||
145304553|NCT00795821|523965337|FG001|Acute Treatment Phase|Physician Decision|1|||
145304554|NCT00795821|523965336|FG000|Acute Treatment Phase|Protocol Violation|1|||
145304555|NCT00795821|523965337|FG001|Acute Treatment Phase|Protocol Violation|2|||
145304556|NCT00795821|523965336|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
145304557|NCT00795821|523965337|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
145304558|NCT00795821|523965336|FG000|Long-term Extension Phase|Adverse Event|25|||
145304559|NCT00795821|523965337|FG001|Long-term Extension Phase|Adverse Event|32|||
145304560|NCT00795821|523965336|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
145304561|NCT00795821|523965337|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
145304562|NCT00795821|523965336|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
145568924|NCT00603746|524942373|FG004|Overall Study|Physician Decision|1|||
145304563|NCT00795821|523965337|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
145304564|NCT00795821|523965336|FG000|Long-term Extension Phase|Physician Decision|1|||
145304565|NCT00795821|523965337|FG001|Long-term Extension Phase|Physician Decision|2|||
145568925|NCT00603746|524942374|FG005|Overall Study|Physician Decision|0|||
145568926|NCT00603746|524942369|FG000|Overall Study|Withdrawal by Subject|1|||
145568927|NCT00603746|524942370|FG001|Overall Study|Withdrawal by Subject|0|||
145304566|NCT00795821|523965336|FG000|Long-term Extension Phase|Protocol Violation|3|||
145304567|NCT00795821|523965337|FG001|Long-term Extension Phase|Protocol Violation|5|||
145304568|NCT00795821|523965336|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
145304569|NCT00795821|523965337|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
145304570|NCT00795821|523965336|FG000|Taper Phase|Adverse Event|2|||
145304571|NCT00795821|523965337|FG001|Taper Phase|Adverse Event|0|||
145304572|NCT00795821|523965336|FG000|Taper Phase|Lost to Follow-up|1|||
145304573|NCT00795821|523965337|FG001|Taper Phase|Lost to Follow-up|0|||
145304574|NCT00795821|523965336|FG000|Taper Phase|Physician Decision|2|||
145304575|NCT00795821|523965337|FG001|Taper Phase|Physician Decision|0|||
145304576|NCT00795821|523965336|FG000|Taper Phase|Withdrawal by Subject|4|||
145304577|NCT00795821|523965337|FG001|Taper Phase|Withdrawal by Subject|0|||
145304578|NCT00712959|523965344|FG000|Overall Study|Protocol Violation|3|||
145304579|NCT00712959|523965345|FG001|Overall Study|Protocol Violation|1|||
145304580|NCT00712959|523965344|FG000|Overall Study|Lost to Follow-up|13|||
145304581|NCT00712959|523965345|FG001|Overall Study|Lost to Follow-up|2|||
145304582|NCT00712959|523965344|FG000|Overall Study|Withdrawal by Subject|3|||
145304583|NCT00712959|523965345|FG001|Overall Study|Withdrawal by Subject|0|||
145304584|NCT02255149|523965346|FG000|Overall Study|Lost to Follow-up|2|||
145304585|NCT02255149|523965346|FG000|Overall Study|Withdrawal by Subject|1|||
145304586|NCT02255149|523965346|FG000|Overall Study|Withdrawal by PI|1|||
145304587|NCT02255149|523965346|FG000|Overall Study|Implant Failure|1|||
145304588|NCT00163657|523965348|FG000|Overall Study|Death|12|||
145304589|NCT00163657|523965349|FG001|Overall Study|Death|14|||
145304590|NCT00163657|523965350|FG002|Overall Study|Death|19|||
145304591|NCT00163657|523965348|FG000|Overall Study|graft loss|4|||
145304592|NCT00163657|523965349|FG001|Overall Study|graft loss|1|||
145304593|NCT00163657|523965350|FG002|Overall Study|graft loss|2|||
145304594|NCT00163657|523965348|FG000|Overall Study|Withdrawal by Subject|2|||
145304595|NCT00163657|523965349|FG001|Overall Study|Withdrawal by Subject|3|||
145304596|NCT00163657|523965350|FG002|Overall Study|Withdrawal by Subject|2|||
145304597|NCT00163657|523965348|FG000|Overall Study|Physician Decision|0|||
145304598|NCT00163657|523965349|FG001|Overall Study|Physician Decision|1|||
145304599|NCT00163657|523965350|FG002|Overall Study|Physician Decision|1|||
145304600|NCT00163657|523965348|FG000|Overall Study|Non Compliance|1|||
145304601|NCT00163657|523965349|FG001|Overall Study|Non Compliance|0|||
145304602|NCT00163657|523965350|FG002|Overall Study|Non Compliance|0|||
145304603|NCT00163657|523965348|FG000|Overall Study|Lost to Follow-up|1|||
145304604|NCT00163657|523965349|FG001|Overall Study|Lost to Follow-up|3|||
145304605|NCT00163657|523965350|FG002|Overall Study|Lost to Follow-up|10|||
145304606|NCT00163657|523965348|FG000|Overall Study|Other reason|0|||
145304607|NCT00163657|523965349|FG001|Overall Study|Other reason|1|||
145304608|NCT00163657|523965350|FG002|Overall Study|Other reason|3|||
145304609|NCT01319383|523965351|FG000|Overall Study|No ex vivo or in vivo response|4|||
145304610|NCT01319383|523965352|FG001|Overall Study|No ex vivo or in vivo response|0|||
145304611|NCT01319383|523965351|FG000|Overall Study|Physician Decision|3|||
145304612|NCT01319383|523965352|FG001|Overall Study|Physician Decision|0|||
145304613|NCT01319383|523965351|FG000|Overall Study|Lack of Efficacy|5|||
145304614|NCT01319383|523965352|FG001|Overall Study|Lack of Efficacy|9|||
145304615|NCT01319383|523965351|FG000|Overall Study|No in vivo response to interval doses|0|||
145304616|NCT01319383|523965352|FG001|Overall Study|No in vivo response to interval doses|1|||
145304617|NCT03600805|523965365|FG000|Overall Study|Adverse Event|2|||
145304618|NCT03600805|523965366|FG001|Overall Study|Adverse Event|1|||
145304619|NCT03600805|523965367|FG002|Overall Study|Adverse Event|1|||
145304620|NCT03600805|523965368|FG003|Overall Study|Adverse Event|7|||
145304621|NCT03600805|523965365|FG000|Overall Study|Lack of Efficacy|2|||
145304622|NCT03600805|523965366|FG001|Overall Study|Lack of Efficacy|1|||
145304623|NCT03600805|523965367|FG002|Overall Study|Lack of Efficacy|0|||
145304624|NCT03600805|523965368|FG003|Overall Study|Lack of Efficacy|0|||
145304625|NCT03600805|523965365|FG000|Overall Study|Withdrawal by Subject|1|||
145304626|NCT03600805|523965366|FG001|Overall Study|Withdrawal by Subject|0|||
145304627|NCT03600805|523965367|FG002|Overall Study|Withdrawal by Subject|0|||
145304628|NCT03600805|523965368|FG003|Overall Study|Withdrawal by Subject|1|||
145304629|NCT03600805|523965365|FG000|Overall Study|Other unspecified|14|||
145304630|NCT03600805|523965366|FG001|Overall Study|Other unspecified|6|||
145304631|NCT03600805|523965367|FG002|Overall Study|Other unspecified|7|||
145304632|NCT03600805|523965368|FG003|Overall Study|Other unspecified|11|||
145304633|NCT06195579|523965369|FG000|Overall Study|Withdrawal by Subject|1|||
145304634|NCT03123094|523965371|FG000|Overall Study|Withdrawal by Subject|0|||
145304635|NCT03123094|523965372|FG001|Overall Study|Withdrawal by Subject|2|||
145304636|NCT03123094|523965373|FG002|Overall Study|Withdrawal by Subject|1|||
145304637|NCT03123094|523965374|FG003|Overall Study|Withdrawal by Subject|0|||
145304638|NCT03123094|523965375|FG004|Overall Study|Withdrawal by Subject|1|||
145304639|NCT01735994|523965376|FG000|Overall Study|Withdrawal by Subject|6|||
145304640|NCT01735994|523965377|FG001|Overall Study|Withdrawal by Subject|4|||
145304641|NCT01735994|523965376|FG000|Overall Study|Injury|2|||
145304642|NCT01735994|523965377|FG001|Overall Study|Injury|0|||
145568928|NCT00603746|524942371|FG002|Overall Study|Withdrawal by Subject|0|||
145568929|NCT00603746|524942372|FG003|Overall Study|Withdrawal by Subject|1|||
145620333|NCT00996580|525123741|FG000|Overall Study|Physician Decision|5|||
145262750|NCT05146999|523808497|FG001|Overall Study|Withdrew consent|1|||
145262751|NCT05146999|523808496|FG000|Overall Study|Lost to Follow-up|3|||
145262752|NCT05146999|523808497|FG001|Overall Study|Lost to Follow-up|2|||
145262753|NCT05146999|523808496|FG000|Overall Study|Other|1|||
145262754|NCT05146999|523808497|FG001|Overall Study|Other|3|||
145262755|NCT03319160|523808498|FG000|Overall Study|Data not available.|7|||
145262756|NCT00665002|523808499|FG000|Overall Study|Progression/relapse during treatment|11|||
145262757|NCT00665002|523808499|FG000|Overall Study|Cytogenetic resistance|1|||
145262758|NCT00697255|523808500|FG000|Stage 1a|Insufficient ovarian response|1|||
145262759|NCT00697255|523808501|FG001|Stage 1a|Insufficient ovarian response|0|||
145262760|NCT00697255|523808500|FG000|Stage 1a|Multifollicular growth|1|||
145262761|NCT00697255|523808501|FG001|Stage 1a|Multifollicular growth|0|||
145262762|NCT00697255|523808500|FG000|Stage 1a|Not growing of dominant follicle|1|||
145262763|NCT00697255|523808501|FG001|Stage 1a|Not growing of dominant follicle|0|||
145262764|NCT00697255|523808500|FG000|Stage 1b|Not growing of dominant follicle|0|||
145262765|NCT00697255|523808501|FG001|Stage 1b|Not growing of dominant follicle|1|||
145262766|NCT00697255|523808500|FG000|Stage 1b|Insufficient ovarian response|0|||
145262767|NCT00697255|523808501|FG001|Stage 1b|Insufficient ovarian response|1|||
145262768|NCT01333501|523808506|FG000|Overall Study|Adverse Event|3|||
145262769|NCT01333501|523808507|FG001|Overall Study|Adverse Event|1|||
145262770|NCT01333501|523808506|FG000|Overall Study|Abnormal laboratory value|2|||
145262771|NCT01333501|523808507|FG001|Overall Study|Abnormal laboratory value|1|||
145262772|NCT01333501|523808506|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145262773|NCT01333501|523808507|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
145262774|NCT01333501|523808506|FG000|Overall Study|Withdrawn consent|3|||
145262775|NCT01333501|523808507|FG001|Overall Study|Withdrawn consent|12|||
145262776|NCT02243306|523808508|FG000|Overall Study|Adverse Event|0|||
145262777|NCT02243306|523808509|FG001|Overall Study|Adverse Event|1|||
145262778|NCT02243306|523808508|FG000|Overall Study|Other: Reached stopping criteria|0|||
145262779|NCT02243306|523808509|FG001|Overall Study|Other: Reached stopping criteria|1|||
145262780|NCT02243306|523808508|FG000|Overall Study|Physician Decision|0|||
145262781|NCT02243306|523808509|FG001|Overall Study|Physician Decision|1|||
145262782|NCT02221882|523808510|FG000|Overall Study|Withdrawal by Subject|0|||
145262783|NCT02221882|523808511|FG001|Overall Study|Withdrawal by Subject|0|||
145262784|NCT02221882|523808512|FG002|Overall Study|Withdrawal by Subject|4|||
145262785|NCT02221882|523808513|FG003|Overall Study|Withdrawal by Subject|2|||
145262786|NCT02221882|523808514|FG004|Overall Study|Withdrawal by Subject|2|||
145262787|NCT02221882|523808515|FG005|Overall Study|Withdrawal by Subject|2|||
145262788|NCT02221882|523808510|FG000|Overall Study|Death|0|||
145262789|NCT02221882|523808511|FG001|Overall Study|Death|1|||
145262790|NCT02221882|523808512|FG002|Overall Study|Death|0|||
145262791|NCT02221882|523808513|FG003|Overall Study|Death|0|||
145262792|NCT02221882|523808514|FG004|Overall Study|Death|0|||
145262793|NCT02221882|523808515|FG005|Overall Study|Death|0|||
145262794|NCT00796367|523808516|FG000|Overall Study|Adverse Event|6|||
145262795|NCT00796367|523808517|FG001|Overall Study|Adverse Event|4|||
145262796|NCT00796367|523808518|FG002|Overall Study|Adverse Event|7|||
145262797|NCT00796367|523808516|FG000|Overall Study|Lost to Follow-up|5|||
145262798|NCT00796367|523808517|FG001|Overall Study|Lost to Follow-up|4|||
145262799|NCT00796367|523808518|FG002|Overall Study|Lost to Follow-up|21|||
145262800|NCT00796367|523808516|FG000|Overall Study|Withdrawal by Subject|9|||
145262801|NCT00796367|523808517|FG001|Overall Study|Withdrawal by Subject|11|||
145262802|NCT00796367|523808518|FG002|Overall Study|Withdrawal by Subject|12|||
145262803|NCT00796367|523808516|FG000|Overall Study|Lack of Efficacy|2|||
145262804|NCT00796367|523808517|FG001|Overall Study|Lack of Efficacy|1|||
145262805|NCT00796367|523808518|FG002|Overall Study|Lack of Efficacy|0|||
145262806|NCT00796367|523808516|FG000|Overall Study|non compliance|3|||
145262807|NCT00796367|523808517|FG001|Overall Study|non compliance|1|||
145262808|NCT00796367|523808518|FG002|Overall Study|non compliance|1|||
145262809|NCT00796367|523808516|FG000|Overall Study|Pregnancy|1|||
145262810|NCT00796367|523808517|FG001|Overall Study|Pregnancy|0|||
145262811|NCT00796367|523808518|FG002|Overall Study|Pregnancy|1|||
145262812|NCT00796367|523808516|FG000|Overall Study|Requirement for restricted medication|2|||
145262813|NCT00796367|523808517|FG001|Overall Study|Requirement for restricted medication|0|||
145262814|NCT00796367|523808518|FG002|Overall Study|Requirement for restricted medication|2|||
145262815|NCT00796367|523808516|FG000|Overall Study|other|2|||
145262816|NCT00796367|523808517|FG001|Overall Study|other|4|||
145262817|NCT00796367|523808518|FG002|Overall Study|other|3|||
145262818|NCT04246996|523808519|FG000|Overall Study|Physician Decision|1|||
145262819|NCT04246996|523808520|FG001|Overall Study|Physician Decision|1|||
145262820|NCT04246996|523808519|FG000|Overall Study|Did not meet eligibility criteria|1|||
145262821|NCT04246996|523808520|FG001|Overall Study|Did not meet eligibility criteria|4|||
145262822|NCT01815099|523808521|FG000|Overall Study|Lack of Efficacy|1|||
145304643|NCT01735994|523965376|FG000|Overall Study|Kicked off team|5|||
145304644|NCT01735994|523965377|FG001|Overall Study|Kicked off team|0|||
145304645|NCT01735994|523965376|FG000|Overall Study|Lost to Follow-up|50|||
145304646|NCT01735994|523965377|FG001|Overall Study|Lost to Follow-up|62|||
145304647|NCT03128723|523965379|FG000|Overall Study|Withdrawal by Subject|2|||
145304648|NCT02699866|523965390|FG000|Overall Study|Withdrawal by Subject|3|||
145304649|NCT02699866|523965390|FG000|Overall Study|Physician Decision|2|||
145304650|NCT02699866|523965390|FG000|Overall Study|Adverse Event|3|||
145304651|NCT02849457|523965391|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
145304652|NCT02849457|523965392|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
145304653|NCT02849457|523965393|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
145304654|NCT02849457|523965394|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
145304655|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
145304656|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
145304657|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
145304658|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
145304659|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
145304660|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
145304661|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
145304662|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
145304663|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
145304664|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
145304665|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
145304666|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
145304667|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
145304668|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
145304669|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
145304670|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
145304671|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
145304672|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
145304673|NCT01667679|523965402|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
145304674|NCT01667679|523965403|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
145304675|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
145304676|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
145304677|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
145304678|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
145304679|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
145304680|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
145304681|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
145304682|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
145304683|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
145304684|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
145304685|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
145304686|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
145304687|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
145304688|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
145304689|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
145304690|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
145304691|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
145304692|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
145304693|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
145304694|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
145304695|NCT01667679|523965402|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
145304696|NCT01667679|523965403|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
145304697|NCT01294917|523965404|FG000|Overall Study|Relocation|5|||
145304698|NCT01294917|523965404|FG000|Overall Study|Inconvenience|1|||
145304699|NCT02558491|523965405|FG000|First Invention|Withdrawal by Subject|3|||
145304700|NCT02558491|523965406|FG001|First Invention|Withdrawal by Subject|1|||
145304701|NCT02558491|523965405|FG000|First Invention|Data collection issues|1|||
145304702|NCT02558491|523965406|FG001|First Invention|Data collection issues|0|||
145304703|NCT02558491|523965405|FG000|First Invention|Stopping criteria|0|||
145304704|NCT02558491|523965406|FG001|First Invention|Stopping criteria|1|||
145304705|NCT02558491|523965405|FG000|First Invention|Changed parameters during trial|1|||
145304706|NCT02558491|523965406|FG001|First Invention|Changed parameters during trial|0|||
145568930|NCT00603746|524942373|FG004|Overall Study|Withdrawal by Subject|3|||
145568931|NCT00603746|524942374|FG005|Overall Study|Withdrawal by Subject|1|||
145304707|NCT02558491|523965405|FG000|Second Intervention|Withdrawal by Subject|1|||
145304708|NCT02558491|523965406|FG001|Second Intervention|Withdrawal by Subject|0|||
145304709|NCT02558491|523965405|FG000|Second Intervention|Stopping Criteria|1|||
145304710|NCT02558491|523965406|FG001|Second Intervention|Stopping Criteria|0|||
145304711|NCT00834431|523965407|FG000|First Intervention|Adverse Event|0|||
145304712|NCT00834431|523965408|FG001|First Intervention|Adverse Event|1|||
145304713|NCT00834431|523965407|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
145304714|NCT00834431|523965408|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145304715|NCT03637764|523965409|FG000|Overall Study|Adverse Event|2|||
145304716|NCT03637764|523965410|FG001|Overall Study|Adverse Event|0|||
145304717|NCT03637764|523965411|FG002|Overall Study|Adverse Event|0|||
145304718|NCT03637764|523965412|FG003|Overall Study|Adverse Event|1|||
145304719|NCT03637764|523965409|FG000|Overall Study|Progressive Disease|23|||
145304720|NCT03637764|523965410|FG001|Overall Study|Progressive Disease|23|||
145304721|NCT03637764|523965411|FG002|Overall Study|Progressive Disease|18|||
145304722|NCT03637764|523965412|FG003|Overall Study|Progressive Disease|31|||
145304723|NCT03637764|523965409|FG000|Overall Study|Withdrawal by Subject|1|||
145304724|NCT03637764|523965410|FG001|Overall Study|Withdrawal by Subject|3|||
145304725|NCT03637764|523965411|FG002|Overall Study|Withdrawal by Subject|0|||
145304726|NCT03637764|523965412|FG003|Overall Study|Withdrawal by Subject|1|||
145304727|NCT00835263|523965413|FG000|Second Intervention|Adverse Event|1|||
145304728|NCT00835263|523965414|FG001|Second Intervention|Adverse Event|0|||
145304729|NCT01020474|523965415|FG000|Overall Study|Adverse Event|4|||
145304730|NCT01020474|523965416|FG001|Overall Study|Adverse Event|4|||
145304731|NCT01020474|523965415|FG000|Overall Study|Protocol Violation|0|||
145304732|NCT01020474|523965416|FG001|Overall Study|Protocol Violation|2|||
145304733|NCT01020474|523965415|FG000|Overall Study|Withdrawal by Subject|5|||
145304734|NCT01020474|523965416|FG001|Overall Study|Withdrawal by Subject|7|||
145304735|NCT01020474|523965415|FG000|Overall Study|Other Reasons|1|||
145304736|NCT01020474|523965416|FG001|Overall Study|Other Reasons|1|||
145304737|NCT01020474|523965415|FG000|Overall Study|Insufficient Clinical Response|0|||
145304738|NCT01020474|523965416|FG001|Overall Study|Insufficient Clinical Response|3|||
145304739|NCT03987191|523965417|FG000|Overall Study|COVID-19 related research disruption|0|||
145304740|NCT03987191|523965418|FG001|Overall Study|COVID-19 related research disruption|2|||
145304741|NCT01576042|523965422|FG000|Overall Study|Physician Decision|2|||
145304742|NCT01576042|523965423|FG001|Overall Study|Physician Decision|0|||
145304743|NCT03769025|523965429|FG000|Overall Study|Withdrawal by Subject|1|||
145304744|NCT03769025|523965430|FG001|Overall Study|Withdrawal by Subject|1|||
145304745|NCT03769025|523965429|FG000|Overall Study|Lost to Follow-up|4|||
145304746|NCT03769025|523965430|FG001|Overall Study|Lost to Follow-up|3|||
145304747|NCT03123471|523965433|FG000|Placebo-controlled Phase|Adverse Event|3|||
145304748|NCT03123471|523965434|FG001|Placebo-controlled Phase|Adverse Event|8|||
145304749|NCT03123471|523965433|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
145304750|NCT03123471|523965434|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
145304751|NCT03123471|523965433|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
145304752|NCT03123471|523965434|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
145304753|NCT03123471|523965433|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
145304754|NCT03123471|523965434|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
145304755|NCT03123471|523965433|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
145304756|NCT03123471|523965434|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
145304757|NCT03123471|523965433|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
145304758|NCT03123471|523965434|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
145304759|NCT03123471|523965433|FG000|Placebo-controlled Phase|Miscellaneous|0|||
145304760|NCT03123471|523965434|FG001|Placebo-controlled Phase|Miscellaneous|1|||
145304761|NCT03123471|523965433|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
145304762|NCT03123471|523965434|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
145304763|NCT03123471|523965433|FG000|Apremilast Extension Phase|Adverse Event|1|||
145304764|NCT03123471|523965434|FG001|Apremilast Extension Phase|Adverse Event|5|||
145304765|NCT03123471|523965433|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
145304766|NCT03123471|523965434|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
145304767|NCT03123471|523965433|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
145304768|NCT03123471|523965434|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
145304769|NCT01686477|523965435|FG000|Feeding Intervention|Death|1|||
145304770|NCT01686477|523965436|FG001|Feeding Intervention|Death|0|||
145304771|NCT01686477|523965437|FG002|Feeding Intervention|Death|1|||
145304772|NCT01686477|523965435|FG000|Feeding Intervention|Withdrawal by Subject|0|||
145304773|NCT01686477|523965436|FG001|Feeding Intervention|Withdrawal by Subject|6|||
145304774|NCT01686477|523965437|FG002|Feeding Intervention|Withdrawal by Subject|0|||
145304775|NCT01686477|523965435|FG000|Feeding Intervention|Physician Decision|1|||
145304776|NCT01686477|523965436|FG001|Feeding Intervention|Physician Decision|2|||
145304777|NCT01686477|523965437|FG002|Feeding Intervention|Physician Decision|0|||
145304778|NCT01686477|523965435|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
145304779|NCT01686477|523965436|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
145304780|NCT01686477|523965437|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
145568932|NCT01524627|524942377|FG000|Overall Study|Physician Decision|0|||
145304781|NCT01686477|523965435|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
145304782|NCT01686477|523965436|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
145304783|NCT01686477|523965437|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
145304784|NCT01686477|523965435|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
145304785|NCT01686477|523965436|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
145304786|NCT01686477|523965437|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
145304787|NCT01686477|523965435|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
145304788|NCT01686477|523965436|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
145304789|NCT01686477|523965437|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
145304790|NCT01686477|523965435|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
145304791|NCT01686477|523965436|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
145304792|NCT01686477|523965437|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
145304793|NCT01686477|523965435|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
145304794|NCT01686477|523965436|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
145304795|NCT01686477|523965437|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
145304796|NCT01686477|523965435|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
145304797|NCT01686477|523965436|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
145304798|NCT01686477|523965437|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
145304799|NCT05341622|523965439|FG000|Overall Study|Death|0|||
145304800|NCT05341622|523965440|FG001|Overall Study|Death|0|||
145304801|NCT05341622|523965441|FG002|Overall Study|Death|0|||
145304802|NCT05341622|523965442|FG003|Overall Study|Death|0|||
145304803|NCT05341622|523965443|FG004|Overall Study|Death|1|||
145304804|NCT05341622|523965444|FG005|Overall Study|Death|0|||
145304805|NCT05341622|523965445|FG006|Overall Study|Death|0|||
145304806|NCT05341622|523965446|FG007|Overall Study|Death|1|||
145304807|NCT05341622|523965439|FG000|Overall Study|Invalid Address|0|||
145304808|NCT05341622|523965440|FG001|Overall Study|Invalid Address|1|||
145304809|NCT05341622|523965441|FG002|Overall Study|Invalid Address|0|||
145304810|NCT05341622|523965442|FG003|Overall Study|Invalid Address|0|||
145304811|NCT05341622|523965443|FG004|Overall Study|Invalid Address|0|||
145304812|NCT05341622|523965444|FG005|Overall Study|Invalid Address|0|||
145304813|NCT05341622|523965445|FG006|Overall Study|Invalid Address|0|||
145304814|NCT05341622|523965446|FG007|Overall Study|Invalid Address|0|||
145304815|NCT05341622|523965439|FG000|Overall Study|Ineligible|26|||
145304816|NCT05341622|523965440|FG001|Overall Study|Ineligible|21|||
145304817|NCT05341622|523965441|FG002|Overall Study|Ineligible|28|||
145304818|NCT05341622|523965442|FG003|Overall Study|Ineligible|24|||
145304819|NCT05341622|523965443|FG004|Overall Study|Ineligible|29|||
145304820|NCT05341622|523965444|FG005|Overall Study|Ineligible|31|||
145304821|NCT05341622|523965445|FG006|Overall Study|Ineligible|28|||
145304822|NCT05341622|523965446|FG007|Overall Study|Ineligible|26|||
145304823|NCT02957942|523965447|FG000|Overall Study|Withdrawal by Subject|0|||
145304824|NCT02957942|523965448|FG001|Overall Study|Withdrawal by Subject|1|||
145304825|NCT02957942|523965447|FG000|Overall Study|Practicing experiment protocol|0|||
145304826|NCT02957942|523965448|FG001|Overall Study|Practicing experiment protocol|6|||
145304827|NCT01249651|523965452|FG000|Overall Study|Withdrawal by Subject|4|||
145304828|NCT01249651|523965452|FG000|Overall Study|Adverse Event|1|||
145304829|NCT01249651|523965452|FG000|Overall Study|Protocol Violation|1|||
145304830|NCT01249651|523965452|FG000|Overall Study|Sponsor Decision|1|||
145304831|NCT00813592|523965453|FG000|Overall Study|Disease assessment was not completed per|2|||
145304832|NCT03873272|523965454|FG000|Overall Study|Withdrawal by Subject|2|||
145304833|NCT03873272|523965455|FG001|Overall Study|Withdrawal by Subject|0|||
145304834|NCT03873272|523965456|FG002|Overall Study|Withdrawal by Subject|1|||
145304835|NCT03873272|523965454|FG000|Overall Study|Death|0|||
145304836|NCT03873272|523965455|FG001|Overall Study|Death|2|||
145304837|NCT03873272|523965456|FG002|Overall Study|Death|1|||
145304838|NCT04544410|523965457|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145304839|NCT04544410|523965458|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145304840|NCT04544410|523965457|FG000|Double-blind Treatment Period|Adverse Event|1|||
145304841|NCT04544410|523965458|FG001|Double-blind Treatment Period|Adverse Event|0|||
145304842|NCT04544410|523965457|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
145304843|NCT04544410|523965458|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145304844|NCT04544410|523965457|FG000|Double-blind Treatment Period|Protocol Violation|1|||
145304845|NCT04544410|523965458|FG001|Double-blind Treatment Period|Protocol Violation|0|||
145304846|NCT04544410|523965457|FG000|Open-Label Treatment Period|Study Terminated|15|||
145304847|NCT04544410|523965458|FG001|Open-Label Treatment Period|Study Terminated|19|||
145304848|NCT04544410|523965457|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
145304849|NCT04544410|523965458|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
145304850|NCT04544410|523965457|FG000|Open-Label Treatment Period|Adverse Event|0|||
145304851|NCT04544410|523965458|FG001|Open-Label Treatment Period|Adverse Event|1|||
145304852|NCT04544410|523965457|FG000|Open-Label Treatment Period|Physician Decision|1|||
145304853|NCT04544410|523965458|FG001|Open-Label Treatment Period|Physician Decision|0|||
145304854|NCT04544410|523965457|FG000|Open-Label Treatment Period|Other|0|||
145568933|NCT01524627|524942378|FG001|Overall Study|Physician Decision|1|||
145568934|NCT01524627|524942377|FG000|Overall Study|Lost to Follow-up|1|||
145568935|NCT01524627|524942378|FG001|Overall Study|Lost to Follow-up|1|||
145568936|NCT03350503|524942379|FG000|Overall Study|Adverse Event|5|||
145568937|NCT03350503|524942379|FG000|Overall Study|Withdrawal by Subject|5|||
145304855|NCT04544410|523965458|FG001|Open-Label Treatment Period|Other|1|||
145304856|NCT02430480|523965459|FG000|Overall Study|Death|1|||
145304857|NCT02430480|523965459|FG000|Overall Study|Anesthesia concerns|1|||
145304858|NCT02430480|523965459|FG000|Overall Study|Progressed on treatment|1|||
145304859|NCT04493684|523965460|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
145304860|NCT04493684|523965461|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304861|NCT04493684|523965462|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
145304862|NCT04493684|523965463|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304863|NCT04493684|523965464|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304864|NCT04493684|523965465|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
145304865|NCT04493684|523965466|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304866|NCT04493684|523965467|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304867|NCT04493684|523965468|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304868|NCT04493684|523965469|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304869|NCT04493684|523965470|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304870|NCT04493684|523965471|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304871|NCT04493684|523965472|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304872|NCT04493684|523965473|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304873|NCT04493684|523965474|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304874|NCT04493684|523965475|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304875|NCT04493684|523965476|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
145304876|NCT04493684|523965460|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
145304877|NCT04493684|523965461|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304878|NCT04493684|523965462|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304879|NCT04493684|523965463|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304880|NCT04493684|523965464|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304881|NCT04493684|523965465|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304882|NCT04493684|523965466|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304883|NCT04493684|523965467|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304884|NCT04493684|523965468|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304885|NCT04493684|523965469|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304886|NCT04493684|523965470|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304887|NCT04493684|523965471|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304888|NCT04493684|523965472|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304889|NCT04493684|523965473|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304890|NCT04493684|523965474|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304891|NCT04493684|523965475|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304892|NCT04493684|523965476|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
145304893|NCT04493684|523965460|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304894|NCT04493684|523965461|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304895|NCT04493684|523965462|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304896|NCT04493684|523965463|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304897|NCT04493684|523965464|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304898|NCT04493684|523965465|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304899|NCT04493684|523965466|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
145304900|NCT04493684|523965467|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304901|NCT04493684|523965468|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304902|NCT04493684|523965469|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304903|NCT04493684|523965470|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304904|NCT04493684|523965471|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304905|NCT04493684|523965472|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304906|NCT04493684|523965473|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304907|NCT04493684|523965474|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304908|NCT04493684|523965475|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304909|NCT04493684|523965476|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
145304910|NCT04493684|523965460|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
145304911|NCT04493684|523965461|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304912|NCT04493684|523965462|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145568938|NCT03350503|524942379|FG000|Overall Study|Continuation impossible due to move|4|||
145304913|NCT04493684|523965463|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304914|NCT04493684|523965464|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304915|NCT04493684|523965465|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304916|NCT04493684|523965466|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304917|NCT04493684|523965467|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304918|NCT04493684|523965468|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304919|NCT04493684|523965469|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304920|NCT04493684|523965470|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304921|NCT04493684|523965471|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304922|NCT04493684|523965472|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304923|NCT04493684|523965473|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304924|NCT04493684|523965474|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304925|NCT04493684|523965475|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304926|NCT04493684|523965476|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
145304927|NCT04493684|523965460|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304928|NCT04493684|523965461|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304929|NCT04493684|523965462|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304930|NCT04493684|523965463|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304931|NCT04493684|523965464|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304932|NCT04493684|523965465|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
145304933|NCT04493684|523965466|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304934|NCT04493684|523965467|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304935|NCT04493684|523965468|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304936|NCT04493684|523965469|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304937|NCT04493684|523965470|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304938|NCT04493684|523965471|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304939|NCT04493684|523965472|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304940|NCT04493684|523965473|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304941|NCT04493684|523965474|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304942|NCT04493684|523965475|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304943|NCT04493684|523965476|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
145304944|NCT04493684|523965460|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304945|NCT04493684|523965461|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304946|NCT04493684|523965462|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304947|NCT04493684|523965463|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304948|NCT04493684|523965464|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304949|NCT04493684|523965465|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304950|NCT04493684|523965466|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304951|NCT04493684|523965467|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304952|NCT04493684|523965468|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304953|NCT04493684|523965469|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304954|NCT04493684|523965470|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304955|NCT04493684|523965471|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
145304956|NCT04493684|523965472|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304957|NCT04493684|523965473|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304958|NCT04493684|523965474|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304959|NCT04493684|523965475|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304960|NCT04493684|523965476|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
145304961|NCT04493684|523965460|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304962|NCT04493684|523965461|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304963|NCT04493684|523965462|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304964|NCT04493684|523965463|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304965|NCT04493684|523965464|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304966|NCT04493684|523965465|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304967|NCT04493684|523965466|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304968|NCT04493684|523965467|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304969|NCT04493684|523965468|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304970|NCT04493684|523965469|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304971|NCT04493684|523965470|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304972|NCT04493684|523965471|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145568939|NCT03350503|524942379|FG000|Overall Study|Physician Decision|3|||
145568940|NCT00560950|524942382|FG000|Overall Study|Lost to Follow-up|1|||
145568941|NCT00560950|524942383|FG001|Overall Study|Lost to Follow-up|0|||
145304973|NCT04493684|523965472|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304974|NCT04493684|523965473|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304975|NCT04493684|523965474|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304976|NCT04493684|523965475|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
145304977|NCT04493684|523965476|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
145304978|NCT04493684|523965460|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304979|NCT04493684|523965461|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304980|NCT04493684|523965462|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304981|NCT04493684|523965463|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304982|NCT04493684|523965464|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304983|NCT04493684|523965465|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304984|NCT04493684|523965466|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304985|NCT04493684|523965467|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304986|NCT04493684|523965468|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304987|NCT04493684|523965469|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304988|NCT04493684|523965470|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304989|NCT04493684|523965471|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304990|NCT04493684|523965472|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304991|NCT04493684|523965473|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304992|NCT04493684|523965474|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304993|NCT04493684|523965475|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
145304994|NCT04493684|523965476|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
145304995|NCT01963728|523965477|FG000|Overall Study|Study terminated early|0|||
145304996|NCT01963728|523965478|FG001|Overall Study|Study terminated early|1|||
145304997|NCT05152576|523965483|FG000|Overall Study|Lost to Follow-up|3|||
145304998|NCT05152576|523965484|FG001|Overall Study|Lost to Follow-up|0|||
145304999|NCT05152576|523965485|FG002|Overall Study|Lost to Follow-up|0|||
145305000|NCT05152576|523965486|FG003|Overall Study|Lost to Follow-up|1|||
145305001|NCT05152576|523965483|FG000|Overall Study|Withdrawal by Subject|0|||
145305002|NCT05152576|523965484|FG001|Overall Study|Withdrawal by Subject|1|||
145305003|NCT05152576|523965485|FG002|Overall Study|Withdrawal by Subject|0|||
145305004|NCT05152576|523965486|FG003|Overall Study|Withdrawal by Subject|1|||
145305005|NCT05152576|523965483|FG000|Overall Study|Other|2|||
145305006|NCT05152576|523965484|FG001|Overall Study|Other|0|||
145305007|NCT05152576|523965485|FG002|Overall Study|Other|0|||
145305008|NCT05152576|523965486|FG003|Overall Study|Other|0|||
145305009|NCT02328040|523966967|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
145305010|NCT02328040|523966968|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
145305011|NCT02301975|523966977|FG000|Overall Study|Adverse Event|8|||
145305012|NCT02301975|523966978|FG001|Overall Study|Adverse Event|3|||
145305013|NCT02301975|523966979|FG002|Overall Study|Adverse Event|2|||
145305014|NCT02301975|523966977|FG000|Overall Study|Lack of Efficacy|1|||
145305015|NCT02301975|523966978|FG001|Overall Study|Lack of Efficacy|1|||
145305016|NCT02301975|523966979|FG002|Overall Study|Lack of Efficacy|1|||
145305017|NCT02301975|523966977|FG000|Overall Study|Protocol Violation|3|||
145305018|NCT02301975|523966978|FG001|Overall Study|Protocol Violation|5|||
145305019|NCT02301975|523966979|FG002|Overall Study|Protocol Violation|3|||
145305020|NCT02301975|523966977|FG000|Overall Study|Lost to Follow-up|0|||
145305021|NCT02301975|523966978|FG001|Overall Study|Lost to Follow-up|2|||
145305022|NCT02301975|523966979|FG002|Overall Study|Lost to Follow-up|2|||
145305023|NCT02301975|523966977|FG000|Overall Study|Physician Decision|4|||
145305024|NCT02301975|523966978|FG001|Overall Study|Physician Decision|2|||
145305025|NCT02301975|523966979|FG002|Overall Study|Physician Decision|3|||
145305026|NCT02301975|523966977|FG000|Overall Study|Withdrawal by Subject|15|||
145305027|NCT02301975|523966978|FG001|Overall Study|Withdrawal by Subject|12|||
145305028|NCT02301975|523966979|FG002|Overall Study|Withdrawal by Subject|11|||
145305029|NCT04278560|523966981|FG000|Overall Study|Adverse Event|1|||
145305030|NCT04278560|523966982|FG001|Overall Study|Adverse Event|2|||
145305031|NCT04278560|523966981|FG000|Overall Study|Withdrawal by Subject|0|||
145305032|NCT04278560|523966982|FG001|Overall Study|Withdrawal by Subject|1|||
145305033|NCT01531894|523966983|FG000|Overall Study|Physician Decision|8|||
145305034|NCT01531894|523966983|FG000|Overall Study|Death|1|||
145305035|NCT03086460|523966984|FG000|Study Participants|Lost to Follow-up|2|||
145305036|NCT03086460|523966984|FG000|Study Participants|Protocol Violation|1|||
145305037|NCT03086460|523966984|FG000|Study Participants|Withdrawal by Subject|6|||
145305038|NCT03086460|523966984|FG000|Treatment A|Lost to Follow-up|1|||
145305039|NCT03086460|523966984|FG000|Treatment A|Protocol Violation|1|||
145305040|NCT03086460|523966984|FG000|Treatment A|Withdrawal by Subject|2|||
145305041|NCT03086460|523966984|FG000|Treatment C|Withdrawal by Subject|2|||
145305042|NCT03086460|523966984|FG000|Treatment E|Lost to Follow-up|1|||
145305043|NCT03086460|523966984|FG000|Treatment E|Withdrawal by Subject|3|||
145305044|NCT00736190|523966991|FG000|Overall Study|Pregnancy|1|||
145305045|NCT00736190|523966991|FG000|Overall Study|Withdrawal by Subject|1|||
145305046|NCT00736190|523966991|FG000|Overall Study|Adverse Event|1|||
145305047|NCT02682238|523966995|FG000|Overall Study|Lost to Follow-up|0|||
145305048|NCT02682238|523966996|FG001|Overall Study|Lost to Follow-up|2|||
145305049|NCT02682238|523966995|FG000|Overall Study|Withdrawal by Subject|1|||
145305050|NCT02682238|523966996|FG001|Overall Study|Withdrawal by Subject|0|||
145305051|NCT02682238|523966995|FG000|Overall Study|Adverse Event|1|||
145305052|NCT02682238|523966996|FG001|Overall Study|Adverse Event|0|||
145305053|NCT02682238|523966995|FG000|Overall Study|Non-compliance with Study Drug|1|||
145305054|NCT02682238|523966996|FG001|Overall Study|Non-compliance with Study Drug|0|||
145305055|NCT02682238|523966995|FG000|Overall Study|Non-compliance with Protocol|0|||
145305056|NCT02682238|523966996|FG001|Overall Study|Non-compliance with Protocol|2|||
145305057|NCT01370317|523966997|FG000|Overall Study|Participant withdrew consent|1|||
145305058|NCT01370317|523966998|FG001|Overall Study|Participant withdrew consent|0|||
145305059|NCT01370317|523966997|FG000|Overall Study|Protocol deviation|0|||
145305060|NCT01370317|523966998|FG001|Overall Study|Protocol deviation|1|||
145305061|NCT02909907|523966999|FG000|Overall Study|Withdrawal by Subject|0|||
145305062|NCT02909907|523967000|FG001|Overall Study|Withdrawal by Subject|1|||
145305063|NCT00075478|523967001|FG000|Overall Study|not eligible|1|||
145305064|NCT00075478|523967002|FG001|Overall Study|not eligible|0|||
145305065|NCT00075478|523967001|FG000|Overall Study|Physician Decision|0|||
145305066|NCT00075478|523967002|FG001|Overall Study|Physician Decision|1|||
145305067|NCT02075463|523967005|FG000|Overall Study|Adverse Event|3|||
145305068|NCT02075463|523967005|FG000|Overall Study|Par. reached stopping criteria|4|||
145305069|NCT02075463|523967005|FG000|Overall Study|Withdrawal by Subject|1|||
145305070|NCT00673660|523967006|FG000|Overall Study|Lost to Follow-up|107|||
145305071|NCT01527006|523967007|FG000|Core Study|Adverse Event|0|||
145305072|NCT01527006|523967008|FG001|Core Study|Adverse Event|2|||
145305073|NCT01527006|523967007|FG000|Core Study|Lost to Follow-up|0|||
145305074|NCT01527006|523967008|FG001|Core Study|Lost to Follow-up|1|||
145305075|NCT01527006|523967007|FG000|Core Study|Subject Choice|1|||
145305076|NCT01527006|523967008|FG001|Core Study|Subject Choice|0|||
145305077|NCT01527006|523967007|FG000|Core Study|Inadequate Therapeutic Effect|1|||
145305078|NCT01527006|523967008|FG001|Core Study|Inadequate Therapeutic Effect|0|||
145305079|NCT01527006|523967007|FG000|Core Study|Withdrawal by Subject|0|||
145305080|NCT01527006|523967008|FG001|Core Study|Withdrawal by Subject|1|||
145305081|NCT01527006|523967007|FG000|Core Study|Other|0|||
145305082|NCT01527006|523967008|FG001|Core Study|Other|2|||
145305083|NCT01527006|523967007|FG000|Extension Phase|Adverse Event|4|||
145305084|NCT01527006|523967008|FG001|Extension Phase|Adverse Event|2|||
145305085|NCT01527006|523967007|FG000|Extension Phase|Lost to Follow-up|0|||
145305086|NCT01527006|523967008|FG001|Extension Phase|Lost to Follow-up|1|||
145305087|NCT01527006|523967007|FG000|Extension Phase|Subject Choice|1|||
145305088|NCT01527006|523967008|FG001|Extension Phase|Subject Choice|1|||
145305089|NCT01527006|523967007|FG000|Extension Phase|Inadequate therapeutic effect|1|||
145305090|NCT01527006|523967008|FG001|Extension Phase|Inadequate therapeutic effect|1|||
145305091|NCT01527006|523967007|FG000|Extension Phase|Other|0|||
145305092|NCT01527006|523967008|FG001|Extension Phase|Other|3|||
145305093|NCT00834340|523967010|FG000|Washout|Adverse Event|1|||
145305094|NCT00834340|523967011|FG001|Washout|Adverse Event|0|||
145305095|NCT00834340|523967010|FG000|Washout|Withdrawal by Subject|1|||
145305096|NCT00834340|523967011|FG001|Washout|Withdrawal by Subject|0|||
145305097|NCT00395694|523967012|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
145305098|NCT00395694|523967013|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
145305099|NCT00395694|523967012|FG000|Continuation Phase|Adverse Event|1|||
145305100|NCT00395694|523967013|FG001|Continuation Phase|Adverse Event|0|||
145305101|NCT00395694|523967012|FG000|Continuation Phase|Lack of Efficacy|12|||
145305102|NCT00395694|523967013|FG001|Continuation Phase|Lack of Efficacy|11|||
145305103|NCT00395694|523967012|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
145305104|NCT00395694|523967013|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
145305105|NCT00395694|523967012|FG000|Continuation Phase|Poor Compliance|1|||
145305106|NCT00395694|523967013|FG001|Continuation Phase|Poor Compliance|0|||
145305107|NCT00395694|523967012|FG000|Continuation Phase|Withdrawal by Subject|0|||
145305108|NCT00395694|523967013|FG001|Continuation Phase|Withdrawal by Subject|2|||
145305109|NCT00392665|523967014|FG000|Overall Study|Death|16|||
145305110|NCT00392665|523967015|FG001|Overall Study|Death|14|||
145305111|NCT00392665|523967014|FG000|Overall Study|Lost to Follow-up|1|||
145305112|NCT00392665|523967015|FG001|Overall Study|Lost to Follow-up|1|||
145305113|NCT02294786|523967021|FG000|Overall Study|Withdrawal by Subject|0|||
145305114|NCT02294786|523967022|FG001|Overall Study|Withdrawal by Subject|1|||
145305115|NCT02294786|523967021|FG000|Overall Study|Physician Decision|6|||
145305116|NCT02294786|523967022|FG001|Overall Study|Physician Decision|7|||
145305117|NCT02294786|523967021|FG000|Overall Study|Lost to Follow-up|1|||
145305118|NCT02294786|523967022|FG001|Overall Study|Lost to Follow-up|2|||
145305119|NCT02294786|523967021|FG000|Overall Study|Protocol Violation|1|||
145305120|NCT02294786|523967022|FG001|Overall Study|Protocol Violation|0|||
145305121|NCT02294786|523967021|FG000|Overall Study|Adverse Event|1|||
145305122|NCT02294786|523967022|FG001|Overall Study|Adverse Event|1|||
145305123|NCT02294786|523967021|FG000|Overall Study|Death|2|||
145305124|NCT02294786|523967022|FG001|Overall Study|Death|3|||
145568942|NCT02970968|524944144|FG000|Overall Study|Withdrawal by Subject|3|||
145305125|NCT01778010|523967023|FG000|Overall Study|Withdrawal by Subject|2|||
145305126|NCT01778010|523967023|FG000|Overall Study|abnormal ECG before meds|1|||
145305127|NCT01778010|523967023|FG000|Overall Study|Arrested|1|||
145305128|NCT01778010|523967023|FG000|Overall Study|rash while on placebo|1|||
145305129|NCT04238754|523967029|FG000|Washout - 1 Week|Lost to Follow-up|1|||
145305130|NCT04238754|523967030|FG001|Washout - 1 Week|Lost to Follow-up|0|||
145305131|NCT02159183|523967031|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
145305132|NCT02159183|523967032|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
145305133|NCT02159183|523967031|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
145305134|NCT02159183|523967032|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
145305135|NCT02159183|523967031|FG000|Analysis After the 36 Months Follow-up|Death|0|||
145305136|NCT02159183|523967032|FG001|Analysis After the 36 Months Follow-up|Death|1|||
145305137|NCT02159183|523967031|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
145305138|NCT02159183|523967032|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
145305139|NCT02159183|523967031|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
145305140|NCT02159183|523967032|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
145305141|NCT01244620|523967036|FG000|Overall Study|Study terminated|4|||
145305142|NCT01244620|523967037|FG001|Overall Study|Study terminated|4|||
145305143|NCT01244620|523967038|FG002|Overall Study|Study terminated|4|||
145305144|NCT01244620|523967039|FG003|Overall Study|Study terminated|4|||
145305145|NCT00840073|523967041|FG000|Second Intervention|Missed 72 hour blood draw|1|||
145305146|NCT00840073|523967042|FG001|Second Intervention|Missed 72 hour blood draw|1|||
145305147|NCT01663233|523967043|FG000|Overall Study|Withdrawal by Subject|3|||
145305148|NCT01663233|523967044|FG001|Overall Study|Withdrawal by Subject|2|||
145305149|NCT01663233|523967043|FG000|Overall Study|Protocol Deviation|1|||
145305150|NCT01663233|523967044|FG001|Overall Study|Protocol Deviation|4|||
145305151|NCT01663233|523967043|FG000|Overall Study|Lost to Follow-up|0|||
145305152|NCT01663233|523967044|FG001|Overall Study|Lost to Follow-up|1|||
145305153|NCT02321098|523967045|FG000|12 Weeks Treament|Lost to Follow-up|1|||
145305154|NCT02321098|523967046|FG001|12 Weeks Treament|Lost to Follow-up|1|||
145305155|NCT02321098|523967047|FG002|12 Weeks Treament|Lost to Follow-up|0|||
145305156|NCT02321098|523967045|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
145305157|NCT02321098|523967046|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
145305158|NCT02321098|523967047|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
145305159|NCT02321098|523967045|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
145305160|NCT02321098|523967046|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
145305161|NCT02321098|523967047|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
145305162|NCT02321098|523967045|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
145305163|NCT02321098|523967046|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
145305164|NCT02321098|523967047|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
145305165|NCT00705666|523967054|FG000|Overall Study|No post-treatment questionnaire|279|||
145305166|NCT00705666|523967054|FG000|Overall Study|Withdrawal by Subject|21|||
145305167|NCT00705666|523967054|FG000|Overall Study|Physician Decision|7|||
145305168|NCT00705666|523967054|FG000|Overall Study|Lost to Follow-up|5|||
145305169|NCT00705666|523967054|FG000|Overall Study|Death|1|||
145305170|NCT00705666|523967054|FG000|Overall Study|Adverse Event|4|||
145305171|NCT00705666|523967054|FG000|Overall Study|Other|12|||
145305172|NCT00705666|523967054|FG000|Overall Study|Other|2|||
145305173|NCT00705666|523967054|FG000|Overall Study|Lack of data|3|||
145305174|NCT00705666|523967054|FG000|Overall Study|Untreated|5|||
145305175|NCT02105272|523967062|FG000|Overall Study|Adverse Event|1|||
145305176|NCT02105272|523967063|FG001|Overall Study|Adverse Event|2|||
145305177|NCT02105272|523967062|FG000|Overall Study|Physician Decision|0|||
145305178|NCT02105272|523967063|FG001|Overall Study|Physician Decision|1|||
145305179|NCT02105272|523967062|FG000|Overall Study|Protocol Violation|2|||
145305180|NCT02105272|523967063|FG001|Overall Study|Protocol Violation|0|||
145305181|NCT02105272|523967062|FG000|Overall Study|Withdrawal by Subject|2|||
145305182|NCT02105272|523967063|FG001|Overall Study|Withdrawal by Subject|0|||
145305183|NCT03406156|523967067|FG000|Overall Study|Death|9|||
145305184|NCT03406156|523967068|FG001|Overall Study|Death|3|||
145305185|NCT03406156|523967067|FG000|Overall Study|Withdrawal by Subject|1|||
145305186|NCT03406156|523967068|FG001|Overall Study|Withdrawal by Subject|2|||
145305187|NCT03406156|523967067|FG000|Overall Study|COVID-19 infection|1|||
145305188|NCT03406156|523967068|FG001|Overall Study|COVID-19 infection|0|||
145305189|NCT03406156|523967067|FG000|Overall Study|Non-compliance with study procedures|1|||
145305190|NCT03406156|523967068|FG001|Overall Study|Non-compliance with study procedures|1|||
145305191|NCT03406156|523967067|FG000|Overall Study|Lost to Follow-up|0|||
145305192|NCT03406156|523967068|FG001|Overall Study|Lost to Follow-up|2|||
145305193|NCT03406156|523967067|FG000|Overall Study|Other, not specified|72|||
145305194|NCT03406156|523967068|FG001|Overall Study|Other, not specified|28|||
145305195|NCT02964039|523967070|FG000|Overall Study|Medical reason unrelated to study participation|1|||
145305196|NCT02964039|523967071|FG001|Overall Study|Medical reason unrelated to study participation|0|||
145305197|NCT02964039|523967072|FG002|Overall Study|Medical reason unrelated to study participation|3|||
145305198|NCT02964039|523967070|FG000|Overall Study|Research shutdown due to pandemic|2|||
145305199|NCT02964039|523967071|FG001|Overall Study|Research shutdown due to pandemic|0|||
145305200|NCT02964039|523967072|FG002|Overall Study|Research shutdown due to pandemic|1|||
145305201|NCT02964039|523967070|FG000|Overall Study|Withdrawal by Subject|0|||
145305202|NCT02964039|523967071|FG001|Overall Study|Withdrawal by Subject|1|||
145305203|NCT02964039|523967072|FG002|Overall Study|Withdrawal by Subject|0|||
145305204|NCT02964039|523967070|FG000|Overall Study|Lost to Follow-up|1|||
145305205|NCT02964039|523967071|FG001|Overall Study|Lost to Follow-up|0|||
145305206|NCT02964039|523967072|FG002|Overall Study|Lost to Follow-up|1|||
145305207|NCT05479058|523967073|FG000|Overall Study|Withdrawal by Subject|1|||
145305208|NCT05479058|523967074|FG001|Overall Study|Withdrawal by Subject|1|||
145305209|NCT05479058|523967073|FG000|Overall Study|Study terminated by sponsor|10|||
145305210|NCT05479058|523967074|FG001|Overall Study|Study terminated by sponsor|10|||
145305211|NCT05630885|523967075|FG000|Study Completion|Took prohibited medications|2|||
145305212|NCT05630885|523967076|FG001|Study Completion|Took prohibited medications|0|||
145305213|NCT05630885|523967075|FG000|Study Completion|Non-compliance with study drug|1|||
145305214|NCT05630885|523967076|FG001|Study Completion|Non-compliance with study drug|0|||
145305215|NCT05630885|523967075|FG000|Study Completion|Adverse Event|1|||
145305216|NCT05630885|523967076|FG001|Study Completion|Adverse Event|0|||
145305217|NCT05630885|523967075|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
145305218|NCT05630885|523967076|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
145305219|NCT05630885|523967075|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
145305220|NCT05630885|523967076|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
145305221|NCT00835536|523967077|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
145305222|NCT00835536|523967078|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
145305223|NCT01983969|523967080|FG000|Overall Study|Disease Progression|0|||
145305224|NCT01983969|523967081|FG001|Overall Study|Disease Progression|1|||
145305225|NCT01983969|523967082|FG002|Overall Study|Disease Progression|0|||
145305226|NCT00268203|523967083|FG000|Overall Study|Lost to Follow-up|92|||
145305227|NCT00268203|523967083|FG000|Overall Study|Withdrawal by Subject|9|||
145305228|NCT00268203|523967083|FG000|Overall Study|Received Other NHL Therapy|7|||
145305229|NCT00268203|523967083|FG000|Overall Study|Progressive Disease|359|||
145305230|NCT00268203|523967083|FG000|Overall Study|Death|84|||
145305231|NCT00268203|523967083|FG000|Overall Study|Reason Not Specified|34|||
145305232|NCT00268203|523967083|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
145305233|NCT00950989|523967084|FG000|Overall Study|Death|0|||
145305234|NCT00950989|523967085|FG001|Overall Study|Death|0|||
145305235|NCT00950989|523967086|FG002|Overall Study|Death|1|||
145305236|NCT00950989|523967087|FG003|Overall Study|Death|0|||
145305237|NCT00950989|523967084|FG000|Overall Study|Administrative Decision|0|||
145305238|NCT00950989|523967085|FG001|Overall Study|Administrative Decision|1|||
145305239|NCT00950989|523967086|FG002|Overall Study|Administrative Decision|0|||
145305240|NCT00950989|523967087|FG003|Overall Study|Administrative Decision|0|||
145305241|NCT00950989|523967084|FG000|Overall Study|Disease Progression|0|||
145305242|NCT00950989|523967085|FG001|Overall Study|Disease Progression|0|||
145305243|NCT00950989|523967086|FG002|Overall Study|Disease Progression|1|||
145305244|NCT00950989|523967087|FG003|Overall Study|Disease Progression|0|||
145305245|NCT00950989|523967084|FG000|Overall Study|Withdrawal by Subject|2|||
145305246|NCT00950989|523967085|FG001|Overall Study|Withdrawal by Subject|1|||
145305247|NCT00950989|523967086|FG002|Overall Study|Withdrawal by Subject|0|||
145305248|NCT00950989|523967087|FG003|Overall Study|Withdrawal by Subject|0|||
145305249|NCT00950989|523967084|FG000|Overall Study|Adverse Event|2|||
145305250|NCT00950989|523967085|FG001|Overall Study|Adverse Event|1|||
145305251|NCT00950989|523967086|FG002|Overall Study|Adverse Event|1|||
145305252|NCT00950989|523967087|FG003|Overall Study|Adverse Event|0|||
145305253|NCT00859430|523967094|FG000|First Intervention|Withdrawal by Subject|0|||
145305254|NCT00859430|523967095|FG001|First Intervention|Withdrawal by Subject|1|||
145305255|NCT05776901|523968922|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
145305256|NCT01660243|523968924|FG000|Overall Study|Adverse Event|1|||
145305257|NCT01660243|523968925|FG001|Overall Study|Adverse Event|0|||
145305258|NCT01660243|523968926|FG002|Overall Study|Adverse Event|1|||
145305259|NCT01660243|523968927|FG003|Overall Study|Adverse Event|0|||
145305260|NCT01660243|523968924|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
145305261|NCT01660243|523968925|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
145305262|NCT01660243|523968926|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
145305263|NCT01660243|523968927|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
145305264|NCT01660243|523968924|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
145305265|NCT01660243|523968925|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
145305266|NCT01660243|523968926|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
145305267|NCT01660243|523968927|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
145305268|NCT01660243|523968924|FG000|Overall Study|Randomization error|0|||
145305269|NCT01660243|523968925|FG001|Overall Study|Randomization error|0|||
145305270|NCT01660243|523968926|FG002|Overall Study|Randomization error|0|||
145305271|NCT01660243|523968927|FG003|Overall Study|Randomization error|1|||
145305272|NCT00665925|523968928|FG000|Overall Study|Lack of Efficacy|10|||
145305273|NCT00665925|523968929|FG001|Overall Study|Lack of Efficacy|8|||
145305274|NCT00665925|523968930|FG002|Overall Study|Lack of Efficacy|9|||
145305275|NCT00665925|523968931|FG003|Overall Study|Lack of Efficacy|8|||
145305276|NCT00665925|523968928|FG000|Overall Study|Lost to Follow-up|1|||
145305277|NCT00665925|523968929|FG001|Overall Study|Lost to Follow-up|2|||
145305278|NCT00665925|523968930|FG002|Overall Study|Lost to Follow-up|2|||
145305279|NCT00665925|523968931|FG003|Overall Study|Lost to Follow-up|2|||
145305280|NCT00665925|523968928|FG000|Overall Study|Withdrawal by Subject|2|||
145305281|NCT00665925|523968929|FG001|Overall Study|Withdrawal by Subject|2|||
145305282|NCT00665925|523968930|FG002|Overall Study|Withdrawal by Subject|3|||
145305283|NCT00665925|523968931|FG003|Overall Study|Withdrawal by Subject|2|||
145305284|NCT00665925|523968928|FG000|Overall Study|Physician Decision|0|||
145305285|NCT00665925|523968929|FG001|Overall Study|Physician Decision|0|||
145305286|NCT00665925|523968930|FG002|Overall Study|Physician Decision|1|||
145305287|NCT00665925|523968931|FG003|Overall Study|Physician Decision|2|||
145305288|NCT00665925|523968928|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
145305289|NCT00665925|523968929|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
145305290|NCT00665925|523968930|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
145305291|NCT00665925|523968931|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
145305292|NCT00665925|523968928|FG000|Overall Study|Adverse Event|1|||
145305293|NCT00665925|523968929|FG001|Overall Study|Adverse Event|5|||
145305294|NCT00665925|523968930|FG002|Overall Study|Adverse Event|10|||
145305295|NCT00665925|523968931|FG003|Overall Study|Adverse Event|5|||
145305296|NCT00665925|523968928|FG000|Overall Study|Enrolled by mistake|0|||
145305297|NCT00665925|523968929|FG001|Overall Study|Enrolled by mistake|0|||
145305298|NCT00665925|523968930|FG002|Overall Study|Enrolled by mistake|0|||
145305299|NCT00665925|523968931|FG003|Overall Study|Enrolled by mistake|1|||
145305300|NCT00665925|523968928|FG000|Overall Study|Due to exclusion criteria|1|||
145305301|NCT00665925|523968929|FG001|Overall Study|Due to exclusion criteria|0|||
145305302|NCT00665925|523968930|FG002|Overall Study|Due to exclusion criteria|0|||
145305303|NCT00665925|523968931|FG003|Overall Study|Due to exclusion criteria|0|||
145305304|NCT01987765|523968946|FG000|Overall Study|Protocol Violation|65|||
145305305|NCT01987765|523968946|FG000|Overall Study|Lost to Follow-up|37|||
145305306|NCT03049748|523968949|FG000|Overall Study|Lost to Follow-up|1|||
145305307|NCT03049748|523968950|FG001|Overall Study|Lost to Follow-up|0|||
145305308|NCT03049748|523968949|FG000|Overall Study|Death|3|||
145305309|NCT03049748|523968950|FG001|Overall Study|Death|0|||
145305310|NCT03049748|523968949|FG000|Overall Study|Withdrawal by Subject|0|||
145305311|NCT03049748|523968950|FG001|Overall Study|Withdrawal by Subject|3|||
145305312|NCT03049748|523968949|FG000|Overall Study|Protocol Violation|0|||
145305313|NCT03049748|523968950|FG001|Overall Study|Protocol Violation|2|||
145305314|NCT03049748|523968949|FG000|Overall Study|Moved out of state (relocation)|0|||
145305315|NCT03049748|523968950|FG001|Overall Study|Moved out of state (relocation)|1|||
145305316|NCT03502811|523968953|FG000|Overall Study|Death|157|||
145305317|NCT03502811|523968953|FG000|Overall Study|Withdrawal by Subject|105|||
145305318|NCT03502811|523968953|FG000|Overall Study|Lost to Follow-up|26|||
145305319|NCT03502811|523968953|FG000|Overall Study|No Visits (Missed)|31|||
145305320|NCT00604162|523968954|FG000|Overall Study|Physician Decision|3|||
145305321|NCT00604162|523968954|FG000|Overall Study|Withdrawal by Subject|1|||
145305322|NCT01492439|523968955|FG000|Overall Study|Withdrew from RTE|4|||
145305323|NCT01492439|523968956|FG001|Overall Study|Withdrew from RTE|9|||
145305324|NCT00824291|523968957|FG000|Overall Study|Adverse Event|15|||
145305325|NCT00824291|523968958|FG001|Overall Study|Adverse Event|6|||
145305326|NCT00824291|523968957|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
145305327|NCT00824291|523968958|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
145305328|NCT00824291|523968957|FG000|Overall Study|Lost to Follow-up|11|||
145305329|NCT00824291|523968958|FG001|Overall Study|Lost to Follow-up|9|||
145305330|NCT00824291|523968957|FG000|Overall Study|Non-compliance|1|||
145305331|NCT00824291|523968958|FG001|Overall Study|Non-compliance|1|||
145305332|NCT00824291|523968957|FG000|Overall Study|Protocol Violation|4|||
145305333|NCT00824291|523968958|FG001|Overall Study|Protocol Violation|1|||
145305334|NCT00824291|523968957|FG000|Overall Study|Withdrawal by Subject|14|||
145305335|NCT00824291|523968958|FG001|Overall Study|Withdrawal by Subject|8|||
145305336|NCT00824291|523968957|FG000|Overall Study|Lack of Efficacy|7|||
145305337|NCT00824291|523968958|FG001|Overall Study|Lack of Efficacy|8|||
145305338|NCT00824291|523968957|FG000|Overall Study|Participant on prohibited medication|1|||
145305339|NCT00824291|523968958|FG001|Overall Study|Participant on prohibited medication|0|||
145305340|NCT00123734|523968959|FG000|Overall Study|Death|3|||
145305341|NCT00123734|523968959|FG000|Overall Study|Lost to Follow-up|3|||
145305342|NCT00123734|523968959|FG000|Overall Study|Dropout|1|||
145305343|NCT00123734|523968959|FG000|Overall Study|Withdrawal by Subject|1|||
145305344|NCT00113386|523968960|FG000|Overall Study|Withdrawal by Subject|1|||
145305345|NCT00113386|523968961|FG001|Overall Study|Withdrawal by Subject|0|||
145305346|NCT00113386|523968960|FG000|Overall Study|Physician Decision|0|||
145568943|NCT02970968|524944145|FG001|Overall Study|Withdrawal by Subject|3|||
145568944|NCT02970968|524944144|FG000|Overall Study|Adverse Event|1|||
145568945|NCT02970968|524944145|FG001|Overall Study|Adverse Event|2|||
145305347|NCT00113386|523968961|FG001|Overall Study|Physician Decision|1|||
145305348|NCT00113386|523968960|FG000|Overall Study|Toxicity|3|||
145305349|NCT00113386|523968961|FG001|Overall Study|Toxicity|0|||
145305350|NCT00113386|523968960|FG000|Overall Study|Ineligible|1|||
145305351|NCT00113386|523968961|FG001|Overall Study|Ineligible|2|||
145305352|NCT00113386|523968960|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
145305353|NCT00113386|523968961|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
145305354|NCT01648582|523968962|FG000|Overall Study|Adverse Event|6|||
145305355|NCT01648582|523968963|FG001|Overall Study|Adverse Event|11|||
145305356|NCT01648582|523968964|FG002|Overall Study|Adverse Event|2|||
145305357|NCT01648582|523968962|FG000|Overall Study|Lost to Follow-up|9|||
145305358|NCT01648582|523968963|FG001|Overall Study|Lost to Follow-up|6|||
145305359|NCT01648582|523968964|FG002|Overall Study|Lost to Follow-up|8|||
145305360|NCT01648582|523968962|FG000|Overall Study|Protocol Violation|1|||
145305361|NCT01648582|523968963|FG001|Overall Study|Protocol Violation|2|||
145305362|NCT01648582|523968964|FG002|Overall Study|Protocol Violation|1|||
145305363|NCT01648582|523968962|FG000|Overall Study|Withdrawal by Subject|15|||
145305364|NCT01648582|523968963|FG001|Overall Study|Withdrawal by Subject|17|||
145305365|NCT01648582|523968964|FG002|Overall Study|Withdrawal by Subject|17|||
145305366|NCT01648582|523968962|FG000|Overall Study|Physician Decision|0|||
145305367|NCT01648582|523968963|FG001|Overall Study|Physician Decision|1|||
145305368|NCT01648582|523968964|FG002|Overall Study|Physician Decision|3|||
145305369|NCT01648582|523968962|FG000|Overall Study|Death|1|||
145305370|NCT01648582|523968963|FG001|Overall Study|Death|0|||
145305371|NCT01648582|523968964|FG002|Overall Study|Death|0|||
145305372|NCT01648582|523968962|FG000|Overall Study|Sponsor Decision|0|||
145305373|NCT01648582|523968963|FG001|Overall Study|Sponsor Decision|1|||
145305374|NCT01648582|523968964|FG002|Overall Study|Sponsor Decision|1|||
145305375|NCT03673670|523968965|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
145305376|NCT03673670|523968966|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
145305377|NCT03673670|523968967|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
145305378|NCT03673670|523968968|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
145305379|NCT03673670|523968969|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
145305380|NCT03673670|523968970|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
145305381|NCT03673670|523968965|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
145305382|NCT03673670|523968966|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
145305383|NCT03673670|523968967|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
145305384|NCT03673670|523968968|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
145305385|NCT03673670|523968969|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
145305386|NCT03673670|523968970|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
145305387|NCT03673670|523968965|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
145305388|NCT03673670|523968966|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
145305389|NCT03673670|523968967|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
145305390|NCT03673670|523968968|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
145305391|NCT03673670|523968969|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
145305392|NCT03673670|523968970|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
145305393|NCT03673670|523968965|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
145305394|NCT03673670|523968966|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
145305395|NCT03673670|523968967|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
145305396|NCT03673670|523968968|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
145305397|NCT03673670|523968969|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
145305398|NCT03673670|523968970|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
145305399|NCT03673670|523968965|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
145305400|NCT03673670|523968966|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
145305401|NCT03673670|523968967|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
145305402|NCT03673670|523968968|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
145305403|NCT03673670|523968969|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
145305404|NCT03673670|523968970|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
145305405|NCT03673670|523968965|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145305406|NCT03673670|523968966|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145305407|NCT03673670|523968967|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145305408|NCT03673670|523968968|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145305409|NCT03673670|523968969|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
145305410|NCT03673670|523968970|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
145305411|NCT03673670|523968965|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
145305412|NCT03673670|523968966|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
145305413|NCT03673670|523968967|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
145305414|NCT03673670|523968968|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
145305415|NCT03673670|523968969|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
145305416|NCT03673670|523968970|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
145568946|NCT02970968|524944144|FG000|Overall Study|Lost to Follow-up|1|||
145568947|NCT02970968|524944145|FG001|Overall Study|Lost to Follow-up|1|||
145568948|NCT02970968|524944144|FG000|Overall Study|Non-Compliance|0|||
145568949|NCT02970968|524944145|FG001|Overall Study|Non-Compliance|1|||
145568950|NCT05308901|524944146|FG000|Overall Study|Death|6|||
145568951|NCT03252522|524944147|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
145305417|NCT04408794|523968971|FG000|Overall Study|Adverse Event|43|||
145305418|NCT04408794|523968971|FG000|Overall Study|Infrequent study drug usage|43|||
145305419|NCT04408794|523968971|FG000|Overall Study|Lack of Efficacy|61|||
145305420|NCT04408794|523968971|FG000|Overall Study|Lost to Follow-up|33|||
145305421|NCT04408794|523968971|FG000|Overall Study|Non-compliance|6|||
145305422|NCT04408794|523968971|FG000|Overall Study|Physician Decision|1|||
145305423|NCT04408794|523968971|FG000|Overall Study|Pregnancy|6|||
145305424|NCT04408794|523968971|FG000|Overall Study|Protocol Deviation|9|||
145305425|NCT04408794|523968971|FG000|Overall Study|Sheehan-STS Result|1|||
145305426|NCT04408794|523968971|FG000|Overall Study|Withdrawal by Subject|57|||
145305427|NCT04408794|523968971|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
145305428|NCT04408794|523968971|FG000|Overall Study|Never Treated Migraine|5|||
145305429|NCT03437265|523968972|FG000|Overall Study|Protocol Violation|6|||
145305430|NCT01444378|523968979|FG000|Overall Study|Lost to Follow-up|1|||
145305431|NCT01444378|523968979|FG000|Overall Study|Withdrawal by Subject|1|||
145305432|NCT01444378|523968979|FG000|Overall Study|Death|3|||
145305433|NCT01444378|523968979|FG000|Overall Study|Administrative Closure Of The Study|2|||
145305434|NCT01444378|523968979|FG000|Overall Study|Missed Visits|10|||
145305435|NCT00556322|523968980|FG000|Overall Study|Insufficient therapeutic response|158|||
145305436|NCT00556322|523968981|FG001|Overall Study|Insufficient therapeutic response|168|||
145305437|NCT00556322|523968980|FG000|Overall Study|Adverse Event|7|||
145305438|NCT00556322|523968981|FG001|Overall Study|Adverse Event|4|||
145305439|NCT00556322|523968980|FG000|Overall Study|Other|4|||
145305440|NCT00556322|523968981|FG001|Overall Study|Other|1|||
145305441|NCT00556322|523968980|FG000|Overall Study|Lost to Follow-up|5|||
145305442|NCT00556322|523968981|FG001|Overall Study|Lost to Follow-up|3|||
145305443|NCT00556322|523968980|FG000|Overall Study|Withdrawal by Subject|19|||
145305444|NCT00556322|523968981|FG001|Overall Study|Withdrawal by Subject|7|||
145305445|NCT00556322|523968980|FG000|Overall Study|Protocol Violation|5|||
145305446|NCT00556322|523968981|FG001|Overall Study|Protocol Violation|1|||
145305447|NCT00556322|523968980|FG000|Overall Study|Ongoing at data cutoff|3|||
145305448|NCT00556322|523968981|FG001|Overall Study|Ongoing at data cutoff|5|||
145305449|NCT00556322|523968980|FG000|Overall Study|Death|20|||
145305450|NCT00556322|523968981|FG001|Overall Study|Death|14|||
145305451|NCT01788423|523968982|FG000|Overall Study|See Comments in Completed (above)|0|||
145305452|NCT01788423|523968983|FG001|Overall Study|See Comments in Completed (above)|4|||
145305453|NCT01788423|523968984|FG002|Overall Study|See Comments in Completed (above)|5|||
145305454|NCT03249454|523968985|FG000|Overall Study|Withdrawal by Subject|0|||
145305455|NCT03249454|523968986|FG001|Overall Study|Withdrawal by Subject|0|||
145305456|NCT03249454|523968987|FG002|Overall Study|Withdrawal by Subject|0|||
145305457|NCT03249454|523968988|FG003|Overall Study|Withdrawal by Subject|0|||
145305458|NCT03249454|523968989|FG004|Overall Study|Withdrawal by Subject|0|||
145305459|NCT03249454|523968990|FG005|Overall Study|Withdrawal by Subject|0|||
145305460|NCT03249454|523968991|FG006|Overall Study|Withdrawal by Subject|0|||
145305461|NCT03249454|523968992|FG007|Overall Study|Withdrawal by Subject|0|||
145305462|NCT03249454|523968993|FG008|Overall Study|Withdrawal by Subject|0|||
145305463|NCT03249454|523968994|FG009|Overall Study|Withdrawal by Subject|1|||
145305464|NCT03249454|523968995|FG010|Overall Study|Withdrawal by Subject|1|||
145305465|NCT01913405|523968996|FG000|Overall Study|Withdrawal by Subject|1|||
145305466|NCT01913405|523968996|FG000|Overall Study|Adverse Event|1|||
145305467|NCT03261167|523968999|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
145305468|NCT03261167|523969000|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
145305469|NCT03261167|523968999|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
145305470|NCT03261167|523969000|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
145305471|NCT03261167|523968999|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
145305472|NCT03261167|523969000|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
145305473|NCT03261167|523968999|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
145305474|NCT03261167|523969000|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
145305475|NCT03261167|523968999|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
145305476|NCT03261167|523969000|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
145305477|NCT01103713|523969003|FG000|Overall Study|Lost to Follow-up|2|||
145305478|NCT01103713|523969003|FG000|Overall Study|Withdrawal by Subject|8|||
145305479|NCT01103713|523969003|FG000|Overall Study|Study terminated by sponsor|2|||
145305480|NCT01103713|523969003|FG000|Overall Study|Other|1|||
145305481|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Adverse Event|11|||
145305482|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Adverse Event|23|||
145305483|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Adverse Event|29|||
145568952|NCT03252522|524944148|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
145568953|NCT03252522|524944149|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
145620334|NCT00996580|525123741|FG000|Overall Study|Pregnancy|68|||
145305484|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Adverse Event|2|||
145305485|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Adverse Event|8|||
145305486|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
145305487|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
145305488|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
145305489|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
145305490|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
145305491|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
145305492|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
145305493|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
145305494|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
145305495|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
145305496|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
145305497|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
145305498|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
145305499|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
145305500|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
145305501|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
145305502|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
145305503|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
145305504|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
145305505|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
145305506|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
145305507|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
145305508|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
145305509|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
145305510|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
145305511|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
145305512|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
145305513|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
145305514|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
145305515|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
145305516|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Move|0|||
145305517|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Move|1|||
145305518|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Move|0|||
145305519|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Move|0|||
145305520|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Move|0|||
145305521|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
145305522|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
145305523|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
145305524|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
145305525|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
145305526|NCT00318461|523969006|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
145305527|NCT00318461|523969007|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
145305528|NCT00318461|523969008|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
145305529|NCT00318461|523969009|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
145305530|NCT00318461|523969010|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
145305531|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Work commitment|0|||
145305532|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Work commitment|0|||
145305533|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Work commitment|0|||
145305534|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Work commitment|0|||
145305535|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Work commitment|1|||
145305536|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Investigator decision|0|||
145305537|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Investigator decision|0|||
145305538|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Investigator decision|0|||
145305539|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Investigator decision|0|||
145305540|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Investigator decision|1|||
145305541|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Lack of time|1|||
145305542|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Lack of time|0|||
145305543|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Lack of time|0|||
145305544|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Lack of time|0|||
145305545|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Lack of time|0|||
145305546|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
145305547|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
145305548|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
145305549|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
145305550|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
145305551|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
145568954|NCT03252522|524944147|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
145305552|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
145305553|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
145305554|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
145305555|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
145305556|NCT00318461|523969006|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
145305557|NCT00318461|523969007|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
145305558|NCT00318461|523969008|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
145305559|NCT00318461|523969009|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
145305560|NCT00318461|523969010|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
145305561|NCT00318461|523969006|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
145305562|NCT00318461|523969007|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
145305563|NCT00318461|523969008|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
145305564|NCT00318461|523969009|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
145305565|NCT00318461|523969010|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
145305566|NCT00318461|523969006|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
145305567|NCT00318461|523969007|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
145305568|NCT00318461|523969008|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
145305569|NCT00318461|523969009|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
145305570|NCT00318461|523969010|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
145305571|NCT00318461|523969006|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
145305572|NCT00318461|523969007|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
145305573|NCT00318461|523969008|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
145305574|NCT00318461|523969009|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
145305575|NCT00318461|523969010|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
145305576|NCT00318461|523969006|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
145305577|NCT00318461|523969007|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
145305578|NCT00318461|523969008|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
145305579|NCT00318461|523969009|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
145305580|NCT00318461|523969010|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
145305581|NCT00318461|523969006|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
145305582|NCT00318461|523969007|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
145305583|NCT00318461|523969008|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
145305584|NCT00318461|523969009|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
145305585|NCT00318461|523969010|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
145305586|NCT01848938|523969019|FG000|Overall Study|Lost to Follow-up|1|||
145305587|NCT01848938|523969020|FG001|Overall Study|Lost to Follow-up|1|||
145305588|NCT01757392|523969021|FG000|Overall Study|Withdrawal by Subject|1|||
145305589|NCT01757392|523969021|FG000|Overall Study|Screen Fail|3|||
145305590|NCT00207090|523969026|FG000|Overall Study|Study drug toxicity|3|||
145305591|NCT00207090|523969026|FG000|Overall Study|Chest wall mass larger|1|||
145305592|NCT00207090|523969026|FG000|Overall Study|Disease progression/relapse|2|||
145305593|NCT00207090|523969026|FG000|Overall Study|Physician Decision|1|||
145305594|NCT00841698|523969029|FG000|First Intervention|Withdrawal by Subject|1|||
145305595|NCT00841698|523969030|FG001|First Intervention|Withdrawal by Subject|0|||
145305596|NCT01929863|523969035|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
145305597|NCT01929863|523969036|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
145305598|NCT01929863|523969035|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
145305599|NCT01929863|523969036|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
145305600|NCT01929863|523969035|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
145305601|NCT01929863|523969036|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
145305602|NCT00251979|523969037|FG000|Overall Study|Protocol Violation|3|||
145305603|NCT00251979|523969038|FG001|Overall Study|Protocol Violation|5|||
145305604|NCT00251979|523969037|FG000|Overall Study|Adverse Event|11|||
145305605|NCT00251979|523969038|FG001|Overall Study|Adverse Event|17|||
145305606|NCT00251979|523969037|FG000|Overall Study|Withdrawal by Subject|13|||
145305607|NCT00251979|523969038|FG001|Overall Study|Withdrawal by Subject|7|||
145305608|NCT00251979|523969037|FG000|Overall Study|Lost to Follow-up|8|||
145305609|NCT00251979|523969038|FG001|Overall Study|Lost to Follow-up|6|||
145305610|NCT00251979|523969037|FG000|Overall Study|Death|3|||
145305611|NCT00251979|523969038|FG001|Overall Study|Death|5|||
145305612|NCT01878292|523969046|FG000|Randomized|Protocol Violation|1|||
145410994|NCT01525589|524356912|FG001|Overall Study|Withdrawal by Subject|1|||
145305613|NCT01878292|523969047|FG001|Randomized|Protocol Violation|0|||
145305614|NCT01878292|523969048|FG002|Randomized|Protocol Violation|0|||
145410995|NCT01525589|524356913|FG002|Overall Study|Withdrawal by Subject|0|||
145305615|NCT01878292|523969046|FG000|Randomized|Lost to Follow-up|1|||
145305616|NCT01878292|523969047|FG001|Randomized|Lost to Follow-up|0|||
145410996|NCT04611126|524356914|FG000|Overall Study|TIL expansion unsuccessful|1|||
145305617|NCT01878292|523969048|FG002|Randomized|Lost to Follow-up|0|||
145305618|NCT01878292|523969046|FG000|Randomized|Adverse Event|1|||
145305619|NCT01878292|523969047|FG001|Randomized|Adverse Event|0|||
145305620|NCT01878292|523969048|FG002|Randomized|Adverse Event|0|||
145305621|NCT01878292|523969046|FG000|Double-blind Treatment Period|Other Reasons|2|||
145305622|NCT01878292|523969047|FG001|Double-blind Treatment Period|Other Reasons|0|||
145305623|NCT01878292|523969048|FG002|Double-blind Treatment Period|Other Reasons|0|||
145305624|NCT01878292|523969046|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
145305625|NCT01878292|523969047|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
145305626|NCT01878292|523969048|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
145305627|NCT01878292|523969046|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
145305628|NCT01878292|523969047|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
145305629|NCT01878292|523969048|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
145305630|NCT01878292|523969046|FG000|Double-blind Treatment Period|Protocol Violation|3|||
145305631|NCT01878292|523969047|FG001|Double-blind Treatment Period|Protocol Violation|4|||
145305632|NCT01878292|523969048|FG002|Double-blind Treatment Period|Protocol Violation|2|||
145305633|NCT01878292|523969046|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
145305634|NCT01878292|523969047|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
145305635|NCT01878292|523969048|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
145305636|NCT01878292|523969046|FG000|Double-blind Treatment Period|Adverse Event|4|||
145305637|NCT01878292|523969047|FG001|Double-blind Treatment Period|Adverse Event|9|||
145305638|NCT01878292|523969048|FG002|Double-blind Treatment Period|Adverse Event|8|||
145305639|NCT01878292|523969046|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
145305640|NCT01878292|523969047|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
145305641|NCT01878292|523969048|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
145305642|NCT00830024|523969051|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145305643|NCT00830024|523969052|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145305644|NCT00730691|523969053|FG000|Overall Study|Adverse Event|4|||
145305645|NCT00730691|523969054|FG001|Overall Study|Adverse Event|8|||
145305646|NCT00730691|523969055|FG002|Overall Study|Adverse Event|11|||
145305647|NCT00730691|523969056|FG003|Overall Study|Adverse Event|11|||
145305648|NCT00730691|523969057|FG004|Overall Study|Adverse Event|23|||
145305649|NCT00730691|523969053|FG000|Overall Study|Lack of Efficacy|4|||
145305650|NCT00730691|523969054|FG001|Overall Study|Lack of Efficacy|4|||
145305651|NCT00730691|523969055|FG002|Overall Study|Lack of Efficacy|2|||
145305652|NCT00730691|523969056|FG003|Overall Study|Lack of Efficacy|1|||
145305653|NCT00730691|523969057|FG004|Overall Study|Lack of Efficacy|1|||
145305654|NCT00730691|523969053|FG000|Overall Study|Non-compliance with Study Drug|6|||
145305655|NCT00730691|523969054|FG001|Overall Study|Non-compliance with Study Drug|1|||
145305656|NCT00730691|523969055|FG002|Overall Study|Non-compliance with Study Drug|6|||
145305657|NCT00730691|523969056|FG003|Overall Study|Non-compliance with Study Drug|3|||
145305658|NCT00730691|523969057|FG004|Overall Study|Non-compliance with Study Drug|3|||
145305659|NCT00730691|523969053|FG000|Overall Study|Protocol Deviations|3|||
145305660|NCT00730691|523969054|FG001|Overall Study|Protocol Deviations|5|||
145305661|NCT00730691|523969055|FG002|Overall Study|Protocol Deviations|3|||
145305662|NCT00730691|523969056|FG003|Overall Study|Protocol Deviations|7|||
145305663|NCT00730691|523969057|FG004|Overall Study|Protocol Deviations|5|||
145305664|NCT00730691|523969053|FG000|Overall Study|Withdrawal of Consent|7|||
145305665|NCT00730691|523969054|FG001|Overall Study|Withdrawal of Consent|9|||
145305666|NCT00730691|523969055|FG002|Overall Study|Withdrawal of Consent|3|||
145305667|NCT00730691|523969056|FG003|Overall Study|Withdrawal of Consent|6|||
145305668|NCT00730691|523969057|FG004|Overall Study|Withdrawal of Consent|3|||
145305669|NCT00730691|523969053|FG000|Overall Study|Lost to Follow-up|11|||
145305670|NCT00730691|523969054|FG001|Overall Study|Lost to Follow-up|8|||
145305671|NCT00730691|523969055|FG002|Overall Study|Lost to Follow-up|13|||
145305672|NCT00730691|523969056|FG003|Overall Study|Lost to Follow-up|15|||
145305673|NCT00730691|523969057|FG004|Overall Study|Lost to Follow-up|13|||
145305674|NCT00730691|523969053|FG000|Overall Study|Other|1|||
145305675|NCT00730691|523969054|FG001|Overall Study|Other|1|||
145305676|NCT00730691|523969055|FG002|Overall Study|Other|1|||
145305677|NCT00730691|523969056|FG003|Overall Study|Other|2|||
145305678|NCT00730691|523969057|FG004|Overall Study|Other|2|||
145305679|NCT02178787|523969058|FG000|Overall Study|Lost to Follow-up|1|||
145305680|NCT02178787|523969059|FG001|Overall Study|Lost to Follow-up|0|||
145305681|NCT02178787|523969058|FG000|Overall Study|Withdrawal by Subject|0|||
145305682|NCT02178787|523969059|FG001|Overall Study|Withdrawal by Subject|2|||
145305683|NCT02178787|523969058|FG000|Overall Study|No TCD window|3|||
145305684|NCT02178787|523969059|FG001|Overall Study|No TCD window|7|||
145305685|NCT02178787|523969058|FG000|Overall Study|Physician Decision|1|||
145305686|NCT02178787|523969059|FG001|Overall Study|Physician Decision|0|||
145305687|NCT02554890|523969060|FG000|Double-blind|Adverse Event|45|||
145305688|NCT02554890|523969061|FG001|Double-blind|Adverse Event|51|||
145305689|NCT02554890|523969060|FG000|Double-blind|Death|6|||
145305690|NCT02554890|523969061|FG001|Double-blind|Death|4|||
145305691|NCT02554890|523969060|FG000|Double-blind|Protocol Violation|1|||
145305692|NCT02554890|523969061|FG001|Double-blind|Protocol Violation|1|||
145305693|NCT02554890|523969060|FG000|Double-blind|Physician Decision|4|||
145305694|NCT02554890|523969061|FG001|Double-blind|Physician Decision|3|||
145305695|NCT02554890|523969060|FG000|Double-blind|Subject/Guardian decision|21|||
145305696|NCT02554890|523969061|FG001|Double-blind|Subject/Guardian decision|16|||
145305697|NCT02554890|523969060|FG000|Double-blind|Lost to Follow-up|7|||
145305698|NCT02554890|523969061|FG001|Double-blind|Lost to Follow-up|5|||
145305699|NCT02554890|523969060|FG000|Double-blind|Technical problems|1|||
145305700|NCT02554890|523969061|FG001|Double-blind|Technical problems|0|||
145305701|NCT02554890|523969060|FG000|Double-blind|Withdrawal by Subject|5|||
145305702|NCT02554890|523969061|FG001|Double-blind|Withdrawal by Subject|6|||
145305703|NCT02554890|523969060|FG000|Double-blind|Noncompliance with study treatment|6|||
145305704|NCT02554890|523969061|FG001|Double-blind|Noncompliance with study treatment|5|||
145305705|NCT02554890|523969060|FG000|Open-label|Adverse Event|0|||
145305706|NCT02554890|523969061|FG001|Open-label|Adverse Event|30|||
145305707|NCT02554890|523969060|FG000|Open-label|Death|0|||
145305708|NCT02554890|523969061|FG001|Open-label|Death|1|||
145305709|NCT02554890|523969060|FG000|Open-label|Physician Decision|0|||
145305710|NCT02554890|523969061|FG001|Open-label|Physician Decision|1|||
145305711|NCT02554890|523969060|FG000|Open-label|Subject/Guardian decision|0|||
145305712|NCT02554890|523969061|FG001|Open-label|Subject/Guardian decision|11|||
145305713|NCT02554890|523969060|FG000|Open-label|Lost to Follow-up|0|||
145305714|NCT02554890|523969061|FG001|Open-label|Lost to Follow-up|7|||
145305715|NCT02554890|523969060|FG000|Open-label|Technical problems|0|||
145305716|NCT02554890|523969061|FG001|Open-label|Technical problems|1|||
145305717|NCT02554890|523969060|FG000|Open-label|Withdrawal by Subject|0|||
145305718|NCT02554890|523969061|FG001|Open-label|Withdrawal by Subject|1|||
145305719|NCT00682461|523970314|FG000|Overall Study|Adverse Event|5|||
145305720|NCT00682461|523970315|FG001|Overall Study|Adverse Event|7|||
145305721|NCT00682461|523970314|FG000|Overall Study|Lost to Follow-up|8|||
145305722|NCT00682461|523970315|FG001|Overall Study|Lost to Follow-up|5|||
145305723|NCT00682461|523970314|FG000|Overall Study|Withdrawal by Subject|12|||
145305724|NCT00682461|523970315|FG001|Overall Study|Withdrawal by Subject|19|||
145305725|NCT00835705|523970317|FG000|First Intervention|Difficulty with vein|1|||
145305726|NCT00835705|523970318|FG001|First Intervention|Difficulty with vein|0|||
145305727|NCT00835705|523970317|FG000|Second Intervention|Difficulty with vein|1|||
145305728|NCT00835705|523970318|FG001|Second Intervention|Difficulty with vein|0|||
145305729|NCT01750294|523970319|FG000|Overall Study|Withdrawal by Subject|1|||
145305730|NCT01750294|523970319|FG000|Overall Study|Safety Endpoint|1|||
145305731|NCT04035187|523970320|FG000|Overall Study|Withdrawal by Subject|2|||
145305732|NCT04035187|523970321|FG001|Overall Study|Withdrawal by Subject|1|||
145305733|NCT04035187|523970322|FG002|Overall Study|Withdrawal by Subject|0|||
145305734|NCT04035187|523970323|FG003|Overall Study|Withdrawal by Subject|0|||
145305735|NCT04035187|523970320|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
145305736|NCT04035187|523970321|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
145305737|NCT04035187|523970322|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
145305738|NCT04035187|523970323|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
145305739|NCT01116739|523970324|FG000|Overall Study|Child had 2 years of HS|110|||
145305740|NCT01116739|523970325|FG001|Overall Study|Child had 2 years of HS|128|||
145305741|NCT01116739|523970324|FG000|Overall Study|Withdrawal by Subject|6|||
145305742|NCT01116739|523970325|FG001|Overall Study|Withdrawal by Subject|0|||
145305743|NCT01116739|523970324|FG000|Overall Study|child too young|2|||
145305744|NCT01116739|523970325|FG001|Overall Study|child too young|6|||
145305745|NCT01116739|523970324|FG000|Overall Study|child not enrolled in head start|10|||
145305746|NCT01116739|523970325|FG001|Overall Study|child not enrolled in head start|2|||
145305747|NCT01116739|523970324|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
145305748|NCT01116739|523970325|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
145305749|NCT01624233|523970326|FG000|Period 2 - Induction|Adverse Event|1|||
145305750|NCT01624233|523970326|FG000|Period 3 - Maintenance|Adverse Event|2|||
145305751|NCT01624233|523970326|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
145305752|NCT01624233|523970326|FG000|Period 3 - Maintenance|Physician Decision|2|||
145305753|NCT01624233|523970326|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
145305754|NCT01624233|523970326|FG000|Period 4 - Drug Free Period|Relapsed|61|||
145305755|NCT01624233|523970326|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
145305756|NCT01624233|523970326|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
145305757|NCT01624233|523970326|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
145305758|NCT01624233|523970326|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
145305759|NCT01624233|523970326|FG000|Period 6: Follow-up|Adverse Event|3|||
145305760|NCT01624233|523970326|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
145305761|NCT01624233|523970326|FG000|Period 6: Follow-up|Physician Decision|1|||
145305762|NCT01624233|523970326|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
145305763|NCT05090839|523970329|FG000|Overall Study|Lost to Follow-up|2|||
145305764|NCT05090839|523970330|FG001|Overall Study|Lost to Follow-up|3|||
145305765|NCT05090839|523970331|FG002|Overall Study|Lost to Follow-up|1|||
145305766|NCT05090839|523970332|FG003|Overall Study|Lost to Follow-up|1|||
145305767|NCT05710718|523970333|FG000|Overall Study|Withdrawal by Subject|5|||
145305768|NCT05710718|523970334|FG001|Overall Study|Withdrawal by Subject|1|||
145305769|NCT05710718|523970333|FG000|Overall Study|Lost to Follow-up|0|||
145305770|NCT05710718|523970334|FG001|Overall Study|Lost to Follow-up|1|||
145568955|NCT03252522|524944148|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
145305771|NCT05710718|523970333|FG000|Overall Study|Death|0|||
145305772|NCT05710718|523970334|FG001|Overall Study|Death|1|||
145305773|NCT01528696|523970336|FG000|Overall Study|See detailed description|18|||
145568956|NCT03252522|524944149|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
145568957|NCT03252522|524944147|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
145305774|NCT01528696|523970337|FG001|Overall Study|See detailed description|19|||
145305775|NCT01056484|523970338|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
145305776|NCT01056484|523970339|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
145305777|NCT01056484|523970338|FG000|Randomized Controlled Trial|Physician Decision|1|||
145305778|NCT01056484|523970339|FG001|Randomized Controlled Trial|Physician Decision|0|||
145305779|NCT01056484|523970338|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
145305780|NCT01056484|523970339|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
145305781|NCT00835575|523970341|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
145305782|NCT00835575|523970342|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
145305783|NCT03606174|523970347|FG000|Overall Study|Death|37|||
145305784|NCT03606174|523970348|FG001|Overall Study|Death|15|||
145305785|NCT03606174|523970349|FG002|Overall Study|Death|15|||
145305786|NCT03606174|523970350|FG003|Overall Study|Death|7|||
145305787|NCT03606174|523970351|FG004|Overall Study|Death|35|||
145305788|NCT03606174|523970352|FG005|Overall Study|Death|12|||
145305789|NCT03606174|523970353|FG006|Overall Study|Death|35|||
145305790|NCT03606174|523970354|FG007|Overall Study|Death|8|||
145305791|NCT03606174|523970355|FG008|Overall Study|Death|5|||
145305792|NCT03606174|523970356|FG009|Overall Study|Death|3|||
145305793|NCT03606174|523970357|FG010|Overall Study|Death|0|||
145305794|NCT03606174|523970347|FG000|Overall Study|Lost to Follow-up|0|||
145305795|NCT03606174|523970348|FG001|Overall Study|Lost to Follow-up|0|||
145305796|NCT03606174|523970349|FG002|Overall Study|Lost to Follow-up|0|||
145305797|NCT03606174|523970350|FG003|Overall Study|Lost to Follow-up|0|||
145305798|NCT03606174|523970351|FG004|Overall Study|Lost to Follow-up|1|||
145305799|NCT03606174|523970352|FG005|Overall Study|Lost to Follow-up|1|||
145305800|NCT03606174|523970353|FG006|Overall Study|Lost to Follow-up|0|||
145305801|NCT03606174|523970354|FG007|Overall Study|Lost to Follow-up|0|||
145305802|NCT03606174|523970355|FG008|Overall Study|Lost to Follow-up|0|||
145305803|NCT03606174|523970356|FG009|Overall Study|Lost to Follow-up|0|||
145305804|NCT03606174|523970357|FG010|Overall Study|Lost to Follow-up|0|||
145305805|NCT03606174|523970347|FG000|Overall Study|Withdrawal by Subject|6|||
145305806|NCT03606174|523970348|FG001|Overall Study|Withdrawal by Subject|0|||
145305807|NCT03606174|523970349|FG002|Overall Study|Withdrawal by Subject|0|||
145305808|NCT03606174|523970350|FG003|Overall Study|Withdrawal by Subject|1|||
145305809|NCT03606174|523970351|FG004|Overall Study|Withdrawal by Subject|2|||
145305810|NCT03606174|523970352|FG005|Overall Study|Withdrawal by Subject|1|||
145305811|NCT03606174|523970353|FG006|Overall Study|Withdrawal by Subject|4|||
145305812|NCT03606174|523970354|FG007|Overall Study|Withdrawal by Subject|0|||
145305813|NCT03606174|523970355|FG008|Overall Study|Withdrawal by Subject|0|||
145305814|NCT03606174|523970356|FG009|Overall Study|Withdrawal by Subject|0|||
145305815|NCT03606174|523970357|FG010|Overall Study|Withdrawal by Subject|1|||
145305816|NCT03606174|523970347|FG000|Overall Study|Study Terminated by Sponsor|5|||
145305817|NCT03606174|523970348|FG001|Overall Study|Study Terminated by Sponsor|7|||
145305818|NCT03606174|523970349|FG002|Overall Study|Study Terminated by Sponsor|3|||
145305819|NCT03606174|523970350|FG003|Overall Study|Study Terminated by Sponsor|0|||
145305820|NCT03606174|523970351|FG004|Overall Study|Study Terminated by Sponsor|11|||
145305821|NCT03606174|523970352|FG005|Overall Study|Study Terminated by Sponsor|6|||
145305822|NCT03606174|523970353|FG006|Overall Study|Study Terminated by Sponsor|12|||
145305823|NCT03606174|523970354|FG007|Overall Study|Study Terminated by Sponsor|1|||
145305824|NCT03606174|523970355|FG008|Overall Study|Study Terminated by Sponsor|3|||
145568958|NCT03252522|524944148|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
145568959|NCT03252522|524944149|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
145568960|NCT03252522|524944147|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
145568961|NCT03252522|524944148|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
145568962|NCT03252522|524944149|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
145305825|NCT03606174|523970356|FG009|Overall Study|Study Terminated by Sponsor|1|||
145305826|NCT03606174|523970357|FG010|Overall Study|Study Terminated by Sponsor|2|||
145305827|NCT03606174|523970347|FG000|Overall Study|Miscellaneous|1|||
145305828|NCT03606174|523970348|FG001|Overall Study|Miscellaneous|1|||
145305829|NCT03606174|523970349|FG002|Overall Study|Miscellaneous|0|||
145568963|NCT03252522|524944147|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
145305830|NCT03606174|523970350|FG003|Overall Study|Miscellaneous|1|||
145305831|NCT03606174|523970351|FG004|Overall Study|Miscellaneous|4|||
145305832|NCT03606174|523970352|FG005|Overall Study|Miscellaneous|7|||
145305833|NCT03606174|523970353|FG006|Overall Study|Miscellaneous|5|||
145305834|NCT03606174|523970354|FG007|Overall Study|Miscellaneous|0|||
145568964|NCT03252522|524944148|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
145305835|NCT03606174|523970355|FG008|Overall Study|Miscellaneous|0|||
145305836|NCT03606174|523970356|FG009|Overall Study|Miscellaneous|0|||
145305837|NCT03606174|523970357|FG010|Overall Study|Miscellaneous|1|||
145305838|NCT05014828|523970360|FG000|Overall Study|Study Completed by Sponsor|16|||
145305839|NCT05014828|523970361|FG001|Overall Study|Study Completed by Sponsor|16|||
145305840|NCT05014828|523970362|FG002|Overall Study|Study Completed by Sponsor|3|||
145305841|NCT05014828|523970363|FG003|Overall Study|Study Completed by Sponsor|3|||
145305842|NCT05014828|523970360|FG000|Overall Study|Death|11|||
145305843|NCT05014828|523970361|FG001|Overall Study|Death|6|||
145305844|NCT05014828|523970362|FG002|Overall Study|Death|0|||
145305845|NCT05014828|523970363|FG003|Overall Study|Death|0|||
145305846|NCT05014828|523970360|FG000|Overall Study|Lost to Follow-up|0|||
145305847|NCT05014828|523970361|FG001|Overall Study|Lost to Follow-up|0|||
145305848|NCT05014828|523970362|FG002|Overall Study|Lost to Follow-up|2|||
145305849|NCT05014828|523970363|FG003|Overall Study|Lost to Follow-up|0|||
145305850|NCT05014828|523970360|FG000|Overall Study|Miscellaneous.|0|||
145305851|NCT05014828|523970361|FG001|Overall Study|Miscellaneous.|1|||
145305852|NCT05014828|523970362|FG002|Overall Study|Miscellaneous.|0|||
145305853|NCT05014828|523970363|FG003|Overall Study|Miscellaneous.|0|||
145305854|NCT02911792|523970366|FG000|Overall Study|Lost to Follow-up|3|||
145305855|NCT02911792|523970367|FG001|Overall Study|Lost to Follow-up|3|||
145305856|NCT02911792|523970368|FG002|Overall Study|Lost to Follow-up|3|||
145305857|NCT02911792|523970369|FG003|Overall Study|Lost to Follow-up|3|||
145305858|NCT00927069|523970370|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
145305859|NCT00927069|523970371|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
145305860|NCT00927069|523970372|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
145305861|NCT00927069|523970373|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
145305862|NCT00927069|523970370|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
145305863|NCT00927069|523970371|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
145305864|NCT00927069|523970372|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
145305865|NCT00927069|523970373|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
145305866|NCT00927069|523970370|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
145305867|NCT00927069|523970371|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
145305868|NCT00927069|523970372|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
145568965|NCT03252522|524944149|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
145568966|NCT03252522|524944147|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
145568967|NCT03252522|524944148|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
145305869|NCT00927069|523970373|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
145305870|NCT00927069|523970370|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
145305871|NCT00927069|523970371|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
145305872|NCT00927069|523970372|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
145305873|NCT00927069|523970373|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
145305874|NCT00927069|523970370|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
145305875|NCT00927069|523970371|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
145305876|NCT00927069|523970372|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
145305877|NCT00927069|523970373|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
145305878|NCT03199963|523970377|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
145305879|NCT03199963|523970378|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
145305880|NCT03199963|523970377|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
145305881|NCT03199963|523970378|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
145305882|NCT03199963|523970377|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
145305883|NCT03199963|523970378|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
145568968|NCT03252522|524944149|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
145568969|NCT03252522|524944147|FG000|Phase 2: Open Label|Adverse Event|0|||
145305884|NCT03199963|523970377|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
145305885|NCT03199963|523970378|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
145305886|NCT03199963|523970377|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
145568970|NCT03252522|524944148|FG001|Phase 2: Open Label|Adverse Event|0|||
145568971|NCT03252522|524944149|FG002|Phase 2: Open Label|Adverse Event|2|||
145568972|NCT03252522|524944147|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
145568973|NCT03252522|524944148|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
145568974|NCT03252522|524944149|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
145568975|NCT01940120|524944153|FG000|Overall Study|Death|40|||
145568976|NCT01940120|524944153|FG000|Overall Study|Withdrawal by Subject|8|||
145568977|NCT03277846|524944154|FG000|Overall Study|Inpatient stay too brief|12|||
145568978|NCT03277846|524944155|FG001|Overall Study|Inpatient stay too brief|11|||
145305887|NCT03199963|523970378|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
145305888|NCT03199963|523970377|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
145305889|NCT03199963|523970378|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
145305890|NCT00107991|523970381|FG000|Eligibility Assessment|Disease not severe enough|7|||
145305891|NCT00107991|523970381|FG000|Eligibility Assessment|Unwilling to participate|7|||
145305892|NCT00107991|523970381|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
145568979|NCT02554656|524944156|FG000|Overall Study|Protocol Violation|3|||
145568980|NCT03240575|524944157|FG000|Overall Study|Adverse Event|0|||
145568981|NCT03240575|524944158|FG001|Overall Study|Adverse Event|2|||
145568982|NCT03240575|524944159|FG002|Overall Study|Adverse Event|0|||
145568983|NCT03240575|524944160|FG003|Overall Study|Adverse Event|1|||
145305893|NCT00107991|523970381|FG000|Eligibility Assessment|Abnormal labs|2|||
145305894|NCT00107991|523970381|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
145305895|NCT00107991|523970381|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
145305896|NCT00107991|523970381|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
145305897|NCT00107991|523970381|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
145305898|NCT00107991|523970381|FG000|12 Week Treatment Period|Adverse Event|1|||
145305899|NCT00107991|523970381|FG000|12 Week Treatment Period|Protocol Violation|1|||
145305900|NCT00107991|523970381|FG000|12 Week Treatment Period|Incarcerated|1|||
145305901|NCT00107991|523970381|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
145305902|NCT01535222|523970382|FG000|Overall Study|Inclusion/exclusion|0|||
145305903|NCT01535222|523970383|FG001|Overall Study|Inclusion/exclusion|0|||
145305904|NCT01535222|523970384|FG002|Overall Study|Inclusion/exclusion|1|||
145305905|NCT01535222|523970385|FG003|Overall Study|Inclusion/exclusion|0|||
145305906|NCT01535222|523970386|FG004|Overall Study|Inclusion/exclusion|0|||
145305907|NCT01535222|523970387|FG005|Overall Study|Inclusion/exclusion|0|||
145305908|NCT03669861|523970388|FG000|Overall Study|Disease Flare|5|||
145305909|NCT03669861|523970388|FG000|Overall Study|Lack of Efficacy|2|||
145305910|NCT02760927|523970389|FG000|Overall Study|Tube Slippage from Device|1|||
145305911|NCT03256695|523970390|FG000|Overall Study|Adverse Event|8|||
145305912|NCT03256695|523970390|FG000|Overall Study|Death|2|||
145305913|NCT03256695|523970390|FG000|Overall Study|Withdrawal by Subject|14|||
145305914|NCT03256695|523970390|FG000|Overall Study|Non-compliance with study drug|1|||
145305915|NCT03256695|523970390|FG000|Overall Study|Lost to Follow-up|3|||
145305916|NCT03256695|523970390|FG000|Overall Study|Lack of Efficacy|3|||
145305917|NCT03256695|523970390|FG000|Overall Study|Protocol Violation|5|||
145305918|NCT03256695|523970390|FG000|Overall Study|Other than specified|3|||
145305919|NCT03930732|523970391|FG000|Overall Study|Adverse Event|9|||
145305920|NCT03930732|523970392|FG001|Overall Study|Adverse Event|7|||
145305921|NCT03930732|523970391|FG000|Overall Study|Poor compliance to protocol|0|||
145305922|NCT03930732|523970392|FG001|Overall Study|Poor compliance to protocol|1|||
145305923|NCT03930732|523970391|FG000|Overall Study|Withdrawal by Subject|23|||
145305924|NCT03930732|523970392|FG001|Overall Study|Withdrawal by Subject|11|||
145305925|NCT03930732|523970391|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
145305926|NCT03930732|523970392|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
145305927|NCT03930732|523970391|FG000|Overall Study|Other reason not related to COVID-19|5|||
145305928|NCT03930732|523970392|FG001|Overall Study|Other reason not related to COVID-19|8|||
145305929|NCT02645409|523970399|FG000|Overall Study|Withdrawal by Subject|3|||
145305930|NCT02645409|523970400|FG001|Overall Study|Withdrawal by Subject|0|||
145305931|NCT02645409|523970399|FG000|Overall Study|Physician Decision|1|||
145305932|NCT02645409|523970400|FG001|Overall Study|Physician Decision|0|||
145305933|NCT02089685|523970405|FG000|Overall Study|Adverse Event|1|||
145305934|NCT02089685|523970406|FG001|Overall Study|Adverse Event|0|||
145305935|NCT02089685|523970407|FG002|Overall Study|Adverse Event|0|||
145305936|NCT02089685|523970408|FG003|Overall Study|Adverse Event|0|||
145305937|NCT02089685|523970409|FG004|Overall Study|Adverse Event|1|||
145305938|NCT02089685|523970410|FG005|Overall Study|Adverse Event|0|||
145305939|NCT02089685|523970405|FG000|Overall Study|Clinical Progression|4|||
145305940|NCT02089685|523970406|FG001|Overall Study|Clinical Progression|0|||
145305941|NCT02089685|523970407|FG002|Overall Study|Clinical Progression|0|||
145305942|NCT02089685|523970408|FG003|Overall Study|Clinical Progression|5|||
145305943|NCT02089685|523970409|FG004|Overall Study|Clinical Progression|1|||
145305944|NCT02089685|523970410|FG005|Overall Study|Clinical Progression|2|||
145305945|NCT02089685|523970405|FG000|Overall Study|Excluded Medication|1|||
145305946|NCT02089685|523970406|FG001|Overall Study|Excluded Medication|0|||
145305947|NCT02089685|523970407|FG002|Overall Study|Excluded Medication|0|||
145568984|NCT03240575|524944157|FG000|Overall Study|Withdrawal by Subject|2|||
145568985|NCT03240575|524944158|FG001|Overall Study|Withdrawal by Subject|11|||
145568986|NCT03240575|524944159|FG002|Overall Study|Withdrawal by Subject|0|||
145568987|NCT03240575|524944160|FG003|Overall Study|Withdrawal by Subject|1|||
145568988|NCT03240575|524944157|FG000|Overall Study|Other|0|||
145568989|NCT03240575|524944158|FG001|Overall Study|Other|1|||
145568990|NCT03240575|524944159|FG002|Overall Study|Other|0|||
145620335|NCT00996580|525123741|FG000|Overall Study|Protocol Violation|16|||
145305948|NCT02089685|523970408|FG003|Overall Study|Excluded Medication|11|||
145305949|NCT02089685|523970409|FG004|Overall Study|Excluded Medication|2|||
145305950|NCT02089685|523970410|FG005|Overall Study|Excluded Medication|1|||
145568991|NCT03240575|524944160|FG003|Overall Study|Other|0|||
145568992|NCT01904604|524944163|FG000|Overall Study|Withdrew before receiving dosing|0|||
145620336|NCT00996580|525123741|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
145305951|NCT02089685|523970405|FG000|Overall Study|Progressive disease|13|||
145305952|NCT02089685|523970406|FG001|Overall Study|Progressive disease|10|||
145305953|NCT02089685|523970407|FG002|Overall Study|Progressive disease|3|||
145305954|NCT02089685|523970408|FG003|Overall Study|Progressive disease|51|||
145305955|NCT02089685|523970409|FG004|Overall Study|Progressive disease|17|||
145305956|NCT02089685|523970410|FG005|Overall Study|Progressive disease|12|||
145305957|NCT02089685|523970405|FG000|Overall Study|Follow up ended by sponsor|2|||
145305958|NCT02089685|523970406|FG001|Overall Study|Follow up ended by sponsor|2|||
145305959|NCT02089685|523970407|FG002|Overall Study|Follow up ended by sponsor|0|||
145305960|NCT02089685|523970408|FG003|Overall Study|Follow up ended by sponsor|70|||
145305961|NCT02089685|523970409|FG004|Overall Study|Follow up ended by sponsor|26|||
145305962|NCT02089685|523970410|FG005|Overall Study|Follow up ended by sponsor|26|||
145305963|NCT02089685|523970405|FG000|Overall Study|Withdrawal by Subject|0|||
145305964|NCT02089685|523970406|FG001|Overall Study|Withdrawal by Subject|2|||
145305965|NCT02089685|523970407|FG002|Overall Study|Withdrawal by Subject|0|||
145305966|NCT02089685|523970408|FG003|Overall Study|Withdrawal by Subject|8|||
145305967|NCT02089685|523970409|FG004|Overall Study|Withdrawal by Subject|1|||
145305968|NCT02089685|523970410|FG005|Overall Study|Withdrawal by Subject|1|||
145305969|NCT02089685|523970405|FG000|Overall Study|Status not recorded|1|||
145305970|NCT02089685|523970406|FG001|Overall Study|Status not recorded|0|||
145305971|NCT02089685|523970407|FG002|Overall Study|Status not recorded|0|||
145305972|NCT02089685|523970408|FG003|Overall Study|Status not recorded|0|||
145305973|NCT02089685|523970409|FG004|Overall Study|Status not recorded|1|||
145305974|NCT02089685|523970410|FG005|Overall Study|Status not recorded|0|||
145305975|NCT02089685|523970405|FG000|Overall Study|Death|0|||
145305976|NCT02089685|523970406|FG001|Overall Study|Death|0|||
145305977|NCT02089685|523970407|FG002|Overall Study|Death|0|||
145305978|NCT02089685|523970408|FG003|Overall Study|Death|7|||
145305979|NCT02089685|523970409|FG004|Overall Study|Death|2|||
145305980|NCT02089685|523970410|FG005|Overall Study|Death|5|||
145305981|NCT02089685|523970405|FG000|Overall Study|Lost to Follow-up|0|||
145305982|NCT02089685|523970406|FG001|Overall Study|Lost to Follow-up|0|||
145305983|NCT02089685|523970407|FG002|Overall Study|Lost to Follow-up|0|||
145305984|NCT02089685|523970408|FG003|Overall Study|Lost to Follow-up|1|||
145305985|NCT02089685|523970409|FG004|Overall Study|Lost to Follow-up|0|||
145305986|NCT02089685|523970410|FG005|Overall Study|Lost to Follow-up|0|||
145305987|NCT02089685|523970405|FG000|Overall Study|Physician Decision|0|||
145305988|NCT02089685|523970406|FG001|Overall Study|Physician Decision|0|||
145305989|NCT02089685|523970407|FG002|Overall Study|Physician Decision|0|||
145305990|NCT02089685|523970408|FG003|Overall Study|Physician Decision|0|||
145305991|NCT02089685|523970409|FG004|Overall Study|Physician Decision|0|||
145305992|NCT02089685|523970410|FG005|Overall Study|Physician Decision|4|||
145305993|NCT02089685|523970405|FG000|Overall Study|Screen failure|1|||
145305994|NCT02089685|523970406|FG001|Overall Study|Screen failure|0|||
145305995|NCT02089685|523970407|FG002|Overall Study|Screen failure|0|||
145305996|NCT02089685|523970408|FG003|Overall Study|Screen failure|0|||
145305997|NCT02089685|523970409|FG004|Overall Study|Screen failure|0|||
145305998|NCT02089685|523970410|FG005|Overall Study|Screen failure|0|||
145305999|NCT00505622|523970418|FG000|Overall Study|Adverse Event|5|||
145306000|NCT00505622|523970419|FG001|Overall Study|Adverse Event|6|||
145306001|NCT00505622|523970420|FG002|Overall Study|Adverse Event|4|||
145306002|NCT00505622|523970418|FG000|Overall Study|Protocol Violation|1|||
145306003|NCT00505622|523970419|FG001|Overall Study|Protocol Violation|1|||
145306004|NCT00505622|523970420|FG002|Overall Study|Protocol Violation|0|||
145306005|NCT00505622|523970418|FG000|Overall Study|Withdrawal by Subject|0|||
145306006|NCT00505622|523970419|FG001|Overall Study|Withdrawal by Subject|3|||
145306007|NCT00505622|523970420|FG002|Overall Study|Withdrawal by Subject|2|||
145306008|NCT00505622|523970418|FG000|Overall Study|Study termination by sponsor|115|||
145306009|NCT00505622|523970419|FG001|Overall Study|Study termination by sponsor|98|||
145306010|NCT00505622|523970420|FG002|Overall Study|Study termination by sponsor|90|||
145306011|NCT03084471|523970421|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
145306012|NCT03084471|523970421|FG000|Overall Study|Condition under investigation worsened|84|||
145306013|NCT03084471|523970421|FG000|Overall Study|Lack of therapeutic response|2|||
145306014|NCT03084471|523970421|FG000|Overall Study|Protocol Violation|1|||
145306015|NCT03084471|523970421|FG000|Overall Study|Adverse Event|73|||
145306016|NCT03084471|523970421|FG000|Overall Study|Withdrawal by Subject|12|||
145306017|NCT03084471|523970421|FG000|Overall Study|Disease relapse|181|||
145306018|NCT03084471|523970421|FG000|Overall Study|Subjective disease progression|359|||
145306019|NCT03084471|523970421|FG000|Overall Study|Other (as recorded)|33|||
145306020|NCT03084471|523970421|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
145306021|NCT01348789|523970422|FG000|Overall Study|Protocol Violation|2|||
145306022|NCT01348789|523970422|FG000|Overall Study|Withdrawal by Subject|2|||
145306023|NCT00323882|523970423|FG000|Overall Study|Adverse Event|2|||
145306024|NCT00323882|523970424|FG001|Overall Study|Adverse Event|1|||
145306025|NCT00323882|523970425|FG002|Overall Study|Adverse Event|1|||
145306026|NCT00323882|523970426|FG003|Overall Study|Adverse Event|1|||
145306027|NCT00323882|523970427|FG004|Overall Study|Adverse Event|3|||
145306028|NCT00323882|523970423|FG000|Overall Study|Disease Progression|6|||
145306029|NCT00323882|523970424|FG001|Overall Study|Disease Progression|4|||
145306030|NCT00323882|523970425|FG002|Overall Study|Disease Progression|10|||
145306031|NCT00323882|523970426|FG003|Overall Study|Disease Progression|5|||
145306032|NCT00323882|523970427|FG004|Overall Study|Disease Progression|22|||
145306033|NCT00323882|523970423|FG000|Overall Study|Death|0|||
145306034|NCT00323882|523970424|FG001|Overall Study|Death|1|||
145306035|NCT00323882|523970425|FG002|Overall Study|Death|1|||
145306036|NCT00323882|523970426|FG003|Overall Study|Death|0|||
145306037|NCT00323882|523970427|FG004|Overall Study|Death|5|||
145306038|NCT00323882|523970423|FG000|Overall Study|Lost to Follow-up|0|||
145306039|NCT00323882|523970424|FG001|Overall Study|Lost to Follow-up|0|||
145306040|NCT00323882|523970425|FG002|Overall Study|Lost to Follow-up|1|||
145306041|NCT00323882|523970426|FG003|Overall Study|Lost to Follow-up|0|||
145306042|NCT00323882|523970427|FG004|Overall Study|Lost to Follow-up|1|||
145306043|NCT00323882|523970423|FG000|Overall Study|Other|0|||
145306044|NCT00323882|523970424|FG001|Overall Study|Other|0|||
145306045|NCT00323882|523970425|FG002|Overall Study|Other|0|||
145306046|NCT00323882|523970426|FG003|Overall Study|Other|1|||
145306047|NCT00323882|523970427|FG004|Overall Study|Other|1|||
145306048|NCT00429416|523970432|FG000|Overall Study|Death|1|||
145306049|NCT02619682|523970433|FG000|Overall Study|Withdrawal by Subject|3|||
145306050|NCT02619682|523970433|FG000|Overall Study|Lack of Efficacy|8|||
145306051|NCT02619682|523970433|FG000|Overall Study|new secondary cancer|1|||
145306052|NCT02619682|523970433|FG000|Overall Study|post surgery complications|2|||
145306053|NCT03600376|523970434|FG000|Overall Study|Adverse Event|1|||
145306054|NCT03600376|523970435|FG001|Overall Study|Adverse Event|1|||
145306055|NCT03600376|523970434|FG000|Overall Study|Transferred to other facility|1|||
145306056|NCT03600376|523970435|FG001|Overall Study|Transferred to other facility|0|||
145306057|NCT03600376|523970434|FG000|Overall Study|Investigator Decision|0|||
145306058|NCT03600376|523970435|FG001|Overall Study|Investigator Decision|4|||
145306059|NCT03600376|523970434|FG000|Overall Study|Determined to be ineligible for study|0|||
145306060|NCT03600376|523970435|FG001|Overall Study|Determined to be ineligible for study|1|||
145306061|NCT02358538|523970436|FG000|Through Week 26|Adverse Event|0|||
145306062|NCT02358538|523970437|FG001|Through Week 26|Adverse Event|1|||
145306063|NCT02358538|523970438|FG002|Through Week 26|Adverse Event|1|||
145306064|NCT02358538|523970439|FG003|Through Week 26|Adverse Event|2|||
145306065|NCT02358538|523970436|FG000|Through Week 26|Lack of Efficacy|1|||
145306066|NCT02358538|523970437|FG001|Through Week 26|Lack of Efficacy|1|||
145306067|NCT02358538|523970438|FG002|Through Week 26|Lack of Efficacy|3|||
145306068|NCT02358538|523970439|FG003|Through Week 26|Lack of Efficacy|3|||
145306069|NCT02358538|523970436|FG000|Through Week 26|Withdrawal by Subject|1|||
145306070|NCT02358538|523970437|FG001|Through Week 26|Withdrawal by Subject|0|||
145306071|NCT02358538|523970438|FG002|Through Week 26|Withdrawal by Subject|0|||
145306072|NCT02358538|523970439|FG003|Through Week 26|Withdrawal by Subject|0|||
145306073|NCT02358538|523970436|FG000|Through Week 26|Non-Compliance|0|||
145306074|NCT02358538|523970437|FG001|Through Week 26|Non-Compliance|0|||
145306075|NCT02358538|523970438|FG002|Through Week 26|Non-Compliance|1|||
145306076|NCT02358538|523970439|FG003|Through Week 26|Non-Compliance|0|||
145306077|NCT02358538|523970436|FG000|Through Week 26|Family did not see benefit from IP|1|||
145306078|NCT02358538|523970437|FG001|Through Week 26|Family did not see benefit from IP|0|||
145306079|NCT02358538|523970438|FG002|Through Week 26|Family did not see benefit from IP|0|||
145306080|NCT02358538|523970439|FG003|Through Week 26|Family did not see benefit from IP|0|||
145306081|NCT02358538|523970436|FG000|52 Week Extension Period|Lack of Efficacy|0|||
145306082|NCT02358538|523970437|FG001|52 Week Extension Period|Lack of Efficacy|0|||
145306083|NCT02358538|523970438|FG002|52 Week Extension Period|Lack of Efficacy|2|||
145306084|NCT02358538|523970439|FG003|52 Week Extension Period|Lack of Efficacy|4|||
145306085|NCT06999265|523970440|FG000|Overall Study|Lost to Follow-up|1|||
145306086|NCT06999265|523970441|FG001|Overall Study|Lost to Follow-up|1|||
145306087|NCT03649477|523970444|FG000|Overall Study|Adverse Event|2|||
145306088|NCT03649477|523970445|FG001|Overall Study|Adverse Event|0|||
145306089|NCT03649477|523970446|FG002|Overall Study|Adverse Event|0|||
145306090|NCT01030133|523970447|FG000|Overall Study|failed to experience pain at level 7/10|2|||
145306091|NCT01030133|523970448|FG001|Overall Study|failed to experience pain at level 7/10|2|||
145306092|NCT03114891|523970459|FG000|First Treatment Round|Lost to Follow-up|0|||
145306093|NCT03114891|523970460|FG001|First Treatment Round|Lost to Follow-up|1|||
145306094|NCT03114891|523970461|FG002|First Treatment Round|Lost to Follow-up|1|||
145306095|NCT03114891|523970462|FG003|First Treatment Round|Lost to Follow-up|0|||
145306096|NCT03114891|523970459|FG000|First Treatment Round|Withdrawal by Subject|0|||
145306097|NCT03114891|523970460|FG001|First Treatment Round|Withdrawal by Subject|2|||
145306098|NCT03114891|523970461|FG002|First Treatment Round|Withdrawal by Subject|0|||
145306099|NCT03114891|523970462|FG003|First Treatment Round|Withdrawal by Subject|1|||
145306100|NCT03114891|523970459|FG000|3 Week Break|Lost to Follow-up|1|||
145306101|NCT03114891|523970460|FG001|3 Week Break|Lost to Follow-up|0|||
145306102|NCT03114891|523970461|FG002|3 Week Break|Lost to Follow-up|0|||
145306103|NCT03114891|523970462|FG003|3 Week Break|Lost to Follow-up|1|||
145306104|NCT03114891|523970459|FG000|3 Week Break|Withdrawal by Subject|0|||
145306105|NCT03114891|523970460|FG001|3 Week Break|Withdrawal by Subject|1|||
145306106|NCT03114891|523970461|FG002|3 Week Break|Withdrawal by Subject|0|||
145306107|NCT03114891|523970462|FG003|3 Week Break|Withdrawal by Subject|0|||
145306108|NCT03114891|523970459|FG000|Second Treatment Round|Lost to Follow-up|1|||
145306109|NCT03114891|523970460|FG001|Second Treatment Round|Lost to Follow-up|0|||
145306110|NCT03114891|523970461|FG002|Second Treatment Round|Lost to Follow-up|0|||
145306111|NCT03114891|523970462|FG003|Second Treatment Round|Lost to Follow-up|0|||
145306112|NCT03114891|523970459|FG000|Second Treatment Round|Physician Decision|1|||
145306113|NCT03114891|523970460|FG001|Second Treatment Round|Physician Decision|0|||
145306114|NCT03114891|523970461|FG002|Second Treatment Round|Physician Decision|0|||
145568993|NCT01904604|524944164|FG001|Overall Study|Withdrew before receiving dosing|1|||
145568994|NCT01904604|524944165|FG002|Overall Study|Withdrew before receiving dosing|0|||
145568995|NCT01904604|524944163|FG000|Overall Study|Non-compliance|1|||
145568996|NCT01904604|524944164|FG001|Overall Study|Non-compliance|0|||
145568997|NCT01904604|524944165|FG002|Overall Study|Non-compliance|0|||
145568998|NCT01904604|524944163|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
145568999|NCT01904604|524944164|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
145306115|NCT03114891|523970462|FG003|Second Treatment Round|Physician Decision|0|||
145306116|NCT05511935|523972443|FG000|Overall Study|Lost to Follow-up|9|||
145306117|NCT05511935|523972444|FG001|Overall Study|Lost to Follow-up|27|||
145306118|NCT03121586|523972445|FG000|Overall Study|Study terminated by sponsor|0|||
145306119|NCT03121586|523972446|FG001|Overall Study|Study terminated by sponsor|0|||
145306120|NCT03121586|523972447|FG002|Overall Study|Study terminated by sponsor|99|||
145306121|NCT03121586|523972445|FG000|Overall Study|Withdrawal by Subject|37|||
145306122|NCT03121586|523972446|FG001|Overall Study|Withdrawal by Subject|14|||
145306123|NCT03121586|523972447|FG002|Overall Study|Withdrawal by Subject|9|||
145306124|NCT03121586|523972445|FG000|Overall Study|Not further specified|6|||
145306125|NCT03121586|523972446|FG001|Overall Study|Not further specified|11|||
145306126|NCT03121586|523972447|FG002|Overall Study|Not further specified|10|||
145306127|NCT03121586|523972445|FG000|Overall Study|Adverse Event|16|||
145306128|NCT03121586|523972446|FG001|Overall Study|Adverse Event|5|||
145306129|NCT03121586|523972447|FG002|Overall Study|Adverse Event|6|||
145306130|NCT03121586|523972445|FG000|Overall Study|Protocol Violation|0|||
145306131|NCT03121586|523972446|FG001|Overall Study|Protocol Violation|5|||
145306132|NCT03121586|523972447|FG002|Overall Study|Protocol Violation|0|||
145306133|NCT03121586|523972445|FG000|Overall Study|Lack of Efficacy|3|||
145306134|NCT03121586|523972446|FG001|Overall Study|Lack of Efficacy|3|||
145306135|NCT03121586|523972447|FG002|Overall Study|Lack of Efficacy|1|||
145306136|NCT03121586|523972445|FG000|Overall Study|Physician Decision|2|||
145306137|NCT03121586|523972446|FG001|Overall Study|Physician Decision|2|||
145306138|NCT03121586|523972447|FG002|Overall Study|Physician Decision|0|||
145306139|NCT03121586|523972445|FG000|Overall Study|Noncompliance with study drug|5|||
145306140|NCT03121586|523972446|FG001|Overall Study|Noncompliance with study drug|3|||
145306141|NCT03121586|523972447|FG002|Overall Study|Noncompliance with study drug|5|||
145306142|NCT03121586|523972445|FG000|Overall Study|Lost to Follow-up|4|||
145306143|NCT03121586|523972446|FG001|Overall Study|Lost to Follow-up|2|||
145306144|NCT03121586|523972447|FG002|Overall Study|Lost to Follow-up|0|||
145306145|NCT03121586|523972445|FG000|Overall Study|Death|2|||
145306146|NCT03121586|523972446|FG001|Overall Study|Death|0|||
145306147|NCT03121586|523972447|FG002|Overall Study|Death|0|||
145306148|NCT06381102|523972448|FG000|Washout 5 Days|Withdrawal by Subject|0|||
145306149|NCT06381102|523972449|FG001|Washout 5 Days|Withdrawal by Subject|2|||
145306150|NCT01440803|523972450|FG000|Overall Study|Met study stopping rule|2|||
145306151|NCT01440803|523972451|FG001|Overall Study|Met study stopping rule|1|||
145306152|NCT01440803|523972450|FG000|Overall Study|Lost to Follow-up|0|||
145306153|NCT01440803|523972451|FG001|Overall Study|Lost to Follow-up|2|||
145306154|NCT01440803|523972450|FG000|Overall Study|Withdrawal by Subject|0|||
145306155|NCT01440803|523972451|FG001|Overall Study|Withdrawal by Subject|1|||
145306156|NCT01564394|523972452|FG000|Overall Study|Withdrawal by Subject|6|||
145306157|NCT01564394|523972453|FG001|Overall Study|Withdrawal by Subject|10|||
145306158|NCT00443651|523972454|FG000|Overall Study|Death|1|||
145306159|NCT00443651|523972455|FG001|Overall Study|Death|5|||
145306160|NCT00443651|523972454|FG000|Overall Study|Adverse Event|5|||
145306161|NCT00443651|523972455|FG001|Overall Study|Adverse Event|6|||
145306162|NCT00443651|523972454|FG000|Overall Study|Lost to Follow-up|18|||
145306163|NCT00443651|523972455|FG001|Overall Study|Lost to Follow-up|12|||
145306164|NCT00443651|523972454|FG000|Overall Study|Patient's/Guardian's Decision|58|||
145306165|NCT00443651|523972455|FG001|Overall Study|Patient's/Guardian's Decision|30|||
145306166|NCT00443651|523972454|FG000|Overall Study|Physician Decision|13|||
145306167|NCT00443651|523972455|FG001|Overall Study|Physician Decision|4|||
145306168|NCT00443651|523972454|FG000|Overall Study|Pregnancy|0|||
145306169|NCT00443651|523972455|FG001|Overall Study|Pregnancy|1|||
145306170|NCT00859521|523972456|FG000|Washout|Withdrawal by Subject|0|||
145306171|NCT00859521|523972457|FG001|Washout|Withdrawal by Subject|1|||
145306172|NCT01609257|523972458|FG000|Overall Study|Lost to Follow-up|2|||
145306173|NCT01609257|523972459|FG001|Overall Study|Lost to Follow-up|1|||
145306174|NCT01609257|523972458|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
145306175|NCT01609257|523972459|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
145306176|NCT01609257|523972458|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
145306177|NCT01609257|523972459|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
145306178|NCT02125461|523972460|FG000|Overall Study|Withdrawal by Subject|30|||
145306179|NCT02125461|523972461|FG001|Overall Study|Withdrawal by Subject|16|||
145569000|NCT01904604|524944165|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
145569001|NCT01904604|524944163|FG000|Overall Study|Patch site reactions|1|||
145569002|NCT01904604|524944164|FG001|Overall Study|Patch site reactions|1|||
145306180|NCT02125461|523972460|FG000|Overall Study|Lost to Follow-up|8|||
145306181|NCT02125461|523972461|FG001|Overall Study|Lost to Follow-up|3|||
145306182|NCT02125461|523972460|FG000|Overall Study|Death|260|||
145569003|NCT01904604|524944165|FG002|Overall Study|Patch site reactions|0|||
145569004|NCT01904604|524944163|FG000|Overall Study|Increased syncope|0|||
145569005|NCT01904604|524944164|FG001|Overall Study|Increased syncope|1|||
145569006|NCT01904604|524944165|FG002|Overall Study|Increased syncope|0|||
145569007|NCT01904604|524944163|FG000|Overall Study|Unrelated illness|0|||
145569008|NCT01904604|524944164|FG001|Overall Study|Unrelated illness|1|||
145569009|NCT01904604|524944165|FG002|Overall Study|Unrelated illness|0|||
145569010|NCT01904604|524944163|FG000|Overall Study|Passed Week 52 OFC|1|||
145569011|NCT01904604|524944164|FG001|Overall Study|Passed Week 52 OFC|0|||
145569012|NCT01904604|524944165|FG002|Overall Study|Passed Week 52 OFC|0|||
145569013|NCT01904604|524944163|FG000|Overall Study|Withdrawal by Subject|1|||
145569014|NCT01904604|524944164|FG001|Overall Study|Withdrawal by Subject|2|||
145306183|NCT02125461|523972461|FG001|Overall Study|Death|149|||
145306184|NCT02125461|523972460|FG000|Overall Study|Missing Termination Reason|0|||
145306185|NCT02125461|523972461|FG001|Overall Study|Missing Termination Reason|1|||
145306186|NCT02888756|523972462|FG000|Analytical Treatment Interruption|Physician Decision|10|||
145306187|NCT02888756|523972463|FG001|Analytical Treatment Interruption|Physician Decision|6|||
145306188|NCT02888756|523972464|FG002|Analytical Treatment Interruption|Physician Decision|5|||
145306189|NCT01547286|523972474|FG000|Overall Study|Did not meet all eligibility criteria|1|||
145306190|NCT01547286|523972474|FG000|Overall Study|Physician Decision|1|||
145306191|NCT03415308|523972478|FG000|Overall Study|Lost to Follow-up|0|||
145306192|NCT03415308|523972479|FG001|Overall Study|Lost to Follow-up|0|||
145306193|NCT03415308|523972480|FG002|Overall Study|Lost to Follow-up|1|||
145306194|NCT03415308|523972478|FG000|Overall Study|Scheduling Conflicts|0|||
145306195|NCT03415308|523972479|FG001|Overall Study|Scheduling Conflicts|0|||
145306196|NCT03415308|523972480|FG002|Overall Study|Scheduling Conflicts|7|||
145306197|NCT01471353|523972481|FG000|Overall Study|remain on study|3|||
145306198|NCT00836472|523972482|FG000|Washout|Adverse Event|1|||
145306199|NCT00836472|523972483|FG001|Washout|Adverse Event|2|||
145306200|NCT00836472|523972482|FG000|Washout|Withdrawal by Subject|1|||
145306201|NCT00836472|523972483|FG001|Washout|Withdrawal by Subject|1|||
145306202|NCT03552484|523972486|FG000|Overall Study|Death|6|||
145306203|NCT03552484|523972487|FG001|Overall Study|Death|4|||
145306204|NCT03552484|523972486|FG000|Overall Study|Lost to Follow-up|0|||
145306205|NCT03552484|523972487|FG001|Overall Study|Lost to Follow-up|16|||
145306206|NCT02241551|523972488|FG000|Overall Study|Adverse Event|1|||
145306207|NCT02241551|523972489|FG001|Overall Study|Adverse Event|0|||
145306208|NCT03499353|523972490|FG000|Treatment|Adverse Event|3|||
145306209|NCT03499353|523972490|FG000|Treatment|Progressive Disease|10|||
145306210|NCT03499353|523972490|FG000|Treatment|Other|1|||
145306211|NCT03499353|523972490|FG000|Treatment|Withdrawal by Subject|2|||
145306212|NCT03499353|523972490|FG000|Long-Term Follow-up|Death|2|||
145306213|NCT03499353|523972490|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
145306214|NCT03499353|523972490|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
145306215|NCT01015287|523972493|FG000|Overall Study|Death|21|||
145306216|NCT01015287|523972494|FG001|Overall Study|Death|16|||
145306217|NCT01015287|523972493|FG000|Overall Study|Adverse Event|1|||
145306218|NCT01015287|523972494|FG001|Overall Study|Adverse Event|0|||
145569015|NCT01904604|524944165|FG002|Overall Study|Withdrawal by Subject|0|||
145569016|NCT01904604|524944163|FG000|Overall Study|Participant Relocated|1|||
145306219|NCT01015287|523972493|FG000|Overall Study|Sponsor Decision|3|||
145306220|NCT01015287|523972494|FG001|Overall Study|Sponsor Decision|7|||
145306221|NCT01015287|523972493|FG000|Overall Study|Physician Decision|19|||
145306222|NCT01015287|523972494|FG001|Overall Study|Physician Decision|21|||
145306223|NCT01015287|523972493|FG000|Overall Study|Withdrawal by Subject|14|||
145306224|NCT01015287|523972494|FG001|Overall Study|Withdrawal by Subject|19|||
145306225|NCT01015287|523972493|FG000|Overall Study|Entry Criteria not Met|11|||
145306226|NCT01015287|523972494|FG001|Overall Study|Entry Criteria not Met|14|||
145306227|NCT01015287|523972493|FG000|Overall Study|Lost to Follow-up|2|||
145306228|NCT01015287|523972494|FG001|Overall Study|Lost to Follow-up|1|||
145306229|NCT01015287|523972493|FG000|Overall Study|Protocol Violation|1|||
145306230|NCT01015287|523972494|FG001|Overall Study|Protocol Violation|1|||
145306231|NCT01592240|523972495|FG000|Overall Study|Adverse Event|1|||
145306232|NCT01592240|523972496|FG001|Overall Study|Adverse Event|0|||
145306233|NCT01592240|523972497|FG002|Overall Study|Adverse Event|0|||
145306234|NCT01592240|523972498|FG003|Overall Study|Adverse Event|1|||
145306235|NCT01592240|523972499|FG004|Overall Study|Adverse Event|1|||
145306236|NCT01592240|523972500|FG005|Overall Study|Adverse Event|0|||
145306237|NCT01592240|523972501|FG006|Overall Study|Adverse Event|0|||
145306238|NCT01592240|523972495|FG000|Overall Study|Death|0|||
145306239|NCT01592240|523972496|FG001|Overall Study|Death|1|||
145306240|NCT01592240|523972497|FG002|Overall Study|Death|0|||
145306241|NCT01592240|523972498|FG003|Overall Study|Death|0|||
145306242|NCT01592240|523972499|FG004|Overall Study|Death|0|||
145306243|NCT01592240|523972500|FG005|Overall Study|Death|0|||
145306244|NCT01592240|523972501|FG006|Overall Study|Death|0|||
145306245|NCT01592240|523972495|FG000|Overall Study|Lost to Follow-up|1|||
145306246|NCT01592240|523972496|FG001|Overall Study|Lost to Follow-up|3|||
145306247|NCT01592240|523972497|FG002|Overall Study|Lost to Follow-up|1|||
145306248|NCT01592240|523972498|FG003|Overall Study|Lost to Follow-up|0|||
145306249|NCT01592240|523972499|FG004|Overall Study|Lost to Follow-up|3|||
145306250|NCT01592240|523972500|FG005|Overall Study|Lost to Follow-up|2|||
145306251|NCT01592240|523972501|FG006|Overall Study|Lost to Follow-up|0|||
145306252|NCT01592240|523972495|FG000|Overall Study|Protocol Violation|0|||
145306253|NCT01592240|523972496|FG001|Overall Study|Protocol Violation|0|||
145306254|NCT01592240|523972497|FG002|Overall Study|Protocol Violation|0|||
145306255|NCT01592240|523972498|FG003|Overall Study|Protocol Violation|0|||
145306256|NCT01592240|523972499|FG004|Overall Study|Protocol Violation|0|||
145306257|NCT01592240|523972500|FG005|Overall Study|Protocol Violation|1|||
145306258|NCT01592240|523972501|FG006|Overall Study|Protocol Violation|0|||
145306259|NCT01592240|523972495|FG000|Overall Study|Withdrawal by Subject|0|||
145306260|NCT01592240|523972496|FG001|Overall Study|Withdrawal by Subject|4|||
145306261|NCT01592240|523972497|FG002|Overall Study|Withdrawal by Subject|4|||
145306262|NCT01592240|523972498|FG003|Overall Study|Withdrawal by Subject|1|||
145306263|NCT01592240|523972499|FG004|Overall Study|Withdrawal by Subject|3|||
145306264|NCT01592240|523972500|FG005|Overall Study|Withdrawal by Subject|0|||
145306265|NCT01592240|523972501|FG006|Overall Study|Withdrawal by Subject|2|||
145306266|NCT01592240|523972495|FG000|Overall Study|Other|0|||
145306267|NCT01592240|523972496|FG001|Overall Study|Other|3|||
145306268|NCT01592240|523972497|FG002|Overall Study|Other|1|||
145306269|NCT01592240|523972498|FG003|Overall Study|Other|1|||
145306270|NCT01592240|523972499|FG004|Overall Study|Other|0|||
145306271|NCT01592240|523972500|FG005|Overall Study|Other|0|||
145306272|NCT01592240|523972501|FG006|Overall Study|Other|1|||
145306273|NCT01592240|523972495|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145306274|NCT01592240|523972496|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
145306275|NCT01592240|523972497|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
145306276|NCT01592240|523972498|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
145306277|NCT01592240|523972499|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
145306278|NCT01592240|523972500|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
145306279|NCT01592240|523972501|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
145306280|NCT01117623|523972502|FG000|Overall Study|Adverse Event|0|||
145306281|NCT01117623|523972503|FG001|Overall Study|Adverse Event|2|||
145306282|NCT01117623|523972504|FG002|Overall Study|Adverse Event|4|||
145306283|NCT01117623|523972505|FG003|Overall Study|Adverse Event|0|||
145306284|NCT01117623|523972506|FG004|Overall Study|Adverse Event|2|||
145306285|NCT01117623|523972507|FG005|Overall Study|Adverse Event|0|||
145306286|NCT01117623|523972508|FG006|Overall Study|Adverse Event|0|||
145306287|NCT01117623|523972509|FG007|Overall Study|Adverse Event|2|||
145306288|NCT01117623|523972502|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
145306289|NCT01117623|523972503|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
145306290|NCT01117623|523972504|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
145306291|NCT01117623|523972505|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
145306292|NCT01117623|523972506|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
145306293|NCT01117623|523972507|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
145306294|NCT01117623|523972508|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
145306295|NCT01117623|523972509|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
145306296|NCT01117623|523972502|FG000|Overall Study|Withdrawal by Subject|0|||
145306297|NCT01117623|523972503|FG001|Overall Study|Withdrawal by Subject|0|||
145306298|NCT01117623|523972504|FG002|Overall Study|Withdrawal by Subject|2|||
145306299|NCT01117623|523972505|FG003|Overall Study|Withdrawal by Subject|0|||
145306300|NCT01117623|523972506|FG004|Overall Study|Withdrawal by Subject|0|||
145306301|NCT01117623|523972507|FG005|Overall Study|Withdrawal by Subject|1|||
145306302|NCT01117623|523972508|FG006|Overall Study|Withdrawal by Subject|1|||
145306303|NCT01117623|523972509|FG007|Overall Study|Withdrawal by Subject|1|||
145306304|NCT01117623|523972502|FG000|Overall Study|Non-compliance with study medication|0|||
145306305|NCT01117623|523972503|FG001|Overall Study|Non-compliance with study medication|0|||
145306306|NCT01117623|523972504|FG002|Overall Study|Non-compliance with study medication|0|||
145306307|NCT01117623|523972505|FG003|Overall Study|Non-compliance with study medication|0|||
145306308|NCT01117623|523972506|FG004|Overall Study|Non-compliance with study medication|0|||
145306309|NCT01117623|523972507|FG005|Overall Study|Non-compliance with study medication|0|||
145306310|NCT01117623|523972508|FG006|Overall Study|Non-compliance with study medication|0|||
145306311|NCT01117623|523972509|FG007|Overall Study|Non-compliance with study medication|1|||
145306312|NCT01117623|523972502|FG000|Overall Study|Invest. text: completed all planned txs|0|||
145306313|NCT01117623|523972503|FG001|Overall Study|Invest. text: completed all planned txs|0|||
145306314|NCT01117623|523972504|FG002|Overall Study|Invest. text: completed all planned txs|0|||
145306315|NCT01117623|523972505|FG003|Overall Study|Invest. text: completed all planned txs|0|||
145306316|NCT01117623|523972506|FG004|Overall Study|Invest. text: completed all planned txs|0|||
145306317|NCT01117623|523972507|FG005|Overall Study|Invest. text: completed all planned txs|1|||
145306318|NCT01117623|523972508|FG006|Overall Study|Invest. text: completed all planned txs|0|||
145306319|NCT01117623|523972509|FG007|Overall Study|Invest. text: completed all planned txs|0|||
145306320|NCT00469898|523972517|FG000|Overall Study|Adverse Event|7|||
145306321|NCT00469898|523972517|FG000|Overall Study|Withdrawal by Subject|4|||
145306322|NCT00469898|523972517|FG000|Overall Study|Death|4|||
145569017|NCT01904604|524944164|FG001|Overall Study|Participant Relocated|1|||
145306323|NCT00469898|523972517|FG000|Overall Study|Disease progression|9|||
145569018|NCT01904604|524944165|FG002|Overall Study|Participant Relocated|1|||
145569019|NCT01904604|524944163|FG000|Overall Study|Lost to Follow-up|0|||
145569020|NCT01904604|524944164|FG001|Overall Study|Lost to Follow-up|0|||
145306324|NCT00469898|523972517|FG000|Overall Study|Decreased performance status|1|||
145306325|NCT01205035|523972522|FG000|Overall Study|Withdrawal by Subject|1|||
145306326|NCT01205035|523972523|FG001|Overall Study|Withdrawal by Subject|0|||
145306327|NCT01205035|523972522|FG000|Overall Study|Physician Decision|1|||
145306328|NCT01205035|523972523|FG001|Overall Study|Physician Decision|0|||
145306329|NCT03246503|523972524|FG000|Overall Study|Lost to Follow-up|23|||
145306330|NCT03246503|523972524|FG000|Overall Study|Withdrawal by Subject|20|||
145306331|NCT03246503|523972524|FG000|Overall Study|Physician Decision|5|||
145306332|NCT03246503|523972524|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
145306333|NCT01896934|523972532|FG000|Overall Study|Adverse Event|1|||
145306334|NCT01896934|523972532|FG000|Overall Study|Withdrawal by Subject|1|||
145306335|NCT02751424|523972533|FG000|Part 2|Adverse Event|0|||
145306336|NCT02751424|523972534|FG001|Part 2|Adverse Event|0|||
145306337|NCT02751424|523972535|FG002|Part 2|Adverse Event|0|||
145306338|NCT02751424|523972536|FG003|Part 2|Adverse Event|0|||
145306339|NCT02751424|523972537|FG004|Part 2|Adverse Event|0|||
145306340|NCT02751424|523972538|FG005|Part 2|Adverse Event|0|||
145306341|NCT02751424|523972539|FG006|Part 2|Adverse Event|0|||
145306342|NCT02751424|523972540|FG007|Part 2|Adverse Event|5|||
145306343|NCT02751424|523972541|FG008|Part 2|Adverse Event|0|||
145306344|NCT02197416|523972542|FG000|Overall Study|Other reasons|0|||
145306345|NCT02197416|523972543|FG001|Overall Study|Other reasons|2|||
145306346|NCT02197416|523972544|FG002|Overall Study|Other reasons|5|||
145306347|NCT02197416|523972542|FG000|Overall Study|Withdrawal by Subject|0|||
145306348|NCT02197416|523972543|FG001|Overall Study|Withdrawal by Subject|2|||
145306349|NCT02197416|523972544|FG002|Overall Study|Withdrawal by Subject|1|||
145306350|NCT02197416|523972542|FG000|Overall Study|Protocol Violation|1|||
145306351|NCT02197416|523972543|FG001|Overall Study|Protocol Violation|0|||
145306352|NCT02197416|523972544|FG002|Overall Study|Protocol Violation|1|||
145306353|NCT02197416|523972542|FG000|Overall Study|Adverse Event|0|||
145306354|NCT02197416|523972543|FG001|Overall Study|Adverse Event|0|||
145306355|NCT02197416|523972544|FG002|Overall Study|Adverse Event|1|||
145306356|NCT00716625|523972545|FG000|Overall Study|Safety was not Assessable|1|||
145306357|NCT01204294|523972546|FG000|Overall Study|Adverse Event|2|||
145306358|NCT01204294|523972547|FG001|Overall Study|Adverse Event|6|||
145306359|NCT01204294|523972548|FG002|Overall Study|Adverse Event|0|||
145306360|NCT01204294|523972549|FG003|Overall Study|Adverse Event|7|||
145306361|NCT01204294|523972550|FG004|Overall Study|Adverse Event|1|||
145306362|NCT01204294|523972551|FG005|Overall Study|Adverse Event|4|||
145306363|NCT01204294|523972552|FG006|Overall Study|Adverse Event|0|||
145306364|NCT01204294|523972546|FG000|Overall Study|Protocol Violation|1|||
145306365|NCT01204294|523972547|FG001|Overall Study|Protocol Violation|0|||
145306366|NCT01204294|523972548|FG002|Overall Study|Protocol Violation|2|||
145306367|NCT01204294|523972549|FG003|Overall Study|Protocol Violation|1|||
145306368|NCT01204294|523972550|FG004|Overall Study|Protocol Violation|0|||
145306369|NCT01204294|523972551|FG005|Overall Study|Protocol Violation|0|||
145306370|NCT01204294|523972552|FG006|Overall Study|Protocol Violation|0|||
145306371|NCT01204294|523972546|FG000|Overall Study|Withdrawal by Subject|0|||
145306372|NCT01204294|523972547|FG001|Overall Study|Withdrawal by Subject|2|||
145306373|NCT01204294|523972548|FG002|Overall Study|Withdrawal by Subject|2|||
145306374|NCT01204294|523972549|FG003|Overall Study|Withdrawal by Subject|1|||
145306375|NCT01204294|523972550|FG004|Overall Study|Withdrawal by Subject|1|||
145306376|NCT01204294|523972551|FG005|Overall Study|Withdrawal by Subject|1|||
145306377|NCT01204294|523972552|FG006|Overall Study|Withdrawal by Subject|2|||
145306378|NCT01204294|523972546|FG000|Overall Study|Lack of Efficacy|0|||
145306379|NCT01204294|523972547|FG001|Overall Study|Lack of Efficacy|0|||
145306380|NCT01204294|523972548|FG002|Overall Study|Lack of Efficacy|0|||
145306381|NCT01204294|523972549|FG003|Overall Study|Lack of Efficacy|2|||
145306382|NCT01204294|523972550|FG004|Overall Study|Lack of Efficacy|0|||
145306383|NCT01204294|523972551|FG005|Overall Study|Lack of Efficacy|0|||
145306384|NCT01204294|523972552|FG006|Overall Study|Lack of Efficacy|0|||
145569021|NCT01904604|524944165|FG002|Overall Study|Lost to Follow-up|1|||
145306385|NCT01204294|523972546|FG000|Overall Study|Other (house moving)|0|||
145306386|NCT01204294|523972547|FG001|Overall Study|Other (house moving)|0|||
145306387|NCT01204294|523972548|FG002|Overall Study|Other (house moving)|1|||
145306388|NCT01204294|523972549|FG003|Overall Study|Other (house moving)|0|||
145306389|NCT01204294|523972550|FG004|Overall Study|Other (house moving)|0|||
145306390|NCT01204294|523972551|FG005|Overall Study|Other (house moving)|0|||
145306391|NCT01204294|523972552|FG006|Overall Study|Other (house moving)|0|||
145306392|NCT04590027|523972553|FG000|Overall Study|Lost to Follow-up|17|||
145306393|NCT04590027|523972554|FG001|Overall Study|Lost to Follow-up|14|||
145306394|NCT04590027|523972553|FG000|Overall Study|Protocol Violation|0|||
145306395|NCT04590027|523972554|FG001|Overall Study|Protocol Violation|3|||
145306396|NCT00933686|523972557|FG000|Overall Study|Protocol Violation|0|||
145306397|NCT00933686|523972558|FG001|Overall Study|Protocol Violation|1|||
145306398|NCT00933686|523972557|FG000|Overall Study|Lost to Follow-up|2|||
145306399|NCT00933686|523972558|FG001|Overall Study|Lost to Follow-up|2|||
145306400|NCT00933686|523972557|FG000|Overall Study|Withdrawal by Subject|6|||
145306401|NCT00933686|523972558|FG001|Overall Study|Withdrawal by Subject|5|||
145306402|NCT00933686|523972557|FG000|Overall Study|Adverse Event|1|||
145306403|NCT00933686|523972558|FG001|Overall Study|Adverse Event|1|||
145306404|NCT00933686|523972557|FG000|Overall Study|Physician Decision|1|||
145306405|NCT00933686|523972558|FG001|Overall Study|Physician Decision|0|||
145306406|NCT00933686|523972557|FG000|Overall Study|Failure to show up at endpoint visits|0|||
145306407|NCT00933686|523972558|FG001|Overall Study|Failure to show up at endpoint visits|2|||
145306408|NCT01383486|523972559|FG000|Overall Study|Lost to Follow-up|10|||
145306409|NCT01383486|523972559|FG000|Overall Study|Incomplete information for analysis|2|||
145306410|NCT01383486|523972559|FG000|Overall Study|Did not take any product|6|||
145306411|NCT00245063|523972560|FG000|Overall Study|Adverse Event|6|||
145306412|NCT00245063|523972561|FG001|Overall Study|Adverse Event|5|||
145306413|NCT00245063|523972560|FG000|Overall Study|Death|1|||
145306414|NCT00245063|523972561|FG001|Overall Study|Death|0|||
145306415|NCT01839279|523972563|FG000|Overall Study|Adverse Event|4|||
145306416|NCT01839279|523972564|FG001|Overall Study|Adverse Event|1|||
145306417|NCT01839279|523972565|FG002|Overall Study|Adverse Event|1|||
145306418|NCT01839279|523972563|FG000|Overall Study|Withdrawal by Subject|4|||
145306419|NCT01839279|523972564|FG001|Overall Study|Withdrawal by Subject|1|||
145306420|NCT01839279|523972565|FG002|Overall Study|Withdrawal by Subject|1|||
145306421|NCT01839279|523972563|FG000|Overall Study|Classified as 'Other'|5|||
145306422|NCT01839279|523972564|FG001|Overall Study|Classified as 'Other'|0|||
145306423|NCT01839279|523972565|FG002|Overall Study|Classified as 'Other'|0|||
145306424|NCT03276754|523972569|FG000|Overall Study|Withdrawal of informed consent|4|||
145306425|NCT03276754|523972569|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
145306426|NCT03276754|523972569|FG000|Overall Study|Lost to Follow-up|27|||
145306427|NCT03276754|523972569|FG000|Overall Study|No data reported at Month 24|31|||
145306428|NCT03276754|523972569|FG000|Overall Study|Death|39|||
145306429|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Adverse Event|8|||
145306430|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Adverse Event|15|||
145306431|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Adverse Event|25|||
145306432|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
145306433|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
145306434|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
145306435|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
145306436|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
145306437|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
145306438|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
145306439|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
145306440|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
145306441|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145306442|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
145306443|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
145306444|NCT01058668|523972570|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
145306445|NCT01058668|523972571|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
145306446|NCT01058668|523972572|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
145306447|NCT00316277|523972573|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
145306448|NCT00316277|523972574|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
145306449|NCT00316277|523972573|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
145306450|NCT00316277|523972574|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
145306451|NCT00316277|523972573|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
145306452|NCT00316277|523972574|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
145306453|NCT00316277|523972573|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
145306454|NCT00316277|523972574|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
145306455|NCT00316277|523972573|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
145306456|NCT00316277|523972574|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
145306457|NCT00796328|523972579|FG000|Overall Study|experienced hypotension requiring tx|6|||
145306458|NCT00466167|523972580|FG000|Overall Study|Adverse Event|8|||
145306459|NCT00466167|523972581|FG001|Overall Study|Adverse Event|8|||
145306460|NCT00466167|523972582|FG002|Overall Study|Adverse Event|7|||
145306461|NCT00466167|523972580|FG000|Overall Study|Lack of Efficacy|2|||
145306462|NCT00466167|523972581|FG001|Overall Study|Lack of Efficacy|0|||
145306463|NCT00466167|523972582|FG002|Overall Study|Lack of Efficacy|3|||
145306464|NCT00466167|523972580|FG000|Overall Study|Protocol Violation|1|||
145306465|NCT00466167|523972581|FG001|Overall Study|Protocol Violation|1|||
145306466|NCT00466167|523972582|FG002|Overall Study|Protocol Violation|2|||
145306467|NCT00466167|523972580|FG000|Overall Study|Lost to Follow-up|3|||
145306468|NCT00466167|523972581|FG001|Overall Study|Lost to Follow-up|2|||
145306469|NCT00466167|523972582|FG002|Overall Study|Lost to Follow-up|2|||
145306470|NCT00466167|523972580|FG000|Overall Study|Withdrawal by Subject|4|||
145569022|NCT01945489|524944166|FG000|Cycle 1|Adverse Event|2|||
145306471|NCT00466167|523972581|FG001|Overall Study|Withdrawal by Subject|1|||
145306472|NCT00466167|523972582|FG002|Overall Study|Withdrawal by Subject|6|||
145306473|NCT00466167|523972580|FG000|Overall Study|patient did not meet inclusion criteria|1|||
145306474|NCT00466167|523972581|FG001|Overall Study|patient did not meet inclusion criteria|0|||
145306475|NCT00466167|523972582|FG002|Overall Study|patient did not meet inclusion criteria|1|||
145306476|NCT00466167|523972580|FG000|Overall Study|Not treated|1|||
145306477|NCT00466167|523972581|FG001|Overall Study|Not treated|0|||
145306478|NCT00466167|523972582|FG002|Overall Study|Not treated|0|||
145306479|NCT01370733|523972583|FG000|Overall Study|Withdrawal by Subject|8|||
145306480|NCT01370733|523972584|FG001|Overall Study|Withdrawal by Subject|8|||
145306481|NCT01370733|523972583|FG000|Overall Study|Lost to Follow-up|3|||
145306482|NCT01370733|523972584|FG001|Overall Study|Lost to Follow-up|0|||
145306483|NCT01370733|523972583|FG000|Overall Study|Adverse Event|2|||
145306484|NCT01370733|523972584|FG001|Overall Study|Adverse Event|4|||
145306485|NCT01370733|523972583|FG000|Overall Study|Lack of Efficacy|3|||
145306486|NCT01370733|523972584|FG001|Overall Study|Lack of Efficacy|5|||
145306487|NCT01370733|523972583|FG000|Overall Study|Physician Decision|0|||
145306488|NCT01370733|523972584|FG001|Overall Study|Physician Decision|2|||
145306489|NCT01370733|523972583|FG000|Overall Study|Protocol Violation|1|||
145306490|NCT01370733|523972584|FG001|Overall Study|Protocol Violation|3|||
145306491|NCT00835692|523972587|FG000|First Intervention|Withdrawal by Subject|1|||
145306492|NCT00835692|523972588|FG001|First Intervention|Withdrawal by Subject|0|||
145306493|NCT04078022|523972591|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
145306494|NCT04078022|523972592|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
145306495|NCT00191815|523972595|FG000|Overall Study|Adverse Event|2|||
145306496|NCT00191815|523972595|FG000|Overall Study|Disease progression or relapse|24|||
145306497|NCT00191815|523972595|FG000|Overall Study|Death|2|||
145306498|NCT00191815|523972595|FG000|Overall Study|Protocol Violation|3|||
145306499|NCT00191815|523972595|FG000|Overall Study|Physician Decision|2|||
145306500|NCT00191815|523972595|FG000|Overall Study|Withdrawal by Subject|7|||
145306501|NCT03808376|523972596|FG000|Overall Study|Withdrawal by Subject|10|||
145306502|NCT03644550|523972597|FG000|Overall Study|Withdrawal by Subject|3|||
145306503|NCT03644550|523972597|FG000|Overall Study|Progressive disease|15|||
145306504|NCT00700739|523972598|FG000|Overall Study|Lost to Follow-up|4|||
145306505|NCT00700739|523972599|FG001|Overall Study|Lost to Follow-up|4|||
145306506|NCT00185458|523972601|FG000|Contraception Phase|Adverse Event|37|||
145306507|NCT00185458|523972601|FG000|Contraception Phase|Lost to Follow-up|10|||
145306508|NCT00185458|523972601|FG000|Contraception Phase|Protocol Violation|2|||
145306509|NCT00185458|523972601|FG000|Contraception Phase|Physician Decision|2|||
145306510|NCT00185458|523972601|FG000|Contraception Phase|Withdrawal by Subject|7|||
145306511|NCT00185458|523972601|FG000|HRT Phase|Adverse Event|18|||
145306512|NCT00185458|523972601|FG000|HRT Phase|Lost to Follow-up|4|||
145306513|NCT00185458|523972601|FG000|HRT Phase|Protocol Violation|2|||
145306514|NCT00185458|523972601|FG000|HRT Phase|Withdrawal by Subject|3|||
145306515|NCT03503318|523972602|FG000|Overall Study|Death|1|||
145306516|NCT03503318|523972603|FG001|Overall Study|Death|0|||
145306517|NCT03503318|523972604|FG002|Overall Study|Death|4|||
145306518|NCT03503318|523972602|FG000|Overall Study|Adverse Event|3|||
145306519|NCT03503318|523972603|FG001|Overall Study|Adverse Event|4|||
145306520|NCT03503318|523972604|FG002|Overall Study|Adverse Event|2|||
145306521|NCT03503318|523972602|FG000|Overall Study|Withdrawal by Subject|12|||
145306522|NCT03503318|523972603|FG001|Overall Study|Withdrawal by Subject|17|||
145306523|NCT03503318|523972604|FG002|Overall Study|Withdrawal by Subject|16|||
145306524|NCT03503318|523972602|FG000|Overall Study|Protocol Violation|5|||
145306525|NCT03503318|523972603|FG001|Overall Study|Protocol Violation|0|||
145306526|NCT03503318|523972604|FG002|Overall Study|Protocol Violation|3|||
145306527|NCT03503318|523972602|FG000|Overall Study|Lost to Follow-up|17|||
145306528|NCT03503318|523972603|FG001|Overall Study|Lost to Follow-up|15|||
145306529|NCT03503318|523972604|FG002|Overall Study|Lost to Follow-up|12|||
145306530|NCT03503318|523972602|FG000|Overall Study|Other than specified|1|||
145306531|NCT03503318|523972603|FG001|Overall Study|Other than specified|3|||
145306532|NCT03503318|523972604|FG002|Overall Study|Other than specified|3|||
145306533|NCT03804983|523972609|FG000|Overall Study|Adverse Event|0|||
145306534|NCT03804983|523972610|FG001|Overall Study|Adverse Event|1|||
145306535|NCT03804983|523972609|FG000|Overall Study|Family Obligation|1|||
145306536|NCT03804983|523972610|FG001|Overall Study|Family Obligation|0|||
145306537|NCT02152163|523972611|FG000|Overall Study|Physician Decision|12|||
145306538|NCT02152163|523972612|FG001|Overall Study|Physician Decision|13|||
145306539|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
145306540|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
145306541|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
145306542|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
145306543|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
145306544|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
145306545|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
145569023|NCT01945489|524944167|FG001|Cycle 1|Adverse Event|0|||
145569024|NCT01945489|524944166|FG000|Cycle 1|Lost to Follow-up|4|||
145569025|NCT01945489|524944167|FG001|Cycle 1|Lost to Follow-up|0|||
145569026|NCT01945489|524944166|FG000|Cycle 1|Personal Reasons|4|||
145569027|NCT01945489|524944167|FG001|Cycle 1|Personal Reasons|2|||
145569028|NCT01945489|524944166|FG000|Cycle 1|Protocol Violation|0|||
145569029|NCT01945489|524944167|FG001|Cycle 1|Protocol Violation|1|||
145569030|NCT01945489|524944166|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
145569031|NCT01945489|524944167|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
145306546|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
145306547|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
145306548|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
145306549|NCT00424047|523972616|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
145306550|NCT00424047|523972617|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
145306551|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Adverse Event|22|||
145306552|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Adverse Event|12|||
145306553|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Progression of disease|92|||
145306554|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Progression of disease|128|||
145306555|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
145306556|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
145306557|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
145306558|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
145306559|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Death|11|||
145306560|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Death|11|||
145306561|NCT00424047|523972616|FG000|On Study at Time of Unblinding|Other|5|||
145306562|NCT00424047|523972617|FG001|On Study at Time of Unblinding|Other|4|||
145306563|NCT00424047|523972616|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
145306564|NCT00424047|523972617|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
145306565|NCT00424047|523972616|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
145306566|NCT00424047|523972617|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
145306567|NCT00424047|523972616|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
145306568|NCT00424047|523972617|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
145306569|NCT00424047|523972616|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
145306570|NCT00424047|523972617|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
145306571|NCT00424047|523972616|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
145306572|NCT00424047|523972617|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
145306573|NCT01154231|523972619|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
145306574|NCT01154231|523972619|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
145306575|NCT01097577|523972620|FG000|Overall Study|Adverse Event|0|||
145306576|NCT01097577|523972621|FG001|Overall Study|Adverse Event|1|||
145306577|NCT01958294|523973979|FG000|Overall Study|Clinical Circumstances|2|||
145306578|NCT03599193|523973980|FG000|Overall Study|Adverse Event|0|||
145306579|NCT03599193|523973981|FG001|Overall Study|Adverse Event|2|||
145306580|NCT03599193|523973980|FG000|Overall Study|Withdrawal by Subject|1|||
145306581|NCT03599193|523973981|FG001|Overall Study|Withdrawal by Subject|0|||
145306582|NCT03599193|523973980|FG000|Overall Study|Protocol Violation|1|||
145306583|NCT03599193|523973981|FG001|Overall Study|Protocol Violation|0|||
145306584|NCT03599193|523973980|FG000|Overall Study|Lost to Follow-up|0|||
145306585|NCT03599193|523973981|FG001|Overall Study|Lost to Follow-up|1|||
145306586|NCT00373256|523973982|FG000|Overall Study|Adverse Event (AE)|1|||
145306587|NCT00373256|523973983|FG001|Overall Study|Adverse Event (AE)|5|||
145306588|NCT00373256|523973982|FG000|Overall Study|Lost to Follow-up|2|||
145306589|NCT00373256|523973983|FG001|Overall Study|Lost to Follow-up|1|||
145306590|NCT00373256|523973982|FG000|Overall Study|Death|9|||
145306591|NCT00373256|523973983|FG001|Overall Study|Death|8|||
145306592|NCT00373256|523973982|FG000|Overall Study|Objective Progression or Relapse|111|||
145306593|NCT00373256|523973983|FG001|Overall Study|Objective Progression or Relapse|104|||
145306594|NCT00373256|523973982|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
145306595|NCT00373256|523973983|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
145569032|NCT01945489|524944166|FG000|Cycle 2|Adverse Event|1|||
145569033|NCT01945489|524944167|FG001|Cycle 2|Adverse Event|0|||
145569034|NCT01945489|524944166|FG000|Cycle 2|Lost to Follow-up|0|||
145569035|NCT01945489|524944167|FG001|Cycle 2|Lost to Follow-up|1|||
145306596|NCT00373256|523973982|FG000|Overall Study|Other|73|||
145306597|NCT00373256|523973983|FG001|Overall Study|Other|107|||
145306598|NCT00373256|523973982|FG000|Overall Study|Protocol Violation|0|||
145306599|NCT00373256|523973983|FG001|Overall Study|Protocol Violation|2|||
145306600|NCT00373256|523973982|FG000|Overall Study|Study Terminated by Sponsor|41|||
145306601|NCT00373256|523973983|FG001|Overall Study|Study Terminated by Sponsor|13|||
145306602|NCT04372238|523973986|FG000|Overall Study|Duplicate|3|||
145306603|NCT04372238|523973987|FG001|Overall Study|Duplicate|3|||
145306604|NCT04372238|523973986|FG000|Overall Study|Did not consent for data linkage|6|||
145569036|NCT04144166|524944171|FG000|Overall Study|Discharged before study start|1|||
145569037|NCT04144166|524944171|FG000|Overall Study|Pregnancy|1|||
145569038|NCT04144166|524944171|FG000|Overall Study|Nail polish could not be removed from finger|1|||
145569039|NCT00697346|524944172|FG000|Overall Study|Adverse Event|4|||
145306605|NCT04372238|523973987|FG001|Overall Study|Did not consent for data linkage|10|||
145306606|NCT04241458|523973988|FG000|Overall Study|Withdrawal by Subject|0|||
145306607|NCT04241458|523973989|FG001|Overall Study|Withdrawal by Subject|0|||
145306608|NCT04241458|523973990|FG002|Overall Study|Withdrawal by Subject|0|||
145306609|NCT04241458|523973991|FG003|Overall Study|Withdrawal by Subject|0|||
145306610|NCT04241458|523973992|FG004|Overall Study|Withdrawal by Subject|1|||
145306611|NCT00334815|523973993|FG000|Overall Study|Adverse Event|3|||
145306612|NCT00334815|523973994|FG001|Overall Study|Adverse Event|2|||
145306613|NCT00334815|523973993|FG000|Overall Study|Death|0|||
145306614|NCT00334815|523973994|FG001|Overall Study|Death|2|||
145306615|NCT00334815|523973993|FG000|Overall Study|Progression|1|||
145306616|NCT00334815|523973994|FG001|Overall Study|Progression|0|||
145306617|NCT00334815|523973993|FG000|Overall Study|ineligible|1|||
145306618|NCT00334815|523973994|FG001|Overall Study|ineligible|1|||
145306619|NCT00334815|523973993|FG000|Overall Study|patient refused treatment|0|||
145306620|NCT00334815|523973994|FG001|Overall Study|patient refused treatment|1|||
145306621|NCT00334815|523973993|FG000|Overall Study|Physician Decision|2|||
145306622|NCT00334815|523973994|FG001|Overall Study|Physician Decision|4|||
145306623|NCT06144424|523973995|FG000|Overall Study|Withdrawal by Subject|2|||
145306624|NCT06144424|523973996|FG001|Overall Study|Withdrawal by Subject|0|||
145306625|NCT06144424|523973995|FG000|Overall Study|Incarceration|1|||
145306626|NCT06144424|523973996|FG001|Overall Study|Incarceration|0|||
145306627|NCT02832063|523973997|FG000|Overall Study|Adverse Event|2|||
145306628|NCT02832063|523973998|FG001|Overall Study|Adverse Event|1|||
145306629|NCT02832063|523973997|FG000|Overall Study|Physician Decision|5|||
145306630|NCT02832063|523973998|FG001|Overall Study|Physician Decision|7|||
145306631|NCT02832063|523973997|FG000|Overall Study|Lost to Follow-up|15|||
145306632|NCT02832063|523973998|FG001|Overall Study|Lost to Follow-up|8|||
145306633|NCT02832063|523973997|FG000|Overall Study|Withdrawal by Subject|10|||
145306634|NCT02832063|523973998|FG001|Overall Study|Withdrawal by Subject|21|||
145306635|NCT02832063|523973997|FG000|Overall Study|Other|2|||
145306636|NCT02832063|523973998|FG001|Overall Study|Other|1|||
145306637|NCT03733730|523973999|FG000|Overall Study|Lost to Follow-up|1|||
145306638|NCT03733730|523974000|FG001|Overall Study|Lost to Follow-up|32|||
145306639|NCT03733730|523973999|FG000|Overall Study|Other|1|||
145306640|NCT03733730|523974000|FG001|Overall Study|Other|0|||
145306641|NCT03733730|523973999|FG000|Overall Study|Adverse Event|0|||
145306642|NCT03733730|523974000|FG001|Overall Study|Adverse Event|4|||
145306643|NCT03733730|523973999|FG000|Overall Study|Death|0|||
145306644|NCT03733730|523974000|FG001|Overall Study|Death|5|||
145306645|NCT03733730|523973999|FG000|Overall Study|Withdrawal by Subject|0|||
145306646|NCT03733730|523974000|FG001|Overall Study|Withdrawal by Subject|8|||
145306647|NCT00772603|523974001|FG000|Overall Study|Withdrawal by Subject|11|||
145306648|NCT00772603|523974002|FG001|Overall Study|Withdrawal by Subject|10|||
145306649|NCT00772603|523974003|FG002|Overall Study|Withdrawal by Subject|6|||
145306650|NCT00772603|523974001|FG000|Overall Study|Adverse Event|37|||
145306651|NCT00772603|523974002|FG001|Overall Study|Adverse Event|18|||
145306652|NCT00772603|523974003|FG002|Overall Study|Adverse Event|10|||
145306653|NCT00772603|523974001|FG000|Overall Study|Subject Non-compliance|1|||
145306654|NCT00772603|523974002|FG001|Overall Study|Subject Non-compliance|6|||
145306655|NCT00772603|523974003|FG002|Overall Study|Subject Non-compliance|4|||
145306656|NCT00772603|523974001|FG000|Overall Study|Protocol Violation|0|||
145306657|NCT00772603|523974002|FG001|Overall Study|Protocol Violation|1|||
145306658|NCT00772603|523974003|FG002|Overall Study|Protocol Violation|1|||
145306659|NCT00772603|523974001|FG000|Overall Study|Lost to Follow-up|1|||
145306660|NCT00772603|523974002|FG001|Overall Study|Lost to Follow-up|5|||
145306661|NCT00772603|523974003|FG002|Overall Study|Lost to Follow-up|2|||
145306662|NCT00772603|523974001|FG000|Overall Study|Physician Decision|0|||
145306663|NCT00772603|523974002|FG001|Overall Study|Physician Decision|0|||
145306664|NCT00772603|523974003|FG002|Overall Study|Physician Decision|1|||
145306665|NCT00772603|523974001|FG000|Overall Study|Other|2|||
145306666|NCT00772603|523974002|FG001|Overall Study|Other|0|||
145306667|NCT00772603|523974003|FG002|Overall Study|Other|2|||
145306668|NCT00446966|523974006|FG000|Overall Study|Lost to Follow-up|10|||
145306669|NCT00446966|523974007|FG001|Overall Study|Lost to Follow-up|7|||
145306670|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
145306671|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
145306672|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
145306673|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
145306674|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306675|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306676|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306677|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306678|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145569040|NCT00697346|524944173|FG001|Overall Study|Adverse Event|5|||
145569041|NCT00697346|524944174|FG002|Overall Study|Adverse Event|0|||
145569042|NCT00697346|524944172|FG000|Overall Study|Progressive Disease|19|||
145569043|NCT00697346|524944173|FG001|Overall Study|Progressive Disease|18|||
145306679|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306680|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306681|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306682|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306683|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
145306684|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
145306685|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
145306686|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
145306687|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
145306688|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306689|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306690|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306691|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306692|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306693|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306694|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306695|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306696|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306697|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
145306698|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
145306699|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306700|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
145306701|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306702|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306703|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306704|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306705|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306706|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306707|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306708|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306709|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306710|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306711|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
145306712|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
145306713|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
145306714|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
145306715|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306716|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306717|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306718|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306719|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306720|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306721|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306722|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306723|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306724|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306725|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
145306726|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
145569044|NCT00697346|524944174|FG002|Overall Study|Progressive Disease|0|||
145569045|NCT00697346|524944172|FG000|Overall Study|Symptomatic Deterioration|0|||
145569046|NCT00697346|524944173|FG001|Overall Study|Symptomatic Deterioration|1|||
145569047|NCT00697346|524944174|FG002|Overall Study|Symptomatic Deterioration|0|||
145569048|NCT00697346|524944172|FG000|Overall Study|Withdrawal by Subject|2|||
145569049|NCT00697346|524944173|FG001|Overall Study|Withdrawal by Subject|2|||
145569050|NCT00697346|524944174|FG002|Overall Study|Withdrawal by Subject|0|||
145569051|NCT00697346|524944172|FG000|Overall Study|Reason not Specified|3|||
145569052|NCT00697346|524944173|FG001|Overall Study|Reason not Specified|0|||
145569053|NCT00697346|524944174|FG002|Overall Study|Reason not Specified|1|||
145569054|NCT03643562|524944175|FG000|Overall Study|Adverse Event|1|||
145569055|NCT03643562|524944176|FG001|Overall Study|Adverse Event|0|||
145569056|NCT03643562|524944175|FG000|Overall Study|Lack of Efficacy|0|||
145569057|NCT03643562|524944176|FG001|Overall Study|Lack of Efficacy|1|||
145569058|NCT03643562|524944175|FG000|Overall Study|Physician Decision|0|||
145569059|NCT03643562|524944176|FG001|Overall Study|Physician Decision|1|||
145569060|NCT03643562|524944175|FG000|Overall Study|Study Terminated by Sponsor|2|||
145569061|NCT03643562|524944176|FG001|Overall Study|Study Terminated by Sponsor|10|||
145569062|NCT03643562|524944175|FG000|Overall Study|Withdrawal by Subject|2|||
145569063|NCT03643562|524944176|FG001|Overall Study|Withdrawal by Subject|2|||
145569064|NCT03643562|524944175|FG000|Overall Study|Other than specified|3|||
145569065|NCT03643562|524944176|FG001|Overall Study|Other than specified|2|||
145306727|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306728|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
145306729|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306730|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306731|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306732|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306733|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306734|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306735|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306736|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306737|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306738|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306739|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
145306740|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
145306741|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306742|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
145306743|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306744|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306745|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306746|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306747|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306748|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306749|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306750|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306751|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306752|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306753|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
145306754|NCT01695239|523974008|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
145306755|NCT01695239|523974009|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306756|NCT01695239|523974010|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306757|NCT01695239|523974011|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306758|NCT01695239|523974012|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306759|NCT01695239|523974013|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306760|NCT01695239|523974014|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306761|NCT01695239|523974015|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306762|NCT01695239|523974016|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306763|NCT01695239|523974017|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306764|NCT01695239|523974018|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306765|NCT01695239|523974019|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306766|NCT01695239|523974020|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306767|NCT01695239|523974021|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
145306768|NCT01695239|523974008|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306769|NCT01695239|523974009|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306770|NCT01695239|523974010|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306771|NCT01695239|523974011|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306772|NCT01695239|523974012|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306773|NCT01695239|523974013|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306774|NCT01695239|523974014|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306775|NCT01695239|523974015|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
145306776|NCT01695239|523974016|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306777|NCT01695239|523974017|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306778|NCT01695239|523974018|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306779|NCT01695239|523974019|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306780|NCT01695239|523974020|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306781|NCT01695239|523974021|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
145306782|NCT01695239|523974008|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306783|NCT01695239|523974009|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306784|NCT01695239|523974010|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306785|NCT01695239|523974011|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306786|NCT01695239|523974012|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306787|NCT01695239|523974013|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306788|NCT01695239|523974014|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306789|NCT01695239|523974015|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
145306790|NCT01695239|523974016|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306791|NCT01695239|523974017|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145569066|NCT04145895|524944177|FG000|Overall Study|Physician Decision|2|||
145306792|NCT01695239|523974018|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306793|NCT01695239|523974019|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306794|NCT01695239|523974020|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306795|NCT01695239|523974021|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
145306796|NCT01695239|523974008|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306797|NCT01695239|523974009|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306798|NCT01695239|523974010|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306799|NCT01695239|523974011|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306800|NCT01695239|523974012|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306801|NCT01695239|523974013|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306802|NCT01695239|523974014|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306803|NCT01695239|523974015|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
145306804|NCT01695239|523974016|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306805|NCT01695239|523974017|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306806|NCT01695239|523974018|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306807|NCT01695239|523974019|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306808|NCT01695239|523974020|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306809|NCT01695239|523974021|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
145306810|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306811|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306812|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306813|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306814|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306815|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306816|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306817|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306818|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
145306819|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
145306820|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306821|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306822|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306823|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
145306824|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
145306825|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
145306826|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
145306827|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
145306828|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
145306829|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
145306830|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
145306831|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
145306832|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
145306833|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
145306834|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
145306835|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
145306836|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
145306837|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
145306838|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306839|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306840|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306841|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306842|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306843|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306844|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306845|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306846|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
145306847|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
145306848|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306849|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306850|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306851|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
145306852|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
145306853|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
145306854|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
145306855|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
145306856|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
145306857|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
145306858|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
145306859|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
145306860|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
145306861|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
145306862|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
145306863|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
145306864|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
145306865|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
145306866|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306867|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306868|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306869|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306870|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306871|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306872|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306873|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306874|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
145306875|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
145306876|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306877|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306878|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306879|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
145306880|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306881|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306882|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306883|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306884|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306885|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306886|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306887|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306888|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
145306889|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
145306890|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306891|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306892|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306893|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
145306894|NCT01695239|523974008|FG000|Extension Long-Term Extension Periods|Death|0|||
145306895|NCT01695239|523974009|FG001|Extension Long-Term Extension Periods|Death|0|||
145306896|NCT01695239|523974010|FG002|Extension Long-Term Extension Periods|Death|0|||
145306897|NCT01695239|523974011|FG003|Extension Long-Term Extension Periods|Death|0|||
145306898|NCT01695239|523974012|FG004|Extension Long-Term Extension Periods|Death|0|||
145306899|NCT01695239|523974013|FG005|Extension Long-Term Extension Periods|Death|0|||
145306900|NCT01695239|523974014|FG006|Extension Long-Term Extension Periods|Death|0|||
145306901|NCT01695239|523974015|FG007|Extension Long-Term Extension Periods|Death|0|||
145306902|NCT01695239|523974016|FG008|Extension Long-Term Extension Periods|Death|1|||
145306903|NCT01695239|523974017|FG009|Extension Long-Term Extension Periods|Death|0|||
145306904|NCT01695239|523974018|FG010|Extension Long-Term Extension Periods|Death|0|||
145306905|NCT01695239|523974019|FG011|Extension Long-Term Extension Periods|Death|0|||
145306906|NCT01695239|523974020|FG012|Extension Long-Term Extension Periods|Death|0|||
145306907|NCT01695239|523974021|FG013|Extension Long-Term Extension Periods|Death|0|||
145306908|NCT01695239|523974008|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306909|NCT01695239|523974009|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306910|NCT01695239|523974010|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306911|NCT01695239|523974011|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306912|NCT01695239|523974012|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306913|NCT01695239|523974013|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306914|NCT01695239|523974014|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306915|NCT01695239|523974015|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306916|NCT01695239|523974016|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306917|NCT01695239|523974017|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306918|NCT01695239|523974018|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
145306919|NCT01695239|523974019|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
145306920|NCT01695239|523974020|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
145306921|NCT01695239|523974021|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
145306922|NCT01695239|523974008|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306923|NCT01695239|523974009|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306924|NCT01695239|523974010|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306925|NCT01695239|523974011|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306926|NCT01695239|523974012|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306927|NCT01695239|523974013|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306928|NCT01695239|523974014|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306929|NCT01695239|523974015|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306930|NCT01695239|523974016|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306931|NCT01695239|523974017|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306932|NCT01695239|523974018|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306933|NCT01695239|523974019|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145306934|NCT01695239|523974020|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
145306935|NCT01695239|523974021|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
145306936|NCT01695239|523974008|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306937|NCT01695239|523974009|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306938|NCT01695239|523974010|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306939|NCT01695239|523974011|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306940|NCT01695239|523974012|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306941|NCT01695239|523974013|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306942|NCT01695239|523974014|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306943|NCT01695239|523974015|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306944|NCT01695239|523974016|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306945|NCT01695239|523974017|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306946|NCT01695239|523974018|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306947|NCT01695239|523974019|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306948|NCT01695239|523974020|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
145306949|NCT01695239|523974021|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
145306950|NCT01695239|523974008|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306951|NCT01695239|523974009|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306952|NCT01695239|523974010|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306953|NCT01695239|523974011|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306954|NCT01695239|523974012|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306955|NCT01695239|523974013|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306956|NCT01695239|523974014|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306957|NCT01695239|523974015|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306958|NCT01695239|523974016|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306959|NCT01695239|523974017|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306960|NCT01695239|523974018|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306961|NCT01695239|523974019|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306962|NCT01695239|523974020|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
145306963|NCT01695239|523974021|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
145306964|NCT03913377|523974024|FG000|Period 1|Test Article no longer available|0|||
145306965|NCT03913377|523974025|FG001|Period 1|Test Article no longer available|1|||
145306966|NCT03913377|523974026|FG002|Period 1|Test Article no longer available|0|||
145306967|NCT03913377|523974024|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
145306968|NCT03913377|523974025|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
145306969|NCT03913377|523974026|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
145306970|NCT05239195|523974027|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
145306971|NCT05239195|523974028|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
145306972|NCT02663349|523974029|FG000|Overall Study|Withdrawal by Subject|6|||
145306973|NCT00928057|523974031|FG000|Overall Study|Adverse Event|1|||
145306974|NCT00928057|523974032|FG001|Overall Study|Adverse Event|2|||
145306975|NCT00928057|523974031|FG000|Overall Study|Withdrawal by Subject|1|||
145306976|NCT00928057|523974032|FG001|Overall Study|Withdrawal by Subject|0|||
145306977|NCT00928057|523974031|FG000|Overall Study|Lost to Follow-up|0|||
145569067|NCT04145895|524944178|FG001|Overall Study|Physician Decision|0|||
145569068|NCT04145895|524944177|FG000|Overall Study|Withdrawal by Subject|0|||
145569069|NCT04145895|524944178|FG001|Overall Study|Withdrawal by Subject|2|||
145569070|NCT01236755|524944179|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
145569071|NCT01236755|524944179|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
145306978|NCT00928057|523974032|FG001|Overall Study|Lost to Follow-up|1|||
145306979|NCT00928057|523974031|FG000|Overall Study|Protocol Violation|0|||
145306980|NCT00928057|523974032|FG001|Overall Study|Protocol Violation|1|||
145306981|NCT02451696|523974033|FG000|Overall Study|Surgery postponed|1|||
145569072|NCT01236755|524944179|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
145306982|NCT02451696|523974034|FG001|Overall Study|Surgery postponed|0|||
145306983|NCT01557751|523974035|FG000|Overall Study|Physician Decision|3|||
145569073|NCT01236755|524944179|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
145306984|NCT03674892|523974037|FG000|Overall Study|Lack of Efficacy|5|||
145306985|NCT03674892|523974037|FG000|Overall Study|Lost to Follow-up|3|||
145306986|NCT03674892|523974037|FG000|Overall Study|Migraine|2|||
145306987|NCT03674892|523974037|FG000|Overall Study|Excessive Tearing|1|||
145306988|NCT03674892|523974037|FG000|Overall Study|Increased Eye Pain|1|||
145306989|NCT03674892|523974037|FG000|Overall Study|Increased Facial Pain|1|||
145306990|NCT03674892|523974037|FG000|Overall Study|Sinus Irritation|1|||
145306991|NCT03674892|523974037|FG000|Overall Study|Sinus Infection|1|||
145306992|NCT05099380|523974038|FG000|Overall Study|Subject enrolled in error|1|||
145306993|NCT05099380|523974039|FG001|Overall Study|Subject enrolled in error|0|||
145306994|NCT05099380|523974038|FG000|Overall Study|Study Procedure|1|||
145306995|NCT05099380|523974039|FG001|Overall Study|Study Procedure|0|||
145306996|NCT05099380|523974038|FG000|Overall Study|Protocol Violation|1|||
145306997|NCT05099380|523974039|FG001|Overall Study|Protocol Violation|0|||
145306998|NCT05099380|523974038|FG000|Overall Study|Adverse Event|1|||
145306999|NCT05099380|523974039|FG001|Overall Study|Adverse Event|1|||
145307000|NCT05099380|523974038|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
145307001|NCT05099380|523974039|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
145307002|NCT00840216|523974040|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145307003|NCT00840216|523974041|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145307004|NCT00848536|523974042|FG000|Overall Study|Adverse Event|2|||
145307005|NCT00848536|523974043|FG001|Overall Study|Adverse Event|2|||
145307006|NCT00848536|523974042|FG000|Overall Study|Withdrawal by Subject|0|||
145307007|NCT00848536|523974043|FG001|Overall Study|Withdrawal by Subject|1|||
145307008|NCT00848536|523974042|FG000|Overall Study|Protocol Violation|0|||
145307009|NCT00848536|523974043|FG001|Overall Study|Protocol Violation|1|||
145307010|NCT00848536|523974042|FG000|Overall Study|Noncompliance|1|||
145307011|NCT00848536|523974043|FG001|Overall Study|Noncompliance|0|||
145307012|NCT00848536|523974042|FG000|Overall Study|Inadequate Control of IOP|1|||
145307013|NCT00848536|523974043|FG001|Overall Study|Inadequate Control of IOP|1|||
145307014|NCT00848536|523974042|FG000|Overall Study|Patient Moved|0|||
145307015|NCT00848536|523974043|FG001|Overall Study|Patient Moved|2|||
145307016|NCT02842853|523974044|FG000|Overall Study|Non-compliance with the protocol|3|||
145307017|NCT02842853|523974045|FG001|Overall Study|Non-compliance with the protocol|7|||
145307018|NCT02842853|523974046|FG002|Overall Study|Non-compliance with the protocol|2|||
145307019|NCT02842853|523974047|FG003|Overall Study|Non-compliance with the protocol|5|||
145307020|NCT02842853|523974044|FG000|Overall Study|Subject met exclusion criteria|0|||
145307021|NCT02842853|523974045|FG001|Overall Study|Subject met exclusion criteria|1|||
145307022|NCT02842853|523974046|FG002|Overall Study|Subject met exclusion criteria|0|||
145307023|NCT02842853|523974047|FG003|Overall Study|Subject met exclusion criteria|0|||
145307024|NCT02842853|523974044|FG000|Overall Study|Withdrawal by Subject|11|||
145307025|NCT02842853|523974045|FG001|Overall Study|Withdrawal by Subject|13|||
145307026|NCT02842853|523974046|FG002|Overall Study|Withdrawal by Subject|9|||
145307027|NCT02842853|523974047|FG003|Overall Study|Withdrawal by Subject|8|||
145307028|NCT02842853|523974044|FG000|Overall Study|Lost to Follow-up|9|||
145307029|NCT02842853|523974045|FG001|Overall Study|Lost to Follow-up|13|||
145307030|NCT02842853|523974046|FG002|Overall Study|Lost to Follow-up|10|||
145307031|NCT02842853|523974047|FG003|Overall Study|Lost to Follow-up|11|||
145307032|NCT04089553|523974048|FG000|Overall Study|Death|1|||
145307033|NCT04089553|523974049|FG001|Overall Study|Death|1|||
145307034|NCT04089553|523974048|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
145307035|NCT04089553|523974049|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
145307036|NCT04089553|523974048|FG000|Overall Study|Withdrawal by Subject|3|||
145307037|NCT04089553|523974049|FG001|Overall Study|Withdrawal by Subject|3|||
145307038|NCT04089553|523974048|FG000|Overall Study|Physician Decision|1|||
145307039|NCT04089553|523974049|FG001|Overall Study|Physician Decision|0|||
145307040|NCT04089553|523974048|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
145307041|NCT04089553|523974049|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
145307042|NCT04089553|523974048|FG000|Overall Study|Other|1|||
145307043|NCT04089553|523974049|FG001|Overall Study|Other|0|||
145307044|NCT04089553|523974048|FG000|Overall Study|Adverse Event|1|||
145307045|NCT04089553|523974049|FG001|Overall Study|Adverse Event|1|||
145569074|NCT01481116|524944180|FG000|Overall Study|Adverse Event|26|||
145307046|NCT01175135|523974057|FG000|Overall Study|Adverse Event|2|||
145307047|NCT01175135|523974058|FG001|Overall Study|Adverse Event|5|||
145307048|NCT01175135|523974059|FG002|Overall Study|Adverse Event|3|||
145307049|NCT01175135|523974060|FG003|Overall Study|Adverse Event|4|||
145307050|NCT01175135|523974057|FG000|Overall Study|Death|1|||
145307051|NCT01175135|523974058|FG001|Overall Study|Death|0|||
145307052|NCT01175135|523974059|FG002|Overall Study|Death|0|||
145307053|NCT01175135|523974060|FG003|Overall Study|Death|0|||
145307054|NCT01175135|523974057|FG000|Overall Study|Lack of Efficacy|4|||
145307055|NCT01175135|523974058|FG001|Overall Study|Lack of Efficacy|5|||
145307056|NCT01175135|523974059|FG002|Overall Study|Lack of Efficacy|0|||
145307057|NCT01175135|523974060|FG003|Overall Study|Lack of Efficacy|5|||
145307058|NCT01175135|523974057|FG000|Overall Study|Lost to Follow-up|1|||
145307059|NCT01175135|523974058|FG001|Overall Study|Lost to Follow-up|2|||
145307060|NCT01175135|523974059|FG002|Overall Study|Lost to Follow-up|0|||
145307061|NCT01175135|523974060|FG003|Overall Study|Lost to Follow-up|0|||
145307062|NCT01175135|523974057|FG000|Overall Study|Protocol Violation|1|||
145307063|NCT01175135|523974058|FG001|Overall Study|Protocol Violation|1|||
145307064|NCT01175135|523974059|FG002|Overall Study|Protocol Violation|0|||
145307065|NCT01175135|523974060|FG003|Overall Study|Protocol Violation|0|||
145307066|NCT01175135|523974057|FG000|Overall Study|Withdrawal by Subject|4|||
145307067|NCT01175135|523974058|FG001|Overall Study|Withdrawal by Subject|8|||
145307068|NCT01175135|523974059|FG002|Overall Study|Withdrawal by Subject|5|||
145307069|NCT01175135|523974060|FG003|Overall Study|Withdrawal by Subject|5|||
145307070|NCT01175135|523974057|FG000|Overall Study|Other|3|||
145307071|NCT01175135|523974058|FG001|Overall Study|Other|1|||
145307072|NCT01175135|523974059|FG002|Overall Study|Other|3|||
145307073|NCT01175135|523974060|FG003|Overall Study|Other|0|||
145307074|NCT01175135|523974057|FG000|Overall Study|Randomized But Not Treated|0|||
145307075|NCT01175135|523974058|FG001|Overall Study|Randomized But Not Treated|0|||
145307076|NCT01175135|523974059|FG002|Overall Study|Randomized But Not Treated|1|||
145307077|NCT01175135|523974060|FG003|Overall Study|Randomized But Not Treated|0|||
145307078|NCT01572662|523974061|FG000|Overall Study|Withdrawal by Subject|1|||
145307079|NCT01572662|523974062|FG001|Overall Study|Withdrawal by Subject|0|||
145307080|NCT01572662|523974061|FG000|Overall Study|Physician Decision|0|||
145307081|NCT01572662|523974062|FG001|Overall Study|Physician Decision|1|||
145307082|NCT03364192|523974063|FG000|Overall Study|Ineligible|10|||
145307083|NCT03364192|523974063|FG000|Overall Study|Withdrawal by Subject|5|||
145307084|NCT03364192|523974063|FG000|Overall Study|Lost to Follow-up|1|||
145307085|NCT00935012|523974066|FG000|Overall Study|Death|19|||
145307086|NCT00935012|523974066|FG000|Overall Study|Withdrawal by Subject|3|||
145307087|NCT00935012|523974066|FG000|Overall Study|Other|5|||
145307088|NCT00935012|523974066|FG000|Overall Study|Adverse Event|2|||
145307089|NCT01442155|523974067|FG000|Overall Study|Complete remission|35|||
145307090|NCT01442155|523974067|FG000|Overall Study|Recurrence|26|||
145307091|NCT01442155|523974067|FG000|Overall Study|Adverse Event|2|||
145307092|NCT01442155|523974067|FG000|Overall Study|Lost to Follow-up|2|||
145307093|NCT01590563|523974074|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
145307094|NCT02699463|523974077|FG000|Overall Study|Lost to Follow-up|11|||
145307095|NCT02699463|523974078|FG001|Overall Study|Lost to Follow-up|8|||
145307096|NCT02699463|523974077|FG000|Overall Study|Withdrawal by Subject|4|||
145307097|NCT02699463|523974078|FG001|Overall Study|Withdrawal by Subject|1|||
145307098|NCT06539676|523974079|FG000|Overall Study|Early study termination|1|||
145307099|NCT06539676|523974080|FG001|Overall Study|Early study termination|0|||
145307100|NCT06539676|523974081|FG002|Overall Study|Early study termination|6|||
145307101|NCT00909038|523974084|FG000|Overall Study|Protocol Violation|187|||
145307102|NCT00909038|523974084|FG000|Overall Study|Non-evaluable Subjects|230|||
145307103|NCT03214588|523974087|FG000|Overall Study|Adverse Event|1|||
145307104|NCT03214588|523974088|FG001|Overall Study|Adverse Event|0|||
145307105|NCT03214588|523974089|FG002|Overall Study|Adverse Event|2|||
145307106|NCT03214588|523974087|FG000|Overall Study|Reason Not Specified|0|||
145307107|NCT03214588|523974088|FG001|Overall Study|Reason Not Specified|1|||
145307108|NCT03214588|523974089|FG002|Overall Study|Reason Not Specified|0|||
145307109|NCT01794845|523974090|FG000|Overall Study|Withdrawal by Subject|1|||
145307110|NCT02139826|523974091|FG000|Overall Study|Adverse Event|1|||
145307111|NCT00436163|523974092|FG000|Overall Study|Lost to Follow-up|2|||
145307112|NCT00436163|523974092|FG000|Overall Study|Adverse Event|1|||
145307113|NCT03719040|523974093|FG000|Overall Study|Withdrawal by Subject|177|||
145307114|NCT03719040|523974093|FG000|Overall Study|Lost to Follow-up|26|||
145307115|NCT00312897|523974096|FG000|Overall Study|Adverse Event|1|||
145307116|NCT00312897|523974097|FG001|Overall Study|Adverse Event|0|||
145307117|NCT00312897|523974096|FG000|Overall Study|Lost to Follow-up|2|||
145307118|NCT00312897|523974097|FG001|Overall Study|Lost to Follow-up|0|||
145307119|NCT00312897|523974096|FG000|Overall Study|Physician Decision|1|||
145307120|NCT00312897|523974097|FG001|Overall Study|Physician Decision|0|||
145307121|NCT00312897|523974096|FG000|Overall Study|Withdrawal by Subject|1|||
145307122|NCT00312897|523974097|FG001|Overall Study|Withdrawal by Subject|3|||
145307123|NCT00312897|523974096|FG000|Overall Study|Pregnancy|1|||
145307124|NCT00312897|523974097|FG001|Overall Study|Pregnancy|0|||
145307125|NCT00312897|523974096|FG000|Overall Study|discontinued prior to getting treatment|0|||
145307126|NCT00312897|523974097|FG001|Overall Study|discontinued prior to getting treatment|3|||
145307127|NCT01473953|523974098|FG000|Overall Study|Other|1|||
145569075|NCT01481116|524944181|FG001|Overall Study|Adverse Event|26|||
145569076|NCT01481116|524944182|FG002|Overall Study|Adverse Event|42|||
145307128|NCT01473953|523974099|FG001|Overall Study|Other|0|||
145307129|NCT01473953|523974100|FG002|Overall Study|Other|0|||
145307130|NCT01473953|523974101|FG003|Overall Study|Other|0|||
145307131|NCT01473953|523974102|FG004|Overall Study|Other|0|||
145307132|NCT03100344|523974105|FG000|Overall Study|Adverse Event|0|||
145307133|NCT03100344|523974106|FG001|Overall Study|Adverse Event|3|||
145307134|NCT03100344|523974107|FG002|Overall Study|Adverse Event|2|||
145569077|NCT01481116|524944180|FG000|Overall Study|Major Protocol Deviation|3|||
145307135|NCT03100344|523974108|FG003|Overall Study|Adverse Event|3|||
145307136|NCT03100344|523974105|FG000|Overall Study|Lack of Efficacy|2|||
145569078|NCT01481116|524944181|FG001|Overall Study|Major Protocol Deviation|7|||
145307137|NCT03100344|523974106|FG001|Overall Study|Lack of Efficacy|0|||
145307138|NCT03100344|523974107|FG002|Overall Study|Lack of Efficacy|0|||
145307139|NCT03100344|523974108|FG003|Overall Study|Lack of Efficacy|0|||
145307140|NCT03100344|523974105|FG000|Overall Study|Protocol Violation|1|||
145307141|NCT03100344|523974106|FG001|Overall Study|Protocol Violation|0|||
145307142|NCT03100344|523974107|FG002|Overall Study|Protocol Violation|0|||
145307143|NCT03100344|523974108|FG003|Overall Study|Protocol Violation|0|||
145307144|NCT03100344|523974105|FG000|Overall Study|Withdrawal by Subject|10|||
145307145|NCT03100344|523974106|FG001|Overall Study|Withdrawal by Subject|7|||
145307146|NCT03100344|523974107|FG002|Overall Study|Withdrawal by Subject|4|||
145307147|NCT03100344|523974108|FG003|Overall Study|Withdrawal by Subject|8|||
145307148|NCT03100344|523974105|FG000|Overall Study|Lost to Follow-up|1|||
145307149|NCT03100344|523974106|FG001|Overall Study|Lost to Follow-up|1|||
145307150|NCT03100344|523974107|FG002|Overall Study|Lost to Follow-up|1|||
145307151|NCT03100344|523974108|FG003|Overall Study|Lost to Follow-up|1|||
145307152|NCT01010503|523974109|FG000|Overall Study|Adverse Event|1|||
145307153|NCT01010503|523974109|FG000|Overall Study|Death|1|||
145307154|NCT04633564|523974110|FG000|Period 1|Adverse Event|28|||
145307155|NCT04633564|523974111|FG001|Period 1|Adverse Event|19|||
145307156|NCT04633564|523974110|FG000|Period 1|Death|8|||
145307157|NCT04633564|523974111|FG001|Period 1|Death|7|||
145307158|NCT04633564|523974110|FG000|Period 1|Lost to Follow-up|3|||
145307159|NCT04633564|523974111|FG001|Period 1|Lost to Follow-up|5|||
145307160|NCT04633564|523974110|FG000|Period 1|Physician Decision|4|||
145307161|NCT04633564|523974111|FG001|Period 1|Physician Decision|12|||
145307162|NCT04633564|523974110|FG000|Period 1|Protocol Violation|0|||
145307163|NCT04633564|523974111|FG001|Period 1|Protocol Violation|1|||
145307164|NCT04633564|523974110|FG000|Period 1|Withdrawal by Subject|10|||
145307165|NCT04633564|523974111|FG001|Period 1|Withdrawal by Subject|8|||
145307166|NCT04633564|523974110|FG000|Period 1|Progressive disease|47|||
145307167|NCT04633564|523974111|FG001|Period 1|Progressive disease|51|||
145307168|NCT04633564|523974110|FG000|Period 1|Terminated by Sponsor|8|||
145307169|NCT04633564|523974111|FG001|Period 1|Terminated by Sponsor|6|||
145307170|NCT04633564|523974110|FG000|Period 2|Adverse Event|3|||
145307171|NCT04633564|523974111|FG001|Period 2|Adverse Event|4|||
145307172|NCT04633564|523974110|FG000|Period 2|Death|0|||
145307173|NCT04633564|523974111|FG001|Period 2|Death|2|||
145307174|NCT04633564|523974110|FG000|Period 2|Lost to Follow-up|0|||
145307175|NCT04633564|523974111|FG001|Period 2|Lost to Follow-up|1|||
145307176|NCT04633564|523974110|FG000|Period 2|Physician Decision|2|||
145307177|NCT04633564|523974111|FG001|Period 2|Physician Decision|4|||
145307178|NCT04633564|523974110|FG000|Period 2|Withdrawal by Subject|5|||
145307179|NCT04633564|523974111|FG001|Period 2|Withdrawal by Subject|1|||
145307180|NCT04633564|523974110|FG000|Period 2|Progressive Disease|74|||
145307181|NCT04633564|523974111|FG001|Period 2|Progressive Disease|82|||
145307182|NCT04633564|523974110|FG000|Period 2|Terminated by Sponsor|9|||
145307183|NCT04633564|523974111|FG001|Period 2|Terminated by Sponsor|3|||
145307184|NCT01952691|523975553|FG000|Overall Study|Lost to Follow-up|2|||
145307185|NCT00199901|523975554|FG000|Overall Study|Protocol Violation|2|||
145307186|NCT00199901|523975555|FG001|Overall Study|Protocol Violation|0|||
145307187|NCT00199901|523975554|FG000|Overall Study|Withdrawal by Subject|1|||
145307188|NCT00199901|523975555|FG001|Overall Study|Withdrawal by Subject|0|||
145307189|NCT00199901|523975554|FG000|Overall Study|Progressive Disease|24|||
145307190|NCT00199901|523975555|FG001|Overall Study|Progressive Disease|24|||
145307191|NCT02566850|523975562|FG000|Overall Study|Protocol Violation|1|||
145307192|NCT00798603|523975563|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
145307193|NCT00798603|523975563|FG000|Overall Study|Withdrawal by Subject|10|||
145307194|NCT00798603|523975563|FG000|Overall Study|Adverse Event|22|||
145307195|NCT00798603|523975563|FG000|Overall Study|Physician Decision|1|||
145307196|NCT00798603|523975563|FG000|Overall Study|Lack of insurance coverage|1|||
145307197|NCT00081653|523975569|FG000|Overall Study|Adverse Event|23|||
145307198|NCT00081653|523975570|FG001|Overall Study|Adverse Event|17|||
145307199|NCT00081653|523975569|FG000|Overall Study|Lost to Follow-up|2|||
145307200|NCT00081653|523975570|FG001|Overall Study|Lost to Follow-up|4|||
145307201|NCT00081653|523975569|FG000|Overall Study|Refused Treatment|18|||
145307202|NCT00081653|523975570|FG001|Overall Study|Refused Treatment|14|||
145307203|NCT00081653|523975569|FG000|Overall Study|Low bone mineral density|1|||
145307204|NCT00081653|523975570|FG001|Overall Study|Low bone mineral density|0|||
145307205|NCT00081653|523975569|FG000|Overall Study|Bone loss|2|||
145569079|NCT01481116|524944182|FG002|Overall Study|Major Protocol Deviation|1|||
145569080|NCT01481116|524944180|FG000|Overall Study|Lost to Follow-up|8|||
145569081|NCT01481116|524944181|FG001|Overall Study|Lost to Follow-up|12|||
145307206|NCT00081653|523975570|FG001|Overall Study|Bone loss|0|||
145307207|NCT00081653|523975569|FG000|Overall Study|Participant leaving country|1|||
145307208|NCT00081653|523975570|FG001|Overall Study|Participant leaving country|0|||
145307209|NCT00081653|523975569|FG000|Overall Study|Loss of bone mass|0|||
145569082|NCT01481116|524944182|FG002|Overall Study|Lost to Follow-up|11|||
145307210|NCT00081653|523975570|FG001|Overall Study|Loss of bone mass|2|||
145307211|NCT03206749|523975571|FG000|Overall Study|Withdrawal of consent|5|||
145307212|NCT03206749|523975572|FG001|Overall Study|Withdrawal of consent|3|||
145307213|NCT03206749|523975573|FG002|Overall Study|Withdrawal of consent|6|||
145307214|NCT03206749|523975571|FG000|Overall Study|Lost to Follow-up|0|||
145307215|NCT03206749|523975572|FG001|Overall Study|Lost to Follow-up|0|||
145307216|NCT03206749|523975573|FG002|Overall Study|Lost to Follow-up|1|||
145307217|NCT02752074|523975574|FG000|Overall Study|Lost to Follow-up|1|||
145307218|NCT02752074|523975575|FG001|Overall Study|Lost to Follow-up|4|||
145307219|NCT02752074|523975574|FG000|Overall Study|Death|146|||
145307220|NCT02752074|523975575|FG001|Overall Study|Death|129|||
145307221|NCT02752074|523975574|FG000|Overall Study|Withdrawal by Subject|9|||
145307222|NCT02752074|523975575|FG001|Overall Study|Withdrawal by Subject|10|||
145307223|NCT00488774|523975576|FG000|Overall Study|Withdrawal of consent|2|||
145307224|NCT00488774|523975577|FG001|Overall Study|Withdrawal of consent|2|||
145620337|NCT00996580|525123741|FG000|Overall Study|Withdrawal by Subject|217|||
145620338|NCT00996580|525123741|FG000|Overall Study|Other|29|||
145620339|NCT00238420|525123742|FG000|Overall Study|Protocol Violation|1|||
145620340|NCT00238420|525123743|FG001|Overall Study|Protocol Violation|1|||
145620341|NCT00442286|525123744|FG000|Overall Study|Death|2|||
145620342|NCT00442286|525123745|FG001|Overall Study|Death|2|||
145307225|NCT00488774|523975578|FG002|Overall Study|Withdrawal of consent|2|||
145307226|NCT00488774|523975579|FG003|Overall Study|Withdrawal of consent|0|||
145307227|NCT00488774|523975576|FG000|Overall Study|Other|6|||
145307228|NCT00488774|523975577|FG001|Overall Study|Other|3|||
145307229|NCT00488774|523975578|FG002|Overall Study|Other|2|||
145307230|NCT00488774|523975579|FG003|Overall Study|Other|2|||
145307231|NCT00488774|523975576|FG000|Overall Study|Lost to Follow-up|0|||
145307232|NCT00488774|523975577|FG001|Overall Study|Lost to Follow-up|0|||
145307233|NCT00488774|523975578|FG002|Overall Study|Lost to Follow-up|1|||
145307234|NCT00488774|523975579|FG003|Overall Study|Lost to Follow-up|1|||
145307235|NCT05523895|523975580|FG000|Overall Study|Adverse Event|2|||
145307236|NCT05523895|523975581|FG001|Overall Study|Adverse Event|1|||
145307237|NCT05523895|523975582|FG002|Overall Study|Adverse Event|1|||
145307238|NCT05523895|523975580|FG000|Overall Study|Lost to Follow-up|0|||
145307239|NCT05523895|523975581|FG001|Overall Study|Lost to Follow-up|1|||
145307240|NCT05523895|523975582|FG002|Overall Study|Lost to Follow-up|2|||
145307241|NCT05523895|523975580|FG000|Overall Study|Noncompliance with study drug|1|||
145307242|NCT05523895|523975581|FG001|Overall Study|Noncompliance with study drug|1|||
145307243|NCT05523895|523975582|FG002|Overall Study|Noncompliance with study drug|1|||
145307244|NCT05523895|523975580|FG000|Overall Study|Protocol Violation|0|||
145307245|NCT05523895|523975581|FG001|Overall Study|Protocol Violation|2|||
145307246|NCT05523895|523975582|FG002|Overall Study|Protocol Violation|0|||
145307247|NCT05523895|523975580|FG000|Overall Study|Withdrawal by Subject|1|||
145307248|NCT05523895|523975581|FG001|Overall Study|Withdrawal by Subject|3|||
145307249|NCT05523895|523975582|FG002|Overall Study|Withdrawal by Subject|1|||
145307250|NCT05523895|523975580|FG000|Overall Study|Not further specified|0|||
145307251|NCT05523895|523975581|FG001|Overall Study|Not further specified|3|||
145307252|NCT05523895|523975582|FG002|Overall Study|Not further specified|1|||
145307253|NCT01959672|523975585|FG000|Overall Study|Death|1|||
145307254|NCT03446768|523975586|FG000|Overall Study|Withdrawal by Subject|0|||
145307255|NCT03446768|523975587|FG001|Overall Study|Withdrawal by Subject|1|||
145307256|NCT04547192|523975588|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
145307257|NCT04547192|523975589|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
145307258|NCT04547192|523975590|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
145307259|NCT04547192|523975591|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
145307260|NCT04547192|523975588|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
145307261|NCT04547192|523975589|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
145307262|NCT04547192|523975590|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
145307263|NCT04547192|523975591|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
145307264|NCT04547192|523975588|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
145307265|NCT04547192|523975589|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
145307266|NCT04547192|523975590|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
145307267|NCT04547192|523975591|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
145307268|NCT04547192|523975588|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
145307269|NCT04547192|523975589|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
145307270|NCT04547192|523975590|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
145307271|NCT04547192|523975591|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
145307272|NCT04547192|523975588|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
145307273|NCT04547192|523975589|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
145307274|NCT04547192|523975590|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
145307275|NCT04547192|523975591|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
145307276|NCT02488239|523975596|FG000|Overall Study|Death|3|||
145307277|NCT02488239|523975596|FG000|Overall Study|Withdrawal by Subject|3|||
145307278|NCT02488239|523975596|FG000|Overall Study|Physician Decision|2|||
145307279|NCT02488239|523975596|FG000|Overall Study|Consent ineligible|1|||
145307280|NCT02488239|523975596|FG000|Overall Study|Did not undergo implant procedure|1|||
145307281|NCT02294981|523975597|FG000|Overall Study|Lost to Follow-up|1|||
145307282|NCT00909753|523975598|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
145307283|NCT00909753|523975599|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
145307284|NCT00909753|523975598|FG000|Period: Second Intervention|Protocol Violation|1|||
145620343|NCT00442286|525123744|FG000|Overall Study|Lost to Follow-up|1|||
145307285|NCT00909753|523975599|FG001|Period: Second Intervention|Protocol Violation|0|||
145307286|NCT04345653|523975600|FG000|Overall Study|Withdrawal by Subject|2|||
145307287|NCT01895335|523975601|FG000|Overall Study|Adverse Event|106|||
145307288|NCT01895335|523975601|FG000|Overall Study|Lack of Efficacy|53|||
145307289|NCT01895335|523975601|FG000|Overall Study|Poor Compliance to Protocol|11|||
145307290|NCT01895335|523975601|FG000|Overall Study|Included But Not treated|1|||
145307291|NCT01895335|523975601|FG000|Overall Study|Other than Specified Above|44|||
145307292|NCT00115063|523975604|FG000|Overall Study|Lost to Follow-up|98|||
145307293|NCT00115063|523975605|FG001|Overall Study|Lost to Follow-up|104|||
145307294|NCT00115063|523975604|FG000|Overall Study|Death|1|||
145307295|NCT00115063|523975605|FG001|Overall Study|Death|0|||
145307296|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
145307297|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
145307298|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
145307299|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
145307300|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
145307301|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
145307302|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Death|9|||
145307303|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Death|7|||
145307304|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Death|14|||
145307305|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Death|7|||
145307306|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Death|0|||
145307307|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Death|0|||
145307308|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
145307309|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
145307310|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
145307311|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
145307312|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
145307313|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
145307314|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Other Event|49|||
145307315|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Other Event|52|||
145307316|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Other Event|41|||
145307317|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Other Event|58|||
145307318|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Other Event|0|||
145307319|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Other Event|0|||
145307320|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
145307321|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
145307322|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
145307323|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
145307324|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
145307325|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
145307326|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
145307327|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
145307328|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
145307329|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
145307330|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
145307331|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
145307332|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
145307333|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
145307334|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
145307335|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
145307336|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
145307337|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
145307338|NCT00205777|523975608|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
145307339|NCT00205777|523975609|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
145307340|NCT00205777|523975610|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
145307341|NCT00205777|523975611|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
145307342|NCT00205777|523975612|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
145307343|NCT00205777|523975613|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
145307344|NCT00205777|523975608|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
145307345|NCT00205777|523975609|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
145307346|NCT00205777|523975610|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
145307347|NCT00205777|523975611|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
145307348|NCT00205777|523975612|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
145307349|NCT00205777|523975613|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
145307350|NCT00205777|523975608|FG000|Completed Core Study, Entered SE I|Other Event|52|||
145307351|NCT00205777|523975609|FG001|Completed Core Study, Entered SE I|Other Event|46|||
145307352|NCT00205777|523975610|FG002|Completed Core Study, Entered SE I|Other Event|47|||
145307353|NCT00205777|523975611|FG003|Completed Core Study, Entered SE I|Other Event|50|||
145307354|NCT00205777|523975612|FG004|Completed Core Study, Entered SE I|Other Event|0|||
145307355|NCT00205777|523975613|FG005|Completed Core Study, Entered SE I|Other Event|0|||
145307356|NCT00205777|523975608|FG000|Study Extension I|Adverse Event|57|||
145307357|NCT00205777|523975609|FG001|Study Extension I|Adverse Event|0|||
145307358|NCT00205777|523975610|FG002|Study Extension I|Adverse Event|0|||
145307359|NCT00205777|523975611|FG003|Study Extension I|Adverse Event|61|||
145307360|NCT00205777|523975612|FG004|Study Extension I|Adverse Event|58|||
145307361|NCT00205777|523975613|FG005|Study Extension I|Adverse Event|0|||
145307362|NCT00205777|523975608|FG000|Study Extension I|Death|5|||
145307363|NCT00205777|523975609|FG001|Study Extension I|Death|0|||
145307364|NCT00205777|523975610|FG002|Study Extension I|Death|0|||
145307365|NCT00205777|523975611|FG003|Study Extension I|Death|1|||
145307366|NCT00205777|523975612|FG004|Study Extension I|Death|2|||
145307367|NCT00205777|523975613|FG005|Study Extension I|Death|0|||
145307368|NCT00205777|523975608|FG000|Study Extension I|Withdrawal by Subject|99|||
145307369|NCT00205777|523975609|FG001|Study Extension I|Withdrawal by Subject|0|||
145307370|NCT00205777|523975610|FG002|Study Extension I|Withdrawal by Subject|0|||
145307371|NCT00205777|523975611|FG003|Study Extension I|Withdrawal by Subject|106|||
145307372|NCT00205777|523975612|FG004|Study Extension I|Withdrawal by Subject|89|||
145307373|NCT00205777|523975613|FG005|Study Extension I|Withdrawal by Subject|0|||
145307374|NCT00205777|523975608|FG000|Study Extension I|Protocol Violation|4|||
145307375|NCT00205777|523975609|FG001|Study Extension I|Protocol Violation|0|||
145307376|NCT00205777|523975610|FG002|Study Extension I|Protocol Violation|0|||
145307377|NCT00205777|523975611|FG003|Study Extension I|Protocol Violation|8|||
145307378|NCT00205777|523975612|FG004|Study Extension I|Protocol Violation|8|||
145307379|NCT00205777|523975613|FG005|Study Extension I|Protocol Violation|0|||
145307380|NCT00205777|523975608|FG000|Study Extension I|Lack of Efficacy|0|||
145307381|NCT00205777|523975609|FG001|Study Extension I|Lack of Efficacy|0|||
145307382|NCT00205777|523975610|FG002|Study Extension I|Lack of Efficacy|0|||
145307383|NCT00205777|523975611|FG003|Study Extension I|Lack of Efficacy|1|||
145307384|NCT00205777|523975612|FG004|Study Extension I|Lack of Efficacy|2|||
145307385|NCT00205777|523975613|FG005|Study Extension I|Lack of Efficacy|0|||
145307386|NCT00205777|523975608|FG000|Study Extension I|Failed to return|15|||
145307387|NCT00205777|523975609|FG001|Study Extension I|Failed to return|0|||
145307388|NCT00205777|523975610|FG002|Study Extension I|Failed to return|0|||
145307389|NCT00205777|523975611|FG003|Study Extension I|Failed to return|17|||
145307390|NCT00205777|523975612|FG004|Study Extension I|Failed to return|13|||
145307391|NCT00205777|523975613|FG005|Study Extension I|Failed to return|0|||
145307392|NCT00205777|523975608|FG000|Study Extension I|Other Event|34|||
145307393|NCT00205777|523975609|FG001|Study Extension I|Other Event|0|||
145307394|NCT00205777|523975610|FG002|Study Extension I|Other Event|0|||
145307395|NCT00205777|523975611|FG003|Study Extension I|Other Event|34|||
145307396|NCT00205777|523975612|FG004|Study Extension I|Other Event|29|||
145307397|NCT00205777|523975613|FG005|Study Extension I|Other Event|0|||
145307398|NCT00205777|523975608|FG000|Study Extension I|Withdrawn as per protocol|0|||
145307399|NCT00205777|523975609|FG001|Study Extension I|Withdrawn as per protocol|0|||
145307400|NCT00205777|523975610|FG002|Study Extension I|Withdrawn as per protocol|1070|||
145307401|NCT00205777|523975611|FG003|Study Extension I|Withdrawn as per protocol|0|||
145307402|NCT00205777|523975612|FG004|Study Extension I|Withdrawn as per protocol|0|||
145307403|NCT00205777|523975613|FG005|Study Extension I|Withdrawn as per protocol|0|||
145307404|NCT00205777|523975608|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
145307405|NCT00205777|523975609|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
145307406|NCT00205777|523975610|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
145307407|NCT00205777|523975611|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
145569083|NCT01481116|524944180|FG000|Overall Study|Withdrawal by Subject|37|||
145569084|NCT01481116|524944181|FG001|Overall Study|Withdrawal by Subject|33|||
145569085|NCT01481116|524944182|FG002|Overall Study|Withdrawal by Subject|37|||
145569086|NCT01481116|524944180|FG000|Overall Study|Study Termination|730|||
145569087|NCT01481116|524944181|FG001|Overall Study|Study Termination|729|||
145569088|NCT01481116|524944182|FG002|Overall Study|Study Termination|713|||
145569089|NCT01481116|524944180|FG000|Overall Study|Pregnancy|0|||
145569090|NCT01481116|524944181|FG001|Overall Study|Pregnancy|0|||
145569091|NCT01481116|524944182|FG002|Overall Study|Pregnancy|1|||
145307408|NCT00205777|523975612|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
145307409|NCT00205777|523975613|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
145307410|NCT00205777|523975608|FG000|Study Extension II|Adverse Event|0|||
145307411|NCT00205777|523975609|FG001|Study Extension II|Adverse Event|0|||
145307412|NCT00205777|523975610|FG002|Study Extension II|Adverse Event|0|||
145307413|NCT00205777|523975611|FG003|Study Extension II|Adverse Event|14|||
145307414|NCT00205777|523975612|FG004|Study Extension II|Adverse Event|0|||
145307415|NCT00205777|523975613|FG005|Study Extension II|Adverse Event|30|||
145307416|NCT00205777|523975608|FG000|Study Extension II|Death|0|||
145307417|NCT00205777|523975609|FG001|Study Extension II|Death|0|||
145307418|NCT00205777|523975610|FG002|Study Extension II|Death|0|||
145307419|NCT00205777|523975611|FG003|Study Extension II|Death|2|||
145307420|NCT00205777|523975612|FG004|Study Extension II|Death|0|||
145307421|NCT00205777|523975613|FG005|Study Extension II|Death|5|||
145569092|NCT01481116|524944180|FG000|Overall Study|Lack of Efficacy|3|||
145569093|NCT01481116|524944181|FG001|Overall Study|Lack of Efficacy|3|||
145307422|NCT00205777|523975608|FG000|Study Extension II|Withdrawal by Subject|0|||
145307423|NCT00205777|523975609|FG001|Study Extension II|Withdrawal by Subject|0|||
145307424|NCT00205777|523975610|FG002|Study Extension II|Withdrawal by Subject|0|||
145307425|NCT00205777|523975611|FG003|Study Extension II|Withdrawal by Subject|35|||
145307426|NCT00205777|523975612|FG004|Study Extension II|Withdrawal by Subject|0|||
145307427|NCT00205777|523975613|FG005|Study Extension II|Withdrawal by Subject|59|||
145307428|NCT00205777|523975608|FG000|Study Extension II|Protocol Violation|0|||
145307429|NCT00205777|523975609|FG001|Study Extension II|Protocol Violation|0|||
145307430|NCT00205777|523975610|FG002|Study Extension II|Protocol Violation|0|||
145307431|NCT00205777|523975611|FG003|Study Extension II|Protocol Violation|1|||
145307432|NCT00205777|523975612|FG004|Study Extension II|Protocol Violation|0|||
145307433|NCT00205777|523975613|FG005|Study Extension II|Protocol Violation|10|||
145307434|NCT00205777|523975608|FG000|Study Extension II|Lack of Efficacy|0|||
145307435|NCT00205777|523975609|FG001|Study Extension II|Lack of Efficacy|0|||
145307436|NCT00205777|523975610|FG002|Study Extension II|Lack of Efficacy|0|||
145307437|NCT00205777|523975611|FG003|Study Extension II|Lack of Efficacy|0|||
145307438|NCT00205777|523975612|FG004|Study Extension II|Lack of Efficacy|0|||
145307439|NCT00205777|523975613|FG005|Study Extension II|Lack of Efficacy|1|||
145307440|NCT00205777|523975608|FG000|Study Extension II|Failed to return|0|||
145307441|NCT00205777|523975609|FG001|Study Extension II|Failed to return|0|||
145307442|NCT00205777|523975610|FG002|Study Extension II|Failed to return|0|||
145307443|NCT00205777|523975611|FG003|Study Extension II|Failed to return|14|||
145307444|NCT00205777|523975612|FG004|Study Extension II|Failed to return|0|||
145307445|NCT00205777|523975613|FG005|Study Extension II|Failed to return|26|||
145307446|NCT00205777|523975608|FG000|Study Extension II|Other Event|0|||
145307447|NCT00205777|523975609|FG001|Study Extension II|Other Event|0|||
145307448|NCT00205777|523975610|FG002|Study Extension II|Other Event|0|||
145307449|NCT00205777|523975611|FG003|Study Extension II|Other Event|12|||
145307450|NCT00205777|523975612|FG004|Study Extension II|Other Event|0|||
145307451|NCT00205777|523975613|FG005|Study Extension II|Other Event|20|||
145307452|NCT00205777|523975608|FG000|Study Extension II|Enrolled but not treated|0|||
145307453|NCT00205777|523975609|FG001|Study Extension II|Enrolled but not treated|0|||
145307454|NCT00205777|523975610|FG002|Study Extension II|Enrolled but not treated|0|||
145307455|NCT00205777|523975611|FG003|Study Extension II|Enrolled but not treated|71|||
145307456|NCT00205777|523975612|FG004|Study Extension II|Enrolled but not treated|0|||
145307457|NCT00205777|523975613|FG005|Study Extension II|Enrolled but not treated|131|||
145307458|NCT01316055|523975616|FG000|Overall Study|Lost to Follow-up|1|||
145307459|NCT01316055|523975617|FG001|Overall Study|Lost to Follow-up|0|||
145307460|NCT01316055|523975618|FG002|Overall Study|Lost to Follow-up|0|||
145307461|NCT00003470|523975619|FG000|Overall Study|Not evaluable|6|||
145307462|NCT01442376|523975621|FG000|Overall Study|Adverse Event|0|||
145307463|NCT01442376|523975622|FG001|Overall Study|Adverse Event|3|||
145307464|NCT01442376|523975623|FG002|Overall Study|Adverse Event|2|||
145307465|NCT01442376|523975621|FG000|Overall Study|Death|0|||
145307466|NCT01442376|523975622|FG001|Overall Study|Death|1|||
145307467|NCT01442376|523975623|FG002|Overall Study|Death|1|||
145307468|NCT01442376|523975621|FG000|Overall Study|Withdrawal of consent|0|||
145307469|NCT01442376|523975622|FG001|Overall Study|Withdrawal of consent|0|||
145307470|NCT01442376|523975623|FG002|Overall Study|Withdrawal of consent|1|||
145307471|NCT01442376|523975621|FG000|Overall Study|Patients not treated|2|||
145307472|NCT01442376|523975622|FG001|Overall Study|Patients not treated|3|||
145307473|NCT01442376|523975623|FG002|Overall Study|Patients not treated|1|||
145307474|NCT01442376|523975621|FG000|Overall Study|Not eligible for subsequent cycles|1|||
145307475|NCT01442376|523975622|FG001|Overall Study|Not eligible for subsequent cycles|2|||
145307476|NCT01442376|523975623|FG002|Overall Study|Not eligible for subsequent cycles|0|||
145307477|NCT00863330|523975624|FG000|Overall Study|study terminated early due to administra|6|||
145307478|NCT04404725|523975625|FG000|First Intervention|Withdrawal by Subject|0|||
145307479|NCT04404725|523975626|FG001|First Intervention|Withdrawal by Subject|2|||
145307480|NCT04404725|523975625|FG000|Second Intervention|Adverse Event|1|||
145307481|NCT04404725|523975626|FG001|Second Intervention|Adverse Event|1|||
145307482|NCT04404725|523975625|FG000|Second Intervention|Withdrawal by Subject|0|||
145307483|NCT04404725|523975626|FG001|Second Intervention|Withdrawal by Subject|1|||
145307484|NCT01075516|523975627|FG000|Overall Study|Death|5|||
145307485|NCT01075516|523975628|FG001|Overall Study|Death|9|||
145307486|NCT01075516|523975627|FG000|Overall Study|Lost to Follow-up|10|||
145307487|NCT01075516|523975628|FG001|Overall Study|Lost to Follow-up|2|||
145307488|NCT01075516|523975627|FG000|Overall Study|Withdrawal by Subject|3|||
145307489|NCT01075516|523975628|FG001|Overall Study|Withdrawal by Subject|5|||
145307490|NCT02252016|523975629|FG000|Overall Study|Lost to Follow-up|2|||
145307491|NCT02252016|523975630|FG001|Overall Study|Lost to Follow-up|1|||
145307492|NCT02252016|523975629|FG000|Overall Study|Physician Decision|1|||
145307493|NCT02252016|523975630|FG001|Overall Study|Physician Decision|0|||
145307494|NCT02252016|523975629|FG000|Overall Study|Withdrawal by Subject|0|||
145307495|NCT02252016|523975630|FG001|Overall Study|Withdrawal by Subject|2|||
145307496|NCT01825798|523975632|FG000|Overall Study|Adverse Event|1|||
145307497|NCT01825798|523975633|FG001|Overall Study|Adverse Event|5|||
145307498|NCT01825798|523975632|FG000|Overall Study|Lost to Follow-up|1|||
145307499|NCT01825798|523975633|FG001|Overall Study|Lost to Follow-up|0|||
145307500|NCT00834873|523975639|FG000|First Intervention|Adverse Event|0|||
145307501|NCT00834873|523975640|FG001|First Intervention|Adverse Event|1|||
145307502|NCT02055547|523975642|FG000|Overall Study|Protocol Violation|0|||
145307503|NCT02055547|523975643|FG001|Overall Study|Protocol Violation|0|||
145307504|NCT02055547|523975644|FG002|Overall Study|Protocol Violation|1|||
145307505|NCT02055547|523975645|FG003|Overall Study|Protocol Violation|0|||
145307506|NCT02055547|523975646|FG004|Overall Study|Protocol Violation|0|||
145307507|NCT02055547|523975647|FG005|Overall Study|Protocol Violation|0|||
145307508|NCT02055547|523975648|FG006|Overall Study|Protocol Violation|1|||
145307509|NCT02055547|523975649|FG007|Overall Study|Protocol Violation|0|||
145307510|NCT02055547|523975650|FG008|Overall Study|Protocol Violation|0|||
145307511|NCT02055547|523975651|FG009|Overall Study|Protocol Violation|0|||
145307512|NCT02055547|523975652|FG010|Overall Study|Protocol Violation|0|||
145307513|NCT02055547|523975653|FG011|Overall Study|Protocol Violation|0|||
145307514|NCT02055547|523975654|FG012|Overall Study|Protocol Violation|0|||
145307515|NCT02055547|523975655|FG013|Overall Study|Protocol Violation|0|||
145307516|NCT02055547|523975656|FG014|Overall Study|Protocol Violation|0|||
145307517|NCT02055547|523975657|FG015|Overall Study|Protocol Violation|0|||
145307518|NCT02055547|523975658|FG016|Overall Study|Protocol Violation|0|||
145307519|NCT02055547|523975659|FG017|Overall Study|Protocol Violation|0|||
145307520|NCT02055547|523975660|FG018|Overall Study|Protocol Violation|0|||
145307521|NCT02055547|523975642|FG000|Overall Study|Physician Decision|0|||
145307522|NCT02055547|523975643|FG001|Overall Study|Physician Decision|1|||
145307523|NCT02055547|523975644|FG002|Overall Study|Physician Decision|1|||
145307524|NCT02055547|523975645|FG003|Overall Study|Physician Decision|0|||
145307525|NCT02055547|523975646|FG004|Overall Study|Physician Decision|1|||
145307526|NCT02055547|523975647|FG005|Overall Study|Physician Decision|0|||
145307527|NCT02055547|523975648|FG006|Overall Study|Physician Decision|0|||
145307528|NCT02055547|523975649|FG007|Overall Study|Physician Decision|0|||
145307529|NCT02055547|523975650|FG008|Overall Study|Physician Decision|0|||
145307530|NCT02055547|523975651|FG009|Overall Study|Physician Decision|1|||
145307531|NCT02055547|523975652|FG010|Overall Study|Physician Decision|1|||
145307532|NCT02055547|523975653|FG011|Overall Study|Physician Decision|0|||
145307533|NCT02055547|523975654|FG012|Overall Study|Physician Decision|0|||
145307534|NCT02055547|523975655|FG013|Overall Study|Physician Decision|0|||
145307535|NCT02055547|523975656|FG014|Overall Study|Physician Decision|0|||
145307536|NCT02055547|523975657|FG015|Overall Study|Physician Decision|0|||
145307537|NCT02055547|523975658|FG016|Overall Study|Physician Decision|0|||
145307538|NCT02055547|523975659|FG017|Overall Study|Physician Decision|0|||
145307539|NCT02055547|523975660|FG018|Overall Study|Physician Decision|0|||
145307540|NCT02055547|523975642|FG000|Overall Study|Adverse Event|0|||
145307541|NCT02055547|523975643|FG001|Overall Study|Adverse Event|0|||
145307542|NCT02055547|523975644|FG002|Overall Study|Adverse Event|0|||
145307543|NCT02055547|523975645|FG003|Overall Study|Adverse Event|0|||
145307544|NCT02055547|523975646|FG004|Overall Study|Adverse Event|0|||
145307545|NCT02055547|523975647|FG005|Overall Study|Adverse Event|0|||
145307546|NCT02055547|523975648|FG006|Overall Study|Adverse Event|1|||
145307547|NCT02055547|523975649|FG007|Overall Study|Adverse Event|0|||
145307548|NCT02055547|523975650|FG008|Overall Study|Adverse Event|1|||
145307549|NCT02055547|523975651|FG009|Overall Study|Adverse Event|0|||
145307550|NCT02055547|523975652|FG010|Overall Study|Adverse Event|0|||
145307551|NCT02055547|523975653|FG011|Overall Study|Adverse Event|0|||
145307552|NCT02055547|523975654|FG012|Overall Study|Adverse Event|0|||
145307553|NCT02055547|523975655|FG013|Overall Study|Adverse Event|0|||
145307554|NCT02055547|523975656|FG014|Overall Study|Adverse Event|0|||
145307555|NCT02055547|523975657|FG015|Overall Study|Adverse Event|0|||
145307556|NCT02055547|523975658|FG016|Overall Study|Adverse Event|0|||
145307557|NCT02055547|523975659|FG017|Overall Study|Adverse Event|0|||
145307558|NCT02055547|523975660|FG018|Overall Study|Adverse Event|0|||
145307559|NCT02055547|523975642|FG000|Overall Study|Withdrawal by Subject|0|||
145307560|NCT02055547|523975643|FG001|Overall Study|Withdrawal by Subject|0|||
145307561|NCT02055547|523975644|FG002|Overall Study|Withdrawal by Subject|0|||
145307562|NCT02055547|523975645|FG003|Overall Study|Withdrawal by Subject|0|||
145307563|NCT02055547|523975646|FG004|Overall Study|Withdrawal by Subject|0|||
145307564|NCT02055547|523975647|FG005|Overall Study|Withdrawal by Subject|1|||
145307565|NCT02055547|523975648|FG006|Overall Study|Withdrawal by Subject|0|||
145307566|NCT02055547|523975649|FG007|Overall Study|Withdrawal by Subject|0|||
145307567|NCT02055547|523975650|FG008|Overall Study|Withdrawal by Subject|1|||
145307568|NCT02055547|523975651|FG009|Overall Study|Withdrawal by Subject|0|||
145307569|NCT02055547|523975652|FG010|Overall Study|Withdrawal by Subject|0|||
145307570|NCT02055547|523975653|FG011|Overall Study|Withdrawal by Subject|0|||
145307571|NCT02055547|523975654|FG012|Overall Study|Withdrawal by Subject|0|||
145307572|NCT02055547|523975655|FG013|Overall Study|Withdrawal by Subject|1|||
145307573|NCT02055547|523975656|FG014|Overall Study|Withdrawal by Subject|0|||
145307574|NCT02055547|523975657|FG015|Overall Study|Withdrawal by Subject|1|||
145307575|NCT02055547|523975658|FG016|Overall Study|Withdrawal by Subject|0|||
145307576|NCT02055547|523975659|FG017|Overall Study|Withdrawal by Subject|0|||
145307577|NCT02055547|523975660|FG018|Overall Study|Withdrawal by Subject|0|||
145307578|NCT02055547|523975642|FG000|Overall Study|Lost to Follow-up|0|||
145307579|NCT02055547|523975643|FG001|Overall Study|Lost to Follow-up|0|||
145307580|NCT02055547|523975644|FG002|Overall Study|Lost to Follow-up|1|||
145307581|NCT02055547|523975645|FG003|Overall Study|Lost to Follow-up|0|||
145307582|NCT02055547|523975646|FG004|Overall Study|Lost to Follow-up|0|||
145307583|NCT02055547|523975647|FG005|Overall Study|Lost to Follow-up|0|||
145307584|NCT02055547|523975648|FG006|Overall Study|Lost to Follow-up|0|||
145307585|NCT02055547|523975649|FG007|Overall Study|Lost to Follow-up|0|||
145307586|NCT02055547|523975650|FG008|Overall Study|Lost to Follow-up|0|||
145307587|NCT02055547|523975651|FG009|Overall Study|Lost to Follow-up|0|||
145307588|NCT02055547|523975652|FG010|Overall Study|Lost to Follow-up|0|||
145307589|NCT02055547|523975653|FG011|Overall Study|Lost to Follow-up|0|||
145307590|NCT02055547|523975654|FG012|Overall Study|Lost to Follow-up|0|||
145307591|NCT02055547|523975655|FG013|Overall Study|Lost to Follow-up|0|||
145307592|NCT02055547|523975656|FG014|Overall Study|Lost to Follow-up|0|||
145307593|NCT02055547|523975657|FG015|Overall Study|Lost to Follow-up|0|||
145307594|NCT02055547|523975658|FG016|Overall Study|Lost to Follow-up|0|||
145307595|NCT02055547|523975659|FG017|Overall Study|Lost to Follow-up|0|||
145307596|NCT02055547|523975660|FG018|Overall Study|Lost to Follow-up|0|||
145307597|NCT02911025|523975663|FG000|Overall Study|Lost to Follow-up|3|||
145307598|NCT06647173|523975667|FG000|Overall Study|Lost to Follow-up|24|||
145307599|NCT02923349|523975668|FG000|Overall Study|Other|1|||
145307600|NCT02923349|523975669|FG001|Overall Study|Other|2|||
145307601|NCT02923349|523975670|FG002|Overall Study|Other|4|||
145307602|NCT02923349|523975671|FG003|Overall Study|Other|1|||
145307603|NCT02923349|523975672|FG004|Overall Study|Other|3|||
145307604|NCT02923349|523975673|FG005|Overall Study|Other|0|||
145307605|NCT02923349|523975674|FG006|Overall Study|Other|1|||
145307606|NCT02923349|523975668|FG000|Overall Study|Withdrawal by Subject|2|||
145307607|NCT02923349|523975669|FG001|Overall Study|Withdrawal by Subject|2|||
145307608|NCT02923349|523975670|FG002|Overall Study|Withdrawal by Subject|8|||
145307609|NCT02923349|523975671|FG003|Overall Study|Withdrawal by Subject|10|||
145307610|NCT02923349|523975672|FG004|Overall Study|Withdrawal by Subject|12|||
145307611|NCT02923349|523975673|FG005|Overall Study|Withdrawal by Subject|3|||
145307612|NCT02923349|523975674|FG006|Overall Study|Withdrawal by Subject|0|||
145307613|NCT02923349|523975668|FG000|Overall Study|Physician Decision|0|||
145307614|NCT02923349|523975669|FG001|Overall Study|Physician Decision|0|||
145307615|NCT02923349|523975670|FG002|Overall Study|Physician Decision|0|||
145307616|NCT02923349|523975671|FG003|Overall Study|Physician Decision|1|||
145307617|NCT02923349|523975672|FG004|Overall Study|Physician Decision|1|||
145307618|NCT02923349|523975673|FG005|Overall Study|Physician Decision|0|||
145307619|NCT02923349|523975674|FG006|Overall Study|Physician Decision|2|||
145307620|NCT02923349|523975668|FG000|Overall Study|Lost to Follow-up|0|||
145307621|NCT02923349|523975669|FG001|Overall Study|Lost to Follow-up|0|||
145307622|NCT02923349|523975670|FG002|Overall Study|Lost to Follow-up|3|||
145307623|NCT02923349|523975671|FG003|Overall Study|Lost to Follow-up|0|||
145307624|NCT02923349|523975672|FG004|Overall Study|Lost to Follow-up|1|||
145307625|NCT02923349|523975673|FG005|Overall Study|Lost to Follow-up|1|||
145307626|NCT02923349|523975674|FG006|Overall Study|Lost to Follow-up|0|||
145307627|NCT02923349|523975668|FG000|Overall Study|Death|1|||
145307628|NCT02923349|523975669|FG001|Overall Study|Death|0|||
145307629|NCT02923349|523975670|FG002|Overall Study|Death|2|||
145307630|NCT02923349|523975671|FG003|Overall Study|Death|4|||
145307631|NCT02923349|523975672|FG004|Overall Study|Death|2|||
145307632|NCT02923349|523975673|FG005|Overall Study|Death|3|||
145307633|NCT02923349|523975674|FG006|Overall Study|Death|0|||
145307634|NCT01120028|523975677|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
145307635|NCT01120028|523975678|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
145307636|NCT01120028|523975679|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
145307637|NCT01120028|523975680|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
145307638|NCT01120028|523975677|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
145307639|NCT01120028|523975678|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
145307640|NCT01120028|523975679|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
145307641|NCT01120028|523975680|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
145307642|NCT03250117|523975681|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
145307643|NCT03250117|523975682|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
145307644|NCT03250117|523975683|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
145307645|NCT03250117|523975684|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
145307646|NCT04063878|523975685|FG000|Overall Study|Withdrawal by Subject|2|||
145307647|NCT04063878|523975685|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
145307648|NCT02751827|523975686|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
145307649|NCT02751827|523975687|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
145377815|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145377816|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145377817|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145307650|NCT02751827|523975688|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
145307651|NCT01248728|523975689|FG000|Overall Study|Adverse Event|1|||
145307652|NCT01248728|523975690|FG001|Overall Study|Adverse Event|1|||
145307653|NCT01248728|523975689|FG000|Overall Study|Withdrawal by Subject|2|||
145307654|NCT01248728|523975690|FG001|Overall Study|Withdrawal by Subject|1|||
145307655|NCT01248728|523975689|FG000|Overall Study|Lack of Efficacy|1|||
145307656|NCT01248728|523975690|FG001|Overall Study|Lack of Efficacy|0|||
145307657|NCT01841554|523975691|FG000|Overall Study|Death|7|||
145307658|NCT01841554|523975691|FG000|Overall Study|No Implantation|1|||
145307659|NCT01841554|523975691|FG000|Overall Study|Discontinued Follow Up|5|||
145307660|NCT01841554|523975691|FG000|Overall Study|Study exit due to secondary intervention|6|||
145307661|NCT01838681|523975692|FG000|Period A|Adverse Event|39|||
145307662|NCT01838681|523975693|FG001|Period A|Adverse Event|0|||
145307663|NCT01838681|523975694|FG002|Period A|Adverse Event|0|||
145307664|NCT01838681|523975695|FG003|Period A|Adverse Event|0|||
145307665|NCT01838681|523975692|FG000|Period A|Lack of Efficacy|21|||
145307666|NCT01838681|523975693|FG001|Period A|Lack of Efficacy|0|||
145307667|NCT01838681|523975694|FG002|Period A|Lack of Efficacy|0|||
145307668|NCT01838681|523975695|FG003|Period A|Lack of Efficacy|0|||
145307669|NCT01838681|523975692|FG000|Period A|Early response|148|||
145307670|NCT01838681|523975693|FG001|Period A|Early response|0|||
145307671|NCT01838681|523975694|FG002|Period A|Early response|0|||
145307672|NCT01838681|523975695|FG003|Period A|Early response|0|||
145307673|NCT01838681|523975692|FG000|Period A|Withdrawal by Subject|70|||
145307674|NCT01838681|523975693|FG001|Period A|Withdrawal by Subject|0|||
145307675|NCT01838681|523975694|FG002|Period A|Withdrawal by Subject|0|||
145307676|NCT01838681|523975695|FG003|Period A|Withdrawal by Subject|0|||
145307677|NCT01838681|523975692|FG000|Period A|Protocol Violation|16|||
145307678|NCT01838681|523975693|FG001|Period A|Protocol Violation|0|||
145307679|NCT01838681|523975694|FG002|Period A|Protocol Violation|0|||
145307680|NCT01838681|523975695|FG003|Period A|Protocol Violation|0|||
145307681|NCT01838681|523975692|FG000|Period A|Non-compliance with IMP|6|||
145307682|NCT01838681|523975693|FG001|Period A|Non-compliance with IMP|0|||
145307683|NCT01838681|523975694|FG002|Period A|Non-compliance with IMP|0|||
145307684|NCT01838681|523975695|FG003|Period A|Non-compliance with IMP|0|||
145307685|NCT01838681|523975692|FG000|Period A|Lost to Follow-up|4|||
145307686|NCT01838681|523975693|FG001|Period A|Lost to Follow-up|0|||
145307687|NCT01838681|523975694|FG002|Period A|Lost to Follow-up|0|||
145307688|NCT01838681|523975695|FG003|Period A|Lost to Follow-up|0|||
145307689|NCT01838681|523975692|FG000|Period A|Withdrawal before treatment|4|||
145307690|NCT01838681|523975693|FG001|Period A|Withdrawal before treatment|0|||
145307691|NCT01838681|523975694|FG002|Period A|Withdrawal before treatment|0|||
145307692|NCT01838681|523975695|FG003|Period A|Withdrawal before treatment|0|||
145307693|NCT01838681|523975692|FG000|Period A|Administrative or other reasons|17|||
145307694|NCT01838681|523975693|FG001|Period A|Administrative or other reasons|0|||
145307695|NCT01838681|523975694|FG002|Period A|Administrative or other reasons|0|||
145307696|NCT01838681|523975695|FG003|Period A|Administrative or other reasons|0|||
145307697|NCT01838681|523975692|FG000|Period B/A+|Adverse Event|0|||
145307698|NCT01838681|523975693|FG001|Period B/A+|Adverse Event|13|||
145307699|NCT01838681|523975694|FG002|Period B/A+|Adverse Event|27|||
145307700|NCT01838681|523975695|FG003|Period B/A+|Adverse Event|16|||
145307701|NCT01838681|523975692|FG000|Period B/A+|Lack of Efficacy|0|||
145307702|NCT01838681|523975693|FG001|Period B/A+|Lack of Efficacy|9|||
145307703|NCT01838681|523975694|FG002|Period B/A+|Lack of Efficacy|11|||
145307704|NCT01838681|523975695|FG003|Period B/A+|Lack of Efficacy|6|||
145307705|NCT01838681|523975692|FG000|Period B/A+|Withdrawal by Subject|0|||
145307706|NCT01838681|523975693|FG001|Period B/A+|Withdrawal by Subject|28|||
145307707|NCT01838681|523975694|FG002|Period B/A+|Withdrawal by Subject|35|||
145307708|NCT01838681|523975695|FG003|Period B/A+|Withdrawal by Subject|47|||
145307709|NCT01838681|523975692|FG000|Period B/A+|Protocol Violation|0|||
145307710|NCT01838681|523975693|FG001|Period B/A+|Protocol Violation|1|||
145307711|NCT01838681|523975694|FG002|Period B/A+|Protocol Violation|4|||
145307712|NCT01838681|523975695|FG003|Period B/A+|Protocol Violation|6|||
145307713|NCT01838681|523975692|FG000|Period B/A+|Non-compliance with IMP|0|||
145307714|NCT01838681|523975693|FG001|Period B/A+|Non-compliance with IMP|2|||
145307715|NCT01838681|523975694|FG002|Period B/A+|Non-compliance with IMP|3|||
145307716|NCT01838681|523975695|FG003|Period B/A+|Non-compliance with IMP|3|||
145410997|NCT04611126|524356915|FG001|Overall Study|TIL expansion unsuccessful|0|||
145569094|NCT01481116|524944182|FG002|Overall Study|Lack of Efficacy|1|||
145307717|NCT01838681|523975692|FG000|Period B/A+|Lost to Follow-up|0|||
145307718|NCT01838681|523975693|FG001|Period B/A+|Lost to Follow-up|2|||
145307719|NCT01838681|523975694|FG002|Period B/A+|Lost to Follow-up|5|||
145307720|NCT01838681|523975695|FG003|Period B/A+|Lost to Follow-up|11|||
145307721|NCT01838681|523975692|FG000|Period B/A+|Withdrawal before treatment|0|||
145307722|NCT01838681|523975693|FG001|Period B/A+|Withdrawal before treatment|1|||
145307723|NCT01838681|523975694|FG002|Period B/A+|Withdrawal before treatment|0|||
145307724|NCT01838681|523975695|FG003|Period B/A+|Withdrawal before treatment|0|||
145307725|NCT01838681|523975692|FG000|Period B/A+|Administrative or other reasons|0|||
145307726|NCT01838681|523975693|FG001|Period B/A+|Administrative or other reasons|6|||
145410998|NCT03459846|524356916|FG000|Overall Study|Death|52|||
145307727|NCT01838681|523975694|FG002|Period B/A+|Administrative or other reasons|10|||
145307728|NCT01838681|523975695|FG003|Period B/A+|Administrative or other reasons|28|||
145307729|NCT00796562|523975696|FG000|Overall Study|Death|49|||
145307730|NCT02011945|523975697|FG000|Overall Study|Participant requested to Discontinue|0|||
145307731|NCT02011945|523975698|FG001|Overall Study|Participant requested to Discontinue|1|||
145307732|NCT02011945|523975699|FG002|Overall Study|Participant requested to Discontinue|1|||
145307733|NCT02011945|523975697|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
145307734|NCT02011945|523975698|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
145307735|NCT02011945|523975699|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
145307736|NCT02011945|523975697|FG000|Overall Study|Study Drug Toxicity|0|||
145307737|NCT02011945|523975698|FG001|Overall Study|Study Drug Toxicity|0|||
145307738|NCT02011945|523975699|FG002|Overall Study|Study Drug Toxicity|1|||
145307739|NCT02011945|523975697|FG000|Overall Study|Treatment Failure|0|||
145307740|NCT02011945|523975698|FG001|Overall Study|Treatment Failure|7|||
145307741|NCT02011945|523975699|FG002|Overall Study|Treatment Failure|6|||
145307742|NCT02011945|523975697|FG000|Overall Study|No Longer Meets Study Criteria|1|||
145307743|NCT02011945|523975698|FG001|Overall Study|No Longer Meets Study Criteria|0|||
145307744|NCT02011945|523975699|FG002|Overall Study|No Longer Meets Study Criteria|0|||
145307745|NCT02011945|523975697|FG000|Overall Study|Proceeded to stem cell transplant|0|||
145307746|NCT02011945|523975698|FG001|Overall Study|Proceeded to stem cell transplant|0|||
145307747|NCT02011945|523975699|FG002|Overall Study|Proceeded to stem cell transplant|1|||
145307748|NCT02011945|523975697|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
145307749|NCT02011945|523975698|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
145307750|NCT02011945|523975699|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
145307751|NCT00902538|523975700|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
145307752|NCT00902538|523975701|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
145307753|NCT00902538|523975702|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
145307754|NCT00902538|523975703|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
145307755|NCT00902538|523975704|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
145307756|NCT00902538|523975705|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
145307757|NCT00902538|523975700|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
145307758|NCT00902538|523975701|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
145307759|NCT00902538|523975702|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
145307760|NCT00902538|523975703|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
145307761|NCT00902538|523975704|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
145307762|NCT00902538|523975705|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
145307763|NCT00902538|523975700|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
145307764|NCT00902538|523975701|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
145307765|NCT00902538|523975702|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
145307766|NCT00902538|523975703|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
145307767|NCT00902538|523975704|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
145307768|NCT00902538|523975705|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
145307769|NCT00902538|523975700|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
145307770|NCT00902538|523975701|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
145307771|NCT00902538|523975702|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
145307772|NCT00902538|523975703|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
145307773|NCT00902538|523975704|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
145307774|NCT00902538|523975705|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
145307775|NCT00902538|523975700|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
145307776|NCT00902538|523975701|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
145307777|NCT00902538|523975702|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
145307778|NCT00902538|523975703|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
145307779|NCT00902538|523975704|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
145307780|NCT00902538|523975705|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
145307781|NCT00902538|523975700|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
145307782|NCT00902538|523975701|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
145307783|NCT00902538|523975702|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
145307784|NCT00902538|523975703|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
145307785|NCT00902538|523975704|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
145307786|NCT00902538|523975705|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
145307787|NCT00902538|523975700|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
145307788|NCT00902538|523975701|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
145307789|NCT00902538|523975702|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
145307790|NCT00902538|523975703|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
145307791|NCT00902538|523975704|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
145307792|NCT00902538|523975705|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
145307793|NCT00902538|523975700|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
145307794|NCT00902538|523975701|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
145307795|NCT00902538|523975702|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
145307796|NCT00902538|523975703|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
145307797|NCT00902538|523975704|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
145307798|NCT00902538|523975705|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
145307799|NCT00902538|523975700|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
145307800|NCT00902538|523975701|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
145307801|NCT00902538|523975702|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
145307802|NCT00902538|523975703|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
145307803|NCT00902538|523975704|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
145307804|NCT00902538|523975705|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
145307805|NCT00902538|523975700|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
145307806|NCT00902538|523975701|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
145307807|NCT00902538|523975702|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
145307808|NCT00902538|523975703|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
145307809|NCT00902538|523975704|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
145307810|NCT00902538|523975705|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
145307811|NCT00902538|523975700|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
145307812|NCT00902538|523975701|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
145307813|NCT00902538|523975702|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
145307814|NCT00902538|523975703|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
145307815|NCT00902538|523975704|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
145307816|NCT00902538|523975705|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
145307817|NCT00902538|523975700|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
145307818|NCT00902538|523975701|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
145307819|NCT00902538|523975702|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
145307820|NCT00902538|523975703|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
145307821|NCT00902538|523975704|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
145307822|NCT00902538|523975705|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
145307823|NCT00902538|523975700|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
145307824|NCT00902538|523975701|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
145307825|NCT00902538|523975702|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
145307826|NCT00902538|523975703|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
145307827|NCT00902538|523975704|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
145307828|NCT00902538|523975705|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
145307829|NCT00902538|523975700|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
145307830|NCT00902538|523975701|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
145307831|NCT00902538|523975702|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
145307832|NCT00902538|523975703|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
145307833|NCT00902538|523975704|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
145307834|NCT00902538|523975705|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
145307835|NCT00902538|523975700|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
145307836|NCT00902538|523975701|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
145307837|NCT00902538|523975702|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
145307838|NCT00902538|523975703|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
145307839|NCT00902538|523975704|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
145569095|NCT01481116|524944180|FG000|Overall Study|Contraindications|1|||
145569096|NCT01481116|524944181|FG001|Overall Study|Contraindications|1|||
145569097|NCT01481116|524944182|FG002|Overall Study|Contraindications|0|||
145569098|NCT01481116|524944180|FG000|Overall Study|Other|1|||
145569099|NCT01481116|524944181|FG001|Overall Study|Other|1|||
145569100|NCT01481116|524944182|FG002|Overall Study|Other|0|||
145569101|NCT01481116|524944180|FG000|Overall Study|Participant Started Taking Glipizide|1|||
145569102|NCT01481116|524944181|FG001|Overall Study|Participant Started Taking Glipizide|0|||
145569103|NCT01481116|524944182|FG002|Overall Study|Participant Started Taking Glipizide|0|||
145569104|NCT01481116|524944180|FG000|Overall Study|Participant Moved Out of Area|2|||
145569105|NCT01481116|524944181|FG001|Overall Study|Participant Moved Out of Area|0|||
145569106|NCT01481116|524944182|FG002|Overall Study|Participant Moved Out of Area|1|||
145569107|NCT01481116|524944180|FG000|Overall Study|Participant Moved Out of Country|1|||
145569108|NCT01481116|524944181|FG001|Overall Study|Participant Moved Out of Country|0|||
145569109|NCT01481116|524944182|FG002|Overall Study|Participant Moved Out of Country|1|||
145307840|NCT00902538|523975705|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
145307841|NCT00902538|523975700|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
145569110|NCT01481116|524944180|FG000|Overall Study|Investigator Decision|3|||
145569111|NCT01481116|524944181|FG001|Overall Study|Investigator Decision|2|||
145569112|NCT01481116|524944182|FG002|Overall Study|Investigator Decision|1|||
145569113|NCT01481116|524944180|FG000|Overall Study|Sponsor Decision|0|||
145569114|NCT01481116|524944181|FG001|Overall Study|Sponsor Decision|1|||
145307842|NCT00902538|523975701|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
145307843|NCT00902538|523975702|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
145307844|NCT00902538|523975703|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
145307845|NCT00902538|523975704|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
145307846|NCT00902538|523975705|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
145307847|NCT00902538|523975700|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
145307848|NCT00902538|523975701|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
145307849|NCT00902538|523975702|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
145307850|NCT00902538|523975703|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
145307851|NCT00902538|523975704|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
145307852|NCT00902538|523975705|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
145307853|NCT04198363|523975711|FG000|Overall Study|Adverse Event|1|||
145307854|NCT04198363|523975712|FG001|Overall Study|Adverse Event|1|||
145307855|NCT04198363|523975711|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
145307856|NCT04198363|523975712|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
145307857|NCT04198363|523975711|FG000|Overall Study|Reason not Specified|1|||
145307858|NCT04198363|523975712|FG001|Overall Study|Reason not Specified|0|||
145307859|NCT03067987|523975714|FG000|Overall Study|Lost to Follow-up|7|||
145307860|NCT03067987|523975715|FG001|Overall Study|Lost to Follow-up|10|||
145307861|NCT03067987|523975714|FG000|Overall Study|Protocol Violation|1|||
145307862|NCT03067987|523975715|FG001|Overall Study|Protocol Violation|2|||
145307863|NCT03067987|523975714|FG000|Overall Study|Withdrawal by Subject|2|||
145307864|NCT03067987|523975715|FG001|Overall Study|Withdrawal by Subject|1|||
145307865|NCT01404988|523975716|FG000|Overall Study|Death|2|||
145307866|NCT01404988|523975717|FG001|Overall Study|Death|0|||
145307867|NCT01404988|523975718|FG002|Overall Study|Death|2|||
145307868|NCT01404988|523975716|FG000|Overall Study|Adverse Event|1|||
145307869|NCT01404988|523975717|FG001|Overall Study|Adverse Event|0|||
145307870|NCT01404988|523975718|FG002|Overall Study|Adverse Event|0|||
145307871|NCT01404988|523975716|FG000|Overall Study|Withdrawal by Subject|2|||
145307872|NCT01404988|523975717|FG001|Overall Study|Withdrawal by Subject|2|||
145307873|NCT01404988|523975718|FG002|Overall Study|Withdrawal by Subject|0|||
145307874|NCT01404988|523975716|FG000|Overall Study|Lost to Follow-up|1|||
145307875|NCT01404988|523975717|FG001|Overall Study|Lost to Follow-up|2|||
145307876|NCT01404988|523975718|FG002|Overall Study|Lost to Follow-up|1|||
145307877|NCT00829764|523975719|FG000|First Intervention|Adverse Event|1|||
145307878|NCT00829764|523975720|FG001|First Intervention|Adverse Event|0|||
145307879|NCT00829764|523975719|FG000|First Intervention|Withdrawal by Subject|1|||
145307880|NCT00829764|523975720|FG001|First Intervention|Withdrawal by Subject|1|||
145307881|NCT04594252|523975721|FG000|Overall Study|Adverse Event|0|||
145307882|NCT04594252|523975722|FG001|Overall Study|Adverse Event|2|||
145307883|NCT00477594|523975723|FG000|Year 1 and Year 2|Adverse Event|4|||
145307884|NCT00477594|523975724|FG001|Year 1 and Year 2|Adverse Event|2|||
145307885|NCT00477594|523975723|FG000|Year 1 and Year 2|Physician Decision|2|||
145307886|NCT00477594|523975724|FG001|Year 1 and Year 2|Physician Decision|1|||
145307887|NCT00477594|523975723|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
145307888|NCT00477594|523975724|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
145620344|NCT00442286|525123745|FG001|Overall Study|Lost to Follow-up|0|||
145620345|NCT00442286|525123744|FG000|Overall Study|Withdrawal by Subject|2|||
145620346|NCT00442286|525123745|FG001|Overall Study|Withdrawal by Subject|0|||
145307889|NCT00477594|523975723|FG000|Year 1 and Year 2|Other|1|||
145307890|NCT00477594|523975724|FG001|Year 1 and Year 2|Other|0|||
145307891|NCT00477594|523975723|FG000|Year 3|Adverse Event|1|||
145307892|NCT00477594|523975724|FG001|Year 3|Adverse Event|0|||
145307893|NCT00477594|523975723|FG000|Year 3|Withdrawal by Subject|1|||
145307894|NCT00477594|523975724|FG001|Year 3|Withdrawal by Subject|0|||
145307895|NCT00477594|523975723|FG000|Follow-up Period|Withdrawal by Subject|2|||
145307896|NCT00477594|523975724|FG001|Follow-up Period|Withdrawal by Subject|1|||
145307897|NCT00477594|523975723|FG000|Follow-up Period|Other|1|||
145307898|NCT00477594|523975724|FG001|Follow-up Period|Other|0|||
145307899|NCT03578809|523977761|FG000|Overall Study|Death|0|||
145307900|NCT03578809|523977762|FG001|Overall Study|Death|2|||
145307901|NCT03578809|523977763|FG002|Overall Study|Death|0|||
145307902|NCT03578809|523977764|FG003|Overall Study|Death|1|||
145307903|NCT03578809|523977761|FG000|Overall Study|Lost to Follow-up|0|||
145307904|NCT03578809|523977762|FG001|Overall Study|Lost to Follow-up|1|||
145307905|NCT03578809|523977763|FG002|Overall Study|Lost to Follow-up|0|||
145307906|NCT03578809|523977764|FG003|Overall Study|Lost to Follow-up|0|||
145307907|NCT03578809|523977761|FG000|Overall Study|Withdrawal by Subject|3|||
145307908|NCT03578809|523977762|FG001|Overall Study|Withdrawal by Subject|5|||
145307909|NCT03578809|523977763|FG002|Overall Study|Withdrawal by Subject|2|||
145307910|NCT03578809|523977764|FG003|Overall Study|Withdrawal by Subject|0|||
145307911|NCT03578809|523977761|FG000|Overall Study|Other|3|||
145307912|NCT03578809|523977762|FG001|Overall Study|Other|6|||
145307913|NCT03578809|523977763|FG002|Overall Study|Other|2|||
145307914|NCT03578809|523977764|FG003|Overall Study|Other|8|||
145307915|NCT00830258|523977765|FG000|First Intervention|Adverse Event|1|||
145620347|NCT00442286|525123744|FG000|Overall Study|System explanted|1|||
145307916|NCT00830258|523977766|FG001|First Intervention|Adverse Event|0|||
145307917|NCT00830258|523977765|FG000|Washout: 7 Days|Protocol Violation|1|||
145307918|NCT00830258|523977766|FG001|Washout: 7 Days|Protocol Violation|0|||
145307919|NCT02392195|523977776|FG000|Overall Study|Lost to Follow-up|4|||
145307920|NCT02392195|523977776|FG000|Overall Study|Withdrawal by Subject|4|||
145307921|NCT00545792|523977779|FG000|Overall Study|Withdrawal by Subject|1|||
145307922|NCT05041361|523977780|FG000|Overall Study|Lost to Follow-up|1|||
145307923|NCT05041361|523977781|FG001|Overall Study|Lost to Follow-up|3|||
145307924|NCT01642277|523977782|FG000|Overall Study|Adverse Event|10|||
145307925|NCT01642277|523977783|FG001|Overall Study|Adverse Event|0|||
145307926|NCT01642277|523977782|FG000|Overall Study|Physician Decision|2|||
145307927|NCT01642277|523977783|FG001|Overall Study|Physician Decision|0|||
145307928|NCT01642277|523977782|FG000|Overall Study|Protocol Violation|1|||
145307929|NCT01642277|523977783|FG001|Overall Study|Protocol Violation|0|||
145307930|NCT01642277|523977782|FG000|Overall Study|Withdrawal by Subject|11|||
145307931|NCT01642277|523977783|FG001|Overall Study|Withdrawal by Subject|0|||
145307932|NCT03679598|523977784|FG000|Overall Study|Adverse Event|2|||
145307933|NCT03679598|523977785|FG001|Overall Study|Adverse Event|0|||
145307934|NCT03605342|523977786|FG000|Overall Study|Withdrawal by Subject|9|||
145307935|NCT03605342|523977787|FG001|Overall Study|Withdrawal by Subject|7|||
145307936|NCT03605342|523977786|FG000|Overall Study|Lost to Follow-up|1|||
145307937|NCT03605342|523977787|FG001|Overall Study|Lost to Follow-up|1|||
145307938|NCT01403194|523977790|FG000|Overall Study|Screen Failure|2|||
145307939|NCT01403194|523977790|FG000|Overall Study|Lost to Follow-up|8|||
145307940|NCT03428750|523977793|FG000|Overall Study|Withdrawal by Subject|11|||
145307941|NCT03428750|523977794|FG001|Overall Study|Withdrawal by Subject|10|||
145307942|NCT03428750|523977793|FG000|Overall Study|Lost to Follow-up|3|||
145307943|NCT03428750|523977794|FG001|Overall Study|Lost to Follow-up|9|||
145307944|NCT03428750|523977793|FG000|Overall Study|Adverse Event|9|||
145307945|NCT03428750|523977794|FG001|Overall Study|Adverse Event|1|||
145307946|NCT03428750|523977793|FG000|Overall Study|Protocol Violation|1|||
145307947|NCT03428750|523977794|FG001|Overall Study|Protocol Violation|0|||
145307948|NCT03428750|523977793|FG000|Overall Study|Administrative|0|||
145307949|NCT03428750|523977794|FG001|Overall Study|Administrative|1|||
145307950|NCT01919112|523977795|FG000|Secondary Analysis-day 30|Death|1|||
145307951|NCT01919112|523977796|FG001|Secondary Analysis-day 30|Death|1|||
145307952|NCT01919112|523977797|FG002|Secondary Analysis-day 30|Death|1|||
145307953|NCT01919112|523977795|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
145307954|NCT01919112|523977796|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
145307955|NCT01919112|523977797|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
145307956|NCT04692155|523977800|FG000|Overall Study|Death|1|||
145307957|NCT02554877|523977801|FG000|Overall Study|Adverse Event|2|||
145307958|NCT02554877|523977802|FG001|Overall Study|Adverse Event|0|||
145307959|NCT02554877|523977803|FG002|Overall Study|Adverse Event|0|||
145307960|NCT02554877|523977804|FG003|Overall Study|Adverse Event|1|||
145307961|NCT02554877|523977801|FG000|Overall Study|Lost to Follow-up|1|||
145307962|NCT02554877|523977802|FG001|Overall Study|Lost to Follow-up|1|||
145307963|NCT02554877|523977803|FG002|Overall Study|Lost to Follow-up|1|||
145307964|NCT02554877|523977804|FG003|Overall Study|Lost to Follow-up|2|||
145307965|NCT02554877|523977801|FG000|Overall Study|Did not meet entrance criteria|0|||
145307966|NCT02554877|523977802|FG001|Overall Study|Did not meet entrance criteria|0|||
145307967|NCT02554877|523977803|FG002|Overall Study|Did not meet entrance criteria|1|||
145307968|NCT02554877|523977804|FG003|Overall Study|Did not meet entrance criteria|0|||
145307969|NCT02554877|523977801|FG000|Overall Study|No longer met eligibility criteria|1|||
145307970|NCT02554877|523977802|FG001|Overall Study|No longer met eligibility criteria|0|||
145307971|NCT02554877|523977803|FG002|Overall Study|No longer met eligibility criteria|1|||
145307972|NCT02554877|523977804|FG003|Overall Study|No longer met eligibility criteria|1|||
145307973|NCT02554877|523977801|FG000|Overall Study|Protocol Violation|3|||
145307974|NCT02554877|523977802|FG001|Overall Study|Protocol Violation|1|||
145307975|NCT02554877|523977803|FG002|Overall Study|Protocol Violation|1|||
145307976|NCT02554877|523977804|FG003|Overall Study|Protocol Violation|0|||
145307977|NCT02554877|523977801|FG000|Overall Study|Other|1|||
145569115|NCT01481116|524944182|FG002|Overall Study|Sponsor Decision|3|||
145307978|NCT02554877|523977802|FG001|Overall Study|Other|3|||
145307979|NCT02554877|523977803|FG002|Overall Study|Other|0|||
145569116|NCT01481116|524944180|FG000|Overall Study|Non-Compliant With Study Drug|0|||
145569117|NCT01481116|524944181|FG001|Overall Study|Non-Compliant With Study Drug|1|||
145569118|NCT01481116|524944182|FG002|Overall Study|Non-Compliant With Study Drug|1|||
145307980|NCT02554877|523977804|FG003|Overall Study|Other|3|||
145307981|NCT02554877|523977801|FG000|Overall Study|Insufficient clinical response|4|||
145307982|NCT02554877|523977802|FG001|Overall Study|Insufficient clinical response|0|||
145307983|NCT02554877|523977803|FG002|Overall Study|Insufficient clinical response|0|||
145307984|NCT02554877|523977804|FG003|Overall Study|Insufficient clinical response|0|||
145307985|NCT02554877|523977801|FG000|Overall Study|No longer willing to participate|0|||
145307986|NCT02554877|523977802|FG001|Overall Study|No longer willing to participate|2|||
145307987|NCT02554877|523977803|FG002|Overall Study|No longer willing to participate|2|||
145307988|NCT02554877|523977804|FG003|Overall Study|No longer willing to participate|0|||
145307989|NCT00274651|523977805|FG000|Overall Study|Adverse Event|6|||
145307990|NCT00274651|523977806|FG001|Overall Study|Adverse Event|3|||
145307991|NCT00274651|523977805|FG000|Overall Study|Lack of Efficacy|13|||
145307992|NCT00274651|523977806|FG001|Overall Study|Lack of Efficacy|6|||
145307993|NCT00274651|523977805|FG000|Overall Study|Death|1|||
145307994|NCT00274651|523977806|FG001|Overall Study|Death|3|||
145307995|NCT00274651|523977805|FG000|Overall Study|Withdrawal by Subject|0|||
145307996|NCT00274651|523977806|FG001|Overall Study|Withdrawal by Subject|1|||
145307997|NCT00274651|523977805|FG000|Overall Study|Physician Decision|8|||
145307998|NCT00274651|523977806|FG001|Overall Study|Physician Decision|7|||
145307999|NCT04474405|523977807|FG000|Overall Study|Withdrawal by Subject|0|||
145308000|NCT04474405|523977808|FG001|Overall Study|Withdrawal by Subject|0|||
145308001|NCT04474405|523977809|FG002|Overall Study|Withdrawal by Subject|1|||
145308002|NCT04474405|523977810|FG003|Overall Study|Withdrawal by Subject|0|||
145308003|NCT04474405|523977811|FG004|Overall Study|Withdrawal by Subject|1|||
145308004|NCT04474405|523977812|FG005|Overall Study|Withdrawal by Subject|0|||
145308005|NCT04474405|523977807|FG000|Overall Study|Other|0|||
145308006|NCT04474405|523977808|FG001|Overall Study|Other|0|||
145308007|NCT04474405|523977809|FG002|Overall Study|Other|0|||
145410999|NCT03459846|524356917|FG001|Overall Study|Death|46|||
145411000|NCT03459846|524356916|FG000|Overall Study|Study terminated by sponsor|24|||
145411001|NCT03459846|524356917|FG001|Overall Study|Study terminated by sponsor|28|||
145411002|NCT03459846|524356916|FG000|Overall Study|Withdrawal by Subject|2|||
145308008|NCT04474405|523977810|FG003|Overall Study|Other|0|||
145308009|NCT04474405|523977811|FG004|Overall Study|Other|3|||
145308010|NCT04474405|523977812|FG005|Overall Study|Other|0|||
145308011|NCT00918645|523977813|FG000|Overall Study|Withdrawal by Subject|1|||
145308012|NCT05133180|523977814|FG000|Overall Study|Withdrawal of consent|1|||
145308013|NCT05133180|523977815|FG001|Overall Study|Withdrawal of consent|1|||
145308014|NCT05133180|523977814|FG000|Overall Study|Lost to Follow-up|1|||
145308015|NCT05133180|523977815|FG001|Overall Study|Lost to Follow-up|1|||
145308016|NCT05133180|523977814|FG000|Overall Study|Documented disease progression|0|||
145308017|NCT05133180|523977815|FG001|Overall Study|Documented disease progression|1|||
145308018|NCT01604941|523977816|FG000|Overall Study|Adverse Event|1|||
145308019|NCT01604941|523977817|FG001|Overall Study|Adverse Event|2|||
145308020|NCT01604941|523977818|FG002|Overall Study|Adverse Event|0|||
145308021|NCT01604941|523977819|FG003|Overall Study|Adverse Event|0|||
145308022|NCT01604941|523977820|FG004|Overall Study|Adverse Event|1|||
145308023|NCT01604941|523977821|FG005|Overall Study|Adverse Event|5|||
145308024|NCT01604941|523977816|FG000|Overall Study|Non-compliance|1|||
145308025|NCT01604941|523977817|FG001|Overall Study|Non-compliance|0|||
145308026|NCT01604941|523977818|FG002|Overall Study|Non-compliance|0|||
145308027|NCT01604941|523977819|FG003|Overall Study|Non-compliance|0|||
145308028|NCT01604941|523977820|FG004|Overall Study|Non-compliance|0|||
145308029|NCT01604941|523977821|FG005|Overall Study|Non-compliance|0|||
145308030|NCT01604941|523977816|FG000|Overall Study|Participant Decision|0|||
145308031|NCT01604941|523977817|FG001|Overall Study|Participant Decision|0|||
145308032|NCT01604941|523977818|FG002|Overall Study|Participant Decision|0|||
145308033|NCT01604941|523977819|FG003|Overall Study|Participant Decision|0|||
145308034|NCT01604941|523977820|FG004|Overall Study|Participant Decision|0|||
145308035|NCT01604941|523977821|FG005|Overall Study|Participant Decision|2|||
145308036|NCT01604941|523977816|FG000|Overall Study|Early Study Termination|9|||
145308037|NCT01604941|523977817|FG001|Overall Study|Early Study Termination|2|||
145308038|NCT01604941|523977818|FG002|Overall Study|Early Study Termination|3|||
145308039|NCT01604941|523977819|FG003|Overall Study|Early Study Termination|3|||
145308040|NCT01604941|523977820|FG004|Overall Study|Early Study Termination|0|||
145411003|NCT03459846|524356917|FG001|Overall Study|Withdrawal by Subject|2|||
145411004|NCT00143507|524357553|FG000|Overall Study|Death|572|||
145411005|NCT00143507|524357554|FG001|Overall Study|Death|547|||
145411006|NCT00143507|524357553|FG000|Overall Study|Withdrawal by Subject|114|||
145411007|NCT00143507|524357554|FG001|Overall Study|Withdrawal by Subject|102|||
145411008|NCT00143507|524357553|FG000|Overall Study|Lost to Follow-up|1|||
145411009|NCT00143507|524357554|FG001|Overall Study|Lost to Follow-up|0|||
145308041|NCT01604941|523977821|FG005|Overall Study|Early Study Termination|0|||
145411010|NCT00143507|524357553|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
145411011|NCT00143507|524357554|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
145411012|NCT00876395|524357555|FG000|Overall Study|Untreated|8|||
145411013|NCT00876395|524357556|FG001|Overall Study|Untreated|1|||
145308042|NCT03366792|523977822|FG000|Overall Study|Withdrawal by Subject|7|||
145308043|NCT03366792|523977822|FG000|Overall Study|Lost to Follow-up|2|||
145308044|NCT03366792|523977822|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
145308045|NCT03366792|523977822|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
145308046|NCT00216736|523977829|FG000|Overall Study|Lost to Follow-up|1|||
145308047|NCT00216736|523977830|FG001|Overall Study|Lost to Follow-up|1|||
145308048|NCT02890992|523977831|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308049|NCT02890992|523977832|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
145308050|NCT02890992|523977833|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145411014|NCT00876395|524357555|FG000|Overall Study|Adverse Event|63|||
145308051|NCT02890992|523977834|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308052|NCT02890992|523977835|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308053|NCT02890992|523977836|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308054|NCT02890992|523977837|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308055|NCT02890992|523977838|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
145308056|NCT02890992|523977831|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308057|NCT02890992|523977832|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308058|NCT02890992|523977833|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308059|NCT02890992|523977834|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308060|NCT02890992|523977835|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308061|NCT02890992|523977836|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
145308062|NCT02890992|523977837|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
145308063|NCT02890992|523977838|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
145308064|NCT02890992|523977831|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308065|NCT02890992|523977832|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
145308066|NCT02890992|523977833|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308067|NCT02890992|523977834|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308068|NCT02890992|523977835|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308069|NCT02890992|523977836|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308070|NCT02890992|523977837|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308071|NCT02890992|523977838|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
145308072|NCT02622386|523977839|FG000|First Assignment|Withdrawal by Subject|3|||
145308073|NCT02622386|523977840|FG001|First Assignment|Withdrawal by Subject|2|||
145308074|NCT02622386|523977839|FG000|Washout|Withdrawal by Subject|4|||
145308075|NCT02622386|523977840|FG001|Washout|Withdrawal by Subject|4|||
145308076|NCT02622386|523977839|FG000|Second Assignment|Withdrawal by Subject|0|||
145308077|NCT02622386|523977840|FG001|Second Assignment|Withdrawal by Subject|2|||
145308078|NCT03236311|523977841|FG000|Overall Study|Study terminated by sponsor|0|||
145308079|NCT03236311|523977842|FG001|Overall Study|Study terminated by sponsor|2|||
145308080|NCT03236311|523977841|FG000|Overall Study|Adverse Event|0|||
145308081|NCT03236311|523977842|FG001|Overall Study|Adverse Event|1|||
145308082|NCT00918684|523977845|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
145308083|NCT00918684|523977845|FG000|Treatment Phase|Lack of Efficacy|6|||
145308084|NCT00918684|523977845|FG000|Treatment Phase|Lost to Follow-up|2|||
145308085|NCT00918684|523977845|FG000|Treatment Phase|Physician Decision|8|||
145308086|NCT00918684|523977845|FG000|Treatment Phase|Protocol Violation|1|||
145308087|NCT00918684|523977845|FG000|Treatment Phase|Withdrawal by Subject|8|||
145308088|NCT00402103|523977846|FG000|Overall Study|Adverse Event|60|||
145308089|NCT00402103|523977847|FG001|Overall Study|Adverse Event|7|||
145308090|NCT00402103|523977846|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145308091|NCT00402103|523977847|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145308092|NCT00402103|523977846|FG000|Overall Study|Condition no longer requires study drug|2|||
145308093|NCT00402103|523977847|FG001|Overall Study|Condition no longer requires study drug|0|||
145308094|NCT00402103|523977846|FG000|Overall Study|Protocol Deviation|8|||
145308095|NCT00402103|523977847|FG001|Overall Study|Protocol Deviation|0|||
145308096|NCT00402103|523977846|FG000|Overall Study|Patient withdrew consent|12|||
145308097|NCT00402103|523977847|FG001|Overall Study|Patient withdrew consent|1|||
145308098|NCT00402103|523977846|FG000|Overall Study|Lost to Follow-up|6|||
145308099|NCT00402103|523977847|FG001|Overall Study|Lost to Follow-up|3|||
145308100|NCT00402103|523977846|FG000|Overall Study|Administrative problems|2|||
145308101|NCT00402103|523977847|FG001|Overall Study|Administrative problems|0|||
145308102|NCT00484679|523977848|FG000|Overall Study|Withdrawal by Subject|3|||
145308103|NCT00841542|523977849|FG000|Period 1|Adverse Event|1|||
145308104|NCT00841542|523977850|FG001|Period 1|Adverse Event|0|||
145308105|NCT00418145|523977851|FG000|Overall Study|study terminated|6|||
145308106|NCT03480763|523977856|FG000|Overall Study|Withdrawal by Subject|18|||
145308107|NCT03480763|523977857|FG001|Overall Study|Withdrawal by Subject|10|||
145308108|NCT03480763|523977856|FG000|Overall Study|Lost to Follow-up|4|||
145308109|NCT03480763|523977857|FG001|Overall Study|Lost to Follow-up|7|||
145308110|NCT03480763|523977856|FG000|Overall Study|non-study pneumococcal vaccine|1|||
145308111|NCT03480763|523977857|FG001|Overall Study|non-study pneumococcal vaccine|0|||
145308112|NCT03480763|523977856|FG000|Overall Study|oncological treatment|0|||
145308113|NCT03480763|523977857|FG001|Overall Study|oncological treatment|2|||
145308114|NCT03480763|523977856|FG000|Overall Study|pain with vaccination|1|||
145308115|NCT03480763|523977857|FG001|Overall Study|pain with vaccination|0|||
145308116|NCT01647828|523977858|FG000|Overall Study|Death|3|||
145308117|NCT01647828|523977859|FG001|Overall Study|Death|4|||
145308118|NCT01647828|523977860|FG002|Overall Study|Death|4|||
145308119|NCT01647828|523977861|FG003|Overall Study|Death|5|||
145308120|NCT01647828|523977862|FG004|Overall Study|Death|6|||
145308121|NCT01647828|523977863|FG005|Overall Study|Death|3|||
145308122|NCT01647828|523977864|FG006|Overall Study|Death|10|||
145308123|NCT01647828|523977865|FG007|Overall Study|Death|60|||
145308124|NCT01647828|523977866|FG008|Overall Study|Death|71|||
145308125|NCT01647828|523977858|FG000|Overall Study|Withdrawal by Subject|2|||
145308126|NCT01647828|523977859|FG001|Overall Study|Withdrawal by Subject|0|||
145308127|NCT01647828|523977860|FG002|Overall Study|Withdrawal by Subject|0|||
145308128|NCT01647828|523977861|FG003|Overall Study|Withdrawal by Subject|1|||
145308129|NCT01647828|523977862|FG004|Overall Study|Withdrawal by Subject|0|||
145308130|NCT01647828|523977863|FG005|Overall Study|Withdrawal by Subject|0|||
145308131|NCT01647828|523977864|FG006|Overall Study|Withdrawal by Subject|1|||
145308132|NCT01647828|523977865|FG007|Overall Study|Withdrawal by Subject|0|||
145308133|NCT01647828|523977866|FG008|Overall Study|Withdrawal by Subject|2|||
145308134|NCT01647828|523977858|FG000|Overall Study|Study terminated by Sponsor|0|||
145308135|NCT01647828|523977859|FG001|Overall Study|Study terminated by Sponsor|0|||
145308136|NCT01647828|523977860|FG002|Overall Study|Study terminated by Sponsor|0|||
145308137|NCT01647828|523977861|FG003|Overall Study|Study terminated by Sponsor|0|||
145308138|NCT01647828|523977862|FG004|Overall Study|Study terminated by Sponsor|0|||
145308139|NCT01647828|523977863|FG005|Overall Study|Study terminated by Sponsor|0|||
145308140|NCT01647828|523977864|FG006|Overall Study|Study terminated by Sponsor|1|||
145308141|NCT01647828|523977865|FG007|Overall Study|Study terminated by Sponsor|26|||
145308142|NCT01647828|523977866|FG008|Overall Study|Study terminated by Sponsor|16|||
145308143|NCT01647828|523977858|FG000|Overall Study|Lost to Follow-up|0|||
145308144|NCT01647828|523977859|FG001|Overall Study|Lost to Follow-up|0|||
145308145|NCT01647828|523977860|FG002|Overall Study|Lost to Follow-up|0|||
145308146|NCT01647828|523977861|FG003|Overall Study|Lost to Follow-up|0|||
145308147|NCT01647828|523977862|FG004|Overall Study|Lost to Follow-up|0|||
145308148|NCT01647828|523977863|FG005|Overall Study|Lost to Follow-up|0|||
145308149|NCT01647828|523977864|FG006|Overall Study|Lost to Follow-up|0|||
145308150|NCT01647828|523977865|FG007|Overall Study|Lost to Follow-up|2|||
145308151|NCT01647828|523977866|FG008|Overall Study|Lost to Follow-up|0|||
145308152|NCT00418938|523977867|FG000|Overall Study|Reimbursement|1|||
145308153|NCT00418938|523977868|FG001|Overall Study|Reimbursement|0|||
145308154|NCT00418938|523977867|FG000|Overall Study|Administrative decision|3|||
145308155|NCT00418938|523977868|FG001|Overall Study|Administrative decision|3|||
145308156|NCT00418938|523977867|FG000|Overall Study|Withdrawal by Subject|16|||
145308157|NCT00418938|523977868|FG001|Overall Study|Withdrawal by Subject|15|||
145308158|NCT00418938|523977867|FG000|Overall Study|Lost to Follow-up|1|||
145308159|NCT00418938|523977868|FG001|Overall Study|Lost to Follow-up|3|||
145308160|NCT00418938|523977867|FG000|Overall Study|Adverse Event|1|||
145308161|NCT00418938|523977868|FG001|Overall Study|Adverse Event|1|||
145308162|NCT00418938|523977867|FG000|Overall Study|On-going|1|||
145308163|NCT00418938|523977868|FG001|Overall Study|On-going|1|||
145308164|NCT00418938|523977867|FG000|Overall Study|Ineligibility Determined|1|||
145308165|NCT00418938|523977868|FG001|Overall Study|Ineligibility Determined|0|||
145308166|NCT01075282|523977869|FG000|Overall Study|Withdrawal by Subject|11|||
145308167|NCT01075282|523977870|FG001|Overall Study|Withdrawal by Subject|7|||
145308168|NCT01075282|523977871|FG002|Overall Study|Withdrawal by Subject|11|||
145308169|NCT01075282|523977869|FG000|Overall Study|Adverse Event|9|||
145308170|NCT01075282|523977870|FG001|Overall Study|Adverse Event|8|||
145308171|NCT01075282|523977871|FG002|Overall Study|Adverse Event|5|||
145308172|NCT01075282|523977869|FG000|Overall Study|Entry Criteria Not Met|3|||
145308173|NCT01075282|523977870|FG001|Overall Study|Entry Criteria Not Met|2|||
145308174|NCT01075282|523977871|FG002|Overall Study|Entry Criteria Not Met|0|||
145308175|NCT01075282|523977869|FG000|Overall Study|Lost to Follow-up|3|||
145308176|NCT01075282|523977870|FG001|Overall Study|Lost to Follow-up|3|||
145308177|NCT01075282|523977871|FG002|Overall Study|Lost to Follow-up|3|||
145308178|NCT01075282|523977869|FG000|Overall Study|Physician Decision|3|||
145308179|NCT01075282|523977870|FG001|Overall Study|Physician Decision|3|||
145308180|NCT01075282|523977871|FG002|Overall Study|Physician Decision|3|||
145308181|NCT01075282|523977869|FG000|Overall Study|Lack of Efficacy|1|||
145308182|NCT01075282|523977870|FG001|Overall Study|Lack of Efficacy|1|||
145308183|NCT01075282|523977871|FG002|Overall Study|Lack of Efficacy|0|||
145308184|NCT01075282|523977869|FG000|Overall Study|Treatment Non-compliance|1|||
145308185|NCT01075282|523977870|FG001|Overall Study|Treatment Non-compliance|2|||
145308186|NCT01075282|523977871|FG002|Overall Study|Treatment Non-compliance|2|||
145308187|NCT01075282|523977869|FG000|Overall Study|Protocol Violation|0|||
145308188|NCT01075282|523977870|FG001|Overall Study|Protocol Violation|2|||
145308189|NCT01075282|523977871|FG002|Overall Study|Protocol Violation|1|||
145308190|NCT01075282|523977869|FG000|Overall Study|Death|0|||
145308191|NCT01075282|523977870|FG001|Overall Study|Death|1|||
145308192|NCT01075282|523977871|FG002|Overall Study|Death|2|||
145308193|NCT02679729|523977872|FG000|Overall Study|Lost to Follow-up|0|||
145308194|NCT02679729|523977873|FG001|Overall Study|Lost to Follow-up|1|||
145308195|NCT02679729|523977874|FG002|Overall Study|Lost to Follow-up|0|||
145308196|NCT02679729|523977875|FG003|Overall Study|Lost to Follow-up|0|||
145308197|NCT02679729|523977876|FG004|Overall Study|Lost to Follow-up|1|||
145308198|NCT02679729|523977877|FG005|Overall Study|Lost to Follow-up|0|||
145308199|NCT02679729|523977878|FG006|Overall Study|Lost to Follow-up|0|||
145308200|NCT02679729|523977879|FG007|Overall Study|Lost to Follow-up|0|||
145308201|NCT02679729|523977880|FG008|Overall Study|Lost to Follow-up|0|||
145308202|NCT02679729|523977872|FG000|Overall Study|Participant decision|0|||
145308203|NCT02679729|523977873|FG001|Overall Study|Participant decision|1|||
145308204|NCT02679729|523977874|FG002|Overall Study|Participant decision|0|||
145308205|NCT02679729|523977875|FG003|Overall Study|Participant decision|0|||
145308206|NCT02679729|523977876|FG004|Overall Study|Participant decision|0|||
145308207|NCT02679729|523977877|FG005|Overall Study|Participant decision|0|||
145308208|NCT02679729|523977878|FG006|Overall Study|Participant decision|1|||
145308209|NCT02679729|523977879|FG007|Overall Study|Participant decision|0|||
145308210|NCT02679729|523977880|FG008|Overall Study|Participant decision|0|||
145308211|NCT00906399|523977898|FG000|Year 1|Randomized But Not Treated|0|||
145308212|NCT00906399|523977899|FG001|Year 1|Randomized But Not Treated|1|||
145308213|NCT00906399|523977900|FG002|Year 1|Randomized But Not Treated|3|||
145308214|NCT00906399|523977901|FG003|Year 1|Randomized But Not Treated|0|||
145308215|NCT00906399|523977902|FG004|Year 1|Randomized But Not Treated|0|||
145308216|NCT00906399|523977903|FG005|Year 1|Randomized But Not Treated|0|||
145308217|NCT00906399|523977904|FG006|Year 1|Randomized But Not Treated|0|||
145308218|NCT00906399|523977898|FG000|Year 1|Adverse Event|4|||
145308219|NCT00906399|523977899|FG001|Year 1|Adverse Event|22|||
145308220|NCT00906399|523977900|FG002|Year 1|Adverse Event|24|||
145308221|NCT00906399|523977901|FG003|Year 1|Adverse Event|0|||
145308222|NCT00906399|523977902|FG004|Year 1|Adverse Event|0|||
145308223|NCT00906399|523977903|FG005|Year 1|Adverse Event|0|||
145308224|NCT00906399|523977904|FG006|Year 1|Adverse Event|0|||
145308225|NCT00906399|523977898|FG000|Year 1|Lost to Follow-up|4|||
145308226|NCT00906399|523977899|FG001|Year 1|Lost to Follow-up|4|||
145308227|NCT00906399|523977900|FG002|Year 1|Lost to Follow-up|2|||
145308228|NCT00906399|523977901|FG003|Year 1|Lost to Follow-up|0|||
145308229|NCT00906399|523977902|FG004|Year 1|Lost to Follow-up|0|||
145308230|NCT00906399|523977903|FG005|Year 1|Lost to Follow-up|0|||
145308231|NCT00906399|523977904|FG006|Year 1|Lost to Follow-up|0|||
145308232|NCT00906399|523977898|FG000|Year 1|Withdrawal by Subject|30|||
145308233|NCT00906399|523977899|FG001|Year 1|Withdrawal by Subject|32|||
145308234|NCT00906399|523977900|FG002|Year 1|Withdrawal by Subject|36|||
145308235|NCT00906399|523977901|FG003|Year 1|Withdrawal by Subject|0|||
145308236|NCT00906399|523977902|FG004|Year 1|Withdrawal by Subject|0|||
145308237|NCT00906399|523977903|FG005|Year 1|Withdrawal by Subject|0|||
145308238|NCT00906399|523977904|FG006|Year 1|Withdrawal by Subject|0|||
145308239|NCT00906399|523977898|FG000|Year 1|Physician Decision|0|||
145308240|NCT00906399|523977899|FG001|Year 1|Physician Decision|1|||
145308241|NCT00906399|523977900|FG002|Year 1|Physician Decision|3|||
145308242|NCT00906399|523977901|FG003|Year 1|Physician Decision|0|||
145308243|NCT00906399|523977902|FG004|Year 1|Physician Decision|0|||
145308244|NCT00906399|523977903|FG005|Year 1|Physician Decision|0|||
145308245|NCT00906399|523977904|FG006|Year 1|Physician Decision|0|||
145308246|NCT00906399|523977898|FG000|Year 1|Death|2|||
145308247|NCT00906399|523977899|FG001|Year 1|Death|1|||
145308248|NCT00906399|523977900|FG002|Year 1|Death|1|||
145308249|NCT00906399|523977901|FG003|Year 1|Death|0|||
145308250|NCT00906399|523977902|FG004|Year 1|Death|0|||
145308251|NCT00906399|523977903|FG005|Year 1|Death|0|||
145308252|NCT00906399|523977904|FG006|Year 1|Death|0|||
145308253|NCT00906399|523977898|FG000|Year 1|Other|4|||
145308254|NCT00906399|523977899|FG001|Year 1|Other|2|||
145308255|NCT00906399|523977900|FG002|Year 1|Other|7|||
145308256|NCT00906399|523977901|FG003|Year 1|Other|0|||
145308257|NCT00906399|523977902|FG004|Year 1|Other|0|||
145308258|NCT00906399|523977903|FG005|Year 1|Other|0|||
145308259|NCT00906399|523977904|FG006|Year 1|Other|0|||
145308260|NCT00906399|523977898|FG000|Year 2|Adverse Event|0|||
145308261|NCT00906399|523977899|FG001|Year 2|Adverse Event|0|||
145308262|NCT00906399|523977900|FG002|Year 2|Adverse Event|0|||
145308263|NCT00906399|523977901|FG003|Year 2|Adverse Event|9|||
145308264|NCT00906399|523977902|FG004|Year 2|Adverse Event|8|||
145308265|NCT00906399|523977903|FG005|Year 2|Adverse Event|11|||
145308266|NCT00906399|523977904|FG006|Year 2|Adverse Event|6|||
145308267|NCT00906399|523977898|FG000|Year 2|Lost to Follow-up|0|||
145308268|NCT00906399|523977899|FG001|Year 2|Lost to Follow-up|0|||
145308269|NCT00906399|523977900|FG002|Year 2|Lost to Follow-up|0|||
145308270|NCT00906399|523977901|FG003|Year 2|Lost to Follow-up|1|||
145308271|NCT00906399|523977902|FG004|Year 2|Lost to Follow-up|4|||
145308272|NCT00906399|523977903|FG005|Year 2|Lost to Follow-up|2|||
145308273|NCT00906399|523977904|FG006|Year 2|Lost to Follow-up|4|||
145411015|NCT00876395|524357556|FG001|Overall Study|Adverse Event|11|||
145308274|NCT00906399|523977898|FG000|Year 2|Withdrawal by Subject|0|||
145308275|NCT00906399|523977899|FG001|Year 2|Withdrawal by Subject|0|||
145308276|NCT00906399|523977900|FG002|Year 2|Withdrawal by Subject|0|||
145308277|NCT00906399|523977901|FG003|Year 2|Withdrawal by Subject|17|||
145308278|NCT00906399|523977902|FG004|Year 2|Withdrawal by Subject|18|||
145308279|NCT00906399|523977903|FG005|Year 2|Withdrawal by Subject|27|||
145308280|NCT00906399|523977904|FG006|Year 2|Withdrawal by Subject|13|||
145308281|NCT00906399|523977898|FG000|Year 2|Physician Decision|0|||
145308282|NCT00906399|523977899|FG001|Year 2|Physician Decision|0|||
145308283|NCT00906399|523977900|FG002|Year 2|Physician Decision|0|||
145308284|NCT00906399|523977901|FG003|Year 2|Physician Decision|0|||
145308285|NCT00906399|523977902|FG004|Year 2|Physician Decision|2|||
145308286|NCT00906399|523977903|FG005|Year 2|Physician Decision|6|||
145308287|NCT00906399|523977904|FG006|Year 2|Physician Decision|3|||
145569119|NCT01481116|524944180|FG000|Overall Study|Investigator's Discretion|2|||
145308288|NCT00906399|523977898|FG000|Year 2|Death|0|||
145308289|NCT00906399|523977899|FG001|Year 2|Death|0|||
145308290|NCT00906399|523977900|FG002|Year 2|Death|0|||
145308291|NCT00906399|523977901|FG003|Year 2|Death|1|||
145308292|NCT00906399|523977902|FG004|Year 2|Death|0|||
145308293|NCT00906399|523977903|FG005|Year 2|Death|0|||
145308294|NCT00906399|523977904|FG006|Year 2|Death|3|||
145308295|NCT00906399|523977898|FG000|Year 2|Other|0|||
145308296|NCT00906399|523977899|FG001|Year 2|Other|0|||
145308297|NCT00906399|523977900|FG002|Year 2|Other|0|||
145308298|NCT00906399|523977901|FG003|Year 2|Other|2|||
145308299|NCT00906399|523977902|FG004|Year 2|Other|3|||
145308300|NCT00906399|523977903|FG005|Year 2|Other|1|||
145308301|NCT00906399|523977904|FG006|Year 2|Other|0|||
145308302|NCT00748566|523977907|FG000|Overall Study|Adverse Event|49|||
145308303|NCT00748566|523977907|FG000|Overall Study|Death|1|||
145308304|NCT00748566|523977907|FG000|Overall Study|Lack of Efficacy|12|||
145308305|NCT00748566|523977907|FG000|Overall Study|Lost to Follow-up|1|||
145308306|NCT00748566|523977907|FG000|Overall Study|Protocol Violation|13|||
145308307|NCT00748566|523977907|FG000|Overall Study|Withdrawal by Subject|22|||
145308308|NCT00748566|523977907|FG000|Overall Study|Study terminated by sponsor|5|||
145308309|NCT00748566|523977907|FG000|Overall Study|Other|9|||
145308310|NCT00624286|523977910|FG000|Overall Study|Protocol Deviation|7|||
145308311|NCT00624286|523977911|FG001|Overall Study|Protocol Deviation|9|||
145308312|NCT00624286|523977910|FG000|Overall Study|Adverse Event|6|||
145308313|NCT00624286|523977911|FG001|Overall Study|Adverse Event|3|||
145569120|NCT01481116|524944181|FG001|Overall Study|Investigator's Discretion|0|||
145569121|NCT01481116|524944182|FG002|Overall Study|Investigator's Discretion|0|||
145569122|NCT01481116|524944180|FG000|Overall Study|Death|2|||
145569123|NCT01481116|524944181|FG001|Overall Study|Death|1|||
145569124|NCT01481116|524944182|FG002|Overall Study|Death|0|||
145569125|NCT01481116|524944180|FG000|Overall Study|Hypoglycemic Event|4|||
145569126|NCT01481116|524944181|FG001|Overall Study|Hypoglycemic Event|0|||
145569127|NCT01481116|524944182|FG002|Overall Study|Hypoglycemic Event|0|||
145569128|NCT00805935|524944183|FG000|Overall Study|Stimulation Failure|1|||
145308314|NCT00624286|523977910|FG000|Overall Study|Withdrawal by Subject|5|||
145308315|NCT00624286|523977911|FG001|Overall Study|Withdrawal by Subject|4|||
145308316|NCT00624286|523977910|FG000|Overall Study|Lost to Follow-up|3|||
145308317|NCT00624286|523977911|FG001|Overall Study|Lost to Follow-up|2|||
145569129|NCT00805935|524944184|FG001|Overall Study|Stimulation Failure|5|||
145569130|NCT00805935|524944185|FG002|Overall Study|Stimulation Failure|2|||
145569131|NCT00805935|524944186|FG003|Overall Study|Stimulation Failure|2|||
145569132|NCT00805935|524944183|FG000|Overall Study|Cycle cancelled|0|||
145569133|NCT00805935|524944184|FG001|Overall Study|Cycle cancelled|0|||
145569134|NCT00805935|524944185|FG002|Overall Study|Cycle cancelled|2|||
145569135|NCT00805935|524944186|FG003|Overall Study|Cycle cancelled|0|||
145308318|NCT00624286|523977910|FG000|Overall Study|Administrative problems|3|||
145308319|NCT00624286|523977911|FG001|Overall Study|Administrative problems|0|||
145308320|NCT00624286|523977910|FG000|Overall Study|Lack of Efficacy|1|||
145308321|NCT00624286|523977911|FG001|Overall Study|Lack of Efficacy|6|||
145308322|NCT00624286|523977910|FG000|Overall Study|Not stated|0|||
145308323|NCT00624286|523977911|FG001|Overall Study|Not stated|1|||
145308324|NCT00624286|523977910|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145308325|NCT00624286|523977911|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145308326|NCT00624286|523977910|FG000|Overall Study|Death|0|||
145308327|NCT00624286|523977911|FG001|Overall Study|Death|1|||
145308328|NCT03488108|523977915|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
145308329|NCT03488108|523977916|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145569136|NCT00805935|524944183|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
145569137|NCT00805935|524944184|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
145308330|NCT03488108|523977915|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
145308331|NCT03488108|523977916|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
145308332|NCT00849797|523977921|FG000|First Intervention|bad veins|1|||
145308333|NCT00849797|523977922|FG001|First Intervention|bad veins|0|||
145308334|NCT00849797|523977921|FG000|First Intervention|Adverse Event|0|||
145308335|NCT00849797|523977922|FG001|First Intervention|Adverse Event|1|||
145308336|NCT00849797|523977921|FG000|Washout: One Week|Withdrawal by Subject|0|||
145308337|NCT00849797|523977922|FG001|Washout: One Week|Withdrawal by Subject|2|||
145308338|NCT00679081|523977923|FG000|Overall Study|Lost to Follow-up|1|||
145308339|NCT00725322|523977924|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
145569138|NCT00805935|524944185|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
145569139|NCT00805935|524944186|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
145569140|NCT00805935|524944183|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
145569141|NCT00805935|524944184|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
145569142|NCT00805935|524944185|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
145308340|NCT00725322|523977925|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
145308341|NCT00725322|523977924|FG000|Washout (28 Days)|Protocol Violation|0|||
145308342|NCT00725322|523977925|FG001|Washout (28 Days)|Protocol Violation|1|||
145308343|NCT01279486|523977928|FG000|Overall Study|Lost to Follow-up|1|||
145411016|NCT00876395|524357555|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145411017|NCT00876395|524357556|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145411018|NCT00876395|524357555|FG000|Overall Study|Disease progression|259|||
145411019|NCT00876395|524357556|FG001|Overall Study|Disease progression|162|||
145411020|NCT00876395|524357555|FG000|Overall Study|New cancer therapy|25|||
145411021|NCT00876395|524357556|FG001|Overall Study|New cancer therapy|7|||
145411022|NCT00876395|524357555|FG000|Overall Study|Protocol Violation|5|||
145411023|NCT00876395|524357556|FG001|Overall Study|Protocol Violation|2|||
145411024|NCT00876395|524357555|FG000|Overall Study|Withdrawal by Subject|66|||
145411025|NCT00876395|524357556|FG001|Overall Study|Withdrawal by Subject|33|||
145411026|NCT00876395|524357555|FG000|Overall Study|Lost to Follow-up|2|||
145411027|NCT00876395|524357556|FG001|Overall Study|Lost to Follow-up|0|||
145411028|NCT00876395|524357555|FG000|Overall Study|Administrative problems|39|||
145411029|NCT00876395|524357556|FG001|Overall Study|Administrative problems|23|||
145411030|NCT00876395|524357555|FG000|Overall Study|Death|12|||
145411031|NCT00876395|524357556|FG001|Overall Study|Death|0|||
145411032|NCT00662259|524357557|FG000|Overall Study|Adverse Event|2|||
145411033|NCT00662259|524357558|FG001|Overall Study|Adverse Event|0|||
145411034|NCT02299167|524357561|FG000|Overall Study|patients were excluded from the study|11|||
145411035|NCT03600428|524357562|FG000|Overall Study|Not eligible|0|||
145411036|NCT03600428|524357563|FG001|Overall Study|Not eligible|1|||
145411037|NCT03600428|524357562|FG000|Overall Study|Lost to Follow-up|5|||
145411038|NCT03600428|524357563|FG001|Overall Study|Lost to Follow-up|4|||
145411039|NCT00975923|524357568|FG000|Overall Study|Withdrawal by Subject|0|||
145411040|NCT00975923|524357569|FG001|Overall Study|Withdrawal by Subject|1|||
145411041|NCT00005047|524357571|FG000|Overall Study|Withdrawal by Subject|12|||
145411042|NCT00005047|524357572|FG001|Overall Study|Withdrawal by Subject|0|||
145411043|NCT00005047|524357573|FG002|Overall Study|Withdrawal by Subject|0|||
145411044|NCT00005047|524357574|FG003|Overall Study|Withdrawal by Subject|0|||
145411045|NCT00005047|524357571|FG000|Overall Study|Adverse Event|5|||
145411046|NCT00005047|524357572|FG001|Overall Study|Adverse Event|0|||
145411047|NCT00005047|524357573|FG002|Overall Study|Adverse Event|0|||
145411048|NCT00005047|524357574|FG003|Overall Study|Adverse Event|0|||
145411049|NCT00005047|524357571|FG000|Overall Study|Lost to Follow-up|1|||
145411050|NCT00005047|524357572|FG001|Overall Study|Lost to Follow-up|0|||
145411051|NCT00005047|524357573|FG002|Overall Study|Lost to Follow-up|0|||
145411052|NCT00005047|524357574|FG003|Overall Study|Lost to Follow-up|0|||
145411053|NCT00005047|524357571|FG000|Overall Study|Lack of Efficacy|1|||
145411054|NCT00005047|524357572|FG001|Overall Study|Lack of Efficacy|0|||
145411055|NCT00005047|524357573|FG002|Overall Study|Lack of Efficacy|0|||
145411056|NCT00005047|524357574|FG003|Overall Study|Lack of Efficacy|0|||
145411057|NCT05436613|524357577|FG000|Overall Study|Lost to Follow-up|9|||
145411058|NCT05436613|524357577|FG000|Overall Study|Withdrawal by Subject|3|||
145308344|NCT04827394|523977932|FG000|Overall Study|Physician Decision|0|||
145308345|NCT04827394|523977933|FG001|Overall Study|Physician Decision|2|||
145308346|NCT00640341|523979622|FG000|Overall Study|Adverse Event|0|||
145308347|NCT00640341|523979623|FG001|Overall Study|Adverse Event|0|||
145308348|NCT00640341|523979624|FG002|Overall Study|Adverse Event|1|||
145308349|NCT00640341|523979622|FG000|Overall Study|Positive Slit Lamp Findings|0|||
145308350|NCT00640341|523979623|FG001|Overall Study|Positive Slit Lamp Findings|0|||
145308351|NCT00640341|523979624|FG002|Overall Study|Positive Slit Lamp Findings|1|||
145308352|NCT00640341|523979622|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
145308353|NCT00640341|523979623|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
145308354|NCT00640341|523979624|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
145308355|NCT00640341|523979622|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
145308356|NCT00640341|523979623|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
145308357|NCT00640341|523979624|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
145308358|NCT00640341|523979622|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
145308359|NCT00640341|523979623|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
145308360|NCT00640341|523979624|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
145308361|NCT00640341|523979622|FG000|Overall Study|Lost to Follow-up|2|||
145308362|NCT00640341|523979623|FG001|Overall Study|Lost to Follow-up|0|||
145308363|NCT00640341|523979624|FG002|Overall Study|Lost to Follow-up|0|||
145308364|NCT00640341|523979622|FG000|Overall Study|Withdrawal by Subject|4|||
145411059|NCT05317546|524357580|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
145411060|NCT05317546|524357581|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
145411061|NCT03331250|524357582|FG000|Overall Study|Withdrawal by Subject|1|||
145411062|NCT02811159|524357584|FG000|Treatment Course 1|Lost to Follow-up|1|||
145411063|NCT06455111|524357593|FG000|Overall Study|Withdrawal by Subject|11|||
145411064|NCT06455111|524357594|FG001|Overall Study|Withdrawal by Subject|4|||
145411065|NCT03069989|524357602|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
145411066|NCT03069989|524357603|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
145411067|NCT06717399|524357604|FG000|Overall Study|Death|1|||
145411068|NCT02145390|524357605|FG000|Overall Study|Withdrawal by Subject|1|||
145411069|NCT00970944|524358760|FG000|Overall Study|Death|1|||
145411070|NCT00970944|524358761|FG001|Overall Study|Death|0|||
145308365|NCT00640341|523979623|FG001|Overall Study|Withdrawal by Subject|0|||
145308366|NCT00640341|523979624|FG002|Overall Study|Withdrawal by Subject|1|||
145308367|NCT00640341|523979622|FG000|Overall Study|Unacceptable Lens Movement|1|||
145308368|NCT00640341|523979623|FG001|Overall Study|Unacceptable Lens Movement|0|||
145308369|NCT00640341|523979624|FG002|Overall Study|Unacceptable Lens Movement|0|||
145308370|NCT00640341|523979622|FG000|Overall Study|Poor fit/Uncomfortable|4|||
145308371|NCT00640341|523979623|FG001|Overall Study|Poor fit/Uncomfortable|0|||
145308372|NCT00640341|523979624|FG002|Overall Study|Poor fit/Uncomfortable|0|||
145308373|NCT00640341|523979622|FG000|Overall Study|Ineligable at Baseline|5|||
145308374|NCT00640341|523979623|FG001|Overall Study|Ineligable at Baseline|3|||
145308375|NCT00640341|523979624|FG002|Overall Study|Ineligable at Baseline|2|||
145308376|NCT00640341|523979622|FG000|Overall Study|Adverse event and positive slit lamp|1|||
145308377|NCT00640341|523979623|FG001|Overall Study|Adverse event and positive slit lamp|0|||
145411071|NCT00970944|524358760|FG000|Overall Study|Physician Decision|0|||
145411072|NCT00970944|524358761|FG001|Overall Study|Physician Decision|2|||
145411073|NCT02008370|524358762|FG000|Overall Study|Lost to Follow-up|7|||
145411074|NCT00972738|524358763|FG000|Overall Study|Adverse Event|7|||
145411075|NCT00972738|524358764|FG001|Overall Study|Adverse Event|1|||
145308378|NCT00640341|523979624|FG002|Overall Study|Adverse event and positive slit lamp|0|||
145308379|NCT02488109|523979625|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
145308380|NCT02488109|523979626|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
145308381|NCT02488109|523979625|FG000|12-month Follow-Up|Lost to Follow-up|4|||
145411076|NCT00972738|524358765|FG002|Overall Study|Adverse Event|8|||
145411077|NCT00972738|524358763|FG000|Overall Study|Protocol Violation|2|||
145411078|NCT00972738|524358764|FG001|Overall Study|Protocol Violation|1|||
145411079|NCT00972738|524358765|FG002|Overall Study|Protocol Violation|3|||
145411080|NCT00972738|524358763|FG000|Overall Study|Lost to Follow-up|1|||
145411081|NCT00972738|524358764|FG001|Overall Study|Lost to Follow-up|0|||
145411082|NCT00972738|524358765|FG002|Overall Study|Lost to Follow-up|1|||
145411083|NCT00972738|524358763|FG000|Overall Study|Lack of Efficacy|5|||
145411084|NCT00972738|524358764|FG001|Overall Study|Lack of Efficacy|1|||
145411085|NCT00972738|524358765|FG002|Overall Study|Lack of Efficacy|11|||
145411086|NCT00972738|524358763|FG000|Overall Study|Withdrawal by Subject|5|||
145411087|NCT00972738|524358764|FG001|Overall Study|Withdrawal by Subject|1|||
145411088|NCT00972738|524358765|FG002|Overall Study|Withdrawal by Subject|4|||
145411089|NCT00972738|524358763|FG000|Overall Study|Moved|0|||
145411090|NCT00972738|524358764|FG001|Overall Study|Moved|0|||
145411091|NCT00972738|524358765|FG002|Overall Study|Moved|1|||
145411092|NCT00972738|524358763|FG000|Overall Study|Other|1|||
145411093|NCT00972738|524358764|FG001|Overall Study|Other|2|||
145411094|NCT00972738|524358765|FG002|Overall Study|Other|1|||
145411095|NCT03915067|524358767|FG000|Overall Study|Adverse Event|0|||
145411096|NCT03915067|524358768|FG001|Overall Study|Adverse Event|0|||
145411097|NCT03915067|524358769|FG002|Overall Study|Adverse Event|1|||
145411098|NCT03915067|524358767|FG000|Overall Study|Withdrawal by Subject|4|||
145411099|NCT03915067|524358768|FG001|Overall Study|Withdrawal by Subject|3|||
145411100|NCT03915067|524358769|FG002|Overall Study|Withdrawal by Subject|0|||
145411101|NCT03915067|524358767|FG000|Overall Study|Lost to Follow-up|3|||
145411102|NCT03915067|524358768|FG001|Overall Study|Lost to Follow-up|2|||
145308382|NCT02488109|523979626|FG001|12-month Follow-Up|Lost to Follow-up|7|||
145308383|NCT02302716|523979627|FG000|Overall Study|Adverse Event|1|||
145308384|NCT02302716|523979628|FG001|Overall Study|Adverse Event|1|||
145308385|NCT02302716|523979627|FG000|Overall Study|Death|0|||
145308386|NCT02302716|523979628|FG001|Overall Study|Death|1|||
145308387|NCT02302716|523979627|FG000|Overall Study|Lack of Efficacy|0|||
145308388|NCT02302716|523979628|FG001|Overall Study|Lack of Efficacy|1|||
145308389|NCT02302716|523979627|FG000|Overall Study|Lost to Follow-up|2|||
145308390|NCT02302716|523979628|FG001|Overall Study|Lost to Follow-up|4|||
145308391|NCT02302716|523979627|FG000|Overall Study|Physician Decision|3|||
145308392|NCT02302716|523979628|FG001|Overall Study|Physician Decision|4|||
145308393|NCT02302716|523979627|FG000|Overall Study|Withdrawal by Subject|13|||
145308394|NCT02302716|523979628|FG001|Overall Study|Withdrawal by Subject|7|||
145411103|NCT03915067|524358769|FG002|Overall Study|Lost to Follow-up|0|||
145411104|NCT03915067|524358767|FG000|Overall Study|Protocol Deviation|0|||
145411105|NCT03915067|524358768|FG001|Overall Study|Protocol Deviation|0|||
145411106|NCT03915067|524358769|FG002|Overall Study|Protocol Deviation|1|||
145411107|NCT03915067|524358767|FG000|Overall Study|Covid-19 Related Issues|2|||
145411108|NCT03915067|524358768|FG001|Overall Study|Covid-19 Related Issues|4|||
145411109|NCT03915067|524358769|FG002|Overall Study|Covid-19 Related Issues|4|||
145411110|NCT03915067|524358767|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
145411111|NCT03915067|524358768|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
145411112|NCT03915067|524358769|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
145411113|NCT02693418|524358770|FG000|Overall Study|Lost to Follow-up|1|||
145411114|NCT02693418|524358771|FG001|Overall Study|Lost to Follow-up|2|||
145411115|NCT02693418|524358772|FG002|Overall Study|Lost to Follow-up|0|||
145411116|NCT02693418|524358773|FG003|Overall Study|Lost to Follow-up|0|||
145411117|NCT02693418|524358774|FG004|Overall Study|Lost to Follow-up|0|||
145411118|NCT02693418|524358770|FG000|Overall Study|Menses during study period|0|||
145308395|NCT02302716|523979627|FG000|Overall Study|Protocol Violation|0|||
145308396|NCT02302716|523979628|FG001|Overall Study|Protocol Violation|1|||
145308397|NCT00557245|523979632|FG000|Overall Study|Lost to Follow-up|7|||
145308398|NCT00557245|523979633|FG001|Overall Study|Lost to Follow-up|8|||
145308399|NCT00557245|523979634|FG002|Overall Study|Lost to Follow-up|10|||
145308400|NCT00557245|523979632|FG000|Overall Study|Ineligible|5|||
145308401|NCT00557245|523979633|FG001|Overall Study|Ineligible|4|||
145308402|NCT00557245|523979634|FG002|Overall Study|Ineligible|2|||
145308403|NCT02727192|523979640|FG000|Overall Study|Lost to Follow-up|1|||
145308404|NCT02727192|523979641|FG001|Overall Study|Lost to Follow-up|0|||
145308405|NCT02727192|523979642|FG002|Overall Study|Lost to Follow-up|0|||
145308406|NCT01410227|523979643|FG000|Overall Study|Adverse Event|1|||
145308407|NCT01410227|523979644|FG001|Overall Study|Adverse Event|0|||
145308408|NCT01410227|523979645|FG002|Overall Study|Adverse Event|0|||
145308409|NCT01410227|523979646|FG003|Overall Study|Adverse Event|0|||
145308410|NCT01410227|523979643|FG000|Overall Study|Withdrawal by Subject|3|||
145308411|NCT01410227|523979644|FG001|Overall Study|Withdrawal by Subject|0|||
145308412|NCT01410227|523979645|FG002|Overall Study|Withdrawal by Subject|1|||
145308413|NCT01410227|523979646|FG003|Overall Study|Withdrawal by Subject|0|||
145308414|NCT01410227|523979643|FG000|Overall Study|Pregnancy|0|||
145308415|NCT01410227|523979644|FG001|Overall Study|Pregnancy|0|||
145308416|NCT01410227|523979645|FG002|Overall Study|Pregnancy|0|||
145308417|NCT01410227|523979646|FG003|Overall Study|Pregnancy|1|||
145308418|NCT01410227|523979643|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
145308419|NCT01410227|523979644|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
145308420|NCT01410227|523979645|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
145308421|NCT01410227|523979646|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
145308422|NCT01808651|523979647|FG000|Study Period 1|Lost to Follow-up|1|||
145308423|NCT01808651|523979648|FG001|Study Period 1|Lost to Follow-up|3|||
145308424|NCT01808651|523979649|FG002|Study Period 1|Lost to Follow-up|0|||
145308425|NCT01808651|523979647|FG000|Study Period 1|Protocol Violation|1|||
145308426|NCT01808651|523979648|FG001|Study Period 1|Protocol Violation|0|||
145308427|NCT01808651|523979649|FG002|Study Period 1|Protocol Violation|1|||
145308428|NCT01808651|523979647|FG000|Study Period 1|Physician Decision|3|||
145308429|NCT01808651|523979648|FG001|Study Period 1|Physician Decision|2|||
145308430|NCT01808651|523979649|FG002|Study Period 1|Physician Decision|0|||
145308431|NCT01808651|523979647|FG000|Study Period 1|Lack of Efficacy|2|||
145308432|NCT01808651|523979648|FG001|Study Period 1|Lack of Efficacy|1|||
145308433|NCT01808651|523979649|FG002|Study Period 1|Lack of Efficacy|0|||
145308434|NCT01808651|523979647|FG000|Study Period 1|Adverse Event|10|||
145308435|NCT01808651|523979648|FG001|Study Period 1|Adverse Event|4|||
145308436|NCT01808651|523979649|FG002|Study Period 1|Adverse Event|1|||
145308437|NCT01808651|523979647|FG000|Study Period 1|Participant Decision|9|||
145308438|NCT01808651|523979648|FG001|Study Period 1|Participant Decision|7|||
145308439|NCT01808651|523979649|FG002|Study Period 1|Participant Decision|3|||
145308440|NCT00585286|523979652|FG000|Overall Study|Lost to Follow-up|1|||
145308441|NCT00608322|523979654|FG000|Overall Study|Death|2|||
145308442|NCT00608322|523979655|FG001|Overall Study|Death|1|||
145308443|NCT03497130|523979656|FG000|Overall Study|Lost to Follow-up|1|||
145308444|NCT03497130|523979657|FG001|Overall Study|Lost to Follow-up|1|||
145308445|NCT04002648|523979658|FG000|Overall Study|Lost to Follow-up|2|||
145308446|NCT04002648|523979659|FG001|Overall Study|Lost to Follow-up|0|||
145308447|NCT03325881|523979663|FG000|Overall Study|Protocol Violation|0|||
145308448|NCT03325881|523979664|FG001|Overall Study|Protocol Violation|1|||
145308449|NCT03325881|523979663|FG000|Overall Study|Withdrawal by Subject|0|||
145308450|NCT03325881|523979664|FG001|Overall Study|Withdrawal by Subject|2|||
145308451|NCT03325881|523979663|FG000|Overall Study|Lack of Efficacy|2|||
145308452|NCT03325881|523979664|FG001|Overall Study|Lack of Efficacy|0|||
145308453|NCT03325881|523979663|FG000|Overall Study|Not treated|1|||
145308454|NCT03325881|523979664|FG001|Overall Study|Not treated|0|||
145308455|NCT03676634|523979666|FG000|Overall Study|Red blood cell loss|1|||
145308456|NCT03676634|523979666|FG000|Overall Study|Out-of-limit pulse|2|||
145308457|NCT00606281|523979670|FG000|Overall Study|Adverse Event|11|||
145308458|NCT00606281|523979671|FG001|Overall Study|Adverse Event|12|||
145308459|NCT00606281|523979670|FG000|Overall Study|Death|1|||
145308460|NCT00606281|523979671|FG001|Overall Study|Death|0|||
145308461|NCT00606281|523979670|FG000|Overall Study|Lack of Efficacy|28|||
145308462|NCT00606281|523979671|FG001|Overall Study|Lack of Efficacy|35|||
145308463|NCT00606281|523979670|FG000|Overall Study|Physician Decision|0|||
145308464|NCT00606281|523979671|FG001|Overall Study|Physician Decision|1|||
145308465|NCT00606281|523979670|FG000|Overall Study|Protocol Violation|3|||
145308466|NCT00606281|523979671|FG001|Overall Study|Protocol Violation|3|||
145308467|NCT00606281|523979670|FG000|Overall Study|Withdrawal by Subject|11|||
145308468|NCT00606281|523979671|FG001|Overall Study|Withdrawal by Subject|13|||
145308469|NCT00606281|523979670|FG000|Overall Study|Progression to depressive phase|1|||
145308470|NCT00606281|523979671|FG001|Overall Study|Progression to depressive phase|1|||
145308471|NCT00606281|523979670|FG000|Overall Study|Change of residence or other commitments|1|||
145308472|NCT00606281|523979671|FG001|Overall Study|Change of residence or other commitments|1|||
145308473|NCT00829712|523979672|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
145620348|NCT00442286|525123745|FG001|Overall Study|System explanted|0|||
145308474|NCT00829712|523979673|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145308475|NCT03131895|523979675|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
145308476|NCT03131895|523979676|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
145308477|NCT03131895|523979677|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
145308478|NCT03131895|523979678|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
145308479|NCT03131895|523979675|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
145308480|NCT03131895|523979676|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
145308481|NCT03131895|523979677|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
145308482|NCT03131895|523979678|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
145308483|NCT03131895|523979675|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145308484|NCT03131895|523979676|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
145308485|NCT03131895|523979677|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145308486|NCT03131895|523979678|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
145308487|NCT03131895|523979675|FG000|Washout Period (at Least 5 Days)|Other|0|||
145308488|NCT03131895|523979676|FG001|Washout Period (at Least 5 Days)|Other|0|||
145308489|NCT03131895|523979677|FG002|Washout Period (at Least 5 Days)|Other|2|||
145308490|NCT03131895|523979678|FG003|Washout Period (at Least 5 Days)|Other|0|||
145308491|NCT03131895|523979675|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
145308492|NCT03131895|523979676|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
145308493|NCT03131895|523979677|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
145308494|NCT03131895|523979678|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
145308495|NCT03131895|523979675|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
145308496|NCT03131895|523979676|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
145308497|NCT03131895|523979677|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
145308498|NCT03131895|523979678|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
145308499|NCT01188681|523979681|FG000|Overall Study|bladder cancer|0|||
145308500|NCT01188681|523979682|FG001|Overall Study|bladder cancer|0|||
145308501|NCT01188681|523979683|FG002|Overall Study|bladder cancer|1|||
145308502|NCT01188681|523979684|FG003|Overall Study|bladder cancer|0|||
145308503|NCT01188681|523979681|FG000|Overall Study|Withdrawal by Subject|0|||
145308504|NCT01188681|523979682|FG001|Overall Study|Withdrawal by Subject|0|||
145308505|NCT01188681|523979683|FG002|Overall Study|Withdrawal by Subject|0|||
145308506|NCT01188681|523979684|FG003|Overall Study|Withdrawal by Subject|1|||
145308507|NCT03158727|523979690|FG000|Overall Study|Withdrawal by Subject|2|||
145308508|NCT03158727|523979691|FG001|Overall Study|Withdrawal by Subject|6|||
145308509|NCT03158727|523979690|FG000|Overall Study|Death|11|||
145308510|NCT03158727|523979691|FG001|Overall Study|Death|12|||
145308511|NCT03158727|523979690|FG000|Overall Study|Lost to Follow-up|1|||
145308512|NCT03158727|523979691|FG001|Overall Study|Lost to Follow-up|0|||
145308513|NCT03158727|523979690|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
145308514|NCT03158727|523979691|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
145308515|NCT03158727|523979690|FG000|Overall Study|Visit 11 not done by mistake|0|||
145308516|NCT03158727|523979691|FG001|Overall Study|Visit 11 not done by mistake|1|||
145308517|NCT03158727|523979690|FG000|Overall Study|Enrolled, not treated|1|||
145308518|NCT03158727|523979691|FG001|Overall Study|Enrolled, not treated|0|||
145308519|NCT00669162|523979692|FG000|Overall Study|Withdrawal by Subject|1|||
145308520|NCT00985439|523979693|FG000|Overall Study|Adverse Event|0|||
145308521|NCT00985439|523979694|FG001|Overall Study|Adverse Event|0|||
145308522|NCT00985439|523979695|FG002|Overall Study|Adverse Event|1|||
145308523|NCT00985439|523979696|FG003|Overall Study|Adverse Event|0|||
145308524|NCT01051349|523979697|FG000|Overall Study|Adverse Event|88|||
145308525|NCT01051349|523979697|FG000|Overall Study|Consent Withdrawn|54|||
145308526|NCT01051349|523979697|FG000|Overall Study|Investigator Decision|6|||
145308527|NCT01051349|523979697|FG000|Overall Study|Lost to Follow-up|6|||
145569143|NCT00805935|524944186|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
145569144|NCT00805935|524944183|FG000|Overall Study|Lost to Follow-up|1|||
145569145|NCT00805935|524944184|FG001|Overall Study|Lost to Follow-up|0|||
145308528|NCT01051349|523979697|FG000|Overall Study|Subject non-compliance|7|||
145308529|NCT01051349|523979697|FG000|Overall Study|Reason not Specified|12|||
145308530|NCT00463684|523979702|FG000|Overall Study|Withdrawal by Subject|1|||
145308531|NCT00463684|523979702|FG000|Overall Study|Lost to Follow-up|3|||
145308532|NCT01906372|523979703|FG000|Overall Study|Withdrawal by Subject|2|||
145308533|NCT02462837|523979705|FG000|Overall Study|pt developed hives|1|||
145569146|NCT00805935|524944185|FG002|Overall Study|Lost to Follow-up|0|||
145308534|NCT02462837|523979706|FG001|Overall Study|pt developed hives|0|||
145308535|NCT02462837|523979705|FG000|Overall Study|Withdrawal by Subject|1|||
145308536|NCT02462837|523979706|FG001|Overall Study|Withdrawal by Subject|0|||
145308537|NCT00367133|523979710|FG000|2 Years|Death|20|||
145308538|NCT00367133|523979711|FG001|2 Years|Death|12|||
145308539|NCT00367133|523979712|FG002|2 Years|Death|12|||
145308540|NCT00367133|523979710|FG000|2 Years|Dropped|34|||
145308541|NCT00367133|523979711|FG001|2 Years|Dropped|19|||
145308542|NCT00367133|523979712|FG002|2 Years|Dropped|33|||
145308543|NCT00367133|523979710|FG000|2 Years|Missed visit|4|||
145308544|NCT00367133|523979711|FG001|2 Years|Missed visit|5|||
145308545|NCT00367133|523979712|FG002|2 Years|Missed visit|4|||
145308546|NCT00847535|523979718|FG000|Overall Study|Withdrawal by Subject|2|||
145308547|NCT00847535|523979719|FG001|Overall Study|Withdrawal by Subject|1|||
145308548|NCT00847535|523979720|FG002|Overall Study|Withdrawal by Subject|1|||
145308549|NCT00847535|523979718|FG000|Overall Study|Lost to Follow-up|0|||
145308550|NCT00847535|523979719|FG001|Overall Study|Lost to Follow-up|1|||
145308551|NCT00847535|523979720|FG002|Overall Study|Lost to Follow-up|0|||
145308552|NCT01252953|523979721|FG000|Overall Study|Withdrawal by Subject|16|||
145308553|NCT01252953|523979722|FG001|Overall Study|Withdrawal by Subject|17|||
145308554|NCT01252953|523979721|FG000|Overall Study|Lost to Follow-up|22|||
145308555|NCT01252953|523979722|FG001|Overall Study|Lost to Follow-up|21|||
145308556|NCT02336074|523979723|FG000|Overall Study|Adverse Event|0|||
145308557|NCT02336074|523979724|FG001|Overall Study|Adverse Event|2|||
145308558|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Refused|1|||
145569147|NCT00805935|524944186|FG003|Overall Study|Lost to Follow-up|0|||
145569148|NCT00805935|524944183|FG000|Overall Study|No positive serum pregnancy|8|||
145569149|NCT00805935|524944184|FG001|Overall Study|No positive serum pregnancy|7|||
145569150|NCT00805935|524944185|FG002|Overall Study|No positive serum pregnancy|6|||
145569151|NCT00805935|524944186|FG003|Overall Study|No positive serum pregnancy|5|||
145569152|NCT00805935|524944183|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
145569153|NCT00805935|524944184|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
145569154|NCT00805935|524944185|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
145569155|NCT00805935|524944186|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
145569156|NCT00805935|524944183|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
145569157|NCT00805935|524944184|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
145569158|NCT00805935|524944185|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
145569159|NCT00805935|524944186|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
145569160|NCT00805935|524944183|FG000|Overall Study|Biochemical pregnancy|0|||
145569161|NCT00805935|524944184|FG001|Overall Study|Biochemical pregnancy|1|||
145569162|NCT00805935|524944185|FG002|Overall Study|Biochemical pregnancy|0|||
145308559|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Refused|3|||
145308560|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Medical|0|||
145308561|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Medical|1|||
145308562|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
145308563|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
145308564|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
145308565|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
145308566|NCT02054715|523979726|FG000|Baseline/Follow-up 1|No Reason|0|||
145308567|NCT02054715|523979727|FG001|Baseline/Follow-up 1|No Reason|1|||
145308568|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
145308569|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
145308570|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Ineligible|3|||
145308571|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Ineligible|0|||
145308572|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Hospitalization|1|||
145308573|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Hospitalization|0|||
145308574|NCT02054715|523979726|FG000|Baseline/Follow-up 1|Changed Mind|1|||
145308575|NCT02054715|523979727|FG001|Baseline/Follow-up 1|Changed Mind|0|||
145308576|NCT02054715|523979726|FG000|Follow-up 2|Lost to Followup|3|||
145308577|NCT02054715|523979727|FG001|Follow-up 2|Lost to Followup|1|||
145308578|NCT02054715|523979726|FG000|Follow-up 2|Refused|3|||
145308579|NCT02054715|523979727|FG001|Follow-up 2|Refused|2|||
145308580|NCT02054715|523979726|FG000|Follow-up 2|Followup Not Completed|3|||
145308581|NCT02054715|523979727|FG001|Follow-up 2|Followup Not Completed|4|||
145308582|NCT02054715|523979726|FG000|Follow-up 2|Ineligible|4|||
145411119|NCT02693418|524358771|FG001|Overall Study|Menses during study period|0|||
145411120|NCT02693418|524358772|FG002|Overall Study|Menses during study period|2|||
145569163|NCT00805935|524944186|FG003|Overall Study|Biochemical pregnancy|0|||
145569164|NCT00805935|524944183|FG000|Overall Study|Chemical pregnancy|0|||
145569165|NCT00805935|524944184|FG001|Overall Study|Chemical pregnancy|5|||
145569166|NCT00805935|524944185|FG002|Overall Study|Chemical pregnancy|3|||
145569167|NCT00805935|524944186|FG003|Overall Study|Chemical pregnancy|2|||
145569168|NCT00805935|524944183|FG000|Overall Study|Ectopic pregnancy|0|||
145569169|NCT00805935|524944184|FG001|Overall Study|Ectopic pregnancy|0|||
145569170|NCT00805935|524944185|FG002|Overall Study|Ectopic pregnancy|1|||
145569171|NCT00805935|524944186|FG003|Overall Study|Ectopic pregnancy|0|||
145569172|NCT00805935|524944183|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
145620349|NCT00442286|525123744|FG000|Overall Study|Patient Injury|1|||
145308583|NCT02054715|523979727|FG001|Follow-up 2|Ineligible|5|||
145308584|NCT02054715|523979726|FG000|Follow-up 2|Death|3|||
145308585|NCT02054715|523979727|FG001|Follow-up 2|Death|3|||
145308586|NCT02054715|523979726|FG000|Follow-up 2|Hospitalization|0|||
145308587|NCT02054715|523979727|FG001|Follow-up 2|Hospitalization|2|||
145308588|NCT02054715|523979726|FG000|Follow-up 2|Changed MD/Facility|0|||
145308589|NCT02054715|523979727|FG001|Follow-up 2|Changed MD/Facility|1|||
145308590|NCT02054715|523979726|FG000|Follow-up 2|Changed Mind|0|||
145308591|NCT02054715|523979727|FG001|Follow-up 2|Changed Mind|1|||
145308592|NCT02054715|523979726|FG000|Follow-up 2|No Reason|2|||
145308593|NCT02054715|523979727|FG001|Follow-up 2|No Reason|0|||
145308594|NCT02054715|523979726|FG000|Follow-up 2|Treatment Change or Delay|1|||
145308595|NCT02054715|523979727|FG001|Follow-up 2|Treatment Change or Delay|0|||
145308596|NCT00858780|523979728|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
145308597|NCT00858780|523979729|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
145308598|NCT00858780|523979730|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
145308599|NCT00858780|523979731|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
145308600|NCT00858780|523979732|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
145308601|NCT00858780|523979728|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
145308602|NCT00858780|523979729|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
145308603|NCT00858780|523979730|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
145308604|NCT00858780|523979731|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
145308605|NCT00858780|523979732|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
145308606|NCT00858780|523979728|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
145308607|NCT00858780|523979729|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
145308608|NCT00858780|523979730|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
145308609|NCT00858780|523979731|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
145308610|NCT00858780|523979732|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
145308611|NCT00858780|523979728|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
145308612|NCT00858780|523979729|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
145308613|NCT00858780|523979730|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
145308614|NCT00858780|523979731|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
145308615|NCT00858780|523979732|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
145308616|NCT00858780|523979728|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
145308617|NCT00858780|523979729|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
145308618|NCT00858780|523979730|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
145308619|NCT00858780|523979731|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
145308620|NCT00858780|523979732|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
145308621|NCT00858780|523979728|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
145308622|NCT00858780|523979729|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
145308623|NCT00858780|523979730|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
145308624|NCT00858780|523979731|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
145308625|NCT00858780|523979732|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
145308626|NCT00674128|523979733|FG000|Overall Study|Withdrawal by Subject|25|||
145308627|NCT00674128|523979734|FG001|Overall Study|Withdrawal by Subject|23|||
145308628|NCT04631562|523979737|FG000|Overall Study|Withdrawal by Subject|0|||
145308629|NCT04631562|523979738|FG001|Overall Study|Withdrawal by Subject|0|||
145308630|NCT04631562|523979739|FG002|Overall Study|Withdrawal by Subject|0|||
145308631|NCT04631562|523979740|FG003|Overall Study|Withdrawal by Subject|0|||
145308632|NCT04631562|523979741|FG004|Overall Study|Withdrawal by Subject|0|||
145308633|NCT04631562|523979742|FG005|Overall Study|Withdrawal by Subject|0|||
145308634|NCT04631562|523979743|FG006|Overall Study|Withdrawal by Subject|0|||
145308635|NCT04631562|523979744|FG007|Overall Study|Withdrawal by Subject|1|||
145308636|NCT04631562|523979745|FG008|Overall Study|Withdrawal by Subject|0|||
145308637|NCT04631562|523979737|FG000|Overall Study|Other|0|||
145308638|NCT04631562|523979738|FG001|Overall Study|Other|0|||
145308639|NCT04631562|523979739|FG002|Overall Study|Other|0|||
145308640|NCT04631562|523979740|FG003|Overall Study|Other|0|||
145308641|NCT04631562|523979741|FG004|Overall Study|Other|0|||
145308642|NCT04631562|523979742|FG005|Overall Study|Other|0|||
145308643|NCT04631562|523979743|FG006|Overall Study|Other|0|||
145308644|NCT04631562|523979744|FG007|Overall Study|Other|0|||
145308645|NCT04631562|523979745|FG008|Overall Study|Other|1|||
145308646|NCT04631562|523979737|FG000|Overall Study|Lost to Follow-up|0|||
145308647|NCT04631562|523979738|FG001|Overall Study|Lost to Follow-up|0|||
145308648|NCT04631562|523979739|FG002|Overall Study|Lost to Follow-up|0|||
145308649|NCT04631562|523979740|FG003|Overall Study|Lost to Follow-up|1|||
145308650|NCT04631562|523979741|FG004|Overall Study|Lost to Follow-up|0|||
145308651|NCT04631562|523979742|FG005|Overall Study|Lost to Follow-up|0|||
145308652|NCT04631562|523979743|FG006|Overall Study|Lost to Follow-up|0|||
145308653|NCT04631562|523979744|FG007|Overall Study|Lost to Follow-up|0|||
145308654|NCT04631562|523979745|FG008|Overall Study|Lost to Follow-up|0|||
145308655|NCT04631562|523979737|FG000|Overall Study|Adverse Event|0|||
145308656|NCT04631562|523979738|FG001|Overall Study|Adverse Event|0|||
145308657|NCT04631562|523979739|FG002|Overall Study|Adverse Event|0|||
145308658|NCT04631562|523979740|FG003|Overall Study|Adverse Event|0|||
145308659|NCT04631562|523979741|FG004|Overall Study|Adverse Event|0|||
145308660|NCT04631562|523979742|FG005|Overall Study|Adverse Event|0|||
145308661|NCT04631562|523979743|FG006|Overall Study|Adverse Event|1|||
145308662|NCT04631562|523979744|FG007|Overall Study|Adverse Event|0|||
145308663|NCT04631562|523979745|FG008|Overall Study|Adverse Event|0|||
145308664|NCT02615249|523979754|FG000|Overall Study|Withdrawal by Subject|1|||
145308665|NCT05098743|523979756|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
145377818|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
145308666|NCT05098743|523979757|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
145308667|NCT05098743|523979756|FG000|Overall Study|Lost to Follow-up|1|||
145308668|NCT05098743|523979757|FG001|Overall Study|Lost to Follow-up|2|||
145308669|NCT01456221|523979759|FG000|Overall Study|Withdrawal by Subject|56|||
145308670|NCT01456221|523979760|FG001|Overall Study|Withdrawal by Subject|49|||
145569173|NCT00805935|524944184|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
145569174|NCT00805935|524944185|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
145569175|NCT00805935|524944186|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
145569176|NCT02347527|524944187|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
145569177|NCT02347527|524944188|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
145569178|NCT02347527|524944189|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
145569179|NCT02347527|524944190|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
145308671|NCT01456221|523979759|FG000|Overall Study|Lost to Follow-up|1|||
145308672|NCT01456221|523979760|FG001|Overall Study|Lost to Follow-up|4|||
145308673|NCT01456221|523979759|FG000|Overall Study|Received medication|3|||
145569180|NCT02347527|524944187|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
145308674|NCT01456221|523979760|FG001|Overall Study|Received medication|2|||
145308675|NCT01456221|523979759|FG000|Overall Study|Incomplete data|4|||
145308676|NCT01456221|523979760|FG001|Overall Study|Incomplete data|2|||
145308677|NCT03498560|523979761|FG000|Overall Study|Found Ineligible|2|||
145308678|NCT03498560|523979761|FG000|Overall Study|Withdrawal by Subject|14|||
145308679|NCT03498560|523979761|FG000|Overall Study|Lost to Follow-up|4|||
145308680|NCT03498560|523979761|FG000|Overall Study|Death|1|||
145308681|NCT00867360|523979766|FG000|Overall Study|Withdrawal by Subject|1|||
145308682|NCT00867360|523979767|FG001|Overall Study|Withdrawal by Subject|0|||
145308683|NCT00867360|523979766|FG000|Overall Study|Physician Decision|0|||
145308684|NCT00867360|523979767|FG001|Overall Study|Physician Decision|1|||
145308685|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
145308686|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
145308687|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
145308688|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
145308689|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
145308690|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308691|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308692|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308693|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308694|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308695|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308696|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308697|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
145620350|NCT00442286|525123745|FG001|Overall Study|Patient Injury|0|||
145620351|NCT00641186|525123746|FG000|Overall Study|Adverse Event|3|||
145620352|NCT02102464|525123749|FG000|Randomized Study|Withdrawal by Subject|0|||
145620353|NCT02102464|525123750|FG001|Randomized Study|Withdrawal by Subject|1|||
145620354|NCT02102464|525123751|FG002|Randomized Study|Withdrawal by Subject|0|||
145620355|NCT04140890|525123752|FG000|Overall Study|Withdrawal by Subject|0|||
145620356|NCT04140890|525123753|FG001|Overall Study|Withdrawal by Subject|1|||
145308698|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308699|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308700|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308701|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308702|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308703|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308704|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308705|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308706|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308707|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
145569181|NCT02347527|524944188|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
145569182|NCT02347527|524944189|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
145569183|NCT02347527|524944190|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
145569184|NCT02347527|524944187|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
145308708|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308709|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308710|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
145308711|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308712|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
145308713|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308714|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308715|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308716|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145620357|NCT01778062|525123756|FG000|Overall Study|Adverse Event|1|||
145308717|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308718|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308719|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308720|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308721|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308722|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308723|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308724|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308725|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308726|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308727|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308728|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308729|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308730|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308731|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308732|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308733|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308734|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308735|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308736|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
145308737|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308738|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
145308739|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308740|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308741|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308742|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308743|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308744|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308745|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308746|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308747|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308748|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308749|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308750|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308751|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308752|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308753|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308754|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308755|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308756|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308757|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308758|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308759|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308760|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308761|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308762|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
145308763|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
145308764|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308765|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
145308766|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
145308767|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
145308768|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308769|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308770|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308771|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308772|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308773|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308774|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308775|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308776|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308777|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145411121|NCT02693418|524358773|FG003|Overall Study|Menses during study period|0|||
145569185|NCT02347527|524944188|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
145569186|NCT02347527|524944189|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
145569187|NCT02347527|524944190|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
145308778|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308779|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308780|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145569188|NCT02347527|524944187|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
145569189|NCT02347527|524944188|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
145569190|NCT02347527|524944189|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
145569191|NCT02347527|524944190|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
145308781|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308782|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308783|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308784|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308785|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308786|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308787|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308788|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
145308789|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
145308790|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
145308791|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
145308792|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
145308793|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
145308794|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308795|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308796|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308797|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308798|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308799|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308800|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308801|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308802|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308803|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308804|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308805|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308806|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308807|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308808|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308809|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308810|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308811|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308812|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308813|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308814|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
145308815|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|moved|0|||
145308816|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|moved|1|||
145308817|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|moved|1|||
145308818|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|moved|0|||
145308819|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|moved|0|||
145308820|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|moved|0|||
145308821|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|moved|0|||
145308822|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|moved|0|||
145308823|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|moved|0|||
145308824|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|moved|0|||
145308825|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|moved|0|||
145308826|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|moved|0|||
145308827|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|moved|0|||
145308828|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|moved|0|||
145308829|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|moved|0|||
145308830|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|moved|0|||
145308831|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|moved|0|||
145308832|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|moved|0|||
145308833|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|moved|0|||
145308834|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|moved|0|||
145308835|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|moved|0|||
145308836|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|moved|0|||
145308837|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|moved|0|||
145308838|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|moved|0|||
145569192|NCT02347527|524944187|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
145569193|NCT02347527|524944188|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
145308839|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|moved|0|||
145308840|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|moved|0|||
145308841|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308842|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145569194|NCT02347527|524944189|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
145308843|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308844|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
145308845|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308846|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308847|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308848|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308849|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308850|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308851|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308852|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308853|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308854|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308855|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308856|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308857|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308858|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308859|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308860|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308861|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308862|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308863|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308864|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308865|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308866|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
145308867|NCT00112437|523979771|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308868|NCT00112437|523979772|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308869|NCT00112437|523979773|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308870|NCT00112437|523979774|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308871|NCT00112437|523979775|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
145308872|NCT00112437|523979776|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308873|NCT00112437|523979777|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308874|NCT00112437|523979778|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308875|NCT00112437|523979779|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145569195|NCT02347527|524944190|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
145308876|NCT00112437|523979780|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308877|NCT00112437|523979781|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308878|NCT00112437|523979782|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308879|NCT00112437|523979783|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308880|NCT00112437|523979784|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308881|NCT00112437|523979785|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308882|NCT00112437|523979786|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308883|NCT00112437|523979787|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308884|NCT00112437|523979788|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308885|NCT00112437|523979789|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308886|NCT00112437|523979790|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308887|NCT00112437|523979791|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308888|NCT00112437|523979792|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308889|NCT00112437|523979793|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308890|NCT00112437|523979794|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308891|NCT00112437|523979795|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308892|NCT00112437|523979796|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
145308893|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
145308894|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
145308895|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
145308896|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
145308897|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
145308898|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
145308899|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
145308900|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
145308901|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
145569196|NCT02643251|524944191|FG000|Overall Study|Adverse Event|3|||
145308902|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
145308903|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
145308904|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
145308905|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
145308906|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
145308907|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
145308908|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
145308909|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
145308910|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
145308911|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
145308912|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
145308913|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
145308914|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
145308915|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
145308916|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
145308917|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
145308918|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
145308919|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308920|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308921|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308922|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308923|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308924|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
145308925|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
145308926|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308927|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308928|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
145308929|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308930|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308931|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308932|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308933|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308934|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308935|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308936|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308937|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308938|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308939|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308940|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308941|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308942|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308943|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308944|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
145308945|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308946|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308947|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308948|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308949|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308950|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308951|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308952|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308953|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
145308954|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308955|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308956|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308957|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308958|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308959|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308960|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308961|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308962|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308963|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308964|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308965|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308966|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308967|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308968|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308969|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308970|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
145308971|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308972|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308973|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308974|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308975|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308976|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308977|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308978|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308979|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
145308980|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308981|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308982|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308983|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308984|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308985|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308986|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308987|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308988|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308989|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308990|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308991|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308992|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308993|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308994|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308995|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308996|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
145308997|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145308998|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145308999|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309000|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309001|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309002|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
145309003|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
145309004|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
145309005|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
145309006|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
145309007|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309008|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309009|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309010|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309011|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309012|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309013|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309014|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309015|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309016|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309017|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309018|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309019|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309020|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309021|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309022|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
145309023|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309024|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309025|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309026|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309027|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309028|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309029|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309030|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309031|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309032|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
145309033|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145569197|NCT02643251|524944192|FG001|Overall Study|Adverse Event|1|||
145309034|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309035|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309036|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309037|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309038|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309039|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309040|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309041|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309042|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309043|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309044|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309045|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309046|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309047|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309048|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
145309049|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309050|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309051|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309052|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309053|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309054|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309055|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309056|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309057|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309058|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
145309059|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309060|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309061|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309062|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309063|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309064|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309065|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309066|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309067|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309068|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309069|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309070|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309071|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309072|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309073|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309074|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
145309075|NCT00112437|523979771|FG000|Year 2 (12-Month Extension)|Moved|0|||
145309076|NCT00112437|523979772|FG001|Year 2 (12-Month Extension)|Moved|0|||
145309077|NCT00112437|523979773|FG002|Year 2 (12-Month Extension)|Moved|0|||
145309078|NCT00112437|523979774|FG003|Year 2 (12-Month Extension)|Moved|0|||
145309079|NCT00112437|523979775|FG004|Year 2 (12-Month Extension)|Moved|0|||
145309080|NCT00112437|523979776|FG005|Year 2 (12-Month Extension)|Moved|0|||
145309081|NCT00112437|523979777|FG006|Year 2 (12-Month Extension)|Moved|0|||
145309082|NCT00112437|523979778|FG007|Year 2 (12-Month Extension)|Moved|0|||
145309083|NCT00112437|523979779|FG008|Year 2 (12-Month Extension)|Moved|0|||
145309084|NCT00112437|523979780|FG009|Year 2 (12-Month Extension)|Moved|1|||
145309085|NCT00112437|523979781|FG010|Year 2 (12-Month Extension)|Moved|0|||
145309086|NCT00112437|523979782|FG011|Year 2 (12-Month Extension)|Moved|0|||
145309087|NCT00112437|523979783|FG012|Year 2 (12-Month Extension)|Moved|0|||
145309088|NCT00112437|523979784|FG013|Year 2 (12-Month Extension)|Moved|0|||
145309089|NCT00112437|523979785|FG014|Year 2 (12-Month Extension)|Moved|0|||
145309090|NCT00112437|523979786|FG015|Year 2 (12-Month Extension)|Moved|0|||
145309091|NCT00112437|523979787|FG016|Year 2 (12-Month Extension)|Moved|0|||
145309092|NCT00112437|523979788|FG017|Year 2 (12-Month Extension)|Moved|0|||
145309093|NCT00112437|523979789|FG018|Year 2 (12-Month Extension)|Moved|0|||
145309094|NCT00112437|523979790|FG019|Year 2 (12-Month Extension)|Moved|0|||
145309095|NCT00112437|523979791|FG020|Year 2 (12-Month Extension)|Moved|0|||
145309096|NCT00112437|523979792|FG021|Year 2 (12-Month Extension)|Moved|0|||
145309097|NCT00112437|523979793|FG022|Year 2 (12-Month Extension)|Moved|0|||
145309098|NCT00112437|523979794|FG023|Year 2 (12-Month Extension)|Moved|0|||
145309099|NCT00112437|523979795|FG024|Year 2 (12-Month Extension)|Moved|0|||
145309100|NCT00112437|523979796|FG025|Year 2 (12-Month Extension)|Moved|0|||
145309101|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
145309102|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
145309103|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
145411122|NCT02693418|524358774|FG004|Overall Study|Menses during study period|0|||
145411123|NCT01750346|524358776|FG000|Overall Study|Adverse Event|1|||
145411124|NCT01750346|524358777|FG001|Overall Study|Adverse Event|0|||
145309104|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
145309105|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
145309106|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
145309107|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
145309108|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
145411125|NCT01750346|524358778|FG002|Overall Study|Adverse Event|0|||
145309109|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
145309110|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
145309111|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
145309112|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
145309113|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
145309114|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
145309115|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
145309116|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
145309117|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
145309118|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
145309119|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
145309120|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
145309121|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
145309122|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
145309123|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
145309124|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
145309125|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
145309126|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
145309127|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309128|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309129|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309130|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309131|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309132|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309133|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309134|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309135|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309136|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309137|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309138|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
145309139|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309140|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
145309141|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309142|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
145309143|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309144|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309145|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
145309146|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309147|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309148|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309149|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309150|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309151|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309152|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
145309153|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309154|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309155|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309156|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309157|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309158|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309159|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309160|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309161|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309162|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309163|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309164|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309165|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309166|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309167|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309168|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
145309169|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309170|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309171|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309172|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309173|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309174|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309175|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309176|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309177|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309178|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
145309179|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309180|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309181|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309182|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309183|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309184|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309185|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309186|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309187|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309188|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309189|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309190|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309191|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309192|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309193|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309194|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
145309195|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309196|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309197|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309198|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309199|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309200|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309201|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309202|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309203|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309204|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
145309205|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309206|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309207|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309208|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309209|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309210|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309211|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309212|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309213|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309214|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309215|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309216|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
145309217|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309218|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309219|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
145309220|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309221|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309222|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309223|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309224|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309225|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309226|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309227|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309228|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309229|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309230|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
145309231|NCT00112437|523979771|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309232|NCT00112437|523979772|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309233|NCT00112437|523979773|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309234|NCT00112437|523979774|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309235|NCT00112437|523979775|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309236|NCT00112437|523979776|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309237|NCT00112437|523979777|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309238|NCT00112437|523979778|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309239|NCT00112437|523979779|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309240|NCT00112437|523979780|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309241|NCT00112437|523979781|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
145309242|NCT00112437|523979782|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
145309243|NCT00112437|523979783|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309244|NCT00112437|523979784|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309245|NCT00112437|523979785|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145411126|NCT01001104|524358779|FG000|Overall Study|Adverse Event|2|||
145411127|NCT01001104|524358780|FG001|Overall Study|Adverse Event|1|||
145309246|NCT00112437|523979786|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309247|NCT00112437|523979787|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309248|NCT00112437|523979788|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309249|NCT00112437|523979789|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309250|NCT00112437|523979790|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309251|NCT00112437|523979791|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309252|NCT00112437|523979792|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309253|NCT00112437|523979793|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309254|NCT00112437|523979794|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309255|NCT00112437|523979795|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309256|NCT00112437|523979796|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
145309257|NCT00112437|523979771|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309258|NCT00112437|523979772|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309259|NCT00112437|523979773|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309260|NCT00112437|523979774|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309261|NCT00112437|523979775|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309262|NCT00112437|523979776|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309263|NCT00112437|523979777|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309264|NCT00112437|523979778|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309265|NCT00112437|523979779|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309266|NCT00112437|523979780|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309267|NCT00112437|523979781|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309268|NCT00112437|523979782|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309269|NCT00112437|523979783|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309270|NCT00112437|523979784|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309271|NCT00112437|523979785|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309272|NCT00112437|523979786|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309273|NCT00112437|523979787|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309274|NCT00112437|523979788|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309275|NCT00112437|523979789|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309276|NCT00112437|523979790|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309277|NCT00112437|523979791|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
145309278|NCT00112437|523979792|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
145309279|NCT00112437|523979793|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309280|NCT00112437|523979794|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309281|NCT00112437|523979795|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309282|NCT00112437|523979796|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
145309283|NCT00112437|523979771|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309284|NCT00112437|523979772|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309285|NCT00112437|523979773|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309286|NCT00112437|523979774|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309287|NCT00112437|523979775|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309288|NCT00112437|523979776|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309289|NCT00112437|523979777|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309290|NCT00112437|523979778|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309291|NCT00112437|523979779|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309292|NCT00112437|523979780|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309293|NCT00112437|523979781|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309294|NCT00112437|523979782|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309295|NCT00112437|523979783|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309296|NCT00112437|523979784|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309297|NCT00112437|523979785|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309298|NCT00112437|523979786|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309299|NCT00112437|523979787|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309300|NCT00112437|523979788|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309301|NCT00112437|523979789|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309302|NCT00112437|523979790|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309303|NCT00112437|523979791|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
145309304|NCT00112437|523979792|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309305|NCT00112437|523979793|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309306|NCT00112437|523979794|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145411128|NCT01001104|524358781|FG002|Overall Study|Adverse Event|0|||
145569198|NCT02643251|524944191|FG000|Overall Study|Withdrawal by Subject|2|||
145569199|NCT02643251|524944192|FG001|Overall Study|Withdrawal by Subject|0|||
145569200|NCT02643251|524944191|FG000|Overall Study|Lost to Follow-up|4|||
145569201|NCT02643251|524944192|FG001|Overall Study|Lost to Follow-up|1|||
145309307|NCT00112437|523979795|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309308|NCT00112437|523979796|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
145309309|NCT00112437|523979771|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309310|NCT00112437|523979772|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309311|NCT00112437|523979773|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309312|NCT00112437|523979774|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309313|NCT00112437|523979775|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309314|NCT00112437|523979776|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309315|NCT00112437|523979777|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309316|NCT00112437|523979778|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309317|NCT00112437|523979779|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309318|NCT00112437|523979780|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309319|NCT00112437|523979781|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309320|NCT00112437|523979782|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309321|NCT00112437|523979783|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309322|NCT00112437|523979784|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309323|NCT00112437|523979785|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309324|NCT00112437|523979786|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309325|NCT00112437|523979787|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309326|NCT00112437|523979788|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309327|NCT00112437|523979789|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309328|NCT00112437|523979790|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309329|NCT00112437|523979791|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309330|NCT00112437|523979792|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
145309331|NCT00112437|523979793|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309332|NCT00112437|523979794|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309333|NCT00112437|523979795|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309334|NCT00112437|523979796|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
145309335|NCT00112437|523979771|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309336|NCT00112437|523979772|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309337|NCT00112437|523979773|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309338|NCT00112437|523979774|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309339|NCT00112437|523979775|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309340|NCT00112437|523979776|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309341|NCT00112437|523979777|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309342|NCT00112437|523979778|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309343|NCT00112437|523979779|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309344|NCT00112437|523979780|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309345|NCT00112437|523979781|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309346|NCT00112437|523979782|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309347|NCT00112437|523979783|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309348|NCT00112437|523979784|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309349|NCT00112437|523979785|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309350|NCT00112437|523979786|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309351|NCT00112437|523979787|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309352|NCT00112437|523979788|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309353|NCT00112437|523979789|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309354|NCT00112437|523979790|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309355|NCT00112437|523979791|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309356|NCT00112437|523979792|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
145309357|NCT00112437|523979793|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309358|NCT00112437|523979794|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309359|NCT00112437|523979795|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309360|NCT00112437|523979796|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
145309361|NCT00112437|523979771|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309362|NCT00112437|523979772|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309363|NCT00112437|523979773|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309364|NCT00112437|523979774|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309365|NCT00112437|523979775|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309366|NCT00112437|523979776|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309367|NCT00112437|523979777|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309368|NCT00112437|523979778|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309369|NCT00112437|523979779|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309370|NCT00112437|523979780|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309371|NCT00112437|523979781|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309372|NCT00112437|523979782|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309373|NCT00112437|523979783|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309374|NCT00112437|523979784|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309375|NCT00112437|523979785|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309376|NCT00112437|523979786|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309377|NCT00112437|523979787|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309378|NCT00112437|523979788|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309379|NCT00112437|523979789|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309380|NCT00112437|523979790|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309381|NCT00112437|523979791|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
145309382|NCT00112437|523979792|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
145309383|NCT00112437|523979793|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309384|NCT00112437|523979794|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309385|NCT00112437|523979795|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309386|NCT00112437|523979796|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
145309387|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309388|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309389|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309390|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309391|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309392|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309393|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309394|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309395|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309396|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309397|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309398|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309399|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309400|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309401|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309402|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309403|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309404|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309405|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309406|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309407|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309408|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309409|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
145309410|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
145309411|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
145309412|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
145309413|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Death|0|||
145309414|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Death|0|||
145309415|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Death|0|||
145309416|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Death|0|||
145309417|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Death|0|||
145309418|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Death|0|||
145309419|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Death|0|||
145309420|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Death|0|||
145309421|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Death|0|||
145309422|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Death|0|||
145309423|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Death|0|||
145309424|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Death|0|||
145309425|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Death|0|||
145309426|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Death|0|||
145309427|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Death|0|||
145309428|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Death|0|||
145309429|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Death|0|||
145309430|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Death|0|||
145309431|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Death|0|||
145309432|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Death|0|||
145309433|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Death|0|||
145411129|NCT01001104|524358782|FG003|Overall Study|Adverse Event|0|||
145411130|NCT01001104|524358779|FG000|Overall Study|Lost to Follow-up|0|||
145411131|NCT01001104|524358780|FG001|Overall Study|Lost to Follow-up|0|||
145569202|NCT02643251|524944191|FG000|Overall Study|Protocol Violation|1|||
145309434|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Death|0|||
145309435|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Death|0|||
145309436|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Death|2|||
145309437|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Death|0|||
145309438|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Death|0|||
145309439|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309440|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309441|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145411132|NCT01001104|524358781|FG002|Overall Study|Lost to Follow-up|1|||
145569203|NCT02643251|524944192|FG001|Overall Study|Protocol Violation|0|||
145309442|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309443|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309444|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309445|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309446|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309447|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309448|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309449|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309450|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309451|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309452|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309453|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309454|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309455|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309456|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309457|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309458|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309459|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309460|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309461|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309462|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309463|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
145309464|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
145309465|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Other|0|||
145309466|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Other|0|||
145309467|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Other|0|||
145309468|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Other|0|||
145309469|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Other|0|||
145309470|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Other|0|||
145309471|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Other|0|||
145309472|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Other|0|||
145309473|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Other|0|||
145309474|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Other|0|||
145309475|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Other|0|||
145309476|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Other|0|||
145309477|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Other|0|||
145309478|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Other|0|||
145309479|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Other|0|||
145309480|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Other|0|||
145309481|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Other|0|||
145309482|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Other|0|||
145309483|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Other|0|||
145309484|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Other|0|||
145309485|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Other|0|||
145309486|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Other|0|||
145309487|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Other|0|||
145309488|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Other|0|||
145309489|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Other|1|||
145309490|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Other|0|||
145309491|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309492|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309493|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309494|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309495|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309496|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309497|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309498|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309499|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309500|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309501|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309502|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309503|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309504|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309505|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309506|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309507|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309508|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309509|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309510|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309511|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309512|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309513|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309514|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
145309515|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309516|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
145309517|NCT00112437|523979771|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309518|NCT00112437|523979772|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309519|NCT00112437|523979773|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309520|NCT00112437|523979774|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309521|NCT00112437|523979775|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309522|NCT00112437|523979776|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309523|NCT00112437|523979777|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309524|NCT00112437|523979778|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309525|NCT00112437|523979779|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309526|NCT00112437|523979780|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309527|NCT00112437|523979781|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309528|NCT00112437|523979782|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309529|NCT00112437|523979783|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309530|NCT00112437|523979784|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309531|NCT00112437|523979785|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309532|NCT00112437|523979786|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309533|NCT00112437|523979787|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309534|NCT00112437|523979788|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309535|NCT00112437|523979789|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309536|NCT00112437|523979790|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309537|NCT00112437|523979791|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309538|NCT00112437|523979792|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309539|NCT00112437|523979793|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
145309540|NCT00112437|523979794|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
145309541|NCT00112437|523979795|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
145309542|NCT00112437|523979796|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
145309543|NCT03531827|523979801|FG000|Overall Study|Adverse Event|2|||
145309544|NCT03531827|523979802|FG001|Overall Study|Adverse Event|0|||
145309545|NCT03531827|523979801|FG000|Overall Study|Progressive disease|1|||
145309546|NCT03531827|523979802|FG001|Overall Study|Progressive disease|0|||
145309547|NCT03500094|523979805|FG000|Overall Study|Withdrawal by Subject|1|||
145309548|NCT03500094|523979805|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
145309549|NCT03500094|523979805|FG000|Overall Study|Lost to Follow-up|1|||
145309550|NCT02316223|523981581|FG000|Overall Study|Lack of Efficacy|0|||
145309551|NCT02316223|523981582|FG001|Overall Study|Lack of Efficacy|1|||
145309552|NCT02316223|523981583|FG002|Overall Study|Lack of Efficacy|1|||
145309553|NCT02316223|523981581|FG000|Overall Study|Lost to Follow-up|27|||
145569204|NCT02643251|524944191|FG000|Overall Study|PI Decision to terminate patient|1|||
145309554|NCT02316223|523981582|FG001|Overall Study|Lost to Follow-up|34|||
145309555|NCT02316223|523981583|FG002|Overall Study|Lost to Follow-up|36|||
145309556|NCT02316223|523981581|FG000|Overall Study|COPD Diagnosis|3|||
145309557|NCT02316223|523981582|FG001|Overall Study|COPD Diagnosis|2|||
145309558|NCT02316223|523981583|FG002|Overall Study|COPD Diagnosis|3|||
145309559|NCT02316223|523981581|FG000|Overall Study|Reside outside study area|1|||
145309560|NCT02316223|523981582|FG001|Overall Study|Reside outside study area|1|||
145309561|NCT02316223|523981583|FG002|Overall Study|Reside outside study area|1|||
145309562|NCT02316223|523981581|FG000|Overall Study|No asthma|2|||
145309563|NCT02316223|523981582|FG001|Overall Study|No asthma|0|||
145309564|NCT02316223|523981583|FG002|Overall Study|No asthma|0|||
145309565|NCT02316223|523981581|FG000|Overall Study|Discontinued by PI|11|||
145309566|NCT02316223|523981582|FG001|Overall Study|Discontinued by PI|19|||
145309567|NCT02316223|523981583|FG002|Overall Study|Discontinued by PI|3|||
145309568|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Subject request|8|||
145309569|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Subject request|11|||
145309570|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
145309571|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
145569205|NCT02643251|524944192|FG001|Overall Study|PI Decision to terminate patient|0|||
145569206|NCT01466270|524944193|FG000|Overall Study|Withdrawal by Subject|4|||
145569207|NCT01466270|524944194|FG001|Overall Study|Withdrawal by Subject|1|||
145309572|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
145309573|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
145309574|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
145309575|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
145309576|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
145309577|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
145569208|NCT01466270|524944193|FG000|Overall Study|Physician Decision|1|||
145309578|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
145309579|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
145309580|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Death|1|||
145309581|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Death|0|||
145309582|NCT00521586|523981585|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
145309583|NCT00521586|523981586|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
145309584|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
145309585|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
145309586|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
145309587|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
145309588|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
145309589|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
145309590|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
145309591|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
145309592|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
145309593|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
145309594|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
145309595|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
145309596|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
145309597|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
145309598|NCT00521586|523981585|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
145309599|NCT00521586|523981586|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
145309600|NCT00521586|523981585|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
145309601|NCT00521586|523981586|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
145309602|NCT00521586|523981585|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
145309603|NCT00521586|523981586|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
145309604|NCT00521586|523981585|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
145309605|NCT00521586|523981586|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
145309606|NCT03669250|523981587|FG000|Overall Study|Adverse Event|0|||
145309607|NCT03669250|523981588|FG001|Overall Study|Adverse Event|0|||
145309608|NCT03669250|523981589|FG002|Overall Study|Adverse Event|0|||
145309609|NCT03669250|523981590|FG003|Overall Study|Adverse Event|0|||
145309610|NCT03669250|523981591|FG004|Overall Study|Adverse Event|1|||
145309611|NCT03669250|523981592|FG005|Overall Study|Adverse Event|0|||
145309612|NCT03669250|523981587|FG000|Overall Study|Withdrawal by Subject|0|||
145309613|NCT03669250|523981588|FG001|Overall Study|Withdrawal by Subject|1|||
145309614|NCT03669250|523981589|FG002|Overall Study|Withdrawal by Subject|0|||
145309615|NCT03669250|523981590|FG003|Overall Study|Withdrawal by Subject|1|||
145309616|NCT03669250|523981591|FG004|Overall Study|Withdrawal by Subject|0|||
145309617|NCT03669250|523981592|FG005|Overall Study|Withdrawal by Subject|0|||
145309618|NCT00828321|523981593|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
145309619|NCT00828321|523981594|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
145309620|NCT00828321|523981593|FG000|Second Intervention|Protocol Violation|0|||
145309621|NCT00828321|523981594|FG001|Second Intervention|Protocol Violation|1|||
145309622|NCT02997176|523981595|FG000|Overall Study|Adverse Event|0|||
145309623|NCT02997176|523981596|FG001|Overall Study|Adverse Event|0|||
145309624|NCT02997176|523981597|FG002|Overall Study|Adverse Event|0|||
145309625|NCT02997176|523981598|FG003|Overall Study|Adverse Event|8|||
145309626|NCT02997176|523981595|FG000|Overall Study|Progressive Disease|1|||
145309627|NCT02997176|523981596|FG001|Overall Study|Progressive Disease|0|||
145309628|NCT02997176|523981597|FG002|Overall Study|Progressive Disease|1|||
145309629|NCT02997176|523981598|FG003|Overall Study|Progressive Disease|1|||
145309630|NCT02997176|523981595|FG000|Overall Study|Death|0|||
145309631|NCT02997176|523981596|FG001|Overall Study|Death|0|||
145309632|NCT02997176|523981597|FG002|Overall Study|Death|1|||
145309633|NCT02997176|523981598|FG003|Overall Study|Death|1|||
145309634|NCT02997176|523981595|FG000|Overall Study|Withdrawal by Subject|0|||
145309635|NCT02997176|523981596|FG001|Overall Study|Withdrawal by Subject|2|||
145309636|NCT02997176|523981597|FG002|Overall Study|Withdrawal by Subject|0|||
145309637|NCT02997176|523981598|FG003|Overall Study|Withdrawal by Subject|1|||
145309638|NCT01630616|523981602|FG000|Overall Study|Adverse Event|0|||
145309639|NCT01630616|523981603|FG001|Overall Study|Adverse Event|0|||
145309640|NCT01630616|523981604|FG002|Overall Study|Adverse Event|0|||
145309641|NCT01630616|523981605|FG003|Overall Study|Adverse Event|1|||
145309642|NCT01630616|523981606|FG004|Overall Study|Adverse Event|0|||
145309643|NCT01630616|523981607|FG005|Overall Study|Adverse Event|0|||
145309644|NCT01630616|523981602|FG000|Overall Study|Withdrawal by Subject|0|||
145309645|NCT01630616|523981603|FG001|Overall Study|Withdrawal by Subject|0|||
145309646|NCT01630616|523981604|FG002|Overall Study|Withdrawal by Subject|0|||
145309647|NCT01630616|523981605|FG003|Overall Study|Withdrawal by Subject|2|||
145309648|NCT01630616|523981606|FG004|Overall Study|Withdrawal by Subject|0|||
145309649|NCT01630616|523981607|FG005|Overall Study|Withdrawal by Subject|0|||
145309650|NCT00691704|523981609|FG000|Induction Therapy|Disease Progression|1|||
145309651|NCT00691704|523981609|FG000|Induction Therapy|Active Hepatitis|1|||
145569209|NCT01466270|524944194|FG001|Overall Study|Physician Decision|0|||
145569210|NCT01466270|524944193|FG000|Overall Study|Lost to Follow-up|1|||
145569211|NCT01466270|524944194|FG001|Overall Study|Lost to Follow-up|3|||
145569212|NCT01466270|524944193|FG000|Overall Study|Progression|1|||
145569213|NCT01466270|524944194|FG001|Overall Study|Progression|0|||
145309652|NCT00691704|523981609|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
145309653|NCT00691704|523981609|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
145309654|NCT00691704|523981609|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
145309655|NCT04406194|523981610|FG000|Period 1|Withdrawal by Subject|0|||
145309656|NCT04406194|523981611|FG001|Period 1|Withdrawal by Subject|1|||
145309657|NCT04102345|523981613|FG000|Overall Study|Withdrawal by Subject|1|||
145309658|NCT04102345|523981614|FG001|Overall Study|Withdrawal by Subject|0|||
145309659|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
145309660|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
145309661|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
145309662|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
145309663|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
145309664|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
145309665|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
145309666|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
145309667|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
145309668|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
145309669|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
145309670|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
145309671|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
145309672|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
145309673|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
145309674|NCT00385736|523981619|FG000|Efficacy Analysis Set - Induction|Other|0|||
145309675|NCT00385736|523981620|FG001|Efficacy Analysis Set - Induction|Other|0|||
145309676|NCT00385736|523981621|FG002|Efficacy Analysis Set - Induction|Other|1|||
145309677|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
145309678|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
145309679|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
145309680|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
145309681|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
145309682|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
145309683|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
145309684|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
145309685|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
145309686|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
145309687|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
145309688|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
145309689|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
145309690|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
145309691|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
145309692|NCT00385736|523981619|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
145309693|NCT00385736|523981620|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
145309694|NCT00385736|523981621|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
145309695|NCT00385736|523981619|FG000|Safety Analysis Set|Adverse Event|23|||
145309696|NCT00385736|523981620|FG001|Safety Analysis Set|Adverse Event|15|||
145309697|NCT00385736|523981621|FG002|Safety Analysis Set|Adverse Event|23|||
145309698|NCT00385736|523981619|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
145309699|NCT00385736|523981620|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
145309700|NCT00385736|523981621|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
145569214|NCT01466270|524944193|FG000|Overall Study|Toxicity|4|||
145569215|NCT01466270|524944194|FG001|Overall Study|Toxicity|1|||
145569216|NCT01466270|524944193|FG000|Overall Study|Multiple|1|||
145569217|NCT01466270|524944194|FG001|Overall Study|Multiple|1|||
145569218|NCT02821962|524944195|FG000|Overall Study|Lost to Follow-up|2|||
145569219|NCT02821962|524944196|FG001|Overall Study|Lost to Follow-up|0|||
145569220|NCT04206293|524944201|FG000|Overall Study|Consent withdrawal|1|||
145569221|NCT00706966|524944203|FG000|Overall Study|Adverse Event|1|||
145569222|NCT03752619|524944207|FG000|Overall Study|Lost to Follow-up|2|||
145569223|NCT03752619|524944208|FG001|Overall Study|Lost to Follow-up|1|||
145309701|NCT00385736|523981619|FG000|Safety Analysis Set|Lost to Follow-up|0|||
145309702|NCT00385736|523981620|FG001|Safety Analysis Set|Lost to Follow-up|2|||
145309703|NCT00385736|523981621|FG002|Safety Analysis Set|Lost to Follow-up|2|||
145309704|NCT00385736|523981619|FG000|Safety Analysis Set|Lack of Efficacy|38|||
145309705|NCT00385736|523981620|FG001|Safety Analysis Set|Lack of Efficacy|16|||
145309706|NCT00385736|523981621|FG002|Safety Analysis Set|Lack of Efficacy|31|||
145569224|NCT03752619|524944207|FG000|Overall Study|Withdrawal by Subject|1|||
145569225|NCT03752619|524944208|FG001|Overall Study|Withdrawal by Subject|1|||
145569226|NCT03752619|524944207|FG000|Overall Study|Adverse Event|0|||
145309707|NCT00385736|523981619|FG000|Safety Analysis Set|Protocol Violation|2|||
145309708|NCT00385736|523981620|FG001|Safety Analysis Set|Protocol Violation|1|||
145309709|NCT00385736|523981621|FG002|Safety Analysis Set|Protocol Violation|6|||
145309710|NCT00385736|523981619|FG000|Safety Analysis Set|Other|1|||
145309711|NCT00385736|523981620|FG001|Safety Analysis Set|Other|4|||
145309712|NCT00385736|523981621|FG002|Safety Analysis Set|Other|4|||
145309713|NCT05497557|523981622|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
145309714|NCT05497557|523981623|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
145309715|NCT05497557|523981624|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
145309716|NCT01380782|523981626|FG000|Overall Study|Adverse Event|0|||
145309717|NCT01380782|523981627|FG001|Overall Study|Adverse Event|1|||
145309718|NCT01380782|523981628|FG002|Overall Study|Adverse Event|0|||
145309719|NCT01380782|523981629|FG003|Overall Study|Adverse Event|0|||
145309720|NCT01380782|523981626|FG000|Overall Study|Death|1|||
145309721|NCT01380782|523981627|FG001|Overall Study|Death|0|||
145309722|NCT01380782|523981628|FG002|Overall Study|Death|0|||
145309723|NCT01380782|523981629|FG003|Overall Study|Death|0|||
145309724|NCT01380782|523981626|FG000|Overall Study|Lack of Efficacy|10|||
145309725|NCT01380782|523981627|FG001|Overall Study|Lack of Efficacy|9|||
145309726|NCT01380782|523981628|FG002|Overall Study|Lack of Efficacy|10|||
145309727|NCT01380782|523981629|FG003|Overall Study|Lack of Efficacy|3|||
145309728|NCT01380782|523981626|FG000|Overall Study|Physician Decision|1|||
145309729|NCT01380782|523981627|FG001|Overall Study|Physician Decision|0|||
145309730|NCT01380782|523981628|FG002|Overall Study|Physician Decision|0|||
145309731|NCT01380782|523981629|FG003|Overall Study|Physician Decision|0|||
145309732|NCT01380782|523981626|FG000|Overall Study|Withdrawal by Subject|0|||
145309733|NCT01380782|523981627|FG001|Overall Study|Withdrawal by Subject|0|||
145309734|NCT01380782|523981628|FG002|Overall Study|Withdrawal by Subject|1|||
145309735|NCT01380782|523981629|FG003|Overall Study|Withdrawal by Subject|1|||
145309736|NCT01701063|523981630|FG000|Overall Study|Lost to Follow-up|0|||
145309737|NCT01701063|523981631|FG001|Overall Study|Lost to Follow-up|1|||
145309738|NCT01701063|523981632|FG002|Overall Study|Lost to Follow-up|0|||
145309739|NCT01701063|523981630|FG000|Overall Study|Withdrawal by Subject|0|||
145309740|NCT01701063|523981631|FG001|Overall Study|Withdrawal by Subject|0|||
145309741|NCT01701063|523981632|FG002|Overall Study|Withdrawal by Subject|1|||
145309742|NCT01701063|523981630|FG000|Overall Study|Other|0|||
145309743|NCT01701063|523981631|FG001|Overall Study|Other|0|||
145309744|NCT01701063|523981632|FG002|Overall Study|Other|1|||
145309745|NCT02043132|523981633|FG000|Overall Study|Lost to Follow-up|1|||
145309746|NCT02043132|523981634|FG001|Overall Study|Lost to Follow-up|1|||
145309747|NCT02043132|523981633|FG000|Overall Study|screen failures|4|||
145309748|NCT02043132|523981634|FG001|Overall Study|screen failures|8|||
145309749|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
145309750|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
145309751|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
145309752|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
145309753|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
145309754|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
145309755|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
145309756|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
145309757|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
145309758|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
145309759|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
145309760|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
145309761|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
145309762|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
145309763|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
145309764|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
145309765|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
145309766|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
145309767|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
145309768|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
145309769|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
145309770|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
145309771|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
145309772|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
145309773|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
145309774|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
145309775|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
145309776|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
145309777|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
145309778|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
145309779|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
145309780|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
145309781|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
145309782|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
145309783|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
145309784|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
145309785|NCT04194801|523981635|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
145309786|NCT04194801|523981636|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
145309787|NCT04194801|523981637|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
145309788|NCT04194801|523981635|FG000|Part Ib/II End of Study|Death|2|||
145309789|NCT04194801|523981636|FG001|Part Ib/II End of Study|Death|3|||
145309790|NCT04194801|523981637|FG002|Part Ib/II End of Study|Death|3|||
145309791|NCT04194801|523981635|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
145309792|NCT04194801|523981636|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
145309793|NCT04194801|523981637|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
145309794|NCT04194801|523981635|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
145309795|NCT04194801|523981636|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
145309796|NCT04194801|523981637|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
145309797|NCT04194801|523981635|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
145309798|NCT04194801|523981636|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
145309799|NCT04194801|523981637|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
145309800|NCT04194801|523981635|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
145309801|NCT04194801|523981636|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
145309802|NCT04194801|523981637|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
145309803|NCT03827395|523981638|FG000|Overall Study|Lost to Follow-up|1|||
145309804|NCT03827395|523981639|FG001|Overall Study|Lost to Follow-up|0|||
145309805|NCT03827395|523981638|FG000|Overall Study|Protocol Violation|1|||
145309806|NCT03827395|523981639|FG001|Overall Study|Protocol Violation|0|||
145309807|NCT03827395|523981638|FG000|Overall Study|Became ineligible after enrollment|1|||
145309808|NCT03827395|523981639|FG001|Overall Study|Became ineligible after enrollment|2|||
145309809|NCT04723693|523981640|FG000|Overall Study|Withdrawal by Subject|2|||
145309810|NCT00294047|523981641|FG000|Month 48|Adverse Event|28|||
145309811|NCT00294047|523981642|FG001|Month 48|Adverse Event|13|||
145309812|NCT00294047|523981641|FG000|Month 48|Protocol Violation|4|||
145309813|NCT00294047|523981642|FG001|Month 48|Protocol Violation|4|||
145309814|NCT00294047|523981641|FG000|Month 48|Withdrawal by Subject|111|||
145309815|NCT00294047|523981642|FG001|Month 48|Withdrawal by Subject|115|||
145309816|NCT00294047|523981641|FG000|Month 48|Lost to Follow-up|272|||
145309817|NCT00294047|523981642|FG001|Month 48|Lost to Follow-up|287|||
145309818|NCT00294047|523981641|FG000|Month 48|Other|10|||
145309819|NCT00294047|523981642|FG001|Month 48|Other|14|||
145309820|NCT00294047|523981641|FG000|Month 84|Adverse Event|4|||
145309821|NCT00294047|523981642|FG001|Month 84|Adverse Event|2|||
145309822|NCT00294047|523981641|FG000|Month 84|Protocol Violation|1|||
145309823|NCT00294047|523981642|FG001|Month 84|Protocol Violation|1|||
145309824|NCT00294047|523981641|FG000|Month 84|Withdrawal by Subject|33|||
145309825|NCT00294047|523981642|FG001|Month 84|Withdrawal by Subject|31|||
145309826|NCT00294047|523981641|FG000|Month 84|Lost to Follow-up|187|||
145309827|NCT00294047|523981642|FG001|Month 84|Lost to Follow-up|190|||
145309828|NCT00294047|523981641|FG000|Month 84|Absent Cervix|2|||
145309829|NCT00294047|523981642|FG001|Month 84|Absent Cervix|0|||
145309830|NCT00294047|523981641|FG000|Month 84|Work related reasons|4|||
145309831|NCT00294047|523981642|FG001|Month 84|Work related reasons|2|||
145309832|NCT00294047|523981641|FG000|Month 84|Center closed, subject did not transfer|1|||
145309833|NCT00294047|523981642|FG001|Month 84|Center closed, subject did not transfer|0|||
145309834|NCT00294047|523981641|FG000|Month 84|Family problems|2|||
145309835|NCT00294047|523981642|FG001|Month 84|Family problems|2|||
145309836|NCT00294047|523981641|FG000|Month 84|Lack of time|3|||
145309837|NCT00294047|523981642|FG001|Month 84|Lack of time|1|||
145309838|NCT00294047|523981641|FG000|Month 84|Personal reason|2|||
145309839|NCT00294047|523981642|FG001|Month 84|Personal reason|4|||
145309840|NCT00294047|523981641|FG000|Month 84|Subject does not want male physician|1|||
145309841|NCT00294047|523981642|FG001|Month 84|Subject does not want male physician|0|||
145309842|NCT00294047|523981641|FG000|Month 84|Transport reimbursement delayed|0|||
145309843|NCT00294047|523981642|FG001|Month 84|Transport reimbursement delayed|1|||
145309844|NCT00294047|523981641|FG000|Month 84|Unable to reach study site|1|||
145309845|NCT00294047|523981642|FG001|Month 84|Unable to reach study site|0|||
145309846|NCT00294047|523981641|FG000|Month 84|Under investigation locally|1|||
145309847|NCT00294047|523981642|FG001|Month 84|Under investigation locally|0|||
145309848|NCT00294047|523981641|FG000|Month 84|Visit missed|0|||
145309849|NCT00294047|523981642|FG001|Month 84|Visit missed|1|||
145309850|NCT00294047|523981641|FG000|Month 84|No consent for Month 84 Follow-up|731|||
145309851|NCT00294047|523981642|FG001|Month 84|No consent for Month 84 Follow-up|754|||
145309852|NCT02157974|523981643|FG000|Overall Study|Withdrawal by Subject|0|||
145309853|NCT02157974|523981644|FG001|Overall Study|Withdrawal by Subject|1|||
145309854|NCT02157974|523981645|FG002|Overall Study|Withdrawal by Subject|0|||
145309855|NCT02157974|523981646|FG003|Overall Study|Withdrawal by Subject|0|||
145309856|NCT02157974|523981647|FG004|Overall Study|Withdrawal by Subject|0|||
145309857|NCT02157974|523981643|FG000|Overall Study|Screen Failure|0|||
145309858|NCT02157974|523981644|FG001|Overall Study|Screen Failure|1|||
145309859|NCT02157974|523981645|FG002|Overall Study|Screen Failure|0|||
145309860|NCT02157974|523981646|FG003|Overall Study|Screen Failure|0|||
145309861|NCT02157974|523981647|FG004|Overall Study|Screen Failure|0|||
145309862|NCT02157974|523981643|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145309863|NCT02157974|523981644|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
145309864|NCT02157974|523981645|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145309865|NCT02157974|523981646|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145309866|NCT02157974|523981647|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
145309867|NCT00506831|523981650|FG000|Overall Study|Death|1|||
145309868|NCT00506831|523981650|FG000|Overall Study|Withdrawal by Subject|1|||
145309869|NCT00540423|523981654|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145309870|NCT00540423|523981655|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145309871|NCT00540423|523981656|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145309872|NCT00540423|523981654|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
145309873|NCT00540423|523981655|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
145309874|NCT00540423|523981656|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
145309875|NCT02213263|523981662|FG000|Overall Study|Insufficient clinical response|4|||
145309876|NCT02213263|523981663|FG001|Overall Study|Insufficient clinical response|3|||
145309877|NCT02213263|523981662|FG000|Overall Study|Lost to Follow-up|0|||
145309878|NCT02213263|523981663|FG001|Overall Study|Lost to Follow-up|1|||
145309879|NCT02213263|523981662|FG000|Overall Study|No longer willing to participate|3|||
145309880|NCT02213263|523981663|FG001|Overall Study|No longer willing to participate|4|||
145309881|NCT02213263|523981662|FG000|Overall Study|Progressive disease|20|||
145309882|NCT02213263|523981663|FG001|Overall Study|Progressive disease|14|||
145309883|NCT02213263|523981662|FG000|Overall Study|Protocol Violation|0|||
145309884|NCT02213263|523981663|FG001|Overall Study|Protocol Violation|1|||
145309885|NCT02213263|523981662|FG000|Overall Study|Adverse Event|1|||
145309886|NCT02213263|523981663|FG001|Overall Study|Adverse Event|3|||
145309887|NCT05752721|523981664|FG000|Overall Study|Lost to Follow-up|22|||
145309888|NCT05752721|523981665|FG001|Overall Study|Lost to Follow-up|20|||
145309889|NCT05752721|523981664|FG000|Overall Study|Withdrawal by Subject|15|||
145309890|NCT05752721|523981665|FG001|Overall Study|Withdrawal by Subject|12|||
145309891|NCT02280863|523981666|FG000|Integrated Platform|Met stopping criteria|0|||
145309892|NCT02280863|523981667|FG001|Integrated Platform|Met stopping criteria|1|||
145309893|NCT00263588|523981668|FG000|Overall Study|Death|54|||
145309894|NCT00263588|523981669|FG001|Overall Study|Death|90|||
145309895|NCT00263588|523981668|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
145309896|NCT00263588|523981669|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
145309897|NCT00263588|523981668|FG000|Overall Study|Lost to Follow-up|7|||
145309898|NCT00263588|523981669|FG001|Overall Study|Lost to Follow-up|10|||
145309899|NCT00263588|523981668|FG000|Overall Study|Withdrawal by Subject|3|||
145309900|NCT00263588|523981669|FG001|Overall Study|Withdrawal by Subject|4|||
145309901|NCT00263588|523981668|FG000|Overall Study|Protocol Violation|0|||
145309902|NCT00263588|523981669|FG001|Overall Study|Protocol Violation|1|||
145309903|NCT00263588|523981668|FG000|Overall Study|Investigator decision|7|||
145309904|NCT00263588|523981669|FG001|Overall Study|Investigator decision|15|||
145309905|NCT00263588|523981668|FG000|Overall Study|Sponsor terminated study|0|||
145309906|NCT00263588|523981669|FG001|Overall Study|Sponsor terminated study|1|||
145309907|NCT00807495|523981676|FG000|Overall Study|Adverse Event|6|||
145309908|NCT00807495|523981677|FG001|Overall Study|Adverse Event|3|||
145309909|NCT00807495|523981678|FG002|Overall Study|Adverse Event|1|||
145309910|NCT00807495|523981679|FG003|Overall Study|Adverse Event|1|||
145309911|NCT00807495|523981680|FG004|Overall Study|Adverse Event|2|||
145309912|NCT00807495|523981676|FG000|Overall Study|Withdrawal by Patient|2|||
145309913|NCT00807495|523981677|FG001|Overall Study|Withdrawal by Patient|0|||
145309914|NCT00807495|523981678|FG002|Overall Study|Withdrawal by Patient|1|||
145309915|NCT00807495|523981679|FG003|Overall Study|Withdrawal by Patient|0|||
145309916|NCT00807495|523981680|FG004|Overall Study|Withdrawal by Patient|0|||
145309917|NCT00807495|523981676|FG000|Overall Study|Reason Not Specified|0|||
145309918|NCT00807495|523981677|FG001|Overall Study|Reason Not Specified|3|||
145309919|NCT00807495|523981678|FG002|Overall Study|Reason Not Specified|2|||
145309920|NCT00807495|523981679|FG003|Overall Study|Reason Not Specified|0|||
145309921|NCT00807495|523981680|FG004|Overall Study|Reason Not Specified|3|||
145309922|NCT02412852|523981681|FG000|Overall Study|Withdrawal by Subject|0|||
145309923|NCT02412852|523981682|FG001|Overall Study|Withdrawal by Subject|1|||
145309924|NCT02412852|523981683|FG002|Overall Study|Withdrawal by Subject|0|||
145309925|NCT02412852|523981684|FG003|Overall Study|Withdrawal by Subject|0|||
145309926|NCT02412852|523981681|FG000|Overall Study|Physician Decision|0|||
145309927|NCT02412852|523981682|FG001|Overall Study|Physician Decision|0|||
145309928|NCT02412852|523981683|FG002|Overall Study|Physician Decision|0|||
145309929|NCT02412852|523981684|FG003|Overall Study|Physician Decision|1|||
145309930|NCT01174186|523981685|FG000|Overall Study|Lost to Follow-up|0|||
145309931|NCT01174186|523981686|FG001|Overall Study|Lost to Follow-up|1|||
145309932|NCT01174186|523981685|FG000|Overall Study|Withdrawal by Subject|0|||
145309933|NCT01174186|523981686|FG001|Overall Study|Withdrawal by Subject|2|||
145309934|NCT05274763|523981687|FG000|Overall Study|Lost to Follow-up|1|||
145309935|NCT03629054|523981688|FG000|Period 2 (4 Days)|Not treated|0|||
145309936|NCT03629054|523981689|FG001|Period 2 (4 Days)|Not treated|1|||
145309937|NCT00924638|523981690|FG000|Overall Study|Death|3|||
145309938|NCT00924638|523981691|FG001|Overall Study|Death|2|||
145309939|NCT00924638|523981690|FG000|Overall Study|Lost to Follow-up|1|||
145309940|NCT00924638|523981691|FG001|Overall Study|Lost to Follow-up|1|||
145309941|NCT00924638|523981690|FG000|Overall Study|Withdrawal by Subject|5|||
145309942|NCT00924638|523981691|FG001|Overall Study|Withdrawal by Subject|7|||
145309943|NCT00924638|523981690|FG000|Overall Study|Physician Decision|3|||
145309944|NCT00924638|523981691|FG001|Overall Study|Physician Decision|3|||
145309945|NCT01151618|523981693|FG000|Overall Study|Adverse Event|2|||
145309946|NCT01151618|523981693|FG000|Overall Study|Withdrawal by Subject|7|||
145309947|NCT04025021|523981694|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
145309948|NCT04025021|523981695|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
145309949|NCT01507662|523981696|FG000|Overall Study|Death|26|||
145309950|NCT01507662|523981697|FG001|Overall Study|Death|18|||
145309951|NCT01507662|523981696|FG000|Overall Study|Withdrawal by Subject|290|||
145309952|NCT01507662|523981697|FG001|Overall Study|Withdrawal by Subject|287|||
145309953|NCT01507662|523981696|FG000|Overall Study|Lost to Follow-up|498|||
145309954|NCT01507662|523981697|FG001|Overall Study|Lost to Follow-up|523|||
145309955|NCT01507662|523981696|FG000|Overall Study|Proxy interview done|2|||
145309956|NCT01507662|523981697|FG001|Overall Study|Proxy interview done|3|||
145309957|NCT01004510|523981701|FG000|Overall Study|Adverse Event|1|||
145309958|NCT01824576|523981702|FG000|Overall Study|Device deficiency|2|||
145309959|NCT03218787|523981703|FG000|Overall Study|Lost to Follow-up|12|||
145309960|NCT03218787|523981703|FG000|Overall Study|Withdrawal by Subject|72|||
145309961|NCT03218787|523981703|FG000|Overall Study|Physician Decision|11|||
145309962|NCT03218787|523981703|FG000|Overall Study|Death|111|||
145309963|NCT03961204|523981704|FG000|Overall Study|Withdrawal by Subject|2|||
145309964|NCT03961204|523981704|FG000|Overall Study|Lost to Follow-up|3|||
145309965|NCT03961204|523981704|FG000|Overall Study|Other|1|||
145309966|NCT03961204|523981704|FG000|Overall Study|Missing|1|||
145309967|NCT00147498|523981707|FG000|Overall Study|Adverse Event|1|||
145309968|NCT00147498|523981708|FG001|Overall Study|Adverse Event|6|||
145309969|NCT00147498|523981709|FG002|Overall Study|Adverse Event|7|||
145309970|NCT00147498|523981710|FG003|Overall Study|Adverse Event|3|||
145309971|NCT00147498|523981707|FG000|Overall Study|Lack of Efficacy|1|||
145309972|NCT00147498|523981708|FG001|Overall Study|Lack of Efficacy|1|||
145309973|NCT00147498|523981709|FG002|Overall Study|Lack of Efficacy|1|||
145309974|NCT00147498|523981710|FG003|Overall Study|Lack of Efficacy|8|||
145309975|NCT00147498|523981707|FG000|Overall Study|Laboratory abnormality|0|||
145309976|NCT00147498|523981708|FG001|Overall Study|Laboratory abnormality|0|||
145309977|NCT00147498|523981709|FG002|Overall Study|Laboratory abnormality|2|||
145309978|NCT00147498|523981710|FG003|Overall Study|Laboratory abnormality|0|||
145309979|NCT00147498|523981707|FG000|Overall Study|Participant defaulted|0|||
145309980|NCT00147498|523981708|FG001|Overall Study|Participant defaulted|1|||
145309981|NCT00147498|523981709|FG002|Overall Study|Participant defaulted|4|||
145309982|NCT00147498|523981710|FG003|Overall Study|Participant defaulted|3|||
145309983|NCT00147498|523981707|FG000|Overall Study|Other|1|||
145309984|NCT00147498|523981708|FG001|Overall Study|Other|1|||
145309985|NCT00147498|523981709|FG002|Overall Study|Other|3|||
145309986|NCT00147498|523981710|FG003|Overall Study|Other|3|||
145309987|NCT02452463|523981711|FG000|Overall Study|Death|1|||
145309988|NCT02452463|523981712|FG001|Overall Study|Death|0|||
145309989|NCT02452463|523981713|FG002|Overall Study|Death|0|||
145309990|NCT02452463|523981711|FG000|Overall Study|Study Suspended|1|||
145309991|NCT02452463|523981712|FG001|Overall Study|Study Suspended|0|||
145309992|NCT02452463|523981713|FG002|Overall Study|Study Suspended|0|||
145309993|NCT02452463|523981711|FG000|Overall Study|Recommended by DSMB|0|||
145309994|NCT02452463|523981712|FG001|Overall Study|Recommended by DSMB|1|||
145309995|NCT02452463|523981713|FG002|Overall Study|Recommended by DSMB|0|||
145309996|NCT02452463|523981711|FG000|Overall Study|Withdrawal by Subject|0|||
145309997|NCT02452463|523981712|FG001|Overall Study|Withdrawal by Subject|1|||
145309998|NCT02452463|523981713|FG002|Overall Study|Withdrawal by Subject|0|||
145309999|NCT01229150|523981714|FG000|Overall Study|Toxicity|2|||
145310000|NCT01229150|523981715|FG001|Overall Study|Toxicity|2|||
145310001|NCT01229150|523981716|FG002|Overall Study|Toxicity|0|||
145310002|NCT01229150|523981717|FG003|Overall Study|Toxicity|0|||
145310003|NCT01494532|523981718|FG000|Overall Study|Adverse Event|4|||
145310004|NCT01494532|523981719|FG001|Overall Study|Adverse Event|1|||
145310005|NCT01494532|523981720|FG002|Overall Study|Adverse Event|8|||
145310006|NCT01494532|523981721|FG003|Overall Study|Adverse Event|6|||
145310007|NCT01494532|523981722|FG004|Overall Study|Adverse Event|5|||
145310008|NCT01494532|523981723|FG005|Overall Study|Adverse Event|0|||
145310009|NCT01494532|523981718|FG000|Overall Study|Lack of Efficacy|0|||
145310010|NCT01494532|523981719|FG001|Overall Study|Lack of Efficacy|0|||
145310011|NCT01494532|523981720|FG002|Overall Study|Lack of Efficacy|0|||
145310012|NCT01494532|523981721|FG003|Overall Study|Lack of Efficacy|0|||
145310013|NCT01494532|523981722|FG004|Overall Study|Lack of Efficacy|2|||
145310014|NCT01494532|523981723|FG005|Overall Study|Lack of Efficacy|0|||
145310015|NCT01494532|523981718|FG000|Overall Study|Protocol deviation|2|||
145310016|NCT01494532|523981719|FG001|Overall Study|Protocol deviation|1|||
145310017|NCT01494532|523981720|FG002|Overall Study|Protocol deviation|3|||
145310018|NCT01494532|523981721|FG003|Overall Study|Protocol deviation|2|||
145310019|NCT01494532|523981722|FG004|Overall Study|Protocol deviation|3|||
145310020|NCT01494532|523981723|FG005|Overall Study|Protocol deviation|0|||
145310021|NCT01494532|523981718|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145310022|NCT01494532|523981719|FG001|Overall Study|Protocol-defined stopping criteria|0|||
145310023|NCT01494532|523981720|FG002|Overall Study|Protocol-defined stopping criteria|1|||
145310024|NCT01494532|523981721|FG003|Overall Study|Protocol-defined stopping criteria|0|||
145310025|NCT01494532|523981722|FG004|Overall Study|Protocol-defined stopping criteria|0|||
145310026|NCT01494532|523981723|FG005|Overall Study|Protocol-defined stopping criteria|0|||
145310027|NCT01494532|523981718|FG000|Overall Study|Lost to Follow-up|1|||
145310028|NCT01494532|523981719|FG001|Overall Study|Lost to Follow-up|0|||
145310029|NCT01494532|523981720|FG002|Overall Study|Lost to Follow-up|0|||
145310030|NCT01494532|523981721|FG003|Overall Study|Lost to Follow-up|2|||
145310031|NCT01494532|523981722|FG004|Overall Study|Lost to Follow-up|0|||
145310032|NCT01494532|523981723|FG005|Overall Study|Lost to Follow-up|0|||
145310033|NCT01494532|523981718|FG000|Overall Study|Physician Decision|0|||
145310034|NCT01494532|523981719|FG001|Overall Study|Physician Decision|1|||
145310035|NCT01494532|523981720|FG002|Overall Study|Physician Decision|1|||
145310036|NCT01494532|523981721|FG003|Overall Study|Physician Decision|2|||
145310037|NCT01494532|523981722|FG004|Overall Study|Physician Decision|0|||
145310038|NCT01494532|523981723|FG005|Overall Study|Physician Decision|0|||
145310039|NCT01494532|523981718|FG000|Overall Study|Withdrawal by Subject|3|||
145310040|NCT01494532|523981719|FG001|Overall Study|Withdrawal by Subject|1|||
145310041|NCT01494532|523981720|FG002|Overall Study|Withdrawal by Subject|4|||
145310042|NCT01494532|523981721|FG003|Overall Study|Withdrawal by Subject|3|||
145310043|NCT01494532|523981722|FG004|Overall Study|Withdrawal by Subject|2|||
145310044|NCT01494532|523981723|FG005|Overall Study|Withdrawal by Subject|0|||
145310045|NCT03506633|523983377|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
145310046|NCT03506633|523983378|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
145310047|NCT00258856|523983382|FG000|Overall Study|Lost to Follow-up|1|||
145310048|NCT00258856|523983383|FG001|Overall Study|Lost to Follow-up|0|||
145310049|NCT00258856|523983384|FG002|Overall Study|Lost to Follow-up|2|||
145310050|NCT00258856|523983385|FG003|Overall Study|Lost to Follow-up|0|||
145310051|NCT00258856|523983382|FG000|Overall Study|Non-compliance|2|||
145310052|NCT00258856|523983383|FG001|Overall Study|Non-compliance|0|||
145310053|NCT00258856|523983384|FG002|Overall Study|Non-compliance|0|||
145310054|NCT00258856|523983385|FG003|Overall Study|Non-compliance|1|||
145310055|NCT03247686|523983386|FG000|Overall Study|Withdrawal by Subject|1|||
145310056|NCT03247686|523983387|FG001|Overall Study|Withdrawal by Subject|2|||
145310057|NCT01109849|523983390|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
145310058|NCT01109849|523983391|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
145310059|NCT01109849|523983392|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
145310060|NCT01109849|523983393|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
145310061|NCT01109849|523983394|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
145411133|NCT01001104|524358782|FG003|Overall Study|Lost to Follow-up|0|||
145310062|NCT01109849|523983390|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
145310063|NCT01109849|523983391|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
145310064|NCT01109849|523983392|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
145310065|NCT01109849|523983393|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
145411134|NCT01001104|524358779|FG000|Overall Study|Entry Criteria Not Met|0|||
145310066|NCT01109849|523983394|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
145310067|NCT01109849|523983390|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
145310068|NCT01109849|523983391|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
145310069|NCT01109849|523983392|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
145310070|NCT01109849|523983393|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
145310071|NCT01109849|523983394|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
145310072|NCT01109849|523983390|FG000|Initial Randomization: ADHD Treatment|move away|2|||
145310073|NCT01109849|523983391|FG001|Initial Randomization: ADHD Treatment|move away|7|||
145310074|NCT01109849|523983392|FG002|Initial Randomization: ADHD Treatment|move away|0|||
145310075|NCT01109849|523983393|FG003|Initial Randomization: ADHD Treatment|move away|0|||
145310076|NCT01109849|523983394|FG004|Initial Randomization: ADHD Treatment|move away|0|||
145310077|NCT01109849|523983390|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
145310078|NCT01109849|523983391|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
145310079|NCT01109849|523983392|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
145310080|NCT01109849|523983393|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
145310081|NCT01109849|523983394|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
145310082|NCT01109849|523983390|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
145310083|NCT01109849|523983391|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
145310084|NCT01109849|523983392|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
145310085|NCT01109849|523983393|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
145310086|NCT01109849|523983394|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
145310087|NCT03969641|523983402|FG000|Overall Study|Lost to Follow-up|5|||
145310088|NCT03969641|523983403|FG001|Overall Study|Lost to Follow-up|3|||
145310089|NCT03969641|523983402|FG000|Overall Study|Withdrawal by Subject|1|||
145310090|NCT03969641|523983403|FG001|Overall Study|Withdrawal by Subject|2|||
145310091|NCT03969641|523983402|FG000|Overall Study|Found to be ineligible|1|||
145310092|NCT03969641|523983403|FG001|Overall Study|Found to be ineligible|1|||
145310093|NCT03969641|523983402|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
145310094|NCT03969641|523983403|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
145310095|NCT03969641|523983402|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
145310096|NCT03969641|523983403|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
145310097|NCT03969641|523983402|FG000|Overall Study|Elective termination|0|||
145310098|NCT03969641|523983403|FG001|Overall Study|Elective termination|1|||
145310099|NCT01541215|523983404|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
145310100|NCT01541215|523983405|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
145310101|NCT01541215|523983404|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
145310102|NCT01541215|523983405|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
145310103|NCT01541215|523983404|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
145310104|NCT01541215|523983405|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
145310105|NCT01541215|523983404|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
145310106|NCT01541215|523983405|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
145310107|NCT01541215|523983404|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
145310108|NCT01541215|523983405|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
145310109|NCT01541215|523983404|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
145310110|NCT01541215|523983405|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
145310111|NCT00754052|523983416|FG000|Overall Study|Study terminated by Sponsor|5|||
145310112|NCT00754052|523983417|FG001|Overall Study|Study terminated by Sponsor|3|||
145310113|NCT02658019|523983419|FG000|Overall Study|Adverse Event|1|||
145310114|NCT00529763|523983420|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
145310115|NCT00529763|523983421|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
145310116|NCT00529763|523983422|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145310117|NCT00529763|523983420|FG000|Overall Study|Death|1|||
145310118|NCT00529763|523983421|FG001|Overall Study|Death|1|||
145310119|NCT00529763|523983422|FG002|Overall Study|Death|1|||
145310120|NCT00529763|523983420|FG000|Overall Study|Disease Progression|10|||
145310121|NCT00529763|523983421|FG001|Overall Study|Disease Progression|16|||
145310122|NCT00529763|523983422|FG002|Overall Study|Disease Progression|11|||
145310123|NCT00529763|523983420|FG000|Overall Study|Lost to Follow-up|1|||
145310124|NCT00529763|523983421|FG001|Overall Study|Lost to Follow-up|2|||
145310125|NCT00529763|523983422|FG002|Overall Study|Lost to Follow-up|3|||
145310126|NCT00529763|523983420|FG000|Overall Study|Stem Cell Transplant|0|||
145310127|NCT00529763|523983421|FG001|Overall Study|Stem Cell Transplant|3|||
145310128|NCT00529763|523983422|FG002|Overall Study|Stem Cell Transplant|1|||
145310129|NCT00529763|523983420|FG000|Overall Study|Study Drug Toxicity|3|||
145310130|NCT00529763|523983421|FG001|Overall Study|Study Drug Toxicity|6|||
145310131|NCT00529763|523983422|FG002|Overall Study|Study Drug Toxicity|4|||
145310132|NCT00529763|523983420|FG000|Overall Study|Participant Withdrew Consent|2|||
145310133|NCT00529763|523983421|FG001|Overall Study|Participant Withdrew Consent|3|||
145310134|NCT00529763|523983422|FG002|Overall Study|Participant Withdrew Consent|4|||
145310135|NCT00529763|523983420|FG000|Overall Study|Other reasons|2|||
145310136|NCT00529763|523983421|FG001|Overall Study|Other reasons|0|||
145310137|NCT00529763|523983422|FG002|Overall Study|Other reasons|2|||
145310138|NCT00529763|523983420|FG000|Overall Study|Participant request to discontinue treatment|1|||
145310139|NCT00529763|523983421|FG001|Overall Study|Participant request to discontinue treatment|1|||
145310140|NCT00529763|523983422|FG002|Overall Study|Participant request to discontinue treatment|3|||
145310141|NCT03234907|523983423|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
145310142|NCT03234907|523983424|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
145310143|NCT03234907|523983425|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
145310144|NCT03234907|523983426|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
145310145|NCT03234907|523983427|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
145310146|NCT03234907|523983428|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
145310147|NCT03234907|523983423|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
145310148|NCT03234907|523983424|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
145310149|NCT03234907|523983425|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
145310150|NCT03234907|523983426|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
145310151|NCT03234907|523983427|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
145310152|NCT03234907|523983428|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
145310153|NCT03234907|523983423|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
145310154|NCT03234907|523983424|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
145310155|NCT03234907|523983425|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
145310156|NCT03234907|523983426|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
145310157|NCT03234907|523983427|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
145310158|NCT03234907|523983428|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
145310159|NCT03234907|523983423|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
145310160|NCT03234907|523983424|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
145310161|NCT03234907|523983425|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
145310162|NCT03234907|523983426|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
145310163|NCT03234907|523983427|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
145310164|NCT03234907|523983428|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
145310165|NCT03234907|523983423|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
145310166|NCT03234907|523983424|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
145310167|NCT03234907|523983425|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
145310168|NCT03234907|523983426|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
145310169|NCT03234907|523983427|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
145310170|NCT03234907|523983428|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
145310171|NCT03234907|523983423|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
145310172|NCT03234907|523983424|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
145310173|NCT03234907|523983425|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
145310174|NCT03234907|523983426|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
145310175|NCT03234907|523983427|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
145310176|NCT03234907|523983428|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
145310177|NCT03234907|523983423|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
145310178|NCT03234907|523983424|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
145310179|NCT03234907|523983425|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
145310180|NCT03234907|523983426|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
145310181|NCT03234907|523983427|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
145310182|NCT03234907|523983428|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
145310183|NCT02986139|523983429|FG000|Overall Study|Sponsor Decision|1|||
145310184|NCT02986139|523983430|FG001|Overall Study|Sponsor Decision|2|||
145310185|NCT02986139|523983429|FG000|Overall Study|Withdrawal by Subject|0|||
145310186|NCT02986139|523983430|FG001|Overall Study|Withdrawal by Subject|1|||
145310187|NCT02986139|523983429|FG000|Overall Study|Lost to Follow-up|0|||
145310188|NCT02986139|523983430|FG001|Overall Study|Lost to Follow-up|1|||
145310189|NCT00414726|523983432|FG000|Overall Study|Withdrawal by Subject|0|||
145310190|NCT00414726|523983433|FG001|Overall Study|Withdrawal by Subject|1|||
145310191|NCT02107196|523983434|FG000|12-week Treatment Period|Adverse Event|6|||
145310192|NCT02107196|523983435|FG001|12-week Treatment Period|Adverse Event|3|||
145310193|NCT02107196|523983434|FG000|12-week Treatment Period|Lack of Efficacy|2|||
145310194|NCT02107196|523983435|FG001|12-week Treatment Period|Lack of Efficacy|1|||
145310195|NCT02107196|523983434|FG000|12-week Treatment Period|Lost to Follow-up|3|||
145310196|NCT02107196|523983435|FG001|12-week Treatment Period|Lost to Follow-up|6|||
145310197|NCT02107196|523983434|FG000|12-week Treatment Period|Physician Decision|0|||
145310198|NCT02107196|523983435|FG001|12-week Treatment Period|Physician Decision|1|||
145310199|NCT02107196|523983434|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
145310200|NCT02107196|523983435|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
145310201|NCT02107196|523983434|FG000|12-week Treatment Period|Protocol Violation|7|||
145310202|NCT02107196|523983435|FG001|12-week Treatment Period|Protocol Violation|8|||
145310203|NCT02107196|523983434|FG000|12-week Treatment Period|Reason Missing|11|||
145310204|NCT02107196|523983435|FG001|12-week Treatment Period|Reason Missing|8|||
145310205|NCT02107196|523983434|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
145310206|NCT02107196|523983435|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
145310207|NCT02107196|523983434|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
145310208|NCT02107196|523983435|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145310209|NCT02107196|523983434|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
145310210|NCT02107196|523983435|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
145310211|NCT02107196|523983434|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
145310212|NCT02107196|523983435|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
145310213|NCT01993186|523983436|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
145310214|NCT01993186|523983437|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
145310215|NCT01993186|523983436|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
145310216|NCT01993186|523983437|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
145310217|NCT01993186|523983436|FG000|Open-Label Extension Period|Other, Not Specified|0|||
145310218|NCT01993186|523983437|FG001|Open-Label Extension Period|Other, Not Specified|1|||
145310219|NCT01993186|523983436|FG000|Open-Label Extension Period|Adverse Event|1|||
145310220|NCT01993186|523983437|FG001|Open-Label Extension Period|Adverse Event|0|||
145310221|NCT01993186|523983436|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
145569227|NCT03752619|524944208|FG001|Overall Study|Adverse Event|1|||
145569228|NCT05040152|524944209|FG000|Overall Study|Withdrawal by Subject|5|||
145569229|NCT05040152|524944210|FG001|Overall Study|Withdrawal by Subject|0|||
145569230|NCT05040152|524944209|FG000|Overall Study|Lost to Follow-up|0|||
145569231|NCT05040152|524944210|FG001|Overall Study|Lost to Follow-up|2|||
145569232|NCT03907683|524944211|FG000|Overall Study|Pregnancy|1|||
145569233|NCT03907683|524944211|FG000|Overall Study|Withdrawal by Subject|1|||
145569234|NCT03400332|524944212|FG000|Pre-Treatment|Other reasons|0|||
145569235|NCT03400332|524944213|FG001|Pre-Treatment|Other reasons|0|||
145569236|NCT03400332|524944214|FG002|Pre-Treatment|Other reasons|0|||
145569237|NCT03400332|524944215|FG003|Pre-Treatment|Other reasons|0|||
145569238|NCT03400332|524944216|FG004|Pre-Treatment|Other reasons|0|||
145310222|NCT01993186|523983437|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
145310223|NCT01993186|523983436|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
145310224|NCT01993186|523983437|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
145310225|NCT01993186|523983436|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
145310226|NCT01993186|523983437|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
145310227|NCT04523480|523983438|FG000|Overall Study|Lost to Follow-up|30|||
145310228|NCT04523480|523983439|FG001|Overall Study|Lost to Follow-up|35|||
145310229|NCT04523480|523983440|FG002|Overall Study|Lost to Follow-up|0|||
145310230|NCT00835666|523983445|FG000|Washout|Protocol Violation|1|||
145310231|NCT00835666|523983446|FG001|Washout|Protocol Violation|0|||
145310232|NCT00835666|523983445|FG000|Washout|Withdrawal by Subject|1|||
145310233|NCT00835666|523983446|FG001|Washout|Withdrawal by Subject|0|||
145310234|NCT00635648|523983447|FG000|Overall Study|Adverse Event|12|||
145310235|NCT00635648|523983447|FG000|Overall Study|Withdrawal by Subject|9|||
145310236|NCT00635648|523983447|FG000|Overall Study|Physician Decision|4|||
145310237|NCT00635648|523983447|FG000|Overall Study|Rapid progression of baseline disease|4|||
145310238|NCT00635648|523983447|FG000|Overall Study|Use of other antifungal agent needed|1|||
145310239|NCT00635648|523983447|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
145310240|NCT00635648|523983447|FG000|Overall Study|Noncompliance with protocol|1|||
145310241|NCT00635648|523983447|FG000|Overall Study|Other reason|2|||
145310242|NCT01923740|523983448|FG000|Overall Study|Lost to Follow-up|4|||
145310243|NCT01923740|523983449|FG001|Overall Study|Lost to Follow-up|9|||
145310244|NCT01923740|523983448|FG000|Overall Study|Withdrawal by Subject|2|||
145310245|NCT01923740|523983449|FG001|Overall Study|Withdrawal by Subject|0|||
145310246|NCT01537887|523983450|FG000|Period 1|Physician Decision|0|||
145310247|NCT01537887|523983451|FG001|Period 1|Physician Decision|0|||
145310248|NCT01537887|523983452|FG002|Period 1|Physician Decision|0|||
145310249|NCT01537887|523983453|FG003|Period 1|Physician Decision|0|||
145310250|NCT01537887|523983454|FG004|Period 1|Physician Decision|1|||
145310251|NCT01537887|523983455|FG005|Period 1|Physician Decision|1|||
145310252|NCT01537887|523983450|FG000|Period 1|Did not receive treatment|0|||
145310253|NCT01537887|523983451|FG001|Period 1|Did not receive treatment|0|||
145310254|NCT01537887|523983452|FG002|Period 1|Did not receive treatment|1|||
145310255|NCT01537887|523983453|FG003|Period 1|Did not receive treatment|0|||
145310256|NCT01537887|523983454|FG004|Period 1|Did not receive treatment|0|||
145310257|NCT01537887|523983455|FG005|Period 1|Did not receive treatment|0|||
145310258|NCT01537887|523983450|FG000|Period 2|Withdrawal by Subject|0|||
145310259|NCT01537887|523983451|FG001|Period 2|Withdrawal by Subject|1|||
145310260|NCT01537887|523983452|FG002|Period 2|Withdrawal by Subject|0|||
145310261|NCT01537887|523983453|FG003|Period 2|Withdrawal by Subject|0|||
145310262|NCT01537887|523983454|FG004|Period 2|Withdrawal by Subject|0|||
145310263|NCT01537887|523983455|FG005|Period 2|Withdrawal by Subject|0|||
145310264|NCT01537887|523983450|FG000|Period 3|Adverse Event|0|||
145310265|NCT01537887|523983451|FG001|Period 3|Adverse Event|0|||
145310266|NCT01537887|523983452|FG002|Period 3|Adverse Event|1|||
145310267|NCT01537887|523983453|FG003|Period 3|Adverse Event|0|||
145310268|NCT01537887|523983454|FG004|Period 3|Adverse Event|0|||
145310269|NCT01537887|523983455|FG005|Period 3|Adverse Event|0|||
145310270|NCT01537887|523983450|FG000|Period 3|Withdrawal by Subject|0|||
145310271|NCT01537887|523983451|FG001|Period 3|Withdrawal by Subject|1|||
145310272|NCT01537887|523983452|FG002|Period 3|Withdrawal by Subject|0|||
145310273|NCT01537887|523983453|FG003|Period 3|Withdrawal by Subject|0|||
145310274|NCT01537887|523983454|FG004|Period 3|Withdrawal by Subject|0|||
145310275|NCT01537887|523983455|FG005|Period 3|Withdrawal by Subject|0|||
145310276|NCT02450539|523983456|FG000|Overall Study|Withdrawal by Subject|12|||
145310277|NCT02450539|523983457|FG001|Overall Study|Withdrawal by Subject|6|||
145310278|NCT02450539|523983456|FG000|Overall Study|Lost to Follow-up|4|||
145310279|NCT02450539|523983457|FG001|Overall Study|Lost to Follow-up|1|||
145310280|NCT01484912|523983460|FG000|Overall Study|Withdrawal by Subject|1|||
145310281|NCT01484912|523983461|FG001|Overall Study|Withdrawal by Subject|0|||
145310282|NCT01484912|523983460|FG000|Overall Study|Physician Decision|0|||
145310283|NCT01484912|523983461|FG001|Overall Study|Physician Decision|1|||
145310284|NCT00472212|523983464|FG000|Overall Study|Lost to Follow-up|6|||
145310285|NCT00472212|523983465|FG001|Overall Study|Lost to Follow-up|4|||
145310286|NCT00958724|523983474|FG000|Overall Study|Disease Progression|6|||
145310287|NCT05604014|523983475|FG000|Overall Study|Lost to Follow-up|13|||
145569239|NCT03400332|524944217|FG005|Pre-Treatment|Other reasons|0|||
145310288|NCT02121184|523983476|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
145310289|NCT02121184|523983477|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
145310290|NCT02121184|523983476|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
145310291|NCT02121184|523983477|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
145310292|NCT02121184|523983476|FG000|Overall Study|Emergency cesarean section required|0|||
145310293|NCT02121184|523983477|FG001|Overall Study|Emergency cesarean section required|2|||
145310294|NCT02121184|523983476|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
145310295|NCT02121184|523983477|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
145310296|NCT00840203|523983481|FG000|First Intervention|Protocol Violation|1|||
145310297|NCT00840203|523983482|FG001|First Intervention|Protocol Violation|1|||
145310298|NCT00840203|523983481|FG000|Washout|Protocol Violation|1|||
145310299|NCT00840203|523983482|FG001|Washout|Protocol Violation|0|||
145310300|NCT00989950|523983495|FG000|Randomized Phase|Protocol Violation|1|||
145310301|NCT00989950|523983496|FG001|Randomized Phase|Protocol Violation|0|||
145310302|NCT00989950|523983497|FG002|Randomized Phase|Protocol Violation|0|||
145310303|NCT00989950|523983498|FG003|Randomized Phase|Protocol Violation|0|||
145310304|NCT00989950|523983495|FG000|Randomized Phase|Adverse Event|0|||
145310305|NCT00989950|523983496|FG001|Randomized Phase|Adverse Event|1|||
145310306|NCT00989950|523983497|FG002|Randomized Phase|Adverse Event|0|||
145310307|NCT00989950|523983498|FG003|Randomized Phase|Adverse Event|0|||
145310308|NCT00101439|523983499|FG000|Period 2|Withdrawal by Subject|0|||
145310309|NCT00101439|523983500|FG001|Period 2|Withdrawal by Subject|2|||
145310310|NCT01867658|523983502|FG000|Overall Study|Withdrawal by Subject|6|||
145310311|NCT01867658|523983502|FG000|Overall Study|Death|2|||
145310312|NCT01867658|523983502|FG000|Overall Study|Subject could not be contacted|1|||
145310313|NCT03101358|523983505|FG000|Overall Study|Non-compliance with study schedule|1|||
145310314|NCT03101358|523983506|FG001|Overall Study|Non-compliance with study schedule|0|||
145310315|NCT03101358|523983507|FG002|Overall Study|Non-compliance with study schedule|0|||
145310316|NCT03101358|523983508|FG003|Overall Study|Non-compliance with study schedule|1|||
145310317|NCT03101358|523983505|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
145310318|NCT03101358|523983506|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
145310319|NCT03101358|523983507|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
145310320|NCT03101358|523983508|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
145310321|NCT03101358|523983505|FG000|Overall Study|Physician Decision|1|||
145310322|NCT03101358|523983506|FG001|Overall Study|Physician Decision|0|||
145310323|NCT03101358|523983507|FG002|Overall Study|Physician Decision|0|||
145310324|NCT03101358|523983508|FG003|Overall Study|Physician Decision|3|||
145310325|NCT03101358|523983505|FG000|Overall Study|Adverse Event|0|||
145310326|NCT03101358|523983506|FG001|Overall Study|Adverse Event|0|||
145310327|NCT03101358|523983507|FG002|Overall Study|Adverse Event|1|||
145310328|NCT03101358|523983508|FG003|Overall Study|Adverse Event|0|||
145310329|NCT03101358|523983505|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
145310330|NCT03101358|523983506|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
145310331|NCT03101358|523983507|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
145310332|NCT03101358|523983508|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
145310333|NCT03101358|523983505|FG000|Overall Study|Lost to Follow-up|1|||
145310334|NCT03101358|523983506|FG001|Overall Study|Lost to Follow-up|0|||
145310335|NCT03101358|523983507|FG002|Overall Study|Lost to Follow-up|0|||
145310336|NCT03101358|523983508|FG003|Overall Study|Lost to Follow-up|1|||
145310337|NCT02426918|523983509|FG000|Overall Study|Adverse Event|2|||
145310338|NCT02426918|523983510|FG001|Overall Study|Adverse Event|2|||
145310339|NCT02426918|523983511|FG002|Overall Study|Adverse Event|0|||
145310340|NCT02426918|523983509|FG000|Overall Study|Physician Decision|1|||
145310341|NCT02426918|523983510|FG001|Overall Study|Physician Decision|1|||
145310342|NCT02426918|523983511|FG002|Overall Study|Physician Decision|1|||
145310343|NCT02426918|523983509|FG000|Overall Study|Withdrawal by Subject|5|||
145310344|NCT02426918|523983510|FG001|Overall Study|Withdrawal by Subject|5|||
145310345|NCT02426918|523983511|FG002|Overall Study|Withdrawal by Subject|4|||
145310346|NCT02426918|523983509|FG000|Overall Study|Other|9|||
145310347|NCT02426918|523983510|FG001|Overall Study|Other|11|||
145310348|NCT02426918|523983511|FG002|Overall Study|Other|9|||
145310349|NCT01496118|523983512|FG000|Overall Study|Disease progression|3|||
145310350|NCT01496118|523983513|FG001|Overall Study|Disease progression|2|||
145310351|NCT01496118|523983514|FG002|Overall Study|Disease progression|3|||
145310352|NCT01496118|523983515|FG003|Overall Study|Disease progression|1|||
145310353|NCT01496118|523983516|FG004|Overall Study|Disease progression|2|||
145310354|NCT01496118|523983517|FG005|Overall Study|Disease progression|2|||
145310355|NCT01496118|523983518|FG006|Overall Study|Disease progression|14|||
145310356|NCT01496118|523983519|FG007|Overall Study|Disease progression|10|||
145310357|NCT01496118|523983512|FG000|Overall Study|Physician Decision|0|||
145310358|NCT01496118|523983513|FG001|Overall Study|Physician Decision|0|||
145310359|NCT01496118|523983514|FG002|Overall Study|Physician Decision|0|||
145310360|NCT01496118|523983515|FG003|Overall Study|Physician Decision|0|||
145310361|NCT01496118|523983516|FG004|Overall Study|Physician Decision|1|||
145310362|NCT01496118|523983517|FG005|Overall Study|Physician Decision|0|||
145310363|NCT01496118|523983518|FG006|Overall Study|Physician Decision|3|||
145310364|NCT01496118|523983519|FG007|Overall Study|Physician Decision|6|||
145310365|NCT01496118|523983512|FG000|Overall Study|Adverse Event|1|||
145310366|NCT01496118|523983513|FG001|Overall Study|Adverse Event|1|||
145310367|NCT01496118|523983514|FG002|Overall Study|Adverse Event|0|||
145310368|NCT01496118|523983515|FG003|Overall Study|Adverse Event|0|||
145310369|NCT01496118|523983516|FG004|Overall Study|Adverse Event|0|||
145310370|NCT01496118|523983517|FG005|Overall Study|Adverse Event|0|||
145310371|NCT01496118|523983518|FG006|Overall Study|Adverse Event|6|||
145310372|NCT01496118|523983519|FG007|Overall Study|Adverse Event|10|||
145310373|NCT01496118|523983512|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310374|NCT01496118|523983513|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310375|NCT01496118|523983514|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310376|NCT01496118|523983515|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310377|NCT01496118|523983516|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310378|NCT01496118|523983517|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310379|NCT01496118|523983518|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
145310380|NCT01496118|523983519|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
145310381|NCT01496118|523983512|FG000|Overall Study|Death|0|||
145310382|NCT01496118|523983513|FG001|Overall Study|Death|0|||
145310383|NCT01496118|523983514|FG002|Overall Study|Death|0|||
145310384|NCT01496118|523983515|FG003|Overall Study|Death|0|||
145310385|NCT01496118|523983516|FG004|Overall Study|Death|0|||
145310386|NCT01496118|523983517|FG005|Overall Study|Death|0|||
145310387|NCT01496118|523983518|FG006|Overall Study|Death|1|||
145310388|NCT01496118|523983519|FG007|Overall Study|Death|1|||
145310389|NCT01496118|523983512|FG000|Overall Study|Withdrawal by Subject|0|||
145310390|NCT01496118|523983513|FG001|Overall Study|Withdrawal by Subject|0|||
145411135|NCT01001104|524358780|FG001|Overall Study|Entry Criteria Not Met|0|||
145310391|NCT01496118|523983514|FG002|Overall Study|Withdrawal by Subject|0|||
145310392|NCT01496118|523983515|FG003|Overall Study|Withdrawal by Subject|2|||
145310393|NCT01496118|523983516|FG004|Overall Study|Withdrawal by Subject|0|||
145310394|NCT01496118|523983517|FG005|Overall Study|Withdrawal by Subject|1|||
145310395|NCT01496118|523983518|FG006|Overall Study|Withdrawal by Subject|6|||
145310396|NCT01496118|523983519|FG007|Overall Study|Withdrawal by Subject|3|||
145310397|NCT02845336|523983520|FG000|Overall Study|Lost to Follow-up|3|||
145310398|NCT02845336|523983521|FG001|Overall Study|Lost to Follow-up|1|||
145310399|NCT02845336|523983520|FG000|Overall Study|Inability to get medication|2|||
145310400|NCT02845336|523983521|FG001|Overall Study|Inability to get medication|0|||
145310401|NCT01190865|523983527|FG000|Overall Study|Withdrawal by Subject|1|||
145310402|NCT01190865|523983527|FG000|Overall Study|Non-compliance|2|||
145310403|NCT00829452|523983528|FG000|First Intervention|Withdrawal by Subject|0|||
145310404|NCT00829452|523983529|FG001|First Intervention|Withdrawal by Subject|1|||
145310405|NCT00829452|523983528|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
145310406|NCT00829452|523983529|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
145310407|NCT00829452|523983528|FG000|Second Intervention|Physician Decision|0|||
145310408|NCT00829452|523983529|FG001|Second Intervention|Physician Decision|1|||
145310409|NCT00574847|523983532|FG000|Overall Study|Adverse Event|2|||
145310410|NCT00574847|523983533|FG001|Overall Study|Adverse Event|0|||
145310411|NCT00574847|523983532|FG000|Overall Study|Death|1|||
145310412|NCT00574847|523983533|FG001|Overall Study|Death|0|||
145411136|NCT01001104|524358781|FG002|Overall Study|Entry Criteria Not Met|0|||
145411137|NCT01001104|524358782|FG003|Overall Study|Entry Criteria Not Met|1|||
145411138|NCT01001104|524358779|FG000|Overall Study|Withdrawal by Subject|0|||
145411139|NCT01001104|524358780|FG001|Overall Study|Withdrawal by Subject|0|||
145411140|NCT01001104|524358781|FG002|Overall Study|Withdrawal by Subject|0|||
145411141|NCT01001104|524358782|FG003|Overall Study|Withdrawal by Subject|2|||
145411142|NCT00599313|524358783|FG000|Overall Study|Adverse Event|19|||
145411143|NCT00599313|524358783|FG000|Overall Study|Disease Progression|12|||
145310413|NCT00574847|523983532|FG000|Overall Study|Withdrawal by Subject|2|||
145310414|NCT00574847|523983533|FG001|Overall Study|Withdrawal by Subject|2|||
145310415|NCT00574847|523983532|FG000|Overall Study|Physician Decision|1|||
145411144|NCT00599313|524358783|FG000|Overall Study|Patient Request|4|||
145310416|NCT00574847|523983533|FG001|Overall Study|Physician Decision|0|||
145310417|NCT00574847|523983532|FG000|Overall Study|Did not receive medication (declined)|2|||
145310418|NCT00574847|523983533|FG001|Overall Study|Did not receive medication (declined)|5|||
145310419|NCT02471807|523983538|FG000|Overall Study|Death|14|||
145310420|NCT02471807|523983538|FG000|Overall Study|Withdrawal by Subject|2|||
145310421|NCT02471807|523983538|FG000|Overall Study|Explant|5|||
145310422|NCT02471807|523983538|FG000|Overall Study|Lost to Follow-up|1|||
145310423|NCT01559363|523983539|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
145310424|NCT01559363|523983540|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
145310425|NCT01559363|523983541|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
145310426|NCT01559363|523983542|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
145310427|NCT01559363|523983543|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
145310428|NCT01559363|523983544|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
145310429|NCT01559363|523983539|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
145310430|NCT01559363|523983540|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
145310431|NCT01559363|523983541|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
145310432|NCT01559363|523983542|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
145310433|NCT01559363|523983543|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
145310434|NCT01559363|523983544|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
145310435|NCT01559363|523983539|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
145310436|NCT01559363|523983540|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
145310437|NCT01559363|523983541|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
145310438|NCT01559363|523983542|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
145310439|NCT01559363|523983543|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
145310440|NCT01559363|523983544|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
145310441|NCT01559363|523983539|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
145310442|NCT01559363|523983540|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
145310443|NCT01559363|523983541|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
145310444|NCT01559363|523983542|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
145310445|NCT01559363|523983543|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
145310446|NCT01559363|523983544|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
145310447|NCT01559363|523983539|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
145310448|NCT01559363|523983540|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
145310449|NCT01559363|523983541|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
145310450|NCT01559363|523983542|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
145310451|NCT01559363|523983543|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
145310452|NCT01559363|523983544|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
145310453|NCT01559363|523983539|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
145310454|NCT01559363|523983540|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
145310455|NCT01559363|523983541|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
145310456|NCT01559363|523983542|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
145310457|NCT01559363|523983543|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
145310458|NCT01559363|523983544|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
145310459|NCT01559363|523983539|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
145310460|NCT01559363|523983540|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
145310461|NCT01559363|523983541|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
145310462|NCT01559363|523983542|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
145310463|NCT01559363|523983543|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
145310464|NCT01559363|523983544|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
145310465|NCT00562718|523983559|FG000|Overall Study|Death|1|||
145310466|NCT00562718|523983559|FG000|Overall Study|Withdrawal by Subject|3|||
145310467|NCT00562718|523983559|FG000|Overall Study|Adverse Event|4|||
145310468|NCT00562718|523983559|FG000|Overall Study|Lack of Efficacy|2|||
145310469|NCT00562718|523983559|FG000|Overall Study|not stated|1|||
145310470|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
145310471|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
145310472|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
145310473|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
145310474|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
145310475|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
145310476|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
145310477|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
145310478|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
145310479|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
145310480|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
145310481|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
145310482|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
145310483|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
145310484|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
145310485|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
145310486|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
145310487|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
145310488|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
145310489|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
145569240|NCT03400332|524944218|FG006|Pre-Treatment|Other reasons|0|||
145310490|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
145310491|NCT02227238|523983560|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
145310492|NCT02227238|523983561|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
145310493|NCT02227238|523983562|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
145310494|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
145310495|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
145411145|NCT00599313|524358783|FG000|Overall Study|Ineligible|1|||
145411146|NCT01793935|524358784|FG000|Overall Study|Pregnancy|1|||
145411147|NCT01793935|524358785|FG001|Overall Study|Pregnancy|0|||
145411148|NCT01793935|524358784|FG000|Overall Study|Protocol Violation|2|||
145411149|NCT01793935|524358785|FG001|Overall Study|Protocol Violation|1|||
145310496|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
145310497|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
145310498|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
145310499|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
145310500|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
145310501|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
145310502|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
145310503|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
145310504|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
145310505|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
145310506|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
145310507|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
145310508|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
145310509|NCT02227238|523983560|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
145310510|NCT02227238|523983561|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
145310511|NCT02227238|523983562|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
145310512|NCT00868998|523983565|FG000|Overall Study|Screen Failure|1|||
145310513|NCT00868998|523983565|FG000|Overall Study|Withdrawal by Subject|1|||
145310514|NCT00868998|523983565|FG000|Overall Study|Progression of disease|2|||
145310515|NCT00868998|523983565|FG000|Overall Study|Death|1|||
145310516|NCT01483820|523983566|FG000|Overall Study|Lack of Efficacy|6|||
145310517|NCT01483820|523983566|FG000|Overall Study|Adverse Event|1|||
145310518|NCT01483820|523983566|FG000|Overall Study|Death|1|||
145310519|NCT01395017|523983569|FG000|Overall Study|Lost to Follow-up|1|||
145310520|NCT01395017|523983570|FG001|Overall Study|Lost to Follow-up|0|||
145310521|NCT01395017|523983569|FG000|Overall Study|Adverse Event|26|||
145310522|NCT01395017|523983570|FG001|Overall Study|Adverse Event|12|||
145310523|NCT01395017|523983569|FG000|Overall Study|Physician Decision|11|||
145310524|NCT01395017|523983570|FG001|Overall Study|Physician Decision|15|||
145310525|NCT01395017|523983569|FG000|Overall Study|Withdrawal by Subject|14|||
145310526|NCT01395017|523983570|FG001|Overall Study|Withdrawal by Subject|8|||
145310527|NCT01395017|523983569|FG000|Overall Study|Protocol deviation|1|||
145310528|NCT01395017|523983570|FG001|Overall Study|Protocol deviation|2|||
145310529|NCT01395017|523983569|FG000|Overall Study|Death|4|||
145310530|NCT01395017|523983570|FG001|Overall Study|Death|3|||
145310531|NCT01395017|523983569|FG000|Overall Study|Disease progression|42|||
145310532|NCT01395017|523983570|FG001|Overall Study|Disease progression|58|||
145310533|NCT01395017|523983569|FG000|Overall Study|Sponsor discontinued study|1|||
145310534|NCT01395017|523983570|FG001|Overall Study|Sponsor discontinued study|4|||
145310535|NCT04158687|523985240|FG000|Overall Study|Adverse Event|2|||
145310536|NCT04158687|523985241|FG001|Overall Study|Adverse Event|3|||
145310537|NCT04158687|523985242|FG002|Overall Study|Adverse Event|0|||
145310538|NCT04158687|523985243|FG003|Overall Study|Adverse Event|3|||
145310539|NCT04158687|523985240|FG000|Overall Study|Lost to Follow-up|5|||
145310540|NCT04158687|523985241|FG001|Overall Study|Lost to Follow-up|12|||
145310541|NCT04158687|523985242|FG002|Overall Study|Lost to Follow-up|4|||
145310542|NCT04158687|523985243|FG003|Overall Study|Lost to Follow-up|5|||
145310543|NCT04158687|523985240|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
145310544|NCT04158687|523985241|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
145310545|NCT04158687|523985242|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
145310546|NCT04158687|523985243|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
145310547|NCT04158687|523985240|FG000|Overall Study|Non-Compliance with Study Medication|2|||
145310548|NCT04158687|523985241|FG001|Overall Study|Non-Compliance with Study Medication|2|||
145310549|NCT04158687|523985242|FG002|Overall Study|Non-Compliance with Study Medication|3|||
145310550|NCT04158687|523985243|FG003|Overall Study|Non-Compliance with Study Medication|0|||
145411150|NCT01793935|524358784|FG000|Overall Study|Adverse Event|2|||
145569241|NCT03400332|524944219|FG007|Pre-Treatment|Other reasons|0|||
145310551|NCT04158687|523985240|FG000|Overall Study|Investigator Decision|0|||
145310552|NCT04158687|523985241|FG001|Overall Study|Investigator Decision|0|||
145310553|NCT04158687|523985242|FG002|Overall Study|Investigator Decision|2|||
145310554|NCT04158687|523985243|FG003|Overall Study|Investigator Decision|0|||
145411151|NCT01793935|524358785|FG001|Overall Study|Adverse Event|0|||
145310555|NCT04158687|523985240|FG000|Overall Study|Protocol Violation|0|||
145310556|NCT04158687|523985241|FG001|Overall Study|Protocol Violation|2|||
145569242|NCT03400332|524944220|FG008|Pre-Treatment|Other reasons|1|||
145569243|NCT03400332|524944212|FG000|Pre-Treatment|No longer met study criteria|0|||
145569244|NCT03400332|524944213|FG001|Pre-Treatment|No longer met study criteria|0|||
145569245|NCT03400332|524944214|FG002|Pre-Treatment|No longer met study criteria|0|||
145310557|NCT04158687|523985242|FG002|Overall Study|Protocol Violation|1|||
145310558|NCT04158687|523985243|FG003|Overall Study|Protocol Violation|0|||
145310559|NCT04158687|523985240|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
145310560|NCT04158687|523985241|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
145310561|NCT04158687|523985242|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
145310562|NCT04158687|523985243|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
145310563|NCT04158687|523985240|FG000|Overall Study|Reason not Specified|3|||
145310564|NCT04158687|523985241|FG001|Overall Study|Reason not Specified|2|||
145310565|NCT04158687|523985242|FG002|Overall Study|Reason not Specified|4|||
145310566|NCT04158687|523985243|FG003|Overall Study|Reason not Specified|4|||
145310567|NCT00640393|523985244|FG000|Part 1|Lost to Follow-up|2|||
145310568|NCT00640393|523985245|FG001|Part 1|Lost to Follow-up|0|||
145310569|NCT00640393|523985246|FG002|Part 1|Lost to Follow-up|0|||
145310570|NCT00640393|523985244|FG000|Part 1|Withdrawal by Subject|3|||
145310571|NCT00640393|523985245|FG001|Part 1|Withdrawal by Subject|0|||
145310572|NCT00640393|523985246|FG002|Part 1|Withdrawal by Subject|0|||
145310573|NCT00640393|523985244|FG000|Randomization|Withdrawn per protocol|17|||
145310574|NCT00640393|523985245|FG001|Randomization|Withdrawn per protocol|0|||
145310575|NCT00640393|523985246|FG002|Randomization|Withdrawn per protocol|0|||
145310576|NCT00640393|523985244|FG000|Randomization|Never randomized by site|2|||
145310577|NCT00640393|523985245|FG001|Randomization|Never randomized by site|0|||
145310578|NCT00640393|523985246|FG002|Randomization|Never randomized by site|0|||
145310579|NCT00640393|523985244|FG000|Part 2|Lost to Follow-up|0|||
145310580|NCT00640393|523985245|FG001|Part 2|Lost to Follow-up|2|||
145310581|NCT00640393|523985246|FG002|Part 2|Lost to Follow-up|2|||
145310582|NCT00640393|523985244|FG000|Part 2|Withdrawal by Subject|0|||
145310583|NCT00640393|523985245|FG001|Part 2|Withdrawal by Subject|6|||
145310584|NCT00640393|523985246|FG002|Part 2|Withdrawal by Subject|1|||
145310585|NCT00640393|523985244|FG000|Part 2|Non-adherence|0|||
145310586|NCT00640393|523985245|FG001|Part 2|Non-adherence|1|||
145310587|NCT00640393|523985246|FG002|Part 2|Non-adherence|0|||
145310588|NCT00640393|523985244|FG000|Part 2|Adverse Event|0|||
145310589|NCT00640393|523985245|FG001|Part 2|Adverse Event|1|||
145310590|NCT00640393|523985246|FG002|Part 2|Adverse Event|0|||
145310591|NCT00198133|523985248|FG000|Overall Study|Disease progression|2|||
145310592|NCT00198133|523985249|FG001|Overall Study|Disease progression|5|||
145310593|NCT00198133|523985248|FG000|Overall Study|Adverse Event|1|||
145310594|NCT00198133|523985249|FG001|Overall Study|Adverse Event|3|||
145310595|NCT00198133|523985248|FG000|Overall Study|Withdrawal by Subject|1|||
145310596|NCT00198133|523985249|FG001|Overall Study|Withdrawal by Subject|0|||
145310597|NCT00198133|523985248|FG000|Overall Study|Physician Decision|1|||
145310598|NCT00198133|523985249|FG001|Overall Study|Physician Decision|0|||
145310599|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
145310600|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
145310601|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
145310602|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
145310603|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
145310604|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
145310605|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
145310606|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
145310607|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
145310608|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
145310609|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
145310610|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
145310611|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
145569246|NCT03400332|524944215|FG003|Pre-Treatment|No longer met study criteria|0|||
145569247|NCT03400332|524944216|FG004|Pre-Treatment|No longer met study criteria|0|||
145310612|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
145310613|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
145310614|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
145310615|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
145310616|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
145310617|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
145310618|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
145310619|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
145310620|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
145310621|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
145377819|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
145310622|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
145310623|NCT00073307|523985258|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
145310624|NCT00073307|523985259|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
145310625|NCT00073307|523985260|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
145310626|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
145310627|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
145310628|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
145310629|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
145310630|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
145310631|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
145310632|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
145310633|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
145310634|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
145310635|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
145310636|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
145310637|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
145310638|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
145310639|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
145310640|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
145310641|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
145310642|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
145310643|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
145310644|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
145310645|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
145310646|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
145310647|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
145310648|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
145310649|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
145310650|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
145310651|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
145310652|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
145310653|NCT00073307|523985258|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
145310654|NCT00073307|523985259|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
145310655|NCT00073307|523985260|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
145310656|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
145310657|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
145310658|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
145310659|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
145310660|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
145310661|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
145310662|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
145310663|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
145310664|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
145310665|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
145310666|NCT01438060|523985261|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
145310667|NCT01438060|523985262|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
145310668|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
145310669|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
145310670|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
145310671|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
145310672|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
145310673|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
145310674|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
145310675|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
145310676|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
145310677|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
145310678|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
145411152|NCT01793935|524358784|FG000|Overall Study|Patient did not take study medication|1|||
145411153|NCT01793935|524358785|FG001|Overall Study|Patient did not take study medication|1|||
145411154|NCT01793935|524358784|FG000|Overall Study|Lost to Follow-up|0|||
145411155|NCT01793935|524358785|FG001|Overall Study|Lost to Follow-up|1|||
145411156|NCT01121926|524358786|FG000|First Intervention Period|Adverse Event|1|||
145411157|NCT01121926|524358787|FG001|First Intervention Period|Adverse Event|0|||
145310679|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
145310680|NCT01438060|523985261|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
145310681|NCT01438060|523985262|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
145310682|NCT01438060|523985261|FG000|On Study Beyond Week 140|Adverse Event|0|||
145310683|NCT01438060|523985262|FG001|On Study Beyond Week 140|Adverse Event|2|||
145310684|NCT01438060|523985261|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
145310685|NCT01438060|523985262|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
145310686|NCT01438060|523985261|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
145310687|NCT01438060|523985262|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
145310688|NCT01438060|523985261|FG000|On Study Beyond Week 140|Death|0|||
145310689|NCT01438060|523985262|FG001|On Study Beyond Week 140|Death|1|||
145310690|NCT01438060|523985261|FG000|On Study Beyond Week 140|Other Reason|0|||
145310691|NCT01438060|523985262|FG001|On Study Beyond Week 140|Other Reason|3|||
145310692|NCT01964950|523985263|FG000|Overall Study|Protocol Violation|25|||
145310693|NCT03499873|523985264|FG000|Overall Study|Withdrawal by Subject|4|||
145310694|NCT03499873|523985265|FG001|Overall Study|Withdrawal by Subject|6|||
145310695|NCT03499873|523985266|FG002|Overall Study|Withdrawal by Subject|1|||
145310696|NCT03499873|523985264|FG000|Overall Study|Subjects condition worsened|0|||
145310697|NCT03499873|523985265|FG001|Overall Study|Subjects condition worsened|3|||
145310698|NCT03499873|523985266|FG002|Overall Study|Subjects condition worsened|11|||
145310699|NCT03499873|523985264|FG000|Overall Study|Adverse Event|8|||
145310700|NCT03499873|523985265|FG001|Overall Study|Adverse Event|3|||
145310701|NCT03499873|523985266|FG002|Overall Study|Adverse Event|6|||
145310702|NCT03499873|523985264|FG000|Overall Study|Physician Decision|1|||
145310703|NCT03499873|523985265|FG001|Overall Study|Physician Decision|0|||
145310704|NCT03499873|523985266|FG002|Overall Study|Physician Decision|0|||
145310705|NCT03499873|523985264|FG000|Overall Study|Administrative reasons|0|||
145310706|NCT03499873|523985265|FG001|Overall Study|Administrative reasons|1|||
145310707|NCT03499873|523985266|FG002|Overall Study|Administrative reasons|0|||
145310708|NCT03499873|523985264|FG000|Overall Study|Concomitant therapy|5|||
145310709|NCT03499873|523985265|FG001|Overall Study|Concomitant therapy|4|||
145310710|NCT03499873|523985266|FG002|Overall Study|Concomitant therapy|7|||
145310711|NCT03499873|523985264|FG000|Overall Study|Miscellaneous|1|||
145310712|NCT03499873|523985265|FG001|Overall Study|Miscellaneous|2|||
145310713|NCT03499873|523985266|FG002|Overall Study|Miscellaneous|2|||
145310714|NCT03499873|523985264|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
145310715|NCT03499873|523985265|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
145310716|NCT03499873|523985266|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
145310717|NCT01297504|523985267|FG000|Overall Study|Invalid Consent|1|||
145310718|NCT01297504|523985267|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
145310719|NCT01297504|523985267|FG000|Overall Study|No Study Visits|4|||
145310720|NCT01297504|523985267|FG000|Overall Study|Death|3|||
145310721|NCT01297504|523985267|FG000|Overall Study|Lost to Follow-up|43|||
145310722|NCT01297504|523985267|FG000|Overall Study|Withdrawal by Subject|9|||
145310723|NCT01297504|523985267|FG000|Overall Study|Site Closure|3|||
145310724|NCT01297504|523985267|FG000|Overall Study|Protocol Violation|3|||
145310725|NCT03602339|523985268|FG000|Overall Study|Withdrawal by Subject|9|||
145310726|NCT03602339|523985268|FG000|Overall Study|Physician Decision|2|||
145310727|NCT03602339|523985268|FG000|Overall Study|Other reason|4|||
145310728|NCT00654186|523985269|FG000|Overall Study|Withdrawal by Subject|5|||
145310729|NCT01024855|523985274|FG000|Overall Study|Inclusion/exclusion criteria|1|||
145310730|NCT03306277|523985276|FG000|Overall Study|Death|1|||
145310731|NCT03306277|523985276|FG000|Overall Study|Adverse Event|1|||
145310732|NCT03306277|523985276|FG000|Overall Study|Withdrawal by Subject|1|||
145310733|NCT00957021|523985280|FG000|Overall Study|Death|5|||
145310734|NCT00957021|523985280|FG000|Overall Study|Lost to Follow-up|8|||
145310735|NCT00957021|523985280|FG000|Overall Study|Withdrawal by Subject|34|||
145310736|NCT00957021|523985280|FG000|Overall Study|No 2 yr ROM data|35|||
145310737|NCT00957021|523985280|FG000|Overall Study|Revised study component by 2 yr visit|8|||
145310738|NCT00957021|523985280|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
145310739|NCT00957021|523985280|FG000|Overall Study|Surgery Cancelled|9|||
145310740|NCT00957021|523985280|FG000|Overall Study|Termination due to language issue|2|||
145310741|NCT00487435|523985281|FG000|Overall Study|Adverse Event|146|||
145310742|NCT00487435|523985281|FG000|Overall Study|Death|2|||
145310743|NCT00487435|523985281|FG000|Overall Study|Lack of Efficacy|33|||
145310744|NCT00487435|523985281|FG000|Overall Study|Lost to Follow-up|54|||
145310745|NCT00487435|523985281|FG000|Overall Study|Pregnancy|2|||
145310746|NCT00487435|523985281|FG000|Overall Study|Withdrawal by Subject|132|||
145310747|NCT00487435|523985281|FG000|Overall Study|Resolution Of Pain|1|||
145310748|NCT00487435|523985281|FG000|Overall Study|Study Medication Non-Compliant|32|||
145310749|NCT00487435|523985281|FG000|Overall Study|Other|83|||
145310750|NCT01155531|523985288|FG000|Overall Study|Adverse Event|0|||
145310751|NCT01155531|523985289|FG001|Overall Study|Adverse Event|0|||
145310752|NCT01155531|523985290|FG002|Overall Study|Adverse Event|1|||
145310753|NCT01155531|523985291|FG003|Overall Study|Adverse Event|0|||
145310754|NCT01155531|523985288|FG000|Overall Study|Lost to Follow-up|0|||
145310755|NCT01155531|523985289|FG001|Overall Study|Lost to Follow-up|0|||
145310756|NCT01155531|523985290|FG002|Overall Study|Lost to Follow-up|0|||
145310757|NCT01155531|523985291|FG003|Overall Study|Lost to Follow-up|1|||
145310758|NCT01155531|523985288|FG000|Overall Study|Withdrawal by Subject|1|||
145310759|NCT01155531|523985289|FG001|Overall Study|Withdrawal by Subject|0|||
145310760|NCT01155531|523985290|FG002|Overall Study|Withdrawal by Subject|1|||
145310761|NCT01155531|523985291|FG003|Overall Study|Withdrawal by Subject|0|||
145310762|NCT01087502|523985292|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
145310763|NCT01087502|523985293|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
145310764|NCT01087502|523985292|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
145310765|NCT01087502|523985293|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
145310766|NCT01087502|523985292|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
145310767|NCT01087502|523985293|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
145310768|NCT01087502|523985292|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
145310769|NCT01087502|523985293|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
145310770|NCT01087502|523985292|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
145310771|NCT01087502|523985293|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
145310772|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
145310773|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
145310774|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
145310775|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
145310776|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
145310777|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
145310778|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
145310779|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
145310780|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
145310781|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
145310782|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
145310783|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
145310784|NCT01087502|523985292|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
145310785|NCT01087502|523985293|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
145310786|NCT01653704|523985294|FG000|Overall Study|Technical failure during recording|1|||
145310787|NCT01653704|523985295|FG001|Overall Study|Technical failure during recording|1|||
145310788|NCT01653704|523985294|FG000|Overall Study|Performance not reflective of training|1|||
145310789|NCT01653704|523985295|FG001|Overall Study|Performance not reflective of training|0|||
145310790|NCT01986647|523985296|FG000|Overall Study|Lost to Follow-up|4|||
145310791|NCT01986647|523985297|FG001|Overall Study|Lost to Follow-up|1|||
145310792|NCT01986647|523985298|FG002|Overall Study|Lost to Follow-up|4|||
145310793|NCT01986647|523985299|FG003|Overall Study|Lost to Follow-up|4|||
145310794|NCT01986647|523985296|FG000|Overall Study|Withdrawal by Subject|1|||
145310795|NCT01986647|523985297|FG001|Overall Study|Withdrawal by Subject|3|||
145310796|NCT01986647|523985298|FG002|Overall Study|Withdrawal by Subject|2|||
145310797|NCT01986647|523985299|FG003|Overall Study|Withdrawal by Subject|3|||
145310798|NCT01986647|523985296|FG000|Overall Study|Health|5|||
145310799|NCT01986647|523985297|FG001|Overall Study|Health|3|||
145310800|NCT01986647|523985298|FG002|Overall Study|Health|6|||
145310801|NCT01986647|523985299|FG003|Overall Study|Health|4|||
145310802|NCT01663896|523985302|FG000|Overall Study|Various reasons|43|||
145310803|NCT00999687|523985303|FG000|First Intervention|Withdrawal by Subject|1|||
145310804|NCT00999687|523985303|FG000|Second Intervention|Withdrawal by Subject|2|||
145310805|NCT00999687|523985303|FG000|Second Intervention|Lack of Efficacy|1|||
145310806|NCT03541252|523985306|FG000|Overall Study|Withdrawal by Subject|1|||
145310807|NCT01960296|523985313|FG000|Overall Study|Postponed surgery|1|||
145310808|NCT01960296|523985314|FG001|Overall Study|Postponed surgery|0|||
145310809|NCT01960296|523985313|FG000|Overall Study|Received different procedure|1|||
145310810|NCT01960296|523985314|FG001|Overall Study|Received different procedure|3|||
145310811|NCT02003391|523985315|FG000|Overall Study|Withdrawal by Subject|2|||
145310812|NCT02003391|523985316|FG001|Overall Study|Withdrawal by Subject|1|||
145310813|NCT02003391|523985315|FG000|Overall Study|Protocol Violation|0|||
145310814|NCT02003391|523985316|FG001|Overall Study|Protocol Violation|1|||
145310815|NCT02003391|523985315|FG000|Overall Study|Adverse Event|1|||
145310816|NCT02003391|523985316|FG001|Overall Study|Adverse Event|0|||
145310817|NCT02896296|523985317|FG000|Overall Study|Adverse Event|1|||
145411158|NCT01121926|524358786|FG000|Washout Period|Adverse Event|0|||
145310818|NCT02896296|523985317|FG000|Overall Study|Lost to Follow-up|19|||
145310819|NCT02896296|523985317|FG000|Overall Study|Pregnancy|1|||
145310820|NCT02896296|523985317|FG000|Overall Study|Physician Decision|2|||
145310821|NCT02896296|523985317|FG000|Overall Study|Withdrawal by Subject|10|||
145310822|NCT02896296|523985317|FG000|Overall Study|Site closing|7|||
145310823|NCT02896296|523985317|FG000|Overall Study|Incarceration|1|||
145310824|NCT02896296|523985317|FG000|Overall Study|Relocation|1|||
145310825|NCT02272803|523985318|FG000|Overall Study|Disease progression|16|||
145411159|NCT01121926|524358787|FG001|Washout Period|Adverse Event|1|||
145310826|NCT02272803|523985319|FG001|Overall Study|Disease progression|8|||
145310827|NCT02272803|523985318|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
145310828|NCT02272803|523985319|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
145310829|NCT02272803|523985318|FG000|Overall Study|Study drug toxicity|4|||
145310830|NCT02272803|523985319|FG001|Overall Study|Study drug toxicity|9|||
145310831|NCT02272803|523985318|FG000|Overall Study|Participant request to discontinue study treatment|3|||
145310832|NCT02272803|523985319|FG001|Overall Study|Participant request to discontinue study treatment|7|||
145310833|NCT02272803|523985318|FG000|Overall Study|Maximum clinical benefit|4|||
145310834|NCT02272803|523985319|FG001|Overall Study|Maximum clinical benefit|2|||
145310835|NCT02272803|523985318|FG000|Overall Study|Poor/non-compliance|2|||
145310836|NCT02272803|523985319|FG001|Overall Study|Poor/non-compliance|2|||
145310837|NCT02272803|523985318|FG000|Overall Study|Withdrawal by Subject|2|||
145310838|NCT02272803|523985319|FG001|Overall Study|Withdrawal by Subject|1|||
145310839|NCT02272803|523985318|FG000|Overall Study|Death|0|||
145310840|NCT02272803|523985319|FG001|Overall Study|Death|1|||
145310841|NCT02272803|523985318|FG000|Overall Study|Other reasons|1|||
145310842|NCT02272803|523985319|FG001|Overall Study|Other reasons|3|||
145310843|NCT02272803|523985318|FG000|Overall Study|Administrative reason by sponsor|5|||
145310844|NCT02272803|523985319|FG001|Overall Study|Administrative reason by sponsor|4|||
145310845|NCT02611323|523985320|FG000|Overall Study|Death|3|||
145310846|NCT02611323|523985321|FG001|Overall Study|Death|1|||
145310847|NCT02611323|523985322|FG002|Overall Study|Death|0|||
145310848|NCT02611323|523985323|FG003|Overall Study|Death|0|||
145310849|NCT02611323|523985324|FG004|Overall Study|Death|1|||
145310850|NCT02611323|523985325|FG005|Overall Study|Death|1|||
145310851|NCT02611323|523985326|FG006|Overall Study|Death|8|||
145310852|NCT02611323|523985327|FG007|Overall Study|Death|0|||
145310853|NCT02611323|523985328|FG008|Overall Study|Death|4|||
145310854|NCT02611323|523985329|FG009|Overall Study|Death|6|||
145310855|NCT02611323|523985330|FG010|Overall Study|Death|26|||
145310856|NCT02611323|523985320|FG000|Overall Study|Lost to Follow-up|1|||
145310857|NCT02611323|523985321|FG001|Overall Study|Lost to Follow-up|0|||
145310858|NCT02611323|523985322|FG002|Overall Study|Lost to Follow-up|0|||
145310859|NCT02611323|523985323|FG003|Overall Study|Lost to Follow-up|0|||
145310860|NCT02611323|523985324|FG004|Overall Study|Lost to Follow-up|0|||
145310861|NCT02611323|523985325|FG005|Overall Study|Lost to Follow-up|0|||
145310862|NCT02611323|523985326|FG006|Overall Study|Lost to Follow-up|3|||
145310863|NCT02611323|523985327|FG007|Overall Study|Lost to Follow-up|0|||
145310864|NCT02611323|523985328|FG008|Overall Study|Lost to Follow-up|0|||
145310865|NCT02611323|523985329|FG009|Overall Study|Lost to Follow-up|0|||
145310866|NCT02611323|523985330|FG010|Overall Study|Lost to Follow-up|2|||
145310867|NCT02611323|523985320|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310868|NCT02611323|523985321|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310869|NCT02611323|523985322|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310870|NCT02611323|523985323|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310871|NCT02611323|523985324|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310872|NCT02611323|523985325|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310873|NCT02611323|523985326|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310874|NCT02611323|523985327|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310875|NCT02611323|523985328|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310876|NCT02611323|523985329|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
145310877|NCT02611323|523985330|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
145310878|NCT02611323|523985320|FG000|Overall Study|Progressive Disease|0|||
145310879|NCT02611323|523985321|FG001|Overall Study|Progressive Disease|0|||
145310880|NCT02611323|523985322|FG002|Overall Study|Progressive Disease|0|||
145310881|NCT02611323|523985323|FG003|Overall Study|Progressive Disease|0|||
145310882|NCT02611323|523985324|FG004|Overall Study|Progressive Disease|0|||
145310883|NCT02611323|523985325|FG005|Overall Study|Progressive Disease|0|||
145310884|NCT02611323|523985326|FG006|Overall Study|Progressive Disease|0|||
145310885|NCT02611323|523985327|FG007|Overall Study|Progressive Disease|0|||
145310886|NCT02611323|523985328|FG008|Overall Study|Progressive Disease|0|||
145310887|NCT02611323|523985329|FG009|Overall Study|Progressive Disease|0|||
145310888|NCT02611323|523985330|FG010|Overall Study|Progressive Disease|1|||
145310889|NCT02611323|523985320|FG000|Overall Study|Withdrawal by Subject|1|||
145310890|NCT02611323|523985321|FG001|Overall Study|Withdrawal by Subject|0|||
145569248|NCT03400332|524944217|FG005|Pre-Treatment|No longer met study criteria|0|||
145569249|NCT03400332|524944218|FG006|Pre-Treatment|No longer met study criteria|0|||
145310891|NCT02611323|523985322|FG002|Overall Study|Withdrawal by Subject|0|||
145310892|NCT02611323|523985323|FG003|Overall Study|Withdrawal by Subject|0|||
145310893|NCT02611323|523985324|FG004|Overall Study|Withdrawal by Subject|0|||
145310894|NCT02611323|523985325|FG005|Overall Study|Withdrawal by Subject|0|||
145310895|NCT02611323|523985326|FG006|Overall Study|Withdrawal by Subject|0|||
145310896|NCT02611323|523985327|FG007|Overall Study|Withdrawal by Subject|1|||
145310897|NCT02611323|523985328|FG008|Overall Study|Withdrawal by Subject|0|||
145310898|NCT02611323|523985329|FG009|Overall Study|Withdrawal by Subject|1|||
145310899|NCT02611323|523985330|FG010|Overall Study|Withdrawal by Subject|0|||
145310900|NCT00858403|523985331|FG000|Overall Study|Withdrawal by Subject|1|||
145310901|NCT00858403|523985331|FG000|Overall Study|Death|3|||
145569250|NCT03400332|524944219|FG007|Pre-Treatment|No longer met study criteria|0|||
145569251|NCT03400332|524944220|FG008|Pre-Treatment|No longer met study criteria|1|||
145569252|NCT03400332|524944212|FG000|Pre-Treatment|Withdrawal by Subject|0|||
145569253|NCT03400332|524944213|FG001|Pre-Treatment|Withdrawal by Subject|0|||
145569254|NCT03400332|524944214|FG002|Pre-Treatment|Withdrawal by Subject|0|||
145569255|NCT03400332|524944215|FG003|Pre-Treatment|Withdrawal by Subject|0|||
145569256|NCT03400332|524944216|FG004|Pre-Treatment|Withdrawal by Subject|0|||
145569257|NCT03400332|524944217|FG005|Pre-Treatment|Withdrawal by Subject|0|||
145569258|NCT03400332|524944218|FG006|Pre-Treatment|Withdrawal by Subject|0|||
145569259|NCT03400332|524944219|FG007|Pre-Treatment|Withdrawal by Subject|0|||
145569260|NCT03400332|524944220|FG008|Pre-Treatment|Withdrawal by Subject|1|||
145569261|NCT03400332|524944212|FG000|Treatment|Participant withdrew consent|2|||
145569262|NCT03400332|524944213|FG001|Treatment|Participant withdrew consent|2|||
145569263|NCT03400332|524944214|FG002|Treatment|Participant withdrew consent|0|||
145569264|NCT03400332|524944215|FG003|Treatment|Participant withdrew consent|0|||
145569265|NCT03400332|524944216|FG004|Treatment|Participant withdrew consent|3|||
145310902|NCT00858403|523985331|FG000|Overall Study|Disease Progression|1|||
145310903|NCT02597049|523985332|FG000|Overall Study|Lost to Follow-up|0|||
145310904|NCT02597049|523985333|FG001|Overall Study|Lost to Follow-up|3|||
145310905|NCT02597049|523985334|FG002|Overall Study|Lost to Follow-up|2|||
145310906|NCT02597049|523985332|FG000|Overall Study|Withdrawal by Subject|2|||
145310907|NCT02597049|523985333|FG001|Overall Study|Withdrawal by Subject|2|||
145310908|NCT02597049|523985334|FG002|Overall Study|Withdrawal by Subject|1|||
145310909|NCT02597049|523985332|FG000|Overall Study|Adverse Event|2|||
145310910|NCT02597049|523985333|FG001|Overall Study|Adverse Event|0|||
145310911|NCT02597049|523985334|FG002|Overall Study|Adverse Event|0|||
145310912|NCT02597049|523985332|FG000|Overall Study|Death|2|||
145310913|NCT02597049|523985333|FG001|Overall Study|Death|0|||
145310914|NCT02597049|523985334|FG002|Overall Study|Death|0|||
145310915|NCT02597049|523985332|FG000|Overall Study|Noncompliant with Study Visits|1|||
145310916|NCT02597049|523985333|FG001|Overall Study|Noncompliant with Study Visits|0|||
145310917|NCT02597049|523985334|FG002|Overall Study|Noncompliant with Study Visits|0|||
145310918|NCT02264977|523985338|FG000|Overall Study|Death|3|||
145310919|NCT02264977|523985338|FG000|Overall Study|Physician Decision|1|||
145310920|NCT02264977|523985338|FG000|Overall Study|Refuse to return|1|||
145310921|NCT00243347|523985339|FG000|Overall Study|Lack of Efficacy|4|||
145310922|NCT00243347|523985339|FG000|Overall Study|Adverse Event|2|||
145310923|NCT00243347|523985339|FG000|Overall Study|Death|1|||
145310924|NCT00243347|523985339|FG000|Overall Study|Withdrawal by Subject|5|||
145310925|NCT00243347|523985339|FG000|Overall Study|Condition worsened|7|||
145310926|NCT03573544|523985340|FG000|Overall Study|Adverse Event|0|||
145310927|NCT03573544|523985341|FG001|Overall Study|Adverse Event|0|||
145310928|NCT03573544|523985342|FG002|Overall Study|Adverse Event|0|||
145310929|NCT03573544|523985343|FG003|Overall Study|Adverse Event|3|||
145310930|NCT03573544|523985344|FG004|Overall Study|Adverse Event|1|||
145310931|NCT03573544|523985345|FG005|Overall Study|Adverse Event|0|||
145310932|NCT03573544|523985346|FG006|Overall Study|Adverse Event|2|||
145310933|NCT03573544|523985347|FG007|Overall Study|Adverse Event|0|||
145310934|NCT03573544|523985340|FG000|Overall Study|Physician Decision|0|||
145310935|NCT03573544|523985341|FG001|Overall Study|Physician Decision|0|||
145310936|NCT03573544|523985342|FG002|Overall Study|Physician Decision|0|||
145310937|NCT03573544|523985343|FG003|Overall Study|Physician Decision|0|||
145310938|NCT03573544|523985344|FG004|Overall Study|Physician Decision|0|||
145310939|NCT03573544|523985345|FG005|Overall Study|Physician Decision|0|||
145310940|NCT03573544|523985346|FG006|Overall Study|Physician Decision|1|||
145310941|NCT03573544|523985347|FG007|Overall Study|Physician Decision|0|||
145310942|NCT03573544|523985340|FG000|Overall Study|Withdrawal by Subject|2|||
145310943|NCT03573544|523985341|FG001|Overall Study|Withdrawal by Subject|0|||
145310944|NCT03573544|523985342|FG002|Overall Study|Withdrawal by Subject|0|||
145310945|NCT03573544|523985343|FG003|Overall Study|Withdrawal by Subject|1|||
145310946|NCT03573544|523985344|FG004|Overall Study|Withdrawal by Subject|1|||
145310947|NCT03573544|523985345|FG005|Overall Study|Withdrawal by Subject|1|||
145310948|NCT03573544|523985346|FG006|Overall Study|Withdrawal by Subject|0|||
145310949|NCT03573544|523985347|FG007|Overall Study|Withdrawal by Subject|1|||
145310950|NCT03573544|523985340|FG000|Overall Study|Disease progression|3|||
145569266|NCT03400332|524944217|FG005|Treatment|Participant withdrew consent|3|||
145569267|NCT03400332|524944218|FG006|Treatment|Participant withdrew consent|1|||
145569268|NCT03400332|524944219|FG007|Treatment|Participant withdrew consent|1|||
145569269|NCT03400332|524944220|FG008|Treatment|Participant withdrew consent|1|||
145310951|NCT03573544|523985341|FG001|Overall Study|Disease progression|3|||
145310952|NCT03573544|523985342|FG002|Overall Study|Disease progression|6|||
145310953|NCT03573544|523985343|FG003|Overall Study|Disease progression|4|||
145310954|NCT03573544|523985344|FG004|Overall Study|Disease progression|5|||
145310955|NCT03573544|523985345|FG005|Overall Study|Disease progression|7|||
145310956|NCT03573544|523985346|FG006|Overall Study|Disease progression|6|||
145310957|NCT03573544|523985347|FG007|Overall Study|Disease progression|7|||
145310958|NCT01899053|523985351|FG000|Overall Study|Progressive Disease|4|||
145310959|NCT01899053|523985352|FG001|Overall Study|Progressive Disease|0|||
145310960|NCT01899053|523985353|FG002|Overall Study|Progressive Disease|3|||
145310961|NCT01899053|523985354|FG003|Overall Study|Progressive Disease|0|||
145310962|NCT01899053|523985355|FG004|Overall Study|Progressive Disease|3|||
145310963|NCT01899053|523985356|FG005|Overall Study|Progressive Disease|1|||
145310964|NCT01899053|523985357|FG006|Overall Study|Progressive Disease|1|||
145310965|NCT01899053|523985358|FG007|Overall Study|Progressive Disease|1|||
145310966|NCT01899053|523985359|FG008|Overall Study|Progressive Disease|4|||
145310967|NCT01899053|523985360|FG009|Overall Study|Progressive Disease|3|||
145310968|NCT01899053|523985361|FG010|Overall Study|Progressive Disease|12|||
145310969|NCT01899053|523985362|FG011|Overall Study|Progressive Disease|5|||
145310970|NCT01899053|523985363|FG012|Overall Study|Progressive Disease|8|||
145310971|NCT01899053|523985364|FG013|Overall Study|Progressive Disease|17|||
145310972|NCT01899053|523985351|FG000|Overall Study|Adverse Event|1|||
145310973|NCT01899053|523985352|FG001|Overall Study|Adverse Event|1|||
145310974|NCT01899053|523985353|FG002|Overall Study|Adverse Event|1|||
145310975|NCT01899053|523985354|FG003|Overall Study|Adverse Event|3|||
145310976|NCT01899053|523985355|FG004|Overall Study|Adverse Event|1|||
145310977|NCT01899053|523985356|FG005|Overall Study|Adverse Event|1|||
145310978|NCT01899053|523985357|FG006|Overall Study|Adverse Event|1|||
145310979|NCT01899053|523985358|FG007|Overall Study|Adverse Event|0|||
145310980|NCT01899053|523985359|FG008|Overall Study|Adverse Event|2|||
145310981|NCT01899053|523985360|FG009|Overall Study|Adverse Event|0|||
145310982|NCT01899053|523985361|FG010|Overall Study|Adverse Event|3|||
145310983|NCT01899053|523985362|FG011|Overall Study|Adverse Event|1|||
145310984|NCT01899053|523985363|FG012|Overall Study|Adverse Event|2|||
145310985|NCT01899053|523985364|FG013|Overall Study|Adverse Event|2|||
145310986|NCT01899053|523985351|FG000|Overall Study|Reason Not Specified|0|||
145310987|NCT01899053|523985352|FG001|Overall Study|Reason Not Specified|0|||
145310988|NCT01899053|523985353|FG002|Overall Study|Reason Not Specified|0|||
145310989|NCT01899053|523985354|FG003|Overall Study|Reason Not Specified|0|||
145310990|NCT01899053|523985355|FG004|Overall Study|Reason Not Specified|0|||
145310991|NCT01899053|523985356|FG005|Overall Study|Reason Not Specified|0|||
145310992|NCT01899053|523985357|FG006|Overall Study|Reason Not Specified|1|||
145310993|NCT01899053|523985358|FG007|Overall Study|Reason Not Specified|0|||
145310994|NCT01899053|523985359|FG008|Overall Study|Reason Not Specified|0|||
145310995|NCT01899053|523985360|FG009|Overall Study|Reason Not Specified|0|||
145310996|NCT01899053|523985361|FG010|Overall Study|Reason Not Specified|0|||
145310997|NCT01899053|523985362|FG011|Overall Study|Reason Not Specified|0|||
145310998|NCT01899053|523985363|FG012|Overall Study|Reason Not Specified|1|||
145310999|NCT01899053|523985364|FG013|Overall Study|Reason Not Specified|0|||
145311000|NCT01899053|523985351|FG000|Overall Study|Withdrawal by Subject|1|||
145311001|NCT01899053|523985352|FG001|Overall Study|Withdrawal by Subject|1|||
145311002|NCT01899053|523985353|FG002|Overall Study|Withdrawal by Subject|2|||
145311003|NCT01899053|523985354|FG003|Overall Study|Withdrawal by Subject|0|||
145311004|NCT01899053|523985355|FG004|Overall Study|Withdrawal by Subject|2|||
145311005|NCT01899053|523985356|FG005|Overall Study|Withdrawal by Subject|0|||
145311006|NCT01899053|523985357|FG006|Overall Study|Withdrawal by Subject|0|||
145311007|NCT01899053|523985358|FG007|Overall Study|Withdrawal by Subject|1|||
145311008|NCT01899053|523985359|FG008|Overall Study|Withdrawal by Subject|0|||
145311009|NCT01899053|523985360|FG009|Overall Study|Withdrawal by Subject|0|||
145311010|NCT01899053|523985361|FG010|Overall Study|Withdrawal by Subject|0|||
145311011|NCT01899053|523985362|FG011|Overall Study|Withdrawal by Subject|0|||
145311012|NCT01899053|523985363|FG012|Overall Study|Withdrawal by Subject|1|||
145311013|NCT01899053|523985364|FG013|Overall Study|Withdrawal by Subject|1|||
145311014|NCT01899053|523985351|FG000|Overall Study|Protocol Violation|0|||
145311015|NCT01899053|523985352|FG001|Overall Study|Protocol Violation|0|||
145311016|NCT01899053|523985353|FG002|Overall Study|Protocol Violation|1|||
145311017|NCT01899053|523985354|FG003|Overall Study|Protocol Violation|0|||
145311018|NCT01899053|523985355|FG004|Overall Study|Protocol Violation|0|||
145311019|NCT01899053|523985356|FG005|Overall Study|Protocol Violation|0|||
145311020|NCT01899053|523985357|FG006|Overall Study|Protocol Violation|0|||
145311021|NCT01899053|523985358|FG007|Overall Study|Protocol Violation|0|||
145311022|NCT01899053|523985359|FG008|Overall Study|Protocol Violation|0|||
145311023|NCT01899053|523985360|FG009|Overall Study|Protocol Violation|0|||
145311024|NCT01899053|523985361|FG010|Overall Study|Protocol Violation|0|||
145311025|NCT01899053|523985362|FG011|Overall Study|Protocol Violation|0|||
145311026|NCT01899053|523985363|FG012|Overall Study|Protocol Violation|0|||
145311027|NCT01899053|523985364|FG013|Overall Study|Protocol Violation|0|||
145311028|NCT01899053|523985351|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
145311029|NCT01899053|523985352|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
145311030|NCT01899053|523985353|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311031|NCT01899053|523985354|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311032|NCT01899053|523985355|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311033|NCT01899053|523985356|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311034|NCT01899053|523985357|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311035|NCT01899053|523985358|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311036|NCT01899053|523985359|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
145569270|NCT03400332|524944212|FG000|Treatment|Other reasons|0|||
145311037|NCT01899053|523985360|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311038|NCT01899053|523985361|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
145311039|NCT01899053|523985362|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311040|NCT01899053|523985363|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311041|NCT01899053|523985364|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
145311042|NCT01899053|523985351|FG000|Overall Study|Symptomatic Deterioration|0|||
145311043|NCT01899053|523985352|FG001|Overall Study|Symptomatic Deterioration|0|||
145311044|NCT01899053|523985353|FG002|Overall Study|Symptomatic Deterioration|0|||
145311045|NCT01899053|523985354|FG003|Overall Study|Symptomatic Deterioration|0|||
145311046|NCT01899053|523985355|FG004|Overall Study|Symptomatic Deterioration|0|||
145311047|NCT01899053|523985356|FG005|Overall Study|Symptomatic Deterioration|1|||
145311048|NCT01899053|523985357|FG006|Overall Study|Symptomatic Deterioration|0|||
145311049|NCT01899053|523985358|FG007|Overall Study|Symptomatic Deterioration|1|||
145311050|NCT01899053|523985359|FG008|Overall Study|Symptomatic Deterioration|0|||
145311051|NCT01899053|523985360|FG009|Overall Study|Symptomatic Deterioration|0|||
145311052|NCT01899053|523985361|FG010|Overall Study|Symptomatic Deterioration|0|||
145311053|NCT01899053|523985362|FG011|Overall Study|Symptomatic Deterioration|1|||
145311054|NCT01899053|523985363|FG012|Overall Study|Symptomatic Deterioration|2|||
145311055|NCT01899053|523985364|FG013|Overall Study|Symptomatic Deterioration|0|||
145311056|NCT03105297|523985365|FG000|Baseline Phase (Day 1)|Other|21|||
145311057|NCT03105297|523985365|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
145311058|NCT03105297|523985365|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
145311059|NCT00227370|523985367|FG000|Overall Study|Withdrawal by Subject|1|||
145311060|NCT00227370|523985368|FG001|Overall Study|Withdrawal by Subject|2|||
145311061|NCT00227370|523985367|FG000|Overall Study|Death|3|||
145311062|NCT00227370|523985368|FG001|Overall Study|Death|4|||
145311063|NCT00227370|523985367|FG000|Overall Study|Adverse Event|6|||
145311064|NCT00227370|523985368|FG001|Overall Study|Adverse Event|11|||
145311065|NCT00227370|523985367|FG000|Overall Study|Physician Decision|9|||
145311066|NCT00227370|523985368|FG001|Overall Study|Physician Decision|6|||
145311067|NCT00227370|523985367|FG000|Overall Study|Other reasons|2|||
145311068|NCT00227370|523985368|FG001|Overall Study|Other reasons|1|||
145311069|NCT03846193|523985369|FG000|Overall Study|Physician Decision|0|||
145311070|NCT03846193|523985370|FG001|Overall Study|Physician Decision|0|||
145311071|NCT03846193|523985371|FG002|Overall Study|Physician Decision|1|||
145311072|NCT03846193|523985372|FG003|Overall Study|Physician Decision|0|||
145311073|NCT03846193|523985373|FG004|Overall Study|Physician Decision|0|||
145311074|NCT03846193|523985369|FG000|Overall Study|Lost to Follow-up|0|||
145311075|NCT03846193|523985370|FG001|Overall Study|Lost to Follow-up|0|||
145311076|NCT03846193|523985371|FG002|Overall Study|Lost to Follow-up|0|||
145311077|NCT03846193|523985372|FG003|Overall Study|Lost to Follow-up|0|||
145311078|NCT03846193|523985373|FG004|Overall Study|Lost to Follow-up|1|||
145311079|NCT03846193|523985369|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
145311080|NCT03846193|523985370|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
145311081|NCT03846193|523985371|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
145311082|NCT03846193|523985372|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
145311083|NCT03846193|523985373|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
145311084|NCT01401062|523985375|FG000|Overall Study|Death|9|||
145311085|NCT01401062|523985376|FG001|Overall Study|Death|7|||
145311086|NCT01401062|523985375|FG000|Overall Study|Physician Decision|1|||
145311087|NCT01401062|523985376|FG001|Overall Study|Physician Decision|0|||
145311088|NCT01401062|523985375|FG000|Overall Study|Withdrawal by Subject|1|||
145311089|NCT01401062|523985376|FG001|Overall Study|Withdrawal by Subject|1|||
145411160|NCT01121926|524358786|FG000|Washout Period|Positive pregnancy test|0|||
145411161|NCT01121926|524358787|FG001|Washout Period|Positive pregnancy test|1|||
145411162|NCT03439514|524358798|FG000|Double-Blind Treatment Period|Other|4|||
145411163|NCT03439514|524358799|FG001|Double-Blind Treatment Period|Other|1|||
145411164|NCT03439514|524358798|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
145411165|NCT03439514|524358799|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145411166|NCT03439514|524358798|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
145411167|NCT03439514|524358799|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
145411168|NCT03439514|524358798|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
145411169|NCT03439514|524358799|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
145311090|NCT01131260|523985379|FG000|Overall Study|Randomization error|5|||
145311091|NCT01131260|523985380|FG001|Overall Study|Randomization error|1|||
145311092|NCT01131260|523985379|FG000|Overall Study|Declined to continue participation|8|||
145311093|NCT01131260|523985380|FG001|Overall Study|Declined to continue participation|13|||
145311094|NCT01131260|523985379|FG000|Overall Study|Physician Decision|22|||
145311095|NCT01131260|523985380|FG001|Overall Study|Physician Decision|24|||
145311096|NCT01131260|523985379|FG000|Overall Study|Technical problems|7|||
145311097|NCT01131260|523985380|FG001|Overall Study|Technical problems|6|||
145311098|NCT01131260|523985379|FG000|Overall Study|Staff error|2|||
145311099|NCT01131260|523985380|FG001|Overall Study|Staff error|1|||
145311100|NCT01131260|523985379|FG000|Overall Study|Ineligible|0|||
145311101|NCT01131260|523985380|FG001|Overall Study|Ineligible|2|||
145311102|NCT03684928|523985384|FG000|First Intervention|Lost to Follow-up|0|||
145311103|NCT03684928|523985385|FG001|First Intervention|Lost to Follow-up|1|||
145311104|NCT03684928|523985384|FG000|First Intervention|Withdrawal by Subject|0|||
145311105|NCT03684928|523985385|FG001|First Intervention|Withdrawal by Subject|2|||
145311106|NCT03684928|523985384|FG000|Second Intervention|Soft Tissue Injury|1|||
145311107|NCT03684928|523985385|FG001|Second Intervention|Soft Tissue Injury|0|||
145311108|NCT01018862|523985395|FG000|Overall Study|Adverse Event|2|||
145311109|NCT01018862|523985396|FG001|Overall Study|Adverse Event|0|||
145311110|NCT01018862|523985397|FG002|Overall Study|Adverse Event|6|||
145311111|NCT01018862|523985395|FG000|Overall Study|Lack of Efficacy|1|||
145311112|NCT01018862|523985396|FG001|Overall Study|Lack of Efficacy|0|||
145311113|NCT01018862|523985397|FG002|Overall Study|Lack of Efficacy|2|||
145311114|NCT01018862|523985395|FG000|Overall Study|Lost to Follow-up|3|||
145311115|NCT01018862|523985396|FG001|Overall Study|Lost to Follow-up|1|||
145311116|NCT01018862|523985397|FG002|Overall Study|Lost to Follow-up|0|||
145311117|NCT01018862|523985395|FG000|Overall Study|Protocol Violation|1|||
145311118|NCT01018862|523985396|FG001|Overall Study|Protocol Violation|3|||
145311119|NCT01018862|523985397|FG002|Overall Study|Protocol Violation|3|||
145311120|NCT01018862|523985395|FG000|Overall Study|Withdrawal by Subject|1|||
145311121|NCT01018862|523985396|FG001|Overall Study|Withdrawal by Subject|2|||
145311122|NCT01018862|523985397|FG002|Overall Study|Withdrawal by Subject|1|||
145311123|NCT01018862|523985395|FG000|Overall Study|administrative problems|5|||
145311124|NCT01018862|523985396|FG001|Overall Study|administrative problems|4|||
145311125|NCT01018862|523985397|FG002|Overall Study|administrative problems|4|||
145311126|NCT01968031|523985401|FG000|Overall Study|Adverse Event|13|||
145311127|NCT01968031|523985402|FG001|Overall Study|Adverse Event|10|||
145311128|NCT01968031|523985403|FG002|Overall Study|Adverse Event|22|||
145311129|NCT01968031|523985401|FG000|Overall Study|Withdrawal by Subject|3|||
145311130|NCT01968031|523985402|FG001|Overall Study|Withdrawal by Subject|7|||
145311131|NCT01968031|523985403|FG002|Overall Study|Withdrawal by Subject|3|||
145311132|NCT01968031|523985401|FG000|Overall Study|Did not meet entry criteria|1|||
145311133|NCT01968031|523985402|FG001|Overall Study|Did not meet entry criteria|1|||
145311134|NCT01968031|523985403|FG002|Overall Study|Did not meet entry criteria|1|||
145311135|NCT01968031|523985401|FG000|Overall Study|Noncompliance|0|||
145311136|NCT01968031|523985402|FG001|Overall Study|Noncompliance|0|||
145311137|NCT01968031|523985403|FG002|Overall Study|Noncompliance|2|||
145311138|NCT01968031|523985401|FG000|Overall Study|Failed inclusion criteria|0|||
145311139|NCT01968031|523985402|FG001|Overall Study|Failed inclusion criteria|2|||
145311140|NCT01968031|523985403|FG002|Overall Study|Failed inclusion criteria|0|||
145311141|NCT01968031|523985401|FG000|Overall Study|Death|0|||
145311142|NCT01968031|523985402|FG001|Overall Study|Death|0|||
145311143|NCT01968031|523985403|FG002|Overall Study|Death|1|||
145311144|NCT01968031|523985401|FG000|Overall Study|Prohibited concomitant medication|1|||
145311145|NCT01968031|523985402|FG001|Overall Study|Prohibited concomitant medication|0|||
145311146|NCT01968031|523985403|FG002|Overall Study|Prohibited concomitant medication|0|||
145311147|NCT01891357|523985404|FG000|Overall Study|Protocol Violation|3|||
145311148|NCT00840879|523985405|FG000|Second Intervention|Withdrawal by Subject|1|||
145311149|NCT00840879|523985406|FG001|Second Intervention|Withdrawal by Subject|0|||
145311150|NCT00874276|523985407|FG000|Overall Study|Withdrawal by Subject|1|||
145311151|NCT00874276|523985408|FG001|Overall Study|Withdrawal by Subject|1|||
145311152|NCT03733145|523985409|FG000|Overall Study|screenfail|3|||
145311153|NCT03733145|523985410|FG001|Overall Study|screenfail|3|||
145311154|NCT03733145|523985411|FG002|Overall Study|screenfail|2|||
145311155|NCT02485158|523987121|FG000|Overall Study|Withdrawal by Subject|3|||
145311156|NCT02485158|523987121|FG000|Overall Study|expected drug side effect|1|||
145311157|NCT01098851|523987122|FG000|Overall Study|Equipment failure|1|||
145311158|NCT01098851|523987123|FG001|Overall Study|Equipment failure|0|||
145311159|NCT03087786|523987124|FG000|Overall Study|Withdrawal by Subject|2|||
145311160|NCT03087786|523987125|FG001|Overall Study|Withdrawal by Subject|0|||
145311161|NCT00516295|523987126|FG000|Overall Study|Lack of Efficacy|2|||
145311162|NCT00516295|523987127|FG001|Overall Study|Lack of Efficacy|0|||
145311163|NCT00516295|523987128|FG002|Overall Study|Lack of Efficacy|0|||
145311164|NCT00516295|523987126|FG000|Overall Study|Ineligible|1|||
145311165|NCT00516295|523987127|FG001|Overall Study|Ineligible|0|||
145311166|NCT00516295|523987128|FG002|Overall Study|Ineligible|0|||
145311167|NCT02034513|523987129|FG000|Overall Study|Adverse Event|11|||
145311168|NCT02034513|523987130|FG001|Overall Study|Adverse Event|10|||
145311169|NCT02034513|523987129|FG000|Overall Study|Lack of Efficacy|0|||
145311170|NCT02034513|523987130|FG001|Overall Study|Lack of Efficacy|1|||
145311171|NCT02034513|523987129|FG000|Overall Study|Lost to Follow-up|6|||
145311172|NCT02034513|523987130|FG001|Overall Study|Lost to Follow-up|7|||
145311173|NCT02034513|523987129|FG000|Overall Study|Pregnancy|0|||
145311174|NCT02034513|523987130|FG001|Overall Study|Pregnancy|3|||
145311175|NCT02034513|523987129|FG000|Overall Study|Protocol Violation|7|||
145311176|NCT02034513|523987130|FG001|Overall Study|Protocol Violation|10|||
145311177|NCT02034513|523987129|FG000|Overall Study|Withdrawal by Subject|25|||
145311178|NCT02034513|523987130|FG001|Overall Study|Withdrawal by Subject|25|||
145311179|NCT02034513|523987129|FG000|Overall Study|Unclassified|0|||
145311180|NCT02034513|523987130|FG001|Overall Study|Unclassified|1|||
145311181|NCT04661202|523987131|FG000|Overall Study|Withdrawal by Subject|1|||
145311182|NCT04661202|523987132|FG001|Overall Study|Withdrawal by Subject|1|||
145311183|NCT04661202|523987131|FG000|Overall Study|Lack of Efficacy|2|||
145311184|NCT04661202|523987132|FG001|Overall Study|Lack of Efficacy|0|||
145311185|NCT02578641|523987133|FG000|Overall Study|Adverse Event|5|||
145311186|NCT02578641|523987134|FG001|Overall Study|Adverse Event|15|||
145311187|NCT02578641|523987133|FG000|Overall Study|Death|16|||
145311188|NCT02578641|523987134|FG001|Overall Study|Death|8|||
145311189|NCT02578641|523987133|FG000|Overall Study|Lost to Follow-up|0|||
145311190|NCT02578641|523987134|FG001|Overall Study|Lost to Follow-up|1|||
145311191|NCT02578641|523987133|FG000|Overall Study|Withdrawal by Subject|14|||
145311192|NCT02578641|523987134|FG001|Overall Study|Withdrawal by Subject|7|||
145311193|NCT02578641|523987133|FG000|Overall Study|Progressive Disease|69|||
145311194|NCT02578641|523987134|FG001|Overall Study|Progressive Disease|21|||
145311195|NCT02578641|523987133|FG000|Overall Study|No Study Drug|2|||
145311196|NCT02578641|523987134|FG001|Overall Study|No Study Drug|0|||
145311197|NCT02578641|523987133|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
145311198|NCT02578641|523987134|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
145311199|NCT02578641|523987133|FG000|Overall Study|Non-compliance with Study Schedule|1|||
145311200|NCT02578641|523987134|FG001|Overall Study|Non-compliance with Study Schedule|0|||
145311201|NCT02578641|523987133|FG000|Overall Study|Other|1|||
145311202|NCT02578641|523987134|FG001|Overall Study|Other|10|||
145311203|NCT02578641|523987133|FG000|Overall Study|Not treated|1|||
145311204|NCT02578641|523987134|FG001|Overall Study|Not treated|4|||
145311205|NCT02313558|523987136|FG000|Overall Study|Withdrawal by Subject|2|||
145311206|NCT02313558|523987137|FG001|Overall Study|Withdrawal by Subject|0|||
145311207|NCT02313558|523987136|FG000|Overall Study|Lost to Follow-up|4|||
145311208|NCT02313558|523987137|FG001|Overall Study|Lost to Follow-up|4|||
145311209|NCT02694536|523987145|FG000|Overall Study|Progressive Disease|40|||
145311210|NCT02694536|523987145|FG000|Overall Study|Lost to Follow-up|1|||
145311211|NCT02694536|523987145|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
145311212|NCT02694536|523987145|FG000|Overall Study|Withdrawal by Subject|8|||
145311213|NCT02694536|523987145|FG000|Overall Study|Death|8|||
145311214|NCT02694536|523987145|FG000|Overall Study|Other|22|||
145311215|NCT01911429|523987146|FG000|Overall Study|Adverse Event|5|||
145311216|NCT01911429|523987147|FG001|Overall Study|Adverse Event|3|||
145311217|NCT01911429|523987148|FG002|Overall Study|Adverse Event|9|||
145311218|NCT01911429|523987146|FG000|Overall Study|Lack of Efficacy|1|||
145311219|NCT01911429|523987147|FG001|Overall Study|Lack of Efficacy|2|||
145311220|NCT01911429|523987148|FG002|Overall Study|Lack of Efficacy|4|||
145311221|NCT01911429|523987146|FG000|Overall Study|Lost to Follow-up|0|||
145311222|NCT01911429|523987147|FG001|Overall Study|Lost to Follow-up|0|||
145311223|NCT01911429|523987148|FG002|Overall Study|Lost to Follow-up|1|||
145311224|NCT01911429|523987146|FG000|Overall Study|Protocol Violation|0|||
145311225|NCT01911429|523987147|FG001|Overall Study|Protocol Violation|0|||
145311226|NCT01911429|523987148|FG002|Overall Study|Protocol Violation|1|||
145311227|NCT01911429|523987146|FG000|Overall Study|Withdrawal by Subject|5|||
145311228|NCT01911429|523987147|FG001|Overall Study|Withdrawal by Subject|5|||
145311229|NCT01911429|523987148|FG002|Overall Study|Withdrawal by Subject|4|||
145311230|NCT01911429|523987146|FG000|Overall Study|Accidental randomization|0|||
145311231|NCT01911429|523987147|FG001|Overall Study|Accidental randomization|0|||
145311232|NCT01911429|523987148|FG002|Overall Study|Accidental randomization|1|||
145311233|NCT01911429|523987146|FG000|Overall Study|subject left study|1|||
145311234|NCT01911429|523987147|FG001|Overall Study|subject left study|0|||
145311235|NCT01911429|523987148|FG002|Overall Study|subject left study|0|||
145311236|NCT03540160|523987149|FG000|Overall Study|Protocol Violation|1|||
145311237|NCT03540160|523987149|FG000|Overall Study|Physician Decision|8|||
145311238|NCT03540160|523987149|FG000|Overall Study|Lack of Efficacy|60|||
145311239|NCT03540160|523987149|FG000|Overall Study|Pregnancy|1|||
145311240|NCT03540160|523987149|FG000|Overall Study|Adverse Event|20|||
145311241|NCT03540160|523987149|FG000|Overall Study|Withdrawal by Subject|68|||
145620358|NCT01778062|525123757|FG001|Overall Study|Adverse Event|3|||
145620359|NCT01778062|525123756|FG000|Overall Study|Consent Withdrawal|1|||
145620360|NCT01778062|525123757|FG001|Overall Study|Consent Withdrawal|5|||
145620361|NCT01778062|525123756|FG000|Overall Study|major protocol deviation|4|||
145620362|NCT01778062|525123757|FG001|Overall Study|major protocol deviation|3|||
145311242|NCT03540160|523987149|FG000|Overall Study|COVID-19|2|||
145311243|NCT03540160|523987149|FG000|Overall Study|Study Closure|10|||
145311244|NCT03540160|523987149|FG000|Overall Study|Lost to Follow-up|18|||
145311245|NCT03540160|523987149|FG000|Overall Study|Sponsor decision|191|||
145311246|NCT03707587|523987156|FG000|Overall Study|Death|0|||
145311247|NCT03707587|523987157|FG001|Overall Study|Death|1|||
145311248|NCT00834444|523987158|FG000|First Intervention|Adverse Event|1|||
145311249|NCT00834444|523987159|FG001|First Intervention|Adverse Event|0|||
145311250|NCT00834444|523987158|FG000|First Intervention|Intolerance to Venopuncture|0|||
145311251|NCT00834444|523987159|FG001|First Intervention|Intolerance to Venopuncture|1|||
145311252|NCT00834444|523987158|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
145311253|NCT00834444|523987159|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
145311254|NCT00834444|523987158|FG000|Second Intervention|Adverse Event|1|||
145311255|NCT00834444|523987159|FG001|Second Intervention|Adverse Event|0|||
145311256|NCT00731939|523987160|FG000|Overall Study|Adverse Event|6|||
145311257|NCT00731939|523987160|FG000|Overall Study|Lost to Follow-up|15|||
145311258|NCT00731939|523987160|FG000|Overall Study|Not implanted with study device|9|||
145311259|NCT00731939|523987160|FG000|Overall Study|Withdrawal by Subject|2|||
145311260|NCT00731939|523987160|FG000|Overall Study|Did not meet enrollment criteria|2|||
145311261|NCT02704091|523987161|FG000|Overall Study|Adverse Event|4|||
145311262|NCT02704091|523987162|FG001|Overall Study|Adverse Event|3|||
145311263|NCT02704091|523987161|FG000|Overall Study|Protocol Violation|5|||
145311264|NCT02704091|523987162|FG001|Overall Study|Protocol Violation|3|||
145311265|NCT02704091|523987161|FG000|Overall Study|Consent withdrawn|4|||
145311266|NCT02704091|523987162|FG001|Overall Study|Consent withdrawn|4|||
145311267|NCT02704091|523987161|FG000|Overall Study|Lost to Follow-up|13|||
145311268|NCT02704091|523987162|FG001|Overall Study|Lost to Follow-up|5|||
145311269|NCT02704091|523987161|FG000|Overall Study|Other|2|||
145311270|NCT02704091|523987162|FG001|Overall Study|Other|8|||
145311271|NCT01634139|523987163|FG000|Overall Study|Non compliant with protocol|1|||
145311272|NCT01634139|523987164|FG001|Overall Study|Non compliant with protocol|0|||
145311273|NCT01634139|523987165|FG002|Overall Study|Non compliant with protocol|0|||
145311274|NCT01634139|523987163|FG000|Overall Study|Consent withdrawn not due to AE|4|||
145311275|NCT01634139|523987164|FG001|Overall Study|Consent withdrawn not due to AE|3|||
145311276|NCT01634139|523987165|FG002|Overall Study|Consent withdrawn not due to AE|2|||
145311277|NCT01634139|523987163|FG000|Overall Study|Other|4|||
145311278|NCT01634139|523987164|FG001|Overall Study|Other|0|||
145311279|NCT01634139|523987165|FG002|Overall Study|Other|3|||
145311280|NCT01634139|523987163|FG000|Overall Study|Lost to Follow-up|0|||
145311281|NCT01634139|523987164|FG001|Overall Study|Lost to Follow-up|2|||
145311282|NCT01634139|523987165|FG002|Overall Study|Lost to Follow-up|0|||
145311283|NCT01634139|523987163|FG000|Overall Study|Not treated|1|||
145311284|NCT01634139|523987164|FG001|Overall Study|Not treated|1|||
145311285|NCT01634139|523987165|FG002|Overall Study|Not treated|0|||
145311286|NCT00425308|523987166|FG000|Overall Study|Adverse Event|2|||
145311287|NCT00425308|523987167|FG001|Overall Study|Adverse Event|1|||
145311288|NCT00425308|523987166|FG000|Overall Study|Withdrawal by Subject|1|||
145311289|NCT00425308|523987167|FG001|Overall Study|Withdrawal by Subject|0|||
145311290|NCT00425308|523987166|FG000|Overall Study|Death|1|||
145311291|NCT00425308|523987167|FG001|Overall Study|Death|0|||
145311292|NCT01266902|523987171|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
145311293|NCT01266902|523987172|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
145311294|NCT01266902|523987173|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
145311295|NCT01266902|523987171|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
145311296|NCT01266902|523987172|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
145311297|NCT01266902|523987173|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
145311298|NCT01266902|523987171|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
145311299|NCT01266902|523987172|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
145311300|NCT01266902|523987173|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
145311301|NCT01266902|523987171|FG000|Period 1 (Main Study)|Adverse Event|3|||
145311302|NCT01266902|523987172|FG001|Period 1 (Main Study)|Adverse Event|11|||
145311303|NCT01266902|523987173|FG002|Period 1 (Main Study)|Adverse Event|0|||
145311304|NCT01266902|523987171|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
145311305|NCT01266902|523987172|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
145311306|NCT01266902|523987173|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
145311307|NCT01266902|523987171|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
145569271|NCT03400332|524944213|FG001|Treatment|Other reasons|1|||
145569272|NCT03400332|524944214|FG002|Treatment|Other reasons|1|||
145569273|NCT03400332|524944215|FG003|Treatment|Other reasons|0|||
145569274|NCT03400332|524944216|FG004|Treatment|Other reasons|3|||
145569275|NCT03400332|524944217|FG005|Treatment|Other reasons|1|||
145569276|NCT03400332|524944218|FG006|Treatment|Other reasons|2|||
145569277|NCT03400332|524944219|FG007|Treatment|Other reasons|0|||
145569278|NCT03400332|524944220|FG008|Treatment|Other reasons|1|||
145569279|NCT03400332|524944212|FG000|Treatment|Lost to Follow-up|0|||
145569280|NCT03400332|524944213|FG001|Treatment|Lost to Follow-up|1|||
145569281|NCT03400332|524944214|FG002|Treatment|Lost to Follow-up|0|||
145311308|NCT01266902|523987172|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
145311309|NCT01266902|523987173|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
145311310|NCT01266902|523987171|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
145311311|NCT01266902|523987172|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
145311312|NCT01266902|523987173|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
145311313|NCT01266902|523987171|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
145311314|NCT01266902|523987172|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
145311315|NCT01266902|523987173|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
145311316|NCT01266902|523987171|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
145569282|NCT03400332|524944215|FG003|Treatment|Lost to Follow-up|0|||
145569283|NCT03400332|524944216|FG004|Treatment|Lost to Follow-up|0|||
145569284|NCT03400332|524944217|FG005|Treatment|Lost to Follow-up|0|||
145569285|NCT03400332|524944218|FG006|Treatment|Lost to Follow-up|0|||
145311317|NCT01266902|523987172|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
145311318|NCT01266902|523987173|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
145311319|NCT01266902|523987171|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
145311320|NCT01266902|523987172|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
145311321|NCT01266902|523987173|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
145311322|NCT05562011|523987174|FG000|Overall Study|Withdrawal by Subject|3|||
145311323|NCT05562011|523987174|FG000|Overall Study|Lost to Follow-up|1|||
145311324|NCT05562011|523987174|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
145311325|NCT05562011|523987174|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
145311326|NCT05562011|523987174|FG000|Overall Study|Device malfunction|13|||
145311327|NCT04567329|523987177|FG000|Overall Study|Withdrawal by Subject|5|||
145311328|NCT04567329|523987178|FG001|Overall Study|Withdrawal by Subject|6|||
145311329|NCT04567329|523987177|FG000|Overall Study|Protocol Violation|2|||
145311330|NCT04567329|523987178|FG001|Overall Study|Protocol Violation|3|||
145311331|NCT04567329|523987177|FG000|Overall Study|Discontinued|2|||
145311332|NCT04567329|523987178|FG001|Overall Study|Discontinued|2|||
145311333|NCT04567329|523987177|FG000|Overall Study|Lost to Follow-up|0|||
145311334|NCT04567329|523987178|FG001|Overall Study|Lost to Follow-up|1|||
145311335|NCT04567329|523987177|FG000|Overall Study|Lack of Efficacy|0|||
145311336|NCT04567329|523987178|FG001|Overall Study|Lack of Efficacy|1|||
145311337|NCT04411680|523987181|FG000|Treatment Period|Adverse Event|3|||
145311338|NCT04411680|523987182|FG001|Treatment Period|Adverse Event|0|||
145311339|NCT04411680|523987181|FG000|Treatment Period|Discharged from hospital|18|||
145311340|NCT04411680|523987182|FG001|Treatment Period|Discharged from hospital|7|||
145311341|NCT04411680|523987181|FG000|Treatment Period|Missed 1 or more doses|8|||
145311342|NCT04411680|523987182|FG001|Treatment Period|Missed 1 or more doses|0|||
145311343|NCT04411680|523987181|FG000|Treatment Period|Transferred to another hospital|0|||
145311344|NCT04411680|523987182|FG001|Treatment Period|Transferred to another hospital|1|||
145311345|NCT04411680|523987181|FG000|Follow up Period|Withdrawal by Subject|2|||
145311346|NCT04411680|523987182|FG001|Follow up Period|Withdrawal by Subject|0|||
145311347|NCT04411680|523987181|FG000|Follow up Period|Lost to Follow-up|5|||
145311348|NCT04411680|523987182|FG001|Follow up Period|Lost to Follow-up|6|||
145311349|NCT04411680|523987181|FG000|Follow up Period|Death|11|||
145311350|NCT04411680|523987182|FG001|Follow up Period|Death|8|||
145311351|NCT00841659|523987183|FG000|Washout: 2 Weeks|Protocol Violation|1|||
145311352|NCT00841659|523987184|FG001|Washout: 2 Weeks|Protocol Violation|0|||
145311353|NCT02420353|523987193|FG000|Overall Study|Withdrawal by Subject|0|||
145311354|NCT02420353|523987194|FG001|Overall Study|Withdrawal by Subject|1|||
145311355|NCT01149057|523987195|FG000|Overall Study|Lack of Efficacy|16|||
145311356|NCT01149057|523987195|FG000|Overall Study|Adverse Event|13|||
145311357|NCT01149057|523987195|FG000|Overall Study|Withdrawal by Subject|9|||
145311358|NCT01149057|523987195|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
145311359|NCT01149057|523987195|FG000|Overall Study|B Cell Depletion|4|||
145311360|NCT01149057|523987195|FG000|Overall Study|Participant Non-Compliance|2|||
145311361|NCT01149057|523987195|FG000|Overall Study|Lost to Follow-up|1|||
145311362|NCT01149057|523987195|FG000|Overall Study|High Parathyroid Hormone Value|1|||
145311363|NCT01149057|523987195|FG000|Overall Study|Other|6|||
145311364|NCT04608448|523987196|FG000|Overall Study|Withdrawal by Subject|1|||
145311365|NCT04608448|523987196|FG000|Overall Study|Adverse Event|1|||
145311366|NCT02436200|523987212|FG000|Overall Study|Significant outlier|1|||
145311367|NCT00672984|523987213|FG000|First Intervention|Adverse Event|5|||
145311368|NCT00672984|523987214|FG001|First Intervention|Adverse Event|0|||
145311369|NCT00672984|523987215|FG002|First Intervention|Adverse Event|0|||
145311370|NCT00672984|523987213|FG000|First Intervention|Withdrawal by Subject|1|||
145311371|NCT00672984|523987214|FG001|First Intervention|Withdrawal by Subject|2|||
145311372|NCT00672984|523987215|FG002|First Intervention|Withdrawal by Subject|2|||
145311373|NCT00672984|523987213|FG000|First Intervention|Sponsor decision|3|||
145311374|NCT00672984|523987214|FG001|First Intervention|Sponsor decision|0|||
145311375|NCT00672984|523987215|FG002|First Intervention|Sponsor decision|0|||
145311376|NCT00672984|523987213|FG000|Second Intervention|Non-compliance with facility policies|0|||
145311377|NCT00672984|523987214|FG001|Second Intervention|Non-compliance with facility policies|2|||
145311378|NCT00672984|523987215|FG002|Second Intervention|Non-compliance with facility policies|0|||
145311379|NCT00672984|523987213|FG000|Second Intervention|Withdrawal by Subject|0|||
145311380|NCT00672984|523987214|FG001|Second Intervention|Withdrawal by Subject|3|||
145311381|NCT00672984|523987215|FG002|Second Intervention|Withdrawal by Subject|0|||
145311382|NCT00672984|523987213|FG000|Second Intervention|Protocol Violation|0|||
145311383|NCT00672984|523987214|FG001|Second Intervention|Protocol Violation|1|||
145311384|NCT00672984|523987215|FG002|Second Intervention|Protocol Violation|1|||
145311385|NCT00672984|523987213|FG000|Third Intervention|Adverse Event|1|||
145311386|NCT00672984|523987214|FG001|Third Intervention|Adverse Event|0|||
145311387|NCT00672984|523987215|FG002|Third Intervention|Adverse Event|1|||
145311388|NCT01968551|523987216|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
145311389|NCT01968551|523987217|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
145311390|NCT01968551|523987218|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
145311391|NCT01968551|523987216|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
145311392|NCT01968551|523987217|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
145311393|NCT01968551|523987218|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
145311394|NCT01968551|523987216|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
145311395|NCT01968551|523987217|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
145311396|NCT01968551|523987218|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
145311397|NCT01968551|523987216|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
145311398|NCT01968551|523987217|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
145311399|NCT01968551|523987218|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
145311400|NCT01968551|523987216|FG000|Extension Phase|Adverse Event|0|||
145311401|NCT01968551|523987217|FG001|Extension Phase|Adverse Event|0|||
145311402|NCT01968551|523987218|FG002|Extension Phase|Adverse Event|2|||
145311403|NCT01968551|523987216|FG000|Extension Phase|Death|0|||
145311404|NCT01968551|523987217|FG001|Extension Phase|Death|1|||
145311405|NCT01968551|523987218|FG002|Extension Phase|Death|0|||
145311406|NCT01968551|523987216|FG000|Extension Phase|Withdrew Consent|0|||
145311407|NCT01968551|523987217|FG001|Extension Phase|Withdrew Consent|0|||
145311408|NCT01968551|523987218|FG002|Extension Phase|Withdrew Consent|1|||
145311409|NCT01968551|523987216|FG000|Extension Phase|Lost to Follow-up|1|||
145311410|NCT01968551|523987217|FG001|Extension Phase|Lost to Follow-up|0|||
145311411|NCT01968551|523987218|FG002|Extension Phase|Lost to Follow-up|1|||
145311412|NCT00406393|523987219|FG000|Overall Study|Did not undergo transplantation|2|||
145311413|NCT00406393|523987220|FG001|Overall Study|Did not undergo transplantation|1|||
145311414|NCT04060251|523987221|FG000|Overall Study|Study terminated due to low enrollment.|7|||
145311415|NCT04060251|523987222|FG001|Overall Study|Study terminated due to low enrollment.|5|||
145311416|NCT04060251|523987223|FG002|Overall Study|Study terminated due to low enrollment.|7|||
145311417|NCT04060251|523987221|FG000|Overall Study|Adverse Event|1|||
145311418|NCT04060251|523987222|FG001|Overall Study|Adverse Event|1|||
145311419|NCT04060251|523987223|FG002|Overall Study|Adverse Event|0|||
145311420|NCT02705716|523987224|FG000|Overall Study|Adverse Event|0|||
145311421|NCT02705716|523987225|FG001|Overall Study|Adverse Event|1|||
145311422|NCT02705716|523987224|FG000|Overall Study|Protocol Violation|3|||
145311423|NCT02705716|523987225|FG001|Overall Study|Protocol Violation|0|||
145311424|NCT02705716|523987224|FG000|Overall Study|Withdrawal of Consent|1|||
145311425|NCT02705716|523987225|FG001|Overall Study|Withdrawal of Consent|1|||
145311426|NCT01632306|523987226|FG000|Overall Study|Protocol Violation|1|||
145311427|NCT01632306|523987227|FG001|Overall Study|Protocol Violation|0|||
145311428|NCT01632306|523987228|FG002|Overall Study|Protocol Violation|0|||
145311429|NCT03966911|523987229|FG000|Overall Study|Adverse Event|1|||
145311430|NCT03966911|523987230|FG001|Overall Study|Adverse Event|1|||
145311431|NCT03966911|523987229|FG000|Overall Study|Withdrawal by Subject|8|||
145311432|NCT03966911|523987230|FG001|Overall Study|Withdrawal by Subject|2|||
145311433|NCT03966911|523987229|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
145311434|NCT03966911|523987230|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
145311435|NCT00985751|523987233|FG000|Overall Study|Adverse Event|0|||
145311436|NCT00985751|523987234|FG001|Overall Study|Adverse Event|0|||
145311437|NCT00985751|523987235|FG002|Overall Study|Adverse Event|0|||
145311438|NCT00985751|523987236|FG003|Overall Study|Adverse Event|0|||
145311439|NCT00985751|523987237|FG004|Overall Study|Adverse Event|1|||
145311440|NCT00380588|523987238|FG000|Overall Study|Unequivocal Disease Progression|25|||
145311441|NCT00380588|523987239|FG001|Overall Study|Unequivocal Disease Progression|34|||
145311442|NCT00380588|523987238|FG000|Overall Study|Next Cycle Not Started|4|||
145311443|NCT00380588|523987239|FG001|Overall Study|Next Cycle Not Started|0|||
145311444|NCT00380588|523987238|FG000|Overall Study|Adverse Event|7|||
145311445|NCT00380588|523987239|FG001|Overall Study|Adverse Event|3|||
145311446|NCT00380588|523987238|FG000|Overall Study|Withdrawal by Subject|1|||
145311447|NCT00380588|523987239|FG001|Overall Study|Withdrawal by Subject|3|||
145311448|NCT00380588|523987238|FG000|Overall Study|Physician Decision|2|||
145311449|NCT00380588|523987239|FG001|Overall Study|Physician Decision|0|||
145311450|NCT02905435|523987240|FG000|Overall Study|Death|2|||
145311451|NCT02905435|523987240|FG000|Overall Study|Physician Decision|1|||
145311452|NCT02905435|523987240|FG000|Overall Study|Lost to Follow-up|4|||
145311453|NCT01046084|523987247|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
145311454|NCT01046084|523987248|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
145311455|NCT00474188|523987249|FG000|Overall Study|Withdrawal by Subject|1|||
145311456|NCT00474188|523987249|FG000|Overall Study|Study discontinued by sponsor|5|||
145311457|NCT03614728|523987250|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
145311458|NCT03614728|523987251|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
145311459|NCT03614728|523987252|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
145311460|NCT03614728|523987253|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
145311461|NCT03614728|523987250|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
145311462|NCT03614728|523987251|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
145311463|NCT03614728|523987252|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
145311464|NCT03614728|523987253|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
145311465|NCT00842309|523987258|FG000|Overall Study|Withdrawal by Subject|3|||
145311466|NCT00842309|523987259|FG001|Overall Study|Withdrawal by Subject|1|||
145311467|NCT04476277|523987260|FG000|Overall Study|Withdrawal by Subject|0|||
145311468|NCT04476277|523987261|FG001|Overall Study|Withdrawal by Subject|0|||
145311469|NCT04476277|523987262|FG002|Overall Study|Withdrawal by Subject|1|||
145311470|NCT04476277|523987263|FG003|Overall Study|Withdrawal by Subject|0|||
145311471|NCT01962298|523987264|FG000|Overall Study|Protocol Violation|1|||
145311472|NCT01962298|523987265|FG001|Overall Study|Protocol Violation|0|||
145311473|NCT01962298|523987266|FG002|Overall Study|Protocol Violation|1|||
145311474|NCT01962298|523987267|FG003|Overall Study|Protocol Violation|1|||
145311475|NCT01962298|523987268|FG004|Overall Study|Protocol Violation|0|||
145311476|NCT01962298|523987264|FG000|Overall Study|Data quality insufficient|2|||
145311477|NCT01962298|523987265|FG001|Overall Study|Data quality insufficient|0|||
145311478|NCT01962298|523987266|FG002|Overall Study|Data quality insufficient|3|||
145311479|NCT01962298|523987267|FG003|Overall Study|Data quality insufficient|1|||
145311480|NCT01962298|523987268|FG004|Overall Study|Data quality insufficient|4|||
145311481|NCT01962298|523987264|FG000|Overall Study|Insufficient data|0|||
145311482|NCT01962298|523987265|FG001|Overall Study|Insufficient data|2|||
145311483|NCT01962298|523987266|FG002|Overall Study|Insufficient data|1|||
145311484|NCT01962298|523987267|FG003|Overall Study|Insufficient data|0|||
145311485|NCT01962298|523987268|FG004|Overall Study|Insufficient data|1|||
145311486|NCT01962298|523987264|FG000|Overall Study|Incorrect data recorded|0|||
145311487|NCT01962298|523987265|FG001|Overall Study|Incorrect data recorded|1|||
145311488|NCT01962298|523987266|FG002|Overall Study|Incorrect data recorded|0|||
145311489|NCT01962298|523987267|FG003|Overall Study|Incorrect data recorded|0|||
145311490|NCT01962298|523987268|FG004|Overall Study|Incorrect data recorded|0|||
145311491|NCT01962298|523987264|FG000|Overall Study|Physician Decision|0|||
145311492|NCT01962298|523987265|FG001|Overall Study|Physician Decision|1|||
145311493|NCT01962298|523987266|FG002|Overall Study|Physician Decision|0|||
145311494|NCT01962298|523987267|FG003|Overall Study|Physician Decision|0|||
145311495|NCT01962298|523987268|FG004|Overall Study|Physician Decision|1|||
145311496|NCT01576705|523987269|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
145311497|NCT01576705|523987270|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
145311498|NCT01576705|523987271|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
145311499|NCT01576705|523987272|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
145311500|NCT01576705|523987269|FG000|Overall Study|invalid ICF|0|||
145311501|NCT01576705|523987270|FG001|Overall Study|invalid ICF|1|||
145311502|NCT01576705|523987271|FG002|Overall Study|invalid ICF|0|||
145311503|NCT01576705|523987272|FG003|Overall Study|invalid ICF|0|||
145311504|NCT03727139|523987273|FG000|Overall Study|Protocol Violation|60|||
145311505|NCT04573309|523988393|FG000|Overall Study|Protocol Violation|1|||
145311506|NCT04573309|523988394|FG001|Overall Study|Protocol Violation|0|||
145311507|NCT01691430|523988397|FG000|Overall Study|Death|17|||
145311508|NCT01691430|523988398|FG001|Overall Study|Death|16|||
145311509|NCT01691430|523988397|FG000|Overall Study|Withdrawal by Subject|5|||
145311510|NCT01691430|523988398|FG001|Overall Study|Withdrawal by Subject|1|||
145311511|NCT01691430|523988397|FG000|Overall Study|Lost to Follow-up|0|||
145311512|NCT01691430|523988398|FG001|Overall Study|Lost to Follow-up|3|||
145311513|NCT01894230|523988399|FG000|Overall Study|Lost to Follow-up|2|||
145311514|NCT01894230|523988400|FG001|Overall Study|Lost to Follow-up|2|||
145311515|NCT01894230|523988399|FG000|Overall Study|Withdrawal by Subject|4|||
145311516|NCT01894230|523988400|FG001|Overall Study|Withdrawal by Subject|4|||
145311517|NCT01894230|523988399|FG000|Overall Study|Non-adherent|0|||
145311518|NCT01894230|523988400|FG001|Overall Study|Non-adherent|1|||
145311519|NCT01894230|523988399|FG000|Overall Study|Death|1|||
145311520|NCT01894230|523988400|FG001|Overall Study|Death|0|||
145311521|NCT02219009|523988403|FG000|Overall Study|Withdrawal by Subject|5|||
145311522|NCT02219009|523988404|FG001|Overall Study|Withdrawal by Subject|1|||
145311523|NCT02219009|523988403|FG000|Overall Study|Adverse Event|2|||
145311524|NCT02219009|523988404|FG001|Overall Study|Adverse Event|4|||
145311525|NCT02219009|523988403|FG000|Overall Study|Lost to Follow-up|2|||
145311526|NCT02219009|523988404|FG001|Overall Study|Lost to Follow-up|2|||
145311527|NCT02219009|523988403|FG000|Overall Study|Protocol deviation|1|||
145311528|NCT02219009|523988404|FG001|Overall Study|Protocol deviation|0|||
145311529|NCT02219009|523988403|FG000|Overall Study|Physician Decision|0|||
145311530|NCT02219009|523988404|FG001|Overall Study|Physician Decision|1|||
145311531|NCT00660387|523988405|FG000|Overall Study|Adverse Event|1|||
145311532|NCT00660387|523988406|FG001|Overall Study|Adverse Event|2|||
145311533|NCT00660387|523988405|FG000|Overall Study|Lack of Efficacy|0|||
145311534|NCT00660387|523988406|FG001|Overall Study|Lack of Efficacy|1|||
145311535|NCT00660387|523988405|FG000|Overall Study|Protocol Violation|1|||
145311536|NCT00660387|523988406|FG001|Overall Study|Protocol Violation|0|||
145311537|NCT02966340|523988407|FG000|Overall Study|Adverse Event|0|||
145311538|NCT02966340|523988408|FG001|Overall Study|Adverse Event|1|||
145311539|NCT02966340|523988407|FG000|Overall Study|Lost to Follow-up|0|||
145311540|NCT02966340|523988408|FG001|Overall Study|Lost to Follow-up|1|||
145311541|NCT02966340|523988407|FG000|Overall Study|Withdrawal by Subject|1|||
145311542|NCT02966340|523988408|FG001|Overall Study|Withdrawal by Subject|0|||
145311543|NCT02966340|523988407|FG000|Overall Study|data acquisition error|1|||
145311544|NCT02966340|523988408|FG001|Overall Study|data acquisition error|0|||
145569286|NCT03400332|524944219|FG007|Treatment|Lost to Follow-up|0|||
145311545|NCT02966340|523988407|FG000|Overall Study|startle non-responder|1|||
145311546|NCT02966340|523988408|FG001|Overall Study|startle non-responder|1|||
145311547|NCT00202839|523988409|FG000|Overall Study|Adverse Event|1|||
145311548|NCT00202839|523988410|FG001|Overall Study|Adverse Event|5|||
145311549|NCT00202839|523988409|FG000|Overall Study|Physician Decision|12|||
145311550|NCT00202839|523988410|FG001|Overall Study|Physician Decision|0|||
145311551|NCT00202839|523988409|FG000|Overall Study|Withdrawal by Subject|6|||
145311552|NCT00202839|523988410|FG001|Overall Study|Withdrawal by Subject|2|||
145311553|NCT00202839|523988409|FG000|Overall Study|Protocol Violation|2|||
145311554|NCT00202839|523988410|FG001|Overall Study|Protocol Violation|1|||
145311555|NCT00202839|523988409|FG000|Overall Study|Lost to Follow-up|3|||
145311556|NCT00202839|523988410|FG001|Overall Study|Lost to Follow-up|2|||
145311557|NCT00642993|523988413|FG000|Overall Study|Adverse Event|85|||
145311558|NCT00642993|523988414|FG001|Overall Study|Adverse Event|4|||
145311559|NCT00642993|523988413|FG000|Overall Study|Lost to Follow-up|8|||
145311560|NCT00642993|523988414|FG001|Overall Study|Lost to Follow-up|4|||
145311561|NCT00642993|523988413|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
145311562|NCT00642993|523988414|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
145311563|NCT00642993|523988413|FG000|Overall Study|Protocol Violation|1|||
145311564|NCT00642993|523988414|FG001|Overall Study|Protocol Violation|4|||
145311565|NCT00642993|523988413|FG000|Overall Study|Did not meet protocol eligibility|0|||
145311566|NCT00642993|523988414|FG001|Overall Study|Did not meet protocol eligibility|1|||
145311567|NCT00642993|523988413|FG000|Overall Study|Administrative|1|||
145311568|NCT00642993|523988414|FG001|Overall Study|Administrative|0|||
145311569|NCT02583048|523988415|FG000|Overall Study|Withdrawal by Subject|0|||
145311570|NCT02583048|523988416|FG001|Overall Study|Withdrawal by Subject|1|||
145311571|NCT02583048|523988417|FG002|Overall Study|Withdrawal by Subject|0|||
145311572|NCT02583048|523988415|FG000|Overall Study|Failed to meet eligibility criterion|0|||
145311573|NCT02583048|523988416|FG001|Overall Study|Failed to meet eligibility criterion|0|||
145311574|NCT02583048|523988417|FG002|Overall Study|Failed to meet eligibility criterion|1|||
145311575|NCT00960154|523988423|FG000|Overall Study|Study termination|25|||
145311576|NCT00960154|523988424|FG001|Overall Study|Study termination|25|||
145311577|NCT03119662|523988425|FG000|Overall Study|Withdrawal by Subject|0|||
145569287|NCT03400332|524944220|FG008|Treatment|Lost to Follow-up|0|||
145569288|NCT03400332|524944212|FG000|Treatment|Death|3|||
145569289|NCT03400332|524944213|FG001|Treatment|Death|1|||
145569290|NCT03400332|524944214|FG002|Treatment|Death|2|||
145569291|NCT03400332|524944215|FG003|Treatment|Death|3|||
145311578|NCT03119662|523988426|FG001|Overall Study|Withdrawal by Subject|1|||
145311579|NCT00757705|523988427|FG000|Overall Study|Adverse Event|19|||
145311580|NCT00757705|523988427|FG000|Overall Study|Lost to Follow-up|16|||
145311581|NCT00757705|523988427|FG000|Overall Study|Withdrawal by Subject|25|||
145311582|NCT00757705|523988427|FG000|Overall Study|Insufficient Response|26|||
145311583|NCT00757705|523988427|FG000|Overall Study|Ineligible to continue|8|||
145311584|NCT00757705|523988427|FG000|Overall Study|Non-compliant|9|||
145311585|NCT00757705|523988427|FG000|Overall Study|Other|18|||
145311586|NCT02817828|523988428|FG000|Overall Study|Lost to Follow-up|41|||
145311587|NCT02817828|523988428|FG000|Overall Study|Adverse event not related to bleeding|104|||
145311588|NCT02817828|523988428|FG000|Overall Study|Adverse event related to bleeding|53|||
145311589|NCT02817828|523988428|FG000|Overall Study|Protocol Violation|11|||
145311590|NCT02817828|523988428|FG000|Overall Study|Pregnancy|7|||
145311591|NCT02817828|523988428|FG000|Overall Study|Pregnancy wish|15|||
145311592|NCT02817828|523988428|FG000|Overall Study|Withdrawal by Subject|78|||
145311593|NCT02817828|523988428|FG000|Overall Study|Other|26|||
145311594|NCT00659815|523988435|FG000|Overall Study|Study related symptoms and complaints|2|||
145311595|NCT00659815|523988436|FG001|Overall Study|Study related symptoms and complaints|1|||
145311596|NCT00659815|523988435|FG000|Overall Study|Inability to maintain wearing schedule|1|||
145311597|NCT00659815|523988436|FG001|Overall Study|Inability to maintain wearing schedule|2|||
145311598|NCT00659815|523988435|FG000|Overall Study|Withdrawal by Subject|1|||
145311599|NCT00659815|523988436|FG001|Overall Study|Withdrawal by Subject|1|||
145311600|NCT02651987|523988437|FG000|Overall Study|Adverse Event|2|||
145311601|NCT02651987|523988438|FG001|Overall Study|Adverse Event|2|||
145311602|NCT02651987|523988437|FG000|Overall Study|Consent Withdrawn|2|||
145311603|NCT02651987|523988438|FG001|Overall Study|Consent Withdrawn|0|||
145569292|NCT03400332|524944216|FG004|Treatment|Death|6|||
145569293|NCT03400332|524944217|FG005|Treatment|Death|2|||
145311604|NCT02651987|523988437|FG000|Overall Study|Local PD|0|||
145311605|NCT02651987|523988438|FG001|Overall Study|Local PD|2|||
145311606|NCT02651987|523988437|FG000|Overall Study|Investigator Decision|1|||
145311607|NCT02651987|523988438|FG001|Overall Study|Investigator Decision|1|||
145311608|NCT04408924|523988439|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
145311609|NCT04408924|523988439|FG000|Overall Study|Lost to Follow-up|3|||
145569294|NCT03400332|524944218|FG006|Treatment|Death|1|||
145311610|NCT04408924|523988439|FG000|Overall Study|Withdrawal by Subject|5|||
145569295|NCT03400332|524944219|FG007|Treatment|Death|3|||
145569296|NCT03400332|524944220|FG008|Treatment|Death|6|||
145569297|NCT02075840|524944223|FG000|Overall Study|Withdrawal by Subject|13|||
145569298|NCT02075840|524944224|FG001|Overall Study|Withdrawal by Subject|22|||
145311611|NCT04408924|523988439|FG000|Overall Study|Sponsor Decision|2|||
145311612|NCT02998541|523988441|FG000|Overall Study|Adverse Event|4|||
145311613|NCT02998541|523988442|FG001|Overall Study|Adverse Event|5|||
145311614|NCT02998541|523988443|FG002|Overall Study|Adverse Event|1|||
145311615|NCT02998541|523988441|FG000|Overall Study|Protocol Violation|1|||
145311616|NCT02998541|523988442|FG001|Overall Study|Protocol Violation|0|||
145311617|NCT02998541|523988443|FG002|Overall Study|Protocol Violation|0|||
145311618|NCT02998541|523988441|FG000|Overall Study|Withdrawal by Subject|3|||
145311619|NCT02998541|523988442|FG001|Overall Study|Withdrawal by Subject|1|||
145311620|NCT02998541|523988443|FG002|Overall Study|Withdrawal by Subject|0|||
145311621|NCT02998541|523988441|FG000|Overall Study|Lost to Follow-up|0|||
145311622|NCT02998541|523988442|FG001|Overall Study|Lost to Follow-up|3|||
145311623|NCT02998541|523988443|FG002|Overall Study|Lost to Follow-up|1|||
145311624|NCT02998541|523988441|FG000|Overall Study|Physician Decision|0|||
145311625|NCT02998541|523988442|FG001|Overall Study|Physician Decision|0|||
145311626|NCT02998541|523988443|FG002|Overall Study|Physician Decision|3|||
145311627|NCT02998541|523988441|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145311628|NCT02998541|523988442|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145311629|NCT02998541|523988443|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
145311630|NCT03358147|523988444|FG000|Overall Study|Withdrawal by Subject|13|||
145311631|NCT03358147|523988445|FG001|Overall Study|Withdrawal by Subject|19|||
145311632|NCT03358147|523988446|FG002|Overall Study|Withdrawal by Subject|16|||
145311633|NCT03358147|523988447|FG003|Overall Study|Withdrawal by Subject|10|||
145311634|NCT03358147|523988448|FG004|Overall Study|Withdrawal by Subject|5|||
145311635|NCT03358147|523988444|FG000|Overall Study|Adverse Event|3|||
145311636|NCT03358147|523988445|FG001|Overall Study|Adverse Event|9|||
145311637|NCT03358147|523988446|FG002|Overall Study|Adverse Event|7|||
145311638|NCT03358147|523988447|FG003|Overall Study|Adverse Event|5|||
145311639|NCT03358147|523988448|FG004|Overall Study|Adverse Event|2|||
145311640|NCT03358147|523988444|FG000|Overall Study|Lost to Follow-up|4|||
145311641|NCT03358147|523988445|FG001|Overall Study|Lost to Follow-up|3|||
145311642|NCT03358147|523988446|FG002|Overall Study|Lost to Follow-up|7|||
145311643|NCT03358147|523988447|FG003|Overall Study|Lost to Follow-up|6|||
145311644|NCT03358147|523988448|FG004|Overall Study|Lost to Follow-up|4|||
145311645|NCT03358147|523988444|FG000|Overall Study|Major Protocol Deviation|11|||
145311646|NCT03358147|523988445|FG001|Overall Study|Major Protocol Deviation|3|||
145311647|NCT03358147|523988446|FG002|Overall Study|Major Protocol Deviation|2|||
145311648|NCT03358147|523988447|FG003|Overall Study|Major Protocol Deviation|3|||
145311649|NCT03358147|523988448|FG004|Overall Study|Major Protocol Deviation|1|||
145311650|NCT03358147|523988444|FG000|Overall Study|Protocol specified criteria|2|||
145311651|NCT03358147|523988445|FG001|Overall Study|Protocol specified criteria|3|||
145311652|NCT03358147|523988446|FG002|Overall Study|Protocol specified criteria|0|||
145311653|NCT03358147|523988447|FG003|Overall Study|Protocol specified criteria|3|||
145311654|NCT03358147|523988448|FG004|Overall Study|Protocol specified criteria|1|||
145311655|NCT03358147|523988444|FG000|Overall Study|Physician Decision|1|||
145311656|NCT03358147|523988445|FG001|Overall Study|Physician Decision|0|||
145311657|NCT03358147|523988446|FG002|Overall Study|Physician Decision|1|||
145311658|NCT03358147|523988447|FG003|Overall Study|Physician Decision|6|||
145311659|NCT03358147|523988448|FG004|Overall Study|Physician Decision|1|||
145311660|NCT03358147|523988444|FG000|Overall Study|Administrative reasons|0|||
145311661|NCT03358147|523988445|FG001|Overall Study|Administrative reasons|1|||
145311662|NCT03358147|523988446|FG002|Overall Study|Administrative reasons|0|||
145311663|NCT03358147|523988447|FG003|Overall Study|Administrative reasons|3|||
145311664|NCT03358147|523988448|FG004|Overall Study|Administrative reasons|0|||
145311665|NCT03358147|523988444|FG000|Overall Study|Lack of Efficacy|0|||
145311666|NCT03358147|523988445|FG001|Overall Study|Lack of Efficacy|1|||
145311667|NCT03358147|523988446|FG002|Overall Study|Lack of Efficacy|1|||
145311668|NCT03358147|523988447|FG003|Overall Study|Lack of Efficacy|0|||
145311669|NCT03358147|523988448|FG004|Overall Study|Lack of Efficacy|0|||
145311670|NCT02933060|523988449|FG000|Overall Study|Withdrawal by Subject|0|||
145311671|NCT02933060|523988450|FG001|Overall Study|Withdrawal by Subject|1|||
145311672|NCT01945580|523988451|FG000|Overall Study|Withdrawal by Subject|13|||
145311673|NCT01945580|523988452|FG001|Overall Study|Withdrawal by Subject|35|||
145311674|NCT01945580|523988451|FG000|Overall Study|Physician Decision|3|||
145311675|NCT01945580|523988452|FG001|Overall Study|Physician Decision|2|||
145311676|NCT01945580|523988451|FG000|Overall Study|Lost to Follow-up|26|||
145311677|NCT01945580|523988452|FG001|Overall Study|Lost to Follow-up|39|||
145311678|NCT01945580|523988451|FG000|Overall Study|Death|7|||
145311679|NCT01945580|523988452|FG001|Overall Study|Death|2|||
145311680|NCT01945580|523988451|FG000|Overall Study|Patient moved out of state|0|||
145311681|NCT01945580|523988452|FG001|Overall Study|Patient moved out of state|1|||
145311682|NCT01945580|523988451|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
145311683|NCT01945580|523988452|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
145311684|NCT01945580|523988451|FG000|Overall Study|Family illness - unable to return|0|||
145311685|NCT01945580|523988452|FG001|Overall Study|Family illness - unable to return|1|||
145311686|NCT01945580|523988451|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
145311687|NCT01945580|523988452|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
145311688|NCT01945580|523988451|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
145311689|NCT01945580|523988452|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
145311690|NCT01945580|523988451|FG000|Overall Study|Noncompliance with 36 month visit|1|||
145311691|NCT01945580|523988452|FG001|Overall Study|Noncompliance with 36 month visit|0|||
145311692|NCT01945580|523988451|FG000|Overall Study|The patient moved.|1|||
145311693|NCT01945580|523988452|FG001|Overall Study|The patient moved.|0|||
145311694|NCT01945580|523988451|FG000|Overall Study|No data available|0|||
145311695|NCT01945580|523988452|FG001|Overall Study|No data available|2|||
145311696|NCT00875524|523988453|FG000|Overall Study|Serious adverse event|0|||
145311697|NCT00875524|523988454|FG001|Overall Study|Serious adverse event|1|||
145311698|NCT00875524|523988453|FG000|Overall Study|Protocol Violation|4|||
145311699|NCT00875524|523988454|FG001|Overall Study|Protocol Violation|0|||
145311700|NCT00875524|523988453|FG000|Overall Study|Lost to Follow-up|1|||
145311701|NCT00875524|523988454|FG001|Overall Study|Lost to Follow-up|0|||
145311702|NCT00875524|523988453|FG000|Overall Study|Withdrawal by Subject|3|||
145311703|NCT00875524|523988454|FG001|Overall Study|Withdrawal by Subject|5|||
145311704|NCT01370863|523988455|FG000|Overall Study|Adverse Event|1|||
145311705|NCT01370863|523988456|FG001|Overall Study|Adverse Event|1|||
145311706|NCT01370863|523988455|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
145311707|NCT01370863|523988456|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
145311708|NCT01370863|523988455|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145311709|NCT01370863|523988456|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
145311710|NCT00881751|523988459|FG000|Overall Study|Physician Decision|0|||
145311711|NCT00881751|523988460|FG001|Overall Study|Physician Decision|1|||
145311712|NCT00881751|523988459|FG000|Overall Study|Adverse Event|0|||
145311713|NCT00881751|523988460|FG001|Overall Study|Adverse Event|2|||
145311714|NCT00881751|523988459|FG000|Overall Study|Withdrawal by Subject|0|||
145311715|NCT00881751|523988460|FG001|Overall Study|Withdrawal by Subject|2|||
145311716|NCT00009945|523988461|FG000|Overall Study|no follow up data|7|||
145311717|NCT00009945|523988462|FG001|Overall Study|no follow up data|5|||
145311718|NCT00819169|523988465|FG000|Overall Study|Withdrawal by Subject|2|||
145311719|NCT00819169|523988466|FG001|Overall Study|Withdrawal by Subject|0|||
145311720|NCT00819169|523988467|FG002|Overall Study|Withdrawal by Subject|0|||
145311721|NCT00819169|523988468|FG003|Overall Study|Withdrawal by Subject|1|||
145311722|NCT00819169|523988469|FG004|Overall Study|Withdrawal by Subject|1|||
145311723|NCT00819169|523988470|FG005|Overall Study|Withdrawal by Subject|1|||
145311724|NCT00819169|523988471|FG006|Overall Study|Withdrawal by Subject|5|||
145311725|NCT00819169|523988472|FG007|Overall Study|Withdrawal by Subject|1|||
145311726|NCT00819169|523988473|FG008|Overall Study|Withdrawal by Subject|4|||
145311727|NCT00819169|523988465|FG000|Overall Study|Lost to Follow-up|0|||
145311728|NCT00819169|523988466|FG001|Overall Study|Lost to Follow-up|2|||
145311729|NCT00819169|523988467|FG002|Overall Study|Lost to Follow-up|0|||
145311730|NCT00819169|523988468|FG003|Overall Study|Lost to Follow-up|1|||
145311731|NCT00819169|523988469|FG004|Overall Study|Lost to Follow-up|0|||
145311732|NCT00819169|523988470|FG005|Overall Study|Lost to Follow-up|6|||
145311733|NCT00819169|523988471|FG006|Overall Study|Lost to Follow-up|2|||
145311734|NCT00819169|523988472|FG007|Overall Study|Lost to Follow-up|2|||
145311735|NCT00819169|523988473|FG008|Overall Study|Lost to Follow-up|1|||
145311736|NCT00819169|523988465|FG000|Overall Study|Death|1|||
145311737|NCT00819169|523988466|FG001|Overall Study|Death|1|||
145311738|NCT00819169|523988467|FG002|Overall Study|Death|3|||
145311739|NCT00819169|523988468|FG003|Overall Study|Death|8|||
145311740|NCT00819169|523988469|FG004|Overall Study|Death|5|||
145311741|NCT00819169|523988470|FG005|Overall Study|Death|7|||
145311742|NCT00819169|523988471|FG006|Overall Study|Death|9|||
145311743|NCT00819169|523988472|FG007|Overall Study|Death|4|||
145311744|NCT00819169|523988473|FG008|Overall Study|Death|7|||
145311745|NCT00819169|523988465|FG000|Overall Study|Ineligibility determined|0|||
145311746|NCT00819169|523988466|FG001|Overall Study|Ineligibility determined|0|||
145311747|NCT00819169|523988467|FG002|Overall Study|Ineligibility determined|0|||
145311748|NCT00819169|523988468|FG003|Overall Study|Ineligibility determined|2|||
145311749|NCT00819169|523988469|FG004|Overall Study|Ineligibility determined|0|||
145311750|NCT00819169|523988470|FG005|Overall Study|Ineligibility determined|0|||
145311751|NCT00819169|523988471|FG006|Overall Study|Ineligibility determined|0|||
145311752|NCT00819169|523988472|FG007|Overall Study|Ineligibility determined|0|||
145311753|NCT00819169|523988473|FG008|Overall Study|Ineligibility determined|1|||
145311754|NCT00819169|523988465|FG000|Overall Study|Adverse Event|0|||
145311755|NCT00819169|523988466|FG001|Overall Study|Adverse Event|0|||
145311756|NCT00819169|523988467|FG002|Overall Study|Adverse Event|0|||
145311757|NCT00819169|523988468|FG003|Overall Study|Adverse Event|0|||
145311758|NCT00819169|523988469|FG004|Overall Study|Adverse Event|1|||
145311759|NCT00819169|523988470|FG005|Overall Study|Adverse Event|0|||
145311760|NCT00819169|523988471|FG006|Overall Study|Adverse Event|0|||
145311761|NCT00819169|523988472|FG007|Overall Study|Adverse Event|0|||
145311762|NCT00819169|523988473|FG008|Overall Study|Adverse Event|0|||
145311763|NCT00819169|523988465|FG000|Overall Study|Administrative Decision|0|||
145311764|NCT00819169|523988466|FG001|Overall Study|Administrative Decision|0|||
145311765|NCT00819169|523988467|FG002|Overall Study|Administrative Decision|0|||
145311766|NCT00819169|523988468|FG003|Overall Study|Administrative Decision|0|||
145311767|NCT00819169|523988469|FG004|Overall Study|Administrative Decision|1|||
145311768|NCT00819169|523988470|FG005|Overall Study|Administrative Decision|2|||
145311769|NCT00819169|523988471|FG006|Overall Study|Administrative Decision|0|||
145311770|NCT00819169|523988472|FG007|Overall Study|Administrative Decision|2|||
145311771|NCT00819169|523988473|FG008|Overall Study|Administrative Decision|0|||
145311772|NCT00566722|523988475|FG000|Overall Study|Adverse Event|0|||
145311773|NCT00566722|523988476|FG001|Overall Study|Adverse Event|1|||
145311774|NCT00566722|523988477|FG002|Overall Study|Adverse Event|0|||
145311775|NCT00566722|523988475|FG000|Overall Study|Withdrawal by Subject|0|||
145311776|NCT00566722|523988476|FG001|Overall Study|Withdrawal by Subject|0|||
145311777|NCT00566722|523988477|FG002|Overall Study|Withdrawal by Subject|1|||
145311778|NCT00566722|523988475|FG000|Overall Study|Lost to Follow-up|1|||
145311779|NCT00566722|523988476|FG001|Overall Study|Lost to Follow-up|1|||
145311780|NCT00566722|523988477|FG002|Overall Study|Lost to Follow-up|1|||
145311781|NCT00566722|523988475|FG000|Overall Study|Lack of Efficacy|1|||
145311782|NCT00566722|523988476|FG001|Overall Study|Lack of Efficacy|2|||
145311783|NCT00566722|523988477|FG002|Overall Study|Lack of Efficacy|4|||
145311784|NCT00566722|523988475|FG000|Overall Study|Did not meet exclusion criteria|0|||
145311785|NCT00566722|523988476|FG001|Overall Study|Did not meet exclusion criteria|0|||
145311786|NCT00566722|523988477|FG002|Overall Study|Did not meet exclusion criteria|2|||
145311787|NCT00566722|523988475|FG000|Overall Study|Serious adverse event|0|||
145311788|NCT00566722|523988476|FG001|Overall Study|Serious adverse event|1|||
145311789|NCT00566722|523988477|FG002|Overall Study|Serious adverse event|0|||
145311790|NCT00566722|523988475|FG000|Overall Study|Noncompliant with drug administration|0|||
145311791|NCT00566722|523988476|FG001|Overall Study|Noncompliant with drug administration|0|||
145311792|NCT00566722|523988477|FG002|Overall Study|Noncompliant with drug administration|1|||
145311793|NCT02218216|523988480|FG000|Overall Study|Study terminated before completed|6|||
145311794|NCT02218216|523988481|FG001|Overall Study|Study terminated before completed|0|||
145311795|NCT02218216|523988482|FG002|Overall Study|Study terminated before completed|0|||
145311796|NCT05740098|523988487|FG000|Overall Study|Lost to Follow-up|26|||
145311797|NCT05740098|523988488|FG001|Overall Study|Lost to Follow-up|17|||
145311798|NCT05740098|523988489|FG002|Overall Study|Lost to Follow-up|21|||
145311799|NCT03867760|523988490|FG000|Overall Study|Lost to Follow-up|2|||
145311800|NCT03867760|523988491|FG001|Overall Study|Lost to Follow-up|3|||
145311801|NCT03867760|523988490|FG000|Overall Study|Withdrawal by Subject|1|||
145311802|NCT03867760|523988491|FG001|Overall Study|Withdrawal by Subject|2|||
145311803|NCT03867760|523988490|FG000|Overall Study|subject could not meet study logistics|3|||
145311804|NCT03867760|523988491|FG001|Overall Study|subject could not meet study logistics|3|||
145311805|NCT01073631|523988492|FG000|Overall Study|Death|82|||
145311806|NCT01073631|523988492|FG000|Overall Study|Adverse Event|24|||
145311807|NCT01073631|523988492|FG000|Overall Study|Other|63|||
145311808|NCT01566435|523988499|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
145311809|NCT04236596|523988500|FG000|Overall Study|Withdrawal by Subject|1|||
145311810|NCT04236596|523988500|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
145311811|NCT04236596|523988500|FG000|Overall Study|Participants did not receive implant at all|4|||
145311812|NCT02957331|523988503|FG000|Overall Study|Protocol Violation|1|||
145311813|NCT02957331|523988504|FG001|Overall Study|Protocol Violation|0|||
145311814|NCT02588339|523988506|FG000|Overall Study|Withdrawal by Subject|1|||
145311815|NCT02588339|523988506|FG000|Overall Study|GVHD Progression prior to treatment|2|||
145311816|NCT02664415|523990172|FG000|Overall Study|Adverse Event|1|||
145311817|NCT02664415|523990173|FG001|Overall Study|Adverse Event|0|||
145311818|NCT01151280|523990174|FG000|Overall Study|Adverse Event|1|||
145311819|NCT01151280|523990174|FG000|Overall Study|Lack of Efficacy|3|||
145311820|NCT00660660|523990175|FG000|Overall Study|Adverse Event|1|||
145311821|NCT00660660|523990176|FG001|Overall Study|Adverse Event|0|||
145311822|NCT00660660|523990175|FG000|Overall Study|Lost to Follow-up|0|||
145311823|NCT00660660|523990176|FG001|Overall Study|Lost to Follow-up|6|||
145311824|NCT00660660|523990175|FG000|Overall Study|Lack of Efficacy|0|||
145311825|NCT00660660|523990176|FG001|Overall Study|Lack of Efficacy|2|||
145311826|NCT00660660|523990175|FG000|Overall Study|Withdrawal by Subject|3|||
145311827|NCT00660660|523990176|FG001|Overall Study|Withdrawal by Subject|0|||
145311828|NCT00660660|523990175|FG000|Overall Study|Incorrect enrollment and other|0|||
145311829|NCT00660660|523990176|FG001|Overall Study|Incorrect enrollment and other|1|||
145311830|NCT00660660|523990175|FG000|Overall Study|New medication after randomization|1|||
145311831|NCT00660660|523990176|FG001|Overall Study|New medication after randomization|0|||
145311832|NCT02308241|523990177|FG000|Overall Study|Withdrawal by Subject|3|||
145311833|NCT00486434|523990178|FG000|Overall Study|Withdrawal by Subject|34|||
145311834|NCT00486434|523990179|FG001|Overall Study|Withdrawal by Subject|39|||
145311835|NCT00486434|523990178|FG000|Overall Study|Adverse Event|118|||
145311836|NCT00486434|523990179|FG001|Overall Study|Adverse Event|44|||
145620363|NCT01824472|525123758|FG000|Overall Study|Lost to Follow-up|0|||
145620364|NCT01824472|525123759|FG001|Overall Study|Lost to Follow-up|0|||
145311837|NCT00486434|523990178|FG000|Overall Study|Protocol Violation|22|||
145311838|NCT00486434|523990179|FG001|Overall Study|Protocol Violation|21|||
145311839|NCT00486434|523990178|FG000|Overall Study|Lack of Efficacy|12|||
145311840|NCT00486434|523990179|FG001|Overall Study|Lack of Efficacy|19|||
145311841|NCT00486434|523990178|FG000|Overall Study|Lost to Follow-up|2|||
145311842|NCT00486434|523990179|FG001|Overall Study|Lost to Follow-up|3|||
145311843|NCT00486434|523990178|FG000|Overall Study|Death|1|||
145311844|NCT00486434|523990179|FG001|Overall Study|Death|2|||
145311845|NCT00486434|523990178|FG000|Overall Study|Personal reasons|5|||
145311846|NCT00486434|523990179|FG001|Overall Study|Personal reasons|6|||
145311847|NCT02218541|523990180|FG000|Overall Study|Lost to Follow-up|2|||
145311848|NCT02218541|523990181|FG001|Overall Study|Lost to Follow-up|1|||
145311849|NCT02218541|523990180|FG000|Overall Study|Implant Failure|4|||
145311850|NCT02218541|523990181|FG001|Overall Study|Implant Failure|1|||
145311851|NCT00856349|523990182|FG000|Overall Study|Death|418|||
145311852|NCT00856349|523990182|FG000|Overall Study|Withdrawal by Subject|116|||
145311853|NCT00856349|523990182|FG000|Overall Study|Lost to Follow-up|91|||
145311854|NCT00856349|523990182|FG000|Overall Study|Protocol Violation|38|||
145311855|NCT00856349|523990182|FG000|Overall Study|Physician Decision|13|||
145311856|NCT00856349|523990182|FG000|Overall Study|Subject relocation|104|||
145311857|NCT00856349|523990182|FG000|Overall Study|Device explant|33|||
145311858|NCT00856349|523990182|FG000|Overall Study|Site closure|78|||
145311859|NCT00856349|523990182|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
145311860|NCT00183196|523990192|FG000|Overall Study|Withdrawal by Subject|18|||
145311861|NCT00183196|523990193|FG001|Overall Study|Withdrawal by Subject|11|||
145311862|NCT00183196|523990194|FG002|Overall Study|Withdrawal by Subject|13|||
145311863|NCT00183196|523990192|FG000|Overall Study|Adverse Event|1|||
145311864|NCT00183196|523990193|FG001|Overall Study|Adverse Event|2|||
145311865|NCT00183196|523990194|FG002|Overall Study|Adverse Event|2|||
145311866|NCT00183196|523990192|FG000|Overall Study|Legal event|1|||
145311867|NCT00183196|523990193|FG001|Overall Study|Legal event|1|||
145311868|NCT00183196|523990194|FG002|Overall Study|Legal event|1|||
145311869|NCT00183196|523990192|FG000|Overall Study|Required more intensive care|0|||
145311870|NCT00183196|523990193|FG001|Overall Study|Required more intensive care|1|||
145311871|NCT00183196|523990194|FG002|Overall Study|Required more intensive care|2|||
145311872|NCT01513239|523990200|FG000|Period 1: Main Phase|Adverse Event|1|||
145311873|NCT01513239|523990201|FG001|Period 1: Main Phase|Adverse Event|1|||
145311874|NCT01513239|523990202|FG002|Period 1: Main Phase|Adverse Event|2|||
145311875|NCT01513239|523990203|FG003|Period 1: Main Phase|Adverse Event|0|||
145311876|NCT01513239|523990204|FG004|Period 1: Main Phase|Adverse Event|0|||
145311877|NCT01513239|523990205|FG005|Period 1: Main Phase|Adverse Event|0|||
145311878|NCT01513239|523990200|FG000|Period 1: Main Phase|Death|29|||
145311879|NCT01513239|523990201|FG001|Period 1: Main Phase|Death|22|||
145311880|NCT01513239|523990202|FG002|Period 1: Main Phase|Death|32|||
145311881|NCT01513239|523990203|FG003|Period 1: Main Phase|Death|0|||
145311882|NCT01513239|523990204|FG004|Period 1: Main Phase|Death|0|||
145311883|NCT01513239|523990205|FG005|Period 1: Main Phase|Death|0|||
145311884|NCT01513239|523990200|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
145311885|NCT01513239|523990201|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
145311886|NCT01513239|523990202|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
145311887|NCT01513239|523990203|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
145311888|NCT01513239|523990204|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
145311889|NCT01513239|523990205|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
145311890|NCT01513239|523990200|FG000|Period 1: Main Phase|Physician Decision|4|||
145311891|NCT01513239|523990201|FG001|Period 1: Main Phase|Physician Decision|4|||
145311892|NCT01513239|523990202|FG002|Period 1: Main Phase|Physician Decision|4|||
145311893|NCT01513239|523990203|FG003|Period 1: Main Phase|Physician Decision|0|||
145569299|NCT02075840|524944223|FG000|Overall Study|Reason not specified|1|||
145569300|NCT02075840|524944224|FG001|Overall Study|Reason not specified|0|||
145569301|NCT02075840|524944223|FG000|Overall Study|Adverse Event|0|||
145569302|NCT02075840|524944224|FG001|Overall Study|Adverse Event|2|||
145569303|NCT02075840|524944223|FG000|Overall Study|Death|35|||
145569304|NCT02075840|524944224|FG001|Overall Study|Death|40|||
145311894|NCT01513239|523990204|FG004|Period 1: Main Phase|Physician Decision|0|||
145311895|NCT01513239|523990205|FG005|Period 1: Main Phase|Physician Decision|0|||
145311896|NCT01513239|523990200|FG000|Period 1: Main Phase|Protocol Violation|2|||
145311897|NCT01513239|523990201|FG001|Period 1: Main Phase|Protocol Violation|2|||
145311898|NCT01513239|523990202|FG002|Period 1: Main Phase|Protocol Violation|2|||
145311899|NCT01513239|523990203|FG003|Period 1: Main Phase|Protocol Violation|0|||
145311900|NCT01513239|523990204|FG004|Period 1: Main Phase|Protocol Violation|0|||
145311901|NCT01513239|523990205|FG005|Period 1: Main Phase|Protocol Violation|0|||
145311902|NCT01513239|523990200|FG000|Period 1: Main Phase|Technical Problems|1|||
145311903|NCT01513239|523990201|FG001|Period 1: Main Phase|Technical Problems|2|||
145311904|NCT01513239|523990202|FG002|Period 1: Main Phase|Technical Problems|0|||
145311905|NCT01513239|523990203|FG003|Period 1: Main Phase|Technical Problems|0|||
145311906|NCT01513239|523990204|FG004|Period 1: Main Phase|Technical Problems|0|||
145569305|NCT02075840|524944223|FG000|Overall Study|Lost to Follow-up|3|||
145569306|NCT02075840|524944224|FG001|Overall Study|Lost to Follow-up|2|||
145311907|NCT01513239|523990205|FG005|Period 1: Main Phase|Technical Problems|0|||
145311908|NCT01513239|523990200|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
145311909|NCT01513239|523990201|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
145311910|NCT01513239|523990202|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
145311911|NCT01513239|523990203|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
145311912|NCT01513239|523990204|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
145311913|NCT01513239|523990205|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
145311914|NCT01513239|523990200|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
145311915|NCT01513239|523990201|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
145311916|NCT01513239|523990202|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
145311917|NCT01513239|523990203|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
145311918|NCT01513239|523990204|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
145311919|NCT01513239|523990205|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
145311920|NCT01513239|523990200|FG000|Period 2: 9 Month Extension Phase|Death|0|||
145311921|NCT01513239|523990201|FG001|Period 2: 9 Month Extension Phase|Death|0|||
145311922|NCT01513239|523990202|FG002|Period 2: 9 Month Extension Phase|Death|0|||
145311923|NCT01513239|523990203|FG003|Period 2: 9 Month Extension Phase|Death|2|||
145311924|NCT01513239|523990204|FG004|Period 2: 9 Month Extension Phase|Death|5|||
145311925|NCT01513239|523990205|FG005|Period 2: 9 Month Extension Phase|Death|2|||
145311926|NCT01513239|523990200|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
145311927|NCT01513239|523990201|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
145311928|NCT01513239|523990202|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
145311929|NCT01513239|523990203|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
145311930|NCT01513239|523990204|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
145311931|NCT01513239|523990205|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
145311932|NCT01513239|523990200|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145311933|NCT01513239|523990201|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145311934|NCT01513239|523990202|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145311935|NCT01513239|523990203|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
145311936|NCT01513239|523990204|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145311937|NCT01513239|523990205|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
145311938|NCT01513239|523990200|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
145311939|NCT01513239|523990201|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
145311940|NCT01513239|523990202|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
145311941|NCT01513239|523990203|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
145311942|NCT01513239|523990204|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
145311943|NCT01513239|523990205|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
145311944|NCT00396162|523990206|FG000|Overall Study|Withdrawal by Subject|2|||
145311945|NCT00396162|523990207|FG001|Overall Study|Withdrawal by Subject|3|||
145311946|NCT01741545|523990208|FG000|Treatment Period|Lack of Efficacy|0|||
145311947|NCT01741545|523990209|FG001|Treatment Period|Lack of Efficacy|1|||
145311948|NCT01741545|523990208|FG000|Treatment Period|Adverse event, non-fatal|1|||
145311949|NCT01741545|523990209|FG001|Treatment Period|Adverse event, non-fatal|3|||
145311950|NCT01741545|523990208|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
145311951|NCT01741545|523990209|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
145311952|NCT01741545|523990208|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
145311953|NCT01741545|523990209|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
145311954|NCT03387462|523990212|FG000|Overall Study|Lost to Follow-up|1|||
145311955|NCT01460628|523990213|FG000|Overall Study|Adverse Event|3|||
145311956|NCT01460628|523990213|FG000|Overall Study|Withdrawal by Subject|2|||
145311957|NCT01664039|523990217|FG000|Overall Study|Adverse Event|3|||
145311958|NCT01664039|523990218|FG001|Overall Study|Adverse Event|4|||
145311959|NCT01664039|523990217|FG000|Overall Study|Lost to Follow-up|1|||
145311960|NCT01664039|523990218|FG001|Overall Study|Lost to Follow-up|1|||
145311961|NCT01664039|523990217|FG000|Overall Study|Withdrawal by Subject|1|||
145311962|NCT01664039|523990218|FG001|Overall Study|Withdrawal by Subject|3|||
145311963|NCT01664039|523990217|FG000|Overall Study|Noncompliance|1|||
145311964|NCT01664039|523990218|FG001|Overall Study|Noncompliance|1|||
145311965|NCT01944722|523990221|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
145311966|NCT01944722|523990221|FG000|Overall Study|Specimen Shipping Issues|34|||
145311967|NCT01944722|523990221|FG000|Overall Study|Improper Storage/Transport|5|||
145311968|NCT01944722|523990221|FG000|Overall Study|Insufficient Volume for Test|1|||
145311969|NCT01944722|523990221|FG000|Overall Study|Missing Specimens|3|||
145311970|NCT01944722|523990221|FG000|Overall Study|Specimens Mislabeled|2|||
145311971|NCT01944722|523990221|FG000|Overall Study|Withdrawal by Subject|8|||
145311972|NCT01944722|523990221|FG000|Overall Study|NILM Subjects <30 years old|8106|||
145311973|NCT01944722|523990221|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
145311974|NCT01944722|523990221|FG000|Overall Study|>ASCUS Cytology|1122|||
145311975|NCT01853176|523990222|FG000|Overall Study|Study terminated|4|||
145311976|NCT01853176|523990223|FG001|Overall Study|Study terminated|0|||
145311977|NCT02906917|523990227|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
145569307|NCT02075840|524944223|FG000|Overall Study|Physician Decision|1|||
145569308|NCT02075840|524944224|FG001|Overall Study|Physician Decision|3|||
145569309|NCT02075840|524944223|FG000|Overall Study|Ongoing at CCOD|99|||
145569310|NCT02075840|524944224|FG001|Overall Study|Ongoing at CCOD|82|||
145569311|NCT03909165|524944227|FG000|Overall Study|Physician Decision|0|||
145569312|NCT03909165|524944228|FG001|Overall Study|Physician Decision|1|||
145569313|NCT03909165|524944229|FG002|Overall Study|Physician Decision|0|||
145569314|NCT03909165|524944230|FG003|Overall Study|Physician Decision|0|||
145569315|NCT03909165|524944231|FG004|Overall Study|Physician Decision|0|||
145311978|NCT02906917|523990228|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
145311979|NCT02906917|523990227|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
145311980|NCT02906917|523990228|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
145311981|NCT02906917|523990227|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
145311982|NCT02906917|523990228|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
145311983|NCT02906917|523990227|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
145311984|NCT02906917|523990228|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
145311985|NCT02906917|523990227|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
145311986|NCT02906917|523990228|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
145311987|NCT02906917|523990227|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
145311988|NCT02906917|523990228|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
145311989|NCT02906917|523990227|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
145311990|NCT02906917|523990228|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
145311991|NCT02906917|523990227|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
145311992|NCT02906917|523990228|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
145311993|NCT05387408|523990229|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
145311994|NCT03599362|523990233|FG000|Overall Study|Screen Failure|3|||
145311995|NCT01370083|523990235|FG000|Overall Study|Lost to Follow-up|2|||
145311996|NCT01370083|523990236|FG001|Overall Study|Lost to Follow-up|0|||
145311997|NCT01370083|523990235|FG000|Overall Study|Adverse Event|0|||
145311998|NCT01370083|523990236|FG001|Overall Study|Adverse Event|1|||
145311999|NCT02072096|523990238|FG000|Overall Study|Lack of Efficacy|18|||
145312000|NCT02072096|523990239|FG001|Overall Study|Lack of Efficacy|29|||
145312001|NCT02072096|523990238|FG000|Overall Study|Protocol Violation|7|||
145312002|NCT02072096|523990239|FG001|Overall Study|Protocol Violation|7|||
145312003|NCT02072096|523990238|FG000|Overall Study|Withdrawal by Subject|5|||
145312004|NCT02072096|523990239|FG001|Overall Study|Withdrawal by Subject|7|||
145312005|NCT02072096|523990238|FG000|Overall Study|Adverse Event|5|||
145312006|NCT02072096|523990239|FG001|Overall Study|Adverse Event|2|||
145312007|NCT02072096|523990238|FG000|Overall Study|No Reason Provided|4|||
145312008|NCT02072096|523990239|FG001|Overall Study|No Reason Provided|2|||
145312009|NCT02072096|523990238|FG000|Overall Study|Death|2|||
145312010|NCT02072096|523990239|FG001|Overall Study|Death|0|||
145312011|NCT02072096|523990238|FG000|Overall Study|Physician Decision|0|||
145312012|NCT02072096|523990239|FG001|Overall Study|Physician Decision|1|||
145312013|NCT02072096|523990238|FG000|Overall Study|Study Terminated by Sponsor|43|||
145312014|NCT02072096|523990239|FG001|Overall Study|Study Terminated by Sponsor|30|||
145312015|NCT02072096|523990238|FG000|Overall Study|Lost to Follow-up|1|||
145312016|NCT02072096|523990239|FG001|Overall Study|Lost to Follow-up|0|||
145312017|NCT01168856|523990242|FG000|Overall Study|Lost to Follow-up|4|||
145312018|NCT01168856|523990243|FG001|Overall Study|Lost to Follow-up|34|||
145312019|NCT01168856|523990242|FG000|Overall Study|Withdrawal by Subject|6|||
145312020|NCT01168856|523990243|FG001|Overall Study|Withdrawal by Subject|8|||
145312021|NCT01168856|523990242|FG000|Overall Study|Physician Decision|2|||
145312022|NCT01168856|523990243|FG001|Overall Study|Physician Decision|1|||
145569316|NCT03909165|524944227|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145312023|NCT01168856|523990242|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
145312024|NCT01168856|523990243|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
145312025|NCT01168856|523990242|FG000|Overall Study|Participant received anti-HCV treatment|1|||
145312026|NCT01168856|523990243|FG001|Overall Study|Participant received anti-HCV treatment|0|||
145312027|NCT01168856|523990242|FG000|Overall Study|Death|0|||
145312028|NCT01168856|523990243|FG001|Overall Study|Death|2|||
145312029|NCT01168856|523990242|FG000|Overall Study|Other|1|||
145312030|NCT01168856|523990243|FG001|Overall Study|Other|291|||
145312031|NCT01168856|523990242|FG000|Overall Study|Protocol Violation|4|||
145312032|NCT01168856|523990243|FG001|Overall Study|Protocol Violation|6|||
145312033|NCT04442503|523990244|FG000|Overall Study|Adverse Event|1|||
145312034|NCT04442503|523990245|FG001|Overall Study|Adverse Event|1|||
145312035|NCT04442503|523990244|FG000|Overall Study|Lost to Follow-up|8|||
145312036|NCT04442503|523990245|FG001|Overall Study|Lost to Follow-up|6|||
145312037|NCT04442503|523990244|FG000|Overall Study|Physician Decision|0|||
145312038|NCT04442503|523990245|FG001|Overall Study|Physician Decision|2|||
145312039|NCT04442503|523990244|FG000|Overall Study|Withdrawal by Subject|3|||
145312040|NCT04442503|523990245|FG001|Overall Study|Withdrawal by Subject|4|||
145569317|NCT03909165|524944228|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145569318|NCT03909165|524944229|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145569319|NCT03909165|524944230|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145312041|NCT04442503|523990244|FG000|Overall Study|Reason not Specified|0|||
145312042|NCT04442503|523990245|FG001|Overall Study|Reason not Specified|1|||
145312043|NCT04442503|523990244|FG000|Overall Study|Randomized but not Treated|3|||
145312044|NCT04442503|523990245|FG001|Overall Study|Randomized but not Treated|1|||
145312045|NCT00387153|523990246|FG000|Overall Study|Adverse Event|1|||
145312046|NCT00387153|523990246|FG000|Overall Study|Disease Progression|3|||
145312047|NCT00387153|523990246|FG000|Overall Study|Lack of Response|4|||
145312048|NCT05034874|523990249|FG000|Overall Study|Withdrawal by Subject|6|||
145312049|NCT05034874|523990250|FG001|Overall Study|Withdrawal by Subject|6|||
145569320|NCT03909165|524944231|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145312050|NCT05034874|523990249|FG000|Overall Study|Lost to Follow-up|18|||
145312051|NCT05034874|523990250|FG001|Overall Study|Lost to Follow-up|8|||
145312052|NCT05034874|523990249|FG000|Overall Study|Physician Decision|0|||
145312053|NCT05034874|523990250|FG001|Overall Study|Physician Decision|1|||
145312054|NCT05034874|523990249|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
145312055|NCT05034874|523990250|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
145312056|NCT00474058|523990251|FG000|Overall Study|Adverse Event|11|||
145312057|NCT00474058|523990252|FG001|Overall Study|Adverse Event|6|||
145312058|NCT00474058|523990251|FG000|Overall Study|Lack of Efficacy|0|||
145312059|NCT00474058|523990252|FG001|Overall Study|Lack of Efficacy|4|||
145312060|NCT00474058|523990251|FG000|Overall Study|Withdrawal by Subject|11|||
145312061|NCT00474058|523990252|FG001|Overall Study|Withdrawal by Subject|7|||
145312062|NCT00474058|523990251|FG000|Overall Study|Other|2|||
145312063|NCT00474058|523990252|FG001|Overall Study|Other|0|||
145312064|NCT02640235|523990257|FG000|Overall Study|Withdrawal by Subject|7|||
145312065|NCT02640235|523990258|FG001|Overall Study|Withdrawal by Subject|6|||
145312066|NCT02640235|523990257|FG000|Overall Study|Lost to Follow-up|4|||
145312067|NCT02640235|523990258|FG001|Overall Study|Lost to Follow-up|3|||
145312068|NCT02640235|523990257|FG000|Overall Study|Death|2|||
145312069|NCT02640235|523990258|FG001|Overall Study|Death|3|||
145312070|NCT02640235|523990257|FG000|Overall Study|Other|1|||
145312071|NCT02640235|523990258|FG001|Overall Study|Other|2|||
145312072|NCT00503867|523990261|FG000|Overall Study|Lost to Follow-up|1|||
145312073|NCT00503867|523990261|FG000|Overall Study|Adverse Event|1|||
145312074|NCT05616728|523990262|FG000|Overall Study|Lost to Follow-up|0|||
145312075|NCT05616728|523990263|FG001|Overall Study|Lost to Follow-up|0|||
145312076|NCT05616728|523990264|FG002|Overall Study|Lost to Follow-up|1|||
145312077|NCT05616728|523990262|FG000|Overall Study|Withdrawal by Subject|1|||
145312078|NCT05616728|523990263|FG001|Overall Study|Withdrawal by Subject|1|||
145312079|NCT05616728|523990264|FG002|Overall Study|Withdrawal by Subject|0|||
145312080|NCT05616728|523990262|FG000|Overall Study|Physician Decision|1|||
145312081|NCT05616728|523990263|FG001|Overall Study|Physician Decision|1|||
145312082|NCT05616728|523990264|FG002|Overall Study|Physician Decision|1|||
145312083|NCT05616728|523990262|FG000|Overall Study|Other|0|||
145312084|NCT05616728|523990263|FG001|Overall Study|Other|2|||
145312085|NCT05616728|523990264|FG002|Overall Study|Other|0|||
145312086|NCT00577655|523990265|FG000|Overall Study|Patient Request|0|||
145312087|NCT00577655|523990266|FG001|Overall Study|Patient Request|2|||
145312088|NCT00577655|523990265|FG000|Overall Study|Protocol Violation|0|||
145312089|NCT00577655|523990266|FG001|Overall Study|Protocol Violation|1|||
145312090|NCT00577655|523990265|FG000|Overall Study|Lost to Follow-up|1|||
145312091|NCT00577655|523990266|FG001|Overall Study|Lost to Follow-up|1|||
145312092|NCT00301964|523990271|FG000|Overall Study|Second primary|2|||
145312093|NCT00301964|523990271|FG000|Overall Study|Wrong primary|1|||
145312094|NCT00301964|523990271|FG000|Overall Study|Inadequate pathology|1|||
145312095|NCT02385708|523990273|FG000|Overall Study|Withdrawal by Subject|0|||
145312096|NCT02385708|523990274|FG001|Overall Study|Withdrawal by Subject|2|||
145312097|NCT02385708|523990273|FG000|Overall Study|Withdrawn - surgery canceled|2|||
145312098|NCT02385708|523990274|FG001|Overall Study|Withdrawn - surgery canceled|5|||
145312099|NCT02385708|523990273|FG000|Overall Study|Investigator decision|5|||
145569321|NCT03909165|524944227|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145569322|NCT03909165|524944228|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
145569323|NCT03909165|524944229|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
145569324|NCT03909165|524944230|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
145312100|NCT02385708|523990274|FG001|Overall Study|Investigator decision|7|||
145569325|NCT03909165|524944231|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
145569326|NCT03909165|524944227|FG000|Overall Study|Previous Drug Exposure|0|||
145312101|NCT02385708|523990273|FG000|Overall Study|Protocol Violation|1|||
145312102|NCT02385708|523990274|FG001|Overall Study|Protocol Violation|1|||
145312103|NCT03504085|523990275|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
145312104|NCT03504085|523990276|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
145312105|NCT03504085|523990275|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
145312106|NCT03504085|523990276|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
145312107|NCT01143337|523990277|FG000|Overall Study|Adverse Event|3|||
145312108|NCT01143337|523990278|FG001|Overall Study|Adverse Event|9|||
145312109|NCT01143337|523990279|FG002|Overall Study|Adverse Event|5|||
145312110|NCT01143337|523990277|FG000|Overall Study|Lack of Efficacy|6|||
145569327|NCT03909165|524944228|FG001|Overall Study|Previous Drug Exposure|0|||
145312111|NCT01143337|523990278|FG001|Overall Study|Lack of Efficacy|2|||
145312112|NCT01143337|523990279|FG002|Overall Study|Lack of Efficacy|1|||
145569328|NCT03909165|524944229|FG002|Overall Study|Previous Drug Exposure|1|||
145569329|NCT03909165|524944230|FG003|Overall Study|Previous Drug Exposure|0|||
145569330|NCT03909165|524944231|FG004|Overall Study|Previous Drug Exposure|0|||
145569331|NCT03909165|524944227|FG000|Overall Study|Early Discharge|1|||
145569332|NCT03909165|524944228|FG001|Overall Study|Early Discharge|0|||
145569333|NCT03909165|524944229|FG002|Overall Study|Early Discharge|0|||
145569334|NCT03909165|524944230|FG003|Overall Study|Early Discharge|0|||
145569335|NCT03909165|524944231|FG004|Overall Study|Early Discharge|0|||
145569336|NCT00414661|524944232|FG000|Overall Study|Death|2|||
145312113|NCT01143337|523990277|FG000|Overall Study|Protocol Violation|1|||
145312114|NCT01143337|523990278|FG001|Overall Study|Protocol Violation|0|||
145312115|NCT01143337|523990279|FG002|Overall Study|Protocol Violation|0|||
145312116|NCT01143337|523990277|FG000|Overall Study|Withdrawal by Subject|0|||
145312117|NCT01143337|523990278|FG001|Overall Study|Withdrawal by Subject|0|||
145312118|NCT01143337|523990279|FG002|Overall Study|Withdrawal by Subject|1|||
145312119|NCT01143337|523990277|FG000|Overall Study|Other reason|0|||
145312120|NCT01143337|523990278|FG001|Overall Study|Other reason|0|||
145312121|NCT01143337|523990279|FG002|Overall Study|Other reason|5|||
145312122|NCT02761915|523990280|FG000|Overall Study|Death|3|||
145312123|NCT02761915|523990281|FG001|Overall Study|Death|1|||
145312124|NCT02761915|523990282|FG002|Overall Study|Death|1|||
145312125|NCT02761915|523990283|FG003|Overall Study|Death|1|||
145312126|NCT02761915|523990284|FG004|Overall Study|Death|0|||
145312127|NCT02761915|523990285|FG005|Overall Study|Death|1|||
145312128|NCT02761915|523990280|FG000|Overall Study|Withdrawal by Subject|1|||
145312129|NCT02761915|523990281|FG001|Overall Study|Withdrawal by Subject|0|||
145312130|NCT02761915|523990282|FG002|Overall Study|Withdrawal by Subject|0|||
145312131|NCT02761915|523990283|FG003|Overall Study|Withdrawal by Subject|0|||
145312132|NCT02761915|523990284|FG004|Overall Study|Withdrawal by Subject|1|||
145312133|NCT02761915|523990285|FG005|Overall Study|Withdrawal by Subject|2|||
145312134|NCT02761915|523990280|FG000|Overall Study|Disease Progression|0|||
145312135|NCT02761915|523990281|FG001|Overall Study|Disease Progression|0|||
145312136|NCT02761915|523990282|FG002|Overall Study|Disease Progression|0|||
145312137|NCT02761915|523990283|FG003|Overall Study|Disease Progression|2|||
145312138|NCT02761915|523990284|FG004|Overall Study|Disease Progression|2|||
145312139|NCT02761915|523990285|FG005|Overall Study|Disease Progression|2|||
145312140|NCT01926119|523990299|FG000|Overall Study|Withdrawal by Subject|1|||
145312141|NCT02654145|523990300|FG000|Overall Study|Lack of Efficacy|1|||
145312142|NCT02654145|523990300|FG000|Overall Study|Protocol Violation|1|||
145312143|NCT02654145|523990300|FG000|Overall Study|Withdrawal by Subject|5|||
145312144|NCT00354835|523990301|FG000|Overall Study|Death|1|||
145312145|NCT00354835|523990302|FG001|Overall Study|Death|1|||
145312146|NCT00354835|523990301|FG000|Overall Study|Physician Decision|8|||
145312147|NCT00354835|523990302|FG001|Overall Study|Physician Decision|13|||
145312148|NCT00354835|523990301|FG000|Overall Study|Withdrawal by Subject|2|||
145312149|NCT00354835|523990302|FG001|Overall Study|Withdrawal by Subject|1|||
145312150|NCT00354835|523990301|FG000|Overall Study|Ineligible|17|||
145312151|NCT00354835|523990302|FG001|Overall Study|Ineligible|16|||
145312152|NCT00354835|523990301|FG000|Overall Study|Disease progression or relapse|15|||
145312153|NCT00354835|523990302|FG001|Overall Study|Disease progression or relapse|22|||
145312154|NCT00354835|523990301|FG000|Overall Study|Adverse Event|6|||
145312155|NCT00354835|523990302|FG001|Overall Study|Adverse Event|0|||
145312156|NCT00354835|523990301|FG000|Overall Study|Refusal of further therapy|3|||
145312157|NCT00354835|523990302|FG001|Overall Study|Refusal of further therapy|8|||
145312158|NCT00645853|523990303|FG000|Overall Study|Adverse Event|18|||
145312159|NCT00645853|523990304|FG001|Overall Study|Adverse Event|7|||
145312160|NCT00645853|523990303|FG000|Overall Study|AZ study closure in Hungary|60|||
145312161|NCT00645853|523990304|FG001|Overall Study|AZ study closure in Hungary|40|||
145312162|NCT00645853|523990303|FG000|Overall Study|Withdrawal by Subject|5|||
145312163|NCT00645853|523990304|FG001|Overall Study|Withdrawal by Subject|2|||
145312164|NCT00645853|523990303|FG000|Overall Study|Protocol Violation|0|||
145312165|NCT00645853|523990304|FG001|Overall Study|Protocol Violation|2|||
145312166|NCT00645853|523990303|FG000|Overall Study|Discontinuation criteria|2|||
145312167|NCT00645853|523990304|FG001|Overall Study|Discontinuation criteria|2|||
145312168|NCT00645853|523990303|FG000|Overall Study|recall of ICF, planned operation, death|7|||
145312169|NCT00645853|523990304|FG001|Overall Study|recall of ICF, planned operation, death|4|||
145312170|NCT02637141|523990307|FG000|Overall Study|Adverse Event|1|||
145312171|NCT02637141|523990308|FG001|Overall Study|Adverse Event|1|||
145312172|NCT02637141|523990309|FG002|Overall Study|Adverse Event|0|||
145312173|NCT02637141|523990307|FG000|Overall Study|Withdrawal by Subject|1|||
145312174|NCT02637141|523990308|FG001|Overall Study|Withdrawal by Subject|1|||
145312175|NCT02637141|523990309|FG002|Overall Study|Withdrawal by Subject|1|||
145312176|NCT01597791|523990310|FG000|Overall Study|Physician Decision|2|||
145312177|NCT01597791|523990311|FG001|Overall Study|Physician Decision|1|||
145312178|NCT01597791|523990310|FG000|Overall Study|Cesarean Section|6|||
145569337|NCT00414661|524944233|FG001|Overall Study|Death|5|||
145569338|NCT00414661|524944234|FG002|Overall Study|Death|0|||
145312179|NCT01597791|523990311|FG001|Overall Study|Cesarean Section|7|||
145312180|NCT01597791|523990310|FG000|Overall Study|Subject withdrawal|0|||
145312181|NCT01597791|523990311|FG001|Overall Study|Subject withdrawal|1|||
145312182|NCT01597791|523990310|FG000|Overall Study|Protocol Violation|0|||
145312183|NCT01597791|523990311|FG001|Overall Study|Protocol Violation|1|||
145312184|NCT01728116|523990314|FG000|Overall Study|Sponsor Terminated Study|106|||
145312185|NCT01728116|523990315|FG001|Overall Study|Sponsor Terminated Study|35|||
145312186|NCT01728116|523990314|FG000|Overall Study|Withdrawal by Subject|16|||
145312187|NCT01728116|523990315|FG001|Overall Study|Withdrawal by Subject|9|||
145312188|NCT01728116|523990314|FG000|Overall Study|Adverse Event|13|||
145312189|NCT01728116|523990315|FG001|Overall Study|Adverse Event|0|||
145312190|NCT01728116|523990314|FG000|Overall Study|Procedure/device failure|7|||
145312191|NCT01728116|523990315|FG001|Overall Study|Procedure/device failure|0|||
145312192|NCT01728116|523990314|FG000|Overall Study|Lost to Follow-up|9|||
145312193|NCT01728116|523990315|FG001|Overall Study|Lost to Follow-up|2|||
145312194|NCT01728116|523990314|FG000|Overall Study|Physician Decision|2|||
145312195|NCT01728116|523990315|FG001|Overall Study|Physician Decision|0|||
145312196|NCT01728116|523990314|FG000|Overall Study|Subject Non-Compliance|2|||
145312197|NCT01728116|523990315|FG001|Overall Study|Subject Non-Compliance|0|||
145312198|NCT01728116|523990314|FG000|Overall Study|Inter-current finding at procedure|1|||
145312199|NCT01728116|523990315|FG001|Overall Study|Inter-current finding at procedure|0|||
145312200|NCT01728116|523990314|FG000|Overall Study|Incorrectly enrolled in Study|0|||
145312201|NCT01728116|523990315|FG001|Overall Study|Incorrectly enrolled in Study|1|||
145312202|NCT01728116|523990314|FG000|Overall Study|various not noted previously|5|||
145312203|NCT01728116|523990315|FG001|Overall Study|various not noted previously|0|||
145312204|NCT01868243|523990316|FG000|Overall Study|Death|0|||
145312205|NCT01868243|523990317|FG001|Overall Study|Death|1|||
145312206|NCT00467597|523990318|FG000|Overall Study|Withdrawal by Subject|2|||
145312207|NCT00467597|523990319|FG001|Overall Study|Withdrawal by Subject|0|||
145312208|NCT02096705|523990320|FG000|Treatment|Adverse Event|6|||
145312209|NCT02096705|523990321|FG001|Treatment|Adverse Event|3|||
145312210|NCT02096705|523990320|FG000|Treatment|Subject request to discontinue treatment|1|||
145312211|NCT02096705|523990321|FG001|Treatment|Subject request to discontinue treatment|1|||
145312212|NCT02096705|523990320|FG000|Treatment|Withdrawal by Subject|1|||
145312213|NCT02096705|523990321|FG001|Treatment|Withdrawal by Subject|0|||
145312214|NCT02096705|523990320|FG000|Treatment|Other|1|||
145312215|NCT02096705|523990321|FG001|Treatment|Other|1|||
145312216|NCT02096705|523990320|FG000|Follow-up|Withdrawal by Subject|1|||
145312217|NCT02096705|523990321|FG001|Follow-up|Withdrawal by Subject|0|||
145312218|NCT02096705|523990320|FG000|Follow-up|Adverse Event|2|||
145312219|NCT02096705|523990321|FG001|Follow-up|Adverse Event|2|||
145312220|NCT02096705|523990320|FG000|Follow-up|Subjects not reporting status|1|||
145312221|NCT02096705|523990321|FG001|Follow-up|Subjects not reporting status|2|||
145312222|NCT02377349|523990322|FG000|Overall Study|Serious Adverse Event|1|||
145312223|NCT02377349|523990323|FG001|Overall Study|Serious Adverse Event|0|||
145312224|NCT02377349|523990322|FG000|Overall Study|Protocol Violation|3|||
145312225|NCT02377349|523990323|FG001|Overall Study|Protocol Violation|2|||
145312226|NCT02377349|523990322|FG000|Overall Study|Withdrawal by Subject|5|||
145312227|NCT02377349|523990323|FG001|Overall Study|Withdrawal by Subject|3|||
145312228|NCT02377349|523990322|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
145312229|NCT02377349|523990323|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
145312230|NCT02377349|523990322|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
145312231|NCT02377349|523990323|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
145312232|NCT02377349|523990322|FG000|Overall Study|Other|0|||
145312233|NCT02377349|523990323|FG001|Overall Study|Other|1|||
145411170|NCT03439514|524358798|FG000|Double-Blind Treatment Period|Death|1|||
145569339|NCT00414661|524944235|FG003|Overall Study|Death|0|||
145569340|NCT00414661|524944232|FG000|Overall Study|Lost to Follow-up|1|||
145312234|NCT03277248|523990326|FG000|Overall Study|Adverse Event|3|||
145312235|NCT03277248|523990327|FG001|Overall Study|Adverse Event|1|||
145312236|NCT03277248|523990326|FG000|Overall Study|Subject Withdrawal of Consent|6|||
145312237|NCT03277248|523990327|FG001|Overall Study|Subject Withdrawal of Consent|23|||
145312238|NCT03277248|523990326|FG000|Overall Study|Investigator/Sponsor Decision|2|||
145312239|NCT03277248|523990327|FG001|Overall Study|Investigator/Sponsor Decision|2|||
145312240|NCT03277248|523990326|FG000|Overall Study|Pregnancy|4|||
145312241|NCT03277248|523990327|FG001|Overall Study|Pregnancy|1|||
145312242|NCT03277248|523990326|FG000|Overall Study|Lost to Follow-up|0|||
145312243|NCT03277248|523990327|FG001|Overall Study|Lost to Follow-up|2|||
145312244|NCT03277248|523990326|FG000|Overall Study|Lack of Efficacy|0|||
145312245|NCT03277248|523990327|FG001|Overall Study|Lack of Efficacy|2|||
145312246|NCT03277248|523990326|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
145312247|NCT03277248|523990327|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
145312248|NCT00379353|523990336|FG000|Overall Study|Hospitalization|3|||
145312249|NCT00379353|523990337|FG001|Overall Study|Hospitalization|3|||
145312250|NCT00379353|523990336|FG000|Overall Study|Withdrawal by Subject|5|||
145312251|NCT00379353|523990337|FG001|Overall Study|Withdrawal by Subject|2|||
145569341|NCT00414661|524944233|FG001|Overall Study|Lost to Follow-up|4|||
145312252|NCT00379353|523990336|FG000|Overall Study|Death|1|||
145312253|NCT00379353|523990337|FG001|Overall Study|Death|0|||
145312254|NCT00379353|523990336|FG000|Overall Study|Cardiac Tamponade|1|||
145312255|NCT00379353|523990337|FG001|Overall Study|Cardiac Tamponade|0|||
145312256|NCT00379353|523990336|FG000|Overall Study|Non-compliance|1|||
145312257|NCT00379353|523990337|FG001|Overall Study|Non-compliance|0|||
145312258|NCT00379353|523990336|FG000|Overall Study|Conflicting drug treatment|0|||
145312259|NCT00379353|523990337|FG001|Overall Study|Conflicting drug treatment|1|||
145312260|NCT01971645|523990338|FG000|Overall Study|Adverse Event|1|||
145312261|NCT01971645|523990339|FG001|Overall Study|Adverse Event|0|||
145312262|NCT01971645|523990340|FG002|Overall Study|Adverse Event|0|||
145312263|NCT01971645|523990338|FG000|Overall Study|Lost to Follow-up|1|||
145312264|NCT01971645|523990339|FG001|Overall Study|Lost to Follow-up|0|||
145312265|NCT01971645|523990340|FG002|Overall Study|Lost to Follow-up|1|||
145312266|NCT01971645|523990338|FG000|Overall Study|Protocol Violation|0|||
145312267|NCT01971645|523990339|FG001|Overall Study|Protocol Violation|0|||
145312268|NCT01971645|523990340|FG002|Overall Study|Protocol Violation|1|||
145312269|NCT02119936|523990341|FG000|Overall Study|Lost to Follow-up|10|||
145312270|NCT01390948|523990342|FG000|Overall Study|End of Study|1|||
145569342|NCT00414661|524944234|FG002|Overall Study|Lost to Follow-up|0|||
145312271|NCT01390948|523990343|FG001|Overall Study|End of Study|0|||
145312272|NCT01390948|523990344|FG002|Overall Study|End of Study|0|||
145312273|NCT01390948|523990342|FG000|Overall Study|Withdrew consent|2|||
145312274|NCT01390948|523990343|FG001|Overall Study|Withdrew consent|2|||
145312275|NCT01390948|523990344|FG002|Overall Study|Withdrew consent|0|||
145312276|NCT01390948|523990342|FG000|Overall Study|Progressive Disease|2|||
145312277|NCT01390948|523990343|FG001|Overall Study|Progressive Disease|5|||
145312278|NCT01390948|523990344|FG002|Overall Study|Progressive Disease|0|||
145312279|NCT01390948|523990342|FG000|Overall Study|Death during follow-up|10|||
145312280|NCT01390948|523990343|FG001|Overall Study|Death during follow-up|11|||
145312281|NCT01390948|523990344|FG002|Overall Study|Death during follow-up|1|||
145312282|NCT05315713|523990345|FG000|Overall Study|Death|5|||
145312283|NCT05315713|523990345|FG000|Overall Study|Progressive disease|1|||
145312284|NCT05315713|523990345|FG000|Overall Study|Withdrawal by Subject|1|||
145312285|NCT05315713|523990345|FG000|Overall Study|Study terminated by sponsor|1|||
145312286|NCT02300987|523991644|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
145312287|NCT02300987|523991645|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
145312288|NCT02300987|523991644|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
145312289|NCT02300987|523991645|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
145312290|NCT02300987|523991644|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
145312291|NCT02300987|523991645|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
145312292|NCT02300987|523991644|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
145312293|NCT02300987|523991645|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
145312294|NCT02300987|523991644|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
145312295|NCT02300987|523991645|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
145312296|NCT03086135|523991646|FG000|Overall Study|Adverse Event|1|||
145312297|NCT03086135|523991646|FG000|Overall Study|Lost to Follow-up|2|||
145312298|NCT01023061|523991647|FG000|Overall Study|Withdrawal prior to treatment|2|||
145312299|NCT02259348|523991648|FG000|Overall Study|Donors|6|||
145312300|NCT02259348|523991648|FG000|Overall Study|Death|4|||
145312301|NCT01622660|523991649|FG000|Overall Study|Adverse Event|1|||
145312302|NCT04211766|523991650|FG000|Overall Study|Withdrawal by Subject|5|||
145312303|NCT04211766|523991651|FG001|Overall Study|Withdrawal by Subject|1|||
145312304|NCT00820599|523991655|FG000|Overall Study|Death|129|||
145312305|NCT00820599|523991655|FG000|Overall Study|Withdrawal by Subject|2|||
145312306|NCT01120899|523991656|FG000|Overall Study|Withdrawal by Subject|3|||
145312307|NCT03686215|523991657|FG000|Overall Study|Adverse Event|0|||
145312308|NCT03686215|523991658|FG001|Overall Study|Adverse Event|0|||
145312309|NCT03686215|523991659|FG002|Overall Study|Adverse Event|7|||
145312310|NCT03686215|523991657|FG000|Overall Study|Physician Decision|0|||
145312311|NCT03686215|523991658|FG001|Overall Study|Physician Decision|0|||
145312312|NCT03686215|523991659|FG002|Overall Study|Physician Decision|1|||
145312313|NCT03686215|523991657|FG000|Overall Study|Protocol Violation|0|||
145312314|NCT03686215|523991658|FG001|Overall Study|Protocol Violation|0|||
145312315|NCT03686215|523991659|FG002|Overall Study|Protocol Violation|4|||
145312316|NCT03686215|523991657|FG000|Overall Study|Device issue|1|||
145312317|NCT03686215|523991658|FG001|Overall Study|Device issue|0|||
145312318|NCT03686215|523991659|FG002|Overall Study|Device issue|2|||
145312319|NCT00522041|523991660|FG000|Overall Study|Adverse Event|9|||
145312320|NCT00522041|523991661|FG001|Overall Study|Adverse Event|3|||
145312321|NCT00522041|523991660|FG000|Overall Study|Protocol Violation|2|||
145312322|NCT00522041|523991661|FG001|Overall Study|Protocol Violation|0|||
145312323|NCT00522041|523991660|FG000|Overall Study|Lost to Follow-up|1|||
145312324|NCT00522041|523991661|FG001|Overall Study|Lost to Follow-up|4|||
145312325|NCT00522041|523991660|FG000|Overall Study|Voluntary withdrawal|5|||
145312326|NCT00522041|523991661|FG001|Overall Study|Voluntary withdrawal|4|||
145312327|NCT00522041|523991660|FG000|Overall Study|Did not receive treatment|0|||
145312328|NCT00522041|523991661|FG001|Overall Study|Did not receive treatment|1|||
145312329|NCT02725515|523991662|FG000|Overall Study|Refused infusion (no study treatment)|1|||
145312330|NCT02725515|523991663|FG001|Overall Study|Refused infusion (no study treatment)|0|||
145312331|NCT02725515|523991662|FG000|Overall Study|Loss of Improvement per Protocol|14|||
145312332|NCT02725515|523991663|FG001|Overall Study|Loss of Improvement per Protocol|25|||
145312333|NCT02725515|523991662|FG000|Overall Study|Withdrawal by Subject|2|||
145312334|NCT02725515|523991663|FG001|Overall Study|Withdrawal by Subject|1|||
145312335|NCT02725515|523991662|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145312336|NCT02725515|523991663|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145312337|NCT02725515|523991662|FG000|Overall Study|Lost to Follow-up|1|||
145312338|NCT02725515|523991663|FG001|Overall Study|Lost to Follow-up|1|||
145312339|NCT02725515|523991662|FG000|Overall Study|Adverse Event|7|||
145312340|NCT02725515|523991663|FG001|Overall Study|Adverse Event|2|||
145312341|NCT02725515|523991662|FG000|Overall Study|No Documented Disease Improvement|0|||
145312342|NCT02725515|523991663|FG001|Overall Study|No Documented Disease Improvement|1|||
145312343|NCT02725515|523991662|FG000|Overall Study|Completed Study Under Original Protocol|0|||
145312344|NCT02725515|523991663|FG001|Overall Study|Completed Study Under Original Protocol|1|||
145312345|NCT02725515|523991662|FG000|Overall Study|Lack of Response|0|||
145312346|NCT02725515|523991663|FG001|Overall Study|Lack of Response|1|||
145312347|NCT00874549|523991664|FG000|Overall Study|Adverse Event|0|||
145312348|NCT00874549|523991665|FG001|Overall Study|Adverse Event|0|||
145312349|NCT00874549|523991666|FG002|Overall Study|Adverse Event|1|||
145312350|NCT00874549|523991667|FG003|Overall Study|Adverse Event|0|||
145312351|NCT00874549|523991664|FG000|Overall Study|Protocol Violation|1|||
145312352|NCT00874549|523991665|FG001|Overall Study|Protocol Violation|0|||
145312353|NCT00874549|523991666|FG002|Overall Study|Protocol Violation|2|||
145312354|NCT00874549|523991667|FG003|Overall Study|Protocol Violation|1|||
145312355|NCT00874549|523991664|FG000|Overall Study|Lost to Follow-up|0|||
145312356|NCT00874549|523991665|FG001|Overall Study|Lost to Follow-up|0|||
145312357|NCT00874549|523991666|FG002|Overall Study|Lost to Follow-up|1|||
145312358|NCT00874549|523991667|FG003|Overall Study|Lost to Follow-up|0|||
145312359|NCT00874549|523991664|FG000|Overall Study|Withdrawal by Subject|0|||
145312360|NCT00874549|523991665|FG001|Overall Study|Withdrawal by Subject|1|||
145312361|NCT00874549|523991666|FG002|Overall Study|Withdrawal by Subject|0|||
145312362|NCT00874549|523991667|FG003|Overall Study|Withdrawal by Subject|1|||
145312363|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
145312364|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
145312365|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
145312366|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
145312367|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
145312368|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
145312369|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
145312370|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
145312371|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
145312372|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
145312373|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
145312374|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
145312375|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
145312376|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
145312377|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
145312378|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
145312379|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
145312380|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
145312381|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
145312382|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
145312383|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
145312384|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
145312385|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
145312386|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
145312387|NCT01710358|523991668|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
145312388|NCT01710358|523991669|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
145312389|NCT01710358|523991670|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
145312390|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
145312391|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
145312392|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
145312393|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
145312394|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
145312395|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
145312396|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
145312397|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
145312398|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
145312399|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
145312400|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
145312401|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
145312402|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
145312403|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
145312404|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
145312405|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
145312406|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
145312407|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
145312408|NCT01710358|523991668|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
145312409|NCT01710358|523991669|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
145312410|NCT01710358|523991670|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
145312411|NCT01710358|523991668|FG000|Rescue Period|Adverse Event|0|||
145312412|NCT01710358|523991669|FG001|Rescue Period|Adverse Event|15|||
145312413|NCT01710358|523991670|FG002|Rescue Period|Adverse Event|0|||
145312414|NCT01710358|523991668|FG000|Rescue Period|Death|0|||
145312415|NCT01710358|523991669|FG001|Rescue Period|Death|1|||
145312416|NCT01710358|523991670|FG002|Rescue Period|Death|0|||
145312417|NCT01710358|523991668|FG000|Rescue Period|Lack of Efficacy|0|||
145312418|NCT01710358|523991669|FG001|Rescue Period|Lack of Efficacy|7|||
145312419|NCT01710358|523991670|FG002|Rescue Period|Lack of Efficacy|0|||
145312420|NCT01710358|523991668|FG000|Rescue Period|Withdrawal by Subject|0|||
145312421|NCT01710358|523991669|FG001|Rescue Period|Withdrawal by Subject|8|||
145312422|NCT01710358|523991670|FG002|Rescue Period|Withdrawal by Subject|0|||
145312423|NCT00084864|523991671|FG000|Overall Study|Adverse Event|1|||
145312424|NCT00084864|523991672|FG001|Overall Study|Adverse Event|0|||
145312425|NCT00084864|523991673|FG002|Overall Study|Adverse Event|0|||
145312426|NCT00084864|523991674|FG003|Overall Study|Adverse Event|0|||
145312427|NCT01456962|523991679|FG000|Overall Study|Lost to Follow-up|2|||
145312428|NCT01456962|523991680|FG001|Overall Study|Lost to Follow-up|1|||
145312429|NCT01721772|523991681|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
145312430|NCT01721772|523991682|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
145312431|NCT01721772|523991681|FG000|Pre-Treatment|Poor/non-compliance|0|||
145312432|NCT01721772|523991682|FG001|Pre-Treatment|Poor/non-compliance|1|||
145312433|NCT01721772|523991681|FG000|Pre-Treatment|Participant withdrew consent|0|||
145312434|NCT01721772|523991682|FG001|Pre-Treatment|Participant withdrew consent|1|||
145312435|NCT01721772|523991681|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
145312436|NCT01721772|523991682|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
145312437|NCT01721772|523991681|FG000|Treatment|Disease progression|119|||
145312438|NCT01721772|523991682|FG001|Treatment|Disease progression|168|||
145312439|NCT01721772|523991681|FG000|Treatment|Study drug toxicity|19|||
145312440|NCT01721772|523991682|FG001|Treatment|Study drug toxicity|10|||
145312441|NCT01721772|523991681|FG000|Treatment|Adverse event unrelated to study drug|7|||
145312442|NCT01721772|523991682|FG001|Treatment|Adverse event unrelated to study drug|7|||
145312443|NCT01721772|523991681|FG000|Treatment|Maximum clinical benefit|16|||
145312444|NCT01721772|523991682|FG001|Treatment|Maximum clinical benefit|4|||
145312445|NCT01721772|523991681|FG000|Treatment|Other|19|||
145312446|NCT01721772|523991682|FG001|Treatment|Other|2|||
145312447|NCT01721772|523991681|FG000|Treatment|Participant withdrew consent|2|||
145312448|NCT01721772|523991682|FG001|Treatment|Participant withdrew consent|5|||
145312449|NCT01721772|523991681|FG000|Treatment|Participant request to discontinue study treatment|21|||
145312450|NCT01721772|523991682|FG001|Treatment|Participant request to discontinue study treatment|8|||
145312451|NCT01721772|523991681|FG000|Treatment|Death|1|||
145312452|NCT01721772|523991682|FG001|Treatment|Death|0|||
145312453|NCT01721772|523991681|FG000|Treatment|Not reported|1|||
145312454|NCT01721772|523991682|FG001|Treatment|Not reported|0|||
145312455|NCT01721772|523991681|FG000|Treatment|Poor/non-compliance|1|||
145312456|NCT01721772|523991682|FG001|Treatment|Poor/non-compliance|0|||
145312457|NCT01721772|523991681|FG000|Treatment|Lost to Follow-up|0|||
145312458|NCT01721772|523991682|FG001|Treatment|Lost to Follow-up|1|||
145312459|NCT04542694|523991684|FG000|Overall Study|The need for prohibited therapy|2|||
145312460|NCT04542694|523991685|FG001|Overall Study|The need for prohibited therapy|0|||
145312461|NCT04542694|523991684|FG000|Overall Study|Adverse Event|1|||
145411171|NCT03439514|524358799|FG001|Double-Blind Treatment Period|Death|2|||
145411172|NCT02362451|524358800|FG000|Overall Study|Withdrawal by Subject|0|||
145569343|NCT00414661|524944235|FG003|Overall Study|Lost to Follow-up|1|||
145312462|NCT04542694|523991685|FG001|Overall Study|Adverse Event|0|||
145312463|NCT04542694|523991684|FG000|Overall Study|Protocol Violation|1|||
145312464|NCT04542694|523991685|FG001|Overall Study|Protocol Violation|0|||
145312465|NCT00969124|523991686|FG000|Overall Study|Protocol Violation|2|||
145312466|NCT00969124|523991686|FG000|Overall Study|Inadequate bowel preparation|15|||
145411173|NCT02362451|524358801|FG001|Overall Study|Withdrawal by Subject|1|||
145569344|NCT00414661|524944232|FG000|Overall Study|Withdrawal by Subject|5|||
145569345|NCT00414661|524944233|FG001|Overall Study|Withdrawal by Subject|2|||
145569346|NCT00414661|524944234|FG002|Overall Study|Withdrawal by Subject|2|||
145569347|NCT00414661|524944235|FG003|Overall Study|Withdrawal by Subject|2|||
145569348|NCT00414661|524944232|FG000|Overall Study|Other|6|||
145569349|NCT00414661|524944233|FG001|Overall Study|Other|3|||
145569350|NCT00414661|524944234|FG002|Overall Study|Other|0|||
145312467|NCT00969124|523991686|FG000|Overall Study|Inability to reach cecum|9|||
145312468|NCT00969124|523991686|FG000|Overall Study|Previously unrecognized disease|3|||
145569351|NCT00414661|524944235|FG003|Overall Study|Other|0|||
145569352|NCT00559962|524944239|FG000|Overall Study|Adverse Event|1|||
145569353|NCT00559962|524944240|FG001|Overall Study|Adverse Event|7|||
145312469|NCT00969124|523991686|FG000|Overall Study|Technical error|1|||
145312470|NCT00687739|523991687|FG000|Overall Study|Lost to Follow-up|2|||
145312471|NCT00687739|523991688|FG001|Overall Study|Lost to Follow-up|2|||
145312472|NCT00687739|523991689|FG002|Overall Study|Lost to Follow-up|1|||
145312473|NCT00687739|523991690|FG003|Overall Study|Lost to Follow-up|2|||
145312474|NCT00687739|523991687|FG000|Overall Study|Adverse Event|0|||
145312475|NCT00687739|523991688|FG001|Overall Study|Adverse Event|1|||
145312476|NCT00687739|523991689|FG002|Overall Study|Adverse Event|1|||
145312477|NCT00687739|523991690|FG003|Overall Study|Adverse Event|0|||
145312478|NCT05278858|523991703|FG000|Overall Study|Withdrawal by Subject|1|||
145312479|NCT01451541|523991706|FG000|Overall Study|Adverse Event|4|||
145312480|NCT01451541|523991707|FG001|Overall Study|Adverse Event|3|||
145312481|NCT01451541|523991708|FG002|Overall Study|Adverse Event|6|||
145312482|NCT01451541|523991706|FG000|Overall Study|Lack of Efficacy|2|||
145312483|NCT01451541|523991707|FG001|Overall Study|Lack of Efficacy|0|||
145312484|NCT01451541|523991708|FG002|Overall Study|Lack of Efficacy|0|||
145312485|NCT01451541|523991706|FG000|Overall Study|Lost to Follow-up|4|||
145312486|NCT01451541|523991707|FG001|Overall Study|Lost to Follow-up|4|||
145312487|NCT01451541|523991708|FG002|Overall Study|Lost to Follow-up|7|||
145312488|NCT01451541|523991706|FG000|Overall Study|Withdrawal by Subject|15|||
145312489|NCT01451541|523991707|FG001|Overall Study|Withdrawal by Subject|8|||
145312490|NCT01451541|523991708|FG002|Overall Study|Withdrawal by Subject|6|||
145312491|NCT01451541|523991706|FG000|Overall Study|randomization error, noncompliance|11|||
145312492|NCT01451541|523991707|FG001|Overall Study|randomization error, noncompliance|10|||
145312493|NCT01451541|523991708|FG002|Overall Study|randomization error, noncompliance|8|||
145312494|NCT03366428|523991709|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
145312495|NCT03366428|523991709|FG000|Overall Study|Adverse Event|12|||
145312496|NCT03366428|523991709|FG000|Overall Study|Clinical progression|2|||
145312497|NCT03366428|523991709|FG000|Overall Study|Withdrawal by Subject|4|||
145312498|NCT02166606|523991710|FG000|Overall Study|Adverse Event|3|||
145312499|NCT02166606|523991710|FG000|Overall Study|Death|31|||
145312500|NCT02166606|523991710|FG000|Overall Study|Protocol Violation|7|||
145312501|NCT02166606|523991710|FG000|Overall Study|Lost to Follow-up|30|||
145312502|NCT02166606|523991710|FG000|Overall Study|Withdrawal by Subject|1|||
145312503|NCT02166606|523991710|FG000|Overall Study|Physician Decision|1|||
145312504|NCT02166606|523991710|FG000|Overall Study|Device upgrade|1|||
145312505|NCT02166606|523991710|FG000|Overall Study|Enrolled after End of Enrollment|4|||
145312506|NCT01958476|523991713|FG000|Overall Study|Parent requested exclusion from analysis|1|||
145312507|NCT01958476|523991714|FG001|Overall Study|Parent requested exclusion from analysis|0|||
145312508|NCT05412121|523991717|FG000|Overall Study|Withdrawal by Subject|4|||
145312509|NCT05412121|523991717|FG000|Overall Study|Physician Decision|1|||
145312510|NCT05412121|523991717|FG000|Overall Study|Lost to Follow-up|5|||
145312511|NCT02670551|523991718|FG000|Overall Study|Adverse Event|4|||
145312512|NCT02670551|523991719|FG001|Overall Study|Adverse Event|7|||
145312513|NCT02670551|523991720|FG002|Overall Study|Adverse Event|9|||
145312514|NCT02670551|523991718|FG000|Overall Study|Lack of Efficacy|2|||
145312515|NCT02670551|523991719|FG001|Overall Study|Lack of Efficacy|0|||
145312516|NCT02670551|523991720|FG002|Overall Study|Lack of Efficacy|3|||
145312517|NCT02670551|523991718|FG000|Overall Study|Withdrawal of Consent|6|||
145312518|NCT02670551|523991719|FG001|Overall Study|Withdrawal of Consent|3|||
145312519|NCT02670551|523991720|FG002|Overall Study|Withdrawal of Consent|8|||
145312520|NCT02670551|523991718|FG000|Overall Study|Lost to Follow-up|5|||
145312521|NCT02670551|523991719|FG001|Overall Study|Lost to Follow-up|7|||
145312522|NCT02670551|523991720|FG002|Overall Study|Lost to Follow-up|6|||
145312523|NCT02670551|523991718|FG000|Overall Study|Protocol Violation|1|||
145312524|NCT02670551|523991719|FG001|Overall Study|Protocol Violation|0|||
145312525|NCT02670551|523991720|FG002|Overall Study|Protocol Violation|0|||
145312526|NCT02670551|523991718|FG000|Overall Study|Noncompliance with study drug|3|||
145312527|NCT02670551|523991719|FG001|Overall Study|Noncompliance with study drug|3|||
145312528|NCT02670551|523991720|FG002|Overall Study|Noncompliance with study drug|2|||
145312529|NCT02670551|523991718|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145312530|NCT02670551|523991719|FG001|Overall Study|Other Miscellaneous Reasons|3|||
145312531|NCT02670551|523991720|FG002|Overall Study|Other Miscellaneous Reasons|3|||
145312532|NCT02670551|523991718|FG000|Overall Study|Did Not Receive Treatment|5|||
145312533|NCT02670551|523991719|FG001|Overall Study|Did Not Receive Treatment|3|||
145569354|NCT00559962|524944241|FG002|Overall Study|Adverse Event|8|||
145569355|NCT00559962|524944242|FG003|Overall Study|Adverse Event|5|||
145569356|NCT00559962|524944243|FG004|Overall Study|Adverse Event|11|||
145569357|NCT00559962|524944244|FG005|Overall Study|Adverse Event|4|||
145569358|NCT00559962|524944245|FG006|Overall Study|Adverse Event|4|||
145569359|NCT00559962|524944246|FG007|Overall Study|Adverse Event|2|||
145569360|NCT00559962|524944239|FG000|Overall Study|Lost to Follow-up|0|||
145569361|NCT00559962|524944240|FG001|Overall Study|Lost to Follow-up|1|||
145569362|NCT00559962|524944241|FG002|Overall Study|Lost to Follow-up|0|||
145569363|NCT00559962|524944242|FG003|Overall Study|Lost to Follow-up|0|||
145569364|NCT00559962|524944243|FG004|Overall Study|Lost to Follow-up|0|||
145569365|NCT00559962|524944244|FG005|Overall Study|Lost to Follow-up|0|||
145569366|NCT00559962|524944245|FG006|Overall Study|Lost to Follow-up|0|||
145569367|NCT00559962|524944246|FG007|Overall Study|Lost to Follow-up|0|||
145569368|NCT00559962|524944239|FG000|Overall Study|Withdrawal by Subject|1|||
145569369|NCT00559962|524944240|FG001|Overall Study|Withdrawal by Subject|1|||
145569370|NCT00559962|524944241|FG002|Overall Study|Withdrawal by Subject|2|||
145569371|NCT00559962|524944242|FG003|Overall Study|Withdrawal by Subject|0|||
145569372|NCT00559962|524944243|FG004|Overall Study|Withdrawal by Subject|3|||
145312534|NCT02670551|523991720|FG002|Overall Study|Did Not Receive Treatment|0|||
145312535|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
145312536|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
145312537|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
145312538|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
145312539|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|Death|3|||
145312540|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|Death|1|||
145312541|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
145312542|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
145312543|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
145312544|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
145312545|NCT00537095|523991722|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
145312546|NCT00537095|523991723|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
145312547|NCT00537095|523991722|FG000|Open-label Period (590 Days)|Adverse Event|2|||
145312548|NCT00537095|523991723|FG001|Open-label Period (590 Days)|Adverse Event|11|||
145312549|NCT00537095|523991722|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
145312550|NCT00537095|523991723|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
145312551|NCT00537095|523991722|FG000|Open-label Period (590 Days)|Death|2|||
145312552|NCT00537095|523991723|FG001|Open-label Period (590 Days)|Death|2|||
145312553|NCT00537095|523991722|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
145312554|NCT00537095|523991723|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
145312555|NCT00537095|523991722|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
145312556|NCT00537095|523991723|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
145312557|NCT00533507|523991724|FG000|Overall Study|Withdrawal by Subject|1|||
145312558|NCT02943096|523991725|FG000|Overall Study|Lack of Efficacy|0|||
145312559|NCT02943096|523991726|FG001|Overall Study|Lack of Efficacy|1|||
145312560|NCT05065619|523991727|FG000|Up to Day 42|Lost to Follow-up|1|||
145312561|NCT05065619|523991728|FG001|Up to Day 42|Lost to Follow-up|0|||
145312562|NCT05065619|523991727|FG000|Up to Day 42|Withdrawal by Subject|1|||
145312563|NCT05065619|523991728|FG001|Up to Day 42|Withdrawal by Subject|0|||
145312564|NCT05065619|523991727|FG000|After Day 43|Lost to Follow-up|1|||
145312565|NCT05065619|523991728|FG001|After Day 43|Lost to Follow-up|0|||
145312566|NCT05065619|523991727|FG000|After Day 43|Physician Decision|3|||
145312567|NCT05065619|523991728|FG001|After Day 43|Physician Decision|0|||
145312568|NCT05065619|523991727|FG000|After Day 43|Withdrawal by Subject|1|||
145312569|NCT05065619|523991728|FG001|After Day 43|Withdrawal by Subject|2|||
145312570|NCT05065619|523991727|FG000|After Day 43|Public vaccination|6|||
145312571|NCT05065619|523991728|FG001|After Day 43|Public vaccination|8|||
145312572|NCT05065619|523991727|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
145312573|NCT05065619|523991728|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
145312574|NCT05065619|523991727|FG000|After Day 43|Study Terminated by Sponsor|88|||
145312575|NCT05065619|523991728|FG001|After Day 43|Study Terminated by Sponsor|16|||
145312576|NCT00714051|523991730|FG000|Overall Study|Withdrawal by Subject|1|||
145312577|NCT00714051|523991731|FG001|Overall Study|Withdrawal by Subject|0|||
145312578|NCT00714051|523991730|FG000|Overall Study|Death|0|||
145312579|NCT00714051|523991731|FG001|Overall Study|Death|1|||
145312580|NCT01929681|523991732|FG000|Overall Study|Withdrawal by Subject|1|||
145312581|NCT01929681|523991733|FG001|Overall Study|Withdrawal by Subject|0|||
145312582|NCT01929681|523991732|FG000|Overall Study|Physician Decision|1|||
145312583|NCT01929681|523991733|FG001|Overall Study|Physician Decision|1|||
145411174|NCT02362451|524358800|FG000|Overall Study|Lack of Efficacy|2|||
145569373|NCT00559962|524944244|FG005|Overall Study|Withdrawal by Subject|1|||
145569374|NCT00559962|524944245|FG006|Overall Study|Withdrawal by Subject|0|||
145569375|NCT00559962|524944246|FG007|Overall Study|Withdrawal by Subject|2|||
145569376|NCT00559962|524944239|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
145312584|NCT03555695|523991736|FG000|Overall Study|Withdrawal by Subject|1|||
145312585|NCT03555695|523991736|FG000|Overall Study|Lost to Follow-up|1|||
145312586|NCT03555695|523991736|FG000|Overall Study|appendicitis (unrelated)|1|||
145312587|NCT03555695|523991736|FG000|Overall Study|pre-existing sciatica|1|||
145312588|NCT01426854|523991737|FG000|Overall Study|Adverse Event|1|||
145312589|NCT01426854|523991738|FG001|Overall Study|Adverse Event|5|||
145312590|NCT01426854|523991737|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
145569377|NCT00559962|524944240|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
145569378|NCT00559962|524944241|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
145569379|NCT00559962|524944242|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
145569380|NCT00559962|524944243|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
145312591|NCT01426854|523991738|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
145312592|NCT01426854|523991737|FG000|Overall Study|Lost to Follow-up|3|||
145312593|NCT01426854|523991738|FG001|Overall Study|Lost to Follow-up|0|||
145312594|NCT01426854|523991737|FG000|Overall Study|Noncompliance|0|||
145312595|NCT01426854|523991738|FG001|Overall Study|Noncompliance|1|||
145312596|NCT01426854|523991737|FG000|Overall Study|Treatment Failure|0|||
145312597|NCT01426854|523991738|FG001|Overall Study|Treatment Failure|16|||
145312598|NCT01426854|523991737|FG000|Overall Study|Protocol Deviation|0|||
145312599|NCT01426854|523991738|FG001|Overall Study|Protocol Deviation|1|||
145312600|NCT01426854|523991737|FG000|Overall Study|Other|3|||
145312601|NCT01426854|523991738|FG001|Overall Study|Other|2|||
145312602|NCT01971554|523991739|FG000|Overall Study|Lost to Follow-up|1|||
145312603|NCT01971554|523991740|FG001|Overall Study|Lost to Follow-up|0|||
145312604|NCT01971554|523991741|FG002|Overall Study|Lost to Follow-up|0|||
145312605|NCT01971554|523991742|FG003|Overall Study|Lost to Follow-up|0|||
145312606|NCT01942135|523991744|FG000|Overall Study|Adverse Event|21|||
145312607|NCT01942135|523991745|FG001|Overall Study|Adverse Event|7|||
145312608|NCT01942135|523991744|FG000|Overall Study|Global Deterioration of Health Status|9|||
145312609|NCT01942135|523991745|FG001|Overall Study|Global Deterioration of Health Status|6|||
145312610|NCT01942135|523991744|FG000|Overall Study|Randomized Not Treated|2|||
145312611|NCT01942135|523991745|FG001|Overall Study|Randomized Not Treated|2|||
145312612|NCT01942135|523991744|FG000|Overall Study|Death|2|||
145312613|NCT01942135|523991745|FG001|Overall Study|Death|1|||
145312614|NCT01942135|523991744|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
145312615|NCT01942135|523991745|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
145312616|NCT01942135|523991744|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
145312617|NCT01942135|523991745|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
145312618|NCT01942135|523991744|FG000|Overall Study|Withdrawal by Subject|4|||
145312619|NCT01942135|523991745|FG001|Overall Study|Withdrawal by Subject|3|||
145312620|NCT01942135|523991744|FG000|Overall Study|Protocol Violation|1|||
145312621|NCT01942135|523991745|FG001|Overall Study|Protocol Violation|0|||
145312622|NCT01942135|523991744|FG000|Overall Study|Other|19|||
145312623|NCT01942135|523991745|FG001|Overall Study|Other|4|||
145312624|NCT01717040|523991746|FG000|Overall Study|Lost to Follow-up|2|||
145312625|NCT01717040|523991747|FG001|Overall Study|Lost to Follow-up|3|||
145312626|NCT01717040|523991746|FG000|Overall Study|Lack of Efficacy|1|||
145312627|NCT01717040|523991747|FG001|Overall Study|Lack of Efficacy|1|||
145312628|NCT01717040|523991746|FG000|Overall Study|Adverse Event|1|||
145312629|NCT01717040|523991747|FG001|Overall Study|Adverse Event|0|||
145312630|NCT01717040|523991746|FG000|Overall Study|Required Medication Change|0|||
145312631|NCT01717040|523991747|FG001|Overall Study|Required Medication Change|1|||
145312632|NCT01717040|523991746|FG000|Overall Study|New Substance Use Disorder|1|||
145312633|NCT01717040|523991747|FG001|Overall Study|New Substance Use Disorder|0|||
145312634|NCT03196284|523991748|FG000|Main Part|Withdrawal by Subject|0|||
145312635|NCT03196284|523991749|FG001|Main Part|Withdrawal by Subject|1|||
145312636|NCT03196284|523991750|FG002|Main Part|Withdrawal by Subject|0|||
145312637|NCT03196284|523991748|FG000|Extension Part|Lack of Efficacy|0|||
145312638|NCT03196284|523991749|FG001|Extension Part|Lack of Efficacy|0|||
145312639|NCT03196284|523991750|FG002|Extension Part|Lack of Efficacy|1|||
145312640|NCT03196284|523991748|FG000|Extension Part|Withdrawal by Subject|0|||
145312641|NCT03196284|523991749|FG001|Extension Part|Withdrawal by Subject|0|||
145312642|NCT03196284|523991750|FG002|Extension Part|Withdrawal by Subject|1|||
145312643|NCT03196284|523991748|FG000|Extension Part|Physician Decision|0|||
145312644|NCT03196284|523991749|FG001|Extension Part|Physician Decision|0|||
145312645|NCT03196284|523991750|FG002|Extension Part|Physician Decision|1|||
145312646|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
145411175|NCT02362451|524358801|FG001|Overall Study|Lack of Efficacy|0|||
145569381|NCT00559962|524944244|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
145569382|NCT00559962|524944245|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
145312647|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
145312648|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
145312649|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
145312650|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
145312651|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
145312652|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
145312653|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
145312654|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
145312655|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
145312656|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
145312657|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
145312658|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
145312659|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
145312660|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
145312661|NCT01139762|523991751|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
145312662|NCT01139762|523991752|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
145312663|NCT01139762|523991753|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
145312664|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
145312665|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
145312666|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
145312667|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Death|0|||
145312668|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Death|1|||
145312669|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Death|1|||
145312670|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
145312671|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
145312672|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
145312673|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
145312674|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
145312675|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
145312676|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
145312677|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
145312678|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
145312679|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
145312680|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
145312681|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
145312682|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
145312683|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
145312684|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
145312685|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
145312686|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
145312687|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
145312688|NCT01139762|523991751|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
145312689|NCT01139762|523991752|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
145312690|NCT01139762|523991753|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
145312691|NCT01675596|523991754|FG000|Overall Study|Death|6|||
145312692|NCT01675596|523991754|FG000|Overall Study|Exit with other reason|1|||
145312693|NCT01675596|523991754|FG000|Overall Study|Missed Visit|1|||
145312694|NCT02535923|523991755|FG000|Overall Study|Lost to Follow-up|5|||
145312695|NCT02535923|523991756|FG001|Overall Study|Lost to Follow-up|5|||
145312696|NCT02535923|523991755|FG000|Overall Study|Withdrawal by Subject|4|||
145312697|NCT02535923|523991756|FG001|Overall Study|Withdrawal by Subject|3|||
145312698|NCT00685334|523991757|FG000|Overall Study|Withdrawal by Subject|5|||
145312699|NCT00685334|523991758|FG001|Overall Study|Withdrawal by Subject|6|||
145312700|NCT00685334|523991757|FG000|Overall Study|Lost to Follow-up|4|||
145312701|NCT00685334|523991758|FG001|Overall Study|Lost to Follow-up|0|||
145312702|NCT00685334|523991757|FG000|Overall Study|Chose to enter hospital|1|||
145312703|NCT00685334|523991758|FG001|Overall Study|Chose to enter hospital|1|||
145312704|NCT03694197|523991759|FG000|Overall Study|Adverse Event|9|||
145312705|NCT03694197|523991759|FG000|Overall Study|Protocol became inconvenient to participate|1|||
145569383|NCT00559962|524944246|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
145569384|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
145312706|NCT03694197|523991759|FG000|Overall Study|Physician Decision|4|||
145312707|NCT03694197|523991759|FG000|Overall Study|Study terminated by sponsor|1350|||
145312708|NCT03694197|523991759|FG000|Overall Study|Participant moved|5|||
145312709|NCT03694197|523991759|FG000|Overall Study|Participant withdrew consent|10|||
145312710|NCT03694197|523991759|FG000|Overall Study|Related to IMP administration|1|||
145312711|NCT03694197|523991759|FG000|Overall Study|Not disclosed|5|||
145312712|NCT01662024|523993325|FG000|Overall Study|Pregnancy|2|||
145312713|NCT01662024|523993325|FG000|Overall Study|Withdrawal by Subject|3|||
145620365|NCT01824472|525123760|FG002|Overall Study|Lost to Follow-up|1|||
145312714|NCT00927251|523993326|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
145312715|NCT01813435|523993327|FG000|Overall Study|did not finish experimental regimen|1902|||
145312716|NCT01813435|523993328|FG001|Overall Study|did not finish experimental regimen|770|||
145312717|NCT01813435|523993327|FG000|Overall Study|Lost to Follow-up|268|||
145569385|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
145569386|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
145569387|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
145569388|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
145569389|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
145569390|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
145569391|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
145569392|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
145569393|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
145569394|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
145569395|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
145569396|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
145569397|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
145569398|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
145569399|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
145569400|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
145569401|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
145569402|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Death|0|||
145569403|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Death|0|||
145569404|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Death|1|||
145569405|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Death|0|||
145569406|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Death|0|||
145569407|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Death|0|||
145569408|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Death|0|||
145569409|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Death|0|||
145569410|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Death|0|||
145569411|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
145569412|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
145569413|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
145569414|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569415|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569416|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569417|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569418|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569419|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
145569420|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
145569421|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
145312718|NCT01813435|523993328|FG001|Overall Study|Lost to Follow-up|237|||
145312719|NCT02435433|523993331|FG000|Overall Study|Withdrawal by Subject|2|||
145312720|NCT02435433|523993332|FG001|Overall Study|Withdrawal by Subject|3|||
145312721|NCT02435433|523993333|FG002|Overall Study|Withdrawal by Subject|1|||
145312722|NCT02435433|523993334|FG003|Overall Study|Withdrawal by Subject|0|||
145312723|NCT02435433|523993335|FG004|Overall Study|Withdrawal by Subject|0|||
145312724|NCT02435433|523993331|FG000|Overall Study|Lost to Follow-up|2|||
145312725|NCT02435433|523993332|FG001|Overall Study|Lost to Follow-up|2|||
145312726|NCT02435433|523993333|FG002|Overall Study|Lost to Follow-up|4|||
145312727|NCT02435433|523993334|FG003|Overall Study|Lost to Follow-up|1|||
145312728|NCT02435433|523993335|FG004|Overall Study|Lost to Follow-up|0|||
145312729|NCT01243151|523993336|FG000|Overall Study|Adverse Event|0|||
145312730|NCT01243151|523993337|FG001|Overall Study|Adverse Event|1|||
145312731|NCT01243151|523993338|FG002|Overall Study|Adverse Event|0|||
145312732|NCT01243151|523993339|FG003|Overall Study|Adverse Event|0|||
145312733|NCT01243151|523993340|FG004|Overall Study|Adverse Event|0|||
145312734|NCT01243151|523993336|FG000|Overall Study|Protocol Violation|0|||
145312735|NCT01243151|523993337|FG001|Overall Study|Protocol Violation|0|||
145312736|NCT01243151|523993338|FG002|Overall Study|Protocol Violation|1|||
145312737|NCT01243151|523993339|FG003|Overall Study|Protocol Violation|0|||
145312738|NCT01243151|523993340|FG004|Overall Study|Protocol Violation|0|||
145312739|NCT01243151|523993336|FG000|Overall Study|Other|0|||
145312740|NCT01243151|523993337|FG001|Overall Study|Other|0|||
145312741|NCT01243151|523993338|FG002|Overall Study|Other|0|||
145312742|NCT01243151|523993339|FG003|Overall Study|Other|1|||
145312743|NCT01243151|523993340|FG004|Overall Study|Other|0|||
145312744|NCT01243151|523993336|FG000|Overall Study|Randomized but not treated|0|||
145312745|NCT01243151|523993337|FG001|Overall Study|Randomized but not treated|0|||
145312746|NCT01243151|523993338|FG002|Overall Study|Randomized but not treated|0|||
145569422|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
145312747|NCT01243151|523993339|FG003|Overall Study|Randomized but not treated|1|||
145312748|NCT01243151|523993340|FG004|Overall Study|Randomized but not treated|0|||
145312749|NCT00210639|523993346|FG000|Overall Study|Lost to Follow-up|37|||
145312750|NCT00210639|523993347|FG001|Overall Study|Lost to Follow-up|29|||
145312751|NCT00210639|523993346|FG000|Overall Study|Withdrawal by Subject|8|||
145312752|NCT00210639|523993347|FG001|Overall Study|Withdrawal by Subject|1|||
145312753|NCT00210639|523993346|FG000|Overall Study|Other|18|||
145312754|NCT00210639|523993347|FG001|Overall Study|Other|12|||
145312755|NCT02786953|523993353|FG000|Overall Study|Withdrawal by Subject|3|||
145569423|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145569424|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145569425|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145569426|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145569427|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145312756|NCT02786953|523993354|FG001|Overall Study|Withdrawal by Subject|0|||
145312757|NCT02786953|523993353|FG000|Overall Study|Physician Decision|0|||
145312758|NCT02786953|523993354|FG001|Overall Study|Physician Decision|1|||
145312759|NCT00874822|523993357|FG000|Overall Study|excluded by criteria|8|||
145312760|NCT02854800|523993358|FG000|Overall Study|Protocol Violation|16|||
145312761|NCT02854800|523993359|FG001|Overall Study|Protocol Violation|11|||
145312762|NCT02854800|523993360|FG002|Overall Study|Protocol Violation|3|||
145312763|NCT02854800|523993358|FG000|Overall Study|Withdrawal by Subject|4|||
145312764|NCT02854800|523993359|FG001|Overall Study|Withdrawal by Subject|2|||
145312765|NCT02854800|523993360|FG002|Overall Study|Withdrawal by Subject|3|||
145312766|NCT00840658|523993366|FG000|Overall Study|Death|2|||
145312767|NCT00840658|523993367|FG001|Overall Study|Death|2|||
145312768|NCT00840658|523993368|FG002|Overall Study|Death|3|||
145312769|NCT00840658|523993369|FG003|Overall Study|Death|3|||
145312770|NCT00840658|523993366|FG000|Overall Study|Lost to Follow-up|3|||
145312771|NCT00840658|523993367|FG001|Overall Study|Lost to Follow-up|1|||
145312772|NCT00840658|523993368|FG002|Overall Study|Lost to Follow-up|2|||
145312773|NCT00840658|523993369|FG003|Overall Study|Lost to Follow-up|1|||
145312774|NCT04697173|523993370|FG000|Overall Study|Withdrawal by Subject|34|||
145312775|NCT04697173|523993371|FG001|Overall Study|Withdrawal by Subject|38|||
145312776|NCT05004649|523993373|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
145312777|NCT05004649|523993373|FG000|Overall Study|Lost to Follow-up|1|||
145312778|NCT05004649|523993373|FG000|Overall Study|Withdrawal by Subject|2|||
145312779|NCT05004649|523993373|FG000|Overall Study|COVID-19|1|||
145312780|NCT04133311|523993375|FG000|Period 1 Double Masked Treatment Period|Death|1|||
145312781|NCT04133311|523993376|FG001|Period 1 Double Masked Treatment Period|Death|0|||
145312782|NCT04133311|523993377|FG002|Period 1 Double Masked Treatment Period|Death|0|||
145312783|NCT04133311|523993378|FG003|Period 1 Double Masked Treatment Period|Death|0|||
145312784|NCT04133311|523993375|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
145312785|NCT04133311|523993376|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
145312786|NCT04133311|523993377|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
145312787|NCT04133311|523993378|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
145312788|NCT04133311|523993375|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
145312789|NCT04133311|523993376|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
145312790|NCT04133311|523993377|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
145312791|NCT04133311|523993378|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
145312792|NCT04133311|523993375|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
145312793|NCT04133311|523993376|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
145312794|NCT04133311|523993377|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
145312795|NCT04133311|523993378|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
145312796|NCT04133311|523993375|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
145312797|NCT04133311|523993376|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
145312798|NCT04133311|523993377|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
145312799|NCT04133311|523993378|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
145569428|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
145569429|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
145569430|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
145569431|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
145312800|NCT04133311|523993375|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
145312801|NCT04133311|523993376|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
145312802|NCT04133311|523993377|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
145312803|NCT04133311|523993378|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
145312804|NCT04133311|523993375|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
145312805|NCT04133311|523993376|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
145312806|NCT04133311|523993377|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
145312807|NCT04133311|523993378|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
145312808|NCT04133311|523993375|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
145312809|NCT04133311|523993376|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
145312810|NCT04133311|523993377|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
145312811|NCT04133311|523993378|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
145312812|NCT00728754|523993381|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
145411176|NCT02362451|524358800|FG000|Overall Study|Progression|1|||
145411177|NCT02362451|524358801|FG001|Overall Study|Progression|0|||
145569432|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
145312813|NCT00728754|523993382|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
145312814|NCT00728754|523993381|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
145312815|NCT00728754|523993382|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
145312816|NCT00728754|523993381|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
145312817|NCT00728754|523993382|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
145312818|NCT01859598|523993383|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
145312819|NCT00573313|523993388|FG000|Overall Study|Protocol Violation|5|||
145312820|NCT00573313|523993389|FG001|Overall Study|Protocol Violation|0|||
145312821|NCT00573313|523993390|FG002|Overall Study|Protocol Violation|6|||
145312822|NCT00573313|523993391|FG003|Overall Study|Protocol Violation|0|||
145312823|NCT00295490|523993394|FG000|Overall Study|Protocol Violation|0|||
145312824|NCT00295490|523993395|FG001|Overall Study|Protocol Violation|0|||
145312825|NCT00295490|523993396|FG002|Overall Study|Protocol Violation|3|||
145312826|NCT00295490|523993397|FG003|Overall Study|Protocol Violation|3|||
145312827|NCT00295490|523993394|FG000|Overall Study|Withdrawal by Subject|0|||
145312828|NCT00295490|523993395|FG001|Overall Study|Withdrawal by Subject|2|||
145312829|NCT00295490|523993396|FG002|Overall Study|Withdrawal by Subject|0|||
145312830|NCT00295490|523993397|FG003|Overall Study|Withdrawal by Subject|1|||
145312831|NCT00295490|523993394|FG000|Overall Study|Lost to Follow-up|0|||
145312832|NCT00295490|523993395|FG001|Overall Study|Lost to Follow-up|0|||
145312833|NCT00295490|523993396|FG002|Overall Study|Lost to Follow-up|1|||
145312834|NCT00295490|523993397|FG003|Overall Study|Lost to Follow-up|0|||
145312835|NCT00295490|523993394|FG000|Overall Study|Adverse Event|1|||
145312836|NCT00295490|523993395|FG001|Overall Study|Adverse Event|0|||
145312837|NCT00295490|523993396|FG002|Overall Study|Adverse Event|0|||
145312838|NCT00295490|523993397|FG003|Overall Study|Adverse Event|0|||
145312839|NCT00295490|523993394|FG000|Overall Study|Other|0|||
145312840|NCT00295490|523993395|FG001|Overall Study|Other|2|||
145312841|NCT00295490|523993396|FG002|Overall Study|Other|0|||
145312842|NCT00295490|523993397|FG003|Overall Study|Other|1|||
145312843|NCT03885934|523993398|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
145312844|NCT03885934|523993399|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
145312845|NCT03885934|523993400|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
145312846|NCT03885934|523993401|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
145312847|NCT03885934|523993402|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
145312848|NCT03885934|523993403|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
145312849|NCT03255980|523993404|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
145312850|NCT03255980|523993405|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
145312851|NCT03255980|523993406|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
145312852|NCT03255980|523993407|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
145312853|NCT03255980|523993404|FG000|Overall Study|Adverse Event|1|||
145312854|NCT03255980|523993405|FG001|Overall Study|Adverse Event|1|||
145312855|NCT03255980|523993406|FG002|Overall Study|Adverse Event|0|||
145312856|NCT03255980|523993407|FG003|Overall Study|Adverse Event|1|||
145312857|NCT03255980|523993404|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
145312858|NCT03255980|523993405|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
145312859|NCT03255980|523993406|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
145312860|NCT03255980|523993407|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
145312861|NCT03255980|523993404|FG000|Overall Study|Lost to Follow-up|1|||
145312862|NCT03255980|523993405|FG001|Overall Study|Lost to Follow-up|1|||
145312863|NCT03255980|523993406|FG002|Overall Study|Lost to Follow-up|0|||
145312864|NCT03255980|523993407|FG003|Overall Study|Lost to Follow-up|3|||
145312865|NCT03255980|523993404|FG000|Overall Study|Withdrawal by Subject|0|||
145312866|NCT03255980|523993405|FG001|Overall Study|Withdrawal by Subject|1|||
145312867|NCT03255980|523993406|FG002|Overall Study|Withdrawal by Subject|0|||
145312868|NCT03255980|523993407|FG003|Overall Study|Withdrawal by Subject|3|||
145312869|NCT04473326|523993408|FG000|Overall Study|Death|0|||
145312870|NCT04473326|523993409|FG001|Overall Study|Death|1|||
145312871|NCT04473326|523993408|FG000|Overall Study|Withdrawal by Subject|1|||
145312872|NCT04473326|523993409|FG001|Overall Study|Withdrawal by Subject|2|||
145312873|NCT00570128|523993418|FG000|Overall Study|Adverse Event|1|||
145312874|NCT00570128|523993419|FG001|Overall Study|Adverse Event|0|||
145569433|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
145312875|NCT00570128|523993418|FG000|Overall Study|Lost to Follow-up|1|||
145312876|NCT00570128|523993419|FG001|Overall Study|Lost to Follow-up|0|||
145312877|NCT00570128|523993418|FG000|Overall Study|Withdrawal by Subject|2|||
145312878|NCT00570128|523993419|FG001|Overall Study|Withdrawal by Subject|0|||
145312879|NCT03868631|523993420|FG000|Baseline to Week 6|Adverse Event|0|||
145312880|NCT03868631|523993421|FG001|Baseline to Week 6|Adverse Event|3|||
145312881|NCT03868631|523993420|FG000|Baseline to Week 6|Protocol Violation|1|||
145312882|NCT03868631|523993421|FG001|Baseline to Week 6|Protocol Violation|1|||
145312883|NCT03868631|523993420|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
145312884|NCT03868631|523993421|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
145312885|NCT03868631|523993420|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
145312886|NCT03868631|523993421|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
145312887|NCT03868631|523993420|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
145569434|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
145569435|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
145569436|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
145312888|NCT03868631|523993421|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
145312889|NCT03868631|523993420|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
145312890|NCT03868631|523993421|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
145312891|NCT01528735|523993423|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
145312892|NCT01528735|523993424|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
145312893|NCT01528735|523993423|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
145312894|NCT01528735|523993424|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
145312895|NCT00556673|523993425|FG000|Overall Study|Protocol deviation|3|||
145312896|NCT00556673|523993426|FG001|Overall Study|Protocol deviation|2|||
145312897|NCT00757172|523993427|FG000|Overall Study|Withdrawal by Subject|4|||
145312898|NCT00757172|523993427|FG000|Overall Study|Physician Decision|3|||
145312899|NCT00757172|523993427|FG000|Overall Study|Progression|4|||
145312900|NCT00494013|523993428|FG000|Overall Study|Adverse Event|0|||
145312901|NCT00494013|523993429|FG001|Overall Study|Adverse Event|1|||
145312902|NCT00494013|523993428|FG000|Overall Study|Entry Criteria Not Met|1|||
145312903|NCT00494013|523993429|FG001|Overall Study|Entry Criteria Not Met|4|||
145312904|NCT00494013|523993428|FG000|Overall Study|Lost to Follow-up|5|||
145312905|NCT00494013|523993429|FG001|Overall Study|Lost to Follow-up|6|||
145312906|NCT00494013|523993428|FG000|Overall Study|Physician Decision|3|||
145312907|NCT00494013|523993429|FG001|Overall Study|Physician Decision|5|||
145312908|NCT00494013|523993428|FG000|Overall Study|Protocol Violation|8|||
145312909|NCT00494013|523993429|FG001|Overall Study|Protocol Violation|5|||
145312910|NCT00494013|523993428|FG000|Overall Study|Withdrawal by Subject|13|||
145312911|NCT00494013|523993429|FG001|Overall Study|Withdrawal by Subject|14|||
145312912|NCT00494013|523993428|FG000|Overall Study|Sponsor Decision|0|||
145312913|NCT00494013|523993429|FG001|Overall Study|Sponsor Decision|1|||
145312914|NCT04194151|523993430|FG000|Overall Study|Physician Decision|1|||
145312915|NCT04194151|523993431|FG001|Overall Study|Physician Decision|1|||
145312916|NCT04194151|523993432|FG002|Overall Study|Physician Decision|1|||
145312917|NCT04194151|523993433|FG003|Overall Study|Physician Decision|1|||
145312918|NCT04194151|523993434|FG004|Overall Study|Physician Decision|0|||
145312919|NCT04194151|523993435|FG005|Overall Study|Physician Decision|1|||
145312920|NCT04194151|523993430|FG000|Overall Study|Monitorization problem|0|||
145312921|NCT04194151|523993431|FG001|Overall Study|Monitorization problem|1|||
145312922|NCT04194151|523993432|FG002|Overall Study|Monitorization problem|0|||
145312923|NCT04194151|523993433|FG003|Overall Study|Monitorization problem|0|||
145312924|NCT04194151|523993434|FG004|Overall Study|Monitorization problem|0|||
145312925|NCT04194151|523993435|FG005|Overall Study|Monitorization problem|0|||
145312926|NCT01499043|523993436|FG000|Overall Study|Progressive disease (radiographic)|2|||
145312927|NCT01499043|523993436|FG000|Overall Study|Progressive disease (clinical)|1|||
145312928|NCT01499043|523993436|FG000|Overall Study|Withdrawal by Subject|2|||
145312929|NCT01499043|523993436|FG000|Overall Study|Adverse Event|1|||
145312930|NCT04203823|523993437|FG000|Overall Study|Withdrawal by Subject|2|||
145312931|NCT04203823|523993438|FG001|Overall Study|Withdrawal by Subject|2|||
145312932|NCT04203823|523993437|FG000|Overall Study|Adverse Event|1|||
145312933|NCT04203823|523993438|FG001|Overall Study|Adverse Event|1|||
145312934|NCT04203823|523993437|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145312935|NCT04203823|523993438|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
145312936|NCT03193021|523993439|FG000|Overall Study|Lost to Follow-up|1|||
145312937|NCT03193021|523993440|FG001|Overall Study|Lost to Follow-up|1|||
145312938|NCT02286466|523993441|FG000|Overall Study|Death|1|||
145312939|NCT02286466|523993442|FG001|Overall Study|Death|3|||
145312940|NCT02286466|523993441|FG000|Overall Study|Withdrawal by Subject|5|||
145312941|NCT02286466|523993442|FG001|Overall Study|Withdrawal by Subject|2|||
145312942|NCT02286466|523993441|FG000|Overall Study|Lost to Follow-up|1|||
145312943|NCT02286466|523993442|FG001|Overall Study|Lost to Follow-up|4|||
145312944|NCT02286466|523993441|FG000|Overall Study|Declined Clinician Assessment|0|||
145312945|NCT02286466|523993442|FG001|Overall Study|Declined Clinician Assessment|1|||
145312946|NCT00835081|523993443|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145312947|NCT00835081|523993444|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145312948|NCT00421304|523993445|FG000|Overall Study|Lost to Follow-up|5|||
145312949|NCT00421304|523993446|FG001|Overall Study|Lost to Follow-up|2|||
145312950|NCT00421304|523993447|FG002|Overall Study|Lost to Follow-up|5|||
145312951|NCT00421304|523993445|FG000|Overall Study|Withdrawal by Subject|2|||
145569437|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
145569438|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
145312952|NCT00421304|523993446|FG001|Overall Study|Withdrawal by Subject|2|||
145312953|NCT00421304|523993447|FG002|Overall Study|Withdrawal by Subject|2|||
145312954|NCT00421304|523993445|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
145312955|NCT00421304|523993446|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
145312956|NCT00421304|523993447|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
145312957|NCT00421304|523993445|FG000|Overall Study|Did not attend Day 360 visit|0|||
145312958|NCT00421304|523993446|FG001|Overall Study|Did not attend Day 360 visit|0|||
145312959|NCT00421304|523993447|FG002|Overall Study|Did not attend Day 360 visit|1|||
145312960|NCT01912807|523993448|FG000|Overall Study|Did not meet elegibility criteria|6|||
145312961|NCT01912807|523993449|FG001|Overall Study|Did not meet elegibility criteria|4|||
145312962|NCT01912807|523993448|FG000|Overall Study|Lost to Follow-up|36|||
145312963|NCT01912807|523993449|FG001|Overall Study|Lost to Follow-up|37|||
145312964|NCT04750239|523993450|FG000|Overall Study|Withdrawal by Subject|2|||
145312965|NCT04750239|523993450|FG000|Overall Study|Trial terminated by sponsor|1|||
145312966|NCT00919711|523993451|FG000|Overall Study|Withdrawal by Subject|15|||
145312967|NCT00919711|523993452|FG001|Overall Study|Withdrawal by Subject|7|||
145312968|NCT00919711|523993451|FG000|Overall Study|Adverse Event|13|||
145312969|NCT00919711|523993452|FG001|Overall Study|Adverse Event|3|||
145312970|NCT00919711|523993451|FG000|Overall Study|Other|1|||
145312971|NCT00919711|523993452|FG001|Overall Study|Other|2|||
145312972|NCT00919711|523993451|FG000|Overall Study|Administrative Decision|0|||
145312973|NCT00919711|523993452|FG001|Overall Study|Administrative Decision|1|||
145312974|NCT00919711|523993451|FG000|Overall Study|Lost to Follow-up|2|||
145312975|NCT00919711|523993452|FG001|Overall Study|Lost to Follow-up|0|||
145312976|NCT00919711|523993451|FG000|Overall Study|Death|1|||
145312977|NCT00919711|523993452|FG001|Overall Study|Death|0|||
145312978|NCT00919711|523993451|FG000|Overall Study|Noncompliance|1|||
145312979|NCT00919711|523993452|FG001|Overall Study|Noncompliance|0|||
145312980|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Adverse Event|8|||
145312981|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Adverse Event|5|||
145312982|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Adverse Event|9|||
145312983|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Adverse Event|0|||
145312984|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Adverse Event|0|||
145312985|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Adverse Event|0|||
145312986|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
145312987|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
145312988|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
145312989|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
145312990|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
145312991|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
145312992|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
145312993|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
145312994|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
145312995|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
145312996|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
145312997|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
145312998|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Physician Decision|4|||
145312999|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Physician Decision|0|||
145313000|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Physician Decision|2|||
145313001|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Physician Decision|0|||
145313002|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Physician Decision|0|||
145313003|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Physician Decision|0|||
145313004|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Pregnancy|1|||
145313005|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Pregnancy|2|||
145313006|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Pregnancy|0|||
145313007|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Pregnancy|0|||
145313008|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Pregnancy|0|||
145313009|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Pregnancy|0|||
145313010|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
145313011|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
145313012|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
145313013|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
145313014|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
145313015|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
145313016|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
145411178|NCT02362451|524358800|FG000|Overall Study|Participant chose other therapy.|1|||
145411179|NCT02362451|524358801|FG001|Overall Study|Participant chose other therapy.|0|||
145411180|NCT04398134|524358802|FG000|Overall Study|Adverse Event|0|||
145569439|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
145569440|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
145569441|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
145569442|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
145569443|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
145569444|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
145569445|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
145569446|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
145569447|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
145569448|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
145313017|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
145313018|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
145313019|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
145313020|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
145313021|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
145313022|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
145313023|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
145313024|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
145313025|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
145313026|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
145313027|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
145313028|NCT02614196|523993453|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
145313029|NCT02614196|523993454|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
145313030|NCT02614196|523993455|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
145313031|NCT02614196|523993456|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
145313032|NCT02614196|523993457|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
145313033|NCT02614196|523993458|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
145313034|NCT02614196|523993453|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
145313035|NCT02614196|523993454|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
145313036|NCT02614196|523993455|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
145313037|NCT02614196|523993456|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
145411181|NCT04398134|524358803|FG001|Overall Study|Adverse Event|0|||
145411182|NCT04398134|524358804|FG002|Overall Study|Adverse Event|1|||
145411183|NCT04398134|524358805|FG003|Overall Study|Adverse Event|0|||
145411184|NCT04398134|524358802|FG000|Overall Study|Withdrawal by Subject|2|||
145411185|NCT04398134|524358803|FG001|Overall Study|Withdrawal by Subject|0|||
145411186|NCT04398134|524358804|FG002|Overall Study|Withdrawal by Subject|0|||
145411187|NCT04398134|524358805|FG003|Overall Study|Withdrawal by Subject|1|||
145411188|NCT04398134|524358802|FG000|Overall Study|Study Terminated by Sponsor|30|||
145411189|NCT04398134|524358803|FG001|Overall Study|Study Terminated by Sponsor|11|||
145411190|NCT04398134|524358804|FG002|Overall Study|Study Terminated by Sponsor|32|||
145411191|NCT04398134|524358805|FG003|Overall Study|Study Terminated by Sponsor|11|||
145411192|NCT03168672|524358810|FG000|Overall Study|Withdrawal by Subject|13|||
145411193|NCT03168672|524358810|FG000|Overall Study|Death|3|||
145411194|NCT03168672|524358810|FG000|Overall Study|Investigator's Decision|137|||
145411195|NCT03168672|524358810|FG000|Overall Study|Adverse Event|1|||
145411196|NCT03168672|524358810|FG000|Overall Study|Other|2|||
145411197|NCT03168672|524358810|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
145411198|NCT03462680|524358811|FG000|Overall Study|Withdrawal by Subject|3|||
145411199|NCT03462680|524358812|FG001|Overall Study|Withdrawal by Subject|5|||
145411200|NCT01757847|524358813|FG000|Overall Study|Withdrawal by Subject|3|||
145411201|NCT01757847|524358814|FG001|Overall Study|Withdrawal by Subject|4|||
145411202|NCT04590963|524358815|FG000|Overall Study|Death|118|||
145411203|NCT04590963|524358816|FG001|Overall Study|Death|59|||
145411204|NCT04590963|524358815|FG000|Overall Study|Lost to Follow-up|1|||
145411205|NCT04590963|524358816|FG001|Overall Study|Lost to Follow-up|1|||
145411206|NCT04590963|524358815|FG000|Overall Study|Progressive disease|0|||
145411207|NCT04590963|524358816|FG001|Overall Study|Progressive disease|1|||
145411208|NCT04590963|524358815|FG000|Overall Study|Study terminated by sponsor|103|||
145411209|NCT04590963|524358816|FG001|Overall Study|Study terminated by sponsor|50|||
145411210|NCT04590963|524358815|FG000|Overall Study|Withdrawal by Subject|15|||
145411211|NCT04590963|524358816|FG001|Overall Study|Withdrawal by Subject|8|||
145411212|NCT04590963|524358815|FG000|Overall Study|Ongoing at data cut-off|9|||
145411213|NCT04590963|524358816|FG001|Overall Study|Ongoing at data cut-off|4|||
145411214|NCT04590963|524358815|FG000|Overall Study|Screen failure|1|||
145411215|NCT04590963|524358816|FG001|Overall Study|Screen failure|0|||
145411216|NCT04057365|524358817|FG000|Overall Study|Withdrawal by Subject|2|||
145411217|NCT04057365|524358818|FG001|Overall Study|Withdrawal by Subject|0|||
145411218|NCT04738487|524358819|FG000|Overall Study|Participant Ongoing in Study|298|||
145411219|NCT04738487|524358820|FG001|Overall Study|Participant Ongoing in Study|297|||
145411220|NCT04738487|524358819|FG000|Overall Study|Withdrawal by Subject|7|||
145411221|NCT04738487|524358820|FG001|Overall Study|Withdrawal by Subject|9|||
145411222|NCT04738487|524358819|FG000|Overall Study|Lost to Follow-up|2|||
145411223|NCT04738487|524358820|FG001|Overall Study|Lost to Follow-up|0|||
145313038|NCT02614196|523993457|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
145313039|NCT02614196|523993458|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
145313040|NCT02614196|523993453|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
145411224|NCT04738487|524358819|FG000|Overall Study|Death|287|||
145411225|NCT04738487|524358820|FG001|Overall Study|Death|306|||
145411226|NCT05350202|524358821|FG000|Visit 1 - Baseline|Not-treated|18|||
145411227|NCT05350202|524358822|FG001|Visit 1 - Baseline|Not-treated|0|||
145411228|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
145411229|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
145313041|NCT02614196|523993454|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
145313042|NCT02614196|523993455|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
145313043|NCT02614196|523993456|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
145313044|NCT02614196|523993457|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
145313045|NCT02614196|523993458|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
145313046|NCT02614196|523993453|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
145313047|NCT02614196|523993454|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
145313048|NCT02614196|523993455|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
145313049|NCT02614196|523993456|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
145313050|NCT02614196|523993457|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
145313051|NCT02614196|523993458|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
145313052|NCT02614196|523993453|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
145313053|NCT02614196|523993454|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
145313054|NCT02614196|523993455|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
145313055|NCT02614196|523993456|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
145313056|NCT02614196|523993457|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
145313057|NCT02614196|523993458|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
145313058|NCT00903877|523993459|FG000|Overall Study|Did not meet study criteria|33|||
145313059|NCT00903877|523993459|FG000|Overall Study|Withdrawal by Subject|3|||
145313060|NCT00903877|523993459|FG000|Overall Study|Adverse Event|2|||
145313061|NCT00903877|523993459|FG000|Overall Study|Lost to Follow-up|1|||
145313062|NCT00903877|523993459|FG000|Overall Study|Participation put on hold|4|||
145313063|NCT00087529|523993461|FG000|Overall Study|Death|1|||
145313064|NCT00087529|523993462|FG001|Overall Study|Death|0|||
145313065|NCT00087529|523993461|FG000|Overall Study|Adverse Event|0|||
145313066|NCT00087529|523993462|FG001|Overall Study|Adverse Event|8|||
145313067|NCT00087529|523993461|FG000|Overall Study|Pregnancy|0|||
145313068|NCT00087529|523993462|FG001|Overall Study|Pregnancy|1|||
145313069|NCT00087529|523993461|FG000|Overall Study|Lost to Follow-up|2|||
145313070|NCT00087529|523993462|FG001|Overall Study|Lost to Follow-up|3|||
145313071|NCT00087529|523993461|FG000|Overall Study|Participant Decision|14|||
145313072|NCT00087529|523993462|FG001|Overall Study|Participant Decision|37|||
145313073|NCT00087529|523993461|FG000|Overall Study|Physician Decision|4|||
145313074|NCT00087529|523993462|FG001|Overall Study|Physician Decision|8|||
145313075|NCT00087529|523993461|FG000|Overall Study|Initiation of Excluded Therapy|0|||
145313076|NCT00087529|523993462|FG001|Overall Study|Initiation of Excluded Therapy|1|||
145313077|NCT00087529|523993461|FG000|Overall Study|Participant Noncompliance|0|||
145313078|NCT00087529|523993462|FG001|Overall Study|Participant Noncompliance|1|||
145313079|NCT00087529|523993461|FG000|Overall Study|Disease Progression|5|||
145313080|NCT00087529|523993462|FG001|Overall Study|Disease Progression|4|||
145313081|NCT00087529|523993461|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
145313082|NCT00087529|523993462|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
145313083|NCT01253564|523993472|FG000|Overall Study|Disease Progression|22|||
145313084|NCT01253564|523993472|FG000|Overall Study|Withdrawal by Subject|1|||
145313085|NCT01253564|523993472|FG000|Overall Study|Serious Adverse Event|1|||
145313086|NCT02005562|523995244|FG000|Overall Study|Death|2|||
145313087|NCT02005562|523995245|FG001|Overall Study|Death|2|||
145313088|NCT02005562|523995244|FG000|Overall Study|Graft loss|7|||
145313089|NCT02005562|523995245|FG001|Overall Study|Graft loss|6|||
145313090|NCT02005562|523995244|FG000|Overall Study|Withdrawal by Subject|2|||
145313091|NCT02005562|523995245|FG001|Overall Study|Withdrawal by Subject|2|||
145313092|NCT02005562|523995244|FG000|Overall Study|No transplant|1|||
145313093|NCT02005562|523995245|FG001|Overall Study|No transplant|4|||
145313094|NCT02005562|523995244|FG000|Overall Study|Physician Decision|0|||
145313095|NCT02005562|523995245|FG001|Overall Study|Physician Decision|1|||
145313096|NCT04729101|523995246|FG000|Overall Study|Adverse Event|1|||
145313097|NCT04729101|523995247|FG001|Overall Study|Adverse Event|0|||
145313098|NCT04729101|523995246|FG000|Overall Study|Physician Decision|1|||
145313099|NCT04729101|523995247|FG001|Overall Study|Physician Decision|0|||
145313100|NCT04729101|523995246|FG000|Overall Study|Withdrawal by Subject|1|||
145313101|NCT04729101|523995247|FG001|Overall Study|Withdrawal by Subject|0|||
145620366|NCT01824472|525123758|FG000|Overall Study|Withdrawal by Subject|1|||
145313102|NCT02940522|523995248|FG000|Overall Study|Lost to Follow-up|1|||
145313103|NCT02940522|523995249|FG001|Overall Study|Lost to Follow-up|2|||
145313104|NCT02940522|523995248|FG000|Overall Study|Withdrawal by Subject|1|||
145313105|NCT02940522|523995249|FG001|Overall Study|Withdrawal by Subject|0|||
145313106|NCT00274625|523995250|FG000|Overall Study|Lost to Follow-up|46|||
145313107|NCT00274625|523995251|FG001|Overall Study|Lost to Follow-up|54|||
145313108|NCT00274625|523995250|FG000|Overall Study|Excluded from analysis|14|||
145313109|NCT00274625|523995251|FG001|Overall Study|Excluded from analysis|8|||
145313110|NCT00762411|523995254|FG000|Initial Treatment|Death|7|||
145313111|NCT00762411|523995255|FG001|Initial Treatment|Death|6|||
145313112|NCT00762411|523995254|FG000|Initial Treatment|Adverse Event|132|||
145313113|NCT00762411|523995255|FG001|Initial Treatment|Adverse Event|40|||
145313114|NCT00762411|523995254|FG000|Initial Treatment|Protocol Violation|4|||
145313115|NCT00762411|523995255|FG001|Initial Treatment|Protocol Violation|1|||
145620367|NCT01824472|525123759|FG001|Overall Study|Withdrawal by Subject|5|||
145313116|NCT00762411|523995254|FG000|Initial Treatment|Withdrawal by Subject|65|||
145313117|NCT00762411|523995255|FG001|Initial Treatment|Withdrawal by Subject|52|||
145569449|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
145569450|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145569451|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145569452|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145569453|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145569454|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145313118|NCT00762411|523995254|FG000|Initial Treatment|Physician Decision|1|||
145313119|NCT00762411|523995255|FG001|Initial Treatment|Physician Decision|0|||
145313120|NCT00762411|523995254|FG000|Initial Treatment|Sponsor Decision|293|||
145313121|NCT00762411|523995255|FG001|Initial Treatment|Sponsor Decision|401|||
145313122|NCT00762411|523995254|FG000|Initial Treatment|Lost to Follow-up|5|||
145313123|NCT00762411|523995255|FG001|Initial Treatment|Lost to Follow-up|0|||
145313124|NCT00762411|523995254|FG000|Initial Treatment|Caregiver Decision|21|||
145313125|NCT00762411|523995255|FG001|Initial Treatment|Caregiver Decision|16|||
145313126|NCT00762411|523995254|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
145313127|NCT00762411|523995255|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
145313128|NCT00762411|523995254|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
145313129|NCT00762411|523995255|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
145313130|NCT00762411|523995254|FG000|Delayed Start|Adverse Event|0|||
145313131|NCT00762411|523995255|FG001|Delayed Start|Adverse Event|4|||
145313132|NCT00762411|523995254|FG000|Delayed Start|Protocol Violation|0|||
145313133|NCT00762411|523995255|FG001|Delayed Start|Protocol Violation|1|||
145313134|NCT00762411|523995254|FG000|Delayed Start|Sponsor Decision|16|||
145313135|NCT00762411|523995255|FG001|Delayed Start|Sponsor Decision|20|||
145313136|NCT00762411|523995254|FG000|Delayed Start|Caregiver Decision|1|||
145313137|NCT00762411|523995255|FG001|Delayed Start|Caregiver Decision|1|||
145313138|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
145313139|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
145313140|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
145313141|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
145313142|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
145313143|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
145411230|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
145411231|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
145411232|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
145411233|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
145411234|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
145411235|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
145411236|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
145411237|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
145411238|NCT05350202|524358821|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
145411239|NCT05350202|524358822|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
145411240|NCT00325416|524358849|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
145411241|NCT00325416|524358850|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
145411242|NCT00325416|524358849|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
145411243|NCT00325416|524358850|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
145411244|NCT00325416|524358849|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
145411245|NCT00325416|524358850|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
145411246|NCT00325416|524358849|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
145411247|NCT00325416|524358850|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
145411248|NCT00325416|524358849|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
145411249|NCT00325416|524358850|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
145411250|NCT00325416|524358849|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
145411251|NCT00325416|524358850|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
145411252|NCT06239610|524358851|FG000|Overall Study|no usable migration data for minimum of one day|11|||
145411253|NCT04589650|524358852|FG000|Overall Study|Subject decision|6|||
145411254|NCT04589650|524358853|FG001|Overall Study|Subject decision|2|||
145411255|NCT04589650|524358854|FG002|Overall Study|Subject decision|2|||
145411256|NCT04589650|524358855|FG003|Overall Study|Subject decision|0|||
145411257|NCT04589650|524358856|FG004|Overall Study|Subject decision|0|||
145411258|NCT04589650|524358857|FG005|Overall Study|Subject decision|0|||
145411259|NCT04589650|524358852|FG000|Overall Study|Adverse Event|3|||
145569455|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
145313144|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
145313145|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
145313146|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
145313147|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
145411260|NCT04589650|524358853|FG001|Overall Study|Adverse Event|1|||
145313148|NCT00762411|523995254|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
145313149|NCT00762411|523995255|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
145313150|NCT04590781|523995259|FG000|Overall Study|Death|0|||
145313151|NCT04590781|523995260|FG001|Overall Study|Death|2|||
145313152|NCT04590781|523995259|FG000|Overall Study|Withdrawal by Subject|2|||
145313153|NCT04590781|523995260|FG001|Overall Study|Withdrawal by Subject|0|||
145313154|NCT01680016|523995261|FG000|Overall Study|Adverse Event|0|||
145313155|NCT01680016|523995262|FG001|Overall Study|Adverse Event|0|||
145313156|NCT01680016|523995263|FG002|Overall Study|Adverse Event|1|||
145313157|NCT01680016|523995264|FG003|Overall Study|Adverse Event|4|||
145313158|NCT01680016|523995261|FG000|Overall Study|The Subject went out of The Trial|1|||
145313159|NCT01680016|523995262|FG001|Overall Study|The Subject went out of The Trial|0|||
145313160|NCT01680016|523995263|FG002|Overall Study|The Subject went out of The Trial|3|||
145313161|NCT01680016|523995264|FG003|Overall Study|The Subject went out of The Trial|0|||
145313162|NCT01680016|523995261|FG000|Overall Study|Protocol Violation|0|||
145313163|NCT01680016|523995262|FG001|Overall Study|Protocol Violation|1|||
145313164|NCT01680016|523995263|FG002|Overall Study|Protocol Violation|0|||
145313165|NCT01680016|523995264|FG003|Overall Study|Protocol Violation|0|||
145313166|NCT01680016|523995261|FG000|Overall Study|Withdrawal by Subject|5|||
145313167|NCT01680016|523995262|FG001|Overall Study|Withdrawal by Subject|7|||
145313168|NCT01680016|523995263|FG002|Overall Study|Withdrawal by Subject|1|||
145313169|NCT01680016|523995264|FG003|Overall Study|Withdrawal by Subject|1|||
145313170|NCT01490190|523995266|FG000|Overall Study|Withdrawal by Subject|9|||
145313171|NCT01490190|523995266|FG000|Overall Study|Adverse Event|17|||
145313172|NCT01490190|523995266|FG000|Overall Study|Protocol Violation|5|||
145313173|NCT01490190|523995266|FG000|Overall Study|Lost to Follow-up|13|||
145313174|NCT01490190|523995266|FG000|Overall Study|Relocation|1|||
145313175|NCT01490190|523995266|FG000|Overall Study|Inconvenience|1|||
145313176|NCT01490190|523995266|FG000|Overall Study|Ring expulsion|2|||
145313177|NCT02655224|523995270|FG000|Overall Study|Adverse Event|1|||
145313178|NCT02655224|523995271|FG001|Overall Study|Adverse Event|1|||
145313179|NCT01119625|523995272|FG000|Overall Study|Lost to Follow-up|1|||
145313180|NCT01119625|523995273|FG001|Overall Study|Lost to Follow-up|2|||
145313181|NCT01119625|523995272|FG000|Overall Study|Withdrawal by Subject|2|||
145313182|NCT01119625|523995273|FG001|Overall Study|Withdrawal by Subject|1|||
145313183|NCT01119625|523995272|FG000|Overall Study|Other|0|||
145313184|NCT01119625|523995273|FG001|Overall Study|Other|1|||
145313185|NCT00397254|523995276|FG000|Overall Study|Lost to Follow-up|2|||
145313186|NCT00397254|523995277|FG001|Overall Study|Lost to Follow-up|2|||
145313187|NCT02627963|523995278|FG000|Overall Study|Randomized but not treated|2|||
145313188|NCT02627963|523995279|FG001|Overall Study|Randomized but not treated|6|||
145313189|NCT03073798|523995283|FG000|Overall Study|Adverse Event|1|||
145313190|NCT03073798|523995283|FG000|Overall Study|Withdrawal by Subject|1|||
145313191|NCT02372006|523995288|FG000|Overall Study|Progressive disease|8|||
145313192|NCT02372006|523995289|FG001|Overall Study|Progressive disease|7|||
145313193|NCT02372006|523995290|FG002|Overall Study|Progressive disease|34|||
145313194|NCT02372006|523995288|FG000|Overall Study|Dose limiting toxicity|0|||
145313195|NCT02372006|523995289|FG001|Overall Study|Dose limiting toxicity|1|||
145313196|NCT02372006|523995290|FG002|Overall Study|Dose limiting toxicity|0|||
145313197|NCT02372006|523995288|FG000|Overall Study|Adverse Event|0|||
145313198|NCT02372006|523995289|FG001|Overall Study|Adverse Event|0|||
145313199|NCT02372006|523995290|FG002|Overall Study|Adverse Event|3|||
145313200|NCT02372006|523995288|FG000|Overall Study|Withdrawal by Subject|0|||
145313201|NCT02372006|523995289|FG001|Overall Study|Withdrawal by Subject|1|||
145313202|NCT02372006|523995290|FG002|Overall Study|Withdrawal by Subject|1|||
145313203|NCT02372006|523995288|FG000|Overall Study|Other reason for not completing|0|||
145313204|NCT02372006|523995289|FG001|Overall Study|Other reason for not completing|0|||
145313205|NCT02372006|523995290|FG002|Overall Study|Other reason for not completing|1|||
145313206|NCT02611362|523995295|FG000|Overall Study|Withdrawal by Subject|7|||
145313207|NCT02611362|523995296|FG001|Overall Study|Withdrawal by Subject|2|||
145313208|NCT02611362|523995295|FG000|Overall Study|Lost to Follow-up|2|||
145313209|NCT02611362|523995296|FG001|Overall Study|Lost to Follow-up|4|||
145313210|NCT00354159|523995297|FG000|Randomized Study Period|Withdrawal by Subject|5|||
145313211|NCT00354159|523995298|FG001|Randomized Study Period|Withdrawal by Subject|3|||
145313212|NCT00354159|523995297|FG000|Randomized Study Period|Physician Decision|6|||
145313213|NCT00354159|523995298|FG001|Randomized Study Period|Physician Decision|10|||
145313214|NCT00354159|523995297|FG000|Randomized Study Period|Lost to Follow-up|4|||
145313215|NCT00354159|523995298|FG001|Randomized Study Period|Lost to Follow-up|0|||
145313216|NCT00354159|523995297|FG000|Randomized Study Period|Death|7|||
145313217|NCT00354159|523995298|FG001|Randomized Study Period|Death|9|||
145313218|NCT00354159|523995297|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
145313219|NCT00354159|523995298|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
145313220|NCT00354159|523995297|FG000|Long-term Follow-up|Physician Decision|127|||
145313221|NCT00354159|523995298|FG001|Long-term Follow-up|Physician Decision|122|||
145313222|NCT00354159|523995297|FG000|Long-term Follow-up|Lost to Follow-up|1|||
145313223|NCT00354159|523995298|FG001|Long-term Follow-up|Lost to Follow-up|0|||
145313224|NCT00354159|523995297|FG000|Long-term Follow-up|Death|14|||
145313225|NCT00354159|523995298|FG001|Long-term Follow-up|Death|11|||
145313226|NCT00354159|523995297|FG000|Long-term Follow-up|Study Closed|29|||
145313227|NCT00354159|523995298|FG001|Long-term Follow-up|Study Closed|34|||
145313228|NCT02229084|523995300|FG000|Overall Study|Adverse Event|1|||
145313229|NCT02229084|523995301|FG001|Overall Study|Adverse Event|0|||
145313230|NCT02229084|523995302|FG002|Overall Study|Adverse Event|0|||
145313231|NCT02229084|523995303|FG003|Overall Study|Adverse Event|0|||
145313232|NCT02229084|523995304|FG004|Overall Study|Adverse Event|0|||
145313233|NCT02229084|523995305|FG005|Overall Study|Adverse Event|0|||
145313234|NCT02229084|523995306|FG006|Overall Study|Adverse Event|0|||
145313235|NCT02229084|523995300|FG000|Overall Study|Lost to Follow-up|0|||
145313236|NCT02229084|523995301|FG001|Overall Study|Lost to Follow-up|0|||
145313237|NCT02229084|523995302|FG002|Overall Study|Lost to Follow-up|1|||
145313238|NCT02229084|523995303|FG003|Overall Study|Lost to Follow-up|1|||
145313239|NCT02229084|523995304|FG004|Overall Study|Lost to Follow-up|0|||
145313240|NCT02229084|523995305|FG005|Overall Study|Lost to Follow-up|0|||
145313241|NCT02229084|523995306|FG006|Overall Study|Lost to Follow-up|1|||
145313242|NCT02229084|523995300|FG000|Overall Study|Physician Decision|0|||
145313243|NCT02229084|523995301|FG001|Overall Study|Physician Decision|0|||
145313244|NCT02229084|523995302|FG002|Overall Study|Physician Decision|0|||
145313245|NCT02229084|523995303|FG003|Overall Study|Physician Decision|1|||
145313246|NCT02229084|523995304|FG004|Overall Study|Physician Decision|3|||
145313247|NCT02229084|523995305|FG005|Overall Study|Physician Decision|0|||
145313248|NCT02229084|523995306|FG006|Overall Study|Physician Decision|1|||
145313249|NCT02229084|523995300|FG000|Overall Study|Withdrawal by Subject|0|||
145313250|NCT02229084|523995301|FG001|Overall Study|Withdrawal by Subject|0|||
145313251|NCT02229084|523995302|FG002|Overall Study|Withdrawal by Subject|1|||
145313252|NCT02229084|523995303|FG003|Overall Study|Withdrawal by Subject|0|||
145313253|NCT02229084|523995304|FG004|Overall Study|Withdrawal by Subject|1|||
145313254|NCT02229084|523995305|FG005|Overall Study|Withdrawal by Subject|1|||
145313255|NCT02229084|523995306|FG006|Overall Study|Withdrawal by Subject|1|||
145313256|NCT02229084|523995300|FG000|Overall Study|Death|0|||
145313257|NCT02229084|523995301|FG001|Overall Study|Death|0|||
145313258|NCT02229084|523995302|FG002|Overall Study|Death|0|||
145569456|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145313259|NCT02229084|523995303|FG003|Overall Study|Death|0|||
145313260|NCT02229084|523995304|FG004|Overall Study|Death|0|||
145313261|NCT02229084|523995305|FG005|Overall Study|Death|0|||
145313262|NCT02229084|523995306|FG006|Overall Study|Death|1|||
145313263|NCT01559116|523995321|FG000|Overall Study|Adverse Event|10|||
145313264|NCT01559116|523995321|FG000|Overall Study|Lack of Efficacy|1|||
145313265|NCT01559116|523995321|FG000|Overall Study|Lost to Follow-up|1|||
145313266|NCT01559116|523995321|FG000|Overall Study|Protocol Violation|1|||
145313267|NCT01559116|523995321|FG000|Overall Study|Withdrawal by Subject|4|||
145313268|NCT01559116|523995321|FG000|Overall Study|other than stated above|9|||
145313269|NCT01532908|523995322|FG000|Overall Study|Not Transplanted|1|||
145313270|NCT01532908|523995323|FG001|Overall Study|Not Transplanted|0|||
145313271|NCT04610580|523995324|FG000|Two-way Crossover Period|Adverse Event|1|||
145313272|NCT04610580|523995325|FG001|Two-way Crossover Period|Adverse Event|0|||
145313273|NCT04610580|523995326|FG002|Two-way Crossover Period|Adverse Event|0|||
145313274|NCT04610580|523995327|FG003|Two-way Crossover Period|Adverse Event|0|||
145313275|NCT04610580|523995328|FG004|Two-way Crossover Period|Adverse Event|0|||
145313276|NCT04610580|523995329|FG005|Two-way Crossover Period|Adverse Event|0|||
145313277|NCT04610580|523995324|FG000|Two-way Crossover Period|Physician Decision|1|||
145313278|NCT04610580|523995325|FG001|Two-way Crossover Period|Physician Decision|0|||
145313279|NCT04610580|523995326|FG002|Two-way Crossover Period|Physician Decision|0|||
145313280|NCT04610580|523995327|FG003|Two-way Crossover Period|Physician Decision|0|||
145313281|NCT04610580|523995328|FG004|Two-way Crossover Period|Physician Decision|0|||
145313282|NCT04610580|523995329|FG005|Two-way Crossover Period|Physician Decision|0|||
145313283|NCT04610580|523995324|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
145313284|NCT04610580|523995325|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
145313285|NCT04610580|523995326|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
145313286|NCT04610580|523995327|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
145313287|NCT04610580|523995328|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
145313288|NCT04610580|523995329|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
145313289|NCT04610580|523995324|FG000|Two-way Crossover Period|Other than specified|0|||
145313290|NCT04610580|523995325|FG001|Two-way Crossover Period|Other than specified|1|||
145313291|NCT04610580|523995326|FG002|Two-way Crossover Period|Other than specified|0|||
145313292|NCT04610580|523995327|FG003|Two-way Crossover Period|Other than specified|0|||
145313293|NCT04610580|523995328|FG004|Two-way Crossover Period|Other than specified|0|||
145313294|NCT04610580|523995329|FG005|Two-way Crossover Period|Other than specified|0|||
145313295|NCT04610580|523995324|FG000|Washout Before Extension Period|Other than specified|0|||
145313296|NCT04610580|523995325|FG001|Washout Before Extension Period|Other than specified|1|||
145313297|NCT04610580|523995326|FG002|Washout Before Extension Period|Other than specified|0|||
145313298|NCT04610580|523995327|FG003|Washout Before Extension Period|Other than specified|0|||
145313299|NCT04610580|523995328|FG004|Washout Before Extension Period|Other than specified|0|||
145313300|NCT04610580|523995329|FG005|Washout Before Extension Period|Other than specified|0|||
145313301|NCT04610580|523995324|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
145313302|NCT04610580|523995325|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
145313303|NCT04610580|523995326|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
145313304|NCT04610580|523995327|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
145313305|NCT04610580|523995328|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
145569457|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
145569458|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569459|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569460|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569461|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569462|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145313306|NCT04610580|523995329|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
145313307|NCT04610580|523995324|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
145313308|NCT04610580|523995325|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
145313309|NCT04610580|523995326|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
145313310|NCT04610580|523995327|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
145313311|NCT04610580|523995328|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
145313312|NCT04610580|523995329|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
145313313|NCT02179190|523995330|FG000|Enrollment|Exit Prior to Device Attempt|11|||
145313314|NCT02179190|523995330|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
145313315|NCT02179190|523995330|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
145313316|NCT02179190|523995330|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
145313317|NCT02179190|523995330|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
145313318|NCT02179190|523995330|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
145313319|NCT00881569|523995333|FG000|Overall Study|Disease progression|1|||
145313320|NCT00881569|523995334|FG001|Overall Study|Disease progression|1|||
145313321|NCT03480022|523995335|FG000|Overall Study|Pregnancy|2|||
145313322|NCT03480022|523995336|FG001|Overall Study|Pregnancy|0|||
145313323|NCT03480022|523995335|FG000|Overall Study|Adverse Event|6|||
145313324|NCT03480022|523995336|FG001|Overall Study|Adverse Event|0|||
145313325|NCT03480022|523995335|FG000|Overall Study|Lack of Efficacy|0|||
145313326|NCT03480022|523995336|FG001|Overall Study|Lack of Efficacy|2|||
145313327|NCT03480022|523995335|FG000|Overall Study|Physician Decision|0|||
145313328|NCT03480022|523995336|FG001|Overall Study|Physician Decision|1|||
145313329|NCT03480022|523995335|FG000|Overall Study|Withdrawal by Subject|2|||
145313330|NCT03480022|523995336|FG001|Overall Study|Withdrawal by Subject|0|||
145313331|NCT03480022|523995335|FG000|Overall Study|Medication concerns|1|||
145313332|NCT03480022|523995336|FG001|Overall Study|Medication concerns|0|||
145313333|NCT03480022|523995335|FG000|Overall Study|Family member COVID exposure|0|||
145313334|NCT03480022|523995336|FG001|Overall Study|Family member COVID exposure|1|||
145313335|NCT01993940|523995341|FG000|Overall Study|Adverse Event|16|||
145313336|NCT01993940|523995342|FG001|Overall Study|Adverse Event|11|||
145313337|NCT01993940|523995341|FG000|Overall Study|Withdrawal by Subject|15|||
145313338|NCT01993940|523995342|FG001|Overall Study|Withdrawal by Subject|19|||
145313339|NCT01993940|523995341|FG000|Overall Study|Lost to Follow-up|2|||
145313340|NCT01993940|523995342|FG001|Overall Study|Lost to Follow-up|5|||
145411261|NCT04589650|524358854|FG002|Overall Study|Adverse Event|1|||
145411262|NCT04589650|524358855|FG003|Overall Study|Adverse Event|1|||
145411263|NCT04589650|524358856|FG004|Overall Study|Adverse Event|0|||
145411264|NCT04589650|524358857|FG005|Overall Study|Adverse Event|1|||
145411265|NCT04589650|524358852|FG000|Overall Study|Physician Decision|1|||
145411266|NCT04589650|524358853|FG001|Overall Study|Physician Decision|1|||
145411267|NCT04589650|524358854|FG002|Overall Study|Physician Decision|0|||
145411268|NCT04589650|524358855|FG003|Overall Study|Physician Decision|0|||
145411269|NCT04589650|524358856|FG004|Overall Study|Physician Decision|0|||
145411270|NCT04589650|524358857|FG005|Overall Study|Physician Decision|0|||
145411271|NCT04589650|524358852|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145411272|NCT04589650|524358853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145411273|NCT04589650|524358854|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145411274|NCT04589650|524358855|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145411275|NCT04589650|524358856|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
145569463|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569464|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
145569465|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
145569466|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
145313341|NCT01993940|523995341|FG000|Overall Study|Protocol Violation|5|||
145313342|NCT01993940|523995342|FG001|Overall Study|Protocol Violation|8|||
145313343|NCT01993940|523995341|FG000|Overall Study|Death|1|||
145411276|NCT04589650|524358857|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
145411277|NCT04589650|524358852|FG000|Overall Study|Death|0|||
145411278|NCT04589650|524358853|FG001|Overall Study|Death|0|||
145411279|NCT04589650|524358854|FG002|Overall Study|Death|0|||
145313344|NCT01993940|523995342|FG001|Overall Study|Death|0|||
145313345|NCT01993940|523995341|FG000|Overall Study|Other - Miscellaneous|1|||
145313346|NCT01993940|523995342|FG001|Overall Study|Other - Miscellaneous|1|||
145313347|NCT04164758|523995347|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
145313348|NCT04164758|523995348|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
145313349|NCT04164758|523995349|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
145313350|NCT04164758|523995347|FG000|Overall Study|Adverse Event|0|||
145313351|NCT04164758|523995348|FG001|Overall Study|Adverse Event|1|||
145313352|NCT04164758|523995349|FG002|Overall Study|Adverse Event|0|||
145313353|NCT01670097|523995350|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
145313354|NCT01670097|523995351|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
145313355|NCT01670097|523995350|FG000|Overall Study|Study burden|1|||
145313356|NCT01670097|523995351|FG001|Overall Study|Study burden|0|||
145313357|NCT01670097|523995350|FG000|Overall Study|COPD exacerbation|0|||
145313358|NCT01670097|523995351|FG001|Overall Study|COPD exacerbation|1|||
145313359|NCT01670097|523995350|FG000|Overall Study|Neutropenia|0|||
145313360|NCT01670097|523995351|FG001|Overall Study|Neutropenia|1|||
145313361|NCT01670097|523995350|FG000|Overall Study|Clinical deterioration|0|||
145313362|NCT01670097|523995351|FG001|Overall Study|Clinical deterioration|1|||
145313363|NCT01670097|523995350|FG000|Overall Study|Disease progression|0|||
145313364|NCT01670097|523995351|FG001|Overall Study|Disease progression|1|||
145313365|NCT03259165|523995352|FG000|Overall Study|COVID 19 pandemic|1|||
145313366|NCT03259165|523995353|FG001|Overall Study|COVID 19 pandemic|1|||
145313367|NCT01949532|523995354|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
145313368|NCT01949532|523995355|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
145313369|NCT05665387|523995358|FG000|Overall Study|Withdrawal by Subject|1|||
145313370|NCT05665387|523995359|FG001|Overall Study|Withdrawal by Subject|0|||
145313371|NCT05665387|523995360|FG002|Overall Study|Withdrawal by Subject|1|||
145313372|NCT01824498|523995361|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
145313373|NCT01824498|523995362|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
145313374|NCT01824498|523995363|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
145313375|NCT01824498|523995364|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
145313376|NCT01824498|523995365|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
145313377|NCT01824498|523995366|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
145313378|NCT01567527|523995367|FG000|Conversion Phase.|Protocol deviation|3|||
145313379|NCT01567527|523995368|FG001|Conversion Phase.|Protocol deviation|0|||
145313380|NCT01567527|523995369|FG002|Conversion Phase.|Protocol deviation|0|||
145313381|NCT01567527|523995370|FG003|Conversion Phase.|Protocol deviation|0|||
145313382|NCT01567527|523995371|FG004|Conversion Phase.|Protocol deviation|0|||
145313383|NCT01567527|523995367|FG000|Conversion Phase.|Met withdrawal criteria|10|||
145313384|NCT01567527|523995368|FG001|Conversion Phase.|Met withdrawal criteria|0|||
145313385|NCT01567527|523995369|FG002|Conversion Phase.|Met withdrawal criteria|0|||
145313386|NCT01567527|523995370|FG003|Conversion Phase.|Met withdrawal criteria|0|||
145313387|NCT01567527|523995371|FG004|Conversion Phase.|Met withdrawal criteria|0|||
145313388|NCT01567527|523995367|FG000|Conversion Phase.|Withdrawal by Subject|32|||
145313389|NCT01567527|523995368|FG001|Conversion Phase.|Withdrawal by Subject|0|||
145313390|NCT01567527|523995369|FG002|Conversion Phase.|Withdrawal by Subject|0|||
145313391|NCT01567527|523995370|FG003|Conversion Phase.|Withdrawal by Subject|0|||
145313392|NCT01567527|523995371|FG004|Conversion Phase.|Withdrawal by Subject|0|||
145313393|NCT01567527|523995367|FG000|Conversion Phase.|Lost to Follow-up|16|||
145313394|NCT01567527|523995368|FG001|Conversion Phase.|Lost to Follow-up|0|||
145313395|NCT01567527|523995369|FG002|Conversion Phase.|Lost to Follow-up|0|||
145313396|NCT01567527|523995370|FG003|Conversion Phase.|Lost to Follow-up|0|||
145313397|NCT01567527|523995371|FG004|Conversion Phase.|Lost to Follow-up|0|||
145313398|NCT01567527|523995367|FG000|Conversion Phase.|Lack of Efficacy|2|||
145313399|NCT01567527|523995368|FG001|Conversion Phase.|Lack of Efficacy|0|||
145313400|NCT01567527|523995369|FG002|Conversion Phase.|Lack of Efficacy|0|||
145313401|NCT01567527|523995370|FG003|Conversion Phase.|Lack of Efficacy|0|||
145313402|NCT01567527|523995371|FG004|Conversion Phase.|Lack of Efficacy|0|||
145313403|NCT01567527|523995367|FG000|Conversion Phase.|Adverse Event|33|||
145313404|NCT01567527|523995368|FG001|Conversion Phase.|Adverse Event|0|||
145313405|NCT01567527|523995369|FG002|Conversion Phase.|Adverse Event|0|||
145313406|NCT01567527|523995370|FG003|Conversion Phase.|Adverse Event|0|||
145313407|NCT01567527|523995371|FG004|Conversion Phase.|Adverse Event|0|||
145313408|NCT01567527|523995367|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
145313409|NCT01567527|523995368|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
145313410|NCT01567527|523995369|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
145313411|NCT01567527|523995370|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
145313412|NCT01567527|523995371|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
145313413|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
145313414|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
145313415|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
145313416|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
145313417|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
145313418|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
145313419|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
145313420|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
145313421|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
145313422|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
145313423|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
145313424|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
145313425|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
145313426|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
145313427|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
145313428|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
145313429|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
145313430|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
145313431|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
145313432|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
145313433|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
145313434|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
145313435|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
145313436|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
145313437|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
145313438|NCT01567527|523995367|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
145313439|NCT01567527|523995368|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
145313440|NCT01567527|523995369|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
145313441|NCT01567527|523995370|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
145313442|NCT01567527|523995371|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
145313443|NCT01567527|523995367|FG000|IM Depot Stabilization.|Protocol deviation|0|||
145313444|NCT01567527|523995368|FG001|IM Depot Stabilization.|Protocol deviation|0|||
145313445|NCT01567527|523995369|FG002|IM Depot Stabilization.|Protocol deviation|5|||
145313446|NCT01567527|523995370|FG003|IM Depot Stabilization.|Protocol deviation|0|||
145313447|NCT01567527|523995371|FG004|IM Depot Stabilization.|Protocol deviation|0|||
145313448|NCT01567527|523995367|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
145313449|NCT01567527|523995368|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
145411280|NCT04589650|524358855|FG003|Overall Study|Death|1|||
145411281|NCT04589650|524358856|FG004|Overall Study|Death|0|||
145411282|NCT04589650|524358857|FG005|Overall Study|Death|0|||
145411283|NCT04589650|524358852|FG000|Overall Study|Guardian Decision|0|||
145411284|NCT04589650|524358853|FG001|Overall Study|Guardian Decision|0|||
145411285|NCT04589650|524358854|FG002|Overall Study|Guardian Decision|0|||
145411286|NCT04589650|524358855|FG003|Overall Study|Guardian Decision|1|||
145411287|NCT04589650|524358856|FG004|Overall Study|Guardian Decision|0|||
145620368|NCT01824472|525123760|FG002|Overall Study|Withdrawal by Subject|3|||
145411288|NCT04589650|524358857|FG005|Overall Study|Guardian Decision|0|||
145411289|NCT02324153|524358858|FG000|Overall Study|Withdrawal by Subject|4|||
145411290|NCT02324153|524358859|FG001|Overall Study|Withdrawal by Subject|1|||
145411291|NCT02324153|524358858|FG000|Overall Study|Surgery postponed after randomization|3|||
145411292|NCT02324153|524358859|FG001|Overall Study|Surgery postponed after randomization|0|||
145411293|NCT02324153|524358858|FG000|Overall Study|Developed delirium preoperatively|1|||
145411294|NCT02324153|524358859|FG001|Overall Study|Developed delirium preoperatively|0|||
145411295|NCT01937299|524358863|FG000|Overall Study|Adverse Event|13|||
145411296|NCT01937299|524358864|FG001|Overall Study|Adverse Event|0|||
145411297|NCT01937299|524358863|FG000|Overall Study|Lack of Efficacy|0|||
145411298|NCT01937299|524358864|FG001|Overall Study|Lack of Efficacy|4|||
145411299|NCT01937299|524358863|FG000|Overall Study|Withdrawal by Subject|1|||
145411300|NCT01937299|524358864|FG001|Overall Study|Withdrawal by Subject|0|||
145411301|NCT04017962|524358865|FG000|Overall Study|Death|2|||
145411302|NCT04017962|524358866|FG001|Overall Study|Death|0|||
145411303|NCT04017962|524358865|FG000|Overall Study|Lost to Follow-up|2|||
145411304|NCT04017962|524358866|FG001|Overall Study|Lost to Follow-up|0|||
145411305|NCT04017962|524358865|FG000|Overall Study|Physician Decision|1|||
145411306|NCT04017962|524358866|FG001|Overall Study|Physician Decision|0|||
145411307|NCT04017962|524358865|FG000|Overall Study|Discontinued LTV|5|||
145411308|NCT04017962|524358866|FG001|Overall Study|Discontinued LTV|0|||
145411309|NCT02875080|524358867|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
145411310|NCT02875080|524358868|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
145411311|NCT02875080|524358869|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
145411312|NCT00768053|524358870|FG000|Overall Study|Adverse Event|10|||
145411313|NCT00768053|524358870|FG000|Overall Study|Lost to Follow-up|1|||
145411314|NCT02782468|524360006|FG000|Overall Study|Progressive Disease|2|||
145411315|NCT02782468|524360007|FG001|Overall Study|Progressive Disease|5|||
145411316|NCT02782468|524360008|FG002|Overall Study|Progressive Disease|0|||
145411317|NCT02782468|524360009|FG003|Overall Study|Progressive Disease|4|||
145411318|NCT02782468|524360006|FG000|Overall Study|Adverse Event|0|||
145313450|NCT01567527|523995369|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
145313451|NCT01567527|523995370|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
145313452|NCT01567527|523995371|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
145313453|NCT01567527|523995367|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
145313454|NCT01567527|523995368|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
145313455|NCT01567527|523995369|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
145313456|NCT01567527|523995370|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
145313457|NCT01567527|523995371|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
145313458|NCT01567527|523995367|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
145313459|NCT01567527|523995368|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
145313460|NCT01567527|523995369|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
145313461|NCT01567527|523995370|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
145313462|NCT01567527|523995371|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
145313463|NCT01567527|523995367|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
145313464|NCT01567527|523995368|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
145313465|NCT01567527|523995369|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
145313466|NCT01567527|523995370|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
145313467|NCT01567527|523995371|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
145313468|NCT01567527|523995367|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
145313469|NCT01567527|523995368|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
145313470|NCT01567527|523995369|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
145313471|NCT01567527|523995370|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
145313472|NCT01567527|523995371|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
145313473|NCT01567527|523995367|FG000|IM Depot Stabilization.|Adverse Event|0|||
145313474|NCT01567527|523995368|FG001|IM Depot Stabilization.|Adverse Event|0|||
145313475|NCT01567527|523995369|FG002|IM Depot Stabilization.|Adverse Event|37|||
145313476|NCT01567527|523995370|FG003|IM Depot Stabilization.|Adverse Event|0|||
145313477|NCT01567527|523995371|FG004|IM Depot Stabilization.|Adverse Event|0|||
145313478|NCT01567527|523995367|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
145313479|NCT01567527|523995368|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
145313480|NCT01567527|523995369|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
145313481|NCT01567527|523995370|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
145313482|NCT01567527|523995371|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
145313483|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
145313484|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
145313485|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
145313486|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
145313487|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
145313488|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
145313489|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
145313490|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
145313491|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
145313492|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
145313493|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
145313494|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
145313495|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
145313496|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
145313497|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
145313498|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
145313499|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
145313500|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
145313501|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
145313502|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
145313503|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145313504|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145313505|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145313506|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
145313507|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
145313508|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
145313509|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
145313510|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
145313511|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
145313512|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
145313513|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
145313514|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
145569467|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
145569468|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
145569469|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
145569470|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
145569471|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
145569472|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
145313515|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
145313516|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
145313517|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
145313518|NCT01567527|523995367|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145313519|NCT01567527|523995368|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145313520|NCT01567527|523995369|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145313521|NCT01567527|523995370|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
145313522|NCT01567527|523995371|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
145313523|NCT02311894|523995373|FG000|Overall Study|Discontinued in error|1|||
145313524|NCT02311894|523995373|FG000|Overall Study|Lost to Follow-up|1|||
145313525|NCT02311894|523995373|FG000|Overall Study|Adverse Event|1|||
145313526|NCT02311894|523995373|FG000|Overall Study|Withdrawal by Subject|1|||
145313527|NCT00884390|523995374|FG000|Overall Study|Adverse Event|0|||
145313528|NCT00884390|523995375|FG001|Overall Study|Adverse Event|1|||
145313529|NCT00884390|523995374|FG000|Overall Study|Lost to Follow-up|0|||
145313530|NCT00884390|523995375|FG001|Overall Study|Lost to Follow-up|1|||
145313531|NCT00884390|523995374|FG000|Overall Study|Physician Decision|2|||
145313532|NCT00884390|523995375|FG001|Overall Study|Physician Decision|1|||
145313533|NCT00884390|523995374|FG000|Overall Study|Protocol Violation|4|||
145313534|NCT00884390|523995375|FG001|Overall Study|Protocol Violation|1|||
145313535|NCT00884390|523995374|FG000|Overall Study|Withdrawal by Subject|4|||
145313536|NCT00884390|523995375|FG001|Overall Study|Withdrawal by Subject|1|||
145313537|NCT00884390|523995374|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
145313538|NCT00884390|523995375|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
145313539|NCT00884390|523995374|FG000|Overall Study|Other|11|||
145313540|NCT00884390|523995375|FG001|Overall Study|Other|1|||
145313541|NCT03980522|523995379|FG000|Treatment Period|Adverse Event|1|||
145313542|NCT03980522|523995380|FG001|Treatment Period|Adverse Event|0|||
145313543|NCT03980522|523995381|FG002|Treatment Period|Adverse Event|0|||
145313544|NCT03980522|523995382|FG003|Treatment Period|Adverse Event|0|||
145313545|NCT03980522|523995383|FG004|Treatment Period|Adverse Event|0|||
145313546|NCT01874535|523995386|FG000|Overall Study|Lost to Follow-up|10|||
145313547|NCT01874535|523995387|FG001|Overall Study|Lost to Follow-up|9|||
145313548|NCT01874535|523995386|FG000|Overall Study|incomplete symptom resolution|45|||
145313549|NCT01874535|523995387|FG001|Overall Study|incomplete symptom resolution|35|||
145313550|NCT01215721|523995388|FG000|Overall Study|Adverse Event|2|||
145313551|NCT00045162|523995389|FG000|Overall Study|Ineligible|12|||
145313552|NCT00045162|523995390|FG001|Overall Study|Ineligible|8|||
145313553|NCT00045162|523995389|FG000|Overall Study|Not treated|7|||
145313554|NCT00045162|523995390|FG001|Overall Study|Not treated|2|||
145313555|NCT00045162|523995389|FG000|Overall Study|Adverse Event|55|||
145313556|NCT00045162|523995390|FG001|Overall Study|Adverse Event|50|||
145313557|NCT00045162|523995389|FG000|Overall Study|Lack of Efficacy|32|||
145313558|NCT00045162|523995390|FG001|Overall Study|Lack of Efficacy|29|||
145313559|NCT00045162|523995389|FG000|Overall Study|Death|10|||
145313560|NCT00045162|523995390|FG001|Overall Study|Death|10|||
145313561|NCT00045162|523995389|FG000|Overall Study|Withdrawal by Subject|5|||
145313562|NCT00045162|523995390|FG001|Overall Study|Withdrawal by Subject|3|||
145313563|NCT00045162|523995389|FG000|Overall Study|Other|21|||
145313564|NCT00045162|523995390|FG001|Overall Study|Other|16|||
145313565|NCT01044433|523995391|FG000|Overall Study|Lost to Follow-up|3|||
145313566|NCT01044433|523995391|FG000|Overall Study|Withdrawal by Subject|3|||
145313567|NCT02616380|523995392|FG000|Overall Study|Lost to Follow-up|1|||
145313568|NCT02616380|523995392|FG000|Overall Study|Other|2|||
145313569|NCT00939523|523995397|FG000|Overall Study|Lack of Efficacy|1|||
145313570|NCT00939523|523995397|FG000|Overall Study|Physician Decision|2|||
145313571|NCT00024258|523995398|FG000|Overall Study|Withdrawal by Subject|1|||
145313572|NCT00024258|523995398|FG000|Overall Study|Disease Progression|8|||
145313573|NCT01050764|523995399|FG000|Overall Study|Death, before HSCT|1|||
145313574|NCT01050764|523995399|FG000|Overall Study|Donor mobilization failure, death|1|||
145313575|NCT01050764|523995399|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
145313576|NCT01562613|523995408|FG000|Overall Study|Lost to Follow-up|2|||
145313577|NCT01562613|523995408|FG000|Overall Study|Withdrawal by Subject|2|||
145313578|NCT04388787|523995409|FG000|Blinded Period|Patient could not follow instructions|1|||
145313579|NCT04388787|523995409|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
145313580|NCT00663234|523995410|FG000|Overall Study|Not willing to adhere to requirements|1|||
145313581|NCT01751087|523995411|FG000|Overall Study|Withdrawal by Subject|1|||
145313582|NCT01751087|523995412|FG001|Overall Study|Withdrawal by Subject|0|||
145313583|NCT01751087|523995413|FG002|Overall Study|Withdrawal by Subject|0|||
145313584|NCT01751087|523995411|FG000|Overall Study|Physician Decision|0|||
145313585|NCT01751087|523995412|FG001|Overall Study|Physician Decision|0|||
145313586|NCT01751087|523995413|FG002|Overall Study|Physician Decision|1|||
145313587|NCT01520987|523996699|FG000|Overall Study|Withdrawal by Subject|1|||
145313588|NCT01520987|523996700|FG001|Overall Study|Withdrawal by Subject|0|||
145313589|NCT01520987|523996701|FG002|Overall Study|Withdrawal by Subject|0|||
145313590|NCT01520987|523996702|FG003|Overall Study|Withdrawal by Subject|0|||
145313591|NCT01520987|523996703|FG004|Overall Study|Withdrawal by Subject|0|||
145313592|NCT01520987|523996704|FG005|Overall Study|Withdrawal by Subject|1|||
145313593|NCT01520987|523996705|FG006|Overall Study|Withdrawal by Subject|0|||
145313594|NCT01520987|523996706|FG007|Overall Study|Withdrawal by Subject|0|||
145313595|NCT02710214|523996707|FG000|Overall Study|Lost to Follow-up|1|||
145313596|NCT02710214|523996708|FG001|Overall Study|Lost to Follow-up|0|||
145313597|NCT02710214|523996707|FG000|Overall Study|Lack of Efficacy|0|||
145313598|NCT02710214|523996708|FG001|Overall Study|Lack of Efficacy|1|||
145313599|NCT02710214|523996707|FG000|Overall Study|Death|0|||
145313600|NCT02710214|523996708|FG001|Overall Study|Death|1|||
145313601|NCT02832167|523996709|FG000|Treatment Period 1|Disease progression|90|||
145313602|NCT02832167|523996709|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
145313603|NCT02832167|523996709|FG000|Treatment Period 1|Death|2|||
145313604|NCT02832167|523996709|FG000|Treatment Period 1|Study Drug Toxicity|6|||
145313605|NCT02832167|523996709|FG000|Treatment Period 1|Participant request to discontinue|9|||
145313606|NCT02832167|523996709|FG000|Treatment Period 1|No longer meet study criteria|1|||
145313607|NCT02832167|523996709|FG000|Treatment Period 1|Participant withdrew consent|3|||
145313608|NCT02832167|523996709|FG000|Treatment Period 1|Other reasons|6|||
145313609|NCT02832167|523996709|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
145313610|NCT02832167|523996709|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
145313611|NCT02832167|523996709|FG000|Transition From Period 1 to Period 2|Death|2|||
145313612|NCT02832167|523996709|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
145313613|NCT02832167|523996709|FG000|Treatment Period 2|Disease progression|69|||
145313614|NCT02832167|523996709|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
145313615|NCT02832167|523996709|FG000|Treatment Period 2|Maximum clinical benefit|1|||
145313616|NCT02832167|523996709|FG000|Treatment Period 2|Study Drug Toxicity|5|||
145313617|NCT02832167|523996709|FG000|Treatment Period 2|Participant request to discontinue|2|||
145313618|NCT02832167|523996709|FG000|Treatment Period 2|Participant withdrew consent|3|||
145313619|NCT02832167|523996709|FG000|Treatment Period 2|Other reasons|3|||
145313620|NCT01754376|523996710|FG000|Overall Study|Adverse Event|1|||
145313621|NCT01754376|523996710|FG000|Overall Study|Lack of Efficacy|2|||
145313622|NCT04556734|523996711|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
145313623|NCT04556734|523996712|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145313624|NCT04556734|523996713|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
145313625|NCT04556734|523996714|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145313626|NCT04556734|523996715|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145313627|NCT04556734|523996716|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145313628|NCT04556734|523996717|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145313629|NCT04556734|523996718|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145313630|NCT04556734|523996711|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
145313631|NCT04556734|523996712|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313632|NCT04556734|523996713|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313633|NCT04556734|523996714|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313634|NCT04556734|523996715|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313635|NCT04556734|523996716|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313636|NCT04556734|523996717|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313637|NCT04556734|523996718|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145313638|NCT04556734|523996711|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145313639|NCT04556734|523996712|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313640|NCT04556734|523996713|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145313641|NCT04556734|523996714|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313642|NCT04556734|523996715|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313643|NCT04556734|523996716|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313644|NCT04556734|523996717|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313645|NCT04556734|523996718|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145313646|NCT04556734|523996711|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
145313647|NCT04556734|523996712|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313648|NCT04556734|523996713|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313649|NCT04556734|523996714|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313650|NCT04556734|523996715|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313651|NCT04556734|523996716|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313652|NCT04556734|523996717|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313653|NCT04556734|523996718|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145313654|NCT04556734|523996711|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313655|NCT04556734|523996712|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313656|NCT04556734|523996713|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
145313657|NCT04556734|523996714|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313658|NCT04556734|523996715|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313659|NCT04556734|523996716|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313660|NCT04556734|523996717|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313661|NCT04556734|523996718|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
145313662|NCT04556734|523996711|FG000|OLE Period (28 Weeks)|Not reported|0|||
145313663|NCT04556734|523996712|FG001|OLE Period (28 Weeks)|Not reported|0|||
145313664|NCT04556734|523996713|FG002|OLE Period (28 Weeks)|Not reported|0|||
145313665|NCT04556734|523996714|FG003|OLE Period (28 Weeks)|Not reported|0|||
145313666|NCT04556734|523996715|FG004|OLE Period (28 Weeks)|Not reported|0|||
145313667|NCT04556734|523996716|FG005|OLE Period (28 Weeks)|Not reported|1|||
145313668|NCT04556734|523996717|FG006|OLE Period (28 Weeks)|Not reported|0|||
145313669|NCT04556734|523996718|FG007|OLE Period (28 Weeks)|Not reported|0|||
145313670|NCT04556734|523996711|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313671|NCT04556734|523996712|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313672|NCT04556734|523996713|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313673|NCT04556734|523996714|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313674|NCT04556734|523996715|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313675|NCT04556734|523996716|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313676|NCT04556734|523996717|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
145313677|NCT04556734|523996718|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
145313678|NCT04556734|523996711|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
145313679|NCT04556734|523996712|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
145313680|NCT04556734|523996713|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
145313681|NCT04556734|523996714|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
145313682|NCT04556734|523996715|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
145313683|NCT04556734|523996716|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
145313684|NCT04556734|523996717|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
145313685|NCT04556734|523996718|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
145313686|NCT04556734|523996711|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145313687|NCT04556734|523996712|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145313688|NCT04556734|523996713|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145313689|NCT04556734|523996714|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
145313690|NCT04556734|523996715|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
145313691|NCT04556734|523996716|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
145313692|NCT04556734|523996717|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
145313693|NCT04556734|523996718|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
145313694|NCT04264819|523996724|FG000|Overall Study|Physician Decision|19|||
145313695|NCT04264819|523996724|FG000|Overall Study|Adverse Event|12|||
145313696|NCT04264819|523996724|FG000|Overall Study|Withdrawal by Subject|11|||
145313697|NCT04264819|523996724|FG000|Overall Study|Lost to Follow-up|2|||
145313698|NCT04264819|523996724|FG000|Overall Study|Death|2|||
145313699|NCT02846883|523996732|FG000|Overall Study|Death|0|||
145313700|NCT02846883|523996733|FG001|Overall Study|Death|1|||
145313701|NCT02846883|523996734|FG002|Overall Study|Death|1|||
145313702|NCT02846883|523996732|FG000|Overall Study|Lost to Follow-up|0|||
145313703|NCT02846883|523996733|FG001|Overall Study|Lost to Follow-up|0|||
145313704|NCT02846883|523996734|FG002|Overall Study|Lost to Follow-up|1|||
145313705|NCT02846883|523996732|FG000|Overall Study|Withdrawal by Subject|1|||
145313706|NCT02846883|523996733|FG001|Overall Study|Withdrawal by Subject|0|||
145313707|NCT02846883|523996734|FG002|Overall Study|Withdrawal by Subject|0|||
145313708|NCT02846883|523996732|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
145313709|NCT02846883|523996733|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
145313710|NCT02846883|523996734|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
145313711|NCT02846883|523996732|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
145313712|NCT02846883|523996733|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
145313713|NCT02846883|523996734|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
145313714|NCT04768296|523996738|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
145313715|NCT04768296|523996739|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
145313716|NCT00442351|523996742|FG000|Overall Study|Administrative|6|||
145569473|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
145569474|NCT00404352|524944247|FG000|Double Blind (up to 24 Month)|Other|0|||
145313717|NCT00442351|523996743|FG001|Overall Study|Administrative|5|||
145313718|NCT00442351|523996742|FG000|Overall Study|Did not meet protocol eligibility|1|||
145313719|NCT00442351|523996743|FG001|Overall Study|Did not meet protocol eligibility|0|||
145313720|NCT00442351|523996742|FG000|Overall Study|Other|0|||
145313721|NCT00442351|523996743|FG001|Overall Study|Other|1|||
145313722|NCT00108628|523996752|FG000|Overall Study|Withdrawal by Subject|17|||
145569475|NCT00404352|524944248|FG001|Double Blind (up to 24 Month)|Other|1|||
145569476|NCT00404352|524944249|FG002|Double Blind (up to 24 Month)|Other|0|||
145569477|NCT00404352|524944250|FG003|Double Blind (up to 24 Month)|Other|0|||
145569478|NCT00404352|524944251|FG004|Double Blind (up to 24 Month)|Other|0|||
145313723|NCT00108628|523996753|FG001|Overall Study|Withdrawal by Subject|9|||
145313724|NCT00108628|523996752|FG000|Overall Study|Lack of Efficacy|2|||
145313725|NCT00108628|523996753|FG001|Overall Study|Lack of Efficacy|1|||
145313726|NCT00108628|523996752|FG000|Overall Study|Death|1|||
145313727|NCT00108628|523996753|FG001|Overall Study|Death|0|||
145313728|NCT01453153|523996754|FG000|Overall Study|Physician Decision|0|||
145313729|NCT01453153|523996755|FG001|Overall Study|Physician Decision|0|||
145313730|NCT01453153|523996756|FG002|Overall Study|Physician Decision|1|||
145313731|NCT01453153|523996754|FG000|Overall Study|Progressive Disease|3|||
145313732|NCT01453153|523996755|FG001|Overall Study|Progressive Disease|2|||
145313733|NCT01453153|523996756|FG002|Overall Study|Progressive Disease|16|||
145313734|NCT01453153|523996754|FG000|Overall Study|Withdrawal by Subject|0|||
145313735|NCT01453153|523996755|FG001|Overall Study|Withdrawal by Subject|1|||
145313736|NCT01453153|523996756|FG002|Overall Study|Withdrawal by Subject|2|||
145313737|NCT01453153|523996754|FG000|Overall Study|Adverse Event|1|||
145313738|NCT01453153|523996755|FG001|Overall Study|Adverse Event|1|||
145313739|NCT01453153|523996756|FG002|Overall Study|Adverse Event|1|||
145313740|NCT03547635|523996757|FG000|Overall Study|Adverse Event|5|||
145313741|NCT03547635|523996758|FG001|Overall Study|Adverse Event|2|||
145313742|NCT03547635|523996759|FG002|Overall Study|Adverse Event|3|||
145313743|NCT03547635|523996757|FG000|Overall Study|Lost to Follow-up|1|||
145313744|NCT03547635|523996758|FG001|Overall Study|Lost to Follow-up|3|||
145313745|NCT03547635|523996759|FG002|Overall Study|Lost to Follow-up|4|||
145313746|NCT03547635|523996757|FG000|Overall Study|Withdrawal by Subject|1|||
145313747|NCT03547635|523996758|FG001|Overall Study|Withdrawal by Subject|0|||
145313748|NCT03547635|523996759|FG002|Overall Study|Withdrawal by Subject|0|||
145313749|NCT03547635|523996757|FG000|Overall Study|Withdrawal By PI|0|||
145313750|NCT03547635|523996758|FG001|Overall Study|Withdrawal By PI|1|||
145313751|NCT03547635|523996759|FG002|Overall Study|Withdrawal By PI|0|||
145313752|NCT03547635|523996757|FG000|Overall Study|Withdrawal by Sponsor|0|||
145313753|NCT03547635|523996758|FG001|Overall Study|Withdrawal by Sponsor|0|||
145313754|NCT03547635|523996759|FG002|Overall Study|Withdrawal by Sponsor|1|||
145313755|NCT03547635|523996757|FG000|Overall Study|Errant Randomization before Treatment|0|||
145411319|NCT02782468|524360007|FG001|Overall Study|Adverse Event|2|||
145411320|NCT02782468|524360008|FG002|Overall Study|Adverse Event|2|||
145411321|NCT02782468|524360009|FG003|Overall Study|Adverse Event|3|||
145411322|NCT02782468|524360006|FG000|Overall Study|Other|0|||
145411323|NCT02782468|524360007|FG001|Overall Study|Other|0|||
145569479|NCT00404352|524944252|FG005|Double Blind (up to 24 Month)|Other|0|||
145569480|NCT00404352|524944253|FG006|Double Blind (up to 24 Month)|Other|0|||
145569481|NCT00404352|524944254|FG007|Double Blind (up to 24 Month)|Other|0|||
145569482|NCT00404352|524944255|FG008|Double Blind (up to 24 Month)|Other|0|||
145569483|NCT00404352|524944247|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
145569484|NCT00404352|524944248|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
145569485|NCT00404352|524944249|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
145569486|NCT00404352|524944250|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
145569487|NCT00404352|524944251|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
145569488|NCT00404352|524944252|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
145569489|NCT00404352|524944253|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
145569490|NCT00404352|524944254|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
145569491|NCT00404352|524944255|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
145569492|NCT00404352|524944247|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
145569493|NCT00404352|524944248|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
145569494|NCT00404352|524944249|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
145569495|NCT00404352|524944250|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
145569496|NCT00404352|524944251|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
145569497|NCT00404352|524944252|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
145569498|NCT00404352|524944253|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
145569499|NCT00404352|524944254|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
145569500|NCT00404352|524944255|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
145569501|NCT00404352|524944247|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569502|NCT00404352|524944248|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569503|NCT00404352|524944249|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569504|NCT00404352|524944250|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569505|NCT00404352|524944251|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
145569506|NCT00404352|524944252|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569507|NCT00404352|524944253|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569508|NCT00404352|524944254|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145569509|NCT00404352|524944255|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
145313756|NCT03547635|523996758|FG001|Overall Study|Errant Randomization before Treatment|1|||
145313757|NCT03547635|523996759|FG002|Overall Study|Errant Randomization before Treatment|0|||
145313758|NCT03547635|523996757|FG000|Overall Study|Withdrawal by Subject|1|||
145313759|NCT03547635|523996758|FG001|Overall Study|Withdrawal by Subject|0|||
145411324|NCT02782468|524360008|FG002|Overall Study|Other|1|||
145569510|NCT00404352|524944247|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145569511|NCT00404352|524944248|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145313760|NCT03547635|523996759|FG002|Overall Study|Withdrawal by Subject|0|||
145313761|NCT02415387|523996764|FG000|Overall Study|Withdrawal by Subject|6|||
145313762|NCT02415387|523996765|FG001|Overall Study|Withdrawal by Subject|1|||
145313763|NCT02415387|523996764|FG000|Overall Study|blood draw problem|0|||
145313764|NCT02415387|523996765|FG001|Overall Study|blood draw problem|1|||
145313765|NCT02415387|523996764|FG000|Overall Study|Protocol Violation|1|||
145313766|NCT02415387|523996765|FG001|Overall Study|Protocol Violation|0|||
145313767|NCT03035890|523996766|FG000|Overall Study|Death|1|||
145313768|NCT03243396|523996767|FG000|Overall Study|Lost to Follow-up|2|||
145313769|NCT03243396|523996768|FG001|Overall Study|Lost to Follow-up|3|||
145313770|NCT03243396|523996769|FG002|Overall Study|Lost to Follow-up|15|||
145313771|NCT03243396|523996770|FG003|Overall Study|Lost to Follow-up|8|||
145313772|NCT03243396|523996771|FG004|Overall Study|Lost to Follow-up|1|||
145313773|NCT03243396|523996772|FG005|Overall Study|Lost to Follow-up|4|||
145313774|NCT03243396|523996773|FG006|Overall Study|Lost to Follow-up|9|||
145313775|NCT00544167|523996776|FG000|Overall Study|Adverse Event|21|||
145313776|NCT00544167|523996776|FG000|Overall Study|Physician Decision|8|||
145313777|NCT00735696|523996783|FG000|Overall Study|Withdrawal by Subject|1|||
145313778|NCT00735696|523996783|FG000|Overall Study|Enrolled but never Treated|1|||
145313779|NCT02274558|523996785|FG000|Overall Study|Adverse Event|2|||
145313780|NCT02274558|523996786|FG001|Overall Study|Adverse Event|4|||
145313781|NCT02274558|523996787|FG002|Overall Study|Adverse Event|2|||
145313782|NCT02274558|523996785|FG000|Overall Study|Non-compliance|2|||
145313783|NCT02274558|523996786|FG001|Overall Study|Non-compliance|1|||
145569512|NCT00404352|524944249|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145569513|NCT00404352|524944250|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145569514|NCT00404352|524944251|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145569515|NCT00404352|524944252|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
145569516|NCT00404352|524944253|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145569517|NCT00404352|524944254|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145313784|NCT02274558|523996787|FG002|Overall Study|Non-compliance|0|||
145313785|NCT02274558|523996785|FG000|Overall Study|Withdrawal by Subject|1|||
145313786|NCT02274558|523996786|FG001|Overall Study|Withdrawal by Subject|5|||
145313787|NCT02274558|523996787|FG002|Overall Study|Withdrawal by Subject|4|||
145313788|NCT02274558|523996785|FG000|Overall Study|Death|0|||
145313789|NCT02274558|523996786|FG001|Overall Study|Death|0|||
145313790|NCT02274558|523996787|FG002|Overall Study|Death|1|||
145313791|NCT02274558|523996785|FG000|Overall Study|Lost to Follow-up|2|||
145313792|NCT02274558|523996786|FG001|Overall Study|Lost to Follow-up|1|||
145313793|NCT02274558|523996787|FG002|Overall Study|Lost to Follow-up|1|||
145313794|NCT02274558|523996785|FG000|Overall Study|Physician Decision|0|||
145313795|NCT02274558|523996786|FG001|Overall Study|Physician Decision|2|||
145313796|NCT02274558|523996787|FG002|Overall Study|Physician Decision|1|||
145313797|NCT02733627|523996794|FG000|Overall Study|Adverse Event|0|||
145313798|NCT02733627|523996795|FG001|Overall Study|Adverse Event|1|||
145313799|NCT02733627|523996796|FG002|Overall Study|Adverse Event|1|||
145313800|NCT02733627|523996797|FG003|Overall Study|Adverse Event|0|||
145313801|NCT02733627|523996794|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
145313802|NCT02733627|523996795|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
145313803|NCT02733627|523996796|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
145313804|NCT02733627|523996797|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
145313805|NCT00059332|523996798|FG000|Overall Study|Withdrawal by Subject|2|||
145313806|NCT00059332|523996799|FG001|Overall Study|Withdrawal by Subject|1|||
145313807|NCT00059332|523996798|FG000|Overall Study|Lost to Follow-up|1|||
145313808|NCT00059332|523996799|FG001|Overall Study|Lost to Follow-up|1|||
145313809|NCT02587143|523996800|FG000|Overall Study|Adverse Event|1|||
145313810|NCT02587143|523996801|FG001|Overall Study|Adverse Event|0|||
145313811|NCT02754492|523996802|FG000|Overall Study|Protocol Violation|2|||
145313812|NCT02754492|523996803|FG001|Overall Study|Protocol Violation|2|||
145313813|NCT02754492|523996804|FG002|Overall Study|Protocol Violation|0|||
145313814|NCT02754492|523996805|FG003|Overall Study|Protocol Violation|1|||
145313815|NCT02754492|523996802|FG000|Overall Study|Withdrawal by Subject|2|||
145313816|NCT02754492|523996803|FG001|Overall Study|Withdrawal by Subject|0|||
145313817|NCT02754492|523996804|FG002|Overall Study|Withdrawal by Subject|0|||
145313818|NCT02754492|523996805|FG003|Overall Study|Withdrawal by Subject|0|||
145313819|NCT02754492|523996802|FG000|Overall Study|Equipment malfuntion|0|||
145313820|NCT02754492|523996803|FG001|Overall Study|Equipment malfuntion|0|||
145313821|NCT02754492|523996804|FG002|Overall Study|Equipment malfuntion|2|||
145313822|NCT02754492|523996805|FG003|Overall Study|Equipment malfuntion|5|||
145313823|NCT02754492|523996802|FG000|Overall Study|Adverse Event|0|||
145411325|NCT02782468|524360009|FG003|Overall Study|Other|1|||
145569518|NCT00404352|524944255|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
145313824|NCT02754492|523996803|FG001|Overall Study|Adverse Event|0|||
145313825|NCT02754492|523996804|FG002|Overall Study|Adverse Event|0|||
145313826|NCT02754492|523996805|FG003|Overall Study|Adverse Event|13|||
145569519|NCT00404352|524944247|FG000|Open Label (up to 24 Month)|Disease progression|0|||
145313827|NCT02754492|523996802|FG000|Overall Study|Venous access issues not resulting in AE|0|||
145313828|NCT02754492|523996803|FG001|Overall Study|Venous access issues not resulting in AE|0|||
145313829|NCT02754492|523996804|FG002|Overall Study|Venous access issues not resulting in AE|0|||
145313830|NCT02754492|523996805|FG003|Overall Study|Venous access issues not resulting in AE|4|||
145313831|NCT00487695|523996806|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
145313832|NCT00487695|523996807|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
145313833|NCT00487695|523996806|FG000|First Procedure|active wheezing (did not have procedure)|1|||
145313834|NCT00487695|523996807|FG001|First Procedure|active wheezing (did not have procedure)|0|||
145313835|NCT00487695|523996806|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
145313836|NCT00487695|523996807|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
145569520|NCT00404352|524944248|FG001|Open Label (up to 24 Month)|Disease progression|0|||
145313837|NCT00487695|523996806|FG000|Second Procedure|active wheezing|0|||
145313838|NCT00487695|523996807|FG001|Second Procedure|active wheezing|1|||
145313839|NCT00487695|523996806|FG000|Second Procedure|Withdrawal by Subject|1|||
145313840|NCT00487695|523996807|FG001|Second Procedure|Withdrawal by Subject|2|||
145313841|NCT01186458|523996810|FG000|Overall Study|Adverse Event|1|||
145313842|NCT04281472|523996811|FG000|Stage A|Lack of Efficacy|8|||
145313843|NCT04281472|523996812|FG001|Stage A|Lack of Efficacy|0|||
145313844|NCT04281472|523996813|FG002|Stage A|Lack of Efficacy|0|||
145313845|NCT04281472|523996811|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
145313846|NCT04281472|523996812|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
145313847|NCT04281472|523996813|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
145313848|NCT04281472|523996811|FG000|Stage A|Adverse Event|20|||
145313849|NCT04281472|523996812|FG001|Stage A|Adverse Event|0|||
145313850|NCT04281472|523996813|FG002|Stage A|Adverse Event|0|||
145313851|NCT04281472|523996811|FG000|Stage A|Death|1|||
145313852|NCT04281472|523996812|FG001|Stage A|Death|0|||
145313853|NCT04281472|523996813|FG002|Stage A|Death|0|||
145313854|NCT04281472|523996811|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
145313855|NCT04281472|523996812|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
145313856|NCT04281472|523996813|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
145313857|NCT04281472|523996811|FG000|Stage A|Lost to Follow-up|2|||
145313858|NCT04281472|523996812|FG001|Stage A|Lost to Follow-up|0|||
145313859|NCT04281472|523996813|FG002|Stage A|Lost to Follow-up|0|||
145313860|NCT04281472|523996811|FG000|Stage A|Non-compliance with study drug|1|||
145313861|NCT04281472|523996812|FG001|Stage A|Non-compliance with study drug|0|||
145313862|NCT04281472|523996813|FG002|Stage A|Non-compliance with study drug|0|||
145313863|NCT04281472|523996811|FG000|Stage A|Physician Decision|1|||
145313864|NCT04281472|523996812|FG001|Stage A|Physician Decision|0|||
145313865|NCT04281472|523996813|FG002|Stage A|Physician Decision|0|||
145313866|NCT04281472|523996811|FG000|Stage A|Prohibited medications|2|||
145313867|NCT04281472|523996812|FG001|Stage A|Prohibited medications|0|||
145313868|NCT04281472|523996813|FG002|Stage A|Prohibited medications|0|||
145313869|NCT04281472|523996811|FG000|Stage A|Withdrawal by Subject|11|||
145313870|NCT04281472|523996812|FG001|Stage A|Withdrawal by Subject|0|||
145313871|NCT04281472|523996813|FG002|Stage A|Withdrawal by Subject|0|||
145313872|NCT04281472|523996811|FG000|Stage A|Other|5|||
145313873|NCT04281472|523996812|FG001|Stage A|Other|0|||
145313874|NCT04281472|523996813|FG002|Stage A|Other|0|||
145313875|NCT04281472|523996811|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
145313876|NCT04281472|523996812|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
145313877|NCT04281472|523996813|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
145569521|NCT00404352|524944249|FG002|Open Label (up to 24 Month)|Disease progression|0|||
145569522|NCT00404352|524944250|FG003|Open Label (up to 24 Month)|Disease progression|1|||
145569523|NCT00404352|524944251|FG004|Open Label (up to 24 Month)|Disease progression|0|||
145569524|NCT00404352|524944252|FG005|Open Label (up to 24 Month)|Disease progression|0|||
145569525|NCT00404352|524944253|FG006|Open Label (up to 24 Month)|Disease progression|0|||
145569526|NCT00404352|524944254|FG007|Open Label (up to 24 Month)|Disease progression|0|||
145569527|NCT00404352|524944255|FG008|Open Label (up to 24 Month)|Disease progression|0|||
145569528|NCT00404352|524944247|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145569529|NCT00404352|524944248|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145313878|NCT04281472|523996811|FG000|Stage B|Adverse Event|0|||
145313879|NCT04281472|523996812|FG001|Stage B|Adverse Event|3|||
145313880|NCT04281472|523996813|FG002|Stage B|Adverse Event|0|||
145313881|NCT04281472|523996811|FG000|Stage B|Death|0|||
145313882|NCT04281472|523996812|FG001|Stage B|Death|0|||
145569530|NCT00404352|524944249|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145620369|NCT01824472|525123758|FG000|Overall Study|Ineligible post randomization&screening|0|||
145313883|NCT04281472|523996813|FG002|Stage B|Death|1|||
145313884|NCT04281472|523996811|FG000|Stage B|Lack of Efficacy|0|||
145313885|NCT04281472|523996812|FG001|Stage B|Lack of Efficacy|0|||
145313886|NCT04281472|523996813|FG002|Stage B|Lack of Efficacy|1|||
145313887|NCT04281472|523996811|FG000|Stage B|Lost to Follow-up|0|||
145313888|NCT04281472|523996812|FG001|Stage B|Lost to Follow-up|0|||
145313889|NCT04281472|523996813|FG002|Stage B|Lost to Follow-up|2|||
145569531|NCT00404352|524944250|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145569532|NCT00404352|524944251|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145569533|NCT00404352|524944252|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145569534|NCT00404352|524944253|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
145569535|NCT00404352|524944254|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
145569536|NCT00404352|524944255|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
145569537|NCT00404352|524944247|FG000|Open Label Extension (up to 36 Months)|Other|0|||
145569538|NCT00404352|524944248|FG001|Open Label Extension (up to 36 Months)|Other|0|||
145569539|NCT00404352|524944249|FG002|Open Label Extension (up to 36 Months)|Other|0|||
145569540|NCT00404352|524944250|FG003|Open Label Extension (up to 36 Months)|Other|0|||
145569541|NCT00404352|524944251|FG004|Open Label Extension (up to 36 Months)|Other|0|||
145569542|NCT00404352|524944252|FG005|Open Label Extension (up to 36 Months)|Other|0|||
145569543|NCT00404352|524944253|FG006|Open Label Extension (up to 36 Months)|Other|0|||
145569544|NCT00404352|524944254|FG007|Open Label Extension (up to 36 Months)|Other|0|||
145569545|NCT00404352|524944255|FG008|Open Label Extension (up to 36 Months)|Other|2|||
145569546|NCT03047135|524944258|FG000|Overall Study|Still being treated|3|||
145569547|NCT00323414|524944259|FG000|Overall Study|Withdrawal by Subject|0|||
145569548|NCT00323414|524944260|FG001|Overall Study|Withdrawal by Subject|1|||
145313890|NCT04281472|523996811|FG000|Stage B|Prohibited medications|0|||
145313891|NCT04281472|523996812|FG001|Stage B|Prohibited medications|2|||
145313892|NCT04281472|523996813|FG002|Stage B|Prohibited medications|1|||
145313893|NCT04281472|523996811|FG000|Stage B|Protocol Violation|0|||
145313894|NCT04281472|523996812|FG001|Stage B|Protocol Violation|1|||
145313895|NCT04281472|523996813|FG002|Stage B|Protocol Violation|1|||
145313896|NCT04281472|523996811|FG000|Stage B|Sponsor decision|0|||
145313897|NCT04281472|523996812|FG001|Stage B|Sponsor decision|0|||
145313898|NCT04281472|523996813|FG002|Stage B|Sponsor decision|1|||
145313899|NCT04281472|523996811|FG000|Stage B|Withdrawal by Subject|0|||
145313900|NCT04281472|523996812|FG001|Stage B|Withdrawal by Subject|3|||
145313901|NCT04281472|523996813|FG002|Stage B|Withdrawal by Subject|3|||
145313902|NCT04281472|523996811|FG000|Stage B|Other|0|||
145313903|NCT04281472|523996812|FG001|Stage B|Other|3|||
145313904|NCT04281472|523996813|FG002|Stage B|Other|0|||
145313905|NCT00152451|523996814|FG000|Overall Study|Adverse Event|4|||
145313906|NCT00323258|523996816|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
145313907|NCT00323258|523996817|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
145313908|NCT00323258|523996816|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
145313909|NCT00323258|523996817|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
145313910|NCT00323258|523996816|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
145313911|NCT00323258|523996817|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
145313912|NCT00323258|523996816|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
145313913|NCT00323258|523996817|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
145313914|NCT00323258|523996816|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
145313915|NCT00323258|523996817|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
145313916|NCT00323258|523996816|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
145313917|NCT00323258|523996817|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
145313918|NCT00323258|523996816|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
145313919|NCT00323258|523996817|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
145569549|NCT01077960|524944261|FG000|Overall Study|Adverse Event|6|||
145569550|NCT01077960|524944261|FG000|Overall Study|Protocol Violation|3|||
145569551|NCT01077960|524944261|FG000|Overall Study|Lost to Follow-up|5|||
145569552|NCT01077960|524944261|FG000|Overall Study|Subject decision|1|||
145569553|NCT01077960|524944261|FG000|Overall Study|Reason unspecified|1|||
145569554|NCT05619692|524944262|FG000|Overall Study|Adverse Event|2|||
145569555|NCT05619692|524944263|FG001|Overall Study|Adverse Event|2|||
145569556|NCT05619692|524944262|FG000|Overall Study|Withdrawal by Participant|3|||
145569557|NCT05619692|524944263|FG001|Overall Study|Withdrawal by Participant|4|||
145569558|NCT05619692|524944262|FG000|Overall Study|Lost to Follow-up|2|||
145569559|NCT05619692|524944263|FG001|Overall Study|Lost to Follow-up|1|||
145569560|NCT05619692|524944262|FG000|Overall Study|Randomized but not treated|1|||
145313920|NCT01055834|523996818|FG000|Treatment Period I|Adverse Event|1|||
145313921|NCT01055834|523996819|FG001|Treatment Period I|Adverse Event|0|||
145313922|NCT01717313|523996820|FG000|Phase A (Weeks 0 to 24)|Death|0|||
145313923|NCT01717313|523996821|FG001|Phase A (Weeks 0 to 24)|Death|1|||
145313924|NCT01717313|523996820|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
145313925|NCT01717313|523996821|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
145313926|NCT01717313|523996820|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
145313927|NCT01717313|523996821|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
145313928|NCT01717313|523996820|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
145313929|NCT01717313|523996821|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
145569561|NCT05619692|524944263|FG001|Overall Study|Randomized but not treated|3|||
145569562|NCT01398956|524944264|FG000|Overall Study|Withdrawal by Subject|4|||
145569563|NCT01398956|524944264|FG000|Overall Study|AE, non-serious non-fatal|4|||
145569564|NCT01398956|524944264|FG000|Overall Study|Withdrawal Criteria No.3|1|||
145569565|NCT01398956|524944264|FG000|Overall Study|Subject moved a long distance|1|||
145569566|NCT00451035|524944265|FG000|Overall Study|Disease progression|11|||
145569567|NCT00451035|524944265|FG000|Overall Study|Death|3|||
145569568|NCT00451035|524944265|FG000|Overall Study|New anti-neoplastic therapy|3|||
145569569|NCT00969553|524944266|FG000|Overall Study|Progressive disease (PD)|2|||
145569570|NCT00969553|524944267|FG001|Overall Study|Progressive disease (PD)|2|||
145569571|NCT00969553|524944268|FG002|Overall Study|Progressive disease (PD)|6|||
145569572|NCT00969553|524944269|FG003|Overall Study|Progressive disease (PD)|9|||
145569573|NCT00969553|524944270|FG004|Overall Study|Progressive disease (PD)|2|||
145569574|NCT00969553|524944271|FG005|Overall Study|Progressive disease (PD)|4|||
145569575|NCT00969553|524944272|FG006|Overall Study|Progressive disease (PD)|2|||
145569576|NCT00969553|524944273|FG007|Overall Study|Progressive disease (PD)|12|||
145569577|NCT00969553|524944274|FG008|Overall Study|Progressive disease (PD)|3|||
145569578|NCT00969553|524944266|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
145569579|NCT00969553|524944267|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
145313930|NCT01717313|523996820|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
145313931|NCT01717313|523996821|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
145313932|NCT01717313|523996820|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
145313933|NCT01717313|523996821|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
145313934|NCT01717313|523996820|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
145313935|NCT01717313|523996821|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
145313936|NCT01717313|523996820|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
145313937|NCT01717313|523996821|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
145313938|NCT01717313|523996820|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
145313939|NCT01717313|523996821|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
145313940|NCT00743145|523996823|FG000|Overall Study|Withdrawal by Subject|1|||
145313941|NCT00743145|523996823|FG000|Overall Study|Adverse Event|2|||
145313942|NCT00743145|523996823|FG000|Overall Study|Pregnancy|1|||
145313943|NCT03732833|523996826|FG000|Overall Study|Adverse Event|0|||
145313944|NCT03732833|523996827|FG001|Overall Study|Adverse Event|3|||
145313945|NCT03732833|523996828|FG002|Overall Study|Adverse Event|1|||
145313946|NCT03732833|523996826|FG000|Overall Study|Withdrawal by Subject|11|||
145313947|NCT03732833|523996827|FG001|Overall Study|Withdrawal by Subject|13|||
145313948|NCT03732833|523996828|FG002|Overall Study|Withdrawal by Subject|8|||
145313949|NCT03732833|523996826|FG000|Overall Study|Lost to Follow-up|3|||
145313950|NCT03732833|523996827|FG001|Overall Study|Lost to Follow-up|5|||
145313951|NCT03732833|523996828|FG002|Overall Study|Lost to Follow-up|4|||
145313952|NCT03732833|523996826|FG000|Overall Study|Pregnancy|0|||
145313953|NCT03732833|523996827|FG001|Overall Study|Pregnancy|2|||
145313954|NCT03732833|523996828|FG002|Overall Study|Pregnancy|0|||
145313955|NCT03732833|523996826|FG000|Overall Study|Physician Decision|2|||
145313956|NCT03732833|523996827|FG001|Overall Study|Physician Decision|3|||
145313957|NCT03732833|523996828|FG002|Overall Study|Physician Decision|1|||
145313958|NCT03732833|523996826|FG000|Overall Study|Covid-19 related and other reasons|2|||
145313959|NCT03732833|523996827|FG001|Overall Study|Covid-19 related and other reasons|7|||
145313960|NCT03732833|523996828|FG002|Overall Study|Covid-19 related and other reasons|3|||
145313961|NCT01691612|523996829|FG000|Overall Study|deemed ineligible after 1st visit|6|||
145313962|NCT01691612|523996829|FG000|Overall Study|Adverse Event|1|||
145313963|NCT02623218|523996830|FG000|Overall Study|Lost to Follow-up|0|||
145313964|NCT02623218|523996831|FG001|Overall Study|Lost to Follow-up|1|||
145313965|NCT02623218|523996832|FG002|Overall Study|Lost to Follow-up|0|||
145313966|NCT02623218|523996833|FG003|Overall Study|Lost to Follow-up|0|||
145313967|NCT02623218|523996834|FG004|Overall Study|Lost to Follow-up|0|||
145313968|NCT01726803|523996835|FG000|Overall Study|Lost to Follow-up|6|||
145313969|NCT01726803|523996836|FG001|Overall Study|Lost to Follow-up|1|||
145313970|NCT01726803|523996835|FG000|Overall Study|Withdrawal by Subject|1|||
145313971|NCT01726803|523996836|FG001|Overall Study|Withdrawal by Subject|0|||
145313972|NCT05263505|523996838|FG000|Overall Study|Adverse Event|0|||
145313973|NCT05263505|523996839|FG001|Overall Study|Adverse Event|1|||
145313974|NCT00452348|523998500|FG000|Overall Study|Adverse Event|6|||
145313975|NCT00452348|523998501|FG001|Overall Study|Adverse Event|9|||
145313976|NCT00452348|523998500|FG000|Overall Study|Lack of Efficacy|10|||
145313977|NCT00452348|523998501|FG001|Overall Study|Lack of Efficacy|9|||
145569580|NCT00969553|524944268|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
145569581|NCT00969553|524944269|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
145620370|NCT01824472|525123759|FG001|Overall Study|Ineligible post randomization&screening|2|||
145313978|NCT00452348|523998500|FG000|Overall Study|Lost to Follow-up|14|||
145313979|NCT00452348|523998501|FG001|Overall Study|Lost to Follow-up|8|||
145313980|NCT00452348|523998500|FG000|Overall Study|Protocol Violation|22|||
145313981|NCT00452348|523998501|FG001|Overall Study|Protocol Violation|28|||
145313982|NCT00452348|523998500|FG000|Overall Study|Withdrawal by Subject|18|||
145313983|NCT00452348|523998501|FG001|Overall Study|Withdrawal by Subject|21|||
145313984|NCT00452348|523998500|FG000|Overall Study|Other|9|||
145313985|NCT00452348|523998501|FG001|Overall Study|Other|9|||
145313986|NCT01257581|523998510|FG000|Overall Study|Early Termination|3|||
145313987|NCT01257581|523998511|FG001|Overall Study|Early Termination|1|||
145313988|NCT01257581|523998512|FG002|Overall Study|Early Termination|2|||
145313989|NCT01257581|523998510|FG000|Overall Study|Death|2|||
145313990|NCT01257581|523998511|FG001|Overall Study|Death|2|||
145313991|NCT01257581|523998512|FG002|Overall Study|Death|4|||
145313992|NCT00517192|523998517|FG000|Overall Study|Adverse Event|1|||
145313993|NCT00517192|523998518|FG001|Overall Study|Adverse Event|1|||
145313994|NCT00517192|523998517|FG000|Overall Study|Lost to Follow-up|1|||
145313995|NCT00517192|523998518|FG001|Overall Study|Lost to Follow-up|1|||
145313996|NCT00517192|523998517|FG000|Overall Study|Withdrawal by Subject|1|||
145313997|NCT00517192|523998518|FG001|Overall Study|Withdrawal by Subject|0|||
145313998|NCT00517192|523998517|FG000|Overall Study|Early termination of the trial|16|||
145313999|NCT00517192|523998518|FG001|Overall Study|Early termination of the trial|18|||
145314000|NCT03167606|523998519|FG000|Overall Study|Lost to Follow-up|73|||
145314001|NCT03167606|523998520|FG001|Overall Study|Lost to Follow-up|64|||
145314002|NCT03167606|523998519|FG000|Overall Study|Withdrawal by Subject|6|||
145314003|NCT03167606|523998520|FG001|Overall Study|Withdrawal by Subject|5|||
145314004|NCT03167606|523998519|FG000|Overall Study|Withdrawal by Investigator|0|||
145314005|NCT03167606|523998520|FG001|Overall Study|Withdrawal by Investigator|2|||
145314006|NCT02483416|523998521|FG000|Overall Study|Other reason|0|||
145314007|NCT02483416|523998522|FG001|Overall Study|Other reason|1|||
145314008|NCT02483416|523998521|FG000|Overall Study|Treatment stop|3|||
145314009|NCT02483416|523998522|FG001|Overall Study|Treatment stop|0|||
145314010|NCT00611884|523998526|FG000|Overall Study|Adverse Event|1|||
145314011|NCT00611884|523998527|FG001|Overall Study|Adverse Event|0|||
145314012|NCT00611884|523998528|FG002|Overall Study|Adverse Event|0|||
145314013|NCT00611884|523998529|FG003|Overall Study|Adverse Event|1|||
145314014|NCT00611884|523998526|FG000|Overall Study|Non-Compliance|1|||
145314015|NCT00611884|523998527|FG001|Overall Study|Non-Compliance|4|||
145314016|NCT00611884|523998528|FG002|Overall Study|Non-Compliance|2|||
145314017|NCT00611884|523998529|FG003|Overall Study|Non-Compliance|2|||
145314018|NCT00611884|523998526|FG000|Overall Study|Lack of Efficacy|0|||
145314019|NCT00611884|523998527|FG001|Overall Study|Lack of Efficacy|1|||
145314020|NCT00611884|523998528|FG002|Overall Study|Lack of Efficacy|0|||
145314021|NCT00611884|523998529|FG003|Overall Study|Lack of Efficacy|0|||
145314022|NCT00611884|523998526|FG000|Overall Study|Unclassified|7|||
145314023|NCT00611884|523998527|FG001|Overall Study|Unclassified|4|||
145314024|NCT00611884|523998528|FG002|Overall Study|Unclassified|2|||
145314025|NCT00611884|523998529|FG003|Overall Study|Unclassified|3|||
145314026|NCT00981799|523998530|FG000|Overall Study|Adverse Event|1|||
145314027|NCT00981799|523998531|FG001|Overall Study|Adverse Event|1|||
145314028|NCT00981799|523998532|FG002|Overall Study|Adverse Event|0|||
145314029|NCT00981799|523998533|FG003|Overall Study|Adverse Event|0|||
145314030|NCT02167594|523998534|FG000|Overall Study|Withdrawal by Subject|2|||
145314031|NCT02167594|523998535|FG001|Overall Study|Withdrawal by Subject|0|||
145314032|NCT02167594|523998536|FG002|Overall Study|Withdrawal by Subject|0|||
145314033|NCT02167594|523998534|FG000|Overall Study|Death|0|||
145314034|NCT02167594|523998535|FG001|Overall Study|Death|1|||
145314035|NCT02167594|523998536|FG002|Overall Study|Death|0|||
145314036|NCT03433703|523998537|FG000|Overall Study|Study terminated by Sponsor|2|||
145314037|NCT01943435|523998550|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
145314038|NCT01943435|523998551|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
145314039|NCT01943435|523998552|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
145314040|NCT01943435|523998550|FG000|Intervention Period|Withdrawal by Subject|3|||
145314041|NCT01943435|523998551|FG001|Intervention Period|Withdrawal by Subject|3|||
145314042|NCT01943435|523998552|FG002|Intervention Period|Withdrawal by Subject|4|||
145314043|NCT01943435|523998550|FG000|2 Month Follow up|Lost to Follow-up|2|||
145411326|NCT02782468|524360006|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145411327|NCT02782468|524360007|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145569582|NCT00969553|524944270|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
145314044|NCT01943435|523998551|FG001|2 Month Follow up|Lost to Follow-up|3|||
145314045|NCT01943435|523998552|FG002|2 Month Follow up|Lost to Follow-up|0|||
145411328|NCT02782468|524360008|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
145411329|NCT02782468|524360009|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
145569583|NCT00969553|524944271|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
145314046|NCT01943435|523998550|FG000|6 Month Follow up|Lost to Follow-up|12|||
145314047|NCT01943435|523998551|FG001|6 Month Follow up|Lost to Follow-up|7|||
145314048|NCT01943435|523998552|FG002|6 Month Follow up|Lost to Follow-up|15|||
145314049|NCT01617096|523998559|FG000|Overall Study|Withdrawal by Subject|96|||
145314050|NCT01617096|523998560|FG001|Overall Study|Withdrawal by Subject|81|||
145314051|NCT01617096|523998559|FG000|Overall Study|Lost to Follow-up|37|||
145314052|NCT01617096|523998560|FG001|Overall Study|Lost to Follow-up|32|||
145314053|NCT01617096|523998559|FG000|Overall Study|Physician Decision|10|||
145314054|NCT01617096|523998560|FG001|Overall Study|Physician Decision|18|||
145314055|NCT01617096|523998559|FG000|Overall Study|Death|4|||
145314056|NCT01617096|523998560|FG001|Overall Study|Death|3|||
145314057|NCT01617096|523998559|FG000|Overall Study|Other|1|||
145314058|NCT01617096|523998560|FG001|Overall Study|Other|3|||
145569584|NCT00969553|524944272|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
145569585|NCT00969553|524944273|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
145569586|NCT00969553|524944274|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
145569587|NCT00969553|524944266|FG000|Overall Study|Other Adverse Event|0|||
145569588|NCT00969553|524944267|FG001|Overall Study|Other Adverse Event|0|||
145569589|NCT00969553|524944268|FG002|Overall Study|Other Adverse Event|0|||
145569590|NCT00969553|524944269|FG003|Overall Study|Other Adverse Event|1|||
145569591|NCT00969553|524944270|FG004|Overall Study|Other Adverse Event|0|||
145569592|NCT00969553|524944271|FG005|Overall Study|Other Adverse Event|0|||
145569593|NCT00969553|524944272|FG006|Overall Study|Other Adverse Event|1|||
145569594|NCT00969553|524944273|FG007|Overall Study|Other Adverse Event|0|||
145569595|NCT00969553|524944274|FG008|Overall Study|Other Adverse Event|0|||
145569596|NCT00969553|524944266|FG000|Overall Study|Refused cont. medication|1|||
145569597|NCT00969553|524944267|FG001|Overall Study|Refused cont. medication|1|||
145569598|NCT00969553|524944268|FG002|Overall Study|Refused cont. medication|0|||
145569599|NCT00969553|524944269|FG003|Overall Study|Refused cont. medication|2|||
145569600|NCT00969553|524944270|FG004|Overall Study|Refused cont. medication|0|||
145569601|NCT00969553|524944271|FG005|Overall Study|Refused cont. medication|0|||
145411330|NCT02782468|524360006|FG000|Overall Study|Symptomatic Deterioration|0|||
145411331|NCT02782468|524360007|FG001|Overall Study|Symptomatic Deterioration|0|||
145569602|NCT00969553|524944272|FG006|Overall Study|Refused cont. medication|0|||
145569603|NCT00969553|524944273|FG007|Overall Study|Refused cont. medication|1|||
145569604|NCT00969553|524944274|FG008|Overall Study|Refused cont. medication|0|||
145314059|NCT02046122|523998565|FG000|Overall Study|Physician Decision|8|||
145314060|NCT02046122|523998565|FG000|Overall Study|Withdrawal by Subject|1|||
145314061|NCT04535986|523998568|FG000|Overall Study|Death|4|||
145314062|NCT04535986|523998569|FG001|Overall Study|Death|5|||
145314063|NCT04535986|523998568|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
145314064|NCT04535986|523998569|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
145314065|NCT04535986|523998568|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
145314066|NCT04535986|523998569|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
145314067|NCT04535986|523998568|FG000|Overall Study|Adverse Event|10|||
145314068|NCT04535986|523998569|FG001|Overall Study|Adverse Event|1|||
145314069|NCT04535986|523998568|FG000|Overall Study|Lack of Efficacy|3|||
145314070|NCT04535986|523998569|FG001|Overall Study|Lack of Efficacy|2|||
145314071|NCT04535986|523998568|FG000|Overall Study|Investigator discretion|3|||
145314072|NCT04535986|523998569|FG001|Overall Study|Investigator discretion|0|||
145314073|NCT04535986|523998568|FG000|Overall Study|Withdrawal by Subject|32|||
145314074|NCT04535986|523998569|FG001|Overall Study|Withdrawal by Subject|14|||
145314075|NCT04535986|523998568|FG000|Overall Study|Lost to Follow-up|5|||
145314076|NCT04535986|523998569|FG001|Overall Study|Lost to Follow-up|3|||
145314077|NCT04535986|523998568|FG000|Overall Study|Other|7|||
145314078|NCT04535986|523998569|FG001|Overall Study|Other|3|||
145314079|NCT01196390|523998570|FG000|Overall Study|Protocol Violation|4|||
145314080|NCT01196390|523998571|FG001|Overall Study|Protocol Violation|5|||
145314081|NCT03141151|523998574|FG000|Overall Study|Lost to Follow-up|3|||
145314082|NCT03141151|523998575|FG001|Overall Study|Lost to Follow-up|2|||
145314083|NCT03141151|523998574|FG000|Overall Study|Withdrawal by Subject|3|||
145314084|NCT03141151|523998575|FG001|Overall Study|Withdrawal by Subject|2|||
145314085|NCT04561115|523998582|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
145314086|NCT04561115|523998583|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
145314087|NCT04561115|523998582|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
145314088|NCT04561115|523998583|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
145314089|NCT04561115|523998582|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
145314090|NCT04561115|523998583|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
145314091|NCT01745094|523998584|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
145314092|NCT01745094|523998585|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
145314093|NCT01745094|523998586|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
145314094|NCT01745094|523998587|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
145314095|NCT01745094|523998584|FG000|Overall Study|Adverse Event|0|||
145314096|NCT01745094|523998585|FG001|Overall Study|Adverse Event|0|||
145314097|NCT01745094|523998586|FG002|Overall Study|Adverse Event|3|||
145314098|NCT01745094|523998587|FG003|Overall Study|Adverse Event|0|||
145314099|NCT01745094|523998584|FG000|Overall Study|Withdrawal by Subject|2|||
145314100|NCT01745094|523998585|FG001|Overall Study|Withdrawal by Subject|0|||
145314101|NCT01745094|523998586|FG002|Overall Study|Withdrawal by Subject|1|||
145569605|NCT00969553|524944266|FG000|Overall Study|Not specified above|0|||
145569606|NCT00969553|524944267|FG001|Overall Study|Not specified above|0|||
145569607|NCT00969553|524944268|FG002|Overall Study|Not specified above|0|||
145569608|NCT00969553|524944269|FG003|Overall Study|Not specified above|4|||
145314102|NCT01745094|523998587|FG003|Overall Study|Withdrawal by Subject|2|||
145569609|NCT00969553|524944270|FG004|Overall Study|Not specified above|0|||
145569610|NCT00969553|524944271|FG005|Overall Study|Not specified above|0|||
145569611|NCT00969553|524944272|FG006|Overall Study|Not specified above|1|||
145569612|NCT00969553|524944273|FG007|Overall Study|Not specified above|1|||
145569613|NCT00969553|524944274|FG008|Overall Study|Not specified above|0|||
145569614|NCT00717769|524944275|FG000|Overall Study|Adverse Event|9|||
145569615|NCT00717769|524944276|FG001|Overall Study|Adverse Event|6|||
145569616|NCT00717769|524944277|FG002|Overall Study|Adverse Event|1|||
145569617|NCT00717769|524944275|FG000|Overall Study|Lack of compliance|0|||
145569618|NCT00717769|524944276|FG001|Overall Study|Lack of compliance|2|||
145569619|NCT00717769|524944277|FG002|Overall Study|Lack of compliance|0|||
145569620|NCT00717769|524944275|FG000|Overall Study|Lost to Follow-up|3|||
145569621|NCT00717769|524944276|FG001|Overall Study|Lost to Follow-up|4|||
145569622|NCT00717769|524944277|FG002|Overall Study|Lost to Follow-up|0|||
145569623|NCT00717769|524944275|FG000|Overall Study|Lack of Efficacy|1|||
145569624|NCT00717769|524944276|FG001|Overall Study|Lack of Efficacy|2|||
145569625|NCT00717769|524944277|FG002|Overall Study|Lack of Efficacy|0|||
145569626|NCT00717769|524944275|FG000|Overall Study|Protocol Violation|0|||
145569627|NCT00717769|524944276|FG001|Overall Study|Protocol Violation|2|||
145569628|NCT00717769|524944277|FG002|Overall Study|Protocol Violation|0|||
145569629|NCT00717769|524944275|FG000|Overall Study|Sponsor decision|1|||
145569630|NCT00717769|524944276|FG001|Overall Study|Sponsor decision|0|||
145569631|NCT00717769|524944277|FG002|Overall Study|Sponsor decision|10|||
145569632|NCT00717769|524944275|FG000|Overall Study|Withdrew consent|2|||
145569633|NCT00717769|524944276|FG001|Overall Study|Withdrew consent|2|||
145569634|NCT00717769|524944277|FG002|Overall Study|Withdrew consent|0|||
145569635|NCT04248816|524944282|FG000|Overall Study|Ineligible post-randomization|7|||
145569636|NCT04248816|524944283|FG001|Overall Study|Ineligible post-randomization|21|||
145569637|NCT04248816|524944284|FG002|Overall Study|Ineligible post-randomization|25|||
145569638|NCT04327986|524944286|FG000|Overall Study|Physician Decision|2|||
145569639|NCT04327986|524944287|FG001|Overall Study|Physician Decision|0|||
145314103|NCT01745094|523998584|FG000|Overall Study|Protocol Violation|1|||
145314104|NCT01745094|523998585|FG001|Overall Study|Protocol Violation|0|||
145314105|NCT01745094|523998586|FG002|Overall Study|Protocol Violation|3|||
145314106|NCT01745094|523998587|FG003|Overall Study|Protocol Violation|1|||
145314107|NCT01745094|523998584|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
145314108|NCT01745094|523998585|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
145314109|NCT01745094|523998586|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
145314110|NCT01745094|523998587|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
145314111|NCT01745094|523998584|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
145314112|NCT01745094|523998585|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
145314113|NCT01745094|523998586|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
145314114|NCT01745094|523998587|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
145314115|NCT01745094|523998584|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
145314116|NCT01745094|523998585|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
145314117|NCT01745094|523998586|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
145314118|NCT01745094|523998587|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
145314119|NCT01097694|523998588|FG000|Overall Study|Adverse Event|5|||
145314120|NCT01097694|523998589|FG001|Overall Study|Adverse Event|0|||
145314121|NCT01097694|523998588|FG000|Overall Study|Lost to Follow-up|0|||
145314122|NCT01097694|523998589|FG001|Overall Study|Lost to Follow-up|3|||
145314123|NCT01097694|523998588|FG000|Overall Study|Withdrawal by Subject|3|||
145314124|NCT01097694|523998589|FG001|Overall Study|Withdrawal by Subject|1|||
145314125|NCT03922750|523998590|FG000|Overall Study|Unclassified|0|||
145314126|NCT03922750|523998591|FG001|Overall Study|Unclassified|0|||
145314127|NCT03922750|523998592|FG002|Overall Study|Unclassified|1|||
145314128|NCT03922750|523998590|FG000|Overall Study|Adverse Event|0|||
145314129|NCT03922750|523998591|FG001|Overall Study|Adverse Event|1|||
145314130|NCT03922750|523998592|FG002|Overall Study|Adverse Event|0|||
145314131|NCT02985398|523998593|FG000|Overall Study|Adverse Event|1|||
145314132|NCT02985398|523998593|FG000|Overall Study|Lost to Follow-up|4|||
145314133|NCT02985398|523998593|FG000|Overall Study|Withdrawal by Subject|8|||
145314134|NCT02985398|523998593|FG000|Overall Study|Study Burden|9|||
145314135|NCT00668395|523998594|FG000|Overall Study|Withdrawal by Subject|4|||
145314136|NCT00668395|523998595|FG001|Overall Study|Withdrawal by Subject|4|||
145314137|NCT00668395|523998596|FG002|Overall Study|Withdrawal by Subject|1|||
145314138|NCT00668395|523998594|FG000|Overall Study|Adverse Event|1|||
145314139|NCT00668395|523998595|FG001|Overall Study|Adverse Event|1|||
145411332|NCT02782468|524360008|FG002|Overall Study|Symptomatic Deterioration|0|||
145569640|NCT04327986|524944288|FG002|Overall Study|Physician Decision|0|||
145569641|NCT04327986|524944286|FG000|Overall Study|Death|1|||
145569642|NCT04327986|524944287|FG001|Overall Study|Death|0|||
145569643|NCT04327986|524944288|FG002|Overall Study|Death|0|||
145569644|NCT03829046|524944291|FG000|Overall Study|Withdrawal by Subject|1|||
145314140|NCT00668395|523998596|FG002|Overall Study|Adverse Event|0|||
145314141|NCT00668395|523998594|FG000|Overall Study|Physician Decision|1|||
145314142|NCT00668395|523998595|FG001|Overall Study|Physician Decision|1|||
145314143|NCT00668395|523998596|FG002|Overall Study|Physician Decision|0|||
145314144|NCT00697827|523998597|FG000|Overall Study|enrolled but not treated|2|||
145569645|NCT03829046|524944292|FG001|Overall Study|Withdrawal by Subject|0|||
145569646|NCT01399593|524944294|FG000|Overall Study|Physician Decision|1|||
145569647|NCT01399593|524944295|FG001|Overall Study|Physician Decision|0|||
145569648|NCT01399593|524944294|FG000|Overall Study|Adverse Event|1|||
145569649|NCT01399593|524944295|FG001|Overall Study|Adverse Event|0|||
145569650|NCT01399593|524944294|FG000|Overall Study|Death|1|||
145569651|NCT01399593|524944295|FG001|Overall Study|Death|1|||
145314145|NCT00697827|523998598|FG001|Overall Study|enrolled but not treated|1|||
145314146|NCT00283842|523998603|FG000|Overall Study|Adverse Event|8|||
145314147|NCT00283842|523998604|FG001|Overall Study|Adverse Event|7|||
145314148|NCT00283842|523998605|FG002|Overall Study|Adverse Event|21|||
145314149|NCT00283842|523998606|FG003|Overall Study|Adverse Event|21|||
145314150|NCT00283842|523998607|FG004|Overall Study|Adverse Event|5|||
145314151|NCT00283842|523998603|FG000|Overall Study|Protocol Violation|1|||
145314152|NCT00283842|523998604|FG001|Overall Study|Protocol Violation|5|||
145314153|NCT00283842|523998605|FG002|Overall Study|Protocol Violation|4|||
145314154|NCT00283842|523998606|FG003|Overall Study|Protocol Violation|0|||
145314155|NCT00283842|523998607|FG004|Overall Study|Protocol Violation|0|||
145314156|NCT00283842|523998603|FG000|Overall Study|Protocol deviation|0|||
145314157|NCT00283842|523998604|FG001|Overall Study|Protocol deviation|0|||
145314158|NCT00283842|523998605|FG002|Overall Study|Protocol deviation|0|||
145314159|NCT00283842|523998606|FG003|Overall Study|Protocol deviation|0|||
145314160|NCT00283842|523998607|FG004|Overall Study|Protocol deviation|2|||
145314161|NCT00283842|523998603|FG000|Overall Study|Withdrawal by Subject|2|||
145314162|NCT00283842|523998604|FG001|Overall Study|Withdrawal by Subject|1|||
145314163|NCT00283842|523998605|FG002|Overall Study|Withdrawal by Subject|1|||
145314164|NCT00283842|523998606|FG003|Overall Study|Withdrawal by Subject|5|||
145314165|NCT00283842|523998607|FG004|Overall Study|Withdrawal by Subject|4|||
145314166|NCT00283842|523998603|FG000|Overall Study|Lack of Efficacy|1|||
145314167|NCT00283842|523998604|FG001|Overall Study|Lack of Efficacy|3|||
145314168|NCT00283842|523998605|FG002|Overall Study|Lack of Efficacy|1|||
145314169|NCT00283842|523998606|FG003|Overall Study|Lack of Efficacy|0|||
145314170|NCT00283842|523998607|FG004|Overall Study|Lack of Efficacy|3|||
145314171|NCT00283842|523998603|FG000|Overall Study|Lost to Follow-up|0|||
145314172|NCT00283842|523998604|FG001|Overall Study|Lost to Follow-up|2|||
145314173|NCT00283842|523998605|FG002|Overall Study|Lost to Follow-up|4|||
145314174|NCT00283842|523998606|FG003|Overall Study|Lost to Follow-up|1|||
145620371|NCT01824472|525123760|FG002|Overall Study|Ineligible post randomization&screening|0|||
145620372|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
145620373|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
145620374|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
145620375|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
145620376|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
145569652|NCT01399593|524944294|FG000|Overall Study|Transplantectomy|0|||
145569653|NCT01399593|524944295|FG001|Overall Study|Transplantectomy|1|||
145620377|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
145314175|NCT00283842|523998607|FG004|Overall Study|Lost to Follow-up|1|||
145314176|NCT02004691|523998608|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
145314177|NCT02004691|523998609|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
145314178|NCT02004691|523998608|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
145314179|NCT02004691|523998609|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
145314180|NCT02004691|523998608|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
145314181|NCT02004691|523998609|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
145314182|NCT02004691|523998608|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
145314183|NCT02004691|523998609|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
145314184|NCT02004691|523998608|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
145314185|NCT02004691|523998609|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
145314186|NCT02004691|523998608|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
145314187|NCT02004691|523998609|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
145314188|NCT02472639|523998610|FG000|Overall Study|Physician Decision|4|||
145314189|NCT02472639|523998611|FG001|Overall Study|Physician Decision|3|||
145314190|NCT00751023|523998612|FG000|Overall Study|Lost to Follow-up|11|||
145314191|NCT00751023|523998613|FG001|Overall Study|Lost to Follow-up|7|||
145314192|NCT01211262|523998617|FG000|Overall Study|Progressive Disease|18|||
145314193|NCT01211262|523998618|FG001|Overall Study|Progressive Disease|9|||
145314194|NCT01211262|523998617|FG000|Overall Study|Adverse Event|4|||
145314195|NCT01211262|523998618|FG001|Overall Study|Adverse Event|0|||
145314196|NCT01211262|523998617|FG000|Overall Study|Withdrawal of Consent|1|||
145314197|NCT01211262|523998618|FG001|Overall Study|Withdrawal of Consent|0|||
145314198|NCT01211262|523998617|FG000|Overall Study|Other|0|||
145569654|NCT02357147|524944298|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
145314199|NCT01211262|523998618|FG001|Overall Study|Other|1|||
145314200|NCT01277510|523998619|FG000|Double-blind Phase|Non-compliance|0|||
145314201|NCT01277510|523998620|FG001|Double-blind Phase|Non-compliance|1|||
145314202|NCT01277510|523998619|FG000|Double-blind Phase|Adverse Event|1|||
145620378|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
145314203|NCT01277510|523998620|FG001|Double-blind Phase|Adverse Event|0|||
145314204|NCT01277510|523998619|FG000|Double-blind Phase|Withdrawal by Subject|2|||
145314205|NCT01277510|523998620|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145314206|NCT01277510|523998619|FG000|Double-blind Phase|Administrative decision|7|||
145314207|NCT01277510|523998620|FG001|Double-blind Phase|Administrative decision|9|||
145314208|NCT01277510|523998619|FG000|Double-blind Phase|Death|0|||
145314209|NCT01277510|523998620|FG001|Double-blind Phase|Death|1|||
145314210|NCT01277510|523998619|FG000|Double-blind Phase|Protocol-specified criteria|2|||
145314211|NCT01277510|523998620|FG001|Double-blind Phase|Protocol-specified criteria|6|||
145314212|NCT01277510|523998619|FG000|Double-blind Phase|Other|1|||
145314213|NCT01277510|523998620|FG001|Double-blind Phase|Other|1|||
145314214|NCT01277510|523998619|FG000|Open-label Phase|Administrative decision|4|||
145314215|NCT01277510|523998620|FG001|Open-label Phase|Administrative decision|3|||
145314216|NCT01277510|523998619|FG000|Open-label Phase|Protocol-specified criteria|1|||
145314217|NCT01277510|523998620|FG001|Open-label Phase|Protocol-specified criteria|0|||
145314218|NCT01277510|523998619|FG000|Open-label Phase|Never received investigational product|2|||
145314219|NCT01277510|523998620|FG001|Open-label Phase|Never received investigational product|0|||
145314220|NCT01685008|523998621|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
145314221|NCT01685008|523998622|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
145314222|NCT01685008|523998623|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
145314223|NCT01685008|523998624|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
145569655|NCT02357147|524944299|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
145314224|NCT01685008|523998621|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
145314225|NCT01685008|523998622|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
145314226|NCT01685008|523998623|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
145314227|NCT01685008|523998624|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
145314228|NCT01685008|523998621|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
145314229|NCT01685008|523998622|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
145314230|NCT01685008|523998623|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
145314231|NCT01685008|523998624|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
145314232|NCT01685008|523998621|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
145314233|NCT01685008|523998622|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
145314234|NCT01685008|523998623|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
145314235|NCT01685008|523998624|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
145314236|NCT01685008|523998621|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
145314237|NCT01685008|523998622|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
145314238|NCT01685008|523998623|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
145314239|NCT01685008|523998624|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
145314240|NCT02005276|523998625|FG000|Overall Study|No longer interested|5|||
145314241|NCT02005276|523998626|FG001|Overall Study|No longer interested|2|||
145314242|NCT02005276|523998627|FG002|Overall Study|No longer interested|3|||
145314243|NCT02005276|523998628|FG003|Overall Study|No longer interested|3|||
145314244|NCT01970592|523998629|FG000|Overall Study|Withdrawal by Subject|4|||
145314245|NCT01970592|523998629|FG000|Overall Study|Physician Decision|1|||
145314246|NCT01970592|523998629|FG000|Overall Study|Adverse Event|1|||
145314247|NCT01320722|523998632|FG000|Overall Study|Did not Receive Intervention|3|||
145314248|NCT01320722|523998633|FG001|Overall Study|Did not Receive Intervention|2|||
145314249|NCT01320722|523998634|FG002|Overall Study|Did not Receive Intervention|1|||
145314250|NCT01320722|523998635|FG003|Overall Study|Did not Receive Intervention|1|||
145314251|NCT01320722|523998636|FG004|Overall Study|Did not Receive Intervention|2|||
145314252|NCT01320722|523998632|FG000|Overall Study|Lost to Follow-up|0|||
145314253|NCT01320722|523998633|FG001|Overall Study|Lost to Follow-up|1|||
145314254|NCT01320722|523998634|FG002|Overall Study|Lost to Follow-up|0|||
145314255|NCT01320722|523998635|FG003|Overall Study|Lost to Follow-up|1|||
145314256|NCT01320722|523998636|FG004|Overall Study|Lost to Follow-up|3|||
145314257|NCT01320722|523998632|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
145314258|NCT01320722|523998633|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
145314259|NCT01320722|523998634|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
145314260|NCT01320722|523998635|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
145314261|NCT01320722|523998636|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
145314262|NCT01320722|523998632|FG000|Overall Study|Participant Developed a Rash|0|||
145314263|NCT01320722|523998633|FG001|Overall Study|Participant Developed a Rash|0|||
145314264|NCT01320722|523998634|FG002|Overall Study|Participant Developed a Rash|2|||
145314265|NCT01320722|523998635|FG003|Overall Study|Participant Developed a Rash|1|||
145314266|NCT01320722|523998636|FG004|Overall Study|Participant Developed a Rash|1|||
145314267|NCT01320722|523998632|FG000|Overall Study|Non-compliant with Medication|0|||
145314268|NCT01320722|523998633|FG001|Overall Study|Non-compliant with Medication|0|||
145314269|NCT01320722|523998634|FG002|Overall Study|Non-compliant with Medication|1|||
145314270|NCT01320722|523998635|FG003|Overall Study|Non-compliant with Medication|0|||
145314271|NCT01320722|523998636|FG004|Overall Study|Non-compliant with Medication|0|||
145314272|NCT01320722|523998632|FG000|Overall Study|Adverse Event|0|||
145314273|NCT01320722|523998633|FG001|Overall Study|Adverse Event|0|||
145314274|NCT01320722|523998634|FG002|Overall Study|Adverse Event|3|||
145314275|NCT01320722|523998635|FG003|Overall Study|Adverse Event|6|||
145314276|NCT01320722|523998636|FG004|Overall Study|Adverse Event|0|||
145314277|NCT01320722|523998632|FG000|Overall Study|Not Compliant with Study Procedures|0|||
145314278|NCT01320722|523998633|FG001|Overall Study|Not Compliant with Study Procedures|0|||
145314279|NCT01320722|523998634|FG002|Overall Study|Not Compliant with Study Procedures|0|||
145314280|NCT01320722|523998635|FG003|Overall Study|Not Compliant with Study Procedures|4|||
145314281|NCT01320722|523998636|FG004|Overall Study|Not Compliant with Study Procedures|0|||
145314282|NCT01320722|523998632|FG000|Overall Study|Pregnancy|0|||
145314283|NCT01320722|523998633|FG001|Overall Study|Pregnancy|0|||
145314284|NCT01320722|523998634|FG002|Overall Study|Pregnancy|0|||
145314285|NCT01320722|523998635|FG003|Overall Study|Pregnancy|1|||
145314286|NCT01320722|523998636|FG004|Overall Study|Pregnancy|0|||
145314287|NCT01320722|523998632|FG000|Overall Study|Started an Exclusionary Medication|0|||
145314288|NCT01320722|523998633|FG001|Overall Study|Started an Exclusionary Medication|0|||
145314289|NCT01320722|523998634|FG002|Overall Study|Started an Exclusionary Medication|0|||
145314290|NCT01320722|523998635|FG003|Overall Study|Started an Exclusionary Medication|0|||
145314291|NCT01320722|523998636|FG004|Overall Study|Started an Exclusionary Medication|1|||
145314292|NCT01320722|523998632|FG000|Overall Study|Withdrew due to Health Condition|0|||
145314293|NCT01320722|523998633|FG001|Overall Study|Withdrew due to Health Condition|0|||
145314294|NCT01320722|523998634|FG002|Overall Study|Withdrew due to Health Condition|0|||
145314295|NCT01320722|523998635|FG003|Overall Study|Withdrew due to Health Condition|0|||
145314296|NCT01320722|523998636|FG004|Overall Study|Withdrew due to Health Condition|1|||
145314297|NCT01091363|523998637|FG000|Overall Study|Withdrawal by Subject|11|||
145314298|NCT01091363|523998638|FG001|Overall Study|Withdrawal by Subject|15|||
145314299|NCT01091363|523998637|FG000|Overall Study|Lost to Follow-up|2|||
145314300|NCT01091363|523998638|FG001|Overall Study|Lost to Follow-up|2|||
145314301|NCT00021541|523998639|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
145569656|NCT02357147|524944298|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
145569657|NCT02357147|524944299|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
145569658|NCT02357147|524944298|FG000|Combination Treatment Phase|Investigator Discretion|1|||
145314302|NCT00021541|523998640|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
145314303|NCT00021541|523998639|FG000|Period 1-First Treatment|Adverse Event|2|||
145314304|NCT00021541|523998640|FG001|Period 1-First Treatment|Adverse Event|1|||
145314305|NCT00021541|523998639|FG000|Period 1-First Treatment|non-adherence|3|||
145314306|NCT00021541|523998640|FG001|Period 1-First Treatment|non-adherence|0|||
145314307|NCT00021541|523998639|FG000|Period 1-First Treatment|Death|1|||
145314308|NCT00021541|523998640|FG001|Period 1-First Treatment|Death|0|||
145314309|NCT00021541|523998639|FG000|Period 1-First Treatment|Pts that did not progress|2|||
145314310|NCT00021541|523998640|FG001|Period 1-First Treatment|Pts that did not progress|2|||
145314311|NCT00021541|523998639|FG000|Period 1-First Treatment|Ineligible|0|||
145314312|NCT00021541|523998640|FG001|Period 1-First Treatment|Ineligible|2|||
145314313|NCT00021541|523998639|FG000|Period 2-crossover|refused phase B|2|||
145314314|NCT00021541|523998640|FG001|Period 2-crossover|refused phase B|2|||
145314315|NCT00021541|523998639|FG000|Period 2-crossover|Withdrawal by Subject|3|||
145314316|NCT00021541|523998640|FG001|Period 2-crossover|Withdrawal by Subject|4|||
145314317|NCT00021541|523998639|FG000|Period 2-crossover|Adverse Event|2|||
145314318|NCT00021541|523998640|FG001|Period 2-crossover|Adverse Event|2|||
145314319|NCT00021541|523998639|FG000|Period 2-crossover|non-adherence|1|||
145314320|NCT00021541|523998640|FG001|Period 2-crossover|non-adherence|0|||
145314321|NCT00021541|523998639|FG000|Period 2-crossover|Pts that did not progress|2|||
145314322|NCT00021541|523998640|FG001|Period 2-crossover|Pts that did not progress|3|||
145314323|NCT01341405|523998647|FG000|Overall Study|Adverse Event|0|||
145314324|NCT01341405|523998648|FG001|Overall Study|Adverse Event|1|||
145314325|NCT01341405|523998649|FG002|Overall Study|Adverse Event|1|||
145314326|NCT01341405|523998647|FG000|Overall Study|Withdrawal by Subject|3|||
145314327|NCT01341405|523998648|FG001|Overall Study|Withdrawal by Subject|2|||
145314328|NCT01341405|523998649|FG002|Overall Study|Withdrawal by Subject|1|||
145314329|NCT00826241|523998650|FG000|Overall Study|Withdrawal from Follow-up|1|||
145314330|NCT00826241|523998650|FG000|Overall Study|Withdrew consent|2|||
145314331|NCT00826241|523998650|FG000|Overall Study|Death|4|||
145314332|NCT00826241|523998650|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
145314333|NCT00826241|523998650|FG000|Overall Study|Non-compliance|1|||
145569659|NCT02357147|524944299|FG001|Combination Treatment Phase|Investigator Discretion|1|||
145569660|NCT02357147|524944298|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
145314334|NCT00826241|523998650|FG000|Overall Study|Progression of disease|1|||
145314335|NCT00826241|523998650|FG000|Overall Study|Patient refused follow-up|3|||
145314336|NCT00826241|523998650|FG000|Overall Study|Lost to Follow-up|9|||
145314337|NCT00826241|523998650|FG000|Overall Study|Could not obtain records|1|||
145314338|NCT00826241|523998650|FG000|Overall Study|Screen failure|2|||
145314339|NCT00826241|523998650|FG000|Overall Study|Pt unable to proceed to registration|1|||
145314340|NCT00826241|523998650|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
145314341|NCT03407729|523998651|FG000|Overall Study|Lost to Follow-up|2|||
145314342|NCT03407729|523998652|FG001|Overall Study|Lost to Follow-up|0|||
145314343|NCT03407729|523998651|FG000|Overall Study|Unable to schedule|0|||
145314344|NCT03407729|523998652|FG001|Overall Study|Unable to schedule|3|||
145314345|NCT01898598|523998653|FG000|Overall Study|Adverse Event|1|||
145314346|NCT01898598|523998654|FG001|Overall Study|Adverse Event|0|||
145314347|NCT01898598|523998653|FG000|Overall Study|Withdrawal by Subject|3|||
145314348|NCT01898598|523998654|FG001|Overall Study|Withdrawal by Subject|0|||
145314349|NCT01898598|523998653|FG000|Overall Study|Lost to Follow-up|0|||
145314350|NCT01898598|523998654|FG001|Overall Study|Lost to Follow-up|1|||
145314351|NCT01898598|523998653|FG000|Overall Study|Other|0|||
145314352|NCT01898598|523998654|FG001|Overall Study|Other|1|||
145314353|NCT03833427|523998655|FG000|Overall Study|Death|4|||
145314354|NCT03833427|523998656|FG001|Overall Study|Death|2|||
145314355|NCT03833427|523998657|FG002|Overall Study|Death|9|||
145314356|NCT03833427|523998658|FG003|Overall Study|Death|11|||
145314357|NCT03833427|523998659|FG004|Overall Study|Death|0|||
145314358|NCT03833427|523998660|FG005|Overall Study|Death|0|||
145314359|NCT03833427|523998661|FG006|Overall Study|Death|0|||
145314360|NCT03833427|523998655|FG000|Overall Study|Withdrawal by Subject|0|||
145314361|NCT03833427|523998656|FG001|Overall Study|Withdrawal by Subject|1|||
145314362|NCT03833427|523998657|FG002|Overall Study|Withdrawal by Subject|1|||
145314363|NCT03833427|523998658|FG003|Overall Study|Withdrawal by Subject|0|||
145314364|NCT03833427|523998659|FG004|Overall Study|Withdrawal by Subject|0|||
145314365|NCT03833427|523998660|FG005|Overall Study|Withdrawal by Subject|0|||
145314366|NCT03833427|523998661|FG006|Overall Study|Withdrawal by Subject|0|||
145314367|NCT03833427|523998655|FG000|Overall Study|Sponsor Decision|0|||
145314368|NCT03833427|523998656|FG001|Overall Study|Sponsor Decision|0|||
145314369|NCT03833427|523998657|FG002|Overall Study|Sponsor Decision|1|||
145314370|NCT03833427|523998658|FG003|Overall Study|Sponsor Decision|3|||
145314371|NCT03833427|523998659|FG004|Overall Study|Sponsor Decision|0|||
145314372|NCT03833427|523998660|FG005|Overall Study|Sponsor Decision|0|||
145314373|NCT03833427|523998661|FG006|Overall Study|Sponsor Decision|0|||
145314374|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
145314375|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
145314376|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
145314377|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
145314378|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
145314379|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
145314380|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
145314381|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
145314382|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
145314383|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
145314384|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
145314385|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
145314386|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
145314387|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
145314388|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
145314389|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
145314390|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
145314391|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
145314392|NCT00950300|523998670|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
145314393|NCT00950300|523998671|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
145314394|NCT00950300|523998670|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
145314395|NCT00950300|523998671|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
145314396|NCT00950300|523998670|FG000|TFFU Period|Death|4|||
145314397|NCT00950300|523998671|FG001|TFFU Period|Death|1|||
145314398|NCT00950300|523998670|FG000|TFFU Period|Refused Treatment|10|||
145314399|NCT00950300|523998671|FG001|TFFU Period|Refused Treatment|11|||
145314400|NCT00950300|523998670|FG000|TFFU Period|Failure to Return|16|||
145314401|NCT00950300|523998671|FG001|TFFU Period|Failure to Return|16|||
145314402|NCT00950300|523998670|FG000|TFFU Period|Recurrence of Disease|63|||
145314403|NCT00950300|523998671|FG001|TFFU Period|Recurrence of Disease|72|||
145314404|NCT00950300|523998670|FG000|TFFU Period|Other|4|||
145314405|NCT00950300|523998671|FG001|TFFU Period|Other|3|||
145314406|NCT00950300|523998670|FG000|SFU Period|Death|44|||
145314407|NCT00950300|523998671|FG001|SFU Period|Death|42|||
145314408|NCT00950300|523998670|FG000|SFU Period|Lost to Follow-up|30|||
145314409|NCT00950300|523998671|FG001|SFU Period|Lost to Follow-up|28|||
145314410|NCT00950300|523998670|FG000|SFU Period|Withdrawal by Subject|4|||
145314411|NCT00950300|523998671|FG001|SFU Period|Withdrawal by Subject|8|||
145314412|NCT01596127|523998673|FG000|Overall Study|Patient Ineligible|1|||
145314413|NCT00438633|523998674|FG000|Overall Study|Withdrawal by Subject|1|||
145314414|NCT00438633|523998675|FG001|Overall Study|Withdrawal by Subject|0|||
145314415|NCT00438633|523998674|FG000|Overall Study|Lost to Follow-up|15|||
145314416|NCT00438633|523998675|FG001|Overall Study|Lost to Follow-up|17|||
145314417|NCT01539239|523998676|FG000|Overall Study|Death|5|||
145569661|NCT02357147|524944299|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
145569662|NCT02357147|524944298|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
145569663|NCT02357147|524944299|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
145569664|NCT02357147|524944298|FG000|Combination Treatment Phase|Adverse Event|12|||
145569665|NCT02357147|524944299|FG001|Combination Treatment Phase|Adverse Event|4|||
145569666|NCT02357147|524944298|FG000|Combination Treatment Phase|Death|1|||
145569667|NCT02357147|524944299|FG001|Combination Treatment Phase|Death|1|||
145569668|NCT02357147|524944298|FG000|Combination Treatment Phase|Sponsor Decision|0|||
145569669|NCT02357147|524944299|FG001|Combination Treatment Phase|Sponsor Decision|12|||
145569670|NCT02357147|524944298|FG000|Combination Treatment Phase|Other|1|||
145569671|NCT02357147|524944299|FG001|Combination Treatment Phase|Other|0|||
145314418|NCT01539239|523998677|FG001|Overall Study|Death|5|||
145314419|NCT01539239|523998676|FG000|Overall Study|Lost to Follow-up|7|||
145314420|NCT01539239|523998677|FG001|Overall Study|Lost to Follow-up|12|||
145314421|NCT00633022|523998680|FG000|Overall Study|Adverse Event|1|||
145314422|NCT00633022|523998681|FG001|Overall Study|Adverse Event|0|||
145314423|NCT00633022|523998682|FG002|Overall Study|Adverse Event|5|||
145314424|NCT00633022|523998680|FG000|Overall Study|Physician Decision|0|||
145314425|NCT00633022|523998681|FG001|Overall Study|Physician Decision|1|||
145314426|NCT00633022|523998682|FG002|Overall Study|Physician Decision|0|||
145314427|NCT05135273|524000068|FG000|Overall Study|Recruited into the army|0|||
145314428|NCT05135273|524000069|FG001|Overall Study|Recruited into the army|0|||
145314429|NCT05135273|524000070|FG002|Overall Study|Recruited into the army|0|||
145569672|NCT02357147|524944298|FG000|Combination Treatment Phase|Not treated|0|||
145569673|NCT02357147|524944299|FG001|Combination Treatment Phase|Not treated|2|||
145314430|NCT05135273|524000071|FG003|Overall Study|Recruited into the army|0|||
145314431|NCT05135273|524000072|FG004|Overall Study|Recruited into the army|1|||
145314432|NCT05135273|524000073|FG005|Overall Study|Recruited into the army|0|||
145314433|NCT05135273|524000074|FG006|Overall Study|Recruited into the army|0|||
145314434|NCT05135273|524000075|FG007|Overall Study|Recruited into the army|0|||
145314435|NCT05135273|524000068|FG000|Overall Study|Moved away from study site|0|||
145314436|NCT05135273|524000069|FG001|Overall Study|Moved away from study site|0|||
145314437|NCT05135273|524000070|FG002|Overall Study|Moved away from study site|0|||
145314438|NCT05135273|524000071|FG003|Overall Study|Moved away from study site|0|||
145314439|NCT05135273|524000072|FG004|Overall Study|Moved away from study site|0|||
145314440|NCT05135273|524000073|FG005|Overall Study|Moved away from study site|1|||
145314441|NCT05135273|524000074|FG006|Overall Study|Moved away from study site|1|||
145314442|NCT05135273|524000075|FG007|Overall Study|Moved away from study site|0|||
145314443|NCT05135273|524000068|FG000|Overall Study|Travel|0|||
145314444|NCT05135273|524000069|FG001|Overall Study|Travel|0|||
145314445|NCT05135273|524000070|FG002|Overall Study|Travel|0|||
145314446|NCT05135273|524000071|FG003|Overall Study|Travel|0|||
145314447|NCT05135273|524000072|FG004|Overall Study|Travel|0|||
145314448|NCT05135273|524000073|FG005|Overall Study|Travel|0|||
145314449|NCT05135273|524000074|FG006|Overall Study|Travel|0|||
145314450|NCT05135273|524000075|FG007|Overall Study|Travel|1|||
145314451|NCT01958060|524000078|FG000|Overall Study|Not treated|2|||
145314452|NCT01958060|524000079|FG001|Overall Study|Not treated|0|||
145314453|NCT01958060|524000080|FG002|Overall Study|Not treated|0|||
145314454|NCT01958060|524000081|FG003|Overall Study|Not treated|0|||
145314455|NCT01958060|524000082|FG004|Overall Study|Not treated|1|||
145314456|NCT01958060|524000083|FG005|Overall Study|Not treated|0|||
145314457|NCT01705717|524000084|FG000|Overall Study|Adverse Event|2|||
145314458|NCT01705717|524000085|FG001|Overall Study|Adverse Event|2|||
145314459|NCT01705717|524000084|FG000|Overall Study|Lack of Efficacy|0|||
145314460|NCT01705717|524000085|FG001|Overall Study|Lack of Efficacy|1|||
145314461|NCT01705717|524000084|FG000|Overall Study|Other|0|||
145569674|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
145314462|NCT01705717|524000085|FG001|Overall Study|Other|2|||
145314463|NCT00500318|524000087|FG000|Overall Study|Adverse Event|3|||
145314464|NCT00500318|524000088|FG001|Overall Study|Adverse Event|8|||
145314465|NCT00500318|524000087|FG000|Overall Study|Protocol Violation|1|||
145314466|NCT00500318|524000088|FG001|Overall Study|Protocol Violation|3|||
145314467|NCT00500318|524000087|FG000|Overall Study|Withdrawal by Subject|1|||
145314468|NCT00500318|524000088|FG001|Overall Study|Withdrawal by Subject|2|||
145314469|NCT00500318|524000087|FG000|Overall Study|Lack of Efficacy|0|||
145314470|NCT00500318|524000088|FG001|Overall Study|Lack of Efficacy|3|||
145314471|NCT00500318|524000087|FG000|Overall Study|Other Reason|0|||
145314472|NCT00500318|524000088|FG001|Overall Study|Other Reason|1|||
145314473|NCT01350934|524000122|FG000|Base Study|Adverse Event|6|||
145314474|NCT01350934|524000123|FG001|Base Study|Adverse Event|0|||
145569675|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
145314475|NCT01350934|524000122|FG000|Base Study|Lost to Follow-up|1|||
145314476|NCT01350934|524000123|FG001|Base Study|Lost to Follow-up|0|||
145314477|NCT01350934|524000122|FG000|Base Study|Protocol Violation|1|||
145314478|NCT01350934|524000123|FG001|Base Study|Protocol Violation|1|||
145314479|NCT01350934|524000122|FG000|Base Study|Withdrawal by Subject|1|||
145314480|NCT01350934|524000123|FG001|Base Study|Withdrawal by Subject|2|||
145314481|NCT01350934|524000122|FG000|Base Study|Non-Compliance With Study Drug|2|||
145314482|NCT01350934|524000123|FG001|Base Study|Non-Compliance With Study Drug|0|||
145314483|NCT01350934|524000122|FG000|Extension Study|Adverse Event|2|||
145314484|NCT01350934|524000123|FG001|Extension Study|Adverse Event|1|||
145314485|NCT01350934|524000122|FG000|Extension Study|Lost to Follow-up|2|||
145314486|NCT01350934|524000123|FG001|Extension Study|Lost to Follow-up|0|||
145314487|NCT01350934|524000122|FG000|Extension Study|Protocol Violation|1|||
145314488|NCT01350934|524000123|FG001|Extension Study|Protocol Violation|1|||
145411333|NCT02782468|524360009|FG003|Overall Study|Symptomatic Deterioration|1|||
145314489|NCT01350934|524000122|FG000|Extension Study|Lack of Efficacy|0|||
145314490|NCT01350934|524000123|FG001|Extension Study|Lack of Efficacy|1|||
145314491|NCT01350934|524000122|FG000|Extension Study|Withdrawal by Subject|0|||
145314492|NCT01350934|524000123|FG001|Extension Study|Withdrawal by Subject|1|||
145314493|NCT01011335|524000124|FG000|Overall Study|Lost to Follow-up|0|||
145314494|NCT01011335|524000125|FG001|Overall Study|Lost to Follow-up|0|||
145314495|NCT01011335|524000126|FG002|Overall Study|Lost to Follow-up|1|||
145314496|NCT01011335|524000127|FG003|Overall Study|Lost to Follow-up|1|||
145314497|NCT01011335|524000128|FG004|Overall Study|Lost to Follow-up|1|||
145314498|NCT01011335|524000129|FG005|Overall Study|Lost to Follow-up|1|||
145314499|NCT01011335|524000130|FG006|Overall Study|Lost to Follow-up|2|||
145314500|NCT01011335|524000131|FG007|Overall Study|Lost to Follow-up|2|||
145314501|NCT01011335|524000132|FG008|Overall Study|Lost to Follow-up|1|||
145314502|NCT01011335|524000133|FG009|Overall Study|Lost to Follow-up|0|||
145314503|NCT01011335|524000134|FG010|Overall Study|Lost to Follow-up|0|||
145314504|NCT01011335|524000135|FG011|Overall Study|Lost to Follow-up|1|||
145314505|NCT01011335|524000136|FG012|Overall Study|Lost to Follow-up|2|||
145314506|NCT01011335|524000124|FG000|Overall Study|Protocol Violation|0|||
145314507|NCT01011335|524000125|FG001|Overall Study|Protocol Violation|1|||
145314508|NCT01011335|524000126|FG002|Overall Study|Protocol Violation|0|||
145314509|NCT01011335|524000127|FG003|Overall Study|Protocol Violation|0|||
145314510|NCT01011335|524000128|FG004|Overall Study|Protocol Violation|0|||
145314511|NCT01011335|524000129|FG005|Overall Study|Protocol Violation|0|||
145314512|NCT01011335|524000130|FG006|Overall Study|Protocol Violation|0|||
145314513|NCT01011335|524000131|FG007|Overall Study|Protocol Violation|0|||
145314514|NCT01011335|524000132|FG008|Overall Study|Protocol Violation|0|||
145314515|NCT01011335|524000133|FG009|Overall Study|Protocol Violation|0|||
145314516|NCT01011335|524000134|FG010|Overall Study|Protocol Violation|0|||
145314517|NCT01011335|524000135|FG011|Overall Study|Protocol Violation|0|||
145314518|NCT01011335|524000136|FG012|Overall Study|Protocol Violation|0|||
145314519|NCT01011335|524000124|FG000|Overall Study|Moved/deployed or no booster|1|||
145314520|NCT01011335|524000125|FG001|Overall Study|Moved/deployed or no booster|0|||
145314521|NCT01011335|524000126|FG002|Overall Study|Moved/deployed or no booster|0|||
145314522|NCT01011335|524000127|FG003|Overall Study|Moved/deployed or no booster|1|||
145314523|NCT01011335|524000128|FG004|Overall Study|Moved/deployed or no booster|0|||
145314524|NCT01011335|524000129|FG005|Overall Study|Moved/deployed or no booster|0|||
145314525|NCT01011335|524000130|FG006|Overall Study|Moved/deployed or no booster|1|||
145314526|NCT01011335|524000131|FG007|Overall Study|Moved/deployed or no booster|0|||
145314527|NCT01011335|524000132|FG008|Overall Study|Moved/deployed or no booster|1|||
145314528|NCT01011335|524000133|FG009|Overall Study|Moved/deployed or no booster|0|||
145314529|NCT01011335|524000134|FG010|Overall Study|Moved/deployed or no booster|2|||
145314530|NCT01011335|524000135|FG011|Overall Study|Moved/deployed or no booster|0|||
145314531|NCT01011335|524000136|FG012|Overall Study|Moved/deployed or no booster|0|||
145314532|NCT01011335|524000124|FG000|Overall Study|Adverse Event|0|||
145314533|NCT01011335|524000125|FG001|Overall Study|Adverse Event|0|||
145314534|NCT01011335|524000126|FG002|Overall Study|Adverse Event|0|||
145314535|NCT01011335|524000127|FG003|Overall Study|Adverse Event|0|||
145314536|NCT01011335|524000128|FG004|Overall Study|Adverse Event|0|||
145314537|NCT01011335|524000129|FG005|Overall Study|Adverse Event|0|||
145314538|NCT01011335|524000130|FG006|Overall Study|Adverse Event|0|||
145314539|NCT01011335|524000131|FG007|Overall Study|Adverse Event|0|||
145314540|NCT01011335|524000132|FG008|Overall Study|Adverse Event|0|||
145314541|NCT01011335|524000133|FG009|Overall Study|Adverse Event|0|||
145314542|NCT01011335|524000134|FG010|Overall Study|Adverse Event|4|||
145314543|NCT01011335|524000135|FG011|Overall Study|Adverse Event|0|||
145314544|NCT01011335|524000136|FG012|Overall Study|Adverse Event|1|||
145314545|NCT01765751|524000144|FG000|Overall Study|Lost to Follow-up|0|||
145314546|NCT01765751|524000145|FG001|Overall Study|Lost to Follow-up|2|||
145314547|NCT01765751|524000146|FG002|Overall Study|Lost to Follow-up|1|||
145314548|NCT00799708|524000147|FG000|Overall Study|non-compliance|1|||
145314549|NCT00799708|524000148|FG001|Overall Study|non-compliance|0|||
145314550|NCT00799708|524000149|FG002|Overall Study|non-compliance|0|||
145314551|NCT00880334|524000150|FG000|Randomized Phase|Physician Decision|1|||
145314552|NCT00880334|524000151|FG001|Randomized Phase|Physician Decision|0|||
145314553|NCT00880334|524000150|FG000|Randomized Phase|Withdrawal by Subject|2|||
145314554|NCT00880334|524000151|FG001|Randomized Phase|Withdrawal by Subject|1|||
145411334|NCT02782468|524360006|FG000|Overall Study|Withdrawal by Subject|1|||
145411335|NCT02782468|524360007|FG001|Overall Study|Withdrawal by Subject|0|||
145314555|NCT00880334|524000150|FG000|Randomized Phase|Inadequate Labs|1|||
145314556|NCT00880334|524000151|FG001|Randomized Phase|Inadequate Labs|1|||
145314557|NCT00880334|524000150|FG000|Randomized Phase|Brain Metastasis|0|||
145314558|NCT00880334|524000151|FG001|Randomized Phase|Brain Metastasis|1|||
145314559|NCT00880334|524000150|FG000|Randomized Phase|Crossover Participants|0|||
145314560|NCT00880334|524000151|FG001|Randomized Phase|Crossover Participants|37|||
145314561|NCT03343639|524000152|FG000|Overall Study|Withdrawal by Subject|10|||
145314562|NCT03343639|524000153|FG001|Overall Study|Withdrawal by Subject|6|||
145314563|NCT03343639|524000152|FG000|Overall Study|Lost to Follow-up|4|||
145314564|NCT03343639|524000153|FG001|Overall Study|Lost to Follow-up|5|||
145314565|NCT03343639|524000152|FG000|Overall Study|Protocol Violation|0|||
145314566|NCT03343639|524000153|FG001|Overall Study|Protocol Violation|1|||
145314567|NCT02473393|524000154|FG000|Overall Study|Adverse Event|0|||
145314568|NCT02473393|524000155|FG001|Overall Study|Adverse Event|0|||
145314569|NCT02473393|524000156|FG002|Overall Study|Adverse Event|1|||
145314570|NCT02473393|524000157|FG003|Overall Study|Adverse Event|0|||
145314571|NCT02473393|524000154|FG000|Overall Study|Withdrawal by Subject|0|||
145314572|NCT02473393|524000155|FG001|Overall Study|Withdrawal by Subject|0|||
145314573|NCT02473393|524000156|FG002|Overall Study|Withdrawal by Subject|1|||
145314574|NCT02473393|524000157|FG003|Overall Study|Withdrawal by Subject|1|||
145314575|NCT02460835|524000160|FG000|Overall Study|Disease progression prior to treatment|3|||
145314576|NCT02460835|524000160|FG000|Overall Study|Unable to complete planning scans|2|||
145314577|NCT02460835|524000160|FG000|Overall Study|Decrease in performance status|1|||
145314578|NCT02460835|524000160|FG000|Overall Study|Withdrawal by Subject|3|||
145314579|NCT02460835|524000160|FG000|Overall Study|Underwent fractionated RT|10|||
145314580|NCT02460835|524000160|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
145314581|NCT01157234|524000161|FG000|Overall Study|Withdrawal by Subject|1|||
145314582|NCT01157234|524000162|FG001|Overall Study|Withdrawal by Subject|0|||
145314583|NCT04633642|524000174|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
145314584|NCT04633642|524000175|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
145314585|NCT04049097|524000178|FG000|Overall Study|Adverse Event|18|||
145314586|NCT04049097|524000178|FG000|Overall Study|Death|2|||
145314587|NCT04049097|524000178|FG000|Overall Study|Lost to Follow-up|1|||
145314588|NCT04049097|524000178|FG000|Overall Study|Physician Decision|2|||
145314589|NCT04049097|524000178|FG000|Overall Study|Withdrawal by Subject|9|||
145314590|NCT04049097|524000178|FG000|Overall Study|Protocol Violation|2|||
145314591|NCT04049097|524000178|FG000|Overall Study|Other|1|||
145314592|NCT04049097|524000178|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
145314593|NCT00160524|524000183|FG000|Overall Study|Adverse Event|119|||
145314594|NCT00160524|524000183|FG000|Overall Study|Adverse Event and Other|94|||
145314595|NCT00160524|524000183|FG000|Overall Study|Protocol Violation|16|||
145314596|NCT00160524|524000183|FG000|Overall Study|Protocol Violation and Other|2|||
145314597|NCT00160524|524000183|FG000|Overall Study|Withdrawal by Subject|141|||
145314598|NCT00160524|524000183|FG000|Overall Study|Withdrawal by Subject and Other|17|||
145314599|NCT00160524|524000183|FG000|Overall Study|Physician Decision|27|||
145314600|NCT00160524|524000183|FG000|Overall Study|Physician Decision and Other|6|||
145314601|NCT00160524|524000183|FG000|Overall Study|Lost to Follow-up|13|||
145314602|NCT00160524|524000183|FG000|Overall Study|Lost to Follow-up and Other|1|||
145314603|NCT00160524|524000183|FG000|Overall Study|Lack of Efficacy|21|||
145314604|NCT00160524|524000183|FG000|Overall Study|Lack of Efficacy and Other|1|||
145314605|NCT00160524|524000183|FG000|Overall Study|Other|20|||
145314606|NCT04892147|524000184|FG000|Overall Study|Withdrawal by Subject|2|||
145314607|NCT04892147|524000185|FG001|Overall Study|Withdrawal by Subject|0|||
145314608|NCT03828539|524000190|FG000|Overall Study|Adverse Event|3|||
145314609|NCT03828539|524000191|FG001|Overall Study|Adverse Event|12|||
145314610|NCT03828539|524000190|FG000|Overall Study|Patient's/guardian's decision|3|||
145314611|NCT03828539|524000191|FG001|Overall Study|Patient's/guardian's decision|5|||
145314612|NCT03828539|524000190|FG000|Overall Study|Lost to Follow-up|4|||
145314613|NCT03828539|524000191|FG001|Overall Study|Lost to Follow-up|2|||
145314614|NCT03828539|524000190|FG000|Overall Study|Protocol Violation|3|||
145314615|NCT03828539|524000191|FG001|Overall Study|Protocol Violation|2|||
145314616|NCT03828539|524000190|FG000|Overall Study|Withdrawal of informed consent|2|||
145314617|NCT03828539|524000191|FG001|Overall Study|Withdrawal of informed consent|1|||
145314618|NCT03828539|524000190|FG000|Overall Study|New therapy for study indication|1|||
145314619|NCT03828539|524000191|FG001|Overall Study|New therapy for study indication|0|||
145314620|NCT00057941|524000192|FG000|Overall Study|Death|1|||
145569676|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
145314621|NCT00057941|524000193|FG001|Overall Study|Death|2|||
145314622|NCT00057941|524000192|FG000|Overall Study|Adverse Event|7|||
145314623|NCT00057941|524000193|FG001|Overall Study|Adverse Event|9|||
145314624|NCT00057941|524000192|FG000|Overall Study|Lack of Efficacy|54|||
145314625|NCT00057941|524000193|FG001|Overall Study|Lack of Efficacy|53|||
145314626|NCT00057941|524000192|FG000|Overall Study|Withdrawal by Subject|6|||
145314627|NCT00057941|524000193|FG001|Overall Study|Withdrawal by Subject|1|||
145314628|NCT00057941|524000192|FG000|Overall Study|still on treatment|3|||
145314629|NCT00057941|524000193|FG001|Overall Study|still on treatment|1|||
145314630|NCT00057941|524000192|FG000|Overall Study|insurance, symptomatic deterioration|1|||
145314631|NCT00057941|524000193|FG001|Overall Study|insurance, symptomatic deterioration|3|||
145314632|NCT00057941|524000192|FG000|Overall Study|Ineligible|2|||
145314633|NCT00057941|524000193|FG001|Overall Study|Ineligible|5|||
145314634|NCT02760433|524000194|FG000|Overall Study|Lost to Follow-up|1|||
145314635|NCT02760433|524000195|FG001|Overall Study|Lost to Follow-up|0|||
145314636|NCT02760433|524000196|FG002|Overall Study|Lost to Follow-up|1|||
145314637|NCT02760433|524000197|FG003|Overall Study|Lost to Follow-up|0|||
145314638|NCT02760433|524000198|FG004|Overall Study|Lost to Follow-up|0|||
145569677|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
145569678|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
145569679|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
145314639|NCT02760433|524000194|FG000|Overall Study|Withdrawal by Subject|23|||
145314640|NCT02760433|524000195|FG001|Overall Study|Withdrawal by Subject|9|||
145314641|NCT02760433|524000196|FG002|Overall Study|Withdrawal by Subject|0|||
145314642|NCT02760433|524000197|FG003|Overall Study|Withdrawal by Subject|2|||
145314643|NCT02760433|524000198|FG004|Overall Study|Withdrawal by Subject|9|||
145314644|NCT02760433|524000194|FG000|Overall Study|Lack of Response At Week 14|0|||
145314645|NCT02760433|524000195|FG001|Overall Study|Lack of Response At Week 14|0|||
145314646|NCT02760433|524000196|FG002|Overall Study|Lack of Response At Week 14|0|||
145314647|NCT02760433|524000197|FG003|Overall Study|Lack of Response At Week 14|0|||
145314648|NCT02760433|524000198|FG004|Overall Study|Lack of Response At Week 14|1|||
145314649|NCT02760433|524000194|FG000|Overall Study|Subject refused to continue the study|1|||
145314650|NCT02760433|524000195|FG001|Overall Study|Subject refused to continue the study|0|||
145314651|NCT02760433|524000196|FG002|Overall Study|Subject refused to continue the study|0|||
145314652|NCT02760433|524000197|FG003|Overall Study|Subject refused to continue the study|0|||
145314653|NCT02760433|524000198|FG004|Overall Study|Subject refused to continue the study|0|||
145314654|NCT02760433|524000194|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
145314655|NCT02760433|524000195|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
145314656|NCT02760433|524000196|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
145314657|NCT02760433|524000197|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
145314658|NCT02760433|524000198|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
145314659|NCT02760433|524000194|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
145314660|NCT02760433|524000195|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
145314661|NCT02760433|524000196|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
145314662|NCT02760433|524000197|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
145314663|NCT02760433|524000198|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
145314664|NCT00766493|524000199|FG000|30 Days Post-Procedure|Discontinued|7|||
145314665|NCT00766493|524000199|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
145314666|NCT00766493|524000199|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
145314667|NCT03439085|524000201|FG000|Overall Study|Death|2|||
145314668|NCT03439085|524000201|FG000|Overall Study|Screen Failure|20|||
145314669|NCT01863433|524000202|FG000|Overall Study|Protocol Violation|1|||
145314670|NCT03950674|524000203|FG000|Overall Study|Death|16|||
145314671|NCT03950674|524000204|FG001|Overall Study|Death|15|||
145314672|NCT03950674|524000203|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
145314673|NCT03950674|524000204|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
145314674|NCT03448692|524000205|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
145314675|NCT03448692|524000206|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
145314676|NCT03448692|524000205|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
145314677|NCT03448692|524000206|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
145314678|NCT03448692|524000205|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
145314679|NCT03448692|524000206|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
145314680|NCT03448692|524000205|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
145314681|NCT03448692|524000206|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
145314682|NCT03448692|524000205|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
145314683|NCT03448692|524000206|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
145314684|NCT03428945|524000207|FG000|Overall Study|Lost to Follow-up|5|||
145314685|NCT03428945|524000208|FG001|Overall Study|Lost to Follow-up|3|||
145314686|NCT03428945|524000207|FG000|Overall Study|Withdrawal by Subject|10|||
145314687|NCT03428945|524000208|FG001|Overall Study|Withdrawal by Subject|10|||
145314688|NCT00982228|524000209|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
145314689|NCT00982228|524000210|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
145314690|NCT00982228|524000209|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
145314691|NCT00982228|524000210|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
145314692|NCT00982228|524000209|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
145314693|NCT00982228|524000210|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
145314694|NCT00982228|524000209|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
145314695|NCT00982228|524000210|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
145314696|NCT00982228|524000209|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
145314697|NCT00982228|524000210|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
145314698|NCT00982228|524000209|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
145314699|NCT00982228|524000210|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
145314700|NCT00982228|524000209|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
145314701|NCT00982228|524000210|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
145314702|NCT00982228|524000209|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
145314703|NCT00982228|524000210|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
145314704|NCT00982228|524000209|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
145314705|NCT00982228|524000210|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
145314706|NCT00982228|524000209|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
145314707|NCT00982228|524000210|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
145314708|NCT00360490|524000213|FG000|Overall Study|Adverse Event|4|||
145314709|NCT00360490|524000214|FG001|Overall Study|Adverse Event|2|||
145314710|NCT00360490|524000213|FG000|Overall Study|Lost to Follow-up|2|||
145314711|NCT00360490|524000214|FG001|Overall Study|Lost to Follow-up|1|||
145314712|NCT00360490|524000213|FG000|Overall Study|Physician Decision|2|||
145314713|NCT00360490|524000214|FG001|Overall Study|Physician Decision|1|||
145314714|NCT00360490|524000213|FG000|Overall Study|Protocol Violation|0|||
145314715|NCT00360490|524000214|FG001|Overall Study|Protocol Violation|4|||
145314716|NCT00360490|524000213|FG000|Overall Study|Withdrawal by Subject|1|||
145314717|NCT00360490|524000214|FG001|Overall Study|Withdrawal by Subject|3|||
145314718|NCT02786927|524000215|FG000|Overall Study|Adverse Event|1|||
145314719|NCT02786927|524000215|FG000|Overall Study|Protocol Violation|4|||
145314720|NCT01801917|524000216|FG000|Period 1 - Randomized|Adverse Event|1|||
145314721|NCT01801917|524000217|FG001|Period 1 - Randomized|Adverse Event|0|||
145314722|NCT01801917|524000218|FG002|Period 1 - Randomized|Adverse Event|1|||
145314723|NCT01801917|524000219|FG003|Period 1 - Randomized|Adverse Event|0|||
145314724|NCT03919695|524000220|FG000|3-month Follow-up|Death|1|||
145314725|NCT03919695|524000221|FG001|3-month Follow-up|Death|1|||
145314726|NCT03919695|524000220|FG000|3-month Follow-up|unable to contact|0|||
145314727|NCT03919695|524000221|FG001|3-month Follow-up|unable to contact|3|||
145314728|NCT03919695|524000220|FG000|3-month Follow-up|in prison|0|||
145314729|NCT03919695|524000221|FG001|3-month Follow-up|in prison|1|||
145314730|NCT03919695|524000220|FG000|6-month Follow-up|Death|0|||
145314731|NCT03919695|524000221|FG001|6-month Follow-up|Death|1|||
145314732|NCT03919695|524000220|FG000|6-month Follow-up|Lost to Follow-up|1|||
145314733|NCT03919695|524000221|FG001|6-month Follow-up|Lost to Follow-up|2|||
145314734|NCT03919695|524000220|FG000|6-month Follow-up|in prison|0|||
145314735|NCT03919695|524000221|FG001|6-month Follow-up|in prison|2|||
145314736|NCT03919695|524000220|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
145314737|NCT03919695|524000221|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
145314738|NCT03919695|524000220|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
145314739|NCT03919695|524000221|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
145314740|NCT02416934|524000223|FG000|Overall Study|given steroids|1|||
145314741|NCT02416934|524000224|FG001|Overall Study|given steroids|2|||
145314742|NCT02416934|524000223|FG000|Overall Study|Lost to Follow-up|0|||
145314743|NCT02416934|524000224|FG001|Overall Study|Lost to Follow-up|2|||
145314744|NCT02416934|524000223|FG000|Overall Study|Withdrawal by Subject|1|||
145314745|NCT02416934|524000224|FG001|Overall Study|Withdrawal by Subject|0|||
145314746|NCT02416934|524000223|FG000|Overall Study|recruited during continuing renewal proc|0|||
145314747|NCT02416934|524000224|FG001|Overall Study|recruited during continuing renewal proc|1|||
145314748|NCT02416934|524000223|FG000|Overall Study|Protocol Violation|0|||
145314749|NCT02416934|524000224|FG001|Overall Study|Protocol Violation|1|||
145314750|NCT02416934|524000223|FG000|Overall Study|surgery started late|0|||
145314751|NCT02416934|524000224|FG001|Overall Study|surgery started late|1|||
145314752|NCT02416934|524000223|FG000|Overall Study|re-operation|1|||
145314753|NCT02416934|524000224|FG001|Overall Study|re-operation|0|||
145314754|NCT01337596|524000236|FG000|Overall Study|Withdrawal by Subject|0|||
145314755|NCT01337596|524000237|FG001|Overall Study|Withdrawal by Subject|0|||
145314756|NCT01337596|524000238|FG002|Overall Study|Withdrawal by Subject|0|||
145314757|NCT01337596|524000239|FG003|Overall Study|Withdrawal by Subject|0|||
145314758|NCT01337596|524000240|FG004|Overall Study|Withdrawal by Subject|2|||
145314759|NCT01337596|524000241|FG005|Overall Study|Withdrawal by Subject|0|||
145314760|NCT01337596|524000242|FG006|Overall Study|Withdrawal by Subject|0|||
145314761|NCT01337596|524000243|FG007|Overall Study|Withdrawal by Subject|0|||
145314762|NCT01337596|524000244|FG008|Overall Study|Withdrawal by Subject|0|||
145314763|NCT03201003|524000248|FG000|Overall Study|Adverse Event|14|||
145314764|NCT03201003|524000249|FG001|Overall Study|Adverse Event|1|||
145314765|NCT03201003|524000248|FG000|Overall Study|Other reasons|5|||
145314766|NCT03201003|524000249|FG001|Overall Study|Other reasons|1|||
145314767|NCT03201003|524000248|FG000|Overall Study|Withdrawal by Subject|4|||
145314768|NCT03201003|524000249|FG001|Overall Study|Withdrawal by Subject|1|||
145314769|NCT03201003|524000248|FG000|Overall Study|Lost to Follow-up|2|||
145314770|NCT03201003|524000249|FG001|Overall Study|Lost to Follow-up|0|||
145314771|NCT03201003|524000248|FG000|Overall Study|Protocol Violation|1|||
145314772|NCT03201003|524000249|FG001|Overall Study|Protocol Violation|0|||
145314773|NCT00834613|524000250|FG000|First Intervention|Protocol Violation|1|||
145314774|NCT00834613|524000251|FG001|First Intervention|Protocol Violation|0|||
145314775|NCT00697619|524000257|FG000|Overall Study|Lack of Efficacy|2|||
145314776|NCT00697619|524000258|FG001|Overall Study|Lack of Efficacy|2|||
145314777|NCT00697619|524000257|FG000|Overall Study|Adverse Event|4|||
145314778|NCT00697619|524000258|FG001|Overall Study|Adverse Event|6|||
145314779|NCT01188226|524002075|FG000|Overall Study|Withdrawal by Subject|4|||
145314780|NCT04832971|524002076|FG000|Overall Study|Death|1|||
145314781|NCT04832971|524002077|FG001|Overall Study|Death|0|||
145314782|NCT04832971|524002078|FG002|Overall Study|Death|0|||
145314783|NCT04832971|524002079|FG003|Overall Study|Death|0|||
145314784|NCT04832971|524002076|FG000|Overall Study|Lost to Follow-up|1|||
145314785|NCT04832971|524002077|FG001|Overall Study|Lost to Follow-up|1|||
145314786|NCT04832971|524002078|FG002|Overall Study|Lost to Follow-up|1|||
145314787|NCT04832971|524002079|FG003|Overall Study|Lost to Follow-up|0|||
145314788|NCT04832971|524002076|FG000|Overall Study|Withdrawal by Subject|1|||
145314789|NCT04832971|524002077|FG001|Overall Study|Withdrawal by Subject|3|||
145314790|NCT04832971|524002078|FG002|Overall Study|Withdrawal by Subject|2|||
145314791|NCT04832971|524002079|FG003|Overall Study|Withdrawal by Subject|2|||
145314792|NCT04832971|524002076|FG000|Overall Study|Other, Not Specified|0|||
145314793|NCT04832971|524002077|FG001|Overall Study|Other, Not Specified|0|||
145314794|NCT04832971|524002078|FG002|Overall Study|Other, Not Specified|1|||
145314795|NCT04832971|524002079|FG003|Overall Study|Other, Not Specified|0|||
145314796|NCT04980456|524002080|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
145314797|NCT04980456|524002081|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
145314798|NCT04980456|524002080|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
145314799|NCT04980456|524002081|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
145314800|NCT04980456|524002080|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
145314801|NCT04980456|524002081|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
145314802|NCT04980456|524002080|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
145314803|NCT04980456|524002081|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
145314804|NCT02293460|524002082|FG000|Overall Study|Protocol Violation|1|||
145314805|NCT02293460|524002082|FG000|Overall Study|Lack of Efficacy|2|||
145314806|NCT02293460|524002082|FG000|Overall Study|Adverse Event|2|||
145314807|NCT02293460|524002082|FG000|Overall Study|Withdrawal by Subject|1|||
145314808|NCT00224484|524002085|FG000|Overall Study|Serious Adverse Event|1|||
145314809|NCT00224484|524002086|FG001|Overall Study|Serious Adverse Event|1|||
145314810|NCT00224484|524002087|FG002|Overall Study|Serious Adverse Event|0|||
145314811|NCT00224484|524002085|FG000|Overall Study|Non-Serious Adverse Event|5|||
145314812|NCT00224484|524002086|FG001|Overall Study|Non-Serious Adverse Event|7|||
145314813|NCT00224484|524002087|FG002|Overall Study|Non-Serious Adverse Event|3|||
145314814|NCT00224484|524002085|FG000|Overall Study|Protocol Violation|2|||
145314815|NCT00224484|524002086|FG001|Overall Study|Protocol Violation|2|||
145314816|NCT00224484|524002087|FG002|Overall Study|Protocol Violation|0|||
145314817|NCT00224484|524002085|FG000|Overall Study|Withdrawal by Subject|49|||
145314818|NCT00224484|524002086|FG001|Overall Study|Withdrawal by Subject|18|||
145314819|NCT00224484|524002087|FG002|Overall Study|Withdrawal by Subject|16|||
145314820|NCT00224484|524002085|FG000|Overall Study|Migrated/moved from study area|18|||
145314821|NCT00224484|524002086|FG001|Overall Study|Migrated/moved from study area|5|||
145314822|NCT00224484|524002087|FG002|Overall Study|Migrated/moved from study area|5|||
145314823|NCT00224484|524002085|FG000|Overall Study|Lost to Follow-up|66|||
145314824|NCT00224484|524002086|FG001|Overall Study|Lost to Follow-up|28|||
145314825|NCT00224484|524002087|FG002|Overall Study|Lost to Follow-up|36|||
145314826|NCT00224484|524002085|FG000|Overall Study|Reason not specified|5|||
145314827|NCT00224484|524002086|FG001|Overall Study|Reason not specified|4|||
145411336|NCT02782468|524360008|FG002|Overall Study|Withdrawal by Subject|0|||
145411337|NCT02782468|524360009|FG003|Overall Study|Withdrawal by Subject|0|||
145411338|NCT00356590|524360010|FG000|Overall Study|Adverse Event|54|||
145411339|NCT00356590|524360010|FG000|Overall Study|Death|10|||
145411340|NCT00356590|524360010|FG000|Overall Study|Lost to Follow-up|35|||
145411341|NCT00356590|524360010|FG000|Overall Study|Physician Decision|46|||
145411342|NCT00356590|524360010|FG000|Overall Study|Withdrawal by Subject|41|||
145411343|NCT00356590|524360010|FG000|Overall Study|Completed month 12 only|2|||
145411344|NCT00356590|524360010|FG000|Overall Study|Protocol issues|6|||
145411345|NCT00356590|524360010|FG000|Overall Study|Response status|28|||
145314828|NCT00224484|524002087|FG002|Overall Study|Reason not specified|2|||
145314829|NCT01074008|524002088|FG000|Overall Study|Adverse Event|0|||
145314830|NCT01074008|524002089|FG001|Overall Study|Adverse Event|1|||
145314831|NCT01074008|524002090|FG002|Overall Study|Adverse Event|0|||
145314832|NCT01074008|524002091|FG003|Overall Study|Adverse Event|0|||
145314833|NCT01074008|524002092|FG004|Overall Study|Adverse Event|0|||
145314834|NCT01074008|524002093|FG005|Overall Study|Adverse Event|0|||
145314835|NCT01074008|524002094|FG006|Overall Study|Adverse Event|0|||
145314836|NCT01074008|524002095|FG007|Overall Study|Adverse Event|0|||
145569680|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Adverse Event|0|||
145569681|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Adverse Event|3|||
145569682|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
145569683|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
145569684|NCT02357147|524944298|FG000|Maintenance Treatment Phase|Not Treated|1|||
145569685|NCT02357147|524944299|FG001|Maintenance Treatment Phase|Not Treated|0|||
145569686|NCT04477304|524944300|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
145569687|NCT04477304|524944301|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
145569688|NCT03962543|524944302|FG000|Treatment Phase|Death|0|||
145569689|NCT03962543|524944303|FG001|Treatment Phase|Death|1|||
145569690|NCT03962543|524944302|FG000|Treatment Phase|Withdrawal by Subject|3|||
145569691|NCT03962543|524944303|FG001|Treatment Phase|Withdrawal by Subject|0|||
145569692|NCT03962543|524944302|FG000|Treatment Phase|Adverse Event|3|||
145569693|NCT03962543|524944303|FG001|Treatment Phase|Adverse Event|12|||
145569694|NCT03962543|524944302|FG000|Treatment Phase|Lost to Follow-up|1|||
145569695|NCT03962543|524944303|FG001|Treatment Phase|Lost to Follow-up|2|||
145569696|NCT03962543|524944302|FG000|Treatment Phase|Radiographic PD|9|||
145569697|NCT03962543|524944303|FG001|Treatment Phase|Radiographic PD|3|||
145569698|NCT03962543|524944302|FG000|Treatment Phase|Participant Decision|3|||
145569699|NCT03962543|524944303|FG001|Treatment Phase|Participant Decision|8|||
145569700|NCT03962543|524944302|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
145569701|NCT03962543|524944303|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
145569702|NCT03962543|524944302|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
145569703|NCT03962543|524944303|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
145569704|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
145569705|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
145569706|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
145569707|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
145569708|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
145569709|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
145569710|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
145569711|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
145569712|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
145569713|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
145569714|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
145569715|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
145314837|NCT01074008|524002096|FG008|Overall Study|Adverse Event|0|||
145314838|NCT01074008|524002088|FG000|Overall Study|Withdrawal by Subject|1|||
145314839|NCT01074008|524002089|FG001|Overall Study|Withdrawal by Subject|1|||
145314840|NCT01074008|524002090|FG002|Overall Study|Withdrawal by Subject|1|||
145314841|NCT01074008|524002091|FG003|Overall Study|Withdrawal by Subject|0|||
145314842|NCT01074008|524002092|FG004|Overall Study|Withdrawal by Subject|1|||
145314843|NCT01074008|524002093|FG005|Overall Study|Withdrawal by Subject|0|||
145314844|NCT01074008|524002094|FG006|Overall Study|Withdrawal by Subject|0|||
145314845|NCT01074008|524002095|FG007|Overall Study|Withdrawal by Subject|0|||
145314846|NCT01074008|524002096|FG008|Overall Study|Withdrawal by Subject|0|||
145314847|NCT01074008|524002088|FG000|Overall Study|Lost to Follow-up|0|||
145314848|NCT01074008|524002089|FG001|Overall Study|Lost to Follow-up|1|||
145314849|NCT01074008|524002090|FG002|Overall Study|Lost to Follow-up|1|||
145314850|NCT01074008|524002091|FG003|Overall Study|Lost to Follow-up|1|||
145314851|NCT01074008|524002092|FG004|Overall Study|Lost to Follow-up|1|||
145314852|NCT01074008|524002093|FG005|Overall Study|Lost to Follow-up|0|||
145314853|NCT01074008|524002094|FG006|Overall Study|Lost to Follow-up|1|||
145314854|NCT01074008|524002095|FG007|Overall Study|Lost to Follow-up|0|||
145314855|NCT01074008|524002096|FG008|Overall Study|Lost to Follow-up|4|||
145314856|NCT02805309|524002097|FG000|Overall Study|Lost to Follow-up|2|||
145314857|NCT02805309|524002098|FG001|Overall Study|Lost to Follow-up|2|||
145314858|NCT02805309|524002099|FG002|Overall Study|Lost to Follow-up|2|||
145314859|NCT02805309|524002097|FG000|Overall Study|Post-Randomization Exclusion|0|||
145314860|NCT02805309|524002098|FG001|Overall Study|Post-Randomization Exclusion|2|||
145314861|NCT02805309|524002099|FG002|Overall Study|Post-Randomization Exclusion|1|||
145314862|NCT01636934|524002102|FG000|Overall Study|Withdrawal by Subject|3|||
145314863|NCT01636934|524002103|FG001|Overall Study|Withdrawal by Subject|2|||
145314864|NCT01636934|524002102|FG000|Overall Study|Chemo cancel|1|||
145569716|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
145569717|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
145569718|NCT03962543|524944302|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
145569719|NCT03962543|524944303|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
145569720|NCT03569371|524945773|FG000|Overall Study|Lack of Efficacy|1|||
145314865|NCT01636934|524002103|FG001|Overall Study|Chemo cancel|0|||
145314866|NCT01636934|524002102|FG000|Overall Study|Too ill to continue|1|||
145314867|NCT01636934|524002103|FG001|Overall Study|Too ill to continue|0|||
145314868|NCT01636934|524002102|FG000|Overall Study|Never started study medication|1|||
145314869|NCT01636934|524002103|FG001|Overall Study|Never started study medication|1|||
145314870|NCT03687242|524002106|FG000|Overall Study|Adverse Event|1|||
145314871|NCT00377156|524002109|FG000|Overall Study|Death|23|||
145314872|NCT00377156|524002110|FG001|Overall Study|Death|19|||
145314873|NCT00377156|524002109|FG000|Overall Study|Withdrawal by Subject|16|||
145314874|NCT00377156|524002110|FG001|Overall Study|Withdrawal by Subject|24|||
145314875|NCT00377156|524002109|FG000|Overall Study|Had follow-up <90 d|3|||
145314876|NCT00377156|524002110|FG001|Overall Study|Had follow-up <90 d|6|||
145314877|NCT00377156|524002109|FG000|Overall Study|Cancellation|1|||
145314878|NCT00377156|524002110|FG001|Overall Study|Cancellation|0|||
145314879|NCT00377156|524002109|FG000|Overall Study|Refused testing|0|||
145314880|NCT00377156|524002110|FG001|Overall Study|Refused testing|1|||
145314881|NCT00377156|524002109|FG000|Overall Study|Ineligible|0|||
145314882|NCT00377156|524002110|FG001|Overall Study|Ineligible|1|||
145314883|NCT00377156|524002109|FG000|Overall Study|Disability or language problem|0|||
145314884|NCT00377156|524002110|FG001|Overall Study|Disability or language problem|1|||
145314885|NCT00377156|524002109|FG000|Overall Study|Other|5|||
145314886|NCT00377156|524002110|FG001|Overall Study|Other|2|||
145314887|NCT00288704|524002111|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
145314888|NCT00288704|524002112|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
145314889|NCT00288704|524002113|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
145314890|NCT00288704|524002111|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
145314891|NCT00288704|524002112|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
145314892|NCT00288704|524002113|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
145314893|NCT00288704|524002111|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
145314894|NCT00288704|524002112|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
145314895|NCT00288704|524002113|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
145314896|NCT00288704|524002111|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
145314897|NCT00288704|524002112|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
145314898|NCT00288704|524002113|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
145314899|NCT00288704|524002111|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
145314900|NCT00288704|524002112|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
145314901|NCT00288704|524002113|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
145314902|NCT00288704|524002111|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
145314903|NCT00288704|524002112|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
145314904|NCT00288704|524002113|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
145314905|NCT00288704|524002111|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
145314906|NCT00288704|524002112|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
145314907|NCT00288704|524002113|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
145314908|NCT01579006|524002114|FG000|Overall Study|Lack of Efficacy|10|||
145314909|NCT01579006|524002114|FG000|Overall Study|Adverse Event|13|||
145314910|NCT01579006|524002114|FG000|Overall Study|Withdrawal by Subject|5|||
145314911|NCT01579006|524002114|FG000|Overall Study|Non-compliance|3|||
145314912|NCT01579006|524002114|FG000|Overall Study|Due to participant's health fund|1|||
145314913|NCT01579006|524002114|FG000|Overall Study|Scheduled surgery|1|||
145314914|NCT01802216|524002117|FG000|4 Month Visit|Participant did not show to visit|3|||
145314915|NCT01802216|524002118|FG001|4 Month Visit|Participant did not show to visit|4|||
145314916|NCT01802216|524002117|FG000|8 Month Visit|Participant did not show to visit|3|||
145314917|NCT01802216|524002118|FG001|8 Month Visit|Participant did not show to visit|5|||
145314918|NCT01802216|524002117|FG000|12 Month Visit|Participant did not show to visit|3|||
145314919|NCT01802216|524002118|FG001|12 Month Visit|Participant did not show to visit|4|||
145314920|NCT00063258|524002123|FG000|Overall Study|Physician Decision|2|||
145314921|NCT00063258|524002124|FG001|Overall Study|Physician Decision|0|||
145314922|NCT00063258|524002123|FG000|Overall Study|Lack of Efficacy|2|||
145314923|NCT00063258|524002124|FG001|Overall Study|Lack of Efficacy|0|||
145314924|NCT02246764|524002125|FG000|Overall Study|Adverse Event|15|||
145314925|NCT02246764|524002126|FG001|Overall Study|Adverse Event|29|||
145314926|NCT02246764|524002127|FG002|Overall Study|Adverse Event|1|||
145314927|NCT02246764|524002125|FG000|Overall Study|Withdrawal by Subject|0|||
145314928|NCT02246764|524002126|FG001|Overall Study|Withdrawal by Subject|0|||
145314929|NCT02246764|524002127|FG002|Overall Study|Withdrawal by Subject|1|||
145314930|NCT02246764|524002125|FG000|Overall Study|Disallowed Concomitant Medication|1|||
145314931|NCT02246764|524002126|FG001|Overall Study|Disallowed Concomitant Medication|0|||
145314932|NCT02246764|524002127|FG002|Overall Study|Disallowed Concomitant Medication|0|||
145314933|NCT02246764|524002125|FG000|Overall Study|Physician Decision|0|||
145314934|NCT02246764|524002126|FG001|Overall Study|Physician Decision|2|||
145314935|NCT02246764|524002127|FG002|Overall Study|Physician Decision|1|||
145314936|NCT02246764|524002125|FG000|Overall Study|Protocol Violation|2|||
145314937|NCT02246764|524002126|FG001|Overall Study|Protocol Violation|1|||
145314938|NCT02246764|524002127|FG002|Overall Study|Protocol Violation|1|||
145314939|NCT05393271|524002128|FG000|Overall Study|Physician Decision|0|||
145314940|NCT05393271|524002129|FG001|Overall Study|Physician Decision|0|||
145314941|NCT05393271|524002130|FG002|Overall Study|Physician Decision|0|||
145314942|NCT05393271|524002131|FG003|Overall Study|Physician Decision|0|||
145314943|NCT05393271|524002132|FG004|Overall Study|Physician Decision|0|||
145314944|NCT05393271|524002133|FG005|Overall Study|Physician Decision|0|||
145314945|NCT05393271|524002134|FG006|Overall Study|Physician Decision|1|||
145314946|NCT05393271|524002135|FG007|Overall Study|Physician Decision|0|||
145314947|NCT05393271|524002136|FG008|Overall Study|Physician Decision|0|||
145314948|NCT05393271|524002137|FG009|Overall Study|Physician Decision|0|||
145314949|NCT05393271|524002138|FG010|Overall Study|Physician Decision|0|||
145314950|NCT00413049|524002143|FG000|Overall Study|Adverse Event|10|||
145314951|NCT00413049|524002144|FG001|Overall Study|Adverse Event|8|||
145314952|NCT00413049|524002143|FG000|Overall Study|Withdrawal by Subject|7|||
145314953|NCT00413049|524002144|FG001|Overall Study|Withdrawal by Subject|5|||
145314954|NCT00413049|524002143|FG000|Overall Study|Lost to Follow-up|2|||
145314955|NCT00413049|524002144|FG001|Overall Study|Lost to Follow-up|3|||
145314956|NCT00413049|524002143|FG000|Overall Study|Protocol Violation|3|||
145314957|NCT00413049|524002144|FG001|Overall Study|Protocol Violation|1|||
145314958|NCT00413049|524002143|FG000|Overall Study|Subject no longer requires study drug|0|||
145314959|NCT00413049|524002144|FG001|Overall Study|Subject no longer requires study drug|1|||
145314960|NCT00413049|524002143|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145314961|NCT00413049|524002144|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145314962|NCT00413049|524002143|FG000|Overall Study|Lack of Efficacy|1|||
145314963|NCT00413049|524002144|FG001|Overall Study|Lack of Efficacy|0|||
145314964|NCT03314857|524002147|FG000|Overall Study|Death|4|||
145314965|NCT03314857|524002147|FG000|Overall Study|Physician Decision|1|||
145314966|NCT01408888|524002150|FG000|First Intervention|Adverse Event|0|||
145314967|NCT01408888|524002151|FG001|First Intervention|Adverse Event|1|||
145314968|NCT01408888|524002150|FG000|First Intervention|Withdrawal by Subject|0|||
145314969|NCT01408888|524002151|FG001|First Intervention|Withdrawal by Subject|2|||
145314970|NCT01408888|524002150|FG000|Second Intervention|Withdrawal by Subject|1|||
145314971|NCT01408888|524002151|FG001|Second Intervention|Withdrawal by Subject|0|||
145314972|NCT01408888|524002150|FG000|Second Intervention|Adverse Event|1|||
145314973|NCT01408888|524002151|FG001|Second Intervention|Adverse Event|0|||
145314974|NCT00695110|524002156|FG000|Treatment Period 1|Adverse Event|1|||
145314975|NCT00695110|524002156|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145314976|NCT00695110|524002156|FG000|Treatment Period 3|Withdrawal by Subject|1|||
145314977|NCT00695110|524002156|FG000|Treatment Period 4|Adverse Event|1|||
145314978|NCT02104817|524002157|FG000|Overall Study|Death|363|||
145314979|NCT02104817|524002158|FG001|Overall Study|Death|330|||
145314980|NCT02104817|524002157|FG000|Overall Study|Lost to Follow-up|3|||
145314981|NCT02104817|524002158|FG001|Overall Study|Lost to Follow-up|2|||
145314982|NCT02104817|524002157|FG000|Overall Study|Protocol Violation|0|||
145314983|NCT02104817|524002158|FG001|Overall Study|Protocol Violation|1|||
145314984|NCT02104817|524002157|FG000|Overall Study|Study terminated by sponsor|5854|||
145314985|NCT02104817|524002158|FG001|Overall Study|Study terminated by sponsor|5901|||
145314986|NCT02104817|524002157|FG000|Overall Study|Withdrawal by Subject|111|||
145314987|NCT02104817|524002158|FG001|Overall Study|Withdrawal by Subject|78|||
145314988|NCT02104817|524002157|FG000|Overall Study|Other reasons|128|||
145314989|NCT02104817|524002158|FG001|Overall Study|Other reasons|135|||
145314990|NCT02575339|524002162|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
145314991|NCT02575339|524002163|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
145314992|NCT02575339|524002164|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
145314993|NCT02575339|524002162|FG000|Study Treatment|Disease Progression|5|||
145314994|NCT02575339|524002163|FG001|Study Treatment|Disease Progression|2|||
145314995|NCT02575339|524002164|FG002|Study Treatment|Disease Progression|0|||
145314996|NCT02575339|524002162|FG000|Study Treatment|Adverse Event|1|||
145314997|NCT02575339|524002163|FG001|Study Treatment|Adverse Event|2|||
145314998|NCT02575339|524002164|FG002|Study Treatment|Adverse Event|0|||
145314999|NCT02575339|524002162|FG000|Follow up|Death|6|||
145315000|NCT02575339|524002163|FG001|Follow up|Death|2|||
145315001|NCT02575339|524002164|FG002|Follow up|Death|0|||
145315002|NCT02575339|524002162|FG000|Follow up|Study Terminated|0|||
145315003|NCT02575339|524002163|FG001|Follow up|Study Terminated|2|||
145315004|NCT02575339|524002164|FG002|Follow up|Study Terminated|0|||
145315005|NCT02575339|524002162|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
145315006|NCT02575339|524002163|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
145315007|NCT02575339|524002164|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
145315008|NCT04675775|524002165|FG000|Overall Study|Withdrawal by Subject|7|||
145315009|NCT02340780|524002167|FG000|Overall Study|Ineligible|1|||
145315010|NCT01957150|524002168|FG000|Overall Study|Adverse Event|23|||
145315011|NCT01957150|524002169|FG001|Overall Study|Adverse Event|20|||
145315012|NCT01957150|524002168|FG000|Overall Study|Withdrawal by Subject|13|||
145315013|NCT01957150|524002169|FG001|Overall Study|Withdrawal by Subject|17|||
145315014|NCT01957150|524002168|FG000|Overall Study|Physician Decision|3|||
145315015|NCT01957150|524002169|FG001|Overall Study|Physician Decision|6|||
145315016|NCT01957150|524002168|FG000|Overall Study|Lost to Follow-up|4|||
145315017|NCT01957150|524002169|FG001|Overall Study|Lost to Follow-up|4|||
145315018|NCT01957150|524002168|FG000|Overall Study|Protocol Violation|1|||
145315019|NCT01957150|524002169|FG001|Overall Study|Protocol Violation|0|||
145315020|NCT01957150|524002168|FG000|Overall Study|Lack of Efficacy|11|||
145315021|NCT01957150|524002169|FG001|Overall Study|Lack of Efficacy|11|||
145569721|NCT03569371|524945773|FG000|Overall Study|Lost to Follow-up|1|||
145569722|NCT03569371|524945773|FG000|Overall Study|Adverse Event|1|||
145569723|NCT02789176|524945774|FG000|Overall Study|Death|0|||
145569724|NCT02789176|524945775|FG001|Overall Study|Death|0|||
145569725|NCT02789176|524945776|FG002|Overall Study|Death|3|||
145569726|NCT02789176|524945777|FG003|Overall Study|Death|0|||
145569727|NCT02789176|524945774|FG000|Overall Study|Withdrawal by Subject|0|||
145569728|NCT02789176|524945775|FG001|Overall Study|Withdrawal by Subject|0|||
145569729|NCT02789176|524945776|FG002|Overall Study|Withdrawal by Subject|1|||
145569730|NCT02789176|524945777|FG003|Overall Study|Withdrawal by Subject|0|||
145569731|NCT02789176|524945774|FG000|Overall Study|Lost to Follow-up|8|||
145569732|NCT02789176|524945775|FG001|Overall Study|Lost to Follow-up|2|||
145569733|NCT02789176|524945776|FG002|Overall Study|Lost to Follow-up|6|||
145569734|NCT02789176|524945777|FG003|Overall Study|Lost to Follow-up|1|||
145315022|NCT03223909|524002170|FG000|Overall Study|Protocol Violation|48|||
145315023|NCT03223909|524002171|FG001|Overall Study|Protocol Violation|45|||
145315024|NCT03223909|524002172|FG002|Overall Study|Protocol Violation|16|||
145315025|NCT01698554|524002175|FG000|Overall Study|Adverse Event|2|||
145315026|NCT01698554|524002176|FG001|Overall Study|Adverse Event|5|||
145315027|NCT01698554|524002177|FG002|Overall Study|Adverse Event|0|||
145315028|NCT01698554|524002178|FG003|Overall Study|Adverse Event|1|||
145315029|NCT01698554|524002175|FG000|Overall Study|Lost to Follow-up|1|||
145315030|NCT01698554|524002176|FG001|Overall Study|Lost to Follow-up|0|||
145315031|NCT01698554|524002177|FG002|Overall Study|Lost to Follow-up|0|||
145315032|NCT01698554|524002178|FG003|Overall Study|Lost to Follow-up|0|||
145315033|NCT01698554|524002175|FG000|Overall Study|Personal Reasons|0|||
145315034|NCT01698554|524002176|FG001|Overall Study|Personal Reasons|5|||
145315035|NCT01698554|524002177|FG002|Overall Study|Personal Reasons|1|||
145315036|NCT01698554|524002178|FG003|Overall Study|Personal Reasons|1|||
145315037|NCT01698554|524002175|FG000|Overall Study|Protocol Violation|2|||
145315038|NCT01698554|524002176|FG001|Overall Study|Protocol Violation|0|||
145315039|NCT01698554|524002177|FG002|Overall Study|Protocol Violation|1|||
145315040|NCT01698554|524002178|FG003|Overall Study|Protocol Violation|0|||
145315041|NCT01698554|524002175|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145315042|NCT01698554|524002176|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145315043|NCT01698554|524002177|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145315044|NCT01698554|524002178|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145315045|NCT00252564|524002179|FG000|Overall Study|Adverse Event|17|||
145315046|NCT00252564|524002180|FG001|Overall Study|Adverse Event|13|||
145315047|NCT00252564|524002179|FG000|Overall Study|Unrelated Complication|2|||
145315048|NCT00252564|524002180|FG001|Overall Study|Unrelated Complication|1|||
145315049|NCT00252564|524002179|FG000|Overall Study|Disease Progression|14|||
145315050|NCT00252564|524002180|FG001|Overall Study|Disease Progression|20|||
145315051|NCT00252564|524002179|FG000|Overall Study|Death|0|||
145315052|NCT00252564|524002180|FG001|Overall Study|Death|3|||
145315053|NCT00252564|524002179|FG000|Overall Study|Physician Decision|1|||
145315054|NCT00252564|524002180|FG001|Overall Study|Physician Decision|0|||
145315055|NCT00252564|524002179|FG000|Overall Study|Lost to Follow-up|1|||
145315056|NCT00252564|524002180|FG001|Overall Study|Lost to Follow-up|0|||
145315057|NCT00252564|524002179|FG000|Overall Study|Patient Request|4|||
145315058|NCT00252564|524002180|FG001|Overall Study|Patient Request|5|||
145315059|NCT00252564|524002179|FG000|Overall Study|Withdrawal by Subject|0|||
145315060|NCT00252564|524002180|FG001|Overall Study|Withdrawal by Subject|2|||
145315061|NCT01583530|524002181|FG000|Overall Study|Adverse Event|0|||
145315062|NCT01583530|524002182|FG001|Overall Study|Adverse Event|0|||
145315063|NCT01583530|524002183|FG002|Overall Study|Adverse Event|0|||
145315064|NCT01583530|524002184|FG003|Overall Study|Adverse Event|0|||
145315065|NCT01583530|524002185|FG004|Overall Study|Adverse Event|0|||
145315066|NCT01583530|524002186|FG005|Overall Study|Adverse Event|1|||
145315067|NCT01583530|524002181|FG000|Overall Study|Withdrawal by Subject|0|||
145315068|NCT01583530|524002182|FG001|Overall Study|Withdrawal by Subject|3|||
145315069|NCT01583530|524002183|FG002|Overall Study|Withdrawal by Subject|0|||
145569735|NCT00596011|524945779|FG000|Overall Study|Withdrawal by Subject|2|||
145620379|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
145569736|NCT00596011|524945780|FG001|Overall Study|Withdrawal by Subject|3|||
145620380|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
145315070|NCT01583530|524002184|FG003|Overall Study|Withdrawal by Subject|1|||
145315071|NCT01583530|524002185|FG004|Overall Study|Withdrawal by Subject|1|||
145315072|NCT01583530|524002186|FG005|Overall Study|Withdrawal by Subject|2|||
145315073|NCT01583530|524002181|FG000|Overall Study|Lost to Follow-up|0|||
145315074|NCT01583530|524002182|FG001|Overall Study|Lost to Follow-up|0|||
145315075|NCT01583530|524002183|FG002|Overall Study|Lost to Follow-up|0|||
145569737|NCT00596011|524945779|FG000|Overall Study|Adverse Event|11|||
145315076|NCT01583530|524002184|FG003|Overall Study|Lost to Follow-up|0|||
145315077|NCT01583530|524002185|FG004|Overall Study|Lost to Follow-up|3|||
145315078|NCT01583530|524002186|FG005|Overall Study|Lost to Follow-up|0|||
145315079|NCT01583530|524002181|FG000|Overall Study|Lack of compliance|0|||
145315080|NCT01583530|524002182|FG001|Overall Study|Lack of compliance|0|||
145315081|NCT01583530|524002183|FG002|Overall Study|Lack of compliance|0|||
145569738|NCT00596011|524945780|FG001|Overall Study|Adverse Event|7|||
145569739|NCT01944059|524945781|FG000|Overall Study|Lost to Follow-up|1|||
145569740|NCT01944059|524945781|FG000|Overall Study|Physician Decision|3|||
145569741|NCT01944059|524945781|FG000|Overall Study|Withdrawal by Subject|1|||
145315082|NCT01583530|524002184|FG003|Overall Study|Lack of compliance|0|||
145315083|NCT01583530|524002185|FG004|Overall Study|Lack of compliance|1|||
145315084|NCT01583530|524002186|FG005|Overall Study|Lack of compliance|0|||
145315085|NCT02416180|524002187|FG000|Overall Study|Withdrawal by Subject|1|||
145315086|NCT00640926|524002188|FG000|Overall Study|Adverse Event|2|||
145315087|NCT00640926|524002189|FG001|Overall Study|Adverse Event|3|||
145315088|NCT00640926|524002190|FG002|Overall Study|Adverse Event|2|||
145315089|NCT00640926|524002188|FG000|Overall Study|Lack of Efficacy|0|||
145315090|NCT00640926|524002189|FG001|Overall Study|Lack of Efficacy|2|||
145315091|NCT00640926|524002190|FG002|Overall Study|Lack of Efficacy|1|||
145315092|NCT00640926|524002188|FG000|Overall Study|Protocol Violation|2|||
145315093|NCT00640926|524002189|FG001|Overall Study|Protocol Violation|0|||
145315094|NCT00640926|524002190|FG002|Overall Study|Protocol Violation|2|||
145315095|NCT00640926|524002188|FG000|Overall Study|Lost to Follow-up|3|||
145315096|NCT00640926|524002189|FG001|Overall Study|Lost to Follow-up|1|||
145315097|NCT00640926|524002190|FG002|Overall Study|Lost to Follow-up|2|||
145315098|NCT00640926|524002188|FG000|Overall Study|Withdrawal by Subject|1|||
145315099|NCT00640926|524002189|FG001|Overall Study|Withdrawal by Subject|0|||
145315100|NCT00640926|524002190|FG002|Overall Study|Withdrawal by Subject|1|||
145315101|NCT01841073|524002191|FG000|Overall Study|Adverse Event|1|||
145315102|NCT01841073|524002192|FG001|Overall Study|Adverse Event|1|||
145315103|NCT01841073|524002191|FG000|Overall Study|Physician Decision|1|||
145315104|NCT01841073|524002192|FG001|Overall Study|Physician Decision|0|||
145315105|NCT01841073|524002191|FG000|Overall Study|Lost to Follow-up|0|||
145315106|NCT01841073|524002192|FG001|Overall Study|Lost to Follow-up|2|||
145315107|NCT02858037|524002195|FG000|Overall Study|Death|1|||
145315108|NCT02858037|524002195|FG000|Overall Study|Withdrawal by Subject|18|||
145315109|NCT02858037|524002195|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
145315110|NCT02858037|524002195|FG000|Overall Study|Lost to Follow-up|3|||
145315111|NCT02858037|524002195|FG000|Overall Study|Other|4|||
145315112|NCT00550147|524002200|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
145315113|NCT00550147|524002200|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
145315114|NCT00550147|524002200|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
145315115|NCT00550147|524002200|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
145315116|NCT00550147|524002200|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
145315117|NCT04320745|524002201|FG000|Overall Study|Adverse Event|26|||
145315118|NCT04320745|524002201|FG000|Overall Study|Withdrawal by Subject|4|||
145315119|NCT04320745|524002201|FG000|Overall Study|Lost to Follow-up|12|||
145315120|NCT04320745|524002201|FG000|Overall Study|Protocol Deviation|2|||
145315121|NCT04320745|524002201|FG000|Overall Study|Non-compliance With Study Drug|2|||
145315122|NCT04320745|524002201|FG000|Overall Study|Reason Not Specified|1|||
145315123|NCT00046839|524002203|FG000|Overall Study|Ineligible / No protocol treatment|0|||
145315124|NCT00046839|524002204|FG001|Overall Study|Ineligible / No protocol treatment|2|||
145315125|NCT00046839|524002203|FG000|Overall Study|Withdrawal of consent|1|||
145315126|NCT00046839|524002204|FG001|Overall Study|Withdrawal of consent|0|||
145315127|NCT02050321|524002208|FG000|Overall Study|Withdrawal by Subject|1|||
145315128|NCT02050321|524002208|FG000|Overall Study|Adverse Event|1|||
145315129|NCT01963260|524002209|FG000|Overall Study|Withdrawal by Subject|2|||
145315130|NCT01963260|524002210|FG001|Overall Study|Withdrawal by Subject|0|||
145315131|NCT01963260|524002211|FG002|Overall Study|Withdrawal by Subject|0|||
145315132|NCT01963260|524002212|FG003|Overall Study|Withdrawal by Subject|1|||
145315133|NCT01963260|524002213|FG004|Overall Study|Withdrawal by Subject|2|||
145315134|NCT01963260|524002214|FG005|Overall Study|Withdrawal by Subject|0|||
145315135|NCT01963260|524002215|FG006|Overall Study|Withdrawal by Subject|0|||
145315136|NCT01963260|524002216|FG007|Overall Study|Withdrawal by Subject|0|||
145315137|NCT01963260|524002217|FG008|Overall Study|Withdrawal by Subject|0|||
145411346|NCT00356590|524360010|FG000|Overall Study|Other|52|||
145569742|NCT01944059|524945781|FG000|Overall Study|Adverse Event|2|||
145569743|NCT00430092|524945791|FG000|Overall Study|Adverse Event|0|||
145569744|NCT00430092|524945792|FG001|Overall Study|Adverse Event|0|||
145569745|NCT00430092|524945793|FG002|Overall Study|Adverse Event|1|||
145569746|NCT00430092|524945791|FG000|Overall Study|Lack of Efficacy|5|||
145620381|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
145315138|NCT01963260|524002218|FG009|Overall Study|Withdrawal by Subject|0|||
145315139|NCT01547728|524002219|FG000|Overall Study|Change in procedure and equipment|1|||
145315140|NCT01547728|524002219|FG000|Overall Study|Drug not ready for subject|1|||
145315141|NCT01547728|524002219|FG000|Overall Study|Screen failure|39|||
145315142|NCT02151149|524002220|FG000|Treatment Period|Death|2|||
145315143|NCT02151149|524002221|FG001|Treatment Period|Death|3|||
145315144|NCT02151149|524002220|FG000|Treatment Period|Adverse Event|17|||
145315145|NCT02151149|524002221|FG001|Treatment Period|Adverse Event|14|||
145569747|NCT00430092|524945792|FG001|Overall Study|Lack of Efficacy|2|||
145569748|NCT00430092|524945793|FG002|Overall Study|Lack of Efficacy|54|||
145411347|NCT02175758|524360013|FG000|Treatment Phase|Lost to Follow-up|0|||
145315146|NCT02151149|524002220|FG000|Treatment Period|Progressive Disease|25|||
145315147|NCT02151149|524002221|FG001|Treatment Period|Progressive Disease|24|||
145315148|NCT02151149|524002220|FG000|Treatment Period|Symptomatic Deterioration|2|||
145315149|NCT02151149|524002221|FG001|Treatment Period|Symptomatic Deterioration|10|||
145315150|NCT02151149|524002220|FG000|Treatment Period|Withdrawal by Subject|13|||
145315151|NCT02151149|524002221|FG001|Treatment Period|Withdrawal by Subject|11|||
145315152|NCT02151149|524002220|FG000|Treatment Period|Miscellaneous|8|||
145315153|NCT02151149|524002221|FG001|Treatment Period|Miscellaneous|7|||
145315154|NCT02151149|524002220|FG000|Treatment Period|Participants randomized but not treated|3|||
145315155|NCT02151149|524002221|FG001|Treatment Period|Participants randomized but not treated|2|||
145315156|NCT02151149|524002220|FG000|Follow-Up Period|Lost to Follow-up|2|||
145315157|NCT02151149|524002221|FG001|Follow-Up Period|Lost to Follow-up|3|||
145315158|NCT02151149|524002220|FG000|Follow-Up Period|Death|37|||
145315159|NCT02151149|524002221|FG001|Follow-Up Period|Death|34|||
145315160|NCT02224053|524002224|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
145315161|NCT02224053|524002224|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
145315162|NCT02224053|524002224|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
145315163|NCT02224053|524002224|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
145315164|NCT02224053|524002224|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
145315165|NCT01499160|524002226|FG000|Overall Study|Adverse Event|1|||
145315166|NCT01499160|524002226|FG000|Overall Study|Withdrawal by Subject|1|||
145315167|NCT01438476|524002227|FG000|Overall Study|Protocol Violation|1|||
145315168|NCT01438476|524002228|FG001|Overall Study|Protocol Violation|0|||
145315169|NCT01438476|524002227|FG000|Overall Study|Withdrawal by Subject|1|||
145315170|NCT01438476|524002228|FG001|Overall Study|Withdrawal by Subject|0|||
145315171|NCT01438476|524002227|FG000|Overall Study|No Surgery- Disease|8|||
145315172|NCT01438476|524002228|FG001|Overall Study|No Surgery- Disease|10|||
145315173|NCT01438476|524002227|FG000|Overall Study|Communication barrier|0|||
145315174|NCT01438476|524002228|FG001|Overall Study|Communication barrier|1|||
145315175|NCT02289820|524002229|FG000|Overall Study|Withdrawal by Subject|2|||
145315176|NCT02289820|524002230|FG001|Overall Study|Withdrawal by Subject|1|||
145315177|NCT02289820|524002231|FG002|Overall Study|Withdrawal by Subject|2|||
145315178|NCT02289820|524002232|FG003|Overall Study|Withdrawal by Subject|1|||
145315179|NCT02289820|524002233|FG004|Overall Study|Withdrawal by Subject|0|||
145315180|NCT02289820|524002234|FG005|Overall Study|Withdrawal by Subject|0|||
145315181|NCT02289820|524002235|FG006|Overall Study|Withdrawal by Subject|1|||
145315182|NCT02289820|524002229|FG000|Overall Study|Death|0|||
145315183|NCT02289820|524002230|FG001|Overall Study|Death|0|||
145315184|NCT02289820|524002231|FG002|Overall Study|Death|1|||
145315185|NCT02289820|524002232|FG003|Overall Study|Death|0|||
145315186|NCT02289820|524002233|FG004|Overall Study|Death|0|||
145315187|NCT02289820|524002234|FG005|Overall Study|Death|0|||
145315188|NCT02289820|524002235|FG006|Overall Study|Death|0|||
145315189|NCT02289820|524002229|FG000|Overall Study|Lost to Follow-up|0|||
145315190|NCT02289820|524002230|FG001|Overall Study|Lost to Follow-up|0|||
145315191|NCT02289820|524002231|FG002|Overall Study|Lost to Follow-up|3|||
145315192|NCT02289820|524002232|FG003|Overall Study|Lost to Follow-up|1|||
145315193|NCT02289820|524002233|FG004|Overall Study|Lost to Follow-up|0|||
145315194|NCT02289820|524002234|FG005|Overall Study|Lost to Follow-up|1|||
145315195|NCT02289820|524002235|FG006|Overall Study|Lost to Follow-up|1|||
145315196|NCT02289820|524002229|FG000|Overall Study|withdrawal of consent|0|||
145315197|NCT02289820|524002230|FG001|Overall Study|withdrawal of consent|1|||
145315198|NCT02289820|524002231|FG002|Overall Study|withdrawal of consent|0|||
145315199|NCT02289820|524002232|FG003|Overall Study|withdrawal of consent|0|||
145315200|NCT02289820|524002233|FG004|Overall Study|withdrawal of consent|0|||
145315201|NCT02289820|524002234|FG005|Overall Study|withdrawal of consent|0|||
145315202|NCT02289820|524002235|FG006|Overall Study|withdrawal of consent|0|||
145315203|NCT01924364|524002242|FG000|Overall Study|Physician Decision|3|||
145315204|NCT00265785|524002243|FG000|Overall Study|Adverse Event|4|||
145315205|NCT00265785|524002243|FG000|Overall Study|Withdrawal by Subject|3|||
145315206|NCT00265785|524002243|FG000|Overall Study|Progression/Relapse|15|||
145315207|NCT00265785|524002243|FG000|Overall Study|Not protocol specified|2|||
145411348|NCT02175758|524360014|FG001|Treatment Phase|Lost to Follow-up|1|||
145315208|NCT00265785|524002243|FG000|Overall Study|Ineligible|1|||
145315209|NCT00265785|524002243|FG000|Overall Study|Did not receive protocol treatment|2|||
145315210|NCT00860262|524002247|FG000|Overall Study|Adverse Event|9|||
145315211|NCT00860262|524002248|FG001|Overall Study|Adverse Event|6|||
145315212|NCT00860262|524002249|FG002|Overall Study|Adverse Event|7|||
145315213|NCT00860262|524002247|FG000|Overall Study|Protocol Violation|0|||
145315214|NCT00860262|524002248|FG001|Overall Study|Protocol Violation|1|||
145315215|NCT00860262|524002249|FG002|Overall Study|Protocol Violation|0|||
145315216|NCT00860262|524002247|FG000|Overall Study|Lost to Follow-up|2|||
145315217|NCT00860262|524002248|FG001|Overall Study|Lost to Follow-up|0|||
145315218|NCT00860262|524002249|FG002|Overall Study|Lost to Follow-up|1|||
145315219|NCT00860262|524002247|FG000|Overall Study|Withdrawal by Subject|4|||
145411349|NCT02175758|524360015|FG002|Treatment Phase|Lost to Follow-up|0|||
145315220|NCT00860262|524002248|FG001|Overall Study|Withdrawal by Subject|8|||
145315221|NCT00860262|524002249|FG002|Overall Study|Withdrawal by Subject|6|||
145315222|NCT00860262|524002247|FG000|Overall Study|Lack of Efficacy|0|||
145315223|NCT00860262|524002248|FG001|Overall Study|Lack of Efficacy|4|||
145315224|NCT00860262|524002249|FG002|Overall Study|Lack of Efficacy|3|||
145315225|NCT00860262|524002247|FG000|Overall Study|Other|5|||
145315226|NCT00860262|524002248|FG001|Overall Study|Other|3|||
145315227|NCT00860262|524002249|FG002|Overall Study|Other|1|||
145315228|NCT04640194|524002255|FG000|Overall Study|Adverse Event|3|||
145315229|NCT04640194|524002256|FG001|Overall Study|Adverse Event|7|||
145315230|NCT04640194|524002257|FG002|Overall Study|Adverse Event|0|||
145315231|NCT04640194|524002258|FG003|Overall Study|Adverse Event|5|||
145315232|NCT04640194|524002259|FG004|Overall Study|Adverse Event|0|||
145315233|NCT04640194|524002260|FG005|Overall Study|Adverse Event|4|||
145315234|NCT04640194|524002261|FG006|Overall Study|Adverse Event|0|||
145315235|NCT04640194|524002255|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
145315236|NCT04640194|524002256|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
145315237|NCT04640194|524002257|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
145315238|NCT04640194|524002258|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
145315239|NCT04640194|524002259|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
145315240|NCT04640194|524002260|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
145315241|NCT04640194|524002261|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
145315242|NCT04640194|524002255|FG000|Overall Study|fibrinogen level too low|0|||
145315243|NCT04640194|524002256|FG001|Overall Study|fibrinogen level too low|0|||
145315244|NCT04640194|524002257|FG002|Overall Study|fibrinogen level too low|0|||
145315245|NCT04640194|524002258|FG003|Overall Study|fibrinogen level too low|1|||
145315246|NCT04640194|524002259|FG004|Overall Study|fibrinogen level too low|0|||
145315247|NCT04640194|524002260|FG005|Overall Study|fibrinogen level too low|0|||
145315248|NCT04640194|524002261|FG006|Overall Study|fibrinogen level too low|0|||
145315249|NCT04640194|524002255|FG000|Overall Study|mild bleeding|0|||
145315250|NCT04640194|524002256|FG001|Overall Study|mild bleeding|0|||
145315251|NCT04640194|524002257|FG002|Overall Study|mild bleeding|0|||
145315252|NCT04640194|524002258|FG003|Overall Study|mild bleeding|1|||
145315253|NCT04640194|524002259|FG004|Overall Study|mild bleeding|0|||
145315254|NCT04640194|524002260|FG005|Overall Study|mild bleeding|0|||
145315255|NCT04640194|524002261|FG006|Overall Study|mild bleeding|0|||
145315256|NCT04640194|524002255|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315257|NCT04640194|524002256|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
145315258|NCT04640194|524002257|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315259|NCT04640194|524002258|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315260|NCT04640194|524002259|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315261|NCT04640194|524002260|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315262|NCT04640194|524002261|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
145315263|NCT01709903|524002262|FG000|Overall Study|administrative problems|2|||
145315264|NCT01709903|524002263|FG001|Overall Study|administrative problems|6|||
145315265|NCT01709903|524002262|FG000|Overall Study|Abnormal test procedure results|1|||
145315266|NCT01709903|524002263|FG001|Overall Study|Abnormal test procedure results|0|||
145315267|NCT01709903|524002262|FG000|Overall Study|In ability to use device|1|||
145315268|NCT01709903|524002263|FG001|Overall Study|In ability to use device|1|||
145315269|NCT01709903|524002262|FG000|Overall Study|no longer needed study drug|0|||
145315270|NCT01709903|524002263|FG001|Overall Study|no longer needed study drug|1|||
145315271|NCT01709903|524002262|FG000|Overall Study|Lost to Follow-up|0|||
145315272|NCT01709903|524002263|FG001|Overall Study|Lost to Follow-up|2|||
145315273|NCT01709903|524002262|FG000|Overall Study|Death|2|||
145315274|NCT01709903|524002263|FG001|Overall Study|Death|0|||
145315275|NCT01709903|524002262|FG000|Overall Study|Protocol Violation|3|||
145315276|NCT01709903|524002263|FG001|Overall Study|Protocol Violation|2|||
145315277|NCT01709903|524002262|FG000|Overall Study|Lack of Efficacy|3|||
145315278|NCT01709903|524002263|FG001|Overall Study|Lack of Efficacy|3|||
145315279|NCT01709903|524002262|FG000|Overall Study|Withdrawal by Subject|6|||
145315280|NCT01709903|524002263|FG001|Overall Study|Withdrawal by Subject|6|||
145315281|NCT01709903|524002262|FG000|Overall Study|Adverse Event|11|||
145315282|NCT01709903|524002263|FG001|Overall Study|Adverse Event|18|||
145315283|NCT02061280|524002264|FG000|Overall Study|Protocol Violation|12|||
145315284|NCT02061280|524002265|FG001|Overall Study|Protocol Violation|8|||
145315285|NCT02061280|524002264|FG000|Overall Study|moved out of state|0|||
145315286|NCT02061280|524002265|FG001|Overall Study|moved out of state|1|||
145315287|NCT02061280|524002264|FG000|Overall Study|Withdrawal by Subject|1|||
145315288|NCT02061280|524002265|FG001|Overall Study|Withdrawal by Subject|2|||
145315289|NCT02061280|524002264|FG000|Overall Study|Lost to Follow-up|5|||
145315290|NCT02061280|524002265|FG001|Overall Study|Lost to Follow-up|1|||
145315291|NCT05061992|524003845|FG000|Overall Study|Excess bowel movements|1|||
145315292|NCT05061992|524003846|FG001|Overall Study|Excess bowel movements|0|||
145315293|NCT05061992|524003845|FG000|Overall Study|Complications of Medical Care|1|||
145315294|NCT05061992|524003846|FG001|Overall Study|Complications of Medical Care|0|||
145315295|NCT05061992|524003845|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
145315296|NCT05061992|524003846|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
145315297|NCT05061992|524003845|FG000|Overall Study|Withdrawal by Subject|0|||
145315298|NCT05061992|524003846|FG001|Overall Study|Withdrawal by Subject|1|||
145315299|NCT02459418|524003847|FG000|Overall Study|Exclusion Criteria|4|||
145315300|NCT02459418|524003848|FG001|Overall Study|Exclusion Criteria|0|||
145315301|NCT02459418|524003847|FG000|Overall Study|Protocol Violation|0|||
145315302|NCT02459418|524003848|FG001|Overall Study|Protocol Violation|2|||
145315303|NCT02459418|524003847|FG000|Overall Study|Physician Decision|0|||
145315304|NCT02459418|524003848|FG001|Overall Study|Physician Decision|2|||
145315305|NCT02459418|524003847|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
145315306|NCT02459418|524003848|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
145315307|NCT02459418|524003847|FG000|Overall Study|Adverse Event|0|||
145315308|NCT02459418|524003848|FG001|Overall Study|Adverse Event|1|||
145315309|NCT02459418|524003847|FG000|Overall Study|Withdrawal by Subject|1|||
145315310|NCT02459418|524003848|FG001|Overall Study|Withdrawal by Subject|1|||
145315311|NCT02459418|524003847|FG000|Overall Study|Elevated Creatine Kinase|1|||
145315312|NCT02459418|524003848|FG001|Overall Study|Elevated Creatine Kinase|0|||
145315313|NCT02459418|524003847|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
145315314|NCT02459418|524003848|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
145315315|NCT00653159|524003849|FG000|Overall Study|Adverse Event|4|||
145315316|NCT00653159|524003850|FG001|Overall Study|Adverse Event|1|||
145315317|NCT00653159|524003849|FG000|Overall Study|Lost to Follow-up|1|||
145315318|NCT00653159|524003850|FG001|Overall Study|Lost to Follow-up|2|||
145315319|NCT01872715|524003851|FG000|Overall Study|Adverse Event|1|||
145315320|NCT01872715|524003851|FG000|Overall Study|Protocol Violation|1|||
145315321|NCT01872715|524003851|FG000|Overall Study|Withdrawal by Subject|2|||
145315322|NCT00683592|524003852|FG000|Overall Study|Adverse Event|12|||
145315323|NCT00683592|524003853|FG001|Overall Study|Adverse Event|4|||
145315324|NCT00683592|524003852|FG000|Overall Study|Withdrawal by Subject|11|||
145315325|NCT00683592|524003853|FG001|Overall Study|Withdrawal by Subject|11|||
145315326|NCT00683592|524003852|FG000|Overall Study|Lost to Follow-up|17|||
145315327|NCT00683592|524003853|FG001|Overall Study|Lost to Follow-up|17|||
145315328|NCT00683592|524003852|FG000|Overall Study|Lack of Efficacy|3|||
145315329|NCT00683592|524003853|FG001|Overall Study|Lack of Efficacy|7|||
145315330|NCT00683592|524003852|FG000|Overall Study|Physician Decision|0|||
145315331|NCT00683592|524003853|FG001|Overall Study|Physician Decision|1|||
145315332|NCT00683592|524003852|FG000|Overall Study|Non-compliance|3|||
145315333|NCT00683592|524003853|FG001|Overall Study|Non-compliance|5|||
145315334|NCT00683592|524003852|FG000|Overall Study|Other|1|||
145315335|NCT00683592|524003853|FG001|Overall Study|Other|1|||
145315336|NCT02697617|524003854|FG000|Overall Study|Withdrawal by Subject|0|||
145315337|NCT02697617|524003855|FG001|Overall Study|Withdrawal by Subject|2|||
145315338|NCT02697617|524003854|FG000|Overall Study|Pregnancy|1|||
145315339|NCT02697617|524003855|FG001|Overall Study|Pregnancy|0|||
145315340|NCT04167618|524003856|FG000|Overall Study|Trial terminated by sponsor|1|||
145315341|NCT04167618|524003857|FG001|Overall Study|Trial terminated by sponsor|1|||
145315342|NCT02943993|524003860|FG000|Overall Study|Withdrawal by Subject|52|||
145315343|NCT02943993|524003860|FG000|Overall Study|Transfer to another institution|6|||
145315344|NCT02943993|524003860|FG000|Overall Study|Lost to Follow-up|135|||
145315345|NCT02943993|524003860|FG000|Overall Study|Death|98|||
145315346|NCT02943993|524003860|FG000|Overall Study|Other reason for premature termination|32|||
145315347|NCT02943993|524003860|FG000|Overall Study|Missing reason for termination|7|||
145315348|NCT05996198|524003864|FG000|Overall Study|Withdrawal by Subject|1|||
145315349|NCT05996198|524003865|FG001|Overall Study|Withdrawal by Subject|0|||
145315350|NCT00876265|524003866|FG000|Overall Study|Miscellaneous reasons|4|||
145315351|NCT00876265|524003866|FG000|Overall Study|Lost to Follow-up|6|||
145315352|NCT00876265|524003866|FG000|Overall Study|Withdrawal by Subject|2|||
145315353|NCT01755975|524003867|FG000|Overall Study|Adverse Event|0|||
145315354|NCT01755975|524003868|FG001|Overall Study|Adverse Event|0|||
145315355|NCT01755975|524003869|FG002|Overall Study|Adverse Event|1|||
145315356|NCT01755975|524003870|FG003|Overall Study|Adverse Event|0|||
145411350|NCT02175758|524360016|FG003|Treatment Phase|Lost to Follow-up|0|||
145315357|NCT01755975|524003871|FG004|Overall Study|Adverse Event|2|||
145315358|NCT00965757|524003880|FG000|Double-blind Phase|Progression of concomitant disease|1|||
145315359|NCT00965757|524003881|FG001|Double-blind Phase|Progression of concomitant disease|2|||
145315360|NCT00965757|524003882|FG002|Double-blind Phase|Progression of concomitant disease|0|||
145315361|NCT00965757|524003883|FG003|Double-blind Phase|Progression of concomitant disease|0|||
145315362|NCT00965757|524003880|FG000|Double-blind Phase|Adverse drug reaction|2|||
145315363|NCT00965757|524003881|FG001|Double-blind Phase|Adverse drug reaction|1|||
145411351|NCT02175758|524360017|FG004|Treatment Phase|Lost to Follow-up|0|||
145315364|NCT00965757|524003882|FG002|Double-blind Phase|Adverse drug reaction|0|||
145315365|NCT00965757|524003883|FG003|Double-blind Phase|Adverse drug reaction|0|||
145315366|NCT00965757|524003880|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
145315367|NCT00965757|524003881|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
145315368|NCT00965757|524003882|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
145315369|NCT00965757|524003883|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
145315370|NCT00965757|524003880|FG000|Double-blind Phase|Lack of Efficacy|7|||
145315371|NCT00965757|524003881|FG001|Double-blind Phase|Lack of Efficacy|11|||
145315372|NCT00965757|524003882|FG002|Double-blind Phase|Lack of Efficacy|0|||
145315373|NCT00965757|524003883|FG003|Double-blind Phase|Lack of Efficacy|0|||
145315374|NCT00965757|524003880|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
145315375|NCT00965757|524003881|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145315376|NCT00965757|524003882|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145315377|NCT00965757|524003883|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
145315378|NCT00965757|524003880|FG000|Double-blind Phase|Lost to Follow-up|0|||
145315379|NCT00965757|524003881|FG001|Double-blind Phase|Lost to Follow-up|1|||
145315380|NCT00965757|524003882|FG002|Double-blind Phase|Lost to Follow-up|0|||
145315381|NCT00965757|524003883|FG003|Double-blind Phase|Lost to Follow-up|0|||
145315382|NCT00965757|524003880|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
145315383|NCT00965757|524003881|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
145315384|NCT00965757|524003882|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
145315385|NCT00965757|524003883|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
145315386|NCT00965757|524003880|FG000|Double-blind Phase|Other|1|||
145315387|NCT00965757|524003881|FG001|Double-blind Phase|Other|0|||
145315388|NCT00965757|524003882|FG002|Double-blind Phase|Other|0|||
145315389|NCT00965757|524003883|FG003|Double-blind Phase|Other|0|||
145315390|NCT00965757|524003880|FG000|Extension Phase|Progression of concomitant disease|0|||
145315391|NCT00965757|524003881|FG001|Extension Phase|Progression of concomitant disease|0|||
145315392|NCT00965757|524003882|FG002|Extension Phase|Progression of concomitant disease|4|||
145315393|NCT00965757|524003883|FG003|Extension Phase|Progression of concomitant disease|2|||
145315394|NCT00965757|524003880|FG000|Extension Phase|Adverse drug reaction|0|||
145315395|NCT00965757|524003881|FG001|Extension Phase|Adverse drug reaction|0|||
145315396|NCT00965757|524003882|FG002|Extension Phase|Adverse drug reaction|6|||
145315397|NCT00965757|524003883|FG003|Extension Phase|Adverse drug reaction|3|||
145315398|NCT00965757|524003880|FG000|Extension Phase|Abnormal Laboratory Value|0|||
145315399|NCT00965757|524003881|FG001|Extension Phase|Abnormal Laboratory Value|0|||
145315400|NCT00965757|524003882|FG002|Extension Phase|Abnormal Laboratory Value|6|||
145315401|NCT00965757|524003883|FG003|Extension Phase|Abnormal Laboratory Value|1|||
145315402|NCT00965757|524003880|FG000|Extension Phase|Lack of Efficacy|0|||
145315403|NCT00965757|524003881|FG001|Extension Phase|Lack of Efficacy|0|||
145315404|NCT00965757|524003882|FG002|Extension Phase|Lack of Efficacy|8|||
145315405|NCT00965757|524003883|FG003|Extension Phase|Lack of Efficacy|12|||
145315406|NCT00965757|524003880|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145315407|NCT00965757|524003881|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145315408|NCT00965757|524003882|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
145315409|NCT00965757|524003883|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
145315410|NCT00965757|524003880|FG000|Extension Phase|Lost to Follow-up|0|||
145315411|NCT00965757|524003881|FG001|Extension Phase|Lost to Follow-up|0|||
145315412|NCT00965757|524003882|FG002|Extension Phase|Lost to Follow-up|0|||
145315413|NCT00965757|524003883|FG003|Extension Phase|Lost to Follow-up|1|||
145315414|NCT00965757|524003880|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
145315415|NCT00965757|524003881|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
145315416|NCT00965757|524003882|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
145315417|NCT00965757|524003883|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
145315418|NCT00965757|524003880|FG000|Extension Phase|Protocol Violation|0|||
145315419|NCT00965757|524003881|FG001|Extension Phase|Protocol Violation|0|||
145315420|NCT00965757|524003882|FG002|Extension Phase|Protocol Violation|0|||
145315421|NCT00965757|524003883|FG003|Extension Phase|Protocol Violation|1|||
145315422|NCT00965757|524003880|FG000|Extension Phase|Other|0|||
145315423|NCT00965757|524003881|FG001|Extension Phase|Other|0|||
145315424|NCT00965757|524003882|FG002|Extension Phase|Other|2|||
145315425|NCT00965757|524003883|FG003|Extension Phase|Other|1|||
145315426|NCT03807440|524003884|FG000|Overall Study|No documentation of index date 2|320|||
145315427|NCT03807440|524003884|FG000|Overall Study|No informed consent for index date 2|117|||
145569749|NCT00430092|524945791|FG000|Overall Study|Lost to Follow-up|1|||
145569750|NCT00430092|524945792|FG001|Overall Study|Lost to Follow-up|0|||
145569751|NCT00430092|524945793|FG002|Overall Study|Lost to Follow-up|0|||
145569752|NCT00430092|524945791|FG000|Overall Study|Protocol Violation|0|||
145569753|NCT00430092|524945792|FG001|Overall Study|Protocol Violation|1|||
145569754|NCT00430092|524945793|FG002|Overall Study|Protocol Violation|1|||
145569755|NCT00430092|524945791|FG000|Overall Study|Withdrawal by Subject|0|||
145315428|NCT02451358|524003885|FG000|Overall Study|Withdrawal by Subject|1|||
145315429|NCT02451358|524003886|FG001|Overall Study|Withdrawal by Subject|1|||
145315430|NCT02451358|524003887|FG002|Overall Study|Withdrawal by Subject|0|||
145315431|NCT02451358|524003888|FG003|Overall Study|Withdrawal by Subject|0|||
145569756|NCT00430092|524945792|FG001|Overall Study|Withdrawal by Subject|1|||
145315432|NCT02451358|524003885|FG000|Overall Study|Protocol Violation|0|||
145315433|NCT02451358|524003886|FG001|Overall Study|Protocol Violation|1|||
145315434|NCT02451358|524003887|FG002|Overall Study|Protocol Violation|1|||
145315435|NCT02451358|524003888|FG003|Overall Study|Protocol Violation|0|||
145315436|NCT03414034|524003891|FG000|Overall Study|Adverse Event|6|||
145315437|NCT03414034|524003892|FG001|Overall Study|Adverse Event|1|||
145315438|NCT03414034|524003893|FG002|Overall Study|Adverse Event|1|||
145315439|NCT03414034|524003891|FG000|Overall Study|Death|0|||
145315440|NCT03414034|524003892|FG001|Overall Study|Death|0|||
145315441|NCT03414034|524003893|FG002|Overall Study|Death|1|||
145315442|NCT03414034|524003891|FG000|Overall Study|Non-compliance With Study Drug|0|||
145315443|NCT03414034|524003892|FG001|Overall Study|Non-compliance With Study Drug|0|||
145315444|NCT03414034|524003893|FG002|Overall Study|Non-compliance With Study Drug|1|||
145315445|NCT03414034|524003891|FG000|Overall Study|Physician Decision|1|||
145315446|NCT03414034|524003892|FG001|Overall Study|Physician Decision|3|||
145315447|NCT03414034|524003893|FG002|Overall Study|Physician Decision|2|||
145315448|NCT03414034|524003891|FG000|Overall Study|Withdrawal of Informed Consent|2|||
145315449|NCT03414034|524003892|FG001|Overall Study|Withdrawal of Informed Consent|1|||
145315450|NCT03414034|524003893|FG002|Overall Study|Withdrawal of Informed Consent|4|||
145315451|NCT03414034|524003891|FG000|Overall Study|Progressive Disease|15|||
145315452|NCT03414034|524003892|FG001|Overall Study|Progressive Disease|15|||
145315453|NCT03414034|524003893|FG002|Overall Study|Progressive Disease|17|||
145315454|NCT03414034|524003891|FG000|Overall Study|Miscellaneous|0|||
145315455|NCT03414034|524003892|FG001|Overall Study|Miscellaneous|0|||
145315456|NCT03414034|524003893|FG002|Overall Study|Miscellaneous|2|||
145315457|NCT01332968|524003895|FG000|Induction Period|Adverse Event|23|||
145315458|NCT01332968|524003896|FG001|Induction Period|Adverse Event|26|||
145315459|NCT01332968|524003897|FG002|Induction Period|Adverse Event|0|||
145315460|NCT01332968|524003898|FG003|Induction Period|Adverse Event|0|||
145315461|NCT01332968|524003899|FG004|Induction Period|Adverse Event|0|||
145315462|NCT01332968|524003900|FG005|Induction Period|Adverse Event|0|||
145315463|NCT01332968|524003901|FG006|Induction Period|Adverse Event|0|||
145315464|NCT01332968|524003902|FG007|Induction Period|Adverse Event|0|||
145315465|NCT01332968|524003895|FG000|Induction Period|Death|1|||
145315466|NCT01332968|524003896|FG001|Induction Period|Death|4|||
145315467|NCT01332968|524003897|FG002|Induction Period|Death|0|||
145315468|NCT01332968|524003898|FG003|Induction Period|Death|0|||
145315469|NCT01332968|524003899|FG004|Induction Period|Death|0|||
145315470|NCT01332968|524003900|FG005|Induction Period|Death|0|||
145315471|NCT01332968|524003901|FG006|Induction Period|Death|0|||
145315472|NCT01332968|524003902|FG007|Induction Period|Death|0|||
145315473|NCT01332968|524003895|FG000|Induction Period|Non-compliance|1|||
145315474|NCT01332968|524003896|FG001|Induction Period|Non-compliance|0|||
145315475|NCT01332968|524003897|FG002|Induction Period|Non-compliance|0|||
145315476|NCT01332968|524003898|FG003|Induction Period|Non-compliance|0|||
145315477|NCT01332968|524003899|FG004|Induction Period|Non-compliance|0|||
145315478|NCT01332968|524003900|FG005|Induction Period|Non-compliance|0|||
145315479|NCT01332968|524003901|FG006|Induction Period|Non-compliance|0|||
145315480|NCT01332968|524003902|FG007|Induction Period|Non-compliance|0|||
145315481|NCT01332968|524003895|FG000|Induction Period|Other|2|||
145315482|NCT01332968|524003896|FG001|Induction Period|Other|2|||
145315483|NCT01332968|524003897|FG002|Induction Period|Other|0|||
145315484|NCT01332968|524003898|FG003|Induction Period|Other|0|||
145315485|NCT01332968|524003899|FG004|Induction Period|Other|0|||
145315486|NCT01332968|524003900|FG005|Induction Period|Other|0|||
145315487|NCT01332968|524003901|FG006|Induction Period|Other|0|||
145315488|NCT01332968|524003902|FG007|Induction Period|Other|0|||
145315489|NCT01332968|524003895|FG000|Induction Period|Physician Decision|6|||
145315490|NCT01332968|524003896|FG001|Induction Period|Physician Decision|1|||
145315491|NCT01332968|524003897|FG002|Induction Period|Physician Decision|0|||
145315492|NCT01332968|524003898|FG003|Induction Period|Physician Decision|0|||
145315493|NCT01332968|524003899|FG004|Induction Period|Physician Decision|0|||
145315494|NCT01332968|524003900|FG005|Induction Period|Physician Decision|0|||
145315495|NCT01332968|524003901|FG006|Induction Period|Physician Decision|0|||
145315496|NCT01332968|524003902|FG007|Induction Period|Physician Decision|0|||
145315497|NCT01332968|524003895|FG000|Induction Period|Progressive Disease|15|||
145315498|NCT01332968|524003896|FG001|Induction Period|Progressive Disease|7|||
145315499|NCT01332968|524003897|FG002|Induction Period|Progressive Disease|0|||
145569757|NCT00430092|524945793|FG002|Overall Study|Withdrawal by Subject|1|||
145315500|NCT01332968|524003898|FG003|Induction Period|Progressive Disease|0|||
145315501|NCT01332968|524003899|FG004|Induction Period|Progressive Disease|0|||
145315502|NCT01332968|524003900|FG005|Induction Period|Progressive Disease|0|||
145315503|NCT01332968|524003901|FG006|Induction Period|Progressive Disease|0|||
145315504|NCT01332968|524003902|FG007|Induction Period|Progressive Disease|0|||
145315505|NCT01332968|524003895|FG000|Induction Period|Protocol Violation|3|||
145315506|NCT01332968|524003896|FG001|Induction Period|Protocol Violation|4|||
145315507|NCT01332968|524003897|FG002|Induction Period|Protocol Violation|0|||
145315508|NCT01332968|524003898|FG003|Induction Period|Protocol Violation|0|||
145315509|NCT01332968|524003899|FG004|Induction Period|Protocol Violation|0|||
145315510|NCT01332968|524003900|FG005|Induction Period|Protocol Violation|0|||
145315511|NCT01332968|524003901|FG006|Induction Period|Protocol Violation|0|||
145315512|NCT01332968|524003902|FG007|Induction Period|Protocol Violation|0|||
145315513|NCT01332968|524003895|FG000|Induction Period|Withdrawal by Subject|3|||
145315514|NCT01332968|524003896|FG001|Induction Period|Withdrawal by Subject|5|||
145411352|NCT02175758|524360018|FG005|Treatment Phase|Lost to Follow-up|0|||
145315515|NCT01332968|524003897|FG002|Induction Period|Withdrawal by Subject|0|||
145315516|NCT01332968|524003898|FG003|Induction Period|Withdrawal by Subject|0|||
145315517|NCT01332968|524003899|FG004|Induction Period|Withdrawal by Subject|0|||
145315518|NCT01332968|524003900|FG005|Induction Period|Withdrawal by Subject|0|||
145315519|NCT01332968|524003901|FG006|Induction Period|Withdrawal by Subject|0|||
145315520|NCT01332968|524003902|FG007|Induction Period|Withdrawal by Subject|0|||
145315521|NCT01332968|524003895|FG000|Induction Period|Randomised but not treated|4|||
145315522|NCT01332968|524003896|FG001|Induction Period|Randomised but not treated|7|||
145315523|NCT01332968|524003897|FG002|Induction Period|Randomised but not treated|0|||
145315524|NCT01332968|524003898|FG003|Induction Period|Randomised but not treated|0|||
145315525|NCT01332968|524003899|FG004|Induction Period|Randomised but not treated|0|||
145411353|NCT02175758|524360013|FG000|Treatment Phase|Adverse Event|0|||
145411354|NCT02175758|524360014|FG001|Treatment Phase|Adverse Event|0|||
145411355|NCT02175758|524360015|FG002|Treatment Phase|Adverse Event|0|||
145411356|NCT02175758|524360016|FG003|Treatment Phase|Adverse Event|0|||
145411357|NCT02175758|524360017|FG004|Treatment Phase|Adverse Event|1|||
145411358|NCT02175758|524360018|FG005|Treatment Phase|Adverse Event|0|||
145411359|NCT03506477|524360026|FG000|Overall Study|Withdrawal by Subject|1|||
145411360|NCT03506477|524360027|FG001|Overall Study|Withdrawal by Subject|0|||
145411361|NCT04556097|524360028|FG000|Overall Study|Death|0|||
145411362|NCT04556097|524360029|FG001|Overall Study|Death|5|||
145411363|NCT04556097|524360030|FG002|Overall Study|Death|0|||
145411364|NCT04556097|524360031|FG003|Overall Study|Death|0|||
145411365|NCT04556097|524360028|FG000|Overall Study|No caregiver|43|||
145411366|NCT04556097|524360029|FG001|Overall Study|No caregiver|53|||
145411367|NCT04556097|524360030|FG002|Overall Study|No caregiver|0|||
145411368|NCT04556097|524360031|FG003|Overall Study|No caregiver|0|||
145411369|NCT04556097|524360028|FG000|Overall Study|Ineligible, SNF|2|||
145411370|NCT04556097|524360029|FG001|Overall Study|Ineligible, SNF|2|||
145411371|NCT04556097|524360030|FG002|Overall Study|Ineligible, SNF|0|||
145411372|NCT04556097|524360031|FG003|Overall Study|Ineligible, SNF|0|||
145411373|NCT04556097|524360028|FG000|Overall Study|Ineligible, health|3|||
145411374|NCT04556097|524360029|FG001|Overall Study|Ineligible, health|4|||
145411375|NCT04556097|524360030|FG002|Overall Study|Ineligible, health|0|||
145411376|NCT04556097|524360031|FG003|Overall Study|Ineligible, health|0|||
145411377|NCT04556097|524360028|FG000|Overall Study|Ineligible, language|0|||
145411378|NCT04556097|524360029|FG001|Overall Study|Ineligible, language|1|||
145411379|NCT04556097|524360030|FG002|Overall Study|Ineligible, language|0|||
145411380|NCT04556097|524360031|FG003|Overall Study|Ineligible, language|0|||
145411381|NCT04556097|524360028|FG000|Overall Study|Ineligible, no longer in care management|0|||
145411382|NCT04556097|524360029|FG001|Overall Study|Ineligible, no longer in care management|2|||
145411383|NCT04556097|524360030|FG002|Overall Study|Ineligible, no longer in care management|1|||
145411384|NCT04556097|524360031|FG003|Overall Study|Ineligible, no longer in care management|0|||
145411385|NCT04556097|524360028|FG000|Overall Study|No dementia|13|||
145411386|NCT04556097|524360029|FG001|Overall Study|No dementia|3|||
145411387|NCT04556097|524360030|FG002|Overall Study|No dementia|0|||
145411388|NCT04556097|524360031|FG003|Overall Study|No dementia|0|||
145411389|NCT04556097|524360028|FG000|Overall Study|Missing identifier|2|||
145411390|NCT04556097|524360029|FG001|Overall Study|Missing identifier|4|||
145411391|NCT04556097|524360030|FG002|Overall Study|Missing identifier|0|||
145411392|NCT04556097|524360031|FG003|Overall Study|Missing identifier|0|||
145411393|NCT04556097|524360028|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
145411394|NCT04556097|524360029|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
145411395|NCT04556097|524360030|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
145411396|NCT04556097|524360031|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
145411397|NCT02516241|524360032|FG000|Overall Study|Death|255|||
145411398|NCT02516241|524360033|FG001|Overall Study|Death|262|||
145411399|NCT02516241|524360034|FG002|Overall Study|Death|270|||
145411400|NCT02516241|524360032|FG000|Overall Study|Lost to Follow-up|1|||
145411401|NCT02516241|524360033|FG001|Overall Study|Lost to Follow-up|1|||
145411402|NCT02516241|524360034|FG002|Overall Study|Lost to Follow-up|3|||
145411403|NCT02516241|524360032|FG000|Overall Study|Withdrawal by Subject|2|||
145411404|NCT02516241|524360033|FG001|Overall Study|Withdrawal by Subject|7|||
145411405|NCT02516241|524360034|FG002|Overall Study|Withdrawal by Subject|12|||
145315526|NCT01332968|524003900|FG005|Induction Period|Randomised but not treated|0|||
145315527|NCT01332968|524003901|FG006|Induction Period|Randomised but not treated|0|||
145315528|NCT01332968|524003902|FG007|Induction Period|Randomised but not treated|0|||
145315529|NCT01332968|524003895|FG000|Maintenance/Observation Period|Adverse Event|0|||
145411406|NCT02516241|524360032|FG000|Overall Study|participants ongoing at data cut-off|84|||
145411407|NCT02516241|524360033|FG001|Overall Study|participants ongoing at data cut-off|76|||
145411408|NCT02516241|524360034|FG002|Overall Study|participants ongoing at data cut-off|59|||
145411409|NCT01260948|524360035|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
145411410|NCT01260948|524360036|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
145411411|NCT01260948|524360035|FG000|Second Intervention|Emesis|0|||
145411412|NCT01260948|524360036|FG001|Second Intervention|Emesis|1|||
145411413|NCT02555878|524360037|FG000|Overall Study|Lost to Follow-up|2|||
145315530|NCT01332968|524003896|FG001|Maintenance/Observation Period|Adverse Event|0|||
145315531|NCT01332968|524003897|FG002|Maintenance/Observation Period|Adverse Event|53|||
145315532|NCT01332968|524003898|FG003|Maintenance/Observation Period|Adverse Event|66|||
145315533|NCT01332968|524003899|FG004|Maintenance/Observation Period|Adverse Event|0|||
145315534|NCT01332968|524003900|FG005|Maintenance/Observation Period|Adverse Event|0|||
145315535|NCT01332968|524003901|FG006|Maintenance/Observation Period|Adverse Event|0|||
145315536|NCT01332968|524003902|FG007|Maintenance/Observation Period|Adverse Event|0|||
145315537|NCT01332968|524003895|FG000|Maintenance/Observation Period|Death|0|||
145315538|NCT01332968|524003896|FG001|Maintenance/Observation Period|Death|0|||
145315539|NCT01332968|524003897|FG002|Maintenance/Observation Period|Death|5|||
145315540|NCT01332968|524003898|FG003|Maintenance/Observation Period|Death|6|||
145315541|NCT01332968|524003899|FG004|Maintenance/Observation Period|Death|0|||
145315542|NCT01332968|524003900|FG005|Maintenance/Observation Period|Death|0|||
145315543|NCT01332968|524003901|FG006|Maintenance/Observation Period|Death|0|||
145315544|NCT01332968|524003902|FG007|Maintenance/Observation Period|Death|0|||
145315545|NCT01332968|524003895|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
145315546|NCT01332968|524003896|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
145315547|NCT01332968|524003897|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
145315548|NCT01332968|524003898|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
145315549|NCT01332968|524003899|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
145315550|NCT01332968|524003900|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
145315551|NCT01332968|524003901|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
145315552|NCT01332968|524003902|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
145315553|NCT01332968|524003895|FG000|Maintenance/Observation Period|Non-compliance|0|||
145315554|NCT01332968|524003896|FG001|Maintenance/Observation Period|Non-compliance|0|||
145315555|NCT01332968|524003897|FG002|Maintenance/Observation Period|Non-compliance|4|||
145315556|NCT01332968|524003898|FG003|Maintenance/Observation Period|Non-compliance|3|||
145315557|NCT01332968|524003899|FG004|Maintenance/Observation Period|Non-compliance|0|||
145315558|NCT01332968|524003900|FG005|Maintenance/Observation Period|Non-compliance|0|||
145315559|NCT01332968|524003901|FG006|Maintenance/Observation Period|Non-compliance|0|||
145315560|NCT01332968|524003902|FG007|Maintenance/Observation Period|Non-compliance|0|||
145315561|NCT01332968|524003895|FG000|Maintenance/Observation Period|Other|0|||
145315562|NCT01332968|524003896|FG001|Maintenance/Observation Period|Other|0|||
145315563|NCT01332968|524003897|FG002|Maintenance/Observation Period|Other|4|||
145315564|NCT01332968|524003898|FG003|Maintenance/Observation Period|Other|7|||
145315565|NCT01332968|524003899|FG004|Maintenance/Observation Period|Other|0|||
145315566|NCT01332968|524003900|FG005|Maintenance/Observation Period|Other|0|||
145315567|NCT01332968|524003901|FG006|Maintenance/Observation Period|Other|0|||
145315568|NCT01332968|524003902|FG007|Maintenance/Observation Period|Other|0|||
145315569|NCT01332968|524003895|FG000|Maintenance/Observation Period|Physician Decision|0|||
145315570|NCT01332968|524003896|FG001|Maintenance/Observation Period|Physician Decision|0|||
145315571|NCT01332968|524003897|FG002|Maintenance/Observation Period|Physician Decision|14|||
145315572|NCT01332968|524003898|FG003|Maintenance/Observation Period|Physician Decision|19|||
145315573|NCT01332968|524003899|FG004|Maintenance/Observation Period|Physician Decision|0|||
145315574|NCT01332968|524003900|FG005|Maintenance/Observation Period|Physician Decision|1|||
145315575|NCT01332968|524003901|FG006|Maintenance/Observation Period|Physician Decision|0|||
145315576|NCT01332968|524003902|FG007|Maintenance/Observation Period|Physician Decision|0|||
145315577|NCT01332968|524003895|FG000|Maintenance/Observation Period|Progressive Disease|0|||
145315578|NCT01332968|524003896|FG001|Maintenance/Observation Period|Progressive Disease|0|||
145315579|NCT01332968|524003897|FG002|Maintenance/Observation Period|Progressive Disease|72|||
145315580|NCT01332968|524003898|FG003|Maintenance/Observation Period|Progressive Disease|40|||
145315581|NCT01332968|524003899|FG004|Maintenance/Observation Period|Progressive Disease|0|||
145315582|NCT01332968|524003900|FG005|Maintenance/Observation Period|Progressive Disease|0|||
145315583|NCT01332968|524003901|FG006|Maintenance/Observation Period|Progressive Disease|0|||
145315584|NCT01332968|524003902|FG007|Maintenance/Observation Period|Progressive Disease|0|||
145315585|NCT01332968|524003895|FG000|Maintenance/Observation Period|Protocol Violation|0|||
145315586|NCT01332968|524003896|FG001|Maintenance/Observation Period|Protocol Violation|0|||
145315587|NCT01332968|524003897|FG002|Maintenance/Observation Period|Protocol Violation|1|||
145315588|NCT01332968|524003898|FG003|Maintenance/Observation Period|Protocol Violation|1|||
145315589|NCT01332968|524003899|FG004|Maintenance/Observation Period|Protocol Violation|0|||
145411414|NCT02555878|524360038|FG001|Overall Study|Lost to Follow-up|3|||
145411415|NCT02555878|524360037|FG000|Overall Study|Withdrawal by Subject|48|||
145315590|NCT01332968|524003900|FG005|Maintenance/Observation Period|Protocol Violation|0|||
145315591|NCT01332968|524003901|FG006|Maintenance/Observation Period|Protocol Violation|0|||
145315592|NCT01332968|524003902|FG007|Maintenance/Observation Period|Protocol Violation|0|||
145315593|NCT01332968|524003895|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
145315594|NCT01332968|524003896|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
145315595|NCT01332968|524003897|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
145315596|NCT01332968|524003898|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
145315597|NCT01332968|524003899|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
145569758|NCT05923229|524945798|FG000|Overall Study|Withdrawal by Subject|3|||
145569759|NCT05923229|524945799|FG001|Overall Study|Withdrawal by Subject|0|||
145569760|NCT05923229|524945798|FG000|Overall Study|Health related|2|||
145315598|NCT01332968|524003900|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
145315599|NCT01332968|524003901|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
145315600|NCT01332968|524003902|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
145315601|NCT01332968|524003895|FG000|Follow-Up Period|Adverse Event|0|||
145315602|NCT01332968|524003896|FG001|Follow-Up Period|Adverse Event|0|||
145315603|NCT01332968|524003897|FG002|Follow-Up Period|Adverse Event|0|||
145315604|NCT01332968|524003898|FG003|Follow-Up Period|Adverse Event|0|||
145315605|NCT01332968|524003899|FG004|Follow-Up Period|Adverse Event|0|||
145315606|NCT01332968|524003900|FG005|Follow-Up Period|Adverse Event|0|||
145315607|NCT01332968|524003901|FG006|Follow-Up Period|Adverse Event|0|||
145315608|NCT01332968|524003902|FG007|Follow-Up Period|Adverse Event|4|||
145315609|NCT01332968|524003895|FG000|Follow-Up Period|Death|0|||
145315610|NCT01332968|524003896|FG001|Follow-Up Period|Death|0|||
145315611|NCT01332968|524003897|FG002|Follow-Up Period|Death|0|||
145315612|NCT01332968|524003898|FG003|Follow-Up Period|Death|0|||
145315613|NCT01332968|524003899|FG004|Follow-Up Period|Death|0|||
145315614|NCT01332968|524003900|FG005|Follow-Up Period|Death|0|||
145315615|NCT01332968|524003901|FG006|Follow-Up Period|Death|27|||
145315616|NCT01332968|524003902|FG007|Follow-Up Period|Death|30|||
145315617|NCT01332968|524003895|FG000|Follow-Up Period|Lost to Follow-up|0|||
145315618|NCT01332968|524003896|FG001|Follow-Up Period|Lost to Follow-up|0|||
145315619|NCT01332968|524003897|FG002|Follow-Up Period|Lost to Follow-up|0|||
145315620|NCT01332968|524003898|FG003|Follow-Up Period|Lost to Follow-up|0|||
145315621|NCT01332968|524003899|FG004|Follow-Up Period|Lost to Follow-up|0|||
145315622|NCT01332968|524003900|FG005|Follow-Up Period|Lost to Follow-up|0|||
145315623|NCT01332968|524003901|FG006|Follow-Up Period|Lost to Follow-up|11|||
145315624|NCT01332968|524003902|FG007|Follow-Up Period|Lost to Follow-up|15|||
145315625|NCT01332968|524003895|FG000|Follow-Up Period|Non-compliance|0|||
145315626|NCT01332968|524003896|FG001|Follow-Up Period|Non-compliance|0|||
145315627|NCT01332968|524003897|FG002|Follow-Up Period|Non-compliance|0|||
145315628|NCT01332968|524003898|FG003|Follow-Up Period|Non-compliance|0|||
145315629|NCT01332968|524003899|FG004|Follow-Up Period|Non-compliance|0|||
145315630|NCT01332968|524003900|FG005|Follow-Up Period|Non-compliance|0|||
145315631|NCT01332968|524003901|FG006|Follow-Up Period|Non-compliance|4|||
145315632|NCT01332968|524003902|FG007|Follow-Up Period|Non-compliance|9|||
145315633|NCT01332968|524003895|FG000|Follow-Up Period|Other|0|||
145315634|NCT01332968|524003896|FG001|Follow-Up Period|Other|0|||
145315635|NCT01332968|524003897|FG002|Follow-Up Period|Other|0|||
145315636|NCT01332968|524003898|FG003|Follow-Up Period|Other|0|||
145315637|NCT01332968|524003899|FG004|Follow-Up Period|Other|0|||
145315638|NCT01332968|524003900|FG005|Follow-Up Period|Other|0|||
145315639|NCT01332968|524003901|FG006|Follow-Up Period|Other|18|||
145315640|NCT01332968|524003902|FG007|Follow-Up Period|Other|21|||
145315641|NCT01332968|524003895|FG000|Follow-Up Period|Physician Decision|0|||
145315642|NCT01332968|524003896|FG001|Follow-Up Period|Physician Decision|0|||
145315643|NCT01332968|524003897|FG002|Follow-Up Period|Physician Decision|0|||
145315644|NCT01332968|524003898|FG003|Follow-Up Period|Physician Decision|0|||
145315645|NCT01332968|524003899|FG004|Follow-Up Period|Physician Decision|0|||
145315646|NCT01332968|524003900|FG005|Follow-Up Period|Physician Decision|0|||
145315647|NCT01332968|524003901|FG006|Follow-Up Period|Physician Decision|12|||
145315648|NCT01332968|524003902|FG007|Follow-Up Period|Physician Decision|15|||
145315649|NCT01332968|524003895|FG000|Follow-Up Period|Progressive Disease|0|||
145315650|NCT01332968|524003896|FG001|Follow-Up Period|Progressive Disease|0|||
145315651|NCT01332968|524003897|FG002|Follow-Up Period|Progressive Disease|0|||
145315652|NCT01332968|524003898|FG003|Follow-Up Period|Progressive Disease|0|||
145315653|NCT01332968|524003899|FG004|Follow-Up Period|Progressive Disease|0|||
145315654|NCT01332968|524003900|FG005|Follow-Up Period|Progressive Disease|0|||
145315655|NCT01332968|524003901|FG006|Follow-Up Period|Progressive Disease|126|||
145315656|NCT01332968|524003902|FG007|Follow-Up Period|Progressive Disease|106|||
145315657|NCT01332968|524003895|FG000|Follow-Up Period|Protocol Violation|0|||
145315658|NCT01332968|524003896|FG001|Follow-Up Period|Protocol Violation|0|||
145315659|NCT01332968|524003897|FG002|Follow-Up Period|Protocol Violation|0|||
145315660|NCT01332968|524003898|FG003|Follow-Up Period|Protocol Violation|0|||
145315661|NCT01332968|524003899|FG004|Follow-Up Period|Protocol Violation|0|||
145315662|NCT01332968|524003900|FG005|Follow-Up Period|Protocol Violation|0|||
145411416|NCT02555878|524360038|FG001|Overall Study|Withdrawal by Subject|48|||
145411417|NCT02555878|524360037|FG000|Overall Study|Adverse Event|12|||
145411418|NCT02555878|524360038|FG001|Overall Study|Adverse Event|8|||
145315663|NCT01332968|524003901|FG006|Follow-Up Period|Protocol Violation|1|||
145315664|NCT01332968|524003902|FG007|Follow-Up Period|Protocol Violation|0|||
145315665|NCT01332968|524003895|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145315666|NCT01332968|524003896|FG001|Follow-Up Period|Withdrawal by Subject|0|||
145315667|NCT01332968|524003897|FG002|Follow-Up Period|Withdrawal by Subject|0|||
145411419|NCT02555878|524360037|FG000|Overall Study|Death|74|||
145315668|NCT01332968|524003898|FG003|Follow-Up Period|Withdrawal by Subject|0|||
145315669|NCT01332968|524003899|FG004|Follow-Up Period|Withdrawal by Subject|0|||
145411420|NCT02555878|524360038|FG001|Overall Study|Death|59|||
145411421|NCT02555878|524360037|FG000|Overall Study|Protocol Violation|1|||
145411422|NCT02555878|524360038|FG001|Overall Study|Protocol Violation|2|||
145411423|NCT02555878|524360037|FG000|Overall Study|Physician Decision|12|||
145569761|NCT05923229|524945799|FG001|Overall Study|Health related|1|||
145569762|NCT03064126|524945800|FG000|Overall Study|Death|40|||
145315670|NCT01332968|524003900|FG005|Follow-Up Period|Withdrawal by Subject|0|||
145315671|NCT01332968|524003901|FG006|Follow-Up Period|Withdrawal by Subject|29|||
145315672|NCT01332968|524003902|FG007|Follow-Up Period|Withdrawal by Subject|32|||
145315673|NCT01332968|524003895|FG000|Follow-Up Period|No reason provided|0|||
145315674|NCT01332968|524003896|FG001|Follow-Up Period|No reason provided|0|||
145315675|NCT01332968|524003897|FG002|Follow-Up Period|No reason provided|0|||
145315676|NCT01332968|524003898|FG003|Follow-Up Period|No reason provided|0|||
145315677|NCT01332968|524003899|FG004|Follow-Up Period|No reason provided|0|||
145315678|NCT01332968|524003900|FG005|Follow-Up Period|No reason provided|0|||
145315679|NCT01332968|524003901|FG006|Follow-Up Period|No reason provided|2|||
145315680|NCT01332968|524003902|FG007|Follow-Up Period|No reason provided|3|||
145315681|NCT04010227|524003903|FG000|Overall Study|Death|1|||
145315682|NCT04010227|524003904|FG001|Overall Study|Death|2|||
145315683|NCT04010227|524003903|FG000|Overall Study|Medical Reasons|4|||
145315684|NCT04010227|524003904|FG001|Overall Study|Medical Reasons|3|||
145315685|NCT04010227|524003903|FG000|Overall Study|Withdrawal by Subject|2|||
145315686|NCT04010227|524003904|FG001|Overall Study|Withdrawal by Subject|0|||
145315687|NCT04010227|524003903|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
145315688|NCT04010227|524003904|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
145315689|NCT00702507|524003905|FG000|Initial Treatment Phase|Adverse Event|2|||
145315690|NCT00702507|524003905|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
145315691|NCT00702507|524003905|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
145315692|NCT00702507|524003905|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
145315693|NCT00702507|524003905|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
145315694|NCT00702507|524003905|FG000|Follow-up Phase|Protocol Violation|2|||
145315695|NCT00702507|524003905|FG000|Follow-up Phase|Lost to Follow-up|23|||
145315696|NCT00702507|524003905|FG000|Follow-up Phase|Late Enrollment|1|||
145315697|NCT02308696|524003907|FG000|Overall Study|Lost to Follow-up|28|||
145315698|NCT02308696|524003908|FG001|Overall Study|Lost to Follow-up|21|||
145315699|NCT02308696|524003907|FG000|Overall Study|Death|8|||
145315700|NCT02308696|524003908|FG001|Overall Study|Death|4|||
145315701|NCT02308696|524003907|FG000|Overall Study|Moved to a Higher Level of Care|17|||
145315702|NCT02308696|524003908|FG001|Overall Study|Moved to a Higher Level of Care|6|||
145315703|NCT04768114|524003909|FG000|Overall Study|Lost to Follow-up|5|||
145315704|NCT04768114|524003910|FG001|Overall Study|Lost to Follow-up|10|||
145315705|NCT04768114|524003909|FG000|Overall Study|Withdrawal by Subject|0|||
145315706|NCT04768114|524003910|FG001|Overall Study|Withdrawal by Subject|1|||
145315707|NCT00715676|524003919|FG000|Overall Study|Adverse Event|3|||
145315708|NCT00715676|524003920|FG001|Overall Study|Adverse Event|5|||
145315709|NCT00715676|524003921|FG002|Overall Study|Adverse Event|21|||
145315710|NCT00715676|524003919|FG000|Overall Study|Withdrawal by Subject|1|||
145315711|NCT00715676|524003920|FG001|Overall Study|Withdrawal by Subject|3|||
145315712|NCT00715676|524003921|FG002|Overall Study|Withdrawal by Subject|8|||
145315713|NCT00715676|524003919|FG000|Overall Study|Lost to Follow-up|1|||
145315714|NCT00715676|524003920|FG001|Overall Study|Lost to Follow-up|2|||
145315715|NCT00715676|524003921|FG002|Overall Study|Lost to Follow-up|1|||
145315716|NCT00715676|524003919|FG000|Overall Study|Terminated by Sponsor|1|||
145315717|NCT00715676|524003920|FG001|Overall Study|Terminated by Sponsor|0|||
145315718|NCT00715676|524003921|FG002|Overall Study|Terminated by Sponsor|0|||
145315719|NCT00715676|524003919|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
145315720|NCT00715676|524003920|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
145315721|NCT00715676|524003921|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
145315722|NCT00715676|524003919|FG000|Overall Study|Use of Exclusionary Medication|0|||
145315723|NCT00715676|524003920|FG001|Overall Study|Use of Exclusionary Medication|0|||
145315724|NCT00715676|524003921|FG002|Overall Study|Use of Exclusionary Medication|1|||
145315725|NCT00715676|524003919|FG000|Overall Study|Elevated Blood Glucose|0|||
145315726|NCT00715676|524003920|FG001|Overall Study|Elevated Blood Glucose|1|||
145315727|NCT00715676|524003921|FG002|Overall Study|Elevated Blood Glucose|0|||
145315728|NCT04994431|524003922|FG000|Overall Study|Adverse Event|1|||
145315729|NCT04994431|524003923|FG001|Overall Study|Adverse Event|0|||
145315730|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
145315731|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
145315732|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
145411424|NCT02555878|524360038|FG001|Overall Study|Physician Decision|13|||
145315733|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
145315734|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
145411425|NCT02555878|524360037|FG000|Overall Study|Other|17|||
145315735|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
145315736|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
145315737|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
145315738|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
145315739|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
145315740|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
145315741|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
145315742|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
145315743|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
145315744|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
145315745|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
145315746|NCT01067521|524003925|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
145315747|NCT01067521|524003926|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
145315748|NCT01067521|524003925|FG000|Open-Label Period|Death|3|||
145315749|NCT01067521|524003926|FG001|Open-Label Period|Death|1|||
145315750|NCT01067521|524003925|FG000|Open-Label Period|Adverse Event|30|||
145315751|NCT01067521|524003926|FG001|Open-Label Period|Adverse Event|28|||
145315752|NCT01067521|524003925|FG000|Open-Label Period|Withdrawal by Subject|160|||
145315753|NCT01067521|524003926|FG001|Open-Label Period|Withdrawal by Subject|88|||
145315754|NCT01067521|524003925|FG000|Open-Label Period|Physician Decision|13|||
145315755|NCT01067521|524003926|FG001|Open-Label Period|Physician Decision|11|||
145315756|NCT01067521|524003925|FG000|Open-Label Period|Non-compliance with study drug|5|||
145315757|NCT01067521|524003926|FG001|Open-Label Period|Non-compliance with study drug|0|||
145315758|NCT01067521|524003925|FG000|Open-Label Period|Protocol Violation|3|||
145315759|NCT01067521|524003926|FG001|Open-Label Period|Protocol Violation|0|||
145315760|NCT01067521|524003925|FG000|Open-Label Period|Pregnancy|14|||
145315761|NCT01067521|524003926|FG001|Open-Label Period|Pregnancy|8|||
145315762|NCT01067521|524003925|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
145315763|NCT01067521|524003926|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
145315764|NCT01067521|524003925|FG000|Open-Label Period|Lost to Follow-up|21|||
145315765|NCT01067521|524003926|FG001|Open-Label Period|Lost to Follow-up|20|||
145315766|NCT03419962|524003927|FG000|Overall Study|Change to other medication|1|||
145315767|NCT03419962|524003927|FG000|Overall Study|Refusal of continuing with trial drug|1|||
145315768|NCT03419962|524003927|FG000|Overall Study|Lost to Follow-up|3|||
145315769|NCT03419962|524003927|FG000|Overall Study|Difficulty in inhaling the doses|1|||
145315770|NCT03419962|524003927|FG000|Overall Study|Missing completion data|31|||
145315771|NCT01849458|524003930|FG000|Overall Study|Lost to Follow-up|4|||
145315772|NCT04142658|524003931|FG000|Overall Study|Death|2|||
145315773|NCT04142658|524003932|FG001|Overall Study|Death|1|||
145315774|NCT04142658|524003931|FG000|Overall Study|Lost to Follow-up|4|||
145315775|NCT04142658|524003932|FG001|Overall Study|Lost to Follow-up|13|||
145315776|NCT04142658|524003931|FG000|Overall Study|Withdrawal by Subject|9|||
145315777|NCT04142658|524003932|FG001|Overall Study|Withdrawal by Subject|16|||
145315778|NCT01781234|524003933|FG000|Overall Study|Adverse Event|2|||
145315779|NCT01781234|524003934|FG001|Overall Study|Adverse Event|0|||
145315780|NCT01781234|524003933|FG000|Overall Study|Protocol Violation|3|||
145315781|NCT01781234|524003934|FG001|Overall Study|Protocol Violation|0|||
145315782|NCT01781234|524003933|FG000|Overall Study|Withdrawal by Subject|4|||
145315783|NCT01781234|524003934|FG001|Overall Study|Withdrawal by Subject|3|||
145315784|NCT00830167|524003935|FG000|Overall Study|Lack of Efficacy|26|||
145315785|NCT00830167|524003936|FG001|Overall Study|Lack of Efficacy|10|||
145315786|NCT00830167|524003935|FG000|Overall Study|Adverse Event|8|||
145315787|NCT00830167|524003936|FG001|Overall Study|Adverse Event|24|||
145315788|NCT00830167|524003935|FG000|Overall Study|Not meeting entrance criteria|2|||
145315789|NCT00830167|524003936|FG001|Overall Study|Not meeting entrance criteria|5|||
145315790|NCT00830167|524003935|FG000|Overall Study|Withdrawal by Subject|2|||
145315791|NCT00830167|524003936|FG001|Overall Study|Withdrawal by Subject|0|||
145315792|NCT00830167|524003935|FG000|Overall Study|Lost to Follow-up|0|||
145315793|NCT00830167|524003936|FG001|Overall Study|Lost to Follow-up|1|||
145315794|NCT00830167|524003935|FG000|Overall Study|Protocol Violation|0|||
145315795|NCT00830167|524003936|FG001|Overall Study|Protocol Violation|1|||
145315796|NCT00830167|524003935|FG000|Overall Study|Other|2|||
145315797|NCT00830167|524003936|FG001|Overall Study|Other|2|||
145315798|NCT04194008|524003939|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
145315799|NCT04194008|524003939|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
145315800|NCT04194008|524003939|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
145315801|NCT04194008|524003939|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
145315802|NCT04194008|524003939|FG000|Treatment Phase With Nerivio|Missing data|4|||
145315803|NCT04194008|524003939|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
145315804|NCT02522780|524003943|FG000|Overall Study|Consent withdrawn by subject|5|||
145315805|NCT02522780|524003944|FG001|Overall Study|Consent withdrawn by subject|7|||
145315806|NCT02522780|524003943|FG000|Overall Study|Protocol deviation|1|||
145315807|NCT02522780|524003944|FG001|Overall Study|Protocol deviation|3|||
145315808|NCT02522780|524003943|FG000|Overall Study|Subject refused endoscopic procedure|0|||
145315809|NCT02522780|524003944|FG001|Overall Study|Subject refused endoscopic procedure|1|||
145315810|NCT02522780|524003943|FG000|Overall Study|Adverse event, non-fatal|11|||
145315811|NCT02522780|524003944|FG001|Overall Study|Adverse event, non-fatal|16|||
145315812|NCT02260635|524003945|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
145315813|NCT02260635|524003946|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
145315814|NCT02260635|524003945|FG000|Open-Label Extension|Study Termination|25|||
145315815|NCT02260635|524003946|FG001|Open-Label Extension|Study Termination|25|||
145315816|NCT02260635|524003945|FG000|Open-Label Extension|Withdrawal by Subject|1|||
145315817|NCT02260635|524003946|FG001|Open-Label Extension|Withdrawal by Subject|0|||
145315818|NCT00926367|524003947|FG000|Overall Study|Withdrawal by Subject|0|||
145315819|NCT00926367|524003948|FG001|Overall Study|Withdrawal by Subject|1|||
145315820|NCT00926367|524003947|FG000|Overall Study|Lost to Follow-up|1|||
145315821|NCT00926367|524003948|FG001|Overall Study|Lost to Follow-up|0|||
145315822|NCT00926367|524003947|FG000|Overall Study|Skin Irritation|1|||
145315823|NCT00926367|524003948|FG001|Overall Study|Skin Irritation|2|||
145315824|NCT01517867|524003949|FG000|Overall Study|never started treatment|29|||
145315825|NCT01517867|524003950|FG001|Overall Study|never started treatment|32|||
145315826|NCT01517867|524003949|FG000|Overall Study|Withdrawal by Subject|34|||
145315827|NCT01517867|524003950|FG001|Overall Study|Withdrawal by Subject|30|||
145315828|NCT01517867|524003949|FG000|Overall Study|Still in treatment at study end|0|||
145315829|NCT01517867|524003950|FG001|Overall Study|Still in treatment at study end|3|||
145315830|NCT03294317|524003952|FG000|Overall Study|Physician Decision|1|||
145315831|NCT03294317|524003952|FG000|Overall Study|Withdrawal by Subject|6|||
145315832|NCT03294317|524003952|FG000|Overall Study|Lost to Follow-up|1|||
145315833|NCT03294317|524003952|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
145315834|NCT03294317|524003952|FG000|Overall Study|Failed HB lead implant|8|||
145315835|NCT03294317|524003952|FG000|Overall Study|Received CRT instead|1|||
145315836|NCT03294317|524003952|FG000|Overall Study|Exited after lead revision|2|||
145315837|NCT01294449|524003953|FG000|Overall Study|Death|11|||
145315838|NCT01294449|524003954|FG001|Overall Study|Death|12|||
145315839|NCT01294449|524003953|FG000|Overall Study|Withdrawal by Subject|1|||
145315840|NCT01294449|524003954|FG001|Overall Study|Withdrawal by Subject|3|||
145315841|NCT02911935|524003955|FG000|Overall Study|Lost to Follow-up|5|||
145315842|NCT02911935|524003956|FG001|Overall Study|Lost to Follow-up|7|||
145315843|NCT01685216|524003957|FG000|Overall Study|Did not receive study drug|1|||
145315844|NCT01688882|524003958|FG000|Overall Study|Adverse Event|1|||
145315845|NCT01688882|524003959|FG001|Overall Study|Adverse Event|0|||
145315846|NCT01688882|524003958|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145315847|NCT01688882|524003959|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145315848|NCT01688882|524003958|FG000|Overall Study|Administrative problems|1|||
145315849|NCT01688882|524003959|FG001|Overall Study|Administrative problems|0|||
145315850|NCT00124618|524003960|FG000|Overall Study|Ineligible|1|||
145315851|NCT02387762|524003961|FG000|Overall Study|Withdrawal by Subject|1|||
145315852|NCT02387762|524003962|FG001|Overall Study|Withdrawal by Subject|0|||
145315853|NCT00593827|524003963|FG000|Overall Study|On Active Treatment/Pending|0|||
145315854|NCT00593827|524003964|FG001|Overall Study|On Active Treatment/Pending|2|||
145315855|NCT01160640|524003965|FG000|Overall Study|Physician Decision|3|||
145315856|NCT01160640|524003966|FG001|Overall Study|Physician Decision|3|||
145315857|NCT01160640|524003965|FG000|Overall Study|Incarceration|1|||
145315858|NCT01160640|524003966|FG001|Overall Study|Incarceration|0|||
145315859|NCT01160640|524003965|FG000|Overall Study|Withdrawal by Subject|0|||
145315860|NCT01160640|524003966|FG001|Overall Study|Withdrawal by Subject|3|||
145315861|NCT02169336|524003967|FG000|Overall Study|Lack of Efficacy|1|||
145315862|NCT02169336|524003968|FG001|Overall Study|Lack of Efficacy|1|||
145315863|NCT02169336|524003969|FG002|Overall Study|Lack of Efficacy|0|||
145315864|NCT02169336|524003967|FG000|Overall Study|Adverse Event|2|||
145315865|NCT02169336|524003968|FG001|Overall Study|Adverse Event|3|||
145315866|NCT02169336|524003969|FG002|Overall Study|Adverse Event|1|||
145315867|NCT02169336|524003967|FG000|Overall Study|Withdrawal by Subject|1|||
145315868|NCT02169336|524003968|FG001|Overall Study|Withdrawal by Subject|0|||
145315869|NCT02169336|524003969|FG002|Overall Study|Withdrawal by Subject|0|||
145315870|NCT02169336|524003967|FG000|Overall Study|Physician Decision|0|||
145315871|NCT02169336|524003968|FG001|Overall Study|Physician Decision|0|||
145315872|NCT02169336|524003969|FG002|Overall Study|Physician Decision|1|||
145315873|NCT02169336|524003967|FG000|Overall Study|Subject declined to continue dosing|0|||
145315874|NCT02169336|524003968|FG001|Overall Study|Subject declined to continue dosing|0|||
145315875|NCT02169336|524003969|FG002|Overall Study|Subject declined to continue dosing|1|||
145315876|NCT01598896|524003972|FG000|Overall Study|Withdrawal by Subject|0|||
145315877|NCT01598896|524003973|FG001|Overall Study|Withdrawal by Subject|1|||
145315878|NCT01598896|524003972|FG000|Overall Study|Lack of Efficacy|0|||
145315879|NCT01598896|524003973|FG001|Overall Study|Lack of Efficacy|1|||
145315880|NCT03382041|524003974|FG000|Overall Study|Consent Form Lost|2|||
145315881|NCT03382041|524003975|FG001|Overall Study|Consent Form Lost|1|||
145315882|NCT03382041|524003974|FG000|Overall Study|Withdrawal by Subject|1|||
145315883|NCT03382041|524003975|FG001|Overall Study|Withdrawal by Subject|4|||
145315884|NCT03382041|524003974|FG000|Overall Study|Lost to Follow-up|1|||
145315885|NCT03382041|524003975|FG001|Overall Study|Lost to Follow-up|4|||
145315886|NCT01374451|524003976|FG000|Overall Study|Administrative problems|1|||
145315887|NCT01374451|524003977|FG001|Overall Study|Administrative problems|0|||
145315888|NCT00724958|524003980|FG000|Overall Study|Adverse Event|28|||
145315889|NCT00724958|524003980|FG000|Overall Study|Loss of Response|40|||
145315890|NCT00724958|524003980|FG000|Overall Study|No Response|18|||
145569763|NCT03064126|524945801|FG001|Overall Study|Death|16|||
145569764|NCT03064126|524945802|FG002|Overall Study|Death|4|||
145569765|NCT03064126|524945803|FG003|Overall Study|Death|2|||
145569766|NCT03064126|524945800|FG000|Overall Study|Withdrawal by Subject|17|||
145569767|NCT03064126|524945801|FG001|Overall Study|Withdrawal by Subject|9|||
145569768|NCT03064126|524945802|FG002|Overall Study|Withdrawal by Subject|0|||
145569769|NCT03064126|524945803|FG003|Overall Study|Withdrawal by Subject|2|||
145569770|NCT03064126|524945800|FG000|Overall Study|Lost to Follow-up|7|||
145569771|NCT03064126|524945801|FG001|Overall Study|Lost to Follow-up|3|||
145569772|NCT03064126|524945802|FG002|Overall Study|Lost to Follow-up|0|||
145569773|NCT03064126|524945803|FG003|Overall Study|Lost to Follow-up|0|||
145569774|NCT03064126|524945800|FG000|Overall Study|Adverse Event|2|||
145569775|NCT03064126|524945801|FG001|Overall Study|Adverse Event|0|||
145569776|NCT03064126|524945802|FG002|Overall Study|Adverse Event|0|||
145569777|NCT03064126|524945803|FG003|Overall Study|Adverse Event|0|||
145569778|NCT03064126|524945800|FG000|Overall Study|Physician Decision|3|||
145569779|NCT03064126|524945801|FG001|Overall Study|Physician Decision|0|||
145569780|NCT03064126|524945802|FG002|Overall Study|Physician Decision|0|||
145569781|NCT03064126|524945803|FG003|Overall Study|Physician Decision|0|||
145569782|NCT03064126|524945800|FG000|Overall Study|Other reason for early termination|3|||
145569783|NCT03064126|524945801|FG001|Overall Study|Other reason for early termination|2|||
145569784|NCT03064126|524945802|FG002|Overall Study|Other reason for early termination|0|||
145569785|NCT03064126|524945803|FG003|Overall Study|Other reason for early termination|0|||
145569786|NCT03064126|524945800|FG000|Overall Study|Missed Visit|3|||
145569787|NCT03064126|524945801|FG001|Overall Study|Missed Visit|1|||
145569788|NCT03064126|524945802|FG002|Overall Study|Missed Visit|0|||
145569789|NCT03064126|524945803|FG003|Overall Study|Missed Visit|0|||
145315891|NCT00724958|524003980|FG000|Overall Study|Remission|7|||
145315892|NCT00724958|524003980|FG000|Overall Study|Other Reason|76|||
145315893|NCT00724958|524003980|FG000|Overall Study|No documentation for end of therapy|13|||
145315894|NCT00965731|524003981|FG000|Overall Study|Death|0|||
145315895|NCT00965731|524003982|FG001|Overall Study|Death|4|||
145315896|NCT00965731|524003981|FG000|Overall Study|Withdrawal by Subject|0|||
145315897|NCT00965731|524003982|FG001|Overall Study|Withdrawal by Subject|1|||
145315898|NCT00965731|524003981|FG000|Overall Study|Other|7|||
145315899|NCT00965731|524003982|FG001|Overall Study|Other|15|||
145315900|NCT04773600|524003983|FG000|Overall Study|Withdrawal by Subject|15|||
145315901|NCT04773600|524003984|FG001|Overall Study|Withdrawal by Subject|9|||
145315902|NCT04773600|524003983|FG000|Overall Study|Lost to Follow-up|10|||
145315903|NCT04773600|524003984|FG001|Overall Study|Lost to Follow-up|6|||
145315904|NCT04773600|524003983|FG000|Overall Study|Adverse Event|8|||
145315905|NCT04773600|524003984|FG001|Overall Study|Adverse Event|2|||
145315906|NCT04773600|524003983|FG000|Overall Study|Lack of Efficacy|2|||
145315907|NCT04773600|524003984|FG001|Overall Study|Lack of Efficacy|3|||
145315908|NCT04773600|524003983|FG000|Overall Study|Noncompliance|2|||
145315909|NCT04773600|524003984|FG001|Overall Study|Noncompliance|0|||
145315910|NCT04773600|524003983|FG000|Overall Study|Protocol Violation|2|||
145315911|NCT04773600|524003984|FG001|Overall Study|Protocol Violation|0|||
145315912|NCT04773600|524003983|FG000|Overall Study|Physician Decision|0|||
145315913|NCT04773600|524003984|FG001|Overall Study|Physician Decision|1|||
145315914|NCT04773600|524003983|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
145315915|NCT04773600|524003984|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
145315916|NCT04773600|524003983|FG000|Overall Study|Emergency Travel Out of Country|1|||
145315917|NCT04773600|524003984|FG001|Overall Study|Emergency Travel Out of Country|0|||
145315918|NCT02722616|524005982|FG000|Overall Study|Sponsor closed study after one month|2|||
145569790|NCT05288556|524945807|FG000|Overall Study|Protocol Violation|1|||
145569791|NCT05288556|524945807|FG000|Overall Study|Withdrawal by Subject|1|||
145569792|NCT02659020|524945808|FG000|Overall Study|Adverse Event|0|||
145569793|NCT02659020|524945809|FG001|Overall Study|Adverse Event|0|||
145569794|NCT02659020|524945810|FG002|Overall Study|Adverse Event|0|||
145569795|NCT02659020|524945811|FG003|Overall Study|Adverse Event|2|||
145569796|NCT02659020|524945812|FG004|Overall Study|Adverse Event|0|||
145569797|NCT02659020|524945813|FG005|Overall Study|Adverse Event|0|||
145569798|NCT02659020|524945814|FG006|Overall Study|Adverse Event|2|||
145569799|NCT02659020|524945808|FG000|Overall Study|Lost to Follow-up|1|||
145569800|NCT02659020|524945809|FG001|Overall Study|Lost to Follow-up|2|||
145569801|NCT02659020|524945810|FG002|Overall Study|Lost to Follow-up|1|||
145315919|NCT02722616|524005983|FG001|Overall Study|Sponsor closed study after one month|0|||
145315920|NCT02722616|524005984|FG002|Overall Study|Sponsor closed study after one month|0|||
145315921|NCT02031237|524005985|FG000|Overall Study|Death|1|||
145315922|NCT02031237|524005986|FG001|Overall Study|Death|5|||
145315923|NCT02031237|524005987|FG002|Overall Study|Death|0|||
145315924|NCT02031237|524005985|FG000|Overall Study|Physician Decision|0|||
145315925|NCT02031237|524005986|FG001|Overall Study|Physician Decision|1|||
145569802|NCT02659020|524945811|FG003|Overall Study|Lost to Follow-up|6|||
145315926|NCT02031237|524005987|FG002|Overall Study|Physician Decision|0|||
145315927|NCT02031237|524005985|FG000|Overall Study|Withdrawal by Subject|2|||
145315928|NCT02031237|524005986|FG001|Overall Study|Withdrawal by Subject|2|||
145315929|NCT02031237|524005987|FG002|Overall Study|Withdrawal by Subject|0|||
145315930|NCT02031237|524005985|FG000|Overall Study|Protocol Violation|2|||
145315931|NCT02031237|524005986|FG001|Overall Study|Protocol Violation|6|||
145315932|NCT02031237|524005987|FG002|Overall Study|Protocol Violation|0|||
145315933|NCT02031237|524005985|FG000|Overall Study|Alternate Treatment Given|0|||
145315934|NCT02031237|524005986|FG001|Overall Study|Alternate Treatment Given|0|||
145315935|NCT02031237|524005987|FG002|Overall Study|Alternate Treatment Given|3|||
145315936|NCT00676650|524005990|FG000|Overall Study|Death|45|||
145315937|NCT00676650|524005991|FG001|Overall Study|Death|14|||
145315938|NCT00676650|524005990|FG000|Overall Study|Adverse Event|159|||
145315939|NCT00676650|524005991|FG001|Overall Study|Adverse Event|21|||
145315940|NCT00676650|524005990|FG000|Overall Study|Global deterioration of health status|66|||
145315941|NCT00676650|524005991|FG001|Overall Study|Global deterioration of health status|31|||
145315942|NCT00676650|524005990|FG000|Overall Study|Lost to Follow-up|0|||
145315943|NCT00676650|524005991|FG001|Overall Study|Lost to Follow-up|1|||
145315944|NCT00676650|524005990|FG000|Overall Study|Objective progression or relapse|189|||
145315945|NCT00676650|524005991|FG001|Overall Study|Objective progression or relapse|140|||
145315946|NCT00676650|524005990|FG000|Overall Study|Other|14|||
145315947|NCT00676650|524005991|FG001|Overall Study|Other|10|||
145315948|NCT00676650|524005990|FG000|Overall Study|Protocol Violation|3|||
145315949|NCT00676650|524005991|FG001|Overall Study|Protocol Violation|1|||
145315950|NCT00676650|524005990|FG000|Overall Study|Study terminated by sponsor|57|||
145315951|NCT00676650|524005991|FG001|Overall Study|Study terminated by sponsor|43|||
145315952|NCT00676650|524005990|FG000|Overall Study|Withdrawal by Subject|48|||
145315953|NCT00676650|524005991|FG001|Overall Study|Withdrawal by Subject|24|||
145315954|NCT00676650|524005990|FG000|Overall Study|Randomized but not treated|3|||
145315955|NCT00676650|524005991|FG001|Overall Study|Randomized but not treated|4|||
145315956|NCT02297841|524005995|FG000|Overall Study|Withdrawal by Subject|1|||
145315957|NCT02297841|524005995|FG000|Overall Study|Protocol Violation|7|||
145315958|NCT01841060|524005999|FG000|Overall Study|Protocol Violation|10|||
145315959|NCT03303417|524006010|FG000|Overall Study|Withdrawal by Subject|1|||
145315960|NCT03303417|524006011|FG001|Overall Study|Withdrawal by Subject|1|||
145315961|NCT01848210|524006014|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
145315962|NCT01848210|524006015|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
145315963|NCT01848210|524006014|FG000|Overall Study|Lost to Follow-up|24|||
145315964|NCT01848210|524006015|FG001|Overall Study|Lost to Follow-up|12|||
145315965|NCT01848210|524006014|FG000|Overall Study|Protocol Violation|3|||
145315966|NCT01848210|524006015|FG001|Overall Study|Protocol Violation|5|||
145315967|NCT01848210|524006014|FG000|Overall Study|Use of Forbidden Drugs|9|||
145315968|NCT01848210|524006015|FG001|Overall Study|Use of Forbidden Drugs|10|||
145315969|NCT01848210|524006014|FG000|Overall Study|Impedition Condition|5|||
145315970|NCT01848210|524006015|FG001|Overall Study|Impedition Condition|9|||
145315971|NCT01848210|524006014|FG000|Overall Study|Adverse Event|7|||
145315972|NCT01848210|524006015|FG001|Overall Study|Adverse Event|9|||
145315973|NCT01848210|524006014|FG000|Overall Study|Discontinuation Criterion|5|||
145315974|NCT01848210|524006015|FG001|Overall Study|Discontinuation Criterion|7|||
145315975|NCT01848210|524006014|FG000|Overall Study|Hypesensitivity|1|||
145315976|NCT01848210|524006015|FG001|Overall Study|Hypesensitivity|0|||
145315977|NCT01848210|524006014|FG000|Overall Study|Hepatic Function Alteration|4|||
145315978|NCT01848210|524006015|FG001|Overall Study|Hepatic Function Alteration|0|||
145315979|NCT01848210|524006014|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
145315980|NCT01848210|524006015|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
145315981|NCT01848210|524006014|FG000|Overall Study|Administrative|1|||
145315982|NCT01848210|524006015|FG001|Overall Study|Administrative|0|||
145315983|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
145315984|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
145315985|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
145315986|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
145315987|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
145411426|NCT02555878|524360038|FG001|Overall Study|Other|17|||
145569803|NCT02659020|524945812|FG004|Overall Study|Lost to Follow-up|1|||
145315988|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
145315989|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
145315990|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
145315991|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
145315992|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
145315993|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
145315994|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
145315995|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
145315996|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
145315997|NCT04592419|524006016|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
145411427|NCT00765076|524360039|FG000|Overall Study|Adverse Event|1|||
145315998|NCT04592419|524006017|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
145315999|NCT04592419|524006016|FG000|Open-Label Extension Period|Adverse Event|1|||
145316000|NCT04592419|524006017|FG001|Open-Label Extension Period|Adverse Event|2|||
145316001|NCT04592419|524006016|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
145316002|NCT04592419|524006017|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
145316003|NCT04592419|524006016|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
145316004|NCT04592419|524006017|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
145316005|NCT04592419|524006016|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
145316006|NCT04592419|524006017|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
145316007|NCT04592419|524006016|FG000|Open-Label Extension Period|Sponsor Request|73|||
145316008|NCT04592419|524006017|FG001|Open-Label Extension Period|Sponsor Request|84|||
145316009|NCT00381849|524006018|FG000|Wash Out|Withdrawal by Subject|0|||
145316010|NCT00381849|524006019|FG001|Wash Out|Withdrawal by Subject|1|||
145316011|NCT01765270|524006023|FG000|Overall Study|Physician Decision|1|||
145316012|NCT01765270|524006024|FG001|Overall Study|Physician Decision|0|||
145316013|NCT01765270|524006023|FG000|Overall Study|Withdrawal by Subject|0|||
145316014|NCT01765270|524006024|FG001|Overall Study|Withdrawal by Subject|1|||
145316015|NCT00329160|524006025|FG000|Overall Study|Adverse Event|27|||
145316016|NCT00329160|524006025|FG000|Overall Study|Withdrawal by Subject|13|||
145316017|NCT00329160|524006025|FG000|Overall Study|Protocol Violation|2|||
145316018|NCT00329160|524006025|FG000|Overall Study|Did not Receive Study Drug|1|||
145316019|NCT00329160|524006025|FG000|Overall Study|Incomplete IVUS|45|||
145316020|NCT00493792|524006026|FG000|Overall Study|Death|55|||
145316021|NCT00493792|524006027|FG001|Overall Study|Death|50|||
145316022|NCT00493792|524006026|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
145316023|NCT00493792|524006027|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
145316024|NCT00685035|524006029|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
145316025|NCT00685035|524006030|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
145316026|NCT04968925|524006034|FG000|Phase I- Period 1|COVID-19 related|0|||
145316027|NCT04968925|524006035|FG001|Phase I- Period 1|COVID-19 related|1|||
145316028|NCT04968925|524006036|FG002|Phase I- Period 1|COVID-19 related|0|||
145316029|NCT04968925|524006037|FG003|Phase I- Period 1|COVID-19 related|0|||
145316030|NCT04968925|524006034|FG000|Phase I- Period 1|Subject enrolled in error|1|||
145316031|NCT04968925|524006035|FG001|Phase I- Period 1|Subject enrolled in error|1|||
145316032|NCT04968925|524006036|FG002|Phase I- Period 1|Subject enrolled in error|0|||
145316033|NCT04968925|524006037|FG003|Phase I- Period 1|Subject enrolled in error|0|||
145316034|NCT04968925|524006034|FG000|Phase II- Period 1|COVID-19 Related|0|||
145316035|NCT04968925|524006035|FG001|Phase II- Period 1|COVID-19 Related|0|||
145316036|NCT04968925|524006036|FG002|Phase II- Period 1|COVID-19 Related|6|||
145316037|NCT04968925|524006037|FG003|Phase II- Period 1|COVID-19 Related|6|||
145316038|NCT04968925|524006034|FG000|Phase II- Period 1|Subject enrolled in error|0|||
145316039|NCT04968925|524006035|FG001|Phase II- Period 1|Subject enrolled in error|0|||
145316040|NCT04968925|524006036|FG002|Phase II- Period 1|Subject enrolled in error|1|||
145316041|NCT04968925|524006037|FG003|Phase II- Period 1|Subject enrolled in error|0|||
145316042|NCT04968925|524006034|FG000|Phase II -Period 2|COVID-19 related|0|||
145316043|NCT04968925|524006035|FG001|Phase II -Period 2|COVID-19 related|0|||
145316044|NCT04968925|524006036|FG002|Phase II -Period 2|COVID-19 related|4|||
145316045|NCT04968925|524006037|FG003|Phase II -Period 2|COVID-19 related|3|||
145316046|NCT04968925|524006034|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
145316047|NCT04968925|524006035|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
145316048|NCT04968925|524006036|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
145316049|NCT04968925|524006037|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
145316050|NCT00996437|524006042|FG000|Overall Study|Death|1|||
145316051|NCT00996437|524006043|FG001|Overall Study|Death|0|||
145316052|NCT00996437|524006042|FG000|Overall Study|Dropped|2|||
145316053|NCT00996437|524006043|FG001|Overall Study|Dropped|2|||
145316054|NCT00996437|524006042|FG000|Overall Study|Missed|2|||
145316055|NCT00996437|524006043|FG001|Overall Study|Missed|5|||
145316056|NCT03653026|524006044|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
145316057|NCT03653026|524006045|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
145316058|NCT03653026|524006046|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
145316059|NCT03653026|524006047|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
145316060|NCT03653026|524006044|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
145316061|NCT03653026|524006045|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
145316062|NCT03653026|524006046|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145316063|NCT03653026|524006047|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145411428|NCT00765076|524360040|FG001|Overall Study|Adverse Event|0|||
145316064|NCT03653026|524006044|FG000|Part 1: Placebo-controlled Period|Other|0|||
145316065|NCT03653026|524006045|FG001|Part 1: Placebo-controlled Period|Other|3|||
145316066|NCT03653026|524006046|FG002|Part 1: Placebo-controlled Period|Other|0|||
145316067|NCT03653026|524006047|FG003|Part 1: Placebo-controlled Period|Other|0|||
145411429|NCT00765076|524360041|FG002|Overall Study|Adverse Event|0|||
145316068|NCT03653026|524006044|FG000|Part 2: Open-label Extension|Adverse Event|0|||
145316069|NCT03653026|524006045|FG001|Part 2: Open-label Extension|Adverse Event|0|||
145316070|NCT03653026|524006046|FG002|Part 2: Open-label Extension|Adverse Event|1|||
145316071|NCT03653026|524006047|FG003|Part 2: Open-label Extension|Adverse Event|1|||
145316072|NCT03653026|524006044|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145316073|NCT03653026|524006045|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
145316074|NCT03653026|524006046|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
145316075|NCT03653026|524006047|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
145316076|NCT03653026|524006044|FG000|Part 2: Open-label Extension|Other|0|||
145316077|NCT03653026|524006045|FG001|Part 2: Open-label Extension|Other|0|||
145316078|NCT03653026|524006046|FG002|Part 2: Open-label Extension|Other|1|||
145316079|NCT03653026|524006047|FG003|Part 2: Open-label Extension|Other|2|||
145316080|NCT02457819|524006053|FG000|Overall Study|reason not given|8|||
145316081|NCT02457819|524006053|FG000|Overall Study|Withdrawal by Subject|24|||
145316082|NCT02457819|524006053|FG000|Overall Study|Protocol Violation|1|||
145316083|NCT02457819|524006053|FG000|Overall Study|non compliance with study drug|4|||
145316084|NCT02457819|524006053|FG000|Overall Study|Lost to Follow-up|10|||
145316085|NCT02457819|524006053|FG000|Overall Study|Lack of Efficacy|19|||
145316086|NCT02457819|524006053|FG000|Overall Study|Adverse Event|33|||
145316087|NCT01933919|524006054|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
145316088|NCT01933919|524006055|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
145316089|NCT01933919|524006054|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
145316090|NCT01933919|524006055|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
145316091|NCT01933919|524006054|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
145316092|NCT01933919|524006055|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
145316093|NCT01933919|524006054|FG000|Open-label Long-term Phase|Adverse Event|2|||
145316094|NCT01933919|524006055|FG001|Open-label Long-term Phase|Adverse Event|0|||
145316095|NCT01933919|524006054|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
145316096|NCT01933919|524006055|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
145316097|NCT01933919|524006054|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
145316098|NCT01933919|524006055|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
145316099|NCT01933919|524006054|FG000|Open-label Long-term Phase|Other|1|||
145316100|NCT01933919|524006055|FG001|Open-label Long-term Phase|Other|2|||
145316101|NCT00852917|524006056|FG000|Overall Study|Adverse Event|13|||
145316102|NCT00852917|524006057|FG001|Overall Study|Adverse Event|20|||
145316103|NCT00852917|524006058|FG002|Overall Study|Adverse Event|35|||
145316104|NCT00852917|524006059|FG003|Overall Study|Adverse Event|17|||
145316105|NCT00852917|524006056|FG000|Overall Study|Lack of Efficacy|21|||
145316106|NCT00852917|524006057|FG001|Overall Study|Lack of Efficacy|11|||
145316107|NCT00852917|524006058|FG002|Overall Study|Lack of Efficacy|11|||
145316108|NCT00852917|524006059|FG003|Overall Study|Lack of Efficacy|47|||
145316109|NCT00852917|524006056|FG000|Overall Study|Withdrawal by Subject|4|||
145316110|NCT00852917|524006057|FG001|Overall Study|Withdrawal by Subject|8|||
145316111|NCT00852917|524006058|FG002|Overall Study|Withdrawal by Subject|10|||
145316112|NCT00852917|524006059|FG003|Overall Study|Withdrawal by Subject|9|||
145316113|NCT00852917|524006056|FG000|Overall Study|Physician Decision|6|||
145316114|NCT00852917|524006057|FG001|Overall Study|Physician Decision|7|||
145316115|NCT00852917|524006058|FG002|Overall Study|Physician Decision|2|||
145316116|NCT00852917|524006059|FG003|Overall Study|Physician Decision|19|||
145316117|NCT00852917|524006056|FG000|Overall Study|Death|0|||
145316118|NCT00852917|524006057|FG001|Overall Study|Death|0|||
145316119|NCT00852917|524006058|FG002|Overall Study|Death|0|||
145316120|NCT00852917|524006059|FG003|Overall Study|Death|1|||
145316121|NCT02161549|524006060|FG000|Overall Study|Physician Decision|6|||
145316122|NCT02161549|524006061|FG001|Overall Study|Physician Decision|2|||
145316123|NCT00979212|524006062|FG000|Overall Study|Protocol Violation|1|||
145316124|NCT00979212|524006063|FG001|Overall Study|Protocol Violation|8|||
145316125|NCT00979212|524006062|FG000|Overall Study|No protocol therapy received|1|||
145316126|NCT00979212|524006063|FG001|Overall Study|No protocol therapy received|0|||
145316127|NCT04886063|524006066|FG000|Overall Study|Adverse Event|50|||
145316128|NCT04886063|524006066|FG000|Overall Study|Lack of Efficacy|31|||
145316129|NCT04886063|524006066|FG000|Overall Study|Withdrawal by Subject|45|||
145316130|NCT04886063|524006066|FG000|Overall Study|Physician Decision|3|||
145316131|NCT04886063|524006066|FG000|Overall Study|Protocol Violation|3|||
145316132|NCT04886063|524006066|FG000|Overall Study|Site closure|4|||
145316133|NCT04886063|524006066|FG000|Overall Study|Nursing home replacement|3|||
145316134|NCT04886063|524006066|FG000|Overall Study|Lost to Follow-up|5|||
145316135|NCT04886063|524006066|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
145316136|NCT04886063|524006066|FG000|Overall Study|>1 reason|20|||
145316137|NCT00177164|524006069|FG000|Overall Study|Protocol Violation|0|||
145316138|NCT00177164|524006070|FG001|Overall Study|Protocol Violation|7|||
145316139|NCT00177164|524006069|FG000|Overall Study|Lost to Follow-up|4|||
145316140|NCT00177164|524006070|FG001|Overall Study|Lost to Follow-up|5|||
145316141|NCT00177164|524006069|FG000|Overall Study|increase in alcohol and drug use|1|||
145316142|NCT00177164|524006070|FG001|Overall Study|increase in alcohol and drug use|2|||
145316143|NCT00177164|524006069|FG000|Overall Study|Adverse Event|1|||
145316144|NCT00177164|524006070|FG001|Overall Study|Adverse Event|0|||
145316145|NCT00177164|524006069|FG000|Overall Study|discharge from hospital|1|||
145316146|NCT00177164|524006070|FG001|Overall Study|discharge from hospital|0|||
145316147|NCT00177164|524006069|FG000|Overall Study|Lack of Efficacy|2|||
145316148|NCT00177164|524006070|FG001|Overall Study|Lack of Efficacy|1|||
145316149|NCT00177164|524006069|FG000|Overall Study|Pregnancy|0|||
145316150|NCT00177164|524006070|FG001|Overall Study|Pregnancy|1|||
145316151|NCT01344018|524006076|FG000|Overall Study|Death|22|||
145316152|NCT01344018|524006077|FG001|Overall Study|Death|25|||
145316153|NCT01344018|524006076|FG000|Overall Study|Lost to Follow-up|4|||
145316154|NCT01344018|524006077|FG001|Overall Study|Lost to Follow-up|7|||
145316155|NCT05070754|524006078|FG000|Overall Study|Withdrawal by Subject|0|||
145316156|NCT05070754|524006079|FG001|Overall Study|Withdrawal by Subject|0|||
145316157|NCT05070754|524006080|FG002|Overall Study|Withdrawal by Subject|0|||
145316158|NCT05070754|524006081|FG003|Overall Study|Withdrawal by Subject|1|||
145316159|NCT05070754|524006078|FG000|Overall Study|Protocol Violation|0|||
145316160|NCT05070754|524006079|FG001|Overall Study|Protocol Violation|0|||
145316161|NCT05070754|524006080|FG002|Overall Study|Protocol Violation|0|||
145316162|NCT05070754|524006081|FG003|Overall Study|Protocol Violation|1|||
145316163|NCT01398787|524006082|FG000|Overall Study|Adverse Event|1|||
145316164|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
145316165|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
145316166|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
145316167|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
145569804|NCT02659020|524945813|FG005|Overall Study|Lost to Follow-up|5|||
145569805|NCT02659020|524945814|FG006|Overall Study|Lost to Follow-up|0|||
145569806|NCT02659020|524945808|FG000|Overall Study|Physician Decision|0|||
145569807|NCT02659020|524945809|FG001|Overall Study|Physician Decision|0|||
145569808|NCT02659020|524945810|FG002|Overall Study|Physician Decision|0|||
145569809|NCT02659020|524945811|FG003|Overall Study|Physician Decision|1|||
145569810|NCT02659020|524945812|FG004|Overall Study|Physician Decision|1|||
145569811|NCT02659020|524945813|FG005|Overall Study|Physician Decision|0|||
145569812|NCT02659020|524945814|FG006|Overall Study|Physician Decision|1|||
145569813|NCT02659020|524945808|FG000|Overall Study|Withdrawal by Subject|2|||
145569814|NCT02659020|524945809|FG001|Overall Study|Withdrawal by Subject|1|||
145569815|NCT02659020|524945810|FG002|Overall Study|Withdrawal by Subject|0|||
145569816|NCT02659020|524945811|FG003|Overall Study|Withdrawal by Subject|3|||
145569817|NCT02659020|524945812|FG004|Overall Study|Withdrawal by Subject|3|||
145569818|NCT02659020|524945813|FG005|Overall Study|Withdrawal by Subject|6|||
145569819|NCT02659020|524945814|FG006|Overall Study|Withdrawal by Subject|3|||
145569820|NCT02659020|524945808|FG000|Overall Study|Progressive Disease|0|||
145569821|NCT02659020|524945809|FG001|Overall Study|Progressive Disease|0|||
145569822|NCT02659020|524945810|FG002|Overall Study|Progressive Disease|0|||
145569823|NCT02659020|524945811|FG003|Overall Study|Progressive Disease|4|||
145569824|NCT02659020|524945812|FG004|Overall Study|Progressive Disease|1|||
145569825|NCT02659020|524945813|FG005|Overall Study|Progressive Disease|0|||
145569826|NCT02659020|524945814|FG006|Overall Study|Progressive Disease|2|||
145569827|NCT02457598|524945815|FG000|Overall Study|Progressive Disease|2|||
145569828|NCT02457598|524945816|FG001|Overall Study|Progressive Disease|2|||
145569829|NCT02457598|524945817|FG002|Overall Study|Progressive Disease|1|||
145569830|NCT02457598|524945818|FG003|Overall Study|Progressive Disease|11|||
145569831|NCT02457598|524945819|FG004|Overall Study|Progressive Disease|7|||
145569832|NCT02457598|524945820|FG005|Overall Study|Progressive Disease|3|||
145569833|NCT02457598|524945821|FG006|Overall Study|Progressive Disease|2|||
145569834|NCT02457598|524945822|FG007|Overall Study|Progressive Disease|1|||
145569835|NCT02457598|524945823|FG008|Overall Study|Progressive Disease|1|||
145569836|NCT02457598|524945824|FG009|Overall Study|Progressive Disease|2|||
145569837|NCT02457598|524945825|FG010|Overall Study|Progressive Disease|45|||
145569838|NCT02457598|524945826|FG011|Overall Study|Progressive Disease|6|||
145569839|NCT02457598|524945827|FG012|Overall Study|Progressive Disease|2|||
145569840|NCT02457598|524945828|FG013|Overall Study|Progressive Disease|2|||
145569841|NCT02457598|524945829|FG014|Overall Study|Progressive Disease|10|||
145569842|NCT02457598|524945830|FG015|Overall Study|Progressive Disease|1|||
145569843|NCT02457598|524945831|FG016|Overall Study|Progressive Disease|1|||
145569844|NCT02457598|524945815|FG000|Overall Study|Investigator's Discretion|0|||
145569845|NCT02457598|524945816|FG001|Overall Study|Investigator's Discretion|2|||
145569846|NCT02457598|524945817|FG002|Overall Study|Investigator's Discretion|2|||
145569847|NCT02457598|524945818|FG003|Overall Study|Investigator's Discretion|2|||
145569848|NCT02457598|524945819|FG004|Overall Study|Investigator's Discretion|0|||
145569849|NCT02457598|524945820|FG005|Overall Study|Investigator's Discretion|0|||
145569850|NCT02457598|524945821|FG006|Overall Study|Investigator's Discretion|0|||
145569851|NCT02457598|524945822|FG007|Overall Study|Investigator's Discretion|1|||
145569852|NCT02457598|524945823|FG008|Overall Study|Investigator's Discretion|2|||
145569853|NCT02457598|524945824|FG009|Overall Study|Investigator's Discretion|0|||
145569854|NCT02457598|524945825|FG010|Overall Study|Investigator's Discretion|10|||
145569855|NCT02457598|524945826|FG011|Overall Study|Investigator's Discretion|2|||
145569856|NCT02457598|524945827|FG012|Overall Study|Investigator's Discretion|2|||
145569857|NCT02457598|524945828|FG013|Overall Study|Investigator's Discretion|1|||
145316168|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
145316169|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
145316170|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
145316171|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
145316172|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
145316173|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Other|1|||
145316174|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Other|4|||
145316175|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Other|5|||
145316176|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
145316177|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
145316178|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
145316179|NCT02725411|524006083|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
145316180|NCT02725411|524006084|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
145316181|NCT02725411|524006085|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
145316182|NCT02725411|524006083|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
145316183|NCT02725411|524006084|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
145316184|NCT02725411|524006085|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
145316185|NCT02725411|524006083|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
145316186|NCT02725411|524006084|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
145316187|NCT02725411|524006085|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
145316188|NCT02725411|524006083|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
145316189|NCT02725411|524006084|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
145316190|NCT02725411|524006085|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
145316191|NCT02725411|524006083|FG000|Follow-up Period (24 Weeks)|Other|1|||
145316192|NCT02725411|524006084|FG001|Follow-up Period (24 Weeks)|Other|4|||
145316193|NCT02725411|524006085|FG002|Follow-up Period (24 Weeks)|Other|2|||
145316194|NCT02725411|524006083|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
145316195|NCT02725411|524006084|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
145316196|NCT02725411|524006085|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
145316197|NCT03847974|524006086|FG000|Overall Study|relocated out of region|3|||
145316198|NCT03847974|524006086|FG000|Overall Study|Withdrawal by Subject|2|||
145316199|NCT03847974|524006086|FG000|Overall Study|Adverse Event|1|||
145316200|NCT04307849|524006087|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
145316201|NCT04307849|524006088|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
145316202|NCT04307849|524006089|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
145316203|NCT04307849|524006090|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
145316204|NCT04307849|524006091|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
145316205|NCT04307849|524006092|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
145316206|NCT04307849|524006087|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145316207|NCT04307849|524006088|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145316208|NCT04307849|524006089|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
145316209|NCT04307849|524006090|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145316210|NCT04307849|524006091|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145316211|NCT04307849|524006092|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
145316212|NCT04307849|524006087|FG000|Overall Study|Family member did not want them to continue|0|||
145316213|NCT04307849|524006088|FG001|Overall Study|Family member did not want them to continue|0|||
145316214|NCT04307849|524006089|FG002|Overall Study|Family member did not want them to continue|1|||
145316215|NCT04307849|524006090|FG003|Overall Study|Family member did not want them to continue|0|||
145316216|NCT04307849|524006091|FG004|Overall Study|Family member did not want them to continue|0|||
145316217|NCT04307849|524006092|FG005|Overall Study|Family member did not want them to continue|0|||
145316218|NCT04307849|524006087|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
145316219|NCT04307849|524006088|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
145316220|NCT04307849|524006089|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
145316221|NCT04307849|524006090|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
145316222|NCT04307849|524006091|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
145316223|NCT04307849|524006092|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
145316224|NCT00603512|524006095|FG000|Overall Study|Adverse Event|0|||
145316225|NCT00603512|524006096|FG001|Overall Study|Adverse Event|2|||
145316226|NCT00603512|524006097|FG002|Overall Study|Adverse Event|4|||
145316227|NCT00603512|524006098|FG003|Overall Study|Adverse Event|4|||
145316228|NCT00603512|524006099|FG004|Overall Study|Adverse Event|2|||
145316229|NCT00603512|524006095|FG000|Overall Study|Lack of Efficacy|0|||
145316230|NCT00603512|524006096|FG001|Overall Study|Lack of Efficacy|1|||
145316231|NCT00603512|524006097|FG002|Overall Study|Lack of Efficacy|0|||
145316232|NCT00603512|524006098|FG003|Overall Study|Lack of Efficacy|0|||
145316233|NCT00603512|524006099|FG004|Overall Study|Lack of Efficacy|1|||
145316234|NCT00603512|524006095|FG000|Overall Study|Other|2|||
145316235|NCT00603512|524006096|FG001|Overall Study|Other|1|||
145316236|NCT00603512|524006097|FG002|Overall Study|Other|0|||
145316237|NCT00603512|524006098|FG003|Overall Study|Other|1|||
145316238|NCT00603512|524006099|FG004|Overall Study|Other|1|||
145316239|NCT00603512|524006095|FG000|Overall Study|Withdrawal by Subject|0|||
145316240|NCT00603512|524006096|FG001|Overall Study|Withdrawal by Subject|0|||
145316241|NCT00603512|524006097|FG002|Overall Study|Withdrawal by Subject|0|||
145316242|NCT00603512|524006098|FG003|Overall Study|Withdrawal by Subject|0|||
145316243|NCT00603512|524006099|FG004|Overall Study|Withdrawal by Subject|1|||
145316244|NCT00603512|524006095|FG000|Overall Study|Randomized but not treated|0|||
145316245|NCT00603512|524006096|FG001|Overall Study|Randomized but not treated|1|||
145316246|NCT00603512|524006097|FG002|Overall Study|Randomized but not treated|1|||
145316247|NCT00603512|524006098|FG003|Overall Study|Randomized but not treated|2|||
145316248|NCT00603512|524006099|FG004|Overall Study|Randomized but not treated|0|||
145316249|NCT04979858|524006100|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
145316250|NCT04979858|524006101|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
145316251|NCT04253236|524006102|FG000|Overall Study|Adverse Event|1|||
145316252|NCT04253236|524006103|FG001|Overall Study|Adverse Event|0|||
145316253|NCT04253236|524006102|FG000|Overall Study|Safety Concerns|1|||
145316254|NCT04253236|524006103|FG001|Overall Study|Safety Concerns|0|||
145316255|NCT04253236|524006102|FG000|Overall Study|Study Terminated by Sponsor|1|||
145316256|NCT04253236|524006103|FG001|Overall Study|Study Terminated by Sponsor|0|||
145316257|NCT02654015|524006104|FG000|Overall Study|Death|12|||
145316258|NCT02654015|524006104|FG000|Overall Study|Lost to Follow-up|3|||
145316259|NCT01896505|524006107|FG000|Overall Study|Adverse Event|1|||
145316260|NCT01896505|524006108|FG001|Overall Study|Adverse Event|0|||
145316261|NCT01896505|524006109|FG002|Overall Study|Adverse Event|2|||
145316262|NCT01896505|524006110|FG003|Overall Study|Adverse Event|1|||
145316263|NCT01896505|524006111|FG004|Overall Study|Adverse Event|1|||
145316264|NCT01896505|524006112|FG005|Overall Study|Adverse Event|0|||
145316265|NCT01896505|524006107|FG000|Overall Study|Physician Decision|1|||
145316266|NCT01896505|524006108|FG001|Overall Study|Physician Decision|3|||
145316267|NCT01896505|524006109|FG002|Overall Study|Physician Decision|2|||
145316268|NCT01896505|524006110|FG003|Overall Study|Physician Decision|0|||
145316269|NCT01896505|524006111|FG004|Overall Study|Physician Decision|0|||
145316270|NCT01896505|524006112|FG005|Overall Study|Physician Decision|1|||
145316271|NCT01896505|524006107|FG000|Overall Study|Withdrawal by Subject|1|||
145316272|NCT01896505|524006108|FG001|Overall Study|Withdrawal by Subject|0|||
145316273|NCT01896505|524006109|FG002|Overall Study|Withdrawal by Subject|3|||
145316274|NCT01896505|524006110|FG003|Overall Study|Withdrawal by Subject|1|||
145316275|NCT01896505|524006111|FG004|Overall Study|Withdrawal by Subject|0|||
145316276|NCT01896505|524006112|FG005|Overall Study|Withdrawal by Subject|0|||
145316277|NCT01896505|524006107|FG000|Overall Study|Disease Progression|7|||
145316278|NCT01896505|524006108|FG001|Overall Study|Disease Progression|5|||
145316279|NCT01896505|524006109|FG002|Overall Study|Disease Progression|8|||
145316280|NCT01896505|524006110|FG003|Overall Study|Disease Progression|4|||
145316281|NCT01896505|524006111|FG004|Overall Study|Disease Progression|4|||
145316282|NCT01896505|524006112|FG005|Overall Study|Disease Progression|4|||
145316283|NCT01896505|524006107|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
145316284|NCT01896505|524006108|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
145316285|NCT01896505|524006109|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
145316286|NCT01896505|524006110|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
145316287|NCT01896505|524006111|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
145316288|NCT01896505|524006112|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
145316289|NCT01896505|524006107|FG000|Overall Study|Intercurrent illness|0|||
145316290|NCT01896505|524006108|FG001|Overall Study|Intercurrent illness|1|||
145316291|NCT01896505|524006109|FG002|Overall Study|Intercurrent illness|0|||
145316292|NCT01896505|524006110|FG003|Overall Study|Intercurrent illness|0|||
145316293|NCT01896505|524006111|FG004|Overall Study|Intercurrent illness|0|||
145316294|NCT01896505|524006112|FG005|Overall Study|Intercurrent illness|0|||
145316295|NCT01896505|524006107|FG000|Overall Study|Death|0|||
145316296|NCT01896505|524006108|FG001|Overall Study|Death|0|||
145316297|NCT01896505|524006109|FG002|Overall Study|Death|1|||
145316298|NCT01896505|524006110|FG003|Overall Study|Death|1|||
145316299|NCT01896505|524006111|FG004|Overall Study|Death|0|||
145620382|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
145620383|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
145316300|NCT01896505|524006112|FG005|Overall Study|Death|1|||
145316301|NCT02466386|524006113|FG000|Overall Study|Adverse Event|5|||
145316302|NCT02466386|524006113|FG000|Overall Study|Protocol Violation|2|||
145316303|NCT02466386|524006113|FG000|Overall Study|Withdrawal by Subject|14|||
145316304|NCT02466386|524006113|FG000|Overall Study|Lost to Follow-up|5|||
145316305|NCT02466386|524006113|FG000|Overall Study|Lack of Efficacy|8|||
145316306|NCT02466386|524006113|FG000|Overall Study|Other|10|||
145316307|NCT05317195|524006114|FG000|Randomization|Withdrawal by Subject|1|||
145316308|NCT05317195|524006114|FG000|Randomization|Discontinued|6|||
145316309|NCT05317195|524006114|FG000|Admission|Withdrawal by Subject|2|||
145316310|NCT00889252|524006115|FG000|Overall Study|Adverse Event|2|||
145316311|NCT00889252|524006116|FG001|Overall Study|Adverse Event|4|||
145316312|NCT00889252|524006115|FG000|Overall Study|Withdrawal by Subject|3|||
145316313|NCT00889252|524006116|FG001|Overall Study|Withdrawal by Subject|0|||
145316314|NCT00889252|524006115|FG000|Overall Study|Protocol Violation|2|||
145316315|NCT00889252|524006116|FG001|Overall Study|Protocol Violation|0|||
145316316|NCT02212457|524006117|FG000|Overall Study|Adverse Event|1|||
145316317|NCT02212457|524006118|FG001|Overall Study|Adverse Event|2|||
145316318|NCT02212457|524006119|FG002|Overall Study|Adverse Event|2|||
145316319|NCT02212457|524006120|FG003|Overall Study|Adverse Event|2|||
145316320|NCT02212457|524006121|FG004|Overall Study|Adverse Event|0|||
145316321|NCT02212457|524006122|FG005|Overall Study|Adverse Event|1|||
145316322|NCT02212457|524006117|FG000|Overall Study|Withdrawal by Subject|8|||
145316323|NCT02212457|524006118|FG001|Overall Study|Withdrawal by Subject|10|||
145316324|NCT02212457|524006119|FG002|Overall Study|Withdrawal by Subject|8|||
145316325|NCT02212457|524006120|FG003|Overall Study|Withdrawal by Subject|6|||
145316326|NCT02212457|524006121|FG004|Overall Study|Withdrawal by Subject|5|||
145316327|NCT02212457|524006122|FG005|Overall Study|Withdrawal by Subject|4|||
145316328|NCT02212457|524006117|FG000|Overall Study|Lost to Follow-up|6|||
145316329|NCT02212457|524006118|FG001|Overall Study|Lost to Follow-up|7|||
145316330|NCT02212457|524006119|FG002|Overall Study|Lost to Follow-up|4|||
145316331|NCT02212457|524006120|FG003|Overall Study|Lost to Follow-up|1|||
145316332|NCT02212457|524006121|FG004|Overall Study|Lost to Follow-up|8|||
145316333|NCT02212457|524006122|FG005|Overall Study|Lost to Follow-up|4|||
145316334|NCT02212457|524006117|FG000|Overall Study|Protocol Violation|2|||
145316335|NCT02212457|524006118|FG001|Overall Study|Protocol Violation|1|||
145316336|NCT02212457|524006119|FG002|Overall Study|Protocol Violation|0|||
145316337|NCT02212457|524006120|FG003|Overall Study|Protocol Violation|1|||
145316338|NCT02212457|524006121|FG004|Overall Study|Protocol Violation|2|||
145316339|NCT02212457|524006122|FG005|Overall Study|Protocol Violation|3|||
145316340|NCT02212457|524006117|FG000|Overall Study|Other|2|||
145316341|NCT02212457|524006118|FG001|Overall Study|Other|1|||
145316342|NCT02212457|524006119|FG002|Overall Study|Other|2|||
145316343|NCT02212457|524006120|FG003|Overall Study|Other|1|||
145316344|NCT02212457|524006121|FG004|Overall Study|Other|0|||
145316345|NCT02212457|524006122|FG005|Overall Study|Other|1|||
145316346|NCT00393705|524006123|FG000|Overall Study|Adverse Event|0|||
145316347|NCT00393705|524006124|FG001|Overall Study|Adverse Event|2|||
145316348|NCT00393705|524006123|FG000|Overall Study|Death|0|||
145316349|NCT00393705|524006124|FG001|Overall Study|Death|1|||
145316350|NCT00393705|524006123|FG000|Overall Study|Lost to Follow-up|2|||
145316351|NCT00393705|524006124|FG001|Overall Study|Lost to Follow-up|2|||
145316352|NCT00393705|524006123|FG000|Overall Study|Entry Criteria Not Met|10|||
145316353|NCT00393705|524006124|FG001|Overall Study|Entry Criteria Not Met|10|||
145316354|NCT00393705|524006123|FG000|Overall Study|Protocol Violation|4|||
145316355|NCT00393705|524006124|FG001|Overall Study|Protocol Violation|3|||
145316356|NCT00393705|524006123|FG000|Overall Study|Withdrawal by Subject|5|||
145316357|NCT00393705|524006124|FG001|Overall Study|Withdrawal by Subject|3|||
145316358|NCT00393705|524006123|FG000|Overall Study|Physician Decision|2|||
145316359|NCT00393705|524006124|FG001|Overall Study|Physician Decision|2|||
145316360|NCT01120691|524006127|FG000|Overall Study|Adverse Event|59|||
145316361|NCT01120691|524006128|FG001|Overall Study|Adverse Event|67|||
145316362|NCT01120691|524006129|FG002|Overall Study|Adverse Event|47|||
145316363|NCT01120691|524006127|FG000|Overall Study|Subject withdrew consent|33|||
145316364|NCT01120691|524006128|FG001|Overall Study|Subject withdrew consent|50|||
145316365|NCT01120691|524006129|FG002|Overall Study|Subject withdrew consent|44|||
145316366|NCT01120691|524006127|FG000|Overall Study|Death|21|||
145316367|NCT01120691|524006128|FG001|Overall Study|Death|22|||
145316368|NCT01120691|524006129|FG002|Overall Study|Death|24|||
145316369|NCT01120691|524006127|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
145316370|NCT01120691|524006128|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
145316371|NCT01120691|524006129|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
145316372|NCT01120691|524006127|FG000|Overall Study|Administrative problems|15|||
145316373|NCT01120691|524006128|FG001|Overall Study|Administrative problems|8|||
145411430|NCT00765076|524360039|FG000|Overall Study|Withdrawal by Subject|0|||
145411431|NCT00765076|524360040|FG001|Overall Study|Withdrawal by Subject|0|||
145411432|NCT00765076|524360041|FG002|Overall Study|Withdrawal by Subject|1|||
145411433|NCT01163617|524360042|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145316374|NCT01120691|524006129|FG002|Overall Study|Administrative problems|9|||
145316375|NCT01120691|524006127|FG000|Overall Study|Protocol deviation|13|||
145316376|NCT01120691|524006128|FG001|Overall Study|Protocol deviation|12|||
145316377|NCT01120691|524006129|FG002|Overall Study|Protocol deviation|12|||
145316378|NCT01120691|524006127|FG000|Overall Study|Lost to Follow-up|5|||
145316379|NCT01120691|524006128|FG001|Overall Study|Lost to Follow-up|6|||
145316380|NCT01120691|524006129|FG002|Overall Study|Lost to Follow-up|4|||
145316381|NCT01120691|524006127|FG000|Overall Study|Abnormal test procedure result(s)|3|||
145316382|NCT01120691|524006128|FG001|Overall Study|Abnormal test procedure result(s)|2|||
145316383|NCT01120691|524006129|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145316384|NCT01120691|524006127|FG000|Overall Study|Patient's inability to use the device|3|||
145316385|NCT01120691|524006128|FG001|Overall Study|Patient's inability to use the device|1|||
145316386|NCT01120691|524006129|FG002|Overall Study|Patient's inability to use the device|0|||
145316387|NCT01120691|524006127|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145316388|NCT01120691|524006128|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145316389|NCT01120691|524006129|FG002|Overall Study|Abnormal laboratory value(s)|4|||
145316390|NCT00642811|524006130|FG000|Overall Study|Adverse Event|2|||
145316391|NCT00642811|524006131|FG001|Overall Study|Adverse Event|3|||
145316392|NCT00642811|524006132|FG002|Overall Study|Adverse Event|0|||
145316393|NCT00642811|524006133|FG003|Overall Study|Adverse Event|0|||
145316394|NCT00642811|524006134|FG004|Overall Study|Adverse Event|0|||
145316395|NCT00642811|524006135|FG005|Overall Study|Adverse Event|1|||
145316396|NCT00642811|524006130|FG000|Overall Study|Developement of discontinuation criteria|0|||
145316397|NCT00642811|524006131|FG001|Overall Study|Developement of discontinuation criteria|0|||
145316398|NCT00642811|524006132|FG002|Overall Study|Developement of discontinuation criteria|0|||
145316399|NCT00642811|524006133|FG003|Overall Study|Developement of discontinuation criteria|0|||
145316400|NCT00642811|524006134|FG004|Overall Study|Developement of discontinuation criteria|1|||
145316401|NCT00642811|524006135|FG005|Overall Study|Developement of discontinuation criteria|0|||
145316402|NCT00642811|524006130|FG000|Overall Study|Severe Non-compliance to protocol|1|||
145316403|NCT00642811|524006131|FG001|Overall Study|Severe Non-compliance to protocol|0|||
145316404|NCT00642811|524006132|FG002|Overall Study|Severe Non-compliance to protocol|0|||
145316405|NCT00642811|524006133|FG003|Overall Study|Severe Non-compliance to protocol|0|||
145316406|NCT00642811|524006134|FG004|Overall Study|Severe Non-compliance to protocol|0|||
145316407|NCT00642811|524006135|FG005|Overall Study|Severe Non-compliance to protocol|0|||
145316408|NCT00642811|524006130|FG000|Overall Study|Other|0|||
145316409|NCT00642811|524006131|FG001|Overall Study|Other|1|||
145316410|NCT00642811|524006132|FG002|Overall Study|Other|0|||
145316411|NCT00642811|524006133|FG003|Overall Study|Other|1|||
145316412|NCT00642811|524006134|FG004|Overall Study|Other|0|||
145316413|NCT00642811|524006135|FG005|Overall Study|Other|0|||
145316414|NCT04553406|524006139|FG000|Overall Study|Study Discontinuation|0|||
145316415|NCT04553406|524006140|FG001|Overall Study|Study Discontinuation|1|||
145316416|NCT03370510|524006141|FG000|Overall Study|COVID-19|2|||
145316417|NCT03370510|524006142|FG001|Overall Study|COVID-19|0|||
145316418|NCT00772148|524006143|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
145316419|NCT00772148|524006144|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
145316420|NCT00772148|524006143|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
145316421|NCT00772148|524006144|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
145316422|NCT00772148|524006143|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
145316423|NCT00772148|524006144|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
145316424|NCT00772148|524006143|FG000|Maintenance Phase (Week 52)|Death|2|||
145316425|NCT00772148|524006144|FG001|Maintenance Phase (Week 52)|Death|2|||
145316426|NCT00772148|524006143|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
145316427|NCT00772148|524006144|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
145316428|NCT00772148|524006143|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
145316429|NCT00772148|524006144|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
145316430|NCT00772148|524006143|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
145316431|NCT00772148|524006144|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
145316432|NCT01525628|524006147|FG000|Overall Study|Adverse Event|1|||
145316433|NCT01525628|524006148|FG001|Overall Study|Adverse Event|1|||
145316434|NCT01525628|524006149|FG002|Overall Study|Adverse Event|2|||
145316435|NCT01525628|524006150|FG003|Overall Study|Adverse Event|0|||
145316436|NCT01525628|524006151|FG004|Overall Study|Adverse Event|1|||
145316437|NCT01525628|524006147|FG000|Overall Study|Lack of Efficacy|0|||
145316438|NCT01525628|524006148|FG001|Overall Study|Lack of Efficacy|2|||
145316439|NCT01525628|524006149|FG002|Overall Study|Lack of Efficacy|2|||
145316440|NCT01525628|524006150|FG003|Overall Study|Lack of Efficacy|1|||
145316441|NCT01525628|524006151|FG004|Overall Study|Lack of Efficacy|2|||
145316442|NCT01525628|524006147|FG000|Overall Study|Protocol Violation|0|||
145316443|NCT01525628|524006148|FG001|Overall Study|Protocol Violation|0|||
145316444|NCT01525628|524006149|FG002|Overall Study|Protocol Violation|1|||
145316445|NCT01525628|524006150|FG003|Overall Study|Protocol Violation|0|||
145316446|NCT01525628|524006151|FG004|Overall Study|Protocol Violation|0|||
145411434|NCT01163617|524360043|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
145316447|NCT01525628|524006147|FG000|Overall Study|Lost to Follow-up|1|||
145316448|NCT01525628|524006148|FG001|Overall Study|Lost to Follow-up|1|||
145316449|NCT01525628|524006149|FG002|Overall Study|Lost to Follow-up|0|||
145411435|NCT01163617|524360044|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145316450|NCT01525628|524006150|FG003|Overall Study|Lost to Follow-up|0|||
145316451|NCT01525628|524006151|FG004|Overall Study|Lost to Follow-up|0|||
145316452|NCT01525628|524006147|FG000|Overall Study|Withdrawal by Subject|0|||
145316453|NCT01525628|524006148|FG001|Overall Study|Withdrawal by Subject|1|||
145316454|NCT01525628|524006149|FG002|Overall Study|Withdrawal by Subject|0|||
145316455|NCT01525628|524006150|FG003|Overall Study|Withdrawal by Subject|0|||
145316456|NCT01525628|524006151|FG004|Overall Study|Withdrawal by Subject|0|||
145316457|NCT01525628|524006147|FG000|Overall Study|Other reason not defined above|0|||
145569858|NCT02457598|524945829|FG014|Overall Study|Investigator's Discretion|5|||
145316458|NCT01525628|524006148|FG001|Overall Study|Other reason not defined above|0|||
145316459|NCT01525628|524006149|FG002|Overall Study|Other reason not defined above|0|||
145316460|NCT01525628|524006150|FG003|Overall Study|Other reason not defined above|3|||
145316461|NCT01525628|524006151|FG004|Overall Study|Other reason not defined above|0|||
145316462|NCT03573336|524006152|FG000|Overall Study|Study terminated|2|||
145316463|NCT03573336|524006153|FG001|Overall Study|Study terminated|4|||
145316464|NCT03573336|524006154|FG002|Overall Study|Study terminated|2|||
145316465|NCT02614898|524006155|FG000|Overall Study|Participated until study termination|10|||
145316466|NCT02614898|524006156|FG001|Overall Study|Participated until study termination|26|||
145316467|NCT02614898|524006155|FG000|Overall Study|Lost to Follow-up|0|||
145316468|NCT02614898|524006156|FG001|Overall Study|Lost to Follow-up|2|||
145316469|NCT02614898|524006155|FG000|Overall Study|Physician Decision|1|||
145316470|NCT02614898|524006156|FG001|Overall Study|Physician Decision|8|||
145316471|NCT02614898|524006155|FG000|Overall Study|Study Terminated by Sponsor|3|||
145316472|NCT02614898|524006156|FG001|Overall Study|Study Terminated by Sponsor|0|||
145316473|NCT02614898|524006155|FG000|Overall Study|Withdrawal by Subject|0|||
145316474|NCT02614898|524006156|FG001|Overall Study|Withdrawal by Subject|2|||
145316475|NCT02614898|524006155|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145316476|NCT02614898|524006156|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145316477|NCT02614898|524006155|FG000|Overall Study|Other-Additional Information Unavailable|0|||
145316478|NCT02614898|524006156|FG001|Overall Study|Other-Additional Information Unavailable|11|||
145316479|NCT02614898|524006155|FG000|Overall Study|Missing|0|||
145316480|NCT02614898|524006156|FG001|Overall Study|Missing|1|||
145316481|NCT00239005|524006157|FG000|Overall Study|Adverse Event|6|||
145316482|NCT00239005|524006158|FG001|Overall Study|Adverse Event|6|||
145316483|NCT00239005|524006157|FG000|Overall Study|Withdrawal by Subject|3|||
145316484|NCT00239005|524006158|FG001|Overall Study|Withdrawal by Subject|4|||
145316485|NCT00239005|524006157|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
145316486|NCT00239005|524006158|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
145316487|NCT00239005|524006157|FG000|Overall Study|Protocol Violation|1|||
145316488|NCT00239005|524006158|FG001|Overall Study|Protocol Violation|0|||
145316489|NCT00239005|524006157|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
145316490|NCT00239005|524006158|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
145316491|NCT00239005|524006157|FG000|Overall Study|Lost to Follow-up|0|||
145316492|NCT00239005|524006158|FG001|Overall Study|Lost to Follow-up|1|||
145316493|NCT00787605|524006159|FG000|Overall Study|Administrative Problems|3|||
145316494|NCT00787605|524006160|FG001|Overall Study|Administrative Problems|0|||
145316495|NCT00787605|524006159|FG000|Overall Study|Adverse Event|14|||
145316496|NCT00787605|524006160|FG001|Overall Study|Adverse Event|25|||
145316497|NCT00787605|524006159|FG000|Overall Study|Lost to Follow-up|3|||
145316498|NCT00787605|524006160|FG001|Overall Study|Lost to Follow-up|6|||
145316499|NCT00787605|524006159|FG000|Overall Study|Protocol Violation|7|||
145316500|NCT00787605|524006160|FG001|Overall Study|Protocol Violation|3|||
145316501|NCT00787605|524006159|FG000|Overall Study|Withdrawal by Subject|6|||
145316502|NCT00787605|524006160|FG001|Overall Study|Withdrawal by Subject|13|||
145316503|NCT00787605|524006159|FG000|Overall Study|Lack of Efficacy|13|||
145316504|NCT00787605|524006160|FG001|Overall Study|Lack of Efficacy|9|||
145316505|NCT00688844|524006161|FG000|Overall Study|Lost to Follow-up|10|||
145316506|NCT01223027|524006163|FG000|Overall Study|Adverse Event|20|||
145316507|NCT01223027|524006164|FG001|Overall Study|Adverse Event|10|||
145316508|NCT01223027|524006163|FG000|Overall Study|Death|42|||
145316509|NCT01223027|524006164|FG001|Overall Study|Death|42|||
145316510|NCT01223027|524006163|FG000|Overall Study|Lost to Follow-up|2|||
145316511|NCT01223027|524006164|FG001|Overall Study|Lost to Follow-up|1|||
145316512|NCT01223027|524006163|FG000|Overall Study|Physician Decision|4|||
145316513|NCT01223027|524006164|FG001|Overall Study|Physician Decision|8|||
145316514|NCT01223027|524006163|FG000|Overall Study|Progressive Disease|167|||
145316515|NCT01223027|524006164|FG001|Overall Study|Progressive Disease|183|||
145316516|NCT01223027|524006163|FG000|Overall Study|Protocol Violation|2|||
145316517|NCT01223027|524006164|FG001|Overall Study|Protocol Violation|1|||
145316518|NCT01223027|524006163|FG000|Overall Study|Subject/guardian decicion|18|||
145316519|NCT01223027|524006164|FG001|Overall Study|Subject/guardian decicion|16|||
145316520|NCT01223027|524006163|FG000|Overall Study|New therapy for study indication|17|||
145316521|NCT01223027|524006164|FG001|Overall Study|New therapy for study indication|8|||
145316522|NCT01223027|524006163|FG000|Overall Study|Study terminated by sponsor|2|||
145316523|NCT01223027|524006164|FG001|Overall Study|Study terminated by sponsor|8|||
145316524|NCT03493919|524006165|FG000|Overall Study|Other|2|||
145316525|NCT03493919|524006166|FG001|Overall Study|Other|0|||
145316526|NCT03493919|524006167|FG002|Overall Study|Other|1|||
145316527|NCT03493919|524006168|FG003|Overall Study|Other|0|||
145316528|NCT03493919|524006165|FG000|Overall Study|Withdrawal by Subject|9|||
145316529|NCT03493919|524006166|FG001|Overall Study|Withdrawal by Subject|3|||
145316530|NCT03493919|524006167|FG002|Overall Study|Withdrawal by Subject|1|||
145316531|NCT03493919|524006168|FG003|Overall Study|Withdrawal by Subject|1|||
145316532|NCT03493919|524006165|FG000|Overall Study|Lost to Follow-up|5|||
145316533|NCT03493919|524006166|FG001|Overall Study|Lost to Follow-up|0|||
145316534|NCT03493919|524006167|FG002|Overall Study|Lost to Follow-up|0|||
145620384|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
145620385|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
145620386|NCT01815736|525123761|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
145620387|NCT01815736|525123762|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
145620388|NCT01815736|525123761|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
145620389|NCT01815736|525123762|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
145620390|NCT01815736|525123761|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
145620391|NCT01815736|525123762|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
145620392|NCT01815736|525123761|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
145620393|NCT01815736|525123762|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
145620394|NCT01815736|525123761|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
145620395|NCT01815736|525123762|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
145620396|NCT01815736|525123761|FG000|Extension Treatment Phase- After Week 96|Death|1|||
145620397|NCT01815736|525123762|FG001|Extension Treatment Phase- After Week 96|Death|0|||
145620398|NCT04039503|525123763|FG000|Overall Study|Adverse Event|3|||
145620399|NCT04039503|525123764|FG001|Overall Study|Adverse Event|0|||
145620400|NCT04039503|525123765|FG002|Overall Study|Adverse Event|2|||
145620401|NCT04039503|525123766|FG003|Overall Study|Adverse Event|0|||
145620402|NCT04039503|525123763|FG000|Overall Study|Lost to Follow-up|0|||
145620403|NCT04039503|525123764|FG001|Overall Study|Lost to Follow-up|0|||
145620404|NCT04039503|525123765|FG002|Overall Study|Lost to Follow-up|1|||
145620405|NCT04039503|525123766|FG003|Overall Study|Lost to Follow-up|0|||
145620406|NCT04039503|525123763|FG000|Overall Study|Protocol Violation|0|||
145620407|NCT04039503|525123764|FG001|Overall Study|Protocol Violation|1|||
145620408|NCT04039503|525123765|FG002|Overall Study|Protocol Violation|2|||
145620409|NCT04039503|525123766|FG003|Overall Study|Protocol Violation|1|||
145620410|NCT04039503|525123763|FG000|Overall Study|Withdrawal by Subject|4|||
145620411|NCT04039503|525123764|FG001|Overall Study|Withdrawal by Subject|3|||
145620412|NCT04039503|525123765|FG002|Overall Study|Withdrawal by Subject|5|||
145620413|NCT04039503|525123766|FG003|Overall Study|Withdrawal by Subject|2|||
145620414|NCT03387514|525123768|FG000|Overall Study|Withdrawal by Subject|2|||
145620415|NCT03387514|525123768|FG000|Overall Study|Physician Decision|1|||
145620416|NCT03387514|525123768|FG000|Overall Study|Lost to Follow-up|2|||
145620417|NCT02846558|525123779|FG000|Overall Study|Adverse Event|1|||
145620418|NCT02846558|525123780|FG001|Overall Study|Adverse Event|0|||
145620419|NCT02846558|525123781|FG002|Overall Study|Adverse Event|0|||
145620420|NCT02846558|525123782|FG003|Overall Study|Adverse Event|0|||
145620421|NCT02846558|525123779|FG000|Overall Study|Withdrawal by Subject|5|||
145620422|NCT02846558|525123780|FG001|Overall Study|Withdrawal by Subject|4|||
145620423|NCT02846558|525123781|FG002|Overall Study|Withdrawal by Subject|2|||
145620424|NCT02846558|525123782|FG003|Overall Study|Withdrawal by Subject|2|||
145620425|NCT02846558|525123779|FG000|Overall Study|Lost to Follow-up|2|||
145316535|NCT03493919|524006168|FG003|Overall Study|Lost to Follow-up|3|||
145316536|NCT03493919|524006165|FG000|Overall Study|Adverse Event|0|||
145316537|NCT03493919|524006166|FG001|Overall Study|Adverse Event|1|||
145316538|NCT03493919|524006167|FG002|Overall Study|Adverse Event|0|||
145316539|NCT03493919|524006168|FG003|Overall Study|Adverse Event|0|||
145316540|NCT01977456|524006170|FG000|Overall Study|Death|5|||
145316541|NCT04982445|524008271|FG000|Overall Study|Protocol Violation|1|||
145316542|NCT04982445|524008271|FG000|Overall Study|Withdrawal by Subject|4|||
145316543|NCT04982445|524008271|FG000|Overall Study|Lost to Follow-up|1|||
145316544|NCT00651183|524008272|FG000|Overall Study|Lack of Efficacy|1|||
145316545|NCT00651183|524008273|FG001|Overall Study|Lack of Efficacy|0|||
145316546|NCT00651183|524008272|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
145316547|NCT00651183|524008273|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
145316548|NCT00651183|524008272|FG000|Overall Study|Tolerability insufficient|5|||
145316549|NCT00651183|524008273|FG001|Overall Study|Tolerability insufficient|2|||
145316550|NCT00651183|524008272|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
145316551|NCT00651183|524008273|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
145316552|NCT00651183|524008272|FG000|Overall Study|Withdrawal by Subject|6|||
145316553|NCT00651183|524008273|FG001|Overall Study|Withdrawal by Subject|3|||
145316554|NCT00651183|524008272|FG000|Overall Study|Lost to Follow-up|3|||
145316555|NCT00651183|524008273|FG001|Overall Study|Lost to Follow-up|1|||
145316556|NCT00651183|524008272|FG000|Overall Study|Other reasons|4|||
145316557|NCT00651183|524008273|FG001|Overall Study|Other reasons|2|||
145316558|NCT00651183|524008272|FG000|Overall Study|missing|1|||
145316559|NCT00651183|524008273|FG001|Overall Study|missing|0|||
145316560|NCT00763555|524008279|FG000|Overall Study|Adverse Event|2|||
145316561|NCT00763555|524008280|FG001|Overall Study|Adverse Event|1|||
145316562|NCT00763555|524008279|FG000|Overall Study|Withdrawal by Subject|2|||
145316563|NCT00763555|524008280|FG001|Overall Study|Withdrawal by Subject|6|||
145316564|NCT00763555|524008279|FG000|Overall Study|Lost to Follow-up|0|||
145316565|NCT00763555|524008280|FG001|Overall Study|Lost to Follow-up|3|||
145316566|NCT02510261|524008282|FG000|Overall Study|Adverse Event|5|||
145316567|NCT02510261|524008283|FG001|Overall Study|Adverse Event|8|||
145316568|NCT02510261|524008284|FG002|Overall Study|Adverse Event|0|||
145316569|NCT02510261|524008282|FG000|Overall Study|Physician Decision|1|||
145316570|NCT02510261|524008283|FG001|Overall Study|Physician Decision|5|||
145316571|NCT02510261|524008284|FG002|Overall Study|Physician Decision|0|||
145316572|NCT02510261|524008282|FG000|Overall Study|Death|19|||
145316573|NCT02510261|524008283|FG001|Overall Study|Death|19|||
145316574|NCT02510261|524008284|FG002|Overall Study|Death|0|||
145316575|NCT02510261|524008282|FG000|Overall Study|Withdrawal by Subject|3|||
145316576|NCT02510261|524008283|FG001|Overall Study|Withdrawal by Subject|10|||
145316577|NCT02510261|524008284|FG002|Overall Study|Withdrawal by Subject|3|||
145316578|NCT01190930|524008288|FG000|Induction|Adverse Event|17|||
145316579|NCT01190930|524008289|FG001|Induction|Adverse Event|0|||
145316580|NCT01190930|524008290|FG002|Induction|Adverse Event|0|||
145316581|NCT01190930|524008291|FG003|Induction|Adverse Event|0|||
145316582|NCT01190930|524008292|FG004|Induction|Adverse Event|0|||
145316583|NCT01190930|524008293|FG005|Induction|Adverse Event|0|||
145316584|NCT01190930|524008294|FG006|Induction|Adverse Event|0|||
145316585|NCT01190930|524008295|FG007|Induction|Adverse Event|0|||
145316586|NCT01190930|524008296|FG008|Induction|Adverse Event|0|||
145316587|NCT01190930|524008297|FG009|Induction|Adverse Event|0|||
145316588|NCT01190930|524008288|FG000|Induction|Death|34|||
145316589|NCT01190930|524008289|FG001|Induction|Death|0|||
145411436|NCT01163617|524360045|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145411437|NCT01163617|524360046|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145411438|NCT01163617|524360047|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145316590|NCT01190930|524008290|FG002|Induction|Death|0|||
145316591|NCT01190930|524008291|FG003|Induction|Death|0|||
145316592|NCT01190930|524008292|FG004|Induction|Death|0|||
145316593|NCT01190930|524008293|FG005|Induction|Death|0|||
145316594|NCT01190930|524008294|FG006|Induction|Death|0|||
145316595|NCT01190930|524008295|FG007|Induction|Death|0|||
145316596|NCT01190930|524008296|FG008|Induction|Death|0|||
145316597|NCT01190930|524008297|FG009|Induction|Death|0|||
145316598|NCT01190930|524008288|FG000|Induction|Lost to Follow-up|1|||
145316599|NCT01190930|524008289|FG001|Induction|Lost to Follow-up|0|||
145316600|NCT01190930|524008290|FG002|Induction|Lost to Follow-up|0|||
145316601|NCT01190930|524008291|FG003|Induction|Lost to Follow-up|0|||
145316602|NCT01190930|524008292|FG004|Induction|Lost to Follow-up|0|||
145316603|NCT01190930|524008293|FG005|Induction|Lost to Follow-up|0|||
145411439|NCT01163617|524360048|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145411440|NCT01163617|524360049|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
145411441|NCT01163617|524360042|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411442|NCT01163617|524360043|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
145411443|NCT01163617|524360044|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411444|NCT01163617|524360045|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411445|NCT01163617|524360046|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411446|NCT01163617|524360047|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411447|NCT01163617|524360048|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411448|NCT01163617|524360049|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
145411449|NCT01163617|524360042|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411450|NCT01163617|524360043|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411451|NCT01163617|524360044|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
145411452|NCT01163617|524360045|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411453|NCT01163617|524360046|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411454|NCT01163617|524360047|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411455|NCT01163617|524360048|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411456|NCT01163617|524360049|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
145411457|NCT02394756|524360050|FG000|Period 1|Lens Discomfort|0|||
145411458|NCT02394756|524360051|FG001|Period 1|Lens Discomfort|0|||
145411459|NCT02394756|524360052|FG002|Period 1|Lens Discomfort|0|||
145411460|NCT02394756|524360053|FG003|Period 1|Lens Discomfort|0|||
145411461|NCT02394756|524360054|FG004|Period 1|Lens Discomfort|0|||
145411462|NCT02394756|524360055|FG005|Period 1|Lens Discomfort|1|||
145411463|NCT02394756|524360050|FG000|Period 1|Withdrawal by Subject|0|||
145411464|NCT02394756|524360051|FG001|Period 1|Withdrawal by Subject|1|||
145411465|NCT02394756|524360052|FG002|Period 1|Withdrawal by Subject|1|||
145411466|NCT02394756|524360053|FG003|Period 1|Withdrawal by Subject|1|||
145411467|NCT02394756|524360054|FG004|Period 1|Withdrawal by Subject|0|||
145411468|NCT02394756|524360055|FG005|Period 1|Withdrawal by Subject|0|||
145411469|NCT02394756|524360050|FG000|Period 2|Unsatisfactory Visual Response|0|||
145411470|NCT02394756|524360051|FG001|Period 2|Unsatisfactory Visual Response|0|||
145411471|NCT02394756|524360052|FG002|Period 2|Unsatisfactory Visual Response|0|||
145411472|NCT02394756|524360053|FG003|Period 2|Unsatisfactory Visual Response|0|||
145411473|NCT02394756|524360054|FG004|Period 2|Unsatisfactory Visual Response|1|||
145411474|NCT02394756|524360055|FG005|Period 2|Unsatisfactory Visual Response|0|||
145569859|NCT02457598|524945830|FG015|Overall Study|Investigator's Discretion|0|||
145569860|NCT02457598|524945831|FG016|Overall Study|Investigator's Discretion|0|||
145569861|NCT02457598|524945815|FG000|Overall Study|Study Terminated by Sponsor|0|||
145569862|NCT02457598|524945816|FG001|Overall Study|Study Terminated by Sponsor|1|||
145569863|NCT02457598|524945817|FG002|Overall Study|Study Terminated by Sponsor|0|||
145569864|NCT02457598|524945818|FG003|Overall Study|Study Terminated by Sponsor|4|||
145569865|NCT02457598|524945819|FG004|Overall Study|Study Terminated by Sponsor|1|||
145569866|NCT02457598|524945820|FG005|Overall Study|Study Terminated by Sponsor|0|||
145569867|NCT02457598|524945821|FG006|Overall Study|Study Terminated by Sponsor|1|||
145569868|NCT02457598|524945822|FG007|Overall Study|Study Terminated by Sponsor|0|||
145569869|NCT02457598|524945823|FG008|Overall Study|Study Terminated by Sponsor|0|||
145569870|NCT02457598|524945824|FG009|Overall Study|Study Terminated by Sponsor|0|||
145569871|NCT02457598|524945825|FG010|Overall Study|Study Terminated by Sponsor|4|||
145569872|NCT02457598|524945826|FG011|Overall Study|Study Terminated by Sponsor|0|||
145569873|NCT02457598|524945827|FG012|Overall Study|Study Terminated by Sponsor|1|||
145569874|NCT02457598|524945828|FG013|Overall Study|Study Terminated by Sponsor|0|||
145569875|NCT02457598|524945829|FG014|Overall Study|Study Terminated by Sponsor|8|||
145569876|NCT02457598|524945830|FG015|Overall Study|Study Terminated by Sponsor|1|||
145569877|NCT02457598|524945831|FG016|Overall Study|Study Terminated by Sponsor|0|||
145569878|NCT02457598|524945815|FG000|Overall Study|Adverse Event|0|||
145569879|NCT02457598|524945816|FG001|Overall Study|Adverse Event|1|||
145411475|NCT01164475|524360056|FG000|Overall Study|Lack of Efficacy|1|||
145411476|NCT01164475|524360057|FG001|Overall Study|Lack of Efficacy|0|||
145411477|NCT01164475|524360056|FG000|Overall Study|Other|0|||
145411478|NCT01164475|524360057|FG001|Overall Study|Other|1|||
145411479|NCT01164475|524360056|FG000|Overall Study|Progressive disease|0|||
145411480|NCT01164475|524360057|FG001|Overall Study|Progressive disease|1|||
145411481|NCT01164475|524360056|FG000|Overall Study|Protocol Violation|1|||
145411482|NCT01164475|524360057|FG001|Overall Study|Protocol Violation|0|||
145411483|NCT02335944|524360058|FG000|Treatment Phase|Progressive Disease|2|||
145411484|NCT02335944|524360059|FG001|Treatment Phase|Progressive Disease|5|||
145411485|NCT02335944|524360060|FG002|Treatment Phase|Progressive Disease|2|||
145411486|NCT02335944|524360061|FG003|Treatment Phase|Progressive Disease|11|||
145411487|NCT02335944|524360062|FG004|Treatment Phase|Progressive Disease|4|||
145411488|NCT02335944|524360063|FG005|Treatment Phase|Progressive Disease|25|||
145411489|NCT02335944|524360064|FG006|Treatment Phase|Progressive Disease|2|||
145411490|NCT02335944|524360065|FG007|Treatment Phase|Progressive Disease|30|||
145411491|NCT02335944|524360066|FG008|Treatment Phase|Progressive Disease|27|||
145411492|NCT02335944|524360067|FG009|Treatment Phase|Progressive Disease|0|||
145411493|NCT02335944|524360058|FG000|Treatment Phase|Adverse Event|2|||
145411494|NCT02335944|524360059|FG001|Treatment Phase|Adverse Event|0|||
145411495|NCT02335944|524360060|FG002|Treatment Phase|Adverse Event|0|||
145411496|NCT02335944|524360061|FG003|Treatment Phase|Adverse Event|2|||
145411497|NCT02335944|524360062|FG004|Treatment Phase|Adverse Event|1|||
145411498|NCT02335944|524360063|FG005|Treatment Phase|Adverse Event|15|||
145411499|NCT02335944|524360064|FG006|Treatment Phase|Adverse Event|0|||
145411500|NCT02335944|524360065|FG007|Treatment Phase|Adverse Event|5|||
145411501|NCT02335944|524360066|FG008|Treatment Phase|Adverse Event|7|||
145411502|NCT02335944|524360067|FG009|Treatment Phase|Adverse Event|0|||
145411503|NCT02335944|524360058|FG000|Treatment Phase|Physician Decision|0|||
145411504|NCT02335944|524360059|FG001|Treatment Phase|Physician Decision|0|||
145411505|NCT02335944|524360060|FG002|Treatment Phase|Physician Decision|0|||
145411506|NCT02335944|524360061|FG003|Treatment Phase|Physician Decision|1|||
145411507|NCT02335944|524360062|FG004|Treatment Phase|Physician Decision|0|||
145411508|NCT02335944|524360063|FG005|Treatment Phase|Physician Decision|6|||
145411509|NCT02335944|524360064|FG006|Treatment Phase|Physician Decision|1|||
145411510|NCT02335944|524360065|FG007|Treatment Phase|Physician Decision|2|||
145411511|NCT02335944|524360066|FG008|Treatment Phase|Physician Decision|1|||
145411512|NCT02335944|524360067|FG009|Treatment Phase|Physician Decision|0|||
145411513|NCT02335944|524360058|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
145411514|NCT02335944|524360059|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
145411515|NCT02335944|524360060|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
145411516|NCT02335944|524360061|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
145569880|NCT02457598|524945817|FG002|Overall Study|Adverse Event|1|||
145569881|NCT02457598|524945818|FG003|Overall Study|Adverse Event|4|||
145411517|NCT02335944|524360062|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
145411518|NCT02335944|524360063|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
145411519|NCT02335944|524360064|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
145411520|NCT02335944|524360065|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
145411521|NCT02335944|524360066|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
145411522|NCT02335944|524360067|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
145569882|NCT02457598|524945819|FG004|Overall Study|Adverse Event|1|||
145411523|NCT02335944|524360058|FG000|Treatment Phase|Subject/Guardian Decision|0|||
145411524|NCT02335944|524360059|FG001|Treatment Phase|Subject/Guardian Decision|0|||
145411525|NCT02335944|524360060|FG002|Treatment Phase|Subject/Guardian Decision|1|||
145411526|NCT02335944|524360061|FG003|Treatment Phase|Subject/Guardian Decision|0|||
145316604|NCT01190930|524008294|FG006|Induction|Lost to Follow-up|0|||
145316605|NCT01190930|524008295|FG007|Induction|Lost to Follow-up|0|||
145316606|NCT01190930|524008296|FG008|Induction|Lost to Follow-up|0|||
145316607|NCT01190930|524008297|FG009|Induction|Lost to Follow-up|0|||
145316608|NCT01190930|524008288|FG000|Induction|Physician Decision|125|||
145316609|NCT01190930|524008289|FG001|Induction|Physician Decision|3|||
145316610|NCT01190930|524008290|FG002|Induction|Physician Decision|0|||
145316611|NCT01190930|524008291|FG003|Induction|Physician Decision|0|||
145316612|NCT01190930|524008292|FG004|Induction|Physician Decision|0|||
145316613|NCT01190930|524008293|FG005|Induction|Physician Decision|0|||
145316614|NCT01190930|524008294|FG006|Induction|Physician Decision|0|||
145316615|NCT01190930|524008295|FG007|Induction|Physician Decision|0|||
145316616|NCT01190930|524008296|FG008|Induction|Physician Decision|0|||
145316617|NCT01190930|524008297|FG009|Induction|Physician Decision|0|||
145316618|NCT01190930|524008288|FG000|Induction|Withdrawal by Subject|9|||
145316619|NCT01190930|524008289|FG001|Induction|Withdrawal by Subject|0|||
145316620|NCT01190930|524008290|FG002|Induction|Withdrawal by Subject|0|||
145316621|NCT01190930|524008291|FG003|Induction|Withdrawal by Subject|0|||
145316622|NCT01190930|524008292|FG004|Induction|Withdrawal by Subject|0|||
145316623|NCT01190930|524008293|FG005|Induction|Withdrawal by Subject|0|||
145316624|NCT01190930|524008294|FG006|Induction|Withdrawal by Subject|0|||
145316625|NCT01190930|524008295|FG007|Induction|Withdrawal by Subject|0|||
145316626|NCT01190930|524008296|FG008|Induction|Withdrawal by Subject|0|||
145316627|NCT01190930|524008297|FG009|Induction|Withdrawal by Subject|0|||
145316628|NCT01190930|524008288|FG000|Induction|Refusal|235|||
145316629|NCT01190930|524008289|FG001|Induction|Refusal|0|||
145316630|NCT01190930|524008290|FG002|Induction|Refusal|0|||
145316631|NCT01190930|524008291|FG003|Induction|Refusal|0|||
145316632|NCT01190930|524008292|FG004|Induction|Refusal|0|||
145316633|NCT01190930|524008293|FG005|Induction|Refusal|0|||
145316634|NCT01190930|524008294|FG006|Induction|Refusal|0|||
145316635|NCT01190930|524008295|FG007|Induction|Refusal|0|||
145316636|NCT01190930|524008296|FG008|Induction|Refusal|0|||
145316637|NCT01190930|524008297|FG009|Induction|Refusal|0|||
145316638|NCT01190930|524008288|FG000|Induction|Inevaluable|23|||
145316639|NCT01190930|524008289|FG001|Induction|Inevaluable|1|||
145316640|NCT01190930|524008290|FG002|Induction|Inevaluable|0|||
145316641|NCT01190930|524008291|FG003|Induction|Inevaluable|0|||
145316642|NCT01190930|524008292|FG004|Induction|Inevaluable|0|||
145316643|NCT01190930|524008293|FG005|Induction|Inevaluable|0|||
145316644|NCT01190930|524008294|FG006|Induction|Inevaluable|0|||
145316645|NCT01190930|524008295|FG007|Induction|Inevaluable|0|||
145316646|NCT01190930|524008296|FG008|Induction|Inevaluable|0|||
145316647|NCT01190930|524008297|FG009|Induction|Inevaluable|0|||
145316648|NCT01190930|524008288|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
145316649|NCT01190930|524008289|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316650|NCT01190930|524008290|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316651|NCT01190930|524008291|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316652|NCT01190930|524008292|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316653|NCT01190930|524008293|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316654|NCT01190930|524008294|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316655|NCT01190930|524008295|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316656|NCT01190930|524008296|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316657|NCT01190930|524008297|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
145316658|NCT01190930|524008288|FG000|Induction|High Risk Downs|80|||
145316659|NCT01190930|524008289|FG001|Induction|High Risk Downs|0|||
145316660|NCT01190930|524008290|FG002|Induction|High Risk Downs|0|||
145316661|NCT01190930|524008291|FG003|Induction|High Risk Downs|0|||
145316662|NCT01190930|524008292|FG004|Induction|High Risk Downs|0|||
145316663|NCT01190930|524008293|FG005|Induction|High Risk Downs|0|||
145316664|NCT01190930|524008294|FG006|Induction|High Risk Downs|0|||
145316665|NCT01190930|524008295|FG007|Induction|High Risk Downs|0|||
145316666|NCT01190930|524008296|FG008|Induction|High Risk Downs|0|||
145316667|NCT01190930|524008297|FG009|Induction|High Risk Downs|0|||
145316668|NCT01190930|524008288|FG000|Induction|Enrollment onto another COG Protocol|1|||
145316669|NCT01190930|524008289|FG001|Induction|Enrollment onto another COG Protocol|0|||
145316670|NCT01190930|524008290|FG002|Induction|Enrollment onto another COG Protocol|0|||
145316671|NCT01190930|524008291|FG003|Induction|Enrollment onto another COG Protocol|0|||
145316672|NCT01190930|524008292|FG004|Induction|Enrollment onto another COG Protocol|0|||
145316673|NCT01190930|524008293|FG005|Induction|Enrollment onto another COG Protocol|0|||
145316674|NCT01190930|524008294|FG006|Induction|Enrollment onto another COG Protocol|0|||
145316675|NCT01190930|524008295|FG007|Induction|Enrollment onto another COG Protocol|0|||
145316676|NCT01190930|524008296|FG008|Induction|Enrollment onto another COG Protocol|0|||
145316677|NCT01190930|524008297|FG009|Induction|Enrollment onto another COG Protocol|0|||
145316678|NCT01190930|524008288|FG000|Induction|Average Risk|1847|||
145316679|NCT01190930|524008289|FG001|Induction|Average Risk|0|||
145316680|NCT01190930|524008290|FG002|Induction|Average Risk|0|||
145316681|NCT01190930|524008291|FG003|Induction|Average Risk|0|||
145316682|NCT01190930|524008292|FG004|Induction|Average Risk|0|||
145316683|NCT01190930|524008293|FG005|Induction|Average Risk|0|||
145316684|NCT01190930|524008294|FG006|Induction|Average Risk|0|||
145316685|NCT01190930|524008295|FG007|Induction|Average Risk|0|||
145316686|NCT01190930|524008296|FG008|Induction|Average Risk|0|||
145316687|NCT01190930|524008297|FG009|Induction|Average Risk|0|||
145316688|NCT01190930|524008288|FG000|Induction|High Risk|1227|||
145316689|NCT01190930|524008289|FG001|Induction|High Risk|0|||
145316690|NCT01190930|524008290|FG002|Induction|High Risk|0|||
145316691|NCT01190930|524008291|FG003|Induction|High Risk|0|||
145316692|NCT01190930|524008292|FG004|Induction|High Risk|0|||
145316693|NCT01190930|524008293|FG005|Induction|High Risk|0|||
145316694|NCT01190930|524008294|FG006|Induction|High Risk|0|||
145316695|NCT01190930|524008295|FG007|Induction|High Risk|0|||
145316696|NCT01190930|524008296|FG008|Induction|High Risk|0|||
145316697|NCT01190930|524008297|FG009|Induction|High Risk|0|||
145316698|NCT01190930|524008288|FG000|Induction|Low Risk|443|||
145316699|NCT01190930|524008289|FG001|Induction|Low Risk|0|||
145316700|NCT01190930|524008290|FG002|Induction|Low Risk|0|||
145316701|NCT01190930|524008291|FG003|Induction|Low Risk|0|||
145316702|NCT01190930|524008292|FG004|Induction|Low Risk|0|||
145316703|NCT01190930|524008293|FG005|Induction|Low Risk|0|||
145316704|NCT01190930|524008294|FG006|Induction|Low Risk|0|||
145316705|NCT01190930|524008295|FG007|Induction|Low Risk|0|||
145316706|NCT01190930|524008296|FG008|Induction|Low Risk|0|||
145316707|NCT01190930|524008297|FG009|Induction|Low Risk|0|||
145316708|NCT01190930|524008288|FG000|Induction|Very High Risk|1012|||
145316709|NCT01190930|524008289|FG001|Induction|Very High Risk|0|||
145316710|NCT01190930|524008290|FG002|Induction|Very High Risk|0|||
145316711|NCT01190930|524008291|FG003|Induction|Very High Risk|0|||
145316712|NCT01190930|524008292|FG004|Induction|Very High Risk|0|||
145316713|NCT01190930|524008293|FG005|Induction|Very High Risk|0|||
145316714|NCT01190930|524008294|FG006|Induction|Very High Risk|0|||
145316715|NCT01190930|524008295|FG007|Induction|Very High Risk|0|||
145316716|NCT01190930|524008296|FG008|Induction|Very High Risk|0|||
145316717|NCT01190930|524008297|FG009|Induction|Very High Risk|0|||
145316718|NCT01190930|524008288|FG000|Induction|Philadelphia chromosome-positive|99|||
145316719|NCT01190930|524008289|FG001|Induction|Philadelphia chromosome-positive|0|||
145316720|NCT01190930|524008290|FG002|Induction|Philadelphia chromosome-positive|0|||
145316721|NCT01190930|524008291|FG003|Induction|Philadelphia chromosome-positive|0|||
145316722|NCT01190930|524008292|FG004|Induction|Philadelphia chromosome-positive|0|||
145316723|NCT01190930|524008293|FG005|Induction|Philadelphia chromosome-positive|0|||
145316724|NCT01190930|524008294|FG006|Induction|Philadelphia chromosome-positive|0|||
145316725|NCT01190930|524008295|FG007|Induction|Philadelphia chromosome-positive|0|||
145316726|NCT01190930|524008296|FG008|Induction|Philadelphia chromosome-positive|0|||
145316727|NCT01190930|524008297|FG009|Induction|Philadelphia chromosome-positive|0|||
145316728|NCT01190930|524008288|FG000|Induction|Incomplete Induction data|63|||
145316729|NCT01190930|524008289|FG001|Induction|Incomplete Induction data|0|||
145316730|NCT01190930|524008290|FG002|Induction|Incomplete Induction data|0|||
145316731|NCT01190930|524008291|FG003|Induction|Incomplete Induction data|0|||
145316732|NCT01190930|524008292|FG004|Induction|Incomplete Induction data|0|||
145316733|NCT01190930|524008293|FG005|Induction|Incomplete Induction data|0|||
145316734|NCT01190930|524008294|FG006|Induction|Incomplete Induction data|0|||
145316735|NCT01190930|524008295|FG007|Induction|Incomplete Induction data|0|||
145316736|NCT01190930|524008296|FG008|Induction|Incomplete Induction data|0|||
145316737|NCT01190930|524008297|FG009|Induction|Incomplete Induction data|0|||
145316738|NCT01190930|524008288|FG000|Induction|Progressive disease|0|||
145316739|NCT01190930|524008289|FG001|Induction|Progressive disease|1|||
145316740|NCT01190930|524008290|FG002|Induction|Progressive disease|0|||
145316741|NCT01190930|524008291|FG003|Induction|Progressive disease|0|||
145316742|NCT01190930|524008292|FG004|Induction|Progressive disease|0|||
145316743|NCT01190930|524008293|FG005|Induction|Progressive disease|0|||
145316744|NCT01190930|524008294|FG006|Induction|Progressive disease|0|||
145316745|NCT01190930|524008295|FG007|Induction|Progressive disease|0|||
145316746|NCT01190930|524008296|FG008|Induction|Progressive disease|0|||
145316747|NCT01190930|524008297|FG009|Induction|Progressive disease|0|||
145316748|NCT01190930|524008288|FG000|Induction|No treatment|3|||
145316749|NCT01190930|524008289|FG001|Induction|No treatment|0|||
145316750|NCT01190930|524008290|FG002|Induction|No treatment|0|||
145316751|NCT01190930|524008291|FG003|Induction|No treatment|0|||
145316752|NCT01190930|524008292|FG004|Induction|No treatment|0|||
145316753|NCT01190930|524008293|FG005|Induction|No treatment|0|||
145316754|NCT01190930|524008294|FG006|Induction|No treatment|0|||
145316755|NCT01190930|524008295|FG007|Induction|No treatment|0|||
145411527|NCT02335944|524360062|FG004|Treatment Phase|Subject/Guardian Decision|0|||
145316756|NCT01190930|524008296|FG008|Induction|No treatment|0|||
145316757|NCT01190930|524008297|FG009|Induction|No treatment|0|||
145316758|NCT01190930|524008288|FG000|Induction|Ineligible|69|||
145316759|NCT01190930|524008289|FG001|Induction|Ineligible|4|||
145316760|NCT01190930|524008290|FG002|Induction|Ineligible|0|||
145316761|NCT01190930|524008291|FG003|Induction|Ineligible|0|||
145316762|NCT01190930|524008292|FG004|Induction|Ineligible|0|||
145316763|NCT01190930|524008293|FG005|Induction|Ineligible|0|||
145316764|NCT01190930|524008294|FG006|Induction|Ineligible|0|||
145316765|NCT01190930|524008295|FG007|Induction|Ineligible|0|||
145316766|NCT01190930|524008296|FG008|Induction|Ineligible|0|||
145316767|NCT01190930|524008297|FG009|Induction|Ineligible|0|||
145316768|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
145316769|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
145316770|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
145316771|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
145316772|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
145316773|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
145316774|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
145316775|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
145316776|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
145316777|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
145316778|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Death|0|||
145316779|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Death|0|||
145316780|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Death|8|||
145316781|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Death|4|||
145316782|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Death|0|||
145316783|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Death|0|||
145316784|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Death|0|||
145316785|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Death|0|||
145316786|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Death|0|||
145316787|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Death|0|||
145316788|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
145316789|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
145316790|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
145316791|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
145316792|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
145316793|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
145316794|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
145316795|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
145316796|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
145316797|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
145316798|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316799|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
145316800|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
145316801|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
145316802|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316803|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316804|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316805|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316806|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316807|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
145316808|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Refusal|0|||
145316809|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Refusal|2|||
145316810|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Refusal|694|||
145316811|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Refusal|4|||
145316812|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Refusal|0|||
145316813|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Refusal|3|||
145316814|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Refusal|0|||
145316815|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Refusal|0|||
145316816|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Refusal|0|||
145316817|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Refusal|0|||
145316818|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
145316819|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
145316820|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
145316821|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
145316822|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
145316823|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
145316824|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
145316825|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
145316826|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
145316827|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
145316828|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316829|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
145316830|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316831|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316832|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145411528|NCT02335944|524360063|FG005|Treatment Phase|Subject/Guardian Decision|1|||
145569883|NCT02457598|524945820|FG005|Overall Study|Adverse Event|0|||
145316833|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316834|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145569884|NCT02457598|524945821|FG006|Overall Study|Adverse Event|0|||
145316835|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316836|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316837|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
145316838|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
145316839|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
145316840|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
145316841|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
145316842|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
145316843|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
145316844|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
145316845|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
145316846|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
145316847|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
145316848|NCT01190930|524008288|FG000|Post Induction Pre-Maintenance|Relapse|0|||
145316849|NCT01190930|524008289|FG001|Post Induction Pre-Maintenance|Relapse|0|||
145316850|NCT01190930|524008290|FG002|Post Induction Pre-Maintenance|Relapse|1|||
145316851|NCT01190930|524008291|FG003|Post Induction Pre-Maintenance|Relapse|0|||
145316852|NCT01190930|524008292|FG004|Post Induction Pre-Maintenance|Relapse|0|||
145316853|NCT01190930|524008293|FG005|Post Induction Pre-Maintenance|Relapse|0|||
145316854|NCT01190930|524008294|FG006|Post Induction Pre-Maintenance|Relapse|0|||
145316855|NCT01190930|524008295|FG007|Post Induction Pre-Maintenance|Relapse|0|||
145316856|NCT01190930|524008296|FG008|Post Induction Pre-Maintenance|Relapse|0|||
145316857|NCT01190930|524008297|FG009|Post Induction Pre-Maintenance|Relapse|0|||
145316858|NCT01190930|524008288|FG000|Maintenance|Adverse Event|0|||
145316859|NCT01190930|524008289|FG001|Maintenance|Adverse Event|0|||
145316860|NCT01190930|524008290|FG002|Maintenance|Adverse Event|0|||
145316861|NCT01190930|524008291|FG003|Maintenance|Adverse Event|0|||
145316862|NCT01190930|524008292|FG004|Maintenance|Adverse Event|0|||
145316863|NCT01190930|524008293|FG005|Maintenance|Adverse Event|1|||
145316864|NCT01190930|524008294|FG006|Maintenance|Adverse Event|1|||
145316865|NCT01190930|524008295|FG007|Maintenance|Adverse Event|3|||
145316866|NCT01190930|524008296|FG008|Maintenance|Adverse Event|3|||
145316867|NCT01190930|524008297|FG009|Maintenance|Adverse Event|0|||
145316868|NCT01190930|524008288|FG000|Maintenance|Death|0|||
145316869|NCT01190930|524008289|FG001|Maintenance|Death|0|||
145316870|NCT01190930|524008290|FG002|Maintenance|Death|0|||
145316871|NCT01190930|524008291|FG003|Maintenance|Death|1|||
145316872|NCT01190930|524008292|FG004|Maintenance|Death|0|||
145316873|NCT01190930|524008293|FG005|Maintenance|Death|0|||
145316874|NCT01190930|524008294|FG006|Maintenance|Death|2|||
145316875|NCT01190930|524008295|FG007|Maintenance|Death|2|||
145316876|NCT01190930|524008296|FG008|Maintenance|Death|2|||
145316877|NCT01190930|524008297|FG009|Maintenance|Death|2|||
145316878|NCT01190930|524008288|FG000|Maintenance|Lost to Follow-up|0|||
145316879|NCT01190930|524008289|FG001|Maintenance|Lost to Follow-up|0|||
145316880|NCT01190930|524008290|FG002|Maintenance|Lost to Follow-up|0|||
145316881|NCT01190930|524008291|FG003|Maintenance|Lost to Follow-up|0|||
145316882|NCT01190930|524008292|FG004|Maintenance|Lost to Follow-up|0|||
145316883|NCT01190930|524008293|FG005|Maintenance|Lost to Follow-up|0|||
145316884|NCT01190930|524008294|FG006|Maintenance|Lost to Follow-up|1|||
145316885|NCT01190930|524008295|FG007|Maintenance|Lost to Follow-up|1|||
145316886|NCT01190930|524008296|FG008|Maintenance|Lost to Follow-up|1|||
145316887|NCT01190930|524008297|FG009|Maintenance|Lost to Follow-up|0|||
145316888|NCT01190930|524008288|FG000|Maintenance|Physician Decision|0|||
145316889|NCT01190930|524008289|FG001|Maintenance|Physician Decision|1|||
145316890|NCT01190930|524008290|FG002|Maintenance|Physician Decision|0|||
145316891|NCT01190930|524008291|FG003|Maintenance|Physician Decision|5|||
145316892|NCT01190930|524008292|FG004|Maintenance|Physician Decision|9|||
145411529|NCT02335944|524360064|FG006|Treatment Phase|Subject/Guardian Decision|0|||
145411530|NCT02335944|524360065|FG007|Treatment Phase|Subject/Guardian Decision|4|||
145411531|NCT02335944|524360066|FG008|Treatment Phase|Subject/Guardian Decision|0|||
145569885|NCT02457598|524945822|FG007|Overall Study|Adverse Event|1|||
145316893|NCT01190930|524008293|FG005|Maintenance|Physician Decision|4|||
145316894|NCT01190930|524008294|FG006|Maintenance|Physician Decision|8|||
145316895|NCT01190930|524008295|FG007|Maintenance|Physician Decision|8|||
145316896|NCT01190930|524008296|FG008|Maintenance|Physician Decision|10|||
145316897|NCT01190930|524008297|FG009|Maintenance|Physician Decision|17|||
145316898|NCT01190930|524008288|FG000|Maintenance|Withdrawal by Subject|0|||
145316899|NCT01190930|524008289|FG001|Maintenance|Withdrawal by Subject|0|||
145316900|NCT01190930|524008290|FG002|Maintenance|Withdrawal by Subject|0|||
145316901|NCT01190930|524008291|FG003|Maintenance|Withdrawal by Subject|0|||
145316902|NCT01190930|524008292|FG004|Maintenance|Withdrawal by Subject|0|||
145316903|NCT01190930|524008293|FG005|Maintenance|Withdrawal by Subject|0|||
145316904|NCT01190930|524008294|FG006|Maintenance|Withdrawal by Subject|2|||
145316905|NCT01190930|524008295|FG007|Maintenance|Withdrawal by Subject|1|||
145411532|NCT02335944|524360067|FG009|Treatment Phase|Subject/Guardian Decision|0|||
145569886|NCT02457598|524945823|FG008|Overall Study|Adverse Event|0|||
145316906|NCT01190930|524008296|FG008|Maintenance|Withdrawal by Subject|4|||
145316907|NCT01190930|524008297|FG009|Maintenance|Withdrawal by Subject|1|||
145620426|NCT02846558|525123780|FG001|Overall Study|Lost to Follow-up|0|||
145620427|NCT02846558|525123781|FG002|Overall Study|Lost to Follow-up|0|||
145620428|NCT02846558|525123782|FG003|Overall Study|Lost to Follow-up|0|||
145620429|NCT04445155|525123783|FG000|Overall Study|Lost to Follow-up|11|||
145620430|NCT04445155|525123784|FG001|Overall Study|Lost to Follow-up|2|||
145620431|NCT04445155|525123785|FG002|Overall Study|Lost to Follow-up|3|||
145620432|NCT04445155|525123786|FG003|Overall Study|Lost to Follow-up|0|||
145620433|NCT04445155|525123783|FG000|Overall Study|Withdrawal by Subject|8|||
145620434|NCT04445155|525123784|FG001|Overall Study|Withdrawal by Subject|0|||
145620435|NCT04445155|525123785|FG002|Overall Study|Withdrawal by Subject|0|||
145620436|NCT04445155|525123786|FG003|Overall Study|Withdrawal by Subject|0|||
145620437|NCT04445155|525123783|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
145620438|NCT04445155|525123784|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
145620439|NCT04445155|525123785|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
145620440|NCT04445155|525123786|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
145620441|NCT04445155|525123783|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
145620442|NCT04445155|525123784|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
145620443|NCT04445155|525123785|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
145620444|NCT04445155|525123786|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
145620445|NCT01477749|525125070|FG000|Overall Study|Physician Decision|4|||
145620446|NCT01347645|525125075|FG000|Overall Study|Death|1|||
145620447|NCT01347645|525125076|FG001|Overall Study|Death|5|||
145620448|NCT01347645|525125077|FG002|Overall Study|Death|2|||
145620449|NCT01347645|525125078|FG003|Overall Study|Death|7|||
145620450|NCT01347645|525125079|FG004|Overall Study|Death|7|||
145620451|NCT01347645|525125075|FG000|Overall Study|Lost to Follow-up|1|||
145620452|NCT01347645|525125076|FG001|Overall Study|Lost to Follow-up|1|||
145620453|NCT01347645|525125077|FG002|Overall Study|Lost to Follow-up|0|||
145620454|NCT01347645|525125078|FG003|Overall Study|Lost to Follow-up|1|||
145620455|NCT01347645|525125079|FG004|Overall Study|Lost to Follow-up|1|||
145620456|NCT01347645|525125075|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
145620457|NCT01347645|525125076|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
145620458|NCT01347645|525125077|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
145620459|NCT01347645|525125078|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
145620460|NCT01347645|525125079|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
145620461|NCT01347645|525125075|FG000|Overall Study|Other|1|||
145620462|NCT01347645|525125076|FG001|Overall Study|Other|0|||
145620463|NCT01347645|525125077|FG002|Overall Study|Other|0|||
145620464|NCT01347645|525125078|FG003|Overall Study|Other|0|||
145620465|NCT01347645|525125079|FG004|Overall Study|Other|1|||
145620466|NCT01347645|525125075|FG000|Overall Study|Withdrawal by Subject|0|||
145620467|NCT01347645|525125076|FG001|Overall Study|Withdrawal by Subject|0|||
145620468|NCT01347645|525125077|FG002|Overall Study|Withdrawal by Subject|0|||
145620469|NCT01347645|525125078|FG003|Overall Study|Withdrawal by Subject|3|||
145620470|NCT01347645|525125079|FG004|Overall Study|Withdrawal by Subject|3|||
145620471|NCT01347645|525125075|FG000|Overall Study|Physician Decision|0|||
145620472|NCT01347645|525125076|FG001|Overall Study|Physician Decision|0|||
145620473|NCT01347645|525125077|FG002|Overall Study|Physician Decision|0|||
145620474|NCT01347645|525125078|FG003|Overall Study|Physician Decision|0|||
145620475|NCT01347645|525125079|FG004|Overall Study|Physician Decision|1|||
145620476|NCT01347645|525125075|FG000|Overall Study|Adverse Event|0|||
145620477|NCT01347645|525125076|FG001|Overall Study|Adverse Event|0|||
145620478|NCT01347645|525125077|FG002|Overall Study|Adverse Event|0|||
145620479|NCT01347645|525125078|FG003|Overall Study|Adverse Event|1|||
145620480|NCT01347645|525125079|FG004|Overall Study|Adverse Event|1|||
145620481|NCT00184028|525125080|FG000|Overall Study|Death|1|||
145620482|NCT00184028|525125080|FG000|Overall Study|Lack of Efficacy|4|||
145620483|NCT00184028|525125080|FG000|Overall Study|Adverse Event|2|||
145316908|NCT01190930|524008288|FG000|Maintenance|Refusal|0|||
145620484|NCT00184028|525125080|FG000|Overall Study|Withdrawal by Subject|1|||
145620485|NCT00184028|525125080|FG000|Overall Study|Non-compliance|2|||
145620486|NCT01141660|525125081|FG000|Overall Study|Physician Decision|0|||
145620487|NCT01141660|525125082|FG001|Overall Study|Physician Decision|12|||
145620488|NCT00209027|525125084|FG000|Overall Study|study terminated|10|||
145620489|NCT00209027|525125085|FG001|Overall Study|study terminated|0|||
145620490|NCT03785340|525125086|FG000|Overall Study|Lost to Follow-up|2|||
145316909|NCT01190930|524008289|FG001|Maintenance|Refusal|1|||
145316910|NCT01190930|524008290|FG002|Maintenance|Refusal|0|||
145620491|NCT03785340|525125087|FG001|Overall Study|Lost to Follow-up|0|||
145620492|NCT03785340|525125086|FG000|Overall Study|Adverse Event|1|||
145620493|NCT03785340|525125087|FG001|Overall Study|Adverse Event|0|||
145620494|NCT01848834|525125088|FG000|Overall Study|Adverse Event|3|||
145316911|NCT01190930|524008291|FG003|Maintenance|Refusal|2|||
145316912|NCT01190930|524008292|FG004|Maintenance|Refusal|0|||
145316913|NCT01190930|524008293|FG005|Maintenance|Refusal|4|||
145316914|NCT01190930|524008294|FG006|Maintenance|Refusal|5|||
145316915|NCT01190930|524008295|FG007|Maintenance|Refusal|17|||
145316916|NCT01190930|524008296|FG008|Maintenance|Refusal|13|||
145316917|NCT01190930|524008297|FG009|Maintenance|Refusal|6|||
145316918|NCT01190930|524008288|FG000|Maintenance|second malignant neoplasm|0|||
145316919|NCT01190930|524008289|FG001|Maintenance|second malignant neoplasm|0|||
145316920|NCT01190930|524008290|FG002|Maintenance|second malignant neoplasm|0|||
145316921|NCT01190930|524008291|FG003|Maintenance|second malignant neoplasm|1|||
145316922|NCT01190930|524008292|FG004|Maintenance|second malignant neoplasm|0|||
145316923|NCT01190930|524008293|FG005|Maintenance|second malignant neoplasm|1|||
145316924|NCT01190930|524008294|FG006|Maintenance|second malignant neoplasm|0|||
145316925|NCT01190930|524008295|FG007|Maintenance|second malignant neoplasm|0|||
145316926|NCT01190930|524008296|FG008|Maintenance|second malignant neoplasm|1|||
145316927|NCT01190930|524008297|FG009|Maintenance|second malignant neoplasm|0|||
145316928|NCT01190930|524008288|FG000|Maintenance|Inevaluable|0|||
145316929|NCT01190930|524008289|FG001|Maintenance|Inevaluable|0|||
145316930|NCT01190930|524008290|FG002|Maintenance|Inevaluable|0|||
145316931|NCT01190930|524008291|FG003|Maintenance|Inevaluable|0|||
145316932|NCT01190930|524008292|FG004|Maintenance|Inevaluable|0|||
145316933|NCT01190930|524008293|FG005|Maintenance|Inevaluable|1|||
145316934|NCT01190930|524008294|FG006|Maintenance|Inevaluable|1|||
145316935|NCT01190930|524008295|FG007|Maintenance|Inevaluable|1|||
145316936|NCT01190930|524008296|FG008|Maintenance|Inevaluable|0|||
145316937|NCT01190930|524008297|FG009|Maintenance|Inevaluable|0|||
145316938|NCT01190930|524008288|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
145316939|NCT01190930|524008289|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
145316940|NCT01190930|524008290|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
145316941|NCT01190930|524008291|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
145316942|NCT01190930|524008292|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
145316943|NCT01190930|524008293|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
145316944|NCT01190930|524008294|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
145316945|NCT01190930|524008295|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
145316946|NCT01190930|524008296|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
145316947|NCT01190930|524008297|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
145316948|NCT01190930|524008288|FG000|Maintenance|Relapse|0|||
145316949|NCT01190930|524008289|FG001|Maintenance|Relapse|0|||
145316950|NCT01190930|524008290|FG002|Maintenance|Relapse|0|||
145316951|NCT01190930|524008291|FG003|Maintenance|Relapse|2|||
145316952|NCT01190930|524008292|FG004|Maintenance|Relapse|0|||
145316953|NCT01190930|524008293|FG005|Maintenance|Relapse|1|||
145316954|NCT01190930|524008294|FG006|Maintenance|Relapse|6|||
145316955|NCT01190930|524008295|FG007|Maintenance|Relapse|13|||
145316956|NCT01190930|524008296|FG008|Maintenance|Relapse|11|||
145316957|NCT01190930|524008297|FG009|Maintenance|Relapse|11|||
145316958|NCT01190930|524008288|FG000|Maintenance|Still on therapy|0|||
145316959|NCT01190930|524008289|FG001|Maintenance|Still on therapy|8|||
145316960|NCT01190930|524008290|FG002|Maintenance|Still on therapy|0|||
145316961|NCT01190930|524008291|FG003|Maintenance|Still on therapy|29|||
145316962|NCT01190930|524008292|FG004|Maintenance|Still on therapy|0|||
145316963|NCT01190930|524008293|FG005|Maintenance|Still on therapy|0|||
145316964|NCT01190930|524008294|FG006|Maintenance|Still on therapy|0|||
145316965|NCT01190930|524008295|FG007|Maintenance|Still on therapy|0|||
145316966|NCT01190930|524008296|FG008|Maintenance|Still on therapy|0|||
145316967|NCT01190930|524008297|FG009|Maintenance|Still on therapy|0|||
145316968|NCT02351167|524008300|FG000|Overall Study|Withdrawal by Subject|19|||
145316969|NCT02351167|524008301|FG001|Overall Study|Withdrawal by Subject|18|||
145316970|NCT02351167|524008302|FG002|Overall Study|Withdrawal by Subject|21|||
145316971|NCT00113919|524008304|FG000|Overall Study|Physician Decision|8|||
145316972|NCT00113919|524008304|FG000|Overall Study|Death|6|||
145316973|NCT02340962|524008305|FG000|Overall Study|Lost to Follow-up|1|||
145316974|NCT02340962|524008306|FG001|Overall Study|Lost to Follow-up|0|||
145316975|NCT02914457|524008309|FG000|Overall Study|Withdrawal by Subject|1|||
145316976|NCT02914457|524008309|FG000|Overall Study|Physician Decision|1|||
145316977|NCT02914457|524008309|FG000|Overall Study|No veins available for lead placement|1|||
145316978|NCT02914457|524008309|FG000|Overall Study|Electrical instability of patient|1|||
145316979|NCT02914457|524008309|FG000|Overall Study|ECG acquisition error due to sweating|1|||
145316980|NCT02914457|524008309|FG000|Overall Study|Protocol Violation|1|||
145316981|NCT01292837|524008315|FG000|Overall Study|Adverse Event|1|||
145316982|NCT01292837|524008315|FG000|Overall Study|Further treatment determined|1|||
145316983|NCT02174276|524008316|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
145316984|NCT02174276|524008317|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145316985|NCT02174276|524008318|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145316986|NCT02174276|524008319|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
145316987|NCT02174276|524008316|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145316988|NCT02174276|524008317|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145316989|NCT02174276|524008318|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
145316990|NCT02174276|524008319|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
145316991|NCT02174276|524008316|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
145316992|NCT02174276|524008317|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
145316993|NCT02174276|524008318|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
145316994|NCT02174276|524008319|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
145316995|NCT02174276|524008316|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145316996|NCT02174276|524008317|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145316997|NCT02174276|524008318|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
145316998|NCT02174276|524008319|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
145316999|NCT02174276|524008316|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145317000|NCT02174276|524008317|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145317001|NCT02174276|524008318|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
145317002|NCT02174276|524008319|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
145317003|NCT02174276|524008316|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
145317004|NCT02174276|524008317|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
145317005|NCT02174276|524008318|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
145317006|NCT02174276|524008319|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
145317007|NCT01206439|524008322|FG000|Overall Study|subject did not meet inclusion criteria|1|||
145317008|NCT05889039|524008323|FG000|Overall Study|error in completing survey|0|||
145317009|NCT05889039|524008324|FG001|Overall Study|error in completing survey|2|||
145317010|NCT05889039|524008325|FG002|Overall Study|error in completing survey|0|||
145317011|NCT05889039|524008326|FG003|Overall Study|error in completing survey|0|||
145317012|NCT05889039|524008323|FG000|Overall Study|Lost to Follow-up|4|||
145317013|NCT05889039|524008324|FG001|Overall Study|Lost to Follow-up|0|||
145317014|NCT05889039|524008325|FG002|Overall Study|Lost to Follow-up|0|||
145317015|NCT05889039|524008326|FG003|Overall Study|Lost to Follow-up|0|||
145317016|NCT02661022|524008328|FG000|Overall Study|Withdrawal by Subject|3|||
145317017|NCT02661022|524008329|FG001|Overall Study|Withdrawal by Subject|0|||
145317018|NCT02661022|524008328|FG000|Overall Study|Adverse Event|1|||
145317019|NCT02661022|524008329|FG001|Overall Study|Adverse Event|1|||
145317020|NCT02661022|524008328|FG000|Overall Study|Physician Decision|1|||
145317021|NCT02661022|524008329|FG001|Overall Study|Physician Decision|0|||
145317022|NCT02661022|524008328|FG000|Overall Study|Progressive Disease|2|||
145317023|NCT02661022|524008329|FG001|Overall Study|Progressive Disease|1|||
145317024|NCT01055886|524008330|FG000|Overall Study|Withdrawal by Subject|4|||
145317025|NCT01055886|524008331|FG001|Overall Study|Withdrawal by Subject|9|||
145317026|NCT01055886|524008330|FG000|Overall Study|Lost to Follow-up|1|||
145317027|NCT01055886|524008331|FG001|Overall Study|Lost to Follow-up|1|||
145317028|NCT01055886|524008330|FG000|Overall Study|Withdrawal by PI|0|||
145317029|NCT01055886|524008331|FG001|Overall Study|Withdrawal by PI|1|||
145317030|NCT00609154|524008332|FG000|Overall Study|Protocol Violation|1|||
145317031|NCT00609154|524008333|FG001|Overall Study|Protocol Violation|2|||
145317032|NCT00609154|524008332|FG000|Overall Study|Unable to establish IV access|0|||
145317033|NCT00609154|524008333|FG001|Overall Study|Unable to establish IV access|4|||
145317034|NCT00609154|524008332|FG000|Overall Study|Adverse Event|0|||
145317035|NCT00609154|524008333|FG001|Overall Study|Adverse Event|2|||
145317036|NCT04531527|524008334|FG000|Overall Study|Found to be Ineligible|3|||
145317037|NCT00434837|524008340|FG000|Overall Study|Lost to Follow-up|20|||
145317038|NCT00434837|524008341|FG001|Overall Study|Lost to Follow-up|23|||
145317039|NCT00434837|524008342|FG002|Overall Study|Lost to Follow-up|30|||
145317040|NCT01785615|524008347|FG000|Dietary Phase|Lost to Follow-up|0|||
145317041|NCT01785615|524008348|FG001|Dietary Phase|Lost to Follow-up|0|||
145317042|NCT01785615|524008349|FG002|Dietary Phase|Lost to Follow-up|0|||
145317043|NCT01785615|524008350|FG003|Dietary Phase|Lost to Follow-up|24|||
145317044|NCT01881737|524008351|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
145317045|NCT01881737|524008351|FG000|Overall Study|Withdrawal by Subject|1|||
145569887|NCT02457598|524945824|FG009|Overall Study|Adverse Event|1|||
145569888|NCT02457598|524945825|FG010|Overall Study|Adverse Event|6|||
145569889|NCT02457598|524945826|FG011|Overall Study|Adverse Event|0|||
145317046|NCT01881737|524008351|FG000|Overall Study|Worsening of baseline behavior|1|||
145317047|NCT02058160|524008356|FG000|Overall Study|Randomized but not treated|2|||
145317048|NCT02058160|524008357|FG001|Overall Study|Randomized but not treated|4|||
145317049|NCT02058160|524008356|FG000|Overall Study|Poor compliance to protocol|4|||
145569890|NCT02457598|524945827|FG012|Overall Study|Adverse Event|0|||
145569891|NCT02457598|524945828|FG013|Overall Study|Adverse Event|1|||
145317050|NCT02058160|524008357|FG001|Overall Study|Poor compliance to protocol|1|||
145317051|NCT02058160|524008356|FG000|Overall Study|Adverse Event|12|||
145317052|NCT02058160|524008357|FG001|Overall Study|Adverse Event|3|||
145317053|NCT02058160|524008356|FG000|Overall Study|Lost to Follow-up|1|||
145317054|NCT02058160|524008357|FG001|Overall Study|Lost to Follow-up|0|||
145411533|NCT02335944|524360058|FG000|Post-treatment Follow-up|Progressive Disease|0|||
145317055|NCT02058160|524008356|FG000|Overall Study|Other than specified above|12|||
145317056|NCT02058160|524008357|FG001|Overall Study|Other than specified above|6|||
145317057|NCT04106817|524008358|FG000|Overall Study|Lost to Follow-up|1|||
145317058|NCT04106817|524008359|FG001|Overall Study|Lost to Follow-up|0|||
145317059|NCT04106817|524008360|FG002|Overall Study|Lost to Follow-up|0|||
145569892|NCT02457598|524945829|FG014|Overall Study|Adverse Event|2|||
145317060|NCT03310619|524008361|FG000|Pre-Treatment Period|Death|1|||
145317061|NCT03310619|524008362|FG001|Pre-Treatment Period|Death|0|||
145317062|NCT03310619|524008363|FG002|Pre-Treatment Period|Death|0|||
145317063|NCT03310619|524008364|FG003|Pre-Treatment Period|Death|0|||
145317064|NCT03310619|524008365|FG004|Pre-Treatment Period|Death|1|||
145317065|NCT03310619|524008366|FG005|Pre-Treatment Period|Death|0|||
145317066|NCT03310619|524008367|FG006|Pre-Treatment Period|Death|0|||
145317067|NCT03310619|524008368|FG007|Pre-Treatment Period|Death|0|||
145317068|NCT03310619|524008361|FG000|Pre-Treatment Period|Other reasons|2|||
145317069|NCT03310619|524008362|FG001|Pre-Treatment Period|Other reasons|1|||
145317070|NCT03310619|524008363|FG002|Pre-Treatment Period|Other reasons|2|||
145317071|NCT03310619|524008364|FG003|Pre-Treatment Period|Other reasons|0|||
145317072|NCT03310619|524008365|FG004|Pre-Treatment Period|Other reasons|0|||
145317073|NCT03310619|524008366|FG005|Pre-Treatment Period|Other reasons|0|||
145317074|NCT03310619|524008367|FG006|Pre-Treatment Period|Other reasons|2|||
145317075|NCT03310619|524008368|FG007|Pre-Treatment Period|Other reasons|0|||
145317076|NCT03310619|524008361|FG000|Treatment Period|Death|1|||
145317077|NCT03310619|524008362|FG001|Treatment Period|Death|2|||
145317078|NCT03310619|524008363|FG002|Treatment Period|Death|0|||
145317079|NCT03310619|524008364|FG003|Treatment Period|Death|0|||
145317080|NCT03310619|524008365|FG004|Treatment Period|Death|1|||
145317081|NCT03310619|524008366|FG005|Treatment Period|Death|0|||
145317082|NCT03310619|524008367|FG006|Treatment Period|Death|2|||
145317083|NCT03310619|524008368|FG007|Treatment Period|Death|0|||
145317084|NCT03310619|524008361|FG000|Treatment Period|Adverse Event|0|||
145317085|NCT03310619|524008362|FG001|Treatment Period|Adverse Event|1|||
145317086|NCT03310619|524008363|FG002|Treatment Period|Adverse Event|4|||
145317087|NCT03310619|524008364|FG003|Treatment Period|Adverse Event|1|||
145317088|NCT03310619|524008365|FG004|Treatment Period|Adverse Event|0|||
145317089|NCT03310619|524008366|FG005|Treatment Period|Adverse Event|0|||
145317090|NCT03310619|524008367|FG006|Treatment Period|Adverse Event|0|||
145317091|NCT03310619|524008368|FG007|Treatment Period|Adverse Event|0|||
145317092|NCT03310619|524008361|FG000|Treatment Period|Withdrawal by participant|0|||
145317093|NCT03310619|524008362|FG001|Treatment Period|Withdrawal by participant|0|||
145317094|NCT03310619|524008363|FG002|Treatment Period|Withdrawal by participant|1|||
145317095|NCT03310619|524008364|FG003|Treatment Period|Withdrawal by participant|0|||
145317096|NCT03310619|524008365|FG004|Treatment Period|Withdrawal by participant|0|||
145317097|NCT03310619|524008366|FG005|Treatment Period|Withdrawal by participant|0|||
145317098|NCT03310619|524008367|FG006|Treatment Period|Withdrawal by participant|0|||
145317099|NCT03310619|524008368|FG007|Treatment Period|Withdrawal by participant|0|||
145317100|NCT03310619|524008361|FG000|Treatment Period|Lost to Follow-up|0|||
145317101|NCT03310619|524008362|FG001|Treatment Period|Lost to Follow-up|0|||
145317102|NCT03310619|524008363|FG002|Treatment Period|Lost to Follow-up|0|||
145317103|NCT03310619|524008364|FG003|Treatment Period|Lost to Follow-up|0|||
145317104|NCT03310619|524008365|FG004|Treatment Period|Lost to Follow-up|0|||
145317105|NCT03310619|524008366|FG005|Treatment Period|Lost to Follow-up|0|||
145317106|NCT03310619|524008367|FG006|Treatment Period|Lost to Follow-up|0|||
145317107|NCT03310619|524008368|FG007|Treatment Period|Lost to Follow-up|1|||
145317108|NCT03310619|524008361|FG000|Treatment Period|Study terminated by sponsor|0|||
145317109|NCT03310619|524008362|FG001|Treatment Period|Study terminated by sponsor|0|||
145317110|NCT03310619|524008363|FG002|Treatment Period|Study terminated by sponsor|0|||
145317111|NCT03310619|524008364|FG003|Treatment Period|Study terminated by sponsor|0|||
145317112|NCT03310619|524008365|FG004|Treatment Period|Study terminated by sponsor|0|||
145317113|NCT03310619|524008366|FG005|Treatment Period|Study terminated by sponsor|0|||
145317114|NCT03310619|524008367|FG006|Treatment Period|Study terminated by sponsor|0|||
145317115|NCT03310619|524008368|FG007|Treatment Period|Study terminated by sponsor|1|||
145317116|NCT03310619|524008361|FG000|Treatment Period|Physician Decision|0|||
145317117|NCT03310619|524008362|FG001|Treatment Period|Physician Decision|0|||
145317118|NCT03310619|524008363|FG002|Treatment Period|Physician Decision|0|||
145317119|NCT03310619|524008364|FG003|Treatment Period|Physician Decision|0|||
145317120|NCT03310619|524008365|FG004|Treatment Period|Physician Decision|3|||
145317121|NCT03310619|524008366|FG005|Treatment Period|Physician Decision|0|||
145317122|NCT03310619|524008367|FG006|Treatment Period|Physician Decision|0|||
145317123|NCT03310619|524008368|FG007|Treatment Period|Physician Decision|0|||
145317124|NCT03310619|524008361|FG000|Treatment Period|Other reasons|1|||
145620495|NCT01848834|525125089|FG001|Overall Study|Adverse Event|11|||
145317125|NCT03310619|524008362|FG001|Treatment Period|Other reasons|0|||
145317126|NCT03310619|524008363|FG002|Treatment Period|Other reasons|2|||
145317127|NCT03310619|524008364|FG003|Treatment Period|Other reasons|0|||
145317128|NCT03310619|524008365|FG004|Treatment Period|Other reasons|0|||
145317129|NCT03310619|524008366|FG005|Treatment Period|Other reasons|0|||
145317130|NCT03310619|524008367|FG006|Treatment Period|Other reasons|0|||
145317131|NCT03310619|524008368|FG007|Treatment Period|Other reasons|0|||
145317132|NCT00152516|524008369|FG000|Overall Study|Adverse Event|18|||
145317133|NCT00152516|524008369|FG000|Overall Study|Lack and Loss of Efficacy|30|||
145317134|NCT00152516|524008369|FG000|Overall Study|Lost to Follow-up|5|||
145317135|NCT00152516|524008369|FG000|Overall Study|Withdrawal by Subject|8|||
145620496|NCT01848834|525125090|FG002|Overall Study|Adverse Event|3|||
145620497|NCT01848834|525125091|FG003|Overall Study|Adverse Event|5|||
145317136|NCT00152516|524008369|FG000|Overall Study|Protocol Violation|3|||
145317137|NCT00152516|524008369|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
145317138|NCT00152516|524008369|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
145317139|NCT00152516|524008369|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
145317140|NCT00152516|524008369|FG000|Overall Study|Other: Non-Compliance|2|||
145317141|NCT00152516|524008369|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
145317142|NCT00152516|524008369|FG000|Overall Study|Other: Moved Out Of State|1|||
145317143|NCT00152516|524008369|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
145317144|NCT00152516|524008369|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
145317145|NCT01266603|524008376|FG000|Overall Study|Adverse Event|1|||
145317146|NCT01266603|524008376|FG000|Overall Study|Lack of Efficacy|14|||
145317147|NCT01266603|524008376|FG000|Overall Study|Withdrawal by Subject|1|||
145317148|NCT01266603|524008376|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
145317149|NCT00756717|524008377|FG000|Overall Study|Withdrawal by Subject|2|||
145317150|NCT03259789|524008378|FG000|Overall Study|Adverse Event|3|||
145317151|NCT03259789|524008379|FG001|Overall Study|Adverse Event|2|||
145317152|NCT03259789|524008380|FG002|Overall Study|Adverse Event|1|||
145317153|NCT03259789|524008378|FG000|Overall Study|Withdrawal by Subject|9|||
145317154|NCT03259789|524008379|FG001|Overall Study|Withdrawal by Subject|5|||
145317155|NCT03259789|524008380|FG002|Overall Study|Withdrawal by Subject|1|||
145317156|NCT03259789|524008378|FG000|Overall Study|Lost to Follow-up|5|||
145317157|NCT03259789|524008379|FG001|Overall Study|Lost to Follow-up|9|||
145317158|NCT03259789|524008380|FG002|Overall Study|Lost to Follow-up|4|||
145317159|NCT03259789|524008378|FG000|Overall Study|Physician Decision|0|||
145317160|NCT03259789|524008379|FG001|Overall Study|Physician Decision|1|||
145620498|NCT01848834|525125092|FG004|Overall Study|Adverse Event|9|||
145620499|NCT01848834|525125088|FG000|Overall Study|Death|2|||
145620500|NCT01848834|525125089|FG001|Overall Study|Death|11|||
145620501|NCT01848834|525125090|FG002|Overall Study|Death|1|||
145620502|NCT01848834|525125091|FG003|Overall Study|Death|8|||
145620503|NCT01848834|525125092|FG004|Overall Study|Death|27|||
145620504|NCT01848834|525125088|FG000|Overall Study|Excluded Medication|5|||
145620505|NCT01848834|525125089|FG001|Overall Study|Excluded Medication|4|||
145620506|NCT01848834|525125090|FG002|Overall Study|Excluded Medication|3|||
145620507|NCT01848834|525125091|FG003|Overall Study|Excluded Medication|6|||
145620508|NCT01848834|525125092|FG004|Overall Study|Excluded Medication|6|||
145620509|NCT01848834|525125088|FG000|Overall Study|Lost to Follow-up|5|||
145620510|NCT01848834|525125089|FG001|Overall Study|Lost to Follow-up|5|||
145620511|NCT01848834|525125090|FG002|Overall Study|Lost to Follow-up|3|||
145620512|NCT01848834|525125091|FG003|Overall Study|Lost to Follow-up|0|||
145620513|NCT01848834|525125092|FG004|Overall Study|Lost to Follow-up|3|||
145620514|NCT01848834|525125088|FG000|Overall Study|Physician Decision|1|||
145620515|NCT01848834|525125089|FG001|Overall Study|Physician Decision|3|||
145620516|NCT01848834|525125090|FG002|Overall Study|Physician Decision|4|||
145620517|NCT01848834|525125091|FG003|Overall Study|Physician Decision|0|||
145620518|NCT01848834|525125092|FG004|Overall Study|Physician Decision|11|||
145620519|NCT01848834|525125088|FG000|Overall Study|Protocol Violation|0|||
145620520|NCT01848834|525125089|FG001|Overall Study|Protocol Violation|0|||
145620521|NCT01848834|525125090|FG002|Overall Study|Protocol Violation|0|||
145620522|NCT01848834|525125091|FG003|Overall Study|Protocol Violation|0|||
145620523|NCT01848834|525125092|FG004|Overall Study|Protocol Violation|1|||
145620524|NCT01848834|525125088|FG000|Overall Study|Sponsor Decision|1|||
145620525|NCT01848834|525125089|FG001|Overall Study|Sponsor Decision|1|||
145620526|NCT01848834|525125090|FG002|Overall Study|Sponsor Decision|0|||
145620527|NCT01848834|525125091|FG003|Overall Study|Sponsor Decision|1|||
145620528|NCT01848834|525125092|FG004|Overall Study|Sponsor Decision|1|||
145620529|NCT01848834|525125088|FG000|Overall Study|Withdrawal by Subject|2|||
145620530|NCT01848834|525125089|FG001|Overall Study|Withdrawal by Subject|13|||
145317161|NCT03259789|524008380|FG002|Overall Study|Physician Decision|0|||
145620531|NCT01848834|525125090|FG002|Overall Study|Withdrawal by Subject|10|||
145620532|NCT01848834|525125091|FG003|Overall Study|Withdrawal by Subject|6|||
145620533|NCT01848834|525125092|FG004|Overall Study|Withdrawal by Subject|36|||
145620534|NCT04894903|525125097|FG000|Overall Study|Death|1|||
145620535|NCT04894903|525125098|FG001|Overall Study|Death|0|||
145620536|NCT04894903|525125097|FG000|Overall Study|Pregnancy|1|||
145620537|NCT04894903|525125098|FG001|Overall Study|Pregnancy|0|||
145620538|NCT04894903|525125097|FG000|Overall Study|Withdrawal by Subject|1|||
145620539|NCT04894903|525125098|FG001|Overall Study|Withdrawal by Subject|1|||
145317162|NCT02063217|524008381|FG000|Overall Study|Withdrawal by Subject|1|||
145317163|NCT02063217|524008382|FG001|Overall Study|Withdrawal by Subject|0|||
145317164|NCT02063217|524008383|FG002|Overall Study|Withdrawal by Subject|0|||
145317165|NCT04291508|524008384|FG000|Overall Study|Withdrawal by Subject|1|||
145317166|NCT04291508|524008385|FG001|Overall Study|Withdrawal by Subject|0|||
145620540|NCT04894903|525125097|FG000|Overall Study|moved or exited health system|1|||
145620541|NCT04894903|525125098|FG001|Overall Study|moved or exited health system|3|||
145620542|NCT01670500|525125099|FG000|Overall Study|Withdrawal by Subject|1|||
145317167|NCT04291508|524008386|FG002|Overall Study|Withdrawal by Subject|1|||
145317168|NCT04291508|524008387|FG003|Overall Study|Withdrawal by Subject|0|||
145317169|NCT04291508|524008384|FG000|Overall Study|lost to follow up|4|||
145317170|NCT04291508|524008385|FG001|Overall Study|lost to follow up|0|||
145317171|NCT04291508|524008386|FG002|Overall Study|lost to follow up|1|||
145317172|NCT04291508|524008387|FG003|Overall Study|lost to follow up|0|||
145317173|NCT00398073|524008392|FG000|Overall Study|Withdrawal by Subject|1|||
145317174|NCT00398073|524008393|FG001|Overall Study|Withdrawal by Subject|0|||
145317175|NCT01263561|524008396|FG000|Overall Study|Death|1|||
145317176|NCT01263561|524008397|FG001|Overall Study|Death|2|||
145317177|NCT04203667|524008398|FG000|Overall Study|Withdrawal by Subject|1|||
145317178|NCT04203667|524008398|FG000|Overall Study|Lost to Follow-up|1|||
145317179|NCT04203667|524008398|FG000|Overall Study|Death|1|||
145317180|NCT04203667|524008398|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
145317181|NCT01833169|524008402|FG000|Overall Study|Disease Progression|99|||
145317182|NCT01833169|524008402|FG000|Overall Study|Adverse Event|33|||
145317183|NCT01833169|524008402|FG000|Overall Study|Withdrawal by Subject|9|||
145317184|NCT01833169|524008402|FG000|Overall Study|Death|3|||
145317185|NCT01833169|524008402|FG000|Overall Study|Physician Decision|2|||
145317186|NCT01183884|524008403|FG000|Overall Study|Progressive Disease|26|||
145317187|NCT01183884|524008403|FG000|Overall Study|Adverse Event|3|||
145317188|NCT01183884|524008403|FG000|Overall Study|Withdrawal by Subject|1|||
145317189|NCT01183884|524008403|FG000|Overall Study|Other Complicating Disease|3|||
145317190|NCT01183884|524008403|FG000|Overall Study|Not Treated|1|||
145317191|NCT01183884|524008403|FG000|Overall Study|Other|4|||
145317192|NCT04718129|524008408|FG000|Overall Study|Lost to Follow-up|6|||
145317193|NCT04718129|524008409|FG001|Overall Study|Lost to Follow-up|7|||
145317194|NCT00420095|524008411|FG000|Overall Study|Adverse Event|1|||
145317195|NCT00420095|524008412|FG001|Overall Study|Adverse Event|0|||
145317196|NCT00420095|524008411|FG000|Overall Study|Protocol Violation|1|||
145317197|NCT00420095|524008412|FG001|Overall Study|Protocol Violation|1|||
145317198|NCT00420095|524008411|FG000|Overall Study|Lost to Follow-up|1|||
145317199|NCT00420095|524008412|FG001|Overall Study|Lost to Follow-up|0|||
145317200|NCT03108820|524008413|FG000|Overall Study|Lost to Follow-up|30|||
145317201|NCT03108820|524008414|FG001|Overall Study|Lost to Follow-up|28|||
145317202|NCT03108820|524008413|FG000|Overall Study|Withdrawal by Subject|32|||
145317203|NCT03108820|524008414|FG001|Overall Study|Withdrawal by Subject|24|||
145317204|NCT03108820|524008413|FG000|Overall Study|Death|6|||
145317205|NCT03108820|524008414|FG001|Overall Study|Death|11|||
145317206|NCT00089973|524008421|FG000|Overall Study|Adverse Event|3|||
145317207|NCT00089973|524008421|FG000|Overall Study|Withdrawal by Subject|1|||
145317208|NCT00089973|524008421|FG000|Overall Study|Disease progression|45|||
145317209|NCT00089973|524008421|FG000|Overall Study|Death|1|||
145317210|NCT01475487|524008422|FG000|Overall Study|had to leave early for personal reasons|2|||
145317211|NCT01475487|524008423|FG001|Overall Study|had to leave early for personal reasons|1|||
145317212|NCT04428645|524008426|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
145317213|NCT03168906|524008429|FG000|Overall Study|Lack of Efficacy|6|||
145317214|NCT03168906|524008430|FG001|Overall Study|Lack of Efficacy|6|||
145317215|NCT01214239|524008431|FG000|Overall Study|Adverse Event|3|||
145317216|NCT01214239|524008432|FG001|Overall Study|Adverse Event|4|||
145317217|NCT01214239|524008431|FG000|Overall Study|Protocol Violation|2|||
145317218|NCT01214239|524008432|FG001|Overall Study|Protocol Violation|1|||
145317219|NCT01214239|524008431|FG000|Overall Study|Lost to Follow-up|1|||
145317220|NCT01214239|524008432|FG001|Overall Study|Lost to Follow-up|1|||
145317221|NCT01214239|524008431|FG000|Overall Study|Withdrawal by Subject|4|||
145317222|NCT01214239|524008432|FG001|Overall Study|Withdrawal by Subject|9|||
145317223|NCT01214239|524008431|FG000|Overall Study|Lack of Efficacy|1|||
145317224|NCT01214239|524008432|FG001|Overall Study|Lack of Efficacy|2|||
145317225|NCT01214239|524008431|FG000|Overall Study|patient's private reason|1|||
145317226|NCT01214239|524008432|FG001|Overall Study|patient's private reason|1|||
145317227|NCT00857818|524008433|FG000|Overall Study|Lack of Efficacy|1|||
145620543|NCT01670500|525125100|FG001|Overall Study|Withdrawal by Subject|0|||
145620544|NCT01923428|525125102|FG000|Overall Study|Adverse Event|8|||
145620545|NCT01923428|525125103|FG001|Overall Study|Adverse Event|6|||
145620546|NCT01923428|525125104|FG002|Overall Study|Adverse Event|3|||
145317228|NCT00857818|524008434|FG001|Overall Study|Lack of Efficacy|0|||
145317229|NCT00857818|524008433|FG000|Overall Study|Adverse Event|3|||
145317230|NCT00857818|524008434|FG001|Overall Study|Adverse Event|0|||
145317231|NCT00857818|524008433|FG000|Overall Study|Withdrawal by Subject|0|||
145317232|NCT00857818|524008434|FG001|Overall Study|Withdrawal by Subject|4|||
145317233|NCT00857818|524008433|FG000|Overall Study|Sponsor terminated study|6|||
145317234|NCT00857818|524008434|FG001|Overall Study|Sponsor terminated study|4|||
145317235|NCT00857818|524008433|FG000|Overall Study|Investigator decision|1|||
145317236|NCT00857818|524008434|FG001|Overall Study|Investigator decision|0|||
145317237|NCT02625974|524008435|FG000|Part 1|Lost to Follow-up|9|||
145317238|NCT02625974|524008436|FG001|Part 1|Lost to Follow-up|3|||
145317239|NCT02625974|524008435|FG000|Part 2|Lost to Follow-up|4|||
145317240|NCT02625974|524008436|FG001|Part 2|Lost to Follow-up|6|||
145317241|NCT02625974|524008435|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
145317242|NCT02625974|524008436|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
145317243|NCT01142661|524008437|FG000|Overall Study|Adverse Event|2|||
145317244|NCT01142661|524008437|FG000|Overall Study|Withdrawal by Subject|1|||
145317245|NCT01142661|524008437|FG000|Overall Study|Physician Decision|1|||
145317246|NCT02129062|524009730|FG000|Overall Study|Death|1|||
145317247|NCT02129062|524009730|FG000|Overall Study|Disease Progression|2|||
145317248|NCT00559637|524009732|FG000|Overall Study|Adverse Event|22|||
145317249|NCT00559637|524009732|FG000|Overall Study|Withdrawal by Subject|4|||
145317250|NCT00559637|524009732|FG000|Overall Study|Protocol Violation|6|||
145317251|NCT00559637|524009732|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
145317252|NCT00559637|524009732|FG000|Overall Study|Failure to return|6|||
145317253|NCT00559637|524009732|FG000|Overall Study|Insufficient response|3|||
145317254|NCT00559637|524009732|FG000|Overall Study|Started requiring dialysis after month 7|2|||
145317255|NCT00559637|524009732|FG000|Overall Study|Suspected lung cancer|1|||
145317256|NCT00559637|524009732|FG000|Overall Study|Participation in another study|1|||
145317257|NCT00559637|524009732|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
145317258|NCT00559637|524009732|FG000|Overall Study|Change of center|1|||
145317259|NCT00559637|524009732|FG000|Overall Study|Change of home|1|||
145317260|NCT00559637|524009732|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
145317261|NCT01923311|524009733|FG000|Overall Study|Pregnancy|1|||
145317262|NCT01923311|524009734|FG001|Overall Study|Pregnancy|0|||
145317263|NCT01923311|524009733|FG000|Overall Study|Investigator's Discretion|1|||
145317264|NCT01923311|524009734|FG001|Overall Study|Investigator's Discretion|0|||
145317265|NCT01923311|524009733|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145317266|NCT01923311|524009734|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145317267|NCT01923311|524009733|FG000|Overall Study|Withdrew Consent|1|||
145317268|NCT01923311|524009734|FG001|Overall Study|Withdrew Consent|0|||
145317269|NCT01923311|524009733|FG000|Overall Study|Study Terminated by Sponsor|12|||
145317270|NCT01923311|524009734|FG001|Overall Study|Study Terminated by Sponsor|0|||
145317271|NCT03429049|524009738|FG000|Overall Study|Adverse Event|2|||
145317272|NCT03429049|524009739|FG001|Overall Study|Adverse Event|3|||
145317273|NCT03429049|524009738|FG000|Overall Study|Death|0|||
145317274|NCT03429049|524009739|FG001|Overall Study|Death|1|||
145317275|NCT03429049|524009738|FG000|Overall Study|Lack of Efficacy|4|||
145317276|NCT03429049|524009739|FG001|Overall Study|Lack of Efficacy|2|||
145317277|NCT03429049|524009738|FG000|Overall Study|Lost to Follow-up|9|||
145317278|NCT03429049|524009739|FG001|Overall Study|Lost to Follow-up|8|||
145317279|NCT03429049|524009738|FG000|Overall Study|Physician Decision|1|||
145317280|NCT03429049|524009739|FG001|Overall Study|Physician Decision|0|||
145317281|NCT03429049|524009738|FG000|Overall Study|Protocol Violation|3|||
145317282|NCT03429049|524009739|FG001|Overall Study|Protocol Violation|0|||
145317283|NCT03429049|524009738|FG000|Overall Study|Sponsor Decision|2|||
145317284|NCT03429049|524009739|FG001|Overall Study|Sponsor Decision|0|||
145317285|NCT03429049|524009738|FG000|Overall Study|Withdrawal by Subject|4|||
145317286|NCT03429049|524009739|FG001|Overall Study|Withdrawal by Subject|20|||
145317287|NCT03429049|524009738|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
145317288|NCT03429049|524009739|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
145317289|NCT04129944|524009741|FG000|Overall Study|Death|0|||
145317290|NCT04129944|524009742|FG001|Overall Study|Death|0|||
145317291|NCT04129944|524009743|FG002|Overall Study|Death|0|||
145317292|NCT04129944|524009744|FG003|Overall Study|Death|1|||
145317293|NCT04129944|524009741|FG000|Overall Study|Lost to Follow-up|1|||
145317294|NCT04129944|524009742|FG001|Overall Study|Lost to Follow-up|0|||
145317295|NCT04129944|524009743|FG002|Overall Study|Lost to Follow-up|0|||
145317296|NCT04129944|524009744|FG003|Overall Study|Lost to Follow-up|0|||
145317297|NCT04129944|524009741|FG000|Overall Study|Withdrawal by Subject|1|||
145317298|NCT04129944|524009742|FG001|Overall Study|Withdrawal by Subject|0|||
145317299|NCT04129944|524009743|FG002|Overall Study|Withdrawal by Subject|1|||
145317300|NCT04129944|524009744|FG003|Overall Study|Withdrawal by Subject|2|||
145317301|NCT02419573|524009747|FG000|Overall Study|Lost to Follow-up|3|||
145317302|NCT02419573|524009748|FG001|Overall Study|Lost to Follow-up|0|||
145317303|NCT02419573|524009747|FG000|Overall Study|Withdrawal by Subject|1|||
145569893|NCT02457598|524945830|FG015|Overall Study|Adverse Event|0|||
145569894|NCT02457598|524945831|FG016|Overall Study|Adverse Event|0|||
145569895|NCT02457598|524945815|FG000|Overall Study|Death|0|||
145569896|NCT02457598|524945816|FG001|Overall Study|Death|0|||
145569897|NCT02457598|524945817|FG002|Overall Study|Death|0|||
145569898|NCT02457598|524945818|FG003|Overall Study|Death|3|||
145569899|NCT02457598|524945819|FG004|Overall Study|Death|0|||
145569900|NCT02457598|524945820|FG005|Overall Study|Death|1|||
145569901|NCT02457598|524945821|FG006|Overall Study|Death|0|||
145569902|NCT02457598|524945822|FG007|Overall Study|Death|0|||
145569903|NCT02457598|524945823|FG008|Overall Study|Death|0|||
145569904|NCT02457598|524945824|FG009|Overall Study|Death|0|||
145569905|NCT02457598|524945825|FG010|Overall Study|Death|3|||
145569906|NCT02457598|524945826|FG011|Overall Study|Death|0|||
145317304|NCT02419573|524009748|FG001|Overall Study|Withdrawal by Subject|0|||
145317305|NCT04501094|524009749|FG000|Overall Study|Death (unrelated to research)|1|||
145569907|NCT02457598|524945827|FG012|Overall Study|Death|0|||
145317306|NCT04501094|524009750|FG001|Overall Study|Death (unrelated to research)|0|||
145317307|NCT02426541|524009757|FG000|Overall Study|Protocol Violation|1|||
145317308|NCT02426541|524009758|FG001|Overall Study|Protocol Violation|0|||
145317309|NCT00784979|524009759|FG000|Overall Study|incomplete data|6|||
145317310|NCT00894933|524009763|FG000|Overall Study|Lost to Follow-up|2|||
145317311|NCT00894933|524009763|FG000|Overall Study|Cancelled Procedure|1|||
145317312|NCT00894933|524009763|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
145317313|NCT04241133|524009764|FG000|Overall Study|COVID19 Precautions|14|||
145317314|NCT04241133|524009765|FG001|Overall Study|COVID19 Precautions|34|||
145317315|NCT00631007|524009769|FG000|Overall Study|Adverse Event|0|||
145317316|NCT00631007|524009770|FG001|Overall Study|Adverse Event|2|||
145317317|NCT00631007|524009771|FG002|Overall Study|Adverse Event|0|||
145317318|NCT00631007|524009772|FG003|Overall Study|Adverse Event|2|||
145317319|NCT00631007|524009773|FG004|Overall Study|Adverse Event|3|||
145317320|NCT00631007|524009774|FG005|Overall Study|Adverse Event|2|||
145317321|NCT00631007|524009769|FG000|Overall Study|Lost to Follow-up|2|||
145317322|NCT00631007|524009770|FG001|Overall Study|Lost to Follow-up|1|||
145317323|NCT00631007|524009771|FG002|Overall Study|Lost to Follow-up|2|||
145317324|NCT00631007|524009772|FG003|Overall Study|Lost to Follow-up|4|||
145317325|NCT00631007|524009773|FG004|Overall Study|Lost to Follow-up|5|||
145317326|NCT00631007|524009774|FG005|Overall Study|Lost to Follow-up|3|||
145317327|NCT00631007|524009769|FG000|Overall Study|Physician Decision|1|||
145317328|NCT00631007|524009770|FG001|Overall Study|Physician Decision|0|||
145317329|NCT00631007|524009771|FG002|Overall Study|Physician Decision|1|||
145317330|NCT00631007|524009772|FG003|Overall Study|Physician Decision|0|||
145317331|NCT00631007|524009773|FG004|Overall Study|Physician Decision|0|||
145317332|NCT00631007|524009774|FG005|Overall Study|Physician Decision|2|||
145317333|NCT00631007|524009769|FG000|Overall Study|Persistent Hyperglycemia|2|||
145317334|NCT00631007|524009770|FG001|Overall Study|Persistent Hyperglycemia|2|||
145317335|NCT00631007|524009771|FG002|Overall Study|Persistent Hyperglycemia|5|||
145317336|NCT00631007|524009772|FG003|Overall Study|Persistent Hyperglycemia|1|||
145317337|NCT00631007|524009773|FG004|Overall Study|Persistent Hyperglycemia|2|||
145317338|NCT00631007|524009774|FG005|Overall Study|Persistent Hyperglycemia|5|||
145317339|NCT00631007|524009769|FG000|Overall Study|Withdrawal by Subject|4|||
145317340|NCT00631007|524009770|FG001|Overall Study|Withdrawal by Subject|5|||
145317341|NCT00631007|524009771|FG002|Overall Study|Withdrawal by Subject|2|||
145317342|NCT00631007|524009772|FG003|Overall Study|Withdrawal by Subject|2|||
145317343|NCT00631007|524009773|FG004|Overall Study|Withdrawal by Subject|1|||
145317344|NCT00631007|524009774|FG005|Overall Study|Withdrawal by Subject|3|||
145317345|NCT00631007|524009769|FG000|Overall Study|Other|2|||
145317346|NCT00631007|524009770|FG001|Overall Study|Other|1|||
145317347|NCT00631007|524009771|FG002|Overall Study|Other|0|||
145317348|NCT00631007|524009772|FG003|Overall Study|Other|0|||
145317349|NCT00631007|524009773|FG004|Overall Study|Other|1|||
145317350|NCT00631007|524009774|FG005|Overall Study|Other|0|||
145317351|NCT02674633|524009775|FG000|Overall Study|Lost to Follow-up|3|||
145317352|NCT02674633|524009776|FG001|Overall Study|Lost to Follow-up|2|||
145317353|NCT02674633|524009775|FG000|Overall Study|Physician Decision|1|||
145317354|NCT02674633|524009776|FG001|Overall Study|Physician Decision|0|||
145317355|NCT02674633|524009775|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145317356|NCT02674633|524009776|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145317357|NCT00683787|524009777|FG000|Overall Study|Progression|3|||
145317358|NCT00683787|524009778|FG001|Overall Study|Progression|3|||
145317359|NCT00683787|524009779|FG002|Overall Study|Progression|0|||
145317360|NCT00683787|524009777|FG000|Overall Study|Adverse Event|0|||
145317361|NCT00683787|524009778|FG001|Overall Study|Adverse Event|0|||
145317362|NCT00683787|524009779|FG002|Overall Study|Adverse Event|2|||
145317363|NCT00460109|524009780|FG000|Overall Study|Death|1|||
145317364|NCT01235715|524009781|FG000|Overall Study|Physician Decision|0|||
145317365|NCT01235715|524009782|FG001|Overall Study|Physician Decision|2|||
145317366|NCT02994394|524009783|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
145317367|NCT02994394|524009784|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
145317368|NCT02994394|524009785|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
145317369|NCT02994394|524009786|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
145317370|NCT02994394|524009787|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
145317371|NCT02994394|524009788|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
145317372|NCT02994394|524009783|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
145317373|NCT02994394|524009784|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
145317374|NCT02994394|524009785|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
145317375|NCT02994394|524009786|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
145317376|NCT02994394|524009787|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
145317377|NCT02994394|524009788|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
145317378|NCT03619876|524009789|FG000|Overall Study|Withdrawal by Subject|1|||
145317379|NCT03619876|524009790|FG001|Overall Study|Withdrawal by Subject|2|||
145317380|NCT03619876|524009789|FG000|Overall Study|Withdrawal due to incidental finding|0|||
145317381|NCT03619876|524009790|FG001|Overall Study|Withdrawal due to incidental finding|2|||
145317382|NCT02344745|524009791|FG000|Overall Study|Data collection sheets were lost|2|||
145317383|NCT02344745|524009792|FG001|Overall Study|Data collection sheets were lost|0|||
145317384|NCT02788513|524009793|FG000|Overall Study|Withdrawal by Subject|3|||
145317385|NCT02788513|524009794|FG001|Overall Study|Withdrawal by Subject|0|||
145317386|NCT02788513|524009795|FG002|Overall Study|Withdrawal by Subject|2|||
145317387|NCT02788513|524009796|FG003|Overall Study|Withdrawal by Subject|3|||
145317388|NCT02788513|524009797|FG004|Overall Study|Withdrawal by Subject|1|||
145317389|NCT02788513|524009793|FG000|Overall Study|Lost to Follow-up|1|||
145317390|NCT02788513|524009794|FG001|Overall Study|Lost to Follow-up|0|||
145317391|NCT02788513|524009795|FG002|Overall Study|Lost to Follow-up|0|||
145317392|NCT02788513|524009796|FG003|Overall Study|Lost to Follow-up|0|||
145569908|NCT02457598|524945828|FG013|Overall Study|Death|1|||
145569909|NCT02457598|524945829|FG014|Overall Study|Death|2|||
145569910|NCT02457598|524945830|FG015|Overall Study|Death|0|||
145569911|NCT02457598|524945831|FG016|Overall Study|Death|1|||
145569912|NCT02457598|524945815|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569913|NCT02457598|524945816|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
145569914|NCT02457598|524945817|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569915|NCT02457598|524945818|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
145569916|NCT02457598|524945819|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569917|NCT02457598|524945820|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
145317393|NCT02788513|524009797|FG004|Overall Study|Lost to Follow-up|1|||
145317394|NCT02788513|524009793|FG000|Overall Study|Adverse Event|5|||
145317395|NCT02788513|524009794|FG001|Overall Study|Adverse Event|8|||
145317396|NCT02788513|524009795|FG002|Overall Study|Adverse Event|4|||
145317397|NCT02788513|524009796|FG003|Overall Study|Adverse Event|2|||
145317398|NCT02788513|524009797|FG004|Overall Study|Adverse Event|2|||
145317399|NCT02788513|524009793|FG000|Overall Study|Protocol Violation|0|||
145317400|NCT02788513|524009794|FG001|Overall Study|Protocol Violation|0|||
145317401|NCT02788513|524009795|FG002|Overall Study|Protocol Violation|1|||
145317402|NCT02788513|524009796|FG003|Overall Study|Protocol Violation|1|||
145317403|NCT02788513|524009797|FG004|Overall Study|Protocol Violation|0|||
145317404|NCT02788513|524009793|FG000|Overall Study|Subject decided to stop taking treatment|0|||
145317405|NCT02788513|524009794|FG001|Overall Study|Subject decided to stop taking treatment|0|||
145317406|NCT02788513|524009795|FG002|Overall Study|Subject decided to stop taking treatment|1|||
145317407|NCT02788513|524009796|FG003|Overall Study|Subject decided to stop taking treatment|0|||
145317408|NCT02788513|524009797|FG004|Overall Study|Subject decided to stop taking treatment|0|||
145317409|NCT02788513|524009793|FG000|Overall Study|Decision by the study team|0|||
145317410|NCT02788513|524009794|FG001|Overall Study|Decision by the study team|0|||
145317411|NCT02788513|524009795|FG002|Overall Study|Decision by the study team|0|||
145317412|NCT02788513|524009796|FG003|Overall Study|Decision by the study team|0|||
145317413|NCT02788513|524009797|FG004|Overall Study|Decision by the study team|1|||
145317414|NCT00835796|524009801|FG000|First Intervention|Withdrawal by Subject|0|||
145317415|NCT00835796|524009802|FG001|First Intervention|Withdrawal by Subject|1|||
145317416|NCT00396630|524009803|FG000|Overall Study|Lost to Follow-up|1|||
145317417|NCT00396630|524009804|FG001|Overall Study|Lost to Follow-up|1|||
145317418|NCT00396630|524009803|FG000|Overall Study|Withdrawal by Subject|1|||
145317419|NCT00396630|524009804|FG001|Overall Study|Withdrawal by Subject|1|||
145317420|NCT00396630|524009803|FG000|Overall Study|Not vaccinated at Visit 3|3|||
145317421|NCT00396630|524009804|FG001|Overall Study|Not vaccinated at Visit 3|3|||
145317422|NCT02327325|524009805|FG000|Overall Study|Withdrawal by Subject|1|||
145317423|NCT02327325|524009806|FG001|Overall Study|Withdrawal by Subject|4|||
145317424|NCT02327325|524009807|FG002|Overall Study|Withdrawal by Subject|4|||
145317425|NCT02327325|524009805|FG000|Overall Study|Excluded by Study Team|0|||
145317426|NCT02327325|524009806|FG001|Overall Study|Excluded by Study Team|0|||
145317427|NCT02327325|524009807|FG002|Overall Study|Excluded by Study Team|1|||
145317428|NCT02576717|524009812|FG000|Overall Study|Other Reasons|16|||
145317429|NCT02576717|524009813|FG001|Overall Study|Other Reasons|18|||
145317430|NCT02576717|524009814|FG002|Overall Study|Other Reasons|15|||
145317431|NCT02576717|524009812|FG000|Overall Study|Covid-19 Pandemic|0|||
145317432|NCT02576717|524009813|FG001|Overall Study|Covid-19 Pandemic|1|||
145317433|NCT02576717|524009814|FG002|Overall Study|Covid-19 Pandemic|1|||
145317434|NCT02576717|524009812|FG000|Overall Study|Sponsor Decision|0|||
145317435|NCT02576717|524009813|FG001|Overall Study|Sponsor Decision|0|||
145317436|NCT02576717|524009814|FG002|Overall Study|Sponsor Decision|1|||
145317437|NCT02576717|524009812|FG000|Overall Study|Physician Decision|3|||
145317438|NCT02576717|524009813|FG001|Overall Study|Physician Decision|8|||
145569918|NCT02457598|524945821|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569919|NCT02457598|524945822|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
145569920|NCT02457598|524945823|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
145317439|NCT02576717|524009814|FG002|Overall Study|Physician Decision|9|||
145317440|NCT02576717|524009812|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
145317441|NCT02576717|524009813|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
145317442|NCT02576717|524009814|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
145569921|NCT02457598|524945824|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
145317443|NCT02576717|524009812|FG000|Overall Study|Death|3|||
145317444|NCT02576717|524009813|FG001|Overall Study|Death|5|||
145317445|NCT02576717|524009814|FG002|Overall Study|Death|3|||
145317446|NCT02576717|524009812|FG000|Overall Study|Lost to Follow-up|9|||
145317447|NCT02576717|524009813|FG001|Overall Study|Lost to Follow-up|10|||
145317448|NCT02576717|524009814|FG002|Overall Study|Lost to Follow-up|19|||
145317449|NCT02576717|524009812|FG000|Overall Study|Protocol Violation|4|||
145317450|NCT02576717|524009813|FG001|Overall Study|Protocol Violation|0|||
145317451|NCT02576717|524009814|FG002|Overall Study|Protocol Violation|5|||
145317452|NCT02576717|524009812|FG000|Overall Study|Lack of Efficacy|24|||
145317453|NCT02576717|524009813|FG001|Overall Study|Lack of Efficacy|28|||
145317454|NCT02576717|524009814|FG002|Overall Study|Lack of Efficacy|20|||
145317455|NCT02576717|524009812|FG000|Overall Study|Adverse Event|26|||
145317456|NCT02576717|524009813|FG001|Overall Study|Adverse Event|32|||
145317457|NCT02576717|524009814|FG002|Overall Study|Adverse Event|26|||
145317458|NCT00399893|524009815|FG000|Overall Study|Withdrawal by Subject|1|||
145317459|NCT00399893|524009816|FG001|Overall Study|Withdrawal by Subject|0|||
145317460|NCT04412057|524009817|FG000|Overall Study|Death|3|||
145317461|NCT04412057|524009818|FG001|Overall Study|Death|7|||
145317462|NCT04412057|524009817|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
145317463|NCT04412057|524009818|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
145317464|NCT03330236|524009820|FG000|Overall Study|Death|2|||
145317465|NCT03330236|524009821|FG001|Overall Study|Death|1|||
145317466|NCT03330236|524009820|FG000|Overall Study|Withdrawal by Subject|2|||
145317467|NCT03330236|524009821|FG001|Overall Study|Withdrawal by Subject|4|||
145317468|NCT03330236|524009820|FG000|Overall Study|Lost to Follow-up|0|||
145317469|NCT03330236|524009821|FG001|Overall Study|Lost to Follow-up|2|||
145317470|NCT03330236|524009820|FG000|Overall Study|Physician Decision|2|||
145317471|NCT03330236|524009821|FG001|Overall Study|Physician Decision|0|||
145317472|NCT03330236|524009820|FG000|Overall Study|Protocol Violation|4|||
145317473|NCT03330236|524009821|FG001|Overall Study|Protocol Violation|3|||
145317474|NCT03330236|524009820|FG000|Overall Study|SedLine malfunction/blinding|19|||
145317475|NCT03330236|524009821|FG001|Overall Study|SedLine malfunction/blinding|14|||
145317476|NCT03330236|524009820|FG000|Overall Study|Volatile anesthetics used|11|||
145317477|NCT03330236|524009821|FG001|Overall Study|Volatile anesthetics used|8|||
145317478|NCT03330236|524009820|FG000|Overall Study|Surgery aborted/converted to open|60|||
145317479|NCT03330236|524009821|FG001|Overall Study|Surgery aborted/converted to open|52|||
145317480|NCT03710590|524009828|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
145317481|NCT03710590|524009829|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
145317482|NCT00407745|524009830|FG000|Overall Study|Lack of Efficacy|1|||
145317483|NCT00407745|524009831|FG001|Overall Study|Lack of Efficacy|2|||
145317484|NCT00407745|524009830|FG000|Overall Study|Withdrawal by Subject|3|||
145317485|NCT00407745|524009831|FG001|Overall Study|Withdrawal by Subject|3|||
145317486|NCT00407745|524009830|FG000|Overall Study|Protocol Violation|5|||
145317487|NCT00407745|524009831|FG001|Overall Study|Protocol Violation|3|||
145317488|NCT00407745|524009830|FG000|Overall Study|Adverse Event|8|||
145317489|NCT00407745|524009831|FG001|Overall Study|Adverse Event|8|||
145317490|NCT00407745|524009830|FG000|Overall Study|Other|2|||
145317491|NCT00407745|524009831|FG001|Overall Study|Other|0|||
145317492|NCT00407745|524009830|FG000|Overall Study|Randomized, unknown if treated|0|||
145317493|NCT00407745|524009831|FG001|Overall Study|Randomized, unknown if treated|1|||
145317494|NCT00108082|524009832|FG000|Overall Study|Adverse Event|14|||
145317495|NCT00108082|524009833|FG001|Overall Study|Adverse Event|12|||
145317496|NCT00108082|524009834|FG002|Overall Study|Adverse Event|17|||
145317497|NCT00108082|524009832|FG000|Overall Study|Lost to Follow-up|6|||
145317498|NCT00108082|524009833|FG001|Overall Study|Lost to Follow-up|3|||
145317499|NCT00108082|524009834|FG002|Overall Study|Lost to Follow-up|7|||
145317500|NCT00108082|524009832|FG000|Overall Study|Consent Withdrawn|3|||
145317501|NCT00108082|524009833|FG001|Overall Study|Consent Withdrawn|3|||
145317502|NCT00108082|524009834|FG002|Overall Study|Consent Withdrawn|5|||
145317503|NCT00108082|524009832|FG000|Overall Study|Protocol Violation|1|||
145317504|NCT00108082|524009833|FG001|Overall Study|Protocol Violation|2|||
145317505|NCT00108082|524009834|FG002|Overall Study|Protocol Violation|0|||
145411534|NCT02335944|524360059|FG001|Post-treatment Follow-up|Progressive Disease|0|||
145411535|NCT02335944|524360060|FG002|Post-treatment Follow-up|Progressive Disease|0|||
145411536|NCT02335944|524360061|FG003|Post-treatment Follow-up|Progressive Disease|1|||
145411537|NCT02335944|524360062|FG004|Post-treatment Follow-up|Progressive Disease|0|||
145411538|NCT02335944|524360063|FG005|Post-treatment Follow-up|Progressive Disease|9|||
145411539|NCT02335944|524360064|FG006|Post-treatment Follow-up|Progressive Disease|0|||
145411540|NCT02335944|524360065|FG007|Post-treatment Follow-up|Progressive Disease|2|||
145317506|NCT00108082|524009832|FG000|Overall Study|Lack of Efficacy|3|||
145317507|NCT00108082|524009833|FG001|Overall Study|Lack of Efficacy|1|||
145317508|NCT00108082|524009834|FG002|Overall Study|Lack of Efficacy|2|||
145317509|NCT00108082|524009832|FG000|Overall Study|Amendment 4: > Month 12|5|||
145317510|NCT00108082|524009833|FG001|Overall Study|Amendment 4: > Month 12|7|||
145317511|NCT00108082|524009834|FG002|Overall Study|Amendment 4: > Month 12|5|||
145317512|NCT00108082|524009832|FG000|Overall Study|Woman of Child-bearing Potential|2|||
145411541|NCT02335944|524360066|FG008|Post-treatment Follow-up|Progressive Disease|3|||
145620547|NCT01923428|525125105|FG003|Overall Study|Adverse Event|3|||
145317513|NCT00108082|524009833|FG001|Overall Study|Woman of Child-bearing Potential|0|||
145317514|NCT00108082|524009834|FG002|Overall Study|Woman of Child-bearing Potential|2|||
145317515|NCT00108082|524009832|FG000|Overall Study|Incorrectly Randomized|0|||
145317516|NCT00108082|524009833|FG001|Overall Study|Incorrectly Randomized|0|||
145317517|NCT00108082|524009834|FG002|Overall Study|Incorrectly Randomized|2|||
145317518|NCT00108082|524009832|FG000|Overall Study|Non-compliance|1|||
145317519|NCT00108082|524009833|FG001|Overall Study|Non-compliance|0|||
145317520|NCT00108082|524009834|FG002|Overall Study|Non-compliance|2|||
145317521|NCT00108082|524009832|FG000|Overall Study|Stopped Study Medication|0|||
145317522|NCT00108082|524009833|FG001|Overall Study|Stopped Study Medication|0|||
145317523|NCT00108082|524009834|FG002|Overall Study|Stopped Study Medication|1|||
145317524|NCT00108082|524009832|FG000|Overall Study|Site Closed Study|0|||
145317525|NCT00108082|524009833|FG001|Overall Study|Site Closed Study|2|||
145317526|NCT00108082|524009834|FG002|Overall Study|Site Closed Study|0|||
145317527|NCT00108082|524009832|FG000|Overall Study|Protocol Amendment|0|||
145317528|NCT00108082|524009833|FG001|Overall Study|Protocol Amendment|1|||
145317529|NCT00108082|524009834|FG002|Overall Study|Protocol Amendment|0|||
145317530|NCT00108082|524009832|FG000|Overall Study|Study Medication Not Tapered|0|||
145317531|NCT00108082|524009833|FG001|Overall Study|Study Medication Not Tapered|1|||
145317532|NCT00108082|524009834|FG002|Overall Study|Study Medication Not Tapered|0|||
145317533|NCT00108082|524009832|FG000|Overall Study|Subject Left Site Location|1|||
145317534|NCT00108082|524009833|FG001|Overall Study|Subject Left Site Location|0|||
145317535|NCT00108082|524009834|FG002|Overall Study|Subject Left Site Location|0|||
145317536|NCT00108082|524009832|FG000|Overall Study|Investigator Not at Site|1|||
145317537|NCT00108082|524009833|FG001|Overall Study|Investigator Not at Site|0|||
145317538|NCT00108082|524009834|FG002|Overall Study|Investigator Not at Site|0|||
145317539|NCT00108082|524009832|FG000|Overall Study|Blood Pressure Not Controlled|1|||
145317540|NCT00108082|524009833|FG001|Overall Study|Blood Pressure Not Controlled|0|||
145317541|NCT00108082|524009834|FG002|Overall Study|Blood Pressure Not Controlled|0|||
145317542|NCT02940730|524009838|FG000|Intervention 2|Physician Decision|7|||
145317543|NCT02940730|524009839|FG001|Intervention 2|Physician Decision|0|||
145317544|NCT01522950|524009840|FG000|Overall Study|Withdrawal by Subject|3|||
145317545|NCT01522950|524009841|FG001|Overall Study|Withdrawal by Subject|2|||
145317546|NCT01522950|524009842|FG002|Overall Study|Withdrawal by Subject|1|||
145317547|NCT01522950|524009840|FG000|Overall Study|Adverse Event|3|||
145317548|NCT01522950|524009841|FG001|Overall Study|Adverse Event|1|||
145317549|NCT01522950|524009842|FG002|Overall Study|Adverse Event|1|||
145317550|NCT01522950|524009840|FG000|Overall Study|Protocol Violation|0|||
145317551|NCT01522950|524009841|FG001|Overall Study|Protocol Violation|0|||
145317552|NCT01522950|524009842|FG002|Overall Study|Protocol Violation|2|||
145317553|NCT01522950|524009840|FG000|Overall Study|Death|0|||
145317554|NCT01522950|524009841|FG001|Overall Study|Death|1|||
145317555|NCT01522950|524009842|FG002|Overall Study|Death|1|||
145317556|NCT01522950|524009840|FG000|Overall Study|Study Medication Sensitivity|0|||
145317557|NCT01522950|524009841|FG001|Overall Study|Study Medication Sensitivity|1|||
145317558|NCT01522950|524009842|FG002|Overall Study|Study Medication Sensitivity|0|||
145317559|NCT01091103|524009846|FG000|Overall Study|Adverse Event|1|||
145317560|NCT01091103|524009846|FG000|Overall Study|Progressive Disease|3|||
145317561|NCT03449199|524009847|FG000|Overall Study|Lost to Follow-up|1|||
145317562|NCT03449199|524009848|FG001|Overall Study|Lost to Follow-up|1|||
145317563|NCT03449199|524009849|FG002|Overall Study|Lost to Follow-up|0|||
145317564|NCT03449199|524009847|FG000|Overall Study|Protocol Deviation|0|||
145317565|NCT03449199|524009848|FG001|Overall Study|Protocol Deviation|0|||
145317566|NCT03449199|524009849|FG002|Overall Study|Protocol Deviation|1|||
145317567|NCT03449199|524009847|FG000|Overall Study|Withdrawal by Subject|0|||
145317568|NCT03449199|524009848|FG001|Overall Study|Withdrawal by Subject|0|||
145317569|NCT03449199|524009849|FG002|Overall Study|Withdrawal by Subject|1|||
145317570|NCT03136406|524009850|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
145317571|NCT01045707|524009851|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
145317572|NCT01045707|524009852|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
145317573|NCT01045707|524009851|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
145317574|NCT01045707|524009852|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
145317575|NCT01045707|524009851|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
145317576|NCT01045707|524009852|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
145317577|NCT01045707|524009851|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
145317578|NCT01045707|524009852|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
145317579|NCT01045707|524009851|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
145317580|NCT01045707|524009852|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
145317581|NCT01045707|524009851|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
145317582|NCT01045707|524009852|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
145317583|NCT01045707|524009851|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
145317584|NCT01045707|524009852|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
145317585|NCT01045707|524009851|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
145317586|NCT01045707|524009852|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
145317587|NCT01045707|524009851|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
145317588|NCT01045707|524009852|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
145317589|NCT00348816|524009853|FG000|Overall Study|Noncompliance with radiation treatment|1|||
145317590|NCT00848042|524009854|FG000|Overall Study|Death|1|||
145317591|NCT00848042|524009855|FG001|Overall Study|Death|2|||
145317592|NCT00848042|524009856|FG002|Overall Study|Death|0|||
145317593|NCT00848042|524009854|FG000|Overall Study|Other Therapy|3|||
145317594|NCT00848042|524009855|FG001|Overall Study|Other Therapy|0|||
145317595|NCT00848042|524009856|FG002|Overall Study|Other Therapy|0|||
145317596|NCT02448563|524009860|FG000|Overall Study|Lost to Follow-up|16|||
145317597|NCT02448563|524009861|FG001|Overall Study|Lost to Follow-up|10|||
145317598|NCT02448563|524009860|FG000|Overall Study|Withdrawal by Subject|0|||
145317599|NCT02448563|524009861|FG001|Overall Study|Withdrawal by Subject|1|||
145317600|NCT03496298|524009866|FG000|Overall Study|Adverse Event|49|||
145317601|NCT03496298|524009867|FG001|Overall Study|Adverse Event|68|||
145317602|NCT03496298|524009868|FG002|Overall Study|Adverse Event|79|||
145317603|NCT03496298|524009866|FG000|Overall Study|Study terminated by Sponsor|1050|||
145569922|NCT02457598|524945825|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
145569923|NCT02457598|524945826|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569924|NCT02457598|524945827|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569925|NCT02457598|524945828|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
145569926|NCT02457598|524945829|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
145569927|NCT02457598|524945830|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
145569928|NCT02457598|524945831|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
145569929|NCT02457598|524945815|FG000|Overall Study|Withdrew Consent|0|||
145569930|NCT02457598|524945816|FG001|Overall Study|Withdrew Consent|0|||
145569931|NCT02457598|524945817|FG002|Overall Study|Withdrew Consent|0|||
145569932|NCT02457598|524945818|FG003|Overall Study|Withdrew Consent|0|||
145569933|NCT02457598|524945819|FG004|Overall Study|Withdrew Consent|0|||
145569934|NCT02457598|524945820|FG005|Overall Study|Withdrew Consent|0|||
145569935|NCT02457598|524945821|FG006|Overall Study|Withdrew Consent|0|||
145569936|NCT02457598|524945822|FG007|Overall Study|Withdrew Consent|2|||
145569937|NCT02457598|524945823|FG008|Overall Study|Withdrew Consent|0|||
145569938|NCT02457598|524945824|FG009|Overall Study|Withdrew Consent|0|||
145569939|NCT02457598|524945825|FG010|Overall Study|Withdrew Consent|3|||
145569940|NCT02457598|524945826|FG011|Overall Study|Withdrew Consent|0|||
145569941|NCT02457598|524945827|FG012|Overall Study|Withdrew Consent|0|||
145569942|NCT02457598|524945828|FG013|Overall Study|Withdrew Consent|1|||
145569943|NCT02457598|524945829|FG014|Overall Study|Withdrew Consent|0|||
145569944|NCT02457598|524945830|FG015|Overall Study|Withdrew Consent|0|||
145317604|NCT03496298|524009867|FG001|Overall Study|Study terminated by Sponsor|1063|||
145317605|NCT03496298|524009868|FG002|Overall Study|Study terminated by Sponsor|1071|||
145317606|NCT03496298|524009866|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
145317607|NCT03496298|524009867|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
145317608|NCT03496298|524009868|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
145317609|NCT03496298|524009866|FG000|Overall Study|Withdrawal by Subject|176|||
145317610|NCT03496298|524009867|FG001|Overall Study|Withdrawal by Subject|154|||
145317611|NCT03496298|524009868|FG002|Overall Study|Withdrawal by Subject|151|||
145317612|NCT03496298|524009866|FG000|Overall Study|Other|29|||
145317613|NCT03496298|524009867|FG001|Overall Study|Other|20|||
145317614|NCT03496298|524009868|FG002|Overall Study|Other|23|||
145317615|NCT03496298|524009866|FG000|Overall Study|Randomized and not treated|1|||
145317616|NCT03496298|524009867|FG001|Overall Study|Randomized and not treated|1|||
145317617|NCT03496298|524009868|FG002|Overall Study|Randomized and not treated|1|||
145317618|NCT02608476|524009871|FG000|Overall Study|Withdrawal by Subject|30|||
145317619|NCT02608476|524009872|FG001|Overall Study|Withdrawal by Subject|37|||
145317620|NCT02608476|524009871|FG000|Overall Study|Lost to Follow-up|24|||
145317621|NCT02608476|524009872|FG001|Overall Study|Lost to Follow-up|24|||
145317622|NCT02608476|524009871|FG000|Overall Study|Adverse Event|2|||
145317623|NCT02608476|524009872|FG001|Overall Study|Adverse Event|8|||
145569945|NCT02457598|524945831|FG016|Overall Study|Withdrew Consent|0|||
145569946|NCT02457598|524945815|FG000|Overall Study|Unacceptable Toxicity|0|||
145569947|NCT02457598|524945816|FG001|Overall Study|Unacceptable Toxicity|0|||
145317624|NCT02608476|524009871|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
145317625|NCT02608476|524009872|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
145569948|NCT02457598|524945817|FG002|Overall Study|Unacceptable Toxicity|0|||
145569949|NCT02457598|524945818|FG003|Overall Study|Unacceptable Toxicity|0|||
145317626|NCT02608476|524009871|FG000|Overall Study|Noncompliance with treatment|1|||
145569950|NCT02457598|524945819|FG004|Overall Study|Unacceptable Toxicity|0|||
145569951|NCT02457598|524945820|FG005|Overall Study|Unacceptable Toxicity|0|||
145569952|NCT02457598|524945821|FG006|Overall Study|Unacceptable Toxicity|0|||
145317627|NCT02608476|524009872|FG001|Overall Study|Noncompliance with treatment|5|||
145317628|NCT02608476|524009871|FG000|Overall Study|Lack of Efficacy|3|||
145569953|NCT02457598|524945822|FG007|Overall Study|Unacceptable Toxicity|0|||
145317629|NCT02608476|524009872|FG001|Overall Study|Lack of Efficacy|1|||
145317630|NCT02608476|524009871|FG000|Overall Study|Other|0|||
145317631|NCT02608476|524009872|FG001|Overall Study|Other|1|||
145317632|NCT02608476|524009871|FG000|Overall Study|Physician Decision|1|||
145317633|NCT02608476|524009872|FG001|Overall Study|Physician Decision|0|||
145317634|NCT02608476|524009871|FG000|Overall Study|Pregnancy|0|||
145317635|NCT02608476|524009872|FG001|Overall Study|Pregnancy|1|||
145317636|NCT02608476|524009871|FG000|Overall Study|Progressive disease|1|||
145317637|NCT02608476|524009872|FG001|Overall Study|Progressive disease|0|||
145317638|NCT03185741|524009875|FG000|Baseline|Withdrawal by Subject|1|||
145317639|NCT03185741|524009876|FG001|Baseline|Withdrawal by Subject|3|||
145317640|NCT03185741|524009877|FG002|Baseline|Withdrawal by Subject|2|||
145317641|NCT03185741|524009875|FG000|Baseline|Lost to Follow-up|1|||
145317642|NCT03185741|524009876|FG001|Baseline|Lost to Follow-up|2|||
145317643|NCT03185741|524009877|FG002|Baseline|Lost to Follow-up|3|||
145317644|NCT03185741|524009875|FG000|3Month|Death|1|||
145317645|NCT03185741|524009876|FG001|3Month|Death|1|||
145317646|NCT03185741|524009877|FG002|3Month|Death|2|||
145317647|NCT03185741|524009875|FG000|3Month|Withdrawal by Subject|1|||
145317648|NCT03185741|524009876|FG001|3Month|Withdrawal by Subject|5|||
145317649|NCT03185741|524009877|FG002|3Month|Withdrawal by Subject|1|||
145317650|NCT03185741|524009875|FG000|3Month|Lost to Follow-up|7|||
145317651|NCT03185741|524009876|FG001|3Month|Lost to Follow-up|9|||
145317652|NCT03185741|524009877|FG002|3Month|Lost to Follow-up|8|||
145317653|NCT03185741|524009875|FG000|3Month|Unavailable for 3Month|11|||
145317654|NCT03185741|524009876|FG001|3Month|Unavailable for 3Month|10|||
145317655|NCT03185741|524009877|FG002|3Month|Unavailable for 3Month|11|||
145317656|NCT03185741|524009875|FG000|3Month|Protocol Violation|0|||
145317657|NCT03185741|524009876|FG001|3Month|Protocol Violation|0|||
145317658|NCT03185741|524009877|FG002|3Month|Protocol Violation|3|||
145317659|NCT03185741|524009875|FG000|6Month|Death|1|||
145317660|NCT03185741|524009876|FG001|6Month|Death|1|||
145317661|NCT03185741|524009877|FG002|6Month|Death|2|||
145317662|NCT03185741|524009875|FG000|6Month|Withdrawal by Subject|2|||
145317663|NCT03185741|524009876|FG001|6Month|Withdrawal by Subject|3|||
145317664|NCT03185741|524009877|FG002|6Month|Withdrawal by Subject|1|||
145317665|NCT03185741|524009875|FG000|6Month|Lost to Follow-up|16|||
145317666|NCT03185741|524009876|FG001|6Month|Lost to Follow-up|15|||
145317667|NCT03185741|524009877|FG002|6Month|Lost to Follow-up|16|||
145317668|NCT02839798|524011691|FG000|Overall Study|Withdrawal by Subject|2|||
145317669|NCT04703855|524011692|FG000|Overall Study|Heart Transplant|1|||
145317670|NCT05258630|524011694|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
145317671|NCT05258630|524011695|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
145317672|NCT05258630|524011694|FG000|Overall Study|Lost to Follow-up|0|||
145317673|NCT05258630|524011695|FG001|Overall Study|Lost to Follow-up|2|||
145317674|NCT03431337|524011696|FG000|Overall Study|Lost to Follow-up|21|||
145317675|NCT03431337|524011697|FG001|Overall Study|Lost to Follow-up|19|||
145317676|NCT03431337|524011696|FG000|Overall Study|Withdrawal by Subject|8|||
145317677|NCT03431337|524011697|FG001|Overall Study|Withdrawal by Subject|3|||
145317678|NCT00401245|524011698|FG000|Double Blind Titration Phase|Adverse Event|3|||
145317679|NCT00401245|524011699|FG001|Double Blind Titration Phase|Adverse Event|2|||
145317680|NCT00401245|524011700|FG002|Double Blind Titration Phase|Adverse Event|5|||
145317681|NCT00401245|524011701|FG003|Double Blind Titration Phase|Adverse Event|12|||
145317682|NCT00401245|524011702|FG004|Double Blind Titration Phase|Adverse Event|0|||
145317683|NCT00401245|524011703|FG005|Double Blind Titration Phase|Adverse Event|0|||
145317684|NCT00401245|524011704|FG006|Double Blind Titration Phase|Adverse Event|0|||
145317685|NCT00401245|524011705|FG007|Double Blind Titration Phase|Adverse Event|0|||
145317686|NCT00401245|524011698|FG000|Double Blind Titration Phase|Other|0|||
145317687|NCT00401245|524011699|FG001|Double Blind Titration Phase|Other|0|||
145317688|NCT00401245|524011700|FG002|Double Blind Titration Phase|Other|1|||
145317689|NCT00401245|524011701|FG003|Double Blind Titration Phase|Other|0|||
145317690|NCT00401245|524011702|FG004|Double Blind Titration Phase|Other|0|||
145317691|NCT00401245|524011703|FG005|Double Blind Titration Phase|Other|0|||
145317692|NCT00401245|524011704|FG006|Double Blind Titration Phase|Other|0|||
145317693|NCT00401245|524011705|FG007|Double Blind Titration Phase|Other|0|||
145620548|NCT01923428|525125102|FG000|Overall Study|Withdrawal by Subject|5|||
145317694|NCT00401245|524011698|FG000|Double Blind Titration Phase|Protocol Violation|0|||
145317695|NCT00401245|524011699|FG001|Double Blind Titration Phase|Protocol Violation|0|||
145317696|NCT00401245|524011700|FG002|Double Blind Titration Phase|Protocol Violation|0|||
145317697|NCT00401245|524011701|FG003|Double Blind Titration Phase|Protocol Violation|1|||
145317698|NCT00401245|524011702|FG004|Double Blind Titration Phase|Protocol Violation|0|||
145317699|NCT00401245|524011703|FG005|Double Blind Titration Phase|Protocol Violation|0|||
145317700|NCT00401245|524011704|FG006|Double Blind Titration Phase|Protocol Violation|0|||
145317701|NCT00401245|524011705|FG007|Double Blind Titration Phase|Protocol Violation|0|||
145317702|NCT00401245|524011698|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
145317703|NCT00401245|524011699|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
145317704|NCT00401245|524011700|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
145317705|NCT00401245|524011701|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
145317706|NCT00401245|524011702|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
145317707|NCT00401245|524011703|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
145620549|NCT01923428|525125103|FG001|Overall Study|Withdrawal by Subject|3|||
145569954|NCT02457598|524945823|FG008|Overall Study|Unacceptable Toxicity|0|||
145569955|NCT02457598|524945824|FG009|Overall Study|Unacceptable Toxicity|0|||
145569956|NCT02457598|524945825|FG010|Overall Study|Unacceptable Toxicity|1|||
145569957|NCT02457598|524945826|FG011|Overall Study|Unacceptable Toxicity|0|||
145569958|NCT02457598|524945827|FG012|Overall Study|Unacceptable Toxicity|1|||
145569959|NCT02457598|524945828|FG013|Overall Study|Unacceptable Toxicity|1|||
145569960|NCT02457598|524945829|FG014|Overall Study|Unacceptable Toxicity|1|||
145569961|NCT02457598|524945830|FG015|Overall Study|Unacceptable Toxicity|0|||
145569962|NCT02457598|524945831|FG016|Overall Study|Unacceptable Toxicity|0|||
145569963|NCT02457598|524945815|FG000|Overall Study|Intercurrent Illness|0|||
145569964|NCT02457598|524945816|FG001|Overall Study|Intercurrent Illness|0|||
145569965|NCT02457598|524945817|FG002|Overall Study|Intercurrent Illness|0|||
145569966|NCT02457598|524945818|FG003|Overall Study|Intercurrent Illness|0|||
145569967|NCT02457598|524945819|FG004|Overall Study|Intercurrent Illness|0|||
145569968|NCT02457598|524945820|FG005|Overall Study|Intercurrent Illness|0|||
145569969|NCT02457598|524945821|FG006|Overall Study|Intercurrent Illness|0|||
145569970|NCT02457598|524945822|FG007|Overall Study|Intercurrent Illness|0|||
145569971|NCT02457598|524945823|FG008|Overall Study|Intercurrent Illness|0|||
145569972|NCT02457598|524945824|FG009|Overall Study|Intercurrent Illness|0|||
145569973|NCT02457598|524945825|FG010|Overall Study|Intercurrent Illness|1|||
145569974|NCT02457598|524945826|FG011|Overall Study|Intercurrent Illness|0|||
145569975|NCT02457598|524945827|FG012|Overall Study|Intercurrent Illness|0|||
145569976|NCT02457598|524945828|FG013|Overall Study|Intercurrent Illness|0|||
145569977|NCT02457598|524945829|FG014|Overall Study|Intercurrent Illness|0|||
145317708|NCT00401245|524011704|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
145317709|NCT00401245|524011705|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
145317710|NCT00401245|524011698|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317711|NCT00401245|524011699|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
145317712|NCT00401245|524011700|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317713|NCT00401245|524011701|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
145317714|NCT00401245|524011702|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317715|NCT00401245|524011703|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317716|NCT00401245|524011704|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317717|NCT00401245|524011705|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
145317718|NCT00401245|524011698|FG000|Open Label Phase|Adverse Event|5|||
145317719|NCT00401245|524011699|FG001|Open Label Phase|Adverse Event|14|||
145317720|NCT00401245|524011700|FG002|Open Label Phase|Adverse Event|6|||
145317721|NCT00401245|524011701|FG003|Open Label Phase|Adverse Event|7|||
145317722|NCT00401245|524011702|FG004|Open Label Phase|Adverse Event|0|||
145317723|NCT00401245|524011703|FG005|Open Label Phase|Adverse Event|0|||
145317724|NCT00401245|524011704|FG006|Open Label Phase|Adverse Event|0|||
145317725|NCT00401245|524011705|FG007|Open Label Phase|Adverse Event|0|||
145317726|NCT00401245|524011698|FG000|Open Label Phase|Lost to Follow-up|5|||
145317727|NCT00401245|524011699|FG001|Open Label Phase|Lost to Follow-up|7|||
145317728|NCT00401245|524011700|FG002|Open Label Phase|Lost to Follow-up|5|||
145317729|NCT00401245|524011701|FG003|Open Label Phase|Lost to Follow-up|4|||
145569978|NCT02457598|524945830|FG015|Overall Study|Intercurrent Illness|0|||
145569979|NCT02457598|524945831|FG016|Overall Study|Intercurrent Illness|0|||
145569980|NCT02457598|524945815|FG000|Overall Study|Protocol Violation|0|||
145569981|NCT02457598|524945816|FG001|Overall Study|Protocol Violation|0|||
145620550|NCT01923428|525125104|FG002|Overall Study|Withdrawal by Subject|0|||
145317730|NCT00401245|524011702|FG004|Open Label Phase|Lost to Follow-up|0|||
145317731|NCT00401245|524011703|FG005|Open Label Phase|Lost to Follow-up|0|||
145317732|NCT00401245|524011704|FG006|Open Label Phase|Lost to Follow-up|0|||
145317733|NCT00401245|524011705|FG007|Open Label Phase|Lost to Follow-up|0|||
145317734|NCT00401245|524011698|FG000|Open Label Phase|Other|4|||
145317735|NCT00401245|524011699|FG001|Open Label Phase|Other|8|||
145317736|NCT00401245|524011700|FG002|Open Label Phase|Other|7|||
145317737|NCT00401245|524011701|FG003|Open Label Phase|Other|8|||
145317738|NCT00401245|524011702|FG004|Open Label Phase|Other|0|||
145317739|NCT00401245|524011703|FG005|Open Label Phase|Other|0|||
145317740|NCT00401245|524011704|FG006|Open Label Phase|Other|0|||
145317741|NCT00401245|524011705|FG007|Open Label Phase|Other|0|||
145317742|NCT00401245|524011698|FG000|Open Label Phase|Protocol Violation|0|||
145317743|NCT00401245|524011699|FG001|Open Label Phase|Protocol Violation|1|||
145317744|NCT00401245|524011700|FG002|Open Label Phase|Protocol Violation|0|||
145317745|NCT00401245|524011701|FG003|Open Label Phase|Protocol Violation|1|||
145317746|NCT00401245|524011702|FG004|Open Label Phase|Protocol Violation|0|||
145317747|NCT00401245|524011703|FG005|Open Label Phase|Protocol Violation|0|||
145317748|NCT00401245|524011704|FG006|Open Label Phase|Protocol Violation|0|||
145317749|NCT00401245|524011705|FG007|Open Label Phase|Protocol Violation|0|||
145317750|NCT00401245|524011698|FG000|Open Label Phase|Withdrawal by Subject|3|||
145317751|NCT00401245|524011699|FG001|Open Label Phase|Withdrawal by Subject|3|||
145317752|NCT00401245|524011700|FG002|Open Label Phase|Withdrawal by Subject|2|||
145569982|NCT02457598|524945817|FG002|Overall Study|Protocol Violation|0|||
145569983|NCT02457598|524945818|FG003|Overall Study|Protocol Violation|0|||
145317753|NCT00401245|524011701|FG003|Open Label Phase|Withdrawal by Subject|1|||
145317754|NCT00401245|524011702|FG004|Open Label Phase|Withdrawal by Subject|0|||
145317755|NCT00401245|524011703|FG005|Open Label Phase|Withdrawal by Subject|0|||
145317756|NCT00401245|524011704|FG006|Open Label Phase|Withdrawal by Subject|0|||
145317757|NCT00401245|524011705|FG007|Open Label Phase|Withdrawal by Subject|0|||
145317758|NCT00401245|524011698|FG000|Open Label Phase|Lack of Efficacy|4|||
145317759|NCT00401245|524011699|FG001|Open Label Phase|Lack of Efficacy|2|||
145317760|NCT00401245|524011700|FG002|Open Label Phase|Lack of Efficacy|3|||
145317761|NCT00401245|524011701|FG003|Open Label Phase|Lack of Efficacy|0|||
145317762|NCT00401245|524011702|FG004|Open Label Phase|Lack of Efficacy|0|||
145317763|NCT00401245|524011703|FG005|Open Label Phase|Lack of Efficacy|0|||
145317764|NCT00401245|524011704|FG006|Open Label Phase|Lack of Efficacy|0|||
145317765|NCT00401245|524011705|FG007|Open Label Phase|Lack of Efficacy|0|||
145317766|NCT00401245|524011698|FG000|Double Blind Tapering Phase|Adverse Event|0|||
145317767|NCT00401245|524011699|FG001|Double Blind Tapering Phase|Adverse Event|0|||
145317768|NCT00401245|524011700|FG002|Double Blind Tapering Phase|Adverse Event|0|||
145317769|NCT00401245|524011701|FG003|Double Blind Tapering Phase|Adverse Event|0|||
145317770|NCT00401245|524011702|FG004|Double Blind Tapering Phase|Adverse Event|1|||
145317771|NCT00401245|524011703|FG005|Double Blind Tapering Phase|Adverse Event|1|||
145317772|NCT00401245|524011704|FG006|Double Blind Tapering Phase|Adverse Event|2|||
145317773|NCT00401245|524011705|FG007|Double Blind Tapering Phase|Adverse Event|4|||
145317774|NCT00401245|524011698|FG000|Double Blind Tapering Phase|Investigator request|0|||
145317775|NCT00401245|524011699|FG001|Double Blind Tapering Phase|Investigator request|0|||
145317776|NCT00401245|524011700|FG002|Double Blind Tapering Phase|Investigator request|0|||
145317777|NCT00401245|524011701|FG003|Double Blind Tapering Phase|Investigator request|0|||
145317778|NCT00401245|524011702|FG004|Double Blind Tapering Phase|Investigator request|0|||
145317779|NCT00401245|524011703|FG005|Double Blind Tapering Phase|Investigator request|0|||
145317780|NCT00401245|524011704|FG006|Double Blind Tapering Phase|Investigator request|0|||
145317781|NCT00401245|524011705|FG007|Double Blind Tapering Phase|Investigator request|1|||
145317782|NCT00401245|524011698|FG000|Double Blind Tapering Phase|Other|0|||
145317783|NCT00401245|524011699|FG001|Double Blind Tapering Phase|Other|0|||
145317784|NCT00401245|524011700|FG002|Double Blind Tapering Phase|Other|0|||
145317785|NCT00401245|524011701|FG003|Double Blind Tapering Phase|Other|0|||
145317786|NCT00401245|524011702|FG004|Double Blind Tapering Phase|Other|1|||
145317787|NCT00401245|524011703|FG005|Double Blind Tapering Phase|Other|0|||
145317788|NCT00401245|524011704|FG006|Double Blind Tapering Phase|Other|2|||
145317789|NCT00401245|524011705|FG007|Double Blind Tapering Phase|Other|2|||
145317790|NCT00401245|524011698|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145317791|NCT00401245|524011699|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145317792|NCT00401245|524011700|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145317793|NCT00401245|524011701|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145317794|NCT00401245|524011702|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
145317795|NCT00401245|524011703|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
145317796|NCT00401245|524011704|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
145317797|NCT00401245|524011705|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
145317798|NCT00401245|524011698|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317799|NCT00401245|524011699|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317800|NCT00401245|524011700|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317801|NCT00401245|524011701|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317802|NCT00401245|524011702|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317803|NCT00401245|524011703|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
145317804|NCT00401245|524011704|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317805|NCT00401245|524011705|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
145317806|NCT01560819|524011709|FG000|Overall Study|Physician Decision|1|||
145317807|NCT01560819|524011710|FG001|Overall Study|Physician Decision|0|||
145317808|NCT02014441|524011711|FG000|Overall Study|Withdrawal by Subject|12|||
145317809|NCT01363011|524011712|FG000|Main Study|Adverse Event|2|||
145317810|NCT01363011|524011713|FG001|Main Study|Adverse Event|3|||
145317811|NCT01363011|524011712|FG000|Main Study|Investigator's Discretion|1|||
145317812|NCT01363011|524011713|FG001|Main Study|Investigator's Discretion|1|||
145317813|NCT01363011|524011712|FG000|Main Study|Withdrew Consent|1|||
145317814|NCT01363011|524011713|FG001|Main Study|Withdrew Consent|4|||
145317815|NCT01363011|524011712|FG000|Main Study|Protocol Violation|0|||
145317816|NCT01363011|524011713|FG001|Main Study|Protocol Violation|1|||
145317817|NCT01363011|524011712|FG000|Extension Phase|Adverse Event|1|||
145317818|NCT01363011|524011713|FG001|Extension Phase|Adverse Event|1|||
145317819|NCT01363011|524011712|FG000|Extension Phase|Lack of Efficacy|0|||
145317820|NCT01363011|524011713|FG001|Extension Phase|Lack of Efficacy|1|||
145317821|NCT01363011|524011712|FG000|Extension Phase|Investigator's Discretion|2|||
145317822|NCT01363011|524011713|FG001|Extension Phase|Investigator's Discretion|2|||
145317823|NCT01363011|524011712|FG000|Extension Phase|Withdrew Consent|0|||
145317824|NCT01363011|524011713|FG001|Extension Phase|Withdrew Consent|1|||
145317825|NCT01363011|524011712|FG000|Extension Phase|Lost to Follow-up|0|||
145317826|NCT01363011|524011713|FG001|Extension Phase|Lost to Follow-up|2|||
145317827|NCT01363011|524011712|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
145317828|NCT01363011|524011713|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
145317829|NCT00114231|524011714|FG000|Overall Study|No consent|2|||
145317830|NCT00114231|524011715|FG001|Overall Study|No consent|0|||
145317831|NCT00114231|524011714|FG000|Overall Study|QARC requirement not met|1|||
145317832|NCT00114231|524011715|FG001|Overall Study|QARC requirement not met|0|||
145317833|NCT00114231|524011714|FG000|Overall Study|Suspected metastatic disease|1|||
145317834|NCT00114231|524011715|FG001|Overall Study|Suspected metastatic disease|0|||
145317835|NCT00114231|524011714|FG000|Overall Study|No adenocarcinoma|1|||
145317836|NCT00114231|524011715|FG001|Overall Study|No adenocarcinoma|0|||
145317837|NCT00114231|524011714|FG000|Overall Study|Low creatinine clearance|0|||
145317838|NCT00114231|524011715|FG001|Overall Study|Low creatinine clearance|1|||
145317839|NCT00114231|524011714|FG000|Overall Study|Tumor size > 4cm|1|||
145317840|NCT00114231|524011715|FG001|Overall Study|Tumor size > 4cm|0|||
145317841|NCT00114231|524011714|FG000|Overall Study|Tumor fixed on digital exam|0|||
145317842|NCT00114231|524011715|FG001|Overall Study|Tumor fixed on digital exam|1|||
145317843|NCT00114231|524011714|FG000|Overall Study|No Absolute Neutrophil Count|2|||
145317844|NCT00114231|524011715|FG001|Overall Study|No Absolute Neutrophil Count|0|||
145317845|NCT00114231|524011714|FG000|Overall Study|Biopsy done after registration|1|||
145317846|NCT00114231|524011715|FG001|Overall Study|Biopsy done after registration|0|||
145317847|NCT01961882|524011720|FG000|Overall Study|Adverse Event|3|||
145317848|NCT01961882|524011721|FG001|Overall Study|Adverse Event|2|||
145317849|NCT01961882|524011720|FG000|Overall Study|Physician Decision|1|||
145317850|NCT01961882|524011721|FG001|Overall Study|Physician Decision|0|||
145317851|NCT01961882|524011720|FG000|Overall Study|Withdrawal by Subject|4|||
145317852|NCT01961882|524011721|FG001|Overall Study|Withdrawal by Subject|1|||
145317853|NCT01961882|524011720|FG000|Overall Study|Relapse of AML|39|||
145317854|NCT01961882|524011721|FG001|Overall Study|Relapse of AML|37|||
145317855|NCT01961882|524011720|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
145317856|NCT01961882|524011721|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
145317857|NCT01961882|524011720|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
145317858|NCT01961882|524011721|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
145317859|NCT01901848|524011722|FG000|Randomized and Treated|Lost to Follow-up|3|||
145317860|NCT01901848|524011723|FG001|Randomized and Treated|Lost to Follow-up|6|||
145317861|NCT01901848|524011722|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
145317862|NCT01901848|524011723|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
145317863|NCT01729026|524011724|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
145317864|NCT01729026|524011725|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
145317865|NCT01729026|524011724|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
145317866|NCT01729026|524011725|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
145317867|NCT02488824|524011726|FG000|Overall Study|Adverse Event|1|||
145317868|NCT02488824|524011727|FG001|Overall Study|Adverse Event|1|||
145317869|NCT00412737|524011728|FG000|Overall Study|Death|1|||
145317870|NCT00412737|524011729|FG001|Overall Study|Death|0|||
145317871|NCT00412737|524011728|FG000|Overall Study|Adverse Event|3|||
145317872|NCT00412737|524011729|FG001|Overall Study|Adverse Event|2|||
145317873|NCT00412737|524011728|FG000|Overall Study|Refused Treatment|6|||
145317874|NCT00412737|524011729|FG001|Overall Study|Refused Treatment|2|||
145317875|NCT00412737|524011728|FG000|Overall Study|Failure to Return|6|||
145317876|NCT00412737|524011729|FG001|Overall Study|Failure to Return|2|||
145317877|NCT01064531|524011730|FG000|Overall Study|Lost to Follow-up|0|||
145317878|NCT01064531|524011731|FG001|Overall Study|Lost to Follow-up|2|||
145317879|NCT01064531|524011730|FG000|Overall Study|Physician Decision|0|||
145317880|NCT01064531|524011731|FG001|Overall Study|Physician Decision|1|||
145317881|NCT01064531|524011730|FG000|Overall Study|Withdrawal by Subject|2|||
145317882|NCT01064531|524011731|FG001|Overall Study|Withdrawal by Subject|2|||
145317883|NCT01064531|524011730|FG000|Overall Study|Revision due to femoral stem loosening|1|||
145317884|NCT01064531|524011731|FG001|Overall Study|Revision due to femoral stem loosening|0|||
145317885|NCT01064531|524011730|FG000|Overall Study|Revision due to dislocation|0|||
145317886|NCT01064531|524011731|FG001|Overall Study|Revision due to dislocation|1|||
145317887|NCT01064531|524011730|FG000|Overall Study|Death|0|||
145317888|NCT01064531|524011731|FG001|Overall Study|Death|1|||
145317889|NCT01270620|524011735|FG000|Overall Study|Withdrawal by Subject|1|||
145317890|NCT01270620|524011736|FG001|Overall Study|Withdrawal by Subject|3|||
145317891|NCT04317599|524011737|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
145317892|NCT04317599|524011737|FG000|Overall Study|treatment outside standard of care|4|||
145317893|NCT00809965|524011738|FG000|Overall Study|Death|194|||
145317894|NCT00809965|524011739|FG001|Overall Study|Death|147|||
145317895|NCT00809965|524011740|FG002|Overall Study|Death|196|||
145317896|NCT00809965|524011738|FG000|Overall Study|Lost to Follow-up|17|||
145317897|NCT00809965|524011739|FG001|Overall Study|Lost to Follow-up|10|||
145317898|NCT00809965|524011740|FG002|Overall Study|Lost to Follow-up|18|||
145317899|NCT00809965|524011738|FG000|Overall Study|Withdrawal by Subject|405|||
145317900|NCT00809965|524011739|FG001|Overall Study|Withdrawal by Subject|448|||
145317901|NCT00809965|524011740|FG002|Overall Study|Withdrawal by Subject|441|||
145411542|NCT02335944|524360067|FG009|Post-treatment Follow-up|Progressive Disease|0|||
145411543|NCT02335944|524360058|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411544|NCT02335944|524360059|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145569984|NCT02457598|524945819|FG004|Overall Study|Protocol Violation|0|||
145569985|NCT02457598|524945820|FG005|Overall Study|Protocol Violation|0|||
145569986|NCT02457598|524945821|FG006|Overall Study|Protocol Violation|0|||
145569987|NCT02457598|524945822|FG007|Overall Study|Protocol Violation|0|||
145317902|NCT00809965|524011738|FG000|Overall Study|Other Reason|167|||
145317903|NCT00809965|524011739|FG001|Overall Study|Other Reason|170|||
145317904|NCT00809965|524011740|FG002|Overall Study|Other Reason|189|||
145317905|NCT01628549|524011743|FG000|Overall Study|Adverse Event|1|||
145317906|NCT01628549|524011744|FG001|Overall Study|Adverse Event|1|||
145317907|NCT01628549|524011745|FG002|Overall Study|Adverse Event|0|||
145317908|NCT01628549|524011746|FG003|Overall Study|Adverse Event|4|||
145317909|NCT01628549|524011743|FG000|Overall Study|Lost to Follow-up|3|||
145317910|NCT01628549|524011744|FG001|Overall Study|Lost to Follow-up|4|||
145317911|NCT01628549|524011745|FG002|Overall Study|Lost to Follow-up|3|||
145317912|NCT01628549|524011746|FG003|Overall Study|Lost to Follow-up|3|||
145317913|NCT01628549|524011743|FG000|Overall Study|Withdrawal by Subject|3|||
145317914|NCT01628549|524011744|FG001|Overall Study|Withdrawal by Subject|4|||
145317915|NCT01628549|524011745|FG002|Overall Study|Withdrawal by Subject|4|||
145317916|NCT01628549|524011746|FG003|Overall Study|Withdrawal by Subject|1|||
145317917|NCT01628549|524011743|FG000|Overall Study|Protocol Violation|2|||
145317918|NCT01628549|524011744|FG001|Overall Study|Protocol Violation|1|||
145317919|NCT01628549|524011745|FG002|Overall Study|Protocol Violation|1|||
145317920|NCT01628549|524011746|FG003|Overall Study|Protocol Violation|0|||
145317921|NCT01628549|524011743|FG000|Overall Study|withdrawn for noncompliance|0|||
145317922|NCT01628549|524011744|FG001|Overall Study|withdrawn for noncompliance|2|||
145317923|NCT01628549|524011745|FG002|Overall Study|withdrawn for noncompliance|1|||
145317924|NCT01628549|524011746|FG003|Overall Study|withdrawn for noncompliance|0|||
145317925|NCT01628549|524011743|FG000|Overall Study|abnormal laboratory test results|0|||
145317926|NCT01628549|524011744|FG001|Overall Study|abnormal laboratory test results|0|||
145317927|NCT01628549|524011745|FG002|Overall Study|abnormal laboratory test results|1|||
145317928|NCT01628549|524011746|FG003|Overall Study|abnormal laboratory test results|0|||
145317929|NCT01628549|524011743|FG000|Overall Study|positive pregnancy test|0|||
145317930|NCT01628549|524011744|FG001|Overall Study|positive pregnancy test|0|||
145317931|NCT01628549|524011745|FG002|Overall Study|positive pregnancy test|0|||
145317932|NCT01628549|524011746|FG003|Overall Study|positive pregnancy test|1|||
145317933|NCT01999894|524011747|FG000|Overall Study|Adverse Event|9|||
145317934|NCT01999894|524011747|FG000|Overall Study|Lack of Efficacy|5|||
145317935|NCT01999894|524011747|FG000|Overall Study|Protocol Violation|1|||
145317936|NCT01999894|524011747|FG000|Overall Study|Withdrawal by Subject|7|||
145317937|NCT01999894|524011747|FG000|Overall Study|Lost to Follow-up|10|||
145317938|NCT01999894|524011747|FG000|Overall Study|Other Reason|3|||
145317939|NCT01999894|524011747|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
145317940|NCT00194792|524011750|FG000|Overall Study|Withdrawal by Subject|1|||
145317941|NCT00372996|524011752|FG000|Overall Study|Death|11|||
145317942|NCT00372996|524011753|FG001|Overall Study|Death|4|||
145317943|NCT00372996|524011754|FG002|Overall Study|Death|8|||
145317944|NCT00372996|524011755|FG003|Overall Study|Death|7|||
145317945|NCT00372996|524011752|FG000|Overall Study|Lost to Follow-up|0|||
145317946|NCT00372996|524011753|FG001|Overall Study|Lost to Follow-up|2|||
145317947|NCT00372996|524011754|FG002|Overall Study|Lost to Follow-up|0|||
145317948|NCT00372996|524011755|FG003|Overall Study|Lost to Follow-up|1|||
145317949|NCT00372996|524011752|FG000|Overall Study|Withdrawal by Subject|12|||
145317950|NCT00372996|524011753|FG001|Overall Study|Withdrawal by Subject|6|||
145317951|NCT00372996|524011754|FG002|Overall Study|Withdrawal by Subject|9|||
145317952|NCT00372996|524011755|FG003|Overall Study|Withdrawal by Subject|5|||
145317953|NCT00372996|524011752|FG000|Overall Study|Study Terminated by Sponsor|4|||
145569988|NCT02457598|524945823|FG008|Overall Study|Protocol Violation|0|||
145569989|NCT02457598|524945824|FG009|Overall Study|Protocol Violation|0|||
145569990|NCT02457598|524945825|FG010|Overall Study|Protocol Violation|1|||
145317954|NCT00372996|524011753|FG001|Overall Study|Study Terminated by Sponsor|0|||
145317955|NCT00372996|524011754|FG002|Overall Study|Study Terminated by Sponsor|4|||
145317956|NCT00372996|524011755|FG003|Overall Study|Study Terminated by Sponsor|0|||
145317957|NCT00372996|524011752|FG000|Overall Study|Other|10|||
145317958|NCT00372996|524011753|FG001|Overall Study|Other|2|||
145317959|NCT00372996|524011754|FG002|Overall Study|Other|7|||
145317960|NCT00372996|524011755|FG003|Overall Study|Other|7|||
145317961|NCT01186016|524011756|FG000|Overall Study|Withdrawal by Subject|46|||
145317962|NCT01186016|524011757|FG001|Overall Study|Withdrawal by Subject|29|||
145317963|NCT00721955|524011761|FG000|Overall Study|Adverse Event|0|||
145317964|NCT00721955|524011762|FG001|Overall Study|Adverse Event|0|||
145317965|NCT00721955|524011763|FG002|Overall Study|Adverse Event|2|||
145317966|NCT01077258|524011768|FG000|Overall Study|Lost to Follow-up|1390|||
145317967|NCT01077258|524011768|FG000|Overall Study|Adverse drug reaction|218|||
145317968|NCT01077258|524011768|FG000|Overall Study|Lack of Efficacy|663|||
145317969|NCT01077258|524011768|FG000|Overall Study|Clinical remission|37|||
145317970|NCT01077258|524011768|FG000|Overall Study|Other reasons|260|||
145317971|NCT00515216|524011769|FG000|Overall Study|Withdrawal by Subject|1|||
145317972|NCT00726895|524011771|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145317973|NCT00726895|524011772|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145317974|NCT01450800|524011782|FG000|Overall Study|Protocol Violation|1|||
145317975|NCT01450800|524011783|FG001|Overall Study|Protocol Violation|3|||
145317976|NCT01115933|524011785|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
145317977|NCT01086969|524011794|FG000|Overall Study|Withdrawal by Subject|1|||
145317978|NCT01086969|524011795|FG001|Overall Study|Withdrawal by Subject|2|||
145317979|NCT01086969|524011796|FG002|Overall Study|Withdrawal by Subject|0|||
145317980|NCT02418754|524011803|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145317981|NCT02418754|524011804|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
145317982|NCT02418754|524011805|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145317983|NCT02418754|524011806|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145317984|NCT02418754|524011807|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
145317985|NCT02418754|524011803|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
145317986|NCT02418754|524011804|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
145317987|NCT02418754|524011805|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
145317988|NCT02418754|524011806|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
145317989|NCT02418754|524011807|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
145317990|NCT02418754|524011803|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
145317991|NCT02418754|524011804|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145317992|NCT02418754|524011805|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145317993|NCT02418754|524011806|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145317994|NCT02418754|524011807|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
145317995|NCT02418754|524011803|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145317996|NCT02418754|524011804|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
145317997|NCT02418754|524011805|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
145317998|NCT02418754|524011806|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145317999|NCT02418754|524011807|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
145318000|NCT02418754|524011803|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145318001|NCT02418754|524011804|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145318002|NCT02418754|524011805|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
145318003|NCT02418754|524011806|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145318004|NCT02418754|524011807|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
145318005|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
145318006|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
145318007|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
145318008|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
145318009|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
145318010|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
145318011|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145318012|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145318013|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145318014|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
145318015|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
145318016|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
145318017|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
145318018|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
145318019|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
145318020|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
145318021|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
145318022|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
145318023|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
145318024|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
145318025|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
145318026|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
145318027|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
145318028|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
145318029|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
145318030|NCT02418754|524011803|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145318031|NCT02418754|524011804|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
145318032|NCT02418754|524011805|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145318033|NCT02418754|524011806|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
145569991|NCT02457598|524945826|FG011|Overall Study|Protocol Violation|0|||
145318034|NCT02418754|524011807|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
145411545|NCT02335944|524360060|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145569992|NCT02457598|524945827|FG012|Overall Study|Protocol Violation|0|||
145569993|NCT02457598|524945828|FG013|Overall Study|Protocol Violation|0|||
145569994|NCT02457598|524945829|FG014|Overall Study|Protocol Violation|0|||
145569995|NCT02457598|524945830|FG015|Overall Study|Protocol Violation|0|||
145318035|NCT00129116|524011816|FG000|Primary Phase|Lost to Follow-up|1|||
145318036|NCT00129116|524011817|FG001|Primary Phase|Lost to Follow-up|1|||
145318037|NCT00129116|524011818|FG002|Primary Phase|Lost to Follow-up|0|||
145318038|NCT00129116|524011819|FG003|Primary Phase|Lost to Follow-up|1|||
145318039|NCT00129116|524011820|FG004|Primary Phase|Lost to Follow-up|1|||
145318040|NCT00129116|524011816|FG000|Primary Phase|Protocol Violation|0|||
145318041|NCT00129116|524011817|FG001|Primary Phase|Protocol Violation|1|||
145318042|NCT00129116|524011818|FG002|Primary Phase|Protocol Violation|0|||
145318043|NCT00129116|524011819|FG003|Primary Phase|Protocol Violation|0|||
145318044|NCT00129116|524011820|FG004|Primary Phase|Protocol Violation|0|||
145318045|NCT00129116|524011816|FG000|Primary Phase|Adverse Event|1|||
145318046|NCT00129116|524011817|FG001|Primary Phase|Adverse Event|1|||
145318047|NCT00129116|524011818|FG002|Primary Phase|Adverse Event|0|||
145318048|NCT00129116|524011819|FG003|Primary Phase|Adverse Event|0|||
145318049|NCT00129116|524011820|FG004|Primary Phase|Adverse Event|0|||
145318050|NCT00129116|524011816|FG000|Primary Phase|Withdrawal by Subject|0|||
145318051|NCT00129116|524011817|FG001|Primary Phase|Withdrawal by Subject|1|||
145318052|NCT00129116|524011818|FG002|Primary Phase|Withdrawal by Subject|0|||
145318053|NCT00129116|524011819|FG003|Primary Phase|Withdrawal by Subject|0|||
145318054|NCT00129116|524011820|FG004|Primary Phase|Withdrawal by Subject|0|||
145318055|NCT00129116|524011816|FG000|Primary Phase|Other|0|||
145318056|NCT00129116|524011817|FG001|Primary Phase|Other|0|||
145318057|NCT00129116|524011818|FG002|Primary Phase|Other|1|||
145318058|NCT00129116|524011819|FG003|Primary Phase|Other|0|||
145318059|NCT00129116|524011820|FG004|Primary Phase|Other|0|||
145318060|NCT00129116|524011816|FG000|Booster Phase|Lost to Follow-up|2|||
145318061|NCT00129116|524011817|FG001|Booster Phase|Lost to Follow-up|0|||
145318062|NCT00129116|524011818|FG002|Booster Phase|Lost to Follow-up|0|||
145318063|NCT00129116|524011819|FG003|Booster Phase|Lost to Follow-up|0|||
145318064|NCT00129116|524011820|FG004|Booster Phase|Lost to Follow-up|1|||
145318065|NCT00879684|524011821|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
145318066|NCT00879684|524011822|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
145318067|NCT00879684|524011823|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
145318068|NCT00879684|524011824|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
145318069|NCT00879684|524011825|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
145318070|NCT00879684|524011826|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
145318071|NCT00879684|524011827|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
145318072|NCT00879684|524011821|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
145318073|NCT00879684|524011822|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
145318074|NCT00879684|524011823|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
145318075|NCT00879684|524011824|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
145318076|NCT00879684|524011825|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
145318077|NCT00879684|524011826|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
145318078|NCT00879684|524011827|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
145318079|NCT00879684|524011821|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
145318080|NCT00879684|524011822|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
145318081|NCT00879684|524011823|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
145318082|NCT00879684|524011824|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
145318083|NCT00879684|524011825|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
145318084|NCT00879684|524011826|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
145318085|NCT00879684|524011827|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
145318086|NCT00879684|524011821|FG000|Stage 1: Dose Escalation|Death|0|||
145318087|NCT00879684|524011822|FG001|Stage 1: Dose Escalation|Death|0|||
145318088|NCT00879684|524011823|FG002|Stage 1: Dose Escalation|Death|1|||
145318089|NCT00879684|524011824|FG003|Stage 1: Dose Escalation|Death|0|||
145318090|NCT00879684|524011825|FG004|Stage 1: Dose Escalation|Death|0|||
145318091|NCT00879684|524011826|FG005|Stage 1: Dose Escalation|Death|0|||
145318092|NCT00879684|524011827|FG006|Stage 1: Dose Escalation|Death|0|||
145318093|NCT00879684|524011821|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318094|NCT00879684|524011822|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318095|NCT00879684|524011823|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318096|NCT00879684|524011824|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318097|NCT00879684|524011825|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318098|NCT00879684|524011826|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
145318099|NCT00879684|524011827|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
145318100|NCT00879684|524011821|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318101|NCT00879684|524011822|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318102|NCT00879684|524011823|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318103|NCT00879684|524011824|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318104|NCT00879684|524011825|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318105|NCT00879684|524011826|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
145318106|NCT00879684|524011827|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
145569996|NCT02457598|524945831|FG016|Overall Study|Protocol Violation|0|||
145569997|NCT03837899|524945832|FG000|Overall Study|Death|6|||
145569998|NCT03837899|524945833|FG001|Overall Study|Death|8|||
145569999|NCT03837899|524945834|FG002|Overall Study|Death|3|||
145570000|NCT03837899|524945835|FG003|Overall Study|Death|7|||
145570001|NCT03837899|524945836|FG004|Overall Study|Death|8|||
145318107|NCT00879684|524011821|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318108|NCT00879684|524011822|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318109|NCT00879684|524011823|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318110|NCT00879684|524011824|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318111|NCT00879684|524011825|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318112|NCT00879684|524011826|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
145318113|NCT00879684|524011827|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
145318114|NCT00708682|524011828|FG000|Infant Series|Adverse Event|1|||
145318115|NCT00708682|524011828|FG000|Infant Series|Lost to Follow-up|4|||
145318116|NCT00708682|524011828|FG000|Infant Series|Protocol Violation|1|||
145318117|NCT00708682|524011828|FG000|Infant Series|Parent/legal guardian request|6|||
145318118|NCT00708682|524011828|FG000|Infant Series|Failed to return|2|||
145318119|NCT00708682|524011828|FG000|Infant Series|Other|19|||
145318120|NCT00708682|524011828|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
145318121|NCT00708682|524011828|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
145318122|NCT00708682|524011828|FG000|Toddler Dose|Lost to Follow-up|3|||
145318123|NCT00708682|524011828|FG000|Toddler Dose|Failed to Return|4|||
145318124|NCT01148225|524011831|FG000|Overall Study|Other|185|||
145318125|NCT03689894|524011832|FG000|Overall Study|Adverse Event|1|||
145318126|NCT01488448|524011833|FG000|Overall Study|Withdrawal by Subject|3|||
145318127|NCT01488448|524011834|FG001|Overall Study|Withdrawal by Subject|1|||
145318128|NCT01488448|524011833|FG000|Overall Study|Adverse Event|9|||
145318129|NCT01488448|524011834|FG001|Overall Study|Adverse Event|4|||
145318130|NCT01488448|524011833|FG000|Overall Study|Physician Decision|4|||
145318131|NCT01488448|524011834|FG001|Overall Study|Physician Decision|9|||
145318132|NCT01488448|524011833|FG000|Overall Study|Protocol Violation|4|||
145318133|NCT01488448|524011834|FG001|Overall Study|Protocol Violation|3|||
145318134|NCT00654641|524011835|FG000|Overall Study|Lost to Follow-up|2|||
145318135|NCT00654641|524011836|FG001|Overall Study|Lost to Follow-up|3|||
145318136|NCT01992094|524011837|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
145318137|NCT01992094|524011838|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
145318138|NCT01992094|524011839|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
145318139|NCT01992094|524011837|FG000|Overall Study|Adverse Event|1|||
145318140|NCT01992094|524011838|FG001|Overall Study|Adverse Event|0|||
145318141|NCT01992094|524011839|FG002|Overall Study|Adverse Event|0|||
145318142|NCT01992094|524011837|FG000|Overall Study|Death|5|||
145318143|NCT01992094|524011838|FG001|Overall Study|Death|5|||
145318144|NCT01992094|524011839|FG002|Overall Study|Death|2|||
145318145|NCT01992094|524011837|FG000|Overall Study|Lost to Follow-up|26|||
145318146|NCT01992094|524011838|FG001|Overall Study|Lost to Follow-up|9|||
145318147|NCT01992094|524011839|FG002|Overall Study|Lost to Follow-up|13|||
145318148|NCT01992094|524011837|FG000|Overall Study|OTHER|4|||
145318149|NCT01992094|524011838|FG001|Overall Study|OTHER|0|||
145318150|NCT01992094|524011839|FG002|Overall Study|OTHER|0|||
145318151|NCT01992094|524011837|FG000|Overall Study|Protocol Violation|1|||
145318152|NCT01992094|524011838|FG001|Overall Study|Protocol Violation|0|||
145318153|NCT01992094|524011839|FG002|Overall Study|Protocol Violation|1|||
145318154|NCT01992094|524011837|FG000|Overall Study|Withdrawal by Subject|7|||
145318155|NCT01992094|524011838|FG001|Overall Study|Withdrawal by Subject|3|||
145318156|NCT01992094|524011839|FG002|Overall Study|Withdrawal by Subject|4|||
145318157|NCT01321697|524011840|FG000|Overall Study|Study Terminated|7|||
145318158|NCT01049581|524011841|FG000|Overall Study|Lost to Follow-up|2|||
145318159|NCT01049581|524011842|FG001|Overall Study|Lost to Follow-up|1|||
145318160|NCT00810602|524011843|FG000|Overall Study|Withdrawal by Subject|8|||
145318161|NCT00810602|524011844|FG001|Overall Study|Withdrawal by Subject|3|||
145318162|NCT03840382|524011848|FG000|Overall Study|Lost to Follow-up|11|||
145570002|NCT03837899|524945837|FG005|Overall Study|Death|7|||
145318163|NCT02668822|524013763|FG000|Overall Study|Protocol Violation|2|||
145318164|NCT02668822|524013764|FG001|Overall Study|Protocol Violation|0|||
145570003|NCT03837899|524945832|FG000|Overall Study|Moved to post-trial access program|0|||
145318165|NCT02668822|524013763|FG000|Overall Study|Study Terminated by Sponsor|7|||
145318166|NCT02668822|524013764|FG001|Overall Study|Study Terminated by Sponsor|9|||
145318167|NCT03036839|524013765|FG000|Overall Study|Adverse Event|0|||
145570004|NCT03837899|524945833|FG001|Overall Study|Moved to post-trial access program|1|||
145570005|NCT03837899|524945834|FG002|Overall Study|Moved to post-trial access program|0|||
145318168|NCT03036839|524013766|FG001|Overall Study|Adverse Event|0|||
145318169|NCT03036839|524013767|FG002|Overall Study|Adverse Event|1|||
145318170|NCT03036839|524013765|FG000|Overall Study|Death|3|||
145318171|NCT03036839|524013766|FG001|Overall Study|Death|0|||
145318172|NCT03036839|524013767|FG002|Overall Study|Death|3|||
145318173|NCT03036839|524013765|FG000|Overall Study|Withdrew Consent|0|||
145318174|NCT03036839|524013766|FG001|Overall Study|Withdrew Consent|0|||
145570006|NCT03837899|524945835|FG003|Overall Study|Moved to post-trial access program|0|||
145318175|NCT03036839|524013767|FG002|Overall Study|Withdrew Consent|1|||
145318176|NCT00298740|524013768|FG000|Overall Study|Lack of Efficacy|6|||
145318177|NCT00298740|524013768|FG000|Overall Study|Withdrawal by Subject|3|||
145318178|NCT00684567|524013769|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
145318179|NCT00684567|524013769|FG000|Monotherapy Period|Adverse Event|2|||
145318180|NCT00684567|524013769|FG000|Monotherapy Period|Death|1|||
145318181|NCT00684567|524013769|FG000|Monotherapy Period|Progression of primary disease|11|||
145318182|NCT00906373|524013770|FG000|Overall Study|Withdrawal by Subject|0|||
145318183|NCT00906373|524013771|FG001|Overall Study|Withdrawal by Subject|5|||
145318184|NCT00906373|524013770|FG000|Overall Study|Other|0|||
145318185|NCT00906373|524013771|FG001|Overall Study|Other|1|||
145318186|NCT00906373|524013770|FG000|Overall Study|Still on treatment at cutoff date|0|||
145318187|NCT00906373|524013771|FG001|Overall Study|Still on treatment at cutoff date|2|||
145318188|NCT01597479|524013772|FG000|Overall Study|Protocol Violation|1|||
145318189|NCT01597479|524013773|FG001|Overall Study|Protocol Violation|0|||
145318190|NCT01597479|524013772|FG000|Overall Study|Lost to Follow-up|1|||
145318191|NCT01597479|524013773|FG001|Overall Study|Lost to Follow-up|0|||
145318192|NCT02780167|524013774|FG000|Overall Study|Adverse Event|9|||
145318193|NCT02780167|524013775|FG001|Overall Study|Adverse Event|8|||
145570007|NCT03837899|524945836|FG004|Overall Study|Moved to post-trial access program|0|||
145570008|NCT03837899|524945837|FG005|Overall Study|Moved to post-trial access program|0|||
145570009|NCT03837899|524945832|FG000|Overall Study|Other|0|||
145570010|NCT03837899|524945833|FG001|Overall Study|Other|0|||
145570011|NCT03837899|524945834|FG002|Overall Study|Other|0|||
145570012|NCT03837899|524945835|FG003|Overall Study|Other|0|||
145570013|NCT03837899|524945836|FG004|Overall Study|Other|0|||
145570014|NCT03837899|524945837|FG005|Overall Study|Other|2|||
145570015|NCT03837899|524945832|FG000|Overall Study|Lost to Follow-up|0|||
145570016|NCT03837899|524945833|FG001|Overall Study|Lost to Follow-up|1|||
145570017|NCT03837899|524945834|FG002|Overall Study|Lost to Follow-up|0|||
145570018|NCT03837899|524945835|FG003|Overall Study|Lost to Follow-up|0|||
145570019|NCT03837899|524945836|FG004|Overall Study|Lost to Follow-up|0|||
145318194|NCT02780167|524013776|FG002|Overall Study|Adverse Event|8|||
145318195|NCT02780167|524013777|FG003|Overall Study|Adverse Event|12|||
145318196|NCT02780167|524013778|FG004|Overall Study|Adverse Event|8|||
145318197|NCT02780167|524013774|FG000|Overall Study|Lack of Efficacy|6|||
145318198|NCT02780167|524013775|FG001|Overall Study|Lack of Efficacy|5|||
145318199|NCT02780167|524013776|FG002|Overall Study|Lack of Efficacy|6|||
145318200|NCT02780167|524013777|FG003|Overall Study|Lack of Efficacy|1|||
145318201|NCT02780167|524013778|FG004|Overall Study|Lack of Efficacy|0|||
145318202|NCT02780167|524013774|FG000|Overall Study|Lost to Follow-up|2|||
145318203|NCT02780167|524013775|FG001|Overall Study|Lost to Follow-up|0|||
145318204|NCT02780167|524013776|FG002|Overall Study|Lost to Follow-up|1|||
145318205|NCT02780167|524013777|FG003|Overall Study|Lost to Follow-up|0|||
145318206|NCT02780167|524013778|FG004|Overall Study|Lost to Follow-up|0|||
145318207|NCT02780167|524013774|FG000|Overall Study|Does not meet entrance criteria|0|||
145318208|NCT02780167|524013775|FG001|Overall Study|Does not meet entrance criteria|0|||
145318209|NCT02780167|524013776|FG002|Overall Study|Does not meet entrance criteria|1|||
145318210|NCT02780167|524013777|FG003|Overall Study|Does not meet entrance criteria|0|||
145318211|NCT02780167|524013778|FG004|Overall Study|Does not meet entrance criteria|0|||
145318212|NCT02780167|524013774|FG000|Overall Study|No longer meets eligibility criteria|0|||
145318213|NCT02780167|524013775|FG001|Overall Study|No longer meets eligibility criteria|0|||
145318214|NCT02780167|524013776|FG002|Overall Study|No longer meets eligibility criteria|0|||
145318215|NCT02780167|524013777|FG003|Overall Study|No longer meets eligibility criteria|1|||
145318216|NCT02780167|524013778|FG004|Overall Study|No longer meets eligibility criteria|1|||
145318217|NCT02780167|524013774|FG000|Overall Study|Protocol Violation|5|||
145318218|NCT02780167|524013775|FG001|Overall Study|Protocol Violation|5|||
145318219|NCT02780167|524013776|FG002|Overall Study|Protocol Violation|1|||
145318220|NCT02780167|524013777|FG003|Overall Study|Protocol Violation|1|||
145318221|NCT02780167|524013778|FG004|Overall Study|Protocol Violation|2|||
145318222|NCT02780167|524013774|FG000|Overall Study|Withdrawal by Subject|6|||
145318223|NCT02780167|524013775|FG001|Overall Study|Withdrawal by Subject|4|||
145318224|NCT02780167|524013776|FG002|Overall Study|Withdrawal by Subject|4|||
145318225|NCT02780167|524013777|FG003|Overall Study|Withdrawal by Subject|3|||
145318226|NCT02780167|524013778|FG004|Overall Study|Withdrawal by Subject|4|||
145318227|NCT02780167|524013774|FG000|Overall Study|Other|0|||
145318228|NCT02780167|524013775|FG001|Overall Study|Other|0|||
145318229|NCT02780167|524013776|FG002|Overall Study|Other|3|||
145318230|NCT02780167|524013777|FG003|Overall Study|Other|1|||
145318231|NCT02780167|524013778|FG004|Overall Study|Other|2|||
145318232|NCT02315066|524013779|FG000|Overall Study|Lost to Follow-up|0|||
145318233|NCT02315066|524013780|FG001|Overall Study|Lost to Follow-up|1|||
145318234|NCT02315066|524013781|FG002|Overall Study|Lost to Follow-up|1|||
145318235|NCT02315066|524013782|FG003|Overall Study|Lost to Follow-up|0|||
145318236|NCT02315066|524013783|FG004|Overall Study|Lost to Follow-up|1|||
145318237|NCT02315066|524013784|FG005|Overall Study|Lost to Follow-up|0|||
145318238|NCT02315066|524013785|FG006|Overall Study|Lost to Follow-up|2|||
145570020|NCT03837899|524945837|FG005|Overall Study|Lost to Follow-up|0|||
145570021|NCT03837899|524945832|FG000|Overall Study|Withdrawal by Subject|0|||
145318239|NCT02315066|524013786|FG007|Overall Study|Lost to Follow-up|1|||
145318240|NCT02315066|524013787|FG008|Overall Study|Lost to Follow-up|0|||
145318241|NCT02315066|524013788|FG009|Overall Study|Lost to Follow-up|0|||
145318242|NCT02315066|524013789|FG010|Overall Study|Lost to Follow-up|1|||
145318243|NCT02315066|524013790|FG011|Overall Study|Lost to Follow-up|2|||
145318244|NCT02315066|524013791|FG012|Overall Study|Lost to Follow-up|0|||
145318245|NCT02315066|524013792|FG013|Overall Study|Lost to Follow-up|4|||
145318246|NCT02315066|524013779|FG000|Overall Study|Death|2|||
145318247|NCT02315066|524013780|FG001|Overall Study|Death|7|||
145318248|NCT02315066|524013781|FG002|Overall Study|Death|6|||
145318249|NCT02315066|524013782|FG003|Overall Study|Death|11|||
145318250|NCT02315066|524013783|FG004|Overall Study|Death|10|||
145318251|NCT02315066|524013784|FG005|Overall Study|Death|3|||
145318252|NCT02315066|524013785|FG006|Overall Study|Death|9|||
145318253|NCT02315066|524013786|FG007|Overall Study|Death|9|||
145318254|NCT02315066|524013787|FG008|Overall Study|Death|10|||
145318255|NCT02315066|524013788|FG009|Overall Study|Death|8|||
145318256|NCT02315066|524013789|FG010|Overall Study|Death|10|||
145318257|NCT02315066|524013790|FG011|Overall Study|Death|7|||
145318258|NCT02315066|524013791|FG012|Overall Study|Death|8|||
145318259|NCT02315066|524013792|FG013|Overall Study|Death|21|||
145318260|NCT02315066|524013779|FG000|Overall Study|Other|0|||
145318261|NCT02315066|524013780|FG001|Overall Study|Other|0|||
145318262|NCT02315066|524013781|FG002|Overall Study|Other|0|||
145318263|NCT02315066|524013782|FG003|Overall Study|Other|0|||
145318264|NCT02315066|524013783|FG004|Overall Study|Other|0|||
145318265|NCT02315066|524013784|FG005|Overall Study|Other|0|||
145318266|NCT02315066|524013785|FG006|Overall Study|Other|0|||
145318267|NCT02315066|524013786|FG007|Overall Study|Other|1|||
145318268|NCT02315066|524013787|FG008|Overall Study|Other|1|||
145318269|NCT02315066|524013788|FG009|Overall Study|Other|2|||
145318270|NCT02315066|524013789|FG010|Overall Study|Other|0|||
145318271|NCT02315066|524013790|FG011|Overall Study|Other|0|||
145318272|NCT02315066|524013791|FG012|Overall Study|Other|0|||
145318273|NCT02315066|524013792|FG013|Overall Study|Other|0|||
145318274|NCT02315066|524013779|FG000|Overall Study|Subject refused further follow-up|0|||
145318275|NCT02315066|524013780|FG001|Overall Study|Subject refused further follow-up|2|||
145318276|NCT02315066|524013781|FG002|Overall Study|Subject refused further follow-up|2|||
145318277|NCT02315066|524013782|FG003|Overall Study|Subject refused further follow-up|0|||
145318278|NCT02315066|524013783|FG004|Overall Study|Subject refused further follow-up|0|||
145318279|NCT02315066|524013784|FG005|Overall Study|Subject refused further follow-up|0|||
145318280|NCT02315066|524013785|FG006|Overall Study|Subject refused further follow-up|2|||
145318281|NCT02315066|524013786|FG007|Overall Study|Subject refused further follow-up|3|||
145318282|NCT02315066|524013787|FG008|Overall Study|Subject refused further follow-up|0|||
145318283|NCT02315066|524013788|FG009|Overall Study|Subject refused further follow-up|1|||
145318284|NCT02315066|524013789|FG010|Overall Study|Subject refused further follow-up|1|||
145318285|NCT02315066|524013790|FG011|Overall Study|Subject refused further follow-up|2|||
145318286|NCT02315066|524013791|FG012|Overall Study|Subject refused further follow-up|2|||
145318287|NCT02315066|524013792|FG013|Overall Study|Subject refused further follow-up|4|||
145318288|NCT02315066|524013779|FG000|Overall Study|Study ongoing at date of cut-off|0|||
145318289|NCT02315066|524013780|FG001|Overall Study|Study ongoing at date of cut-off|0|||
145318290|NCT02315066|524013781|FG002|Overall Study|Study ongoing at date of cut-off|0|||
145318291|NCT02315066|524013782|FG003|Overall Study|Study ongoing at date of cut-off|0|||
145318292|NCT02315066|524013783|FG004|Overall Study|Study ongoing at date of cut-off|0|||
145318293|NCT02315066|524013784|FG005|Overall Study|Study ongoing at date of cut-off|0|||
145318294|NCT02315066|524013785|FG006|Overall Study|Study ongoing at date of cut-off|0|||
145318295|NCT02315066|524013786|FG007|Overall Study|Study ongoing at date of cut-off|0|||
145318296|NCT02315066|524013787|FG008|Overall Study|Study ongoing at date of cut-off|0|||
145318297|NCT02315066|524013788|FG009|Overall Study|Study ongoing at date of cut-off|0|||
145318298|NCT02315066|524013789|FG010|Overall Study|Study ongoing at date of cut-off|0|||
145318299|NCT02315066|524013790|FG011|Overall Study|Study ongoing at date of cut-off|0|||
145318300|NCT02315066|524013791|FG012|Overall Study|Study ongoing at date of cut-off|0|||
145318301|NCT02315066|524013792|FG013|Overall Study|Study ongoing at date of cut-off|1|||
145318302|NCT01098539|524013795|FG000|Overall Study|Adverse Event|26|||
145318303|NCT01098539|524013796|FG001|Overall Study|Adverse Event|26|||
145318304|NCT01098539|524013795|FG000|Overall Study|Protocol Violation|1|||
145318305|NCT01098539|524013796|FG001|Overall Study|Protocol Violation|4|||
145318306|NCT01098539|524013795|FG000|Overall Study|Noncompliance|3|||
145318307|NCT01098539|524013796|FG001|Overall Study|Noncompliance|5|||
145318308|NCT01098539|524013795|FG000|Overall Study|Lost to Follow-up|4|||
145318309|NCT01098539|524013796|FG001|Overall Study|Lost to Follow-up|4|||
145318310|NCT01098539|524013795|FG000|Overall Study|Withdrawal by Subject|12|||
145318311|NCT01098539|524013796|FG001|Overall Study|Withdrawal by Subject|26|||
145318312|NCT01098539|524013795|FG000|Overall Study|Physician Decision|5|||
145318313|NCT01098539|524013796|FG001|Overall Study|Physician Decision|3|||
145318314|NCT03843125|524013797|FG000|Overall Study|Adverse Event|17|||
145318315|NCT03843125|524013798|FG001|Overall Study|Adverse Event|13|||
145318316|NCT03843125|524013799|FG002|Overall Study|Adverse Event|5|||
145318317|NCT03843125|524013800|FG003|Overall Study|Adverse Event|9|||
145570022|NCT03837899|524945833|FG001|Overall Study|Withdrawal by Subject|0|||
145570023|NCT03837899|524945834|FG002|Overall Study|Withdrawal by Subject|0|||
145570024|NCT03837899|524945835|FG003|Overall Study|Withdrawal by Subject|1|||
145570025|NCT03837899|524945836|FG004|Overall Study|Withdrawal by Subject|0|||
145570026|NCT03837899|524945837|FG005|Overall Study|Withdrawal by Subject|0|||
145570027|NCT03837899|524945832|FG000|Overall Study|Study specific discontinuation criteria|0|||
145570028|NCT03837899|524945833|FG001|Overall Study|Study specific discontinuation criteria|1|||
145570029|NCT03837899|524945834|FG002|Overall Study|Study specific discontinuation criteria|0|||
145570030|NCT03837899|524945835|FG003|Overall Study|Study specific discontinuation criteria|0|||
145570031|NCT03837899|524945836|FG004|Overall Study|Study specific discontinuation criteria|3|||
145570032|NCT03837899|524945837|FG005|Overall Study|Study specific discontinuation criteria|1|||
145570033|NCT02703636|524945847|FG000|Overall Study|Adverse Event|14|||
145570034|NCT02703636|524945847|FG000|Overall Study|Study stopped by sponsor|1|||
145570035|NCT02703636|524945847|FG000|Overall Study|Withdrawal by Subject|1|||
145570036|NCT04334460|524945856|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
145570037|NCT04334460|524945857|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
145620551|NCT01923428|525125105|FG003|Overall Study|Withdrawal by Subject|4|||
145318318|NCT03843125|524013797|FG000|Overall Study|Death|0|||
145318319|NCT03843125|524013798|FG001|Overall Study|Death|6|||
145318320|NCT03843125|524013799|FG002|Overall Study|Death|2|||
145318321|NCT03843125|524013800|FG003|Overall Study|Death|0|||
145318322|NCT03843125|524013797|FG000|Overall Study|Lack of Efficacy|14|||
145318323|NCT03843125|524013798|FG001|Overall Study|Lack of Efficacy|11|||
145318324|NCT03843125|524013799|FG002|Overall Study|Lack of Efficacy|9|||
145318325|NCT03843125|524013800|FG003|Overall Study|Lack of Efficacy|4|||
145318326|NCT03843125|524013797|FG000|Overall Study|Lost to Follow-up|3|||
145318327|NCT03843125|524013798|FG001|Overall Study|Lost to Follow-up|4|||
145318328|NCT03843125|524013799|FG002|Overall Study|Lost to Follow-up|0|||
145318329|NCT03843125|524013800|FG003|Overall Study|Lost to Follow-up|2|||
145318330|NCT03843125|524013797|FG000|Overall Study|Other|12|||
145318331|NCT03843125|524013798|FG001|Overall Study|Other|14|||
145318332|NCT03843125|524013799|FG002|Overall Study|Other|3|||
145318333|NCT03843125|524013800|FG003|Overall Study|Other|4|||
145318334|NCT03843125|524013797|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
145318335|NCT03843125|524013798|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
145318336|NCT03843125|524013799|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
145318337|NCT03843125|524013800|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
145318338|NCT03843125|524013797|FG000|Overall Study|Study Terminated by Sponsor|318|||
145318339|NCT03843125|524013798|FG001|Overall Study|Study Terminated by Sponsor|318|||
145318340|NCT03843125|524013799|FG002|Overall Study|Study Terminated by Sponsor|163|||
145318341|NCT03843125|524013800|FG003|Overall Study|Study Terminated by Sponsor|163|||
145318342|NCT03843125|524013797|FG000|Overall Study|Withdrawal by Subject|23|||
145318343|NCT03843125|524013798|FG001|Overall Study|Withdrawal by Subject|12|||
145318344|NCT03843125|524013799|FG002|Overall Study|Withdrawal by Subject|6|||
145318345|NCT03843125|524013800|FG003|Overall Study|Withdrawal by Subject|9|||
145318346|NCT03843125|524013797|FG000|Overall Study|Missing data|0|||
145318347|NCT03843125|524013798|FG001|Overall Study|Missing data|1|||
145318348|NCT03843125|524013799|FG002|Overall Study|Missing data|1|||
145318349|NCT03843125|524013800|FG003|Overall Study|Missing data|0|||
145318350|NCT04254809|524013802|FG000|Overall Study|Lost to Follow-up|5|||
145318351|NCT04254809|524013803|FG001|Overall Study|Lost to Follow-up|10|||
145318352|NCT01928615|524013804|FG000|Overall Study|Study Terminated by Sponsor|2|||
145318353|NCT02972515|524013805|FG000|Overall Study|Lost to Follow-up|78|||
145318354|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
145318355|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
145318356|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
145318357|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
145318358|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
145318359|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
145318360|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
145318361|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
145318362|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
145318363|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
145318364|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
145318365|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
145318366|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
145318367|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
145318368|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
145318369|NCT02250651|524013808|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
145318370|NCT02250651|524013809|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
145318371|NCT02250651|524013810|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
145318372|NCT02250651|524013808|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
145318373|NCT02250651|524013809|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
145318374|NCT02250651|524013810|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
145318375|NCT02250651|524013808|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
145318376|NCT02250651|524013809|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
145318377|NCT02250651|524013810|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
145318378|NCT02250651|524013808|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
145318379|NCT02250651|524013809|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
145318380|NCT02250651|524013810|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
145318381|NCT02250651|524013808|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
145318382|NCT02250651|524013809|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
145318383|NCT02250651|524013810|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
145318384|NCT02250651|524013808|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
145318385|NCT02250651|524013809|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
145318386|NCT02250651|524013810|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
145318387|NCT02250651|524013808|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
145318388|NCT02250651|524013809|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
145318389|NCT02250651|524013810|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
145318390|NCT02250651|524013808|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
145318391|NCT02250651|524013809|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
145318392|NCT02250651|524013810|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
145318393|NCT02250651|524013808|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
145318394|NCT02250651|524013809|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
145318395|NCT02250651|524013810|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
145318396|NCT02250651|524013808|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
145318397|NCT02250651|524013809|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
145318398|NCT02250651|524013810|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
145318399|NCT00732160|524013811|FG000|Overall Study|Adverse Event|1|||
145318400|NCT00732160|524013812|FG001|Overall Study|Adverse Event|0|||
145318401|NCT00732160|524013813|FG002|Overall Study|Adverse Event|1|||
145318402|NCT00732160|524013814|FG003|Overall Study|Adverse Event|1|||
145318403|NCT00732160|524013811|FG000|Overall Study|scheduling|4|||
145318404|NCT00732160|524013812|FG001|Overall Study|scheduling|4|||
145318405|NCT00732160|524013813|FG002|Overall Study|scheduling|2|||
145318406|NCT00732160|524013814|FG003|Overall Study|scheduling|1|||
145318407|NCT00676494|524013815|FG000|Overall Study|Missed Visit|8|||
145318408|NCT00676494|524013815|FG000|Overall Study|Withdrawal by Subject|6|||
145318409|NCT01264835|524013816|FG000|Overall Study|Lost to Follow-up|1|||
145318410|NCT02427399|524013819|FG000|Overall Study|Protocol Violation|14|||
145318411|NCT02427399|524013820|FG001|Overall Study|Protocol Violation|16|||
145318412|NCT02427399|524013821|FG002|Overall Study|Protocol Violation|12|||
145318413|NCT02427399|524013822|FG003|Overall Study|Protocol Violation|18|||
145318414|NCT02427399|524013823|FG004|Overall Study|Protocol Violation|15|||
145318415|NCT04660032|524013824|FG000|Overall Study|Protocol Violation|1|||
145318416|NCT04660032|524013825|FG001|Overall Study|Protocol Violation|1|||
145318417|NCT00090753|524013826|FG000|First Treatment Period|Adverse Event|20|||
145318418|NCT00090753|524013827|FG001|First Treatment Period|Adverse Event|8|||
145318419|NCT00090753|524013826|FG000|First Treatment Period|Death|88|||
145318420|NCT00090753|524013827|FG001|First Treatment Period|Death|62|||
145318421|NCT00090753|524013826|FG000|First Treatment Period|Lack of Efficacy|2|||
145318422|NCT00090753|524013827|FG001|First Treatment Period|Lack of Efficacy|1|||
145318423|NCT00090753|524013826|FG000|First Treatment Period|Refused Treatment|32|||
145318424|NCT00090753|524013827|FG001|First Treatment Period|Refused Treatment|25|||
145318425|NCT00090753|524013826|FG000|First Treatment Period|Lost to Follow-up|4|||
145318426|NCT00090753|524013827|FG001|First Treatment Period|Lost to Follow-up|4|||
145318427|NCT00090753|524013826|FG000|First Treatment Period|Renal Transplant|70|||
145318428|NCT00090753|524013827|FG001|First Treatment Period|Renal Transplant|50|||
145318429|NCT00090753|524013826|FG000|First Treatment Period|Mircera Commercialization|1|||
145318430|NCT00090753|524013827|FG001|First Treatment Period|Mircera Commercialization|0|||
145318431|NCT00090753|524013826|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
145318432|NCT00090753|524013827|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
145318433|NCT00090753|524013826|FG000|Extended Treatment Period|Adverse Event|11|||
145318434|NCT00090753|524013827|FG001|Extended Treatment Period|Adverse Event|0|||
145318435|NCT00090753|524013826|FG000|Extended Treatment Period|Death|58|||
145318436|NCT00090753|524013827|FG001|Extended Treatment Period|Death|30|||
145620552|NCT01923428|525125102|FG000|Overall Study|Lost to Follow-up|2|||
145620553|NCT01923428|525125103|FG001|Overall Study|Lost to Follow-up|1|||
145318437|NCT00090753|524013826|FG000|Extended Treatment Period|Lack of Efficacy|1|||
145318438|NCT00090753|524013827|FG001|Extended Treatment Period|Lack of Efficacy|0|||
145318439|NCT00090753|524013826|FG000|Extended Treatment Period|Refused Treatment|18|||
145318440|NCT00090753|524013827|FG001|Extended Treatment Period|Refused Treatment|12|||
145318441|NCT00090753|524013826|FG000|Extended Treatment Period|Lost to Follow-up|3|||
145318442|NCT00090753|524013827|FG001|Extended Treatment Period|Lost to Follow-up|1|||
145318443|NCT00090753|524013826|FG000|Extended Treatment Period|Renal Transplant|15|||
145318444|NCT00090753|524013827|FG001|Extended Treatment Period|Renal Transplant|12|||
145318445|NCT00090753|524013826|FG000|Extended Treatment Period|Mircera Commercialization|188|||
145318446|NCT00090753|524013827|FG001|Extended Treatment Period|Mircera Commercialization|93|||
145318447|NCT00090753|524013826|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
145318448|NCT00090753|524013827|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
145318449|NCT01466036|524013830|FG000|Overall Study|Death|1|||
145318450|NCT01466036|524013831|FG001|Overall Study|Death|1|||
145318451|NCT01466036|524013830|FG000|Overall Study|Physician Decision|0|||
145318452|NCT01466036|524013831|FG001|Overall Study|Physician Decision|4|||
145318453|NCT01466036|524013830|FG000|Overall Study|Adverse Event|2|||
145318454|NCT01466036|524013831|FG001|Overall Study|Adverse Event|6|||
145318455|NCT01466036|524013830|FG000|Overall Study|Withdrawal by Subject|2|||
145318456|NCT01466036|524013831|FG001|Overall Study|Withdrawal by Subject|8|||
145318457|NCT01466036|524013830|FG000|Overall Study|progression/relapse|14|||
145318458|NCT01466036|524013831|FG001|Overall Study|progression/relapse|21|||
145318459|NCT01466036|524013830|FG000|Overall Study|prolonged treatment delay|1|||
145318460|NCT01466036|524013831|FG001|Overall Study|prolonged treatment delay|1|||
145318461|NCT01609582|524013832|FG000|Overall Study|Adverse Event|20|||
145318462|NCT01609582|524013833|FG001|Overall Study|Adverse Event|18|||
145318463|NCT01609582|524013832|FG000|Overall Study|Lost to Follow-up|10|||
145318464|NCT01609582|524013833|FG001|Overall Study|Lost to Follow-up|10|||
145318465|NCT01609582|524013832|FG000|Overall Study|Withdrawal by Subject|21|||
145318466|NCT01609582|524013833|FG001|Overall Study|Withdrawal by Subject|15|||
145318467|NCT01609582|524013832|FG000|Overall Study|Study Terminated by Sponsor|1543|||
145318468|NCT01609582|524013833|FG001|Overall Study|Study Terminated by Sponsor|1548|||
145318469|NCT01609582|524013832|FG000|Overall Study|Other|9|||
145318470|NCT01609582|524013833|FG001|Overall Study|Other|10|||
145318471|NCT01609582|524013832|FG000|Overall Study|Randomized, but not treated|0|||
145318472|NCT01609582|524013833|FG001|Overall Study|Randomized, but not treated|3|||
145318473|NCT00819767|524013834|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145318474|NCT00819767|524013835|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145318475|NCT00685750|524013838|FG000|Overall Study|Tumor sampling failure|0|||
145318476|NCT00685750|524013839|FG001|Overall Study|Tumor sampling failure|0|||
145318477|NCT00685750|524013840|FG002|Overall Study|Tumor sampling failure|1|||
145318478|NCT00685750|524013841|FG003|Overall Study|Tumor sampling failure|0|||
145318479|NCT00685750|524013842|FG004|Overall Study|Tumor sampling failure|0|||
145318480|NCT00685750|524013843|FG005|Overall Study|Tumor sampling failure|0|||
145318481|NCT00685750|524013844|FG006|Overall Study|Tumor sampling failure|0|||
145318482|NCT00685750|524013838|FG000|Overall Study|Patient didn't receive the treatment|0|||
145318483|NCT00685750|524013839|FG001|Overall Study|Patient didn't receive the treatment|0|||
145318484|NCT00685750|524013840|FG002|Overall Study|Patient didn't receive the treatment|0|||
145318485|NCT00685750|524013841|FG003|Overall Study|Patient didn't receive the treatment|0|||
145318486|NCT00685750|524013842|FG004|Overall Study|Patient didn't receive the treatment|0|||
145318487|NCT00685750|524013843|FG005|Overall Study|Patient didn't receive the treatment|0|||
145318488|NCT00685750|524013844|FG006|Overall Study|Patient didn't receive the treatment|1|||
145318489|NCT00685750|524013838|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145318490|NCT00685750|524013839|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145318491|NCT00685750|524013840|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145318492|NCT00685750|524013841|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
145318493|NCT00685750|524013842|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
145318494|NCT00685750|524013843|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
145318495|NCT00685750|524013844|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
145318496|NCT04974580|524013845|FG000|Overall Study|Lost to Follow-up|33|||
145318497|NCT04974580|524013846|FG001|Overall Study|Lost to Follow-up|39|||
145411546|NCT02335944|524360061|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411547|NCT02335944|524360062|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411548|NCT02335944|524360063|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
145411549|NCT02335944|524360064|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411550|NCT02335944|524360065|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411551|NCT02335944|524360066|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411552|NCT02335944|524360067|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
145411553|NCT02335944|524360058|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411554|NCT02335944|524360059|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411555|NCT02335944|524360060|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
145620554|NCT01923428|525125104|FG002|Overall Study|Lost to Follow-up|5|||
145318498|NCT04974580|524013847|FG002|Overall Study|Lost to Follow-up|30|||
145411556|NCT02335944|524360061|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
145318499|NCT04974580|524013848|FG003|Overall Study|Lost to Follow-up|29|||
145318500|NCT00250705|524013851|FG000|Overall Study|Lack of Efficacy|2|||
145318501|NCT00587431|524013852|FG000|Overall Study|Adverse Event|1|||
145318502|NCT00587431|524013853|FG001|Overall Study|Adverse Event|0|||
145318503|NCT00587431|524013852|FG000|Overall Study|Withdrawal by Subject|0|||
145318504|NCT00587431|524013853|FG001|Overall Study|Withdrawal by Subject|1|||
145318505|NCT05467982|524013854|FG000|Overall Study|Death|0|||
145318506|NCT05467982|524013855|FG001|Overall Study|Death|1|||
145318507|NCT05467982|524013854|FG000|Overall Study|Lost to Follow-up|3|||
145318508|NCT05467982|524013855|FG001|Overall Study|Lost to Follow-up|1|||
145318509|NCT00761176|524013883|FG000|Overall Study|Death|1|||
145318510|NCT00761176|524013884|FG001|Overall Study|Death|0|||
145318511|NCT00761176|524013883|FG000|Overall Study|Withdrawal by Subject|1|||
145318512|NCT00761176|524013884|FG001|Overall Study|Withdrawal by Subject|1|||
145318513|NCT02762994|524013885|FG000|Overall Study|Withdrawal by Subject|0|||
145318514|NCT02762994|524013886|FG001|Overall Study|Withdrawal by Subject|1|||
145318515|NCT02762994|524013887|FG002|Overall Study|Withdrawal by Subject|2|||
145318516|NCT02762994|524013888|FG003|Overall Study|Withdrawal by Subject|0|||
145318517|NCT02762994|524013885|FG000|Overall Study|Protocol Violation|1|||
145318518|NCT02762994|524013886|FG001|Overall Study|Protocol Violation|0|||
145318519|NCT02762994|524013887|FG002|Overall Study|Protocol Violation|0|||
145318520|NCT02762994|524013888|FG003|Overall Study|Protocol Violation|2|||
145318521|NCT05103657|524013891|FG000|Overall Study|Other reasons than listed|9|||
145318522|NCT05103657|524013892|FG001|Overall Study|Other reasons than listed|8|||
145318523|NCT05103657|524013891|FG000|Overall Study|Protocol deviation|2|||
145318524|NCT05103657|524013892|FG001|Overall Study|Protocol deviation|2|||
145318525|NCT05103657|524013891|FG000|Overall Study|No reason available|5|||
145318526|NCT05103657|524013892|FG001|Overall Study|No reason available|4|||
145318527|NCT05103657|524013891|FG000|Overall Study|Burden of study procedures|3|||
145318528|NCT05103657|524013892|FG001|Overall Study|Burden of study procedures|1|||
145318529|NCT05103657|524013891|FG000|Overall Study|Perceived lack of efficacy|1|||
145318530|NCT05103657|524013892|FG001|Overall Study|Perceived lack of efficacy|1|||
145318531|NCT05103657|524013891|FG000|Overall Study|Adverse Event|6|||
145318532|NCT05103657|524013892|FG001|Overall Study|Adverse Event|14|||
145318533|NCT05103657|524013891|FG000|Overall Study|Not Treated|1|||
145318534|NCT05103657|524013892|FG001|Overall Study|Not Treated|1|||
145318535|NCT02020967|524013893|FG000|Overall Study|Withdrawal by Subject|51|||
145318536|NCT00585312|524013894|FG000|Overall Study|Adverse Event|3|||
145318537|NCT00585312|524013895|FG001|Overall Study|Adverse Event|0|||
145318538|NCT00585312|524013894|FG000|Overall Study|Lack of Efficacy|6|||
145318539|NCT00585312|524013895|FG001|Overall Study|Lack of Efficacy|11|||
145318540|NCT00585312|524013894|FG000|Overall Study|Lost to Follow-up|1|||
145318541|NCT00585312|524013895|FG001|Overall Study|Lost to Follow-up|1|||
145318542|NCT00585312|524013894|FG000|Overall Study|Reason not specified|2|||
145318543|NCT00585312|524013895|FG001|Overall Study|Reason not specified|0|||
145318544|NCT00585312|524013894|FG000|Overall Study|Withdrawal by Subject|5|||
145318545|NCT00585312|524013895|FG001|Overall Study|Withdrawal by Subject|1|||
145318546|NCT00585312|524013894|FG000|Overall Study|Study terminated by the sponsor|34|||
145318547|NCT00585312|524013895|FG001|Overall Study|Study terminated by the sponsor|31|||
145318548|NCT04234464|524013896|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
145318549|NCT04234464|524013897|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
145318550|NCT00983528|524013898|FG000|Overall Study|Death|4|||
145318551|NCT00983528|524013898|FG000|Overall Study|Lost to Follow-up|1|||
145318552|NCT00983528|524013898|FG000|Overall Study|Study Terminated|1|||
145318553|NCT00330460|524013903|FG000|Overall Study|Physician Decision|1|||
145318554|NCT00330460|524013904|FG001|Overall Study|Physician Decision|0|||
145318555|NCT00330460|524013903|FG000|Overall Study|Adverse Event|10|||
145318556|NCT00330460|524013904|FG001|Overall Study|Adverse Event|8|||
145318557|NCT00330460|524013903|FG000|Overall Study|Withdrawal by Subject|18|||
145318558|NCT00330460|524013904|FG001|Overall Study|Withdrawal by Subject|17|||
145318559|NCT00330460|524013903|FG000|Overall Study|Death|1|||
145318560|NCT00330460|524013904|FG001|Overall Study|Death|1|||
145318561|NCT00330460|524013903|FG000|Overall Study|Ineligibility determined|1|||
145318562|NCT00330460|524013904|FG001|Overall Study|Ineligibility determined|3|||
145318563|NCT00330460|524013903|FG000|Overall Study|Lost to Follow-up|8|||
145318564|NCT00330460|524013904|FG001|Overall Study|Lost to Follow-up|3|||
145318565|NCT00330460|524013903|FG000|Overall Study|Noncompliance|2|||
145318566|NCT00330460|524013904|FG001|Overall Study|Noncompliance|1|||
145318567|NCT00330460|524013903|FG000|Overall Study|Other|1|||
145318568|NCT00330460|524013904|FG001|Overall Study|Other|0|||
145318569|NCT03712124|524013905|FG000|Overall Study|Protocol Violation|1|||
145318570|NCT03712124|524013906|FG001|Overall Study|Protocol Violation|0|||
145318571|NCT00105157|524013908|FG000|Double-Blind (DB)|Never Treated|1|||
145318572|NCT00105157|524013909|FG001|Double-Blind (DB)|Never Treated|0|||
145318573|NCT00105157|524013910|FG002|Double-Blind (DB)|Never Treated|0|||
145318574|NCT00105157|524013911|FG003|Double-Blind (DB)|Never Treated|0|||
145318575|NCT00105157|524013908|FG000|Double-Blind (DB)|Adverse Event|2|||
145318576|NCT00105157|524013909|FG001|Double-Blind (DB)|Adverse Event|0|||
145318577|NCT00105157|524013910|FG002|Double-Blind (DB)|Adverse Event|1|||
145318578|NCT00105157|524013911|FG003|Double-Blind (DB)|Adverse Event|1|||
145318579|NCT00105157|524013908|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
145318580|NCT00105157|524013909|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
145318581|NCT00105157|524013910|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
145318582|NCT00105157|524013911|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
145318583|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Adverse Event|3|||
145318584|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Adverse Event|1|||
145318585|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Adverse Event|0|||
145318586|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Adverse Event|0|||
145318587|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
145318588|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
145318589|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
145318590|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
145318591|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
145318592|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
145318593|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
145318594|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
145318595|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
145318596|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
145318597|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
145318598|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
145318599|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
145318600|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
145318601|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
145318602|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
145318603|NCT00105157|524013908|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
145318604|NCT00105157|524013909|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
145318605|NCT00105157|524013910|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
145318606|NCT00105157|524013911|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
145318607|NCT00105157|524013908|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145318608|NCT00105157|524013909|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145318609|NCT00105157|524013910|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
145318610|NCT00105157|524013911|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
145318611|NCT00105157|524013908|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
145318612|NCT00105157|524013909|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
145318613|NCT00105157|524013910|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
145318614|NCT00105157|524013911|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
145318615|NCT00105157|524013908|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
145318616|NCT00105157|524013909|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
145318617|NCT00105157|524013910|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
145318618|NCT00105157|524013911|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
145318619|NCT00105157|524013908|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145318620|NCT00105157|524013909|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145318621|NCT00105157|524013910|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
145318622|NCT00105157|524013911|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
145318623|NCT00105157|524013908|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145318624|NCT00105157|524013909|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
145318625|NCT00105157|524013910|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145318626|NCT00105157|524013911|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
145318627|NCT00127166|524013912|FG000|Period I|Protocol Violation|0|||
145318628|NCT00127166|524013913|FG001|Period I|Protocol Violation|2|||
145318629|NCT00127166|524013912|FG000|Period I|Withdrawal by Subject|2|||
145318630|NCT00127166|524013913|FG001|Period I|Withdrawal by Subject|0|||
145318631|NCT00127166|524013912|FG000|Period I|Patient did not meet inclusion criteria|1|||
145318632|NCT00127166|524013913|FG001|Period I|Patient did not meet inclusion criteria|0|||
145318633|NCT00127166|524013912|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
145318634|NCT00127166|524013913|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
145318635|NCT00127166|524013912|FG000|Period II|Withdrawal by Subject|2|||
145318636|NCT00127166|524013913|FG001|Period II|Withdrawal by Subject|0|||
145318637|NCT00127166|524013912|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
145318638|NCT00127166|524013913|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
145318639|NCT02030535|524013917|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
145318640|NCT01169038|524013919|FG000|Overall Study|Death|1|||
145318641|NCT01169038|524013919|FG000|Overall Study|Adverse Event|5|||
145318642|NCT01169038|524013919|FG000|Overall Study|Required antibiotic administration|1|||
145318643|NCT03257254|524013920|FG000|Overall Study|Withdrawal by Subject|7|||
145318644|NCT03257254|524013920|FG000|Overall Study|Lost to Follow-up|9|||
145318645|NCT03257254|524013920|FG000|Overall Study|Study discontinued by sponsor|5|||
145318646|NCT02329431|524013921|FG000|Overall Study|Lost to Follow-up|20|||
145318647|NCT02329431|524013922|FG001|Overall Study|Lost to Follow-up|13|||
145570038|NCT04334460|524945856|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
145318648|NCT01557582|524013923|FG000|Overall Study|Protocol Violation|4|||
145318649|NCT01557582|524013923|FG000|Overall Study|Operator error|2|||
145318650|NCT02843659|524013924|FG000|Overall Study|Subject Withdrew Consent|0|||
145318651|NCT02843659|524013925|FG001|Overall Study|Subject Withdrew Consent|0|||
145318652|NCT02843659|524013926|FG002|Overall Study|Subject Withdrew Consent|1|||
145318653|NCT02843659|524013924|FG000|Overall Study|Administrative Reason by Sponsor|4|||
145318654|NCT02843659|524013925|FG001|Overall Study|Administrative Reason by Sponsor|5|||
145318655|NCT02843659|524013926|FG002|Overall Study|Administrative Reason by Sponsor|4|||
145318656|NCT02843659|524013924|FG000|Overall Study|Adverse Event|0|||
145318657|NCT02843659|524013925|FG001|Overall Study|Adverse Event|1|||
145318658|NCT02843659|524013926|FG002|Overall Study|Adverse Event|0|||
145318659|NCT03203642|524013927|FG000|Overall Study|Adverse Event|3|||
145318660|NCT03203642|524013928|FG001|Overall Study|Adverse Event|1|||
145318661|NCT03203642|524013927|FG000|Overall Study|Withdrawal by Subject|6|||
145318662|NCT03203642|524013928|FG001|Overall Study|Withdrawal by Subject|6|||
145318663|NCT03203642|524013927|FG000|Overall Study|Lost to Follow-up|2|||
145318664|NCT03203642|524013928|FG001|Overall Study|Lost to Follow-up|1|||
145318665|NCT03203642|524013927|FG000|Overall Study|Termination of the study by sponsor|1|||
145318666|NCT03203642|524013928|FG001|Overall Study|Termination of the study by sponsor|1|||
145318667|NCT03203642|524013927|FG000|Overall Study|Participant moved|0|||
145318668|NCT03203642|524013928|FG001|Overall Study|Participant moved|1|||
145318669|NCT03203642|524013927|FG000|Overall Study|Investigator's decision|3|||
145318670|NCT03203642|524013928|FG001|Overall Study|Investigator's decision|0|||
145318671|NCT03203642|524013927|FG000|Overall Study|Other than above specified|0|||
145318672|NCT03203642|524013928|FG001|Overall Study|Other than above specified|1|||
145318673|NCT02413294|524013929|FG000|Overall Study|Withdrawal by Subject|1|||
145318674|NCT00434590|524013930|FG000|Overall Study|Administrative problems|5|||
145570039|NCT04334460|524945857|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
145570040|NCT03778931|524945858|FG000|Overall Study|Withdrawal by Subject|12|||
145570041|NCT03778931|524945859|FG001|Overall Study|Withdrawal by Subject|25|||
145570042|NCT03778931|524945858|FG000|Overall Study|Physician Decision|1|||
145570043|NCT03778931|524945859|FG001|Overall Study|Physician Decision|3|||
145570044|NCT03778931|524945858|FG000|Overall Study|Participant Noncompliance|1|||
145570045|NCT03778931|524945859|FG001|Overall Study|Participant Noncompliance|1|||
145570046|NCT03778931|524945858|FG000|Overall Study|Lost to Follow-up|4|||
145570047|NCT03778931|524945859|FG001|Overall Study|Lost to Follow-up|1|||
145570048|NCT03778931|524945858|FG000|Overall Study|Death|69|||
145570049|NCT03778931|524945859|FG001|Overall Study|Death|79|||
145570050|NCT02130765|524945867|FG000|Overall Study|Did not receive treatment|4|||
145570051|NCT02130765|524945868|FG001|Overall Study|Did not receive treatment|0|||
145570052|NCT02130765|524945869|FG002|Overall Study|Did not receive treatment|0|||
145570053|NCT02130765|524945870|FG003|Overall Study|Did not receive treatment|0|||
145570054|NCT01537783|524945878|FG000|Overall Study|Lost to Follow-up|11|||
145570055|NCT01537783|524945879|FG001|Overall Study|Lost to Follow-up|2|||
145570056|NCT01554618|524945880|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
145570057|NCT01554618|524945881|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
145570058|NCT01554618|524945880|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
145570059|NCT01554618|524945881|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
145570060|NCT01554618|524945880|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
145318675|NCT00434590|524013931|FG001|Overall Study|Administrative problems|5|||
145318676|NCT03180528|524015502|FG000|Overall Study|Adverse Event|1|||
145318677|NCT03180528|524015502|FG000|Overall Study|Withdrawal by Subject|1|||
145318678|NCT03180528|524015502|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
145318679|NCT02447887|524015503|FG000|Overall Study|Study was terminated|3|||
145318680|NCT00109837|524015504|FG000|Overall Study|Adverse Event|2|||
145318681|NCT00109837|524015504|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
145318682|NCT00109837|524015504|FG000|Overall Study|Death|1|||
145318683|NCT00109837|524015504|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
145318684|NCT00109837|524015504|FG000|Overall Study|Not treated|1|||
145318685|NCT00109837|524015504|FG000|Overall Study|Ineligible|1|||
145411557|NCT02335944|524360062|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411558|NCT02335944|524360063|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
145570061|NCT01554618|524945881|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
145570062|NCT01554618|524945880|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
145570063|NCT01554618|524945881|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
145570064|NCT01554618|524945880|FG000|Open-Label Extension Period|Physician Decision|0|||
145318686|NCT01563237|524015506|FG000|Overall Study|Lost to Follow-up|6|||
145318687|NCT01563237|524015507|FG001|Overall Study|Lost to Follow-up|0|||
145318688|NCT01563237|524015506|FG000|Overall Study|Withdrawal by Subject|1|||
145318689|NCT01563237|524015507|FG001|Overall Study|Withdrawal by Subject|0|||
145570065|NCT01554618|524945881|FG001|Open-Label Extension Period|Physician Decision|1|||
145570066|NCT01554618|524945880|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
145620555|NCT01923428|525125105|FG003|Overall Study|Lost to Follow-up|0|||
145318690|NCT01563237|524015506|FG000|Overall Study|Adverse Event|1|||
145318691|NCT01563237|524015507|FG001|Overall Study|Adverse Event|0|||
145318692|NCT01563237|524015506|FG000|Overall Study|Medical Reasons|1|||
145318693|NCT01563237|524015507|FG001|Overall Study|Medical Reasons|0|||
145318694|NCT01563237|524015506|FG000|Overall Study|Death|1|||
145318695|NCT01563237|524015507|FG001|Overall Study|Death|0|||
145318696|NCT00988208|524015512|FG000|Overall Study|Adverse Event|71|||
145318697|NCT00988208|524015513|FG001|Overall Study|Adverse Event|122|||
145318698|NCT00988208|524015512|FG000|Overall Study|Disease Progression|103|||
145318699|NCT00988208|524015513|FG001|Overall Study|Disease Progression|89|||
145318700|NCT00988208|524015512|FG000|Overall Study|Withdrawal by Subject|50|||
145318701|NCT00988208|524015513|FG001|Overall Study|Withdrawal by Subject|57|||
145318702|NCT00988208|524015512|FG000|Overall Study|Death|9|||
145318703|NCT00988208|524015513|FG001|Overall Study|Death|15|||
145318704|NCT00988208|524015512|FG000|Overall Study|Lost to Follow-up|2|||
145318705|NCT00988208|524015513|FG001|Overall Study|Lost to Follow-up|3|||
145318706|NCT00988208|524015512|FG000|Overall Study|Protocol Violation|9|||
145318707|NCT00988208|524015513|FG001|Overall Study|Protocol Violation|2|||
145318708|NCT00988208|524015512|FG000|Overall Study|Sponsor Decision|102|||
145318709|NCT00988208|524015513|FG001|Overall Study|Sponsor Decision|78|||
145318710|NCT00988208|524015512|FG000|Overall Study|Clinical Progression|17|||
145318711|NCT00988208|524015513|FG001|Overall Study|Clinical Progression|16|||
145318712|NCT00988208|524015512|FG000|Overall Study|Biochemical Progression|21|||
145318713|NCT00988208|524015513|FG001|Overall Study|Biochemical Progression|7|||
145318714|NCT00988208|524015512|FG000|Overall Study|Clinical Deterioration|7|||
145318715|NCT00988208|524015513|FG001|Overall Study|Clinical Deterioration|14|||
145318716|NCT00988208|524015512|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
145318717|NCT00988208|524015513|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
145318718|NCT00988208|524015512|FG000|Overall Study|Other|8|||
145318719|NCT00988208|524015513|FG001|Overall Study|Other|3|||
145318720|NCT01201759|524015516|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
145318721|NCT01201759|524015517|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
145318722|NCT01201759|524015516|FG000|Visit 3 - Washout|Adverse Event|0|||
145318723|NCT01201759|524015517|FG001|Visit 3 - Washout|Adverse Event|3|||
145318724|NCT01201759|524015516|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
145318725|NCT01201759|524015517|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
145318726|NCT01201759|524015516|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
145318727|NCT01201759|524015517|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
145318728|NCT02744755|524015518|FG000|Study Period 1|Protocol Violation|2|||
145318729|NCT02744755|524015519|FG001|Study Period 1|Protocol Violation|1|||
145318730|NCT02744755|524015518|FG000|Study Period 1|not defined|0|||
145318731|NCT02744755|524015519|FG001|Study Period 1|not defined|1|||
145318732|NCT02744755|524015518|FG000|Study Period 1|Pregnancy|1|||
145318733|NCT02744755|524015519|FG001|Study Period 1|Pregnancy|0|||
145318734|NCT02744755|524015518|FG000|Study Period 1|Adverse Event|1|||
145318735|NCT02744755|524015519|FG001|Study Period 1|Adverse Event|1|||
145318736|NCT02744755|524015518|FG000|Study Period 1|Lost to Follow-up|1|||
145318737|NCT02744755|524015519|FG001|Study Period 1|Lost to Follow-up|1|||
145318738|NCT02744755|524015518|FG000|Study Period 1|Lack of Efficacy|1|||
145318739|NCT02744755|524015519|FG001|Study Period 1|Lack of Efficacy|0|||
145318740|NCT02744755|524015518|FG000|Study Period 1|Withdrawal by Subject|8|||
145318741|NCT02744755|524015519|FG001|Study Period 1|Withdrawal by Subject|4|||
145318742|NCT02744755|524015518|FG000|Study Period 2|Adverse Event|5|||
145318743|NCT02744755|524015519|FG001|Study Period 2|Adverse Event|0|||
145318744|NCT02744755|524015518|FG000|Study Period 2|Protocol Violation|1|||
145318745|NCT02744755|524015519|FG001|Study Period 2|Protocol Violation|0|||
145318746|NCT02744755|524015518|FG000|Study Period 2|not defined|3|||
145318747|NCT02744755|524015519|FG001|Study Period 2|not defined|2|||
145318748|NCT02744755|524015518|FG000|Study Period 2|Lost to Follow-up|0|||
145318749|NCT02744755|524015519|FG001|Study Period 2|Lost to Follow-up|2|||
145318750|NCT02744755|524015518|FG000|Study Period 2|Withdrawal by Subject|2|||
145318751|NCT02744755|524015519|FG001|Study Period 2|Withdrawal by Subject|2|||
145318752|NCT02744755|524015518|FG000|Study Period 2|Lack of Efficacy|3|||
145318753|NCT02744755|524015519|FG001|Study Period 2|Lack of Efficacy|2|||
145318754|NCT02916693|524015520|FG000|Overall Study|Lost to Follow-up|7|||
145318755|NCT03180801|524015521|FG000|Overall Study|Physician Decision|3|||
145318756|NCT03180801|524015522|FG001|Overall Study|Physician Decision|3|||
145318757|NCT03180801|524015523|FG002|Overall Study|Physician Decision|1|||
145318758|NCT03180801|524015521|FG000|Overall Study|Non-compliance|1|||
145318759|NCT03180801|524015522|FG001|Overall Study|Non-compliance|4|||
145318760|NCT03180801|524015523|FG002|Overall Study|Non-compliance|0|||
145411559|NCT02335944|524360064|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411560|NCT02335944|524360065|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
145318761|NCT03180801|524015521|FG000|Overall Study|Inoculation Target Reached|1|||
145318762|NCT03180801|524015522|FG001|Overall Study|Inoculation Target Reached|1|||
145318763|NCT03180801|524015523|FG002|Overall Study|Inoculation Target Reached|3|||
145318764|NCT03180801|524015521|FG000|Overall Study|Adverse Event|1|||
145318765|NCT03180801|524015522|FG001|Overall Study|Adverse Event|0|||
145318766|NCT03180801|524015523|FG002|Overall Study|Adverse Event|2|||
145318767|NCT03180801|524015521|FG000|Overall Study|Withdrawal by Subject|2|||
145318768|NCT03180801|524015522|FG001|Overall Study|Withdrawal by Subject|2|||
145318769|NCT03180801|524015523|FG002|Overall Study|Withdrawal by Subject|1|||
145318770|NCT03180801|524015521|FG000|Overall Study|Lost to Follow-up|0|||
145318771|NCT03180801|524015522|FG001|Overall Study|Lost to Follow-up|2|||
145318772|NCT03180801|524015523|FG002|Overall Study|Lost to Follow-up|3|||
145318773|NCT04364737|524015525|FG000|Overall Study|Withdrawal by Subject|4|||
145318774|NCT04364737|524015526|FG001|Overall Study|Withdrawal by Subject|9|||
145318775|NCT04364737|524015525|FG000|Overall Study|Lost to Follow-up|1|||
145318776|NCT04364737|524015526|FG001|Overall Study|Lost to Follow-up|1|||
145318777|NCT01220609|524015527|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
145318778|NCT01220609|524015527|FG000|Overall Study|Ineligible- Wrong cell type|1|||
145318779|NCT01220609|524015527|FG000|Overall Study|Ineligible-Never treated|1|||
145318780|NCT00868296|524015530|FG000|Overall Study|Adverse Event|0|||
145318781|NCT00868296|524015531|FG001|Overall Study|Adverse Event|2|||
145318782|NCT00868296|524015530|FG000|Overall Study|Withdrawal by Subject|0|||
145318783|NCT00868296|524015531|FG001|Overall Study|Withdrawal by Subject|1|||
145318784|NCT00112294|524015532|FG000|Overall Study|Still on study|5|||
145318785|NCT00112294|524015533|FG001|Overall Study|Still on study|0|||
145318786|NCT01142908|524015534|FG000|Overall Study|Lost to Follow-up|19|||
145318787|NCT01142908|524015535|FG001|Overall Study|Lost to Follow-up|13|||
145318788|NCT01142908|524015534|FG000|Overall Study|Death|1|||
145318789|NCT01142908|524015535|FG001|Overall Study|Death|4|||
145318790|NCT01142908|524015534|FG000|Overall Study|Excluded - did not meet criteria|9|||
145318791|NCT01142908|524015535|FG001|Overall Study|Excluded - did not meet criteria|5|||
145318792|NCT01142908|524015534|FG000|Overall Study|Withdrawal by Subject|3|||
145318793|NCT01142908|524015535|FG001|Overall Study|Withdrawal by Subject|0|||
145318794|NCT00035555|524015537|FG000|Overall Study|Adverse Event|5|||
145318795|NCT00035555|524015538|FG001|Overall Study|Adverse Event|8|||
145318796|NCT00035555|524015539|FG002|Overall Study|Adverse Event|9|||
145318797|NCT00035555|524015537|FG000|Overall Study|Allograft loss|1|||
145318798|NCT00035555|524015538|FG001|Overall Study|Allograft loss|1|||
145318799|NCT00035555|524015539|FG002|Overall Study|Allograft loss|2|||
145318800|NCT00035555|524015537|FG000|Overall Study|Death|0|||
145318801|NCT00035555|524015538|FG001|Overall Study|Death|0|||
145318802|NCT00035555|524015539|FG002|Overall Study|Death|2|||
145318803|NCT00035555|524015537|FG000|Overall Study|Lost to Follow-up|0|||
145318804|NCT00035555|524015538|FG001|Overall Study|Lost to Follow-up|0|||
145318805|NCT00035555|524015539|FG002|Overall Study|Lost to Follow-up|1|||
145318806|NCT00035555|524015537|FG000|Overall Study|Noncompliance|0|||
145318807|NCT00035555|524015538|FG001|Overall Study|Noncompliance|1|||
145318808|NCT00035555|524015539|FG002|Overall Study|Noncompliance|1|||
145318809|NCT00035555|524015537|FG000|Overall Study|Prohibited medication|1|||
145318810|NCT00035555|524015538|FG001|Overall Study|Prohibited medication|1|||
145318811|NCT00035555|524015539|FG002|Overall Study|Prohibited medication|0|||
145318812|NCT00035555|524015537|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
145318813|NCT00035555|524015538|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
145318814|NCT00035555|524015539|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
145318815|NCT00035555|524015537|FG000|Overall Study|Withdrawal by Subject|2|||
145318816|NCT00035555|524015538|FG001|Overall Study|Withdrawal by Subject|0|||
145318817|NCT00035555|524015539|FG002|Overall Study|Withdrawal by Subject|2|||
145318818|NCT00035555|524015537|FG000|Overall Study|Investigator deemed not a good candidate|0|||
145318819|NCT00035555|524015538|FG001|Overall Study|Investigator deemed not a good candidate|0|||
145318820|NCT00035555|524015539|FG002|Overall Study|Investigator deemed not a good candidate|1|||
145318821|NCT00035555|524015537|FG000|Overall Study|Received cyclosporin in error|0|||
145318822|NCT00035555|524015538|FG001|Overall Study|Received cyclosporin in error|0|||
145318823|NCT00035555|524015539|FG002|Overall Study|Received cyclosporin in error|1|||
145318824|NCT00337428|524015540|FG000|Overall Study|Withdrawal by Subject|1|||
145318825|NCT00337428|524015541|FG001|Overall Study|Withdrawal by Subject|2|||
145318826|NCT00337428|524015540|FG000|Overall Study|Lack of Time|1|||
145318827|NCT00337428|524015541|FG001|Overall Study|Lack of Time|1|||
145318828|NCT00337428|524015540|FG000|Overall Study|Unwilling to Continue|1|||
145318829|NCT00337428|524015541|FG001|Overall Study|Unwilling to Continue|0|||
145318830|NCT00337428|524015540|FG000|Overall Study|Anorexia|1|||
145620556|NCT01923428|525125102|FG000|Overall Study|Protocol Violation|3|||
145318831|NCT00337428|524015541|FG001|Overall Study|Anorexia|0|||
145318832|NCT02618382|524015542|FG000|Overall Study|Physician Decision|1|||
145318833|NCT02618382|524015542|FG000|Overall Study|Withdrawal by Subject|1|||
145318834|NCT02618382|524015542|FG000|Overall Study|Protocol Violation|1|||
145318835|NCT04205162|524015547|FG000|Overall Study|Lost to Follow-up|1|||
145318836|NCT04205162|524015548|FG001|Overall Study|Lost to Follow-up|0|||
145318837|NCT04205162|524015547|FG000|Overall Study|Withdrawal by Subject|2|||
145318838|NCT04205162|524015548|FG001|Overall Study|Withdrawal by Subject|0|||
145318839|NCT04205162|524015547|FG000|Overall Study|University closure due to COVID-19|1|||
145318840|NCT04205162|524015548|FG001|Overall Study|University closure due to COVID-19|0|||
145318841|NCT00529217|524015549|FG000|Overall Study|Lack of Efficacy|2|||
145318842|NCT00529217|524015549|FG000|Overall Study|Unable to adhere to study schedule|2|||
145318843|NCT00779402|524015551|FG000|Treatment Phase 1|Disease Progression|1|||
145318844|NCT00779402|524015552|FG001|Treatment Phase 1|Disease Progression|0|||
145318845|NCT00779402|524015551|FG000|Treatment Phase 1|Adverse Event|2|||
145318846|NCT00779402|524015552|FG001|Treatment Phase 1|Adverse Event|0|||
145318847|NCT00779402|524015551|FG000|Treatment Phase 1|Protocol Violation|1|||
145318848|NCT00779402|524015552|FG001|Treatment Phase 1|Protocol Violation|0|||
145318849|NCT00779402|524015551|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
145318850|NCT00779402|524015552|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
145318851|NCT00779402|524015551|FG000|Treatment Phase 1|Lost to Follow-up|0|||
145318852|NCT00779402|524015552|FG001|Treatment Phase 1|Lost to Follow-up|1|||
145318853|NCT00779402|524015551|FG000|Treatment Phase 1|Death|0|||
145318854|NCT00779402|524015552|FG001|Treatment Phase 1|Death|1|||
145318855|NCT00779402|524015551|FG000|Treatment Phase 1|Intercurrent Illness|1|||
145318856|NCT00779402|524015552|FG001|Treatment Phase 1|Intercurrent Illness|1|||
145318857|NCT00779402|524015551|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
145318858|NCT00779402|524015552|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
145318859|NCT00779402|524015551|FG000|Treatment Phase 1|Other|4|||
145318860|NCT00779402|524015552|FG001|Treatment Phase 1|Other|2|||
145318861|NCT00779402|524015551|FG000|Treatment Phase 1|Closure of Study|3|||
145318862|NCT00779402|524015552|FG001|Treatment Phase 1|Closure of Study|2|||
145318863|NCT00779402|524015551|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
145318864|NCT00779402|524015552|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
145318865|NCT00779402|524015551|FG000|Surveillance Phase|Protocol Violation|0|||
145318866|NCT00779402|524015552|FG001|Surveillance Phase|Protocol Violation|1|||
145318867|NCT00779402|524015551|FG000|Surveillance Phase|Patient refused to continue|22|||
145318868|NCT00779402|524015552|FG001|Surveillance Phase|Patient refused to continue|14|||
145318869|NCT00779402|524015551|FG000|Surveillance Phase|Lost to Follow-up|2|||
145318870|NCT00779402|524015552|FG001|Surveillance Phase|Lost to Follow-up|1|||
145318871|NCT00779402|524015551|FG000|Surveillance Phase|Death|0|||
145318872|NCT00779402|524015552|FG001|Surveillance Phase|Death|1|||
145318873|NCT00779402|524015551|FG000|Surveillance Phase|Intercurrent Illness|2|||
145318874|NCT00779402|524015552|FG001|Surveillance Phase|Intercurrent Illness|0|||
145318875|NCT00779402|524015551|FG000|Surveillance Phase|Other|5|||
145318876|NCT00779402|524015552|FG001|Surveillance Phase|Other|5|||
145318877|NCT00779402|524015551|FG000|Surveillance Phase|Withdrawal by Subject|4|||
145318878|NCT00779402|524015552|FG001|Surveillance Phase|Withdrawal by Subject|1|||
145318879|NCT00779402|524015551|FG000|Surveillance Phase|Closure of study|5|||
145318880|NCT00779402|524015552|FG001|Surveillance Phase|Closure of study|6|||
145318881|NCT00779402|524015551|FG000|Surveillance Phase|Completed Protocol Visits|3|||
145318882|NCT00779402|524015552|FG001|Surveillance Phase|Completed Protocol Visits|2|||
145318883|NCT00779402|524015551|FG000|Long-term Follow-up|Patient refused to continue|2|||
145318884|NCT00779402|524015552|FG001|Long-term Follow-up|Patient refused to continue|0|||
145318885|NCT00779402|524015551|FG000|Long-term Follow-up|Other|5|||
145318886|NCT00779402|524015552|FG001|Long-term Follow-up|Other|0|||
145318887|NCT00779402|524015551|FG000|Long-term Follow-up|Closure of Study|8|||
145318888|NCT00779402|524015552|FG001|Long-term Follow-up|Closure of Study|4|||
145318889|NCT00779402|524015551|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
145318890|NCT00779402|524015552|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
145318891|NCT01519947|524015557|FG000|Overall Study|Death|0|||
145318892|NCT01519947|524015558|FG001|Overall Study|Death|0|||
145318893|NCT01519947|524015559|FG002|Overall Study|Death|0|||
145318894|NCT01519947|524015560|FG003|Overall Study|Death|1|||
145318895|NCT01519947|524015557|FG000|Overall Study|Protocol Violation|0|||
145318896|NCT01519947|524015558|FG001|Overall Study|Protocol Violation|0|||
145318897|NCT01519947|524015559|FG002|Overall Study|Protocol Violation|2|||
145318898|NCT01519947|524015560|FG003|Overall Study|Protocol Violation|1|||
145318899|NCT01519947|524015557|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
145318900|NCT01519947|524015558|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
145318901|NCT01519947|524015559|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
145318902|NCT01519947|524015560|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
145318903|NCT01519947|524015557|FG000|Overall Study|Development of Anemia|0|||
145318904|NCT01519947|524015558|FG001|Overall Study|Development of Anemia|1|||
145318905|NCT01519947|524015559|FG002|Overall Study|Development of Anemia|0|||
145318906|NCT01519947|524015560|FG003|Overall Study|Development of Anemia|1|||
145318907|NCT01519947|524015557|FG000|Overall Study|Blood Transfusion|0|||
145318908|NCT01519947|524015558|FG001|Overall Study|Blood Transfusion|1|||
145318909|NCT01519947|524015559|FG002|Overall Study|Blood Transfusion|1|||
145318910|NCT01519947|524015560|FG003|Overall Study|Blood Transfusion|0|||
145318911|NCT01519947|524015557|FG000|Overall Study|Withdrawal by Subject|0|||
145318912|NCT01519947|524015558|FG001|Overall Study|Withdrawal by Subject|1|||
145318913|NCT01519947|524015559|FG002|Overall Study|Withdrawal by Subject|0|||
145318914|NCT01519947|524015560|FG003|Overall Study|Withdrawal by Subject|1|||
145318915|NCT01519947|524015557|FG000|Overall Study|Lost to Follow-up|0|||
145318916|NCT01519947|524015558|FG001|Overall Study|Lost to Follow-up|0|||
145318917|NCT01519947|524015559|FG002|Overall Study|Lost to Follow-up|3|||
145318918|NCT01519947|524015560|FG003|Overall Study|Lost to Follow-up|2|||
145318919|NCT01519947|524015557|FG000|Overall Study|Poor Response|1|||
145318920|NCT01519947|524015558|FG001|Overall Study|Poor Response|0|||
145318921|NCT01519947|524015559|FG002|Overall Study|Poor Response|0|||
145318922|NCT01519947|524015560|FG003|Overall Study|Poor Response|1|||
145318923|NCT01519947|524015557|FG000|Overall Study|Adverse Event|1|||
145318924|NCT01519947|524015558|FG001|Overall Study|Adverse Event|0|||
145318925|NCT01519947|524015559|FG002|Overall Study|Adverse Event|1|||
145318926|NCT01519947|524015560|FG003|Overall Study|Adverse Event|1|||
145318927|NCT00693225|524015561|FG000|Overall Study|Lost to Follow-up|1|||
145318928|NCT00693225|524015562|FG001|Overall Study|Lost to Follow-up|2|||
145318929|NCT00693225|524015561|FG000|Overall Study|Adverse Event|1|||
145318930|NCT00693225|524015562|FG001|Overall Study|Adverse Event|3|||
145318931|NCT01315028|524015563|FG000|Overall Study|Lost to Follow-up|1|||
145318932|NCT01315028|524015564|FG001|Overall Study|Lost to Follow-up|0|||
145318933|NCT01315028|524015563|FG000|Overall Study|Death|0|||
145318934|NCT01315028|524015564|FG001|Overall Study|Death|1|||
145318935|NCT01386125|524015565|FG000|Overall Study|Lost to Follow-up|3|||
145318936|NCT01386125|524015566|FG001|Overall Study|Lost to Follow-up|9|||
145318937|NCT01386125|524015565|FG000|Overall Study|Physician Decision|0|||
145318938|NCT01386125|524015566|FG001|Overall Study|Physician Decision|1|||
145318939|NCT01386125|524015565|FG000|Overall Study|Protocol Violation|5|||
145318940|NCT01386125|524015566|FG001|Overall Study|Protocol Violation|7|||
145318941|NCT01386125|524015565|FG000|Overall Study|Disease Progress|1|||
145318942|NCT01386125|524015566|FG001|Overall Study|Disease Progress|2|||
145318943|NCT01386125|524015565|FG000|Overall Study|Withdrawal by Subject|13|||
145318944|NCT01386125|524015566|FG001|Overall Study|Withdrawal by Subject|12|||
145318945|NCT01386125|524015565|FG000|Overall Study|Adverse Event|2|||
145318946|NCT01386125|524015566|FG001|Overall Study|Adverse Event|5|||
145318947|NCT01386125|524015565|FG000|Overall Study|Lack of Efficacy|0|||
145318948|NCT01386125|524015566|FG001|Overall Study|Lack of Efficacy|1|||
145318949|NCT01386125|524015565|FG000|Overall Study|Participant Leaving Country|1|||
145318950|NCT01386125|524015566|FG001|Overall Study|Participant Leaving Country|0|||
145318951|NCT03173560|524015567|FG000|Overall Study|Death|70|||
145318952|NCT03173560|524015568|FG001|Overall Study|Death|60|||
145318953|NCT03173560|524015567|FG000|Overall Study|Lost to Follow-up|1|||
145318954|NCT03173560|524015568|FG001|Overall Study|Lost to Follow-up|4|||
145318955|NCT03173560|524015567|FG000|Overall Study|Withdrawal by Subject|10|||
145318956|NCT03173560|524015568|FG001|Overall Study|Withdrawal by Subject|5|||
145318957|NCT03173560|524015567|FG000|Overall Study|Other|0|||
145318958|NCT03173560|524015568|FG001|Overall Study|Other|1|||
145318959|NCT03023137|524015571|FG000|Overall Study|Multiple pregnancy|2|||
145318960|NCT03023137|524015572|FG001|Overall Study|Multiple pregnancy|4|||
145318961|NCT03023137|524015571|FG000|Overall Study|Lost to Follow-up|1|||
145318962|NCT03023137|524015572|FG001|Overall Study|Lost to Follow-up|1|||
145318963|NCT03023137|524015571|FG000|Overall Study|Protocol Violation|0|||
145318964|NCT03023137|524015572|FG001|Overall Study|Protocol Violation|4|||
145318965|NCT03023137|524015571|FG000|Overall Study|Lost the baby in a car accident|1|||
145318966|NCT03023137|524015572|FG001|Overall Study|Lost the baby in a car accident|0|||
145318967|NCT02795676|524015576|FG000|Overall Study|Adverse Event|2|||
145318968|NCT02795676|524015577|FG001|Overall Study|Adverse Event|0|||
145318969|NCT02795676|524015576|FG000|Overall Study|Withdrawal by Subject|3|||
145318970|NCT02795676|524015577|FG001|Overall Study|Withdrawal by Subject|1|||
145318971|NCT01203917|524015578|FG000|Overall Study|Death|29|||
145318972|NCT01203917|524015578|FG000|Overall Study|Lost to Follow-up|2|||
145318973|NCT01203917|524015578|FG000|Overall Study|Withdrawal by Subject|3|||
145318974|NCT01203917|524015578|FG000|Overall Study|Due to objective disease progression|1|||
145318975|NCT01203917|524015578|FG000|Overall Study|Due to EGFR M+I patient|1|||
145318976|NCT00476593|524015582|FG000|Overall Study|Lost to Follow-up|10|||
145318977|NCT00476593|524015583|FG001|Overall Study|Lost to Follow-up|2|||
145318978|NCT00476593|524015584|FG002|Overall Study|Lost to Follow-up|8|||
145318979|NCT00476593|524015585|FG003|Overall Study|Lost to Follow-up|22|||
145318980|NCT03430011|524015586|FG000|Pre-Treatment|Death|1|||
145318981|NCT03430011|524015587|FG001|Pre-Treatment|Death|0|||
145318982|NCT03430011|524015588|FG002|Pre-Treatment|Death|0|||
145318983|NCT03430011|524015589|FG003|Pre-Treatment|Death|0|||
145318984|NCT03430011|524015590|FG004|Pre-Treatment|Death|1|||
145318985|NCT03430011|524015591|FG005|Pre-Treatment|Death|0|||
145318986|NCT03430011|524015592|FG006|Pre-Treatment|Death|1|||
145318987|NCT03430011|524015593|FG007|Pre-Treatment|Death|0|||
145318988|NCT03430011|524015586|FG000|Pre-Treatment|Screen Fail|0|||
145318989|NCT03430011|524015587|FG001|Pre-Treatment|Screen Fail|0|||
145318990|NCT03430011|524015588|FG002|Pre-Treatment|Screen Fail|0|||
145318991|NCT03430011|524015589|FG003|Pre-Treatment|Screen Fail|0|||
145318992|NCT03430011|524015590|FG004|Pre-Treatment|Screen Fail|1|||
145318993|NCT03430011|524015591|FG005|Pre-Treatment|Screen Fail|0|||
145318994|NCT03430011|524015592|FG006|Pre-Treatment|Screen Fail|0|||
145318995|NCT03430011|524015593|FG007|Pre-Treatment|Screen Fail|0|||
145318996|NCT03430011|524015586|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
145318997|NCT03430011|524015587|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
145318998|NCT03430011|524015588|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
145318999|NCT03430011|524015589|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
145319000|NCT03430011|524015590|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
145319001|NCT03430011|524015591|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
145319002|NCT03430011|524015592|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
145319003|NCT03430011|524015593|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
145319004|NCT03430011|524015586|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
145319005|NCT03430011|524015587|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
145319006|NCT03430011|524015588|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
145319007|NCT03430011|524015589|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
145319008|NCT03430011|524015590|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
145319009|NCT03430011|524015591|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
145319010|NCT03430011|524015592|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
145319011|NCT03430011|524015593|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
145319012|NCT03430011|524015586|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
145319013|NCT03430011|524015587|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
145319014|NCT03430011|524015588|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
145319015|NCT03430011|524015589|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
145319016|NCT03430011|524015590|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
145319017|NCT03430011|524015591|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
145319018|NCT03430011|524015592|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
145319019|NCT03430011|524015593|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
145319020|NCT03430011|524015586|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
145319021|NCT03430011|524015587|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
145319022|NCT03430011|524015588|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
145319023|NCT03430011|524015589|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
145319024|NCT03430011|524015590|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
145319025|NCT03430011|524015591|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
145319026|NCT03430011|524015592|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
145319027|NCT03430011|524015593|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
145319028|NCT03430011|524015586|FG000|JCARH125 Treatment|Death|4|||
145319029|NCT03430011|524015587|FG001|JCARH125 Treatment|Death|19|||
145319030|NCT03430011|524015588|FG002|JCARH125 Treatment|Death|10|||
145319031|NCT03430011|524015589|FG003|JCARH125 Treatment|Death|8|||
145319032|NCT03430011|524015590|FG004|JCARH125 Treatment|Death|5|||
145319033|NCT03430011|524015591|FG005|JCARH125 Treatment|Death|3|||
145319034|NCT03430011|524015592|FG006|JCARH125 Treatment|Death|4|||
145319035|NCT03430011|524015593|FG007|JCARH125 Treatment|Death|2|||
145319036|NCT03430011|524015586|FG000|JCARH125 Treatment|Other reasons|1|||
145319037|NCT03430011|524015587|FG001|JCARH125 Treatment|Other reasons|0|||
145319038|NCT03430011|524015588|FG002|JCARH125 Treatment|Other reasons|4|||
145319039|NCT03430011|524015589|FG003|JCARH125 Treatment|Other reasons|2|||
145319040|NCT03430011|524015590|FG004|JCARH125 Treatment|Other reasons|2|||
145319041|NCT03430011|524015591|FG005|JCARH125 Treatment|Other reasons|1|||
145319042|NCT03430011|524015592|FG006|JCARH125 Treatment|Other reasons|3|||
145319043|NCT03430011|524015593|FG007|JCARH125 Treatment|Other reasons|2|||
145319044|NCT04126343|524015595|FG000|Overall Study|Adverse Event|0|||
145319045|NCT04126343|524015596|FG001|Overall Study|Adverse Event|0|||
145319046|NCT04126343|524015597|FG002|Overall Study|Adverse Event|0|||
145319047|NCT04126343|524015598|FG003|Overall Study|Adverse Event|0|||
145319048|NCT04126343|524015599|FG004|Overall Study|Adverse Event|0|||
145319049|NCT04126343|524015600|FG005|Overall Study|Adverse Event|1|||
145319050|NCT04126343|524015595|FG000|Overall Study|Withdrawal by Subject|0|||
145319051|NCT04126343|524015596|FG001|Overall Study|Withdrawal by Subject|0|||
145319052|NCT04126343|524015597|FG002|Overall Study|Withdrawal by Subject|0|||
145319053|NCT04126343|524015598|FG003|Overall Study|Withdrawal by Subject|1|||
145319054|NCT04126343|524015599|FG004|Overall Study|Withdrawal by Subject|0|||
145319055|NCT04126343|524015600|FG005|Overall Study|Withdrawal by Subject|0|||
145319056|NCT04126343|524015595|FG000|Overall Study|Related to COVID-19 pandemic|3|||
145319057|NCT04126343|524015596|FG001|Overall Study|Related to COVID-19 pandemic|4|||
145319058|NCT04126343|524015597|FG002|Overall Study|Related to COVID-19 pandemic|3|||
145319059|NCT04126343|524015598|FG003|Overall Study|Related to COVID-19 pandemic|3|||
145319060|NCT04126343|524015599|FG004|Overall Study|Related to COVID-19 pandemic|3|||
145319061|NCT04126343|524015600|FG005|Overall Study|Related to COVID-19 pandemic|3|||
145319062|NCT02941523|524015607|FG000|Monotherapy|Withdrawal by Subject|0|||
145319063|NCT02941523|524015608|FG001|Monotherapy|Withdrawal by Subject|1|||
145319064|NCT02941523|524015607|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
145319065|NCT02941523|524015608|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
145319066|NCT02941523|524015607|FG000|Carboplatin Combination Therapy|Death|1|||
145319067|NCT02941523|524015608|FG001|Carboplatin Combination Therapy|Death|2|||
145319068|NCT02941523|524015607|FG000|Carboplatin Combination Therapy|Disease progression|2|||
145319069|NCT02941523|524015608|FG001|Carboplatin Combination Therapy|Disease progression|0|||
145319070|NCT02941523|524015607|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
145319071|NCT02941523|524015608|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
145319072|NCT02539368|524015609|FG000|Overall Study|Death|4|||
145319073|NCT02539368|524015610|FG001|Overall Study|Death|2|||
145319074|NCT02539368|524015611|FG002|Overall Study|Death|1|||
145319075|NCT02539368|524015612|FG003|Overall Study|Death|0|||
145319076|NCT02539368|524015613|FG004|Overall Study|Death|0|||
145319077|NCT02539368|524015609|FG000|Overall Study|Withdrawal by Subject|44|||
145319078|NCT02539368|524015610|FG001|Overall Study|Withdrawal by Subject|35|||
145319079|NCT02539368|524015611|FG002|Overall Study|Withdrawal by Subject|9|||
145319080|NCT02539368|524015612|FG003|Overall Study|Withdrawal by Subject|1|||
145319081|NCT02539368|524015613|FG004|Overall Study|Withdrawal by Subject|3|||
145319082|NCT02539368|524015609|FG000|Overall Study|Physician Decision|49|||
145319083|NCT02539368|524015610|FG001|Overall Study|Physician Decision|15|||
145319084|NCT02539368|524015611|FG002|Overall Study|Physician Decision|7|||
145319085|NCT02539368|524015612|FG003|Overall Study|Physician Decision|0|||
145319086|NCT02539368|524015613|FG004|Overall Study|Physician Decision|2|||
145319087|NCT02539368|524015609|FG000|Overall Study|Lost to Follow-up|96|||
145319088|NCT02539368|524015610|FG001|Overall Study|Lost to Follow-up|21|||
145319089|NCT02539368|524015611|FG002|Overall Study|Lost to Follow-up|16|||
145319090|NCT02539368|524015612|FG003|Overall Study|Lost to Follow-up|4|||
145319091|NCT02539368|524015613|FG004|Overall Study|Lost to Follow-up|3|||
145319092|NCT02539368|524015609|FG000|Overall Study|Adverse Event|44|||
145319093|NCT02539368|524015610|FG001|Overall Study|Adverse Event|5|||
145319094|NCT02539368|524015611|FG002|Overall Study|Adverse Event|9|||
145319095|NCT02539368|524015612|FG003|Overall Study|Adverse Event|0|||
145319096|NCT02539368|524015613|FG004|Overall Study|Adverse Event|3|||
145319097|NCT02539368|524015609|FG000|Overall Study|Participant Non-compliant|13|||
145319098|NCT02539368|524015610|FG001|Overall Study|Participant Non-compliant|2|||
145319099|NCT02539368|524015611|FG002|Overall Study|Participant Non-compliant|1|||
145319100|NCT02539368|524015612|FG003|Overall Study|Participant Non-compliant|1|||
145319101|NCT02539368|524015613|FG004|Overall Study|Participant Non-compliant|0|||
145319102|NCT02539368|524015609|FG000|Overall Study|Other|145|||
145319103|NCT02539368|524015610|FG001|Overall Study|Other|18|||
145319104|NCT02539368|524015611|FG002|Overall Study|Other|24|||
145319105|NCT02539368|524015612|FG003|Overall Study|Other|1|||
145319106|NCT02539368|524015613|FG004|Overall Study|Other|3|||
145319107|NCT02539368|524015609|FG000|Overall Study|Missing|10|||
145319108|NCT02539368|524015610|FG001|Overall Study|Missing|3|||
145319109|NCT02539368|524015611|FG002|Overall Study|Missing|0|||
145319110|NCT02539368|524015612|FG003|Overall Study|Missing|0|||
145319111|NCT02539368|524015613|FG004|Overall Study|Missing|0|||
145319112|NCT01020526|524015615|FG000|Overall Study|Withdrawal by Subject|5|||
145319113|NCT01020526|524015615|FG000|Overall Study|Other reasons|3|||
145319114|NCT01020526|524015615|FG000|Overall Study|Insufficient clinical response|3|||
145319115|NCT01020526|524015615|FG000|Overall Study|Lost to Follow-up|1|||
145319116|NCT01020526|524015615|FG000|Overall Study|Adverse Event|2|||
145319117|NCT01899326|524015616|FG000|Overall Study|Withdrawal by Subject|1|||
145319118|NCT01899326|524015616|FG000|Overall Study|Adverse Event|2|||
145319119|NCT01899326|524015616|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
145319120|NCT00373425|524015618|FG000|Overall Study|Relapse of NSCLC|116|||
145319121|NCT00373425|524015619|FG001|Overall Study|Relapse of NSCLC|104|||
145319122|NCT00373425|524015620|FG002|Overall Study|Relapse of NSCLC|19|||
145319123|NCT00373425|524015621|FG003|Overall Study|Relapse of NSCLC|2|||
145319124|NCT00373425|524015622|FG004|Overall Study|Relapse of NSCLC|26|||
145319125|NCT00373425|524015618|FG000|Overall Study|Adverse Event|191|||
145319126|NCT00373425|524015619|FG001|Overall Study|Adverse Event|22|||
145319127|NCT00373425|524015620|FG002|Overall Study|Adverse Event|59|||
145319128|NCT00373425|524015621|FG003|Overall Study|Adverse Event|0|||
145319129|NCT00373425|524015622|FG004|Overall Study|Adverse Event|34|||
145319130|NCT00373425|524015618|FG000|Overall Study|Patient request|35|||
145319131|NCT00373425|524015619|FG001|Overall Study|Patient request|18|||
145319132|NCT00373425|524015620|FG002|Overall Study|Patient request|43|||
145319133|NCT00373425|524015621|FG003|Overall Study|Patient request|6|||
145319134|NCT00373425|524015622|FG004|Overall Study|Patient request|7|||
145319135|NCT00373425|524015618|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
145319136|NCT00373425|524015619|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
145319137|NCT00373425|524015620|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
145319138|NCT00373425|524015621|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
145319139|NCT00373425|524015622|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
145319140|NCT00373425|524015618|FG000|Overall Study|Death|7|||
145319141|NCT00373425|524015619|FG001|Overall Study|Death|0|||
145319142|NCT00373425|524015620|FG002|Overall Study|Death|3|||
145319143|NCT00373425|524015621|FG003|Overall Study|Death|1|||
145319144|NCT00373425|524015622|FG004|Overall Study|Death|0|||
145319145|NCT03558139|524015623|FG000|Overall Study|Consent Withdrawn|1|||
145319146|NCT03558139|524015624|FG001|Overall Study|Consent Withdrawn|1|||
145319147|NCT03558139|524015625|FG002|Overall Study|Consent Withdrawn|4|||
145319148|NCT03558139|524015623|FG000|Overall Study|Death|5|||
145319149|NCT03558139|524015624|FG001|Overall Study|Death|3|||
145319150|NCT03558139|524015625|FG002|Overall Study|Death|8|||
145319151|NCT03558139|524015623|FG000|Overall Study|Lost to Follow-up|0|||
145319152|NCT03558139|524015624|FG001|Overall Study|Lost to Follow-up|0|||
145319153|NCT03558139|524015625|FG002|Overall Study|Lost to Follow-up|3|||
145319154|NCT03558139|524015623|FG000|Overall Study|Study Ended Per Protocol|0|||
145319155|NCT03558139|524015624|FG001|Overall Study|Study Ended Per Protocol|3|||
145319156|NCT03558139|524015625|FG002|Overall Study|Study Ended Per Protocol|6|||
145319157|NCT00551616|524015628|FG000|Overall Study|Lost to Follow-up|48|||
145319158|NCT00551616|524015629|FG001|Overall Study|Lost to Follow-up|40|||
145319159|NCT02752802|524015630|FG000|Overall Study|Contrast Volume Not Collected|1|||
145319160|NCT02752802|524015631|FG001|Overall Study|Contrast Volume Not Collected|0|||
145319161|NCT00569777|524015632|FG000|Overall Study|Withdrawal by Subject|4|||
145319162|NCT00569777|524015633|FG001|Overall Study|Withdrawal by Subject|0|||
145319163|NCT00569777|524015632|FG000|Overall Study|Adverse Event|3|||
145319164|NCT00569777|524015633|FG001|Overall Study|Adverse Event|0|||
145319165|NCT00569777|524015632|FG000|Overall Study|Lost to Follow-up|1|||
145319166|NCT00569777|524015633|FG001|Overall Study|Lost to Follow-up|0|||
145319167|NCT00569777|524015632|FG000|Overall Study|scheduled eye surgery|0|||
145319168|NCT00569777|524015633|FG001|Overall Study|scheduled eye surgery|1|||
145319169|NCT00569777|524015632|FG000|Overall Study|did not meet exclusion criteria|1|||
145319170|NCT00569777|524015633|FG001|Overall Study|did not meet exclusion criteria|2|||
145319171|NCT00569777|524015632|FG000|Overall Study|pregnant|1|||
145319172|NCT00569777|524015633|FG001|Overall Study|pregnant|0|||
145319173|NCT01835548|524015638|FG000|Dose Optimization Period|Adverse Event|0|||
145319174|NCT01835548|524015639|FG001|Dose Optimization Period|Adverse Event|0|||
145319175|NCT01835548|524015640|FG002|Dose Optimization Period|Adverse Event|1|||
145319176|NCT01835548|524015638|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
145319177|NCT01835548|524015639|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
145319178|NCT01835548|524015640|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
145319179|NCT01835548|524015638|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145319180|NCT01835548|524015639|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145319181|NCT01835548|524015640|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145319182|NCT01835548|524015638|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145319183|NCT01835548|524015639|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
145319184|NCT01835548|524015640|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145319185|NCT02490800|524015641|FG000|Overall Study|Adverse Event|0|||
145319186|NCT02490800|524015642|FG001|Overall Study|Adverse Event|0|||
145319187|NCT02490800|524015643|FG002|Overall Study|Adverse Event|0|||
145319188|NCT02490800|524015644|FG003|Overall Study|Adverse Event|2|||
145319189|NCT02490800|524015645|FG004|Overall Study|Adverse Event|3|||
145319190|NCT02490800|524015646|FG005|Overall Study|Adverse Event|2|||
145319191|NCT02490800|524015647|FG006|Overall Study|Adverse Event|0|||
145319192|NCT02490800|524015648|FG007|Overall Study|Adverse Event|0|||
145319193|NCT02490800|524015649|FG008|Overall Study|Adverse Event|0|||
145319194|NCT02490800|524015650|FG009|Overall Study|Adverse Event|0|||
145319195|NCT02490800|524015651|FG010|Overall Study|Adverse Event|0|||
145319196|NCT02490800|524015652|FG011|Overall Study|Adverse Event|2|||
145319197|NCT02490800|524015653|FG012|Overall Study|Adverse Event|2|||
145319198|NCT02490800|524015641|FG000|Overall Study|Withdrawal by Subject|0|||
145319199|NCT02490800|524015642|FG001|Overall Study|Withdrawal by Subject|0|||
145319200|NCT02490800|524015643|FG002|Overall Study|Withdrawal by Subject|0|||
145319201|NCT02490800|524015644|FG003|Overall Study|Withdrawal by Subject|1|||
145319202|NCT02490800|524015645|FG004|Overall Study|Withdrawal by Subject|0|||
145319203|NCT02490800|524015646|FG005|Overall Study|Withdrawal by Subject|0|||
145319204|NCT02490800|524015647|FG006|Overall Study|Withdrawal by Subject|0|||
145319205|NCT02490800|524015648|FG007|Overall Study|Withdrawal by Subject|0|||
145319206|NCT02490800|524015649|FG008|Overall Study|Withdrawal by Subject|1|||
145319207|NCT02490800|524015650|FG009|Overall Study|Withdrawal by Subject|0|||
145319208|NCT02490800|524015651|FG010|Overall Study|Withdrawal by Subject|0|||
145319209|NCT02490800|524015652|FG011|Overall Study|Withdrawal by Subject|0|||
145319210|NCT02490800|524015653|FG012|Overall Study|Withdrawal by Subject|0|||
145319211|NCT02490800|524015641|FG000|Overall Study|Progressive disease|3|||
145319212|NCT02490800|524015642|FG001|Overall Study|Progressive disease|3|||
145319213|NCT02490800|524015643|FG002|Overall Study|Progressive disease|3|||
145319214|NCT02490800|524015644|FG003|Overall Study|Progressive disease|4|||
145319215|NCT02490800|524015645|FG004|Overall Study|Progressive disease|4|||
145319216|NCT02490800|524015646|FG005|Overall Study|Progressive disease|1|||
145319217|NCT02490800|524015647|FG006|Overall Study|Progressive disease|4|||
145319218|NCT02490800|524015648|FG007|Overall Study|Progressive disease|3|||
145319219|NCT02490800|524015649|FG008|Overall Study|Progressive disease|6|||
145319220|NCT02490800|524015650|FG009|Overall Study|Progressive disease|2|||
145319221|NCT02490800|524015651|FG010|Overall Study|Progressive disease|7|||
145319222|NCT02490800|524015652|FG011|Overall Study|Progressive disease|1|||
145319223|NCT02490800|524015653|FG012|Overall Study|Progressive disease|10|||
145319224|NCT02490800|524015641|FG000|Overall Study|Patient enrolled in post-trial access|0|||
145319225|NCT02490800|524015642|FG001|Overall Study|Patient enrolled in post-trial access|0|||
145319226|NCT02490800|524015643|FG002|Overall Study|Patient enrolled in post-trial access|0|||
145319227|NCT02490800|524015644|FG003|Overall Study|Patient enrolled in post-trial access|0|||
145319228|NCT02490800|524015645|FG004|Overall Study|Patient enrolled in post-trial access|0|||
145319229|NCT02490800|524015646|FG005|Overall Study|Patient enrolled in post-trial access|0|||
145319230|NCT02490800|524015647|FG006|Overall Study|Patient enrolled in post-trial access|0|||
145319231|NCT02490800|524015648|FG007|Overall Study|Patient enrolled in post-trial access|0|||
145319232|NCT02490800|524015649|FG008|Overall Study|Patient enrolled in post-trial access|0|||
145319233|NCT02490800|524015650|FG009|Overall Study|Patient enrolled in post-trial access|1|||
145319234|NCT02490800|524015651|FG010|Overall Study|Patient enrolled in post-trial access|1|||
145319235|NCT02490800|524015652|FG011|Overall Study|Patient enrolled in post-trial access|0|||
145319236|NCT02490800|524015653|FG012|Overall Study|Patient enrolled in post-trial access|6|||
145319237|NCT00537017|524015654|FG000|Treatment Phase|Adverse Event|19|||
145319238|NCT00537017|524015654|FG000|Treatment Phase|Withdrawal by Subject|13|||
145319239|NCT00537017|524015654|FG000|Treatment Phase|Protocol Violation|2|||
145319240|NCT00537017|524015654|FG000|Follow-up Phase|Withdrawal by Subject|9|||
145319241|NCT00987831|524015655|FG000|Overall Study|Never flared in 12 months|1|||
145319242|NCT00987831|524015656|FG001|Overall Study|Never flared in 12 months|0|||
145319243|NCT00987831|524015657|FG002|Overall Study|Never flared in 12 months|0|||
145319244|NCT00987831|524015655|FG000|Overall Study|Lost to Follow-up|0|||
145319245|NCT00987831|524015656|FG001|Overall Study|Lost to Follow-up|3|||
145319246|NCT00987831|524015657|FG002|Overall Study|Lost to Follow-up|0|||
145319247|NCT04149535|524015660|FG000|Overall Study|Death|11|||
145319248|NCT04149535|524015661|FG001|Overall Study|Death|7|||
145319249|NCT04149535|524015660|FG000|Overall Study|Physician Decision|10|||
145319250|NCT04149535|524015661|FG001|Overall Study|Physician Decision|4|||
145319251|NCT04149535|524015660|FG000|Overall Study|Withdrawal by Subject|6|||
145319252|NCT04149535|524015661|FG001|Overall Study|Withdrawal by Subject|7|||
145319253|NCT04149535|524015660|FG000|Overall Study|Not described|2|||
145319254|NCT04149535|524015661|FG001|Overall Study|Not described|0|||
145319255|NCT02175368|524015662|FG000|Overall Study|Lost to Follow-up|1|||
145319256|NCT02875028|524015663|FG000|Washout Period|Withdrawal by Subject|0|||
145319257|NCT02875028|524015664|FG001|Washout Period|Withdrawal by Subject|1|||
145319258|NCT05068284|524015665|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
145319259|NCT05068284|524015666|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
145319260|NCT05068284|524015667|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319261|NCT05068284|524015668|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319262|NCT05068284|524015669|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319263|NCT05068284|524015670|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319264|NCT05068284|524015671|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319265|NCT05068284|524015672|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
145319266|NCT05068284|524015665|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319267|NCT05068284|524015666|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319268|NCT05068284|524015667|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
145319269|NCT05068284|524015668|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319270|NCT05068284|524015669|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319271|NCT05068284|524015670|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319272|NCT05068284|524015671|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319273|NCT05068284|524015672|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
145319274|NCT05068284|524015665|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
145319275|NCT05068284|524015666|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
145319276|NCT05068284|524015667|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
145319277|NCT05068284|524015668|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
145319278|NCT05068284|524015669|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
145319279|NCT05068284|524015670|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145319280|NCT05068284|524015671|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145319281|NCT05068284|524015672|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
145319282|NCT05068284|524015665|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319283|NCT05068284|524015666|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319284|NCT05068284|524015667|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
145319285|NCT05068284|524015668|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319286|NCT05068284|524015669|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
145319287|NCT05068284|524015670|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319288|NCT05068284|524015671|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319289|NCT05068284|524015672|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
145319290|NCT05068284|524015665|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319291|NCT05068284|524015666|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319292|NCT05068284|524015667|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145620557|NCT01923428|525125103|FG001|Overall Study|Protocol Violation|0|||
145620558|NCT01923428|525125104|FG002|Overall Study|Protocol Violation|2|||
145620559|NCT01923428|525125105|FG003|Overall Study|Protocol Violation|1|||
145319293|NCT05068284|524015668|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
145319294|NCT05068284|524015669|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319295|NCT05068284|524015670|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319296|NCT05068284|524015671|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319297|NCT05068284|524015672|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
145319298|NCT05068284|524015665|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145620560|NCT01923428|525125102|FG000|Overall Study|Non Compliance to treatment|1|||
145620561|NCT01923428|525125103|FG001|Overall Study|Non Compliance to treatment|2|||
145319299|NCT05068284|524015666|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145319300|NCT05068284|524015667|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
145319301|NCT05068284|524015668|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
145319302|NCT05068284|524015669|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145319303|NCT05068284|524015670|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145319304|NCT05068284|524015671|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145319305|NCT05068284|524015672|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
145319306|NCT05068284|524015665|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319307|NCT05068284|524015666|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319308|NCT05068284|524015667|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
145319309|NCT05068284|524015668|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319310|NCT05068284|524015669|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319311|NCT05068284|524015670|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319312|NCT05068284|524015671|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319313|NCT05068284|524015672|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
145319314|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
145319315|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319316|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319317|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319318|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319319|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319320|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319321|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
145319322|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
145319323|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145319324|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145319325|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145319326|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145319327|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
145319328|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
145319329|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
145319330|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
145319331|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319332|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319333|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319334|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319335|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319336|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
145319337|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
145319338|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
145319339|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319340|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319341|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319342|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319343|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319344|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319345|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
145319346|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
145319347|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319348|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319349|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319350|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319351|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319352|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145319353|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
145377820|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
145620562|NCT01923428|525125104|FG002|Overall Study|Non Compliance to treatment|0|||
145319354|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
145319355|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145319356|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145319357|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145319358|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
145319359|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
145319360|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
145319361|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
145319362|NCT05068284|524015665|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319363|NCT05068284|524015666|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319364|NCT05068284|524015667|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319365|NCT05068284|524015668|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319366|NCT05068284|524015669|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319367|NCT05068284|524015670|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319368|NCT05068284|524015671|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
145319369|NCT05068284|524015672|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
145319370|NCT04100096|524017618|FG000|Overall Study|Adverse Event|19|||
145319371|NCT04100096|524017619|FG001|Overall Study|Adverse Event|7|||
145319372|NCT04100096|524017618|FG000|Overall Study|Lack of Efficacy|0|||
145319373|NCT04100096|524017619|FG001|Overall Study|Lack of Efficacy|1|||
145319374|NCT04100096|524017618|FG000|Overall Study|Lost to Follow-up|13|||
145319375|NCT04100096|524017619|FG001|Overall Study|Lost to Follow-up|11|||
145319376|NCT04100096|524017618|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145319377|NCT04100096|524017619|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145319378|NCT04100096|524017618|FG000|Overall Study|Protocol Deviation|1|||
145319379|NCT04100096|524017619|FG001|Overall Study|Protocol Deviation|1|||
145319380|NCT04100096|524017618|FG000|Overall Study|Withdrawal by Participant|13|||
145319381|NCT04100096|524017619|FG001|Overall Study|Withdrawal by Participant|15|||
145319382|NCT00991510|524017622|FG000|Period I (Days 1-14)|Adverse Event|1|||
145411561|NCT02335944|524360066|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411562|NCT02335944|524360067|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
145411563|NCT02335944|524360058|FG000|Post-treatment Follow-up|Adverse Event|0|||
145411564|NCT02335944|524360059|FG001|Post-treatment Follow-up|Adverse Event|0|||
145411565|NCT02335944|524360060|FG002|Post-treatment Follow-up|Adverse Event|0|||
145411566|NCT02335944|524360061|FG003|Post-treatment Follow-up|Adverse Event|0|||
145411567|NCT02335944|524360062|FG004|Post-treatment Follow-up|Adverse Event|0|||
145411568|NCT02335944|524360063|FG005|Post-treatment Follow-up|Adverse Event|1|||
145411569|NCT02335944|524360064|FG006|Post-treatment Follow-up|Adverse Event|0|||
145411570|NCT02335944|524360065|FG007|Post-treatment Follow-up|Adverse Event|0|||
145411571|NCT02335944|524360066|FG008|Post-treatment Follow-up|Adverse Event|0|||
145411572|NCT02335944|524360067|FG009|Post-treatment Follow-up|Adverse Event|0|||
145411573|NCT02335944|524360058|FG000|Post-treatment Follow-up|Death|0|||
145411574|NCT02335944|524360059|FG001|Post-treatment Follow-up|Death|0|||
145411575|NCT02335944|524360060|FG002|Post-treatment Follow-up|Death|0|||
145411576|NCT02335944|524360061|FG003|Post-treatment Follow-up|Death|1|||
145411577|NCT02335944|524360062|FG004|Post-treatment Follow-up|Death|0|||
145411578|NCT02335944|524360063|FG005|Post-treatment Follow-up|Death|1|||
145411579|NCT02335944|524360064|FG006|Post-treatment Follow-up|Death|0|||
145319383|NCT00991510|524017623|FG001|Period I (Days 1-14)|Adverse Event|0|||
145319384|NCT00991510|524017622|FG000|Period III (Days 29-112)|Adverse Event|1|||
145319385|NCT00991510|524017623|FG001|Period III (Days 29-112)|Adverse Event|1|||
145319386|NCT01796964|524017627|FG000|Overall Study|Adverse Event|1|||
145319387|NCT01796964|524017628|FG001|Overall Study|Adverse Event|1|||
145319388|NCT01796964|524017627|FG000|Overall Study|Death|1|||
145319389|NCT01796964|524017628|FG001|Overall Study|Death|0|||
145319390|NCT01796964|524017627|FG000|Overall Study|Protocol Violation|0|||
145319391|NCT01796964|524017628|FG001|Overall Study|Protocol Violation|1|||
145319392|NCT01796964|524017627|FG000|Overall Study|Withdrawal by Subject|1|||
145319393|NCT01796964|524017628|FG001|Overall Study|Withdrawal by Subject|1|||
145411580|NCT02335944|524360065|FG007|Post-treatment Follow-up|Death|0|||
145411581|NCT02335944|524360066|FG008|Post-treatment Follow-up|Death|0|||
145319394|NCT04025684|524017629|FG000|Overall Study|Withdrawal by Subject|1|||
145319395|NCT04025684|524017630|FG001|Overall Study|Withdrawal by Subject|1|||
145319396|NCT04025684|524017631|FG002|Overall Study|Withdrawal by Subject|0|||
145319397|NCT04025684|524017632|FG003|Overall Study|Withdrawal by Subject|0|||
145411582|NCT02335944|524360067|FG009|Post-treatment Follow-up|Death|0|||
145319398|NCT04025684|524017629|FG000|Overall Study|Multiple reasons|1|||
145319399|NCT04025684|524017630|FG001|Overall Study|Multiple reasons|3|||
145319400|NCT04025684|524017631|FG002|Overall Study|Multiple reasons|0|||
145319401|NCT04025684|524017632|FG003|Overall Study|Multiple reasons|1|||
145319402|NCT00794417|524017645|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145411583|NCT02335944|524360058|FG000|Post-treatment Follow-up|Physician Decision|1|||
145411584|NCT02335944|524360059|FG001|Post-treatment Follow-up|Physician Decision|0|||
145319403|NCT00794417|524017646|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145319404|NCT00794417|524017647|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
145319405|NCT00794417|524017648|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
145319406|NCT00794417|524017645|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
145319407|NCT00794417|524017646|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
145319408|NCT00794417|524017647|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
145319409|NCT00794417|524017648|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
145319410|NCT00794417|524017645|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145319411|NCT00794417|524017646|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145319412|NCT00794417|524017647|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
145319413|NCT00794417|524017648|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
145319414|NCT00794417|524017645|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
145319415|NCT00794417|524017646|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
145319416|NCT00794417|524017647|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
145319417|NCT00794417|524017648|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
145319418|NCT00794417|524017645|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145319419|NCT00794417|524017646|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145319420|NCT00794417|524017647|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
145319421|NCT00794417|524017648|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
145319422|NCT00794417|524017645|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145319423|NCT00794417|524017646|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145319424|NCT00794417|524017647|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
145319425|NCT00794417|524017648|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
145319426|NCT00317642|524017652|FG000|Overall Study|Not Received Either Study Drug|1|||
145319427|NCT00317642|524017653|FG001|Overall Study|Not Received Either Study Drug|3|||
145319428|NCT00317642|524017652|FG000|Overall Study|Physician Decision|15|||
145319429|NCT00317642|524017653|FG001|Overall Study|Physician Decision|7|||
145319430|NCT00317642|524017652|FG000|Overall Study|Participant declined treatment|14|||
145319431|NCT00317642|524017653|FG001|Overall Study|Participant declined treatment|3|||
145319432|NCT00317642|524017652|FG000|Overall Study|Adverse Event|17|||
145319433|NCT00317642|524017653|FG001|Overall Study|Adverse Event|5|||
145319434|NCT00317642|524017652|FG000|Overall Study|Treatment Failure|56|||
145319435|NCT00317642|524017653|FG001|Overall Study|Treatment Failure|102|||
145319436|NCT00317642|524017652|FG000|Overall Study|Disease Recurrence|1|||
145319437|NCT00317642|524017653|FG001|Overall Study|Disease Recurrence|2|||
145319438|NCT00317642|524017652|FG000|Overall Study|Death|14|||
145319439|NCT00317642|524017653|FG001|Overall Study|Death|7|||
145319440|NCT00317642|524017652|FG000|Overall Study|Not Continue to Consolidation|2|||
145319441|NCT00317642|524017653|FG001|Overall Study|Not Continue to Consolidation|0|||
145319442|NCT00317642|524017652|FG000|Overall Study|Withdrawal by Subject|0|||
145319443|NCT00317642|524017653|FG001|Overall Study|Withdrawal by Subject|1|||
145319444|NCT00317642|524017652|FG000|Overall Study|Referred For Transplantation|1|||
145319445|NCT00317642|524017653|FG001|Overall Study|Referred For Transplantation|0|||
145319446|NCT00317642|524017652|FG000|Overall Study|AML Not Centrally Confirmed|1|||
145319447|NCT00317642|524017653|FG001|Overall Study|AML Not Centrally Confirmed|5|||
145411585|NCT02335944|524360060|FG002|Post-treatment Follow-up|Physician Decision|0|||
145411586|NCT02335944|524360061|FG003|Post-treatment Follow-up|Physician Decision|0|||
145411587|NCT02335944|524360062|FG004|Post-treatment Follow-up|Physician Decision|0|||
145411588|NCT02335944|524360063|FG005|Post-treatment Follow-up|Physician Decision|0|||
145411589|NCT02335944|524360064|FG006|Post-treatment Follow-up|Physician Decision|0|||
145411590|NCT02335944|524360065|FG007|Post-treatment Follow-up|Physician Decision|1|||
145411591|NCT02335944|524360066|FG008|Post-treatment Follow-up|Physician Decision|0|||
145411592|NCT02335944|524360067|FG009|Post-treatment Follow-up|Physician Decision|0|||
145411593|NCT03018938|524360068|FG000|Overall Study|Death|0|||
145411594|NCT03018938|524360069|FG001|Overall Study|Death|1|||
145411595|NCT03018938|524360068|FG000|Overall Study|Lost to Follow-up|21|||
145411596|NCT03018938|524360069|FG001|Overall Study|Lost to Follow-up|32|||
145411597|NCT03018938|524360068|FG000|Overall Study|Withdrawal by Subject|38|||
145411598|NCT03018938|524360069|FG001|Overall Study|Withdrawal by Subject|45|||
145411599|NCT03018938|524360068|FG000|Overall Study|Physician Decision|3|||
145411600|NCT03018938|524360069|FG001|Overall Study|Physician Decision|2|||
145411601|NCT03018938|524360068|FG000|Overall Study|Sponsor Decision|0|||
145411602|NCT03018938|524360069|FG001|Overall Study|Sponsor Decision|1|||
145411603|NCT03018938|524360068|FG000|Overall Study|Screen failure-After randomization|4|||
145319448|NCT02695719|524017657|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
145319449|NCT02695719|524017658|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
145319450|NCT02695719|524017657|FG000|Overall Study|Significant Protocol Deviation|0|||
145319451|NCT02695719|524017658|FG001|Overall Study|Significant Protocol Deviation|1|||
145319452|NCT02695719|524017657|FG000|Overall Study|Voluntary Withdrawal|1|||
145319453|NCT02695719|524017658|FG001|Overall Study|Voluntary Withdrawal|0|||
145319454|NCT01534078|524017661|FG000|Overall Study|Death|1|||
145411604|NCT03018938|524360069|FG001|Overall Study|Screen failure-After randomization|2|||
145319455|NCT01534078|524017661|FG000|Overall Study|Withdrawal by Subject|1|||
145319456|NCT01049412|524017662|FG000|Period I|Withdrawal by Subject|4|||
145319457|NCT01049412|524017663|FG001|Period I|Withdrawal by Subject|6|||
145319458|NCT01049412|524017662|FG000|Period I|Lost to Follow-up|2|||
145319459|NCT01049412|524017663|FG001|Period I|Lost to Follow-up|2|||
145319460|NCT01049412|524017662|FG000|Period I|Physician Decision|0|||
145319461|NCT01049412|524017663|FG001|Period I|Physician Decision|3|||
145319462|NCT01049412|524017662|FG000|Period I|Protocol Violation|1|||
145319463|NCT01049412|524017663|FG001|Period I|Protocol Violation|2|||
145319464|NCT01049412|524017662|FG000|Period I|Adverse Event|1|||
145319465|NCT01049412|524017663|FG001|Period I|Adverse Event|0|||
145319466|NCT01049412|524017662|FG000|Period II|Withdrawal by Subject|2|||
145319467|NCT01049412|524017663|FG001|Period II|Withdrawal by Subject|3|||
145319468|NCT01049412|524017662|FG000|Period II|Adverse Event|1|||
145319469|NCT01049412|524017663|FG001|Period II|Adverse Event|0|||
145319470|NCT01049412|524017662|FG000|Period II|Lost to Follow-up|1|||
145319471|NCT01049412|524017663|FG001|Period II|Lost to Follow-up|0|||
145319472|NCT05966090|524017664|FG000|Overall Study|Lost to Follow-up|6|||
145319473|NCT05966090|524017665|FG001|Overall Study|Lost to Follow-up|6|||
145319474|NCT05966090|524017664|FG000|Overall Study|Adverse Event|1|||
145319475|NCT05966090|524017665|FG001|Overall Study|Adverse Event|1|||
145319476|NCT05966090|524017664|FG000|Overall Study|Withdrawal by Subject|1|||
145319477|NCT05966090|524017665|FG001|Overall Study|Withdrawal by Subject|1|||
145319478|NCT05966090|524017664|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145319479|NCT05966090|524017665|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145319480|NCT05966090|524017664|FG000|Overall Study|Other|1|||
145319481|NCT05966090|524017665|FG001|Overall Study|Other|1|||
145319482|NCT03235479|524017668|FG000|Overall Study|Lost to Follow-up|8|||
145319483|NCT03235479|524017669|FG001|Overall Study|Lost to Follow-up|11|||
145319484|NCT03235479|524017668|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
145319485|NCT03235479|524017669|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
145319486|NCT03235479|524017668|FG000|Overall Study|Pregnancy|1|||
145319487|NCT03235479|524017669|FG001|Overall Study|Pregnancy|0|||
145319488|NCT03235479|524017668|FG000|Overall Study|Protocol Deviation|1|||
145319489|NCT03235479|524017669|FG001|Overall Study|Protocol Deviation|3|||
145319490|NCT03235479|524017668|FG000|Overall Study|Technical Problems|3|||
145319491|NCT03235479|524017669|FG001|Overall Study|Technical Problems|2|||
145319492|NCT03235479|524017668|FG000|Overall Study|Withdrawal by Subject|2|||
145319493|NCT03235479|524017669|FG001|Overall Study|Withdrawal by Subject|2|||
145319494|NCT03235479|524017668|FG000|Overall Study|Other Reasons|3|||
145319495|NCT03235479|524017669|FG001|Overall Study|Other Reasons|5|||
145319496|NCT02001051|524017672|FG000|Overall Study|Deemed not eligible following enrollment|0|||
145319497|NCT02001051|524017673|FG001|Overall Study|Deemed not eligible following enrollment|1|||
145319498|NCT00309985|524017680|FG000|Overall Study|Disease progression|12|||
145319499|NCT00309985|524017681|FG001|Overall Study|Disease progression|0|||
145319500|NCT00309985|524017680|FG000|Overall Study|Adverse Event|30|||
145319501|NCT00309985|524017681|FG001|Overall Study|Adverse Event|0|||
145319502|NCT00309985|524017680|FG000|Overall Study|Death|2|||
145319503|NCT00309985|524017681|FG001|Overall Study|Death|0|||
145319504|NCT00309985|524017680|FG000|Overall Study|Withdrawal by Subject|5|||
145319505|NCT00309985|524017681|FG001|Overall Study|Withdrawal by Subject|1|||
145319506|NCT00309985|524017680|FG000|Overall Study|Physician Decision|3|||
145319507|NCT00309985|524017681|FG001|Overall Study|Physician Decision|0|||
145319508|NCT00309985|524017680|FG000|Overall Study|Never started treatment|7|||
145319509|NCT00309985|524017681|FG001|Overall Study|Never started treatment|0|||
145319510|NCT00309985|524017680|FG000|Overall Study|Complicating disease|1|||
145319511|NCT00309985|524017681|FG001|Overall Study|Complicating disease|0|||
145319512|NCT00309985|524017680|FG000|Overall Study|Non-compliance|1|||
145319513|NCT00309985|524017681|FG001|Overall Study|Non-compliance|0|||
145319514|NCT00309985|524017680|FG000|Overall Study|Chemotherapy discontinued only|1|||
145319515|NCT00309985|524017681|FG001|Overall Study|Chemotherapy discontinued only|0|||
145319516|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
145319517|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
145319518|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
145319519|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145319520|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
145319521|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
145319522|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145319523|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145319524|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
145319525|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
145319526|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145319527|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145319528|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
145319529|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
145319530|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145319531|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145319532|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Death|2|||
145319533|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Death|1|||
145319534|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Death|0|||
145319535|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Death|0|||
145319536|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
145319537|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
145319538|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
145319539|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
145319540|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
145319541|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145319542|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145319543|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
145319544|NCT03110380|524017691|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145319545|NCT03110380|524017692|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
145319546|NCT03110380|524017693|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145319547|NCT03110380|524017694|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
145319548|NCT03110380|524017691|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145319549|NCT03110380|524017692|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
145319550|NCT03110380|524017693|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
145319551|NCT03110380|524017694|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
145319552|NCT03110380|524017691|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
145319553|NCT03110380|524017692|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
145319554|NCT03110380|524017693|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
145319555|NCT03110380|524017694|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
145319556|NCT03110380|524017691|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145319557|NCT03110380|524017692|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145319558|NCT03110380|524017693|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
145319559|NCT03110380|524017694|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
145319560|NCT01714739|524017695|FG000|Overall Study|Disease progression|3|||
145319561|NCT01714739|524017696|FG001|Overall Study|Disease progression|5|||
145319562|NCT01714739|524017697|FG002|Overall Study|Disease progression|5|||
145319563|NCT01714739|524017698|FG003|Overall Study|Disease progression|204|||
145319564|NCT01714739|524017699|FG004|Overall Study|Disease progression|1|||
145319565|NCT01714739|524017700|FG005|Overall Study|Disease progression|3|||
145319566|NCT01714739|524017701|FG006|Overall Study|Disease progression|5|||
145319567|NCT01714739|524017695|FG000|Overall Study|Study drug toxicity|1|||
145319568|NCT01714739|524017696|FG001|Overall Study|Study drug toxicity|1|||
145319569|NCT01714739|524017697|FG002|Overall Study|Study drug toxicity|1|||
145319570|NCT01714739|524017698|FG003|Overall Study|Study drug toxicity|15|||
145319571|NCT01714739|524017699|FG004|Overall Study|Study drug toxicity|0|||
145319572|NCT01714739|524017700|FG005|Overall Study|Study drug toxicity|0|||
145319573|NCT01714739|524017701|FG006|Overall Study|Study drug toxicity|5|||
145319574|NCT01714739|524017695|FG000|Overall Study|Death|0|||
145319575|NCT01714739|524017696|FG001|Overall Study|Death|0|||
145319576|NCT01714739|524017697|FG002|Overall Study|Death|0|||
145319577|NCT01714739|524017698|FG003|Overall Study|Death|1|||
145319578|NCT01714739|524017699|FG004|Overall Study|Death|0|||
145319579|NCT01714739|524017700|FG005|Overall Study|Death|0|||
145319580|NCT01714739|524017701|FG006|Overall Study|Death|0|||
145319581|NCT01714739|524017695|FG000|Overall Study|Adverse Event unrelated to drug|0|||
145319582|NCT01714739|524017696|FG001|Overall Study|Adverse Event unrelated to drug|0|||
145319583|NCT01714739|524017697|FG002|Overall Study|Adverse Event unrelated to drug|3|||
145319584|NCT01714739|524017698|FG003|Overall Study|Adverse Event unrelated to drug|21|||
145319585|NCT01714739|524017699|FG004|Overall Study|Adverse Event unrelated to drug|0|||
145319586|NCT01714739|524017700|FG005|Overall Study|Adverse Event unrelated to drug|0|||
145411605|NCT03018938|524360068|FG000|Overall Study|Not recorded|0|||
145411606|NCT03018938|524360069|FG001|Overall Study|Not recorded|2|||
145411607|NCT01202591|524360070|FG000|Overall Study|Adverse Event|2|||
145411608|NCT01202591|524360071|FG001|Overall Study|Adverse Event|1|||
145411609|NCT01202591|524360072|FG002|Overall Study|Adverse Event|4|||
145570067|NCT01554618|524945881|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
145319587|NCT01714739|524017701|FG006|Overall Study|Adverse Event unrelated to drug|0|||
145319588|NCT01714739|524017695|FG000|Overall Study|Participant request to stop therapy|0|||
145319589|NCT01714739|524017696|FG001|Overall Study|Participant request to stop therapy|1|||
145319590|NCT01714739|524017697|FG002|Overall Study|Participant request to stop therapy|0|||
145319591|NCT01714739|524017698|FG003|Overall Study|Participant request to stop therapy|6|||
145319592|NCT01714739|524017699|FG004|Overall Study|Participant request to stop therapy|0|||
145319593|NCT01714739|524017700|FG005|Overall Study|Participant request to stop therapy|0|||
145319594|NCT01714739|524017701|FG006|Overall Study|Participant request to stop therapy|0|||
145411610|NCT01202591|524360073|FG003|Overall Study|Adverse Event|4|||
145319595|NCT01714739|524017695|FG000|Overall Study|Participant withdrew consent|0|||
145319596|NCT01714739|524017696|FG001|Overall Study|Participant withdrew consent|1|||
145319597|NCT01714739|524017697|FG002|Overall Study|Participant withdrew consent|0|||
145319598|NCT01714739|524017698|FG003|Overall Study|Participant withdrew consent|8|||
145319599|NCT01714739|524017699|FG004|Overall Study|Participant withdrew consent|0|||
145319600|NCT01714739|524017700|FG005|Overall Study|Participant withdrew consent|0|||
145319601|NCT01714739|524017701|FG006|Overall Study|Participant withdrew consent|0|||
145319602|NCT01714739|524017695|FG000|Overall Study|Lost to Follow-up|0|||
145319603|NCT01714739|524017696|FG001|Overall Study|Lost to Follow-up|0|||
145319604|NCT01714739|524017697|FG002|Overall Study|Lost to Follow-up|0|||
145319605|NCT01714739|524017698|FG003|Overall Study|Lost to Follow-up|1|||
145319606|NCT01714739|524017699|FG004|Overall Study|Lost to Follow-up|0|||
145319607|NCT01714739|524017700|FG005|Overall Study|Lost to Follow-up|0|||
145319608|NCT01714739|524017701|FG006|Overall Study|Lost to Follow-up|0|||
145319609|NCT01714739|524017695|FG000|Overall Study|Maximum clinical benefit|0|||
145319610|NCT01714739|524017696|FG001|Overall Study|Maximum clinical benefit|1|||
145319611|NCT01714739|524017697|FG002|Overall Study|Maximum clinical benefit|1|||
145319612|NCT01714739|524017698|FG003|Overall Study|Maximum clinical benefit|3|||
145319613|NCT01714739|524017699|FG004|Overall Study|Maximum clinical benefit|0|||
145319614|NCT01714739|524017700|FG005|Overall Study|Maximum clinical benefit|0|||
145319615|NCT01714739|524017701|FG006|Overall Study|Maximum clinical benefit|0|||
145319616|NCT01714739|524017695|FG000|Overall Study|Poor/non-comliance|0|||
145319617|NCT01714739|524017696|FG001|Overall Study|Poor/non-comliance|1|||
145319618|NCT01714739|524017697|FG002|Overall Study|Poor/non-comliance|0|||
145319619|NCT01714739|524017698|FG003|Overall Study|Poor/non-comliance|1|||
145319620|NCT01714739|524017699|FG004|Overall Study|Poor/non-comliance|0|||
145319621|NCT01714739|524017700|FG005|Overall Study|Poor/non-comliance|0|||
145319622|NCT01714739|524017701|FG006|Overall Study|Poor/non-comliance|0|||
145319623|NCT01714739|524017695|FG000|Overall Study|No longer meets study criteria|0|||
145319624|NCT01714739|524017696|FG001|Overall Study|No longer meets study criteria|0|||
145319625|NCT01714739|524017697|FG002|Overall Study|No longer meets study criteria|0|||
145319626|NCT01714739|524017698|FG003|Overall Study|No longer meets study criteria|1|||
145319627|NCT01714739|524017699|FG004|Overall Study|No longer meets study criteria|0|||
145319628|NCT01714739|524017700|FG005|Overall Study|No longer meets study criteria|0|||
145319629|NCT01714739|524017701|FG006|Overall Study|No longer meets study criteria|0|||
145319630|NCT01714739|524017695|FG000|Overall Study|Other reason|0|||
145319631|NCT01714739|524017696|FG001|Overall Study|Other reason|0|||
145319632|NCT01714739|524017697|FG002|Overall Study|Other reason|0|||
145319633|NCT01714739|524017698|FG003|Overall Study|Other reason|3|||
145319634|NCT01714739|524017699|FG004|Overall Study|Other reason|1|||
145319635|NCT01714739|524017700|FG005|Overall Study|Other reason|0|||
145319636|NCT01714739|524017701|FG006|Overall Study|Other reason|0|||
145319637|NCT02274948|524017708|FG000|Overall Study|Lost to Follow-up|28|||
145319638|NCT02274948|524017709|FG001|Overall Study|Lost to Follow-up|25|||
145319639|NCT02274948|524017708|FG000|Overall Study|Withdrawal by Subject|64|||
145319640|NCT02274948|524017709|FG001|Overall Study|Withdrawal by Subject|58|||
145319641|NCT02274948|524017708|FG000|Overall Study|Stopped on family Practitioner advice|2|||
145319642|NCT02274948|524017709|FG001|Overall Study|Stopped on family Practitioner advice|5|||
145319643|NCT02274948|524017708|FG000|Overall Study|Left the area|4|||
145319644|NCT02274948|524017709|FG001|Overall Study|Left the area|3|||
145319645|NCT00707434|524017710|FG000|Overall Study|Adverse Event|1|||
145319646|NCT03585959|524017711|FG000|Overall Study|Physician Decision|1|||
145319647|NCT03585959|524017711|FG000|Overall Study|Unsuccessful Procedure|2|||
145319648|NCT02531594|524017712|FG000|Overall Study|Withdrawal by Subject|7|||
145319649|NCT02531594|524017713|FG001|Overall Study|Withdrawal by Subject|8|||
145319650|NCT00614822|524017714|FG000|Overall Study|Adverse Event|3|||
145319651|NCT03750695|524017715|FG000|Overall Study|Lost to Follow-up|0|||
145319652|NCT03750695|524017716|FG001|Overall Study|Lost to Follow-up|1|||
145319653|NCT04480307|524017718|FG000|Overall Study|Withdrawal by Subject|0|||
145319654|NCT04480307|524017719|FG001|Overall Study|Withdrawal by Subject|1|||
145319655|NCT04480307|524017720|FG002|Overall Study|Withdrawal by Subject|0|||
145319656|NCT04480307|524017721|FG003|Overall Study|Withdrawal by Subject|0|||
145319657|NCT04480307|524017718|FG000|Overall Study|Adverse Event|0|||
145319658|NCT04480307|524017719|FG001|Overall Study|Adverse Event|0|||
145319659|NCT04480307|524017720|FG002|Overall Study|Adverse Event|0|||
145570068|NCT00477672|524945882|FG000|Overall Study|Adverse Event|3|||
145570069|NCT00477672|524945883|FG001|Overall Study|Adverse Event|5|||
145319660|NCT04480307|524017721|FG003|Overall Study|Adverse Event|1|||
145319661|NCT00605176|524017729|FG000|Overall Study|Adverse Event|2|||
145319662|NCT00605176|524017730|FG001|Overall Study|Adverse Event|1|||
145319663|NCT00605176|524017731|FG002|Overall Study|Adverse Event|3|||
145319664|NCT00605176|524017729|FG000|Overall Study|Withdrawal by Subject|4|||
145319665|NCT00605176|524017730|FG001|Overall Study|Withdrawal by Subject|2|||
145319666|NCT00605176|524017731|FG002|Overall Study|Withdrawal by Subject|4|||
145319667|NCT00605176|524017729|FG000|Overall Study|Lost to Follow-up|2|||
145319668|NCT00605176|524017730|FG001|Overall Study|Lost to Follow-up|2|||
145319669|NCT00605176|524017731|FG002|Overall Study|Lost to Follow-up|1|||
145319670|NCT00605176|524017729|FG000|Overall Study|Non-complicance with study procedures|1|||
145411611|NCT01202591|524360074|FG004|Overall Study|Adverse Event|0|||
145570070|NCT00477672|524945884|FG002|Overall Study|Adverse Event|6|||
145319671|NCT00605176|524017730|FG001|Overall Study|Non-complicance with study procedures|0|||
145319672|NCT00605176|524017731|FG002|Overall Study|Non-complicance with study procedures|0|||
145319673|NCT00605176|524017729|FG000|Overall Study|Use of concomitant therapy|1|||
145319674|NCT00605176|524017730|FG001|Overall Study|Use of concomitant therapy|0|||
145319675|NCT00605176|524017731|FG002|Overall Study|Use of concomitant therapy|1|||
145319676|NCT00605176|524017729|FG000|Overall Study|Other (not due to AE)|1|||
145319677|NCT00605176|524017730|FG001|Overall Study|Other (not due to AE)|1|||
145319678|NCT00605176|524017731|FG002|Overall Study|Other (not due to AE)|0|||
145319679|NCT01256060|524017732|FG000|Overall Study|Lost to Follow-up|0|||
145319680|NCT01256060|524017733|FG001|Overall Study|Lost to Follow-up|1|||
145319681|NCT01256060|524017734|FG002|Overall Study|Lost to Follow-up|0|||
145319682|NCT01256060|524017735|FG003|Overall Study|Lost to Follow-up|0|||
145319683|NCT01808248|524017736|FG000|Overall Study|Lack of Efficacy|3|||
145319684|NCT01808248|524017736|FG000|Overall Study|Withdrawal by Subject|1|||
145319685|NCT01808248|524017736|FG000|Overall Study|Lost to Follow-up|1|||
145319686|NCT00220727|524017737|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
145319687|NCT00220727|524017738|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
145319688|NCT03507686|524017739|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
145319689|NCT03507686|524017740|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
145319690|NCT03507686|524017739|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
145319691|NCT03507686|524017740|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
145319692|NCT03507686|524017739|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
145319693|NCT03507686|524017740|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
145319694|NCT03507686|524017739|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
145319695|NCT03507686|524017740|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
145319696|NCT03507686|524017739|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
145319697|NCT03507686|524017740|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
145319698|NCT03507686|524017739|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
145319699|NCT03507686|524017740|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
145319700|NCT02508116|524017741|FG000|Overall Study|Lost to Follow-up|2|||
145319701|NCT02508116|524017742|FG001|Overall Study|Lost to Follow-up|3|||
145319702|NCT02508116|524017741|FG000|Overall Study|Withdrawal by Subject|3|||
145319703|NCT02508116|524017742|FG001|Overall Study|Withdrawal by Subject|2|||
145319704|NCT02508116|524017741|FG000|Overall Study|Protocol Violation|1|||
145319705|NCT02508116|524017742|FG001|Overall Study|Protocol Violation|2|||
145319706|NCT02508116|524017741|FG000|Overall Study|Physician Decision|2|||
145319707|NCT02508116|524017742|FG001|Overall Study|Physician Decision|0|||
145319708|NCT00109850|524017743|FG000|Overall Study|Adverse Event|1|||
145319709|NCT00109850|524017743|FG000|Overall Study|Death|2|||
145319710|NCT00109850|524017743|FG000|Overall Study|Ineligible|1|||
145319711|NCT03635983|524017744|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
145319712|NCT03635983|524017745|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
145319713|NCT03635983|524017744|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145319714|NCT03635983|524017745|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145319715|NCT03635983|524017744|FG000|Pre-Treatment Period|Other reasons|0|||
145319716|NCT03635983|524017745|FG001|Pre-Treatment Period|Other reasons|1|||
145319717|NCT03635983|524017744|FG000|Pre-Treatment Period|Disease Progression|0|||
145319718|NCT03635983|524017745|FG001|Pre-Treatment Period|Disease Progression|1|||
145319719|NCT03635983|524017744|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
145319720|NCT03635983|524017745|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
145319721|NCT03635983|524017744|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
145319722|NCT03635983|524017745|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
145319723|NCT03635983|524017744|FG000|Treatment Period|Withdrawal by Subject|3|||
145319724|NCT03635983|524017745|FG001|Treatment Period|Withdrawal by Subject|5|||
145319725|NCT03635983|524017744|FG000|Treatment Period|Death|3|||
145319726|NCT03635983|524017745|FG001|Treatment Period|Death|5|||
145319727|NCT03635983|524017744|FG000|Treatment Period|Poor/Non-compliance|2|||
145319728|NCT03635983|524017745|FG001|Treatment Period|Poor/Non-compliance|1|||
145319729|NCT03635983|524017744|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
145319730|NCT03635983|524017745|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
145319731|NCT03635983|524017744|FG000|Treatment Period|Other reasons|7|||
145319732|NCT03635983|524017745|FG001|Treatment Period|Other reasons|4|||
145319733|NCT03635983|524017744|FG000|Treatment Period|Disease progression|230|||
145319734|NCT03635983|524017745|FG001|Treatment Period|Disease progression|201|||
145319735|NCT03635983|524017744|FG000|Treatment Period|Study drug toxicity|35|||
145319736|NCT03635983|524017745|FG001|Treatment Period|Study drug toxicity|36|||
145319737|NCT03635983|524017744|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
145319738|NCT03635983|524017745|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
145319739|NCT03635983|524017744|FG000|Treatment Period|Maximum clinical benefit|3|||
145319740|NCT03635983|524017745|FG001|Treatment Period|Maximum clinical benefit|5|||
145570071|NCT00477672|524945882|FG000|Overall Study|Death|0|||
145570072|NCT00477672|524945883|FG001|Overall Study|Death|1|||
145570073|NCT00477672|524945884|FG002|Overall Study|Death|0|||
145570074|NCT00477672|524945882|FG000|Overall Study|Disease progression|0|||
145570075|NCT00477672|524945883|FG001|Overall Study|Disease progression|1|||
145570076|NCT00477672|524945884|FG002|Overall Study|Disease progression|0|||
145319741|NCT03635983|524017744|FG000|Treatment Period|Administrative reason by the sponsor|1|||
145570077|NCT00477672|524945882|FG000|Overall Study|Physician Decision|1|||
145570078|NCT00477672|524945883|FG001|Overall Study|Physician Decision|0|||
145570079|NCT00477672|524945884|FG002|Overall Study|Physician Decision|0|||
145570080|NCT00477672|524945882|FG000|Overall Study|Protocol noncompliance|0|||
145570081|NCT00477672|524945883|FG001|Overall Study|Protocol noncompliance|2|||
145570082|NCT00477672|524945884|FG002|Overall Study|Protocol noncompliance|0|||
145570083|NCT00477672|524945882|FG000|Overall Study|Consent withdrawn|2|||
145570084|NCT00477672|524945883|FG001|Overall Study|Consent withdrawn|5|||
145570085|NCT00477672|524945884|FG002|Overall Study|Consent withdrawn|10|||
145570086|NCT00477672|524945882|FG000|Overall Study|Discretion of Sponsor|1|||
145570087|NCT00477672|524945883|FG001|Overall Study|Discretion of Sponsor|2|||
145570088|NCT00477672|524945884|FG002|Overall Study|Discretion of Sponsor|0|||
145570089|NCT02722928|524945887|FG000|Overall Study|Standard CT was not as required per prot|5|||
145570090|NCT02722928|524945888|FG001|Overall Study|Standard CT was not as required per prot|13|||
145570091|NCT02722928|524945887|FG000|Overall Study|Required Intraoperative MRI|5|||
145570092|NCT02722928|524945888|FG001|Overall Study|Required Intraoperative MRI|7|||
145570093|NCT04011410|524945889|FG000|Overall Study|Withdrawal by Subject|1|||
145570094|NCT01557400|524945890|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
145570095|NCT01557400|524945890|FG000|Overall Study|Adverse Event|3|||
145570096|NCT01557400|524945890|FG000|Overall Study|Lost to Follow-up|5|||
145570097|NCT01557400|524945890|FG000|Overall Study|Withdrawal by Subject|9|||
145319742|NCT03635983|524017745|FG001|Treatment Period|Administrative reason by the sponsor|2|||
145319743|NCT03635983|524017744|FG000|Treatment Period|Lost to Follow-up|0|||
145319744|NCT03635983|524017745|FG001|Treatment Period|Lost to Follow-up|1|||
145319745|NCT00559364|524017747|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
145319746|NCT00559364|524017748|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
145319747|NCT02808819|524017749|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
145319748|NCT02808819|524017750|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
145319749|NCT02808819|524017749|FG000|Overall Study|Withdrawal by Subject|10|||
145319750|NCT02808819|524017750|FG001|Overall Study|Withdrawal by Subject|13|||
145319751|NCT02808819|524017749|FG000|Overall Study|Site terminated by sponsor|2|||
145319752|NCT02808819|524017750|FG001|Overall Study|Site terminated by sponsor|0|||
145319753|NCT02808819|524017749|FG000|Overall Study|Pregnancy|1|||
145319754|NCT02808819|524017750|FG001|Overall Study|Pregnancy|0|||
145319755|NCT02808819|524017749|FG000|Overall Study|Lost to Follow-up|1|||
145319756|NCT02808819|524017750|FG001|Overall Study|Lost to Follow-up|6|||
145319757|NCT02808819|524017749|FG000|Overall Study|Protocol Violation|0|||
145319758|NCT02808819|524017750|FG001|Overall Study|Protocol Violation|1|||
145319759|NCT02808819|524017749|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
145319760|NCT02808819|524017750|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
145319761|NCT02808819|524017749|FG000|Overall Study|Death|1|||
145319762|NCT02808819|524017750|FG001|Overall Study|Death|0|||
145319763|NCT02808819|524017749|FG000|Overall Study|Adverse Event|3|||
145319764|NCT02808819|524017750|FG001|Overall Study|Adverse Event|4|||
145319765|NCT01396421|524017757|FG000|Overall Study|Lost to Follow-up|0|||
145319766|NCT01396421|524017758|FG001|Overall Study|Lost to Follow-up|0|||
145319767|NCT01396421|524017759|FG002|Overall Study|Lost to Follow-up|0|||
145319768|NCT01396421|524017760|FG003|Overall Study|Lost to Follow-up|1|||
145319769|NCT01396421|524017757|FG000|Overall Study|Adverse Event|17|||
145319770|NCT01396421|524017758|FG001|Overall Study|Adverse Event|15|||
145319771|NCT01396421|524017759|FG002|Overall Study|Adverse Event|12|||
145319772|NCT01396421|524017760|FG003|Overall Study|Adverse Event|32|||
145319773|NCT01396421|524017757|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
145319774|NCT01396421|524017758|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
145319775|NCT01396421|524017759|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
145319776|NCT01396421|524017760|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
145319777|NCT01396421|524017757|FG000|Overall Study|Physician Decision|1|||
145411612|NCT01202591|524360075|FG005|Overall Study|Adverse Event|0|||
145570098|NCT01393405|524945893|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
145570099|NCT01393405|524945894|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
145570100|NCT01393405|524945895|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
145570101|NCT01393405|524945893|FG000|Induction Period (week1-16)|Adverse Event|16|||
145570102|NCT01393405|524945894|FG001|Induction Period (week1-16)|Adverse Event|0|||
145319778|NCT01396421|524017758|FG001|Overall Study|Physician Decision|1|||
145319779|NCT01396421|524017759|FG002|Overall Study|Physician Decision|0|||
145319780|NCT01396421|524017760|FG003|Overall Study|Physician Decision|3|||
145319781|NCT01396421|524017757|FG000|Overall Study|Withdrawal by Subject|31|||
145319782|NCT01396421|524017758|FG001|Overall Study|Withdrawal by Subject|24|||
145570103|NCT01393405|524945895|FG002|Induction Period (week1-16)|Adverse Event|0|||
145319783|NCT01396421|524017759|FG002|Overall Study|Withdrawal by Subject|13|||
145319784|NCT01396421|524017760|FG003|Overall Study|Withdrawal by Subject|21|||
145319785|NCT01396421|524017757|FG000|Overall Study|Protocol Deviation|2|||
145319786|NCT01396421|524017758|FG001|Overall Study|Protocol Deviation|1|||
145319787|NCT01396421|524017759|FG002|Overall Study|Protocol Deviation|1|||
145319788|NCT01396421|524017760|FG003|Overall Study|Protocol Deviation|0|||
145319789|NCT01396421|524017757|FG000|Overall Study|Lack of Efficacy|7|||
145319790|NCT01396421|524017758|FG001|Overall Study|Lack of Efficacy|17|||
145319791|NCT01396421|524017759|FG002|Overall Study|Lack of Efficacy|7|||
145319792|NCT01396421|524017760|FG003|Overall Study|Lack of Efficacy|18|||
145319793|NCT01610063|524017761|FG000|Overall Study|Lost to Follow-up|42|||
145319794|NCT01610063|524017762|FG001|Overall Study|Lost to Follow-up|20|||
145319795|NCT03314662|524017763|FG000|Overall Study|Withdrawal by Subject|1|||
145319796|NCT03314662|524017764|FG001|Overall Study|Withdrawal by Subject|1|||
145319797|NCT03314662|524017765|FG002|Overall Study|Withdrawal by Subject|1|||
145319798|NCT03314662|524017763|FG000|Overall Study|Lost to Follow-up|5|||
145319799|NCT03314662|524017764|FG001|Overall Study|Lost to Follow-up|4|||
145319800|NCT03314662|524017765|FG002|Overall Study|Lost to Follow-up|4|||
145319801|NCT03314662|524017763|FG000|Overall Study|Death|2|||
145319802|NCT03314662|524017764|FG001|Overall Study|Death|0|||
145319803|NCT03314662|524017765|FG002|Overall Study|Death|0|||
145319804|NCT01867606|524017768|FG000|Overall Study|Withdrawal by Subject|10|||
145319805|NCT01867606|524017769|FG001|Overall Study|Withdrawal by Subject|14|||
145319806|NCT01867606|524017768|FG000|Overall Study|Protocol Violation|0|||
145319807|NCT01867606|524017769|FG001|Overall Study|Protocol Violation|1|||
145319808|NCT01378962|524017770|FG000|Overall Study|Death|14|||
145319809|NCT01378962|524017770|FG000|Overall Study|Lost to Follow-up|1|||
145319810|NCT01378962|524017770|FG000|Overall Study|Other|2|||
145319811|NCT01588548|524017776|FG000|Overall Study|Withdrawal by Subject|0|||
145319812|NCT01588548|524017777|FG001|Overall Study|Withdrawal by Subject|1|||
145319813|NCT01588548|524017778|FG002|Overall Study|Withdrawal by Subject|1|||
145319814|NCT01588548|524017779|FG003|Overall Study|Withdrawal by Subject|1|||
145319815|NCT01588548|524017780|FG004|Overall Study|Withdrawal by Subject|2|||
145319816|NCT01588548|524017781|FG005|Overall Study|Withdrawal by Subject|3|||
145319817|NCT01588548|524017776|FG000|Overall Study|Adverse Event|0|||
145319818|NCT01588548|524017777|FG001|Overall Study|Adverse Event|0|||
145319819|NCT01588548|524017778|FG002|Overall Study|Adverse Event|1|||
145319820|NCT01588548|524017779|FG003|Overall Study|Adverse Event|2|||
145319821|NCT01588548|524017780|FG004|Overall Study|Adverse Event|1|||
145319822|NCT01588548|524017781|FG005|Overall Study|Adverse Event|0|||
145319823|NCT01588548|524017776|FG000|Overall Study|Condition Under Investigation Worsened|3|||
145319824|NCT01588548|524017777|FG001|Overall Study|Condition Under Investigation Worsened|6|||
145319825|NCT01588548|524017778|FG002|Overall Study|Condition Under Investigation Worsened|4|||
145319826|NCT01588548|524017779|FG003|Overall Study|Condition Under Investigation Worsened|4|||
145319827|NCT01588548|524017780|FG004|Overall Study|Condition Under Investigation Worsened|3|||
145319828|NCT01588548|524017781|FG005|Overall Study|Condition Under Investigation Worsened|3|||
145319829|NCT03365791|524017783|FG000|Overall Study|Adverse Event|5|||
145319830|NCT03365791|524017783|FG000|Overall Study|Death|1|||
145319831|NCT03365791|524017783|FG000|Overall Study|Lost to Follow-up|1|||
145319832|NCT03365791|524017783|FG000|Overall Study|Physician Decision|9|||
145319833|NCT03365791|524017783|FG000|Overall Study|Progressive disease|51|||
145319834|NCT03365791|524017783|FG000|Overall Study|Subject/guardian decision|5|||
145319835|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
145319836|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319837|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319838|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319839|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319840|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319841|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319842|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319843|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
145319844|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
145319845|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319846|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319847|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319848|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319849|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319850|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319851|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319852|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
145319853|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
145319854|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319855|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145570104|NCT01393405|524945893|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
145570105|NCT01393405|524945894|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
145570106|NCT01393405|524945895|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
145570107|NCT01393405|524945893|FG000|Maintenance Period Week|Lack of Efficacy|0|||
145570108|NCT01393405|524945894|FG001|Maintenance Period Week|Lack of Efficacy|22|||
145319856|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319857|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319858|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319859|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319860|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319861|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
145319862|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
145319863|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319864|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319865|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319866|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319867|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319868|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319869|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319870|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
145319871|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
145319872|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319873|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319874|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319875|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319876|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319877|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319878|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319879|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
145319880|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
145319881|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319882|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319883|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319884|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319885|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319886|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319887|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319888|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
145319889|NCT00739973|524017784|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
145319890|NCT00739973|524017785|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319891|NCT00739973|524017786|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319892|NCT00739973|524017787|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319893|NCT00739973|524017788|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319894|NCT00739973|524017789|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319895|NCT00739973|524017790|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319896|NCT00739973|524017791|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319897|NCT00739973|524017792|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
145319898|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145319899|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145319900|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
145319901|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
145319902|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
145319903|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
145319904|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
145319905|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
145319906|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
145319907|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319908|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319909|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319910|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319911|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
145319912|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145570109|NCT01393405|524945895|FG002|Maintenance Period Week|Lack of Efficacy|22|||
145319913|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319914|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
145319915|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
145319916|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
145319917|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
145319918|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319919|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319920|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319921|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319922|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319923|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319924|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
145319925|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
145319926|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
145319927|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
145319928|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
145319929|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145319930|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145319931|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
145319932|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
145319933|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
145319934|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319935|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319936|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
145319937|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319938|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319939|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319940|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319941|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319942|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
145319943|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145319944|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
145319945|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145319946|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
145319947|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145319948|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145319949|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
145319950|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
145319951|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
145319952|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
145319953|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145319954|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
145319955|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
145319956|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145319957|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
145319958|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
145319959|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
145319960|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
145319961|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319962|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319963|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319964|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319965|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319966|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319967|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
145319968|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145319969|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
145411613|NCT01202591|524360070|FG000|Overall Study|Other reason as per investigator|3|||
145411614|NCT01202591|524360071|FG001|Overall Study|Other reason as per investigator|4|||
145319970|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
145319971|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145319972|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
145319973|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145319974|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145319975|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
145319976|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145319977|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
145319978|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
145319979|NCT00739973|524017784|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319980|NCT00739973|524017785|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
145319981|NCT00739973|524017786|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319982|NCT00739973|524017787|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319983|NCT00739973|524017788|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319984|NCT00739973|524017789|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319985|NCT00739973|524017790|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
145319986|NCT00739973|524017791|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319987|NCT00739973|524017792|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
145319988|NCT02219308|524017793|FG000|Overall Study|Withdrawal by Subject|1|||
145319989|NCT02219308|524017794|FG001|Overall Study|Withdrawal by Subject|2|||
145319990|NCT01989676|524019581|FG000|Overall Study|Death|52|||
145319991|NCT01989676|524019582|FG001|Overall Study|Death|60|||
145319992|NCT01989676|524019581|FG000|Overall Study|Protocol Violation|2|||
145319993|NCT01989676|524019582|FG001|Overall Study|Protocol Violation|1|||
145319994|NCT01989676|524019581|FG000|Overall Study|Lost to Follow-up|8|||
145319995|NCT01989676|524019582|FG001|Overall Study|Lost to Follow-up|18|||
145319996|NCT01989676|524019581|FG000|Overall Study|No longer willing to participate in study|26|||
145319997|NCT01989676|524019582|FG001|Overall Study|No longer willing to participate in study|26|||
145319998|NCT01989676|524019581|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
145319999|NCT01989676|524019582|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
145320000|NCT01989676|524019581|FG000|Overall Study|Other|4|||
145320001|NCT01989676|524019582|FG001|Overall Study|Other|3|||
145320002|NCT03941834|524019583|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
145320003|NCT03941834|524019584|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
145320004|NCT03941834|524019585|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
145320005|NCT03941834|524019583|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
145320006|NCT03941834|524019584|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
145320007|NCT03941834|524019585|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
145320008|NCT03941834|524019583|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
145320009|NCT03941834|524019584|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
145320010|NCT03941834|524019585|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
145320011|NCT03941834|524019583|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
145320012|NCT03941834|524019584|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
145320013|NCT03941834|524019585|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
145320014|NCT03941834|524019583|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
145320015|NCT03941834|524019584|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
145320016|NCT03941834|524019585|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
145320017|NCT03941834|524019583|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
145320018|NCT03941834|524019584|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
145320019|NCT03941834|524019585|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
145320020|NCT02688387|524019586|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320021|NCT02688387|524019587|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320022|NCT02688387|524019588|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
145320023|NCT02688387|524019589|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320024|NCT02688387|524019590|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320025|NCT02688387|524019591|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320026|NCT02688387|524019592|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320027|NCT02688387|524019593|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320028|NCT02688387|524019594|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320029|NCT02688387|524019595|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320030|NCT02688387|524019596|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320031|NCT02688387|524019597|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320032|NCT02688387|524019598|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320033|NCT02688387|524019599|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145411615|NCT01202591|524360072|FG002|Overall Study|Other reason as per investigator|7|||
145411616|NCT01202591|524360073|FG003|Overall Study|Other reason as per investigator|3|||
145411617|NCT01202591|524360074|FG004|Overall Study|Other reason as per investigator|1|||
145570110|NCT01393405|524945893|FG000|Maintenance Period Week|Adverse Event|0|||
145570111|NCT01393405|524945894|FG001|Maintenance Period Week|Adverse Event|5|||
145570112|NCT01393405|524945895|FG002|Maintenance Period Week|Adverse Event|2|||
145320034|NCT02688387|524019600|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320035|NCT02688387|524019601|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320036|NCT02688387|524019602|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320037|NCT02688387|524019603|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320038|NCT02688387|524019604|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320039|NCT02688387|524019605|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320040|NCT02688387|524019606|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320041|NCT02688387|524019607|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
145320042|NCT02688387|524019586|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320043|NCT02688387|524019587|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320044|NCT02688387|524019588|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320045|NCT02688387|524019589|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
145320046|NCT02688387|524019590|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320047|NCT02688387|524019591|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320048|NCT02688387|524019592|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320049|NCT02688387|524019593|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320050|NCT02688387|524019594|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320051|NCT02688387|524019595|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320052|NCT02688387|524019596|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320053|NCT02688387|524019597|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320054|NCT02688387|524019598|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320055|NCT02688387|524019599|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320056|NCT02688387|524019600|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320057|NCT02688387|524019601|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320058|NCT02688387|524019602|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320059|NCT02688387|524019603|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320060|NCT02688387|524019604|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320061|NCT02688387|524019605|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320062|NCT02688387|524019606|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320063|NCT02688387|524019607|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320064|NCT02688387|524019586|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320065|NCT02688387|524019587|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
145320066|NCT02688387|524019588|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320067|NCT02688387|524019589|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320068|NCT02688387|524019590|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320069|NCT02688387|524019591|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320070|NCT02688387|524019592|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320071|NCT02688387|524019593|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320072|NCT02688387|524019594|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320073|NCT02688387|524019595|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320074|NCT02688387|524019596|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320075|NCT02688387|524019597|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320076|NCT02688387|524019598|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320077|NCT02688387|524019599|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320078|NCT02688387|524019600|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320079|NCT02688387|524019601|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320080|NCT02688387|524019602|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320081|NCT02688387|524019603|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320082|NCT02688387|524019604|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320083|NCT02688387|524019605|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320084|NCT02688387|524019606|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320085|NCT02688387|524019607|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
145320086|NCT02688387|524019586|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320087|NCT02688387|524019587|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320088|NCT02688387|524019588|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
145320089|NCT02688387|524019589|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145570113|NCT01393405|524945893|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
145570114|NCT01393405|524945894|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
145570115|NCT01393405|524945895|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
145570116|NCT01393405|524945893|FG000|Maintenance Period Week|Lost to Follow-up|0|||
145411618|NCT01202591|524360075|FG005|Overall Study|Other reason as per investigator|3|||
145411619|NCT01202591|524360070|FG000|Overall Study|Withdrawal by Subject|0|||
145411620|NCT01202591|524360071|FG001|Overall Study|Withdrawal by Subject|0|||
145411621|NCT01202591|524360072|FG002|Overall Study|Withdrawal by Subject|0|||
145411622|NCT01202591|524360073|FG003|Overall Study|Withdrawal by Subject|0|||
145411623|NCT01202591|524360074|FG004|Overall Study|Withdrawal by Subject|2|||
145411624|NCT01202591|524360075|FG005|Overall Study|Withdrawal by Subject|1|||
145411625|NCT01202591|524360070|FG000|Overall Study|Objective Disease Progression|0|||
145411626|NCT01202591|524360071|FG001|Overall Study|Objective Disease Progression|0|||
145411627|NCT01202591|524360072|FG002|Overall Study|Objective Disease Progression|0|||
145411628|NCT01202591|524360073|FG003|Overall Study|Objective Disease Progression|0|||
145411629|NCT01202591|524360074|FG004|Overall Study|Objective Disease Progression|2|||
145570117|NCT01393405|524945894|FG001|Maintenance Period Week|Lost to Follow-up|1|||
145570118|NCT01393405|524945895|FG002|Maintenance Period Week|Lost to Follow-up|0|||
145570119|NCT04365699|524945898|FG000|Overall Study|Death|2|||
145570120|NCT04365699|524945899|FG001|Overall Study|Death|5|||
145570121|NCT04365699|524945900|FG002|Overall Study|Death|15|||
145570122|NCT02321462|524945904|FG000|Overall Study|Withdrawal by Subject|5|||
145570123|NCT02321462|524945905|FG001|Overall Study|Withdrawal by Subject|2|||
145320090|NCT02688387|524019590|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
145320091|NCT02688387|524019591|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320092|NCT02688387|524019592|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320093|NCT02688387|524019593|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320094|NCT02688387|524019594|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320095|NCT02688387|524019595|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320096|NCT02688387|524019596|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320097|NCT02688387|524019597|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320098|NCT02688387|524019598|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320099|NCT02688387|524019599|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320100|NCT02688387|524019600|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320101|NCT02688387|524019601|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320102|NCT02688387|524019602|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320103|NCT02688387|524019603|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320104|NCT02688387|524019604|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320105|NCT02688387|524019605|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320106|NCT02688387|524019606|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320107|NCT02688387|524019607|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
145320108|NCT02688387|524019586|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
145320109|NCT02688387|524019587|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320110|NCT02688387|524019588|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320111|NCT02688387|524019589|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320112|NCT02688387|524019590|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320113|NCT02688387|524019591|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320114|NCT02688387|524019592|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320115|NCT02688387|524019593|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320116|NCT02688387|524019594|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320117|NCT02688387|524019595|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320118|NCT02688387|524019596|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320119|NCT02688387|524019597|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320120|NCT02688387|524019598|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320121|NCT02688387|524019599|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320122|NCT02688387|524019600|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320123|NCT02688387|524019601|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320124|NCT02688387|524019602|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320125|NCT02688387|524019603|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320126|NCT02688387|524019604|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320127|NCT02688387|524019605|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320128|NCT02688387|524019606|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320129|NCT02688387|524019607|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
145320130|NCT02688387|524019586|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320131|NCT02688387|524019587|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320132|NCT02688387|524019588|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320133|NCT02688387|524019589|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320134|NCT02688387|524019590|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145411630|NCT01202591|524360075|FG005|Overall Study|Objective Disease Progression|0|||
145570124|NCT02321462|524945904|FG000|Overall Study|Subject withdrawn before any treatment|1|||
145320135|NCT02688387|524019591|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320136|NCT02688387|524019592|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320137|NCT02688387|524019593|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320138|NCT02688387|524019594|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320139|NCT02688387|524019595|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320140|NCT02688387|524019596|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
145320141|NCT02688387|524019597|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320142|NCT02688387|524019598|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320143|NCT02688387|524019599|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320144|NCT02688387|524019600|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320145|NCT02688387|524019601|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320146|NCT02688387|524019602|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320147|NCT02688387|524019603|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145411631|NCT00191100|524360076|FG000|Overall Study|Adverse Event|18|||
145411632|NCT00191100|524360077|FG001|Overall Study|Adverse Event|1|||
145411633|NCT00191100|524360076|FG000|Overall Study|Lost to Follow-up|2|||
145411634|NCT00191100|524360077|FG001|Overall Study|Lost to Follow-up|0|||
145411635|NCT00191100|524360076|FG000|Overall Study|Patient Moved|0|||
145411636|NCT00191100|524360077|FG001|Overall Study|Patient Moved|1|||
145411637|NCT00191100|524360076|FG000|Overall Study|Withdrawal by Subject|9|||
145411638|NCT00191100|524360077|FG001|Overall Study|Withdrawal by Subject|3|||
145411639|NCT00191100|524360076|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
145411640|NCT00191100|524360077|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
145411641|NCT00191100|524360076|FG000|Overall Study|Clinical Relapse|2|||
145411642|NCT00191100|524360077|FG001|Overall Study|Clinical Relapse|1|||
145411643|NCT00191100|524360076|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
145411644|NCT00191100|524360077|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
145411645|NCT00191100|524360076|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
145411646|NCT00191100|524360077|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
145411647|NCT00191100|524360076|FG000|Overall Study|Physician Decision|3|||
145411648|NCT00191100|524360077|FG001|Overall Study|Physician Decision|1|||
145411649|NCT00191100|524360076|FG000|Overall Study|Death from Study Drug Toxicity|2|||
145570125|NCT02321462|524945905|FG001|Overall Study|Subject withdrawn before any treatment|1|||
145570126|NCT00692770|524945916|FG000|Overall Study|Protocol Violation|2|||
145570127|NCT00692770|524945917|FG001|Overall Study|Protocol Violation|7|||
145411650|NCT00191100|524360077|FG001|Overall Study|Death from Study Drug Toxicity|0|||
145411651|NCT00191100|524360076|FG000|Overall Study|Protocol Violation|1|||
145411652|NCT00191100|524360077|FG001|Overall Study|Protocol Violation|1|||
145411653|NCT00191100|524360076|FG000|Overall Study|Death from Other Cause|1|||
145411654|NCT00191100|524360077|FG001|Overall Study|Death from Other Cause|0|||
145411655|NCT00191100|524360076|FG000|Overall Study|Reason Not Specified|0|||
145411656|NCT00191100|524360077|FG001|Overall Study|Reason Not Specified|1|||
145411657|NCT02406612|524360080|FG000|Overall Study|Screening Failure|3|||
145411658|NCT02406612|524360081|FG001|Overall Study|Screening Failure|0|||
145411659|NCT02406612|524360080|FG000|Overall Study|Intra-procedural Exclusion|1|||
145411660|NCT02406612|524360081|FG001|Overall Study|Intra-procedural Exclusion|3|||
145411661|NCT02406612|524360080|FG000|Overall Study|Guidewire Failure|0|||
145411662|NCT02406612|524360081|FG001|Overall Study|Guidewire Failure|1|||
145411663|NCT02916771|524360086|FG000|Overall Study|Withdrawal by Subject|9|||
145411664|NCT02916771|524360086|FG000|Overall Study|Physician Decision|1|||
145411665|NCT02916771|524360086|FG000|Overall Study|Began treatment for another active malignancy|1|||
145411666|NCT05578872|524360097|FG000|Overall Study|Withdrawal by Subject|2|||
145411667|NCT05578872|524360098|FG001|Overall Study|Withdrawal by Subject|1|||
145411668|NCT05578872|524360097|FG000|Overall Study|Adverse Event|1|||
145411669|NCT05578872|524360098|FG001|Overall Study|Adverse Event|1|||
145411670|NCT05578872|524360097|FG000|Overall Study|Physician Decision|1|||
145411671|NCT05578872|524360098|FG001|Overall Study|Physician Decision|2|||
145411672|NCT05578872|524360097|FG000|Overall Study|Progressive disease|10|||
145411673|NCT05578872|524360098|FG001|Overall Study|Progressive disease|9|||
145411674|NCT05578872|524360097|FG000|Overall Study|Sponsor decision|0|||
145411675|NCT05578872|524360098|FG001|Overall Study|Sponsor decision|1|||
145411676|NCT05578872|524360097|FG000|Overall Study|Toxicity and Patient's decision|0|||
145411677|NCT05578872|524360098|FG001|Overall Study|Toxicity and Patient's decision|1|||
145411678|NCT02737618|524360571|FG000|Overall Study|Withdrawal by Subject|9|||
145411679|NCT00313170|524360573|FG000|Overall Study|Death|2|||
145411680|NCT00313170|524360574|FG001|Overall Study|Death|4|||
145411681|NCT00313170|524360575|FG002|Overall Study|Death|2|||
145411682|NCT00313170|524360573|FG000|Overall Study|Adverse Event|1|||
145570128|NCT00692770|524945916|FG000|Overall Study|Withdrawal by Subject|97|||
145570129|NCT00692770|524945917|FG001|Overall Study|Withdrawal by Subject|36|||
145320148|NCT02688387|524019604|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145411683|NCT00313170|524360574|FG001|Overall Study|Adverse Event|2|||
145411684|NCT00313170|524360575|FG002|Overall Study|Adverse Event|0|||
145570130|NCT00692770|524945916|FG000|Overall Study|Adverse Event|136|||
145411685|NCT00313170|524360573|FG000|Overall Study|Disease progression|31|||
145411686|NCT00313170|524360574|FG001|Overall Study|Disease progression|26|||
145320149|NCT02688387|524019605|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320150|NCT02688387|524019606|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320151|NCT02688387|524019607|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
145320152|NCT02688387|524019586|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320153|NCT02688387|524019587|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320154|NCT02688387|524019588|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320155|NCT02688387|524019589|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320156|NCT02688387|524019590|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320157|NCT02688387|524019591|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320158|NCT02688387|524019592|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320159|NCT02688387|524019593|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320160|NCT02688387|524019594|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320161|NCT02688387|524019595|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320162|NCT02688387|524019596|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320163|NCT02688387|524019597|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320164|NCT02688387|524019598|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320165|NCT02688387|524019599|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320166|NCT02688387|524019600|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
145320167|NCT02688387|524019601|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320168|NCT02688387|524019602|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320169|NCT02688387|524019603|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320170|NCT02688387|524019604|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320171|NCT02688387|524019605|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320172|NCT02688387|524019606|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320173|NCT02688387|524019607|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
145320174|NCT02688387|524019586|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320175|NCT02688387|524019587|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320176|NCT02688387|524019588|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320177|NCT02688387|524019589|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320178|NCT02688387|524019590|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320179|NCT02688387|524019591|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320180|NCT02688387|524019592|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320181|NCT02688387|524019593|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320182|NCT02688387|524019594|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320183|NCT02688387|524019595|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320184|NCT02688387|524019596|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320185|NCT02688387|524019597|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320186|NCT02688387|524019598|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320187|NCT02688387|524019599|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320188|NCT02688387|524019600|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320189|NCT02688387|524019601|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320190|NCT02688387|524019602|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320191|NCT02688387|524019603|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320192|NCT02688387|524019604|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320193|NCT02688387|524019605|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320194|NCT02688387|524019606|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
145320195|NCT02688387|524019607|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
145320196|NCT02688387|524019586|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320197|NCT02688387|524019587|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320198|NCT02688387|524019588|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320199|NCT02688387|524019589|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320200|NCT02688387|524019590|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320201|NCT02688387|524019591|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320202|NCT02688387|524019592|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320203|NCT02688387|524019593|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320204|NCT02688387|524019594|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320205|NCT02688387|524019595|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320206|NCT02688387|524019596|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320207|NCT02688387|524019597|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320208|NCT02688387|524019598|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320209|NCT02688387|524019599|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320210|NCT02688387|524019600|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320211|NCT02688387|524019601|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320212|NCT02688387|524019602|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320213|NCT02688387|524019603|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145411687|NCT00313170|524360575|FG002|Overall Study|Disease progression|27|||
145411688|NCT00313170|524360573|FG000|Overall Study|Withdrawal by Subject|1|||
145320214|NCT02688387|524019604|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
145320215|NCT02688387|524019605|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320216|NCT02688387|524019606|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
145320217|NCT02688387|524019607|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
145320218|NCT02688387|524019586|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320219|NCT02688387|524019587|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320220|NCT02688387|524019588|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320221|NCT02688387|524019589|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320222|NCT02688387|524019590|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320223|NCT02688387|524019591|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320224|NCT02688387|524019592|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320225|NCT02688387|524019593|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320226|NCT02688387|524019594|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320227|NCT02688387|524019595|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320228|NCT02688387|524019596|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320229|NCT02688387|524019597|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320230|NCT02688387|524019598|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320231|NCT02688387|524019599|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320232|NCT02688387|524019600|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320233|NCT02688387|524019601|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320234|NCT02688387|524019602|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320235|NCT02688387|524019603|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320236|NCT02688387|524019604|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320237|NCT02688387|524019605|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
145320238|NCT02688387|524019606|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320239|NCT02688387|524019607|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
145320240|NCT00802178|524019610|FG000|Overall Study|Lack of Efficacy|36|||
145320241|NCT00802178|524019610|FG000|Overall Study|Insufficient tolerability (IT)|17|||
145320242|NCT00802178|524019610|FG000|Overall Study|Withdrawal by Subject|18|||
145320243|NCT00802178|524019610|FG000|Overall Study|Other|32|||
145320244|NCT00802178|524019610|FG000|Overall Study|Lack of efficacy and patient wish|1|||
145320245|NCT00802178|524019610|FG000|Overall Study|IT and patient wish|8|||
145320246|NCT00802178|524019610|FG000|Overall Study|Patients wish and other reason|1|||
145320247|NCT01606228|524019611|FG000|Overall Study|Lost to Follow-up|20|||
145320248|NCT01606228|524019611|FG000|Overall Study|Withdrawal by Subject|3|||
145320249|NCT01606228|524019611|FG000|Overall Study|Non-compliant|3|||
145320250|NCT01606228|524019611|FG000|Overall Study|Lack of Efficacy|2|||
145320251|NCT01606228|524019611|FG000|Overall Study|Adverse Event|1|||
145320252|NCT01115855|524019612|FG000|Overall Study|Adverse Event|16|||
145320253|NCT01115855|524019613|FG001|Overall Study|Adverse Event|18|||
145320254|NCT01115855|524019612|FG000|Overall Study|Death|6|||
145320255|NCT01115855|524019613|FG001|Overall Study|Death|5|||
145320256|NCT01115855|524019612|FG000|Overall Study|Lab Abnormality|1|||
145320257|NCT01115855|524019613|FG001|Overall Study|Lab Abnormality|1|||
145320258|NCT01115855|524019612|FG000|Overall Study|Protocol Violation|0|||
145320259|NCT01115855|524019613|FG001|Overall Study|Protocol Violation|1|||
145320260|NCT01115855|524019612|FG000|Overall Study|Withdrawal by Subject|5|||
145320261|NCT01115855|524019613|FG001|Overall Study|Withdrawal by Subject|5|||
145320262|NCT01115855|524019612|FG000|Overall Study|Other|8|||
145320263|NCT01115855|524019613|FG001|Overall Study|Other|6|||
145320264|NCT00831233|524019614|FG000|Overall Study|Adverse Event|0|||
145320265|NCT00831233|524019615|FG001|Overall Study|Adverse Event|1|||
145320266|NCT00831233|524019614|FG000|Overall Study|Protocol Violation|1|||
145320267|NCT00831233|524019615|FG001|Overall Study|Protocol Violation|0|||
145320268|NCT00831233|524019614|FG000|Overall Study|Selection Criteria Not Met|2|||
145320269|NCT00831233|524019615|FG001|Overall Study|Selection Criteria Not Met|0|||
145320270|NCT02356211|524019616|FG000|Overall Study|Withdrawal by Subject|2|||
145320271|NCT02356211|524019617|FG001|Overall Study|Withdrawal by Subject|2|||
145320272|NCT02356211|524019616|FG000|Overall Study|ineligible|1|||
145411689|NCT00313170|524360574|FG001|Overall Study|Withdrawal by Subject|0|||
145411690|NCT00313170|524360575|FG002|Overall Study|Withdrawal by Subject|1|||
145570131|NCT00692770|524945917|FG001|Overall Study|Adverse Event|41|||
145570132|NCT00692770|524945916|FG000|Overall Study|Death|10|||
145570133|NCT00692770|524945917|FG001|Overall Study|Death|5|||
145570134|NCT00692770|524945916|FG000|Overall Study|Lost to Follow-up|7|||
145570135|NCT00692770|524945917|FG001|Overall Study|Lost to Follow-up|3|||
145570136|NCT00692770|524945916|FG000|Overall Study|Non-compliant with study medication|11|||
145320273|NCT02356211|524019617|FG001|Overall Study|ineligible|8|||
145320274|NCT01976728|524019618|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
145320275|NCT01976728|524019619|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
145320276|NCT01976728|524019620|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
145320277|NCT01976728|524019621|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
145320278|NCT02211014|524019622|FG000|Overall Study|Adverse Event|0|||
145320279|NCT02211014|524019623|FG001|Overall Study|Adverse Event|2|||
145320280|NCT02211014|524019622|FG000|Overall Study|Physician Decision|1|||
145320281|NCT02211014|524019623|FG001|Overall Study|Physician Decision|2|||
145320282|NCT02211014|524019622|FG000|Overall Study|Started another cancer therapy|1|||
145320283|NCT02211014|524019623|FG001|Overall Study|Started another cancer therapy|0|||
145320284|NCT02211014|524019622|FG000|Overall Study|Withdrawal by Subject|0|||
145320285|NCT02211014|524019623|FG001|Overall Study|Withdrawal by Subject|1|||
145320286|NCT02211014|524019622|FG000|Overall Study|In agreement with patient, no benefit|0|||
145320287|NCT02211014|524019623|FG001|Overall Study|In agreement with patient, no benefit|1|||
145320288|NCT00966381|524019624|FG000|Overall Study|Withdrawal by Subject|2|||
145320289|NCT00966381|524019625|FG001|Overall Study|Withdrawal by Subject|2|||
145320290|NCT01124695|524019626|FG000|Overall Study|Disease progression|77|||
145320291|NCT01124695|524019626|FG000|Overall Study|Adverse Event|11|||
145320292|NCT01124695|524019626|FG000|Overall Study|Death|1|||
145320293|NCT01124695|524019626|FG000|Overall Study|Withdrawal by Subject|7|||
145320294|NCT01124695|524019626|FG000|Overall Study|Physician Decision|3|||
145320295|NCT01124695|524019626|FG000|Overall Study|Alternative therapy|9|||
145320296|NCT01124695|524019626|FG000|Overall Study|No documentation that patient went off treatment|4|||
145320297|NCT01124695|524019626|FG000|Overall Study|Ineligible|9|||
145320298|NCT01124695|524019626|FG000|Overall Study|Ineligible and never start treatment|2|||
145320299|NCT01546922|524019631|FG000|First Period of 10 Weeks|Protocol Violation|3|||
145320300|NCT01546922|524019632|FG001|First Period of 10 Weeks|Protocol Violation|1|||
145320301|NCT01546922|524019631|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
145320302|NCT01546922|524019632|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
145320303|NCT01546922|524019631|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
145320304|NCT01546922|524019632|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
145320305|NCT01546922|524019631|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
145320306|NCT01546922|524019632|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
145320307|NCT01546922|524019631|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
145320308|NCT01546922|524019632|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
145320309|NCT01613378|524019633|FG000|Overall Study|Lack of Efficacy|13|||
145320310|NCT01613378|524019633|FG000|Overall Study|Adverse Event|11|||
145320311|NCT01613378|524019633|FG000|Overall Study|Withdrawal by Subject|8|||
145320312|NCT01613378|524019633|FG000|Overall Study|Death|2|||
145320313|NCT01613378|524019633|FG000|Overall Study|Lost to Follow-up|1|||
145320314|NCT01613378|524019633|FG000|Overall Study|Other Reason|4|||
145320315|NCT02000531|524019634|FG000|Overall Study|Lost to Follow-up|1|||
145320316|NCT02000531|524019635|FG001|Overall Study|Lost to Follow-up|0|||
145320317|NCT02000531|524019634|FG000|Overall Study|Discontinued due to data cut-off|3|||
145411691|NCT00313170|524360573|FG000|Overall Study|Incorrect enrollment|0|||
145411692|NCT00313170|524360574|FG001|Overall Study|Incorrect enrollment|2|||
145411693|NCT00313170|524360575|FG002|Overall Study|Incorrect enrollment|1|||
145411694|NCT00313170|524360573|FG000|Overall Study|Lost to Follow-up|0|||
145411695|NCT00313170|524360574|FG001|Overall Study|Lost to Follow-up|0|||
145411696|NCT00313170|524360575|FG002|Overall Study|Lost to Follow-up|1|||
145411697|NCT00313170|524360573|FG000|Overall Study|Progression (investigators opinion)|1|||
145411698|NCT00313170|524360574|FG001|Overall Study|Progression (investigators opinion)|0|||
145411699|NCT00313170|524360575|FG002|Overall Study|Progression (investigators opinion)|0|||
145411700|NCT01879852|524360576|FG000|Overall Study|Withdrawal by Subject|2|||
145411701|NCT01879852|524360577|FG001|Overall Study|Withdrawal by Subject|0|||
145411702|NCT02115386|524360578|FG000|Overall Study|Protocol Violation|1|||
145411703|NCT02115386|524360578|FG000|Overall Study|Administrative - trial was terminated|6|||
145411704|NCT02453048|524360579|FG000|Overall Study|Only part of initial 6 mo. study|0|||
145411705|NCT02453048|524360580|FG001|Overall Study|Only part of initial 6 mo. study|0|||
145411706|NCT02453048|524360581|FG002|Overall Study|Only part of initial 6 mo. study|0|||
145411707|NCT02453048|524360582|FG003|Overall Study|Only part of initial 6 mo. study|0|||
145411708|NCT02453048|524360583|FG004|Overall Study|Only part of initial 6 mo. study|6|||
145411709|NCT02453048|524360579|FG000|Overall Study|Lost to Follow-up|0|||
145411710|NCT02453048|524360580|FG001|Overall Study|Lost to Follow-up|1|||
145411711|NCT02453048|524360581|FG002|Overall Study|Lost to Follow-up|2|||
145411712|NCT02453048|524360582|FG003|Overall Study|Lost to Follow-up|0|||
145411713|NCT02453048|524360583|FG004|Overall Study|Lost to Follow-up|0|||
145411714|NCT01482221|524360584|FG000|Overall Study|Lack of Efficacy|1|||
145411715|NCT01482221|524360585|FG001|Overall Study|Lack of Efficacy|0|||
145411716|NCT01482221|524360586|FG002|Overall Study|Lack of Efficacy|1|||
145320318|NCT02000531|524019635|FG001|Overall Study|Discontinued due to data cut-off|8|||
145320319|NCT01345318|524019642|FG000|Overall Study|Adverse Event|16|||
145320320|NCT01345318|524019642|FG000|Overall Study|Lack of Efficacy|17|||
145411717|NCT01482221|524360584|FG000|Overall Study|Lost to Follow-up|3|||
145411718|NCT01482221|524360585|FG001|Overall Study|Lost to Follow-up|2|||
145320321|NCT01345318|524019642|FG000|Overall Study|Lost to Follow-up|2|||
145320322|NCT01345318|524019642|FG000|Overall Study|Protocol Violation|1|||
145320323|NCT01345318|524019642|FG000|Overall Study|Withdrawal by Subject|41|||
145411719|NCT01482221|524360586|FG002|Overall Study|Lost to Follow-up|1|||
145411720|NCT01482221|524360584|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
145320324|NCT01345318|524019642|FG000|Overall Study|Other|3|||
145320325|NCT00743509|524019643|FG000|Overall Study|Withdrawal by Subject|2|||
145320326|NCT01239472|524019644|FG000|Overall Study|Withdrawal by Subject|5|||
145320327|NCT01239472|524019645|FG001|Overall Study|Withdrawal by Subject|1|||
145320328|NCT01239472|524019644|FG000|Overall Study|Adverse Event|0|||
145320329|NCT01239472|524019645|FG001|Overall Study|Adverse Event|1|||
145320330|NCT01239472|524019644|FG000|Overall Study|Lack of Efficacy|0|||
145320331|NCT01239472|524019645|FG001|Overall Study|Lack of Efficacy|1|||
145320332|NCT00573170|524019649|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
145320333|NCT00573170|524019650|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
145320334|NCT00573170|524019651|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
145320335|NCT00573170|524019652|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
145320336|NCT00573170|524019653|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
145320337|NCT00573170|524019654|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
145320338|NCT00573170|524019649|FG000|First Washout Period|Adverse Event|1|||
145320339|NCT00573170|524019650|FG001|First Washout Period|Adverse Event|1|||
145320340|NCT00573170|524019651|FG002|First Washout Period|Adverse Event|0|||
145320341|NCT00573170|524019652|FG003|First Washout Period|Adverse Event|0|||
145320342|NCT00573170|524019653|FG004|First Washout Period|Adverse Event|0|||
145320343|NCT00573170|524019654|FG005|First Washout Period|Adverse Event|1|||
145320344|NCT00573170|524019649|FG000|First Washout Period|Lack of Efficacy|0|||
145320345|NCT00573170|524019650|FG001|First Washout Period|Lack of Efficacy|0|||
145320346|NCT00573170|524019651|FG002|First Washout Period|Lack of Efficacy|0|||
145320347|NCT00573170|524019652|FG003|First Washout Period|Lack of Efficacy|0|||
145320348|NCT00573170|524019653|FG004|First Washout Period|Lack of Efficacy|0|||
145320349|NCT00573170|524019654|FG005|First Washout Period|Lack of Efficacy|1|||
145320350|NCT00573170|524019649|FG000|First Washout Period|Lost to Follow-up|1|||
145320351|NCT00573170|524019650|FG001|First Washout Period|Lost to Follow-up|1|||
145320352|NCT00573170|524019651|FG002|First Washout Period|Lost to Follow-up|0|||
145570137|NCT00692770|524945917|FG001|Overall Study|Non-compliant with study medication|5|||
145570138|NCT00692770|524945916|FG000|Overall Study|Progression by clinical judgment|2|||
145570139|NCT00692770|524945917|FG001|Overall Study|Progression by clinical judgment|3|||
145570140|NCT00692770|524945916|FG000|Overall Study|Physician decision not protocol driven|10|||
145570141|NCT00692770|524945917|FG001|Overall Study|Physician decision not protocol driven|14|||
145570142|NCT00692770|524945916|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
145570143|NCT00692770|524945917|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
145570144|NCT00692770|524945916|FG000|Overall Study|Protocol driven decision point|3|||
145570145|NCT00692770|524945917|FG001|Overall Study|Protocol driven decision point|7|||
145570146|NCT00692770|524945916|FG000|Overall Study|Completed all planned assessments|79|||
145570147|NCT00692770|524945917|FG001|Overall Study|Completed all planned assessments|101|||
145570148|NCT00692770|524945916|FG000|Overall Study|Radiological and clinical progression|8|||
145570149|NCT00692770|524945917|FG001|Overall Study|Radiological and clinical progression|8|||
145570150|NCT00692770|524945916|FG000|Overall Study|Clinical endpoint reached|16|||
145570151|NCT00692770|524945917|FG001|Overall Study|Clinical endpoint reached|43|||
145570152|NCT00692770|524945916|FG000|Overall Study|Study terminated by sponsor|2|||
145570153|NCT00692770|524945917|FG001|Overall Study|Study terminated by sponsor|2|||
145570154|NCT00692770|524945916|FG000|Overall Study|Randomized but not treated|3|||
145570155|NCT00692770|524945917|FG001|Overall Study|Randomized but not treated|4|||
145570156|NCT03044197|524945918|FG000|Overall Study|Withdrawal by Subject|3|||
145570157|NCT03044197|524945919|FG001|Overall Study|Withdrawal by Subject|1|||
145570158|NCT00834912|524945920|FG000|Treatment Period 1|Adverse Event|0|||
145320353|NCT00573170|524019652|FG003|First Washout Period|Lost to Follow-up|2|||
145570159|NCT00834912|524945921|FG001|Treatment Period 1|Adverse Event|1|||
145320354|NCT00573170|524019653|FG004|First Washout Period|Lost to Follow-up|0|||
145320355|NCT00573170|524019654|FG005|First Washout Period|Lost to Follow-up|2|||
145320356|NCT00573170|524019649|FG000|First Washout Period|Withdrawal by Subject|2|||
145320357|NCT00573170|524019650|FG001|First Washout Period|Withdrawal by Subject|0|||
145320358|NCT00573170|524019651|FG002|First Washout Period|Withdrawal by Subject|0|||
145320359|NCT00573170|524019652|FG003|First Washout Period|Withdrawal by Subject|2|||
145570160|NCT00834912|524945922|FG002|Treatment Period 1|Adverse Event|0|||
145320360|NCT00573170|524019653|FG004|First Washout Period|Withdrawal by Subject|3|||
145320361|NCT00573170|524019654|FG005|First Washout Period|Withdrawal by Subject|3|||
145570161|NCT00834912|524945923|FG003|Treatment Period 1|Adverse Event|1|||
145320362|NCT00573170|524019649|FG000|First Washout Period|Other|4|||
145320363|NCT00573170|524019650|FG001|First Washout Period|Other|0|||
145320364|NCT00573170|524019651|FG002|First Washout Period|Other|1|||
145570162|NCT00834912|524945924|FG004|Treatment Period 1|Adverse Event|0|||
145570163|NCT00834912|524945925|FG005|Treatment Period 1|Adverse Event|0|||
145320365|NCT00573170|524019652|FG003|First Washout Period|Other|1|||
145320366|NCT00573170|524019653|FG004|First Washout Period|Other|0|||
145320367|NCT00573170|524019654|FG005|First Washout Period|Other|0|||
145570164|NCT00834912|524945920|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145320368|NCT00573170|524019649|FG000|Second Washout Period|Adverse Event|1|||
145570165|NCT00834912|524945921|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145570166|NCT00834912|524945922|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145570167|NCT00834912|524945923|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145570168|NCT00834912|524945924|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145570169|NCT00834912|524945925|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145570170|NCT00262067|524945928|FG000|Overall Study|Death|190|||
145570171|NCT00262067|524945929|FG001|Overall Study|Death|89|||
145570172|NCT00262067|524945930|FG002|Overall Study|Death|186|||
145570173|NCT00262067|524945931|FG003|Overall Study|Death|99|||
145570174|NCT00262067|524945928|FG000|Overall Study|Lost to Follow-up|5|||
145570175|NCT00262067|524945929|FG001|Overall Study|Lost to Follow-up|4|||
145570176|NCT00262067|524945930|FG002|Overall Study|Lost to Follow-up|7|||
145570177|NCT00262067|524945931|FG003|Overall Study|Lost to Follow-up|5|||
145570178|NCT00262067|524945928|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
145570179|NCT00262067|524945929|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
145570180|NCT00262067|524945930|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
145570181|NCT00262067|524945931|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
145570182|NCT00262067|524945928|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
145320369|NCT00573170|524019650|FG001|Second Washout Period|Adverse Event|0|||
145320370|NCT00573170|524019651|FG002|Second Washout Period|Adverse Event|0|||
145320371|NCT00573170|524019652|FG003|Second Washout Period|Adverse Event|0|||
145320372|NCT00573170|524019653|FG004|Second Washout Period|Adverse Event|1|||
145320373|NCT00573170|524019654|FG005|Second Washout Period|Adverse Event|0|||
145320374|NCT00573170|524019649|FG000|Second Washout Period|Protocol Violation|2|||
145320375|NCT00573170|524019650|FG001|Second Washout Period|Protocol Violation|1|||
145570183|NCT00262067|524945929|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
145570184|NCT00262067|524945930|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
145570185|NCT00262067|524945931|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
145570186|NCT02849548|524945937|FG000|Overall Study|Lost to Follow-up|1|||
145570187|NCT02849548|524945938|FG001|Overall Study|Lost to Follow-up|2|||
145570188|NCT02849548|524945937|FG000|Overall Study|Protocol Violation|1|||
145570189|NCT02849548|524945938|FG001|Overall Study|Protocol Violation|0|||
145570190|NCT00714259|524945939|FG000|Overall Study|Death|2|||
145570191|NCT00256698|524945942|FG000|Overall Study|Withdrawal by Subject|7|||
145570192|NCT00256698|524945943|FG001|Overall Study|Withdrawal by Subject|7|||
145570193|NCT00256698|524945942|FG000|Overall Study|Adverse Event|13|||
145320376|NCT00573170|524019651|FG002|Second Washout Period|Protocol Violation|1|||
145320377|NCT00573170|524019652|FG003|Second Washout Period|Protocol Violation|0|||
145320378|NCT00573170|524019653|FG004|Second Washout Period|Protocol Violation|0|||
145320379|NCT00573170|524019654|FG005|Second Washout Period|Protocol Violation|0|||
145570194|NCT00256698|524945943|FG001|Overall Study|Adverse Event|6|||
145570195|NCT00256698|524945942|FG000|Overall Study|Protocol Violation|6|||
145570196|NCT00256698|524945943|FG001|Overall Study|Protocol Violation|5|||
145570197|NCT00256698|524945942|FG000|Overall Study|Lost to Follow-up|1|||
145570198|NCT00256698|524945943|FG001|Overall Study|Lost to Follow-up|3|||
145570199|NCT00256698|524945942|FG000|Overall Study|disease progression|97|||
145570200|NCT00256698|524945943|FG001|Overall Study|disease progression|105|||
145570201|NCT00256698|524945942|FG000|Overall Study|still ongoing at data cut-off|41|||
145570202|NCT00256698|524945943|FG001|Overall Study|still ongoing at data cut-off|46|||
145570203|NCT00256698|524945942|FG000|Overall Study|withdrawn due to osteoporosis|1|||
145570204|NCT00256698|524945943|FG001|Overall Study|withdrawn due to osteoporosis|0|||
145320380|NCT00573170|524019649|FG000|Second Washout Period|Withdrawal by Subject|1|||
145320381|NCT00573170|524019650|FG001|Second Washout Period|Withdrawal by Subject|1|||
145320382|NCT00573170|524019651|FG002|Second Washout Period|Withdrawal by Subject|2|||
145570205|NCT00256698|524945942|FG000|Overall Study|Prematurely Discontinued|1|||
145570206|NCT00256698|524945943|FG001|Overall Study|Prematurely Discontinued|0|||
145570207|NCT01589822|524947311|FG000|Overall Study|Withdrawal by Subject|1|||
145570208|NCT01589822|524947312|FG001|Overall Study|Withdrawal by Subject|2|||
145570209|NCT01589822|524947313|FG002|Overall Study|Withdrawal by Subject|0|||
145570210|NCT01589822|524947311|FG000|Overall Study|Death|1|||
145570211|NCT01589822|524947312|FG001|Overall Study|Death|0|||
145570212|NCT01589822|524947313|FG002|Overall Study|Death|0|||
145570213|NCT01589822|524947311|FG000|Overall Study|Missed 90 day visit|2|||
145570214|NCT01589822|524947312|FG001|Overall Study|Missed 90 day visit|1|||
145570215|NCT01589822|524947313|FG002|Overall Study|Missed 90 day visit|1|||
145570216|NCT05168475|524947314|FG000|Period 1|Protocol Violation|1|||
145320383|NCT00573170|524019652|FG003|Second Washout Period|Withdrawal by Subject|0|||
145570217|NCT05168475|524947314|FG000|Period 1|IMP shortage|2|||
145570218|NCT05168475|524947314|FG000|Period 1|Not randomised|2|||
145320384|NCT00573170|524019653|FG004|Second Washout Period|Withdrawal by Subject|1|||
145570219|NCT05168475|524947314|FG000|Period 2|IMP shortage|1|||
145570220|NCT01140477|524947315|FG000|Overall Study|Lost to Follow-up|4|||
145570221|NCT01140477|524947316|FG001|Overall Study|Lost to Follow-up|0|||
145320385|NCT00573170|524019654|FG005|Second Washout Period|Withdrawal by Subject|0|||
145620563|NCT01923428|525125105|FG003|Overall Study|Non Compliance to treatment|1|||
145570222|NCT01140477|524947315|FG000|Overall Study|Withdrawal by Subject|1|||
145570223|NCT01140477|524947316|FG001|Overall Study|Withdrawal by Subject|4|||
145620564|NCT01923428|525125102|FG000|Overall Study|Lack of Efficacy|0|||
145570224|NCT01140477|524947315|FG000|Overall Study|Surgical complication preventing implant|2|||
145320386|NCT00573170|524019649|FG000|Second Washout Period|Lost to Follow-up|0|||
145320387|NCT00573170|524019650|FG001|Second Washout Period|Lost to Follow-up|0|||
145320388|NCT00573170|524019651|FG002|Second Washout Period|Lost to Follow-up|0|||
145320389|NCT00573170|524019652|FG003|Second Washout Period|Lost to Follow-up|1|||
145320390|NCT00573170|524019653|FG004|Second Washout Period|Lost to Follow-up|0|||
145320391|NCT00573170|524019654|FG005|Second Washout Period|Lost to Follow-up|0|||
145320392|NCT00573170|524019649|FG000|Second Washout Period|Other|1|||
145320393|NCT00573170|524019650|FG001|Second Washout Period|Other|2|||
145320394|NCT00573170|524019651|FG002|Second Washout Period|Other|1|||
145320395|NCT00573170|524019652|FG003|Second Washout Period|Other|4|||
145320396|NCT00573170|524019653|FG004|Second Washout Period|Other|6|||
145320397|NCT00573170|524019654|FG005|Second Washout Period|Other|2|||
145320398|NCT00573170|524019649|FG000|Third Treatment Period|Withdrawal by Subject|1|||
145320399|NCT00573170|524019650|FG001|Third Treatment Period|Withdrawal by Subject|0|||
145320400|NCT00573170|524019651|FG002|Third Treatment Period|Withdrawal by Subject|0|||
145320401|NCT00573170|524019652|FG003|Third Treatment Period|Withdrawal by Subject|0|||
145320402|NCT00573170|524019653|FG004|Third Treatment Period|Withdrawal by Subject|0|||
145320403|NCT00573170|524019654|FG005|Third Treatment Period|Withdrawal by Subject|0|||
145320404|NCT00573170|524019649|FG000|Third Treatment Period|Lost to Follow-up|0|||
145320405|NCT00573170|524019650|FG001|Third Treatment Period|Lost to Follow-up|0|||
145320406|NCT00573170|524019651|FG002|Third Treatment Period|Lost to Follow-up|0|||
145320407|NCT00573170|524019652|FG003|Third Treatment Period|Lost to Follow-up|0|||
145320408|NCT00573170|524019653|FG004|Third Treatment Period|Lost to Follow-up|0|||
145320409|NCT00573170|524019654|FG005|Third Treatment Period|Lost to Follow-up|2|||
145320410|NCT00804141|524019655|FG000|Overall Study|Adverse Event|157|||
145320411|NCT00804141|524019655|FG000|Overall Study|Death|4|||
145320412|NCT00804141|524019655|FG000|Overall Study|Failed to return|96|||
145320413|NCT00804141|524019655|FG000|Overall Study|Investigator request|8|||
145320414|NCT00804141|524019655|FG000|Overall Study|Protocol Violation|85|||
145320415|NCT00804141|524019655|FG000|Overall Study|Withdrawal by Subject|131|||
145320416|NCT00804141|524019655|FG000|Overall Study|Lack of Efficacy|46|||
145320417|NCT00804141|524019655|FG000|Overall Study|Other than specified|30|||
145320418|NCT00804141|524019655|FG000|Overall Study|Enrolled but not treated|6|||
145320419|NCT02418455|524019656|FG000|48-Week Treatment Period|Other- Not Specified|1|||
145320420|NCT02418455|524019656|FG000|Continuation Period|Sponsor Decision|7|||
145320421|NCT01546519|524019660|FG000|Overall Study|Adverse Event|0|||
145320422|NCT01546519|524019661|FG001|Overall Study|Adverse Event|0|||
145320423|NCT01546519|524019662|FG002|Overall Study|Adverse Event|1|||
145320424|NCT01546519|524019663|FG003|Overall Study|Adverse Event|1|||
145320425|NCT01546519|524019660|FG000|Overall Study|Death|0|||
145320426|NCT01546519|524019661|FG001|Overall Study|Death|1|||
145320427|NCT01546519|524019662|FG002|Overall Study|Death|3|||
145320428|NCT01546519|524019663|FG003|Overall Study|Death|1|||
145320429|NCT01546519|524019660|FG000|Overall Study|related to disease progression|2|||
145320430|NCT01546519|524019661|FG001|Overall Study|related to disease progression|2|||
145320431|NCT01546519|524019662|FG002|Overall Study|related to disease progression|2|||
145320432|NCT01546519|524019663|FG003|Overall Study|related to disease progression|1|||
145320433|NCT01546519|524019660|FG000|Overall Study|Physician Decision|6|||
145320434|NCT01546519|524019661|FG001|Overall Study|Physician Decision|5|||
145320435|NCT01546519|524019662|FG002|Overall Study|Physician Decision|2|||
145320436|NCT01546519|524019663|FG003|Overall Study|Physician Decision|3|||
145320437|NCT01546519|524019660|FG000|Overall Study|Withdrawal by Subject|1|||
145320438|NCT01546519|524019661|FG001|Overall Study|Withdrawal by Subject|0|||
145320439|NCT01546519|524019662|FG002|Overall Study|Withdrawal by Subject|0|||
145320440|NCT01546519|524019663|FG003|Overall Study|Withdrawal by Subject|0|||
145320441|NCT00263887|524019664|FG000|Overall Study|Withdrawal by Subject|1|||
145320442|NCT00263887|524019665|FG001|Overall Study|Withdrawal by Subject|1|||
145320443|NCT00263887|524019664|FG000|Overall Study|Lung transplantation|1|||
145320444|NCT00263887|524019665|FG001|Overall Study|Lung transplantation|2|||
145570225|NCT01140477|524947316|FG001|Overall Study|Surgical complication preventing implant|0|||
145570226|NCT01140477|524947315|FG000|Overall Study|Death|1|||
145570227|NCT01140477|524947316|FG001|Overall Study|Death|1|||
145570228|NCT01140477|524947315|FG000|Overall Study|Subject explanted|0|||
145570229|NCT01140477|524947316|FG001|Overall Study|Subject explanted|1|||
145570230|NCT04482179|524947317|FG000|Overall Study|Death|1|||
145320445|NCT00263887|524019664|FG000|Overall Study|Too ill to attend visit|1|||
145320446|NCT00263887|524019665|FG001|Overall Study|Too ill to attend visit|0|||
145320447|NCT00263887|524019664|FG000|Overall Study|Adverse Event|0|||
145320448|NCT00263887|524019665|FG001|Overall Study|Adverse Event|2|||
145570231|NCT04482179|524947318|FG001|Overall Study|Death|0|||
145320449|NCT00263887|524019664|FG000|Overall Study|Disease progression|0|||
145320450|NCT00263887|524019665|FG001|Overall Study|Disease progression|1|||
145320451|NCT00263887|524019664|FG000|Overall Study|Lack of Efficacy|0|||
145320452|NCT00263887|524019665|FG001|Overall Study|Lack of Efficacy|1|||
145320453|NCT04364763|524019666|FG000|Overall Study|Death|1|||
145320454|NCT04364763|524019667|FG001|Overall Study|Death|2|||
145570232|NCT04482179|524947317|FG000|Overall Study|Withdrawal by Subject|1|||
145320455|NCT04364763|524019666|FG000|Overall Study|Lost to Follow-up|1|||
145320456|NCT04364763|524019667|FG001|Overall Study|Lost to Follow-up|0|||
145320457|NCT02359864|524019669|FG000|Overall Study|Withdrawal by Subject|1|||
145320458|NCT02359864|524019670|FG001|Overall Study|Withdrawal by Subject|0|||
145320459|NCT00725764|524019671|FG000|Overall Study|Withdrawal by Subject|2|||
145320460|NCT00725764|524019671|FG000|Overall Study|Physician Decision|1|||
145320461|NCT00725764|524019671|FG000|Overall Study|Progressive Disease|7|||
145320462|NCT00725764|524019671|FG000|Overall Study|Lost to Follow-up|1|||
145320463|NCT00725764|524019671|FG000|Overall Study|Death|1|||
145320464|NCT00725764|524019671|FG000|Overall Study|Participant non compliant with protocol|1|||
145320465|NCT00725764|524019671|FG000|Overall Study|Decline in performance status|1|||
145320466|NCT00985231|524019684|FG000|Overall Study|ineligible|1|||
145320467|NCT00985231|524019685|FG001|Overall Study|ineligible|0|||
145320468|NCT00985231|524019684|FG000|Overall Study|Protocol Violation|1|||
145320469|NCT00985231|524019685|FG001|Overall Study|Protocol Violation|0|||
145320470|NCT00985231|524019684|FG000|Overall Study|Withdrawal by Subject|1|||
145320471|NCT00985231|524019685|FG001|Overall Study|Withdrawal by Subject|0|||
145320472|NCT00985231|524019684|FG000|Overall Study|Lost to Follow-up|0|||
145320473|NCT00985231|524019685|FG001|Overall Study|Lost to Follow-up|1|||
145320474|NCT00985231|524019684|FG000|Overall Study|Study related symptoms & complaints|0|||
145320475|NCT00985231|524019685|FG001|Overall Study|Study related symptoms & complaints|2|||
145320476|NCT00983476|524019691|FG000|Overall Study|Did not receive intervention|17|||
145320477|NCT00983476|524019692|FG001|Overall Study|Did not receive intervention|22|||
145320478|NCT00983476|524019693|FG002|Overall Study|Did not receive intervention|0|||
145320479|NCT01857206|524019697|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
145320480|NCT01857206|524019698|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
145320481|NCT01857206|524019697|FG000|Overall Study|Lost to Follow-up|9|||
145320482|NCT01857206|524019698|FG001|Overall Study|Lost to Follow-up|6|||
145320483|NCT01857206|524019697|FG000|Overall Study|Unclassified|3|||
145320484|NCT01857206|524019698|FG001|Overall Study|Unclassified|3|||
145320485|NCT01857206|524019697|FG000|Overall Study|Withdrawal by Subject|1|||
145320486|NCT01857206|524019698|FG001|Overall Study|Withdrawal by Subject|0|||
145320487|NCT00575380|524019705|FG000|Overall Study|Withdrawal by Subject|1|||
145320488|NCT00575380|524019706|FG001|Overall Study|Withdrawal by Subject|0|||
145320489|NCT00575380|524019705|FG000|Overall Study|Adverse Event|0|||
145320490|NCT00575380|524019706|FG001|Overall Study|Adverse Event|1|||
145320491|NCT00575380|524019705|FG000|Overall Study|Various|0|||
145320492|NCT00575380|524019706|FG001|Overall Study|Various|2|||
145320493|NCT01235442|524019707|FG000|Overall Study|Lost to Follow-up|12|||
145320494|NCT01235442|524019708|FG001|Overall Study|Lost to Follow-up|10|||
145320495|NCT01235442|524019707|FG000|Overall Study|Death|0|||
145320496|NCT01235442|524019708|FG001|Overall Study|Death|2|||
145320497|NCT01235442|524019707|FG000|Overall Study|Pregnancy|1|||
145320498|NCT01235442|524019708|FG001|Overall Study|Pregnancy|1|||
145320499|NCT01235442|524019707|FG000|Overall Study|Ineligibility determined|5|||
145320500|NCT01235442|524019708|FG001|Overall Study|Ineligibility determined|4|||
145320501|NCT01235442|524019707|FG000|Overall Study|Protocol Violation|3|||
145320502|NCT01235442|524019708|FG001|Overall Study|Protocol Violation|3|||
145320503|NCT01235442|524019707|FG000|Overall Study|Adverse Event|4|||
145320504|NCT01235442|524019708|FG001|Overall Study|Adverse Event|6|||
145320505|NCT01235442|524019707|FG000|Overall Study|Withdrawal by Subject|15|||
145320506|NCT01235442|524019708|FG001|Overall Study|Withdrawal by Subject|9|||
145320507|NCT01235442|524019707|FG000|Overall Study|Lack of Efficacy|1|||
145320508|NCT01235442|524019708|FG001|Overall Study|Lack of Efficacy|3|||
145320509|NCT01235442|524019707|FG000|Overall Study|Noncompliance|1|||
145320510|NCT01235442|524019708|FG001|Overall Study|Noncompliance|2|||
145320511|NCT01235442|524019707|FG000|Overall Study|Administrative decision|1|||
145320512|NCT01235442|524019708|FG001|Overall Study|Administrative decision|2|||
145320513|NCT01235442|524019707|FG000|Overall Study|Other unspecified|1|||
145320514|NCT01235442|524019708|FG001|Overall Study|Other unspecified|2|||
145320515|NCT00084799|524019709|FG000|Overall Study|Disease Progression|1|||
145320516|NCT00084799|524019710|FG001|Overall Study|Disease Progression|0|||
145320517|NCT01857973|524019711|FG000|Overall Study|Subject did not meet required BG range|3|||
145320518|NCT01857973|524019711|FG000|Overall Study|drop out after 3 failed attempts|1|||
145320519|NCT01857973|524019711|FG000|Overall Study|Physician Decision|1|||
145320520|NCT01701973|524019712|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320521|NCT01701973|524019713|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
145320522|NCT01701973|524019714|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320523|NCT01701973|524019715|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320524|NCT01701973|524019716|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320525|NCT01701973|524019717|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320526|NCT01701973|524019718|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320527|NCT01701973|524019719|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
145320528|NCT02663882|524019722|FG000|Overall Study|Lost to Follow-up|4|||
145320529|NCT02663882|524019723|FG001|Overall Study|Lost to Follow-up|2|||
145320530|NCT00602537|524019728|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
145320531|NCT00602537|524019729|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
145320532|NCT00602537|524019728|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
145320533|NCT00602537|524019729|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
145320534|NCT00602537|524019728|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
145320535|NCT00602537|524019729|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
145320536|NCT00602537|524019728|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
145320537|NCT00602537|524019729|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
145320538|NCT00602537|524019728|FG000|Follow Up Study Comparison|Adverse Event|1|||
145320539|NCT00602537|524019729|FG001|Follow Up Study Comparison|Adverse Event|0|||
145320540|NCT00602537|524019728|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
145320541|NCT00602537|524019729|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
145320542|NCT00602537|524019728|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
145320543|NCT00602537|524019729|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
145320544|NCT00388037|524019730|FG000|Overall Study|Protocol Violation|1|||
145320545|NCT02412722|524019735|FG000|Overall Study|Adverse Event|0|||
145320546|NCT02412722|524019736|FG001|Overall Study|Adverse Event|2|||
145320547|NCT02412722|524019737|FG002|Overall Study|Adverse Event|0|||
145320548|NCT02412722|524019738|FG003|Overall Study|Adverse Event|3|||
145320549|NCT02412722|524019739|FG004|Overall Study|Adverse Event|0|||
145320550|NCT02412722|524019740|FG005|Overall Study|Adverse Event|3|||
145320551|NCT02412722|524019735|FG000|Overall Study|Progressive Disease|6|||
145320552|NCT02412722|524019736|FG001|Overall Study|Progressive Disease|4|||
145320553|NCT02412722|524019737|FG002|Overall Study|Progressive Disease|4|||
145320554|NCT02412722|524019738|FG003|Overall Study|Progressive Disease|9|||
145320555|NCT02412722|524019739|FG004|Overall Study|Progressive Disease|3|||
145320556|NCT02412722|524019740|FG005|Overall Study|Progressive Disease|3|||
145320557|NCT02412722|524019735|FG000|Overall Study|Withdrawal by Subject|2|||
145320558|NCT02412722|524019736|FG001|Overall Study|Withdrawal by Subject|0|||
145320559|NCT02412722|524019737|FG002|Overall Study|Withdrawal by Subject|1|||
145320560|NCT02412722|524019738|FG003|Overall Study|Withdrawal by Subject|2|||
145320561|NCT02412722|524019739|FG004|Overall Study|Withdrawal by Subject|1|||
145320562|NCT02412722|524019740|FG005|Overall Study|Withdrawal by Subject|1|||
145320563|NCT02412722|524019735|FG000|Overall Study|Lost to Follow-up|0|||
145320564|NCT02412722|524019736|FG001|Overall Study|Lost to Follow-up|0|||
145320565|NCT02412722|524019737|FG002|Overall Study|Lost to Follow-up|0|||
145320566|NCT02412722|524019738|FG003|Overall Study|Lost to Follow-up|0|||
145320567|NCT02412722|524019739|FG004|Overall Study|Lost to Follow-up|1|||
145320568|NCT02412722|524019740|FG005|Overall Study|Lost to Follow-up|0|||
145320569|NCT02412722|524019735|FG000|Overall Study|Received drug in run-in and discontinued|0|||
145320570|NCT02412722|524019736|FG001|Overall Study|Received drug in run-in and discontinued|2|||
145320571|NCT02412722|524019737|FG002|Overall Study|Received drug in run-in and discontinued|0|||
145320572|NCT02412722|524019738|FG003|Overall Study|Received drug in run-in and discontinued|0|||
145320573|NCT02412722|524019739|FG004|Overall Study|Received drug in run-in and discontinued|0|||
145320574|NCT02412722|524019740|FG005|Overall Study|Received drug in run-in and discontinued|0|||
145320575|NCT02412722|524019735|FG000|Overall Study|Reason not Specified|3|||
145320576|NCT02412722|524019736|FG001|Overall Study|Reason not Specified|0|||
145320577|NCT02412722|524019737|FG002|Overall Study|Reason not Specified|2|||
145320578|NCT02412722|524019738|FG003|Overall Study|Reason not Specified|1|||
145320579|NCT02412722|524019739|FG004|Overall Study|Reason not Specified|2|||
145320580|NCT02412722|524019740|FG005|Overall Study|Reason not Specified|6|||
145320581|NCT04449341|524019741|FG000|Overall Study|Protocol Violation|1|||
145320582|NCT04449341|524019742|FG001|Overall Study|Protocol Violation|0|||
145320583|NCT04330157|524019743|FG000|Overall Study|Protocol Violation|4|||
145320584|NCT04330157|524019743|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
145320585|NCT04499482|524019744|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
145320586|NCT04314843|524019745|FG000|Overall Study|Death|2|||
145320587|NCT04314843|524019746|FG001|Overall Study|Death|2|||
145320588|NCT04314843|524019745|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
145320589|NCT04314843|524019746|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
145320590|NCT00292227|524019749|FG000|Patch Period|Adverse Event|1|||
145320591|NCT00292227|524019750|FG001|Patch Period|Adverse Event|0|||
145320592|NCT00292227|524019751|FG002|Patch Period|Adverse Event|2|||
145320593|NCT00292227|524019749|FG000|Patch Period|Withdrawal by Subject|0|||
145320594|NCT00292227|524019750|FG001|Patch Period|Withdrawal by Subject|0|||
145320595|NCT00292227|524019751|FG002|Patch Period|Withdrawal by Subject|1|||
145320596|NCT01634854|524019756|FG000|Overall Study|Cesarean delivery|2|||
145320597|NCT01634854|524019757|FG001|Overall Study|Cesarean delivery|7|||
145320598|NCT03253094|524019758|FG000|Overall Study|Adverse Event|2|||
145320599|NCT03253094|524019759|FG001|Overall Study|Adverse Event|0|||
145320600|NCT03253094|524019760|FG002|Overall Study|Adverse Event|0|||
145320601|NCT03253094|524019761|FG003|Overall Study|Adverse Event|0|||
145320602|NCT03253094|524019762|FG004|Overall Study|Adverse Event|0|||
145320603|NCT03253094|524019763|FG005|Overall Study|Adverse Event|0|||
145320604|NCT03253094|524019758|FG000|Overall Study|Lack of Efficacy|0|||
145320605|NCT03253094|524019759|FG001|Overall Study|Lack of Efficacy|0|||
145320606|NCT03253094|524019760|FG002|Overall Study|Lack of Efficacy|2|||
145320607|NCT03253094|524019761|FG003|Overall Study|Lack of Efficacy|1|||
145320608|NCT03253094|524019762|FG004|Overall Study|Lack of Efficacy|2|||
145320609|NCT03253094|524019763|FG005|Overall Study|Lack of Efficacy|1|||
145320610|NCT03253094|524019758|FG000|Overall Study|Lost to Follow-up|0|||
145320611|NCT03253094|524019759|FG001|Overall Study|Lost to Follow-up|0|||
145320612|NCT03253094|524019760|FG002|Overall Study|Lost to Follow-up|1|||
145320613|NCT03253094|524019761|FG003|Overall Study|Lost to Follow-up|1|||
145320614|NCT03253094|524019762|FG004|Overall Study|Lost to Follow-up|0|||
145320615|NCT03253094|524019763|FG005|Overall Study|Lost to Follow-up|1|||
145320616|NCT03253094|524019758|FG000|Overall Study|Physician Decision|1|||
145570233|NCT04482179|524947318|FG001|Overall Study|Withdrawal by Subject|0|||
145570234|NCT01302964|524947319|FG000|Overall Study|Adverse Event|1|||
145570235|NCT01302964|524947320|FG001|Overall Study|Adverse Event|0|||
145570236|NCT05723770|524947321|FG000|Overall Study|Lost to Follow-up|4|||
145570237|NCT05723770|524947321|FG000|Overall Study|Withdrawal by Subject|2|||
145570238|NCT04127786|524947322|FG000|Primary Series|Adverse Event|1|||
145570239|NCT04127786|524947323|FG001|Primary Series|Adverse Event|0|||
145570240|NCT04127786|524947324|FG002|Primary Series|Adverse Event|0|||
145570241|NCT04127786|524947325|FG003|Primary Series|Adverse Event|1|||
145570242|NCT04127786|524947326|FG004|Primary Series|Adverse Event|0|||
145570243|NCT04127786|524947327|FG005|Primary Series|Adverse Event|1|||
145570244|NCT04127786|524947322|FG000|Primary Series|Protocol Violation|5|||
145570245|NCT04127786|524947323|FG001|Primary Series|Protocol Violation|3|||
145570246|NCT04127786|524947324|FG002|Primary Series|Protocol Violation|4|||
145570247|NCT04127786|524947325|FG003|Primary Series|Protocol Violation|3|||
145570248|NCT04127786|524947326|FG004|Primary Series|Protocol Violation|2|||
145570249|NCT04127786|524947327|FG005|Primary Series|Protocol Violation|0|||
145570250|NCT04127786|524947322|FG000|Primary Series|Withdrawal by Subject|0|||
145570251|NCT04127786|524947323|FG001|Primary Series|Withdrawal by Subject|0|||
145570252|NCT04127786|524947324|FG002|Primary Series|Withdrawal by Subject|0|||
145570253|NCT04127786|524947325|FG003|Primary Series|Withdrawal by Subject|1|||
145570254|NCT04127786|524947326|FG004|Primary Series|Withdrawal by Subject|0|||
145570255|NCT04127786|524947327|FG005|Primary Series|Withdrawal by Subject|0|||
145570256|NCT04127786|524947322|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
145570257|NCT04127786|524947323|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
145570258|NCT04127786|524947324|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
145570259|NCT04127786|524947325|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
145570260|NCT04127786|524947326|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
145570261|NCT04127786|524947327|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
145320617|NCT03253094|524019759|FG001|Overall Study|Physician Decision|0|||
145320618|NCT03253094|524019760|FG002|Overall Study|Physician Decision|0|||
145320619|NCT03253094|524019761|FG003|Overall Study|Physician Decision|1|||
145320620|NCT03253094|524019762|FG004|Overall Study|Physician Decision|0|||
145320621|NCT03253094|524019763|FG005|Overall Study|Physician Decision|2|||
145320622|NCT03253094|524019758|FG000|Overall Study|Withdrawal by Subject|1|||
145320623|NCT03253094|524019759|FG001|Overall Study|Withdrawal by Subject|2|||
145320624|NCT03253094|524019760|FG002|Overall Study|Withdrawal by Subject|1|||
145320625|NCT03253094|524019761|FG003|Overall Study|Withdrawal by Subject|0|||
145320626|NCT03253094|524019762|FG004|Overall Study|Withdrawal by Subject|3|||
145320627|NCT03253094|524019763|FG005|Overall Study|Withdrawal by Subject|0|||
145320628|NCT03253094|524019758|FG000|Overall Study|Other|0|||
145320629|NCT03253094|524019759|FG001|Overall Study|Other|1|||
145320630|NCT03253094|524019760|FG002|Overall Study|Other|2|||
145320631|NCT03253094|524019761|FG003|Overall Study|Other|1|||
145320632|NCT03253094|524019762|FG004|Overall Study|Other|0|||
145320633|NCT03253094|524019763|FG005|Overall Study|Other|0|||
145320634|NCT00480324|524021563|FG000|Overall Study|Adverse Event|1|||
145320635|NCT00480324|524021564|FG001|Overall Study|Adverse Event|1|||
145320636|NCT00480324|524021563|FG000|Overall Study|Protocol Violation|0|||
145320637|NCT00480324|524021564|FG001|Overall Study|Protocol Violation|1|||
145320638|NCT00480324|524021563|FG000|Overall Study|Withdrawal by Subject|14|||
145320639|NCT00480324|524021564|FG001|Overall Study|Withdrawal by Subject|5|||
145320640|NCT00480324|524021563|FG000|Overall Study|Lost to Follow-up|17|||
145320641|NCT00480324|524021564|FG001|Overall Study|Lost to Follow-up|8|||
145320642|NCT00480324|524021563|FG000|Overall Study|Subject's mother pregnant|0|||
145320643|NCT00480324|524021564|FG001|Overall Study|Subject's mother pregnant|1|||
145320644|NCT00784134|524021565|FG000|Overall Study|Lost to Follow-up|3|||
145320645|NCT00784134|524021566|FG001|Overall Study|Lost to Follow-up|6|||
145320646|NCT03785145|524021567|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
145320647|NCT03785145|524021568|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
145320648|NCT03785145|524021567|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
145320649|NCT03785145|524021568|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
145320650|NCT03785145|524021567|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
145320651|NCT03785145|524021568|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
145570262|NCT04127786|524947322|FG000|Booster Phase|Withdrawal by Subject|2|||
145570263|NCT04127786|524947323|FG001|Booster Phase|Withdrawal by Subject|0|||
145570264|NCT04127786|524947324|FG002|Booster Phase|Withdrawal by Subject|0|||
145570265|NCT04127786|524947325|FG003|Booster Phase|Withdrawal by Subject|0|||
145570266|NCT04127786|524947326|FG004|Booster Phase|Withdrawal by Subject|0|||
145570267|NCT04127786|524947327|FG005|Booster Phase|Withdrawal by Subject|0|||
145570268|NCT01982253|524947337|FG000|Overall Study|Withdrawal by Subject|1|||
145320652|NCT03785145|524021567|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
145320653|NCT03785145|524021568|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
145320654|NCT03785145|524021567|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
145320655|NCT03785145|524021568|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
145320656|NCT03785145|524021567|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
145320657|NCT03785145|524021568|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
145320658|NCT03785145|524021567|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
145320659|NCT03785145|524021568|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
145320660|NCT03785145|524021567|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
145320661|NCT03785145|524021568|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
145320662|NCT03785145|524021567|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
145320663|NCT03785145|524021568|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
145320664|NCT03785145|524021567|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
145320665|NCT03785145|524021568|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
145320666|NCT03785145|524021567|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
145320667|NCT03785145|524021568|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
145320668|NCT00097786|524021569|FG000|Overall Study|lost to follow-up for all-cause death|296|||
145320669|NCT00097786|524021570|FG001|Overall Study|lost to follow-up for all-cause death|292|||
145320670|NCT00097786|524021571|FG002|Overall Study|lost to follow-up for all-cause death|313|||
145320671|NCT00097786|524021572|FG003|Overall Study|lost to follow-up for all-cause death|310|||
145320672|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
145320673|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
145320674|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
145320675|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
145320676|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
145320677|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
145320678|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
145320679|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
145320680|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
145320681|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145320682|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145320683|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
145320684|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
145320685|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
145320686|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
145320687|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
145320688|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145320689|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145320690|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
145320691|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
145320692|NCT02960438|524021573|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
145320693|NCT02960438|524021574|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
145320694|NCT02960438|524021575|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
145320695|NCT02960438|524021576|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
145320696|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
145320697|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
145320698|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
145320699|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
145320700|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145320701|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145320702|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
145320703|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
145320704|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145320705|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145411721|NCT01482221|524360585|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
145570269|NCT01982253|524947338|FG001|Overall Study|Withdrawal by Subject|0|||
145570270|NCT01982253|524947339|FG002|Overall Study|Withdrawal by Subject|0|||
145570271|NCT01982253|524947337|FG000|Overall Study|Study terminated by sponsor|1|||
145570272|NCT01982253|524947338|FG001|Overall Study|Study terminated by sponsor|4|||
145570273|NCT01982253|524947339|FG002|Overall Study|Study terminated by sponsor|4|||
145570274|NCT03848845|524947340|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
145320706|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
145320707|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
145320708|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
145320709|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
145320710|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
145320711|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
145320712|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
145320713|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
145320714|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
145320715|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
145320716|NCT02960438|524021573|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
145320717|NCT02960438|524021574|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
145320718|NCT02960438|524021575|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
145320719|NCT02960438|524021576|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
145320720|NCT03686150|524021577|FG000|Overall Study|Withdrawal by Subject|1|||
145320721|NCT03686150|524021578|FG001|Overall Study|Withdrawal by Subject|1|||
145320722|NCT03686150|524021579|FG002|Overall Study|Withdrawal by Subject|1|||
145320723|NCT03686150|524021580|FG003|Overall Study|Withdrawal by Subject|0|||
145320724|NCT03686150|524021581|FG004|Overall Study|Withdrawal by Subject|1|||
145320725|NCT03686150|524021582|FG005|Overall Study|Withdrawal by Subject|2|||
145320726|NCT03686150|524021577|FG000|Overall Study|Physician Decision|1|||
145320727|NCT03686150|524021578|FG001|Overall Study|Physician Decision|0|||
145320728|NCT03686150|524021579|FG002|Overall Study|Physician Decision|0|||
145320729|NCT03686150|524021580|FG003|Overall Study|Physician Decision|0|||
145320730|NCT03686150|524021581|FG004|Overall Study|Physician Decision|0|||
145320731|NCT03686150|524021582|FG005|Overall Study|Physician Decision|1|||
145320732|NCT03686150|524021577|FG000|Overall Study|Lost to Follow-up|0|||
145320733|NCT03686150|524021578|FG001|Overall Study|Lost to Follow-up|1|||
145320734|NCT03686150|524021579|FG002|Overall Study|Lost to Follow-up|0|||
145320735|NCT03686150|524021580|FG003|Overall Study|Lost to Follow-up|0|||
145320736|NCT03686150|524021581|FG004|Overall Study|Lost to Follow-up|0|||
145320737|NCT03686150|524021582|FG005|Overall Study|Lost to Follow-up|0|||
145320738|NCT02443324|524021584|FG000|Overall Study|Death|4|||
145320739|NCT02443324|524021585|FG001|Overall Study|Death|1|||
145320740|NCT02443324|524021586|FG002|Overall Study|Death|0|||
145320741|NCT02443324|524021587|FG003|Overall Study|Death|3|||
145320742|NCT02443324|524021588|FG004|Overall Study|Death|1|||
145320743|NCT02443324|524021589|FG005|Overall Study|Death|3|||
145320744|NCT02443324|524021590|FG006|Overall Study|Death|2|||
145320745|NCT02443324|524021584|FG000|Overall Study|Lost to Follow-up|0|||
145320746|NCT02443324|524021585|FG001|Overall Study|Lost to Follow-up|0|||
145320747|NCT02443324|524021586|FG002|Overall Study|Lost to Follow-up|0|||
145320748|NCT02443324|524021587|FG003|Overall Study|Lost to Follow-up|1|||
145320749|NCT02443324|524021588|FG004|Overall Study|Lost to Follow-up|0|||
145320750|NCT02443324|524021589|FG005|Overall Study|Lost to Follow-up|1|||
145320751|NCT02443324|524021590|FG006|Overall Study|Lost to Follow-up|0|||
145320752|NCT02443324|524021584|FG000|Overall Study|Physician Decision|0|||
145320753|NCT02443324|524021585|FG001|Overall Study|Physician Decision|3|||
145320754|NCT02443324|524021586|FG002|Overall Study|Physician Decision|5|||
145320755|NCT02443324|524021587|FG003|Overall Study|Physician Decision|1|||
145320756|NCT02443324|524021588|FG004|Overall Study|Physician Decision|1|||
145320757|NCT02443324|524021589|FG005|Overall Study|Physician Decision|0|||
145320758|NCT02443324|524021590|FG006|Overall Study|Physician Decision|2|||
145320759|NCT02443324|524021584|FG000|Overall Study|Progressive Disease|20|||
145320760|NCT02443324|524021585|FG001|Overall Study|Progressive Disease|20|||
145320761|NCT02443324|524021586|FG002|Overall Study|Progressive Disease|13|||
145320762|NCT02443324|524021587|FG003|Overall Study|Progressive Disease|10|||
145320763|NCT02443324|524021588|FG004|Overall Study|Progressive Disease|13|||
145320764|NCT02443324|524021589|FG005|Overall Study|Progressive Disease|17|||
145320765|NCT02443324|524021590|FG006|Overall Study|Progressive Disease|10|||
145320766|NCT02443324|524021584|FG000|Overall Study|Withdrawal by Subject|0|||
145320767|NCT02443324|524021585|FG001|Overall Study|Withdrawal by Subject|0|||
145320768|NCT02443324|524021586|FG002|Overall Study|Withdrawal by Subject|3|||
145570275|NCT03848845|524947341|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
145570276|NCT03848845|524947342|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
145570277|NCT03848845|524947343|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
145570278|NCT03848845|524947340|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
145620565|NCT01923428|525125103|FG001|Overall Study|Lack of Efficacy|0|||
145320769|NCT02443324|524021587|FG003|Overall Study|Withdrawal by Subject|1|||
145320770|NCT02443324|524021588|FG004|Overall Study|Withdrawal by Subject|1|||
145320771|NCT02443324|524021589|FG005|Overall Study|Withdrawal by Subject|0|||
145320772|NCT02443324|524021590|FG006|Overall Study|Withdrawal by Subject|1|||
145320773|NCT02443324|524021584|FG000|Overall Study|Adverse Event|0|||
145320774|NCT02443324|524021585|FG001|Overall Study|Adverse Event|1|||
145320775|NCT02443324|524021586|FG002|Overall Study|Adverse Event|3|||
145320776|NCT02443324|524021587|FG003|Overall Study|Adverse Event|0|||
145320777|NCT02443324|524021588|FG004|Overall Study|Adverse Event|4|||
145320778|NCT02443324|524021589|FG005|Overall Study|Adverse Event|3|||
145320779|NCT02443324|524021590|FG006|Overall Study|Adverse Event|3|||
145320780|NCT02443324|524021584|FG000|Overall Study|Enrolled but Never Treated|0|||
145320781|NCT02443324|524021585|FG001|Overall Study|Enrolled but Never Treated|0|||
145320782|NCT02443324|524021586|FG002|Overall Study|Enrolled but Never Treated|1|||
145320783|NCT02443324|524021587|FG003|Overall Study|Enrolled but Never Treated|0|||
145320784|NCT02443324|524021588|FG004|Overall Study|Enrolled but Never Treated|1|||
145320785|NCT02443324|524021589|FG005|Overall Study|Enrolled but Never Treated|0|||
145320786|NCT02443324|524021590|FG006|Overall Study|Enrolled but Never Treated|1|||
145320787|NCT01647711|524021591|FG000|Overall Study|Progressive disease|6|||
145320788|NCT01647711|524021592|FG001|Overall Study|Progressive disease|2|||
145320789|NCT01647711|524021593|FG002|Overall Study|Progressive disease|6|||
145320790|NCT01647711|524021594|FG003|Overall Study|Progressive disease|8|||
145320791|NCT01647711|524021595|FG004|Overall Study|Progressive disease|2|||
145320792|NCT01647711|524021591|FG000|Overall Study|Other adverse event|0|||
145320793|NCT01647711|524021592|FG001|Overall Study|Other adverse event|0|||
145320794|NCT01647711|524021593|FG002|Overall Study|Other adverse event|2|||
145320795|NCT01647711|524021594|FG003|Overall Study|Other adverse event|0|||
145320796|NCT01647711|524021595|FG004|Overall Study|Other adverse event|2|||
145320797|NCT01647711|524021591|FG000|Overall Study|Protocol Violation|0|||
145320798|NCT01647711|524021592|FG001|Overall Study|Protocol Violation|0|||
145320799|NCT01647711|524021593|FG002|Overall Study|Protocol Violation|0|||
145320800|NCT01647711|524021594|FG003|Overall Study|Protocol Violation|0|||
145320801|NCT01647711|524021595|FG004|Overall Study|Protocol Violation|1|||
145320802|NCT01647711|524021591|FG000|Overall Study|Refused to continue taking medication|0|||
145320803|NCT01647711|524021592|FG001|Overall Study|Refused to continue taking medication|0|||
145320804|NCT01647711|524021593|FG002|Overall Study|Refused to continue taking medication|0|||
145320805|NCT01647711|524021594|FG003|Overall Study|Refused to continue taking medication|2|||
145320806|NCT01647711|524021595|FG004|Overall Study|Refused to continue taking medication|1|||
145320807|NCT01647711|524021591|FG000|Overall Study|Other reason not defined|0|||
145320808|NCT01647711|524021592|FG001|Overall Study|Other reason not defined|1|||
145320809|NCT01647711|524021593|FG002|Overall Study|Other reason not defined|1|||
145320810|NCT01647711|524021594|FG003|Overall Study|Other reason not defined|1|||
145320811|NCT01647711|524021595|FG004|Overall Study|Other reason not defined|0|||
145320812|NCT01844531|524021599|FG000|Overall Study|Withdrawal by Subject|0|||
145320813|NCT01844531|524021600|FG001|Overall Study|Withdrawal by Subject|1|||
145320814|NCT01844531|524021601|FG002|Overall Study|Withdrawal by Subject|0|||
145320815|NCT01844531|524021602|FG003|Overall Study|Withdrawal by Subject|0|||
145320816|NCT00418522|524021604|FG000|Overall Study|Adverse Event|7|||
145320817|NCT00418522|524021605|FG001|Overall Study|Adverse Event|1|||
145320818|NCT00418522|524021604|FG000|Overall Study|Lack of Efficacy|1|||
145320819|NCT00418522|524021605|FG001|Overall Study|Lack of Efficacy|3|||
145320820|NCT00418522|524021604|FG000|Overall Study|Lost to Follow-up|10|||
145320821|NCT00418522|524021605|FG001|Overall Study|Lost to Follow-up|4|||
145320822|NCT00418522|524021604|FG000|Overall Study|Withdrawal by Subject|31|||
145320823|NCT00418522|524021605|FG001|Overall Study|Withdrawal by Subject|7|||
145320824|NCT00418522|524021604|FG000|Overall Study|Other|27|||
145320825|NCT00418522|524021605|FG001|Overall Study|Other|23|||
145320826|NCT00418522|524021604|FG000|Overall Study|Randomized but did not receive treatment|7|||
145320827|NCT00418522|524021605|FG001|Overall Study|Randomized but did not receive treatment|4|||
145320828|NCT01652729|524021606|FG000|Overall Study|Withdrawal by Subject|14|||
145320829|NCT01652729|524021607|FG001|Overall Study|Withdrawal by Subject|7|||
145320830|NCT01652729|524021608|FG002|Overall Study|Withdrawal by Subject|7|||
145320831|NCT01652729|524021606|FG000|Overall Study|Adverse Event|4|||
145320832|NCT01652729|524021607|FG001|Overall Study|Adverse Event|0|||
145320833|NCT01652729|524021608|FG002|Overall Study|Adverse Event|3|||
145320834|NCT01652729|524021606|FG000|Overall Study|Physician Decision|1|||
145320835|NCT01652729|524021607|FG001|Overall Study|Physician Decision|0|||
145320836|NCT01652729|524021608|FG002|Overall Study|Physician Decision|1|||
145320837|NCT01652729|524021606|FG000|Overall Study|Protocol Violation|1|||
145320838|NCT01652729|524021607|FG001|Overall Study|Protocol Violation|0|||
145320839|NCT01652729|524021608|FG002|Overall Study|Protocol Violation|0|||
145320840|NCT01652729|524021606|FG000|Overall Study|Lost to Follow-up|6|||
145570279|NCT03848845|524947341|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
145570280|NCT03848845|524947342|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
145570281|NCT03848845|524947343|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
145570282|NCT03848845|524947340|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
145570283|NCT03848845|524947341|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
145570284|NCT03848845|524947342|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
145570285|NCT03848845|524947343|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
145570286|NCT03848845|524947340|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
145620566|NCT01923428|525125104|FG002|Overall Study|Lack of Efficacy|1|||
145320841|NCT01652729|524021607|FG001|Overall Study|Lost to Follow-up|6|||
145320842|NCT01652729|524021608|FG002|Overall Study|Lost to Follow-up|3|||
145320843|NCT01652729|524021606|FG000|Overall Study|Administrative|1|||
145570287|NCT03848845|524947341|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
145570288|NCT03848845|524947342|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
145570289|NCT03848845|524947343|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
145570290|NCT00348556|524947344|FG000|Overall Study|Adverse Event|1|||
145570291|NCT00192075|524947345|FG000|Overall Study|Disease Progression|23|||
145320844|NCT01652729|524021607|FG001|Overall Study|Administrative|0|||
145320845|NCT01652729|524021608|FG002|Overall Study|Administrative|0|||
145320846|NCT00483548|524021609|FG000|Overall Study|Randomized; not treated with study drug|1|||
145320847|NCT00483548|524021610|FG001|Overall Study|Randomized; not treated with study drug|3|||
145320848|NCT00483548|524021609|FG000|Overall Study|Adverse Event|25|||
145320849|NCT00483548|524021610|FG001|Overall Study|Adverse Event|14|||
145320850|NCT00483548|524021609|FG000|Overall Study|Laboratory abnormality|1|||
145320851|NCT00483548|524021610|FG001|Overall Study|Laboratory abnormality|2|||
145320852|NCT00483548|524021609|FG000|Overall Study|Lack of Efficacy|4|||
145320853|NCT00483548|524021610|FG001|Overall Study|Lack of Efficacy|8|||
145320854|NCT00483548|524021609|FG000|Overall Study|Protocol Violation|11|||
145320855|NCT00483548|524021610|FG001|Overall Study|Protocol Violation|7|||
145320856|NCT00483548|524021609|FG000|Overall Study|Pregnancy|1|||
145320857|NCT00483548|524021610|FG001|Overall Study|Pregnancy|0|||
145320858|NCT00483548|524021609|FG000|Overall Study|Protocol required discontinuation|6|||
145320859|NCT00483548|524021610|FG001|Overall Study|Protocol required discontinuation|6|||
145320860|NCT00483548|524021609|FG000|Overall Study|Unable to comply with protocol schedule|1|||
145320861|NCT00483548|524021610|FG001|Overall Study|Unable to comply with protocol schedule|0|||
145320862|NCT00483548|524021609|FG000|Overall Study|Non-compliance with medication|2|||
145320863|NCT00483548|524021610|FG001|Overall Study|Non-compliance with medication|0|||
145320864|NCT00483548|524021609|FG000|Overall Study|Lost to Follow-up|3|||
145320865|NCT00483548|524021610|FG001|Overall Study|Lost to Follow-up|4|||
145320866|NCT00483548|524021609|FG000|Overall Study|Withdrawal by Subject|5|||
145320867|NCT00483548|524021610|FG001|Overall Study|Withdrawal by Subject|2|||
145320868|NCT01280617|524021613|FG000|Overall Study|Adverse Event|0|||
145320869|NCT01280617|524021614|FG001|Overall Study|Adverse Event|1|||
145320870|NCT00089076|524021615|FG000|Overall Study|Alternate Therapy|1|||
145320871|NCT00089076|524021615|FG000|Overall Study|Withdrawal by Subject|2|||
145320872|NCT00089076|524021615|FG000|Overall Study|Progression|7|||
145320873|NCT01175473|524021616|FG000|Overall Study|Adverse Event|2|||
145320874|NCT01175473|524021617|FG001|Overall Study|Adverse Event|2|||
145320875|NCT00869440|524021624|FG000|Overall Study|Withdrawal by Subject|1|||
145320876|NCT00869440|524021625|FG001|Overall Study|Withdrawal by Subject|0|||
145320877|NCT00869440|524021626|FG002|Overall Study|Withdrawal by Subject|0|||
145320878|NCT00869440|524021627|FG003|Overall Study|Withdrawal by Subject|0|||
145320879|NCT00869440|524021624|FG000|Overall Study|Physician Decision|1|||
145320880|NCT00869440|524021625|FG001|Overall Study|Physician Decision|1|||
145320881|NCT00869440|524021626|FG002|Overall Study|Physician Decision|0|||
145320882|NCT00869440|524021627|FG003|Overall Study|Physician Decision|0|||
145320883|NCT01083680|524021629|FG000|Overall Study|Lost to Follow-up|2758|||
145320884|NCT01083680|524021629|FG000|Overall Study|Withdrawal by Subject|1086|||
145320885|NCT03546647|524021630|FG000|Overall Study|Adverse Event|1|||
145411722|NCT01482221|524360586|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
145411723|NCT01482221|524360584|FG000|Overall Study|Condition under Investigation Worsened|3|||
145411724|NCT01482221|524360585|FG001|Overall Study|Condition under Investigation Worsened|2|||
145411725|NCT01482221|524360586|FG002|Overall Study|Condition under Investigation Worsened|4|||
145411726|NCT01482221|524360584|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
145411727|NCT01482221|524360585|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
145411728|NCT01482221|524360586|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
145411729|NCT01482221|524360584|FG000|Overall Study|Adverse Event|1|||
145411730|NCT01482221|524360585|FG001|Overall Study|Adverse Event|7|||
145411731|NCT01482221|524360586|FG002|Overall Study|Adverse Event|3|||
145411732|NCT01482221|524360584|FG000|Overall Study|Withdrawal by Subject|10|||
145411733|NCT01482221|524360585|FG001|Overall Study|Withdrawal by Subject|7|||
145411734|NCT01482221|524360586|FG002|Overall Study|Withdrawal by Subject|12|||
145411735|NCT01482221|524360584|FG000|Overall Study|Incorrect randomization|0|||
145411736|NCT01482221|524360585|FG001|Overall Study|Incorrect randomization|1|||
145570292|NCT00192075|524947346|FG001|Overall Study|Disease Progression|6|||
145570293|NCT00192075|524947345|FG000|Overall Study|Adverse Event|1|||
145570294|NCT00192075|524947346|FG001|Overall Study|Adverse Event|3|||
145320886|NCT03546647|524021631|FG001|Overall Study|Adverse Event|0|||
145320887|NCT00124462|524021634|FG000|Overall Study|Lost to Follow-up|3|||
145320888|NCT00124462|524021635|FG001|Overall Study|Lost to Follow-up|3|||
145320889|NCT00124462|524021634|FG000|Overall Study|Physician Decision|3|||
145320890|NCT00124462|524021635|FG001|Overall Study|Physician Decision|4|||
145320891|NCT00124462|524021634|FG000|Overall Study|Withdrawal by Subject|4|||
145320892|NCT00124462|524021635|FG001|Overall Study|Withdrawal by Subject|5|||
145320893|NCT00124462|524021634|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
145411737|NCT01482221|524360586|FG002|Overall Study|Incorrect randomization|0|||
145411738|NCT01482221|524360584|FG000|Overall Study|Physician Decision|0|||
145320894|NCT00124462|524021635|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
145320895|NCT02400476|524021636|FG000|Overall Study|Adverse Event|57|||
145320896|NCT02400476|524021637|FG001|Overall Study|Adverse Event|10|||
145320897|NCT02400476|524021638|FG002|Overall Study|Adverse Event|22|||
145320898|NCT02400476|524021639|FG003|Overall Study|Adverse Event|19|||
145320899|NCT02400476|524021640|FG004|Overall Study|Adverse Event|5|||
145320900|NCT02400476|524021641|FG005|Overall Study|Adverse Event|8|||
145320901|NCT02400476|524021636|FG000|Overall Study|Withdrawal by Subject|4|||
145320902|NCT02400476|524021637|FG001|Overall Study|Withdrawal by Subject|1|||
145320903|NCT02400476|524021638|FG002|Overall Study|Withdrawal by Subject|12|||
145320904|NCT02400476|524021639|FG003|Overall Study|Withdrawal by Subject|7|||
145570295|NCT00192075|524947345|FG000|Overall Study|Death|0|||
145320905|NCT02400476|524021640|FG004|Overall Study|Withdrawal by Subject|5|||
145320906|NCT02400476|524021641|FG005|Overall Study|Withdrawal by Subject|5|||
145320907|NCT02400476|524021636|FG000|Overall Study|Lost to Follow-up|0|||
145320908|NCT02400476|524021637|FG001|Overall Study|Lost to Follow-up|0|||
145320909|NCT02400476|524021638|FG002|Overall Study|Lost to Follow-up|0|||
145320910|NCT02400476|524021639|FG003|Overall Study|Lost to Follow-up|1|||
145320911|NCT02400476|524021640|FG004|Overall Study|Lost to Follow-up|3|||
145320912|NCT02400476|524021641|FG005|Overall Study|Lost to Follow-up|1|||
145320913|NCT02400476|524021636|FG000|Overall Study|Physician Decision|0|||
145320914|NCT02400476|524021637|FG001|Overall Study|Physician Decision|0|||
145320915|NCT02400476|524021638|FG002|Overall Study|Physician Decision|1|||
145320916|NCT02400476|524021639|FG003|Overall Study|Physician Decision|1|||
145320917|NCT02400476|524021640|FG004|Overall Study|Physician Decision|0|||
145320918|NCT02400476|524021641|FG005|Overall Study|Physician Decision|1|||
145320919|NCT02400476|524021636|FG000|Overall Study|Other, Disease Progression|0|||
145320920|NCT02400476|524021637|FG001|Overall Study|Other, Disease Progression|1|||
145320921|NCT02400476|524021638|FG002|Overall Study|Other, Disease Progression|2|||
145320922|NCT02400476|524021639|FG003|Overall Study|Other, Disease Progression|1|||
145320923|NCT02400476|524021640|FG004|Overall Study|Other, Disease Progression|2|||
145320924|NCT02400476|524021641|FG005|Overall Study|Other, Disease Progression|1|||
145320925|NCT02400476|524021636|FG000|Overall Study|Other, Decreased Quality of Life|0|||
145320926|NCT02400476|524021637|FG001|Overall Study|Other, Decreased Quality of Life|0|||
145320927|NCT02400476|524021638|FG002|Overall Study|Other, Decreased Quality of Life|2|||
145320928|NCT02400476|524021639|FG003|Overall Study|Other, Decreased Quality of Life|0|||
145320929|NCT02400476|524021640|FG004|Overall Study|Other, Decreased Quality of Life|0|||
145320930|NCT02400476|524021641|FG005|Overall Study|Other, Decreased Quality of Life|0|||
145320931|NCT02400476|524021636|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145320932|NCT02400476|524021637|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145320933|NCT02400476|524021638|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
145320934|NCT02400476|524021639|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
145320935|NCT02400476|524021640|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145320936|NCT02400476|524021641|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
145320937|NCT02487082|524021642|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
145320938|NCT02487082|524021643|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
145320939|NCT02487082|524021642|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
145320940|NCT02487082|524021643|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
145320941|NCT00003531|524021644|FG000|Overall Study|Not evaluable|10|||
145320942|NCT00588731|524021645|FG000|Overall Study|Withdrawal by Subject|3|||
145320943|NCT00588731|524021646|FG001|Overall Study|Withdrawal by Subject|2|||
145320944|NCT00251316|524021647|FG000|Overall Study|Physician Decision|2|||
145320945|NCT00251316|524021648|FG001|Overall Study|Physician Decision|3|||
145320946|NCT00346164|524021649|FG000|Overall Study|Adverse Event|0|||
145570296|NCT00192075|524947346|FG001|Overall Study|Death|1|||
145570297|NCT00192075|524947345|FG000|Overall Study|Lack of Efficacy|0|||
145320947|NCT00346164|524021650|FG001|Overall Study|Adverse Event|0|||
145320948|NCT00346164|524021651|FG002|Overall Study|Adverse Event|0|||
145320949|NCT00346164|524021652|FG003|Overall Study|Adverse Event|1|||
145320950|NCT00346164|524021649|FG000|Overall Study|Lack of Efficacy|0|||
145320951|NCT00346164|524021650|FG001|Overall Study|Lack of Efficacy|1|||
145570298|NCT00192075|524947346|FG001|Overall Study|Lack of Efficacy|0|||
145570299|NCT00192075|524947345|FG000|Overall Study|Physician Decision|3|||
145570300|NCT00192075|524947346|FG001|Overall Study|Physician Decision|0|||
145320952|NCT00346164|524021651|FG002|Overall Study|Lack of Efficacy|7|||
145320953|NCT00346164|524021652|FG003|Overall Study|Lack of Efficacy|25|||
145320954|NCT00346164|524021649|FG000|Overall Study|Physician Decision|0|||
145320955|NCT00346164|524021650|FG001|Overall Study|Physician Decision|1|||
145570301|NCT00192075|524947345|FG000|Overall Study|Withdrawal by Subject|5|||
145570302|NCT00192075|524947346|FG001|Overall Study|Withdrawal by Subject|5|||
145320956|NCT00346164|524021651|FG002|Overall Study|Physician Decision|2|||
145320957|NCT00346164|524021652|FG003|Overall Study|Physician Decision|27|||
145320958|NCT00346164|524021649|FG000|Overall Study|Protocol Violation|6|||
145320959|NCT00346164|524021650|FG001|Overall Study|Protocol Violation|2|||
145320960|NCT00346164|524021651|FG002|Overall Study|Protocol Violation|10|||
145320961|NCT00346164|524021652|FG003|Overall Study|Protocol Violation|4|||
145570303|NCT00192075|524947345|FG000|Overall Study|Patient Non-Compliance|0|||
145570304|NCT00192075|524947346|FG001|Overall Study|Patient Non-Compliance|1|||
145570305|NCT00192075|524947345|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
145570306|NCT00192075|524947346|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
145570307|NCT00192075|524947345|FG000|Overall Study|Other|5|||
145570308|NCT00192075|524947346|FG001|Overall Study|Other|2|||
145570309|NCT02365636|524947347|FG000|Overall Study|Adverse Event|3|||
145570310|NCT02365636|524947348|FG001|Overall Study|Adverse Event|3|||
145570311|NCT02365636|524947349|FG002|Overall Study|Adverse Event|2|||
145570312|NCT02365636|524947347|FG000|Overall Study|Protocol Violation|1|||
145570313|NCT02365636|524947348|FG001|Overall Study|Protocol Violation|4|||
145570314|NCT02365636|524947349|FG002|Overall Study|Protocol Violation|0|||
145570315|NCT02365636|524947347|FG000|Overall Study|Lost to Follow-up|0|||
145570316|NCT02365636|524947348|FG001|Overall Study|Lost to Follow-up|0|||
145570317|NCT02365636|524947349|FG002|Overall Study|Lost to Follow-up|1|||
145570318|NCT02365636|524947347|FG000|Overall Study|Other|2|||
145570319|NCT02365636|524947348|FG001|Overall Study|Other|0|||
145570320|NCT02365636|524947349|FG002|Overall Study|Other|0|||
145570321|NCT00355238|524947350|FG000|Overall Study|Adverse event unrelated to study drug|2|||
145570322|NCT00355238|524947351|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145570323|NCT00355238|524947352|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145570324|NCT00355238|524947353|FG003|Overall Study|Adverse event unrelated to study drug|1|||
145570325|NCT00355238|524947350|FG000|Overall Study|Death|1|||
145570326|NCT00355238|524947351|FG001|Overall Study|Death|0|||
145570327|NCT00355238|524947352|FG002|Overall Study|Death|0|||
145570328|NCT00355238|524947353|FG003|Overall Study|Death|0|||
145570329|NCT00355238|524947350|FG000|Overall Study|Disease progression|37|||
145570330|NCT00355238|524947351|FG001|Overall Study|Disease progression|36|||
145320962|NCT00346164|524021649|FG000|Overall Study|Withdrawal by Subject|0|||
145320963|NCT00346164|524021650|FG001|Overall Study|Withdrawal by Subject|0|||
145320964|NCT00346164|524021651|FG002|Overall Study|Withdrawal by Subject|2|||
145320965|NCT00346164|524021652|FG003|Overall Study|Withdrawal by Subject|0|||
145320966|NCT00346164|524021649|FG000|Overall Study|Ineligible|11|||
145320967|NCT00346164|524021650|FG001|Overall Study|Ineligible|2|||
145320968|NCT00346164|524021651|FG002|Overall Study|Ineligible|2|||
145320969|NCT00346164|524021652|FG003|Overall Study|Ineligible|23|||
145320970|NCT00346164|524021649|FG000|Overall Study|Refusal of further protocol therapy|0|||
145320971|NCT00346164|524021650|FG001|Overall Study|Refusal of further protocol therapy|1|||
145320972|NCT00346164|524021651|FG002|Overall Study|Refusal of further protocol therapy|3|||
145320973|NCT00346164|524021652|FG003|Overall Study|Refusal of further protocol therapy|15|||
145320974|NCT00346164|524021649|FG000|Overall Study|Inability to start week 16 tx on time|0|||
145320975|NCT00346164|524021650|FG001|Overall Study|Inability to start week 16 tx on time|0|||
145320976|NCT00346164|524021651|FG002|Overall Study|Inability to start week 16 tx on time|0|||
145320977|NCT00346164|524021652|FG003|Overall Study|Inability to start week 16 tx on time|11|||
145320978|NCT03297294|524021653|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
145320979|NCT03297294|524021654|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
145320980|NCT03297294|524021655|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145320981|NCT03297294|524021656|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145320982|NCT03297294|524021657|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
145320983|NCT03297294|524021653|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
145320984|NCT03297294|524021654|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
145320985|NCT03297294|524021655|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145320986|NCT03297294|524021656|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145320987|NCT03297294|524021657|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
145320988|NCT03297294|524021653|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
145320989|NCT03297294|524021654|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
145320990|NCT03297294|524021655|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145320991|NCT03297294|524021656|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145320992|NCT03297294|524021657|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
145411739|NCT01482221|524360585|FG001|Overall Study|Physician Decision|1|||
145570331|NCT00355238|524947352|FG002|Overall Study|Disease progression|16|||
145320993|NCT03297294|524021653|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
145320994|NCT03297294|524021654|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
145320995|NCT03297294|524021655|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145320996|NCT03297294|524021656|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145570332|NCT00355238|524947353|FG003|Overall Study|Disease progression|11|||
145570333|NCT00355238|524947350|FG000|Overall Study|Study drug toxicity|11|||
145320997|NCT03297294|524021657|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
145320998|NCT03297294|524021653|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145411740|NCT01482221|524360586|FG002|Overall Study|Physician Decision|0|||
145570334|NCT00355238|524947351|FG001|Overall Study|Study drug toxicity|7|||
145570335|NCT00355238|524947352|FG002|Overall Study|Study drug toxicity|5|||
145570336|NCT00355238|524947353|FG003|Overall Study|Study drug toxicity|2|||
145570337|NCT00355238|524947350|FG000|Overall Study|Participant withdrew consent|3|||
145570338|NCT00355238|524947351|FG001|Overall Study|Participant withdrew consent|1|||
145320999|NCT03297294|524021654|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145321000|NCT03297294|524021655|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145321001|NCT03297294|524021656|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
145321002|NCT03297294|524021657|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
145321003|NCT01198873|524021658|FG000|Overall Study|Adverse Event|4|||
145321004|NCT01198873|524021659|FG001|Overall Study|Adverse Event|7|||
145321005|NCT01198873|524021658|FG000|Overall Study|Study closure|29|||
145321006|NCT01198873|524021659|FG001|Overall Study|Study closure|23|||
145321007|NCT01198873|524021658|FG000|Overall Study|Other than above|4|||
145321008|NCT01198873|524021659|FG001|Overall Study|Other than above|2|||
145321009|NCT03139240|524021660|FG000|Overall Study|Lost to Follow-up|0|||
145321010|NCT03139240|524021661|FG001|Overall Study|Lost to Follow-up|1|||
145321011|NCT03139240|524021662|FG002|Overall Study|Lost to Follow-up|1|||
145321012|NCT03139240|524021663|FG003|Overall Study|Lost to Follow-up|0|||
145321013|NCT04569786|524021664|FG000|Overall Study|Lost to Follow-up|1|||
145321014|NCT04569786|524021665|FG001|Overall Study|Lost to Follow-up|0|||
145321015|NCT04569786|524021666|FG002|Overall Study|Lost to Follow-up|4|||
145321016|NCT04569786|524021667|FG003|Overall Study|Lost to Follow-up|1|||
145321017|NCT04569786|524021668|FG004|Overall Study|Lost to Follow-up|0|||
145321018|NCT04569786|524021664|FG000|Overall Study|Withdrawal by Subject|0|||
145321019|NCT04569786|524021665|FG001|Overall Study|Withdrawal by Subject|0|||
145321020|NCT04569786|524021666|FG002|Overall Study|Withdrawal by Subject|0|||
145321021|NCT04569786|524021667|FG003|Overall Study|Withdrawal by Subject|5|||
145321022|NCT04569786|524021668|FG004|Overall Study|Withdrawal by Subject|1|||
145321023|NCT04569786|524021664|FG000|Overall Study|Physician Decision|0|||
145321024|NCT04569786|524021665|FG001|Overall Study|Physician Decision|0|||
145321025|NCT04569786|524021666|FG002|Overall Study|Physician Decision|0|||
145321026|NCT04569786|524021667|FG003|Overall Study|Physician Decision|1|||
145321027|NCT04569786|524021668|FG004|Overall Study|Physician Decision|0|||
145321028|NCT02692482|524021669|FG000|Overall Study|Death|2|||
145321029|NCT02692482|524021670|FG001|Overall Study|Death|2|||
145321030|NCT02692482|524021669|FG000|Overall Study|Withdrawal by Subject|1|||
145321031|NCT02692482|524021670|FG001|Overall Study|Withdrawal by Subject|2|||
145321032|NCT03942211|524021673|FG000|Overall Study|Death|1|||
145321033|NCT03942211|524021674|FG001|Overall Study|Death|0|||
145321034|NCT03942211|524021673|FG000|Overall Study|Study terminated by sponsor|5|||
145321035|NCT03942211|524021674|FG001|Overall Study|Study terminated by sponsor|3|||
145321036|NCT03942211|524021673|FG000|Overall Study|Adverse Event|0|||
145321037|NCT03942211|524021674|FG001|Overall Study|Adverse Event|1|||
145321038|NCT01955044|524021675|FG000|Overall Study|Death|1|||
145321039|NCT01955044|524021676|FG001|Overall Study|Death|1|||
145321040|NCT01955044|524021677|FG002|Overall Study|Death|0|||
145321041|NCT02260258|524021681|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
145321042|NCT02260258|524021682|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
145321043|NCT00690482|524021683|FG000|Overall Study|Adverse Event|2|||
145321044|NCT00690482|524021684|FG001|Overall Study|Adverse Event|1|||
145321045|NCT00690482|524021683|FG000|Overall Study|Incorrect enrolment|0|||
145321046|NCT00690482|524021684|FG001|Overall Study|Incorrect enrolment|1|||
145321047|NCT00690482|524021683|FG000|Overall Study|Study-specific discontinuation criteria|1|||
145321048|NCT00690482|524021684|FG001|Overall Study|Study-specific discontinuation criteria|0|||
145321049|NCT00690482|524021683|FG000|Overall Study|Intake of prohibited medicine|1|||
145321050|NCT00690482|524021684|FG001|Overall Study|Intake of prohibited medicine|0|||
145321051|NCT00690482|524021683|FG000|Overall Study|withdrew consent at rand.day|0|||
145321052|NCT00690482|524021684|FG001|Overall Study|withdrew consent at rand.day|1|||
145321053|NCT00724373|524021685|FG000|Overall Study|Adverse Event|41|||
145321054|NCT00724373|524021685|FG000|Overall Study|Lack of Efficacy|82|||
145321055|NCT00724373|524021685|FG000|Overall Study|Lost to Follow-up|7|||
145321056|NCT00724373|524021685|FG000|Overall Study|Non-compliance|2|||
145321057|NCT00724373|524021685|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
145321058|NCT00724373|524021685|FG000|Overall Study|Participant moved away|1|||
145321059|NCT00724373|524021685|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
145321060|NCT00724373|524021685|FG000|Overall Study|Only to have 24 week regimen|1|||
145321061|NCT00724373|524021685|FG000|Overall Study|Viral Relapse|1|||
145620567|NCT01923428|525125105|FG003|Overall Study|Lack of Efficacy|1|||
145620568|NCT02550873|525125106|FG000|Randomized Double Blind|Adverse Event|3|||
145321062|NCT00724373|524021685|FG000|Overall Study|Acute HCV infection|1|||
145620569|NCT02550873|525125107|FG001|Randomized Double Blind|Adverse Event|1|||
145321063|NCT00724373|524021685|FG000|Overall Study|Drug Relapse|1|||
145321064|NCT00724373|524021685|FG000|Overall Study|Tolerability|23|||
145321065|NCT01506908|524021686|FG000|Overall Study|Adverse Event|1|||
145321066|NCT01506908|524021687|FG001|Overall Study|Adverse Event|0|||
145620570|NCT02550873|525125108|FG002|Randomized Double Blind|Adverse Event|0|||
145321067|NCT00925301|524021698|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
145620571|NCT02550873|525125106|FG000|Randomized Double Blind|Disease progression|1|||
145321068|NCT00925301|524021699|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
145321069|NCT00925301|524021700|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
145321070|NCT00925301|524021701|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
145321071|NCT00925301|524021698|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145321072|NCT00925301|524021699|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
145321073|NCT00925301|524021700|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145321074|NCT00925301|524021701|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
145321075|NCT00925301|524021698|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145321076|NCT00925301|524021699|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145321077|NCT00925301|524021700|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
145321078|NCT00925301|524021701|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
145321079|NCT00925301|524021698|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
145321080|NCT00925301|524021699|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
145321081|NCT00925301|524021700|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
145321082|NCT00925301|524021701|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
145321083|NCT00925301|524021698|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
145321084|NCT00925301|524021699|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
145321085|NCT00925301|524021700|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
145321086|NCT00925301|524021701|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
145321087|NCT00925301|524021698|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
145321088|NCT00925301|524021699|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
145321089|NCT00925301|524021700|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
145321090|NCT00925301|524021701|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
145321091|NCT00925301|524021698|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145321092|NCT00925301|524021699|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145321093|NCT00925301|524021700|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
145321094|NCT00925301|524021701|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
145321095|NCT03043560|524021702|FG000|Overall Study|Discontinued Intervention|1|||
145321096|NCT03043560|524021703|FG001|Overall Study|Discontinued Intervention|2|||
145321097|NCT03043560|524021702|FG000|Overall Study|Lost to Follow-up|0|||
145321098|NCT03043560|524021703|FG001|Overall Study|Lost to Follow-up|1|||
145321099|NCT01117766|524021704|FG000|First Intervention|Adverse Event|0|||
145321100|NCT01117766|524021705|FG001|First Intervention|Adverse Event|1|||
145321101|NCT01117766|524021704|FG000|First Intervention|Protocol Violation|1|||
145321102|NCT01117766|524021705|FG001|First Intervention|Protocol Violation|0|||
145321103|NCT01117766|524021704|FG000|Washout Period|Protocol Violation|0|||
145321104|NCT01117766|524021705|FG001|Washout Period|Protocol Violation|2|||
145321105|NCT01117766|524021704|FG000|Second Intervention|Lost to Follow-up|1|||
145321106|NCT01117766|524021705|FG001|Second Intervention|Lost to Follow-up|0|||
145321107|NCT01117766|524021704|FG000|Second Intervention|Other|1|||
145321108|NCT01117766|524021705|FG001|Second Intervention|Other|2|||
145321109|NCT01117766|524021704|FG000|Second Intervention|Adverse Event|0|||
145321110|NCT01117766|524021705|FG001|Second Intervention|Adverse Event|2|||
145321111|NCT01117766|524021704|FG000|Second Intervention|Withdrawal by Subject|0|||
145321112|NCT01117766|524021705|FG001|Second Intervention|Withdrawal by Subject|1|||
145321113|NCT04405739|524021706|FG000|Overall Study|Adverse Event|0|||
145321114|NCT04405739|524021707|FG001|Overall Study|Adverse Event|1|||
145321115|NCT04405739|524021708|FG002|Overall Study|Adverse Event|0|||
145321116|NCT04405739|524021709|FG003|Overall Study|Adverse Event|0|||
145321117|NCT04405739|524021706|FG000|Overall Study|Lost to Follow-up|0|||
145321118|NCT04405739|524021707|FG001|Overall Study|Lost to Follow-up|2|||
145321119|NCT04405739|524021708|FG002|Overall Study|Lost to Follow-up|1|||
145321120|NCT04405739|524021709|FG003|Overall Study|Lost to Follow-up|3|||
145321121|NCT04405739|524021706|FG000|Overall Study|Withdrawal by Subject|0|||
145321122|NCT04405739|524021707|FG001|Overall Study|Withdrawal by Subject|2|||
145321123|NCT04405739|524021708|FG002|Overall Study|Withdrawal by Subject|1|||
145321124|NCT04405739|524021709|FG003|Overall Study|Withdrawal by Subject|1|||
145321125|NCT04405739|524021706|FG000|Overall Study|Death|0|||
145321126|NCT04405739|524021707|FG001|Overall Study|Death|0|||
145321127|NCT04405739|524021708|FG002|Overall Study|Death|1|||
145321128|NCT04405739|524021709|FG003|Overall Study|Death|0|||
145321129|NCT04405739|524021706|FG000|Overall Study|Transferred to rehab|0|||
145321130|NCT04405739|524021707|FG001|Overall Study|Transferred to rehab|0|||
145321131|NCT04405739|524021708|FG002|Overall Study|Transferred to rehab|0|||
145321132|NCT04405739|524021709|FG003|Overall Study|Transferred to rehab|1|||
145321133|NCT04405739|524021706|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
145321134|NCT04405739|524021707|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
145321135|NCT04405739|524021708|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
145321136|NCT04405739|524021709|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
145321137|NCT01436643|524021710|FG000|2-week Pre-treatment|Abnormal test result|0|||
145321138|NCT01436643|524021711|FG001|2-week Pre-treatment|Abnormal test result|0|||
145321139|NCT01436643|524021712|FG002|2-week Pre-treatment|Abnormal test result|0|||
145321140|NCT01436643|524021713|FG003|2-week Pre-treatment|Abnormal test result|1|||
145321141|NCT01436643|524021710|FG000|2-week Pre-treatment|Adverse Event|0|||
145321142|NCT01436643|524021711|FG001|2-week Pre-treatment|Adverse Event|0|||
145321143|NCT01436643|524021712|FG002|2-week Pre-treatment|Adverse Event|0|||
145321144|NCT01436643|524021713|FG003|2-week Pre-treatment|Adverse Event|5|||
145321145|NCT01436643|524021710|FG000|2-week Pre-treatment|Protocol Violation|0|||
145321146|NCT01436643|524021711|FG001|2-week Pre-treatment|Protocol Violation|0|||
145321147|NCT01436643|524021712|FG002|2-week Pre-treatment|Protocol Violation|0|||
145321148|NCT01436643|524021713|FG003|2-week Pre-treatment|Protocol Violation|4|||
145321149|NCT01436643|524021710|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
145321150|NCT01436643|524021711|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
145321151|NCT01436643|524021712|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
145321152|NCT01436643|524021713|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
145321153|NCT01436643|524021710|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
145321154|NCT01436643|524021711|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
145321155|NCT01436643|524021712|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
145321156|NCT01436643|524021713|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
145321157|NCT01436643|524021710|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
145321158|NCT01436643|524021711|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
145321159|NCT01436643|524021712|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
145321160|NCT01436643|524021713|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
145321161|NCT05766787|524021714|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
145321162|NCT05766787|524021715|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
145321163|NCT05766787|524021714|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
145321164|NCT05766787|524021715|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
145321165|NCT05766787|524021714|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
145321166|NCT05766787|524021715|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
145321167|NCT00438659|524021716|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
145321168|NCT00438659|524021717|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
145321169|NCT00438659|524021716|FG000|Overall Study|Cancel|5|||
145321170|NCT00438659|524021717|FG001|Overall Study|Cancel|2|||
145321171|NCT02056652|524021718|FG000|Overall Study|Withdrawal by Subject|1|||
145321172|NCT02056652|524021719|FG001|Overall Study|Withdrawal by Subject|0|||
145321173|NCT02056652|524021718|FG000|Overall Study|Lost to Follow-up|0|||
145321174|NCT02056652|524021719|FG001|Overall Study|Lost to Follow-up|3|||
145321175|NCT01917968|524021720|FG000|Overall Study|Death|3|||
145321176|NCT01917968|524021721|FG001|Overall Study|Death|2|||
145321177|NCT01917968|524021720|FG000|Overall Study|Lost to Follow-up|21|||
145321178|NCT01917968|524021721|FG001|Overall Study|Lost to Follow-up|39|||
145321179|NCT01917968|524021720|FG000|Overall Study|Physician Decision|1|||
145321180|NCT01917968|524021721|FG001|Overall Study|Physician Decision|2|||
145321181|NCT01917968|524021720|FG000|Overall Study|Withdrawal by Subject|20|||
145321182|NCT01917968|524021721|FG001|Overall Study|Withdrawal by Subject|35|||
145321183|NCT01917968|524021720|FG000|Overall Study|Subject Relocation|5|||
145321184|NCT01917968|524021721|FG001|Overall Study|Subject Relocation|1|||
145321185|NCT01917968|524021720|FG000|Overall Study|36M Missed Visit|3|||
145321186|NCT01917968|524021721|FG001|Overall Study|36M Missed Visit|2|||
145321187|NCT01917968|524021720|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
145321188|NCT01917968|524021721|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
145321189|NCT01917968|524021720|FG000|Overall Study|Change in Family Circumstances|0|||
145321190|NCT01917968|524021721|FG001|Overall Study|Change in Family Circumstances|1|||
145321191|NCT01917968|524021720|FG000|Overall Study|No Data Available|0|||
145321192|NCT01917968|524021721|FG001|Overall Study|No Data Available|2|||
145321193|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
145321194|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
145321195|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
145321196|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
145321197|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
145321198|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
145321199|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
145321200|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
145321201|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
145570339|NCT00355238|524947352|FG002|Overall Study|Participant withdrew consent|0|||
145570340|NCT00355238|524947353|FG003|Overall Study|Participant withdrew consent|0|||
145570341|NCT00355238|524947350|FG000|Overall Study|Participant request to discontinue study treatment|1|||
145321202|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
145321203|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
145570342|NCT00355238|524947351|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145570343|NCT00355238|524947352|FG002|Overall Study|Participant request to discontinue study treatment|1|||
145570344|NCT00355238|524947353|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145321204|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
145321205|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
145321206|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
145321207|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
145321208|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
145321209|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
145321210|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
145321211|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
145321212|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
145321213|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
145321214|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
145321215|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
145321216|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
145321217|NCT01435928|524021722|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
145321218|NCT01435928|524021723|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
145321219|NCT01435928|524021724|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
145321220|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
145321221|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
145321222|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
145321223|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
145321224|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
145321225|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
145321226|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
145321227|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
145321228|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
145321229|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
145321230|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
145321231|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
145321232|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
145321233|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
145321234|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
145321235|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
145321236|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
145321237|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
145321238|NCT01435928|524021722|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
145321239|NCT01435928|524021723|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
145321240|NCT01435928|524021724|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
145321241|NCT03234608|524021726|FG000|Overall Study|Lost to Follow-up|23|||
145321242|NCT03234608|524021727|FG001|Overall Study|Lost to Follow-up|21|||
145321243|NCT02105701|524021728|FG000|Overall Study|Lost to Follow-up|1|||
145321244|NCT02105701|524021729|FG001|Overall Study|Lost to Follow-up|0|||
145321245|NCT02105701|524021730|FG002|Overall Study|Lost to Follow-up|2|||
145321246|NCT02105701|524021731|FG003|Overall Study|Lost to Follow-up|1|||
145321247|NCT02105701|524021728|FG000|Overall Study|Protocol Violation|0|||
145321248|NCT02105701|524021729|FG001|Overall Study|Protocol Violation|0|||
145321249|NCT02105701|524021730|FG002|Overall Study|Protocol Violation|1|||
145321250|NCT02105701|524021731|FG003|Overall Study|Protocol Violation|0|||
145321251|NCT02105701|524021728|FG000|Overall Study|Withdrawal by Subject|2|||
145321252|NCT02105701|524021729|FG001|Overall Study|Withdrawal by Subject|1|||
145321253|NCT02105701|524021730|FG002|Overall Study|Withdrawal by Subject|0|||
145321254|NCT02105701|524021731|FG003|Overall Study|Withdrawal by Subject|1|||
145321255|NCT02105701|524021728|FG000|Overall Study|Death|1|||
145321256|NCT02105701|524021729|FG001|Overall Study|Death|0|||
145321257|NCT02105701|524021730|FG002|Overall Study|Death|0|||
145321258|NCT02105701|524021731|FG003|Overall Study|Death|0|||
145321259|NCT01362296|524021732|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
145321260|NCT01362296|524021733|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
145321261|NCT01362296|524021734|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
145321262|NCT01362296|524021735|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
145321263|NCT01362296|524021732|FG000|Randomized Phase (RP)|Physician Decision|1|||
145321264|NCT01362296|524021733|FG001|Randomized Phase (RP)|Physician Decision|9|||
145321265|NCT01362296|524021734|FG002|Randomized Phase (RP)|Physician Decision|0|||
145321266|NCT01362296|524021735|FG003|Randomized Phase (RP)|Physician Decision|0|||
145321267|NCT01362296|524021732|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
145321268|NCT01362296|524021733|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
145321269|NCT01362296|524021734|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
145321270|NCT01362296|524021735|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
145321271|NCT01362296|524021732|FG000|Randomized Phase (RP)|Adverse Event|20|||
145321272|NCT01362296|524021733|FG001|Randomized Phase (RP)|Adverse Event|4|||
145321273|NCT01362296|524021734|FG002|Randomized Phase (RP)|Adverse Event|0|||
145321274|NCT01362296|524021735|FG003|Randomized Phase (RP)|Adverse Event|0|||
145321275|NCT01362296|524021732|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
145321276|NCT01362296|524021733|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
145321277|NCT01362296|524021734|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
145321278|NCT01362296|524021735|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
145321279|NCT01362296|524021732|FG000|Crossover Phase|PD including Death due to PD|0|||
145321280|NCT01362296|524021733|FG001|Crossover Phase|PD including Death due to PD|0|||
145321281|NCT01362296|524021734|FG002|Crossover Phase|PD including Death due to PD|16|||
145321282|NCT01362296|524021735|FG003|Crossover Phase|PD including Death due to PD|1|||
145321283|NCT01362296|524021732|FG000|Crossover Phase|Withdrawal by Subject|0|||
145321284|NCT01362296|524021733|FG001|Crossover Phase|Withdrawal by Subject|0|||
145321285|NCT01362296|524021734|FG002|Crossover Phase|Withdrawal by Subject|2|||
145321286|NCT01362296|524021735|FG003|Crossover Phase|Withdrawal by Subject|1|||
145321287|NCT01362296|524021732|FG000|Crossover Phase|Adverse Event|0|||
145321288|NCT01362296|524021733|FG001|Crossover Phase|Adverse Event|0|||
145321289|NCT01362296|524021734|FG002|Crossover Phase|Adverse Event|4|||
145321290|NCT01362296|524021735|FG003|Crossover Phase|Adverse Event|0|||
145321291|NCT01362296|524021732|FG000|Crossover Phase|Study Closed/Terminated|0|||
145321292|NCT01362296|524021733|FG001|Crossover Phase|Study Closed/Terminated|0|||
145321293|NCT01362296|524021734|FG002|Crossover Phase|Study Closed/Terminated|1|||
145321294|NCT01362296|524021735|FG003|Crossover Phase|Study Closed/Terminated|0|||
145321295|NCT03693950|524021736|FG000|Overall Study|Withdrawal by Subject|1|||
145321296|NCT03693950|524021737|FG001|Overall Study|Withdrawal by Subject|0|||
145321297|NCT00576303|524021738|FG000|Dose Titration Period|Early withdrawal|17|||
145321298|NCT00576303|524021738|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
145321299|NCT00576303|524021738|FG000|Long Term Safety Period|Early withdrawal|16|||
145321300|NCT00824369|524021739|FG000|Overall Study|Nolonger willing to participate in study|1|||
145321301|NCT00824369|524021740|FG001|Overall Study|Nolonger willing to participate in study|0|||
145321302|NCT00824369|524021741|FG002|Overall Study|Nolonger willing to participate in study|1|||
145321303|NCT00824369|524021742|FG003|Overall Study|Nolonger willing to participate in study|2|||
145321304|NCT00824369|524021743|FG004|Overall Study|Nolonger willing to participate in study|0|||
145321305|NCT00824369|524021744|FG005|Overall Study|Nolonger willing to participate in study|1|||
145321306|NCT00824369|524021739|FG000|Overall Study|Lost to Follow-up|0|||
145321307|NCT00824369|524021740|FG001|Overall Study|Lost to Follow-up|0|||
145321308|NCT00824369|524021741|FG002|Overall Study|Lost to Follow-up|0|||
145321309|NCT00824369|524021742|FG003|Overall Study|Lost to Follow-up|0|||
145321310|NCT00824369|524021743|FG004|Overall Study|Lost to Follow-up|1|||
145321311|NCT00824369|524021744|FG005|Overall Study|Lost to Follow-up|0|||
145321312|NCT00442546|524021745|FG000|Overall Study|Adverse Event|11|||
145321313|NCT00442546|524021746|FG001|Overall Study|Adverse Event|17|||
145321314|NCT00442546|524021747|FG002|Overall Study|Adverse Event|13|||
145321315|NCT00442546|524021745|FG000|Overall Study|Lost to Follow-up|1|||
145321316|NCT00442546|524021746|FG001|Overall Study|Lost to Follow-up|2|||
145321317|NCT00442546|524021747|FG002|Overall Study|Lost to Follow-up|1|||
145321318|NCT00442546|524021745|FG000|Overall Study|Other|4|||
145321319|NCT00442546|524021746|FG001|Overall Study|Other|9|||
145321320|NCT00442546|524021747|FG002|Overall Study|Other|6|||
145321321|NCT00442546|524021745|FG000|Overall Study|Withdrawal by Subject|5|||
145321322|NCT00442546|524021746|FG001|Overall Study|Withdrawal by Subject|5|||
145321323|NCT00442546|524021747|FG002|Overall Study|Withdrawal by Subject|7|||
145321324|NCT00442546|524021745|FG000|Overall Study|Randomized But Not Treated|5|||
145321325|NCT00442546|524021746|FG001|Overall Study|Randomized But Not Treated|4|||
145321326|NCT00442546|524021747|FG002|Overall Study|Randomized But Not Treated|6|||
145321327|NCT00248170|524021748|FG000|Overall Study|Withdrawal by Subject|71|||
145321328|NCT00248170|524021749|FG001|Overall Study|Withdrawal by Subject|79|||
145321329|NCT00248170|524021748|FG000|Overall Study|Protocol Violation|35|||
145321330|NCT00248170|524021749|FG001|Overall Study|Protocol Violation|30|||
145321331|NCT00248170|524021748|FG000|Overall Study|Lost to Follow-up|28|||
145321332|NCT00248170|524021749|FG001|Overall Study|Lost to Follow-up|35|||
145321333|NCT00248170|524021748|FG000|Overall Study|Disease progression|196|||
145321334|NCT00248170|524021749|FG001|Overall Study|Disease progression|216|||
145321335|NCT00248170|524021748|FG000|Overall Study|Death|28|||
145321336|NCT00248170|524021749|FG001|Overall Study|Death|47|||
145321337|NCT00248170|524021748|FG000|Overall Study|Adverse Event|311|||
145321338|NCT00248170|524021749|FG001|Overall Study|Adverse Event|296|||
145321339|NCT00248170|524021748|FG000|Overall Study|Administrative problems|22|||
145321340|NCT00248170|524021749|FG001|Overall Study|Administrative problems|25|||
145321341|NCT00248170|524021748|FG000|Overall Study|Abnormal test procedure(s) result|49|||
145321342|NCT00248170|524021749|FG001|Overall Study|Abnormal test procedure(s) result|61|||
145321343|NCT00248170|524021748|FG000|Overall Study|Abnormal laboratory values|4|||
145321344|NCT00248170|524021749|FG001|Overall Study|Abnormal laboratory values|0|||
145321345|NCT00248170|524021748|FG000|Overall Study|Protocol deviation|17|||
145411741|NCT03086343|524360587|FG000|Period 1|Adverse Event|7|||
145321346|NCT00248170|524021749|FG001|Overall Study|Protocol deviation|19|||
145321347|NCT03123783|524021752|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145321348|NCT03123783|524021753|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
145321349|NCT03123783|524021754|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145321350|NCT03123783|524021755|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145321351|NCT03123783|524021756|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145570345|NCT01454934|524947354|FG000|Overall Study|Clinical progression|28|||
145411742|NCT03086343|524360588|FG001|Period 1|Adverse Event|7|||
145570346|NCT01454934|524947355|FG001|Overall Study|Clinical progression|25|||
145321352|NCT03123783|524021757|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145321353|NCT03123783|524021758|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
145321354|NCT03123783|524021752|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
145321355|NCT03123783|524021753|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
145321356|NCT03123783|524021754|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
145321357|NCT03123783|524021755|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
145321358|NCT03123783|524021756|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
145321359|NCT03123783|524021757|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
145321360|NCT03123783|524021758|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
145321361|NCT03123783|524021752|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
145321362|NCT03123783|524021753|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
145321363|NCT03123783|524021754|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
145321364|NCT03123783|524021755|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
145321365|NCT03123783|524021756|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
145321366|NCT03123783|524021757|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
145321367|NCT03123783|524021758|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
145321368|NCT03123783|524021752|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321369|NCT03123783|524021753|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321370|NCT03123783|524021754|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321371|NCT03123783|524021755|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321372|NCT03123783|524021756|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
145321373|NCT03123783|524021757|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321374|NCT03123783|524021758|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
145321375|NCT02070757|524023595|FG000|Overall Study|Adverse Event|107|||
145321376|NCT02070757|524023596|FG001|Overall Study|Adverse Event|99|||
145321377|NCT02070757|524023595|FG000|Overall Study|Lost to Follow-up|7|||
145321378|NCT02070757|524023596|FG001|Overall Study|Lost to Follow-up|4|||
145321379|NCT02070757|524023595|FG000|Overall Study|Protocol Violation|0|||
145321380|NCT02070757|524023596|FG001|Overall Study|Protocol Violation|4|||
145321381|NCT02070757|524023595|FG000|Overall Study|Withdrawal by Subject|1|||
145321382|NCT02070757|524023596|FG001|Overall Study|Withdrawal by Subject|3|||
145321383|NCT02070757|524023595|FG000|Overall Study|Investigator Decision|0|||
145321384|NCT02070757|524023596|FG001|Overall Study|Investigator Decision|2|||
145321385|NCT02070757|524023595|FG000|Overall Study|Discharged from Study Hospital|2|||
145321386|NCT02070757|524023596|FG001|Overall Study|Discharged from Study Hospital|2|||
145321387|NCT00572039|524023597|FG000|Overall Study|Withdrawal by Subject|9|||
145321388|NCT00572039|524023598|FG001|Overall Study|Withdrawal by Subject|6|||
145321389|NCT00572039|524023597|FG000|Overall Study|Death|2|||
145321390|NCT00572039|524023598|FG001|Overall Study|Death|3|||
145321391|NCT00572039|524023597|FG000|Overall Study|Ill|5|||
145321392|NCT00572039|524023598|FG001|Overall Study|Ill|1|||
145321393|NCT03756883|524023599|FG000|Overall Study|Adverse Event|2|||
145321394|NCT03756883|524023600|FG001|Overall Study|Adverse Event|2|||
145321395|NCT03756883|524023601|FG002|Overall Study|Adverse Event|2|||
145321396|NCT03756883|524023599|FG000|Overall Study|Lack of Efficacy|0|||
145321397|NCT03756883|524023600|FG001|Overall Study|Lack of Efficacy|1|||
145321398|NCT03756883|524023601|FG002|Overall Study|Lack of Efficacy|2|||
145321399|NCT03756883|524023599|FG000|Overall Study|Lost to Follow-up|3|||
145321400|NCT03756883|524023600|FG001|Overall Study|Lost to Follow-up|3|||
145321401|NCT03756883|524023601|FG002|Overall Study|Lost to Follow-up|0|||
145321402|NCT03756883|524023599|FG000|Overall Study|Protocol Violation|2|||
145321403|NCT03756883|524023600|FG001|Overall Study|Protocol Violation|0|||
145321404|NCT03756883|524023601|FG002|Overall Study|Protocol Violation|1|||
145321405|NCT03756883|524023599|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
145321406|NCT03756883|524023600|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
145321407|NCT03756883|524023601|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
145321408|NCT03756883|524023599|FG000|Overall Study|Withdrawal by Subject|4|||
145321409|NCT03756883|524023600|FG001|Overall Study|Withdrawal by Subject|1|||
145321410|NCT03756883|524023601|FG002|Overall Study|Withdrawal by Subject|0|||
145321411|NCT03756883|524023599|FG000|Overall Study|Other Reasons|2|||
145321412|NCT03756883|524023600|FG001|Overall Study|Other Reasons|4|||
145321413|NCT03756883|524023601|FG002|Overall Study|Other Reasons|0|||
145321414|NCT01011556|524023605|FG000|Overall Study|Adverse Event|1|||
145321415|NCT01011556|524023606|FG001|Overall Study|Adverse Event|3|||
145321416|NCT01011556|524023607|FG002|Overall Study|Adverse Event|2|||
145321417|NCT01011556|524023608|FG003|Overall Study|Adverse Event|1|||
145321418|NCT01011556|524023605|FG000|Overall Study|Lost to Follow-up|1|||
145321419|NCT01011556|524023606|FG001|Overall Study|Lost to Follow-up|0|||
145321420|NCT01011556|524023607|FG002|Overall Study|Lost to Follow-up|0|||
145321421|NCT01011556|524023608|FG003|Overall Study|Lost to Follow-up|0|||
145570347|NCT01454934|524947354|FG000|Overall Study|Other|6|||
145570348|NCT01454934|524947355|FG001|Overall Study|Other|17|||
145570349|NCT01454934|524947354|FG000|Overall Study|Adverse Event|28|||
145570350|NCT01454934|524947355|FG001|Overall Study|Adverse Event|24|||
145321422|NCT01011556|524023605|FG000|Overall Study|Physician Decision|1|||
145321423|NCT01011556|524023606|FG001|Overall Study|Physician Decision|0|||
145321424|NCT01011556|524023607|FG002|Overall Study|Physician Decision|0|||
145321425|NCT01011556|524023608|FG003|Overall Study|Physician Decision|1|||
145321426|NCT01011556|524023605|FG000|Overall Study|Protocol Violation|0|||
145321427|NCT01011556|524023606|FG001|Overall Study|Protocol Violation|1|||
145321428|NCT01011556|524023607|FG002|Overall Study|Protocol Violation|0|||
145321429|NCT01011556|524023608|FG003|Overall Study|Protocol Violation|0|||
145321430|NCT01011556|524023605|FG000|Overall Study|Withdrawal by Subject|1|||
145321431|NCT01011556|524023606|FG001|Overall Study|Withdrawal by Subject|2|||
145321432|NCT01011556|524023607|FG002|Overall Study|Withdrawal by Subject|4|||
145321433|NCT01011556|524023608|FG003|Overall Study|Withdrawal by Subject|4|||
145321434|NCT01011556|524023605|FG000|Overall Study|Sponsor decision|0|||
145321435|NCT01011556|524023606|FG001|Overall Study|Sponsor decision|1|||
145321436|NCT01011556|524023607|FG002|Overall Study|Sponsor decision|1|||
145321437|NCT01011556|524023608|FG003|Overall Study|Sponsor decision|2|||
145321438|NCT01011556|524023605|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
145321439|NCT01011556|524023606|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
145321440|NCT01011556|524023607|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
145321441|NCT01011556|524023608|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
145321442|NCT02147587|524023612|FG000|Overall Study|Adverse Event|9|||
145570351|NCT01454934|524947354|FG000|Overall Study|Withdrawn consent|2|||
145570352|NCT01454934|524947355|FG001|Overall Study|Withdrawn consent|5|||
145570353|NCT01454934|524947354|FG000|Overall Study|Withdrawal by Subject|11|||
145570354|NCT01454934|524947355|FG001|Overall Study|Withdrawal by Subject|15|||
145570355|NCT01454934|524947354|FG000|Overall Study|Disease progression|194|||
145570356|NCT01454934|524947355|FG001|Overall Study|Disease progression|181|||
145570357|NCT01454934|524947354|FG000|Overall Study|Lost to Follow-up|0|||
145570358|NCT01454934|524947355|FG001|Overall Study|Lost to Follow-up|1|||
145570359|NCT01454934|524947354|FG000|Overall Study|Not treated|1|||
145570360|NCT01454934|524947355|FG001|Overall Study|Not treated|2|||
145570361|NCT02465528|524947364|FG000|Overall Study|Progressive disease|0|||
145570362|NCT02465528|524947365|FG001|Overall Study|Progressive disease|2|||
145570363|NCT02465528|524947366|FG002|Overall Study|Progressive disease|9|||
145570364|NCT02465528|524947367|FG003|Overall Study|Progressive disease|4|||
145570365|NCT02465528|524947364|FG000|Overall Study|Study terminated by sponsor|1|||
145570366|NCT02465528|524947365|FG001|Overall Study|Study terminated by sponsor|2|||
145570367|NCT02465528|524947366|FG002|Overall Study|Study terminated by sponsor|0|||
145570368|NCT02465528|524947367|FG003|Overall Study|Study terminated by sponsor|0|||
145570369|NCT02465528|524947364|FG000|Overall Study|Withdrawal by Subject|0|||
145570370|NCT02465528|524947365|FG001|Overall Study|Withdrawal by Subject|0|||
145570371|NCT02465528|524947366|FG002|Overall Study|Withdrawal by Subject|2|||
145570372|NCT02465528|524947367|FG003|Overall Study|Withdrawal by Subject|0|||
145570373|NCT02465528|524947364|FG000|Overall Study|Adverse Event|0|||
145570374|NCT02465528|524947365|FG001|Overall Study|Adverse Event|0|||
145570375|NCT02465528|524947366|FG002|Overall Study|Adverse Event|0|||
145570376|NCT02465528|524947367|FG003|Overall Study|Adverse Event|1|||
145570377|NCT02465528|524947364|FG000|Overall Study|Physician Decision|0|||
145570378|NCT02465528|524947365|FG001|Overall Study|Physician Decision|0|||
145570379|NCT02465528|524947366|FG002|Overall Study|Physician Decision|1|||
145570380|NCT02465528|524947367|FG003|Overall Study|Physician Decision|0|||
145570381|NCT03795610|524947368|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
145570382|NCT03795610|524947368|FG000|Overall Study|Withdrawal by Subject|1|||
145570383|NCT03795610|524947368|FG000|Overall Study|Screen Failure (Unknown)|1|||
145570384|NCT02018458|524947377|FG000|Overall Study|Death|4|||
145570385|NCT01428193|524947380|FG000|Overall Study|Physician Decision|1|||
145570386|NCT01428193|524947380|FG000|Overall Study|Elevated screening liver enzymes|1|||
145620572|NCT02550873|525125107|FG001|Randomized Double Blind|Disease progression|1|||
145321443|NCT02147587|524023613|FG001|Overall Study|Adverse Event|4|||
145321444|NCT02147587|524023612|FG000|Overall Study|Lack of Efficacy|2|||
145570387|NCT03762083|524947381|FG000|Overall Study|Withdrawal by Subject|2|||
145570388|NCT03762083|524947381|FG000|Overall Study|Physician Decision|1|||
145570389|NCT02027844|524947382|FG000|Overall Study|Withdrawal by Subject|3|||
145570390|NCT02027844|524947383|FG001|Overall Study|Withdrawal by Subject|2|||
145570391|NCT02027844|524947384|FG002|Overall Study|Withdrawal by Subject|1|||
145570392|NCT02027844|524947382|FG000|Overall Study|Lost to Follow-up|0|||
145620573|NCT02550873|525125108|FG002|Randomized Double Blind|Disease progression|0|||
145620574|NCT02550873|525125106|FG000|Open Label Extension|Study ongoing|0|||
145570393|NCT02027844|524947383|FG001|Overall Study|Lost to Follow-up|2|||
145570394|NCT02027844|524947384|FG002|Overall Study|Lost to Follow-up|1|||
145570395|NCT02027844|524947382|FG000|Overall Study|Protocol Violation|0|||
145321445|NCT02147587|524023613|FG001|Overall Study|Lack of Efficacy|1|||
145570396|NCT02027844|524947383|FG001|Overall Study|Protocol Violation|2|||
145570397|NCT02027844|524947384|FG002|Overall Study|Protocol Violation|0|||
145570398|NCT02027844|524947382|FG000|Overall Study|Incomlete data|2|||
145570399|NCT02027844|524947383|FG001|Overall Study|Incomlete data|0|||
145570400|NCT02027844|524947384|FG002|Overall Study|Incomlete data|0|||
145321446|NCT01355302|524023614|FG000|Phase 1b|Death|4|||
145321447|NCT01355302|524023615|FG001|Phase 1b|Death|0|||
145321448|NCT01355302|524023616|FG002|Phase 1b|Death|0|||
145321449|NCT01355302|524023614|FG000|Phase 1b|Study terminated by sponsor|2|||
145321450|NCT01355302|524023615|FG001|Phase 1b|Study terminated by sponsor|0|||
145321451|NCT01355302|524023616|FG002|Phase 1b|Study terminated by sponsor|0|||
145321452|NCT01557920|524023623|FG000|Overall Study|Withdrawal by Subject|2|||
145321453|NCT01557920|524023624|FG001|Overall Study|Withdrawal by Subject|3|||
145321454|NCT01557920|524023623|FG000|Overall Study|Lack of Efficacy|1|||
145321455|NCT01557920|524023624|FG001|Overall Study|Lack of Efficacy|0|||
145321456|NCT04220775|524023631|FG000|Overall Study|Adverse Event|1|||
145321457|NCT04220775|524023632|FG001|Overall Study|Adverse Event|0|||
145321458|NCT04220775|524023631|FG000|Overall Study|Disease Progression|1|||
145321459|NCT04220775|524023632|FG001|Overall Study|Disease Progression|0|||
145321460|NCT00931463|524023633|FG000|Overall Study|Death|8|||
145321461|NCT00931463|524023634|FG001|Overall Study|Death|4|||
145321462|NCT00931463|524023633|FG000|Overall Study|Withdrawal by Subject|5|||
145321463|NCT00931463|524023634|FG001|Overall Study|Withdrawal by Subject|0|||
145321464|NCT00931463|524023633|FG000|Overall Study|Lost to Follow-up|4|||
145321465|NCT00931463|524023634|FG001|Overall Study|Lost to Follow-up|1|||
145321466|NCT00808509|524023635|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
145321467|NCT00808509|524023636|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
145321468|NCT00808509|524023635|FG000|Randomized Phase|Reduced methotrexate dose|1|||
145321469|NCT00808509|524023636|FG001|Randomized Phase|Reduced methotrexate dose|2|||
145321470|NCT00808509|524023635|FG000|Randomized Phase|Patient refused rescue therapy|0|||
145321471|NCT00808509|524023636|FG001|Randomized Phase|Patient refused rescue therapy|3|||
145321472|NCT00436917|524023637|FG000|Overall Study|Withdrawal by Subject|13|||
145321473|NCT00436917|524023637|FG000|Overall Study|Adverse Event|2|||
145321474|NCT00436917|524023637|FG000|Overall Study|Physician Decision|1|||
145321475|NCT00436917|524023637|FG000|Overall Study|Death|1|||
145321476|NCT00436917|524023637|FG000|Overall Study|Lost to Follow-up|1|||
145321477|NCT00436917|524023637|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
145321478|NCT00436917|524023637|FG000|Overall Study|Increased creatinine|1|||
145321479|NCT00436917|524023637|FG000|Overall Study|Personal conflicts of patient|1|||
145321480|NCT02169791|524023640|FG000|Overall Study|Death|6|||
145321481|NCT02169791|524023640|FG000|Overall Study|patient withdrew consent|1|||
145321482|NCT03170869|524023641|FG000|Overall Study|Protocol Violation|5|||
145321483|NCT03170869|524023641|FG000|Overall Study|Early study termination|3|||
145321484|NCT01009515|524023648|FG000|Overall Study|Withdrawal by Subject|3|||
145321485|NCT01501110|524023650|FG000|Overall Study|Death|0|||
145321486|NCT01501110|524023651|FG001|Overall Study|Death|1|||
145321487|NCT01040793|524023660|FG000|Overall Study|Adverse Event|5|||
145321488|NCT01040793|524023661|FG001|Overall Study|Adverse Event|3|||
145321489|NCT01040793|524023662|FG002|Overall Study|Adverse Event|0|||
145321490|NCT01040793|524023663|FG003|Overall Study|Adverse Event|2|||
145321491|NCT01040793|524023664|FG004|Overall Study|Adverse Event|2|||
145321492|NCT01040793|524023665|FG005|Overall Study|Adverse Event|1|||
145321493|NCT01040793|524023660|FG000|Overall Study|Protocol Violation|1|||
145321494|NCT01040793|524023661|FG001|Overall Study|Protocol Violation|1|||
145321495|NCT01040793|524023662|FG002|Overall Study|Protocol Violation|1|||
145570401|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
145570402|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
145321496|NCT01040793|524023663|FG003|Overall Study|Protocol Violation|0|||
145321497|NCT01040793|524023664|FG004|Overall Study|Protocol Violation|1|||
145321498|NCT01040793|524023665|FG005|Overall Study|Protocol Violation|0|||
145321499|NCT01040793|524023660|FG000|Overall Study|Lost to Follow-up|0|||
145321500|NCT01040793|524023661|FG001|Overall Study|Lost to Follow-up|1|||
145321501|NCT01040793|524023662|FG002|Overall Study|Lost to Follow-up|1|||
145321502|NCT01040793|524023663|FG003|Overall Study|Lost to Follow-up|0|||
145321503|NCT01040793|524023664|FG004|Overall Study|Lost to Follow-up|0|||
145321504|NCT01040793|524023665|FG005|Overall Study|Lost to Follow-up|0|||
145321505|NCT01040793|524023660|FG000|Overall Study|Withdrawal by Subject|0|||
145570403|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Graft loss|1|||
145321506|NCT01040793|524023661|FG001|Overall Study|Withdrawal by Subject|0|||
145570404|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Graft loss|2|||
145570405|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Death|5|||
145570406|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Death|3|||
145620575|NCT02550873|525125107|FG001|Open Label Extension|Study ongoing|0|||
145321507|NCT01040793|524023662|FG002|Overall Study|Withdrawal by Subject|0|||
145321508|NCT01040793|524023663|FG003|Overall Study|Withdrawal by Subject|2|||
145321509|NCT01040793|524023664|FG004|Overall Study|Withdrawal by Subject|0|||
145321510|NCT01040793|524023665|FG005|Overall Study|Withdrawal by Subject|0|||
145321511|NCT01040793|524023660|FG000|Overall Study|Other reasons not listed above|0|||
145321512|NCT01040793|524023661|FG001|Overall Study|Other reasons not listed above|0|||
145411743|NCT03086343|524360589|FG002|Period 1|Adverse Event|0|||
145321513|NCT01040793|524023662|FG002|Overall Study|Other reasons not listed above|1|||
145321514|NCT01040793|524023663|FG003|Overall Study|Other reasons not listed above|0|||
145321515|NCT01040793|524023664|FG004|Overall Study|Other reasons not listed above|1|||
145321516|NCT01040793|524023665|FG005|Overall Study|Other reasons not listed above|0|||
145321517|NCT03573817|524023667|FG000|Overall Study|Adverse Event|0|||
145321518|NCT03573817|524023668|FG001|Overall Study|Adverse Event|2|||
145321519|NCT03573817|524023667|FG000|Overall Study|Protocol Violation|0|||
145321520|NCT03573817|524023668|FG001|Overall Study|Protocol Violation|1|||
145321521|NCT03573817|524023667|FG000|Overall Study|Withdrawal by Subject|1|||
145321522|NCT03573817|524023668|FG001|Overall Study|Withdrawal by Subject|1|||
145321523|NCT03554317|524023669|FG000|Overall Study|Withdrawal by Subject|1|||
145321524|NCT03554317|524023669|FG000|Overall Study|PSA Progression|3|||
145321525|NCT03554317|524023669|FG000|Overall Study|Radiographic Progression|4|||
145321526|NCT00612677|524023672|FG000|Overall Study|study closed before treatment started|1|||
145321527|NCT00860743|524023673|FG000|Overall Study|Withdrawal by Subject|3|||
145321528|NCT00860743|524023674|FG001|Overall Study|Withdrawal by Subject|0|||
145321529|NCT00823199|524023675|FG000|Overall Study|Withdrawal by Subject|2|||
145321530|NCT01640184|524023680|FG000|Overall Study|Death|1|||
145321531|NCT01640184|524023681|FG001|Overall Study|Death|0|||
145321532|NCT01640184|524023682|FG002|Overall Study|Death|0|||
145321533|NCT01640184|524023680|FG000|Overall Study|Lost to Follow-up|4|||
145321534|NCT01640184|524023681|FG001|Overall Study|Lost to Follow-up|1|||
145321535|NCT01640184|524023682|FG002|Overall Study|Lost to Follow-up|0|||
145321536|NCT01640184|524023680|FG000|Overall Study|Physician Decision|3|||
145321537|NCT01640184|524023681|FG001|Overall Study|Physician Decision|0|||
145321538|NCT01640184|524023682|FG002|Overall Study|Physician Decision|0|||
145321539|NCT01640184|524023680|FG000|Overall Study|Withdrawal by Subject|0|||
145321540|NCT01640184|524023681|FG001|Overall Study|Withdrawal by Subject|1|||
145411744|NCT03086343|524360590|FG003|Period 1|Adverse Event|1|||
145411745|NCT03086343|524360587|FG000|Period 1|Withdrawal by Subject|6|||
145411746|NCT03086343|524360588|FG001|Period 1|Withdrawal by Subject|10|||
145411747|NCT03086343|524360589|FG002|Period 1|Withdrawal by Subject|0|||
145411748|NCT03086343|524360590|FG003|Period 1|Withdrawal by Subject|0|||
145411749|NCT03086343|524360587|FG000|Period 1|Lost to Follow-up|1|||
145411750|NCT03086343|524360588|FG001|Period 1|Lost to Follow-up|3|||
145411751|NCT03086343|524360589|FG002|Period 1|Lost to Follow-up|1|||
145411752|NCT03086343|524360590|FG003|Period 1|Lost to Follow-up|0|||
145411753|NCT03086343|524360587|FG000|Period 1|Other, Not Specified|10|||
145411754|NCT03086343|524360588|FG001|Period 1|Other, Not Specified|12|||
145411755|NCT03086343|524360589|FG002|Period 1|Other, Not Specified|2|||
145411756|NCT03086343|524360590|FG003|Period 1|Other, Not Specified|1|||
145411757|NCT03086343|524360587|FG000|Period 1|Missing|1|||
145411758|NCT03086343|524360588|FG001|Period 1|Missing|0|||
145411759|NCT03086343|524360589|FG002|Period 1|Missing|0|||
145411760|NCT03086343|524360590|FG003|Period 1|Missing|0|||
145411761|NCT03086343|524360587|FG000|Period 2|Adverse Event|20|||
145411762|NCT03086343|524360588|FG001|Period 2|Adverse Event|11|||
145411763|NCT03086343|524360589|FG002|Period 2|Adverse Event|1|||
145411764|NCT03086343|524360590|FG003|Period 2|Adverse Event|2|||
145411765|NCT03086343|524360587|FG000|Period 2|Withdrawal by Subject|15|||
145411766|NCT03086343|524360588|FG001|Period 2|Withdrawal by Subject|25|||
145411767|NCT03086343|524360589|FG002|Period 2|Withdrawal by Subject|2|||
145411768|NCT03086343|524360590|FG003|Period 2|Withdrawal by Subject|2|||
145411769|NCT03086343|524360587|FG000|Period 2|Lost to Follow-up|6|||
145411770|NCT03086343|524360588|FG001|Period 2|Lost to Follow-up|11|||
145411771|NCT03086343|524360589|FG002|Period 2|Lost to Follow-up|1|||
145411772|NCT03086343|524360590|FG003|Period 2|Lost to Follow-up|0|||
145411773|NCT03086343|524360587|FG000|Period 2|COVID-19 Infection|5|||
145570407|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
145570408|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
145570409|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
145411774|NCT03086343|524360588|FG001|Period 2|COVID-19 Infection|0|||
145570410|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
145321541|NCT01640184|524023682|FG002|Overall Study|Withdrawal by Subject|1|||
145321542|NCT01640184|524023680|FG000|Overall Study|Protocol Violation|0|||
145321543|NCT01640184|524023681|FG001|Overall Study|Protocol Violation|0|||
145321544|NCT01640184|524023682|FG002|Overall Study|Protocol Violation|1|||
145321545|NCT01684878|524023683|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
145321546|NCT01684878|524023684|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
145411775|NCT03086343|524360589|FG002|Period 2|COVID-19 Infection|0|||
145411776|NCT03086343|524360590|FG003|Period 2|COVID-19 Infection|0|||
145411777|NCT03086343|524360587|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
145411778|NCT03086343|524360588|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
145411779|NCT03086343|524360589|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
145411780|NCT03086343|524360590|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
145411781|NCT03086343|524360587|FG000|Period 2|Other, Not Specified|23|||
145411782|NCT03086343|524360588|FG001|Period 2|Other, Not Specified|22|||
145411783|NCT03086343|524360589|FG002|Period 2|Other, Not Specified|2|||
145411784|NCT03086343|524360590|FG003|Period 2|Other, Not Specified|4|||
145570411|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
145570412|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
145570413|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
145570414|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
145570415|NCT00378014|524947385|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
145570416|NCT00378014|524947386|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
145570417|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
145321547|NCT01684878|524023685|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
145570418|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
145570419|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Death|1|||
145570420|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Death|2|||
145570421|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
145570422|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
145570423|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
145570424|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
145570425|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
145321548|NCT01684878|524023686|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
145321549|NCT01684878|524023683|FG000|Part 1: Safety Run in Phase|Death|15|||
145321550|NCT01684878|524023684|FG001|Part 1: Safety Run in Phase|Death|20|||
145321551|NCT01684878|524023685|FG002|Part 1: Safety Run in Phase|Death|0|||
145321552|NCT01684878|524023686|FG003|Part 1: Safety Run in Phase|Death|0|||
145321553|NCT01684878|524023683|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145321554|NCT01684878|524023684|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
145321555|NCT01684878|524023685|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145321556|NCT01684878|524023686|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
145321557|NCT01684878|524023683|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
145321558|NCT01684878|524023684|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
145321559|NCT01684878|524023685|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
145321560|NCT01684878|524023686|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
145321561|NCT01684878|524023683|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
145321562|NCT01684878|524023684|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
145321563|NCT01684878|524023685|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
145321564|NCT01684878|524023686|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
145321565|NCT01684878|524023683|FG000|Part 2: Randomized Phase|Death|0|||
145321566|NCT01684878|524023684|FG001|Part 2: Randomized Phase|Death|0|||
145321567|NCT01684878|524023685|FG002|Part 2: Randomized Phase|Death|62|||
145321568|NCT01684878|524023686|FG003|Part 2: Randomized Phase|Death|68|||
145321569|NCT01684878|524023683|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
145321570|NCT01684878|524023684|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
145321571|NCT01684878|524023685|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
145321572|NCT01684878|524023686|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
145321573|NCT01684878|524023683|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
145321574|NCT01684878|524023684|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
145321575|NCT01684878|524023685|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
145321576|NCT01684878|524023686|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
145321577|NCT01435031|524023690|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
145321578|NCT01435031|524023690|FG000|ITT at 1 Month|Death|1|||
145321579|NCT01435031|524023690|FG000|ITT at 1 Month|Lost to Follow-up|4|||
145321580|NCT01435031|524023690|FG000|ITT at 6 Months|Death|2|||
145321581|NCT01435031|524023690|FG000|ITT at 6 Months|Lost to Follow-up|3|||
145321582|NCT01435031|524023690|FG000|ITT at 1 Year|Death|1|||
145321583|NCT01435031|524023690|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
145321584|NCT01435031|524023690|FG000|ITT at 1 Year|Lost to Follow-up|6|||
145321585|NCT01435031|524023690|FG000|ITT at 2 Years|Death|7|||
145321586|NCT01435031|524023690|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
145321587|NCT01435031|524023690|FG000|ITT at 2 Years|Lost to Follow-up|4|||
145321588|NCT01435031|524023690|FG000|ITT at 3 Years|Death|5|||
145321589|NCT01435031|524023690|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
145321590|NCT01435031|524023690|FG000|ITT at 3 Years|Lost to Follow-up|4|||
145321591|NCT01435031|524023690|FG000|ITT at 4 Years|Death|4|||
145321592|NCT01435031|524023690|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
145321593|NCT01435031|524023690|FG000|ITT at 4 Years|Lost to Follow-up|1|||
145321594|NCT02927834|524023691|FG000|Overall Study|Lost to Follow-up|1|||
145321595|NCT02927834|524023692|FG001|Overall Study|Lost to Follow-up|2|||
145321596|NCT02927834|524023693|FG002|Overall Study|Lost to Follow-up|2|||
145321597|NCT00613730|524023697|FG000|Overall Study|Disease progression|2|||
145321598|NCT00613730|524023697|FG000|Overall Study|Administrative decision|1|||
145570426|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
145570427|NCT00378014|524947385|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
145570428|NCT00378014|524947386|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
145321599|NCT00479388|524023698|FG000|Overall Study|Adverse Event|90|||
145321600|NCT00479388|524023699|FG001|Overall Study|Adverse Event|45|||
145321601|NCT00479388|524023698|FG000|Overall Study|Lost to Follow-up|0|||
145570429|NCT00357370|524947387|FG000|Cohort 2|Lack of Efficacy|0|||
145570430|NCT00357370|524947388|FG001|Cohort 2|Lack of Efficacy|2|||
145570431|NCT00357370|524947389|FG002|Cohort 2|Lack of Efficacy|1|||
145570432|NCT00357370|524947387|FG000|Cohort 2|Adverse Event|1|||
145570433|NCT00357370|524947388|FG001|Cohort 2|Adverse Event|1|||
145570434|NCT00357370|524947389|FG002|Cohort 2|Adverse Event|1|||
145570435|NCT00357370|524947387|FG000|Cohort 2|Lost to Follow-up|0|||
145321602|NCT00479388|524023699|FG001|Overall Study|Lost to Follow-up|2|||
145321603|NCT00479388|524023698|FG000|Overall Study|Protocol Violation|10|||
145321604|NCT00479388|524023699|FG001|Overall Study|Protocol Violation|9|||
145321605|NCT00479388|524023698|FG000|Overall Study|Withdrawal by Subject|32|||
145570436|NCT00357370|524947388|FG001|Cohort 2|Lost to Follow-up|1|||
145321606|NCT00479388|524023699|FG001|Overall Study|Withdrawal by Subject|17|||
145321607|NCT01876368|524023702|FG000|Overall Study|Adverse Event|2|||
145321608|NCT01876368|524023703|FG001|Overall Study|Adverse Event|5|||
145321609|NCT01876368|524023702|FG000|Overall Study|Lack of Efficacy|1|||
145321610|NCT01876368|524023703|FG001|Overall Study|Lack of Efficacy|0|||
145321611|NCT01876368|524023702|FG000|Overall Study|Lost to Follow-up|0|||
145321612|NCT01876368|524023703|FG001|Overall Study|Lost to Follow-up|1|||
145321613|NCT01876368|524023702|FG000|Overall Study|Non-compliance with study treatment|0|||
145321614|NCT01876368|524023703|FG001|Overall Study|Non-compliance with study treatment|1|||
145321615|NCT01876368|524023702|FG000|Overall Study|Physician Decision|0|||
145321616|NCT01876368|524023703|FG001|Overall Study|Physician Decision|2|||
145321617|NCT01876368|524023702|FG000|Overall Study|Protocol deviation|3|||
145321618|NCT01876368|524023703|FG001|Overall Study|Protocol deviation|3|||
145321619|NCT01876368|524023702|FG000|Overall Study|Subject/guardian decision|3|||
145321620|NCT01876368|524023703|FG001|Overall Study|Subject/guardian decision|1|||
145321621|NCT02563769|524023704|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
145321622|NCT02563769|524023705|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
145321623|NCT02563769|524023706|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
145321624|NCT00104247|524023709|FG000|Overall Study|Withdrawal by Subject|1|||
145321625|NCT00104247|524023710|FG001|Overall Study|Withdrawal by Subject|0|||
145321626|NCT00104247|524023709|FG000|Overall Study|Noncompliant with dosing|0|||
145321627|NCT00104247|524023710|FG001|Overall Study|Noncompliant with dosing|1|||
145321628|NCT01644149|524023711|FG000|Overall Study|Withdrawal by Subject|1|||
145321629|NCT01644149|524023712|FG001|Overall Study|Withdrawal by Subject|0|||
145321630|NCT01644149|524023711|FG000|Overall Study|Lost to Follow-up|3|||
145321631|NCT01644149|524023712|FG001|Overall Study|Lost to Follow-up|1|||
145321632|NCT04798482|524023715|FG000|Overall Study|Physician Decision|1|||
145321633|NCT04798482|524023715|FG000|Overall Study|Lost eligibility|1|||
145321634|NCT01930175|524023721|FG000|Core Study|Lost to Follow-up|0|||
145321635|NCT01930175|524023722|FG001|Core Study|Lost to Follow-up|1|||
145321636|NCT01930175|524023723|FG002|Core Study|Lost to Follow-up|0|||
145321637|NCT01930175|524023721|FG000|Core Study|Adverse Event|0|||
145321638|NCT01930175|524023722|FG001|Core Study|Adverse Event|0|||
145321639|NCT01930175|524023723|FG002|Core Study|Adverse Event|1|||
145321640|NCT00605917|524023724|FG000|Overall Study|Protocol Violation|79|||
145321641|NCT00890552|524023726|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
145321642|NCT00890552|524023726|FG000|On-treatment|Early prog disease/ death|10|||
145321643|NCT03718117|524023728|FG000|Overall Study|Death|12|||
145321644|NCT03718117|524023729|FG001|Overall Study|Death|11|||
145321645|NCT03718117|524023730|FG002|Overall Study|Death|0|||
145321646|NCT03718117|524023728|FG000|Overall Study|Other|0|||
145321647|NCT03718117|524023729|FG001|Overall Study|Other|1|||
145321648|NCT03718117|524023730|FG002|Overall Study|Other|0|||
145321649|NCT03718117|524023728|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
145321650|NCT03718117|524023729|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
145321651|NCT03718117|524023730|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
145321652|NCT03718117|524023728|FG000|Overall Study|Participant not met eligibility criteria|0|||
145321653|NCT03718117|524023729|FG001|Overall Study|Participant not met eligibility criteria|0|||
145321654|NCT03718117|524023730|FG002|Overall Study|Participant not met eligibility criteria|2|||
145321655|NCT01382251|524023731|FG000|Overall Study|Surgeries cancelled or delayed|16|||
145570437|NCT00357370|524947389|FG002|Cohort 2|Lost to Follow-up|0|||
145570438|NCT00357370|524947387|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
145570439|NCT00357370|524947388|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
145570440|NCT00357370|524947389|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
145570441|NCT00357370|524947387|FG000|Cohort 2|Withdrawal by Subject|0|||
145321656|NCT01382251|524023732|FG001|Overall Study|Surgeries cancelled or delayed|16|||
145321657|NCT01382251|524023731|FG000|Overall Study|Lost to Follow-up|4|||
145321658|NCT01382251|524023732|FG001|Overall Study|Lost to Follow-up|4|||
145321659|NCT01382251|524023731|FG000|Overall Study|Contacted after study closed|1|||
145321660|NCT01382251|524023732|FG001|Overall Study|Contacted after study closed|1|||
145321661|NCT01117987|524023733|FG000|Overall Study|Protocol deviation|0|||
145570442|NCT00357370|524947388|FG001|Cohort 2|Withdrawal by Subject|2|||
145321662|NCT01117987|524023734|FG001|Overall Study|Protocol deviation|1|||
145411785|NCT00741611|524360591|FG000|Overall Study|Death|0|||
145411786|NCT00741611|524360592|FG001|Overall Study|Death|0|||
145570443|NCT00357370|524947389|FG002|Cohort 2|Withdrawal by Subject|0|||
145321663|NCT01117987|524023733|FG000|Overall Study|Subject no longer requires study drug|1|||
145321664|NCT01117987|524023734|FG001|Overall Study|Subject no longer requires study drug|0|||
145321665|NCT01117987|524023733|FG000|Overall Study|Lost to Follow-up|1|||
145321666|NCT01117987|524023734|FG001|Overall Study|Lost to Follow-up|1|||
145321667|NCT01117987|524023733|FG000|Overall Study|Abnormal test procedure result|2|||
145321668|NCT01117987|524023734|FG001|Overall Study|Abnormal test procedure result|0|||
145321669|NCT01117987|524023733|FG000|Overall Study|Lack of Efficacy|3|||
145321670|NCT01117987|524023734|FG001|Overall Study|Lack of Efficacy|4|||
145321671|NCT01117987|524023733|FG000|Overall Study|Death|5|||
145321672|NCT01117987|524023734|FG001|Overall Study|Death|10|||
145321673|NCT01117987|524023733|FG000|Overall Study|Withdrawal by Subject|5|||
145321674|NCT01117987|524023734|FG001|Overall Study|Withdrawal by Subject|10|||
145321675|NCT01117987|524023733|FG000|Overall Study|Adverse Event|19|||
145321676|NCT01117987|524023734|FG001|Overall Study|Adverse Event|26|||
145321677|NCT01117987|524023733|FG000|Overall Study|Administrative problems|25|||
145321678|NCT01117987|524023734|FG001|Overall Study|Administrative problems|22|||
145321679|NCT04232540|524023738|FG000|Overall Study|Lost to Follow-up|1|||
145321680|NCT04232540|524023739|FG001|Overall Study|Lost to Follow-up|0|||
145321681|NCT02339090|524023745|FG000|Overall Study|Adverse Event|1|||
145321682|NCT02339090|524023746|FG001|Overall Study|Adverse Event|0|||
145321683|NCT02339090|524023745|FG000|Overall Study|Lost to Follow-up|0|||
145321684|NCT02339090|524023746|FG001|Overall Study|Lost to Follow-up|1|||
145321685|NCT02339090|524023745|FG000|Overall Study|Non-compliance With Study Drug|0|||
145321686|NCT02339090|524023746|FG001|Overall Study|Non-compliance With Study Drug|1|||
145321687|NCT02339090|524023745|FG000|Overall Study|Withdrawal by Subject|2|||
145321688|NCT02339090|524023746|FG001|Overall Study|Withdrawal by Subject|1|||
145411787|NCT00741611|524360593|FG002|Overall Study|Death|1|||
145411788|NCT00741611|524360591|FG000|Overall Study|Withdrawal by Subject|0|||
145411789|NCT00741611|524360592|FG001|Overall Study|Withdrawal by Subject|2|||
145411790|NCT00741611|524360593|FG002|Overall Study|Withdrawal by Subject|2|||
145411791|NCT01913353|524360600|FG000|Overall Study|Adverse Event|2|||
145411792|NCT01913353|524360601|FG001|Overall Study|Adverse Event|0|||
145411793|NCT01913353|524360600|FG000|Overall Study|Physician Decision|0|||
145411794|NCT01913353|524360601|FG001|Overall Study|Physician Decision|2|||
145411795|NCT01913353|524360600|FG000|Overall Study|Withdrawal by Subject|20|||
145411796|NCT01913353|524360601|FG001|Overall Study|Withdrawal by Subject|6|||
145411797|NCT01913353|524360600|FG000|Overall Study|multiple reasons|10|||
145411798|NCT01913353|524360601|FG001|Overall Study|multiple reasons|7|||
145411799|NCT00385840|524360602|FG000|Overall Study|Adverse Event|1|||
145411800|NCT00385840|524360603|FG001|Overall Study|Adverse Event|1|||
145411801|NCT00385840|524360602|FG000|Overall Study|Lost to Follow-up|3|||
145411802|NCT00385840|524360603|FG001|Overall Study|Lost to Follow-up|13|||
145411803|NCT00462462|524360605|FG000|Overall Study|Physician Decision|0|||
145411804|NCT00462462|524360606|FG001|Overall Study|Physician Decision|1|||
145411805|NCT02830087|524360607|FG000|Overall Study|No study staff to follow-up patients|4|||
145411806|NCT02830087|524360608|FG001|Overall Study|No study staff to follow-up patients|4|||
145411807|NCT02830087|524360609|FG002|Overall Study|No study staff to follow-up patients|4|||
145411808|NCT02830087|524360610|FG003|Overall Study|No study staff to follow-up patients|3|||
145411809|NCT02830087|524360611|FG004|Overall Study|No study staff to follow-up patients|3|||
145411810|NCT02830087|524360612|FG005|Overall Study|No study staff to follow-up patients|3|||
145411811|NCT00632359|524360618|FG000|Overall Study|Withdrawal by Subject|2|||
145411812|NCT03043573|524360619|FG000|Overall Study|Lost to Follow-up|3|||
145411813|NCT03043573|524360620|FG001|Overall Study|Lost to Follow-up|3|||
145411814|NCT03043573|524360619|FG000|Overall Study|Physician Decision|0|||
145411815|NCT03043573|524360620|FG001|Overall Study|Physician Decision|5|||
145411816|NCT03043573|524360619|FG000|Overall Study|Withdrawal by Subject|0|||
145411817|NCT03043573|524360620|FG001|Overall Study|Withdrawal by Subject|4|||
145411818|NCT02337686|524360621|FG000|Overall Study|Adverse Event|1|||
145411819|NCT01239680|524362075|FG000|Overall Study|Withdrawal by Subject|2|||
145411820|NCT01239680|524362076|FG001|Overall Study|Withdrawal by Subject|0|||
145620576|NCT02550873|525125108|FG002|Open Label Extension|Study ongoing|111|||
145620577|NCT01822353|525125109|FG000|Overall Study|Adverse Event|1|||
145411821|NCT03033901|524362077|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
145411822|NCT03033901|524362077|FG000|Overall Study|Refused PSG|23|||
145411823|NCT03033901|524362077|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
145411824|NCT03033901|524362077|FG000|Overall Study|Missing Oximetry Data|3|||
145411825|NCT00729586|524362078|FG000|Overall Study|Ineligible|0|||
145411826|NCT00729586|524362079|FG001|Overall Study|Ineligible|1|||
145411827|NCT00729586|524362078|FG000|Overall Study|never treated|1|||
145411828|NCT00729586|524362079|FG001|Overall Study|never treated|0|||
145411829|NCT05177094|524362082|FG000|Overall Study|Adverse Event|5|||
145411830|NCT05177094|524362083|FG001|Overall Study|Adverse Event|5|||
145411831|NCT05177094|524362082|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
145411832|NCT05177094|524362083|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
145321689|NCT02339090|524023745|FG000|Overall Study|Poor Growth|3|||
145321690|NCT02339090|524023746|FG001|Overall Study|Poor Growth|0|||
145321691|NCT02339090|524023745|FG000|Overall Study|Randomized but not treated|0|||
145321692|NCT02339090|524023746|FG001|Overall Study|Randomized but not treated|2|||
145321693|NCT02737592|524023747|FG000|Overall Study|Withdrawal by Subject|1|||
145321694|NCT00749411|524023754|FG000|Overall Study|Adverse Event|0|||
145321695|NCT00749411|524023755|FG001|Overall Study|Adverse Event|2|||
145321696|NCT00749411|524023754|FG000|Overall Study|Lack of Efficacy|0|||
145321697|NCT00749411|524023755|FG001|Overall Study|Lack of Efficacy|1|||
145321698|NCT00749411|524023754|FG000|Overall Study|Protocol Violation|1|||
145321699|NCT00749411|524023755|FG001|Overall Study|Protocol Violation|1|||
145321700|NCT00749411|524023754|FG000|Overall Study|Protocol-defined stopping criteria|0|||
145321701|NCT00749411|524023755|FG001|Overall Study|Protocol-defined stopping criteria|1|||
145321702|NCT03581188|524026105|FG000|Overall Study|Inclusion criteria not met|3|||
145321703|NCT03581188|524026106|FG001|Overall Study|Inclusion criteria not met|2|||
145321704|NCT03581188|524026105|FG000|Overall Study|Lost to Follow-up|5|||
145321705|NCT03581188|524026106|FG001|Overall Study|Lost to Follow-up|5|||
145321706|NCT03581188|524026105|FG000|Overall Study|Discontinued intervention|11|||
145321707|NCT03581188|524026106|FG001|Overall Study|Discontinued intervention|8|||
145321708|NCT01619579|524026107|FG000|Overall Study|Withdrawal by Subject|0|||
145321709|NCT01619579|524026108|FG001|Overall Study|Withdrawal by Subject|3|||
145321710|NCT02012452|524026110|FG000|Overall Study|Lost to Follow-up|2|||
145321711|NCT02012452|524026111|FG001|Overall Study|Lost to Follow-up|1|||
145321712|NCT02012452|524026110|FG000|Overall Study|Withdrawal by Subject|4|||
145321713|NCT02012452|524026111|FG001|Overall Study|Withdrawal by Subject|0|||
145321714|NCT02190279|524026112|FG000|Overall Study|Withdrawal consent|1|||
145321715|NCT02190279|524026113|FG001|Overall Study|Withdrawal consent|0|||
145321716|NCT02190279|524026114|FG002|Overall Study|Withdrawal consent|1|||
145321717|NCT02190279|524026112|FG000|Overall Study|Lost to Follow-up|2|||
145321718|NCT02190279|524026113|FG001|Overall Study|Lost to Follow-up|0|||
145321719|NCT02190279|524026114|FG002|Overall Study|Lost to Follow-up|0|||
145321720|NCT02190279|524026112|FG000|Overall Study|Refused further treatment|0|||
145321721|NCT02190279|524026113|FG001|Overall Study|Refused further treatment|0|||
145321722|NCT02190279|524026114|FG002|Overall Study|Refused further treatment|1|||
145321723|NCT02190279|524026112|FG000|Overall Study|Screening failure|0|||
145321724|NCT02190279|524026113|FG001|Overall Study|Screening failure|0|||
145321725|NCT02190279|524026114|FG002|Overall Study|Screening failure|1|||
145321726|NCT02938442|524026115|FG000|Overall Study|Death|0|||
145321727|NCT02938442|524026116|FG001|Overall Study|Death|1|||
145321728|NCT02938442|524026115|FG000|Overall Study|Lost to Follow-up|0|||
145321729|NCT02938442|524026116|FG001|Overall Study|Lost to Follow-up|1|||
145321730|NCT02938442|524026115|FG000|Overall Study|Physician Decision|0|||
145321731|NCT02938442|524026116|FG001|Overall Study|Physician Decision|1|||
145570444|NCT02644967|524947399|FG000|Overall Study|Death|26|||
145570445|NCT02644967|524947399|FG000|Overall Study|Physician Decision|1|||
145570446|NCT02644967|524947399|FG000|Overall Study|Withdrawal by Subject|2|||
145570447|NCT02644967|524947399|FG000|Overall Study|Protocol Violation|1|||
145321732|NCT02938442|524026115|FG000|Overall Study|Withdrawal by Subject|2|||
145321733|NCT02938442|524026116|FG001|Overall Study|Withdrawal by Subject|0|||
145321734|NCT04403399|524026117|FG000|Period 2|Physician Decision|0|||
145321735|NCT04403399|524026118|FG001|Period 2|Physician Decision|1|||
145321736|NCT01316419|524026120|FG000|Overall Study|Not treated|103|||
145321737|NCT01316419|524026120|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
145321738|NCT01316419|524026120|FG000|Overall Study|Lost to Follow-up|19|||
145321739|NCT00983918|524026129|FG000|Overall Study|conversion to open cholecystectomy|0|||
145321740|NCT00983918|524026130|FG001|Overall Study|conversion to open cholecystectomy|2|||
145321741|NCT00983918|524026131|FG002|Overall Study|conversion to open cholecystectomy|2|||
145321742|NCT00983918|524026132|FG003|Overall Study|conversion to open cholecystectomy|2|||
145321743|NCT03346070|524026142|FG000|Overall Study|Death|0|||
145321744|NCT03346070|524026143|FG001|Overall Study|Death|0|||
145321745|NCT03346070|524026144|FG002|Overall Study|Death|0|||
145321746|NCT03346070|524026145|FG003|Overall Study|Death|0|||
145321747|NCT03346070|524026146|FG004|Overall Study|Death|1|||
145321748|NCT03346070|524026142|FG000|Overall Study|Lost to Follow-up|0|||
145321749|NCT03346070|524026143|FG001|Overall Study|Lost to Follow-up|1|||
145321750|NCT03346070|524026144|FG002|Overall Study|Lost to Follow-up|2|||
145321751|NCT03346070|524026145|FG003|Overall Study|Lost to Follow-up|0|||
145321752|NCT03346070|524026146|FG004|Overall Study|Lost to Follow-up|0|||
145321753|NCT03346070|524026142|FG000|Overall Study|Physician Decision|0|||
145570448|NCT02644967|524947399|FG000|Overall Study|Progressive Disease|1|||
145570449|NCT02644967|524947399|FG000|Overall Study|Study Terminated by Sponsor|4|||
145321754|NCT03346070|524026143|FG001|Overall Study|Physician Decision|0|||
145570450|NCT02287896|524947400|FG000|Second Injection Visit|Withdrawal by Subject|0|||
145321755|NCT03346070|524026144|FG002|Overall Study|Physician Decision|0|||
145321756|NCT03346070|524026145|FG003|Overall Study|Physician Decision|1|||
145321757|NCT03346070|524026146|FG004|Overall Study|Physician Decision|1|||
145321758|NCT03346070|524026142|FG000|Overall Study|Withdrawal by Subject|1|||
145321759|NCT03346070|524026143|FG001|Overall Study|Withdrawal by Subject|0|||
145321760|NCT03346070|524026144|FG002|Overall Study|Withdrawal by Subject|0|||
145321761|NCT03346070|524026145|FG003|Overall Study|Withdrawal by Subject|1|||
145321762|NCT03346070|524026146|FG004|Overall Study|Withdrawal by Subject|0|||
145411833|NCT05177094|524362082|FG000|Overall Study|Protocol Deviation|3|||
145321763|NCT03346070|524026142|FG000|Overall Study|Study medication not received as planned|2|||
145321764|NCT03346070|524026143|FG001|Overall Study|Study medication not received as planned|3|||
145321765|NCT03346070|524026144|FG002|Overall Study|Study medication not received as planned|2|||
145321766|NCT03346070|524026145|FG003|Overall Study|Study medication not received as planned|3|||
145321767|NCT03346070|524026146|FG004|Overall Study|Study medication not received as planned|2|||
145321768|NCT03346070|524026142|FG000|Overall Study|Screen Failure|0|||
145321769|NCT03346070|524026143|FG001|Overall Study|Screen Failure|0|||
145321770|NCT03346070|524026144|FG002|Overall Study|Screen Failure|0|||
145321771|NCT03346070|524026145|FG003|Overall Study|Screen Failure|1|||
145321772|NCT03346070|524026146|FG004|Overall Study|Screen Failure|1|||
145321773|NCT04086641|524026149|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
145321774|NCT04086641|524026150|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
145321775|NCT00255151|524026151|FG000|Overall Study|Adverse Event|10|||
145321776|NCT00255151|524026152|FG001|Overall Study|Adverse Event|6|||
145321777|NCT00255151|524026153|FG002|Overall Study|Adverse Event|9|||
145321778|NCT00255151|524026151|FG000|Overall Study|Lost to Follow-up|4|||
145321779|NCT00255151|524026152|FG001|Overall Study|Lost to Follow-up|3|||
145321780|NCT00255151|524026153|FG002|Overall Study|Lost to Follow-up|4|||
145321781|NCT00255151|524026151|FG000|Overall Study|Withdrawal by Subject|18|||
145321782|NCT00255151|524026152|FG001|Overall Study|Withdrawal by Subject|17|||
145321783|NCT00255151|524026153|FG002|Overall Study|Withdrawal by Subject|8|||
145321784|NCT00255151|524026151|FG000|Overall Study|Noncompliance|0|||
145321785|NCT00255151|524026152|FG001|Overall Study|Noncompliance|1|||
145321786|NCT00255151|524026153|FG002|Overall Study|Noncompliance|2|||
145321787|NCT00255151|524026151|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
145321788|NCT00255151|524026152|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
145321789|NCT00255151|524026153|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
145321790|NCT00255151|524026151|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
145321791|NCT00255151|524026152|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
145321792|NCT00255151|524026153|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
145321793|NCT00255151|524026151|FG000|Overall Study|Possible Barrett's Esophagus|1|||
145321794|NCT00255151|524026152|FG001|Overall Study|Possible Barrett's Esophagus|3|||
145321795|NCT00255151|524026153|FG002|Overall Study|Possible Barrett's Esophagus|8|||
145321796|NCT00255151|524026151|FG000|Overall Study|Esophageal Stricture|0|||
145321797|NCT00255151|524026152|FG001|Overall Study|Esophageal Stricture|0|||
145321798|NCT00255151|524026153|FG002|Overall Study|Esophageal Stricture|1|||
145321799|NCT00255151|524026151|FG000|Overall Study|Therapeutic Failure|11|||
145321800|NCT00255151|524026152|FG001|Overall Study|Therapeutic Failure|2|||
145321801|NCT00255151|524026153|FG002|Overall Study|Therapeutic Failure|3|||
145321802|NCT00792623|524026154|FG000|Overall Study|Adverse Event|2|||
145321803|NCT00792623|524026154|FG000|Overall Study|Withdrawal by Subject|5|||
145321804|NCT01685073|524026155|FG000|Overall Study|Lost to Follow-up|6|||
145321805|NCT01685073|524026156|FG001|Overall Study|Lost to Follow-up|8|||
145321806|NCT01685073|524026155|FG000|Overall Study|Withdrawal by Subject|24|||
145321807|NCT01685073|524026156|FG001|Overall Study|Withdrawal by Subject|24|||
145321808|NCT00880087|524026159|FG000|Overall Study|Lost to Follow-up|0|||
145321809|NCT00880087|524026160|FG001|Overall Study|Lost to Follow-up|2|||
145321810|NCT00126126|524026161|FG000|Overall Study|Lost to Follow-up|0|||
145321811|NCT00126126|524026162|FG001|Overall Study|Lost to Follow-up|2|||
145321812|NCT01470417|524026168|FG000|Overall Study|Disease progression|0|||
145321813|NCT01470417|524026169|FG001|Overall Study|Disease progression|2|||
145321814|NCT02973321|524026172|FG000|Overall Study|Other than specified|0|||
145321815|NCT02973321|524026173|FG001|Overall Study|Other than specified|5|||
145321816|NCT02973321|524026174|FG002|Overall Study|Other than specified|3|||
145321817|NCT02973321|524026175|FG003|Overall Study|Other than specified|3|||
145321818|NCT02973321|524026176|FG004|Overall Study|Other than specified|1|||
145321819|NCT02973321|524026172|FG000|Overall Study|Lack of Efficacy|0|||
145321820|NCT02973321|524026173|FG001|Overall Study|Lack of Efficacy|0|||
145321821|NCT02973321|524026174|FG002|Overall Study|Lack of Efficacy|0|||
145321822|NCT02973321|524026175|FG003|Overall Study|Lack of Efficacy|0|||
145321823|NCT02973321|524026176|FG004|Overall Study|Lack of Efficacy|1|||
145321824|NCT02973321|524026172|FG000|Overall Study|Adverse Event|1|||
145321825|NCT02973321|524026173|FG001|Overall Study|Adverse Event|10|||
145321826|NCT02973321|524026174|FG002|Overall Study|Adverse Event|11|||
145321827|NCT02973321|524026175|FG003|Overall Study|Adverse Event|13|||
145321828|NCT02973321|524026176|FG004|Overall Study|Adverse Event|3|||
145321829|NCT01098110|524026178|FG000|Overall Study|Withdrawal by Subject|14|||
145321830|NCT01098110|524026179|FG001|Overall Study|Withdrawal by Subject|24|||
145321831|NCT01098110|524026180|FG002|Overall Study|Withdrawal by Subject|19|||
145321832|NCT01098110|524026178|FG000|Overall Study|Adverse Event|30|||
145321833|NCT01098110|524026179|FG001|Overall Study|Adverse Event|32|||
145321834|NCT01098110|524026180|FG002|Overall Study|Adverse Event|43|||
145321835|NCT01098110|524026178|FG000|Overall Study|Lack of Efficacy|13|||
145321836|NCT01098110|524026179|FG001|Overall Study|Lack of Efficacy|9|||
145321837|NCT01098110|524026180|FG002|Overall Study|Lack of Efficacy|27|||
145321838|NCT01098110|524026178|FG000|Overall Study|Other|4|||
145321839|NCT01098110|524026179|FG001|Overall Study|Other|7|||
145321840|NCT01098110|524026180|FG002|Overall Study|Other|5|||
145321841|NCT01098110|524026178|FG000|Overall Study|Untreated|1|||
145321842|NCT01098110|524026179|FG001|Overall Study|Untreated|1|||
145321843|NCT01098110|524026180|FG002|Overall Study|Untreated|0|||
145321844|NCT00865514|524026181|FG000|Overall Study|Infusion cost exceeded funding|2|||
145321845|NCT03649412|524026182|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
145321846|NCT03649412|524026183|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
145321847|NCT03649412|524026182|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
145321848|NCT03649412|524026183|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
145321849|NCT03649412|524026182|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
145321850|NCT03649412|524026183|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145321851|NCT03649412|524026182|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
145321852|NCT03649412|524026183|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
145321853|NCT03649412|524026182|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
145321854|NCT03649412|524026183|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
145321855|NCT03649412|524026182|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
145321856|NCT03649412|524026183|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
145321857|NCT02865395|524026184|FG000|Overall Study|Physician Decision|6|||
145321858|NCT02865395|524026185|FG001|Overall Study|Physician Decision|10|||
145321859|NCT02865395|524026186|FG002|Overall Study|Physician Decision|7|||
145321860|NCT00530348|524026187|FG000|Overall Study|Adverse Event|5|||
145321861|NCT00530348|524026188|FG001|Overall Study|Adverse Event|1|||
145321862|NCT00530348|524026187|FG000|Overall Study|Death|0|||
145321863|NCT00530348|524026188|FG001|Overall Study|Death|1|||
145321864|NCT00530348|524026187|FG000|Overall Study|Lack of Efficacy|2|||
145321865|NCT00530348|524026188|FG001|Overall Study|Lack of Efficacy|0|||
145321866|NCT00530348|524026187|FG000|Overall Study|Lost to Follow-up|0|||
145321867|NCT00530348|524026188|FG001|Overall Study|Lost to Follow-up|2|||
145321868|NCT00530348|524026187|FG000|Overall Study|Physician Decision|1|||
145321869|NCT00530348|524026188|FG001|Overall Study|Physician Decision|2|||
145321870|NCT00530348|524026187|FG000|Overall Study|Pregnancy|1|||
145321871|NCT00530348|524026188|FG001|Overall Study|Pregnancy|0|||
145321872|NCT00530348|524026187|FG000|Overall Study|Withdrawal by Subject|12|||
145321873|NCT00530348|524026188|FG001|Overall Study|Withdrawal by Subject|12|||
145321874|NCT00530348|524026187|FG000|Overall Study|Randomised in error|1|||
145321875|NCT00530348|524026188|FG001|Overall Study|Randomised in error|0|||
145321876|NCT00530348|524026187|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
145321877|NCT00530348|524026188|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
145321878|NCT03920280|524026189|FG000|Overall Study|Adverse Event|2|||
145321879|NCT03920280|524026190|FG001|Overall Study|Adverse Event|3|||
145321880|NCT03920280|524026189|FG000|Overall Study|Lost to Follow-up|0|||
145321881|NCT03920280|524026190|FG001|Overall Study|Lost to Follow-up|1|||
145321882|NCT03920280|524026189|FG000|Overall Study|Withdrawal by Subject|1|||
145321883|NCT03920280|524026190|FG001|Overall Study|Withdrawal by Subject|1|||
145321884|NCT03920280|524026189|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
145321885|NCT03920280|524026190|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
145321886|NCT00939627|524026191|FG000|Overall Study|Disease Progression|16|||
145321887|NCT00939627|524026192|FG001|Overall Study|Disease Progression|12|||
145321888|NCT00939627|524026193|FG002|Overall Study|Disease Progression|0|||
145321889|NCT00939627|524026191|FG000|Overall Study|Adverse Event|6|||
145321890|NCT00939627|524026192|FG001|Overall Study|Adverse Event|7|||
145321891|NCT00939627|524026193|FG002|Overall Study|Adverse Event|0|||
145321892|NCT00939627|524026191|FG000|Overall Study|Death|0|||
145321893|NCT00939627|524026192|FG001|Overall Study|Death|2|||
145321894|NCT00939627|524026193|FG002|Overall Study|Death|0|||
145321895|NCT00939627|524026191|FG000|Overall Study|Withdrawal by Subject|2|||
145321896|NCT00939627|524026192|FG001|Overall Study|Withdrawal by Subject|4|||
145321897|NCT00939627|524026193|FG002|Overall Study|Withdrawal by Subject|0|||
145321898|NCT00939627|524026191|FG000|Overall Study|Other complicating disease|1|||
145321899|NCT00939627|524026192|FG001|Overall Study|Other complicating disease|1|||
145321900|NCT00939627|524026193|FG002|Overall Study|Other complicating disease|0|||
145321901|NCT00939627|524026191|FG000|Overall Study|Not compliant|2|||
145321902|NCT00939627|524026192|FG001|Overall Study|Not compliant|0|||
145321903|NCT00939627|524026193|FG002|Overall Study|Not compliant|0|||
145321904|NCT00939627|524026191|FG000|Overall Study|No off-tx reason given|0|||
145321905|NCT00939627|524026192|FG001|Overall Study|No off-tx reason given|2|||
145321906|NCT00939627|524026193|FG002|Overall Study|No off-tx reason given|0|||
145321907|NCT00537199|524026194|FG000|Overall Study|Study Terminated|1|||
145321908|NCT02039063|524026197|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
145321909|NCT02039063|524026198|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
145321910|NCT02039063|524026199|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
145321911|NCT02039063|524026200|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
145321912|NCT02039063|524026197|FG000|Treatment Phase|Progression of disease|0|||
145321913|NCT02039063|524026198|FG001|Treatment Phase|Progression of disease|0|||
145321914|NCT02039063|524026199|FG002|Treatment Phase|Progression of disease|1|||
145321915|NCT02039063|524026200|FG003|Treatment Phase|Progression of disease|1|||
145321916|NCT02039063|524026197|FG000|Extension Phase|Inadequate therapeutic effect|0|||
145321917|NCT02039063|524026198|FG001|Extension Phase|Inadequate therapeutic effect|1|||
145321918|NCT02039063|524026199|FG002|Extension Phase|Inadequate therapeutic effect|2|||
145321919|NCT02039063|524026200|FG003|Extension Phase|Inadequate therapeutic effect|0|||
145321920|NCT02039063|524026197|FG000|Extension Phase|Progression of disease|0|||
145321921|NCT02039063|524026198|FG001|Extension Phase|Progression of disease|0|||
145321922|NCT02039063|524026199|FG002|Extension Phase|Progression of disease|0|||
145321923|NCT02039063|524026200|FG003|Extension Phase|Progression of disease|1|||
145321924|NCT02039063|524026197|FG000|Extension Phase|Adverse Event|0|||
145321925|NCT02039063|524026198|FG001|Extension Phase|Adverse Event|0|||
145321926|NCT02039063|524026199|FG002|Extension Phase|Adverse Event|1|||
145321927|NCT02039063|524026200|FG003|Extension Phase|Adverse Event|0|||
145321928|NCT00467831|524026203|FG000|Overall Study|Death|2|||
145321929|NCT00467831|524026203|FG000|Overall Study|Withdrawal by Subject|1|||
145321930|NCT01832402|524026206|FG000|Overall Study|Lost to Follow-up|2|||
145321931|NCT01832402|524026207|FG001|Overall Study|Lost to Follow-up|0|||
145321932|NCT01832402|524026206|FG000|Overall Study|Withdrawal by Subject|3|||
145321933|NCT01832402|524026207|FG001|Overall Study|Withdrawal by Subject|3|||
145321934|NCT01832402|524026206|FG000|Overall Study|Declining Performance status|2|||
145321935|NCT01832402|524026207|FG001|Overall Study|Declining Performance status|1|||
145321936|NCT02776553|524026209|FG000|Overall Study|Lost to Follow-up|1|||
145321937|NCT02776553|524026210|FG001|Overall Study|Lost to Follow-up|0|||
145321938|NCT02776553|524026209|FG000|Overall Study|got liver transplant|1|||
145321939|NCT02776553|524026210|FG001|Overall Study|got liver transplant|2|||
145321940|NCT02776553|524026209|FG000|Overall Study|had other surgery|1|||
145321941|NCT02776553|524026210|FG001|Overall Study|had other surgery|0|||
145321942|NCT02776553|524026209|FG000|Overall Study|Protocol Violation|0|||
145321943|NCT02776553|524026210|FG001|Overall Study|Protocol Violation|1|||
145321944|NCT01998243|524026211|FG000|Overall Study|Pregnancy|0|||
145321945|NCT01998243|524026212|FG001|Overall Study|Pregnancy|1|||
145321946|NCT01998243|524026211|FG000|Overall Study|Protocol Violation|5|||
145321947|NCT01998243|524026212|FG001|Overall Study|Protocol Violation|2|||
145321948|NCT01998243|524026211|FG000|Overall Study|Withdrawal by Subject|3|||
145321949|NCT01998243|524026212|FG001|Overall Study|Withdrawal by Subject|4|||
145321950|NCT02492841|524026213|FG000|Overall Study|Lost to Follow-up|34|||
145321951|NCT02492841|524026214|FG001|Overall Study|Lost to Follow-up|31|||
145321952|NCT02492841|524026215|FG002|Overall Study|Lost to Follow-up|35|||
145321953|NCT02820740|524026216|FG000|Overall Study|Did not have procedure|2|||
145321954|NCT04965389|524026217|FG000|Overall Study|Other reasons|1|||
145321955|NCT04965389|524026218|FG001|Overall Study|Other reasons|0|||
145321956|NCT04965389|524026219|FG002|Overall Study|Other reasons|0|||
145321957|NCT04965389|524026220|FG003|Overall Study|Other reasons|0|||
145321958|NCT04965389|524026217|FG000|Overall Study|Participant withdrew consent|0|||
145321959|NCT04965389|524026218|FG001|Overall Study|Participant withdrew consent|1|||
145321960|NCT04965389|524026219|FG002|Overall Study|Participant withdrew consent|0|||
145321961|NCT04965389|524026220|FG003|Overall Study|Participant withdrew consent|0|||
145321962|NCT04965389|524026217|FG000|Overall Study|Poor/Non-compliance|0|||
145321963|NCT04965389|524026218|FG001|Overall Study|Poor/Non-compliance|1|||
145321964|NCT04965389|524026219|FG002|Overall Study|Poor/Non-compliance|0|||
145321965|NCT04965389|524026220|FG003|Overall Study|Poor/Non-compliance|0|||
145321966|NCT03903159|524026221|FG000|Overall Study|Discharged with Staff Approval|2|||
145321967|NCT03903159|524026221|FG000|Overall Study|Discharged at Staff Request|2|||
145321968|NCT03903159|524026221|FG000|Overall Study|Discharged Against Staff Advice|1|||
145321969|NCT00206102|524026227|FG000|Overall Study|Adverse Event|119|||
145321970|NCT00206102|524026228|FG001|Overall Study|Adverse Event|82|||
145321971|NCT00206102|524026227|FG000|Overall Study|Protocol Violation|0|||
145321972|NCT00206102|524026228|FG001|Overall Study|Protocol Violation|2|||
145321973|NCT00206102|524026227|FG000|Overall Study|Lack of therapeutic response|16|||
145321974|NCT00206102|524026228|FG001|Overall Study|Lack of therapeutic response|11|||
145321975|NCT00206102|524026227|FG000|Overall Study|Lost to Follow-up|95|||
145321976|NCT00206102|524026228|FG001|Overall Study|Lost to Follow-up|66|||
145321977|NCT00206102|524026227|FG000|Overall Study|Withdrawal by Subject|118|||
145321978|NCT00206102|524026228|FG001|Overall Study|Withdrawal by Subject|101|||
145321979|NCT00206102|524026227|FG000|Overall Study|Study-specific discontinuation criteria|18|||
145321980|NCT00206102|524026228|FG001|Overall Study|Study-specific discontinuation criteria|17|||
145321981|NCT00206102|524026227|FG000|Overall Study|None of those categories|42|||
145321982|NCT00206102|524026228|FG001|Overall Study|None of those categories|36|||
145321983|NCT04117945|524026229|FG000|Overall Study|Death|1|||
145321984|NCT04117945|524026230|FG001|Overall Study|Death|0|||
145321985|NCT04117945|524026229|FG000|Overall Study|Withdrawal by Subject|3|||
145321986|NCT04117945|524026230|FG001|Overall Study|Withdrawal by Subject|1|||
145321987|NCT04117945|524026229|FG000|Overall Study|Disease Progression|0|||
145321988|NCT04117945|524026230|FG001|Overall Study|Disease Progression|2|||
145321989|NCT04117945|524026229|FG000|Overall Study|Ineligible|8|||
145321990|NCT04117945|524026230|FG001|Overall Study|Ineligible|7|||
145321991|NCT00562120|524026236|FG000|First Intervention Period|Adverse Event|1|||
145321992|NCT00562120|524026237|FG001|First Intervention Period|Adverse Event|0|||
145321993|NCT00562120|524026238|FG002|First Intervention Period|Adverse Event|0|||
145321994|NCT00562120|524026239|FG003|First Intervention Period|Adverse Event|0|||
145321995|NCT00562120|524026236|FG000|First Intervention Period|Randomized but not Treated|1|||
145321996|NCT00562120|524026237|FG001|First Intervention Period|Randomized but not Treated|0|||
145321997|NCT00562120|524026238|FG002|First Intervention Period|Randomized but not Treated|0|||
145321998|NCT00562120|524026239|FG003|First Intervention Period|Randomized but not Treated|0|||
145321999|NCT02148445|524026240|FG000|Overall Study|Death|1|||
145322000|NCT02148445|524026241|FG001|Overall Study|Death|3|||
145322001|NCT03450629|524026242|FG000|Overall Study|Adverse Event|15|||
145322002|NCT03450629|524026243|FG001|Overall Study|Adverse Event|14|||
145322003|NCT03450629|524026242|FG000|Overall Study|Physician Decision|2|||
145322004|NCT03450629|524026243|FG001|Overall Study|Physician Decision|2|||
145322005|NCT03450629|524026242|FG000|Overall Study|Lack of Efficacy|2|||
145322006|NCT03450629|524026243|FG001|Overall Study|Lack of Efficacy|0|||
145322007|NCT03450629|524026242|FG000|Overall Study|Lost to Follow-up|4|||
145322008|NCT03450629|524026243|FG001|Overall Study|Lost to Follow-up|2|||
145322009|NCT03450629|524026242|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145322010|NCT03450629|524026243|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
145322011|NCT03450629|524026242|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145322012|NCT03450629|524026243|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145322013|NCT03450629|524026242|FG000|Overall Study|Protocol Violation|11|||
145322014|NCT03450629|524026243|FG001|Overall Study|Protocol Violation|8|||
145322015|NCT03450629|524026242|FG000|Overall Study|Withdrawal by Subject|12|||
145322016|NCT03450629|524026243|FG001|Overall Study|Withdrawal by Subject|6|||
145322017|NCT04230876|524026244|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
145322018|NCT04230876|524026245|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
145322019|NCT02093923|524026247|FG000|Overall Study|Lost to Follow-up|0|||
145322020|NCT02093923|524026248|FG001|Overall Study|Lost to Follow-up|0|||
145322021|NCT02093923|524026249|FG002|Overall Study|Lost to Follow-up|0|||
145322022|NCT02093923|524026250|FG003|Overall Study|Lost to Follow-up|1|||
145322023|NCT02093923|524026251|FG004|Overall Study|Lost to Follow-up|0|||
145322024|NCT02093923|524026247|FG000|Overall Study|Screen failure after randomization|0|||
145322025|NCT02093923|524026248|FG001|Overall Study|Screen failure after randomization|0|||
145322026|NCT02093923|524026249|FG002|Overall Study|Screen failure after randomization|0|||
145322027|NCT02093923|524026250|FG003|Overall Study|Screen failure after randomization|1|||
145322028|NCT02093923|524026251|FG004|Overall Study|Screen failure after randomization|0|||
145322029|NCT03438006|524026252|FG000|Overall Study|Adverse Event|1|||
145322030|NCT03438006|524026252|FG000|Overall Study|Lost to Follow-up|67|||
145322031|NCT03438006|524026252|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
145322032|NCT03438006|524026252|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
145322033|NCT01662362|524026267|FG000|Overall Study|Lost to Follow-up|38|||
145322034|NCT01181531|524026268|FG000|Overall Study|Other|17|||
145322035|NCT01181531|524026269|FG001|Overall Study|Other|12|||
145322036|NCT01181531|524026268|FG000|Overall Study|Partial consent by subject withdrawn|0|||
145322037|NCT01181531|524026269|FG001|Overall Study|Partial consent by subject withdrawn|1|||
145322038|NCT01181531|524026268|FG000|Overall Study|Physician Decision|3|||
145322039|NCT01181531|524026269|FG001|Overall Study|Physician Decision|1|||
145322040|NCT01181531|524026268|FG000|Overall Study|Noncompliance|2|||
145322041|NCT01181531|524026269|FG001|Overall Study|Noncompliance|2|||
145322042|NCT01181531|524026268|FG000|Overall Study|Ineligibility determined|1|||
145322043|NCT01181531|524026269|FG001|Overall Study|Ineligibility determined|2|||
145322044|NCT01181531|524026268|FG000|Overall Study|Protocol Specified Criteria|15|||
145322045|NCT01181531|524026269|FG001|Overall Study|Protocol Specified Criteria|8|||
145322046|NCT01181531|524026268|FG000|Overall Study|Pregnancy|0|||
145322047|NCT01181531|524026269|FG001|Overall Study|Pregnancy|1|||
145322048|NCT01181531|524026268|FG000|Overall Study|Withdrawal by Subject|8|||
145322049|NCT01181531|524026269|FG001|Overall Study|Withdrawal by Subject|7|||
145322050|NCT01181531|524026268|FG000|Overall Study|Protocol Violation|6|||
145322051|NCT01181531|524026269|FG001|Overall Study|Protocol Violation|6|||
145322052|NCT01181531|524026268|FG000|Overall Study|Death|9|||
145322053|NCT01181531|524026269|FG001|Overall Study|Death|12|||
145322054|NCT01181531|524026268|FG000|Overall Study|Adverse Event|0|||
145322055|NCT01181531|524026269|FG001|Overall Study|Adverse Event|1|||
145322056|NCT03183141|524026275|FG000|Overall Study|Withdrawal by Subject|2|||
145322057|NCT03183141|524026276|FG001|Overall Study|Withdrawal by Subject|4|||
145322058|NCT03183141|524026275|FG000|Overall Study|Death|0|||
145322059|NCT03183141|524026276|FG001|Overall Study|Death|8|||
145322060|NCT02756637|524026277|FG000|Overall Study|Not eligible for initial SWOG study|10|||
145322061|NCT02756637|524026278|FG001|Overall Study|Not eligible for initial SWOG study|10|||
145322062|NCT02756637|524026277|FG000|Overall Study|No available NLR value|44|||
145322063|NCT02756637|524026278|FG001|Overall Study|No available NLR value|44|||
145322064|NCT02756637|524026277|FG000|Overall Study|Did not complete curative therapy|33|||
145322065|NCT02756637|524026278|FG001|Overall Study|Did not complete curative therapy|0|||
145322066|NCT01507090|524026279|FG000|Overall Study|incomplete dataset|18|||
145322067|NCT01213836|524027765|FG000|Period 1, First Intervention|Adverse Event|2|||
145322068|NCT01213836|524027766|FG001|Period 1, First Intervention|Adverse Event|1|||
145570451|NCT02287896|524947401|FG001|Second Injection Visit|Withdrawal by Subject|1|||
145322069|NCT01213836|524027765|FG000|Period 1, First Intervention|Protocol Violation|0|||
145322070|NCT01213836|524027766|FG001|Period 1, First Intervention|Protocol Violation|1|||
145322071|NCT01213836|524027765|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
145322072|NCT01213836|524027766|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
145322073|NCT00706095|524027773|FG000|Overall Study|Progressive Disease|4|||
145322074|NCT00706095|524027774|FG001|Overall Study|Progressive Disease|5|||
145322075|NCT00706095|524027775|FG002|Overall Study|Progressive Disease|3|||
145322076|NCT00706095|524027773|FG000|Overall Study|Clinical Progression|1|||
145322077|NCT00706095|524027774|FG001|Overall Study|Clinical Progression|2|||
145322078|NCT00706095|524027775|FG002|Overall Study|Clinical Progression|2|||
145322079|NCT00706095|524027773|FG000|Overall Study|Withdrawal by Subject|1|||
145322080|NCT00706095|524027774|FG001|Overall Study|Withdrawal by Subject|0|||
145322081|NCT00706095|524027775|FG002|Overall Study|Withdrawal by Subject|0|||
145322082|NCT01005329|524027787|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
145322083|NCT02129647|524027792|FG000|Overall Study|Adverse Event|2|||
145322084|NCT02129647|524027792|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
145322085|NCT00986570|524027793|FG000|Overall Study|Lost to Follow-up|6|||
145322086|NCT00986570|524027793|FG000|Overall Study|Potential bias for objective assessment|1|||
145322087|NCT02225665|524027794|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
145322088|NCT02225665|524027795|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
145322089|NCT02225665|524027794|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
145322090|NCT02225665|524027795|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
145322091|NCT01311557|524027796|FG000|Overall Study|Serious adverse event|0|||
145322092|NCT01311557|524027797|FG001|Overall Study|Serious adverse event|1|||
145411834|NCT05177094|524362083|FG001|Overall Study|Protocol Deviation|0|||
145411835|NCT05177094|524362082|FG000|Overall Study|Withdrawal by Subject|6|||
145411836|NCT05177094|524362083|FG001|Overall Study|Withdrawal by Subject|3|||
145411837|NCT05177094|524362082|FG000|Overall Study|Participant could not tolerate long study visits|1|||
145411838|NCT05177094|524362083|FG001|Overall Study|Participant could not tolerate long study visits|0|||
145411839|NCT01033942|524362086|FG000|Overall Study|Withdrawal by Subject|1|||
145411840|NCT01033942|524362087|FG001|Overall Study|Withdrawal by Subject|1|||
145411841|NCT01033942|524362088|FG002|Overall Study|Withdrawal by Subject|1|||
145411842|NCT01033942|524362086|FG000|Overall Study|Lost to Follow-up|1|||
145411843|NCT01033942|524362087|FG001|Overall Study|Lost to Follow-up|0|||
145411844|NCT01033942|524362088|FG002|Overall Study|Lost to Follow-up|0|||
145411845|NCT01033942|524362086|FG000|Overall Study|Enrolled in Extension Study|0|||
145411846|NCT01033942|524362087|FG001|Overall Study|Enrolled in Extension Study|3|||
145411847|NCT01033942|524362088|FG002|Overall Study|Enrolled in Extension Study|0|||
145411848|NCT02513199|524362089|FG000|Treatment|Death|1|||
145411849|NCT02513199|524362089|FG000|Treatment|Lost to Follow-up|1|||
145411850|NCT02513199|524362089|FG000|Follow-Up|Death|11|||
145411851|NCT02260986|524362097|FG000|Overall Study|Adverse Event|24|||
145411852|NCT02260986|524362098|FG001|Overall Study|Adverse Event|0|||
145411853|NCT02260986|524362099|FG002|Overall Study|Adverse Event|11|||
145322093|NCT01311557|524027796|FG000|Overall Study|Protocol Violation|4|||
145322094|NCT01311557|524027797|FG001|Overall Study|Protocol Violation|2|||
145322095|NCT01311557|524027796|FG000|Overall Study|Lost to Follow-up|0|||
145322096|NCT01311557|524027797|FG001|Overall Study|Lost to Follow-up|1|||
145322097|NCT01311557|524027796|FG000|Overall Study|Withdrawal by Subject|1|||
145322098|NCT01311557|524027797|FG001|Overall Study|Withdrawal by Subject|2|||
145322099|NCT00608517|524027798|FG000|Overall Study|Death|1|||
145322100|NCT00608517|524027799|FG001|Overall Study|Death|0|||
145322101|NCT00608517|524027800|FG002|Overall Study|Death|0|||
145322102|NCT01833533|524027801|FG000|Overall Study|Adverse Event|0|||
145322103|NCT01833533|524027802|FG001|Overall Study|Adverse Event|1|||
145322104|NCT01833533|524027801|FG000|Overall Study|Lost to Follow-up|4|||
145322105|NCT01833533|524027802|FG001|Overall Study|Lost to Follow-up|9|||
145322106|NCT01833533|524027801|FG000|Overall Study|To Enter an Extension Study|0|||
145570452|NCT02552316|524947402|FG000|Overall Study|Withdrawal by Subject|1|||
145570453|NCT02552316|524947402|FG000|Overall Study|Withdrawal due to non-compliance|1|||
145570454|NCT04382911|524947403|FG000|Overall Study|unable to be imaged prior to surgery|2|||
145570455|NCT04049760|524947407|FG000|Overall Study|Withdrawal by Subject|1|||
145570456|NCT04697628|524947408|FG000|Overall Study|Withdrawal by Subject|17|||
145322107|NCT01833533|524027802|FG001|Overall Study|To Enter an Extension Study|4|||
145322108|NCT01833533|524027801|FG000|Overall Study|Other|2|||
145322109|NCT01833533|524027802|FG001|Overall Study|Other|7|||
145322110|NCT05212883|524027805|FG000|Overall Study|Invalid test result|125|||
145322111|NCT02502734|524027806|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
145570457|NCT04697628|524947409|FG001|Overall Study|Withdrawal by Subject|23|||
145322112|NCT02502734|524027807|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
145322113|NCT02502734|524027806|FG000|Washout Period|Adverse Event|1|||
145322114|NCT02502734|524027807|FG001|Washout Period|Adverse Event|0|||
145322115|NCT01740791|524027811|FG000|Overall Study|Randomized but never treated|5|||
145322116|NCT01740791|524027812|FG001|Overall Study|Randomized but never treated|3|||
145322117|NCT01740791|524027813|FG002|Overall Study|Randomized but never treated|2|||
145322118|NCT01740791|524027814|FG003|Overall Study|Randomized but never treated|2|||
145322119|NCT01740791|524027815|FG004|Overall Study|Randomized but never treated|1|||
145322120|NCT01740791|524027816|FG005|Overall Study|Randomized but never treated|3|||
145322121|NCT01740791|524027811|FG000|Overall Study|Lost to Follow-up|2|||
145322122|NCT01740791|524027812|FG001|Overall Study|Lost to Follow-up|0|||
145322123|NCT01740791|524027813|FG002|Overall Study|Lost to Follow-up|2|||
145322124|NCT01740791|524027814|FG003|Overall Study|Lost to Follow-up|3|||
145322125|NCT01740791|524027815|FG004|Overall Study|Lost to Follow-up|2|||
145322126|NCT01740791|524027816|FG005|Overall Study|Lost to Follow-up|3|||
145322127|NCT01740791|524027811|FG000|Overall Study|Withdrew Consent|4|||
145322128|NCT01740791|524027812|FG001|Overall Study|Withdrew Consent|0|||
145322129|NCT01740791|524027813|FG002|Overall Study|Withdrew Consent|1|||
145322130|NCT01740791|524027814|FG003|Overall Study|Withdrew Consent|2|||
145322131|NCT01740791|524027815|FG004|Overall Study|Withdrew Consent|0|||
145322132|NCT01740791|524027816|FG005|Overall Study|Withdrew Consent|3|||
145322133|NCT01740791|524027811|FG000|Overall Study|Investigator's discretion|1|||
145411854|NCT02260986|524362097|FG000|Overall Study|Lack of Efficacy|27|||
145411855|NCT02260986|524362098|FG001|Overall Study|Lack of Efficacy|3|||
145411856|NCT02260986|524362099|FG002|Overall Study|Lack of Efficacy|0|||
145411857|NCT02260986|524362097|FG000|Overall Study|Protocol Violation|14|||
145411858|NCT02260986|524362098|FG001|Overall Study|Protocol Violation|5|||
145411859|NCT02260986|524362099|FG002|Overall Study|Protocol Violation|16|||
145411860|NCT02260986|524362097|FG000|Overall Study|Car accident|0|||
145411861|NCT02260986|524362098|FG001|Overall Study|Car accident|0|||
145411862|NCT02260986|524362099|FG002|Overall Study|Car accident|1|||
145411863|NCT02260986|524362097|FG000|Overall Study|Withdrawal by Subject|17|||
145411864|NCT02260986|524362098|FG001|Overall Study|Withdrawal by Subject|4|||
145411865|NCT02260986|524362099|FG002|Overall Study|Withdrawal by Subject|9|||
145411866|NCT02260986|524362097|FG000|Overall Study|Incorrect randomization|0|||
145411867|NCT02260986|524362098|FG001|Overall Study|Incorrect randomization|1|||
145411868|NCT02260986|524362099|FG002|Overall Study|Incorrect randomization|0|||
145411869|NCT02260986|524362097|FG000|Overall Study|Lack of investigation product supply|2|||
145411870|NCT02260986|524362098|FG001|Overall Study|Lack of investigation product supply|0|||
145411871|NCT02260986|524362099|FG002|Overall Study|Lack of investigation product supply|1|||
145411872|NCT02260986|524362097|FG000|Overall Study|Lost to Follow-up|4|||
145411873|NCT02260986|524362098|FG001|Overall Study|Lost to Follow-up|0|||
145411874|NCT02260986|524362099|FG002|Overall Study|Lost to Follow-up|3|||
145411875|NCT02260986|524362097|FG000|Overall Study|Pregnancy|2|||
145411876|NCT02260986|524362098|FG001|Overall Study|Pregnancy|0|||
145411877|NCT02260986|524362099|FG002|Overall Study|Pregnancy|0|||
145411878|NCT02397837|524362101|FG000|Overall Study|Withdrawal by Subject|6|||
145411879|NCT02397837|524362102|FG001|Overall Study|Withdrawal by Subject|5|||
145411880|NCT02397837|524362101|FG000|Overall Study|Physician Decision|1|||
145411881|NCT02397837|524362102|FG001|Overall Study|Physician Decision|1|||
145411882|NCT00407511|524362110|FG000|Overall Study|Adverse Event|9|||
145411883|NCT00407511|524362110|FG000|Overall Study|Lost to Follow-up|4|||
145411884|NCT00407511|524362110|FG000|Overall Study|Other|5|||
145411885|NCT00407511|524362110|FG000|Overall Study|Withdrawal by Subject|4|||
145411886|NCT00529035|524362111|FG000|Overall Study|Withdrawal by Subject|1|||
145411887|NCT02493855|524362114|FG000|Overall Study|Non-compliance|1|||
145411888|NCT02493855|524362115|FG001|Overall Study|Non-compliance|0|||
145411889|NCT02493855|524362116|FG002|Overall Study|Non-compliance|0|||
145411890|NCT02493855|524362114|FG000|Overall Study|Adverse Event|0|||
145411891|NCT02493855|524362115|FG001|Overall Study|Adverse Event|1|||
145411892|NCT02493855|524362116|FG002|Overall Study|Adverse Event|0|||
145411893|NCT02493855|524362114|FG000|Overall Study|Withdrawal by Subject|1|||
145411894|NCT02493855|524362115|FG001|Overall Study|Withdrawal by Subject|0|||
145411895|NCT02493855|524362116|FG002|Overall Study|Withdrawal by Subject|0|||
145411896|NCT04339972|524362120|FG000|Overall Study|Scheduling Issues|3|||
145322134|NCT01740791|524027812|FG001|Overall Study|Investigator's discretion|0|||
145322135|NCT01740791|524027813|FG002|Overall Study|Investigator's discretion|1|||
145322136|NCT01740791|524027814|FG003|Overall Study|Investigator's discretion|0|||
145322137|NCT01740791|524027815|FG004|Overall Study|Investigator's discretion|0|||
145411897|NCT04339972|524362121|FG001|Overall Study|Scheduling Issues|3|||
145411898|NCT04339972|524362120|FG000|Overall Study|dropout|1|||
145411899|NCT04339972|524362121|FG001|Overall Study|dropout|1|||
145411900|NCT04339972|524362120|FG000|Overall Study|Technical issues|1|||
145322138|NCT01740791|524027816|FG005|Overall Study|Investigator's discretion|1|||
145322139|NCT01740791|524027811|FG000|Overall Study|Adverse Event|0|||
145411901|NCT04339972|524362121|FG001|Overall Study|Technical issues|0|||
145411902|NCT04339972|524362120|FG000|Overall Study|Claustraphobia|0|||
145411903|NCT04339972|524362121|FG001|Overall Study|Claustraphobia|1|||
145411904|NCT00776997|524362122|FG000|Overall Study|Adverse Event|2|||
145411905|NCT02403271|524362123|FG000|Period 1|Other varied reasons|1|||
145411906|NCT02403271|524362124|FG001|Period 1|Other varied reasons|0|||
145411907|NCT02403271|524362123|FG000|Period 2|Withdrawal by Subject|0|||
145322140|NCT01740791|524027812|FG001|Overall Study|Adverse Event|0|||
145411908|NCT02403271|524362124|FG001|Period 2|Withdrawal by Subject|14|||
145411909|NCT02403271|524362123|FG000|Period 2|Death|0|||
145411910|NCT02403271|524362124|FG001|Period 2|Death|84|||
145411911|NCT02403271|524362123|FG000|Period 2|Lost to Follow-up|0|||
145411912|NCT02403271|524362124|FG001|Period 2|Lost to Follow-up|2|||
145411913|NCT02403271|524362123|FG000|Period 2|Study Terminated by Sponsor|0|||
145411914|NCT02403271|524362124|FG001|Period 2|Study Terminated by Sponsor|14|||
145411915|NCT02403271|524362123|FG000|Period 2|Other varied reasons|0|||
145411916|NCT02403271|524362124|FG001|Period 2|Other varied reasons|10|||
145411917|NCT05221866|524362127|FG000|Overall Study|Withdrawal by Subject|5|||
145411918|NCT05221866|524362128|FG001|Overall Study|Withdrawal by Subject|7|||
145411919|NCT05221866|524362129|FG002|Overall Study|Withdrawal by Subject|6|||
145411920|NCT05221866|524362130|FG003|Overall Study|Withdrawal by Subject|4|||
145411921|NCT05221866|524362127|FG000|Overall Study|Physician Decision|3|||
145411922|NCT05221866|524362128|FG001|Overall Study|Physician Decision|2|||
145411923|NCT05221866|524362129|FG002|Overall Study|Physician Decision|1|||
145411924|NCT05221866|524362130|FG003|Overall Study|Physician Decision|4|||
145411925|NCT05221866|524362127|FG000|Overall Study|Lost to Follow-up|12|||
145411926|NCT05221866|524362128|FG001|Overall Study|Lost to Follow-up|17|||
145411927|NCT05221866|524362129|FG002|Overall Study|Lost to Follow-up|14|||
145411928|NCT05221866|524362130|FG003|Overall Study|Lost to Follow-up|14|||
145411929|NCT05221866|524362127|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
145411930|NCT05221866|524362128|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
145411931|NCT05221866|524362129|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
145411932|NCT05221866|524362130|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
145411933|NCT03487445|524362131|FG000|Randomization|Not treated for administrative reasons|1|||
145411934|NCT03487445|524362132|FG001|Randomization|Not treated for administrative reasons|0|||
145411935|NCT00221104|524362133|FG000|Overall Study|Adverse Event|1|||
145411936|NCT00221104|524362134|FG001|Overall Study|Adverse Event|0|||
145411937|NCT00221104|524362133|FG000|Overall Study|Physician Decision|1|||
145411938|NCT00221104|524362134|FG001|Overall Study|Physician Decision|0|||
145411939|NCT00221104|524362133|FG000|Overall Study|Protocol Violation|2|||
145411940|NCT00221104|524362134|FG001|Overall Study|Protocol Violation|0|||
145411941|NCT00221104|524362133|FG000|Overall Study|Withdrawal by Subject|42|||
145411942|NCT00221104|524362134|FG001|Overall Study|Withdrawal by Subject|29|||
145411943|NCT00221104|524362133|FG000|Overall Study|Others|37|||
145411944|NCT00221104|524362134|FG001|Overall Study|Others|47|||
145411945|NCT02989389|524362135|FG000|Period 1|Lost to Follow-up|0|||
145411946|NCT02989389|524362136|FG001|Period 1|Lost to Follow-up|1|||
145411947|NCT02989389|524362137|FG002|Period 1|Lost to Follow-up|0|||
145411948|NCT02989389|524362138|FG003|Period 1|Lost to Follow-up|0|||
145322141|NCT01740791|524027813|FG002|Overall Study|Adverse Event|0|||
145322142|NCT01740791|524027814|FG003|Overall Study|Adverse Event|0|||
145322143|NCT01740791|524027815|FG004|Overall Study|Adverse Event|0|||
145322144|NCT01740791|524027816|FG005|Overall Study|Adverse Event|1|||
145322145|NCT01463982|524027817|FG000|Overall Study|Withdrawal by Subject|0|||
145322146|NCT01463982|524027818|FG001|Overall Study|Withdrawal by Subject|1|||
145322147|NCT01463982|524027819|FG002|Overall Study|Withdrawal by Subject|1|||
145322148|NCT01463982|524027820|FG003|Overall Study|Withdrawal by Subject|0|||
145322149|NCT01463982|524027817|FG000|Overall Study|Treatment delay over 5 week|0|||
145322150|NCT01463982|524027818|FG001|Overall Study|Treatment delay over 5 week|0|||
145322151|NCT01463982|524027819|FG002|Overall Study|Treatment delay over 5 week|1|||
145322152|NCT01463982|524027820|FG003|Overall Study|Treatment delay over 5 week|0|||
145322153|NCT02075606|524027823|FG000|Overall Study|Adverse Event|5|||
145322154|NCT02075606|524027823|FG000|Overall Study|Withdrawal by Subject|1|||
145322155|NCT02075606|524027823|FG000|Overall Study|Death|1|||
145322156|NCT02075606|524027823|FG000|Overall Study|Investigator's decision|1|||
145322157|NCT02075606|524027823|FG000|Overall Study|Symptom management|1|||
145322158|NCT02075606|524027823|FG000|Overall Study|Increasing Symptoms|1|||
145322159|NCT01439724|524027826|FG000|Overall Study|missing consultation|9|||
145322160|NCT01439724|524027827|FG001|Overall Study|missing consultation|8|||
145322161|NCT04019054|524027828|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
145322162|NCT04019054|524027829|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
145322163|NCT04019054|524027828|FG000|Overall Study|Withdrawal by Subject|3|||
145322164|NCT04019054|524027829|FG001|Overall Study|Withdrawal by Subject|1|||
145322165|NCT01261624|524027835|FG000|Week 0 to Week 12|Disease Progression|1|||
145322166|NCT01261624|524027836|FG001|Week 0 to Week 12|Disease Progression|1|||
145322167|NCT01261624|524027835|FG000|Week 0 to Week 12|Insufficient Response|0|||
145322168|NCT01261624|524027836|FG001|Week 0 to Week 12|Insufficient Response|2|||
145322169|NCT01261624|524027835|FG000|Week 13 to Week 24|Insufficient Response|0|||
145322170|NCT01261624|524027836|FG001|Week 13 to Week 24|Insufficient Response|1|||
145322171|NCT00271024|524027837|FG000|Overall Study|Lost Interest|3|||
145322172|NCT00271024|524027838|FG001|Overall Study|Lost Interest|4|||
145411949|NCT02989389|524362139|FG004|Period 1|Lost to Follow-up|0|||
145411950|NCT02989389|524362140|FG005|Period 1|Lost to Follow-up|0|||
145411951|NCT02989389|524362141|FG006|Period 1|Lost to Follow-up|0|||
145322173|NCT00271024|524027839|FG002|Overall Study|Lost Interest|2|||
145322174|NCT00271024|524027840|FG003|Overall Study|Lost Interest|3|||
145322175|NCT00271024|524027837|FG000|Overall Study|Unknown/Unspecified|11|||
145322176|NCT00271024|524027838|FG001|Overall Study|Unknown/Unspecified|11|||
145322177|NCT00271024|524027839|FG002|Overall Study|Unknown/Unspecified|8|||
145322178|NCT00271024|524027840|FG003|Overall Study|Unknown/Unspecified|4|||
145322179|NCT00271024|524027837|FG000|Overall Study|Protocol Violation|1|||
145322180|NCT00271024|524027838|FG001|Overall Study|Protocol Violation|6|||
145322181|NCT00271024|524027839|FG002|Overall Study|Protocol Violation|5|||
145322182|NCT00271024|524027840|FG003|Overall Study|Protocol Violation|11|||
145322183|NCT00271024|524027837|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
145322184|NCT00271024|524027838|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
145322185|NCT00271024|524027839|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
145322186|NCT00271024|524027840|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
145322187|NCT00271024|524027837|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
145322188|NCT00271024|524027838|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
145322189|NCT00271024|524027839|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
145322190|NCT00271024|524027840|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
145322191|NCT00508027|524027851|FG000|Dose Level 1|Lost to Follow-up|4|||
145322192|NCT00508027|524027851|FG000|Dose Level 1|Withdrawal by Subject|2|||
145322193|NCT00508027|524027851|FG000|Dose Level 1|Physician Decision|2|||
145322194|NCT00508027|524027851|FG000|Dose Level 2|Lost to Follow-up|2|||
145322195|NCT00508027|524027851|FG000|Dose Level 2|Withdrawal by Subject|2|||
145322196|NCT01719562|524027852|FG000|Overall Study|Lost to Follow-up|1|||
145322197|NCT01719562|524027853|FG001|Overall Study|Lost to Follow-up|0|||
145322198|NCT01719562|524027852|FG000|Overall Study|Death|1|||
145322199|NCT01719562|524027853|FG001|Overall Study|Death|0|||
145322200|NCT01719562|524027852|FG000|Overall Study|New cancer diagnosis|1|||
145322201|NCT01719562|524027853|FG001|Overall Study|New cancer diagnosis|0|||
145322202|NCT02013531|524027856|FG000|Overall Study|Lost to Follow-up|3|||
145322203|NCT02013531|524027856|FG000|Overall Study|Met Withdrawal Criteria|1|||
145322204|NCT02013531|524027856|FG000|Overall Study|Withdrawal by Subject|1|||
145322205|NCT03877926|524027857|FG000|Overall Study|Adverse Event|1|||
145322206|NCT03877926|524027858|FG001|Overall Study|Adverse Event|0|||
145322207|NCT03877926|524027859|FG002|Overall Study|Adverse Event|0|||
145322208|NCT03877926|524027860|FG003|Overall Study|Adverse Event|0|||
145322209|NCT03877926|524027857|FG000|Overall Study|Death|2|||
145411952|NCT02989389|524362142|FG007|Period 1|Lost to Follow-up|0|||
145411953|NCT02989389|524362143|FG008|Period 1|Lost to Follow-up|0|||
145411954|NCT02989389|524362144|FG009|Period 1|Lost to Follow-up|0|||
145411955|NCT02989389|524362135|FG000|Period 1|Physician Decision|0|||
145411956|NCT02989389|524362136|FG001|Period 1|Physician Decision|0|||
145411957|NCT02989389|524362137|FG002|Period 1|Physician Decision|0|||
145411958|NCT02989389|524362138|FG003|Period 1|Physician Decision|0|||
145411959|NCT02989389|524362139|FG004|Period 1|Physician Decision|0|||
145411960|NCT02989389|524362140|FG005|Period 1|Physician Decision|0|||
145411961|NCT02989389|524362141|FG006|Period 1|Physician Decision|0|||
145411962|NCT02989389|524362142|FG007|Period 1|Physician Decision|0|||
145411963|NCT02989389|524362143|FG008|Period 1|Physician Decision|1|||
145411964|NCT02989389|524362144|FG009|Period 1|Physician Decision|0|||
145411965|NCT01666652|524362145|FG000|Overall Study|Serious Adverse Event|0|||
145411966|NCT01666652|524362146|FG001|Overall Study|Serious Adverse Event|0|||
145411967|NCT01666652|524362147|FG002|Overall Study|Serious Adverse Event|0|||
145411968|NCT01666652|524362148|FG003|Overall Study|Serious Adverse Event|1|||
145322210|NCT03877926|524027858|FG001|Overall Study|Death|2|||
145322211|NCT03877926|524027859|FG002|Overall Study|Death|2|||
145322212|NCT03877926|524027860|FG003|Overall Study|Death|0|||
145322213|NCT03877926|524027857|FG000|Overall Study|Lost to Follow-up|41|||
145322214|NCT03877926|524027858|FG001|Overall Study|Lost to Follow-up|52|||
145322215|NCT03877926|524027859|FG002|Overall Study|Lost to Follow-up|45|||
145411969|NCT01666652|524362149|FG004|Overall Study|Serious Adverse Event|0|||
145411970|NCT01666652|524362145|FG000|Overall Study|Withdrawal by Subject|0|||
145411971|NCT01666652|524362146|FG001|Overall Study|Withdrawal by Subject|0|||
145411972|NCT01666652|524362147|FG002|Overall Study|Withdrawal by Subject|0|||
145411973|NCT01666652|524362148|FG003|Overall Study|Withdrawal by Subject|0|||
145411974|NCT01666652|524362149|FG004|Overall Study|Withdrawal by Subject|1|||
145411975|NCT01666652|524362145|FG000|Overall Study|Moved from study area|1|||
145411976|NCT01666652|524362146|FG001|Overall Study|Moved from study area|0|||
145322216|NCT03877926|524027860|FG003|Overall Study|Lost to Follow-up|17|||
145322217|NCT03877926|524027857|FG000|Overall Study|Physician Decision|2|||
145411977|NCT01666652|524362147|FG002|Overall Study|Moved from study area|0|||
145322218|NCT03877926|524027858|FG001|Overall Study|Physician Decision|0|||
145322219|NCT03877926|524027859|FG002|Overall Study|Physician Decision|2|||
145322220|NCT03877926|524027860|FG003|Overall Study|Physician Decision|0|||
145322221|NCT03877926|524027857|FG000|Overall Study|Withdrawal by Subject|18|||
145322222|NCT03877926|524027858|FG001|Overall Study|Withdrawal by Subject|21|||
145411978|NCT01666652|524362148|FG003|Overall Study|Moved from study area|2|||
145411979|NCT01666652|524362149|FG004|Overall Study|Moved from study area|0|||
145411980|NCT01666652|524362145|FG000|Overall Study|Lost to Follow-up|1|||
145411981|NCT01666652|524362146|FG001|Overall Study|Lost to Follow-up|1|||
145411982|NCT01666652|524362147|FG002|Overall Study|Lost to Follow-up|1|||
145411983|NCT01666652|524362148|FG003|Overall Study|Lost to Follow-up|1|||
145411984|NCT01666652|524362149|FG004|Overall Study|Lost to Follow-up|0|||
145411985|NCT04470427|524362150|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
145411986|NCT04470427|524362151|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
145411987|NCT04470427|524362152|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
145411988|NCT04470427|524362153|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
145411989|NCT04470427|524362154|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
145411990|NCT04470427|524362155|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
145411991|NCT04470427|524362150|FG000|Part B :Open-label|Other than specified|0|||
145411992|NCT04470427|524362151|FG001|Part B :Open-label|Other than specified|0|||
145411993|NCT04470427|524362152|FG002|Part B :Open-label|Other than specified|788|||
145411994|NCT04470427|524362153|FG003|Part B :Open-label|Other than specified|0|||
145411995|NCT04470427|524362154|FG004|Part B :Open-label|Other than specified|523|||
145411996|NCT04470427|524362155|FG005|Part B :Open-label|Other than specified|0|||
145411997|NCT04470427|524362150|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
145411998|NCT04470427|524362151|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
145411999|NCT04470427|524362152|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
145412000|NCT04470427|524362153|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
145412001|NCT04470427|524362154|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
145412002|NCT04470427|524362155|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
145412003|NCT04470427|524362150|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
145412004|NCT04470427|524362151|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
145412005|NCT04470427|524362152|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
145412006|NCT04470427|524362153|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
145412007|NCT04470427|524362154|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
145412008|NCT04470427|524362155|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
145412009|NCT01018979|524362156|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
145412010|NCT01018979|524362157|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
145412011|NCT01018979|524362156|FG000|Overall Study|Not received at least one dose|0|||
145412012|NCT01018979|524362157|FG001|Overall Study|Not received at least one dose|1|||
145412013|NCT01695746|524362158|FG000|Overall Study|Adverse Event|1|||
145412014|NCT01695746|524362158|FG000|Overall Study|Non-compliance by the participant|3|||
145412015|NCT01695746|524362158|FG000|Overall Study|Protocol Violation|5|||
145412016|NCT01695746|524362158|FG000|Overall Study|Participant not willing to participate|3|||
145412017|NCT03976375|524362161|FG000|Overall Study|Death|158|||
145322223|NCT03877926|524027859|FG002|Overall Study|Withdrawal by Subject|12|||
145322224|NCT03877926|524027860|FG003|Overall Study|Withdrawal by Subject|4|||
145322225|NCT03877926|524027857|FG000|Overall Study|Other - Various|4|||
145322226|NCT03877926|524027858|FG001|Overall Study|Other - Various|1|||
145322227|NCT03877926|524027859|FG002|Overall Study|Other - Various|1|||
145322228|NCT03877926|524027860|FG003|Overall Study|Other - Various|0|||
145322229|NCT03877926|524027857|FG000|Overall Study|Not Treated|3|||
145322230|NCT03877926|524027858|FG001|Overall Study|Not Treated|1|||
145322231|NCT03877926|524027859|FG002|Overall Study|Not Treated|1|||
145322232|NCT03877926|524027860|FG003|Overall Study|Not Treated|0|||
145322233|NCT03417830|524027866|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
145322234|NCT03417830|524027867|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
145322235|NCT00941720|524027872|FG000|Overall Study|Withdrawal by Subject|1|||
145322236|NCT00941720|524027872|FG000|Overall Study|Insurance denied participation|11|||
145322237|NCT00941720|524027872|FG000|Overall Study|ineligible|2|||
145322238|NCT03827018|524027875|FG000|Overall Study|Adverse Event|1|||
145322239|NCT03827018|524027876|FG001|Overall Study|Adverse Event|0|||
145322240|NCT03827018|524027875|FG000|Overall Study|Withdrawal by Subject|2|||
145322241|NCT03827018|524027876|FG001|Overall Study|Withdrawal by Subject|2|||
145322242|NCT03827018|524027875|FG000|Overall Study|Lack of Efficacy|0|||
145322243|NCT03827018|524027876|FG001|Overall Study|Lack of Efficacy|1|||
145322244|NCT03078478|524027878|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
145322245|NCT03078478|524027879|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
145412018|NCT03976375|524362162|FG001|Overall Study|Death|160|||
145322246|NCT03078478|524027878|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
145322247|NCT03078478|524027879|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
145412019|NCT03976375|524362163|FG002|Overall Study|Death|42|||
145412020|NCT03976375|524362161|FG000|Overall Study|Lost to Follow-up|2|||
145412021|NCT03976375|524362162|FG001|Overall Study|Lost to Follow-up|1|||
145412022|NCT03976375|524362163|FG002|Overall Study|Lost to Follow-up|1|||
145412023|NCT03976375|524362161|FG000|Overall Study|Withdrawal by Subject|5|||
145412024|NCT03976375|524362162|FG001|Overall Study|Withdrawal by Subject|9|||
145322248|NCT03078478|524027878|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
145322249|NCT03078478|524027879|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
145322250|NCT03078478|524027878|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
145322251|NCT03078478|524027879|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
145570458|NCT04697628|524947408|FG000|Overall Study|Lost to Follow-up|0|||
145570459|NCT04697628|524947409|FG001|Overall Study|Lost to Follow-up|4|||
145570460|NCT04697628|524947408|FG000|Overall Study|On-going in study|122|||
145570461|NCT04697628|524947409|FG001|Overall Study|On-going in study|91|||
145570462|NCT00974571|524947410|FG000|Overall Study|Adverse Event|31|||
145570463|NCT00974571|524947411|FG001|Overall Study|Adverse Event|4|||
145570464|NCT00974571|524947412|FG002|Overall Study|Adverse Event|27|||
145570465|NCT00974571|524947410|FG000|Overall Study|Lack of Efficacy|3|||
145570466|NCT00974571|524947411|FG001|Overall Study|Lack of Efficacy|2|||
145570467|NCT00974571|524947412|FG002|Overall Study|Lack of Efficacy|9|||
145322252|NCT03078478|524027878|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
145570468|NCT00974571|524947410|FG000|Overall Study|Lost to Follow-up|2|||
145570469|NCT00974571|524947411|FG001|Overall Study|Lost to Follow-up|1|||
145570470|NCT00974571|524947412|FG002|Overall Study|Lost to Follow-up|2|||
145570471|NCT00974571|524947410|FG000|Overall Study|Protocol Violation|13|||
145570472|NCT00974571|524947411|FG001|Overall Study|Protocol Violation|4|||
145570473|NCT00974571|524947412|FG002|Overall Study|Protocol Violation|18|||
145570474|NCT00974571|524947410|FG000|Overall Study|Withdrawal by Subject|14|||
145570475|NCT00974571|524947411|FG001|Overall Study|Withdrawal by Subject|5|||
145570476|NCT00974571|524947412|FG002|Overall Study|Withdrawal by Subject|16|||
145570477|NCT00974571|524947410|FG000|Overall Study|Patient Moved|1|||
145570478|NCT00974571|524947411|FG001|Overall Study|Patient Moved|0|||
145570479|NCT00974571|524947412|FG002|Overall Study|Patient Moved|1|||
145570480|NCT00974571|524947410|FG000|Overall Study|Other|4|||
145570481|NCT00974571|524947411|FG001|Overall Study|Other|0|||
145570482|NCT00974571|524947412|FG002|Overall Study|Other|10|||
145570483|NCT00393939|524947413|FG000|Overall Study|Protocol Violation|1|||
145570484|NCT00393939|524947414|FG001|Overall Study|Protocol Violation|1|||
145570485|NCT00393939|524947413|FG000|Overall Study|Lost to Follow-up|2|||
145570486|NCT00393939|524947414|FG001|Overall Study|Lost to Follow-up|4|||
145570487|NCT00393939|524947413|FG000|Overall Study|Death|10|||
145570488|NCT00393939|524947414|FG001|Overall Study|Death|4|||
145570489|NCT00393939|524947413|FG000|Overall Study|Sponsor|5|||
145570490|NCT00393939|524947414|FG001|Overall Study|Sponsor|13|||
145570491|NCT00393939|524947413|FG000|Overall Study|Objective progression or relapse|239|||
145570492|NCT00393939|524947414|FG001|Overall Study|Objective progression or relapse|223|||
145570493|NCT00393939|524947413|FG000|Overall Study|Withdrawal by Subject|2|||
145570494|NCT00393939|524947414|FG001|Overall Study|Withdrawal by Subject|7|||
145570495|NCT00393939|524947413|FG000|Overall Study|Other|37|||
145570496|NCT00393939|524947414|FG001|Overall Study|Other|45|||
145570497|NCT02385799|524947415|FG000|Overall Study|Lost to Follow-up|1|||
145570498|NCT02385799|524947416|FG001|Overall Study|Lost to Follow-up|2|||
145570499|NCT02385799|524947415|FG000|Overall Study|Adverse Event|4|||
145570500|NCT02385799|524947416|FG001|Overall Study|Adverse Event|2|||
145570501|NCT02385799|524947415|FG000|Overall Study|Withdrawal by Subject|0|||
145570502|NCT02385799|524947416|FG001|Overall Study|Withdrawal by Subject|4|||
145570503|NCT00547703|524947417|FG000|Overall Study|Lost to Follow-up|1|||
145570504|NCT00547703|524947418|FG001|Overall Study|Lost to Follow-up|0|||
145570505|NCT02275481|524947419|FG000|Overall Study|Death|2|||
145570506|NCT02275481|524947420|FG001|Overall Study|Death|1|||
145570507|NCT02275481|524947419|FG000|Overall Study|Lost to Follow-up|2|||
145570508|NCT02275481|524947420|FG001|Overall Study|Lost to Follow-up|0|||
145570509|NCT02275481|524947419|FG000|Overall Study|Withdrawal by Subject|3|||
145570510|NCT02275481|524947420|FG001|Overall Study|Withdrawal by Subject|0|||
145570511|NCT02275481|524947419|FG000|Overall Study|all other reasons combined|2|||
145570512|NCT02275481|524947420|FG001|Overall Study|all other reasons combined|1|||
145570513|NCT02275481|524947419|FG000|Overall Study|Physician Decision|0|||
145570514|NCT02275481|524947420|FG001|Overall Study|Physician Decision|1|||
145570515|NCT01838642|524947422|FG000|Overall Study|Died on study|1|||
145322253|NCT03078478|524027879|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
145322254|NCT03078478|524027878|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
145570516|NCT01215227|524947426|FG000|Overall Study|Adverse Event|11|||
145570517|NCT01215227|524947427|FG001|Overall Study|Adverse Event|11|||
145570518|NCT01215227|524947428|FG002|Overall Study|Adverse Event|4|||
145570519|NCT01215227|524947429|FG003|Overall Study|Adverse Event|8|||
145570520|NCT01215227|524947430|FG004|Overall Study|Adverse Event|7|||
145570521|NCT01215227|524947431|FG005|Overall Study|Adverse Event|6|||
145570522|NCT01215227|524947426|FG000|Overall Study|Treatment Failure|8|||
145570523|NCT01215227|524947427|FG001|Overall Study|Treatment Failure|4|||
145570524|NCT01215227|524947428|FG002|Overall Study|Treatment Failure|1|||
145570525|NCT01215227|524947429|FG003|Overall Study|Treatment Failure|5|||
145570526|NCT01215227|524947430|FG004|Overall Study|Treatment Failure|1|||
145570527|NCT01215227|524947431|FG005|Overall Study|Treatment Failure|1|||
145570528|NCT01215227|524947426|FG000|Overall Study|Lost to Follow-up|1|||
145620578|NCT01822353|525125110|FG001|Overall Study|Adverse Event|3|||
145322255|NCT03078478|524027879|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
145570529|NCT01215227|524947427|FG001|Overall Study|Lost to Follow-up|4|||
145570530|NCT01215227|524947428|FG002|Overall Study|Lost to Follow-up|1|||
145570531|NCT01215227|524947429|FG003|Overall Study|Lost to Follow-up|1|||
145570532|NCT01215227|524947430|FG004|Overall Study|Lost to Follow-up|1|||
145322256|NCT03078478|524027878|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
145322257|NCT03078478|524027879|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
145322258|NCT03078478|524027878|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
145322259|NCT03078478|524027879|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
145322260|NCT02792218|524027880|FG000|Overall Study|Patient/guardian decision|15|||
145322261|NCT02792218|524027881|FG001|Overall Study|Patient/guardian decision|42|||
145322262|NCT02792218|524027880|FG000|Overall Study|Adverse Event|15|||
145322263|NCT02792218|524027881|FG001|Overall Study|Adverse Event|14|||
145322264|NCT02792218|524027880|FG000|Overall Study|Lost to Follow-up|10|||
145322265|NCT02792218|524027881|FG001|Overall Study|Lost to Follow-up|5|||
145322266|NCT02792218|524027880|FG000|Overall Study|Lack of Efficacy|1|||
145322267|NCT02792218|524027881|FG001|Overall Study|Lack of Efficacy|12|||
145322268|NCT02792218|524027880|FG000|Overall Study|Physician Decision|4|||
145322269|NCT02792218|524027881|FG001|Overall Study|Physician Decision|4|||
145322270|NCT02792218|524027880|FG000|Overall Study|Protocol deviation|3|||
145322271|NCT02792218|524027881|FG001|Overall Study|Protocol deviation|2|||
145322272|NCT02792218|524027880|FG000|Overall Study|New therapy for study indication|0|||
145322273|NCT02792218|524027881|FG001|Overall Study|New therapy for study indication|1|||
145322274|NCT02792218|524027880|FG000|Overall Study|Non-compliance with study treatment|0|||
145322275|NCT02792218|524027881|FG001|Overall Study|Non-compliance with study treatment|1|||
145322276|NCT02792218|524027880|FG000|Overall Study|Pregnancy|1|||
145322277|NCT02792218|524027881|FG001|Overall Study|Pregnancy|0|||
145322278|NCT00955721|524027882|FG000|Overall Study|Physician Decision|1|||
145322279|NCT00955721|524027883|FG001|Overall Study|Physician Decision|0|||
145322280|NCT00955721|524027882|FG000|Overall Study|Death|1|||
145322281|NCT00955721|524027883|FG001|Overall Study|Death|0|||
145322282|NCT00955721|524027882|FG000|Overall Study|Withdrawal by Subject|1|||
145322283|NCT00955721|524027883|FG001|Overall Study|Withdrawal by Subject|0|||
145322284|NCT01253317|524027888|FG000|Overall Study|Adverse Event|2|||
145322285|NCT04034355|524027893|FG000|Overall Study|Study terminated by Sponsor|10|||
145322286|NCT04034355|524027894|FG001|Overall Study|Study terminated by Sponsor|17|||
145322287|NCT04034355|524027893|FG000|Overall Study|Withdrawal by Subject|12|||
145322288|NCT04034355|524027894|FG001|Overall Study|Withdrawal by Subject|11|||
145322289|NCT04034355|524027893|FG000|Overall Study|Site terminated by Sponsor|4|||
145322290|NCT04034355|524027894|FG001|Overall Study|Site terminated by Sponsor|5|||
145322291|NCT04034355|524027893|FG000|Overall Study|Adverse Event|2|||
145322292|NCT04034355|524027894|FG001|Overall Study|Adverse Event|0|||
145322293|NCT04034355|524027893|FG000|Overall Study|Death|1|||
145322294|NCT04034355|524027894|FG001|Overall Study|Death|1|||
145322295|NCT04034355|524027893|FG000|Overall Study|Not reported|2|||
145322296|NCT04034355|524027894|FG001|Overall Study|Not reported|0|||
145322297|NCT04034355|524027893|FG000|Overall Study|Lost to Follow-up|1|||
145322298|NCT04034355|524027894|FG001|Overall Study|Lost to Follow-up|0|||
145322299|NCT04034355|524027893|FG000|Overall Study|Physician Decision|1|||
145322300|NCT04034355|524027894|FG001|Overall Study|Physician Decision|0|||
145322301|NCT04034355|524027893|FG000|Overall Study|Protocol Violation|0|||
145322302|NCT04034355|524027894|FG001|Overall Study|Protocol Violation|1|||
145322303|NCT04034355|524027893|FG000|Overall Study|Progressive disease|1|||
145322304|NCT04034355|524027894|FG001|Overall Study|Progressive disease|0|||
145322305|NCT04678817|524029211|FG000|Overall Study|Lost to Follow-up|28|||
145322306|NCT04678817|524029212|FG001|Overall Study|Lost to Follow-up|0|||
145322307|NCT04678817|524029213|FG002|Overall Study|Lost to Follow-up|0|||
145322308|NCT02124902|524029217|FG000|Overall Study|Adverse Event|7|||
145322309|NCT02124902|524029218|FG001|Overall Study|Adverse Event|2|||
145322310|NCT02124902|524029217|FG000|Overall Study|Went to alternative treatment|4|||
145322311|NCT02124902|524029218|FG001|Overall Study|Went to alternative treatment|0|||
145322312|NCT02124902|524029217|FG000|Overall Study|Withdrawal by Subject|2|||
145322313|NCT02124902|524029218|FG001|Overall Study|Withdrawal by Subject|1|||
145322314|NCT02124902|524029217|FG000|Overall Study|Physician Decision|2|||
145322315|NCT02124902|524029218|FG001|Overall Study|Physician Decision|0|||
145322316|NCT02124902|524029217|FG000|Overall Study|Not eligible|1|||
145322317|NCT02124902|524029218|FG001|Overall Study|Not eligible|0|||
145322318|NCT02124902|524029217|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
145322319|NCT02124902|524029218|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
145322320|NCT00546910|524029222|FG000|Overall Study|Adverse Event|2|||
145322321|NCT00546910|524029223|FG001|Overall Study|Adverse Event|3|||
145322322|NCT00546910|524029222|FG000|Overall Study|Lack of Efficacy|5|||
145322323|NCT00546910|524029223|FG001|Overall Study|Lack of Efficacy|7|||
145322324|NCT00546910|524029222|FG000|Overall Study|Physician Decision|0|||
145322325|NCT00546910|524029223|FG001|Overall Study|Physician Decision|1|||
145322326|NCT00546910|524029222|FG000|Overall Study|Withdrawal by Subject|2|||
145322327|NCT00546910|524029223|FG001|Overall Study|Withdrawal by Subject|0|||
145322328|NCT01467479|524029224|FG000|Overall Study|No Study Medication|1|||
145322329|NCT01467479|524029225|FG001|Overall Study|No Study Medication|0|||
145322330|NCT01467479|524029226|FG002|Overall Study|No Study Medication|2|||
145322331|NCT01467479|524029224|FG000|Overall Study|Adverse Event|1|||
145322332|NCT01467479|524029225|FG001|Overall Study|Adverse Event|2|||
145322333|NCT01467479|524029226|FG002|Overall Study|Adverse Event|0|||
145322334|NCT01467479|524029224|FG000|Overall Study|Death|0|||
145322335|NCT01467479|524029225|FG001|Overall Study|Death|0|||
145322336|NCT01467479|524029226|FG002|Overall Study|Death|1|||
145322337|NCT01467479|524029224|FG000|Overall Study|Lost to Follow-up|2|||
145322338|NCT01467479|524029225|FG001|Overall Study|Lost to Follow-up|5|||
145322339|NCT01467479|524029226|FG002|Overall Study|Lost to Follow-up|3|||
145322340|NCT01467479|524029224|FG000|Overall Study|Withdrawal of Consent|3|||
145322341|NCT01467479|524029225|FG001|Overall Study|Withdrawal of Consent|7|||
145322342|NCT01467479|524029226|FG002|Overall Study|Withdrawal of Consent|7|||
145322343|NCT01467479|524029224|FG000|Overall Study|Study Terminated by Sponsor|1|||
145322344|NCT01467479|524029225|FG001|Overall Study|Study Terminated by Sponsor|3|||
145322345|NCT01467479|524029226|FG002|Overall Study|Study Terminated by Sponsor|3|||
145322346|NCT01467479|524029224|FG000|Overall Study|Other|1|||
145322347|NCT01467479|524029225|FG001|Overall Study|Other|0|||
145322348|NCT01467479|524029226|FG002|Overall Study|Other|0|||
145322349|NCT02284347|524029236|FG000|Overall Study|Lost to Follow-up|2|||
145322350|NCT02284347|524029236|FG000|Overall Study|Withdrawn prior to treatment|1|||
145322351|NCT01684215|524029240|FG000|Phase 1, Part 1|Adverse Event|1|||
145322352|NCT01684215|524029241|FG001|Phase 1, Part 1|Adverse Event|0|||
145322353|NCT01684215|524029242|FG002|Phase 1, Part 1|Adverse Event|0|||
145322354|NCT01684215|524029243|FG003|Phase 1, Part 1|Adverse Event|0|||
145322355|NCT01684215|524029240|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
145322356|NCT01684215|524029241|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
145322357|NCT01684215|524029242|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
145322358|NCT01684215|524029243|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
145322359|NCT01684215|524029240|FG000|Phase 1, Part 2|Adverse Event|0|||
145322360|NCT01684215|524029241|FG001|Phase 1, Part 2|Adverse Event|0|||
145322361|NCT01684215|524029242|FG002|Phase 1, Part 2|Adverse Event|1|||
145322362|NCT01684215|524029243|FG003|Phase 1, Part 2|Adverse Event|0|||
145322363|NCT01684215|524029240|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145322364|NCT01684215|524029241|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145322365|NCT01684215|524029242|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
145322366|NCT01684215|524029243|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
145322367|NCT01684215|524029240|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
145322368|NCT01684215|524029241|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
145322369|NCT01684215|524029242|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
145322370|NCT01684215|524029243|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
145322371|NCT01684215|524029240|FG000|Phase 2|Death|0|||
145322372|NCT01684215|524029241|FG001|Phase 2|Death|0|||
145322373|NCT01684215|524029242|FG002|Phase 2|Death|0|||
145322374|NCT01684215|524029243|FG003|Phase 2|Death|8|||
145322375|NCT01684215|524029240|FG000|Phase 2|Study terminated by sponsor|0|||
145322376|NCT01684215|524029241|FG001|Phase 2|Study terminated by sponsor|0|||
145322377|NCT01684215|524029242|FG002|Phase 2|Study terminated by sponsor|0|||
145322378|NCT01684215|524029243|FG003|Phase 2|Study terminated by sponsor|30|||
145322379|NCT01684215|524029240|FG000|Phase 2|Enrolled but not treated|0|||
145322380|NCT01684215|524029241|FG001|Phase 2|Enrolled but not treated|0|||
145322381|NCT01684215|524029242|FG002|Phase 2|Enrolled but not treated|0|||
145322382|NCT01684215|524029243|FG003|Phase 2|Enrolled but not treated|1|||
145322383|NCT01684215|524029240|FG000|Phase 2|Lost to Follow-up|0|||
145322384|NCT01684215|524029241|FG001|Phase 2|Lost to Follow-up|0|||
145322385|NCT01684215|524029242|FG002|Phase 2|Lost to Follow-up|0|||
145322386|NCT01684215|524029243|FG003|Phase 2|Lost to Follow-up|4|||
145322387|NCT01301482|524029244|FG000|Overall Study|Withdrawal by Subject|1|||
145322388|NCT01552369|524029247|FG000|Overall Study|Did not consent to extended follow up|8|||
145322389|NCT01552369|524029248|FG001|Overall Study|Did not consent to extended follow up|9|||
145322390|NCT01915940|524029250|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
145322391|NCT01915940|524029251|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
145322392|NCT01915940|524029252|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
145322393|NCT01915940|524029250|FG000|Treatment Period|Decision of Participant|0|||
145322394|NCT01915940|524029251|FG001|Treatment Period|Decision of Participant|1|||
145322395|NCT01915940|524029252|FG002|Treatment Period|Decision of Participant|3|||
145322396|NCT01915940|524029250|FG000|Treatment Period|Adverse Event|0|||
145322397|NCT01915940|524029251|FG001|Treatment Period|Adverse Event|9|||
145322398|NCT01915940|524029252|FG002|Treatment Period|Adverse Event|1|||
145322399|NCT01915940|524029250|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
145322400|NCT01915940|524029251|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
145322401|NCT01915940|524029252|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
145322402|NCT00614926|524029255|FG000|Overall Study|Burden of travel|1|||
145322403|NCT00614926|524029256|FG001|Overall Study|Burden of travel|0|||
145322404|NCT00614926|524029255|FG000|Overall Study|Adverse Event|3|||
145322405|NCT00614926|524029256|FG001|Overall Study|Adverse Event|0|||
145322406|NCT02999984|524029264|FG000|Overall Study|Treatment Failure|1|||
145322407|NCT04039919|524029267|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145322408|NCT04039919|524029268|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145322409|NCT04039919|524029269|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145322410|NCT04039919|524029270|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145322411|NCT04039919|524029271|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145570533|NCT01215227|524947431|FG005|Overall Study|Lost to Follow-up|2|||
145322412|NCT04039919|524029267|FG000|Treatment Period 1|Sponsor's decision|0|||
145322413|NCT04039919|524029268|FG001|Treatment Period 1|Sponsor's decision|0|||
145322414|NCT04039919|524029269|FG002|Treatment Period 1|Sponsor's decision|0|||
145322415|NCT04039919|524029270|FG003|Treatment Period 1|Sponsor's decision|0|||
145322416|NCT04039919|524029271|FG004|Treatment Period 1|Sponsor's decision|16|||
145322417|NCT04039919|524029267|FG000|Treatment Period 5|Withdrawal by Subject|1|||
145322418|NCT04039919|524029268|FG001|Treatment Period 5|Withdrawal by Subject|0|||
145322419|NCT04039919|524029269|FG002|Treatment Period 5|Withdrawal by Subject|0|||
145322420|NCT04039919|524029270|FG003|Treatment Period 5|Withdrawal by Subject|0|||
145322421|NCT04039919|524029271|FG004|Treatment Period 5|Withdrawal by Subject|0|||
145322422|NCT00754013|524029272|FG000|Overall Study|Lost to Follow-up|1|||
145322423|NCT00754013|524029273|FG001|Overall Study|Lost to Follow-up|1|||
145322424|NCT00754013|524029272|FG000|Overall Study|didn't return after study termed|3|||
145322425|NCT00754013|524029273|FG001|Overall Study|didn't return after study termed|4|||
145322426|NCT02310789|524029274|FG000|Overall Study|Adverse Event|1|||
145322427|NCT01197417|524029275|FG000|Overall Study|Physician Decision|3|||
145322428|NCT01197417|524029276|FG001|Overall Study|Physician Decision|2|||
145322429|NCT01197417|524029275|FG000|Overall Study|Withdrawal by Subject|2|||
145322430|NCT01197417|524029276|FG001|Overall Study|Withdrawal by Subject|4|||
145322431|NCT01197417|524029275|FG000|Overall Study|Site miscommunication|0|||
145322432|NCT01197417|524029276|FG001|Overall Study|Site miscommunication|1|||
145322433|NCT01197417|524029275|FG000|Overall Study|Subject transferred to intensive care|0|||
145322434|NCT01197417|524029276|FG001|Overall Study|Subject transferred to intensive care|1|||
145322435|NCT01197417|524029275|FG000|Overall Study|Not consented in time to receive drug|0|||
145322436|NCT01197417|524029276|FG001|Overall Study|Not consented in time to receive drug|1|||
145322437|NCT01197417|524029275|FG000|Overall Study|Hypotension|1|||
145322438|NCT01197417|524029276|FG001|Overall Study|Hypotension|2|||
145322439|NCT01197417|524029275|FG000|Overall Study|Found to be ineligible|2|||
145322440|NCT01197417|524029276|FG001|Overall Study|Found to be ineligible|5|||
145322441|NCT01197417|524029275|FG000|Overall Study|No 25-hour magnesium level|0|||
145322442|NCT01197417|524029276|FG001|Overall Study|No 25-hour magnesium level|2|||
145322443|NCT03250299|524029277|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
145322444|NCT03250299|524029278|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
145322445|NCT03250299|524029279|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
145322446|NCT03250299|524029280|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
145322447|NCT03250299|524029281|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
145322448|NCT03250299|524029277|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
145322449|NCT03250299|524029278|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
145322450|NCT03250299|524029279|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
145322451|NCT03250299|524029280|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
145322452|NCT03250299|524029281|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
145322453|NCT03250299|524029277|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145322454|NCT03250299|524029278|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145322455|NCT03250299|524029279|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
145322456|NCT03250299|524029280|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145322457|NCT03250299|524029281|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
145322458|NCT03250299|524029277|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
145322459|NCT03250299|524029278|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
145322460|NCT03250299|524029279|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
145322461|NCT03250299|524029280|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
145322462|NCT03250299|524029281|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
145322463|NCT01546142|524029286|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
145322464|NCT01546142|524029287|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
145322465|NCT01546142|524029286|FG000|Overall Study|Subject Noncompliance|1|||
145322466|NCT01546142|524029287|FG001|Overall Study|Subject Noncompliance|1|||
145322467|NCT01546142|524029286|FG000|Overall Study|Adverse Event|6|||
145322468|NCT01546142|524029287|FG001|Overall Study|Adverse Event|3|||
145322469|NCT01546142|524029286|FG000|Overall Study|Lost to Follow-up|20|||
145322470|NCT01546142|524029287|FG001|Overall Study|Lost to Follow-up|15|||
145322471|NCT01546142|524029286|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
145322472|NCT01546142|524029287|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
145570534|NCT01215227|524947426|FG000|Overall Study|Subject Withdrew Consent|16|||
145570535|NCT01215227|524947427|FG001|Overall Study|Subject Withdrew Consent|20|||
145570536|NCT01215227|524947428|FG002|Overall Study|Subject Withdrew Consent|7|||
145322473|NCT01546142|524029286|FG000|Overall Study|Subject Randomized but Not Treated|1|||
145570537|NCT01215227|524947429|FG003|Overall Study|Subject Withdrew Consent|10|||
145570538|NCT01215227|524947430|FG004|Overall Study|Subject Withdrew Consent|11|||
145570539|NCT01215227|524947431|FG005|Overall Study|Subject Withdrew Consent|8|||
145322474|NCT01546142|524029287|FG001|Overall Study|Subject Randomized but Not Treated|0|||
145322475|NCT04213209|524029297|FG000|Overall Study|Protocol Violation|1|||
145322476|NCT04213209|524029298|FG001|Overall Study|Protocol Violation|0|||
145322477|NCT04213209|524029299|FG002|Overall Study|Protocol Violation|0|||
145570540|NCT01215227|524947426|FG000|Overall Study|Non-Compliance With Protocol|2|||
145620579|NCT01822353|525125111|FG002|Overall Study|Adverse Event|1|||
145322478|NCT04213209|524029300|FG003|Overall Study|Protocol Violation|0|||
145322479|NCT04213209|524029301|FG004|Overall Study|Protocol Violation|0|||
145322480|NCT04213209|524029302|FG005|Overall Study|Protocol Violation|0|||
145322481|NCT02065713|524029306|FG000|Overall Study|Adverse Event|0|||
145322482|NCT02065713|524029307|FG001|Overall Study|Adverse Event|1|||
145322483|NCT02065713|524029306|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145322484|NCT02065713|524029307|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145322485|NCT00619359|524029308|FG000|Overall Study|Adverse Event|32|||
145322486|NCT00619359|524029309|FG001|Overall Study|Adverse Event|36|||
145322487|NCT00619359|524029308|FG000|Overall Study|Lost to Follow-up|12|||
145322488|NCT00619359|524029309|FG001|Overall Study|Lost to Follow-up|16|||
145322489|NCT00619359|524029308|FG000|Overall Study|Physician Decision|0|||
145322490|NCT00619359|524029309|FG001|Overall Study|Physician Decision|7|||
145322491|NCT00619359|524029308|FG000|Overall Study|Protocol Violation|1|||
145322492|NCT00619359|524029309|FG001|Overall Study|Protocol Violation|1|||
145322493|NCT00619359|524029308|FG000|Overall Study|Withdrawal by Subject|19|||
145322494|NCT00619359|524029309|FG001|Overall Study|Withdrawal by Subject|20|||
145322495|NCT00619359|524029308|FG000|Overall Study|Progressive Disease|3|||
145322496|NCT00619359|524029309|FG001|Overall Study|Progressive Disease|1|||
145322497|NCT00268892|524029310|FG000|Overall Study|Adverse Event|14|||
145322498|NCT00268892|524029311|FG001|Overall Study|Adverse Event|17|||
145322499|NCT00268892|524029312|FG002|Overall Study|Adverse Event|20|||
145322500|NCT00268892|524029310|FG000|Overall Study|Lack of Efficacy|1|||
145322501|NCT00268892|524029311|FG001|Overall Study|Lack of Efficacy|3|||
145322502|NCT00268892|524029312|FG002|Overall Study|Lack of Efficacy|0|||
145322503|NCT00268892|524029310|FG000|Overall Study|Withdrawal by Subject|14|||
145322504|NCT00268892|524029311|FG001|Overall Study|Withdrawal by Subject|15|||
145322505|NCT00268892|524029312|FG002|Overall Study|Withdrawal by Subject|13|||
145322506|NCT00268892|524029310|FG000|Overall Study|Physician Decision|0|||
145322507|NCT00268892|524029311|FG001|Overall Study|Physician Decision|1|||
145322508|NCT00268892|524029312|FG002|Overall Study|Physician Decision|0|||
145322509|NCT00268892|524029310|FG000|Overall Study|Lost to Follow-up|5|||
145322510|NCT00268892|524029311|FG001|Overall Study|Lost to Follow-up|2|||
145322511|NCT00268892|524029312|FG002|Overall Study|Lost to Follow-up|4|||
145322512|NCT00268892|524029310|FG000|Overall Study|Protocol Violation|0|||
145322513|NCT00268892|524029311|FG001|Overall Study|Protocol Violation|1|||
145322514|NCT00268892|524029312|FG002|Overall Study|Protocol Violation|0|||
145322515|NCT00268892|524029310|FG000|Overall Study|Disease Progression|1|||
145322516|NCT00268892|524029311|FG001|Overall Study|Disease Progression|1|||
145322517|NCT00268892|524029312|FG002|Overall Study|Disease Progression|0|||
145322518|NCT00268892|524029310|FG000|Overall Study|Trial Site Closed|4|||
145322519|NCT00268892|524029311|FG001|Overall Study|Trial Site Closed|2|||
145322520|NCT00268892|524029312|FG002|Overall Study|Trial Site Closed|2|||
145322521|NCT02470091|524029319|FG000|Overall Study|Withdrawal by Subject|1|||
145322522|NCT02470091|524029320|FG001|Overall Study|Withdrawal by Subject|0|||
145322523|NCT02470091|524029319|FG000|Overall Study|Ineligible|0|||
145322524|NCT02470091|524029320|FG001|Overall Study|Ineligible|2|||
145322525|NCT01192399|524029331|FG000|Overall Study|Lack of Efficacy|2|||
145322526|NCT00303667|524029332|FG000|Overall Study|Death|0|||
145322527|NCT00303667|524029333|FG001|Overall Study|Death|4|||
145322528|NCT02244424|524029334|FG000|Overall Study|Lost to Follow-up|20|||
145322529|NCT02244424|524029335|FG001|Overall Study|Lost to Follow-up|10|||
145322530|NCT00402025|524029336|FG000|Overall Study|Adverse Event|0|||
145322531|NCT00402025|524029337|FG001|Overall Study|Adverse Event|0|||
145322532|NCT00402025|524029338|FG002|Overall Study|Adverse Event|2|||
145322533|NCT00402025|524029336|FG000|Overall Study|Death|0|||
145322534|NCT00402025|524029337|FG001|Overall Study|Death|1|||
145322535|NCT00402025|524029338|FG002|Overall Study|Death|5|||
145322536|NCT00402025|524029336|FG000|Overall Study|Disease Progression|1|||
145322537|NCT00402025|524029337|FG001|Overall Study|Disease Progression|1|||
145322538|NCT00402025|524029338|FG002|Overall Study|Disease Progression|2|||
145322539|NCT00402025|524029336|FG000|Overall Study|Physician Decision|1|||
145322540|NCT00402025|524029337|FG001|Overall Study|Physician Decision|1|||
145322541|NCT00402025|524029338|FG002|Overall Study|Physician Decision|0|||
145322542|NCT00402025|524029336|FG000|Overall Study|Participant Decision|0|||
145322543|NCT00402025|524029337|FG001|Overall Study|Participant Decision|0|||
145322544|NCT00402025|524029338|FG002|Overall Study|Participant Decision|1|||
145322545|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145322546|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
145322547|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145322548|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
145322549|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
145322550|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
145322551|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
145322552|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
145322553|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
145322554|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145322555|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145322556|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
145322557|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Death|0|||
145322558|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Death|1|||
145322559|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Death|0|||
145322560|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Death|0|||
145322561|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
145322562|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
145322563|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
145322564|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
145322565|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
145322566|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145322567|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145322568|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
145322569|NCT00545688|524029345|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
145322570|NCT00545688|524029346|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
145322571|NCT00545688|524029347|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
145322572|NCT00545688|524029348|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
145322573|NCT00545688|524029345|FG000|Adjuvant Treatment Period|Disease Progression|3|||
145322574|NCT00545688|524029346|FG001|Adjuvant Treatment Period|Disease Progression|3|||
145322575|NCT00545688|524029347|FG002|Adjuvant Treatment Period|Disease Progression|0|||
145322576|NCT00545688|524029348|FG003|Adjuvant Treatment Period|Disease Progression|7|||
145322577|NCT00545688|524029345|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
145322578|NCT00545688|524029346|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
145322579|NCT00545688|524029347|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
145322580|NCT00545688|524029348|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
145322581|NCT00545688|524029345|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
145322582|NCT00545688|524029346|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
145322583|NCT00545688|524029347|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
145322584|NCT00545688|524029348|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
145322585|NCT00545688|524029345|FG000|Adjuvant Treatment Period|Adverse Event|0|||
145322586|NCT00545688|524029346|FG001|Adjuvant Treatment Period|Adverse Event|3|||
145322587|NCT00545688|524029347|FG002|Adjuvant Treatment Period|Adverse Event|2|||
145322588|NCT00545688|524029348|FG003|Adjuvant Treatment Period|Adverse Event|2|||
145322589|NCT00545688|524029345|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
145322590|NCT00545688|524029346|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
145322591|NCT00545688|524029347|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
145322592|NCT00545688|524029348|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
145322593|NCT00545688|524029345|FG000|Follow-Up Period|Death|4|||
145322594|NCT00545688|524029346|FG001|Follow-Up Period|Death|2|||
145322595|NCT00545688|524029347|FG002|Follow-Up Period|Death|2|||
145322596|NCT00545688|524029348|FG003|Follow-Up Period|Death|6|||
145322597|NCT00545688|524029345|FG000|Follow-Up Period|Disease Progression|6|||
145322598|NCT00545688|524029346|FG001|Follow-Up Period|Disease Progression|5|||
145322599|NCT00545688|524029347|FG002|Follow-Up Period|Disease Progression|9|||
145322600|NCT00545688|524029348|FG003|Follow-Up Period|Disease Progression|9|||
145322601|NCT00545688|524029345|FG000|Follow-Up Period|Refused Treatment|6|||
145322602|NCT00545688|524029346|FG001|Follow-Up Period|Refused Treatment|2|||
145322603|NCT00545688|524029347|FG002|Follow-Up Period|Refused Treatment|0|||
145322604|NCT00545688|524029348|FG003|Follow-Up Period|Refused Treatment|2|||
145322605|NCT00545688|524029345|FG000|Follow-Up Period|Lost to Follow-up|3|||
145322606|NCT00545688|524029346|FG001|Follow-Up Period|Lost to Follow-up|3|||
145322607|NCT00545688|524029347|FG002|Follow-Up Period|Lost to Follow-up|3|||
145322608|NCT00545688|524029348|FG003|Follow-Up Period|Lost to Follow-up|1|||
145322609|NCT00545688|524029345|FG000|Follow-Up Period|Unspecified Reason|2|||
145322610|NCT00545688|524029346|FG001|Follow-Up Period|Unspecified Reason|5|||
145322611|NCT00545688|524029347|FG002|Follow-Up Period|Unspecified Reason|6|||
145322612|NCT00545688|524029348|FG003|Follow-Up Period|Unspecified Reason|8|||
145322613|NCT00545688|524029345|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
145322614|NCT00545688|524029346|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
145322615|NCT00545688|524029347|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
145322616|NCT00545688|524029348|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
145377821|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
145377822|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377823|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377824|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377825|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377826|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377827|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377828|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377829|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377830|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377831|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145377832|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145322617|NCT01961687|524030410|FG000|Overall Study|Lost to Follow-up|19|||
145322618|NCT01961687|524030410|FG000|Overall Study|Re-operation|17|||
145322619|NCT01961687|524030410|FG000|Overall Study|Death|7|||
145322620|NCT01961687|524030410|FG000|Overall Study|Withdrawal by Subject|6|||
145322621|NCT01961687|524030410|FG000|Overall Study|Adverse Event|6|||
145322622|NCT01961687|524030410|FG000|Overall Study|Moved to area without study site|2|||
145322623|NCT01961687|524030410|FG000|Overall Study|Sponsor decision|2|||
145322624|NCT01961687|524030410|FG000|Overall Study|Physician Decision|1|||
145322625|NCT01961687|524030410|FG000|Overall Study|Unable to meet follow-up requirements|1|||
145322626|NCT00544817|524030411|FG000|Combined Modality|Lack of Efficacy|2|||
145322627|NCT00544817|524030411|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
145322628|NCT00544817|524030411|FG000|Combined Modality|Adverse Event|2|||
145322629|NCT00544817|524030411|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
145322630|NCT00544817|524030411|FG000|No Treatment Interval|Lack of Efficacy|8|||
145322631|NCT00544817|524030411|FG000|No Treatment Interval|Physician Decision|3|||
145322632|NCT00544817|524030411|FG000|No Treatment Interval|Adverse Event|1|||
145322633|NCT00544817|524030411|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
145322634|NCT00544817|524030411|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
145322635|NCT00544817|524030411|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
145322636|NCT02813421|524030412|FG000|Overall Study|Withdrawal by Subject|1|||
145322637|NCT02813421|524030413|FG001|Overall Study|Withdrawal by Subject|2|||
145322638|NCT02813421|524030412|FG000|Overall Study|Lost to Follow-up|1|||
145322639|NCT02813421|524030413|FG001|Overall Study|Lost to Follow-up|1|||
145322640|NCT00977548|524030414|FG000|Overall Study|Ineligible|4|||
145322641|NCT00977548|524030414|FG000|Overall Study|Adverse Event|8|||
145322642|NCT00977548|524030414|FG000|Overall Study|Withdrawal by Subject|1|||
145322643|NCT01042535|524030415|FG000|Overall Study|disease progression prior to treatment|3|||
145322644|NCT01042535|524030415|FG000|Overall Study|disease progression during treatment|3|||
145322645|NCT01042535|524030415|FG000|Overall Study|complications from other disease|2|||
145322646|NCT00107042|524030418|FG000|Overall Study|Lost to Follow-up|9|||
145322647|NCT00107042|524030419|FG001|Overall Study|Lost to Follow-up|7|||
145322648|NCT00107042|524030418|FG000|Overall Study|Withdrawal by Subject|6|||
145322649|NCT00107042|524030419|FG001|Overall Study|Withdrawal by Subject|1|||
145322650|NCT00107042|524030418|FG000|Overall Study|Moved out of area|5|||
145322651|NCT00107042|524030419|FG001|Overall Study|Moved out of area|3|||
145322652|NCT00107042|524030418|FG000|Overall Study|Pregnancy|1|||
145322653|NCT00107042|524030419|FG001|Overall Study|Pregnancy|1|||
145322654|NCT00107042|524030418|FG000|Overall Study|Inadvertent enrollment|0|||
145322655|NCT00107042|524030419|FG001|Overall Study|Inadvertent enrollment|1|||
145322656|NCT00107042|524030418|FG000|Overall Study|vaccinated outside window|1|||
145322657|NCT00107042|524030419|FG001|Overall Study|vaccinated outside window|1|||
145322658|NCT00107042|524030418|FG000|Overall Study|Disallowed medications|0|||
145322659|NCT00107042|524030419|FG001|Overall Study|Disallowed medications|2|||
145322660|NCT03919448|524030420|FG000|Overall Study|Withdrawal by Subject|1|||
145322661|NCT03919448|524030421|FG001|Overall Study|Withdrawal by Subject|0|||
145322662|NCT03919448|524030422|FG002|Overall Study|Withdrawal by Subject|0|||
145322663|NCT03438539|524030424|FG000|Overall Study|Lost to Follow-up|8|||
145322664|NCT03438539|524030425|FG001|Overall Study|Lost to Follow-up|4|||
145322665|NCT03438539|524030426|FG002|Overall Study|Lost to Follow-up|10|||
145322666|NCT03438539|524030427|FG003|Overall Study|Lost to Follow-up|9|||
145322667|NCT03438539|524030428|FG004|Overall Study|Lost to Follow-up|3|||
145322668|NCT03438539|524030429|FG005|Overall Study|Lost to Follow-up|8|||
145322669|NCT01221090|524030430|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
145322670|NCT01221090|524030431|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
145322671|NCT01221090|524030432|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
145322672|NCT01221090|524030433|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
145322673|NCT01221090|524030430|FG000|Overall Study|Withdrawal by Subject|0|||
145322674|NCT01221090|524030431|FG001|Overall Study|Withdrawal by Subject|22|||
145322675|NCT01221090|524030432|FG002|Overall Study|Withdrawal by Subject|27|||
145322676|NCT01221090|524030433|FG003|Overall Study|Withdrawal by Subject|2|||
145322677|NCT00440466|524030434|FG000|Overall Study|Death|3|||
145322678|NCT00440466|524030435|FG001|Overall Study|Death|2|||
145322679|NCT00440466|524030436|FG002|Overall Study|Death|9|||
145322680|NCT00440466|524030434|FG000|Overall Study|Adverse Event|3|||
145322681|NCT00440466|524030435|FG001|Overall Study|Adverse Event|4|||
145322682|NCT00440466|524030436|FG002|Overall Study|Adverse Event|11|||
145322683|NCT00440466|524030434|FG000|Overall Study|Lost to Follow-up|1|||
145322684|NCT00440466|524030435|FG001|Overall Study|Lost to Follow-up|0|||
145322685|NCT00440466|524030436|FG002|Overall Study|Lost to Follow-up|2|||
145322686|NCT00440466|524030434|FG000|Overall Study|Physician Decision|2|||
145322687|NCT00440466|524030435|FG001|Overall Study|Physician Decision|0|||
145322688|NCT00440466|524030436|FG002|Overall Study|Physician Decision|1|||
145322689|NCT00440466|524030434|FG000|Overall Study|Protocol Violation|2|||
145322690|NCT00440466|524030435|FG001|Overall Study|Protocol Violation|0|||
145322691|NCT00440466|524030436|FG002|Overall Study|Protocol Violation|4|||
145322692|NCT00440466|524030434|FG000|Overall Study|Withdrawal by Subject|2|||
145322693|NCT00440466|524030435|FG001|Overall Study|Withdrawal by Subject|5|||
145322694|NCT00440466|524030436|FG002|Overall Study|Withdrawal by Subject|9|||
145322695|NCT00440466|524030434|FG000|Overall Study|Began Dialysis|0|||
145322696|NCT00440466|524030435|FG001|Overall Study|Began Dialysis|0|||
145322697|NCT00440466|524030436|FG002|Overall Study|Began Dialysis|1|||
145570541|NCT01215227|524947427|FG001|Overall Study|Non-Compliance With Protocol|6|||
145570542|NCT01215227|524947428|FG002|Overall Study|Non-Compliance With Protocol|1|||
145322698|NCT00440466|524030434|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
145322699|NCT00440466|524030435|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
145322700|NCT00440466|524030436|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
145322701|NCT00892281|524030445|FG000|Overall Study|Adverse Event|65|||
145322702|NCT00892281|524030446|FG001|Overall Study|Adverse Event|8|||
145322703|NCT00892281|524030445|FG000|Overall Study|Lost to Follow-up|81|||
145322704|NCT00892281|524030446|FG001|Overall Study|Lost to Follow-up|8|||
145322705|NCT00892281|524030445|FG000|Overall Study|Pregnancy|1|||
145322706|NCT00892281|524030446|FG001|Overall Study|Pregnancy|0|||
145322707|NCT00892281|524030445|FG000|Overall Study|Protocol Violation|7|||
145322708|NCT00892281|524030446|FG001|Overall Study|Protocol Violation|2|||
145322709|NCT00892281|524030445|FG000|Overall Study|Withdrawal by Subject|86|||
145322710|NCT00892281|524030446|FG001|Overall Study|Withdrawal by Subject|14|||
145322711|NCT00892281|524030445|FG000|Overall Study|Subject failed to return for final visit|2|||
145322712|NCT00892281|524030446|FG001|Overall Study|Subject failed to return for final visit|0|||
145322713|NCT00892281|524030445|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
145322714|NCT00892281|524030446|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
145322715|NCT00892281|524030445|FG000|Overall Study|Final visit completed 4 weeks late|0|||
145322716|NCT00892281|524030446|FG001|Overall Study|Final visit completed 4 weeks late|1|||
145322717|NCT00892281|524030445|FG000|Overall Study|Subject completed day after study closed|1|||
145322718|NCT00892281|524030446|FG001|Overall Study|Subject completed day after study closed|0|||
145322719|NCT00892281|524030445|FG000|Overall Study|Family emergency|1|||
145322720|NCT00892281|524030446|FG001|Overall Study|Family emergency|0|||
145322721|NCT00892281|524030445|FG000|Overall Study|Last visit not done - death in family|1|||
145322722|NCT00892281|524030446|FG001|Overall Study|Last visit not done - death in family|0|||
145322723|NCT00892281|524030445|FG000|Overall Study|Did not meet incl/excl criteria|1|||
145322724|NCT00892281|524030446|FG001|Overall Study|Did not meet incl/excl criteria|0|||
145322725|NCT00892281|524030445|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
145322726|NCT00892281|524030446|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
145322727|NCT00892281|524030445|FG000|Overall Study|Unable to redeem the drug voucher|1|||
145322728|NCT00892281|524030446|FG001|Overall Study|Unable to redeem the drug voucher|0|||
145322729|NCT00892281|524030445|FG000|Overall Study|Subject not good candidate for study|1|||
145322730|NCT00892281|524030446|FG001|Overall Study|Subject not good candidate for study|0|||
145322731|NCT00892281|524030445|FG000|Overall Study|Subject did not return for any visits|1|||
145322732|NCT00892281|524030446|FG001|Overall Study|Subject did not return for any visits|0|||
145322733|NCT00892281|524030445|FG000|Overall Study|Subject missed several visits/lost meds|1|||
145322734|NCT00892281|524030446|FG001|Overall Study|Subject missed several visits/lost meds|0|||
145322735|NCT00892281|524030445|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
145322736|NCT00892281|524030446|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
145322737|NCT00892281|524030445|FG000|Overall Study|Scheduled for knee replacement|0|||
145322738|NCT00892281|524030446|FG001|Overall Study|Scheduled for knee replacement|1|||
145322739|NCT00892281|524030445|FG000|Overall Study|PI complained of inadequate compensation|3|||
145322740|NCT00892281|524030446|FG001|Overall Study|PI complained of inadequate compensation|0|||
145322741|NCT00892281|524030445|FG000|Overall Study|Subject lost interest in program|0|||
145322742|NCT00892281|524030446|FG001|Overall Study|Subject lost interest in program|1|||
145322743|NCT00892281|524030445|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
145412025|NCT03976375|524362163|FG002|Overall Study|Withdrawal by Subject|4|||
145570543|NCT01215227|524947429|FG003|Overall Study|Non-Compliance With Protocol|0|||
145570544|NCT01215227|524947430|FG004|Overall Study|Non-Compliance With Protocol|0|||
145570545|NCT01215227|524947431|FG005|Overall Study|Non-Compliance With Protocol|0|||
145570546|NCT01215227|524947426|FG000|Overall Study|Administrative|83|||
145570547|NCT01215227|524947427|FG001|Overall Study|Administrative|73|||
145570548|NCT01215227|524947428|FG002|Overall Study|Administrative|42|||
145570549|NCT01215227|524947429|FG003|Overall Study|Administrative|24|||
145570550|NCT01215227|524947430|FG004|Overall Study|Administrative|28|||
145570551|NCT01215227|524947431|FG005|Overall Study|Administrative|40|||
145412026|NCT03976375|524362161|FG000|Overall Study|Sponsor decision|20|||
145412027|NCT03976375|524362162|FG001|Overall Study|Sponsor decision|19|||
145570552|NCT01215227|524947426|FG000|Overall Study|Missing Status|0|||
145412028|NCT03976375|524362163|FG002|Overall Study|Sponsor decision|1|||
145412029|NCT02676973|524362164|FG000|Overall Study|Withdrawal by Subject|9|||
145570553|NCT01215227|524947427|FG001|Overall Study|Missing Status|1|||
145412030|NCT02676973|524362165|FG001|Overall Study|Withdrawal by Subject|8|||
145412031|NCT02676973|524362166|FG002|Overall Study|Withdrawal by Subject|11|||
145412032|NCT02676973|524362164|FG000|Overall Study|Lost to Follow-up|8|||
145412033|NCT02676973|524362165|FG001|Overall Study|Lost to Follow-up|12|||
145412034|NCT02676973|524362166|FG002|Overall Study|Lost to Follow-up|8|||
145322744|NCT00892281|524030446|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
145322745|NCT00892281|524030445|FG000|Overall Study|Death in family|1|||
145322746|NCT00892281|524030446|FG001|Overall Study|Death in family|0|||
145322747|NCT00892281|524030445|FG000|Overall Study|Lack of efficacy of study product|2|||
145322748|NCT00892281|524030446|FG001|Overall Study|Lack of efficacy of study product|0|||
145322749|NCT00892281|524030445|FG000|Overall Study|Subject not seen by PI at final visit|1|||
145322750|NCT00892281|524030446|FG001|Overall Study|Subject not seen by PI at final visit|0|||
145322751|NCT00892281|524030445|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
145322752|NCT00892281|524030446|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
145322753|NCT00892281|524030445|FG000|Overall Study|Missed multiple visits|1|||
145322754|NCT00892281|524030446|FG001|Overall Study|Missed multiple visits|0|||
145322755|NCT00892281|524030445|FG000|Overall Study|Missed visits rescheduled out of window|1|||
145322756|NCT00892281|524030446|FG001|Overall Study|Missed visits rescheduled out of window|0|||
145322757|NCT00892281|524030445|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
145322758|NCT00892281|524030446|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
145322759|NCT00892281|524030445|FG000|Overall Study|Subject had history of drug abuse|1|||
145322760|NCT00892281|524030446|FG001|Overall Study|Subject had history of drug abuse|0|||
145322761|NCT00892281|524030445|FG000|Overall Study|Rash on hand|1|||
145322762|NCT00892281|524030446|FG001|Overall Study|Rash on hand|0|||
145322763|NCT00892281|524030445|FG000|Overall Study|Visit 4 date out of window|1|||
145322764|NCT00892281|524030446|FG001|Overall Study|Visit 4 date out of window|0|||
145322765|NCT00655850|524030447|FG000|Overall Study|Death|2|||
145322766|NCT00655850|524030447|FG000|Overall Study|Withdrawal by Subject|1|||
145322767|NCT02459665|524030448|FG000|Overall Study|Withdrawal by Subject|0|||
145322768|NCT02459665|524030449|FG001|Overall Study|Withdrawal by Subject|1|||
145322769|NCT02459665|524030450|FG002|Overall Study|Withdrawal by Subject|1|||
145322770|NCT02459665|524030451|FG003|Overall Study|Withdrawal by Subject|2|||
145322771|NCT00685802|524030458|FG000|Washout Period of 7 Days|Protocol Violation|2|||
145322772|NCT00685802|524030459|FG001|Washout Period of 7 Days|Protocol Violation|0|||
145322773|NCT00685802|524030458|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145322774|NCT00685802|524030459|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145322775|NCT01048502|524030460|FG000|Overall Study|Lost to Follow-up|2|||
145322776|NCT01048502|524030461|FG001|Overall Study|Lost to Follow-up|0|||
145322777|NCT01048502|524030462|FG002|Overall Study|Lost to Follow-up|0|||
145322778|NCT01048502|524030463|FG003|Overall Study|Lost to Follow-up|0|||
145322779|NCT01048502|524030460|FG000|Overall Study|Adverse Event|1|||
145322780|NCT01048502|524030461|FG001|Overall Study|Adverse Event|0|||
145322781|NCT01048502|524030462|FG002|Overall Study|Adverse Event|0|||
145322782|NCT01048502|524030463|FG003|Overall Study|Adverse Event|0|||
145322783|NCT01048502|524030460|FG000|Overall Study|Withdrawal by Subject|1|||
145322784|NCT01048502|524030461|FG001|Overall Study|Withdrawal by Subject|4|||
145322785|NCT01048502|524030462|FG002|Overall Study|Withdrawal by Subject|5|||
145322786|NCT01048502|524030463|FG003|Overall Study|Withdrawal by Subject|3|||
145322787|NCT01048502|524030460|FG000|Overall Study|Physician Decision|0|||
145322788|NCT01048502|524030461|FG001|Overall Study|Physician Decision|3|||
145322789|NCT01048502|524030462|FG002|Overall Study|Physician Decision|0|||
145322790|NCT01048502|524030463|FG003|Overall Study|Physician Decision|1|||
145322791|NCT01333072|524030464|FG000|Overall Study|Lost to Follow-up|3|||
145322792|NCT01333072|524030465|FG001|Overall Study|Lost to Follow-up|0|||
145322793|NCT01333072|524030464|FG000|Overall Study|Adverse Event|2|||
145620580|NCT01822353|525125109|FG000|Overall Study|Pregnancy|0|||
145620581|NCT01822353|525125110|FG001|Overall Study|Pregnancy|1|||
145620582|NCT01822353|525125111|FG002|Overall Study|Pregnancy|0|||
145620583|NCT01822353|525125109|FG000|Overall Study|Withdrawal by Subject|3|||
145620584|NCT01822353|525125110|FG001|Overall Study|Withdrawal by Subject|1|||
145620585|NCT01822353|525125111|FG002|Overall Study|Withdrawal by Subject|0|||
145620586|NCT03873246|525125112|FG000|Overall Study|Adverse Event|1|||
145620587|NCT03873246|525125113|FG001|Overall Study|Adverse Event|3|||
145322794|NCT01333072|524030465|FG001|Overall Study|Adverse Event|4|||
145322795|NCT01333072|524030464|FG000|Overall Study|Physician Decision|1|||
145322796|NCT01333072|524030465|FG001|Overall Study|Physician Decision|0|||
145322797|NCT00493454|524030467|FG000|Overall Study|Withdrawal by Subject|1|||
145322798|NCT00103038|524030471|FG000|Overall Study|Withdrawal by Subject|8|||
145322799|NCT00103038|524030471|FG000|Overall Study|Screen failure|3|||
145322800|NCT00103038|524030471|FG000|Overall Study|Death|1|||
145322801|NCT00103038|524030471|FG000|Overall Study|Physician Decision|1|||
145322802|NCT03095118|524030477|FG000|Overall Study|Adverse Event|1|||
145322803|NCT03095118|524030477|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
145322804|NCT01483625|524030478|FG000|Overall Study|Adverse Event|1|||
145322805|NCT01483625|524030479|FG001|Overall Study|Adverse Event|1|||
145322806|NCT01483625|524030478|FG000|Overall Study|Refused to continue medication|2|||
145322807|NCT01483625|524030479|FG001|Overall Study|Refused to continue medication|1|||
145322808|NCT01483625|524030478|FG000|Overall Study|Due to other reason|1|||
145322809|NCT01483625|524030479|FG001|Overall Study|Due to other reason|0|||
145412035|NCT02676973|524362164|FG000|Overall Study|Death|2|||
145412036|NCT02676973|524362165|FG001|Overall Study|Death|1|||
145570554|NCT01215227|524947428|FG002|Overall Study|Missing Status|0|||
145570555|NCT01215227|524947429|FG003|Overall Study|Missing Status|0|||
145322810|NCT01731886|524030480|FG000|Overall Study|Death|1|||
145322811|NCT01731886|524030481|FG001|Overall Study|Death|0|||
145322812|NCT01731886|524030480|FG000|Overall Study|Never started treatment|0|||
145322813|NCT01731886|524030481|FG001|Overall Study|Never started treatment|1|||
145322814|NCT01731886|524030480|FG000|Overall Study|Non-compliant|1|||
145322815|NCT01731886|524030481|FG001|Overall Study|Non-compliant|0|||
145322816|NCT02280187|524030482|FG000|Overall Study|Lost to Follow-up|218|||
145322817|NCT04668274|524030483|FG000|Part 1 Study Period 1|Adverse Event|3|||
145322818|NCT04668274|524030484|FG001|Part 1 Study Period 1|Adverse Event|0|||
145322819|NCT04668274|524030485|FG002|Part 1 Study Period 1|Adverse Event|0|||
145322820|NCT04668274|524030486|FG003|Part 1 Study Period 1|Adverse Event|0|||
145322821|NCT04668274|524030483|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
145322822|NCT04668274|524030484|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
145322823|NCT04668274|524030485|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
145322824|NCT04668274|524030486|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
145322825|NCT04668274|524030483|FG000|Part 1 Study Period 2|Other|0|||
145322826|NCT04668274|524030484|FG001|Part 1 Study Period 2|Other|1|||
145322827|NCT04668274|524030485|FG002|Part 1 Study Period 2|Other|0|||
145322828|NCT04668274|524030486|FG003|Part 1 Study Period 2|Other|0|||
145322829|NCT04668274|524030483|FG000|Part 1 Study Period 3|Adverse Event|0|||
145322830|NCT04668274|524030484|FG001|Part 1 Study Period 3|Adverse Event|0|||
145322831|NCT04668274|524030485|FG002|Part 1 Study Period 3|Adverse Event|1|||
145322832|NCT04668274|524030486|FG003|Part 1 Study Period 3|Adverse Event|0|||
145322833|NCT04668274|524030483|FG000|Part 1 Study Period 3|Other|0|||
145322834|NCT04668274|524030484|FG001|Part 1 Study Period 3|Other|0|||
145322835|NCT04668274|524030485|FG002|Part 1 Study Period 3|Other|2|||
145322836|NCT04668274|524030486|FG003|Part 1 Study Period 3|Other|0|||
145322837|NCT04668274|524030483|FG000|Part 2 Study Period 4|Other|0|||
145322838|NCT04668274|524030484|FG001|Part 2 Study Period 4|Other|0|||
145322839|NCT04668274|524030485|FG002|Part 2 Study Period 4|Other|0|||
145322840|NCT04668274|524030486|FG003|Part 2 Study Period 4|Other|1|||
145322841|NCT02363439|524030489|FG000|Overall Study|Lack of Efficacy|4|||
145322842|NCT01682148|524030495|FG000|Overall Study|Withdrawal by Subject|2|||
145322843|NCT01682148|524030496|FG001|Overall Study|Withdrawal by Subject|0|||
145322844|NCT01682148|524030495|FG000|Overall Study|Lost to Follow-up|1|||
145322845|NCT01682148|524030496|FG001|Overall Study|Lost to Follow-up|2|||
145322846|NCT01682148|524030495|FG000|Overall Study|Protocol Violation|1|||
145322847|NCT01682148|524030496|FG001|Overall Study|Protocol Violation|1|||
145322848|NCT00171340|524030497|FG000|Overall Study|Adverse Event|46|||
145322849|NCT00171340|524030498|FG001|Overall Study|Adverse Event|42|||
145322850|NCT00171340|524030497|FG000|Overall Study|Lack of Efficacy|29|||
145322851|NCT00171340|524030498|FG001|Overall Study|Lack of Efficacy|41|||
145322852|NCT00171340|524030497|FG000|Overall Study|Protocol Violation|7|||
145322853|NCT00171340|524030498|FG001|Overall Study|Protocol Violation|8|||
145322854|NCT00171340|524030497|FG000|Overall Study|Withdrawal by Subject|22|||
145322855|NCT00171340|524030498|FG001|Overall Study|Withdrawal by Subject|19|||
145322856|NCT00171340|524030497|FG000|Overall Study|Lost to Follow-up|0|||
145322857|NCT00171340|524030498|FG001|Overall Study|Lost to Follow-up|5|||
145322858|NCT00171340|524030497|FG000|Overall Study|Abnormal Laboratory Results|2|||
145322859|NCT00171340|524030498|FG001|Overall Study|Abnormal Laboratory Results|0|||
145322860|NCT00171340|524030497|FG000|Overall Study|Abnormal Test Procedure Results|6|||
145322861|NCT00171340|524030498|FG001|Overall Study|Abnormal Test Procedure Results|11|||
145322862|NCT00171340|524030497|FG000|Overall Study|No Longer Required Study Drug|1|||
145322863|NCT00171340|524030498|FG001|Overall Study|No Longer Required Study Drug|1|||
145322864|NCT00171340|524030497|FG000|Overall Study|Administrative Problems|5|||
145570556|NCT01215227|524947430|FG004|Overall Study|Missing Status|0|||
145322865|NCT00171340|524030498|FG001|Overall Study|Administrative Problems|2|||
145322866|NCT00171340|524030497|FG000|Overall Study|Death|6|||
145322867|NCT00171340|524030498|FG001|Overall Study|Death|6|||
145322868|NCT01056640|524030499|FG000|Overall Study|Withdrawal by Subject|11|||
145322869|NCT01056640|524030500|FG001|Overall Study|Withdrawal by Subject|8|||
145322870|NCT01056640|524030499|FG000|Overall Study|Death|15|||
145322871|NCT01056640|524030500|FG001|Overall Study|Death|4|||
145322872|NCT01803269|524030501|FG000|Overall Study|Withdrawal by Subject|3|||
145322873|NCT01803269|524030502|FG001|Overall Study|Withdrawal by Subject|0|||
145322874|NCT01803269|524030503|FG002|Overall Study|Withdrawal by Subject|0|||
145322875|NCT02087176|524030504|FG000|Overall Study|Withdrawal by Subject|1|||
145322876|NCT02087176|524030504|FG000|Overall Study|Death|10|||
145322877|NCT02087176|524030504|FG000|Overall Study|Censored|19|||
145570557|NCT01215227|524947431|FG005|Overall Study|Missing Status|0|||
145322878|NCT02087176|524030504|FG000|Overall Study|Study Terminated by Sponsor|2|||
145322879|NCT00285584|524030505|FG000|Month 3|Lost to Follow-up|3|||
145322880|NCT00285584|524030506|FG001|Month 3|Lost to Follow-up|3|||
145322881|NCT00285584|524030505|FG000|Month 3|Withdrawal by Subject|1|||
145322882|NCT00285584|524030506|FG001|Month 3|Withdrawal by Subject|0|||
145570558|NCT01215227|524947426|FG000|Overall Study|Randomized but not treated|0|||
145570559|NCT01215227|524947427|FG001|Overall Study|Randomized but not treated|0|||
145570560|NCT01215227|524947428|FG002|Overall Study|Randomized but not treated|1|||
145570561|NCT01215227|524947429|FG003|Overall Study|Randomized but not treated|1|||
145570562|NCT01215227|524947430|FG004|Overall Study|Randomized but not treated|0|||
145570563|NCT01215227|524947431|FG005|Overall Study|Randomized but not treated|1|||
145570564|NCT00291668|524947432|FG000|Overall Study|Lack of Efficacy|1|||
145570565|NCT00291668|524947433|FG001|Overall Study|Lack of Efficacy|0|||
145570566|NCT00291668|524947434|FG002|Overall Study|Lack of Efficacy|0|||
145570567|NCT00291668|524947432|FG000|Overall Study|SAE, non-fatal|1|||
145570568|NCT00291668|524947433|FG001|Overall Study|SAE, non-fatal|1|||
145570569|NCT00291668|524947434|FG002|Overall Study|SAE, non-fatal|1|||
145570570|NCT00291668|524947432|FG000|Overall Study|AE, non-serious non-fatal|1|||
145570571|NCT00291668|524947433|FG001|Overall Study|AE, non-serious non-fatal|0|||
145570572|NCT00291668|524947434|FG002|Overall Study|AE, non-serious non-fatal|0|||
145570573|NCT00291668|524947432|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145570574|NCT00291668|524947433|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145570575|NCT00291668|524947434|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145570576|NCT00313612|524947437|FG000|Overall Study|Patient never received treatment|0|||
145620588|NCT03873246|525125114|FG002|Overall Study|Adverse Event|3|||
145322883|NCT00285584|524030505|FG000|Month 6|Lost to Follow-up|0|||
145322884|NCT00285584|524030506|FG001|Month 6|Lost to Follow-up|1|||
145322885|NCT04099641|524030510|FG000|Overall Study|Death|46|||
145322886|NCT04099641|524030511|FG001|Overall Study|Death|12|||
145322887|NCT04099641|524030510|FG000|Overall Study|Lost to Follow-up|1|||
145322888|NCT04099641|524030511|FG001|Overall Study|Lost to Follow-up|0|||
145322889|NCT04099641|524030510|FG000|Overall Study|Withdrawal by Subject|2|||
145322890|NCT04099641|524030511|FG001|Overall Study|Withdrawal by Subject|0|||
145322891|NCT00895037|524030516|FG000|Overall Study|Death|0|||
145322892|NCT00895037|524030517|FG001|Overall Study|Death|2|||
145322893|NCT00895037|524030518|FG002|Overall Study|Death|1|||
145322894|NCT01029392|524030520|FG000|Overall Study|Withdrawal by Subject|18|||
145322895|NCT01029392|524030521|FG001|Overall Study|Withdrawal by Subject|11|||
145322896|NCT01029392|524030520|FG000|Overall Study|Physician Decision|2|||
145322897|NCT01029392|524030521|FG001|Overall Study|Physician Decision|0|||
145322898|NCT00536484|524030522|FG000|Overall Study|Adverse Event|21|||
145322899|NCT00536484|524030523|FG001|Overall Study|Adverse Event|34|||
145322900|NCT00536484|524030522|FG000|Overall Study|Withdrawal by Subject|11|||
145322901|NCT00536484|524030523|FG001|Overall Study|Withdrawal by Subject|11|||
145322902|NCT00536484|524030522|FG000|Overall Study|Lost to Follow-up|8|||
145322903|NCT00536484|524030523|FG001|Overall Study|Lost to Follow-up|6|||
145322904|NCT00536484|524030522|FG000|Overall Study|Lack of Efficacy|16|||
145322905|NCT00536484|524030523|FG001|Overall Study|Lack of Efficacy|5|||
145322906|NCT00536484|524030522|FG000|Overall Study|Other|4|||
145322907|NCT00536484|524030523|FG001|Overall Study|Other|0|||
145322908|NCT02691741|524030525|FG000|Overall Study|Adverse Event|0|||
145322909|NCT02691741|524030526|FG001|Overall Study|Adverse Event|2|||
145322910|NCT02691741|524030525|FG000|Overall Study|Lost to Follow-up|1|||
145322911|NCT02691741|524030526|FG001|Overall Study|Lost to Follow-up|0|||
145322912|NCT02691741|524030525|FG000|Overall Study|Physician Decision|0|||
145322913|NCT02691741|524030526|FG001|Overall Study|Physician Decision|1|||
145322914|NCT02691741|524030525|FG000|Overall Study|Withdrawal by Subject|0|||
145322915|NCT02691741|524030526|FG001|Overall Study|Withdrawal by Subject|4|||
145322916|NCT02139124|524030527|FG000|Overall Study|Adverse Event|2|||
145322917|NCT02139124|524030528|FG001|Overall Study|Adverse Event|0|||
145322918|NCT02139124|524030529|FG002|Overall Study|Adverse Event|1|||
145322919|NCT02139124|524030530|FG003|Overall Study|Adverse Event|2|||
145322920|NCT02139124|524030531|FG004|Overall Study|Adverse Event|5|||
145322921|NCT02139124|524030527|FG000|Overall Study|Withdrawal by Subject|2|||
145322922|NCT02139124|524030528|FG001|Overall Study|Withdrawal by Subject|2|||
145322923|NCT02139124|524030529|FG002|Overall Study|Withdrawal by Subject|2|||
145322924|NCT02139124|524030530|FG003|Overall Study|Withdrawal by Subject|2|||
145322925|NCT02139124|524030531|FG004|Overall Study|Withdrawal by Subject|3|||
145322926|NCT02139124|524030527|FG000|Overall Study|Protocol Violation|0|||
145322927|NCT02139124|524030528|FG001|Overall Study|Protocol Violation|0|||
145322928|NCT02139124|524030529|FG002|Overall Study|Protocol Violation|0|||
145322929|NCT02139124|524030530|FG003|Overall Study|Protocol Violation|1|||
145322930|NCT02139124|524030531|FG004|Overall Study|Protocol Violation|1|||
145322931|NCT02139124|524030527|FG000|Overall Study|non-compliant|1|||
145322932|NCT02139124|524030528|FG001|Overall Study|non-compliant|0|||
145322933|NCT02139124|524030529|FG002|Overall Study|non-compliant|0|||
145322934|NCT02139124|524030530|FG003|Overall Study|non-compliant|2|||
145322935|NCT02139124|524030531|FG004|Overall Study|non-compliant|0|||
145322936|NCT02139124|524030527|FG000|Overall Study|incarceration|0|||
145322937|NCT02139124|524030528|FG001|Overall Study|incarceration|0|||
145322938|NCT02139124|524030529|FG002|Overall Study|incarceration|1|||
145322939|NCT02139124|524030530|FG003|Overall Study|incarceration|0|||
145322940|NCT02139124|524030531|FG004|Overall Study|incarceration|0|||
145570577|NCT00313612|524947438|FG001|Overall Study|Patient never received treatment|1|||
145322941|NCT02139124|524030527|FG000|Overall Study|subject moved|1|||
145322942|NCT02139124|524030528|FG001|Overall Study|subject moved|0|||
145570578|NCT02777125|524947439|FG000|Overall Study|Consent form violation|14|||
145322943|NCT02139124|524030529|FG002|Overall Study|subject moved|0|||
145322944|NCT02139124|524030530|FG003|Overall Study|subject moved|0|||
145322945|NCT02139124|524030531|FG004|Overall Study|subject moved|0|||
145322946|NCT02139124|524030527|FG000|Overall Study|Lost to Follow-up|3|||
145322947|NCT02139124|524030528|FG001|Overall Study|Lost to Follow-up|2|||
145322948|NCT02139124|524030529|FG002|Overall Study|Lost to Follow-up|0|||
145322949|NCT02139124|524030530|FG003|Overall Study|Lost to Follow-up|5|||
145322950|NCT02139124|524030531|FG004|Overall Study|Lost to Follow-up|4|||
145322951|NCT01425528|524030532|FG000|Overall Study|Withdrawal by Subject|1|||
145322952|NCT01425528|524030533|FG001|Overall Study|Withdrawal by Subject|1|||
145322953|NCT03069417|524030534|FG000|Overall Study|Lost to Follow-up|2|||
145322954|NCT03069417|524030535|FG001|Overall Study|Lost to Follow-up|0|||
145322955|NCT03069417|524030534|FG000|Overall Study|Reason Unknown|4|||
145322956|NCT03069417|524030535|FG001|Overall Study|Reason Unknown|7|||
145322957|NCT03366194|524030542|FG000|Overall Study|Lost to Follow-up|2|||
145322958|NCT02953678|524030545|FG000|Overall Study|Adverse Event|20|||
145322959|NCT02953678|524030545|FG000|Overall Study|Death|7|||
145322960|NCT02953678|524030545|FG000|Overall Study|Physician Decision|23|||
145322961|NCT02953678|524030545|FG000|Overall Study|Progressive Disease of GVHD|7|||
145322962|NCT02953678|524030545|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
145322963|NCT02953678|524030545|FG000|Overall Study|Withdrawal by participant|3|||
145322964|NCT02953678|524030545|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
145322965|NCT02953678|524030545|FG000|Overall Study|Participants were transferred to commercial product.|3|||
145322966|NCT01937351|524033102|FG000|Overall Study|Withdrawal by Subject|4|||
145322967|NCT01937351|524033103|FG001|Overall Study|Withdrawal by Subject|2|||
145322968|NCT01937351|524033102|FG000|Overall Study|Death|1|||
145322969|NCT01937351|524033103|FG001|Overall Study|Death|0|||
145570579|NCT02777125|524947440|FG001|Overall Study|Consent form violation|12|||
145570580|NCT02777125|524947439|FG000|Overall Study|Assent form violation|21|||
145570581|NCT02777125|524947440|FG001|Overall Study|Assent form violation|23|||
145570582|NCT02777125|524947439|FG000|Overall Study|Protocol Violation|8|||
145570583|NCT02777125|524947440|FG001|Overall Study|Protocol Violation|12|||
145570584|NCT02283788|524947443|FG000|Overall Study|Adverse Event|1|||
145570585|NCT02283788|524947444|FG001|Overall Study|Adverse Event|3|||
145570586|NCT02283788|524947445|FG002|Overall Study|Adverse Event|5|||
145570587|NCT02283788|524947446|FG003|Overall Study|Adverse Event|1|||
145570588|NCT02283788|524947443|FG000|Overall Study|Withdrawal by Subject|0|||
145570589|NCT02283788|524947444|FG001|Overall Study|Withdrawal by Subject|1|||
145570590|NCT02283788|524947445|FG002|Overall Study|Withdrawal by Subject|0|||
145570591|NCT02283788|524947446|FG003|Overall Study|Withdrawal by Subject|1|||
145570592|NCT00653224|524949977|FG000|Overall Study|Adverse Event|2|||
145570593|NCT00653224|524949978|FG001|Overall Study|Adverse Event|1|||
145570594|NCT00653224|524949977|FG000|Overall Study|Lack of Efficacy|1|||
145570595|NCT00653224|524949978|FG001|Overall Study|Lack of Efficacy|2|||
145570596|NCT00653224|524949977|FG000|Overall Study|Loss of efficacy|1|||
145570597|NCT00653224|524949978|FG001|Overall Study|Loss of efficacy|0|||
145570598|NCT00653224|524949977|FG000|Overall Study|Lost to Follow-up|1|||
145570599|NCT00653224|524949978|FG001|Overall Study|Lost to Follow-up|0|||
145570600|NCT00653224|524949977|FG000|Overall Study|Other|2|||
145570601|NCT00653224|524949978|FG001|Overall Study|Other|4|||
145570602|NCT00773175|524949979|FG000|Overall Study|Adverse Event|2|||
145570603|NCT00773175|524949980|FG001|Overall Study|Adverse Event|0|||
145570604|NCT00773175|524949979|FG000|Overall Study|Consent Withdrawn|0|||
145570605|NCT00773175|524949980|FG001|Overall Study|Consent Withdrawn|2|||
145322970|NCT01937351|524033102|FG000|Overall Study|Not treated w device, per protocol fail|4|||
145322971|NCT01937351|524033103|FG001|Overall Study|Not treated w device, per protocol fail|0|||
145322972|NCT01730040|524033104|FG000|Overall Study|Randomized but not treated|0|||
145322973|NCT01730040|524033105|FG001|Overall Study|Randomized but not treated|0|||
145322974|NCT01730040|524033106|FG002|Overall Study|Randomized but not treated|0|||
145570606|NCT00503841|524949981|FG000|Overall Study|All screen failures|44|||
145570607|NCT00770120|524949987|FG000|Overall Study|Progression|31|||
145570608|NCT00770120|524949987|FG000|Overall Study|Adverse Event|11|||
145570609|NCT00770120|524949987|FG000|Overall Study|Not Protocol Specified|11|||
145570610|NCT00770120|524949987|FG000|Overall Study|Death|3|||
145570611|NCT00770120|524949987|FG000|Overall Study|Withdrawal by Subject|2|||
145322975|NCT01730040|524033107|FG003|Overall Study|Randomized but not treated|0|||
145322976|NCT01730040|524033108|FG004|Overall Study|Randomized but not treated|0|||
145322977|NCT01730040|524033109|FG005|Overall Study|Randomized but not treated|1|||
145322978|NCT01730040|524033110|FG006|Overall Study|Randomized but not treated|0|||
145322979|NCT01730040|524033104|FG000|Overall Study|Subject moved|0|||
145322980|NCT01730040|524033105|FG001|Overall Study|Subject moved|0|||
145322981|NCT01730040|524033106|FG002|Overall Study|Subject moved|1|||
145570612|NCT00770120|524949987|FG000|Overall Study|Ineligible|1|||
145570613|NCT00770120|524949987|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
145570614|NCT00770120|524949987|FG000|Overall Study|Reason under Review|1|||
145322982|NCT01730040|524033107|FG003|Overall Study|Subject moved|0|||
145322983|NCT01730040|524033108|FG004|Overall Study|Subject moved|0|||
145322984|NCT01730040|524033109|FG005|Overall Study|Subject moved|0|||
145322985|NCT01730040|524033110|FG006|Overall Study|Subject moved|1|||
145322986|NCT01730040|524033104|FG000|Overall Study|Physician Decision|0|||
145322987|NCT01730040|524033105|FG001|Overall Study|Physician Decision|0|||
145322988|NCT01730040|524033106|FG002|Overall Study|Physician Decision|0|||
145322989|NCT01730040|524033107|FG003|Overall Study|Physician Decision|0|||
145322990|NCT01730040|524033108|FG004|Overall Study|Physician Decision|0|||
145322991|NCT01730040|524033109|FG005|Overall Study|Physician Decision|1|||
145322992|NCT01730040|524033110|FG006|Overall Study|Physician Decision|1|||
145570615|NCT02412631|524949988|FG000|Overall Study|Adverse Event|1|||
145570616|NCT02412631|524949989|FG001|Overall Study|Adverse Event|2|||
145570617|NCT02412631|524949988|FG000|Overall Study|Lost to Follow-up|5|||
145570618|NCT02412631|524949989|FG001|Overall Study|Lost to Follow-up|9|||
145570619|NCT02412631|524949988|FG000|Overall Study|Withdrawal by Subject|9|||
145570620|NCT02412631|524949989|FG001|Overall Study|Withdrawal by Subject|3|||
145570621|NCT02412631|524949988|FG000|Overall Study|Early stop by FDA|5|||
145570622|NCT02412631|524949989|FG001|Overall Study|Early stop by FDA|2|||
145570623|NCT02412631|524949988|FG000|Overall Study|Unspecified reason|6|||
145570624|NCT02412631|524949989|FG001|Overall Study|Unspecified reason|8|||
145570625|NCT02884089|524949992|FG000|Period 1|Dosing error|2|||
145570626|NCT02884089|524949993|FG001|Period 1|Dosing error|2|||
145570627|NCT02884089|524949994|FG002|Period 1|Dosing error|0|||
145570628|NCT02884089|524949995|FG003|Period 1|Dosing error|0|||
145570629|NCT02884089|524949992|FG000|Washout Period 1|Lost to Follow-up|0|||
145322993|NCT01730040|524033104|FG000|Overall Study|Other than specified|7|||
145322994|NCT01730040|524033105|FG001|Overall Study|Other than specified|8|||
145322995|NCT01730040|524033106|FG002|Overall Study|Other than specified|5|||
145322996|NCT01730040|524033107|FG003|Overall Study|Other than specified|5|||
145322997|NCT01730040|524033108|FG004|Overall Study|Other than specified|5|||
145322998|NCT01730040|524033109|FG005|Overall Study|Other than specified|4|||
145322999|NCT01730040|524033110|FG006|Overall Study|Other than specified|4|||
145323000|NCT01730040|524033104|FG000|Overall Study|Adverse Event|4|||
145323001|NCT01730040|524033105|FG001|Overall Study|Adverse Event|3|||
145323002|NCT01730040|524033106|FG002|Overall Study|Adverse Event|5|||
145323003|NCT01730040|524033107|FG003|Overall Study|Adverse Event|3|||
145323004|NCT01730040|524033108|FG004|Overall Study|Adverse Event|1|||
145323005|NCT01730040|524033109|FG005|Overall Study|Adverse Event|1|||
145323006|NCT01730040|524033110|FG006|Overall Study|Adverse Event|2|||
145323007|NCT01730040|524033104|FG000|Overall Study|Poor compliance to protocol|2|||
145323008|NCT01730040|524033105|FG001|Overall Study|Poor compliance to protocol|4|||
145323009|NCT01730040|524033106|FG002|Overall Study|Poor compliance to protocol|0|||
145323010|NCT01730040|524033107|FG003|Overall Study|Poor compliance to protocol|0|||
145323011|NCT01730040|524033108|FG004|Overall Study|Poor compliance to protocol|0|||
145323012|NCT01730040|524033109|FG005|Overall Study|Poor compliance to protocol|0|||
145323013|NCT01730040|524033110|FG006|Overall Study|Poor compliance to protocol|1|||
145323014|NCT04776746|524033111|FG000|Overall Study|Study terminated by sponsor|61|||
145323015|NCT04776746|524033111|FG000|Overall Study|Adverse Event|5|||
145323016|NCT04776746|524033111|FG000|Overall Study|Death|4|||
145323017|NCT04776746|524033111|FG000|Overall Study|Lack of Efficacy|3|||
145323018|NCT04776746|524033111|FG000|Overall Study|Noncompliance with study drug|2|||
145323019|NCT04776746|524033111|FG000|Overall Study|Not related to COVID-19|2|||
145323020|NCT01223235|524033112|FG000|Overall Study|Withdrawal by Subject|1|||
145323021|NCT01360866|524033113|FG000|Overall Study|Lost to Follow-up|11|||
145323022|NCT01360866|524033114|FG001|Overall Study|Lost to Follow-up|28|||
145323023|NCT01360866|524033115|FG002|Overall Study|Lost to Follow-up|41|||
145323024|NCT01360866|524033116|FG003|Overall Study|Lost to Follow-up|0|||
145323025|NCT01360866|524033113|FG000|Overall Study|Adverse Event|56|||
145323026|NCT01360866|524033114|FG001|Overall Study|Adverse Event|61|||
145323027|NCT01360866|524033115|FG002|Overall Study|Adverse Event|134|||
145323028|NCT01360866|524033116|FG003|Overall Study|Adverse Event|6|||
145323029|NCT01360866|524033113|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
145570630|NCT02884089|524949993|FG001|Washout Period 1|Lost to Follow-up|1|||
145570631|NCT02884089|524949994|FG002|Washout Period 1|Lost to Follow-up|0|||
145570632|NCT02884089|524949995|FG003|Washout Period 1|Lost to Follow-up|1|||
145570633|NCT02884089|524949992|FG000|Washout Period 1|Withdrawal by Subject|0|||
145570634|NCT02884089|524949993|FG001|Washout Period 1|Withdrawal by Subject|1|||
145323030|NCT01360866|524033114|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
145323031|NCT01360866|524033115|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
145323032|NCT01360866|524033116|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
145323033|NCT01360866|524033113|FG000|Overall Study|Withdrawn by Investigator|9|||
145323034|NCT01360866|524033114|FG001|Overall Study|Withdrawn by Investigator|8|||
145323035|NCT01360866|524033115|FG002|Overall Study|Withdrawn by Investigator|31|||
145323036|NCT01360866|524033116|FG003|Overall Study|Withdrawn by Investigator|2|||
145323037|NCT01360866|524033113|FG000|Overall Study|Withdrawal by participant|79|||
145323038|NCT01360866|524033114|FG001|Overall Study|Withdrawal by participant|89|||
145323039|NCT01360866|524033115|FG002|Overall Study|Withdrawal by participant|168|||
145323040|NCT01360866|524033116|FG003|Overall Study|Withdrawal by participant|8|||
145570635|NCT02884089|524949994|FG002|Washout Period 1|Withdrawal by Subject|0|||
145570636|NCT02884089|524949995|FG003|Washout Period 1|Withdrawal by Subject|0|||
145570637|NCT02884089|524949992|FG000|Period 2|Adverse Event|1|||
145570638|NCT02884089|524949993|FG001|Period 2|Adverse Event|0|||
145323041|NCT01360866|524033113|FG000|Overall Study|Protocol Deviation|25|||
145323042|NCT01360866|524033114|FG001|Overall Study|Protocol Deviation|33|||
145323043|NCT01360866|524033115|FG002|Overall Study|Protocol Deviation|61|||
145323044|NCT01360866|524033116|FG003|Overall Study|Protocol Deviation|2|||
145323045|NCT01360866|524033113|FG000|Overall Study|Lack of Efficacy|30|||
145323046|NCT01360866|524033114|FG001|Overall Study|Lack of Efficacy|40|||
145323047|NCT01360866|524033115|FG002|Overall Study|Lack of Efficacy|30|||
145323048|NCT01360866|524033116|FG003|Overall Study|Lack of Efficacy|4|||
145570639|NCT02884089|524949994|FG002|Period 2|Adverse Event|0|||
145570640|NCT02884089|524949995|FG003|Period 2|Adverse Event|0|||
145570641|NCT02884089|524949992|FG000|Period 3|Withdrawal by Subject|0|||
145570642|NCT02884089|524949993|FG001|Period 3|Withdrawal by Subject|0|||
145570643|NCT02884089|524949994|FG002|Period 3|Withdrawal by Subject|1|||
145570644|NCT02884089|524949995|FG003|Period 3|Withdrawal by Subject|0|||
145570645|NCT02884089|524949992|FG000|Washout Period 3|Withdrawal by Subject|0|||
145570646|NCT02884089|524949993|FG001|Washout Period 3|Withdrawal by Subject|0|||
145570647|NCT02884089|524949994|FG002|Washout Period 3|Withdrawal by Subject|1|||
145570648|NCT02884089|524949995|FG003|Washout Period 3|Withdrawal by Subject|0|||
145570649|NCT02884089|524949992|FG000|Washout Period 3|Lost to Follow-up|0|||
145323049|NCT03702049|524033117|FG000|Overall Study|Lost to Follow-up|4|||
145323050|NCT03702049|524033117|FG000|Overall Study|Physician Decision|1|||
145323051|NCT01014624|524033126|FG000|Overall Study|Adverse Event|0|||
145323052|NCT01014624|524033127|FG001|Overall Study|Adverse Event|1|||
145323053|NCT01014624|524033126|FG000|Overall Study|Protocol Violation|1|||
145323054|NCT01014624|524033127|FG001|Overall Study|Protocol Violation|0|||
145323055|NCT01014624|524033126|FG000|Overall Study|Withdrawal by Subject|1|||
145323056|NCT01014624|524033127|FG001|Overall Study|Withdrawal by Subject|0|||
145570650|NCT02884089|524949993|FG001|Washout Period 3|Lost to Follow-up|0|||
145570651|NCT02884089|524949994|FG002|Washout Period 3|Lost to Follow-up|0|||
145570652|NCT02884089|524949995|FG003|Washout Period 3|Lost to Follow-up|1|||
145570653|NCT02884089|524949992|FG000|Period 4|Withdrawal by Subject|0|||
145570654|NCT02884089|524949993|FG001|Period 4|Withdrawal by Subject|1|||
145570655|NCT02884089|524949994|FG002|Period 4|Withdrawal by Subject|0|||
145570656|NCT02884089|524949995|FG003|Period 4|Withdrawal by Subject|0|||
145570657|NCT02884089|524949992|FG000|Period 4|Lost to Follow-up|1|||
145570658|NCT02884089|524949993|FG001|Period 4|Lost to Follow-up|0|||
145570659|NCT02884089|524949994|FG002|Period 4|Lost to Follow-up|0|||
145570660|NCT02884089|524949995|FG003|Period 4|Lost to Follow-up|0|||
145570661|NCT02884089|524949992|FG000|Follow-up Visit|Withdrawal by Subject|1|||
145570662|NCT02884089|524949993|FG001|Follow-up Visit|Withdrawal by Subject|0|||
145570663|NCT02884089|524949994|FG002|Follow-up Visit|Withdrawal by Subject|0|||
145570664|NCT02884089|524949995|FG003|Follow-up Visit|Withdrawal by Subject|1|||
145570665|NCT01631474|524949996|FG000|Overall Study|Lost to Follow-up|8|||
145570666|NCT01631474|524949997|FG001|Overall Study|Lost to Follow-up|5|||
145570667|NCT01631474|524949998|FG002|Overall Study|Lost to Follow-up|7|||
145570668|NCT01631474|524949999|FG003|Overall Study|Lost to Follow-up|5|||
145570669|NCT01631474|524950000|FG004|Overall Study|Lost to Follow-up|5|||
145570670|NCT01631474|524949996|FG000|Overall Study|Withdrawal by Subject|4|||
145570671|NCT01631474|524949997|FG001|Overall Study|Withdrawal by Subject|4|||
145570672|NCT01631474|524949998|FG002|Overall Study|Withdrawal by Subject|2|||
145570673|NCT01631474|524949999|FG003|Overall Study|Withdrawal by Subject|6|||
145570674|NCT01631474|524950000|FG004|Overall Study|Withdrawal by Subject|5|||
145570675|NCT01631474|524949996|FG000|Overall Study|Lack of Efficacy|2|||
145323057|NCT01117337|524033131|FG000|Overall Study|Lost to Follow-up|4|||
145323058|NCT01117337|524033132|FG001|Overall Study|Lost to Follow-up|0|||
145323059|NCT02791893|524033138|FG000|Blinded Phase|Lost to Follow-up|2|||
145570676|NCT01631474|524949997|FG001|Overall Study|Lack of Efficacy|2|||
145570677|NCT01631474|524949998|FG002|Overall Study|Lack of Efficacy|0|||
145570678|NCT01631474|524949999|FG003|Overall Study|Lack of Efficacy|0|||
145570679|NCT01631474|524950000|FG004|Overall Study|Lack of Efficacy|2|||
145570680|NCT01631474|524949996|FG000|Overall Study|Noncompliance with Study Drug|0|||
145570681|NCT01631474|524949997|FG001|Overall Study|Noncompliance with Study Drug|0|||
145570682|NCT01631474|524949998|FG002|Overall Study|Noncompliance with Study Drug|0|||
145570683|NCT01631474|524949999|FG003|Overall Study|Noncompliance with Study Drug|0|||
145620589|NCT03873246|525125112|FG000|Overall Study|Lost to Follow-up|4|||
145323060|NCT02791893|524033139|FG001|Blinded Phase|Lost to Follow-up|2|||
145323061|NCT02791893|524033138|FG000|Blinded Phase|Withdrawal by Subject|1|||
145323062|NCT02791893|524033139|FG001|Blinded Phase|Withdrawal by Subject|2|||
145323063|NCT02791893|524033138|FG000|Open Label Phase|Lost to Follow-up|3|||
145570684|NCT01631474|524950000|FG004|Overall Study|Noncompliance with Study Drug|1|||
145570685|NCT01631474|524949996|FG000|Overall Study|Adverse Event|0|||
145323064|NCT02791893|524033139|FG001|Open Label Phase|Lost to Follow-up|0|||
145570686|NCT01631474|524949997|FG001|Overall Study|Adverse Event|1|||
145570687|NCT01631474|524949998|FG002|Overall Study|Adverse Event|0|||
145570688|NCT01631474|524949999|FG003|Overall Study|Adverse Event|0|||
145570689|NCT01631474|524950000|FG004|Overall Study|Adverse Event|0|||
145323065|NCT02791893|524033138|FG000|Open Label Phase|Withdrawal by Subject|0|||
145323066|NCT02791893|524033139|FG001|Open Label Phase|Withdrawal by Subject|2|||
145323067|NCT03336242|524033140|FG000|Overall Study|Adverse Event|0|||
145323068|NCT03336242|524033141|FG001|Overall Study|Adverse Event|1|||
145323069|NCT03005067|524033145|FG000|Overall Study|Withdrawal by Subject|3|||
145323070|NCT03005067|524033146|FG001|Overall Study|Withdrawal by Subject|2|||
145323071|NCT03005067|524033145|FG000|Overall Study|Adverse Event|4|||
145323072|NCT03005067|524033146|FG001|Overall Study|Adverse Event|3|||
145323073|NCT03005067|524033145|FG000|Overall Study|Other (reason not specified)|3|||
145323074|NCT03005067|524033146|FG001|Overall Study|Other (reason not specified)|1|||
145323075|NCT03005067|524033145|FG000|Overall Study|Protocol Violation|0|||
145323076|NCT03005067|524033146|FG001|Overall Study|Protocol Violation|1|||
145323077|NCT01790113|524033151|FG000|Overall Study|Adverse Event|2|||
145323078|NCT01790113|524033152|FG001|Overall Study|Adverse Event|7|||
145323079|NCT01790113|524033151|FG000|Overall Study|Study ended due to FDA clearance|1|||
145323080|NCT01790113|524033152|FG001|Overall Study|Study ended due to FDA clearance|68|||
145323081|NCT02674386|524033153|FG000|Overall Study|Lost to Follow-up|0|||
145323082|NCT02674386|524033154|FG001|Overall Study|Lost to Follow-up|1|||
145323083|NCT02674386|524033155|FG002|Overall Study|Lost to Follow-up|1|||
145323084|NCT02674386|524033153|FG000|Overall Study|Withdrawal by Subject|0|||
145323085|NCT02674386|524033154|FG001|Overall Study|Withdrawal by Subject|4|||
145323086|NCT02674386|524033155|FG002|Overall Study|Withdrawal by Subject|0|||
145323087|NCT02674386|524033153|FG000|Overall Study|Other|0|||
145323088|NCT02674386|524033154|FG001|Overall Study|Other|1|||
145323089|NCT02674386|524033155|FG002|Overall Study|Other|0|||
145323090|NCT02674386|524033153|FG000|Overall Study|Enrolled but not evaluated|0|||
145323091|NCT02674386|524033154|FG001|Overall Study|Enrolled but not evaluated|4|||
145323092|NCT02674386|524033155|FG002|Overall Study|Enrolled but not evaluated|0|||
145323093|NCT02462486|524033160|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145323094|NCT02462486|524033161|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
145323095|NCT02462486|524033162|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
145323096|NCT02462486|524033160|FG000|Overall Study|Adverse Event|53|||
145323097|NCT02462486|524033161|FG001|Overall Study|Adverse Event|48|||
145323098|NCT02462486|524033162|FG002|Overall Study|Adverse Event|21|||
145323099|NCT02462486|524033160|FG000|Overall Study|Lack of Efficacy|6|||
145323100|NCT02462486|524033161|FG001|Overall Study|Lack of Efficacy|12|||
145323101|NCT02462486|524033162|FG002|Overall Study|Lack of Efficacy|3|||
145323102|NCT02462486|524033160|FG000|Overall Study|Lost to Follow-up|3|||
145323103|NCT02462486|524033161|FG001|Overall Study|Lost to Follow-up|4|||
145323104|NCT02462486|524033162|FG002|Overall Study|Lost to Follow-up|2|||
145323105|NCT02462486|524033160|FG000|Overall Study|Withdrawal by Subject|25|||
145323106|NCT02462486|524033161|FG001|Overall Study|Withdrawal by Subject|22|||
145323107|NCT02462486|524033162|FG002|Overall Study|Withdrawal by Subject|19|||
145323108|NCT02462486|524033160|FG000|Overall Study|Protocol Violation|3|||
145323109|NCT02462486|524033161|FG001|Overall Study|Protocol Violation|1|||
145323110|NCT02462486|524033162|FG002|Overall Study|Protocol Violation|1|||
145323111|NCT02462486|524033160|FG000|Overall Study|Reason not Specified|3|||
145323112|NCT02462486|524033161|FG001|Overall Study|Reason not Specified|4|||
145323113|NCT02462486|524033162|FG002|Overall Study|Reason not Specified|3|||
145323114|NCT02310763|524033163|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145323115|NCT02310763|524033164|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145323116|NCT02310763|524033165|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
145323117|NCT02310763|524033163|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
145323118|NCT02310763|524033164|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
145323119|NCT02310763|524033165|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
145323120|NCT02310763|524033163|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
145323121|NCT02310763|524033164|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
145323122|NCT02310763|524033165|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
145323123|NCT02310763|524033163|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
145323124|NCT02310763|524033164|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
145323125|NCT02310763|524033165|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
145323126|NCT02310763|524033163|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145323127|NCT02310763|524033164|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145323128|NCT02310763|524033165|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
145323129|NCT02094261|524033168|FG000|Overall Study|Death|24|||
145323130|NCT02094261|524033168|FG000|Overall Study|Lost to Follow-up|1|||
145323131|NCT02094261|524033168|FG000|Overall Study|Withdrawal by Subject|4|||
145323132|NCT02094261|524033168|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
145323133|NCT01202877|524033171|FG000|Overall Study|Disease Progression|0|||
145323134|NCT01202877|524033172|FG001|Overall Study|Disease Progression|1|||
145323135|NCT01202877|524033173|FG002|Overall Study|Disease Progression|2|||
145323136|NCT01202877|524033171|FG000|Overall Study|Adverse Event|0|||
145323137|NCT01202877|524033172|FG001|Overall Study|Adverse Event|0|||
145323138|NCT01202877|524033173|FG002|Overall Study|Adverse Event|2|||
145323139|NCT01202877|524033171|FG000|Overall Study|Withdrawal by Subject|0|||
145323140|NCT01202877|524033172|FG001|Overall Study|Withdrawal by Subject|0|||
145323141|NCT01202877|524033173|FG002|Overall Study|Withdrawal by Subject|1|||
145323142|NCT01202877|524033171|FG000|Overall Study|Death|0|||
145323143|NCT01202877|524033172|FG001|Overall Study|Death|0|||
145323144|NCT01202877|524033173|FG002|Overall Study|Death|1|||
145323145|NCT00396331|524033174|FG000|Overall Study|Failed to mobilize - no transplant|8|||
145323146|NCT00396331|524033174|FG000|Overall Study|Did not go on to transplant|5|||
145323147|NCT00396331|524033174|FG000|Overall Study|Lost to Follow-up|3|||
145323148|NCT00396331|524033174|FG000|Overall Study|Death|16|||
145323149|NCT00680186|524033175|FG000|Overall Study|Adverse Event|47|||
145323150|NCT00680186|524033176|FG001|Overall Study|Adverse Event|44|||
145323151|NCT00680186|524033175|FG000|Overall Study|Protocol Violation|31|||
145323152|NCT00680186|524033176|FG001|Overall Study|Protocol Violation|26|||
145323153|NCT00680186|524033175|FG000|Overall Study|Lost to Follow-up|11|||
145323154|NCT00680186|524033176|FG001|Overall Study|Lost to Follow-up|6|||
145323155|NCT00680186|524033175|FG000|Overall Study|Withdrawal by Subject|32|||
145323156|NCT00680186|524033176|FG001|Overall Study|Withdrawal by Subject|39|||
145323157|NCT00680186|524033175|FG000|Overall Study|Other|4|||
145323158|NCT00680186|524033176|FG001|Overall Study|Other|1|||
145323159|NCT01351350|524033179|FG000|Overall Study|Disease Progression|5|||
145323160|NCT01351350|524033180|FG001|Overall Study|Disease Progression|13|||
145323161|NCT01351350|524033181|FG002|Overall Study|Disease Progression|6|||
145323162|NCT01351350|524033182|FG003|Overall Study|Disease Progression|8|||
145323163|NCT01351350|524033183|FG004|Overall Study|Disease Progression|5|||
145323164|NCT01351350|524033179|FG000|Overall Study|Adverse Event|1|||
145323165|NCT01351350|524033180|FG001|Overall Study|Adverse Event|10|||
145323166|NCT01351350|524033181|FG002|Overall Study|Adverse Event|1|||
145323167|NCT01351350|524033182|FG003|Overall Study|Adverse Event|2|||
145323168|NCT01351350|524033183|FG004|Overall Study|Adverse Event|0|||
145323169|NCT01351350|524033179|FG000|Overall Study|Participant Decision|2|||
145323170|NCT01351350|524033180|FG001|Overall Study|Participant Decision|6|||
145323171|NCT01351350|524033181|FG002|Overall Study|Participant Decision|3|||
145323172|NCT01351350|524033182|FG003|Overall Study|Participant Decision|3|||
145323173|NCT01351350|524033183|FG004|Overall Study|Participant Decision|2|||
145323174|NCT01351350|524033179|FG000|Overall Study|Enrolled but not Treated|0|||
145323175|NCT01351350|524033180|FG001|Overall Study|Enrolled but not Treated|0|||
145323176|NCT01351350|524033181|FG002|Overall Study|Enrolled but not Treated|1|||
145323177|NCT01351350|524033182|FG003|Overall Study|Enrolled but not Treated|0|||
145323178|NCT01351350|524033183|FG004|Overall Study|Enrolled but not Treated|0|||
145323179|NCT00775528|524033186|FG000|Overall Study|Protocol Violation|1|||
145323180|NCT04647383|524033187|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
145323181|NCT04647383|524033188|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
145323182|NCT04647383|524033189|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
145323183|NCT04647383|524033190|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
145323184|NCT03812991|524033199|FG000|Overall Study|Lost to Follow-up|3|||
145323185|NCT03812991|524033200|FG001|Overall Study|Lost to Follow-up|1|||
145323186|NCT01884688|524033205|FG000|Overall Study|Screen Failure|2|||
145323187|NCT01103479|524033209|FG000|Overall Study|Up to date with CRC screening|1|||
145323188|NCT01103479|524033210|FG001|Overall Study|Up to date with CRC screening|9|||
145323189|NCT01103479|524033211|FG002|Overall Study|Up to date with CRC screening|12|||
145323190|NCT01103479|524033209|FG000|Overall Study|Family history of CRC|1|||
145323191|NCT01103479|524033210|FG001|Overall Study|Family history of CRC|0|||
145323192|NCT01103479|524033211|FG002|Overall Study|Family history of CRC|2|||
145323193|NCT01103479|524033209|FG000|Overall Study|Active cancer|1|||
145323194|NCT01103479|524033210|FG001|Overall Study|Active cancer|0|||
145323195|NCT01103479|524033211|FG002|Overall Study|Active cancer|0|||
145323196|NCT01103479|524033209|FG000|Overall Study|Saw non-study physician|2|||
145323197|NCT01103479|524033210|FG001|Overall Study|Saw non-study physician|0|||
145323198|NCT01103479|524033211|FG002|Overall Study|Saw non-study physician|0|||
145323199|NCT01523587|524033212|FG000|Overall Study|Other than listed|5|||
145323200|NCT01523587|524033213|FG001|Overall Study|Other than listed|5|||
145323201|NCT01523587|524033212|FG000|Overall Study|Worsening of underlying cancer disease|19|||
145323202|NCT01523587|524033213|FG001|Overall Study|Worsening of underlying cancer disease|34|||
145323203|NCT01523587|524033212|FG000|Overall Study|Adverse Event|68|||
145323204|NCT01523587|524033213|FG001|Overall Study|Adverse Event|52|||
145323205|NCT01523587|524033212|FG000|Overall Study|Protocol Violation|5|||
145323206|NCT01523587|524033213|FG001|Overall Study|Protocol Violation|3|||
145323207|NCT01523587|524033212|FG000|Overall Study|Lost to Follow-up|2|||
145323208|NCT01523587|524033213|FG001|Overall Study|Lost to Follow-up|2|||
145323209|NCT01523587|524033212|FG000|Overall Study|Withdrawal by Subject|28|||
145323210|NCT01523587|524033213|FG001|Overall Study|Withdrawal by Subject|20|||
145323211|NCT01523587|524033212|FG000|Overall Study|Withdrew due to Progressive disease|265|||
145323212|NCT01523587|524033213|FG001|Overall Study|Withdrew due to Progressive disease|279|||
145323213|NCT01523587|524033212|FG000|Overall Study|Randomised but bot treated|6|||
145323214|NCT01523587|524033213|FG001|Overall Study|Randomised but bot treated|2|||
145323215|NCT01298778|524033214|FG000|Overall Study|Lost to Follow-up|2|||
145323216|NCT01298778|524033215|FG001|Overall Study|Lost to Follow-up|3|||
145323217|NCT01298778|524033214|FG000|Overall Study|Incorrect use of VAS|1|||
145323218|NCT01298778|524033215|FG001|Overall Study|Incorrect use of VAS|0|||
145323219|NCT01298778|524033214|FG000|Overall Study|Withdrawal by Subject|0|||
145323220|NCT01298778|524033215|FG001|Overall Study|Withdrawal by Subject|1|||
145323221|NCT01298778|524033214|FG000|Overall Study|Protocol Violation|0|||
145323222|NCT01298778|524033215|FG001|Overall Study|Protocol Violation|1|||
145323223|NCT01298778|524033214|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
145323224|NCT01298778|524033215|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
145323225|NCT02709486|524033221|FG000|Overall Study|Adverse Event|2|||
145323226|NCT02709486|524033222|FG001|Overall Study|Adverse Event|5|||
145323227|NCT02709486|524033223|FG002|Overall Study|Adverse Event|3|||
145323228|NCT02709486|524033221|FG000|Overall Study|Death|0|||
145323229|NCT02709486|524033222|FG001|Overall Study|Death|0|||
145323230|NCT02709486|524033223|FG002|Overall Study|Death|2|||
145323231|NCT02709486|524033221|FG000|Overall Study|Insufficient clinical response|7|||
145323232|NCT02709486|524033222|FG001|Overall Study|Insufficient clinical response|3|||
145323233|NCT02709486|524033223|FG002|Overall Study|Insufficient clinical response|3|||
145323234|NCT02709486|524033221|FG000|Overall Study|Lost to Follow-up|3|||
145323235|NCT02709486|524033222|FG001|Overall Study|Lost to Follow-up|2|||
145323236|NCT02709486|524033223|FG002|Overall Study|Lost to Follow-up|2|||
145323237|NCT02709486|524033221|FG000|Overall Study|Other|0|||
145323238|NCT02709486|524033222|FG001|Overall Study|Other|2|||
145323239|NCT02709486|524033223|FG002|Overall Study|Other|3|||
145323240|NCT02709486|524033221|FG000|Overall Study|Withdrawal by Subject|32|||
145323241|NCT02709486|524033222|FG001|Overall Study|Withdrawal by Subject|22|||
145323242|NCT02709486|524033223|FG002|Overall Study|Withdrawal by Subject|32|||
145323243|NCT00606502|524033224|FG000|Randomization|Randomized but not treated|3|||
145323244|NCT00606502|524033225|FG001|Randomization|Randomized but not treated|0|||
145323245|NCT00606502|524033224|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
145323246|NCT00606502|524033225|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
145323247|NCT02443545|524033228|FG000|Overall Study|Adverse Event|1|||
145323248|NCT02443545|524033229|FG001|Overall Study|Adverse Event|1|||
145323249|NCT02443545|524033228|FG000|Overall Study|Lost to Follow-up|0|||
145323250|NCT02443545|524033229|FG001|Overall Study|Lost to Follow-up|2|||
145323251|NCT02443545|524033228|FG000|Overall Study|Physician Decision|3|||
145323252|NCT02443545|524033229|FG001|Overall Study|Physician Decision|0|||
145323253|NCT02443545|524033228|FG000|Overall Study|Protocol Violation|8|||
145323254|NCT02443545|524033229|FG001|Overall Study|Protocol Violation|1|||
145323255|NCT02443545|524033228|FG000|Overall Study|Pregnancy|1|||
145323256|NCT02443545|524033229|FG001|Overall Study|Pregnancy|1|||
145323257|NCT02443545|524033228|FG000|Overall Study|Withdrawal by Subject|6|||
145323258|NCT02443545|524033229|FG001|Overall Study|Withdrawal by Subject|3|||
145323259|NCT02443545|524033228|FG000|Overall Study|Termination of study|20|||
145323260|NCT02443545|524033229|FG001|Overall Study|Termination of study|11|||
145323261|NCT02549573|524033233|FG000|Overall Study|Withdrawal by Subject|0|||
145323262|NCT02549573|524033234|FG001|Overall Study|Withdrawal by Subject|2|||
145323263|NCT02549573|524033233|FG000|Overall Study|Protocol Violation|0|||
145323264|NCT02549573|524033234|FG001|Overall Study|Protocol Violation|1|||
145323265|NCT02083926|524033237|FG000|Overall Study|Withdrawal by Subject|1|||
145323266|NCT02083926|524033238|FG001|Overall Study|Withdrawal by Subject|0|||
145323267|NCT02610816|524033239|FG000|Phase 1|Withdrawal by Subject|2|||
145323268|NCT02610816|524033240|FG001|Phase 1|Withdrawal by Subject|6|||
145323269|NCT02610816|524033241|FG002|Phase 1|Withdrawal by Subject|0|||
145323270|NCT02610816|524033242|FG003|Phase 1|Withdrawal by Subject|0|||
145323271|NCT02610816|524033239|FG000|Phase 1|Lost to Follow-up|2|||
145323272|NCT02610816|524033240|FG001|Phase 1|Lost to Follow-up|1|||
145323273|NCT02610816|524033241|FG002|Phase 1|Lost to Follow-up|0|||
145323274|NCT02610816|524033242|FG003|Phase 1|Lost to Follow-up|0|||
145323275|NCT02610816|524033239|FG000|Phase 1|Physician Decision|0|||
145323276|NCT02610816|524033240|FG001|Phase 1|Physician Decision|1|||
145570690|NCT01467076|524950001|FG000|Overall Study|Lost to Follow-up|1|||
145323277|NCT02610816|524033241|FG002|Phase 1|Physician Decision|0|||
145323278|NCT02610816|524033242|FG003|Phase 1|Physician Decision|0|||
145323279|NCT02610816|524033239|FG000|Phase 2|Withdrawal by Subject|0|||
145323280|NCT02610816|524033240|FG001|Phase 2|Withdrawal by Subject|0|||
145323281|NCT02610816|524033241|FG002|Phase 2|Withdrawal by Subject|9|||
145323282|NCT02610816|524033242|FG003|Phase 2|Withdrawal by Subject|3|||
145323283|NCT02610816|524033239|FG000|Phase 2|Lost to Follow-up|0|||
145323284|NCT02610816|524033240|FG001|Phase 2|Lost to Follow-up|0|||
145323285|NCT02610816|524033241|FG002|Phase 2|Lost to Follow-up|2|||
145323286|NCT02610816|524033242|FG003|Phase 2|Lost to Follow-up|0|||
145323287|NCT02610816|524033239|FG000|Phase 2|Physician Decision|0|||
145323288|NCT02610816|524033240|FG001|Phase 2|Physician Decision|0|||
145323289|NCT02610816|524033241|FG002|Phase 2|Physician Decision|0|||
145323290|NCT02610816|524033242|FG003|Phase 2|Physician Decision|2|||
145323291|NCT02610816|524033239|FG000|Phase 2|Pregnancy|0|||
145323292|NCT02610816|524033240|FG001|Phase 2|Pregnancy|0|||
145323293|NCT02610816|524033241|FG002|Phase 2|Pregnancy|0|||
145323294|NCT02610816|524033242|FG003|Phase 2|Pregnancy|1|||
145323295|NCT00384176|524033245|FG000|Overall Study|Death|239|||
145323296|NCT00384176|524033246|FG001|Overall Study|Death|247|||
145323297|NCT00384176|524033247|FG002|Overall Study|Death|105|||
145323298|NCT00384176|524033245|FG000|Overall Study|Withdrawal by Subject|52|||
145323299|NCT00384176|524033246|FG001|Overall Study|Withdrawal by Subject|48|||
145323300|NCT00384176|524033247|FG002|Overall Study|Withdrawal by Subject|22|||
145323301|NCT00384176|524033245|FG000|Overall Study|Lost to Follow-up|16|||
145323302|NCT00384176|524033246|FG001|Overall Study|Lost to Follow-up|18|||
145323303|NCT00384176|524033247|FG002|Overall Study|Lost to Follow-up|4|||
145323304|NCT00384176|524033245|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
145323305|NCT00384176|524033246|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
145323306|NCT00384176|524033247|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
145323307|NCT00384176|524033245|FG000|Overall Study|Longer QTC as Visit 1|1|||
145323308|NCT00384176|524033246|FG001|Overall Study|Longer QTC as Visit 1|0|||
145323309|NCT00384176|524033247|FG002|Overall Study|Longer QTC as Visit 1|0|||
145323310|NCT00384176|524033245|FG000|Overall Study|Toxicity of treatment|1|||
145323311|NCT00384176|524033246|FG001|Overall Study|Toxicity of treatment|0|||
145323312|NCT00384176|524033247|FG002|Overall Study|Toxicity of treatment|0|||
145323313|NCT00384176|524033245|FG000|Overall Study|Did not receive study treatment|0|||
145323314|NCT00384176|524033246|FG001|Overall Study|Did not receive study treatment|1|||
145323315|NCT00384176|524033247|FG002|Overall Study|Did not receive study treatment|1|||
145323316|NCT00384176|524033245|FG000|Overall Study|Physician Decision|0|||
145323317|NCT00384176|524033246|FG001|Overall Study|Physician Decision|2|||
145323318|NCT00384176|524033247|FG002|Overall Study|Physician Decision|0|||
145323319|NCT00384176|524033245|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
145323320|NCT00384176|524033246|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
145323321|NCT00384176|524033247|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
145323322|NCT01855048|524033248|FG000|Overall Study|Withdrawal by Subject|0|||
145323323|NCT01855048|524033249|FG001|Overall Study|Withdrawal by Subject|1|||
145323324|NCT01855048|524033250|FG002|Overall Study|Withdrawal by Subject|0|||
145323325|NCT01855048|524033251|FG003|Overall Study|Withdrawal by Subject|0|||
145323326|NCT01855048|524033252|FG004|Overall Study|Withdrawal by Subject|1|||
145323327|NCT01855048|524033253|FG005|Overall Study|Withdrawal by Subject|0|||
145323328|NCT03465436|524033254|FG000|Period 1|Protocol Violation|0|||
145323329|NCT03465436|524033255|FG001|Period 1|Protocol Violation|0|||
145323330|NCT03465436|524033256|FG002|Period 1|Protocol Violation|1|||
145323331|NCT03465436|524033257|FG003|Period 1|Protocol Violation|0|||
145323332|NCT03465436|524033254|FG000|Period 2|Protocol Violation|0|||
145323333|NCT03465436|524033255|FG001|Period 2|Protocol Violation|1|||
145323334|NCT03465436|524033256|FG002|Period 2|Protocol Violation|0|||
145323335|NCT03465436|524033257|FG003|Period 2|Protocol Violation|0|||
145323336|NCT03465436|524033254|FG000|Period 3|Protocol Violation|1|||
145323337|NCT03465436|524033255|FG001|Period 3|Protocol Violation|1|||
145323338|NCT03465436|524033256|FG002|Period 3|Protocol Violation|0|||
145323339|NCT03465436|524033257|FG003|Period 3|Protocol Violation|0|||
145323340|NCT03465436|524033254|FG000|Period 4|Protocol Violation|0|||
145323341|NCT03465436|524033255|FG001|Period 4|Protocol Violation|0|||
145323342|NCT03465436|524033256|FG002|Period 4|Protocol Violation|1|||
145323343|NCT03465436|524033257|FG003|Period 4|Protocol Violation|0|||
145323344|NCT01813071|524033258|FG000|Overall Study|Protocol Violation|0|||
145323345|NCT01813071|524033259|FG001|Overall Study|Protocol Violation|0|||
145323346|NCT01813071|524033260|FG002|Overall Study|Protocol Violation|0|||
145323347|NCT01813071|524033261|FG003|Overall Study|Protocol Violation|0|||
145323348|NCT01813071|524033262|FG004|Overall Study|Protocol Violation|1|||
145323349|NCT01813071|524033263|FG005|Overall Study|Protocol Violation|4|||
145323350|NCT01813071|524033264|FG006|Overall Study|Protocol Violation|2|||
145323351|NCT01813071|524033265|FG007|Overall Study|Protocol Violation|4|||
145323352|NCT01813071|524033266|FG008|Overall Study|Protocol Violation|2|||
145323353|NCT01813071|524033258|FG000|Overall Study|Withdrawal by Subject|0|||
145323354|NCT01813071|524033259|FG001|Overall Study|Withdrawal by Subject|0|||
145323355|NCT01813071|524033260|FG002|Overall Study|Withdrawal by Subject|0|||
145323356|NCT01813071|524033261|FG003|Overall Study|Withdrawal by Subject|0|||
145323357|NCT01813071|524033262|FG004|Overall Study|Withdrawal by Subject|0|||
145323358|NCT01813071|524033263|FG005|Overall Study|Withdrawal by Subject|1|||
145323359|NCT01813071|524033264|FG006|Overall Study|Withdrawal by Subject|0|||
145323360|NCT01813071|524033265|FG007|Overall Study|Withdrawal by Subject|0|||
145323361|NCT01813071|524033266|FG008|Overall Study|Withdrawal by Subject|0|||
145323362|NCT01813071|524033258|FG000|Overall Study|Adverse Event|0|||
145323363|NCT01813071|524033259|FG001|Overall Study|Adverse Event|0|||
145323364|NCT01813071|524033260|FG002|Overall Study|Adverse Event|0|||
145323365|NCT01813071|524033261|FG003|Overall Study|Adverse Event|0|||
145620590|NCT03873246|525125113|FG001|Overall Study|Lost to Follow-up|4|||
145323366|NCT01813071|524033262|FG004|Overall Study|Adverse Event|0|||
145323367|NCT01813071|524033263|FG005|Overall Study|Adverse Event|1|||
145323368|NCT01813071|524033264|FG006|Overall Study|Adverse Event|0|||
145323369|NCT01813071|524033265|FG007|Overall Study|Adverse Event|0|||
145323370|NCT01813071|524033266|FG008|Overall Study|Adverse Event|0|||
145323371|NCT01813071|524033258|FG000|Overall Study|Physician Decision|0|||
145323372|NCT01813071|524033259|FG001|Overall Study|Physician Decision|0|||
145323373|NCT01813071|524033260|FG002|Overall Study|Physician Decision|0|||
145323374|NCT01813071|524033261|FG003|Overall Study|Physician Decision|0|||
145323375|NCT01813071|524033262|FG004|Overall Study|Physician Decision|0|||
145323376|NCT01813071|524033263|FG005|Overall Study|Physician Decision|0|||
145323377|NCT01813071|524033264|FG006|Overall Study|Physician Decision|1|||
145323378|NCT01813071|524033265|FG007|Overall Study|Physician Decision|0|||
145323379|NCT01813071|524033266|FG008|Overall Study|Physician Decision|0|||
145323380|NCT01813071|524033258|FG000|Overall Study|Met inc/exc criteria|0|||
145323381|NCT01813071|524033259|FG001|Overall Study|Met inc/exc criteria|0|||
145323382|NCT01813071|524033260|FG002|Overall Study|Met inc/exc criteria|0|||
145323383|NCT01813071|524033261|FG003|Overall Study|Met inc/exc criteria|0|||
145323384|NCT01813071|524033262|FG004|Overall Study|Met inc/exc criteria|0|||
145323385|NCT01813071|524033263|FG005|Overall Study|Met inc/exc criteria|1|||
145323386|NCT01813071|524033264|FG006|Overall Study|Met inc/exc criteria|0|||
145323387|NCT01813071|524033265|FG007|Overall Study|Met inc/exc criteria|1|||
145323388|NCT01813071|524033266|FG008|Overall Study|Met inc/exc criteria|1|||
145323389|NCT00307931|524033267|FG000|Overall Study|Adverse Event|1|||
145323390|NCT02697773|524033268|FG000|Overall Study|Adverse Event|2|||
145323391|NCT02697773|524033269|FG001|Overall Study|Adverse Event|1|||
145323392|NCT02697773|524033270|FG002|Overall Study|Adverse Event|2|||
145323393|NCT02697773|524033268|FG000|Overall Study|Death|0|||
145323394|NCT02697773|524033269|FG001|Overall Study|Death|0|||
145323395|NCT02697773|524033270|FG002|Overall Study|Death|2|||
145323396|NCT02697773|524033268|FG000|Overall Study|Lack of Efficacy|4|||
145323397|NCT02697773|524033269|FG001|Overall Study|Lack of Efficacy|6|||
145323398|NCT02697773|524033270|FG002|Overall Study|Lack of Efficacy|6|||
145323399|NCT02697773|524033268|FG000|Overall Study|Lost to Follow-up|5|||
145323400|NCT02697773|524033269|FG001|Overall Study|Lost to Follow-up|5|||
145323401|NCT02697773|524033270|FG002|Overall Study|Lost to Follow-up|7|||
145323402|NCT02697773|524033268|FG000|Overall Study|Other|15|||
145323403|NCT02697773|524033269|FG001|Overall Study|Other|11|||
145323404|NCT02697773|524033270|FG002|Overall Study|Other|10|||
145323405|NCT02697773|524033268|FG000|Overall Study|Protocol Violation|1|||
145323406|NCT02697773|524033269|FG001|Overall Study|Protocol Violation|1|||
145323407|NCT02697773|524033270|FG002|Overall Study|Protocol Violation|0|||
145323408|NCT02697773|524033268|FG000|Overall Study|Withdrawal by Subject|10|||
145323409|NCT02697773|524033269|FG001|Overall Study|Withdrawal by Subject|13|||
145323410|NCT02697773|524033270|FG002|Overall Study|Withdrawal by Subject|13|||
145323411|NCT02697773|524033268|FG000|Overall Study|Randomized but not treated|1|||
145323412|NCT02697773|524033269|FG001|Overall Study|Randomized but not treated|1|||
145323413|NCT02697773|524033270|FG002|Overall Study|Randomized but not treated|0|||
145323414|NCT00613834|524033271|FG000|Overall Study|Withdrawal by Subject|0|||
145323415|NCT00613834|524033272|FG001|Overall Study|Withdrawal by Subject|3|||
145323416|NCT00842530|524033273|FG000|Overall Study|Serious adverse event|0|||
145323417|NCT00842530|524033274|FG001|Overall Study|Serious adverse event|6|||
145323418|NCT00842530|524033273|FG000|Overall Study|Other adverse event|6|||
145323419|NCT00842530|524033274|FG001|Overall Study|Other adverse event|1|||
145323420|NCT00842530|524033273|FG000|Overall Study|Protocol Violation|32|||
145323421|NCT00842530|524033274|FG001|Overall Study|Protocol Violation|14|||
145323422|NCT00842530|524033273|FG000|Overall Study|Lost to Follow-up|6|||
145323423|NCT00842530|524033274|FG001|Overall Study|Lost to Follow-up|8|||
145323424|NCT00842530|524033273|FG000|Overall Study|Withdrawal by Subject|73|||
145323425|NCT00842530|524033274|FG001|Overall Study|Withdrawal by Subject|28|||
145323426|NCT02939950|524033275|FG000|Overall Study|Lost to Follow-up|13|||
145323427|NCT02939950|524033276|FG001|Overall Study|Lost to Follow-up|16|||
145323428|NCT02939950|524033275|FG000|Overall Study|Positive slit lamp findings|0|||
145323429|NCT02939950|524033276|FG001|Overall Study|Positive slit lamp findings|1|||
145323430|NCT02939950|524033275|FG000|Overall Study|Chalazion upper lid|0|||
145323431|NCT02939950|524033276|FG001|Overall Study|Chalazion upper lid|1|||
145323432|NCT02939950|524033275|FG000|Overall Study|Lack of motivation|0|||
145323433|NCT02939950|524033276|FG001|Overall Study|Lack of motivation|2|||
145323434|NCT02939950|524033275|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
145323435|NCT02939950|524033276|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
145570691|NCT01467076|524950002|FG001|Overall Study|Lost to Follow-up|0|||
145323436|NCT02939950|524033275|FG000|Overall Study|Military orders|1|||
145570692|NCT01467076|524950003|FG002|Overall Study|Lost to Follow-up|0|||
145570693|NCT03354429|524950004|FG000|Overall Study|Withdrawal by Subject|8|||
145323437|NCT02939950|524033276|FG001|Overall Study|Military orders|0|||
145570694|NCT03354429|524950005|FG001|Overall Study|Withdrawal by Subject|7|||
145323438|NCT02939950|524033275|FG000|Overall Study|Participant Relocated|5|||
145323439|NCT02939950|524033276|FG001|Overall Study|Participant Relocated|3|||
145323440|NCT02939950|524033275|FG000|Overall Study|Study related symptoms|8|||
145323441|NCT02939950|524033276|FG001|Overall Study|Study related symptoms|8|||
145323442|NCT02939950|524033275|FG000|Overall Study|Unacceptable lens movement|2|||
145323443|NCT02939950|524033276|FG001|Overall Study|Unacceptable lens movement|0|||
145323444|NCT02939950|524033275|FG000|Overall Study|Protocol Violation|6|||
145323445|NCT02939950|524033276|FG001|Overall Study|Protocol Violation|3|||
145323446|NCT02939950|524033275|FG000|Overall Study|Physician Decision|2|||
145323447|NCT02939950|524033276|FG001|Overall Study|Physician Decision|0|||
145323448|NCT02939950|524033275|FG000|Overall Study|Pregnancy|6|||
145323449|NCT02939950|524033276|FG001|Overall Study|Pregnancy|7|||
145323450|NCT02939950|524033275|FG000|Overall Study|Withdrawal by Subject|12|||
145323451|NCT02939950|524033276|FG001|Overall Study|Withdrawal by Subject|28|||
145323452|NCT02939950|524033275|FG000|Overall Study|Adverse Event|7|||
145323453|NCT02939950|524033276|FG001|Overall Study|Adverse Event|3|||
145323454|NCT02939950|524033275|FG000|Overall Study|Randomized, not dispensed|1|||
145323455|NCT02939950|524033276|FG001|Overall Study|Randomized, not dispensed|0|||
145323456|NCT02939950|524033275|FG000|Overall Study|Ineligible at Baseline|2|||
145323457|NCT02939950|524033276|FG001|Overall Study|Ineligible at Baseline|8|||
145323458|NCT02243293|524033277|FG000|Overall Study|Adverse Event|1|||
145323459|NCT02243293|524033278|FG001|Overall Study|Adverse Event|0|||
145323460|NCT02243293|524033279|FG002|Overall Study|Adverse Event|0|||
145323461|NCT02243293|524033280|FG003|Overall Study|Adverse Event|0|||
145323462|NCT02243293|524033281|FG004|Overall Study|Adverse Event|0|||
145323463|NCT02243293|524033282|FG005|Overall Study|Adverse Event|0|||
145323464|NCT02243293|524033283|FG006|Overall Study|Adverse Event|0|||
145323465|NCT02243293|524033284|FG007|Overall Study|Adverse Event|0|||
145323466|NCT02243293|524033285|FG008|Overall Study|Adverse Event|0|||
145323467|NCT02243293|524033286|FG009|Overall Study|Adverse Event|0|||
145323468|NCT02243293|524033287|FG010|Overall Study|Adverse Event|0|||
145323469|NCT02243293|524033288|FG011|Overall Study|Adverse Event|0|||
145323470|NCT02243293|524033289|FG012|Overall Study|Adverse Event|0|||
145323471|NCT02243293|524033290|FG013|Overall Study|Adverse Event|0|||
145323472|NCT02243293|524033291|FG014|Overall Study|Adverse Event|0|||
145323473|NCT02243293|524033292|FG015|Overall Study|Adverse Event|1|||
145323474|NCT02243293|524033293|FG016|Overall Study|Adverse Event|0|||
145323475|NCT02243293|524033294|FG017|Overall Study|Adverse Event|0|||
145323476|NCT02243293|524033295|FG018|Overall Study|Adverse Event|0|||
145323477|NCT02243293|524033296|FG019|Overall Study|Adverse Event|0|||
145323478|NCT02243293|524033297|FG020|Overall Study|Adverse Event|1|||
145323479|NCT02243293|524033298|FG021|Overall Study|Adverse Event|0|||
145323480|NCT02243293|524033277|FG000|Overall Study|Withdrawal by Subject|1|||
145323481|NCT02243293|524033278|FG001|Overall Study|Withdrawal by Subject|0|||
145323482|NCT02243293|524033279|FG002|Overall Study|Withdrawal by Subject|0|||
145323483|NCT02243293|524033280|FG003|Overall Study|Withdrawal by Subject|0|||
145323484|NCT02243293|524033281|FG004|Overall Study|Withdrawal by Subject|0|||
145323485|NCT02243293|524033282|FG005|Overall Study|Withdrawal by Subject|0|||
145323486|NCT02243293|524033283|FG006|Overall Study|Withdrawal by Subject|0|||
145323487|NCT02243293|524033284|FG007|Overall Study|Withdrawal by Subject|0|||
145323488|NCT02243293|524033285|FG008|Overall Study|Withdrawal by Subject|0|||
145323489|NCT02243293|524033286|FG009|Overall Study|Withdrawal by Subject|1|||
145323490|NCT02243293|524033287|FG010|Overall Study|Withdrawal by Subject|0|||
145323491|NCT02243293|524033288|FG011|Overall Study|Withdrawal by Subject|1|||
145323492|NCT02243293|524033289|FG012|Overall Study|Withdrawal by Subject|0|||
145323493|NCT02243293|524033290|FG013|Overall Study|Withdrawal by Subject|0|||
145323494|NCT02243293|524033291|FG014|Overall Study|Withdrawal by Subject|0|||
145323495|NCT02243293|524033292|FG015|Overall Study|Withdrawal by Subject|0|||
145323496|NCT02243293|524033293|FG016|Overall Study|Withdrawal by Subject|0|||
145323497|NCT02243293|524033294|FG017|Overall Study|Withdrawal by Subject|0|||
145323498|NCT02243293|524033295|FG018|Overall Study|Withdrawal by Subject|0|||
145323499|NCT02243293|524033296|FG019|Overall Study|Withdrawal by Subject|0|||
145323500|NCT02243293|524033297|FG020|Overall Study|Withdrawal by Subject|0|||
145323501|NCT02243293|524033298|FG021|Overall Study|Withdrawal by Subject|1|||
145323502|NCT02243293|524033277|FG000|Overall Study|Lost to Follow-up|0|||
145323503|NCT02243293|524033278|FG001|Overall Study|Lost to Follow-up|1|||
145323504|NCT02243293|524033279|FG002|Overall Study|Lost to Follow-up|1|||
145323505|NCT02243293|524033280|FG003|Overall Study|Lost to Follow-up|1|||
145323506|NCT02243293|524033281|FG004|Overall Study|Lost to Follow-up|0|||
145323507|NCT02243293|524033282|FG005|Overall Study|Lost to Follow-up|0|||
145323508|NCT02243293|524033283|FG006|Overall Study|Lost to Follow-up|3|||
145323509|NCT02243293|524033284|FG007|Overall Study|Lost to Follow-up|0|||
145323510|NCT02243293|524033285|FG008|Overall Study|Lost to Follow-up|0|||
145323511|NCT02243293|524033286|FG009|Overall Study|Lost to Follow-up|0|||
145323512|NCT02243293|524033287|FG010|Overall Study|Lost to Follow-up|0|||
145323513|NCT02243293|524033288|FG011|Overall Study|Lost to Follow-up|2|||
145323514|NCT02243293|524033289|FG012|Overall Study|Lost to Follow-up|0|||
145323515|NCT02243293|524033290|FG013|Overall Study|Lost to Follow-up|0|||
145323516|NCT02243293|524033291|FG014|Overall Study|Lost to Follow-up|0|||
145323517|NCT02243293|524033292|FG015|Overall Study|Lost to Follow-up|0|||
145323518|NCT02243293|524033293|FG016|Overall Study|Lost to Follow-up|3|||
145323519|NCT02243293|524033294|FG017|Overall Study|Lost to Follow-up|1|||
145323520|NCT02243293|524033295|FG018|Overall Study|Lost to Follow-up|0|||
145323521|NCT02243293|524033296|FG019|Overall Study|Lost to Follow-up|0|||
145323522|NCT02243293|524033297|FG020|Overall Study|Lost to Follow-up|1|||
145323523|NCT02243293|524033298|FG021|Overall Study|Lost to Follow-up|2|||
145323524|NCT02243293|524033277|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
145323525|NCT02243293|524033278|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
145323526|NCT02243293|524033279|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
145323527|NCT02243293|524033280|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
145323528|NCT02243293|524033281|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
145323529|NCT02243293|524033282|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
145323530|NCT02243293|524033283|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
145323531|NCT02243293|524033284|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
145323532|NCT02243293|524033285|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
145323533|NCT02243293|524033286|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
145323534|NCT02243293|524033287|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
145323535|NCT02243293|524033288|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
145323536|NCT02243293|524033289|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
145323537|NCT02243293|524033290|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
145323538|NCT02243293|524033291|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
145323539|NCT02243293|524033292|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
145323540|NCT02243293|524033293|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
145323541|NCT02243293|524033294|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
145323542|NCT02243293|524033295|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
145323543|NCT02243293|524033296|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
145323544|NCT02243293|524033297|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
145323545|NCT02243293|524033298|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
145323546|NCT02243293|524033277|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
145323547|NCT02243293|524033278|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
145323548|NCT02243293|524033279|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
145323549|NCT02243293|524033280|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
145323550|NCT02243293|524033281|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
145323551|NCT02243293|524033282|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
145323552|NCT02243293|524033283|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
145323553|NCT02243293|524033284|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
145323554|NCT02243293|524033285|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
145323555|NCT02243293|524033286|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
145323556|NCT02243293|524033287|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
145323557|NCT02243293|524033288|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
145323558|NCT02243293|524033289|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
145323559|NCT02243293|524033290|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
145323560|NCT02243293|524033291|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
145323561|NCT02243293|524033292|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
145323562|NCT02243293|524033293|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
145323563|NCT02243293|524033294|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
145323564|NCT02243293|524033295|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
145323565|NCT02243293|524033296|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
145323566|NCT02243293|524033297|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
145323567|NCT02243293|524033298|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
145323568|NCT00440115|524033299|FG000|Overall Study|Death|7|||
145323569|NCT00440115|524033300|FG001|Overall Study|Death|9|||
145323570|NCT00440115|524033301|FG002|Overall Study|Death|5|||
145323571|NCT00440115|524033299|FG000|Overall Study|Incarceration|0|||
145323572|NCT00440115|524033300|FG001|Overall Study|Incarceration|2|||
145323573|NCT00440115|524033301|FG002|Overall Study|Incarceration|1|||
145323574|NCT03064438|524034977|FG000|Overall Study|Lost to Follow-up|1|||
145323575|NCT03064438|524034978|FG001|Overall Study|Lost to Follow-up|0|||
145323576|NCT03064438|524034977|FG000|Overall Study|Withdrawal by Subject|0|||
145323577|NCT03064438|524034978|FG001|Overall Study|Withdrawal by Subject|1|||
145323578|NCT02658487|524034983|FG000|Overall Study|Death|2|||
145323579|NCT02658487|524034983|FG000|Overall Study|Disease progression|10|||
145323580|NCT02658487|524034983|FG000|Overall Study|Alternative therapy|1|||
145323581|NCT02658487|524034983|FG000|Overall Study|Adverse Event|1|||
145323582|NCT02658487|524034983|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
145323583|NCT02658487|524034983|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
145323584|NCT01647958|524034984|FG000|Initial Study|Lost to Follow-up|2|||
145323585|NCT01647958|524034985|FG001|Initial Study|Lost to Follow-up|3|||
145323586|NCT01647958|524034984|FG000|Continuation Phase|treatment received during Overall Study|39|||
145323587|NCT01647958|524034985|FG001|Continuation Phase|treatment received during Overall Study|0|||
145323588|NCT01647958|524034984|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
145323589|NCT01647958|524034985|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
145323590|NCT01432574|524034986|FG000|Overall Study|Moved|2|||
145323591|NCT01432574|524034986|FG000|Overall Study|Not interested|1|||
145323592|NCT01475253|524034989|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
145323593|NCT01475253|524034990|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
145323594|NCT01475253|524034991|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
145323595|NCT01475253|524034992|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
145323596|NCT01475253|524034989|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
145323597|NCT01475253|524034990|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
145570695|NCT03354429|524950004|FG000|Overall Study|Lost to Follow-up|1|||
145323598|NCT01475253|524034991|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
145323599|NCT01475253|524034992|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
145323600|NCT03135899|524034993|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323601|NCT03135899|524034994|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323602|NCT03135899|524034995|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323603|NCT03135899|524034996|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323604|NCT03135899|524034997|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323605|NCT03135899|524034998|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323606|NCT03135899|524034999|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
145323607|NCT03135899|524035000|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
145323608|NCT03135899|524034993|FG000|Overall Study|Withdrawal by Subject|0|||
145323609|NCT03135899|524034994|FG001|Overall Study|Withdrawal by Subject|0|||
145323610|NCT03135899|524034995|FG002|Overall Study|Withdrawal by Subject|0|||
145323611|NCT03135899|524034996|FG003|Overall Study|Withdrawal by Subject|0|||
145323612|NCT03135899|524034997|FG004|Overall Study|Withdrawal by Subject|0|||
145323613|NCT03135899|524034998|FG005|Overall Study|Withdrawal by Subject|2|||
145323614|NCT03135899|524034999|FG006|Overall Study|Withdrawal by Subject|0|||
145323615|NCT03135899|524035000|FG007|Overall Study|Withdrawal by Subject|0|||
145323616|NCT04146363|524035001|FG000|Induction Period|Adverse Event|1|||
145323617|NCT04146363|524035002|FG001|Induction Period|Adverse Event|2|||
145323618|NCT04146363|524035003|FG002|Induction Period|Adverse Event|0|||
145323619|NCT04146363|524035004|FG003|Induction Period|Adverse Event|0|||
145323620|NCT04146363|524035005|FG004|Induction Period|Adverse Event|0|||
145323621|NCT04146363|524035006|FG005|Induction Period|Adverse Event|0|||
145323622|NCT04146363|524035007|FG006|Induction Period|Adverse Event|0|||
145323623|NCT04146363|524035008|FG007|Induction Period|Adverse Event|0|||
145323624|NCT04146363|524035009|FG008|Induction Period|Adverse Event|0|||
145323625|NCT04146363|524035010|FG009|Induction Period|Adverse Event|0|||
145323626|NCT04146363|524035011|FG010|Induction Period|Adverse Event|0|||
145323627|NCT04146363|524035001|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
145323628|NCT04146363|524035002|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
145323629|NCT04146363|524035003|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
145323630|NCT04146363|524035004|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
145323631|NCT04146363|524035005|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
145323632|NCT04146363|524035006|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
145323633|NCT04146363|524035007|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
145323634|NCT04146363|524035008|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
145323635|NCT04146363|524035009|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
145323636|NCT04146363|524035010|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
145323637|NCT04146363|524035011|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
145323638|NCT04146363|524035001|FG000|Induction Period|Lack of Efficacy|7|||
145323639|NCT04146363|524035002|FG001|Induction Period|Lack of Efficacy|2|||
145323640|NCT04146363|524035003|FG002|Induction Period|Lack of Efficacy|0|||
145323641|NCT04146363|524035004|FG003|Induction Period|Lack of Efficacy|0|||
145570696|NCT03354429|524950005|FG001|Overall Study|Lost to Follow-up|0|||
145570697|NCT02624284|524950006|FG000|Overall Study|Withdrawal by Subject|3|||
145570698|NCT02624284|524950007|FG001|Overall Study|Withdrawal by Subject|6|||
145570699|NCT02624284|524950008|FG002|Overall Study|Withdrawal by Subject|3|||
145570700|NCT02624284|524950006|FG000|Overall Study|Protocol Violation|9|||
145570701|NCT02624284|524950007|FG001|Overall Study|Protocol Violation|10|||
145323642|NCT04146363|524035005|FG004|Induction Period|Lack of Efficacy|0|||
145323643|NCT04146363|524035006|FG005|Induction Period|Lack of Efficacy|0|||
145570702|NCT02624284|524950008|FG002|Overall Study|Protocol Violation|7|||
145570703|NCT02624284|524950006|FG000|Overall Study|Revealed exclusionary condition|2|||
145570704|NCT02624284|524950007|FG001|Overall Study|Revealed exclusionary condition|2|||
145620591|NCT03873246|525125114|FG002|Overall Study|Lost to Follow-up|5|||
145323644|NCT04146363|524035007|FG006|Induction Period|Lack of Efficacy|0|||
145323645|NCT04146363|524035008|FG007|Induction Period|Lack of Efficacy|0|||
145323646|NCT04146363|524035009|FG008|Induction Period|Lack of Efficacy|0|||
145323647|NCT04146363|524035010|FG009|Induction Period|Lack of Efficacy|0|||
145323648|NCT04146363|524035011|FG010|Induction Period|Lack of Efficacy|0|||
145323649|NCT04146363|524035001|FG000|Induction Period|Lost to Follow-up|1|||
145323650|NCT04146363|524035002|FG001|Induction Period|Lost to Follow-up|4|||
145323651|NCT04146363|524035003|FG002|Induction Period|Lost to Follow-up|0|||
145323652|NCT04146363|524035004|FG003|Induction Period|Lost to Follow-up|0|||
145620592|NCT03873246|525125112|FG000|Overall Study|Protocol Violation|0|||
145323653|NCT04146363|524035005|FG004|Induction Period|Lost to Follow-up|0|||
145323654|NCT04146363|524035006|FG005|Induction Period|Lost to Follow-up|0|||
145323655|NCT04146363|524035007|FG006|Induction Period|Lost to Follow-up|0|||
145323656|NCT04146363|524035008|FG007|Induction Period|Lost to Follow-up|0|||
145323657|NCT04146363|524035009|FG008|Induction Period|Lost to Follow-up|0|||
145323658|NCT04146363|524035010|FG009|Induction Period|Lost to Follow-up|0|||
145323659|NCT04146363|524035011|FG010|Induction Period|Lost to Follow-up|0|||
145570705|NCT02624284|524950008|FG002|Overall Study|Revealed exclusionary condition|0|||
145620593|NCT03873246|525125113|FG001|Overall Study|Protocol Violation|1|||
145323660|NCT04146363|524035001|FG000|Induction Period|Positive quantiferon test|0|||
145323661|NCT04146363|524035002|FG001|Induction Period|Positive quantiferon test|1|||
145323662|NCT04146363|524035003|FG002|Induction Period|Positive quantiferon test|0|||
145323663|NCT04146363|524035004|FG003|Induction Period|Positive quantiferon test|0|||
145323664|NCT04146363|524035005|FG004|Induction Period|Positive quantiferon test|0|||
145323665|NCT04146363|524035006|FG005|Induction Period|Positive quantiferon test|0|||
145323666|NCT04146363|524035007|FG006|Induction Period|Positive quantiferon test|0|||
145323667|NCT04146363|524035008|FG007|Induction Period|Positive quantiferon test|0|||
145323668|NCT04146363|524035009|FG008|Induction Period|Positive quantiferon test|0|||
145323669|NCT04146363|524035010|FG009|Induction Period|Positive quantiferon test|0|||
145323670|NCT04146363|524035011|FG010|Induction Period|Positive quantiferon test|0|||
145323671|NCT04146363|524035001|FG000|Induction Period|Protocol Deviation|5|||
145323672|NCT04146363|524035002|FG001|Induction Period|Protocol Deviation|6|||
145323673|NCT04146363|524035003|FG002|Induction Period|Protocol Deviation|0|||
145323674|NCT04146363|524035004|FG003|Induction Period|Protocol Deviation|0|||
145323675|NCT04146363|524035005|FG004|Induction Period|Protocol Deviation|0|||
145323676|NCT04146363|524035006|FG005|Induction Period|Protocol Deviation|0|||
145323677|NCT04146363|524035007|FG006|Induction Period|Protocol Deviation|0|||
145323678|NCT04146363|524035008|FG007|Induction Period|Protocol Deviation|0|||
145323679|NCT04146363|524035009|FG008|Induction Period|Protocol Deviation|0|||
145323680|NCT04146363|524035010|FG009|Induction Period|Protocol Deviation|0|||
145323681|NCT04146363|524035011|FG010|Induction Period|Protocol Deviation|0|||
145323682|NCT04146363|524035001|FG000|Induction Period|Withdrawal by Subject|6|||
145323683|NCT04146363|524035002|FG001|Induction Period|Withdrawal by Subject|3|||
145323684|NCT04146363|524035003|FG002|Induction Period|Withdrawal by Subject|0|||
145323685|NCT04146363|524035004|FG003|Induction Period|Withdrawal by Subject|0|||
145323686|NCT04146363|524035005|FG004|Induction Period|Withdrawal by Subject|0|||
145323687|NCT04146363|524035006|FG005|Induction Period|Withdrawal by Subject|0|||
145323688|NCT04146363|524035007|FG006|Induction Period|Withdrawal by Subject|0|||
145323689|NCT04146363|524035008|FG007|Induction Period|Withdrawal by Subject|0|||
145323690|NCT04146363|524035009|FG008|Induction Period|Withdrawal by Subject|0|||
145323691|NCT04146363|524035010|FG009|Induction Period|Withdrawal by Subject|0|||
145323692|NCT04146363|524035011|FG010|Induction Period|Withdrawal by Subject|0|||
145323693|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323694|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323695|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323696|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323697|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323698|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323699|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
145323700|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
145323701|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323702|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323703|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
145323704|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323705|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323706|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323707|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323708|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323709|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323710|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323711|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
145323712|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323713|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323714|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
145323715|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323716|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323717|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323718|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323719|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323720|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323721|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
145323722|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
145323723|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145620594|NCT03873246|525125114|FG002|Overall Study|Protocol Violation|0|||
145620595|NCT03873246|525125112|FG000|Overall Study|Withdrawal by Subject|0|||
145323724|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323725|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
145323726|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323727|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323728|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
145323729|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323730|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323731|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
145323732|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323733|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323734|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323735|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323736|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
145323737|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323738|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323739|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323740|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323741|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
145323742|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
145323743|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
145323744|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
145323745|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323746|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323747|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
145323748|NCT04146363|524035001|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323749|NCT04146363|524035002|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323750|NCT04146363|524035003|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
145323751|NCT04146363|524035004|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323752|NCT04146363|524035005|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323753|NCT04146363|524035006|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
145323754|NCT04146363|524035007|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
145323755|NCT04146363|524035008|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
145323756|NCT04146363|524035009|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323757|NCT04146363|524035010|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323758|NCT04146363|524035011|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
145323759|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323760|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323761|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323762|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323763|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323764|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323765|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323766|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323767|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
145323768|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
145323769|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
145323770|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323771|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323772|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323773|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323774|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323775|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323776|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323777|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
145323778|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
145323779|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
145323780|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
145323781|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323782|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323783|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323784|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323785|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323786|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323787|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323788|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323789|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
145323790|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
145323791|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
145323792|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
145412037|NCT02676973|524362166|FG002|Overall Study|Death|5|||
145323793|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323794|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323795|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323796|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323797|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323798|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323799|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323800|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
145323801|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
145323802|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
145323803|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323804|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323805|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323806|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323807|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323808|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323809|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323810|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
145323811|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
145323812|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
145323813|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
145323814|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323815|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323816|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323817|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323818|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323819|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323820|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323821|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323822|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323823|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
145323824|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
145323825|NCT04146363|524035001|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323826|NCT04146363|524035002|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323827|NCT04146363|524035003|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323828|NCT04146363|524035004|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323829|NCT04146363|524035005|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323830|NCT04146363|524035006|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323831|NCT04146363|524035007|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323832|NCT04146363|524035008|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323833|NCT04146363|524035009|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323834|NCT04146363|524035010|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
145323835|NCT04146363|524035011|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
145323836|NCT02914236|524035016|FG000|Overall Study|Lost to Follow-up|1|||
145323837|NCT02676284|524035017|FG000|Overall Study|Withdrawal by Subject|1|||
145323838|NCT00708708|524035019|FG000|Overall Study|Another therapy instead of Enbrel|141|||
145323839|NCT00708708|524035019|FG000|Overall Study|Lost to Follow-up|52|||
145323840|NCT00708708|524035019|FG000|Overall Study|Withdrawal by Subject|51|||
145323841|NCT00708708|524035019|FG000|Overall Study|Intolerance|42|||
145323842|NCT00708708|524035019|FG000|Overall Study|Another therapy along with Enbrel|15|||
145323843|NCT00708708|524035019|FG000|Overall Study|Other unspecified|11|||
145323844|NCT00708708|524035019|FG000|Overall Study|Good effectiveness|9|||
145323845|NCT00708708|524035019|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
145323846|NCT00708708|524035019|FG000|Overall Study|Administrative reasons|7|||
145323847|NCT00708708|524035019|FG000|Overall Study|Lack of effectiveness|4|||
145323848|NCT00708708|524035019|FG000|Overall Study|Lack of compliance|3|||
145323849|NCT00708708|524035019|FG000|Overall Study|Pregnancy|3|||
145323850|NCT00708708|524035019|FG000|Overall Study|Adverse Event|3|||
145323851|NCT00708708|524035019|FG000|Overall Study|Missing values|392|||
145323852|NCT00856830|524035020|FG000|Irinotecan & Bendamustine|Death|0|||
145323853|NCT00856830|524035021|FG001|Irinotecan & Bendamustine|Death|0|||
145323854|NCT00856830|524035022|FG002|Irinotecan & Bendamustine|Death|0|||
145323855|NCT00856830|524035023|FG003|Irinotecan & Bendamustine|Death|2|||
145323856|NCT00856830|524035020|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
145323857|NCT00856830|524035021|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
145323858|NCT00856830|524035022|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
145323859|NCT00856830|524035023|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
145323860|NCT03768726|524035026|FG000|Treatment Phase|Adverse Event|2|||
145412038|NCT01078662|524362167|FG000|Overall Study|Death|41|||
145412039|NCT01078662|524362168|FG001|Overall Study|Death|103|||
145412040|NCT01078662|524362169|FG002|Overall Study|Death|18|||
145323861|NCT03768726|524035027|FG001|Treatment Phase|Adverse Event|2|||
145323862|NCT03768726|524035026|FG000|Treatment Phase|Lost to Follow-up|1|||
145323863|NCT03768726|524035027|FG001|Treatment Phase|Lost to Follow-up|0|||
145323864|NCT03768726|524035026|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
145323865|NCT03768726|524035027|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
145323866|NCT03768726|524035026|FG000|Treatment Phase|Withdrawal by Subject|3|||
145323867|NCT03768726|524035027|FG001|Treatment Phase|Withdrawal by Subject|1|||
145323868|NCT03768726|524035026|FG000|Follow-Up|Adverse Event|2|||
145323869|NCT03768726|524035027|FG001|Follow-Up|Adverse Event|2|||
145323870|NCT03768726|524035026|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
145323871|NCT03768726|524035027|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
145323872|NCT03768726|524035026|FG000|Follow-Up|Withdrawal by Subject|2|||
145323873|NCT03768726|524035027|FG001|Follow-Up|Withdrawal by Subject|0|||
145323874|NCT03768726|524035026|FG000|Follow-Up|Other|1|||
145323875|NCT03768726|524035027|FG001|Follow-Up|Other|0|||
145323876|NCT01286558|524035028|FG000|Overall Study|Adverse Event|1|||
145323877|NCT01286558|524035029|FG001|Overall Study|Adverse Event|1|||
145323878|NCT01286558|524035028|FG000|Overall Study|Withdrawal by Subject|0|||
145323879|NCT01286558|524035029|FG001|Overall Study|Withdrawal by Subject|1|||
145323880|NCT01787279|524035031|FG000|Overall Study|Lost to Follow-up|2|||
145323881|NCT01787279|524035031|FG000|Overall Study|Lack of Efficacy|1|||
145323882|NCT00140413|524035034|FG000|Overall Study|Lost to Follow-up|1|||
145323883|NCT00140413|524035035|FG001|Overall Study|Lost to Follow-up|0|||
145323884|NCT00140413|524035034|FG000|Overall Study|Withdrawal by Subject|2|||
145323885|NCT00140413|524035035|FG001|Overall Study|Withdrawal by Subject|0|||
145323886|NCT02694549|524035036|FG000|Overall Study|screen failures|2|||
145323887|NCT01567826|524035039|FG000|Overall Study|Lost to Follow-up|3|||
145323888|NCT01567826|524035040|FG001|Overall Study|Lost to Follow-up|2|||
145323889|NCT00865098|524035046|FG000|Overall Study|Progressive disease|1|||
145323890|NCT03265288|524035049|FG000|Overall Study|Adverse Event|0|||
145323891|NCT03265288|524035050|FG001|Overall Study|Adverse Event|1|||
145323892|NCT03265288|524035049|FG000|Overall Study|Withdrawal by Subject|13|||
145323893|NCT03265288|524035050|FG001|Overall Study|Withdrawal by Subject|5|||
145323894|NCT03265288|524035049|FG000|Overall Study|Drug Withdrawn|3|||
145323895|NCT03265288|524035050|FG001|Overall Study|Drug Withdrawn|3|||
145323896|NCT03265288|524035049|FG000|Overall Study|Any Other Reason|7|||
145323897|NCT03265288|524035050|FG001|Overall Study|Any Other Reason|3|||
145323898|NCT00099268|524035056|FG000|Overall Study|Withdrawal by Subject|46|||
145323899|NCT00099268|524035057|FG001|Overall Study|Withdrawal by Subject|28|||
145323900|NCT00099268|524035056|FG000|Overall Study|Adverse Event|19|||
145323901|NCT00099268|524035057|FG001|Overall Study|Adverse Event|19|||
145323902|NCT00099268|524035056|FG000|Overall Study|Protocol Violation|9|||
145323903|NCT00099268|524035057|FG001|Overall Study|Protocol Violation|8|||
145323904|NCT00099268|524035056|FG000|Overall Study|Lost to Follow-up|6|||
145323905|NCT00099268|524035057|FG001|Overall Study|Lost to Follow-up|4|||
145323906|NCT00099268|524035056|FG000|Overall Study|Lack of Efficacy|5|||
145323907|NCT00099268|524035057|FG001|Overall Study|Lack of Efficacy|18|||
145323908|NCT00099268|524035056|FG000|Overall Study|Administrative problems|4|||
145323909|NCT00099268|524035057|FG001|Overall Study|Administrative problems|4|||
145323910|NCT00099268|524035056|FG000|Overall Study|Death|3|||
145323911|NCT00099268|524035057|FG001|Overall Study|Death|1|||
145323912|NCT00918463|524035060|FG000|Overall Study|Death|1|||
145323913|NCT00918463|524035060|FG000|Overall Study|Lack of Efficacy|1|||
145323914|NCT01715896|524035061|FG000|Overall Study|Lost to Follow-up|0|||
145323915|NCT01715896|524035062|FG001|Overall Study|Lost to Follow-up|2|||
145323916|NCT01715896|524035061|FG000|Overall Study|Withdrawal by Subject|1|||
145323917|NCT01715896|524035062|FG001|Overall Study|Withdrawal by Subject|4|||
145323918|NCT01715896|524035061|FG000|Overall Study|Other|2|||
145323919|NCT01715896|524035062|FG001|Overall Study|Other|5|||
145323920|NCT03575871|524035071|FG000|Overall Study|Adverse Event|5|||
145323921|NCT03575871|524035072|FG001|Overall Study|Adverse Event|5|||
145323922|NCT03575871|524035073|FG002|Overall Study|Adverse Event|8|||
145323923|NCT03575871|524035071|FG000|Overall Study|Death|1|||
145323924|NCT03575871|524035072|FG001|Overall Study|Death|0|||
145323925|NCT03575871|524035073|FG002|Overall Study|Death|0|||
145323926|NCT03575871|524035071|FG000|Overall Study|Lack of Efficacy|5|||
145323927|NCT03575871|524035072|FG001|Overall Study|Lack of Efficacy|4|||
145323928|NCT03575871|524035073|FG002|Overall Study|Lack of Efficacy|7|||
145323929|NCT03575871|524035071|FG000|Overall Study|Lost to Follow-up|1|||
145323930|NCT03575871|524035072|FG001|Overall Study|Lost to Follow-up|1|||
145323931|NCT03575871|524035073|FG002|Overall Study|Lost to Follow-up|1|||
145323932|NCT03575871|524035071|FG000|Overall Study|Protocol Deviation|1|||
145323933|NCT03575871|524035072|FG001|Overall Study|Protocol Deviation|1|||
145323934|NCT03575871|524035073|FG002|Overall Study|Protocol Deviation|1|||
145323935|NCT03575871|524035071|FG000|Overall Study|Withdrawal by Subject|6|||
145323936|NCT03575871|524035072|FG001|Overall Study|Withdrawal by Subject|1|||
145323937|NCT03575871|524035073|FG002|Overall Study|Withdrawal by Subject|9|||
145323938|NCT03575871|524035071|FG000|Overall Study|Other than specified|2|||
145323939|NCT03575871|524035072|FG001|Overall Study|Other than specified|2|||
145412041|NCT01078662|524362170|FG003|Overall Study|Death|5|||
145323940|NCT03575871|524035073|FG002|Overall Study|Other than specified|0|||
145323941|NCT01045993|524035074|FG000|Overall Study|Treated-later found eligibility not met|0|||
145323942|NCT01045993|524035075|FG001|Overall Study|Treated-later found eligibility not met|1|||
145323943|NCT01045993|524035076|FG002|Overall Study|Treated-later found eligibility not met|0|||
145323944|NCT01045993|524035077|FG003|Overall Study|Treated-later found eligibility not met|0|||
145323945|NCT05506358|524035078|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
145323946|NCT05506358|524035079|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145323947|NCT05506358|524035080|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145323948|NCT05506358|524035081|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145323949|NCT05506358|524035082|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
145323950|NCT05506358|524035078|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
145323951|NCT05506358|524035079|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145323952|NCT05506358|524035080|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145323953|NCT05506358|524035081|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145323954|NCT05506358|524035082|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
145323955|NCT05506358|524035078|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145323956|NCT05506358|524035079|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145323957|NCT05506358|524035080|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145323958|NCT05506358|524035081|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
145323959|NCT05506358|524035082|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
145323960|NCT05506358|524035078|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
145323961|NCT05506358|524035079|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
145323962|NCT05506358|524035080|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
145323963|NCT05506358|524035081|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
145323964|NCT05506358|524035082|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
145323965|NCT05506358|524035078|FG000|Overall Study|HbE trait|0|||
145323966|NCT05506358|524035079|FG001|Overall Study|HbE trait|0|||
145323967|NCT05506358|524035080|FG002|Overall Study|HbE trait|0|||
145323968|NCT05506358|524035081|FG003|Overall Study|HbE trait|1|||
145323969|NCT05506358|524035082|FG004|Overall Study|HbE trait|0|||
145323970|NCT01659736|524035083|FG000|Treatment Period|Adverse Event|1|||
145323971|NCT01659736|524035084|FG001|Treatment Period|Adverse Event|1|||
145323972|NCT01659736|524035083|FG000|Treatment Period|Protocol Violation|3|||
145323973|NCT01659736|524035084|FG001|Treatment Period|Protocol Violation|1|||
145323974|NCT01659736|524035083|FG000|Treatment Period|Withdrawal by Subject|1|||
145323975|NCT01659736|524035084|FG001|Treatment Period|Withdrawal by Subject|0|||
145323976|NCT01659736|524035083|FG000|3-month Follow-up|Lost to Follow-up|0|||
145323977|NCT01659736|524035084|FG001|3-month Follow-up|Lost to Follow-up|1|||
145323978|NCT01570283|524035089|FG000|Cohort 1: Dose Level 1|Death|0|||
145323979|NCT01570283|524035090|FG001|Cohort 1: Dose Level 1|Death|1|||
145323980|NCT01570283|524035091|FG002|Cohort 1: Dose Level 1|Death|0|||
145323981|NCT01570283|524035092|FG003|Cohort 1: Dose Level 1|Death|0|||
145323982|NCT01570283|524035093|FG004|Cohort 1: Dose Level 1|Death|0|||
145323983|NCT01570283|524035094|FG005|Cohort 1: Dose Level 1|Death|0|||
145323984|NCT01570283|524035089|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145323985|NCT01570283|524035090|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
145323986|NCT01570283|524035091|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145323987|NCT01570283|524035092|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145323988|NCT01570283|524035093|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145323989|NCT01570283|524035094|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
145323990|NCT01570283|524035089|FG000|Cohort 2: Dose Level 2|Death|0|||
145323991|NCT01570283|524035090|FG001|Cohort 2: Dose Level 2|Death|0|||
145323992|NCT01570283|524035091|FG002|Cohort 2: Dose Level 2|Death|1|||
145323993|NCT01570283|524035092|FG003|Cohort 2: Dose Level 2|Death|0|||
145323994|NCT01570283|524035093|FG004|Cohort 2: Dose Level 2|Death|0|||
145323995|NCT01570283|524035094|FG005|Cohort 2: Dose Level 2|Death|0|||
145323996|NCT01570283|524035089|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145323997|NCT01570283|524035090|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145323998|NCT01570283|524035091|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145323999|NCT01570283|524035092|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
145324000|NCT01570283|524035093|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145324001|NCT01570283|524035094|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
145324002|NCT01570283|524035089|FG000|Cohort 3: Dose Level 3|Death|0|||
145324003|NCT01570283|524035090|FG001|Cohort 3: Dose Level 3|Death|0|||
145324004|NCT01570283|524035091|FG002|Cohort 3: Dose Level 3|Death|0|||
145324005|NCT01570283|524035092|FG003|Cohort 3: Dose Level 3|Death|0|||
145324006|NCT01570283|524035093|FG004|Cohort 3: Dose Level 3|Death|0|||
145324007|NCT01570283|524035094|FG005|Cohort 3: Dose Level 3|Death|1|||
145324008|NCT01570283|524035089|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145570706|NCT02624284|524950006|FG000|Overall Study|Adverse Event|0|||
145570707|NCT02624284|524950007|FG001|Overall Study|Adverse Event|0|||
145570708|NCT02624284|524950008|FG002|Overall Study|Adverse Event|1|||
145570709|NCT00116558|524950009|FG000|Overall Study|Death|11|||
145570710|NCT00116558|524950010|FG001|Overall Study|Death|5|||
145570711|NCT00116558|524950011|FG002|Overall Study|Death|3|||
145570712|NCT00116558|524950009|FG000|Overall Study|Withdrawal by Subject|17|||
145570713|NCT00116558|524950010|FG001|Overall Study|Withdrawal by Subject|3|||
145570714|NCT00116558|524950011|FG002|Overall Study|Withdrawal by Subject|12|||
145324009|NCT01570283|524035090|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145324010|NCT01570283|524035091|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145324011|NCT01570283|524035092|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145324012|NCT01570283|524035093|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
145324013|NCT01570283|524035094|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
145324014|NCT02017860|524035098|FG000|Overall Study|Adverse Event|1|||
145324015|NCT02017860|524035098|FG000|Overall Study|Withdrawal by Subject|1|||
145324016|NCT00252174|524035109|FG000|Overall Study|Withdrawal by Subject|0|||
145324017|NCT00252174|524035110|FG001|Overall Study|Withdrawal by Subject|1|||
145324018|NCT00252174|524035111|FG002|Overall Study|Withdrawal by Subject|0|||
145324019|NCT02224573|524035112|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
145324020|NCT02224573|524035113|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
145324021|NCT02224573|524035112|FG000|Treatment Phase|Started on Other IMP|1|||
145324022|NCT02224573|524035113|FG001|Treatment Phase|Started on Other IMP|0|||
145324023|NCT02224573|524035112|FG000|Treatment Phase|Participant Discontinued IMP|0|||
145324024|NCT02224573|524035113|FG001|Treatment Phase|Participant Discontinued IMP|1|||
145324025|NCT02224573|524035112|FG000|Treatment Phase|Lack of Efficacy|15|||
145324026|NCT02224573|524035113|FG001|Treatment Phase|Lack of Efficacy|8|||
145324027|NCT02224573|524035112|FG000|Treatment Phase|Began Commercial Product|1|||
145324028|NCT02224573|524035113|FG001|Treatment Phase|Began Commercial Product|0|||
145324029|NCT02224573|524035112|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
145324030|NCT02224573|524035113|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
145324031|NCT02224573|524035112|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
145324032|NCT02224573|524035113|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
145324033|NCT02224573|524035112|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
145324034|NCT02224573|524035113|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
145324035|NCT02224573|524035112|FG000|Treatment Phase|Continued Compassionate Use|1|||
145324036|NCT02224573|524035113|FG001|Treatment Phase|Continued Compassionate Use|0|||
145324037|NCT02224573|524035112|FG000|Treatment Phase|Lack of Efficiency|2|||
145324038|NCT02224573|524035113|FG001|Treatment Phase|Lack of Efficiency|1|||
145324039|NCT02224573|524035112|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
145324040|NCT02224573|524035113|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
145324041|NCT02224573|524035112|FG000|Treatment Phase|Participant Moved|2|||
145324042|NCT02224573|524035113|FG001|Treatment Phase|Participant Moved|0|||
145324043|NCT02224573|524035112|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
145324044|NCT02224573|524035113|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
145324045|NCT02224573|524035112|FG000|Treatment Phase|Refused Medication|1|||
145324046|NCT02224573|524035113|FG001|Treatment Phase|Refused Medication|1|||
145324047|NCT02224573|524035112|FG000|Treatment Phase|Adverse Event|26|||
145324048|NCT02224573|524035113|FG001|Treatment Phase|Adverse Event|38|||
145324049|NCT02224573|524035112|FG000|Treatment Phase|Placed in Group Home|0|||
145324050|NCT02224573|524035113|FG001|Treatment Phase|Placed in Group Home|1|||
145324051|NCT02224573|524035112|FG000|Treatment Phase|Pursued Other Trials|1|||
145324052|NCT02224573|524035113|FG001|Treatment Phase|Pursued Other Trials|0|||
145324053|NCT02224573|524035112|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
145324054|NCT02224573|524035113|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
145324055|NCT02224573|524035112|FG000|Treatment Phase|Lost to Follow-up|2|||
145324056|NCT02224573|524035113|FG001|Treatment Phase|Lost to Follow-up|1|||
145324057|NCT02224573|524035112|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
145324058|NCT02224573|524035113|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
145324059|NCT02224573|524035112|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
145324060|NCT02224573|524035113|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
145324061|NCT02224573|524035112|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
145324062|NCT02224573|524035113|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
145412042|NCT01078662|524362171|FG004|Overall Study|Death|8|||
145412043|NCT01078662|524362167|FG000|Overall Study|Patients reached data cut-off|12|||
145570715|NCT00116558|524950009|FG000|Overall Study|disease progression|3|||
145570716|NCT00116558|524950010|FG001|Overall Study|disease progression|7|||
145324063|NCT02224573|524035112|FG000|Taper Phase|Adverse Event|1|||
145324064|NCT02224573|524035113|FG001|Taper Phase|Adverse Event|1|||
145324065|NCT02546362|524035114|FG000|4-week Treatment Period|Lost to Follow-up|1|||
145412044|NCT01078662|524362168|FG001|Overall Study|Patients reached data cut-off|53|||
145570717|NCT00116558|524950011|FG002|Overall Study|disease progression|18|||
145570718|NCT03491150|524950012|FG000|Overall Study|Adverse Event|1|||
145324066|NCT02546362|524035114|FG000|4-week Treatment Period|Change in medication|2|||
145324067|NCT02546362|524035114|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
145324068|NCT02546362|524035114|FG000|12-week Treatment Period|Lost to Follow-up|2|||
145324069|NCT02546362|524035114|FG000|12-week Treatment Period|Change in medication|1|||
145324070|NCT01138826|524035115|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145324071|NCT01138826|524035116|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145324072|NCT01138826|524035117|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145324073|NCT01138826|524035118|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145324074|NCT01138826|524035119|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
145324075|NCT01138826|524035120|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
145324076|NCT05206448|524035121|FG000|Overall Study|Lost to Follow-up|2|||
145324077|NCT05206448|524035122|FG001|Overall Study|Lost to Follow-up|2|||
145324078|NCT05206448|524035121|FG000|Overall Study|Withdrawal by Subject|2|||
145324079|NCT05206448|524035122|FG001|Overall Study|Withdrawal by Subject|0|||
145324080|NCT05206448|524035121|FG000|Overall Study|found ineligible after randomization|1|||
145324081|NCT05206448|524035122|FG001|Overall Study|found ineligible after randomization|1|||
145324082|NCT05206448|524035121|FG000|Overall Study|unable to complete study due to personal constraints|1|||
145324083|NCT05206448|524035122|FG001|Overall Study|unable to complete study due to personal constraints|0|||
145324084|NCT05206448|524035121|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
145324085|NCT05206448|524035122|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
145324086|NCT01557842|524035126|FG000|Overall Study|Lost to Follow-up|0|||
145324087|NCT01557842|524035127|FG001|Overall Study|Lost to Follow-up|1|||
145324088|NCT01557842|524035126|FG000|Overall Study|Death|1|||
145324089|NCT01557842|524035127|FG001|Overall Study|Death|0|||
145324090|NCT01557842|524035126|FG000|Overall Study|Lack of Efficacy|0|||
145324091|NCT01557842|524035127|FG001|Overall Study|Lack of Efficacy|1|||
145324092|NCT01557842|524035126|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
145324093|NCT01557842|524035127|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
145324094|NCT01557842|524035126|FG000|Overall Study|Study Terminated by Sponsor|3|||
145324095|NCT01557842|524035127|FG001|Overall Study|Study Terminated by Sponsor|4|||
145324096|NCT01557842|524035126|FG000|Overall Study|Not Ablated|2|||
145324097|NCT01557842|524035127|FG001|Overall Study|Not Ablated|0|||
145324098|NCT02457611|524035128|FG000|Overall Study|Lost to Follow-up|3|||
145324099|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
145324100|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
145324101|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
145324102|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
145324103|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
145324104|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
145324105|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
145324106|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
145324107|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
145324108|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
145324109|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
145324110|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
145324111|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
145324112|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
145324113|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
145324114|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
145324115|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
145324116|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
145324117|NCT00384293|524035129|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
145324118|NCT00384293|524035130|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
145324119|NCT00384293|524035131|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
145324120|NCT00384293|524035129|FG000|Post-randomization Period|Adverse Event|0|||
145324121|NCT00384293|524035130|FG001|Post-randomization Period|Adverse Event|23|||
145324122|NCT00384293|524035131|FG002|Post-randomization Period|Adverse Event|7|||
145324123|NCT00384293|524035129|FG000|Post-randomization Period|Lost to Follow-up|0|||
145324124|NCT00384293|524035130|FG001|Post-randomization Period|Lost to Follow-up|2|||
145324125|NCT00384293|524035131|FG002|Post-randomization Period|Lost to Follow-up|1|||
145324126|NCT00384293|524035129|FG000|Post-randomization Period|Protocol Violation|0|||
145324127|NCT00384293|524035130|FG001|Post-randomization Period|Protocol Violation|1|||
145324128|NCT00384293|524035131|FG002|Post-randomization Period|Protocol Violation|0|||
145324129|NCT00384293|524035129|FG000|Post-randomization Period|Withdrawal by Subject|0|||
145324130|NCT00384293|524035130|FG001|Post-randomization Period|Withdrawal by Subject|8|||
145324131|NCT00384293|524035131|FG002|Post-randomization Period|Withdrawal by Subject|6|||
145324132|NCT00384293|524035129|FG000|Post-randomization Period|Trial Termination|0|||
145570719|NCT03491150|524950013|FG001|Overall Study|Adverse Event|0|||
145570720|NCT03491150|524950012|FG000|Overall Study|Study Terminated by Sponsor|74|||
145570721|NCT03491150|524950013|FG001|Overall Study|Study Terminated by Sponsor|70|||
145570722|NCT03491150|524950012|FG000|Overall Study|Other|0|||
145324133|NCT00384293|524035130|FG001|Post-randomization Period|Trial Termination|180|||
145324134|NCT00384293|524035131|FG002|Post-randomization Period|Trial Termination|204|||
145324135|NCT00384293|524035129|FG000|Post-randomization Period|Patient Randomized in Error|0|||
145324136|NCT00384293|524035130|FG001|Post-randomization Period|Patient Randomized in Error|0|||
145324137|NCT00384293|524035131|FG002|Post-randomization Period|Patient Randomized in Error|1|||
145324138|NCT04553913|524035134|FG000|Overall Study|patient's block resolved prior to PACU|1|||
145324139|NCT04553913|524035134|FG000|Overall Study|did not use the device properly|5|||
145324140|NCT01172821|524035135|FG000|Overall Study|Adverse Event|5|||
145324141|NCT01172821|524035136|FG001|Overall Study|Adverse Event|2|||
145324142|NCT01172821|524035137|FG002|Overall Study|Adverse Event|2|||
145324143|NCT01172821|524035138|FG003|Overall Study|Adverse Event|7|||
145324144|NCT01172821|524035135|FG000|Overall Study|Protocol Violation|0|||
145324145|NCT01172821|524035136|FG001|Overall Study|Protocol Violation|2|||
145324146|NCT01172821|524035137|FG002|Overall Study|Protocol Violation|1|||
145324147|NCT01172821|524035138|FG003|Overall Study|Protocol Violation|2|||
145324148|NCT01172821|524035135|FG000|Overall Study|Lost to Follow-up|4|||
145324149|NCT01172821|524035136|FG001|Overall Study|Lost to Follow-up|1|||
145324150|NCT01172821|524035137|FG002|Overall Study|Lost to Follow-up|2|||
145324151|NCT01172821|524035138|FG003|Overall Study|Lost to Follow-up|2|||
145324152|NCT01172821|524035135|FG000|Overall Study|Withdrawal by Subject|2|||
145324153|NCT01172821|524035136|FG001|Overall Study|Withdrawal by Subject|3|||
145324154|NCT01172821|524035137|FG002|Overall Study|Withdrawal by Subject|3|||
145324155|NCT01172821|524035138|FG003|Overall Study|Withdrawal by Subject|3|||
145324156|NCT01172821|524035135|FG000|Overall Study|Other|3|||
145324157|NCT01172821|524035136|FG001|Overall Study|Other|4|||
145324158|NCT01172821|524035137|FG002|Overall Study|Other|5|||
145324159|NCT01172821|524035138|FG003|Overall Study|Other|3|||
145324160|NCT00710749|524035140|FG000|First Intervention|Withdrawal by Subject|1|||
145324161|NCT00710749|524035141|FG001|First Intervention|Withdrawal by Subject|0|||
145324162|NCT02985879|524035144|FG000|Overall Study|Adverse Event|7|||
145324163|NCT02985879|524035145|FG001|Overall Study|Adverse Event|9|||
145324164|NCT02985879|524035146|FG002|Overall Study|Adverse Event|7|||
145324165|NCT02985879|524035144|FG000|Overall Study|Withdrew consent|6|||
145324166|NCT02985879|524035145|FG001|Overall Study|Withdrew consent|8|||
145324167|NCT02985879|524035146|FG002|Overall Study|Withdrew consent|10|||
145324168|NCT02985879|524035144|FG000|Overall Study|Lost to Follow-up|1|||
145324169|NCT02985879|524035145|FG001|Overall Study|Lost to Follow-up|0|||
145324170|NCT02985879|524035146|FG002|Overall Study|Lost to Follow-up|2|||
145324171|NCT02985879|524035144|FG000|Overall Study|Other, not specified|62|||
145324172|NCT02985879|524035145|FG001|Overall Study|Other, not specified|58|||
145324173|NCT02985879|524035146|FG002|Overall Study|Other, not specified|58|||
145324174|NCT04974619|524037063|FG000|Overall Study|Lost to Follow-up|0|||
145324175|NCT04974619|524037064|FG001|Overall Study|Lost to Follow-up|0|||
145324176|NCT04974619|524037065|FG002|Overall Study|Lost to Follow-up|1|||
145324177|NCT04974619|524037063|FG000|Overall Study|Withdrawal by Subject|0|||
145324178|NCT04974619|524037064|FG001|Overall Study|Withdrawal by Subject|0|||
145324179|NCT04974619|524037065|FG002|Overall Study|Withdrawal by Subject|1|||
145324180|NCT04974619|524037063|FG000|Overall Study|Protocol Violation|0|||
145324181|NCT04974619|524037064|FG001|Overall Study|Protocol Violation|1|||
145324182|NCT04974619|524037065|FG002|Overall Study|Protocol Violation|0|||
145324183|NCT03959527|524037072|FG000|Overall Study|Withdrawal by Subject|8|||
145324184|NCT03959527|524037073|FG001|Overall Study|Withdrawal by Subject|3|||
145324185|NCT03959527|524037072|FG000|Overall Study|Lost to Follow-up|31|||
145324186|NCT03959527|524037073|FG001|Overall Study|Lost to Follow-up|15|||
145324187|NCT03959527|524037072|FG000|Overall Study|Did not meet eligibility criteria|1|||
145324188|NCT03959527|524037073|FG001|Overall Study|Did not meet eligibility criteria|1|||
145324189|NCT03959527|524037072|FG000|Overall Study|Protocol Violation|10|||
145324190|NCT03959527|524037073|FG001|Overall Study|Protocol Violation|5|||
145324191|NCT01688466|524037074|FG000|Overall Study|Withdrawal by Subject|2|||
145324192|NCT01688466|524037075|FG001|Overall Study|Withdrawal by Subject|1|||
145324193|NCT01688466|524037074|FG000|Overall Study|Death|0|||
145324194|NCT01688466|524037075|FG001|Overall Study|Death|1|||
145412045|NCT01078662|524362169|FG002|Overall Study|Patients reached data cut-off|2|||
145412046|NCT01078662|524362170|FG003|Overall Study|Patients reached data cut-off|2|||
145412047|NCT01078662|524362171|FG004|Overall Study|Patients reached data cut-off|3|||
145570723|NCT03491150|524950013|FG001|Overall Study|Other|1|||
145570724|NCT03491150|524950012|FG000|Overall Study|Withdrawal by Subject|1|||
145324195|NCT01688466|524037074|FG000|Overall Study|Adverse Event|0|||
145324196|NCT01688466|524037075|FG001|Overall Study|Adverse Event|4|||
145324197|NCT01688466|524037074|FG000|Overall Study|Not evaluable|0|||
145324198|NCT01688466|524037075|FG001|Overall Study|Not evaluable|1|||
145324199|NCT01000610|524037080|FG000|Overall Study|Adverse Event|1|||
145324200|NCT01000610|524037080|FG000|Overall Study|Lost to Follow-up|4|||
145324201|NCT01000610|524037080|FG000|Overall Study|Treatment failure|1|||
145324202|NCT00595335|524037085|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
145324203|NCT00595335|524037086|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
145324204|NCT00595335|524037085|FG000|Baseline to Six Months|Disease Progression|1|||
145324205|NCT00595335|524037086|FG001|Baseline to Six Months|Disease Progression|1|||
145324206|NCT00595335|524037085|FG000|Baseline to Six Months|Adverse Event|1|||
145324207|NCT00595335|524037086|FG001|Baseline to Six Months|Adverse Event|0|||
145324208|NCT00595335|524037085|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
145324209|NCT00595335|524037086|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
145324210|NCT00595335|524037085|FG000|Six Months to Twelve Months|Disease Progression|1|||
145324211|NCT00595335|524037086|FG001|Six Months to Twelve Months|Disease Progression|0|||
145324212|NCT00493779|524037098|FG000|Overall Study|Logistical issue at site|1|||
145324213|NCT02516410|524037100|FG000|Overall Study|Adverse Event|0|||
145324214|NCT02516410|524037101|FG001|Overall Study|Adverse Event|1|||
145324215|NCT02516410|524037100|FG000|Overall Study|Withdrawal by Subject|0|||
145324216|NCT02516410|524037101|FG001|Overall Study|Withdrawal by Subject|1|||
145324217|NCT06005597|524037102|FG000|Overall Study|Lost to Follow-up|1|||
145324218|NCT06005597|524037103|FG001|Overall Study|Lost to Follow-up|2|||
145324219|NCT06005597|524037104|FG002|Overall Study|Lost to Follow-up|1|||
145324220|NCT06005597|524037105|FG003|Overall Study|Lost to Follow-up|2|||
145324221|NCT06005597|524037102|FG000|Overall Study|Death|1|||
145324222|NCT06005597|524037103|FG001|Overall Study|Death|1|||
145324223|NCT06005597|524037104|FG002|Overall Study|Death|1|||
145324224|NCT06005597|524037105|FG003|Overall Study|Death|0|||
145324225|NCT02010255|524037109|FG000|Overall Study|Death|0|||
145324226|NCT02010255|524037110|FG001|Overall Study|Death|1|||
145324227|NCT02010255|524037111|FG002|Overall Study|Death|4|||
145324228|NCT02010255|524037112|FG003|Overall Study|Death|4|||
145324229|NCT02010255|524037113|FG004|Overall Study|Death|2|||
145324230|NCT02010255|524037114|FG005|Overall Study|Death|0|||
145324231|NCT02010255|524037115|FG006|Overall Study|Death|1|||
145324232|NCT02010255|524037116|FG007|Overall Study|Death|1|||
145324233|NCT02010255|524037117|FG008|Overall Study|Death|1|||
145324234|NCT02010255|524037118|FG009|Overall Study|Death|0|||
145324235|NCT02010255|524037119|FG010|Overall Study|Death|1|||
145324236|NCT02010255|524037120|FG011|Overall Study|Death|1|||
145324237|NCT02010255|524037121|FG012|Overall Study|Death|0|||
145324238|NCT02010255|524037122|FG013|Overall Study|Death|0|||
145324239|NCT02010255|524037109|FG000|Overall Study|Lack of Efficacy|4|||
145324240|NCT02010255|524037110|FG001|Overall Study|Lack of Efficacy|1|||
145324241|NCT02010255|524037111|FG002|Overall Study|Lack of Efficacy|2|||
145324242|NCT02010255|524037112|FG003|Overall Study|Lack of Efficacy|1|||
145324243|NCT02010255|524037113|FG004|Overall Study|Lack of Efficacy|1|||
145620596|NCT03873246|525125113|FG001|Overall Study|Withdrawal by Subject|4|||
145324244|NCT02010255|524037114|FG005|Overall Study|Lack of Efficacy|0|||
145324245|NCT02010255|524037115|FG006|Overall Study|Lack of Efficacy|0|||
145324246|NCT02010255|524037116|FG007|Overall Study|Lack of Efficacy|0|||
145324247|NCT02010255|524037117|FG008|Overall Study|Lack of Efficacy|0|||
145324248|NCT02010255|524037118|FG009|Overall Study|Lack of Efficacy|0|||
145324249|NCT02010255|524037119|FG010|Overall Study|Lack of Efficacy|1|||
145324250|NCT02010255|524037120|FG011|Overall Study|Lack of Efficacy|0|||
145324251|NCT02010255|524037121|FG012|Overall Study|Lack of Efficacy|0|||
145324252|NCT02010255|524037122|FG013|Overall Study|Lack of Efficacy|0|||
145324253|NCT02010255|524037109|FG000|Overall Study|Withdrew Consent|1|||
145324254|NCT02010255|524037110|FG001|Overall Study|Withdrew Consent|0|||
145324255|NCT02010255|524037111|FG002|Overall Study|Withdrew Consent|0|||
145324256|NCT02010255|524037112|FG003|Overall Study|Withdrew Consent|1|||
145324257|NCT02010255|524037113|FG004|Overall Study|Withdrew Consent|0|||
145324258|NCT02010255|524037114|FG005|Overall Study|Withdrew Consent|0|||
145620597|NCT03873246|525125114|FG002|Overall Study|Withdrawal by Subject|1|||
145324259|NCT02010255|524037115|FG006|Overall Study|Withdrew Consent|0|||
145324260|NCT02010255|524037116|FG007|Overall Study|Withdrew Consent|0|||
145324261|NCT02010255|524037117|FG008|Overall Study|Withdrew Consent|0|||
145324262|NCT02010255|524037118|FG009|Overall Study|Withdrew Consent|0|||
145324263|NCT02010255|524037119|FG010|Overall Study|Withdrew Consent|0|||
145324264|NCT02010255|524037120|FG011|Overall Study|Withdrew Consent|0|||
145324265|NCT02010255|524037121|FG012|Overall Study|Withdrew Consent|0|||
145324266|NCT02010255|524037122|FG013|Overall Study|Withdrew Consent|0|||
145324267|NCT02010255|524037109|FG000|Overall Study|Adverse Event|1|||
145324268|NCT02010255|524037110|FG001|Overall Study|Adverse Event|0|||
145324269|NCT02010255|524037111|FG002|Overall Study|Adverse Event|0|||
145324270|NCT02010255|524037112|FG003|Overall Study|Adverse Event|0|||
145324271|NCT02010255|524037113|FG004|Overall Study|Adverse Event|0|||
145324272|NCT02010255|524037114|FG005|Overall Study|Adverse Event|0|||
145324273|NCT02010255|524037115|FG006|Overall Study|Adverse Event|0|||
145620598|NCT04209790|525125115|FG000|Overall Study|Physician Decision|1|||
145324274|NCT02010255|524037116|FG007|Overall Study|Adverse Event|0|||
145324275|NCT02010255|524037117|FG008|Overall Study|Adverse Event|0|||
145324276|NCT02010255|524037118|FG009|Overall Study|Adverse Event|0|||
145324277|NCT02010255|524037119|FG010|Overall Study|Adverse Event|0|||
145324278|NCT02010255|524037120|FG011|Overall Study|Adverse Event|0|||
145620599|NCT03057834|525125116|FG000|Overall Study|Withdrawal by Subject|25|||
145324279|NCT02010255|524037121|FG012|Overall Study|Adverse Event|0|||
145324280|NCT02010255|524037122|FG013|Overall Study|Adverse Event|0|||
145324281|NCT02010255|524037109|FG000|Overall Study|Lost to Follow-up|0|||
145324282|NCT02010255|524037110|FG001|Overall Study|Lost to Follow-up|0|||
145324283|NCT02010255|524037111|FG002|Overall Study|Lost to Follow-up|1|||
145324284|NCT02010255|524037112|FG003|Overall Study|Lost to Follow-up|0|||
145324285|NCT02010255|524037113|FG004|Overall Study|Lost to Follow-up|1|||
145324286|NCT02010255|524037114|FG005|Overall Study|Lost to Follow-up|0|||
145324287|NCT02010255|524037115|FG006|Overall Study|Lost to Follow-up|0|||
145324288|NCT02010255|524037116|FG007|Overall Study|Lost to Follow-up|0|||
145324289|NCT02010255|524037117|FG008|Overall Study|Lost to Follow-up|0|||
145324290|NCT02010255|524037118|FG009|Overall Study|Lost to Follow-up|0|||
145324291|NCT02010255|524037119|FG010|Overall Study|Lost to Follow-up|0|||
145324292|NCT02010255|524037120|FG011|Overall Study|Lost to Follow-up|0|||
145324293|NCT02010255|524037121|FG012|Overall Study|Lost to Follow-up|0|||
145324294|NCT02010255|524037122|FG013|Overall Study|Lost to Follow-up|0|||
145324295|NCT02010255|524037109|FG000|Overall Study|Randomized but Not Treated|0|||
145324296|NCT02010255|524037110|FG001|Overall Study|Randomized but Not Treated|0|||
145324297|NCT02010255|524037111|FG002|Overall Study|Randomized but Not Treated|0|||
145324298|NCT02010255|524037112|FG003|Overall Study|Randomized but Not Treated|0|||
145324299|NCT02010255|524037113|FG004|Overall Study|Randomized but Not Treated|0|||
145324300|NCT02010255|524037114|FG005|Overall Study|Randomized but Not Treated|0|||
145324301|NCT02010255|524037115|FG006|Overall Study|Randomized but Not Treated|0|||
145324302|NCT02010255|524037116|FG007|Overall Study|Randomized but Not Treated|0|||
145324303|NCT02010255|524037117|FG008|Overall Study|Randomized but Not Treated|0|||
145324304|NCT02010255|524037118|FG009|Overall Study|Randomized but Not Treated|0|||
145324305|NCT02010255|524037119|FG010|Overall Study|Randomized but Not Treated|0|||
145324306|NCT02010255|524037120|FG011|Overall Study|Randomized but Not Treated|0|||
145324307|NCT02010255|524037121|FG012|Overall Study|Randomized but Not Treated|0|||
145324308|NCT02010255|524037122|FG013|Overall Study|Randomized but Not Treated|1|||
145324309|NCT00351351|524037123|FG000|Overall Study|surgical access pbs; device issues|9|||
145324310|NCT00351351|524037124|FG001|Overall Study|surgical access pbs; device issues|4|||
145324311|NCT01341587|524037125|FG000|Overall Study|Lost to Follow-up|2|||
145324312|NCT01341587|524037126|FG001|Overall Study|Lost to Follow-up|0|||
145324313|NCT01341587|524037125|FG000|Overall Study|stopped using the meters|2|||
145324314|NCT01341587|524037126|FG001|Overall Study|stopped using the meters|10|||
145324315|NCT03176784|524037127|FG000|Overall Study|Lost to Follow-up|77|||
145324316|NCT03176784|524037128|FG001|Overall Study|Lost to Follow-up|79|||
145324317|NCT03176784|524037129|FG002|Overall Study|Lost to Follow-up|79|||
145324318|NCT03176784|524037130|FG003|Overall Study|Lost to Follow-up|49|||
145324319|NCT03176784|524037127|FG000|Overall Study|Withdrawal by Subject|28|||
145324320|NCT03176784|524037128|FG001|Overall Study|Withdrawal by Subject|34|||
145324321|NCT03176784|524037129|FG002|Overall Study|Withdrawal by Subject|34|||
145324322|NCT03176784|524037130|FG003|Overall Study|Withdrawal by Subject|21|||
145324323|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
145324324|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
145324325|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
145324326|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
145324327|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
145324328|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
145324329|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
145324330|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
145324331|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
145324332|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
145324333|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
145324334|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
145324335|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324336|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324337|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145324338|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145324339|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
145324340|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
145324341|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
145324342|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
145324343|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
145324344|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
145324345|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
145324346|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
145324347|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
145324348|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
145324349|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
145324350|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
145324351|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Death|0|||
145324352|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Death|1|||
145324353|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Death|0|||
145324354|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Death|0|||
145324355|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145324356|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
145324357|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145324358|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
145324359|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
145324360|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
145324361|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
145324362|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
145324363|NCT02990806|524037131|FG000|Stage 1 (22 Weeks)|Other|1|||
145324364|NCT02990806|524037132|FG001|Stage 1 (22 Weeks)|Other|3|||
145324365|NCT02990806|524037133|FG002|Stage 1 (22 Weeks)|Other|0|||
145324366|NCT02990806|524037134|FG003|Stage 1 (22 Weeks)|Other|0|||
145324367|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
145324368|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
145324369|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
145324370|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
145324371|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Death|1|||
145324372|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Death|0|||
145324373|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Death|0|||
145324374|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Death|0|||
145324375|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
145324376|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
145324377|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
145324378|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
145324379|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
145324380|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
145324381|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
145324382|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
145324383|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145324384|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
145324385|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145324386|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
145324387|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
145324388|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
145324389|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
145324390|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
145324391|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324392|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145324393|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
145324394|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
145324395|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
145324396|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
145324397|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
145324398|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
145324399|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
145324400|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
145324401|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
145324402|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
145324403|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
145324404|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
145324405|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
145324406|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
145324407|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
145324408|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
145324409|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
145324410|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
145324411|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Other|3|||
145324412|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Other|0|||
145324413|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Other|4|||
145324414|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Other|1|||
145324415|NCT02990806|524037131|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
145324416|NCT02990806|524037132|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
145324417|NCT02990806|524037133|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
145324418|NCT02990806|524037134|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
145324419|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
145324420|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
145324421|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
145324422|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
145620600|NCT03057834|525125117|FG001|Overall Study|Withdrawal by Subject|29|||
145620601|NCT05617040|525125118|FG000|Overall Study|Adverse Event|0|||
145324423|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145324424|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
145324425|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145324426|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
145324427|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324428|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
145324429|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324430|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
145324431|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
145324432|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
145324433|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
145324434|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
145324435|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
145324436|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
145324437|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
145324438|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
145324439|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145324440|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145324441|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
145324442|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
145324443|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145324444|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145324445|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
145324446|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
145324447|NCT02990806|524037131|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145324448|NCT02990806|524037132|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145324449|NCT02990806|524037133|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
145324450|NCT02990806|524037134|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
145324451|NCT01010750|524037135|FG000|Second Intervention|Adverse Event|0|||
145324452|NCT01010750|524037136|FG001|Second Intervention|Adverse Event|1|||
145324453|NCT01010750|524037137|FG002|Second Intervention|Adverse Event|0|||
145324454|NCT01010750|524037138|FG003|Second Intervention|Adverse Event|0|||
145324455|NCT01010750|524037139|FG004|Second Intervention|Adverse Event|0|||
145324456|NCT01010750|524037140|FG005|Second Intervention|Adverse Event|0|||
145324457|NCT02654587|524037141|FG000|Overall Study|patient alive at end of study|22|||
145324458|NCT02654587|524037142|FG001|Overall Study|patient alive at end of study|8|||
145324459|NCT02654587|524037141|FG000|Overall Study|Withdrawal by Subject|1|||
145324460|NCT02654587|524037142|FG001|Overall Study|Withdrawal by Subject|7|||
145324461|NCT01825837|524037143|FG000|PART I|Withdrawal by Subject|0|||
145324462|NCT01825837|524037144|FG001|PART I|Withdrawal by Subject|0|||
145324463|NCT01825837|524037145|FG002|PART I|Withdrawal by Subject|0|||
145324464|NCT01825837|524037146|FG003|PART I|Withdrawal by Subject|6|||
145324465|NCT01825837|524037143|FG000|PART I|Patient non-compliance|0|||
145324466|NCT01825837|524037144|FG001|PART I|Patient non-compliance|0|||
145324467|NCT01825837|524037145|FG002|PART I|Patient non-compliance|0|||
145324468|NCT01825837|524037146|FG003|PART I|Patient non-compliance|1|||
145324469|NCT01825837|524037143|FG000|PART I|Treatment failure|0|||
145324470|NCT01825837|524037144|FG001|PART I|Treatment failure|0|||
145324471|NCT01825837|524037145|FG002|PART I|Treatment failure|0|||
145324472|NCT01825837|524037146|FG003|PART I|Treatment failure|7|||
145324473|NCT01825837|524037143|FG000|PART I|reason unspecified|0|||
145324474|NCT01825837|524037144|FG001|PART I|reason unspecified|0|||
145324475|NCT01825837|524037145|FG002|PART I|reason unspecified|0|||
145324476|NCT01825837|524037146|FG003|PART I|reason unspecified|3|||
145324477|NCT01825837|524037143|FG000|PART II|Withdrawal by Subject|3|||
145324478|NCT01825837|524037144|FG001|PART II|Withdrawal by Subject|3|||
145324479|NCT01825837|524037145|FG002|PART II|Withdrawal by Subject|7|||
145324480|NCT01825837|524037146|FG003|PART II|Withdrawal by Subject|0|||
145324481|NCT01825837|524037143|FG000|PART II|Patient non-compliance|5|||
145324482|NCT01825837|524037144|FG001|PART II|Patient non-compliance|2|||
145324483|NCT01825837|524037145|FG002|PART II|Patient non-compliance|4|||
145324484|NCT01825837|524037146|FG003|PART II|Patient non-compliance|0|||
145324485|NCT01825837|524037143|FG000|PART II|Adverse Event|3|||
145324486|NCT01825837|524037144|FG001|PART II|Adverse Event|3|||
145324487|NCT01825837|524037145|FG002|PART II|Adverse Event|1|||
145324488|NCT01825837|524037146|FG003|PART II|Adverse Event|0|||
145324489|NCT01825837|524037143|FG000|PART II|Treatment failure|6|||
145324490|NCT01825837|524037144|FG001|PART II|Treatment failure|4|||
145324491|NCT01825837|524037145|FG002|PART II|Treatment failure|5|||
145324492|NCT01825837|524037146|FG003|PART II|Treatment failure|0|||
145324493|NCT01825837|524037143|FG000|PART II|reason unspecified|2|||
145324494|NCT01825837|524037144|FG001|PART II|reason unspecified|2|||
145324495|NCT01825837|524037145|FG002|PART II|reason unspecified|2|||
145570725|NCT03491150|524950013|FG001|Overall Study|Withdrawal by Subject|2|||
145570726|NCT01143090|524950014|FG000|Overall Study|Lack of Efficacy|2|||
145570727|NCT01143090|524950014|FG000|Overall Study|Adverse Event|17|||
145570728|NCT01143090|524950014|FG000|Overall Study|Lost to Follow-up|9|||
145570729|NCT01143090|524950014|FG000|Overall Study|Protocol Violation|2|||
145570730|NCT01143090|524950014|FG000|Overall Study|Withdrawal by Subject|18|||
145570731|NCT01143090|524950014|FG000|Overall Study|Non-compliance with study drug|1|||
145570732|NCT01143090|524950014|FG000|Overall Study|Failure to meet eligibility criteria|1|||
145570733|NCT01143090|524950014|FG000|Overall Study|Administrative|1|||
145570734|NCT00727714|524950018|FG000|Overall Study|Lost to Follow-up|2|||
145570735|NCT00325234|524950021|FG000|Overall Study|Adverse Event|10|||
145570736|NCT00325234|524950022|FG001|Overall Study|Adverse Event|7|||
145570737|NCT00325234|524950021|FG000|Overall Study|Death due to Study Disease|1|||
145570738|NCT00325234|524950022|FG001|Overall Study|Death due to Study Disease|0|||
145570739|NCT00325234|524950021|FG000|Overall Study|Entry Criteria Not Met|1|||
145570740|NCT00325234|524950022|FG001|Overall Study|Entry Criteria Not Met|2|||
145570741|NCT00325234|524950021|FG000|Overall Study|Subject Decision|6|||
145570742|NCT00325234|524950022|FG001|Overall Study|Subject Decision|8|||
145570743|NCT00325234|524950021|FG000|Overall Study|Physician Decision|17|||
145570744|NCT00325234|524950022|FG001|Overall Study|Physician Decision|12|||
145570745|NCT00325234|524950021|FG000|Overall Study|Progressive Disease|34|||
145570746|NCT00325234|524950022|FG001|Overall Study|Progressive Disease|37|||
145570747|NCT03746522|524950025|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
145570748|NCT03746522|524950026|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
145570749|NCT03746522|524950027|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
145570750|NCT03746522|524950025|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
145570751|NCT03746522|524950026|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
145570752|NCT03746522|524950027|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
145570753|NCT03746522|524950025|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
145570754|NCT03746522|524950026|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
145570755|NCT03746522|524950027|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
145570756|NCT03746522|524950025|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
145570757|NCT03746522|524950026|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
145570758|NCT03746522|524950027|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
145570759|NCT03746522|524950025|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
145570760|NCT03746522|524950026|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
145570761|NCT03746522|524950027|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
145570762|NCT01639040|524950028|FG000|Overall Study|Adverse Event|1|||
145570763|NCT01639040|524950029|FG001|Overall Study|Adverse Event|0|||
145570764|NCT00486265|524950033|FG000|Overall Study|Adverse Event|1|||
145570765|NCT00486265|524950033|FG000|Overall Study|Lack of Efficacy|8|||
145324496|NCT01825837|524037146|FG003|PART II|reason unspecified|0|||
145324497|NCT00904748|524037149|FG000|Overall Study|Withdrawal by Subject|1|||
145324498|NCT00904748|524037150|FG001|Overall Study|Withdrawal by Subject|1|||
145324499|NCT00904748|524037151|FG002|Overall Study|Withdrawal by Subject|1|||
145324500|NCT00904748|524037152|FG003|Overall Study|Withdrawal by Subject|2|||
145324501|NCT00904748|524037153|FG004|Overall Study|Withdrawal by Subject|0|||
145324502|NCT00904748|524037154|FG005|Overall Study|Withdrawal by Subject|0|||
145324503|NCT00904748|524037149|FG000|Overall Study|Adverse Event|0|||
145324504|NCT00904748|524037150|FG001|Overall Study|Adverse Event|0|||
145324505|NCT00904748|524037151|FG002|Overall Study|Adverse Event|0|||
145324506|NCT00904748|524037152|FG003|Overall Study|Adverse Event|0|||
145324507|NCT00904748|524037153|FG004|Overall Study|Adverse Event|1|||
145324508|NCT00904748|524037154|FG005|Overall Study|Adverse Event|0|||
145324509|NCT00873119|524037159|FG000|Overall Study|Patient request|4|||
145324510|NCT00873119|524037160|FG001|Overall Study|Patient request|2|||
145324511|NCT00873119|524037159|FG000|Overall Study|Adverse Event|8|||
145324512|NCT00873119|524037160|FG001|Overall Study|Adverse Event|0|||
145324513|NCT00873119|524037159|FG000|Overall Study|Progressive disease|26|||
145324514|NCT00873119|524037160|FG001|Overall Study|Progressive disease|18|||
145324515|NCT00873119|524037159|FG000|Overall Study|Death|2|||
145324516|NCT00873119|524037160|FG001|Overall Study|Death|1|||
145570766|NCT01452412|524950034|FG000|Overall Study|Withdrawal by Subject|15|||
145570767|NCT01452412|524950035|FG001|Overall Study|Withdrawal by Subject|11|||
145570768|NCT01452412|524950034|FG000|Overall Study|Adverse Event|4|||
145324517|NCT00873119|524037159|FG000|Overall Study|Other|2|||
145324518|NCT00873119|524037160|FG001|Overall Study|Other|5|||
145324519|NCT00873119|524037159|FG000|Overall Study|Not treated|2|||
145570769|NCT01452412|524950035|FG001|Overall Study|Adverse Event|3|||
145570770|NCT01452412|524950034|FG000|Overall Study|Lost to Follow-up|5|||
145570771|NCT01452412|524950035|FG001|Overall Study|Lost to Follow-up|3|||
145324520|NCT00873119|524037160|FG001|Overall Study|Not treated|0|||
145324521|NCT03648879|524037161|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
145324522|NCT00466726|524037162|FG000|Overall Study|Not evaluable for response|14|||
145570772|NCT01452412|524950034|FG000|Overall Study|Death|1|||
145570773|NCT01452412|524950035|FG001|Overall Study|Death|0|||
145570774|NCT01452412|524950034|FG000|Overall Study|Initiated dialysis|1|||
145570775|NCT01452412|524950035|FG001|Overall Study|Initiated dialysis|0|||
145570776|NCT01452412|524950034|FG000|Overall Study|Other|2|||
145570777|NCT01452412|524950035|FG001|Overall Study|Other|0|||
145570778|NCT05132127|524950036|FG000|Overall Study|Adverse Event|1|||
145570779|NCT03013543|524950037|FG000|Overall Study|Withdrawal by Subject|0|||
145570780|NCT03013543|524950038|FG001|Overall Study|Withdrawal by Subject|2|||
145570781|NCT03013543|524950039|FG002|Overall Study|Withdrawal by Subject|0|||
145570782|NCT03013543|524950040|FG003|Overall Study|Withdrawal by Subject|5|||
145570783|NCT03013543|524950041|FG004|Overall Study|Withdrawal by Subject|6|||
145570784|NCT03013543|524950042|FG005|Overall Study|Withdrawal by Subject|2|||
145570785|NCT03013543|524950043|FG006|Overall Study|Withdrawal by Subject|3|||
145570786|NCT03013543|524950044|FG007|Overall Study|Withdrawal by Subject|1|||
145570787|NCT03013543|524950045|FG008|Overall Study|Withdrawal by Subject|0|||
145570788|NCT03013543|524950046|FG009|Overall Study|Withdrawal by Subject|4|||
145570789|NCT03013543|524950037|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145570790|NCT03013543|524950038|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145570791|NCT03013543|524950039|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
145570792|NCT03013543|524950040|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
145570793|NCT03013543|524950041|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
145570794|NCT03013543|524950042|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
145570795|NCT03013543|524950043|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
145570796|NCT03013543|524950044|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
145570797|NCT03013543|524950045|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
145570798|NCT03013543|524950046|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
145570799|NCT03013543|524950037|FG000|Overall Study|Other|0|||
145570800|NCT03013543|524950038|FG001|Overall Study|Other|0|||
145570801|NCT03013543|524950039|FG002|Overall Study|Other|2|||
145570802|NCT03013543|524950040|FG003|Overall Study|Other|0|||
145570803|NCT03013543|524950041|FG004|Overall Study|Other|2|||
145570804|NCT03013543|524950042|FG005|Overall Study|Other|0|||
145570805|NCT03013543|524950043|FG006|Overall Study|Other|0|||
145570806|NCT03013543|524950044|FG007|Overall Study|Other|0|||
145570807|NCT03013543|524950045|FG008|Overall Study|Other|1|||
145570808|NCT03013543|524950046|FG009|Overall Study|Other|0|||
145324523|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
145324524|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
145324525|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
145324526|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
145324527|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
145324528|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
145324529|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
145324530|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
145324531|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
145324532|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
145324533|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
145324534|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
145324535|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
145324536|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
145324537|NCT04740931|524037163|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
145324538|NCT04740931|524037164|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
145324539|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
145324540|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
145324541|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
145324542|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
145324543|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
145324544|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
145324545|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
145324546|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
145324547|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
145324548|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
145324549|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
145324550|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
145324551|NCT04740931|524037163|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
145570809|NCT03013543|524950037|FG000|Overall Study|Adverse Event|0|||
145570810|NCT03013543|524950038|FG001|Overall Study|Adverse Event|0|||
145570811|NCT03013543|524950039|FG002|Overall Study|Adverse Event|0|||
145570812|NCT03013543|524950040|FG003|Overall Study|Adverse Event|3|||
145324552|NCT04740931|524037164|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
145570813|NCT03013543|524950041|FG004|Overall Study|Adverse Event|2|||
145570814|NCT03013543|524950042|FG005|Overall Study|Adverse Event|1|||
145570815|NCT03013543|524950043|FG006|Overall Study|Adverse Event|3|||
145570816|NCT03013543|524950044|FG007|Overall Study|Adverse Event|8|||
145570817|NCT03013543|524950045|FG008|Overall Study|Adverse Event|0|||
145570818|NCT03013543|524950046|FG009|Overall Study|Adverse Event|2|||
145324553|NCT04403763|524037165|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
145324554|NCT04403763|524037166|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
145324555|NCT04403763|524037167|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
145324556|NCT04403763|524037168|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
145324557|NCT04403763|524037169|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
145324558|NCT04403763|524037170|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
145324559|NCT04403763|524037171|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
145324560|NCT04403763|524037165|FG000|Stage 1|Early termination due to PK tube failure|0|||
145324561|NCT04403763|524037166|FG001|Stage 1|Early termination due to PK tube failure|0|||
145324562|NCT04403763|524037167|FG002|Stage 1|Early termination due to PK tube failure|1|||
145324563|NCT04403763|524037168|FG003|Stage 1|Early termination due to PK tube failure|0|||
145324564|NCT04403763|524037169|FG004|Stage 1|Early termination due to PK tube failure|0|||
145324565|NCT04403763|524037170|FG005|Stage 1|Early termination due to PK tube failure|0|||
145324566|NCT04403763|524037171|FG006|Stage 1|Early termination due to PK tube failure|0|||
145324567|NCT04403763|524037165|FG000|Stage 2A|Adverse Event|0|||
145324568|NCT04403763|524037166|FG001|Stage 2A|Adverse Event|0|||
145324569|NCT04403763|524037167|FG002|Stage 2A|Adverse Event|0|||
145324570|NCT04403763|524037168|FG003|Stage 2A|Adverse Event|0|||
145324571|NCT04403763|524037169|FG004|Stage 2A|Adverse Event|0|||
145324572|NCT04403763|524037170|FG005|Stage 2A|Adverse Event|0|||
145324573|NCT04403763|524037171|FG006|Stage 2A|Adverse Event|1|||
145324574|NCT00350402|524037172|FG000|Overall Study|Lost to Follow-up|1|||
145324575|NCT00350402|524037173|FG001|Overall Study|Lost to Follow-up|1|||
145324576|NCT01376310|524037174|FG000|Overall Study|Study closed/terminated|1|||
145324577|NCT01376310|524037175|FG001|Overall Study|Study closed/terminated|2|||
145324578|NCT01376310|524037174|FG000|Overall Study|Withdrawal by Subject|8|||
145324579|NCT01376310|524037175|FG001|Overall Study|Withdrawal by Subject|2|||
145324580|NCT01376310|524037174|FG000|Overall Study|Physician Decision|26|||
145324581|NCT01376310|524037175|FG001|Overall Study|Physician Decision|7|||
145324582|NCT01376310|524037174|FG000|Overall Study|Lost to Follow-up|1|||
145324583|NCT01376310|524037175|FG001|Overall Study|Lost to Follow-up|0|||
145324584|NCT02339740|524037178|FG000|Overall Study|Death|1|||
145324585|NCT02339740|524037179|FG001|Overall Study|Death|0|||
145324586|NCT02339740|524037178|FG000|Overall Study|Physician Decision|0|||
145324587|NCT02339740|524037179|FG001|Overall Study|Physician Decision|2|||
145324588|NCT02339740|524037178|FG000|Overall Study|Withdrawal by Subject|5|||
145324589|NCT02339740|524037179|FG001|Overall Study|Withdrawal by Subject|1|||
145324590|NCT02339740|524037178|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
145324591|NCT02339740|524037179|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
145324592|NCT00645944|524037180|FG000|Randomized|Withdrawal by Subject|1|||
145324593|NCT00645944|524037181|FG001|Randomized|Withdrawal by Subject|2|||
145324594|NCT00645944|524037180|FG000|Received Medication|Adverse Event|2|||
145324595|NCT00645944|524037181|FG001|Received Medication|Adverse Event|1|||
145324596|NCT00645944|524037180|FG000|Received Medication|Withdrawal by Subject|1|||
145324597|NCT00645944|524037181|FG001|Received Medication|Withdrawal by Subject|1|||
145324598|NCT00645944|524037180|FG000|Received Medication|Lost to Follow-up|1|||
145324599|NCT00645944|524037181|FG001|Received Medication|Lost to Follow-up|0|||
145324600|NCT00645944|524037180|FG000|Received Medication|Protocol Violation|2|||
145570819|NCT03013543|524950037|FG000|Overall Study|Death|0|||
145324601|NCT00645944|524037181|FG001|Received Medication|Protocol Violation|1|||
145324602|NCT01807117|524037182|FG000|Overall Study|Physician Decision|2|||
145324603|NCT01807117|524037182|FG000|Overall Study|Disease diagnosis not a study disease|1|||
145324604|NCT01534637|524037183|FG000|Overall Study|Physician Decision|3|||
145324605|NCT01534637|524037183|FG000|Overall Study|Lack of Efficacy|3|||
145324606|NCT01534637|524037183|FG000|Overall Study|Withdrawal by Subject|1|||
145324607|NCT01534637|524037183|FG000|Overall Study|Adverse Event|1|||
145324608|NCT01534637|524037183|FG000|Overall Study|Liver Mets before treatment|1|||
145324609|NCT00834899|524037184|FG000|Overall Study|Withdrawal by Subject|1|||
145324610|NCT00834899|524037185|FG001|Overall Study|Withdrawal by Subject|1|||
145324611|NCT02377921|524037193|FG000|Overall Study|Subject non-compliance|1|||
145324612|NCT02377921|524037194|FG001|Overall Study|Subject non-compliance|1|||
145324613|NCT00706355|524037201|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
145324614|NCT00706355|524037202|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145324615|NCT00706355|524037203|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145324616|NCT00706355|524037204|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
145324617|NCT00706355|524037201|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
145324618|NCT00706355|524037202|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145324619|NCT00706355|524037203|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145570820|NCT03013543|524950038|FG001|Overall Study|Death|0|||
145324620|NCT00706355|524037204|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
145324621|NCT00706355|524037201|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
145324622|NCT00706355|524037202|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
145324623|NCT00706355|524037203|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
145570821|NCT03013543|524950039|FG002|Overall Study|Death|0|||
145570822|NCT03013543|524950040|FG003|Overall Study|Death|1|||
145570823|NCT03013543|524950041|FG004|Overall Study|Death|0|||
145570824|NCT03013543|524950042|FG005|Overall Study|Death|0|||
145570825|NCT03013543|524950043|FG006|Overall Study|Death|0|||
145570826|NCT03013543|524950044|FG007|Overall Study|Death|0|||
145570827|NCT03013543|524950045|FG008|Overall Study|Death|0|||
145570828|NCT03013543|524950046|FG009|Overall Study|Death|0|||
145570829|NCT03013543|524950037|FG000|Overall Study|Lack of Efficacy|0|||
145570830|NCT03013543|524950038|FG001|Overall Study|Lack of Efficacy|0|||
145570831|NCT03013543|524950039|FG002|Overall Study|Lack of Efficacy|0|||
145570832|NCT03013543|524950040|FG003|Overall Study|Lack of Efficacy|1|||
145570833|NCT03013543|524950041|FG004|Overall Study|Lack of Efficacy|0|||
145570834|NCT03013543|524950042|FG005|Overall Study|Lack of Efficacy|0|||
145570835|NCT03013543|524950043|FG006|Overall Study|Lack of Efficacy|0|||
145570836|NCT03013543|524950044|FG007|Overall Study|Lack of Efficacy|0|||
145570837|NCT03013543|524950045|FG008|Overall Study|Lack of Efficacy|0|||
145570838|NCT03013543|524950046|FG009|Overall Study|Lack of Efficacy|0|||
145570839|NCT03013543|524950037|FG000|Overall Study|Lost to Follow-up|0|||
145324624|NCT00706355|524037204|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
145324625|NCT00706355|524037201|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145324626|NCT00706355|524037202|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
145324627|NCT00706355|524037203|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145324628|NCT00706355|524037204|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
145324629|NCT00706355|524037201|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145324630|NCT00706355|524037202|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
145324631|NCT00706355|524037203|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145324632|NCT00706355|524037204|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
145324633|NCT00706355|524037201|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145324634|NCT00706355|524037202|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145324635|NCT00706355|524037203|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
145324636|NCT00706355|524037204|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
145324637|NCT00706355|524037201|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
145324638|NCT00706355|524037202|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
145324639|NCT00706355|524037203|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
145324640|NCT00706355|524037204|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
145324641|NCT00706355|524037201|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145324642|NCT00706355|524037202|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145324643|NCT00706355|524037203|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
145324644|NCT00706355|524037204|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
145324645|NCT00706355|524037201|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145324646|NCT00706355|524037202|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145324647|NCT00706355|524037203|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
145324648|NCT00706355|524037204|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
145324649|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
145324650|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
145324651|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
145324652|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
145324653|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
145324654|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
145324655|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
145324656|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
145324657|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
145324658|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
145324659|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
145324660|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
145324661|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
145324662|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
145324663|NCT02510014|524037205|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
145324664|NCT02510014|524037206|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
145324665|NCT02510014|524037205|FG000|Treatment Period|Adverse Event|11|||
145324666|NCT02510014|524037206|FG001|Treatment Period|Adverse Event|4|||
145324667|NCT02510014|524037205|FG000|Treatment Period|Withdrawal symptoms|3|||
145324668|NCT02510014|524037206|FG001|Treatment Period|Withdrawal symptoms|0|||
145324669|NCT02510014|524037205|FG000|Treatment Period|Lost to Follow-up|80|||
145324670|NCT02510014|524037206|FG001|Treatment Period|Lost to Follow-up|19|||
145324671|NCT02510014|524037205|FG000|Treatment Period|Physician Decision|5|||
145324672|NCT02510014|524037206|FG001|Treatment Period|Physician Decision|0|||
145324673|NCT02510014|524037205|FG000|Treatment Period|Withdrawal by Subject|67|||
145324674|NCT02510014|524037206|FG001|Treatment Period|Withdrawal by Subject|24|||
145570840|NCT03013543|524950038|FG001|Overall Study|Lost to Follow-up|0|||
145570841|NCT03013543|524950039|FG002|Overall Study|Lost to Follow-up|0|||
145570842|NCT03013543|524950040|FG003|Overall Study|Lost to Follow-up|1|||
145324675|NCT02510014|524037205|FG000|Treatment Period|Withdrawn by the investigator|7|||
145324676|NCT02510014|524037206|FG001|Treatment Period|Withdrawn by the investigator|1|||
145324677|NCT02510014|524037205|FG000|Treatment Period|Protocol Violation|4|||
145324678|NCT02510014|524037206|FG001|Treatment Period|Protocol Violation|4|||
145324679|NCT02510014|524037205|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
145324680|NCT02510014|524037206|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
145324681|NCT01020799|524037209|FG000|Overall Study|Adverse Event|4|||
145324682|NCT01020799|524037210|FG001|Overall Study|Adverse Event|3|||
145324683|NCT01020799|524037211|FG002|Overall Study|Adverse Event|2|||
145324684|NCT01020799|524037209|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
145324685|NCT01020799|524037210|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
145324686|NCT01020799|524037211|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
145324687|NCT01020799|524037209|FG000|Overall Study|Protocol Violation|3|||
145324688|NCT01020799|524037210|FG001|Overall Study|Protocol Violation|2|||
145324689|NCT01020799|524037211|FG002|Overall Study|Protocol Violation|0|||
145324690|NCT01020799|524037209|FG000|Overall Study|Withdrawal by Subject|2|||
145324691|NCT01020799|524037210|FG001|Overall Study|Withdrawal by Subject|2|||
145324692|NCT01020799|524037211|FG002|Overall Study|Withdrawal by Subject|3|||
145324693|NCT01020799|524037209|FG000|Overall Study|Lost to Follow-up|6|||
145324694|NCT01020799|524037210|FG001|Overall Study|Lost to Follow-up|4|||
145324695|NCT01020799|524037211|FG002|Overall Study|Lost to Follow-up|2|||
145324696|NCT04179019|524037212|FG000|Overall Study|Lost to Follow-up|2|||
145324697|NCT04179019|524037212|FG000|Overall Study|Physician Decision|2|||
145324698|NCT04179019|524037212|FG000|Overall Study|Withdrawal by Subject|5|||
145324699|NCT04179019|524037212|FG000|Overall Study|Adverse Event|4|||
145324700|NCT00854373|524037213|FG000|Overall Study|Withdrawal by Subject|1|||
145324701|NCT00854373|524037214|FG001|Overall Study|Withdrawal by Subject|3|||
145324702|NCT00854373|524037213|FG000|Overall Study|Forgot to take study drug|1|||
145324703|NCT00854373|524037214|FG001|Overall Study|Forgot to take study drug|1|||
145324704|NCT02377063|524037221|FG000|Overall Study|Non-compliance|5|||
145324705|NCT01524913|524037222|FG000|Overall Study|Lost to Follow-up|4|||
145324706|NCT01524913|524037223|FG001|Overall Study|Lost to Follow-up|0|||
145324707|NCT01524913|524037224|FG002|Overall Study|Lost to Follow-up|0|||
145324708|NCT00702208|524037225|FG000|Overall Study|Lost to Follow-up|28|||
145324709|NCT00702208|524037225|FG000|Overall Study|Did not self-lavage|1|||
145324710|NCT00702208|524037225|FG000|Overall Study|Unsatisfactory colposcopy|2|||
145324711|NCT02149121|524037228|FG000|Main Study Period|Lack of Efficacy|2|||
145324712|NCT02149121|524037229|FG001|Main Study Period|Lack of Efficacy|2|||
145324713|NCT02149121|524037230|FG002|Main Study Period|Lack of Efficacy|1|||
145324714|NCT02149121|524037231|FG003|Main Study Period|Lack of Efficacy|0|||
145324715|NCT02149121|524037232|FG004|Main Study Period|Lack of Efficacy|0|||
145324716|NCT02149121|524037233|FG005|Main Study Period|Lack of Efficacy|0|||
145324717|NCT02149121|524037234|FG006|Main Study Period|Lack of Efficacy|0|||
145324718|NCT02149121|524037228|FG000|Main Study Period|Withdrawal by Subject|9|||
145324719|NCT02149121|524037229|FG001|Main Study Period|Withdrawal by Subject|5|||
145324720|NCT02149121|524037230|FG002|Main Study Period|Withdrawal by Subject|1|||
145324721|NCT02149121|524037231|FG003|Main Study Period|Withdrawal by Subject|0|||
145324722|NCT02149121|524037232|FG004|Main Study Period|Withdrawal by Subject|0|||
145620602|NCT05617040|525125119|FG001|Overall Study|Adverse Event|1|||
145620603|NCT05617040|525125120|FG002|Overall Study|Adverse Event|0|||
145620604|NCT05617040|525125118|FG000|Overall Study|Death|0|||
145620605|NCT05617040|525125119|FG001|Overall Study|Death|0|||
145620606|NCT05617040|525125120|FG002|Overall Study|Death|1|||
145620607|NCT04630756|525125121|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
145620608|NCT04630756|525125122|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
145620609|NCT04630756|525125123|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
145620610|NCT03621982|525125124|FG000|Overall Study|Withdrawal by Subject|1|||
145324723|NCT02149121|524037233|FG005|Main Study Period|Withdrawal by Subject|0|||
145324724|NCT02149121|524037234|FG006|Main Study Period|Withdrawal by Subject|0|||
145324725|NCT02149121|524037228|FG000|Main Study Period|Adverse Event|2|||
145324726|NCT02149121|524037229|FG001|Main Study Period|Adverse Event|5|||
145324727|NCT02149121|524037230|FG002|Main Study Period|Adverse Event|1|||
145324728|NCT02149121|524037231|FG003|Main Study Period|Adverse Event|0|||
145324729|NCT02149121|524037232|FG004|Main Study Period|Adverse Event|0|||
145324730|NCT02149121|524037233|FG005|Main Study Period|Adverse Event|0|||
145324731|NCT02149121|524037234|FG006|Main Study Period|Adverse Event|0|||
145324732|NCT02149121|524037228|FG000|Main Study Period|Protocol Violation|2|||
145324733|NCT02149121|524037229|FG001|Main Study Period|Protocol Violation|0|||
145324734|NCT02149121|524037230|FG002|Main Study Period|Protocol Violation|0|||
145324735|NCT02149121|524037231|FG003|Main Study Period|Protocol Violation|0|||
145324736|NCT02149121|524037232|FG004|Main Study Period|Protocol Violation|0|||
145324737|NCT02149121|524037233|FG005|Main Study Period|Protocol Violation|0|||
145324738|NCT02149121|524037234|FG006|Main Study Period|Protocol Violation|0|||
145324739|NCT02149121|524037228|FG000|Main Study Period|Lost to Follow-up|2|||
145324740|NCT02149121|524037229|FG001|Main Study Period|Lost to Follow-up|1|||
145620611|NCT03621982|525125125|FG001|Overall Study|Withdrawal by Subject|0|||
145324741|NCT02149121|524037230|FG002|Main Study Period|Lost to Follow-up|0|||
145324742|NCT02149121|524037231|FG003|Main Study Period|Lost to Follow-up|0|||
145324743|NCT02149121|524037232|FG004|Main Study Period|Lost to Follow-up|0|||
145324744|NCT02149121|524037233|FG005|Main Study Period|Lost to Follow-up|0|||
145324745|NCT02149121|524037234|FG006|Main Study Period|Lost to Follow-up|0|||
145324746|NCT02149121|524037228|FG000|Main Study Period|Death|1|||
145324747|NCT02149121|524037229|FG001|Main Study Period|Death|0|||
145324748|NCT02149121|524037230|FG002|Main Study Period|Death|0|||
145324749|NCT02149121|524037231|FG003|Main Study Period|Death|0|||
145324750|NCT02149121|524037232|FG004|Main Study Period|Death|0|||
145324751|NCT02149121|524037233|FG005|Main Study Period|Death|0|||
145324752|NCT02149121|524037234|FG006|Main Study Period|Death|0|||
145324753|NCT02149121|524037228|FG000|Main Study Period|Physician Decision|1|||
145324754|NCT02149121|524037229|FG001|Main Study Period|Physician Decision|0|||
145324755|NCT02149121|524037230|FG002|Main Study Period|Physician Decision|0|||
145324756|NCT02149121|524037231|FG003|Main Study Period|Physician Decision|0|||
145324757|NCT02149121|524037232|FG004|Main Study Period|Physician Decision|0|||
145324758|NCT02149121|524037233|FG005|Main Study Period|Physician Decision|0|||
145324759|NCT02149121|524037234|FG006|Main Study Period|Physician Decision|0|||
145324760|NCT02149121|524037228|FG000|Main Study Period|Developed any malignancy|0|||
145324761|NCT02149121|524037229|FG001|Main Study Period|Developed any malignancy|1|||
145324762|NCT02149121|524037230|FG002|Main Study Period|Developed any malignancy|1|||
145324763|NCT02149121|524037231|FG003|Main Study Period|Developed any malignancy|0|||
145324764|NCT02149121|524037232|FG004|Main Study Period|Developed any malignancy|0|||
145324765|NCT02149121|524037233|FG005|Main Study Period|Developed any malignancy|0|||
145324766|NCT02149121|524037234|FG006|Main Study Period|Developed any malignancy|0|||
145324767|NCT02149121|524037228|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
145324768|NCT02149121|524037229|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
145324769|NCT02149121|524037230|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
145324770|NCT02149121|524037231|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
145324771|NCT02149121|524037232|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
145324772|NCT02149121|524037233|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
145324773|NCT02149121|524037234|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
145324774|NCT02149121|524037228|FG000|Main Study Period|Disease progression|0|||
145324775|NCT02149121|524037229|FG001|Main Study Period|Disease progression|1|||
145324776|NCT02149121|524037230|FG002|Main Study Period|Disease progression|0|||
145324777|NCT02149121|524037231|FG003|Main Study Period|Disease progression|0|||
145324778|NCT02149121|524037232|FG004|Main Study Period|Disease progression|0|||
145324779|NCT02149121|524037233|FG005|Main Study Period|Disease progression|0|||
145324780|NCT02149121|524037234|FG006|Main Study Period|Disease progression|0|||
145324781|NCT02149121|524037228|FG000|Extension Study Period|Withdrawal by Subject|0|||
145324782|NCT02149121|524037229|FG001|Extension Study Period|Withdrawal by Subject|0|||
145324783|NCT02149121|524037230|FG002|Extension Study Period|Withdrawal by Subject|0|||
145324784|NCT02149121|524037231|FG003|Extension Study Period|Withdrawal by Subject|1|||
145324785|NCT02149121|524037232|FG004|Extension Study Period|Withdrawal by Subject|0|||
145324786|NCT02149121|524037233|FG005|Extension Study Period|Withdrawal by Subject|2|||
145324787|NCT02149121|524037234|FG006|Extension Study Period|Withdrawal by Subject|0|||
145324788|NCT03166124|524037235|FG000|Treatment Period 1|Adverse Event|0|||
145324789|NCT03166124|524037236|FG001|Treatment Period 1|Adverse Event|0|||
145324790|NCT03166124|524037237|FG002|Treatment Period 1|Adverse Event|1|||
145324791|NCT03166124|524037238|FG003|Treatment Period 1|Adverse Event|0|||
145324792|NCT03166124|524037235|FG000|Wash-out Period|Withdrawal by Subject|0|||
145324793|NCT03166124|524037236|FG001|Wash-out Period|Withdrawal by Subject|1|||
145324794|NCT03166124|524037237|FG002|Wash-out Period|Withdrawal by Subject|0|||
145324795|NCT03166124|524037238|FG003|Wash-out Period|Withdrawal by Subject|1|||
145324796|NCT03166124|524037235|FG000|Wash-out Period|Adverse Event|0|||
145324797|NCT03166124|524037236|FG001|Wash-out Period|Adverse Event|1|||
145324798|NCT03166124|524037237|FG002|Wash-out Period|Adverse Event|1|||
145324799|NCT03166124|524037238|FG003|Wash-out Period|Adverse Event|0|||
145324800|NCT00788593|524037241|FG000|Placebo Run-in Phase|Adverse Event|2|||
145324801|NCT00788593|524037242|FG001|Placebo Run-in Phase|Adverse Event|0|||
145324802|NCT00788593|524037243|FG002|Placebo Run-in Phase|Adverse Event|0|||
145324803|NCT00788593|524037241|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
145324804|NCT00788593|524037242|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
145324805|NCT00788593|524037243|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
145324806|NCT00788593|524037241|FG000|Placebo Run-in Phase|Protocol Violation|2|||
145324807|NCT00788593|524037242|FG001|Placebo Run-in Phase|Protocol Violation|0|||
145324808|NCT00788593|524037243|FG002|Placebo Run-in Phase|Protocol Violation|0|||
145324809|NCT00788593|524037241|FG000|First Intervention Period|Adverse Event|0|||
145324810|NCT00788593|524037242|FG001|First Intervention Period|Adverse Event|1|||
145324811|NCT00788593|524037243|FG002|First Intervention Period|Adverse Event|0|||
145324812|NCT00788593|524037241|FG000|Second Intervention Period|Lost to Follow-up|0|||
145324813|NCT00788593|524037242|FG001|Second Intervention Period|Lost to Follow-up|1|||
145324814|NCT00788593|524037243|FG002|Second Intervention Period|Lost to Follow-up|0|||
145324815|NCT00788593|524037241|FG000|Second Intervention Period|Other|0|||
145324816|NCT00788593|524037242|FG001|Second Intervention Period|Other|0|||
145324817|NCT00788593|524037243|FG002|Second Intervention Period|Other|1|||
145324818|NCT00515034|524037244|FG000|Overall Study|Adverse Event|2|||
145324819|NCT00515034|524037245|FG001|Overall Study|Adverse Event|0|||
145324820|NCT00515034|524037246|FG002|Overall Study|Adverse Event|1|||
145324821|NCT00515034|524037247|FG003|Overall Study|Adverse Event|0|||
145324822|NCT00515034|524037244|FG000|Overall Study|Death|4|||
145324823|NCT00515034|524037245|FG001|Overall Study|Death|2|||
145324824|NCT00515034|524037246|FG002|Overall Study|Death|1|||
145324825|NCT00515034|524037247|FG003|Overall Study|Death|3|||
145324826|NCT00515034|524037244|FG000|Overall Study|Withdrawal by Subject|1|||
145324827|NCT00515034|524037245|FG001|Overall Study|Withdrawal by Subject|0|||
145324828|NCT00515034|524037246|FG002|Overall Study|Withdrawal by Subject|3|||
145324829|NCT00515034|524037247|FG003|Overall Study|Withdrawal by Subject|0|||
145324830|NCT00515034|524037244|FG000|Overall Study|Physician Decision|0|||
145324831|NCT00515034|524037245|FG001|Overall Study|Physician Decision|0|||
145324832|NCT00515034|524037246|FG002|Overall Study|Physician Decision|1|||
145324833|NCT00515034|524037247|FG003|Overall Study|Physician Decision|1|||
145324834|NCT00515034|524037244|FG000|Overall Study|Other|1|||
145324835|NCT00515034|524037245|FG001|Overall Study|Other|0|||
145324836|NCT00515034|524037246|FG002|Overall Study|Other|2|||
145324837|NCT00515034|524037247|FG003|Overall Study|Other|1|||
145324838|NCT02858726|524037248|FG000|Overall Study|Adverse Event|4|||
145324839|NCT02858726|524037249|FG001|Overall Study|Adverse Event|4|||
145324840|NCT02858726|524037250|FG002|Overall Study|Adverse Event|9|||
145324841|NCT02858726|524037251|FG003|Overall Study|Adverse Event|1|||
145324842|NCT02858726|524037248|FG000|Overall Study|Physician Decision|0|||
145324843|NCT02858726|524037249|FG001|Overall Study|Physician Decision|0|||
145324844|NCT02858726|524037250|FG002|Overall Study|Physician Decision|1|||
145324845|NCT02858726|524037251|FG003|Overall Study|Physician Decision|0|||
145324846|NCT02858726|524037248|FG000|Overall Study|Protocol Violation|0|||
145324847|NCT02858726|524037249|FG001|Overall Study|Protocol Violation|0|||
145324848|NCT02858726|524037250|FG002|Overall Study|Protocol Violation|0|||
145324849|NCT02858726|524037251|FG003|Overall Study|Protocol Violation|1|||
145324850|NCT02858726|524037248|FG000|Overall Study|Study Terminated by Sponsor|0|||
145324851|NCT02858726|524037249|FG001|Overall Study|Study Terminated by Sponsor|0|||
145324852|NCT02858726|524037250|FG002|Overall Study|Study Terminated by Sponsor|0|||
145324853|NCT02858726|524037251|FG003|Overall Study|Study Terminated by Sponsor|1|||
145324854|NCT02858726|524037248|FG000|Overall Study|Withdrawal by Subject|1|||
145324855|NCT02858726|524037249|FG001|Overall Study|Withdrawal by Subject|2|||
145324856|NCT02858726|524037250|FG002|Overall Study|Withdrawal by Subject|1|||
145324857|NCT02858726|524037251|FG003|Overall Study|Withdrawal by Subject|0|||
145324858|NCT02858726|524037248|FG000|Overall Study|Noncompliance|0|||
145324859|NCT02858726|524037249|FG001|Overall Study|Noncompliance|1|||
145324860|NCT02858726|524037250|FG002|Overall Study|Noncompliance|0|||
145324861|NCT02858726|524037251|FG003|Overall Study|Noncompliance|0|||
145324862|NCT00233987|524037258|FG000|Overall Study|Withdrawal by Subject|1|||
145324863|NCT00233987|524037258|FG000|Overall Study|Lack of Efficacy|2|||
145324864|NCT00233987|524037258|FG000|Overall Study|Reason Under Review|1|||
145324865|NCT00233987|524037258|FG000|Overall Study|Other - Not Protocol Specified|5|||
145324866|NCT00233987|524037258|FG000|Overall Study|Eligible but No Treatment Received|2|||
145324867|NCT00233987|524037258|FG000|Overall Study|Ineligible|4|||
145324868|NCT01688726|524037261|FG000|Overall Study|Adverse Event|1|||
145324869|NCT01688726|524037262|FG001|Overall Study|Adverse Event|0|||
145324870|NCT01688726|524037261|FG000|Overall Study|Relocated abroad|0|||
145324871|NCT01688726|524037262|FG001|Overall Study|Relocated abroad|1|||
145324872|NCT01481324|524037263|FG000|Overall Study|Missing Data|0|||
145324873|NCT01481324|524037264|FG001|Overall Study|Missing Data|2|||
145324874|NCT01481324|524037265|FG002|Overall Study|Missing Data|2|||
145324875|NCT00952276|524037269|FG000|Overall Study|Withdrawal by Subject|1|||
145324876|NCT00952276|524037270|FG001|Overall Study|Withdrawal by Subject|0|||
145324877|NCT00952276|524037271|FG002|Overall Study|Withdrawal by Subject|0|||
145324878|NCT00952276|524037272|FG003|Overall Study|Withdrawal by Subject|1|||
145324879|NCT00952276|524037273|FG004|Overall Study|Withdrawal by Subject|0|||
145324880|NCT02427984|524037274|FG000|Overall Study|Lost to Follow-up|13|||
145324881|NCT02427984|524037275|FG001|Overall Study|Lost to Follow-up|5|||
145324882|NCT02427984|524037276|FG002|Overall Study|Lost to Follow-up|18|||
145324883|NCT01010126|524038938|FG000|Overall Study|Withdrawal by Subject|1|||
145324884|NCT01010126|524038939|FG001|Overall Study|Withdrawal by Subject|0|||
145324885|NCT01010126|524038940|FG002|Overall Study|Withdrawal by Subject|1|||
145324886|NCT01010126|524038941|FG003|Overall Study|Withdrawal by Subject|0|||
145324887|NCT01010126|524038942|FG004|Overall Study|Withdrawal by Subject|3|||
145324888|NCT01010126|524038943|FG005|Overall Study|Withdrawal by Subject|0|||
145324889|NCT01131299|524038946|FG000|Overall Study|Withdrawal by Subject|4|||
145324890|NCT01131299|524038947|FG001|Overall Study|Withdrawal by Subject|7|||
145324891|NCT01885182|524038955|FG000|Overall Study|Adverse Event|11|||
145324892|NCT01885182|524038956|FG001|Overall Study|Adverse Event|13|||
145324893|NCT01885182|524038955|FG000|Overall Study|Withdrawal by Subject|13|||
145324894|NCT01885182|524038956|FG001|Overall Study|Withdrawal by Subject|6|||
145324895|NCT01885182|524038955|FG000|Overall Study|Lost to Follow-up|2|||
145324896|NCT01885182|524038956|FG001|Overall Study|Lost to Follow-up|2|||
145324897|NCT01885182|524038955|FG000|Overall Study|Lack of Efficacy|8|||
145324898|NCT01885182|524038956|FG001|Overall Study|Lack of Efficacy|1|||
145324899|NCT01207440|524038963|FG000|Overall Study|Adverse Event|46|||
145324900|NCT01207440|524038964|FG001|Overall Study|Adverse Event|11|||
145324901|NCT01207440|524038965|FG002|Overall Study|Adverse Event|7|||
145324902|NCT01207440|524038966|FG003|Overall Study|Adverse Event|2|||
145324903|NCT01207440|524038967|FG004|Overall Study|Adverse Event|6|||
145324904|NCT01207440|524038968|FG005|Overall Study|Adverse Event|6|||
145324905|NCT01207440|524038969|FG006|Overall Study|Adverse Event|2|||
145324906|NCT01207440|524038963|FG000|Overall Study|Death|6|||
145324907|NCT01207440|524038964|FG001|Overall Study|Death|3|||
145324908|NCT01207440|524038965|FG002|Overall Study|Death|2|||
145324909|NCT01207440|524038966|FG003|Overall Study|Death|2|||
145324910|NCT01207440|524038967|FG004|Overall Study|Death|7|||
145324911|NCT01207440|524038968|FG005|Overall Study|Death|5|||
145324912|NCT01207440|524038969|FG006|Overall Study|Death|1|||
145324913|NCT01207440|524038963|FG000|Overall Study|Lack of Efficacy|13|||
145324914|NCT01207440|524038964|FG001|Overall Study|Lack of Efficacy|2|||
145324915|NCT01207440|524038965|FG002|Overall Study|Lack of Efficacy|5|||
145324916|NCT01207440|524038966|FG003|Overall Study|Lack of Efficacy|1|||
145324917|NCT01207440|524038967|FG004|Overall Study|Lack of Efficacy|2|||
145324918|NCT01207440|524038968|FG005|Overall Study|Lack of Efficacy|3|||
145324919|NCT01207440|524038969|FG006|Overall Study|Lack of Efficacy|0|||
145324920|NCT01207440|524038963|FG000|Overall Study|Lost to Follow-up|0|||
145324921|NCT01207440|524038964|FG001|Overall Study|Lost to Follow-up|0|||
145324922|NCT01207440|524038965|FG002|Overall Study|Lost to Follow-up|2|||
145324923|NCT01207440|524038966|FG003|Overall Study|Lost to Follow-up|1|||
145324924|NCT01207440|524038967|FG004|Overall Study|Lost to Follow-up|0|||
145324925|NCT01207440|524038968|FG005|Overall Study|Lost to Follow-up|0|||
145324926|NCT01207440|524038969|FG006|Overall Study|Lost to Follow-up|0|||
145324927|NCT01207440|524038963|FG000|Overall Study|Non-compliance with Study Drug|3|||
145324928|NCT01207440|524038964|FG001|Overall Study|Non-compliance with Study Drug|0|||
145324929|NCT01207440|524038965|FG002|Overall Study|Non-compliance with Study Drug|1|||
145324930|NCT01207440|524038966|FG003|Overall Study|Non-compliance with Study Drug|0|||
145412048|NCT01078662|524362167|FG000|Overall Study|Withdrawal by Subject|4|||
145570843|NCT03013543|524950041|FG004|Overall Study|Lost to Follow-up|0|||
145570844|NCT03013543|524950042|FG005|Overall Study|Lost to Follow-up|0|||
145570845|NCT03013543|524950043|FG006|Overall Study|Lost to Follow-up|1|||
145570846|NCT03013543|524950044|FG007|Overall Study|Lost to Follow-up|0|||
145570847|NCT03013543|524950045|FG008|Overall Study|Lost to Follow-up|0|||
145570848|NCT03013543|524950046|FG009|Overall Study|Lost to Follow-up|2|||
145570849|NCT03013543|524950037|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145570850|NCT03013543|524950038|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145570851|NCT03013543|524950039|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145570852|NCT03013543|524950040|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145570853|NCT03013543|524950041|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145570854|NCT03013543|524950042|FG005|Overall Study|Non-Compliance With Study Drug|0|||
145570855|NCT03013543|524950043|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145570856|NCT03013543|524950044|FG007|Overall Study|Non-Compliance With Study Drug|0|||
145570857|NCT03013543|524950045|FG008|Overall Study|Non-Compliance With Study Drug|1|||
145570858|NCT03013543|524950046|FG009|Overall Study|Non-Compliance With Study Drug|0|||
145570859|NCT03013543|524950037|FG000|Overall Study|Physician Decision|0|||
145570860|NCT03013543|524950038|FG001|Overall Study|Physician Decision|0|||
145570861|NCT03013543|524950039|FG002|Overall Study|Physician Decision|0|||
145570862|NCT03013543|524950040|FG003|Overall Study|Physician Decision|0|||
145570863|NCT03013543|524950041|FG004|Overall Study|Physician Decision|1|||
145570864|NCT03013543|524950042|FG005|Overall Study|Physician Decision|0|||
145570865|NCT03013543|524950043|FG006|Overall Study|Physician Decision|0|||
145570866|NCT03013543|524950044|FG007|Overall Study|Physician Decision|0|||
145570867|NCT03013543|524950045|FG008|Overall Study|Physician Decision|0|||
145570868|NCT03013543|524950046|FG009|Overall Study|Physician Decision|0|||
145570869|NCT03013543|524950037|FG000|Overall Study|Protocol Violation|0|||
145570870|NCT03013543|524950038|FG001|Overall Study|Protocol Violation|0|||
145570871|NCT03013543|524950039|FG002|Overall Study|Protocol Violation|0|||
145570872|NCT03013543|524950040|FG003|Overall Study|Protocol Violation|0|||
145570873|NCT03013543|524950041|FG004|Overall Study|Protocol Violation|0|||
145324931|NCT01207440|524038967|FG004|Overall Study|Non-compliance with Study Drug|0|||
145570874|NCT03013543|524950042|FG005|Overall Study|Protocol Violation|0|||
145570875|NCT03013543|524950043|FG006|Overall Study|Protocol Violation|0|||
145570876|NCT03013543|524950044|FG007|Overall Study|Protocol Violation|0|||
145324932|NCT01207440|524038968|FG005|Overall Study|Non-compliance with Study Drug|0|||
145324933|NCT01207440|524038969|FG006|Overall Study|Non-compliance with Study Drug|0|||
145412049|NCT01078662|524362168|FG001|Overall Study|Withdrawal by Subject|11|||
145324934|NCT01207440|524038963|FG000|Overall Study|Physician Decision|6|||
145324935|NCT01207440|524038964|FG001|Overall Study|Physician Decision|5|||
145570877|NCT03013543|524950045|FG008|Overall Study|Protocol Violation|0|||
145620612|NCT03621982|525125126|FG002|Overall Study|Withdrawal by Subject|0|||
145620613|NCT03621982|525125127|FG003|Overall Study|Withdrawal by Subject|1|||
145324936|NCT01207440|524038965|FG002|Overall Study|Physician Decision|5|||
145324937|NCT01207440|524038966|FG003|Overall Study|Physician Decision|0|||
145324938|NCT01207440|524038967|FG004|Overall Study|Physician Decision|1|||
145324939|NCT01207440|524038968|FG005|Overall Study|Physician Decision|0|||
145324940|NCT01207440|524038969|FG006|Overall Study|Physician Decision|0|||
145324941|NCT01207440|524038963|FG000|Overall Study|Progressive Disease|19|||
145324942|NCT01207440|524038964|FG001|Overall Study|Progressive Disease|10|||
145324943|NCT01207440|524038965|FG002|Overall Study|Progressive Disease|19|||
145324944|NCT01207440|524038966|FG003|Overall Study|Progressive Disease|7|||
145324945|NCT01207440|524038967|FG004|Overall Study|Progressive Disease|23|||
145324946|NCT01207440|524038968|FG005|Overall Study|Progressive Disease|27|||
145324947|NCT01207440|524038969|FG006|Overall Study|Progressive Disease|0|||
145324948|NCT01207440|524038963|FG000|Overall Study|Protocol Violation|2|||
145324949|NCT01207440|524038964|FG001|Overall Study|Protocol Violation|0|||
145324950|NCT01207440|524038965|FG002|Overall Study|Protocol Violation|0|||
145324951|NCT01207440|524038966|FG003|Overall Study|Protocol Violation|0|||
145324952|NCT01207440|524038967|FG004|Overall Study|Protocol Violation|0|||
145324953|NCT01207440|524038968|FG005|Overall Study|Protocol Violation|0|||
145324954|NCT01207440|524038969|FG006|Overall Study|Protocol Violation|0|||
145324955|NCT01207440|524038963|FG000|Overall Study|Site Terminated by Sponsor|69|||
145324956|NCT01207440|524038964|FG001|Overall Study|Site Terminated by Sponsor|19|||
145324957|NCT01207440|524038965|FG002|Overall Study|Site Terminated by Sponsor|12|||
145324958|NCT01207440|524038966|FG003|Overall Study|Site Terminated by Sponsor|2|||
145324959|NCT01207440|524038967|FG004|Overall Study|Site Terminated by Sponsor|3|||
145324960|NCT01207440|524038968|FG005|Overall Study|Site Terminated by Sponsor|0|||
145324961|NCT01207440|524038969|FG006|Overall Study|Site Terminated by Sponsor|2|||
145324962|NCT01207440|524038963|FG000|Overall Study|Withdrawal by Subject|29|||
145324963|NCT01207440|524038964|FG001|Overall Study|Withdrawal by Subject|4|||
145324964|NCT01207440|524038965|FG002|Overall Study|Withdrawal by Subject|5|||
145324965|NCT01207440|524038966|FG003|Overall Study|Withdrawal by Subject|3|||
145324966|NCT01207440|524038967|FG004|Overall Study|Withdrawal by Subject|2|||
145324967|NCT01207440|524038968|FG005|Overall Study|Withdrawal by Subject|2|||
145324968|NCT01207440|524038969|FG006|Overall Study|Withdrawal by Subject|0|||
145324969|NCT01207440|524038963|FG000|Overall Study|Reason Not Specified|10|||
145324970|NCT01207440|524038964|FG001|Overall Study|Reason Not Specified|10|||
145324971|NCT01207440|524038965|FG002|Overall Study|Reason Not Specified|7|||
145324972|NCT01207440|524038966|FG003|Overall Study|Reason Not Specified|0|||
145324973|NCT01207440|524038967|FG004|Overall Study|Reason Not Specified|4|||
145324974|NCT01207440|524038968|FG005|Overall Study|Reason Not Specified|3|||
145324975|NCT01207440|524038969|FG006|Overall Study|Reason Not Specified|0|||
145324976|NCT03341000|524038970|FG000|Overall Study|Adverse Event|1|||
145324977|NCT01592721|524038971|FG000|Long-term Follow-up|Death|1|||
145324978|NCT02148913|524038978|FG000|Overall Study|Death|0|||
145324979|NCT02148913|524038979|FG001|Overall Study|Death|1|||
145324980|NCT02148913|524038980|FG002|Overall Study|Death|0|||
145324981|NCT02148913|524038981|FG003|Overall Study|Death|0|||
145324982|NCT01287039|524038982|FG000|Overall Study|Noncompliance with study procedures|0|||
145324983|NCT01287039|524038983|FG001|Overall Study|Noncompliance with study procedures|1|||
145324984|NCT01287039|524038982|FG000|Overall Study|Change of location/residence|0|||
145324985|NCT01287039|524038983|FG001|Overall Study|Change of location/residence|3|||
145324986|NCT01287039|524038982|FG000|Overall Study|Elective surgery|0|||
145324987|NCT01287039|524038983|FG001|Overall Study|Elective surgery|1|||
145324988|NCT01287039|524038982|FG000|Overall Study|Protocol Violation|2|||
145324989|NCT01287039|524038983|FG001|Overall Study|Protocol Violation|3|||
145324990|NCT01287039|524038982|FG000|Overall Study|Excluded medication taken|1|||
145324991|NCT01287039|524038983|FG001|Overall Study|Excluded medication taken|0|||
145324992|NCT01287039|524038982|FG000|Overall Study|Noncompliance with study medication|0|||
145324993|NCT01287039|524038983|FG001|Overall Study|Noncompliance with study medication|1|||
145324994|NCT01287039|524038982|FG000|Overall Study|Problem with travel|0|||
145324995|NCT01287039|524038983|FG001|Overall Study|Problem with travel|1|||
145324996|NCT01287039|524038982|FG000|Overall Study|Death|1|||
145620614|NCT03621982|525125128|FG004|Overall Study|Withdrawal by Subject|0|||
145324997|NCT01287039|524038983|FG001|Overall Study|Death|0|||
145324998|NCT01287039|524038982|FG000|Overall Study|Change of residence|1|||
145324999|NCT01287039|524038983|FG001|Overall Study|Change of residence|0|||
145325000|NCT01287039|524038982|FG000|Overall Study|Adverse Event|7|||
145325001|NCT01287039|524038983|FG001|Overall Study|Adverse Event|4|||
145620615|NCT03621982|525125129|FG005|Overall Study|Withdrawal by Subject|1|||
145325002|NCT01287039|524038982|FG000|Overall Study|Withdrawal by Subject|14|||
145325003|NCT01287039|524038983|FG001|Overall Study|Withdrawal by Subject|11|||
145620616|NCT03621982|525125130|FG006|Overall Study|Withdrawal by Subject|1|||
145620617|NCT03621982|525125131|FG007|Overall Study|Withdrawal by Subject|0|||
145325004|NCT01287039|524038982|FG000|Overall Study|Lost to Follow-up|3|||
145325005|NCT01287039|524038983|FG001|Overall Study|Lost to Follow-up|2|||
145620618|NCT03621982|525125132|FG008|Overall Study|Withdrawal by Subject|1|||
145325006|NCT04109313|524038984|FG000|Overall Study|Pregnancy|1|||
145325007|NCT04109313|524038984|FG000|Overall Study|Adverse Event|11|||
145325008|NCT04109313|524038984|FG000|Overall Study|Lack of Efficacy|11|||
145325009|NCT04109313|524038984|FG000|Overall Study|Lost to Follow-up|1|||
145325010|NCT04109313|524038984|FG000|Overall Study|Physician Decision|2|||
145325011|NCT04109313|524038984|FG000|Overall Study|Subject Decision|13|||
145325012|NCT04109313|524038984|FG000|Overall Study|Covid-19 situation|2|||
145325013|NCT01272921|524038985|FG000|Overall Study|Protocol Violation|2|||
145325014|NCT01272921|524038986|FG001|Overall Study|Protocol Violation|1|||
145325015|NCT01132664|524038987|FG000|Phase lb|Adverse Event|0|||
145325016|NCT01132664|524038988|FG001|Phase lb|Adverse Event|1|||
145325017|NCT01132664|524038989|FG002|Phase lb|Adverse Event|0|||
145325018|NCT01132664|524038990|FG003|Phase lb|Adverse Event|0|||
145325019|NCT01132664|524038991|FG004|Phase lb|Adverse Event|0|||
145325020|NCT01132664|524038987|FG000|Phase lb|Withdrawal by Subject|1|||
145325021|NCT01132664|524038988|FG001|Phase lb|Withdrawal by Subject|2|||
145325022|NCT01132664|524038989|FG002|Phase lb|Withdrawal by Subject|0|||
145325023|NCT01132664|524038990|FG003|Phase lb|Withdrawal by Subject|0|||
145325024|NCT01132664|524038991|FG004|Phase lb|Withdrawal by Subject|0|||
145325025|NCT01132664|524038987|FG000|Phase lb|Disease Progression|4|||
145325026|NCT01132664|524038988|FG001|Phase lb|Disease Progression|9|||
145325027|NCT01132664|524038989|FG002|Phase lb|Disease Progression|0|||
145325028|NCT01132664|524038990|FG003|Phase lb|Disease Progression|0|||
145325029|NCT01132664|524038991|FG004|Phase lb|Disease Progression|0|||
145325030|NCT01132664|524038987|FG000|Phase ll|Death|0|||
145325031|NCT01132664|524038988|FG001|Phase ll|Death|0|||
145325032|NCT01132664|524038989|FG002|Phase ll|Death|2|||
145325033|NCT01132664|524038990|FG003|Phase ll|Death|0|||
145325034|NCT01132664|524038991|FG004|Phase ll|Death|0|||
145325035|NCT01132664|524038987|FG000|Phase ll|Adverse Event|0|||
145325036|NCT01132664|524038988|FG001|Phase ll|Adverse Event|0|||
145325037|NCT01132664|524038989|FG002|Phase ll|Adverse Event|10|||
145325038|NCT01132664|524038990|FG003|Phase ll|Adverse Event|0|||
145325039|NCT01132664|524038991|FG004|Phase ll|Adverse Event|0|||
145325040|NCT01132664|524038987|FG000|Phase ll|Withdrawal by Subject|0|||
145325041|NCT01132664|524038988|FG001|Phase ll|Withdrawal by Subject|0|||
145325042|NCT01132664|524038989|FG002|Phase ll|Withdrawal by Subject|3|||
145325043|NCT01132664|524038990|FG003|Phase ll|Withdrawal by Subject|0|||
145325044|NCT01132664|524038991|FG004|Phase ll|Withdrawal by Subject|0|||
145325045|NCT01132664|524038987|FG000|Phase ll|Disease progression|0|||
145325046|NCT01132664|524038988|FG001|Phase ll|Disease progression|0|||
145325047|NCT01132664|524038989|FG002|Phase ll|Disease progression|35|||
145325048|NCT01132664|524038990|FG003|Phase ll|Disease progression|0|||
145325049|NCT01132664|524038991|FG004|Phase ll|Disease progression|0|||
145325050|NCT01132664|524038987|FG000|BM Cohort|Disease progression|0|||
145325051|NCT01132664|524038988|FG001|BM Cohort|Disease progression|0|||
145325052|NCT01132664|524038989|FG002|BM Cohort|Disease progression|0|||
145325053|NCT01132664|524038990|FG003|BM Cohort|Disease progression|3|||
145325054|NCT01132664|524038991|FG004|BM Cohort|Disease progression|4|||
145325055|NCT01132664|524038987|FG000|BM Cohort|Adverse Event|0|||
145325056|NCT01132664|524038988|FG001|BM Cohort|Adverse Event|0|||
145325057|NCT01132664|524038989|FG002|BM Cohort|Adverse Event|0|||
145325058|NCT01132664|524038990|FG003|BM Cohort|Adverse Event|0|||
145325059|NCT01132664|524038991|FG004|BM Cohort|Adverse Event|1|||
145325060|NCT01132664|524038987|FG000|BM Cohort|Withdrawal by Subject|0|||
145325061|NCT01132664|524038988|FG001|BM Cohort|Withdrawal by Subject|0|||
145325062|NCT01132664|524038989|FG002|BM Cohort|Withdrawal by Subject|0|||
145325063|NCT01132664|524038990|FG003|BM Cohort|Withdrawal by Subject|0|||
145325064|NCT01132664|524038991|FG004|BM Cohort|Withdrawal by Subject|1|||
145325065|NCT02113189|524038993|FG000|Overall Study|Lost to follow up|2|||
145325066|NCT02113189|524038994|FG001|Overall Study|Lost to follow up|1|||
145570878|NCT03013543|524950046|FG009|Overall Study|Protocol Violation|1|||
145570879|NCT01120210|524950051|FG000|MAIN INFUSION|Adverse Event|1|||
145570880|NCT01120210|524950052|FG001|MAIN INFUSION|Adverse Event|0|||
145325067|NCT02113189|524038995|FG002|Overall Study|Lost to follow up|3|||
145325068|NCT05016622|524038996|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
145325069|NCT05016622|524038996|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
145325070|NCT02954159|524038997|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
145325071|NCT02954159|524038998|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
145325072|NCT02954159|524038997|FG000|Overall Study|Withdrawal by Subject|0|||
145325073|NCT02954159|524038998|FG001|Overall Study|Withdrawal by Subject|1|||
145325074|NCT02581163|524039000|FG000|Overall Study|Failure to return|15|||
145325075|NCT02581163|524039000|FG000|Overall Study|Insufficient virological response|3|||
145325076|NCT02581163|524039000|FG000|Overall Study|Withdrew consent|1|||
145325077|NCT02581163|524039000|FG000|Overall Study|Death|1|||
145325078|NCT02581163|524039000|FG000|Overall Study|Other, not specified|9|||
145325079|NCT00262041|524039001|FG000|Overall Study|Withdrawal by Subject|0|||
145325080|NCT00262041|524039002|FG001|Overall Study|Withdrawal by Subject|3|||
145325081|NCT00262041|524039003|FG002|Overall Study|Withdrawal by Subject|1|||
145325082|NCT00262041|524039001|FG000|Overall Study|Lost to Follow-up|1|||
145325083|NCT00262041|524039002|FG001|Overall Study|Lost to Follow-up|1|||
145325084|NCT00262041|524039003|FG002|Overall Study|Lost to Follow-up|5|||
145412050|NCT01078662|524362169|FG002|Overall Study|Withdrawal by Subject|1|||
145325085|NCT00262041|524039001|FG000|Overall Study|Unable to classify|1|||
145325086|NCT00262041|524039002|FG001|Overall Study|Unable to classify|0|||
145325087|NCT00262041|524039003|FG002|Overall Study|Unable to classify|0|||
145325088|NCT03578237|524039006|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
145325089|NCT03578237|524039007|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
145325090|NCT01173471|524039008|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145325091|NCT01173471|524039009|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145325092|NCT01173471|524039010|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145325093|NCT01173471|524039011|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145325094|NCT01173471|524039008|FG000|Overall Study|Condition under investigation worsened|2|||
145325095|NCT01173471|524039009|FG001|Overall Study|Condition under investigation worsened|0|||
145325096|NCT01173471|524039010|FG002|Overall Study|Condition under investigation worsened|0|||
145325097|NCT01173471|524039011|FG003|Overall Study|Condition under investigation worsened|0|||
145325098|NCT01173471|524039008|FG000|Overall Study|Lost to Follow-up|0|||
145325099|NCT01173471|524039009|FG001|Overall Study|Lost to Follow-up|0|||
145325100|NCT01173471|524039010|FG002|Overall Study|Lost to Follow-up|1|||
145325101|NCT01173471|524039011|FG003|Overall Study|Lost to Follow-up|0|||
145325102|NCT01173471|524039008|FG000|Overall Study|Reason given as Other|0|||
145325103|NCT01173471|524039009|FG001|Overall Study|Reason given as Other|0|||
145325104|NCT01173471|524039010|FG002|Overall Study|Reason given as Other|1|||
145325105|NCT01173471|524039011|FG003|Overall Study|Reason given as Other|0|||
145325106|NCT04132336|524039012|FG000|Overall Study|Investigator Decision|0|||
145325107|NCT04132336|524039013|FG001|Overall Study|Investigator Decision|1|||
145325108|NCT04132336|524039014|FG002|Overall Study|Investigator Decision|0|||
145325109|NCT04132336|524039015|FG003|Overall Study|Investigator Decision|0|||
145325110|NCT04132336|524039016|FG004|Overall Study|Investigator Decision|0|||
145325111|NCT04132336|524039017|FG005|Overall Study|Investigator Decision|0|||
145325112|NCT04132336|524039018|FG006|Overall Study|Investigator Decision|0|||
145325113|NCT02488330|524039020|FG000|Overall Study|Adverse Event|1|||
145325114|NCT02488330|524039020|FG000|Overall Study|Physician Decision|2|||
145325115|NCT02488330|524039020|FG000|Overall Study|Death|2|||
145325116|NCT02488330|524039020|FG000|Overall Study|Disease Progression|3|||
145325117|NCT02488330|524039020|FG000|Overall Study|Study Termination by Sponsor|4|||
145325118|NCT00584844|524039021|FG000|Overall Study|Withdrawal by Subject|59|||
145325119|NCT00584844|524039021|FG000|Overall Study|Screen Failure|20|||
145325120|NCT01206816|524039024|FG000|Overall Study|Protocol Violation|0|||
145325121|NCT01206816|524039025|FG001|Overall Study|Protocol Violation|0|||
145325122|NCT01206816|524039026|FG002|Overall Study|Protocol Violation|1|||
145325123|NCT01206816|524039027|FG003|Overall Study|Protocol Violation|0|||
145325124|NCT01206816|524039028|FG004|Overall Study|Protocol Violation|0|||
145325125|NCT01206816|524039029|FG005|Overall Study|Protocol Violation|0|||
145325126|NCT01206816|524039030|FG006|Overall Study|Protocol Violation|0|||
145325127|NCT01206816|524039024|FG000|Overall Study|Withdrawal by Subject|0|||
145325128|NCT01206816|524039025|FG001|Overall Study|Withdrawal by Subject|0|||
145325129|NCT01206816|524039026|FG002|Overall Study|Withdrawal by Subject|1|||
145325130|NCT01206816|524039027|FG003|Overall Study|Withdrawal by Subject|0|||
145325131|NCT01206816|524039028|FG004|Overall Study|Withdrawal by Subject|0|||
145325132|NCT01206816|524039029|FG005|Overall Study|Withdrawal by Subject|0|||
145325133|NCT01206816|524039030|FG006|Overall Study|Withdrawal by Subject|0|||
145325134|NCT01206816|524039024|FG000|Overall Study|Progressive disease|3|||
145325135|NCT01206816|524039025|FG001|Overall Study|Progressive disease|3|||
145325136|NCT01206816|524039026|FG002|Overall Study|Progressive disease|13|||
145325137|NCT01206816|524039027|FG003|Overall Study|Progressive disease|3|||
145325138|NCT01206816|524039028|FG004|Overall Study|Progressive disease|3|||
145325139|NCT01206816|524039029|FG005|Overall Study|Progressive disease|16|||
145325140|NCT01206816|524039030|FG006|Overall Study|Progressive disease|3|||
145325141|NCT01206816|524039024|FG000|Overall Study|Other AE|0|||
145325142|NCT01206816|524039025|FG001|Overall Study|Other AE|0|||
145325143|NCT01206816|524039026|FG002|Overall Study|Other AE|4|||
145325144|NCT01206816|524039027|FG003|Overall Study|Other AE|0|||
145325145|NCT01206816|524039028|FG004|Overall Study|Other AE|0|||
145325146|NCT01206816|524039029|FG005|Overall Study|Other AE|3|||
145325147|NCT01206816|524039030|FG006|Overall Study|Other AE|2|||
145325148|NCT01206816|524039024|FG000|Overall Study|other than stated above|0|||
145325149|NCT01206816|524039025|FG001|Overall Study|other than stated above|0|||
145325150|NCT01206816|524039026|FG002|Overall Study|other than stated above|1|||
145325151|NCT01206816|524039027|FG003|Overall Study|other than stated above|0|||
145325152|NCT01206816|524039028|FG004|Overall Study|other than stated above|0|||
145325153|NCT01206816|524039029|FG005|Overall Study|other than stated above|0|||
145325154|NCT01206816|524039030|FG006|Overall Study|other than stated above|1|||
145325155|NCT01939496|524039031|FG000|Overall Study|Adverse Event|2|||
145325156|NCT01939496|524039032|FG001|Overall Study|Adverse Event|0|||
145325157|NCT01939496|524039033|FG002|Overall Study|Adverse Event|0|||
145325158|NCT01939496|524039031|FG000|Overall Study|Lost to Follow-up|1|||
145412051|NCT01078662|524362170|FG003|Overall Study|Withdrawal by Subject|0|||
145570881|NCT01120210|524950051|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
145325159|NCT01939496|524039032|FG001|Overall Study|Lost to Follow-up|1|||
145325160|NCT01939496|524039033|FG002|Overall Study|Lost to Follow-up|0|||
145325161|NCT01939496|524039031|FG000|Overall Study|Physician Decision|1|||
145325162|NCT01939496|524039032|FG001|Overall Study|Physician Decision|0|||
145325163|NCT01939496|524039033|FG002|Overall Study|Physician Decision|0|||
145325164|NCT01939496|524039031|FG000|Overall Study|Protocol Violation|3|||
145325165|NCT01939496|524039032|FG001|Overall Study|Protocol Violation|0|||
145325166|NCT01939496|524039033|FG002|Overall Study|Protocol Violation|0|||
145325167|NCT01939496|524039031|FG000|Overall Study|Withdrawal by Subject|0|||
145325168|NCT01939496|524039032|FG001|Overall Study|Withdrawal by Subject|1|||
145325169|NCT01939496|524039033|FG002|Overall Study|Withdrawal by Subject|1|||
145325170|NCT01939496|524039031|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
145325171|NCT01939496|524039032|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
145325172|NCT01939496|524039033|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
145325173|NCT01939496|524039031|FG000|Overall Study|Other|2|||
145325174|NCT01939496|524039032|FG001|Overall Study|Other|0|||
145325175|NCT01939496|524039033|FG002|Overall Study|Other|1|||
145325176|NCT03028740|524039034|FG000|Overall Study|Did not Receive Study Drug|4|||
145325177|NCT03028740|524039035|FG001|Overall Study|Did not Receive Study Drug|5|||
145325178|NCT03028740|524039034|FG000|Overall Study|Adverse Event|8|||
145325179|NCT03028740|524039035|FG001|Overall Study|Adverse Event|26|||
145325180|NCT03028740|524039034|FG000|Overall Study|Lack of Efficacy|0|||
145325181|NCT03028740|524039035|FG001|Overall Study|Lack of Efficacy|1|||
145325182|NCT03028740|524039034|FG000|Overall Study|Withdrawal by Subject|48|||
145325183|NCT03028740|524039035|FG001|Overall Study|Withdrawal by Subject|101|||
145325184|NCT03028740|524039034|FG000|Overall Study|Lost to Follow-up|30|||
145325185|NCT03028740|524039035|FG001|Overall Study|Lost to Follow-up|54|||
145325186|NCT03028740|524039034|FG000|Overall Study|Physician Decision|4|||
145325187|NCT03028740|524039035|FG001|Overall Study|Physician Decision|11|||
145325188|NCT03028740|524039034|FG000|Overall Study|Protocol Violation|4|||
145325189|NCT03028740|524039035|FG001|Overall Study|Protocol Violation|8|||
145325190|NCT03028740|524039034|FG000|Overall Study|Non-compliance with Study Drug|0|||
145325191|NCT03028740|524039035|FG001|Overall Study|Non-compliance with Study Drug|2|||
145325192|NCT03028740|524039034|FG000|Overall Study|Study Terminated by Sponsor|467|||
145325193|NCT03028740|524039035|FG001|Overall Study|Study Terminated by Sponsor|917|||
145325194|NCT03028740|524039034|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
145325195|NCT03028740|524039035|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
145325196|NCT03028740|524039034|FG000|Overall Study|Reason not Specified|1|||
145325197|NCT03028740|524039035|FG001|Overall Study|Reason not Specified|5|||
145325198|NCT00171301|524039036|FG000|Overall Study|Death|1|||
145325199|NCT00171301|524039037|FG001|Overall Study|Death|2|||
145325200|NCT00171301|524039036|FG000|Overall Study|Adverse Event|1|||
145325201|NCT00171301|524039037|FG001|Overall Study|Adverse Event|2|||
145325202|NCT00171301|524039036|FG000|Overall Study|Lost to Follow-up|6|||
145325203|NCT00171301|524039037|FG001|Overall Study|Lost to Follow-up|2|||
145325204|NCT00171301|524039036|FG000|Overall Study|Protocol Violation|0|||
145325205|NCT00171301|524039037|FG001|Overall Study|Protocol Violation|2|||
145325206|NCT00171301|524039036|FG000|Overall Study|Withdrawal by Subject|0|||
145325207|NCT00171301|524039037|FG001|Overall Study|Withdrawal by Subject|1|||
145325208|NCT04319159|524039039|FG000|Overall Study|Screening failure|13|||
145325209|NCT04319159|524039039|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
145325210|NCT04319159|524039039|FG000|Overall Study|Withdrawal by Subject|1|||
145325211|NCT02100319|524039042|FG000|Overall Study|Case Report Forms Uncollected|11|||
145325212|NCT02100319|524039042|FG000|Overall Study|Protocol Deviation|5|||
145325213|NCT02370914|524039043|FG000|Overall Study|Protocol Violation|2|||
145325214|NCT02589522|524039046|FG000|Overall Study|Physician Decision|1|||
145325215|NCT02589522|524039047|FG001|Overall Study|Physician Decision|2|||
145325216|NCT02589522|524039048|FG002|Overall Study|Physician Decision|0|||
145325217|NCT02589522|524039046|FG000|Overall Study|Did not start treatment|1|||
145325218|NCT02589522|524039047|FG001|Overall Study|Did not start treatment|0|||
145325219|NCT02589522|524039048|FG002|Overall Study|Did not start treatment|0|||
145325220|NCT01478828|524039049|FG000|Overall Study|Adverse Event|1|||
145325221|NCT00754442|524039050|FG000|Overall Study|Withdrawal by Subject|5|||
145570882|NCT01120210|524950052|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
145570883|NCT02043015|524950063|FG000|Overall Study|Lost to Follow-up|4|||
145570884|NCT02043015|524950063|FG000|Overall Study|Withdrawal by Subject|4|||
145325222|NCT00754442|524039051|FG001|Overall Study|Withdrawal by Subject|3|||
145325223|NCT05611996|524039052|FG000|Overall Study|Ineligible|1|||
145325224|NCT05611996|524039052|FG000|Overall Study|Withdrawal by Subject|9|||
145325225|NCT04479475|524039053|FG000|Overall Study|Withdrawal by Subject|7|||
145325226|NCT02025010|524039054|FG000|Overall Study|Symptomatic or radiographic progression|36|||
145325227|NCT02025010|524039054|FG000|Overall Study|Adverse Event|6|||
145325228|NCT02025010|524039054|FG000|Overall Study|Physician Decision|7|||
145325229|NCT02025010|524039054|FG000|Overall Study|Withdrawal by Subject|3|||
145325230|NCT02025010|524039054|FG000|Overall Study|Intercurrent illness|3|||
145325231|NCT02025010|524039054|FG000|Overall Study|Patients still on treatment|3|||
145325232|NCT02025010|524039054|FG000|Overall Study|Never initiate the treatment|2|||
145325233|NCT05560763|524039055|FG000|Overall Study|Withdrawal by Subject|4|||
145325234|NCT00296491|524039057|FG000|Overall Study|Low Pollen Counts|18|||
145325235|NCT00296491|524039058|FG001|Overall Study|Low Pollen Counts|26|||
145325236|NCT00296491|524039059|FG002|Overall Study|Low Pollen Counts|25|||
145325237|NCT00296491|524039060|FG003|Overall Study|Low Pollen Counts|16|||
145325238|NCT00296491|524039057|FG000|Overall Study|Protocol Violation|4|||
145325239|NCT00296491|524039058|FG001|Overall Study|Protocol Violation|6|||
145325240|NCT00296491|524039059|FG002|Overall Study|Protocol Violation|2|||
145325241|NCT00296491|524039060|FG003|Overall Study|Protocol Violation|3|||
145325242|NCT00296491|524039057|FG000|Overall Study|Adverse Event|1|||
145325243|NCT00296491|524039058|FG001|Overall Study|Adverse Event|3|||
145325244|NCT00296491|524039059|FG002|Overall Study|Adverse Event|1|||
145325245|NCT00296491|524039060|FG003|Overall Study|Adverse Event|4|||
145325246|NCT00296491|524039057|FG000|Overall Study|Withdrawn due to Asthma|0|||
145325247|NCT00296491|524039058|FG001|Overall Study|Withdrawn due to Asthma|0|||
145325248|NCT00296491|524039059|FG002|Overall Study|Withdrawn due to Asthma|0|||
145325249|NCT00296491|524039060|FG003|Overall Study|Withdrawn due to Asthma|4|||
145325250|NCT00296491|524039057|FG000|Overall Study|Withdrawal by Subject|7|||
145325251|NCT00296491|524039058|FG001|Overall Study|Withdrawal by Subject|3|||
145325252|NCT00296491|524039059|FG002|Overall Study|Withdrawal by Subject|3|||
145325253|NCT00296491|524039060|FG003|Overall Study|Withdrawal by Subject|2|||
145325254|NCT00296491|524039057|FG000|Overall Study|Non-Compliance|12|||
145325255|NCT00296491|524039058|FG001|Overall Study|Non-Compliance|13|||
145325256|NCT00296491|524039059|FG002|Overall Study|Non-Compliance|10|||
145325257|NCT00296491|524039060|FG003|Overall Study|Non-Compliance|14|||
145325258|NCT00296491|524039057|FG000|Overall Study|Lost to Follow-up|0|||
145325259|NCT00296491|524039058|FG001|Overall Study|Lost to Follow-up|2|||
145325260|NCT00296491|524039059|FG002|Overall Study|Lost to Follow-up|2|||
145325261|NCT00296491|524039060|FG003|Overall Study|Lost to Follow-up|0|||
145325262|NCT01300052|524039063|FG000|Overall Study|Adverse Event|3|||
145325263|NCT01300052|524039064|FG001|Overall Study|Adverse Event|0|||
145325264|NCT01300052|524039063|FG000|Overall Study|Withdrawal by Subject|2|||
145325265|NCT01300052|524039064|FG001|Overall Study|Withdrawal by Subject|2|||
145325266|NCT01300052|524039063|FG000|Overall Study|Protocol Violation|1|||
145325267|NCT01300052|524039064|FG001|Overall Study|Protocol Violation|1|||
145325268|NCT06972251|524039065|FG000|Overall Study|Withdrawal by Subject|1|||
145325269|NCT06972251|524039066|FG001|Overall Study|Withdrawal by Subject|0|||
145325270|NCT06972251|524039065|FG000|Overall Study|Lost to Follow-up|10|||
145325271|NCT06972251|524039066|FG001|Overall Study|Lost to Follow-up|2|||
145325272|NCT03451006|524039067|FG000|Overall Study|Withdrawal by Subject|2|||
145325273|NCT03451006|524039068|FG001|Overall Study|Withdrawal by Subject|2|||
145325274|NCT00949988|524039069|FG000|Overall Study|Withdrawal by Subject|3|||
145325275|NCT01929395|524039070|FG000|Overall Study|Did not complete - non-related toxicity|1|||
145325276|NCT01929395|524039071|FG001|Overall Study|Did not complete - non-related toxicity|0|||
145325277|NCT01929395|524039072|FG002|Overall Study|Did not complete - non-related toxicity|0|||
145325278|NCT01929395|524039070|FG000|Overall Study|Withdrawal by Subject|0|||
145325279|NCT01929395|524039071|FG001|Overall Study|Withdrawal by Subject|1|||
145325280|NCT01929395|524039072|FG002|Overall Study|Withdrawal by Subject|0|||
145325281|NCT01929395|524039070|FG000|Overall Study|Screen Fail|0|||
145325282|NCT01929395|524039071|FG001|Overall Study|Screen Fail|0|||
145325283|NCT01929395|524039072|FG002|Overall Study|Screen Fail|1|||
145325284|NCT02547766|524039073|FG000|Overall Study|Withdrawal by Subject|1|||
145325285|NCT00484419|524039077|FG000|Overall Study|Adverse Event|3|||
145412052|NCT01078662|524362171|FG004|Overall Study|Withdrawal by Subject|0|||
145412053|NCT01078662|524362167|FG000|Overall Study|Protocol Violation|0|||
145412054|NCT01078662|524362168|FG001|Overall Study|Protocol Violation|1|||
145412055|NCT01078662|524362169|FG002|Overall Study|Protocol Violation|0|||
145412056|NCT01078662|524362170|FG003|Overall Study|Protocol Violation|0|||
145412057|NCT01078662|524362171|FG004|Overall Study|Protocol Violation|0|||
145412058|NCT01078662|524362167|FG000|Overall Study|Lost to Follow-up|1|||
145412059|NCT01078662|524362168|FG001|Overall Study|Lost to Follow-up|0|||
145325286|NCT00484419|524039078|FG001|Overall Study|Adverse Event|0|||
145325287|NCT00484419|524039079|FG002|Overall Study|Adverse Event|0|||
145325288|NCT00484419|524039077|FG000|Overall Study|Lost to Follow-up|1|||
145325289|NCT00484419|524039078|FG001|Overall Study|Lost to Follow-up|0|||
145325290|NCT00484419|524039079|FG002|Overall Study|Lost to Follow-up|2|||
145325291|NCT00484419|524039077|FG000|Overall Study|Withdrawal by Subject|3|||
145325292|NCT00484419|524039078|FG001|Overall Study|Withdrawal by Subject|1|||
145412060|NCT01078662|524362169|FG002|Overall Study|Lost to Follow-up|0|||
145325293|NCT00484419|524039079|FG002|Overall Study|Withdrawal by Subject|1|||
145412061|NCT01078662|524362170|FG003|Overall Study|Lost to Follow-up|0|||
145325294|NCT00484419|524039077|FG000|Overall Study|subject met discontinuation criteria|2|||
145325295|NCT00484419|524039078|FG001|Overall Study|subject met discontinuation criteria|2|||
145325296|NCT00484419|524039079|FG002|Overall Study|subject met discontinuation criteria|4|||
145325297|NCT00484419|524039077|FG000|Overall Study|required restricted medication|1|||
145325298|NCT00484419|524039078|FG001|Overall Study|required restricted medication|0|||
145412062|NCT01078662|524362171|FG004|Overall Study|Lost to Follow-up|0|||
145325299|NCT00484419|524039079|FG002|Overall Study|required restricted medication|1|||
145325300|NCT00484419|524039077|FG000|Overall Study|Physician Decision|1|||
145325301|NCT00484419|524039078|FG001|Overall Study|Physician Decision|1|||
145325302|NCT00484419|524039079|FG002|Overall Study|Physician Decision|1|||
145325303|NCT00484419|524039077|FG000|Overall Study|subject unable to receive medication|1|||
145325304|NCT00484419|524039078|FG001|Overall Study|subject unable to receive medication|0|||
145325305|NCT00484419|524039079|FG002|Overall Study|subject unable to receive medication|0|||
145325306|NCT00484419|524039077|FG000|Overall Study|subject relocated|0|||
145325307|NCT00484419|524039078|FG001|Overall Study|subject relocated|1|||
145325308|NCT00484419|524039079|FG002|Overall Study|subject relocated|0|||
145325309|NCT00484419|524039077|FG000|Overall Study|sponsor decision, randomized in error|0|||
145325310|NCT00484419|524039078|FG001|Overall Study|sponsor decision, randomized in error|0|||
145325311|NCT00484419|524039079|FG002|Overall Study|sponsor decision, randomized in error|2|||
145325312|NCT03604341|524039080|FG000|Overall Study|Withdrawal by Subject|1|||
145325313|NCT03604341|524039081|FG001|Overall Study|Withdrawal by Subject|1|||
145325314|NCT03604341|524039080|FG000|Overall Study|Adverse Event|1|||
145325315|NCT03604341|524039081|FG001|Overall Study|Adverse Event|0|||
145325316|NCT03604341|524039080|FG000|Overall Study|Protocol Violation|0|||
145325317|NCT03604341|524039081|FG001|Overall Study|Protocol Violation|1|||
145325318|NCT01829113|524039083|FG000|Overall Study|Disease Progression|37|||
145325319|NCT01829113|524039084|FG001|Overall Study|Disease Progression|48|||
145325320|NCT01829113|524039083|FG000|Overall Study|Adverse Event|14|||
145325321|NCT01829113|524039084|FG001|Overall Study|Adverse Event|10|||
145325322|NCT01829113|524039083|FG000|Overall Study|Withdrawal by Subject|17|||
145325323|NCT01829113|524039084|FG001|Overall Study|Withdrawal by Subject|10|||
145325324|NCT01829113|524039083|FG000|Overall Study|Death|4|||
145325325|NCT01829113|524039084|FG001|Overall Study|Death|6|||
145325326|NCT01829113|524039083|FG000|Overall Study|Sponsor Decision|1|||
145325327|NCT01829113|524039084|FG001|Overall Study|Sponsor Decision|1|||
145325328|NCT01829113|524039083|FG000|Overall Study|No Study Treatment Received|3|||
145325329|NCT01829113|524039084|FG001|Overall Study|No Study Treatment Received|2|||
145325330|NCT01829113|524039083|FG000|Overall Study|Physician Decision|1|||
145325331|NCT01829113|524039084|FG001|Overall Study|Physician Decision|1|||
145325332|NCT00355472|524039085|FG000|Overall Study|Physician Decision|1|||
145325333|NCT05444543|524039092|FG000|Overall Study|Withdrawal by Subject|1|||
145325334|NCT05444543|524039093|FG001|Overall Study|Withdrawal by Subject|0|||
145325335|NCT05444543|524039092|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
145325336|NCT05444543|524039093|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
145325337|NCT05444543|524039092|FG000|Overall Study|Adverse Event|0|||
145325338|NCT05444543|524039093|FG001|Overall Study|Adverse Event|1|||
145325339|NCT05444543|524039092|FG000|Overall Study|Family relocating at a distance from study site|0|||
145325340|NCT05444543|524039093|FG001|Overall Study|Family relocating at a distance from study site|1|||
145325341|NCT03847194|524039094|FG000|Overall Study|Lost to Follow-up|2|||
145325342|NCT03847194|524039095|FG001|Overall Study|Lost to Follow-up|5|||
145325343|NCT03847194|524039094|FG000|Overall Study|Withdrawal by Subject|1|||
145325344|NCT03847194|524039095|FG001|Overall Study|Withdrawal by Subject|2|||
145325345|NCT03847194|524039094|FG000|Overall Study|Death|0|||
145325346|NCT03847194|524039095|FG001|Overall Study|Death|1|||
145325347|NCT01144403|524039097|FG000|Overall Study|Lost to Follow-up|3|||
145325348|NCT01144403|524039097|FG000|Overall Study|Death|1|||
145325349|NCT01144403|524039097|FG000|Overall Study|Adverse Event|1|||
145325350|NCT03891329|524039098|FG000|Overall Study|Death|5|||
145325351|NCT03891329|524039098|FG000|Overall Study|Lost to Follow-up|4|||
145325352|NCT03891329|524039098|FG000|Overall Study|Physician Decision|4|||
145325353|NCT03891329|524039098|FG000|Overall Study|Device explanted|3|||
145325354|NCT03891329|524039098|FG000|Overall Study|No study device implanted|3|||
145325355|NCT02096588|524039099|FG000|Overall Study|Lack of Efficacy|2|||
145325356|NCT02096588|524039100|FG001|Overall Study|Lack of Efficacy|0|||
145325357|NCT02096588|524039099|FG000|Overall Study|Withdrawal by Subject|0|||
145325358|NCT02096588|524039100|FG001|Overall Study|Withdrawal by Subject|1|||
145325359|NCT01258101|524039102|FG000|Overall Study|Adverse Event|5|||
145325360|NCT01258101|524039103|FG001|Overall Study|Adverse Event|6|||
145325361|NCT01258101|524039104|FG002|Overall Study|Adverse Event|0|||
145325362|NCT01258101|524039105|FG003|Overall Study|Adverse Event|0|||
145325363|NCT01258101|524039102|FG000|Overall Study|Extra exclusion criterion amended|2|||
145325364|NCT01258101|524039103|FG001|Overall Study|Extra exclusion criterion amended|1|||
145325365|NCT01258101|524039104|FG002|Overall Study|Extra exclusion criterion amended|1|||
145325366|NCT01258101|524039105|FG003|Overall Study|Extra exclusion criterion amended|1|||
145325367|NCT01258101|524039102|FG000|Overall Study|Informed consent has been withdrawn|2|||
145325368|NCT01258101|524039103|FG001|Overall Study|Informed consent has been withdrawn|2|||
145325369|NCT01258101|524039104|FG002|Overall Study|Informed consent has been withdrawn|1|||
145325370|NCT01258101|524039105|FG003|Overall Study|Informed consent has been withdrawn|1|||
145325371|NCT01258101|524039102|FG000|Overall Study|Patient is not able to attend visits|8|||
145325372|NCT01258101|524039103|FG001|Overall Study|Patient is not able to attend visits|9|||
145325373|NCT01258101|524039104|FG002|Overall Study|Patient is not able to attend visits|7|||
145325374|NCT01258101|524039105|FG003|Overall Study|Patient is not able to attend visits|6|||
145325375|NCT01258101|524039102|FG000|Overall Study|Patient´s compliance|4|||
145325376|NCT01258101|524039103|FG001|Overall Study|Patient´s compliance|3|||
145325377|NCT01258101|524039104|FG002|Overall Study|Patient´s compliance|1|||
145325378|NCT01258101|524039105|FG003|Overall Study|Patient´s compliance|2|||
145325379|NCT01258101|524039102|FG000|Overall Study|Lost to Follow-up|5|||
145325380|NCT01258101|524039103|FG001|Overall Study|Lost to Follow-up|5|||
145325381|NCT01258101|524039104|FG002|Overall Study|Lost to Follow-up|0|||
145325382|NCT01258101|524039105|FG003|Overall Study|Lost to Follow-up|6|||
145325383|NCT01258101|524039102|FG000|Overall Study|PCR positive at week 24|0|||
145325384|NCT01258101|524039103|FG001|Overall Study|PCR positive at week 24|0|||
145325385|NCT01258101|524039104|FG002|Overall Study|PCR positive at week 24|0|||
145325386|NCT01258101|524039105|FG003|Overall Study|PCR positive at week 24|1|||
145325387|NCT01258101|524039102|FG000|Overall Study|Other reason|7|||
145325388|NCT01258101|524039103|FG001|Overall Study|Other reason|8|||
145325389|NCT01258101|524039104|FG002|Overall Study|Other reason|1|||
145325390|NCT01258101|524039105|FG003|Overall Study|Other reason|8|||
145325391|NCT00063882|524039106|FG000|Overall Study|Protocol Violation|3|||
145325392|NCT00063882|524039107|FG001|Overall Study|Protocol Violation|3|||
145325393|NCT00063882|524039106|FG000|Overall Study|Withdrawal by Subject|2|||
145325394|NCT00063882|524039107|FG001|Overall Study|Withdrawal by Subject|1|||
145325395|NCT03438227|524039109|FG000|Overall Study|Withdrawal by Subject|10|||
145325396|NCT03438227|524039110|FG001|Overall Study|Withdrawal by Subject|5|||
145325397|NCT03821272|524040998|FG000|Overall Study|Death|1|||
145325398|NCT03821272|524040999|FG001|Overall Study|Death|0|||
145325399|NCT03821272|524040998|FG000|Overall Study|Physician Decision|1|||
145325400|NCT03821272|524040999|FG001|Overall Study|Physician Decision|0|||
145325401|NCT03821272|524040998|FG000|Overall Study|Withdrawal by Subject|1|||
145325402|NCT03821272|524040999|FG001|Overall Study|Withdrawal by Subject|0|||
145325403|NCT05904769|524041000|FG000|Overall Study|Physician Decision|0|||
145325404|NCT05904769|524041001|FG001|Overall Study|Physician Decision|6|||
145325405|NCT05626803|524041002|FG000|Overall Study|Lost to Follow-up|0|||
145325406|NCT05626803|524041003|FG001|Overall Study|Lost to Follow-up|1|||
145325407|NCT05626803|524041004|FG002|Overall Study|Lost to Follow-up|0|||
145325408|NCT05626803|524041005|FG003|Overall Study|Lost to Follow-up|0|||
145325409|NCT00493246|524041010|FG000|Overall Study|Withdrawal by Subject|0|||
145325410|NCT00493246|524041011|FG001|Overall Study|Withdrawal by Subject|0|||
145325411|NCT00493246|524041012|FG002|Overall Study|Withdrawal by Subject|0|||
145325412|NCT00493246|524041013|FG003|Overall Study|Withdrawal by Subject|0|||
145325413|NCT00493246|524041014|FG004|Overall Study|Withdrawal by Subject|1|||
145325414|NCT00493246|524041015|FG005|Overall Study|Withdrawal by Subject|0|||
145325415|NCT00493246|524041016|FG006|Overall Study|Withdrawal by Subject|0|||
145325416|NCT00493246|524041017|FG007|Overall Study|Withdrawal by Subject|0|||
145325417|NCT00493246|524041010|FG000|Overall Study|No access to draw blood|0|||
145325418|NCT00493246|524041011|FG001|Overall Study|No access to draw blood|0|||
145325419|NCT00493246|524041012|FG002|Overall Study|No access to draw blood|0|||
145325420|NCT00493246|524041013|FG003|Overall Study|No access to draw blood|0|||
145325421|NCT00493246|524041014|FG004|Overall Study|No access to draw blood|0|||
145325422|NCT00493246|524041015|FG005|Overall Study|No access to draw blood|1|||
145325423|NCT00493246|524041016|FG006|Overall Study|No access to draw blood|0|||
145325424|NCT00493246|524041017|FG007|Overall Study|No access to draw blood|0|||
145325425|NCT00493246|524041010|FG000|Overall Study|Lost to Follow-up|0|||
145325426|NCT00493246|524041011|FG001|Overall Study|Lost to Follow-up|0|||
145325427|NCT00493246|524041012|FG002|Overall Study|Lost to Follow-up|0|||
145325428|NCT00493246|524041013|FG003|Overall Study|Lost to Follow-up|0|||
145325429|NCT00493246|524041014|FG004|Overall Study|Lost to Follow-up|0|||
145325430|NCT00493246|524041015|FG005|Overall Study|Lost to Follow-up|0|||
145570885|NCT02043015|524950063|FG000|Overall Study|Removed once target enrollment reached|15|||
145570886|NCT02043015|524950063|FG000|Overall Study|Participant moved away from study city|4|||
145570887|NCT02043015|524950063|FG000|Overall Study|Incarceration|1|||
145570888|NCT01403974|524950064|FG000|Overall Study|Progressive disease according to RECIST|3|||
145570889|NCT01403974|524950065|FG001|Overall Study|Progressive disease according to RECIST|3|||
145325431|NCT00493246|524041016|FG006|Overall Study|Lost to Follow-up|1|||
145570890|NCT01403974|524950066|FG002|Overall Study|Progressive disease according to RECIST|2|||
145570891|NCT01403974|524950067|FG003|Overall Study|Progressive disease according to RECIST|3|||
145325432|NCT00493246|524041017|FG007|Overall Study|Lost to Follow-up|0|||
145325433|NCT00380692|524041023|FG000|Study Period II - Double Blind|Adverse Event|1|||
145412063|NCT03122106|524362172|FG000|Overall Study|Not enough tissue|1|||
145325434|NCT00380692|524041024|FG001|Study Period II - Double Blind|Adverse Event|0|||
145325435|NCT00380692|524041023|FG000|Study Period II - Double Blind|Protocol Violation|2|||
145325436|NCT00380692|524041024|FG001|Study Period II - Double Blind|Protocol Violation|2|||
145325437|NCT00380692|524041023|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
145325438|NCT00380692|524041024|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
145325439|NCT00380692|524041023|FG000|Study Period II - Double Blind|Physician Decision|0|||
145325440|NCT00380692|524041024|FG001|Study Period II - Double Blind|Physician Decision|1|||
145325441|NCT00380692|524041023|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
145325442|NCT00380692|524041024|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
145325443|NCT00380692|524041023|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
145325444|NCT00380692|524041024|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
145325445|NCT00380692|524041023|FG000|Study Period III - Open Label|Adverse Event|5|||
145325446|NCT00380692|524041024|FG001|Study Period III - Open Label|Adverse Event|3|||
145325447|NCT00380692|524041023|FG000|Study Period III - Open Label|Protocol Violation|0|||
145325448|NCT00380692|524041024|FG001|Study Period III - Open Label|Protocol Violation|0|||
145325449|NCT00380692|524041023|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
145325450|NCT00380692|524041024|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
145570892|NCT01403974|524950068|FG004|Overall Study|Progressive disease according to RECIST|3|||
145570893|NCT01403974|524950069|FG005|Overall Study|Progressive disease according to RECIST|2|||
145570894|NCT01403974|524950070|FG006|Overall Study|Progressive disease according to RECIST|3|||
145325451|NCT00380692|524041023|FG000|Study Period III - Open Label|Physician Decision|0|||
145325452|NCT00380692|524041024|FG001|Study Period III - Open Label|Physician Decision|3|||
145325453|NCT00380692|524041023|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
145325454|NCT00380692|524041024|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
145325455|NCT00380692|524041023|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
145325456|NCT00380692|524041024|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
145325457|NCT02698865|524041027|FG000|Overall Study|Other|11|||
145325458|NCT02698865|524041028|FG001|Overall Study|Other|11|||
145325459|NCT02698865|524041027|FG000|Overall Study|Withdrawal by Subject|20|||
145325460|NCT02698865|524041028|FG001|Overall Study|Withdrawal by Subject|16|||
145325461|NCT02698865|524041027|FG000|Overall Study|Physician Decision|0|||
145325462|NCT02698865|524041028|FG001|Overall Study|Physician Decision|4|||
145325463|NCT02698865|524041027|FG000|Overall Study|Lost to Follow-up|4|||
145325464|NCT02698865|524041028|FG001|Overall Study|Lost to Follow-up|2|||
145325465|NCT03861481|524041029|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
145325466|NCT03861481|524041030|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
145325467|NCT03861481|524041029|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
145325468|NCT03861481|524041030|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
145325469|NCT03861481|524041029|FG000|Overall Study|Relapse|1|||
145325470|NCT03861481|524041030|FG001|Overall Study|Relapse|0|||
145325471|NCT03861481|524041029|FG000|Overall Study|Withdrawal by Subject|0|||
145325472|NCT03861481|524041030|FG001|Overall Study|Withdrawal by Subject|1|||
145325473|NCT03861481|524041029|FG000|Overall Study|Lack of Efficacy|4|||
145325474|NCT03861481|524041030|FG001|Overall Study|Lack of Efficacy|5|||
145325475|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
145325476|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
145325477|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
145325478|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
145325479|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
145325480|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
145325481|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
145325482|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
145325483|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
145325484|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
145325485|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
145325486|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
145325487|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
145325488|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
145325489|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
145325490|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
145325491|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145325492|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
145325493|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
145325494|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145325495|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145325496|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145325497|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145325498|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
145325499|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
145325500|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145325501|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145325502|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
145325503|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145325504|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
145412064|NCT03122106|524362172|FG000|Overall Study|Disease progression during screening|2|||
145325505|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
145325506|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
145325507|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
145325508|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
145325509|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
145325510|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
145325511|NCT00773734|524041031|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145325512|NCT00773734|524041032|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145325513|NCT00773734|524041033|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145325514|NCT00773734|524041034|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
145325515|NCT00773734|524041035|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
145325516|NCT00773734|524041036|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
145325517|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145325518|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
145325519|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145325520|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
145325521|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
145325522|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
145325523|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145325524|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
145325525|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
145325526|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
145325527|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145325528|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
145325529|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145325530|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
145325531|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
145325532|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145325533|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
145325534|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
145325535|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145325536|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
145325537|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
145325538|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145325539|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145325540|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
145325541|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
145325542|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145325543|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145325544|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145325545|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
145325546|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
145325547|NCT00773734|524041031|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
145325548|NCT00773734|524041032|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
145325549|NCT00773734|524041033|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
145325550|NCT00773734|524041034|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
145325551|NCT00773734|524041035|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
145325552|NCT00773734|524041036|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
145325553|NCT00773734|524041031|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145325554|NCT00773734|524041032|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145325555|NCT00773734|524041033|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145325556|NCT00773734|524041034|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
145325557|NCT00773734|524041035|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
145325558|NCT00773734|524041036|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
145325559|NCT00773734|524041031|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
145325560|NCT00773734|524041032|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
145325561|NCT00773734|524041033|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
145325562|NCT00773734|524041034|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
145620619|NCT03621982|525125133|FG009|Overall Study|Withdrawal by Subject|0|||
145620620|NCT03621982|525125134|FG010|Overall Study|Withdrawal by Subject|2|||
145620621|NCT03621982|525125135|FG011|Overall Study|Withdrawal by Subject|1|||
145620622|NCT03621982|525125136|FG012|Overall Study|Withdrawal by Subject|2|||
145325563|NCT00773734|524041035|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
145325564|NCT00773734|524041036|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
145325565|NCT00773734|524041031|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
145620623|NCT03621982|525125137|FG013|Overall Study|Withdrawal by Subject|2|||
145620624|NCT03621982|525125124|FG000|Overall Study|Investigator/Sponsor decision|0|||
145620625|NCT03621982|525125125|FG001|Overall Study|Investigator/Sponsor decision|0|||
145325566|NCT00773734|524041032|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
145325567|NCT00773734|524041033|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
145325568|NCT00773734|524041034|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
145325569|NCT00773734|524041035|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
145325570|NCT00773734|524041036|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
145325571|NCT00773734|524041031|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
145325572|NCT00773734|524041032|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
145325573|NCT00773734|524041033|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
145325574|NCT00773734|524041034|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
145325575|NCT00773734|524041035|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
145325576|NCT00773734|524041036|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
145325577|NCT00773734|524041031|FG000|Extension: Active Treatment Week 24-52|Other|0|||
145325578|NCT00773734|524041032|FG001|Extension: Active Treatment Week 24-52|Other|0|||
145325579|NCT00773734|524041033|FG002|Extension: Active Treatment Week 24-52|Other|1|||
145325580|NCT00773734|524041034|FG003|Extension: Active Treatment Week 24-52|Other|2|||
145325581|NCT00773734|524041035|FG004|Extension: Active Treatment Week 24-52|Other|0|||
145325582|NCT00773734|524041036|FG005|Extension: Active Treatment Week 24-52|Other|1|||
145325583|NCT00773734|524041031|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145325584|NCT00773734|524041032|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145325585|NCT00773734|524041033|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145325586|NCT00773734|524041034|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
145325587|NCT00773734|524041035|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145325588|NCT00773734|524041036|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
145325589|NCT00773734|524041031|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145325590|NCT00773734|524041032|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145325591|NCT00773734|524041033|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
145325592|NCT00773734|524041034|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
145325593|NCT00773734|524041035|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145325594|NCT00773734|524041036|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
145325595|NCT00773734|524041031|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145325596|NCT00773734|524041032|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145325597|NCT00773734|524041033|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
145325598|NCT00773734|524041034|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
145325599|NCT00773734|524041035|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145325600|NCT00773734|524041036|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
145325601|NCT00773734|524041031|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145325602|NCT00773734|524041032|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145325603|NCT00773734|524041033|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
145325604|NCT00773734|524041034|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
145325605|NCT00773734|524041035|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145325606|NCT00773734|524041036|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
145325607|NCT01220297|524041043|FG000|Overall Study|Death|2|||
145325608|NCT01220297|524041043|FG000|Overall Study|Lost to Follow-up|1|||
145325609|NCT02119286|524041045|FG000|Overall Study|Adverse Event|9|||
145325610|NCT02119286|524041046|FG001|Overall Study|Adverse Event|7|||
145325611|NCT02119286|524041047|FG002|Overall Study|Adverse Event|2|||
145325612|NCT02119286|524041045|FG000|Overall Study|Lack of Efficacy|11|||
145325613|NCT02119286|524041046|FG001|Overall Study|Lack of Efficacy|3|||
145325614|NCT02119286|524041047|FG002|Overall Study|Lack of Efficacy|4|||
145325615|NCT02119286|524041045|FG000|Overall Study|Lost to Follow-up|2|||
145325616|NCT02119286|524041046|FG001|Overall Study|Lost to Follow-up|0|||
145325617|NCT02119286|524041047|FG002|Overall Study|Lost to Follow-up|1|||
145325618|NCT02119286|524041045|FG000|Overall Study|Withdrawal by Subject|4|||
145325619|NCT02119286|524041046|FG001|Overall Study|Withdrawal by Subject|1|||
145325620|NCT02119286|524041047|FG002|Overall Study|Withdrawal by Subject|0|||
145325621|NCT01996332|524041048|FG000|Overall Study|Adverse Event|117|||
145325622|NCT01996332|524041048|FG000|Overall Study|Lack of Efficacy|1245|||
145325623|NCT01996332|524041048|FG000|Overall Study|Death|264|||
145325624|NCT01996332|524041048|FG000|Overall Study|Protocol Violation|9|||
145325625|NCT01996332|524041048|FG000|Overall Study|Withdrawal by Subject|71|||
145325626|NCT01996332|524041048|FG000|Overall Study|Other|20|||
145325627|NCT01996332|524041048|FG000|Overall Study|Clinical Deterioration|28|||
145325628|NCT01996332|524041048|FG000|Overall Study|Physician Decision|17|||
145570895|NCT01403974|524950071|FG007|Overall Study|Progressive disease according to RECIST|2|||
145325629|NCT01996332|524041048|FG000|Overall Study|Lost to Follow-up|34|||
145325630|NCT01304693|524041049|FG000|Overall Study|Adverse Event|0|||
145325631|NCT01304693|524041050|FG001|Overall Study|Adverse Event|0|||
145570896|NCT01403974|524950072|FG008|Overall Study|Progressive disease according to RECIST|6|||
145325632|NCT01304693|524041051|FG002|Overall Study|Adverse Event|0|||
145325633|NCT01304693|524041052|FG003|Overall Study|Adverse Event|0|||
145325634|NCT01304693|524041053|FG004|Overall Study|Adverse Event|1|||
145570897|NCT01403974|524950073|FG009|Overall Study|Progressive disease according to RECIST|2|||
145570898|NCT01403974|524950074|FG010|Overall Study|Progressive disease according to RECIST|3|||
145570899|NCT01403974|524950075|FG011|Overall Study|Progressive disease according to RECIST|2|||
145325635|NCT01304693|524041049|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
145325636|NCT01304693|524041050|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
145325637|NCT01304693|524041051|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
145325638|NCT01304693|524041052|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
145325639|NCT01304693|524041053|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
145325640|NCT03438396|524041055|FG000|Overall Study|Reason Not Specified|9|||
145325641|NCT03438396|524041055|FG000|Overall Study|Withdrawal by Subject|5|||
145325642|NCT03438396|524041055|FG000|Overall Study|Lost to Follow-up|2|||
145325643|NCT03438396|524041055|FG000|Overall Study|Death|85|||
145325644|NCT03438396|524041055|FG000|Overall Study|Not treated|1|||
145325645|NCT01744093|524041059|FG000|Overall Study|Withdrawal by Subject|6|||
145325646|NCT01744093|524041060|FG001|Overall Study|Withdrawal by Subject|1|||
145325647|NCT02006628|524041061|FG000|Overall Study|Adverse Event|1|||
145325648|NCT02006628|524041062|FG001|Overall Study|Adverse Event|1|||
145325649|NCT02006628|524041061|FG000|Overall Study|Withdrawal by Subject|2|||
145325650|NCT02006628|524041062|FG001|Overall Study|Withdrawal by Subject|1|||
145325651|NCT02384941|524041065|FG000|Overall Study|Adverse Event|11|||
145325652|NCT02384941|524041066|FG001|Overall Study|Adverse Event|13|||
145325653|NCT02384941|524041067|FG002|Overall Study|Adverse Event|17|||
145325654|NCT02384941|524041065|FG000|Overall Study|Lost to Follow-up|3|||
145325655|NCT02384941|524041066|FG001|Overall Study|Lost to Follow-up|2|||
145325656|NCT02384941|524041067|FG002|Overall Study|Lost to Follow-up|1|||
145325657|NCT02384941|524041065|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145325658|NCT02384941|524041066|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145325659|NCT02384941|524041067|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145325660|NCT02384941|524041065|FG000|Overall Study|Physician Decision|1|||
145325661|NCT02384941|524041066|FG001|Overall Study|Physician Decision|1|||
145325662|NCT02384941|524041067|FG002|Overall Study|Physician Decision|0|||
145325663|NCT02384941|524041065|FG000|Overall Study|Protocol Violation|3|||
145325664|NCT02384941|524041066|FG001|Overall Study|Protocol Violation|0|||
145325665|NCT02384941|524041067|FG002|Overall Study|Protocol Violation|0|||
145325666|NCT02384941|524041065|FG000|Overall Study|Withdrawal by Subject|26|||
145325667|NCT02384941|524041066|FG001|Overall Study|Withdrawal by Subject|19|||
145325668|NCT02384941|524041067|FG002|Overall Study|Withdrawal by Subject|20|||
145325669|NCT02384941|524041065|FG000|Overall Study|Pregnancy|0|||
145325670|NCT02384941|524041066|FG001|Overall Study|Pregnancy|0|||
145325671|NCT02384941|524041067|FG002|Overall Study|Pregnancy|1|||
145325672|NCT02384941|524041065|FG000|Overall Study|Other than specified above|4|||
145325673|NCT02384941|524041066|FG001|Overall Study|Other than specified above|0|||
145325674|NCT02384941|524041067|FG002|Overall Study|Other than specified above|1|||
145325675|NCT02493777|524041068|FG000|Overall Study|Lost to Follow-up|0|||
145325676|NCT02493777|524041069|FG001|Overall Study|Lost to Follow-up|1|||
145325677|NCT00468728|524041070|FG000|Treatment|criteria for mITT population|4|||
145325678|NCT00468728|524041071|FG001|Treatment|criteria for mITT population|11|||
145325679|NCT00468728|524041070|FG000|Follow-up|mITT failure|34|||
145325680|NCT00468728|524041071|FG001|Follow-up|mITT failure|31|||
145325681|NCT01642914|524041072|FG000|Overall Study|Adverse Event|11|||
145325682|NCT01642914|524041073|FG001|Overall Study|Adverse Event|7|||
145325683|NCT01642914|524041074|FG002|Overall Study|Adverse Event|15|||
145325684|NCT01642914|524041072|FG000|Overall Study|Lack of Efficacy|9|||
145325685|NCT01642914|524041073|FG001|Overall Study|Lack of Efficacy|4|||
145325686|NCT01642914|524041074|FG002|Overall Study|Lack of Efficacy|2|||
145325687|NCT01642914|524041072|FG000|Overall Study|Protocol Violation|15|||
145325688|NCT01642914|524041073|FG001|Overall Study|Protocol Violation|13|||
145325689|NCT01642914|524041074|FG002|Overall Study|Protocol Violation|6|||
145325690|NCT01642914|524041072|FG000|Overall Study|Withdrawal by Subject|5|||
145325691|NCT01642914|524041073|FG001|Overall Study|Withdrawal by Subject|5|||
145325692|NCT01642914|524041074|FG002|Overall Study|Withdrawal by Subject|10|||
145570900|NCT01403974|524950076|FG012|Overall Study|Progressive disease according to RECIST|2|||
145570901|NCT01403974|524950077|FG013|Overall Study|Progressive disease according to RECIST|3|||
145570902|NCT01403974|524950078|FG014|Overall Study|Progressive disease according to RECIST|1|||
145325693|NCT01642914|524041072|FG000|Overall Study|Lost to Follow-up|5|||
145325694|NCT01642914|524041073|FG001|Overall Study|Lost to Follow-up|3|||
145325695|NCT01642914|524041074|FG002|Overall Study|Lost to Follow-up|7|||
145325696|NCT01642914|524041072|FG000|Overall Study|Other Reason|1|||
145325697|NCT01642914|524041073|FG001|Overall Study|Other Reason|0|||
145325698|NCT01642914|524041074|FG002|Overall Study|Other Reason|0|||
145325699|NCT01705236|524041075|FG000|Overall Study|Lost to Follow-up|1|||
145570903|NCT01403974|524950079|FG015|Overall Study|Progressive disease according to RECIST|8|||
145325700|NCT01705236|524041075|FG000|Overall Study|Administrative problems|2|||
145325701|NCT01705236|524041075|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145325702|NCT01705236|524041075|FG000|Overall Study|Protocol Violation|3|||
145325703|NCT01705236|524041075|FG000|Overall Study|Abnormal test procedure result(s)|4|||
145325704|NCT01705236|524041075|FG000|Overall Study|Abnormal laboratory value(s)|4|||
145325705|NCT01705236|524041075|FG000|Overall Study|Withdrawal by Subject|5|||
145325706|NCT01705236|524041075|FG000|Overall Study|Adverse Event|5|||
145325707|NCT04572243|524041076|FG000|Core Study: 14 Weeks|Adverse Event|1|||
145325708|NCT04572243|524041077|FG001|Core Study: 14 Weeks|Adverse Event|2|||
145325709|NCT04572243|524041078|FG002|Core Study: 14 Weeks|Adverse Event|0|||
145325710|NCT04572243|524041079|FG003|Core Study: 14 Weeks|Adverse Event|0|||
145325711|NCT04572243|524041076|FG000|Core Study: 14 Weeks|Subject choice|0|||
145325712|NCT04572243|524041077|FG001|Core Study: 14 Weeks|Subject choice|2|||
145325713|NCT04572243|524041078|FG002|Core Study: 14 Weeks|Subject choice|0|||
145325714|NCT04572243|524041079|FG003|Core Study: 14 Weeks|Subject choice|0|||
145325715|NCT04572243|524041076|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
145325716|NCT04572243|524041077|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
145325717|NCT04572243|524041078|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
145325718|NCT04572243|524041079|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
145325719|NCT04572243|524041076|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
145325720|NCT04572243|524041077|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
145325721|NCT04572243|524041078|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
145325722|NCT04572243|524041079|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
145325723|NCT01661881|524041080|FG000|Overall Study|Disease Progression|1|||
145325724|NCT01231373|524041081|FG000|Overall Study|Withdrew consent prior to randomization|2|||
145325725|NCT01231373|524041082|FG001|Overall Study|Withdrew consent prior to randomization|1|||
145325726|NCT01231373|524041083|FG002|Overall Study|Withdrew consent prior to randomization|0|||
145325727|NCT01231373|524041084|FG003|Overall Study|Withdrew consent prior to randomization|0|||
145325728|NCT01231373|524041081|FG000|Overall Study|Lost to Follow-up|0|||
145325729|NCT01231373|524041082|FG001|Overall Study|Lost to Follow-up|0|||
145325730|NCT01231373|524041083|FG002|Overall Study|Lost to Follow-up|0|||
145325731|NCT01231373|524041084|FG003|Overall Study|Lost to Follow-up|1|||
145325732|NCT01231373|524041081|FG000|Overall Study|Withdrew Consent|1|||
145325733|NCT01231373|524041082|FG001|Overall Study|Withdrew Consent|0|||
145325734|NCT01231373|524041083|FG002|Overall Study|Withdrew Consent|0|||
145325735|NCT01231373|524041084|FG003|Overall Study|Withdrew Consent|0|||
145325736|NCT00775606|524041089|FG000|Overall Study|Study sponsor terminated funding|3|||
145325737|NCT00775606|524041090|FG001|Overall Study|Study sponsor terminated funding|0|||
145325738|NCT00767520|524041091|FG000|Overall Study|Participants still on treatment|11|||
145325739|NCT00767520|524041092|FG001|Overall Study|Participants still on treatment|15|||
145325740|NCT00767520|524041091|FG000|Overall Study|Randomized in error and Never treated|0|||
145325741|NCT00767520|524041092|FG001|Overall Study|Randomized in error and Never treated|2|||
145325742|NCT01338987|524041093|FG000|Overall Study|enrolled on new protocol|0|||
145325743|NCT01338987|524041094|FG001|Overall Study|enrolled on new protocol|0|||
145325744|NCT01338987|524041095|FG002|Overall Study|enrolled on new protocol|1|||
145325745|NCT01338987|524041096|FG003|Overall Study|enrolled on new protocol|0|||
145325746|NCT01338987|524041097|FG004|Overall Study|enrolled on new protocol|0|||
145325747|NCT01338987|524041093|FG000|Overall Study|Disease progression on study|2|||
145325748|NCT01338987|524041094|FG001|Overall Study|Disease progression on study|1|||
145325749|NCT01338987|524041095|FG002|Overall Study|Disease progression on study|1|||
145325750|NCT01338987|524041096|FG003|Overall Study|Disease progression on study|0|||
145325751|NCT01338987|524041097|FG004|Overall Study|Disease progression on study|0|||
145325752|NCT02972502|524041103|FG000|Overall Study|Lost to Follow-up|3|||
145325753|NCT02972502|524041104|FG001|Overall Study|Lost to Follow-up|1|||
145325754|NCT02972502|524041103|FG000|Overall Study|Withdrawal by Subject|1|||
145325755|NCT02972502|524041104|FG001|Overall Study|Withdrawal by Subject|1|||
145325756|NCT00293202|524041108|FG000|Overall Study|Withdrawal by Subject|1|||
145325757|NCT00293202|524041109|FG001|Overall Study|Withdrawal by Subject|2|||
145325758|NCT00293202|524041108|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
145325759|NCT00293202|524041109|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
145325760|NCT00293202|524041108|FG000|Overall Study|on-hold due to fistula maturation time|1|||
145325761|NCT00293202|524041109|FG001|Overall Study|on-hold due to fistula maturation time|0|||
145325762|NCT02442271|524041110|FG000|Overall Study|Adverse Event|1|||
145325763|NCT02442271|524041110|FG000|Overall Study|Withdrew Consent|1|||
145325764|NCT02442271|524041110|FG000|Overall Study|Lost to Follow-up|1|||
145325765|NCT02442271|524041110|FG000|Overall Study|Other|1|||
145325766|NCT01560507|524041116|FG000|Overall Study|Lost to Follow-up|3|||
145325767|NCT01560507|524041117|FG001|Overall Study|Lost to Follow-up|1|||
145325768|NCT01560507|524041118|FG002|Overall Study|Lost to Follow-up|2|||
145325769|NCT01560507|524041116|FG000|Overall Study|Withdrawal by Subject|1|||
145325770|NCT01560507|524041117|FG001|Overall Study|Withdrawal by Subject|1|||
145325771|NCT01560507|524041118|FG002|Overall Study|Withdrawal by Subject|0|||
145325772|NCT01138111|524041119|FG000|Overall Study|Withdrawal by Subject|5|||
145325773|NCT01138111|524041119|FG000|Overall Study|Adverse Event|1|||
145325774|NCT01138111|524041119|FG000|Overall Study|Death|1|||
145325775|NCT01138111|524041119|FG000|Overall Study|Lost to Follow-up|2|||
145325776|NCT00560937|524041120|FG000|Overall Study|Withdrawal by Subject|0|||
145325777|NCT00560937|524041121|FG001|Overall Study|Withdrawal by Subject|1|||
145325778|NCT00560937|524041120|FG000|Overall Study|Physician Decision|1|||
145325779|NCT00560937|524041121|FG001|Overall Study|Physician Decision|1|||
145325780|NCT01118117|524041122|FG000|Overall Study|Death|8|||
145325781|NCT01118117|524041123|FG001|Overall Study|Death|0|||
145325782|NCT01118117|524041122|FG000|Overall Study|Lost to Follow-up|6|||
145325783|NCT01118117|524041123|FG001|Overall Study|Lost to Follow-up|0|||
145325784|NCT01118117|524041122|FG000|Overall Study|Missed 12 Month Visit|7|||
145325785|NCT01118117|524041123|FG001|Overall Study|Missed 12 Month Visit|0|||
145325786|NCT01660022|524041124|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
145325787|NCT01660022|524041125|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
145325788|NCT01660022|524041126|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
145325789|NCT01660022|524041127|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
145325790|NCT01660022|524041128|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
145325791|NCT01660022|524041129|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
145325792|NCT01660022|524041124|FG000|First Sequence (7 Days)|Adverse Event|0|||
145325793|NCT01660022|524041125|FG001|First Sequence (7 Days)|Adverse Event|0|||
145325794|NCT01660022|524041126|FG002|First Sequence (7 Days)|Adverse Event|0|||
145325795|NCT01660022|524041127|FG003|First Sequence (7 Days)|Adverse Event|0|||
145325796|NCT01660022|524041128|FG004|First Sequence (7 Days)|Adverse Event|1|||
145325797|NCT01660022|524041129|FG005|First Sequence (7 Days)|Adverse Event|3|||
145325798|NCT01660022|524041124|FG000|First Sequence (7 Days)|Protocol Violation|0|||
145325799|NCT01660022|524041125|FG001|First Sequence (7 Days)|Protocol Violation|0|||
145325800|NCT01660022|524041126|FG002|First Sequence (7 Days)|Protocol Violation|0|||
145325801|NCT01660022|524041127|FG003|First Sequence (7 Days)|Protocol Violation|0|||
145325802|NCT01660022|524041128|FG004|First Sequence (7 Days)|Protocol Violation|0|||
145325803|NCT01660022|524041129|FG005|First Sequence (7 Days)|Protocol Violation|1|||
145325804|NCT00706992|524041131|FG000|Overall Study|Study termination|5|||
145325805|NCT00706992|524041132|FG001|Overall Study|Study termination|5|||
145325806|NCT00706992|524041133|FG002|Overall Study|Study termination|6|||
145325807|NCT00706992|524041134|FG003|Overall Study|Study termination|2|||
145325808|NCT00706992|524041135|FG004|Overall Study|Study termination|3|||
145325809|NCT00706992|524041136|FG005|Overall Study|Study termination|2|||
145325810|NCT00706992|524041137|FG006|Overall Study|Study termination|3|||
145325811|NCT00706992|524041131|FG000|Overall Study|Disease progression before treatment|0|||
145325812|NCT00706992|524041132|FG001|Overall Study|Disease progression before treatment|0|||
145325813|NCT00706992|524041133|FG002|Overall Study|Disease progression before treatment|0|||
145325814|NCT00706992|524041134|FG003|Overall Study|Disease progression before treatment|0|||
145325815|NCT00706992|524041135|FG004|Overall Study|Disease progression before treatment|1|||
145325816|NCT00706992|524041136|FG005|Overall Study|Disease progression before treatment|0|||
145325817|NCT00706992|524041137|FG006|Overall Study|Disease progression before treatment|0|||
145325818|NCT01277718|524041138|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
145325819|NCT01277718|524041139|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
145325820|NCT01277718|524041138|FG000|Period 2 - Second Intervention|Physician Decision|0|||
145325821|NCT01277718|524041139|FG001|Period 2 - Second Intervention|Physician Decision|2|||
145325822|NCT02746627|524041141|FG000|Overall Study|Withdrawal by Subject|1|||
145325823|NCT02746627|524041142|FG001|Overall Study|Withdrawal by Subject|1|||
145325824|NCT02746627|524041143|FG002|Overall Study|Withdrawal by Subject|1|||
145325825|NCT00766831|524041144|FG000|Overall Study|Withdrawal by Subject|4|||
145325826|NCT00766831|524041144|FG000|Overall Study|Lost to Follow-up|3|||
145325827|NCT00766831|524041144|FG000|Overall Study|Adverse Event|20|||
145325828|NCT00766831|524041144|FG000|Overall Study|Protocol Violation|15|||
145325829|NCT00766831|524041144|FG000|Overall Study|Physician Decision|5|||
145325830|NCT00766831|524041144|FG000|Overall Study|Withdrawal of consent|26|||
145325831|NCT00766831|524041144|FG000|Overall Study|Non cooperation by participants|14|||
145325832|NCT00766831|524041144|FG000|Overall Study|Other|28|||
145325833|NCT04459715|524041148|FG000|Overall Study|Adverse Event|3|||
145325834|NCT04459715|524041149|FG001|Overall Study|Adverse Event|3|||
145325835|NCT04459715|524041148|FG000|Overall Study|Death|111|||
145325836|NCT04459715|524041149|FG001|Overall Study|Death|93|||
145325837|NCT04459715|524041148|FG000|Overall Study|Lost to Follow-up|10|||
145325838|NCT04459715|524041149|FG001|Overall Study|Lost to Follow-up|9|||
145570904|NCT01403974|524950064|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
145325839|NCT04459715|524041148|FG000|Overall Study|Other Reasons|4|||
145325840|NCT04459715|524041149|FG001|Overall Study|Other Reasons|5|||
145325841|NCT04459715|524041148|FG000|Overall Study|PROTOCOL DEVIATION|0|||
145325842|NCT04459715|524041149|FG001|Overall Study|PROTOCOL DEVIATION|1|||
145325843|NCT04459715|524041148|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
145325844|NCT04459715|524041149|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
145325845|NCT04459715|524041148|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
145325846|NCT04459715|524041149|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
145325847|NCT04459715|524041148|FG000|Overall Study|Withdrawal by Subject|22|||
145325848|NCT04459715|524041149|FG001|Overall Study|Withdrawal by Subject|22|||
145325849|NCT02712333|524042995|FG000|First Period|Withdrawal by Subject|3|||
145325850|NCT02712333|524042996|FG001|First Period|Withdrawal by Subject|2|||
145325851|NCT02278718|524042997|FG000|Overall Study|Adverse Event|1|||
145325852|NCT02278718|524042998|FG001|Overall Study|Adverse Event|0|||
145325853|NCT02278718|524042997|FG000|Overall Study|Lost to Follow-up|2|||
145325854|NCT02278718|524042998|FG001|Overall Study|Lost to Follow-up|4|||
145412065|NCT03122106|524362172|FG000|Overall Study|Poor RNA quality for vaccine|1|||
145412066|NCT03244189|524362173|FG000|Overall Study|Death|0|||
145620626|NCT03621982|525125126|FG002|Overall Study|Investigator/Sponsor decision|0|||
145325855|NCT02278718|524042997|FG000|Overall Study|Withdrawal by Subject|1|||
145325856|NCT02278718|524042998|FG001|Overall Study|Withdrawal by Subject|4|||
145325857|NCT02278718|524042997|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
145325858|NCT02278718|524042998|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
145325859|NCT02278718|524042997|FG000|Overall Study|Missing|0|||
145325860|NCT02278718|524042998|FG001|Overall Study|Missing|1|||
145325861|NCT03212794|524042999|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
145325862|NCT03212794|524043000|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
145325863|NCT03212794|524042999|FG000|Overall Study|Lost to Follow-up|5|||
145325864|NCT03212794|524043000|FG001|Overall Study|Lost to Follow-up|6|||
145325865|NCT03212794|524042999|FG000|Overall Study|Incarcerated; unable to participate|2|||
145325866|NCT03212794|524043000|FG001|Overall Study|Incarcerated; unable to participate|0|||
145325867|NCT03212794|524042999|FG000|Overall Study|Withdrawal by Subject|1|||
145325868|NCT03212794|524043000|FG001|Overall Study|Withdrawal by Subject|0|||
145325869|NCT03212794|524042999|FG000|Overall Study|Death|0|||
145325870|NCT03212794|524043000|FG001|Overall Study|Death|1|||
145325871|NCT03212794|524042999|FG000|Overall Study|Found to be ineligible after allocation|0|||
145325872|NCT03212794|524043000|FG001|Overall Study|Found to be ineligible after allocation|1|||
145325873|NCT03212794|524042999|FG000|Overall Study|Relocated out of area|2|||
145325874|NCT03212794|524043000|FG001|Overall Study|Relocated out of area|0|||
145325875|NCT00897949|524043001|FG000|Overall Study|Adverse Event|1|||
145325876|NCT00897949|524043002|FG001|Overall Study|Adverse Event|1|||
145325877|NCT00897949|524043003|FG002|Overall Study|Adverse Event|0|||
145325878|NCT00897949|524043001|FG000|Overall Study|Lost to Follow-up|0|||
145325879|NCT00897949|524043002|FG001|Overall Study|Lost to Follow-up|2|||
145325880|NCT00897949|524043003|FG002|Overall Study|Lost to Follow-up|1|||
145325881|NCT00897949|524043001|FG000|Overall Study|Protocol Violation|6|||
145325882|NCT00897949|524043002|FG001|Overall Study|Protocol Violation|3|||
145325883|NCT00897949|524043003|FG002|Overall Study|Protocol Violation|1|||
145325884|NCT00897949|524043001|FG000|Overall Study|Withdrawal by Subject|1|||
145325885|NCT00897949|524043002|FG001|Overall Study|Withdrawal by Subject|2|||
145325886|NCT00897949|524043003|FG002|Overall Study|Withdrawal by Subject|0|||
145325887|NCT00897949|524043001|FG000|Overall Study|Patient Uncoorperative|0|||
145325888|NCT00897949|524043002|FG001|Overall Study|Patient Uncoorperative|2|||
145325889|NCT00897949|524043003|FG002|Overall Study|Patient Uncoorperative|1|||
145325890|NCT00897949|524043001|FG000|Overall Study|Lost to Follow-up|30|||
145325891|NCT00897949|524043002|FG001|Overall Study|Lost to Follow-up|23|||
145325892|NCT00897949|524043003|FG002|Overall Study|Lost to Follow-up|17|||
145325893|NCT00897949|524043001|FG000|Overall Study|Withdrawal by Subject|24|||
145325894|NCT00897949|524043002|FG001|Overall Study|Withdrawal by Subject|31|||
145325895|NCT00897949|524043003|FG002|Overall Study|Withdrawal by Subject|17|||
145325896|NCT00897949|524043001|FG000|Overall Study|Abnormal Prestudy Labs|2|||
145325897|NCT00897949|524043002|FG001|Overall Study|Abnormal Prestudy Labs|3|||
145325898|NCT00897949|524043003|FG002|Overall Study|Abnormal Prestudy Labs|4|||
145325899|NCT00897949|524043001|FG000|Overall Study|Abnormal Baseline ECG|2|||
145325900|NCT00897949|524043002|FG001|Overall Study|Abnormal Baseline ECG|2|||
145325901|NCT00897949|524043003|FG002|Overall Study|Abnormal Baseline ECG|4|||
145325902|NCT00897949|524043001|FG000|Overall Study|Need for Concom. Med.|0|||
145325903|NCT00897949|524043002|FG001|Overall Study|Need for Concom. Med.|1|||
145325904|NCT00897949|524043003|FG002|Overall Study|Need for Concom. Med.|1|||
145325905|NCT00897949|524043001|FG000|Overall Study|Lack of Migraine Attack|29|||
145325906|NCT00897949|524043002|FG001|Overall Study|Lack of Migraine Attack|30|||
145325907|NCT00897949|524043003|FG002|Overall Study|Lack of Migraine Attack|19|||
145325908|NCT00897949|524043001|FG000|Overall Study|Did not take study drug|9|||
145325909|NCT00897949|524043002|FG001|Overall Study|Did not take study drug|3|||
145325910|NCT00897949|524043003|FG002|Overall Study|Did not take study drug|4|||
145325911|NCT01763918|524043004|FG000|Overall Study|Withdrawal by Subject|2|||
145325912|NCT01763918|524043005|FG001|Overall Study|Withdrawal by Subject|1|||
145325913|NCT01763918|524043006|FG002|Overall Study|Withdrawal by Subject|1|||
145325914|NCT01763918|524043007|FG003|Overall Study|Withdrawal by Subject|2|||
145325915|NCT01763918|524043004|FG000|Overall Study|Sponsor Decision|4|||
145325916|NCT01763918|524043005|FG001|Overall Study|Sponsor Decision|0|||
145412067|NCT03244189|524362174|FG001|Overall Study|Death|2|||
145325917|NCT01763918|524043006|FG002|Overall Study|Sponsor Decision|9|||
145325918|NCT01763918|524043007|FG003|Overall Study|Sponsor Decision|0|||
145412068|NCT03244189|524362173|FG000|Overall Study|Lost to Follow-up|92|||
145325919|NCT01553747|524043008|FG000|Overall Study|Protocol Violation|0|||
145412069|NCT03244189|524362174|FG001|Overall Study|Lost to Follow-up|107|||
145412070|NCT03244189|524362173|FG000|Overall Study|Physician Decision|4|||
145325920|NCT01553747|524043009|FG001|Overall Study|Protocol Violation|2|||
145325921|NCT01553747|524043010|FG002|Overall Study|Protocol Violation|0|||
145325922|NCT01553747|524043008|FG000|Overall Study|Voluntarily withdrew|70|||
145620627|NCT03621982|525125127|FG003|Overall Study|Investigator/Sponsor decision|0|||
145620628|NCT03621982|525125128|FG004|Overall Study|Investigator/Sponsor decision|0|||
145620629|NCT03621982|525125129|FG005|Overall Study|Investigator/Sponsor decision|0|||
145620630|NCT03621982|525125130|FG006|Overall Study|Investigator/Sponsor decision|0|||
145620631|NCT03621982|525125131|FG007|Overall Study|Investigator/Sponsor decision|0|||
145325923|NCT01553747|524043009|FG001|Overall Study|Voluntarily withdrew|66|||
145325924|NCT01553747|524043010|FG002|Overall Study|Voluntarily withdrew|74|||
145325925|NCT01553747|524043008|FG000|Overall Study|Adverse event or SAE|32|||
145325926|NCT01553747|524043009|FG001|Overall Study|Adverse event or SAE|28|||
145325927|NCT01553747|524043010|FG002|Overall Study|Adverse event or SAE|19|||
145325928|NCT01553747|524043008|FG000|Overall Study|Physician decision: other|10|||
145325929|NCT01553747|524043009|FG001|Overall Study|Physician decision: other|8|||
145325930|NCT01553747|524043010|FG002|Overall Study|Physician decision: other|7|||
145325931|NCT01553747|524043008|FG000|Overall Study|Lost to Follow-up|11|||
145325932|NCT01553747|524043009|FG001|Overall Study|Lost to Follow-up|5|||
145325933|NCT01553747|524043010|FG002|Overall Study|Lost to Follow-up|6|||
145325934|NCT01553747|524043008|FG000|Overall Study|Sponsor decision, specify|7|||
145325935|NCT01553747|524043009|FG001|Overall Study|Sponsor decision, specify|5|||
145325936|NCT01553747|524043010|FG002|Overall Study|Sponsor decision, specify|0|||
145325937|NCT01553747|524043008|FG000|Overall Study|Physician decision: lack of efficacy|1|||
145325938|NCT01553747|524043009|FG001|Overall Study|Physician decision: lack of efficacy|5|||
145325939|NCT01553747|524043010|FG002|Overall Study|Physician decision: lack of efficacy|3|||
145325940|NCT00102687|524043011|FG000|Initial Period|Withdrawal by Subject|6|||
145325941|NCT00102687|524043012|FG001|Initial Period|Withdrawal by Subject|3|||
145325942|NCT00102687|524043013|FG002|Initial Period|Withdrawal by Subject|5|||
145325943|NCT00102687|524043014|FG003|Initial Period|Withdrawal by Subject|0|||
145325944|NCT00102687|524043015|FG004|Initial Period|Withdrawal by Subject|0|||
145325945|NCT00102687|524043011|FG000|Initial Period|Adverse Event|4|||
145325946|NCT00102687|524043012|FG001|Initial Period|Adverse Event|7|||
145325947|NCT00102687|524043013|FG002|Initial Period|Adverse Event|9|||
145325948|NCT00102687|524043014|FG003|Initial Period|Adverse Event|0|||
145325949|NCT00102687|524043015|FG004|Initial Period|Adverse Event|0|||
145325950|NCT00102687|524043011|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
145325951|NCT00102687|524043012|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
145325952|NCT00102687|524043013|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
145325953|NCT00102687|524043014|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
145325954|NCT00102687|524043015|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
145325955|NCT00102687|524043011|FG000|Initial Period|Protocol Violation|0|||
145325956|NCT00102687|524043012|FG001|Initial Period|Protocol Violation|0|||
145325957|NCT00102687|524043013|FG002|Initial Period|Protocol Violation|2|||
145325958|NCT00102687|524043014|FG003|Initial Period|Protocol Violation|0|||
145325959|NCT00102687|524043015|FG004|Initial Period|Protocol Violation|0|||
145325960|NCT00102687|524043011|FG000|Initial Period|Physician Decision|2|||
145325961|NCT00102687|524043012|FG001|Initial Period|Physician Decision|9|||
145325962|NCT00102687|524043013|FG002|Initial Period|Physician Decision|6|||
145325963|NCT00102687|524043014|FG003|Initial Period|Physician Decision|0|||
145325964|NCT00102687|524043015|FG004|Initial Period|Physician Decision|0|||
145325965|NCT00102687|524043011|FG000|Initial Period|Sponsor's decision|0|||
145325966|NCT00102687|524043012|FG001|Initial Period|Sponsor's decision|1|||
145325967|NCT00102687|524043013|FG002|Initial Period|Sponsor's decision|1|||
145325968|NCT00102687|524043014|FG003|Initial Period|Sponsor's decision|0|||
145325969|NCT00102687|524043015|FG004|Initial Period|Sponsor's decision|0|||
145325970|NCT00102687|524043011|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
145325971|NCT00102687|524043012|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
145325972|NCT00102687|524043013|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
145325973|NCT00102687|524043014|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
145620632|NCT03621982|525125132|FG008|Overall Study|Investigator/Sponsor decision|0|||
145620633|NCT03621982|525125133|FG009|Overall Study|Investigator/Sponsor decision|0|||
145620634|NCT03621982|525125134|FG010|Overall Study|Investigator/Sponsor decision|0|||
145325974|NCT00102687|524043015|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
145325975|NCT00102687|524043011|FG000|Initial Period|Death|1|||
145325976|NCT00102687|524043012|FG001|Initial Period|Death|1|||
145325977|NCT00102687|524043013|FG002|Initial Period|Death|1|||
145325978|NCT00102687|524043014|FG003|Initial Period|Death|0|||
145325979|NCT00102687|524043015|FG004|Initial Period|Death|0|||
145325980|NCT00102687|524043011|FG000|Maintenance Period|Withdrawal by Subject|4|||
145325981|NCT00102687|524043012|FG001|Maintenance Period|Withdrawal by Subject|0|||
145325982|NCT00102687|524043013|FG002|Maintenance Period|Withdrawal by Subject|2|||
145325983|NCT00102687|524043014|FG003|Maintenance Period|Withdrawal by Subject|3|||
145325984|NCT00102687|524043015|FG004|Maintenance Period|Withdrawal by Subject|1|||
145325985|NCT00102687|524043011|FG000|Maintenance Period|Adverse Event|1|||
145325986|NCT00102687|524043012|FG001|Maintenance Period|Adverse Event|0|||
145325987|NCT00102687|524043013|FG002|Maintenance Period|Adverse Event|0|||
145325988|NCT00102687|524043014|FG003|Maintenance Period|Adverse Event|1|||
145325989|NCT00102687|524043015|FG004|Maintenance Period|Adverse Event|3|||
145325990|NCT00102687|524043011|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145325991|NCT00102687|524043012|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
145325992|NCT00102687|524043013|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145325993|NCT00102687|524043014|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
145325994|NCT00102687|524043015|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
145325995|NCT00102687|524043011|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145325996|NCT00102687|524043012|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145325997|NCT00102687|524043013|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
145325998|NCT00102687|524043014|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
145325999|NCT00102687|524043015|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
145326000|NCT00102687|524043011|FG000|Maintenance Period|Death|0|||
145326001|NCT00102687|524043012|FG001|Maintenance Period|Death|0|||
145326002|NCT00102687|524043013|FG002|Maintenance Period|Death|0|||
145326003|NCT00102687|524043014|FG003|Maintenance Period|Death|1|||
145326004|NCT00102687|524043015|FG004|Maintenance Period|Death|1|||
145326005|NCT00102687|524043011|FG000|Maintenance Period|Physician Decision|1|||
145326006|NCT00102687|524043012|FG001|Maintenance Period|Physician Decision|2|||
145326007|NCT00102687|524043013|FG002|Maintenance Period|Physician Decision|3|||
145326008|NCT00102687|524043014|FG003|Maintenance Period|Physician Decision|0|||
145326009|NCT00102687|524043015|FG004|Maintenance Period|Physician Decision|4|||
145326010|NCT02408120|524043021|FG000|Overall Study|Withdrawal by Subject|0|||
145326011|NCT02408120|524043022|FG001|Overall Study|Withdrawal by Subject|1|||
145326012|NCT02408120|524043021|FG000|Overall Study|Treatment Refusal|1|||
145326013|NCT02408120|524043022|FG001|Overall Study|Treatment Refusal|0|||
145326014|NCT02408120|524043021|FG000|Overall Study|Received Steroids|1|||
145326015|NCT02408120|524043022|FG001|Overall Study|Received Steroids|1|||
145326016|NCT02408120|524043021|FG000|Overall Study|Discharged same day|1|||
145326017|NCT02408120|524043022|FG001|Overall Study|Discharged same day|1|||
145326018|NCT02408120|524043021|FG000|Overall Study|Did not receive insulin|1|||
145326019|NCT02408120|524043022|FG001|Overall Study|Did not receive insulin|2|||
145326020|NCT03739138|524043029|FG000|Overall Study|Death|0|||
145326021|NCT03739138|524043030|FG001|Overall Study|Death|7|||
145326022|NCT03739138|524043031|FG002|Overall Study|Death|4|||
145326023|NCT03739138|524043032|FG003|Overall Study|Death|13|||
145326024|NCT03739138|524043033|FG004|Overall Study|Death|0|||
145326025|NCT03739138|524043029|FG000|Overall Study|Lost to Follow-up|0|||
145326026|NCT03739138|524043030|FG001|Overall Study|Lost to Follow-up|0|||
145326027|NCT03739138|524043031|FG002|Overall Study|Lost to Follow-up|1|||
145326028|NCT03739138|524043032|FG003|Overall Study|Lost to Follow-up|0|||
145326029|NCT03739138|524043033|FG004|Overall Study|Lost to Follow-up|0|||
145326030|NCT03739138|524043029|FG000|Overall Study|Study Terminated By Sponsor|0|||
145326031|NCT03739138|524043030|FG001|Overall Study|Study Terminated By Sponsor|0|||
145326032|NCT03739138|524043031|FG002|Overall Study|Study Terminated By Sponsor|0|||
145326033|NCT03739138|524043032|FG003|Overall Study|Study Terminated By Sponsor|4|||
145326034|NCT03739138|524043033|FG004|Overall Study|Study Terminated By Sponsor|0|||
145326035|NCT03739138|524043029|FG000|Overall Study|Withdrawal by Subject|0|||
145326036|NCT03739138|524043030|FG001|Overall Study|Withdrawal by Subject|0|||
145326037|NCT03739138|524043031|FG002|Overall Study|Withdrawal by Subject|0|||
145326038|NCT03739138|524043032|FG003|Overall Study|Withdrawal by Subject|1|||
145326039|NCT03739138|524043033|FG004|Overall Study|Withdrawal by Subject|0|||
145326040|NCT00597116|524043037|FG000|Overall Study|Adverse Event|2|||
145326041|NCT00597116|524043038|FG001|Overall Study|Adverse Event|1|||
145326042|NCT00597116|524043037|FG000|Overall Study|Withdrawal by Subject|0|||
145326043|NCT00597116|524043038|FG001|Overall Study|Withdrawal by Subject|2|||
145326044|NCT00597116|524043037|FG000|Overall Study|Physician Decision|0|||
145326045|NCT00597116|524043038|FG001|Overall Study|Physician Decision|1|||
145326046|NCT00597116|524043037|FG000|Overall Study|Death|0|||
145326047|NCT00597116|524043038|FG001|Overall Study|Death|1|||
145326048|NCT00597116|524043037|FG000|Overall Study|Lost to Follow-up|1|||
145326049|NCT00597116|524043038|FG001|Overall Study|Lost to Follow-up|0|||
145326050|NCT00597116|524043037|FG000|Overall Study|Progressive disease|11|||
145326051|NCT00597116|524043038|FG001|Overall Study|Progressive disease|6|||
145326052|NCT02903238|524043042|FG000|Overall Study|Lost to Follow-up|4|||
145326053|NCT00700817|524043047|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
145412071|NCT03244189|524362174|FG001|Overall Study|Physician Decision|2|||
145412072|NCT03244189|524362173|FG000|Overall Study|Pregnancy|7|||
145326054|NCT00700817|524043048|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
145326055|NCT00700817|524043049|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
145326056|NCT00700817|524043050|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
145326057|NCT00700817|524043051|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
145326058|NCT00700817|524043047|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
145326059|NCT00700817|524043048|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145326060|NCT00700817|524043049|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
145326061|NCT00700817|524043050|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145326062|NCT00700817|524043051|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
145326063|NCT00700817|524043047|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
145412073|NCT03244189|524362174|FG001|Overall Study|Pregnancy|5|||
145326064|NCT00700817|524043048|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
145326065|NCT00700817|524043049|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
145326066|NCT00700817|524043050|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
145326067|NCT00700817|524043051|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
145326068|NCT00700817|524043047|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
145326069|NCT00700817|524043048|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
145326070|NCT00700817|524043049|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
145326071|NCT00700817|524043050|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
145326072|NCT00700817|524043051|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
145326073|NCT00700817|524043047|FG000|Week 0-26 (Main Period)|Unclassified|14|||
145326074|NCT00700817|524043048|FG001|Week 0-26 (Main Period)|Unclassified|4|||
145326075|NCT00700817|524043049|FG002|Week 0-26 (Main Period)|Unclassified|8|||
145326076|NCT00700817|524043050|FG003|Week 0-26 (Main Period)|Unclassified|0|||
145326077|NCT00700817|524043051|FG004|Week 0-26 (Main Period)|Unclassified|0|||
145326078|NCT00700817|524043047|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
145326079|NCT00700817|524043048|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
145326080|NCT00700817|524043049|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
145326081|NCT00700817|524043050|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
145326082|NCT00700817|524043051|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
145326083|NCT00700817|524043047|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
145326084|NCT00700817|524043048|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
145326085|NCT00700817|524043049|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
145326086|NCT00700817|524043050|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
145326087|NCT00700817|524043051|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
145326088|NCT00700817|524043047|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
145326089|NCT00700817|524043048|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
145326090|NCT00700817|524043049|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
145326091|NCT00700817|524043050|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
145326092|NCT00700817|524043051|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
145326093|NCT00700817|524043047|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
145326094|NCT00700817|524043048|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
145326095|NCT00700817|524043049|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
145326096|NCT00700817|524043050|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
145326097|NCT00700817|524043051|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
145326098|NCT00700817|524043047|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
145326099|NCT00700817|524043048|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
145326100|NCT00700817|524043049|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
145326101|NCT00700817|524043050|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
145326102|NCT00700817|524043051|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
145326103|NCT00700817|524043047|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145326104|NCT00700817|524043048|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
145326105|NCT00700817|524043049|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145326106|NCT00700817|524043050|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
145326107|NCT00700817|524043051|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
145326108|NCT00700817|524043047|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145326109|NCT00700817|524043048|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
145326110|NCT00700817|524043049|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
145326111|NCT00700817|524043050|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145326112|NCT00700817|524043051|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
145326113|NCT00700817|524043047|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
145326114|NCT00700817|524043048|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
145326115|NCT00700817|524043049|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145326116|NCT00700817|524043050|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145326117|NCT00700817|524043051|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
145326118|NCT00700817|524043047|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
145326119|NCT00700817|524043048|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
145326120|NCT00700817|524043049|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
145326121|NCT00700817|524043050|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
145326122|NCT00700817|524043051|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
145326123|NCT00700817|524043047|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
145326124|NCT00700817|524043048|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
145326125|NCT00700817|524043049|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
145326126|NCT00700817|524043050|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
145326127|NCT00700817|524043051|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
145326128|NCT02777918|524043054|FG000|Overall Study|Medical reasons|1|||
145326129|NCT02777918|524043055|FG001|Overall Study|Medical reasons|2|||
145326130|NCT02777918|524043054|FG000|Overall Study|Too busy / stressed|1|||
145326131|NCT02777918|524043055|FG001|Overall Study|Too busy / stressed|1|||
145570905|NCT01403974|524950065|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
145326132|NCT02777918|524043054|FG000|Overall Study|Withdrawal by Subject|1|||
145326133|NCT02777918|524043055|FG001|Overall Study|Withdrawal by Subject|1|||
145326134|NCT00757848|524043056|FG000|Overall Study|Voluntary discontinuation|1|||
145326135|NCT00757848|524043057|FG001|Overall Study|Voluntary discontinuation|0|||
145326136|NCT00757848|524043056|FG000|Overall Study|Adverse Event|1|||
145326137|NCT00757848|524043057|FG001|Overall Study|Adverse Event|2|||
145326138|NCT00757848|524043056|FG000|Overall Study|Incorrect enrolment|1|||
145326139|NCT00757848|524043057|FG001|Overall Study|Incorrect enrolment|0|||
145326140|NCT00058214|524043060|FG000|Overall Study|Adverse Event|1|||
145326141|NCT00958126|524043067|FG000|Overall Study|Serious Adverse Event|0|||
145326142|NCT00958126|524043068|FG001|Overall Study|Serious Adverse Event|2|||
145326143|NCT00958126|524043069|FG002|Overall Study|Serious Adverse Event|0|||
145326144|NCT00958126|524043070|FG003|Overall Study|Serious Adverse Event|0|||
145326145|NCT00958126|524043071|FG004|Overall Study|Serious Adverse Event|0|||
145326146|NCT00958126|524043072|FG005|Overall Study|Serious Adverse Event|0|||
145326147|NCT00958126|524043073|FG006|Overall Study|Serious Adverse Event|1|||
145326148|NCT00958126|524043074|FG007|Overall Study|Serious Adverse Event|0|||
145326149|NCT00958126|524043067|FG000|Overall Study|Withdrawal by Subject|0|||
145326150|NCT00958126|524043068|FG001|Overall Study|Withdrawal by Subject|2|||
145326151|NCT00958126|524043069|FG002|Overall Study|Withdrawal by Subject|0|||
145326152|NCT00958126|524043070|FG003|Overall Study|Withdrawal by Subject|0|||
145326153|NCT00958126|524043071|FG004|Overall Study|Withdrawal by Subject|0|||
145326154|NCT00958126|524043072|FG005|Overall Study|Withdrawal by Subject|0|||
145326155|NCT00958126|524043073|FG006|Overall Study|Withdrawal by Subject|0|||
145326156|NCT00958126|524043074|FG007|Overall Study|Withdrawal by Subject|0|||
145326157|NCT00958126|524043067|FG000|Overall Study|Moved away from study area|0|||
145326158|NCT00958126|524043068|FG001|Overall Study|Moved away from study area|0|||
145326159|NCT00958126|524043069|FG002|Overall Study|Moved away from study area|1|||
145326160|NCT00958126|524043070|FG003|Overall Study|Moved away from study area|1|||
145326161|NCT00958126|524043071|FG004|Overall Study|Moved away from study area|0|||
145326162|NCT00958126|524043072|FG005|Overall Study|Moved away from study area|0|||
145326163|NCT00958126|524043073|FG006|Overall Study|Moved away from study area|0|||
145326164|NCT00958126|524043074|FG007|Overall Study|Moved away from study area|0|||
145326165|NCT00958126|524043067|FG000|Overall Study|Lost to Follow-up|1|||
145326166|NCT00958126|524043068|FG001|Overall Study|Lost to Follow-up|5|||
145326167|NCT00958126|524043069|FG002|Overall Study|Lost to Follow-up|9|||
145326168|NCT00958126|524043070|FG003|Overall Study|Lost to Follow-up|8|||
145326169|NCT00958126|524043071|FG004|Overall Study|Lost to Follow-up|0|||
145326170|NCT00958126|524043072|FG005|Overall Study|Lost to Follow-up|0|||
145326171|NCT00958126|524043073|FG006|Overall Study|Lost to Follow-up|0|||
145326172|NCT00958126|524043074|FG007|Overall Study|Lost to Follow-up|0|||
145326173|NCT00958126|524043067|FG000|Overall Study|Sponsor/Investigator decision|0|||
145326174|NCT00958126|524043068|FG001|Overall Study|Sponsor/Investigator decision|0|||
145326175|NCT00958126|524043069|FG002|Overall Study|Sponsor/Investigator decision|0|||
145326176|NCT00958126|524043070|FG003|Overall Study|Sponsor/Investigator decision|1|||
145326177|NCT00958126|524043071|FG004|Overall Study|Sponsor/Investigator decision|0|||
145326178|NCT00958126|524043072|FG005|Overall Study|Sponsor/Investigator decision|0|||
145326179|NCT00958126|524043073|FG006|Overall Study|Sponsor/Investigator decision|0|||
145326180|NCT00958126|524043074|FG007|Overall Study|Sponsor/Investigator decision|0|||
145326181|NCT00958126|524043067|FG000|Overall Study|Other Reason|0|||
145326182|NCT00958126|524043068|FG001|Overall Study|Other Reason|0|||
145326183|NCT00958126|524043069|FG002|Overall Study|Other Reason|0|||
145326184|NCT00958126|524043070|FG003|Overall Study|Other Reason|1|||
145326185|NCT00958126|524043071|FG004|Overall Study|Other Reason|0|||
145326186|NCT00958126|524043072|FG005|Overall Study|Other Reason|1|||
145326187|NCT00958126|524043073|FG006|Overall Study|Other Reason|0|||
145326188|NCT00958126|524043074|FG007|Overall Study|Other Reason|0|||
145326189|NCT00720226|524043075|FG000|Overall Study|Withdrawal by Subject|7|||
145326190|NCT00720226|524043076|FG001|Overall Study|Withdrawal by Subject|4|||
145326191|NCT00733369|524043077|FG000|Overall Study|Lost to Follow-up|2|||
145326192|NCT00733369|524043078|FG001|Overall Study|Lost to Follow-up|1|||
145326193|NCT00733369|524043077|FG000|Overall Study|Adverse Event|4|||
145326194|NCT00733369|524043078|FG001|Overall Study|Adverse Event|4|||
145326195|NCT00733369|524043077|FG000|Overall Study|Protocol Violation|4|||
145326196|NCT00733369|524043078|FG001|Overall Study|Protocol Violation|4|||
145326197|NCT03401073|524043079|FG000|Overall Study|Lost to Follow-up|1|||
145326198|NCT03401073|524043080|FG001|Overall Study|Lost to Follow-up|2|||
145326199|NCT01470612|524043084|FG000|Overall Study|Adverse Event|20|||
145326200|NCT01470612|524043085|FG001|Overall Study|Adverse Event|80|||
145326201|NCT01470612|524043084|FG000|Overall Study|Death|0|||
145326202|NCT01470612|524043085|FG001|Overall Study|Death|1|||
145326203|NCT01470612|524043084|FG000|Overall Study|Lack of Efficacy|20|||
145326204|NCT01470612|524043085|FG001|Overall Study|Lack of Efficacy|326|||
145326205|NCT01470612|524043084|FG000|Overall Study|Lost to Follow-up|2|||
145326206|NCT01470612|524043085|FG001|Overall Study|Lost to Follow-up|5|||
145326207|NCT01470612|524043084|FG000|Overall Study|Did not meet entrance criteria|0|||
145412074|NCT03244189|524362173|FG000|Overall Study|Protocol Violation|0|||
145326208|NCT01470612|524043085|FG001|Overall Study|Did not meet entrance criteria|1|||
145326209|NCT01470612|524043084|FG000|Overall Study|Pregnancy|2|||
145326210|NCT01470612|524043085|FG001|Overall Study|Pregnancy|10|||
145326211|NCT01470612|524043084|FG000|Overall Study|Protocol Violation|2|||
145326212|NCT01470612|524043085|FG001|Overall Study|Protocol Violation|7|||
145326213|NCT01470612|524043084|FG000|Overall Study|Withdrawal by Subject|24|||
145326214|NCT01470612|524043085|FG001|Overall Study|Withdrawal by Subject|79|||
145326215|NCT01470612|524043084|FG000|Overall Study|Other|14|||
145326216|NCT01470612|524043085|FG001|Overall Study|Other|156|||
145326217|NCT01949116|524043091|FG000|Overall Study|Death|2|||
145326218|NCT01949116|524043092|FG001|Overall Study|Death|0|||
145326219|NCT01949116|524043091|FG000|Overall Study|Lost to Follow-up|1|||
145326220|NCT01949116|524043092|FG001|Overall Study|Lost to Follow-up|3|||
145326221|NCT01949116|524043091|FG000|Overall Study|Withdrawal by Subject|5|||
145326222|NCT01949116|524043092|FG001|Overall Study|Withdrawal by Subject|3|||
145326223|NCT02556307|524043098|FG000|Overall Study|Premature treatment interruption|11|||
145326224|NCT02556307|524043098|FG000|Overall Study|Lost to Follow-up|36|||
145326225|NCT02556307|524043098|FG000|Overall Study|Change to triple therapy|4|||
145326226|NCT02556307|524043098|FG000|Overall Study|Enrolled but not treated|2|||
145326227|NCT03078582|524043099|FG000|Overall Study|Adverse Event|0|||
145326228|NCT03078582|524043100|FG001|Overall Study|Adverse Event|8|||
145326229|NCT00430950|524043105|FG000|Overall Study|Adverse Event|7|||
145326230|NCT00430950|524043106|FG001|Overall Study|Adverse Event|6|||
145326231|NCT00430950|524043105|FG000|Overall Study|Withdrawal by Subject|1|||
145326232|NCT00430950|524043106|FG001|Overall Study|Withdrawal by Subject|0|||
145326233|NCT00430950|524043105|FG000|Overall Study|concomitant medication,etc.|5|||
145326234|NCT00430950|524043106|FG001|Overall Study|concomitant medication,etc.|7|||
145326235|NCT00831623|524043112|FG000|Overall Study|Withdrawal by Subject|9|||
145326236|NCT00831623|524043112|FG000|Overall Study|Lost to Follow-up|1|||
145326237|NCT00831623|524043112|FG000|Overall Study|Not 2 years post-treatment|12|||
145326238|NCT01564459|524043115|FG000|Run-In|Adverse Event|7|||
145326239|NCT01564459|524043116|FG001|Run-In|Adverse Event|0|||
145326240|NCT01564459|524043117|FG002|Run-In|Adverse Event|0|||
145326241|NCT01564459|524043115|FG000|Run-In|Lost to Follow-up|1|||
145326242|NCT01564459|524043116|FG001|Run-In|Lost to Follow-up|0|||
145326243|NCT01564459|524043117|FG002|Run-In|Lost to Follow-up|0|||
145326244|NCT01564459|524043115|FG000|Run-In|Non-compliance with study drug|2|||
145326245|NCT01564459|524043116|FG001|Run-In|Non-compliance with study drug|0|||
145326246|NCT01564459|524043117|FG002|Run-In|Non-compliance with study drug|0|||
145326247|NCT01564459|524043115|FG000|Run-In|Protocol Violation|1|||
145326248|NCT01564459|524043116|FG001|Run-In|Protocol Violation|0|||
145326249|NCT01564459|524043117|FG002|Run-In|Protocol Violation|0|||
145326250|NCT01564459|524043115|FG000|Run-In|Withdrawal by Subject|1|||
145326251|NCT01564459|524043116|FG001|Run-In|Withdrawal by Subject|0|||
145326252|NCT01564459|524043117|FG002|Run-In|Withdrawal by Subject|0|||
145326253|NCT01564459|524043115|FG000|Double-blind Treatment|Adverse Event|0|||
145326254|NCT01564459|524043116|FG001|Double-blind Treatment|Adverse Event|0|||
145326255|NCT01564459|524043117|FG002|Double-blind Treatment|Adverse Event|1|||
145326256|NCT02080832|524043122|FG000|Overall Study|Excluded from analysis by MRI|9|||
145326257|NCT02080832|524043123|FG001|Overall Study|Excluded from analysis by MRI|10|||
145326258|NCT02080832|524043124|FG002|Overall Study|Excluded from analysis by MRI|14|||
145326259|NCT02080832|524043122|FG000|Overall Study|Lost to Follow-up|0|||
145326260|NCT02080832|524043123|FG001|Overall Study|Lost to Follow-up|2|||
145326261|NCT02080832|524043124|FG002|Overall Study|Lost to Follow-up|2|||
145326262|NCT01392326|524043133|FG000|Overall Study|Death|2|||
145326263|NCT01392326|524043134|FG001|Overall Study|Death|0|||
145326264|NCT01392326|524043135|FG002|Overall Study|Death|0|||
145326265|NCT01392326|524043133|FG000|Overall Study|Withdrawal by Subject|12|||
145326266|NCT01392326|524043134|FG001|Overall Study|Withdrawal by Subject|11|||
145326267|NCT01392326|524043135|FG002|Overall Study|Withdrawal by Subject|15|||
145620635|NCT03621982|525125135|FG011|Overall Study|Investigator/Sponsor decision|4|||
145326268|NCT01392326|524043133|FG000|Overall Study|Protocol Violation|2|||
145326269|NCT01392326|524043134|FG001|Overall Study|Protocol Violation|0|||
145326270|NCT01392326|524043135|FG002|Overall Study|Protocol Violation|0|||
145326271|NCT01392326|524043133|FG000|Overall Study|Pregnancy|0|||
145326272|NCT01392326|524043134|FG001|Overall Study|Pregnancy|0|||
145326273|NCT01392326|524043135|FG002|Overall Study|Pregnancy|1|||
145326274|NCT01392326|524043133|FG000|Overall Study|Physician Decision|7|||
145326275|NCT01392326|524043134|FG001|Overall Study|Physician Decision|5|||
145620636|NCT03621982|525125136|FG012|Overall Study|Investigator/Sponsor decision|0|||
145326276|NCT01392326|524043135|FG002|Overall Study|Physician Decision|2|||
145326277|NCT01392326|524043133|FG000|Overall Study|Lost to Follow-up|1|||
145326278|NCT01392326|524043134|FG001|Overall Study|Lost to Follow-up|3|||
145326279|NCT01392326|524043135|FG002|Overall Study|Lost to Follow-up|4|||
145326280|NCT01392326|524043133|FG000|Overall Study|Lack of Efficacy|14|||
145326281|NCT01392326|524043134|FG001|Overall Study|Lack of Efficacy|10|||
145326282|NCT01392326|524043135|FG002|Overall Study|Lack of Efficacy|15|||
145326283|NCT01392326|524043133|FG000|Overall Study|Adverse Event|9|||
145326284|NCT01392326|524043134|FG001|Overall Study|Adverse Event|6|||
145326285|NCT01392326|524043135|FG002|Overall Study|Adverse Event|11|||
145326286|NCT00094094|524043138|FG000|Overall Study|Death|2|||
145326287|NCT00094094|524043138|FG000|Overall Study|Lack of Efficacy|23|||
145326288|NCT00094094|524043138|FG000|Overall Study|Adverse Event|7|||
145326289|NCT06029959|524044865|FG000|Overall Study|Physician Decision|6|||
145326290|NCT00003138|524044866|FG000|Step 1|Reasons off treatment not documented|60|||
145326291|NCT00003138|524044867|FG001|Step 1|Reasons off treatment not documented|57|||
145326292|NCT00003138|524044866|FG000|Step 1|Never started treatment|1|||
145326293|NCT00003138|524044867|FG001|Step 1|Never started treatment|0|||
145326294|NCT00003138|524044866|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
145326295|NCT00003138|524044867|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
145326296|NCT00003138|524044866|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
145326297|NCT00003138|524044867|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
145326298|NCT00003138|524044866|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
145326299|NCT00003138|524044867|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
145326300|NCT00003138|524044866|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
145326301|NCT00003138|524044867|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
145326302|NCT04495283|524044868|FG000|Overall Study|Physician Decision|0|||
145326303|NCT04495283|524044869|FG001|Overall Study|Physician Decision|0|||
145326304|NCT04495283|524044870|FG002|Overall Study|Physician Decision|1|||
145326305|NCT04495283|524044868|FG000|Overall Study|Withdrawal by Subject|0|||
145326306|NCT04495283|524044869|FG001|Overall Study|Withdrawal by Subject|1|||
145326307|NCT04495283|524044870|FG002|Overall Study|Withdrawal by Subject|1|||
145326308|NCT04495283|524044868|FG000|Overall Study|Other|1|||
145326309|NCT04495283|524044869|FG001|Overall Study|Other|0|||
145326310|NCT04495283|524044870|FG002|Overall Study|Other|1|||
145326311|NCT02091141|524044871|FG000|Overall Study|Death|280|||
145326312|NCT02091141|524044872|FG001|Overall Study|Death|118|||
145326313|NCT02091141|524044873|FG002|Overall Study|Death|46|||
145326314|NCT02091141|524044874|FG003|Overall Study|Death|13|||
145326315|NCT02091141|524044875|FG004|Overall Study|Death|31|||
145326316|NCT02091141|524044876|FG005|Overall Study|Death|16|||
145326317|NCT02091141|524044877|FG006|Overall Study|Death|12|||
145326318|NCT02091141|524044871|FG000|Overall Study|Withdrawal by Subject|21|||
145326319|NCT02091141|524044872|FG001|Overall Study|Withdrawal by Subject|13|||
145326320|NCT02091141|524044873|FG002|Overall Study|Withdrawal by Subject|3|||
145326321|NCT02091141|524044874|FG003|Overall Study|Withdrawal by Subject|2|||
145326322|NCT02091141|524044875|FG004|Overall Study|Withdrawal by Subject|2|||
145326323|NCT02091141|524044876|FG005|Overall Study|Withdrawal by Subject|3|||
145326324|NCT02091141|524044877|FG006|Overall Study|Withdrawal by Subject|0|||
145326325|NCT02091141|524044871|FG000|Overall Study|Lost to Follow-up|21|||
145326326|NCT02091141|524044872|FG001|Overall Study|Lost to Follow-up|5|||
145326327|NCT02091141|524044873|FG002|Overall Study|Lost to Follow-up|1|||
145326328|NCT02091141|524044874|FG003|Overall Study|Lost to Follow-up|0|||
145326329|NCT02091141|524044875|FG004|Overall Study|Lost to Follow-up|1|||
145326330|NCT02091141|524044876|FG005|Overall Study|Lost to Follow-up|2|||
145326331|NCT02091141|524044877|FG006|Overall Study|Lost to Follow-up|0|||
145326332|NCT02091141|524044871|FG000|Overall Study|Reason Not Specified|6|||
145326333|NCT02091141|524044872|FG001|Overall Study|Reason Not Specified|5|||
145326334|NCT02091141|524044873|FG002|Overall Study|Reason Not Specified|2|||
145326335|NCT02091141|524044874|FG003|Overall Study|Reason Not Specified|0|||
145326336|NCT02091141|524044875|FG004|Overall Study|Reason Not Specified|0|||
145326337|NCT02091141|524044876|FG005|Overall Study|Reason Not Specified|0|||
145326338|NCT02091141|524044877|FG006|Overall Study|Reason Not Specified|1|||
145326339|NCT02091141|524044871|FG000|Overall Study|Study Ended by Sponsor|1|||
145326340|NCT02091141|524044872|FG001|Overall Study|Study Ended by Sponsor|9|||
145326341|NCT02091141|524044873|FG002|Overall Study|Study Ended by Sponsor|0|||
145326342|NCT02091141|524044874|FG003|Overall Study|Study Ended by Sponsor|0|||
145326343|NCT02091141|524044875|FG004|Overall Study|Study Ended by Sponsor|0|||
145326344|NCT02091141|524044876|FG005|Overall Study|Study Ended by Sponsor|0|||
145326345|NCT02091141|524044877|FG006|Overall Study|Study Ended by Sponsor|0|||
145326346|NCT02091141|524044871|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
145326347|NCT02091141|524044872|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
145326348|NCT02091141|524044873|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
145326349|NCT02091141|524044874|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
145326350|NCT02091141|524044875|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
145326351|NCT02091141|524044876|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
145570906|NCT01403974|524950066|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
145326352|NCT02091141|524044877|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
145326353|NCT04440449|524044878|FG000|Overall Study|Lost to Follow-up|2|||
145326354|NCT04440449|524044879|FG001|Overall Study|Lost to Follow-up|0|||
145326355|NCT03253744|524044883|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
145326356|NCT03253744|524044884|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
145326357|NCT03253744|524044885|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
145326358|NCT03253744|524044886|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
145326359|NCT01134627|524044889|FG000|Overall Study|Adverse Event|47|||
145326360|NCT01134627|524044890|FG001|Overall Study|Adverse Event|31|||
145326361|NCT01134627|524044889|FG000|Overall Study|Lost to Follow-up|1|||
145326362|NCT01134627|524044890|FG001|Overall Study|Lost to Follow-up|2|||
145326363|NCT01134627|524044889|FG000|Overall Study|Protocol Violation|3|||
145326364|NCT01134627|524044890|FG001|Overall Study|Protocol Violation|5|||
145326365|NCT01134627|524044889|FG000|Overall Study|Lack of Efficacy|2|||
145326366|NCT01134627|524044890|FG001|Overall Study|Lack of Efficacy|12|||
145326367|NCT01134627|524044889|FG000|Overall Study|Withdrawal by Subject|4|||
145326368|NCT01134627|524044890|FG001|Overall Study|Withdrawal by Subject|3|||
145326369|NCT01134627|524044889|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
145326370|NCT01134627|524044890|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
145326371|NCT01134627|524044889|FG000|Overall Study|Other|11|||
145326372|NCT01134627|524044890|FG001|Overall Study|Other|14|||
145326373|NCT00977431|524044891|FG000|Overall Study|Other than listed|1|||
145326374|NCT00977431|524044892|FG001|Overall Study|Other than listed|0|||
145326375|NCT00977431|524044893|FG002|Overall Study|Other than listed|0|||
145326376|NCT00977431|524044894|FG003|Overall Study|Other than listed|0|||
145326377|NCT00977431|524044895|FG004|Overall Study|Other than listed|2|||
145326378|NCT00977431|524044891|FG000|Overall Study|Protocol Violation|0|||
145326379|NCT00977431|524044892|FG001|Overall Study|Protocol Violation|0|||
145326380|NCT00977431|524044893|FG002|Overall Study|Protocol Violation|1|||
145326381|NCT00977431|524044894|FG003|Overall Study|Protocol Violation|0|||
145326382|NCT00977431|524044895|FG004|Overall Study|Protocol Violation|0|||
145326383|NCT00977431|524044891|FG000|Overall Study|Adverse Event|3|||
145326384|NCT00977431|524044892|FG001|Overall Study|Adverse Event|0|||
145326385|NCT00977431|524044893|FG002|Overall Study|Adverse Event|4|||
145326386|NCT00977431|524044894|FG003|Overall Study|Adverse Event|0|||
145326387|NCT00977431|524044895|FG004|Overall Study|Adverse Event|6|||
145326388|NCT00977431|524044891|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
145326389|NCT00977431|524044892|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
145326390|NCT00977431|524044893|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
145326391|NCT00977431|524044894|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
145326392|NCT00977431|524044895|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
145326393|NCT00977431|524044891|FG000|Overall Study|Progressive disease|2|||
145326394|NCT00977431|524044892|FG001|Overall Study|Progressive disease|6|||
145326395|NCT00977431|524044893|FG002|Overall Study|Progressive disease|1|||
145326396|NCT00977431|524044894|FG003|Overall Study|Progressive disease|3|||
145326397|NCT00977431|524044895|FG004|Overall Study|Progressive disease|5|||
145326398|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
145326399|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
145326400|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
145326401|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
145326402|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
145326403|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
145326404|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
145326405|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
145326406|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
145326407|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
145326408|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Subject decision|1|||
145326409|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Subject decision|1|||
145326410|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
145326411|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
145326412|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
145326413|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
145326414|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
145326415|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
145326416|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
145326417|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
145326418|NCT00518882|524044901|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
145326419|NCT00518882|524044902|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
145326420|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
145326421|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
145326422|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
145326423|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
145326424|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
145326425|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
145326426|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
145326427|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
145412075|NCT03244189|524362174|FG001|Overall Study|Protocol Violation|2|||
145326428|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
145326429|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
145326430|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
145412076|NCT03244189|524362173|FG000|Overall Study|Withdrawal by Subject|45|||
145326431|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
145326432|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
145326433|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
145326434|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
145326435|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
145326436|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
145326437|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
145326438|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
145326439|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
145326440|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
145326441|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
145570907|NCT01403974|524950067|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
145326442|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
145326443|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
145326444|NCT00518882|524044901|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
145326445|NCT00518882|524044902|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
145326446|NCT02696031|524044903|FG000|Up to Week 24|Adverse Event|2|||
145326447|NCT02696031|524044904|FG001|Up to Week 24|Adverse Event|4|||
145326448|NCT02696031|524044905|FG002|Up to Week 24|Adverse Event|2|||
145326449|NCT02696031|524044906|FG003|Up to Week 24|Adverse Event|0|||
145326450|NCT02696031|524044907|FG004|Up to Week 24|Adverse Event|0|||
145326451|NCT02696031|524044908|FG005|Up to Week 24|Adverse Event|0|||
145326452|NCT02696031|524044903|FG000|Up to Week 24|Lack of Efficacy|2|||
145326453|NCT02696031|524044904|FG001|Up to Week 24|Lack of Efficacy|1|||
145326454|NCT02696031|524044905|FG002|Up to Week 24|Lack of Efficacy|2|||
145326455|NCT02696031|524044906|FG003|Up to Week 24|Lack of Efficacy|0|||
145326456|NCT02696031|524044907|FG004|Up to Week 24|Lack of Efficacy|0|||
145326457|NCT02696031|524044908|FG005|Up to Week 24|Lack of Efficacy|0|||
145326458|NCT02696031|524044903|FG000|Up to Week 24|Lost to Follow-up|0|||
145326459|NCT02696031|524044904|FG001|Up to Week 24|Lost to Follow-up|1|||
145326460|NCT02696031|524044905|FG002|Up to Week 24|Lost to Follow-up|1|||
145326461|NCT02696031|524044906|FG003|Up to Week 24|Lost to Follow-up|0|||
145326462|NCT02696031|524044907|FG004|Up to Week 24|Lost to Follow-up|0|||
145326463|NCT02696031|524044908|FG005|Up to Week 24|Lost to Follow-up|0|||
145326464|NCT02696031|524044903|FG000|Up to Week 24|Physician Decision|1|||
145326465|NCT02696031|524044904|FG001|Up to Week 24|Physician Decision|0|||
145326466|NCT02696031|524044905|FG002|Up to Week 24|Physician Decision|1|||
145326467|NCT02696031|524044906|FG003|Up to Week 24|Physician Decision|0|||
145326468|NCT02696031|524044907|FG004|Up to Week 24|Physician Decision|0|||
145326469|NCT02696031|524044908|FG005|Up to Week 24|Physician Decision|0|||
145326470|NCT02696031|524044903|FG000|Up to Week 24|Protocol Violation|1|||
145326471|NCT02696031|524044904|FG001|Up to Week 24|Protocol Violation|0|||
145570908|NCT01403974|524950068|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
145570909|NCT01403974|524950069|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
145570910|NCT01403974|524950070|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
145570911|NCT01403974|524950071|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
145570912|NCT01403974|524950072|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
145570913|NCT01403974|524950073|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
145570914|NCT01403974|524950074|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
145570915|NCT01403974|524950075|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
145570916|NCT01403974|524950076|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
145570917|NCT01403974|524950077|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
145570918|NCT01403974|524950078|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
145570919|NCT01403974|524950079|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
145570920|NCT01403974|524950064|FG000|Overall Study|Refused to continue study medication|0|||
145570921|NCT01403974|524950065|FG001|Overall Study|Refused to continue study medication|0|||
145570922|NCT01403974|524950066|FG002|Overall Study|Refused to continue study medication|0|||
145570923|NCT01403974|524950067|FG003|Overall Study|Refused to continue study medication|0|||
145570924|NCT01403974|524950068|FG004|Overall Study|Refused to continue study medication|0|||
145570925|NCT01403974|524950069|FG005|Overall Study|Refused to continue study medication|1|||
145570926|NCT01403974|524950070|FG006|Overall Study|Refused to continue study medication|0|||
145570927|NCT01403974|524950071|FG007|Overall Study|Refused to continue study medication|0|||
145570928|NCT01403974|524950072|FG008|Overall Study|Refused to continue study medication|1|||
145570929|NCT01403974|524950073|FG009|Overall Study|Refused to continue study medication|0|||
145570930|NCT01403974|524950074|FG010|Overall Study|Refused to continue study medication|1|||
145326472|NCT02696031|524044905|FG002|Up to Week 24|Protocol Violation|0|||
145326473|NCT02696031|524044906|FG003|Up to Week 24|Protocol Violation|0|||
145326474|NCT02696031|524044907|FG004|Up to Week 24|Protocol Violation|0|||
145326475|NCT02696031|524044908|FG005|Up to Week 24|Protocol Violation|0|||
145326476|NCT02696031|524044903|FG000|Up to Week 24|Withdrawal by Subject|4|||
145326477|NCT02696031|524044904|FG001|Up to Week 24|Withdrawal by Subject|1|||
145326478|NCT02696031|524044905|FG002|Up to Week 24|Withdrawal by Subject|5|||
145326479|NCT02696031|524044906|FG003|Up to Week 24|Withdrawal by Subject|0|||
145326480|NCT02696031|524044907|FG004|Up to Week 24|Withdrawal by Subject|0|||
145326481|NCT02696031|524044908|FG005|Up to Week 24|Withdrawal by Subject|0|||
145326482|NCT02696031|524044903|FG000|Up to Week 52|Adverse Event|4|||
145326483|NCT02696031|524044904|FG001|Up to Week 52|Adverse Event|5|||
145326484|NCT02696031|524044905|FG002|Up to Week 52|Adverse Event|3|||
145326485|NCT02696031|524044906|FG003|Up to Week 52|Adverse Event|0|||
145326486|NCT02696031|524044907|FG004|Up to Week 52|Adverse Event|0|||
145326487|NCT02696031|524044908|FG005|Up to Week 52|Adverse Event|0|||
145326488|NCT02696031|524044903|FG000|Up to Week 52|Lack of Efficacy|10|||
145326489|NCT02696031|524044904|FG001|Up to Week 52|Lack of Efficacy|7|||
145326490|NCT02696031|524044905|FG002|Up to Week 52|Lack of Efficacy|11|||
145326491|NCT02696031|524044906|FG003|Up to Week 52|Lack of Efficacy|0|||
145326492|NCT02696031|524044907|FG004|Up to Week 52|Lack of Efficacy|0|||
145326493|NCT02696031|524044908|FG005|Up to Week 52|Lack of Efficacy|0|||
145326494|NCT02696031|524044903|FG000|Up to Week 52|Lost to Follow-up|1|||
145326495|NCT02696031|524044904|FG001|Up to Week 52|Lost to Follow-up|1|||
145326496|NCT02696031|524044905|FG002|Up to Week 52|Lost to Follow-up|1|||
145326497|NCT02696031|524044906|FG003|Up to Week 52|Lost to Follow-up|0|||
145326498|NCT02696031|524044907|FG004|Up to Week 52|Lost to Follow-up|0|||
145326499|NCT02696031|524044908|FG005|Up to Week 52|Lost to Follow-up|0|||
145326500|NCT02696031|524044903|FG000|Up to Week 52|Physician Decision|1|||
145326501|NCT02696031|524044904|FG001|Up to Week 52|Physician Decision|1|||
145326502|NCT02696031|524044905|FG002|Up to Week 52|Physician Decision|2|||
145326503|NCT02696031|524044906|FG003|Up to Week 52|Physician Decision|0|||
145326504|NCT02696031|524044907|FG004|Up to Week 52|Physician Decision|0|||
145326505|NCT02696031|524044908|FG005|Up to Week 52|Physician Decision|0|||
145326506|NCT02696031|524044903|FG000|Up to Week 52|Pregnancy|0|||
145326507|NCT02696031|524044904|FG001|Up to Week 52|Pregnancy|2|||
145326508|NCT02696031|524044905|FG002|Up to Week 52|Pregnancy|0|||
145326509|NCT02696031|524044906|FG003|Up to Week 52|Pregnancy|0|||
145326510|NCT02696031|524044907|FG004|Up to Week 52|Pregnancy|0|||
145326511|NCT02696031|524044908|FG005|Up to Week 52|Pregnancy|0|||
145326512|NCT02696031|524044903|FG000|Up to Week 52|Protocol Violation|1|||
145326513|NCT02696031|524044904|FG001|Up to Week 52|Protocol Violation|0|||
145326514|NCT02696031|524044905|FG002|Up to Week 52|Protocol Violation|0|||
145326515|NCT02696031|524044906|FG003|Up to Week 52|Protocol Violation|0|||
145326516|NCT02696031|524044907|FG004|Up to Week 52|Protocol Violation|0|||
145326517|NCT02696031|524044908|FG005|Up to Week 52|Protocol Violation|0|||
145326518|NCT02696031|524044903|FG000|Up to Week 52|Withdrawal by Subject|12|||
145326519|NCT02696031|524044904|FG001|Up to Week 52|Withdrawal by Subject|3|||
145326520|NCT02696031|524044905|FG002|Up to Week 52|Withdrawal by Subject|9|||
145326521|NCT02696031|524044906|FG003|Up to Week 52|Withdrawal by Subject|0|||
145326522|NCT02696031|524044907|FG004|Up to Week 52|Withdrawal by Subject|0|||
145326523|NCT02696031|524044908|FG005|Up to Week 52|Withdrawal by Subject|0|||
145326524|NCT02696031|524044903|FG000|Up to Week 104|Pregnancy|0|||
145326525|NCT02696031|524044904|FG001|Up to Week 104|Pregnancy|2|||
145326526|NCT02696031|524044905|FG002|Up to Week 104|Pregnancy|1|||
145326527|NCT02696031|524044906|FG003|Up to Week 104|Pregnancy|0|||
145326528|NCT02696031|524044907|FG004|Up to Week 104|Pregnancy|0|||
145326529|NCT02696031|524044908|FG005|Up to Week 104|Pregnancy|0|||
145326530|NCT02696031|524044903|FG000|Up to Week 104|Withdrawal by Subject|15|||
145326531|NCT02696031|524044904|FG001|Up to Week 104|Withdrawal by Subject|10|||
145326532|NCT02696031|524044905|FG002|Up to Week 104|Withdrawal by Subject|16|||
145326533|NCT02696031|524044906|FG003|Up to Week 104|Withdrawal by Subject|0|||
145326534|NCT02696031|524044907|FG004|Up to Week 104|Withdrawal by Subject|0|||
145326535|NCT02696031|524044908|FG005|Up to Week 104|Withdrawal by Subject|0|||
145326536|NCT02696031|524044903|FG000|Up to Week 104|Protocol Violation|1|||
145326537|NCT02696031|524044904|FG001|Up to Week 104|Protocol Violation|0|||
145570931|NCT01403974|524950075|FG011|Overall Study|Refused to continue study medication|0|||
145570932|NCT01403974|524950076|FG012|Overall Study|Refused to continue study medication|0|||
145570933|NCT01403974|524950077|FG013|Overall Study|Refused to continue study medication|0|||
145570934|NCT01403974|524950078|FG014|Overall Study|Refused to continue study medication|0|||
145570935|NCT01403974|524950079|FG015|Overall Study|Refused to continue study medication|4|||
145570936|NCT01403974|524950064|FG000|Overall Study|Adverse Event|0|||
145326538|NCT02696031|524044905|FG002|Up to Week 104|Protocol Violation|0|||
145326539|NCT02696031|524044906|FG003|Up to Week 104|Protocol Violation|0|||
145326540|NCT02696031|524044907|FG004|Up to Week 104|Protocol Violation|0|||
145326541|NCT02696031|524044908|FG005|Up to Week 104|Protocol Violation|0|||
145326542|NCT02696031|524044903|FG000|Up to Week 104|Physician Decision|1|||
145326543|NCT02696031|524044904|FG001|Up to Week 104|Physician Decision|2|||
145326544|NCT02696031|524044905|FG002|Up to Week 104|Physician Decision|3|||
145326545|NCT02696031|524044906|FG003|Up to Week 104|Physician Decision|0|||
145326546|NCT02696031|524044907|FG004|Up to Week 104|Physician Decision|0|||
145326547|NCT02696031|524044908|FG005|Up to Week 104|Physician Decision|0|||
145326548|NCT02696031|524044903|FG000|Up to Week 104|Lost to Follow-up|2|||
145326549|NCT02696031|524044904|FG001|Up to Week 104|Lost to Follow-up|3|||
145570937|NCT01403974|524950065|FG001|Overall Study|Adverse Event|0|||
145326550|NCT02696031|524044905|FG002|Up to Week 104|Lost to Follow-up|1|||
145326551|NCT02696031|524044906|FG003|Up to Week 104|Lost to Follow-up|0|||
145326552|NCT02696031|524044907|FG004|Up to Week 104|Lost to Follow-up|0|||
145326553|NCT02696031|524044908|FG005|Up to Week 104|Lost to Follow-up|0|||
145326554|NCT02696031|524044903|FG000|Up to Week 104|Lack of Efficacy|13|||
145326555|NCT02696031|524044904|FG001|Up to Week 104|Lack of Efficacy|12|||
145326556|NCT02696031|524044905|FG002|Up to Week 104|Lack of Efficacy|11|||
145326557|NCT02696031|524044906|FG003|Up to Week 104|Lack of Efficacy|0|||
145326558|NCT02696031|524044907|FG004|Up to Week 104|Lack of Efficacy|0|||
145326559|NCT02696031|524044908|FG005|Up to Week 104|Lack of Efficacy|0|||
145326560|NCT02696031|524044903|FG000|Up to Week 104|Adverse Event|7|||
145326561|NCT02696031|524044904|FG001|Up to Week 104|Adverse Event|11|||
145326562|NCT02696031|524044905|FG002|Up to Week 104|Adverse Event|5|||
145326563|NCT02696031|524044906|FG003|Up to Week 104|Adverse Event|0|||
145326564|NCT02696031|524044907|FG004|Up to Week 104|Adverse Event|0|||
145326565|NCT02696031|524044908|FG005|Up to Week 104|Adverse Event|0|||
145326566|NCT02696031|524044903|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145326567|NCT02696031|524044904|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
145326568|NCT02696031|524044905|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145326569|NCT02696031|524044906|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145326570|NCT02696031|524044907|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145326571|NCT02696031|524044908|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
145326572|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145326573|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145326574|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
145326575|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
145326576|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
145326577|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
145326578|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145326579|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145326580|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145326581|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
145326582|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
145326583|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
145326584|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145326585|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145326586|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145326587|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
145326588|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145326589|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
145326590|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145326591|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145326592|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145326593|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145326594|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
145326595|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
145326596|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145326597|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145326598|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
145326599|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
145326600|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
145326601|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
145326602|NCT02696031|524044903|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145326603|NCT02696031|524044904|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145326604|NCT02696031|524044905|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
145326605|NCT02696031|524044906|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
145326606|NCT02696031|524044907|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
145326607|NCT02696031|524044908|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
145326608|NCT03856593|524044909|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
145326609|NCT03856593|524044910|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
145326610|NCT01901874|524044911|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
145326611|NCT01901874|524044911|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
145326612|NCT01901874|524044911|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
145326613|NCT01901874|524044911|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
145326614|NCT01901874|524044911|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
145326615|NCT01901874|524044911|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
145570938|NCT01403974|524950066|FG002|Overall Study|Adverse Event|1|||
145570939|NCT01403974|524950067|FG003|Overall Study|Adverse Event|0|||
145326616|NCT02039414|524044924|FG000|Overall Study|Delivered|1|||
145326617|NCT02039414|524044925|FG001|Overall Study|Delivered|1|||
145326618|NCT02039414|524044924|FG000|Overall Study|Lost to Follow-up|2|||
145326619|NCT02039414|524044925|FG001|Overall Study|Lost to Follow-up|0|||
145620637|NCT03621982|525125137|FG013|Overall Study|Investigator/Sponsor decision|2|||
145620638|NCT03621982|525125124|FG000|Overall Study|Death|2|||
145620639|NCT03621982|525125125|FG001|Overall Study|Death|4|||
145620640|NCT03621982|525125126|FG002|Overall Study|Death|4|||
145620641|NCT03621982|525125127|FG003|Overall Study|Death|3|||
145326620|NCT02039414|524044924|FG000|Overall Study|Protocol Violation|3|||
145326621|NCT02039414|524044925|FG001|Overall Study|Protocol Violation|1|||
145326622|NCT03832738|524044928|FG000|Overall Study|Withdrawal by Subject|6|||
145326623|NCT03832738|524044929|FG001|Overall Study|Withdrawal by Subject|7|||
145326624|NCT03832738|524044930|FG002|Overall Study|Withdrawal by Subject|16|||
145326625|NCT03832738|524044928|FG000|Overall Study|Physician Decision|0|||
145326626|NCT03832738|524044929|FG001|Overall Study|Physician Decision|1|||
145326627|NCT03832738|524044930|FG002|Overall Study|Physician Decision|2|||
145326628|NCT03832738|524044928|FG000|Overall Study|Adverse Event|2|||
145326629|NCT03832738|524044929|FG001|Overall Study|Adverse Event|3|||
145326630|NCT03832738|524044930|FG002|Overall Study|Adverse Event|1|||
145326631|NCT03832738|524044928|FG000|Overall Study|Pregnancy|0|||
145326632|NCT03832738|524044929|FG001|Overall Study|Pregnancy|1|||
145326633|NCT03832738|524044930|FG002|Overall Study|Pregnancy|0|||
145326634|NCT03852459|524044931|FG000|Overall Study|Adverse Event|2|||
145326635|NCT03852459|524044932|FG001|Overall Study|Adverse Event|2|||
145326636|NCT03852459|524044931|FG000|Overall Study|Withdrawal by Subject|1|||
145326637|NCT03852459|524044932|FG001|Overall Study|Withdrawal by Subject|1|||
145326638|NCT00049842|524044933|FG000|Treatment Phase|Adverse Event|47|||
145326639|NCT00049842|524044934|FG001|Treatment Phase|Adverse Event|12|||
145326640|NCT00049842|524044933|FG000|Treatment Phase|Withdrawal by Subject|35|||
145326641|NCT00049842|524044934|FG001|Treatment Phase|Withdrawal by Subject|46|||
145326642|NCT00049842|524044933|FG000|Treatment Phase|Non-compliance with protocol|7|||
145326643|NCT00049842|524044934|FG001|Treatment Phase|Non-compliance with protocol|8|||
145326644|NCT00049842|524044933|FG000|Treatment Phase|Lost to Follow-up|4|||
145326645|NCT00049842|524044934|FG001|Treatment Phase|Lost to Follow-up|8|||
145326646|NCT00049842|524044933|FG000|Treatment Phase|Administrative|0|||
145326647|NCT00049842|524044934|FG001|Treatment Phase|Administrative|3|||
145326648|NCT00049842|524044933|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
145326649|NCT00049842|524044934|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
145326650|NCT00049842|524044933|FG000|Follow-up Phase|Adverse Event|6|||
145326651|NCT00049842|524044934|FG001|Follow-up Phase|Adverse Event|1|||
145326652|NCT00049842|524044933|FG000|Follow-up Phase|Other|1|||
145326653|NCT00049842|524044934|FG001|Follow-up Phase|Other|4|||
145326654|NCT03977701|524044935|FG000|Overall Study|COVID-19 pandemic|0|||
145326655|NCT03977701|524044936|FG001|Overall Study|COVID-19 pandemic|0|||
145326656|NCT03977701|524044937|FG002|Overall Study|COVID-19 pandemic|0|||
145326657|NCT03977701|524044938|FG003|Overall Study|COVID-19 pandemic|0|||
145326658|NCT03977701|524044939|FG004|Overall Study|COVID-19 pandemic|0|||
145326659|NCT03977701|524044940|FG005|Overall Study|COVID-19 pandemic|1|||
145326660|NCT03977701|524044941|FG006|Overall Study|COVID-19 pandemic|0|||
145326661|NCT03977701|524044942|FG007|Overall Study|COVID-19 pandemic|1|||
145326662|NCT03977701|524044943|FG008|Overall Study|COVID-19 pandemic|0|||
145326663|NCT03977701|524044944|FG009|Overall Study|COVID-19 pandemic|0|||
145326664|NCT01347866|524044945|FG000|Overall Study|Death|0|||
145326665|NCT01347866|524044946|FG001|Overall Study|Death|0|||
145326666|NCT01347866|524044947|FG002|Overall Study|Death|0|||
145326667|NCT01347866|524044948|FG003|Overall Study|Death|1|||
145326668|NCT01347866|524044949|FG004|Overall Study|Death|2|||
145326669|NCT01347866|524044950|FG005|Overall Study|Death|2|||
145326670|NCT01347866|524044951|FG006|Overall Study|Death|1|||
145326671|NCT01347866|524044952|FG007|Overall Study|Death|0|||
145326672|NCT01347866|524044953|FG008|Overall Study|Death|4|||
145620642|NCT03621982|525125128|FG004|Overall Study|Death|8|||
145326673|NCT01347866|524044954|FG009|Overall Study|Death|1|||
145620643|NCT03621982|525125129|FG005|Overall Study|Death|4|||
145326674|NCT01347866|524044955|FG010|Overall Study|Death|3|||
145326675|NCT01347866|524044956|FG011|Overall Study|Death|1|||
145326676|NCT01347866|524044957|FG012|Overall Study|Death|2|||
145326677|NCT01347866|524044958|FG013|Overall Study|Death|0|||
145326678|NCT01347866|524044959|FG014|Overall Study|Death|0|||
145326679|NCT01347866|524044960|FG015|Overall Study|Death|1|||
145326680|NCT01347866|524044961|FG016|Overall Study|Death|0|||
145326681|NCT01347866|524044945|FG000|Overall Study|Lost to Follow-up|0|||
145326682|NCT01347866|524044946|FG001|Overall Study|Lost to Follow-up|0|||
145326683|NCT01347866|524044947|FG002|Overall Study|Lost to Follow-up|0|||
145326684|NCT01347866|524044948|FG003|Overall Study|Lost to Follow-up|0|||
145326685|NCT01347866|524044949|FG004|Overall Study|Lost to Follow-up|0|||
145326686|NCT01347866|524044950|FG005|Overall Study|Lost to Follow-up|0|||
145326687|NCT01347866|524044951|FG006|Overall Study|Lost to Follow-up|0|||
145326688|NCT01347866|524044952|FG007|Overall Study|Lost to Follow-up|1|||
145326689|NCT01347866|524044953|FG008|Overall Study|Lost to Follow-up|1|||
145326690|NCT01347866|524044954|FG009|Overall Study|Lost to Follow-up|0|||
145326691|NCT01347866|524044955|FG010|Overall Study|Lost to Follow-up|0|||
145326692|NCT01347866|524044956|FG011|Overall Study|Lost to Follow-up|0|||
145326693|NCT01347866|524044957|FG012|Overall Study|Lost to Follow-up|0|||
145326694|NCT01347866|524044958|FG013|Overall Study|Lost to Follow-up|0|||
145326695|NCT01347866|524044959|FG014|Overall Study|Lost to Follow-up|0|||
145326696|NCT01347866|524044960|FG015|Overall Study|Lost to Follow-up|0|||
145326697|NCT01347866|524044961|FG016|Overall Study|Lost to Follow-up|0|||
145326698|NCT01347866|524044945|FG000|Overall Study|Other|3|||
145326699|NCT01347866|524044946|FG001|Overall Study|Other|1|||
145326700|NCT01347866|524044947|FG002|Overall Study|Other|1|||
145326701|NCT01347866|524044948|FG003|Overall Study|Other|4|||
145326702|NCT01347866|524044949|FG004|Overall Study|Other|5|||
145326703|NCT01347866|524044950|FG005|Overall Study|Other|0|||
145326704|NCT01347866|524044951|FG006|Overall Study|Other|5|||
145326705|NCT01347866|524044952|FG007|Overall Study|Other|3|||
145326706|NCT01347866|524044953|FG008|Overall Study|Other|22|||
145326707|NCT01347866|524044954|FG009|Overall Study|Other|5|||
145326708|NCT01347866|524044955|FG010|Overall Study|Other|0|||
145326709|NCT01347866|524044956|FG011|Overall Study|Other|3|||
145326710|NCT01347866|524044957|FG012|Overall Study|Other|4|||
145326711|NCT01347866|524044958|FG013|Overall Study|Other|4|||
145326712|NCT01347866|524044959|FG014|Overall Study|Other|2|||
145326713|NCT01347866|524044960|FG015|Overall Study|Other|3|||
145326714|NCT01347866|524044961|FG016|Overall Study|Other|0|||
145326715|NCT01347866|524044945|FG000|Overall Study|Subject refused further follow-up|2|||
145326716|NCT01347866|524044946|FG001|Overall Study|Subject refused further follow-up|0|||
145326717|NCT01347866|524044947|FG002|Overall Study|Subject refused further follow-up|0|||
145326718|NCT01347866|524044948|FG003|Overall Study|Subject refused further follow-up|2|||
145326719|NCT01347866|524044949|FG004|Overall Study|Subject refused further follow-up|0|||
145326720|NCT01347866|524044950|FG005|Overall Study|Subject refused further follow-up|1|||
145326721|NCT01347866|524044951|FG006|Overall Study|Subject refused further follow-up|0|||
145326722|NCT01347866|524044952|FG007|Overall Study|Subject refused further follow-up|0|||
145326723|NCT01347866|524044953|FG008|Overall Study|Subject refused further follow-up|4|||
145326724|NCT01347866|524044954|FG009|Overall Study|Subject refused further follow-up|1|||
145326725|NCT01347866|524044955|FG010|Overall Study|Subject refused further follow-up|0|||
145326726|NCT01347866|524044956|FG011|Overall Study|Subject refused further follow-up|0|||
145326727|NCT01347866|524044957|FG012|Overall Study|Subject refused further follow-up|1|||
145326728|NCT01347866|524044958|FG013|Overall Study|Subject refused further follow-up|3|||
145326729|NCT01347866|524044959|FG014|Overall Study|Subject refused further follow-up|1|||
145326730|NCT01347866|524044960|FG015|Overall Study|Subject refused further follow-up|0|||
145326731|NCT01347866|524044961|FG016|Overall Study|Subject refused further follow-up|2|||
145326732|NCT02429934|524044962|FG000|Overall Study|Withdrawal by Subject|0|||
145326733|NCT02429934|524044963|FG001|Overall Study|Withdrawal by Subject|2|||
145326734|NCT02429934|524044962|FG000|Overall Study|Adverse Event|2|||
145326735|NCT02429934|524044963|FG001|Overall Study|Adverse Event|0|||
145326736|NCT02429934|524044962|FG000|Overall Study|Lost to Follow-up|1|||
145326737|NCT02429934|524044963|FG001|Overall Study|Lost to Follow-up|1|||
145326738|NCT02429934|524044962|FG000|Overall Study|Physician Decision|1|||
145326739|NCT02429934|524044963|FG001|Overall Study|Physician Decision|0|||
145326740|NCT00869024|524044964|FG000|Overall Study|Death|2|||
145326741|NCT00869024|524044965|FG001|Overall Study|Death|3|||
145326742|NCT00869024|524044964|FG000|Overall Study|Lost to Follow-up|0|||
145326743|NCT00869024|524044965|FG001|Overall Study|Lost to Follow-up|1|||
145326744|NCT00869024|524044964|FG000|Overall Study|Protocol Violation|0|||
145326745|NCT00869024|524044965|FG001|Overall Study|Protocol Violation|1|||
145326746|NCT03545191|524044973|FG000|Overall Study|Death|1|||
145326747|NCT03545191|524044974|FG001|Overall Study|Death|0|||
145326748|NCT03545191|524044975|FG002|Overall Study|Death|0|||
145326749|NCT03545191|524044973|FG000|Overall Study|Adverse Event|4|||
145326750|NCT03545191|524044974|FG001|Overall Study|Adverse Event|2|||
145326751|NCT03545191|524044975|FG002|Overall Study|Adverse Event|7|||
145326752|NCT03545191|524044973|FG000|Overall Study|Other reasons|3|||
145326753|NCT03545191|524044974|FG001|Overall Study|Other reasons|11|||
145326754|NCT03545191|524044975|FG002|Overall Study|Other reasons|8|||
145326755|NCT03545191|524044973|FG000|Overall Study|Withdrawal by Subject|13|||
145412077|NCT03244189|524362174|FG001|Overall Study|Withdrawal by Subject|23|||
145326756|NCT03545191|524044974|FG001|Overall Study|Withdrawal by Subject|10|||
145326757|NCT03545191|524044975|FG002|Overall Study|Withdrawal by Subject|12|||
145326758|NCT03545191|524044973|FG000|Overall Study|Lost to Follow-up|1|||
145326759|NCT03545191|524044974|FG001|Overall Study|Lost to Follow-up|2|||
145326760|NCT03545191|524044975|FG002|Overall Study|Lost to Follow-up|3|||
145412078|NCT03244189|524362173|FG000|Overall Study|Technical Problems|2|||
145326761|NCT02025751|524044979|FG000|Overall Study|Lost to Follow-up|1|||
145326762|NCT02025751|524044980|FG001|Overall Study|Lost to Follow-up|0|||
145326763|NCT02025751|524044979|FG000|Overall Study|Adverse Event|0|||
145326764|NCT02025751|524044980|FG001|Overall Study|Adverse Event|1|||
145326765|NCT02025751|524044979|FG000|Overall Study|Physician Decision|0|||
145326766|NCT02025751|524044980|FG001|Overall Study|Physician Decision|1|||
145326767|NCT02025751|524044979|FG000|Overall Study|Withdrawal by Subject|0|||
145326768|NCT02025751|524044980|FG001|Overall Study|Withdrawal by Subject|1|||
145326769|NCT00653991|524044981|FG000|3 Month Follow-up|Participant would not respond|150|||
145326770|NCT00653991|524044982|FG001|3 Month Follow-up|Participant would not respond|157|||
145326771|NCT00653991|524044981|FG000|6 Month Follow-up|Participant would not respond|133|||
145326772|NCT00653991|524044982|FG001|6 Month Follow-up|Participant would not respond|141|||
145326773|NCT02181296|524044983|FG000|Overall Study|Lost to Follow-up|7|||
145326774|NCT02181296|524044984|FG001|Overall Study|Lost to Follow-up|6|||
145326775|NCT02939014|524044985|FG000|Overall Study|Lost to Follow-up|1|||
145326776|NCT02939014|524044986|FG001|Overall Study|Lost to Follow-up|0|||
145326777|NCT02939014|524044985|FG000|Overall Study|Death|4|||
145326778|NCT02939014|524044986|FG001|Overall Study|Death|3|||
145326779|NCT03351231|524044989|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
145326780|NCT03351231|524044989|FG000|Combination Therapy Period|Disease progression|2|||
145326781|NCT03351231|524044989|FG000|Combination Therapy Period|Study drug toxicity|1|||
145326782|NCT03351231|524044989|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
145326783|NCT03351231|524044989|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
145326784|NCT03351231|524044989|FG000|Safety Follow-Up Period|Other reason|2|||
145326785|NCT02340221|524044994|FG000|Overall Study|Death|100|||
145326786|NCT02340221|524044995|FG001|Overall Study|Death|197|||
145326787|NCT02340221|524044994|FG000|Overall Study|Withdrawal by Participant|24|||
145326788|NCT02340221|524044995|FG001|Overall Study|Withdrawal by Participant|37|||
145326789|NCT02340221|524044994|FG000|Overall Study|Lost to Follow-up|4|||
145326790|NCT02340221|524044995|FG001|Overall Study|Lost to Follow-up|15|||
145326791|NCT02340221|524044994|FG000|Overall Study|Reason Not Specified|85|||
145326792|NCT02340221|524044995|FG001|Overall Study|Reason Not Specified|165|||
145326793|NCT02340221|524044994|FG000|Overall Study|Study Terminated by Sponsor|1|||
145326794|NCT02340221|524044995|FG001|Overall Study|Study Terminated by Sponsor|3|||
145326795|NCT00518622|524044996|FG000|Overall Study|Lost to Follow-up|0|||
145326796|NCT00518622|524044997|FG001|Overall Study|Lost to Follow-up|0|||
145326797|NCT00518622|524044998|FG002|Overall Study|Lost to Follow-up|1|||
145326798|NCT00518622|524044999|FG003|Overall Study|Lost to Follow-up|0|||
145326799|NCT00518622|524045000|FG004|Overall Study|Lost to Follow-up|0|||
145326800|NCT00518622|524045001|FG005|Overall Study|Lost to Follow-up|0|||
145326801|NCT00518622|524045002|FG006|Overall Study|Lost to Follow-up|0|||
145326802|NCT00518622|524045003|FG007|Overall Study|Lost to Follow-up|0|||
145326803|NCT00518622|524044996|FG000|Overall Study|Study medication taken incorrectly|0|||
145326804|NCT00518622|524044997|FG001|Overall Study|Study medication taken incorrectly|1|||
145326805|NCT00518622|524044998|FG002|Overall Study|Study medication taken incorrectly|0|||
145326806|NCT00518622|524044999|FG003|Overall Study|Study medication taken incorrectly|0|||
145326807|NCT00518622|524045000|FG004|Overall Study|Study medication taken incorrectly|0|||
145326808|NCT00518622|524045001|FG005|Overall Study|Study medication taken incorrectly|0|||
145326809|NCT00518622|524045002|FG006|Overall Study|Study medication taken incorrectly|0|||
145326810|NCT00518622|524045003|FG007|Overall Study|Study medication taken incorrectly|0|||
145326811|NCT03487848|524045004|FG000|Overall Study|Lost to Follow-up|1|||
145326812|NCT03499119|524045005|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
145326813|NCT03499119|524045006|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
145326814|NCT03499119|524045007|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
145326815|NCT03499119|524045008|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
145326816|NCT03499119|524045005|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
145326817|NCT03499119|524045006|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
145326818|NCT03499119|524045007|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
145326819|NCT03499119|524045008|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
145326820|NCT03499119|524045005|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
145326821|NCT03499119|524045006|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
145326822|NCT03499119|524045007|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
145326823|NCT03499119|524045008|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
145326824|NCT03499119|524045005|FG000|Optional Extension Phase|Lost to Follow-up|0|||
145326825|NCT03499119|524045006|FG001|Optional Extension Phase|Lost to Follow-up|0|||
145326826|NCT03499119|524045007|FG002|Optional Extension Phase|Lost to Follow-up|0|||
145326827|NCT03499119|524045008|FG003|Optional Extension Phase|Lost to Follow-up|1|||
145326828|NCT03499119|524045005|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
145326829|NCT03499119|524045006|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
145326830|NCT03499119|524045007|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
145326831|NCT03499119|524045008|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
145326832|NCT03499119|524045005|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
145326833|NCT03499119|524045006|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
145326834|NCT03499119|524045007|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
145326835|NCT03499119|524045008|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
145326836|NCT02333487|524045009|FG000|Overall Study|Adverse Event|0|||
145326837|NCT02333487|524045010|FG001|Overall Study|Adverse Event|2|||
145326838|NCT02333487|524045011|FG002|Overall Study|Adverse Event|0|||
145326839|NCT02631876|524046533|FG000|Overall Study|Death|96|||
145326840|NCT02631876|524046534|FG001|Overall Study|Death|50|||
145412079|NCT03244189|524362174|FG001|Overall Study|Technical Problems|0|||
145326841|NCT02631876|524046533|FG000|Overall Study|Investigator's discretion|1|||
145326842|NCT02631876|524046534|FG001|Overall Study|Investigator's discretion|0|||
145326843|NCT02631876|524046533|FG000|Overall Study|Lost to Follow-up|2|||
145326844|NCT02631876|524046534|FG001|Overall Study|Lost to Follow-up|0|||
145326845|NCT02631876|524046533|FG000|Overall Study|Withdrawal by Subject|16|||
145326846|NCT02631876|524046534|FG001|Overall Study|Withdrawal by Subject|9|||
145326847|NCT02631876|524046533|FG000|Overall Study|Other than specified|4|||
145326848|NCT02631876|524046534|FG001|Overall Study|Other than specified|4|||
145326849|NCT01013649|524046537|FG000|First Step|Withdrawal by Subject|36|||
145326850|NCT01013649|524046538|FG001|First Step|Withdrawal by Subject|19|||
145326851|NCT01013649|524046539|FG002|First Step|Withdrawal by Subject|0|||
145326852|NCT01013649|524046540|FG003|First Step|Withdrawal by Subject|0|||
145326853|NCT01013649|524046537|FG000|First Step|Progression|58|||
145326854|NCT01013649|524046538|FG001|First Step|Progression|23|||
145326855|NCT01013649|524046539|FG002|First Step|Progression|0|||
145326856|NCT01013649|524046540|FG003|First Step|Progression|0|||
145326857|NCT01013649|524046537|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
145326858|NCT01013649|524046538|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
145326859|NCT01013649|524046539|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
145326860|NCT01013649|524046540|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
145326861|NCT01013649|524046537|FG000|First Step|Death|3|||
145326862|NCT01013649|524046538|FG001|First Step|Death|4|||
145326863|NCT01013649|524046539|FG002|First Step|Death|0|||
145326864|NCT01013649|524046540|FG003|First Step|Death|0|||
145326865|NCT01013649|524046537|FG000|First Step|Adverse Event|9|||
145326866|NCT01013649|524046538|FG001|First Step|Adverse Event|5|||
145326867|NCT01013649|524046539|FG002|First Step|Adverse Event|0|||
145326868|NCT01013649|524046540|FG003|First Step|Adverse Event|0|||
145326869|NCT01013649|524046537|FG000|First Step|Other|4|||
145326870|NCT01013649|524046538|FG001|First Step|Other|6|||
145326871|NCT01013649|524046539|FG002|First Step|Other|0|||
145326872|NCT01013649|524046540|FG003|First Step|Other|0|||
145326873|NCT04285567|524046541|FG000|Overall Study|Death|3|||
145326874|NCT04285567|524046542|FG001|Overall Study|Death|3|||
145326875|NCT04285567|524046541|FG000|Overall Study|Lost to Follow-up|1|||
145326876|NCT04285567|524046542|FG001|Overall Study|Lost to Follow-up|1|||
145326877|NCT04285567|524046541|FG000|Overall Study|Reason Not Specified|1|||
145326878|NCT04285567|524046542|FG001|Overall Study|Reason Not Specified|1|||
145326879|NCT04285567|524046541|FG000|Overall Study|Physician Decision|2|||
145326880|NCT04285567|524046542|FG001|Overall Study|Physician Decision|1|||
145326881|NCT04285567|524046541|FG000|Overall Study|Withdrawal by Subject|2|||
145326882|NCT04285567|524046542|FG001|Overall Study|Withdrawal by Subject|6|||
145326883|NCT04285567|524046541|FG000|Overall Study|Adverse Event|1|||
145326884|NCT04285567|524046542|FG001|Overall Study|Adverse Event|0|||
145326885|NCT04285567|524046541|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
145326886|NCT04285567|524046542|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
145326887|NCT01408563|524046543|FG000|Overall Study|Ineligible after consent/ registration|2|||
145326888|NCT02246439|524046549|FG000|Overall Study|Adverse Event|3|||
145326889|NCT02246439|524046550|FG001|Overall Study|Adverse Event|0|||
145326890|NCT02246439|524046549|FG000|Overall Study|Lost to Follow-up|7|||
145326891|NCT02246439|524046550|FG001|Overall Study|Lost to Follow-up|5|||
145326892|NCT02246439|524046549|FG000|Overall Study|Protocol Violation|0|||
145326893|NCT02246439|524046550|FG001|Overall Study|Protocol Violation|2|||
145326894|NCT02246439|524046549|FG000|Overall Study|Physician Decision|0|||
145326895|NCT02246439|524046550|FG001|Overall Study|Physician Decision|1|||
145326896|NCT02246439|524046549|FG000|Overall Study|Unkonwn|1|||
145326897|NCT02246439|524046550|FG001|Overall Study|Unkonwn|3|||
145326898|NCT02246439|524046549|FG000|Overall Study|Withdrawal by Subject|1|||
145326899|NCT02246439|524046550|FG001|Overall Study|Withdrawal by Subject|0|||
145326900|NCT03439852|524046551|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
145326901|NCT03439852|524046552|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
145326902|NCT03439852|524046551|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
145326903|NCT03439852|524046552|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
145326904|NCT03439852|524046551|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
145326905|NCT03439852|524046552|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
145326906|NCT02177136|524046557|FG000|DB Phase|Withdrawal by Subject|2|||
145326907|NCT02177136|524046558|FG001|DB Phase|Withdrawal by Subject|0|||
145326908|NCT02177136|524046559|FG002|DB Phase|Withdrawal by Subject|0|||
145326909|NCT02177136|524046560|FG003|DB Phase|Withdrawal by Subject|0|||
145326910|NCT02177136|524046557|FG000|DB Phase|Discontinued Due to Pruritus|1|||
145326911|NCT02177136|524046558|FG001|DB Phase|Discontinued Due to Pruritus|3|||
145326912|NCT02177136|524046559|FG002|DB Phase|Discontinued Due to Pruritus|0|||
145326913|NCT02177136|524046560|FG003|DB Phase|Discontinued Due to Pruritus|0|||
145326914|NCT02177136|524046557|FG000|DB Phase|Adverse Event|3|||
145326915|NCT02177136|524046558|FG001|DB Phase|Adverse Event|2|||
145326916|NCT02177136|524046559|FG002|DB Phase|Adverse Event|3|||
145326917|NCT02177136|524046560|FG003|DB Phase|Adverse Event|0|||
145326918|NCT02177136|524046557|FG000|DB Phase|Protocol Violation|0|||
145326919|NCT02177136|524046558|FG001|DB Phase|Protocol Violation|0|||
145326920|NCT02177136|524046559|FG002|DB Phase|Protocol Violation|1|||
145326921|NCT02177136|524046560|FG003|DB Phase|Protocol Violation|0|||
145326922|NCT02177136|524046557|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
145326923|NCT02177136|524046558|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
145326924|NCT02177136|524046559|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
145326925|NCT02177136|524046560|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
145326926|NCT02177136|524046557|FG000|LTSE Phase|Withdrawal by Subject|0|||
145326927|NCT02177136|524046558|FG001|LTSE Phase|Withdrawal by Subject|0|||
145326928|NCT02177136|524046559|FG002|LTSE Phase|Withdrawal by Subject|0|||
145326929|NCT02177136|524046560|FG003|LTSE Phase|Withdrawal by Subject|6|||
145326930|NCT02177136|524046557|FG000|LTSE Phase|Adverse Event|0|||
145326931|NCT02177136|524046558|FG001|LTSE Phase|Adverse Event|0|||
145326932|NCT02177136|524046559|FG002|LTSE Phase|Adverse Event|0|||
145326933|NCT02177136|524046560|FG003|LTSE Phase|Adverse Event|10|||
145326934|NCT02177136|524046557|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
145326935|NCT02177136|524046558|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
145326936|NCT02177136|524046559|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
145326937|NCT02177136|524046560|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
145326938|NCT02177136|524046557|FG000|LTSE Phase|Physician Decision|0|||
145326939|NCT02177136|524046558|FG001|LTSE Phase|Physician Decision|0|||
145326940|NCT02177136|524046559|FG002|LTSE Phase|Physician Decision|0|||
145326941|NCT02177136|524046560|FG003|LTSE Phase|Physician Decision|2|||
145326942|NCT02177136|524046557|FG000|LTSE Phase|Lost to Follow-up|0|||
145326943|NCT02177136|524046558|FG001|LTSE Phase|Lost to Follow-up|0|||
145326944|NCT02177136|524046559|FG002|LTSE Phase|Lost to Follow-up|0|||
145326945|NCT02177136|524046560|FG003|LTSE Phase|Lost to Follow-up|1|||
145326946|NCT02177136|524046557|FG000|LTSE Phase|Participant Moved|0|||
145326947|NCT02177136|524046558|FG001|LTSE Phase|Participant Moved|0|||
145326948|NCT02177136|524046559|FG002|LTSE Phase|Participant Moved|0|||
145326949|NCT02177136|524046560|FG003|LTSE Phase|Participant Moved|1|||
145326950|NCT02054130|524046561|FG000|Overall Study|Withdrawal by Subject|4|||
145326951|NCT02054130|524046562|FG001|Overall Study|Withdrawal by Subject|4|||
145326952|NCT02054130|524046563|FG002|Overall Study|Withdrawal by Subject|7|||
145326953|NCT02054130|524046564|FG003|Overall Study|Withdrawal by Subject|10|||
145326954|NCT02054130|524046561|FG000|Overall Study|Death|0|||
145326955|NCT02054130|524046562|FG001|Overall Study|Death|1|||
145326956|NCT02054130|524046563|FG002|Overall Study|Death|0|||
145326957|NCT02054130|524046564|FG003|Overall Study|Death|0|||
145326958|NCT02054130|524046561|FG000|Overall Study|Lost to Follow-up|0|||
145326959|NCT02054130|524046562|FG001|Overall Study|Lost to Follow-up|0|||
145326960|NCT02054130|524046563|FG002|Overall Study|Lost to Follow-up|1|||
145326961|NCT02054130|524046564|FG003|Overall Study|Lost to Follow-up|2|||
145326962|NCT02054130|524046561|FG000|Overall Study|Missed dose|4|||
145326963|NCT02054130|524046562|FG001|Overall Study|Missed dose|6|||
145326964|NCT02054130|524046563|FG002|Overall Study|Missed dose|7|||
145326965|NCT02054130|524046564|FG003|Overall Study|Missed dose|10|||
145326966|NCT01386684|524046565|FG000|Overall Study|Lost to Follow-up|51|||
145326967|NCT01386684|524046565|FG000|Overall Study|Other|51|||
145326968|NCT01386684|524046565|FG000|Overall Study|Death|47|||
145326969|NCT01386684|524046565|FG000|Overall Study|Withdrawal of Consent|44|||
145326970|NCT01386684|524046565|FG000|Overall Study|Alternative Therapy Required|37|||
145326971|NCT01386684|524046565|FG000|Overall Study|Disease Progression|28|||
145326972|NCT01386684|524046565|FG000|Overall Study|Adverse Event|20|||
145326973|NCT01386684|524046565|FG000|Overall Study|Noncompliance|8|||
145326974|NCT01386684|524046565|FG000|Overall Study|Protocol Violation|4|||
145326975|NCT01386684|524046565|FG000|Overall Study|Missing|3|||
145326976|NCT00094458|524046566|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
145326977|NCT00094458|524046567|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
145326978|NCT00094458|524046568|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
145326979|NCT00094458|524046569|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
145326980|NCT00094458|524046570|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
145326981|NCT00094458|524046571|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
145326982|NCT00094458|524046566|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
145326983|NCT00094458|524046567|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
145326984|NCT00094458|524046568|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
145326985|NCT00094458|524046569|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
145326986|NCT00094458|524046570|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
145326987|NCT00094458|524046571|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
145326988|NCT00094458|524046566|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
145326989|NCT00094458|524046567|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
145326990|NCT00094458|524046568|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
145326991|NCT00094458|524046569|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
145326992|NCT00094458|524046570|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
145326993|NCT00094458|524046571|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
145326994|NCT00094458|524046566|FG000|Main Study: Through Week 30|Adverse Event|38|||
145326995|NCT00094458|524046567|FG001|Main Study: Through Week 30|Adverse Event|20|||
145570940|NCT01403974|524950068|FG004|Overall Study|Adverse Event|0|||
145570941|NCT01403974|524950069|FG005|Overall Study|Adverse Event|0|||
145326996|NCT00094458|524046568|FG002|Main Study: Through Week 30|Adverse Event|28|||
145326997|NCT00094458|524046569|FG003|Main Study: Through Week 30|Adverse Event|0|||
145326998|NCT00094458|524046570|FG004|Main Study: Through Week 30|Adverse Event|0|||
145570942|NCT01403974|524950070|FG006|Overall Study|Adverse Event|0|||
145570943|NCT01403974|524950071|FG007|Overall Study|Adverse Event|1|||
145570944|NCT01403974|524950072|FG008|Overall Study|Adverse Event|0|||
145570945|NCT01403974|524950073|FG009|Overall Study|Adverse Event|0|||
145570946|NCT01403974|524950074|FG010|Overall Study|Adverse Event|0|||
145570947|NCT01403974|524950075|FG011|Overall Study|Adverse Event|0|||
145570948|NCT01403974|524950076|FG012|Overall Study|Adverse Event|1|||
145570949|NCT01403974|524950077|FG013|Overall Study|Adverse Event|0|||
145570950|NCT01403974|524950078|FG014|Overall Study|Adverse Event|0|||
145570951|NCT01403974|524950079|FG015|Overall Study|Adverse Event|0|||
145570952|NCT01403974|524950064|FG000|Overall Study|Other than specified|0|||
145570953|NCT01403974|524950065|FG001|Overall Study|Other than specified|0|||
145570954|NCT01403974|524950066|FG002|Overall Study|Other than specified|0|||
145570955|NCT01403974|524950067|FG003|Overall Study|Other than specified|0|||
145570956|NCT01403974|524950068|FG004|Overall Study|Other than specified|0|||
145570957|NCT01403974|524950069|FG005|Overall Study|Other than specified|0|||
145570958|NCT01403974|524950070|FG006|Overall Study|Other than specified|0|||
145570959|NCT01403974|524950071|FG007|Overall Study|Other than specified|0|||
145570960|NCT01403974|524950072|FG008|Overall Study|Other than specified|0|||
145570961|NCT01403974|524950073|FG009|Overall Study|Other than specified|1|||
145570962|NCT01403974|524950074|FG010|Overall Study|Other than specified|0|||
145570963|NCT01403974|524950075|FG011|Overall Study|Other than specified|1|||
145570964|NCT01403974|524950076|FG012|Overall Study|Other than specified|0|||
145570965|NCT01403974|524950077|FG013|Overall Study|Other than specified|0|||
145570966|NCT01403974|524950078|FG014|Overall Study|Other than specified|0|||
145570967|NCT01403974|524950079|FG015|Overall Study|Other than specified|0|||
145570968|NCT01494610|524950082|FG000|Period 1|Withdrawal by Subject|1|||
145570969|NCT01494610|524950083|FG001|Period 1|Withdrawal by Subject|1|||
145570970|NCT01494610|524950082|FG000|Period 3|Adverse Event|1|||
145570971|NCT01494610|524950083|FG001|Period 3|Adverse Event|0|||
145570972|NCT01494610|524950082|FG000|Period 3|Withdrawal by Subject|1|||
145570973|NCT01494610|524950083|FG001|Period 3|Withdrawal by Subject|0|||
145326999|NCT00094458|524046571|FG005|Main Study: Through Week 30|Adverse Event|0|||
145327000|NCT00094458|524046566|FG000|Main Study: Through Week 30|Death|1|||
145327001|NCT00094458|524046567|FG001|Main Study: Through Week 30|Death|0|||
145327002|NCT00094458|524046568|FG002|Main Study: Through Week 30|Death|0|||
145327003|NCT00094458|524046569|FG003|Main Study: Through Week 30|Death|0|||
145327004|NCT00094458|524046570|FG004|Main Study: Through Week 30|Death|0|||
145327005|NCT00094458|524046571|FG005|Main Study: Through Week 30|Death|0|||
145327006|NCT00094458|524046566|FG000|Main Study: Through Week 30|Other|19|||
145327007|NCT00094458|524046567|FG001|Main Study: Through Week 30|Other|16|||
145327008|NCT00094458|524046568|FG002|Main Study: Through Week 30|Other|9|||
145327009|NCT00094458|524046569|FG003|Main Study: Through Week 30|Other|0|||
145327010|NCT00094458|524046570|FG004|Main Study: Through Week 30|Other|0|||
145327011|NCT00094458|524046571|FG005|Main Study: Through Week 30|Other|0|||
145327012|NCT00094458|524046566|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
145327013|NCT00094458|524046567|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
145327014|NCT00094458|524046568|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
145327015|NCT00094458|524046569|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145327016|NCT00094458|524046570|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145327017|NCT00094458|524046571|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
145327018|NCT00094458|524046566|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
145327019|NCT00094458|524046567|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145327020|NCT00094458|524046568|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
145570974|NCT01494610|524950082|FG000|Period 4|Protocol Violation|1|||
145570975|NCT01494610|524950083|FG001|Period 4|Protocol Violation|0|||
145327021|NCT00094458|524046569|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145327022|NCT00094458|524046570|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145327023|NCT00094458|524046571|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
145327024|NCT00094458|524046566|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
145327025|NCT00094458|524046567|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
145570976|NCT03995953|524950086|FG000|Overall Study|Death|3|||
145570977|NCT03995953|524950087|FG001|Overall Study|Death|0|||
145570978|NCT03995953|524950088|FG002|Overall Study|Death|3|||
145570979|NCT03995953|524950089|FG003|Overall Study|Death|0|||
145327026|NCT00094458|524046568|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
145327027|NCT00094458|524046569|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145327028|NCT00094458|524046570|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145570980|NCT03995953|524950090|FG004|Overall Study|Death|3|||
145570981|NCT03995953|524950091|FG005|Overall Study|Death|0|||
145570982|NCT03995953|524950092|FG006|Overall Study|Death|0|||
145570983|NCT03995953|524950093|FG007|Overall Study|Death|0|||
145327029|NCT00094458|524046571|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
145327030|NCT00094458|524046566|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
145327031|NCT00094458|524046567|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
145327032|NCT00094458|524046568|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
145327033|NCT00094458|524046569|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
145327034|NCT00094458|524046570|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
145327035|NCT00094458|524046571|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
145327036|NCT00094458|524046566|FG000|OLE: Open-Label Extension|Adverse Event|0|||
145327037|NCT00094458|524046567|FG001|OLE: Open-Label Extension|Adverse Event|0|||
145327038|NCT00094458|524046568|FG002|OLE: Open-Label Extension|Adverse Event|0|||
145327039|NCT00094458|524046569|FG003|OLE: Open-Label Extension|Adverse Event|0|||
145327040|NCT00094458|524046570|FG004|OLE: Open-Label Extension|Adverse Event|3|||
145327041|NCT00094458|524046571|FG005|OLE: Open-Label Extension|Adverse Event|4|||
145327042|NCT00094458|524046566|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145327043|NCT00094458|524046567|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145327044|NCT00094458|524046568|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145327045|NCT00094458|524046569|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
145327046|NCT00094458|524046570|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
145327047|NCT00094458|524046571|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
145327048|NCT00094458|524046566|FG000|OLE: Open-Label Extension|Patient decision|0|||
145327049|NCT00094458|524046567|FG001|OLE: Open-Label Extension|Patient decision|0|||
145327050|NCT00094458|524046568|FG002|OLE: Open-Label Extension|Patient decision|0|||
145327051|NCT00094458|524046569|FG003|OLE: Open-Label Extension|Patient decision|0|||
145327052|NCT00094458|524046570|FG004|OLE: Open-Label Extension|Patient decision|1|||
145327053|NCT00094458|524046571|FG005|OLE: Open-Label Extension|Patient decision|0|||
145327054|NCT03247517|524046578|FG000|Overall Study|Adverse Event|0|||
145327055|NCT03247517|524046579|FG001|Overall Study|Adverse Event|4|||
145327056|NCT03247517|524046580|FG002|Overall Study|Adverse Event|2|||
145327057|NCT03247517|524046578|FG000|Overall Study|Lost to Follow-up|2|||
145327058|NCT03247517|524046579|FG001|Overall Study|Lost to Follow-up|6|||
145327059|NCT03247517|524046580|FG002|Overall Study|Lost to Follow-up|4|||
145327060|NCT03247517|524046578|FG000|Overall Study|Consent withdrawn by caregiver|1|||
145327061|NCT03247517|524046579|FG001|Overall Study|Consent withdrawn by caregiver|4|||
145327062|NCT03247517|524046580|FG002|Overall Study|Consent withdrawn by caregiver|7|||
145327063|NCT03247517|524046578|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
145327064|NCT03247517|524046579|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
145327065|NCT03247517|524046580|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
145327066|NCT03247517|524046578|FG000|Overall Study|Protocol Violation|0|||
145327067|NCT03247517|524046579|FG001|Overall Study|Protocol Violation|2|||
145327068|NCT03247517|524046580|FG002|Overall Study|Protocol Violation|0|||
145327069|NCT03247517|524046578|FG000|Overall Study|Multiple reasons|3|||
145327070|NCT03247517|524046579|FG001|Overall Study|Multiple reasons|1|||
145327071|NCT03247517|524046580|FG002|Overall Study|Multiple reasons|0|||
145327072|NCT03623386|524046581|FG000|Overall Study|Protocol Violation|3|||
145327073|NCT03623386|524046582|FG001|Overall Study|Protocol Violation|2|||
145327074|NCT03623386|524046583|FG002|Overall Study|Protocol Violation|0|||
145327075|NCT03623386|524046581|FG000|Overall Study|Physician Decision|1|||
145327076|NCT03623386|524046582|FG001|Overall Study|Physician Decision|1|||
145327077|NCT03623386|524046583|FG002|Overall Study|Physician Decision|0|||
145327078|NCT03623386|524046581|FG000|Overall Study|Lost to Follow-up|0|||
145327079|NCT03623386|524046582|FG001|Overall Study|Lost to Follow-up|2|||
145327080|NCT03623386|524046583|FG002|Overall Study|Lost to Follow-up|0|||
145327081|NCT03623386|524046581|FG000|Overall Study|COVID-19|0|||
145327082|NCT03623386|524046582|FG001|Overall Study|COVID-19|1|||
145327083|NCT03623386|524046583|FG002|Overall Study|COVID-19|0|||
145327084|NCT04271735|524046586|FG000|Overall Study|Physician Decision|2|||
145327085|NCT04271735|524046587|FG001|Overall Study|Physician Decision|0|||
145327086|NCT02132637|524046588|FG000|Study Period 1|Withdrawal by Subject|0|||
145327087|NCT02132637|524046589|FG001|Study Period 1|Withdrawal by Subject|4|||
145327088|NCT02132637|524046588|FG000|Study Period 1|Physician Decision|1|||
145327089|NCT02132637|524046589|FG001|Study Period 1|Physician Decision|0|||
145327090|NCT02132637|524046588|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
145327091|NCT02132637|524046589|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
145327092|NCT02132637|524046588|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
145327093|NCT02132637|524046589|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
145327094|NCT03197558|524046590|FG000|Overall Study|Tubes not placed|1|||
145327095|NCT00931268|524046594|FG000|Overall Study|Lost to Follow-up|6|||
145327096|NCT02072148|524046596|FG000|Overall Study|withdrew prior to surgery|23|||
145327097|NCT02072148|524046597|FG001|Overall Study|withdrew prior to surgery|0|||
145327098|NCT02072148|524046598|FG002|Overall Study|withdrew prior to surgery|0|||
145327099|NCT02072148|524046596|FG000|Overall Study|Death|0|||
145327100|NCT02072148|524046597|FG001|Overall Study|Death|0|||
145327101|NCT02072148|524046598|FG002|Overall Study|Death|1|||
145327102|NCT02072148|524046596|FG000|Overall Study|Withdrawal by Subject|0|||
145327103|NCT02072148|524046597|FG001|Overall Study|Withdrawal by Subject|13|||
145327104|NCT02072148|524046598|FG002|Overall Study|Withdrawal by Subject|12|||
145327105|NCT00430495|524046599|FG000|Overall Study|Adverse Event|2|||
145327106|NCT00430495|524046600|FG001|Overall Study|Adverse Event|3|||
145327107|NCT00430495|524046601|FG002|Overall Study|Adverse Event|2|||
145327108|NCT00430495|524046602|FG003|Overall Study|Adverse Event|0|||
145327109|NCT00430495|524046599|FG000|Overall Study|Death|0|||
145327110|NCT00430495|524046600|FG001|Overall Study|Death|0|||
145327111|NCT00430495|524046601|FG002|Overall Study|Death|1|||
145327112|NCT00430495|524046602|FG003|Overall Study|Death|0|||
145327113|NCT00430495|524046599|FG000|Overall Study|Lost to Follow-up|0|||
145327114|NCT00430495|524046600|FG001|Overall Study|Lost to Follow-up|1|||
145327115|NCT00430495|524046601|FG002|Overall Study|Lost to Follow-up|4|||
145327116|NCT00430495|524046602|FG003|Overall Study|Lost to Follow-up|0|||
145327117|NCT00430495|524046599|FG000|Overall Study|Protocol Violation|1|||
145327118|NCT00430495|524046600|FG001|Overall Study|Protocol Violation|0|||
145327119|NCT00430495|524046601|FG002|Overall Study|Protocol Violation|1|||
145327120|NCT00430495|524046602|FG003|Overall Study|Protocol Violation|0|||
145327121|NCT00430495|524046599|FG000|Overall Study|Disease Progression|1|||
145327122|NCT00430495|524046600|FG001|Overall Study|Disease Progression|1|||
145327123|NCT00430495|524046601|FG002|Overall Study|Disease Progression|0|||
145327124|NCT00430495|524046602|FG003|Overall Study|Disease Progression|0|||
145327125|NCT00430495|524046599|FG000|Overall Study|Other|8|||
145327126|NCT00430495|524046600|FG001|Overall Study|Other|2|||
145327127|NCT00430495|524046601|FG002|Overall Study|Other|5|||
145327128|NCT00430495|524046602|FG003|Overall Study|Other|4|||
145327129|NCT00430495|524046599|FG000|Overall Study|Randomized but not Treated|2|||
145327130|NCT00430495|524046600|FG001|Overall Study|Randomized but not Treated|0|||
145327131|NCT00430495|524046601|FG002|Overall Study|Randomized but not Treated|0|||
145327132|NCT00430495|524046602|FG003|Overall Study|Randomized but not Treated|0|||
145327133|NCT02400671|524046603|FG000|Overall Study|Death|5|||
145327134|NCT02400671|524046604|FG001|Overall Study|Death|3|||
145327135|NCT02400671|524046605|FG002|Overall Study|Death|4|||
145327136|NCT02400671|524046603|FG000|Overall Study|Lost to Follow-up|20|||
145327137|NCT02400671|524046604|FG001|Overall Study|Lost to Follow-up|27|||
145327138|NCT02400671|524046605|FG002|Overall Study|Lost to Follow-up|24|||
145327139|NCT02400671|524046603|FG000|Overall Study|Withdrawal by Subject|2|||
145327140|NCT02400671|524046604|FG001|Overall Study|Withdrawal by Subject|2|||
145327141|NCT02400671|524046605|FG002|Overall Study|Withdrawal by Subject|0|||
145327142|NCT00158756|524046606|FG000|Overall Study|Withdrawal by Subject|5|||
145327143|NCT00158756|524046607|FG001|Overall Study|Withdrawal by Subject|0|||
145327144|NCT00158756|524046608|FG002|Overall Study|Withdrawal by Subject|6|||
145327145|NCT00158756|524046609|FG003|Overall Study|Withdrawal by Subject|1|||
145327146|NCT00158756|524046610|FG004|Overall Study|Withdrawal by Subject|3|||
145327147|NCT00158756|524046606|FG000|Overall Study|Adverse Event|0|||
145327148|NCT00158756|524046607|FG001|Overall Study|Adverse Event|0|||
145327149|NCT00158756|524046608|FG002|Overall Study|Adverse Event|1|||
145327150|NCT00158756|524046609|FG003|Overall Study|Adverse Event|0|||
145327151|NCT00158756|524046610|FG004|Overall Study|Adverse Event|0|||
145327152|NCT00158756|524046606|FG000|Overall Study|Serious adverse event|0|||
145327153|NCT00158756|524046607|FG001|Overall Study|Serious adverse event|0|||
145327154|NCT00158756|524046608|FG002|Overall Study|Serious adverse event|1|||
145327155|NCT00158756|524046609|FG003|Overall Study|Serious adverse event|0|||
145327156|NCT00158756|524046610|FG004|Overall Study|Serious adverse event|0|||
145327157|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
145327158|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
145327159|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
145327160|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
145327161|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
145412080|NCT06170827|524362175|FG000|Overall Study|Withdrawal by Subject|1|||
145412081|NCT06170827|524362176|FG001|Overall Study|Withdrawal by Subject|1|||
145412082|NCT05800145|524362182|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
145412083|NCT05800145|524362183|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145570984|NCT03995953|524950094|FG008|Overall Study|Death|1|||
145570985|NCT03995953|524950095|FG009|Overall Study|Death|0|||
145327162|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
145327163|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
145327164|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
145327165|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
145327166|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
145327167|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
145327168|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
145327169|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
145327170|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
145327171|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
145327172|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
145327173|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
145327174|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
145327175|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
145327176|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
145327177|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
145327178|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
145327179|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
145327180|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
145327181|NCT01421342|524046611|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
145327182|NCT01421342|524046612|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
145327183|NCT01421342|524046613|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
145327184|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
145327185|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
145327186|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
145327187|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
145327188|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
145570986|NCT03995953|524950096|FG010|Overall Study|Death|0|||
145570987|NCT03995953|524950097|FG011|Overall Study|Death|0|||
145570988|NCT03995953|524950086|FG000|Overall Study|Lost to Follow-up|6|||
145570989|NCT03995953|524950087|FG001|Overall Study|Lost to Follow-up|54|||
145570990|NCT03995953|524950088|FG002|Overall Study|Lost to Follow-up|3|||
145570991|NCT03995953|524950089|FG003|Overall Study|Lost to Follow-up|32|||
145570992|NCT03995953|524950090|FG004|Overall Study|Lost to Follow-up|5|||
145570993|NCT03995953|524950091|FG005|Overall Study|Lost to Follow-up|44|||
145570994|NCT03995953|524950092|FG006|Overall Study|Lost to Follow-up|0|||
145570995|NCT03995953|524950093|FG007|Overall Study|Lost to Follow-up|31|||
145570996|NCT03995953|524950094|FG008|Overall Study|Lost to Follow-up|8|||
145570997|NCT03995953|524950095|FG009|Overall Study|Lost to Follow-up|36|||
145570998|NCT03995953|524950096|FG010|Overall Study|Lost to Follow-up|5|||
145570999|NCT03995953|524950097|FG011|Overall Study|Lost to Follow-up|41|||
145571000|NCT03995953|524950086|FG000|Overall Study|Withdrawal by Subject|4|||
145571001|NCT03995953|524950087|FG001|Overall Study|Withdrawal by Subject|0|||
145571002|NCT03995953|524950088|FG002|Overall Study|Withdrawal by Subject|1|||
145571003|NCT03995953|524950089|FG003|Overall Study|Withdrawal by Subject|0|||
145571004|NCT03995953|524950090|FG004|Overall Study|Withdrawal by Subject|1|||
145571005|NCT03995953|524950091|FG005|Overall Study|Withdrawal by Subject|0|||
145571006|NCT03995953|524950092|FG006|Overall Study|Withdrawal by Subject|1|||
145571007|NCT03995953|524950093|FG007|Overall Study|Withdrawal by Subject|0|||
145571008|NCT03995953|524950094|FG008|Overall Study|Withdrawal by Subject|3|||
145571009|NCT03995953|524950095|FG009|Overall Study|Withdrawal by Subject|0|||
145571010|NCT03995953|524950096|FG010|Overall Study|Withdrawal by Subject|3|||
145571011|NCT03995953|524950097|FG011|Overall Study|Withdrawal by Subject|0|||
145571012|NCT03995953|524950086|FG000|Overall Study|Health Issues|0|||
145571013|NCT03995953|524950087|FG001|Overall Study|Health Issues|0|||
145571014|NCT03995953|524950088|FG002|Overall Study|Health Issues|0|||
145571015|NCT03995953|524950089|FG003|Overall Study|Health Issues|0|||
145571016|NCT03995953|524950090|FG004|Overall Study|Health Issues|1|||
145571017|NCT03995953|524950091|FG005|Overall Study|Health Issues|0|||
145571018|NCT03995953|524950092|FG006|Overall Study|Health Issues|0|||
145571019|NCT03995953|524950093|FG007|Overall Study|Health Issues|0|||
145571020|NCT03995953|524950094|FG008|Overall Study|Health Issues|4|||
145571021|NCT03995953|524950095|FG009|Overall Study|Health Issues|0|||
145327189|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
145327190|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
145327191|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
145327192|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
145327193|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
145327194|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
145327195|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
145327196|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
145571022|NCT03995953|524950096|FG010|Overall Study|Health Issues|0|||
145571023|NCT03995953|524950097|FG011|Overall Study|Health Issues|0|||
145571024|NCT03995953|524950086|FG000|Overall Study|Relocated|11|||
145571025|NCT03995953|524950087|FG001|Overall Study|Relocated|0|||
145571026|NCT03995953|524950088|FG002|Overall Study|Relocated|16|||
145571027|NCT03995953|524950089|FG003|Overall Study|Relocated|0|||
145571028|NCT03995953|524950090|FG004|Overall Study|Relocated|14|||
145571029|NCT03995953|524950091|FG005|Overall Study|Relocated|0|||
145571030|NCT03995953|524950092|FG006|Overall Study|Relocated|16|||
145571031|NCT03995953|524950093|FG007|Overall Study|Relocated|0|||
145571032|NCT03995953|524950094|FG008|Overall Study|Relocated|14|||
145571033|NCT03995953|524950095|FG009|Overall Study|Relocated|0|||
145327197|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
145571034|NCT03995953|524950096|FG010|Overall Study|Relocated|15|||
145571035|NCT03995953|524950097|FG011|Overall Study|Relocated|0|||
145571036|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
145571037|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
145571038|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
145327198|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
145327199|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
145327200|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
145327201|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
145327202|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
145327203|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
145327204|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
145327205|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
145327206|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
145327207|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
145327208|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
145327209|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
145327210|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
145327211|NCT01421342|524046611|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
145327212|NCT01421342|524046612|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
145327213|NCT01421342|524046613|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
145327214|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
145327215|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
145327216|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
145327217|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
145327218|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
145327219|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
145327220|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
145327221|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
145327222|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
145327223|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
145327224|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
145327225|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
145327226|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
145327227|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
145327228|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
145327229|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
145327230|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
145327231|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
145327232|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
145327233|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
145327234|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
145327235|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145327236|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145327237|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
145327238|NCT01421342|524046611|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
145327239|NCT01421342|524046612|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
145327240|NCT01421342|524046613|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
145327241|NCT01892657|524046616|FG000|Overall Study|Withdrawal by Subject|6|||
145327242|NCT01892657|524046616|FG000|Overall Study|Protocol Violation|12|||
145327243|NCT00076804|524046617|FG000|Overall Study|Death|9|||
145327244|NCT00076804|524046618|FG001|Overall Study|Death|20|||
145327245|NCT00076804|524046617|FG000|Overall Study|Lost to Follow-up|9|||
145327246|NCT00076804|524046618|FG001|Overall Study|Lost to Follow-up|9|||
145327247|NCT00076804|524046617|FG000|Overall Study|Withdrawal by Subject|10|||
145327248|NCT00076804|524046618|FG001|Overall Study|Withdrawal by Subject|8|||
145327249|NCT00076804|524046617|FG000|Overall Study|Early study Closure|32|||
145327250|NCT00076804|524046618|FG001|Overall Study|Early study Closure|32|||
145327251|NCT00354341|524046619|FG000|Overall Study|Adverse Event|1|||
145327252|NCT00354341|524046620|FG001|Overall Study|Adverse Event|0|||
145327253|NCT00354341|524046619|FG000|Overall Study|Death|0|||
145327254|NCT00354341|524046620|FG001|Overall Study|Death|2|||
145327255|NCT00354341|524046619|FG000|Overall Study|Refused treatment|1|||
145327256|NCT00354341|524046620|FG001|Overall Study|Refused treatment|2|||
145327257|NCT00354341|524046619|FG000|Overall Study|Failure to return|0|||
145327258|NCT00354341|524046620|FG001|Overall Study|Failure to return|1|||
145327259|NCT00354341|524046619|FG000|Overall Study|Other|1|||
145327260|NCT00354341|524046620|FG001|Overall Study|Other|2|||
145327261|NCT04295135|524046621|FG000|Overall Study|Withdrawal by Subject|2|||
145327262|NCT04295135|524046622|FG001|Overall Study|Withdrawal by Subject|1|||
145327263|NCT04295135|524046621|FG000|Overall Study|Subject left organization|8|||
145327264|NCT04295135|524046622|FG001|Overall Study|Subject left organization|4|||
145327265|NCT03463993|524046624|FG000|Overall Study|Lost to Follow-up|7|||
145327266|NCT03463993|524046625|FG001|Overall Study|Lost to Follow-up|8|||
145327267|NCT03463993|524046624|FG000|Overall Study|Withdrawal by Subject|2|||
145327268|NCT03463993|524046625|FG001|Overall Study|Withdrawal by Subject|0|||
145327269|NCT03463993|524046624|FG000|Overall Study|Protocol Violation|4|||
145327270|NCT03463993|524046625|FG001|Overall Study|Protocol Violation|1|||
145327271|NCT03463993|524046624|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
145327272|NCT03463993|524046625|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
145327273|NCT03463993|524046624|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
145327274|NCT03463993|524046625|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
145327275|NCT01621191|524046627|FG000|Overall Study|Adverse Event|9|||
145327276|NCT01621191|524046627|FG000|Overall Study|Withdrawal by Subject|8|||
145327277|NCT01621191|524046627|FG000|Overall Study|Lack of Efficacy|6|||
145327278|NCT01621191|524046627|FG000|Overall Study|Lost to Follow-up|1|||
145327279|NCT01621191|524046627|FG000|Overall Study|Site Removed From Study|1|||
145327280|NCT05420012|524046630|FG000|Overall Study|Lost to Follow-up|0|||
145327281|NCT05420012|524046631|FG001|Overall Study|Lost to Follow-up|1|||
145327282|NCT01244061|524046635|FG000|Overall Study|Death|1|||
145327283|NCT01244061|524046636|FG001|Overall Study|Death|0|||
145327284|NCT01244061|524046635|FG000|Overall Study|Did not meet entrance criteria|1|||
145327285|NCT01244061|524046636|FG001|Overall Study|Did not meet entrance criteria|0|||
145327286|NCT01244061|524046635|FG000|Overall Study|Lack of Efficacy|1|||
145327287|NCT01244061|524046636|FG001|Overall Study|Lack of Efficacy|3|||
145327288|NCT01244061|524046635|FG000|Overall Study|Lost to Follow-up|34|||
145327289|NCT01244061|524046636|FG001|Overall Study|Lost to Follow-up|30|||
145327290|NCT01244061|524046635|FG000|Overall Study|Withdrawal by Subject|29|||
145327291|NCT01244061|524046636|FG001|Overall Study|Withdrawal by Subject|46|||
145327292|NCT01244061|524046635|FG000|Overall Study|Other|8|||
145327293|NCT01244061|524046636|FG001|Overall Study|Other|19|||
145327294|NCT01244061|524046635|FG000|Overall Study|Protocol Violation|1|||
145327295|NCT01244061|524046636|FG001|Overall Study|Protocol Violation|1|||
145327296|NCT01244061|524046635|FG000|Overall Study|Adverse Event|5|||
145327297|NCT01244061|524046636|FG001|Overall Study|Adverse Event|2|||
145327298|NCT01244061|524046635|FG000|Overall Study|Randomized but not treated|2|||
145327299|NCT01244061|524046636|FG001|Overall Study|Randomized but not treated|2|||
145327300|NCT02143583|524046637|FG000|Overall Study|Withdrawal by Subject|1|||
145327301|NCT02143583|524046638|FG001|Overall Study|Withdrawal by Subject|0|||
145327302|NCT02143583|524046639|FG002|Overall Study|Withdrawal by Subject|1|||
145327303|NCT02143583|524046637|FG000|Overall Study|husband illness|0|||
145327304|NCT02143583|524046638|FG001|Overall Study|husband illness|0|||
145327305|NCT02143583|524046639|FG002|Overall Study|husband illness|1|||
145327306|NCT01641133|524046640|FG000|Overall Study|Protocol Violation|0|||
145327307|NCT01641133|524046641|FG001|Overall Study|Protocol Violation|1|||
145327308|NCT01641133|524046642|FG002|Overall Study|Protocol Violation|1|||
145327309|NCT01641133|524046640|FG000|Overall Study|Migrated/moved from study area|5|||
145327310|NCT01641133|524046641|FG001|Overall Study|Migrated/moved from study area|3|||
145327311|NCT01641133|524046642|FG002|Overall Study|Migrated/moved from study area|1|||
145327312|NCT01641133|524046640|FG000|Overall Study|Adverse Event|0|||
145327313|NCT01641133|524046641|FG001|Overall Study|Adverse Event|0|||
145327314|NCT01641133|524046642|FG002|Overall Study|Adverse Event|1|||
145327315|NCT01641133|524046640|FG000|Overall Study|Withdrawal by Subject|5|||
145327316|NCT01641133|524046641|FG001|Overall Study|Withdrawal by Subject|3|||
145327317|NCT01641133|524046642|FG002|Overall Study|Withdrawal by Subject|3|||
145327318|NCT01641133|524046640|FG000|Overall Study|Lost to Follow-up|0|||
145327319|NCT01641133|524046641|FG001|Overall Study|Lost to Follow-up|2|||
145327320|NCT01641133|524046642|FG002|Overall Study|Lost to Follow-up|2|||
145327321|NCT01393730|524046643|FG000|Overall Study|Withdrawal by Subject|3|||
145327322|NCT01393730|524046643|FG000|Overall Study|Other|2|||
145327323|NCT01393730|524046643|FG000|Overall Study|Adverse Event|1|||
145571039|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
145571040|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
145571041|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
145327324|NCT00103402|524046644|FG000|Overall Study|Adverse Event|3|||
145327325|NCT00103402|524046645|FG001|Overall Study|Adverse Event|4|||
145327326|NCT00103402|524046644|FG000|Overall Study|Lost to Follow-up|8|||
145412084|NCT05800145|524362184|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145412085|NCT05800145|524362185|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
145412086|NCT05800145|524362186|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145327327|NCT00103402|524046645|FG001|Overall Study|Lost to Follow-up|7|||
145327328|NCT00103402|524046644|FG000|Overall Study|Dissatisfied/No longer interested|6|||
145327329|NCT00103402|524046645|FG001|Overall Study|Dissatisfied/No longer interested|6|||
145327330|NCT00103402|524046644|FG000|Overall Study|Personal constraints/Other|5|||
145327331|NCT00103402|524046645|FG001|Overall Study|Personal constraints/Other|0|||
145327332|NCT02674061|524046646|FG000|Overall Study|Death|229|||
145327333|NCT02674061|524046647|FG001|Overall Study|Death|77|||
145327334|NCT02674061|524046646|FG000|Overall Study|Lost to Follow-up|3|||
145327335|NCT02674061|524046647|FG001|Overall Study|Lost to Follow-up|3|||
145327336|NCT02674061|524046646|FG000|Overall Study|Withdrawal by Subject|9|||
145327337|NCT02674061|524046647|FG001|Overall Study|Withdrawal by Subject|1|||
145327338|NCT02674061|524046646|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
145327339|NCT02674061|524046647|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
145327340|NCT00123955|524046650|FG000|Overall Study|Adverse Event|1|||
145327341|NCT00123955|524046651|FG001|Overall Study|Adverse Event|0|||
145327342|NCT00123955|524046650|FG000|Overall Study|Withdrawal by Subject|4|||
145327343|NCT00123955|524046651|FG001|Overall Study|Withdrawal by Subject|3|||
145327344|NCT00123955|524046650|FG000|Overall Study|Death|0|||
145327345|NCT00123955|524046651|FG001|Overall Study|Death|1|||
145327346|NCT03334721|524046652|FG000|Overall Study|Withdrawal by Subject|1|||
145327347|NCT03334721|524046653|FG001|Overall Study|Withdrawal by Subject|0|||
145327348|NCT03334721|524046652|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
145327349|NCT03334721|524046653|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
145327350|NCT01558297|524046654|FG000|Overall Study|Withdrawal by Subject|2|||
145327351|NCT01558297|524046655|FG001|Overall Study|Withdrawal by Subject|2|||
145327352|NCT01558297|524046656|FG002|Overall Study|Withdrawal by Subject|1|||
145327353|NCT02655016|524046659|FG000|Overall Study|Disease progression|6|||
145327354|NCT02655016|524046660|FG001|Overall Study|Disease progression|4|||
145327355|NCT02655016|524046659|FG000|Overall Study|Site closed|0|||
145327356|NCT02655016|524046660|FG001|Overall Study|Site closed|1|||
145327357|NCT02655016|524046659|FG000|Overall Study|Death|30|||
145327358|NCT02655016|524046660|FG001|Overall Study|Death|48|||
145327359|NCT02655016|524046659|FG000|Overall Study|Lost to Follow-up|1|||
145327360|NCT02655016|524046660|FG001|Overall Study|Lost to Follow-up|1|||
145327361|NCT02655016|524046659|FG000|Overall Study|Withdrawal by Subject|18|||
145327362|NCT02655016|524046660|FG001|Overall Study|Withdrawal by Subject|36|||
145327363|NCT04189445|524048196|FG000|Overall Study|Withdrawal of consent|8|||
145327364|NCT04189445|524048197|FG001|Overall Study|Withdrawal of consent|1|||
145327365|NCT04189445|524048198|FG002|Overall Study|Withdrawal of consent|0|||
145412087|NCT05800145|524362187|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145412088|NCT05800145|524362182|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
145327366|NCT04189445|524048196|FG000|Overall Study|Study Terminated by Sponsor|25|||
145327367|NCT04189445|524048197|FG001|Overall Study|Study Terminated by Sponsor|3|||
145327368|NCT04189445|524048198|FG002|Overall Study|Study Terminated by Sponsor|0|||
145327369|NCT04189445|524048196|FG000|Overall Study|Death|54|||
145327370|NCT04189445|524048197|FG001|Overall Study|Death|24|||
145327371|NCT04189445|524048198|FG002|Overall Study|Death|0|||
145327372|NCT02960893|524048200|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
145327373|NCT02960893|524048201|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
145327374|NCT02960893|524048202|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
145327375|NCT02960893|524048203|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
145327376|NCT02960893|524048200|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
145327377|NCT02960893|524048201|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
145327378|NCT02960893|524048202|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
145327379|NCT02960893|524048203|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
145327380|NCT02960893|524048200|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
145327381|NCT02960893|524048201|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
145571042|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
145571043|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
145571044|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
145571045|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
145571046|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
145571047|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
145327382|NCT02960893|524048202|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
145412089|NCT05800145|524362183|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145412090|NCT05800145|524362184|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145412091|NCT05800145|524362185|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
145571048|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
145571049|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
145571050|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
145571051|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
145327383|NCT02960893|524048203|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
145327384|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
145327385|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
145327386|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
145412092|NCT05800145|524362186|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145327387|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
145327388|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
145327389|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
145327390|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
145327391|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
145327392|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
145327393|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
145327394|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
145327395|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
145327396|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
145327397|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
145327398|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
145327399|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
145327400|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
145327401|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
145327402|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
145327403|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
145327404|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
145327405|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
145327406|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
145327407|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
145327408|NCT02960893|524048200|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
145327409|NCT02960893|524048201|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
145327410|NCT02960893|524048202|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
145327411|NCT02960893|524048203|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
145327412|NCT01995266|524048209|FG000|Overall Study|Death|1|||
145327413|NCT01995266|524048209|FG000|Overall Study|Lack of Efficacy|6|||
145327414|NCT01995266|524048209|FG000|Overall Study|Adverse Event|2|||
145327415|NCT03310411|524048210|FG000|Period 1|Adverse Event|0|||
145327416|NCT03310411|524048211|FG001|Period 1|Adverse Event|0|||
145327417|NCT03310411|524048212|FG002|Period 1|Adverse Event|0|||
145327418|NCT03310411|524048213|FG003|Period 1|Adverse Event|1|||
145327419|NCT00619112|524048214|FG000|Overall Study|Adverse Event|1|||
145327420|NCT00619112|524048215|FG001|Overall Study|Adverse Event|2|||
145327421|NCT04268316|524048218|FG000|Overall Study|Withdrawal by Subject|2|||
145327422|NCT04268316|524048219|FG001|Overall Study|Withdrawal by Subject|1|||
145327423|NCT04268316|524048220|FG002|Overall Study|Withdrawal by Subject|0|||
145327424|NCT00515541|524048221|FG000|Overall Study|Physician Decision|0|||
145327425|NCT00515541|524048222|FG001|Overall Study|Physician Decision|2|||
145327426|NCT00515541|524048223|FG002|Overall Study|Physician Decision|0|||
145327427|NCT00515541|524048224|FG003|Overall Study|Physician Decision|1|||
145327428|NCT00515541|524048221|FG000|Overall Study|No show for appointments|0|||
145327429|NCT00515541|524048222|FG001|Overall Study|No show for appointments|1|||
145327430|NCT00515541|524048223|FG002|Overall Study|No show for appointments|0|||
145327431|NCT00515541|524048224|FG003|Overall Study|No show for appointments|2|||
145327432|NCT00515541|524048221|FG000|Overall Study|Withdrawal by Subject|0|||
145327433|NCT00515541|524048222|FG001|Overall Study|Withdrawal by Subject|2|||
145327434|NCT00515541|524048223|FG002|Overall Study|Withdrawal by Subject|0|||
145327435|NCT00515541|524048224|FG003|Overall Study|Withdrawal by Subject|2|||
145327436|NCT02072824|524048236|FG000|Overall Study|Insufficient clinical response|1|||
145327437|NCT02072824|524048237|FG001|Overall Study|Insufficient clinical response|0|||
145327438|NCT02072824|524048238|FG002|Overall Study|Insufficient clinical response|1|||
145327439|NCT02072824|524048236|FG000|Overall Study|No longer willing to participate|1|||
145327440|NCT02072824|524048237|FG001|Overall Study|No longer willing to participate|0|||
145327441|NCT02072824|524048238|FG002|Overall Study|No longer willing to participate|1|||
145327442|NCT02072824|524048236|FG000|Overall Study|Medication error|0|||
145327443|NCT02072824|524048237|FG001|Overall Study|Medication error|1|||
145327444|NCT02072824|524048238|FG002|Overall Study|Medication error|0|||
145327445|NCT02072824|524048236|FG000|Overall Study|Adverse Event|0|||
145327446|NCT02072824|524048237|FG001|Overall Study|Adverse Event|0|||
145327447|NCT02072824|524048238|FG002|Overall Study|Adverse Event|1|||
145327448|NCT02145026|524048242|FG000|Overall Study|Adverse Event|2|||
145327449|NCT02145026|524048242|FG000|Overall Study|Death|4|||
145327450|NCT02145026|524048242|FG000|Overall Study|Withdrawal by Subject|2|||
145327451|NCT02145026|524048242|FG000|Overall Study|Physician Decision|4|||
145327452|NCT03656874|524048243|FG000|Overall Study|Lost to Follow-up|3|||
145327453|NCT03656874|524048244|FG001|Overall Study|Lost to Follow-up|17|||
145327454|NCT03052322|524048246|FG000|Overall Study|Other un-specified|1|||
145327455|NCT03052322|524048247|FG001|Overall Study|Other un-specified|2|||
145327456|NCT03052322|524048246|FG000|Overall Study|Withdrawal by Subject|10|||
145327457|NCT03052322|524048247|FG001|Overall Study|Withdrawal by Subject|9|||
145327458|NCT03052322|524048246|FG000|Overall Study|Death|0|||
145327459|NCT03052322|524048247|FG001|Overall Study|Death|2|||
145327460|NCT03052322|524048246|FG000|Overall Study|Lack of Efficacy|1|||
145327461|NCT03052322|524048247|FG001|Overall Study|Lack of Efficacy|2|||
145327462|NCT03052322|524048246|FG000|Overall Study|Protocol Violation|1|||
145327463|NCT03052322|524048247|FG001|Overall Study|Protocol Violation|0|||
145327464|NCT03052322|524048246|FG000|Overall Study|Lost to Follow-up|2|||
145327465|NCT03052322|524048247|FG001|Overall Study|Lost to Follow-up|4|||
145327466|NCT03052322|524048246|FG000|Overall Study|Adverse Event|6|||
145327467|NCT03052322|524048247|FG001|Overall Study|Adverse Event|13|||
145327468|NCT04920916|524048248|FG000|Phase IIa 60 Day Study|Death|2|||
145327469|NCT04920916|524048249|FG001|Phase IIa 60 Day Study|Death|5|||
145327470|NCT04920916|524048248|FG000|1 Year Follow up (Phone Call)|Death|1|||
145327471|NCT04920916|524048249|FG001|1 Year Follow up (Phone Call)|Death|3|||
145327472|NCT04920916|524048248|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
145327473|NCT04920916|524048249|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
145327474|NCT00973765|524048250|FG000|Overall Study|Lost to Follow-up|8|||
145327475|NCT00973765|524048251|FG001|Overall Study|Lost to Follow-up|14|||
145327476|NCT02566993|524048253|FG000|Overall Study|Randomized but not treated|5|||
145327477|NCT02566993|524048254|FG001|Overall Study|Randomized but not treated|16|||
145327478|NCT02566993|524048253|FG000|Overall Study|Progressive disease|213|||
145327479|NCT02566993|524048254|FG001|Overall Study|Progressive disease|152|||
145327480|NCT02566993|524048253|FG000|Overall Study|Withdrawal by Subject|12|||
145327481|NCT02566993|524048254|FG001|Overall Study|Withdrawal by Subject|28|||
145327482|NCT02566993|524048253|FG000|Overall Study|Death|17|||
145327483|NCT02566993|524048254|FG001|Overall Study|Death|23|||
145327484|NCT02566993|524048253|FG000|Overall Study|Physician Decision|10|||
145327485|NCT02566993|524048254|FG001|Overall Study|Physician Decision|17|||
145327486|NCT02566993|524048253|FG000|Overall Study|Study drug-related adverse event|20|||
145327487|NCT02566993|524048254|FG001|Overall Study|Study drug-related adverse event|41|||
145327488|NCT02566993|524048253|FG000|Overall Study|Non study drug-related adverse event|9|||
145327489|NCT02566993|524048254|FG001|Overall Study|Non study drug-related adverse event|9|||
145327490|NCT02566993|524048253|FG000|Overall Study|Symptomatic deterioration|9|||
145327491|NCT02566993|524048254|FG001|Overall Study|Symptomatic deterioration|16|||
145327492|NCT02566993|524048253|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
145327493|NCT02566993|524048254|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
145327494|NCT02566993|524048253|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
145327495|NCT02566993|524048254|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
145327496|NCT02566993|524048253|FG000|Overall Study|Screening failure|2|||
145327497|NCT02566993|524048254|FG001|Overall Study|Screening failure|0|||
145327498|NCT02566993|524048253|FG000|Overall Study|Lost to Follow-up|0|||
145327499|NCT02566993|524048254|FG001|Overall Study|Lost to Follow-up|1|||
145327500|NCT02566993|524048253|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
145327501|NCT02566993|524048254|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
145327502|NCT01546649|524048257|FG000|Overall Study|Adverse Event|4|||
145327503|NCT01546649|524048258|FG001|Overall Study|Adverse Event|5|||
145327504|NCT01546649|524048257|FG000|Overall Study|Protocol Violation|1|||
145327505|NCT01546649|524048258|FG001|Overall Study|Protocol Violation|0|||
145327506|NCT01546649|524048257|FG000|Overall Study|Lack of Efficacy|1|||
145327507|NCT01546649|524048258|FG001|Overall Study|Lack of Efficacy|0|||
145327508|NCT01546649|524048257|FG000|Overall Study|Recurrence|1|||
145327509|NCT01546649|524048258|FG001|Overall Study|Recurrence|1|||
145327510|NCT01546649|524048257|FG000|Overall Study|Discovery of secondary cancer|0|||
145327511|NCT01546649|524048258|FG001|Overall Study|Discovery of secondary cancer|1|||
145327512|NCT01546649|524048257|FG000|Overall Study|Withdrawal by Subject|1|||
145327513|NCT01546649|524048258|FG001|Overall Study|Withdrawal by Subject|2|||
145327514|NCT00706381|524048260|FG000|Overall Study|Lost to Follow-up|0|||
145327515|NCT00706381|524048261|FG001|Overall Study|Lost to Follow-up|1|||
145327516|NCT00706381|524048262|FG002|Overall Study|Lost to Follow-up|1|||
145327517|NCT00706381|524048263|FG003|Overall Study|Lost to Follow-up|0|||
145327518|NCT04355663|524048264|FG000|Overall Study|Physician Decision|2|||
145327519|NCT04355663|524048265|FG001|Overall Study|Physician Decision|7|||
145327520|NCT04355663|524048266|FG002|Overall Study|Physician Decision|0|||
145327521|NCT04355663|524048264|FG000|Overall Study|Adverse Event|0|||
145327522|NCT04355663|524048265|FG001|Overall Study|Adverse Event|0|||
145327523|NCT04355663|524048266|FG002|Overall Study|Adverse Event|1|||
145327524|NCT04355663|524048264|FG000|Overall Study|Withdrawal by Subject|0|||
145327525|NCT04355663|524048265|FG001|Overall Study|Withdrawal by Subject|8|||
145327526|NCT04355663|524048266|FG002|Overall Study|Withdrawal by Subject|3|||
145327527|NCT00038649|524048274|FG000|Overall Study|Adverse Event|9|||
145327528|NCT00942331|524048275|FG000|Overall Study|Did not start treatment|15|||
145327529|NCT00942331|524048276|FG001|Overall Study|Did not start treatment|22|||
145327530|NCT00567476|524048278|FG000|Overall Study|Adverse Event|2|||
145327531|NCT00567476|524048279|FG001|Overall Study|Adverse Event|0|||
145327532|NCT00567476|524048278|FG000|Overall Study|Pregnancy|1|||
145327533|NCT00567476|524048279|FG001|Overall Study|Pregnancy|0|||
145327534|NCT00567476|524048278|FG000|Overall Study|Protocol Violation|4|||
145327535|NCT00567476|524048279|FG001|Overall Study|Protocol Violation|1|||
145327536|NCT00567476|524048278|FG000|Overall Study|Lost to Follow-up|0|||
145327537|NCT00567476|524048279|FG001|Overall Study|Lost to Follow-up|1|||
145327538|NCT00567476|524048278|FG000|Overall Study|Administrative issues|1|||
145327539|NCT00567476|524048279|FG001|Overall Study|Administrative issues|0|||
145327540|NCT00567476|524048278|FG000|Overall Study|Medical Decision|0|||
145327541|NCT00567476|524048279|FG001|Overall Study|Medical Decision|1|||
145571052|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
145571053|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
145571054|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
145571055|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
145571056|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
145571057|NCT02161718|524950100|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
145571058|NCT02161718|524950101|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
145571059|NCT02161718|524950102|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
145571060|NCT02161718|524950100|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
145571061|NCT02161718|524950101|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
145571062|NCT02161718|524950102|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
145571063|NCT02161718|524950100|FG000|Post- Randomization Period|Lost to Follow-up|0|||
145571064|NCT02161718|524950101|FG001|Post- Randomization Period|Lost to Follow-up|9|||
145571065|NCT02161718|524950102|FG002|Post- Randomization Period|Lost to Follow-up|15|||
145571066|NCT02161718|524950100|FG000|Post- Randomization Period|Adverse Event|0|||
145571067|NCT02161718|524950101|FG001|Post- Randomization Period|Adverse Event|9|||
145571068|NCT02161718|524950102|FG002|Post- Randomization Period|Adverse Event|10|||
145571069|NCT02161718|524950100|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
145571070|NCT02161718|524950101|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
145571071|NCT02161718|524950102|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
145571072|NCT02161718|524950100|FG000|Post- Randomization Period|Physician Decision|0|||
145571073|NCT02161718|524950101|FG001|Post- Randomization Period|Physician Decision|2|||
145571074|NCT02161718|524950102|FG002|Post- Randomization Period|Physician Decision|4|||
145571075|NCT02161718|524950100|FG000|Post- Randomization Period|Protocol Violation|0|||
145571076|NCT02161718|524950101|FG001|Post- Randomization Period|Protocol Violation|2|||
145571077|NCT02161718|524950102|FG002|Post- Randomization Period|Protocol Violation|3|||
145571078|NCT02161718|524950100|FG000|Post- Randomization Period|Lack of Efficacy|0|||
145571079|NCT02161718|524950101|FG001|Post- Randomization Period|Lack of Efficacy|0|||
145571080|NCT02161718|524950102|FG002|Post- Randomization Period|Lack of Efficacy|1|||
145571081|NCT02161718|524950100|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
145571082|NCT02161718|524950101|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
145571083|NCT02161718|524950102|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
145571084|NCT02161718|524950100|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
145571085|NCT02161718|524950101|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
145571086|NCT02161718|524950102|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
145571087|NCT02161718|524950100|FG000|Post- Randomization Period|Relocation|0|||
145571088|NCT02161718|524950101|FG001|Post- Randomization Period|Relocation|3|||
145571089|NCT02161718|524950102|FG002|Post- Randomization Period|Relocation|0|||
145620644|NCT03621982|525125130|FG006|Overall Study|Death|6|||
145327542|NCT00567476|524048278|FG000|Overall Study|Non-adherence to protocol|0|||
145327543|NCT00567476|524048279|FG001|Overall Study|Non-adherence to protocol|1|||
145327544|NCT01491035|524048285|FG000|Overall Study|Lost to Follow-up|0|||
145327545|NCT01491035|524048286|FG001|Overall Study|Lost to Follow-up|0|||
145327546|NCT01491035|524048287|FG002|Overall Study|Lost to Follow-up|0|||
145327547|NCT01491035|524048288|FG003|Overall Study|Lost to Follow-up|0|||
145327548|NCT01491035|524048289|FG004|Overall Study|Lost to Follow-up|1|||
145327549|NCT01491035|524048290|FG005|Overall Study|Lost to Follow-up|0|||
145327550|NCT01491035|524048291|FG006|Overall Study|Lost to Follow-up|0|||
145327551|NCT01491035|524048292|FG007|Overall Study|Lost to Follow-up|0|||
145327552|NCT02999477|524048295|FG000|Overall Study|found ineligible after first dose|0|||
145327553|NCT02999477|524048296|FG001|Overall Study|found ineligible after first dose|1|||
145327554|NCT02999477|524048295|FG000|Overall Study|Withdrawal by Subject|1|||
145327555|NCT02999477|524048296|FG001|Overall Study|Withdrawal by Subject|1|||
145327556|NCT00891839|524048298|FG000|Overall Study|Adverse Event|2|||
145327557|NCT00891839|524048298|FG000|Overall Study|Withdrawal by Subject|2|||
145327558|NCT00891839|524048298|FG000|Overall Study|Disease progression|3|||
145327559|NCT00851643|524048302|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
145327560|NCT00851643|524048303|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145327561|NCT00851643|524048304|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145327562|NCT00851643|524048305|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145327563|NCT00851643|524048306|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145327564|NCT00851643|524048307|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
145327565|NCT00851643|524048302|FG000|Base Study (Up to 12 Months)|Other|0|||
145327566|NCT00851643|524048303|FG001|Base Study (Up to 12 Months)|Other|0|||
145327567|NCT00851643|524048304|FG002|Base Study (Up to 12 Months)|Other|0|||
145620645|NCT03621982|525125131|FG007|Overall Study|Death|3|||
145327568|NCT00851643|524048305|FG003|Base Study (Up to 12 Months)|Other|0|||
145327569|NCT00851643|524048306|FG004|Base Study (Up to 12 Months)|Other|0|||
145327570|NCT00851643|524048307|FG005|Base Study (Up to 12 Months)|Other|1|||
145412093|NCT05800145|524362187|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
145620646|NCT03621982|525125132|FG008|Overall Study|Death|0|||
145571090|NCT02350309|524950107|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
145571091|NCT02350309|524950108|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
145571092|NCT02350309|524950109|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
145571093|NCT02350309|524950110|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
145571094|NCT02350309|524950111|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
145571095|NCT02350309|524950112|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
145571096|NCT02350309|524950107|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
145571097|NCT02350309|524950108|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
145571098|NCT02350309|524950109|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
145571099|NCT02350309|524950110|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
145571100|NCT02350309|524950111|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
145571101|NCT02350309|524950112|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
145571102|NCT01256710|524950113|FG000|Overall Study|Death|449|||
145571103|NCT01256710|524950113|FG000|Overall Study|System Explant|67|||
145571104|NCT01256710|524950113|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
145571105|NCT01256710|524950113|FG000|Overall Study|Lost to Follow-up|67|||
145571106|NCT01256710|524950113|FG000|Overall Study|Withdrawal by Subject|29|||
145571107|NCT01256710|524950113|FG000|Overall Study|Physician Decision|9|||
145571108|NCT01256710|524950113|FG000|Overall Study|Subject Noncompliance|2|||
145571109|NCT01256710|524950113|FG000|Overall Study|Study Terminated by Sponsor|273|||
145571110|NCT01205165|524950114|FG000|Overall Study|Lost to Follow-up|2|||
145571111|NCT02681302|524950118|FG000|Overall Study|Withdrawal by Subject|1|||
145327571|NCT00851643|524048302|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
145327572|NCT00851643|524048303|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
145327573|NCT00851643|524048304|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
145327574|NCT00851643|524048305|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
145327575|NCT00851643|524048306|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
145327576|NCT00851643|524048307|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
145327577|NCT00851643|524048302|FG000|Extension Study (Up to 36 Months)|Moved|0|||
145327578|NCT00851643|524048303|FG001|Extension Study (Up to 36 Months)|Moved|2|||
145327579|NCT00851643|524048304|FG002|Extension Study (Up to 36 Months)|Moved|1|||
145327580|NCT00851643|524048305|FG003|Extension Study (Up to 36 Months)|Moved|1|||
145327581|NCT00851643|524048306|FG004|Extension Study (Up to 36 Months)|Moved|0|||
145327582|NCT00851643|524048307|FG005|Extension Study (Up to 36 Months)|Moved|1|||
145327583|NCT01568866|524048308|FG000|Overall Study|Disease Progression|208|||
145327584|NCT01568866|524048309|FG001|Overall Study|Disease Progression|183|||
145327585|NCT01568866|524048308|FG000|Overall Study|Adverse Event|94|||
145327586|NCT01568866|524048309|FG001|Overall Study|Adverse Event|96|||
145327587|NCT01568866|524048308|FG000|Overall Study|Patient Request|55|||
145327588|NCT01568866|524048309|FG001|Overall Study|Patient Request|71|||
145327589|NCT01568866|524048308|FG000|Overall Study|Physician Decision|40|||
145327590|NCT01568866|524048309|FG001|Overall Study|Physician Decision|32|||
145327591|NCT01568866|524048308|FG000|Overall Study|Withdrawal by Subject|19|||
145327592|NCT01568866|524048309|FG001|Overall Study|Withdrawal by Subject|11|||
145327593|NCT01568866|524048308|FG000|Overall Study|Death|10|||
145327594|NCT01568866|524048309|FG001|Overall Study|Death|18|||
145327595|NCT01568866|524048308|FG000|Overall Study|Protocol Non-compliance|2|||
145327596|NCT01568866|524048309|FG001|Overall Study|Protocol Non-compliance|4|||
145327597|NCT01568866|524048308|FG000|Overall Study|Lost to Follow-up|1|||
145327598|NCT01568866|524048309|FG001|Overall Study|Lost to Follow-up|0|||
145327599|NCT01568866|524048308|FG000|Overall Study|Randomized but Not Dosed|9|||
145327600|NCT01568866|524048309|FG001|Overall Study|Randomized but Not Dosed|1|||
145327601|NCT03864042|524048310|FG000|DDI Phase|Adverse Event|2|||
145327602|NCT03864042|524048311|FG001|DDI Phase|Adverse Event|0|||
145327603|NCT03864042|524048312|FG002|DDI Phase|Adverse Event|0|||
145327604|NCT03864042|524048310|FG000|DDI Phase|Physician Decision|1|||
145327605|NCT03864042|524048311|FG001|DDI Phase|Physician Decision|0|||
145327606|NCT03864042|524048312|FG002|DDI Phase|Physician Decision|0|||
145571112|NCT02681302|524950119|FG001|Overall Study|Withdrawal by Subject|1|||
145571113|NCT02681302|524950120|FG002|Overall Study|Withdrawal by Subject|0|||
145571114|NCT02681302|524950121|FG003|Overall Study|Withdrawal by Subject|0|||
145571115|NCT02681302|524950122|FG004|Overall Study|Withdrawal by Subject|1|||
145327607|NCT03864042|524048310|FG000|DDI Phase|Progressive Disease|1|||
145327608|NCT03864042|524048311|FG001|DDI Phase|Progressive Disease|0|||
145571116|NCT02681302|524950123|FG005|Overall Study|Withdrawal by Subject|0|||
145327609|NCT03864042|524048312|FG002|DDI Phase|Progressive Disease|0|||
145327610|NCT03864042|524048310|FG000|Post-DDI Phase|Adverse Event|5|||
145327611|NCT03864042|524048311|FG001|Post-DDI Phase|Adverse Event|3|||
145327612|NCT03864042|524048312|FG002|Post-DDI Phase|Adverse Event|2|||
145571117|NCT02681302|524950118|FG000|Overall Study|Screen Failure|2|||
145571118|NCT02681302|524950119|FG001|Overall Study|Screen Failure|4|||
145571119|NCT02681302|524950120|FG002|Overall Study|Screen Failure|2|||
145571120|NCT02681302|524950121|FG003|Overall Study|Screen Failure|0|||
145327613|NCT03864042|524048310|FG000|Post-DDI Phase|Progressive Disease|11|||
145327614|NCT03864042|524048311|FG001|Post-DDI Phase|Progressive Disease|6|||
145327615|NCT03864042|524048312|FG002|Post-DDI Phase|Progressive Disease|13|||
145620647|NCT03621982|525125133|FG009|Overall Study|Death|3|||
145620648|NCT03621982|525125134|FG010|Overall Study|Death|8|||
145620649|NCT03621982|525125135|FG011|Overall Study|Death|4|||
145620650|NCT03621982|525125136|FG012|Overall Study|Death|2|||
145620651|NCT03621982|525125137|FG013|Overall Study|Death|2|||
145620652|NCT03621982|525125124|FG000|Overall Study|Lost to Follow-up|0|||
145620653|NCT03621982|525125125|FG001|Overall Study|Lost to Follow-up|0|||
145620654|NCT03621982|525125126|FG002|Overall Study|Lost to Follow-up|1|||
145620655|NCT03621982|525125127|FG003|Overall Study|Lost to Follow-up|0|||
145620656|NCT03621982|525125128|FG004|Overall Study|Lost to Follow-up|0|||
145620657|NCT03621982|525125129|FG005|Overall Study|Lost to Follow-up|0|||
145620658|NCT03621982|525125130|FG006|Overall Study|Lost to Follow-up|1|||
145327616|NCT03864042|524048310|FG000|Post-DDI Phase|Discretion of investigator|1|||
145327617|NCT03864042|524048311|FG001|Post-DDI Phase|Discretion of investigator|1|||
145327618|NCT03864042|524048312|FG002|Post-DDI Phase|Discretion of investigator|0|||
145327619|NCT03864042|524048310|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
145620659|NCT03621982|525125131|FG007|Overall Study|Lost to Follow-up|0|||
145327620|NCT03864042|524048311|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
145327621|NCT03864042|524048312|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
145327622|NCT03864042|524048310|FG000|Post-DDI Phase|Withdrawal of consent|1|||
145327623|NCT03864042|524048311|FG001|Post-DDI Phase|Withdrawal of consent|2|||
145327624|NCT03864042|524048312|FG002|Post-DDI Phase|Withdrawal of consent|0|||
145327625|NCT01698775|524048313|FG000|Phase A|Adverse Event|2|||
145327626|NCT01698775|524048314|FG001|Phase A|Adverse Event|1|||
145327627|NCT01698775|524048313|FG000|Phase A|Death|1|||
145327628|NCT01698775|524048314|FG001|Phase A|Death|1|||
145327629|NCT01698775|524048313|FG000|Phase A|Lack of Efficacy|1|||
145327630|NCT01698775|524048314|FG001|Phase A|Lack of Efficacy|0|||
145327631|NCT01698775|524048313|FG000|Phase A|Lost to Follow-up|1|||
145327632|NCT01698775|524048314|FG001|Phase A|Lost to Follow-up|2|||
145327633|NCT01698775|524048313|FG000|Phase A|Protocol Violation|1|||
145327634|NCT01698775|524048314|FG001|Phase A|Protocol Violation|0|||
145327635|NCT01698775|524048313|FG000|Phase A|Withdrawal by Subject|3|||
145327636|NCT01698775|524048314|FG001|Phase A|Withdrawal by Subject|4|||
145327637|NCT01698775|524048313|FG000|Phase A|Kidney [transplant]|0|||
145327638|NCT01698775|524048314|FG001|Phase A|Kidney [transplant]|1|||
145327639|NCT01698775|524048313|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
145327640|NCT01698775|524048314|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
145327641|NCT01698775|524048313|FG000|Phase B|Adverse Event|6|||
145327642|NCT01698775|524048314|FG001|Phase B|Adverse Event|3|||
145327643|NCT01698775|524048313|FG000|Phase B|Death|0|||
145327644|NCT01698775|524048314|FG001|Phase B|Death|1|||
145327645|NCT01698775|524048313|FG000|Phase B|Lack of Efficacy|0|||
145327646|NCT01698775|524048314|FG001|Phase B|Lack of Efficacy|1|||
145327647|NCT01698775|524048313|FG000|Phase B|Lost to Follow-up|0|||
145327648|NCT01698775|524048314|FG001|Phase B|Lost to Follow-up|1|||
145327649|NCT01698775|524048313|FG000|Phase B|Physician Decision|1|||
145327650|NCT01698775|524048314|FG001|Phase B|Physician Decision|1|||
145327651|NCT01698775|524048313|FG000|Phase B|Protocol Violation|1|||
145327652|NCT01698775|524048314|FG001|Phase B|Protocol Violation|1|||
145327653|NCT01698775|524048313|FG000|Phase B|Withdrawal by Subject|6|||
145327654|NCT01698775|524048314|FG001|Phase B|Withdrawal by Subject|2|||
145327655|NCT00359788|524048315|FG000|Overall Study|Adverse Event|11|||
145327656|NCT00359788|524048316|FG001|Overall Study|Adverse Event|10|||
145327657|NCT00359788|524048315|FG000|Overall Study|Lack of Efficacy|1|||
145327658|NCT00359788|524048316|FG001|Overall Study|Lack of Efficacy|2|||
145327659|NCT00359788|524048315|FG000|Overall Study|Lost to Follow-up|3|||
145327660|NCT00359788|524048316|FG001|Overall Study|Lost to Follow-up|2|||
145327661|NCT00359788|524048315|FG000|Overall Study|Withdrawal by Subject|4|||
145327662|NCT00359788|524048316|FG001|Overall Study|Withdrawal by Subject|1|||
145327663|NCT00359788|524048315|FG000|Overall Study|Protocol Violation|4|||
145327664|NCT00359788|524048316|FG001|Overall Study|Protocol Violation|2|||
145327665|NCT01232491|524048319|FG000|Overall Study|Adverse Event|13|||
145327666|NCT01232491|524048320|FG001|Overall Study|Adverse Event|8|||
145327667|NCT01232491|524048319|FG000|Overall Study|Lack of Efficacy|1|||
145620660|NCT03621982|525125132|FG008|Overall Study|Lost to Follow-up|0|||
145327668|NCT01232491|524048320|FG001|Overall Study|Lack of Efficacy|5|||
145620661|NCT03621982|525125133|FG009|Overall Study|Lost to Follow-up|1|||
145620662|NCT03621982|525125134|FG010|Overall Study|Lost to Follow-up|0|||
145620663|NCT03621982|525125135|FG011|Overall Study|Lost to Follow-up|0|||
145327669|NCT01232491|524048319|FG000|Overall Study|Protocol Violation|13|||
145327670|NCT01232491|524048320|FG001|Overall Study|Protocol Violation|11|||
145327671|NCT01232491|524048319|FG000|Overall Study|Withdrawal Criteria|12|||
145327672|NCT01232491|524048320|FG001|Overall Study|Withdrawal Criteria|21|||
145327673|NCT01232491|524048319|FG000|Overall Study|Other|21|||
145327674|NCT01232491|524048320|FG001|Overall Study|Other|18|||
145327675|NCT02932228|524048323|FG000|Overall Study|Death|8|||
145327676|NCT02932228|524048324|FG001|Overall Study|Death|23|||
145327677|NCT02932228|524048323|FG000|Overall Study|not eligible upon chart review|2|||
145327678|NCT02932228|524048324|FG001|Overall Study|not eligible upon chart review|5|||
145327679|NCT03955471|524049964|FG000|Overall Study|Death|22|||
145620664|NCT03621982|525125136|FG012|Overall Study|Lost to Follow-up|0|||
145327680|NCT03955471|524049964|FG000|Overall Study|Lost to Follow-up|1|||
145327681|NCT03955471|524049964|FG000|Overall Study|Withdrawal by Subject|6|||
145327682|NCT03955471|524049964|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
145327683|NCT00821873|524049965|FG000|Overall Study|Lost to Follow-up|4|||
145327684|NCT01884311|524049968|FG000|Overall Study|Withdrawal by Subject|3|||
145327685|NCT01884311|524049968|FG000|Overall Study|withdrew consent due to AEs|1|||
145327686|NCT01884311|524049968|FG000|Overall Study|Precautionary measure|1|||
145327687|NCT02856880|524049971|FG000|Overall Study|Withdrawal of consent|1|||
145327688|NCT00793780|524049972|FG000|Overall Study|Withdrawal by Subject|2|||
145327689|NCT00793780|524049973|FG001|Overall Study|Withdrawal by Subject|1|||
145327690|NCT02858492|524049974|FG000|Overall Study|Withdrawal by Subject|0|||
145327691|NCT02858492|524049975|FG001|Overall Study|Withdrawal by Subject|1|||
145327692|NCT02858492|524049976|FG002|Overall Study|Withdrawal by Subject|0|||
145327693|NCT02858492|524049977|FG003|Overall Study|Withdrawal by Subject|1|||
145327694|NCT02858492|524049974|FG000|Overall Study|Adverse Event|0|||
145327695|NCT02858492|524049975|FG001|Overall Study|Adverse Event|0|||
145327696|NCT02858492|524049976|FG002|Overall Study|Adverse Event|0|||
145327697|NCT02858492|524049977|FG003|Overall Study|Adverse Event|3|||
145327698|NCT02858492|524049974|FG000|Overall Study|Lack of Efficacy|0|||
145327699|NCT02858492|524049975|FG001|Overall Study|Lack of Efficacy|0|||
145327700|NCT02858492|524049976|FG002|Overall Study|Lack of Efficacy|0|||
145327701|NCT02858492|524049977|FG003|Overall Study|Lack of Efficacy|1|||
145327702|NCT02858492|524049974|FG000|Overall Study|Protocol defined stopping criteria|0|||
145327703|NCT02858492|524049975|FG001|Overall Study|Protocol defined stopping criteria|0|||
145412094|NCT05800145|524362182|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
145412095|NCT05800145|524362183|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
145412096|NCT05800145|524362184|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
145571121|NCT02681302|524950122|FG004|Overall Study|Screen Failure|1|||
145327704|NCT02858492|524049976|FG002|Overall Study|Protocol defined stopping criteria|0|||
145327705|NCT02858492|524049977|FG003|Overall Study|Protocol defined stopping criteria|1|||
145327706|NCT00573157|524049978|FG000|Overall Study|Adverse Event|3|||
145327707|NCT00573157|524049979|FG001|Overall Study|Adverse Event|1|||
145327708|NCT00573157|524049978|FG000|Overall Study|Other|1|||
145327709|NCT00573157|524049979|FG001|Overall Study|Other|1|||
145327710|NCT01032018|524049982|FG000|Overall Study|Lost to Follow-up|6|||
145327711|NCT01032018|524049983|FG001|Overall Study|Lost to Follow-up|5|||
145327712|NCT01032018|524049982|FG000|Overall Study|Death|0|||
145327713|NCT01032018|524049983|FG001|Overall Study|Death|1|||
145327714|NCT00729248|524049987|FG000|Overall Study|Physician Decision|2|||
145327715|NCT03573505|524049990|FG000|Overall Study|Adverse Event|1|||
145327716|NCT03573505|524049991|FG001|Overall Study|Adverse Event|1|||
145327717|NCT03573505|524049990|FG000|Overall Study|Consent withdrawn|0|||
145327718|NCT03573505|524049991|FG001|Overall Study|Consent withdrawn|1|||
145327719|NCT03573505|524049990|FG000|Overall Study|Disease progression|0|||
145327720|NCT03573505|524049991|FG001|Overall Study|Disease progression|1|||
145327721|NCT03573505|524049990|FG000|Overall Study|Site Terminated by Sponsor|1|||
145327722|NCT03573505|524049991|FG001|Overall Study|Site Terminated by Sponsor|1|||
145327723|NCT03573505|524049990|FG000|Overall Study|Study terminated by sponsor|50|||
145327724|NCT03573505|524049991|FG001|Overall Study|Study terminated by sponsor|45|||
145327725|NCT03573505|524049990|FG000|Overall Study|Reason not specified|0|||
145327726|NCT03573505|524049991|FG001|Overall Study|Reason not specified|1|||
145327727|NCT03573505|524049990|FG000|Overall Study|Death|0|||
145327728|NCT03573505|524049991|FG001|Overall Study|Death|4|||
145327729|NCT02040779|524049992|FG000|Overall Study|Adverse Event|1|||
145327730|NCT02040779|524049993|FG001|Overall Study|Adverse Event|0|||
145327731|NCT02040779|524049994|FG002|Overall Study|Adverse Event|0|||
145327732|NCT02040779|524049992|FG000|Overall Study|Withdrawal by Subject|4|||
145327733|NCT02040779|524049993|FG001|Overall Study|Withdrawal by Subject|1|||
145327734|NCT02040779|524049994|FG002|Overall Study|Withdrawal by Subject|3|||
145327735|NCT02040779|524049992|FG000|Overall Study|Non-compliance|0|||
145571122|NCT02681302|524950123|FG005|Overall Study|Screen Failure|1|||
145571123|NCT02681302|524950118|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
145571124|NCT02681302|524950119|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
145571125|NCT02681302|524950120|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
145571126|NCT02681302|524950121|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
145571127|NCT02681302|524950122|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
145571128|NCT02681302|524950123|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
145571129|NCT02942017|524950124|FG000|Overall Study|Adverse Event|0|||
145327736|NCT02040779|524049993|FG001|Overall Study|Non-compliance|1|||
145327737|NCT02040779|524049994|FG002|Overall Study|Non-compliance|0|||
145327738|NCT02040779|524049992|FG000|Overall Study|Protocol Violation|2|||
145327739|NCT02040779|524049993|FG001|Overall Study|Protocol Violation|1|||
145327740|NCT02040779|524049994|FG002|Overall Study|Protocol Violation|0|||
145327741|NCT02040779|524049992|FG000|Overall Study|Lost to Follow-up|1|||
145327742|NCT02040779|524049993|FG001|Overall Study|Lost to Follow-up|2|||
145327743|NCT02040779|524049994|FG002|Overall Study|Lost to Follow-up|1|||
145327744|NCT02040779|524049992|FG000|Overall Study|Lack of Efficacy|4|||
145327745|NCT02040779|524049993|FG001|Overall Study|Lack of Efficacy|2|||
145327746|NCT02040779|524049994|FG002|Overall Study|Lack of Efficacy|0|||
145327747|NCT00922272|524049995|FG000|Open-label Phase|Adverse Event|5|||
145327748|NCT00922272|524049996|FG001|Open-label Phase|Adverse Event|0|||
145327749|NCT00922272|524049995|FG000|Open-label Phase|Protocol Violation|1|||
145327750|NCT00922272|524049996|FG001|Open-label Phase|Protocol Violation|0|||
145327751|NCT00922272|524049995|FG000|Open-label Phase|Withdrawal by Subject|11|||
145327752|NCT00922272|524049996|FG001|Open-label Phase|Withdrawal by Subject|0|||
145327753|NCT00922272|524049995|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
145327754|NCT00922272|524049996|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
145327755|NCT00922272|524049995|FG000|Open-label Phase|Withdrawal criteria met|5|||
145327756|NCT00922272|524049996|FG001|Open-label Phase|Withdrawal criteria met|0|||
145327757|NCT00922272|524049995|FG000|Double-blind Phase|Adverse Event|1|||
145327758|NCT00922272|524049996|FG001|Double-blind Phase|Adverse Event|1|||
145327759|NCT00922272|524049995|FG000|Double-blind Phase|Withdrawal by Subject|1|||
145327760|NCT00922272|524049996|FG001|Double-blind Phase|Withdrawal by Subject|1|||
145327761|NCT00922272|524049995|FG000|Double-blind Phase|Lost to Follow-up|2|||
145327762|NCT00922272|524049996|FG001|Double-blind Phase|Lost to Follow-up|1|||
145327763|NCT00922272|524049995|FG000|Double-blind Phase|Withdrawal criteria met|1|||
145327764|NCT00922272|524049996|FG001|Double-blind Phase|Withdrawal criteria met|1|||
145327765|NCT00922272|524049995|FG000|Double-blind Phase|Noncompliance|1|||
145327766|NCT00922272|524049996|FG001|Double-blind Phase|Noncompliance|1|||
145327767|NCT00922272|524049995|FG000|Double-blind Phase|Positive urine drug screen|1|||
145327768|NCT00922272|524049996|FG001|Double-blind Phase|Positive urine drug screen|1|||
145327769|NCT02588950|524050003|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
145327770|NCT02588950|524050004|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
145327771|NCT02588950|524050005|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
145327772|NCT02588950|524050006|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
145327773|NCT02588950|524050003|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
145327774|NCT02588950|524050004|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
145327775|NCT02588950|524050005|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
145327776|NCT02588950|524050006|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
145327777|NCT00866658|524050007|FG000|Overall Study|Adverse Event|5|||
145327778|NCT00866658|524050008|FG001|Overall Study|Adverse Event|14|||
145327779|NCT00866658|524050007|FG000|Overall Study|Lack of Efficacy|2|||
145327780|NCT00866658|524050008|FG001|Overall Study|Lack of Efficacy|1|||
145327781|NCT00866658|524050007|FG000|Overall Study|Withdrawal by Subject|1|||
145327782|NCT00866658|524050008|FG001|Overall Study|Withdrawal by Subject|0|||
145327783|NCT00866658|524050007|FG000|Overall Study|Protocol Violation|1|||
145327784|NCT00866658|524050008|FG001|Overall Study|Protocol Violation|1|||
145327785|NCT00866658|524050007|FG000|Overall Study|Familial and Personal Reasons|4|||
145327786|NCT00866658|524050008|FG001|Overall Study|Familial and Personal Reasons|5|||
145327787|NCT00652028|524050009|FG000|Overall Study|Adverse Event|1|||
145327788|NCT00652028|524050010|FG001|Overall Study|Adverse Event|0|||
145327789|NCT00652028|524050011|FG002|Overall Study|Adverse Event|0|||
145327790|NCT00652028|524050012|FG003|Overall Study|Adverse Event|0|||
145327791|NCT00652028|524050009|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
145327792|NCT00652028|524050010|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
145327793|NCT00652028|524050011|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
145327794|NCT00652028|524050012|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
145327795|NCT00652028|524050009|FG000|Overall Study|Physician Decision|0|||
145327796|NCT00652028|524050010|FG001|Overall Study|Physician Decision|0|||
145327797|NCT00652028|524050011|FG002|Overall Study|Physician Decision|1|||
145327798|NCT00652028|524050012|FG003|Overall Study|Physician Decision|0|||
145327799|NCT02751359|524050013|FG000|Overall Study|Lost to Follow-up|1|||
145571130|NCT02942017|524950125|FG001|Overall Study|Adverse Event|1|||
145327800|NCT02011113|524050014|FG000|Overall Study|Adverse Event|4|||
145327801|NCT02011113|524050014|FG000|Overall Study|Disease Progression (DP)|16|||
145327802|NCT02011113|524050014|FG000|Overall Study|Death|1|||
145327803|NCT02011113|524050014|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
145327804|NCT02011113|524050014|FG000|Overall Study|Investigator's judgement- DP|3|||
145327805|NCT02011113|524050014|FG000|Overall Study|Study terminated by sponsor|11|||
145327806|NCT02669940|524050017|FG000|Overall Study|Failure to return|0|||
145327807|NCT02669940|524050018|FG001|Overall Study|Failure to return|3|||
145327808|NCT02669940|524050017|FG000|Overall Study|Insufficient follow-up data|1|||
145327809|NCT02669940|524050018|FG001|Overall Study|Insufficient follow-up data|0|||
145327810|NCT05065983|524050027|FG000|Overall Study|Lost to Follow-up|2|||
145327811|NCT01765582|524050028|FG000|Overall Study|Other|3|||
145327812|NCT01765582|524050029|FG001|Overall Study|Other|6|||
145412097|NCT05800145|524362185|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
145571131|NCT02942017|524950124|FG000|Overall Study|Withdrawal by Subject|0|||
145327813|NCT01765582|524050030|FG002|Overall Study|Other|9|||
145327814|NCT01765582|524050028|FG000|Overall Study|Lost to Follow-up|2|||
145327815|NCT01765582|524050029|FG001|Overall Study|Lost to Follow-up|2|||
145327816|NCT01765582|524050030|FG002|Overall Study|Lost to Follow-up|1|||
145327817|NCT01765582|524050028|FG000|Overall Study|Death|31|||
145327818|NCT01765582|524050029|FG001|Overall Study|Death|36|||
145327819|NCT01765582|524050030|FG002|Overall Study|Death|33|||
145327820|NCT01765582|524050028|FG000|Overall Study|Sponsor Decision|46|||
145327821|NCT01765582|524050029|FG001|Overall Study|Sponsor Decision|42|||
145327822|NCT01765582|524050030|FG002|Overall Study|Sponsor Decision|42|||
145327823|NCT01765582|524050028|FG000|Overall Study|Withdrawal of Consent|11|||
145327824|NCT01765582|524050029|FG001|Overall Study|Withdrawal of Consent|6|||
145327825|NCT01765582|524050030|FG002|Overall Study|Withdrawal of Consent|10|||
145327826|NCT00986180|524050031|FG000|Overall Study|Adverse Event|21|||
145327827|NCT00986180|524050032|FG001|Overall Study|Adverse Event|23|||
145327828|NCT00986180|524050031|FG000|Overall Study|Lack of Efficacy|4|||
145327829|NCT00986180|524050032|FG001|Overall Study|Lack of Efficacy|3|||
145327830|NCT00986180|524050031|FG000|Overall Study|Lost to Follow-up|5|||
145327831|NCT00986180|524050032|FG001|Overall Study|Lost to Follow-up|7|||
145327832|NCT00986180|524050031|FG000|Overall Study|Physician Decision|1|||
145327833|NCT00986180|524050032|FG001|Overall Study|Physician Decision|3|||
145327834|NCT00986180|524050031|FG000|Overall Study|Protocol Violation|2|||
145327835|NCT00986180|524050032|FG001|Overall Study|Protocol Violation|0|||
145327836|NCT00986180|524050031|FG000|Overall Study|Withdrawal by Subject|1|||
145327837|NCT00986180|524050032|FG001|Overall Study|Withdrawal by Subject|9|||
145327838|NCT00986180|524050031|FG000|Overall Study|Miscellanies|10|||
145327839|NCT00986180|524050032|FG001|Overall Study|Miscellanies|11|||
145327840|NCT03251963|524050037|FG000|Overall Study|inappropriate Xa level timing|6|||
145327841|NCT03251963|524050038|FG001|Overall Study|inappropriate Xa level timing|3|||
145327842|NCT03251963|524050037|FG000|Overall Study|no peak Xa level drawn|2|||
145327843|NCT03251963|524050038|FG001|Overall Study|no peak Xa level drawn|0|||
145327844|NCT03251963|524050037|FG000|Overall Study|bled prior to Xa level|1|||
145327845|NCT03251963|524050038|FG001|Overall Study|bled prior to Xa level|2|||
145327846|NCT00616941|524050039|FG000|Overall Study|Progressive Disease|1|||
145327847|NCT00616941|524050040|FG001|Overall Study|Progressive Disease|2|||
145327848|NCT00616941|524050041|FG002|Overall Study|Progressive Disease|1|||
145327849|NCT00616941|524050039|FG000|Overall Study|Adverse Event|0|||
145327850|NCT00616941|524050040|FG001|Overall Study|Adverse Event|1|||
145327851|NCT00616941|524050041|FG002|Overall Study|Adverse Event|1|||
145327852|NCT00616941|524050039|FG000|Overall Study|Subject Non-compliance|0|||
145327853|NCT00616941|524050040|FG001|Overall Study|Subject Non-compliance|0|||
145327854|NCT00616941|524050041|FG002|Overall Study|Subject Non-compliance|1|||
145327855|NCT00616941|524050039|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
145327856|NCT00616941|524050040|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
145327857|NCT00616941|524050041|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
145327858|NCT00616941|524050039|FG000|Overall Study|Vaccination Suspended|0|||
145327859|NCT00616941|524050040|FG001|Overall Study|Vaccination Suspended|0|||
145327860|NCT00616941|524050041|FG002|Overall Study|Vaccination Suspended|3|||
145327861|NCT00714493|524050049|FG000|Overall Study|Adverse Event|11|||
145327862|NCT00714493|524050049|FG000|Overall Study|Death|3|||
145327863|NCT00714493|524050049|FG000|Overall Study|Lack of Efficacy|10|||
145327864|NCT00714493|524050049|FG000|Overall Study|Lost to Follow-up|3|||
145327865|NCT00714493|524050049|FG000|Overall Study|Protocol Violation|12|||
145327866|NCT00714493|524050049|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
145327867|NCT00714493|524050049|FG000|Overall Study|OTHER|2|||
145327868|NCT01732874|524050050|FG000|Overall Study|Withdrawal by Subject|5|||
145327869|NCT01732874|524050051|FG001|Overall Study|Withdrawal by Subject|1|||
145327870|NCT01732874|524050050|FG000|Overall Study|Death of Infant|3|||
145327871|NCT01732874|524050051|FG001|Overall Study|Death of Infant|2|||
145327872|NCT00688376|524050052|FG000|Double-Blind Phase|Adverse Event|4|||
145327873|NCT00688376|524050053|FG001|Double-Blind Phase|Adverse Event|4|||
145327874|NCT00688376|524050052|FG000|Double-Blind Phase|Protocol Violation|1|||
145327875|NCT00688376|524050053|FG001|Double-Blind Phase|Protocol Violation|2|||
145327876|NCT00688376|524050052|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
145327877|NCT00688376|524050053|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
145327878|NCT00688376|524050052|FG000|Double-Blind Phase|Not treated|0|||
145327879|NCT00688376|524050053|FG001|Double-Blind Phase|Not treated|1|||
145327880|NCT00688376|524050052|FG000|Blinded Extension Phase|Adverse Event|3|||
145327881|NCT00688376|524050053|FG001|Blinded Extension Phase|Adverse Event|4|||
145327882|NCT00688376|524050052|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
145327883|NCT00688376|524050053|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
145327884|NCT00688376|524050052|FG000|Blinded Extension Phase|Physician Decision|1|||
145412098|NCT05800145|524362186|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
145327885|NCT00688376|524050053|FG001|Blinded Extension Phase|Physician Decision|0|||
145327886|NCT00688376|524050052|FG000|Blinded Extension Phase|Other|1|||
145327887|NCT00688376|524050053|FG001|Blinded Extension Phase|Other|0|||
145327888|NCT00557076|524050054|FG000|Overall Study|Unblinding|0|||
145327889|NCT00557076|524050055|FG001|Overall Study|Unblinding|1|||
145327890|NCT04392583|524050057|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
145327891|NCT03484117|524050058|FG000|Overall Study|Lost to Follow-up|1|||
145327892|NCT03484117|524050059|FG001|Overall Study|Lost to Follow-up|3|||
145327893|NCT03484117|524050058|FG000|Overall Study|Declined participation in exit assess|1|||
145327894|NCT03484117|524050059|FG001|Overall Study|Declined participation in exit assess|1|||
145327895|NCT02303041|524050060|FG000|Overall Study|Adverse Event|1|||
145327896|NCT02303041|524050061|FG001|Overall Study|Adverse Event|2|||
145327897|NCT01070771|524050062|FG000|Overall Study|Adverse Event|2|||
145327898|NCT01070771|524050062|FG000|Overall Study|Protocol Violation|1|||
145327899|NCT00289874|524050063|FG000|Overall Study|Adverse Event|1|||
145327900|NCT00289874|524050064|FG001|Overall Study|Adverse Event|5|||
145327901|NCT00289874|524050063|FG000|Overall Study|Lost to Follow-up|1|||
145327902|NCT00289874|524050064|FG001|Overall Study|Lost to Follow-up|1|||
145327903|NCT00289874|524050063|FG000|Overall Study|Protocol Violation|3|||
145327904|NCT00289874|524050064|FG001|Overall Study|Protocol Violation|2|||
145327905|NCT00289874|524050063|FG000|Overall Study|Did not meet eligibility|1|||
145327906|NCT00289874|524050064|FG001|Overall Study|Did not meet eligibility|0|||
145327907|NCT00136318|524050065|FG000|Overall Study|Adverse Event|5|||
145327908|NCT00136318|524050066|FG001|Overall Study|Adverse Event|5|||
145327909|NCT00136318|524050065|FG000|Overall Study|Withdrawal by Subject|2|||
145327910|NCT00136318|524050066|FG001|Overall Study|Withdrawal by Subject|2|||
145327911|NCT03835325|524050067|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
145327912|NCT03835325|524050067|FG000|Overall Study|Selection failure|1|||
145327913|NCT01370213|524050068|FG000|Overall Study|Early Death|1|||
145327914|NCT01370213|524050069|FG001|Overall Study|Early Death|0|||
145327915|NCT01370213|524050070|FG002|Overall Study|Early Death|0|||
145571132|NCT02942017|524950125|FG001|Overall Study|Withdrawal by Subject|1|||
145327916|NCT01370213|524050068|FG000|Overall Study|Not evaluable|0|||
145571133|NCT02942017|524950124|FG000|Overall Study|Lost to Follow-up|1|||
145571134|NCT02942017|524950125|FG001|Overall Study|Lost to Follow-up|1|||
145571135|NCT02942017|524950124|FG000|Overall Study|Randomized but not dosed|1|||
145571136|NCT02942017|524950125|FG001|Overall Study|Randomized but not dosed|3|||
145571137|NCT04399161|524950126|FG000|Overall Study|Withdrawal by Subject|1|||
145571138|NCT04399161|524950127|FG001|Overall Study|Withdrawal by Subject|0|||
145571139|NCT04399161|524950128|FG002|Overall Study|Withdrawal by Subject|2|||
145571140|NCT04399161|524950126|FG000|Overall Study|Protocol Violation|1|||
145571141|NCT04399161|524950127|FG001|Overall Study|Protocol Violation|2|||
145571142|NCT04399161|524950128|FG002|Overall Study|Protocol Violation|0|||
145571143|NCT03417141|524950129|FG000|Overall Study|Withdrawal by Subject|1|||
145571144|NCT03417141|524950129|FG000|Overall Study|Protocol Violation|3|||
145571145|NCT01736696|524950130|FG000|Overall Study|Withdrawal by Subject|0|||
145327917|NCT01370213|524050069|FG001|Overall Study|Not evaluable|2|||
145327918|NCT01370213|524050070|FG002|Overall Study|Not evaluable|0|||
145327919|NCT01550744|524050073|FG000|Open-Label|Lost to Follow-up|7|||
145327920|NCT01550744|524050074|FG001|Open-Label|Lost to Follow-up|0|||
145571146|NCT01736696|524950131|FG001|Overall Study|Withdrawal by Subject|0|||
145571147|NCT01736696|524950132|FG002|Overall Study|Withdrawal by Subject|1|||
145571148|NCT01736696|524950133|FG003|Overall Study|Withdrawal by Subject|0|||
145327921|NCT01550744|524050075|FG002|Open-Label|Lost to Follow-up|0|||
145327922|NCT01550744|524050073|FG000|Open-Label|Withdrawal by Subject|13|||
145327923|NCT01550744|524050074|FG001|Open-Label|Withdrawal by Subject|0|||
145327924|NCT01550744|524050075|FG002|Open-Label|Withdrawal by Subject|0|||
145327925|NCT01550744|524050073|FG000|Open-Label|Adverse Event|11|||
145327926|NCT01550744|524050074|FG001|Open-Label|Adverse Event|0|||
145327927|NCT01550744|524050075|FG002|Open-Label|Adverse Event|0|||
145327928|NCT01550744|524050073|FG000|Open-Label|Lack of Efficacy|4|||
145327929|NCT01550744|524050074|FG001|Open-Label|Lack of Efficacy|0|||
145327930|NCT01550744|524050075|FG002|Open-Label|Lack of Efficacy|0|||
145327931|NCT01550744|524050073|FG000|Open-Label|Protocol Violation|4|||
145327932|NCT01550744|524050074|FG001|Open-Label|Protocol Violation|0|||
145327933|NCT01550744|524050075|FG002|Open-Label|Protocol Violation|0|||
145327934|NCT01550744|524050073|FG000|Open-Label|Not all 3 study drug injections received|2|||
145571149|NCT01736696|524950134|FG004|Overall Study|Withdrawal by Subject|0|||
145327935|NCT01550744|524050074|FG001|Open-Label|Not all 3 study drug injections received|0|||
145327936|NCT01550744|524050075|FG002|Open-Label|Not all 3 study drug injections received|0|||
145327937|NCT01550744|524050073|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
145327938|NCT01550744|524050074|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
145571150|NCT01736696|524950135|FG005|Overall Study|Withdrawal by Subject|0|||
145571151|NCT01736696|524950136|FG006|Overall Study|Withdrawal by Subject|0|||
145327939|NCT01550744|524050075|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
145571152|NCT00838565|524950137|FG000|Overall Study|Withdrawal by Subject|0|||
145571153|NCT00838565|524950138|FG001|Overall Study|Withdrawal by Subject|0|||
145327940|NCT01550744|524050073|FG000|Open-Label|Other|1|||
145327941|NCT01550744|524050074|FG001|Open-Label|Other|0|||
145327942|NCT01550744|524050075|FG002|Open-Label|Other|0|||
145327943|NCT01550744|524050073|FG000|Double-Blind|Lost to Follow-up|0|||
145327944|NCT01550744|524050074|FG001|Double-Blind|Lost to Follow-up|6|||
145327945|NCT01550744|524050075|FG002|Double-Blind|Lost to Follow-up|12|||
145327946|NCT01550744|524050073|FG000|Double-Blind|Withdrawal by Subject|0|||
145327947|NCT01550744|524050074|FG001|Double-Blind|Withdrawal by Subject|2|||
145571154|NCT00838565|524950139|FG002|Overall Study|Withdrawal by Subject|1|||
145571155|NCT00838565|524950140|FG003|Overall Study|Withdrawal by Subject|0|||
145571156|NCT00838565|524950141|FG004|Overall Study|Withdrawal by Subject|0|||
145571157|NCT00838565|524950142|FG005|Overall Study|Withdrawal by Subject|2|||
145571158|NCT00838565|524950137|FG000|Overall Study|Other|0|||
145571159|NCT00838565|524950138|FG001|Overall Study|Other|2|||
145571160|NCT00838565|524950139|FG002|Overall Study|Other|0|||
145571161|NCT00838565|524950140|FG003|Overall Study|Other|0|||
145571162|NCT00838565|524950141|FG004|Overall Study|Other|0|||
145571163|NCT00838565|524950142|FG005|Overall Study|Other|0|||
145327948|NCT01550744|524050075|FG002|Double-Blind|Withdrawal by Subject|15|||
145327949|NCT01550744|524050073|FG000|Double-Blind|Adverse Event|0|||
145327950|NCT01550744|524050074|FG001|Double-Blind|Adverse Event|4|||
145327951|NCT01550744|524050075|FG002|Double-Blind|Adverse Event|15|||
145327952|NCT01550744|524050073|FG000|Double-Blind|Death|0|||
145327953|NCT01550744|524050074|FG001|Double-Blind|Death|1|||
145327954|NCT01550744|524050075|FG002|Double-Blind|Death|0|||
145327955|NCT01550744|524050073|FG000|Double-Blind|Lack of Efficacy|0|||
145327956|NCT01550744|524050074|FG001|Double-Blind|Lack of Efficacy|2|||
145327957|NCT01550744|524050075|FG002|Double-Blind|Lack of Efficacy|8|||
145327958|NCT01550744|524050073|FG000|Double-Blind|Protocol Violation|0|||
145327959|NCT01550744|524050074|FG001|Double-Blind|Protocol Violation|0|||
145327960|NCT01550744|524050075|FG002|Double-Blind|Protocol Violation|4|||
145327961|NCT01550744|524050073|FG000|Double-Blind|Pregnancy|0|||
145327962|NCT01550744|524050074|FG001|Double-Blind|Pregnancy|0|||
145327963|NCT01550744|524050075|FG002|Double-Blind|Pregnancy|3|||
145327964|NCT01550744|524050073|FG000|Double-Blind|Other|0|||
145327965|NCT01550744|524050074|FG001|Double-Blind|Other|2|||
145327966|NCT01550744|524050075|FG002|Double-Blind|Other|10|||
145327967|NCT03395639|524050077|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
145327968|NCT03395639|524050078|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
145327969|NCT03395639|524050079|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
145327970|NCT03395639|524050077|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
145327971|NCT03395639|524050078|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
145327972|NCT03395639|524050079|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
145327973|NCT03395639|524050077|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
145327974|NCT03395639|524050078|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
145327975|NCT03395639|524050079|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
145327976|NCT03395639|524050077|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
145327977|NCT03395639|524050078|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
145327978|NCT03395639|524050079|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
145327979|NCT03395639|524050077|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
145327980|NCT03395639|524050078|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
145327981|NCT03395639|524050079|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
145327982|NCT00995085|524050083|FG000|Overall Study|Withdrawal by Subject|5|||
145327983|NCT02595008|524050087|FG000|Overall Study|Enrolled In Error|1|||
145327984|NCT02595008|524050088|FG001|Overall Study|Enrolled In Error|0|||
145327985|NCT03407118|524050089|FG000|Period 2|Withdrawal by Subject|1|||
145327986|NCT03407118|524050090|FG001|Period 2|Withdrawal by Subject|0|||
145327987|NCT01846273|524050091|FG000|Overall Study|Adverse Event|9|||
145327988|NCT01846273|524050092|FG001|Overall Study|Adverse Event|7|||
145327989|NCT01846273|524050093|FG002|Overall Study|Adverse Event|0|||
145327990|NCT01846273|524050091|FG000|Overall Study|Subject withdrew consent|5|||
145327991|NCT01846273|524050092|FG001|Overall Study|Subject withdrew consent|8|||
145327992|NCT01846273|524050093|FG002|Overall Study|Subject withdrew consent|0|||
145327993|NCT01846273|524050091|FG000|Overall Study|Lost to Follow-up|2|||
145327994|NCT01846273|524050092|FG001|Overall Study|Lost to Follow-up|1|||
145327995|NCT01846273|524050093|FG002|Overall Study|Lost to Follow-up|0|||
145327996|NCT01846273|524050091|FG000|Overall Study|Administrative problems|1|||
145327997|NCT01846273|524050092|FG001|Overall Study|Administrative problems|0|||
145327998|NCT01846273|524050093|FG002|Overall Study|Administrative problems|0|||
145327999|NCT01846273|524050091|FG000|Overall Study|Death|2|||
145328000|NCT01846273|524050092|FG001|Overall Study|Death|1|||
145328001|NCT01846273|524050093|FG002|Overall Study|Death|0|||
145328002|NCT01846273|524050091|FG000|Overall Study|Disease Progression|0|||
145328003|NCT01846273|524050092|FG001|Overall Study|Disease Progression|4|||
145328004|NCT01846273|524050093|FG002|Overall Study|Disease Progression|0|||
145328005|NCT01846273|524050091|FG000|Overall Study|Protocol Deviation|2|||
145328006|NCT01846273|524050092|FG001|Overall Study|Protocol Deviation|3|||
145328007|NCT01846273|524050093|FG002|Overall Study|Protocol Deviation|0|||
145328008|NCT01846273|524050091|FG000|Overall Study|Physician Decision|1|||
145328009|NCT01846273|524050092|FG001|Overall Study|Physician Decision|2|||
145328010|NCT01846273|524050093|FG002|Overall Study|Physician Decision|0|||
145328011|NCT02037165|524050094|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145328012|NCT02037165|524050095|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145412099|NCT05800145|524362187|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
145571164|NCT00838565|524950137|FG000|Overall Study|Randomized but not Treated|0|||
145571165|NCT00838565|524950138|FG001|Overall Study|Randomized but not Treated|1|||
145571166|NCT00838565|524950139|FG002|Overall Study|Randomized but not Treated|0|||
145328013|NCT02037165|524050096|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145328014|NCT02037165|524050097|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
145328015|NCT02037165|524050098|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
145328016|NCT02220725|524050101|FG000|Overall Study|Lost to Follow-up|0|||
145328017|NCT02220725|524050102|FG001|Overall Study|Lost to Follow-up|0|||
145328018|NCT02220725|524050103|FG002|Overall Study|Lost to Follow-up|0|||
145328019|NCT02220725|524050104|FG003|Overall Study|Lost to Follow-up|1|||
145328020|NCT02220725|524050101|FG000|Overall Study|Withdrawal by Subject|0|||
145328021|NCT02220725|524050102|FG001|Overall Study|Withdrawal by Subject|0|||
145328022|NCT02220725|524050103|FG002|Overall Study|Withdrawal by Subject|0|||
145328023|NCT02220725|524050104|FG003|Overall Study|Withdrawal by Subject|1|||
145328024|NCT01673698|524050105|FG000|Overall Study|Lost to Follow-up|51|||
145328025|NCT01673698|524050106|FG001|Overall Study|Lost to Follow-up|13|||
145328026|NCT01297322|524050107|FG000|Overall Study|Lost to Follow-up|1|||
145328027|NCT01297322|524050108|FG001|Overall Study|Lost to Follow-up|0|||
145328028|NCT01297322|524050107|FG000|Overall Study|Withdrawal by Subject|0|||
145328029|NCT01297322|524050108|FG001|Overall Study|Withdrawal by Subject|1|||
145328030|NCT01297322|524050107|FG000|Overall Study|Protocol Violation|0|||
145328031|NCT01297322|524050108|FG001|Overall Study|Protocol Violation|3|||
145328032|NCT01583218|524050109|FG000|Overall Study|Withdrawal by Subject|43|||
145328033|NCT01583218|524050110|FG001|Overall Study|Withdrawal by Subject|29|||
145328034|NCT01583218|524050109|FG000|Overall Study|Death|206|||
145328035|NCT01583218|524050110|FG001|Overall Study|Death|211|||
145328036|NCT01583218|524050109|FG000|Overall Study|Lost to Follow-up|11|||
145328037|NCT01583218|524050110|FG001|Overall Study|Lost to Follow-up|17|||
145328038|NCT01583218|524050109|FG000|Overall Study|Adverse event or serious adverse event|3|||
145328039|NCT01583218|524050110|FG001|Overall Study|Adverse event or serious adverse event|3|||
145328040|NCT01583218|524050109|FG000|Overall Study|Patient /Family decision|3|||
145328041|NCT01583218|524050110|FG001|Overall Study|Patient /Family decision|0|||
145328042|NCT01583218|524050109|FG000|Overall Study|Cannot contact patient directly|1|||
145328043|NCT01583218|524050110|FG001|Overall Study|Cannot contact patient directly|2|||
145328044|NCT01583218|524050109|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
145328045|NCT01583218|524050110|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
145328046|NCT01583218|524050109|FG000|Overall Study|Patient did not wish to attend visits|0|||
145328047|NCT01583218|524050110|FG001|Overall Study|Patient did not wish to attend visits|1|||
145328048|NCT01583218|524050109|FG000|Overall Study|Patient randomized but not dosed|17|||
145328049|NCT01583218|524050110|FG001|Overall Study|Patient randomized but not dosed|16|||
145328050|NCT01583218|524050109|FG000|Overall Study|Patient was assessed via phone in person|1|||
145328051|NCT01583218|524050110|FG001|Overall Study|Patient was assessed via phone in person|0|||
145328052|NCT01583218|524050109|FG000|Overall Study|Patient deemed ineligible after random|2|||
145328053|NCT01583218|524050110|FG001|Overall Study|Patient deemed ineligible after random|0|||
145328054|NCT01583218|524050109|FG000|Overall Study|Patient was early terminated from study|0|||
145328055|NCT01583218|524050110|FG001|Overall Study|Patient was early terminated from study|1|||
145328056|NCT01583218|524050109|FG000|Overall Study|Patient was randomized due to mistake|1|||
145328057|NCT01583218|524050110|FG001|Overall Study|Patient was randomized due to mistake|0|||
145328058|NCT01583218|524050109|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
145328059|NCT01583218|524050110|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
145328060|NCT01583218|524050109|FG000|Overall Study|Withdraw of consent on day of random|1|||
145328061|NCT01583218|524050110|FG001|Overall Study|Withdraw of consent on day of random|0|||
145328062|NCT02013375|524050113|FG000|Overall Study|Did not engraft|1|||
145328063|NCT02013375|524050113|FG000|Overall Study|Did not engraft|1|||
145328064|NCT00712985|524050114|FG000|Overall Study|1 withdrew prior to start of drug|1|||
145328065|NCT00712985|524050114|FG000|Overall Study|1 patient moved out of state|1|||
145328066|NCT00712985|524050114|FG000|Overall Study|Lack of Efficacy|3|||
145328067|NCT01663727|524050117|FG000|Overall Study|Death|161|||
145328068|NCT01663727|524050118|FG001|Overall Study|Death|155|||
145328069|NCT01663727|524050117|FG000|Overall Study|Lost to Follow-up|10|||
145328070|NCT01663727|524050118|FG001|Overall Study|Lost to Follow-up|8|||
145328071|NCT01663727|524050117|FG000|Overall Study|Withdrawal by Subject|18|||
145328072|NCT01663727|524050118|FG001|Overall Study|Withdrawal by Subject|25|||
145328073|NCT01663727|524050117|FG000|Overall Study|Study Terminated|51|||
145328074|NCT01663727|524050118|FG001|Overall Study|Study Terminated|50|||
145328075|NCT01663727|524050117|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
145328076|NCT01663727|524050118|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
145328077|NCT01663727|524050117|FG000|Overall Study|Withdrawal prior to dosing.|1|||
145328078|NCT01663727|524050118|FG001|Overall Study|Withdrawal prior to dosing.|0|||
145328079|NCT01902628|524050119|FG000|Overall Study|Withdrawal of participant's consent|7|||
145328080|NCT01902628|524050119|FG000|Overall Study|Adverse Event|41|||
145328081|NCT01902628|524050119|FG000|Overall Study|Lost to Follow-up|35|||
145328082|NCT06204887|524051579|FG000|Overall Study|Lost to Follow-up|3|||
145328083|NCT06204887|524051580|FG001|Overall Study|Lost to Follow-up|4|||
145328084|NCT06204887|524051581|FG002|Overall Study|Lost to Follow-up|1|||
145328085|NCT06204887|524051582|FG003|Overall Study|Lost to Follow-up|6|||
145328086|NCT02522403|524051583|FG000|Overall Study|Lost to Follow-up|2|||
145571167|NCT00838565|524950140|FG003|Overall Study|Randomized but not Treated|0|||
145571168|NCT00838565|524950141|FG004|Overall Study|Randomized but not Treated|0|||
145571169|NCT00838565|524950142|FG005|Overall Study|Randomized but not Treated|0|||
145328087|NCT02522403|524051584|FG001|Overall Study|Lost to Follow-up|2|||
145328088|NCT02522403|524051583|FG000|Overall Study|Withdrawal by Subject|2|||
145328089|NCT02522403|524051584|FG001|Overall Study|Withdrawal by Subject|4|||
145328090|NCT05142566|524051585|FG000|Overall Study|Protocol Violation|1|||
145328091|NCT04718194|524051588|FG000|Overall Study|Withdrawal by Subject|3|||
145328092|NCT04718194|524051589|FG001|Overall Study|Withdrawal by Subject|0|||
145328093|NCT04718194|524051588|FG000|Overall Study|Lost to Follow-up|3|||
145328094|NCT04718194|524051589|FG001|Overall Study|Lost to Follow-up|0|||
145328095|NCT00856973|524051590|FG000|Overall Study|Adverse Event|5|||
145328096|NCT00856973|524051591|FG001|Overall Study|Adverse Event|5|||
145328097|NCT00856973|524051592|FG002|Overall Study|Adverse Event|3|||
145328098|NCT00856973|524051590|FG000|Overall Study|Lost to Follow-up|6|||
145328099|NCT00856973|524051591|FG001|Overall Study|Lost to Follow-up|3|||
145328100|NCT00856973|524051592|FG002|Overall Study|Lost to Follow-up|5|||
145328101|NCT00856973|524051590|FG000|Overall Study|Physician Decision|0|||
145328102|NCT00856973|524051591|FG001|Overall Study|Physician Decision|3|||
145328103|NCT00856973|524051592|FG002|Overall Study|Physician Decision|1|||
145328104|NCT00856973|524051590|FG000|Overall Study|Protocol Violation|1|||
145328105|NCT00856973|524051591|FG001|Overall Study|Protocol Violation|2|||
145328106|NCT00856973|524051592|FG002|Overall Study|Protocol Violation|1|||
145328107|NCT00856973|524051590|FG000|Overall Study|Withdrawal by Subject|13|||
145328108|NCT00856973|524051591|FG001|Overall Study|Withdrawal by Subject|16|||
145328109|NCT00856973|524051592|FG002|Overall Study|Withdrawal by Subject|15|||
145328110|NCT00856973|524051590|FG000|Overall Study|Other|11|||
145328111|NCT00856973|524051591|FG001|Overall Study|Other|12|||
145328112|NCT00856973|524051592|FG002|Overall Study|Other|13|||
145328113|NCT04556552|524051595|FG000|Overall Study|Lost to Follow-up|1|||
145328114|NCT04556552|524051596|FG001|Overall Study|Lost to Follow-up|0|||
145328115|NCT04556552|524051595|FG000|Overall Study|Claustrophobia|0|||
145328116|NCT04556552|524051596|FG001|Overall Study|Claustrophobia|1|||
145328117|NCT04556552|524051595|FG000|Overall Study|Inability to continue|0|||
145328118|NCT04556552|524051596|FG001|Overall Study|Inability to continue|1|||
145328119|NCT04551911|524051597|FG000|Overall Study|Lost to Follow-up|2|||
145328120|NCT04551911|524051598|FG001|Overall Study|Lost to Follow-up|1|||
145328121|NCT04551911|524051597|FG000|Overall Study|Withdrawal by Subject|10|||
145328122|NCT04551911|524051598|FG001|Overall Study|Withdrawal by Subject|10|||
145328123|NCT04551911|524051597|FG000|Overall Study|Did not receive the study drug|3|||
145328124|NCT04551911|524051598|FG001|Overall Study|Did not receive the study drug|4|||
145328125|NCT01553279|524051599|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
145328126|NCT01553279|524051600|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
145328127|NCT01553279|524051599|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
145328128|NCT01553279|524051600|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
145328129|NCT01553279|524051599|FG000|Interim Period|Withdrawal by Subject|2|||
145328130|NCT01553279|524051600|FG001|Interim Period|Withdrawal by Subject|2|||
145328131|NCT01553279|524051599|FG000|Interim Period|Lost to Follow-up|1|||
145328132|NCT01553279|524051600|FG001|Interim Period|Lost to Follow-up|0|||
145328133|NCT01553279|524051599|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
145328134|NCT01553279|524051600|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
145328135|NCT01553279|524051599|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
145328136|NCT01553279|524051600|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
145328137|NCT01215513|524051601|FG000|Overall Study|Not completed CS42|9|||
145328138|NCT01215513|524051601|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
145328139|NCT01215513|524051601|FG000|Overall Study|Adverse event (CS42A)|2|||
145328140|NCT01215513|524051601|FG000|Overall Study|Physician decision (CS42A)|6|||
145328141|NCT01215513|524051601|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
145328142|NCT01215513|524051601|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
145328143|NCT00605865|524051603|FG000|Overall Study|Protocol Violation|115|||
145328144|NCT01030341|524051606|FG000|Overall Study|Withdrawal by Subject|1|||
145328145|NCT01030341|524051606|FG000|Overall Study|Lost to Follow-up|2|||
145571170|NCT00458484|524950143|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
145328146|NCT00321828|524051607|FG000|Overall Study|Ineligible|3|||
145328147|NCT00321828|524051607|FG000|Overall Study|No follow up data|1|||
145328148|NCT02307266|524051608|FG000|Overall Study|Adverse Event|3|||
145328149|NCT02307266|524051609|FG001|Overall Study|Adverse Event|1|||
145328150|NCT02307266|524051610|FG002|Overall Study|Adverse Event|5|||
145328151|NCT02307266|524051608|FG000|Overall Study|Withdrawal by Subject|2|||
145328152|NCT02307266|524051609|FG001|Overall Study|Withdrawal by Subject|0|||
145328153|NCT02307266|524051610|FG002|Overall Study|Withdrawal by Subject|1|||
145328154|NCT02307266|524051608|FG000|Overall Study|Lost to Follow-up|3|||
145328155|NCT02307266|524051609|FG001|Overall Study|Lost to Follow-up|0|||
145412100|NCT02850406|524362188|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
145328156|NCT02307266|524051610|FG002|Overall Study|Lost to Follow-up|0|||
145328157|NCT00858143|524051615|FG000|Overall Study|Adverse Event|16|||
145571171|NCT00458484|524950144|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
145328158|NCT00858143|524051615|FG000|Overall Study|Lack of Efficacy|4|||
145328159|NCT00858143|524051615|FG000|Overall Study|Death|7|||
145328160|NCT00858143|524051615|FG000|Overall Study|Other|23|||
145328161|NCT00059787|524051616|FG000|Overall Study|Adverse Event|13|||
145328162|NCT00059787|524051616|FG000|Overall Study|disease progression|2|||
145328163|NCT00059787|524051616|FG000|Overall Study|ineligible|1|||
145328164|NCT00059787|524051616|FG000|Overall Study|Other|4|||
145328165|NCT01248013|524051619|FG000|Overall Study|Withdrawal by Subject|14|||
145328166|NCT01388166|524051622|FG000|Overall Study|Adverse Event|16|||
145328167|NCT01388166|524051622|FG000|Overall Study|Lost to Follow-up|30|||
145328168|NCT01388166|524051622|FG000|Overall Study|Others than specified above|13|||
145328169|NCT00841906|524051623|FG000|Overall Study|Withdrawal by Subject|2|||
145328170|NCT00841906|524051624|FG001|Overall Study|Withdrawal by Subject|0|||
145328171|NCT01196078|524051629|FG000|Overall Study|Withdrawal by Subject|3|||
145328172|NCT01196078|524051630|FG001|Overall Study|Withdrawal by Subject|5|||
145328173|NCT01196078|524051629|FG000|Overall Study|Adverse Event|4|||
145328174|NCT01196078|524051630|FG001|Overall Study|Adverse Event|4|||
145328175|NCT01196078|524051629|FG000|Overall Study|Protocol Violation|2|||
145328176|NCT01196078|524051630|FG001|Overall Study|Protocol Violation|1|||
145328177|NCT01196078|524051629|FG000|Overall Study|Lack of Efficacy|17|||
145328178|NCT01196078|524051630|FG001|Overall Study|Lack of Efficacy|23|||
145328179|NCT01196078|524051629|FG000|Overall Study|Lost to Follow-up|1|||
145328180|NCT01196078|524051630|FG001|Overall Study|Lost to Follow-up|0|||
145328181|NCT01196078|524051629|FG000|Overall Study|Death|6|||
145328182|NCT01196078|524051630|FG001|Overall Study|Death|4|||
145328183|NCT02667288|524051631|FG000|Overall Study|Protocol Violation|5|||
145328184|NCT02667288|524051631|FG000|Overall Study|Lost to Follow-up|3|||
145328185|NCT02667288|524051631|FG000|Overall Study|Withdrawal by Subject|5|||
145328186|NCT00127036|524051632|FG000|Overall Study|Insufficient Data for Analysis|6|||
145328187|NCT00127036|524051633|FG001|Overall Study|Insufficient Data for Analysis|11|||
145328188|NCT00127036|524051632|FG000|Overall Study|Screen Failure|2|||
145328189|NCT00127036|524051633|FG001|Overall Study|Screen Failure|0|||
145328190|NCT03921151|524051636|FG000|Overall Study|Withdrawal by Subject|11|||
145328191|NCT03921151|524051637|FG001|Overall Study|Withdrawal by Subject|16|||
145328192|NCT00857792|524051638|FG000|Overall Study|inadequate image quality for analysis|12|||
145328193|NCT03001219|524051644|FG000|Proof of Concept|Study Termination by Sponsor|0|||
145328194|NCT03001219|524051645|FG001|Proof of Concept|Study Termination by Sponsor|1|||
145328195|NCT03001219|524051644|FG000|Proof of Concept|Withdrawal by Subject|0|||
145328196|NCT03001219|524051645|FG001|Proof of Concept|Withdrawal by Subject|4|||
145328197|NCT03001219|524051644|FG000|Proof of Concept|Protocol Deviation|0|||
145328198|NCT03001219|524051645|FG001|Proof of Concept|Protocol Deviation|1|||
145328199|NCT03001219|524051644|FG000|Proof of Concept|Adverse Event|1|||
145328200|NCT03001219|524051645|FG001|Proof of Concept|Adverse Event|1|||
145328201|NCT03001219|524051644|FG000|Proof of Concept|Physician Decision|1|||
145328202|NCT03001219|524051645|FG001|Proof of Concept|Physician Decision|0|||
145328203|NCT03001219|524051644|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
145328204|NCT03001219|524051645|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
145328205|NCT03001219|524051644|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
145328206|NCT03001219|524051645|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
145328207|NCT03001219|524051644|FG000|Extension Period Analysis|Physician Decision|0|||
145328208|NCT03001219|524051645|FG001|Extension Period Analysis|Physician Decision|1|||
145328209|NCT03001219|524051644|FG000|Extension Period Analysis|Adverse Event|1|||
145328210|NCT03001219|524051645|FG001|Extension Period Analysis|Adverse Event|1|||
145328211|NCT03001219|524051644|FG000|Extension Period Analysis|Protocol Deviation|0|||
145328212|NCT03001219|524051645|FG001|Extension Period Analysis|Protocol Deviation|1|||
145328213|NCT03001219|524051644|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
145328214|NCT03001219|524051645|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
145328215|NCT01797835|524051646|FG000|Overall Study|Lost to Follow-up|31|||
145328216|NCT01797835|524051647|FG001|Overall Study|Lost to Follow-up|27|||
145328217|NCT01403064|524051648|FG000|Overall Study|Death|0|||
145328218|NCT01403064|524051649|FG001|Overall Study|Death|0|||
145328219|NCT01403064|524051650|FG002|Overall Study|Death|1|||
145328220|NCT01403064|524051651|FG003|Overall Study|Death|1|||
145328221|NCT01403064|524051648|FG000|Overall Study|Withdrawal by Subject|0|||
145328222|NCT01403064|524051649|FG001|Overall Study|Withdrawal by Subject|0|||
145328223|NCT01403064|524051650|FG002|Overall Study|Withdrawal by Subject|1|||
145328224|NCT01403064|524051651|FG003|Overall Study|Withdrawal by Subject|1|||
145328225|NCT01403064|524051648|FG000|Overall Study|Other|1|||
145328226|NCT01403064|524051649|FG001|Overall Study|Other|0|||
145328227|NCT01403064|524051650|FG002|Overall Study|Other|2|||
145328228|NCT01403064|524051651|FG003|Overall Study|Other|1|||
145328229|NCT03760250|524051653|FG000|Overall Study|Withdrawal by Subject|1|||
145328230|NCT03760250|524051653|FG000|Overall Study|Physician Decision|1|||
145328231|NCT03733210|524051654|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
145328232|NCT03733210|524051655|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
145328233|NCT04421586|524051662|FG000|Overall Study|Death|0|||
145328234|NCT04421586|524051663|FG001|Overall Study|Death|1|||
145328235|NCT04421586|524051662|FG000|Overall Study|Lost to Follow-up|2|||
145328236|NCT04421586|524051663|FG001|Overall Study|Lost to Follow-up|2|||
145328237|NCT04421586|524051662|FG000|Overall Study|Withdrawn by PI|1|||
145328238|NCT04421586|524051663|FG001|Overall Study|Withdrawn by PI|0|||
145328239|NCT04421586|524051662|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
145328240|NCT04421586|524051663|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
145328241|NCT04505293|524051664|FG000|Overall Study|Lost to Follow-up|2|||
145328242|NCT04505293|524051664|FG000|Overall Study|Withdrawal by Subject|6|||
145328243|NCT04505293|524051664|FG000|Overall Study|CT scan unreadable|277|||
145328244|NCT01400919|524051668|FG000|Overall Study|Withdrawal by Subject|4|||
145328245|NCT01400919|524051668|FG000|Overall Study|Lost to Follow-up|2|||
145328246|NCT01400919|524051668|FG000|Overall Study|Missed visit|2|||
145328247|NCT02923674|524051669|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
145328248|NCT02923674|524051670|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
145328249|NCT02923674|524051671|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
145328250|NCT02923674|524051669|FG000|Overall Study|Lost to Follow-up|7|||
145328251|NCT02923674|524051670|FG001|Overall Study|Lost to Follow-up|12|||
145328252|NCT02923674|524051671|FG002|Overall Study|Lost to Follow-up|7|||
145328253|NCT02923674|524051669|FG000|Overall Study|Problem with intervention|2|||
145328254|NCT02923674|524051670|FG001|Overall Study|Problem with intervention|2|||
145328255|NCT02923674|524051671|FG002|Overall Study|Problem with intervention|1|||
145328256|NCT02923674|524051669|FG000|Overall Study|Adverse Event|3|||
145328257|NCT02923674|524051670|FG001|Overall Study|Adverse Event|1|||
145328258|NCT02923674|524051671|FG002|Overall Study|Adverse Event|1|||
145328259|NCT02923674|524051669|FG000|Overall Study|Withdrawal by Subject|2|||
145328260|NCT02923674|524051670|FG001|Overall Study|Withdrawal by Subject|2|||
145328261|NCT02923674|524051671|FG002|Overall Study|Withdrawal by Subject|2|||
145328262|NCT00846521|524051674|FG000|Overall Study|Withdrawal by Subject|5|||
145328263|NCT00846521|524051674|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
145328264|NCT00846521|524051674|FG000|Overall Study|Protocol Violation|1|||
145328265|NCT02408068|524051675|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
145328266|NCT02408068|524051676|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
145328267|NCT02408068|524051677|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
145328268|NCT02408068|524051678|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
145328269|NCT02408068|524051679|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
145328270|NCT02408068|524051680|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
145328271|NCT00003875|524051684|FG000|Overall Study|Screen Failed|1|||
145328272|NCT00886288|524051685|FG000|Overall Study|no respect of the 12 weeks period|657|||
145328273|NCT00886288|524051686|FG001|Overall Study|no respect of the 12 weeks period|227|||
145328274|NCT00886288|524051685|FG000|Overall Study|Lost to Follow-up|86|||
145328275|NCT00886288|524051686|FG001|Overall Study|Lost to Follow-up|0|||
145328276|NCT02335983|524051687|FG000|Overall Study|Sponsor Decision|0|||
145328277|NCT02335983|524051688|FG001|Overall Study|Sponsor Decision|0|||
145328278|NCT02335983|524051689|FG002|Overall Study|Sponsor Decision|1|||
145328279|NCT02335983|524051690|FG003|Overall Study|Sponsor Decision|1|||
145328280|NCT02335983|524051691|FG004|Overall Study|Sponsor Decision|0|||
145328281|NCT02335983|524051692|FG005|Overall Study|Sponsor Decision|1|||
145328282|NCT02335983|524051687|FG000|Overall Study|Withdrawal by Subject|3|||
145328283|NCT02335983|524051688|FG001|Overall Study|Withdrawal by Subject|2|||
145328284|NCT02335983|524051689|FG002|Overall Study|Withdrawal by Subject|2|||
145328285|NCT02335983|524051690|FG003|Overall Study|Withdrawal by Subject|1|||
145328286|NCT02335983|524051691|FG004|Overall Study|Withdrawal by Subject|3|||
145328287|NCT02335983|524051692|FG005|Overall Study|Withdrawal by Subject|9|||
145328288|NCT02335983|524051687|FG000|Overall Study|Death|0|||
145328289|NCT02335983|524051688|FG001|Overall Study|Death|0|||
145328290|NCT02335983|524051689|FG002|Overall Study|Death|2|||
145328291|NCT02335983|524051690|FG003|Overall Study|Death|0|||
145328292|NCT02335983|524051691|FG004|Overall Study|Death|0|||
145328293|NCT02335983|524051692|FG005|Overall Study|Death|0|||
145328294|NCT02335983|524051687|FG000|Overall Study|Lost to Follow-up|0|||
145328295|NCT02335983|524051688|FG001|Overall Study|Lost to Follow-up|0|||
145620665|NCT03621982|525125137|FG013|Overall Study|Lost to Follow-up|0|||
145328296|NCT02335983|524051689|FG002|Overall Study|Lost to Follow-up|0|||
145328297|NCT02335983|524051690|FG003|Overall Study|Lost to Follow-up|0|||
145328298|NCT02335983|524051691|FG004|Overall Study|Lost to Follow-up|0|||
145328299|NCT02335983|524051692|FG005|Overall Study|Lost to Follow-up|1|||
145328300|NCT02335983|524051687|FG000|Overall Study|Protocol Specified Criteria|5|||
145328301|NCT02335983|524051688|FG001|Overall Study|Protocol Specified Criteria|7|||
145328302|NCT02335983|524051689|FG002|Overall Study|Protocol Specified Criteria|27|||
145328303|NCT02335983|524051690|FG003|Overall Study|Protocol Specified Criteria|7|||
145328304|NCT02335983|524051691|FG004|Overall Study|Protocol Specified Criteria|5|||
145328305|NCT02335983|524051692|FG005|Overall Study|Protocol Specified Criteria|21|||
145328306|NCT03127644|524051693|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145620666|NCT03040687|525125142|FG000|Overall Study|Withdrawal by Subject|1|||
145620667|NCT03040687|525125143|FG001|Overall Study|Withdrawal by Subject|0|||
145620668|NCT03040687|525125144|FG002|Overall Study|Withdrawal by Subject|0|||
145620669|NCT03317379|525125145|FG000|Overall Study|Lost to Follow-up|0|||
145328307|NCT03127644|524051694|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145328308|NCT03127644|524051695|FG002|Overall Study|Study-specific withdrawal criteria|2|||
145328309|NCT04700280|524051700|FG000|Overall Study|Adverse Event|4|||
145328310|NCT04700280|524051701|FG001|Overall Study|Adverse Event|0|||
145328311|NCT04700280|524051700|FG000|Overall Study|Lack of Efficacy|1|||
145328312|NCT04700280|524051701|FG001|Overall Study|Lack of Efficacy|0|||
145328313|NCT04700280|524051700|FG000|Overall Study|Study terminated by sponsor|5|||
145328314|NCT04700280|524051701|FG001|Overall Study|Study terminated by sponsor|3|||
145328315|NCT04700280|524051700|FG000|Overall Study|Other than specified|1|||
145328316|NCT04700280|524051701|FG001|Overall Study|Other than specified|0|||
145328317|NCT02093221|524051704|FG000|Overall Study|Adverse Event|1|||
145328318|NCT02093221|524051705|FG001|Overall Study|Adverse Event|0|||
145328319|NCT02093221|524051706|FG002|Overall Study|Adverse Event|0|||
145328320|NCT02093221|524051707|FG003|Overall Study|Adverse Event|0|||
145328321|NCT02093221|524051708|FG004|Overall Study|Adverse Event|0|||
145328322|NCT02093221|524051704|FG000|Overall Study|Withdrawal by Subject|1|||
145620670|NCT03317379|525125146|FG001|Overall Study|Lost to Follow-up|3|||
145620671|NCT03317379|525125147|FG002|Overall Study|Lost to Follow-up|2|||
145328323|NCT02093221|524051705|FG001|Overall Study|Withdrawal by Subject|1|||
145328324|NCT02093221|524051706|FG002|Overall Study|Withdrawal by Subject|4|||
145328325|NCT02093221|524051707|FG003|Overall Study|Withdrawal by Subject|1|||
145328326|NCT02093221|524051708|FG004|Overall Study|Withdrawal by Subject|1|||
145328327|NCT02093221|524051704|FG000|Overall Study|Lost to Follow-up|2|||
145328328|NCT02093221|524051705|FG001|Overall Study|Lost to Follow-up|0|||
145328329|NCT02093221|524051706|FG002|Overall Study|Lost to Follow-up|1|||
145328330|NCT02093221|524051707|FG003|Overall Study|Lost to Follow-up|1|||
145328331|NCT02093221|524051708|FG004|Overall Study|Lost to Follow-up|0|||
145328332|NCT02093221|524051704|FG000|Overall Study|Death|0|||
145328333|NCT02093221|524051705|FG001|Overall Study|Death|1|||
145328334|NCT02093221|524051706|FG002|Overall Study|Death|0|||
145328335|NCT02093221|524051707|FG003|Overall Study|Death|0|||
145328336|NCT02093221|524051708|FG004|Overall Study|Death|0|||
145328337|NCT02093221|524051704|FG000|Overall Study|Protocol Violation|0|||
145328338|NCT02093221|524051705|FG001|Overall Study|Protocol Violation|1|||
145328339|NCT02093221|524051706|FG002|Overall Study|Protocol Violation|0|||
145328340|NCT02093221|524051707|FG003|Overall Study|Protocol Violation|0|||
145328341|NCT02093221|524051708|FG004|Overall Study|Protocol Violation|0|||
145328342|NCT02093221|524051704|FG000|Overall Study|Study termination|6|||
145328343|NCT02093221|524051705|FG001|Overall Study|Study termination|5|||
145328344|NCT02093221|524051706|FG002|Overall Study|Study termination|4|||
145328345|NCT02093221|524051707|FG003|Overall Study|Study termination|6|||
145328346|NCT02093221|524051708|FG004|Overall Study|Study termination|7|||
145328347|NCT00257920|524051709|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
145328348|NCT00257920|524051710|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
145328349|NCT00257920|524051709|FG000|Period: Second Intervention|Other|2|||
145412101|NCT02850406|524362189|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
145620672|NCT00550173|525125148|FG000|Overall Study|Death|45|||
145620673|NCT00550173|525125149|FG001|Overall Study|Death|38|||
145620674|NCT00550173|525125150|FG002|Overall Study|Death|50|||
145620675|NCT00550173|525125148|FG000|Overall Study|Physician Decision|1|||
145620676|NCT00550173|525125149|FG001|Overall Study|Physician Decision|2|||
145620677|NCT00550173|525125150|FG002|Overall Study|Physician Decision|2|||
145620678|NCT00550173|525125148|FG000|Overall Study|Withdrawal by Subject|9|||
145620679|NCT00550173|525125149|FG001|Overall Study|Withdrawal by Subject|12|||
145620680|NCT00550173|525125150|FG002|Overall Study|Withdrawal by Subject|17|||
145620681|NCT00550173|525125148|FG000|Overall Study|Sponsor Decision|13|||
145620682|NCT00550173|525125149|FG001|Overall Study|Sponsor Decision|7|||
145620683|NCT00550173|525125150|FG002|Overall Study|Sponsor Decision|1|||
145620684|NCT00550173|525125148|FG000|Overall Study|Lost to Follow-up|4|||
145620685|NCT00550173|525125149|FG001|Overall Study|Lost to Follow-up|4|||
145620686|NCT00550173|525125150|FG002|Overall Study|Lost to Follow-up|3|||
145620687|NCT00810641|525125159|FG000|Overall Study|Withdrawal by Subject|0|||
145620688|NCT00810641|525125160|FG001|Overall Study|Withdrawal by Subject|1|||
145328350|NCT00257920|524051710|FG001|Period: Second Intervention|Other|1|||
145328351|NCT00770692|524051711|FG000|Overall Study|Withdrawal by Subject|7|||
145328352|NCT00770692|524051712|FG001|Overall Study|Withdrawal by Subject|9|||
145328353|NCT00770692|524051713|FG002|Overall Study|Withdrawal by Subject|9|||
145328354|NCT00770692|524051714|FG003|Overall Study|Withdrawal by Subject|6|||
145328355|NCT00770692|524051711|FG000|Overall Study|Adverse Event|3|||
145328356|NCT00770692|524051712|FG001|Overall Study|Adverse Event|0|||
145620689|NCT00810641|525125161|FG002|Overall Study|Withdrawal by Subject|2|||
145620690|NCT01388543|525125162|FG000|Day 14|Adverse Event|1|||
145620691|NCT01388543|525125163|FG001|Day 14|Adverse Event|4|||
145620692|NCT01556243|525125164|FG000|Overall Study|Ineligible|34|||
145620693|NCT01556243|525125164|FG000|Overall Study|Converted to mastectomy|14|||
145328357|NCT00770692|524051713|FG002|Overall Study|Adverse Event|4|||
145328358|NCT00770692|524051714|FG003|Overall Study|Adverse Event|4|||
145328359|NCT00770692|524051711|FG000|Overall Study|Investigator judgment|2|||
145328360|NCT00770692|524051712|FG001|Overall Study|Investigator judgment|0|||
145571172|NCT00458484|524950145|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
145571173|NCT00458484|524950146|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
145571174|NCT00458484|524950147|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
145328361|NCT00770692|524051713|FG002|Overall Study|Investigator judgment|1|||
145328362|NCT00770692|524051714|FG003|Overall Study|Investigator judgment|1|||
145328363|NCT03629028|524051715|FG000|Overall Study|Lost to Follow-up|26|||
145328364|NCT03629028|524051716|FG001|Overall Study|Lost to Follow-up|23|||
145328365|NCT03629028|524051715|FG000|Overall Study|Pregnancy|4|||
145328366|NCT03629028|524051716|FG001|Overall Study|Pregnancy|2|||
145328367|NCT03629028|524051715|FG000|Overall Study|intolerance to examination|2|||
145328368|NCT03629028|524051716|FG001|Overall Study|intolerance to examination|0|||
145328369|NCT02687360|524051717|FG000|Overall Study|Withdrawal by Subject|3|||
145328370|NCT02687360|524051718|FG001|Overall Study|Withdrawal by Subject|0|||
145328371|NCT04932941|524051719|FG000|Overall Study|Lost to Follow-up|3|||
145328372|NCT04932941|524051720|FG001|Overall Study|Lost to Follow-up|1|||
145328373|NCT04932941|524051719|FG000|Overall Study|Withdrawal by Subject|7|||
145328374|NCT04932941|524051720|FG001|Overall Study|Withdrawal by Subject|4|||
145328375|NCT04932941|524051719|FG000|Overall Study|Other|4|||
145328376|NCT04932941|524051720|FG001|Overall Study|Other|2|||
145328377|NCT05069155|524051721|FG000|Overall Study|Withdrawal by Subject|1|||
145328378|NCT05069155|524051722|FG001|Overall Study|Withdrawal by Subject|3|||
145328379|NCT01366443|524051723|FG000|Overall Study|Lost to Follow-up|2|||
145328380|NCT01366443|524051723|FG000|Overall Study|Under 18 yo|1|||
145328381|NCT00731549|524051724|FG000|Overall Study|Lost to Follow-up|19|||
145328382|NCT00731549|524051724|FG000|Overall Study|Met withdrawal criteria|24|||
145328383|NCT00731549|524051724|FG000|Overall Study|Physician Decision|16|||
145328384|NCT00731549|524051724|FG000|Overall Study|Withdrawal by Subject|89|||
145328385|NCT00731549|524051724|FG000|Overall Study|Protocol deviation|1|||
145328386|NCT00731549|524051724|FG000|Overall Study|Adverse Event|31|||
145328387|NCT00731549|524051724|FG000|Overall Study|Lack of efficacy with AE|37|||
145328388|NCT00731549|524051724|FG000|Overall Study|Lack of efficacy without AE|6|||
145328389|NCT00588640|524051725|FG000|Overall Study|Physician Decision|1|||
145328390|NCT00588640|524051725|FG000|Overall Study|Ineligible Patient|1|||
145328391|NCT01111019|524051726|FG000|Overall Study|Withdrew Prematurely|2|||
145328392|NCT01111019|524051726|FG000|Overall Study|Other|1|||
145328393|NCT03853148|524053127|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
145328394|NCT03853148|524053128|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
145328395|NCT03853148|524053129|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
145328396|NCT03853148|524053130|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
145328397|NCT04397445|524053131|FG000|Overall Study|Withdrawal by Subject|1|||
145328398|NCT04397445|524053132|FG001|Overall Study|Withdrawal by Subject|0|||
145328399|NCT04397445|524053133|FG002|Overall Study|Withdrawal by Subject|0|||
145328400|NCT04397445|524053134|FG003|Overall Study|Withdrawal by Subject|0|||
145328401|NCT01429051|524053135|FG000|Titration Phase|Death|1|||
145328402|NCT01429051|524053135|FG000|Titration Phase|Withdrawal by Subject|7|||
145328403|NCT01429051|524053135|FG000|Titration Phase|Physician Decision|1|||
145328404|NCT01429051|524053135|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
145328405|NCT01429051|524053135|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
145328406|NCT01429051|524053135|FG000|Efficacy Phase|Adverse Event|1|||
145328407|NCT01429051|524053135|FG000|Efficacy Phase|Death|1|||
145328408|NCT01429051|524053135|FG000|Tolerability Phase|Death|5|||
145328409|NCT01429051|524053135|FG000|Tolerability Phase|Adverse Event|2|||
145328410|NCT01429051|524053135|FG000|Tolerability Phase|Withdrawal by Subject|5|||
145328411|NCT01429051|524053135|FG000|Tolerability Phase|Physician Decision|1|||
145328412|NCT01429051|524053135|FG000|Tolerability Phase|Other|2|||
145328413|NCT02528123|524053140|FG000|Overall Study|Lost to Follow-up|1|||
145328414|NCT02963441|524053143|FG000|Overall Study|Protocol violation or withdrawn|8|||
145328415|NCT02963441|524053143|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
145328416|NCT02963441|524053143|FG000|Overall Study|IDx-DR insufficient quality|33|||
145328417|NCT04688931|524053144|FG000|Overall Study|Adverse Event|4|||
145328418|NCT04688931|524053145|FG001|Overall Study|Adverse Event|1|||
145571175|NCT00458484|524950148|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
145571176|NCT00458484|524950149|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
145328419|NCT04688931|524053144|FG000|Overall Study|Withdrawal by Subject|5|||
145328420|NCT04688931|524053145|FG001|Overall Study|Withdrawal by Subject|16|||
145328421|NCT04688931|524053144|FG000|Overall Study|Physician Decision|3|||
145328422|NCT04688931|524053145|FG001|Overall Study|Physician Decision|5|||
145328423|NCT04688931|524053144|FG000|Overall Study|Noncompliance|0|||
145328424|NCT04688931|524053145|FG001|Overall Study|Noncompliance|1|||
145328425|NCT04688931|524053144|FG000|Overall Study|Lost to Follow-up|1|||
145328426|NCT04688931|524053145|FG001|Overall Study|Lost to Follow-up|3|||
145328427|NCT04688931|524053144|FG000|Overall Study|Randomization Error|3|||
145328428|NCT04688931|524053145|FG001|Overall Study|Randomization Error|0|||
145328429|NCT04688931|524053144|FG000|Overall Study|Not Eligible|1|||
145571177|NCT03571516|524950150|FG000|Overall Study|Severe diarrhea|1|||
145328430|NCT04688931|524053145|FG001|Overall Study|Not Eligible|3|||
145328431|NCT04688931|524053144|FG000|Overall Study|Disease Progression|0|||
145571178|NCT03571516|524950151|FG001|Overall Study|Severe diarrhea|0|||
145571179|NCT03571516|524950150|FG000|Overall Study|Withdrawal by Subject|0|||
145571180|NCT03571516|524950151|FG001|Overall Study|Withdrawal by Subject|1|||
145328432|NCT04688931|524053145|FG001|Overall Study|Disease Progression|2|||
145328433|NCT04688931|524053144|FG000|Overall Study|Sponsor Requirement|1|||
145328434|NCT04688931|524053145|FG001|Overall Study|Sponsor Requirement|1|||
145328435|NCT04688931|524053144|FG000|Overall Study|Other Reason|1|||
145328436|NCT04688931|524053145|FG001|Overall Study|Other Reason|2|||
145328437|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Adverse Event|9|||
145328438|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Adverse Event|4|||
145328439|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Adverse Event|5|||
145328440|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Adverse Event|9|||
145328441|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Adverse Event|8|||
145328442|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Adverse Event|0|||
145328443|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Adverse Event|0|||
145328444|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
145328445|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
145328446|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
145328447|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
145328448|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
145328449|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
145328450|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
145328451|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Death|1|||
145328452|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Death|1|||
145328453|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Death|1|||
145328454|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Death|1|||
145328455|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Death|0|||
145328456|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Death|0|||
145328457|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Death|0|||
145328458|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
145328459|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
145328460|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
145328461|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
145328462|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
145328463|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
145328464|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
145328465|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328466|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328467|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
145328468|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328469|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328470|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328471|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
145328472|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
145328473|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
145328474|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
145328475|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
145328476|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
145328477|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
145328478|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
145328479|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Other|2|||
145328480|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Other|9|||
145328481|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Other|9|||
145328482|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Other|3|||
145328483|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Other|2|||
145328484|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Other|0|||
145328485|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Other|0|||
145328486|NCT00361335|524053146|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
145328487|NCT00361335|524053147|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
145328488|NCT00361335|524053148|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
145328489|NCT00361335|524053149|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
145328490|NCT00361335|524053150|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
145328491|NCT00361335|524053151|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
145571181|NCT02253810|524950152|FG000|Overall Study|Withdrawal by Subject|2|||
145328492|NCT00361335|524053152|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
145328493|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
145328494|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
145328495|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
145328496|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
145328497|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
145571182|NCT02253810|524950153|FG001|Overall Study|Withdrawal by Subject|1|||
145571183|NCT02253810|524950152|FG000|Overall Study|Unknown concomitant procedure|3|||
145571184|NCT02253810|524950153|FG001|Overall Study|Unknown concomitant procedure|2|||
145571185|NCT01434290|524950161|FG000|Overall Study|Protocol Violation|6|||
145571186|NCT01434290|524950162|FG001|Overall Study|Protocol Violation|3|||
145571187|NCT01434290|524950161|FG000|Overall Study|No protocol treatment|2|||
145571188|NCT01434290|524950162|FG001|Overall Study|No protocol treatment|4|||
145571189|NCT02281552|524950163|FG000|Overall Study|Medication error|1|||
145571190|NCT02281552|524950164|FG001|Overall Study|Medication error|0|||
145571191|NCT02281552|524950163|FG000|Overall Study|Insufficient clinical response|0|||
145328498|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
145328499|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
145328500|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145328501|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145328502|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145328503|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145328504|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145328505|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
145328506|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
145328507|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Death|0|||
145328508|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Death|0|||
145328509|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Death|0|||
145328510|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Death|0|||
145328511|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Death|0|||
145328512|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Death|0|||
145328513|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Death|1|||
145328514|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145328515|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145328516|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145328517|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
145328518|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145328519|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145328520|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
145328521|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Other|1|||
145328522|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Other|0|||
145328523|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Other|0|||
145328524|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Other|1|||
145328525|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Other|0|||
145328526|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Other|1|||
145571192|NCT02281552|524950164|FG001|Overall Study|Insufficient clinical response|1|||
145571193|NCT02281552|524950163|FG000|Overall Study|Adverse Event|3|||
145571194|NCT02281552|524950164|FG001|Overall Study|Adverse Event|9|||
145571195|NCT01224639|524950167|FG000|Overall Study|Withdrawal by Subject|0|||
145571196|NCT01224639|524950168|FG001|Overall Study|Withdrawal by Subject|0|||
145571197|NCT01224639|524950169|FG002|Overall Study|Withdrawal by Subject|0|||
145571198|NCT01224639|524950170|FG003|Overall Study|Withdrawal by Subject|0|||
145571199|NCT01224639|524950171|FG004|Overall Study|Withdrawal by Subject|2|||
145571200|NCT01224639|524950172|FG005|Overall Study|Withdrawal by Subject|0|||
145571201|NCT01224639|524950173|FG006|Overall Study|Withdrawal by Subject|1|||
145571202|NCT01224639|524950174|FG007|Overall Study|Withdrawal by Subject|1|||
145571203|NCT01224639|524950167|FG000|Overall Study|Adverse Event|0|||
145571204|NCT01224639|524950168|FG001|Overall Study|Adverse Event|0|||
145571205|NCT01224639|524950169|FG002|Overall Study|Adverse Event|0|||
145571206|NCT01224639|524950170|FG003|Overall Study|Adverse Event|0|||
145571207|NCT01224639|524950171|FG004|Overall Study|Adverse Event|0|||
145571208|NCT01224639|524950172|FG005|Overall Study|Adverse Event|0|||
145571209|NCT01224639|524950173|FG006|Overall Study|Adverse Event|0|||
145571210|NCT01224639|524950174|FG007|Overall Study|Adverse Event|1|||
145328527|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Other|2|||
145328528|NCT00361335|524053146|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145571211|NCT03465878|524950175|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
145328529|NCT00361335|524053147|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145571212|NCT03465878|524950176|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
145571213|NCT03465878|524950177|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
145571214|NCT03465878|524950178|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
145620694|NCT01556243|525125164|FG000|Overall Study|Unable to achieve negative margins|2|||
145328530|NCT00361335|524053148|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
145571215|NCT03465878|524950175|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
145571216|NCT03465878|524950176|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
145571217|NCT03465878|524950177|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
145571218|NCT03465878|524950178|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
145571219|NCT03465878|524950175|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
145571220|NCT03465878|524950176|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
145328531|NCT00361335|524053149|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145328532|NCT00361335|524053150|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145328533|NCT00361335|524053151|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
145328534|NCT00361335|524053152|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
145328535|NCT00506129|524053153|FG000|Overall Study|Disease Progression/Relapse|15|||
145328536|NCT00506129|524053153|FG000|Overall Study|Death|7|||
145328537|NCT01968694|524053154|FG000|Washout (1 Month)|Lost to Follow-up|0|||
145328538|NCT01968694|524053155|FG001|Washout (1 Month)|Lost to Follow-up|1|||
145328539|NCT00251719|524053156|FG000|Overall Study|Adverse Event|14|||
145328540|NCT00251719|524053157|FG001|Overall Study|Adverse Event|8|||
145328541|NCT00251719|524053158|FG002|Overall Study|Adverse Event|7|||
145328542|NCT00251719|524053156|FG000|Overall Study|Protocol Violation|1|||
145328543|NCT00251719|524053157|FG001|Overall Study|Protocol Violation|1|||
145328544|NCT00251719|524053158|FG002|Overall Study|Protocol Violation|1|||
145328545|NCT00251719|524053156|FG000|Overall Study|Lost to Follow-up|5|||
145328546|NCT00251719|524053157|FG001|Overall Study|Lost to Follow-up|11|||
145328547|NCT00251719|524053158|FG002|Overall Study|Lost to Follow-up|8|||
145328548|NCT00251719|524053156|FG000|Overall Study|Withdrawal by Subject|14|||
145328549|NCT00251719|524053157|FG001|Overall Study|Withdrawal by Subject|12|||
145328550|NCT00251719|524053158|FG002|Overall Study|Withdrawal by Subject|11|||
145328551|NCT00251719|524053156|FG000|Overall Study|Lack of Efficacy|2|||
145328552|NCT00251719|524053157|FG001|Overall Study|Lack of Efficacy|1|||
145328553|NCT00251719|524053158|FG002|Overall Study|Lack of Efficacy|0|||
145328554|NCT00251719|524053156|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
145328555|NCT00251719|524053157|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
145328556|NCT00251719|524053158|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
145328557|NCT00251719|524053156|FG000|Overall Study|Investigator decision|1|||
145328558|NCT00251719|524053157|FG001|Overall Study|Investigator decision|1|||
145328559|NCT00251719|524053158|FG002|Overall Study|Investigator decision|0|||
145328560|NCT00251719|524053156|FG000|Overall Study|Noncompliance|2|||
145328561|NCT00251719|524053157|FG001|Overall Study|Noncompliance|3|||
145328562|NCT00251719|524053158|FG002|Overall Study|Noncompliance|1|||
145328563|NCT00251719|524053156|FG000|Overall Study|Barrett's esophagus|2|||
145328564|NCT00251719|524053157|FG001|Overall Study|Barrett's esophagus|2|||
145328565|NCT00251719|524053158|FG002|Overall Study|Barrett's esophagus|0|||
145328566|NCT02792959|524053161|FG000|Overall Study|Protocol Violation|1|||
145328567|NCT01780987|524053168|FG000|Overall Study|Adverse Event|0|||
145328568|NCT01780987|524053169|FG001|Overall Study|Adverse Event|4|||
145328569|NCT01780987|524053168|FG000|Overall Study|Withdrawal by Subject|2|||
145328570|NCT01780987|524053169|FG001|Overall Study|Withdrawal by Subject|0|||
145328571|NCT01780987|524053168|FG000|Overall Study|Request of Changing Hospital|0|||
145328572|NCT01780987|524053169|FG001|Overall Study|Request of Changing Hospital|1|||
145328573|NCT01780987|524053168|FG000|Overall Study|Changing Residence|1|||
145328574|NCT01780987|524053169|FG001|Overall Study|Changing Residence|0|||
145328575|NCT01780987|524053168|FG000|Overall Study|Not Receiving any Study Medication|0|||
145328576|NCT01780987|524053169|FG001|Overall Study|Not Receiving any Study Medication|1|||
145328577|NCT04168190|524053170|FG000|Overall Study|Lost to Follow-up|0|||
145328578|NCT04168190|524053171|FG001|Overall Study|Lost to Follow-up|1|||
145328579|NCT04168190|524053172|FG002|Overall Study|Lost to Follow-up|0|||
145328580|NCT04168190|524053173|FG003|Overall Study|Lost to Follow-up|7|||
145328581|NCT04168190|524053174|FG004|Overall Study|Lost to Follow-up|5|||
145328582|NCT04168190|524053170|FG000|Overall Study|Withdrawal by Subject|1|||
145328583|NCT04168190|524053171|FG001|Overall Study|Withdrawal by Subject|0|||
145328584|NCT04168190|524053172|FG002|Overall Study|Withdrawal by Subject|0|||
145328585|NCT04168190|524053173|FG003|Overall Study|Withdrawal by Subject|2|||
145328586|NCT04168190|524053174|FG004|Overall Study|Withdrawal by Subject|4|||
145328587|NCT04168190|524053170|FG000|Overall Study|Death|0|||
145328588|NCT04168190|524053171|FG001|Overall Study|Death|0|||
145328589|NCT04168190|524053172|FG002|Overall Study|Death|0|||
145328590|NCT04168190|524053173|FG003|Overall Study|Death|1|||
145328591|NCT04168190|524053174|FG004|Overall Study|Death|0|||
145328592|NCT00629265|524053175|FG000|Overall Study|Lost to Follow-up|4|||
145328593|NCT00629265|524053176|FG001|Overall Study|Lost to Follow-up|5|||
145328594|NCT00629265|524053175|FG000|Overall Study|Withdrawal by Subject|11|||
145328595|NCT00629265|524053176|FG001|Overall Study|Withdrawal by Subject|8|||
145328596|NCT00629265|524053175|FG000|Overall Study|Death|1|||
145328597|NCT00629265|524053176|FG001|Overall Study|Death|0|||
145328598|NCT00629265|524053175|FG000|Overall Study|Adverse Event|2|||
145328599|NCT00629265|524053176|FG001|Overall Study|Adverse Event|0|||
145328600|NCT00629265|524053175|FG000|Overall Study|HNC Recurrence|4|||
145328601|NCT00629265|524053176|FG001|Overall Study|HNC Recurrence|0|||
145328602|NCT00629265|524053175|FG000|Overall Study|Other CA Requiring Treatment|1|||
145328603|NCT00629265|524053176|FG001|Overall Study|Other CA Requiring Treatment|3|||
145328604|NCT00629265|524053175|FG000|Overall Study|Needed Esophageal Dilation|4|||
145328605|NCT00629265|524053176|FG001|Overall Study|Needed Esophageal Dilation|1|||
145328606|NCT00629265|524053175|FG000|Overall Study|Unrelated Medical Complications|3|||
145328607|NCT00629265|524053176|FG001|Overall Study|Unrelated Medical Complications|1|||
145328608|NCT00629265|524053175|FG000|Overall Study|Unknown Reason|2|||
145328609|NCT00629265|524053176|FG001|Overall Study|Unknown Reason|2|||
145328610|NCT01782482|524053183|FG000|Overall Study|Adverse Event|2|||
145328611|NCT01782482|524053184|FG001|Overall Study|Adverse Event|1|||
145328612|NCT01782482|524053183|FG000|Overall Study|Lost to Follow-up|2|||
145328613|NCT01782482|524053184|FG001|Overall Study|Lost to Follow-up|3|||
145328614|NCT01782482|524053183|FG000|Overall Study|Physician Decision|1|||
145328615|NCT01782482|524053184|FG001|Overall Study|Physician Decision|0|||
145328616|NCT01782482|524053183|FG000|Overall Study|Protocol Violation|1|||
145328617|NCT01782482|524053184|FG001|Overall Study|Protocol Violation|0|||
145328618|NCT01782482|524053183|FG000|Overall Study|Withdrawal by Subject|2|||
145328619|NCT01782482|524053184|FG001|Overall Study|Withdrawal by Subject|3|||
145328620|NCT01782482|524053183|FG000|Overall Study|Randomized in Error|2|||
145328621|NCT01782482|524053184|FG001|Overall Study|Randomized in Error|2|||
145328622|NCT01782482|524053183|FG000|Overall Study|Habitually wearing toric lens OS|0|||
145328623|NCT01782482|524053184|FG001|Overall Study|Habitually wearing toric lens OS|1|||
145328624|NCT01194973|524053190|FG000|Screening Period|Screen Failure|3|||
145328625|NCT01194973|524053190|FG000|26 Week Treatment Period|Adverse Event|1|||
145328626|NCT01194973|524053190|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
145328627|NCT01194973|524053190|FG000|26 Week Treatment Period|Pregnancy|1|||
145328628|NCT01640873|524053191|FG000|Overall Study|Protocol Violation|2|||
145328629|NCT01640873|524053192|FG001|Overall Study|Protocol Violation|1|||
145328630|NCT01875471|524053195|FG000|Overall Study|Adverse Event|0|||
145328631|NCT01875471|524053196|FG001|Overall Study|Adverse Event|1|||
145328632|NCT01875471|524053195|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
145328633|NCT01875471|524053196|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
145328634|NCT01321008|524053199|FG000|Overall Study|Early Study Termination|1|||
145328635|NCT03978091|524053200|FG000|Overall Study|Lost to Follow-up|0|||
145328636|NCT03978091|524053201|FG001|Overall Study|Lost to Follow-up|0|||
145328637|NCT03978091|524053202|FG002|Overall Study|Lost to Follow-up|1|||
145328638|NCT03978091|524053203|FG003|Overall Study|Lost to Follow-up|0|||
145328639|NCT03978091|524053204|FG004|Overall Study|Lost to Follow-up|0|||
145328640|NCT03978091|524053205|FG005|Overall Study|Lost to Follow-up|0|||
145328641|NCT03978091|524053200|FG000|Overall Study|Withdrawal by Subject|0|||
145328642|NCT03978091|524053201|FG001|Overall Study|Withdrawal by Subject|0|||
145328643|NCT03978091|524053202|FG002|Overall Study|Withdrawal by Subject|0|||
145328644|NCT03978091|524053203|FG003|Overall Study|Withdrawal by Subject|1|||
145328645|NCT03978091|524053204|FG004|Overall Study|Withdrawal by Subject|1|||
145328646|NCT03978091|524053205|FG005|Overall Study|Withdrawal by Subject|0|||
145328647|NCT02749292|524053206|FG000|Overall Study|Physician Decision|1|||
145328648|NCT02749292|524053207|FG001|Overall Study|Physician Decision|0|||
145328649|NCT02749292|524053206|FG000|Overall Study|Withdrawal by Subject|5|||
145328650|NCT02749292|524053207|FG001|Overall Study|Withdrawal by Subject|7|||
145328651|NCT02749292|524053206|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
145328652|NCT02749292|524053207|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
145328653|NCT02749292|524053206|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
145328654|NCT02749292|524053207|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
145328655|NCT02749292|524053206|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
145328656|NCT02749292|524053207|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
145328657|NCT02749292|524053206|FG000|Overall Study|Adverse Event|4|||
145328658|NCT02749292|524053207|FG001|Overall Study|Adverse Event|1|||
145328659|NCT02749292|524053206|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
145328660|NCT02749292|524053207|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
145328661|NCT02749292|524053206|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
145328662|NCT02749292|524053207|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
145328663|NCT02749292|524053206|FG000|Overall Study|Requiring glucocorticoids|0|||
145328664|NCT02749292|524053207|FG001|Overall Study|Requiring glucocorticoids|3|||
145328665|NCT02749292|524053206|FG000|Overall Study|Cancer|1|||
145328666|NCT02749292|524053207|FG001|Overall Study|Cancer|0|||
145328667|NCT01843348|524053208|FG000|Overall Study|Withdrawal by Subject|4|||
145328668|NCT01843348|524053209|FG001|Overall Study|Withdrawal by Subject|16|||
145328669|NCT01843348|524053210|FG002|Overall Study|Withdrawal by Subject|18|||
145328670|NCT01843348|524053208|FG000|Overall Study|Lost to Follow-up|5|||
145328671|NCT01843348|524053209|FG001|Overall Study|Lost to Follow-up|4|||
145571221|NCT03465878|524950177|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
145571222|NCT03465878|524950178|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
145328672|NCT01843348|524053210|FG002|Overall Study|Lost to Follow-up|2|||
145328673|NCT01843348|524053208|FG000|Overall Study|Death|5|||
145412102|NCT02850406|524362190|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
145328674|NCT01843348|524053209|FG001|Overall Study|Death|3|||
145328675|NCT01843348|524053210|FG002|Overall Study|Death|4|||
145328676|NCT01843348|524053208|FG000|Overall Study|Graft loss/retransplantation|5|||
145328677|NCT01843348|524053209|FG001|Overall Study|Graft loss/retransplantation|8|||
145328678|NCT01843348|524053210|FG002|Overall Study|Graft loss/retransplantation|11|||
145328679|NCT01843348|524053208|FG000|Overall Study|Various reasons|4|||
145571223|NCT04656132|524950179|FG000|Overall Study|Lost to Follow-up|4|||
145620695|NCT01556243|525125164|FG000|Overall Study|Withdrawal by Subject|16|||
145620696|NCT02325713|525125167|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145328680|NCT01843348|524053209|FG001|Overall Study|Various reasons|9|||
145328681|NCT01843348|524053210|FG002|Overall Study|Various reasons|6|||
145328682|NCT00679913|524053211|FG000|Overall Study|Protocol Violation|18|||
145328683|NCT00679913|524053212|FG001|Overall Study|Protocol Violation|13|||
145328684|NCT00062751|524053213|FG000|Overall Study|Disease progression|24|||
145328685|NCT00062751|524053214|FG001|Overall Study|Disease progression|17|||
145328686|NCT00062751|524053215|FG002|Overall Study|Disease progression|24|||
145328687|NCT00062751|524053216|FG003|Overall Study|Disease progression|2|||
145328688|NCT00062751|524053217|FG004|Overall Study|Disease progression|2|||
145328689|NCT00062751|524053213|FG000|Overall Study|Adverse Event|4|||
145328690|NCT00062751|524053214|FG001|Overall Study|Adverse Event|7|||
145328691|NCT00062751|524053215|FG002|Overall Study|Adverse Event|2|||
145328692|NCT00062751|524053216|FG003|Overall Study|Adverse Event|2|||
145328693|NCT00062751|524053217|FG004|Overall Study|Adverse Event|2|||
145328694|NCT00062751|524053213|FG000|Overall Study|Other|2|||
145328695|NCT00062751|524053214|FG001|Overall Study|Other|3|||
145328696|NCT00062751|524053215|FG002|Overall Study|Other|1|||
145328697|NCT00062751|524053216|FG003|Overall Study|Other|0|||
145328698|NCT00062751|524053217|FG004|Overall Study|Other|1|||
145328699|NCT00062751|524053213|FG000|Overall Study|Withdrawal by Subject|1|||
145328700|NCT00062751|524053214|FG001|Overall Study|Withdrawal by Subject|2|||
145328701|NCT00062751|524053215|FG002|Overall Study|Withdrawal by Subject|2|||
145328702|NCT00062751|524053216|FG003|Overall Study|Withdrawal by Subject|1|||
145328703|NCT00062751|524053217|FG004|Overall Study|Withdrawal by Subject|0|||
145328704|NCT00062751|524053213|FG000|Overall Study|Symptomatic deterioration|1|||
145328705|NCT00062751|524053214|FG001|Overall Study|Symptomatic deterioration|1|||
145328706|NCT00062751|524053215|FG002|Overall Study|Symptomatic deterioration|0|||
145328707|NCT00062751|524053216|FG003|Overall Study|Symptomatic deterioration|0|||
145328708|NCT00062751|524053217|FG004|Overall Study|Symptomatic deterioration|1|||
145328709|NCT00062751|524053213|FG000|Overall Study|Death|1|||
145328710|NCT00062751|524053214|FG001|Overall Study|Death|0|||
145328711|NCT00062751|524053215|FG002|Overall Study|Death|1|||
145328712|NCT00062751|524053216|FG003|Overall Study|Death|0|||
145328713|NCT00062751|524053217|FG004|Overall Study|Death|0|||
145328714|NCT03097588|524053224|FG000|Overall Study|Adverse Event|1|||
145328715|NCT03828448|524053229|FG000|Overall Study|Sponsor's Discretion|34|||
145328716|NCT00456495|524053230|FG000|Overall Study|Physician Decision|2|||
145328717|NCT02192164|524053231|FG000|Overall Study|Other|8|||
145328718|NCT02192164|524053231|FG000|Overall Study|Withdrawal by Subject|1|||
145328719|NCT02192164|524053231|FG000|Overall Study|Physician Decision|4|||
145328720|NCT02192164|524053231|FG000|Overall Study|Did not meet the exclusion criteria|1|||
145328721|NCT00673933|524053232|FG000|Overall Study|Withdrawal by Subject|2|||
145328722|NCT00673933|524053232|FG000|Overall Study|Lost to Follow-up|1|||
145328723|NCT02206620|524053233|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145328724|NCT02206620|524053234|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145328725|NCT02206620|524053233|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
145328726|NCT02206620|524053234|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
145328727|NCT01346774|524053235|FG000|Overall Study|Did not take a single dose|6|||
145328728|NCT01346774|524053236|FG001|Overall Study|Did not take a single dose|4|||
145328729|NCT01346774|524053235|FG000|Overall Study|Lost to Follow-up|3|||
145328730|NCT01346774|524053236|FG001|Overall Study|Lost to Follow-up|4|||
145328731|NCT01346774|524053235|FG000|Overall Study|Withdrawal by Subject|1|||
145328732|NCT01346774|524053236|FG001|Overall Study|Withdrawal by Subject|4|||
145328733|NCT01346774|524053235|FG000|Overall Study|Protocol Violation|2|||
145328734|NCT01346774|524053236|FG001|Overall Study|Protocol Violation|3|||
145328735|NCT01346774|524053235|FG000|Overall Study|Adverse Event|1|||
145328736|NCT01346774|524053236|FG001|Overall Study|Adverse Event|2|||
145328737|NCT01929031|524053239|FG000|Overall Study|Adverse Event|3|||
145328738|NCT01929031|524053240|FG001|Overall Study|Adverse Event|1|||
145328739|NCT01929031|524053241|FG002|Overall Study|Adverse Event|1|||
145328740|NCT01929031|524053242|FG003|Overall Study|Adverse Event|0|||
145328741|NCT01929031|524053243|FG004|Overall Study|Adverse Event|0|||
145620697|NCT02325713|525125168|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145328742|NCT01929031|524053244|FG005|Overall Study|Adverse Event|0|||
145328743|NCT01929031|524053239|FG000|Overall Study|Protocol Violation|1|||
145328744|NCT01929031|524053240|FG001|Overall Study|Protocol Violation|0|||
145328745|NCT01929031|524053241|FG002|Overall Study|Protocol Violation|0|||
145328746|NCT01929031|524053242|FG003|Overall Study|Protocol Violation|0|||
145328747|NCT01929031|524053243|FG004|Overall Study|Protocol Violation|0|||
145328748|NCT01929031|524053244|FG005|Overall Study|Protocol Violation|1|||
145328749|NCT01929031|524053239|FG000|Overall Study|Reason other than specified above|0|||
145328750|NCT01929031|524053240|FG001|Overall Study|Reason other than specified above|1|||
145328751|NCT01929031|524053241|FG002|Overall Study|Reason other than specified above|0|||
145328752|NCT01929031|524053242|FG003|Overall Study|Reason other than specified above|0|||
145328753|NCT01929031|524053243|FG004|Overall Study|Reason other than specified above|1|||
145328754|NCT01929031|524053244|FG005|Overall Study|Reason other than specified above|0|||
145571224|NCT04656132|524950179|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
145571225|NCT04019041|524950180|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
145571226|NCT04019041|524950181|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
145571227|NCT04019041|524950182|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
145328755|NCT05816200|524053245|FG000|Overall Study|Lost to Follow-up|2|||
145328756|NCT05816200|524053246|FG001|Overall Study|Lost to Follow-up|1|||
145328757|NCT02394730|524053252|FG000|Overall Study|Lost to Follow-up|1|||
145328758|NCT02394730|524053253|FG001|Overall Study|Lost to Follow-up|0|||
145328759|NCT02394730|524053252|FG000|Overall Study|Withdrawal by Subject|0|||
145328760|NCT02394730|524053253|FG001|Overall Study|Withdrawal by Subject|1|||
145328761|NCT02384850|524053254|FG000|Overall Study|Withdrawal by Subject|2|||
145328762|NCT02384850|524053255|FG001|Overall Study|Withdrawal by Subject|2|||
145328763|NCT00507546|524053256|FG000|Overall Study|Withdrawal by Subject|1|||
145328764|NCT00507546|524053257|FG001|Overall Study|Withdrawal by Subject|0|||
145328765|NCT00507546|524053256|FG000|Overall Study|Protocol Violation|1|||
145328766|NCT00507546|524053257|FG001|Overall Study|Protocol Violation|0|||
145328767|NCT00507546|524053256|FG000|Overall Study|Physician Decision|0|||
145328768|NCT00507546|524053257|FG001|Overall Study|Physician Decision|1|||
145328769|NCT03512262|524053259|FG000|Overall Study|Adverse Event|8|||
145328770|NCT03512262|524053260|FG001|Overall Study|Adverse Event|3|||
145328771|NCT03512262|524053259|FG000|Overall Study|Death (non-treatment emergent)|1|||
145328772|NCT03512262|524053260|FG001|Overall Study|Death (non-treatment emergent)|0|||
145328773|NCT03512262|524053259|FG000|Overall Study|Withdrawal by Subject|17|||
145328774|NCT03512262|524053260|FG001|Overall Study|Withdrawal by Subject|9|||
145328775|NCT03512262|524053259|FG000|Overall Study|Lost to Follow-up|7|||
145328776|NCT03512262|524053260|FG001|Overall Study|Lost to Follow-up|1|||
145328777|NCT03512262|524053259|FG000|Overall Study|Other than Specified|2|||
145328778|NCT03512262|524053260|FG001|Overall Study|Other than Specified|2|||
145328779|NCT03510182|524053261|FG000|Overall Study|Withdrawal by Subject|2|||
145328780|NCT04062448|524054985|FG000|Overall Study|Lost to Follow-up|1|||
145328781|NCT04062448|524054985|FG000|Overall Study|Withdrawal by Subject|2|||
145328782|NCT04319718|524054986|FG000|Overall Study|Adverse Event|0|||
145328783|NCT04319718|524054987|FG001|Overall Study|Adverse Event|2|||
145328784|NCT04319718|524054986|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
145328785|NCT04319718|524054987|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
145328786|NCT01045421|524054988|FG000|Phase 1|Progressive Disease|0|||
145328787|NCT01045421|524054989|FG001|Phase 1|Progressive Disease|0|||
145328788|NCT01045421|524054990|FG002|Phase 1|Progressive Disease|0|||
145328789|NCT01045421|524054991|FG003|Phase 1|Progressive Disease|0|||
145328790|NCT01045421|524054992|FG004|Phase 1|Progressive Disease|1|||
145328791|NCT01045421|524054993|FG005|Phase 1|Progressive Disease|0|||
145328792|NCT01045421|524054994|FG006|Phase 1|Progressive Disease|0|||
145328793|NCT01045421|524054995|FG007|Phase 1|Progressive Disease|0|||
145328794|NCT01045421|524054996|FG008|Phase 1|Progressive Disease|0|||
145328795|NCT01045421|524054997|FG009|Phase 1|Progressive Disease|0|||
145328796|NCT01045421|524054998|FG010|Phase 1|Progressive Disease|0|||
145328797|NCT01045421|524054988|FG000|Phase 1|Withdrawal by Subject|0|||
145328798|NCT01045421|524054989|FG001|Phase 1|Withdrawal by Subject|0|||
145328799|NCT01045421|524054990|FG002|Phase 1|Withdrawal by Subject|0|||
145328800|NCT01045421|524054991|FG003|Phase 1|Withdrawal by Subject|1|||
145328801|NCT01045421|524054992|FG004|Phase 1|Withdrawal by Subject|0|||
145328802|NCT01045421|524054993|FG005|Phase 1|Withdrawal by Subject|0|||
145328803|NCT01045421|524054994|FG006|Phase 1|Withdrawal by Subject|0|||
145328804|NCT01045421|524054995|FG007|Phase 1|Withdrawal by Subject|0|||
145328805|NCT01045421|524054996|FG008|Phase 1|Withdrawal by Subject|0|||
145328806|NCT01045421|524054997|FG009|Phase 1|Withdrawal by Subject|0|||
145328807|NCT01045421|524054998|FG010|Phase 1|Withdrawal by Subject|0|||
145328808|NCT01045421|524054988|FG000|Phase 2|Progressive Disease|0|||
145328809|NCT01045421|524054989|FG001|Phase 2|Progressive Disease|0|||
145328810|NCT01045421|524054990|FG002|Phase 2|Progressive Disease|0|||
145328811|NCT01045421|524054991|FG003|Phase 2|Progressive Disease|0|||
145328812|NCT01045421|524054992|FG004|Phase 2|Progressive Disease|0|||
145328813|NCT01045421|524054993|FG005|Phase 2|Progressive Disease|0|||
145328814|NCT01045421|524054994|FG006|Phase 2|Progressive Disease|0|||
145328815|NCT01045421|524054995|FG007|Phase 2|Progressive Disease|1|||
145328816|NCT01045421|524054996|FG008|Phase 2|Progressive Disease|1|||
145328817|NCT01045421|524054997|FG009|Phase 2|Progressive Disease|1|||
145328818|NCT01045421|524054998|FG010|Phase 2|Progressive Disease|1|||
145571228|NCT04019041|524950183|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145328819|NCT01045421|524054988|FG000|Phase 2|Death|0|||
145328820|NCT01045421|524054989|FG001|Phase 2|Death|0|||
145328821|NCT01045421|524054990|FG002|Phase 2|Death|0|||
145328822|NCT01045421|524054991|FG003|Phase 2|Death|0|||
145328823|NCT01045421|524054992|FG004|Phase 2|Death|0|||
145328824|NCT01045421|524054993|FG005|Phase 2|Death|0|||
145328825|NCT01045421|524054994|FG006|Phase 2|Death|0|||
145571229|NCT04019041|524950184|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145328826|NCT01045421|524054995|FG007|Phase 2|Death|1|||
145328827|NCT01045421|524054996|FG008|Phase 2|Death|1|||
145328828|NCT01045421|524054997|FG009|Phase 2|Death|2|||
145328829|NCT01045421|524054998|FG010|Phase 2|Death|0|||
145328830|NCT01045421|524054988|FG000|Phase 2|Other|0|||
145328831|NCT01045421|524054989|FG001|Phase 2|Other|0|||
145328832|NCT01045421|524054990|FG002|Phase 2|Other|0|||
145328833|NCT01045421|524054991|FG003|Phase 2|Other|0|||
145328834|NCT01045421|524054992|FG004|Phase 2|Other|0|||
145328835|NCT01045421|524054993|FG005|Phase 2|Other|0|||
145328836|NCT01045421|524054994|FG006|Phase 2|Other|0|||
145328837|NCT01045421|524054995|FG007|Phase 2|Other|3|||
145328838|NCT01045421|524054996|FG008|Phase 2|Other|0|||
145328839|NCT01045421|524054997|FG009|Phase 2|Other|0|||
145328840|NCT01045421|524054998|FG010|Phase 2|Other|1|||
145328841|NCT01293539|524054999|FG000|Overall Study|Physician Decision|1|||
145328842|NCT00891371|524055004|FG000|Pre-assignment|Inclusion/exclusion|5|||
145328843|NCT00891371|524055004|FG000|Pre-assignment|Consent withdrawal|1|||
145328844|NCT00891371|524055004|FG000|Treatment|Lack of Efficacy|5|||
145328845|NCT00891371|524055004|FG000|Treatment|Adverse Event|2|||
145328846|NCT00891371|524055004|FG000|Treatment|Death|1|||
145328847|NCT00891371|524055004|FG000|Treatment|Lost to Follow-up|1|||
145328848|NCT00307034|524055005|FG000|Overall Study|Adverse Event|1|||
145328849|NCT00307034|524055006|FG001|Overall Study|Adverse Event|2|||
145328850|NCT00307034|524055005|FG000|Overall Study|Withdrawal by Subject|1|||
145328851|NCT00307034|524055006|FG001|Overall Study|Withdrawal by Subject|2|||
145328852|NCT00307034|524055005|FG000|Overall Study|Lost to Follow-up|0|||
145328853|NCT00307034|524055006|FG001|Overall Study|Lost to Follow-up|3|||
145328854|NCT01691820|524055011|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
145328855|NCT01691820|524055012|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
145328856|NCT01691820|524055011|FG000|Overall Study|Migrated/moved from study area|7|||
145328857|NCT01691820|524055012|FG001|Overall Study|Migrated/moved from study area|4|||
145328858|NCT01691820|524055011|FG000|Overall Study|Lost to Follow-up|6|||
145328859|NCT01691820|524055012|FG001|Overall Study|Lost to Follow-up|17|||
145328860|NCT01691820|524055011|FG000|Overall Study|Other (unspecified)|4|||
145328861|NCT01691820|524055012|FG001|Overall Study|Other (unspecified)|1|||
145328862|NCT02836496|524055025|FG000|Overall Study|Adverse Event|2|||
145328863|NCT02836496|524055026|FG001|Overall Study|Adverse Event|1|||
145328864|NCT02836496|524055025|FG000|Overall Study|Withdrawal by Subject|0|||
145328865|NCT02836496|524055026|FG001|Overall Study|Withdrawal by Subject|1|||
145328866|NCT02618408|524055027|FG000|Overall Study|Withdrawal by Subject|1|||
145328867|NCT02618408|524055028|FG001|Overall Study|Withdrawal by Subject|0|||
145328868|NCT02618408|524055029|FG002|Overall Study|Withdrawal by Subject|4|||
145328869|NCT02618408|524055027|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
145328870|NCT02618408|524055028|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
145328871|NCT02618408|524055029|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
145328872|NCT02618408|524055027|FG000|Overall Study|Lost to Follow-up|4|||
145328873|NCT02618408|524055028|FG001|Overall Study|Lost to Follow-up|2|||
145328874|NCT02618408|524055029|FG002|Overall Study|Lost to Follow-up|6|||
145328875|NCT02618408|524055027|FG000|Overall Study|Adverse Event|4|||
145328876|NCT02618408|524055028|FG001|Overall Study|Adverse Event|0|||
145328877|NCT02618408|524055029|FG002|Overall Study|Adverse Event|10|||
145328878|NCT02618408|524055027|FG000|Overall Study|Physician Decision|1|||
145328879|NCT02618408|524055028|FG001|Overall Study|Physician Decision|1|||
145571230|NCT04019041|524950185|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145571231|NCT04019041|524950180|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
145571232|NCT04019041|524950181|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
145571233|NCT04019041|524950182|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
145571234|NCT04019041|524950183|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
145571235|NCT04019041|524950184|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
145571236|NCT04019041|524950185|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
145571237|NCT04019041|524950180|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
145328880|NCT02618408|524055029|FG002|Overall Study|Physician Decision|2|||
145328881|NCT02618408|524055027|FG000|Overall Study|Protocol Violation|1|||
145328882|NCT02618408|524055028|FG001|Overall Study|Protocol Violation|1|||
145328883|NCT02618408|524055029|FG002|Overall Study|Protocol Violation|2|||
145328884|NCT02618408|524055027|FG000|Overall Study|Other, Multiple Categories|0|||
145328885|NCT02618408|524055028|FG001|Overall Study|Other, Multiple Categories|0|||
145328886|NCT02618408|524055029|FG002|Overall Study|Other, Multiple Categories|4|||
145328887|NCT03914950|524055034|FG000|Overall Study|Physician Decision|54|||
145328888|NCT03201250|524055035|FG000|Overall Study|screen failures|3|||
145328889|NCT03201250|524055036|FG001|Overall Study|screen failures|0|||
145328890|NCT03201250|524055037|FG002|Overall Study|screen failures|0|||
145328891|NCT01524679|524055044|FG000|Overall Study|Lost to Follow-up|1|||
145328892|NCT01524679|524055045|FG001|Overall Study|Lost to Follow-up|4|||
145328893|NCT01524679|524055044|FG000|Overall Study|Withdrawal by Subject|4|||
145328894|NCT01524679|524055045|FG001|Overall Study|Withdrawal by Subject|4|||
145571238|NCT04019041|524950181|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
145571239|NCT04019041|524950182|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
145328895|NCT01524679|524055044|FG000|Overall Study|Adverse Event|9|||
145328896|NCT01524679|524055045|FG001|Overall Study|Adverse Event|0|||
145328897|NCT01524679|524055044|FG000|Overall Study|Protocol Violation|1|||
145328898|NCT01524679|524055045|FG001|Overall Study|Protocol Violation|0|||
145328899|NCT01524679|524055044|FG000|Overall Study|Lack of Efficacy|2|||
145328900|NCT01524679|524055045|FG001|Overall Study|Lack of Efficacy|0|||
145328901|NCT01524679|524055044|FG000|Overall Study|e.g.wish for children, relocation|6|||
145571240|NCT04019041|524950183|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145571241|NCT04019041|524950184|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145571242|NCT04019041|524950185|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145328902|NCT01524679|524055045|FG001|Overall Study|e.g.wish for children, relocation|1|||
145328903|NCT03321630|524055048|FG000|Overall Study|Adverse Event|1|||
145328904|NCT03321630|524055048|FG000|Overall Study|Investigator Discretion|2|||
145328905|NCT03321630|524055048|FG000|Overall Study|Withdrawal by Subject|1|||
145328906|NCT00140426|524055049|FG000|Overall Study|Withdrawal by Subject|0|||
145328907|NCT00140426|524055050|FG001|Overall Study|Withdrawal by Subject|3|||
145328908|NCT04765384|524055051|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
145328909|NCT04765384|524055052|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
145328910|NCT04765384|524055053|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
145328911|NCT04765384|524055054|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
145328912|NCT04765384|524055055|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
145328913|NCT04765384|524055056|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
145328914|NCT04765384|524055051|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
145328915|NCT04765384|524055052|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
145328916|NCT04765384|524055053|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
145328917|NCT04765384|524055054|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
145328918|NCT04765384|524055055|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
145328919|NCT04765384|524055056|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
145328920|NCT04765384|524055051|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145328921|NCT04765384|524055052|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145328922|NCT04765384|524055053|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145328923|NCT04765384|524055054|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145328924|NCT04765384|524055055|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
145328925|NCT04765384|524055056|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
145328926|NCT04765384|524055051|FG000|Post-natal: Neonates and Infants|Death|0|||
145328927|NCT04765384|524055052|FG001|Post-natal: Neonates and Infants|Death|0|||
145328928|NCT04765384|524055053|FG002|Post-natal: Neonates and Infants|Death|0|||
145328929|NCT04765384|524055054|FG003|Post-natal: Neonates and Infants|Death|1|||
145328930|NCT04765384|524055055|FG004|Post-natal: Neonates and Infants|Death|0|||
145328931|NCT04765384|524055056|FG005|Post-natal: Neonates and Infants|Death|0|||
145328932|NCT04765384|524055051|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145328933|NCT04765384|524055052|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145328934|NCT04765384|524055053|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145328935|NCT04765384|524055054|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145328936|NCT04765384|524055055|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
145328937|NCT04765384|524055056|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
145328938|NCT01169532|524055061|FG000|Overall Study|Withdrawal by Subject|1|||
145328939|NCT02032706|524055065|FG000|Overall Study|Did not qualify|5|||
145328940|NCT02032706|524055065|FG000|Overall Study|Protocol Violation|1|||
145328941|NCT05070546|524055070|FG000|Overall Study|Death|0|||
145328942|NCT05070546|524055071|FG001|Overall Study|Death|0|||
145328943|NCT05070546|524055072|FG002|Overall Study|Death|0|||
145328944|NCT05070546|524055073|FG003|Overall Study|Death|0|||
145328945|NCT05070546|524055074|FG004|Overall Study|Death|0|||
145328946|NCT05070546|524055075|FG005|Overall Study|Death|1|||
145328947|NCT05070546|524055070|FG000|Overall Study|Lost to Follow-up|8|||
145328948|NCT05070546|524055071|FG001|Overall Study|Lost to Follow-up|2|||
145328949|NCT05070546|524055072|FG002|Overall Study|Lost to Follow-up|7|||
145328950|NCT05070546|524055073|FG003|Overall Study|Lost to Follow-up|1|||
145328951|NCT05070546|524055074|FG004|Overall Study|Lost to Follow-up|2|||
145328952|NCT05070546|524055075|FG005|Overall Study|Lost to Follow-up|0|||
145571243|NCT04019041|524950180|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
145328953|NCT05070546|524055070|FG000|Overall Study|Withdrawal by Subject|1|||
145328954|NCT05070546|524055071|FG001|Overall Study|Withdrawal by Subject|1|||
145328955|NCT05070546|524055072|FG002|Overall Study|Withdrawal by Subject|3|||
145328956|NCT05070546|524055073|FG003|Overall Study|Withdrawal by Subject|0|||
145328957|NCT05070546|524055074|FG004|Overall Study|Withdrawal by Subject|0|||
145328958|NCT05070546|524055075|FG005|Overall Study|Withdrawal by Subject|0|||
145328959|NCT05070546|524055070|FG000|Overall Study|Other|0|||
145571244|NCT04019041|524950181|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
145328960|NCT05070546|524055071|FG001|Overall Study|Other|0|||
145328961|NCT05070546|524055072|FG002|Overall Study|Other|0|||
145328962|NCT05070546|524055073|FG003|Overall Study|Other|0|||
145328963|NCT05070546|524055074|FG004|Overall Study|Other|3|||
145571245|NCT04019041|524950182|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
145571246|NCT04019041|524950183|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
145571247|NCT04019041|524950184|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
145571248|NCT04019041|524950185|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
145571249|NCT04019041|524950180|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145571250|NCT04019041|524950181|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145571251|NCT04019041|524950182|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145571252|NCT04019041|524950183|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
145571253|NCT04019041|524950184|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
145571254|NCT04019041|524950185|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
145620698|NCT02325713|525125169|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620699|NCT02325713|525125170|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620700|NCT02325713|525125171|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620701|NCT02325713|525125172|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620702|NCT02325713|525125173|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620703|NCT02325713|525125174|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620704|NCT02325713|525125175|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620705|NCT02325713|525125176|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620706|NCT02325713|525125177|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
145620707|NCT02325713|525125178|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620708|NCT02325713|525125179|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620709|NCT02325713|525125180|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620710|NCT02325713|525125181|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620711|NCT02325713|525125182|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
145620712|NCT02325713|525125167|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
145620713|NCT02325713|525125168|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620714|NCT02325713|525125169|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620715|NCT02325713|525125170|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620716|NCT02325713|525125171|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620717|NCT02325713|525125172|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620718|NCT02325713|525125173|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620719|NCT02325713|525125174|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620720|NCT02325713|525125175|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620721|NCT02325713|525125176|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620722|NCT02325713|525125177|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145328964|NCT05070546|524055075|FG005|Overall Study|Other|0|||
145328965|NCT05070546|524055070|FG000|Overall Study|Randomized but not vaccinated|1|||
145328966|NCT05070546|524055071|FG001|Overall Study|Randomized but not vaccinated|0|||
145328967|NCT05070546|524055072|FG002|Overall Study|Randomized but not vaccinated|1|||
145328968|NCT05070546|524055073|FG003|Overall Study|Randomized but not vaccinated|1|||
145328969|NCT05070546|524055074|FG004|Overall Study|Randomized but not vaccinated|3|||
145328970|NCT05070546|524055075|FG005|Overall Study|Randomized but not vaccinated|0|||
145620723|NCT02325713|525125178|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145328971|NCT00160641|524055076|FG000|Overall Study|Adverse Event|102|||
145328972|NCT00160641|524055076|FG000|Overall Study|Withdrawal by Subject|87|||
145328973|NCT00160641|524055076|FG000|Overall Study|Lost to Follow-up|8|||
145328974|NCT00160641|524055076|FG000|Overall Study|Lack of Efficacy|12|||
145328975|NCT00160641|524055076|FG000|Overall Study|Protocol Violation|3|||
145328976|NCT00160641|524055076|FG000|Overall Study|Other|9|||
145328977|NCT02787408|524055077|FG000|Overall Study|Death|16|||
145328978|NCT02787408|524055077|FG000|Overall Study|Withdrawal by Subject|1|||
145328979|NCT02787408|524055077|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
145328980|NCT00985712|524055079|FG000|Overall Study|Adverse Event|0|||
145328981|NCT00985712|524055080|FG001|Overall Study|Adverse Event|1|||
145328982|NCT00985712|524055079|FG000|Overall Study|Lost to Follow-up|2|||
145328983|NCT00985712|524055080|FG001|Overall Study|Lost to Follow-up|2|||
145328984|NCT00985712|524055079|FG000|Overall Study|Protocol Violation|0|||
145328985|NCT00985712|524055080|FG001|Overall Study|Protocol Violation|1|||
145620724|NCT02325713|525125179|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145620725|NCT02325713|525125180|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145328986|NCT00985712|524055079|FG000|Overall Study|Withdrawal by Subject|4|||
145571255|NCT04019041|524950180|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
145620726|NCT02325713|525125181|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145328987|NCT00985712|524055080|FG001|Overall Study|Withdrawal by Subject|1|||
145328988|NCT00985712|524055079|FG000|Overall Study|Sponsor decision|0|||
145328989|NCT00985712|524055080|FG001|Overall Study|Sponsor decision|2|||
145328990|NCT03096847|524055081|FG000|Overall Study|Other|2|||
145328991|NCT03096847|524055082|FG001|Overall Study|Other|1|||
145328992|NCT03096847|524055083|FG002|Overall Study|Other|2|||
145328993|NCT03096847|524055081|FG000|Overall Study|Lost to Follow-up|1|||
145328994|NCT03096847|524055082|FG001|Overall Study|Lost to Follow-up|0|||
145328995|NCT03096847|524055083|FG002|Overall Study|Lost to Follow-up|1|||
145328996|NCT03096847|524055081|FG000|Overall Study|Death|6|||
145328997|NCT03096847|524055082|FG001|Overall Study|Death|0|||
145328998|NCT03096847|524055083|FG002|Overall Study|Death|2|||
145328999|NCT03096847|524055081|FG000|Overall Study|Protocol Violation|3|||
145329000|NCT03096847|524055082|FG001|Overall Study|Protocol Violation|0|||
145329001|NCT03096847|524055083|FG002|Overall Study|Protocol Violation|6|||
145329002|NCT03096847|524055081|FG000|Overall Study|Physician Decision|12|||
145329003|NCT03096847|524055082|FG001|Overall Study|Physician Decision|2|||
145329004|NCT03096847|524055083|FG002|Overall Study|Physician Decision|8|||
145329005|NCT03096847|524055081|FG000|Overall Study|Withdrawal by Subject|24|||
145329006|NCT03096847|524055082|FG001|Overall Study|Withdrawal by Subject|1|||
145329007|NCT03096847|524055083|FG002|Overall Study|Withdrawal by Subject|12|||
145329008|NCT03096847|524055081|FG000|Overall Study|Adverse Event|72|||
145329009|NCT03096847|524055082|FG001|Overall Study|Adverse Event|6|||
145329010|NCT03096847|524055083|FG002|Overall Study|Adverse Event|28|||
145329011|NCT03096847|524055081|FG000|Overall Study|Progressive disease|97|||
145329012|NCT03096847|524055082|FG001|Overall Study|Progressive disease|10|||
145329013|NCT03096847|524055083|FG002|Overall Study|Progressive disease|78|||
145571256|NCT04019041|524950181|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
145571257|NCT04019041|524950182|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
145571258|NCT04019041|524950183|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
145571259|NCT04019041|524950184|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
145571260|NCT04019041|524950185|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
145571261|NCT04019041|524950180|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
145571262|NCT04019041|524950181|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
145571263|NCT04019041|524950182|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
145571264|NCT04019041|524950183|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
145571265|NCT04019041|524950184|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
145571266|NCT04019041|524950185|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
145571267|NCT04019041|524950180|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145571268|NCT04019041|524950181|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145571269|NCT04019041|524950182|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145571270|NCT04019041|524950183|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
145571271|NCT04019041|524950184|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
145571272|NCT04019041|524950185|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
145571273|NCT04019041|524950180|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145571274|NCT04019041|524950181|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145571275|NCT04019041|524950182|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145571276|NCT04019041|524950183|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145571277|NCT04019041|524950184|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
145571278|NCT04019041|524950185|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
145571279|NCT02540954|524950187|FG000|Overall Study|Physician Decision|3|||
145571280|NCT02540954|524950188|FG001|Overall Study|Physician Decision|1|||
145571281|NCT02540954|524950187|FG000|Overall Study|Withdrawal by Subject|6|||
145571282|NCT02540954|524950188|FG001|Overall Study|Withdrawal by Subject|5|||
145571283|NCT02540954|524950187|FG000|Overall Study|Lost to Follow-up|1|||
145571284|NCT02540954|524950188|FG001|Overall Study|Lost to Follow-up|1|||
145571285|NCT02540954|524950187|FG000|Overall Study|Adverse Event|4|||
145571286|NCT02540954|524950188|FG001|Overall Study|Adverse Event|2|||
145571287|NCT02540954|524950187|FG000|Overall Study|Death|0|||
145571288|NCT02540954|524950188|FG001|Overall Study|Death|3|||
145571289|NCT02540954|524950187|FG000|Overall Study|Treatment failure|1|||
145571290|NCT02540954|524950188|FG001|Overall Study|Treatment failure|0|||
145571291|NCT02540954|524950187|FG000|Overall Study|Other reason|4|||
145571292|NCT02540954|524950188|FG001|Overall Study|Other reason|2|||
145571293|NCT03925727|524950189|FG000|Overall Study|Adverse Event|4|||
145571294|NCT03925727|524950190|FG001|Overall Study|Adverse Event|0|||
145329014|NCT03096847|524055081|FG000|Overall Study|Non-compliance with study medication|1|||
145571295|NCT03925727|524950191|FG002|Overall Study|Adverse Event|3|||
145571296|NCT03925727|524950189|FG000|Overall Study|Protocol Violation|1|||
145571297|NCT03925727|524950190|FG001|Overall Study|Protocol Violation|2|||
145571298|NCT03925727|524950191|FG002|Overall Study|Protocol Violation|2|||
145571299|NCT03925727|524950189|FG000|Overall Study|Withdrawal by Subject|3|||
145571300|NCT03925727|524950190|FG001|Overall Study|Withdrawal by Subject|2|||
145571301|NCT03925727|524950191|FG002|Overall Study|Withdrawal by Subject|4|||
145571302|NCT03925727|524950189|FG000|Overall Study|Administrative Reasons|3|||
145329015|NCT03096847|524055082|FG001|Overall Study|Non-compliance with study medication|0|||
145329016|NCT03096847|524055083|FG002|Overall Study|Non-compliance with study medication|0|||
145329017|NCT03096847|524055081|FG000|Overall Study|New therapy for study indication|1|||
145329018|NCT03096847|524055082|FG001|Overall Study|New therapy for study indication|0|||
145329019|NCT03096847|524055083|FG002|Overall Study|New therapy for study indication|1|||
145329020|NCT00359632|524055084|FG000|Overall Study|Death|2|||
145329021|NCT00359632|524055085|FG001|Overall Study|Death|0|||
145329022|NCT00359632|524055084|FG000|Overall Study|Adverse Event|1|||
145329023|NCT00359632|524055085|FG001|Overall Study|Adverse Event|0|||
145329024|NCT00359632|524055084|FG000|Overall Study|Non-compliance with visit schedule|1|||
145329025|NCT00359632|524055085|FG001|Overall Study|Non-compliance with visit schedule|0|||
145329026|NCT02458092|524055091|FG000|Overall Study|Withdrawal by Subject|1|||
145329027|NCT02458092|524055092|FG001|Overall Study|Withdrawal by Subject|0|||
145329028|NCT00251641|524055093|FG000|Overall Study|Adverse Event|80|||
145329029|NCT00251641|524055094|FG001|Overall Study|Adverse Event|8|||
145329030|NCT00251641|524055093|FG000|Overall Study|Lack of Efficacy|2|||
145329031|NCT00251641|524055094|FG001|Overall Study|Lack of Efficacy|1|||
145329032|NCT00251641|524055093|FG000|Overall Study|Progression of Disease|0|||
145329033|NCT00251641|524055094|FG001|Overall Study|Progression of Disease|2|||
145329034|NCT00251641|524055093|FG000|Overall Study|Lost to Follow-up|3|||
145329035|NCT00251641|524055094|FG001|Overall Study|Lost to Follow-up|3|||
145329036|NCT00251641|524055093|FG000|Overall Study|Withdrawal by Subject|6|||
145329037|NCT00251641|524055094|FG001|Overall Study|Withdrawal by Subject|8|||
145329038|NCT00251641|524055093|FG000|Overall Study|Protocol Violation|10|||
145329039|NCT00251641|524055094|FG001|Overall Study|Protocol Violation|2|||
145329040|NCT00251641|524055093|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
145329041|NCT00251641|524055094|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
145329042|NCT00251641|524055093|FG000|Overall Study|Switched Treatment|9|||
145329043|NCT00251641|524055094|FG001|Overall Study|Switched Treatment|63|||
145329044|NCT00876018|524055095|FG000|Overall Study|Lost to Follow-up|0|||
145329045|NCT00876018|524055096|FG001|Overall Study|Lost to Follow-up|1|||
145329046|NCT00876018|524055097|FG002|Overall Study|Lost to Follow-up|1|||
145329047|NCT00876018|524055095|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
145329048|NCT00876018|524055096|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
145329049|NCT00876018|524055097|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
145329050|NCT01230892|524055098|FG000|Overall Study|Withdrawal by Subject|1|||
145329051|NCT01230892|524055099|FG001|Overall Study|Withdrawal by Subject|1|||
145329052|NCT01230892|524055098|FG000|Overall Study|Lost to Follow-up|2|||
145329053|NCT01230892|524055099|FG001|Overall Study|Lost to Follow-up|0|||
145329054|NCT00725621|524055102|FG000|Overall Study|Adverse Event|25|||
145329055|NCT00725621|524055102|FG000|Overall Study|Lack of Efficacy|46|||
145329056|NCT00725621|524055102|FG000|Overall Study|Withdrawal by Subject|57|||
145329057|NCT00725621|524055102|FG000|Overall Study|Physician Decision|19|||
145329058|NCT00725621|524055102|FG000|Overall Study|Lost to Follow-up|52|||
145329059|NCT00725621|524055102|FG000|Overall Study|Non-compliance|8|||
145329060|NCT00725621|524055102|FG000|Overall Study|Continued treatment by other physician|6|||
145329061|NCT00725621|524055102|FG000|Overall Study|Switched to other study|1|||
145329062|NCT00725621|524055102|FG000|Overall Study|Switched to other drug|1|||
145329063|NCT00725621|524055102|FG000|Overall Study|Prepared for elective surgery|1|||
145329064|NCT00725621|524055102|FG000|Overall Study|Reason not specified|55|||
145329065|NCT01189500|524055103|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
145329066|NCT01189500|524055103|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
145329067|NCT01000493|524055104|FG000|Overall Study|Adverse Event|3|||
145329068|NCT01000493|524055105|FG001|Overall Study|Adverse Event|6|||
145329069|NCT01000493|524055104|FG000|Overall Study|Lack of Efficacy|1|||
145329070|NCT01000493|524055105|FG001|Overall Study|Lack of Efficacy|1|||
145329071|NCT01000493|524055104|FG000|Overall Study|Protocol Violation|1|||
145329072|NCT01000493|524055105|FG001|Overall Study|Protocol Violation|8|||
145329073|NCT01000493|524055104|FG000|Overall Study|Study closed/terminated|25|||
145329074|NCT01000493|524055105|FG001|Overall Study|Study closed/terminated|23|||
145329075|NCT01000493|524055104|FG000|Overall Study|Lost to Follow-up|5|||
145329076|NCT01000493|524055105|FG001|Overall Study|Lost to Follow-up|9|||
145329077|NCT01000493|524055104|FG000|Overall Study|Physician Decision|1|||
145329078|NCT01000493|524055105|FG001|Overall Study|Physician Decision|1|||
145329079|NCT01000493|524055104|FG000|Overall Study|Withdrawal by Subject|3|||
145329080|NCT01000493|524055105|FG001|Overall Study|Withdrawal by Subject|7|||
145329081|NCT01144364|524055111|FG000|Induction Phase|Disease progression|14|||
145329082|NCT01144364|524055112|FG001|Induction Phase|Disease progression|0|||
145329083|NCT01144364|524055113|FG002|Induction Phase|Disease progression|0|||
145329084|NCT01144364|524055111|FG000|Induction Phase|Adverse Event|9|||
145329085|NCT01144364|524055112|FG001|Induction Phase|Adverse Event|0|||
145329086|NCT01144364|524055113|FG002|Induction Phase|Adverse Event|0|||
145329087|NCT01144364|524055111|FG000|Induction Phase|Death|1|||
145329088|NCT01144364|524055112|FG001|Induction Phase|Death|0|||
145329089|NCT01144364|524055113|FG002|Induction Phase|Death|0|||
145329090|NCT01144364|524055111|FG000|Induction Phase|Withdrawal by Subject|1|||
145329091|NCT01144364|524055112|FG001|Induction Phase|Withdrawal by Subject|0|||
145329092|NCT01144364|524055113|FG002|Induction Phase|Withdrawal by Subject|0|||
145329093|NCT01144364|524055111|FG000|Induction Phase|Lost to Follow-up|2|||
145329094|NCT01144364|524055112|FG001|Induction Phase|Lost to Follow-up|0|||
145329095|NCT01144364|524055113|FG002|Induction Phase|Lost to Follow-up|0|||
145329096|NCT01144364|524055111|FG000|Induction Phase|Physician Decision|1|||
145329097|NCT01144364|524055112|FG001|Induction Phase|Physician Decision|0|||
145329098|NCT01144364|524055113|FG002|Induction Phase|Physician Decision|0|||
145329099|NCT01144364|524055111|FG000|Induction Phase|Stable disease|2|||
145329100|NCT01144364|524055112|FG001|Induction Phase|Stable disease|0|||
145329101|NCT01144364|524055113|FG002|Induction Phase|Stable disease|0|||
145329102|NCT01144364|524055111|FG000|Induction Phase|Secondary neoplasia|1|||
145329103|NCT01144364|524055112|FG001|Induction Phase|Secondary neoplasia|0|||
145329104|NCT01144364|524055113|FG002|Induction Phase|Secondary neoplasia|0|||
145329105|NCT01144364|524055111|FG000|Induction Phase|Protocol Violation|1|||
145329106|NCT01144364|524055112|FG001|Induction Phase|Protocol Violation|0|||
145329107|NCT01144364|524055113|FG002|Induction Phase|Protocol Violation|0|||
145329108|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
145329109|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
145329110|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
145329111|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
145329112|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
145329113|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
145329114|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Death|0|||
145329115|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Death|2|||
145329116|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Death|0|||
145329117|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
145329118|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
145329119|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
145329120|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
145329121|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
145329122|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
145329123|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
145329124|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
145329125|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
145329126|NCT01144364|524055111|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
145329127|NCT01144364|524055112|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
145329128|NCT01144364|524055113|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
145329129|NCT02989168|524055114|FG000|Overall Study|Withdrawal by Subject|2|||
145329130|NCT02989168|524055115|FG001|Overall Study|Withdrawal by Subject|0|||
145329131|NCT02989168|524055114|FG000|Overall Study|Physician Decision|0|||
145329132|NCT02989168|524055115|FG001|Overall Study|Physician Decision|1|||
145329133|NCT02989168|524055114|FG000|Overall Study|Adverse Event|1|||
145329134|NCT02989168|524055115|FG001|Overall Study|Adverse Event|2|||
145329135|NCT02989168|524055114|FG000|Overall Study|Sponsor stopped study.|1|||
145329136|NCT02989168|524055115|FG001|Overall Study|Sponsor stopped study.|0|||
145329137|NCT03456960|524055116|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145329138|NCT03456960|524055117|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145329139|NCT03456960|524055118|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
145329140|NCT03456960|524055119|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
145329141|NCT03456960|524055120|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145329142|NCT03456960|524055121|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
145329143|NCT03456960|524055116|FG000|Period 2 (1 Day)|Adverse Event|1|||
145329144|NCT03456960|524055117|FG001|Period 2 (1 Day)|Adverse Event|0|||
145329145|NCT03456960|524055118|FG002|Period 2 (1 Day)|Adverse Event|0|||
145329146|NCT03456960|524055119|FG003|Period 2 (1 Day)|Adverse Event|1|||
145329147|NCT03456960|524055120|FG004|Period 2 (1 Day)|Adverse Event|0|||
145329148|NCT03456960|524055121|FG005|Period 2 (1 Day)|Adverse Event|0|||
145329149|NCT00532935|524055122|FG000|Overall Study|Adverse Event|11|||
145329150|NCT00532935|524055123|FG001|Overall Study|Adverse Event|12|||
145329151|NCT00532935|524055122|FG000|Overall Study|Lack of Efficacy|0|||
145329152|NCT00532935|524055123|FG001|Overall Study|Lack of Efficacy|3|||
145329153|NCT00532935|524055122|FG000|Overall Study|Lost to Follow-up|10|||
145329154|NCT00532935|524055123|FG001|Overall Study|Lost to Follow-up|6|||
145329155|NCT00532935|524055122|FG000|Overall Study|Physician Decision|4|||
145329156|NCT00532935|524055123|FG001|Overall Study|Physician Decision|5|||
145329157|NCT00532935|524055122|FG000|Overall Study|Pregnancy|1|||
145329158|NCT00532935|524055123|FG001|Overall Study|Pregnancy|0|||
145329159|NCT00532935|524055122|FG000|Overall Study|Protocol Violation|4|||
145571303|NCT03925727|524950190|FG001|Overall Study|Administrative Reasons|1|||
145571304|NCT03925727|524950191|FG002|Overall Study|Administrative Reasons|2|||
145329160|NCT00532935|524055123|FG001|Overall Study|Protocol Violation|2|||
145329161|NCT00532935|524055122|FG000|Overall Study|Withdrawal by Subject|10|||
145329162|NCT00532935|524055123|FG001|Overall Study|Withdrawal by Subject|9|||
145329163|NCT00532935|524055122|FG000|Overall Study|Protocol Specific Criteria|11|||
145329164|NCT00532935|524055123|FG001|Overall Study|Protocol Specific Criteria|15|||
145329165|NCT01301508|524055124|FG000|Overall Study|Withdrawal by Subject|1|||
145329166|NCT01301508|524055125|FG001|Overall Study|Withdrawal by Subject|2|||
145329167|NCT01301508|524055124|FG000|Overall Study|Lost to Follow-up|0|||
145329168|NCT01301508|524055125|FG001|Overall Study|Lost to Follow-up|1|||
145329169|NCT01300923|524055126|FG000|Overall Study|Physician Decision|0|||
145571305|NCT03925727|524950189|FG000|Overall Study|Randomized in error or Disqualified|8|||
145329170|NCT01300923|524055127|FG001|Overall Study|Physician Decision|2|||
145329171|NCT01940497|524055130|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
145329172|NCT01940497|524055131|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
145329173|NCT01940497|524055130|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
145329174|NCT01940497|524055131|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
145329175|NCT01940497|524055130|FG000|Overall Study|Violation of Entry Criteria|1|||
145329176|NCT01940497|524055131|FG001|Overall Study|Violation of Entry Criteria|1|||
145329177|NCT01940497|524055130|FG000|Overall Study|Refused Treatment|1|||
145329178|NCT01940497|524055131|FG001|Overall Study|Refused Treatment|3|||
145329179|NCT01940497|524055130|FG000|Overall Study|Withdrew Consent|6|||
145329180|NCT01940497|524055131|FG001|Overall Study|Withdrew Consent|2|||
145329181|NCT01940497|524055130|FG000|Overall Study|Administrative/Other|1|||
145329182|NCT01940497|524055131|FG001|Overall Study|Administrative/Other|1|||
145329183|NCT02707861|524055132|FG000|Overall Study|Went onto commercial drug|30|||
145329184|NCT02707861|524055133|FG001|Overall Study|Went onto commercial drug|23|||
145329185|NCT02707861|524055132|FG000|Overall Study|Adverse Event|2|||
145329186|NCT02707861|524055133|FG001|Overall Study|Adverse Event|3|||
145329187|NCT02707861|524055132|FG000|Overall Study|Death|5|||
145329188|NCT02707861|524055133|FG001|Overall Study|Death|2|||
145329189|NCT02707861|524055132|FG000|Overall Study|Lack of Efficacy|0|||
145329190|NCT02707861|524055133|FG001|Overall Study|Lack of Efficacy|2|||
145329191|NCT02707861|524055132|FG000|Overall Study|Physician Decision|1|||
145329192|NCT02707861|524055133|FG001|Overall Study|Physician Decision|4|||
145329193|NCT02707861|524055132|FG000|Overall Study|Withdrawal by Subject|2|||
145329194|NCT02707861|524055133|FG001|Overall Study|Withdrawal by Subject|1|||
145329195|NCT02707861|524055132|FG000|Overall Study|Lost to Follow-up|1|||
145329196|NCT02707861|524055133|FG001|Overall Study|Lost to Follow-up|3|||
145329197|NCT03123861|524055134|FG000|Overall Study|Protocol Violation|1|||
145329198|NCT03123861|524055135|FG001|Overall Study|Protocol Violation|1|||
145329199|NCT03123861|524055134|FG000|Overall Study|Withdrawal by Subject|2|||
145329200|NCT03123861|524055135|FG001|Overall Study|Withdrawal by Subject|2|||
145329201|NCT00448136|524055140|FG000|Overall Study|Death|3|||
145329202|NCT00448136|524055141|FG001|Overall Study|Death|8|||
145329203|NCT00448136|524055140|FG000|Overall Study|Investigator's decision (progression)|1|||
145329204|NCT00448136|524055141|FG001|Overall Study|Investigator's decision (progression)|0|||
145329205|NCT00609466|524055142|FG000|Overall Study|Withdrawal by Subject|0|||
145329206|NCT00609466|524055143|FG001|Overall Study|Withdrawal by Subject|1|||
145329207|NCT00609466|524055144|FG002|Overall Study|Withdrawal by Subject|1|||
145329208|NCT00609466|524055142|FG000|Overall Study|Adverse Event|2|||
145329209|NCT00609466|524055143|FG001|Overall Study|Adverse Event|3|||
145329210|NCT00609466|524055144|FG002|Overall Study|Adverse Event|1|||
145329211|NCT00609466|524055142|FG000|Overall Study|Lack of Efficacy|0|||
145329212|NCT00609466|524055143|FG001|Overall Study|Lack of Efficacy|2|||
145329213|NCT00609466|524055144|FG002|Overall Study|Lack of Efficacy|2|||
145329214|NCT01299805|524055147|FG000|Overall Study|Adverse Event|2|||
145329215|NCT01299805|524055148|FG001|Overall Study|Adverse Event|0|||
145329216|NCT03407430|524055149|FG000|Washout|Protocol Violation|1|||
145329217|NCT03407430|524055150|FG001|Washout|Protocol Violation|0|||
145329218|NCT00922987|524055152|FG000|Overall Study|Insufficient clinical response|1|||
145329219|NCT00922987|524055152|FG000|Overall Study|Protocol Violation|2|||
145329220|NCT00922987|524055152|FG000|Overall Study|Adverse Event|1|||
145329221|NCT01334710|524055159|FG000|Overall Study|Trial was terminated|3|||
145329222|NCT00375492|524055160|FG000|Overall Study|Adverse Event|4|||
145329223|NCT00375492|524055161|FG001|Overall Study|Adverse Event|5|||
145329224|NCT00375492|524055160|FG000|Overall Study|Entry Criteria Not Met|0|||
145329225|NCT00375492|524055161|FG001|Overall Study|Entry Criteria Not Met|1|||
145412103|NCT02850406|524362191|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
145412104|NCT02850406|524362192|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
145571306|NCT03925727|524950190|FG001|Overall Study|Randomized in error or Disqualified|1|||
145571307|NCT03925727|524950191|FG002|Overall Study|Randomized in error or Disqualified|7|||
145571308|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
145329226|NCT00375492|524055160|FG000|Overall Study|Loss of Glucose Control|0|||
145412105|NCT02850406|524362193|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
145412106|NCT02850406|524362194|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
145412107|NCT02850406|524362195|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
145329227|NCT00375492|524055161|FG001|Overall Study|Loss of Glucose Control|1|||
145329228|NCT00375492|524055160|FG000|Overall Study|Lost to Follow-up|10|||
145329229|NCT00375492|524055161|FG001|Overall Study|Lost to Follow-up|5|||
145329230|NCT00375492|524055160|FG000|Overall Study|Physician Decision|0|||
145329231|NCT00375492|524055161|FG001|Overall Study|Physician Decision|4|||
145329232|NCT00375492|524055160|FG000|Overall Study|Protocol Violation|6|||
145329233|NCT00375492|524055161|FG001|Overall Study|Protocol Violation|3|||
145329234|NCT00375492|524055160|FG000|Overall Study|Sponsor Decision|0|||
145412108|NCT02850406|524362188|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145329235|NCT00375492|524055161|FG001|Overall Study|Sponsor Decision|1|||
145329236|NCT00375492|524055160|FG000|Overall Study|Withdrawal by Subject|6|||
145329237|NCT00375492|524055161|FG001|Overall Study|Withdrawal by Subject|6|||
145329238|NCT04969861|524055162|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
145329239|NCT04969861|524055163|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
145329240|NCT00290251|524055164|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145329241|NCT00290251|524055165|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145329242|NCT00290251|524055166|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145329243|NCT00290251|524055167|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145329244|NCT00290251|524055168|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
145329245|NCT00290251|524055169|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
145329246|NCT00290251|524055164|FG000|Treatment 1 (Months 2-4)|headache|0|||
145329247|NCT00290251|524055165|FG001|Treatment 1 (Months 2-4)|headache|0|||
145329248|NCT00290251|524055166|FG002|Treatment 1 (Months 2-4)|headache|0|||
145329249|NCT00290251|524055167|FG003|Treatment 1 (Months 2-4)|headache|0|||
145329250|NCT00290251|524055168|FG004|Treatment 1 (Months 2-4)|headache|1|||
145329251|NCT00290251|524055169|FG005|Treatment 1 (Months 2-4)|headache|0|||
145329252|NCT00290251|524055164|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
145329253|NCT00290251|524055165|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
145329254|NCT00290251|524055166|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
145329255|NCT00290251|524055167|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
145329256|NCT00290251|524055168|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
145329257|NCT00290251|524055169|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
145329258|NCT03303625|524056773|FG000|Overall Study|Withdrawal by Subject|2|||
145329259|NCT03303625|524056774|FG001|Overall Study|Withdrawal by Subject|0|||
145329260|NCT03303625|524056775|FG002|Overall Study|Withdrawal by Subject|0|||
145329261|NCT03303625|524056776|FG003|Overall Study|Withdrawal by Subject|0|||
145329262|NCT01288053|524056777|FG000|Overall Study|Death|1|||
145329263|NCT03188666|524056778|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
145329264|NCT03188666|524056779|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
145329265|NCT03188666|524056780|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
145329266|NCT03188666|524056781|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
145329267|NCT03188666|524056778|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
145412109|NCT02850406|524362189|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145571309|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
145571310|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
145571311|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
145571312|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
145571313|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
145571314|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
145571315|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
145571316|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
145571317|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
145571318|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
145571319|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
145571320|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
145571321|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
145571322|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
145571323|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
145571324|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
145571325|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
145571326|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
145571327|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
145571328|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Other|3|||
145571329|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Other|0|||
145571330|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Other|2|||
145571331|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Other|2|||
145571332|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Other|7|||
145571333|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571334|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571335|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571336|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
145571337|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571338|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571339|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571340|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571341|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571342|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
145571343|NCT00213148|524950192|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
145571344|NCT00213148|524950193|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
145571345|NCT00213148|524950194|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
145571346|NCT00213148|524950195|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
145571347|NCT00213148|524950196|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
145571348|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
145571349|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
145571350|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
145571351|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
145571352|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
145329268|NCT03188666|524056779|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
145329269|NCT03188666|524056780|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
145329270|NCT03188666|524056781|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
145329271|NCT03188666|524056778|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145329272|NCT03188666|524056779|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145329273|NCT03188666|524056780|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
145329274|NCT03188666|524056781|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
145329275|NCT03188666|524056778|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
145329276|NCT03188666|524056779|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
145329277|NCT03188666|524056780|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
145329278|NCT03188666|524056781|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
145329279|NCT00144781|524056782|FG000|Overall Study|Adverse Event|0|||
145329280|NCT00144781|524056783|FG001|Overall Study|Adverse Event|1|||
145329281|NCT00144781|524056784|FG002|Overall Study|Adverse Event|0|||
145329282|NCT00144781|524056785|FG003|Overall Study|Adverse Event|0|||
145329283|NCT00144781|524056782|FG000|Overall Study|Non-compliant|0|||
145329284|NCT00144781|524056783|FG001|Overall Study|Non-compliant|1|||
145329285|NCT00144781|524056784|FG002|Overall Study|Non-compliant|0|||
145329286|NCT00144781|524056785|FG003|Overall Study|Non-compliant|0|||
145329287|NCT02068092|524056786|FG000|Overall Study|Physician Decision|2|||
145329288|NCT02068092|524056786|FG000|Overall Study|Adverse Event|2|||
145329289|NCT02068092|524056786|FG000|Overall Study|Lost to Follow-up|4|||
145329290|NCT02068092|524056786|FG000|Overall Study|Withdrawal by Subject|2|||
145329291|NCT03502707|524056787|FG000|Overall Study|Adverse Event|0|||
145329292|NCT03502707|524056788|FG001|Overall Study|Adverse Event|0|||
145329293|NCT03502707|524056789|FG002|Overall Study|Adverse Event|0|||
145329294|NCT03502707|524056790|FG003|Overall Study|Adverse Event|0|||
145329295|NCT03502707|524056791|FG004|Overall Study|Adverse Event|0|||
145329296|NCT03502707|524056792|FG005|Overall Study|Adverse Event|0|||
145329297|NCT03502707|524056793|FG006|Overall Study|Adverse Event|0|||
145329298|NCT03502707|524056794|FG007|Overall Study|Adverse Event|0|||
145329299|NCT03502707|524056795|FG008|Overall Study|Adverse Event|0|||
145329300|NCT03502707|524056796|FG009|Overall Study|Adverse Event|0|||
145329301|NCT03502707|524056797|FG010|Overall Study|Adverse Event|0|||
145329302|NCT03502707|524056798|FG011|Overall Study|Adverse Event|0|||
145329303|NCT03502707|524056799|FG012|Overall Study|Adverse Event|0|||
145329304|NCT03502707|524056800|FG013|Overall Study|Adverse Event|0|||
145329305|NCT03502707|524056801|FG014|Overall Study|Adverse Event|0|||
145329306|NCT03502707|524056802|FG015|Overall Study|Adverse Event|1|||
145571353|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
145329307|NCT03502707|524056803|FG016|Overall Study|Adverse Event|5|||
145329308|NCT03502707|524056804|FG017|Overall Study|Adverse Event|0|||
145329309|NCT03502707|524056787|FG000|Overall Study|Death|0|||
145329310|NCT03502707|524056788|FG001|Overall Study|Death|0|||
145329311|NCT03502707|524056789|FG002|Overall Study|Death|0|||
145329312|NCT03502707|524056790|FG003|Overall Study|Death|1|||
145329313|NCT03502707|524056791|FG004|Overall Study|Death|0|||
145329314|NCT03502707|524056792|FG005|Overall Study|Death|0|||
145329315|NCT03502707|524056793|FG006|Overall Study|Death|0|||
145329316|NCT03502707|524056794|FG007|Overall Study|Death|0|||
145329317|NCT03502707|524056795|FG008|Overall Study|Death|1|||
145329318|NCT03502707|524056796|FG009|Overall Study|Death|1|||
145329319|NCT03502707|524056797|FG010|Overall Study|Death|0|||
145329320|NCT03502707|524056798|FG011|Overall Study|Death|0|||
145329321|NCT03502707|524056799|FG012|Overall Study|Death|1|||
145329322|NCT03502707|524056800|FG013|Overall Study|Death|0|||
145329323|NCT03502707|524056801|FG014|Overall Study|Death|0|||
145329324|NCT03502707|524056802|FG015|Overall Study|Death|1|||
145571354|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
145571355|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
145329325|NCT03502707|524056803|FG016|Overall Study|Death|0|||
145329326|NCT03502707|524056804|FG017|Overall Study|Death|0|||
145571356|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
145329327|NCT03502707|524056787|FG000|Overall Study|Lost to Follow-up|0|||
145329328|NCT03502707|524056788|FG001|Overall Study|Lost to Follow-up|0|||
145329329|NCT03502707|524056789|FG002|Overall Study|Lost to Follow-up|0|||
145329330|NCT03502707|524056790|FG003|Overall Study|Lost to Follow-up|0|||
145329331|NCT03502707|524056791|FG004|Overall Study|Lost to Follow-up|0|||
145571357|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
145329332|NCT03502707|524056792|FG005|Overall Study|Lost to Follow-up|0|||
145329333|NCT03502707|524056793|FG006|Overall Study|Lost to Follow-up|0|||
145329334|NCT03502707|524056794|FG007|Overall Study|Lost to Follow-up|5|||
145329335|NCT03502707|524056795|FG008|Overall Study|Lost to Follow-up|0|||
145329336|NCT03502707|524056796|FG009|Overall Study|Lost to Follow-up|2|||
145329337|NCT03502707|524056797|FG010|Overall Study|Lost to Follow-up|1|||
145329338|NCT03502707|524056798|FG011|Overall Study|Lost to Follow-up|2|||
145329339|NCT03502707|524056799|FG012|Overall Study|Lost to Follow-up|1|||
145329340|NCT03502707|524056800|FG013|Overall Study|Lost to Follow-up|1|||
145329341|NCT03502707|524056801|FG014|Overall Study|Lost to Follow-up|0|||
145329342|NCT03502707|524056802|FG015|Overall Study|Lost to Follow-up|4|||
145329343|NCT03502707|524056803|FG016|Overall Study|Lost to Follow-up|9|||
145329344|NCT03502707|524056804|FG017|Overall Study|Lost to Follow-up|2|||
145329345|NCT03502707|524056787|FG000|Overall Study|Physician Decision|0|||
145329346|NCT03502707|524056788|FG001|Overall Study|Physician Decision|0|||
145329347|NCT03502707|524056789|FG002|Overall Study|Physician Decision|0|||
145329348|NCT03502707|524056790|FG003|Overall Study|Physician Decision|0|||
145329349|NCT03502707|524056791|FG004|Overall Study|Physician Decision|0|||
145329350|NCT03502707|524056792|FG005|Overall Study|Physician Decision|0|||
145329351|NCT03502707|524056793|FG006|Overall Study|Physician Decision|0|||
145329352|NCT03502707|524056794|FG007|Overall Study|Physician Decision|0|||
145329353|NCT03502707|524056795|FG008|Overall Study|Physician Decision|2|||
145329354|NCT03502707|524056796|FG009|Overall Study|Physician Decision|1|||
145329355|NCT03502707|524056797|FG010|Overall Study|Physician Decision|0|||
145329356|NCT03502707|524056798|FG011|Overall Study|Physician Decision|0|||
145329357|NCT03502707|524056799|FG012|Overall Study|Physician Decision|0|||
145329358|NCT03502707|524056800|FG013|Overall Study|Physician Decision|0|||
145329359|NCT03502707|524056801|FG014|Overall Study|Physician Decision|1|||
145329360|NCT03502707|524056802|FG015|Overall Study|Physician Decision|3|||
145329361|NCT03502707|524056803|FG016|Overall Study|Physician Decision|0|||
145329362|NCT03502707|524056804|FG017|Overall Study|Physician Decision|0|||
145329363|NCT03502707|524056787|FG000|Overall Study|Protocol Violation|0|||
145329364|NCT03502707|524056788|FG001|Overall Study|Protocol Violation|0|||
145329365|NCT03502707|524056789|FG002|Overall Study|Protocol Violation|0|||
145329366|NCT03502707|524056790|FG003|Overall Study|Protocol Violation|0|||
145329367|NCT03502707|524056791|FG004|Overall Study|Protocol Violation|0|||
145329368|NCT03502707|524056792|FG005|Overall Study|Protocol Violation|0|||
145329369|NCT03502707|524056793|FG006|Overall Study|Protocol Violation|0|||
145329370|NCT03502707|524056794|FG007|Overall Study|Protocol Violation|0|||
145329371|NCT03502707|524056795|FG008|Overall Study|Protocol Violation|0|||
145329372|NCT03502707|524056796|FG009|Overall Study|Protocol Violation|0|||
145329373|NCT03502707|524056797|FG010|Overall Study|Protocol Violation|0|||
145329374|NCT03502707|524056798|FG011|Overall Study|Protocol Violation|0|||
145329375|NCT03502707|524056799|FG012|Overall Study|Protocol Violation|0|||
145329376|NCT03502707|524056800|FG013|Overall Study|Protocol Violation|0|||
145329377|NCT03502707|524056801|FG014|Overall Study|Protocol Violation|0|||
145329378|NCT03502707|524056802|FG015|Overall Study|Protocol Violation|1|||
145329379|NCT03502707|524056803|FG016|Overall Study|Protocol Violation|0|||
145329380|NCT03502707|524056804|FG017|Overall Study|Protocol Violation|0|||
145329381|NCT03502707|524056787|FG000|Overall Study|Withdrawal by Subject|1|||
145329382|NCT03502707|524056788|FG001|Overall Study|Withdrawal by Subject|1|||
145329383|NCT03502707|524056789|FG002|Overall Study|Withdrawal by Subject|0|||
145329384|NCT03502707|524056790|FG003|Overall Study|Withdrawal by Subject|0|||
145329385|NCT03502707|524056791|FG004|Overall Study|Withdrawal by Subject|0|||
145329386|NCT03502707|524056792|FG005|Overall Study|Withdrawal by Subject|2|||
145329387|NCT03502707|524056793|FG006|Overall Study|Withdrawal by Subject|0|||
145329388|NCT03502707|524056794|FG007|Overall Study|Withdrawal by Subject|3|||
145329389|NCT03502707|524056795|FG008|Overall Study|Withdrawal by Subject|1|||
145329390|NCT03502707|524056796|FG009|Overall Study|Withdrawal by Subject|2|||
145571358|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Other|2|||
145571359|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Other|1|||
145571360|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Other|2|||
145571361|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Other|8|||
145571362|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Other|7|||
145571363|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571364|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
145329391|NCT03502707|524056797|FG010|Overall Study|Withdrawal by Subject|12|||
145329392|NCT03502707|524056798|FG011|Overall Study|Withdrawal by Subject|23|||
145329393|NCT03502707|524056799|FG012|Overall Study|Withdrawal by Subject|5|||
145329394|NCT03502707|524056800|FG013|Overall Study|Withdrawal by Subject|3|||
145329395|NCT03502707|524056801|FG014|Overall Study|Withdrawal by Subject|3|||
145329396|NCT03502707|524056802|FG015|Overall Study|Withdrawal by Subject|43|||
145329397|NCT03502707|524056803|FG016|Overall Study|Withdrawal by Subject|44|||
145329398|NCT03502707|524056804|FG017|Overall Study|Withdrawal by Subject|18|||
145329399|NCT03502707|524056787|FG000|Overall Study|Sponsor's Decision|1|||
145329400|NCT03502707|524056788|FG001|Overall Study|Sponsor's Decision|0|||
145329401|NCT03502707|524056789|FG002|Overall Study|Sponsor's Decision|0|||
145571365|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571366|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145329402|NCT03502707|524056790|FG003|Overall Study|Sponsor's Decision|0|||
145329403|NCT03502707|524056791|FG004|Overall Study|Sponsor's Decision|0|||
145329404|NCT03502707|524056792|FG005|Overall Study|Sponsor's Decision|0|||
145329405|NCT03502707|524056793|FG006|Overall Study|Sponsor's Decision|0|||
145329406|NCT03502707|524056794|FG007|Overall Study|Sponsor's Decision|0|||
145329407|NCT03502707|524056795|FG008|Overall Study|Sponsor's Decision|0|||
145329408|NCT03502707|524056796|FG009|Overall Study|Sponsor's Decision|1|||
145329409|NCT03502707|524056797|FG010|Overall Study|Sponsor's Decision|0|||
145329410|NCT03502707|524056798|FG011|Overall Study|Sponsor's Decision|0|||
145329411|NCT03502707|524056799|FG012|Overall Study|Sponsor's Decision|0|||
145329412|NCT03502707|524056800|FG013|Overall Study|Sponsor's Decision|0|||
145329413|NCT03502707|524056801|FG014|Overall Study|Sponsor's Decision|0|||
145571367|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
145571368|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
145571369|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571370|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571371|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571372|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
145571373|NCT00213148|524950192|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
145571374|NCT00213148|524950193|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
145571375|NCT00213148|524950194|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
145571376|NCT00213148|524950195|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
145571377|NCT00213148|524950196|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
145571378|NCT00213148|524950192|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
145571379|NCT00213148|524950193|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
145329414|NCT03502707|524056802|FG015|Overall Study|Sponsor's Decision|2|||
145329415|NCT03502707|524056803|FG016|Overall Study|Sponsor's Decision|1|||
145329416|NCT03502707|524056804|FG017|Overall Study|Sponsor's Decision|0|||
145412110|NCT02850406|524362190|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
145412111|NCT02850406|524362191|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
145412112|NCT02850406|524362192|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145412113|NCT02850406|524362193|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145412114|NCT02850406|524362194|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145412115|NCT02850406|524362195|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
145412116|NCT02850406|524362188|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412117|NCT02850406|524362189|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412118|NCT02850406|524362190|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
145412119|NCT02850406|524362191|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412120|NCT02850406|524362192|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412121|NCT02850406|524362193|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412122|NCT02850406|524362194|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412123|NCT02850406|524362195|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
145412124|NCT02850406|524362188|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
145412125|NCT02850406|524362189|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
145412126|NCT02850406|524362190|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
145412127|NCT02850406|524362191|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
145412128|NCT02850406|524362192|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
145412129|NCT02850406|524362193|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
145412130|NCT02850406|524362194|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
145412131|NCT02850406|524362195|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
145412132|NCT02850406|524362188|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
145412133|NCT02850406|524362189|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
145412134|NCT02850406|524362190|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
145412135|NCT02850406|524362191|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
145412136|NCT02850406|524362192|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
145412137|NCT02850406|524362193|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
145571380|NCT00213148|524950194|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
145329417|NCT03502707|524056787|FG000|Overall Study|Initiated Prohibited Medication|0|||
145329418|NCT03502707|524056788|FG001|Overall Study|Initiated Prohibited Medication|0|||
145329419|NCT03502707|524056789|FG002|Overall Study|Initiated Prohibited Medication|0|||
145329420|NCT03502707|524056790|FG003|Overall Study|Initiated Prohibited Medication|0|||
145329421|NCT03502707|524056791|FG004|Overall Study|Initiated Prohibited Medication|0|||
145329422|NCT03502707|524056792|FG005|Overall Study|Initiated Prohibited Medication|0|||
145329423|NCT03502707|524056793|FG006|Overall Study|Initiated Prohibited Medication|0|||
145329424|NCT03502707|524056794|FG007|Overall Study|Initiated Prohibited Medication|0|||
145329425|NCT03502707|524056795|FG008|Overall Study|Initiated Prohibited Medication|0|||
145329426|NCT03502707|524056796|FG009|Overall Study|Initiated Prohibited Medication|0|||
145329427|NCT03502707|524056797|FG010|Overall Study|Initiated Prohibited Medication|0|||
145329428|NCT03502707|524056798|FG011|Overall Study|Initiated Prohibited Medication|0|||
145329429|NCT03502707|524056799|FG012|Overall Study|Initiated Prohibited Medication|0|||
145329430|NCT03502707|524056800|FG013|Overall Study|Initiated Prohibited Medication|0|||
145412138|NCT02850406|524362194|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
145571381|NCT00213148|524950195|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
145571382|NCT00213148|524950196|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
145329431|NCT03502707|524056801|FG014|Overall Study|Initiated Prohibited Medication|0|||
145329432|NCT03502707|524056802|FG015|Overall Study|Initiated Prohibited Medication|0|||
145412139|NCT02850406|524362195|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
145412140|NCT02850406|524362188|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412141|NCT02850406|524362189|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145571383|NCT00213148|524950192|FG000|Cycle 3 (1 Month)|Other|0|||
145329433|NCT03502707|524056803|FG016|Overall Study|Initiated Prohibited Medication|1|||
145329434|NCT03502707|524056804|FG017|Overall Study|Initiated Prohibited Medication|0|||
145412142|NCT02850406|524362190|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412143|NCT02850406|524362191|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145329435|NCT03502707|524056787|FG000|Overall Study|Other|0|||
145329436|NCT03502707|524056788|FG001|Overall Study|Other|0|||
145329437|NCT03502707|524056789|FG002|Overall Study|Other|0|||
145329438|NCT03502707|524056790|FG003|Overall Study|Other|0|||
145329439|NCT03502707|524056791|FG004|Overall Study|Other|0|||
145329440|NCT03502707|524056792|FG005|Overall Study|Other|0|||
145329441|NCT03502707|524056793|FG006|Overall Study|Other|0|||
145329442|NCT03502707|524056794|FG007|Overall Study|Other|0|||
145329443|NCT03502707|524056795|FG008|Overall Study|Other|1|||
145329444|NCT03502707|524056796|FG009|Overall Study|Other|1|||
145329445|NCT03502707|524056797|FG010|Overall Study|Other|2|||
145329446|NCT03502707|524056798|FG011|Overall Study|Other|0|||
145329447|NCT03502707|524056799|FG012|Overall Study|Other|0|||
145329448|NCT03502707|524056800|FG013|Overall Study|Other|0|||
145329449|NCT03502707|524056801|FG014|Overall Study|Other|0|||
145329450|NCT03502707|524056802|FG015|Overall Study|Other|4|||
145329451|NCT03502707|524056803|FG016|Overall Study|Other|1|||
145329452|NCT03502707|524056804|FG017|Overall Study|Other|0|||
145329453|NCT03502707|524056787|FG000|Overall Study|Randomized but not vaccinated|0|||
145329454|NCT03502707|524056788|FG001|Overall Study|Randomized but not vaccinated|0|||
145329455|NCT03502707|524056789|FG002|Overall Study|Randomized but not vaccinated|0|||
145329456|NCT03502707|524056790|FG003|Overall Study|Randomized but not vaccinated|0|||
145329457|NCT03502707|524056791|FG004|Overall Study|Randomized but not vaccinated|0|||
145329458|NCT03502707|524056792|FG005|Overall Study|Randomized but not vaccinated|0|||
145329459|NCT03502707|524056793|FG006|Overall Study|Randomized but not vaccinated|0|||
145329460|NCT03502707|524056794|FG007|Overall Study|Randomized but not vaccinated|0|||
145329461|NCT03502707|524056795|FG008|Overall Study|Randomized but not vaccinated|0|||
145329462|NCT03502707|524056796|FG009|Overall Study|Randomized but not vaccinated|0|||
145329463|NCT03502707|524056797|FG010|Overall Study|Randomized but not vaccinated|0|||
145329464|NCT03502707|524056798|FG011|Overall Study|Randomized but not vaccinated|1|||
145329465|NCT03502707|524056799|FG012|Overall Study|Randomized but not vaccinated|0|||
145329466|NCT03502707|524056800|FG013|Overall Study|Randomized but not vaccinated|0|||
145329467|NCT03502707|524056801|FG014|Overall Study|Randomized but not vaccinated|0|||
145329468|NCT03502707|524056802|FG015|Overall Study|Randomized but not vaccinated|0|||
145329469|NCT03502707|524056803|FG016|Overall Study|Randomized but not vaccinated|0|||
145329470|NCT03502707|524056804|FG017|Overall Study|Randomized but not vaccinated|1|||
145329471|NCT03340064|524056806|FG000|First Period|Adverse Event, non-fatal|2|||
145329472|NCT03340064|524056807|FG001|First Period|Adverse Event, non-fatal|0|||
145329473|NCT03340064|524056806|FG000|First Period|Lack of Efficacy|3|||
145329474|NCT03340064|524056807|FG001|First Period|Lack of Efficacy|0|||
145329475|NCT03340064|524056806|FG000|Second Period|Adverse Event, non-fatal|1|||
145329476|NCT03340064|524056807|FG001|Second Period|Adverse Event, non-fatal|1|||
145329477|NCT03340064|524056806|FG000|Second Period|Lack of Efficacy|11|||
145329478|NCT03340064|524056807|FG001|Second Period|Lack of Efficacy|0|||
145329479|NCT03340064|524056806|FG000|Second Period|Physician Decision|3|||
145329480|NCT03340064|524056807|FG001|Second Period|Physician Decision|0|||
145329481|NCT03340064|524056806|FG000|Second Period|Withdrawal by Subject|2|||
145329482|NCT03340064|524056807|FG001|Second Period|Withdrawal by Subject|1|||
145329483|NCT03340064|524056806|FG000|Second Period|Approved Drug Available For Indication|1|||
145329484|NCT03340064|524056807|FG001|Second Period|Approved Drug Available For Indication|0|||
145329485|NCT03340064|524056806|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
145329486|NCT03340064|524056807|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
145329487|NCT02221037|524056808|FG000|Overall Study|Physician Decision|0|||
145329488|NCT02221037|524056809|FG001|Overall Study|Physician Decision|0|||
145329489|NCT02221037|524056810|FG002|Overall Study|Physician Decision|1|||
145329490|NCT02221037|524056811|FG003|Overall Study|Physician Decision|0|||
145571384|NCT00213148|524950193|FG001|Cycle 3 (1 Month)|Other|0|||
145571385|NCT00213148|524950194|FG002|Cycle 3 (1 Month)|Other|1|||
145571386|NCT00213148|524950195|FG003|Cycle 3 (1 Month)|Other|1|||
145571387|NCT00213148|524950196|FG004|Cycle 3 (1 Month)|Other|0|||
145571388|NCT01574352|524950198|FG000|Overall Study|Withdrawal by Subject|6|||
145329491|NCT00062010|524056814|FG000|Overall Study|Ineligible|3|||
145329492|NCT02944383|524056815|FG000|Overall Study|Lost to Follow-up|0|||
145329493|NCT02944383|524056816|FG001|Overall Study|Lost to Follow-up|0|||
145329494|NCT02944383|524056817|FG002|Overall Study|Lost to Follow-up|1|||
145329495|NCT02944383|524056815|FG000|Overall Study|Withdrawal by Subject|1|||
145329496|NCT02944383|524056816|FG001|Overall Study|Withdrawal by Subject|0|||
145329497|NCT02944383|524056817|FG002|Overall Study|Withdrawal by Subject|0|||
145329498|NCT00852969|524056822|FG000|Overall Study|Adverse Event|0|||
145329499|NCT00852969|524056823|FG001|Overall Study|Adverse Event|1|||
145329500|NCT00852969|524056822|FG000|Overall Study|Lost to Follow-up|0|||
145329501|NCT00852969|524056823|FG001|Overall Study|Lost to Follow-up|1|||
145329502|NCT02358343|524056826|FG000|Screening Intervention|Death|0|||
145329503|NCT02358343|524056827|FG001|Screening Intervention|Death|2|||
145329504|NCT02358343|524056828|FG002|Screening Intervention|Death|0|||
145329505|NCT02358343|524056829|FG003|Screening Intervention|Death|0|||
145571389|NCT01574352|524950199|FG001|Overall Study|Withdrawal by Subject|13|||
145571390|NCT01574352|524950198|FG000|Overall Study|Injury in non-camp related sport|1|||
145329506|NCT02358343|524056830|FG004|Screening Intervention|Death|0|||
145329507|NCT02358343|524056826|FG000|Screening Intervention|Withdrawal by Subject|1|||
145329508|NCT02358343|524056827|FG001|Screening Intervention|Withdrawal by Subject|0|||
145329509|NCT02358343|524056828|FG002|Screening Intervention|Withdrawal by Subject|0|||
145329510|NCT02358343|524056829|FG003|Screening Intervention|Withdrawal by Subject|0|||
145329511|NCT02358343|524056830|FG004|Screening Intervention|Withdrawal by Subject|0|||
145329512|NCT02358343|524056826|FG000|Screening Intervention|Determined Ineligible|5|||
145329513|NCT02358343|524056827|FG001|Screening Intervention|Determined Ineligible|6|||
145329514|NCT02358343|524056828|FG002|Screening Intervention|Determined Ineligible|0|||
145329515|NCT02358343|524056829|FG003|Screening Intervention|Determined Ineligible|0|||
145329516|NCT02358343|524056830|FG004|Screening Intervention|Determined Ineligible|0|||
145329517|NCT02358343|524056826|FG000|Comparative Efficacy Trial / Observation|Death|0|||
145329518|NCT02358343|524056827|FG001|Comparative Efficacy Trial / Observation|Death|0|||
145329519|NCT02358343|524056828|FG002|Comparative Efficacy Trial / Observation|Death|2|||
145329520|NCT02358343|524056829|FG003|Comparative Efficacy Trial / Observation|Death|0|||
145329521|NCT02358343|524056830|FG004|Comparative Efficacy Trial / Observation|Death|0|||
145329522|NCT02358343|524056826|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
145329523|NCT02358343|524056827|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
145329524|NCT02358343|524056828|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145329525|NCT02358343|524056829|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145329526|NCT02358343|524056830|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
145329527|NCT02358343|524056826|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145329528|NCT02358343|524056827|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145329529|NCT02358343|524056828|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
145329530|NCT02358343|524056829|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145329531|NCT02358343|524056830|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
145329532|NCT00090610|524056833|FG000|Overall Study|Withdrawal by Subject|1|||
145329533|NCT00090610|524056834|FG001|Overall Study|Withdrawal by Subject|1|||
145329534|NCT00599521|524056837|FG000|Overall Study|Lack of Efficacy|4|||
145329535|NCT00599521|524056838|FG001|Overall Study|Lack of Efficacy|8|||
145329536|NCT00599521|524056837|FG000|Overall Study|Adverse Event|4|||
145329537|NCT00599521|524056838|FG001|Overall Study|Adverse Event|1|||
145329538|NCT00599521|524056837|FG000|Overall Study|Withdrawal by Subject|28|||
145329539|NCT00599521|524056838|FG001|Overall Study|Withdrawal by Subject|34|||
145329540|NCT00599521|524056837|FG000|Overall Study|Protocol Violation|1|||
145329541|NCT00599521|524056838|FG001|Overall Study|Protocol Violation|1|||
145329542|NCT00599521|524056837|FG000|Overall Study|Lost to Follow-up|23|||
145329543|NCT00599521|524056838|FG001|Overall Study|Lost to Follow-up|23|||
145329544|NCT00599521|524056837|FG000|Overall Study|Pregnancy|0|||
145329545|NCT00599521|524056838|FG001|Overall Study|Pregnancy|2|||
145329546|NCT00292188|524056841|FG000|Single-Blind|Adverse Event|14|||
145329547|NCT00292188|524056842|FG001|Single-Blind|Adverse Event|0|||
145329548|NCT00292188|524056843|FG002|Single-Blind|Adverse Event|0|||
145329549|NCT00292188|524056841|FG000|Single-Blind|Lack of Efficacy|2|||
145329550|NCT00292188|524056842|FG001|Single-Blind|Lack of Efficacy|0|||
145329551|NCT00292188|524056843|FG002|Single-Blind|Lack of Efficacy|0|||
145329552|NCT00292188|524056841|FG000|Single-Blind|Laboratory Abnormality|5|||
145329553|NCT00292188|524056842|FG001|Single-Blind|Laboratory Abnormality|0|||
145329554|NCT00292188|524056843|FG002|Single-Blind|Laboratory Abnormality|0|||
145329555|NCT00292188|524056841|FG000|Single-Blind|Lost to Follow-up|3|||
145329556|NCT00292188|524056842|FG001|Single-Blind|Lost to Follow-up|0|||
145329557|NCT00292188|524056843|FG002|Single-Blind|Lost to Follow-up|0|||
145329558|NCT00292188|524056841|FG000|Single-Blind|Other|77|||
145329559|NCT00292188|524056842|FG001|Single-Blind|Other|0|||
145329560|NCT00292188|524056843|FG002|Single-Blind|Other|0|||
145329561|NCT00292188|524056841|FG000|Single-Blind|Withdrawal by Subject|12|||
145329562|NCT00292188|524056842|FG001|Single-Blind|Withdrawal by Subject|0|||
145329563|NCT00292188|524056843|FG002|Single-Blind|Withdrawal by Subject|0|||
145329564|NCT00292188|524056841|FG000|Single-Blind|Did not receive treatment|1|||
145329565|NCT00292188|524056842|FG001|Single-Blind|Did not receive treatment|0|||
145329566|NCT00292188|524056843|FG002|Single-Blind|Did not receive treatment|0|||
145329567|NCT00292188|524056841|FG000|Double-Blind|Adverse Event|0|||
145329568|NCT00292188|524056842|FG001|Double-Blind|Adverse Event|25|||
145329569|NCT00292188|524056843|FG002|Double-Blind|Adverse Event|9|||
145329570|NCT00292188|524056841|FG000|Double-Blind|Lack of Efficacy|0|||
145329571|NCT00292188|524056842|FG001|Double-Blind|Lack of Efficacy|2|||
145329572|NCT00292188|524056843|FG002|Double-Blind|Lack of Efficacy|12|||
145329573|NCT00292188|524056841|FG000|Double-Blind|Lost to Follow-up|0|||
145329574|NCT00292188|524056842|FG001|Double-Blind|Lost to Follow-up|1|||
145329575|NCT00292188|524056843|FG002|Double-Blind|Lost to Follow-up|0|||
145329576|NCT00292188|524056841|FG000|Double-Blind|Other|0|||
145329577|NCT00292188|524056842|FG001|Double-Blind|Other|3|||
145329578|NCT00292188|524056843|FG002|Double-Blind|Other|4|||
145329579|NCT00292188|524056841|FG000|Double-Blind|Withdrawal by Subject|0|||
145329580|NCT00292188|524056842|FG001|Double-Blind|Withdrawal by Subject|0|||
145329581|NCT00292188|524056843|FG002|Double-Blind|Withdrawal by Subject|3|||
145329582|NCT00292188|524056841|FG000|Double-Blind|Laboratory Abnormality|0|||
145329583|NCT00292188|524056842|FG001|Double-Blind|Laboratory Abnormality|0|||
145329584|NCT00292188|524056843|FG002|Double-Blind|Laboratory Abnormality|1|||
145329585|NCT04322149|524056844|FG000|Overall Study|Adverse Event|1|||
145329586|NCT04322149|524056845|FG001|Overall Study|Adverse Event|1|||
145329587|NCT04322149|524056846|FG002|Overall Study|Adverse Event|0|||
145329588|NCT04322149|524056847|FG003|Overall Study|Adverse Event|0|||
145329589|NCT04322149|524056844|FG000|Overall Study|Withdrawal by Subject|0|||
145329590|NCT04322149|524056845|FG001|Overall Study|Withdrawal by Subject|0|||
145329591|NCT04322149|524056846|FG002|Overall Study|Withdrawal by Subject|0|||
145329592|NCT04322149|524056847|FG003|Overall Study|Withdrawal by Subject|2|||
145329593|NCT04322149|524056844|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145329594|NCT04322149|524056845|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
145329595|NCT04322149|524056846|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145329596|NCT04322149|524056847|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
145329597|NCT01700049|524056854|FG000|Overall Study|Withdrawal by Subject|1|||
145329598|NCT03084367|524056857|FG000|Overall Study|Lost to Follow-up|32|||
145329599|NCT03084367|524056857|FG000|Overall Study|Withdrawal by Subject|4|||
145329600|NCT03084367|524056857|FG000|Overall Study|Other|1|||
145329601|NCT01206101|524056858|FG000|Overall Study|Adverse Event|1|||
145329602|NCT01206101|524056859|FG001|Overall Study|Adverse Event|0|||
145329603|NCT01206101|524056858|FG000|Overall Study|Physician Decision|0|||
145329604|NCT01206101|524056859|FG001|Overall Study|Physician Decision|1|||
145329605|NCT01206101|524056858|FG000|Overall Study|Unclassified|1|||
145329606|NCT01206101|524056859|FG001|Overall Study|Unclassified|0|||
145329607|NCT04709835|524056862|FG000|Overall Study|Withdrawal by Subject|0|||
145329608|NCT04709835|524056863|FG001|Overall Study|Withdrawal by Subject|1|||
145329609|NCT04709835|524056864|FG002|Overall Study|Withdrawal by Subject|0|||
145329610|NCT01859130|524056865|FG000|Overall Study|Death|4|||
145329611|NCT01859130|524056865|FG000|Overall Study|Lost to Follow-up|16|||
145329612|NCT01859130|524056865|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
145329613|NCT01859130|524056865|FG000|Overall Study|Physician Decision|6|||
145329614|NCT01859130|524056865|FG000|Overall Study|Withdrawal by Subject|17|||
145329615|NCT01859130|524056865|FG000|Overall Study|Adverse Event|11|||
145329616|NCT04325204|524056866|FG000|Overall Study|Death|0|||
145329617|NCT04325204|524056867|FG001|Overall Study|Death|1|||
145329618|NCT04325204|524056866|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
145329619|NCT04325204|524056867|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
145329620|NCT04325204|524056866|FG000|Overall Study|Lost to Follow-up|8|||
145329621|NCT04325204|524056867|FG001|Overall Study|Lost to Follow-up|8|||
145329622|NCT04325204|524056866|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
145329623|NCT04325204|524056867|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
145329624|NCT00103311|524056873|FG000|Overall Study|Lost to Follow-up|1|||
145329625|NCT00103311|524056874|FG001|Overall Study|Lost to Follow-up|0|||
145329626|NCT00103311|524056873|FG000|Overall Study|Withdrawal by Subject|2|||
145329627|NCT00103311|524056874|FG001|Overall Study|Withdrawal by Subject|1|||
145329628|NCT00103311|524056873|FG000|Overall Study|Adverse Event|1|||
145329629|NCT00103311|524056874|FG001|Overall Study|Adverse Event|0|||
145329630|NCT00912093|524056875|FG000|The Controlled Phase|Death|0|||
145329631|NCT00912093|524056876|FG001|The Controlled Phase|Death|1|||
145329632|NCT00912093|524056877|FG002|The Controlled Phase|Death|0|||
145329633|NCT00912093|524056878|FG003|The Controlled Phase|Death|0|||
145329634|NCT00912093|524056879|FG004|The Controlled Phase|Death|0|||
145329635|NCT00912093|524056875|FG000|The Controlled Phase|Medical Condition|0|||
145329636|NCT00912093|524056876|FG001|The Controlled Phase|Medical Condition|1|||
145329637|NCT00912093|524056877|FG002|The Controlled Phase|Medical Condition|0|||
145329638|NCT00912093|524056878|FG003|The Controlled Phase|Medical Condition|0|||
145329639|NCT00912093|524056879|FG004|The Controlled Phase|Medical Condition|0|||
145329640|NCT00912093|524056875|FG000|The Controlled Phase|Lost to Follow-up|0|||
145329641|NCT00912093|524056876|FG001|The Controlled Phase|Lost to Follow-up|0|||
145329642|NCT00912093|524056877|FG002|The Controlled Phase|Lost to Follow-up|0|||
145329643|NCT00912093|524056878|FG003|The Controlled Phase|Lost to Follow-up|0|||
145329644|NCT00912093|524056879|FG004|The Controlled Phase|Lost to Follow-up|1|||
145329645|NCT03827564|524056880|FG000|Overall Study|Discontinued due to Study Termination|1|||
145329646|NCT03827564|524056881|FG001|Overall Study|Discontinued due to Study Termination|0|||
145329647|NCT00270257|524056884|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
145329648|NCT00270257|524056885|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
145329649|NCT01195103|524056886|FG000|Overall Study|Withdrawal by Subject|1|||
145329650|NCT01195103|524056887|FG001|Overall Study|Withdrawal by Subject|0|||
145329651|NCT01195103|524056888|FG002|Overall Study|Withdrawal by Subject|0|||
145329652|NCT02621034|524056889|FG000|Overall Study|Lost to Follow-up|3|||
145412144|NCT02850406|524362192|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
145412145|NCT02850406|524362193|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
145412146|NCT02850406|524362194|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412147|NCT02850406|524362195|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412148|NCT02850406|524362188|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412149|NCT02850406|524362189|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412150|NCT02850406|524362190|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412151|NCT02850406|524362191|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412152|NCT02850406|524362192|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
145329653|NCT02621034|524056890|FG001|Overall Study|Lost to Follow-up|2|||
145329654|NCT02621034|524056891|FG002|Overall Study|Lost to Follow-up|5|||
145329655|NCT00450619|524056902|FG000|Overall Study|refused treatment after randomization|2|||
145329656|NCT00450619|524056903|FG001|Overall Study|refused treatment after randomization|0|||
145329657|NCT00450619|524056902|FG000|Overall Study|did not progress; refused further trmt|1|||
145329658|NCT00450619|524056903|FG001|Overall Study|did not progress; refused further trmt|1|||
145329659|NCT00450619|524056902|FG000|Overall Study|Adverse Event|1|||
145329660|NCT00450619|524056903|FG001|Overall Study|Adverse Event|0|||
145329661|NCT02034058|524056904|FG000|Overall Study|Death|3|||
145329662|NCT03254602|524056905|FG000|Overall Study|Lost to Follow-up|4|||
145329663|NCT02963311|524056908|FG000|Overall Study|Withdrawal by Subject|1|||
145329664|NCT02963311|524056908|FG000|Overall Study|Screen Failure|4|||
145329665|NCT04442490|524056909|FG000|Overall Study|Withdrawal by Subject|18|||
145329666|NCT04442490|524056910|FG001|Overall Study|Withdrawal by Subject|10|||
145329667|NCT04442490|524056909|FG000|Overall Study|Lost to Follow-up|7|||
145329668|NCT04442490|524056910|FG001|Overall Study|Lost to Follow-up|7|||
145329669|NCT04442490|524056909|FG000|Overall Study|Adverse Event|2|||
145329670|NCT04442490|524056910|FG001|Overall Study|Adverse Event|6|||
145329671|NCT04442490|524056909|FG000|Overall Study|Noncompliance|3|||
145329672|NCT04442490|524056910|FG001|Overall Study|Noncompliance|1|||
145329673|NCT04442490|524056909|FG000|Overall Study|Physician Decision|2|||
145329674|NCT04442490|524056910|FG001|Overall Study|Physician Decision|1|||
145329675|NCT04442490|524056909|FG000|Overall Study|Reason not Specified|2|||
145329676|NCT04442490|524056910|FG001|Overall Study|Reason not Specified|1|||
145329677|NCT04442490|524056909|FG000|Overall Study|Randomized but not Treated|3|||
145329678|NCT04442490|524056910|FG001|Overall Study|Randomized but not Treated|3|||
145329679|NCT02372071|524056911|FG000|Overall Study|Protocol Violation|18|||
145329680|NCT01449279|524056912|FG000|Overall Study|Lack of Efficacy|5|||
145329681|NCT01449279|524056912|FG000|Overall Study|Toxicity|2|||
145329682|NCT01936623|524056917|FG000|Overall Study|Lost to Follow-up|0|||
145329683|NCT01936623|524056918|FG001|Overall Study|Lost to Follow-up|5|||
145329684|NCT02575911|524056919|FG000|Overall Study|Lost to Follow-up|1|||
145329685|NCT03579966|524056920|FG000|Overall Study|Adverse Event|6|||
145329686|NCT03579966|524056920|FG000|Overall Study|Lost to Follow-up|4|||
145329687|NCT03579966|524056920|FG000|Overall Study|Physician Decision|10|||
145329688|NCT03579966|524056920|FG000|Overall Study|Pregnancy|1|||
145329689|NCT03579966|524056920|FG000|Overall Study|Withdrawal by Subject|16|||
145329690|NCT03579966|524056920|FG000|Overall Study|Study terminated by Sponsor|22|||
145329691|NCT03579966|524056920|FG000|Overall Study|Protocol Violation|1|||
145329692|NCT01249365|524056921|FG000|Overall Study|Lost to Follow-up|1|||
145329693|NCT01340768|524056922|FG000|Overall Study|Lost to Follow-up|10|||
145329694|NCT01340768|524056923|FG001|Overall Study|Lost to Follow-up|4|||
145329695|NCT01340768|524056922|FG000|Overall Study|Withdrawal by Subject|5|||
145329696|NCT01340768|524056923|FG001|Overall Study|Withdrawal by Subject|1|||
145329697|NCT01340768|524056922|FG000|Overall Study|Other|2|||
145329698|NCT01340768|524056923|FG001|Overall Study|Other|0|||
145329699|NCT03052959|524056924|FG000|Overall Study|Lost to Follow-up|4|||
145329700|NCT03052959|524056925|FG001|Overall Study|Lost to Follow-up|5|||
145329701|NCT03551496|524056926|FG000|Overall Study|Death|11|||
145329702|NCT03551496|524056927|FG001|Overall Study|Death|7|||
145329703|NCT03551496|524056926|FG000|Overall Study|Withdrawal by Subject|4|||
145329704|NCT03551496|524056927|FG001|Overall Study|Withdrawal by Subject|3|||
145329705|NCT03551496|524056926|FG000|Overall Study|Other Reasons|1|||
145412153|NCT02850406|524362193|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412154|NCT02850406|524362194|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412155|NCT02850406|524362195|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
145412156|NCT02850406|524362188|FG000|Part C (Up to 52 Weeks)|Other|0|||
145412157|NCT02850406|524362189|FG001|Part C (Up to 52 Weeks)|Other|0|||
145329706|NCT03551496|524056927|FG001|Overall Study|Other Reasons|0|||
145329707|NCT00801099|524056928|FG000|Overall Study|Lost to Follow-up|101|||
145329708|NCT00950963|524056929|FG000|Overall Study|Lost to Follow-up|29|||
145329709|NCT00950963|524056930|FG001|Overall Study|Lost to Follow-up|24|||
145329710|NCT01675661|524056931|FG000|Overall Study|Lost to Follow-up|22|||
145329711|NCT01675661|524056932|FG001|Overall Study|Lost to Follow-up|23|||
145329712|NCT01675661|524056931|FG000|Overall Study|Practical problems|9|||
145329713|NCT01675661|524056932|FG001|Overall Study|Practical problems|5|||
145329714|NCT01675661|524056931|FG000|Overall Study|Moved away|5|||
145329715|NCT01675661|524056932|FG001|Overall Study|Moved away|6|||
145329716|NCT01675661|524056931|FG000|Overall Study|Withdrawal by Subject|3|||
145329717|NCT01675661|524056932|FG001|Overall Study|Withdrawal by Subject|7|||
145329718|NCT01675661|524056931|FG000|Overall Study|Physician Decision|0|||
145329719|NCT01675661|524056932|FG001|Overall Study|Physician Decision|2|||
145329720|NCT01675661|524056931|FG000|Overall Study|Death|0|||
145329721|NCT01675661|524056932|FG001|Overall Study|Death|1|||
145329722|NCT01675661|524056931|FG000|Overall Study|Other reason|1|||
145329723|NCT01675661|524056932|FG001|Overall Study|Other reason|2|||
145329724|NCT01006135|524056935|FG000|Overall Study|Adverse Event|22|||
145329725|NCT01006135|524056935|FG000|Overall Study|Protocol Violation|14|||
145329726|NCT01006135|524056935|FG000|Overall Study|Lost to Follow-up|32|||
145329727|NCT01006135|524056935|FG000|Overall Study|Other|72|||
145329728|NCT01732484|524056937|FG000|Overall Study|Death|7|||
145329729|NCT01732484|524056937|FG000|Overall Study|Lost to Follow-up|14|||
145329730|NCT01732484|524056937|FG000|Overall Study|chronical illness|5|||
145329731|NCT00928707|524056945|FG000|Overall Study|Protocol Violation|1|||
145329732|NCT00928707|524056946|FG001|Overall Study|Protocol Violation|0|||
145329733|NCT00132028|524056947|FG000|Overall Study|Adverse Event|7|||
145329734|NCT00132028|524056947|FG000|Overall Study|Death|2|||
145329735|NCT00132028|524056947|FG000|Overall Study|Lack of Efficacy|11|||
145329736|NCT00132028|524056947|FG000|Overall Study|Withdrawal by Subject|2|||
145329737|NCT00132028|524056947|FG000|Overall Study|not eligible|2|||
145329738|NCT00132028|524056947|FG000|Overall Study|Physician Decision|3|||
145329739|NCT02140411|524056948|FG000|Overall Study|Adverse Event|1|||
145329740|NCT06077487|524059633|FG000|Overall Study|Withdrawal by Subject|0|||
145329741|NCT06077487|524059634|FG001|Overall Study|Withdrawal by Subject|1|||
145329742|NCT04905290|524059635|FG000|Overall Study|Adverse Event|4|||
145329743|NCT04905290|524059635|FG000|Overall Study|Death|2|||
145329744|NCT04905290|524059635|FG000|Overall Study|Withdrawal by Subject|4|||
145329745|NCT04905290|524059635|FG000|Overall Study|Physician Decision|2|||
145329746|NCT04905290|524059635|FG000|Overall Study|Lost to Follow-up|2|||
145329747|NCT04905290|524059635|FG000|Overall Study|Screen Failure|2|||
145329748|NCT04905290|524059635|FG000|Overall Study|Unsuccessful Procedure|2|||
145329749|NCT05101486|524059636|FG000|Overall Study|Death|1|||
145329750|NCT05101486|524059637|FG001|Overall Study|Death|0|||
145329751|NCT05101486|524059638|FG002|Overall Study|Death|1|||
145329752|NCT05101486|524059636|FG000|Overall Study|Lost to Follow-up|12|||
145329753|NCT05101486|524059637|FG001|Overall Study|Lost to Follow-up|8|||
145329754|NCT05101486|524059638|FG002|Overall Study|Lost to Follow-up|17|||
145329755|NCT05101486|524059636|FG000|Overall Study|Physician Decision|1|||
145329756|NCT05101486|524059637|FG001|Overall Study|Physician Decision|0|||
145329757|NCT05101486|524059638|FG002|Overall Study|Physician Decision|0|||
145329758|NCT05101486|524059636|FG000|Overall Study|Protocol Violation|0|||
145329759|NCT05101486|524059637|FG001|Overall Study|Protocol Violation|0|||
145329760|NCT05101486|524059638|FG002|Overall Study|Protocol Violation|1|||
145329761|NCT05101486|524059636|FG000|Overall Study|Withdrawal by Subject|5|||
145329762|NCT05101486|524059637|FG001|Overall Study|Withdrawal by Subject|2|||
145329763|NCT05101486|524059638|FG002|Overall Study|Withdrawal by Subject|4|||
145329764|NCT05101486|524059636|FG000|Overall Study|Randomized but not vaccinated|1|||
145329765|NCT05101486|524059637|FG001|Overall Study|Randomized but not vaccinated|1|||
145329766|NCT05101486|524059638|FG002|Overall Study|Randomized but not vaccinated|1|||
145329767|NCT03295318|524059639|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
145329768|NCT03295318|524059640|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
145329769|NCT03295318|524059641|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
145329770|NCT03295318|524059639|FG000|Overall Study|Death|1|||
145329771|NCT03295318|524059640|FG001|Overall Study|Death|1|||
145329772|NCT03295318|524059641|FG002|Overall Study|Death|1|||
145329773|NCT03295318|524059639|FG000|Overall Study|Protocol Violation|4|||
145329774|NCT03295318|524059640|FG001|Overall Study|Protocol Violation|3|||
145329775|NCT03295318|524059641|FG002|Overall Study|Protocol Violation|3|||
145571391|NCT01574352|524950199|FG001|Overall Study|Injury in non-camp related sport|0|||
145571392|NCT00245765|524950200|FG000|Overall Study|Adverse Event|1|||
145329776|NCT03295318|524059639|FG000|Overall Study|Withdrawal by Subject|0|||
145329777|NCT03295318|524059640|FG001|Overall Study|Withdrawal by Subject|0|||
145329778|NCT03295318|524059641|FG002|Overall Study|Withdrawal by Subject|1|||
145329779|NCT03295318|524059639|FG000|Overall Study|Subject discontinued due to travel|0|||
145329780|NCT03295318|524059640|FG001|Overall Study|Subject discontinued due to travel|1|||
145329781|NCT03295318|524059641|FG002|Overall Study|Subject discontinued due to travel|0|||
145329782|NCT03747601|524059642|FG000|Overall Study|COVID halt to visits|4|||
145329783|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
145329784|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
145329785|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
145329786|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
145329787|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
145329788|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
145329789|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
145329790|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
145329791|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
145571393|NCT00245765|524950201|FG001|Overall Study|Adverse Event|1|||
145329792|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
145329793|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
145329794|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
145329795|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
145329796|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
145329797|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
145329798|NCT02788045|524059643|FG000|Main Study (Up to Week 72)|Other|3|||
145329799|NCT02788045|524059644|FG001|Main Study (Up to Week 72)|Other|0|||
145329800|NCT02788045|524059645|FG002|Main Study (Up to Week 72)|Other|0|||
145329801|NCT02788045|524059643|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
145329802|NCT02788045|524059644|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
145329803|NCT02788045|524059645|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
145329804|NCT02788045|524059643|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
145329805|NCT02788045|524059644|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
145329806|NCT02788045|524059645|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
145329807|NCT02788045|524059643|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
145329808|NCT02788045|524059644|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
145571394|NCT00245765|524950202|FG002|Overall Study|Adverse Event|0|||
145571395|NCT00245765|524950200|FG000|Overall Study|Lack of Efficacy|14|||
145571396|NCT00245765|524950201|FG001|Overall Study|Lack of Efficacy|7|||
145571397|NCT00245765|524950202|FG002|Overall Study|Lack of Efficacy|0|||
145571398|NCT00245765|524950200|FG000|Overall Study|Lost to Follow-up|1|||
145571399|NCT00245765|524950201|FG001|Overall Study|Lost to Follow-up|2|||
145571400|NCT00245765|524950202|FG002|Overall Study|Lost to Follow-up|0|||
145571401|NCT00245765|524950200|FG000|Overall Study|Withdrawal by Subject|1|||
145571402|NCT00245765|524950201|FG001|Overall Study|Withdrawal by Subject|0|||
145571403|NCT00245765|524950202|FG002|Overall Study|Withdrawal by Subject|3|||
145571404|NCT00245765|524950200|FG000|Overall Study|Other reason|2|||
145571405|NCT00245765|524950201|FG001|Overall Study|Other reason|0|||
145571406|NCT00245765|524950202|FG002|Overall Study|Other reason|1|||
145571407|NCT00245765|524950200|FG000|Overall Study|Other|13|||
145571408|NCT00245765|524950201|FG001|Overall Study|Other|4|||
145571409|NCT00245765|524950202|FG002|Overall Study|Other|4|||
145571410|NCT03080961|524950203|FG000|Overall Study|Withdrawal by Subject|3|||
145571411|NCT02741115|524950204|FG000|Overall Study|Adverse Event|1|||
145571412|NCT02741115|524950205|FG001|Overall Study|Adverse Event|0|||
145571413|NCT02741115|524950204|FG000|Overall Study|Lost to Follow-up|7|||
145571414|NCT02741115|524950205|FG001|Overall Study|Lost to Follow-up|4|||
145571415|NCT02741115|524950204|FG000|Overall Study|Withdrawal by Subject|4|||
145571416|NCT02741115|524950205|FG001|Overall Study|Withdrawal by Subject|2|||
145571417|NCT04602624|524950206|FG000|Overall Study|Protocol Deviation|1|||
145571418|NCT04602624|524950206|FG000|Overall Study|Withdrawal by Participant|1|||
145571419|NCT06425458|524950207|FG000|Overall Study|Removed by study team|2|||
145571420|NCT06425458|524950207|FG000|Overall Study|Lost to Follow-up|5|||
145571421|NCT03945981|524950210|FG000|Overall Study|Lost to Follow-up|12|||
145571422|NCT03945981|524950210|FG000|Overall Study|Physician Decision|4|||
145571423|NCT03945981|524950210|FG000|Overall Study|Withdrawal by Subject|6|||
145571424|NCT03945981|524950210|FG000|Overall Study|Protocol Violation|1|||
145571425|NCT00326612|524951648|FG000|Overall Study|They did not have a seizure requiring tx|129|||
145571426|NCT00326612|524951649|FG001|Overall Study|They did not have a seizure requiring tx|137|||
145571427|NCT00419562|524951650|FG000|Overall Study|Lost to Follow-up|12|||
145571428|NCT00419562|524951651|FG001|Overall Study|Lost to Follow-up|13|||
145571429|NCT00419562|524951650|FG000|Overall Study|Withdrawal by Subject|20|||
145571430|NCT00419562|524951651|FG001|Overall Study|Withdrawal by Subject|18|||
145571431|NCT00419562|524951650|FG000|Overall Study|Participant Institutionalized|1|||
145571432|NCT00419562|524951651|FG001|Overall Study|Participant Institutionalized|0|||
145571433|NCT00640510|524951652|FG000|Overall Study|Lack of Efficacy|0|||
145571434|NCT00640510|524951653|FG001|Overall Study|Lack of Efficacy|1|||
145571435|NCT00640510|524951652|FG000|Overall Study|Protocol Violation|1|||
145571436|NCT00640510|524951653|FG001|Overall Study|Protocol Violation|0|||
145571437|NCT00640510|524951652|FG000|Overall Study|Physician Decision|0|||
145571438|NCT00640510|524951653|FG001|Overall Study|Physician Decision|1|||
145571439|NCT00779675|524951654|FG000|Treatment Period|Adverse Event|87|||
145571440|NCT00779675|524951654|FG000|Treatment Period|Treatment Failure|80|||
145571441|NCT00779675|524951654|FG000|Treatment Period|Transferred to Another Study|38|||
145571442|NCT00779675|524951654|FG000|Treatment Period|Lost to Follow-up|23|||
145571443|NCT00779675|524951654|FG000|Treatment Period|Withdrawal by Subject|46|||
145571444|NCT00779675|524951654|FG000|Treatment Period|Protocol Violation|54|||
145571445|NCT00779675|524951654|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
145571446|NCT00779675|524951654|FG000|Treatment Period|Administrative|3|||
145571447|NCT00779675|524951654|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
145571448|NCT00779675|524951654|FG000|Extended Treatment Period|Protocol Violation|13|||
145571449|NCT00779675|524951654|FG000|Extended Treatment Period|Adverse Event|6|||
145571450|NCT00779675|524951654|FG000|Extended Treatment Period|Treatment Failure|11|||
145620727|NCT02325713|525125182|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
145329809|NCT02788045|524059645|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
145329810|NCT00678041|524059649|FG000|Overall Study|Physician Decision|5|||
145329811|NCT00678041|524059650|FG001|Overall Study|Physician Decision|5|||
145329812|NCT00807248|524059651|FG000|Overall Study|Adverse Event|1|||
145329813|NCT00807248|524059652|FG001|Overall Study|Adverse Event|2|||
145329814|NCT00807248|524059653|FG002|Overall Study|Adverse Event|2|||
145329815|NCT00807248|524059654|FG003|Overall Study|Adverse Event|6|||
145329816|NCT00807248|524059651|FG000|Overall Study|Lack of Efficacy|14|||
145329817|NCT00807248|524059652|FG001|Overall Study|Lack of Efficacy|4|||
145329818|NCT00807248|524059653|FG002|Overall Study|Lack of Efficacy|8|||
145329819|NCT00807248|524059654|FG003|Overall Study|Lack of Efficacy|3|||
145329820|NCT00807248|524059651|FG000|Overall Study|Protocol Violation|0|||
145329821|NCT00807248|524059652|FG001|Overall Study|Protocol Violation|1|||
145329822|NCT00807248|524059653|FG002|Overall Study|Protocol Violation|1|||
145329823|NCT00807248|524059654|FG003|Overall Study|Protocol Violation|0|||
145329824|NCT00807248|524059651|FG000|Overall Study|Withdrawal of Consent|5|||
145329825|NCT00807248|524059652|FG001|Overall Study|Withdrawal of Consent|5|||
145329826|NCT00807248|524059653|FG002|Overall Study|Withdrawal of Consent|5|||
145329827|NCT00807248|524059654|FG003|Overall Study|Withdrawal of Consent|5|||
145329828|NCT00807248|524059651|FG000|Overall Study|Lost to Follow-up|1|||
145329829|NCT00807248|524059652|FG001|Overall Study|Lost to Follow-up|0|||
145329830|NCT00807248|524059653|FG002|Overall Study|Lost to Follow-up|0|||
145329831|NCT00807248|524059654|FG003|Overall Study|Lost to Follow-up|0|||
145329832|NCT00807248|524059651|FG000|Overall Study|Other Reason|0|||
145329833|NCT00807248|524059652|FG001|Overall Study|Other Reason|0|||
145329834|NCT00807248|524059653|FG002|Overall Study|Other Reason|2|||
145329835|NCT00807248|524059654|FG003|Overall Study|Other Reason|0|||
145329836|NCT02444793|524059655|FG000|Overall Study|Lost to Follow-up|2|||
145412158|NCT02850406|524362190|FG002|Part C (Up to 52 Weeks)|Other|0|||
145412159|NCT02850406|524362191|FG003|Part C (Up to 52 Weeks)|Other|0|||
145412160|NCT02850406|524362192|FG004|Part C (Up to 52 Weeks)|Other|1|||
145412161|NCT02850406|524362193|FG005|Part C (Up to 52 Weeks)|Other|3|||
145412162|NCT02850406|524362194|FG006|Part C (Up to 52 Weeks)|Other|0|||
145412163|NCT02850406|524362195|FG007|Part C (Up to 52 Weeks)|Other|0|||
145412164|NCT02850406|524362188|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
145412165|NCT02850406|524362189|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
145412166|NCT02850406|524362190|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
145329837|NCT02444793|524059656|FG001|Overall Study|Lost to Follow-up|2|||
145329838|NCT02444793|524059657|FG002|Overall Study|Lost to Follow-up|0|||
145329839|NCT02444793|524059658|FG003|Overall Study|Lost to Follow-up|0|||
145329840|NCT02444793|524059655|FG000|Overall Study|Death|0|||
145329841|NCT02444793|524059656|FG001|Overall Study|Death|3|||
145329842|NCT02444793|524059657|FG002|Overall Study|Death|0|||
145329843|NCT02444793|524059658|FG003|Overall Study|Death|0|||
145329844|NCT02444793|524059655|FG000|Overall Study|Other|0|||
145329845|NCT02444793|524059656|FG001|Overall Study|Other|0|||
145329846|NCT02444793|524059657|FG002|Overall Study|Other|2|||
145329847|NCT02444793|524059658|FG003|Overall Study|Other|0|||
145329848|NCT02444793|524059655|FG000|Overall Study|Objective progression or relapse|9|||
145329849|NCT02444793|524059656|FG001|Overall Study|Objective progression or relapse|1|||
145329850|NCT02444793|524059657|FG002|Overall Study|Objective progression or relapse|2|||
145329851|NCT02444793|524059658|FG003|Overall Study|Objective progression or relapse|3|||
145329852|NCT02504671|524059662|FG000|Overall Study|Withdrawal by Subject|1|||
145329853|NCT02504671|524059663|FG001|Overall Study|Withdrawal by Subject|5|||
145329854|NCT02504671|524059664|FG002|Overall Study|Withdrawal by Subject|4|||
145329855|NCT02504671|524059665|FG003|Overall Study|Withdrawal by Subject|4|||
145329856|NCT02504671|524059666|FG004|Overall Study|Withdrawal by Subject|5|||
145329857|NCT02504671|524059667|FG005|Overall Study|Withdrawal by Subject|3|||
145329858|NCT02504671|524059662|FG000|Overall Study|Lack of Efficacy|1|||
145329859|NCT02504671|524059663|FG001|Overall Study|Lack of Efficacy|3|||
145329860|NCT02504671|524059664|FG002|Overall Study|Lack of Efficacy|1|||
145329861|NCT02504671|524059665|FG003|Overall Study|Lack of Efficacy|0|||
145329862|NCT02504671|524059666|FG004|Overall Study|Lack of Efficacy|4|||
145329863|NCT02504671|524059667|FG005|Overall Study|Lack of Efficacy|4|||
145329864|NCT02504671|524059662|FG000|Overall Study|Adverse Event|1|||
145329865|NCT02504671|524059663|FG001|Overall Study|Adverse Event|1|||
145329866|NCT02504671|524059664|FG002|Overall Study|Adverse Event|0|||
145329867|NCT02504671|524059665|FG003|Overall Study|Adverse Event|1|||
145412167|NCT02850406|524362191|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
145329868|NCT02504671|524059666|FG004|Overall Study|Adverse Event|0|||
145329869|NCT02504671|524059667|FG005|Overall Study|Adverse Event|2|||
145329870|NCT02504671|524059662|FG000|Overall Study|Protocol Violation|2|||
145329871|NCT02504671|524059663|FG001|Overall Study|Protocol Violation|1|||
145329872|NCT02504671|524059664|FG002|Overall Study|Protocol Violation|0|||
145412168|NCT02850406|524362192|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
145412169|NCT02850406|524362193|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
145329873|NCT02504671|524059665|FG003|Overall Study|Protocol Violation|0|||
145329874|NCT02504671|524059666|FG004|Overall Study|Protocol Violation|0|||
145412170|NCT02850406|524362194|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
145329875|NCT02504671|524059667|FG005|Overall Study|Protocol Violation|1|||
145620728|NCT02325713|525125167|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620729|NCT02325713|525125168|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620730|NCT02325713|525125169|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620731|NCT02325713|525125170|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620732|NCT02325713|525125171|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620733|NCT02325713|525125172|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620734|NCT02325713|525125173|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620735|NCT02325713|525125174|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620736|NCT02325713|525125175|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620737|NCT02325713|525125176|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
145620738|NCT02325713|525125177|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620739|NCT02325713|525125178|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620740|NCT02325713|525125179|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620741|NCT02325713|525125180|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620742|NCT02325713|525125181|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620743|NCT02325713|525125182|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
145620744|NCT01213173|525125183|FG000|Overall Study|Protocol Violation|2|||
145620745|NCT01213173|525125184|FG001|Overall Study|Protocol Violation|0|||
145620746|NCT01213173|525125183|FG000|Overall Study|Adverse Event|4|||
145620747|NCT01213173|525125184|FG001|Overall Study|Adverse Event|8|||
145620748|NCT01213173|525125183|FG000|Overall Study|Withdrawal by Subject|5|||
145620749|NCT01213173|525125184|FG001|Overall Study|Withdrawal by Subject|5|||
145620750|NCT01213173|525125183|FG000|Overall Study|Incorrect Enrollment|1|||
145620751|NCT01213173|525125184|FG001|Overall Study|Incorrect Enrollment|3|||
145620752|NCT02253316|525125185|FG000|Consolidation|Progression|4|||
145620753|NCT02253316|525125186|FG001|Consolidation|Progression|0|||
145620754|NCT02253316|525125187|FG002|Consolidation|Progression|0|||
145620755|NCT02253316|525125185|FG000|Consolidation|Non-Compliance|1|||
145620756|NCT02253316|525125186|FG001|Consolidation|Non-Compliance|0|||
145620757|NCT02253316|525125187|FG002|Consolidation|Non-Compliance|0|||
145620758|NCT02253316|525125185|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
145620759|NCT02253316|525125186|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
145620760|NCT02253316|525125187|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
145620761|NCT02253316|525125185|FG000|Consolidation|Secondary Malignancy|2|||
145620762|NCT02253316|525125186|FG001|Consolidation|Secondary Malignancy|0|||
145620763|NCT02253316|525125187|FG002|Consolidation|Secondary Malignancy|0|||
145620764|NCT02253316|525125185|FG000|Consolidation|Adverse Event|7|||
145620765|NCT02253316|525125186|FG001|Consolidation|Adverse Event|0|||
145329876|NCT02504671|524059662|FG000|Overall Study|Lost to Follow-up|0|||
145329877|NCT02504671|524059663|FG001|Overall Study|Lost to Follow-up|0|||
145329878|NCT02504671|524059664|FG002|Overall Study|Lost to Follow-up|2|||
145329879|NCT02504671|524059665|FG003|Overall Study|Lost to Follow-up|0|||
145329880|NCT02504671|524059666|FG004|Overall Study|Lost to Follow-up|0|||
145329881|NCT02504671|524059667|FG005|Overall Study|Lost to Follow-up|1|||
145329882|NCT02504671|524059662|FG000|Overall Study|Protocol defined stopping criteria|7|||
145329883|NCT02504671|524059663|FG001|Overall Study|Protocol defined stopping criteria|4|||
145329884|NCT02504671|524059664|FG002|Overall Study|Protocol defined stopping criteria|3|||
145329885|NCT02504671|524059665|FG003|Overall Study|Protocol defined stopping criteria|5|||
145329886|NCT02504671|524059666|FG004|Overall Study|Protocol defined stopping criteria|3|||
145329887|NCT02504671|524059667|FG005|Overall Study|Protocol defined stopping criteria|3|||
145329888|NCT00210249|524059668|FG000|Overall Study|Lost to Follow-up|5|||
145329889|NCT00210249|524059668|FG000|Overall Study|Protocol Violation|11|||
145329890|NCT04280705|524059669|FG000|Overall Study|Enrolled but not treated|4|||
145329891|NCT04280705|524059670|FG001|Overall Study|Enrolled but not treated|10|||
145329892|NCT04280705|524059669|FG000|Overall Study|Physician Decision|1|||
145329893|NCT04280705|524059670|FG001|Overall Study|Physician Decision|0|||
145329894|NCT04280705|524059669|FG000|Overall Study|Withdrawal by Subject|7|||
145329895|NCT04280705|524059670|FG001|Overall Study|Withdrawal by Subject|9|||
145329896|NCT04280705|524059669|FG000|Overall Study|Adverse Event|0|||
145329897|NCT04280705|524059670|FG001|Overall Study|Adverse Event|4|||
145329898|NCT04280705|524059669|FG000|Overall Study|Transferred to another hospital|1|||
145329899|NCT04280705|524059670|FG001|Overall Study|Transferred to another hospital|1|||
145329900|NCT03222583|524059671|FG000|Overall Study|Withdrawal by Subject|3|||
145329901|NCT03222583|524059672|FG001|Overall Study|Withdrawal by Subject|3|||
145329902|NCT03222583|524059671|FG000|Overall Study|Lost to Follow-up|1|||
145329903|NCT03222583|524059672|FG001|Overall Study|Lost to Follow-up|0|||
145329904|NCT03222583|524059671|FG000|Overall Study|Other|1|||
145329905|NCT03222583|524059672|FG001|Overall Study|Other|3|||
145620766|NCT02253316|525125187|FG002|Consolidation|Adverse Event|0|||
145329906|NCT02518919|524059675|FG000|Overall Study|Protocol Violation|1|||
145620767|NCT02253316|525125185|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
145329907|NCT02518919|524059676|FG001|Overall Study|Protocol Violation|1|||
145329908|NCT02518919|524059677|FG002|Overall Study|Protocol Violation|2|||
145329909|NCT04498403|524059678|FG000|Overall Study|Adverse Event|1|||
145329910|NCT04498403|524059679|FG001|Overall Study|Adverse Event|0|||
145329911|NCT04498403|524059678|FG000|Overall Study|Study Terminated By Sponsor|29|||
145329912|NCT04498403|524059679|FG001|Overall Study|Study Terminated By Sponsor|10|||
145329913|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Death|89|||
145329914|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Death|193|||
145329915|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Death|198|||
145329916|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
145329917|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
145329918|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
145329919|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
145329920|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
145329921|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
145329922|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
145329923|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
145329924|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
145329925|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
145329926|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
145329927|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
145329928|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
145329929|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
145329930|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
145329931|NCT02031458|524059680|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
145329932|NCT02031458|524059681|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
145329933|NCT02031458|524059682|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
145329934|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Death|36|||
145329935|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Death|87|||
145329936|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Death|100|||
145329937|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
145329938|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
145329939|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
145329940|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Physician Decision|0|||
145329941|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Physician Decision|1|||
145329942|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Physician Decision|0|||
145329943|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
145329944|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
145329945|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
145329946|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
145329947|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
145329948|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
145329949|NCT02031458|524059680|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
145329950|NCT02031458|524059681|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
145329951|NCT02031458|524059682|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
145329952|NCT02031458|524059680|FG000|Baseline to May 8, 2015|On Treatment|43|||
145329953|NCT02031458|524059681|FG001|Baseline to May 8, 2015|On Treatment|81|||
145329954|NCT02031458|524059682|FG002|Baseline to May 8, 2015|On Treatment|73|||
145329955|NCT02031458|524059680|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
145329956|NCT02031458|524059681|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
145329957|NCT02031458|524059682|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
145329958|NCT00609518|524059685|FG000|Overall Study|Death from Study Disease|32|||
145329959|NCT00609518|524059686|FG001|Overall Study|Death from Study Disease|32|||
145329960|NCT00609518|524059685|FG000|Overall Study|Withdrawal by Subject|5|||
145329961|NCT00609518|524059686|FG001|Overall Study|Withdrawal by Subject|3|||
145329962|NCT00609518|524059685|FG000|Overall Study|Lost to Follow-up|3|||
145329963|NCT00609518|524059686|FG001|Overall Study|Lost to Follow-up|0|||
145329964|NCT00609518|524059685|FG000|Overall Study|Physician Decision|1|||
145329965|NCT00609518|524059686|FG001|Overall Study|Physician Decision|3|||
145329966|NCT00609518|524059685|FG000|Overall Study|Death from Adverse Event|2|||
145329967|NCT00609518|524059686|FG001|Overall Study|Death from Adverse Event|2|||
145329968|NCT01687478|524059687|FG000|Overall Study|Adverse Event|3|||
145329969|NCT01687478|524059688|FG001|Overall Study|Adverse Event|10|||
145329970|NCT01687478|524059687|FG000|Overall Study|Lost to Follow-up|1|||
145329971|NCT01687478|524059688|FG001|Overall Study|Lost to Follow-up|3|||
145329972|NCT01687478|524059687|FG000|Overall Study|Protocol Violation|0|||
145329973|NCT01687478|524059688|FG001|Overall Study|Protocol Violation|2|||
145329974|NCT01687478|524059687|FG000|Overall Study|Withdrawal by Subject|21|||
145329975|NCT01687478|524059688|FG001|Overall Study|Withdrawal by Subject|19|||
145329976|NCT01687478|524059687|FG000|Overall Study|Physician Decision|1|||
145329977|NCT01687478|524059688|FG001|Overall Study|Physician Decision|3|||
145329978|NCT01687478|524059687|FG000|Overall Study|Entry Criteria Not Met|6|||
145329979|NCT01687478|524059688|FG001|Overall Study|Entry Criteria Not Met|2|||
145329980|NCT03188718|524059689|FG000|Overall Study|Participant noncompliance|4|||
145329981|NCT03188718|524059689|FG000|Overall Study|Withdrawal by Subject|1|||
145329982|NCT03188718|524059689|FG000|Overall Study|Device failure|3|||
145329983|NCT02049450|524059690|FG000|Overall Study|Adverse Event|2|||
145329984|NCT02049450|524059690|FG000|Overall Study|Withdrawal by Subject|1|||
145329985|NCT02049450|524059690|FG000|Overall Study|Patients/guardian decision|1|||
145329986|NCT05855616|524059694|FG000|Overall Study|Lost to Follow-up|1|||
145329987|NCT05855616|524059695|FG001|Overall Study|Lost to Follow-up|2|||
145329988|NCT04032158|524059696|FG000|Overall Study|Study Termination|2|||
145329989|NCT04032158|524059697|FG001|Overall Study|Study Termination|1|||
145329990|NCT04710979|524059699|FG000|Overall Study|Lost to Follow-up|2|||
145329991|NCT04710979|524059700|FG001|Overall Study|Lost to Follow-up|4|||
145329992|NCT04710979|524059699|FG000|Overall Study|Withdrawal by Subject|1|||
145329993|NCT04710979|524059700|FG001|Overall Study|Withdrawal by Subject|0|||
145329994|NCT01462318|524059703|FG000|Main Study / TP-DI Study|Other|2|||
145329995|NCT01462318|524059704|FG001|Main Study / TP-DI Study|Other|0|||
145329996|NCT01462318|524059705|FG002|Main Study / TP-DI Study|Other|0|||
145329997|NCT01462318|524059703|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
145329998|NCT01462318|524059704|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
145329999|NCT01462318|524059705|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
145330000|NCT01462318|524059703|FG000|Main Study / TP-DI Study|Adverse Event|4|||
145330001|NCT01462318|524059704|FG001|Main Study / TP-DI Study|Adverse Event|0|||
145330002|NCT01462318|524059705|FG002|Main Study / TP-DI Study|Adverse Event|0|||
145330003|NCT01462318|524059703|FG000|Extension Phase|Lost to Follow-up|0|||
145330004|NCT01462318|524059704|FG001|Extension Phase|Lost to Follow-up|0|||
145330005|NCT01462318|524059705|FG002|Extension Phase|Lost to Follow-up|1|||
145330006|NCT01462318|524059703|FG000|Extension Phase|Other|0|||
145330007|NCT01462318|524059704|FG001|Extension Phase|Other|0|||
145330008|NCT01462318|524059705|FG002|Extension Phase|Other|1|||
145330009|NCT01462318|524059703|FG000|Extension Phase|Disease Progression|0|||
145330010|NCT01462318|524059704|FG001|Extension Phase|Disease Progression|0|||
145330011|NCT01462318|524059705|FG002|Extension Phase|Disease Progression|1|||
145330012|NCT01462318|524059703|FG000|Extension Phase|Withdrawal by Subject|0|||
145330013|NCT01462318|524059704|FG001|Extension Phase|Withdrawal by Subject|0|||
145330014|NCT01462318|524059705|FG002|Extension Phase|Withdrawal by Subject|15|||
145330015|NCT01462318|524059703|FG000|Extension Phase|Investigator Decision|0|||
145330016|NCT01462318|524059704|FG001|Extension Phase|Investigator Decision|0|||
145330017|NCT01462318|524059705|FG002|Extension Phase|Investigator Decision|5|||
145330018|NCT01462318|524059703|FG000|Extension Phase|Adverse Event|0|||
145330019|NCT01462318|524059704|FG001|Extension Phase|Adverse Event|0|||
145330020|NCT01462318|524059705|FG002|Extension Phase|Adverse Event|22|||
145330021|NCT00974974|524059706|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
145330022|NCT00974974|524059707|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
145330023|NCT00974974|524059706|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
145330024|NCT00974974|524059707|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
145330025|NCT00974974|524059706|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
145330026|NCT00974974|524059707|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
145412171|NCT02850406|524362195|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
145412172|NCT02850406|524362188|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412173|NCT02850406|524362189|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412174|NCT02850406|524362190|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412175|NCT02850406|524362191|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412176|NCT02850406|524362192|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412177|NCT02850406|524362193|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412178|NCT02850406|524362194|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
145412179|NCT02850406|524362195|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
145412180|NCT02850406|524362188|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
145412181|NCT02850406|524362189|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
145412182|NCT02850406|524362190|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
145571451|NCT00779675|524951654|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
145571452|NCT00779675|524951654|FG000|Extended Treatment Period|Lost to Follow-up|6|||
145571453|NCT01440322|524951655|FG000|Overall Study|Discomfort|2|||
145571454|NCT01440322|524951656|FG001|Overall Study|Discomfort|0|||
145571455|NCT01440322|524951655|FG000|Overall Study|Biomicroscopy|1|||
145571456|NCT01440322|524951656|FG001|Overall Study|Biomicroscopy|0|||
145571457|NCT01440322|524951655|FG000|Overall Study|Symptoms and Problems|1|||
145571458|NCT01440322|524951656|FG001|Overall Study|Symptoms and Problems|0|||
145412183|NCT02850406|524362191|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
145571459|NCT01440322|524951655|FG000|Overall Study|Unacceptable Subjective Vision|1|||
145571460|NCT01440322|524951656|FG001|Overall Study|Unacceptable Subjective Vision|0|||
145620768|NCT02253316|525125186|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
145330027|NCT00974974|524059706|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
145571461|NCT01440322|524951655|FG000|Overall Study|Other Product Related|1|||
145330028|NCT00974974|524059707|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
145330029|NCT00974974|524059706|FG000|IR CD-LD Dose Adjustment|Various|0|||
145330030|NCT00974974|524059707|FG001|IR CD-LD Dose Adjustment|Various|9|||
145330031|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Adverse Event|23|||
145330032|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Adverse Event|0|||
145330033|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Death|2|||
145330034|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Death|0|||
145330035|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
145330036|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
145330037|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
145330038|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
145330039|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Various|3|||
145330040|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Various|0|||
145330041|NCT00974974|524059706|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
145330042|NCT00974974|524059707|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
145330043|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
145330044|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
145330045|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
145330046|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
145330047|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
145330048|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
145330049|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
145330050|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
145330051|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
145330052|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
145330053|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
145330054|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
145330055|NCT00974974|524059706|FG000|Maintenance - Double Blind Treatment|Various|4|||
145330056|NCT00974974|524059707|FG001|Maintenance - Double Blind Treatment|Various|0|||
145330057|NCT01959035|524059708|FG000|Overall Study|Adverse Event|5|||
145330058|NCT01959035|524059708|FG000|Overall Study|Withdrawal by Subject|4|||
145330059|NCT01959035|524059708|FG000|Overall Study|Lost to Follow-up|1|||
145330060|NCT01959035|524059708|FG000|Overall Study|Other (no primary reason given)|1|||
145330061|NCT03347422|524059711|FG000|Part A (26 Weeks)|Adverse Event|3|||
145330062|NCT03347422|524059712|FG001|Part A (26 Weeks)|Adverse Event|0|||
145330063|NCT03347422|524059711|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
145330064|NCT03347422|524059712|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
145330065|NCT03347422|524059711|FG000|Part B (149 Weeks)|Adverse Event|0|||
145330066|NCT03347422|524059712|FG001|Part B (149 Weeks)|Adverse Event|1|||
145330067|NCT03347422|524059711|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
145330068|NCT03347422|524059712|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
145330069|NCT03347422|524059711|FG000|Part B (149 Weeks)|Other|1|||
145330070|NCT03347422|524059712|FG001|Part B (149 Weeks)|Other|0|||
145330071|NCT00158600|524059715|FG000|Overall Study|unable to commit time to study|0|||
145330072|NCT00158600|524059716|FG001|Overall Study|unable to commit time to study|1|||
145330073|NCT00158600|524059715|FG000|Overall Study|Adverse Event|2|||
145330074|NCT00158600|524059716|FG001|Overall Study|Adverse Event|1|||
145330075|NCT00158600|524059715|FG000|Overall Study|Death|1|||
145330076|NCT00158600|524059716|FG001|Overall Study|Death|0|||
145330077|NCT00158600|524059715|FG000|Overall Study|Withdrawal by Subject|2|||
145330078|NCT00158600|524059716|FG001|Overall Study|Withdrawal by Subject|2|||
145330079|NCT02038907|524059717|FG000|Overall Study|Protocol Violation|0|||
145330080|NCT02038907|524059718|FG001|Overall Study|Protocol Violation|0|||
145330081|NCT02038907|524059719|FG002|Overall Study|Protocol Violation|0|||
145330082|NCT02038907|524059720|FG003|Overall Study|Protocol Violation|0|||
145330083|NCT02038907|524059721|FG004|Overall Study|Protocol Violation|0|||
145330084|NCT02038907|524059722|FG005|Overall Study|Protocol Violation|0|||
145330085|NCT02038907|524059723|FG006|Overall Study|Protocol Violation|0|||
145330086|NCT02038907|524059724|FG007|Overall Study|Protocol Violation|0|||
145330087|NCT02038907|524059725|FG008|Overall Study|Protocol Violation|0|||
145330088|NCT02038907|524059726|FG009|Overall Study|Protocol Violation|0|||
145330089|NCT02038907|524059727|FG010|Overall Study|Protocol Violation|1|||
145330090|NCT02038907|524059728|FG011|Overall Study|Protocol Violation|0|||
145330091|NCT02038907|524059729|FG012|Overall Study|Protocol Violation|0|||
145330092|NCT02038907|524059730|FG013|Overall Study|Protocol Violation|0|||
145330093|NCT02038907|524059717|FG000|Overall Study|Withdrawal by Subject|0|||
145330094|NCT02038907|524059718|FG001|Overall Study|Withdrawal by Subject|0|||
145330095|NCT02038907|524059719|FG002|Overall Study|Withdrawal by Subject|0|||
145330096|NCT02038907|524059720|FG003|Overall Study|Withdrawal by Subject|0|||
145330097|NCT02038907|524059721|FG004|Overall Study|Withdrawal by Subject|0|||
145330098|NCT02038907|524059722|FG005|Overall Study|Withdrawal by Subject|0|||
145330099|NCT02038907|524059723|FG006|Overall Study|Withdrawal by Subject|0|||
145330100|NCT02038907|524059724|FG007|Overall Study|Withdrawal by Subject|0|||
145330101|NCT02038907|524059725|FG008|Overall Study|Withdrawal by Subject|0|||
145330102|NCT02038907|524059726|FG009|Overall Study|Withdrawal by Subject|0|||
145330103|NCT02038907|524059727|FG010|Overall Study|Withdrawal by Subject|1|||
145330104|NCT02038907|524059728|FG011|Overall Study|Withdrawal by Subject|0|||
145330105|NCT02038907|524059729|FG012|Overall Study|Withdrawal by Subject|0|||
145330106|NCT02038907|524059730|FG013|Overall Study|Withdrawal by Subject|0|||
145330107|NCT04049617|524059733|FG000|Overall Study|Adverse Event|0|||
145330108|NCT04049617|524059734|FG001|Overall Study|Adverse Event|0|||
145330109|NCT04049617|524059735|FG002|Overall Study|Adverse Event|0|||
145330110|NCT04049617|524059736|FG003|Overall Study|Adverse Event|1|||
145330111|NCT04049617|524059737|FG004|Overall Study|Adverse Event|0|||
145330112|NCT04049617|524059738|FG005|Overall Study|Adverse Event|0|||
145330113|NCT04049617|524059733|FG000|Overall Study|Death|0|||
145330114|NCT04049617|524059734|FG001|Overall Study|Death|0|||
145330115|NCT04049617|524059735|FG002|Overall Study|Death|0|||
145330116|NCT04049617|524059736|FG003|Overall Study|Death|0|||
145330117|NCT04049617|524059737|FG004|Overall Study|Death|0|||
145330118|NCT04049617|524059738|FG005|Overall Study|Death|1|||
145330119|NCT04049617|524059733|FG000|Overall Study|Lost to Follow-up|0|||
145330120|NCT04049617|524059734|FG001|Overall Study|Lost to Follow-up|0|||
145330121|NCT04049617|524059735|FG002|Overall Study|Lost to Follow-up|0|||
145330122|NCT04049617|524059736|FG003|Overall Study|Lost to Follow-up|1|||
145330123|NCT04049617|524059737|FG004|Overall Study|Lost to Follow-up|0|||
145330124|NCT04049617|524059738|FG005|Overall Study|Lost to Follow-up|0|||
145330125|NCT04049617|524059733|FG000|Overall Study|Withdrew consent|0|||
145330126|NCT04049617|524059734|FG001|Overall Study|Withdrew consent|0|||
145330127|NCT04049617|524059735|FG002|Overall Study|Withdrew consent|1|||
145330128|NCT04049617|524059736|FG003|Overall Study|Withdrew consent|0|||
145330129|NCT04049617|524059737|FG004|Overall Study|Withdrew consent|0|||
145330130|NCT04049617|524059738|FG005|Overall Study|Withdrew consent|0|||
145330131|NCT00987389|524059741|FG000|Overall Study|Ineligible|0|||
145330132|NCT00987389|524059742|FG001|Overall Study|Ineligible|3|||
145330133|NCT00987389|524059743|FG002|Overall Study|Ineligible|0|||
145330134|NCT00987389|524059744|FG003|Overall Study|Ineligible|0|||
145330135|NCT00987389|524059741|FG000|Overall Study|Lost to Follow-up|4|||
145330136|NCT00987389|524059742|FG001|Overall Study|Lost to Follow-up|1|||
145330137|NCT00987389|524059743|FG002|Overall Study|Lost to Follow-up|3|||
145330138|NCT00987389|524059744|FG003|Overall Study|Lost to Follow-up|1|||
145330139|NCT00987389|524059741|FG000|Overall Study|Withdrawal by Subject|4|||
145330140|NCT00987389|524059742|FG001|Overall Study|Withdrawal by Subject|3|||
145330141|NCT00987389|524059743|FG002|Overall Study|Withdrawal by Subject|2|||
145330142|NCT00987389|524059744|FG003|Overall Study|Withdrawal by Subject|1|||
145330143|NCT00987389|524059741|FG000|Overall Study|Withdrawn from Treatment|0|||
145330144|NCT00987389|524059742|FG001|Overall Study|Withdrawn from Treatment|1|||
145330145|NCT00987389|524059743|FG002|Overall Study|Withdrawn from Treatment|0|||
145330146|NCT00987389|524059744|FG003|Overall Study|Withdrawn from Treatment|0|||
145330147|NCT00987389|524059741|FG000|Overall Study|Multiple different reasons|1|||
145330148|NCT00987389|524059742|FG001|Overall Study|Multiple different reasons|0|||
145330149|NCT00987389|524059743|FG002|Overall Study|Multiple different reasons|3|||
145330150|NCT00987389|524059744|FG003|Overall Study|Multiple different reasons|1|||
145330151|NCT02992418|524059745|FG000|Overall Study|Withdrawal by Subject|11|||
145330152|NCT02992418|524059746|FG001|Overall Study|Withdrawal by Subject|12|||
145330153|NCT02992418|524059745|FG000|Overall Study|Non-compliance with the protocol|308|||
145330154|NCT02992418|524059746|FG001|Overall Study|Non-compliance with the protocol|308|||
145330155|NCT02992418|524059745|FG000|Overall Study|Lost to Follow-up|27|||
145330156|NCT02992418|524059746|FG001|Overall Study|Lost to Follow-up|22|||
145330157|NCT04465630|524059747|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
145330158|NCT04465630|524059747|FG000|Overall Study|Screen failure|8|||
145330159|NCT04465630|524059747|FG000|Overall Study|Baseline failure|16|||
145330160|NCT01087489|524059748|FG000|Overall Study|enrolled in another VA study|0|||
145330161|NCT01087489|524059749|FG001|Overall Study|enrolled in another VA study|1|||
145330162|NCT01087489|524059748|FG000|Overall Study|Death|0|||
145330163|NCT01087489|524059749|FG001|Overall Study|Death|1|||
145330164|NCT01087489|524059748|FG000|Overall Study|unable to survey by telephone|0|||
145330165|NCT01087489|524059749|FG001|Overall Study|unable to survey by telephone|1|||
145330166|NCT02005887|524059764|FG000|Overall Study|Protocol Violation|0|||
145330167|NCT02005887|524059765|FG001|Overall Study|Protocol Violation|2|||
145330168|NCT01615263|524059766|FG000|Overall Study|Post-randomization exclusion|0|||
145330169|NCT01615263|524059767|FG001|Overall Study|Post-randomization exclusion|2|||
145330170|NCT00857259|524059768|FG000|Overall Study|Protocol Violation|1|||
145330171|NCT00857259|524059769|FG001|Overall Study|Protocol Violation|0|||
145330172|NCT00857259|524059770|FG002|Overall Study|Protocol Violation|1|||
145330173|NCT02701413|524059771|FG000|Overall Study|Withdrawal by Subject|7|||
145330174|NCT02701413|524059772|FG001|Overall Study|Withdrawal by Subject|11|||
145330175|NCT02138136|524059773|FG000|Overall Study|Protocol Violation|4|||
145330176|NCT02138136|524059773|FG000|Overall Study|Physician Decision|7|||
145330177|NCT02138136|524059773|FG000|Overall Study|Lack of Efficacy|35|||
145330178|NCT02138136|524059773|FG000|Overall Study|Pregnancy|2|||
145330179|NCT02138136|524059773|FG000|Overall Study|Adverse Event|18|||
145330180|NCT02138136|524059773|FG000|Overall Study|Withdrawal by Subject|36|||
145330181|NCT02138136|524059773|FG000|Overall Study|Lost to Follow-up|32|||
145330182|NCT02138136|524059773|FG000|Overall Study|Withdrawn by Sponsor|5|||
145412184|NCT02850406|524362192|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
145330183|NCT01359644|524059778|FG000|Treatment Period|Lack of Efficacy|0|||
145330184|NCT01359644|524059779|FG001|Treatment Period|Lack of Efficacy|1|||
145330185|NCT01359644|524059780|FG002|Treatment Period|Lack of Efficacy|0|||
145330186|NCT01359644|524059781|FG003|Treatment Period|Lack of Efficacy|0|||
145330187|NCT01359644|524059782|FG004|Treatment Period|Lack of Efficacy|0|||
145330188|NCT01359644|524059783|FG005|Treatment Period|Lack of Efficacy|0|||
145330189|NCT01359644|524059784|FG006|Treatment Period|Lack of Efficacy|0|||
145330190|NCT01359644|524059785|FG007|Treatment Period|Lack of Efficacy|0|||
145330191|NCT01359644|524059786|FG008|Treatment Period|Lack of Efficacy|0|||
145330192|NCT01359644|524059787|FG009|Treatment Period|Lack of Efficacy|0|||
145330193|NCT01359644|524059778|FG000|Treatment Period|Adverse Event|0|||
145330194|NCT01359644|524059779|FG001|Treatment Period|Adverse Event|0|||
145330195|NCT01359644|524059780|FG002|Treatment Period|Adverse Event|1|||
145330196|NCT01359644|524059781|FG003|Treatment Period|Adverse Event|0|||
145330197|NCT01359644|524059782|FG004|Treatment Period|Adverse Event|0|||
145330198|NCT01359644|524059783|FG005|Treatment Period|Adverse Event|1|||
145330199|NCT01359644|524059784|FG006|Treatment Period|Adverse Event|0|||
145330200|NCT01359644|524059785|FG007|Treatment Period|Adverse Event|0|||
145330201|NCT01359644|524059786|FG008|Treatment Period|Adverse Event|0|||
145330202|NCT01359644|524059787|FG009|Treatment Period|Adverse Event|0|||
145330203|NCT01359644|524059778|FG000|Treatment Period|Lost to Follow-up|0|||
145330204|NCT01359644|524059779|FG001|Treatment Period|Lost to Follow-up|0|||
145330205|NCT01359644|524059780|FG002|Treatment Period|Lost to Follow-up|0|||
145330206|NCT01359644|524059781|FG003|Treatment Period|Lost to Follow-up|0|||
145330207|NCT01359644|524059782|FG004|Treatment Period|Lost to Follow-up|0|||
145330208|NCT01359644|524059783|FG005|Treatment Period|Lost to Follow-up|1|||
145330209|NCT01359644|524059784|FG006|Treatment Period|Lost to Follow-up|0|||
145330210|NCT01359644|524059785|FG007|Treatment Period|Lost to Follow-up|0|||
145330211|NCT01359644|524059786|FG008|Treatment Period|Lost to Follow-up|0|||
145330212|NCT01359644|524059787|FG009|Treatment Period|Lost to Follow-up|0|||
145330213|NCT01359644|524059778|FG000|Follow-up Period|Withdrawal by Subject|0|||
145330214|NCT01359644|524059779|FG001|Follow-up Period|Withdrawal by Subject|0|||
145330215|NCT01359644|524059780|FG002|Follow-up Period|Withdrawal by Subject|0|||
145330216|NCT01359644|524059781|FG003|Follow-up Period|Withdrawal by Subject|0|||
145330217|NCT01359644|524059782|FG004|Follow-up Period|Withdrawal by Subject|0|||
145330218|NCT01359644|524059783|FG005|Follow-up Period|Withdrawal by Subject|1|||
145330219|NCT01359644|524059784|FG006|Follow-up Period|Withdrawal by Subject|0|||
145330220|NCT01359644|524059785|FG007|Follow-up Period|Withdrawal by Subject|0|||
145330221|NCT01359644|524059786|FG008|Follow-up Period|Withdrawal by Subject|0|||
145330222|NCT01359644|524059787|FG009|Follow-up Period|Withdrawal by Subject|0|||
145330223|NCT01359644|524059778|FG000|Follow-up Period|Lost to Follow-up|0|||
145330224|NCT01359644|524059779|FG001|Follow-up Period|Lost to Follow-up|0|||
145330225|NCT01359644|524059780|FG002|Follow-up Period|Lost to Follow-up|0|||
145330226|NCT01359644|524059781|FG003|Follow-up Period|Lost to Follow-up|0|||
145330227|NCT01359644|524059782|FG004|Follow-up Period|Lost to Follow-up|0|||
145330228|NCT01359644|524059783|FG005|Follow-up Period|Lost to Follow-up|0|||
145330229|NCT01359644|524059784|FG006|Follow-up Period|Lost to Follow-up|1|||
145330230|NCT01359644|524059785|FG007|Follow-up Period|Lost to Follow-up|2|||
145330231|NCT01359644|524059786|FG008|Follow-up Period|Lost to Follow-up|0|||
145330232|NCT01359644|524059787|FG009|Follow-up Period|Lost to Follow-up|0|||
145330233|NCT01660334|524059789|FG000|Overall Study|Lost to Follow-up|1|||
145330234|NCT00311311|524059790|FG000|Overall Study|Adverse Event|3|||
145330235|NCT00311311|524059791|FG001|Overall Study|Adverse Event|2|||
145330236|NCT00311311|524059790|FG000|Overall Study|Withdrawal by Subject|1|||
145330237|NCT00311311|524059791|FG001|Overall Study|Withdrawal by Subject|1|||
145330238|NCT00311311|524059790|FG000|Overall Study|Noncompliance|0|||
145330239|NCT00311311|524059791|FG001|Overall Study|Noncompliance|1|||
145330240|NCT00311311|524059790|FG000|Overall Study|Study Termination by Sponsor|3|||
145571462|NCT01440322|524951656|FG001|Overall Study|Other Product Related|0|||
145571463|NCT01440322|524951655|FG000|Overall Study|Unrelated Medical Problem|0|||
145571464|NCT01440322|524951656|FG001|Overall Study|Unrelated Medical Problem|1|||
145571465|NCT01440322|524951655|FG000|Overall Study|Other Non-Product Related|1|||
145571466|NCT01440322|524951656|FG001|Overall Study|Other Non-Product Related|0|||
145571467|NCT01956110|524951665|FG000|Overall Study|Protocol Violation|25|||
145571468|NCT01956110|524951666|FG001|Overall Study|Protocol Violation|11|||
145571469|NCT01956110|524951665|FG000|Overall Study|Adverse Event|9|||
145571470|NCT01956110|524951666|FG001|Overall Study|Adverse Event|10|||
145620769|NCT02253316|525125187|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
145330241|NCT00311311|524059791|FG001|Overall Study|Study Termination by Sponsor|4|||
145330242|NCT00311311|524059790|FG000|Overall Study|Death|1|||
145330243|NCT00311311|524059791|FG001|Overall Study|Death|0|||
145330244|NCT00311311|524059790|FG000|Overall Study|Lack of ancillary assistance|0|||
145330245|NCT00311311|524059791|FG001|Overall Study|Lack of ancillary assistance|1|||
145571471|NCT01956110|524951665|FG000|Overall Study|Personal reasons|1|||
145330246|NCT00546572|524059792|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
145330247|NCT00546572|524059793|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
145330248|NCT00546572|524059792|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
145330249|NCT00546572|524059793|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
145330250|NCT00546572|524059792|FG000|Vax 1 / Year 0|Protocol Violation|3|||
145412185|NCT02850406|524362193|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
145571472|NCT01956110|524951666|FG001|Overall Study|Personal reasons|1|||
145330251|NCT00546572|524059793|FG001|Vax 1 / Year 0|Protocol Violation|4|||
145330252|NCT00546572|524059792|FG000|Vax 1 / Year 0|Death|2|||
145330253|NCT00546572|524059793|FG001|Vax 1 / Year 0|Death|2|||
145330254|NCT00546572|524059792|FG000|Vax 1 / Year 0|Adverse Event|0|||
145330255|NCT00546572|524059793|FG001|Vax 1 / Year 0|Adverse Event|1|||
145330256|NCT00546572|524059792|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
145330257|NCT00546572|524059793|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
145330258|NCT00546572|524059792|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
145330259|NCT00546572|524059793|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
145330260|NCT00546572|524059792|FG000|Vax 2 / Year 1|Other|1|||
145330261|NCT00546572|524059793|FG001|Vax 2 / Year 1|Other|1|||
145330262|NCT00546572|524059792|FG000|Vax 2 / Year 1|Adverse Event|1|||
145330263|NCT00546572|524059793|FG001|Vax 2 / Year 1|Adverse Event|0|||
145330264|NCT00546572|524059792|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
145330265|NCT00546572|524059793|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
145330266|NCT02685202|524059794|FG000|Overall Study|Lost to Follow-up|9|||
145330267|NCT01229735|524059795|FG000|Overall Study|Lack of Efficacy|8|||
145330268|NCT01229735|524059796|FG001|Overall Study|Lack of Efficacy|8|||
145330269|NCT01229735|524059795|FG000|Overall Study|Protocol Violation|13|||
145330270|NCT01229735|524059796|FG001|Overall Study|Protocol Violation|8|||
145330271|NCT01229735|524059795|FG000|Overall Study|Lost to Follow-up|0|||
145330272|NCT01229735|524059796|FG001|Overall Study|Lost to Follow-up|2|||
145330273|NCT01229735|524059795|FG000|Overall Study|Withdrawal by Subject|18|||
145330274|NCT01229735|524059796|FG001|Overall Study|Withdrawal by Subject|17|||
145330275|NCT01229735|524059795|FG000|Overall Study|Other Reason|13|||
145330276|NCT01229735|524059796|FG001|Overall Study|Other Reason|10|||
145330277|NCT01229735|524059795|FG000|Overall Study|SAE, non-fatal|0|||
145330278|NCT01229735|524059796|FG001|Overall Study|SAE, non-fatal|4|||
145330279|NCT01229735|524059795|FG000|Overall Study|AE, non-serious non-fatal|13|||
145330280|NCT01229735|524059796|FG001|Overall Study|AE, non-serious non-fatal|17|||
145330281|NCT01229735|524059795|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145330282|NCT01229735|524059796|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
145330283|NCT02130882|524059797|FG000|Overall Study|Withdrawal by Subject|0|||
145330284|NCT02130882|524059798|FG001|Overall Study|Withdrawal by Subject|1|||
145330285|NCT02615171|524059807|FG000|Overall Study|Lost to Follow-up|2|||
145330286|NCT02615171|524059808|FG001|Overall Study|Lost to Follow-up|1|||
145330287|NCT00741936|524059821|FG000|Overall Study|Lost to Follow-up|1|||
145330288|NCT00741936|524059822|FG001|Overall Study|Lost to Follow-up|1|||
145330289|NCT00741936|524059821|FG000|Overall Study|Adverse Event|3|||
145330290|NCT00741936|524059822|FG001|Overall Study|Adverse Event|4|||
145330291|NCT00741936|524059821|FG000|Overall Study|Pregnancy|0|||
145330292|NCT00741936|524059822|FG001|Overall Study|Pregnancy|1|||
145330293|NCT00741936|524059821|FG000|Overall Study|Protocol Violation|2|||
145330294|NCT00741936|524059822|FG001|Overall Study|Protocol Violation|0|||
145330295|NCT00741936|524059821|FG000|Overall Study|Lack of Efficacy|0|||
145330296|NCT00741936|524059822|FG001|Overall Study|Lack of Efficacy|2|||
145330297|NCT00741936|524059821|FG000|Overall Study|Low compliance|3|||
145330298|NCT00741936|524059822|FG001|Overall Study|Low compliance|0|||
145330299|NCT03176459|524059824|FG000|Overall Study|Lost to Follow-up|5|||
145330300|NCT03176459|524059825|FG001|Overall Study|Lost to Follow-up|7|||
145330301|NCT03696953|524061796|FG000|Overall Study|Withdrawal by Subject|6|||
145330302|NCT03696953|524061797|FG001|Overall Study|Withdrawal by Subject|1|||
145412186|NCT02850406|524362194|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
145412187|NCT02850406|524362195|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
145571473|NCT03325166|524951669|FG000|Overall Study|Adverse Event|1|||
145571474|NCT01633944|524951670|FG000|Open-label Titration Phase|Adverse Event|109|||
145571475|NCT01633944|524951671|FG001|Open-label Titration Phase|Adverse Event|0|||
145571476|NCT01633944|524951672|FG002|Open-label Titration Phase|Adverse Event|0|||
145571477|NCT01633944|524951670|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
145571478|NCT01633944|524951671|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
145571479|NCT01633944|524951672|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
145571480|NCT01633944|524951670|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
145330303|NCT03696953|524061796|FG000|Overall Study|missed GBS swabs|2|||
145330304|NCT03696953|524061797|FG001|Overall Study|missed GBS swabs|2|||
145330305|NCT03696953|524061796|FG000|Overall Study|lost study bottle containing capsules|2|||
145330306|NCT03696953|524061797|FG001|Overall Study|lost study bottle containing capsules|0|||
145330307|NCT03696953|524061796|FG000|Overall Study|Premature birth|1|||
145330308|NCT03696953|524061797|FG001|Overall Study|Premature birth|4|||
145330309|NCT03696953|524061796|FG000|Overall Study|Gestational hypertension|1|||
145330310|NCT03696953|524061797|FG001|Overall Study|Gestational hypertension|1|||
145330311|NCT03696953|524061796|FG000|Overall Study|Gestational diabetes|2|||
145330312|NCT03696953|524061797|FG001|Overall Study|Gestational diabetes|1|||
145330313|NCT03696953|524061796|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
145412188|NCT02850406|524362188|FG000|Part D (Up to 52 Weeks)|Other|0|||
145571481|NCT01633944|524951671|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
145330314|NCT03696953|524061797|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
145330315|NCT03696953|524061796|FG000|Overall Study|Changed prenatal provider|1|||
145330316|NCT03696953|524061797|FG001|Overall Study|Changed prenatal provider|1|||
145330317|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
145330318|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145330319|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145330320|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145330321|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
145330322|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
145330323|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
145330324|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
145330325|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
145330326|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
145330327|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145330328|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
145330329|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145330330|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145330331|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
145330332|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
145330333|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
145330334|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
145330335|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
145330336|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
145330337|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
145330338|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
145330339|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
145330340|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
145330341|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
145330342|NCT02935686|524061799|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145330343|NCT02935686|524061800|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
145330344|NCT02935686|524061801|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145330345|NCT02935686|524061802|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145330346|NCT02935686|524061803|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
145330347|NCT02935686|524061799|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
145330348|NCT02935686|524061800|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
145330349|NCT02935686|524061801|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
145330350|NCT02935686|524061802|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
145330351|NCT02935686|524061803|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
145330352|NCT02935686|524061799|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145330353|NCT02935686|524061800|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
145330354|NCT02935686|524061801|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145330355|NCT02935686|524061802|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145330356|NCT02935686|524061803|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
145330357|NCT02935686|524061799|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145330358|NCT02935686|524061800|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
145412189|NCT02850406|524362189|FG001|Part D (Up to 52 Weeks)|Other|0|||
145412190|NCT02850406|524362190|FG002|Part D (Up to 52 Weeks)|Other|0|||
145412191|NCT02850406|524362191|FG003|Part D (Up to 52 Weeks)|Other|0|||
145412192|NCT02850406|524362192|FG004|Part D (Up to 52 Weeks)|Other|0|||
145412193|NCT02850406|524362193|FG005|Part D (Up to 52 Weeks)|Other|0|||
145412194|NCT02850406|524362194|FG006|Part D (Up to 52 Weeks)|Other|0|||
145412195|NCT02850406|524362195|FG007|Part D (Up to 52 Weeks)|Other|1|||
145412196|NCT03641924|524363514|FG000|Overall Study|Withdrawal by Subject|26|||
145412197|NCT03641924|524363514|FG000|Overall Study|Lost to Follow-up|16|||
145412198|NCT03641924|524363514|FG000|Overall Study|Protocol Violation|10|||
145412199|NCT04333498|524363515|FG000|Overall Study|Lost to Follow-up|1|||
145412200|NCT04333498|524363516|FG001|Overall Study|Lost to Follow-up|0|||
145412201|NCT04333498|524363515|FG000|Overall Study|Lost to Follow-up|0|||
145330359|NCT02935686|524061801|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145412202|NCT04333498|524363516|FG001|Overall Study|Lost to Follow-up|1|||
145412203|NCT01565694|524363517|FG000|Dose-Titration Period|Adverse Event|4|||
145412204|NCT01565694|524363517|FG000|Dose-Titration Period|Protocol Violation|10|||
145571482|NCT01633944|524951672|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
145571483|NCT01633944|524951670|FG000|Open-label Titration Phase|Protocol Violation|24|||
145412205|NCT01565694|524363517|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
145412206|NCT00479232|524363518|FG000|Overall Study|Adverse Event|0|||
145330360|NCT02935686|524061802|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145330361|NCT02935686|524061803|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
145330362|NCT02935686|524061799|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145412207|NCT00479232|524363519|FG001|Overall Study|Adverse Event|0|||
145620770|NCT02253316|525125185|FG000|Maintenance|Physician Decision|0|||
145330363|NCT02935686|524061800|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145330364|NCT02935686|524061801|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145330365|NCT02935686|524061802|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
145330366|NCT02935686|524061803|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
145330367|NCT02935686|524061799|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
145330368|NCT02935686|524061800|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
145330369|NCT02935686|524061801|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
145330370|NCT02935686|524061802|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
145330371|NCT02935686|524061803|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
145330372|NCT00759902|524061804|FG000|Overall Study|Adverse Event|0|||
145330373|NCT00759902|524061805|FG001|Overall Study|Adverse Event|1|||
145330374|NCT02128217|524061810|FG000|Overall Study|Lost to Follow-up|0|||
145330375|NCT02128217|524061811|FG001|Overall Study|Lost to Follow-up|1|||
145330376|NCT05071313|524061812|FG000|Overall Study|Lost to Follow-up|17|||
145330377|NCT05071313|524061813|FG001|Overall Study|Lost to Follow-up|10|||
145330378|NCT05071313|524061812|FG000|Overall Study|Physician Decision|1|||
145330379|NCT05071313|524061813|FG001|Overall Study|Physician Decision|6|||
145330380|NCT05071313|524061812|FG000|Overall Study|Death|1|||
145330381|NCT05071313|524061813|FG001|Overall Study|Death|0|||
145330382|NCT05071313|524061812|FG000|Overall Study|Withdrawal by Subject|10|||
145330383|NCT05071313|524061813|FG001|Overall Study|Withdrawal by Subject|15|||
145330384|NCT05071313|524061812|FG000|Overall Study|Other|1|||
145330385|NCT05071313|524061813|FG001|Overall Study|Other|0|||
145412208|NCT00479232|524363520|FG002|Overall Study|Adverse Event|5|||
145412209|NCT00479232|524363521|FG003|Overall Study|Adverse Event|0|||
145571484|NCT01633944|524951671|FG001|Open-label Titration Phase|Protocol Violation|0|||
145571485|NCT01633944|524951672|FG002|Open-label Titration Phase|Protocol Violation|0|||
145571486|NCT01633944|524951670|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
145571487|NCT01633944|524951671|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
145571488|NCT01633944|524951672|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
145571489|NCT01633944|524951670|FG000|Open-label Titration Phase|Other|68|||
145571490|NCT01633944|524951671|FG001|Open-label Titration Phase|Other|0|||
145571491|NCT01633944|524951672|FG002|Open-label Titration Phase|Other|0|||
145571492|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145571493|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Adverse Event|13|||
145571494|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Adverse Event|7|||
145571495|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
145571496|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
145571497|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
145571498|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145571499|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
145571500|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
145571501|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
145571502|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
145571503|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
145571504|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145571505|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
145571506|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
145571507|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
145571508|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
145571509|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
145571510|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
145571511|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
145571512|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
145571513|NCT01633944|524951670|FG000|Double-blind Treatment Phase|Other|0|||
145571514|NCT01633944|524951671|FG001|Double-blind Treatment Phase|Other|7|||
145571515|NCT01633944|524951672|FG002|Double-blind Treatment Phase|Other|0|||
145571516|NCT00463060|524951676|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
145330386|NCT05071313|524061812|FG000|Overall Study|Randomized but not vaccinated|4|||
145330387|NCT05071313|524061813|FG001|Overall Study|Randomized but not vaccinated|2|||
145330388|NCT00541970|524061814|FG000|Month 7|Protocol Violation|9|||
145330389|NCT00541970|524061815|FG001|Month 7|Protocol Violation|13|||
145330390|NCT00541970|524061816|FG002|Month 7|Protocol Violation|11|||
145330391|NCT00541970|524061817|FG003|Month 7|Protocol Violation|5|||
145330392|NCT00541970|524061814|FG000|Month 12|Adverse Event|0|||
145330393|NCT00541970|524061815|FG001|Month 12|Adverse Event|1|||
145330394|NCT00541970|524061816|FG002|Month 12|Adverse Event|1|||
145330395|NCT00541970|524061817|FG003|Month 12|Adverse Event|1|||
145412210|NCT00479232|524363522|FG004|Overall Study|Adverse Event|0|||
145330396|NCT00541970|524061814|FG000|Month 12|Protocol Violation|12|||
145412211|NCT00479232|524363523|FG005|Overall Study|Adverse Event|10|||
145571517|NCT00463060|524951676|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
145571518|NCT01400841|524951677|FG000|Initial Study Phase (6 Months)|Death|1|||
145412212|NCT00479232|524363518|FG000|Overall Study|Deviation from Protocol|0|||
145412213|NCT00479232|524363519|FG001|Overall Study|Deviation from Protocol|0|||
145412214|NCT00479232|524363520|FG002|Overall Study|Deviation from Protocol|1|||
145412215|NCT00479232|524363521|FG003|Overall Study|Deviation from Protocol|0|||
145412216|NCT00479232|524363522|FG004|Overall Study|Deviation from Protocol|0|||
145412217|NCT00479232|524363523|FG005|Overall Study|Deviation from Protocol|0|||
145412218|NCT00479232|524363518|FG000|Overall Study|Lack of Efficacy|0|||
145330397|NCT00541970|524061815|FG001|Month 12|Protocol Violation|21|||
145330398|NCT00541970|524061816|FG002|Month 12|Protocol Violation|20|||
145330399|NCT00541970|524061817|FG003|Month 12|Protocol Violation|15|||
145330400|NCT00541970|524061814|FG000|Month 18|Adverse Event|0|||
145330401|NCT00541970|524061815|FG001|Month 18|Adverse Event|1|||
145330402|NCT00541970|524061816|FG002|Month 18|Adverse Event|1|||
145330403|NCT00541970|524061817|FG003|Month 18|Adverse Event|1|||
145330404|NCT00541970|524061814|FG000|Month 18|Protocol Violation|14|||
145330405|NCT00541970|524061815|FG001|Month 18|Protocol Violation|23|||
145330406|NCT00541970|524061816|FG002|Month 18|Protocol Violation|24|||
145330407|NCT00541970|524061817|FG003|Month 18|Protocol Violation|16|||
145330408|NCT00541970|524061814|FG000|Month 24|Adverse Event|0|||
145330409|NCT00541970|524061815|FG001|Month 24|Adverse Event|1|||
145330410|NCT00541970|524061816|FG002|Month 24|Adverse Event|1|||
145330411|NCT00541970|524061817|FG003|Month 24|Adverse Event|1|||
145330412|NCT00541970|524061814|FG000|Month 24|Protocol Violation|29|||
145330413|NCT00541970|524061815|FG001|Month 24|Protocol Violation|31|||
145330414|NCT00541970|524061816|FG002|Month 24|Protocol Violation|31|||
145330415|NCT00541970|524061817|FG003|Month 24|Protocol Violation|21|||
145330416|NCT00541970|524061814|FG000|Month 36|Protocol Violation|61|||
145330417|NCT00541970|524061815|FG001|Month 36|Protocol Violation|66|||
145330418|NCT00541970|524061816|FG002|Month 36|Protocol Violation|66|||
145330419|NCT00541970|524061817|FG003|Month 36|Protocol Violation|60|||
145330420|NCT00541970|524061814|FG000|Month 48|Withdrawal by Subject|2|||
145330421|NCT00541970|524061815|FG001|Month 48|Withdrawal by Subject|4|||
145330422|NCT00541970|524061816|FG002|Month 48|Withdrawal by Subject|4|||
145330423|NCT00541970|524061817|FG003|Month 48|Withdrawal by Subject|2|||
145330424|NCT00541970|524061814|FG000|Month 48|Other|3|||
145330425|NCT00541970|524061815|FG001|Month 48|Other|1|||
145330426|NCT00541970|524061816|FG002|Month 48|Other|1|||
145330427|NCT00541970|524061817|FG003|Month 48|Other|0|||
145330428|NCT00541970|524061814|FG000|Month 48|Lost to Follow-up|66|||
145330429|NCT00541970|524061815|FG001|Month 48|Lost to Follow-up|68|||
145330430|NCT00541970|524061816|FG002|Month 48|Lost to Follow-up|68|||
145330431|NCT00541970|524061817|FG003|Month 48|Lost to Follow-up|73|||
145330432|NCT00541970|524061814|FG000|Month 60|Protocol Violation|78|||
145330433|NCT00541970|524061815|FG001|Month 60|Protocol Violation|77|||
145330434|NCT00541970|524061816|FG002|Month 60|Protocol Violation|82|||
145330435|NCT00541970|524061817|FG003|Month 60|Protocol Violation|72|||
145330436|NCT03107026|524061818|FG000|Overall Study|Adverse Event|2|||
145330437|NCT03107026|524061819|FG001|Overall Study|Adverse Event|14|||
145330438|NCT03107026|524061820|FG002|Overall Study|Adverse Event|23|||
145330439|NCT03107026|524061818|FG000|Overall Study|Lost to Follow-up|12|||
145330440|NCT03107026|524061819|FG001|Overall Study|Lost to Follow-up|12|||
145330441|NCT03107026|524061820|FG002|Overall Study|Lost to Follow-up|13|||
145330442|NCT03107026|524061818|FG000|Overall Study|Protocol Violation|1|||
145330443|NCT03107026|524061819|FG001|Overall Study|Protocol Violation|2|||
145330444|NCT03107026|524061820|FG002|Overall Study|Protocol Violation|0|||
145330445|NCT03107026|524061818|FG000|Overall Study|Pregnancy|1|||
145412219|NCT00479232|524363519|FG001|Overall Study|Lack of Efficacy|0|||
145412220|NCT00479232|524363520|FG002|Overall Study|Lack of Efficacy|2|||
145412221|NCT00479232|524363521|FG003|Overall Study|Lack of Efficacy|0|||
145412222|NCT00479232|524363522|FG004|Overall Study|Lack of Efficacy|0|||
145412223|NCT00479232|524363523|FG005|Overall Study|Lack of Efficacy|4|||
145412224|NCT00479232|524363518|FG000|Overall Study|Physician Decision|0|||
145412225|NCT00479232|524363519|FG001|Overall Study|Physician Decision|0|||
145330446|NCT03107026|524061819|FG001|Overall Study|Pregnancy|0|||
145330447|NCT03107026|524061820|FG002|Overall Study|Pregnancy|0|||
145330448|NCT03107026|524061818|FG000|Overall Study|Withdrawal by Subject|13|||
145330449|NCT03107026|524061819|FG001|Overall Study|Withdrawal by Subject|5|||
145330450|NCT03107026|524061820|FG002|Overall Study|Withdrawal by Subject|17|||
145330451|NCT03107026|524061818|FG000|Overall Study|non compliance with study visits|1|||
145330452|NCT03107026|524061819|FG001|Overall Study|non compliance with study visits|2|||
145330453|NCT03107026|524061820|FG002|Overall Study|non compliance with study visits|0|||
145330454|NCT03107026|524061818|FG000|Overall Study|non-compliance with study drug|2|||
145330455|NCT03107026|524061819|FG001|Overall Study|non-compliance with study drug|2|||
145330456|NCT03107026|524061820|FG002|Overall Study|non-compliance with study drug|3|||
145330457|NCT03107026|524061818|FG000|Overall Study|Physician Decision|0|||
145330458|NCT03107026|524061819|FG001|Overall Study|Physician Decision|1|||
145330459|NCT03107026|524061820|FG002|Overall Study|Physician Decision|0|||
145330460|NCT01183221|524061821|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
145412226|NCT00479232|524363520|FG002|Overall Study|Physician Decision|2|||
145412227|NCT00479232|524363521|FG003|Overall Study|Physician Decision|0|||
145412228|NCT00479232|524363522|FG004|Overall Study|Physician Decision|0|||
145620771|NCT02253316|525125186|FG001|Maintenance|Physician Decision|7|||
145620772|NCT02253316|525125187|FG002|Maintenance|Physician Decision|16|||
145620773|NCT02253316|525125185|FG000|Maintenance|Non-Compliance|0|||
145620774|NCT02253316|525125186|FG001|Maintenance|Non-Compliance|1|||
145620775|NCT02253316|525125187|FG002|Maintenance|Non-Compliance|1|||
145620776|NCT02253316|525125185|FG000|Maintenance|Secondary Malignancy|0|||
145620777|NCT02253316|525125186|FG001|Maintenance|Secondary Malignancy|2|||
145620778|NCT02253316|525125187|FG002|Maintenance|Secondary Malignancy|6|||
145620779|NCT02253316|525125185|FG000|Maintenance|Adverse Event|0|||
145620780|NCT02253316|525125186|FG001|Maintenance|Adverse Event|8|||
145620781|NCT02253316|525125187|FG002|Maintenance|Adverse Event|12|||
145620782|NCT02253316|525125185|FG000|Maintenance|Still receiving active treatment|0|||
145620783|NCT02253316|525125186|FG001|Maintenance|Still receiving active treatment|4|||
145620784|NCT02253316|525125187|FG002|Maintenance|Still receiving active treatment|0|||
145620785|NCT02353832|525125188|FG000|Overall Study|Ineligible after enrollment|1|||
145620786|NCT02353832|525125188|FG000|Overall Study|Lost to Follow-up|1|||
145620787|NCT02684903|525125189|FG000|Overall Study|COVID-19 shutdown of lab|4|||
145620788|NCT02684903|525125190|FG001|Overall Study|COVID-19 shutdown of lab|6|||
145330461|NCT01183221|524061822|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
145330462|NCT03596151|524061825|FG000|Overall Study|Withdrawal by Subject|1|||
145330463|NCT00824616|524061829|FG000|Overall Study|Adverse Event|2|||
145330464|NCT00824616|524061830|FG001|Overall Study|Adverse Event|1|||
145330465|NCT00824616|524061829|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
145330466|NCT00824616|524061830|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
145330467|NCT00824616|524061829|FG000|Overall Study|Hyperglycemia|1|||
145330468|NCT00824616|524061830|FG001|Overall Study|Hyperglycemia|1|||
145330469|NCT00824616|524061829|FG000|Overall Study|Lack of Efficacy|2|||
145330470|NCT00824616|524061830|FG001|Overall Study|Lack of Efficacy|1|||
145330471|NCT00824616|524061829|FG000|Overall Study|Lost to Follow-up|0|||
145330472|NCT00824616|524061830|FG001|Overall Study|Lost to Follow-up|1|||
145330473|NCT00824616|524061829|FG000|Overall Study|Withdrawal by Subject|1|||
145330474|NCT00824616|524061830|FG001|Overall Study|Withdrawal by Subject|1|||
145330475|NCT00577395|524061831|FG000|Overall Study|Study was terminated early by Sponsor|7|||
145330476|NCT00577395|524061832|FG001|Overall Study|Study was terminated early by Sponsor|6|||
145330477|NCT04711902|524061833|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
145330478|NCT04711902|524061834|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
145330479|NCT04711902|524061835|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
145330480|NCT04711902|524061836|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
145571519|NCT01400841|524951677|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
145571520|NCT00701129|524951678|FG000|Overall Study|Death|2|||
145571521|NCT00910715|524951679|FG000|Overall Study|Lost to Follow-up|22|||
145571522|NCT00910715|524951680|FG001|Overall Study|Lost to Follow-up|26|||
145571523|NCT00910715|524951681|FG002|Overall Study|Lost to Follow-up|0|||
145571524|NCT01782313|524951689|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
145571525|NCT01782313|524951689|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
145571526|NCT01782313|524951689|FG000|Treated Cycle 3|Progressive Disease|21|||
145571527|NCT01782313|524951689|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
145571528|NCT01782313|524951689|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
145571529|NCT01782313|524951689|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
145571530|NCT01782313|524951689|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
145571531|NCT01782313|524951689|FG000|Survival Follow up|Lost to Follow-up|1|||
145571532|NCT00958776|524951690|FG000|Overall Study|Adverse Event|0|||
145571533|NCT00958776|524951691|FG001|Overall Study|Adverse Event|1|||
145571534|NCT00958776|524951690|FG000|Overall Study|Physician Decision|1|||
145571535|NCT00958776|524951691|FG001|Overall Study|Physician Decision|0|||
145571536|NCT00958776|524951690|FG000|Overall Study|Lost to Follow-up|2|||
145571537|NCT00958776|524951691|FG001|Overall Study|Lost to Follow-up|6|||
145571538|NCT00958776|524951690|FG000|Overall Study|Withdrawal by Subject|7|||
145571539|NCT00958776|524951691|FG001|Overall Study|Withdrawal by Subject|16|||
145571540|NCT00958776|524951690|FG000|Overall Study|Protocol Violation|1|||
145571541|NCT00958776|524951691|FG001|Overall Study|Protocol Violation|1|||
145571542|NCT00958776|524951690|FG000|Overall Study|Death|2|||
145571543|NCT00958776|524951691|FG001|Overall Study|Death|1|||
145571544|NCT00958776|524951690|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
145571545|NCT00958776|524951691|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
145620789|NCT02684903|525125189|FG000|Overall Study|Lost to Follow-up|31|||
145330481|NCT04711902|524061837|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
145330482|NCT04711902|524061838|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
145330483|NCT00394524|524061839|FG000|Overall Study|Protocol Violation|2|||
145330484|NCT00394524|524061840|FG001|Overall Study|Protocol Violation|3|||
145571546|NCT00958776|524951690|FG000|Overall Study|Missing|1|||
145571547|NCT00958776|524951691|FG001|Overall Study|Missing|1|||
145571548|NCT00480636|524951692|FG000|Overall Study|Death|12|||
145620790|NCT02684903|525125190|FG001|Overall Study|Lost to Follow-up|41|||
145571549|NCT00480636|524951692|FG000|Overall Study|Lost to Follow-up|4|||
145620791|NCT03280563|525126627|FG000|Stage 1|Death|2|||
145620792|NCT03280563|525126628|FG001|Stage 1|Death|1|||
145330485|NCT00394524|524061839|FG000|Overall Study|Death|1|||
145330486|NCT00394524|524061840|FG001|Overall Study|Death|0|||
145330487|NCT00394524|524061839|FG000|Overall Study|Withdrawal by Subject|0|||
145330488|NCT00394524|524061840|FG001|Overall Study|Withdrawal by Subject|1|||
145330489|NCT02227147|524061842|FG000|Controlled Treatment Period|Adverse Event|4|||
145330490|NCT02227147|524061843|FG001|Controlled Treatment Period|Adverse Event|3|||
145330491|NCT02227147|524061842|FG000|Controlled Treatment Period|Other|2|||
145330492|NCT02227147|524061843|FG001|Controlled Treatment Period|Other|0|||
145330493|NCT02227147|524061842|FG000|Follow-up Period|Other|3|||
145330494|NCT02227147|524061843|FG001|Follow-up Period|Other|5|||
145330495|NCT03709823|524061844|FG000|Overall Study|Adverse Event|0|||
145330496|NCT03709823|524061845|FG001|Overall Study|Adverse Event|0|||
145330497|NCT03709823|524061846|FG002|Overall Study|Adverse Event|1|||
145330498|NCT03709823|524061847|FG003|Overall Study|Adverse Event|0|||
145330499|NCT03709823|524061848|FG004|Overall Study|Adverse Event|0|||
145330500|NCT03709823|524061849|FG005|Overall Study|Adverse Event|0|||
145330501|NCT03709823|524061844|FG000|Overall Study|Lost to Follow-up|2|||
145330502|NCT03709823|524061845|FG001|Overall Study|Lost to Follow-up|2|||
145330503|NCT03709823|524061846|FG002|Overall Study|Lost to Follow-up|2|||
145330504|NCT03709823|524061847|FG003|Overall Study|Lost to Follow-up|1|||
145330505|NCT03709823|524061848|FG004|Overall Study|Lost to Follow-up|1|||
145330506|NCT03709823|524061849|FG005|Overall Study|Lost to Follow-up|0|||
145330507|NCT03709823|524061844|FG000|Overall Study|Withdrawal by Subject|1|||
145330508|NCT03709823|524061845|FG001|Overall Study|Withdrawal by Subject|3|||
145330509|NCT03709823|524061846|FG002|Overall Study|Withdrawal by Subject|0|||
145330510|NCT03709823|524061847|FG003|Overall Study|Withdrawal by Subject|0|||
145330511|NCT03709823|524061848|FG004|Overall Study|Withdrawal by Subject|0|||
145330512|NCT03709823|524061849|FG005|Overall Study|Withdrawal by Subject|0|||
145330513|NCT03709823|524061844|FG000|Overall Study|Other, Not Specified|0|||
145330514|NCT03709823|524061845|FG001|Overall Study|Other, Not Specified|0|||
145330515|NCT03709823|524061846|FG002|Overall Study|Other, Not Specified|0|||
145330516|NCT03709823|524061847|FG003|Overall Study|Other, Not Specified|1|||
145330517|NCT03709823|524061848|FG004|Overall Study|Other, Not Specified|0|||
145330518|NCT03709823|524061849|FG005|Overall Study|Other, Not Specified|0|||
145330519|NCT01246011|524061854|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
145330520|NCT01246011|524061855|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
145330521|NCT01246011|524061856|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
145330522|NCT01246011|524061854|FG000|Overall Study|Withdrawal by Subject|0|||
145330523|NCT01246011|524061855|FG001|Overall Study|Withdrawal by Subject|0|||
145330524|NCT01246011|524061856|FG002|Overall Study|Withdrawal by Subject|1|||
145330525|NCT01155024|524061861|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
145330526|NCT01155024|524061862|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
145330527|NCT01155024|524061861|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
145330528|NCT01155024|524061862|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
145330529|NCT01155024|524061861|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
145330530|NCT01155024|524061862|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
145330531|NCT03412396|524061863|FG000|Overall Study|Withdrawal by Subject|2|||
145330532|NCT03412396|524061863|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
145330533|NCT03412396|524061863|FG000|Overall Study|Did not undergo RP|2|||
145330534|NCT01593696|524061864|FG000|Dose Escalation|Progressive Disease|2|||
145330535|NCT01593696|524061865|FG001|Dose Escalation|Progressive Disease|0|||
145330536|NCT01593696|524061866|FG002|Dose Escalation|Progressive Disease|0|||
145330537|NCT01593696|524061867|FG003|Dose Escalation|Progressive Disease|0|||
145330538|NCT01593696|524061864|FG000|Dose Expansion|Fungal infection|0|||
145330539|NCT01593696|524061865|FG001|Dose Expansion|Fungal infection|0|||
145330540|NCT01593696|524061866|FG002|Dose Expansion|Fungal infection|1|||
145330541|NCT01593696|524061867|FG003|Dose Expansion|Fungal infection|0|||
145330542|NCT01383135|524061868|FG000|Overall Study|Not Scanned / Imaged|1|||
145330543|NCT01383135|524061869|FG001|Overall Study|Not Scanned / Imaged|0|||
145330544|NCT01383135|524061870|FG002|Overall Study|Not Scanned / Imaged|1|||
145330545|NCT01383135|524061871|FG003|Overall Study|Not Scanned / Imaged|0|||
145330546|NCT03167723|524061875|FG000|Overall Study|Protocol Violation|4|||
145330547|NCT03167723|524061876|FG001|Overall Study|Protocol Violation|6|||
145330548|NCT02397408|524061877|FG000|Overall Study|Physician Decision|4|||
145330549|NCT02397408|524061877|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
145330550|NCT03397771|524061878|FG000|Overall Study|2 erroneously randomized, never treated|3|||
145330551|NCT03397771|524061879|FG001|Overall Study|2 erroneously randomized, never treated|1|||
145330552|NCT03397771|524061878|FG000|Overall Study|Withdrawal by Subject|1|||
145330553|NCT03397771|524061879|FG001|Overall Study|Withdrawal by Subject|3|||
145330554|NCT03397771|524061878|FG000|Overall Study|Protocol Violation|2|||
145330555|NCT03397771|524061879|FG001|Overall Study|Protocol Violation|2|||
145330556|NCT03397771|524061878|FG000|Overall Study|Adverse Event|2|||
145330557|NCT03397771|524061879|FG001|Overall Study|Adverse Event|1|||
145330558|NCT04078126|524061880|FG000|Washout|Study put on hold due to COVID-19|0|||
145330559|NCT04078126|524061881|FG001|Washout|Study put on hold due to COVID-19|2|||
145620793|NCT03280563|525126629|FG002|Stage 1|Death|0|||
145620794|NCT03280563|525126630|FG003|Stage 1|Death|0|||
145620795|NCT03280563|525126631|FG004|Stage 1|Death|0|||
145620796|NCT03280563|525126632|FG005|Stage 1|Death|3|||
145620797|NCT03280563|525126633|FG006|Stage 1|Death|0|||
145620798|NCT03280563|525126634|FG007|Stage 1|Death|0|||
145620799|NCT03280563|525126635|FG008|Stage 1|Death|0|||
145620800|NCT03280563|525126627|FG000|Stage 1|Study Ended by Sponsor|0|||
145620801|NCT03280563|525126628|FG001|Stage 1|Study Ended by Sponsor|0|||
145620802|NCT03280563|525126629|FG002|Stage 1|Study Ended by Sponsor|1|||
145620803|NCT03280563|525126630|FG003|Stage 1|Study Ended by Sponsor|0|||
145620804|NCT03280563|525126631|FG004|Stage 1|Study Ended by Sponsor|0|||
145620805|NCT03280563|525126632|FG005|Stage 1|Study Ended by Sponsor|1|||
145620806|NCT03280563|525126633|FG006|Stage 1|Study Ended by Sponsor|0|||
145620807|NCT03280563|525126634|FG007|Stage 1|Study Ended by Sponsor|0|||
145620808|NCT03280563|525126635|FG008|Stage 1|Study Ended by Sponsor|0|||
145620809|NCT03280563|525126627|FG000|Stage 1|Withdrawal by Subject|5|||
145620810|NCT03280563|525126628|FG001|Stage 1|Withdrawal by Subject|1|||
145620811|NCT03280563|525126629|FG002|Stage 1|Withdrawal by Subject|2|||
145620812|NCT03280563|525126630|FG003|Stage 1|Withdrawal by Subject|0|||
145620813|NCT03280563|525126631|FG004|Stage 1|Withdrawal by Subject|0|||
145620814|NCT03280563|525126632|FG005|Stage 1|Withdrawal by Subject|2|||
145620815|NCT03280563|525126633|FG006|Stage 1|Withdrawal by Subject|0|||
145620816|NCT03280563|525126634|FG007|Stage 1|Withdrawal by Subject|0|||
145620817|NCT03280563|525126635|FG008|Stage 1|Withdrawal by Subject|0|||
145620818|NCT03280563|525126627|FG000|Stage 1|Reason Not Specified|0|||
145620819|NCT03280563|525126628|FG001|Stage 1|Reason Not Specified|0|||
145620820|NCT03280563|525126629|FG002|Stage 1|Reason Not Specified|0|||
145620821|NCT03280563|525126630|FG003|Stage 1|Reason Not Specified|0|||
145620822|NCT03280563|525126631|FG004|Stage 1|Reason Not Specified|0|||
145620823|NCT03280563|525126632|FG005|Stage 1|Reason Not Specified|1|||
145620824|NCT03280563|525126633|FG006|Stage 1|Reason Not Specified|0|||
145620825|NCT03280563|525126634|FG007|Stage 1|Reason Not Specified|0|||
145620826|NCT03280563|525126635|FG008|Stage 1|Reason Not Specified|0|||
145620827|NCT03280563|525126627|FG000|Stage 1|Physician Decision|0|||
145620828|NCT03280563|525126628|FG001|Stage 1|Physician Decision|1|||
145620829|NCT03280563|525126629|FG002|Stage 1|Physician Decision|0|||
145620830|NCT03280563|525126630|FG003|Stage 1|Physician Decision|0|||
145620831|NCT03280563|525126631|FG004|Stage 1|Physician Decision|0|||
145620832|NCT03280563|525126632|FG005|Stage 1|Physician Decision|0|||
145620833|NCT03280563|525126633|FG006|Stage 1|Physician Decision|0|||
145620834|NCT03280563|525126634|FG007|Stage 1|Physician Decision|0|||
145620835|NCT03280563|525126635|FG008|Stage 1|Physician Decision|0|||
145620836|NCT03280563|525126627|FG000|Stage 2|Death|0|||
145620837|NCT03280563|525126628|FG001|Stage 2|Death|0|||
145620838|NCT03280563|525126629|FG002|Stage 2|Death|0|||
145620839|NCT03280563|525126630|FG003|Stage 2|Death|0|||
145330560|NCT04078126|524061880|FG000|Period 2|Study put on hold due to COVID-19|1|||
145330561|NCT04078126|524061881|FG001|Period 2|Study put on hold due to COVID-19|1|||
145330562|NCT02669758|524061884|FG000|Overall Study|Withdrawal by Subject|43|||
145330563|NCT02669758|524061884|FG000|Overall Study|Lost to Follow-up|19|||
145330564|NCT02669758|524061884|FG000|Overall Study|Adverse Event|16|||
145330565|NCT02669758|524061884|FG000|Overall Study|Non-Compliance with Study Drug|8|||
145330566|NCT02669758|524061884|FG000|Overall Study|Lack of Efficacy|5|||
145330567|NCT02669758|524061884|FG000|Overall Study|Pregnancy|1|||
145330568|NCT02669758|524061884|FG000|Overall Study|Study noncompliance|1|||
145330569|NCT02669758|524061884|FG000|Overall Study|Protocol Violation|1|||
145330570|NCT02149108|524061885|FG000|Overall Study|Not treated|1|||
145620840|NCT03280563|525126631|FG004|Stage 2|Death|0|||
145620841|NCT03280563|525126632|FG005|Stage 2|Death|0|||
145620842|NCT03280563|525126633|FG006|Stage 2|Death|0|||
145620843|NCT03280563|525126634|FG007|Stage 2|Death|1|||
145330571|NCT02149108|524061886|FG001|Overall Study|Not treated|2|||
145330572|NCT02149108|524061885|FG000|Overall Study|Progressive Disease (PD)|324|||
145330573|NCT02149108|524061886|FG001|Overall Study|Progressive Disease (PD)|318|||
145330574|NCT02149108|524061885|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
145330575|NCT02149108|524061886|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
145412229|NCT00479232|524363523|FG005|Overall Study|Physician Decision|1|||
145620844|NCT03280563|525126635|FG008|Stage 2|Death|0|||
145620845|NCT03280563|525126627|FG000|Stage 2|Progressive Disease|0|||
145620846|NCT03280563|525126628|FG001|Stage 2|Progressive Disease|0|||
145620847|NCT03280563|525126629|FG002|Stage 2|Progressive Disease|0|||
145620848|NCT03280563|525126630|FG003|Stage 2|Progressive Disease|0|||
145620849|NCT03280563|525126631|FG004|Stage 2|Progressive Disease|0|||
145620850|NCT03280563|525126632|FG005|Stage 2|Progressive Disease|0|||
145620851|NCT03280563|525126633|FG006|Stage 2|Progressive Disease|2|||
145620852|NCT03280563|525126634|FG007|Stage 2|Progressive Disease|0|||
145620853|NCT03280563|525126635|FG008|Stage 2|Progressive Disease|0|||
145620854|NCT03280563|525126627|FG000|Long-term Survival Follow-up|Death|10|||
145620855|NCT03280563|525126628|FG001|Long-term Survival Follow-up|Death|14|||
145620856|NCT03280563|525126629|FG002|Long-term Survival Follow-up|Death|15|||
145620857|NCT03280563|525126630|FG003|Long-term Survival Follow-up|Death|3|||
145330576|NCT02149108|524061885|FG000|Overall Study|Other Adverse Event (AE)|8|||
145330577|NCT02149108|524061886|FG001|Overall Study|Other Adverse Event (AE)|18|||
145330578|NCT02149108|524061885|FG000|Overall Study|Other not defined above|0|||
145330579|NCT02149108|524061886|FG001|Overall Study|Other not defined above|2|||
145330580|NCT02149108|524061885|FG000|Overall Study|Refusal to continue trial medication|15|||
145330581|NCT02149108|524061886|FG001|Overall Study|Refusal to continue trial medication|11|||
145330582|NCT02149108|524061885|FG000|Overall Study|Lost to Follow-up|1|||
145330583|NCT02149108|524061886|FG001|Overall Study|Lost to Follow-up|0|||
145330584|NCT02455050|524061887|FG000|Treatment Period 1|Lost to Follow-up|1|||
145330585|NCT02455050|524061888|FG001|Treatment Period 1|Lost to Follow-up|1|||
145330586|NCT02455050|524061889|FG002|Treatment Period 1|Lost to Follow-up|1|||
145330587|NCT02455050|524061890|FG003|Treatment Period 1|Lost to Follow-up|2|||
145330588|NCT02455050|524061887|FG000|Treatment Period 2|Lost to Follow-up|1|||
145330589|NCT02455050|524061888|FG001|Treatment Period 2|Lost to Follow-up|0|||
145330590|NCT02455050|524061889|FG002|Treatment Period 2|Lost to Follow-up|2|||
145330591|NCT02455050|524061890|FG003|Treatment Period 2|Lost to Follow-up|1|||
145330592|NCT03402750|524061891|FG000|Overall Study|Lost to Follow-up|2|||
145330593|NCT03402750|524061892|FG001|Overall Study|Lost to Follow-up|1|||
145330594|NCT02981303|524061893|FG000|Overall Study|Progressive Disease|17|||
145330595|NCT02981303|524061894|FG001|Overall Study|Progressive Disease|37|||
145330596|NCT02981303|524061893|FG000|Overall Study|Adverse Event|1|||
145330597|NCT02981303|524061894|FG001|Overall Study|Adverse Event|4|||
145330598|NCT02981303|524061893|FG000|Overall Study|Withdrawal by Subject|0|||
145330599|NCT02981303|524061894|FG001|Overall Study|Withdrawal by Subject|1|||
145330600|NCT00848107|524061895|FG000|Overall Study|Lost to Follow-up|2|||
145330601|NCT00848107|524061895|FG000|Overall Study|Withdrawal by Subject|8|||
145330602|NCT00848107|524061895|FG000|Overall Study|Adverse Event|9|||
145330603|NCT00848107|524061895|FG000|Overall Study|Death|1|||
145330604|NCT00848107|524061895|FG000|Overall Study|Pregnancy|1|||
145330605|NCT01831765|524061896|FG000|Overall Study|Lack of Efficacy|1|||
145330606|NCT01831765|524061897|FG001|Overall Study|Lack of Efficacy|0|||
145330607|NCT01831765|524061898|FG002|Overall Study|Lack of Efficacy|0|||
145330608|NCT01831765|524061896|FG000|Overall Study|Other, sponsor withdrew subject|0|||
145330609|NCT01831765|524061897|FG001|Overall Study|Other, sponsor withdrew subject|1|||
145330610|NCT01831765|524061898|FG002|Overall Study|Other, sponsor withdrew subject|0|||
145330611|NCT01831765|524061896|FG000|Overall Study|Pregnancy|1|||
145330612|NCT01831765|524061897|FG001|Overall Study|Pregnancy|1|||
145330613|NCT01831765|524061898|FG002|Overall Study|Pregnancy|2|||
145330614|NCT01831765|524061896|FG000|Overall Study|Death|0|||
145330615|NCT01831765|524061897|FG001|Overall Study|Death|1|||
145330616|NCT01831765|524061898|FG002|Overall Study|Death|1|||
145330617|NCT01831765|524061896|FG000|Overall Study|Other, site closed|1|||
145330618|NCT01831765|524061897|FG001|Overall Study|Other, site closed|1|||
145330619|NCT01831765|524061898|FG002|Overall Study|Other, site closed|0|||
145330620|NCT01831765|524061896|FG000|Overall Study|Adverse Event|5|||
145330621|NCT01831765|524061897|FG001|Overall Study|Adverse Event|3|||
145330622|NCT01831765|524061898|FG002|Overall Study|Adverse Event|3|||
145330623|NCT01831765|524061896|FG000|Overall Study|Withdrawal by Subject|22|||
145330624|NCT01831765|524061897|FG001|Overall Study|Withdrawal by Subject|7|||
145330625|NCT01831765|524061898|FG002|Overall Study|Withdrawal by Subject|17|||
145330626|NCT01831765|524061896|FG000|Overall Study|Withdrawal criteria|12|||
145330627|NCT01831765|524061897|FG001|Overall Study|Withdrawal criteria|10|||
145330628|NCT01831765|524061898|FG002|Overall Study|Withdrawal criteria|16|||
145330629|NCT01831765|524061896|FG000|Overall Study|Lost to Follow-up|2|||
145330630|NCT01831765|524061897|FG001|Overall Study|Lost to Follow-up|3|||
145330631|NCT01831765|524061898|FG002|Overall Study|Lost to Follow-up|3|||
145330632|NCT00507130|524061899|FG000|Overall Study|Lost to Follow-up|0|||
145330633|NCT00507130|524061900|FG001|Overall Study|Lost to Follow-up|0|||
145330634|NCT00507130|524061901|FG002|Overall Study|Lost to Follow-up|1|||
145330635|NCT00507130|524061902|FG003|Overall Study|Lost to Follow-up|1|||
145330636|NCT00507130|524061899|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
145330637|NCT00507130|524061900|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145330638|NCT00507130|524061901|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145330639|NCT00507130|524061902|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
145330640|NCT00859586|524061903|FG000|Overall Study|Donors|4|||
145330641|NCT02524730|524061904|FG000|Overall Study|Lost to Follow-up|5|||
145330642|NCT02524730|524061904|FG000|Overall Study|Withdrawal by Subject|18|||
145330643|NCT02524730|524061904|FG000|Overall Study|Death|10|||
145330644|NCT02524730|524061904|FG000|Overall Study|Adverse Event|8|||
145330645|NCT02524730|524061904|FG000|Overall Study|Protocol Violation|1|||
145330646|NCT02524730|524061904|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
145330647|NCT00080938|524061911|FG000|Overall Study|Adverse Event|3|||
145330648|NCT00080938|524061911|FG000|Overall Study|Withdrawal by Subject|6|||
145330649|NCT00080938|524061911|FG000|Overall Study|Death|2|||
145330650|NCT00080938|524061911|FG000|Overall Study|Lack of Efficacy|7|||
145330651|NCT00080938|524061911|FG000|Overall Study|other disease|1|||
145330652|NCT00080938|524061911|FG000|Overall Study|Not started protocol therapy|1|||
145330653|NCT00080938|524061911|FG000|Overall Study|Ineligible|4|||
145412230|NCT00479232|524363518|FG000|Overall Study|Progressive Disease|3|||
145412231|NCT00479232|524363519|FG001|Overall Study|Progressive Disease|1|||
145412232|NCT00479232|524363520|FG002|Overall Study|Progressive Disease|12|||
145412233|NCT00479232|524363521|FG003|Overall Study|Progressive Disease|3|||
145412234|NCT00479232|524363522|FG004|Overall Study|Progressive Disease|3|||
145412235|NCT00479232|524363523|FG005|Overall Study|Progressive Disease|12|||
145412236|NCT00479232|524363518|FG000|Overall Study|Withdrew Consent|0|||
145412237|NCT00479232|524363519|FG001|Overall Study|Withdrew Consent|2|||
145412238|NCT00479232|524363520|FG002|Overall Study|Withdrew Consent|6|||
145412239|NCT00479232|524363521|FG003|Overall Study|Withdrew Consent|0|||
145412240|NCT00479232|524363522|FG004|Overall Study|Withdrew Consent|1|||
145412241|NCT00479232|524363523|FG005|Overall Study|Withdrew Consent|3|||
145412242|NCT05399771|524363524|FG000|Overall Study|Physician Decision|3|||
145412243|NCT05399771|524363524|FG000|Overall Study|Adverse Event|1|||
145412244|NCT01373229|524363525|FG000|Overall Study|Death|3|||
145412245|NCT01373229|524363525|FG000|Overall Study|Physician Decision|3|||
145412246|NCT00484159|524363528|FG000|Overall Study|Lost to Follow-up|1|||
145412247|NCT00484159|524363529|FG001|Overall Study|Lost to Follow-up|1|||
145412248|NCT00484159|524363530|FG002|Overall Study|Lost to Follow-up|0|||
145412249|NCT04766333|524363531|FG000|Overall Study|Lost to Follow-up|40|||
145412250|NCT04766333|524363532|FG001|Overall Study|Lost to Follow-up|826|||
145412251|NCT03234881|524363533|FG000|Overall Study|Lost to Follow-up|9|||
145412252|NCT03234881|524363534|FG001|Overall Study|Lost to Follow-up|3|||
145412253|NCT03807843|524363535|FG000|Overall Study|Lost to Follow-up|1|||
145412254|NCT03807843|524363536|FG001|Overall Study|Lost to Follow-up|0|||
145412255|NCT01312129|524363537|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
145412256|NCT01312129|524363538|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
145412257|NCT03720847|524363539|FG000|Washout|Physician Decision|1|||
145412258|NCT03720847|524363540|FG001|Washout|Physician Decision|2|||
145412259|NCT01797185|524363545|FG000|Overall Study|Adverse Event|5|||
145412260|NCT01797185|524363546|FG001|Overall Study|Adverse Event|15|||
145412261|NCT01797185|524363547|FG002|Overall Study|Adverse Event|6|||
145412262|NCT01797185|524363545|FG000|Overall Study|Withdrawal by Subject|6|||
145412263|NCT01797185|524363546|FG001|Overall Study|Withdrawal by Subject|9|||
145571550|NCT00480636|524951692|FG000|Overall Study|Other|2|||
145571551|NCT00480636|524951692|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
145571552|NCT02583256|524951693|FG000|Overall Study|Withdrawal by Subject|0|||
145571553|NCT02583256|524951694|FG001|Overall Study|Withdrawal by Subject|1|||
145571554|NCT02583256|524951695|FG002|Overall Study|Withdrawal by Subject|1|||
145330654|NCT00706511|524061916|FG000|Overall Study|Withdrawal by Subject|1|||
145330655|NCT00706511|524061917|FG001|Overall Study|Withdrawal by Subject|0|||
145330656|NCT00706511|524061918|FG002|Overall Study|Withdrawal by Subject|0|||
145330657|NCT00706511|524061919|FG003|Overall Study|Withdrawal by Subject|0|||
145330658|NCT02605993|524061921|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145330659|NCT02605993|524061922|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145330660|NCT02605993|524061923|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
145330661|NCT02605993|524061924|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
145330662|NCT03493386|524061928|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145330663|NCT03493386|524061929|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
145330664|NCT03493386|524061930|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145330665|NCT03493386|524061931|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145330666|NCT04645966|524061932|FG000|Vaccination Phase|Adverse Event|1|||
145330667|NCT04645966|524061933|FG001|Vaccination Phase|Adverse Event|0|||
145330668|NCT04645966|524061934|FG002|Vaccination Phase|Adverse Event|0|||
145571555|NCT02583256|524951696|FG003|Overall Study|Withdrawal by Subject|0|||
145571556|NCT02583256|524951693|FG000|Overall Study|Lost to Follow-up|1|||
145571557|NCT02583256|524951694|FG001|Overall Study|Lost to Follow-up|1|||
145571558|NCT02583256|524951695|FG002|Overall Study|Lost to Follow-up|0|||
145330669|NCT04645966|524061935|FG003|Vaccination Phase|Adverse Event|0|||
145571559|NCT02583256|524951696|FG003|Overall Study|Lost to Follow-up|1|||
145571560|NCT02583256|524951693|FG000|Overall Study|Administrative/Other|2|||
145571561|NCT02583256|524951694|FG001|Overall Study|Administrative/Other|0|||
145571562|NCT02583256|524951695|FG002|Overall Study|Administrative/Other|1|||
145412264|NCT01797185|524363547|FG002|Overall Study|Withdrawal by Subject|5|||
145571563|NCT02583256|524951696|FG003|Overall Study|Administrative/Other|2|||
145571564|NCT02177266|524951703|FG000|Overall Study|Adverse Event|0|||
145412265|NCT01797185|524363545|FG000|Overall Study|Site terminated|8|||
145412266|NCT01797185|524363546|FG001|Overall Study|Site terminated|4|||
145412267|NCT01797185|524363547|FG002|Overall Study|Site terminated|0|||
145412268|NCT01797185|524363545|FG000|Overall Study|Lost to Follow-up|2|||
145412269|NCT01797185|524363546|FG001|Overall Study|Lost to Follow-up|6|||
145412270|NCT01797185|524363547|FG002|Overall Study|Lost to Follow-up|1|||
145412271|NCT01797185|524363545|FG000|Overall Study|Withdrawn per sponsor|5|||
145571565|NCT02177266|524951704|FG001|Overall Study|Adverse Event|1|||
145571566|NCT02177266|524951703|FG000|Overall Study|Withdrawal by Subject|1|||
145571567|NCT02177266|524951704|FG001|Overall Study|Withdrawal by Subject|0|||
145571568|NCT03364049|524951706|FG000|Overall Study|Death|6|||
145571569|NCT03364049|524951707|FG001|Overall Study|Death|4|||
145571570|NCT03364049|524951708|FG002|Overall Study|Death|5|||
145571571|NCT03364049|524951709|FG003|Overall Study|Death|14|||
145571572|NCT03364049|524951706|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
145571573|NCT03364049|524951707|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
145571574|NCT03364049|524951708|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
145571575|NCT03364049|524951709|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
145571576|NCT03364049|524951706|FG000|Overall Study|Withdrawal by Subject|0|||
145571577|NCT03364049|524951707|FG001|Overall Study|Withdrawal by Subject|1|||
145571578|NCT03364049|524951708|FG002|Overall Study|Withdrawal by Subject|1|||
145571579|NCT03364049|524951709|FG003|Overall Study|Withdrawal by Subject|1|||
145571580|NCT00546715|524951710|FG000|Overall Study|Withdrawal by Subject|0|||
145571581|NCT00546715|524951711|FG001|Overall Study|Withdrawal by Subject|1|||
145571582|NCT00546715|524951712|FG002|Overall Study|Withdrawal by Subject|0|||
145571583|NCT00546715|524951713|FG003|Overall Study|Withdrawal by Subject|0|||
145571584|NCT00418691|524951714|FG000|Overall Study|Lost to Follow-up|1|||
145571585|NCT00418691|524951715|FG001|Overall Study|Lost to Follow-up|2|||
145571586|NCT00418691|524951716|FG002|Overall Study|Lost to Follow-up|3|||
145571587|NCT00418691|524951714|FG000|Overall Study|Started new medication voiding entry|0|||
145571588|NCT00418691|524951715|FG001|Overall Study|Started new medication voiding entry|0|||
145571589|NCT00418691|524951716|FG002|Overall Study|Started new medication voiding entry|1|||
145571590|NCT00418691|524951714|FG000|Overall Study|Progressive Disease|1|||
145571591|NCT00418691|524951715|FG001|Overall Study|Progressive Disease|0|||
145571592|NCT00418691|524951716|FG002|Overall Study|Progressive Disease|1|||
145571593|NCT01802775|524951717|FG000|Overall Study|Death|0|||
145571594|NCT01802775|524951718|FG001|Overall Study|Death|3|||
145571595|NCT01802775|524951717|FG000|Overall Study|Reason not provided|0|||
145571596|NCT01802775|524951718|FG001|Overall Study|Reason not provided|1|||
145571597|NCT01802775|524951717|FG000|Overall Study|Physician Decision|1|||
145571598|NCT01802775|524951718|FG001|Overall Study|Physician Decision|0|||
145571599|NCT01802775|524951717|FG000|Overall Study|Adverse Event|1|||
145571600|NCT01802775|524951718|FG001|Overall Study|Adverse Event|1|||
145571601|NCT01802775|524951717|FG000|Overall Study|Withdrawal by Subject|3|||
145571602|NCT01802775|524951718|FG001|Overall Study|Withdrawal by Subject|5|||
145571603|NCT01802775|524951717|FG000|Overall Study|Lost to Follow-up|1|||
145571604|NCT01802775|524951718|FG001|Overall Study|Lost to Follow-up|2|||
145571605|NCT01096784|524951719|FG000|Overall Study|Withdrawal by Subject|2|||
145571606|NCT01096784|524951720|FG001|Overall Study|Withdrawal by Subject|1|||
145571607|NCT01096784|524951719|FG000|Overall Study|Adverse Event|11|||
145571608|NCT01096784|524951720|FG001|Overall Study|Adverse Event|9|||
145571609|NCT01096784|524951719|FG000|Overall Study|Protocol Deviation|2|||
145571610|NCT01096784|524951720|FG001|Overall Study|Protocol Deviation|2|||
145571611|NCT01096784|524951719|FG000|Overall Study|Administrative Decision|0|||
145571612|NCT01096784|524951720|FG001|Overall Study|Administrative Decision|1|||
145571613|NCT01096784|524951719|FG000|Overall Study|Other Unspecified|0|||
145571614|NCT01096784|524951720|FG001|Overall Study|Other Unspecified|1|||
145571615|NCT03761628|524951721|FG000|Overall Study|Withdrawal by Subject|3|||
145571616|NCT03761628|524951721|FG000|Overall Study|Physician Decision|1|||
145571617|NCT03761628|524951721|FG000|Overall Study|Pregnancy|1|||
145571618|NCT03761628|524951721|FG000|Overall Study|Lost to Follow-up|1|||
145571619|NCT04649151|524951724|FG000|Overall Study|Pregnancy|0|||
145571620|NCT04649151|524951725|FG001|Overall Study|Pregnancy|0|||
145330670|NCT04645966|524061936|FG004|Vaccination Phase|Adverse Event|0|||
145330671|NCT04645966|524061937|FG005|Vaccination Phase|Adverse Event|0|||
145330672|NCT04645966|524061938|FG006|Vaccination Phase|Adverse Event|1|||
145330673|NCT04645966|524061939|FG007|Vaccination Phase|Adverse Event|0|||
145571621|NCT04649151|524951726|FG002|Overall Study|Pregnancy|0|||
145571622|NCT04649151|524951727|FG003|Overall Study|Pregnancy|0|||
145571623|NCT04649151|524951728|FG004|Overall Study|Pregnancy|3|||
145571624|NCT04649151|524951724|FG000|Overall Study|Physician Decision|10|||
145571625|NCT04649151|524951725|FG001|Overall Study|Physician Decision|0|||
145571626|NCT04649151|524951726|FG002|Overall Study|Physician Decision|0|||
145571627|NCT04649151|524951727|FG003|Overall Study|Physician Decision|1|||
145571628|NCT04649151|524951728|FG004|Overall Study|Physician Decision|1|||
145571629|NCT04649151|524951724|FG000|Overall Study|Protocol Deviation|25|||
145571630|NCT04649151|524951725|FG001|Overall Study|Protocol Deviation|3|||
145571631|NCT04649151|524951726|FG002|Overall Study|Protocol Deviation|0|||
145571632|NCT04649151|524951727|FG003|Overall Study|Protocol Deviation|0|||
145571633|NCT04649151|524951728|FG004|Overall Study|Protocol Deviation|0|||
145571634|NCT04649151|524951724|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
145571635|NCT04649151|524951725|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
145571636|NCT04649151|524951726|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
145571637|NCT04649151|524951727|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
145620858|NCT03280563|525126631|FG004|Long-term Survival Follow-up|Death|6|||
145330674|NCT04645966|524061940|FG008|Vaccination Phase|Adverse Event|0|||
145330675|NCT04645966|524061932|FG000|Vaccination Phase|Death|0|||
145330676|NCT04645966|524061933|FG001|Vaccination Phase|Death|0|||
145620859|NCT03280563|525126632|FG005|Long-term Survival Follow-up|Death|18|||
145620860|NCT03280563|525126633|FG006|Long-term Survival Follow-up|Death|11|||
145620861|NCT03280563|525126634|FG007|Long-term Survival Follow-up|Death|1|||
145620862|NCT03280563|525126635|FG008|Long-term Survival Follow-up|Death|3|||
145620863|NCT03280563|525126627|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
145620864|NCT03280563|525126628|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
145620865|NCT03280563|525126629|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
145620866|NCT03280563|525126630|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
145620867|NCT03280563|525126631|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
145620868|NCT03280563|525126632|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
145620869|NCT03280563|525126633|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
145620870|NCT03280563|525126634|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
145620871|NCT03280563|525126635|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
145620872|NCT03280563|525126627|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
145620873|NCT03280563|525126628|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
145620874|NCT03280563|525126629|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
145620875|NCT03280563|525126630|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
145620876|NCT03280563|525126631|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
145620877|NCT03280563|525126632|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
145620878|NCT03280563|525126633|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
145330677|NCT04645966|524061934|FG002|Vaccination Phase|Death|0|||
145330678|NCT04645966|524061935|FG003|Vaccination Phase|Death|0|||
145330679|NCT04645966|524061936|FG004|Vaccination Phase|Death|0|||
145330680|NCT04645966|524061937|FG005|Vaccination Phase|Death|1|||
145330681|NCT04645966|524061938|FG006|Vaccination Phase|Death|0|||
145330682|NCT04645966|524061939|FG007|Vaccination Phase|Death|0|||
145330683|NCT04645966|524061940|FG008|Vaccination Phase|Death|0|||
145330684|NCT04645966|524061932|FG000|Vaccination Phase|Protocol Violation|0|||
145571638|NCT04649151|524951728|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
145571639|NCT04649151|524951724|FG000|Overall Study|Withdrawal by Subject|370|||
145571640|NCT04649151|524951725|FG001|Overall Study|Withdrawal by Subject|113|||
145571641|NCT04649151|524951726|FG002|Overall Study|Withdrawal by Subject|2|||
145571642|NCT04649151|524951727|FG003|Overall Study|Withdrawal by Subject|7|||
145571643|NCT04649151|524951728|FG004|Overall Study|Withdrawal by Subject|15|||
145571644|NCT04649151|524951724|FG000|Overall Study|Adverse Event|1|||
145571645|NCT04649151|524951725|FG001|Overall Study|Adverse Event|0|||
145571646|NCT04649151|524951726|FG002|Overall Study|Adverse Event|0|||
145571647|NCT04649151|524951727|FG003|Overall Study|Adverse Event|0|||
145571648|NCT04649151|524951728|FG004|Overall Study|Adverse Event|0|||
145571649|NCT04649151|524951724|FG000|Overall Study|Lost to Follow-up|256|||
145571650|NCT04649151|524951725|FG001|Overall Study|Lost to Follow-up|29|||
145571651|NCT04649151|524951726|FG002|Overall Study|Lost to Follow-up|10|||
145571652|NCT04649151|524951727|FG003|Overall Study|Lost to Follow-up|3|||
145571653|NCT04649151|524951728|FG004|Overall Study|Lost to Follow-up|6|||
145571654|NCT04649151|524951724|FG000|Overall Study|Other than specified|59|||
145571655|NCT04649151|524951725|FG001|Overall Study|Other than specified|294|||
145571656|NCT04649151|524951726|FG002|Overall Study|Other than specified|0|||
145571657|NCT04649151|524951727|FG003|Overall Study|Other than specified|0|||
145571658|NCT04649151|524951728|FG004|Overall Study|Other than specified|4|||
145571659|NCT04649151|524951724|FG000|Overall Study|Death|0|||
145571660|NCT04649151|524951725|FG001|Overall Study|Death|0|||
145571661|NCT04649151|524951726|FG002|Overall Study|Death|0|||
145571662|NCT04649151|524951727|FG003|Overall Study|Death|0|||
145571663|NCT04649151|524951728|FG004|Overall Study|Death|1|||
145571664|NCT02975934|524951729|FG000|Treatment Phase|Never initiated study drug|0|||
145571665|NCT02975934|524951730|FG001|Treatment Phase|Never initiated study drug|5|||
145571666|NCT02975934|524951731|FG002|Treatment Phase|Never initiated study drug|0|||
145571667|NCT03362502|524951732|FG000|Overall Study|Death|0|||
145620879|NCT03280563|525126634|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
145620880|NCT03280563|525126635|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
145330685|NCT04645966|524061933|FG001|Vaccination Phase|Protocol Violation|0|||
145330686|NCT04645966|524061934|FG002|Vaccination Phase|Protocol Violation|0|||
145330687|NCT04645966|524061935|FG003|Vaccination Phase|Protocol Violation|0|||
145330688|NCT04645966|524061936|FG004|Vaccination Phase|Protocol Violation|1|||
145571668|NCT03362502|524951733|FG001|Overall Study|Death|0|||
145571669|NCT03362502|524951734|FG002|Overall Study|Death|1|||
145571670|NCT00433654|524951737|FG000|Overall Study|Death|4|||
145571671|NCT00433654|524951738|FG001|Overall Study|Death|0|||
145571672|NCT00433654|524951737|FG000|Overall Study|Missed visit|6|||
145330689|NCT04645966|524061937|FG005|Vaccination Phase|Protocol Violation|0|||
145571673|NCT00433654|524951738|FG001|Overall Study|Missed visit|3|||
145571674|NCT00433654|524951737|FG000|Overall Study|Subject not yet due for visit|4|||
145571675|NCT00433654|524951738|FG001|Overall Study|Subject not yet due for visit|0|||
145620881|NCT03280563|525126627|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
145620882|NCT03280563|525126628|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
145620883|NCT03280563|525126629|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
145620884|NCT03280563|525126630|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
145620885|NCT03280563|525126631|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
145620886|NCT03280563|525126632|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
145620887|NCT03280563|525126633|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
145620888|NCT03280563|525126634|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
145620889|NCT03280563|525126635|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
145620890|NCT04213846|525126636|FG000|Overall Study|Withdrawal by Subject|7|||
145620891|NCT04213846|525126637|FG001|Overall Study|Withdrawal by Subject|6|||
145620892|NCT04213846|525126636|FG000|Overall Study|Lost to Follow-up|15|||
145620893|NCT04213846|525126637|FG001|Overall Study|Lost to Follow-up|21|||
145330690|NCT04645966|524061938|FG006|Vaccination Phase|Protocol Violation|0|||
145620894|NCT00354029|525126640|FG000|Overall Study|Protocol Violation|4|||
145620895|NCT00354029|525126641|FG001|Overall Study|Protocol Violation|2|||
145620896|NCT03930186|525126642|FG000|Weeks 0 to 16|Adverse Event|6|||
145620897|NCT03930186|525126642|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
145620898|NCT03930186|525126642|FG000|Weeks 16 to 32|Adverse Event|1|||
145620899|NCT03930186|525126642|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
145620900|NCT01782326|525126648|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
145620901|NCT01782326|525126649|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
145620902|NCT01782326|525126648|FG000|Planned Treatment Epoch|Death|29|||
145620903|NCT01782326|525126649|FG001|Planned Treatment Epoch|Death|30|||
145620904|NCT01782326|525126648|FG000|Planned Treatment Epoch|Physician Decision|18|||
145620905|NCT01782326|525126649|FG001|Planned Treatment Epoch|Physician Decision|16|||
145620906|NCT01782326|525126648|FG000|Planned Treatment Epoch|Protocol deviation|2|||
145620907|NCT01782326|525126649|FG001|Planned Treatment Epoch|Protocol deviation|3|||
145620908|NCT01782326|525126648|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
145620909|NCT01782326|525126649|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
145620910|NCT01782326|525126648|FG000|Planned Treatment Epoch|Technical problems|0|||
145620911|NCT01782326|525126649|FG001|Planned Treatment Epoch|Technical problems|4|||
145620912|NCT01782326|525126648|FG000|Double-blind Treatment|Adverse Event|129|||
145620913|NCT01782326|525126649|FG001|Double-blind Treatment|Adverse Event|145|||
145620914|NCT01782326|525126648|FG000|Double-blind Treatment|Subject/guardian decision|111|||
145620915|NCT01782326|525126649|FG001|Double-blind Treatment|Subject/guardian decision|125|||
145620916|NCT01782326|525126648|FG000|Double-blind Treatment|Lack of Efficacy|17|||
145620917|NCT01782326|525126649|FG001|Double-blind Treatment|Lack of Efficacy|22|||
145620918|NCT01782326|525126648|FG000|Double-blind Treatment|Physician Decision|13|||
145620919|NCT01782326|525126649|FG001|Double-blind Treatment|Physician Decision|16|||
145620920|NCT01782326|525126648|FG000|Double-blind Treatment|Protocol deviation|8|||
145620921|NCT01782326|525126649|FG001|Double-blind Treatment|Protocol deviation|7|||
145620922|NCT01782326|525126648|FG000|Double-blind Treatment|Technical problems|0|||
145620923|NCT01782326|525126649|FG001|Double-blind Treatment|Technical problems|5|||
145620924|NCT02559817|525126650|FG000|Treatment Period|Adverse Event|1|||
145620925|NCT02559817|525126651|FG001|Treatment Period|Adverse Event|0|||
145620926|NCT02559817|525126652|FG002|Treatment Period|Adverse Event|1|||
145620927|NCT02559817|525126653|FG003|Treatment Period|Adverse Event|0|||
145620928|NCT02559817|525126654|FG004|Treatment Period|Adverse Event|0|||
145620929|NCT02559817|525126650|FG000|Treatment Period|Lack of Efficacy|0|||
145620930|NCT02559817|525126651|FG001|Treatment Period|Lack of Efficacy|1|||
145620931|NCT02559817|525126652|FG002|Treatment Period|Lack of Efficacy|0|||
145620932|NCT02559817|525126653|FG003|Treatment Period|Lack of Efficacy|0|||
145620933|NCT02559817|525126654|FG004|Treatment Period|Lack of Efficacy|0|||
145620934|NCT02559817|525126650|FG000|Treatment Period|Lost to Follow-up|0|||
145620935|NCT02559817|525126651|FG001|Treatment Period|Lost to Follow-up|1|||
145620936|NCT02559817|525126652|FG002|Treatment Period|Lost to Follow-up|0|||
145620937|NCT02559817|525126653|FG003|Treatment Period|Lost to Follow-up|1|||
145620938|NCT02559817|525126654|FG004|Treatment Period|Lost to Follow-up|0|||
145620939|NCT02559817|525126650|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
145330691|NCT04645966|524061939|FG007|Vaccination Phase|Protocol Violation|0|||
145330692|NCT04645966|524061940|FG008|Vaccination Phase|Protocol Violation|0|||
145330693|NCT04645966|524061932|FG000|Vaccination Phase|Study terminated by sponsor|0|||
145330694|NCT04645966|524061933|FG001|Vaccination Phase|Study terminated by sponsor|0|||
145330695|NCT04645966|524061934|FG002|Vaccination Phase|Study terminated by sponsor|14|||
145330696|NCT04645966|524061935|FG003|Vaccination Phase|Study terminated by sponsor|15|||
145620940|NCT02559817|525126651|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
145620941|NCT02559817|525126652|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
145620942|NCT02559817|525126653|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
145620943|NCT02559817|525126654|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
145620944|NCT02559817|525126650|FG000|Treatment Period|Protocol Violation|0|||
145620945|NCT02559817|525126651|FG001|Treatment Period|Protocol Violation|0|||
145620946|NCT02559817|525126652|FG002|Treatment Period|Protocol Violation|0|||
145620947|NCT02559817|525126653|FG003|Treatment Period|Protocol Violation|1|||
145412272|NCT01797185|524363546|FG001|Overall Study|Withdrawn per sponsor|0|||
145412273|NCT01797185|524363547|FG002|Overall Study|Withdrawn per sponsor|0|||
145412274|NCT01797185|524363545|FG000|Overall Study|Physician Decision|1|||
145412275|NCT01797185|524363546|FG001|Overall Study|Physician Decision|3|||
145412276|NCT01797185|524363547|FG002|Overall Study|Physician Decision|0|||
145412277|NCT01797185|524363545|FG000|Overall Study|Protocol Violation|1|||
145412278|NCT01797185|524363546|FG001|Overall Study|Protocol Violation|1|||
145412279|NCT01797185|524363547|FG002|Overall Study|Protocol Violation|0|||
145412280|NCT01047501|524363549|FG000|Overall Study|Adverse Event|7|||
145412281|NCT01047501|524363550|FG001|Overall Study|Adverse Event|8|||
145412282|NCT01047501|524363551|FG002|Overall Study|Adverse Event|5|||
145412283|NCT01047501|524363549|FG000|Overall Study|Withdrew Consent|6|||
145412284|NCT01047501|524363550|FG001|Overall Study|Withdrew Consent|2|||
145412285|NCT01047501|524363551|FG002|Overall Study|Withdrew Consent|4|||
145412286|NCT01047501|524363549|FG000|Overall Study|Lost to Follow-up|0|||
145412287|NCT01047501|524363550|FG001|Overall Study|Lost to Follow-up|1|||
145412288|NCT01047501|524363551|FG002|Overall Study|Lost to Follow-up|1|||
145412289|NCT01047501|524363549|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
145412290|NCT01047501|524363550|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
145412291|NCT01047501|524363551|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
145412292|NCT01047501|524363549|FG000|Overall Study|Death|1|||
145412293|NCT01047501|524363550|FG001|Overall Study|Death|0|||
145412294|NCT01047501|524363551|FG002|Overall Study|Death|0|||
145412295|NCT01047501|524363549|FG000|Overall Study|Other discontinuation|1|||
145412296|NCT01047501|524363550|FG001|Overall Study|Other discontinuation|0|||
145412297|NCT01047501|524363551|FG002|Overall Study|Other discontinuation|1|||
145412298|NCT01047501|524363549|FG000|Overall Study|Investigator judgement|0|||
145412299|NCT01047501|524363550|FG001|Overall Study|Investigator judgement|0|||
145412300|NCT01047501|524363551|FG002|Overall Study|Investigator judgement|1|||
145412301|NCT04602000|524363552|FG000|Overall Study|Withdrawal by Subject|3|||
145412302|NCT04602000|524363553|FG001|Overall Study|Withdrawal by Subject|6|||
145412303|NCT04602000|524363554|FG002|Overall Study|Withdrawal by Subject|3|||
145412304|NCT04602000|524363555|FG003|Overall Study|Withdrawal by Subject|27|||
145412305|NCT04602000|524363556|FG004|Overall Study|Withdrawal by Subject|39|||
145412306|NCT04602000|524363552|FG000|Overall Study|Physician Decision|1|||
145412307|NCT04602000|524363553|FG001|Overall Study|Physician Decision|0|||
145412308|NCT04602000|524363554|FG002|Overall Study|Physician Decision|0|||
145412309|NCT04602000|524363555|FG003|Overall Study|Physician Decision|2|||
145412310|NCT04602000|524363556|FG004|Overall Study|Physician Decision|2|||
145412311|NCT04602000|524363552|FG000|Overall Study|Death|0|||
145412312|NCT04602000|524363553|FG001|Overall Study|Death|1|||
145412313|NCT04602000|524363554|FG002|Overall Study|Death|0|||
145412314|NCT04602000|524363555|FG003|Overall Study|Death|1|||
145412315|NCT04602000|524363556|FG004|Overall Study|Death|2|||
145412316|NCT04602000|524363552|FG000|Overall Study|Lost to Follow-up|0|||
145412317|NCT04602000|524363553|FG001|Overall Study|Lost to Follow-up|0|||
145412318|NCT04602000|524363554|FG002|Overall Study|Lost to Follow-up|0|||
145412319|NCT04602000|524363555|FG003|Overall Study|Lost to Follow-up|3|||
145330697|NCT04645966|524061936|FG004|Vaccination Phase|Study terminated by sponsor|47|||
145330698|NCT04645966|524061937|FG005|Vaccination Phase|Study terminated by sponsor|43|||
145330699|NCT04645966|524061938|FG006|Vaccination Phase|Study terminated by sponsor|29|||
145330700|NCT04645966|524061939|FG007|Vaccination Phase|Study terminated by sponsor|29|||
145330701|NCT04645966|524061940|FG008|Vaccination Phase|Study terminated by sponsor|12|||
145330702|NCT04645966|524061932|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
145330703|NCT04645966|524061933|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
145330704|NCT04645966|524061934|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
145330705|NCT04645966|524061935|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
145330706|NCT04645966|524061936|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
145330707|NCT04645966|524061937|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
145330708|NCT04645966|524061938|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
145330709|NCT04645966|524061939|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
145330710|NCT04645966|524061940|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
145330711|NCT04645966|524061932|FG000|Vaccination Phase|Other|0|||
145330712|NCT04645966|524061933|FG001|Vaccination Phase|Other|0|||
145330713|NCT04645966|524061934|FG002|Vaccination Phase|Other|0|||
145330714|NCT04645966|524061935|FG003|Vaccination Phase|Other|0|||
145330715|NCT04645966|524061936|FG004|Vaccination Phase|Other|0|||
145330716|NCT04645966|524061937|FG005|Vaccination Phase|Other|2|||
145412320|NCT04602000|524363556|FG004|Overall Study|Lost to Follow-up|4|||
145412321|NCT04602000|524363552|FG000|Overall Study|Other|4|||
145330717|NCT04645966|524061938|FG006|Vaccination Phase|Other|0|||
145330718|NCT04645966|524061939|FG007|Vaccination Phase|Other|0|||
145412322|NCT04602000|524363553|FG001|Overall Study|Other|1|||
145412323|NCT04602000|524363554|FG002|Overall Study|Other|2|||
145412324|NCT04602000|524363555|FG003|Overall Study|Other|5|||
145412325|NCT04602000|524363556|FG004|Overall Study|Other|4|||
145412326|NCT04602000|524363552|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145412327|NCT04602000|524363553|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145330719|NCT04645966|524061940|FG008|Vaccination Phase|Other|0|||
145330720|NCT04645966|524061932|FG000|Vaccination Phase|Lost to Follow-up|0|||
145330721|NCT04645966|524061933|FG001|Vaccination Phase|Lost to Follow-up|0|||
145330722|NCT04645966|524061934|FG002|Vaccination Phase|Lost to Follow-up|0|||
145330723|NCT04645966|524061935|FG003|Vaccination Phase|Lost to Follow-up|0|||
145330724|NCT04645966|524061936|FG004|Vaccination Phase|Lost to Follow-up|0|||
145330725|NCT04645966|524061937|FG005|Vaccination Phase|Lost to Follow-up|0|||
145330726|NCT04645966|524061938|FG006|Vaccination Phase|Lost to Follow-up|0|||
145330727|NCT04645966|524061939|FG007|Vaccination Phase|Lost to Follow-up|1|||
145330728|NCT04645966|524061940|FG008|Vaccination Phase|Lost to Follow-up|0|||
145330729|NCT04645966|524061932|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
145330730|NCT04645966|524061933|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
145330731|NCT04645966|524061934|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
145330732|NCT04645966|524061935|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
145330733|NCT04645966|524061936|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
145330734|NCT04645966|524061937|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
145330735|NCT04645966|524061938|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
145330736|NCT04645966|524061939|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
145330737|NCT04645966|524061940|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
145330738|NCT04645966|524061932|FG000|Follow-up Phase|Lost to Follow-up|0|||
145330739|NCT04645966|524061933|FG001|Follow-up Phase|Lost to Follow-up|0|||
145330740|NCT04645966|524061934|FG002|Follow-up Phase|Lost to Follow-up|0|||
145330741|NCT04645966|524061935|FG003|Follow-up Phase|Lost to Follow-up|0|||
145330742|NCT04645966|524061936|FG004|Follow-up Phase|Lost to Follow-up|0|||
145330743|NCT04645966|524061937|FG005|Follow-up Phase|Lost to Follow-up|0|||
145330744|NCT04645966|524061938|FG006|Follow-up Phase|Lost to Follow-up|0|||
145330745|NCT04645966|524061939|FG007|Follow-up Phase|Lost to Follow-up|1|||
145330746|NCT04645966|524061940|FG008|Follow-up Phase|Lost to Follow-up|0|||
145412328|NCT04602000|524363554|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
145620948|NCT02559817|525126654|FG004|Treatment Period|Protocol Violation|0|||
145620949|NCT03389893|525126655|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
145620950|NCT03389893|525126656|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
145620951|NCT03389893|525126657|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
145620952|NCT03389893|525126658|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
145620953|NCT03389893|525126655|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
145620954|NCT03389893|525126656|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
145620955|NCT03389893|525126657|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
145620956|NCT03389893|525126658|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
145620957|NCT03389893|525126655|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
145620958|NCT03389893|525126656|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
145620959|NCT03389893|525126657|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
145620960|NCT03389893|525126658|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
145620961|NCT03389893|525126655|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
145620962|NCT03389893|525126656|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
145620963|NCT03389893|525126657|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
145620964|NCT03389893|525126658|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
145620965|NCT03160079|525126661|FG000|Overall Study|Adverse Event|2|||
145620966|NCT03160079|525126662|FG001|Overall Study|Adverse Event|0|||
145620967|NCT03160079|525126661|FG000|Overall Study|Disease Progression|1|||
145620968|NCT03160079|525126662|FG001|Overall Study|Disease Progression|0|||
145620969|NCT03160079|525126661|FG000|Overall Study|Physician Decision|1|||
145620970|NCT03160079|525126662|FG001|Overall Study|Physician Decision|0|||
145620971|NCT04955626|525126672|FG000|Blinded Period|Lost to Follow-up|28|||
145620972|NCT04955626|525126673|FG001|Blinded Period|Lost to Follow-up|28|||
145620973|NCT04955626|525126674|FG002|Blinded Period|Lost to Follow-up|7|||
145620974|NCT04955626|525126675|FG003|Blinded Period|Lost to Follow-up|14|||
145620975|NCT04955626|525126676|FG004|Blinded Period|Lost to Follow-up|3|||
145620976|NCT04955626|525126677|FG005|Blinded Period|Lost to Follow-up|2|||
145620977|NCT04955626|525126678|FG006|Blinded Period|Lost to Follow-up|6|||
145620978|NCT04955626|525126679|FG007|Blinded Period|Lost to Follow-up|4|||
145620979|NCT04955626|525126680|FG008|Blinded Period|Lost to Follow-up|5|||
145620980|NCT04955626|525126681|FG009|Blinded Period|Lost to Follow-up|8|||
145620981|NCT04955626|525126682|FG010|Blinded Period|Lost to Follow-up|10|||
145620982|NCT04955626|525126683|FG011|Blinded Period|Lost to Follow-up|32|||
145620983|NCT04955626|525126684|FG012|Blinded Period|Lost to Follow-up|0|||
145620984|NCT04955626|525126685|FG013|Blinded Period|Lost to Follow-up|0|||
145620985|NCT04955626|525126686|FG014|Blinded Period|Lost to Follow-up|0|||
145620986|NCT04955626|525126687|FG015|Blinded Period|Lost to Follow-up|12|||
145620987|NCT04955626|525126688|FG016|Blinded Period|Lost to Follow-up|2|||
145620988|NCT04955626|525126689|FG017|Blinded Period|Lost to Follow-up|5|||
145620989|NCT04955626|525126690|FG018|Blinded Period|Lost to Follow-up|0|||
145620990|NCT04955626|525126691|FG019|Blinded Period|Lost to Follow-up|0|||
145620991|NCT04955626|525126692|FG020|Blinded Period|Lost to Follow-up|0|||
145620992|NCT04955626|525126693|FG021|Blinded Period|Lost to Follow-up|0|||
145620993|NCT04955626|525126694|FG022|Blinded Period|Lost to Follow-up|0|||
145620994|NCT04955626|525126695|FG023|Blinded Period|Lost to Follow-up|0|||
145620995|NCT04955626|525126696|FG024|Blinded Period|Lost to Follow-up|3|||
145620996|NCT04955626|525126697|FG025|Blinded Period|Lost to Follow-up|1|||
145620997|NCT04955626|525126698|FG026|Blinded Period|Lost to Follow-up|2|||
145620998|NCT04955626|525126699|FG027|Blinded Period|Lost to Follow-up|2|||
145620999|NCT04955626|525126700|FG028|Blinded Period|Lost to Follow-up|2|||
145330747|NCT03246126|524061941|FG000|Overall Study|Withdrawal by Subject|0|||
145330748|NCT03246126|524061942|FG001|Overall Study|Withdrawal by Subject|1|||
145330749|NCT01460901|524061943|FG000|Overall Study|Withdrawal by Subject|2|||
145571676|NCT00433654|524951737|FG000|Overall Study|Withdrawal by Subject|1|||
145571677|NCT00433654|524951738|FG001|Overall Study|Withdrawal by Subject|2|||
145571678|NCT06034496|524951739|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
145571679|NCT06034496|524951740|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
145571680|NCT06034496|524951739|FG000|Overall Study|Withdrawal by Subject|5|||
145571681|NCT06034496|524951740|FG001|Overall Study|Withdrawal by Subject|4|||
145571682|NCT05179421|524951741|FG000|First Infusion Day|Adverse Event|1|||
145571683|NCT05179421|524951742|FG001|First Infusion Day|Adverse Event|0|||
145571684|NCT01393743|524951748|FG000|Core Study|Adverse Event|5|||
145571685|NCT01393743|524951749|FG001|Core Study|Adverse Event|9|||
145571686|NCT01393743|524951750|FG002|Core Study|Adverse Event|0|||
145571687|NCT01393743|524951748|FG000|Core Study|Lost to Follow-up|1|||
145571688|NCT01393743|524951749|FG001|Core Study|Lost to Follow-up|1|||
145571689|NCT01393743|524951750|FG002|Core Study|Lost to Follow-up|0|||
145571690|NCT01393743|524951748|FG000|Core Study|Participant's Choice|2|||
145571691|NCT01393743|524951749|FG001|Core Study|Participant's Choice|3|||
145571692|NCT01393743|524951750|FG002|Core Study|Participant's Choice|0|||
145571693|NCT01393743|524951748|FG000|Core Study|Inadequate therapeutic effect|2|||
145571694|NCT01393743|524951749|FG001|Core Study|Inadequate therapeutic effect|0|||
145571695|NCT01393743|524951750|FG002|Core Study|Inadequate therapeutic effect|0|||
145571696|NCT01393743|524951748|FG000|Extension Phase|Adverse Event|0|||
145571697|NCT01393743|524951749|FG001|Extension Phase|Adverse Event|0|||
145571698|NCT01393743|524951750|FG002|Extension Phase|Adverse Event|12|||
145571699|NCT01393743|524951748|FG000|Extension Phase|Lost to Follow-up|0|||
145571700|NCT01393743|524951749|FG001|Extension Phase|Lost to Follow-up|0|||
145571701|NCT01393743|524951750|FG002|Extension Phase|Lost to Follow-up|2|||
145571702|NCT01393743|524951748|FG000|Extension Phase|Participant choice|0|||
145571703|NCT01393743|524951749|FG001|Extension Phase|Participant choice|0|||
145571704|NCT01393743|524951750|FG002|Extension Phase|Participant choice|16|||
145571705|NCT01393743|524951748|FG000|Extension Phase|Inadequate therapeutic effect|0|||
145571706|NCT01393743|524951749|FG001|Extension Phase|Inadequate therapeutic effect|0|||
145571707|NCT01393743|524951750|FG002|Extension Phase|Inadequate therapeutic effect|7|||
145571708|NCT01393743|524951748|FG000|Extension Phase|Withdrawal by Subject|0|||
145571709|NCT01393743|524951749|FG001|Extension Phase|Withdrawal by Subject|0|||
145571710|NCT01393743|524951750|FG002|Extension Phase|Withdrawal by Subject|8|||
145571711|NCT01393743|524951748|FG000|Extension Phase|Pregnancy|0|||
145571712|NCT01393743|524951749|FG001|Extension Phase|Pregnancy|0|||
145571713|NCT01393743|524951750|FG002|Extension Phase|Pregnancy|1|||
145571714|NCT01393743|524951748|FG000|Extension Phase|Other|0|||
145571715|NCT01393743|524951749|FG001|Extension Phase|Other|0|||
145571716|NCT01393743|524951750|FG002|Extension Phase|Other|14|||
145571717|NCT01723228|524951752|FG000|Overall Study|Adverse Event|2|||
145571718|NCT01723228|524951753|FG001|Overall Study|Adverse Event|6|||
145571719|NCT01723228|524951752|FG000|Overall Study|Withdrawal by Subject|2|||
145571720|NCT01723228|524951753|FG001|Overall Study|Withdrawal by Subject|1|||
145571721|NCT01723228|524951752|FG000|Overall Study|Protocol Violation|0|||
145571722|NCT01723228|524951753|FG001|Overall Study|Protocol Violation|2|||
145571723|NCT01723228|524951752|FG000|Overall Study|Lost to Follow-up|2|||
145571724|NCT01723228|524951753|FG001|Overall Study|Lost to Follow-up|1|||
145571725|NCT01723228|524951752|FG000|Overall Study|Other|2|||
145571726|NCT01723228|524951753|FG001|Overall Study|Other|1|||
145571727|NCT01806896|524951754|FG000|Overall Study|Adverse Event|2|||
145571728|NCT01806896|524951755|FG001|Overall Study|Adverse Event|0|||
145571729|NCT01806896|524951754|FG000|Overall Study|Other|1|||
145571730|NCT01806896|524951755|FG001|Overall Study|Other|0|||
145571731|NCT02434770|524951756|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
145571732|NCT02434770|524951757|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
145621000|NCT04955626|525126701|FG029|Blinded Period|Lost to Follow-up|0|||
145571733|NCT02434770|524951758|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
145571734|NCT02434770|524951756|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
145571735|NCT02434770|524951757|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
145571736|NCT02434770|524951758|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
145571737|NCT02434770|524951756|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
145571738|NCT02434770|524951757|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
145571739|NCT02434770|524951758|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
145571740|NCT02434770|524951756|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
145571741|NCT02434770|524951757|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
145571742|NCT02434770|524951758|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
145571743|NCT02434770|524951756|FG000|Week 1 to Week 18|Death|1|||
145571744|NCT02434770|524951757|FG001|Week 1 to Week 18|Death|0|||
145571745|NCT02434770|524951758|FG002|Week 1 to Week 18|Death|0|||
145330750|NCT01156142|524061944|FG000|Overall Study|Withdrawal by Subject|8|||
145330751|NCT01156142|524061945|FG001|Overall Study|Withdrawal by Subject|6|||
145330752|NCT01156142|524061944|FG000|Overall Study|Ineligible|0|||
145330753|NCT01156142|524061945|FG001|Overall Study|Ineligible|1|||
145330754|NCT00893737|524061946|FG000|Overall Study|Adverse Event|4|||
145330755|NCT00893737|524061946|FG000|Overall Study|Withdrawal by Subject|2|||
145330756|NCT00893737|524061946|FG000|Overall Study|Lost to Follow-up|6|||
145330757|NCT03981419|524061947|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
145330758|NCT03981419|524061948|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
145330759|NCT01330459|524061949|FG000|Overall Study|Physician Decision|0|||
145330760|NCT01330459|524061950|FG001|Overall Study|Physician Decision|2|||
145330761|NCT00895947|524061952|FG000|Overall Study|Adverse Event|3|||
145330762|NCT00895947|524061953|FG001|Overall Study|Adverse Event|4|||
145330763|NCT00895947|524061952|FG000|Overall Study|Lost to Follow-up|3|||
145330764|NCT00895947|524061953|FG001|Overall Study|Lost to Follow-up|4|||
145330765|NCT00895947|524061952|FG000|Overall Study|Protocol Violation|4|||
145330766|NCT00895947|524061953|FG001|Overall Study|Protocol Violation|2|||
145330767|NCT00895947|524061952|FG000|Overall Study|Withdrawal by Subject|2|||
145330768|NCT00895947|524061953|FG001|Overall Study|Withdrawal by Subject|0|||
145330769|NCT02272634|524061956|FG000|Overall Study|Adverse Event|1|||
145330770|NCT02272634|524061957|FG001|Overall Study|Adverse Event|0|||
145330771|NCT02272634|524061958|FG002|Overall Study|Adverse Event|0|||
145330772|NCT02272634|524061956|FG000|Overall Study|Protocol Violation|0|||
145330773|NCT02272634|524061957|FG001|Overall Study|Protocol Violation|0|||
145330774|NCT02272634|524061958|FG002|Overall Study|Protocol Violation|1|||
145330775|NCT02272634|524061956|FG000|Overall Study|Withdrawal by Subject|0|||
145330776|NCT02272634|524061957|FG001|Overall Study|Withdrawal by Subject|1|||
145330777|NCT02272634|524061958|FG002|Overall Study|Withdrawal by Subject|0|||
145330778|NCT04620135|524061959|FG000|Study Completion|Adverse Event|2|||
145330779|NCT04620135|524061960|FG001|Study Completion|Adverse Event|3|||
145330780|NCT04620135|524061959|FG000|Study Completion|Withdrawal by Subject|2|||
145330781|NCT04620135|524061960|FG001|Study Completion|Withdrawal by Subject|0|||
145330782|NCT01437943|524061961|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
145330783|NCT01437943|524061962|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
145330784|NCT01437943|524061961|FG000|Overall Study|Subject expressed pregnancy plans|1|||
145330785|NCT01437943|524061962|FG001|Overall Study|Subject expressed pregnancy plans|0|||
145330786|NCT01437943|524061961|FG000|Overall Study|Adverse Event|2|||
145330787|NCT01437943|524061962|FG001|Overall Study|Adverse Event|0|||
145330788|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
145330789|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
145330790|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
145330791|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
145330792|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
145330793|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
145330794|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
145330795|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
145330796|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
145330797|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
145330798|NCT04771403|524061963|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
145330799|NCT04771403|524061964|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
145330800|NCT04771403|524061963|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
145330801|NCT04771403|524061964|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
145330802|NCT04771403|524061963|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
145330803|NCT04771403|524061964|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
145330804|NCT00369382|524061965|FG000|Overall Study|Death|0|||
145330805|NCT00369382|524061966|FG001|Overall Study|Death|2|||
145330806|NCT00369382|524061965|FG000|Overall Study|Physician Decision|2|||
145571746|NCT02434770|524951756|FG000|Week 18 to Week|Lost to Follow-up|2|||
145330807|NCT00369382|524061966|FG001|Overall Study|Physician Decision|1|||
145330808|NCT00369382|524061965|FG000|Overall Study|Withdrawal by Subject|5|||
145330809|NCT00369382|524061966|FG001|Overall Study|Withdrawal by Subject|0|||
145571747|NCT02434770|524951757|FG001|Week 18 to Week|Lost to Follow-up|2|||
145571748|NCT02434770|524951758|FG002|Week 18 to Week|Lost to Follow-up|1|||
145330810|NCT00369382|524061965|FG000|Overall Study|Randomized, not treated|2|||
145330811|NCT00369382|524061966|FG001|Overall Study|Randomized, not treated|0|||
145330812|NCT00369382|524061965|FG000|Overall Study|Other|1|||
145330813|NCT00369382|524061966|FG001|Overall Study|Other|0|||
145330814|NCT00446199|524061970|FG000|Overall Study|Adverse Event|7|||
145330815|NCT00446199|524061971|FG001|Overall Study|Adverse Event|4|||
145330816|NCT00446199|524061972|FG002|Overall Study|Adverse Event|6|||
145330817|NCT00446199|524061973|FG003|Overall Study|Adverse Event|4|||
145330818|NCT00446199|524061970|FG000|Overall Study|Lost to Follow-up|4|||
145330819|NCT00446199|524061971|FG001|Overall Study|Lost to Follow-up|5|||
145330820|NCT00446199|524061972|FG002|Overall Study|Lost to Follow-up|2|||
145330821|NCT00446199|524061973|FG003|Overall Study|Lost to Follow-up|6|||
145330822|NCT00446199|524061970|FG000|Overall Study|Protocol Violation|1|||
145330823|NCT00446199|524061971|FG001|Overall Study|Protocol Violation|2|||
145330824|NCT00446199|524061972|FG002|Overall Study|Protocol Violation|1|||
145330825|NCT00446199|524061973|FG003|Overall Study|Protocol Violation|3|||
145330826|NCT00446199|524061970|FG000|Overall Study|Withdrawal by Subject|2|||
145330827|NCT00446199|524061971|FG001|Overall Study|Withdrawal by Subject|5|||
145330828|NCT00446199|524061972|FG002|Overall Study|Withdrawal by Subject|9|||
145330829|NCT00446199|524061973|FG003|Overall Study|Withdrawal by Subject|10|||
145330830|NCT00446199|524061970|FG000|Overall Study|Site termination|2|||
145330831|NCT00446199|524061971|FG001|Overall Study|Site termination|0|||
145330832|NCT00446199|524061972|FG002|Overall Study|Site termination|0|||
145330833|NCT00446199|524061973|FG003|Overall Study|Site termination|1|||
145330834|NCT00446199|524061970|FG000|Overall Study|Randomization in Error|2|||
145330835|NCT00446199|524061971|FG001|Overall Study|Randomization in Error|0|||
145330836|NCT00446199|524061972|FG002|Overall Study|Randomization in Error|1|||
145330837|NCT00446199|524061973|FG003|Overall Study|Randomization in Error|1|||
145330838|NCT00446199|524061970|FG000|Overall Study|Lack of Efficacy|1|||
145330839|NCT00446199|524061971|FG001|Overall Study|Lack of Efficacy|0|||
145330840|NCT00446199|524061972|FG002|Overall Study|Lack of Efficacy|0|||
145330841|NCT00446199|524061973|FG003|Overall Study|Lack of Efficacy|1|||
145330842|NCT00446199|524061970|FG000|Overall Study|Non-compliant with study drug|1|||
145330843|NCT00446199|524061971|FG001|Overall Study|Non-compliant with study drug|0|||
145330844|NCT00446199|524061972|FG002|Overall Study|Non-compliant with study drug|5|||
145330845|NCT00446199|524061973|FG003|Overall Study|Non-compliant with study drug|0|||
145330846|NCT00446199|524061970|FG000|Overall Study|Non-compliant with visit schedule|1|||
145330847|NCT00446199|524061971|FG001|Overall Study|Non-compliant with visit schedule|1|||
145330848|NCT00446199|524061972|FG002|Overall Study|Non-compliant with visit schedule|1|||
145330849|NCT00446199|524061973|FG003|Overall Study|Non-compliant with visit schedule|2|||
145330850|NCT00446199|524061970|FG000|Overall Study|Hormone fear|0|||
145330851|NCT00446199|524061971|FG001|Overall Study|Hormone fear|0|||
145330852|NCT00446199|524061972|FG002|Overall Study|Hormone fear|0|||
145330853|NCT00446199|524061973|FG003|Overall Study|Hormone fear|1|||
145330854|NCT00446199|524061970|FG000|Overall Study|Lost interest in study participation|0|||
145330855|NCT00446199|524061971|FG001|Overall Study|Lost interest in study participation|1|||
145330856|NCT00446199|524061972|FG002|Overall Study|Lost interest in study participation|0|||
145330857|NCT00446199|524061973|FG003|Overall Study|Lost interest in study participation|0|||
145330858|NCT00446199|524061970|FG000|Overall Study|In-/Exclusion criterion violated|2|||
145330859|NCT00446199|524061971|FG001|Overall Study|In-/Exclusion criterion violated|1|||
145330860|NCT00446199|524061972|FG002|Overall Study|In-/Exclusion criterion violated|2|||
145330861|NCT00446199|524061973|FG003|Overall Study|In-/Exclusion criterion violated|1|||
145330862|NCT00446199|524061970|FG000|Overall Study|Move|0|||
145330863|NCT00446199|524061971|FG001|Overall Study|Move|1|||
145330864|NCT00446199|524061972|FG002|Overall Study|Move|0|||
145330865|NCT00446199|524061973|FG003|Overall Study|Move|0|||
145330866|NCT04221789|524063190|FG000|Overall Study|deviation from protoco|22|||
145330867|NCT04221789|524063191|FG001|Overall Study|deviation from protoco|8|||
145330868|NCT00369655|524063192|FG000|Overall Study|Refusal of further treatment|2|||
145330869|NCT01683838|524063193|FG000|Overall Study|Adverse Event|12|||
145330870|NCT01683838|524063194|FG001|Overall Study|Adverse Event|2|||
145330871|NCT01683838|524063193|FG000|Overall Study|Protocol Violation|3|||
145330872|NCT01683838|524063194|FG001|Overall Study|Protocol Violation|1|||
145330873|NCT01683838|524063193|FG000|Overall Study|Withdrawal by Subject|6|||
145330874|NCT01683838|524063194|FG001|Overall Study|Withdrawal by Subject|5|||
145330875|NCT01683838|524063193|FG000|Overall Study|Lost to Follow-up|1|||
145330876|NCT01683838|524063194|FG001|Overall Study|Lost to Follow-up|1|||
145330877|NCT01683838|524063193|FG000|Overall Study|Other|4|||
145330878|NCT01683838|524063194|FG001|Overall Study|Other|3|||
145412329|NCT04602000|524363555|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145412330|NCT04602000|524363556|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
145412331|NCT05607043|524363557|FG000|Overall Study|Lost to Follow-up|2|||
145412332|NCT00429299|524363562|FG000|Overall Study|Disease Progression|1|||
145330879|NCT01646138|524063195|FG000|Overall Study|Lost to Follow-up|0|||
145330880|NCT01646138|524063196|FG001|Overall Study|Lost to Follow-up|0|||
145330881|NCT01646138|524063197|FG002|Overall Study|Lost to Follow-up|0|||
145330882|NCT01646138|524063198|FG003|Overall Study|Lost to Follow-up|0|||
145330883|NCT01646138|524063199|FG004|Overall Study|Lost to Follow-up|2|||
145330884|NCT02325518|524063203|FG000|Overall Study|Adverse Event|4|||
145330885|NCT02325518|524063204|FG001|Overall Study|Adverse Event|1|||
145330886|NCT02325518|524063203|FG000|Overall Study|Physician Decision|0|||
145330887|NCT02325518|524063204|FG001|Overall Study|Physician Decision|1|||
145330888|NCT02325518|524063203|FG000|Overall Study|Withdrawal by Subject|0|||
145330889|NCT02325518|524063204|FG001|Overall Study|Withdrawal by Subject|1|||
145330890|NCT03393806|524063207|FG000|Overall Study|Physician Decision|1|||
145330891|NCT03393806|524063208|FG001|Overall Study|Physician Decision|0|||
145330892|NCT01259115|524063209|FG000|Period 1|Adverse Event|1|||
145330893|NCT01259115|524063210|FG001|Period 1|Adverse Event|0|||
145330894|NCT01259115|524063209|FG000|Period 1|Protocol Violation|2|||
145330895|NCT01259115|524063210|FG001|Period 1|Protocol Violation|0|||
145330896|NCT01259115|524063209|FG000|Period 1|Lost to Follow-up|0|||
145330897|NCT01259115|524063210|FG001|Period 1|Lost to Follow-up|1|||
145330898|NCT01259115|524063209|FG000|Period 2|Adverse Event|1|||
145330899|NCT01259115|524063210|FG001|Period 2|Adverse Event|0|||
145330900|NCT01971970|524063211|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
145330901|NCT01971970|524063212|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
145330902|NCT01971970|524063211|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
145330903|NCT01971970|524063212|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
145330904|NCT01971970|524063211|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
145330905|NCT01971970|524063212|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
145330906|NCT01971970|524063211|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
145330907|NCT01971970|524063212|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
145330908|NCT01971970|524063211|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
145330909|NCT01971970|524063212|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
145330910|NCT01971970|524063211|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
145330911|NCT01971970|524063212|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
145330912|NCT01971970|524063211|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
145330913|NCT01971970|524063212|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
145330914|NCT00289536|524063213|FG000|Period 3|Lost to Follow-up|0|||
145330915|NCT00289536|524063214|FG001|Period 3|Lost to Follow-up|0|||
145330916|NCT00289536|524063215|FG002|Period 3|Lost to Follow-up|1|||
145330917|NCT05297578|524063228|FG000|Overall Study|Lost to Follow-up|1|||
145330918|NCT05297578|524063229|FG001|Overall Study|Lost to Follow-up|1|||
145330919|NCT05297578|524063230|FG002|Overall Study|Lost to Follow-up|2|||
145330920|NCT05297578|524063231|FG003|Overall Study|Lost to Follow-up|1|||
145330921|NCT05297578|524063228|FG000|Overall Study|Death|0|||
145330922|NCT05297578|524063229|FG001|Overall Study|Death|1|||
145330923|NCT05297578|524063230|FG002|Overall Study|Death|0|||
145330924|NCT05297578|524063231|FG003|Overall Study|Death|0|||
145330925|NCT05297578|524063228|FG000|Overall Study|Withdrawal by Subject|0|||
145330926|NCT05297578|524063229|FG001|Overall Study|Withdrawal by Subject|0|||
145330927|NCT05297578|524063230|FG002|Overall Study|Withdrawal by Subject|1|||
145330928|NCT05297578|524063231|FG003|Overall Study|Withdrawal by Subject|0|||
145330929|NCT00117325|524063233|FG000|Overall Study|Adverse Event|3|||
145330930|NCT00117325|524063234|FG001|Overall Study|Adverse Event|3|||
145330931|NCT00117325|524063233|FG000|Overall Study|Lost to Follow-up|1|||
145330932|NCT00117325|524063234|FG001|Overall Study|Lost to Follow-up|1|||
145330933|NCT00117325|524063233|FG000|Overall Study|Protocol Violation|2|||
145330934|NCT00117325|524063234|FG001|Overall Study|Protocol Violation|3|||
145330935|NCT00117325|524063233|FG000|Overall Study|Withdrawal by Subject|3|||
145330936|NCT00117325|524063234|FG001|Overall Study|Withdrawal by Subject|2|||
145330937|NCT00117325|524063233|FG000|Overall Study|Lack of Efficacy|1|||
145330938|NCT00117325|524063234|FG001|Overall Study|Lack of Efficacy|0|||
145330939|NCT00117325|524063233|FG000|Overall Study|Use of prohibited medicine|1|||
145412333|NCT00429299|524363563|FG001|Overall Study|Disease Progression|1|||
145412334|NCT00429299|524363564|FG002|Overall Study|Disease Progression|0|||
145412335|NCT00429299|524363562|FG000|Overall Study|Adverse Event|2|||
145412336|NCT00429299|524363563|FG001|Overall Study|Adverse Event|5|||
145412337|NCT00429299|524363564|FG002|Overall Study|Adverse Event|1|||
145412338|NCT00429299|524363562|FG000|Overall Study|Protocol Violation|1|||
145412339|NCT00429299|524363563|FG001|Overall Study|Protocol Violation|0|||
145412340|NCT00429299|524363564|FG002|Overall Study|Protocol Violation|0|||
145330940|NCT00117325|524063234|FG001|Overall Study|Use of prohibited medicine|2|||
145330941|NCT00117325|524063233|FG000|Overall Study|Early termination|1|||
145330942|NCT00117325|524063234|FG001|Overall Study|Early termination|1|||
145330943|NCT00117325|524063233|FG000|Overall Study|Admisnitrative|1|||
145330944|NCT00117325|524063234|FG001|Overall Study|Admisnitrative|0|||
145330945|NCT04647721|524063235|FG000|Overall Study|Withdrawal by Subject|0|||
145330946|NCT04647721|524063236|FG001|Overall Study|Withdrawal by Subject|2|||
145330947|NCT04647721|524063235|FG000|Overall Study|Lost to Follow-up|2|||
145330948|NCT04647721|524063236|FG001|Overall Study|Lost to Follow-up|0|||
145330949|NCT01974440|524063240|FG000|Overall Study|Lost to Follow-up|7|||
145330950|NCT01974440|524063241|FG001|Overall Study|Lost to Follow-up|7|||
145330951|NCT01974440|524063240|FG000|Overall Study|Withdrawal by Subject|24|||
145330952|NCT01974440|524063241|FG001|Overall Study|Withdrawal by Subject|20|||
145330953|NCT01974440|524063240|FG000|Overall Study|Sponsor decision|109|||
145330954|NCT01974440|524063241|FG001|Overall Study|Sponsor decision|110|||
145330955|NCT00762437|524063242|FG000|Overall Study|Lost to Follow-up|7|||
145330956|NCT00762437|524063242|FG000|Overall Study|Missed final study visit|11|||
145330957|NCT00762437|524063242|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
145571749|NCT02434770|524951756|FG000|Week 18 to Week|Withdrawal by Subject|0|||
145571750|NCT02434770|524951757|FG001|Week 18 to Week|Withdrawal by Subject|0|||
145571751|NCT02434770|524951758|FG002|Week 18 to Week|Withdrawal by Subject|2|||
145571752|NCT02434770|524951756|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
145330958|NCT03979820|524063243|FG000|Overall Study|Protocol Violation|1|||
145330959|NCT03979820|524063244|FG001|Overall Study|Protocol Violation|0|||
145330960|NCT03979820|524063245|FG002|Overall Study|Protocol Violation|0|||
145330961|NCT03979820|524063246|FG003|Overall Study|Protocol Violation|0|||
145571753|NCT02434770|524951757|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
145571754|NCT02434770|524951758|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
145571755|NCT00660348|524951759|FG000|Overall Study|Withdrawal by Subject|1|||
145571756|NCT00660348|524951760|FG001|Overall Study|Withdrawal by Subject|0|||
145571757|NCT01282424|524951766|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
145571758|NCT01282424|524951766|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
145571759|NCT01282424|524951766|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
145571760|NCT01282424|524951766|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
145571761|NCT01282424|524951766|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
145571762|NCT01282424|524951766|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
145571763|NCT01282424|524951766|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
145571764|NCT01282424|524951766|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
145571765|NCT00528528|524951767|FG000|Overall Study|Lost to Follow-up|0|||
145571766|NCT00528528|524951768|FG001|Overall Study|Lost to Follow-up|0|||
145571767|NCT00528528|524951769|FG002|Overall Study|Lost to Follow-up|1|||
145571768|NCT00528528|524951770|FG003|Overall Study|Lost to Follow-up|1|||
145571769|NCT00528528|524951767|FG000|Overall Study|Ineligible to continue the trial|0|||
145571770|NCT00528528|524951768|FG001|Overall Study|Ineligible to continue the trial|0|||
145571771|NCT00528528|524951769|FG002|Overall Study|Ineligible to continue the trial|0|||
145571772|NCT00528528|524951770|FG003|Overall Study|Ineligible to continue the trial|1|||
145571773|NCT00528528|524951767|FG000|Overall Study|Other|0|||
145571774|NCT00528528|524951768|FG001|Overall Study|Other|1|||
145571775|NCT00528528|524951769|FG002|Overall Study|Other|0|||
145571776|NCT00528528|524951770|FG003|Overall Study|Other|0|||
145571777|NCT00528528|524951767|FG000|Overall Study|Withdrawal by Subject|3|||
145571778|NCT00528528|524951768|FG001|Overall Study|Withdrawal by Subject|2|||
145571779|NCT00528528|524951769|FG002|Overall Study|Withdrawal by Subject|1|||
145330962|NCT03979820|524063243|FG000|Overall Study|Withdrawal by Subject|0|||
145330963|NCT03979820|524063244|FG001|Overall Study|Withdrawal by Subject|0|||
145330964|NCT03979820|524063245|FG002|Overall Study|Withdrawal by Subject|1|||
145330965|NCT03979820|524063246|FG003|Overall Study|Withdrawal by Subject|0|||
145330966|NCT03979820|524063243|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
145330967|NCT03979820|524063244|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
145330968|NCT03979820|524063245|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
145330969|NCT03979820|524063246|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
145330970|NCT00988065|524063247|FG000|Overall Study|Adverse Event|4|||
145330971|NCT00988065|524063248|FG001|Overall Study|Adverse Event|10|||
145330972|NCT00988065|524063249|FG002|Overall Study|Adverse Event|2|||
145330973|NCT00988065|524063247|FG000|Overall Study|Lost to Follow-up|1|||
145330974|NCT00988065|524063248|FG001|Overall Study|Lost to Follow-up|2|||
145330975|NCT00988065|524063249|FG002|Overall Study|Lost to Follow-up|2|||
145330976|NCT00988065|524063247|FG000|Overall Study|Subject withdrew consent|3|||
145330977|NCT00988065|524063248|FG001|Overall Study|Subject withdrew consent|5|||
145330978|NCT00988065|524063249|FG002|Overall Study|Subject withdrew consent|2|||
145330979|NCT00988065|524063247|FG000|Overall Study|Noncompliance with protocol|5|||
145330980|NCT00988065|524063248|FG001|Overall Study|Noncompliance with protocol|6|||
145330981|NCT00988065|524063249|FG002|Overall Study|Noncompliance with protocol|9|||
145571780|NCT00528528|524951770|FG003|Overall Study|Withdrawal by Subject|1|||
145571781|NCT00528528|524951767|FG000|Overall Study|Ongoing participant|0|||
145571782|NCT00528528|524951768|FG001|Overall Study|Ongoing participant|0|||
145330982|NCT01355159|524063266|FG000|Overall Study|Withdrew consent|39|||
145571783|NCT00528528|524951769|FG002|Overall Study|Ongoing participant|1|||
145571784|NCT00528528|524951770|FG003|Overall Study|Ongoing participant|0|||
145330983|NCT01355159|524063267|FG001|Overall Study|Withdrew consent|47|||
145571785|NCT03508219|524951773|FG000|Overall Study|Death|2|||
145412341|NCT00429299|524363562|FG000|Overall Study|Withdrawal by Subject|0|||
145330984|NCT01355159|524063266|FG000|Overall Study|No primary outcome data|17|||
145330985|NCT01355159|524063267|FG001|Overall Study|No primary outcome data|11|||
145330986|NCT01355159|524063266|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
145330987|NCT01355159|524063267|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
145330988|NCT01355159|524063266|FG000|Overall Study|Early intrauterine fetal death|6|||
145330989|NCT01355159|524063267|FG001|Overall Study|Early intrauterine fetal death|6|||
145330990|NCT01941940|524063268|FG000|Overall Study|Adverse Event|11|||
145330991|NCT01941940|524063268|FG000|Overall Study|Lost to Follow-up|2|||
145330992|NCT01941940|524063268|FG000|Overall Study|Physician Decision|2|||
145330993|NCT01941940|524063268|FG000|Overall Study|Withdrawal by Subject|15|||
145330994|NCT01941940|524063268|FG000|Overall Study|Death|1|||
145330995|NCT01941940|524063268|FG000|Overall Study|Other|1|||
145330996|NCT01941940|524063268|FG000|Overall Study|Other|1|||
145330997|NCT00502801|524063269|FG000|Treatment Period|Withdrawal by Subject|3|||
145330998|NCT00502801|524063269|FG000|Treatment Period|Adverse Event|7|||
145330999|NCT00502801|524063269|FG000|Treatment Period|Death|14|||
145331000|NCT00502801|524063269|FG000|Treatment Period|OTHER|30|||
145331001|NCT00502801|524063269|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
145331002|NCT00502801|524063269|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
145331003|NCT00502801|524063269|FG000|End of Therapy to Test of Cure|Death|3|||
145331004|NCT00502801|524063269|FG000|End of Therapy to Test of Cure|OTHER|2|||
145331005|NCT03212521|524063274|FG000|Overall Study|Adverse Event|1|||
145331006|NCT03212521|524063274|FG000|Overall Study|Lost to Follow-up|4|||
145331007|NCT03212521|524063274|FG000|Overall Study|Withdrawal by Subject|1|||
145331008|NCT03212521|524063274|FG000|Overall Study|Other|1|||
145331009|NCT00444457|524063275|FG000|Infant Series|Other|0|||
145331010|NCT00444457|524063276|FG001|Infant Series|Other|1|||
145331011|NCT00444457|524063277|FG002|Infant Series|Other|0|||
145331012|NCT00444457|524063278|FG003|Infant Series|Other|0|||
145331013|NCT00444457|524063275|FG000|Infant Series|Parent or legal guardian request|18|||
145331014|NCT00444457|524063276|FG001|Infant Series|Parent or legal guardian request|29|||
145331015|NCT00444457|524063277|FG002|Infant Series|Parent or legal guardian request|34|||
145331016|NCT00444457|524063278|FG003|Infant Series|Parent or legal guardian request|14|||
145331017|NCT00444457|524063275|FG000|Infant Series|Lost to Follow-up|10|||
145331018|NCT00444457|524063276|FG001|Infant Series|Lost to Follow-up|11|||
145331019|NCT00444457|524063277|FG002|Infant Series|Lost to Follow-up|7|||
145331020|NCT00444457|524063278|FG003|Infant Series|Lost to Follow-up|6|||
145331021|NCT00444457|524063275|FG000|Infant Series|Protocol Violation|16|||
145331022|NCT00444457|524063276|FG001|Infant Series|Protocol Violation|8|||
145331023|NCT00444457|524063277|FG002|Infant Series|Protocol Violation|6|||
145331024|NCT00444457|524063278|FG003|Infant Series|Protocol Violation|3|||
145331025|NCT00444457|524063275|FG000|Infant Series|Failed to return|5|||
145331026|NCT00444457|524063276|FG001|Infant Series|Failed to return|4|||
145331027|NCT00444457|524063277|FG002|Infant Series|Failed to return|4|||
145331028|NCT00444457|524063278|FG003|Infant Series|Failed to return|2|||
145331029|NCT00444457|524063275|FG000|Infant Series|Investigator request|4|||
145331030|NCT00444457|524063276|FG001|Infant Series|Investigator request|3|||
145331031|NCT00444457|524063277|FG002|Infant Series|Investigator request|3|||
145331032|NCT00444457|524063278|FG003|Infant Series|Investigator request|2|||
145331033|NCT00444457|524063275|FG000|Infant Series|Other|0|||
145331034|NCT00444457|524063276|FG001|Infant Series|Other|2|||
145331035|NCT00444457|524063277|FG002|Infant Series|Other|4|||
145331036|NCT00444457|524063278|FG003|Infant Series|Other|0|||
145331037|NCT00444457|524063275|FG000|Infant Series|Adverse Event|1|||
145331038|NCT00444457|524063276|FG001|Infant Series|Adverse Event|2|||
145331039|NCT00444457|524063277|FG002|Infant Series|Adverse Event|2|||
145331040|NCT00444457|524063278|FG003|Infant Series|Adverse Event|0|||
145331041|NCT00444457|524063275|FG000|Infant Series|Death|0|||
145331042|NCT00444457|524063276|FG001|Infant Series|Death|1|||
145331043|NCT00444457|524063277|FG002|Infant Series|Death|1|||
145331044|NCT00444457|524063278|FG003|Infant Series|Death|1|||
145331045|NCT00444457|524063275|FG000|After Infant Series|Other|0|||
145331046|NCT00444457|524063276|FG001|After Infant Series|Other|1|||
145331047|NCT00444457|524063277|FG002|After Infant Series|Other|1|||
145331048|NCT00444457|524063278|FG003|After Infant Series|Other|1|||
145331049|NCT00444457|524063275|FG000|After Infant Series|Parent or legal guardian request|4|||
145331050|NCT00444457|524063276|FG001|After Infant Series|Parent or legal guardian request|11|||
145331051|NCT00444457|524063277|FG002|After Infant Series|Parent or legal guardian request|6|||
145331052|NCT00444457|524063278|FG003|After Infant Series|Parent or legal guardian request|3|||
145331053|NCT00444457|524063275|FG000|After Infant Series|Failed to return|7|||
145331054|NCT00444457|524063276|FG001|After Infant Series|Failed to return|6|||
145331055|NCT00444457|524063277|FG002|After Infant Series|Failed to return|5|||
145331056|NCT00444457|524063278|FG003|After Infant Series|Failed to return|1|||
145331057|NCT00444457|524063275|FG000|After Infant Series|Lost to Follow-up|5|||
145331058|NCT00444457|524063276|FG001|After Infant Series|Lost to Follow-up|5|||
145331059|NCT00444457|524063277|FG002|After Infant Series|Lost to Follow-up|5|||
145331060|NCT00444457|524063278|FG003|After Infant Series|Lost to Follow-up|2|||
145331061|NCT00444457|524063275|FG000|After Infant Series|Protocol Violation|2|||
145331062|NCT00444457|524063276|FG001|After Infant Series|Protocol Violation|4|||
145331063|NCT00444457|524063277|FG002|After Infant Series|Protocol Violation|2|||
145331064|NCT00444457|524063278|FG003|After Infant Series|Protocol Violation|2|||
145331065|NCT00444457|524063275|FG000|After Infant Series|Adverse Event|2|||
145331066|NCT00444457|524063276|FG001|After Infant Series|Adverse Event|2|||
145621001|NCT04955626|525126702|FG030|Blinded Period|Lost to Follow-up|0|||
145621002|NCT04955626|525126703|FG031|Blinded Period|Lost to Follow-up|0|||
145621003|NCT04955626|525126704|FG032|Blinded Period|Lost to Follow-up|0|||
145621004|NCT04955626|525126705|FG033|Blinded Period|Lost to Follow-up|0|||
145621005|NCT04955626|525126706|FG034|Blinded Period|Lost to Follow-up|0|||
145621006|NCT04955626|525126707|FG035|Blinded Period|Lost to Follow-up|0|||
145621007|NCT04955626|525126672|FG000|Blinded Period|Protocol Violation|5|||
145621008|NCT04955626|525126673|FG001|Blinded Period|Protocol Violation|14|||
145621009|NCT04955626|525126674|FG002|Blinded Period|Protocol Violation|0|||
145621010|NCT04955626|525126675|FG003|Blinded Period|Protocol Violation|1|||
145331067|NCT00444457|524063277|FG002|After Infant Series|Adverse Event|0|||
145331068|NCT00444457|524063278|FG003|After Infant Series|Adverse Event|0|||
145331069|NCT00444457|524063275|FG000|After Infant Series|Investigator request|0|||
145331070|NCT00444457|524063276|FG001|After Infant Series|Investigator request|0|||
145331071|NCT00444457|524063277|FG002|After Infant Series|Investigator request|0|||
145331072|NCT00444457|524063278|FG003|After Infant Series|Investigator request|1|||
145331073|NCT00444457|524063275|FG000|After Infant Series|Other|0|||
145331074|NCT00444457|524063276|FG001|After Infant Series|Other|1|||
145571786|NCT03508219|524951773|FG000|Overall Study|Withdrawal by Subject|1|||
145571787|NCT03508219|524951773|FG000|Overall Study|Lost to Follow-up|4|||
145571788|NCT03508219|524951773|FG000|Overall Study|Missed visit|2|||
145571789|NCT04466891|524951774|FG000|Overall Study|Death|60|||
145571790|NCT04466891|524951775|FG001|Overall Study|Death|6|||
145571791|NCT04466891|524951774|FG000|Overall Study|Withdrawal by Subject|8|||
145571792|NCT04466891|524951775|FG001|Overall Study|Withdrawal by Subject|1|||
145571793|NCT04466891|524951774|FG000|Overall Study|Study terminated by sponsor|5|||
145571794|NCT04466891|524951775|FG001|Overall Study|Study terminated by sponsor|0|||
145571795|NCT04466891|524951774|FG000|Overall Study|Lost to Follow-up|2|||
145571796|NCT04466891|524951775|FG001|Overall Study|Lost to Follow-up|0|||
145571797|NCT04466891|524951774|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
145571798|NCT04466891|524951775|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
145571799|NCT00445328|524951776|FG000|Overall Study|Death|0|||
145571800|NCT00445328|524951777|FG001|Overall Study|Death|1|||
145571801|NCT00445328|524951776|FG000|Overall Study|Adverse Event|0|||
145571802|NCT00445328|524951777|FG001|Overall Study|Adverse Event|3|||
145571803|NCT00445328|524951776|FG000|Overall Study|Other|0|||
145571804|NCT00445328|524951777|FG001|Overall Study|Other|2|||
145571805|NCT00445328|524951776|FG000|Overall Study|Withdrawal by Subject|2|||
145571806|NCT00445328|524951777|FG001|Overall Study|Withdrawal by Subject|0|||
145571807|NCT00445328|524951776|FG000|Overall Study|Protocol Violation|1|||
145571808|NCT00445328|524951777|FG001|Overall Study|Protocol Violation|0|||
145571809|NCT00316199|524951778|FG000|Overall Study|Adverse Event|2|||
145571810|NCT00316199|524951778|FG000|Overall Study|Death|8|||
145571811|NCT00316199|524951778|FG000|Overall Study|Lost to Follow-up|2|||
145571812|NCT00590954|524951779|FG000|Overall Study|Inevaluable|2|||
145571813|NCT02782949|524951781|FG000|Overall Study|Protocol Violation|1|||
145571814|NCT02782949|524951782|FG001|Overall Study|Protocol Violation|0|||
145571815|NCT02782949|524951781|FG000|Overall Study|Withdrawal by Subject|0|||
145571816|NCT02782949|524951782|FG001|Overall Study|Withdrawal by Subject|1|||
145571817|NCT03316872|524951783|FG000|Overall Study|Death|1|||
145571818|NCT06023394|524951786|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
145571819|NCT06023394|524951787|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
145571820|NCT06023394|524951786|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
145571821|NCT06023394|524951787|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
145571822|NCT06023394|524951786|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
145571823|NCT06023394|524951787|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
145571824|NCT06023394|524951786|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
145571825|NCT06023394|524951787|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
145571826|NCT01101841|524953107|FG000|Overall Study|Adverse Event|15|||
145571827|NCT01101841|524953108|FG001|Overall Study|Adverse Event|15|||
145571828|NCT01101841|524953107|FG000|Overall Study|Lost to Follow-up|9|||
145571829|NCT01101841|524953108|FG001|Overall Study|Lost to Follow-up|3|||
145571830|NCT01101841|524953107|FG000|Overall Study|Withdrawal by Subject|21|||
145571831|NCT01101841|524953108|FG001|Overall Study|Withdrawal by Subject|40|||
145571832|NCT01101841|524953107|FG000|Overall Study|Protocol Violation|1|||
145571833|NCT01101841|524953108|FG001|Overall Study|Protocol Violation|1|||
145571834|NCT01101841|524953107|FG000|Overall Study|Physician Decision|0|||
145571835|NCT01101841|524953108|FG001|Overall Study|Physician Decision|2|||
145571836|NCT01101841|524953107|FG000|Overall Study|Lack of Efficacy|0|||
145571837|NCT01101841|524953108|FG001|Overall Study|Lack of Efficacy|2|||
145571838|NCT01101841|524953107|FG000|Overall Study|Other|0|||
145621011|NCT04955626|525126676|FG004|Blinded Period|Protocol Violation|2|||
145331075|NCT00444457|524063277|FG002|After Infant Series|Other|0|||
145331076|NCT00444457|524063278|FG003|After Infant Series|Other|0|||
145331077|NCT00444457|524063275|FG000|Toddler Dose|Lost to Follow-up|4|||
145571839|NCT01101841|524953108|FG001|Overall Study|Other|1|||
145621012|NCT04955626|525126677|FG005|Blinded Period|Protocol Violation|2|||
145621013|NCT04955626|525126678|FG006|Blinded Period|Protocol Violation|0|||
145621014|NCT04955626|525126679|FG007|Blinded Period|Protocol Violation|0|||
145621015|NCT04955626|525126680|FG008|Blinded Period|Protocol Violation|0|||
145621016|NCT04955626|525126681|FG009|Blinded Period|Protocol Violation|4|||
145621017|NCT04955626|525126682|FG010|Blinded Period|Protocol Violation|6|||
145621018|NCT04955626|525126683|FG011|Blinded Period|Protocol Violation|1|||
145621019|NCT04955626|525126684|FG012|Blinded Period|Protocol Violation|0|||
145621020|NCT04955626|525126685|FG013|Blinded Period|Protocol Violation|0|||
145621021|NCT04955626|525126686|FG014|Blinded Period|Protocol Violation|2|||
145621022|NCT04955626|525126687|FG015|Blinded Period|Protocol Violation|6|||
145621023|NCT04955626|525126688|FG016|Blinded Period|Protocol Violation|4|||
145621024|NCT04955626|525126689|FG017|Blinded Period|Protocol Violation|6|||
145621025|NCT04955626|525126690|FG018|Blinded Period|Protocol Violation|0|||
145621026|NCT04955626|525126691|FG019|Blinded Period|Protocol Violation|1|||
145621027|NCT04955626|525126692|FG020|Blinded Period|Protocol Violation|0|||
145621028|NCT04955626|525126693|FG021|Blinded Period|Protocol Violation|1|||
145621029|NCT04955626|525126694|FG022|Blinded Period|Protocol Violation|0|||
145621030|NCT04955626|525126695|FG023|Blinded Period|Protocol Violation|0|||
145621031|NCT04955626|525126696|FG024|Blinded Period|Protocol Violation|4|||
145621032|NCT04955626|525126697|FG025|Blinded Period|Protocol Violation|6|||
145621033|NCT04955626|525126698|FG026|Blinded Period|Protocol Violation|5|||
145621034|NCT04955626|525126699|FG027|Blinded Period|Protocol Violation|3|||
145621035|NCT04955626|525126700|FG028|Blinded Period|Protocol Violation|4|||
145621036|NCT04955626|525126701|FG029|Blinded Period|Protocol Violation|3|||
145621037|NCT04955626|525126702|FG030|Blinded Period|Protocol Violation|0|||
145621038|NCT04955626|525126703|FG031|Blinded Period|Protocol Violation|0|||
145621039|NCT04955626|525126704|FG032|Blinded Period|Protocol Violation|0|||
145621040|NCT04955626|525126705|FG033|Blinded Period|Protocol Violation|0|||
145621041|NCT04955626|525126706|FG034|Blinded Period|Protocol Violation|0|||
145621042|NCT04955626|525126707|FG035|Blinded Period|Protocol Violation|0|||
145621043|NCT04955626|525126672|FG000|Blinded Period|Death|0|||
145621044|NCT04955626|525126673|FG001|Blinded Period|Death|2|||
145331078|NCT00444457|524063276|FG001|Toddler Dose|Lost to Follow-up|1|||
145571840|NCT01101841|524953107|FG000|Overall Study|Suicidality Tracking Scale|3|||
145571841|NCT01101841|524953108|FG001|Overall Study|Suicidality Tracking Scale|1|||
145571842|NCT01101841|524953107|FG000|Overall Study|Eligibility Criteria|1|||
145571843|NCT01101841|524953108|FG001|Overall Study|Eligibility Criteria|2|||
145571844|NCT02896400|524953112|FG000|1 Month Follow-up|Lost to Follow-up|7|||
145571845|NCT02896400|524953113|FG001|1 Month Follow-up|Lost to Follow-up|7|||
145571846|NCT02896400|524953114|FG002|1 Month Follow-up|Lost to Follow-up|5|||
145571847|NCT02896400|524953115|FG003|1 Month Follow-up|Lost to Follow-up|8|||
145571848|NCT02896400|524953116|FG004|1 Month Follow-up|Lost to Follow-up|9|||
145571849|NCT02896400|524953117|FG005|1 Month Follow-up|Lost to Follow-up|6|||
145571850|NCT02896400|524953118|FG006|1 Month Follow-up|Lost to Follow-up|5|||
145571851|NCT02896400|524953119|FG007|1 Month Follow-up|Lost to Follow-up|6|||
145571852|NCT02896400|524953120|FG008|1 Month Follow-up|Lost to Follow-up|4|||
145571853|NCT02896400|524953121|FG009|1 Month Follow-up|Lost to Follow-up|7|||
145571854|NCT02896400|524953122|FG010|1 Month Follow-up|Lost to Follow-up|5|||
145571855|NCT02896400|524953123|FG011|1 Month Follow-up|Lost to Follow-up|5|||
145571856|NCT02896400|524953124|FG012|1 Month Follow-up|Lost to Follow-up|3|||
145571857|NCT02896400|524953125|FG013|1 Month Follow-up|Lost to Follow-up|4|||
145571858|NCT02896400|524953126|FG014|1 Month Follow-up|Lost to Follow-up|1|||
145571859|NCT02896400|524953127|FG015|1 Month Follow-up|Lost to Follow-up|2|||
145571860|NCT02896400|524953112|FG000|1 Month Follow-up|Death|0|||
145571861|NCT02896400|524953113|FG001|1 Month Follow-up|Death|0|||
145571862|NCT02896400|524953114|FG002|1 Month Follow-up|Death|0|||
145571863|NCT02896400|524953115|FG003|1 Month Follow-up|Death|0|||
145571864|NCT02896400|524953116|FG004|1 Month Follow-up|Death|0|||
145571865|NCT02896400|524953117|FG005|1 Month Follow-up|Death|0|||
145571866|NCT02896400|524953118|FG006|1 Month Follow-up|Death|0|||
145571867|NCT02896400|524953119|FG007|1 Month Follow-up|Death|0|||
145571868|NCT02896400|524953120|FG008|1 Month Follow-up|Death|0|||
145571869|NCT02896400|524953121|FG009|1 Month Follow-up|Death|0|||
145571870|NCT02896400|524953122|FG010|1 Month Follow-up|Death|0|||
145571871|NCT02896400|524953123|FG011|1 Month Follow-up|Death|0|||
145621045|NCT04955626|525126674|FG002|Blinded Period|Death|0|||
145621046|NCT04955626|525126675|FG003|Blinded Period|Death|0|||
145621047|NCT04955626|525126676|FG004|Blinded Period|Death|0|||
145621048|NCT04955626|525126677|FG005|Blinded Period|Death|0|||
145621049|NCT04955626|525126678|FG006|Blinded Period|Death|0|||
145621050|NCT04955626|525126679|FG007|Blinded Period|Death|2|||
145331079|NCT00444457|524063277|FG002|Toddler Dose|Lost to Follow-up|1|||
145571872|NCT02896400|524953124|FG012|1 Month Follow-up|Death|0|||
145571873|NCT02896400|524953125|FG013|1 Month Follow-up|Death|0|||
145571874|NCT02896400|524953126|FG014|1 Month Follow-up|Death|0|||
145571875|NCT02896400|524953127|FG015|1 Month Follow-up|Death|1|||
145571876|NCT02896400|524953112|FG000|3 Month Follow-up|Lost to Follow-up|6|||
145621051|NCT04955626|525126680|FG008|Blinded Period|Death|1|||
145621052|NCT04955626|525126681|FG009|Blinded Period|Death|1|||
145621053|NCT04955626|525126682|FG010|Blinded Period|Death|0|||
145621054|NCT04955626|525126683|FG011|Blinded Period|Death|2|||
145621055|NCT04955626|525126684|FG012|Blinded Period|Death|0|||
145331080|NCT00444457|524063278|FG003|Toddler Dose|Lost to Follow-up|3|||
145331081|NCT00444457|524063275|FG000|Toddler Dose|Failed to return|2|||
145331082|NCT00444457|524063276|FG001|Toddler Dose|Failed to return|2|||
145331083|NCT00444457|524063277|FG002|Toddler Dose|Failed to return|1|||
145331084|NCT00444457|524063278|FG003|Toddler Dose|Failed to return|3|||
145331085|NCT00444457|524063275|FG000|Toddler Dose|Parent or legal guardian request|0|||
145331086|NCT00444457|524063276|FG001|Toddler Dose|Parent or legal guardian request|3|||
145331087|NCT00444457|524063277|FG002|Toddler Dose|Parent or legal guardian request|2|||
145331088|NCT00444457|524063278|FG003|Toddler Dose|Parent or legal guardian request|1|||
145331089|NCT00444457|524063275|FG000|Toddler Dose|Protocol Violation|1|||
145331090|NCT00444457|524063276|FG001|Toddler Dose|Protocol Violation|0|||
145331091|NCT00444457|524063277|FG002|Toddler Dose|Protocol Violation|0|||
145331092|NCT00444457|524063278|FG003|Toddler Dose|Protocol Violation|1|||
145331093|NCT00914459|524063281|FG000|Overall Study|Protocol Violation|0|||
145331094|NCT00914459|524063282|FG001|Overall Study|Protocol Violation|1|||
145331095|NCT00914459|524063281|FG000|Overall Study|Parent/Legal guardian request|1|||
145331096|NCT00914459|524063282|FG001|Overall Study|Parent/Legal guardian request|0|||
145331097|NCT01661179|524063283|FG000|Overall Study|Death|1|||
145331098|NCT01661179|524063283|FG000|Overall Study|Withdrawal by Subject|1|||
145331099|NCT01661179|524063283|FG000|Overall Study|Other Eligibility criteria|4|||
145331100|NCT01602965|524063284|FG000|Overall Study|Lost to Follow-up|4|||
145331101|NCT01602965|524063285|FG001|Overall Study|Lost to Follow-up|2|||
145331102|NCT03118570|524063286|FG000|Overall Study|Adverse Event|2|||
145331103|NCT03118570|524063287|FG001|Overall Study|Adverse Event|0|||
145331104|NCT03118570|524063288|FG002|Overall Study|Adverse Event|0|||
145331105|NCT03118570|524063289|FG003|Overall Study|Adverse Event|0|||
145331106|NCT03118570|524063290|FG004|Overall Study|Adverse Event|3|||
145331107|NCT03118570|524063286|FG000|Overall Study|Withdrawal by Subject|0|||
145331108|NCT03118570|524063287|FG001|Overall Study|Withdrawal by Subject|1|||
145331109|NCT03118570|524063288|FG002|Overall Study|Withdrawal by Subject|4|||
145331110|NCT03118570|524063289|FG003|Overall Study|Withdrawal by Subject|0|||
145331111|NCT03118570|524063290|FG004|Overall Study|Withdrawal by Subject|1|||
145331112|NCT03118570|524063286|FG000|Overall Study|Lost to Follow-up|2|||
145331113|NCT03118570|524063287|FG001|Overall Study|Lost to Follow-up|3|||
145331114|NCT03118570|524063288|FG002|Overall Study|Lost to Follow-up|1|||
145331115|NCT03118570|524063289|FG003|Overall Study|Lost to Follow-up|0|||
145412342|NCT00429299|524363563|FG001|Overall Study|Withdrawal by Subject|1|||
145412343|NCT00429299|524363564|FG002|Overall Study|Withdrawal by Subject|3|||
145412344|NCT01510756|524363565|FG000|Overall Study|Death|1|||
145412345|NCT01510756|524363565|FG000|Overall Study|Lack of Efficacy|2|||
145412346|NCT01510756|524363565|FG000|Overall Study|Physician Decision|1|||
145412347|NCT02447029|524363566|FG000|Overall Study|Withdrawal by Subject|3|||
145412348|NCT02447029|524363567|FG001|Overall Study|Withdrawal by Subject|2|||
145412349|NCT01239745|524363568|FG000|Overall Study|Study terminated by sponsor|45|||
145412350|NCT01239745|524363568|FG000|Overall Study|Adverse Event|1|||
145412351|NCT00081458|524363571|FG000|Overall Study|Adverse Event|1|||
145412352|NCT00081458|524363572|FG001|Overall Study|Adverse Event|5|||
145412353|NCT00081458|524363573|FG002|Overall Study|Adverse Event|2|||
145412354|NCT00081458|524363571|FG000|Overall Study|Withdrawal by Subject|0|||
145412355|NCT00081458|524363572|FG001|Overall Study|Withdrawal by Subject|3|||
145412356|NCT00081458|524363573|FG002|Overall Study|Withdrawal by Subject|1|||
145412357|NCT00081458|524363571|FG000|Overall Study|Randomized but not dosed|0|||
145412358|NCT00081458|524363572|FG001|Overall Study|Randomized but not dosed|0|||
145412359|NCT00081458|524363573|FG002|Overall Study|Randomized but not dosed|1|||
145412360|NCT00549328|524363577|FG000|Overall Study|Adverse Event|2|||
145412361|NCT00549328|524363577|FG000|Overall Study|Disease Progression|10|||
145412362|NCT00549328|524363577|FG000|Overall Study|Death|1|||
145412363|NCT00549328|524363577|FG000|Overall Study|Use of Prohibited Medication|1|||
145412364|NCT01946802|524363582|FG000|Overall Study|Death|1|||
145412365|NCT01946802|524363582|FG000|Overall Study|Withdrawal by Subject|2|||
145412366|NCT01946802|524363582|FG000|Overall Study|Combined septic shock|1|||
145412367|NCT01946802|524363582|FG000|Overall Study|Protocol Violation|1|||
145412368|NCT03097315|524363583|FG000|Overall Study|Withdrawal by Subject|1|||
145412369|NCT00153920|524363584|FG000|Overall Study|Adverse Event|9|||
145412370|NCT00153920|524363584|FG000|Overall Study|Progressive Disease|9|||
145412371|NCT00153920|524363584|FG000|Overall Study|Physician Decision|3|||
145412372|NCT00153920|524363584|FG000|Overall Study|Lack of Response|3|||
145412373|NCT00153920|524363584|FG000|Overall Study|Death|2|||
145412374|NCT00153920|524363584|FG000|Overall Study|Withdrawal by Subject|1|||
145412375|NCT00153920|524363584|FG000|Overall Study|Non-Protocol Therapy|1|||
145412376|NCT00153920|524363584|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
145412377|NCT00153920|524363584|FG000|Overall Study|Progressive Disease before Trt|1|||
145412378|NCT02202616|524363588|FG000|Overall Study|Screen failed|24|||
145331116|NCT03118570|524063290|FG004|Overall Study|Lost to Follow-up|1|||
145331117|NCT03118570|524063286|FG000|Overall Study|Other, Not Specified|1|||
145331118|NCT03118570|524063287|FG001|Overall Study|Other, Not Specified|3|||
145331119|NCT03118570|524063288|FG002|Overall Study|Other, Not Specified|0|||
145412379|NCT02202616|524363588|FG000|Overall Study|Adverse Event|32|||
145331120|NCT03118570|524063289|FG003|Overall Study|Other, Not Specified|0|||
145331121|NCT03118570|524063290|FG004|Overall Study|Other, Not Specified|0|||
145331122|NCT03071094|524063294|FG000|Overall Study|Death|1|||
145331123|NCT03071094|524063295|FG001|Overall Study|Death|1|||
145331124|NCT03071094|524063294|FG000|Overall Study|Adverse Event|1|||
145571877|NCT02896400|524953113|FG001|3 Month Follow-up|Lost to Follow-up|3|||
145571878|NCT02896400|524953114|FG002|3 Month Follow-up|Lost to Follow-up|6|||
145571879|NCT02896400|524953115|FG003|3 Month Follow-up|Lost to Follow-up|11|||
145571880|NCT02896400|524953116|FG004|3 Month Follow-up|Lost to Follow-up|12|||
145571881|NCT02896400|524953117|FG005|3 Month Follow-up|Lost to Follow-up|6|||
145571882|NCT02896400|524953118|FG006|3 Month Follow-up|Lost to Follow-up|4|||
145571883|NCT02896400|524953119|FG007|3 Month Follow-up|Lost to Follow-up|3|||
145571884|NCT02896400|524953120|FG008|3 Month Follow-up|Lost to Follow-up|6|||
145571885|NCT02896400|524953121|FG009|3 Month Follow-up|Lost to Follow-up|5|||
145571886|NCT02896400|524953122|FG010|3 Month Follow-up|Lost to Follow-up|6|||
145571887|NCT02896400|524953123|FG011|3 Month Follow-up|Lost to Follow-up|6|||
145571888|NCT02896400|524953124|FG012|3 Month Follow-up|Lost to Follow-up|3|||
145571889|NCT02896400|524953125|FG013|3 Month Follow-up|Lost to Follow-up|5|||
145571890|NCT02896400|524953126|FG014|3 Month Follow-up|Lost to Follow-up|3|||
145571891|NCT02896400|524953127|FG015|3 Month Follow-up|Lost to Follow-up|2|||
145571892|NCT02896400|524953112|FG000|3 Month Follow-up|Death|0|||
145571893|NCT02896400|524953113|FG001|3 Month Follow-up|Death|0|||
145571894|NCT02896400|524953114|FG002|3 Month Follow-up|Death|0|||
145571895|NCT02896400|524953115|FG003|3 Month Follow-up|Death|0|||
145571896|NCT02896400|524953116|FG004|3 Month Follow-up|Death|0|||
145571897|NCT02896400|524953117|FG005|3 Month Follow-up|Death|0|||
145571898|NCT02896400|524953118|FG006|3 Month Follow-up|Death|0|||
145571899|NCT02896400|524953119|FG007|3 Month Follow-up|Death|0|||
145571900|NCT02896400|524953120|FG008|3 Month Follow-up|Death|0|||
145571901|NCT02896400|524953121|FG009|3 Month Follow-up|Death|0|||
145571902|NCT02896400|524953122|FG010|3 Month Follow-up|Death|0|||
145571903|NCT02896400|524953123|FG011|3 Month Follow-up|Death|0|||
145571904|NCT02896400|524953124|FG012|3 Month Follow-up|Death|0|||
145571905|NCT02896400|524953125|FG013|3 Month Follow-up|Death|1|||
145571906|NCT02896400|524953126|FG014|3 Month Follow-up|Death|1|||
145571907|NCT02896400|524953127|FG015|3 Month Follow-up|Death|0|||
145571908|NCT02896400|524953112|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571909|NCT02896400|524953113|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
145571910|NCT02896400|524953114|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571911|NCT02896400|524953115|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571912|NCT02896400|524953116|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
145571913|NCT02896400|524953117|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571914|NCT02896400|524953118|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
145571915|NCT02896400|524953119|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
145571916|NCT02896400|524953120|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571917|NCT02896400|524953121|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571918|NCT02896400|524953122|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
145571919|NCT02896400|524953123|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
145571920|NCT02896400|524953124|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571921|NCT02896400|524953125|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
145571922|NCT02896400|524953126|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
145571923|NCT02896400|524953127|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
145571924|NCT02896400|524953112|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
145571925|NCT02896400|524953113|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
145571926|NCT02896400|524953114|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
145571927|NCT02896400|524953115|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
145571928|NCT02896400|524953116|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
145571929|NCT02896400|524953117|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
145571930|NCT02896400|524953118|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
145571931|NCT02896400|524953119|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
145571932|NCT02896400|524953120|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
145571933|NCT02896400|524953121|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
145331125|NCT03071094|524063295|FG001|Overall Study|Adverse Event|0|||
145331126|NCT02312063|524063296|FG000|Overall Study|Withdrawal by Subject|0|||
145571934|NCT02896400|524953122|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
145571935|NCT02896400|524953123|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
145621056|NCT04955626|525126685|FG013|Blinded Period|Death|0|||
145331127|NCT02312063|524063297|FG001|Overall Study|Withdrawal by Subject|1|||
145331128|NCT00321737|524063303|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
145331129|NCT00321737|524063304|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
145331130|NCT00321737|524063305|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
145331131|NCT00321737|524063303|FG000|Overall Study|Adverse Event|11|||
145331132|NCT00321737|524063304|FG001|Overall Study|Adverse Event|3|||
145331133|NCT00321737|524063305|FG002|Overall Study|Adverse Event|6|||
145331134|NCT00321737|524063303|FG000|Overall Study|Lost to Follow-up|5|||
145331135|NCT00321737|524063304|FG001|Overall Study|Lost to Follow-up|5|||
145331136|NCT00321737|524063305|FG002|Overall Study|Lost to Follow-up|6|||
145331137|NCT00321737|524063303|FG000|Overall Study|Withdrawal by Subject|19|||
145331138|NCT00321737|524063304|FG001|Overall Study|Withdrawal by Subject|12|||
145331139|NCT00321737|524063305|FG002|Overall Study|Withdrawal by Subject|17|||
145331140|NCT00321737|524063303|FG000|Overall Study|Protocol Violation|0|||
145331141|NCT00321737|524063304|FG001|Overall Study|Protocol Violation|0|||
145331142|NCT00321737|524063305|FG002|Overall Study|Protocol Violation|1|||
145331143|NCT00321737|524063303|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
145331144|NCT00321737|524063304|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145331145|NCT00321737|524063305|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145331146|NCT00321737|524063303|FG000|Overall Study|Possible Barrett's Esophagus|2|||
145331147|NCT00321737|524063304|FG001|Overall Study|Possible Barrett's Esophagus|1|||
145331148|NCT00321737|524063305|FG002|Overall Study|Possible Barrett's Esophagus|1|||
145331149|NCT00321737|524063303|FG000|Overall Study|Therapeutic Failure|6|||
145331150|NCT00321737|524063304|FG001|Overall Study|Therapeutic Failure|0|||
145331151|NCT00321737|524063305|FG002|Overall Study|Therapeutic Failure|2|||
145331152|NCT00321737|524063303|FG000|Overall Study|Pregnancy|0|||
145331153|NCT00321737|524063304|FG001|Overall Study|Pregnancy|2|||
145331154|NCT00321737|524063305|FG002|Overall Study|Pregnancy|0|||
145331155|NCT00321737|524063303|FG000|Overall Study|Noncompliance|2|||
145331156|NCT00321737|524063304|FG001|Overall Study|Noncompliance|0|||
145331157|NCT00321737|524063305|FG002|Overall Study|Noncompliance|0|||
145331158|NCT00321737|524063303|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
145331159|NCT00321737|524063304|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
145331160|NCT00321737|524063305|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
145331161|NCT01079832|524063306|FG000|Overall Study|Withdrawal by Subject|1|||
145331162|NCT02283294|524063307|FG000|Overall Study|Lost to Follow-up|1|||
145331163|NCT02283294|524063308|FG001|Overall Study|Lost to Follow-up|1|||
145331164|NCT02283294|524063307|FG000|Overall Study|Withdrawal by Subject|1|||
145331165|NCT02283294|524063308|FG001|Overall Study|Withdrawal by Subject|6|||
145331166|NCT02283294|524063307|FG000|Overall Study|Protocol Violation|1|||
145331167|NCT02283294|524063308|FG001|Overall Study|Protocol Violation|0|||
145331168|NCT02283294|524063307|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
145331169|NCT02283294|524063308|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
145331170|NCT00594646|524063309|FG000|Overall Study|Withdrawal by Subject|1|||
145331171|NCT00594646|524063309|FG000|Overall Study|Lost to Follow-up|15|||
145331172|NCT01195272|524063310|FG000|Overall Study|Adverse Event|1|||
145331173|NCT01195272|524063310|FG000|Overall Study|Lack of Efficacy|3|||
145331174|NCT01769339|524063311|FG000|Overall Study|Lost to Follow-up|42|||
145331175|NCT01769339|524063311|FG000|Overall Study|Adverse Event|1|||
145331176|NCT05011123|524066111|FG000|Overall Study|Withdrawal by Subject|4|||
145331177|NCT05011123|524066112|FG001|Overall Study|Withdrawal by Subject|2|||
145331178|NCT05011123|524066111|FG000|Overall Study|Lost to Follow-up|7|||
145331179|NCT05011123|524066112|FG001|Overall Study|Lost to Follow-up|6|||
145331180|NCT05011123|524066111|FG000|Overall Study|Ongoing at the time of DBL date|36|||
145331181|NCT05011123|524066112|FG001|Overall Study|Ongoing at the time of DBL date|10|||
145331182|NCT05011123|524066111|FG000|Overall Study|Randomized but did not receive vaccination|1|||
145331183|NCT05011123|524066112|FG001|Overall Study|Randomized but did not receive vaccination|0|||
145331184|NCT03845296|524066116|FG000|Overall Study|On Treatment|2|||
145331185|NCT03845296|524066117|FG001|Overall Study|On Treatment|1|||
145331186|NCT03845296|524066116|FG000|Overall Study|Adverse Event|4|||
145331187|NCT03845296|524066117|FG001|Overall Study|Adverse Event|11|||
145331188|NCT03845296|524066116|FG000|Overall Study|Refusal unrelated to adverse event|0|||
145331189|NCT03845296|524066117|FG001|Overall Study|Refusal unrelated to adverse event|1|||
145331190|NCT03845296|524066116|FG000|Overall Study|Progression/relapse|14|||
145331191|NCT03845296|524066117|FG001|Overall Study|Progression/relapse|18|||
145331192|NCT03845296|524066116|FG000|Overall Study|Death|4|||
145331193|NCT03845296|524066117|FG001|Overall Study|Death|0|||
145331194|NCT03845296|524066116|FG000|Overall Study|Other - not protocol specified|1|||
145331195|NCT03845296|524066117|FG001|Overall Study|Other - not protocol specified|3|||
145331196|NCT06218823|524066120|FG000|Overall Study|Death|3|||
145331197|NCT06218823|524066121|FG001|Overall Study|Death|0|||
145331198|NCT06218823|524066120|FG000|Overall Study|Lost to Follow-up|0|||
145331199|NCT06218823|524066121|FG001|Overall Study|Lost to Follow-up|2|||
145331200|NCT04732221|524066122|FG000|Base Period|Death|2|||
145331201|NCT04732221|524066123|FG001|Base Period|Death|0|||
145331202|NCT04732221|524066124|FG002|Base Period|Death|0|||
145331203|NCT04732221|524066125|FG003|Base Period|Death|0|||
145331204|NCT04732221|524066126|FG004|Base Period|Death|0|||
145331205|NCT04732221|524066127|FG005|Base Period|Death|0|||
145331206|NCT04732221|524066128|FG006|Base Period|Death|0|||
145331207|NCT04732221|524066122|FG000|Base Period|Withdrawal by Subject|0|||
145331208|NCT04732221|524066123|FG001|Base Period|Withdrawal by Subject|1|||
145331209|NCT04732221|524066124|FG002|Base Period|Withdrawal by Subject|1|||
145412380|NCT02202616|524363588|FG000|Overall Study|Protocol deviation|18|||
145412381|NCT02202616|524363588|FG000|Overall Study|Patient withdrew consent|12|||
145412382|NCT02202616|524363588|FG000|Overall Study|Lost to Follow-up|6|||
145412383|NCT02202616|524363588|FG000|Overall Study|Administrative problems|6|||
145412384|NCT02202616|524363588|FG000|Overall Study|Abnormal test procedure result|1|||
145412385|NCT02202616|524363588|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145412386|NCT04327271|524363589|FG000|Overall Study|Death|1|||
145412387|NCT04327271|524363590|FG001|Overall Study|Death|0|||
145621057|NCT04955626|525126686|FG014|Blinded Period|Death|0|||
145621058|NCT04955626|525126687|FG015|Blinded Period|Death|0|||
145621059|NCT04955626|525126688|FG016|Blinded Period|Death|0|||
145621060|NCT04955626|525126689|FG017|Blinded Period|Death|0|||
145621061|NCT04955626|525126690|FG018|Blinded Period|Death|0|||
145621062|NCT04955626|525126691|FG019|Blinded Period|Death|0|||
145621063|NCT04955626|525126692|FG020|Blinded Period|Death|0|||
145621064|NCT04955626|525126693|FG021|Blinded Period|Death|0|||
145621065|NCT04955626|525126694|FG022|Blinded Period|Death|0|||
145621066|NCT04955626|525126695|FG023|Blinded Period|Death|1|||
145621067|NCT04955626|525126696|FG024|Blinded Period|Death|0|||
145621068|NCT04955626|525126697|FG025|Blinded Period|Death|0|||
145621069|NCT04955626|525126698|FG026|Blinded Period|Death|1|||
145621070|NCT04955626|525126699|FG027|Blinded Period|Death|1|||
145621071|NCT04955626|525126700|FG028|Blinded Period|Death|0|||
145621072|NCT04955626|525126701|FG029|Blinded Period|Death|1|||
145621073|NCT04955626|525126702|FG030|Blinded Period|Death|0|||
145621074|NCT04955626|525126703|FG031|Blinded Period|Death|0|||
145621075|NCT04955626|525126704|FG032|Blinded Period|Death|0|||
145621076|NCT04955626|525126705|FG033|Blinded Period|Death|0|||
145331210|NCT04732221|524066125|FG003|Base Period|Withdrawal by Subject|0|||
145331211|NCT04732221|524066126|FG004|Base Period|Withdrawal by Subject|0|||
145331212|NCT04732221|524066127|FG005|Base Period|Withdrawal by Subject|0|||
145331213|NCT04732221|524066128|FG006|Base Period|Withdrawal by Subject|0|||
145331214|NCT04732221|524066122|FG000|Extension Period|Adverse Event|0|||
145331215|NCT04732221|524066123|FG001|Extension Period|Adverse Event|0|||
145331216|NCT04732221|524066124|FG002|Extension Period|Adverse Event|0|||
145331217|NCT04732221|524066125|FG003|Extension Period|Adverse Event|0|||
145331218|NCT04732221|524066126|FG004|Extension Period|Adverse Event|0|||
145331219|NCT04732221|524066127|FG005|Extension Period|Adverse Event|1|||
145331220|NCT04732221|524066128|FG006|Extension Period|Adverse Event|0|||
145412388|NCT04327271|524363589|FG000|Overall Study|Withdrawal by Subject|1|||
145412389|NCT04327271|524363590|FG001|Overall Study|Withdrawal by Subject|0|||
145412390|NCT04327271|524363589|FG000|Overall Study|randomization error (data capture)|4|||
145412391|NCT04327271|524363590|FG001|Overall Study|randomization error (data capture)|3|||
145412392|NCT02948400|524363591|FG000|Overall Study|Withdrawal by Subject|17|||
145412393|NCT02948400|524363592|FG001|Overall Study|Withdrawal by Subject|10|||
145412394|NCT02948400|524363591|FG000|Overall Study|failed to attend appointments|47|||
145412395|NCT02948400|524363592|FG001|Overall Study|failed to attend appointments|34|||
145412396|NCT02948400|524363591|FG000|Overall Study|COVID-related closure|6|||
145412397|NCT02948400|524363592|FG001|Overall Study|COVID-related closure|2|||
145412398|NCT02948400|524363591|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
145412399|NCT02948400|524363592|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
145412400|NCT02948400|524363591|FG000|Overall Study|motion sickness in virtual reality|2|||
145412401|NCT02948400|524363592|FG001|Overall Study|motion sickness in virtual reality|0|||
145412402|NCT02717611|524363593|FG000|Overall Study|Death|13|||
145412403|NCT02717611|524363593|FG000|Overall Study|Withdrawal by Subject|6|||
145412404|NCT02717611|524363593|FG000|Overall Study|Active, not recruiting|40|||
145412405|NCT02717611|524363593|FG000|Overall Study|Complicating disease|1|||
145412406|NCT04598828|524363594|FG000|Overall Study|Physician Decision|1|||
145412407|NCT04598828|524363595|FG001|Overall Study|Physician Decision|0|||
145412408|NCT04598828|524363594|FG000|Overall Study|Withdrawal by Subject|0|||
145412409|NCT04598828|524363595|FG001|Overall Study|Withdrawal by Subject|1|||
145412410|NCT04598828|524363594|FG000|Overall Study|Withdrawal by Subject|0|||
145412411|NCT04598828|524363595|FG001|Overall Study|Withdrawal by Subject|1|||
145621077|NCT04955626|525126706|FG034|Blinded Period|Death|0|||
145621078|NCT04955626|525126707|FG035|Blinded Period|Death|0|||
145621079|NCT04955626|525126672|FG000|Blinded Period|Adverse Event|0|||
145412412|NCT04818112|524363596|FG000|Overall Study|Withdrawal by Subject|54|||
145412413|NCT04818112|524363597|FG001|Overall Study|Withdrawal by Subject|12|||
145412414|NCT04818112|524363596|FG000|Overall Study|Lost to Follow-up|38|||
145412415|NCT04818112|524363597|FG001|Overall Study|Lost to Follow-up|10|||
145412416|NCT00700635|524363599|FG000|Overall Study|Adverse Event|1|||
145412417|NCT00700635|524363600|FG001|Overall Study|Adverse Event|0|||
145412418|NCT00700635|524363601|FG002|Overall Study|Adverse Event|0|||
145412419|NCT00700635|524363599|FG000|Overall Study|Lost to Follow-up|1|||
145412420|NCT00700635|524363600|FG001|Overall Study|Lost to Follow-up|3|||
145412421|NCT00700635|524363601|FG002|Overall Study|Lost to Follow-up|0|||
145621080|NCT04955626|525126673|FG001|Blinded Period|Adverse Event|1|||
145621081|NCT04955626|525126674|FG002|Blinded Period|Adverse Event|1|||
145331221|NCT04732221|524066122|FG000|Extension Period|Death|0|||
145621082|NCT04955626|525126675|FG003|Blinded Period|Adverse Event|1|||
145331222|NCT04732221|524066123|FG001|Extension Period|Death|0|||
145331223|NCT04732221|524066124|FG002|Extension Period|Death|0|||
145331224|NCT04732221|524066125|FG003|Extension Period|Death|0|||
145331225|NCT04732221|524066126|FG004|Extension Period|Death|1|||
145331226|NCT04732221|524066127|FG005|Extension Period|Death|0|||
145331227|NCT04732221|524066128|FG006|Extension Period|Death|2|||
145331228|NCT04732221|524066122|FG000|Extension Period|Pregnancy|0|||
145331229|NCT04732221|524066123|FG001|Extension Period|Pregnancy|0|||
145331230|NCT04732221|524066124|FG002|Extension Period|Pregnancy|0|||
145331231|NCT04732221|524066125|FG003|Extension Period|Pregnancy|0|||
145331232|NCT04732221|524066126|FG004|Extension Period|Pregnancy|1|||
145571936|NCT02896400|524953124|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
145571937|NCT02896400|524953125|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
145571938|NCT02896400|524953126|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
145571939|NCT02896400|524953127|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
145571940|NCT00634647|524953128|FG000|Overall Study|death on study|3|||
145571941|NCT00634647|524953128|FG000|Overall Study|refused further treatment|3|||
145571942|NCT00634647|524953128|FG000|Overall Study|declined to participate before treatment|1|||
145571943|NCT02984020|524953129|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
145571944|NCT02984020|524953129|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
145571945|NCT02984020|524953129|FG000|Overall Study|Other significant protocol violation|2|||
145571946|NCT01896895|524953130|FG000|Double-blind MP|Physician Decision|0|||
145571947|NCT01896895|524953131|FG001|Double-blind MP|Physician Decision|0|||
145571948|NCT01896895|524953132|FG002|Double-blind MP|Physician Decision|1|||
145571949|NCT01896895|524953133|FG003|Double-blind MP|Physician Decision|0|||
145571950|NCT01896895|524953130|FG000|Double-blind MP|Withdrawal by Subject|0|||
145571951|NCT01896895|524953131|FG001|Double-blind MP|Withdrawal by Subject|2|||
145571952|NCT01896895|524953132|FG002|Double-blind MP|Withdrawal by Subject|1|||
145571953|NCT01896895|524953133|FG003|Double-blind MP|Withdrawal by Subject|0|||
145571954|NCT01896895|524953130|FG000|Double-blind MP|Lost to Follow-up|1|||
145571955|NCT01896895|524953131|FG001|Double-blind MP|Lost to Follow-up|0|||
145571956|NCT01896895|524953132|FG002|Double-blind MP|Lost to Follow-up|1|||
145571957|NCT01896895|524953133|FG003|Double-blind MP|Lost to Follow-up|0|||
145571958|NCT00667342|524953134|FG000|Overall Study|Protocol Violation|1|||
145571959|NCT00667342|524953135|FG001|Overall Study|Protocol Violation|0|||
145571960|NCT00667342|524953136|FG002|Overall Study|Protocol Violation|0|||
145571961|NCT00667342|524953134|FG000|Overall Study|Withdrawal by Subject|1|||
145571962|NCT00667342|524953135|FG001|Overall Study|Withdrawal by Subject|0|||
145571963|NCT00667342|524953136|FG002|Overall Study|Withdrawal by Subject|0|||
145571964|NCT00667342|524953134|FG000|Overall Study|Physician Decision|3|||
145571965|NCT00667342|524953135|FG001|Overall Study|Physician Decision|0|||
145571966|NCT00667342|524953136|FG002|Overall Study|Physician Decision|0|||
145571967|NCT00667342|524953134|FG000|Overall Study|Relapse or tumor progression|9|||
145571968|NCT00667342|524953135|FG001|Overall Study|Relapse or tumor progression|0|||
145571969|NCT00667342|524953136|FG002|Overall Study|Relapse or tumor progression|7|||
145571970|NCT00667342|524953134|FG000|Overall Study|Adverse Event|0|||
145571971|NCT00667342|524953135|FG001|Overall Study|Adverse Event|0|||
145571972|NCT00667342|524953136|FG002|Overall Study|Adverse Event|1|||
145571973|NCT00667342|524953134|FG000|Overall Study|Ineligible|0|||
145571974|NCT00667342|524953135|FG001|Overall Study|Ineligible|0|||
145571975|NCT00667342|524953136|FG002|Overall Study|Ineligible|1|||
145571976|NCT01207778|524953137|FG000|Overall Study|Lost to Follow-up|0|||
145331233|NCT04732221|524066127|FG005|Extension Period|Pregnancy|0|||
145331234|NCT04732221|524066128|FG006|Extension Period|Pregnancy|0|||
145331235|NCT04732221|524066122|FG000|Extension Period|Sponsors Decision|0|||
145331236|NCT04732221|524066123|FG001|Extension Period|Sponsors Decision|0|||
145331237|NCT04732221|524066124|FG002|Extension Period|Sponsors Decision|0|||
145331238|NCT04732221|524066125|FG003|Extension Period|Sponsors Decision|0|||
145331239|NCT04732221|524066126|FG004|Extension Period|Sponsors Decision|41|||
145331240|NCT04732221|524066127|FG005|Extension Period|Sponsors Decision|40|||
145571977|NCT01207778|524953138|FG001|Overall Study|Lost to Follow-up|3|||
145571978|NCT01207778|524953139|FG002|Overall Study|Lost to Follow-up|3|||
145571979|NCT03107988|524953140|FG000|Overall Study|Adverse Event|0|||
145571980|NCT03107988|524953141|FG001|Overall Study|Adverse Event|0|||
145331241|NCT04732221|524066128|FG006|Extension Period|Sponsors Decision|40|||
145331242|NCT04732221|524066122|FG000|Extension Period|Withdrawal by Subject|0|||
145331243|NCT04732221|524066123|FG001|Extension Period|Withdrawal by Subject|0|||
145571981|NCT03107988|524953142|FG002|Overall Study|Adverse Event|0|||
145571982|NCT03107988|524953143|FG003|Overall Study|Adverse Event|1|||
145571983|NCT03107988|524953144|FG004|Overall Study|Adverse Event|0|||
145571984|NCT03107988|524953145|FG005|Overall Study|Adverse Event|1|||
145571985|NCT03107988|524953146|FG006|Overall Study|Adverse Event|0|||
145571986|NCT03107988|524953147|FG007|Overall Study|Adverse Event|1|||
145331244|NCT04732221|524066124|FG002|Extension Period|Withdrawal by Subject|0|||
145331245|NCT04732221|524066125|FG003|Extension Period|Withdrawal by Subject|0|||
145331246|NCT04732221|524066126|FG004|Extension Period|Withdrawal by Subject|1|||
145621083|NCT04955626|525126676|FG004|Blinded Period|Adverse Event|0|||
145621084|NCT04955626|525126677|FG005|Blinded Period|Adverse Event|0|||
145621085|NCT04955626|525126678|FG006|Blinded Period|Adverse Event|0|||
145621086|NCT04955626|525126679|FG007|Blinded Period|Adverse Event|0|||
145621087|NCT04955626|525126680|FG008|Blinded Period|Adverse Event|0|||
145621088|NCT04955626|525126681|FG009|Blinded Period|Adverse Event|1|||
145621089|NCT04955626|525126682|FG010|Blinded Period|Adverse Event|1|||
145331247|NCT04732221|524066127|FG005|Extension Period|Withdrawal by Subject|5|||
145331248|NCT04732221|524066128|FG006|Extension Period|Withdrawal by Subject|2|||
145331249|NCT04385277|524066129|FG000|Overall Study|Physician Decision|2|||
145331250|NCT04385277|524066129|FG000|Overall Study|Ineligible|1|||
145331251|NCT04385277|524066129|FG000|Overall Study|Patient/Parent Refusal|2|||
145331252|NCT00461253|524066133|FG000|Overall Study|Death|985|||
145331253|NCT00461253|524066134|FG001|Overall Study|Death|0|||
145331254|NCT00461253|524066133|FG000|Overall Study|Protocol Violation|613|||
145331255|NCT00461253|524066134|FG001|Overall Study|Protocol Violation|236|||
145331256|NCT00461253|524066133|FG000|Overall Study|no response|2609|||
145331257|NCT00461253|524066134|FG001|Overall Study|no response|11789|||
145571987|NCT03107988|524953148|FG008|Overall Study|Adverse Event|0|||
145571988|NCT03107988|524953149|FG009|Overall Study|Adverse Event|0|||
145571989|NCT03107988|524953150|FG010|Overall Study|Adverse Event|0|||
145571990|NCT03107988|524953151|FG011|Overall Study|Adverse Event|0|||
145571991|NCT03107988|524953152|FG012|Overall Study|Adverse Event|0|||
145571992|NCT03107988|524953140|FG000|Overall Study|Disease Progression or Relapse|1|||
145571993|NCT03107988|524953141|FG001|Overall Study|Disease Progression or Relapse|2|||
145571994|NCT03107988|524953142|FG002|Overall Study|Disease Progression or Relapse|2|||
145571995|NCT03107988|524953143|FG003|Overall Study|Disease Progression or Relapse|5|||
145571996|NCT03107988|524953144|FG004|Overall Study|Disease Progression or Relapse|1|||
145571997|NCT03107988|524953145|FG005|Overall Study|Disease Progression or Relapse|1|||
145571998|NCT03107988|524953146|FG006|Overall Study|Disease Progression or Relapse|0|||
145571999|NCT03107988|524953147|FG007|Overall Study|Disease Progression or Relapse|0|||
145572000|NCT03107988|524953148|FG008|Overall Study|Disease Progression or Relapse|0|||
145572001|NCT03107988|524953149|FG009|Overall Study|Disease Progression or Relapse|1|||
145572002|NCT03107988|524953150|FG010|Overall Study|Disease Progression or Relapse|4|||
145331258|NCT00461253|524066133|FG000|Overall Study|administrative|773|||
145331259|NCT00461253|524066134|FG001|Overall Study|administrative|7773|||
145331260|NCT02799095|524066135|FG000|Part A|Adverse Event|1|||
145331261|NCT02799095|524066136|FG001|Part A|Adverse Event|0|||
145331262|NCT02799095|524066137|FG002|Part A|Adverse Event|1|||
145331263|NCT02799095|524066138|FG003|Part A|Adverse Event|4|||
145331264|NCT02799095|524066139|FG004|Part A|Adverse Event|1|||
145331265|NCT02799095|524066140|FG005|Part A|Adverse Event|0|||
145331266|NCT02799095|524066141|FG006|Part A|Adverse Event|0|||
145331267|NCT02799095|524066142|FG007|Part A|Adverse Event|0|||
145331268|NCT02799095|524066143|FG008|Part A|Adverse Event|0|||
145331269|NCT02799095|524066144|FG009|Part A|Adverse Event|0|||
145331270|NCT02799095|524066145|FG010|Part A|Adverse Event|0|||
145331271|NCT02799095|524066146|FG011|Part A|Adverse Event|0|||
145331272|NCT02799095|524066147|FG012|Part A|Adverse Event|0|||
145331273|NCT02799095|524066148|FG013|Part A|Adverse Event|0|||
145331274|NCT02799095|524066149|FG014|Part A|Adverse Event|0|||
145331275|NCT02799095|524066150|FG015|Part A|Adverse Event|0|||
145331276|NCT02799095|524066151|FG016|Part A|Adverse Event|0|||
145331277|NCT02799095|524066135|FG000|Part A|Death|0|||
145331278|NCT02799095|524066136|FG001|Part A|Death|0|||
145331279|NCT02799095|524066137|FG002|Part A|Death|0|||
145331280|NCT02799095|524066138|FG003|Part A|Death|0|||
145331281|NCT02799095|524066139|FG004|Part A|Death|0|||
145331282|NCT02799095|524066140|FG005|Part A|Death|0|||
145331283|NCT02799095|524066141|FG006|Part A|Death|3|||
145331284|NCT02799095|524066142|FG007|Part A|Death|0|||
145331285|NCT02799095|524066143|FG008|Part A|Death|0|||
145331286|NCT02799095|524066144|FG009|Part A|Death|0|||
145331287|NCT02799095|524066145|FG010|Part A|Death|0|||
145331288|NCT02799095|524066146|FG011|Part A|Death|0|||
145331289|NCT02799095|524066147|FG012|Part A|Death|0|||
145331290|NCT02799095|524066148|FG013|Part A|Death|0|||
145331291|NCT02799095|524066149|FG014|Part A|Death|0|||
145572003|NCT03107988|524953151|FG011|Overall Study|Disease Progression or Relapse|0|||
145331292|NCT02799095|524066150|FG015|Part A|Death|0|||
145412422|NCT00700635|524363599|FG000|Overall Study|Protocol Violation|2|||
145572004|NCT03107988|524953152|FG012|Overall Study|Disease Progression or Relapse|0|||
145572005|NCT03107988|524953140|FG000|Overall Study|Ineligible|0|||
145621090|NCT04955626|525126683|FG011|Blinded Period|Adverse Event|0|||
145572006|NCT03107988|524953141|FG001|Overall Study|Ineligible|0|||
145621091|NCT04955626|525126684|FG012|Blinded Period|Adverse Event|0|||
145331293|NCT02799095|524066151|FG016|Part A|Death|0|||
145331294|NCT02799095|524066135|FG000|Part A|Lost to Follow-up|0|||
145331295|NCT02799095|524066136|FG001|Part A|Lost to Follow-up|1|||
145621092|NCT04955626|525126685|FG013|Blinded Period|Adverse Event|0|||
145331296|NCT02799095|524066137|FG002|Part A|Lost to Follow-up|0|||
145331297|NCT02799095|524066138|FG003|Part A|Lost to Follow-up|0|||
145331298|NCT02799095|524066139|FG004|Part A|Lost to Follow-up|0|||
145331299|NCT02799095|524066140|FG005|Part A|Lost to Follow-up|0|||
145331300|NCT02799095|524066141|FG006|Part A|Lost to Follow-up|1|||
145331301|NCT02799095|524066142|FG007|Part A|Lost to Follow-up|0|||
145331302|NCT02799095|524066143|FG008|Part A|Lost to Follow-up|0|||
145331303|NCT02799095|524066144|FG009|Part A|Lost to Follow-up|0|||
145331304|NCT02799095|524066145|FG010|Part A|Lost to Follow-up|0|||
145331305|NCT02799095|524066146|FG011|Part A|Lost to Follow-up|0|||
145331306|NCT02799095|524066147|FG012|Part A|Lost to Follow-up|0|||
145331307|NCT02799095|524066148|FG013|Part A|Lost to Follow-up|0|||
145331308|NCT02799095|524066149|FG014|Part A|Lost to Follow-up|0|||
145331309|NCT02799095|524066150|FG015|Part A|Lost to Follow-up|0|||
145331310|NCT02799095|524066151|FG016|Part A|Lost to Follow-up|0|||
145331311|NCT02799095|524066135|FG000|Part A|Progressive Disease|3|||
145331312|NCT02799095|524066136|FG001|Part A|Progressive Disease|3|||
145331313|NCT02799095|524066137|FG002|Part A|Progressive Disease|3|||
145331314|NCT02799095|524066138|FG003|Part A|Progressive Disease|2|||
145331315|NCT02799095|524066139|FG004|Part A|Progressive Disease|2|||
145331316|NCT02799095|524066140|FG005|Part A|Progressive Disease|0|||
145331317|NCT02799095|524066141|FG006|Part A|Progressive Disease|0|||
145331318|NCT02799095|524066142|FG007|Part A|Progressive Disease|0|||
145331319|NCT02799095|524066143|FG008|Part A|Progressive Disease|0|||
145331320|NCT02799095|524066144|FG009|Part A|Progressive Disease|0|||
145331321|NCT02799095|524066145|FG010|Part A|Progressive Disease|0|||
145331322|NCT02799095|524066146|FG011|Part A|Progressive Disease|0|||
145331323|NCT02799095|524066147|FG012|Part A|Progressive Disease|0|||
145331324|NCT02799095|524066148|FG013|Part A|Progressive Disease|0|||
145572007|NCT03107988|524953142|FG002|Overall Study|Ineligible|0|||
145572008|NCT03107988|524953143|FG003|Overall Study|Ineligible|0|||
145572009|NCT03107988|524953144|FG004|Overall Study|Ineligible|0|||
145572010|NCT03107988|524953145|FG005|Overall Study|Ineligible|0|||
145572011|NCT03107988|524953146|FG006|Overall Study|Ineligible|0|||
145572012|NCT03107988|524953147|FG007|Overall Study|Ineligible|0|||
145572013|NCT03107988|524953148|FG008|Overall Study|Ineligible|1|||
145572014|NCT03107988|524953149|FG009|Overall Study|Ineligible|0|||
145572015|NCT03107988|524953150|FG010|Overall Study|Ineligible|0|||
145572016|NCT03107988|524953151|FG011|Overall Study|Ineligible|0|||
145572017|NCT03107988|524953152|FG012|Overall Study|Ineligible|0|||
145572018|NCT04709237|524953153|FG000|Overall Study|Lost to Follow-up|1|||
145572019|NCT04709237|524953154|FG001|Overall Study|Lost to Follow-up|0|||
145572020|NCT04709237|524953155|FG002|Overall Study|Lost to Follow-up|0|||
145572021|NCT00145509|524953156|FG000|Overall Study|Adverse Event|10|||
145572022|NCT00145509|524953157|FG001|Overall Study|Adverse Event|3|||
145572023|NCT00145509|524953156|FG000|Overall Study|Lack of Efficacy|3|||
145572024|NCT00145509|524953157|FG001|Overall Study|Lack of Efficacy|1|||
145572025|NCT00145509|524953156|FG000|Overall Study|Lost to Follow-up|5|||
145572026|NCT00145509|524953157|FG001|Overall Study|Lost to Follow-up|9|||
145572027|NCT00145509|524953156|FG000|Overall Study|Withdrew Consent|2|||
145572028|NCT00145509|524953157|FG001|Overall Study|Withdrew Consent|7|||
145572029|NCT00145509|524953156|FG000|Overall Study|Reason not provided|2|||
145572030|NCT00145509|524953157|FG001|Overall Study|Reason not provided|1|||
145572031|NCT01359592|524953158|FG000|Initial Registration|Adverse Event|1|||
145572032|NCT01359592|524953159|FG001|Initial Registration|Adverse Event|0|||
145572033|NCT01359592|524953160|FG002|Initial Registration|Adverse Event|0|||
145572034|NCT01359592|524953161|FG003|Initial Registration|Adverse Event|0|||
145572035|NCT01359592|524953158|FG000|Initial Registration|Death|1|||
145572036|NCT01359592|524953159|FG001|Initial Registration|Death|0|||
145572037|NCT01359592|524953160|FG002|Initial Registration|Death|0|||
145572038|NCT01359592|524953161|FG003|Initial Registration|Death|0|||
145572039|NCT01359592|524953158|FG000|Initial Registration|Other reason not protocol specified|1|||
145572040|NCT01359592|524953159|FG001|Initial Registration|Other reason not protocol specified|0|||
145572041|NCT01359592|524953160|FG002|Initial Registration|Other reason not protocol specified|0|||
145572042|NCT01359592|524953161|FG003|Initial Registration|Other reason not protocol specified|0|||
145572043|NCT01359592|524953158|FG000|Initial Registration|Ineligible|26|||
145572044|NCT01359592|524953159|FG001|Initial Registration|Ineligible|0|||
145572045|NCT01359592|524953160|FG002|Initial Registration|Ineligible|0|||
145572046|NCT01359592|524953161|FG003|Initial Registration|Ineligible|0|||
145572047|NCT01359592|524953158|FG000|PET-Directed Therapy|Adverse Event|0|||
145572048|NCT01359592|524953159|FG001|PET-Directed Therapy|Adverse Event|0|||
145572049|NCT01359592|524953160|FG002|PET-Directed Therapy|Adverse Event|1|||
145572050|NCT01359592|524953161|FG003|PET-Directed Therapy|Adverse Event|0|||
145331325|NCT02799095|524066149|FG014|Part A|Progressive Disease|0|||
145331326|NCT02799095|524066150|FG015|Part A|Progressive Disease|0|||
145572051|NCT01359592|524953158|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
145572052|NCT01359592|524953159|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
145572053|NCT01359592|524953160|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
145572054|NCT01359592|524953161|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
145572055|NCT01359592|524953158|FG000|PET-Directed Therapy|Ineligible|0|||
145572056|NCT01359592|524953159|FG001|PET-Directed Therapy|Ineligible|0|||
145572057|NCT01359592|524953160|FG002|PET-Directed Therapy|Ineligible|24|||
145331327|NCT02799095|524066151|FG016|Part A|Progressive Disease|0|||
145331328|NCT02799095|524066135|FG000|Part A|Clinical Progression|1|||
145572058|NCT01359592|524953161|FG003|PET-Directed Therapy|Ineligible|0|||
145572059|NCT00749775|524953168|FG000|Overall Study|Protocol Violation|24|||
145572060|NCT00749775|524953168|FG000|Overall Study|Lost to Follow-up|36|||
145572061|NCT00749775|524953168|FG000|Overall Study|No visit after first day of treatment|44|||
145572062|NCT00749775|524953168|FG000|Overall Study|No drug administration|3|||
145572063|NCT02506816|524953173|FG000|Overall Study|Adverse Event|3|||
145572064|NCT03019627|524953174|FG000|Overall Study|Adverse Event|8|||
145572065|NCT03019627|524953175|FG001|Overall Study|Adverse Event|0|||
145572066|NCT03019627|524953174|FG000|Overall Study|Unrelated to adverse event|1|||
145572067|NCT03019627|524953175|FG001|Overall Study|Unrelated to adverse event|3|||
145572068|NCT03019627|524953174|FG000|Overall Study|Lost to Follow-up|2|||
145572069|NCT03019627|524953175|FG001|Overall Study|Lost to Follow-up|1|||
145572070|NCT03019627|524953174|FG000|Overall Study|not compliance|2|||
145572071|NCT03019627|524953175|FG001|Overall Study|not compliance|2|||
145572072|NCT03019627|524953174|FG000|Overall Study|Other|2|||
145572073|NCT03019627|524953175|FG001|Overall Study|Other|2|||
145572074|NCT02103478|524953178|FG000|Overall Study|Adverse Event|0|||
145572075|NCT02103478|524953179|FG001|Overall Study|Adverse Event|0|||
145572076|NCT02103478|524953180|FG002|Overall Study|Adverse Event|1|||
145572077|NCT02103478|524953181|FG003|Overall Study|Adverse Event|1|||
145572078|NCT02103478|524953182|FG004|Overall Study|Adverse Event|2|||
145572079|NCT02103478|524953183|FG005|Overall Study|Adverse Event|1|||
145572080|NCT02103478|524953184|FG006|Overall Study|Adverse Event|0|||
145572081|NCT02103478|524953185|FG007|Overall Study|Adverse Event|0|||
145572082|NCT02103478|524953186|FG008|Overall Study|Adverse Event|0|||
145572083|NCT02103478|524953178|FG000|Overall Study|Death|2|||
145572084|NCT02103478|524953179|FG001|Overall Study|Death|2|||
145572085|NCT02103478|524953180|FG002|Overall Study|Death|1|||
145572086|NCT02103478|524953181|FG003|Overall Study|Death|1|||
145572087|NCT02103478|524953182|FG004|Overall Study|Death|5|||
145572088|NCT02103478|524953183|FG005|Overall Study|Death|15|||
145572089|NCT02103478|524953184|FG006|Overall Study|Death|14|||
145572090|NCT02103478|524953185|FG007|Overall Study|Death|10|||
145572091|NCT02103478|524953186|FG008|Overall Study|Death|11|||
145572092|NCT02103478|524953178|FG000|Overall Study|Progressive Disease|2|||
145572093|NCT02103478|524953179|FG001|Overall Study|Progressive Disease|1|||
145572094|NCT02103478|524953180|FG002|Overall Study|Progressive Disease|2|||
145572095|NCT02103478|524953181|FG003|Overall Study|Progressive Disease|0|||
145572096|NCT02103478|524953182|FG004|Overall Study|Progressive Disease|9|||
145572097|NCT02103478|524953183|FG005|Overall Study|Progressive Disease|1|||
145572098|NCT02103478|524953184|FG006|Overall Study|Progressive Disease|2|||
145572099|NCT02103478|524953185|FG007|Overall Study|Progressive Disease|0|||
145572100|NCT02103478|524953186|FG008|Overall Study|Progressive Disease|1|||
145572101|NCT02103478|524953178|FG000|Overall Study|Withdrawal by Subject|2|||
145572102|NCT02103478|524953179|FG001|Overall Study|Withdrawal by Subject|0|||
145572103|NCT02103478|524953180|FG002|Overall Study|Withdrawal by Subject|0|||
145572104|NCT02103478|524953181|FG003|Overall Study|Withdrawal by Subject|4|||
145572105|NCT02103478|524953182|FG004|Overall Study|Withdrawal by Subject|0|||
145572106|NCT02103478|524953183|FG005|Overall Study|Withdrawal by Subject|0|||
145572107|NCT02103478|524953184|FG006|Overall Study|Withdrawal by Subject|1|||
145572108|NCT02103478|524953185|FG007|Overall Study|Withdrawal by Subject|1|||
145572109|NCT02103478|524953186|FG008|Overall Study|Withdrawal by Subject|0|||
145621093|NCT04955626|525126686|FG014|Blinded Period|Adverse Event|0|||
145621094|NCT04955626|525126687|FG015|Blinded Period|Adverse Event|0|||
145572110|NCT02103478|524953178|FG000|Overall Study|Lost to Follow-up|0|||
145572111|NCT02103478|524953179|FG001|Overall Study|Lost to Follow-up|0|||
145572112|NCT02103478|524953180|FG002|Overall Study|Lost to Follow-up|0|||
145572113|NCT02103478|524953181|FG003|Overall Study|Lost to Follow-up|0|||
145572114|NCT02103478|524953182|FG004|Overall Study|Lost to Follow-up|0|||
145572115|NCT02103478|524953183|FG005|Overall Study|Lost to Follow-up|0|||
145572116|NCT02103478|524953184|FG006|Overall Study|Lost to Follow-up|0|||
145572117|NCT02103478|524953185|FG007|Overall Study|Lost to Follow-up|1|||
145572118|NCT02103478|524953186|FG008|Overall Study|Lost to Follow-up|0|||
145572119|NCT02103478|524953178|FG000|Overall Study|Other|1|||
145572120|NCT02103478|524953179|FG001|Overall Study|Other|3|||
145572121|NCT02103478|524953180|FG002|Overall Study|Other|2|||
145572122|NCT02103478|524953181|FG003|Overall Study|Other|0|||
145572123|NCT02103478|524953182|FG004|Overall Study|Other|3|||
145572124|NCT02103478|524953183|FG005|Overall Study|Other|8|||
145572125|NCT02103478|524953184|FG006|Overall Study|Other|8|||
145572126|NCT02103478|524953185|FG007|Overall Study|Other|4|||
145572127|NCT02103478|524953186|FG008|Overall Study|Other|2|||
145572128|NCT00723606|524953187|FG000|Overall Study|Adverse Event|2|||
145572129|NCT00723606|524953188|FG001|Overall Study|Adverse Event|5|||
145572130|NCT00723606|524953187|FG000|Overall Study|Other|2|||
145572131|NCT00723606|524953188|FG001|Overall Study|Other|0|||
145572132|NCT00723606|524953187|FG000|Overall Study|Withdrawal by Subject|0|||
145572133|NCT00723606|524953188|FG001|Overall Study|Withdrawal by Subject|2|||
145572134|NCT00976898|524953189|FG000|Overall Study|Protocol Violation|1|||
145572135|NCT00976898|524953189|FG000|Overall Study|Adverse Event|1|||
145572136|NCT00976898|524953189|FG000|Overall Study|Physician Decision|1|||
145621095|NCT04955626|525126688|FG016|Blinded Period|Adverse Event|0|||
145331329|NCT02799095|524066136|FG001|Part A|Clinical Progression|0|||
145331330|NCT02799095|524066137|FG002|Part A|Clinical Progression|2|||
145331331|NCT02799095|524066138|FG003|Part A|Clinical Progression|1|||
145331332|NCT02799095|524066139|FG004|Part A|Clinical Progression|5|||
145331333|NCT02799095|524066140|FG005|Part A|Clinical Progression|0|||
145331334|NCT02799095|524066141|FG006|Part A|Clinical Progression|0|||
145331335|NCT02799095|524066142|FG007|Part A|Clinical Progression|0|||
145331336|NCT02799095|524066143|FG008|Part A|Clinical Progression|0|||
145331337|NCT02799095|524066144|FG009|Part A|Clinical Progression|0|||
145331338|NCT02799095|524066145|FG010|Part A|Clinical Progression|0|||
145331339|NCT02799095|524066146|FG011|Part A|Clinical Progression|0|||
145331340|NCT02799095|524066147|FG012|Part A|Clinical Progression|0|||
145331341|NCT02799095|524066148|FG013|Part A|Clinical Progression|0|||
145331342|NCT02799095|524066149|FG014|Part A|Clinical Progression|0|||
145331343|NCT02799095|524066150|FG015|Part A|Clinical Progression|0|||
145331344|NCT02799095|524066151|FG016|Part A|Clinical Progression|0|||
145331345|NCT02799095|524066135|FG000|Part A|Protocol Deviation|0|||
145331346|NCT02799095|524066136|FG001|Part A|Protocol Deviation|0|||
145331347|NCT02799095|524066137|FG002|Part A|Protocol Deviation|1|||
145331348|NCT02799095|524066138|FG003|Part A|Protocol Deviation|0|||
145331349|NCT02799095|524066139|FG004|Part A|Protocol Deviation|0|||
145331350|NCT02799095|524066140|FG005|Part A|Protocol Deviation|0|||
145331351|NCT02799095|524066141|FG006|Part A|Protocol Deviation|0|||
145331352|NCT02799095|524066142|FG007|Part A|Protocol Deviation|0|||
145331353|NCT02799095|524066143|FG008|Part A|Protocol Deviation|0|||
145331354|NCT02799095|524066144|FG009|Part A|Protocol Deviation|0|||
145331355|NCT02799095|524066145|FG010|Part A|Protocol Deviation|0|||
145331356|NCT02799095|524066146|FG011|Part A|Protocol Deviation|0|||
145331357|NCT02799095|524066147|FG012|Part A|Protocol Deviation|0|||
145331358|NCT02799095|524066148|FG013|Part A|Protocol Deviation|0|||
145331359|NCT02799095|524066149|FG014|Part A|Protocol Deviation|0|||
145331360|NCT02799095|524066150|FG015|Part A|Protocol Deviation|0|||
145331361|NCT02799095|524066151|FG016|Part A|Protocol Deviation|0|||
145331362|NCT02799095|524066135|FG000|Part A|Withdrawal by Subject|0|||
145331363|NCT02799095|524066136|FG001|Part A|Withdrawal by Subject|0|||
145331364|NCT02799095|524066137|FG002|Part A|Withdrawal by Subject|0|||
145621096|NCT04955626|525126689|FG017|Blinded Period|Adverse Event|0|||
145621097|NCT04955626|525126690|FG018|Blinded Period|Adverse Event|1|||
145621098|NCT04955626|525126691|FG019|Blinded Period|Adverse Event|0|||
145621099|NCT04955626|525126692|FG020|Blinded Period|Adverse Event|0|||
145621100|NCT04955626|525126693|FG021|Blinded Period|Adverse Event|0|||
145621101|NCT04955626|525126694|FG022|Blinded Period|Adverse Event|0|||
145331365|NCT02799095|524066138|FG003|Part A|Withdrawal by Subject|1|||
145331366|NCT02799095|524066139|FG004|Part A|Withdrawal by Subject|3|||
145331367|NCT02799095|524066140|FG005|Part A|Withdrawal by Subject|1|||
145331368|NCT02799095|524066141|FG006|Part A|Withdrawal by Subject|1|||
145331369|NCT02799095|524066142|FG007|Part A|Withdrawal by Subject|0|||
145331370|NCT02799095|524066143|FG008|Part A|Withdrawal by Subject|0|||
145331371|NCT02799095|524066144|FG009|Part A|Withdrawal by Subject|0|||
145331372|NCT02799095|524066145|FG010|Part A|Withdrawal by Subject|0|||
145331373|NCT02799095|524066146|FG011|Part A|Withdrawal by Subject|0|||
145331374|NCT02799095|524066147|FG012|Part A|Withdrawal by Subject|0|||
145331375|NCT02799095|524066148|FG013|Part A|Withdrawal by Subject|0|||
145331376|NCT02799095|524066149|FG014|Part A|Withdrawal by Subject|0|||
145331377|NCT02799095|524066150|FG015|Part A|Withdrawal by Subject|0|||
145331378|NCT02799095|524066151|FG016|Part A|Withdrawal by Subject|0|||
145331379|NCT02799095|524066135|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
145331380|NCT02799095|524066136|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
145331381|NCT02799095|524066137|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
145331382|NCT02799095|524066138|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
145331383|NCT02799095|524066139|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
145331384|NCT02799095|524066140|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
145331385|NCT02799095|524066141|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
145331386|NCT02799095|524066142|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
145331387|NCT02799095|524066143|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
145331388|NCT02799095|524066144|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
145331389|NCT02799095|524066145|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
145331390|NCT02799095|524066146|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
145331391|NCT02799095|524066147|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
145331392|NCT02799095|524066148|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
145331393|NCT02799095|524066149|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
145331394|NCT02799095|524066150|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
145331395|NCT02799095|524066151|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
145331396|NCT02799095|524066135|FG000|Part B|Death|0|||
145331397|NCT02799095|524066136|FG001|Part B|Death|0|||
145331398|NCT02799095|524066137|FG002|Part B|Death|0|||
145331399|NCT02799095|524066138|FG003|Part B|Death|0|||
145331400|NCT02799095|524066139|FG004|Part B|Death|0|||
145331401|NCT02799095|524066140|FG005|Part B|Death|0|||
145331402|NCT02799095|524066141|FG006|Part B|Death|0|||
145331403|NCT02799095|524066142|FG007|Part B|Death|7|||
145331404|NCT02799095|524066143|FG008|Part B|Death|7|||
145621102|NCT04955626|525126695|FG023|Blinded Period|Adverse Event|0|||
145621103|NCT04955626|525126696|FG024|Blinded Period|Adverse Event|0|||
145621104|NCT04955626|525126697|FG025|Blinded Period|Adverse Event|0|||
145621105|NCT04955626|525126698|FG026|Blinded Period|Adverse Event|1|||
145621106|NCT04955626|525126699|FG027|Blinded Period|Adverse Event|0|||
145621107|NCT04955626|525126700|FG028|Blinded Period|Adverse Event|0|||
145621108|NCT04955626|525126701|FG029|Blinded Period|Adverse Event|0|||
145621109|NCT04955626|525126702|FG030|Blinded Period|Adverse Event|0|||
145621110|NCT04955626|525126703|FG031|Blinded Period|Adverse Event|0|||
145621111|NCT04955626|525126704|FG032|Blinded Period|Adverse Event|0|||
145621112|NCT04955626|525126705|FG033|Blinded Period|Adverse Event|0|||
145621113|NCT04955626|525126706|FG034|Blinded Period|Adverse Event|0|||
145621114|NCT04955626|525126707|FG035|Blinded Period|Adverse Event|0|||
145621115|NCT04955626|525126672|FG000|Blinded Period|No longer meets eligibility criteria|1|||
145621116|NCT04955626|525126673|FG001|Blinded Period|No longer meets eligibility criteria|2|||
145621117|NCT04955626|525126674|FG002|Blinded Period|No longer meets eligibility criteria|0|||
145621118|NCT04955626|525126675|FG003|Blinded Period|No longer meets eligibility criteria|1|||
145621119|NCT04955626|525126676|FG004|Blinded Period|No longer meets eligibility criteria|0|||
145621120|NCT04955626|525126677|FG005|Blinded Period|No longer meets eligibility criteria|0|||
145621121|NCT04955626|525126678|FG006|Blinded Period|No longer meets eligibility criteria|0|||
145621122|NCT04955626|525126679|FG007|Blinded Period|No longer meets eligibility criteria|0|||
145621123|NCT04955626|525126680|FG008|Blinded Period|No longer meets eligibility criteria|1|||
145621124|NCT04955626|525126681|FG009|Blinded Period|No longer meets eligibility criteria|0|||
145621125|NCT04955626|525126682|FG010|Blinded Period|No longer meets eligibility criteria|1|||
145621126|NCT04955626|525126683|FG011|Blinded Period|No longer meets eligibility criteria|1|||
145621127|NCT04955626|525126684|FG012|Blinded Period|No longer meets eligibility criteria|0|||
145621128|NCT04955626|525126685|FG013|Blinded Period|No longer meets eligibility criteria|0|||
145621129|NCT04955626|525126686|FG014|Blinded Period|No longer meets eligibility criteria|0|||
145621130|NCT04955626|525126687|FG015|Blinded Period|No longer meets eligibility criteria|3|||
145621131|NCT04955626|525126688|FG016|Blinded Period|No longer meets eligibility criteria|0|||
145621132|NCT04955626|525126689|FG017|Blinded Period|No longer meets eligibility criteria|2|||
145621133|NCT04955626|525126690|FG018|Blinded Period|No longer meets eligibility criteria|0|||
145331405|NCT02799095|524066144|FG009|Part B|Death|0|||
145331406|NCT02799095|524066145|FG010|Part B|Death|0|||
145331407|NCT02799095|524066146|FG011|Part B|Death|0|||
145331408|NCT02799095|524066147|FG012|Part B|Death|0|||
145331409|NCT02799095|524066148|FG013|Part B|Death|0|||
145331410|NCT02799095|524066149|FG014|Part B|Death|0|||
145331411|NCT02799095|524066150|FG015|Part B|Death|0|||
145331412|NCT02799095|524066151|FG016|Part B|Death|0|||
145331413|NCT02799095|524066135|FG000|Part B|Progressive Disease|0|||
145331414|NCT02799095|524066136|FG001|Part B|Progressive Disease|0|||
145331415|NCT02799095|524066137|FG002|Part B|Progressive Disease|0|||
145331416|NCT02799095|524066138|FG003|Part B|Progressive Disease|0|||
145331417|NCT02799095|524066139|FG004|Part B|Progressive Disease|0|||
145331418|NCT02799095|524066140|FG005|Part B|Progressive Disease|0|||
145331419|NCT02799095|524066141|FG006|Part B|Progressive Disease|0|||
145331420|NCT02799095|524066142|FG007|Part B|Progressive Disease|1|||
145331421|NCT02799095|524066143|FG008|Part B|Progressive Disease|0|||
145331422|NCT02799095|524066144|FG009|Part B|Progressive Disease|0|||
145331423|NCT02799095|524066145|FG010|Part B|Progressive Disease|0|||
145331424|NCT02799095|524066146|FG011|Part B|Progressive Disease|0|||
145331425|NCT02799095|524066147|FG012|Part B|Progressive Disease|0|||
145331426|NCT02799095|524066148|FG013|Part B|Progressive Disease|0|||
145331427|NCT02799095|524066149|FG014|Part B|Progressive Disease|0|||
145331428|NCT02799095|524066150|FG015|Part B|Progressive Disease|0|||
145331429|NCT02799095|524066151|FG016|Part B|Progressive Disease|0|||
145331430|NCT02799095|524066135|FG000|Part B|Withdrawal by Subject|0|||
145331431|NCT02799095|524066136|FG001|Part B|Withdrawal by Subject|0|||
145331432|NCT02799095|524066137|FG002|Part B|Withdrawal by Subject|0|||
145331433|NCT02799095|524066138|FG003|Part B|Withdrawal by Subject|0|||
145331434|NCT02799095|524066139|FG004|Part B|Withdrawal by Subject|0|||
145331435|NCT02799095|524066140|FG005|Part B|Withdrawal by Subject|0|||
145331436|NCT02799095|524066141|FG006|Part B|Withdrawal by Subject|0|||
145331437|NCT02799095|524066142|FG007|Part B|Withdrawal by Subject|10|||
145331438|NCT02799095|524066143|FG008|Part B|Withdrawal by Subject|7|||
145331439|NCT02799095|524066144|FG009|Part B|Withdrawal by Subject|0|||
145331440|NCT02799095|524066145|FG010|Part B|Withdrawal by Subject|0|||
145331441|NCT02799095|524066146|FG011|Part B|Withdrawal by Subject|0|||
145331442|NCT02799095|524066147|FG012|Part B|Withdrawal by Subject|0|||
145331443|NCT02799095|524066148|FG013|Part B|Withdrawal by Subject|0|||
145331444|NCT02799095|524066149|FG014|Part B|Withdrawal by Subject|0|||
145331445|NCT02799095|524066150|FG015|Part B|Withdrawal by Subject|0|||
145331446|NCT02799095|524066151|FG016|Part B|Withdrawal by Subject|0|||
145331447|NCT02799095|524066135|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
145331448|NCT02799095|524066136|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
145331449|NCT02799095|524066137|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
145331450|NCT02799095|524066138|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
145331451|NCT02799095|524066139|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
145572137|NCT00976898|524953189|FG000|Overall Study|Liver Transplant|1|||
145572138|NCT00976898|524953189|FG000|Overall Study|Progressive Disease|1|||
145572139|NCT04033159|524953216|FG000|Washout Period|Physician Decision|0|||
145572140|NCT04033159|524953217|FG001|Washout Period|Physician Decision|1|||
145572141|NCT04033159|524953218|FG002|Washout Period|Physician Decision|0|||
145572142|NCT04033159|524953216|FG000|Washout Period|Study terminated by Sponsor|0|||
145572143|NCT04033159|524953217|FG001|Washout Period|Study terminated by Sponsor|7|||
145572144|NCT04033159|524953218|FG002|Washout Period|Study terminated by Sponsor|0|||
145572145|NCT04033159|524953216|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
145572146|NCT04033159|524953217|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
145572147|NCT04033159|524953218|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
145572148|NCT03277261|524953225|FG000|Overall Study|Adverse Event|17|||
145572149|NCT03277261|524953226|FG001|Overall Study|Adverse Event|1|||
145331452|NCT02799095|524066140|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
145331453|NCT02799095|524066141|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
145331454|NCT02799095|524066142|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
145331455|NCT02799095|524066143|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
145331456|NCT02799095|524066144|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
145331457|NCT02799095|524066145|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
145331458|NCT02799095|524066146|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
145331459|NCT02799095|524066147|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
145331460|NCT02799095|524066148|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
145331461|NCT02799095|524066149|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
145331462|NCT02799095|524066150|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
145331463|NCT02799095|524066151|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
145331464|NCT02799095|524066135|FG000|Part C|Adverse Event|0|||
145331465|NCT02799095|524066136|FG001|Part C|Adverse Event|0|||
145331466|NCT02799095|524066137|FG002|Part C|Adverse Event|0|||
145331467|NCT02799095|524066138|FG003|Part C|Adverse Event|0|||
145331468|NCT02799095|524066139|FG004|Part C|Adverse Event|0|||
145331469|NCT02799095|524066140|FG005|Part C|Adverse Event|0|||
145331470|NCT02799095|524066141|FG006|Part C|Adverse Event|0|||
145331471|NCT02799095|524066142|FG007|Part C|Adverse Event|0|||
145331472|NCT02799095|524066143|FG008|Part C|Adverse Event|0|||
145331473|NCT02799095|524066144|FG009|Part C|Adverse Event|0|||
145331474|NCT02799095|524066145|FG010|Part C|Adverse Event|3|||
145331475|NCT02799095|524066146|FG011|Part C|Adverse Event|1|||
145331476|NCT02799095|524066147|FG012|Part C|Adverse Event|0|||
145331477|NCT02799095|524066148|FG013|Part C|Adverse Event|1|||
145331478|NCT02799095|524066149|FG014|Part C|Adverse Event|0|||
145331479|NCT02799095|524066150|FG015|Part C|Adverse Event|0|||
145331480|NCT02799095|524066151|FG016|Part C|Adverse Event|0|||
145331481|NCT02799095|524066135|FG000|Part C|Death|0|||
145331482|NCT02799095|524066136|FG001|Part C|Death|0|||
145331483|NCT02799095|524066137|FG002|Part C|Death|0|||
145331484|NCT02799095|524066138|FG003|Part C|Death|0|||
145331485|NCT02799095|524066139|FG004|Part C|Death|0|||
145331486|NCT02799095|524066140|FG005|Part C|Death|0|||
145331487|NCT02799095|524066141|FG006|Part C|Death|0|||
145331488|NCT02799095|524066142|FG007|Part C|Death|0|||
145331489|NCT02799095|524066143|FG008|Part C|Death|0|||
145331490|NCT02799095|524066144|FG009|Part C|Death|0|||
145331491|NCT02799095|524066145|FG010|Part C|Death|7|||
145331492|NCT02799095|524066146|FG011|Part C|Death|5|||
145331493|NCT02799095|524066147|FG012|Part C|Death|6|||
145331494|NCT02799095|524066148|FG013|Part C|Death|8|||
145331495|NCT02799095|524066149|FG014|Part C|Death|1|||
145412423|NCT00700635|524363600|FG001|Overall Study|Protocol Violation|2|||
145412424|NCT00700635|524363601|FG002|Overall Study|Protocol Violation|0|||
145412425|NCT00700635|524363599|FG000|Overall Study|Withdrawal by Subject|7|||
145412426|NCT00700635|524363600|FG001|Overall Study|Withdrawal by Subject|3|||
145572150|NCT03277261|524953225|FG000|Overall Study|Participant Withdrawal of Consent|6|||
145572151|NCT03277261|524953226|FG001|Overall Study|Participant Withdrawal of Consent|15|||
145572152|NCT03277261|524953225|FG000|Overall Study|Investigator / Sponsor Decision|4|||
145572153|NCT03277261|524953226|FG001|Overall Study|Investigator / Sponsor Decision|2|||
145331496|NCT02799095|524066150|FG015|Part C|Death|8|||
145331497|NCT02799095|524066151|FG016|Part C|Death|1|||
145331498|NCT02799095|524066135|FG000|Part C|Lost to Follow-up|0|||
145331499|NCT02799095|524066136|FG001|Part C|Lost to Follow-up|0|||
145331500|NCT02799095|524066137|FG002|Part C|Lost to Follow-up|0|||
145331501|NCT02799095|524066138|FG003|Part C|Lost to Follow-up|0|||
145331502|NCT02799095|524066139|FG004|Part C|Lost to Follow-up|0|||
145331503|NCT02799095|524066140|FG005|Part C|Lost to Follow-up|0|||
145331504|NCT02799095|524066141|FG006|Part C|Lost to Follow-up|0|||
145331505|NCT02799095|524066142|FG007|Part C|Lost to Follow-up|0|||
145331506|NCT02799095|524066143|FG008|Part C|Lost to Follow-up|0|||
145331507|NCT02799095|524066144|FG009|Part C|Lost to Follow-up|0|||
145331508|NCT02799095|524066145|FG010|Part C|Lost to Follow-up|1|||
145331509|NCT02799095|524066146|FG011|Part C|Lost to Follow-up|1|||
145331510|NCT02799095|524066147|FG012|Part C|Lost to Follow-up|1|||
145331511|NCT02799095|524066148|FG013|Part C|Lost to Follow-up|3|||
145331512|NCT02799095|524066149|FG014|Part C|Lost to Follow-up|0|||
145331513|NCT02799095|524066150|FG015|Part C|Lost to Follow-up|0|||
145331514|NCT02799095|524066151|FG016|Part C|Lost to Follow-up|0|||
145331515|NCT02799095|524066135|FG000|Part C|Progressive Disease|0|||
145331516|NCT02799095|524066136|FG001|Part C|Progressive Disease|0|||
145331517|NCT02799095|524066137|FG002|Part C|Progressive Disease|0|||
145331518|NCT02799095|524066138|FG003|Part C|Progressive Disease|0|||
145331519|NCT02799095|524066139|FG004|Part C|Progressive Disease|0|||
145331520|NCT02799095|524066140|FG005|Part C|Progressive Disease|0|||
145331521|NCT02799095|524066141|FG006|Part C|Progressive Disease|0|||
145331522|NCT02799095|524066142|FG007|Part C|Progressive Disease|0|||
145572154|NCT03277261|524953225|FG000|Overall Study|Pregnancy|2|||
145572155|NCT03277261|524953226|FG001|Overall Study|Pregnancy|0|||
145572156|NCT03277261|524953225|FG000|Overall Study|Lost to Follow-up|2|||
145572157|NCT03277261|524953226|FG001|Overall Study|Lost to Follow-up|2|||
145572158|NCT03277261|524953225|FG000|Overall Study|Lack of Efficacy|2|||
145572159|NCT03277261|524953226|FG001|Overall Study|Lack of Efficacy|2|||
145572160|NCT03277261|524953225|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
145572161|NCT03277261|524953226|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
145572162|NCT00499603|524953227|FG000|Overall Study|Adverse Event|0|||
145572163|NCT00499603|524953228|FG001|Overall Study|Adverse Event|1|||
145572164|NCT03323099|524953229|FG000|Overall Study|Withdrawal by Subject|6|||
145572165|NCT03323099|524953230|FG001|Overall Study|Withdrawal by Subject|12|||
145572166|NCT03323099|524953229|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
145572167|NCT03323099|524953230|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
145572168|NCT01502644|524953231|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
145572169|NCT01502644|524953232|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
145572170|NCT01502644|524953233|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
145572171|NCT01502644|524953234|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
145572172|NCT01502644|524953231|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
145572173|NCT01502644|524953232|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
145572174|NCT01502644|524953233|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
145572175|NCT01502644|524953234|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
145572176|NCT01502644|524953231|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
145572177|NCT01502644|524953232|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
145572178|NCT01502644|524953233|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
145572179|NCT01502644|524953234|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
145572180|NCT01502644|524953231|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
145572181|NCT01502644|524953232|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
145572182|NCT01502644|524953233|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
145572183|NCT01502644|524953234|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
145572184|NCT01502644|524953231|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
145572185|NCT01502644|524953232|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
145572186|NCT01502644|524953233|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
145572187|NCT01502644|524953234|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
145572188|NCT00006184|524953235|FG000|Overall Study|Death|1|||
145572189|NCT00006184|524953236|FG001|Overall Study|Death|0|||
145572190|NCT02948842|524953242|FG000|Overall Study|Withdrawal by Subject|4|||
145572191|NCT00207142|524953243|FG000|Induction Phase|Adverse Event|9|||
145572192|NCT00207142|524953244|FG001|Induction Phase|Adverse Event|0|||
145572193|NCT00207142|524953245|FG002|Induction Phase|Adverse Event|0|||
145572194|NCT00207142|524953246|FG003|Induction Phase|Adverse Event|0|||
145572195|NCT00207142|524953243|FG000|Induction Phase|Death|1|||
145572196|NCT00207142|524953244|FG001|Induction Phase|Death|0|||
145572197|NCT00207142|524953245|FG002|Induction Phase|Death|0|||
145572198|NCT00207142|524953246|FG003|Induction Phase|Death|0|||
145572199|NCT00207142|524953243|FG000|Induction Phase|Lack of Efficacy|1|||
145572200|NCT00207142|524953244|FG001|Induction Phase|Lack of Efficacy|0|||
145572201|NCT00207142|524953245|FG002|Induction Phase|Lack of Efficacy|0|||
145572202|NCT00207142|524953246|FG003|Induction Phase|Lack of Efficacy|0|||
145572203|NCT00207142|524953243|FG000|Induction Phase|Lost to Follow-up|5|||
145572204|NCT00207142|524953244|FG001|Induction Phase|Lost to Follow-up|0|||
145572205|NCT00207142|524953245|FG002|Induction Phase|Lost to Follow-up|0|||
145572206|NCT00207142|524953246|FG003|Induction Phase|Lost to Follow-up|0|||
145572207|NCT00207142|524953243|FG000|Induction Phase|Physician Decision|2|||
145572208|NCT00207142|524953244|FG001|Induction Phase|Physician Decision|0|||
145572209|NCT00207142|524953245|FG002|Induction Phase|Physician Decision|0|||
145572210|NCT00207142|524953246|FG003|Induction Phase|Physician Decision|0|||
145572211|NCT00207142|524953243|FG000|Induction Phase|Poor/noncompliance|2|||
145331523|NCT02799095|524066143|FG008|Part C|Progressive Disease|0|||
145331524|NCT02799095|524066144|FG009|Part C|Progressive Disease|2|||
145331525|NCT02799095|524066145|FG010|Part C|Progressive Disease|13|||
145331526|NCT02799095|524066146|FG011|Part C|Progressive Disease|2|||
145621134|NCT04955626|525126691|FG019|Blinded Period|No longer meets eligibility criteria|0|||
145621135|NCT04955626|525126692|FG020|Blinded Period|No longer meets eligibility criteria|0|||
145621136|NCT04955626|525126693|FG021|Blinded Period|No longer meets eligibility criteria|0|||
145621137|NCT04955626|525126694|FG022|Blinded Period|No longer meets eligibility criteria|0|||
145331527|NCT02799095|524066147|FG012|Part C|Progressive Disease|0|||
145331528|NCT02799095|524066148|FG013|Part C|Progressive Disease|1|||
145621138|NCT04955626|525126695|FG023|Blinded Period|No longer meets eligibility criteria|0|||
145621139|NCT04955626|525126696|FG024|Blinded Period|No longer meets eligibility criteria|1|||
145621140|NCT04955626|525126697|FG025|Blinded Period|No longer meets eligibility criteria|0|||
145621141|NCT04955626|525126698|FG026|Blinded Period|No longer meets eligibility criteria|0|||
145621142|NCT04955626|525126699|FG027|Blinded Period|No longer meets eligibility criteria|1|||
145621143|NCT04955626|525126700|FG028|Blinded Period|No longer meets eligibility criteria|0|||
145621144|NCT04955626|525126701|FG029|Blinded Period|No longer meets eligibility criteria|0|||
145621145|NCT04955626|525126702|FG030|Blinded Period|No longer meets eligibility criteria|0|||
145621146|NCT04955626|525126703|FG031|Blinded Period|No longer meets eligibility criteria|0|||
145621147|NCT04955626|525126704|FG032|Blinded Period|No longer meets eligibility criteria|0|||
145621148|NCT04955626|525126705|FG033|Blinded Period|No longer meets eligibility criteria|0|||
145621149|NCT04955626|525126706|FG034|Blinded Period|No longer meets eligibility criteria|0|||
145621150|NCT04955626|525126707|FG035|Blinded Period|No longer meets eligibility criteria|0|||
145621151|NCT04955626|525126672|FG000|Blinded Period|Other|54|||
145621152|NCT04955626|525126673|FG001|Blinded Period|Other|3|||
145621153|NCT04955626|525126674|FG002|Blinded Period|Other|4|||
145621154|NCT04955626|525126675|FG003|Blinded Period|Other|2|||
145621155|NCT04955626|525126676|FG004|Blinded Period|Other|0|||
145621156|NCT04955626|525126677|FG005|Blinded Period|Other|0|||
145621157|NCT04955626|525126678|FG006|Blinded Period|Other|2|||
145621158|NCT04955626|525126679|FG007|Blinded Period|Other|2|||
145621159|NCT04955626|525126680|FG008|Blinded Period|Other|1|||
145621160|NCT04955626|525126681|FG009|Blinded Period|Other|0|||
145621161|NCT04955626|525126682|FG010|Blinded Period|Other|1|||
145621162|NCT04955626|525126683|FG011|Blinded Period|Other|1|||
145621163|NCT04955626|525126684|FG012|Blinded Period|Other|0|||
145621164|NCT04955626|525126685|FG013|Blinded Period|Other|0|||
145621165|NCT04955626|525126686|FG014|Blinded Period|Other|0|||
145621166|NCT04955626|525126687|FG015|Blinded Period|Other|0|||
145621167|NCT04955626|525126688|FG016|Blinded Period|Other|0|||
145621168|NCT04955626|525126689|FG017|Blinded Period|Other|1|||
145621169|NCT04955626|525126690|FG018|Blinded Period|Other|0|||
145621170|NCT04955626|525126691|FG019|Blinded Period|Other|0|||
145621171|NCT04955626|525126692|FG020|Blinded Period|Other|0|||
145621172|NCT04955626|525126693|FG021|Blinded Period|Other|0|||
145621173|NCT04955626|525126694|FG022|Blinded Period|Other|0|||
145621174|NCT04955626|525126695|FG023|Blinded Period|Other|0|||
145621175|NCT04955626|525126696|FG024|Blinded Period|Other|0|||
145621176|NCT04955626|525126697|FG025|Blinded Period|Other|0|||
145621177|NCT04955626|525126698|FG026|Blinded Period|Other|2|||
145621178|NCT04955626|525126699|FG027|Blinded Period|Other|0|||
145621179|NCT04955626|525126700|FG028|Blinded Period|Other|0|||
145621180|NCT04955626|525126701|FG029|Blinded Period|Other|0|||
145621181|NCT04955626|525126702|FG030|Blinded Period|Other|0|||
145621182|NCT04955626|525126703|FG031|Blinded Period|Other|0|||
145621183|NCT04955626|525126704|FG032|Blinded Period|Other|0|||
145621184|NCT04955626|525126705|FG033|Blinded Period|Other|0|||
145331529|NCT02799095|524066149|FG014|Part C|Progressive Disease|0|||
145331530|NCT02799095|524066150|FG015|Part C|Progressive Disease|0|||
145331531|NCT02799095|524066151|FG016|Part C|Progressive Disease|0|||
145331532|NCT02799095|524066135|FG000|Part C|Clinical Progression|0|||
145331533|NCT02799095|524066136|FG001|Part C|Clinical Progression|0|||
145331534|NCT02799095|524066137|FG002|Part C|Clinical Progression|0|||
145621185|NCT04955626|525126706|FG034|Blinded Period|Other|0|||
145621186|NCT04955626|525126707|FG035|Blinded Period|Other|0|||
145621187|NCT04955626|525126672|FG000|Blinded Period|Physician Decision|1|||
145621188|NCT04955626|525126673|FG001|Blinded Period|Physician Decision|1|||
145621189|NCT04955626|525126674|FG002|Blinded Period|Physician Decision|0|||
145621190|NCT04955626|525126675|FG003|Blinded Period|Physician Decision|3|||
145621191|NCT04955626|525126676|FG004|Blinded Period|Physician Decision|0|||
145621192|NCT04955626|525126677|FG005|Blinded Period|Physician Decision|0|||
145621193|NCT04955626|525126678|FG006|Blinded Period|Physician Decision|1|||
145621194|NCT04955626|525126679|FG007|Blinded Period|Physician Decision|1|||
145621195|NCT04955626|525126680|FG008|Blinded Period|Physician Decision|0|||
145621196|NCT04955626|525126681|FG009|Blinded Period|Physician Decision|0|||
145331535|NCT02799095|524066138|FG003|Part C|Clinical Progression|0|||
145331536|NCT02799095|524066139|FG004|Part C|Clinical Progression|0|||
145331537|NCT02799095|524066140|FG005|Part C|Clinical Progression|0|||
145331538|NCT02799095|524066141|FG006|Part C|Clinical Progression|0|||
145331539|NCT02799095|524066142|FG007|Part C|Clinical Progression|0|||
145331540|NCT02799095|524066143|FG008|Part C|Clinical Progression|0|||
145621197|NCT04955626|525126682|FG010|Blinded Period|Physician Decision|0|||
145621198|NCT04955626|525126683|FG011|Blinded Period|Physician Decision|5|||
145621199|NCT04955626|525126684|FG012|Blinded Period|Physician Decision|0|||
145621200|NCT04955626|525126685|FG013|Blinded Period|Physician Decision|0|||
145331541|NCT02799095|524066144|FG009|Part C|Clinical Progression|1|||
145331542|NCT02799095|524066145|FG010|Part C|Clinical Progression|3|||
145331543|NCT02799095|524066146|FG011|Part C|Clinical Progression|0|||
145331544|NCT02799095|524066147|FG012|Part C|Clinical Progression|0|||
145331545|NCT02799095|524066148|FG013|Part C|Clinical Progression|1|||
145331546|NCT02799095|524066149|FG014|Part C|Clinical Progression|0|||
145331547|NCT02799095|524066150|FG015|Part C|Clinical Progression|0|||
145331548|NCT02799095|524066151|FG016|Part C|Clinical Progression|0|||
145331549|NCT02799095|524066135|FG000|Part C|Withdrawal by Subject|0|||
145331550|NCT02799095|524066136|FG001|Part C|Withdrawal by Subject|0|||
145331551|NCT02799095|524066137|FG002|Part C|Withdrawal by Subject|0|||
145331552|NCT02799095|524066138|FG003|Part C|Withdrawal by Subject|0|||
145331553|NCT02799095|524066139|FG004|Part C|Withdrawal by Subject|0|||
145331554|NCT02799095|524066140|FG005|Part C|Withdrawal by Subject|0|||
145331555|NCT02799095|524066141|FG006|Part C|Withdrawal by Subject|0|||
145331556|NCT02799095|524066142|FG007|Part C|Withdrawal by Subject|0|||
145331557|NCT02799095|524066143|FG008|Part C|Withdrawal by Subject|0|||
145331558|NCT02799095|524066144|FG009|Part C|Withdrawal by Subject|0|||
145331559|NCT02799095|524066145|FG010|Part C|Withdrawal by Subject|13|||
145331560|NCT02799095|524066146|FG011|Part C|Withdrawal by Subject|15|||
145331561|NCT02799095|524066147|FG012|Part C|Withdrawal by Subject|13|||
145331562|NCT02799095|524066148|FG013|Part C|Withdrawal by Subject|21|||
145331563|NCT02799095|524066149|FG014|Part C|Withdrawal by Subject|0|||
145331564|NCT02799095|524066150|FG015|Part C|Withdrawal by Subject|12|||
145331565|NCT02799095|524066151|FG016|Part C|Withdrawal by Subject|1|||
145331566|NCT02799095|524066135|FG000|Part C|Physician Decision|0|||
145331567|NCT02799095|524066136|FG001|Part C|Physician Decision|0|||
145331568|NCT02799095|524066137|FG002|Part C|Physician Decision|0|||
145331569|NCT02799095|524066138|FG003|Part C|Physician Decision|0|||
145331570|NCT02799095|524066139|FG004|Part C|Physician Decision|0|||
145331571|NCT02799095|524066140|FG005|Part C|Physician Decision|0|||
145331572|NCT02799095|524066141|FG006|Part C|Physician Decision|0|||
145331573|NCT02799095|524066142|FG007|Part C|Physician Decision|0|||
145331574|NCT02799095|524066143|FG008|Part C|Physician Decision|0|||
145331575|NCT02799095|524066144|FG009|Part C|Physician Decision|0|||
145331576|NCT02799095|524066145|FG010|Part C|Physician Decision|1|||
145331577|NCT02799095|524066146|FG011|Part C|Physician Decision|0|||
145331578|NCT02799095|524066147|FG012|Part C|Physician Decision|0|||
145331579|NCT02799095|524066148|FG013|Part C|Physician Decision|0|||
145572212|NCT00207142|524953244|FG001|Induction Phase|Poor/noncompliance|0|||
145572213|NCT00207142|524953245|FG002|Induction Phase|Poor/noncompliance|0|||
145572214|NCT00207142|524953246|FG003|Induction Phase|Poor/noncompliance|0|||
145572215|NCT00207142|524953243|FG000|Induction Phase|Pregnancy|1|||
145572216|NCT00207142|524953244|FG001|Induction Phase|Pregnancy|0|||
145572217|NCT00207142|524953245|FG002|Induction Phase|Pregnancy|0|||
145572218|NCT00207142|524953246|FG003|Induction Phase|Pregnancy|0|||
145572219|NCT00207142|524953243|FG000|Induction Phase|Subject no longer meets study criteria|3|||
145572220|NCT00207142|524953244|FG001|Induction Phase|Subject no longer meets study criteria|0|||
145572221|NCT00207142|524953245|FG002|Induction Phase|Subject no longer meets study criteria|0|||
145572222|NCT00207142|524953246|FG003|Induction Phase|Subject no longer meets study criteria|0|||
145572223|NCT00207142|524953243|FG000|Induction Phase|Withdrawal by Subject|4|||
145572224|NCT00207142|524953244|FG001|Induction Phase|Withdrawal by Subject|0|||
145572225|NCT00207142|524953245|FG002|Induction Phase|Withdrawal by Subject|0|||
145572226|NCT00207142|524953246|FG003|Induction Phase|Withdrawal by Subject|0|||
145572227|NCT00207142|524953243|FG000|Induction Phase|Incarceration|1|||
145572228|NCT00207142|524953244|FG001|Induction Phase|Incarceration|0|||
145572229|NCT00207142|524953245|FG002|Induction Phase|Incarceration|0|||
145572230|NCT00207142|524953246|FG003|Induction Phase|Incarceration|0|||
145331580|NCT02799095|524066149|FG014|Part C|Physician Decision|0|||
145331581|NCT02799095|524066150|FG015|Part C|Physician Decision|0|||
145572231|NCT00207142|524953243|FG000|Induction Phase|Missing lab data|1|||
145572232|NCT00207142|524953244|FG001|Induction Phase|Missing lab data|0|||
145572233|NCT00207142|524953245|FG002|Induction Phase|Missing lab data|0|||
145572234|NCT00207142|524953246|FG003|Induction Phase|Missing lab data|0|||
145331582|NCT02799095|524066151|FG016|Part C|Physician Decision|0|||
145331583|NCT02799095|524066135|FG000|Part C|Other|0|||
145331584|NCT02799095|524066136|FG001|Part C|Other|0|||
145331585|NCT02799095|524066137|FG002|Part C|Other|0|||
145331586|NCT02799095|524066138|FG003|Part C|Other|0|||
145331587|NCT02799095|524066139|FG004|Part C|Other|0|||
145331588|NCT02799095|524066140|FG005|Part C|Other|0|||
145331589|NCT02799095|524066141|FG006|Part C|Other|0|||
145572235|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
145331590|NCT02799095|524066142|FG007|Part C|Other|0|||
145331591|NCT02799095|524066143|FG008|Part C|Other|0|||
145331592|NCT02799095|524066144|FG009|Part C|Other|0|||
145331593|NCT02799095|524066145|FG010|Part C|Other|0|||
145331594|NCT02799095|524066146|FG011|Part C|Other|2|||
145331595|NCT02799095|524066147|FG012|Part C|Other|2|||
145331596|NCT02799095|524066148|FG013|Part C|Other|0|||
145331597|NCT02799095|524066149|FG014|Part C|Other|0|||
145331598|NCT02799095|524066150|FG015|Part C|Other|0|||
145572236|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
145621201|NCT04955626|525126686|FG014|Blinded Period|Physician Decision|0|||
145572237|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
145572238|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
145572239|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
145572240|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
145572241|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
145572242|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
145572243|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
145572244|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
145572245|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
145572246|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
145572247|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
145572248|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
145572249|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
145572250|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
145572251|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
145572252|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
145572253|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
145572254|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
145572255|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
145572256|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
145572257|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
145572258|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
145572259|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
145572260|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
145572261|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
145572262|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
145572263|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Death|0|||
145572264|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Death|0|||
145572265|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Death|0|||
145572266|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Death|1|||
145572267|NCT00207142|524953243|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
145572268|NCT00207142|524953244|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
145572269|NCT00207142|524953245|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
145572270|NCT00207142|524953246|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
145572271|NCT01857063|524953247|FG000|Period 1 (7 Days)|Adverse Event|0|||
145572272|NCT01857063|524953248|FG001|Period 1 (7 Days)|Adverse Event|1|||
145572273|NCT01857063|524953247|FG000|Period 1 (7 Days)|Physician Decision|1|||
145572274|NCT01857063|524953248|FG001|Period 1 (7 Days)|Physician Decision|0|||
145572275|NCT01857063|524953247|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
145572276|NCT01857063|524953248|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
145572277|NCT01857063|524953247|FG000|Period 2 (7 Days)|Adverse Event|2|||
145572278|NCT01857063|524953248|FG001|Period 2 (7 Days)|Adverse Event|1|||
145572279|NCT01857063|524953247|FG000|Period 2 (7 Days)|Physician Decision|1|||
145572280|NCT01857063|524953248|FG001|Period 2 (7 Days)|Physician Decision|1|||
145572281|NCT01857063|524953247|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
145572282|NCT01857063|524953248|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
145572283|NCT01455012|524953251|FG000|Overall Study|Adverse Event|0|||
145572284|NCT01455012|524953252|FG001|Overall Study|Adverse Event|2|||
145621202|NCT04955626|525126687|FG015|Blinded Period|Physician Decision|0|||
145621203|NCT04955626|525126688|FG016|Blinded Period|Physician Decision|0|||
145621204|NCT04955626|525126689|FG017|Blinded Period|Physician Decision|0|||
145621205|NCT04955626|525126690|FG018|Blinded Period|Physician Decision|0|||
145621206|NCT04955626|525126691|FG019|Blinded Period|Physician Decision|0|||
145621207|NCT04955626|525126692|FG020|Blinded Period|Physician Decision|0|||
145621208|NCT04955626|525126693|FG021|Blinded Period|Physician Decision|0|||
145621209|NCT04955626|525126694|FG022|Blinded Period|Physician Decision|0|||
145621210|NCT04955626|525126695|FG023|Blinded Period|Physician Decision|0|||
145621211|NCT04955626|525126696|FG024|Blinded Period|Physician Decision|0|||
145621212|NCT04955626|525126697|FG025|Blinded Period|Physician Decision|0|||
145621213|NCT04955626|525126698|FG026|Blinded Period|Physician Decision|0|||
145621214|NCT04955626|525126699|FG027|Blinded Period|Physician Decision|0|||
145621215|NCT04955626|525126700|FG028|Blinded Period|Physician Decision|0|||
145572285|NCT01455012|524953251|FG000|Overall Study|Lack of Efficacy|6|||
145572286|NCT01455012|524953252|FG001|Overall Study|Lack of Efficacy|1|||
145572287|NCT01455012|524953251|FG000|Overall Study|Withdrawal by Subject|3|||
145572288|NCT01455012|524953252|FG001|Overall Study|Withdrawal by Subject|1|||
145572289|NCT01455012|524953251|FG000|Overall Study|Unknown reason|2|||
145621216|NCT04955626|525126701|FG029|Blinded Period|Physician Decision|0|||
145621217|NCT04955626|525126702|FG030|Blinded Period|Physician Decision|0|||
145331599|NCT02799095|524066151|FG016|Part C|Other|0|||
145331600|NCT01933113|524066152|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
145331601|NCT02297438|524066153|FG000|Overall Study|Death|79|||
145331602|NCT02297438|524066154|FG001|Overall Study|Death|86|||
145331603|NCT02297438|524066153|FG000|Overall Study|Lost to Follow-up|9|||
145621218|NCT04955626|525126703|FG031|Blinded Period|Physician Decision|0|||
145621219|NCT04955626|525126704|FG032|Blinded Period|Physician Decision|0|||
145621220|NCT04955626|525126705|FG033|Blinded Period|Physician Decision|0|||
145621221|NCT04955626|525126706|FG034|Blinded Period|Physician Decision|0|||
145621222|NCT04955626|525126707|FG035|Blinded Period|Physician Decision|0|||
145621223|NCT04955626|525126672|FG000|Blinded Period|Withdrawal by Subject|26|||
145621224|NCT04955626|525126673|FG001|Blinded Period|Withdrawal by Subject|62|||
145621225|NCT04955626|525126674|FG002|Blinded Period|Withdrawal by Subject|14|||
145621226|NCT04955626|525126675|FG003|Blinded Period|Withdrawal by Subject|16|||
145621227|NCT04955626|525126676|FG004|Blinded Period|Withdrawal by Subject|1|||
145621228|NCT04955626|525126677|FG005|Blinded Period|Withdrawal by Subject|2|||
145621229|NCT04955626|525126678|FG006|Blinded Period|Withdrawal by Subject|9|||
145621230|NCT04955626|525126679|FG007|Blinded Period|Withdrawal by Subject|5|||
145621231|NCT04955626|525126680|FG008|Blinded Period|Withdrawal by Subject|3|||
145621232|NCT04955626|525126681|FG009|Blinded Period|Withdrawal by Subject|15|||
145621233|NCT04955626|525126682|FG010|Blinded Period|Withdrawal by Subject|11|||
145621234|NCT04955626|525126683|FG011|Blinded Period|Withdrawal by Subject|7|||
145621235|NCT04955626|525126684|FG012|Blinded Period|Withdrawal by Subject|2|||
145621236|NCT04955626|525126685|FG013|Blinded Period|Withdrawal by Subject|0|||
145621237|NCT04955626|525126686|FG014|Blinded Period|Withdrawal by Subject|1|||
145621238|NCT04955626|525126687|FG015|Blinded Period|Withdrawal by Subject|11|||
145621239|NCT04955626|525126688|FG016|Blinded Period|Withdrawal by Subject|2|||
145621240|NCT04955626|525126689|FG017|Blinded Period|Withdrawal by Subject|5|||
145621241|NCT04955626|525126690|FG018|Blinded Period|Withdrawal by Subject|0|||
145621242|NCT04955626|525126691|FG019|Blinded Period|Withdrawal by Subject|0|||
145621243|NCT04955626|525126692|FG020|Blinded Period|Withdrawal by Subject|1|||
145621244|NCT04955626|525126693|FG021|Blinded Period|Withdrawal by Subject|0|||
145621245|NCT04955626|525126694|FG022|Blinded Period|Withdrawal by Subject|0|||
145621246|NCT04955626|525126695|FG023|Blinded Period|Withdrawal by Subject|0|||
145621247|NCT04955626|525126696|FG024|Blinded Period|Withdrawal by Subject|5|||
145621248|NCT04955626|525126697|FG025|Blinded Period|Withdrawal by Subject|1|||
145621249|NCT04955626|525126698|FG026|Blinded Period|Withdrawal by Subject|5|||
145621250|NCT04955626|525126699|FG027|Blinded Period|Withdrawal by Subject|1|||
145621251|NCT04955626|525126700|FG028|Blinded Period|Withdrawal by Subject|4|||
145621252|NCT04955626|525126701|FG029|Blinded Period|Withdrawal by Subject|2|||
145621253|NCT04955626|525126702|FG030|Blinded Period|Withdrawal by Subject|0|||
145621254|NCT04955626|525126703|FG031|Blinded Period|Withdrawal by Subject|0|||
145621255|NCT04955626|525126704|FG032|Blinded Period|Withdrawal by Subject|0|||
145621256|NCT04955626|525126705|FG033|Blinded Period|Withdrawal by Subject|0|||
145621257|NCT04955626|525126706|FG034|Blinded Period|Withdrawal by Subject|0|||
145621258|NCT04955626|525126707|FG035|Blinded Period|Withdrawal by Subject|0|||
145621259|NCT04955626|525126672|FG000|Blinded Period|Refused further study procedures|0|||
145621260|NCT04955626|525126673|FG001|Blinded Period|Refused further study procedures|0|||
145621261|NCT04955626|525126674|FG002|Blinded Period|Refused further study procedures|0|||
145621262|NCT04955626|525126675|FG003|Blinded Period|Refused further study procedures|0|||
145621263|NCT04955626|525126676|FG004|Blinded Period|Refused further study procedures|0|||
145621264|NCT04955626|525126677|FG005|Blinded Period|Refused further study procedures|0|||
145621265|NCT04955626|525126678|FG006|Blinded Period|Refused further study procedures|1|||
145621266|NCT04955626|525126679|FG007|Blinded Period|Refused further study procedures|0|||
145621267|NCT04955626|525126680|FG008|Blinded Period|Refused further study procedures|0|||
145621268|NCT04955626|525126681|FG009|Blinded Period|Refused further study procedures|0|||
145621269|NCT04955626|525126682|FG010|Blinded Period|Refused further study procedures|0|||
145621270|NCT04955626|525126683|FG011|Blinded Period|Refused further study procedures|2|||
145621271|NCT04955626|525126684|FG012|Blinded Period|Refused further study procedures|0|||
145621272|NCT04955626|525126685|FG013|Blinded Period|Refused further study procedures|0|||
145621273|NCT04955626|525126686|FG014|Blinded Period|Refused further study procedures|0|||
145621274|NCT04955626|525126687|FG015|Blinded Period|Refused further study procedures|0|||
145621275|NCT04955626|525126688|FG016|Blinded Period|Refused further study procedures|0|||
145621276|NCT04955626|525126689|FG017|Blinded Period|Refused further study procedures|0|||
145621277|NCT04955626|525126690|FG018|Blinded Period|Refused further study procedures|0|||
145621278|NCT04955626|525126691|FG019|Blinded Period|Refused further study procedures|0|||
145621279|NCT04955626|525126692|FG020|Blinded Period|Refused further study procedures|0|||
145621280|NCT04955626|525126693|FG021|Blinded Period|Refused further study procedures|0|||
145621281|NCT04955626|525126694|FG022|Blinded Period|Refused further study procedures|0|||
145621282|NCT04955626|525126695|FG023|Blinded Period|Refused further study procedures|0|||
145621283|NCT04955626|525126696|FG024|Blinded Period|Refused further study procedures|0|||
145412427|NCT00700635|524363601|FG002|Overall Study|Withdrawal by Subject|1|||
145412428|NCT03611946|524363602|FG000|Overall Study|Withdrawal by Subject|0|||
145412429|NCT03611946|524363603|FG001|Overall Study|Withdrawal by Subject|0|||
145412430|NCT03611946|524363604|FG002|Overall Study|Withdrawal by Subject|1|||
145621284|NCT04955626|525126697|FG025|Blinded Period|Refused further study procedures|0|||
145621285|NCT04955626|525126698|FG026|Blinded Period|Refused further study procedures|0|||
145621286|NCT04955626|525126699|FG027|Blinded Period|Refused further study procedures|0|||
145412431|NCT03611946|524363605|FG003|Overall Study|Withdrawal by Subject|0|||
145412432|NCT02872714|524363609|FG000|Overall Study|Progressive Disease|1|||
145412433|NCT02872714|524363610|FG001|Overall Study|Progressive Disease|2|||
145412434|NCT02872714|524363611|FG002|Overall Study|Progressive Disease|0|||
145412435|NCT02872714|524363612|FG003|Overall Study|Progressive Disease|0|||
145412436|NCT02872714|524363613|FG004|Overall Study|Progressive Disease|0|||
145412437|NCT02872714|524363609|FG000|Overall Study|Death|87|||
145412438|NCT02872714|524363610|FG001|Overall Study|Death|36|||
145412439|NCT02872714|524363611|FG002|Overall Study|Death|8|||
145412440|NCT02872714|524363612|FG003|Overall Study|Death|81|||
145412441|NCT02872714|524363613|FG004|Overall Study|Death|2|||
145412442|NCT02872714|524363609|FG000|Overall Study|Lost to Follow-up|2|||
145412443|NCT02872714|524363610|FG001|Overall Study|Lost to Follow-up|1|||
145412444|NCT02872714|524363611|FG002|Overall Study|Lost to Follow-up|0|||
145412445|NCT02872714|524363612|FG003|Overall Study|Lost to Follow-up|3|||
145412446|NCT02872714|524363613|FG004|Overall Study|Lost to Follow-up|0|||
145412447|NCT02872714|524363609|FG000|Overall Study|Physician Decision|0|||
145412448|NCT02872714|524363610|FG001|Overall Study|Physician Decision|0|||
145412449|NCT02872714|524363611|FG002|Overall Study|Physician Decision|0|||
145412450|NCT02872714|524363612|FG003|Overall Study|Physician Decision|1|||
145412451|NCT02872714|524363613|FG004|Overall Study|Physician Decision|0|||
145412452|NCT02872714|524363609|FG000|Overall Study|Withdrawal by Subject|1|||
145412453|NCT02872714|524363610|FG001|Overall Study|Withdrawal by Subject|3|||
145412454|NCT02872714|524363611|FG002|Overall Study|Withdrawal by Subject|0|||
145412455|NCT02872714|524363612|FG003|Overall Study|Withdrawal by Subject|2|||
145412456|NCT02872714|524363613|FG004|Overall Study|Withdrawal by Subject|0|||
145412457|NCT02872714|524363609|FG000|Overall Study|Captured as Other|2|||
145412458|NCT02872714|524363610|FG001|Overall Study|Captured as Other|0|||
145412459|NCT02872714|524363611|FG002|Overall Study|Captured as Other|0|||
145412460|NCT02872714|524363612|FG003|Overall Study|Captured as Other|1|||
145412461|NCT02872714|524363613|FG004|Overall Study|Captured as Other|0|||
145412462|NCT03599713|524363616|FG000|Overall Study|Death|38|||
145412463|NCT03599713|524363617|FG001|Overall Study|Death|3|||
145412464|NCT03599713|524363616|FG000|Overall Study|Withdrawal by Subject|17|||
145412465|NCT03599713|524363617|FG001|Overall Study|Withdrawal by Subject|0|||
145412466|NCT03599713|524363616|FG000|Overall Study|Lost to Follow-up|4|||
145412467|NCT03599713|524363617|FG001|Overall Study|Lost to Follow-up|0|||
145412468|NCT03599713|524363616|FG000|Overall Study|Discontinued Due to End of Study|42|||
145412469|NCT03599713|524363617|FG001|Overall Study|Discontinued Due to End of Study|3|||
145412470|NCT03580928|524363622|FG000|Overall Study|Death|0|||
145412471|NCT03580928|524363623|FG001|Overall Study|Death|3|||
145412472|NCT03580928|524363622|FG000|Overall Study|Withdrawal by Subject|2|||
145412473|NCT03580928|524363623|FG001|Overall Study|Withdrawal by Subject|1|||
145412474|NCT03580928|524363622|FG000|Overall Study|Lost to Follow-up|2|||
145412475|NCT03580928|524363623|FG001|Overall Study|Lost to Follow-up|0|||
145412476|NCT03580928|524363622|FG000|Overall Study|Progressive Disease|0|||
145412477|NCT03580928|524363623|FG001|Overall Study|Progressive Disease|1|||
145412478|NCT05643794|524364836|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
145412479|NCT05643794|524364837|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
145412480|NCT05643794|524364838|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145412481|NCT05643794|524364836|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145412482|NCT05643794|524364837|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145412483|NCT05643794|524364838|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145572290|NCT01455012|524953252|FG001|Overall Study|Unknown reason|0|||
145412484|NCT05643794|524364836|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145412485|NCT05643794|524364837|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
145412486|NCT05643794|524364838|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145412487|NCT05643794|524364836|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145412488|NCT05643794|524364837|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145412489|NCT05643794|524364838|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145412490|NCT05643794|524364836|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
145412491|NCT05643794|524364837|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145412492|NCT05643794|524364838|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
145412493|NCT05643794|524364836|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
145412494|NCT05643794|524364837|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
145412495|NCT05643794|524364838|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
145412496|NCT04167670|524364841|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
145412497|NCT04167670|524364842|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
145412498|NCT04167670|524364843|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
145412499|NCT04167670|524364841|FG000|Overall Study|Significant protocol deviation|3|||
145412500|NCT04167670|524364842|FG001|Overall Study|Significant protocol deviation|1|||
145412501|NCT04167670|524364843|FG002|Overall Study|Significant protocol deviation|0|||
145412502|NCT04167670|524364841|FG000|Overall Study|Lost to Follow-up|0|||
145572291|NCT04552587|524953253|FG000|Overall Study|Lost to Follow-up|4|||
145572292|NCT01822132|524953254|FG000|Overall Study|Lost to Follow-up|4|||
145572293|NCT01822132|524953255|FG001|Overall Study|Lost to Follow-up|2|||
145572294|NCT00613509|524953256|FG000|Cycle 1|Adverse Event|2|||
145572295|NCT00613509|524953257|FG001|Cycle 1|Adverse Event|1|||
145572296|NCT00613509|524953256|FG000|Cycle 1|Disease Progression|2|||
145572297|NCT00613509|524953257|FG001|Cycle 1|Disease Progression|6|||
145572298|NCT00613509|524953256|FG000|Cycle 1|Unacceptable Toxicity|1|||
145331604|NCT02297438|524066154|FG001|Overall Study|Lost to Follow-up|7|||
145331605|NCT02297438|524066153|FG000|Overall Study|Withdrawal by Subject|7|||
145331606|NCT02297438|524066154|FG001|Overall Study|Withdrawal by Subject|0|||
145331607|NCT02297438|524066153|FG000|Overall Study|Other|9|||
145331608|NCT02297438|524066154|FG001|Overall Study|Other|5|||
145331609|NCT02297438|524066153|FG000|Overall Study|Ongoing|65|||
145331610|NCT02297438|524066154|FG001|Overall Study|Ongoing|73|||
145331611|NCT04092894|524066159|FG000|Overall Study|Withdrawal by Subject|2|||
145331612|NCT04092894|524066160|FG001|Overall Study|Withdrawal by Subject|4|||
145331613|NCT04092894|524066159|FG000|Overall Study|Discontinued EEG after randomization|10|||
145331614|NCT04092894|524066160|FG001|Overall Study|Discontinued EEG after randomization|6|||
145331615|NCT01951885|524066161|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
145331616|NCT01951885|524066162|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
145331617|NCT01951885|524066161|FG000|Overall Study|Adverse Event|1|||
145331618|NCT01951885|524066162|FG001|Overall Study|Adverse Event|0|||
145331619|NCT01951885|524066161|FG000|Overall Study|Withdrawal by Subject|0|||
145331620|NCT01951885|524066162|FG001|Overall Study|Withdrawal by Subject|1|||
145331621|NCT01951885|524066161|FG000|Overall Study|ineligible due to a change in donor|0|||
145331622|NCT01951885|524066162|FG001|Overall Study|ineligible due to a change in donor|1|||
145331623|NCT01951885|524066161|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
145331624|NCT01951885|524066162|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
145331625|NCT00368979|524066166|FG000|Overall Study|Adverse Event|9|||
145331626|NCT00368979|524066167|FG001|Overall Study|Adverse Event|16|||
145331627|NCT00368979|524066166|FG000|Overall Study|Lack of Efficacy|5|||
145331628|NCT00368979|524066167|FG001|Overall Study|Lack of Efficacy|3|||
145331629|NCT00368979|524066166|FG000|Overall Study|Other|3|||
145331630|NCT00368979|524066167|FG001|Overall Study|Other|1|||
145331631|NCT00368979|524066166|FG000|Overall Study|Lost to Follow-up|1|||
145331632|NCT00368979|524066167|FG001|Overall Study|Lost to Follow-up|0|||
145331633|NCT00368979|524066166|FG000|Overall Study|Protocol Violation|2|||
145331634|NCT00368979|524066167|FG001|Overall Study|Protocol Violation|1|||
145331635|NCT00368979|524066166|FG000|Overall Study|Withdrawal by Subject|5|||
145331636|NCT00368979|524066167|FG001|Overall Study|Withdrawal by Subject|9|||
145331637|NCT02238626|524066168|FG000|Overall Study|Adverse Event|3|||
145331638|NCT02238626|524066169|FG001|Overall Study|Adverse Event|5|||
145331639|NCT02238626|524066170|FG002|Overall Study|Adverse Event|0|||
145331640|NCT02238626|524066171|FG003|Overall Study|Adverse Event|3|||
145331641|NCT02238626|524066168|FG000|Overall Study|Lost to Follow-up|2|||
145331642|NCT02238626|524066169|FG001|Overall Study|Lost to Follow-up|4|||
145331643|NCT02238626|524066170|FG002|Overall Study|Lost to Follow-up|2|||
145331644|NCT02238626|524066171|FG003|Overall Study|Lost to Follow-up|2|||
145331645|NCT02238626|524066168|FG000|Overall Study|Withdrawal by Subject|0|||
145331646|NCT02238626|524066169|FG001|Overall Study|Withdrawal by Subject|3|||
145331647|NCT02238626|524066170|FG002|Overall Study|Withdrawal by Subject|0|||
145331648|NCT02238626|524066171|FG003|Overall Study|Withdrawal by Subject|1|||
145331649|NCT02238626|524066168|FG000|Overall Study|Death|0|||
145331650|NCT02238626|524066169|FG001|Overall Study|Death|0|||
145331651|NCT02238626|524066170|FG002|Overall Study|Death|1|||
145331652|NCT02238626|524066171|FG003|Overall Study|Death|1|||
145331653|NCT02238626|524066168|FG000|Overall Study|Other|0|||
145331654|NCT02238626|524066169|FG001|Overall Study|Other|2|||
145331655|NCT02238626|524066170|FG002|Overall Study|Other|0|||
145331656|NCT02238626|524066171|FG003|Overall Study|Other|0|||
145331657|NCT02622113|524066174|FG000|Overall Study|Adverse Event|4|||
145331658|NCT02622113|524066175|FG001|Overall Study|Adverse Event|4|||
145331659|NCT02622113|524066174|FG000|Overall Study|Physician Decision|0|||
145331660|NCT02622113|524066175|FG001|Overall Study|Physician Decision|1|||
145331661|NCT02622113|524066174|FG000|Overall Study|Withdrawal by Subject|0|||
145331662|NCT02622113|524066175|FG001|Overall Study|Withdrawal by Subject|2|||
145331663|NCT02622113|524066174|FG000|Overall Study|Stopping Criteria|1|||
145331664|NCT02622113|524066175|FG001|Overall Study|Stopping Criteria|3|||
145331665|NCT00667810|524066176|FG000|Overall Study|Adverse Event|13|||
145331666|NCT00667810|524066177|FG001|Overall Study|Adverse Event|14|||
145331667|NCT00667810|524066178|FG002|Overall Study|Adverse Event|19|||
145331668|NCT00667810|524066179|FG003|Overall Study|Adverse Event|1|||
145412503|NCT04167670|524364842|FG001|Overall Study|Lost to Follow-up|3|||
145572299|NCT00613509|524953257|FG001|Cycle 1|Unacceptable Toxicity|0|||
145572300|NCT00613509|524953256|FG000|Cycle 1|Other administrative reason|0|||
145331669|NCT00667810|524066176|FG000|Overall Study|Death|1|||
145331670|NCT00667810|524066177|FG001|Overall Study|Death|1|||
145331671|NCT00667810|524066178|FG002|Overall Study|Death|3|||
145331672|NCT00667810|524066179|FG003|Overall Study|Death|0|||
145331673|NCT00667810|524066176|FG000|Overall Study|Lack of Efficacy|1|||
145572301|NCT00613509|524953257|FG001|Cycle 1|Other administrative reason|1|||
145572302|NCT00314366|524953258|FG000|Overall Study|not treated due to patient medical condi|1|||
145572303|NCT00314366|524953259|FG001|Overall Study|not treated due to patient medical condi|0|||
145572304|NCT03400033|524953260|FG000|Overall Study|Withdrawal by Subject|1|||
145572305|NCT03400033|524953261|FG001|Overall Study|Withdrawal by Subject|2|||
145572306|NCT02469610|524953271|FG000|Overall Study|Death|1|||
145572307|NCT02469610|524953272|FG001|Overall Study|Death|0|||
145572308|NCT02469610|524953271|FG000|Overall Study|Lost to Follow-up|1|||
145572309|NCT02469610|524953272|FG001|Overall Study|Lost to Follow-up|0|||
145572310|NCT02469610|524953271|FG000|Overall Study|exclusion criteria|2|||
145572311|NCT02469610|524953272|FG001|Overall Study|exclusion criteria|1|||
145572312|NCT04074317|524953276|FG000|Third Period|Withdrawal by Subject|0|||
145572313|NCT04074317|524953277|FG001|Third Period|Withdrawal by Subject|0|||
145572314|NCT04074317|524953278|FG002|Third Period|Withdrawal by Subject|0|||
145572315|NCT04074317|524953279|FG003|Third Period|Withdrawal by Subject|1|||
145572316|NCT04074317|524953280|FG004|Third Period|Withdrawal by Subject|0|||
145572317|NCT04074317|524953281|FG005|Third Period|Withdrawal by Subject|0|||
145572318|NCT03756558|524954719|FG000|Overall Study|Death|1|||
145572319|NCT03756558|524954719|FG000|Overall Study|Lost to Follow-up|2|||
145572320|NCT03756558|524954719|FG000|Overall Study|Withdrawal by Subject|2|||
145572321|NCT01700179|524954722|FG000|Overall Study|Physician Decision|2|||
145572322|NCT01433263|524954725|FG000|Overall Study|Adverse Event|3|||
145572323|NCT01433263|524954726|FG001|Overall Study|Adverse Event|1|||
145572324|NCT01433263|524954725|FG000|Overall Study|Death|5|||
145572325|NCT01433263|524954726|FG001|Overall Study|Death|3|||
145572326|NCT01433263|524954725|FG000|Overall Study|Lost to Follow-up|0|||
145572327|NCT01433263|524954726|FG001|Overall Study|Lost to Follow-up|1|||
145572328|NCT01433263|524954725|FG000|Overall Study|Protocol Deviation|1|||
145572329|NCT01433263|524954726|FG001|Overall Study|Protocol Deviation|0|||
145572330|NCT01433263|524954725|FG000|Overall Study|Withdrawal by Subject|10|||
145572331|NCT01433263|524954726|FG001|Overall Study|Withdrawal by Subject|7|||
145572332|NCT00646204|524954727|FG000|Overall Study|Adverse Event|3|||
145572333|NCT00646204|524954728|FG001|Overall Study|Adverse Event|0|||
145572334|NCT00646204|524954727|FG000|Overall Study|Withdrawal by Subject|1|||
145572335|NCT00646204|524954728|FG001|Overall Study|Withdrawal by Subject|0|||
145572336|NCT00293384|524954734|FG000|Overall Study|Non-compliance|2|||
145572337|NCT00293384|524954734|FG000|Overall Study|Missed dosage/study drug|1|||
145572338|NCT00293384|524954734|FG000|Overall Study|Ineligible|2|||
145572339|NCT02610192|524954736|FG000|Overall Study|Received other treatment|8|||
145572340|NCT02610192|524954736|FG000|Overall Study|Physician Decision|1|||
145572341|NCT01344057|524954738|FG000|Overall Study|Premature Withdrawal|1|||
145572342|NCT04300296|524954744|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
145572343|NCT04300296|524954745|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
145572344|NCT04300296|524954746|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
145572345|NCT04300296|524954747|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
145572346|NCT04300296|524954748|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
145572347|NCT04300296|524954749|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
145572348|NCT04300296|524954744|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
145572349|NCT04300296|524954745|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
145572350|NCT04300296|524954746|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
145572351|NCT04300296|524954747|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
145331674|NCT00667810|524066177|FG001|Overall Study|Lack of Efficacy|0|||
145572352|NCT04300296|524954748|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
145572353|NCT04300296|524954749|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
145572354|NCT04300296|524954744|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
145572355|NCT04300296|524954745|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
145572356|NCT04300296|524954746|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
145572357|NCT04300296|524954747|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
145572358|NCT04300296|524954748|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
145572359|NCT04300296|524954749|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
145572360|NCT04300296|524954744|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
145572361|NCT04300296|524954745|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
145572362|NCT04300296|524954746|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
145572363|NCT04300296|524954747|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
145572364|NCT04300296|524954748|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
145572365|NCT04300296|524954749|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
145572366|NCT04300296|524954744|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
145572367|NCT04300296|524954745|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
145572368|NCT04300296|524954746|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
145331675|NCT00667810|524066178|FG002|Overall Study|Lack of Efficacy|2|||
145331676|NCT00667810|524066179|FG003|Overall Study|Lack of Efficacy|0|||
145331677|NCT00667810|524066176|FG000|Overall Study|Lost to Follow-up|1|||
145331678|NCT00667810|524066177|FG001|Overall Study|Lost to Follow-up|4|||
145331679|NCT00667810|524066178|FG002|Overall Study|Lost to Follow-up|2|||
145331680|NCT00667810|524066179|FG003|Overall Study|Lost to Follow-up|0|||
145331681|NCT00667810|524066176|FG000|Overall Study|Physician Decision|1|||
145331682|NCT00667810|524066177|FG001|Overall Study|Physician Decision|1|||
145331683|NCT00667810|524066178|FG002|Overall Study|Physician Decision|2|||
145572369|NCT04300296|524954747|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
145572370|NCT04300296|524954748|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
145572371|NCT04300296|524954749|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
145572372|NCT04300296|524954744|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
145572373|NCT04300296|524954745|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
145572374|NCT04300296|524954746|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
145572375|NCT04300296|524954747|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
145572376|NCT04300296|524954748|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
145572377|NCT04300296|524954749|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
145572378|NCT04300296|524954744|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
145572379|NCT04300296|524954745|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
145572380|NCT04300296|524954746|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
145572381|NCT04300296|524954747|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
145572382|NCT04300296|524954748|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
145572383|NCT04300296|524954749|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
145572384|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Adverse Event|9|||
145572385|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Adverse Event|2|||
145572386|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
145572387|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
145572388|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
145572389|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
145572390|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Physician Decision|1|||
145572391|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Physician Decision|1|||
145572392|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Pregnancy|2|||
145572393|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Pregnancy|0|||
145572394|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
145572395|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
145572396|NCT02896127|524954750|FG000|COMPLETED WEEK 52|Technical problems|1|||
145572397|NCT02896127|524954751|FG001|COMPLETED WEEK 52|Technical problems|0|||
145572398|NCT02896127|524954750|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
145331684|NCT00667810|524066179|FG003|Overall Study|Physician Decision|0|||
145331685|NCT00667810|524066176|FG000|Overall Study|Protocol Violation|0|||
145331686|NCT00667810|524066177|FG001|Overall Study|Protocol Violation|2|||
145331687|NCT00667810|524066178|FG002|Overall Study|Protocol Violation|0|||
145331688|NCT00667810|524066179|FG003|Overall Study|Protocol Violation|0|||
145331689|NCT00667810|524066176|FG000|Overall Study|Withdrawal by Subject|14|||
145331690|NCT00667810|524066177|FG001|Overall Study|Withdrawal by Subject|20|||
145331691|NCT00667810|524066178|FG002|Overall Study|Withdrawal by Subject|29|||
145331692|NCT00667810|524066179|FG003|Overall Study|Withdrawal by Subject|1|||
145331693|NCT00667810|524066176|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
145331694|NCT00667810|524066177|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
145331695|NCT00667810|524066178|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
145331696|NCT00667810|524066179|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145331697|NCT00667810|524066176|FG000|Overall Study|Failed to Return|0|||
145331698|NCT00667810|524066177|FG001|Overall Study|Failed to Return|0|||
145331699|NCT00667810|524066178|FG002|Overall Study|Failed to Return|2|||
145331700|NCT00667810|524066179|FG003|Overall Study|Failed to Return|0|||
145331701|NCT00667810|524066176|FG000|Overall Study|Loss of Caregiver|0|||
145331702|NCT00667810|524066177|FG001|Overall Study|Loss of Caregiver|1|||
145331703|NCT00667810|524066178|FG002|Overall Study|Loss of Caregiver|3|||
145331704|NCT00667810|524066179|FG003|Overall Study|Loss of Caregiver|0|||
145572399|NCT02896127|524954751|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
145572400|NCT02896127|524954750|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
145331705|NCT00667810|524066176|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
145572401|NCT02896127|524954751|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
145572402|NCT02896127|524954750|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
145572403|NCT02896127|524954751|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
145572404|NCT02896127|524954750|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
145572405|NCT02896127|524954751|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
145572406|NCT02896127|524954750|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
145572407|NCT02896127|524954751|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
145331706|NCT00667810|524066177|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
145331707|NCT00667810|524066178|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
145331708|NCT00667810|524066179|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
145331709|NCT00667810|524066176|FG000|Overall Study|Other|6|||
145572408|NCT00326911|524954752|FG000|Overall Study|Hospitalization prior to treatment|0|||
145572409|NCT00326911|524954753|FG001|Overall Study|Hospitalization prior to treatment|1|||
145572410|NCT00326911|524954752|FG000|Overall Study|Physician decision prior to treatment|1|||
145572411|NCT00326911|524954753|FG001|Overall Study|Physician decision prior to treatment|0|||
145572412|NCT00326911|524954752|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
145572413|NCT00326911|524954753|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
145572414|NCT04537806|524954758|FG000|Overall Study|Randomized but not treated|1|||
145572415|NCT04537806|524954759|FG001|Overall Study|Randomized but not treated|0|||
145572416|NCT04537806|524954758|FG000|Overall Study|Adverse Event|1|||
145572417|NCT04537806|524954759|FG001|Overall Study|Adverse Event|1|||
145572418|NCT02477020|524954768|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
145572419|NCT02477020|524954769|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
145572420|NCT02477020|524954768|FG000|Overall Study|Voluntary Withdrawal|7|||
145572421|NCT02477020|524954769|FG001|Overall Study|Voluntary Withdrawal|16|||
145572422|NCT02477020|524954768|FG000|Overall Study|Reason not Specified|3|||
145572423|NCT02477020|524954769|FG001|Overall Study|Reason not Specified|1|||
145572424|NCT02477020|524954768|FG000|Overall Study|Lack of Efficacy|14|||
145572425|NCT02477020|524954769|FG001|Overall Study|Lack of Efficacy|5|||
145572426|NCT00519649|524954770|FG000|Overall Study|Withdrawal by Subject|1|||
145572427|NCT00501540|524954771|FG000|Overall Study|Death|5|||
145572428|NCT01465802|524954772|FG000|Overall Study|Study terminated by sponsor|1|||
145572429|NCT01465802|524954773|FG001|Overall Study|Study terminated by sponsor|0|||
145572430|NCT01465802|524954774|FG002|Overall Study|Study terminated by sponsor|0|||
145572431|NCT01465802|524954775|FG003|Overall Study|Study terminated by sponsor|1|||
145572432|NCT01465802|524954776|FG004|Overall Study|Study terminated by sponsor|7|||
145572433|NCT01465802|524954772|FG000|Overall Study|Withdrawal by Subject|7|||
145572434|NCT01465802|524954773|FG001|Overall Study|Withdrawal by Subject|7|||
145572435|NCT01465802|524954774|FG002|Overall Study|Withdrawal by Subject|0|||
145572436|NCT01465802|524954775|FG003|Overall Study|Withdrawal by Subject|8|||
145572437|NCT01465802|524954776|FG004|Overall Study|Withdrawal by Subject|1|||
145572438|NCT01465802|524954772|FG000|Overall Study|Lost to Follow-up|1|||
145572439|NCT01465802|524954773|FG001|Overall Study|Lost to Follow-up|1|||
145572440|NCT01465802|524954774|FG002|Overall Study|Lost to Follow-up|0|||
145572441|NCT01465802|524954775|FG003|Overall Study|Lost to Follow-up|0|||
145572442|NCT01465802|524954776|FG004|Overall Study|Lost to Follow-up|0|||
145572443|NCT01465802|524954772|FG000|Overall Study|Reason not specified|9|||
145572444|NCT01465802|524954773|FG001|Overall Study|Reason not specified|4|||
145572445|NCT01465802|524954774|FG002|Overall Study|Reason not specified|0|||
145331710|NCT00667810|524066177|FG001|Overall Study|Other|6|||
145331711|NCT00667810|524066178|FG002|Overall Study|Other|5|||
145331712|NCT00667810|524066179|FG003|Overall Study|Other|0|||
145331713|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
145572446|NCT01465802|524954775|FG003|Overall Study|Reason not specified|10|||
145331714|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
145331715|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
145331716|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
145572447|NCT01465802|524954776|FG004|Overall Study|Reason not specified|2|||
145572448|NCT01465802|524954772|FG000|Overall Study|Death|15|||
145572449|NCT01465802|524954773|FG001|Overall Study|Death|12|||
145572450|NCT01465802|524954774|FG002|Overall Study|Death|0|||
145572451|NCT01465802|524954775|FG003|Overall Study|Death|10|||
145572452|NCT01465802|524954776|FG004|Overall Study|Death|2|||
145572453|NCT01340976|524954777|FG000|Overall Study|Physician Decision|2|||
145572454|NCT01340976|524954778|FG001|Overall Study|Physician Decision|0|||
145331717|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
145331718|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
145331719|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
145331720|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
145331721|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
145331722|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
145331723|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
145331724|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
145331725|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
145331726|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
145331727|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
145331728|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
145331729|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
145331730|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
145331731|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
145331732|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
145331733|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
145572455|NCT01340976|524954779|FG002|Overall Study|Physician Decision|1|||
145572456|NCT01340976|524954780|FG003|Overall Study|Physician Decision|1|||
145572457|NCT01340976|524954781|FG004|Overall Study|Physician Decision|1|||
145572458|NCT01340976|524954782|FG005|Overall Study|Physician Decision|0|||
145572459|NCT01340976|524954777|FG000|Overall Study|Death|0|||
145572460|NCT01340976|524954778|FG001|Overall Study|Death|1|||
145572461|NCT01340976|524954779|FG002|Overall Study|Death|0|||
145572462|NCT01340976|524954780|FG003|Overall Study|Death|0|||
145572463|NCT01340976|524954781|FG004|Overall Study|Death|0|||
145572464|NCT01340976|524954782|FG005|Overall Study|Death|0|||
145572465|NCT01340976|524954777|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
145572466|NCT01340976|524954778|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
145572467|NCT01340976|524954779|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
145572468|NCT01340976|524954780|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
145572469|NCT01340976|524954781|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
145572470|NCT01340976|524954782|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
145572471|NCT01340976|524954777|FG000|Overall Study|Withdrawal by Subject|0|||
145572472|NCT01340976|524954778|FG001|Overall Study|Withdrawal by Subject|0|||
145572473|NCT01340976|524954779|FG002|Overall Study|Withdrawal by Subject|0|||
145572474|NCT01340976|524954780|FG003|Overall Study|Withdrawal by Subject|1|||
145572475|NCT01340976|524954781|FG004|Overall Study|Withdrawal by Subject|1|||
145572476|NCT01340976|524954782|FG005|Overall Study|Withdrawal by Subject|0|||
145572477|NCT01340976|524954777|FG000|Overall Study|Other anemia treatment|1|||
145572478|NCT01340976|524954778|FG001|Overall Study|Other anemia treatment|0|||
145572479|NCT01340976|524954779|FG002|Overall Study|Other anemia treatment|2|||
145572480|NCT01340976|524954780|FG003|Overall Study|Other anemia treatment|1|||
145572481|NCT01340976|524954781|FG004|Overall Study|Other anemia treatment|0|||
145572482|NCT01340976|524954782|FG005|Overall Study|Other anemia treatment|1|||
145572483|NCT01340976|524954777|FG000|Overall Study|Adverse Event|0|||
145572484|NCT01340976|524954778|FG001|Overall Study|Adverse Event|1|||
145572485|NCT01340976|524954779|FG002|Overall Study|Adverse Event|0|||
145572486|NCT01340976|524954780|FG003|Overall Study|Adverse Event|0|||
145572487|NCT01340976|524954781|FG004|Overall Study|Adverse Event|0|||
145572488|NCT01340976|524954782|FG005|Overall Study|Adverse Event|0|||
145572489|NCT02953821|524954783|FG000|Overall Study|Adverse Event|0|||
145572490|NCT02953821|524954784|FG001|Overall Study|Adverse Event|4|||
145572491|NCT02953821|524954783|FG000|Overall Study|Death|1|||
145572492|NCT02953821|524954784|FG001|Overall Study|Death|0|||
145572493|NCT02953821|524954783|FG000|Overall Study|Progressive Disease|5|||
145572494|NCT02953821|524954784|FG001|Overall Study|Progressive Disease|1|||
145572495|NCT02953821|524954783|FG000|Overall Study|Lost to Follow-up|2|||
145572496|NCT02953821|524954784|FG001|Overall Study|Lost to Follow-up|0|||
145572497|NCT02953821|524954783|FG000|Overall Study|Physician Decision|1|||
145572498|NCT02953821|524954784|FG001|Overall Study|Physician Decision|1|||
145572499|NCT02953821|524954783|FG000|Overall Study|Withdrawal by Subject|3|||
145572500|NCT02953821|524954784|FG001|Overall Study|Withdrawal by Subject|3|||
145572501|NCT02953821|524954783|FG000|Overall Study|Change of address|0|||
145572502|NCT02953821|524954784|FG001|Overall Study|Change of address|1|||
145572503|NCT02953821|524954783|FG000|Overall Study|Lack of Efficacy|1|||
145572504|NCT02953821|524954784|FG001|Overall Study|Lack of Efficacy|0|||
145572505|NCT02953821|524954783|FG000|Overall Study|Out of state for indeterminate time|0|||
145572506|NCT02953821|524954784|FG001|Overall Study|Out of state for indeterminate time|1|||
145572507|NCT02953821|524954783|FG000|Overall Study|No improvement|0|||
145572508|NCT02953821|524954784|FG001|Overall Study|No improvement|1|||
145572509|NCT02953821|524954783|FG000|Overall Study|Refused follow-up visit|2|||
145572510|NCT02953821|524954784|FG001|Overall Study|Refused follow-up visit|1|||
145572511|NCT01067352|524954785|FG000|Overall Study|Withdrawal by Subject|1|||
145572512|NCT01067352|524954786|FG001|Overall Study|Withdrawal by Subject|2|||
145572513|NCT01067352|524954787|FG002|Overall Study|Withdrawal by Subject|1|||
145572514|NCT01067352|524954785|FG000|Overall Study|Physician Decision|0|||
145572515|NCT01067352|524954786|FG001|Overall Study|Physician Decision|1|||
145572516|NCT01067352|524954787|FG002|Overall Study|Physician Decision|0|||
145572517|NCT05107128|524954788|FG000|Overall Study|Adverse Event|2|||
145572518|NCT05107128|524954789|FG001|Overall Study|Adverse Event|0|||
145572519|NCT05107128|524954788|FG000|Overall Study|Withdrawal by Subject|3|||
145621287|NCT04955626|525126700|FG028|Blinded Period|Refused further study procedures|0|||
145621288|NCT04955626|525126701|FG029|Blinded Period|Refused further study procedures|0|||
145572520|NCT05107128|524954789|FG001|Overall Study|Withdrawal by Subject|3|||
145331734|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145572521|NCT05107128|524954788|FG000|Overall Study|Withdrawal of Consent|0|||
145572522|NCT05107128|524954789|FG001|Overall Study|Withdrawal of Consent|1|||
145572523|NCT05107128|524954788|FG000|Overall Study|Reason Not Specified|2|||
145572524|NCT05107128|524954789|FG001|Overall Study|Reason Not Specified|0|||
145572525|NCT05220397|524954790|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
145572526|NCT05220397|524954791|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
145572527|NCT05220397|524954792|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
145572528|NCT05220397|524954793|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
145572529|NCT05220397|524954794|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
145572530|NCT02052739|524954797|FG000|Overall Study|Withdrew due to Adverse Event|3|||
145412504|NCT04167670|524364843|FG002|Overall Study|Lost to Follow-up|3|||
145572531|NCT02052739|524954798|FG001|Overall Study|Withdrew due to Adverse Event|0|||
145572532|NCT02052739|524954797|FG000|Overall Study|Participant Died|2|||
145572533|NCT02052739|524954798|FG001|Overall Study|Participant Died|1|||
145572534|NCT01526889|524954799|FG000|Treatment Period|Adverse Event|2|||
145572535|NCT01526889|524954800|FG001|Treatment Period|Adverse Event|0|||
145572536|NCT01526889|524954799|FG000|Treatment Extension Period|Administrative problems|1|||
145572537|NCT01526889|524954800|FG001|Treatment Extension Period|Administrative problems|0|||
145572538|NCT02388997|524954801|FG000|Overall Study|Adverse Event|1|||
145572539|NCT02388997|524954802|FG001|Overall Study|Adverse Event|2|||
145572540|NCT02388997|524954801|FG000|Overall Study|Withdrawal by Subject|2|||
145572541|NCT02388997|524954802|FG001|Overall Study|Withdrawal by Subject|1|||
145572542|NCT02388997|524954801|FG000|Overall Study|Lung function exclusion criteria|0|||
145572543|NCT02388997|524954802|FG001|Overall Study|Lung function exclusion criteria|2|||
145572544|NCT02388997|524954801|FG000|Overall Study|Tested positive for virus during run-in|0|||
145572545|NCT02388997|524954802|FG001|Overall Study|Tested positive for virus during run-in|1|||
145572546|NCT01110915|524954803|FG000|Overall Study|Death|2|||
145572547|NCT01110915|524954804|FG001|Overall Study|Death|1|||
145572548|NCT01110915|524954803|FG000|Overall Study|Lost to Follow-up|1|||
145572549|NCT01110915|524954804|FG001|Overall Study|Lost to Follow-up|0|||
145572550|NCT01110915|524954803|FG000|Overall Study|Withdrawal by Subject|7|||
145572551|NCT01110915|524954804|FG001|Overall Study|Withdrawal by Subject|1|||
145572552|NCT04958109|524954811|FG000|Overall Study|Withdrawal by Subject|0|||
145572553|NCT04958109|524954812|FG001|Overall Study|Withdrawal by Subject|1|||
145572554|NCT04958109|524954811|FG000|Overall Study|Lost to Follow-up|0|||
145572555|NCT04958109|524954812|FG001|Overall Study|Lost to Follow-up|1|||
145572556|NCT00715793|524954813|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
145572557|NCT00715793|524954814|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
145572558|NCT00715793|524954813|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
145572559|NCT00715793|524954814|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
145572560|NCT00058825|524954815|FG000|Overall Study|Relapse|9|||
145572561|NCT00058825|524954815|FG000|Overall Study|Progressive Disease|5|||
145572562|NCT00058825|524954815|FG000|Overall Study|Graft Failure|5|||
145572563|NCT00058825|524954815|FG000|Overall Study|Death|3|||
145621289|NCT04955626|525126702|FG030|Blinded Period|Refused further study procedures|0|||
145621290|NCT04955626|525126703|FG031|Blinded Period|Refused further study procedures|0|||
145621291|NCT04955626|525126704|FG032|Blinded Period|Refused further study procedures|0|||
145621292|NCT04955626|525126705|FG033|Blinded Period|Refused further study procedures|0|||
145331735|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145331736|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
145331737|NCT03514641|524066189|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145331738|NCT03514641|524066190|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
145331739|NCT03514641|524066191|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145331740|NCT03514641|524066192|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
145331741|NCT03514641|524066189|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
145331742|NCT03514641|524066190|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
145331743|NCT03514641|524066191|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
145331744|NCT03514641|524066192|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
145331745|NCT03514641|524066189|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
145331746|NCT03514641|524066190|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
145331747|NCT03514641|524066191|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
145331748|NCT03514641|524066192|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
145331749|NCT03514641|524066189|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
145331750|NCT03514641|524066190|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
145331751|NCT03514641|524066191|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
145331752|NCT03514641|524066192|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
145331753|NCT03514641|524066189|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
145331754|NCT03514641|524066190|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
145331755|NCT03514641|524066191|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
145331756|NCT03514641|524066192|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
145331757|NCT03514641|524066189|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
145331758|NCT03514641|524066190|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
145331759|NCT03514641|524066191|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
145331760|NCT03514641|524066192|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
145331761|NCT00505375|524066193|FG000|Overall Study|Death|1|||
145331762|NCT00505375|524066194|FG001|Overall Study|Death|0|||
145331763|NCT00505375|524066193|FG000|Overall Study|Withdrawal by Subject|2|||
145572564|NCT04115358|524954816|FG000|Overall Study|exfoliation|0|||
145572565|NCT04115358|524954817|FG001|Overall Study|exfoliation|0|||
145572566|NCT04115358|524954818|FG002|Overall Study|exfoliation|1|||
145572567|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145621293|NCT04955626|525126706|FG034|Blinded Period|Refused further study procedures|0|||
145621294|NCT04955626|525126707|FG035|Blinded Period|Refused further study procedures|0|||
145331764|NCT00505375|524066194|FG001|Overall Study|Withdrawal by Subject|2|||
145331765|NCT00505375|524066193|FG000|Overall Study|Lost to Follow-up|0|||
145331766|NCT00505375|524066194|FG001|Overall Study|Lost to Follow-up|2|||
145331767|NCT00505375|524066193|FG000|Overall Study|Pregnancy|1|||
145331768|NCT00505375|524066194|FG001|Overall Study|Pregnancy|0|||
145331769|NCT00505375|524066193|FG000|Overall Study|Travel issues|0|||
145572568|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
145572569|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
145572570|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
145572571|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572572|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572573|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572574|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145331770|NCT00505375|524066194|FG001|Overall Study|Travel issues|1|||
145572575|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572576|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572577|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572578|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572579|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572580|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572581|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572582|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572583|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572584|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572585|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572586|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572587|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572588|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572589|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572590|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
145572591|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572592|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
145572593|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572594|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572595|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572596|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572597|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572598|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572599|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572600|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572601|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572602|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572603|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572604|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572605|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572606|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572607|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572608|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572609|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572610|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572611|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572612|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572613|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572614|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
145572615|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572616|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
145572617|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572618|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572619|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145331771|NCT01561430|524066195|FG000|Overall Study|Adverse Event|0|||
145331772|NCT01561430|524066196|FG001|Overall Study|Adverse Event|0|||
145331773|NCT01561430|524066197|FG002|Overall Study|Adverse Event|3|||
145572620|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572621|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572622|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145331774|NCT01561430|524066198|FG003|Overall Study|Adverse Event|1|||
145331775|NCT01561430|524066195|FG000|Overall Study|Withdrawal by Subject|0|||
145331776|NCT01561430|524066196|FG001|Overall Study|Withdrawal by Subject|0|||
145572623|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572624|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572625|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572626|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572627|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572628|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572629|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572630|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572631|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572632|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572633|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572634|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572635|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572636|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572637|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572638|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
145572639|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
145572640|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
145572641|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
145572642|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
145572643|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572644|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572645|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572646|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572647|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572648|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572649|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572650|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572651|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572652|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572653|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572654|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572655|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572656|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572657|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572658|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572659|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572660|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572661|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572662|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
145572663|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
145572664|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
145572665|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
145572666|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
145572667|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572668|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572669|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572670|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572671|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572672|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572673|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572674|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145331777|NCT01561430|524066197|FG002|Overall Study|Withdrawal by Subject|1|||
145331778|NCT01561430|524066198|FG003|Overall Study|Withdrawal by Subject|0|||
145331779|NCT01561430|524066195|FG000|Overall Study|Physician Decision|0|||
145331780|NCT01561430|524066196|FG001|Overall Study|Physician Decision|1|||
145331781|NCT01561430|524066197|FG002|Overall Study|Physician Decision|0|||
145331782|NCT01561430|524066198|FG003|Overall Study|Physician Decision|0|||
145331783|NCT01561430|524066195|FG000|Overall Study|Sponsor Decision|1|||
145331784|NCT01561430|524066196|FG001|Overall Study|Sponsor Decision|14|||
145331785|NCT01561430|524066197|FG002|Overall Study|Sponsor Decision|13|||
145572675|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572676|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572677|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572678|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145331786|NCT01561430|524066198|FG003|Overall Study|Sponsor Decision|12|||
145331787|NCT04234984|524066206|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
145331788|NCT04234984|524066206|FG000|Follow-up at the Second Time Point|Death|1|||
145331789|NCT04234984|524066206|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
145331790|NCT01055132|524066207|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
145331791|NCT01055132|524066208|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
145572679|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572680|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572681|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572682|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572683|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572684|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572685|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572686|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
145572687|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572688|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
145572689|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572690|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
145572691|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572692|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572693|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572694|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572695|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572696|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572697|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572698|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572699|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572700|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572701|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572702|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572703|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572704|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572705|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572706|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572707|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572708|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572709|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572710|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
145572711|NCT02346240|524954819|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572712|NCT02346240|524954820|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572713|NCT02346240|524954821|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
145572714|NCT02346240|524954822|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145331792|NCT01055132|524066207|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
145331793|NCT01055132|524066208|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
145331794|NCT02570113|524066209|FG000|Overall Study|Withdrawal by Subject|3|||
145331795|NCT02564211|524066210|FG000|Overall Study|Adverse Event|4|||
145331796|NCT05183217|524066214|FG000|Overall Study|Withdrawal by Subject|1|||
145331797|NCT05183217|524066215|FG001|Overall Study|Withdrawal by Subject|1|||
145331798|NCT00415194|524066226|FG000|Overall Study|Adverse Event|37|||
145331799|NCT00415194|524066227|FG001|Overall Study|Adverse Event|32|||
145331800|NCT00415194|524066226|FG000|Overall Study|Entry Criteria Not Met|4|||
145331801|NCT00415194|524066227|FG001|Overall Study|Entry Criteria Not Met|8|||
145331802|NCT00415194|524066226|FG000|Overall Study|Lost to Follow-up|1|||
145331803|NCT00415194|524066227|FG001|Overall Study|Lost to Follow-up|0|||
145331804|NCT00415194|524066226|FG000|Overall Study|Physician Decision|10|||
145331805|NCT00415194|524066227|FG001|Overall Study|Physician Decision|16|||
145331806|NCT00415194|524066226|FG000|Overall Study|Progressive Disease|180|||
145331807|NCT00415194|524066227|FG001|Overall Study|Progressive Disease|217|||
145331808|NCT00415194|524066226|FG000|Overall Study|Protocol Violation|4|||
145331809|NCT00415194|524066227|FG001|Overall Study|Protocol Violation|2|||
145331810|NCT00415194|524066226|FG000|Overall Study|Withdrawal by Subject|28|||
145331811|NCT00415194|524066227|FG001|Overall Study|Withdrawal by Subject|21|||
145331812|NCT00415194|524066226|FG000|Overall Study|Death Due to Study Disease|26|||
145331813|NCT00415194|524066227|FG001|Overall Study|Death Due to Study Disease|29|||
145331814|NCT00415194|524066226|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
145331815|NCT00415194|524066227|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
145331816|NCT00415194|524066226|FG000|Overall Study|Death Due to Procedural Related AE|0|||
145331817|NCT00415194|524066227|FG001|Overall Study|Death Due to Procedural Related AE|1|||
145572715|NCT02346240|524954823|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572716|NCT02346240|524954824|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572717|NCT02346240|524954825|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572718|NCT02346240|524954826|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572719|NCT02346240|524954827|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572720|NCT02346240|524954828|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572721|NCT02346240|524954829|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572722|NCT02346240|524954830|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572723|NCT02346240|524954831|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572724|NCT02346240|524954832|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572725|NCT02346240|524954833|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572726|NCT02346240|524954834|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572727|NCT02346240|524954835|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572728|NCT02346240|524954836|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572729|NCT02346240|524954837|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572730|NCT02346240|524954838|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572731|NCT02346240|524954839|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572732|NCT02346240|524954840|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572733|NCT02346240|524954841|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572734|NCT02346240|524954842|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
145572735|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572736|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572737|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572738|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572739|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572740|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572741|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572742|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145572743|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145572744|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145621295|NCT04955626|525126672|FG000|Blinded Period|Participants entered open label period|4544|||
145621296|NCT04955626|525126673|FG001|Blinded Period|Participants entered open label period|4906|||
145621297|NCT04955626|525126674|FG002|Blinded Period|Participants entered open label period|0|||
145621298|NCT04955626|525126675|FG003|Blinded Period|Participants entered open label period|0|||
145621299|NCT04955626|525126676|FG004|Blinded Period|Participants entered open label period|0|||
145331818|NCT00415194|524066226|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
145331819|NCT00415194|524066227|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
145331820|NCT01297465|524066228|FG000|Overall Study|Lack of Ovarian Response|1|||
145331821|NCT01297465|524066229|FG001|Overall Study|Lack of Ovarian Response|1|||
145331822|NCT01297465|524066228|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
145331823|NCT01297465|524066229|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
145331824|NCT01297465|524066228|FG000|Overall Study|No Oocytes Retrieved|1|||
145331825|NCT01297465|524066229|FG001|Overall Study|No Oocytes Retrieved|1|||
145331826|NCT01297465|524066228|FG000|Overall Study|Poor oocyte quality|0|||
145331827|NCT01297465|524066229|FG001|Overall Study|Poor oocyte quality|1|||
145331828|NCT01297465|524066228|FG000|Overall Study|No Fertilization|6|||
145331829|NCT01297465|524066229|FG001|Overall Study|No Fertilization|4|||
145331830|NCT01297465|524066228|FG000|Overall Study|All Embryos Discarded|0|||
145331831|NCT01297465|524066229|FG001|Overall Study|All Embryos Discarded|1|||
145331832|NCT01297465|524066228|FG000|Overall Study|Intention to Freeze all Embryos|0|||
145331833|NCT01297465|524066229|FG001|Overall Study|Intention to Freeze all Embryos|1|||
145331834|NCT00969540|524066230|FG000|Overall Study|Lost to Follow-up|1|||
145331835|NCT00969540|524066231|FG001|Overall Study|Lost to Follow-up|1|||
145331836|NCT02116608|524066237|FG000|Overall Study|Lost to Follow-up|0|||
145331837|NCT02116608|524066238|FG001|Overall Study|Lost to Follow-up|0|||
145331838|NCT02116608|524066239|FG002|Overall Study|Lost to Follow-up|1|||
145331839|NCT02116608|524066237|FG000|Overall Study|Physician Decision|0|||
145331840|NCT02116608|524066238|FG001|Overall Study|Physician Decision|1|||
145331841|NCT02116608|524066239|FG002|Overall Study|Physician Decision|0|||
145331842|NCT02116608|524066237|FG000|Overall Study|Death|0|||
145331843|NCT02116608|524066238|FG001|Overall Study|Death|1|||
145331844|NCT02116608|524066239|FG002|Overall Study|Death|0|||
145331845|NCT00988442|524066241|FG000|Overall Study|Death|1|||
145331846|NCT00988442|524066242|FG001|Overall Study|Death|2|||
145331847|NCT00988442|524066241|FG000|Overall Study|Lost to Follow-up|0|||
145331848|NCT00988442|524066242|FG001|Overall Study|Lost to Follow-up|1|||
145331849|NCT00988442|524066241|FG000|Overall Study|Early Study Closure|29|||
145331850|NCT00988442|524066242|FG001|Overall Study|Early Study Closure|25|||
145331851|NCT02731326|524066247|FG000|Overall Study|Withdrawal by Subject|4|||
145331852|NCT02731326|524066248|FG001|Overall Study|Withdrawal by Subject|1|||
145331853|NCT02731326|524066247|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
145412505|NCT04167670|524364841|FG000|Overall Study|Voluntary Withdrawal|0|||
145412506|NCT04167670|524364842|FG001|Overall Study|Voluntary Withdrawal|1|||
145412507|NCT04167670|524364843|FG002|Overall Study|Voluntary Withdrawal|1|||
145412508|NCT04167670|524364841|FG000|Overall Study|Withdrawal of Consent|4|||
145412509|NCT04167670|524364842|FG001|Overall Study|Withdrawal of Consent|1|||
145412510|NCT04167670|524364843|FG002|Overall Study|Withdrawal of Consent|3|||
145412511|NCT04167670|524364841|FG000|Overall Study|Miscellaneous|7|||
145412512|NCT04167670|524364842|FG001|Overall Study|Miscellaneous|5|||
145412513|NCT04167670|524364843|FG002|Overall Study|Miscellaneous|3|||
145412514|NCT01363076|524364846|FG000|Overall Study|Withdrawal by Subject|0|||
145412515|NCT01363076|524364847|FG001|Overall Study|Withdrawal by Subject|1|||
145412516|NCT01922011|524364849|FG000|Overall Study|Protocol Violation|0|||
145412517|NCT01922011|524364850|FG001|Overall Study|Protocol Violation|1|||
145412518|NCT01922011|524364849|FG000|Overall Study|Physician Decision|0|||
145412519|NCT01922011|524364850|FG001|Overall Study|Physician Decision|1|||
145412520|NCT01922011|524364849|FG000|Overall Study|Parent/Guardian Decision|3|||
145412521|NCT01922011|524364850|FG001|Overall Study|Parent/Guardian Decision|0|||
145412522|NCT01922011|524364849|FG000|Overall Study|Lost to Follow-up|0|||
145412523|NCT01922011|524364850|FG001|Overall Study|Lost to Follow-up|1|||
145412524|NCT01922011|524364849|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
145412525|NCT01922011|524364850|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
145412526|NCT01922011|524364849|FG000|Overall Study|Not Treated|1|||
145412527|NCT01922011|524364850|FG001|Overall Study|Not Treated|0|||
145412528|NCT01922011|524364849|FG000|Overall Study|Lack of willing home health agency|1|||
145412529|NCT01922011|524364850|FG001|Overall Study|Lack of willing home health agency|0|||
145412530|NCT01922011|524364849|FG000|Overall Study|Randomized in error|1|||
145412531|NCT01922011|524364850|FG001|Overall Study|Randomized in error|0|||
145412532|NCT04871113|524364851|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412533|NCT04871113|524364852|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412534|NCT04871113|524364853|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412535|NCT04871113|524364854|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412536|NCT04871113|524364855|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412537|NCT04871113|524364856|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
145412538|NCT04871113|524364857|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412539|NCT04871113|524364858|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412540|NCT04871113|524364859|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412541|NCT04871113|524364860|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
145412542|NCT04871113|524364851|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412543|NCT04871113|524364852|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412544|NCT04871113|524364853|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412545|NCT04871113|524364854|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412546|NCT04871113|524364855|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412547|NCT04871113|524364856|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412548|NCT04871113|524364857|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
145412549|NCT04871113|524364858|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
145412550|NCT04871113|524364859|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412551|NCT04871113|524364860|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
145412552|NCT00770484|524364863|FG000|Overall Study|Withdrawal by Subject|1|||
145412553|NCT00770484|524364864|FG001|Overall Study|Withdrawal by Subject|0|||
145412554|NCT00195429|524364865|FG000|Overall Study|Adverse Event|2|||
145412555|NCT00195429|524364866|FG001|Overall Study|Adverse Event|4|||
145572745|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572746|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572747|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572748|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145572749|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
145572750|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145572751|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
145572752|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572753|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572754|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145621300|NCT04955626|525126677|FG005|Blinded Period|Participants entered open label period|0|||
145412556|NCT00195429|524364865|FG000|Overall Study|Lack of Efficacy|2|||
145412557|NCT00195429|524364866|FG001|Overall Study|Lack of Efficacy|1|||
145412558|NCT00195429|524364865|FG000|Overall Study|Lost to Follow-up|1|||
145412559|NCT00195429|524364866|FG001|Overall Study|Lost to Follow-up|0|||
145412560|NCT02143778|524364867|FG000|Overall Study|Withdrawal by Subject|2|||
145412561|NCT02143778|524364867|FG000|Overall Study|Device malfunction|1|||
145412562|NCT03384966|524364868|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
145572755|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572756|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145621301|NCT04955626|525126678|FG006|Blinded Period|Participants entered open label period|0|||
145621302|NCT04955626|525126679|FG007|Blinded Period|Participants entered open label period|0|||
145621303|NCT04955626|525126680|FG008|Blinded Period|Participants entered open label period|0|||
145621304|NCT04955626|525126681|FG009|Blinded Period|Participants entered open label period|0|||
145621305|NCT04955626|525126682|FG010|Blinded Period|Participants entered open label period|0|||
145331854|NCT02731326|524066248|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
145331855|NCT02731326|524066247|FG000|Overall Study|Discharged without AliveCor|10|||
145331856|NCT02731326|524066248|FG001|Overall Study|Discharged without AliveCor|0|||
145331857|NCT02731326|524066247|FG000|Overall Study|Duplicate Participant|1|||
145331858|NCT02731326|524066248|FG001|Overall Study|Duplicate Participant|1|||
145331859|NCT00302081|524066250|FG000|Overall Study|Adverse Event|6|||
145331860|NCT00302081|524066251|FG001|Overall Study|Adverse Event|5|||
145331861|NCT00302081|524066252|FG002|Overall Study|Adverse Event|4|||
145331862|NCT00302081|524066250|FG000|Overall Study|Lost to Follow-up|21|||
145331863|NCT00302081|524066251|FG001|Overall Study|Lost to Follow-up|18|||
145331864|NCT00302081|524066252|FG002|Overall Study|Lost to Follow-up|28|||
145331865|NCT00302081|524066250|FG000|Overall Study|Withdrawal by Subject|8|||
145331866|NCT00302081|524066251|FG001|Overall Study|Withdrawal by Subject|12|||
145331867|NCT00302081|524066252|FG002|Overall Study|Withdrawal by Subject|8|||
145331868|NCT00302081|524066250|FG000|Overall Study|Protocol Violation|5|||
145331869|NCT00302081|524066251|FG001|Overall Study|Protocol Violation|1|||
145331870|NCT00302081|524066252|FG002|Overall Study|Protocol Violation|2|||
145331871|NCT00302081|524066250|FG000|Overall Study|Lack of Efficacy|1|||
145331872|NCT00302081|524066251|FG001|Overall Study|Lack of Efficacy|0|||
145331873|NCT00302081|524066252|FG002|Overall Study|Lack of Efficacy|5|||
145331874|NCT00302081|524066250|FG000|Overall Study|Death|2|||
145331875|NCT00302081|524066251|FG001|Overall Study|Death|1|||
145331876|NCT00302081|524066252|FG002|Overall Study|Death|0|||
145331877|NCT00302081|524066250|FG000|Overall Study|Other|13|||
145331878|NCT00302081|524066251|FG001|Overall Study|Other|6|||
145331879|NCT00302081|524066252|FG002|Overall Study|Other|5|||
145331880|NCT04480710|524066253|FG000|Overall Study|Adverse Event|0|||
145331881|NCT04480710|524066254|FG001|Overall Study|Adverse Event|2|||
145331882|NCT04480710|524066255|FG002|Overall Study|Adverse Event|0|||
145331883|NCT04480710|524066256|FG003|Overall Study|Adverse Event|0|||
145331884|NCT04480710|524066253|FG000|Overall Study|Withdrawal by Subject|0|||
145331885|NCT04480710|524066254|FG001|Overall Study|Withdrawal by Subject|1|||
145331886|NCT04480710|524066255|FG002|Overall Study|Withdrawal by Subject|0|||
145331887|NCT04480710|524066256|FG003|Overall Study|Withdrawal by Subject|0|||
145331888|NCT04480710|524066253|FG000|Overall Study|Physician Decision|0|||
145331889|NCT04480710|524066254|FG001|Overall Study|Physician Decision|0|||
145331890|NCT04480710|524066255|FG002|Overall Study|Physician Decision|1|||
145331891|NCT04480710|524066256|FG003|Overall Study|Physician Decision|0|||
145331892|NCT05084963|524066258|FG000|Overall Study|Withdrawal by Subject|0|||
145331893|NCT05084963|524066259|FG001|Overall Study|Withdrawal by Subject|0|||
145331894|NCT05084963|524066260|FG002|Overall Study|Withdrawal by Subject|1|||
145331895|NCT03569228|524066261|FG000|Overall Study|Withdrawal by PI|0|||
145331896|NCT03569228|524066262|FG001|Overall Study|Withdrawal by PI|0|||
145331897|NCT03569228|524066263|FG002|Overall Study|Withdrawal by PI|2|||
145331898|NCT03569228|524066264|FG003|Overall Study|Withdrawal by PI|2|||
145331899|NCT03569228|524066265|FG004|Overall Study|Withdrawal by PI|1|||
145331900|NCT03569228|524066266|FG005|Overall Study|Withdrawal by PI|0|||
145331901|NCT03569228|524066267|FG006|Overall Study|Withdrawal by PI|0|||
145331902|NCT03569228|524066268|FG007|Overall Study|Withdrawal by PI|0|||
145331903|NCT03569228|524066269|FG008|Overall Study|Withdrawal by PI|0|||
145331904|NCT03569228|524066261|FG000|Overall Study|Lost to Follow-up|0|||
145331905|NCT03569228|524066262|FG001|Overall Study|Lost to Follow-up|0|||
145331906|NCT03569228|524066263|FG002|Overall Study|Lost to Follow-up|0|||
145331907|NCT03569228|524066264|FG003|Overall Study|Lost to Follow-up|0|||
145331908|NCT03569228|524066265|FG004|Overall Study|Lost to Follow-up|0|||
145331909|NCT03569228|524066266|FG005|Overall Study|Lost to Follow-up|0|||
145331910|NCT03569228|524066267|FG006|Overall Study|Lost to Follow-up|0|||
145412563|NCT03384966|524364869|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
145412564|NCT03384966|524364870|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
145331911|NCT03569228|524066268|FG007|Overall Study|Lost to Follow-up|0|||
145331912|NCT03569228|524066269|FG008|Overall Study|Lost to Follow-up|1|||
145331913|NCT03569228|524066261|FG000|Overall Study|Screen Fail|2|||
145331914|NCT03569228|524066262|FG001|Overall Study|Screen Fail|2|||
145331915|NCT03569228|524066263|FG002|Overall Study|Screen Fail|1|||
145331916|NCT03569228|524066264|FG003|Overall Study|Screen Fail|1|||
145331917|NCT03569228|524066265|FG004|Overall Study|Screen Fail|1|||
145331918|NCT03569228|524066266|FG005|Overall Study|Screen Fail|3|||
145331919|NCT03569228|524066267|FG006|Overall Study|Screen Fail|1|||
145331920|NCT03569228|524066268|FG007|Overall Study|Screen Fail|5|||
145331921|NCT03569228|524066269|FG008|Overall Study|Screen Fail|2|||
145331922|NCT05442866|524066270|FG000|Overall Study|Death|1|||
145331923|NCT05442866|524066270|FG000|Overall Study|Lost to Follow-up|9|||
145331924|NCT05442866|524066270|FG000|Overall Study|Protocol Violation|1|||
145331925|NCT03819049|524066271|FG000|Overall Study|Lost to Follow-up|1|||
145331926|NCT03819049|524066272|FG001|Overall Study|Lost to Follow-up|2|||
145331927|NCT03819049|524066273|FG002|Overall Study|Lost to Follow-up|9|||
145572757|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572758|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145572759|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572760|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572761|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572762|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572763|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572764|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572765|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572766|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572767|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572768|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572769|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572770|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572771|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572772|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
145572773|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572774|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
145572775|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572776|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572777|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572778|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572779|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572780|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572781|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572782|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
145572783|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572784|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572785|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572786|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572787|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572788|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572789|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572790|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572791|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572792|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572793|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572794|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572795|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572796|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572797|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
145572798|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572799|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572800|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572801|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572802|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572803|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572804|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572805|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572806|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145572807|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572808|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572809|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572810|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572811|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572812|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572813|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572814|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572815|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572816|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572817|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572818|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
145572819|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572820|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
145572821|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
145572822|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
145331928|NCT03819049|524066274|FG003|Overall Study|Lost to Follow-up|0|||
145331929|NCT03819049|524066275|FG004|Overall Study|Lost to Follow-up|3|||
145331930|NCT03819049|524066276|FG005|Overall Study|Lost to Follow-up|1|||
145331931|NCT03819049|524066277|FG006|Overall Study|Lost to Follow-up|0|||
145331932|NCT03819049|524066271|FG000|Overall Study|Withdrawal by Subject|0|||
145331933|NCT03819049|524066272|FG001|Overall Study|Withdrawal by Subject|0|||
145331934|NCT03819049|524066273|FG002|Overall Study|Withdrawal by Subject|18|||
145331935|NCT03819049|524066274|FG003|Overall Study|Withdrawal by Subject|0|||
145331936|NCT03819049|524066275|FG004|Overall Study|Withdrawal by Subject|10|||
145331937|NCT03819049|524066276|FG005|Overall Study|Withdrawal by Subject|9|||
145331938|NCT03819049|524066277|FG006|Overall Study|Withdrawal by Subject|1|||
145331939|NCT03819049|524066271|FG000|Overall Study|Ongoing|0|||
145331940|NCT03819049|524066272|FG001|Overall Study|Ongoing|0|||
145331941|NCT03819049|524066273|FG002|Overall Study|Ongoing|75|||
145331942|NCT03819049|524066274|FG003|Overall Study|Ongoing|0|||
145331943|NCT03819049|524066275|FG004|Overall Study|Ongoing|41|||
145331944|NCT03819049|524066276|FG005|Overall Study|Ongoing|0|||
145331945|NCT03819049|524066277|FG006|Overall Study|Ongoing|0|||
145331946|NCT03819049|524066271|FG000|Overall Study|Other|0|||
145331947|NCT03819049|524066272|FG001|Overall Study|Other|0|||
145331948|NCT03819049|524066273|FG002|Overall Study|Other|2|||
145331949|NCT03819049|524066274|FG003|Overall Study|Other|0|||
145331950|NCT03819049|524066275|FG004|Overall Study|Other|0|||
145331951|NCT03819049|524066276|FG005|Overall Study|Other|0|||
145331952|NCT03819049|524066277|FG006|Overall Study|Other|0|||
145331953|NCT03819049|524066271|FG000|Overall Study|Randomized but not vaccinated|0|||
145331954|NCT03819049|524066272|FG001|Overall Study|Randomized but not vaccinated|0|||
145331955|NCT03819049|524066273|FG002|Overall Study|Randomized but not vaccinated|0|||
145331956|NCT03819049|524066274|FG003|Overall Study|Randomized but not vaccinated|1|||
145331957|NCT03819049|524066275|FG004|Overall Study|Randomized but not vaccinated|0|||
145331958|NCT03819049|524066276|FG005|Overall Study|Randomized but not vaccinated|2|||
145331959|NCT03819049|524066277|FG006|Overall Study|Randomized but not vaccinated|1|||
145331960|NCT03819049|524066271|FG000|Overall Study|Physician Decision|0|||
145331961|NCT03819049|524066272|FG001|Overall Study|Physician Decision|0|||
145331962|NCT03819049|524066273|FG002|Overall Study|Physician Decision|0|||
145331963|NCT03819049|524066274|FG003|Overall Study|Physician Decision|0|||
145331964|NCT03819049|524066275|FG004|Overall Study|Physician Decision|0|||
145331965|NCT03819049|524066276|FG005|Overall Study|Physician Decision|0|||
145331966|NCT03819049|524066277|FG006|Overall Study|Physician Decision|1|||
145572823|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145572824|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572825|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572826|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572827|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572828|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572829|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572830|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145572831|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572832|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145331967|NCT01568320|524066278|FG000|Overall Study|Death|20|||
145331968|NCT01568320|524066278|FG000|Overall Study|Lost to Follow-up|9|||
145331969|NCT01568320|524066278|FG000|Overall Study|Withdrawal by Subject|10|||
145331970|NCT01568320|524066278|FG000|Overall Study|Conversion to open repair|1|||
145331971|NCT01568320|524066278|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
145331972|NCT01616953|524066279|FG000|Overall Study|Lost to Follow-up|1|||
145331973|NCT01616953|524066280|FG001|Overall Study|Lost to Follow-up|0|||
145331974|NCT01616953|524066279|FG000|Overall Study|lack of bone and soft tissue|1|||
145331975|NCT01616953|524066280|FG001|Overall Study|lack of bone and soft tissue|0|||
145331976|NCT00816361|524066282|FG000|Overall Study|Withdrawal by Subject|0|||
145331977|NCT00816361|524066283|FG001|Overall Study|Withdrawal by Subject|0|||
145572833|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572834|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572835|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145331978|NCT00816361|524066284|FG002|Overall Study|Withdrawal by Subject|0|||
145331979|NCT00816361|524066285|FG003|Overall Study|Withdrawal by Subject|0|||
145331980|NCT00816361|524066286|FG004|Overall Study|Withdrawal by Subject|1|||
145331981|NCT00816361|524066287|FG005|Overall Study|Withdrawal by Subject|2|||
145331982|NCT00816361|524066288|FG006|Overall Study|Withdrawal by Subject|0|||
145331983|NCT00816361|524066289|FG007|Overall Study|Withdrawal by Subject|2|||
145331984|NCT00816361|524066290|FG008|Overall Study|Withdrawal by Subject|1|||
145331985|NCT00816361|524066282|FG000|Overall Study|Death|4|||
145572836|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572837|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572838|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572839|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572840|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572841|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572842|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572843|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572844|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
145572845|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
145572846|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
145572847|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
145572848|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572849|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572850|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572851|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572852|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572853|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572854|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
145572855|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572856|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572857|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572858|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572859|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572860|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572861|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
145572862|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572863|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572864|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572865|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572866|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572867|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572868|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572869|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572870|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572871|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572872|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572873|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572874|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572875|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572876|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572877|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572878|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
145572879|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572880|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572881|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572882|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572883|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572884|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572885|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572886|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572887|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
145572888|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572889|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572890|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
145572891|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572892|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
145572893|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
145572894|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145331986|NCT00816361|524066283|FG001|Overall Study|Death|3|||
145572895|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572896|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572897|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572898|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572899|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572900|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572901|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572902|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
145572903|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572904|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572905|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572906|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572907|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572908|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572909|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572910|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572911|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572912|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
145572913|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572914|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572915|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572916|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572917|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572918|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572919|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572920|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572921|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572922|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572923|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572924|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572925|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572926|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
145572927|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572928|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572929|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572930|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572931|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572932|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572933|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572934|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572935|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572936|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572937|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
145572938|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572939|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572940|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572941|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572942|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572943|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572944|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572945|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572946|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145621306|NCT04955626|525126683|FG011|Blinded Period|Participants entered open label period|0|||
145621307|NCT04955626|525126684|FG012|Blinded Period|Participants entered open label period|0|||
145621308|NCT04955626|525126685|FG013|Blinded Period|Participants entered open label period|0|||
145621309|NCT04955626|525126686|FG014|Blinded Period|Participants entered open label period|0|||
145621310|NCT04955626|525126687|FG015|Blinded Period|Participants entered open label period|0|||
145621311|NCT04955626|525126688|FG016|Blinded Period|Participants entered open label period|0|||
145572947|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572948|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572949|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572950|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
145572951|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572952|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572953|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572954|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572955|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572956|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572957|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572958|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572959|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572960|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572961|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572962|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572963|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572964|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572965|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
145572966|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572967|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572968|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572969|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572970|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572971|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572972|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572973|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572974|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
145572975|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572976|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572977|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572978|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572979|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572980|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572981|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572982|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572983|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572984|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572985|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572986|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572987|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572988|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572989|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
145572990|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572991|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572992|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572993|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572994|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572995|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572996|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572997|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572998|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
145572999|NCT02346240|524954819|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573000|NCT02346240|524954820|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573001|NCT02346240|524954821|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573002|NCT02346240|524954822|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573003|NCT02346240|524954823|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573004|NCT02346240|524954824|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145621312|NCT04955626|525126689|FG017|Blinded Period|Participants entered open label period|0|||
145621313|NCT04955626|525126690|FG018|Blinded Period|Participants entered open label period|0|||
145621314|NCT04955626|525126691|FG019|Blinded Period|Participants entered open label period|0|||
145621315|NCT04955626|525126692|FG020|Blinded Period|Participants entered open label period|0|||
145621316|NCT04955626|525126693|FG021|Blinded Period|Participants entered open label period|0|||
145621317|NCT04955626|525126694|FG022|Blinded Period|Participants entered open label period|0|||
145621318|NCT04955626|525126695|FG023|Blinded Period|Participants entered open label period|0|||
145621319|NCT04955626|525126696|FG024|Blinded Period|Participants entered open label period|0|||
145621320|NCT04955626|525126697|FG025|Blinded Period|Participants entered open label period|0|||
145621321|NCT04955626|525126698|FG026|Blinded Period|Participants entered open label period|0|||
145621322|NCT04955626|525126699|FG027|Blinded Period|Participants entered open label period|0|||
145621323|NCT04955626|525126700|FG028|Blinded Period|Participants entered open label period|0|||
145621324|NCT04955626|525126701|FG029|Blinded Period|Participants entered open label period|0|||
145621325|NCT04955626|525126702|FG030|Blinded Period|Participants entered open label period|0|||
145621326|NCT04955626|525126703|FG031|Blinded Period|Participants entered open label period|0|||
145621327|NCT04955626|525126704|FG032|Blinded Period|Participants entered open label period|0|||
145621328|NCT04955626|525126705|FG033|Blinded Period|Participants entered open label period|0|||
145621329|NCT04955626|525126706|FG034|Blinded Period|Participants entered open label period|0|||
145621330|NCT04955626|525126707|FG035|Blinded Period|Participants entered open label period|0|||
145621331|NCT04955626|525126672|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
145621332|NCT04955626|525126673|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
145621333|NCT04955626|525126674|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
145621334|NCT04955626|525126675|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
145621335|NCT04955626|525126676|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
145621336|NCT04955626|525126677|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
145621337|NCT04955626|525126678|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
145621338|NCT04955626|525126679|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
145621339|NCT04955626|525126680|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
145331987|NCT00816361|524066284|FG002|Overall Study|Death|3|||
145331988|NCT00816361|524066285|FG003|Overall Study|Death|3|||
145331989|NCT00816361|524066286|FG004|Overall Study|Death|1|||
145331990|NCT00816361|524066287|FG005|Overall Study|Death|1|||
145331991|NCT00816361|524066288|FG006|Overall Study|Death|3|||
145331992|NCT00816361|524066289|FG007|Overall Study|Death|7|||
145331993|NCT00816361|524066290|FG008|Overall Study|Death|8|||
145331994|NCT00816361|524066282|FG000|Overall Study|Other|0|||
145331995|NCT00816361|524066283|FG001|Overall Study|Other|0|||
145331996|NCT00816361|524066284|FG002|Overall Study|Other|0|||
145331997|NCT00816361|524066285|FG003|Overall Study|Other|0|||
145331998|NCT00816361|524066286|FG004|Overall Study|Other|0|||
145331999|NCT00816361|524066287|FG005|Overall Study|Other|0|||
145332000|NCT00816361|524066288|FG006|Overall Study|Other|0|||
145332001|NCT00816361|524066289|FG007|Overall Study|Other|0|||
145332002|NCT00816361|524066290|FG008|Overall Study|Other|1|||
145332003|NCT01394952|524066291|FG000|Overall Study|Lost to Follow-up|0|||
145332004|NCT01394952|524066292|FG001|Overall Study|Lost to Follow-up|5|||
145332005|NCT01394952|524066291|FG000|Overall Study|Withdrawal by Subject|10|||
145332006|NCT01394952|524066292|FG001|Overall Study|Withdrawal by Subject|5|||
145332007|NCT01394952|524066291|FG000|Overall Study|Physician Decision|2|||
145332008|NCT01394952|524066292|FG001|Overall Study|Physician Decision|0|||
145332009|NCT01394952|524066291|FG000|Overall Study|Sponsor Decision|5|||
145332010|NCT01394952|524066292|FG001|Overall Study|Sponsor Decision|7|||
145332011|NCT01986010|524066293|FG000|Overall Study|Adverse Event|0|||
145332012|NCT01986010|524066294|FG001|Overall Study|Adverse Event|1|||
145332013|NCT01986010|524066295|FG002|Overall Study|Adverse Event|0|||
145621340|NCT04955626|525126681|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
145332014|NCT01986010|524066296|FG003|Overall Study|Adverse Event|0|||
145332015|NCT01986010|524066297|FG004|Overall Study|Adverse Event|0|||
145332016|NCT01986010|524066298|FG005|Overall Study|Adverse Event|0|||
145332017|NCT01986010|524066299|FG006|Overall Study|Adverse Event|0|||
145332018|NCT01986010|524066300|FG007|Overall Study|Adverse Event|0|||
145332019|NCT01986010|524066301|FG008|Overall Study|Adverse Event|0|||
145621341|NCT04955626|525126682|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
145332020|NCT01986010|524066302|FG009|Overall Study|Adverse Event|0|||
145332021|NCT01986010|524066303|FG010|Overall Study|Adverse Event|0|||
145332022|NCT01986010|524066304|FG011|Overall Study|Adverse Event|0|||
145332023|NCT01986010|524066305|FG012|Overall Study|Adverse Event|0|||
145332024|NCT01986010|524066306|FG013|Overall Study|Adverse Event|0|||
145621342|NCT04955626|525126683|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
145621343|NCT04955626|525126684|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
145332025|NCT01986010|524066307|FG014|Overall Study|Adverse Event|0|||
145332026|NCT01986010|524066308|FG015|Overall Study|Adverse Event|1|||
145332027|NCT01986010|524066309|FG016|Overall Study|Adverse Event|0|||
145332028|NCT01986010|524066293|FG000|Overall Study|Lost to Follow-up|2|||
145332029|NCT01986010|524066294|FG001|Overall Study|Lost to Follow-up|1|||
145621344|NCT04955626|525126685|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
145621345|NCT04955626|525126686|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
145621346|NCT04955626|525126687|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
145621347|NCT04955626|525126688|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
145621348|NCT04955626|525126689|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
145412565|NCT03384966|524364868|FG000|Follow-up Period|Adverse Event|1|||
145412566|NCT03384966|524364869|FG001|Follow-up Period|Adverse Event|0|||
145412567|NCT03384966|524364870|FG002|Follow-up Period|Adverse Event|0|||
145412568|NCT00367458|524364871|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
145412569|NCT00367458|524364872|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
145412570|NCT01334515|524364875|FG000|Overall Study|Adverse Event|1|||
145412571|NCT01334515|524364876|FG001|Overall Study|Adverse Event|6|||
145412572|NCT01334515|524364875|FG000|Overall Study|Death|1|||
145412573|NCT01334515|524364876|FG001|Overall Study|Death|0|||
145412574|NCT01334515|524364875|FG000|Overall Study|Lack of Efficacy|8|||
145412575|NCT01334515|524364876|FG001|Overall Study|Lack of Efficacy|21|||
145412576|NCT01334515|524364875|FG000|Overall Study|Physician Decision|1|||
145412577|NCT01334515|524364876|FG001|Overall Study|Physician Decision|1|||
145412578|NCT01334515|524364875|FG000|Overall Study|Withdrawal by Subject|1|||
145412579|NCT01334515|524364876|FG001|Overall Study|Withdrawal by Subject|1|||
145412580|NCT01479530|524364880|FG000|Overall Study|Adverse Event|5|||
145412581|NCT01479530|524364881|FG001|Overall Study|Adverse Event|6|||
145412582|NCT01479530|524364880|FG000|Overall Study|Lack of Efficacy|0|||
145412583|NCT01479530|524364881|FG001|Overall Study|Lack of Efficacy|1|||
145412584|NCT01479530|524364880|FG000|Overall Study|Protocol Violation|2|||
145412585|NCT01479530|524364881|FG001|Overall Study|Protocol Violation|3|||
145412586|NCT01479530|524364880|FG000|Overall Study|Withdrawal of Consent|3|||
145412587|NCT01479530|524364881|FG001|Overall Study|Withdrawal of Consent|2|||
145412588|NCT04795323|524364882|FG000|Overall Study|Did not interact with TARA|1|||
145412589|NCT04795323|524364883|FG001|Overall Study|Did not interact with TARA|0|||
145412590|NCT00303628|524364886|FG000|Overall Study|Disease progression|0|||
145412591|NCT00303628|524364887|FG001|Overall Study|Disease progression|1|||
145412592|NCT00303628|524364886|FG000|Overall Study|Adverse Event|26|||
145412593|NCT00303628|524364887|FG001|Overall Study|Adverse Event|36|||
145412594|NCT00303628|524364886|FG000|Overall Study|Death|0|||
145412595|NCT00303628|524364887|FG001|Overall Study|Death|1|||
145412596|NCT00303628|524364886|FG000|Overall Study|Withdrawal by Subject|11|||
145412597|NCT00303628|524364887|FG001|Overall Study|Withdrawal by Subject|20|||
145412598|NCT00303628|524364886|FG000|Overall Study|Alternative therapy|2|||
145412599|NCT00303628|524364887|FG001|Overall Study|Alternative therapy|0|||
145412600|NCT00303628|524364886|FG000|Overall Study|Other complicating disease|0|||
145412601|NCT00303628|524364887|FG001|Overall Study|Other complicating disease|1|||
145412602|NCT00303628|524364886|FG000|Overall Study|Not start protocol therapy|3|||
145412603|NCT00303628|524364887|FG001|Overall Study|Not start protocol therapy|5|||
145412604|NCT00303628|524364886|FG000|Overall Study|Other|8|||
145412605|NCT00303628|524364887|FG001|Overall Study|Other|9|||
145412606|NCT00376506|524364888|FG000|Overall Study|Death|0|||
145412607|NCT00376506|524364889|FG001|Overall Study|Death|2|||
145412608|NCT04925934|524364890|FG000|Overall Study|Adverse Event|1|||
145412609|NCT04925934|524364891|FG001|Overall Study|Adverse Event|0|||
145412610|NCT04925934|524364892|FG002|Overall Study|Adverse Event|0|||
145412611|NCT04925934|524364890|FG000|Overall Study|Lost to Follow-up|2|||
145412612|NCT04925934|524364891|FG001|Overall Study|Lost to Follow-up|0|||
145412613|NCT04925934|524364892|FG002|Overall Study|Lost to Follow-up|1|||
145412614|NCT04925934|524364890|FG000|Overall Study|Death|0|||
145412615|NCT04925934|524364891|FG001|Overall Study|Death|1|||
145412616|NCT04925934|524364892|FG002|Overall Study|Death|0|||
145621349|NCT04955626|525126690|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
145621350|NCT04955626|525126691|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
145621351|NCT04955626|525126692|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
145621352|NCT04955626|525126693|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
145412617|NCT04925934|524364890|FG000|Overall Study|Withdrawal by Subject|8|||
145412618|NCT04925934|524364891|FG001|Overall Study|Withdrawal by Subject|5|||
145412619|NCT04925934|524364892|FG002|Overall Study|Withdrawal by Subject|9|||
145412620|NCT04925934|524364890|FG000|Overall Study|Other|2|||
145412621|NCT04925934|524364891|FG001|Overall Study|Other|2|||
145412622|NCT04925934|524364892|FG002|Overall Study|Other|2|||
145412623|NCT04925934|524364890|FG000|Overall Study|Eastern European Conflict|7|||
145412624|NCT04925934|524364891|FG001|Overall Study|Eastern European Conflict|3|||
145412625|NCT04925934|524364892|FG002|Overall Study|Eastern European Conflict|2|||
145412626|NCT03158688|524364893|FG000|Overall Study|Withdrawal by Subject|14|||
145412627|NCT03158688|524364894|FG001|Overall Study|Withdrawal by Subject|28|||
145412628|NCT03158688|524364893|FG000|Overall Study|Decision by sponsor|13|||
145412629|NCT03158688|524364894|FG001|Overall Study|Decision by sponsor|37|||
145412630|NCT03158688|524364893|FG000|Overall Study|Lost to Follow-up|4|||
145412631|NCT03158688|524364894|FG001|Overall Study|Lost to Follow-up|3|||
145412632|NCT03158688|524364893|FG000|Overall Study|Death|74|||
145412633|NCT03158688|524364894|FG001|Overall Study|Death|142|||
145412634|NCT01716156|524364899|FG000|Overall Study|Protocol Violation|1|||
145573005|NCT02346240|524954825|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573006|NCT02346240|524954826|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573007|NCT02346240|524954827|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573008|NCT02346240|524954828|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573009|NCT02346240|524954829|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573010|NCT02346240|524954830|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573011|NCT02346240|524954831|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145332030|NCT01986010|524066295|FG002|Overall Study|Lost to Follow-up|2|||
145332031|NCT01986010|524066296|FG003|Overall Study|Lost to Follow-up|2|||
145332032|NCT01986010|524066297|FG004|Overall Study|Lost to Follow-up|2|||
145332033|NCT01986010|524066298|FG005|Overall Study|Lost to Follow-up|2|||
145332034|NCT01986010|524066299|FG006|Overall Study|Lost to Follow-up|0|||
145332035|NCT01986010|524066300|FG007|Overall Study|Lost to Follow-up|0|||
145573012|NCT02346240|524954832|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145332036|NCT01986010|524066301|FG008|Overall Study|Lost to Follow-up|4|||
145332037|NCT01986010|524066302|FG009|Overall Study|Lost to Follow-up|2|||
145332038|NCT01986010|524066303|FG010|Overall Study|Lost to Follow-up|0|||
145332039|NCT01986010|524066304|FG011|Overall Study|Lost to Follow-up|1|||
145332040|NCT01986010|524066305|FG012|Overall Study|Lost to Follow-up|1|||
145332041|NCT01986010|524066306|FG013|Overall Study|Lost to Follow-up|1|||
145332042|NCT01986010|524066307|FG014|Overall Study|Lost to Follow-up|2|||
145332043|NCT01986010|524066308|FG015|Overall Study|Lost to Follow-up|0|||
145332044|NCT01986010|524066309|FG016|Overall Study|Lost to Follow-up|0|||
145332045|NCT01986010|524066293|FG000|Overall Study|Physician Decision|0|||
145332046|NCT01986010|524066294|FG001|Overall Study|Physician Decision|0|||
145332047|NCT01986010|524066295|FG002|Overall Study|Physician Decision|0|||
145332048|NCT01986010|524066296|FG003|Overall Study|Physician Decision|0|||
145332049|NCT01986010|524066297|FG004|Overall Study|Physician Decision|0|||
145332050|NCT01986010|524066298|FG005|Overall Study|Physician Decision|0|||
145332051|NCT01986010|524066299|FG006|Overall Study|Physician Decision|0|||
145332052|NCT01986010|524066300|FG007|Overall Study|Physician Decision|0|||
145332053|NCT01986010|524066301|FG008|Overall Study|Physician Decision|0|||
145332054|NCT01986010|524066302|FG009|Overall Study|Physician Decision|0|||
145332055|NCT01986010|524066303|FG010|Overall Study|Physician Decision|0|||
145332056|NCT01986010|524066304|FG011|Overall Study|Physician Decision|0|||
145332057|NCT01986010|524066305|FG012|Overall Study|Physician Decision|0|||
145332058|NCT01986010|524066306|FG013|Overall Study|Physician Decision|0|||
145332059|NCT01986010|524066307|FG014|Overall Study|Physician Decision|1|||
145332060|NCT01986010|524066308|FG015|Overall Study|Physician Decision|0|||
145332061|NCT01986010|524066309|FG016|Overall Study|Physician Decision|0|||
145332062|NCT01986010|524066293|FG000|Overall Study|Withdrawal by Subject|2|||
145332063|NCT01986010|524066294|FG001|Overall Study|Withdrawal by Subject|2|||
145332064|NCT01986010|524066295|FG002|Overall Study|Withdrawal by Subject|3|||
145332065|NCT01986010|524066296|FG003|Overall Study|Withdrawal by Subject|0|||
145332066|NCT01986010|524066297|FG004|Overall Study|Withdrawal by Subject|2|||
145332067|NCT01986010|524066298|FG005|Overall Study|Withdrawal by Subject|4|||
145332068|NCT01986010|524066299|FG006|Overall Study|Withdrawal by Subject|0|||
145332069|NCT01986010|524066300|FG007|Overall Study|Withdrawal by Subject|0|||
145332070|NCT01986010|524066301|FG008|Overall Study|Withdrawal by Subject|0|||
145332071|NCT01986010|524066302|FG009|Overall Study|Withdrawal by Subject|0|||
145332072|NCT01986010|524066303|FG010|Overall Study|Withdrawal by Subject|0|||
145332073|NCT01986010|524066304|FG011|Overall Study|Withdrawal by Subject|2|||
145332074|NCT01986010|524066305|FG012|Overall Study|Withdrawal by Subject|0|||
145332075|NCT01986010|524066306|FG013|Overall Study|Withdrawal by Subject|1|||
145332076|NCT01986010|524066307|FG014|Overall Study|Withdrawal by Subject|2|||
145332077|NCT01986010|524066308|FG015|Overall Study|Withdrawal by Subject|0|||
145332078|NCT01986010|524066309|FG016|Overall Study|Withdrawal by Subject|0|||
145332079|NCT01986010|524066293|FG000|Overall Study|Status Not Recorded|2|||
145332080|NCT01986010|524066294|FG001|Overall Study|Status Not Recorded|4|||
145332081|NCT01986010|524066295|FG002|Overall Study|Status Not Recorded|2|||
145332082|NCT01986010|524066296|FG003|Overall Study|Status Not Recorded|0|||
145332083|NCT01986010|524066297|FG004|Overall Study|Status Not Recorded|1|||
145332084|NCT01986010|524066298|FG005|Overall Study|Status Not Recorded|2|||
145332085|NCT01986010|524066299|FG006|Overall Study|Status Not Recorded|0|||
145332086|NCT01986010|524066300|FG007|Overall Study|Status Not Recorded|0|||
145332087|NCT01986010|524066301|FG008|Overall Study|Status Not Recorded|2|||
145332088|NCT01986010|524066302|FG009|Overall Study|Status Not Recorded|1|||
145332089|NCT01986010|524066303|FG010|Overall Study|Status Not Recorded|7|||
145332090|NCT01986010|524066304|FG011|Overall Study|Status Not Recorded|7|||
145332091|NCT01986010|524066305|FG012|Overall Study|Status Not Recorded|9|||
145332092|NCT01986010|524066306|FG013|Overall Study|Status Not Recorded|9|||
145332093|NCT01986010|524066307|FG014|Overall Study|Status Not Recorded|5|||
145332094|NCT01986010|524066308|FG015|Overall Study|Status Not Recorded|10|||
145332095|NCT01986010|524066309|FG016|Overall Study|Status Not Recorded|4|||
145332096|NCT01335997|524066310|FG000|Period I and II|Adverse Event|63|||
145332097|NCT01335997|524066311|FG001|Period I and II|Adverse Event|43|||
145573013|NCT02346240|524954833|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
145573014|NCT02346240|524954834|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573015|NCT02346240|524954835|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573016|NCT02346240|524954836|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573017|NCT02346240|524954837|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573018|NCT02346240|524954838|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573019|NCT02346240|524954839|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573020|NCT02346240|524954840|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145332098|NCT01335997|524066310|FG000|Period I and II|Noncompliance with Study Drug|1|||
145332099|NCT01335997|524066311|FG001|Period I and II|Noncompliance with Study Drug|1|||
145332100|NCT01335997|524066310|FG000|Period I and II|Lost to Follow-up|3|||
145332101|NCT01335997|524066311|FG001|Period I and II|Lost to Follow-up|5|||
145332102|NCT01335997|524066310|FG000|Period I and II|Withdrawal by Subject|9|||
145332103|NCT01335997|524066311|FG001|Period I and II|Withdrawal by Subject|4|||
145332104|NCT01335997|524066310|FG000|Period I and II|Study Terminated by Sponsor|406|||
145332105|NCT01335997|524066311|FG001|Period I and II|Study Terminated by Sponsor|415|||
145332106|NCT01335997|524066310|FG000|Period I and II|Protocol Violation|9|||
145332107|NCT01335997|524066311|FG001|Period I and II|Protocol Violation|10|||
145332108|NCT01335997|524066310|FG000|Period I and II|Physician Decision|2|||
145332109|NCT01335997|524066311|FG001|Period I and II|Physician Decision|1|||
145332110|NCT01335997|524066310|FG000|Period III|Adverse Event|0|||
145332111|NCT01335997|524066311|FG001|Period III|Adverse Event|2|||
145332112|NCT01335997|524066310|FG000|Period III|Study Terminated by Sponsor|77|||
145332113|NCT01335997|524066311|FG001|Period III|Study Terminated by Sponsor|76|||
145332114|NCT01335997|524066310|FG000|Period III|Protocol Violation|0|||
145332115|NCT01335997|524066311|FG001|Period III|Protocol Violation|1|||
145332116|NCT01335997|524066310|FG000|Period III|Lost to Follow-up|1|||
145332117|NCT01335997|524066311|FG001|Period III|Lost to Follow-up|0|||
145332118|NCT02440568|524066314|FG000|Overall Study|Death|1|||
145332119|NCT02440568|524066315|FG001|Overall Study|Death|3|||
145332120|NCT02440568|524066316|FG002|Overall Study|Death|4|||
145332121|NCT02440568|524066317|FG003|Overall Study|Death|2|||
145332122|NCT02440568|524066314|FG000|Overall Study|Lack of Efficacy|2|||
145332123|NCT02440568|524066315|FG001|Overall Study|Lack of Efficacy|0|||
145332124|NCT02440568|524066316|FG002|Overall Study|Lack of Efficacy|1|||
145332125|NCT02440568|524066317|FG003|Overall Study|Lack of Efficacy|0|||
145332126|NCT02440568|524066314|FG000|Overall Study|Lost to Follow-up|1|||
145332127|NCT02440568|524066315|FG001|Overall Study|Lost to Follow-up|0|||
145332128|NCT02440568|524066316|FG002|Overall Study|Lost to Follow-up|0|||
145332129|NCT02440568|524066317|FG003|Overall Study|Lost to Follow-up|0|||
145332130|NCT00536263|524066318|FG000|Overall Study|Adverse Event|5|||
145332131|NCT00536263|524066319|FG001|Overall Study|Adverse Event|5|||
145332132|NCT00536263|524066320|FG002|Overall Study|Adverse Event|7|||
145332133|NCT00536263|524066318|FG000|Overall Study|Lost to Follow-up|3|||
145332134|NCT00536263|524066319|FG001|Overall Study|Lost to Follow-up|4|||
145332135|NCT00536263|524066320|FG002|Overall Study|Lost to Follow-up|4|||
145332136|NCT00536263|524066318|FG000|Overall Study|Subject withdrew - not treatment related|2|||
145332137|NCT00536263|524066319|FG001|Overall Study|Subject withdrew - not treatment related|0|||
145332138|NCT00536263|524066320|FG002|Overall Study|Subject withdrew - not treatment related|5|||
145332139|NCT00536263|524066318|FG000|Overall Study|Subject withdrew - treatment related|0|||
145332140|NCT00536263|524066319|FG001|Overall Study|Subject withdrew - treatment related|3|||
145332141|NCT00536263|524066320|FG002|Overall Study|Subject withdrew - treatment related|2|||
145332142|NCT00536263|524066318|FG000|Overall Study|Noncompliance with protocol|0|||
145332143|NCT00536263|524066319|FG001|Overall Study|Noncompliance with protocol|0|||
145332144|NCT00536263|524066320|FG002|Overall Study|Noncompliance with protocol|1|||
145332145|NCT00536263|524066318|FG000|Overall Study|Did not meet protocol eligibility|1|||
145332146|NCT00536263|524066319|FG001|Overall Study|Did not meet protocol eligibility|2|||
145332147|NCT00536263|524066320|FG002|Overall Study|Did not meet protocol eligibility|2|||
145332148|NCT00826449|524066321|FG000|Overall Study|Disease Progression|4|||
145332149|NCT00826449|524066321|FG000|Overall Study|Withdrawal by Subject|1|||
145332150|NCT01103466|524066322|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
145332151|NCT01103466|524066323|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
145332152|NCT01103466|524066324|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
145332153|NCT01103466|524066322|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
145332154|NCT01103466|524066323|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
145332155|NCT01103466|524066324|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
145332156|NCT01103466|524066322|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145332157|NCT01103466|524066323|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145332158|NCT01103466|524066324|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145412635|NCT01716156|524364900|FG001|Overall Study|Protocol Violation|0|||
145412636|NCT01716156|524364901|FG002|Overall Study|Protocol Violation|0|||
145332159|NCT01103466|524066322|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
145412637|NCT01716156|524364899|FG000|Overall Study|Withdrawal by Subject|0|||
145412638|NCT01716156|524364900|FG001|Overall Study|Withdrawal by Subject|1|||
145412639|NCT01716156|524364901|FG002|Overall Study|Withdrawal by Subject|2|||
145412640|NCT01716156|524364899|FG000|Overall Study|Lost to Follow-up|1|||
145412641|NCT01716156|524364900|FG001|Overall Study|Lost to Follow-up|0|||
145412642|NCT01716156|524364901|FG002|Overall Study|Lost to Follow-up|0|||
145412643|NCT01132755|524364908|FG000|Overall Study|Procedure not done due to medical reason|23|||
145412644|NCT01132755|524364908|FG000|Overall Study|Protocol Violation|15|||
145412645|NCT01132755|524364908|FG000|Overall Study|Withdrawal by Subject|4|||
145412646|NCT02393755|524364909|FG000|Overall Study|Withdrawal by Subject|0|||
145412647|NCT02393755|524364910|FG001|Overall Study|Withdrawal by Subject|3|||
145412648|NCT02393755|524364909|FG000|Overall Study|Adverse Event|0|||
145412649|NCT02393755|524364910|FG001|Overall Study|Adverse Event|2|||
145412650|NCT02393755|524364909|FG000|Overall Study|Physician Decision|0|||
145412651|NCT02393755|524364910|FG001|Overall Study|Physician Decision|2|||
145412652|NCT02949934|524364913|FG000|Natural Drinking Period|Adverse Event|1|||
145412653|NCT02949934|524364914|FG001|Natural Drinking Period|Adverse Event|0|||
145412654|NCT02949934|524364915|FG002|Natural Drinking Period|Adverse Event|0|||
145412655|NCT02949934|524364916|FG003|Natural Drinking Period|Adverse Event|1|||
145412656|NCT02949934|524364917|FG004|Natural Drinking Period|Adverse Event|0|||
145412657|NCT02949934|524364918|FG005|Natural Drinking Period|Adverse Event|0|||
145412658|NCT02949934|524364913|FG000|Natural Drinking Period|Lost to Follow-up|0|||
145412659|NCT02949934|524364914|FG001|Natural Drinking Period|Lost to Follow-up|0|||
145412660|NCT02949934|524364915|FG002|Natural Drinking Period|Lost to Follow-up|0|||
145412661|NCT02949934|524364916|FG003|Natural Drinking Period|Lost to Follow-up|0|||
145412662|NCT02949934|524364917|FG004|Natural Drinking Period|Lost to Follow-up|1|||
145412663|NCT02949934|524364918|FG005|Natural Drinking Period|Lost to Follow-up|0|||
145412664|NCT02949934|524364913|FG000|Neuroimaging|Protocol Violation|2|||
145412665|NCT02949934|524364914|FG001|Neuroimaging|Protocol Violation|0|||
145412666|NCT02949934|524364915|FG002|Neuroimaging|Protocol Violation|0|||
145412667|NCT02949934|524364916|FG003|Neuroimaging|Protocol Violation|0|||
145412668|NCT02949934|524364917|FG004|Neuroimaging|Protocol Violation|1|||
145412669|NCT02949934|524364918|FG005|Neuroimaging|Protocol Violation|0|||
145412670|NCT02949934|524364913|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
145412671|NCT02949934|524364914|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
145412672|NCT02949934|524364915|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
145412673|NCT02949934|524364916|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
145412674|NCT02949934|524364917|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
145412675|NCT02949934|524364918|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
145412676|NCT02949934|524364913|FG000|Neuroimaging|Not scanned|0|||
145412677|NCT02949934|524364914|FG001|Neuroimaging|Not scanned|0|||
145412678|NCT02949934|524364915|FG002|Neuroimaging|Not scanned|1|||
145573021|NCT02346240|524954841|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573022|NCT02346240|524954842|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
145573023|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573024|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573025|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573026|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573027|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573028|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573029|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573030|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573031|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573032|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573033|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573034|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573035|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573036|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573037|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573038|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145573039|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
145412679|NCT02949934|524364916|FG003|Neuroimaging|Not scanned|0|||
145412680|NCT02949934|524364917|FG004|Neuroimaging|Not scanned|0|||
145412681|NCT02949934|524364918|FG005|Neuroimaging|Not scanned|2|||
145412682|NCT02949934|524364913|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
145412683|NCT02949934|524364914|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145412684|NCT02949934|524364915|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145412685|NCT02949934|524364916|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
145412686|NCT02949934|524364917|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
145412687|NCT02949934|524364918|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
145412688|NCT02949934|524364913|FG000|Bar Laboratory|Adverse Event|1|||
145412689|NCT02949934|524364914|FG001|Bar Laboratory|Adverse Event|0|||
145621353|NCT04955626|525126694|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
145621354|NCT04955626|525126695|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
145621355|NCT04955626|525126696|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
145621356|NCT04955626|525126697|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
145621357|NCT04955626|525126698|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
145621358|NCT04955626|525126699|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
145621359|NCT04955626|525126700|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
145621360|NCT04955626|525126701|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
145621361|NCT04955626|525126702|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
145621362|NCT04955626|525126703|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
145621363|NCT04955626|525126704|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
145621364|NCT04955626|525126705|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
145621365|NCT04955626|525126706|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
145621366|NCT04955626|525126707|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
145621367|NCT04955626|525126672|FG000|Blinded Period|Medication error|0|||
145621368|NCT04955626|525126673|FG001|Blinded Period|Medication error|0|||
145621369|NCT04955626|525126674|FG002|Blinded Period|Medication error|0|||
145621370|NCT04955626|525126675|FG003|Blinded Period|Medication error|0|||
145621371|NCT04955626|525126676|FG004|Blinded Period|Medication error|0|||
145621372|NCT04955626|525126677|FG005|Blinded Period|Medication error|0|||
145621373|NCT04955626|525126678|FG006|Blinded Period|Medication error|0|||
145621374|NCT04955626|525126679|FG007|Blinded Period|Medication error|0|||
145621375|NCT04955626|525126680|FG008|Blinded Period|Medication error|0|||
145621376|NCT04955626|525126681|FG009|Blinded Period|Medication error|0|||
145621377|NCT04955626|525126682|FG010|Blinded Period|Medication error|2|||
145621378|NCT04955626|525126683|FG011|Blinded Period|Medication error|0|||
145621379|NCT04955626|525126684|FG012|Blinded Period|Medication error|0|||
145621380|NCT04955626|525126685|FG013|Blinded Period|Medication error|0|||
145621381|NCT04955626|525126686|FG014|Blinded Period|Medication error|0|||
145621382|NCT04955626|525126687|FG015|Blinded Period|Medication error|0|||
145621383|NCT04955626|525126688|FG016|Blinded Period|Medication error|0|||
145621384|NCT04955626|525126689|FG017|Blinded Period|Medication error|0|||
145621385|NCT04955626|525126690|FG018|Blinded Period|Medication error|0|||
145621386|NCT04955626|525126691|FG019|Blinded Period|Medication error|0|||
145621387|NCT04955626|525126692|FG020|Blinded Period|Medication error|0|||
145621388|NCT04955626|525126693|FG021|Blinded Period|Medication error|0|||
145621389|NCT04955626|525126694|FG022|Blinded Period|Medication error|0|||
145621390|NCT04955626|525126695|FG023|Blinded Period|Medication error|0|||
145621391|NCT04955626|525126696|FG024|Blinded Period|Medication error|0|||
145621392|NCT04955626|525126697|FG025|Blinded Period|Medication error|0|||
145621393|NCT04955626|525126698|FG026|Blinded Period|Medication error|0|||
145621394|NCT04955626|525126699|FG027|Blinded Period|Medication error|0|||
145621395|NCT04955626|525126700|FG028|Blinded Period|Medication error|4|||
145621396|NCT04955626|525126701|FG029|Blinded Period|Medication error|0|||
145621397|NCT04955626|525126702|FG030|Blinded Period|Medication error|0|||
145621398|NCT04955626|525126703|FG031|Blinded Period|Medication error|0|||
145621399|NCT04955626|525126704|FG032|Blinded Period|Medication error|0|||
145621400|NCT04955626|525126705|FG033|Blinded Period|Medication error|0|||
145621401|NCT04955626|525126706|FG034|Blinded Period|Medication error|0|||
145621402|NCT04955626|525126707|FG035|Blinded Period|Medication error|0|||
145621403|NCT04955626|525126672|FG000|Open-Label Period|Lost to Follow-up|109|||
145621404|NCT04955626|525126673|FG001|Open-Label Period|Lost to Follow-up|41|||
145621405|NCT04955626|525126674|FG002|Open-Label Period|Lost to Follow-up|0|||
145621406|NCT04955626|525126675|FG003|Open-Label Period|Lost to Follow-up|0|||
145621407|NCT04955626|525126676|FG004|Open-Label Period|Lost to Follow-up|0|||
145621408|NCT04955626|525126677|FG005|Open-Label Period|Lost to Follow-up|0|||
145621409|NCT04955626|525126678|FG006|Open-Label Period|Lost to Follow-up|0|||
145621410|NCT04955626|525126679|FG007|Open-Label Period|Lost to Follow-up|0|||
145332160|NCT01103466|524066323|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
145332161|NCT01103466|524066324|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
145332162|NCT01103466|524066322|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
145332163|NCT01103466|524066323|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145332164|NCT01103466|524066324|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
145332165|NCT01103466|524066322|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
145621411|NCT04955626|525126680|FG008|Open-Label Period|Lost to Follow-up|0|||
145621412|NCT04955626|525126681|FG009|Open-Label Period|Lost to Follow-up|0|||
145621413|NCT04955626|525126682|FG010|Open-Label Period|Lost to Follow-up|0|||
145621414|NCT04955626|525126683|FG011|Open-Label Period|Lost to Follow-up|0|||
145621415|NCT04955626|525126684|FG012|Open-Label Period|Lost to Follow-up|0|||
145621416|NCT04955626|525126685|FG013|Open-Label Period|Lost to Follow-up|0|||
145621417|NCT04955626|525126686|FG014|Open-Label Period|Lost to Follow-up|0|||
145621418|NCT04955626|525126687|FG015|Open-Label Period|Lost to Follow-up|0|||
145621419|NCT04955626|525126688|FG016|Open-Label Period|Lost to Follow-up|0|||
145621420|NCT04955626|525126689|FG017|Open-Label Period|Lost to Follow-up|0|||
145621421|NCT04955626|525126690|FG018|Open-Label Period|Lost to Follow-up|0|||
145621422|NCT04955626|525126691|FG019|Open-Label Period|Lost to Follow-up|0|||
145332166|NCT01103466|524066323|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
145332167|NCT01103466|524066324|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
145332168|NCT02994940|524066325|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
145332169|NCT02994940|524066326|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
145332170|NCT02994940|524066325|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
145332171|NCT02994940|524066326|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
145332172|NCT02994940|524066325|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
145332173|NCT02994940|524066326|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
145332174|NCT00975286|524066333|FG000|Overall Study|Adverse Event|9|||
145332175|NCT00975286|524066334|FG001|Overall Study|Adverse Event|19|||
145332176|NCT00975286|524066333|FG000|Overall Study|Protocol Violation|1|||
145332177|NCT00975286|524066334|FG001|Overall Study|Protocol Violation|2|||
145332178|NCT00975286|524066333|FG000|Overall Study|Withdrawal by Subject|0|||
145332179|NCT00975286|524066334|FG001|Overall Study|Withdrawal by Subject|2|||
145332180|NCT00975286|524066333|FG000|Overall Study|Familial and Personal Reasons|2|||
145332181|NCT00975286|524066334|FG001|Overall Study|Familial and Personal Reasons|2|||
145332182|NCT00975286|524066333|FG000|Overall Study|Poor Compliance to Protocol|0|||
145332183|NCT00975286|524066334|FG001|Overall Study|Poor Compliance to Protocol|2|||
145332184|NCT00975286|524066333|FG000|Overall Study|Sponsor Decision|0|||
145332185|NCT00975286|524066334|FG001|Overall Study|Sponsor Decision|2|||
145332186|NCT02357342|524066335|FG000|First 6 Months|Death|2|||
145332187|NCT02357342|524066336|FG001|First 6 Months|Death|0|||
145332188|NCT01674647|524066337|FG000|Treatment Period|Death|4|||
145332189|NCT01674647|524066338|FG001|Treatment Period|Death|1|||
145332190|NCT01674647|524066337|FG000|Treatment Period|Efficacy outcome reached|0|||
145332191|NCT01674647|524066338|FG001|Treatment Period|Efficacy outcome reached|1|||
145332192|NCT01674647|524066337|FG000|Treatment Period|Physician Decision|3|||
145332193|NCT01674647|524066338|FG001|Treatment Period|Physician Decision|1|||
145332194|NCT01674647|524066337|FG000|Treatment Period|Adverse Event|60|||
145332195|NCT01674647|524066338|FG001|Treatment Period|Adverse Event|22|||
145332196|NCT01674647|524066337|FG000|Treatment Period|Non-compliance with study drug|3|||
145332197|NCT01674647|524066338|FG001|Treatment Period|Non-compliance with study drug|0|||
145332198|NCT01674647|524066337|FG000|Treatment Period|Lost to Follow-up|1|||
145332199|NCT01674647|524066338|FG001|Treatment Period|Lost to Follow-up|1|||
145332200|NCT01674647|524066337|FG000|Treatment Period|Withdrawal by Subject|19|||
145332201|NCT01674647|524066338|FG001|Treatment Period|Withdrawal by Subject|16|||
145332202|NCT01674647|524066337|FG000|Treatment Period|Switching to other therapy|5|||
145332203|NCT01674647|524066338|FG001|Treatment Period|Switching to other therapy|2|||
145332204|NCT01674647|524066337|FG000|Treatment Period|Logistical difficulties|5|||
145332205|NCT01674647|524066338|FG001|Treatment Period|Logistical difficulties|8|||
145332206|NCT01674647|524066337|FG000|Treatment Period|Treatment failure|0|||
145332207|NCT01674647|524066338|FG001|Treatment Period|Treatment failure|14|||
145332208|NCT01674647|524066337|FG000|Treatment Period|Protocol Violation|56|||
145332209|NCT01674647|524066338|FG001|Treatment Period|Protocol Violation|36|||
145332210|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Death|3|||
145332211|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Death|2|||
145332212|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
145332213|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
145332214|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
145332215|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
145332216|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
145332217|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
145332218|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
145332219|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
145332220|NCT01674647|524066337|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
145332221|NCT01674647|524066338|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
145332222|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
145332223|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
145332224|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
145332225|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
145332226|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
145332227|NCT01490866|524066340|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
145412690|NCT02949934|524364915|FG002|Bar Laboratory|Adverse Event|2|||
145332228|NCT01490866|524066340|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
145332229|NCT01490866|524066340|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
145332230|NCT01490866|524066340|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
145332231|NCT01490866|524066340|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
145332232|NCT01490866|524066340|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
145332233|NCT03201211|524066341|FG000|Overall Study|Adverse Event|1|||
145332234|NCT03201211|524066342|FG001|Overall Study|Adverse Event|0|||
145332235|NCT03201211|524066343|FG002|Overall Study|Adverse Event|0|||
145332236|NCT03201211|524066341|FG000|Overall Study|Protocol Violation|1|||
145332237|NCT03201211|524066342|FG001|Overall Study|Protocol Violation|0|||
145332238|NCT03201211|524066343|FG002|Overall Study|Protocol Violation|0|||
145332239|NCT03201211|524066341|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145332240|NCT03201211|524066342|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
145332241|NCT03201211|524066343|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
145332242|NCT03201211|524066341|FG000|Overall Study|OTHER unknown reasons|0|||
145332243|NCT03201211|524066342|FG001|Overall Study|OTHER unknown reasons|1|||
145332244|NCT03201211|524066343|FG002|Overall Study|OTHER unknown reasons|0|||
145332245|NCT01970865|524066344|FG000|Overall Study|Death|3|||
145332246|NCT01970865|524066345|FG001|Overall Study|Death|2|||
145332247|NCT01970865|524066346|FG002|Overall Study|Death|3|||
145332248|NCT01970865|524066347|FG003|Overall Study|Death|6|||
145332249|NCT01970865|524066348|FG004|Overall Study|Death|9|||
145332250|NCT01970865|524066349|FG005|Overall Study|Death|3|||
145332251|NCT01970865|524066350|FG006|Overall Study|Death|2|||
145332252|NCT01970865|524066351|FG007|Overall Study|Death|3|||
145332253|NCT01970865|524066352|FG008|Overall Study|Death|2|||
145332254|NCT01970865|524066353|FG009|Overall Study|Death|2|||
145332255|NCT01970865|524066354|FG010|Overall Study|Death|8|||
145332256|NCT01970865|524066355|FG011|Overall Study|Death|13|||
145332257|NCT01970865|524066356|FG012|Overall Study|Death|25|||
145332258|NCT01970865|524066357|FG013|Overall Study|Death|46|||
145332259|NCT01970865|524066358|FG014|Overall Study|Death|37|||
145332260|NCT01970865|524066359|FG015|Overall Study|Death|22|||
145332261|NCT01970865|524066360|FG016|Overall Study|Death|1|||
145332262|NCT01970865|524066361|FG017|Overall Study|Death|17|||
145332263|NCT01970865|524066344|FG000|Overall Study|Lost to Follow-up|0|||
145332264|NCT01970865|524066345|FG001|Overall Study|Lost to Follow-up|0|||
145332265|NCT01970865|524066346|FG002|Overall Study|Lost to Follow-up|0|||
145332266|NCT01970865|524066347|FG003|Overall Study|Lost to Follow-up|1|||
145332267|NCT01970865|524066348|FG004|Overall Study|Lost to Follow-up|1|||
145332268|NCT01970865|524066349|FG005|Overall Study|Lost to Follow-up|0|||
145332269|NCT01970865|524066350|FG006|Overall Study|Lost to Follow-up|0|||
145332270|NCT01970865|524066351|FG007|Overall Study|Lost to Follow-up|0|||
145332271|NCT01970865|524066352|FG008|Overall Study|Lost to Follow-up|0|||
145332272|NCT01970865|524066353|FG009|Overall Study|Lost to Follow-up|0|||
145332273|NCT01970865|524066354|FG010|Overall Study|Lost to Follow-up|1|||
145332274|NCT01970865|524066355|FG011|Overall Study|Lost to Follow-up|0|||
145332275|NCT01970865|524066356|FG012|Overall Study|Lost to Follow-up|2|||
145332276|NCT01970865|524066357|FG013|Overall Study|Lost to Follow-up|0|||
145332277|NCT01970865|524066358|FG014|Overall Study|Lost to Follow-up|1|||
145332278|NCT01970865|524066359|FG015|Overall Study|Lost to Follow-up|4|||
145332279|NCT01970865|524066360|FG016|Overall Study|Lost to Follow-up|0|||
145332280|NCT01970865|524066361|FG017|Overall Study|Lost to Follow-up|1|||
145332281|NCT01970865|524066344|FG000|Overall Study|Other|0|||
145332282|NCT01970865|524066345|FG001|Overall Study|Other|1|||
145332283|NCT01970865|524066346|FG002|Overall Study|Other|0|||
145332284|NCT01970865|524066347|FG003|Overall Study|Other|1|||
145332285|NCT01970865|524066348|FG004|Overall Study|Other|1|||
145332286|NCT01970865|524066349|FG005|Overall Study|Other|0|||
145332287|NCT01970865|524066350|FG006|Overall Study|Other|1|||
145332288|NCT01970865|524066351|FG007|Overall Study|Other|0|||
145332289|NCT01970865|524066352|FG008|Overall Study|Other|0|||
145332290|NCT01970865|524066353|FG009|Overall Study|Other|0|||
145332291|NCT01970865|524066354|FG010|Overall Study|Other|2|||
145332292|NCT01970865|524066355|FG011|Overall Study|Other|3|||
145332293|NCT01970865|524066356|FG012|Overall Study|Other|8|||
145332294|NCT01970865|524066357|FG013|Overall Study|Other|3|||
145332295|NCT01970865|524066358|FG014|Overall Study|Other|2|||
145332296|NCT01970865|524066359|FG015|Overall Study|Other|3|||
145332297|NCT01970865|524066360|FG016|Overall Study|Other|0|||
145332298|NCT01970865|524066361|FG017|Overall Study|Other|2|||
145332299|NCT01970865|524066344|FG000|Overall Study|Participant refused further follow-up|0|||
145332300|NCT01970865|524066345|FG001|Overall Study|Participant refused further follow-up|0|||
145332301|NCT01970865|524066346|FG002|Overall Study|Participant refused further follow-up|0|||
145332302|NCT01970865|524066347|FG003|Overall Study|Participant refused further follow-up|2|||
145332303|NCT01970865|524066348|FG004|Overall Study|Participant refused further follow-up|3|||
145332304|NCT01970865|524066349|FG005|Overall Study|Participant refused further follow-up|0|||
145332305|NCT01970865|524066350|FG006|Overall Study|Participant refused further follow-up|0|||
145332306|NCT01970865|524066351|FG007|Overall Study|Participant refused further follow-up|0|||
145332307|NCT01970865|524066352|FG008|Overall Study|Participant refused further follow-up|0|||
145332308|NCT01970865|524066353|FG009|Overall Study|Participant refused further follow-up|0|||
145332309|NCT01970865|524066354|FG010|Overall Study|Participant refused further follow-up|1|||
145332310|NCT01970865|524066355|FG011|Overall Study|Participant refused further follow-up|4|||
145332311|NCT01970865|524066356|FG012|Overall Study|Participant refused further follow-up|7|||
145332312|NCT01970865|524066357|FG013|Overall Study|Participant refused further follow-up|8|||
145332313|NCT01970865|524066358|FG014|Overall Study|Participant refused further follow-up|3|||
145332314|NCT01970865|524066359|FG015|Overall Study|Participant refused further follow-up|11|||
145621423|NCT04955626|525126692|FG020|Open-Label Period|Lost to Follow-up|0|||
145621424|NCT04955626|525126693|FG021|Open-Label Period|Lost to Follow-up|0|||
145621425|NCT04955626|525126694|FG022|Open-Label Period|Lost to Follow-up|0|||
145621426|NCT04955626|525126695|FG023|Open-Label Period|Lost to Follow-up|0|||
145621427|NCT04955626|525126696|FG024|Open-Label Period|Lost to Follow-up|0|||
145621428|NCT04955626|525126697|FG025|Open-Label Period|Lost to Follow-up|0|||
145621429|NCT04955626|525126698|FG026|Open-Label Period|Lost to Follow-up|0|||
145621430|NCT04955626|525126699|FG027|Open-Label Period|Lost to Follow-up|0|||
145621431|NCT04955626|525126700|FG028|Open-Label Period|Lost to Follow-up|0|||
145621432|NCT04955626|525126701|FG029|Open-Label Period|Lost to Follow-up|0|||
145621433|NCT04955626|525126702|FG030|Open-Label Period|Lost to Follow-up|0|||
145621434|NCT04955626|525126703|FG031|Open-Label Period|Lost to Follow-up|0|||
145621435|NCT04955626|525126704|FG032|Open-Label Period|Lost to Follow-up|0|||
145621436|NCT04955626|525126705|FG033|Open-Label Period|Lost to Follow-up|0|||
145621437|NCT04955626|525126706|FG034|Open-Label Period|Lost to Follow-up|0|||
145621438|NCT04955626|525126707|FG035|Open-Label Period|Lost to Follow-up|0|||
145621439|NCT04955626|525126672|FG000|Open-Label Period|Protocol Violation|377|||
145621440|NCT04955626|525126673|FG001|Open-Label Period|Protocol Violation|48|||
145621441|NCT04955626|525126674|FG002|Open-Label Period|Protocol Violation|0|||
145621442|NCT04955626|525126675|FG003|Open-Label Period|Protocol Violation|0|||
145621443|NCT04955626|525126676|FG004|Open-Label Period|Protocol Violation|0|||
145621444|NCT04955626|525126677|FG005|Open-Label Period|Protocol Violation|0|||
145621445|NCT04955626|525126678|FG006|Open-Label Period|Protocol Violation|0|||
145621446|NCT04955626|525126679|FG007|Open-Label Period|Protocol Violation|0|||
145621447|NCT04955626|525126680|FG008|Open-Label Period|Protocol Violation|0|||
145621448|NCT04955626|525126681|FG009|Open-Label Period|Protocol Violation|0|||
145621449|NCT04955626|525126682|FG010|Open-Label Period|Protocol Violation|0|||
145621450|NCT04955626|525126683|FG011|Open-Label Period|Protocol Violation|0|||
145621451|NCT04955626|525126684|FG012|Open-Label Period|Protocol Violation|0|||
145621452|NCT04955626|525126685|FG013|Open-Label Period|Protocol Violation|0|||
145621453|NCT04955626|525126686|FG014|Open-Label Period|Protocol Violation|0|||
145621454|NCT04955626|525126687|FG015|Open-Label Period|Protocol Violation|0|||
145621455|NCT04955626|525126688|FG016|Open-Label Period|Protocol Violation|0|||
145621456|NCT04955626|525126689|FG017|Open-Label Period|Protocol Violation|0|||
145621457|NCT04955626|525126690|FG018|Open-Label Period|Protocol Violation|0|||
145621458|NCT04955626|525126691|FG019|Open-Label Period|Protocol Violation|0|||
145621459|NCT04955626|525126692|FG020|Open-Label Period|Protocol Violation|0|||
145621460|NCT04955626|525126693|FG021|Open-Label Period|Protocol Violation|0|||
145621461|NCT04955626|525126694|FG022|Open-Label Period|Protocol Violation|0|||
145621462|NCT04955626|525126695|FG023|Open-Label Period|Protocol Violation|0|||
145621463|NCT04955626|525126696|FG024|Open-Label Period|Protocol Violation|0|||
145621464|NCT04955626|525126697|FG025|Open-Label Period|Protocol Violation|0|||
145621465|NCT04955626|525126698|FG026|Open-Label Period|Protocol Violation|0|||
145621466|NCT04955626|525126699|FG027|Open-Label Period|Protocol Violation|0|||
145621467|NCT04955626|525126700|FG028|Open-Label Period|Protocol Violation|0|||
145621468|NCT04955626|525126701|FG029|Open-Label Period|Protocol Violation|0|||
145621469|NCT04955626|525126702|FG030|Open-Label Period|Protocol Violation|0|||
145621470|NCT04955626|525126703|FG031|Open-Label Period|Protocol Violation|0|||
145621471|NCT04955626|525126704|FG032|Open-Label Period|Protocol Violation|0|||
145621472|NCT04955626|525126705|FG033|Open-Label Period|Protocol Violation|0|||
145621473|NCT04955626|525126706|FG034|Open-Label Period|Protocol Violation|0|||
145621474|NCT04955626|525126707|FG035|Open-Label Period|Protocol Violation|0|||
145621475|NCT04955626|525126672|FG000|Open-Label Period|Death|5|||
145621476|NCT04955626|525126673|FG001|Open-Label Period|Death|5|||
145621477|NCT04955626|525126674|FG002|Open-Label Period|Death|0|||
145621478|NCT04955626|525126675|FG003|Open-Label Period|Death|0|||
145621479|NCT04955626|525126676|FG004|Open-Label Period|Death|0|||
145621480|NCT04955626|525126677|FG005|Open-Label Period|Death|0|||
145332315|NCT01970865|524066360|FG016|Overall Study|Participant refused further follow-up|0|||
145332316|NCT01970865|524066361|FG017|Overall Study|Participant refused further follow-up|6|||
145332317|NCT01946191|524066362|FG000|Allocation|Did not complete orientation|1|||
145332318|NCT01946191|524066363|FG001|Allocation|Did not complete orientation|1|||
145332319|NCT01946191|524066362|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
145621481|NCT04955626|525126678|FG006|Open-Label Period|Death|0|||
145332320|NCT01946191|524066363|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
145332321|NCT01946191|524066362|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
145412691|NCT02949934|524364916|FG003|Bar Laboratory|Adverse Event|0|||
145621482|NCT04955626|525126679|FG007|Open-Label Period|Death|0|||
145621483|NCT04955626|525126680|FG008|Open-Label Period|Death|0|||
145621484|NCT04955626|525126681|FG009|Open-Label Period|Death|0|||
145621485|NCT04955626|525126682|FG010|Open-Label Period|Death|0|||
145621486|NCT04955626|525126683|FG011|Open-Label Period|Death|0|||
145621487|NCT04955626|525126684|FG012|Open-Label Period|Death|0|||
145621488|NCT04955626|525126685|FG013|Open-Label Period|Death|0|||
145621489|NCT04955626|525126686|FG014|Open-Label Period|Death|0|||
145621490|NCT04955626|525126687|FG015|Open-Label Period|Death|0|||
145621491|NCT04955626|525126688|FG016|Open-Label Period|Death|0|||
145332322|NCT01946191|524066363|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
145332323|NCT01946191|524066362|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
145332324|NCT01946191|524066363|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
145332325|NCT02041091|524066364|FG000|Treatment|Adverse Event|3|||
145332326|NCT02041091|524066365|FG001|Treatment|Adverse Event|3|||
145332327|NCT02041091|524066364|FG000|Treatment|Withdrawal by Subject|2|||
145332328|NCT02041091|524066365|FG001|Treatment|Withdrawal by Subject|4|||
145332329|NCT02041091|524066364|FG000|Treatment|Physician Decision|1|||
145332330|NCT02041091|524066365|FG001|Treatment|Physician Decision|0|||
145332331|NCT02041091|524066364|FG000|Treatment|Sponsor Decision|15|||
145332332|NCT02041091|524066365|FG001|Treatment|Sponsor Decision|16|||
145332333|NCT02041091|524066364|FG000|Treatment|Lost to Follow-up|1|||
145332334|NCT02041091|524066365|FG001|Treatment|Lost to Follow-up|0|||
145332335|NCT02041091|524066364|FG000|Optional Safety Extension Period|Adverse Event|4|||
145332336|NCT02041091|524066365|FG001|Optional Safety Extension Period|Adverse Event|2|||
145332337|NCT02041091|524066364|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
145332338|NCT02041091|524066365|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
145332339|NCT02041091|524066364|FG000|Optional Safety Extension Period|Protocol Violation|2|||
145332340|NCT02041091|524066365|FG001|Optional Safety Extension Period|Protocol Violation|0|||
145332341|NCT02041091|524066364|FG000|Optional Safety Extension Period|Physician Decision|2|||
145332342|NCT02041091|524066365|FG001|Optional Safety Extension Period|Physician Decision|1|||
145332343|NCT02041091|524066364|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
145332344|NCT02041091|524066365|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
145332345|NCT02041091|524066364|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
145332346|NCT02041091|524066365|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
145332347|NCT01855074|524066366|FG000|Overall Study|Adverse Event|1|||
145332348|NCT01855074|524066366|FG000|Overall Study|Lost to Follow-up|4|||
145332349|NCT01855074|524066366|FG000|Overall Study|Withdrawal by Subject|8|||
145332350|NCT01855074|524066366|FG000|Overall Study|Started but not treated|1|||
145332351|NCT01150890|524066367|FG000|Overall Study|Other|0|||
145332352|NCT01150890|524066368|FG001|Overall Study|Other|1|||
145332353|NCT01150890|524066369|FG002|Overall Study|Other|0|||
145332354|NCT01150890|524066370|FG003|Overall Study|Other|2|||
145332355|NCT01150890|524066367|FG000|Overall Study|Pregnancy|0|||
145332356|NCT01150890|524066368|FG001|Overall Study|Pregnancy|0|||
145332357|NCT01150890|524066369|FG002|Overall Study|Pregnancy|0|||
145332358|NCT01150890|524066370|FG003|Overall Study|Pregnancy|1|||
145332359|NCT01150890|524066367|FG000|Overall Study|Administrative Decision|4|||
145332360|NCT01150890|524066368|FG001|Overall Study|Administrative Decision|4|||
145332361|NCT01150890|524066369|FG002|Overall Study|Administrative Decision|5|||
145332362|NCT01150890|524066370|FG003|Overall Study|Administrative Decision|6|||
145332363|NCT01150890|524066367|FG000|Overall Study|Ineligibility determined|0|||
145332364|NCT01150890|524066368|FG001|Overall Study|Ineligibility determined|1|||
145332365|NCT01150890|524066369|FG002|Overall Study|Ineligibility determined|0|||
145332366|NCT01150890|524066370|FG003|Overall Study|Ineligibility determined|0|||
145332367|NCT01150890|524066367|FG000|Overall Study|Adverse Event|0|||
145332368|NCT01150890|524066368|FG001|Overall Study|Adverse Event|0|||
145332369|NCT01150890|524066369|FG002|Overall Study|Adverse Event|2|||
145332370|NCT01150890|524066370|FG003|Overall Study|Adverse Event|0|||
145332371|NCT01150890|524066367|FG000|Overall Study|Withdrawal by Subject|0|||
145332372|NCT01150890|524066368|FG001|Overall Study|Withdrawal by Subject|0|||
145332373|NCT01150890|524066369|FG002|Overall Study|Withdrawal by Subject|2|||
145332374|NCT01150890|524066370|FG003|Overall Study|Withdrawal by Subject|1|||
145332375|NCT01150890|524066367|FG000|Overall Study|Disease progression|0|||
145332376|NCT01150890|524066368|FG001|Overall Study|Disease progression|7|||
145332377|NCT01150890|524066369|FG002|Overall Study|Disease progression|3|||
145332378|NCT01150890|524066370|FG003|Overall Study|Disease progression|7|||
145332379|NCT03548064|524068879|FG000|Overall Study|Withdrawal by Subject|0|||
145332380|NCT03548064|524068880|FG001|Overall Study|Withdrawal by Subject|0|||
145332381|NCT03548064|524068881|FG002|Overall Study|Withdrawal by Subject|0|||
145332382|NCT03548064|524068882|FG003|Overall Study|Withdrawal by Subject|1|||
145332383|NCT03548064|524068883|FG004|Overall Study|Withdrawal by Subject|0|||
145332384|NCT03548064|524068884|FG005|Overall Study|Withdrawal by Subject|0|||
145332385|NCT03548064|524068885|FG006|Overall Study|Withdrawal by Subject|0|||
145332386|NCT03548064|524068886|FG007|Overall Study|Withdrawal by Subject|0|||
145332387|NCT03548064|524068879|FG000|Overall Study|Lost to Follow-up|0|||
145332388|NCT03548064|524068880|FG001|Overall Study|Lost to Follow-up|0|||
145332389|NCT03548064|524068881|FG002|Overall Study|Lost to Follow-up|0|||
145332390|NCT03548064|524068882|FG003|Overall Study|Lost to Follow-up|0|||
145332391|NCT03548064|524068883|FG004|Overall Study|Lost to Follow-up|2|||
145332392|NCT03548064|524068884|FG005|Overall Study|Lost to Follow-up|0|||
145332393|NCT03548064|524068885|FG006|Overall Study|Lost to Follow-up|0|||
145332394|NCT03548064|524068886|FG007|Overall Study|Lost to Follow-up|0|||
145332395|NCT03548064|524068879|FG000|Overall Study|Covid-19 Pandemic|0|||
145332396|NCT03548064|524068880|FG001|Overall Study|Covid-19 Pandemic|0|||
145332397|NCT03548064|524068881|FG002|Overall Study|Covid-19 Pandemic|0|||
145332398|NCT03548064|524068882|FG003|Overall Study|Covid-19 Pandemic|0|||
145332399|NCT03548064|524068883|FG004|Overall Study|Covid-19 Pandemic|10|||
145332400|NCT03548064|524068884|FG005|Overall Study|Covid-19 Pandemic|3|||
145332401|NCT03548064|524068885|FG006|Overall Study|Covid-19 Pandemic|0|||
145332402|NCT03548064|524068886|FG007|Overall Study|Covid-19 Pandemic|0|||
145332403|NCT04941729|524068887|FG000|Overall Study|Death|0|||
145332404|NCT04941729|524068888|FG001|Overall Study|Death|1|||
145332405|NCT04941729|524068887|FG000|Overall Study|Study terminated by sponsor|11|||
145332406|NCT04941729|524068888|FG001|Overall Study|Study terminated by sponsor|10|||
145332407|NCT05327816|524068897|FG000|Overall Study|Lost to Follow-up|1|||
145332408|NCT05327816|524068898|FG001|Overall Study|Lost to Follow-up|0|||
145332409|NCT05327816|524068899|FG002|Overall Study|Lost to Follow-up|0|||
145332410|NCT05327816|524068900|FG003|Overall Study|Lost to Follow-up|0|||
145332411|NCT05327816|524068901|FG004|Overall Study|Lost to Follow-up|0|||
145332412|NCT05327816|524068902|FG005|Overall Study|Lost to Follow-up|0|||
145332413|NCT05327816|524068903|FG006|Overall Study|Lost to Follow-up|0|||
145332414|NCT05327816|524068904|FG007|Overall Study|Lost to Follow-up|0|||
145332415|NCT05327816|524068905|FG008|Overall Study|Lost to Follow-up|0|||
145332416|NCT05327816|524068906|FG009|Overall Study|Lost to Follow-up|1|||
145332417|NCT05327816|524068907|FG010|Overall Study|Lost to Follow-up|0|||
145332418|NCT05327816|524068897|FG000|Overall Study|Withdrawal by Subject|0|||
145332419|NCT05327816|524068898|FG001|Overall Study|Withdrawal by Subject|0|||
145332420|NCT05327816|524068899|FG002|Overall Study|Withdrawal by Subject|0|||
145332421|NCT05327816|524068900|FG003|Overall Study|Withdrawal by Subject|0|||
145332422|NCT05327816|524068901|FG004|Overall Study|Withdrawal by Subject|1|||
145332423|NCT05327816|524068902|FG005|Overall Study|Withdrawal by Subject|1|||
145332424|NCT05327816|524068903|FG006|Overall Study|Withdrawal by Subject|0|||
145332425|NCT05327816|524068904|FG007|Overall Study|Withdrawal by Subject|0|||
145332426|NCT05327816|524068905|FG008|Overall Study|Withdrawal by Subject|0|||
145332427|NCT05327816|524068906|FG009|Overall Study|Withdrawal by Subject|0|||
145332428|NCT05327816|524068907|FG010|Overall Study|Withdrawal by Subject|0|||
145332429|NCT05327816|524068897|FG000|Overall Study|Study Terminated by Sponsor|11|||
145332430|NCT05327816|524068898|FG001|Overall Study|Study Terminated by Sponsor|12|||
145332431|NCT05327816|524068899|FG002|Overall Study|Study Terminated by Sponsor|12|||
145332432|NCT05327816|524068900|FG003|Overall Study|Study Terminated by Sponsor|12|||
145332433|NCT05327816|524068901|FG004|Overall Study|Study Terminated by Sponsor|11|||
145332434|NCT05327816|524068902|FG005|Overall Study|Study Terminated by Sponsor|11|||
145332435|NCT05327816|524068903|FG006|Overall Study|Study Terminated by Sponsor|11|||
145332436|NCT05327816|524068904|FG007|Overall Study|Study Terminated by Sponsor|11|||
145332437|NCT05327816|524068905|FG008|Overall Study|Study Terminated by Sponsor|11|||
145332438|NCT05327816|524068906|FG009|Overall Study|Study Terminated by Sponsor|11|||
145332439|NCT05327816|524068907|FG010|Overall Study|Study Terminated by Sponsor|12|||
145332440|NCT05327816|524068897|FG000|Overall Study|Randomized but not treated|0|||
145332441|NCT05327816|524068898|FG001|Overall Study|Randomized but not treated|0|||
145332442|NCT05327816|524068899|FG002|Overall Study|Randomized but not treated|0|||
145332443|NCT05327816|524068900|FG003|Overall Study|Randomized but not treated|0|||
145332444|NCT05327816|524068901|FG004|Overall Study|Randomized but not treated|0|||
145332445|NCT05327816|524068902|FG005|Overall Study|Randomized but not treated|0|||
145332446|NCT05327816|524068903|FG006|Overall Study|Randomized but not treated|1|||
145332447|NCT05327816|524068904|FG007|Overall Study|Randomized but not treated|1|||
145332448|NCT05327816|524068905|FG008|Overall Study|Randomized but not treated|1|||
145332449|NCT05327816|524068906|FG009|Overall Study|Randomized but not treated|0|||
145332450|NCT05327816|524068907|FG010|Overall Study|Randomized but not treated|0|||
145332451|NCT01106014|524068908|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
145332452|NCT01106014|524068909|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
145332453|NCT01106014|524068908|FG000|Overall Study|Adverse Event|78|||
145573040|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
145573041|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
145573042|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
145573043|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
145573044|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
145573045|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
145573046|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
145573047|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573048|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573049|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573050|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573051|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573052|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
145332454|NCT01106014|524068909|FG001|Overall Study|Adverse Event|42|||
145332455|NCT01106014|524068908|FG000|Overall Study|Withdrawal by Subject|43|||
145332456|NCT01106014|524068909|FG001|Overall Study|Withdrawal by Subject|37|||
145332457|NCT01106014|524068908|FG000|Overall Study|Administrative reason|7|||
145332458|NCT01106014|524068909|FG001|Overall Study|Administrative reason|6|||
145332459|NCT01106014|524068908|FG000|Overall Study|Lost to Follow-up|2|||
145332460|NCT01106014|524068909|FG001|Overall Study|Lost to Follow-up|3|||
145332461|NCT00658658|524068916|FG000|Overall Study|Withdrawal by Subject|0|||
145332462|NCT00658658|524068917|FG001|Overall Study|Withdrawal by Subject|1|||
145332463|NCT00658658|524068918|FG002|Overall Study|Withdrawal by Subject|0|||
145332464|NCT00658658|524068919|FG003|Overall Study|Withdrawal by Subject|0|||
145332465|NCT00658658|524068920|FG004|Overall Study|Withdrawal by Subject|0|||
145332466|NCT00658658|524068916|FG000|Overall Study|Death|4|||
145332467|NCT00658658|524068917|FG001|Overall Study|Death|0|||
145332468|NCT00658658|524068918|FG002|Overall Study|Death|0|||
145332469|NCT00658658|524068919|FG003|Overall Study|Death|1|||
145332470|NCT00658658|524068920|FG004|Overall Study|Death|1|||
145332471|NCT00658658|524068916|FG000|Overall Study|Disease Progression|0|||
145332472|NCT00658658|524068917|FG001|Overall Study|Disease Progression|1|||
145332473|NCT00658658|524068918|FG002|Overall Study|Disease Progression|0|||
145332474|NCT00658658|524068919|FG003|Overall Study|Disease Progression|1|||
145332475|NCT00658658|524068920|FG004|Overall Study|Disease Progression|3|||
145332476|NCT00658658|524068916|FG000|Overall Study|Protocol-specified Criteria|1|||
145332477|NCT00658658|524068917|FG001|Overall Study|Protocol-specified Criteria|0|||
145332478|NCT00658658|524068918|FG002|Overall Study|Protocol-specified Criteria|0|||
145332479|NCT00658658|524068919|FG003|Overall Study|Protocol-specified Criteria|0|||
145332480|NCT00658658|524068920|FG004|Overall Study|Protocol-specified Criteria|0|||
145332481|NCT00658658|524068916|FG000|Overall Study|Other|0|||
145332482|NCT00658658|524068917|FG001|Overall Study|Other|0|||
145332483|NCT00658658|524068918|FG002|Overall Study|Other|0|||
145332484|NCT00658658|524068919|FG003|Overall Study|Other|0|||
145332485|NCT00658658|524068920|FG004|Overall Study|Other|1|||
145332486|NCT03986138|524068921|FG000|First MRI Examination|Physician Decision|0|||
145332487|NCT03986138|524068922|FG001|First MRI Examination|Physician Decision|1|||
145332488|NCT03986138|524068921|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
145332489|NCT03986138|524068922|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
145332490|NCT03986138|524068921|FG000|Washout|Withdrawal by Subject|4|||
145332491|NCT03986138|524068922|FG001|Washout|Withdrawal by Subject|5|||
145332492|NCT03986138|524068921|FG000|Washout|Lost to Follow-up|0|||
145332493|NCT03986138|524068922|FG001|Washout|Lost to Follow-up|2|||
145332494|NCT03986138|524068921|FG000|Washout|Adverse Event|1|||
145332495|NCT03986138|524068922|FG001|Washout|Adverse Event|1|||
145332496|NCT03986138|524068921|FG000|Washout|Other reason|5|||
145332497|NCT03986138|524068922|FG001|Washout|Other reason|5|||
145332498|NCT03986138|524068921|FG000|Second MRI Examination|Withdrawal by Subject|0|||
145332499|NCT03986138|524068922|FG001|Second MRI Examination|Withdrawal by Subject|2|||
145332500|NCT04305587|524068924|FG000|Overall Study|Withdrawal by Subject|0|||
145332501|NCT04305587|524068925|FG001|Overall Study|Withdrawal by Subject|0|||
145332502|NCT04305587|524068926|FG002|Overall Study|Withdrawal by Subject|0|||
145332503|NCT04305587|524068927|FG003|Overall Study|Withdrawal by Subject|1|||
145332504|NCT04305587|524068928|FG004|Overall Study|Withdrawal by Subject|0|||
145332505|NCT04305587|524068929|FG005|Overall Study|Withdrawal by Subject|0|||
145332506|NCT04305587|524068930|FG006|Overall Study|Withdrawal by Subject|0|||
145332507|NCT04305587|524068931|FG007|Overall Study|Withdrawal by Subject|0|||
145332508|NCT04305587|524068932|FG008|Overall Study|Withdrawal by Subject|0|||
145332509|NCT01523457|524068933|FG000|Overall Study|Withdrawal by Subject|7|||
145332510|NCT01523457|524068934|FG001|Overall Study|Withdrawal by Subject|2|||
145332511|NCT01367665|524068935|FG000|Overall Study|Death|102|||
145332512|NCT01367665|524068936|FG001|Overall Study|Death|19|||
145332513|NCT01367665|524068935|FG000|Overall Study|Lost to Follow-up|222|||
145332514|NCT01367665|524068936|FG001|Overall Study|Lost to Follow-up|22|||
145332515|NCT01367665|524068935|FG000|Overall Study|Not Done|118|||
145332516|NCT01367665|524068936|FG001|Overall Study|Not Done|14|||
145332517|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
145332518|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
145332519|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
145332520|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
145332521|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
145332522|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
145332523|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
145332524|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
145332525|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
145332526|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
145332527|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
145332528|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
145332529|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
145332530|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
145332531|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
145332532|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
145332533|NCT03182244|524068937|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
145332534|NCT03182244|524068938|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
145332535|NCT03182244|524068937|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
145332536|NCT03182244|524068938|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
145332537|NCT03182244|524068937|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
145332538|NCT03182244|524068938|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
145332539|NCT03182244|524068937|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
145332540|NCT03182244|524068938|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
145332541|NCT03182244|524068937|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
145332542|NCT03182244|524068938|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
145332543|NCT02752906|524068939|FG000|Overall Study|Protocol Violation|2|||
145332544|NCT02752906|524068940|FG001|Overall Study|Protocol Violation|1|||
145332545|NCT02752906|524068939|FG000|Overall Study|Withdrawal by Subject|2|||
145332546|NCT02752906|524068940|FG001|Overall Study|Withdrawal by Subject|2|||
145332547|NCT02752906|524068939|FG000|Overall Study|Lost to Follow-up|3|||
145332548|NCT02752906|524068940|FG001|Overall Study|Lost to Follow-up|2|||
145332549|NCT02492880|524068941|FG000|Overall Study|Lost to Follow-up|1|||
145332550|NCT02492880|524068941|FG000|Overall Study|Protocol Violation|1|||
145332551|NCT01200992|524068942|FG000|Overall Study|Study terminated early|35|||
145332552|NCT01200992|524068943|FG001|Overall Study|Study terminated early|41|||
145332553|NCT01200992|524068942|FG000|Overall Study|Randomized but not treated|2|||
145332554|NCT01200992|524068943|FG001|Overall Study|Randomized but not treated|0|||
145332555|NCT03186781|524068944|FG000|Overall Study|Lost to Follow-up|0|||
145332556|NCT03186781|524068945|FG001|Overall Study|Lost to Follow-up|0|||
145332557|NCT03186781|524068946|FG002|Overall Study|Lost to Follow-up|1|||
145332558|NCT03186781|524068947|FG003|Overall Study|Lost to Follow-up|0|||
145332559|NCT03186781|524068948|FG004|Overall Study|Lost to Follow-up|1|||
145332560|NCT03186781|524068949|FG005|Overall Study|Lost to Follow-up|0|||
145332561|NCT03186781|524068944|FG000|Overall Study|Moved from Area|0|||
145332562|NCT03186781|524068945|FG001|Overall Study|Moved from Area|0|||
145332563|NCT03186781|524068946|FG002|Overall Study|Moved from Area|0|||
145332564|NCT03186781|524068947|FG003|Overall Study|Moved from Area|0|||
145332565|NCT03186781|524068948|FG004|Overall Study|Moved from Area|1|||
145332566|NCT03186781|524068949|FG005|Overall Study|Moved from Area|0|||
145332567|NCT03186781|524068944|FG000|Overall Study|Withdrawal by Subject|0|||
145332568|NCT03186781|524068945|FG001|Overall Study|Withdrawal by Subject|0|||
145332569|NCT03186781|524068946|FG002|Overall Study|Withdrawal by Subject|0|||
145332570|NCT03186781|524068947|FG003|Overall Study|Withdrawal by Subject|0|||
145332571|NCT03186781|524068948|FG004|Overall Study|Withdrawal by Subject|1|||
145332572|NCT03186781|524068949|FG005|Overall Study|Withdrawal by Subject|0|||
145332573|NCT00792935|524068950|FG000|Overall Study|Adverse Event|2|||
145332574|NCT00792935|524068951|FG001|Overall Study|Adverse Event|1|||
145332575|NCT00792935|524068950|FG000|Overall Study|Lost to Follow-up|0|||
145332576|NCT00792935|524068951|FG001|Overall Study|Lost to Follow-up|1|||
145332577|NCT00792935|524068950|FG000|Overall Study|Protocol Violation|2|||
145332578|NCT00792935|524068951|FG001|Overall Study|Protocol Violation|0|||
145332579|NCT00792935|524068950|FG000|Overall Study|Withdrawal by Subject|0|||
145332580|NCT00792935|524068951|FG001|Overall Study|Withdrawal by Subject|1|||
145332581|NCT01345175|524068956|FG000|Overall Study|Physician Decision|0|||
145332582|NCT01345175|524068957|FG001|Overall Study|Physician Decision|1|||
145332583|NCT01345175|524068956|FG000|Overall Study|Withdrawal by Subject|1|||
145332584|NCT01345175|524068957|FG001|Overall Study|Withdrawal by Subject|1|||
145332585|NCT01345175|524068956|FG000|Overall Study|Failed to complete BFI|3|||
145332586|NCT01345175|524068957|FG001|Overall Study|Failed to complete BFI|2|||
145573053|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573054|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573055|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573056|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573057|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573058|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573059|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573060|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
145621492|NCT04955626|525126689|FG017|Open-Label Period|Death|0|||
145621493|NCT04955626|525126690|FG018|Open-Label Period|Death|0|||
145332587|NCT01345175|524068956|FG000|Overall Study|Stopped taking medication|2|||
145332588|NCT01345175|524068957|FG001|Overall Study|Stopped taking medication|2|||
145332589|NCT04112173|524068958|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
145332590|NCT02746471|524068959|FG000|Overall Study|Death|43|||
145332591|NCT02746471|524068959|FG000|Overall Study|Exited before 36 months|1119|||
145332592|NCT04492020|524068961|FG000|Overall Study|Adverse Event|1|||
145332593|NCT04492020|524068962|FG001|Overall Study|Adverse Event|3|||
145332594|NCT04492020|524068961|FG000|Overall Study|Withdrawal by Subject|4|||
145573061|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
145621494|NCT04955626|525126691|FG019|Open-Label Period|Death|0|||
145621495|NCT04955626|525126692|FG020|Open-Label Period|Death|0|||
145332595|NCT04492020|524068962|FG001|Overall Study|Withdrawal by Subject|3|||
145332596|NCT04492020|524068961|FG000|Overall Study|Lost to Follow-up|4|||
145332597|NCT04492020|524068962|FG001|Overall Study|Lost to Follow-up|3|||
145573062|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573063|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
145332598|NCT04492020|524068961|FG000|Overall Study|Protocol Violation|5|||
145332599|NCT04492020|524068962|FG001|Overall Study|Protocol Violation|2|||
145332600|NCT04492020|524068961|FG000|Overall Study|Lack of Qualifying Event|25|||
145332601|NCT04492020|524068962|FG001|Overall Study|Lack of Qualifying Event|27|||
145332602|NCT04492020|524068961|FG000|Overall Study|Non-compliance with Study Drug|2|||
145332603|NCT04492020|524068962|FG001|Overall Study|Non-compliance with Study Drug|1|||
145332604|NCT04594707|524068963|FG000|Overall Study|Adverse Event|0|||
145332605|NCT04594707|524068964|FG001|Overall Study|Adverse Event|0|||
145332606|NCT04594707|524068965|FG002|Overall Study|Adverse Event|1|||
145332607|NCT04594707|524068963|FG000|Overall Study|Death|0|||
145412692|NCT02949934|524364917|FG004|Bar Laboratory|Adverse Event|1|||
145332608|NCT04594707|524068964|FG001|Overall Study|Death|2|||
145332609|NCT04594707|524068965|FG002|Overall Study|Death|2|||
145412693|NCT02949934|524364918|FG005|Bar Laboratory|Adverse Event|0|||
145412694|NCT02949934|524364913|FG000|Bar Laboratory|Protocol Violation|0|||
145412695|NCT02949934|524364914|FG001|Bar Laboratory|Protocol Violation|0|||
145412696|NCT02949934|524364915|FG002|Bar Laboratory|Protocol Violation|0|||
145412697|NCT02949934|524364916|FG003|Bar Laboratory|Protocol Violation|1|||
145412698|NCT02949934|524364917|FG004|Bar Laboratory|Protocol Violation|0|||
145412699|NCT02949934|524364918|FG005|Bar Laboratory|Protocol Violation|0|||
145412700|NCT04069520|524364922|FG000|Overall Study|Lost to Follow-up|0|||
145412701|NCT04069520|524364923|FG001|Overall Study|Lost to Follow-up|2|||
145412702|NCT04069520|524364922|FG000|Overall Study|Withdrawal by Subject|0|||
145412703|NCT04069520|524364923|FG001|Overall Study|Withdrawal by Subject|1|||
145412704|NCT04069520|524364922|FG000|Overall Study|Prior Injury|1|||
145412705|NCT04069520|524364923|FG001|Overall Study|Prior Injury|0|||
145412706|NCT04069520|524364922|FG000|Overall Study|Orthodontia|1|||
145412707|NCT04069520|524364923|FG001|Overall Study|Orthodontia|0|||
145412708|NCT04069520|524364922|FG000|Overall Study|Cut from team|0|||
145412709|NCT04069520|524364923|FG001|Overall Study|Cut from team|2|||
145412710|NCT00849472|524364924|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
145412711|NCT00849472|524364924|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
145412712|NCT00849472|524364924|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
145412713|NCT00849472|524364924|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
145412714|NCT00849472|524364924|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
145412715|NCT00849472|524364924|FG000|Weekly Paclitaxel|Disease Progression|1|||
145412716|NCT00849472|524364924|FG000|Weekly Paclitaxel|Adverse Event|11|||
145412717|NCT00849472|524364924|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
145412718|NCT00849472|524364924|FG000|Weekly Paclitaxel|Physician Decision|3|||
145412719|NCT00849472|524364924|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
145412720|NCT00849472|524364924|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
145412721|NCT00849472|524364924|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
145412722|NCT00849472|524364924|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
145412723|NCT00849472|524364924|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
145412724|NCT00849472|524364924|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
145412725|NCT00849472|524364924|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
145412726|NCT00849472|524364924|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
145412727|NCT00825175|524364925|FG000|Overall Study|Withdrawal by Subject|0|||
145412728|NCT00825175|524364926|FG001|Overall Study|Withdrawal by Subject|5|||
145412729|NCT04822194|524364927|FG000|Overall Study|Withdrawal by Subject|5|||
145412730|NCT04822194|524364928|FG001|Overall Study|Withdrawal by Subject|4|||
145412731|NCT04822194|524364927|FG000|Overall Study|Technical issues with MR scanner|1|||
145412732|NCT04822194|524364928|FG001|Overall Study|Technical issues with MR scanner|0|||
145412733|NCT04822194|524364927|FG000|Overall Study|Lost to Follow-up|5|||
145412734|NCT04822194|524364928|FG001|Overall Study|Lost to Follow-up|7|||
145412735|NCT04615507|524364929|FG000|Period 1|Covid-19 exposure|2|||
145412736|NCT04615507|524364930|FG001|Period 1|Covid-19 exposure|1|||
145412737|NCT04615507|524364929|FG000|Period 2|Covid-19 exposure|0|||
145412738|NCT04615507|524364930|FG001|Period 2|Covid-19 exposure|1|||
145412739|NCT04615507|524364929|FG000|Period 2|Protocol Violation|1|||
145412740|NCT04615507|524364930|FG001|Period 2|Protocol Violation|0|||
145412741|NCT04615507|524364929|FG000|Period 2|Withdrawal by Subject|1|||
145412742|NCT04615507|524364930|FG001|Period 2|Withdrawal by Subject|0|||
145573064|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
145332610|NCT04594707|524068963|FG000|Overall Study|Lung Transplant|0|||
145332611|NCT04594707|524068964|FG001|Overall Study|Lung Transplant|0|||
145332612|NCT04594707|524068965|FG002|Overall Study|Lung Transplant|1|||
145412743|NCT04615507|524364929|FG000|Period 2|Adverse Event|0|||
145412744|NCT04615507|524364930|FG001|Period 2|Adverse Event|1|||
145412745|NCT04615507|524364929|FG000|Period 3|Covid-19 exposure|0|||
145412746|NCT04615507|524364930|FG001|Period 3|Covid-19 exposure|1|||
145412747|NCT00118287|524364933|FG000|Overall Study|Intracranial haemorrhage|1|||
145332613|NCT04594707|524068963|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
145332614|NCT04594707|524068964|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
145412748|NCT00118287|524364933|FG000|Overall Study|Muscle pain|1|||
145412749|NCT03091439|524364938|FG000|Overall Study|Study Terminated by the Sponsor|1|||
145332615|NCT04594707|524068965|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
145332616|NCT04594707|524068963|FG000|Overall Study|Study Terminated By Sponsor|19|||
145332617|NCT04594707|524068964|FG001|Overall Study|Study Terminated By Sponsor|47|||
145332618|NCT04594707|524068965|FG002|Overall Study|Study Terminated By Sponsor|41|||
145332619|NCT04594707|524068963|FG000|Overall Study|Withdrawal by Subject|1|||
145332620|NCT04594707|524068964|FG001|Overall Study|Withdrawal by Subject|0|||
145332621|NCT04594707|524068965|FG002|Overall Study|Withdrawal by Subject|2|||
145332622|NCT04585789|524068966|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
145332623|NCT04585789|524068967|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
145332624|NCT04585789|524068968|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
145332625|NCT04585789|524068966|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
145332626|NCT04585789|524068967|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
145332627|NCT04585789|524068968|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
145332628|NCT01175811|524068969|FG000|Overall Study|Adverse Event|1|||
145332629|NCT01175811|524068970|FG001|Overall Study|Adverse Event|1|||
145332630|NCT01175811|524068969|FG000|Overall Study|Entry criteria not met|3|||
145332631|NCT01175811|524068970|FG001|Overall Study|Entry criteria not met|1|||
145332632|NCT01175811|524068969|FG000|Overall Study|Lack of Efficacy|1|||
145332633|NCT01175811|524068970|FG001|Overall Study|Lack of Efficacy|0|||
145332634|NCT01175811|524068969|FG000|Overall Study|Lost to Follow-up|3|||
145332635|NCT01175811|524068970|FG001|Overall Study|Lost to Follow-up|2|||
145332636|NCT01175811|524068969|FG000|Overall Study|Physician Decision|1|||
145332637|NCT01175811|524068970|FG001|Overall Study|Physician Decision|1|||
145332638|NCT01175811|524068969|FG000|Overall Study|Protocol Violation|1|||
145332639|NCT01175811|524068970|FG001|Overall Study|Protocol Violation|2|||
145332640|NCT01175811|524068969|FG000|Overall Study|Withdrawal by Subject|6|||
145332641|NCT01175811|524068970|FG001|Overall Study|Withdrawal by Subject|7|||
145332642|NCT02628743|524068972|FG000|Overall Study|Other|3|||
145332643|NCT02628743|524068972|FG000|Overall Study|Withdrawal by Subject|50|||
145332644|NCT02628743|524068972|FG000|Overall Study|Study Terminated by Sponsor|76|||
145332645|NCT02628743|524068972|FG000|Overall Study|Physician Decision|2|||
145332646|NCT02534844|524068973|FG000|Part B|Withdrawal by Subject|0|||
145332647|NCT02534844|524068974|FG001|Part B|Withdrawal by Subject|0|||
145332648|NCT02534844|524068975|FG002|Part B|Withdrawal by Subject|0|||
145332649|NCT02534844|524068976|FG003|Part B|Withdrawal by Subject|0|||
145332650|NCT02534844|524068977|FG004|Part B|Withdrawal by Subject|2|||
145332651|NCT02534844|524068978|FG005|Part B|Withdrawal by Subject|1|||
145332652|NCT00655876|524068979|FG000|Overall Study|Protocol Violation|9|||
145332653|NCT00655876|524068980|FG001|Overall Study|Protocol Violation|7|||
145332654|NCT00326963|524068981|FG000|Overall Study|Adverse Event|2|||
145332655|NCT00326963|524068981|FG000|Overall Study|Injection site reaction|1|||
145332656|NCT00326963|524068981|FG000|Overall Study|Death|1|||
145332657|NCT00326963|524068981|FG000|Overall Study|Failure to return|10|||
145332658|NCT00326963|524068981|FG000|Overall Study|Withdrawal by Subject|10|||
145573065|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
145573066|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
145573067|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573068|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
145573069|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573070|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
145573071|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573072|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573073|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573074|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573075|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573076|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573077|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573078|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573079|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573080|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573081|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145621496|NCT04955626|525126693|FG021|Open-Label Period|Death|0|||
145621497|NCT04955626|525126694|FG022|Open-Label Period|Death|0|||
145332659|NCT00326963|524068981|FG000|Overall Study|Refused treatment / did not cooperate|5|||
145332660|NCT00326963|524068981|FG000|Overall Study|Violation of selection criteria at entry|2|||
145332661|NCT00326963|524068981|FG000|Overall Study|Other protocol violation|1|||
145332662|NCT00326963|524068981|FG000|Overall Study|Administrative / other|1|||
145332663|NCT02331368|524068985|FG000|Overall Study|Withdrawal by Subject|3|||
145332664|NCT01763684|524068987|FG000|Overall Study|Study terminated early due to low enrollment|126|||
145332665|NCT01763684|524068988|FG001|Overall Study|Study terminated early due to low enrollment|127|||
145332666|NCT01763684|524068987|FG000|Overall Study|Study surgery not performed|7|||
145332667|NCT01763684|524068988|FG001|Overall Study|Study surgery not performed|6|||
145573082|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145621498|NCT04955626|525126695|FG023|Open-Label Period|Death|0|||
145332668|NCT02987959|524068989|FG000|Overall Study|Grantor stopped supply of drugs|6|||
145332669|NCT02302859|524068991|FG000|Overall Study|Lost Phone|1|||
145332670|NCT02302859|524068992|FG001|Overall Study|Lost Phone|1|||
145332671|NCT02302859|524068991|FG000|Overall Study|Withdrawal by Subject|0|||
145332672|NCT02302859|524068992|FG001|Overall Study|Withdrawal by Subject|1|||
145332673|NCT00643565|524068994|FG000|Overall Study|Death|12|||
145332674|NCT00643565|524068995|FG001|Overall Study|Death|11|||
145332675|NCT00643565|524068994|FG000|Overall Study|Withdrawal by Subject|4|||
145332676|NCT00643565|524068995|FG001|Overall Study|Withdrawal by Subject|1|||
145332677|NCT00643565|524068994|FG000|Overall Study|Lost to Follow-up|0|||
145332678|NCT00643565|524068995|FG001|Overall Study|Lost to Follow-up|6|||
145332679|NCT00643565|524068994|FG000|Overall Study|Other|7|||
145332680|NCT00643565|524068995|FG001|Overall Study|Other|8|||
145332681|NCT00643565|524068994|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
145332682|NCT00643565|524068995|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
145332683|NCT00643565|524068994|FG000|Overall Study|Recurrence of Disease|2|||
145332684|NCT00643565|524068995|FG001|Overall Study|Recurrence of Disease|1|||
145332685|NCT00643565|524068994|FG000|Overall Study|Progression of Disease|18|||
145332686|NCT00643565|524068995|FG001|Overall Study|Progression of Disease|14|||
145332687|NCT00643565|524068994|FG000|Overall Study|Protocol Violation|3|||
145332688|NCT00643565|524068995|FG001|Overall Study|Protocol Violation|0|||
145332689|NCT00643565|524068994|FG000|Overall Study|Did Not Cooperate|0|||
145332690|NCT00643565|524068995|FG001|Overall Study|Did Not Cooperate|1|||
145332691|NCT00643565|524068994|FG000|Overall Study|Administrative|22|||
145332692|NCT00643565|524068995|FG001|Overall Study|Administrative|16|||
145332693|NCT00643565|524068994|FG000|Overall Study|Adverse Event|5|||
145332694|NCT00643565|524068995|FG001|Overall Study|Adverse Event|8|||
145332695|NCT04305496|524069000|FG000|Global Cohort|Withdrawal by Subject|13|||
145332696|NCT04305496|524069001|FG001|Global Cohort|Withdrawal by Subject|6|||
145332697|NCT04305496|524069000|FG000|Global Cohort|Physician Decision|1|||
145332698|NCT04305496|524069001|FG001|Global Cohort|Physician Decision|1|||
145332699|NCT04305496|524069000|FG000|Global Cohort|Subjective disease progression|16|||
145332700|NCT04305496|524069001|FG001|Global Cohort|Subjective disease progression|17|||
145332701|NCT04305496|524069000|FG000|Global Cohort|Condition under investigation worsened|209|||
145332702|NCT04305496|524069001|FG001|Global Cohort|Condition under investigation worsened|273|||
145332703|NCT04305496|524069000|FG000|Global Cohort|Protocol Violation|2|||
145332704|NCT04305496|524069001|FG001|Global Cohort|Protocol Violation|0|||
145332705|NCT04305496|524069000|FG000|Global Cohort|Adverse Event|44|||
145332706|NCT04305496|524069001|FG001|Global Cohort|Adverse Event|6|||
145332707|NCT04305496|524069000|FG000|Global Cohort|Death|3|||
145332708|NCT04305496|524069001|FG001|Global Cohort|Death|2|||
145332709|NCT04305496|524069000|FG000|Global Cohort|Any reason not specifically recorded|4|||
145332710|NCT04305496|524069001|FG001|Global Cohort|Any reason not specifically recorded|5|||
145332711|NCT04305496|524069000|FG000|China Cohort|Any reason not specifically recorded|1|||
145332712|NCT04305496|524069001|FG001|China Cohort|Any reason not specifically recorded|1|||
145332713|NCT04305496|524069000|FG000|China Cohort|Adverse Event|8|||
145332714|NCT04305496|524069001|FG001|China Cohort|Adverse Event|2|||
145332715|NCT04305496|524069000|FG000|China Cohort|Condition under investigation worsened|40|||
145332716|NCT04305496|524069001|FG001|China Cohort|Condition under investigation worsened|47|||
145332717|NCT04305496|524069000|FG000|China Cohort|Subjective disease progression|2|||
145332718|NCT04305496|524069001|FG001|China Cohort|Subjective disease progression|2|||
145332719|NCT04305496|524069000|FG000|China Cohort|Withdrawal by Subject|2|||
145332720|NCT04305496|524069001|FG001|China Cohort|Withdrawal by Subject|1|||
145332721|NCT01157897|524069002|FG000|Overall Study|Lost to Follow-up|2|||
145332722|NCT01157897|524069003|FG001|Overall Study|Lost to Follow-up|0|||
145332723|NCT01157897|524069004|FG002|Overall Study|Lost to Follow-up|0|||
145332724|NCT01157897|524069005|FG003|Overall Study|Lost to Follow-up|1|||
145332725|NCT01157897|524069002|FG000|Overall Study|Relocated|0|||
145332726|NCT01157897|524069003|FG001|Overall Study|Relocated|2|||
145332727|NCT01157897|524069004|FG002|Overall Study|Relocated|0|||
145332728|NCT01157897|524069005|FG003|Overall Study|Relocated|0|||
145332729|NCT00681590|524069006|FG000|Overall Study|Withdrawal by Subject|2|||
145332730|NCT00681590|524069007|FG001|Overall Study|Withdrawal by Subject|12|||
145332731|NCT02912650|524069008|FG000|Overall Study|Withdrawal by Subject|1|||
145332732|NCT02912650|524069009|FG001|Overall Study|Withdrawal by Subject|0|||
145332733|NCT02912650|524069010|FG002|Overall Study|Withdrawal by Subject|1|||
145332734|NCT02912650|524069011|FG003|Overall Study|Withdrawal by Subject|5|||
145332735|NCT02912650|524069008|FG000|Overall Study|Adverse Event|0|||
145573083|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573084|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573085|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145332736|NCT02912650|524069009|FG001|Overall Study|Adverse Event|0|||
145332737|NCT02912650|524069010|FG002|Overall Study|Adverse Event|1|||
145332738|NCT02912650|524069011|FG003|Overall Study|Adverse Event|0|||
145332739|NCT01791153|524069013|FG000|Part 1: Blinded Period|Adverse Event|7|||
145332740|NCT01791153|524069014|FG001|Part 1: Blinded Period|Adverse Event|3|||
145332741|NCT01791153|524069015|FG002|Part 1: Blinded Period|Adverse Event|2|||
145332742|NCT01791153|524069016|FG003|Part 1: Blinded Period|Adverse Event|0|||
145332743|NCT01791153|524069017|FG004|Part 1: Blinded Period|Adverse Event|0|||
145332744|NCT01791153|524069018|FG005|Part 1: Blinded Period|Adverse Event|0|||
145332745|NCT01791153|524069019|FG006|Part 1: Blinded Period|Adverse Event|0|||
145332746|NCT01791153|524069020|FG007|Part 1: Blinded Period|Adverse Event|0|||
145332747|NCT01791153|524069013|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
145332748|NCT01791153|524069014|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
145332749|NCT01791153|524069015|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
145332750|NCT01791153|524069016|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
145332751|NCT01791153|524069017|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
145332752|NCT01791153|524069018|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
145332753|NCT01791153|524069019|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
145332754|NCT01791153|524069020|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
145332755|NCT01791153|524069013|FG000|Part 1: Blinded Period|Non-Compliance|1|||
145332756|NCT01791153|524069014|FG001|Part 1: Blinded Period|Non-Compliance|0|||
145332757|NCT01791153|524069015|FG002|Part 1: Blinded Period|Non-Compliance|0|||
145332758|NCT01791153|524069016|FG003|Part 1: Blinded Period|Non-Compliance|0|||
145332759|NCT01791153|524069017|FG004|Part 1: Blinded Period|Non-Compliance|0|||
145332760|NCT01791153|524069018|FG005|Part 1: Blinded Period|Non-Compliance|0|||
145332761|NCT01791153|524069019|FG006|Part 1: Blinded Period|Non-Compliance|0|||
145332762|NCT01791153|524069020|FG007|Part 1: Blinded Period|Non-Compliance|0|||
145332763|NCT01791153|524069013|FG000|Part 1: Blinded Period|Physician Decision|0|||
145332764|NCT01791153|524069014|FG001|Part 1: Blinded Period|Physician Decision|0|||
145332765|NCT01791153|524069015|FG002|Part 1: Blinded Period|Physician Decision|0|||
145332766|NCT01791153|524069016|FG003|Part 1: Blinded Period|Physician Decision|1|||
145332767|NCT01791153|524069017|FG004|Part 1: Blinded Period|Physician Decision|0|||
145332768|NCT01791153|524069018|FG005|Part 1: Blinded Period|Physician Decision|0|||
145332769|NCT01791153|524069019|FG006|Part 1: Blinded Period|Physician Decision|0|||
145332770|NCT01791153|524069020|FG007|Part 1: Blinded Period|Physician Decision|0|||
145332771|NCT01791153|524069013|FG000|Part 1: Blinded Period|Protocol Violation|0|||
145332772|NCT01791153|524069014|FG001|Part 1: Blinded Period|Protocol Violation|0|||
145332773|NCT01791153|524069015|FG002|Part 1: Blinded Period|Protocol Violation|0|||
145332774|NCT01791153|524069016|FG003|Part 1: Blinded Period|Protocol Violation|1|||
145332775|NCT01791153|524069017|FG004|Part 1: Blinded Period|Protocol Violation|0|||
145332776|NCT01791153|524069018|FG005|Part 1: Blinded Period|Protocol Violation|0|||
145332777|NCT01791153|524069019|FG006|Part 1: Blinded Period|Protocol Violation|0|||
145332778|NCT01791153|524069020|FG007|Part 1: Blinded Period|Protocol Violation|0|||
145332779|NCT01791153|524069013|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
145332780|NCT01791153|524069014|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
145332781|NCT01791153|524069015|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
145332782|NCT01791153|524069016|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
145332783|NCT01791153|524069017|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
145332784|NCT01791153|524069018|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
145332785|NCT01791153|524069019|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
145332786|NCT01791153|524069020|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
145332787|NCT01791153|524069013|FG000|Part 2: Open-label Period|Adverse Event|0|||
145332788|NCT01791153|524069014|FG001|Part 2: Open-label Period|Adverse Event|0|||
145332789|NCT01791153|524069015|FG002|Part 2: Open-label Period|Adverse Event|0|||
145332790|NCT01791153|524069016|FG003|Part 2: Open-label Period|Adverse Event|0|||
145332791|NCT01791153|524069017|FG004|Part 2: Open-label Period|Adverse Event|0|||
145332792|NCT01791153|524069018|FG005|Part 2: Open-label Period|Adverse Event|1|||
145332793|NCT01791153|524069019|FG006|Part 2: Open-label Period|Adverse Event|1|||
145573086|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573087|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573088|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573089|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145573090|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573091|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573092|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145573093|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573094|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145573095|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573096|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573097|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332794|NCT01791153|524069020|FG007|Part 2: Open-label Period|Adverse Event|2|||
145332795|NCT01791153|524069013|FG000|Part 2: Open-label Period|Death|0|||
145332796|NCT01791153|524069014|FG001|Part 2: Open-label Period|Death|0|||
145332797|NCT01791153|524069015|FG002|Part 2: Open-label Period|Death|0|||
145332798|NCT01791153|524069016|FG003|Part 2: Open-label Period|Death|0|||
145573098|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573099|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145621499|NCT04955626|525126696|FG024|Open-Label Period|Death|0|||
145332799|NCT01791153|524069017|FG004|Part 2: Open-label Period|Death|0|||
145412750|NCT03091439|524364939|FG001|Overall Study|Study Terminated by the Sponsor|0|||
145412751|NCT03010501|524364942|FG000|Study Week 1|Withdrawal by Subject|2|||
145412752|NCT03010501|524364943|FG001|Study Week 1|Withdrawal by Subject|1|||
145412753|NCT03010501|524364944|FG002|Study Week 1|Withdrawal by Subject|0|||
145412754|NCT03010501|524364945|FG003|Study Week 1|Withdrawal by Subject|2|||
145412755|NCT03010501|524364946|FG004|Study Week 1|Withdrawal by Subject|0|||
145412756|NCT03010501|524364947|FG005|Study Week 1|Withdrawal by Subject|0|||
145412757|NCT03010501|524364942|FG000|Study Week 3|Withdrawal by Subject|0|||
145412758|NCT03010501|524364943|FG001|Study Week 3|Withdrawal by Subject|0|||
145412759|NCT03010501|524364944|FG002|Study Week 3|Withdrawal by Subject|0|||
145412760|NCT03010501|524364945|FG003|Study Week 3|Withdrawal by Subject|1|||
145412761|NCT03010501|524364946|FG004|Study Week 3|Withdrawal by Subject|0|||
145412762|NCT03010501|524364947|FG005|Study Week 3|Withdrawal by Subject|0|||
145412763|NCT05172570|524364948|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
145412764|NCT05172570|524364949|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
145412765|NCT05172570|524364950|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
145412766|NCT05172570|524364948|FG000|Overall Study|PI Decision due to equipment shortages|0|||
145412767|NCT05172570|524364949|FG001|Overall Study|PI Decision due to equipment shortages|0|||
145412768|NCT05172570|524364950|FG002|Overall Study|PI Decision due to equipment shortages|1|||
145412769|NCT00640289|524364953|FG000|Overall Study|Death|3|||
145412770|NCT00640289|524364953|FG000|Overall Study|Withdrawal by Subject|1|||
145412771|NCT00640289|524364953|FG000|Overall Study|Lost to Follow-up|1|||
145412772|NCT00640289|524364953|FG000|Overall Study|Data collected under different amendment|2|||
145573100|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573101|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573102|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332800|NCT01791153|524069018|FG005|Part 2: Open-label Period|Death|1|||
145332801|NCT01791153|524069019|FG006|Part 2: Open-label Period|Death|1|||
145332802|NCT01791153|524069020|FG007|Part 2: Open-label Period|Death|1|||
145332803|NCT01791153|524069013|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
145332804|NCT01791153|524069014|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
145332805|NCT01791153|524069015|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
145332806|NCT01791153|524069016|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
145332807|NCT01791153|524069017|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
145332808|NCT01791153|524069018|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
145332809|NCT01791153|524069019|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
145332810|NCT01791153|524069020|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
145332811|NCT01791153|524069013|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
145332812|NCT01791153|524069014|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
145332813|NCT01791153|524069015|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
145332814|NCT01791153|524069016|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
145332815|NCT01791153|524069017|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
145332816|NCT01791153|524069018|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
145332817|NCT01791153|524069019|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
145332818|NCT01791153|524069020|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
145332819|NCT01791153|524069013|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
145332820|NCT01791153|524069014|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
145332821|NCT01791153|524069015|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
145332822|NCT01791153|524069016|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
145332823|NCT01791153|524069017|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
145332824|NCT01791153|524069018|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
145332825|NCT01791153|524069019|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
145332826|NCT01791153|524069020|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
145332827|NCT01791153|524069013|FG000|Part 2: Open-label Period|Physician Decision|0|||
145332828|NCT01791153|524069014|FG001|Part 2: Open-label Period|Physician Decision|0|||
145332829|NCT01791153|524069015|FG002|Part 2: Open-label Period|Physician Decision|0|||
145332830|NCT01791153|524069016|FG003|Part 2: Open-label Period|Physician Decision|0|||
145332831|NCT01791153|524069017|FG004|Part 2: Open-label Period|Physician Decision|1|||
145332832|NCT01791153|524069018|FG005|Part 2: Open-label Period|Physician Decision|1|||
145332833|NCT01791153|524069019|FG006|Part 2: Open-label Period|Physician Decision|0|||
145573103|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573104|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332834|NCT01791153|524069020|FG007|Part 2: Open-label Period|Physician Decision|0|||
145332835|NCT02562482|524069021|FG000|Overall Study|Enrolled, but did not receive product|4|||
145332836|NCT02562482|524069022|FG001|Overall Study|Enrolled, but did not receive product|0|||
145332837|NCT02562482|524069021|FG000|Overall Study|Lost to Follow-up|9|||
145412773|NCT00640289|524364953|FG000|Overall Study|Transferred to another center|1|||
145412774|NCT00640289|524364953|FG000|Overall Study|Missing status|5|||
145412775|NCT03550209|524364955|FG000|Overall Study|Lost to Follow-up|1|||
145573105|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332838|NCT02562482|524069022|FG001|Overall Study|Lost to Follow-up|6|||
145332839|NCT02562482|524069021|FG000|Overall Study|Moved from area|2|||
145332840|NCT02562482|524069022|FG001|Overall Study|Moved from area|3|||
145332841|NCT02562482|524069021|FG000|Overall Study|Withdrawal by Subject|5|||
145332842|NCT02562482|524069022|FG001|Overall Study|Withdrawal by Subject|3|||
145332843|NCT02562482|524069021|FG000|Overall Study|Physician Decision|1|||
145332844|NCT02562482|524069022|FG001|Overall Study|Physician Decision|3|||
145332845|NCT02562482|524069021|FG000|Overall Study|Illness/Injury unrelated to product|0|||
145332846|NCT02562482|524069022|FG001|Overall Study|Illness/Injury unrelated to product|1|||
145332847|NCT04135196|524069033|FG000|Overall Study|Lost to Follow-up|8|||
145332848|NCT04135196|524069034|FG001|Overall Study|Lost to Follow-up|7|||
145332849|NCT04135196|524069035|FG002|Overall Study|Lost to Follow-up|8|||
145332850|NCT04135196|524069036|FG003|Overall Study|Lost to Follow-up|9|||
145332851|NCT04135196|524069037|FG004|Overall Study|Lost to Follow-up|1|||
145332852|NCT04135196|524069033|FG000|Overall Study|Pregnancy|0|||
145332853|NCT04135196|524069034|FG001|Overall Study|Pregnancy|0|||
145332854|NCT04135196|524069035|FG002|Overall Study|Pregnancy|1|||
145332855|NCT04135196|524069036|FG003|Overall Study|Pregnancy|0|||
145332856|NCT04135196|524069037|FG004|Overall Study|Pregnancy|0|||
145332857|NCT04135196|524069033|FG000|Overall Study|Withdrawal by Subject|0|||
145332858|NCT04135196|524069034|FG001|Overall Study|Withdrawal by Subject|0|||
145332859|NCT04135196|524069035|FG002|Overall Study|Withdrawal by Subject|0|||
145332860|NCT04135196|524069036|FG003|Overall Study|Withdrawal by Subject|0|||
145332861|NCT04135196|524069037|FG004|Overall Study|Withdrawal by Subject|1|||
145332862|NCT01121666|524069038|FG000|Overall Study|Protocol Violation|29|||
145332863|NCT01121666|524069039|FG001|Overall Study|Protocol Violation|10|||
145332864|NCT01083810|524069042|FG000|Overall Study|Lost to Follow-up|23|||
145332865|NCT01083810|524069043|FG001|Overall Study|Lost to Follow-up|11|||
145332866|NCT01083810|524069044|FG002|Overall Study|Lost to Follow-up|4|||
145332867|NCT01083810|524069042|FG000|Overall Study|Adverse Event|15|||
145573106|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332868|NCT01083810|524069043|FG001|Overall Study|Adverse Event|11|||
145332869|NCT01083810|524069044|FG002|Overall Study|Adverse Event|4|||
145332870|NCT01083810|524069042|FG000|Overall Study|Withdrawal by Subject|7|||
145332871|NCT01083810|524069043|FG001|Overall Study|Withdrawal by Subject|2|||
145332872|NCT01083810|524069044|FG002|Overall Study|Withdrawal by Subject|4|||
145332873|NCT01083810|524069042|FG000|Overall Study|Reason not reported|6|||
145332874|NCT01083810|524069043|FG001|Overall Study|Reason not reported|1|||
145332875|NCT01083810|524069044|FG002|Overall Study|Reason not reported|1|||
145332876|NCT01083810|524069042|FG000|Overall Study|Non-compliance|4|||
145332877|NCT01083810|524069043|FG001|Overall Study|Non-compliance|7|||
145332878|NCT01083810|524069044|FG002|Overall Study|Non-compliance|2|||
145332879|NCT01083810|524069042|FG000|Overall Study|Simplification|4|||
145332880|NCT01083810|524069043|FG001|Overall Study|Simplification|1|||
145332881|NCT01083810|524069044|FG002|Overall Study|Simplification|0|||
145332882|NCT01083810|524069042|FG000|Overall Study|Death|2|||
145332883|NCT01083810|524069043|FG001|Overall Study|Death|2|||
145332884|NCT01083810|524069044|FG002|Overall Study|Death|3|||
145332885|NCT01083810|524069042|FG000|Overall Study|Co-morbidities|1|||
145332886|NCT01083810|524069043|FG001|Overall Study|Co-morbidities|0|||
145332887|NCT01083810|524069044|FG002|Overall Study|Co-morbidities|0|||
145332888|NCT01083810|524069042|FG000|Overall Study|Participation in study|1|||
145332889|NCT01083810|524069043|FG001|Overall Study|Participation in study|0|||
145332890|NCT01083810|524069044|FG002|Overall Study|Participation in study|0|||
145332891|NCT01083810|524069042|FG000|Overall Study|Therapy break|1|||
145332892|NCT01083810|524069043|FG001|Overall Study|Therapy break|2|||
145332893|NCT01083810|524069044|FG002|Overall Study|Therapy break|2|||
145332894|NCT01083810|524069042|FG000|Overall Study|Virologic failure|1|||
145332895|NCT01083810|524069043|FG001|Overall Study|Virologic failure|8|||
145332896|NCT01083810|524069044|FG002|Overall Study|Virologic failure|0|||
145573107|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573108|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332897|NCT02132754|524069045|FG000|Overall Study|Adverse Event|0|||
145332898|NCT02132754|524069046|FG001|Overall Study|Adverse Event|0|||
145332899|NCT02132754|524069047|FG002|Overall Study|Adverse Event|0|||
145412776|NCT03550209|524364956|FG001|Overall Study|Lost to Follow-up|0|||
145573109|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332900|NCT02132754|524069048|FG003|Overall Study|Adverse Event|0|||
145332901|NCT02132754|524069049|FG004|Overall Study|Adverse Event|0|||
145332902|NCT02132754|524069050|FG005|Overall Study|Adverse Event|0|||
145332903|NCT02132754|524069051|FG006|Overall Study|Adverse Event|0|||
145412777|NCT03550209|524364957|FG002|Overall Study|Lost to Follow-up|1|||
145332904|NCT02132754|524069052|FG007|Overall Study|Adverse Event|0|||
145332905|NCT02132754|524069053|FG008|Overall Study|Adverse Event|0|||
145332906|NCT02132754|524069054|FG009|Overall Study|Adverse Event|0|||
145332907|NCT02132754|524069055|FG010|Overall Study|Adverse Event|0|||
145332908|NCT02132754|524069056|FG011|Overall Study|Adverse Event|0|||
145332909|NCT02132754|524069057|FG012|Overall Study|Adverse Event|0|||
145332910|NCT02132754|524069058|FG013|Overall Study|Adverse Event|0|||
145573110|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573111|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332911|NCT02132754|524069059|FG014|Overall Study|Adverse Event|0|||
145332912|NCT02132754|524069060|FG015|Overall Study|Adverse Event|0|||
145332913|NCT02132754|524069061|FG016|Overall Study|Adverse Event|0|||
145332914|NCT02132754|524069062|FG017|Overall Study|Adverse Event|1|||
145332915|NCT02132754|524069063|FG018|Overall Study|Adverse Event|0|||
145332916|NCT02132754|524069064|FG019|Overall Study|Adverse Event|0|||
145332917|NCT02132754|524069065|FG020|Overall Study|Adverse Event|0|||
145332918|NCT02132754|524069066|FG021|Overall Study|Adverse Event|0|||
145332919|NCT02132754|524069067|FG022|Overall Study|Adverse Event|0|||
145332920|NCT02132754|524069068|FG023|Overall Study|Adverse Event|0|||
145332921|NCT02132754|524069069|FG024|Overall Study|Adverse Event|0|||
145332922|NCT02132754|524069070|FG025|Overall Study|Adverse Event|1|||
145332923|NCT02132754|524069071|FG026|Overall Study|Adverse Event|1|||
145332924|NCT02132754|524069072|FG027|Overall Study|Adverse Event|0|||
145332925|NCT02132754|524069073|FG028|Overall Study|Adverse Event|0|||
145332926|NCT02132754|524069074|FG029|Overall Study|Adverse Event|0|||
145332927|NCT02132754|524069075|FG030|Overall Study|Adverse Event|1|||
145332928|NCT02132754|524069076|FG031|Overall Study|Adverse Event|0|||
145332929|NCT02132754|524069077|FG032|Overall Study|Adverse Event|1|||
145332930|NCT02132754|524069078|FG033|Overall Study|Adverse Event|1|||
145332931|NCT02132754|524069045|FG000|Overall Study|Clinical Progression|0|||
145332932|NCT02132754|524069046|FG001|Overall Study|Clinical Progression|0|||
145332933|NCT02132754|524069047|FG002|Overall Study|Clinical Progression|0|||
145332934|NCT02132754|524069048|FG003|Overall Study|Clinical Progression|0|||
145332935|NCT02132754|524069049|FG004|Overall Study|Clinical Progression|0|||
145332936|NCT02132754|524069050|FG005|Overall Study|Clinical Progression|0|||
145332937|NCT02132754|524069051|FG006|Overall Study|Clinical Progression|0|||
145332938|NCT02132754|524069052|FG007|Overall Study|Clinical Progression|0|||
145332939|NCT02132754|524069053|FG008|Overall Study|Clinical Progression|0|||
145332940|NCT02132754|524069054|FG009|Overall Study|Clinical Progression|1|||
145332941|NCT02132754|524069055|FG010|Overall Study|Clinical Progression|0|||
145332942|NCT02132754|524069056|FG011|Overall Study|Clinical Progression|0|||
145332943|NCT02132754|524069057|FG012|Overall Study|Clinical Progression|0|||
145332944|NCT02132754|524069058|FG013|Overall Study|Clinical Progression|0|||
145332945|NCT02132754|524069059|FG014|Overall Study|Clinical Progression|0|||
145332946|NCT02132754|524069060|FG015|Overall Study|Clinical Progression|0|||
145332947|NCT02132754|524069061|FG016|Overall Study|Clinical Progression|1|||
145332948|NCT02132754|524069062|FG017|Overall Study|Clinical Progression|1|||
145332949|NCT02132754|524069063|FG018|Overall Study|Clinical Progression|0|||
145332950|NCT02132754|524069064|FG019|Overall Study|Clinical Progression|1|||
145332951|NCT02132754|524069065|FG020|Overall Study|Clinical Progression|0|||
145332952|NCT02132754|524069066|FG021|Overall Study|Clinical Progression|0|||
145332953|NCT02132754|524069067|FG022|Overall Study|Clinical Progression|1|||
145332954|NCT02132754|524069068|FG023|Overall Study|Clinical Progression|0|||
145332955|NCT02132754|524069069|FG024|Overall Study|Clinical Progression|1|||
145332956|NCT02132754|524069070|FG025|Overall Study|Clinical Progression|1|||
145332957|NCT02132754|524069071|FG026|Overall Study|Clinical Progression|0|||
145332958|NCT02132754|524069072|FG027|Overall Study|Clinical Progression|1|||
145332959|NCT02132754|524069073|FG028|Overall Study|Clinical Progression|1|||
145332960|NCT02132754|524069074|FG029|Overall Study|Clinical Progression|0|||
145332961|NCT02132754|524069075|FG030|Overall Study|Clinical Progression|1|||
145332962|NCT02132754|524069076|FG031|Overall Study|Clinical Progression|0|||
145332963|NCT02132754|524069077|FG032|Overall Study|Clinical Progression|0|||
145332964|NCT02132754|524069078|FG033|Overall Study|Clinical Progression|2|||
145332965|NCT02132754|524069045|FG000|Overall Study|Death|0|||
145332966|NCT02132754|524069046|FG001|Overall Study|Death|0|||
145332967|NCT02132754|524069047|FG002|Overall Study|Death|0|||
145332968|NCT02132754|524069048|FG003|Overall Study|Death|0|||
145332969|NCT02132754|524069049|FG004|Overall Study|Death|0|||
145332970|NCT02132754|524069050|FG005|Overall Study|Death|0|||
145332971|NCT02132754|524069051|FG006|Overall Study|Death|0|||
145332972|NCT02132754|524069052|FG007|Overall Study|Death|0|||
145332973|NCT02132754|524069053|FG008|Overall Study|Death|0|||
145573112|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573113|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145332974|NCT02132754|524069054|FG009|Overall Study|Death|0|||
145621500|NCT04955626|525126697|FG025|Open-Label Period|Death|0|||
145332975|NCT02132754|524069055|FG010|Overall Study|Death|0|||
145412778|NCT03550209|524364958|FG003|Overall Study|Lost to Follow-up|0|||
145332976|NCT02132754|524069056|FG011|Overall Study|Death|0|||
145332977|NCT02132754|524069057|FG012|Overall Study|Death|0|||
145332978|NCT02132754|524069058|FG013|Overall Study|Death|0|||
145332979|NCT02132754|524069059|FG014|Overall Study|Death|0|||
145332980|NCT02132754|524069060|FG015|Overall Study|Death|1|||
145332981|NCT02132754|524069061|FG016|Overall Study|Death|0|||
145332982|NCT02132754|524069062|FG017|Overall Study|Death|0|||
145332983|NCT02132754|524069063|FG018|Overall Study|Death|0|||
145332984|NCT02132754|524069064|FG019|Overall Study|Death|1|||
145332985|NCT02132754|524069065|FG020|Overall Study|Death|0|||
145332986|NCT02132754|524069066|FG021|Overall Study|Death|1|||
145332987|NCT02132754|524069067|FG022|Overall Study|Death|0|||
145332988|NCT02132754|524069068|FG023|Overall Study|Death|0|||
145332989|NCT02132754|524069069|FG024|Overall Study|Death|0|||
145332990|NCT02132754|524069070|FG025|Overall Study|Death|0|||
145332991|NCT02132754|524069071|FG026|Overall Study|Death|1|||
145332992|NCT02132754|524069072|FG027|Overall Study|Death|0|||
145332993|NCT02132754|524069073|FG028|Overall Study|Death|0|||
145332994|NCT02132754|524069074|FG029|Overall Study|Death|0|||
145332995|NCT02132754|524069075|FG030|Overall Study|Death|0|||
145332996|NCT02132754|524069076|FG031|Overall Study|Death|0|||
145332997|NCT02132754|524069077|FG032|Overall Study|Death|0|||
145332998|NCT02132754|524069078|FG033|Overall Study|Death|2|||
145332999|NCT02132754|524069045|FG000|Overall Study|Excluded Medication|0|||
145333000|NCT02132754|524069046|FG001|Overall Study|Excluded Medication|0|||
145333001|NCT02132754|524069047|FG002|Overall Study|Excluded Medication|0|||
145333002|NCT02132754|524069048|FG003|Overall Study|Excluded Medication|0|||
145333003|NCT02132754|524069049|FG004|Overall Study|Excluded Medication|0|||
145333004|NCT02132754|524069050|FG005|Overall Study|Excluded Medication|0|||
145333005|NCT02132754|524069051|FG006|Overall Study|Excluded Medication|0|||
145333006|NCT02132754|524069052|FG007|Overall Study|Excluded Medication|0|||
145333007|NCT02132754|524069053|FG008|Overall Study|Excluded Medication|0|||
145333008|NCT02132754|524069054|FG009|Overall Study|Excluded Medication|0|||
145333009|NCT02132754|524069055|FG010|Overall Study|Excluded Medication|0|||
145333010|NCT02132754|524069056|FG011|Overall Study|Excluded Medication|0|||
145333011|NCT02132754|524069057|FG012|Overall Study|Excluded Medication|0|||
145333012|NCT02132754|524069058|FG013|Overall Study|Excluded Medication|0|||
145333013|NCT02132754|524069059|FG014|Overall Study|Excluded Medication|0|||
145333014|NCT02132754|524069060|FG015|Overall Study|Excluded Medication|0|||
145333015|NCT02132754|524069061|FG016|Overall Study|Excluded Medication|0|||
145333016|NCT02132754|524069062|FG017|Overall Study|Excluded Medication|0|||
145333017|NCT02132754|524069063|FG018|Overall Study|Excluded Medication|0|||
145333018|NCT02132754|524069064|FG019|Overall Study|Excluded Medication|0|||
145333019|NCT02132754|524069065|FG020|Overall Study|Excluded Medication|1|||
145333020|NCT02132754|524069066|FG021|Overall Study|Excluded Medication|0|||
145333021|NCT02132754|524069067|FG022|Overall Study|Excluded Medication|0|||
145333022|NCT02132754|524069068|FG023|Overall Study|Excluded Medication|0|||
145333023|NCT02132754|524069069|FG024|Overall Study|Excluded Medication|0|||
145333024|NCT02132754|524069070|FG025|Overall Study|Excluded Medication|0|||
145333025|NCT02132754|524069071|FG026|Overall Study|Excluded Medication|0|||
145333026|NCT02132754|524069072|FG027|Overall Study|Excluded Medication|0|||
145333027|NCT02132754|524069073|FG028|Overall Study|Excluded Medication|0|||
145333028|NCT02132754|524069074|FG029|Overall Study|Excluded Medication|0|||
145333029|NCT02132754|524069075|FG030|Overall Study|Excluded Medication|0|||
145333030|NCT02132754|524069076|FG031|Overall Study|Excluded Medication|0|||
145333031|NCT02132754|524069077|FG032|Overall Study|Excluded Medication|0|||
145333032|NCT02132754|524069078|FG033|Overall Study|Excluded Medication|1|||
145333033|NCT02132754|524069045|FG000|Overall Study|Physician Decision|0|||
145333034|NCT02132754|524069046|FG001|Overall Study|Physician Decision|0|||
145333035|NCT02132754|524069047|FG002|Overall Study|Physician Decision|0|||
145333036|NCT02132754|524069048|FG003|Overall Study|Physician Decision|0|||
145333037|NCT02132754|524069049|FG004|Overall Study|Physician Decision|0|||
145333038|NCT02132754|524069050|FG005|Overall Study|Physician Decision|0|||
145333039|NCT02132754|524069051|FG006|Overall Study|Physician Decision|0|||
145333040|NCT02132754|524069052|FG007|Overall Study|Physician Decision|0|||
145333041|NCT02132754|524069053|FG008|Overall Study|Physician Decision|0|||
145333042|NCT02132754|524069054|FG009|Overall Study|Physician Decision|1|||
145573114|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145621501|NCT04955626|525126698|FG026|Open-Label Period|Death|0|||
145333043|NCT02132754|524069055|FG010|Overall Study|Physician Decision|0|||
145333044|NCT02132754|524069056|FG011|Overall Study|Physician Decision|1|||
145333045|NCT02132754|524069057|FG012|Overall Study|Physician Decision|1|||
145412779|NCT03550209|524364955|FG000|Overall Study|Withdrawal by Subject|0|||
145412780|NCT03550209|524364956|FG001|Overall Study|Withdrawal by Subject|3|||
145412781|NCT03550209|524364957|FG002|Overall Study|Withdrawal by Subject|1|||
145333046|NCT02132754|524069058|FG013|Overall Study|Physician Decision|0|||
145333047|NCT02132754|524069059|FG014|Overall Study|Physician Decision|0|||
145333048|NCT02132754|524069060|FG015|Overall Study|Physician Decision|1|||
145333049|NCT02132754|524069061|FG016|Overall Study|Physician Decision|0|||
145333050|NCT02132754|524069062|FG017|Overall Study|Physician Decision|0|||
145333051|NCT02132754|524069063|FG018|Overall Study|Physician Decision|0|||
145333052|NCT02132754|524069064|FG019|Overall Study|Physician Decision|0|||
145333053|NCT02132754|524069065|FG020|Overall Study|Physician Decision|0|||
145333054|NCT02132754|524069066|FG021|Overall Study|Physician Decision|0|||
145333055|NCT02132754|524069067|FG022|Overall Study|Physician Decision|0|||
145333056|NCT02132754|524069068|FG023|Overall Study|Physician Decision|0|||
145333057|NCT02132754|524069069|FG024|Overall Study|Physician Decision|1|||
145333058|NCT02132754|524069070|FG025|Overall Study|Physician Decision|0|||
145333059|NCT02132754|524069071|FG026|Overall Study|Physician Decision|0|||
145333060|NCT02132754|524069072|FG027|Overall Study|Physician Decision|0|||
145573115|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573116|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
145573117|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573118|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
145573119|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573120|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573121|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573122|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573123|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573124|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573125|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573126|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573127|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573128|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573129|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573130|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573131|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573132|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573133|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573134|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573135|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145573136|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
145573137|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
145573138|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
145573139|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
145333061|NCT02132754|524069073|FG028|Overall Study|Physician Decision|0|||
145333062|NCT02132754|524069074|FG029|Overall Study|Physician Decision|0|||
145333063|NCT02132754|524069075|FG030|Overall Study|Physician Decision|0|||
145333064|NCT02132754|524069076|FG031|Overall Study|Physician Decision|1|||
145333065|NCT02132754|524069077|FG032|Overall Study|Physician Decision|0|||
145333066|NCT02132754|524069078|FG033|Overall Study|Physician Decision|3|||
145333067|NCT02132754|524069045|FG000|Overall Study|Progressive Disease|1|||
145333068|NCT02132754|524069046|FG001|Overall Study|Progressive Disease|1|||
145333069|NCT02132754|524069047|FG002|Overall Study|Progressive Disease|1|||
145333070|NCT02132754|524069048|FG003|Overall Study|Progressive Disease|1|||
145333071|NCT02132754|524069049|FG004|Overall Study|Progressive Disease|1|||
145333072|NCT02132754|524069050|FG005|Overall Study|Progressive Disease|1|||
145333073|NCT02132754|524069051|FG006|Overall Study|Progressive Disease|1|||
145333074|NCT02132754|524069052|FG007|Overall Study|Progressive Disease|1|||
145333075|NCT02132754|524069053|FG008|Overall Study|Progressive Disease|1|||
145333076|NCT02132754|524069054|FG009|Overall Study|Progressive Disease|3|||
145333077|NCT02132754|524069055|FG010|Overall Study|Progressive Disease|3|||
145333078|NCT02132754|524069056|FG011|Overall Study|Progressive Disease|2|||
145333079|NCT02132754|524069057|FG012|Overall Study|Progressive Disease|2|||
145333080|NCT02132754|524069058|FG013|Overall Study|Progressive Disease|3|||
145333081|NCT02132754|524069059|FG014|Overall Study|Progressive Disease|2|||
145333082|NCT02132754|524069060|FG015|Overall Study|Progressive Disease|1|||
145333083|NCT02132754|524069061|FG016|Overall Study|Progressive Disease|2|||
145333084|NCT02132754|524069062|FG017|Overall Study|Progressive Disease|1|||
145333085|NCT02132754|524069063|FG018|Overall Study|Progressive Disease|3|||
145333086|NCT02132754|524069064|FG019|Overall Study|Progressive Disease|1|||
145333087|NCT02132754|524069065|FG020|Overall Study|Progressive Disease|1|||
145333088|NCT02132754|524069066|FG021|Overall Study|Progressive Disease|3|||
145333089|NCT02132754|524069067|FG022|Overall Study|Progressive Disease|2|||
145333090|NCT02132754|524069068|FG023|Overall Study|Progressive Disease|3|||
145333091|NCT02132754|524069069|FG024|Overall Study|Progressive Disease|0|||
145333092|NCT02132754|524069070|FG025|Overall Study|Progressive Disease|1|||
145333093|NCT02132754|524069071|FG026|Overall Study|Progressive Disease|2|||
145333094|NCT02132754|524069072|FG027|Overall Study|Progressive Disease|1|||
145333095|NCT02132754|524069073|FG028|Overall Study|Progressive Disease|2|||
145333096|NCT02132754|524069074|FG029|Overall Study|Progressive Disease|3|||
145333097|NCT02132754|524069075|FG030|Overall Study|Progressive Disease|1|||
145333098|NCT02132754|524069076|FG031|Overall Study|Progressive Disease|1|||
145333099|NCT02132754|524069077|FG032|Overall Study|Progressive Disease|3|||
145333100|NCT02132754|524069078|FG033|Overall Study|Progressive Disease|6|||
145333101|NCT02132754|524069045|FG000|Overall Study|Screen Failure|0|||
145333102|NCT02132754|524069046|FG001|Overall Study|Screen Failure|0|||
145333103|NCT02132754|524069047|FG002|Overall Study|Screen Failure|0|||
145333104|NCT02132754|524069048|FG003|Overall Study|Screen Failure|0|||
145333105|NCT02132754|524069049|FG004|Overall Study|Screen Failure|0|||
145333106|NCT02132754|524069050|FG005|Overall Study|Screen Failure|0|||
145333107|NCT02132754|524069051|FG006|Overall Study|Screen Failure|0|||
145333108|NCT02132754|524069052|FG007|Overall Study|Screen Failure|0|||
145333109|NCT02132754|524069053|FG008|Overall Study|Screen Failure|0|||
145333110|NCT02132754|524069054|FG009|Overall Study|Screen Failure|0|||
145333111|NCT02132754|524069055|FG010|Overall Study|Screen Failure|0|||
145333112|NCT02132754|524069056|FG011|Overall Study|Screen Failure|0|||
145333113|NCT02132754|524069057|FG012|Overall Study|Screen Failure|0|||
145333114|NCT02132754|524069058|FG013|Overall Study|Screen Failure|0|||
145333115|NCT02132754|524069059|FG014|Overall Study|Screen Failure|0|||
145333116|NCT02132754|524069060|FG015|Overall Study|Screen Failure|0|||
145333117|NCT02132754|524069061|FG016|Overall Study|Screen Failure|0|||
145333118|NCT02132754|524069062|FG017|Overall Study|Screen Failure|0|||
145333119|NCT02132754|524069063|FG018|Overall Study|Screen Failure|0|||
145333120|NCT02132754|524069064|FG019|Overall Study|Screen Failure|1|||
145333121|NCT02132754|524069065|FG020|Overall Study|Screen Failure|0|||
145333122|NCT02132754|524069066|FG021|Overall Study|Screen Failure|1|||
145333123|NCT02132754|524069067|FG022|Overall Study|Screen Failure|0|||
145333124|NCT02132754|524069068|FG023|Overall Study|Screen Failure|0|||
145333125|NCT02132754|524069069|FG024|Overall Study|Screen Failure|0|||
145333126|NCT02132754|524069070|FG025|Overall Study|Screen Failure|0|||
145333127|NCT02132754|524069071|FG026|Overall Study|Screen Failure|0|||
145333128|NCT02132754|524069072|FG027|Overall Study|Screen Failure|0|||
145333129|NCT02132754|524069073|FG028|Overall Study|Screen Failure|0|||
145333130|NCT02132754|524069074|FG029|Overall Study|Screen Failure|0|||
145333131|NCT02132754|524069075|FG030|Overall Study|Screen Failure|0|||
145333132|NCT02132754|524069076|FG031|Overall Study|Screen Failure|0|||
145333133|NCT02132754|524069077|FG032|Overall Study|Screen Failure|0|||
145333134|NCT02132754|524069078|FG033|Overall Study|Screen Failure|0|||
145333135|NCT02132754|524069045|FG000|Overall Study|Transferred to Extension Study|0|||
145333136|NCT02132754|524069046|FG001|Overall Study|Transferred to Extension Study|0|||
145333137|NCT02132754|524069047|FG002|Overall Study|Transferred to Extension Study|0|||
145333138|NCT02132754|524069048|FG003|Overall Study|Transferred to Extension Study|0|||
145333139|NCT02132754|524069049|FG004|Overall Study|Transferred to Extension Study|0|||
145333140|NCT02132754|524069050|FG005|Overall Study|Transferred to Extension Study|0|||
145333141|NCT02132754|524069051|FG006|Overall Study|Transferred to Extension Study|0|||
145333142|NCT02132754|524069052|FG007|Overall Study|Transferred to Extension Study|0|||
145333143|NCT02132754|524069053|FG008|Overall Study|Transferred to Extension Study|0|||
145333144|NCT02132754|524069054|FG009|Overall Study|Transferred to Extension Study|0|||
145333145|NCT02132754|524069055|FG010|Overall Study|Transferred to Extension Study|0|||
145333146|NCT02132754|524069056|FG011|Overall Study|Transferred to Extension Study|0|||
145333147|NCT02132754|524069057|FG012|Overall Study|Transferred to Extension Study|0|||
145333148|NCT02132754|524069058|FG013|Overall Study|Transferred to Extension Study|0|||
145333149|NCT02132754|524069059|FG014|Overall Study|Transferred to Extension Study|0|||
145333150|NCT02132754|524069060|FG015|Overall Study|Transferred to Extension Study|0|||
145333151|NCT02132754|524069061|FG016|Overall Study|Transferred to Extension Study|0|||
145333152|NCT02132754|524069062|FG017|Overall Study|Transferred to Extension Study|0|||
145333153|NCT02132754|524069063|FG018|Overall Study|Transferred to Extension Study|0|||
145333154|NCT02132754|524069064|FG019|Overall Study|Transferred to Extension Study|0|||
145333155|NCT02132754|524069065|FG020|Overall Study|Transferred to Extension Study|0|||
145333156|NCT02132754|524069066|FG021|Overall Study|Transferred to Extension Study|0|||
145333157|NCT02132754|524069067|FG022|Overall Study|Transferred to Extension Study|0|||
145333158|NCT02132754|524069068|FG023|Overall Study|Transferred to Extension Study|0|||
145333159|NCT02132754|524069069|FG024|Overall Study|Transferred to Extension Study|0|||
145333160|NCT02132754|524069070|FG025|Overall Study|Transferred to Extension Study|0|||
145573140|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
145333161|NCT02132754|524069071|FG026|Overall Study|Transferred to Extension Study|0|||
145333162|NCT02132754|524069072|FG027|Overall Study|Transferred to Extension Study|0|||
145333163|NCT02132754|524069073|FG028|Overall Study|Transferred to Extension Study|0|||
145333164|NCT02132754|524069074|FG029|Overall Study|Transferred to Extension Study|0|||
145333165|NCT02132754|524069075|FG030|Overall Study|Transferred to Extension Study|0|||
145333166|NCT02132754|524069076|FG031|Overall Study|Transferred to Extension Study|0|||
145333167|NCT02132754|524069077|FG032|Overall Study|Transferred to Extension Study|0|||
145333168|NCT02132754|524069078|FG033|Overall Study|Transferred to Extension Study|6|||
145333169|NCT02132754|524069045|FG000|Overall Study|Withdrawal by Subject|0|||
145333170|NCT02132754|524069046|FG001|Overall Study|Withdrawal by Subject|0|||
145333171|NCT02132754|524069047|FG002|Overall Study|Withdrawal by Subject|0|||
145333172|NCT02132754|524069048|FG003|Overall Study|Withdrawal by Subject|0|||
145333173|NCT02132754|524069049|FG004|Overall Study|Withdrawal by Subject|0|||
145333174|NCT02132754|524069050|FG005|Overall Study|Withdrawal by Subject|0|||
145333175|NCT02132754|524069051|FG006|Overall Study|Withdrawal by Subject|0|||
145333176|NCT02132754|524069052|FG007|Overall Study|Withdrawal by Subject|0|||
145333177|NCT02132754|524069053|FG008|Overall Study|Withdrawal by Subject|0|||
145333178|NCT02132754|524069054|FG009|Overall Study|Withdrawal by Subject|1|||
145333179|NCT02132754|524069055|FG010|Overall Study|Withdrawal by Subject|0|||
145333180|NCT02132754|524069056|FG011|Overall Study|Withdrawal by Subject|0|||
145333181|NCT02132754|524069057|FG012|Overall Study|Withdrawal by Subject|1|||
145573141|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
145573142|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
145412782|NCT03550209|524364958|FG003|Overall Study|Withdrawal by Subject|2|||
145333182|NCT02132754|524069058|FG013|Overall Study|Withdrawal by Subject|0|||
145333183|NCT02132754|524069059|FG014|Overall Study|Withdrawal by Subject|1|||
145333184|NCT02132754|524069060|FG015|Overall Study|Withdrawal by Subject|2|||
145333185|NCT02132754|524069061|FG016|Overall Study|Withdrawal by Subject|1|||
145333186|NCT02132754|524069062|FG017|Overall Study|Withdrawal by Subject|0|||
145333187|NCT02132754|524069063|FG018|Overall Study|Withdrawal by Subject|0|||
145333188|NCT02132754|524069064|FG019|Overall Study|Withdrawal by Subject|0|||
145333189|NCT02132754|524069065|FG020|Overall Study|Withdrawal by Subject|1|||
145333190|NCT02132754|524069066|FG021|Overall Study|Withdrawal by Subject|0|||
145333191|NCT02132754|524069067|FG022|Overall Study|Withdrawal by Subject|0|||
145333192|NCT02132754|524069068|FG023|Overall Study|Withdrawal by Subject|0|||
145333193|NCT02132754|524069069|FG024|Overall Study|Withdrawal by Subject|1|||
145333194|NCT02132754|524069070|FG025|Overall Study|Withdrawal by Subject|0|||
145333195|NCT02132754|524069071|FG026|Overall Study|Withdrawal by Subject|0|||
145333196|NCT02132754|524069072|FG027|Overall Study|Withdrawal by Subject|1|||
145333197|NCT02132754|524069073|FG028|Overall Study|Withdrawal by Subject|0|||
145333198|NCT02132754|524069074|FG029|Overall Study|Withdrawal by Subject|0|||
145333199|NCT02132754|524069075|FG030|Overall Study|Withdrawal by Subject|0|||
145333200|NCT02132754|524069076|FG031|Overall Study|Withdrawal by Subject|1|||
145333201|NCT02132754|524069077|FG032|Overall Study|Withdrawal by Subject|0|||
145333202|NCT02132754|524069078|FG033|Overall Study|Withdrawal by Subject|2|||
145333203|NCT00006721|524071532|FG000|Overall Study|Adverse Event|0|||
145333204|NCT00006721|524071533|FG001|Overall Study|Adverse Event|4|||
145333205|NCT00006721|524071534|FG002|Overall Study|Adverse Event|4|||
145333206|NCT00006721|524071532|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145333207|NCT00006721|524071533|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
145333208|NCT00006721|524071534|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
145333209|NCT00006721|524071532|FG000|Overall Study|Progression/Relapse|0|||
145333210|NCT00006721|524071533|FG001|Overall Study|Progression/Relapse|1|||
145333211|NCT00006721|524071534|FG002|Overall Study|Progression/Relapse|2|||
145333212|NCT00006721|524071532|FG000|Overall Study|Death|0|||
145333213|NCT00006721|524071533|FG001|Overall Study|Death|1|||
145333214|NCT00006721|524071534|FG002|Overall Study|Death|2|||
145333215|NCT00006721|524071532|FG000|Overall Study|Other - Not Protocol Specified|0|||
145333216|NCT00006721|524071533|FG001|Overall Study|Other - Not Protocol Specified|7|||
145333217|NCT00006721|524071534|FG002|Overall Study|Other - Not Protocol Specified|7|||
145333218|NCT00006721|524071532|FG000|Overall Study|Ineligible|2|||
145333219|NCT00006721|524071533|FG001|Overall Study|Ineligible|12|||
145333220|NCT00006721|524071534|FG002|Overall Study|Ineligible|10|||
145333221|NCT00006721|524071532|FG000|Overall Study|Eligible but no Treatment Received|1|||
145333222|NCT00006721|524071533|FG001|Overall Study|Eligible but no Treatment Received|0|||
145333223|NCT00006721|524071534|FG002|Overall Study|Eligible but no Treatment Received|0|||
145333224|NCT05424042|524071535|FG000|Overall Study|Withdrawal by Subject|2|||
145333225|NCT05424042|524071536|FG001|Overall Study|Withdrawal by Subject|0|||
145333226|NCT05424042|524071537|FG002|Overall Study|Withdrawal by Subject|4|||
145333227|NCT05424042|524071535|FG000|Overall Study|Lost to Follow-up|0|||
145333228|NCT05424042|524071536|FG001|Overall Study|Lost to Follow-up|0|||
145333229|NCT05424042|524071537|FG002|Overall Study|Lost to Follow-up|1|||
145333230|NCT05091307|524071538|FG000|Overall Study|Death|0|||
145333231|NCT05091307|524071539|FG001|Overall Study|Death|0|||
145333232|NCT05091307|524071540|FG002|Overall Study|Death|1|||
145333233|NCT05091307|524071541|FG003|Overall Study|Death|0|||
145333234|NCT05091307|524071538|FG000|Overall Study|Lost to Follow-up|33|||
145333235|NCT05091307|524071539|FG001|Overall Study|Lost to Follow-up|33|||
145333236|NCT05091307|524071540|FG002|Overall Study|Lost to Follow-up|2|||
145333237|NCT05091307|524071541|FG003|Overall Study|Lost to Follow-up|0|||
145333238|NCT05091307|524071538|FG000|Overall Study|Physician Decision|1|||
145333239|NCT05091307|524071539|FG001|Overall Study|Physician Decision|0|||
145333240|NCT05091307|524071540|FG002|Overall Study|Physician Decision|0|||
145333241|NCT05091307|524071541|FG003|Overall Study|Physician Decision|0|||
145333242|NCT05091307|524071538|FG000|Overall Study|Protocol Violation|1|||
145333243|NCT05091307|524071539|FG001|Overall Study|Protocol Violation|0|||
145333244|NCT05091307|524071540|FG002|Overall Study|Protocol Violation|0|||
145333245|NCT05091307|524071541|FG003|Overall Study|Protocol Violation|0|||
145333246|NCT05091307|524071538|FG000|Overall Study|Withdrawal by Subject|16|||
145333247|NCT05091307|524071539|FG001|Overall Study|Withdrawal by Subject|16|||
145333248|NCT05091307|524071540|FG002|Overall Study|Withdrawal by Subject|0|||
145333249|NCT05091307|524071541|FG003|Overall Study|Withdrawal by Subject|1|||
145333250|NCT05091307|524071538|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
145333251|NCT05091307|524071539|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
145333252|NCT05091307|524071540|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
145333253|NCT05091307|524071541|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
145333254|NCT05091307|524071538|FG000|Overall Study|Initiated Prohibited Medication|1|||
145333255|NCT05091307|524071539|FG001|Overall Study|Initiated Prohibited Medication|0|||
145333256|NCT05091307|524071540|FG002|Overall Study|Initiated Prohibited Medication|0|||
145333257|NCT05091307|524071541|FG003|Overall Study|Initiated Prohibited Medication|0|||
145333258|NCT05091307|524071538|FG000|Overall Study|Other|4|||
145333259|NCT05091307|524071539|FG001|Overall Study|Other|4|||
145333260|NCT05091307|524071540|FG002|Overall Study|Other|0|||
145333261|NCT05091307|524071541|FG003|Overall Study|Other|0|||
145333262|NCT05091307|524071538|FG000|Overall Study|Randomized but not vaccinated|0|||
145333263|NCT05091307|524071539|FG001|Overall Study|Randomized but not vaccinated|2|||
145333264|NCT05091307|524071540|FG002|Overall Study|Randomized but not vaccinated|0|||
145333265|NCT05091307|524071541|FG003|Overall Study|Randomized but not vaccinated|0|||
145333266|NCT03611543|524071542|FG000|Overall Study|Withdrawal by Subject|4|||
145333267|NCT03611543|524071543|FG001|Overall Study|Withdrawal by Subject|4|||
145333268|NCT03611543|524071542|FG000|Overall Study|Physician Decision|1|||
145333269|NCT03611543|524071543|FG001|Overall Study|Physician Decision|1|||
145333270|NCT03611543|524071542|FG000|Overall Study|Protocol Violation|2|||
145333271|NCT03611543|524071543|FG001|Overall Study|Protocol Violation|2|||
145333272|NCT03611543|524071542|FG000|Overall Study|Device failure|2|||
145333273|NCT03611543|524071543|FG001|Overall Study|Device failure|2|||
145333274|NCT03611543|524071542|FG000|Overall Study|Missing information|5|||
145333275|NCT03611543|524071543|FG001|Overall Study|Missing information|5|||
145333276|NCT04394351|524071544|FG000|Part A (16 Weeks)|Adverse Event|1|||
145333277|NCT04394351|524071545|FG001|Part A (16 Weeks)|Adverse Event|0|||
145333278|NCT04394351|524071546|FG002|Part A (16 Weeks)|Adverse Event|0|||
145333279|NCT04394351|524071547|FG003|Part A (16 Weeks)|Adverse Event|0|||
145333280|NCT04394351|524071548|FG004|Part A (16 Weeks)|Adverse Event|0|||
145333281|NCT04394351|524071549|FG005|Part A (16 Weeks)|Adverse Event|0|||
145333282|NCT04394351|524071550|FG006|Part A (16 Weeks)|Adverse Event|0|||
145333283|NCT04394351|524071551|FG007|Part A (16 Weeks)|Adverse Event|0|||
145333284|NCT04394351|524071544|FG000|Part A (16 Weeks)|Physician Decision|0|||
145333285|NCT04394351|524071545|FG001|Part A (16 Weeks)|Physician Decision|1|||
145333286|NCT04394351|524071546|FG002|Part A (16 Weeks)|Physician Decision|0|||
145333287|NCT04394351|524071547|FG003|Part A (16 Weeks)|Physician Decision|0|||
145333288|NCT04394351|524071548|FG004|Part A (16 Weeks)|Physician Decision|0|||
145333289|NCT04394351|524071549|FG005|Part A (16 Weeks)|Physician Decision|0|||
145333290|NCT04394351|524071550|FG006|Part A (16 Weeks)|Physician Decision|0|||
145333291|NCT04394351|524071551|FG007|Part A (16 Weeks)|Physician Decision|0|||
145333292|NCT04394351|524071544|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333293|NCT04394351|524071545|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
145333294|NCT04394351|524071546|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333295|NCT04394351|524071547|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333296|NCT04394351|524071548|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333297|NCT04394351|524071549|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333298|NCT04394351|524071550|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333299|NCT04394351|524071551|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
145333300|NCT04394351|524071544|FG000|Part B (36 Weeks)|Adverse Event|0|||
145333301|NCT04394351|524071545|FG001|Part B (36 Weeks)|Adverse Event|0|||
145333302|NCT04394351|524071546|FG002|Part B (36 Weeks)|Adverse Event|0|||
145333303|NCT04394351|524071547|FG003|Part B (36 Weeks)|Adverse Event|0|||
145333304|NCT04394351|524071548|FG004|Part B (36 Weeks)|Adverse Event|0|||
145333305|NCT04394351|524071549|FG005|Part B (36 Weeks)|Adverse Event|0|||
145333306|NCT04394351|524071550|FG006|Part B (36 Weeks)|Adverse Event|1|||
145333307|NCT04394351|524071551|FG007|Part B (36 Weeks)|Adverse Event|0|||
145333308|NCT04394351|524071544|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333309|NCT04394351|524071545|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333310|NCT04394351|524071546|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333311|NCT04394351|524071547|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333312|NCT04394351|524071548|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333313|NCT04394351|524071549|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333314|NCT04394351|524071550|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
145333315|NCT04394351|524071551|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
145333316|NCT04394351|524071544|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333317|NCT04394351|524071545|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333318|NCT04394351|524071546|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333319|NCT04394351|524071547|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333320|NCT04394351|524071548|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333321|NCT04394351|524071549|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145573143|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145333322|NCT04394351|524071550|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
145333323|NCT04394351|524071551|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
145333324|NCT04394351|524071544|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333325|NCT04394351|524071545|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333326|NCT04394351|524071546|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333327|NCT04394351|524071547|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333328|NCT04394351|524071548|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145573144|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145333329|NCT04394351|524071549|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333330|NCT04394351|524071550|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
145333331|NCT04394351|524071551|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
145333332|NCT04394351|524071544|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333333|NCT04394351|524071545|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333334|NCT04394351|524071546|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333335|NCT04394351|524071547|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333336|NCT04394351|524071548|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333337|NCT04394351|524071549|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333338|NCT04394351|524071550|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
145333339|NCT04394351|524071551|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
145333340|NCT03653507|524071552|FG000|Overall Study|Miscellaneous|28|||
145333341|NCT03653507|524071553|FG001|Overall Study|Miscellaneous|19|||
145333342|NCT03653507|524071552|FG000|Overall Study|Withdrawal by Subject|37|||
145333343|NCT03653507|524071553|FG001|Overall Study|Withdrawal by Subject|22|||
145333344|NCT03653507|524071552|FG000|Overall Study|Protocol Deviation|2|||
145333345|NCT03653507|524071553|FG001|Overall Study|Protocol Deviation|1|||
145333346|NCT03653507|524071552|FG000|Overall Study|Progressive disease|117|||
145333347|NCT03653507|524071553|FG001|Overall Study|Progressive disease|168|||
145333348|NCT03653507|524071552|FG000|Overall Study|Lost to Follow-up|1|||
145333349|NCT03653507|524071553|FG001|Overall Study|Lost to Follow-up|1|||
145333350|NCT03653507|524071552|FG000|Overall Study|Death|25|||
145333351|NCT03653507|524071553|FG001|Overall Study|Death|22|||
145333352|NCT03653507|524071552|FG000|Overall Study|Adverse Event|35|||
145333353|NCT03653507|524071553|FG001|Overall Study|Adverse Event|14|||
145333354|NCT03047473|524071564|FG000|Overall Study|Lost to Follow-up|2|||
145333355|NCT01468818|524071567|FG000|Overall Study|Death during treatment|2|||
145333356|NCT00338455|524071570|FG000|Overall Study|Death|2|||
145333357|NCT00338455|524071571|FG001|Overall Study|Death|1|||
145333358|NCT00338455|524071570|FG000|Overall Study|Physician Decision|1|||
145333359|NCT00338455|524071571|FG001|Overall Study|Physician Decision|0|||
145333360|NCT02266134|524071574|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
145333361|NCT02266134|524071575|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
145333362|NCT02266134|524071576|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
145333363|NCT02266134|524071577|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
145333364|NCT02266134|524071574|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
145333365|NCT02266134|524071575|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
145333366|NCT02266134|524071576|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
145333367|NCT02266134|524071577|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
145333368|NCT02266134|524071574|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
145333369|NCT02266134|524071575|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
145333370|NCT02266134|524071576|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
145333371|NCT02266134|524071577|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
145333372|NCT02266134|524071574|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
145333373|NCT02266134|524071575|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145333374|NCT02266134|524071576|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145333375|NCT02266134|524071577|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
145333376|NCT02266134|524071574|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
145333377|NCT02266134|524071575|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
145333378|NCT02266134|524071576|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
145333379|NCT02266134|524071577|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
145333380|NCT02266134|524071574|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
145333381|NCT02266134|524071575|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145333382|NCT02266134|524071576|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145333383|NCT02266134|524071577|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
145333384|NCT01739348|524071578|FG000|Part I (Base Study)|Adverse Event|41|||
145333385|NCT01739348|524071579|FG001|Part I (Base Study)|Adverse Event|52|||
145333386|NCT01739348|524071580|FG002|Part I (Base Study)|Adverse Event|8|||
145333387|NCT01739348|524071581|FG003|Part I (Base Study)|Adverse Event|33|||
145333388|NCT01739348|524071578|FG000|Part I (Base Study)|Death|10|||
145333389|NCT01739348|524071579|FG001|Part I (Base Study)|Death|7|||
145333390|NCT01739348|524071580|FG002|Part I (Base Study)|Death|2|||
145333391|NCT01739348|524071581|FG003|Part I (Base Study)|Death|8|||
145333392|NCT01739348|524071578|FG000|Part I (Base Study)|Lack of Efficacy|3|||
145333393|NCT01739348|524071579|FG001|Part I (Base Study)|Lack of Efficacy|8|||
145333394|NCT01739348|524071580|FG002|Part I (Base Study)|Lack of Efficacy|0|||
145333395|NCT01739348|524071581|FG003|Part I (Base Study)|Lack of Efficacy|7|||
145333396|NCT01739348|524071578|FG000|Part I (Base Study)|Lost to Follow-up|4|||
145333397|NCT01739348|524071579|FG001|Part I (Base Study)|Lost to Follow-up|2|||
145333398|NCT01739348|524071580|FG002|Part I (Base Study)|Lost to Follow-up|4|||
145333399|NCT01739348|524071581|FG003|Part I (Base Study)|Lost to Follow-up|4|||
145333400|NCT01739348|524071578|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
145333401|NCT01739348|524071579|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
145621502|NCT04955626|525126699|FG027|Open-Label Period|Death|0|||
145621503|NCT04955626|525126700|FG028|Open-Label Period|Death|0|||
145621504|NCT04955626|525126701|FG029|Open-Label Period|Death|0|||
145621505|NCT04955626|525126702|FG030|Open-Label Period|Death|0|||
145621506|NCT04955626|525126703|FG031|Open-Label Period|Death|0|||
145621507|NCT04955626|525126704|FG032|Open-Label Period|Death|0|||
145621508|NCT04955626|525126705|FG033|Open-Label Period|Death|0|||
145621509|NCT04955626|525126706|FG034|Open-Label Period|Death|0|||
145621510|NCT04955626|525126707|FG035|Open-Label Period|Death|0|||
145621511|NCT04955626|525126672|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
145621512|NCT04955626|525126673|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
145621513|NCT04955626|525126674|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
145621514|NCT04955626|525126675|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
145621515|NCT04955626|525126676|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
145621516|NCT04955626|525126677|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
145621517|NCT04955626|525126678|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
145621518|NCT04955626|525126679|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
145333402|NCT01739348|524071580|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
145333403|NCT01739348|524071581|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
145333404|NCT01739348|524071578|FG000|Part I (Base Study)|Physician Decision|10|||
145333405|NCT01739348|524071579|FG001|Part I (Base Study)|Physician Decision|7|||
145333406|NCT01739348|524071580|FG002|Part I (Base Study)|Physician Decision|1|||
145333407|NCT01739348|524071581|FG003|Part I (Base Study)|Physician Decision|4|||
145333408|NCT01739348|524071578|FG000|Part I (Base Study)|Protocol Violation|2|||
145333409|NCT01739348|524071579|FG001|Part I (Base Study)|Protocol Violation|0|||
145333410|NCT01739348|524071580|FG002|Part I (Base Study)|Protocol Violation|1|||
145333411|NCT01739348|524071581|FG003|Part I (Base Study)|Protocol Violation|2|||
145333412|NCT01739348|524071578|FG000|Part I (Base Study)|Screen Failure|2|||
145333413|NCT01739348|524071579|FG001|Part I (Base Study)|Screen Failure|0|||
145333414|NCT01739348|524071580|FG002|Part I (Base Study)|Screen Failure|0|||
145333415|NCT01739348|524071581|FG003|Part I (Base Study)|Screen Failure|0|||
145333416|NCT01739348|524071578|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
145333417|NCT01739348|524071579|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
145333418|NCT01739348|524071580|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
145333419|NCT01739348|524071581|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
145333420|NCT01739348|524071578|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
145333421|NCT01739348|524071579|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
145333422|NCT01739348|524071580|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
145333423|NCT01739348|524071581|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
145333424|NCT01739348|524071578|FG000|Part I (Base Study)|Participant Moved|4|||
145333425|NCT01739348|524071579|FG001|Part I (Base Study)|Participant Moved|3|||
145333426|NCT01739348|524071580|FG002|Part I (Base Study)|Participant Moved|1|||
145333427|NCT01739348|524071581|FG003|Part I (Base Study)|Participant Moved|7|||
145333428|NCT01739348|524071578|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
145333429|NCT01739348|524071579|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
145333430|NCT01739348|524071580|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
145333431|NCT01739348|524071581|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
145333432|NCT01739348|524071578|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
145333433|NCT01739348|524071579|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
145333434|NCT01739348|524071580|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
145333435|NCT01739348|524071581|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
145333436|NCT01739348|524071578|FG000|Part II (Extension Study)|Adverse Event|10|||
145333437|NCT01739348|524071579|FG001|Part II (Extension Study)|Adverse Event|11|||
145333438|NCT01739348|524071580|FG002|Part II (Extension Study)|Adverse Event|7|||
145333439|NCT01739348|524071581|FG003|Part II (Extension Study)|Adverse Event|26|||
145333440|NCT01739348|524071578|FG000|Part II (Extension Study)|Death|3|||
145333441|NCT01739348|524071579|FG001|Part II (Extension Study)|Death|3|||
145333442|NCT01739348|524071580|FG002|Part II (Extension Study)|Death|2|||
145333443|NCT01739348|524071581|FG003|Part II (Extension Study)|Death|6|||
145333444|NCT01739348|524071578|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
145333445|NCT01739348|524071579|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
145333446|NCT01739348|524071580|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
145621519|NCT04955626|525126680|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
145621520|NCT04955626|525126681|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
145621521|NCT04955626|525126682|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
145621522|NCT04955626|525126683|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
145621523|NCT04955626|525126684|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
145621524|NCT04955626|525126685|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
145621525|NCT04955626|525126686|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
145333447|NCT01739348|524071581|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
145333448|NCT01739348|524071578|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
145333449|NCT01739348|524071579|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
145333450|NCT01739348|524071580|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
145333451|NCT01739348|524071581|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
145333452|NCT01739348|524071578|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145333453|NCT01739348|524071579|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145333454|NCT01739348|524071580|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
145333455|NCT01739348|524071581|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
145333456|NCT01739348|524071578|FG000|Part II (Extension Study)|Physician Decision|7|||
145333457|NCT01739348|524071579|FG001|Part II (Extension Study)|Physician Decision|11|||
145333458|NCT01739348|524071580|FG002|Part II (Extension Study)|Physician Decision|6|||
145333459|NCT01739348|524071581|FG003|Part II (Extension Study)|Physician Decision|12|||
145333460|NCT01739348|524071578|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
145333461|NCT01739348|524071579|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
145333462|NCT01739348|524071580|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
145333463|NCT01739348|524071581|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
145333464|NCT01739348|524071578|FG000|Part II (Extension Study)|Participant Moved|3|||
145333465|NCT01739348|524071579|FG001|Part II (Extension Study)|Participant Moved|3|||
145333466|NCT01739348|524071580|FG002|Part II (Extension Study)|Participant Moved|0|||
145333467|NCT01739348|524071581|FG003|Part II (Extension Study)|Participant Moved|3|||
145333468|NCT01739348|524071578|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
145333469|NCT01739348|524071579|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
145333470|NCT01739348|524071580|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
145333471|NCT01739348|524071581|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
145333472|NCT01739348|524071578|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
145333473|NCT01739348|524071579|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
145333474|NCT01739348|524071580|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
145333475|NCT01739348|524071581|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
145333476|NCT01447420|524071584|FG000|Overall Study|Adverse Event|2|||
145333477|NCT01447420|524071585|FG001|Overall Study|Adverse Event|4|||
145333478|NCT01447420|524071586|FG002|Overall Study|Adverse Event|2|||
145333479|NCT01447420|524071584|FG000|Overall Study|Protocol Violation|3|||
145333480|NCT01447420|524071585|FG001|Overall Study|Protocol Violation|3|||
145333481|NCT01447420|524071586|FG002|Overall Study|Protocol Violation|0|||
145333482|NCT01447420|524071584|FG000|Overall Study|Withdrawal by Subject|4|||
145333483|NCT01447420|524071585|FG001|Overall Study|Withdrawal by Subject|1|||
145333484|NCT01447420|524071586|FG002|Overall Study|Withdrawal by Subject|0|||
145333485|NCT01447420|524071584|FG000|Overall Study|Lack of Efficacy|1|||
145333486|NCT01447420|524071585|FG001|Overall Study|Lack of Efficacy|19|||
145333487|NCT01447420|524071586|FG002|Overall Study|Lack of Efficacy|8|||
145333488|NCT01085201|524071588|FG000|Overall Study|Scheduling conflict|1|||
145333489|NCT01085201|524071589|FG001|Overall Study|Scheduling conflict|0|||
145333490|NCT01085201|524071590|FG002|Overall Study|Scheduling conflict|1|||
145333491|NCT01085201|524071591|FG003|Overall Study|Scheduling conflict|0|||
145333492|NCT01085201|524071592|FG004|Overall Study|Scheduling conflict|0|||
145333493|NCT01085201|524071588|FG000|Overall Study|Unknown- no study drug|2|||
145333494|NCT01085201|524071589|FG001|Overall Study|Unknown- no study drug|0|||
145333495|NCT01085201|524071590|FG002|Overall Study|Unknown- no study drug|0|||
145333496|NCT01085201|524071591|FG003|Overall Study|Unknown- no study drug|0|||
145333497|NCT01085201|524071592|FG004|Overall Study|Unknown- no study drug|0|||
145333498|NCT01085201|524071588|FG000|Overall Study|Fond ineligible after consent|0|||
145333499|NCT01085201|524071589|FG001|Overall Study|Fond ineligible after consent|1|||
145333500|NCT01085201|524071590|FG002|Overall Study|Fond ineligible after consent|1|||
145333501|NCT01085201|524071591|FG003|Overall Study|Fond ineligible after consent|0|||
145333502|NCT01085201|524071592|FG004|Overall Study|Fond ineligible after consent|0|||
145333503|NCT02643355|524071593|FG000|Overall Study|Withdrawal by Subject|1|||
145333504|NCT02643355|524071594|FG001|Overall Study|Withdrawal by Subject|3|||
145333505|NCT02643355|524071593|FG000|Overall Study|Protocol Violation|0|||
145333506|NCT02643355|524071594|FG001|Overall Study|Protocol Violation|2|||
145333507|NCT05187013|524071595|FG000|Overall Study|Withdrawal by Subject|1|||
145333508|NCT05187013|524071596|FG001|Overall Study|Withdrawal by Subject|1|||
145333509|NCT05187013|524071597|FG002|Overall Study|Withdrawal by Subject|0|||
145412783|NCT03550209|524364955|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
145333510|NCT05187013|524071595|FG000|Overall Study|Death|0|||
145333511|NCT05187013|524071596|FG001|Overall Study|Death|1|||
145333512|NCT05187013|524071597|FG002|Overall Study|Death|0|||
145412784|NCT03550209|524364956|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
145412785|NCT03550209|524364957|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
145412786|NCT03550209|524364958|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
145333513|NCT05187013|524071595|FG000|Overall Study|Lost to Follow-up|20|||
145333514|NCT05187013|524071596|FG001|Overall Study|Lost to Follow-up|17|||
145333515|NCT05187013|524071597|FG002|Overall Study|Lost to Follow-up|0|||
145333516|NCT05187013|524071595|FG000|Overall Study|Ongoing Participants|3|||
145333517|NCT05187013|524071596|FG001|Overall Study|Ongoing Participants|5|||
145333518|NCT05187013|524071597|FG002|Overall Study|Ongoing Participants|0|||
145333519|NCT01096368|524071600|FG000|Overall Study|Death|0|||
145333520|NCT01096368|524071601|FG001|Overall Study|Death|1|||
145333521|NCT01096368|524071602|FG002|Overall Study|Death|0|||
145333522|NCT01096368|524071603|FG003|Overall Study|Death|0|||
145333523|NCT01096368|524071604|FG004|Overall Study|Death|0|||
145333524|NCT01096368|524071600|FG000|Overall Study|Physician Decision|0|||
145333525|NCT01096368|524071601|FG001|Overall Study|Physician Decision|13|||
145333526|NCT01096368|524071602|FG002|Overall Study|Physician Decision|2|||
145333527|NCT01096368|524071603|FG003|Overall Study|Physician Decision|4|||
145333528|NCT01096368|524071604|FG004|Overall Study|Physician Decision|6|||
145333529|NCT01096368|524071600|FG000|Overall Study|Withdrawal by Subject|0|||
145333530|NCT01096368|524071601|FG001|Overall Study|Withdrawal by Subject|52|||
145333531|NCT01096368|524071602|FG002|Overall Study|Withdrawal by Subject|0|||
145333532|NCT01096368|524071603|FG003|Overall Study|Withdrawal by Subject|10|||
145333533|NCT01096368|524071604|FG004|Overall Study|Withdrawal by Subject|14|||
145333534|NCT01096368|524071600|FG000|Overall Study|Ineligible|0|||
145333535|NCT01096368|524071601|FG001|Overall Study|Ineligible|3|||
145333536|NCT01096368|524071602|FG002|Overall Study|Ineligible|2|||
145333537|NCT01096368|524071603|FG003|Overall Study|Ineligible|0|||
145333538|NCT01096368|524071604|FG004|Overall Study|Ineligible|25|||
145333539|NCT01096368|524071600|FG000|Overall Study|Did not start treatment|0|||
145333540|NCT01096368|524071601|FG001|Overall Study|Did not start treatment|4|||
145333541|NCT01096368|524071602|FG002|Overall Study|Did not start treatment|4|||
145333542|NCT01096368|524071603|FG003|Overall Study|Did not start treatment|0|||
145333543|NCT01096368|524071604|FG004|Overall Study|Did not start treatment|0|||
145333544|NCT01096368|524071600|FG000|Overall Study|Progressive disease|0|||
145333545|NCT01096368|524071601|FG001|Overall Study|Progressive disease|6|||
145333546|NCT01096368|524071602|FG002|Overall Study|Progressive disease|0|||
145333547|NCT01096368|524071603|FG003|Overall Study|Progressive disease|10|||
145333548|NCT01096368|524071604|FG004|Overall Study|Progressive disease|3|||
145333549|NCT01096368|524071600|FG000|Overall Study|Other|0|||
145333550|NCT01096368|524071601|FG001|Overall Study|Other|0|||
145333551|NCT01096368|524071602|FG002|Overall Study|Other|1|||
145333552|NCT01096368|524071603|FG003|Overall Study|Other|0|||
145333553|NCT01096368|524071604|FG004|Overall Study|Other|0|||
145333554|NCT01096368|524071600|FG000|Overall Study|Treated with institutional review|0|||
145333555|NCT01096368|524071601|FG001|Overall Study|Treated with institutional review|0|||
145333556|NCT01096368|524071602|FG002|Overall Study|Treated with institutional review|0|||
145333557|NCT01096368|524071603|FG003|Overall Study|Treated with institutional review|0|||
145333558|NCT01096368|524071604|FG004|Overall Study|Treated with institutional review|1|||
145333559|NCT04740814|524071606|FG000|Overall Study|Adverse Event|3|||
145333560|NCT04740814|524071606|FG000|Overall Study|Protocol Violation|2|||
145333561|NCT04740814|524071606|FG000|Overall Study|Lost to Follow-up|2|||
145333562|NCT04740814|524071606|FG000|Overall Study|Withdrawal by Subject|3|||
145333563|NCT00085423|524071607|FG000|Overall Study|Withdrawal by Subject|1|||
145333564|NCT00085423|524071607|FG000|Overall Study|screen failure|1|||
145333565|NCT02500641|524071610|FG000|Overall Study|Adverse Event|0|||
145333566|NCT02500641|524071611|FG001|Overall Study|Adverse Event|2|||
145333567|NCT02500641|524071610|FG000|Overall Study|Withdrawal by Subject|4|||
145333568|NCT02500641|524071611|FG001|Overall Study|Withdrawal by Subject|5|||
145333569|NCT02500641|524071610|FG000|Overall Study|Unable to follow study procedures|3|||
145333570|NCT02500641|524071611|FG001|Overall Study|Unable to follow study procedures|2|||
145333571|NCT02500641|524071610|FG000|Overall Study|Protocol Violation|1|||
145333572|NCT02500641|524071611|FG001|Overall Study|Protocol Violation|2|||
145333573|NCT02500641|524071610|FG000|Overall Study|Lost to Follow-up|1|||
145333574|NCT02500641|524071611|FG001|Overall Study|Lost to Follow-up|0|||
145333575|NCT02500641|524071610|FG000|Overall Study|Sponsor decision|1|||
145333576|NCT02500641|524071611|FG001|Overall Study|Sponsor decision|0|||
145333577|NCT02500641|524071610|FG000|Overall Study|Non compliance to study drug|0|||
145333578|NCT02500641|524071611|FG001|Overall Study|Non compliance to study drug|1|||
145333579|NCT02317614|524071619|FG000|Overall Study|Lost to Follow-up|1|||
145412787|NCT02347787|524364961|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
145333580|NCT02317614|524071620|FG001|Overall Study|Lost to Follow-up|1|||
145333581|NCT02317614|524071619|FG000|Overall Study|Withdrawal by Subject|1|||
145333582|NCT02317614|524071620|FG001|Overall Study|Withdrawal by Subject|0|||
145333583|NCT02317614|524071619|FG000|Overall Study|Death|1|||
145412788|NCT02347787|524364962|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
145412789|NCT02347787|524364961|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
145412790|NCT02347787|524364962|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
145412791|NCT02347787|524364961|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
145412792|NCT02347787|524364962|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
145412793|NCT02347787|524364961|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
145333584|NCT02317614|524071620|FG001|Overall Study|Death|1|||
145333585|NCT03285308|524071625|FG000|Overall Study|Adverse Event|3|||
145333586|NCT03285308|524071626|FG001|Overall Study|Adverse Event|7|||
145333587|NCT03285308|524071625|FG000|Overall Study|Withdrawal by Subject|8|||
145333588|NCT03285308|524071626|FG001|Overall Study|Withdrawal by Subject|9|||
145412794|NCT02347787|524364962|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
145333589|NCT03285308|524071625|FG000|Overall Study|Lost to Follow-up|3|||
145333590|NCT03285308|524071626|FG001|Overall Study|Lost to Follow-up|1|||
145333591|NCT03285308|524071625|FG000|Overall Study|Protocol Deviation|6|||
145333592|NCT03285308|524071626|FG001|Overall Study|Protocol Deviation|5|||
145333593|NCT03285308|524071625|FG000|Overall Study|Reason not Specified|0|||
145333594|NCT03285308|524071626|FG001|Overall Study|Reason not Specified|1|||
145333595|NCT02283983|524071627|FG000|Overall Study|Inclusion criteria not met|0|||
145333596|NCT02283983|524071628|FG001|Overall Study|Inclusion criteria not met|1|||
145333597|NCT02283983|524071627|FG000|Overall Study|Withdrawal by Subject|4|||
145333598|NCT02283983|524071628|FG001|Overall Study|Withdrawal by Subject|2|||
145333599|NCT02283983|524071627|FG000|Overall Study|Protocol Violation|0|||
145333600|NCT02283983|524071628|FG001|Overall Study|Protocol Violation|4|||
145333601|NCT02283983|524071627|FG000|Overall Study|Physician Decision|2|||
145333602|NCT02283983|524071628|FG001|Overall Study|Physician Decision|4|||
145333603|NCT02283983|524071627|FG000|Overall Study|Death|1|||
145333604|NCT02283983|524071628|FG001|Overall Study|Death|0|||
145333605|NCT02283983|524071627|FG000|Overall Study|Adverse Event|1|||
145333606|NCT02283983|524071628|FG001|Overall Study|Adverse Event|0|||
145333607|NCT02283983|524071627|FG000|Overall Study|Lost to Follow-up|9|||
145333608|NCT02283983|524071628|FG001|Overall Study|Lost to Follow-up|8|||
145333609|NCT02283983|524071627|FG000|Overall Study|Relapse|1|||
145333610|NCT02283983|524071628|FG001|Overall Study|Relapse|0|||
145333611|NCT03283761|524071629|FG000|Study Treatment|Patient Non-Compliance|1|||
145333612|NCT03283761|524071629|FG000|Study Treatment|Alternative Cancer Therapy|7|||
145333613|NCT03283761|524071629|FG000|Study Treatment|Disease progression|21|||
145333614|NCT03283761|524071629|FG000|Study Treatment|Adverse Event|3|||
145333615|NCT03283761|524071629|FG000|Study Treatment|Withdrawal by Subject|4|||
145333616|NCT03283761|524071629|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
145333617|NCT03283761|524071629|FG000|Study Treatment|Symptomatic Deterioration|1|||
145333618|NCT03283761|524071629|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
145333619|NCT03283761|524071629|FG000|Follow up|Lost to Follow-up|1|||
145333620|NCT03283761|524071629|FG000|Follow up|Symptomatic Deterioration|1|||
145333621|NCT03283761|524071629|FG000|Follow up|Death|29|||
145333622|NCT03283761|524071629|FG000|Follow up|study terminated|4|||
145333623|NCT03283761|524071629|FG000|Follow up|Primary Investigator Withdrawal|1|||
145333624|NCT03283761|524071629|FG000|Follow up|Switched to alternative therapy|1|||
145333625|NCT03283761|524071629|FG000|Follow up|Subject is now in Hospice|1|||
145333626|NCT04453202|524071635|FG000|Overall Study|Adverse Event|0|||
145333627|NCT04453202|524071636|FG001|Overall Study|Adverse Event|0|||
145333628|NCT04453202|524071637|FG002|Overall Study|Adverse Event|0|||
145333629|NCT04453202|524071638|FG003|Overall Study|Adverse Event|0|||
145333630|NCT04453202|524071639|FG004|Overall Study|Adverse Event|0|||
145333631|NCT04453202|524071640|FG005|Overall Study|Adverse Event|0|||
145333632|NCT04453202|524071641|FG006|Overall Study|Adverse Event|1|||
145333633|NCT04453202|524071642|FG007|Overall Study|Adverse Event|0|||
145333634|NCT04453202|524071643|FG008|Overall Study|Adverse Event|0|||
145333635|NCT04453202|524071644|FG009|Overall Study|Adverse Event|0|||
145333636|NCT04453202|524071645|FG010|Overall Study|Adverse Event|0|||
145333637|NCT04453202|524071635|FG000|Overall Study|Death|0|||
145333638|NCT04453202|524071636|FG001|Overall Study|Death|0|||
145333639|NCT04453202|524071637|FG002|Overall Study|Death|0|||
145333640|NCT04453202|524071638|FG003|Overall Study|Death|0|||
145333641|NCT04453202|524071639|FG004|Overall Study|Death|0|||
145333642|NCT04453202|524071640|FG005|Overall Study|Death|0|||
145333643|NCT04453202|524071641|FG006|Overall Study|Death|0|||
145333644|NCT04453202|524071642|FG007|Overall Study|Death|0|||
145333645|NCT04453202|524071643|FG008|Overall Study|Death|0|||
145333646|NCT04453202|524071644|FG009|Overall Study|Death|1|||
145333647|NCT04453202|524071645|FG010|Overall Study|Death|0|||
145573145|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573146|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573147|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573148|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573149|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573150|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573151|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573152|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573153|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573154|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573155|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145333648|NCT04453202|524071635|FG000|Overall Study|Lost to Follow-up|0|||
145333649|NCT04453202|524071636|FG001|Overall Study|Lost to Follow-up|1|||
145333650|NCT04453202|524071637|FG002|Overall Study|Lost to Follow-up|0|||
145333651|NCT04453202|524071638|FG003|Overall Study|Lost to Follow-up|1|||
145333652|NCT04453202|524071639|FG004|Overall Study|Lost to Follow-up|0|||
145333653|NCT04453202|524071640|FG005|Overall Study|Lost to Follow-up|0|||
145412795|NCT01127061|524365886|FG000|Overall Study|Lost to Follow-up|7|||
145333654|NCT04453202|524071641|FG006|Overall Study|Lost to Follow-up|0|||
145333655|NCT04453202|524071642|FG007|Overall Study|Lost to Follow-up|0|||
145333656|NCT04453202|524071643|FG008|Overall Study|Lost to Follow-up|0|||
145333657|NCT04453202|524071644|FG009|Overall Study|Lost to Follow-up|1|||
145333658|NCT04453202|524071645|FG010|Overall Study|Lost to Follow-up|1|||
145333659|NCT04453202|524071635|FG000|Overall Study|Withdrawal by Subject|1|||
145333660|NCT04453202|524071636|FG001|Overall Study|Withdrawal by Subject|2|||
145333661|NCT04453202|524071637|FG002|Overall Study|Withdrawal by Subject|1|||
145333662|NCT04453202|524071638|FG003|Overall Study|Withdrawal by Subject|2|||
145333663|NCT04453202|524071639|FG004|Overall Study|Withdrawal by Subject|1|||
145333664|NCT04453202|524071640|FG005|Overall Study|Withdrawal by Subject|1|||
145333665|NCT04453202|524071641|FG006|Overall Study|Withdrawal by Subject|0|||
145333666|NCT04453202|524071642|FG007|Overall Study|Withdrawal by Subject|0|||
145333667|NCT04453202|524071643|FG008|Overall Study|Withdrawal by Subject|0|||
145333668|NCT04453202|524071644|FG009|Overall Study|Withdrawal by Subject|1|||
145333669|NCT04453202|524071645|FG010|Overall Study|Withdrawal by Subject|0|||
145333670|NCT04453202|524071635|FG000|Overall Study|Adverse Event|0|||
145333671|NCT04453202|524071636|FG001|Overall Study|Adverse Event|0|||
145333672|NCT04453202|524071637|FG002|Overall Study|Adverse Event|0|||
145333673|NCT04453202|524071638|FG003|Overall Study|Adverse Event|0|||
145412796|NCT01127061|524365887|FG001|Overall Study|Lost to Follow-up|10|||
145412797|NCT01127061|524365886|FG000|Overall Study|Physician Decision|3|||
145412798|NCT01127061|524365887|FG001|Overall Study|Physician Decision|3|||
145412799|NCT04827446|524365890|FG000|Overall Study|Lost to Follow-up|1|||
145412800|NCT04827446|524365891|FG001|Overall Study|Lost to Follow-up|1|||
145412801|NCT04827446|524365890|FG000|Overall Study|Death|2|||
145412802|NCT04827446|524365891|FG001|Overall Study|Death|0|||
145412803|NCT04827446|524365890|FG000|Overall Study|Withdrawal by Subject|2|||
145412804|NCT04827446|524365891|FG001|Overall Study|Withdrawal by Subject|2|||
145412805|NCT01112267|524365892|FG000|Overall Study|Adverse Event|24|||
145412806|NCT01112267|524365893|FG001|Overall Study|Adverse Event|6|||
145412807|NCT01112267|524365892|FG000|Overall Study|Withdrawal by Subject|3|||
145412808|NCT01112267|524365893|FG001|Overall Study|Withdrawal by Subject|5|||
145412809|NCT01112267|524365892|FG000|Overall Study|Protocol Violation|5|||
145412810|NCT01112267|524365893|FG001|Overall Study|Protocol Violation|3|||
145412811|NCT01112267|524365892|FG000|Overall Study|Participants not compliant|1|||
145412812|NCT01112267|524365893|FG001|Overall Study|Participants not compliant|2|||
145412813|NCT01112267|524365892|FG000|Overall Study|Participants not receive any study drug|1|||
145412814|NCT01112267|524365893|FG001|Overall Study|Participants not receive any study drug|2|||
145412815|NCT00003456|524365894|FG000|Overall Study|Not evaluable|8|||
145412816|NCT00587457|524365897|FG000|Overall Study|Adverse Event|1|||
145412817|NCT00587457|524365898|FG001|Overall Study|Adverse Event|2|||
145412818|NCT00587457|524365899|FG002|Overall Study|Adverse Event|1|||
145412819|NCT00587457|524365897|FG000|Overall Study|Disease progression|2|||
145412820|NCT00587457|524365898|FG001|Overall Study|Disease progression|0|||
145412821|NCT00587457|524365899|FG002|Overall Study|Disease progression|2|||
145412822|NCT00587457|524365897|FG000|Overall Study|Initiation of alternative therapy|0|||
145412823|NCT00587457|524365898|FG001|Overall Study|Initiation of alternative therapy|1|||
145412824|NCT00587457|524365899|FG002|Overall Study|Initiation of alternative therapy|0|||
145412825|NCT00587457|524365897|FG000|Overall Study|Undefined|0|||
145412826|NCT00587457|524365898|FG001|Overall Study|Undefined|0|||
145412827|NCT00587457|524365899|FG002|Overall Study|Undefined|1|||
145412828|NCT00587457|524365897|FG000|Overall Study|Development of neutralizing Abs|0|||
145412829|NCT00587457|524365898|FG001|Overall Study|Development of neutralizing Abs|0|||
145412830|NCT00587457|524365899|FG002|Overall Study|Development of neutralizing Abs|1|||
145412831|NCT00541229|524365900|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
145412832|NCT00541229|524365901|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
145412833|NCT00541229|524365902|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
145412834|NCT00541229|524365903|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
145412835|NCT00541229|524365904|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
145412836|NCT00541229|524365905|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
145333674|NCT04453202|524071639|FG004|Overall Study|Adverse Event|0|||
145333675|NCT04453202|524071640|FG005|Overall Study|Adverse Event|1|||
145412837|NCT00541229|524365900|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145412838|NCT00541229|524365901|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145412839|NCT00541229|524365902|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145412840|NCT00541229|524365903|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145412841|NCT00541229|524365904|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
145412842|NCT00541229|524365905|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
145412843|NCT00541229|524365900|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145412844|NCT00541229|524365901|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145333676|NCT04453202|524071641|FG006|Overall Study|Adverse Event|0|||
145333677|NCT04453202|524071642|FG007|Overall Study|Adverse Event|0|||
145333678|NCT04453202|524071643|FG008|Overall Study|Adverse Event|0|||
145333679|NCT04453202|524071644|FG009|Overall Study|Adverse Event|0|||
145621526|NCT04955626|525126687|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
145621527|NCT04955626|525126688|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
145621528|NCT04955626|525126689|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
145621529|NCT04955626|525126690|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
145621530|NCT04955626|525126691|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
145621531|NCT04955626|525126692|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
145621532|NCT04955626|525126693|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
145621533|NCT04955626|525126694|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
145621534|NCT04955626|525126695|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
145621535|NCT04955626|525126696|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
145621536|NCT04955626|525126697|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
145621537|NCT04955626|525126698|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
145621538|NCT04955626|525126699|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
145621539|NCT04955626|525126700|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
145621540|NCT04955626|525126701|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
145621541|NCT04955626|525126702|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
145621542|NCT04955626|525126703|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
145621543|NCT04955626|525126704|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
145621544|NCT04955626|525126705|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
145621545|NCT04955626|525126706|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
145621546|NCT04955626|525126707|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
145621547|NCT04955626|525126672|FG000|Open-Label Period|Other|621|||
145621548|NCT04955626|525126673|FG001|Open-Label Period|Other|429|||
145621549|NCT04955626|525126674|FG002|Open-Label Period|Other|0|||
145621550|NCT04955626|525126675|FG003|Open-Label Period|Other|0|||
145333680|NCT04453202|524071645|FG010|Overall Study|Adverse Event|0|||
145333681|NCT00669071|524071649|FG000|Overall Study|Lost to Follow-up|3|||
145333682|NCT00669071|524071649|FG000|Overall Study|Final visit 40 days out of window|1|||
145333683|NCT03276221|524071650|FG000|Overall Study|Lost to Follow-up|6|||
145333684|NCT03276221|524071651|FG001|Overall Study|Lost to Follow-up|2|||
145333685|NCT03276221|524071652|FG002|Overall Study|Lost to Follow-up|0|||
145333686|NCT03276221|524071650|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
145333687|NCT03276221|524071651|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
145333688|NCT03276221|524071652|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
145333689|NCT00424775|524071653|FG000|Overall Study|Adverse Event|2|||
145333690|NCT00424775|524071654|FG001|Overall Study|Adverse Event|0|||
145333691|NCT00424775|524071653|FG000|Overall Study|Lack of Efficacy|1|||
145333692|NCT00424775|524071654|FG001|Overall Study|Lack of Efficacy|0|||
145333693|NCT02900976|524071656|FG000|Overall Study|Adverse Event|0|||
145333694|NCT02900976|524071657|FG001|Overall Study|Adverse Event|1|||
145333695|NCT02900976|524071656|FG000|Overall Study|Physician Decision|0|||
145333696|NCT02900976|524071657|FG001|Overall Study|Physician Decision|2|||
145333697|NCT02900976|524071656|FG000|Overall Study|Progressive disease|0|||
145333698|NCT02900976|524071657|FG001|Overall Study|Progressive disease|6|||
145333699|NCT01408628|524071658|FG000|Consented|Withdrawal by Subject|12|||
145333700|NCT01408628|524071658|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
145333701|NCT01408628|524071658|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
145333702|NCT01408628|524071658|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
145333703|NCT01181271|524071659|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
145333704|NCT01181271|524071659|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
145333705|NCT01181271|524071659|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
145333706|NCT01181271|524071659|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
145333707|NCT00750308|524071660|FG000|First Treatment|Adverse Event|0|||
145333708|NCT00750308|524071661|FG001|First Treatment|Adverse Event|1|||
145333709|NCT00750308|524071662|FG002|First Treatment|Adverse Event|0|||
145333710|NCT00750308|524071663|FG003|First Treatment|Adverse Event|0|||
145333711|NCT00750308|524071664|FG004|First Treatment|Adverse Event|0|||
145333712|NCT00750308|524071665|FG005|First Treatment|Adverse Event|0|||
145333713|NCT00750308|524071666|FG006|First Treatment|Adverse Event|0|||
145333714|NCT00750308|524071667|FG007|First Treatment|Adverse Event|0|||
145333715|NCT00750308|524071668|FG008|First Treatment|Adverse Event|0|||
145333716|NCT00750308|524071669|FG009|First Treatment|Adverse Event|0|||
145333717|NCT00750308|524071670|FG010|First Treatment|Adverse Event|1|||
145333718|NCT00750308|524071671|FG011|First Treatment|Adverse Event|1|||
145333719|NCT00750308|524071660|FG000|First Treatment|Withdrawal by Subject|0|||
145333720|NCT00750308|524071661|FG001|First Treatment|Withdrawal by Subject|0|||
145333721|NCT00750308|524071662|FG002|First Treatment|Withdrawal by Subject|0|||
145333722|NCT00750308|524071663|FG003|First Treatment|Withdrawal by Subject|1|||
145333723|NCT00750308|524071664|FG004|First Treatment|Withdrawal by Subject|0|||
145333724|NCT00750308|524071665|FG005|First Treatment|Withdrawal by Subject|0|||
145333725|NCT00750308|524071666|FG006|First Treatment|Withdrawal by Subject|0|||
145333726|NCT00750308|524071667|FG007|First Treatment|Withdrawal by Subject|1|||
145333727|NCT00750308|524071668|FG008|First Treatment|Withdrawal by Subject|0|||
145621551|NCT04955626|525126676|FG004|Open-Label Period|Other|0|||
145621552|NCT04955626|525126677|FG005|Open-Label Period|Other|0|||
145621553|NCT04955626|525126678|FG006|Open-Label Period|Other|0|||
145621554|NCT04955626|525126679|FG007|Open-Label Period|Other|0|||
145621555|NCT04955626|525126680|FG008|Open-Label Period|Other|0|||
145621556|NCT04955626|525126681|FG009|Open-Label Period|Other|0|||
145621557|NCT04955626|525126682|FG010|Open-Label Period|Other|0|||
145621558|NCT04955626|525126683|FG011|Open-Label Period|Other|0|||
145621559|NCT04955626|525126684|FG012|Open-Label Period|Other|0|||
145621560|NCT04955626|525126685|FG013|Open-Label Period|Other|0|||
145621561|NCT04955626|525126686|FG014|Open-Label Period|Other|0|||
145621562|NCT04955626|525126687|FG015|Open-Label Period|Other|0|||
145621563|NCT04955626|525126688|FG016|Open-Label Period|Other|0|||
145621564|NCT04955626|525126689|FG017|Open-Label Period|Other|0|||
145621565|NCT04955626|525126690|FG018|Open-Label Period|Other|0|||
145621566|NCT04955626|525126691|FG019|Open-Label Period|Other|0|||
145621567|NCT04955626|525126692|FG020|Open-Label Period|Other|0|||
145621568|NCT04955626|525126693|FG021|Open-Label Period|Other|0|||
145333728|NCT00750308|524071669|FG009|First Treatment|Withdrawal by Subject|0|||
145333729|NCT00750308|524071670|FG010|First Treatment|Withdrawal by Subject|0|||
145333730|NCT00750308|524071671|FG011|First Treatment|Withdrawal by Subject|0|||
145333731|NCT00750308|524071660|FG000|Second Treatment|Adverse Event|0|||
145412845|NCT00541229|524365902|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145333732|NCT00750308|524071661|FG001|Second Treatment|Adverse Event|0|||
145333733|NCT00750308|524071662|FG002|Second Treatment|Adverse Event|0|||
145333734|NCT00750308|524071663|FG003|Second Treatment|Adverse Event|0|||
145333735|NCT00750308|524071664|FG004|Second Treatment|Adverse Event|0|||
145333736|NCT00750308|524071665|FG005|Second Treatment|Adverse Event|1|||
145333737|NCT00750308|524071666|FG006|Second Treatment|Adverse Event|0|||
145333738|NCT00750308|524071667|FG007|Second Treatment|Adverse Event|0|||
145333739|NCT00750308|524071668|FG008|Second Treatment|Adverse Event|1|||
145333740|NCT00750308|524071669|FG009|Second Treatment|Adverse Event|0|||
145333741|NCT00750308|524071670|FG010|Second Treatment|Adverse Event|0|||
145333742|NCT00750308|524071671|FG011|Second Treatment|Adverse Event|0|||
145333743|NCT00750308|524071660|FG000|Second Treatment|Withdrawal by Subject|0|||
145333744|NCT00750308|524071661|FG001|Second Treatment|Withdrawal by Subject|0|||
145333745|NCT00750308|524071662|FG002|Second Treatment|Withdrawal by Subject|0|||
145333746|NCT00750308|524071663|FG003|Second Treatment|Withdrawal by Subject|0|||
145333747|NCT00750308|524071664|FG004|Second Treatment|Withdrawal by Subject|1|||
145333748|NCT00750308|524071665|FG005|Second Treatment|Withdrawal by Subject|0|||
145333749|NCT00750308|524071666|FG006|Second Treatment|Withdrawal by Subject|0|||
145333750|NCT00750308|524071667|FG007|Second Treatment|Withdrawal by Subject|0|||
145333751|NCT00750308|524071668|FG008|Second Treatment|Withdrawal by Subject|0|||
145333752|NCT00750308|524071669|FG009|Second Treatment|Withdrawal by Subject|0|||
145333753|NCT00750308|524071670|FG010|Second Treatment|Withdrawal by Subject|0|||
145333754|NCT00750308|524071671|FG011|Second Treatment|Withdrawal by Subject|0|||
145333755|NCT00750308|524071660|FG000|Third Treatment|Withdrawal by Subject|0|||
145333756|NCT00750308|524071661|FG001|Third Treatment|Withdrawal by Subject|1|||
145333757|NCT00750308|524071662|FG002|Third Treatment|Withdrawal by Subject|0|||
145333758|NCT00750308|524071663|FG003|Third Treatment|Withdrawal by Subject|0|||
145333759|NCT00750308|524071664|FG004|Third Treatment|Withdrawal by Subject|0|||
145333760|NCT00750308|524071665|FG005|Third Treatment|Withdrawal by Subject|0|||
145333761|NCT00750308|524071666|FG006|Third Treatment|Withdrawal by Subject|0|||
145333762|NCT00750308|524071667|FG007|Third Treatment|Withdrawal by Subject|0|||
145333763|NCT00750308|524071668|FG008|Third Treatment|Withdrawal by Subject|0|||
145333764|NCT00750308|524071669|FG009|Third Treatment|Withdrawal by Subject|0|||
145333765|NCT00750308|524071670|FG010|Third Treatment|Withdrawal by Subject|0|||
145333766|NCT00750308|524071671|FG011|Third Treatment|Withdrawal by Subject|0|||
145333767|NCT00513682|524071672|FG000|Washout Phase|Adverse Event|2|||
145412846|NCT00541229|524365903|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145333768|NCT04156620|524071673|FG000|Overall Study|Adverse event - TP 1|5|||
145333769|NCT04156620|524071674|FG001|Overall Study|Adverse event - TP 1|2|||
145573156|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573157|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573158|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573159|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573160|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573161|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
145573162|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
145573163|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145573164|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
145573165|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
145621569|NCT04955626|525126694|FG022|Open-Label Period|Other|0|||
145621570|NCT04955626|525126695|FG023|Open-Label Period|Other|0|||
145621571|NCT04955626|525126696|FG024|Open-Label Period|Other|0|||
145621572|NCT04955626|525126697|FG025|Open-Label Period|Other|0|||
145621573|NCT04955626|525126698|FG026|Open-Label Period|Other|0|||
145412847|NCT00541229|524365904|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
145412848|NCT00541229|524365905|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
145412849|NCT00541229|524365900|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
145412850|NCT00541229|524365901|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
145412851|NCT00541229|524365902|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
145412852|NCT00541229|524365903|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
145412853|NCT00541229|524365904|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
145412854|NCT00541229|524365905|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
145412855|NCT00541229|524365900|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
145412856|NCT00541229|524365901|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
145412857|NCT00541229|524365902|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
145412858|NCT00541229|524365903|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
145412859|NCT00541229|524365904|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
145412860|NCT00541229|524365905|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
145412861|NCT00541229|524365900|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
145412862|NCT00541229|524365901|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
145412863|NCT00541229|524365902|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
145412864|NCT00541229|524365903|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
145412865|NCT00541229|524365904|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
145412866|NCT00541229|524365905|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
145412867|NCT00541229|524365900|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
145412868|NCT00541229|524365901|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
145412869|NCT00541229|524365902|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
145412870|NCT00541229|524365903|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
145412871|NCT00541229|524365904|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
145412872|NCT00541229|524365905|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
145412873|NCT00541229|524365900|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145412874|NCT00541229|524365901|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
145412875|NCT00541229|524365902|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145412876|NCT00541229|524365903|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
145412877|NCT00541229|524365904|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
145412878|NCT00541229|524365905|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
145412879|NCT00541229|524365900|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
145412880|NCT00541229|524365901|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
145412881|NCT00541229|524365902|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
145412882|NCT00541229|524365903|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
145412883|NCT00541229|524365904|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
145412884|NCT00541229|524365905|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
145412885|NCT00541229|524365900|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
145412886|NCT00541229|524365901|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145333770|NCT04156620|524071673|FG000|Overall Study|Lost to follow-up TP 1|1|||
145333771|NCT04156620|524071674|FG001|Overall Study|Lost to follow-up TP 1|1|||
145333772|NCT04156620|524071673|FG000|Overall Study|Progressive disease - TP 1|0|||
145333773|NCT04156620|524071674|FG001|Overall Study|Progressive disease - TP 1|1|||
145333774|NCT04156620|524071673|FG000|Overall Study|Subject decision - TP 1|3|||
145333775|NCT04156620|524071674|FG001|Overall Study|Subject decision - TP 1|5|||
145333776|NCT04156620|524071673|FG000|Overall Study|Adverse event - TP 2|5|||
145333777|NCT04156620|524071674|FG001|Overall Study|Adverse event - TP 2|6|||
145333778|NCT04156620|524071673|FG000|Overall Study|Death - TP 2|1|||
145333779|NCT04156620|524071674|FG001|Overall Study|Death - TP 2|0|||
145333780|NCT04156620|524071673|FG000|Overall Study|Lost to follow-up - TP 2|5|||
145333781|NCT04156620|524071674|FG001|Overall Study|Lost to follow-up - TP 2|2|||
145333782|NCT04156620|524071673|FG000|Overall Study|Physician decision - TP 2|4|||
145333783|NCT04156620|524071674|FG001|Overall Study|Physician decision - TP 2|2|||
145333784|NCT04156620|524071673|FG000|Overall Study|Pregnancy - TP 2|1|||
145333785|NCT04156620|524071674|FG001|Overall Study|Pregnancy - TP 2|1|||
145412887|NCT00541229|524365902|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145412888|NCT00541229|524365903|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145621574|NCT04955626|525126699|FG027|Open-Label Period|Other|0|||
145621575|NCT04955626|525126700|FG028|Open-Label Period|Other|0|||
145333786|NCT04156620|524071673|FG000|Overall Study|Subject decision - TP 2|11|||
145333787|NCT04156620|524071674|FG001|Overall Study|Subject decision - TP 2|9|||
145333788|NCT04156620|524071673|FG000|Overall Study|New therapy for study indication - TP 2|1|||
145333789|NCT04156620|524071674|FG001|Overall Study|New therapy for study indication - TP 2|0|||
145333790|NCT02980874|524071675|FG000|Overall Study|Adverse Event|2|||
145333791|NCT02980874|524071676|FG001|Overall Study|Adverse Event|7|||
145333792|NCT02980874|524071675|FG000|Overall Study|Withdrawal by Subject|7|||
145412889|NCT00541229|524365904|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
145412890|NCT00541229|524365905|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
145412891|NCT00541229|524365900|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
145412892|NCT00541229|524365901|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
145333793|NCT02980874|524071676|FG001|Overall Study|Withdrawal by Subject|2|||
145333794|NCT02980874|524071675|FG000|Overall Study|Lost to Follow-up|5|||
145333795|NCT02980874|524071676|FG001|Overall Study|Lost to Follow-up|5|||
145333796|NCT02980874|524071675|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
145333797|NCT02980874|524071676|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
145333798|NCT02980874|524071675|FG000|Overall Study|Unknown study completion status|1|||
145333799|NCT02980874|524071676|FG001|Overall Study|Unknown study completion status|0|||
145333800|NCT02450526|524071677|FG000|DB Period (Cycle 1)|Adverse Event|0|||
145333801|NCT02450526|524071678|FG001|DB Period (Cycle 1)|Adverse Event|0|||
145333802|NCT02450526|524071679|FG002|DB Period (Cycle 1)|Adverse Event|2|||
145333803|NCT02450526|524071680|FG003|DB Period (Cycle 1)|Adverse Event|0|||
145333804|NCT02450526|524071681|FG004|DB Period (Cycle 1)|Adverse Event|0|||
145333805|NCT02450526|524071677|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
145333806|NCT02450526|524071678|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
145333807|NCT02450526|524071679|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
145333808|NCT02450526|524071680|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
145333809|NCT02450526|524071681|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
145333810|NCT02450526|524071677|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
145333811|NCT02450526|524071678|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
145333812|NCT02450526|524071679|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
145333813|NCT02450526|524071680|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
145333814|NCT02450526|524071681|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
145333815|NCT02450526|524071677|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
145333816|NCT02450526|524071678|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
145333817|NCT02450526|524071679|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
145333818|NCT02450526|524071680|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
145333819|NCT02450526|524071681|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
145333820|NCT02450526|524071677|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
145333821|NCT02450526|524071678|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
145333822|NCT02450526|524071679|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
145333823|NCT02450526|524071680|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
145333824|NCT02450526|524071681|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
145333825|NCT02450526|524071677|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145333826|NCT02450526|524071678|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145333827|NCT02450526|524071679|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145333828|NCT02450526|524071680|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
145333829|NCT02450526|524071681|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
145333830|NCT02450526|524071677|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145333831|NCT02450526|524071678|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145333832|NCT02450526|524071679|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145333833|NCT02450526|524071680|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
145333834|NCT02450526|524071681|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
145333835|NCT02450526|524071677|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
145333836|NCT02450526|524071678|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
145333837|NCT02450526|524071679|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
145333838|NCT02450526|524071680|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
145333839|NCT02450526|524071681|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
145333840|NCT01753336|524071682|FG000|Overall Study|Patient decision|12|||
145333841|NCT01753336|524071682|FG000|Overall Study|Lost to Follow-up|3|||
145333842|NCT01753336|524071682|FG000|Overall Study|Physician Decision|2|||
145333843|NCT01753336|524071682|FG000|Overall Study|Sponsor's decision|2|||
145333844|NCT01753336|524071682|FG000|Overall Study|Withdrawal by Subject|1|||
145333845|NCT02435836|524071683|FG000|Overall Study|Lost to Follow-up|21|||
145333846|NCT02435836|524071683|FG000|Overall Study|Lack of Efficacy|1|||
145333847|NCT02435836|524071683|FG000|Overall Study|Withdrawal by Subject|236|||
145333848|NCT02435836|524071683|FG000|Overall Study|Insufficient Clinical Response|26|||
145333849|NCT02435836|524071683|FG000|Overall Study|Adverse Event|44|||
145333850|NCT02435836|524071683|FG000|Overall Study|Sponsor discontinued trial|167|||
145333851|NCT02435836|524071683|FG000|Overall Study|Noncompliance|27|||
145333852|NCT02435836|524071683|FG000|Overall Study|Protocol Violation|6|||
145333853|NCT02435836|524071683|FG000|Overall Study|Met Withdrawal Criteria|7|||
145573166|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
145333854|NCT02435836|524071683|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
145333855|NCT01629966|524071684|FG000|Overall Study|Pregnancy|0|||
145333856|NCT01629966|524071685|FG001|Overall Study|Pregnancy|1|||
145333857|NCT01629966|524071686|FG002|Overall Study|Pregnancy|0|||
145333858|NCT01629966|524071684|FG000|Overall Study|Lost to Follow-up|10|||
145333859|NCT01629966|524071685|FG001|Overall Study|Lost to Follow-up|13|||
145333860|NCT01629966|524071686|FG002|Overall Study|Lost to Follow-up|9|||
145333861|NCT01629966|524071684|FG000|Overall Study|Withdrawal by Subject|8|||
145333862|NCT01629966|524071685|FG001|Overall Study|Withdrawal by Subject|9|||
145333863|NCT01629966|524071686|FG002|Overall Study|Withdrawal by Subject|16|||
145333864|NCT01629966|524071684|FG000|Overall Study|Protocol Violation|7|||
145621576|NCT04955626|525126701|FG029|Open-Label Period|Other|0|||
145333865|NCT01629966|524071685|FG001|Overall Study|Protocol Violation|9|||
145333866|NCT01629966|524071686|FG002|Overall Study|Protocol Violation|7|||
145333867|NCT01629966|524071684|FG000|Overall Study|Lack of Efficacy|5|||
145333868|NCT01629966|524071685|FG001|Overall Study|Lack of Efficacy|2|||
145333869|NCT01629966|524071686|FG002|Overall Study|Lack of Efficacy|4|||
145333870|NCT01629966|524071684|FG000|Overall Study|Adverse Event|11|||
145333871|NCT01629966|524071685|FG001|Overall Study|Adverse Event|18|||
145333872|NCT01629966|524071686|FG002|Overall Study|Adverse Event|30|||
145333873|NCT02991430|524071689|FG000|Treatment Period 1|Adverse Event|1|||
145333874|NCT02991430|524071690|FG001|Treatment Period 1|Adverse Event|0|||
145333875|NCT02991430|524071691|FG002|Treatment Period 1|Adverse Event|2|||
145333876|NCT02991430|524071689|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145333877|NCT02991430|524071690|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145333878|NCT02991430|524071691|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145333879|NCT02991430|524071689|FG000|Treatment Period 2|Study Termination|6|||
145333880|NCT02991430|524071690|FG001|Treatment Period 2|Study Termination|3|||
145333881|NCT02991430|524071691|FG002|Treatment Period 2|Study Termination|3|||
145333882|NCT02991430|524071689|FG000|Treatment Period 2|Lost to Follow-up|0|||
145333883|NCT02991430|524071690|FG001|Treatment Period 2|Lost to Follow-up|0|||
145333884|NCT02991430|524071691|FG002|Treatment Period 2|Lost to Follow-up|1|||
145333885|NCT02991430|524071689|FG000|Post-treatment Observation Period|Study Termination|3|||
145333886|NCT02991430|524071690|FG001|Post-treatment Observation Period|Study Termination|6|||
145333887|NCT02991430|524071691|FG002|Post-treatment Observation Period|Study Termination|5|||
145333888|NCT03970837|524071692|FG000|Overall Study|Adverse Event|23|||
145333889|NCT03970837|524071693|FG001|Overall Study|Adverse Event|20|||
145333890|NCT03970837|524071694|FG002|Overall Study|Adverse Event|16|||
145333891|NCT03970837|524071695|FG003|Overall Study|Adverse Event|6|||
145333892|NCT03970837|524071696|FG004|Overall Study|Adverse Event|4|||
145333893|NCT03970837|524071697|FG005|Overall Study|Adverse Event|5|||
145333894|NCT03970837|524071698|FG006|Overall Study|Adverse Event|1|||
145333895|NCT03970837|524071699|FG007|Overall Study|Adverse Event|5|||
145333896|NCT03970837|524071700|FG008|Overall Study|Adverse Event|0|||
145333897|NCT03970837|524071701|FG009|Overall Study|Adverse Event|0|||
145333898|NCT03970837|524071702|FG010|Overall Study|Adverse Event|1|||
145333899|NCT03970837|524071703|FG011|Overall Study|Adverse Event|1|||
145333900|NCT03970837|524071692|FG000|Overall Study|Lack of Efficacy|14|||
145333901|NCT03970837|524071693|FG001|Overall Study|Lack of Efficacy|12|||
145333902|NCT03970837|524071694|FG002|Overall Study|Lack of Efficacy|1|||
145333903|NCT03970837|524071695|FG003|Overall Study|Lack of Efficacy|2|||
145333904|NCT03970837|524071696|FG004|Overall Study|Lack of Efficacy|3|||
145333905|NCT03970837|524071697|FG005|Overall Study|Lack of Efficacy|4|||
145333906|NCT03970837|524071698|FG006|Overall Study|Lack of Efficacy|6|||
145333907|NCT03970837|524071699|FG007|Overall Study|Lack of Efficacy|1|||
145333908|NCT03970837|524071700|FG008|Overall Study|Lack of Efficacy|1|||
145333909|NCT03970837|524071701|FG009|Overall Study|Lack of Efficacy|0|||
145333910|NCT03970837|524071702|FG010|Overall Study|Lack of Efficacy|0|||
145333911|NCT03970837|524071703|FG011|Overall Study|Lack of Efficacy|0|||
145333912|NCT03970837|524071692|FG000|Overall Study|Lost to Follow-up|6|||
145333913|NCT03970837|524071693|FG001|Overall Study|Lost to Follow-up|5|||
145333914|NCT03970837|524071694|FG002|Overall Study|Lost to Follow-up|5|||
145333915|NCT03970837|524071695|FG003|Overall Study|Lost to Follow-up|1|||
145333916|NCT03970837|524071696|FG004|Overall Study|Lost to Follow-up|0|||
145333917|NCT03970837|524071697|FG005|Overall Study|Lost to Follow-up|2|||
145333918|NCT03970837|524071698|FG006|Overall Study|Lost to Follow-up|0|||
145333919|NCT03970837|524071699|FG007|Overall Study|Lost to Follow-up|0|||
145333920|NCT03970837|524071700|FG008|Overall Study|Lost to Follow-up|0|||
145333921|NCT03970837|524071701|FG009|Overall Study|Lost to Follow-up|0|||
145333922|NCT03970837|524071702|FG010|Overall Study|Lost to Follow-up|0|||
145333923|NCT03970837|524071703|FG011|Overall Study|Lost to Follow-up|0|||
145333924|NCT03970837|524071692|FG000|Overall Study|Protocol Violation|1|||
145333925|NCT03970837|524071693|FG001|Overall Study|Protocol Violation|0|||
145333926|NCT03970837|524071694|FG002|Overall Study|Protocol Violation|0|||
145333927|NCT03970837|524071695|FG003|Overall Study|Protocol Violation|0|||
145333928|NCT03970837|524071696|FG004|Overall Study|Protocol Violation|0|||
145333929|NCT03970837|524071697|FG005|Overall Study|Protocol Violation|0|||
145333930|NCT03970837|524071698|FG006|Overall Study|Protocol Violation|0|||
145333931|NCT03970837|524071699|FG007|Overall Study|Protocol Violation|0|||
145333932|NCT03970837|524071700|FG008|Overall Study|Protocol Violation|0|||
145333933|NCT03970837|524071701|FG009|Overall Study|Protocol Violation|0|||
145333934|NCT03970837|524071702|FG010|Overall Study|Protocol Violation|0|||
145333935|NCT03970837|524071703|FG011|Overall Study|Protocol Violation|0|||
145333936|NCT03970837|524071692|FG000|Overall Study|Physician Decision|5|||
145333937|NCT03970837|524071693|FG001|Overall Study|Physician Decision|8|||
145333938|NCT03970837|524071694|FG002|Overall Study|Physician Decision|4|||
145333939|NCT03970837|524071695|FG003|Overall Study|Physician Decision|1|||
145333940|NCT03970837|524071696|FG004|Overall Study|Physician Decision|5|||
145333941|NCT03970837|524071697|FG005|Overall Study|Physician Decision|2|||
145333942|NCT03970837|524071698|FG006|Overall Study|Physician Decision|4|||
145333943|NCT03970837|524071699|FG007|Overall Study|Physician Decision|5|||
145333944|NCT03970837|524071700|FG008|Overall Study|Physician Decision|0|||
145333945|NCT03970837|524071701|FG009|Overall Study|Physician Decision|1|||
145333946|NCT03970837|524071702|FG010|Overall Study|Physician Decision|0|||
145333947|NCT03970837|524071703|FG011|Overall Study|Physician Decision|0|||
145333948|NCT03970837|524071692|FG000|Overall Study|Withdrawal by Subject|32|||
145333949|NCT03970837|524071693|FG001|Overall Study|Withdrawal by Subject|35|||
145333950|NCT03970837|524071694|FG002|Overall Study|Withdrawal by Subject|12|||
145333951|NCT03970837|524071695|FG003|Overall Study|Withdrawal by Subject|8|||
145333952|NCT03970837|524071696|FG004|Overall Study|Withdrawal by Subject|6|||
145333953|NCT03970837|524071697|FG005|Overall Study|Withdrawal by Subject|8|||
145333954|NCT03970837|524071698|FG006|Overall Study|Withdrawal by Subject|2|||
145333955|NCT03970837|524071699|FG007|Overall Study|Withdrawal by Subject|3|||
145333956|NCT03970837|524071700|FG008|Overall Study|Withdrawal by Subject|0|||
145333957|NCT03970837|524071701|FG009|Overall Study|Withdrawal by Subject|0|||
145333958|NCT03970837|524071702|FG010|Overall Study|Withdrawal by Subject|0|||
145333959|NCT03970837|524071703|FG011|Overall Study|Withdrawal by Subject|1|||
145333960|NCT03970837|524071692|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
145333961|NCT03970837|524071693|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
145333962|NCT03970837|524071694|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
145333963|NCT03970837|524071695|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145333964|NCT03970837|524071696|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
145333965|NCT03970837|524071697|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145333966|NCT03970837|524071698|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145333967|NCT03970837|524071699|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145333968|NCT03970837|524071700|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
145333969|NCT03970837|524071701|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145333970|NCT03970837|524071702|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145333971|NCT03970837|524071703|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
145333972|NCT03970837|524071692|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333973|NCT03970837|524071693|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333974|NCT03970837|524071694|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333975|NCT03970837|524071695|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333976|NCT03970837|524071696|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333977|NCT03970837|524071697|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145333978|NCT03970837|524071698|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
145333979|NCT03970837|524071699|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
145333980|NCT03970837|524071700|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
145333981|NCT03970837|524071701|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
145333982|NCT03970837|524071702|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
145333983|NCT03970837|524071703|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
145333984|NCT04568031|524071706|FG000|Overall Study|Lost to Follow-up|1|||
145333985|NCT04568031|524071707|FG001|Overall Study|Lost to Follow-up|0|||
145333986|NCT04568031|524071708|FG002|Overall Study|Lost to Follow-up|0|||
145333987|NCT04568031|524071709|FG003|Overall Study|Lost to Follow-up|0|||
145333988|NCT04568031|524071706|FG000|Overall Study|Physician Decision|1|||
145333989|NCT04568031|524071707|FG001|Overall Study|Physician Decision|0|||
145333990|NCT04568031|524071708|FG002|Overall Study|Physician Decision|1|||
145333991|NCT04568031|524071709|FG003|Overall Study|Physician Decision|0|||
145333992|NCT04568031|524071706|FG000|Overall Study|Withdrawal by Subject|1|||
145333993|NCT04568031|524071707|FG001|Overall Study|Withdrawal by Subject|0|||
145333994|NCT04568031|524071708|FG002|Overall Study|Withdrawal by Subject|4|||
145333995|NCT04568031|524071709|FG003|Overall Study|Withdrawal by Subject|1|||
145333996|NCT00228423|524071712|FG000|Overall Study|Adverse Event|2|||
145333997|NCT00228423|524071713|FG001|Overall Study|Adverse Event|5|||
145333998|NCT00228423|524071712|FG000|Overall Study|Withdrawal by Subject|7|||
145333999|NCT00228423|524071713|FG001|Overall Study|Withdrawal by Subject|3|||
145334000|NCT00228423|524071712|FG000|Overall Study|Protocol Violation|1|||
145334001|NCT00228423|524071713|FG001|Overall Study|Protocol Violation|3|||
145334002|NCT00228423|524071712|FG000|Overall Study|Physician Decision|0|||
145334003|NCT00228423|524071713|FG001|Overall Study|Physician Decision|1|||
145334004|NCT03870477|524071722|FG000|Overall Study|Early Study Termination|1|||
145334005|NCT04555720|524071727|FG000|Overall Study|Lost to Follow-up|2|||
145334006|NCT04555720|524071728|FG001|Overall Study|Lost to Follow-up|0|||
145334007|NCT04555720|524071729|FG002|Overall Study|Lost to Follow-up|0|||
145334008|NCT04555720|524071730|FG003|Overall Study|Lost to Follow-up|0|||
145334009|NCT04555720|524071727|FG000|Overall Study|Withdrawal by Subject|4|||
145334010|NCT04555720|524071728|FG001|Overall Study|Withdrawal by Subject|6|||
145334011|NCT04555720|524071729|FG002|Overall Study|Withdrawal by Subject|0|||
145334012|NCT04555720|524071730|FG003|Overall Study|Withdrawal by Subject|0|||
145334013|NCT00719849|524071731|FG000|Overall Study|Death|0|||
145334014|NCT00719849|524071732|FG001|Overall Study|Death|1|||
145334015|NCT02201290|524071734|FG000|Overall Study|Withdrawal by Subject|2|||
145334016|NCT02201290|524071734|FG000|Overall Study|Lack of Efficacy|2|||
145334017|NCT02201290|524071734|FG000|Overall Study|Adverse Event|1|||
145334018|NCT03907462|524071735|FG000|Overall Study|Physician Decision|1|||
145334019|NCT03907462|524071736|FG001|Overall Study|Physician Decision|3|||
145334020|NCT03907462|524071737|FG002|Overall Study|Physician Decision|1|||
145334021|NCT03907462|524071735|FG000|Overall Study|Withdrawal by Subject|6|||
145334022|NCT03907462|524071736|FG001|Overall Study|Withdrawal by Subject|3|||
145334023|NCT03907462|524071737|FG002|Overall Study|Withdrawal by Subject|3|||
145334024|NCT03907462|524071735|FG000|Overall Study|Pregnancy|4|||
145334025|NCT03907462|524071736|FG001|Overall Study|Pregnancy|2|||
145334026|NCT03907462|524071737|FG002|Overall Study|Pregnancy|6|||
145334027|NCT03907462|524071735|FG000|Overall Study|Lost to Follow-up|16|||
145334028|NCT03907462|524071736|FG001|Overall Study|Lost to Follow-up|18|||
145334029|NCT03907462|524071737|FG002|Overall Study|Lost to Follow-up|22|||
145334030|NCT02370329|524074103|FG000|Overall Study|Alternate treatment|1|||
145334031|NCT02370329|524074103|FG000|Overall Study|Adverse Event|1|||
145334032|NCT02370329|524074103|FG000|Overall Study|Disease progression|3|||
145334033|NCT02370329|524074103|FG000|Overall Study|Physician Decision|2|||
145334034|NCT02370329|524074103|FG000|Overall Study|Study closure|4|||
145334035|NCT01167257|524074105|FG000|Overall Study|Lost to Follow-up|2|||
145334036|NCT01167257|524074106|FG001|Overall Study|Lost to Follow-up|2|||
145334037|NCT01167257|524074105|FG000|Overall Study|Withdrew consent|1|||
145334038|NCT01167257|524074106|FG001|Overall Study|Withdrew consent|1|||
145334039|NCT03283319|524074110|FG000|Overall Study|Lost to Follow-up|5|||
145334040|NCT03283319|524074111|FG001|Overall Study|Lost to Follow-up|4|||
145334041|NCT03283319|524074112|FG002|Overall Study|Lost to Follow-up|5|||
145334042|NCT03283319|524074113|FG003|Overall Study|Lost to Follow-up|5|||
145334043|NCT03283319|524074114|FG004|Overall Study|Lost to Follow-up|4|||
145334044|NCT03283319|524074115|FG005|Overall Study|Lost to Follow-up|3|||
145334045|NCT03283319|524074110|FG000|Overall Study|Withdrawal by Subject|2|||
145334046|NCT03283319|524074111|FG001|Overall Study|Withdrawal by Subject|2|||
145334047|NCT03283319|524074112|FG002|Overall Study|Withdrawal by Subject|2|||
145334048|NCT03283319|524074113|FG003|Overall Study|Withdrawal by Subject|1|||
145334049|NCT03283319|524074114|FG004|Overall Study|Withdrawal by Subject|0|||
145334050|NCT03283319|524074115|FG005|Overall Study|Withdrawal by Subject|1|||
145334051|NCT03283319|524074110|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
145334052|NCT03283319|524074111|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
145334053|NCT03283319|524074112|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
145334054|NCT03283319|524074113|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
145334055|NCT03283319|524074114|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
145334056|NCT03283319|524074115|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
145334057|NCT00721630|524074116|FG000|Overall Study|Participant found to be ineligible|1|||
145334058|NCT02213510|524074118|FG000|Overall Study|Death|0|||
145334059|NCT02213510|524074119|FG001|Overall Study|Death|1|||
145334060|NCT02213510|524074118|FG000|Overall Study|Lost to Follow-up|1|||
145334061|NCT02213510|524074119|FG001|Overall Study|Lost to Follow-up|0|||
145334062|NCT03954834|524074121|FG000|Overall Study|Adverse Event|1|||
145334063|NCT03954834|524074122|FG001|Overall Study|Adverse Event|3|||
145334064|NCT03954834|524074123|FG002|Overall Study|Adverse Event|1|||
145334065|NCT03954834|524074124|FG003|Overall Study|Adverse Event|1|||
145334066|NCT03954834|524074121|FG000|Overall Study|Death|0|||
145334067|NCT03954834|524074122|FG001|Overall Study|Death|0|||
145334068|NCT03954834|524074123|FG002|Overall Study|Death|0|||
145334069|NCT03954834|524074124|FG003|Overall Study|Death|1|||
145334070|NCT03954834|524074121|FG000|Overall Study|Physician Decision|0|||
145334071|NCT03954834|524074122|FG001|Overall Study|Physician Decision|1|||
145334072|NCT03954834|524074123|FG002|Overall Study|Physician Decision|0|||
145334073|NCT03954834|524074124|FG003|Overall Study|Physician Decision|2|||
145334074|NCT03954834|524074121|FG000|Overall Study|Protocol Violation|1|||
145334075|NCT03954834|524074122|FG001|Overall Study|Protocol Violation|0|||
145334076|NCT03954834|524074123|FG002|Overall Study|Protocol Violation|0|||
145334077|NCT03954834|524074124|FG003|Overall Study|Protocol Violation|1|||
145334078|NCT03954834|524074121|FG000|Overall Study|Withdrawal by Subject|2|||
145334079|NCT03954834|524074122|FG001|Overall Study|Withdrawal by Subject|3|||
145334080|NCT03954834|524074123|FG002|Overall Study|Withdrawal by Subject|13|||
145334081|NCT03954834|524074124|FG003|Overall Study|Withdrawal by Subject|6|||
145334082|NCT03954834|524074121|FG000|Overall Study|Participant left the country|0|||
145334083|NCT03954834|524074122|FG001|Overall Study|Participant left the country|0|||
145334084|NCT03954834|524074123|FG002|Overall Study|Participant left the country|1|||
145334085|NCT03954834|524074124|FG003|Overall Study|Participant left the country|0|||
145573167|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573168|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573169|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573170|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573171|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573172|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145621577|NCT04955626|525126702|FG030|Open-Label Period|Other|0|||
145621578|NCT04955626|525126703|FG031|Open-Label Period|Other|0|||
145334086|NCT03954834|524074121|FG000|Overall Study|Lost to Follow-up|3|||
145334087|NCT03954834|524074122|FG001|Overall Study|Lost to Follow-up|2|||
145334088|NCT03954834|524074123|FG002|Overall Study|Lost to Follow-up|3|||
145334089|NCT03954834|524074124|FG003|Overall Study|Lost to Follow-up|5|||
145334090|NCT00372411|524074135|FG000|Overall Study|Withdrawal by Subject|3|||
145334091|NCT00372411|524074136|FG001|Overall Study|Withdrawal by Subject|4|||
145334092|NCT00372411|524074137|FG002|Overall Study|Withdrawal by Subject|1|||
145334093|NCT00372411|524074135|FG000|Overall Study|Death|0|||
145334094|NCT00372411|524074136|FG001|Overall Study|Death|2|||
145334095|NCT00372411|524074137|FG002|Overall Study|Death|1|||
145334096|NCT00372411|524074135|FG000|Overall Study|Lost to Follow-up|1|||
145334097|NCT00372411|524074136|FG001|Overall Study|Lost to Follow-up|1|||
145334098|NCT00372411|524074137|FG002|Overall Study|Lost to Follow-up|1|||
145334099|NCT00372411|524074135|FG000|Overall Study|Adverse Event|1|||
145334100|NCT00372411|524074136|FG001|Overall Study|Adverse Event|1|||
145334101|NCT00372411|524074137|FG002|Overall Study|Adverse Event|0|||
145334102|NCT01398514|524074138|FG000|Overall Study|Adverse Event|1|||
145334103|NCT01398514|524074139|FG001|Overall Study|Adverse Event|0|||
145334104|NCT01398514|524074138|FG000|Overall Study|Non-compliance with study procedures|2|||
145334105|NCT01398514|524074139|FG001|Overall Study|Non-compliance with study procedures|0|||
145334106|NCT01398514|524074138|FG000|Overall Study|Physiologic non-responsiveness|1|||
145334107|NCT01398514|524074139|FG001|Overall Study|Physiologic non-responsiveness|3|||
145334108|NCT01398514|524074138|FG000|Overall Study|Failure to show a conditioned response|4|||
145334109|NCT01398514|524074139|FG001|Overall Study|Failure to show a conditioned response|3|||
145334110|NCT00805675|524074140|FG000|Overall Study|Adverse Event|0|||
145334111|NCT00805675|524074141|FG001|Overall Study|Adverse Event|0|||
145334112|NCT00805675|524074142|FG002|Overall Study|Adverse Event|1|||
145334113|NCT02906930|524074143|FG000|Overall Study|Withdrawal by Subject|0|||
145334114|NCT02906930|524074144|FG001|Overall Study|Withdrawal by Subject|5|||
145334115|NCT02906930|524074145|FG002|Overall Study|Withdrawal by Subject|5|||
145334116|NCT02906930|524074146|FG003|Overall Study|Withdrawal by Subject|4|||
145334117|NCT02906930|524074143|FG000|Overall Study|Lost to Follow-up|5|||
145334118|NCT02906930|524074144|FG001|Overall Study|Lost to Follow-up|7|||
145334119|NCT02906930|524074145|FG002|Overall Study|Lost to Follow-up|5|||
145334120|NCT02906930|524074146|FG003|Overall Study|Lost to Follow-up|2|||
145334121|NCT02906930|524074143|FG000|Overall Study|Death|0|||
145334122|NCT02906930|524074144|FG001|Overall Study|Death|0|||
145334123|NCT02906930|524074145|FG002|Overall Study|Death|1|||
145334124|NCT02906930|524074146|FG003|Overall Study|Death|0|||
145334125|NCT02906930|524074143|FG000|Overall Study|Other|1|||
145334126|NCT02906930|524074144|FG001|Overall Study|Other|2|||
145334127|NCT02906930|524074145|FG002|Overall Study|Other|1|||
145334128|NCT02906930|524074146|FG003|Overall Study|Other|2|||
145334129|NCT00910091|524074149|FG000|Pre-assignment|Withdrawal by Subject|0|||
145334130|NCT00910091|524074150|FG001|Pre-assignment|Withdrawal by Subject|2|||
145334131|NCT00910091|524074149|FG000|Treatment and Survival|Withdrawal by Subject|3|||
145334132|NCT00910091|524074150|FG001|Treatment and Survival|Withdrawal by Subject|4|||
145334133|NCT00910091|524074149|FG000|Treatment and Survival|Adverse Event|1|||
145334134|NCT00910091|524074150|FG001|Treatment and Survival|Adverse Event|0|||
145334135|NCT01908816|524074151|FG000|Overall Study|Subject's no longer requires study drug|0|||
145334136|NCT01908816|524074152|FG001|Overall Study|Subject's no longer requires study drug|0|||
145334137|NCT01908816|524074153|FG002|Overall Study|Subject's no longer requires study drug|0|||
145334138|NCT01908816|524074154|FG003|Overall Study|Subject's no longer requires study drug|1|||
145334139|NCT01908816|524074151|FG000|Overall Study|Protocol deviation|1|||
145334140|NCT01908816|524074152|FG001|Overall Study|Protocol deviation|2|||
145334141|NCT01908816|524074153|FG002|Overall Study|Protocol deviation|1|||
145334142|NCT01908816|524074154|FG003|Overall Study|Protocol deviation|1|||
145334143|NCT01908816|524074151|FG000|Overall Study|Withdrawal by Subject|0|||
145334144|NCT01908816|524074152|FG001|Overall Study|Withdrawal by Subject|4|||
145334145|NCT01908816|524074153|FG002|Overall Study|Withdrawal by Subject|2|||
145334146|NCT01908816|524074154|FG003|Overall Study|Withdrawal by Subject|2|||
145334147|NCT01908816|524074151|FG000|Overall Study|Lost to Follow-up|3|||
145334148|NCT01908816|524074152|FG001|Overall Study|Lost to Follow-up|5|||
145334149|NCT01908816|524074153|FG002|Overall Study|Lost to Follow-up|4|||
145334150|NCT01908816|524074154|FG003|Overall Study|Lost to Follow-up|2|||
145334151|NCT01908816|524074151|FG000|Overall Study|Death|1|||
145334152|NCT01908816|524074152|FG001|Overall Study|Death|0|||
145334153|NCT01908816|524074153|FG002|Overall Study|Death|7|||
145334154|NCT01908816|524074154|FG003|Overall Study|Death|1|||
145334155|NCT01908816|524074151|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145334156|NCT01908816|524074152|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
145334157|NCT01908816|524074153|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
145334158|NCT01908816|524074154|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145334159|NCT01908816|524074151|FG000|Overall Study|Early termination|87|||
145334160|NCT01908816|524074152|FG001|Overall Study|Early termination|60|||
145334161|NCT01908816|524074153|FG002|Overall Study|Early termination|43|||
145334162|NCT01908816|524074154|FG003|Overall Study|Early termination|28|||
145621579|NCT04955626|525126704|FG032|Open-Label Period|Other|0|||
145334163|NCT00114166|524074155|FG000|Overall Study|Wrong primary|0|||
145334164|NCT00114166|524074156|FG001|Overall Study|Wrong primary|1|||
145334165|NCT01154816|524074157|FG000|Overall Study|Withdrawal by Subject|1|||
145334166|NCT01154816|524074158|FG001|Overall Study|Withdrawal by Subject|0|||
145334167|NCT01154816|524074159|FG002|Overall Study|Withdrawal by Subject|0|||
145621580|NCT04955626|525126705|FG033|Open-Label Period|Other|0|||
145621581|NCT04955626|525126706|FG034|Open-Label Period|Other|0|||
145621582|NCT04955626|525126707|FG035|Open-Label Period|Other|0|||
145621583|NCT04955626|525126672|FG000|Open-Label Period|Physician Decision|2|||
145621584|NCT04955626|525126673|FG001|Open-Label Period|Physician Decision|0|||
145621585|NCT04955626|525126674|FG002|Open-Label Period|Physician Decision|0|||
145621586|NCT04955626|525126675|FG003|Open-Label Period|Physician Decision|0|||
145621587|NCT04955626|525126676|FG004|Open-Label Period|Physician Decision|0|||
145621588|NCT04955626|525126677|FG005|Open-Label Period|Physician Decision|0|||
145621589|NCT04955626|525126678|FG006|Open-Label Period|Physician Decision|0|||
145621590|NCT04955626|525126679|FG007|Open-Label Period|Physician Decision|0|||
145621591|NCT04955626|525126680|FG008|Open-Label Period|Physician Decision|0|||
145621592|NCT04955626|525126681|FG009|Open-Label Period|Physician Decision|0|||
145621593|NCT04955626|525126682|FG010|Open-Label Period|Physician Decision|0|||
145621594|NCT04955626|525126683|FG011|Open-Label Period|Physician Decision|0|||
145621595|NCT04955626|525126684|FG012|Open-Label Period|Physician Decision|0|||
145621596|NCT04955626|525126685|FG013|Open-Label Period|Physician Decision|0|||
145621597|NCT04955626|525126686|FG014|Open-Label Period|Physician Decision|0|||
145621598|NCT04955626|525126687|FG015|Open-Label Period|Physician Decision|0|||
145621599|NCT04955626|525126688|FG016|Open-Label Period|Physician Decision|0|||
145621600|NCT04955626|525126689|FG017|Open-Label Period|Physician Decision|0|||
145621601|NCT04955626|525126690|FG018|Open-Label Period|Physician Decision|0|||
145621602|NCT04955626|525126691|FG019|Open-Label Period|Physician Decision|0|||
145621603|NCT04955626|525126692|FG020|Open-Label Period|Physician Decision|0|||
145621604|NCT04955626|525126693|FG021|Open-Label Period|Physician Decision|0|||
145621605|NCT04955626|525126694|FG022|Open-Label Period|Physician Decision|0|||
145621606|NCT04955626|525126695|FG023|Open-Label Period|Physician Decision|0|||
145621607|NCT04955626|525126696|FG024|Open-Label Period|Physician Decision|0|||
145621608|NCT04955626|525126697|FG025|Open-Label Period|Physician Decision|0|||
145621609|NCT04955626|525126698|FG026|Open-Label Period|Physician Decision|0|||
145621610|NCT04955626|525126699|FG027|Open-Label Period|Physician Decision|0|||
145621611|NCT04955626|525126700|FG028|Open-Label Period|Physician Decision|0|||
145621612|NCT04955626|525126701|FG029|Open-Label Period|Physician Decision|0|||
145621613|NCT04955626|525126702|FG030|Open-Label Period|Physician Decision|0|||
145621614|NCT04955626|525126703|FG031|Open-Label Period|Physician Decision|0|||
145621615|NCT04955626|525126704|FG032|Open-Label Period|Physician Decision|0|||
145621616|NCT04955626|525126705|FG033|Open-Label Period|Physician Decision|0|||
145621617|NCT04955626|525126706|FG034|Open-Label Period|Physician Decision|0|||
145621618|NCT04955626|525126707|FG035|Open-Label Period|Physician Decision|0|||
145621619|NCT04955626|525126672|FG000|Open-Label Period|Withdrawal by Subject|135|||
145621620|NCT04955626|525126673|FG001|Open-Label Period|Withdrawal by Subject|25|||
145621621|NCT04955626|525126674|FG002|Open-Label Period|Withdrawal by Subject|0|||
145621622|NCT04955626|525126675|FG003|Open-Label Period|Withdrawal by Subject|0|||
145621623|NCT04955626|525126676|FG004|Open-Label Period|Withdrawal by Subject|0|||
145621624|NCT04955626|525126677|FG005|Open-Label Period|Withdrawal by Subject|0|||
145621625|NCT04955626|525126678|FG006|Open-Label Period|Withdrawal by Subject|0|||
145621626|NCT04955626|525126679|FG007|Open-Label Period|Withdrawal by Subject|0|||
145621627|NCT04955626|525126680|FG008|Open-Label Period|Withdrawal by Subject|0|||
145621628|NCT04955626|525126681|FG009|Open-Label Period|Withdrawal by Subject|0|||
145621629|NCT04955626|525126682|FG010|Open-Label Period|Withdrawal by Subject|0|||
145621630|NCT04955626|525126683|FG011|Open-Label Period|Withdrawal by Subject|0|||
145621631|NCT04955626|525126684|FG012|Open-Label Period|Withdrawal by Subject|0|||
145621632|NCT04955626|525126685|FG013|Open-Label Period|Withdrawal by Subject|0|||
145621633|NCT04955626|525126686|FG014|Open-Label Period|Withdrawal by Subject|0|||
145621634|NCT04955626|525126687|FG015|Open-Label Period|Withdrawal by Subject|0|||
145621635|NCT04955626|525126688|FG016|Open-Label Period|Withdrawal by Subject|0|||
145621636|NCT04955626|525126689|FG017|Open-Label Period|Withdrawal by Subject|0|||
145621637|NCT04955626|525126690|FG018|Open-Label Period|Withdrawal by Subject|0|||
145334168|NCT01154816|524074160|FG003|Overall Study|Withdrawal by Subject|1|||
145334169|NCT01154816|524074161|FG004|Overall Study|Withdrawal by Subject|0|||
145334170|NCT01154816|524074162|FG005|Overall Study|Withdrawal by Subject|0|||
145334171|NCT01154816|524074163|FG006|Overall Study|Withdrawal by Subject|0|||
145621638|NCT04955626|525126691|FG019|Open-Label Period|Withdrawal by Subject|0|||
145621639|NCT04955626|525126692|FG020|Open-Label Period|Withdrawal by Subject|0|||
145621640|NCT04955626|525126693|FG021|Open-Label Period|Withdrawal by Subject|0|||
145621641|NCT04955626|525126694|FG022|Open-Label Period|Withdrawal by Subject|0|||
145621642|NCT04955626|525126695|FG023|Open-Label Period|Withdrawal by Subject|0|||
145621643|NCT04955626|525126696|FG024|Open-Label Period|Withdrawal by Subject|0|||
145621644|NCT04955626|525126697|FG025|Open-Label Period|Withdrawal by Subject|0|||
145621645|NCT04955626|525126698|FG026|Open-Label Period|Withdrawal by Subject|0|||
145334172|NCT01154816|524074164|FG007|Overall Study|Withdrawal by Subject|0|||
145621646|NCT04955626|525126699|FG027|Open-Label Period|Withdrawal by Subject|0|||
145621647|NCT04955626|525126700|FG028|Open-Label Period|Withdrawal by Subject|0|||
145621648|NCT04955626|525126701|FG029|Open-Label Period|Withdrawal by Subject|0|||
145621649|NCT04955626|525126702|FG030|Open-Label Period|Withdrawal by Subject|0|||
145621650|NCT04955626|525126703|FG031|Open-Label Period|Withdrawal by Subject|0|||
145334173|NCT01154816|524074165|FG008|Overall Study|Withdrawal by Subject|1|||
145334174|NCT01154816|524074166|FG009|Overall Study|Withdrawal by Subject|3|||
145334175|NCT01154816|524074167|FG010|Overall Study|Withdrawal by Subject|0|||
145334176|NCT01154816|524074168|FG011|Overall Study|Withdrawal by Subject|0|||
145334177|NCT01154816|524074157|FG000|Overall Study|Progressive Disease|13|||
145334178|NCT01154816|524074158|FG001|Overall Study|Progressive Disease|8|||
145334179|NCT01154816|524074159|FG002|Overall Study|Progressive Disease|9|||
145334180|NCT01154816|524074160|FG003|Overall Study|Progressive Disease|9|||
145334181|NCT01154816|524074161|FG004|Overall Study|Progressive Disease|8|||
145334182|NCT01154816|524074162|FG005|Overall Study|Progressive Disease|8|||
145334183|NCT01154816|524074163|FG006|Overall Study|Progressive Disease|5|||
145334184|NCT01154816|524074164|FG007|Overall Study|Progressive Disease|6|||
145334185|NCT01154816|524074165|FG008|Overall Study|Progressive Disease|8|||
145334186|NCT01154816|524074166|FG009|Overall Study|Progressive Disease|6|||
145334187|NCT01154816|524074167|FG010|Overall Study|Progressive Disease|10|||
145334188|NCT01154816|524074168|FG011|Overall Study|Progressive Disease|3|||
145334189|NCT01154816|524074157|FG000|Overall Study|Physician Decision|1|||
145334190|NCT01154816|524074158|FG001|Overall Study|Physician Decision|0|||
145334191|NCT01154816|524074159|FG002|Overall Study|Physician Decision|1|||
145334192|NCT01154816|524074160|FG003|Overall Study|Physician Decision|0|||
145334193|NCT01154816|524074161|FG004|Overall Study|Physician Decision|2|||
145334194|NCT01154816|524074162|FG005|Overall Study|Physician Decision|0|||
145334195|NCT01154816|524074163|FG006|Overall Study|Physician Decision|0|||
145334196|NCT01154816|524074164|FG007|Overall Study|Physician Decision|0|||
145334197|NCT01154816|524074165|FG008|Overall Study|Physician Decision|0|||
145334198|NCT01154816|524074166|FG009|Overall Study|Physician Decision|1|||
145334199|NCT01154816|524074167|FG010|Overall Study|Physician Decision|1|||
145334200|NCT01154816|524074168|FG011|Overall Study|Physician Decision|1|||
145334201|NCT01154816|524074157|FG000|Overall Study|Adverse Event|5|||
145334202|NCT01154816|524074158|FG001|Overall Study|Adverse Event|2|||
145334203|NCT01154816|524074159|FG002|Overall Study|Adverse Event|0|||
145334204|NCT01154816|524074160|FG003|Overall Study|Adverse Event|0|||
145334205|NCT01154816|524074161|FG004|Overall Study|Adverse Event|0|||
145334206|NCT01154816|524074162|FG005|Overall Study|Adverse Event|0|||
145334207|NCT01154816|524074163|FG006|Overall Study|Adverse Event|1|||
145334208|NCT01154816|524074164|FG007|Overall Study|Adverse Event|1|||
145334209|NCT01154816|524074165|FG008|Overall Study|Adverse Event|0|||
145334210|NCT01154816|524074166|FG009|Overall Study|Adverse Event|0|||
145334211|NCT01154816|524074167|FG010|Overall Study|Adverse Event|0|||
145334212|NCT01154816|524074168|FG011|Overall Study|Adverse Event|0|||
145334213|NCT03560986|524074169|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
145334214|NCT03560986|524074170|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
145334215|NCT03560986|524074169|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
145334216|NCT03560986|524074170|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
145334217|NCT03560986|524074169|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
145334218|NCT03560986|524074170|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
145334219|NCT03560986|524074169|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
145334220|NCT03560986|524074170|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
145334221|NCT03560986|524074169|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
145334222|NCT03560986|524074170|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
145334223|NCT03560986|524074169|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
145334224|NCT03560986|524074170|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
145334225|NCT03560986|524074169|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
145334226|NCT03560986|524074170|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
145334227|NCT01783548|524074171|FG000|Overall Study|Adverse Event|8|||
145334228|NCT01783548|524074172|FG001|Overall Study|Adverse Event|4|||
145334229|NCT01783548|524074171|FG000|Overall Study|Withdrawal by Subject|11|||
145334230|NCT01783548|524074172|FG001|Overall Study|Withdrawal by Subject|8|||
145334231|NCT01783548|524074171|FG000|Overall Study|Non-compliance|4|||
145334232|NCT01783548|524074172|FG001|Overall Study|Non-compliance|0|||
145334233|NCT01783548|524074171|FG000|Overall Study|Protocol Violation|2|||
145334234|NCT01783548|524074172|FG001|Overall Study|Protocol Violation|2|||
145334235|NCT01783548|524074171|FG000|Overall Study|Lost to Follow-up|8|||
145334236|NCT01783548|524074172|FG001|Overall Study|Lost to Follow-up|3|||
145334237|NCT01783548|524074171|FG000|Overall Study|Lack of Efficacy|1|||
145334238|NCT01783548|524074172|FG001|Overall Study|Lack of Efficacy|1|||
145334239|NCT03825341|524074173|FG000|Overall Study|Withdrawal by Subject|0|||
145334240|NCT03825341|524074174|FG001|Overall Study|Withdrawal by Subject|1|||
145334241|NCT04053465|524074178|FG000|Overall Study|Withdrawal by Subject|4|||
145334242|NCT04053465|524074179|FG001|Overall Study|Withdrawal by Subject|4|||
145334243|NCT04091659|524074183|FG000|Overall Study|Protocol Violation|3|||
145334244|NCT04091659|524074184|FG001|Overall Study|Protocol Violation|0|||
145334245|NCT04091659|524074183|FG000|Overall Study|Lost to Follow-up|0|||
145334246|NCT04091659|524074184|FG001|Overall Study|Lost to Follow-up|1|||
145334247|NCT03678285|524074195|FG000|Overall Study|Adverse Event|2|||
145334248|NCT03678285|524074195|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
145334249|NCT03678285|524074195|FG000|Overall Study|Dehydrated prior to start of workout|1|||
145334250|NCT00123474|524074196|FG000|Randomized to Treatment|Randomized, never treated|1|||
145334251|NCT00123474|524074197|FG001|Randomized to Treatment|Randomized, never treated|4|||
145334252|NCT00123474|524074198|FG002|Randomized to Treatment|Randomized, never treated|2|||
145334253|NCT00123474|524074199|FG003|Randomized to Treatment|Randomized, never treated|1|||
145334254|NCT00123474|524074196|FG000|As Treated at Study Closure|not reported when site closed|1|||
145334255|NCT00123474|524074197|FG001|As Treated at Study Closure|not reported when site closed|0|||
145334256|NCT00123474|524074198|FG002|As Treated at Study Closure|not reported when site closed|1|||
145334257|NCT00123474|524074199|FG003|As Treated at Study Closure|not reported when site closed|0|||
145334258|NCT00123474|524074196|FG000|As Treated at Study Closure|Adverse Event|10|||
145334259|NCT00123474|524074197|FG001|As Treated at Study Closure|Adverse Event|4|||
145334260|NCT00123474|524074198|FG002|As Treated at Study Closure|Adverse Event|10|||
145334261|NCT00123474|524074199|FG003|As Treated at Study Closure|Adverse Event|8|||
145334262|NCT00123474|524074196|FG000|As Treated at Study Closure|Disease Progression|35|||
145334263|NCT00123474|524074197|FG001|As Treated at Study Closure|Disease Progression|42|||
145334264|NCT00123474|524074198|FG002|As Treated at Study Closure|Disease Progression|29|||
145334265|NCT00123474|524074199|FG003|As Treated at Study Closure|Disease Progression|27|||
145334266|NCT00123474|524074196|FG000|As Treated at Study Closure|Investigator Request|12|||
145334267|NCT00123474|524074197|FG001|As Treated at Study Closure|Investigator Request|6|||
145334268|NCT00123474|524074198|FG002|As Treated at Study Closure|Investigator Request|7|||
145334269|NCT00123474|524074199|FG003|As Treated at Study Closure|Investigator Request|5|||
145334270|NCT00123474|524074196|FG000|As Treated at Study Closure|non-specified|54|||
145334271|NCT00123474|524074197|FG001|As Treated at Study Closure|non-specified|47|||
145334272|NCT00123474|524074198|FG002|As Treated at Study Closure|non-specified|57|||
145334273|NCT00123474|524074199|FG003|As Treated at Study Closure|non-specified|60|||
145334274|NCT00123474|524074196|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
145334275|NCT00123474|524074197|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
145334276|NCT00123474|524074198|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
145334277|NCT00123474|524074199|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
145334278|NCT00123474|524074196|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
145334279|NCT00123474|524074197|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
145334280|NCT00123474|524074198|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
145334281|NCT00123474|524074199|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
145334282|NCT00616629|524074200|FG000|Overall Study|Protocol Violation|1|||
145334283|NCT00616629|524074201|FG001|Overall Study|Protocol Violation|2|||
145334284|NCT00616629|524074202|FG002|Overall Study|Protocol Violation|1|||
145334285|NCT00616629|524074203|FG003|Overall Study|Protocol Violation|0|||
145334286|NCT00616629|524074204|FG004|Overall Study|Protocol Violation|0|||
145334287|NCT00616629|524074200|FG000|Overall Study|AV-block|1|||
145334288|NCT00616629|524074201|FG001|Overall Study|AV-block|0|||
145334289|NCT00616629|524074202|FG002|Overall Study|AV-block|0|||
145334290|NCT00616629|524074203|FG003|Overall Study|AV-block|0|||
145334291|NCT00616629|524074204|FG004|Overall Study|AV-block|0|||
145334292|NCT01059344|524074205|FG000|Overall Study|Adverse Event|12|||
145334293|NCT01059344|524074206|FG001|Overall Study|Adverse Event|30|||
145334294|NCT01059344|524074205|FG000|Overall Study|Withdrawal by Subject|6|||
145334295|NCT01059344|524074206|FG001|Overall Study|Withdrawal by Subject|9|||
145334296|NCT01059344|524074205|FG000|Overall Study|Lost to Follow-up|1|||
145334297|NCT01059344|524074206|FG001|Overall Study|Lost to Follow-up|1|||
145334298|NCT01059344|524074205|FG000|Overall Study|Other|3|||
145334299|NCT01059344|524074206|FG001|Overall Study|Other|6|||
145334300|NCT00660400|524074210|FG000|Overall Study|Lack of insurance approval|1|||
145334301|NCT00660400|524074210|FG000|Overall Study|Suboptimal organ function|1|||
145334302|NCT00660400|524074210|FG000|Overall Study|Intracranial hemorrhage|1|||
145334303|NCT00660400|524074210|FG000|Overall Study|Withdrawal by Subject|1|||
145334304|NCT04562155|524074211|FG000|Overall Study|COVID-19 pandemic|0|||
145334305|NCT04562155|524074212|FG001|Overall Study|COVID-19 pandemic|0|||
145334306|NCT04562155|524074213|FG002|Overall Study|COVID-19 pandemic|0|||
145334307|NCT04562155|524074214|FG003|Overall Study|COVID-19 pandemic|1|||
145334308|NCT04562155|524074211|FG000|Overall Study|Adverse Event|7|||
145334309|NCT04562155|524074212|FG001|Overall Study|Adverse Event|3|||
145334310|NCT04562155|524074213|FG002|Overall Study|Adverse Event|8|||
145334311|NCT04562155|524074214|FG003|Overall Study|Adverse Event|1|||
145334312|NCT04562155|524074211|FG000|Overall Study|Withdrawal by Subject|3|||
145334313|NCT04562155|524074212|FG001|Overall Study|Withdrawal by Subject|6|||
145334314|NCT04562155|524074213|FG002|Overall Study|Withdrawal by Subject|3|||
145334315|NCT04562155|524074214|FG003|Overall Study|Withdrawal by Subject|3|||
145334316|NCT04562155|524074211|FG000|Overall Study|Participant personal reason|1|||
145334317|NCT04562155|524074212|FG001|Overall Study|Participant personal reason|0|||
145334318|NCT04562155|524074213|FG002|Overall Study|Participant personal reason|2|||
145334319|NCT04562155|524074214|FG003|Overall Study|Participant personal reason|1|||
145334320|NCT00528411|524074218|FG000|Overall Study|Adverse Event|4|||
145334321|NCT00528411|524074219|FG001|Overall Study|Adverse Event|0|||
145334322|NCT00528411|524074220|FG002|Overall Study|Adverse Event|1|||
145334323|NCT00528411|524074218|FG000|Overall Study|Incorrect Enrolment|1|||
145334324|NCT00528411|524074219|FG001|Overall Study|Incorrect Enrolment|1|||
145334325|NCT00528411|524074220|FG002|Overall Study|Incorrect Enrolment|0|||
145334326|NCT00528411|524074218|FG000|Overall Study|Severe non-compliance to protocol|0|||
145334327|NCT00528411|524074219|FG001|Overall Study|Severe non-compliance to protocol|1|||
145334328|NCT00528411|524074220|FG002|Overall Study|Severe non-compliance to protocol|0|||
145621651|NCT04955626|525126704|FG032|Open-Label Period|Withdrawal by Subject|0|||
145621652|NCT04955626|525126705|FG033|Open-Label Period|Withdrawal by Subject|0|||
145621653|NCT04955626|525126706|FG034|Open-Label Period|Withdrawal by Subject|0|||
145621654|NCT04955626|525126707|FG035|Open-Label Period|Withdrawal by Subject|0|||
145621655|NCT04955626|525126672|FG000|Open-Label Period|Refused further study procedures|1|||
145334329|NCT00528411|524074218|FG000|Overall Study|Prior commitment medication|0|||
145334330|NCT00528411|524074219|FG001|Overall Study|Prior commitment medication|1|||
145334331|NCT00528411|524074220|FG002|Overall Study|Prior commitment medication|0|||
145334332|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
145334333|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
145334334|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334335|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334336|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
145334337|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334338|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334339|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334340|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
145334341|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334342|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
145334343|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334344|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334345|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334346|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334347|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334348|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334349|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
145334350|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334351|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
145334352|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334353|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
145334354|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334355|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334356|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334357|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334358|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334359|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334360|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
145334361|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334362|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
145334363|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334364|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334365|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334366|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334367|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
145334368|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
145334369|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
145334370|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
145334371|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334372|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
145334373|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334374|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334375|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334376|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334377|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334378|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
145334379|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334380|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145621656|NCT04955626|525126673|FG001|Open-Label Period|Refused further study procedures|0|||
145334381|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334382|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334383|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334384|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334385|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
145334386|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334387|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334388|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334389|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
145334390|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334391|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334392|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334393|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334394|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334395|NCT03893565|524074221|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334396|NCT03893565|524074222|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
145334397|NCT03893565|524074223|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
145334398|NCT03893565|524074224|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
145334399|NCT03893565|524074225|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334400|NCT03893565|524074226|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334401|NCT03893565|524074227|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334402|NCT03893565|524074228|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334403|NCT03893565|524074229|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
145334404|NCT03893565|524074221|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
145334405|NCT03893565|524074222|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
145334406|NCT03893565|524074223|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
145334407|NCT03893565|524074224|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
145334408|NCT03893565|524074225|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
145334409|NCT03893565|524074226|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
145334410|NCT03893565|524074227|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
145334411|NCT03893565|524074228|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
145334412|NCT03893565|524074229|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
145334413|NCT03893565|524074221|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334414|NCT03893565|524074222|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334415|NCT03893565|524074223|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334416|NCT03893565|524074224|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334417|NCT03893565|524074225|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334418|NCT03893565|524074226|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334419|NCT03893565|524074227|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
145334420|NCT03893565|524074228|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334421|NCT03893565|524074229|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
145334422|NCT03893565|524074221|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334423|NCT03893565|524074222|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334424|NCT03893565|524074223|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334425|NCT03893565|524074224|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334426|NCT03893565|524074225|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334427|NCT03893565|524074226|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
145334428|NCT03893565|524074227|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
145334429|NCT03893565|524074228|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334430|NCT03893565|524074229|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
145334431|NCT03893565|524074221|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
145334432|NCT03893565|524074222|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
145334433|NCT03893565|524074223|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
145334434|NCT03893565|524074224|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
145334435|NCT03893565|524074225|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
145334436|NCT03893565|524074226|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
145334437|NCT03893565|524074227|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
145334438|NCT03893565|524074228|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
145334439|NCT03893565|524074229|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
145334440|NCT03893565|524074221|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334441|NCT03893565|524074222|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334442|NCT03893565|524074223|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334443|NCT03893565|524074224|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334444|NCT03893565|524074225|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334445|NCT03893565|524074226|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334446|NCT03893565|524074227|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334447|NCT03893565|524074228|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
145334448|NCT03893565|524074229|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
145334449|NCT03893565|524074221|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334450|NCT03893565|524074222|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334451|NCT03893565|524074223|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334452|NCT03893565|524074224|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334453|NCT03893565|524074225|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334454|NCT03893565|524074226|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334455|NCT03893565|524074227|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334456|NCT03893565|524074228|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
145334457|NCT03893565|524074229|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
145334458|NCT03893565|524074221|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334459|NCT03893565|524074222|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334460|NCT03893565|524074223|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334461|NCT03893565|524074224|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334462|NCT03893565|524074225|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334463|NCT03893565|524074226|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334464|NCT03893565|524074227|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334465|NCT03893565|524074228|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
145334466|NCT03893565|524074229|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
145334467|NCT03893565|524074221|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334468|NCT03893565|524074222|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334469|NCT03893565|524074223|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334470|NCT03893565|524074224|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334471|NCT03893565|524074225|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334472|NCT03893565|524074226|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334473|NCT03893565|524074227|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334474|NCT03893565|524074228|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
145334475|NCT03893565|524074229|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
145334476|NCT04005352|524074230|FG000|Overall Study|Adverse Event|4|||
145334477|NCT04005352|524074231|FG001|Overall Study|Adverse Event|5|||
145334478|NCT04005352|524074230|FG000|Overall Study|Death|4|||
145334479|NCT04005352|524074231|FG001|Overall Study|Death|2|||
145334480|NCT04005352|524074230|FG000|Overall Study|Lost to Follow-up|6|||
145334481|NCT04005352|524074231|FG001|Overall Study|Lost to Follow-up|2|||
145334482|NCT04005352|524074230|FG000|Overall Study|Physician Decision|7|||
145334483|NCT04005352|524074231|FG001|Overall Study|Physician Decision|13|||
145334484|NCT04005352|524074230|FG000|Overall Study|Protocol Violation|0|||
145334485|NCT04005352|524074231|FG001|Overall Study|Protocol Violation|1|||
145334486|NCT04005352|524074230|FG000|Overall Study|Withdrawal by Subject|28|||
145334487|NCT04005352|524074231|FG001|Overall Study|Withdrawal by Subject|38|||
145334488|NCT00851318|524074232|FG000|Overall Study|Withdrawal by Subject|7|||
145334489|NCT00851318|524074233|FG001|Overall Study|Withdrawal by Subject|1|||
145334490|NCT00851318|524074234|FG002|Overall Study|Withdrawal by Subject|5|||
145334491|NCT00851318|524074235|FG003|Overall Study|Withdrawal by Subject|3|||
145334492|NCT00851318|524074232|FG000|Overall Study|Adverse Event|13|||
145334493|NCT00851318|524074233|FG001|Overall Study|Adverse Event|2|||
145334494|NCT00851318|524074234|FG002|Overall Study|Adverse Event|9|||
145334495|NCT00851318|524074235|FG003|Overall Study|Adverse Event|12|||
145334496|NCT00851318|524074232|FG000|Overall Study|Pregnancy|0|||
145334497|NCT00851318|524074233|FG001|Overall Study|Pregnancy|0|||
145334498|NCT00851318|524074234|FG002|Overall Study|Pregnancy|1|||
145334499|NCT00851318|524074235|FG003|Overall Study|Pregnancy|1|||
145334500|NCT00851318|524074232|FG000|Overall Study|Lack of Efficacy|8|||
145334501|NCT00851318|524074233|FG001|Overall Study|Lack of Efficacy|2|||
145334502|NCT00851318|524074234|FG002|Overall Study|Lack of Efficacy|4|||
145334503|NCT00851318|524074235|FG003|Overall Study|Lack of Efficacy|2|||
145334504|NCT00851318|524074232|FG000|Overall Study|Non-compliance with Study Procedures|2|||
145412893|NCT00541229|524365902|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
145412894|NCT00541229|524365903|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
145334505|NCT00851318|524074233|FG001|Overall Study|Non-compliance with Study Procedures|0|||
145334506|NCT00851318|524074234|FG002|Overall Study|Non-compliance with Study Procedures|1|||
145334507|NCT00851318|524074235|FG003|Overall Study|Non-compliance with Study Procedures|0|||
145334508|NCT00851318|524074232|FG000|Overall Study|Physician Decision|0|||
145334509|NCT00851318|524074233|FG001|Overall Study|Physician Decision|0|||
145334510|NCT00851318|524074234|FG002|Overall Study|Physician Decision|1|||
145412895|NCT00541229|524365904|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
145334511|NCT00851318|524074235|FG003|Overall Study|Physician Decision|1|||
145334512|NCT01442688|524074236|FG000|First Intervention|Withdrawal by Subject|1|||
145334513|NCT01442688|524074237|FG001|First Intervention|Withdrawal by Subject|0|||
145334514|NCT01442688|524074236|FG000|First Intervention|subject incarcerated|1|||
145334515|NCT01442688|524074237|FG001|First Intervention|subject incarcerated|0|||
145334516|NCT01442688|524074236|FG000|Second Intervention|Adverse Event|1|||
145334517|NCT01442688|524074237|FG001|Second Intervention|Adverse Event|0|||
145334518|NCT01715571|524074249|FG000|Overall Study|Lost to Follow-up|8|||
145334519|NCT04658095|524074256|FG000|Overall Study|Study terminated|5|||
145334520|NCT04658095|524074257|FG001|Overall Study|Study terminated|1|||
145334521|NCT04658095|524074258|FG002|Overall Study|Study terminated|4|||
145334522|NCT05788289|524074259|FG000|Overall Study|Death|3|||
145334523|NCT05961215|524074260|FG000|Overall Study|Withdrawal by Subject|1|||
145334524|NCT02387983|524074263|FG000|Overall Study|Adverse Event|4|||
145334525|NCT02387983|524074263|FG000|Overall Study|Protocol Violation|1|||
145334526|NCT02387983|524074263|FG000|Overall Study|Withdrawal by Subject|2|||
145334527|NCT00077857|524074264|FG000|Overall Study|Adverse Event|30|||
145334528|NCT00077857|524074265|FG001|Overall Study|Adverse Event|32|||
145334529|NCT00077857|524074264|FG000|Overall Study|Death|7|||
145334530|NCT00077857|524074265|FG001|Overall Study|Death|3|||
145334531|NCT00077857|524074264|FG000|Overall Study|Insufficient therapeutic response|112|||
145334532|NCT00077857|524074265|FG001|Overall Study|Insufficient therapeutic response|128|||
145334533|NCT00077857|524074264|FG000|Overall Study|Violation of selection criteria at entry|3|||
145334534|NCT00077857|524074265|FG001|Overall Study|Violation of selection criteria at entry|1|||
145334535|NCT00077857|524074264|FG000|Overall Study|Other protocol violation|0|||
145334536|NCT00077857|524074265|FG001|Overall Study|Other protocol violation|1|||
145334537|NCT00077857|524074264|FG000|Overall Study|Refused treatment|29|||
145334538|NCT00077857|524074265|FG001|Overall Study|Refused treatment|21|||
145334539|NCT00077857|524074264|FG000|Overall Study|Failure to return|5|||
145334540|NCT00077857|524074265|FG001|Overall Study|Failure to return|5|||
145334541|NCT00077857|524074264|FG000|Overall Study|Other|15|||
145334542|NCT00077857|524074265|FG001|Overall Study|Other|13|||
145334543|NCT04480021|524074266|FG000|Overall Study|Lost to Follow-up|3|||
145334544|NCT04480021|524074267|FG001|Overall Study|Lost to Follow-up|4|||
145334545|NCT02970318|524074268|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
145334546|NCT02970318|524074269|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
145334547|NCT02970318|524074270|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
145334548|NCT02970318|524074271|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
145334549|NCT02970318|524074268|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
145334550|NCT02970318|524074269|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
145334551|NCT02970318|524074270|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
145334552|NCT02970318|524074271|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
145334553|NCT02970318|524074268|FG000|Overall for Arm A & Main for Arm B|Death|41|||
145334554|NCT02970318|524074269|FG001|Overall for Arm A & Main for Arm B|Death|33|||
145334555|NCT02970318|524074270|FG002|Overall for Arm A & Main for Arm B|Death|0|||
145334556|NCT02970318|524074271|FG003|Overall for Arm A & Main for Arm B|Death|0|||
145334557|NCT02970318|524074268|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145334558|NCT02970318|524074269|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
145334559|NCT02970318|524074270|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145334560|NCT02970318|524074271|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
145334561|NCT02970318|524074268|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145334562|NCT02970318|524074269|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145334563|NCT02970318|524074270|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
145334564|NCT02970318|524074271|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
145334565|NCT02970318|524074268|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
145334566|NCT02970318|524074269|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
145334567|NCT02970318|524074270|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
145334568|NCT02970318|524074271|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
145334569|NCT02970318|524074268|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
145334570|NCT02970318|524074269|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
145334571|NCT02970318|524074270|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
145334572|NCT02970318|524074271|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
145334573|NCT06187909|524074272|FG000|Overall Study|Withdrawal by Subject|2|||
145334574|NCT06187909|524074273|FG001|Overall Study|Withdrawal by Subject|2|||
145334575|NCT06354998|524074274|FG000|Overall Study|Withdrawal by Subject|3|||
145334576|NCT06354998|524074275|FG001|Overall Study|Withdrawal by Subject|0|||
145334577|NCT00809159|524074277|FG000|Part 1|Adverse Event|1|||
145334578|NCT00809159|524074278|FG001|Part 1|Adverse Event|1|||
145334579|NCT00809159|524074279|FG002|Part 1|Adverse Event|0|||
145334580|NCT00809159|524074280|FG003|Part 1|Adverse Event|0|||
145334581|NCT00809159|524074281|FG004|Part 1|Adverse Event|0|||
145334582|NCT00809159|524074282|FG005|Part 1|Adverse Event|0|||
145334583|NCT00809159|524074277|FG000|Part 1|Lost to Follow-up|1|||
145621657|NCT04955626|525126674|FG002|Open-Label Period|Refused further study procedures|0|||
145621658|NCT04955626|525126675|FG003|Open-Label Period|Refused further study procedures|0|||
145621659|NCT04955626|525126676|FG004|Open-Label Period|Refused further study procedures|0|||
145621660|NCT04955626|525126677|FG005|Open-Label Period|Refused further study procedures|0|||
145621661|NCT04955626|525126678|FG006|Open-Label Period|Refused further study procedures|0|||
145621662|NCT04955626|525126679|FG007|Open-Label Period|Refused further study procedures|0|||
145621663|NCT04955626|525126680|FG008|Open-Label Period|Refused further study procedures|0|||
145621664|NCT04955626|525126681|FG009|Open-Label Period|Refused further study procedures|0|||
145621665|NCT04955626|525126682|FG010|Open-Label Period|Refused further study procedures|0|||
145621666|NCT04955626|525126683|FG011|Open-Label Period|Refused further study procedures|0|||
145621667|NCT04955626|525126684|FG012|Open-Label Period|Refused further study procedures|0|||
145621668|NCT04955626|525126685|FG013|Open-Label Period|Refused further study procedures|0|||
145621669|NCT04955626|525126686|FG014|Open-Label Period|Refused further study procedures|0|||
145621670|NCT04955626|525126687|FG015|Open-Label Period|Refused further study procedures|0|||
145621671|NCT04955626|525126688|FG016|Open-Label Period|Refused further study procedures|0|||
145621672|NCT04955626|525126689|FG017|Open-Label Period|Refused further study procedures|0|||
145621673|NCT04955626|525126690|FG018|Open-Label Period|Refused further study procedures|0|||
145621674|NCT04955626|525126691|FG019|Open-Label Period|Refused further study procedures|0|||
145621675|NCT04955626|525126692|FG020|Open-Label Period|Refused further study procedures|0|||
145621676|NCT04955626|525126693|FG021|Open-Label Period|Refused further study procedures|0|||
145621677|NCT04955626|525126694|FG022|Open-Label Period|Refused further study procedures|0|||
145621678|NCT04955626|525126695|FG023|Open-Label Period|Refused further study procedures|0|||
145621679|NCT04955626|525126696|FG024|Open-Label Period|Refused further study procedures|0|||
145621680|NCT04955626|525126697|FG025|Open-Label Period|Refused further study procedures|0|||
145621681|NCT04955626|525126698|FG026|Open-Label Period|Refused further study procedures|0|||
145621682|NCT04955626|525126699|FG027|Open-Label Period|Refused further study procedures|0|||
145621683|NCT04955626|525126700|FG028|Open-Label Period|Refused further study procedures|0|||
145621684|NCT04955626|525126701|FG029|Open-Label Period|Refused further study procedures|0|||
145621685|NCT04955626|525126702|FG030|Open-Label Period|Refused further study procedures|0|||
145621686|NCT04955626|525126703|FG031|Open-Label Period|Refused further study procedures|0|||
145621687|NCT04955626|525126704|FG032|Open-Label Period|Refused further study procedures|0|||
145621688|NCT04955626|525126705|FG033|Open-Label Period|Refused further study procedures|0|||
145621689|NCT04955626|525126706|FG034|Open-Label Period|Refused further study procedures|0|||
145621690|NCT04955626|525126707|FG035|Open-Label Period|Refused further study procedures|0|||
145621691|NCT04955626|525126672|FG000|Open-Label Period|Adverse Event|1|||
145621692|NCT04955626|525126673|FG001|Open-Label Period|Adverse Event|0|||
145621693|NCT04955626|525126674|FG002|Open-Label Period|Adverse Event|0|||
145621694|NCT04955626|525126675|FG003|Open-Label Period|Adverse Event|0|||
145621695|NCT04955626|525126676|FG004|Open-Label Period|Adverse Event|0|||
145621696|NCT04955626|525126677|FG005|Open-Label Period|Adverse Event|0|||
145621697|NCT04955626|525126678|FG006|Open-Label Period|Adverse Event|0|||
145621698|NCT04955626|525126679|FG007|Open-Label Period|Adverse Event|0|||
145334584|NCT00809159|524074278|FG001|Part 1|Lost to Follow-up|0|||
145334585|NCT00809159|524074279|FG002|Part 1|Lost to Follow-up|0|||
145334586|NCT00809159|524074280|FG003|Part 1|Lost to Follow-up|0|||
145334587|NCT00809159|524074281|FG004|Part 1|Lost to Follow-up|0|||
145334588|NCT00809159|524074282|FG005|Part 1|Lost to Follow-up|0|||
145334589|NCT00809159|524074277|FG000|Part 1|Withdrawal by Subject|3|||
145334590|NCT00809159|524074278|FG001|Part 1|Withdrawal by Subject|1|||
145334591|NCT00809159|524074279|FG002|Part 1|Withdrawal by Subject|0|||
145334592|NCT00809159|524074280|FG003|Part 1|Withdrawal by Subject|0|||
145334593|NCT00809159|524074281|FG004|Part 1|Withdrawal by Subject|0|||
145334594|NCT00809159|524074282|FG005|Part 1|Withdrawal by Subject|0|||
145334595|NCT00809159|524074277|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
145334596|NCT00809159|524074278|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
145334597|NCT00809159|524074279|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
145334598|NCT00809159|524074280|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
145334599|NCT00809159|524074281|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
145334600|NCT00809159|524074282|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
145334601|NCT00809159|524074277|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
145334602|NCT00809159|524074278|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
145621699|NCT04955626|525126680|FG008|Open-Label Period|Adverse Event|0|||
145621700|NCT04955626|525126681|FG009|Open-Label Period|Adverse Event|0|||
145621701|NCT04955626|525126682|FG010|Open-Label Period|Adverse Event|0|||
145621702|NCT04955626|525126683|FG011|Open-Label Period|Adverse Event|0|||
145621703|NCT04955626|525126684|FG012|Open-Label Period|Adverse Event|0|||
145621704|NCT04955626|525126685|FG013|Open-Label Period|Adverse Event|0|||
145621705|NCT04955626|525126686|FG014|Open-Label Period|Adverse Event|0|||
145334603|NCT00809159|524074279|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
145334604|NCT00809159|524074280|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
145334605|NCT00809159|524074281|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
145334606|NCT00809159|524074282|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
145334607|NCT00809159|524074277|FG000|Part 1 and 2|Administrative problems|0|||
145334608|NCT00809159|524074278|FG001|Part 1 and 2|Administrative problems|0|||
145334609|NCT00809159|524074279|FG002|Part 1 and 2|Administrative problems|0|||
145334610|NCT00809159|524074280|FG003|Part 1 and 2|Administrative problems|1|||
145334611|NCT00809159|524074281|FG004|Part 1 and 2|Administrative problems|0|||
145334612|NCT00809159|524074282|FG005|Part 1 and 2|Administrative problems|0|||
145334613|NCT00809159|524074277|FG000|Part 1 and 2|Adverse Event|0|||
145334614|NCT00809159|524074278|FG001|Part 1 and 2|Adverse Event|0|||
145334615|NCT00809159|524074279|FG002|Part 1 and 2|Adverse Event|1|||
145334616|NCT00809159|524074280|FG003|Part 1 and 2|Adverse Event|0|||
145334617|NCT00809159|524074281|FG004|Part 1 and 2|Adverse Event|1|||
145334618|NCT00809159|524074282|FG005|Part 1 and 2|Adverse Event|1|||
145334619|NCT00809159|524074277|FG000|Part 1 and 2|Lost to Follow-up|0|||
145334620|NCT00809159|524074278|FG001|Part 1 and 2|Lost to Follow-up|0|||
145334621|NCT00809159|524074279|FG002|Part 1 and 2|Lost to Follow-up|1|||
145334622|NCT00809159|524074280|FG003|Part 1 and 2|Lost to Follow-up|1|||
145334623|NCT00809159|524074281|FG004|Part 1 and 2|Lost to Follow-up|0|||
145412896|NCT00541229|524365905|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
145412897|NCT00541229|524365900|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145412898|NCT00541229|524365901|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145412899|NCT00541229|524365902|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145412900|NCT00541229|524365903|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145412901|NCT00541229|524365904|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
145412902|NCT00541229|524365905|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
145412903|NCT00541229|524365900|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145412904|NCT00541229|524365901|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
145412905|NCT00541229|524365902|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
145334624|NCT00809159|524074282|FG005|Part 1 and 2|Lost to Follow-up|0|||
145334625|NCT00809159|524074277|FG000|Part 1 and 2|Withdrawal by Subject|0|||
145334626|NCT00809159|524074278|FG001|Part 1 and 2|Withdrawal by Subject|0|||
145334627|NCT00809159|524074279|FG002|Part 1 and 2|Withdrawal by Subject|4|||
145412906|NCT00541229|524365903|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
145412907|NCT00541229|524365904|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145334628|NCT00809159|524074280|FG003|Part 1 and 2|Withdrawal by Subject|0|||
145334629|NCT00809159|524074281|FG004|Part 1 and 2|Withdrawal by Subject|0|||
145334630|NCT00809159|524074282|FG005|Part 1 and 2|Withdrawal by Subject|1|||
145334631|NCT04188301|524074283|FG000|Month 3|Lost to Follow-up|0|||
145334632|NCT04188301|524074284|FG001|Month 3|Lost to Follow-up|0|||
145334633|NCT04188301|524074285|FG002|Month 3|Lost to Follow-up|1|||
145334634|NCT04188301|524074283|FG000|Month 12|Lost to Follow-up|0|||
145334635|NCT04188301|524074284|FG001|Month 12|Lost to Follow-up|0|||
145334636|NCT04188301|524074285|FG002|Month 12|Lost to Follow-up|2|||
145334637|NCT04188301|524074283|FG000|Month 12|Death|1|||
145334638|NCT04188301|524074284|FG001|Month 12|Death|1|||
145334639|NCT04188301|524074285|FG002|Month 12|Death|0|||
145334640|NCT04188301|524074283|FG000|Month 18|Lost to Follow-up|6|||
145334641|NCT04188301|524074284|FG001|Month 18|Lost to Follow-up|0|||
145334642|NCT04188301|524074285|FG002|Month 18|Lost to Follow-up|0|||
145334643|NCT01770392|524074286|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
145334644|NCT03401450|524074287|FG000|Overall Study|Lost to Follow-up|4|||
145334645|NCT03401450|524074288|FG001|Overall Study|Lost to Follow-up|6|||
145334646|NCT03401450|524074287|FG000|Overall Study|Anesthesia plan changed|2|||
145334647|NCT03401450|524074288|FG001|Overall Study|Anesthesia plan changed|2|||
145412908|NCT00541229|524365905|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
145412909|NCT00541229|524365900|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
145412910|NCT00541229|524365901|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
145412911|NCT00541229|524365902|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
145412912|NCT00541229|524365903|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
145412913|NCT00541229|524365904|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
145412914|NCT00541229|524365905|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
145412915|NCT00541229|524365900|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145412916|NCT00541229|524365901|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145412917|NCT00541229|524365902|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145334648|NCT03401450|524074287|FG000|Overall Study|Did not complete medication diary|4|||
145334649|NCT03401450|524074288|FG001|Overall Study|Did not complete medication diary|2|||
145334650|NCT03401450|524074287|FG000|Overall Study|post surgery medication change|2|||
145334651|NCT03401450|524074288|FG001|Overall Study|post surgery medication change|1|||
145334652|NCT03401450|524074287|FG000|Overall Study|Cancelled surgery|0|||
145334653|NCT03401450|524074288|FG001|Overall Study|Cancelled surgery|2|||
145334654|NCT02352779|524074295|FG000|Overall Study|Personal Issues|1|||
145334655|NCT02352779|524074296|FG001|Overall Study|Personal Issues|1|||
145334656|NCT02352779|524074297|FG002|Overall Study|Personal Issues|0|||
145334657|NCT02352779|524074295|FG000|Overall Study|Too Many Forms|2|||
145334658|NCT02352779|524074296|FG001|Overall Study|Too Many Forms|0|||
145334659|NCT02352779|524074297|FG002|Overall Study|Too Many Forms|0|||
145412918|NCT00541229|524365903|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145621706|NCT04955626|525126687|FG015|Open-Label Period|Adverse Event|0|||
145621707|NCT04955626|525126688|FG016|Open-Label Period|Adverse Event|0|||
145334660|NCT02352779|524074295|FG000|Overall Study|Feeling Overwhelmed|1|||
145334661|NCT02352779|524074296|FG001|Overall Study|Feeling Overwhelmed|0|||
145334662|NCT02352779|524074297|FG002|Overall Study|Feeling Overwhelmed|0|||
145334663|NCT02352779|524074295|FG000|Overall Study|Disliked Intervention|1|||
145334664|NCT02352779|524074296|FG001|Overall Study|Disliked Intervention|0|||
145334665|NCT02352779|524074297|FG002|Overall Study|Disliked Intervention|0|||
145334666|NCT02352779|524074295|FG000|Overall Study|Changed Mind|1|||
145334667|NCT02352779|524074296|FG001|Overall Study|Changed Mind|0|||
145334668|NCT02352779|524074297|FG002|Overall Study|Changed Mind|0|||
145412919|NCT00541229|524365904|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
145412920|NCT00541229|524365905|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
145573173|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573174|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573175|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573176|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573177|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573178|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573179|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573180|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573181|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573182|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573183|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573184|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573185|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
145573186|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573187|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
145573188|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
145573189|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
145573190|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
145573191|NCT02346240|524954819|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573192|NCT02346240|524954820|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573193|NCT02346240|524954821|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573194|NCT02346240|524954822|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573195|NCT02346240|524954823|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573196|NCT02346240|524954824|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573197|NCT02346240|524954825|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573198|NCT02346240|524954826|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573199|NCT02346240|524954827|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573200|NCT02346240|524954828|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573201|NCT02346240|524954829|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573202|NCT02346240|524954830|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573203|NCT02346240|524954831|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573204|NCT02346240|524954832|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573205|NCT02346240|524954833|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573206|NCT02346240|524954834|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573207|NCT02346240|524954835|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573208|NCT02346240|524954836|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573209|NCT02346240|524954837|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
145573210|NCT02346240|524954838|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573211|NCT02346240|524954839|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573212|NCT02346240|524954840|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573213|NCT02346240|524954841|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573214|NCT02346240|524954842|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
145573215|NCT01573624|524954843|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
145573216|NCT01573624|524954844|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
145573217|NCT01573624|524954845|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
145573218|NCT01573624|524954846|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
145621708|NCT04955626|525126689|FG017|Open-Label Period|Adverse Event|0|||
145621709|NCT04955626|525126690|FG018|Open-Label Period|Adverse Event|0|||
145334669|NCT02352779|524074295|FG000|Overall Study|Study Related Symptoms|1|||
145334670|NCT02352779|524074296|FG001|Overall Study|Study Related Symptoms|0|||
145334671|NCT02352779|524074297|FG002|Overall Study|Study Related Symptoms|0|||
145334672|NCT02352779|524074295|FG000|Overall Study|Absence of Symptoms|1|||
145334673|NCT02352779|524074296|FG001|Overall Study|Absence of Symptoms|0|||
145334674|NCT02352779|524074297|FG002|Overall Study|Absence of Symptoms|0|||
145334675|NCT02352779|524074295|FG000|Overall Study|Other Medical Reason|0|||
145334676|NCT02352779|524074296|FG001|Overall Study|Other Medical Reason|0|||
145334677|NCT02352779|524074297|FG002|Overall Study|Other Medical Reason|1|||
145334678|NCT02352779|524074295|FG000|Overall Study|No Reason|0|||
145334679|NCT02352779|524074296|FG001|Overall Study|No Reason|0|||
145334680|NCT02352779|524074297|FG002|Overall Study|No Reason|1|||
145334681|NCT00968799|524074300|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
145334682|NCT03753763|524074305|FG000|Overall Study|Adverse Event|2|||
145334683|NCT03753763|524074306|FG001|Overall Study|Adverse Event|0|||
145334684|NCT03753763|524074305|FG000|Overall Study|Withdrawal by Subject|3|||
145334685|NCT03753763|524074306|FG001|Overall Study|Withdrawal by Subject|1|||
145334686|NCT03753763|524074305|FG000|Overall Study|clinical deterioration|1|||
145334687|NCT03753763|524074306|FG001|Overall Study|clinical deterioration|0|||
145334688|NCT01104779|524074307|FG000|Overall Study|Protocol Violation|1|||
145334689|NCT01104779|524074308|FG001|Overall Study|Protocol Violation|2|||
145334690|NCT01104779|524074309|FG002|Overall Study|Protocol Violation|2|||
145334691|NCT01104779|524074307|FG000|Overall Study|Lack of Efficacy|26|||
145334692|NCT01104779|524074308|FG001|Overall Study|Lack of Efficacy|12|||
145334693|NCT01104779|524074309|FG002|Overall Study|Lack of Efficacy|13|||
145334694|NCT01104779|524074307|FG000|Overall Study|Adverse Event|13|||
145334695|NCT01104779|524074308|FG001|Overall Study|Adverse Event|14|||
145334696|NCT01104779|524074309|FG002|Overall Study|Adverse Event|13|||
145334697|NCT01104779|524074307|FG000|Overall Study|Did not meet inc/exc criteria|1|||
145334698|NCT01104779|524074308|FG001|Overall Study|Did not meet inc/exc criteria|1|||
145334699|NCT01104779|524074309|FG002|Overall Study|Did not meet inc/exc criteria|1|||
145334700|NCT01104779|524074307|FG000|Overall Study|Other reasons|0|||
145334701|NCT01104779|524074308|FG001|Overall Study|Other reasons|1|||
145334702|NCT01104779|524074309|FG002|Overall Study|Other reasons|0|||
145334703|NCT01104779|524074307|FG000|Overall Study|Lost to Follow-up|2|||
145334704|NCT01104779|524074308|FG001|Overall Study|Lost to Follow-up|0|||
145334705|NCT01104779|524074309|FG002|Overall Study|Lost to Follow-up|1|||
145334706|NCT01104779|524074307|FG000|Overall Study|Withdrawal by Subject|16|||
145334707|NCT01104779|524074308|FG001|Overall Study|Withdrawal by Subject|25|||
145334708|NCT01104779|524074309|FG002|Overall Study|Withdrawal by Subject|32|||
145334709|NCT01372774|524074312|FG000|Overall Study|Withdrawal prior to treatment|4|||
145334710|NCT01372774|524074313|FG001|Overall Study|Withdrawal prior to treatment|5|||
145334711|NCT00389831|524074314|FG000|Overall Study|Lack of Efficacy|0|||
145334712|NCT00389831|524074315|FG001|Overall Study|Lack of Efficacy|2|||
145334713|NCT00389831|524074314|FG000|Overall Study|Did not receive treatment.|0|||
145334714|NCT00389831|524074315|FG001|Overall Study|Did not receive treatment.|2|||
145334715|NCT00389831|524074314|FG000|Overall Study|Other reasons|0|||
145412921|NCT00541229|524365900|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145412922|NCT00541229|524365901|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145412923|NCT00541229|524365902|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
145412924|NCT00541229|524365903|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145412925|NCT00541229|524365904|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145334716|NCT00389831|524074315|FG001|Overall Study|Other reasons|2|||
145334717|NCT00389831|524074314|FG000|Overall Study|Lost to Follow-up|0|||
145334718|NCT00389831|524074315|FG001|Overall Study|Lost to Follow-up|1|||
145412926|NCT00541229|524365905|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
145412927|NCT00924651|524365906|FG000|Overall Study|Chemo started too soon|2|||
145412928|NCT00924651|524365907|FG001|Overall Study|Chemo started too soon|3|||
145412929|NCT00924651|524365906|FG000|Overall Study|No Reason|3|||
145412930|NCT00924651|524365907|FG001|Overall Study|No Reason|7|||
145412931|NCT00924651|524365906|FG000|Overall Study|Overwhelmed|6|||
145412932|NCT00924651|524365907|FG001|Overall Study|Overwhelmed|6|||
145412933|NCT00924651|524365906|FG000|Overall Study|Noncompliant|1|||
145412934|NCT00924651|524365907|FG001|Overall Study|Noncompliant|4|||
145412935|NCT00924651|524365906|FG000|Overall Study|Medical|1|||
145412936|NCT00924651|524365907|FG001|Overall Study|Medical|3|||
145412937|NCT00924651|524365906|FG000|Overall Study|Changed Mind|10|||
145412938|NCT00924651|524365907|FG001|Overall Study|Changed Mind|1|||
145412939|NCT00924651|524365906|FG000|Overall Study|Incomplete Form|2|||
145412940|NCT00924651|524365907|FG001|Overall Study|Incomplete Form|1|||
145412941|NCT03298061|524365908|FG000|Overall Study|Adverse Event|3|||
145412942|NCT03298061|524365908|FG000|Overall Study|Lack of Efficacy|6|||
145412943|NCT03298061|524365908|FG000|Overall Study|Protocol Violation|1|||
145412944|NCT03298061|524365908|FG000|Overall Study|Physician Decision|7|||
145412945|NCT03298061|524365908|FG000|Overall Study|Withdrawal by Subject|10|||
145412946|NCT00992836|524365909|FG000|Overall Study|Lost to Follow-up|1|||
145412947|NCT00992836|524365909|FG000|Overall Study|Withdrawal by Subject|2|||
145412948|NCT00992836|524365909|FG000|Overall Study|Protocol Violation|2|||
145621710|NCT04955626|525126691|FG019|Open-Label Period|Adverse Event|0|||
145334719|NCT04639713|524074320|FG000|Overall Study|Protocol Noncompliance|2|||
145334720|NCT04639713|524074320|FG000|Overall Study|Withdrawal by Subject|1|||
145334721|NCT03786718|524076985|FG000|Overall Study|Lost to Follow-up|3|||
145334722|NCT03786718|524076985|FG000|Overall Study|Withdrawal by Subject|1|||
145334723|NCT03786718|524076985|FG000|Overall Study|Did not use the intervention|2|||
145334724|NCT03786718|524076985|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
145334725|NCT00699283|524076990|FG000|Overall Study|Lack of Efficacy|15|||
145334726|NCT00699283|524076991|FG001|Overall Study|Lack of Efficacy|5|||
145334727|NCT00699283|524076990|FG000|Overall Study|Lost to Follow-up|2|||
145334728|NCT00699283|524076991|FG001|Overall Study|Lost to Follow-up|0|||
145334729|NCT00699283|524076990|FG000|Overall Study|Withdrawal by Subject|1|||
145334730|NCT00699283|524076991|FG001|Overall Study|Withdrawal by Subject|0|||
145334731|NCT00699283|524076990|FG000|Overall Study|Other Reason|5|||
145334732|NCT00699283|524076991|FG001|Overall Study|Other Reason|1|||
145334733|NCT00699283|524076990|FG000|Overall Study|SAE, non-fatal|1|||
145334734|NCT00699283|524076991|FG001|Overall Study|SAE, non-fatal|1|||
145334735|NCT00699283|524076990|FG000|Overall Study|AE, non-serious non-fatal|8|||
145334736|NCT00699283|524076991|FG001|Overall Study|AE, non-serious non-fatal|1|||
145334737|NCT00699283|524076990|FG000|Overall Study|AE of unknown type|1|||
145334738|NCT00699283|524076991|FG001|Overall Study|AE of unknown type|0|||
145334739|NCT01570686|524076995|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145334740|NCT01570686|524076996|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145334741|NCT01570686|524076995|FG000|Overall Study|Administrative problems|0|||
145334742|NCT01570686|524076996|FG001|Overall Study|Administrative problems|1|||
145334743|NCT01570686|524076995|FG000|Overall Study|Adverse Event|8|||
145334744|NCT01570686|524076996|FG001|Overall Study|Adverse Event|6|||
145334745|NCT01570686|524076995|FG000|Overall Study|Lost to Follow-up|4|||
145334746|NCT01570686|524076996|FG001|Overall Study|Lost to Follow-up|3|||
145334747|NCT01570686|524076995|FG000|Overall Study|Protocol Deviation|3|||
145334748|NCT01570686|524076996|FG001|Overall Study|Protocol Deviation|0|||
145334749|NCT01570686|524076995|FG000|Overall Study|Withdrawal by Subject|4|||
145334750|NCT01570686|524076996|FG001|Overall Study|Withdrawal by Subject|4|||
145334751|NCT01570686|524076995|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145334752|NCT01570686|524076996|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145334753|NCT00754650|524076997|FG000|Overall Study|Disease Progression|2|||
145334754|NCT02771795|524076998|FG000|Overall Study|Withdrawal by Subject|47|||
145334755|NCT02771795|524076999|FG001|Overall Study|Withdrawal by Subject|37|||
145334756|NCT02771795|524076998|FG000|Overall Study|Termination by premature discontinuation of study|168|||
145334757|NCT02771795|524076999|FG001|Overall Study|Termination by premature discontinuation of study|185|||
145334758|NCT00622466|524077003|FG000|Overall Study|Death|1|||
145334759|NCT00622466|524077003|FG000|Overall Study|Adverse Event|1|||
145334760|NCT00622466|524077003|FG000|Overall Study|Withdrawal by Subject|2|||
145334761|NCT01007942|524077004|FG000|Overall Study|Adverse Event|29|||
145334762|NCT01007942|524077005|FG001|Overall Study|Adverse Event|14|||
145334763|NCT01007942|524077004|FG000|Overall Study|Abnormal test procedure|0|||
145334764|NCT01007942|524077005|FG001|Overall Study|Abnormal test procedure|1|||
145334765|NCT01007942|524077004|FG000|Overall Study|Disease progression|217|||
145334766|NCT01007942|524077005|FG001|Overall Study|Disease progression|242|||
145334767|NCT01007942|524077004|FG000|Overall Study|New cancer therapy|5|||
145334768|NCT01007942|524077005|FG001|Overall Study|New cancer therapy|1|||
145334769|NCT01007942|524077004|FG000|Overall Study|Protocol Violation|1|||
145334770|NCT01007942|524077005|FG001|Overall Study|Protocol Violation|1|||
145334771|NCT01007942|524077004|FG000|Overall Study|Withdrawal by Subject|19|||
145334772|NCT01007942|524077005|FG001|Overall Study|Withdrawal by Subject|14|||
145334773|NCT01007942|524077004|FG000|Overall Study|Lost to Follow-up|1|||
145334774|NCT01007942|524077005|FG001|Overall Study|Lost to Follow-up|0|||
145334775|NCT01007942|524077004|FG000|Overall Study|Administrative problems|2|||
145334776|NCT01007942|524077005|FG001|Overall Study|Administrative problems|0|||
145334777|NCT01007942|524077004|FG000|Overall Study|Death|3|||
145334778|NCT01007942|524077005|FG001|Overall Study|Death|2|||
145334779|NCT01007942|524077004|FG000|Overall Study|Patients untreated|4|||
145334780|NCT01007942|524077005|FG001|Overall Study|Patients untreated|3|||
145334781|NCT03929757|524077006|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
145334782|NCT03929757|524077007|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
145334783|NCT03929757|524077008|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
145573219|NCT01573624|524954847|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
145334784|NCT03929757|524077006|FG000|Main Study: Up to Day 365|Other|1|||
145334785|NCT03929757|524077007|FG001|Main Study: Up to Day 365|Other|0|||
145334786|NCT03929757|524077008|FG002|Main Study: Up to Day 365|Other|0|||
145334787|NCT03929757|524077006|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
145334788|NCT03929757|524077007|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
145334789|NCT03929757|524077008|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
145334790|NCT04715932|524077009|FG000|Overall Study|Lost to Follow-up|1|||
145334791|NCT04715932|524077010|FG001|Overall Study|Lost to Follow-up|0|||
145334792|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334793|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145621711|NCT04955626|525126692|FG020|Open-Label Period|Adverse Event|0|||
145621712|NCT04955626|525126693|FG021|Open-Label Period|Adverse Event|0|||
145621713|NCT04955626|525126694|FG022|Open-Label Period|Adverse Event|0|||
145621714|NCT04955626|525126695|FG023|Open-Label Period|Adverse Event|0|||
145621715|NCT04955626|525126696|FG024|Open-Label Period|Adverse Event|0|||
145621716|NCT04955626|525126697|FG025|Open-Label Period|Adverse Event|0|||
145621717|NCT04955626|525126698|FG026|Open-Label Period|Adverse Event|0|||
145621718|NCT04955626|525126699|FG027|Open-Label Period|Adverse Event|0|||
145621719|NCT04955626|525126700|FG028|Open-Label Period|Adverse Event|0|||
145621720|NCT04955626|525126701|FG029|Open-Label Period|Adverse Event|0|||
145621721|NCT04955626|525126702|FG030|Open-Label Period|Adverse Event|0|||
145621722|NCT04955626|525126703|FG031|Open-Label Period|Adverse Event|0|||
145621723|NCT04955626|525126704|FG032|Open-Label Period|Adverse Event|0|||
145621724|NCT04955626|525126705|FG033|Open-Label Period|Adverse Event|0|||
145621725|NCT04955626|525126706|FG034|Open-Label Period|Adverse Event|0|||
145621726|NCT04955626|525126707|FG035|Open-Label Period|Adverse Event|0|||
145621727|NCT04955626|525126672|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
145621728|NCT04955626|525126673|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
145621729|NCT04955626|525126674|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
145621730|NCT04955626|525126675|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
145621731|NCT04955626|525126676|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
145621732|NCT04955626|525126677|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
145621733|NCT04955626|525126678|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
145621734|NCT04955626|525126679|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
145621735|NCT04955626|525126680|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
145621736|NCT04955626|525126681|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
145621737|NCT04955626|525126682|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
145621738|NCT04955626|525126683|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
145621739|NCT04955626|525126684|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
145621740|NCT04955626|525126685|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
145621741|NCT04955626|525126686|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
145621742|NCT04955626|525126687|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
145621743|NCT04955626|525126688|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
145621744|NCT04955626|525126689|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
145334794|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334795|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334796|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334797|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145334798|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
145334799|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334800|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334801|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334802|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334803|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334804|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334805|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334806|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334807|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334808|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334809|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334810|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334811|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334812|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334813|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334814|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334815|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334816|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
145334817|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334818|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
145621745|NCT04955626|525126690|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
145621746|NCT04955626|525126691|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
145621747|NCT04955626|525126692|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
145334819|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334820|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334821|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334822|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334823|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145621748|NCT04955626|525126693|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
145621749|NCT04955626|525126694|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
145621750|NCT04955626|525126695|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
145334824|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334825|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334826|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334827|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334828|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334829|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334830|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334831|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334832|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334833|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334834|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334835|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334836|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334837|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334838|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334839|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334840|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334841|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
145334842|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
145334843|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
145334844|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
145334845|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
145334846|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
145334847|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
145334848|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
145334849|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
145334850|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
145334851|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
145334852|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
145334853|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
145334854|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
145334855|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
145334856|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
145334857|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
145334858|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
145334859|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
145334860|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
145334861|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
145334862|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
145334863|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
145334864|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
145334865|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
145334866|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
145334867|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
145334868|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334869|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334870|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334871|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334872|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334873|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334874|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334875|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334876|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334877|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334878|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334879|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334880|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334881|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334882|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334883|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334884|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145573220|NCT01573624|524954848|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
145573221|NCT01573624|524954849|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
145573222|NCT01573624|524954843|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
145573223|NCT01573624|524954844|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
145334885|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145573224|NCT01573624|524954845|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
145334886|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334887|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334888|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334889|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334890|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334891|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
145334892|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334893|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334894|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334895|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334896|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334897|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
145334898|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
145334899|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334900|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334901|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
145334902|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334903|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334904|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334905|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334906|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334907|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334908|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334909|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334910|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334911|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334912|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334913|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334914|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334915|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334916|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
145334917|NCT02393248|524077011|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334918|NCT02393248|524077012|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334919|NCT02393248|524077013|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334920|NCT02393248|524077014|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334921|NCT02393248|524077015|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334922|NCT02393248|524077016|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334923|NCT02393248|524077017|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
145334924|NCT02393248|524077018|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334925|NCT02393248|524077019|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145412949|NCT02506036|524365910|FG000|First Intervention (4-6 Weeks)|Death|1|||
145412950|NCT02506036|524365911|FG001|First Intervention (4-6 Weeks)|Death|0|||
145412951|NCT02506036|524365910|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
145412952|NCT02506036|524365911|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
145412953|NCT02506036|524365910|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
145412954|NCT02506036|524365911|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
145412955|NCT05276804|524365914|FG000|Overall Study|screen failure|23|||
145412956|NCT05276804|524365915|FG001|Overall Study|screen failure|0|||
145412957|NCT01410604|524365916|FG000|Overall Study|Adverse Event|2|||
145412958|NCT01410604|524365917|FG001|Overall Study|Adverse Event|1|||
145412959|NCT01410604|524365916|FG000|Overall Study|Lost to Follow-up|1|||
145412960|NCT01410604|524365917|FG001|Overall Study|Lost to Follow-up|0|||
145412961|NCT01410604|524365916|FG000|Overall Study|Physician Decision|0|||
145334926|NCT02393248|524077020|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334927|NCT02393248|524077021|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334928|NCT02393248|524077022|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334929|NCT02393248|524077023|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334930|NCT02393248|524077024|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334931|NCT02393248|524077025|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334932|NCT02393248|524077026|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145412962|NCT01410604|524365917|FG001|Overall Study|Physician Decision|1|||
145412963|NCT02827708|524365918|FG000|Overall Study|Lost to Follow-up|3|||
145412964|NCT02827708|524365919|FG001|Overall Study|Lost to Follow-up|1|||
145412965|NCT02827708|524365918|FG000|Overall Study|Withdrawal by Subject|1|||
145412966|NCT02827708|524365919|FG001|Overall Study|Withdrawal by Subject|2|||
145412967|NCT02827708|524365918|FG000|Overall Study|Death|1|||
145334933|NCT02393248|524077027|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334934|NCT02393248|524077028|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334935|NCT02393248|524077029|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334936|NCT02393248|524077030|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334937|NCT02393248|524077031|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334938|NCT02393248|524077032|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334939|NCT02393248|524077033|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334940|NCT02393248|524077034|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334941|NCT02393248|524077035|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
145334942|NCT02393248|524077011|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334943|NCT02393248|524077012|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334944|NCT02393248|524077013|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334945|NCT02393248|524077014|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334946|NCT02393248|524077015|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334947|NCT02393248|524077016|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334948|NCT02393248|524077017|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334949|NCT02393248|524077018|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334950|NCT02393248|524077019|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334951|NCT02393248|524077020|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334952|NCT02393248|524077021|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334953|NCT02393248|524077022|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
145334954|NCT02393248|524077023|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
145334955|NCT02393248|524077024|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
145334956|NCT02393248|524077025|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
145334957|NCT02393248|524077026|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334958|NCT02393248|524077027|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334959|NCT02393248|524077028|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334960|NCT02393248|524077029|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334961|NCT02393248|524077030|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334962|NCT02393248|524077031|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334963|NCT02393248|524077032|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334964|NCT02393248|524077033|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334965|NCT02393248|524077034|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334966|NCT02393248|524077035|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
145334967|NCT02393248|524077011|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334968|NCT02393248|524077012|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334969|NCT02393248|524077013|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334970|NCT02393248|524077014|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334971|NCT02393248|524077015|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334972|NCT02393248|524077016|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334973|NCT02393248|524077017|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334974|NCT02393248|524077018|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334975|NCT02393248|524077019|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334976|NCT02393248|524077020|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334977|NCT02393248|524077021|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
145334978|NCT02393248|524077022|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
145334979|NCT02393248|524077023|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334980|NCT02393248|524077024|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334981|NCT02393248|524077025|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334982|NCT02393248|524077026|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334983|NCT02393248|524077027|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334984|NCT02393248|524077028|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334985|NCT02393248|524077029|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334986|NCT02393248|524077030|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334987|NCT02393248|524077031|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334988|NCT02393248|524077032|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334989|NCT02393248|524077033|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334990|NCT02393248|524077034|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334991|NCT02393248|524077035|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
145334992|NCT02393248|524077011|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
145334993|NCT02393248|524077012|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
145334994|NCT02393248|524077013|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
145334995|NCT02393248|524077014|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
145334996|NCT02393248|524077015|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
145334997|NCT02393248|524077016|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
145334998|NCT02393248|524077017|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
145334999|NCT02393248|524077018|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
145335000|NCT02393248|524077019|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
145335001|NCT02393248|524077020|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
145335002|NCT02393248|524077021|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
145335003|NCT02393248|524077022|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
145335004|NCT02393248|524077023|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
145335005|NCT02393248|524077024|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
145335006|NCT02393248|524077025|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
145335007|NCT02393248|524077026|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
145335008|NCT02393248|524077027|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
145335009|NCT02393248|524077028|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
145335010|NCT02393248|524077029|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
145335011|NCT02393248|524077030|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
145335012|NCT02393248|524077031|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
145335013|NCT02393248|524077032|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
145335014|NCT02393248|524077033|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
145335015|NCT02393248|524077034|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
145335016|NCT02393248|524077035|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
145335017|NCT02393248|524077011|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335018|NCT02393248|524077012|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335019|NCT02393248|524077013|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335020|NCT02393248|524077014|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335021|NCT02393248|524077015|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335022|NCT02393248|524077016|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335023|NCT02393248|524077017|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335024|NCT02393248|524077018|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335025|NCT02393248|524077019|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335026|NCT02393248|524077020|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335027|NCT02393248|524077021|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335028|NCT02393248|524077022|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
145335029|NCT02393248|524077023|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335030|NCT02393248|524077024|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
145335031|NCT02393248|524077025|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335032|NCT02393248|524077026|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335033|NCT02393248|524077027|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335034|NCT02393248|524077028|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335035|NCT02393248|524077029|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335036|NCT02393248|524077030|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335037|NCT02393248|524077031|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335038|NCT02393248|524077032|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335039|NCT02393248|524077033|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335040|NCT02393248|524077034|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335041|NCT02393248|524077035|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
145335042|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335043|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335044|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335045|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335046|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335047|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335048|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335049|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335050|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335051|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335052|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335053|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335054|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145412968|NCT02827708|524365919|FG001|Overall Study|Death|2|||
145412969|NCT00898807|524365920|FG000|Overall Study|Withdrawal by Subject|5|||
145412970|NCT00898807|524365921|FG001|Overall Study|Withdrawal by Subject|3|||
145335055|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335056|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335057|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335058|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335059|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335060|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145335061|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145621751|NCT04955626|525126696|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
145621752|NCT04955626|525126697|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
145621753|NCT04955626|525126698|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
145621754|NCT04955626|525126699|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
145621755|NCT04955626|525126700|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
145621756|NCT04955626|525126701|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
145621757|NCT04955626|525126702|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
145621758|NCT04955626|525126703|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
145621759|NCT04955626|525126704|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
145621760|NCT04955626|525126705|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
145621761|NCT04955626|525126706|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
145621762|NCT04955626|525126707|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
145621763|NCT04955626|525126672|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621764|NCT04955626|525126673|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
145621765|NCT04955626|525126674|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621766|NCT04955626|525126675|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621767|NCT04955626|525126676|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621768|NCT04955626|525126677|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145335062|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
145335063|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145335064|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335065|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
145335066|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
145335067|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Death|0|||
145335068|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Death|0|||
145335069|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Death|0|||
145335070|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Death|0|||
145335071|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Death|0|||
145335072|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Death|0|||
145335073|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Death|0|||
145335074|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Death|0|||
145335075|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Death|0|||
145335076|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Death|0|||
145335077|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Death|0|||
145335078|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Death|0|||
145335079|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Death|0|||
145335080|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Death|0|||
145335081|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Death|0|||
145335082|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Death|1|||
145335083|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Death|7|||
145335084|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Death|5|||
145335085|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Death|5|||
145335086|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Death|3|||
145335087|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Death|7|||
145335088|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Death|5|||
145335089|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Death|6|||
145335090|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Death|3|||
145335091|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Death|0|||
145335092|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335093|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335094|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335095|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335096|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335097|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335098|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335099|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335100|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145621769|NCT04955626|525126678|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621770|NCT04955626|525126679|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621771|NCT04955626|525126680|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621772|NCT04955626|525126681|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621773|NCT04955626|525126682|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621774|NCT04955626|525126683|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621775|NCT04955626|525126684|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145335101|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335102|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335103|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335104|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335105|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335106|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335107|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335108|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335109|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335110|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335111|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
145335112|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335113|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335114|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335115|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
145335116|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
145335117|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Disease Progression|0|||
145335118|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Disease Progression|0|||
145335119|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Disease Progression|0|||
145335120|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Disease Progression|0|||
145335121|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Disease Progression|0|||
145335122|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Disease Progression|0|||
145335123|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Disease Progression|0|||
145335124|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Disease Progression|0|||
145335125|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Disease Progression|0|||
145335126|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Disease Progression|0|||
145335127|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Disease Progression|0|||
145335128|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Disease Progression|0|||
145335129|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Disease Progression|0|||
145335130|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Disease Progression|0|||
145335131|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Disease Progression|0|||
145335132|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Disease Progression|0|||
145335133|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Disease Progression|0|||
145335134|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Disease Progression|0|||
145335135|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Disease Progression|0|||
145335136|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Disease Progression|0|||
145335137|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Disease Progression|2|||
145335138|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Disease Progression|1|||
145335139|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Disease Progression|0|||
145335140|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Disease Progression|0|||
145335141|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Disease Progression|0|||
145335142|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335143|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335144|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335145|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335146|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335147|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335148|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335149|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335150|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335151|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335152|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335153|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335154|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335155|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335156|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335157|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335158|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335159|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335160|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335161|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335162|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
145335163|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
145335164|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335165|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335166|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
145335167|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335168|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335169|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335170|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335171|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335172|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145377833|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
145335173|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335174|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335175|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335176|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335177|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335178|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335179|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335180|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335181|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335182|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335183|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335184|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335185|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335186|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335187|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
145335188|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335189|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335190|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335191|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
145335192|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Adverse Event|0|||
145335193|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Adverse Event|0|||
145335194|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Adverse Event|0|||
145335195|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Adverse Event|0|||
145335196|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Adverse Event|0|||
145335197|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Adverse Event|0|||
145335198|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Adverse Event|0|||
145335199|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Adverse Event|0|||
145335200|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Adverse Event|0|||
145335201|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Adverse Event|0|||
145335202|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Adverse Event|0|||
145335203|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Adverse Event|0|||
145335204|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Adverse Event|0|||
145335205|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Adverse Event|0|||
145335206|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Adverse Event|0|||
145335207|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Adverse Event|0|||
145335208|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Adverse Event|0|||
145335209|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Adverse Event|0|||
145335210|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Adverse Event|0|||
145335211|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Adverse Event|0|||
145335212|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Adverse Event|0|||
145335213|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Adverse Event|0|||
145335214|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Adverse Event|0|||
145335215|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Adverse Event|1|||
145335216|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Adverse Event|0|||
145335217|NCT02393248|524077011|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335218|NCT02393248|524077012|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335219|NCT02393248|524077013|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335220|NCT02393248|524077014|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335221|NCT02393248|524077015|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335222|NCT02393248|524077016|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335223|NCT02393248|524077017|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335224|NCT02393248|524077018|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335225|NCT02393248|524077019|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335226|NCT02393248|524077020|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335227|NCT02393248|524077021|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145573225|NCT01573624|524954846|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
145573226|NCT01573624|524954847|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
145573227|NCT01573624|524954848|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145573228|NCT01573624|524954849|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
145573229|NCT01573624|524954843|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
145573230|NCT01573624|524954844|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145335228|NCT02393248|524077022|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335229|NCT02393248|524077023|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335230|NCT02393248|524077024|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335231|NCT02393248|524077025|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335232|NCT02393248|524077026|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335233|NCT02393248|524077027|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335234|NCT02393248|524077028|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335235|NCT02393248|524077029|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335236|NCT02393248|524077030|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335237|NCT02393248|524077031|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335238|NCT02393248|524077032|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335239|NCT02393248|524077033|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335240|NCT02393248|524077034|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
145335241|NCT02393248|524077035|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
145335242|NCT00977379|524077048|FG000|Overall Study|Withdrawal by Subject|1|||
145335243|NCT00977379|524077049|FG001|Overall Study|Withdrawal by Subject|1|||
145335244|NCT00977379|524077048|FG000|Overall Study|Death|7|||
145335245|NCT00977379|524077049|FG001|Overall Study|Death|9|||
145335246|NCT00977379|524077048|FG000|Overall Study|Premature Study Termination|4|||
145335247|NCT00977379|524077049|FG001|Overall Study|Premature Study Termination|0|||
145335248|NCT00977379|524077048|FG000|Overall Study|Participant Moving House|0|||
145335249|NCT00977379|524077049|FG001|Overall Study|Participant Moving House|1|||
145335250|NCT00977379|524077048|FG000|Overall Study|Randomization Error|0|||
145335251|NCT00977379|524077049|FG001|Overall Study|Randomization Error|1|||
145335252|NCT02603393|524077050|FG000|Overall Study|Patient/guardian decision|32|||
145335253|NCT02603393|524077051|FG001|Overall Study|Patient/guardian decision|18|||
145335254|NCT02603393|524077050|FG000|Overall Study|Adverse Event|17|||
145335255|NCT02603393|524077051|FG001|Overall Study|Adverse Event|15|||
145335256|NCT02603393|524077050|FG000|Overall Study|Technical problems|4|||
145335257|NCT02603393|524077051|FG001|Overall Study|Technical problems|7|||
145335258|NCT02603393|524077050|FG000|Overall Study|Lack of Efficacy|7|||
145335259|NCT02603393|524077051|FG001|Overall Study|Lack of Efficacy|2|||
145335260|NCT02603393|524077050|FG000|Overall Study|Death|3|||
145335261|NCT02603393|524077051|FG001|Overall Study|Death|4|||
145335262|NCT02603393|524077050|FG000|Overall Study|Physician Decision|3|||
145335263|NCT02603393|524077051|FG001|Overall Study|Physician Decision|3|||
145335264|NCT02603393|524077050|FG000|Overall Study|Protocol deviation|2|||
145335265|NCT02603393|524077051|FG001|Overall Study|Protocol deviation|3|||
145335266|NCT02603393|524077050|FG000|Overall Study|Lost to Follow-up|1|||
145335267|NCT02603393|524077051|FG001|Overall Study|Lost to Follow-up|2|||
145335268|NCT02603393|524077050|FG000|Overall Study|Non-compliance with study treatment|1|||
145335269|NCT02603393|524077051|FG001|Overall Study|Non-compliance with study treatment|0|||
145335270|NCT02603393|524077050|FG000|Overall Study|Sponsor decision|1|||
145335271|NCT02603393|524077051|FG001|Overall Study|Sponsor decision|0|||
145335272|NCT00699374|524077052|FG000|Overall Study|Death|93|||
145335273|NCT00699374|524077053|FG001|Overall Study|Death|83|||
145335274|NCT00699374|524077052|FG000|Overall Study|Adverse Event|70|||
145335275|NCT00699374|524077053|FG001|Overall Study|Adverse Event|67|||
145335276|NCT00699374|524077052|FG000|Overall Study|Global deterioration of health status|7|||
145335277|NCT00699374|524077053|FG001|Overall Study|Global deterioration of health status|8|||
145335278|NCT00699374|524077052|FG000|Overall Study|Lost to Follow-up|3|||
145335279|NCT00699374|524077053|FG001|Overall Study|Lost to Follow-up|5|||
145335280|NCT00699374|524077052|FG000|Overall Study|Withdrawal by Subject|34|||
145335281|NCT00699374|524077053|FG001|Overall Study|Withdrawal by Subject|44|||
145335282|NCT00699374|524077052|FG000|Overall Study|Objective progression or relapse|281|||
145335283|NCT00699374|524077053|FG001|Overall Study|Objective progression or relapse|277|||
145335284|NCT00699374|524077052|FG000|Overall Study|Other|18|||
145335285|NCT00699374|524077053|FG001|Overall Study|Other|15|||
145335286|NCT00699374|524077052|FG000|Overall Study|Protocol Violation|2|||
145335287|NCT00699374|524077053|FG001|Overall Study|Protocol Violation|6|||
145335288|NCT00699374|524077052|FG000|Overall Study|Study terminated by sponsor|13|||
145335289|NCT00699374|524077053|FG001|Overall Study|Study terminated by sponsor|28|||
145335290|NCT00699374|524077052|FG000|Overall Study|Randomized but not treated|4|||
145335291|NCT00699374|524077053|FG001|Overall Study|Randomized but not treated|2|||
145335292|NCT00699374|524077052|FG000|Overall Study|Died 28 days after last dose|5|||
145335293|NCT00699374|524077053|FG001|Overall Study|Died 28 days after last dose|9|||
145335294|NCT01359969|524077057|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
145335295|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
145335296|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
145335297|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
145335298|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
145335299|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145412971|NCT00898807|524365920|FG000|Overall Study|Family pressure to discontinue|2|||
145335300|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145335301|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
145335302|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
145335303|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145335304|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145335305|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
145335306|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
145335307|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
145335308|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
145335309|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
145335310|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
145335311|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145335312|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145335313|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
145335314|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
145335315|NCT00593736|524077061|FG000|Screening Period and Placebo Run-in|Various|0|||
145335316|NCT00593736|524077062|FG001|Screening Period and Placebo Run-in|Various|0|||
145335317|NCT00593736|524077063|FG002|Screening Period and Placebo Run-in|Various|0|||
145335318|NCT00593736|524077064|FG003|Screening Period and Placebo Run-in|Various|25|||
145335319|NCT00593736|524077061|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
145335320|NCT00593736|524077062|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
145335321|NCT00593736|524077063|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
145335322|NCT00593736|524077064|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
145335323|NCT00593736|524077061|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
145335324|NCT00593736|524077062|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
145335325|NCT00593736|524077063|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
145335326|NCT00593736|524077064|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
145335327|NCT00593736|524077061|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
145335328|NCT00593736|524077062|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
145335329|NCT00593736|524077063|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
145335330|NCT00593736|524077064|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
145335331|NCT00593736|524077061|FG000|Treatment Period and Placebo Run-out|Various|1|||
145335332|NCT00593736|524077062|FG001|Treatment Period and Placebo Run-out|Various|1|||
145335333|NCT00593736|524077063|FG002|Treatment Period and Placebo Run-out|Various|1|||
145335334|NCT00593736|524077064|FG003|Treatment Period and Placebo Run-out|Various|0|||
145335335|NCT01868893|524077065|FG000|Overall Study|Adverse Event|2|||
145335336|NCT01868893|524077065|FG000|Overall Study|Commercial availability of study drug|17|||
145335337|NCT01868893|524077065|FG000|Overall Study|Neutropenia|1|||
145335338|NCT01857271|524077066|FG000|Overall Study|Lost to Follow-up|1|||
145335339|NCT04283500|524077071|FG000|Overall Study|Lost to Follow-up|8|||
145335340|NCT04283500|524077071|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
145335341|NCT02006693|524077075|FG000|Overall Study|No Reason Specified|6|||
145335342|NCT02006693|524077076|FG001|Overall Study|No Reason Specified|8|||
145335343|NCT02006693|524077075|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
145335344|NCT02006693|524077076|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
145335345|NCT02006693|524077075|FG000|Overall Study|XEN Implant Explantation|0|||
145335346|NCT02006693|524077076|FG001|Overall Study|XEN Implant Explantation|1|||
145335347|NCT02006693|524077075|FG000|Overall Study|Death|2|||
145335348|NCT02006693|524077076|FG001|Overall Study|Death|2|||
145335349|NCT02006693|524077075|FG000|Overall Study|Lost to Follow-up|4|||
145335350|NCT02006693|524077076|FG001|Overall Study|Lost to Follow-up|1|||
145335351|NCT02006693|524077075|FG000|Overall Study|Patient Decision|4|||
145335352|NCT02006693|524077076|FG001|Overall Study|Patient Decision|0|||
145335353|NCT01119508|524077079|FG000|Overall Study|Adverse Event|56|||
145335354|NCT01119508|524077079|FG000|Overall Study|Withdrawal by Subject|2|||
145335355|NCT01119508|524077079|FG000|Overall Study|Died before tumor response evaluation|1|||
145335356|NCT00265395|524077080|FG000|Overall Study|Adverse Event|3|||
145335357|NCT00265395|524077081|FG001|Overall Study|Adverse Event|6|||
145335358|NCT00265395|524077080|FG000|Overall Study|Lost to Follow-up|2|||
145335359|NCT00265395|524077081|FG001|Overall Study|Lost to Follow-up|1|||
145335360|NCT00265395|524077080|FG000|Overall Study|Withdrawal by Subject|1|||
145335361|NCT00265395|524077081|FG001|Overall Study|Withdrawal by Subject|6|||
145335362|NCT00265395|524077080|FG000|Overall Study|Protocol Violation|2|||
145412972|NCT00898807|524365921|FG001|Overall Study|Family pressure to discontinue|2|||
145335363|NCT00265395|524077081|FG001|Overall Study|Protocol Violation|2|||
145335364|NCT00265395|524077080|FG000|Overall Study|Lack of Efficacy|0|||
145335365|NCT00265395|524077081|FG001|Overall Study|Lack of Efficacy|1|||
145412973|NCT00898807|524365920|FG000|Overall Study|Lost to Follow-up|1|||
145412974|NCT00898807|524365921|FG001|Overall Study|Lost to Follow-up|3|||
145412975|NCT00898807|524365920|FG000|Overall Study|Death|0|||
145335366|NCT00265395|524077080|FG000|Overall Study|Administrative|0|||
145335367|NCT00265395|524077081|FG001|Overall Study|Administrative|1|||
145335368|NCT00552578|524077089|FG000|Overall Study|Lost to Follow-up|1|||
145335369|NCT00552578|524077090|FG001|Overall Study|Lost to Follow-up|1|||
145335370|NCT00470067|524077091|FG000|Overall Study|Death|1|||
145335371|NCT00470067|524077091|FG000|Overall Study|Disease Progression|6|||
145335372|NCT02563106|524077092|FG000|Overall Study|Withdrawal by Subject|7|||
145335373|NCT02563106|524077093|FG001|Overall Study|Withdrawal by Subject|8|||
145335374|NCT02563106|524077092|FG000|Overall Study|Adverse Event|17|||
145335375|NCT02563106|524077093|FG001|Overall Study|Adverse Event|15|||
145335376|NCT02563106|524077092|FG000|Overall Study|Protocol Violation|1|||
145335377|NCT02563106|524077093|FG001|Overall Study|Protocol Violation|0|||
145335378|NCT02563106|524077092|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
145335379|NCT02563106|524077093|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
145335380|NCT02563106|524077092|FG000|Overall Study|Lost to Follow-up|3|||
145335381|NCT02563106|524077093|FG001|Overall Study|Lost to Follow-up|2|||
145335382|NCT02563106|524077092|FG000|Overall Study|Physician Decision|3|||
145335383|NCT02563106|524077093|FG001|Overall Study|Physician Decision|1|||
145335384|NCT02563106|524077092|FG000|Overall Study|Other reason - not specified|2|||
145335385|NCT02563106|524077093|FG001|Overall Study|Other reason - not specified|1|||
145335386|NCT04729309|524077094|FG000|Period 1|Subject unable to return for Period 2|3|||
145335387|NCT04729309|524077095|FG001|Period 1|Subject unable to return for Period 2|0|||
145335388|NCT04729309|524077094|FG000|Period 1|Lost to Follow-up|1|||
145335389|NCT04729309|524077095|FG001|Period 1|Lost to Follow-up|0|||
145335390|NCT01059539|524077096|FG000|Overall Study|Adverse Event|66|||
145335391|NCT01059539|524077096|FG000|Overall Study|Insufficient Therapeutic Response|26|||
145335392|NCT01059539|524077096|FG000|Overall Study|Protocol Violation|55|||
145335393|NCT01059539|524077096|FG000|Overall Study|Withdrawal of Consent|80|||
145335394|NCT01059539|524077096|FG000|Overall Study|Lost to Follow-up|42|||
145335395|NCT01059539|524077096|FG000|Overall Study|Reason Not Specified|2|||
145335396|NCT02085135|524077097|FG000|Overall Study|Adverse Event|4|||
145335397|NCT02085135|524077098|FG001|Overall Study|Adverse Event|7|||
145335398|NCT02085135|524077097|FG000|Overall Study|Lost to Follow-up|2|||
145335399|NCT02085135|524077098|FG001|Overall Study|Lost to Follow-up|2|||
145335400|NCT02085135|524077097|FG000|Overall Study|Withdrawal by Subject|3|||
145335401|NCT02085135|524077098|FG001|Overall Study|Withdrawal by Subject|0|||
145335402|NCT02085135|524077097|FG000|Overall Study|Lack of Efficacy|2|||
145335403|NCT02085135|524077098|FG001|Overall Study|Lack of Efficacy|0|||
145335404|NCT01212588|524077099|FG000|Overall Study|Physician Decision|0|||
145335405|NCT01212588|524077100|FG001|Overall Study|Physician Decision|1|||
145335406|NCT01212588|524077099|FG000|Overall Study|Protocol Violation|1|||
145335407|NCT01212588|524077100|FG001|Overall Study|Protocol Violation|1|||
145335408|NCT03317834|524077101|FG000|Overall Study|Death|2|||
145335409|NCT03317834|524077101|FG000|Overall Study|Device Revision|5|||
145335410|NCT03317834|524077101|FG000|Overall Study|Withdrawal by Subject|13|||
145335411|NCT03317834|524077101|FG000|Overall Study|Lost to Follow-up|13|||
145335412|NCT01517373|524077106|FG000|Run-in Period|Death|1|||
145335413|NCT01517373|524077107|FG001|Run-in Period|Death|0|||
145335414|NCT01517373|524077108|FG002|Run-in Period|Death|0|||
145335415|NCT01517373|524077109|FG003|Run-in Period|Death|0|||
145335416|NCT01517373|524077110|FG004|Run-in Period|Death|0|||
145412976|NCT00898807|524365921|FG001|Overall Study|Death|1|||
145412977|NCT01521364|524365924|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
145412978|NCT01521364|524365924|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
145412979|NCT02636283|524365925|FG000|Overall Study|Adverse Event|2|||
145412980|NCT02636283|524365926|FG001|Overall Study|Adverse Event|0|||
145412981|NCT02636283|524365925|FG000|Overall Study|Trial Terminated Prematurely|0|||
145412982|NCT02636283|524365926|FG001|Overall Study|Trial Terminated Prematurely|3|||
145335417|NCT01517373|524077111|FG005|Run-in Period|Death|0|||
145335418|NCT01517373|524077106|FG000|Run-in Period|Adverse Event|5|||
145335419|NCT01517373|524077107|FG001|Run-in Period|Adverse Event|0|||
145335420|NCT01517373|524077108|FG002|Run-in Period|Adverse Event|0|||
145335421|NCT01517373|524077109|FG003|Run-in Period|Adverse Event|0|||
145335422|NCT01517373|524077110|FG004|Run-in Period|Adverse Event|0|||
145335423|NCT01517373|524077111|FG005|Run-in Period|Adverse Event|0|||
145335424|NCT01517373|524077106|FG000|Run-in Period|Did not meet eligibility criteria|34|||
145335425|NCT01517373|524077107|FG001|Run-in Period|Did not meet eligibility criteria|0|||
145335426|NCT01517373|524077108|FG002|Run-in Period|Did not meet eligibility criteria|0|||
145335427|NCT01517373|524077109|FG003|Run-in Period|Did not meet eligibility criteria|0|||
145335428|NCT01517373|524077110|FG004|Run-in Period|Did not meet eligibility criteria|0|||
145335429|NCT01517373|524077111|FG005|Run-in Period|Did not meet eligibility criteria|0|||
145412983|NCT03418675|524365927|FG000|Overall Study|Lost to Follow-up|13|||
145335430|NCT01517373|524077106|FG000|Run-in Period|Lost to Follow-up|1|||
145335431|NCT01517373|524077107|FG001|Run-in Period|Lost to Follow-up|0|||
145412984|NCT03418675|524365928|FG001|Overall Study|Lost to Follow-up|10|||
145335432|NCT01517373|524077108|FG002|Run-in Period|Lost to Follow-up|0|||
145335433|NCT01517373|524077109|FG003|Run-in Period|Lost to Follow-up|0|||
145335434|NCT01517373|524077110|FG004|Run-in Period|Lost to Follow-up|0|||
145335435|NCT01517373|524077111|FG005|Run-in Period|Lost to Follow-up|0|||
145335436|NCT01517373|524077106|FG000|Run-in Period|Withdrawal by Subject|12|||
145335437|NCT01517373|524077107|FG001|Run-in Period|Withdrawal by Subject|0|||
145335438|NCT01517373|524077108|FG002|Run-in Period|Withdrawal by Subject|0|||
145335439|NCT01517373|524077109|FG003|Run-in Period|Withdrawal by Subject|0|||
145335440|NCT01517373|524077110|FG004|Run-in Period|Withdrawal by Subject|0|||
145335441|NCT01517373|524077111|FG005|Run-in Period|Withdrawal by Subject|0|||
145335442|NCT01517373|524077106|FG000|Run-in Period|Sponsor Decision|3|||
145335443|NCT01517373|524077107|FG001|Run-in Period|Sponsor Decision|0|||
145335444|NCT01517373|524077108|FG002|Run-in Period|Sponsor Decision|0|||
145335445|NCT01517373|524077109|FG003|Run-in Period|Sponsor Decision|0|||
145335446|NCT01517373|524077110|FG004|Run-in Period|Sponsor Decision|0|||
145335447|NCT01517373|524077111|FG005|Run-in Period|Sponsor Decision|0|||
145335448|NCT01517373|524077106|FG000|Run-in Period|Other|1|||
145335449|NCT01517373|524077107|FG001|Run-in Period|Other|0|||
145335450|NCT01517373|524077108|FG002|Run-in Period|Other|0|||
145335451|NCT01517373|524077109|FG003|Run-in Period|Other|0|||
145335452|NCT01517373|524077110|FG004|Run-in Period|Other|0|||
145335453|NCT01517373|524077111|FG005|Run-in Period|Other|0|||
145335454|NCT01517373|524077106|FG000|Treatment Period|Adverse Event|0|||
145335455|NCT01517373|524077107|FG001|Treatment Period|Adverse Event|0|||
145335456|NCT01517373|524077108|FG002|Treatment Period|Adverse Event|0|||
145335457|NCT01517373|524077109|FG003|Treatment Period|Adverse Event|0|||
145335458|NCT01517373|524077110|FG004|Treatment Period|Adverse Event|0|||
145335459|NCT01517373|524077111|FG005|Treatment Period|Adverse Event|2|||
145335460|NCT01517373|524077106|FG000|Treatment Period|Lost to Follow-up|0|||
145335461|NCT01517373|524077107|FG001|Treatment Period|Lost to Follow-up|0|||
145335462|NCT01517373|524077108|FG002|Treatment Period|Lost to Follow-up|1|||
145335463|NCT01517373|524077109|FG003|Treatment Period|Lost to Follow-up|1|||
145335464|NCT01517373|524077110|FG004|Treatment Period|Lost to Follow-up|0|||
145335465|NCT01517373|524077111|FG005|Treatment Period|Lost to Follow-up|0|||
145335466|NCT01517373|524077106|FG000|Treatment Period|Withdrawal by Subject|0|||
145335467|NCT01517373|524077107|FG001|Treatment Period|Withdrawal by Subject|3|||
145335468|NCT01517373|524077108|FG002|Treatment Period|Withdrawal by Subject|2|||
145335469|NCT01517373|524077109|FG003|Treatment Period|Withdrawal by Subject|2|||
145335470|NCT01517373|524077110|FG004|Treatment Period|Withdrawal by Subject|2|||
145335471|NCT01517373|524077111|FG005|Treatment Period|Withdrawal by Subject|3|||
145335472|NCT01517373|524077106|FG000|Treatment Period|Other|0|||
145335473|NCT01517373|524077107|FG001|Treatment Period|Other|0|||
145335474|NCT01517373|524077108|FG002|Treatment Period|Other|0|||
145335475|NCT01517373|524077109|FG003|Treatment Period|Other|0|||
145335476|NCT01517373|524077110|FG004|Treatment Period|Other|1|||
145335477|NCT01517373|524077111|FG005|Treatment Period|Other|0|||
145335478|NCT01517373|524077106|FG000|Treatment Period|Protocol Violation|0|||
145335479|NCT01517373|524077107|FG001|Treatment Period|Protocol Violation|0|||
145335480|NCT01517373|524077108|FG002|Treatment Period|Protocol Violation|0|||
145335481|NCT01517373|524077109|FG003|Treatment Period|Protocol Violation|0|||
145335482|NCT01517373|524077110|FG004|Treatment Period|Protocol Violation|1|||
145335483|NCT01517373|524077111|FG005|Treatment Period|Protocol Violation|0|||
145335484|NCT01517373|524077106|FG000|Treatment Period|Lack of Efficacy|0|||
145335485|NCT01517373|524077107|FG001|Treatment Period|Lack of Efficacy|1|||
145335486|NCT01517373|524077108|FG002|Treatment Period|Lack of Efficacy|1|||
145335487|NCT01517373|524077109|FG003|Treatment Period|Lack of Efficacy|3|||
145335488|NCT01517373|524077110|FG004|Treatment Period|Lack of Efficacy|2|||
145335489|NCT01517373|524077111|FG005|Treatment Period|Lack of Efficacy|0|||
145335490|NCT01517373|524077106|FG000|Treatment Period|Medication error without AEs|0|||
145335491|NCT01517373|524077107|FG001|Treatment Period|Medication error without AEs|0|||
145335492|NCT01517373|524077108|FG002|Treatment Period|Medication error without AEs|2|||
145335493|NCT01517373|524077109|FG003|Treatment Period|Medication error without AEs|1|||
145335494|NCT01517373|524077110|FG004|Treatment Period|Medication error without AEs|0|||
145335495|NCT01517373|524077111|FG005|Treatment Period|Medication error without AEs|2|||
145573231|NCT01573624|524954845|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145573232|NCT01573624|524954846|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145335496|NCT01085734|524077116|FG000|Overall Study|Adverse Event|0|||
145335497|NCT01085734|524077117|FG001|Overall Study|Adverse Event|2|||
145335498|NCT01085734|524077116|FG000|Overall Study|Death|1|||
145335499|NCT01085734|524077117|FG001|Overall Study|Death|0|||
145335500|NCT01085734|524077116|FG000|Overall Study|Lost to Follow-up|0|||
145335501|NCT01085734|524077117|FG001|Overall Study|Lost to Follow-up|1|||
145335502|NCT01085734|524077116|FG000|Overall Study|Withdrawal by Subject|0|||
145335503|NCT01085734|524077117|FG001|Overall Study|Withdrawal by Subject|1|||
145335504|NCT02695537|524077119|FG000|Overall Study|Adverse Event|3|||
145335505|NCT02695537|524077119|FG000|Overall Study|Lack of Efficacy|28|||
145335506|NCT02695537|524077119|FG000|Overall Study|Withdrawal by Subject|4|||
145335507|NCT02695537|524077119|FG000|Overall Study|Protocol Violation|3|||
145335508|NCT02792699|524077120|FG000|Overall Study|Adverse Event|1|||
145335509|NCT02792699|524077121|FG001|Overall Study|Adverse Event|2|||
145335510|NCT02792699|524077122|FG002|Overall Study|Adverse Event|4|||
145573233|NCT01573624|524954847|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145573234|NCT01573624|524954848|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145335511|NCT02792699|524077120|FG000|Overall Study|Withdrawal by Subject|4|||
145335512|NCT02792699|524077121|FG001|Overall Study|Withdrawal by Subject|4|||
145335513|NCT02792699|524077122|FG002|Overall Study|Withdrawal by Subject|3|||
145335514|NCT02792699|524077120|FG000|Overall Study|Lost to Follow-up|0|||
145335515|NCT02792699|524077121|FG001|Overall Study|Lost to Follow-up|1|||
145335516|NCT02792699|524077122|FG002|Overall Study|Lost to Follow-up|2|||
145335517|NCT02792699|524077120|FG000|Overall Study|Physician Decision|2|||
145335518|NCT02792699|524077121|FG001|Overall Study|Physician Decision|0|||
145335519|NCT02792699|524077122|FG002|Overall Study|Physician Decision|0|||
145335520|NCT02792699|524077120|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
145335521|NCT02792699|524077121|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
145335522|NCT02792699|524077122|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
145335523|NCT02792699|524077120|FG000|Overall Study|Other|1|||
145335524|NCT02792699|524077121|FG001|Overall Study|Other|0|||
145335525|NCT02792699|524077122|FG002|Overall Study|Other|0|||
145335526|NCT04524364|524077123|FG000|Overall Study|Physician Decision|3|||
145335527|NCT04524364|524077124|FG001|Overall Study|Physician Decision|6|||
145335528|NCT04524364|524077123|FG000|Overall Study|Adverse Event|0|||
145335529|NCT04524364|524077124|FG001|Overall Study|Adverse Event|1|||
145335530|NCT04524364|524077123|FG000|Overall Study|Investigational device deficiency|0|||
145335531|NCT04524364|524077124|FG001|Overall Study|Investigational device deficiency|1|||
145335532|NCT04524364|524077123|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
145335533|NCT04524364|524077124|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
145335534|NCT04524364|524077123|FG000|Overall Study|Device unavailability|0|||
145335535|NCT04524364|524077124|FG001|Overall Study|Device unavailability|2|||
145335536|NCT04524364|524077123|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
145335537|NCT04524364|524077124|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
145335538|NCT04524364|524077123|FG000|Overall Study|Low International normalized ratio (INR)|1|||
145335539|NCT04524364|524077124|FG001|Overall Study|Low International normalized ratio (INR)|0|||
145335540|NCT03233230|524077130|FG000|Overall Study|Adverse Event|6|||
145335541|NCT03233230|524077131|FG001|Overall Study|Adverse Event|3|||
145335542|NCT03233230|524077132|FG002|Overall Study|Adverse Event|6|||
145335543|NCT03233230|524077133|FG003|Overall Study|Adverse Event|3|||
145335544|NCT03233230|524077130|FG000|Overall Study|Protocol Violation|1|||
145335545|NCT03233230|524077131|FG001|Overall Study|Protocol Violation|2|||
145335546|NCT03233230|524077132|FG002|Overall Study|Protocol Violation|1|||
145335547|NCT03233230|524077133|FG003|Overall Study|Protocol Violation|1|||
145335548|NCT03233230|524077130|FG000|Overall Study|Lack of Efficacy|1|||
145335549|NCT03233230|524077131|FG001|Overall Study|Lack of Efficacy|0|||
145335550|NCT03233230|524077132|FG002|Overall Study|Lack of Efficacy|0|||
145335551|NCT03233230|524077133|FG003|Overall Study|Lack of Efficacy|0|||
145335552|NCT03233230|524077130|FG000|Overall Study|Other|5|||
145335553|NCT03233230|524077131|FG001|Overall Study|Other|5|||
145335554|NCT03233230|524077132|FG002|Overall Study|Other|5|||
145335555|NCT03233230|524077133|FG003|Overall Study|Other|3|||
145335556|NCT03233230|524077130|FG000|Overall Study|Withdrawal by Subject|2|||
145335557|NCT03233230|524077131|FG001|Overall Study|Withdrawal by Subject|2|||
145335558|NCT03233230|524077132|FG002|Overall Study|Withdrawal by Subject|0|||
145335559|NCT03233230|524077133|FG003|Overall Study|Withdrawal by Subject|1|||
145335560|NCT03233230|524077130|FG000|Overall Study|Lost to Follow-up|0|||
145335561|NCT03233230|524077131|FG001|Overall Study|Lost to Follow-up|3|||
145335562|NCT03233230|524077132|FG002|Overall Study|Lost to Follow-up|0|||
145335563|NCT03233230|524077133|FG003|Overall Study|Lost to Follow-up|0|||
145335564|NCT01584843|524077134|FG000|First Treatment Period|Adverse Event|0|||
145335565|NCT01584843|524077135|FG001|First Treatment Period|Adverse Event|0|||
145335566|NCT01584843|524077136|FG002|First Treatment Period|Adverse Event|1|||
145335567|NCT01584843|524077137|FG003|First Treatment Period|Adverse Event|0|||
145335568|NCT01584843|524077138|FG004|First Treatment Period|Adverse Event|0|||
145335569|NCT01584843|524077139|FG005|First Treatment Period|Adverse Event|0|||
145335570|NCT01584843|524077134|FG000|First Treatment Period|Protocol Violation|0|||
145335571|NCT01584843|524077135|FG001|First Treatment Period|Protocol Violation|0|||
145335572|NCT01584843|524077136|FG002|First Treatment Period|Protocol Violation|0|||
145335573|NCT01584843|524077137|FG003|First Treatment Period|Protocol Violation|0|||
145335574|NCT01584843|524077138|FG004|First Treatment Period|Protocol Violation|0|||
145335575|NCT01584843|524077139|FG005|First Treatment Period|Protocol Violation|1|||
145335576|NCT01584843|524077134|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145335577|NCT01584843|524077135|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145335578|NCT01584843|524077136|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145335579|NCT01584843|524077137|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145335580|NCT01584843|524077138|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
145335581|NCT01584843|524077139|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
145335582|NCT01584843|524077134|FG000|Second Treatment Period|Withdrawal by Subject|0|||
145621776|NCT04955626|525126685|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621777|NCT04955626|525126686|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621778|NCT04955626|525126687|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621779|NCT04955626|525126688|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621780|NCT04955626|525126689|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621781|NCT04955626|525126690|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621782|NCT04955626|525126691|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621783|NCT04955626|525126692|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621784|NCT04955626|525126693|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621785|NCT04955626|525126694|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621786|NCT04955626|525126695|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621787|NCT04955626|525126696|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621788|NCT04955626|525126697|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621789|NCT04955626|525126698|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621790|NCT04955626|525126699|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621791|NCT04955626|525126700|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621792|NCT04955626|525126701|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621793|NCT04955626|525126702|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621794|NCT04955626|525126703|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621795|NCT04955626|525126704|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621796|NCT04955626|525126705|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621797|NCT04955626|525126706|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621798|NCT04955626|525126707|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
145621799|NCT04320615|525126708|FG000|Overall Study|Withdrawal by Subject|4|||
145621800|NCT04320615|525126709|FG001|Overall Study|Withdrawal by Subject|10|||
145621801|NCT04320615|525126708|FG000|Overall Study|Physician Decision|2|||
145621802|NCT04320615|525126709|FG001|Overall Study|Physician Decision|0|||
145621803|NCT04320615|525126708|FG000|Overall Study|Other|2|||
145621804|NCT04320615|525126709|FG001|Overall Study|Other|0|||
145621805|NCT04320615|525126708|FG000|Overall Study|Lost to Follow-up|5|||
145621806|NCT04320615|525126709|FG001|Overall Study|Lost to Follow-up|23|||
145621807|NCT04320615|525126708|FG000|Overall Study|Death|35|||
145621808|NCT04320615|525126709|FG001|Overall Study|Death|71|||
145621809|NCT01857323|525126710|FG000|Overall Study|Adverse Event|1|||
145621810|NCT01857323|525126710|FG000|Overall Study|Withdrawal by Subject|3|||
145621811|NCT01857323|525126710|FG000|Overall Study|Non-compliance|1|||
145621812|NCT01857323|525126710|FG000|Overall Study|Protocol Violation|6|||
145621813|NCT01857323|525126710|FG000|Overall Study|Lost to Follow-up|1|||
145621814|NCT01857323|525126710|FG000|Overall Study|Other|4|||
145621815|NCT01857323|525126710|FG000|Overall Study|Did not complete 180 doses|48|||
145335583|NCT01584843|524077135|FG001|Second Treatment Period|Withdrawal by Subject|0|||
145335584|NCT01584843|524077136|FG002|Second Treatment Period|Withdrawal by Subject|0|||
145335585|NCT01584843|524077137|FG003|Second Treatment Period|Withdrawal by Subject|0|||
145335586|NCT01584843|524077138|FG004|Second Treatment Period|Withdrawal by Subject|0|||
145335587|NCT01584843|524077139|FG005|Second Treatment Period|Withdrawal by Subject|1|||
145335588|NCT04126213|524077142|FG000|Overall Study|Lost to Follow-up|9|||
145335589|NCT04126213|524077143|FG001|Overall Study|Lost to Follow-up|1|||
145335590|NCT04126213|524077144|FG002|Overall Study|Lost to Follow-up|5|||
145335591|NCT04126213|524077145|FG003|Overall Study|Lost to Follow-up|10|||
145335592|NCT04126213|524077146|FG004|Overall Study|Lost to Follow-up|4|||
145335593|NCT04126213|524077147|FG005|Overall Study|Lost to Follow-up|7|||
145335594|NCT04126213|524077142|FG000|Overall Study|Withdrawal by Subject|3|||
145335595|NCT04126213|524077143|FG001|Overall Study|Withdrawal by Subject|2|||
145335596|NCT04126213|524077144|FG002|Overall Study|Withdrawal by Subject|1|||
145335597|NCT04126213|524077145|FG003|Overall Study|Withdrawal by Subject|1|||
145335598|NCT04126213|524077146|FG004|Overall Study|Withdrawal by Subject|1|||
145335599|NCT04126213|524077147|FG005|Overall Study|Withdrawal by Subject|1|||
145335600|NCT04126213|524077142|FG000|Overall Study|Other|0|||
145621816|NCT02107443|525126711|FG000|Overall Study|Death|42|||
145621817|NCT02107443|525126712|FG001|Overall Study|Death|30|||
145621818|NCT02107443|525126711|FG000|Overall Study|Study Protocol Violation|3|||
145621819|NCT02107443|525126712|FG001|Overall Study|Study Protocol Violation|1|||
145621820|NCT02107443|525126711|FG000|Overall Study|Registered but Not Eligible|0|||
145621821|NCT02107443|525126712|FG001|Overall Study|Registered but Not Eligible|1|||
145621822|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
145621823|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
145335601|NCT04126213|524077143|FG001|Overall Study|Other|0|||
145621824|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
145621825|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
145335602|NCT04126213|524077144|FG002|Overall Study|Other|2|||
145335603|NCT04126213|524077145|FG003|Overall Study|Other|2|||
145335604|NCT04126213|524077146|FG004|Overall Study|Other|0|||
145335605|NCT04126213|524077147|FG005|Overall Study|Other|1|||
145335606|NCT04126213|524077142|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145335607|NCT04126213|524077143|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145335608|NCT04126213|524077144|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145335609|NCT04126213|524077145|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145335610|NCT04126213|524077146|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145335611|NCT04126213|524077147|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145335612|NCT02853370|524077148|FG000|Overall Study|Physician Decision|1|||
145412985|NCT03418675|524365927|FG000|Overall Study|Adverse Event|2|||
145412986|NCT03418675|524365928|FG001|Overall Study|Adverse Event|0|||
145412987|NCT01178411|524365929|FG000|Overall Study|Adverse Event|5|||
145412988|NCT01178411|524365929|FG000|Overall Study|Withdrawal by Subject|4|||
145412989|NCT01178411|524365929|FG000|Overall Study|Protocol Violation|1|||
145412990|NCT01178411|524365929|FG000|Overall Study|Progressive disease per RECIST|32|||
145412991|NCT01178411|524365929|FG000|Overall Study|Progressive disease per clinician|9|||
145412992|NCT01178411|524365929|FG000|Overall Study|Physician Decision|6|||
145412993|NCT01178411|524365929|FG000|Overall Study|Death|1|||
145412994|NCT01178411|524365929|FG000|Overall Study|No reason provided|1|||
145412995|NCT01178411|524365929|FG000|Overall Study|Drug manufacturing ended|1|||
145412996|NCT02383173|524365933|FG000|Overall Study|Palliative Care Team withdrew|0|||
145412997|NCT02383173|524365934|FG001|Overall Study|Palliative Care Team withdrew|2|||
145412998|NCT04900272|524365935|FG000|Overall Study|Lost to Follow-up|2|||
145412999|NCT04900272|524365935|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
145413000|NCT04900272|524365935|FG000|Overall Study|Withdrawal by Subject|1|||
145413001|NCT01625182|524365936|FG000|Overall Study|Administrative problems|1|||
145413002|NCT01625182|524365937|FG001|Overall Study|Administrative problems|0|||
145413003|NCT01625182|524365936|FG000|Overall Study|Protocol deviation|0|||
145413004|NCT01625182|524365937|FG001|Overall Study|Protocol deviation|2|||
145413005|NCT01625182|524365936|FG000|Overall Study|Adverse Event|2|||
145413006|NCT01625182|524365937|FG001|Overall Study|Adverse Event|0|||
145413007|NCT01625182|524365936|FG000|Overall Study|Withdrawal by Subject|5|||
145413008|NCT01625182|524365937|FG001|Overall Study|Withdrawal by Subject|1|||
145413009|NCT01625182|524365936|FG000|Overall Study|Lack of Efficacy|12|||
145413010|NCT01625182|524365937|FG001|Overall Study|Lack of Efficacy|8|||
145413011|NCT00263562|524365938|FG000|Overall Study|Protocol Violation|3|||
145413012|NCT00263562|524365939|FG001|Overall Study|Protocol Violation|0|||
145413013|NCT05059080|524365940|FG000|Overall Study|Withdrawal by Subject|3|||
145413014|NCT05059080|524365940|FG000|Overall Study|Study Terminated by Sponsor|64|||
145413015|NCT00800540|524365941|FG000|Period One: 6 Weeks|Noncompliance|1|||
145413016|NCT00800540|524365942|FG001|Period One: 6 Weeks|Noncompliance|0|||
145413017|NCT00800540|524365941|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
145413018|NCT00800540|524365942|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
145413019|NCT00800540|524365941|FG000|Period 2: 6 Weeks|Adverse Event|0|||
145413020|NCT00800540|524365942|FG001|Period 2: 6 Weeks|Adverse Event|1|||
145413021|NCT03927157|524365946|FG000|Overall Study|Adverse Event|1|||
145413022|NCT03927157|524365947|FG001|Overall Study|Adverse Event|3|||
145413023|NCT03927157|524365946|FG000|Overall Study|Protocol Violation|1|||
145413024|NCT03927157|524365947|FG001|Overall Study|Protocol Violation|2|||
145413025|NCT03927157|524365946|FG000|Overall Study|Withdrawal by Subject|8|||
145413026|NCT03927157|524365947|FG001|Overall Study|Withdrawal by Subject|21|||
145413027|NCT03927157|524365946|FG000|Overall Study|Due to COVID-19 pandemic|5|||
145413028|NCT03927157|524365947|FG001|Overall Study|Due to COVID-19 pandemic|2|||
145413029|NCT03927157|524365946|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
145413030|NCT03927157|524365947|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
145413031|NCT03927157|524365946|FG000|Overall Study|Other than above|0|||
145413032|NCT03927157|524365947|FG001|Overall Study|Other than above|1|||
145413033|NCT00726557|524365948|FG000|Overall Study|Screening failure|4|||
145413034|NCT00726557|524365948|FG000|Overall Study|No end of treatment documentation|37|||
145413035|NCT00726557|524365948|FG000|Overall Study|No follow-up documentation available|55|||
145413036|NCT00726557|524365948|FG000|Overall Study|Treatment less than 3 months|17|||
145413037|NCT00726557|524365948|FG000|Overall Study|Inclusion criteria not met|15|||
145413038|NCT01257542|524365953|FG000|Overall Study|Protocol Violation|3|||
145413039|NCT01257542|524365954|FG001|Overall Study|Protocol Violation|5|||
145335613|NCT02853370|524077148|FG000|Overall Study|Lack of Efficacy|2|||
145335614|NCT02853370|524077148|FG000|Overall Study|Death|1|||
145413040|NCT01257542|524365953|FG000|Overall Study|Withdrawal by Subject|0|||
145335615|NCT02853370|524077148|FG000|Overall Study|Adverse Event|4|||
145413041|NCT01257542|524365954|FG001|Overall Study|Withdrawal by Subject|2|||
145413042|NCT03637374|524365955|FG000|Overall Study|Death|2|||
145413043|NCT03637374|524365956|FG001|Overall Study|Death|0|||
145413044|NCT05561140|524365961|FG000|Randomized Treatment Period|Adverse Event|1|||
145413045|NCT05561140|524365962|FG001|Randomized Treatment Period|Adverse Event|0|||
145413046|NCT05561140|524365961|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
145413047|NCT05561140|524365962|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
145335616|NCT02853370|524077148|FG000|Overall Study|Withdrawal by Subject|3|||
145335617|NCT02196701|524077149|FG000|Overall Study|Adverse Event|1|||
145413048|NCT05561140|524365961|FG000|Open Label Treatment Period|Adverse Event|6|||
145413049|NCT05561140|524365962|FG001|Open Label Treatment Period|Adverse Event|4|||
145413050|NCT05561140|524365961|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
145413051|NCT05561140|524365962|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
145413052|NCT05561140|524365961|FG000|Open Label Treatment Period|Physician Decision|0|||
145413053|NCT05561140|524365962|FG001|Open Label Treatment Period|Physician Decision|1|||
145413054|NCT05561140|524365961|FG000|Open Label Treatment Period|Pregnancy|1|||
145413055|NCT05561140|524365962|FG001|Open Label Treatment Period|Pregnancy|0|||
145335618|NCT02196701|524077149|FG000|Overall Study|Lost to Follow-up|1|||
145335619|NCT02196701|524077149|FG000|Overall Study|Non-adherence to Protocol|1|||
145335620|NCT03275064|524077150|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145335621|NCT03275064|524077151|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145335622|NCT03275064|524077152|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145335623|NCT03275064|524077153|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
145335624|NCT03275064|524077154|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
145335625|NCT03275064|524077150|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
145335626|NCT03275064|524077151|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145335627|NCT03275064|524077152|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145335628|NCT03275064|524077153|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145335629|NCT03275064|524077154|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
145335630|NCT03275064|524077150|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
145413056|NCT05561140|524365961|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
145413057|NCT05561140|524365962|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
145413058|NCT05561140|524365961|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
145413059|NCT05561140|524365962|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
145413060|NCT05561140|524365961|FG000|Open Label Treatment Period|Other|1|||
145413061|NCT05561140|524365962|FG001|Open Label Treatment Period|Other|0|||
145413062|NCT03301714|524365965|FG000|Overall Study|Lost to Follow-up|10|||
145573235|NCT01573624|524954849|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
145573236|NCT01573624|524954843|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145573237|NCT01573624|524954844|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145573238|NCT01573624|524954845|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145573239|NCT01573624|524954846|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145573240|NCT01573624|524954847|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145573241|NCT01573624|524954848|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
145573242|NCT01573624|524954849|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145573243|NCT01573624|524954843|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
145573244|NCT01573624|524954844|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
145573245|NCT01573624|524954845|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
145573246|NCT01573624|524954846|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
145573247|NCT01573624|524954847|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
145573248|NCT01573624|524954848|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
145573249|NCT01573624|524954849|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
145573250|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573251|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573252|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573253|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573254|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573255|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
145573256|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
145573257|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
145573258|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
145573259|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
145573260|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
145573261|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
145573262|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
145573263|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
145573264|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
145573265|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145573266|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
145573267|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
145573268|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145573269|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145573270|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
145573271|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573272|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573273|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573274|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573275|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573276|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
145573277|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
145573278|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145573279|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145573280|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145573281|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
145573282|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145573283|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
145573284|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
145573285|NCT01573624|524954843|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573286|NCT01573624|524954844|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573287|NCT01573624|524954845|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573288|NCT01573624|524954846|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573289|NCT01573624|524954847|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573290|NCT01573624|524954848|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573291|NCT01573624|524954849|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573292|NCT01573624|524954843|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
145573293|NCT01573624|524954844|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
145573294|NCT01573624|524954845|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
145573295|NCT01573624|524954846|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
145573296|NCT01573624|524954847|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
145573297|NCT01573624|524954848|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
145573298|NCT01573624|524954849|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
145573299|NCT01573624|524954843|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
145573300|NCT01573624|524954844|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
145573301|NCT01573624|524954845|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
145573302|NCT01573624|524954846|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
145573303|NCT01573624|524954847|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
145573304|NCT01573624|524954848|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
145573305|NCT01573624|524954849|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
145573306|NCT01573624|524954843|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
145573307|NCT01573624|524954844|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573308|NCT01573624|524954845|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573309|NCT01573624|524954846|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573310|NCT01573624|524954847|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573311|NCT01573624|524954848|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573312|NCT01573624|524954849|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
145573313|NCT01573624|524954843|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145573314|NCT01573624|524954844|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
145573315|NCT01573624|524954845|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
145573316|NCT01573624|524954846|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145573317|NCT01573624|524954847|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145335631|NCT03275064|524077151|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
145335632|NCT03275064|524077152|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
145335633|NCT03275064|524077153|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
145335634|NCT03275064|524077154|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
145335635|NCT03275064|524077150|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145335636|NCT03275064|524077151|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145335637|NCT03275064|524077152|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145335638|NCT03275064|524077153|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
145335639|NCT03275064|524077154|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
145335640|NCT03275064|524077150|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
145335641|NCT03275064|524077151|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145335642|NCT03275064|524077152|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
145621826|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Changed Mind|2|||
145621827|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Changed Mind|0|||
145621828|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
145621829|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
145621830|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
145621831|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
145621832|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
145621833|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
145621834|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
145621835|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
145621836|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Other Medical|9|||
145621837|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Other Medical|5|||
145621838|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Disease Progression|4|||
145621839|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Disease Progression|2|||
145621840|NCT02107443|525126711|FG000|Overall Study|Withdrawal: Personal Issues|0|||
145621841|NCT02107443|525126712|FG001|Overall Study|Withdrawal: Personal Issues|3|||
145621842|NCT01400893|525126713|FG000|Overall Study|Death|27|||
145621843|NCT01400893|525126714|FG001|Overall Study|Death|21|||
145621844|NCT01400893|525126713|FG000|Overall Study|Lost to Follow-up|0|||
145621845|NCT01400893|525126714|FG001|Overall Study|Lost to Follow-up|6|||
145621846|NCT00946647|525126715|FG000|Phase 1 Part|Adverse Event|2|||
145621847|NCT00946647|525126716|FG001|Phase 1 Part|Adverse Event|5|||
145621848|NCT00946647|525126717|FG002|Phase 1 Part|Adverse Event|3|||
145621849|NCT00946647|525126718|FG003|Phase 1 Part|Adverse Event|0|||
145621850|NCT00946647|525126719|FG004|Phase 1 Part|Adverse Event|0|||
145621851|NCT00946647|525126715|FG000|Phase 1 Part|Disease progression|3|||
145621852|NCT00946647|525126716|FG001|Phase 1 Part|Disease progression|6|||
145621853|NCT00946647|525126717|FG002|Phase 1 Part|Disease progression|1|||
145621854|NCT00946647|525126718|FG003|Phase 1 Part|Disease progression|0|||
145621855|NCT00946647|525126719|FG004|Phase 1 Part|Disease progression|0|||
145621856|NCT00946647|525126715|FG000|Phase 1 Part|Withdrawal by Subject|1|||
145621857|NCT00946647|525126716|FG001|Phase 1 Part|Withdrawal by Subject|4|||
145621858|NCT00946647|525126717|FG002|Phase 1 Part|Withdrawal by Subject|3|||
145621859|NCT00946647|525126718|FG003|Phase 1 Part|Withdrawal by Subject|0|||
145621860|NCT00946647|525126719|FG004|Phase 1 Part|Withdrawal by Subject|0|||
145621861|NCT00946647|525126715|FG000|Phase 1 Part|Abnormal values|0|||
145621862|NCT00946647|525126716|FG001|Phase 1 Part|Abnormal values|2|||
145621863|NCT00946647|525126717|FG002|Phase 1 Part|Abnormal values|0|||
145621864|NCT00946647|525126718|FG003|Phase 1 Part|Abnormal values|0|||
145621865|NCT00946647|525126719|FG004|Phase 1 Part|Abnormal values|0|||
145621866|NCT00946647|525126715|FG000|Phase 1 Part|Reason missing|0|||
145621867|NCT00946647|525126716|FG001|Phase 1 Part|Reason missing|1|||
145621868|NCT00946647|525126717|FG002|Phase 1 Part|Reason missing|0|||
145621869|NCT00946647|525126718|FG003|Phase 1 Part|Reason missing|0|||
145621870|NCT00946647|525126719|FG004|Phase 1 Part|Reason missing|0|||
145621871|NCT00946647|525126715|FG000|Phase ll Part|Untreated|0|||
145621872|NCT00946647|525126716|FG001|Phase ll Part|Untreated|0|||
145621873|NCT00946647|525126717|FG002|Phase ll Part|Untreated|0|||
145621874|NCT00946647|525126718|FG003|Phase ll Part|Untreated|0|||
145621875|NCT00946647|525126719|FG004|Phase ll Part|Untreated|2|||
145621876|NCT00946647|525126715|FG000|Phase ll Part|Adverse Event|0|||
145621877|NCT00946647|525126716|FG001|Phase ll Part|Adverse Event|0|||
145621878|NCT00946647|525126717|FG002|Phase ll Part|Adverse Event|0|||
145335643|NCT03275064|524077153|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145335644|NCT03275064|524077154|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
145335645|NCT00855803|524077156|FG000|Overall Study|Death|2|||
145335646|NCT00855803|524077156|FG000|Overall Study|Lost to Follow-up|2|||
145335647|NCT00855803|524077156|FG000|Overall Study|Technical inability to undergo procedure|2|||
145335648|NCT00855803|524077156|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
145335649|NCT00855803|524077156|FG000|Overall Study|Withdrawal by Subject|3|||
145335650|NCT00855803|524077156|FG000|Overall Study|Physician Decision|3|||
145335651|NCT04430855|524077162|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
145335652|NCT04430855|524077163|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
145335653|NCT04430855|524077162|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
145335654|NCT04430855|524077163|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
145621879|NCT00946647|525126718|FG003|Phase ll Part|Adverse Event|10|||
145621880|NCT00946647|525126719|FG004|Phase ll Part|Adverse Event|6|||
145621881|NCT00946647|525126715|FG000|Phase ll Part|Withdrawal by Subject|0|||
145621882|NCT00946647|525126716|FG001|Phase ll Part|Withdrawal by Subject|0|||
145335655|NCT04430855|524077162|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
145335656|NCT04430855|524077163|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
145621883|NCT00946647|525126717|FG002|Phase ll Part|Withdrawal by Subject|0|||
145621884|NCT00946647|525126718|FG003|Phase ll Part|Withdrawal by Subject|8|||
145621885|NCT00946647|525126719|FG004|Phase ll Part|Withdrawal by Subject|6|||
145621886|NCT00946647|525126715|FG000|Phase ll Part|Administrative problems|0|||
145621887|NCT00946647|525126716|FG001|Phase ll Part|Administrative problems|0|||
145621888|NCT00946647|525126717|FG002|Phase ll Part|Administrative problems|0|||
145621889|NCT00946647|525126718|FG003|Phase ll Part|Administrative problems|3|||
145621890|NCT00946647|525126719|FG004|Phase ll Part|Administrative problems|8|||
145621891|NCT00946647|525126715|FG000|Phase ll Part|Death|0|||
145621892|NCT00946647|525126716|FG001|Phase ll Part|Death|0|||
145621893|NCT00946647|525126717|FG002|Phase ll Part|Death|0|||
145621894|NCT00946647|525126718|FG003|Phase ll Part|Death|7|||
145621895|NCT00946647|525126719|FG004|Phase ll Part|Death|4|||
145621896|NCT00946647|525126715|FG000|Phase ll Part|Disease progression|0|||
145621897|NCT00946647|525126716|FG001|Phase ll Part|Disease progression|0|||
145621898|NCT00946647|525126717|FG002|Phase ll Part|Disease progression|0|||
145621899|NCT00946647|525126718|FG003|Phase ll Part|Disease progression|6|||
145621900|NCT00946647|525126719|FG004|Phase ll Part|Disease progression|14|||
145621901|NCT00946647|525126715|FG000|Phase ll Part|Protocol Violation|0|||
145621902|NCT00946647|525126716|FG001|Phase ll Part|Protocol Violation|0|||
145621903|NCT00946647|525126717|FG002|Phase ll Part|Protocol Violation|0|||
145621904|NCT00946647|525126718|FG003|Phase ll Part|Protocol Violation|4|||
145621905|NCT00946647|525126719|FG004|Phase ll Part|Protocol Violation|2|||
145621906|NCT00946647|525126715|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
145621907|NCT00946647|525126716|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
145621908|NCT00946647|525126717|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
145621909|NCT00946647|525126718|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
145621910|NCT00946647|525126719|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
145621911|NCT04060680|525126723|FG000|Overall Study|Unsuccessful implant|17|||
145335657|NCT04430855|524077162|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
145335658|NCT04430855|524077163|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
145335659|NCT04430855|524077162|FG000|Period 1 (Weeks 1-12)|Other|0|||
145335660|NCT04430855|524077163|FG001|Period 1 (Weeks 1-12)|Other|1|||
145335661|NCT04430855|524077162|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
145335662|NCT04430855|524077163|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
145335663|NCT04430855|524077162|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
145335664|NCT04430855|524077163|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
145335665|NCT04430855|524077162|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
145335666|NCT04430855|524077163|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
145335667|NCT01425723|524077164|FG000|Overall Study|Lack of Efficacy|0|||
145335668|NCT01425723|524077165|FG001|Overall Study|Lack of Efficacy|1|||
145335669|NCT01425723|524077164|FG000|Overall Study|Withdrawal by Subject|1|||
145335670|NCT01425723|524077165|FG001|Overall Study|Withdrawal by Subject|4|||
145335671|NCT01425723|524077164|FG000|Overall Study|Lost to Follow-up|0|||
145335672|NCT01425723|524077165|FG001|Overall Study|Lost to Follow-up|3|||
145335673|NCT01425723|524077164|FG000|Overall Study|Physician Decision|2|||
145335674|NCT01425723|524077165|FG001|Overall Study|Physician Decision|0|||
145335675|NCT01425723|524077164|FG000|Overall Study|Other|1|||
145335676|NCT01425723|524077165|FG001|Overall Study|Other|10|||
145335677|NCT03567382|524077179|FG000|Overall Study|Lost to Follow-up|1|||
145335678|NCT03567382|524077180|FG001|Overall Study|Lost to Follow-up|21|||
145335679|NCT03567382|524077181|FG002|Overall Study|Lost to Follow-up|1|||
145335680|NCT03567382|524077182|FG003|Overall Study|Lost to Follow-up|21|||
145335681|NCT03567382|524077179|FG000|Overall Study|Withdrawal by Subject|2|||
145335682|NCT03567382|524077180|FG001|Overall Study|Withdrawal by Subject|14|||
145335683|NCT03567382|524077181|FG002|Overall Study|Withdrawal by Subject|1|||
145335684|NCT03567382|524077182|FG003|Overall Study|Withdrawal by Subject|12|||
145335685|NCT01709838|524077183|FG000|Overall Study|Withdrawal by Subject|21|||
145335686|NCT01709838|524077183|FG000|Overall Study|Lost to Follow-up|16|||
145335687|NCT01709838|524077183|FG000|Overall Study|Pregnancy|10|||
145335688|NCT01709838|524077183|FG000|Overall Study|Subject/guardian decision|8|||
145335689|NCT01709838|524077183|FG000|Overall Study|Adverse Event|4|||
145335690|NCT01709838|524077183|FG000|Overall Study|Physician Decision|4|||
145335691|NCT01709838|524077183|FG000|Overall Study|Death|3|||
145335692|NCT01709838|524077183|FG000|Overall Study|Protocol Violation|1|||
145335693|NCT00620659|524077184|FG000|Treatment Period 1|Adverse Event|1|||
145335694|NCT00620659|524077185|FG001|Treatment Period 1|Adverse Event|0|||
145335695|NCT00620659|524077186|FG002|Treatment Period 1|Adverse Event|0|||
145335696|NCT00620659|524077187|FG003|Treatment Period 1|Adverse Event|3|||
145621912|NCT04060680|525126724|FG001|Overall Study|Unsuccessful implant|2|||
145621913|NCT04060680|525126723|FG000|Overall Study|Adverse Event|3|||
145621914|NCT04060680|525126724|FG001|Overall Study|Adverse Event|0|||
145335697|NCT00620659|524077188|FG004|Treatment Period 1|Adverse Event|0|||
145335698|NCT00620659|524077189|FG005|Treatment Period 1|Adverse Event|0|||
145335699|NCT00620659|524077184|FG000|Treatment Period 1|Protocol Violation|1|||
145335700|NCT00620659|524077185|FG001|Treatment Period 1|Protocol Violation|0|||
145621915|NCT04060680|525126723|FG000|Overall Study|Death|2|||
145621916|NCT04060680|525126724|FG001|Overall Study|Death|0|||
145621917|NCT04060680|525126723|FG000|Overall Study|Study product no longer in use|1|||
145621918|NCT04060680|525126724|FG001|Overall Study|Study product no longer in use|0|||
145621919|NCT04060680|525126723|FG000|Overall Study|Withdrawal by Subject|1|||
145335701|NCT00620659|524077186|FG002|Treatment Period 1|Protocol Violation|0|||
145335702|NCT00620659|524077187|FG003|Treatment Period 1|Protocol Violation|0|||
145621920|NCT04060680|525126724|FG001|Overall Study|Withdrawal by Subject|0|||
145335703|NCT00620659|524077188|FG004|Treatment Period 1|Protocol Violation|0|||
145335704|NCT00620659|524077189|FG005|Treatment Period 1|Protocol Violation|0|||
145335705|NCT00620659|524077184|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145335706|NCT00620659|524077185|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145335707|NCT00620659|524077186|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145335708|NCT00620659|524077187|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145335709|NCT00620659|524077188|FG004|Treatment Period 1|Withdrawal by Subject|1|||
145335710|NCT00620659|524077189|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145335711|NCT00620659|524077184|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
145335712|NCT00620659|524077185|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
145335713|NCT00620659|524077186|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
145335714|NCT00620659|524077187|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
145335715|NCT00620659|524077188|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
145335716|NCT00620659|524077189|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
145335717|NCT00620659|524077184|FG000|Treatment Period 2|Adverse Event|0|||
145335718|NCT00620659|524077185|FG001|Treatment Period 2|Adverse Event|3|||
145335719|NCT00620659|524077186|FG002|Treatment Period 2|Adverse Event|0|||
145335720|NCT00620659|524077187|FG003|Treatment Period 2|Adverse Event|0|||
145335721|NCT00620659|524077188|FG004|Treatment Period 2|Adverse Event|2|||
145335722|NCT00620659|524077189|FG005|Treatment Period 2|Adverse Event|0|||
145335723|NCT00620659|524077184|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145335724|NCT00620659|524077185|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145335725|NCT00620659|524077186|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145335726|NCT00620659|524077187|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145335727|NCT00620659|524077188|FG004|Treatment Period 2|Withdrawal by Subject|3|||
145335728|NCT00620659|524077189|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145335729|NCT00620659|524077184|FG000|Placebo Washout Period 2|Adverse Event|2|||
145335730|NCT00620659|524077185|FG001|Placebo Washout Period 2|Adverse Event|0|||
145335731|NCT00620659|524077186|FG002|Placebo Washout Period 2|Adverse Event|0|||
145335732|NCT00620659|524077187|FG003|Placebo Washout Period 2|Adverse Event|0|||
145335733|NCT00620659|524077188|FG004|Placebo Washout Period 2|Adverse Event|0|||
145335734|NCT00620659|524077189|FG005|Placebo Washout Period 2|Adverse Event|0|||
145335735|NCT00620659|524077184|FG000|Treatment Period 3|Adverse Event|0|||
145335736|NCT00620659|524077185|FG001|Treatment Period 3|Adverse Event|2|||
145335737|NCT00620659|524077186|FG002|Treatment Period 3|Adverse Event|0|||
145335738|NCT00620659|524077187|FG003|Treatment Period 3|Adverse Event|0|||
145335739|NCT00620659|524077188|FG004|Treatment Period 3|Adverse Event|0|||
145335740|NCT00620659|524077189|FG005|Treatment Period 3|Adverse Event|0|||
145335741|NCT00620659|524077184|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145335742|NCT00620659|524077185|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145335743|NCT00620659|524077186|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145335744|NCT00620659|524077187|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145335745|NCT00620659|524077188|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145335746|NCT00620659|524077189|FG005|Treatment Period 3|Withdrawal by Subject|0|||
145335747|NCT01193127|524077190|FG000|Randomized|Surgery Cancelled|0|||
145335748|NCT01193127|524077191|FG001|Randomized|Surgery Cancelled|0|||
145335749|NCT01193127|524077192|FG002|Randomized|Surgery Cancelled|0|||
145335750|NCT01193127|524077193|FG003|Randomized|Surgery Cancelled|1|||
145335751|NCT01193127|524077190|FG000|Treated|Withdrawal by Subject|0|||
145335752|NCT01193127|524077191|FG001|Treated|Withdrawal by Subject|0|||
145335753|NCT01193127|524077192|FG002|Treated|Withdrawal by Subject|0|||
145335754|NCT01193127|524077193|FG003|Treated|Withdrawal by Subject|1|||
145335755|NCT03246646|524077196|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
145335756|NCT03246646|524077197|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
145335757|NCT03246646|524077196|FG000|Overall Study|Withdrawal by Subject|3|||
145335758|NCT03246646|524077197|FG001|Overall Study|Withdrawal by Subject|0|||
145335759|NCT03246646|524077196|FG000|Overall Study|Lost to Follow-up|7|||
145335760|NCT03246646|524077197|FG001|Overall Study|Lost to Follow-up|0|||
145335761|NCT03190330|524079369|FG000|Overall Study|Adverse Event|2|||
145335762|NCT03190330|524079369|FG000|Overall Study|Death|10|||
145335763|NCT03190330|524079369|FG000|Overall Study|Lost to Follow-up|1|||
145335764|NCT03190330|524079369|FG000|Overall Study|Withdrawal by Subject|6|||
145335765|NCT03190330|524079369|FG000|Overall Study|Progressive Disease|1|||
145335766|NCT02081209|524079370|FG000|Overall Study|Withdrawal by Subject|1|||
145335767|NCT00633243|524079374|FG000|Overall Study|Withdrawal by Subject|0|||
145335768|NCT00633243|524079375|FG001|Overall Study|Withdrawal by Subject|1|||
145335769|NCT00633243|524079374|FG000|Overall Study|incarceration|0|||
145335770|NCT00633243|524079375|FG001|Overall Study|incarceration|2|||
145335771|NCT00633243|524079374|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
145335772|NCT00633243|524079375|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
145335773|NCT00633243|524079374|FG000|Overall Study|Not comfortable with self-injecting|0|||
145335774|NCT00633243|524079375|FG001|Overall Study|Not comfortable with self-injecting|1|||
145335775|NCT00633243|524079374|FG000|Overall Study|Mental Health--Depression|0|||
145335776|NCT00633243|524079375|FG001|Overall Study|Mental Health--Depression|1|||
145335777|NCT00633243|524079374|FG000|Overall Study|Couldn't tolerate side-effects|1|||
145335778|NCT00633243|524079375|FG001|Overall Study|Couldn't tolerate side-effects|1|||
145335779|NCT02022748|524079376|FG000|Overall Study|Adverse Event|1|||
145335780|NCT02022748|524079377|FG001|Overall Study|Adverse Event|1|||
145335781|NCT02022748|524079378|FG002|Overall Study|Adverse Event|0|||
145335782|NCT02022748|524079376|FG000|Overall Study|Withdrawal by Subject|0|||
145335783|NCT02022748|524079377|FG001|Overall Study|Withdrawal by Subject|1|||
145335784|NCT02022748|524079378|FG002|Overall Study|Withdrawal by Subject|0|||
145335785|NCT04345601|524079382|FG000|Overall Study|Death|0|||
145335786|NCT04345601|524079383|FG001|Overall Study|Death|3|||
145335787|NCT04345601|524079384|FG002|Overall Study|Death|2|||
145335788|NCT04345601|524079382|FG000|Overall Study|Lost to Follow-up|0|||
145335789|NCT04345601|524079383|FG001|Overall Study|Lost to Follow-up|0|||
145335790|NCT04345601|524079384|FG002|Overall Study|Lost to Follow-up|2|||
145335791|NCT03537599|524079385|FG000|Overall Study|Disease Progression|2|||
145335792|NCT03537599|524079386|FG001|Overall Study|Disease Progression|1|||
145335793|NCT03537599|524079385|FG000|Overall Study|Death|0|||
145335794|NCT03537599|524079386|FG001|Overall Study|Death|1|||
145335795|NCT02585934|524079387|FG000|Overall Study|Lost to Follow-up|2|||
145335796|NCT02585934|524079388|FG001|Overall Study|Lost to Follow-up|2|||
145335797|NCT02585934|524079387|FG000|Overall Study|Protocol Violation|14|||
145335798|NCT02585934|524079388|FG001|Overall Study|Protocol Violation|11|||
145335799|NCT02585934|524079387|FG000|Overall Study|Adverse Event|21|||
145335800|NCT02585934|524079388|FG001|Overall Study|Adverse Event|22|||
145335801|NCT02585934|524079387|FG000|Overall Study|Physician Decision|3|||
145335802|NCT02585934|524079388|FG001|Overall Study|Physician Decision|2|||
145335803|NCT02585934|524079387|FG000|Overall Study|Withdrawal by Subject|7|||
145335804|NCT02585934|524079388|FG001|Overall Study|Withdrawal by Subject|21|||
145335805|NCT02585934|524079387|FG000|Overall Study|Lack of Efficacy|2|||
145335806|NCT02585934|524079388|FG001|Overall Study|Lack of Efficacy|1|||
145335807|NCT02585934|524079387|FG000|Overall Study|Death|2|||
145335808|NCT02585934|524079388|FG001|Overall Study|Death|0|||
145335809|NCT02585934|524079387|FG000|Overall Study|Caregiver Withdrew Consent|7|||
145335810|NCT02585934|524079388|FG001|Overall Study|Caregiver Withdrew Consent|7|||
145335811|NCT02585934|524079387|FG000|Overall Study|Sponsor Termination|1|||
145335812|NCT02585934|524079388|FG001|Overall Study|Sponsor Termination|2|||
145335813|NCT02585934|524079387|FG000|Overall Study|Another Reason|10|||
145335814|NCT02585934|524079388|FG001|Overall Study|Another Reason|5|||
145335815|NCT02338193|524079389|FG000|Overall Study|Withdrawal by Subject|0|||
145335816|NCT02338193|524079390|FG001|Overall Study|Withdrawal by Subject|0|||
145335817|NCT02338193|524079391|FG002|Overall Study|Withdrawal by Subject|2|||
145335818|NCT02338193|524079389|FG000|Overall Study|Pregnancy|0|||
145335819|NCT02338193|524079390|FG001|Overall Study|Pregnancy|1|||
145335820|NCT02338193|524079391|FG002|Overall Study|Pregnancy|1|||
145335821|NCT02338193|524079389|FG000|Overall Study|Noncompliant with visits|2|||
145335822|NCT02338193|524079390|FG001|Overall Study|Noncompliant with visits|2|||
145335823|NCT02338193|524079391|FG002|Overall Study|Noncompliant with visits|7|||
145335824|NCT02338193|524079389|FG000|Overall Study|moved out of state|0|||
145335825|NCT02338193|524079390|FG001|Overall Study|moved out of state|1|||
145335826|NCT02338193|524079391|FG002|Overall Study|moved out of state|0|||
145335827|NCT02338193|524079389|FG000|Overall Study|intolerant of side effects|1|||
145335828|NCT02338193|524079390|FG001|Overall Study|intolerant of side effects|0|||
145335829|NCT02338193|524079391|FG002|Overall Study|intolerant of side effects|0|||
145335830|NCT01136967|524079393|FG000|Overall Study|Adverse Event|9|||
145335831|NCT01136967|524079394|FG001|Overall Study|Adverse Event|12|||
145335832|NCT01136967|524079393|FG000|Overall Study|Participant Choice|8|||
145335833|NCT01136967|524079394|FG001|Overall Study|Participant Choice|3|||
145335834|NCT01136967|524079393|FG000|Overall Study|Lost to Follow-up|0|||
145335835|NCT01136967|524079394|FG001|Overall Study|Lost to Follow-up|1|||
145335836|NCT01136967|524079393|FG000|Overall Study|Withdrawal by Subject|1|||
145335837|NCT01136967|524079394|FG001|Overall Study|Withdrawal by Subject|2|||
145335838|NCT01136967|524079393|FG000|Overall Study|Clinical Progression|3|||
145335839|NCT01136967|524079394|FG001|Overall Study|Clinical Progression|5|||
145335840|NCT01136967|524079393|FG000|Overall Study|Radiation|1|||
145335841|NCT01136967|524079394|FG001|Overall Study|Radiation|0|||
145335842|NCT01136967|524079393|FG000|Overall Study|Non-compliance|1|||
145335843|NCT01136967|524079394|FG001|Overall Study|Non-compliance|0|||
145335844|NCT01136967|524079393|FG000|Overall Study|Investigator's Choice|1|||
145335845|NCT01136967|524079394|FG001|Overall Study|Investigator's Choice|1|||
145573318|NCT01573624|524954848|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
145573319|NCT01573624|524954849|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
145335846|NCT01136967|524079393|FG000|Overall Study|Increase in Lesion Size|0|||
145335847|NCT01136967|524079394|FG001|Overall Study|Increase in Lesion Size|2|||
145335848|NCT01136967|524079393|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
145335849|NCT01136967|524079394|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
145335850|NCT01735955|524079398|FG000|Overall Study|Administrative problems|1|||
145335851|NCT01735955|524079398|FG000|Overall Study|Patient/guardian decision|1|||
145335852|NCT01735955|524079398|FG000|Overall Study|Patient withdrew consent|2|||
145335853|NCT01735955|524079398|FG000|Overall Study|Physician Decision|4|||
145335854|NCT01735955|524079398|FG000|Overall Study|Disease progression|24|||
145335855|NCT01735955|524079398|FG000|Overall Study|Adverse Event|5|||
145621921|NCT03990363|525126725|FG000|Overall Study|Withdrawal by Subject|10|||
145621922|NCT03990363|525126726|FG001|Overall Study|Withdrawal by Subject|9|||
145621923|NCT03990363|525126727|FG002|Overall Study|Withdrawal by Subject|18|||
145621924|NCT03990363|525126728|FG003|Overall Study|Withdrawal by Subject|11|||
145621925|NCT03990363|525126729|FG004|Overall Study|Withdrawal by Subject|9|||
145621926|NCT03990363|525126725|FG000|Overall Study|Physician Decision|1|||
145621927|NCT03990363|525126726|FG001|Overall Study|Physician Decision|0|||
145621928|NCT03990363|525126727|FG002|Overall Study|Physician Decision|0|||
145621929|NCT03990363|525126728|FG003|Overall Study|Physician Decision|0|||
145621930|NCT03990363|525126729|FG004|Overall Study|Physician Decision|0|||
145621931|NCT03990363|525126725|FG000|Overall Study|Adverse Event|1|||
145621932|NCT03990363|525126726|FG001|Overall Study|Adverse Event|3|||
145621933|NCT03990363|525126727|FG002|Overall Study|Adverse Event|2|||
145621934|NCT03990363|525126728|FG003|Overall Study|Adverse Event|2|||
145621935|NCT03990363|525126729|FG004|Overall Study|Adverse Event|0|||
145621936|NCT03990363|525126725|FG000|Overall Study|Death|14|||
145621937|NCT03990363|525126726|FG001|Overall Study|Death|8|||
145621938|NCT03990363|525126727|FG002|Overall Study|Death|14|||
145621939|NCT03990363|525126728|FG003|Overall Study|Death|10|||
145621940|NCT03990363|525126729|FG004|Overall Study|Death|11|||
145621941|NCT03990363|525126725|FG000|Overall Study|Failure to meet randomization criteria|0|||
145621942|NCT03990363|525126726|FG001|Overall Study|Failure to meet randomization criteria|1|||
145621943|NCT03990363|525126727|FG002|Overall Study|Failure to meet randomization criteria|1|||
145621944|NCT03990363|525126728|FG003|Overall Study|Failure to meet randomization criteria|0|||
145621945|NCT03990363|525126729|FG004|Overall Study|Failure to meet randomization criteria|0|||
145621946|NCT03990363|525126725|FG000|Overall Study|Lost to Follow-up|0|||
145621947|NCT03990363|525126726|FG001|Overall Study|Lost to Follow-up|0|||
145621948|NCT03990363|525126727|FG002|Overall Study|Lost to Follow-up|0|||
145621949|NCT03990363|525126728|FG003|Overall Study|Lost to Follow-up|1|||
145621950|NCT03990363|525126729|FG004|Overall Study|Lost to Follow-up|2|||
145621951|NCT03990363|525126725|FG000|Overall Study|Non-compliance with study drug|2|||
145621952|NCT03990363|525126726|FG001|Overall Study|Non-compliance with study drug|1|||
145621953|NCT03990363|525126727|FG002|Overall Study|Non-compliance with study drug|2|||
145621954|NCT03990363|525126728|FG003|Overall Study|Non-compliance with study drug|0|||
145621955|NCT03990363|525126729|FG004|Overall Study|Non-compliance with study drug|0|||
145621956|NCT03990363|525126725|FG000|Overall Study|Study terminated by sponsor|0|||
145621957|NCT03990363|525126726|FG001|Overall Study|Study terminated by sponsor|1|||
145621958|NCT03990363|525126727|FG002|Overall Study|Study terminated by sponsor|0|||
145621959|NCT03990363|525126728|FG003|Overall Study|Study terminated by sponsor|0|||
145335856|NCT02885181|524079399|FG000|Overall Study|Investigator's Discretion|0|||
145335857|NCT02885181|524079400|FG001|Overall Study|Investigator's Discretion|1|||
145335858|NCT02885181|524079401|FG002|Overall Study|Investigator's Discretion|0|||
145335859|NCT02885181|524079402|FG003|Overall Study|Investigator's Discretion|1|||
145335860|NCT02885181|524079399|FG000|Overall Study|Adverse Event|0|||
145335861|NCT02885181|524079400|FG001|Overall Study|Adverse Event|0|||
145335862|NCT02885181|524079401|FG002|Overall Study|Adverse Event|0|||
145335863|NCT02885181|524079402|FG003|Overall Study|Adverse Event|1|||
145335864|NCT02885181|524079399|FG000|Overall Study|Withdrawal by Subject|0|||
145335865|NCT02885181|524079400|FG001|Overall Study|Withdrawal by Subject|0|||
145335866|NCT02885181|524079401|FG002|Overall Study|Withdrawal by Subject|0|||
145335867|NCT02885181|524079402|FG003|Overall Study|Withdrawal by Subject|1|||
145335868|NCT01716715|524079403|FG000|Overall Study|Never Treated|2|||
145335869|NCT01716715|524079404|FG001|Overall Study|Never Treated|4|||
145335870|NCT04228783|524079405|FG000|Overall Study|Adverse Event|1|||
145335871|NCT04228783|524079406|FG001|Overall Study|Adverse Event|0|||
145335872|NCT04228783|524079407|FG002|Overall Study|Adverse Event|2|||
145335873|NCT04228783|524079408|FG003|Overall Study|Adverse Event|0|||
145335874|NCT04228783|524079409|FG004|Overall Study|Adverse Event|0|||
145335875|NCT04228783|524079410|FG005|Overall Study|Adverse Event|1|||
145335876|NCT04228783|524079405|FG000|Overall Study|Death|0|||
145335877|NCT04228783|524079406|FG001|Overall Study|Death|0|||
145335878|NCT04228783|524079407|FG002|Overall Study|Death|0|||
145335879|NCT04228783|524079408|FG003|Overall Study|Death|0|||
145335880|NCT04228783|524079409|FG004|Overall Study|Death|1|||
145335881|NCT04228783|524079410|FG005|Overall Study|Death|0|||
145413063|NCT03301714|524365966|FG001|Overall Study|Lost to Follow-up|4|||
145413064|NCT03301714|524365967|FG002|Overall Study|Lost to Follow-up|4|||
145621960|NCT03990363|525126729|FG004|Overall Study|Study terminated by sponsor|0|||
145621961|NCT03990363|525126725|FG000|Overall Study|Site terminated by sponsor|2|||
145621962|NCT03990363|525126726|FG001|Overall Study|Site terminated by sponsor|1|||
145621963|NCT03990363|525126727|FG002|Overall Study|Site terminated by sponsor|2|||
145335882|NCT04228783|524079405|FG000|Overall Study|Lost to Follow-up|36|||
145335883|NCT04228783|524079406|FG001|Overall Study|Lost to Follow-up|36|||
145335884|NCT04228783|524079407|FG002|Overall Study|Lost to Follow-up|28|||
145335885|NCT04228783|524079408|FG003|Overall Study|Lost to Follow-up|6|||
145621964|NCT03990363|525126728|FG003|Overall Study|Site terminated by sponsor|0|||
145621965|NCT03990363|525126729|FG004|Overall Study|Site terminated by sponsor|2|||
145621966|NCT03990363|525126725|FG000|Overall Study|Not categorized|5|||
145335886|NCT04228783|524079409|FG004|Overall Study|Lost to Follow-up|14|||
145335887|NCT04228783|524079410|FG005|Overall Study|Lost to Follow-up|3|||
145335888|NCT04228783|524079405|FG000|Overall Study|Physician Decision|1|||
145335889|NCT04228783|524079406|FG001|Overall Study|Physician Decision|2|||
145335890|NCT04228783|524079407|FG002|Overall Study|Physician Decision|0|||
145335891|NCT04228783|524079408|FG003|Overall Study|Physician Decision|0|||
145335892|NCT04228783|524079409|FG004|Overall Study|Physician Decision|0|||
145335893|NCT04228783|524079410|FG005|Overall Study|Physician Decision|0|||
145335894|NCT04228783|524079405|FG000|Overall Study|Protocol Violation|0|||
145335895|NCT04228783|524079406|FG001|Overall Study|Protocol Violation|0|||
145335896|NCT04228783|524079407|FG002|Overall Study|Protocol Violation|0|||
145335897|NCT04228783|524079408|FG003|Overall Study|Protocol Violation|1|||
145335898|NCT04228783|524079409|FG004|Overall Study|Protocol Violation|0|||
145335899|NCT04228783|524079410|FG005|Overall Study|Protocol Violation|0|||
145335900|NCT04228783|524079405|FG000|Overall Study|Withdrawal by Subject|6|||
145335901|NCT04228783|524079406|FG001|Overall Study|Withdrawal by Subject|10|||
145335902|NCT04228783|524079407|FG002|Overall Study|Withdrawal by Subject|19|||
145335903|NCT04228783|524079408|FG003|Overall Study|Withdrawal by Subject|1|||
145335904|NCT04228783|524079409|FG004|Overall Study|Withdrawal by Subject|2|||
145335905|NCT04228783|524079410|FG005|Overall Study|Withdrawal by Subject|0|||
145335906|NCT04228783|524079405|FG000|Overall Study|Other|4|||
145335907|NCT04228783|524079406|FG001|Overall Study|Other|3|||
145335908|NCT04228783|524079407|FG002|Overall Study|Other|2|||
145335909|NCT04228783|524079408|FG003|Overall Study|Other|1|||
145335910|NCT04228783|524079409|FG004|Overall Study|Other|0|||
145335911|NCT04228783|524079410|FG005|Overall Study|Other|0|||
145335912|NCT00626392|524079411|FG000|Run-in Period|Adverse Event|0|||
145335913|NCT00626392|524079412|FG001|Run-in Period|Adverse Event|0|||
145335914|NCT00626392|524079413|FG002|Run-in Period|Adverse Event|1|||
145335915|NCT00626392|524079414|FG003|Run-in Period|Adverse Event|0|||
145335916|NCT00626392|524079415|FG004|Run-in Period|Adverse Event|1|||
145335917|NCT00626392|524079416|FG005|Run-in Period|Adverse Event|0|||
145335918|NCT00626392|524079411|FG000|Run-in Period|Withdrawal by Subject|0|||
145335919|NCT00626392|524079412|FG001|Run-in Period|Withdrawal by Subject|1|||
145335920|NCT00626392|524079413|FG002|Run-in Period|Withdrawal by Subject|1|||
145335921|NCT00626392|524079414|FG003|Run-in Period|Withdrawal by Subject|1|||
145335922|NCT00626392|524079415|FG004|Run-in Period|Withdrawal by Subject|3|||
145335923|NCT00626392|524079416|FG005|Run-in Period|Withdrawal by Subject|1|||
145335924|NCT00626392|524079411|FG000|Run-in Period|Noncompliance|1|||
145335925|NCT00626392|524079412|FG001|Run-in Period|Noncompliance|0|||
145335926|NCT00626392|524079413|FG002|Run-in Period|Noncompliance|1|||
145335927|NCT00626392|524079414|FG003|Run-in Period|Noncompliance|0|||
145335928|NCT00626392|524079415|FG004|Run-in Period|Noncompliance|0|||
145335929|NCT00626392|524079416|FG005|Run-in Period|Noncompliance|0|||
145335930|NCT00626392|524079411|FG000|Coadministration Period|Adverse Event|3|||
145335931|NCT00626392|524079412|FG001|Coadministration Period|Adverse Event|1|||
145335932|NCT00626392|524079413|FG002|Coadministration Period|Adverse Event|7|||
145335933|NCT00626392|524079414|FG003|Coadministration Period|Adverse Event|4|||
145335934|NCT00626392|524079415|FG004|Coadministration Period|Adverse Event|3|||
145335935|NCT00626392|524079416|FG005|Coadministration Period|Adverse Event|4|||
145335936|NCT00626392|524079411|FG000|Coadministration Period|Withdrawal by Subject|1|||
145335937|NCT00626392|524079412|FG001|Coadministration Period|Withdrawal by Subject|1|||
145335938|NCT00626392|524079413|FG002|Coadministration Period|Withdrawal by Subject|0|||
145335939|NCT00626392|524079414|FG003|Coadministration Period|Withdrawal by Subject|1|||
145335940|NCT00626392|524079415|FG004|Coadministration Period|Withdrawal by Subject|0|||
145335941|NCT00626392|524079416|FG005|Coadministration Period|Withdrawal by Subject|1|||
145335942|NCT00626392|524079411|FG000|Coadministration Period|Protocol Violation|0|||
145335943|NCT00626392|524079412|FG001|Coadministration Period|Protocol Violation|1|||
145335944|NCT00626392|524079413|FG002|Coadministration Period|Protocol Violation|0|||
145335945|NCT00626392|524079414|FG003|Coadministration Period|Protocol Violation|1|||
145621967|NCT03990363|525126726|FG001|Overall Study|Not categorized|5|||
145335946|NCT00626392|524079415|FG004|Coadministration Period|Protocol Violation|1|||
145621968|NCT03990363|525126727|FG002|Overall Study|Not categorized|3|||
145621969|NCT03990363|525126728|FG003|Overall Study|Not categorized|2|||
145621970|NCT03990363|525126729|FG004|Overall Study|Not categorized|2|||
145335947|NCT00626392|524079416|FG005|Coadministration Period|Protocol Violation|0|||
145335948|NCT00626392|524079411|FG000|Coadministration Period|Other|0|||
145335949|NCT00626392|524079412|FG001|Coadministration Period|Other|2|||
145335950|NCT00626392|524079413|FG002|Coadministration Period|Other|3|||
145335951|NCT00626392|524079414|FG003|Coadministration Period|Other|1|||
145335952|NCT00626392|524079415|FG004|Coadministration Period|Other|1|||
145335953|NCT00626392|524079416|FG005|Coadministration Period|Other|1|||
145335954|NCT03151811|524079417|FG000|Overall Study|Randomized But Not Treated|18|||
145335955|NCT03151811|524079418|FG001|Overall Study|Randomized But Not Treated|3|||
145335956|NCT03151811|524079417|FG000|Overall Study|Progressive Disease|130|||
145335957|NCT03151811|524079418|FG001|Overall Study|Progressive Disease|170|||
145335958|NCT03151811|524079417|FG000|Overall Study|Adverse Event|49|||
145335959|NCT03151811|524079418|FG001|Overall Study|Adverse Event|40|||
145335960|NCT03151811|524079417|FG000|Overall Study|Lack of Efficacy|6|||
145335961|NCT03151811|524079418|FG001|Overall Study|Lack of Efficacy|8|||
145335962|NCT03151811|524079417|FG000|Overall Study|Physician Decision|21|||
145335963|NCT03151811|524079418|FG001|Overall Study|Physician Decision|9|||
145335964|NCT03151811|524079417|FG000|Overall Study|Withdrawal by Subject|17|||
145335965|NCT03151811|524079418|FG001|Overall Study|Withdrawal by Subject|7|||
145335966|NCT03151811|524079417|FG000|Overall Study|Lost to Follow-up|0|||
145335967|NCT03151811|524079418|FG001|Overall Study|Lost to Follow-up|1|||
145335968|NCT03151811|524079417|FG000|Overall Study|Study Terminated by Sponsor|5|||
145335969|NCT03151811|524079418|FG001|Overall Study|Study Terminated by Sponsor|11|||
145335970|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
145335971|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
145335972|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
145335973|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
145335974|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
145335975|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
145335976|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
145335977|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
145335978|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
145335979|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
145335980|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Death|1|||
145335981|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Death|0|||
145335982|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Death|0|||
145335983|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Death|0|||
145335984|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Death|0|||
145335985|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
145335986|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
145335987|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
145335988|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
145335989|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
145335990|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
145335991|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
145335992|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
145335993|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
145335994|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
145335995|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
145335996|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145335997|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
145335998|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145335999|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
145336000|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
145336001|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
145336002|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
145336003|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
145336004|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145336005|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
145336006|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145336007|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145336008|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145336009|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
145336010|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Other|4|||
145336011|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Other|4|||
145336012|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Other|3|||
145336013|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Other|1|||
145336014|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Other|0|||
145336015|NCT01081834|524079421|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
145336016|NCT01081834|524079422|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
145336017|NCT01081834|524079423|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145336018|NCT01081834|524079424|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145336019|NCT01081834|524079425|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
145336020|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145336021|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145336022|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145336023|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145336024|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
145336025|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Death|1|||
145336026|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Death|0|||
145336027|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145336028|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Death|0|||
145336029|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Death|0|||
145336030|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
145336031|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
145336032|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145336033|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145336034|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145336035|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145336036|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145336037|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145336038|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145336039|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145336040|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145336041|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
145336042|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145336043|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145336044|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
145336045|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145336046|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145336047|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145336048|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145336049|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145336050|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
145336051|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
145336052|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145336053|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145336054|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
145336055|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Other|4|||
145336056|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Other|5|||
145336057|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Other|4|||
145336058|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Other|0|||
145336059|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Other|0|||
145336060|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
145336061|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
145336062|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145336063|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145336064|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
145336065|NCT01081834|524079421|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145336066|NCT01081834|524079422|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
145336067|NCT01081834|524079423|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145336068|NCT01081834|524079424|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145336069|NCT01081834|524079425|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
145336070|NCT00742924|524079426|FG000|Overall Study|Adverse Event|0|||
145336071|NCT00742924|524079427|FG001|Overall Study|Adverse Event|0|||
145336072|NCT00742924|524079428|FG002|Overall Study|Adverse Event|1|||
145336073|NCT00742924|524079429|FG003|Overall Study|Adverse Event|1|||
145336074|NCT00742924|524079426|FG000|Overall Study|Lack of Efficacy|5|||
145336075|NCT00742924|524079427|FG001|Overall Study|Lack of Efficacy|1|||
145336076|NCT00742924|524079428|FG002|Overall Study|Lack of Efficacy|2|||
145336077|NCT00742924|524079429|FG003|Overall Study|Lack of Efficacy|4|||
145336078|NCT00742924|524079426|FG000|Overall Study|Physician Decision|0|||
145336079|NCT00742924|524079427|FG001|Overall Study|Physician Decision|0|||
145336080|NCT00742924|524079428|FG002|Overall Study|Physician Decision|0|||
145336081|NCT00742924|524079429|FG003|Overall Study|Physician Decision|1|||
145336082|NCT00742924|524079426|FG000|Overall Study|Withdrawal by Subject|0|||
145336083|NCT00742924|524079427|FG001|Overall Study|Withdrawal by Subject|1|||
145336084|NCT00742924|524079428|FG002|Overall Study|Withdrawal by Subject|1|||
145336085|NCT00742924|524079429|FG003|Overall Study|Withdrawal by Subject|0|||
145336086|NCT01777620|524079430|FG000|Overall Study|Subject Withdrawal|1|||
145336087|NCT01777620|524079431|FG001|Overall Study|Subject Withdrawal|0|||
145336088|NCT00936897|524079453|FG000|Overall Study|Withdrawal by Subject|9|||
145336089|NCT00936897|524079454|FG001|Overall Study|Withdrawal by Subject|19|||
145336090|NCT00936897|524079453|FG000|Overall Study|Adverse Event|4|||
145336091|NCT00936897|524079454|FG001|Overall Study|Adverse Event|13|||
145336092|NCT00936897|524079453|FG000|Overall Study|Other|3|||
145336093|NCT00936897|524079454|FG001|Overall Study|Other|9|||
145336094|NCT00936897|524079453|FG000|Overall Study|Lost to Follow-up|1|||
145336095|NCT00936897|524079454|FG001|Overall Study|Lost to Follow-up|10|||
145336096|NCT00936897|524079453|FG000|Overall Study|Administrative Decision|1|||
145336097|NCT00936897|524079454|FG001|Overall Study|Administrative Decision|2|||
145336098|NCT00936897|524079453|FG000|Overall Study|Protocol Violation|1|||
145336099|NCT00936897|524079454|FG001|Overall Study|Protocol Violation|1|||
145336100|NCT00936897|524079453|FG000|Overall Study|Ineligibility Determined|0|||
145336101|NCT00936897|524079454|FG001|Overall Study|Ineligibility Determined|3|||
145336102|NCT00936897|524079453|FG000|Overall Study|Noncompliance|0|||
145336103|NCT00936897|524079454|FG001|Overall Study|Noncompliance|2|||
145336104|NCT00936897|524079453|FG000|Overall Study|Death|0|||
145336105|NCT00936897|524079454|FG001|Overall Study|Death|1|||
145336106|NCT04058067|524079455|FG000|Overall Study|Adverse Event|2|||
145336107|NCT04058067|524079456|FG001|Overall Study|Adverse Event|0|||
145336108|NCT04058067|524079455|FG000|Overall Study|Death|0|||
145336109|NCT04058067|524079456|FG001|Overall Study|Death|1|||
145336110|NCT04058067|524079455|FG000|Overall Study|Physician Decision|3|||
145336111|NCT04058067|524079456|FG001|Overall Study|Physician Decision|1|||
145336112|NCT04058067|524079455|FG000|Overall Study|Protocol Violation|0|||
145336113|NCT04058067|524079456|FG001|Overall Study|Protocol Violation|1|||
145336114|NCT04058067|524079455|FG000|Overall Study|Withdrawal by Subject|7|||
145336115|NCT04058067|524079456|FG001|Overall Study|Withdrawal by Subject|8|||
145336116|NCT00417170|524079457|FG000|Overall Study|Adverse Event|1|||
145336117|NCT00417170|524079458|FG001|Overall Study|Adverse Event|1|||
145336118|NCT00417170|524079457|FG000|Overall Study|Withdrawal by Subject|1|||
145336119|NCT00417170|524079458|FG001|Overall Study|Withdrawal by Subject|1|||
145336120|NCT00417170|524079457|FG000|Overall Study|Lost to Follow-up|0|||
145336121|NCT00417170|524079458|FG001|Overall Study|Lost to Follow-up|1|||
145336122|NCT05005312|524079459|FG000|Overall Study|Enrolled, but not treated|0|||
145336123|NCT05005312|524079460|FG001|Overall Study|Enrolled, but not treated|1|||
145336124|NCT01283035|524079461|FG000|Overall Study|Subject later found ineligible|1|||
145336125|NCT03597529|524079466|FG000|Overall Study|Lost to Follow-up|10|||
145336126|NCT03597529|524079467|FG001|Overall Study|Lost to Follow-up|12|||
145336127|NCT03597529|524079466|FG000|Overall Study|Physician Decision|3|||
145336128|NCT03597529|524079467|FG001|Overall Study|Physician Decision|1|||
145336129|NCT03597529|524079466|FG000|Overall Study|Withdrawal by Subject|6|||
145336130|NCT03597529|524079467|FG001|Overall Study|Withdrawal by Subject|3|||
145336131|NCT03597529|524079466|FG000|Overall Study|Non-compliant with study activities|1|||
145336132|NCT03597529|524079467|FG001|Overall Study|Non-compliant with study activities|2|||
145336133|NCT03464630|524079470|FG000|Overall Study|Lost to Follow-up|62|||
145336134|NCT03464630|524079471|FG001|Overall Study|Lost to Follow-up|52|||
145336135|NCT03464630|524079470|FG000|Overall Study|Withdrawal by Subject|16|||
145336136|NCT03464630|524079471|FG001|Overall Study|Withdrawal by Subject|10|||
145336137|NCT03464630|524079470|FG000|Overall Study|Passive Disengagement|8|||
145336138|NCT03464630|524079471|FG001|Overall Study|Passive Disengagement|4|||
145336139|NCT06077149|524079474|FG000|Overall Study|Death|1|||
145336140|NCT06077149|524079475|FG001|Overall Study|Death|0|||
145336141|NCT06077149|524079474|FG000|Overall Study|Withdrawal by Subject|2|||
145336142|NCT06077149|524079475|FG001|Overall Study|Withdrawal by Subject|0|||
145336143|NCT06077149|524079474|FG000|Overall Study|RSV infection before vaccination|3|||
145336144|NCT06077149|524079475|FG001|Overall Study|RSV infection before vaccination|0|||
145336145|NCT04154631|524079476|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
145336146|NCT04154631|524079477|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
145336147|NCT02238795|524079478|FG000|Overall Study|Patient without purpura fulminans|1|||
145336148|NCT03384654|524079481|FG000|Overall Study|Withdrawal by Subject|0|||
145336149|NCT03384654|524079482|FG001|Overall Study|Withdrawal by Subject|0|||
145336150|NCT03384654|524079483|FG002|Overall Study|Withdrawal by Subject|1|||
145336151|NCT03384654|524079484|FG003|Overall Study|Withdrawal by Subject|0|||
145336152|NCT04159935|524079487|FG000|Overall Study|Study terminated due to COVID-19|1|||
145336153|NCT04159935|524079488|FG001|Overall Study|Study terminated due to COVID-19|3|||
145336154|NCT01341782|524079489|FG000|Overall Study|Adverse Event|1|||
145336155|NCT01341782|524079490|FG001|Overall Study|Adverse Event|1|||
145336156|NCT01341782|524079489|FG000|Overall Study|Withdrawal by Subject|6|||
145336157|NCT01341782|524079490|FG001|Overall Study|Withdrawal by Subject|5|||
145336158|NCT01341782|524079489|FG000|Overall Study|Missed 3 consecutive doses|0|||
145336159|NCT01341782|524079490|FG001|Overall Study|Missed 3 consecutive doses|4|||
145413065|NCT03301714|524365965|FG000|Overall Study|Did not receive allocated intervention|0|||
145336160|NCT01341782|524079489|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
145336161|NCT01341782|524079490|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
145336162|NCT01341782|524079489|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
145336163|NCT01341782|524079490|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
145336164|NCT01341782|524079489|FG000|Overall Study|Other|5|||
145573320|NCT01573624|524954843|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
145336165|NCT01341782|524079490|FG001|Overall Study|Other|0|||
145336166|NCT00620555|524079492|FG000|Overall Study|Adverse Event|4|||
145336167|NCT00620555|524079492|FG000|Overall Study|Protocol Violation|2|||
145336168|NCT00620555|524079492|FG000|Overall Study|Lack of Efficacy|12|||
145336169|NCT00620555|524079492|FG000|Overall Study|Withdrawal by Subject|1|||
145413066|NCT03301714|524365966|FG001|Overall Study|Did not receive allocated intervention|2|||
145413067|NCT03301714|524365967|FG002|Overall Study|Did not receive allocated intervention|3|||
145413068|NCT02112552|524365970|FG000|Overall Study|Withdrawal by Subject|1|||
145413069|NCT02112552|524365970|FG000|Overall Study|Adverse Event|1|||
145413070|NCT03349515|524365971|FG000|Overall Study|Lack of Efficacy|2|||
145413071|NCT03349515|524365972|FG001|Overall Study|Lack of Efficacy|0|||
145413072|NCT03349515|524365971|FG000|Overall Study|Physician Decision|3|||
145413073|NCT03349515|524365972|FG001|Overall Study|Physician Decision|1|||
145413074|NCT00544882|524365976|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
145413075|NCT00544882|524365977|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
145413076|NCT00544882|524365978|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
145413077|NCT00544882|524365976|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
145413078|NCT00544882|524365977|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
145413079|NCT00544882|524365978|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
145621971|NCT02169219|525126732|FG000|Overall Study|Lack of Efficacy|6|||
145336170|NCT00620555|524079492|FG000|Overall Study|Choice of other treatment|1|||
145336171|NCT00620555|524079492|FG000|Overall Study|Visit failure against planned|1|||
145336172|NCT02036775|524079493|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145336173|NCT02036775|524079494|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145336174|NCT02036775|524079495|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145336175|NCT02036775|524079496|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145336176|NCT02036775|524079497|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
145336177|NCT02036775|524079498|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
145336178|NCT01140503|524079499|FG000|Overall Study|Withdrawal by Subject|1|||
145336179|NCT00206323|524079502|FG000|Overall Study|Lack of Efficacy|4|||
145336180|NCT00206323|524079503|FG001|Overall Study|Lack of Efficacy|1|||
145336181|NCT00206323|524079502|FG000|Overall Study|Adverse Event|1|||
145336182|NCT00206323|524079503|FG001|Overall Study|Adverse Event|1|||
145336183|NCT00206323|524079502|FG000|Overall Study|Lost to Follow-up|1|||
145336184|NCT00206323|524079503|FG001|Overall Study|Lost to Follow-up|1|||
145336185|NCT03334617|524079504|FG000|Overall Study|Adverse Event|0|||
145336186|NCT03334617|524079505|FG001|Overall Study|Adverse Event|0|||
145336187|NCT03334617|524079506|FG002|Overall Study|Adverse Event|0|||
145336188|NCT03334617|524079507|FG003|Overall Study|Adverse Event|0|||
145336189|NCT03334617|524079508|FG004|Overall Study|Adverse Event|0|||
145336190|NCT03334617|524079509|FG005|Overall Study|Adverse Event|0|||
145336191|NCT03334617|524079510|FG006|Overall Study|Adverse Event|0|||
145336192|NCT03334617|524079511|FG007|Overall Study|Adverse Event|0|||
145336193|NCT03334617|524079512|FG008|Overall Study|Adverse Event|1|||
145336194|NCT03334617|524079513|FG009|Overall Study|Adverse Event|0|||
145336195|NCT03334617|524079514|FG010|Overall Study|Adverse Event|0|||
145336196|NCT03334617|524079515|FG011|Overall Study|Adverse Event|0|||
145336197|NCT03334617|524079516|FG012|Overall Study|Adverse Event|1|||
145336198|NCT03334617|524079517|FG013|Overall Study|Adverse Event|0|||
145336199|NCT03334617|524079518|FG014|Overall Study|Adverse Event|0|||
145336200|NCT03334617|524079519|FG015|Overall Study|Adverse Event|0|||
145336201|NCT03334617|524079520|FG016|Overall Study|Adverse Event|0|||
145336202|NCT03334617|524079521|FG017|Overall Study|Adverse Event|0|||
145336203|NCT03334617|524079522|FG018|Overall Study|Adverse Event|0|||
145336204|NCT03334617|524079523|FG019|Overall Study|Adverse Event|0|||
145336205|NCT03334617|524079524|FG020|Overall Study|Adverse Event|0|||
145336206|NCT03334617|524079525|FG021|Overall Study|Adverse Event|0|||
145336207|NCT03334617|524079504|FG000|Overall Study|Death|18|||
145336208|NCT03334617|524079505|FG001|Overall Study|Death|18|||
145336209|NCT03334617|524079506|FG002|Overall Study|Death|20|||
145336210|NCT03334617|524079507|FG003|Overall Study|Death|21|||
145336211|NCT03334617|524079508|FG004|Overall Study|Death|20|||
145336212|NCT03334617|524079509|FG005|Overall Study|Death|16|||
145336213|NCT03334617|524079510|FG006|Overall Study|Death|28|||
145336214|NCT03334617|524079511|FG007|Overall Study|Death|35|||
145336215|NCT03334617|524079512|FG008|Overall Study|Death|47|||
145336216|NCT03334617|524079513|FG009|Overall Study|Death|0|||
145336217|NCT03334617|524079514|FG010|Overall Study|Death|19|||
145336218|NCT03334617|524079515|FG011|Overall Study|Death|6|||
145336219|NCT03334617|524079516|FG012|Overall Study|Death|20|||
145336220|NCT03334617|524079517|FG013|Overall Study|Death|22|||
145336221|NCT03334617|524079518|FG014|Overall Study|Death|17|||
145336222|NCT03334617|524079519|FG015|Overall Study|Death|18|||
145336223|NCT03334617|524079520|FG016|Overall Study|Death|12|||
145413080|NCT00544882|524365976|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
145413081|NCT00544882|524365977|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
145413082|NCT00544882|524365978|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
145413083|NCT00544882|524365976|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
145413084|NCT00544882|524365977|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
145413085|NCT00544882|524365978|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
145336224|NCT03334617|524079521|FG017|Overall Study|Death|15|||
145336225|NCT03334617|524079522|FG018|Overall Study|Death|16|||
145336226|NCT03334617|524079523|FG019|Overall Study|Death|27|||
145336227|NCT03334617|524079524|FG020|Overall Study|Death|14|||
145573321|NCT01573624|524954844|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145336228|NCT03334617|524079525|FG021|Overall Study|Death|27|||
145336229|NCT03334617|524079504|FG000|Overall Study|Lost to Follow-up|0|||
145336230|NCT03334617|524079505|FG001|Overall Study|Lost to Follow-up|0|||
145336231|NCT03334617|524079506|FG002|Overall Study|Lost to Follow-up|0|||
145336232|NCT03334617|524079507|FG003|Overall Study|Lost to Follow-up|1|||
145336233|NCT03334617|524079508|FG004|Overall Study|Lost to Follow-up|0|||
145336234|NCT03334617|524079509|FG005|Overall Study|Lost to Follow-up|1|||
145336235|NCT03334617|524079510|FG006|Overall Study|Lost to Follow-up|0|||
145336236|NCT03334617|524079511|FG007|Overall Study|Lost to Follow-up|0|||
145336237|NCT03334617|524079512|FG008|Overall Study|Lost to Follow-up|1|||
145336238|NCT03334617|524079513|FG009|Overall Study|Lost to Follow-up|0|||
145336239|NCT03334617|524079514|FG010|Overall Study|Lost to Follow-up|0|||
145336240|NCT03334617|524079515|FG011|Overall Study|Lost to Follow-up|0|||
145336241|NCT03334617|524079516|FG012|Overall Study|Lost to Follow-up|0|||
145336242|NCT03334617|524079517|FG013|Overall Study|Lost to Follow-up|0|||
145336243|NCT03334617|524079518|FG014|Overall Study|Lost to Follow-up|0|||
145336244|NCT03334617|524079519|FG015|Overall Study|Lost to Follow-up|0|||
145336245|NCT03334617|524079520|FG016|Overall Study|Lost to Follow-up|0|||
145336246|NCT03334617|524079521|FG017|Overall Study|Lost to Follow-up|0|||
145336247|NCT03334617|524079522|FG018|Overall Study|Lost to Follow-up|0|||
145336248|NCT03334617|524079523|FG019|Overall Study|Lost to Follow-up|0|||
145336249|NCT03334617|524079524|FG020|Overall Study|Lost to Follow-up|0|||
145336250|NCT03334617|524079525|FG021|Overall Study|Lost to Follow-up|0|||
145336251|NCT03334617|524079504|FG000|Overall Study|Withdrawal by Subject|0|||
145336252|NCT03334617|524079505|FG001|Overall Study|Withdrawal by Subject|1|||
145336253|NCT03334617|524079506|FG002|Overall Study|Withdrawal by Subject|0|||
145336254|NCT03334617|524079507|FG003|Overall Study|Withdrawal by Subject|0|||
145336255|NCT03334617|524079508|FG004|Overall Study|Withdrawal by Subject|1|||
145336256|NCT03334617|524079509|FG005|Overall Study|Withdrawal by Subject|1|||
145336257|NCT03334617|524079510|FG006|Overall Study|Withdrawal by Subject|1|||
145336258|NCT03334617|524079511|FG007|Overall Study|Withdrawal by Subject|2|||
145336259|NCT03334617|524079512|FG008|Overall Study|Withdrawal by Subject|0|||
145336260|NCT03334617|524079513|FG009|Overall Study|Withdrawal by Subject|0|||
145336261|NCT03334617|524079514|FG010|Overall Study|Withdrawal by Subject|0|||
145336262|NCT03334617|524079515|FG011|Overall Study|Withdrawal by Subject|1|||
145336263|NCT03334617|524079516|FG012|Overall Study|Withdrawal by Subject|1|||
145336264|NCT03334617|524079517|FG013|Overall Study|Withdrawal by Subject|0|||
145336265|NCT03334617|524079518|FG014|Overall Study|Withdrawal by Subject|2|||
145336266|NCT03334617|524079519|FG015|Overall Study|Withdrawal by Subject|1|||
145336267|NCT03334617|524079520|FG016|Overall Study|Withdrawal by Subject|0|||
145336268|NCT03334617|524079521|FG017|Overall Study|Withdrawal by Subject|1|||
145336269|NCT03334617|524079522|FG018|Overall Study|Withdrawal by Subject|1|||
145336270|NCT03334617|524079523|FG019|Overall Study|Withdrawal by Subject|1|||
145336271|NCT03334617|524079524|FG020|Overall Study|Withdrawal by Subject|0|||
145336272|NCT03334617|524079525|FG021|Overall Study|Withdrawal by Subject|1|||
145336273|NCT03334617|524079504|FG000|Overall Study|Other|1|||
145573322|NCT01573624|524954845|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145573323|NCT01573624|524954846|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145573324|NCT01573624|524954847|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145573325|NCT01573624|524954848|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145573326|NCT01573624|524954849|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
145573327|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
145573328|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
145573329|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
145573330|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
145573331|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
145573332|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
145573333|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
145573334|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
145573335|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
145573336|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
145573337|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
145336274|NCT03334617|524079505|FG001|Overall Study|Other|2|||
145336275|NCT03334617|524079506|FG002|Overall Study|Other|0|||
145336276|NCT03334617|524079507|FG003|Overall Study|Other|1|||
145336277|NCT03334617|524079508|FG004|Overall Study|Other|1|||
145336278|NCT03334617|524079509|FG005|Overall Study|Other|0|||
145336279|NCT03334617|524079510|FG006|Overall Study|Other|2|||
145336280|NCT03334617|524079511|FG007|Overall Study|Other|1|||
145336281|NCT03334617|524079512|FG008|Overall Study|Other|8|||
145336282|NCT03334617|524079513|FG009|Overall Study|Other|0|||
145336283|NCT03334617|524079514|FG010|Overall Study|Other|3|||
145336284|NCT03334617|524079515|FG011|Overall Study|Other|1|||
145336285|NCT03334617|524079516|FG012|Overall Study|Other|3|||
145621972|NCT02886936|525126733|FG000|Overall Study|Lost to Follow-up|4|||
145621973|NCT02886936|525126734|FG001|Overall Study|Lost to Follow-up|3|||
145621974|NCT02886936|525126735|FG002|Overall Study|Lost to Follow-up|0|||
145621975|NCT04562779|525126736|FG000|Overall Study|Lost to Follow-up|7|||
145621976|NCT04562779|525126737|FG001|Overall Study|Lost to Follow-up|5|||
145621977|NCT04562779|525126738|FG002|Overall Study|Lost to Follow-up|10|||
145621978|NCT04562779|525126736|FG000|Overall Study|Protocol Violation|2|||
145621979|NCT04562779|525126737|FG001|Overall Study|Protocol Violation|2|||
145621980|NCT04562779|525126738|FG002|Overall Study|Protocol Violation|0|||
145621981|NCT02320721|525126739|FG000|Overall Study|Adverse Event|6|||
145621982|NCT02320721|525126740|FG001|Overall Study|Adverse Event|6|||
145621983|NCT02320721|525126739|FG000|Overall Study|Lack of Efficacy|2|||
145621984|NCT02320721|525126740|FG001|Overall Study|Lack of Efficacy|0|||
145621985|NCT02320721|525126739|FG000|Overall Study|Poor compliance to protocol|3|||
145621986|NCT02320721|525126740|FG001|Overall Study|Poor compliance to protocol|7|||
145621987|NCT02320721|525126739|FG000|Overall Study|Randomized but not treated|0|||
145621988|NCT02320721|525126740|FG001|Overall Study|Randomized but not treated|1|||
145621989|NCT02320721|525126739|FG000|Overall Study|Hypoglycemia|1|||
145621990|NCT02320721|525126740|FG001|Overall Study|Hypoglycemia|0|||
145621991|NCT02320721|525126739|FG000|Overall Study|Other than specified above|15|||
145621992|NCT02320721|525126740|FG001|Overall Study|Other than specified above|20|||
145621993|NCT03173248|525126741|FG000|Overall Study|Death|28|||
145621994|NCT03173248|525126742|FG001|Overall Study|Death|46|||
145621995|NCT03173248|525126741|FG000|Overall Study|Lost to Follow-up|0|||
145621996|NCT03173248|525126742|FG001|Overall Study|Lost to Follow-up|1|||
145621997|NCT03173248|525126741|FG000|Overall Study|Withdrawal by Subject|6|||
145621998|NCT03173248|525126742|FG001|Overall Study|Withdrawal by Subject|4|||
145621999|NCT03173248|525126741|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
145622000|NCT03173248|525126742|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
145622001|NCT03077620|525126744|FG000|Overall Study|Unable to place lumbar catheter|1|||
145622002|NCT03077620|525126745|FG001|Overall Study|Unable to place lumbar catheter|0|||
145622003|NCT03077620|525126746|FG002|Overall Study|Unable to place lumbar catheter|1|||
145336286|NCT03334617|524079517|FG013|Overall Study|Other|1|||
145336287|NCT03334617|524079518|FG014|Overall Study|Other|1|||
145336288|NCT03334617|524079519|FG015|Overall Study|Other|3|||
145336289|NCT03334617|524079520|FG016|Overall Study|Other|3|||
145336290|NCT03334617|524079521|FG017|Overall Study|Other|3|||
145622004|NCT03077620|525126747|FG003|Overall Study|Unable to place lumbar catheter|0|||
145622005|NCT03077620|525126744|FG000|Overall Study|Withdrawal by Subject|0|||
145622006|NCT03077620|525126745|FG001|Overall Study|Withdrawal by Subject|1|||
145622007|NCT03077620|525126746|FG002|Overall Study|Withdrawal by Subject|0|||
145622008|NCT03077620|525126747|FG003|Overall Study|Withdrawal by Subject|0|||
145336291|NCT03334617|524079522|FG018|Overall Study|Other|7|||
145336292|NCT03334617|524079523|FG019|Overall Study|Other|4|||
145336293|NCT03334617|524079524|FG020|Overall Study|Other|1|||
145336294|NCT03334617|524079525|FG021|Overall Study|Other|4|||
145336295|NCT03334617|524079504|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
145336296|NCT03334617|524079505|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
145336297|NCT03334617|524079506|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
145336298|NCT03334617|524079507|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
145336299|NCT03334617|524079508|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
145336300|NCT03334617|524079509|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
145336301|NCT03334617|524079510|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
145336302|NCT03334617|524079511|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
145336303|NCT03334617|524079512|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
145336304|NCT03334617|524079513|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
145336305|NCT03334617|524079514|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
145336306|NCT03334617|524079515|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
145336307|NCT03334617|524079516|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
145336308|NCT03334617|524079517|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
145336309|NCT03334617|524079518|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
145336310|NCT03334617|524079519|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
145336311|NCT03334617|524079520|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
145336312|NCT03334617|524079521|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
145622009|NCT03077620|525126744|FG000|Overall Study|Physician Decision|0|||
145622010|NCT03077620|525126745|FG001|Overall Study|Physician Decision|0|||
145622011|NCT03077620|525126746|FG002|Overall Study|Physician Decision|1|||
145622012|NCT03077620|525126747|FG003|Overall Study|Physician Decision|0|||
145622013|NCT01544582|525126748|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
145622014|NCT01544582|525126749|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
145622015|NCT01544582|525126750|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
145622016|NCT01544582|525126751|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
145622017|NCT01544582|525126748|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
145622018|NCT01544582|525126749|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
145622019|NCT01544582|525126750|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
145622020|NCT01544582|525126751|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
145622021|NCT01544582|525126748|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
145622022|NCT01544582|525126749|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
145622023|NCT01544582|525126750|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
145622024|NCT01544582|525126751|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
145622025|NCT01544582|525126748|FG000|Analysis Population|Physician Decision|0|||
145622026|NCT01544582|525126749|FG001|Analysis Population|Physician Decision|13|||
145622027|NCT01544582|525126750|FG002|Analysis Population|Physician Decision|10|||
145622028|NCT01544582|525126751|FG003|Analysis Population|Physician Decision|9|||
145622029|NCT01544582|525126748|FG000|Analysis Population|Safety Reason|0|||
145622030|NCT01544582|525126749|FG001|Analysis Population|Safety Reason|33|||
145622031|NCT01544582|525126750|FG002|Analysis Population|Safety Reason|31|||
145622032|NCT01544582|525126751|FG003|Analysis Population|Safety Reason|8|||
145622033|NCT01544582|525126748|FG000|Analysis Population|Effectiveness Reason|0|||
145622034|NCT01544582|525126749|FG001|Analysis Population|Effectiveness Reason|48|||
145622035|NCT01544582|525126750|FG002|Analysis Population|Effectiveness Reason|29|||
145622036|NCT01544582|525126751|FG003|Analysis Population|Effectiveness Reason|12|||
145622037|NCT01544582|525126748|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
145622038|NCT01544582|525126749|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
145622039|NCT01544582|525126750|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
145336313|NCT03334617|524079522|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
145336314|NCT03334617|524079523|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
145336315|NCT03334617|524079524|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
145336316|NCT03334617|524079525|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
145336317|NCT03657342|524079526|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
145336318|NCT03657342|524079527|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
145336319|NCT03657342|524079526|FG000|Overall Study|Withdrawal by Subject|4|||
145336320|NCT03657342|524079527|FG001|Overall Study|Withdrawal by Subject|4|||
145336321|NCT03657342|524079526|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
145336322|NCT03657342|524079527|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
145336323|NCT03657342|524079526|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
145336324|NCT03657342|524079527|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
145336325|NCT00827632|524079528|FG000|Overall Study|Lost to Follow-up|8|||
145336326|NCT00827632|524079529|FG001|Overall Study|Lost to Follow-up|12|||
145336327|NCT00827632|524079528|FG000|Overall Study|Early withdrawal|14|||
145336328|NCT00827632|524079529|FG001|Overall Study|Early withdrawal|11|||
145336329|NCT03734666|524079530|FG000|Overall Study|Other|7|||
145336330|NCT03734666|524079531|FG001|Overall Study|Other|4|||
145336331|NCT03734666|524079530|FG000|Overall Study|Lost to Follow-up|12|||
145336332|NCT03734666|524079531|FG001|Overall Study|Lost to Follow-up|12|||
145336333|NCT01910389|524079534|FG000|Overall Study|Withdrawal by Subject|2|||
145336334|NCT01910389|524079535|FG001|Overall Study|Withdrawal by Subject|0|||
145336335|NCT01910389|524079534|FG000|Overall Study|Study Closed|13|||
145336336|NCT01910389|524079535|FG001|Overall Study|Study Closed|8|||
145336337|NCT01898650|524079537|FG000|Overall Study|the subject would not lie still for imaging|1|||
145336338|NCT05896202|524079538|FG000|Overall Study|Lost to Follow-up|2|||
145336339|NCT05896202|524079539|FG001|Overall Study|Lost to Follow-up|2|||
145336340|NCT03923530|524079540|FG000|Overall Study|Withdrawal by Subject|1|||
145336341|NCT03923530|524079540|FG000|Overall Study|screen failure|3|||
145336342|NCT00407758|524079541|FG000|Overall Study|ineligible -improper prior treatment|1|||
145336343|NCT04669691|524079552|FG000|Overall Study|Death|0|||
145336344|NCT04669691|524079553|FG001|Overall Study|Death|1|||
145413086|NCT00544882|524365976|FG000|Cycle 3: Follow-up|Noncompliance|0|||
145413087|NCT00544882|524365977|FG001|Cycle 3: Follow-up|Noncompliance|1|||
145413088|NCT00544882|524365978|FG002|Cycle 3: Follow-up|Noncompliance|0|||
145413089|NCT00544882|524365976|FG000|Cycle 3: Follow-up|Pregnancy|0|||
145413090|NCT00544882|524365977|FG001|Cycle 3: Follow-up|Pregnancy|1|||
145336345|NCT04669691|524079554|FG002|Overall Study|Death|0|||
145336346|NCT04669691|524079555|FG003|Overall Study|Death|0|||
145336347|NCT04669691|524079556|FG004|Overall Study|Death|0|||
145413091|NCT00544882|524365978|FG002|Cycle 3: Follow-up|Pregnancy|0|||
145413092|NCT04937387|524365979|FG000|Overall Study|Adverse Event|1|||
145413093|NCT04937387|524365980|FG001|Overall Study|Adverse Event|0|||
145413094|NCT04937387|524365981|FG002|Overall Study|Adverse Event|2|||
145413095|NCT04937387|524365982|FG003|Overall Study|Adverse Event|0|||
145622040|NCT01544582|525126751|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
145622041|NCT01544582|525126748|FG000|Analysis Population|Lost to Follow-up|0|||
145622042|NCT01544582|525126749|FG001|Analysis Population|Lost to Follow-up|6|||
145622043|NCT01544582|525126750|FG002|Analysis Population|Lost to Follow-up|6|||
145622044|NCT01544582|525126751|FG003|Analysis Population|Lost to Follow-up|5|||
145622045|NCT01544582|525126748|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
145336348|NCT04669691|524079557|FG005|Overall Study|Death|0|||
145336349|NCT02722148|524079558|FG000|Overall Study|Lost to Follow-up|2|||
145336350|NCT02722148|524079558|FG000|Overall Study|Non compliant with treatment regimen|3|||
145336351|NCT04874636|524079560|FG000|Overall Study|Adverse Event|17|||
145336352|NCT04874636|524079561|FG001|Overall Study|Adverse Event|7|||
145336353|NCT04874636|524079560|FG000|Overall Study|Lost to Follow-up|1|||
145336354|NCT04874636|524079561|FG001|Overall Study|Lost to Follow-up|0|||
145336355|NCT04874636|524079560|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145336356|NCT04874636|524079561|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145336357|NCT04874636|524079560|FG000|Overall Study|Physician Decision|1|||
145336358|NCT04874636|524079561|FG001|Overall Study|Physician Decision|0|||
145413096|NCT04937387|524365979|FG000|Overall Study|Lack of Efficacy|1|||
145413097|NCT04937387|524365980|FG001|Overall Study|Lack of Efficacy|0|||
145413098|NCT04937387|524365981|FG002|Overall Study|Lack of Efficacy|0|||
145336359|NCT04874636|524079560|FG000|Overall Study|Withdrawal by Subject|6|||
145336360|NCT04874636|524079561|FG001|Overall Study|Withdrawal by Subject|5|||
145336361|NCT02582866|524079562|FG000|Overall Study|Death|1|||
145336362|NCT02582866|524079562|FG000|Overall Study|Lack of Efficacy|2|||
145336363|NCT02582866|524079562|FG000|Overall Study|Lost to Follow-up|2|||
145336364|NCT02582866|524079562|FG000|Overall Study|Withdrawal by Subject|7|||
145336365|NCT02582866|524079562|FG000|Overall Study|Investigator decision|5|||
145336366|NCT02582866|524079562|FG000|Overall Study|Participant wants to get pregnant|1|||
145336367|NCT02582866|524079562|FG000|Overall Study|Pregnancy|2|||
145336368|NCT02582866|524079562|FG000|Overall Study|Sponsor decision|1|||
145336369|NCT02582866|524079562|FG000|Overall Study|Withdrawal due to personal reasons|1|||
145336370|NCT02011386|524079563|FG000|Overall Study|Non-compliance|2|||
145336371|NCT02011386|524079563|FG000|Overall Study|Lack of Efficacy|3|||
145336372|NCT00871741|524079566|FG000|Overall Study|Premature study termination|9|||
145336373|NCT00871741|524079567|FG001|Overall Study|Premature study termination|7|||
145336374|NCT01565850|524079568|FG000|Overall Study|Adverse Event|0|||
145336375|NCT01565850|524079569|FG001|Overall Study|Adverse Event|1|||
145336376|NCT01565850|524079568|FG000|Overall Study|Lost to Follow-up|12|||
145336377|NCT01565850|524079569|FG001|Overall Study|Lost to Follow-up|4|||
145336378|NCT01565850|524079568|FG000|Overall Study|Investigator's Discretion|2|||
145336379|NCT01565850|524079569|FG001|Overall Study|Investigator's Discretion|1|||
145336380|NCT01565850|524079568|FG000|Overall Study|Participant noncompliance|2|||
145336381|NCT01565850|524079569|FG001|Overall Study|Participant noncompliance|0|||
145336382|NCT01565850|524079568|FG000|Overall Study|Withdrew Consent|4|||
145336383|NCT01565850|524079569|FG001|Overall Study|Withdrew Consent|2|||
145336384|NCT05323123|524079570|FG000|Overall Study|Withdrawal by Subject|2|||
145336385|NCT05323123|524079571|FG001|Overall Study|Withdrawal by Subject|1|||
145336386|NCT05323123|524079570|FG000|Overall Study|Lost to Follow-up|4|||
145336387|NCT05323123|524079571|FG001|Overall Study|Lost to Follow-up|2|||
145336388|NCT05323123|524079570|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
145336389|NCT05323123|524079571|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
145336390|NCT05529472|524079572|FG000|Overall Study|Withdrawal by Subject|1|||
145336391|NCT05529472|524079573|FG001|Overall Study|Withdrawal by Subject|1|||
145336392|NCT00379340|524081657|FG000|Overall Study|Death|0|||
145336393|NCT00379340|524081658|FG001|Overall Study|Death|0|||
145336394|NCT00379340|524081659|FG002|Overall Study|Death|0|||
145336395|NCT00379340|524081660|FG003|Overall Study|Death|2|||
145336396|NCT00379340|524081661|FG004|Overall Study|Death|0|||
145336397|NCT00379340|524081657|FG000|Overall Study|Lack of Efficacy|6|||
145336398|NCT00379340|524081658|FG001|Overall Study|Lack of Efficacy|1|||
145336399|NCT00379340|524081659|FG002|Overall Study|Lack of Efficacy|0|||
145336400|NCT00379340|524081660|FG003|Overall Study|Lack of Efficacy|4|||
145336401|NCT00379340|524081661|FG004|Overall Study|Lack of Efficacy|3|||
145336402|NCT00379340|524081657|FG000|Overall Study|Physician Decision|6|||
145573338|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
145573339|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
145336403|NCT00379340|524081658|FG001|Overall Study|Physician Decision|2|||
145336404|NCT00379340|524081659|FG002|Overall Study|Physician Decision|1|||
145336405|NCT00379340|524081660|FG003|Overall Study|Physician Decision|2|||
145336406|NCT00379340|524081661|FG004|Overall Study|Physician Decision|3|||
145336407|NCT00379340|524081657|FG000|Overall Study|Withdrawal by Subject|0|||
145336408|NCT00379340|524081658|FG001|Overall Study|Withdrawal by Subject|0|||
145336409|NCT00379340|524081659|FG002|Overall Study|Withdrawal by Subject|0|||
145336410|NCT00379340|524081660|FG003|Overall Study|Withdrawal by Subject|1|||
145336411|NCT00379340|524081661|FG004|Overall Study|Withdrawal by Subject|0|||
145336412|NCT00379340|524081657|FG000|Overall Study|Refusal of further protocol therapy|1|||
145336413|NCT00379340|524081658|FG001|Overall Study|Refusal of further protocol therapy|0|||
145336414|NCT00379340|524081659|FG002|Overall Study|Refusal of further protocol therapy|1|||
145336415|NCT00379340|524081660|FG003|Overall Study|Refusal of further protocol therapy|1|||
145336416|NCT00379340|524081661|FG004|Overall Study|Refusal of further protocol therapy|7|||
145336417|NCT00379340|524081657|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
145336418|NCT00379340|524081658|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
145336419|NCT00379340|524081659|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
145336420|NCT00379340|524081660|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
145336421|NCT00379340|524081661|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
145336422|NCT00379340|524081657|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
145336423|NCT00379340|524081658|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
145336424|NCT00379340|524081659|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
145336425|NCT00379340|524081660|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
145336426|NCT00379340|524081661|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
145336427|NCT04347122|524081662|FG000|Overall Study|Physician Decision|0|||
145336428|NCT04347122|524081663|FG001|Overall Study|Physician Decision|3|||
145336429|NCT04347122|524081664|FG002|Overall Study|Physician Decision|3|||
145336430|NCT04347122|524081665|FG003|Overall Study|Physician Decision|6|||
145336431|NCT04994483|524081666|FG000|Overall Study|Adverse Event|26|||
145336432|NCT04994483|524081667|FG001|Overall Study|Adverse Event|17|||
145336433|NCT04994483|524081666|FG000|Overall Study|Lost to Follow-up|6|||
145336434|NCT04994483|524081667|FG001|Overall Study|Lost to Follow-up|10|||
145336435|NCT04994483|524081666|FG000|Overall Study|Noncompliance with study drug|8|||
145336436|NCT04994483|524081667|FG001|Overall Study|Noncompliance with study drug|5|||
145336437|NCT04994483|524081666|FG000|Overall Study|Physician Decision|5|||
145336438|NCT04994483|524081667|FG001|Overall Study|Physician Decision|0|||
145336439|NCT04994483|524081666|FG000|Overall Study|Withdrawal by Subject|41|||
145336440|NCT04994483|524081667|FG001|Overall Study|Withdrawal by Subject|38|||
145336441|NCT04994483|524081666|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
145336442|NCT04994483|524081667|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
145336443|NCT04994483|524081666|FG000|Overall Study|Met stopping criteria|1|||
145336444|NCT04994483|524081667|FG001|Overall Study|Met stopping criteria|0|||
145336445|NCT04994483|524081666|FG000|Overall Study|Randomized in error, not treated|4|||
145336446|NCT04994483|524081667|FG001|Overall Study|Randomized in error, not treated|3|||
145336447|NCT04994483|524081666|FG000|Overall Study|Lack of a reliable study partner|0|||
145336448|NCT04994483|524081667|FG001|Overall Study|Lack of a reliable study partner|1|||
145336449|NCT04994483|524081666|FG000|Overall Study|Met MRI exclusion criteria|0|||
145336450|NCT04994483|524081667|FG001|Overall Study|Met MRI exclusion criteria|1|||
145336451|NCT00112866|524081668|FG000|Overall Study|Protocol Violation|1|||
145336452|NCT00112866|524081669|FG001|Overall Study|Protocol Violation|0|||
145336453|NCT00112866|524081668|FG000|Overall Study|did not start treatment post-op|1|||
145336454|NCT00112866|524081669|FG001|Overall Study|did not start treatment post-op|2|||
145336455|NCT00554190|524081670|FG000|Overall Study|Termination forms not completed|10|||
145336456|NCT02903030|524081671|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145336457|NCT02903030|524081672|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145336458|NCT01502410|524081673|FG000|Overall Study|Adverse Event|1|||
145336459|NCT01502410|524081674|FG001|Overall Study|Adverse Event|2|||
145336460|NCT01502410|524081675|FG002|Overall Study|Adverse Event|0|||
145336461|NCT01502410|524081676|FG003|Overall Study|Adverse Event|0|||
145336462|NCT01502410|524081673|FG000|Overall Study|Lack of Efficacy|7|||
145336463|NCT01502410|524081674|FG001|Overall Study|Lack of Efficacy|7|||
145336464|NCT01502410|524081675|FG002|Overall Study|Lack of Efficacy|0|||
145336465|NCT01502410|524081676|FG003|Overall Study|Lack of Efficacy|0|||
145336466|NCT01502410|524081673|FG000|Overall Study|Physician Decision|0|||
145336467|NCT01502410|524081674|FG001|Overall Study|Physician Decision|1|||
145336468|NCT01502410|524081675|FG002|Overall Study|Physician Decision|0|||
145336469|NCT01502410|524081676|FG003|Overall Study|Physician Decision|0|||
145336470|NCT01502410|524081673|FG000|Overall Study|Withdrawal by Subject|2|||
145336471|NCT01502410|524081674|FG001|Overall Study|Withdrawal by Subject|0|||
145336472|NCT01502410|524081675|FG002|Overall Study|Withdrawal by Subject|0|||
145336473|NCT01502410|524081676|FG003|Overall Study|Withdrawal by Subject|0|||
145336474|NCT03700385|524081677|FG000|Overall Study|Lost to Follow-up|1|||
145336475|NCT01555671|524081679|FG000|Overall Study|Physician Decision|20|||
145336476|NCT01555671|524081680|FG001|Overall Study|Physician Decision|25|||
145336477|NCT04590040|524081681|FG000|Treatment Period|Lost to Follow-up|2|||
145336478|NCT04590040|524081682|FG001|Treatment Period|Lost to Follow-up|5|||
145573340|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
145573341|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145573342|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
145336479|NCT04590040|524081683|FG002|Treatment Period|Lost to Follow-up|0|||
145336480|NCT04590040|524081681|FG000|Treatment Period|Physician Decision|0|||
145336481|NCT04590040|524081682|FG001|Treatment Period|Physician Decision|0|||
145336482|NCT04590040|524081683|FG002|Treatment Period|Physician Decision|2|||
145336483|NCT00631657|524081691|FG000|6-Month Treatment Period|Adverse Event|47|||
145336484|NCT00631657|524081692|FG001|6-Month Treatment Period|Adverse Event|0|||
145336485|NCT00631657|524081693|FG002|6-Month Treatment Period|Adverse Event|7|||
145336486|NCT00631657|524081691|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
145336487|NCT00631657|524081692|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
145336488|NCT00631657|524081693|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
145573343|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145622046|NCT01544582|525126749|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
145622047|NCT01544582|525126750|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
145622048|NCT01544582|525126751|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
145622049|NCT01544582|525126748|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
145622050|NCT01544582|525126749|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
145622051|NCT01544582|525126750|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
145622052|NCT01544582|525126751|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
145336489|NCT00631657|524081691|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
145336490|NCT00631657|524081692|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
145336491|NCT00631657|524081693|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
145336492|NCT00631657|524081691|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
145336493|NCT00631657|524081692|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
145336494|NCT00631657|524081693|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
145336495|NCT00631657|524081691|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
145336496|NCT00631657|524081692|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
145336497|NCT00631657|524081693|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
145336498|NCT00631657|524081691|FG000|6-Month Treatment Period|Other|16|||
145336499|NCT00631657|524081692|FG001|6-Month Treatment Period|Other|0|||
145336500|NCT00631657|524081693|FG002|6-Month Treatment Period|Other|4|||
145336501|NCT00631657|524081691|FG000|6-Month Treatment Period|Not Treated|2|||
145336502|NCT00631657|524081692|FG001|6-Month Treatment Period|Not Treated|0|||
145336503|NCT00631657|524081693|FG002|6-Month Treatment Period|Not Treated|1|||
145336504|NCT00631657|524081691|FG000|7-Day Discontinuation Period|Not Treated|1|||
145336505|NCT00631657|524081692|FG001|7-Day Discontinuation Period|Not Treated|1|||
145336506|NCT00631657|524081693|FG002|7-Day Discontinuation Period|Not Treated|1|||
145336507|NCT00631657|524081691|FG000|7-Day Discontinuation Period|Other|1|||
145336508|NCT00631657|524081692|FG001|7-Day Discontinuation Period|Other|0|||
145336509|NCT00631657|524081693|FG002|7-Day Discontinuation Period|Other|0|||
145336510|NCT01284361|524081698|FG000|Overall Study|Withdrawal by Subject|1|||
145336511|NCT01284361|524081698|FG000|Overall Study|Protocol Violation|5|||
145336512|NCT01284361|524081698|FG000|Overall Study|Adverse Event|1|||
145336513|NCT01284361|524081698|FG000|Overall Study|Lost to Follow-up|2|||
145336514|NCT01957397|524081704|FG000|Test Period 1|sudden leakage/small bag|1|||
145336515|NCT01957397|524081705|FG001|Test Period 1|sudden leakage/small bag|1|||
145336516|NCT01957397|524081704|FG000|Test Period 1|Withdrawal by Subject|1|||
145336517|NCT01957397|524081705|FG001|Test Period 1|Withdrawal by Subject|0|||
145336518|NCT01957397|524081704|FG000|Test Period 2|Adverse Event|0|||
145336519|NCT01957397|524081705|FG001|Test Period 2|Adverse Event|1|||
145336520|NCT01957397|524081704|FG000|Test Period 3|Adverse Event|1|||
145336521|NCT01957397|524081705|FG001|Test Period 3|Adverse Event|2|||
145336522|NCT01957397|524081704|FG000|Test Period 3|the adhesive did not work|1|||
145336523|NCT01957397|524081705|FG001|Test Period 3|the adhesive did not work|0|||
145336524|NCT00540293|524081706|FG000|Overall Study|Adverse event related to study drug|10|||
145336525|NCT00540293|524081706|FG000|Overall Study|Adverse event not related to study drug|7|||
145336526|NCT00540293|524081706|FG000|Overall Study|Withdrawal by Subject|6|||
145336527|NCT00540293|524081706|FG000|Overall Study|Protocol violation, & subject schedule|12|||
145336528|NCT00325195|524081709|FG000|Randomized|Not dosed|5|||
145336529|NCT00325195|524081710|FG001|Randomized|Not dosed|5|||
145336530|NCT00325195|524081711|FG002|Randomized|Not dosed|3|||
145336531|NCT00325195|524081709|FG000|Received Intervention: ITT Population|Adverse Event|15|||
145336532|NCT00325195|524081710|FG001|Received Intervention: ITT Population|Adverse Event|17|||
145336533|NCT00325195|524081711|FG002|Received Intervention: ITT Population|Adverse Event|1|||
145336534|NCT00325195|524081709|FG000|Received Intervention: ITT Population|Death|3|||
145336535|NCT00325195|524081710|FG001|Received Intervention: ITT Population|Death|1|||
145336536|NCT00325195|524081711|FG002|Received Intervention: ITT Population|Death|0|||
145336537|NCT00325195|524081709|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
145336538|NCT00325195|524081710|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
145336539|NCT00325195|524081711|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
145336540|NCT00325195|524081709|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
145336541|NCT00325195|524081710|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
145336542|NCT00325195|524081711|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
145336543|NCT00325195|524081709|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
145336544|NCT00325195|524081710|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
145336545|NCT00325195|524081711|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
145336546|NCT05083585|524081712|FG000|Overall Study|Death|1|||
145336547|NCT05083585|524081713|FG001|Overall Study|Death|1|||
145336548|NCT05083585|524081712|FG000|Overall Study|Lost to Follow-up|1|||
145336549|NCT05083585|524081713|FG001|Overall Study|Lost to Follow-up|1|||
145336550|NCT05083585|524081712|FG000|Overall Study|Withdrawal by Subject|2|||
145336551|NCT05083585|524081713|FG001|Overall Study|Withdrawal by Subject|0|||
145622053|NCT01544582|525126748|FG000|Analysis Population|Intolerance|0|||
145336552|NCT05083585|524081712|FG000|Overall Study|Randomized but not vaccinated|2|||
145622054|NCT01544582|525126749|FG001|Analysis Population|Intolerance|1|||
145622055|NCT01544582|525126750|FG002|Analysis Population|Intolerance|0|||
145622056|NCT01544582|525126751|FG003|Analysis Population|Intolerance|0|||
145622057|NCT01544582|525126748|FG000|Analysis Population|Liver Transplantation|0|||
145622058|NCT01544582|525126749|FG001|Analysis Population|Liver Transplantation|0|||
145622059|NCT01544582|525126750|FG002|Analysis Population|Liver Transplantation|1|||
145622060|NCT01544582|525126751|FG003|Analysis Population|Liver Transplantation|0|||
145622061|NCT01544582|525126748|FG000|Analysis Population|No Social Insurance|0|||
145622062|NCT01544582|525126749|FG001|Analysis Population|No Social Insurance|0|||
145622063|NCT01544582|525126750|FG002|Analysis Population|No Social Insurance|1|||
145622064|NCT01544582|525126751|FG003|Analysis Population|No Social Insurance|0|||
145622065|NCT01544582|525126748|FG000|Analysis Population|Poor Adherence|0|||
145622066|NCT01544582|525126749|FG001|Analysis Population|Poor Adherence|0|||
145622067|NCT01544582|525126750|FG002|Analysis Population|Poor Adherence|1|||
145622068|NCT01544582|525126751|FG003|Analysis Population|Poor Adherence|0|||
145622069|NCT01544582|525126748|FG000|Analysis Population|Poor Participant Compliance|0|||
145622070|NCT01544582|525126749|FG001|Analysis Population|Poor Participant Compliance|1|||
145622071|NCT01544582|525126750|FG002|Analysis Population|Poor Participant Compliance|0|||
145622072|NCT01544582|525126751|FG003|Analysis Population|Poor Participant Compliance|0|||
145622073|NCT01544582|525126748|FG000|Analysis Population|Programmed Surgery|0|||
145622074|NCT01544582|525126749|FG001|Analysis Population|Programmed Surgery|1|||
145622075|NCT01544582|525126750|FG002|Analysis Population|Programmed Surgery|0|||
145622076|NCT01544582|525126751|FG003|Analysis Population|Programmed Surgery|0|||
145622077|NCT01544582|525126748|FG000|Analysis Population|Participant in Jail|0|||
145622078|NCT01544582|525126749|FG001|Analysis Population|Participant in Jail|0|||
145622079|NCT01544582|525126750|FG002|Analysis Population|Participant in Jail|1|||
145622080|NCT01544582|525126751|FG003|Analysis Population|Participant in Jail|0|||
145622081|NCT00245011|525126752|FG000|Overall Study|Lack of Efficacy|1|||
145622082|NCT05397470|525126755|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
145622083|NCT05397470|525126756|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
145622084|NCT05397470|525126757|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
145622085|NCT05397470|525126755|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
145336553|NCT05083585|524081713|FG001|Overall Study|Randomized but not vaccinated|0|||
145336554|NCT00806286|524081714|FG000|Overall Study|Adverse Event|5|||
145336555|NCT00806286|524081715|FG001|Overall Study|Adverse Event|2|||
145336556|NCT00806286|524081716|FG002|Overall Study|Adverse Event|0|||
145336557|NCT00806286|524081714|FG000|Overall Study|Disease progression|31|||
145336558|NCT00806286|524081715|FG001|Overall Study|Disease progression|38|||
145336559|NCT00806286|524081716|FG002|Overall Study|Disease progression|1|||
145336560|NCT00806286|524081714|FG000|Overall Study|Death|1|||
145336561|NCT00806286|524081715|FG001|Overall Study|Death|6|||
145336562|NCT00806286|524081716|FG002|Overall Study|Death|0|||
145336563|NCT00806286|524081714|FG000|Overall Study|Lost to Follow-up|0|||
145336564|NCT00806286|524081715|FG001|Overall Study|Lost to Follow-up|1|||
145336565|NCT00806286|524081716|FG002|Overall Study|Lost to Follow-up|0|||
145336566|NCT00806286|524081714|FG000|Overall Study|Withdrawal by Subject|8|||
145336567|NCT00806286|524081715|FG001|Overall Study|Withdrawal by Subject|3|||
145336568|NCT00806286|524081716|FG002|Overall Study|Withdrawal by Subject|1|||
145336569|NCT00806286|524081714|FG000|Overall Study|Physician Decision|2|||
145336570|NCT00806286|524081715|FG001|Overall Study|Physician Decision|2|||
145336571|NCT00806286|524081716|FG002|Overall Study|Physician Decision|0|||
145336572|NCT00806286|524081714|FG000|Overall Study|Due to a variety of reasons|7|||
145336573|NCT00806286|524081715|FG001|Overall Study|Due to a variety of reasons|2|||
145336574|NCT00806286|524081716|FG002|Overall Study|Due to a variety of reasons|1|||
145336575|NCT03469336|524081717|FG000|Overall Study|Adverse Event|1|||
145336576|NCT00686075|524081719|FG000|Overall Study|Withdrawal by Subject|4|||
145336577|NCT00686075|524081720|FG001|Overall Study|Withdrawal by Subject|3|||
145336578|NCT00686075|524081721|FG002|Overall Study|Withdrawal by Subject|3|||
145336579|NCT00686075|524081722|FG003|Overall Study|Withdrawal by Subject|7|||
145336580|NCT00686075|524081723|FG004|Overall Study|Withdrawal by Subject|1|||
145336581|NCT00686075|524081724|FG005|Overall Study|Withdrawal by Subject|0|||
145336582|NCT00686075|524081725|FG006|Overall Study|Withdrawal by Subject|0|||
145336583|NCT00686075|524081726|FG007|Overall Study|Withdrawal by Subject|2|||
145336584|NCT00686075|524081727|FG008|Overall Study|Withdrawal by Subject|4|||
145336585|NCT00686075|524081728|FG009|Overall Study|Withdrawal by Subject|6|||
145336586|NCT00686075|524081719|FG000|Overall Study|Lost to Follow-up|3|||
145336587|NCT00686075|524081720|FG001|Overall Study|Lost to Follow-up|6|||
145336588|NCT00686075|524081721|FG002|Overall Study|Lost to Follow-up|3|||
145336589|NCT00686075|524081722|FG003|Overall Study|Lost to Follow-up|2|||
145336590|NCT00686075|524081723|FG004|Overall Study|Lost to Follow-up|3|||
145336591|NCT00686075|524081724|FG005|Overall Study|Lost to Follow-up|3|||
145336592|NCT00686075|524081725|FG006|Overall Study|Lost to Follow-up|0|||
145336593|NCT00686075|524081726|FG007|Overall Study|Lost to Follow-up|0|||
145336594|NCT00686075|524081727|FG008|Overall Study|Lost to Follow-up|2|||
145336595|NCT00686075|524081728|FG009|Overall Study|Lost to Follow-up|3|||
145336596|NCT00686075|524081719|FG000|Overall Study|Other|1|||
145336597|NCT00686075|524081720|FG001|Overall Study|Other|1|||
145413099|NCT04937387|524365982|FG003|Overall Study|Lack of Efficacy|1|||
145413100|NCT04937387|524365979|FG000|Overall Study|Withdrawal by Subject|1|||
145413101|NCT04937387|524365980|FG001|Overall Study|Withdrawal by Subject|0|||
145413102|NCT04937387|524365981|FG002|Overall Study|Withdrawal by Subject|1|||
145413103|NCT04937387|524365982|FG003|Overall Study|Withdrawal by Subject|1|||
145413104|NCT04937387|524365979|FG000|Overall Study|Randomized in error|0|||
145413105|NCT04937387|524365980|FG001|Overall Study|Randomized in error|0|||
145413106|NCT04937387|524365981|FG002|Overall Study|Randomized in error|0|||
145413107|NCT04937387|524365982|FG003|Overall Study|Randomized in error|1|||
145413108|NCT02583269|524365983|FG000|Overall Study|Patient hospitalized prior to start|1|||
145413109|NCT02583269|524365984|FG001|Overall Study|Patient hospitalized prior to start|0|||
145413110|NCT02583269|524365985|FG002|Overall Study|Patient hospitalized prior to start|0|||
145413111|NCT02583269|524365986|FG003|Overall Study|Patient hospitalized prior to start|0|||
145413112|NCT02583269|524365987|FG004|Overall Study|Patient hospitalized prior to start|0|||
145413113|NCT01039675|524365988|FG000|Overall Study|Adverse Event|0|||
145413114|NCT01039675|524365989|FG001|Overall Study|Adverse Event|2|||
145413115|NCT01039675|524365988|FG000|Overall Study|Lack of Efficacy|0|||
145413116|NCT01039675|524365989|FG001|Overall Study|Lack of Efficacy|2|||
145413117|NCT01039675|524365988|FG000|Overall Study|Withdrawal by Subject|0|||
145413118|NCT01039675|524365989|FG001|Overall Study|Withdrawal by Subject|1|||
145573344|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145573345|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145573346|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145336598|NCT00686075|524081721|FG002|Overall Study|Other|0|||
145336599|NCT00686075|524081722|FG003|Overall Study|Other|0|||
145336600|NCT00686075|524081723|FG004|Overall Study|Other|0|||
145336601|NCT00686075|524081724|FG005|Overall Study|Other|0|||
145336602|NCT00686075|524081725|FG006|Overall Study|Other|0|||
145336603|NCT00686075|524081726|FG007|Overall Study|Other|0|||
145336604|NCT00686075|524081727|FG008|Overall Study|Other|0|||
145336605|NCT00686075|524081728|FG009|Overall Study|Other|1|||
145336606|NCT02740699|524081729|FG000|Overall Study|Lost to Follow-up|5|||
145336607|NCT02740699|524081729|FG000|Overall Study|Withdrawal by Subject|14|||
145336608|NCT02740699|524081729|FG000|Overall Study|Physician Decision|5|||
145336609|NCT04713553|524081731|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
145336610|NCT04713553|524081732|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
145336611|NCT04713553|524081733|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
145336612|NCT04713553|524081734|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
145336613|NCT04713553|524081735|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
145336614|NCT04713553|524081736|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
145336615|NCT04713553|524081737|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
145336616|NCT04713553|524081731|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145336617|NCT04713553|524081732|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145336618|NCT04713553|524081733|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145413119|NCT01039675|524365988|FG000|Overall Study|Lost to Follow-up|0|||
145413120|NCT01039675|524365989|FG001|Overall Study|Lost to Follow-up|1|||
145413121|NCT01039675|524365988|FG000|Overall Study|Physician Decision|0|||
145413122|NCT01039675|524365989|FG001|Overall Study|Physician Decision|1|||
145573347|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
145573348|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573349|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
145573350|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573351|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573352|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573353|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573354|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
145573355|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145573356|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145573357|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145573358|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145573359|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
145413123|NCT02207608|524365991|FG000|Overall Study|Adverse Event|1|||
145413124|NCT02207608|524365992|FG001|Overall Study|Adverse Event|0|||
145413125|NCT03921541|524366932|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
145413126|NCT03921541|524366933|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
145413127|NCT04706403|524366936|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
145413128|NCT04706403|524366937|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
145336619|NCT04713553|524081734|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
145336620|NCT04713553|524081735|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145336621|NCT04713553|524081736|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145336622|NCT04713553|524081737|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
145336623|NCT04713553|524081731|FG000|Primary Study (2 Months)|Other|1|||
145336624|NCT04713553|524081732|FG001|Primary Study (2 Months)|Other|2|||
145336625|NCT04713553|524081733|FG002|Primary Study (2 Months)|Other|0|||
145336626|NCT04713553|524081734|FG003|Primary Study (2 Months)|Other|0|||
145336627|NCT04713553|524081735|FG004|Primary Study (2 Months)|Other|1|||
145336628|NCT04713553|524081736|FG005|Primary Study (2 Months)|Other|0|||
145336629|NCT04713553|524081737|FG006|Primary Study (2 Months)|Other|0|||
145336630|NCT04713553|524081731|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
145336631|NCT04713553|524081732|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
145336632|NCT04713553|524081733|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
145336633|NCT04713553|524081734|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
145336634|NCT04713553|524081735|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
145336635|NCT04713553|524081736|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
145336636|NCT04713553|524081737|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
145336637|NCT04713553|524081731|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336638|NCT04713553|524081732|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336639|NCT04713553|524081733|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
145336640|NCT04713553|524081734|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336641|NCT04713553|524081735|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336642|NCT04713553|524081736|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336643|NCT04713553|524081737|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
145336644|NCT03783039|524081739|FG000|Overall Study|Death|2|||
145336645|NCT03783039|524081740|FG001|Overall Study|Death|1|||
145336646|NCT00918138|524081741|FG000|Overall Study|Subject withdrew consent|1|||
145336647|NCT00918138|524081742|FG001|Overall Study|Subject withdrew consent|1|||
145336648|NCT00918138|524081741|FG000|Overall Study|Death|1|||
145336649|NCT00918138|524081742|FG001|Overall Study|Death|0|||
145336650|NCT02315196|524081743|FG000|Overall Study|Withdrew consent|9|||
145336651|NCT03400943|524081744|FG000|Treatment Period 1|Adverse Event|0|||
145336652|NCT03400943|524081745|FG001|Treatment Period 1|Adverse Event|0|||
145336653|NCT03400943|524081746|FG002|Treatment Period 1|Adverse Event|0|||
145336654|NCT03400943|524081747|FG003|Treatment Period 1|Adverse Event|1|||
145336655|NCT03400943|524081744|FG000|Treatment Period 1|Lost to Follow-up|1|||
145336656|NCT03400943|524081745|FG001|Treatment Period 1|Lost to Follow-up|0|||
145336657|NCT03400943|524081746|FG002|Treatment Period 1|Lost to Follow-up|0|||
145336658|NCT03400943|524081747|FG003|Treatment Period 1|Lost to Follow-up|0|||
145336659|NCT03400943|524081744|FG000|Treatment Period 1|Protocol Violation|0|||
145336660|NCT03400943|524081745|FG001|Treatment Period 1|Protocol Violation|1|||
145336661|NCT03400943|524081746|FG002|Treatment Period 1|Protocol Violation|1|||
145336662|NCT03400943|524081747|FG003|Treatment Period 1|Protocol Violation|0|||
145336663|NCT03400943|524081744|FG000|Treatment Period 1|Study terminated by sponsor|2|||
145336664|NCT03400943|524081745|FG001|Treatment Period 1|Study terminated by sponsor|0|||
145336665|NCT03400943|524081746|FG002|Treatment Period 1|Study terminated by sponsor|0|||
145336666|NCT03400943|524081747|FG003|Treatment Period 1|Study terminated by sponsor|1|||
145336667|NCT03400943|524081744|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145336668|NCT03400943|524081745|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145336669|NCT03400943|524081746|FG002|Treatment Period 1|Withdrawal by Subject|3|||
145336670|NCT03400943|524081747|FG003|Treatment Period 1|Withdrawal by Subject|1|||
145336671|NCT03400943|524081744|FG000|Treatment Period 1|Other|2|||
145336672|NCT03400943|524081745|FG001|Treatment Period 1|Other|1|||
145336673|NCT03400943|524081746|FG002|Treatment Period 1|Other|2|||
145336674|NCT03400943|524081747|FG003|Treatment Period 1|Other|2|||
145336675|NCT03400943|524081744|FG000|Post-treatment Period 1|Adverse Event|2|||
145336676|NCT03400943|524081745|FG001|Post-treatment Period 1|Adverse Event|0|||
145336677|NCT03400943|524081746|FG002|Post-treatment Period 1|Adverse Event|0|||
145336678|NCT03400943|524081747|FG003|Post-treatment Period 1|Adverse Event|0|||
145336679|NCT03400943|524081744|FG000|Post-treatment Period 1|Protocol Violation|1|||
145336680|NCT03400943|524081745|FG001|Post-treatment Period 1|Protocol Violation|0|||
145336681|NCT03400943|524081746|FG002|Post-treatment Period 1|Protocol Violation|0|||
145336682|NCT03400943|524081747|FG003|Post-treatment Period 1|Protocol Violation|0|||
145573360|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
145573361|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
145336683|NCT03400943|524081744|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
145336684|NCT03400943|524081745|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
145336685|NCT03400943|524081746|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
145336686|NCT03400943|524081747|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
145336687|NCT03400943|524081744|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
145336688|NCT03400943|524081745|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
145336689|NCT03400943|524081746|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
145336690|NCT03400943|524081747|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
145336691|NCT03400943|524081744|FG000|Post-treatment Period 1|Other|2|||
145336692|NCT03400943|524081745|FG001|Post-treatment Period 1|Other|0|||
145336693|NCT03400943|524081746|FG002|Post-treatment Period 1|Other|4|||
145336694|NCT03400943|524081747|FG003|Post-treatment Period 1|Other|5|||
145336695|NCT03400943|524081744|FG000|Treatment Period 2|Study terminated by sponsor|0|||
145336696|NCT03400943|524081745|FG001|Treatment Period 2|Study terminated by sponsor|1|||
145336697|NCT03400943|524081746|FG002|Treatment Period 2|Study terminated by sponsor|0|||
145336698|NCT03400943|524081747|FG003|Treatment Period 2|Study terminated by sponsor|0|||
145336699|NCT03400943|524081744|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145336700|NCT03400943|524081745|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145336701|NCT03400943|524081746|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145413129|NCT04706403|524366938|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
145413130|NCT04706403|524366939|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
145413131|NCT04706403|524366940|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
145413132|NCT00182637|524366941|FG000|Overall Study|Adverse Event|2|||
145413133|NCT00182637|524366941|FG000|Overall Study|Disease Progression|1|||
145413134|NCT02642679|524366942|FG000|Overall Study|Withdrawal by Subject|1|||
145413135|NCT02642679|524366942|FG000|Overall Study|Physician Decision|1|||
145413136|NCT02642679|524366942|FG000|Overall Study|Physician Decision|1|||
145413137|NCT04941898|524366943|FG000|Overall Study|Protocol Violation|1|||
145413138|NCT01653262|524366944|FG000|Overall Study|Lack of Efficacy|1|||
145413139|NCT01653262|524366944|FG000|Overall Study|SAE, non-fatal|1|||
145336702|NCT03400943|524081747|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145336703|NCT03400943|524081744|FG000|Treatment Period 2|Other|1|||
145336704|NCT03400943|524081745|FG001|Treatment Period 2|Other|6|||
145336705|NCT03400943|524081746|FG002|Treatment Period 2|Other|0|||
145336706|NCT03400943|524081747|FG003|Treatment Period 2|Other|0|||
145336707|NCT03400943|524081744|FG000|Follow-up Period|Withdrawal by Subject|1|||
145336708|NCT03400943|524081745|FG001|Follow-up Period|Withdrawal by Subject|0|||
145336709|NCT03400943|524081746|FG002|Follow-up Period|Withdrawal by Subject|0|||
145336710|NCT03400943|524081747|FG003|Follow-up Period|Withdrawal by Subject|0|||
145336711|NCT03839823|524081748|FG000|Overall Study|Adverse Event|8|||
145336712|NCT03839823|524081749|FG001|Overall Study|Adverse Event|4|||
145336713|NCT03839823|524081748|FG000|Overall Study|Death|1|||
145336714|NCT03839823|524081749|FG001|Overall Study|Death|0|||
145336715|NCT03839823|524081748|FG000|Overall Study|Physician Decision|1|||
145336716|NCT03839823|524081749|FG001|Overall Study|Physician Decision|5|||
145336717|NCT03839823|524081748|FG000|Overall Study|Progressive Disease (PD)|65|||
145336718|NCT03839823|524081749|FG001|Overall Study|Progressive Disease (PD)|65|||
145336719|NCT03839823|524081748|FG000|Overall Study|Subject Decision|2|||
145336720|NCT03839823|524081749|FG001|Overall Study|Subject Decision|9|||
145336721|NCT03839823|524081748|FG000|Overall Study|Not Treated|0|||
145336722|NCT03839823|524081749|FG001|Overall Study|Not Treated|10|||
145336723|NCT03327792|524081750|FG000|Overall Study|Adverse Event|4|||
145336724|NCT03327792|524081751|FG001|Overall Study|Adverse Event|0|||
145336725|NCT03327792|524081750|FG000|Overall Study|Family/Personal issues|3|||
145336726|NCT03327792|524081751|FG001|Overall Study|Family/Personal issues|2|||
145336727|NCT03327792|524081750|FG000|Overall Study|Lost to Follow-up|0|||
145336728|NCT03327792|524081751|FG001|Overall Study|Lost to Follow-up|1|||
145336729|NCT01475097|524081756|FG000|Overall Study|Protocol Violation|1|||
145336730|NCT01475097|524081757|FG001|Overall Study|Protocol Violation|1|||
145336731|NCT04516759|524081759|FG000|Overall Study|Withdrawal by Subject|1|||
145336732|NCT04516759|524081760|FG001|Overall Study|Withdrawal by Subject|1|||
145336733|NCT04516759|524081759|FG000|Overall Study|Other|0|||
145336734|NCT04516759|524081760|FG001|Overall Study|Other|1|||
145336735|NCT01001988|524081761|FG000|Overall Study|Protocol Violation|84|||
145336736|NCT01001988|524081761|FG000|Overall Study|Withdrawal by Subject|18|||
145336737|NCT01001988|524081761|FG000|Overall Study|Lost to Follow-up|15|||
145336738|NCT01221363|524081764|FG000|Overall Study|Pregnancy|1|||
145336739|NCT01221363|524081765|FG001|Overall Study|Pregnancy|0|||
145336740|NCT01221363|524081764|FG000|Overall Study|Withdrawal by Subject|11|||
145336741|NCT01221363|524081765|FG001|Overall Study|Withdrawal by Subject|5|||
145336742|NCT01756079|524081770|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
145336743|NCT01756079|524081770|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
145336744|NCT01756079|524081770|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
145336745|NCT01756079|524081770|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
145336746|NCT01756079|524081770|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
145336747|NCT04015908|524081771|FG000|Overall Study|Lost to Follow-up|0|||
145336748|NCT04015908|524081772|FG001|Overall Study|Lost to Follow-up|1|||
145336749|NCT01775189|524081773|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145573362|NCT01573624|524954843|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
145336750|NCT01775189|524081774|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
145336751|NCT01775189|524081775|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145336752|NCT01775189|524081776|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145336753|NCT01775189|524081777|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145336754|NCT01775189|524081778|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145336755|NCT01775189|524081779|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
145336756|NCT01775189|524081773|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336757|NCT01775189|524081774|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
145336758|NCT01775189|524081775|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336759|NCT01775189|524081776|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336760|NCT01775189|524081777|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336761|NCT01775189|524081778|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336762|NCT01775189|524081779|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
145336763|NCT01775189|524081773|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145336764|NCT01775189|524081774|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
145336765|NCT01775189|524081775|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
145336766|NCT01775189|524081776|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145336767|NCT01775189|524081777|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145336768|NCT01775189|524081778|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145336769|NCT01775189|524081779|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
145336770|NCT01775189|524081773|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336771|NCT01775189|524081774|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336772|NCT01775189|524081775|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336773|NCT01775189|524081776|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336774|NCT01775189|524081777|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336775|NCT01775189|524081778|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
145336776|NCT01775189|524081779|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
145336777|NCT01775189|524081773|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336778|NCT01775189|524081774|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336779|NCT01775189|524081775|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336780|NCT01775189|524081776|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
145336781|NCT01775189|524081777|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336782|NCT01775189|524081778|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336783|NCT01775189|524081779|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
145336784|NCT01775189|524081773|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145336785|NCT01775189|524081774|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145336786|NCT01775189|524081775|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145336787|NCT01775189|524081776|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
145336788|NCT01775189|524081777|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145336789|NCT01775189|524081778|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
145336790|NCT01775189|524081779|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
145336791|NCT01755767|524081780|FG000|Overall Study|Progressive Disease|8|||
145336792|NCT01755767|524081781|FG001|Overall Study|Progressive Disease|7|||
145336793|NCT01755767|524081782|FG002|Overall Study|Progressive Disease|91|||
145336794|NCT01755767|524081783|FG003|Overall Study|Progressive Disease|43|||
145413140|NCT01653262|524366944|FG000|Overall Study|AE, non-serious non-fatal|1|||
145573363|NCT01573624|524954844|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573364|NCT01573624|524954845|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573365|NCT01573624|524954846|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573366|NCT01573624|524954847|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573367|NCT01573624|524954848|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
145573368|NCT01573624|524954849|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
145573369|NCT01573624|524954843|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
145573370|NCT01573624|524954844|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145573371|NCT01573624|524954845|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145573372|NCT01573624|524954846|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145573373|NCT01573624|524954847|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
145573374|NCT01573624|524954848|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
145573375|NCT01573624|524954849|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
145573376|NCT01573624|524954843|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
145573377|NCT01573624|524954844|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
145573378|NCT01573624|524954845|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
145573379|NCT01573624|524954846|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
145573380|NCT01573624|524954847|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
145573381|NCT01573624|524954848|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
145573382|NCT01573624|524954849|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
145336795|NCT01755767|524081780|FG000|Overall Study|Clinical Disease Progression|4|||
145336796|NCT01755767|524081781|FG001|Overall Study|Clinical Disease Progression|2|||
145336797|NCT01755767|524081782|FG002|Overall Study|Clinical Disease Progression|29|||
145336798|NCT01755767|524081783|FG003|Overall Study|Clinical Disease Progression|20|||
145336799|NCT01755767|524081780|FG000|Overall Study|Radiographic Disease Progression|9|||
145336800|NCT01755767|524081781|FG001|Overall Study|Radiographic Disease Progression|4|||
145336801|NCT01755767|524081782|FG002|Overall Study|Radiographic Disease Progression|44|||
145413141|NCT00420407|524366946|FG000|Overall Study|Lost to Follow-up|0|||
145413142|NCT00420407|524366947|FG001|Overall Study|Lost to Follow-up|3|||
145413143|NCT00420407|524366946|FG000|Overall Study|Physician Decision|2|||
145336802|NCT01755767|524081783|FG003|Overall Study|Radiographic Disease Progression|27|||
145336803|NCT01755767|524081780|FG000|Overall Study|Adverse Event|6|||
145336804|NCT01755767|524081781|FG001|Overall Study|Adverse Event|0|||
145336805|NCT01755767|524081782|FG002|Overall Study|Adverse Event|28|||
145336806|NCT01755767|524081783|FG003|Overall Study|Adverse Event|11|||
145336807|NCT01755767|524081780|FG000|Overall Study|Death|1|||
145336808|NCT01755767|524081781|FG001|Overall Study|Death|2|||
145336809|NCT01755767|524081782|FG002|Overall Study|Death|15|||
145336810|NCT01755767|524081783|FG003|Overall Study|Death|4|||
145336811|NCT01755767|524081780|FG000|Overall Study|Subject Decision|0|||
145336812|NCT01755767|524081781|FG001|Overall Study|Subject Decision|0|||
145336813|NCT01755767|524081782|FG002|Overall Study|Subject Decision|10|||
145413144|NCT00420407|524366947|FG001|Overall Study|Physician Decision|1|||
145413145|NCT00420407|524366946|FG000|Overall Study|subject identified as detainee|1|||
145413146|NCT00420407|524366947|FG001|Overall Study|subject identified as detainee|0|||
145413147|NCT00420407|524366946|FG000|Overall Study|subject identified as Jehovah's witness|1|||
145413148|NCT00420407|524366947|FG001|Overall Study|subject identified as Jehovah's witness|0|||
145413149|NCT00420407|524366946|FG000|Overall Study|Withdrawal by Subject|0|||
145413150|NCT00420407|524366947|FG001|Overall Study|Withdrawal by Subject|2|||
145413151|NCT05417113|524366951|FG000|Overall Study|Lost to Follow-up|2|||
145413152|NCT05417113|524366952|FG001|Overall Study|Lost to Follow-up|2|||
145413153|NCT00134719|524366953|FG000|Primary Vaccination Phase|Adverse Event|4|||
145336814|NCT01755767|524081783|FG003|Overall Study|Subject Decision|3|||
145336815|NCT01755767|524081780|FG000|Overall Study|Withdrawal by Subject|0|||
145336816|NCT01755767|524081781|FG001|Overall Study|Withdrawal by Subject|0|||
145336817|NCT01755767|524081782|FG002|Overall Study|Withdrawal by Subject|2|||
145336818|NCT01755767|524081783|FG003|Overall Study|Withdrawal by Subject|1|||
145336819|NCT01755767|524081780|FG000|Overall Study|Other|0|||
145336820|NCT01755767|524081781|FG001|Overall Study|Other|0|||
145336821|NCT01755767|524081782|FG002|Overall Study|Other|2|||
145336822|NCT01755767|524081783|FG003|Overall Study|Other|3|||
145336823|NCT01755767|524081780|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
145336824|NCT01755767|524081781|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
145336825|NCT01755767|524081782|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
145336826|NCT01755767|524081783|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
145336827|NCT04623086|524081784|FG000|Overall Study|Withdrawal by Subject|0|||
145336828|NCT04623086|524081785|FG001|Overall Study|Withdrawal by Subject|0|||
145336829|NCT04623086|524081786|FG002|Overall Study|Withdrawal by Subject|10|||
145336830|NCT00715624|524081787|FG000|Overall Study|Adverse Event|12|||
145336831|NCT00715624|524081788|FG001|Overall Study|Adverse Event|37|||
145336832|NCT00715624|524081787|FG000|Overall Study|Lack of Efficacy|11|||
145336833|NCT00715624|524081788|FG001|Overall Study|Lack of Efficacy|11|||
145336834|NCT00715624|524081787|FG000|Overall Study|Lost to Follow-up|1|||
145336835|NCT00715624|524081788|FG001|Overall Study|Lost to Follow-up|2|||
145336836|NCT00715624|524081787|FG000|Overall Study|Protocol Violation|1|||
145336837|NCT00715624|524081788|FG001|Overall Study|Protocol Violation|0|||
145336838|NCT00715624|524081787|FG000|Overall Study|Withdrawal by Subject|11|||
145336839|NCT00715624|524081788|FG001|Overall Study|Withdrawal by Subject|25|||
145336840|NCT00715624|524081787|FG000|Overall Study|Familial and personal reasons|10|||
145336841|NCT00715624|524081788|FG001|Overall Study|Familial and personal reasons|22|||
145336842|NCT00715624|524081787|FG000|Overall Study|Poor compliance|6|||
145336843|NCT00715624|524081788|FG001|Overall Study|Poor compliance|13|||
145336844|NCT00715624|524081787|FG000|Overall Study|Sponsor decision|0|||
145336845|NCT00715624|524081788|FG001|Overall Study|Sponsor decision|4|||
145336846|NCT00715624|524081787|FG000|Overall Study|Incorrect randomization (not treated)|0|||
145413154|NCT00134719|524366954|FG001|Primary Vaccination Phase|Adverse Event|0|||
145413155|NCT00134719|524366955|FG002|Primary Vaccination Phase|Adverse Event|0|||
145413156|NCT00134719|524366953|FG000|Primary Vaccination Phase|Protocol Violation|1|||
145413157|NCT00134719|524366954|FG001|Primary Vaccination Phase|Protocol Violation|0|||
145413158|NCT00134719|524366955|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145622086|NCT05397470|525126756|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
145336847|NCT00715624|524081788|FG001|Overall Study|Incorrect randomization (not treated)|1|||
145336848|NCT00715624|524081787|FG000|Overall Study|Other|0|||
145336849|NCT00715624|524081788|FG001|Overall Study|Other|1|||
145336850|NCT03196635|524081790|FG000|Overall Study|Withdrawal by Subject|1|||
145336851|NCT00998309|524081794|FG000|Overall Study|Protocol Violation|4|||
145336852|NCT00735397|524081796|FG000|Overall Study|Adverse Event|194|||
145336853|NCT00735397|524081796|FG000|Overall Study|Lost to Follow-up|33|||
145336854|NCT00735397|524081796|FG000|Overall Study|Participant choice|252|||
145336855|NCT00735397|524081796|FG000|Overall Study|Inadequate therapeutic effect|202|||
145336856|NCT00735397|524081796|FG000|Overall Study|Administrative/Other|502|||
145336857|NCT02256436|524081799|FG000|Overall Study|Adverse Event|9|||
145336858|NCT02256436|524081800|FG001|Overall Study|Adverse Event|14|||
145336859|NCT02256436|524081799|FG000|Overall Study|Death|216|||
145336860|NCT02256436|524081800|FG001|Overall Study|Death|208|||
145336861|NCT02256436|524081799|FG000|Overall Study|Lost to Follow-up|1|||
145336862|NCT02256436|524081800|FG001|Overall Study|Lost to Follow-up|2|||
145336863|NCT02256436|524081799|FG000|Overall Study|Physician Decision|1|||
145336864|NCT02256436|524081800|FG001|Overall Study|Physician Decision|0|||
145573383|NCT01573624|524954843|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
145336865|NCT02256436|524081799|FG000|Overall Study|Protocol Violation|0|||
145336866|NCT02256436|524081800|FG001|Overall Study|Protocol Violation|1|||
145336867|NCT02256436|524081799|FG000|Overall Study|Withdrawal by Subject|26|||
145336868|NCT02256436|524081800|FG001|Overall Study|Withdrawal by Subject|10|||
145336869|NCT02256436|524081799|FG000|Overall Study|Transferred to Extension Study|11|||
145336870|NCT02256436|524081800|FG001|Overall Study|Transferred to Extension Study|23|||
145336871|NCT02256436|524081799|FG000|Overall Study|Did Not Continue on Extension Study|8|||
145336872|NCT02256436|524081800|FG001|Overall Study|Did Not Continue on Extension Study|12|||
145336873|NCT01696279|524081801|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
145336874|NCT01696279|524081802|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145336875|NCT01696279|524081803|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145336876|NCT01696279|524081804|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
145336877|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145336878|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
145413159|NCT00134719|524366953|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
145573384|NCT01573624|524954844|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573385|NCT01573624|524954845|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573386|NCT01573624|524954846|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573387|NCT01573624|524954847|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573388|NCT01573624|524954848|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573389|NCT01573624|524954849|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
145573390|NCT01573624|524954843|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
145573391|NCT01573624|524954844|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
145573392|NCT01573624|524954845|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
145573393|NCT01573624|524954846|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
145573394|NCT01573624|524954847|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
145573395|NCT01573624|524954848|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
145573396|NCT01573624|524954849|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
145573397|NCT01573624|524954843|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
145573398|NCT01573624|524954844|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573399|NCT01573624|524954845|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573400|NCT01573624|524954846|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573401|NCT01573624|524954847|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573402|NCT01573624|524954848|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573403|NCT01573624|524954849|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
145573404|NCT05059600|524954850|FG000|Overall Study|Enrolled but not Treated|10|||
145573405|NCT04907032|524954852|FG000|Overall Study|Withdrawal by Subject|7|||
145573406|NCT04907032|524954853|FG001|Overall Study|Withdrawal by Subject|1|||
145573407|NCT02519712|524954855|FG000|Overall Study|Disease Relapse|1|||
145573408|NCT02519712|524954855|FG000|Overall Study|Disease Progression|1|||
145573409|NCT02519712|524954855|FG000|Overall Study|Accruals are donors|2|||
145573410|NCT04847674|524954864|FG000|Overall Study|Withdrawal by Subject|0|||
145573411|NCT04847674|524954865|FG001|Overall Study|Withdrawal by Subject|1|||
145573412|NCT04847674|524954866|FG002|Overall Study|Withdrawal by Subject|0|||
145573413|NCT04847674|524954864|FG000|Overall Study|Lost to Follow-up|0|||
145573414|NCT04847674|524954865|FG001|Overall Study|Lost to Follow-up|0|||
145573415|NCT04847674|524954866|FG002|Overall Study|Lost to Follow-up|2|||
145573416|NCT04847674|524954864|FG000|Overall Study|Other than specified|21|||
145573417|NCT04847674|524954865|FG001|Overall Study|Other than specified|20|||
145573418|NCT04847674|524954866|FG002|Overall Study|Other than specified|20|||
145573419|NCT02705820|524954867|FG000|Overall Study|Death|2|||
145573420|NCT02705820|524954867|FG000|Overall Study|Disease Progression|34|||
145573421|NCT02705820|524954867|FG000|Overall Study|Clinical Deterioration|3|||
145573422|NCT01524770|524954868|FG000|First Intervention|Withdrawal by Subject|1|||
145573423|NCT01524770|524954869|FG001|First Intervention|Withdrawal by Subject|0|||
145573424|NCT01524770|524954868|FG000|First Intervention|Adverse Event|1|||
145573425|NCT01524770|524954869|FG001|First Intervention|Adverse Event|1|||
145573426|NCT01524770|524954868|FG000|First Intervention|Protocol Violation|1|||
145573427|NCT01524770|524954869|FG001|First Intervention|Protocol Violation|0|||
145336879|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145336880|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
145336881|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145336882|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
145336883|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145336884|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
145336885|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145336886|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
145336887|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145336888|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
145336889|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145336890|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
145336891|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145336892|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
145336893|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145336894|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
145336895|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145336896|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
145336897|NCT01696279|524081801|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145336898|NCT01696279|524081802|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
145336899|NCT01696279|524081803|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145336900|NCT01696279|524081804|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
145336901|NCT01696279|524081801|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145336902|NCT01696279|524081802|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145336903|NCT01696279|524081803|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
145336904|NCT01696279|524081804|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
145336905|NCT01696279|524081801|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145336906|NCT01696279|524081802|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145336907|NCT01696279|524081803|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
145336908|NCT01696279|524081804|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
145336909|NCT01696279|524081801|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145336910|NCT01696279|524081802|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145336911|NCT01696279|524081803|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
145336912|NCT01696279|524081804|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
145336913|NCT01696279|524081801|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145336914|NCT01696279|524081802|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145336915|NCT01696279|524081803|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
145336916|NCT01696279|524081804|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
145336917|NCT01441947|524081806|FG000|Overall Study|Withdrawal by Subject|3|||
145336918|NCT01441947|524081807|FG001|Overall Study|Withdrawal by Subject|0|||
145336919|NCT03796039|524081808|FG000|Overall Study|Death|2|||
145336920|NCT03796039|524081809|FG001|Overall Study|Death|1|||
145336921|NCT03796039|524081808|FG000|Overall Study|Withdrawal by Subject|7|||
145336922|NCT03796039|524081809|FG001|Overall Study|Withdrawal by Subject|4|||
145336923|NCT02927366|524081810|FG000|Overall Study|Adverse Event|1|||
145336924|NCT02927366|524081811|FG001|Overall Study|Adverse Event|0|||
145336925|NCT02927366|524081810|FG000|Overall Study|Patient schedule|1|||
145336926|NCT02927366|524081811|FG001|Overall Study|Patient schedule|0|||
145336927|NCT00724048|524081812|FG000|Overall Study|Adverse Event|1|||
145336928|NCT00724048|524081813|FG001|Overall Study|Adverse Event|1|||
145336929|NCT00724048|524081814|FG002|Overall Study|Adverse Event|1|||
145336930|NCT00724048|524081815|FG003|Overall Study|Adverse Event|0|||
145336931|NCT00724048|524081812|FG000|Overall Study|Lost to Follow-up|0|||
145336932|NCT00724048|524081813|FG001|Overall Study|Lost to Follow-up|1|||
145336933|NCT00724048|524081814|FG002|Overall Study|Lost to Follow-up|0|||
145336934|NCT00724048|524081815|FG003|Overall Study|Lost to Follow-up|0|||
145336935|NCT00724048|524081812|FG000|Overall Study|Withdrawal by Subject|1|||
145336936|NCT00724048|524081813|FG001|Overall Study|Withdrawal by Subject|2|||
145336937|NCT00724048|524081814|FG002|Overall Study|Withdrawal by Subject|1|||
145336938|NCT00724048|524081815|FG003|Overall Study|Withdrawal by Subject|2|||
145336939|NCT00724048|524081812|FG000|Overall Study|Investigator decision|0|||
145336940|NCT00724048|524081813|FG001|Overall Study|Investigator decision|0|||
145336941|NCT00724048|524081814|FG002|Overall Study|Investigator decision|1|||
145622087|NCT05397470|525126757|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
145336942|NCT00724048|524081815|FG003|Overall Study|Investigator decision|0|||
145336943|NCT00724048|524081812|FG000|Overall Study|Did not tolerate study drug|0|||
145336944|NCT00724048|524081813|FG001|Overall Study|Did not tolerate study drug|0|||
145336945|NCT00724048|524081814|FG002|Overall Study|Did not tolerate study drug|0|||
145336946|NCT00724048|524081815|FG003|Overall Study|Did not tolerate study drug|1|||
145336947|NCT00724048|524081812|FG000|Overall Study|Other than specified|1|||
145336948|NCT00724048|524081813|FG001|Overall Study|Other than specified|1|||
145336949|NCT00724048|524081814|FG002|Overall Study|Other than specified|0|||
145336950|NCT00724048|524081815|FG003|Overall Study|Other than specified|0|||
145336951|NCT00587990|524081816|FG000|Overall Study|Death|0|||
145622088|NCT05397470|525126755|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
145622089|NCT05397470|525126756|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
145622090|NCT05397470|525126757|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
145622091|NCT05397470|525126755|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
145622092|NCT05397470|525126756|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
145622093|NCT05397470|525126757|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
145622094|NCT05397470|525126755|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
145622095|NCT05397470|525126756|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
145622096|NCT05397470|525126757|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
145622097|NCT05397470|525126755|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
145622098|NCT05397470|525126756|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
145622099|NCT05397470|525126757|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
145622100|NCT05397470|525126755|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
145622101|NCT05397470|525126756|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
145622102|NCT05397470|525126757|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
145622103|NCT01950390|525126762|FG000|Overall Study|Never started treatment|3|||
145622104|NCT01950390|525126763|FG001|Overall Study|Never started treatment|2|||
145622105|NCT01950390|525126762|FG000|Overall Study|Disease progression|45|||
145622106|NCT01950390|525126763|FG001|Overall Study|Disease progression|52|||
145622107|NCT01950390|525126762|FG000|Overall Study|Adverse Event|22|||
145622108|NCT01950390|525126763|FG001|Overall Study|Adverse Event|16|||
145622109|NCT01950390|525126762|FG000|Overall Study|Death|5|||
145622110|NCT01950390|525126763|FG001|Overall Study|Death|3|||
145622111|NCT01950390|525126762|FG000|Overall Study|Withdrawal by Subject|5|||
145622112|NCT01950390|525126763|FG001|Overall Study|Withdrawal by Subject|1|||
145622113|NCT01950390|525126762|FG000|Overall Study|Alternative therapy|0|||
145622114|NCT01950390|525126763|FG001|Overall Study|Alternative therapy|3|||
145622115|NCT01950390|525126762|FG000|Overall Study|Complicating disease|1|||
145622116|NCT01950390|525126763|FG001|Overall Study|Complicating disease|0|||
145622117|NCT01950390|525126762|FG000|Overall Study|On treatment|1|||
145622118|NCT01950390|525126763|FG001|Overall Study|On treatment|0|||
145622119|NCT01950390|525126762|FG000|Overall Study|Symptomatic deterioration|2|||
145622120|NCT01950390|525126763|FG001|Overall Study|Symptomatic deterioration|1|||
145622121|NCT01950390|525126762|FG000|Overall Study|Physician Decision|0|||
145622122|NCT01950390|525126763|FG001|Overall Study|Physician Decision|4|||
145622123|NCT01950390|525126762|FG000|Overall Study|Lack of clinical benefit|0|||
145622124|NCT01950390|525126763|FG001|Overall Study|Lack of clinical benefit|1|||
145622125|NCT01950390|525126762|FG000|Overall Study|Maintained PR and moved to observation only|0|||
145622126|NCT01950390|525126763|FG001|Overall Study|Maintained PR and moved to observation only|1|||
145622127|NCT05567952|525128013|FG000|Overall Study|Lost to Follow-up|3|||
145622128|NCT05567952|525128014|FG001|Overall Study|Lost to Follow-up|2|||
145622129|NCT05567952|525128013|FG000|Overall Study|Withdrawal by Subject|6|||
145622130|NCT05567952|525128014|FG001|Overall Study|Withdrawal by Subject|3|||
145622131|NCT05567952|525128013|FG000|Overall Study|Other|3|||
145622132|NCT05567952|525128014|FG001|Overall Study|Other|1|||
145622133|NCT05194735|525128015|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
145622134|NCT05194735|525128016|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
145622135|NCT05194735|525128017|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
145622136|NCT05194735|525128015|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
145622137|NCT05194735|525128016|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
145622138|NCT05194735|525128017|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
145622139|NCT05194735|525128015|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
145622140|NCT05194735|525128016|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
145622141|NCT05194735|525128017|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
145622142|NCT05194735|525128015|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
145622143|NCT05194735|525128016|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
145413160|NCT00134719|524366954|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
145413161|NCT00134719|524366955|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
145413162|NCT00134719|524366953|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
145622144|NCT05194735|525128017|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
145622145|NCT00731042|525128018|FG000|Second Intervention|Did not meet inclusion criteria|0|||
145622146|NCT00731042|525128019|FG001|Second Intervention|Did not meet inclusion criteria|2|||
145622147|NCT00802841|525128028|FG000|Overall Study|Administrative problems|1|||
145622148|NCT00802841|525128029|FG001|Overall Study|Administrative problems|0|||
145622149|NCT00802841|525128028|FG000|Overall Study|Lost to Follow-up|2|||
145413163|NCT00134719|524366954|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
145413164|NCT00134719|524366955|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
145413165|NCT00134719|524366953|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
145413166|NCT00134719|524366954|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
145413167|NCT00134719|524366955|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
145413168|NCT00134719|524366953|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
145413169|NCT00134719|524366954|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
145413170|NCT00134719|524366955|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
145413171|NCT01500096|524366958|FG000|Overall Study|Lost to Follow-up|1|||
145413172|NCT01500096|524366959|FG001|Overall Study|Lost to Follow-up|0|||
145413173|NCT01500096|524366960|FG002|Overall Study|Lost to Follow-up|0|||
145413174|NCT01500096|524366961|FG003|Overall Study|Lost to Follow-up|2|||
145413175|NCT00639379|524366962|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
145413176|NCT00639379|524366963|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
145413177|NCT00639379|524366962|FG000|Period 1 - 2 Weeks|lens issue|3|||
145413178|NCT00639379|524366963|FG001|Period 1 - 2 Weeks|lens issue|0|||
145413179|NCT02582632|524366964|FG000|Overall Study|Other|1|||
145413180|NCT04307394|524366968|FG000|Overall Study|Lost to Follow-up|3|||
145413181|NCT04307394|524366968|FG000|Overall Study|Withdrawal by Subject|2|||
145413182|NCT01617967|524366972|FG000|Overall Study|Protocol Violation|0|||
145413183|NCT01617967|524366973|FG001|Overall Study|Protocol Violation|0|||
145413184|NCT01617967|524366974|FG002|Overall Study|Protocol Violation|0|||
145413185|NCT01617967|524366975|FG003|Overall Study|Protocol Violation|1|||
145413186|NCT01617967|524366976|FG004|Overall Study|Protocol Violation|0|||
145413187|NCT01617967|524366977|FG005|Overall Study|Protocol Violation|0|||
145413188|NCT01617967|524366972|FG000|Overall Study|Withdrawal by Subject|0|||
145413189|NCT01617967|524366973|FG001|Overall Study|Withdrawal by Subject|0|||
145413190|NCT01617967|524366974|FG002|Overall Study|Withdrawal by Subject|0|||
145413191|NCT01617967|524366975|FG003|Overall Study|Withdrawal by Subject|0|||
145413192|NCT01617967|524366976|FG004|Overall Study|Withdrawal by Subject|0|||
145413193|NCT01617967|524366977|FG005|Overall Study|Withdrawal by Subject|1|||
145413194|NCT01617967|524366972|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
145413195|NCT01617967|524366973|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
145413196|NCT01617967|524366974|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
145413197|NCT01617967|524366975|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
145413198|NCT01617967|524366976|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
145413199|NCT01617967|524366977|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
145413200|NCT02536794|524366978|FG000|Reached 1st Response Assessment|Adverse Event|2|||
145413201|NCT02536794|524366978|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
145413202|NCT02536794|524366978|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
145413203|NCT02536794|524366978|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
145413204|NCT02536794|524366978|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
145413205|NCT02536794|524366978|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
145413206|NCT00416949|524366979|FG000|Overall Study|Patients refused to participate|5|||
145413207|NCT01177410|524366984|FG000|Overall Study|Adverse Event|0|||
145413208|NCT01177410|524366985|FG001|Overall Study|Adverse Event|2|||
145413209|NCT01177410|524366986|FG002|Overall Study|Adverse Event|2|||
145413210|NCT01177410|524366984|FG000|Overall Study|Withdrawal by Subject|1|||
145413211|NCT01177410|524366985|FG001|Overall Study|Withdrawal by Subject|4|||
145413212|NCT01177410|524366986|FG002|Overall Study|Withdrawal by Subject|3|||
145413213|NCT01177410|524366984|FG000|Overall Study|Lost to Follow-up|0|||
145413214|NCT01177410|524366985|FG001|Overall Study|Lost to Follow-up|1|||
145413215|NCT01177410|524366986|FG002|Overall Study|Lost to Follow-up|0|||
145413216|NCT00471354|524366987|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
145413217|NCT00471354|524366987|FG000|Overall Study|Adverse Event|13|||
145413218|NCT00471354|524366987|FG000|Overall Study|Protocol Violation|12|||
145413219|NCT00471354|524366987|FG000|Overall Study|Withdrawal by Subject|1|||
145413220|NCT00471354|524366987|FG000|Overall Study|Physician Decision|4|||
145413221|NCT00471354|524366987|FG000|Overall Study|Sponsor Decision|1|||
145413222|NCT00471354|524366987|FG000|Overall Study|Lost to Follow-up|3|||
145413223|NCT00471354|524366987|FG000|Overall Study|Lack of Efficacy|5|||
145413224|NCT00471354|524366987|FG000|Overall Study|Patient/Caregiver Decision|12|||
145413225|NCT02503865|524366992|FG000|Overall Study|Moved out of area|1|||
145413226|NCT02503865|524366993|FG001|Overall Study|Moved out of area|8|||
145413227|NCT02503865|524366994|FG002|Overall Study|Moved out of area|0|||
145413228|NCT02503865|524366992|FG000|Overall Study|Refused treatment|4|||
145413229|NCT02503865|524366993|FG001|Overall Study|Refused treatment|39|||
145413230|NCT02503865|524366994|FG002|Overall Study|Refused treatment|2|||
145413231|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
145413232|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
145413233|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
145413234|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Death|1|||
145413235|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Death|0|||
145413236|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Death|0|||
145413237|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
145413238|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
145413239|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
145413240|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
145413241|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
145413242|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
145413243|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
145413244|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
145413245|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
145413246|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
145413247|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
145413248|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
145413249|NCT05073315|524366995|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
145413250|NCT05073315|524366996|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
145413251|NCT05073315|524366997|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
145413252|NCT05073315|524366995|FG000|Period 2|Adverse Event|0|||
145413253|NCT05073315|524366996|FG001|Period 2|Adverse Event|3|||
145413254|NCT05073315|524366997|FG002|Period 2|Adverse Event|6|||
145413255|NCT05073315|524366995|FG000|Period 2|Lost to Follow-up|0|||
145413256|NCT05073315|524366996|FG001|Period 2|Lost to Follow-up|5|||
145413257|NCT05073315|524366997|FG002|Period 2|Lost to Follow-up|5|||
145413258|NCT05073315|524366995|FG000|Period 2|Withdrawal by Subject|0|||
145413259|NCT05073315|524366996|FG001|Period 2|Withdrawal by Subject|4|||
145413260|NCT05073315|524366997|FG002|Period 2|Withdrawal by Subject|9|||
145413261|NCT05073315|524366995|FG000|Period 2|Protocol Violation|0|||
145413262|NCT05073315|524366996|FG001|Period 2|Protocol Violation|0|||
145413263|NCT05073315|524366997|FG002|Period 2|Protocol Violation|1|||
145413264|NCT00303953|524366998|FG000|Overall Study|Ineligible|1|||
145413265|NCT00303953|524366998|FG000|Overall Study|Death|1|||
145413266|NCT00303953|524366998|FG000|Overall Study|Adverse Event|4|||
145413267|NCT00303953|524366998|FG000|Overall Study|Lack of Efficacy|12|||
145336952|NCT00587990|524081817|FG001|Overall Study|Death|0|||
145336953|NCT00587990|524081818|FG002|Overall Study|Death|1|||
145336954|NCT02329847|524081819|FG000|Overall Study|Death|4|||
145336955|NCT02329847|524081820|FG001|Overall Study|Death|4|||
145336956|NCT02329847|524081821|FG002|Overall Study|Death|22|||
145336957|NCT02329847|524081822|FG003|Overall Study|Death|12|||
145336958|NCT02329847|524081823|FG004|Overall Study|Death|20|||
145336959|NCT02329847|524081824|FG005|Overall Study|Death|13|||
145336960|NCT02329847|524081819|FG000|Overall Study|Lost to Follow-up|0|||
145336961|NCT02329847|524081820|FG001|Overall Study|Lost to Follow-up|0|||
145336962|NCT02329847|524081821|FG002|Overall Study|Lost to Follow-up|2|||
145336963|NCT02329847|524081822|FG003|Overall Study|Lost to Follow-up|3|||
145336964|NCT02329847|524081823|FG004|Overall Study|Lost to Follow-up|0|||
145336965|NCT02329847|524081824|FG005|Overall Study|Lost to Follow-up|1|||
145336966|NCT02329847|524081819|FG000|Overall Study|Physician Decision|0|||
145336967|NCT02329847|524081820|FG001|Overall Study|Physician Decision|0|||
145336968|NCT02329847|524081821|FG002|Overall Study|Physician Decision|0|||
145336969|NCT02329847|524081822|FG003|Overall Study|Physician Decision|0|||
145336970|NCT02329847|524081823|FG004|Overall Study|Physician Decision|1|||
145336971|NCT02329847|524081824|FG005|Overall Study|Physician Decision|0|||
145336972|NCT02329847|524081819|FG000|Overall Study|Withdrawal by Subject|2|||
145336973|NCT02329847|524081820|FG001|Overall Study|Withdrawal by Subject|1|||
145336974|NCT02329847|524081821|FG002|Overall Study|Withdrawal by Subject|5|||
145336975|NCT02329847|524081822|FG003|Overall Study|Withdrawal by Subject|7|||
145336976|NCT02329847|524081823|FG004|Overall Study|Withdrawal by Subject|8|||
145336977|NCT02329847|524081824|FG005|Overall Study|Withdrawal by Subject|3|||
145336978|NCT02329847|524081819|FG000|Overall Study|Other|1|||
145336979|NCT02329847|524081820|FG001|Overall Study|Other|2|||
145336980|NCT02329847|524081821|FG002|Overall Study|Other|6|||
145336981|NCT02329847|524081822|FG003|Overall Study|Other|13|||
145336982|NCT02329847|524081823|FG004|Overall Study|Other|10|||
145336983|NCT02329847|524081824|FG005|Overall Study|Other|3|||
145336984|NCT01822275|524081826|FG000|Overall Study|Withdrawal by Subject|3|||
145336985|NCT01822275|524081826|FG000|Overall Study|Adverse Event|3|||
145336986|NCT01822275|524081826|FG000|Overall Study|Progression|14|||
145336987|NCT01822275|524081826|FG000|Overall Study|Physician Decision|2|||
145336988|NCT00911807|524081827|FG000|Overall Study|Adverse Event|2|||
145336989|NCT00911807|524081828|FG001|Overall Study|Adverse Event|1|||
145413268|NCT00303953|524366998|FG000|Overall Study|Physician Decision|1|||
145413269|NCT00021255|524366999|FG000|Overall Study|Death|1|||
145413270|NCT00021255|524367000|FG001|Overall Study|Death|0|||
145413271|NCT00021255|524367001|FG002|Overall Study|Death|2|||
145336990|NCT00911807|524081829|FG002|Overall Study|Adverse Event|5|||
145336991|NCT00911807|524081827|FG000|Overall Study|Death|0|||
145336992|NCT00911807|524081828|FG001|Overall Study|Death|0|||
145336993|NCT00911807|524081829|FG002|Overall Study|Death|1|||
145336994|NCT00911807|524081827|FG000|Overall Study|Protocol Violation|6|||
145336995|NCT00911807|524081828|FG001|Overall Study|Protocol Violation|4|||
145336996|NCT00911807|524081829|FG002|Overall Study|Protocol Violation|9|||
145336997|NCT00911807|524081827|FG000|Overall Study|Withdrawal by Subject|8|||
145336998|NCT00911807|524081828|FG001|Overall Study|Withdrawal by Subject|10|||
145336999|NCT00911807|524081829|FG002|Overall Study|Withdrawal by Subject|7|||
145337000|NCT00911807|524081827|FG000|Overall Study|Organizational reasons|1|||
145337001|NCT00911807|524081828|FG001|Overall Study|Organizational reasons|3|||
145337002|NCT00911807|524081829|FG002|Overall Study|Organizational reasons|1|||
145337003|NCT01672970|524081830|FG000|Overall Study|Lack of Efficacy|12|||
145337004|NCT01672970|524081830|FG000|Overall Study|Adverse Event|18|||
145337005|NCT01672970|524081830|FG000|Overall Study|Withdrawal by Subject|2|||
145337006|NCT01672970|524081830|FG000|Overall Study|Lost to Follow-up|5|||
145337007|NCT01672970|524081830|FG000|Overall Study|Other|9|||
145337008|NCT01672970|524081830|FG000|Overall Study|Enrolled but not treated|1|||
145337009|NCT03918109|524081831|FG000|Overall Study|Withdrawal by Subject|0|||
145337010|NCT03918109|524081832|FG001|Overall Study|Withdrawal by Subject|0|||
145337011|NCT03918109|524081833|FG002|Overall Study|Withdrawal by Subject|2|||
145337012|NCT03918109|524081834|FG003|Overall Study|Withdrawal by Subject|1|||
145337013|NCT03918109|524081831|FG000|Overall Study|Lost to Follow-up|0|||
145337014|NCT03918109|524081832|FG001|Overall Study|Lost to Follow-up|0|||
145337015|NCT03918109|524081833|FG002|Overall Study|Lost to Follow-up|0|||
145337016|NCT03918109|524081834|FG003|Overall Study|Lost to Follow-up|1|||
145337017|NCT00186043|524081837|FG000|Overall Study|Lack of Efficacy|1|||
145337018|NCT00186043|524081838|FG001|Overall Study|Lack of Efficacy|3|||
145337019|NCT00186043|524081837|FG000|Overall Study|Lost to Follow-up|4|||
145337020|NCT00186043|524081838|FG001|Overall Study|Lost to Follow-up|6|||
145337021|NCT00186043|524081837|FG000|Overall Study|Withdrawal by Subject|1|||
145337022|NCT00186043|524081838|FG001|Overall Study|Withdrawal by Subject|0|||
145337023|NCT00186043|524081837|FG000|Overall Study|Adverse Event|7|||
145337024|NCT00186043|524081838|FG001|Overall Study|Adverse Event|3|||
145337025|NCT00186043|524081837|FG000|Overall Study|Protocol Violation|2|||
145337026|NCT00186043|524081838|FG001|Overall Study|Protocol Violation|1|||
145337027|NCT00390221|524081839|FG000|Overall Study|Lost to Follow-up|0|||
145337028|NCT00390221|524081840|FG001|Overall Study|Lost to Follow-up|3|||
145337029|NCT00390221|524081841|FG002|Overall Study|Lost to Follow-up|0|||
145337030|NCT00390221|524081839|FG000|Overall Study|Adverse Event|1|||
145337031|NCT00390221|524081840|FG001|Overall Study|Adverse Event|4|||
145337032|NCT00390221|524081841|FG002|Overall Study|Adverse Event|3|||
145573428|NCT01387607|524954872|FG000|Overall Study|Adverse Event|23|||
145573429|NCT01387607|524954873|FG001|Overall Study|Adverse Event|11|||
145573430|NCT01387607|524954872|FG000|Overall Study|Lack of Efficacy|8|||
145573431|NCT01387607|524954873|FG001|Overall Study|Lack of Efficacy|6|||
145573432|NCT01387607|524954872|FG000|Overall Study|Lost to Follow-up|2|||
145573433|NCT01387607|524954873|FG001|Overall Study|Lost to Follow-up|1|||
145573434|NCT01387607|524954872|FG000|Overall Study|No longer meets eligibility criteria|0|||
145573435|NCT01387607|524954873|FG001|Overall Study|No longer meets eligibility criteria|1|||
145573436|NCT01387607|524954872|FG000|Overall Study|Protocol Violation|1|||
145573437|NCT01387607|524954873|FG001|Overall Study|Protocol Violation|5|||
145573438|NCT01387607|524954872|FG000|Overall Study|Withdrawal by Subject|13|||
145573439|NCT01387607|524954873|FG001|Overall Study|Withdrawal by Subject|14|||
145573440|NCT01387607|524954872|FG000|Overall Study|Other|1|||
145573441|NCT01387607|524954873|FG001|Overall Study|Other|1|||
145573442|NCT01387607|524954872|FG000|Overall Study|Randomized, not treated|3|||
145573443|NCT01387607|524954873|FG001|Overall Study|Randomized, not treated|6|||
145573444|NCT03548584|524956502|FG000|Overall Study|Lost to Follow-up|0|||
145573445|NCT03548584|524956503|FG001|Overall Study|Lost to Follow-up|0|||
145573446|NCT03548584|524956504|FG002|Overall Study|Lost to Follow-up|1|||
145573447|NCT03548584|524956502|FG000|Overall Study|Adverse Event|1|||
145573448|NCT03548584|524956503|FG001|Overall Study|Adverse Event|11|||
145573449|NCT03548584|524956504|FG002|Overall Study|Adverse Event|5|||
145573450|NCT03548584|524956502|FG000|Overall Study|Site Terminated by Sponsor|1|||
145573451|NCT03548584|524956503|FG001|Overall Study|Site Terminated by Sponsor|3|||
145573452|NCT03548584|524956504|FG002|Overall Study|Site Terminated by Sponsor|2|||
145573453|NCT03548584|524956502|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
145573454|NCT03548584|524956503|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
145573455|NCT03548584|524956504|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
145573456|NCT03548584|524956502|FG000|Overall Study|Lack of Efficacy|0|||
145573457|NCT03548584|524956503|FG001|Overall Study|Lack of Efficacy|1|||
145573458|NCT03548584|524956504|FG002|Overall Study|Lack of Efficacy|0|||
145573459|NCT03548584|524956502|FG000|Overall Study|Non-compliance with Study Drug|0|||
145573460|NCT03548584|524956503|FG001|Overall Study|Non-compliance with Study Drug|1|||
145573461|NCT03548584|524956504|FG002|Overall Study|Non-compliance with Study Drug|0|||
145573462|NCT03548584|524956502|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
145573463|NCT03548584|524956503|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
145622150|NCT00802841|525128029|FG001|Overall Study|Lost to Follow-up|1|||
145337033|NCT00390221|524081839|FG000|Overall Study|Investigator Decision|0|||
145337034|NCT00390221|524081840|FG001|Overall Study|Investigator Decision|0|||
145337035|NCT00390221|524081841|FG002|Overall Study|Investigator Decision|1|||
145337036|NCT00390221|524081839|FG000|Overall Study|Withdrawal by Subject|13|||
145337037|NCT00390221|524081840|FG001|Overall Study|Withdrawal by Subject|9|||
145337038|NCT00390221|524081841|FG002|Overall Study|Withdrawal by Subject|7|||
145337039|NCT00390221|524081839|FG000|Overall Study|Subject Non-compliance|1|||
145337040|NCT00390221|524081840|FG001|Overall Study|Subject Non-compliance|0|||
145337041|NCT00390221|524081841|FG002|Overall Study|Subject Non-compliance|2|||
145337042|NCT00390221|524081839|FG000|Overall Study|Other|3|||
145337043|NCT00390221|524081840|FG001|Overall Study|Other|4|||
145337044|NCT00390221|524081841|FG002|Overall Study|Other|2|||
145337045|NCT03258853|524081842|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
145337046|NCT03258853|524081843|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
145337047|NCT03433755|524081852|FG000|Overall Study|Lost to Follow-up|1|||
145337048|NCT03433755|524081853|FG001|Overall Study|Lost to Follow-up|0|||
145337049|NCT03433755|524081854|FG002|Overall Study|Lost to Follow-up|0|||
145337050|NCT03433755|524081855|FG003|Overall Study|Lost to Follow-up|0|||
145337051|NCT03433755|524081852|FG000|Overall Study|Decision by Sponsor|1|||
145337052|NCT03433755|524081853|FG001|Overall Study|Decision by Sponsor|0|||
145337053|NCT03433755|524081854|FG002|Overall Study|Decision by Sponsor|0|||
145337054|NCT03433755|524081855|FG003|Overall Study|Decision by Sponsor|0|||
145337055|NCT03589768|524084035|FG000|Overall Study|Death|1|||
145337056|NCT03589768|524084036|FG001|Overall Study|Death|0|||
145337057|NCT03589768|524084037|FG002|Overall Study|Death|8|||
145337058|NCT03589768|524084038|FG003|Overall Study|Death|3|||
145337059|NCT03589768|524084035|FG000|Overall Study|Withdrawal by Subject|2|||
145337060|NCT03589768|524084036|FG001|Overall Study|Withdrawal by Subject|0|||
145337061|NCT03589768|524084037|FG002|Overall Study|Withdrawal by Subject|0|||
145337062|NCT03589768|524084038|FG003|Overall Study|Withdrawal by Subject|0|||
145337063|NCT03589768|524084035|FG000|Overall Study|Protocol Violation|1|||
145337064|NCT03589768|524084036|FG001|Overall Study|Protocol Violation|0|||
145337065|NCT03589768|524084037|FG002|Overall Study|Protocol Violation|0|||
145337066|NCT03589768|524084038|FG003|Overall Study|Protocol Violation|0|||
145337067|NCT04663295|524084039|FG000|Run-in Period|Withdrawal by Subject|3|||
145337068|NCT04663295|524084039|FG000|Overall Study Period|Pregnancy|1|||
145337069|NCT04663295|524084039|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
145337070|NCT03972163|524084053|FG000|Overall Study|Death|0|||
145337071|NCT03972163|524084054|FG001|Overall Study|Death|1|||
145337072|NCT00537303|524084055|FG000|Overall Study|Adverse Event|1|||
145337073|NCT00537303|524084056|FG001|Overall Study|Adverse Event|4|||
145337074|NCT00537303|524084055|FG000|Overall Study|Lack of Efficacy|6|||
145337075|NCT00537303|524084056|FG001|Overall Study|Lack of Efficacy|7|||
145337076|NCT00537303|524084055|FG000|Overall Study|Protocol Violation|8|||
145337077|NCT00537303|524084056|FG001|Overall Study|Protocol Violation|4|||
145337078|NCT00537303|524084055|FG000|Overall Study|Withdrawal criteria|3|||
145337079|NCT00537303|524084056|FG001|Overall Study|Withdrawal criteria|3|||
145337080|NCT00537303|524084055|FG000|Overall Study|Unclassified|8|||
145337081|NCT00537303|524084056|FG001|Overall Study|Unclassified|7|||
145337082|NCT01844856|524084058|FG000|Overall Study|Lost to Follow-up|15|||
145337083|NCT01844856|524084059|FG001|Overall Study|Lost to Follow-up|3|||
145337084|NCT01844856|524084058|FG000|Overall Study|Adverse Event|3|||
145337085|NCT01844856|524084059|FG001|Overall Study|Adverse Event|6|||
145337086|NCT01844856|524084058|FG000|Overall Study|Withdrawal by Subject|3|||
145337087|NCT01844856|524084059|FG001|Overall Study|Withdrawal by Subject|2|||
145337088|NCT01844856|524084058|FG000|Overall Study|Noncompliance|2|||
145337089|NCT01844856|524084059|FG001|Overall Study|Noncompliance|3|||
145337090|NCT01844856|524084058|FG000|Overall Study|Enterococcus Resistant|0|||
145337091|NCT01844856|524084059|FG001|Overall Study|Enterococcus Resistant|1|||
145337092|NCT01844856|524084058|FG000|Overall Study|Inadvertently Not Scheduled|1|||
145337093|NCT01844856|524084059|FG001|Overall Study|Inadvertently Not Scheduled|0|||
145337094|NCT01844856|524084058|FG000|Overall Study|Randomized but was a Screen Failure|0|||
145337095|NCT01844856|524084059|FG001|Overall Study|Randomized but was a Screen Failure|1|||
145337096|NCT00927394|524084060|FG000|Overall Study|Adverse Event|14|||
145337097|NCT00927394|524084061|FG001|Overall Study|Adverse Event|9|||
145337098|NCT00927394|524084060|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
145337099|NCT00927394|524084061|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
145337100|NCT00927394|524084060|FG000|Overall Study|Withdrawal by Subject|20|||
145337101|NCT00927394|524084061|FG001|Overall Study|Withdrawal by Subject|24|||
145337102|NCT00927394|524084060|FG000|Overall Study|Lost to Follow-up|8|||
145413272|NCT00021255|524366999|FG000|Overall Study|Breast cancer relapse|5|||
145413273|NCT00021255|524367000|FG001|Overall Study|Breast cancer relapse|18|||
145337103|NCT00927394|524084061|FG001|Overall Study|Lost to Follow-up|14|||
145337104|NCT00927394|524084060|FG000|Overall Study|Administrative Problem|1|||
145337105|NCT00927394|524084061|FG001|Overall Study|Administrative Problem|0|||
145413274|NCT00021255|524367001|FG002|Overall Study|Breast cancer relapse|11|||
145413275|NCT00021255|524366999|FG000|Overall Study|Second primary malignancy|0|||
145337106|NCT00927394|524084060|FG000|Overall Study|Death|1|||
145337107|NCT00927394|524084061|FG001|Overall Study|Death|1|||
145337108|NCT00927394|524084060|FG000|Overall Study|Protocol deviation|16|||
145337109|NCT00927394|524084061|FG001|Overall Study|Protocol deviation|13|||
145337110|NCT00927394|524084060|FG000|Overall Study|Randomized in error|0|||
145337111|NCT00927394|524084061|FG001|Overall Study|Randomized in error|1|||
145337112|NCT01329549|524084062|FG000|Overall Study|Withdrawal by Subject|1|||
145337113|NCT01329549|524084062|FG000|Overall Study|Adverse Event|1|||
145337114|NCT00191165|524084063|FG000|Overall Study|Adverse Event|2|||
145337115|NCT00191165|524084064|FG001|Overall Study|Adverse Event|0|||
145337116|NCT00191165|524084063|FG000|Overall Study|Protocol Violation|0|||
145337117|NCT00191165|524084064|FG001|Overall Study|Protocol Violation|1|||
145337118|NCT00191165|524084063|FG000|Overall Study|Participant Moved Away|0|||
145337119|NCT00191165|524084064|FG001|Overall Study|Participant Moved Away|1|||
145337120|NCT03200912|524084065|FG000|Overall Study|Adverse Event|3|||
145337121|NCT03200912|524084066|FG001|Overall Study|Adverse Event|0|||
145337122|NCT03200912|524084067|FG002|Overall Study|Adverse Event|0|||
145337123|NCT03200912|524084065|FG000|Overall Study|Withdrawal by Subject|1|||
145337124|NCT03200912|524084066|FG001|Overall Study|Withdrawal by Subject|2|||
145337125|NCT03200912|524084067|FG002|Overall Study|Withdrawal by Subject|4|||
145337126|NCT03200912|524084065|FG000|Overall Study|Non-compliance with study drug|0|||
145337127|NCT03200912|524084066|FG001|Overall Study|Non-compliance with study drug|1|||
145337128|NCT03200912|524084067|FG002|Overall Study|Non-compliance with study drug|0|||
145337129|NCT00229723|524084069|FG000|Concomitant Phase|Adverse Event|4|||
145337130|NCT00229723|524084070|FG001|Concomitant Phase|Adverse Event|2|||
145337131|NCT00229723|524084071|FG002|Concomitant Phase|Adverse Event|5|||
145337132|NCT00229723|524084072|FG003|Concomitant Phase|Adverse Event|2|||
145337133|NCT00229723|524084073|FG004|Concomitant Phase|Adverse Event|0|||
145337134|NCT00229723|524084074|FG005|Concomitant Phase|Adverse Event|1|||
145337135|NCT00229723|524084075|FG006|Concomitant Phase|Adverse Event|2|||
145337136|NCT00229723|524084069|FG000|Concomitant Phase|Objective disease progression|0|||
145337137|NCT00229723|524084070|FG001|Concomitant Phase|Objective disease progression|0|||
145337138|NCT00229723|524084071|FG002|Concomitant Phase|Objective disease progression|0|||
145337139|NCT00229723|524084072|FG003|Concomitant Phase|Objective disease progression|0|||
145337140|NCT00229723|524084073|FG004|Concomitant Phase|Objective disease progression|0|||
145337141|NCT00229723|524084074|FG005|Concomitant Phase|Objective disease progression|0|||
145337142|NCT00229723|524084075|FG006|Concomitant Phase|Objective disease progression|0|||
145337143|NCT00229723|524084069|FG000|Concomitant Phase|Clinical progression|0|||
145337144|NCT00229723|524084070|FG001|Concomitant Phase|Clinical progression|0|||
145337145|NCT00229723|524084071|FG002|Concomitant Phase|Clinical progression|0|||
145337146|NCT00229723|524084072|FG003|Concomitant Phase|Clinical progression|0|||
145337147|NCT00229723|524084073|FG004|Concomitant Phase|Clinical progression|0|||
145337148|NCT00229723|524084074|FG005|Concomitant Phase|Clinical progression|0|||
145337149|NCT00229723|524084075|FG006|Concomitant Phase|Clinical progression|1|||
145337150|NCT00229723|524084069|FG000|Concomitant Phase|Lost to Follow-up|0|||
145337151|NCT00229723|524084070|FG001|Concomitant Phase|Lost to Follow-up|0|||
145337152|NCT00229723|524084071|FG002|Concomitant Phase|Lost to Follow-up|0|||
145337153|NCT00229723|524084072|FG003|Concomitant Phase|Lost to Follow-up|0|||
145337154|NCT00229723|524084073|FG004|Concomitant Phase|Lost to Follow-up|1|||
145337155|NCT00229723|524084074|FG005|Concomitant Phase|Lost to Follow-up|0|||
145337156|NCT00229723|524084075|FG006|Concomitant Phase|Lost to Follow-up|0|||
145337157|NCT00229723|524084069|FG000|Concomitant Phase|Informed consent withdrawn|3|||
145337158|NCT00229723|524084070|FG001|Concomitant Phase|Informed consent withdrawn|2|||
145337159|NCT00229723|524084071|FG002|Concomitant Phase|Informed consent withdrawn|0|||
145337160|NCT00229723|524084072|FG003|Concomitant Phase|Informed consent withdrawn|2|||
145337161|NCT00229723|524084073|FG004|Concomitant Phase|Informed consent withdrawn|0|||
145337162|NCT00229723|524084074|FG005|Concomitant Phase|Informed consent withdrawn|0|||
145337163|NCT00229723|524084075|FG006|Concomitant Phase|Informed consent withdrawn|0|||
145337164|NCT00229723|524084069|FG000|Concomitant Phase|Severe non-compliance|0|||
145337165|NCT00229723|524084070|FG001|Concomitant Phase|Severe non-compliance|1|||
145337166|NCT00229723|524084071|FG002|Concomitant Phase|Severe non-compliance|0|||
145337167|NCT00229723|524084072|FG003|Concomitant Phase|Severe non-compliance|0|||
145337168|NCT00229723|524084073|FG004|Concomitant Phase|Severe non-compliance|1|||
145337169|NCT00229723|524084074|FG005|Concomitant Phase|Severe non-compliance|0|||
145337170|NCT00229723|524084075|FG006|Concomitant Phase|Severe non-compliance|0|||
145337171|NCT00229723|524084069|FG000|Concomitant Phase|Other|3|||
145337172|NCT00229723|524084070|FG001|Concomitant Phase|Other|0|||
145337173|NCT00229723|524084071|FG002|Concomitant Phase|Other|1|||
145337174|NCT00229723|524084072|FG003|Concomitant Phase|Other|1|||
145337175|NCT00229723|524084073|FG004|Concomitant Phase|Other|0|||
145337176|NCT00229723|524084074|FG005|Concomitant Phase|Other|2|||
145337177|NCT00229723|524084075|FG006|Concomitant Phase|Other|0|||
145337178|NCT00229723|524084069|FG000|Maintenance Phase|Adverse Event|7|||
145337179|NCT00229723|524084070|FG001|Maintenance Phase|Adverse Event|2|||
145337180|NCT00229723|524084071|FG002|Maintenance Phase|Adverse Event|1|||
145337181|NCT00229723|524084072|FG003|Maintenance Phase|Adverse Event|4|||
145337182|NCT00229723|524084073|FG004|Maintenance Phase|Adverse Event|7|||
145337183|NCT00229723|524084074|FG005|Maintenance Phase|Adverse Event|5|||
145337184|NCT00229723|524084075|FG006|Maintenance Phase|Adverse Event|2|||
145337185|NCT00229723|524084069|FG000|Maintenance Phase|Objective disease progression|5|||
145337186|NCT00229723|524084070|FG001|Maintenance Phase|Objective disease progression|5|||
145337187|NCT00229723|524084071|FG002|Maintenance Phase|Objective disease progression|3|||
145337188|NCT00229723|524084072|FG003|Maintenance Phase|Objective disease progression|6|||
145337189|NCT00229723|524084073|FG004|Maintenance Phase|Objective disease progression|2|||
145337190|NCT00229723|524084074|FG005|Maintenance Phase|Objective disease progression|9|||
145337191|NCT00229723|524084075|FG006|Maintenance Phase|Objective disease progression|5|||
145622151|NCT00802841|525128028|FG000|Overall Study|Death|1|||
145622152|NCT00802841|525128029|FG001|Overall Study|Death|2|||
145622153|NCT00802841|525128028|FG000|Overall Study|Adverse Event|8|||
145622154|NCT00802841|525128029|FG001|Overall Study|Adverse Event|2|||
145622155|NCT00802841|525128028|FG000|Overall Study|Disease progression|7|||
145622156|NCT00802841|525128029|FG001|Overall Study|Disease progression|3|||
145622157|NCT00802841|525128028|FG000|Overall Study|Withdrawal by Subject|9|||
145622158|NCT00802841|525128029|FG001|Overall Study|Withdrawal by Subject|5|||
145622159|NCT00802841|525128028|FG000|Overall Study|Protocol deviation|2|||
145622160|NCT00802841|525128029|FG001|Overall Study|Protocol deviation|6|||
145622161|NCT00802841|525128028|FG000|Overall Study|Treatment duration completed|66|||
145622162|NCT00802841|525128029|FG001|Overall Study|Treatment duration completed|76|||
145622163|NCT00432159|525128032|FG000|Overall Study|Death|0|||
145622164|NCT00432159|525128033|FG001|Overall Study|Death|1|||
145622165|NCT00432159|525128034|FG002|Overall Study|Death|0|||
145622166|NCT00432159|525128035|FG003|Overall Study|Death|0|||
145622167|NCT00432159|525128036|FG004|Overall Study|Death|0|||
145337192|NCT00229723|524084069|FG000|Maintenance Phase|Clinical progression|4|||
145337193|NCT00229723|524084070|FG001|Maintenance Phase|Clinical progression|1|||
145337194|NCT00229723|524084071|FG002|Maintenance Phase|Clinical progression|2|||
145337195|NCT00229723|524084072|FG003|Maintenance Phase|Clinical progression|2|||
145337196|NCT00229723|524084073|FG004|Maintenance Phase|Clinical progression|1|||
145337197|NCT00229723|524084074|FG005|Maintenance Phase|Clinical progression|1|||
145337198|NCT00229723|524084075|FG006|Maintenance Phase|Clinical progression|1|||
145337199|NCT00229723|524084069|FG000|Maintenance Phase|Lost to Follow-up|0|||
145337200|NCT00229723|524084070|FG001|Maintenance Phase|Lost to Follow-up|1|||
145337201|NCT00229723|524084071|FG002|Maintenance Phase|Lost to Follow-up|2|||
145337202|NCT00229723|524084072|FG003|Maintenance Phase|Lost to Follow-up|2|||
145337203|NCT00229723|524084073|FG004|Maintenance Phase|Lost to Follow-up|0|||
145337204|NCT00229723|524084074|FG005|Maintenance Phase|Lost to Follow-up|0|||
145337205|NCT00229723|524084075|FG006|Maintenance Phase|Lost to Follow-up|1|||
145337206|NCT00229723|524084069|FG000|Maintenance Phase|Informed consent withdrawn|1|||
145337207|NCT00229723|524084070|FG001|Maintenance Phase|Informed consent withdrawn|0|||
145337208|NCT00229723|524084071|FG002|Maintenance Phase|Informed consent withdrawn|0|||
145337209|NCT00229723|524084072|FG003|Maintenance Phase|Informed consent withdrawn|1|||
145337210|NCT00229723|524084073|FG004|Maintenance Phase|Informed consent withdrawn|1|||
145337211|NCT00229723|524084074|FG005|Maintenance Phase|Informed consent withdrawn|1|||
145337212|NCT00229723|524084075|FG006|Maintenance Phase|Informed consent withdrawn|0|||
145337213|NCT00229723|524084069|FG000|Maintenance Phase|Severe non-compliance|3|||
145337214|NCT00229723|524084070|FG001|Maintenance Phase|Severe non-compliance|1|||
145337215|NCT00229723|524084071|FG002|Maintenance Phase|Severe non-compliance|0|||
145337216|NCT00229723|524084072|FG003|Maintenance Phase|Severe non-compliance|0|||
145337217|NCT00229723|524084073|FG004|Maintenance Phase|Severe non-compliance|1|||
145337218|NCT00229723|524084074|FG005|Maintenance Phase|Severe non-compliance|0|||
145337219|NCT00229723|524084075|FG006|Maintenance Phase|Severe non-compliance|0|||
145337220|NCT00229723|524084069|FG000|Maintenance Phase|Other|5|||
145337221|NCT00229723|524084070|FG001|Maintenance Phase|Other|4|||
145337222|NCT00229723|524084071|FG002|Maintenance Phase|Other|1|||
145337223|NCT00229723|524084072|FG003|Maintenance Phase|Other|2|||
145337224|NCT00229723|524084073|FG004|Maintenance Phase|Other|3|||
145337225|NCT00229723|524084074|FG005|Maintenance Phase|Other|3|||
145337226|NCT00229723|524084075|FG006|Maintenance Phase|Other|1|||
145337227|NCT02309138|524084076|FG000|Overall Study|Withdrawal by Subject|44|||
145337228|NCT02309138|524084077|FG001|Overall Study|Withdrawal by Subject|15|||
145337229|NCT02309138|524084076|FG000|Overall Study|Protocol Violation|4|||
145337230|NCT02309138|524084077|FG001|Overall Study|Protocol Violation|2|||
145337231|NCT02309138|524084076|FG000|Overall Study|delivered before visit 2|0|||
145337232|NCT02309138|524084077|FG001|Overall Study|delivered before visit 2|1|||
145337233|NCT03421730|524084083|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145622168|NCT00432159|525128032|FG000|Overall Study|Failure|9|||
145622169|NCT00432159|525128033|FG001|Overall Study|Failure|5|||
145622170|NCT00432159|525128034|FG002|Overall Study|Failure|3|||
145337234|NCT03421730|524084084|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
145337235|NCT03421730|524084085|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337236|NCT03421730|524084086|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337237|NCT03421730|524084087|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337238|NCT03421730|524084088|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337239|NCT03421730|524084089|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145622171|NCT00432159|525128035|FG003|Overall Study|Failure|2|||
145622172|NCT00432159|525128036|FG004|Overall Study|Failure|3|||
145337240|NCT03421730|524084090|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337241|NCT03421730|524084091|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145622173|NCT00432159|525128032|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
145622174|NCT00432159|525128033|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
145573464|NCT03548584|524956504|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
145573465|NCT00533949|524956505|FG000|Overall Study|Protocol Violation|12|||
145573466|NCT00533949|524956506|FG001|Overall Study|Protocol Violation|12|||
145573467|NCT00533949|524956507|FG002|Overall Study|Protocol Violation|9|||
145573468|NCT00533949|524956508|FG003|Overall Study|Protocol Violation|9|||
145573469|NCT00533949|524956505|FG000|Overall Study|Withdrawal by Subject|3|||
145573470|NCT00533949|524956506|FG001|Overall Study|Withdrawal by Subject|2|||
145573471|NCT00533949|524956507|FG002|Overall Study|Withdrawal by Subject|1|||
145573472|NCT00533949|524956508|FG003|Overall Study|Withdrawal by Subject|1|||
145573473|NCT00727194|524956509|FG000|Screening Period|Low QMG scores|0|||
145573474|NCT00727194|524956510|FG001|Screening Period|Low QMG scores|0|||
145573475|NCT00727194|524956511|FG002|Screening Period|Low QMG scores|6|||
145573476|NCT00727194|524956509|FG000|Screening Period|Lacked AChR antibodies|0|||
145573477|NCT00727194|524956510|FG001|Screening Period|Lacked AChR antibodies|0|||
145337242|NCT03421730|524084092|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337243|NCT03421730|524084093|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337244|NCT03421730|524084094|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
145337245|NCT03421730|524084083|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337246|NCT03421730|524084084|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337247|NCT03421730|524084085|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337248|NCT03421730|524084086|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337249|NCT03421730|524084087|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
145337250|NCT03421730|524084088|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337251|NCT03421730|524084089|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337252|NCT03421730|524084090|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337253|NCT03421730|524084091|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337254|NCT03421730|524084092|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337255|NCT03421730|524084093|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337256|NCT03421730|524084094|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
145337257|NCT02865460|524084097|FG000|Overall Study|Adverse Event|1|||
145337258|NCT02865460|524084098|FG001|Overall Study|Adverse Event|0|||
145337259|NCT02865460|524084097|FG000|Overall Study|Withdrawal by Subject|1|||
145337260|NCT02865460|524084098|FG001|Overall Study|Withdrawal by Subject|1|||
145337261|NCT02865460|524084097|FG000|Overall Study|Lost to Follow-up|7|||
145337262|NCT02865460|524084098|FG001|Overall Study|Lost to Follow-up|4|||
145337263|NCT02865460|524084097|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
145337264|NCT02865460|524084098|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
145337265|NCT00380744|524084099|FG000|Overall Study|Death|0|||
145337266|NCT00380744|524084100|FG001|Overall Study|Death|0|||
145262823|NCT01815099|523808521|FG000|Overall Study|unable to attend study visits|1|||
145262824|NCT01475214|523808522|FG000|Overall Study|Lost to Follow-up|1|||
145262825|NCT01475214|523808523|FG001|Overall Study|Lost to Follow-up|0|||
145262826|NCT01475214|523808524|FG002|Overall Study|Lost to Follow-up|1|||
145262827|NCT01475214|523808522|FG000|Overall Study|Physician Decision|2|||
145262828|NCT01475214|523808523|FG001|Overall Study|Physician Decision|0|||
145262829|NCT01475214|523808524|FG002|Overall Study|Physician Decision|0|||
145262830|NCT01475214|523808522|FG000|Overall Study|Withdrawal by Subject|2|||
145262831|NCT01475214|523808523|FG001|Overall Study|Withdrawal by Subject|4|||
145262832|NCT01475214|523808524|FG002|Overall Study|Withdrawal by Subject|1|||
145337267|NCT00380744|524084101|FG002|Overall Study|Death|0|||
145337268|NCT00380744|524084102|FG003|Overall Study|Death|0|||
145337269|NCT00380744|524084103|FG004|Overall Study|Death|0|||
145337270|NCT00380744|524084104|FG005|Overall Study|Death|0|||
145337271|NCT00380744|524084105|FG006|Overall Study|Death|1|||
145337272|NCT00380744|524084099|FG000|Overall Study|Withdrawal by Subject|1|||
145337273|NCT00380744|524084100|FG001|Overall Study|Withdrawal by Subject|0|||
145337274|NCT00380744|524084101|FG002|Overall Study|Withdrawal by Subject|0|||
145337275|NCT00380744|524084102|FG003|Overall Study|Withdrawal by Subject|0|||
145337276|NCT00380744|524084103|FG004|Overall Study|Withdrawal by Subject|0|||
145337277|NCT00380744|524084104|FG005|Overall Study|Withdrawal by Subject|0|||
145337278|NCT00380744|524084105|FG006|Overall Study|Withdrawal by Subject|0|||
145573478|NCT00727194|524956511|FG002|Screening Period|Lacked AChR antibodies|5|||
145573479|NCT00727194|524956509|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
145573480|NCT00727194|524956510|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
145573481|NCT00727194|524956511|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
145622175|NCT00432159|525128034|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
145622176|NCT00432159|525128035|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
145337279|NCT01338870|524084106|FG000|Overall Study|Lost to Follow-up|0|||
145337280|NCT01338870|524084107|FG001|Overall Study|Lost to Follow-up|0|||
145337281|NCT01338870|524084108|FG002|Overall Study|Lost to Follow-up|1|||
145337282|NCT01338870|524084109|FG003|Overall Study|Lost to Follow-up|0|||
145337283|NCT01338870|524084110|FG004|Overall Study|Lost to Follow-up|1|||
145622177|NCT00432159|525128036|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
145622178|NCT04096365|525128038|FG000|Overall Study|Adverse Event|1|||
145622179|NCT01939158|525128041|FG000|Overall Study|Adverse Event|1|||
145622180|NCT01939158|525128042|FG001|Overall Study|Adverse Event|0|||
145622181|NCT01939158|525128043|FG002|Overall Study|Adverse Event|0|||
145622182|NCT01939158|525128044|FG003|Overall Study|Adverse Event|0|||
145622183|NCT01939158|525128041|FG000|Overall Study|Withdrawal by Subject|22|||
145622184|NCT01939158|525128042|FG001|Overall Study|Withdrawal by Subject|25|||
145622185|NCT01939158|525128043|FG002|Overall Study|Withdrawal by Subject|15|||
145622186|NCT01939158|525128044|FG003|Overall Study|Withdrawal by Subject|17|||
145622187|NCT01939158|525128041|FG000|Overall Study|Migrated/moved from study area|5|||
145622188|NCT01939158|525128042|FG001|Overall Study|Migrated/moved from study area|7|||
145622189|NCT01939158|525128043|FG002|Overall Study|Migrated/moved from study area|3|||
145622190|NCT01939158|525128044|FG003|Overall Study|Migrated/moved from study area|6|||
145622191|NCT01939158|525128041|FG000|Overall Study|Lost to Follow-up|18|||
145622192|NCT01939158|525128042|FG001|Overall Study|Lost to Follow-up|17|||
145622193|NCT01939158|525128043|FG002|Overall Study|Lost to Follow-up|17|||
145622194|NCT01939158|525128044|FG003|Overall Study|Lost to Follow-up|17|||
145622195|NCT01939158|525128041|FG000|Overall Study|Death|0|||
145622196|NCT01939158|525128042|FG001|Overall Study|Death|0|||
145622197|NCT01939158|525128043|FG002|Overall Study|Death|1|||
145622198|NCT01939158|525128044|FG003|Overall Study|Death|1|||
145622199|NCT01939158|525128041|FG000|Overall Study|No longer meets eligibility criteria|0|||
145622200|NCT01939158|525128042|FG001|Overall Study|No longer meets eligibility criteria|0|||
145622201|NCT01939158|525128043|FG002|Overall Study|No longer meets eligibility criteria|1|||
145622202|NCT01939158|525128044|FG003|Overall Study|No longer meets eligibility criteria|0|||
145622203|NCT01939158|525128041|FG000|Overall Study|Other|1|||
145622204|NCT01939158|525128042|FG001|Overall Study|Other|3|||
145622205|NCT01939158|525128043|FG002|Overall Study|Other|4|||
145622206|NCT01939158|525128044|FG003|Overall Study|Other|3|||
145622207|NCT05310084|525128045|FG000|Overall Study|Withdrawal by Subject|2|||
145622208|NCT05310084|525128046|FG001|Overall Study|Withdrawal by Subject|3|||
145622209|NCT05310084|525128045|FG000|Overall Study|Participant availability|0|||
145622210|NCT05310084|525128046|FG001|Overall Study|Participant availability|4|||
145622211|NCT05310084|525128045|FG000|Overall Study|Lost to Follow-up|1|||
145622212|NCT05310084|525128046|FG001|Overall Study|Lost to Follow-up|1|||
145622213|NCT05310084|525128045|FG000|Overall Study|Adverse Event|1|||
145622214|NCT05310084|525128046|FG001|Overall Study|Adverse Event|1|||
145622215|NCT05310084|525128045|FG000|Overall Study|Randomized but not vaccinated|4|||
145622216|NCT05310084|525128046|FG001|Overall Study|Randomized but not vaccinated|2|||
145622217|NCT02065245|525128048|FG000|Infusion 1|Lost to Follow-up|0|||
145622218|NCT02065245|525128049|FG001|Infusion 1|Lost to Follow-up|0|||
145622219|NCT02065245|525128050|FG002|Infusion 1|Lost to Follow-up|0|||
145622220|NCT02065245|525128051|FG003|Infusion 1|Lost to Follow-up|0|||
145622221|NCT02065245|525128052|FG004|Infusion 1|Lost to Follow-up|0|||
145622222|NCT02065245|525128053|FG005|Infusion 1|Lost to Follow-up|0|||
145622223|NCT02065245|525128054|FG006|Infusion 1|Lost to Follow-up|1|||
145622224|NCT02065245|525128048|FG000|Infusion 1|Death|0|||
145622225|NCT02065245|525128049|FG001|Infusion 1|Death|0|||
145622226|NCT02065245|525128050|FG002|Infusion 1|Death|1|||
145622227|NCT02065245|525128051|FG003|Infusion 1|Death|0|||
145622228|NCT02065245|525128052|FG004|Infusion 1|Death|1|||
145622229|NCT02065245|525128053|FG005|Infusion 1|Death|0|||
145622230|NCT02065245|525128054|FG006|Infusion 1|Death|0|||
145622231|NCT02065245|525128048|FG000|Infusion 2|Death|0|||
145622232|NCT02065245|525128049|FG001|Infusion 2|Death|0|||
145622233|NCT02065245|525128050|FG002|Infusion 2|Death|0|||
145622234|NCT02065245|525128051|FG003|Infusion 2|Death|0|||
145622235|NCT02065245|525128052|FG004|Infusion 2|Death|0|||
145622236|NCT02065245|525128053|FG005|Infusion 2|Death|0|||
145622237|NCT02065245|525128054|FG006|Infusion 2|Death|1|||
145622238|NCT02065245|525128048|FG000|Infusion 3|Lost to Follow-up|1|||
145622239|NCT02065245|525128049|FG001|Infusion 3|Lost to Follow-up|1|||
145622240|NCT02065245|525128050|FG002|Infusion 3|Lost to Follow-up|0|||
145622241|NCT02065245|525128051|FG003|Infusion 3|Lost to Follow-up|0|||
145622242|NCT02065245|525128052|FG004|Infusion 3|Lost to Follow-up|0|||
145622243|NCT02065245|525128053|FG005|Infusion 3|Lost to Follow-up|0|||
145262833|NCT00643851|523808525|FG000|Overall Study|Death|0|||
145622244|NCT02065245|525128054|FG006|Infusion 3|Lost to Follow-up|0|||
145622245|NCT01518257|525128055|FG000|Overall Study|Lost to Follow-up|1|||
145622246|NCT01518257|525128056|FG001|Overall Study|Lost to Follow-up|0|||
145262834|NCT00643851|523808526|FG001|Overall Study|Death|1|||
145262835|NCT00643851|523808527|FG002|Overall Study|Death|0|||
145262836|NCT00643851|523808525|FG000|Overall Study|Lack of Efficacy|0|||
145622247|NCT01518257|525128055|FG000|Overall Study|Other Miscellaneous Reason|1|||
145622248|NCT01518257|525128056|FG001|Overall Study|Other Miscellaneous Reason|0|||
145622249|NCT02107274|525128057|FG000|Treatment vs. Placebo|Adverse Event|3|||
145622250|NCT02107274|525128058|FG001|Treatment vs. Placebo|Adverse Event|0|||
145622251|NCT02107274|525128057|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
145622252|NCT02107274|525128058|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
145622253|NCT02107274|525128057|FG000|Control Phase|Lost to Follow-up|1|||
145337284|NCT01338870|524084111|FG005|Overall Study|Lost to Follow-up|0|||
145337285|NCT01338870|524084106|FG000|Overall Study|Withdrawal by Subject|2|||
145337286|NCT01338870|524084107|FG001|Overall Study|Withdrawal by Subject|3|||
145337287|NCT01338870|524084108|FG002|Overall Study|Withdrawal by Subject|4|||
145337288|NCT01338870|524084109|FG003|Overall Study|Withdrawal by Subject|0|||
145337289|NCT01338870|524084110|FG004|Overall Study|Withdrawal by Subject|0|||
145337290|NCT01338870|524084111|FG005|Overall Study|Withdrawal by Subject|2|||
145337291|NCT01338870|524084106|FG000|Overall Study|Other|3|||
145337292|NCT01338870|524084107|FG001|Overall Study|Other|3|||
145337293|NCT01338870|524084108|FG002|Overall Study|Other|3|||
145337294|NCT01338870|524084109|FG003|Overall Study|Other|2|||
145337295|NCT01338870|524084110|FG004|Overall Study|Other|0|||
145337296|NCT01338870|524084111|FG005|Overall Study|Other|2|||
145337297|NCT01338870|524084106|FG000|Overall Study|Protocol Violation|0|||
145337298|NCT01338870|524084107|FG001|Overall Study|Protocol Violation|2|||
145337299|NCT01338870|524084108|FG002|Overall Study|Protocol Violation|2|||
145337300|NCT01338870|524084109|FG003|Overall Study|Protocol Violation|2|||
145337301|NCT01338870|524084110|FG004|Overall Study|Protocol Violation|1|||
145337302|NCT01338870|524084111|FG005|Overall Study|Protocol Violation|1|||
145337303|NCT01338870|524084106|FG000|Overall Study|Adverse Event|4|||
145337304|NCT01338870|524084107|FG001|Overall Study|Adverse Event|4|||
145337305|NCT01338870|524084108|FG002|Overall Study|Adverse Event|1|||
145337306|NCT01338870|524084109|FG003|Overall Study|Adverse Event|5|||
145337307|NCT01338870|524084110|FG004|Overall Study|Adverse Event|4|||
145337308|NCT01338870|524084111|FG005|Overall Study|Adverse Event|1|||
145337309|NCT01955083|524084112|FG000|Overall Study|Lost to Follow-up|1|||
145337310|NCT01955083|524084113|FG001|Overall Study|Lost to Follow-up|1|||
145337311|NCT00901576|524084122|FG000|Second Intervention|Withdrawal by Subject|0|||
145337312|NCT00901576|524084123|FG001|Second Intervention|Withdrawal by Subject|0|||
145337313|NCT00901576|524084124|FG002|Second Intervention|Withdrawal by Subject|0|||
145337314|NCT00901576|524084125|FG003|Second Intervention|Withdrawal by Subject|1|||
145337315|NCT00901576|524084126|FG004|Second Intervention|Withdrawal by Subject|0|||
145337316|NCT00901576|524084127|FG005|Second Intervention|Withdrawal by Subject|1|||
145337317|NCT00901576|524084122|FG000|Second Intervention|Physician Decision|1|||
145337318|NCT00901576|524084123|FG001|Second Intervention|Physician Decision|0|||
145337319|NCT00901576|524084124|FG002|Second Intervention|Physician Decision|0|||
145337320|NCT00901576|524084125|FG003|Second Intervention|Physician Decision|0|||
145337321|NCT00901576|524084126|FG004|Second Intervention|Physician Decision|0|||
145337322|NCT00901576|524084127|FG005|Second Intervention|Physician Decision|0|||
145337323|NCT01559389|524084128|FG000|Overall Study|Withdrawal by Subject|20|||
145337324|NCT01559389|524084129|FG001|Overall Study|Withdrawal by Subject|20|||
145337325|NCT02871492|524084130|FG000|Overall Study|Lost to Follow-up|6|||
145337326|NCT02871492|524084131|FG001|Overall Study|Lost to Follow-up|3|||
145337327|NCT02871492|524084132|FG002|Overall Study|Lost to Follow-up|5|||
145622254|NCT02107274|525128058|FG001|Control Phase|Lost to Follow-up|1|||
145262837|NCT00643851|523808526|FG001|Overall Study|Lack of Efficacy|1|||
145262838|NCT00643851|523808527|FG002|Overall Study|Lack of Efficacy|0|||
145262839|NCT00643851|523808525|FG000|Overall Study|Adverse Event|2|||
145262840|NCT00643851|523808526|FG001|Overall Study|Adverse Event|6|||
145262841|NCT00643851|523808527|FG002|Overall Study|Adverse Event|6|||
145262842|NCT00643851|523808525|FG000|Overall Study|Lost to Follow-up|4|||
145262843|NCT00643851|523808526|FG001|Overall Study|Lost to Follow-up|6|||
145262844|NCT00643851|523808527|FG002|Overall Study|Lost to Follow-up|9|||
145262845|NCT00643851|523808525|FG000|Overall Study|Withdrawal by Subject|8|||
145262846|NCT00643851|523808526|FG001|Overall Study|Withdrawal by Subject|15|||
145262847|NCT00643851|523808527|FG002|Overall Study|Withdrawal by Subject|9|||
145262848|NCT00643851|523808525|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
145262849|NCT00643851|523808526|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
145262850|NCT00643851|523808527|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
145262851|NCT02354599|523808530|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145262852|NCT02354599|523808531|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
145262853|NCT02354599|523808532|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145262854|NCT02354599|523808533|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
145262855|NCT02354599|523808534|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
145262856|NCT02354599|523808535|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
145262857|NCT02354599|523808530|FG000|Overall Study|Withdrawal by Subject|1|||
145262858|NCT02354599|523808531|FG001|Overall Study|Withdrawal by Subject|1|||
145262859|NCT02354599|523808532|FG002|Overall Study|Withdrawal by Subject|0|||
145262860|NCT02354599|523808533|FG003|Overall Study|Withdrawal by Subject|0|||
145262861|NCT02354599|523808534|FG004|Overall Study|Withdrawal by Subject|0|||
145262862|NCT02354599|523808535|FG005|Overall Study|Withdrawal by Subject|0|||
145262863|NCT04806334|523808536|FG000|Overall Study|Withdrawal by Subject|1|||
145262864|NCT00465894|523808537|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
145262865|NCT00465894|523808538|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
145262866|NCT00465894|523808537|FG000|Treatment For 12 Weeks|Family Issues|1|||
145262867|NCT00465894|523808538|FG001|Treatment For 12 Weeks|Family Issues|1|||
145337328|NCT02871492|524084130|FG000|Overall Study|Withdrawal by Subject|0|||
145337329|NCT02871492|524084131|FG001|Overall Study|Withdrawal by Subject|0|||
145337330|NCT02871492|524084132|FG002|Overall Study|Withdrawal by Subject|1|||
145337331|NCT04546724|524084135|FG000|Overall Study|Withdrawal by Subject|145|||
145337332|NCT04546724|524084136|FG001|Overall Study|Withdrawal by Subject|41|||
145337333|NCT04546724|524084135|FG000|Overall Study|Adverse Event|1|||
145337334|NCT04546724|524084136|FG001|Overall Study|Adverse Event|1|||
145337335|NCT04546724|524084135|FG000|Overall Study|Lost to Follow-up|186|||
145337336|NCT04546724|524084136|FG001|Overall Study|Lost to Follow-up|63|||
145337337|NCT04546724|524084135|FG000|Overall Study|Physician Decision|8|||
145337338|NCT04546724|524084136|FG001|Overall Study|Physician Decision|2|||
145337339|NCT04546724|524084135|FG000|Overall Study|Death|2|||
145337340|NCT04546724|524084136|FG001|Overall Study|Death|1|||
145337341|NCT04546724|524084135|FG000|Overall Study|subject has been out of town|1|||
145337342|NCT04546724|524084136|FG001|Overall Study|subject has been out of town|0|||
145337343|NCT04546724|524084135|FG000|Overall Study|subject is incarcerated|2|||
145337344|NCT04546724|524084136|FG001|Overall Study|subject is incarcerated|0|||
145337345|NCT04546724|524084135|FG000|Overall Study|subject is relocating|12|||
145337346|NCT04546724|524084136|FG001|Overall Study|subject is relocating|4|||
145337347|NCT04546724|524084135|FG000|Overall Study|Subject in another study|1|||
145337348|NCT04546724|524084136|FG001|Overall Study|Subject in another study|1|||
145337349|NCT03583086|524084137|FG000|Overall Study|Death|2|||
145337350|NCT03583086|524084138|FG001|Overall Study|Death|6|||
145337351|NCT03583086|524084139|FG002|Overall Study|Death|12|||
145337352|NCT03583086|524084140|FG003|Overall Study|Death|10|||
145337353|NCT03583086|524084141|FG004|Overall Study|Death|14|||
145337354|NCT03583086|524084142|FG005|Overall Study|Death|14|||
145337355|NCT03583086|524084143|FG006|Overall Study|Death|4|||
145337356|NCT03583086|524084137|FG000|Overall Study|Withdrawal by Subject|0|||
145337357|NCT03583086|524084138|FG001|Overall Study|Withdrawal by Subject|0|||
145337358|NCT03583086|524084139|FG002|Overall Study|Withdrawal by Subject|1|||
145337359|NCT03583086|524084140|FG003|Overall Study|Withdrawal by Subject|0|||
145337360|NCT03583086|524084141|FG004|Overall Study|Withdrawal by Subject|0|||
145337361|NCT03583086|524084142|FG005|Overall Study|Withdrawal by Subject|0|||
145337362|NCT03583086|524084143|FG006|Overall Study|Withdrawal by Subject|1|||
145337363|NCT03583086|524084137|FG000|Overall Study|Refused follow-up|0|||
145337364|NCT03583086|524084138|FG001|Overall Study|Refused follow-up|0|||
145337365|NCT03583086|524084139|FG002|Overall Study|Refused follow-up|1|||
145337366|NCT03583086|524084140|FG003|Overall Study|Refused follow-up|0|||
145337367|NCT03583086|524084141|FG004|Overall Study|Refused follow-up|1|||
145337368|NCT03583086|524084142|FG005|Overall Study|Refused follow-up|0|||
145337369|NCT03583086|524084143|FG006|Overall Study|Refused follow-up|0|||
145337370|NCT03583086|524084137|FG000|Overall Study|Declining Performance Status|0|||
145337371|NCT03583086|524084138|FG001|Overall Study|Declining Performance Status|0|||
145337372|NCT03583086|524084139|FG002|Overall Study|Declining Performance Status|1|||
145337373|NCT03583086|524084140|FG003|Overall Study|Declining Performance Status|0|||
145337374|NCT03583086|524084141|FG004|Overall Study|Declining Performance Status|0|||
145337375|NCT03583086|524084142|FG005|Overall Study|Declining Performance Status|0|||
145337376|NCT03583086|524084143|FG006|Overall Study|Declining Performance Status|0|||
145337377|NCT03583086|524084137|FG000|Overall Study|Still on study|0|||
145337378|NCT03583086|524084138|FG001|Overall Study|Still on study|0|||
145337379|NCT03583086|524084139|FG002|Overall Study|Still on study|0|||
145337380|NCT03583086|524084140|FG003|Overall Study|Still on study|1|||
145337381|NCT03583086|524084141|FG004|Overall Study|Still on study|0|||
145337382|NCT03583086|524084142|FG005|Overall Study|Still on study|0|||
145337383|NCT03583086|524084143|FG006|Overall Study|Still on study|1|||
145337384|NCT03583086|524084137|FG000|Overall Study|Disease progression|0|||
145337385|NCT03583086|524084138|FG001|Overall Study|Disease progression|0|||
145337386|NCT03583086|524084139|FG002|Overall Study|Disease progression|0|||
145413276|NCT00021255|524367000|FG001|Overall Study|Second primary malignancy|4|||
145413277|NCT00021255|524367001|FG002|Overall Study|Second primary malignancy|1|||
145413278|NCT00021255|524366999|FG000|Overall Study|Withdrawal by Subject|41|||
145337387|NCT03583086|524084140|FG003|Overall Study|Disease progression|0|||
145337388|NCT03583086|524084141|FG004|Overall Study|Disease progression|0|||
145413279|NCT00021255|524367000|FG001|Overall Study|Withdrawal by Subject|64|||
145337389|NCT03583086|524084142|FG005|Overall Study|Disease progression|0|||
145337390|NCT03583086|524084143|FG006|Overall Study|Disease progression|1|||
145337391|NCT03583086|524084137|FG000|Overall Study|Undergoing radiation therapy|0|||
145337392|NCT03583086|524084138|FG001|Overall Study|Undergoing radiation therapy|0|||
145337393|NCT03583086|524084139|FG002|Overall Study|Undergoing radiation therapy|0|||
145337394|NCT03583086|524084140|FG003|Overall Study|Undergoing radiation therapy|0|||
145337395|NCT03583086|524084141|FG004|Overall Study|Undergoing radiation therapy|0|||
145337396|NCT03583086|524084142|FG005|Overall Study|Undergoing radiation therapy|0|||
145337397|NCT03583086|524084143|FG006|Overall Study|Undergoing radiation therapy|1|||
145337398|NCT03583086|524084137|FG000|Overall Study|Lost to Follow-up|0|||
145337399|NCT03583086|524084138|FG001|Overall Study|Lost to Follow-up|0|||
145337400|NCT03583086|524084139|FG002|Overall Study|Lost to Follow-up|0|||
145413280|NCT00021255|524367001|FG002|Overall Study|Withdrawal by Subject|26|||
145337401|NCT03583086|524084140|FG003|Overall Study|Lost to Follow-up|0|||
145337402|NCT03583086|524084141|FG004|Overall Study|Lost to Follow-up|0|||
145337403|NCT03583086|524084142|FG005|Overall Study|Lost to Follow-up|1|||
145337404|NCT03583086|524084143|FG006|Overall Study|Lost to Follow-up|0|||
145337405|NCT03583086|524084137|FG000|Overall Study|Adverse Event|0|||
145337406|NCT03583086|524084138|FG001|Overall Study|Adverse Event|0|||
145337407|NCT03583086|524084139|FG002|Overall Study|Adverse Event|0|||
145337408|NCT03583086|524084140|FG003|Overall Study|Adverse Event|0|||
145337409|NCT03583086|524084141|FG004|Overall Study|Adverse Event|0|||
145337410|NCT03583086|524084142|FG005|Overall Study|Adverse Event|1|||
145337411|NCT03583086|524084143|FG006|Overall Study|Adverse Event|0|||
145337412|NCT00171951|524084145|FG000|Overall Study|Adverse Event|1|||
145337413|NCT00171951|524084145|FG000|Overall Study|Abnormal Laboratory Values|2|||
145337414|NCT00171951|524084145|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145337415|NCT00171951|524084145|FG000|Overall Study|Participants Withdrew Consent|3|||
145337416|NCT00171951|524084145|FG000|Overall Study|New Cancer Therapy|5|||
145337417|NCT00171951|524084145|FG000|Overall Study|Reason not Specified|2|||
145337418|NCT00396812|524084146|FG000|Overall Study|Physician Decision|1|||
145337419|NCT03201445|524084150|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
145337420|NCT03201445|524084151|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
145337421|NCT03201445|524084150|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
145337422|NCT03201445|524084151|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
145337423|NCT03201445|524084150|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
145337424|NCT03201445|524084151|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
145337425|NCT03201445|524084150|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
145337426|NCT03201445|524084151|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
145337427|NCT03201445|524084150|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
145337428|NCT03201445|524084151|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
145337429|NCT03201445|524084150|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
145337430|NCT03201445|524084151|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
145337431|NCT03201445|524084150|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
145337432|NCT03201445|524084151|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
145337433|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
145337434|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
145337435|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
145337436|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
145337437|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
145337438|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
145337439|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
145337440|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
145337441|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
145337442|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
145337443|NCT03201445|524084150|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
145337444|NCT03201445|524084151|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
145337445|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
145337446|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
145337447|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
145337448|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
145337449|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
145337450|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
145337451|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
145337452|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
145337453|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
145337454|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
145337455|NCT03201445|524084150|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
145337456|NCT03201445|524084151|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
145337457|NCT03201445|524084150|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
145337458|NCT03201445|524084151|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
145337459|NCT03201445|524084150|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
145337460|NCT03201445|524084151|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
145337461|NCT01346293|524084154|FG000|Overall Study|Protocol Violation|30|||
145337462|NCT01346293|524084155|FG001|Overall Study|Protocol Violation|9|||
145573482|NCT00727194|524956509|FG000|Screening Period|Severe infections|0|||
145573483|NCT00727194|524956510|FG001|Screening Period|Severe infections|0|||
145573484|NCT00727194|524956511|FG002|Screening Period|Severe infections|2|||
145573485|NCT00727194|524956509|FG000|Screening Period|History of thymoma|0|||
145573486|NCT00727194|524956510|FG001|Screening Period|History of thymoma|0|||
145573487|NCT00727194|524956511|FG002|Screening Period|History of thymoma|1|||
145573488|NCT00727194|524956509|FG000|Treatment Period 2|Lack of Efficacy|0|||
145337463|NCT01346293|524084154|FG000|Overall Study|Lost to Follow-up|21|||
145337464|NCT01346293|524084155|FG001|Overall Study|Lost to Follow-up|8|||
145337465|NCT01346293|524084154|FG000|Overall Study|Withdrawal by Subject|15|||
145337466|NCT01346293|524084155|FG001|Overall Study|Withdrawal by Subject|4|||
145337467|NCT01346293|524084154|FG000|Overall Study|Other|1|||
145337468|NCT01346293|524084155|FG001|Overall Study|Other|0|||
145337469|NCT01844505|524084158|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
145337470|NCT01844505|524084159|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
145337471|NCT01844505|524084160|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
145337472|NCT01844505|524084158|FG000|Treatment Period|Other Reasons|120|||
145337473|NCT01844505|524084159|FG001|Treatment Period|Other Reasons|136|||
145337474|NCT01844505|524084160|FG002|Treatment Period|Other Reasons|58|||
145337475|NCT01844505|524084158|FG000|Treatment Period|Lost to Follow-up|9|||
145337476|NCT01844505|524084159|FG001|Treatment Period|Lost to Follow-up|11|||
145337477|NCT01844505|524084160|FG002|Treatment Period|Lost to Follow-up|6|||
145337478|NCT01844505|524084158|FG000|Treatment Period|Death|175|||
145337479|NCT01844505|524084159|FG001|Treatment Period|Death|154|||
145337480|NCT01844505|524084160|FG002|Treatment Period|Death|228|||
145337481|NCT00128830|524084161|FG000|Overall Study|Adverse Event|10|||
145337482|NCT00128830|524084161|FG000|Overall Study|Withdrawal by Subject|14|||
145337483|NCT00128830|524084161|FG000|Overall Study|Lost to Follow-up|4|||
145337484|NCT00128830|524084161|FG000|Overall Study|Reached a virologic endpoint|29|||
145337485|NCT00128830|524084161|FG000|Overall Study|Non-compliant|4|||
145337486|NCT00128830|524084161|FG000|Overall Study|Discontinued or ineligible for study|2|||
145337487|NCT00128830|524084161|FG000|Overall Study|Other|9|||
145337488|NCT02730351|524084162|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
145337489|NCT02730351|524084163|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
145337490|NCT02730351|524084162|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
145337491|NCT02730351|524084163|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
145337492|NCT02730351|524084162|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
145337493|NCT02730351|524084163|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
145337494|NCT02730351|524084162|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
145337495|NCT02730351|524084163|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
145337496|NCT02730351|524084162|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
145337497|NCT02730351|524084163|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
145337498|NCT00311402|524084164|FG000|Overall Study|Adverse Event|118|||
145337499|NCT00311402|524084165|FG001|Overall Study|Adverse Event|105|||
145337500|NCT00311402|524084164|FG000|Overall Study|Lost to Follow-up|0|||
145337501|NCT00311402|524084165|FG001|Overall Study|Lost to Follow-up|3|||
145337502|NCT00311402|524084164|FG000|Overall Study|Withdrawal by Subject|17|||
145337503|NCT00311402|524084165|FG001|Overall Study|Withdrawal by Subject|18|||
145337504|NCT00311402|524084164|FG000|Overall Study|Lack of Efficacy|58|||
145337505|NCT00311402|524084165|FG001|Overall Study|Lack of Efficacy|42|||
145337506|NCT00311402|524084164|FG000|Overall Study|Protocol Violation|7|||
145337507|NCT00311402|524084165|FG001|Overall Study|Protocol Violation|6|||
145337508|NCT00311402|524084164|FG000|Overall Study|IRB's rejection etc.|10|||
145337509|NCT00311402|524084165|FG001|Overall Study|IRB's rejection etc.|3|||
145337510|NCT00838435|524084166|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
145337511|NCT00838435|524084166|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
145337512|NCT00838435|524084166|FG000|Part 2 (7 Years)|Adverse Event|2|||
145337513|NCT00838435|524084166|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
145337514|NCT00838435|524084166|FG000|Part 2 (7 Years)|Physician Decision|1|||
145337515|NCT00838435|524084166|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
145337516|NCT00838435|524084166|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
145337517|NCT02754856|524084172|FG000|Overall Study|Withdrawal by Subject|1|||
145337518|NCT04874155|524084173|FG000|Overall Study|Lost to Follow-up|1|||
145337519|NCT04874155|524084174|FG001|Overall Study|Lost to Follow-up|1|||
145337520|NCT04874155|524084173|FG000|Overall Study|Withdrawal by Subject|2|||
145337521|NCT04874155|524084174|FG001|Overall Study|Withdrawal by Subject|2|||
145337522|NCT00530218|524084177|FG000|Overall Study|CMV Not Detected|13|||
145337523|NCT00530218|524084177|FG000|Overall Study|Death|12|||
145337524|NCT00678886|524084180|FG000|Overall Study|Withdrawal by Subject|0|||
145337525|NCT00678886|524084181|FG001|Overall Study|Withdrawal by Subject|0|||
145337526|NCT00678886|524084182|FG002|Overall Study|Withdrawal by Subject|4|||
145337527|NCT00678886|524084183|FG003|Overall Study|Withdrawal by Subject|6|||
145337528|NCT00678886|524084180|FG000|Overall Study|Physician Decision|0|||
145337529|NCT00678886|524084181|FG001|Overall Study|Physician Decision|0|||
145337530|NCT00678886|524084182|FG002|Overall Study|Physician Decision|1|||
145337531|NCT00678886|524084183|FG003|Overall Study|Physician Decision|1|||
145337532|NCT00678886|524084180|FG000|Overall Study|Lost to Follow-up|0|||
145337533|NCT00678886|524084181|FG001|Overall Study|Lost to Follow-up|0|||
145337534|NCT00678886|524084182|FG002|Overall Study|Lost to Follow-up|3|||
145337535|NCT00678886|524084183|FG003|Overall Study|Lost to Follow-up|2|||
145337536|NCT00678886|524084180|FG000|Overall Study|Other|0|||
145337537|NCT00678886|524084181|FG001|Overall Study|Other|0|||
145337538|NCT00678886|524084182|FG002|Overall Study|Other|1|||
145337539|NCT00678886|524084183|FG003|Overall Study|Other|0|||
145337540|NCT03477903|524084184|FG000|Overall Study|Study Terminated by Sponsor|1|||
145573489|NCT00727194|524956510|FG001|Treatment Period 2|Lack of Efficacy|1|||
145573490|NCT00727194|524956511|FG002|Treatment Period 2|Lack of Efficacy|0|||
145573491|NCT04269161|524956512|FG000|Overall Study|Change of modality and no longer eligible|3|||
145573492|NCT04269161|524956513|FG001|Overall Study|Change of modality and no longer eligible|3|||
145573493|NCT04269161|524956512|FG000|Overall Study|Required procedure outside of NICU|1|||
145573494|NCT04269161|524956513|FG001|Overall Study|Required procedure outside of NICU|0|||
145573495|NCT04269161|524956512|FG000|Overall Study|Equipment issue|1|||
145573496|NCT04269161|524956513|FG001|Overall Study|Equipment issue|1|||
145573497|NCT01677195|524956514|FG000|Overall Study|Lost to Follow-up|14|||
145573498|NCT01677195|524956515|FG001|Overall Study|Lost to Follow-up|22|||
145573499|NCT01677195|524956516|FG002|Overall Study|Lost to Follow-up|22|||
145573500|NCT01677195|524956514|FG000|Overall Study|Withdrawal by Subject|1|||
145573501|NCT01677195|524956515|FG001|Overall Study|Withdrawal by Subject|0|||
145573502|NCT01677195|524956516|FG002|Overall Study|Withdrawal by Subject|1|||
145573503|NCT01677195|524956514|FG000|Overall Study|Adverse Event|6|||
145573504|NCT01677195|524956515|FG001|Overall Study|Adverse Event|4|||
145573505|NCT01677195|524956516|FG002|Overall Study|Adverse Event|1|||
145573506|NCT01677195|524956514|FG000|Overall Study|Physician Decision|1|||
145573507|NCT01677195|524956515|FG001|Overall Study|Physician Decision|2|||
145573508|NCT01677195|524956516|FG002|Overall Study|Physician Decision|2|||
145573509|NCT01677195|524956514|FG000|Overall Study|Pregnancy|0|||
145573510|NCT01677195|524956515|FG001|Overall Study|Pregnancy|1|||
145573511|NCT01677195|524956516|FG002|Overall Study|Pregnancy|0|||
145573512|NCT01677195|524956514|FG000|Overall Study|Protocol Violation|7|||
145573513|NCT01677195|524956515|FG001|Overall Study|Protocol Violation|3|||
145573514|NCT01677195|524956516|FG002|Overall Study|Protocol Violation|4|||
145573515|NCT04368429|524956517|FG000|Overall Study|Adverse Event|1|||
145573516|NCT04368429|524956518|FG001|Overall Study|Adverse Event|0|||
145573517|NCT03633396|524956521|FG000|Overall Study|Withdrawal by Subject|4|||
145573518|NCT03633396|524956522|FG001|Overall Study|Withdrawal by Subject|4|||
145573519|NCT03633396|524956521|FG000|Overall Study|Adverse Event|1|||
145573520|NCT03633396|524956522|FG001|Overall Study|Adverse Event|1|||
145573521|NCT03633396|524956521|FG000|Overall Study|Lack of Efficacy|1|||
145573522|NCT03633396|524956522|FG001|Overall Study|Lack of Efficacy|0|||
145573523|NCT03633396|524956521|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
145573524|NCT03633396|524956522|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
145573525|NCT01012817|524956523|FG000|Overall Study|Withdrawal by Subject|0|||
145573526|NCT01012817|524956524|FG001|Overall Study|Withdrawal by Subject|0|||
145573527|NCT01012817|524956525|FG002|Overall Study|Withdrawal by Subject|0|||
145573528|NCT01012817|524956526|FG003|Overall Study|Withdrawal by Subject|1|||
145573529|NCT01012817|524956527|FG004|Overall Study|Withdrawal by Subject|0|||
145573530|NCT01012817|524956528|FG005|Overall Study|Withdrawal by Subject|0|||
145573531|NCT01012817|524956529|FG006|Overall Study|Withdrawal by Subject|0|||
145573532|NCT01012817|524956530|FG007|Overall Study|Withdrawal by Subject|1|||
145573533|NCT01012817|524956531|FG008|Overall Study|Withdrawal by Subject|0|||
145573534|NCT01012817|524956532|FG009|Overall Study|Withdrawal by Subject|0|||
145573535|NCT01012817|524956533|FG010|Overall Study|Withdrawal by Subject|1|||
145573536|NCT01012817|524956534|FG011|Overall Study|Withdrawal by Subject|1|||
145573537|NCT01012817|524956535|FG012|Overall Study|Withdrawal by Subject|0|||
145573538|NCT01012817|524956536|FG013|Overall Study|Withdrawal by Subject|1|||
145573539|NCT01012817|524956523|FG000|Overall Study|Adverse Event|0|||
145573540|NCT01012817|524956524|FG001|Overall Study|Adverse Event|0|||
145622255|NCT02107274|525128057|FG000|Control Phase|Death|2|||
145622256|NCT02107274|525128058|FG001|Control Phase|Death|0|||
145622257|NCT02107274|525128057|FG000|Control Phase|Adverse Event|0|||
145337541|NCT01147107|524084185|FG000|Overall Study|Lack of Efficacy|5|||
145573541|NCT01012817|524956525|FG002|Overall Study|Adverse Event|0|||
145573542|NCT01012817|524956526|FG003|Overall Study|Adverse Event|0|||
145622258|NCT02107274|525128058|FG001|Control Phase|Adverse Event|1|||
145337542|NCT01147107|524084186|FG001|Overall Study|Lack of Efficacy|0|||
145337543|NCT01147107|524084185|FG000|Overall Study|Withdrawal by Subject|1|||
145337544|NCT01147107|524084186|FG001|Overall Study|Withdrawal by Subject|1|||
145337545|NCT03496610|524084187|FG000|Overall Study|Lost to Follow-up|3|||
145337546|NCT03496610|524084188|FG001|Overall Study|Lost to Follow-up|2|||
145337547|NCT03496610|524084187|FG000|Overall Study|Physician Decision|1|||
145337548|NCT03496610|524084188|FG001|Overall Study|Physician Decision|0|||
145337549|NCT03496610|524084187|FG000|Overall Study|Withdrawal by Subject|1|||
145337550|NCT03496610|524084188|FG001|Overall Study|Withdrawal by Subject|0|||
145337551|NCT05330468|524084189|FG000|Overall Study|Death|6|||
145337552|NCT05330468|524084189|FG000|Overall Study|Withdrawal by Subject|4|||
145337553|NCT05330468|524084189|FG000|Overall Study|Lost to Follow-up|4|||
145337554|NCT00477295|524084193|FG000|Overall Study|Adverse Event|31|||
145337555|NCT00477295|524084194|FG001|Overall Study|Adverse Event|35|||
145337556|NCT00477295|524084193|FG000|Overall Study|Withdrawal by Subject|35|||
145337557|NCT00477295|524084194|FG001|Overall Study|Withdrawal by Subject|24|||
145337558|NCT00477295|524084193|FG000|Overall Study|Lack of Efficacy|23|||
145337559|NCT00477295|524084194|FG001|Overall Study|Lack of Efficacy|23|||
145337560|NCT00477295|524084193|FG000|Overall Study|Protocol Violation|3|||
145337561|NCT00477295|524084194|FG001|Overall Study|Protocol Violation|8|||
145337562|NCT00477295|524084193|FG000|Overall Study|Physician Decision|4|||
145337563|NCT00477295|524084194|FG001|Overall Study|Physician Decision|5|||
145337564|NCT00477295|524084193|FG000|Overall Study|Lost to Follow-up|21|||
145337565|NCT00477295|524084194|FG001|Overall Study|Lost to Follow-up|11|||
145337566|NCT00477295|524084193|FG000|Overall Study|Other|4|||
145337567|NCT00477295|524084194|FG001|Overall Study|Other|3|||
145337568|NCT03276780|524084197|FG000|Overall Study|Withdrawal by Subject|5|||
145337569|NCT03276780|524084198|FG001|Overall Study|Withdrawal by Subject|3|||
145337570|NCT03276780|524084197|FG000|Overall Study|Lost to Follow-up|3|||
145337571|NCT03276780|524084198|FG001|Overall Study|Lost to Follow-up|5|||
145337572|NCT03276780|524084197|FG000|Overall Study|Moved out of state|1|||
145337573|NCT03276780|524084198|FG001|Overall Study|Moved out of state|1|||
145337574|NCT03276780|524084197|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
145337575|NCT03276780|524084198|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
145337576|NCT03276780|524084197|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
145337577|NCT03276780|524084198|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
145337578|NCT02304458|524084199|FG000|Overall Study|Adverse Event|0|||
145337579|NCT02304458|524084200|FG001|Overall Study|Adverse Event|0|||
145337580|NCT02304458|524084201|FG002|Overall Study|Adverse Event|7|||
145337581|NCT02304458|524084202|FG003|Overall Study|Adverse Event|0|||
145337582|NCT02304458|524084203|FG004|Overall Study|Adverse Event|0|||
145337583|NCT02304458|524084204|FG005|Overall Study|Adverse Event|0|||
145337584|NCT02304458|524084205|FG006|Overall Study|Adverse Event|3|||
145337585|NCT02304458|524084206|FG007|Overall Study|Adverse Event|4|||
145337586|NCT02304458|524084199|FG000|Overall Study|Death|0|||
145337587|NCT02304458|524084200|FG001|Overall Study|Death|0|||
145337588|NCT02304458|524084201|FG002|Overall Study|Death|2|||
145337589|NCT02304458|524084202|FG003|Overall Study|Death|0|||
145337590|NCT02304458|524084203|FG004|Overall Study|Death|0|||
145337591|NCT02304458|524084204|FG005|Overall Study|Death|0|||
145337592|NCT02304458|524084205|FG006|Overall Study|Death|1|||
145337593|NCT02304458|524084206|FG007|Overall Study|Death|0|||
145337594|NCT02304458|524084199|FG000|Overall Study|Lack of Efficacy|4|||
145337595|NCT02304458|524084200|FG001|Overall Study|Lack of Efficacy|6|||
145337596|NCT02304458|524084201|FG002|Overall Study|Lack of Efficacy|38|||
145337597|NCT02304458|524084202|FG003|Overall Study|Lack of Efficacy|5|||
145337598|NCT02304458|524084203|FG004|Overall Study|Lack of Efficacy|6|||
145337599|NCT02304458|524084204|FG005|Overall Study|Lack of Efficacy|6|||
145337600|NCT02304458|524084205|FG006|Overall Study|Lack of Efficacy|21|||
145337601|NCT02304458|524084206|FG007|Overall Study|Lack of Efficacy|4|||
145337602|NCT02304458|524084199|FG000|Overall Study|Physician Decision|2|||
145337603|NCT02304458|524084200|FG001|Overall Study|Physician Decision|0|||
145337604|NCT02304458|524084201|FG002|Overall Study|Physician Decision|16|||
145337605|NCT02304458|524084202|FG003|Overall Study|Physician Decision|1|||
145337606|NCT02304458|524084203|FG004|Overall Study|Physician Decision|0|||
145337607|NCT02304458|524084204|FG005|Overall Study|Physician Decision|0|||
145337608|NCT02304458|524084205|FG006|Overall Study|Physician Decision|3|||
145337609|NCT02304458|524084206|FG007|Overall Study|Physician Decision|0|||
145337610|NCT02304458|524084199|FG000|Overall Study|Protocol Violation|0|||
145337611|NCT02304458|524084200|FG001|Overall Study|Protocol Violation|0|||
145337612|NCT02304458|524084201|FG002|Overall Study|Protocol Violation|1|||
145337613|NCT02304458|524084202|FG003|Overall Study|Protocol Violation|0|||
145337614|NCT02304458|524084203|FG004|Overall Study|Protocol Violation|0|||
145337615|NCT02304458|524084204|FG005|Overall Study|Protocol Violation|0|||
145337616|NCT02304458|524084205|FG006|Overall Study|Protocol Violation|0|||
145337617|NCT02304458|524084206|FG007|Overall Study|Protocol Violation|0|||
145337618|NCT02304458|524084199|FG000|Overall Study|Withdrawal by Subject|1|||
145337619|NCT02304458|524084200|FG001|Overall Study|Withdrawal by Subject|0|||
145573543|NCT01012817|524956527|FG004|Overall Study|Adverse Event|0|||
145573544|NCT01012817|524956528|FG005|Overall Study|Adverse Event|1|||
145573545|NCT01012817|524956529|FG006|Overall Study|Adverse Event|0|||
145337620|NCT02304458|524084201|FG002|Overall Study|Withdrawal by Subject|7|||
145337621|NCT02304458|524084202|FG003|Overall Study|Withdrawal by Subject|0|||
145337622|NCT02304458|524084203|FG004|Overall Study|Withdrawal by Subject|0|||
145337623|NCT02304458|524084204|FG005|Overall Study|Withdrawal by Subject|0|||
145337624|NCT02304458|524084205|FG006|Overall Study|Withdrawal by Subject|1|||
145337625|NCT02304458|524084206|FG007|Overall Study|Withdrawal by Subject|0|||
145337626|NCT02013674|524084207|FG000|Overall Study|Death|0|||
145337627|NCT02013674|524084208|FG001|Overall Study|Death|1|||
145337628|NCT02013674|524084207|FG000|Overall Study|Lost to Follow-up|1|||
145337629|NCT02013674|524084208|FG001|Overall Study|Lost to Follow-up|0|||
145337630|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
145337631|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
145573546|NCT01012817|524956530|FG007|Overall Study|Adverse Event|0|||
145573547|NCT01012817|524956531|FG008|Overall Study|Adverse Event|0|||
145337632|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145573548|NCT01012817|524956532|FG009|Overall Study|Adverse Event|0|||
145337633|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337634|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337635|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337636|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337637|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337638|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337639|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337640|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337641|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337642|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337643|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
145337644|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
145337645|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
145337646|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337647|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337648|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337649|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337650|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337651|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337652|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337653|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337654|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337655|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337656|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337657|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
145337658|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
145337659|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
145337660|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337661|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337662|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337663|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337664|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337665|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337666|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337667|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337668|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337669|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337670|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337671|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
145337672|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
145337673|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
145337674|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337675|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337676|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337677|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337678|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337679|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337680|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337681|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337682|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337683|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337684|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337685|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
145337686|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
145337687|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
145337688|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337689|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337690|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337691|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337692|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337693|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337694|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337695|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145573549|NCT01012817|524956533|FG010|Overall Study|Adverse Event|1|||
145573550|NCT01012817|524956534|FG011|Overall Study|Adverse Event|0|||
145573551|NCT01012817|524956535|FG012|Overall Study|Adverse Event|0|||
145573552|NCT01012817|524956536|FG013|Overall Study|Adverse Event|1|||
145573553|NCT02472756|524956537|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
145573554|NCT02472756|524956537|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
145573555|NCT02472756|524956537|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
145337696|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337697|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337698|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337699|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
145337700|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
145337701|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
145337702|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337703|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337704|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337705|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337706|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337707|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337708|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337709|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337710|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337711|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337712|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337713|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
145337714|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
145337715|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
145337716|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337717|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337718|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337719|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337720|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337721|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337722|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337723|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337724|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337725|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337726|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337727|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
145337728|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
145337729|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
145337730|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337731|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337732|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337733|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337734|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337735|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337736|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337737|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337738|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337739|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337740|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337741|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
145337742|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
145337743|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
145337744|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337745|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337746|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337747|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337748|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337749|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337750|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337751|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337752|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337753|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337754|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337755|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
145337756|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
145337757|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
145573556|NCT02472756|524956537|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
145573557|NCT02472756|524956537|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
145337758|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337759|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337760|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337761|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337762|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337763|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337764|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337765|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337766|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337767|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337768|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337769|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
145337770|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
145337771|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
145337772|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337773|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337774|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337775|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337776|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337777|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337778|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337779|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337780|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337781|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337782|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337783|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
145337784|NCT03982199|524084212|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
145337785|NCT03982199|524084213|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
145337786|NCT03982199|524084214|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337787|NCT03982199|524084215|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337788|NCT03982199|524084216|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337789|NCT03982199|524084217|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337790|NCT03982199|524084218|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337791|NCT03982199|524084219|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337792|NCT03982199|524084220|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337793|NCT03982199|524084221|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337794|NCT03982199|524084222|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337795|NCT03982199|524084223|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337796|NCT03982199|524084224|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337797|NCT03982199|524084225|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
145337798|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337799|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337800|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337801|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
145337802|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337803|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337804|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337805|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337806|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337807|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337808|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337809|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337810|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337811|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
145337812|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337813|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337814|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
145337815|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337816|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337817|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337818|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337819|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337820|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337821|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337822|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337823|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337824|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337825|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
145337826|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337827|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337828|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
145337829|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337830|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337831|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337832|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337833|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337834|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337835|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337836|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337837|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337838|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337839|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
145337840|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337841|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337842|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
145337843|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
145337844|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337845|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337846|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337847|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337848|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337849|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337850|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337851|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337852|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337853|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
145337854|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337855|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337856|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337857|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
145337858|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337859|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337860|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337861|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337862|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337863|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337864|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337865|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337866|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337867|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
145337868|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337869|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337870|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
145337871|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
145337872|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337873|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337874|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337875|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337876|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337877|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337878|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337879|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337880|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337881|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
145337882|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337883|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337884|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145622259|NCT03158948|525128062|FG000|Overall Study|Death|1|||
145337885|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337886|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337887|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337888|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337889|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337890|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
145337891|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337892|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337893|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337894|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337895|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
145337896|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337897|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337898|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337899|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337900|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337901|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337902|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337903|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337904|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
145337905|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337906|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337907|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337908|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337909|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
145337910|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337911|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337912|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337913|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337914|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337915|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337916|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337917|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337918|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
145337919|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145413281|NCT00021255|524366999|FG000|Overall Study|Lost to Follow-up|0|||
145573558|NCT02143414|524956538|FG000|Induction|Adverse Event|1|||
145573559|NCT02143414|524956539|FG001|Induction|Adverse Event|2|||
145573560|NCT02143414|524956538|FG000|Induction|Death|1|||
145573561|NCT02143414|524956539|FG001|Induction|Death|2|||
145573562|NCT02143414|524956538|FG000|Induction|Patient refusal|1|||
145573563|NCT02143414|524956539|FG001|Induction|Patient refusal|1|||
145573564|NCT02143414|524956538|FG000|Induction|Refractory|1|||
145573565|NCT02143414|524956539|FG001|Induction|Refractory|0|||
145573566|NCT02143414|524956538|FG000|Induction|Began alternative treatment|1|||
145573567|NCT02143414|524956539|FG001|Induction|Began alternative treatment|0|||
145573568|NCT02143414|524956538|FG000|Induction|Ineligible for postremission|5|||
145573569|NCT02143414|524956539|FG001|Induction|Ineligible for postremission|1|||
145573570|NCT02143414|524956538|FG000|Post-remission|Adverse Event|0|||
145573571|NCT02143414|524956539|FG001|Post-remission|Adverse Event|2|||
145573572|NCT02143414|524956538|FG000|Post-remission|Disease progression/relapse|5|||
145573573|NCT02143414|524956539|FG001|Post-remission|Disease progression/relapse|0|||
145573574|NCT02143414|524956538|FG000|Maintenance|Adverse Event|4|||
145573575|NCT02143414|524956539|FG001|Maintenance|Adverse Event|6|||
145573576|NCT02143414|524956538|FG000|Maintenance|Disease progression/relapse|3|||
145573577|NCT02143414|524956539|FG001|Maintenance|Disease progression/relapse|2|||
145573578|NCT02143414|524956538|FG000|Maintenance|Patient refusal|2|||
145573579|NCT02143414|524956539|FG001|Maintenance|Patient refusal|1|||
145573580|NCT02143414|524956538|FG000|Maintenance|Physician Decision|1|||
145573581|NCT02143414|524956539|FG001|Maintenance|Physician Decision|0|||
145573582|NCT02143414|524956538|FG000|Maintenance|Death|0|||
145573583|NCT02143414|524956539|FG001|Maintenance|Death|1|||
145573584|NCT02143414|524956538|FG000|Maintenance|On protocol treatment|0|||
145573585|NCT02143414|524956539|FG001|Maintenance|On protocol treatment|6|||
145573586|NCT00110266|524956543|FG000|Overall Study|Adverse Event|27|||
145573587|NCT00110266|524956543|FG000|Overall Study|Abnormal laboratory value|15|||
145573588|NCT00110266|524956543|FG000|Overall Study|Withdrawal by Subject|16|||
145573589|NCT00110266|524956543|FG000|Overall Study|Death|17|||
145573590|NCT00110266|524956543|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145622260|NCT03158948|525128063|FG001|Overall Study|Death|1|||
145413282|NCT00021255|524367000|FG001|Overall Study|Lost to Follow-up|2|||
145413283|NCT00021255|524367001|FG002|Overall Study|Lost to Follow-up|3|||
145413284|NCT00021255|524366999|FG000|Overall Study|Cardiac toxicity|0|||
145413285|NCT00021255|524367000|FG001|Overall Study|Cardiac toxicity|61|||
145413286|NCT00021255|524367001|FG002|Overall Study|Cardiac toxicity|32|||
145413287|NCT00021255|524366999|FG000|Overall Study|Herceptin toxicity|0|||
145413288|NCT00021255|524367000|FG001|Overall Study|Herceptin toxicity|22|||
145413289|NCT00021255|524367001|FG002|Overall Study|Herceptin toxicity|6|||
145413290|NCT00021255|524366999|FG000|Overall Study|Adverse Event|46|||
145413291|NCT00021255|524367000|FG001|Overall Study|Adverse Event|30|||
145413292|NCT00021255|524367001|FG002|Overall Study|Adverse Event|18|||
145413293|NCT00021255|524366999|FG000|Overall Study|Protocol Violation|0|||
145413294|NCT00021255|524367000|FG001|Overall Study|Protocol Violation|2|||
145413295|NCT00021255|524367001|FG002|Overall Study|Protocol Violation|0|||
145413296|NCT00021255|524366999|FG000|Overall Study|Other than specified above|0|||
145413297|NCT00021255|524367000|FG001|Overall Study|Other than specified above|38|||
145413298|NCT00021255|524367001|FG002|Overall Study|Other than specified above|19|||
145413299|NCT00021255|524366999|FG000|Overall Study|Missing|0|||
145413300|NCT00021255|524367000|FG001|Overall Study|Missing|27|||
145413301|NCT00021255|524367001|FG002|Overall Study|Missing|13|||
145413302|NCT00021255|524366999|FG000|Overall Study|Randomized but not treated|28|||
145413303|NCT00021255|524367000|FG001|Overall Study|Randomized but not treated|2|||
145413304|NCT00021255|524367001|FG002|Overall Study|Randomized but not treated|18|||
145413305|NCT02232698|524367002|FG000|Overall Study|Pregnancy|1|||
145413306|NCT02232698|524367003|FG001|Overall Study|Pregnancy|1|||
145413307|NCT02232698|524367002|FG000|Overall Study|Met exclusion criteria|1|||
145413308|NCT02232698|524367003|FG001|Overall Study|Met exclusion criteria|1|||
145413309|NCT02232698|524367002|FG000|Overall Study|Had device-associated symptoms|7|||
145413310|NCT02232698|524367003|FG001|Overall Study|Had device-associated symptoms|0|||
145413311|NCT02232698|524367002|FG000|Overall Study|Non-compliance with study device|1|||
145413312|NCT02232698|524367003|FG001|Overall Study|Non-compliance with study device|4|||
145413313|NCT02232698|524367002|FG000|Overall Study|Allocated to control group|0|||
145413314|NCT02232698|524367003|FG001|Overall Study|Allocated to control group|3|||
145413315|NCT02232698|524367002|FG000|Overall Study|Withdrawal by Subject|0|||
145413316|NCT02232698|524367003|FG001|Overall Study|Withdrawal by Subject|11|||
145413317|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
145413318|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
145413319|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
145413320|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
145413321|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
145413322|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
145413323|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
145413324|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
145413325|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
145413326|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
145413327|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
145413328|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
145413329|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
145413330|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
145413331|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
145413332|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
145413333|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
145413334|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
145413335|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
145413336|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
145413337|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
145413338|NCT02337946|524367004|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
145413339|NCT02337946|524367005|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
145413340|NCT02337946|524367006|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
145413341|NCT02337946|524367004|FG000|In-between Period|Without Informed Consent|1|||
145413342|NCT02337946|524367005|FG001|In-between Period|Without Informed Consent|0|||
145413343|NCT02337946|524367006|FG002|In-between Period|Without Informed Consent|0|||
145413344|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
145413345|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
145413346|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
145413347|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
145413348|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
145413349|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
145413350|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
145413351|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
145413352|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
145622261|NCT03158948|525128064|FG002|Overall Study|Death|3|||
145337920|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337921|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337922|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337923|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
145337924|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337925|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337926|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337927|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337928|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337929|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337930|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337931|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337932|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
145337933|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337934|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337935|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337936|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337937|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
145337938|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337939|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337940|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337941|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337942|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337943|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337944|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337945|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337946|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
145337947|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337948|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337949|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337950|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337951|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
145337952|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337953|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337954|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337955|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337956|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337957|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
145337958|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337959|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
145337960|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
145337961|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337962|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337963|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337964|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337965|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
145337966|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337967|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337968|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337969|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337970|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337971|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337972|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337973|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337974|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
145337975|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337976|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337977|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337978|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145413353|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
145413354|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
145413355|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
145413356|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
145573591|NCT00110266|524956543|FG000|Overall Study|Participant condition no longer requires study drug|1|||
145337979|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
145337980|NCT03982199|524084212|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337981|NCT03982199|524084213|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337982|NCT03982199|524084214|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337983|NCT03982199|524084215|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337984|NCT03982199|524084216|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337985|NCT03982199|524084217|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
145337986|NCT03982199|524084218|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337987|NCT03982199|524084219|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
145337988|NCT03982199|524084220|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
145337989|NCT03982199|524084221|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337990|NCT03982199|524084222|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337991|NCT03982199|524084223|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337992|NCT03982199|524084224|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337993|NCT03982199|524084225|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
145337994|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145337995|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145337996|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145337997|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145337998|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145337999|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145338000|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145338001|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145338002|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
145338003|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
145338004|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
145338005|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
145338006|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
145338007|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
145338008|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338009|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338010|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338011|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338012|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338013|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338014|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338015|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338016|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338017|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
145338018|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338019|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338020|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338021|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
145338022|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338023|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338024|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338025|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338026|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338027|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338028|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338029|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338030|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338031|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338032|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338033|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338034|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
145338035|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
145338036|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338037|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338038|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145573592|NCT00978731|524956544|FG000|Overall Study|Death|4|||
145573593|NCT00978731|524956545|FG001|Overall Study|Death|1|||
145573594|NCT00978731|524956546|FG002|Overall Study|Death|1|||
145573595|NCT00978731|524956547|FG003|Overall Study|Death|0|||
145573596|NCT00978731|524956544|FG000|Overall Study|Lost to Follow-up|0|||
145573597|NCT00978731|524956545|FG001|Overall Study|Lost to Follow-up|0|||
145573598|NCT00978731|524956546|FG002|Overall Study|Lost to Follow-up|0|||
145573599|NCT00978731|524956547|FG003|Overall Study|Lost to Follow-up|1|||
145573600|NCT00978731|524956544|FG000|Overall Study|Adverse Event|5|||
145573601|NCT00978731|524956545|FG001|Overall Study|Adverse Event|2|||
145573602|NCT00978731|524956546|FG002|Overall Study|Adverse Event|0|||
145573603|NCT00978731|524956547|FG003|Overall Study|Adverse Event|0|||
145573604|NCT00978731|524956544|FG000|Overall Study|Participant's request|1|||
145573605|NCT00978731|524956545|FG001|Overall Study|Participant's request|0|||
145573606|NCT00978731|524956546|FG002|Overall Study|Participant's request|0|||
145573607|NCT00978731|524956547|FG003|Overall Study|Participant's request|0|||
145573608|NCT00978731|524956544|FG000|Overall Study|Administrative reason|3|||
145573609|NCT00978731|524956545|FG001|Overall Study|Administrative reason|3|||
145573610|NCT00978731|524956546|FG002|Overall Study|Administrative reason|1|||
145573611|NCT00978731|524956547|FG003|Overall Study|Administrative reason|0|||
145573612|NCT00978731|524956544|FG000|Overall Study|Deterioration without progression|0|||
145573613|NCT00978731|524956545|FG001|Overall Study|Deterioration without progression|1|||
145573614|NCT00978731|524956546|FG002|Overall Study|Deterioration without progression|0|||
145573615|NCT00978731|524956547|FG003|Overall Study|Deterioration without progression|0|||
145573616|NCT00978731|524956544|FG000|Overall Study|Disease progression/relapse|5|||
145573617|NCT00978731|524956545|FG001|Overall Study|Disease progression/relapse|4|||
145573618|NCT00978731|524956546|FG002|Overall Study|Disease progression/relapse|2|||
145573619|NCT00978731|524956547|FG003|Overall Study|Disease progression/relapse|2|||
145573620|NCT00978731|524956544|FG000|Overall Study|Study closure|3|||
145573621|NCT00978731|524956545|FG001|Overall Study|Study closure|4|||
145573622|NCT00978731|524956546|FG002|Overall Study|Study closure|1|||
145573623|NCT00978731|524956547|FG003|Overall Study|Study closure|1|||
145573624|NCT00978731|524956544|FG000|Overall Study|No response|1|||
145573625|NCT00978731|524956545|FG001|Overall Study|No response|0|||
145573626|NCT00978731|524956546|FG002|Overall Study|No response|0|||
145573627|NCT00978731|524956547|FG003|Overall Study|No response|0|||
145573628|NCT00548808|524956548|FG000|Overall Study|Lost to Follow-up|9|||
145573629|NCT00548808|524956549|FG001|Overall Study|Lost to Follow-up|3|||
145573630|NCT00548808|524956548|FG000|Overall Study|Protocol Violation|8|||
145573631|NCT00548808|524956549|FG001|Overall Study|Protocol Violation|8|||
145573632|NCT00548808|524956548|FG000|Overall Study|Withdrawal by Subject|8|||
145573633|NCT00548808|524956549|FG001|Overall Study|Withdrawal by Subject|4|||
145573634|NCT00548808|524956548|FG000|Overall Study|Physician Decision|6|||
145573635|NCT00548808|524956549|FG001|Overall Study|Physician Decision|3|||
145573636|NCT00548808|524956548|FG000|Overall Study|Adverse Event|4|||
145573637|NCT00548808|524956549|FG001|Overall Study|Adverse Event|5|||
145573638|NCT00548808|524956548|FG000|Overall Study|Death|2|||
145573639|NCT00548808|524956549|FG001|Overall Study|Death|0|||
145573640|NCT00548808|524956548|FG000|Overall Study|Entry Criteria Not Met|2|||
145573641|NCT00548808|524956549|FG001|Overall Study|Entry Criteria Not Met|2|||
145573642|NCT00548808|524956548|FG000|Overall Study|Lack of Efficacy|2|||
145573643|NCT00548808|524956549|FG001|Overall Study|Lack of Efficacy|0|||
145573644|NCT00548808|524956548|FG000|Overall Study|Sponsor Decision|1|||
145573645|NCT00548808|524956549|FG001|Overall Study|Sponsor Decision|1|||
145573646|NCT05044234|524956551|FG000|Overall Study|Lost to Follow-up|2|||
145573647|NCT05044234|524956552|FG001|Overall Study|Lost to Follow-up|1|||
145573648|NCT05044234|524956553|FG002|Overall Study|Lost to Follow-up|1|||
145573649|NCT05044234|524956554|FG003|Overall Study|Lost to Follow-up|2|||
145573650|NCT05044234|524956551|FG000|Overall Study|Withdrawal by Subject|6|||
145573651|NCT05044234|524956552|FG001|Overall Study|Withdrawal by Subject|4|||
145573652|NCT05044234|524956553|FG002|Overall Study|Withdrawal by Subject|5|||
145573653|NCT05044234|524956554|FG003|Overall Study|Withdrawal by Subject|8|||
145573654|NCT05044234|524956551|FG000|Overall Study|Study terminated by Sponsor|21|||
145573655|NCT05044234|524956552|FG001|Overall Study|Study terminated by Sponsor|21|||
145573656|NCT05044234|524956553|FG002|Overall Study|Study terminated by Sponsor|20|||
145573657|NCT05044234|524956554|FG003|Overall Study|Study terminated by Sponsor|14|||
145573658|NCT05044234|524956551|FG000|Overall Study|Other, not specified|0|||
145573659|NCT05044234|524956552|FG001|Overall Study|Other, not specified|0|||
145573660|NCT05044234|524956553|FG002|Overall Study|Other, not specified|1|||
145573661|NCT05044234|524956554|FG003|Overall Study|Other, not specified|2|||
145573662|NCT05044234|524956551|FG000|Overall Study|Delayed data entry|0|||
145573663|NCT05044234|524956552|FG001|Overall Study|Delayed data entry|0|||
145573664|NCT05044234|524956553|FG002|Overall Study|Delayed data entry|0|||
145573665|NCT05044234|524956554|FG003|Overall Study|Delayed data entry|1|||
145573666|NCT00279708|524956555|FG000|Overall Study|Withdrawal by Subject|2|||
145573667|NCT00279708|524956556|FG001|Overall Study|Withdrawal by Subject|3|||
145573668|NCT00279708|524956555|FG000|Overall Study|Adverse Event|1|||
145573669|NCT00279708|524956556|FG001|Overall Study|Adverse Event|1|||
145573670|NCT02940691|524956557|FG000|Overall Study|Lost to Follow-up|5|||
145573671|NCT02940691|524956557|FG000|Overall Study|Incarceration|1|||
145573672|NCT03912233|524956558|FG000|Overall Study|Adverse Event|1|||
145622262|NCT03158948|525128065|FG003|Overall Study|Death|2|||
145622263|NCT03158948|525128062|FG000|Overall Study|Physician Decision|0|||
145622264|NCT03158948|525128063|FG001|Overall Study|Physician Decision|0|||
145622265|NCT03158948|525128064|FG002|Overall Study|Physician Decision|0|||
145622266|NCT03158948|525128065|FG003|Overall Study|Physician Decision|1|||
145622267|NCT04730947|525128066|FG000|Overall Study|Withdrawal by Subject|0|||
145622268|NCT04730947|525128067|FG001|Overall Study|Withdrawal by Subject|1|||
145622269|NCT01097655|525128070|FG000|Overall Study|Withdrawal by Subject|1|||
145622270|NCT01097655|525128070|FG000|Overall Study|Subject Documented Twice|1|||
145622271|NCT01097655|525128070|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
145622272|NCT03527277|525128071|FG000|Overall Study|Withdrawal by Subject|5|||
145622273|NCT03527277|525128072|FG001|Overall Study|Withdrawal by Subject|0|||
145622274|NCT03527277|525128071|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
145622275|NCT03527277|525128072|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
145622276|NCT03527277|525128071|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
145622277|NCT03527277|525128072|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
145622278|NCT01021332|525128073|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
145622279|NCT01021332|525128073|FG000|Overall Study|Adverse Event|43|||
145622280|NCT01021332|525128073|FG000|Overall Study|Lack of Efficacy|19|||
145622281|NCT01021332|525128073|FG000|Overall Study|Withdrawal of Consent|23|||
145622282|NCT01021332|525128073|FG000|Overall Study|Lost to Follow-up|4|||
145622283|NCT01021332|525128073|FG000|Overall Study|Protocol Violation|9|||
145622284|NCT01021332|525128073|FG000|Overall Study|Miscellaneous|3|||
145622285|NCT02800928|525128078|FG000|Overall Study|Withdrawal by Subject|1|||
145622286|NCT02800928|525128079|FG001|Overall Study|Withdrawal by Subject|1|||
145622287|NCT02800928|525128078|FG000|Overall Study|Protocol Violation|1|||
145622288|NCT02800928|525128079|FG001|Overall Study|Protocol Violation|1|||
145622289|NCT02118714|525128088|FG000|Overall Study|Lost to Follow-up|2|||
145622290|NCT02118714|525128088|FG000|Overall Study|Protocol Violation|1|||
145622291|NCT02013687|525128089|FG000|Overall Study|Lost to Follow-up|0|||
145622292|NCT02013687|525128090|FG001|Overall Study|Lost to Follow-up|0|||
145622293|NCT02013687|525128091|FG002|Overall Study|Lost to Follow-up|1|||
145622294|NCT02013687|525128092|FG003|Overall Study|Lost to Follow-up|0|||
145338039|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338040|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338041|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338042|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338043|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338044|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338045|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338046|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
145338047|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
145338048|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
145338049|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
145338050|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338051|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338052|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338053|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338054|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338055|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338056|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338057|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338058|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338059|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338060|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338061|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338062|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
145338063|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
145338064|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338065|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338066|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338067|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145622295|NCT02013687|525128089|FG000|Overall Study|Protocol Violation|0|||
145622296|NCT02013687|525128090|FG001|Overall Study|Protocol Violation|0|||
145622297|NCT02013687|525128091|FG002|Overall Study|Protocol Violation|0|||
145622298|NCT02013687|525128092|FG003|Overall Study|Protocol Violation|1|||
145622299|NCT02013687|525128089|FG000|Overall Study|Withdrawal by Subject|0|||
145622300|NCT02013687|525128090|FG001|Overall Study|Withdrawal by Subject|0|||
145622301|NCT02013687|525128091|FG002|Overall Study|Withdrawal by Subject|0|||
145622302|NCT02013687|525128092|FG003|Overall Study|Withdrawal by Subject|1|||
145622303|NCT02013687|525128089|FG000|Overall Study|Missed visits due to patient travel|0|||
145622304|NCT02013687|525128090|FG001|Overall Study|Missed visits due to patient travel|0|||
145622305|NCT02013687|525128091|FG002|Overall Study|Missed visits due to patient travel|1|||
145622306|NCT02013687|525128092|FG003|Overall Study|Missed visits due to patient travel|0|||
145622307|NCT01653847|525128093|FG000|Overall Study|Withdrawal by Subject|1|||
145622308|NCT01653847|525128094|FG001|Overall Study|Withdrawal by Subject|0|||
145622309|NCT00388362|525128095|FG000|Enrolled|Ineligible|1|||
145622310|NCT00388362|525128095|FG000|Enrolled|Adverse Event|9|||
145622311|NCT00388362|525128095|FG000|Enrolled|Death|1|||
145622312|NCT00388362|525128095|FG000|Enrolled|Loss insurance|1|||
145622313|NCT00388362|525128095|FG000|Enrolled|Withdrawal by Subject|1|||
145622314|NCT00388362|525128095|FG000|Remained on Study Median of 514 Days|Death|2|||
145622315|NCT02335268|525128096|FG000|Overall Study|Physician Decision|5|||
145622316|NCT02335268|525128097|FG001|Overall Study|Physician Decision|1|||
145622317|NCT02335268|525128096|FG000|Overall Study|Lack of Efficacy|2|||
145622318|NCT02335268|525128097|FG001|Overall Study|Lack of Efficacy|1|||
145622319|NCT02335268|525128096|FG000|Overall Study|Adverse Event|5|||
145622320|NCT02335268|525128097|FG001|Overall Study|Adverse Event|2|||
145622321|NCT02335268|525128096|FG000|Overall Study|increase blasts|2|||
145622322|NCT02335268|525128097|FG001|Overall Study|increase blasts|0|||
145622323|NCT02335268|525128096|FG000|Overall Study|Withdrawal by Subject|3|||
145622324|NCT02335268|525128097|FG001|Overall Study|Withdrawal by Subject|2|||
145622325|NCT05893797|525128102|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
145622326|NCT05893797|525128102|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
145622327|NCT05893797|525128102|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
145622328|NCT05893797|525128102|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
145622329|NCT04770220|525128103|FG000|Overall Study|Adverse Event|2|||
145622330|NCT04770220|525128104|FG001|Overall Study|Adverse Event|11|||
145622331|NCT04770220|525128103|FG000|Overall Study|Withdrawal by Subject|5|||
145622332|NCT04770220|525128104|FG001|Overall Study|Withdrawal by Subject|11|||
145622333|NCT04770220|525128103|FG000|Overall Study|Lost to Follow-up|4|||
145622334|NCT04770220|525128104|FG001|Overall Study|Lost to Follow-up|3|||
145622335|NCT04770220|525128103|FG000|Overall Study|not otherwise specified|2|||
145622336|NCT04770220|525128104|FG001|Overall Study|not otherwise specified|3|||
145622337|NCT04770220|525128103|FG000|Overall Study|Physician Decision|1|||
145622338|NCT04770220|525128104|FG001|Overall Study|Physician Decision|3|||
145622339|NCT00003509|525128106|FG000|Overall Study|Not evaluable|5|||
145622340|NCT03658811|525128107|FG000|Overall Study|Lost to Follow-up|3|||
145622341|NCT04951479|525128109|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
145622342|NCT03706690|525128110|FG000|Overall Study|Withdrawal by Subject|8|||
145622343|NCT03706690|525128111|FG001|Overall Study|Withdrawal by Subject|8|||
145622344|NCT03706690|525128110|FG000|Overall Study|Death|143|||
145622345|NCT03706690|525128111|FG001|Overall Study|Death|75|||
145622346|NCT03706690|525128110|FG000|Overall Study|Ongoing at DCO|121|||
145622347|NCT03706690|525128111|FG001|Overall Study|Ongoing at DCO|52|||
145622348|NCT03803774|525128112|FG000|Dose Escalation|Withdrawal by Subject|0|||
145622349|NCT03803774|525128113|FG001|Dose Escalation|Withdrawal by Subject|0|||
145622350|NCT03803774|525128114|FG002|Dose Escalation|Withdrawal by Subject|0|||
145622351|NCT03803774|525128115|FG003|Dose Escalation|Withdrawal by Subject|1|||
145622352|NCT03803774|525128116|FG004|Dose Escalation|Withdrawal by Subject|0|||
145622353|NCT02711826|525128117|FG000|Overall Study|Physician Decision|0|||
145622354|NCT02711826|525128118|FG001|Overall Study|Physician Decision|0|||
145622355|NCT02711826|525128119|FG002|Overall Study|Physician Decision|0|||
145622356|NCT02711826|525128120|FG003|Overall Study|Physician Decision|1|||
145622357|NCT02711826|525128121|FG004|Overall Study|Physician Decision|0|||
145622358|NCT02711826|525128117|FG000|Overall Study|Withdrawal by Subject|0|||
145622359|NCT02711826|525128118|FG001|Overall Study|Withdrawal by Subject|1|||
145622360|NCT02711826|525128119|FG002|Overall Study|Withdrawal by Subject|0|||
145622361|NCT02711826|525128120|FG003|Overall Study|Withdrawal by Subject|4|||
145338068|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338069|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338070|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338071|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338072|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145622362|NCT02711826|525128121|FG004|Overall Study|Withdrawal by Subject|0|||
145622363|NCT02711826|525128117|FG000|Overall Study|Failure to manufacture cellular product|0|||
145622364|NCT02711826|525128118|FG001|Overall Study|Failure to manufacture cellular product|0|||
145622365|NCT02711826|525128119|FG002|Overall Study|Failure to manufacture cellular product|5|||
145622366|NCT02711826|525128120|FG003|Overall Study|Failure to manufacture cellular product|0|||
145622367|NCT02711826|525128121|FG004|Overall Study|Failure to manufacture cellular product|0|||
145622368|NCT02711826|525128117|FG000|Overall Study|Infusion canceled for active infection|0|||
145622369|NCT02711826|525128118|FG001|Overall Study|Infusion canceled for active infection|1|||
145622370|NCT02711826|525128119|FG002|Overall Study|Infusion canceled for active infection|0|||
145622371|NCT02711826|525128120|FG003|Overall Study|Infusion canceled for active infection|0|||
145338073|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338074|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338075|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
145338076|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
145573673|NCT03912233|524956559|FG001|Overall Study|Adverse Event|0|||
145573674|NCT03912233|524956560|FG002|Overall Study|Adverse Event|0|||
145573675|NCT03912233|524956561|FG003|Overall Study|Adverse Event|0|||
145573676|NCT03912233|524956562|FG004|Overall Study|Adverse Event|0|||
145573677|NCT03912233|524956563|FG005|Overall Study|Adverse Event|0|||
145573678|NCT03912233|524956558|FG000|Overall Study|Physician Decision|1|||
145573679|NCT03912233|524956559|FG001|Overall Study|Physician Decision|0|||
145573680|NCT03912233|524956560|FG002|Overall Study|Physician Decision|0|||
145573681|NCT03912233|524956561|FG003|Overall Study|Physician Decision|0|||
145573682|NCT03912233|524956562|FG004|Overall Study|Physician Decision|0|||
145573683|NCT03912233|524956563|FG005|Overall Study|Physician Decision|0|||
145573684|NCT03912233|524956558|FG000|Overall Study|Other|0|||
145573685|NCT03912233|524956559|FG001|Overall Study|Other|0|||
145573686|NCT03912233|524956560|FG002|Overall Study|Other|0|||
145573687|NCT03912233|524956561|FG003|Overall Study|Other|0|||
145573688|NCT03912233|524956562|FG004|Overall Study|Other|7|||
145573689|NCT03912233|524956563|FG005|Overall Study|Other|12|||
145573690|NCT04879745|524956565|FG000|Overall Study|Lost to Follow-up|4|||
145573691|NCT04879745|524956566|FG001|Overall Study|Lost to Follow-up|1|||
145573692|NCT03219333|524956567|FG000|Overall Study|Withdrawal by Subject|9|||
145573693|NCT03219333|524956568|FG001|Overall Study|Withdrawal by Subject|4|||
145573694|NCT03219333|524956567|FG000|Overall Study|Lost to Follow-up|1|||
145573695|NCT03219333|524956568|FG001|Overall Study|Lost to Follow-up|1|||
145573696|NCT03219333|524956567|FG000|Overall Study|Death|104|||
145573697|NCT03219333|524956568|FG001|Overall Study|Death|72|||
145573698|NCT03219333|524956567|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
145573699|NCT03219333|524956568|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
145573700|NCT03219333|524956567|FG000|Overall Study|Other|2|||
145573701|NCT03219333|524956568|FG001|Overall Study|Other|2|||
145573702|NCT02566759|524956569|FG000|All Parts|Withdrawal by Subject|0|||
145573703|NCT02566759|524956570|FG001|All Parts|Withdrawal by Subject|1|||
145573704|NCT02566759|524956571|FG002|All Parts|Withdrawal by Subject|0|||
145573705|NCT02566759|524956572|FG003|All Parts|Withdrawal by Subject|0|||
145573706|NCT02566759|524956573|FG004|All Parts|Withdrawal by Subject|0|||
145573707|NCT02566759|524956574|FG005|All Parts|Withdrawal by Subject|0|||
145573708|NCT02566759|524956575|FG006|All Parts|Withdrawal by Subject|0|||
145573709|NCT02566759|524956576|FG007|All Parts|Withdrawal by Subject|0|||
145573710|NCT02566759|524956577|FG008|All Parts|Withdrawal by Subject|0|||
145573711|NCT02566759|524956578|FG009|All Parts|Withdrawal by Subject|0|||
145573712|NCT02566759|524956579|FG010|All Parts|Withdrawal by Subject|0|||
145573713|NCT02566759|524956580|FG011|All Parts|Withdrawal by Subject|0|||
145573714|NCT02566759|524956581|FG012|All Parts|Withdrawal by Subject|0|||
145573715|NCT02566759|524956582|FG013|All Parts|Withdrawal by Subject|0|||
145573716|NCT02566759|524956583|FG014|All Parts|Withdrawal by Subject|0|||
145573717|NCT02566759|524956584|FG015|All Parts|Withdrawal by Subject|0|||
145573718|NCT02566759|524956585|FG016|All Parts|Withdrawal by Subject|0|||
145573719|NCT02566759|524956569|FG000|All Parts|Adverse Event|0|||
145573720|NCT02566759|524956570|FG001|All Parts|Adverse Event|0|||
145573721|NCT02566759|524956571|FG002|All Parts|Adverse Event|0|||
145573722|NCT02566759|524956572|FG003|All Parts|Adverse Event|0|||
145573723|NCT02566759|524956573|FG004|All Parts|Adverse Event|0|||
145573724|NCT02566759|524956574|FG005|All Parts|Adverse Event|0|||
145573725|NCT02566759|524956575|FG006|All Parts|Adverse Event|0|||
145573726|NCT02566759|524956576|FG007|All Parts|Adverse Event|0|||
145573727|NCT02566759|524956577|FG008|All Parts|Adverse Event|0|||
145573728|NCT02566759|524956578|FG009|All Parts|Adverse Event|0|||
145573729|NCT02566759|524956579|FG010|All Parts|Adverse Event|0|||
145338077|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
145338078|NCT03982199|524084212|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145573730|NCT02566759|524956580|FG011|All Parts|Adverse Event|0|||
145573731|NCT02566759|524956581|FG012|All Parts|Adverse Event|1|||
145573732|NCT02566759|524956582|FG013|All Parts|Adverse Event|3|||
145573733|NCT02566759|524956583|FG014|All Parts|Adverse Event|0|||
145573734|NCT02566759|524956584|FG015|All Parts|Adverse Event|0|||
145573735|NCT02566759|524956585|FG016|All Parts|Adverse Event|0|||
145573736|NCT02566759|524956569|FG000|All Parts|Other|0|||
145573737|NCT02566759|524956570|FG001|All Parts|Other|0|||
145573738|NCT02566759|524956571|FG002|All Parts|Other|0|||
145573739|NCT02566759|524956572|FG003|All Parts|Other|0|||
145573740|NCT02566759|524956573|FG004|All Parts|Other|0|||
145573741|NCT02566759|524956574|FG005|All Parts|Other|0|||
145573742|NCT02566759|524956575|FG006|All Parts|Other|0|||
145573743|NCT02566759|524956576|FG007|All Parts|Other|0|||
145573744|NCT02566759|524956577|FG008|All Parts|Other|0|||
145573745|NCT02566759|524956578|FG009|All Parts|Other|0|||
145573746|NCT02566759|524956579|FG010|All Parts|Other|0|||
145573747|NCT02566759|524956580|FG011|All Parts|Other|0|||
145573748|NCT02566759|524956581|FG012|All Parts|Other|0|||
145338079|NCT03982199|524084213|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338080|NCT03982199|524084214|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338081|NCT03982199|524084215|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338082|NCT03982199|524084216|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338083|NCT03982199|524084217|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338084|NCT03982199|524084218|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338085|NCT03982199|524084219|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338086|NCT03982199|524084220|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338087|NCT03982199|524084221|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338088|NCT03982199|524084222|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338089|NCT03982199|524084223|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338090|NCT03982199|524084224|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
145338091|NCT03982199|524084225|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
145338092|NCT05065567|524084227|FG000|Overall Study|Lost to Follow-up|10|||
145338093|NCT05065567|524084228|FG001|Overall Study|Lost to Follow-up|9|||
145338094|NCT05065567|524084229|FG002|Overall Study|Lost to Follow-up|6|||
145338095|NCT04240392|524085738|FG000|Overall Study|Withdrawal by Subject|13|||
145338096|NCT04240392|524085739|FG001|Overall Study|Withdrawal by Subject|4|||
145338097|NCT04240392|524085738|FG000|Overall Study|Lost to Follow-up|11|||
145338098|NCT04240392|524085739|FG001|Overall Study|Lost to Follow-up|12|||
145338099|NCT03665441|524085747|FG000|Overall Study|survival follow up ongoing|23|||
145338100|NCT03665441|524085748|FG001|Overall Study|survival follow up ongoing|0|||
145338101|NCT03665441|524085747|FG000|Overall Study|Patients ongoing on treatment|9|||
145338102|NCT03665441|524085748|FG001|Overall Study|Patients ongoing on treatment|6|||
145338103|NCT03665441|524085747|FG000|Overall Study|Randomized but not treated|7|||
145338104|NCT03665441|524085748|FG001|Overall Study|Randomized but not treated|11|||
145338105|NCT00191113|524085749|FG000|Core Study|Withdrawal by Subject|25|||
145338106|NCT00191113|524085750|FG001|Core Study|Withdrawal by Subject|9|||
145338107|NCT00191113|524085749|FG000|Core Study|Protocol Violation|6|||
145338108|NCT00191113|524085750|FG001|Core Study|Protocol Violation|2|||
145338109|NCT00191113|524085749|FG000|Core Study|Lost to Follow-up|3|||
145338110|NCT00191113|524085750|FG001|Core Study|Lost to Follow-up|0|||
145338111|NCT00191113|524085749|FG000|Core Study|Adverse Event|0|||
145338112|NCT00191113|524085750|FG001|Core Study|Adverse Event|2|||
145338113|NCT00191113|524085749|FG000|Core Study|Lack of Efficacy|0|||
145338114|NCT00191113|524085750|FG001|Core Study|Lack of Efficacy|2|||
145338115|NCT00191113|524085749|FG000|Core Study|Death|1|||
145338116|NCT00191113|524085750|FG001|Core Study|Death|0|||
145338117|NCT03610516|524085751|FG000|Treatment Epoch|Adverse Event|3|||
145338118|NCT03610516|524085752|FG001|Treatment Epoch|Adverse Event|1|||
145338119|NCT03610516|524085751|FG000|Treatment Epoch|Death|1|||
145338120|NCT03610516|524085752|FG001|Treatment Epoch|Death|0|||
145338121|NCT03610516|524085751|FG000|Treatment Epoch|Lack of Efficacy|0|||
145338122|NCT03610516|524085752|FG001|Treatment Epoch|Lack of Efficacy|1|||
145338123|NCT03610516|524085751|FG000|Treatment Epoch|No longer requires treatment|1|||
145338124|NCT03610516|524085752|FG001|Treatment Epoch|No longer requires treatment|0|||
145338125|NCT03610516|524085751|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
145338126|NCT03610516|524085752|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
145338127|NCT03610516|524085751|FG000|Treatment Epoch|Physician Decision|8|||
145338128|NCT03610516|524085752|FG001|Treatment Epoch|Physician Decision|5|||
145338129|NCT03610516|524085751|FG000|Treatment Epoch|Protocol Deviation|1|||
145338130|NCT03610516|524085752|FG001|Treatment Epoch|Protocol Deviation|0|||
145338131|NCT03610516|524085751|FG000|Treatment Epoch|Withdrawal by Subject|3|||
145338132|NCT03610516|524085752|FG001|Treatment Epoch|Withdrawal by Subject|1|||
145338133|NCT03610516|524085751|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
145338134|NCT03610516|524085752|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
145338135|NCT03610516|524085751|FG000|Post-Treatment Follow-up|Death|1|||
145338136|NCT03610516|524085752|FG001|Post-Treatment Follow-up|Death|0|||
145338137|NCT04241315|524085753|FG000|Overall Study|Withdrawal by Subject|0|||
145338138|NCT04241315|524085754|FG001|Overall Study|Withdrawal by Subject|1|||
145338139|NCT03047330|524085755|FG000|Sleep Block 1|Withdrawal by Subject|3|||
145338140|NCT00000378|524085756|FG000|Overall Study|Lack of Efficacy|16|||
145338141|NCT00000378|524085757|FG001|Overall Study|Lack of Efficacy|14|||
145338142|NCT00663026|524085762|FG000|Overall Study|Lost to Follow-up|1|||
145413357|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
145338143|NCT00663026|524085763|FG001|Overall Study|Lost to Follow-up|0|||
145338144|NCT00663026|524085764|FG002|Overall Study|Lost to Follow-up|0|||
145413358|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
145338145|NCT00663026|524085762|FG000|Overall Study|Other|1|||
145338146|NCT00663026|524085763|FG001|Overall Study|Other|2|||
145338147|NCT00663026|524085764|FG002|Overall Study|Other|0|||
145338148|NCT00663026|524085762|FG000|Overall Study|Adverse Event|0|||
145338149|NCT00663026|524085763|FG001|Overall Study|Adverse Event|2|||
145338150|NCT00663026|524085764|FG002|Overall Study|Adverse Event|3|||
145338151|NCT00663026|524085762|FG000|Overall Study|Caregiver Request|0|||
145338152|NCT00663026|524085763|FG001|Overall Study|Caregiver Request|2|||
145338153|NCT00663026|524085764|FG002|Overall Study|Caregiver Request|0|||
145338154|NCT00663026|524085762|FG000|Overall Study|Withdrawal by Subject|0|||
145338155|NCT00663026|524085763|FG001|Overall Study|Withdrawal by Subject|0|||
145338156|NCT00663026|524085764|FG002|Overall Study|Withdrawal by Subject|1|||
145338157|NCT01682863|524085765|FG000|Overall Study|Subject/guardian decision|19|||
145338158|NCT01682863|524085766|FG001|Overall Study|Subject/guardian decision|12|||
145338159|NCT01682863|524085767|FG002|Overall Study|Subject/guardian decision|10|||
145338160|NCT01682863|524085765|FG000|Overall Study|Lost to Follow-up|5|||
145338161|NCT01682863|524085766|FG001|Overall Study|Lost to Follow-up|1|||
145338162|NCT01682863|524085767|FG002|Overall Study|Lost to Follow-up|6|||
145338163|NCT01682863|524085765|FG000|Overall Study|Death|1|||
145338164|NCT01682863|524085766|FG001|Overall Study|Death|3|||
145338165|NCT01682863|524085767|FG002|Overall Study|Death|4|||
145338166|NCT01682863|524085765|FG000|Overall Study|Protocol deviation|1|||
145338167|NCT01682863|524085766|FG001|Overall Study|Protocol deviation|0|||
145338168|NCT01682863|524085767|FG002|Overall Study|Protocol deviation|1|||
145338169|NCT01682863|524085765|FG000|Overall Study|Technical problems|1|||
145338170|NCT01682863|524085766|FG001|Overall Study|Technical problems|0|||
145338171|NCT01682863|524085767|FG002|Overall Study|Technical problems|0|||
145338172|NCT01682863|524085765|FG000|Overall Study|Adverse Event|0|||
145338173|NCT01682863|524085766|FG001|Overall Study|Adverse Event|1|||
145338174|NCT01682863|524085767|FG002|Overall Study|Adverse Event|2|||
145338175|NCT01682863|524085765|FG000|Overall Study|Physician Decision|0|||
145338176|NCT01682863|524085766|FG001|Overall Study|Physician Decision|0|||
145338177|NCT01682863|524085767|FG002|Overall Study|Physician Decision|1|||
145338178|NCT01161407|524085768|FG000|Overall Study|Protocol Violation|3|||
145338179|NCT01161407|524085769|FG001|Overall Study|Protocol Violation|1|||
145338180|NCT01635283|524085770|FG000|Overall Study|Tumor Progression|3|||
145338181|NCT01635283|524085770|FG000|Overall Study|Lost to Follow-up|1|||
145338182|NCT03511326|524085773|FG000|Overall Study|Withdrawal by Subject|1|||
145338183|NCT01305044|524085776|FG000|Overall Study|Withdrawal by Subject|3|||
145338184|NCT01305044|524085777|FG001|Overall Study|Withdrawal by Subject|6|||
145338185|NCT00849186|524085780|FG000|Overall Study|Adverse Event|2|||
145338186|NCT00849186|524085780|FG000|Overall Study|Withdrawal by Subject|1|||
145338187|NCT00849186|524085780|FG000|Overall Study|not treated|6|||
145338188|NCT00849186|524085780|FG000|Overall Study|Other|1|||
145338189|NCT00492024|524085783|FG000|Treatment|Adverse Event|3|||
145338190|NCT00492024|524085784|FG001|Treatment|Adverse Event|1|||
145338191|NCT00492024|524085783|FG000|Treatment|Lack of Efficacy|21|||
145338192|NCT00492024|524085784|FG001|Treatment|Lack of Efficacy|20|||
145338193|NCT00492024|524085783|FG000|Treatment|Lost to Follow-up|3|||
145338194|NCT00492024|524085784|FG001|Treatment|Lost to Follow-up|1|||
145338195|NCT00492024|524085783|FG000|Treatment|Withdrawal by Subject|2|||
145338196|NCT00492024|524085784|FG001|Treatment|Withdrawal by Subject|0|||
145338197|NCT00492024|524085783|FG000|Follow up|Lack of Efficacy|0|||
145338198|NCT00492024|524085784|FG001|Follow up|Lack of Efficacy|1|||
145338199|NCT00492024|524085783|FG000|Follow up|Lost to Follow-up|1|||
145338200|NCT00492024|524085784|FG001|Follow up|Lost to Follow-up|1|||
145573749|NCT02566759|524956582|FG013|All Parts|Other|2|||
145573750|NCT02566759|524956583|FG014|All Parts|Other|0|||
145573751|NCT02566759|524956584|FG015|All Parts|Other|0|||
145573752|NCT02566759|524956585|FG016|All Parts|Other|0|||
145573753|NCT02566759|524956569|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573754|NCT02566759|524956570|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573755|NCT02566759|524956571|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573756|NCT02566759|524956572|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573757|NCT02566759|524956573|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573758|NCT02566759|524956574|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573759|NCT02566759|524956575|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573760|NCT02566759|524956576|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573761|NCT02566759|524956577|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573762|NCT02566759|524956578|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573763|NCT02566759|524956579|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573764|NCT02566759|524956580|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573765|NCT02566759|524956581|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573766|NCT02566759|524956582|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145338201|NCT00867503|524085791|FG000|Overall Study|Withdrawal by Subject|1|||
145338202|NCT02704403|524085792|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
145338203|NCT02704403|524085793|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
145573767|NCT02566759|524956583|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573768|NCT02566759|524956584|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
145573769|NCT02566759|524956585|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
145338204|NCT02704403|524085792|FG000|Overall Study|Administrative reasons by sponsor|1251|||
145338205|NCT02704403|524085793|FG001|Overall Study|Administrative reasons by sponsor|616|||
145338206|NCT02704403|524085792|FG000|Overall Study|Death|4|||
145338207|NCT02704403|524085793|FG001|Overall Study|Death|3|||
145338208|NCT02704403|524085792|FG000|Overall Study|Endpoint event|52|||
145338209|NCT02704403|524085793|FG001|Overall Study|Endpoint event|24|||
145338210|NCT02704403|524085792|FG000|Overall Study|Lost to Follow-up|22|||
145338211|NCT02704403|524085793|FG001|Overall Study|Lost to Follow-up|11|||
145338212|NCT02704403|524085792|FG000|Overall Study|Protocol Violation|15|||
145338213|NCT02704403|524085793|FG001|Overall Study|Protocol Violation|15|||
145338214|NCT02704403|524085792|FG000|Overall Study|Adverse Event|2|||
145338215|NCT02704403|524085793|FG001|Overall Study|Adverse Event|0|||
145338216|NCT02704403|524085792|FG000|Overall Study|Withdrawal by Subject|85|||
145338217|NCT02704403|524085793|FG001|Overall Study|Withdrawal by Subject|45|||
145338218|NCT02704403|524085792|FG000|Overall Study|Investigator decision|1|||
145573770|NCT01126541|524956586|FG000|Overall Study|Adverse Event|0|||
145573771|NCT01126541|524956587|FG001|Overall Study|Adverse Event|2|||
145573772|NCT01126541|524956588|FG002|Overall Study|Adverse Event|4|||
145573773|NCT01126541|524956586|FG000|Overall Study|Death|0|||
145338219|NCT02704403|524085793|FG001|Overall Study|Investigator decision|1|||
145338220|NCT02704403|524085792|FG000|Overall Study|Follow-up not possible|1|||
145338221|NCT02704403|524085793|FG001|Overall Study|Follow-up not possible|2|||
145338222|NCT02677714|524085802|FG000|Overall Study|Withdrawal by Subject|2|||
145338223|NCT02677714|524085803|FG001|Overall Study|Withdrawal by Subject|0|||
145338224|NCT04628793|524085804|FG000|Overall Study|Study terminated by sponsor|0|||
145338225|NCT04628793|524085805|FG001|Overall Study|Study terminated by sponsor|0|||
145338226|NCT04628793|524085806|FG002|Overall Study|Study terminated by sponsor|8|||
145338227|NCT04628793|524085804|FG000|Overall Study|Withdrawal by Subject|2|||
145338228|NCT04628793|524085805|FG001|Overall Study|Withdrawal by Subject|3|||
145338229|NCT04628793|524085806|FG002|Overall Study|Withdrawal by Subject|0|||
145338230|NCT04628793|524085804|FG000|Overall Study|Lost to Follow-up|0|||
145338231|NCT04628793|524085805|FG001|Overall Study|Lost to Follow-up|1|||
145338232|NCT04628793|524085806|FG002|Overall Study|Lost to Follow-up|0|||
145338233|NCT02278055|524085809|FG000|Overall Study|Adverse Event|1|||
145338234|NCT02278055|524085809|FG000|Overall Study|Lost to Follow-up|1|||
145338235|NCT02278055|524085809|FG000|Overall Study|Withdrawal by Subject|2|||
145338236|NCT02278055|524085809|FG000|Overall Study|Progressive Disease|4|||
145338237|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
145338238|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
145338239|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
145338240|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
145338241|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
145338242|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
145338243|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
145338244|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
145338245|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
145338246|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
145338247|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
145338248|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
145338249|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
145338250|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
145338251|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
145338252|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
145338253|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
145338254|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
145338255|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
145338256|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
145338257|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
145338258|NCT04040192|524085810|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
145338259|NCT04040192|524085811|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
145338260|NCT04040192|524085812|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
145413359|NCT02337946|524367004|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
145573774|NCT01126541|524956587|FG001|Overall Study|Death|1|||
145573775|NCT01126541|524956588|FG002|Overall Study|Death|0|||
145573776|NCT01126541|524956586|FG000|Overall Study|Lack of Efficacy|6|||
145573777|NCT01126541|524956587|FG001|Overall Study|Lack of Efficacy|1|||
145573778|NCT01126541|524956588|FG002|Overall Study|Lack of Efficacy|11|||
145573779|NCT01126541|524956586|FG000|Overall Study|Lost to Follow-up|1|||
145573780|NCT01126541|524956587|FG001|Overall Study|Lost to Follow-up|2|||
145573781|NCT01126541|524956588|FG002|Overall Study|Lost to Follow-up|2|||
145573782|NCT01126541|524956586|FG000|Overall Study|Withdrawal by Subject|2|||
145573783|NCT01126541|524956587|FG001|Overall Study|Withdrawal by Subject|5|||
145573784|NCT01126541|524956588|FG002|Overall Study|Withdrawal by Subject|6|||
145573785|NCT01126541|524956586|FG000|Overall Study|Protocol Violation|0|||
145573786|NCT01126541|524956587|FG001|Overall Study|Protocol Violation|0|||
145573787|NCT01126541|524956588|FG002|Overall Study|Protocol Violation|1|||
145573788|NCT01126541|524956586|FG000|Overall Study|Administrative reason or other|1|||
145338261|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
145338262|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
145338263|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
145338264|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
145573789|NCT01126541|524956587|FG001|Overall Study|Administrative reason or other|1|||
145573790|NCT01126541|524956588|FG002|Overall Study|Administrative reason or other|2|||
145573791|NCT01470469|524956591|FG000|Overall Study|Withdrawal by Subject|4|||
145573792|NCT01470469|524956592|FG001|Overall Study|Withdrawal by Subject|6|||
145573793|NCT01470469|524956591|FG000|Overall Study|Lack of Efficacy|1|||
145573794|NCT01470469|524956592|FG001|Overall Study|Lack of Efficacy|7|||
145573795|NCT01470469|524956591|FG000|Overall Study|Adverse Event|0|||
145573796|NCT01470469|524956592|FG001|Overall Study|Adverse Event|7|||
145573797|NCT01470469|524956591|FG000|Overall Study|Lost to Follow-up|2|||
145573798|NCT01470469|524956592|FG001|Overall Study|Lost to Follow-up|2|||
145573799|NCT01470469|524956591|FG000|Overall Study|Protocol Violation|1|||
145573800|NCT01470469|524956592|FG001|Overall Study|Protocol Violation|1|||
145573801|NCT01470469|524956591|FG000|Overall Study|Other|2|||
145573802|NCT01470469|524956592|FG001|Overall Study|Other|1|||
145573803|NCT03670810|524956593|FG000|Main Study|Adverse Event|37|||
145573804|NCT03670810|524956594|FG001|Main Study|Adverse Event|38|||
145573805|NCT03670810|524956595|FG002|Main Study|Adverse Event|3|||
145573806|NCT03670810|524956596|FG003|Main Study|Adverse Event|4|||
145573807|NCT03670810|524956597|FG004|Main Study|Adverse Event|4|||
145573808|NCT03670810|524956598|FG005|Main Study|Adverse Event|5|||
145573809|NCT03670810|524956599|FG006|Main Study|Adverse Event|0|||
145573810|NCT03670810|524956600|FG007|Main Study|Adverse Event|0|||
145573811|NCT03670810|524956601|FG008|Main Study|Adverse Event|0|||
145573812|NCT03670810|524956593|FG000|Main Study|Lack of Efficacy|8|||
145573813|NCT03670810|524956594|FG001|Main Study|Lack of Efficacy|9|||
145573814|NCT03670810|524956595|FG002|Main Study|Lack of Efficacy|3|||
145573815|NCT03670810|524956596|FG003|Main Study|Lack of Efficacy|4|||
145573816|NCT03670810|524956597|FG004|Main Study|Lack of Efficacy|0|||
145573817|NCT03670810|524956598|FG005|Main Study|Lack of Efficacy|0|||
145573818|NCT03670810|524956599|FG006|Main Study|Lack of Efficacy|0|||
145573819|NCT03670810|524956600|FG007|Main Study|Lack of Efficacy|0|||
145573820|NCT03670810|524956601|FG008|Main Study|Lack of Efficacy|0|||
145573821|NCT03670810|524956593|FG000|Main Study|Lost to Follow-up|9|||
145573822|NCT03670810|524956594|FG001|Main Study|Lost to Follow-up|7|||
145573823|NCT03670810|524956595|FG002|Main Study|Lost to Follow-up|4|||
145573824|NCT03670810|524956596|FG003|Main Study|Lost to Follow-up|6|||
145573825|NCT03670810|524956597|FG004|Main Study|Lost to Follow-up|1|||
145573826|NCT03670810|524956598|FG005|Main Study|Lost to Follow-up|0|||
145573827|NCT03670810|524956599|FG006|Main Study|Lost to Follow-up|0|||
145573828|NCT03670810|524956600|FG007|Main Study|Lost to Follow-up|0|||
145573829|NCT03670810|524956601|FG008|Main Study|Lost to Follow-up|0|||
145573830|NCT03670810|524956593|FG000|Main Study|Non-compliance with Study Drug|0|||
145573831|NCT03670810|524956594|FG001|Main Study|Non-compliance with Study Drug|2|||
145573832|NCT03670810|524956595|FG002|Main Study|Non-compliance with Study Drug|3|||
145573833|NCT03670810|524956596|FG003|Main Study|Non-compliance with Study Drug|0|||
145573834|NCT03670810|524956597|FG004|Main Study|Non-compliance with Study Drug|0|||
145573835|NCT03670810|524956598|FG005|Main Study|Non-compliance with Study Drug|0|||
145573836|NCT03670810|524956599|FG006|Main Study|Non-compliance with Study Drug|0|||
145573837|NCT03670810|524956600|FG007|Main Study|Non-compliance with Study Drug|1|||
145573838|NCT03670810|524956601|FG008|Main Study|Non-compliance with Study Drug|0|||
145573839|NCT03670810|524956593|FG000|Main Study|Physician Decision|3|||
145338265|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
145338266|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
145338267|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
145573840|NCT03670810|524956594|FG001|Main Study|Physician Decision|0|||
145573841|NCT03670810|524956595|FG002|Main Study|Physician Decision|1|||
145573842|NCT03670810|524956596|FG003|Main Study|Physician Decision|0|||
145573843|NCT03670810|524956597|FG004|Main Study|Physician Decision|0|||
145573844|NCT03670810|524956598|FG005|Main Study|Physician Decision|0|||
145573845|NCT03670810|524956599|FG006|Main Study|Physician Decision|1|||
145573846|NCT03670810|524956600|FG007|Main Study|Physician Decision|1|||
145573847|NCT03670810|524956601|FG008|Main Study|Physician Decision|0|||
145573848|NCT03670810|524956593|FG000|Main Study|Pregnancy|1|||
145573849|NCT03670810|524956594|FG001|Main Study|Pregnancy|2|||
145573850|NCT03670810|524956595|FG002|Main Study|Pregnancy|0|||
145573851|NCT03670810|524956596|FG003|Main Study|Pregnancy|0|||
145573852|NCT03670810|524956597|FG004|Main Study|Pregnancy|0|||
145573853|NCT03670810|524956598|FG005|Main Study|Pregnancy|0|||
145573854|NCT03670810|524956599|FG006|Main Study|Pregnancy|0|||
145573855|NCT03670810|524956600|FG007|Main Study|Pregnancy|0|||
145573856|NCT03670810|524956601|FG008|Main Study|Pregnancy|0|||
145573857|NCT03670810|524956593|FG000|Main Study|Protocol Deviation|2|||
145573858|NCT03670810|524956594|FG001|Main Study|Protocol Deviation|12|||
145573859|NCT03670810|524956595|FG002|Main Study|Protocol Deviation|8|||
145573860|NCT03670810|524956596|FG003|Main Study|Protocol Deviation|4|||
145573861|NCT03670810|524956597|FG004|Main Study|Protocol Deviation|0|||
145338268|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
145338269|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
145338270|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
145338271|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
145338272|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
145338273|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145338274|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
145338275|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
145338276|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
145338277|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
145338278|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
145338279|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
145338280|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
145338281|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
145338282|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
145338283|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
145338284|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
145338285|NCT04040192|524085810|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
145338286|NCT04040192|524085811|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
145338287|NCT04040192|524085812|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
145338288|NCT00469144|524085813|FG000|Overall Study|Death|0|||
145338289|NCT00469144|524085814|FG001|Overall Study|Death|1|||
145338290|NCT00469144|524085813|FG000|Overall Study|No Response|5|||
145338291|NCT00469144|524085814|FG001|Overall Study|No Response|5|||
145338292|NCT00469144|524085813|FG000|Overall Study|Progressive Disease|1|||
145338293|NCT00469144|524085814|FG001|Overall Study|Progressive Disease|0|||
145338294|NCT01994291|524085815|FG000|Overall Study|Adverse Event|4|||
145338295|NCT01994291|524085816|FG001|Overall Study|Adverse Event|1|||
145338296|NCT01994291|524085817|FG002|Overall Study|Adverse Event|3|||
145338297|NCT01994291|524085815|FG000|Overall Study|Lost to Follow-up|1|||
145338298|NCT01994291|524085816|FG001|Overall Study|Lost to Follow-up|1|||
145338299|NCT01994291|524085817|FG002|Overall Study|Lost to Follow-up|0|||
145338300|NCT01994291|524085815|FG000|Overall Study|Does not meet entrance criteria|1|||
145338301|NCT01994291|524085816|FG001|Overall Study|Does not meet entrance criteria|0|||
145338302|NCT01994291|524085817|FG002|Overall Study|Does not meet entrance criteria|0|||
145338303|NCT01994291|524085815|FG000|Overall Study|Medication error without associated AE|1|||
145338304|NCT01994291|524085816|FG001|Overall Study|Medication error without associated AE|0|||
145338305|NCT01994291|524085817|FG002|Overall Study|Medication error without associated AE|1|||
145338306|NCT01994291|524085815|FG000|Overall Study|Protocol Violation|1|||
145338307|NCT01994291|524085816|FG001|Overall Study|Protocol Violation|0|||
145338308|NCT01994291|524085817|FG002|Overall Study|Protocol Violation|0|||
145338309|NCT01994291|524085815|FG000|Overall Study|Withdrawal by Subject|6|||
145338310|NCT01994291|524085816|FG001|Overall Study|Withdrawal by Subject|3|||
145338311|NCT01994291|524085817|FG002|Overall Study|Withdrawal by Subject|5|||
145338312|NCT01994291|524085815|FG000|Overall Study|Other|1|||
145338313|NCT01994291|524085816|FG001|Overall Study|Other|2|||
145338314|NCT01994291|524085817|FG002|Overall Study|Other|0|||
145338315|NCT00856375|524085818|FG000|Overall Study|Other|0|||
145338316|NCT00856375|524085819|FG001|Overall Study|Other|1|||
145338317|NCT00856375|524085818|FG000|Overall Study|Death|32|||
145338318|NCT00856375|524085819|FG001|Overall Study|Death|30|||
145338319|NCT00856375|524085818|FG000|Overall Study|Sponsor Terminated Study|7|||
145338320|NCT00856375|524085819|FG001|Overall Study|Sponsor Terminated Study|7|||
145338321|NCT00856375|524085818|FG000|Overall Study|Withdrawal by Subject|2|||
145338322|NCT00856375|524085819|FG001|Overall Study|Withdrawal by Subject|1|||
145338323|NCT00856375|524085818|FG000|Overall Study|Lost to Follow-up|1|||
145338324|NCT00856375|524085819|FG001|Overall Study|Lost to Follow-up|2|||
145338325|NCT02227446|524085820|FG000|Overall Study|not eligible post randomization|18|||
145338326|NCT02227446|524085821|FG001|Overall Study|not eligible post randomization|29|||
145338327|NCT02227446|524085820|FG000|Overall Study|Withdrawal by Subject|4|||
145338328|NCT02227446|524085821|FG001|Overall Study|Withdrawal by Subject|5|||
145338329|NCT02121392|524085822|FG000|Prior to Intervention|Protocol Violation|40|||
145338330|NCT02121392|524085823|FG001|Prior to Intervention|Protocol Violation|35|||
145338331|NCT02121392|524085822|FG000|Prior to Intervention|Withdrawal by Subject|8|||
145338332|NCT02121392|524085823|FG001|Prior to Intervention|Withdrawal by Subject|6|||
145338333|NCT02121392|524085822|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
145338334|NCT02121392|524085823|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
145338335|NCT02121392|524085822|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
145338336|NCT02121392|524085823|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
145338337|NCT01352416|524085824|FG000|Overall Study|Physician Decision|1|||
145338338|NCT01352416|524085825|FG001|Overall Study|Physician Decision|2|||
145338339|NCT01352416|524085826|FG002|Overall Study|Physician Decision|2|||
145338340|NCT01352416|524085827|FG003|Overall Study|Physician Decision|1|||
145338341|NCT02640053|524085839|FG000|Overall Study|Withdrawal by Subject|2|||
145573862|NCT03670810|524956598|FG005|Main Study|Protocol Deviation|0|||
145573863|NCT03670810|524956599|FG006|Main Study|Protocol Deviation|0|||
145573864|NCT03670810|524956600|FG007|Main Study|Protocol Deviation|0|||
145573865|NCT03670810|524956601|FG008|Main Study|Protocol Deviation|0|||
145573866|NCT03670810|524956593|FG000|Main Study|Withdrawal by Subject|21|||
145573867|NCT03670810|524956594|FG001|Main Study|Withdrawal by Subject|21|||
145573868|NCT03670810|524956595|FG002|Main Study|Withdrawal by Subject|8|||
145573869|NCT03670810|524956596|FG003|Main Study|Withdrawal by Subject|9|||
145573870|NCT03670810|524956597|FG004|Main Study|Withdrawal by Subject|5|||
145573871|NCT03670810|524956598|FG005|Main Study|Withdrawal by Subject|2|||
145573872|NCT03670810|524956599|FG006|Main Study|Withdrawal by Subject|1|||
145573873|NCT03670810|524956600|FG007|Main Study|Withdrawal by Subject|1|||
145573874|NCT03670810|524956601|FG008|Main Study|Withdrawal by Subject|0|||
145573875|NCT03670810|524956593|FG000|Main Study|Participant did not want to take the three other treatments|1|||
145573876|NCT03670810|524956594|FG001|Main Study|Participant did not want to take the three other treatments|0|||
145573877|NCT03670810|524956595|FG002|Main Study|Participant did not want to take the three other treatments|0|||
145573878|NCT03670810|524956596|FG003|Main Study|Participant did not want to take the three other treatments|0|||
145573879|NCT03670810|524956597|FG004|Main Study|Participant did not want to take the three other treatments|0|||
145573880|NCT03670810|524956598|FG005|Main Study|Participant did not want to take the three other treatments|0|||
145338342|NCT02640053|524085840|FG001|Overall Study|Withdrawal by Subject|1|||
145338343|NCT02640053|524085839|FG000|Overall Study|Adverse Event|1|||
145338344|NCT02640053|524085840|FG001|Overall Study|Adverse Event|1|||
145338345|NCT02640053|524085839|FG000|Overall Study|Alternative Therapy|1|||
145338346|NCT02640053|524085840|FG001|Overall Study|Alternative Therapy|1|||
145338347|NCT02640053|524085839|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
145338348|NCT02640053|524085840|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
145338349|NCT02348723|524085842|FG000|Overall Study|No ablation|21|||
145338350|NCT02348723|524085843|FG001|Overall Study|No ablation|20|||
145338351|NCT02348723|524085842|FG000|Overall Study|Non-compliant with Protocol|1|||
145338352|NCT02348723|524085843|FG001|Overall Study|Non-compliant with Protocol|0|||
145338353|NCT02348723|524085842|FG000|Overall Study|Lost to Follow-up|1|||
145338354|NCT02348723|524085843|FG001|Overall Study|Lost to Follow-up|1|||
145338355|NCT02348723|524085842|FG000|Overall Study|Consent withdrawn|1|||
145338356|NCT02348723|524085843|FG001|Overall Study|Consent withdrawn|3|||
145338357|NCT02348723|524085842|FG000|Overall Study|Reason other than specified|1|||
145338358|NCT02348723|524085843|FG001|Overall Study|Reason other than specified|1|||
145338359|NCT02348723|524085842|FG000|Overall Study|Adverse Event|3|||
145338360|NCT02348723|524085843|FG001|Overall Study|Adverse Event|1|||
145338361|NCT01268501|524085844|FG000|Overall Study|Lost to Follow-up|1|||
145338362|NCT01268501|524085844|FG000|Overall Study|Withdrawal by Subject|3|||
145338363|NCT01268501|524085844|FG000|Overall Study|Unacceptable Subjective Vision|3|||
145338364|NCT01268501|524085844|FG000|Overall Study|Handling Difficulties|2|||
145338365|NCT01458106|524085847|FG000|Overall Study|Withdrawal by Subject|2|||
145338366|NCT01458106|524085848|FG001|Overall Study|Withdrawal by Subject|0|||
145338367|NCT01458106|524085847|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
145338368|NCT01458106|524085848|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
145338369|NCT01458106|524085847|FG000|Overall Study|Withdrawn Per Protocol|0|||
145338370|NCT01458106|524085848|FG001|Overall Study|Withdrawn Per Protocol|1|||
145338371|NCT00073021|524085849|FG000|Overall Study|Protocol Violation|2|||
145338372|NCT00073021|524085850|FG001|Overall Study|Protocol Violation|1|||
145338373|NCT00073021|524085849|FG000|Overall Study|Adverse Event|4|||
145338374|NCT00073021|524085850|FG001|Overall Study|Adverse Event|4|||
145338375|NCT00073021|524085849|FG000|Overall Study|Withdrawal by Subject|6|||
145338376|NCT00073021|524085850|FG001|Overall Study|Withdrawal by Subject|5|||
145338377|NCT00073021|524085849|FG000|Overall Study|Physician Decision|3|||
145338378|NCT00073021|524085850|FG001|Overall Study|Physician Decision|1|||
145338379|NCT00073021|524085849|FG000|Overall Study|Lack of Efficacy|11|||
145338380|NCT00073021|524085850|FG001|Overall Study|Lack of Efficacy|5|||
145338381|NCT03050060|524085851|FG000|Overall Study|Adverse Event|7|||
145338382|NCT03050060|524085851|FG000|Overall Study|Withdrawal by Subject|1|||
145338383|NCT03050060|524085851|FG000|Overall Study|Progression|7|||
145338384|NCT03835221|524085852|FG000|Methafilcon A|Withdrawal by Subject|1|||
145413360|NCT02337946|524367005|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
145338385|NCT01197755|524085859|FG000|Overall Study|Adverse Event|8|||
145338386|NCT01197755|524085860|FG001|Overall Study|Adverse Event|10|||
145338387|NCT01197755|524085861|FG002|Overall Study|Adverse Event|10|||
145338388|NCT01197755|524085859|FG000|Overall Study|Study-specific discontinuation criteria|2|||
145338389|NCT01197755|524085860|FG001|Overall Study|Study-specific discontinuation criteria|1|||
145338390|NCT01197755|524085861|FG002|Overall Study|Study-specific discontinuation criteria|0|||
145573881|NCT03670810|524956599|FG006|Main Study|Participant did not want to take the three other treatments|0|||
145573882|NCT03670810|524956600|FG007|Main Study|Participant did not want to take the three other treatments|0|||
145573883|NCT03670810|524956601|FG008|Main Study|Participant did not want to take the three other treatments|0|||
145573884|NCT03670810|524956593|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145338391|NCT01197755|524085859|FG000|Overall Study|Entered the long-term extension study|18|||
145573885|NCT03670810|524956594|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
145573886|NCT03670810|524956595|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145338392|NCT01197755|524085860|FG001|Overall Study|Entered the long-term extension study|21|||
145338393|NCT01197755|524085861|FG002|Overall Study|Entered the long-term extension study|35|||
145338394|NCT01197755|524085859|FG000|Overall Study|Lack of therapeutic response|0|||
145338395|NCT01197755|524085860|FG001|Overall Study|Lack of therapeutic response|7|||
145338396|NCT01197755|524085861|FG002|Overall Study|Lack of therapeutic response|4|||
145338397|NCT01197755|524085859|FG000|Overall Study|Severe non-compliance to the protocol|2|||
145338398|NCT01197755|524085860|FG001|Overall Study|Severe non-compliance to the protocol|1|||
145338399|NCT01197755|524085861|FG002|Overall Study|Severe non-compliance to the protocol|2|||
145338400|NCT01197755|524085859|FG000|Overall Study|Withdrawal by Subject|1|||
145338401|NCT01197755|524085860|FG001|Overall Study|Withdrawal by Subject|0|||
145338402|NCT01197755|524085861|FG002|Overall Study|Withdrawal by Subject|0|||
145338403|NCT01197755|524085859|FG000|Overall Study|Lost to Follow-up|0|||
145338404|NCT01197755|524085860|FG001|Overall Study|Lost to Follow-up|0|||
145338405|NCT01197755|524085861|FG002|Overall Study|Lost to Follow-up|1|||
145338406|NCT01197755|524085859|FG000|Overall Study|eg, change in circumstances|7|||
145338407|NCT01197755|524085860|FG001|Overall Study|eg, change in circumstances|3|||
145338408|NCT01197755|524085861|FG002|Overall Study|eg, change in circumstances|2|||
145338409|NCT03365011|524085862|FG000|Overall Study|Withdrawal by Subject|1|||
145338410|NCT03365011|524085863|FG001|Overall Study|Withdrawal by Subject|2|||
145338411|NCT00499174|524085864|FG000|Overall Study|Physician Decision|78|||
145338412|NCT00499174|524085865|FG001|Overall Study|Physician Decision|9|||
145338413|NCT03582826|524085866|FG000|Overall Study|Lost to Follow-up|39|||
145338414|NCT03582826|524085867|FG001|Overall Study|Lost to Follow-up|0|||
145338415|NCT03582826|524085866|FG000|Overall Study|Withdrawal by Subject|2|||
145338416|NCT03582826|524085867|FG001|Overall Study|Withdrawal by Subject|0|||
145338417|NCT01214915|524085869|FG000|Overall Study|Adverse Event|8|||
145338418|NCT01214915|524085869|FG000|Overall Study|Lack of Efficacy|3|||
145338419|NCT00761865|524085870|FG000|Overall Study|Lost to Follow-up|8|||
145338420|NCT00761865|524085871|FG001|Overall Study|Lost to Follow-up|7|||
145338421|NCT01094886|524085872|FG000|Overall Study|Adverse Event|2|||
145338422|NCT01094886|524085872|FG000|Overall Study|Withdrawal by Subject|5|||
145338423|NCT03866902|524085874|FG000|Overall Study|Lost to Follow-up|98|||
145338424|NCT03866902|524085875|FG001|Overall Study|Lost to Follow-up|82|||
145338425|NCT03866902|524085874|FG000|Overall Study|Pregnancy|18|||
145338426|NCT03866902|524085875|FG001|Overall Study|Pregnancy|24|||
145338427|NCT04730349|524085876|FG000|Overall Study|Participant withdrew consent|1|||
145338428|NCT04730349|524085877|FG001|Overall Study|Participant withdrew consent|0|||
145338429|NCT04730349|524085876|FG000|Overall Study|Disease progression|6|||
145338430|NCT04730349|524085877|FG001|Overall Study|Disease progression|4|||
145338431|NCT04730349|524085876|FG000|Overall Study|Study drug toxicity|0|||
145338432|NCT04730349|524085877|FG001|Overall Study|Study drug toxicity|1|||
145338433|NCT03155945|524085884|FG000|Overall Study|Lost to Follow-up|0|||
145338434|NCT03155945|524085885|FG001|Overall Study|Lost to Follow-up|1|||
145338435|NCT03155945|524085884|FG000|Overall Study|Withdrawal by Subject|0|||
145338436|NCT03155945|524085885|FG001|Overall Study|Withdrawal by Subject|1|||
145338437|NCT03155945|524085884|FG000|Overall Study|Other Reason|0|||
145338438|NCT03155945|524085885|FG001|Overall Study|Other Reason|1|||
145338439|NCT03510598|524087223|FG000|Overall Study|Withdrawal by Subject|1|||
145338440|NCT05307510|524087224|FG000|Overall Study|Lost to Follow-up|3|||
145338441|NCT05307510|524087225|FG001|Overall Study|Lost to Follow-up|6|||
145338442|NCT05307510|524087224|FG000|Overall Study|Withdrawal by Subject|0|||
145338443|NCT05307510|524087225|FG001|Overall Study|Withdrawal by Subject|1|||
145338444|NCT04003896|524087241|FG000|Overall Study|Withdrawal by Subject|3|||
145338445|NCT04003896|524087241|FG000|Overall Study|Physician Decision|1|||
145338446|NCT00837473|524087242|FG000|Overall Study|Lost to Follow-up|1|||
145338447|NCT00837473|524087242|FG000|Overall Study|Withdrawal by Subject|2|||
145338448|NCT04576923|524087243|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
145338449|NCT03016975|524087250|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
145338450|NCT03016975|524087251|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
145338451|NCT03016975|524087252|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
145338452|NCT03016975|524087250|FG000|At 6 Months Follow-up|Death|2|||
145338453|NCT03016975|524087251|FG001|At 6 Months Follow-up|Death|0|||
145338454|NCT03016975|524087252|FG002|At 6 Months Follow-up|Death|0|||
145338455|NCT03016975|524087250|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
145338456|NCT03016975|524087251|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
145338457|NCT03016975|524087252|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
145338458|NCT03016975|524087250|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
145338459|NCT03016975|524087251|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
145338460|NCT03016975|524087252|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
145338461|NCT03016975|524087250|FG000|At 6 Months Follow-up|Aborted implant|1|||
145338462|NCT03016975|524087251|FG001|At 6 Months Follow-up|Aborted implant|0|||
145338463|NCT03016975|524087252|FG002|At 6 Months Follow-up|Aborted implant|0|||
145338464|NCT03016975|524087250|FG000|At 2 Year Follow-up|Death|1|||
145338465|NCT03016975|524087251|FG001|At 2 Year Follow-up|Death|0|||
145338466|NCT03016975|524087252|FG002|At 2 Year Follow-up|Death|0|||
145338467|NCT03016975|524087250|FG000|At 3 Year Follow-up|Death|1|||
145338468|NCT03016975|524087251|FG001|At 3 Year Follow-up|Death|0|||
145338469|NCT03016975|524087252|FG002|At 3 Year Follow-up|Death|0|||
145338470|NCT03016975|524087250|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
145338471|NCT03016975|524087251|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
145338472|NCT03016975|524087252|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
145338473|NCT03016975|524087250|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
145338474|NCT03016975|524087251|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
145338475|NCT03016975|524087252|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
145338476|NCT02901548|524087253|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
145338477|NCT01228019|524087256|FG000|Overall Study|Dose Violation|70|||
145338478|NCT01228019|524087256|FG000|Overall Study|Duplicate enrollment|1|||
145338479|NCT01228019|524087256|FG000|Overall Study|Missing pre-treatment data|72|||
145338480|NCT01228019|524087256|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
145338481|NCT01228019|524087256|FG000|Overall Study|Violation of Entry Criterion|9|||
145338482|NCT02910063|524087261|FG000|Phase 2|Withdrawal by Subject|3|||
145338483|NCT02910063|524087262|FG001|Phase 2|Withdrawal by Subject|0|||
145338484|NCT02910063|524087263|FG002|Phase 2|Withdrawal by Subject|0|||
145338485|NCT02910063|524087261|FG000|Phase 2|Lost to Follow-up|1|||
145338486|NCT02910063|524087262|FG001|Phase 2|Lost to Follow-up|0|||
145338487|NCT02910063|524087263|FG002|Phase 2|Lost to Follow-up|0|||
145338488|NCT02910063|524087261|FG000|Phase 2|Death|24|||
145338489|NCT02910063|524087262|FG001|Phase 2|Death|0|||
145338490|NCT02910063|524087263|FG002|Phase 2|Death|0|||
145338491|NCT04435184|524087264|FG000|Overall Study|follow-up blood draws missing|3|||
145338492|NCT04435184|524087265|FG001|Overall Study|follow-up blood draws missing|5|||
145338493|NCT04693416|524087266|FG000|Overall Study|Lost to Follow-up|13|||
145338494|NCT04693416|524087267|FG001|Overall Study|Lost to Follow-up|0|||
145338495|NCT00474266|524087270|FG000|Overall Study|Withdrawal by Subject|7|||
145338496|NCT00474266|524087271|FG001|Overall Study|Withdrawal by Subject|20|||
145338497|NCT00474266|524087272|FG002|Overall Study|Withdrawal by Subject|4|||
145338498|NCT00474266|524087273|FG003|Overall Study|Withdrawal by Subject|7|||
145338499|NCT02774642|524087275|FG000|Overall Study|Lost to Follow-up|9|||
145338500|NCT02774642|524087276|FG001|Overall Study|Lost to Follow-up|7|||
145338501|NCT02365558|524087280|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
145338502|NCT02365558|524087281|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
145338503|NCT02365558|524087280|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
145338504|NCT02365558|524087281|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
145338505|NCT00369317|524087282|FG000|Overall Study|Adverse Event|3|||
145338506|NCT00369317|524087282|FG000|Overall Study|Death|1|||
145338507|NCT00369317|524087282|FG000|Overall Study|Lack of Efficacy|5|||
145338508|NCT00369317|524087282|FG000|Overall Study|Physician Decision|2|||
145338509|NCT00369317|524087282|FG000|Overall Study|Withdrawal by Subject|8|||
145338510|NCT00369317|524087282|FG000|Overall Study|Ineligible|1|||
145338511|NCT00426361|524087290|FG000|Overall Study|Lost to Follow-up|3|||
145338512|NCT00426361|524087291|FG001|Overall Study|Lost to Follow-up|2|||
145338513|NCT00426361|524087292|FG002|Overall Study|Lost to Follow-up|5|||
145338514|NCT00426361|524087290|FG000|Overall Study|Withdrawal by Subject|1|||
145338515|NCT00426361|524087291|FG001|Overall Study|Withdrawal by Subject|3|||
145338516|NCT00426361|524087292|FG002|Overall Study|Withdrawal by Subject|0|||
145338517|NCT02828241|524087295|FG000|Overall Study|Adverse Event|7|||
145338518|NCT02828241|524087296|FG001|Overall Study|Adverse Event|2|||
145338519|NCT02828241|524087295|FG000|Overall Study|Protocol Violation|1|||
145338520|NCT02828241|524087296|FG001|Overall Study|Protocol Violation|0|||
145338521|NCT06281171|524087308|FG000|Timepoint 2|Lost to Follow-up|6|||
145338522|NCT06281171|524087309|FG001|Timepoint 2|Lost to Follow-up|4|||
145338523|NCT06281171|524087308|FG000|Timepoint 3|Lost to Follow-up|0|||
145338524|NCT06281171|524087309|FG001|Timepoint 3|Lost to Follow-up|5|||
145338525|NCT00510289|524087314|FG000|Overall Study|Withdrawal by Subject|7|||
145338526|NCT00510289|524087314|FG000|Overall Study|Refused bone marrow biopsy|2|||
145338527|NCT00510289|524087314|FG000|Overall Study|Lost to Follow-up|1|||
145338528|NCT00510289|524087314|FG000|Overall Study|Progressed prior to starting drug|2|||
145338529|NCT00861198|524087317|FG000|Overall Study|SpyGlass Failed|5|||
145338530|NCT02288182|524087318|FG000|Overall Study|Adverse Event|0|||
145338531|NCT02288182|524087319|FG001|Overall Study|Adverse Event|1|||
145338532|NCT02288182|524087318|FG000|Overall Study|Lost to Follow-up|0|||
145338533|NCT02288182|524087319|FG001|Overall Study|Lost to Follow-up|1|||
145338534|NCT02823652|524087320|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
145338535|NCT02823652|524087321|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
145573887|NCT03670810|524956596|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145573888|NCT03670810|524956597|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145573889|NCT03670810|524956598|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145573890|NCT03670810|524956599|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145338536|NCT02823652|524087322|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
145338537|NCT02823652|524087320|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
145338538|NCT02823652|524087321|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
145338539|NCT02823652|524087322|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
145338540|NCT02823652|524087320|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
145338541|NCT02823652|524087321|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
145338542|NCT02823652|524087322|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
145338543|NCT02823652|524087320|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
145338544|NCT02823652|524087321|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
145338545|NCT02823652|524087322|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
145338546|NCT00319982|524087325|FG000|Overall Study|Withdrawal by Subject|1|||
145338547|NCT00319982|524087326|FG001|Overall Study|Withdrawal by Subject|0|||
145338548|NCT02351960|524087327|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
145338549|NCT02351960|524087328|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
145338550|NCT02351960|524087327|FG000|Overall Study|Voluntary Withdrawal|5|||
145338551|NCT02351960|524087328|FG001|Overall Study|Voluntary Withdrawal|4|||
145338552|NCT02351960|524087327|FG000|Overall Study|Significant Protocol Deviation|0|||
145338553|NCT02351960|524087328|FG001|Overall Study|Significant Protocol Deviation|5|||
145338554|NCT03480386|524087329|FG000|Overall Study|Did not complete measures at 3-months|17|||
145338555|NCT03480386|524087330|FG001|Overall Study|Did not complete measures at 3-months|14|||
145338556|NCT03480386|524087329|FG000|Overall Study|No baseline measures|11|||
145338557|NCT03480386|524087330|FG001|Overall Study|No baseline measures|14|||
145338558|NCT03480386|524087329|FG000|Overall Study|Death|0|||
145338559|NCT03480386|524087330|FG001|Overall Study|Death|5|||
145338560|NCT03480386|524087329|FG000|Overall Study|Withdrawal by Subject|12|||
145338561|NCT03480386|524087330|FG001|Overall Study|Withdrawal by Subject|8|||
145338562|NCT03480386|524087329|FG000|Overall Study|Lost to Follow-up|2|||
145338563|NCT03480386|524087330|FG001|Overall Study|Lost to Follow-up|1|||
145338564|NCT03480386|524087329|FG000|Overall Study|Complicating disease|0|||
145338565|NCT03480386|524087330|FG001|Overall Study|Complicating disease|1|||
145338566|NCT03480386|524087329|FG000|Overall Study|Disease progression|3|||
145338567|NCT03480386|524087330|FG001|Overall Study|Disease progression|0|||
145338568|NCT03480386|524087329|FG000|Overall Study|Became ineligible|0|||
145338569|NCT03480386|524087330|FG001|Overall Study|Became ineligible|2|||
145338570|NCT00574912|524087331|FG000|Overall Study|Could not place IV lines.|3|||
145338571|NCT00574912|524087331|FG000|Overall Study|scheduling conflicts|3|||
145338572|NCT00574912|524087331|FG000|Overall Study|Physician Decision|2|||
145338573|NCT00638027|524087341|FG000|Overall Study|Adverse Event|0|||
145338574|NCT00638027|524087342|FG001|Overall Study|Adverse Event|2|||
145338575|NCT00371397|524087344|FG000|Session 1|Withdrawal by Subject|1|||
145338576|NCT00371397|524087345|FG001|Session 1|Withdrawal by Subject|0|||
145338577|NCT00371397|524087346|FG002|Session 1|Withdrawal by Subject|0|||
145338578|NCT00371397|524087347|FG003|Session 1|Withdrawal by Subject|0|||
145338579|NCT00371397|524087348|FG004|Session 1|Withdrawal by Subject|0|||
145338580|NCT00371397|524087349|FG005|Session 1|Withdrawal by Subject|0|||
145338581|NCT00371397|524087350|FG006|Session 1|Withdrawal by Subject|0|||
145338582|NCT00371397|524087351|FG007|Session 1|Withdrawal by Subject|1|||
145338583|NCT00371397|524087352|FG008|Session 1|Withdrawal by Subject|0|||
145338584|NCT00371397|524087353|FG009|Session 1|Withdrawal by Subject|0|||
145338585|NCT00371397|524087354|FG010|Session 1|Withdrawal by Subject|0|||
145338586|NCT00371397|524087355|FG011|Session 1|Withdrawal by Subject|0|||
145338587|NCT03014180|524087356|FG000|Overall Study|Protocol Violation|2|||
145338588|NCT02377427|524087357|FG000|Part A (Up to Week 20)|Physician Decision|1|||
145338589|NCT02377427|524087358|FG001|Part A (Up to Week 20)|Physician Decision|0|||
145338590|NCT02377427|524087359|FG002|Part A (Up to Week 20)|Physician Decision|0|||
145338591|NCT02377427|524087360|FG003|Part A (Up to Week 20)|Physician Decision|0|||
145338592|NCT02377427|524087361|FG004|Part A (Up to Week 20)|Physician Decision|0|||
145338593|NCT02377427|524087357|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
145338594|NCT02377427|524087358|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145338595|NCT02377427|524087359|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145338596|NCT02377427|524087360|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145338597|NCT02377427|524087361|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
145338598|NCT02377427|524087357|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
145338599|NCT02377427|524087358|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145338600|NCT02377427|524087359|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145338601|NCT02377427|524087360|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145338602|NCT02377427|524087361|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
145338603|NCT02377427|524087357|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145622372|NCT02711826|525128121|FG004|Overall Study|Infusion canceled for active infection|0|||
145622373|NCT02711826|525128117|FG000|Overall Study|Screen failures|0|||
145338604|NCT02377427|524087358|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145338605|NCT02377427|524087359|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
145338606|NCT02377427|524087360|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145622374|NCT02711826|525128118|FG001|Overall Study|Screen failures|0|||
145338607|NCT02377427|524087361|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
145338608|NCT03395405|524089054|FG000|Overall Study|Death|0|||
145338609|NCT03395405|524089055|FG001|Overall Study|Death|2|||
145338610|NCT03395405|524089054|FG000|Overall Study|Lost to Follow-up|0|||
145338611|NCT03395405|524089055|FG001|Overall Study|Lost to Follow-up|1|||
145338612|NCT03395405|524089054|FG000|Overall Study|Protocol Violation|0|||
145338613|NCT03395405|524089055|FG001|Overall Study|Protocol Violation|1|||
145338614|NCT03395405|524089054|FG000|Overall Study|Withdrawal by Subject|3|||
145338615|NCT03395405|524089055|FG001|Overall Study|Withdrawal by Subject|1|||
145338616|NCT03395405|524089054|FG000|Overall Study|COVID-19 Pandemic|1|||
145338617|NCT03395405|524089055|FG001|Overall Study|COVID-19 Pandemic|0|||
145338618|NCT00213135|524089060|FG000|Overall Study|Adverse Event|9|||
145338619|NCT00213135|524089061|FG001|Overall Study|Adverse Event|5|||
145338620|NCT00213135|524089062|FG002|Overall Study|Adverse Event|5|||
145338621|NCT00213135|524089060|FG000|Overall Study|Lost to Follow-up|11|||
145338622|NCT00213135|524089061|FG001|Overall Study|Lost to Follow-up|8|||
145338623|NCT00213135|524089062|FG002|Overall Study|Lost to Follow-up|4|||
145338624|NCT00213135|524089060|FG000|Overall Study|Protocol Violation|4|||
145338625|NCT00213135|524089061|FG001|Overall Study|Protocol Violation|4|||
145338626|NCT00213135|524089062|FG002|Overall Study|Protocol Violation|10|||
145338627|NCT00213135|524089060|FG000|Overall Study|Death|1|||
145338628|NCT00213135|524089061|FG001|Overall Study|Death|1|||
145338629|NCT00213135|524089062|FG002|Overall Study|Death|2|||
145338630|NCT00213135|524089060|FG000|Overall Study|Disease progression|4|||
145338631|NCT00213135|524089061|FG001|Overall Study|Disease progression|5|||
145338632|NCT00213135|524089062|FG002|Overall Study|Disease progression|21|||
145338633|NCT00213135|524089060|FG000|Overall Study|Other|21|||
145338634|NCT00213135|524089061|FG001|Overall Study|Other|12|||
145338635|NCT00213135|524089062|FG002|Overall Study|Other|15|||
145338636|NCT01908907|524089066|FG000|Overall Study|Physician Decision|1|||
145338637|NCT01908907|524089067|FG001|Overall Study|Physician Decision|0|||
145338638|NCT01908907|524089066|FG000|Overall Study|Protocol Violation|1|||
145338639|NCT01908907|524089067|FG001|Overall Study|Protocol Violation|0|||
145338640|NCT00660907|524089068|FG000|Overall Study|Incorrect Enrollment|1|||
145338641|NCT00660907|524089069|FG001|Overall Study|Incorrect Enrollment|1|||
145338642|NCT00660907|524089068|FG000|Overall Study|Adverse Event|33|||
145338643|NCT00660907|524089069|FG001|Overall Study|Adverse Event|19|||
145338644|NCT00660907|524089068|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
145338645|NCT00660907|524089069|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
145338646|NCT00660907|524089068|FG000|Overall Study|Withdrawal by Subject|23|||
145338647|NCT00660907|524089069|FG001|Overall Study|Withdrawal by Subject|32|||
145338648|NCT00660907|524089068|FG000|Overall Study|Lost to Follow-up|3|||
145338649|NCT00660907|524089069|FG001|Overall Study|Lost to Follow-up|3|||
145338650|NCT00660907|524089068|FG000|Overall Study|Poor/Non-Compliance|5|||
145338651|NCT00660907|524089069|FG001|Overall Study|Poor/Non-Compliance|1|||
145338652|NCT00660907|524089068|FG000|Overall Study|Safety|1|||
145338653|NCT00660907|524089069|FG001|Overall Study|Safety|0|||
145338654|NCT00660907|524089068|FG000|Overall Study|Death|1|||
145338655|NCT00660907|524089069|FG001|Overall Study|Death|3|||
145338656|NCT00660907|524089068|FG000|Overall Study|Various|11|||
145338657|NCT00660907|524089069|FG001|Overall Study|Various|8|||
145338658|NCT02886624|524089072|FG000|12-week Post Treatment Follow-up|Death|1|||
145338659|NCT02886624|524089072|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
145338660|NCT00359801|524089073|FG000|Overall Study|Lost to Follow-up|72|||
145338661|NCT00359801|524089074|FG001|Overall Study|Lost to Follow-up|58|||
145338662|NCT00359801|524089073|FG000|Overall Study|Withdrawal by Subject|143|||
145338663|NCT00359801|524089074|FG001|Overall Study|Withdrawal by Subject|96|||
145338664|NCT00359801|524089073|FG000|Overall Study|Other|66|||
145338665|NCT00359801|524089074|FG001|Overall Study|Other|46|||
145338666|NCT00359801|524089073|FG000|Overall Study|Final Status Unknown: missing data|7|||
145338667|NCT00359801|524089074|FG001|Overall Study|Final Status Unknown: missing data|4|||
145338668|NCT00359801|524089073|FG000|Overall Study|Sponsor Decision|17|||
145338669|NCT00359801|524089074|FG001|Overall Study|Sponsor Decision|16|||
145338670|NCT01056289|524089076|FG000|Open-label Phase|Adverse Event|29|||
145338671|NCT01056289|524089077|FG001|Open-label Phase|Adverse Event|0|||
145338672|NCT01056289|524089078|FG002|Open-label Phase|Adverse Event|0|||
145338673|NCT01056289|524089079|FG003|Open-label Phase|Adverse Event|0|||
145338674|NCT01056289|524089076|FG000|Open-label Phase|Lost to Follow-up|30|||
145338675|NCT01056289|524089077|FG001|Open-label Phase|Lost to Follow-up|0|||
145338676|NCT01056289|524089078|FG002|Open-label Phase|Lost to Follow-up|0|||
145338677|NCT01056289|524089079|FG003|Open-label Phase|Lost to Follow-up|0|||
145338678|NCT01056289|524089076|FG000|Open-label Phase|Other|9|||
145338679|NCT01056289|524089077|FG001|Open-label Phase|Other|0|||
145338680|NCT01056289|524089078|FG002|Open-label Phase|Other|0|||
145338681|NCT01056289|524089079|FG003|Open-label Phase|Other|0|||
145338682|NCT01056289|524089076|FG000|Open-label Phase|Protocol Violation|6|||
145338683|NCT01056289|524089077|FG001|Open-label Phase|Protocol Violation|0|||
145338684|NCT01056289|524089078|FG002|Open-label Phase|Protocol Violation|0|||
145338685|NCT01056289|524089079|FG003|Open-label Phase|Protocol Violation|0|||
145338686|NCT01056289|524089076|FG000|Open-label Phase|Withdrawal by Subject|26|||
145622375|NCT02711826|525128119|FG002|Overall Study|Screen failures|0|||
145622376|NCT02711826|525128120|FG003|Overall Study|Screen failures|4|||
145622377|NCT02711826|525128121|FG004|Overall Study|Screen failures|0|||
145622378|NCT00729690|525128122|FG000|Overall Study|IT Catheter Malfunction|0|||
145622379|NCT00729690|525128123|FG001|Overall Study|IT Catheter Malfunction|2|||
145622380|NCT00729690|525128124|FG002|Overall Study|IT Catheter Malfunction|2|||
145622381|NCT02507219|525128125|FG000|Overall Study|Physician Decision|1|||
145622382|NCT02507219|525128126|FG001|Overall Study|Physician Decision|0|||
145622383|NCT02507219|525128127|FG002|Overall Study|Physician Decision|0|||
145622384|NCT02507219|525128128|FG003|Overall Study|Physician Decision|0|||
145622385|NCT02507219|525128129|FG004|Overall Study|Physician Decision|0|||
145622386|NCT02507219|525128130|FG005|Overall Study|Physician Decision|0|||
145622387|NCT02507219|525128125|FG000|Overall Study|Withdrawal by Subject|0|||
145622388|NCT02507219|525128126|FG001|Overall Study|Withdrawal by Subject|0|||
145622389|NCT02507219|525128127|FG002|Overall Study|Withdrawal by Subject|0|||
145622390|NCT02507219|525128128|FG003|Overall Study|Withdrawal by Subject|0|||
145622391|NCT02507219|525128129|FG004|Overall Study|Withdrawal by Subject|1|||
145622392|NCT02507219|525128130|FG005|Overall Study|Withdrawal by Subject|0|||
145622393|NCT02419755|525128131|FG000|Overall Study|Death|1|||
145622394|NCT02419755|525128132|FG001|Overall Study|Death|3|||
145622395|NCT02419755|525128131|FG000|Overall Study|Relapse|0|||
145622396|NCT02419755|525128132|FG001|Overall Study|Relapse|1|||
145622397|NCT02419755|525128131|FG000|Overall Study|Ineligible|1|||
145622398|NCT02419755|525128132|FG001|Overall Study|Ineligible|0|||
145622399|NCT02419755|525128131|FG000|Overall Study|Withdrawal by Subject|1|||
145622400|NCT02419755|525128132|FG001|Overall Study|Withdrawal by Subject|0|||
145622401|NCT06403605|525128135|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
145622402|NCT06403605|525128136|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
145622403|NCT06403605|525128135|FG000|Follow-up|Adverse Event|4|||
145622404|NCT06403605|525128136|FG001|Follow-up|Adverse Event|2|||
145622405|NCT06403605|525128135|FG000|Follow-up|Withdrawal by Subject|2|||
145622406|NCT06403605|525128136|FG001|Follow-up|Withdrawal by Subject|3|||
145622407|NCT06403605|525128135|FG000|Follow-up|Lost to Follow-up|1|||
145622408|NCT06403605|525128136|FG001|Follow-up|Lost to Follow-up|0|||
145622409|NCT06403605|525128135|FG000|Follow-up|Death|1|||
145622410|NCT06403605|525128136|FG001|Follow-up|Death|0|||
145622411|NCT06403605|525128135|FG000|Follow-up|Other reasons|0|||
145622412|NCT06403605|525128136|FG001|Follow-up|Other reasons|4|||
145622413|NCT00924664|525130077|FG000|Overall Study|Adverse Event|23|||
145622414|NCT00924664|525130078|FG001|Overall Study|Adverse Event|39|||
145622415|NCT00924664|525130077|FG000|Overall Study|Lack of Efficacy|10|||
145622416|NCT00924664|525130078|FG001|Overall Study|Lack of Efficacy|15|||
145622417|NCT00924664|525130077|FG000|Overall Study|Lost to Follow-up|10|||
145622418|NCT00924664|525130078|FG001|Overall Study|Lost to Follow-up|12|||
145622419|NCT00924664|525130077|FG000|Overall Study|Withdrawal by Subject|47|||
145622420|NCT00924664|525130078|FG001|Overall Study|Withdrawal by Subject|71|||
145622421|NCT00924664|525130077|FG000|Overall Study|Protocol Violation|2|||
145622422|NCT00924664|525130078|FG001|Overall Study|Protocol Violation|5|||
145573891|NCT03670810|524956600|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145573892|NCT03670810|524956601|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
145573893|NCT03670810|524956593|FG000|Main Study|Travel and Coronavirus issues|0|||
145573894|NCT03670810|524956594|FG001|Main Study|Travel and Coronavirus issues|0|||
145573895|NCT03670810|524956595|FG002|Main Study|Travel and Coronavirus issues|0|||
145573896|NCT03670810|524956596|FG003|Main Study|Travel and Coronavirus issues|1|||
145573897|NCT03670810|524956597|FG004|Main Study|Travel and Coronavirus issues|0|||
145573898|NCT03670810|524956598|FG005|Main Study|Travel and Coronavirus issues|0|||
145573899|NCT03670810|524956599|FG006|Main Study|Travel and Coronavirus issues|0|||
145573900|NCT03670810|524956600|FG007|Main Study|Travel and Coronavirus issues|0|||
145573901|NCT03670810|524956601|FG008|Main Study|Travel and Coronavirus issues|0|||
145573902|NCT03670810|524956593|FG000|Open Label Extension|Protocol Deviation|0|||
145622423|NCT00924664|525130077|FG000|Overall Study|Pregnancy|1|||
145622424|NCT00924664|525130078|FG001|Overall Study|Pregnancy|1|||
145622425|NCT00924664|525130077|FG000|Overall Study|Death|0|||
145622426|NCT00924664|525130078|FG001|Overall Study|Death|2|||
145622427|NCT00924664|525130077|FG000|Overall Study|Study terminated by sponsor|199|||
145622428|NCT00924664|525130078|FG001|Overall Study|Study terminated by sponsor|330|||
145622429|NCT00924664|525130077|FG000|Overall Study|Other|29|||
145622430|NCT00924664|525130078|FG001|Overall Study|Other|52|||
145622431|NCT00924664|525130077|FG000|Overall Study|Randomized but not Treated|1|||
145622432|NCT00924664|525130078|FG001|Overall Study|Randomized but not Treated|0|||
145622433|NCT01616563|525130081|FG000|Overall Study|Lost to Follow-up|40|||
145622434|NCT01106287|525130082|FG000|Overall Study|Adverse Event|1|||
145622435|NCT01106287|525130083|FG001|Overall Study|Adverse Event|0|||
145622436|NCT01106287|525130084|FG002|Overall Study|Adverse Event|0|||
145622437|NCT01106287|525130085|FG003|Overall Study|Adverse Event|0|||
145573903|NCT03670810|524956594|FG001|Open Label Extension|Protocol Deviation|0|||
145622438|NCT00072475|525130086|FG000|Overall Study|Adverse Event|44|||
145622439|NCT00072475|525130086|FG000|Overall Study|Death|3|||
145622440|NCT00072475|525130086|FG000|Overall Study|Withdrawal by Subject|46|||
145338687|NCT01056289|524089077|FG001|Open-label Phase|Withdrawal by Subject|0|||
145338688|NCT01056289|524089078|FG002|Open-label Phase|Withdrawal by Subject|0|||
145338689|NCT01056289|524089079|FG003|Open-label Phase|Withdrawal by Subject|0|||
145338690|NCT01056289|524089076|FG000|Open-label Phase|Lack of Efficacy|18|||
145338691|NCT01056289|524089077|FG001|Open-label Phase|Lack of Efficacy|0|||
145338692|NCT01056289|524089078|FG002|Open-label Phase|Lack of Efficacy|0|||
145338693|NCT01056289|524089079|FG003|Open-label Phase|Lack of Efficacy|0|||
145338694|NCT01056289|524089076|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
145338695|NCT01056289|524089077|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
145338696|NCT01056289|524089078|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
145338697|NCT01056289|524089079|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
145338698|NCT01056289|524089076|FG000|Double-blind Phase|Adverse Event|0|||
145338699|NCT01056289|524089077|FG001|Double-blind Phase|Adverse Event|1|||
145338700|NCT01056289|524089078|FG002|Double-blind Phase|Adverse Event|2|||
145338701|NCT01056289|524089079|FG003|Double-blind Phase|Adverse Event|1|||
145338702|NCT01056289|524089076|FG000|Double-blind Phase|Lost to Follow-up|0|||
145338703|NCT01056289|524089077|FG001|Double-blind Phase|Lost to Follow-up|2|||
145338704|NCT01056289|524089078|FG002|Double-blind Phase|Lost to Follow-up|2|||
145338705|NCT01056289|524089079|FG003|Double-blind Phase|Lost to Follow-up|2|||
145338706|NCT01056289|524089076|FG000|Double-blind Phase|Other|0|||
145338707|NCT01056289|524089077|FG001|Double-blind Phase|Other|0|||
145338708|NCT01056289|524089078|FG002|Double-blind Phase|Other|1|||
145338709|NCT01056289|524089079|FG003|Double-blind Phase|Other|2|||
145338710|NCT01056289|524089076|FG000|Double-blind Phase|Protocol Violation|0|||
145338711|NCT01056289|524089077|FG001|Double-blind Phase|Protocol Violation|0|||
145338712|NCT01056289|524089078|FG002|Double-blind Phase|Protocol Violation|1|||
145338713|NCT01056289|524089079|FG003|Double-blind Phase|Protocol Violation|1|||
145338714|NCT01056289|524089076|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145338715|NCT01056289|524089077|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145338716|NCT01056289|524089078|FG002|Double-blind Phase|Withdrawal by Subject|4|||
145338717|NCT01056289|524089079|FG003|Double-blind Phase|Withdrawal by Subject|2|||
145338718|NCT01056289|524089076|FG000|Double-blind Phase|Discontinuation symptom|0|||
145338719|NCT01056289|524089077|FG001|Double-blind Phase|Discontinuation symptom|1|||
145338720|NCT01056289|524089078|FG002|Double-blind Phase|Discontinuation symptom|2|||
145338721|NCT01056289|524089079|FG003|Double-blind Phase|Discontinuation symptom|2|||
145338722|NCT01056289|524089076|FG000|Double-blind Phase|Physician Decision|0|||
145338723|NCT01056289|524089077|FG001|Double-blind Phase|Physician Decision|0|||
145338724|NCT01056289|524089078|FG002|Double-blind Phase|Physician Decision|1|||
145338725|NCT01056289|524089079|FG003|Double-blind Phase|Physician Decision|0|||
145338726|NCT00402116|524089080|FG000|Overall Study|Jaw infection after surgery-other|1|||
145338727|NCT00402116|524089081|FG001|Overall Study|Jaw infection after surgery-other|0|||
145338728|NCT00402116|524089082|FG002|Overall Study|Jaw infection after surgery-other|0|||
145338729|NCT00402116|524089080|FG000|Overall Study|Withdrawal by Subject|1|||
145338730|NCT00402116|524089081|FG001|Overall Study|Withdrawal by Subject|0|||
145338731|NCT00402116|524089082|FG002|Overall Study|Withdrawal by Subject|5|||
145338732|NCT00402116|524089080|FG000|Overall Study|Treatment completed per protocol|1|||
145338733|NCT00402116|524089081|FG001|Overall Study|Treatment completed per protocol|1|||
145338734|NCT00402116|524089082|FG002|Overall Study|Treatment completed per protocol|2|||
145338735|NCT00402116|524089080|FG000|Overall Study|other complicating disease|0|||
145338736|NCT00402116|524089081|FG001|Overall Study|other complicating disease|0|||
145338737|NCT00402116|524089082|FG002|Overall Study|other complicating disease|2|||
145338738|NCT00402116|524089080|FG000|Overall Study|Disease Progression|0|||
145338739|NCT00402116|524089081|FG001|Overall Study|Disease Progression|4|||
145338740|NCT00402116|524089082|FG002|Overall Study|Disease Progression|38|||
145338741|NCT00402116|524089080|FG000|Overall Study|mistaken thrombocytopenia|0|||
145338742|NCT00402116|524089081|FG001|Overall Study|mistaken thrombocytopenia|0|||
145338743|NCT00402116|524089082|FG002|Overall Study|mistaken thrombocytopenia|1|||
145338744|NCT00402116|524089080|FG000|Overall Study|decline related hyponatremia/tumor|0|||
145338745|NCT00402116|524089081|FG001|Overall Study|decline related hyponatremia/tumor|0|||
145338746|NCT00402116|524089082|FG002|Overall Study|decline related hyponatremia/tumor|1|||
145338747|NCT00402116|524089080|FG000|Overall Study|Adverse Event|0|||
145338748|NCT00402116|524089081|FG001|Overall Study|Adverse Event|1|||
145338749|NCT00402116|524089082|FG002|Overall Study|Adverse Event|6|||
145338750|NCT00450801|524089083|FG000|Overall Study|Death|1|||
145338751|NCT05048329|524089084|FG000|Overall Study|Withdrawal by Subject|1|||
145338752|NCT05048329|524089084|FG000|Overall Study|Screenfail|1|||
145338753|NCT00324649|524089085|FG000|Overall Study|Adverse Event|1|||
145338754|NCT00324649|524089086|FG001|Overall Study|Adverse Event|4|||
145338755|NCT00324649|524089085|FG000|Overall Study|Withdrawal by Subject|0|||
145338756|NCT00324649|524089086|FG001|Overall Study|Withdrawal by Subject|1|||
145338757|NCT00324649|524089085|FG000|Overall Study|Noncompliance|1|||
145338758|NCT00324649|524089086|FG001|Overall Study|Noncompliance|0|||
145338759|NCT01396512|524089089|FG000|Overall Study|Withdrawal by Subject|0|||
145338760|NCT01396512|524089090|FG001|Overall Study|Withdrawal by Subject|1|||
145338761|NCT02856555|524089091|FG000|Overall Study|Adverse Event|1|||
145338762|NCT02856555|524089092|FG001|Overall Study|Adverse Event|0|||
145573904|NCT03670810|524956595|FG002|Open Label Extension|Protocol Deviation|0|||
145573905|NCT03670810|524956596|FG003|Open Label Extension|Protocol Deviation|0|||
145573906|NCT03670810|524956597|FG004|Open Label Extension|Protocol Deviation|0|||
145573907|NCT03670810|524956598|FG005|Open Label Extension|Protocol Deviation|0|||
145573908|NCT03670810|524956599|FG006|Open Label Extension|Protocol Deviation|0|||
145573909|NCT03670810|524956600|FG007|Open Label Extension|Protocol Deviation|0|||
145573910|NCT03670810|524956601|FG008|Open Label Extension|Protocol Deviation|5|||
145573911|NCT03670810|524956593|FG000|Open Label Extension|Death|0|||
145573912|NCT03670810|524956594|FG001|Open Label Extension|Death|0|||
145573913|NCT03670810|524956595|FG002|Open Label Extension|Death|0|||
145573914|NCT03670810|524956596|FG003|Open Label Extension|Death|0|||
145573915|NCT03670810|524956597|FG004|Open Label Extension|Death|0|||
145573916|NCT03670810|524956598|FG005|Open Label Extension|Death|0|||
145573917|NCT03670810|524956599|FG006|Open Label Extension|Death|0|||
145573918|NCT03670810|524956600|FG007|Open Label Extension|Death|0|||
145573919|NCT03670810|524956601|FG008|Open Label Extension|Death|1|||
145573920|NCT03670810|524956593|FG000|Open Label Extension|COVID-19|0|||
145573921|NCT03670810|524956594|FG001|Open Label Extension|COVID-19|0|||
145573922|NCT03670810|524956595|FG002|Open Label Extension|COVID-19|0|||
145573923|NCT03670810|524956596|FG003|Open Label Extension|COVID-19|0|||
145573924|NCT03670810|524956597|FG004|Open Label Extension|COVID-19|0|||
145573925|NCT03670810|524956598|FG005|Open Label Extension|COVID-19|0|||
145573926|NCT03670810|524956599|FG006|Open Label Extension|COVID-19|0|||
145573927|NCT03670810|524956600|FG007|Open Label Extension|COVID-19|0|||
145573928|NCT03670810|524956601|FG008|Open Label Extension|COVID-19|1|||
145573929|NCT03670810|524956593|FG000|Open Label Extension|Lack of Efficacy|0|||
145573930|NCT03670810|524956594|FG001|Open Label Extension|Lack of Efficacy|0|||
145573931|NCT03670810|524956595|FG002|Open Label Extension|Lack of Efficacy|0|||
145573932|NCT03670810|524956596|FG003|Open Label Extension|Lack of Efficacy|0|||
145573933|NCT03670810|524956597|FG004|Open Label Extension|Lack of Efficacy|0|||
145573934|NCT03670810|524956598|FG005|Open Label Extension|Lack of Efficacy|0|||
145573935|NCT03670810|524956599|FG006|Open Label Extension|Lack of Efficacy|0|||
145573936|NCT03670810|524956600|FG007|Open Label Extension|Lack of Efficacy|0|||
145573937|NCT03670810|524956601|FG008|Open Label Extension|Lack of Efficacy|39|||
145573938|NCT03670810|524956593|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
145573939|NCT03670810|524956594|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
145573940|NCT03670810|524956595|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
145573941|NCT03670810|524956596|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
145573942|NCT03670810|524956597|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
145573943|NCT03670810|524956598|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
145573944|NCT03670810|524956599|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
145573945|NCT03670810|524956600|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
145573946|NCT03670810|524956601|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
145573947|NCT03670810|524956593|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573948|NCT03670810|524956594|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573949|NCT03670810|524956595|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573950|NCT03670810|524956596|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573951|NCT03670810|524956597|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573952|NCT03670810|524956598|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573953|NCT03670810|524956599|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573954|NCT03670810|524956600|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
145573955|NCT03670810|524956601|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
145573956|NCT03670810|524956593|FG000|Open Label Extension|Withdrawal by Subject|0|||
145573957|NCT03670810|524956594|FG001|Open Label Extension|Withdrawal by Subject|0|||
145573958|NCT03670810|524956595|FG002|Open Label Extension|Withdrawal by Subject|0|||
145573959|NCT03670810|524956596|FG003|Open Label Extension|Withdrawal by Subject|0|||
145573960|NCT03670810|524956597|FG004|Open Label Extension|Withdrawal by Subject|0|||
145573961|NCT03670810|524956598|FG005|Open Label Extension|Withdrawal by Subject|0|||
145573962|NCT03670810|524956599|FG006|Open Label Extension|Withdrawal by Subject|0|||
145573963|NCT03670810|524956600|FG007|Open Label Extension|Withdrawal by Subject|0|||
145573964|NCT03670810|524956601|FG008|Open Label Extension|Withdrawal by Subject|46|||
145338763|NCT02856555|524089093|FG002|Overall Study|Adverse Event|0|||
145338764|NCT02856555|524089091|FG000|Overall Study|Lost to Follow-up|1|||
145338765|NCT02856555|524089092|FG001|Overall Study|Lost to Follow-up|3|||
145338766|NCT02856555|524089093|FG002|Overall Study|Lost to Follow-up|0|||
145573965|NCT03670810|524956593|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573966|NCT03670810|524956594|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145622441|NCT00072475|525130086|FG000|Overall Study|Patient/Investigator Decision|4|||
145622442|NCT02123966|525130087|FG000|Overall Study|Intercurrent Illness|1|||
145338767|NCT02856555|524089091|FG000|Overall Study|Withdrawal by Subject|3|||
145573967|NCT03670810|524956595|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573968|NCT03670810|524956596|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573969|NCT03670810|524956597|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573970|NCT03670810|524956598|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573971|NCT03670810|524956599|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573972|NCT03670810|524956600|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
145573973|NCT03670810|524956601|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
145573974|NCT03670810|524956593|FG000|Open Label Extension|Physician Decision|0|||
145573975|NCT03670810|524956594|FG001|Open Label Extension|Physician Decision|0|||
145573976|NCT03670810|524956595|FG002|Open Label Extension|Physician Decision|0|||
145573977|NCT03670810|524956596|FG003|Open Label Extension|Physician Decision|0|||
145573978|NCT03670810|524956597|FG004|Open Label Extension|Physician Decision|0|||
145573979|NCT03670810|524956598|FG005|Open Label Extension|Physician Decision|0|||
145573980|NCT03670810|524956599|FG006|Open Label Extension|Physician Decision|0|||
145573981|NCT03670810|524956600|FG007|Open Label Extension|Physician Decision|0|||
145573982|NCT03670810|524956601|FG008|Open Label Extension|Physician Decision|2|||
145573983|NCT03670810|524956593|FG000|Open Label Extension|Non-compliance with study drug|0|||
145573984|NCT03670810|524956594|FG001|Open Label Extension|Non-compliance with study drug|0|||
145573985|NCT03670810|524956595|FG002|Open Label Extension|Non-compliance with study drug|0|||
145573986|NCT03670810|524956596|FG003|Open Label Extension|Non-compliance with study drug|0|||
145573987|NCT03670810|524956597|FG004|Open Label Extension|Non-compliance with study drug|0|||
145573988|NCT03670810|524956598|FG005|Open Label Extension|Non-compliance with study drug|0|||
145573989|NCT03670810|524956599|FG006|Open Label Extension|Non-compliance with study drug|0|||
145573990|NCT03670810|524956600|FG007|Open Label Extension|Non-compliance with study drug|0|||
145573991|NCT03670810|524956601|FG008|Open Label Extension|Non-compliance with study drug|5|||
145573992|NCT03670810|524956593|FG000|Open Label Extension|Pregnancy|0|||
145573993|NCT03670810|524956594|FG001|Open Label Extension|Pregnancy|0|||
145573994|NCT03670810|524956595|FG002|Open Label Extension|Pregnancy|0|||
145573995|NCT03670810|524956596|FG003|Open Label Extension|Pregnancy|0|||
145573996|NCT03670810|524956597|FG004|Open Label Extension|Pregnancy|0|||
145573997|NCT03670810|524956598|FG005|Open Label Extension|Pregnancy|0|||
145573998|NCT03670810|524956599|FG006|Open Label Extension|Pregnancy|0|||
145573999|NCT03670810|524956600|FG007|Open Label Extension|Pregnancy|0|||
145574000|NCT03670810|524956601|FG008|Open Label Extension|Pregnancy|3|||
145574001|NCT03670810|524956593|FG000|Open Label Extension|Adverse Event|0|||
145574002|NCT03670810|524956594|FG001|Open Label Extension|Adverse Event|0|||
145574003|NCT03670810|524956595|FG002|Open Label Extension|Adverse Event|0|||
145574004|NCT03670810|524956596|FG003|Open Label Extension|Adverse Event|0|||
145574005|NCT03670810|524956597|FG004|Open Label Extension|Adverse Event|0|||
145574006|NCT03670810|524956598|FG005|Open Label Extension|Adverse Event|0|||
145574007|NCT03670810|524956599|FG006|Open Label Extension|Adverse Event|0|||
145574008|NCT03670810|524956600|FG007|Open Label Extension|Adverse Event|0|||
145574009|NCT03670810|524956601|FG008|Open Label Extension|Adverse Event|24|||
145574010|NCT03670810|524956593|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
145574011|NCT03670810|524956594|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
145574012|NCT03670810|524956595|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
145574013|NCT03670810|524956596|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
145574014|NCT03670810|524956597|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
145574015|NCT03670810|524956598|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
145338768|NCT02856555|524089092|FG001|Overall Study|Withdrawal by Subject|0|||
145338769|NCT02856555|524089093|FG002|Overall Study|Withdrawal by Subject|0|||
145338770|NCT02856555|524089091|FG000|Overall Study|Randomized but Never Treated|0|||
145338771|NCT02856555|524089092|FG001|Overall Study|Randomized but Never Treated|1|||
145338772|NCT02856555|524089093|FG002|Overall Study|Randomized but Never Treated|0|||
145338773|NCT01564537|524089097|FG000|Overall Study|Site Terminated by Sponsor|1|||
145338774|NCT01564537|524089098|FG001|Overall Study|Site Terminated by Sponsor|0|||
145338775|NCT01564537|524089097|FG000|Overall Study|Withdrawal by Subject|12|||
145338776|NCT01564537|524089098|FG001|Overall Study|Withdrawal by Subject|14|||
145338777|NCT01564537|524089097|FG000|Overall Study|Lost to Follow-up|7|||
145338778|NCT01564537|524089098|FG001|Overall Study|Lost to Follow-up|3|||
145338779|NCT01564537|524089097|FG000|Overall Study|Reason not specified|81|||
145338780|NCT01564537|524089098|FG001|Overall Study|Reason not specified|82|||
145338781|NCT05776862|524089099|FG000|Overall Study|Adverse Event|0|||
145338782|NCT05776862|524089100|FG001|Overall Study|Adverse Event|1|||
145338783|NCT05776862|524089099|FG000|Overall Study|non-compliance|1|||
145338784|NCT05776862|524089100|FG001|Overall Study|non-compliance|0|||
145574016|NCT03670810|524956599|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
145574017|NCT03670810|524956600|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
145338785|NCT02448706|524089101|FG000|Overall Study|Withdrawal by Subject|4|||
145338786|NCT02448706|524089102|FG001|Overall Study|Withdrawal by Subject|3|||
145574018|NCT03670810|524956601|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
145574019|NCT03670810|524956593|FG000|Open Label Extension|Lost to Follow-up|0|||
145574020|NCT03670810|524956594|FG001|Open Label Extension|Lost to Follow-up|0|||
145574021|NCT03670810|524956595|FG002|Open Label Extension|Lost to Follow-up|0|||
145574022|NCT03670810|524956596|FG003|Open Label Extension|Lost to Follow-up|0|||
145574023|NCT03670810|524956597|FG004|Open Label Extension|Lost to Follow-up|0|||
145574024|NCT03670810|524956598|FG005|Open Label Extension|Lost to Follow-up|0|||
145574025|NCT03670810|524956599|FG006|Open Label Extension|Lost to Follow-up|0|||
145574026|NCT03670810|524956600|FG007|Open Label Extension|Lost to Follow-up|0|||
145574027|NCT03670810|524956601|FG008|Open Label Extension|Lost to Follow-up|23|||
145574028|NCT05459129|524956602|FG000|Overall Study|Death|1|||
145574029|NCT05459129|524956603|FG001|Overall Study|Death|0|||
145574030|NCT05459129|524956602|FG000|Overall Study|Study Terminated By Sponsor|5|||
145574031|NCT05459129|524956603|FG001|Overall Study|Study Terminated By Sponsor|6|||
145574032|NCT04182100|524956604|FG000|Overall Study|Adverse Event|1|||
145574033|NCT04182100|524956604|FG000|Overall Study|Withdrawal by Subject|1|||
145574034|NCT04304001|524956608|FG000|Overall Study|Lost to Follow-up|13|||
145574035|NCT04304001|524956609|FG001|Overall Study|Lost to Follow-up|9|||
145574036|NCT02504372|524956610|FG000|Overall Study|Death|136|||
145574037|NCT02504372|524956611|FG001|Overall Study|Death|154|||
145574038|NCT02504372|524956610|FG000|Overall Study|Lost to Follow-up|0|||
145574039|NCT02504372|524956611|FG001|Overall Study|Lost to Follow-up|2|||
145574040|NCT02504372|524956610|FG000|Overall Study|Withdrawal of consent|25|||
145574041|NCT02504372|524956611|FG001|Overall Study|Withdrawal of consent|16|||
145574042|NCT02504372|524956610|FG000|Overall Study|Participants ongoing|429|||
145574043|NCT02504372|524956611|FG001|Overall Study|Participants ongoing|415|||
145574044|NCT04530552|524956614|FG000|Overall Study|Physician Decision|0|||
145574045|NCT04530552|524956615|FG001|Overall Study|Physician Decision|1|||
145574046|NCT04530552|524956614|FG000|Overall Study|Withdrawal by Subject|0|||
145574047|NCT04530552|524956615|FG001|Overall Study|Withdrawal by Subject|1|||
145574048|NCT04530552|524956614|FG000|Overall Study|Adverse Event|0|||
145574049|NCT04530552|524956615|FG001|Overall Study|Adverse Event|1|||
145574050|NCT04530552|524956614|FG000|Overall Study|No surgery|0|||
145574051|NCT04530552|524956615|FG001|Overall Study|No surgery|1|||
145574052|NCT00376168|524956619|FG000|Overall Study|Adverse Event|1|||
145574053|NCT00376168|524956620|FG001|Overall Study|Adverse Event|1|||
145574054|NCT00376168|524956619|FG000|Overall Study|Pregnancy|1|||
145574055|NCT00376168|524956620|FG001|Overall Study|Pregnancy|0|||
145574056|NCT02214121|524956621|FG000|Part A|Patient decision|2|||
145574057|NCT02214121|524956622|FG001|Part A|Patient decision|0|||
145574058|NCT02214121|524956623|FG002|Part A|Patient decision|0|||
145574059|NCT02214121|524956621|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
145574060|NCT02214121|524956622|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
145574061|NCT02214121|524956623|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
145574062|NCT02214121|524956621|FG000|Part A|Other|1|||
145574063|NCT02214121|524956622|FG001|Part A|Other|0|||
145574064|NCT02214121|524956623|FG002|Part A|Other|0|||
145574065|NCT02214121|524956621|FG000|Part B|Patient decision|0|||
145574066|NCT02214121|524956622|FG001|Part B|Patient decision|1|||
145574067|NCT02214121|524956623|FG002|Part B|Patient decision|0|||
145574068|NCT02214121|524956621|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
145574069|NCT02214121|524956622|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
145574070|NCT02214121|524956623|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
145574071|NCT02214121|524956621|FG000|Part B|Lost to Follow-up|0|||
145574072|NCT02214121|524956622|FG001|Part B|Lost to Follow-up|0|||
145574073|NCT02214121|524956623|FG002|Part B|Lost to Follow-up|1|||
145574074|NCT02114879|524956626|FG000|Overall Study|Withdrawal by Subject|9|||
145574075|NCT02114879|524956627|FG001|Overall Study|Withdrawal by Subject|5|||
145338787|NCT02448706|524089101|FG000|Overall Study|Protocol Violation|1|||
145338788|NCT02448706|524089102|FG001|Overall Study|Protocol Violation|1|||
145338789|NCT01199471|524089103|FG000|Overall Study|Protocol Violation|4|||
145338790|NCT01199471|524089103|FG000|Overall Study|Withdrawal by Subject|1|||
145338791|NCT01199471|524089103|FG000|Overall Study|Physician Decision|1|||
145338792|NCT02065700|524089104|FG000|Overall Study|Adverse Event|165|||
145338793|NCT02065700|524089105|FG001|Overall Study|Adverse Event|101|||
145338794|NCT02065700|524089104|FG000|Overall Study|Withdrawal by Subject|90|||
145574076|NCT02114879|524956626|FG000|Overall Study|Death|6|||
145574077|NCT02114879|524956627|FG001|Overall Study|Death|11|||
145574078|NCT02114879|524956626|FG000|Overall Study|Lost to Follow-up|4|||
145574079|NCT02114879|524956627|FG001|Overall Study|Lost to Follow-up|6|||
145574080|NCT02114879|524956626|FG000|Overall Study|Physician Decision|0|||
145574081|NCT02114879|524956627|FG001|Overall Study|Physician Decision|2|||
145574082|NCT02152995|524956628|FG000|Overall Study|Withdrawal by Subject|1|||
145574083|NCT02152995|524956629|FG001|Overall Study|Withdrawal by Subject|0|||
145574084|NCT01365273|524956630|FG000|Overall Study|Lost to Follow-up|1|||
145574085|NCT01365273|524956631|FG001|Overall Study|Lost to Follow-up|0|||
145574086|NCT01365273|524956630|FG000|Overall Study|Protocol Violation|0|||
145574087|NCT01365273|524956631|FG001|Overall Study|Protocol Violation|1|||
145574088|NCT01365273|524956630|FG000|Overall Study|Physician Decision|1|||
145574089|NCT01365273|524956631|FG001|Overall Study|Physician Decision|0|||
145338795|NCT02065700|524089105|FG001|Overall Study|Withdrawal by Subject|29|||
145338796|NCT02065700|524089104|FG000|Overall Study|Lost to Follow-up|12|||
145338797|NCT02065700|524089105|FG001|Overall Study|Lost to Follow-up|9|||
145338798|NCT02065700|524089104|FG000|Overall Study|Physician Decision|2|||
145338799|NCT02065700|524089105|FG001|Overall Study|Physician Decision|0|||
145338800|NCT02065700|524089104|FG000|Overall Study|Sponsor Request|38|||
145338801|NCT02065700|524089105|FG001|Overall Study|Sponsor Request|15|||
145338802|NCT02065700|524089104|FG000|Overall Study|Treatment Failure|3|||
145338803|NCT02065700|524089105|FG001|Overall Study|Treatment Failure|2|||
145338804|NCT02065700|524089104|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
145338805|NCT02065700|524089105|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
145338806|NCT02065700|524089104|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
145338807|NCT02065700|524089105|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
145338808|NCT02065700|524089104|FG000|Overall Study|Non-compliance with Study Procedures|2|||
145338809|NCT02065700|524089105|FG001|Overall Study|Non-compliance with Study Procedures|0|||
145338810|NCT02065700|524089104|FG000|Overall Study|Not Defined|21|||
145338811|NCT02065700|524089105|FG001|Overall Study|Not Defined|3|||
145338812|NCT03151408|524089106|FG000|Overall Study|Adverse Event|24|||
145338813|NCT03151408|524089107|FG001|Overall Study|Adverse Event|23|||
145338814|NCT03151408|524089106|FG000|Overall Study|Death|46|||
145338815|NCT03151408|524089107|FG001|Overall Study|Death|26|||
145338816|NCT03151408|524089106|FG000|Overall Study|Physician Decision|13|||
145338817|NCT03151408|524089107|FG001|Overall Study|Physician Decision|19|||
145338818|NCT03151408|524089106|FG000|Overall Study|Withdrawal by Subject|16|||
145338819|NCT03151408|524089107|FG001|Overall Study|Withdrawal by Subject|20|||
145338820|NCT03151408|524089106|FG000|Overall Study|Progressive disease|45|||
145338821|NCT03151408|524089107|FG001|Overall Study|Progressive disease|61|||
145338822|NCT03151408|524089106|FG000|Overall Study|non-compliance by patient|1|||
145338823|NCT03151408|524089107|FG001|Overall Study|non-compliance by patient|0|||
145338824|NCT03151408|524089106|FG000|Overall Study|other reasons|56|||
145338825|NCT03151408|524089107|FG001|Overall Study|other reasons|52|||
145338826|NCT03151408|524089106|FG000|Overall Study|randomized and not treated|2|||
145338827|NCT03151408|524089107|FG001|Overall Study|randomized and not treated|2|||
145338828|NCT01635218|524089108|FG000|Overall Study|Lost to Follow-up|3|||
145338829|NCT01635218|524089109|FG001|Overall Study|Lost to Follow-up|7|||
145338830|NCT01635218|524089110|FG002|Overall Study|Lost to Follow-up|6|||
145338831|NCT03262038|524089115|FG000|Overall Study|Withdrawal by Subject|0|||
145338832|NCT03262038|524089116|FG001|Overall Study|Withdrawal by Subject|1|||
145338833|NCT04933968|524089117|FG000|Overall Study|Adverse Event|0|||
145338834|NCT04933968|524089118|FG001|Overall Study|Adverse Event|0|||
145338835|NCT04933968|524089119|FG002|Overall Study|Adverse Event|1|||
145338836|NCT04933968|524089120|FG003|Overall Study|Adverse Event|1|||
145338837|NCT04933968|524089121|FG004|Overall Study|Adverse Event|0|||
145338838|NCT04933968|524089122|FG005|Overall Study|Adverse Event|0|||
145338839|NCT04933968|524089117|FG000|Overall Study|Lost to Follow-up|1|||
145338840|NCT04933968|524089118|FG001|Overall Study|Lost to Follow-up|0|||
145338841|NCT04933968|524089119|FG002|Overall Study|Lost to Follow-up|1|||
145338842|NCT04933968|524089120|FG003|Overall Study|Lost to Follow-up|0|||
145338843|NCT04933968|524089121|FG004|Overall Study|Lost to Follow-up|0|||
145338844|NCT04933968|524089122|FG005|Overall Study|Lost to Follow-up|0|||
145338845|NCT04933968|524089117|FG000|Overall Study|Randomized not treated|1|||
145338846|NCT04933968|524089118|FG001|Overall Study|Randomized not treated|0|||
145338847|NCT04933968|524089119|FG002|Overall Study|Randomized not treated|0|||
145338848|NCT04933968|524089120|FG003|Overall Study|Randomized not treated|0|||
145338849|NCT04933968|524089121|FG004|Overall Study|Randomized not treated|0|||
145338850|NCT04933968|524089122|FG005|Overall Study|Randomized not treated|0|||
145338851|NCT04933968|524089117|FG000|Overall Study|Sponsor terminated study|0|||
145338852|NCT04933968|524089118|FG001|Overall Study|Sponsor terminated study|0|||
145338853|NCT04933968|524089119|FG002|Overall Study|Sponsor terminated study|0|||
145338854|NCT04933968|524089120|FG003|Overall Study|Sponsor terminated study|1|||
145338855|NCT04933968|524089121|FG004|Overall Study|Sponsor terminated study|2|||
145338856|NCT04933968|524089122|FG005|Overall Study|Sponsor terminated study|0|||
145338857|NCT04933968|524089117|FG000|Overall Study|Other|0|||
145338858|NCT04933968|524089118|FG001|Overall Study|Other|0|||
145338859|NCT04933968|524089119|FG002|Overall Study|Other|0|||
145338860|NCT04933968|524089120|FG003|Overall Study|Other|1|||
145338861|NCT04933968|524089121|FG004|Overall Study|Other|0|||
145338862|NCT04933968|524089122|FG005|Overall Study|Other|0|||
145338863|NCT04933968|524089117|FG000|Overall Study|Missing|1|||
145338864|NCT04933968|524089118|FG001|Overall Study|Missing|3|||
145338865|NCT04933968|524089119|FG002|Overall Study|Missing|2|||
145338866|NCT04933968|524089120|FG003|Overall Study|Missing|1|||
145338867|NCT04933968|524089121|FG004|Overall Study|Missing|1|||
145338868|NCT04933968|524089122|FG005|Overall Study|Missing|0|||
145338869|NCT01724489|524089123|FG000|Overall Study|Adverse Event|8|||
145338870|NCT01724489|524089124|FG001|Overall Study|Adverse Event|3|||
145338871|NCT01724489|524089123|FG000|Overall Study|Surgery, medication|1|||
145338872|NCT01724489|524089124|FG001|Overall Study|Surgery, medication|1|||
145338873|NCT01724489|524089123|FG000|Overall Study|Lost to Follow-up|1|||
145338874|NCT01724489|524089124|FG001|Overall Study|Lost to Follow-up|2|||
145338875|NCT01724489|524089123|FG000|Overall Study|Withdrawal by Subject|6|||
145338876|NCT01724489|524089124|FG001|Overall Study|Withdrawal by Subject|6|||
145338877|NCT01664130|524089127|FG000|Overall Study|competing secondary disease|2|||
145338878|NCT00554606|524089131|FG000|Overall Study|Adverse Event|3|||
145338879|NCT00554606|524089131|FG000|Overall Study|Abnormal laboratory values|1|||
145574090|NCT00677807|524956635|FG000|Overall Study|Adverse Event|4|||
145574091|NCT00677807|524956636|FG001|Overall Study|Adverse Event|1|||
145574092|NCT00677807|524956637|FG002|Overall Study|Adverse Event|6|||
145574093|NCT00677807|524956635|FG000|Overall Study|Lack of Efficacy|0|||
145574094|NCT00677807|524956636|FG001|Overall Study|Lack of Efficacy|0|||
145574095|NCT00677807|524956637|FG002|Overall Study|Lack of Efficacy|2|||
145574096|NCT00677807|524956635|FG000|Overall Study|Participant no longer needs study drug|0|||
145574097|NCT00677807|524956636|FG001|Overall Study|Participant no longer needs study drug|0|||
145574098|NCT00677807|524956637|FG002|Overall Study|Participant no longer needs study drug|1|||
145574099|NCT00677807|524956635|FG000|Overall Study|Withdrawal by Subject|10|||
145574100|NCT00677807|524956636|FG001|Overall Study|Withdrawal by Subject|3|||
145574101|NCT00677807|524956637|FG002|Overall Study|Withdrawal by Subject|6|||
145574102|NCT00677807|524956635|FG000|Overall Study|Lost to Follow-up|2|||
145574103|NCT00677807|524956636|FG001|Overall Study|Lost to Follow-up|2|||
145574104|NCT00677807|524956637|FG002|Overall Study|Lost to Follow-up|2|||
145574105|NCT00677807|524956635|FG000|Overall Study|Administrative problems|1|||
145574106|NCT00677807|524956636|FG001|Overall Study|Administrative problems|1|||
145574107|NCT00677807|524956637|FG002|Overall Study|Administrative problems|2|||
145574108|NCT00677807|524956635|FG000|Overall Study|Death|0|||
145574109|NCT00677807|524956636|FG001|Overall Study|Death|1|||
145574110|NCT00677807|524956637|FG002|Overall Study|Death|1|||
145574111|NCT00677807|524956635|FG000|Overall Study|Protocol Deviation|1|||
145574112|NCT00677807|524956636|FG001|Overall Study|Protocol Deviation|3|||
145574113|NCT00677807|524956637|FG002|Overall Study|Protocol Deviation|0|||
145574114|NCT00989833|524956643|FG000|Overall Study|Lost to Follow-up|0|||
145574115|NCT00989833|524956644|FG001|Overall Study|Lost to Follow-up|1|||
145574116|NCT00989833|524956645|FG002|Overall Study|Lost to Follow-up|0|||
145574117|NCT00989833|524956643|FG000|Overall Study|Protocol Violation|1|||
145574118|NCT00989833|524956644|FG001|Overall Study|Protocol Violation|2|||
145574119|NCT00989833|524956645|FG002|Overall Study|Protocol Violation|1|||
145574120|NCT00989833|524956643|FG000|Overall Study|Withdrawal by Subject|0|||
145574121|NCT00989833|524956644|FG001|Overall Study|Withdrawal by Subject|0|||
145574122|NCT00989833|524956645|FG002|Overall Study|Withdrawal by Subject|1|||
145574123|NCT00989833|524956643|FG000|Overall Study|Incorrectly randomized|1|||
145574124|NCT00989833|524956644|FG001|Overall Study|Incorrectly randomized|0|||
145574125|NCT00989833|524956645|FG002|Overall Study|Incorrectly randomized|0|||
145574126|NCT02167256|524956646|FG000|Overall Study|Adverse Event|13|||
145574127|NCT02167256|524956647|FG001|Overall Study|Adverse Event|6|||
145574128|NCT02167256|524956646|FG000|Overall Study|Withdrawal by Subject|4|||
145574129|NCT02167256|524956647|FG001|Overall Study|Withdrawal by Subject|4|||
145574130|NCT02167256|524956646|FG000|Overall Study|non-compliance|3|||
145574131|NCT02167256|524956647|FG001|Overall Study|non-compliance|0|||
145574132|NCT02167256|524956646|FG000|Overall Study|Study partner unable to participate|1|||
145574133|NCT02167256|524956647|FG001|Overall Study|Study partner unable to participate|0|||
145574134|NCT00414388|524956648|FG000|Overall Study|Adverse Event|1|||
145574135|NCT03467425|524956649|FG000|Overall Study|Adverse Event|9|||
145574136|NCT03467425|524956650|FG001|Overall Study|Adverse Event|9|||
145574137|NCT03467425|524956649|FG000|Overall Study|Lack of Efficacy|3|||
145574138|NCT03467425|524956650|FG001|Overall Study|Lack of Efficacy|1|||
145574139|NCT03467425|524956649|FG000|Overall Study|Protocol Violation|0|||
145574140|NCT03467425|524956650|FG001|Overall Study|Protocol Violation|1|||
145574141|NCT03467425|524956649|FG000|Overall Study|Lost to Follow-up|18|||
145574142|NCT03467425|524956650|FG001|Overall Study|Lost to Follow-up|25|||
145574143|NCT03467425|524956649|FG000|Overall Study|Physician Decision|2|||
145574144|NCT03467425|524956650|FG001|Overall Study|Physician Decision|1|||
145574145|NCT03467425|524956649|FG000|Overall Study|Withdrawal by Subject|15|||
145574146|NCT03467425|524956650|FG001|Overall Study|Withdrawal by Subject|17|||
145574147|NCT01864291|524956651|FG000|Overall Study|need for revision surgery|2|||
145574148|NCT00689481|524956658|FG000|Overall Study|Adverse Event|7|||
145574149|NCT00689481|524956659|FG001|Overall Study|Adverse Event|1|||
145574150|NCT00689481|524956658|FG000|Overall Study|Lost to Follow-up|4|||
145574151|NCT00689481|524956659|FG001|Overall Study|Lost to Follow-up|3|||
145574152|NCT00689481|524956658|FG000|Overall Study|Lack of Efficacy|4|||
145574153|NCT00689481|524956659|FG001|Overall Study|Lack of Efficacy|3|||
145574154|NCT00689481|524956658|FG000|Overall Study|Non-compliance with study treatment|1|||
145574155|NCT00689481|524956659|FG001|Overall Study|Non-compliance with study treatment|1|||
145574156|NCT00689481|524956658|FG000|Overall Study|Withdrawal by Subject|8|||
145574157|NCT00689481|524956659|FG001|Overall Study|Withdrawal by Subject|4|||
145574158|NCT00689481|524956658|FG000|Overall Study|Excluded medication started during study|0|||
145574159|NCT00689481|524956659|FG001|Overall Study|Excluded medication started during study|1|||
145574160|NCT00689481|524956658|FG000|Overall Study|Subject early term, left on vacation|0|||
145574161|NCT00689481|524956659|FG001|Overall Study|Subject early term, left on vacation|1|||
145574162|NCT03091192|524956660|FG000|Overall Study|Study terminated by sponsor|21|||
145574163|NCT03091192|524956661|FG001|Overall Study|Study terminated by sponsor|14|||
145574164|NCT03091192|524956660|FG000|Overall Study|Death|9|||
145574165|NCT03091192|524956661|FG001|Overall Study|Death|13|||
145574166|NCT03091192|524956660|FG000|Overall Study|Withdrawal by Subject|2|||
145574167|NCT03091192|524956661|FG001|Overall Study|Withdrawal by Subject|0|||
145574168|NCT03091192|524956660|FG000|Overall Study|Lost to Follow-up|1|||
145574169|NCT03091192|524956661|FG001|Overall Study|Lost to Follow-up|0|||
145574170|NCT05645432|524956662|FG000|Overall Study|Withdrawal by Subject|1|||
145574171|NCT03195478|524956663|FG000|Overall Study|Disease Progression|5|||
145574172|NCT03195478|524956664|FG001|Overall Study|Disease Progression|4|||
145574173|NCT03195478|524956665|FG002|Overall Study|Disease Progression|6|||
145574174|NCT03195478|524956666|FG003|Overall Study|Disease Progression|1|||
145574175|NCT03195478|524956663|FG000|Overall Study|Study Drug Toxicity|2|||
145574176|NCT03195478|524956664|FG001|Overall Study|Study Drug Toxicity|0|||
145574177|NCT03195478|524956665|FG002|Overall Study|Study Drug Toxicity|0|||
145574178|NCT03195478|524956666|FG003|Overall Study|Study Drug Toxicity|1|||
145574179|NCT03195478|524956663|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
145574180|NCT03195478|524956664|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
145338880|NCT00554606|524089131|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
145338881|NCT00554606|524089131|FG000|Overall Study|Subject withdrew consent|2|||
145338882|NCT00554606|524089131|FG000|Overall Study|Lost to Follow-up|2|||
145338883|NCT00554606|524089131|FG000|Overall Study|Administrative problems|60|||
145338884|NCT00554606|524089131|FG000|Overall Study|Death|1|||
145338885|NCT00554606|524089131|FG000|Overall Study|Protocol deviation|2|||
145338886|NCT03323437|524089132|FG000|Overall Study|Withdrawal by Subject|0|||
145338887|NCT03323437|524089133|FG001|Overall Study|Withdrawal by Subject|4|||
145338888|NCT00926783|524089134|FG000|Overall Study|Incomplete CFAE Procedures|3|||
145338889|NCT00926783|524089135|FG001|Overall Study|Incomplete CFAE Procedures|3|||
145338890|NCT01439009|524089136|FG000|Overall Study|Physician Decision|5|||
145338891|NCT01439009|524089137|FG001|Overall Study|Physician Decision|3|||
145338892|NCT01439009|524089136|FG000|Overall Study|Protocol Violation|2|||
145338893|NCT01439009|524089137|FG001|Overall Study|Protocol Violation|0|||
145338894|NCT01439009|524089136|FG000|Overall Study|Deviation of exclusion criteria|1|||
145338895|NCT01439009|524089137|FG001|Overall Study|Deviation of exclusion criteria|0|||
145338896|NCT03257865|524089138|FG000|Overall Study|Adverse Event|4|||
145338897|NCT03257865|524089139|FG001|Overall Study|Adverse Event|8|||
145338898|NCT03257865|524089138|FG000|Overall Study|Lack of Efficacy|1|||
145338899|NCT03257865|524089139|FG001|Overall Study|Lack of Efficacy|2|||
145338900|NCT03257865|524089138|FG000|Overall Study|Non-compliance with Study Drug|0|||
145338901|NCT03257865|524089139|FG001|Overall Study|Non-compliance with Study Drug|2|||
145338902|NCT03257865|524089138|FG000|Overall Study|Withdrawal by Subject|23|||
145338903|NCT03257865|524089139|FG001|Overall Study|Withdrawal by Subject|17|||
145338904|NCT03257865|524089138|FG000|Overall Study|Physician Decision|3|||
145338905|NCT03257865|524089139|FG001|Overall Study|Physician Decision|1|||
145338906|NCT03257865|524089138|FG000|Overall Study|Other|0|||
145338907|NCT03257865|524089139|FG001|Overall Study|Other|1|||
145338908|NCT03257865|524089138|FG000|Overall Study|Lost to Follow-up|4|||
145338909|NCT03257865|524089139|FG001|Overall Study|Lost to Follow-up|4|||
145338910|NCT01934335|524089140|FG000|Overall Study|Withdrawal by Subject|1|||
145338911|NCT01934335|524089141|FG001|Overall Study|Withdrawal by Subject|1|||
145338912|NCT01421511|524089142|FG000|Overall Study|Lost to Follow-up|11|||
145338913|NCT01421511|524089143|FG001|Overall Study|Lost to Follow-up|14|||
145338914|NCT01421511|524089142|FG000|Overall Study|Randomized but didn't receive study drug|1|||
145338915|NCT01421511|524089143|FG001|Overall Study|Randomized but didn't receive study drug|7|||
145338916|NCT01421511|524089142|FG000|Overall Study|Physician Decision|0|||
145338917|NCT01421511|524089143|FG001|Overall Study|Physician Decision|1|||
145338918|NCT01421511|524089142|FG000|Overall Study|Withdrawal by Subject|6|||
145338919|NCT01421511|524089143|FG001|Overall Study|Withdrawal by Subject|5|||
145338920|NCT01421511|524089142|FG000|Overall Study|Death|1|||
145338921|NCT01421511|524089143|FG001|Overall Study|Death|1|||
145338922|NCT01661062|524089146|FG000|Overall Study|Completed Treatment Off Study|3|||
145338923|NCT01661062|524089146|FG000|Overall Study|Withdrawal by Subject|2|||
145338924|NCT01292226|524089149|FG000|Overall Study|Adverse Event|5|||
145574181|NCT03195478|524956665|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
145574182|NCT03195478|524956666|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
145574183|NCT03195478|524956663|FG000|Overall Study|Participant Withdrew Consent|1|||
145574184|NCT03195478|524956664|FG001|Overall Study|Participant Withdrew Consent|0|||
145574185|NCT03195478|524956665|FG002|Overall Study|Participant Withdrew Consent|0|||
145338925|NCT01292226|524089149|FG000|Overall Study|Death|1|||
145338926|NCT01292226|524089149|FG000|Overall Study|Graft loss|1|||
145338927|NCT01292226|524089149|FG000|Overall Study|Protocol Violation|3|||
145338928|NCT01292226|524089149|FG000|Overall Study|Withdrawal by Subject|1|||
145338929|NCT01292226|524089149|FG000|Overall Study|Other|2|||
145338930|NCT04106661|524089150|FG000|Overall Study|Protocol Violation|3|||
145338931|NCT04106661|524089151|FG001|Overall Study|Protocol Violation|0|||
145338932|NCT04106661|524089150|FG000|Overall Study|Scheduling difficulties|1|||
145338933|NCT04106661|524089151|FG001|Overall Study|Scheduling difficulties|1|||
145338934|NCT00233402|524089152|FG000|Overall Study|No pathology data|12|||
145338935|NCT00233402|524089153|FG001|Overall Study|No pathology data|9|||
145338936|NCT00233402|524089152|FG000|Overall Study|No Ta/T1|89|||
145338937|NCT00233402|524089153|FG001|Overall Study|No Ta/T1|94|||
145338938|NCT00233402|524089152|FG000|Overall Study|Lost to follow up etc|3|||
145338939|NCT00233402|524089153|FG001|Overall Study|Lost to follow up etc|21|||
145338940|NCT00423319|524089156|FG000|Overall Study|Death|2|||
145338941|NCT00423319|524089157|FG001|Overall Study|Death|0|||
145338942|NCT00423319|524089156|FG000|Overall Study|Adverse Event|93|||
145338943|NCT00423319|524089157|FG001|Overall Study|Adverse Event|112|||
145338944|NCT00423319|524089156|FG000|Overall Study|Withdrawal by Subject|86|||
145338945|NCT00423319|524089157|FG001|Overall Study|Withdrawal by Subject|99|||
145338946|NCT00423319|524089156|FG000|Overall Study|Lost to Follow-up|4|||
145338947|NCT00423319|524089157|FG001|Overall Study|Lost to Follow-up|3|||
145338948|NCT00423319|524089156|FG000|Overall Study|Poor compliance or noncompliance|1|||
145338949|NCT00423319|524089157|FG001|Overall Study|Poor compliance or noncompliance|1|||
145338950|NCT00423319|524089156|FG000|Overall Study|No longer meets study criteria|15|||
145338951|NCT00423319|524089157|FG001|Overall Study|No longer meets study criteria|15|||
145338952|NCT00423319|524089156|FG000|Overall Study|Other|23|||
145338953|NCT00423319|524089157|FG001|Overall Study|Other|22|||
145338954|NCT02639052|524089158|FG000|Overall Study|Lost to Follow-up|1|||
145338955|NCT04572893|524089164|FG000|Part A|Adverse Event|1|||
145338956|NCT04572893|524089165|FG001|Part A|Adverse Event|0|||
145338957|NCT04572893|524089166|FG002|Part A|Adverse Event|0|||
145338958|NCT04572893|524089167|FG003|Part A|Adverse Event|0|||
145338959|NCT04572893|524089168|FG004|Part A|Adverse Event|0|||
145338960|NCT04572893|524089169|FG005|Part A|Adverse Event|0|||
145338961|NCT04572893|524089170|FG006|Part A|Adverse Event|0|||
145338962|NCT04572893|524089164|FG000|Part B|Withdrawal by Subject|0|||
145338963|NCT04572893|524089165|FG001|Part B|Withdrawal by Subject|0|||
145338964|NCT04572893|524089166|FG002|Part B|Withdrawal by Subject|0|||
145338965|NCT04572893|524089167|FG003|Part B|Withdrawal by Subject|0|||
145338966|NCT04572893|524089168|FG004|Part B|Withdrawal by Subject|0|||
145338967|NCT04572893|524089169|FG005|Part B|Withdrawal by Subject|1|||
145338968|NCT04572893|524089170|FG006|Part B|Withdrawal by Subject|0|||
145338969|NCT04572893|524089164|FG000|Part B|Study terminated by sponsor|0|||
145338970|NCT04572893|524089165|FG001|Part B|Study terminated by sponsor|0|||
145338971|NCT04572893|524089166|FG002|Part B|Study terminated by sponsor|0|||
145338972|NCT04572893|524089167|FG003|Part B|Study terminated by sponsor|0|||
145338973|NCT04572893|524089168|FG004|Part B|Study terminated by sponsor|7|||
145338974|NCT04572893|524089169|FG005|Part B|Study terminated by sponsor|5|||
145338975|NCT04572893|524089170|FG006|Part B|Study terminated by sponsor|3|||
145338976|NCT04572893|524089164|FG000|Part B|Lost to Follow-up|0|||
145338977|NCT04572893|524089165|FG001|Part B|Lost to Follow-up|0|||
145338978|NCT04572893|524089166|FG002|Part B|Lost to Follow-up|0|||
145338979|NCT04572893|524089167|FG003|Part B|Lost to Follow-up|0|||
145338980|NCT04572893|524089168|FG004|Part B|Lost to Follow-up|0|||
145338981|NCT04572893|524089169|FG005|Part B|Lost to Follow-up|0|||
145338982|NCT04572893|524089170|FG006|Part B|Lost to Follow-up|1|||
145338983|NCT04572893|524089164|FG000|Part B|Adverse Event|0|||
145338984|NCT04572893|524089165|FG001|Part B|Adverse Event|0|||
145338985|NCT04572893|524089166|FG002|Part B|Adverse Event|0|||
145338986|NCT04572893|524089167|FG003|Part B|Adverse Event|0|||
145338987|NCT04572893|524089168|FG004|Part B|Adverse Event|1|||
145338988|NCT04572893|524089169|FG005|Part B|Adverse Event|1|||
145338989|NCT04572893|524089170|FG006|Part B|Adverse Event|0|||
145338990|NCT05038800|524089171|FG000|Overall Study|Death|1|||
145338991|NCT05038800|524089172|FG001|Overall Study|Death|1|||
145574186|NCT03195478|524956666|FG003|Overall Study|Participant Withdrew Consent|0|||
145574187|NCT03195478|524956663|FG000|Overall Study|Maximum Clinical benefit|0|||
145574188|NCT03195478|524956664|FG001|Overall Study|Maximum Clinical benefit|0|||
145338992|NCT05038800|524089173|FG002|Overall Study|Death|5|||
145338993|NCT05038800|524089174|FG003|Overall Study|Death|3|||
145574189|NCT03195478|524956665|FG002|Overall Study|Maximum Clinical benefit|1|||
145338994|NCT05038800|524089175|FG004|Overall Study|Death|1|||
145338995|NCT05038800|524089171|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145574190|NCT03195478|524956666|FG003|Overall Study|Maximum Clinical benefit|0|||
145338996|NCT05038800|524089172|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145338997|NCT05038800|524089173|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145338998|NCT05038800|524089174|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145338999|NCT05038800|524089175|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145339000|NCT05038800|524089171|FG000|Overall Study|Lack of Efficacy|0|||
145339001|NCT05038800|524089172|FG001|Overall Study|Lack of Efficacy|0|||
145339002|NCT05038800|524089173|FG002|Overall Study|Lack of Efficacy|0|||
145339003|NCT05038800|524089174|FG003|Overall Study|Lack of Efficacy|0|||
145339004|NCT05038800|524089175|FG004|Overall Study|Lack of Efficacy|1|||
145339005|NCT00121134|524089176|FG000|Overall Study|Progression of Disease|5|||
145339006|NCT00121134|524089177|FG001|Overall Study|Progression of Disease|3|||
145339007|NCT00121134|524089178|FG002|Overall Study|Progression of Disease|4|||
145339008|NCT00121134|524089179|FG003|Overall Study|Progression of Disease|2|||
145339009|NCT00121134|524089176|FG000|Overall Study|Toxicity|4|||
145339010|NCT00121134|524089177|FG001|Overall Study|Toxicity|7|||
145339011|NCT00121134|524089178|FG002|Overall Study|Toxicity|13|||
145339012|NCT00121134|524089179|FG003|Overall Study|Toxicity|5|||
145339013|NCT00121134|524089176|FG000|Overall Study|Physician Decision|6|||
145339014|NCT00121134|524089177|FG001|Overall Study|Physician Decision|4|||
145339015|NCT00121134|524089178|FG002|Overall Study|Physician Decision|4|||
145339016|NCT00121134|524089179|FG003|Overall Study|Physician Decision|1|||
145339017|NCT00121134|524089176|FG000|Overall Study|Treatment Delay|1|||
145339018|NCT00121134|524089177|FG001|Overall Study|Treatment Delay|0|||
145339019|NCT00121134|524089178|FG002|Overall Study|Treatment Delay|0|||
145339020|NCT00121134|524089179|FG003|Overall Study|Treatment Delay|0|||
145339021|NCT00121134|524089176|FG000|Overall Study|Intercurrent Illness|0|||
145339022|NCT00121134|524089177|FG001|Overall Study|Intercurrent Illness|0|||
145339023|NCT00121134|524089178|FG002|Overall Study|Intercurrent Illness|0|||
145339024|NCT00121134|524089179|FG003|Overall Study|Intercurrent Illness|1|||
145339025|NCT00121134|524089176|FG000|Overall Study|Patient Personal Reasons|0|||
145339026|NCT00121134|524089177|FG001|Overall Study|Patient Personal Reasons|1|||
145339027|NCT00121134|524089178|FG002|Overall Study|Patient Personal Reasons|0|||
145339028|NCT00121134|524089179|FG003|Overall Study|Patient Personal Reasons|0|||
145339029|NCT02478320|524089182|FG000|Overall Study|Adverse Event|2|||
145339030|NCT02478320|524089183|FG001|Overall Study|Adverse Event|0|||
145339031|NCT02478320|524089182|FG000|Overall Study|Death|1|||
145339032|NCT02478320|524089183|FG001|Overall Study|Death|0|||
145339033|NCT02478320|524089182|FG000|Overall Study|Lack of Efficacy|4|||
145339034|NCT02478320|524089183|FG001|Overall Study|Lack of Efficacy|0|||
145339035|NCT02478320|524089182|FG000|Overall Study|Withdrawal by Subject|2|||
145339036|NCT02478320|524089183|FG001|Overall Study|Withdrawal by Subject|0|||
145339037|NCT02478320|524089182|FG000|Overall Study|Screen Failure|3|||
145339038|NCT02478320|524089183|FG001|Overall Study|Screen Failure|0|||
145339039|NCT04428333|524089184|FG000|Overall Study|Physician Decision|5|||
145339040|NCT04428333|524089185|FG001|Overall Study|Physician Decision|6|||
145339041|NCT04428333|524089184|FG000|Overall Study|Withdrawal by Subject|1|||
145339042|NCT04428333|524089185|FG001|Overall Study|Withdrawal by Subject|3|||
145339043|NCT04428333|524089184|FG000|Overall Study|Study Terminated By Sponsor|14|||
145339044|NCT04428333|524089185|FG001|Overall Study|Study Terminated By Sponsor|16|||
145339045|NCT04853992|524089186|FG000|Treatment Period A|Adverse Event|0|||
145339046|NCT04853992|524089187|FG001|Treatment Period A|Adverse Event|1|||
145339047|NCT04853992|524089186|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
145339048|NCT04853992|524089187|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
145339049|NCT02269163|524089188|FG000|Overall Study|Lost to Follow-up|1|||
145339050|NCT02269163|524089189|FG001|Overall Study|Lost to Follow-up|0|||
145339051|NCT02269163|524089188|FG000|Overall Study|Major protocol violation|0|||
145339052|NCT02269163|524089189|FG001|Overall Study|Major protocol violation|1|||
145339053|NCT02269163|524089188|FG000|Overall Study|Other|2|||
145339054|NCT02269163|524089189|FG001|Overall Study|Other|2|||
145339055|NCT02269163|524089188|FG000|Overall Study|Withdrawal by Subject|0|||
145339056|NCT02269163|524089189|FG001|Overall Study|Withdrawal by Subject|3|||
145339057|NCT02269163|524089188|FG000|Overall Study|Physician Decision|0|||
145339058|NCT02269163|524089189|FG001|Overall Study|Physician Decision|1|||
145339059|NCT00758680|524089190|FG000|Overall Study|Adverse Event|0|||
145339060|NCT00758680|524089191|FG001|Overall Study|Adverse Event|0|||
145339061|NCT00758680|524089192|FG002|Overall Study|Adverse Event|0|||
145339062|NCT00758680|524089193|FG003|Overall Study|Adverse Event|0|||
145339063|NCT00758680|524089194|FG004|Overall Study|Adverse Event|0|||
145339064|NCT00758680|524089195|FG005|Overall Study|Adverse Event|0|||
145339065|NCT00758680|524089196|FG006|Overall Study|Adverse Event|0|||
145339066|NCT00758680|524089197|FG007|Overall Study|Adverse Event|1|||
145339067|NCT00758680|524089198|FG008|Overall Study|Adverse Event|0|||
145339068|NCT00758680|524089199|FG009|Overall Study|Adverse Event|1|||
145339069|NCT00758680|524089190|FG000|Overall Study|Laboratory Adverse Event|0|||
145339070|NCT00758680|524089191|FG001|Overall Study|Laboratory Adverse Event|0|||
145339071|NCT00758680|524089192|FG002|Overall Study|Laboratory Adverse Event|0|||
145339072|NCT00758680|524089193|FG003|Overall Study|Laboratory Adverse Event|0|||
145339073|NCT00758680|524089194|FG004|Overall Study|Laboratory Adverse Event|0|||
145339074|NCT00758680|524089195|FG005|Overall Study|Laboratory Adverse Event|0|||
145339075|NCT00758680|524089196|FG006|Overall Study|Laboratory Adverse Event|0|||
145339076|NCT00758680|524089197|FG007|Overall Study|Laboratory Adverse Event|0|||
145339077|NCT00758680|524089198|FG008|Overall Study|Laboratory Adverse Event|1|||
145339078|NCT00758680|524089199|FG009|Overall Study|Laboratory Adverse Event|0|||
145339079|NCT00758680|524089190|FG000|Overall Study|Withdrawal by Subject|0|||
145339080|NCT00758680|524089191|FG001|Overall Study|Withdrawal by Subject|0|||
145339081|NCT00758680|524089192|FG002|Overall Study|Withdrawal by Subject|0|||
145339082|NCT00758680|524089193|FG003|Overall Study|Withdrawal by Subject|0|||
145574191|NCT03195478|524956663|FG000|Overall Study|Other Reasons|0|||
145574192|NCT03195478|524956664|FG001|Overall Study|Other Reasons|0|||
145574193|NCT03195478|524956665|FG002|Overall Study|Other Reasons|1|||
145574194|NCT03195478|524956666|FG003|Overall Study|Other Reasons|0|||
145574195|NCT02349711|524958192|FG000|Overall Study|Withdrawal by Subject|2|||
145574196|NCT02349711|524958193|FG001|Overall Study|Withdrawal by Subject|1|||
145574197|NCT02349711|524958192|FG000|Overall Study|Lost to Follow-up|1|||
145574198|NCT02349711|524958193|FG001|Overall Study|Lost to Follow-up|1|||
145574199|NCT01105533|524958199|FG000|Overall Study|Death|0|||
145574200|NCT01105533|524958200|FG001|Overall Study|Death|0|||
145574201|NCT01105533|524958201|FG002|Overall Study|Death|0|||
145574202|NCT01105533|524958202|FG003|Overall Study|Death|0|||
145574203|NCT01105533|524958203|FG004|Overall Study|Death|1|||
145574204|NCT01105533|524958204|FG005|Overall Study|Death|0|||
145574205|NCT01105533|524958205|FG006|Overall Study|Death|0|||
145574206|NCT01105533|524958206|FG007|Overall Study|Death|0|||
145574207|NCT01105533|524958207|FG008|Overall Study|Death|0|||
145574208|NCT01105533|524958199|FG000|Overall Study|Lack of Efficacy|1|||
145574209|NCT01105533|524958200|FG001|Overall Study|Lack of Efficacy|1|||
145574210|NCT01105533|524958201|FG002|Overall Study|Lack of Efficacy|3|||
145574211|NCT01105533|524958202|FG003|Overall Study|Lack of Efficacy|3|||
145574212|NCT01105533|524958203|FG004|Overall Study|Lack of Efficacy|4|||
145574213|NCT01105533|524958204|FG005|Overall Study|Lack of Efficacy|5|||
145574214|NCT01105533|524958205|FG006|Overall Study|Lack of Efficacy|3|||
145574215|NCT01105533|524958206|FG007|Overall Study|Lack of Efficacy|2|||
145574216|NCT01105533|524958207|FG008|Overall Study|Lack of Efficacy|9|||
145574217|NCT01105533|524958199|FG000|Overall Study|Adverse Event|0|||
145574218|NCT01105533|524958200|FG001|Overall Study|Adverse Event|0|||
145574219|NCT01105533|524958201|FG002|Overall Study|Adverse Event|0|||
145574220|NCT01105533|524958202|FG003|Overall Study|Adverse Event|0|||
145574221|NCT01105533|524958203|FG004|Overall Study|Adverse Event|1|||
145574222|NCT01105533|524958204|FG005|Overall Study|Adverse Event|2|||
145574223|NCT01105533|524958205|FG006|Overall Study|Adverse Event|2|||
145574224|NCT01105533|524958206|FG007|Overall Study|Adverse Event|0|||
145574225|NCT01105533|524958207|FG008|Overall Study|Adverse Event|1|||
145574226|NCT01105533|524958199|FG000|Overall Study|Other|0|||
145574227|NCT01105533|524958200|FG001|Overall Study|Other|0|||
145574228|NCT01105533|524958201|FG002|Overall Study|Other|0|||
145574229|NCT01105533|524958202|FG003|Overall Study|Other|0|||
145574230|NCT01105533|524958203|FG004|Overall Study|Other|1|||
145574231|NCT01105533|524958204|FG005|Overall Study|Other|0|||
145574232|NCT01105533|524958205|FG006|Overall Study|Other|3|||
145574233|NCT01105533|524958206|FG007|Overall Study|Other|1|||
145574234|NCT01105533|524958207|FG008|Overall Study|Other|2|||
145574235|NCT01105533|524958199|FG000|Overall Study|Physician Decision|0|||
145574236|NCT01105533|524958200|FG001|Overall Study|Physician Decision|0|||
145574237|NCT01105533|524958201|FG002|Overall Study|Physician Decision|0|||
145574238|NCT01105533|524958202|FG003|Overall Study|Physician Decision|0|||
145574239|NCT01105533|524958203|FG004|Overall Study|Physician Decision|0|||
145339083|NCT00758680|524089194|FG004|Overall Study|Withdrawal by Subject|0|||
145339084|NCT00758680|524089195|FG005|Overall Study|Withdrawal by Subject|0|||
145339085|NCT00758680|524089196|FG006|Overall Study|Withdrawal by Subject|1|||
145339086|NCT00758680|524089197|FG007|Overall Study|Withdrawal by Subject|0|||
145339087|NCT00758680|524089198|FG008|Overall Study|Withdrawal by Subject|1|||
145339088|NCT00758680|524089199|FG009|Overall Study|Withdrawal by Subject|0|||
145339089|NCT01284621|524089200|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145339090|NCT01284621|524089201|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145339091|NCT01284621|524089202|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145339092|NCT01284621|524089203|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145339093|NCT01284621|524089204|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
145339094|NCT01284621|524089205|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
145339095|NCT02099682|524089208|FG000|Overall Study|Data Not Available|51|||
145339096|NCT02099682|524089208|FG000|Overall Study|Lost to Follow-up|31|||
145339097|NCT02099682|524089208|FG000|Overall Study|Other|29|||
145339098|NCT02802631|524089209|FG000|Overall Study|Withdrawal by Subject|1|||
145339099|NCT02802631|524089210|FG001|Overall Study|Withdrawal by Subject|0|||
145339100|NCT02802631|524089211|FG002|Overall Study|Withdrawal by Subject|0|||
145339101|NCT02802631|524089212|FG003|Overall Study|Withdrawal by Subject|0|||
145339102|NCT02802631|524089213|FG004|Overall Study|Withdrawal by Subject|0|||
145339103|NCT02802631|524089214|FG005|Overall Study|Withdrawal by Subject|0|||
145339104|NCT02802631|524089215|FG006|Overall Study|Withdrawal by Subject|0|||
145339105|NCT02802631|524089216|FG007|Overall Study|Withdrawal by Subject|0|||
145339106|NCT02802631|524089209|FG000|Overall Study|Physician Decision|1|||
145339107|NCT02802631|524089210|FG001|Overall Study|Physician Decision|0|||
145339108|NCT02802631|524089211|FG002|Overall Study|Physician Decision|0|||
145574240|NCT01105533|524958204|FG005|Overall Study|Physician Decision|0|||
145574241|NCT01105533|524958205|FG006|Overall Study|Physician Decision|0|||
145574242|NCT01105533|524958206|FG007|Overall Study|Physician Decision|1|||
145574243|NCT01105533|524958207|FG008|Overall Study|Physician Decision|0|||
145339109|NCT02802631|524089212|FG003|Overall Study|Physician Decision|0|||
145339110|NCT02802631|524089213|FG004|Overall Study|Physician Decision|0|||
145339111|NCT02802631|524089214|FG005|Overall Study|Physician Decision|0|||
145339112|NCT02802631|524089215|FG006|Overall Study|Physician Decision|1|||
145339113|NCT02802631|524089216|FG007|Overall Study|Physician Decision|0|||
145339114|NCT02802631|524089209|FG000|Overall Study|Adverse Event|0|||
145339115|NCT02802631|524089210|FG001|Overall Study|Adverse Event|2|||
145339116|NCT02802631|524089211|FG002|Overall Study|Adverse Event|0|||
145339117|NCT02802631|524089212|FG003|Overall Study|Adverse Event|1|||
145339118|NCT02802631|524089213|FG004|Overall Study|Adverse Event|6|||
145339119|NCT02802631|524089214|FG005|Overall Study|Adverse Event|1|||
145339120|NCT02802631|524089215|FG006|Overall Study|Adverse Event|4|||
145339121|NCT02802631|524089216|FG007|Overall Study|Adverse Event|0|||
145339122|NCT02802631|524089209|FG000|Overall Study|Sponsor Decision|0|||
145339123|NCT02802631|524089210|FG001|Overall Study|Sponsor Decision|0|||
145339124|NCT02802631|524089211|FG002|Overall Study|Sponsor Decision|6|||
145339125|NCT02802631|524089212|FG003|Overall Study|Sponsor Decision|0|||
145339126|NCT02802631|524089213|FG004|Overall Study|Sponsor Decision|2|||
145339127|NCT02802631|524089214|FG005|Overall Study|Sponsor Decision|0|||
145339128|NCT02802631|524089215|FG006|Overall Study|Sponsor Decision|0|||
145339129|NCT02802631|524089216|FG007|Overall Study|Sponsor Decision|4|||
145339130|NCT02342639|524089217|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
145339131|NCT02342639|524089218|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
145339132|NCT02342639|524089217|FG000|Overall Study|Protocol Violation|0|||
145339133|NCT02342639|524089218|FG001|Overall Study|Protocol Violation|2|||
145339134|NCT02293863|524089219|FG000|Overall Study|Death|4|||
145339135|NCT02293863|524089220|FG001|Overall Study|Death|6|||
145339136|NCT02293863|524089221|FG002|Overall Study|Death|4|||
145339137|NCT02293863|524089219|FG000|Overall Study|Lost to Follow-up|2|||
145339138|NCT02293863|524089220|FG001|Overall Study|Lost to Follow-up|2|||
145339139|NCT02293863|524089221|FG002|Overall Study|Lost to Follow-up|2|||
145339140|NCT02293863|524089219|FG000|Overall Study|Withdrawal by Subject|3|||
145339141|NCT02293863|524089220|FG001|Overall Study|Withdrawal by Subject|3|||
145339142|NCT02293863|524089221|FG002|Overall Study|Withdrawal by Subject|1|||
145339143|NCT02293863|524089219|FG000|Overall Study|Reason Not Specified|0|||
145339144|NCT02293863|524089220|FG001|Overall Study|Reason Not Specified|2|||
145339145|NCT02293863|524089221|FG002|Overall Study|Reason Not Specified|2|||
145339146|NCT02212379|524089222|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
145339147|NCT02212379|524089222|FG000|From Baseline to Week 48|Adverse Event|7|||
145339148|NCT02212379|524089222|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
145339149|NCT02212379|524089222|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
145339150|NCT02212379|524089222|FG000|From Week 48 to Week 96|Adverse Event|1|||
145339151|NCT02212379|524089222|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
145339152|NCT00416884|524089225|FG000|Overall Study|Study terminated due to low accrual|1|||
145339153|NCT00704730|524089226|FG000|Overall Study|Adverse Event|35|||
145339154|NCT00704730|524089227|FG001|Overall Study|Adverse Event|9|||
145339155|NCT00704730|524089226|FG000|Overall Study|Death|11|||
145339156|NCT00704730|524089227|FG001|Overall Study|Death|5|||
145339157|NCT00704730|524089226|FG000|Overall Study|Physician Decision|2|||
145339158|NCT00704730|524089227|FG001|Overall Study|Physician Decision|0|||
145339159|NCT00704730|524089226|FG000|Overall Study|Did not receive drug|5|||
145339160|NCT00704730|524089227|FG001|Overall Study|Did not receive drug|2|||
145339161|NCT00704730|524089226|FG000|Overall Study|Disease progression per PI|58|||
145339162|NCT00704730|524089227|FG001|Overall Study|Disease progression per PI|67|||
145339163|NCT00704730|524089226|FG000|Overall Study|data unavailable|1|||
145339164|NCT00704730|524089227|FG001|Overall Study|data unavailable|0|||
145339165|NCT00704730|524089226|FG000|Overall Study|Withdrawal by Subject|9|||
145339166|NCT00704730|524089227|FG001|Overall Study|Withdrawal by Subject|13|||
145339167|NCT04975191|524091048|FG000|Overall Study|Protocol Violation|1|||
145339168|NCT04975191|524091049|FG001|Overall Study|Protocol Violation|2|||
145339169|NCT04975191|524091050|FG002|Overall Study|Protocol Violation|2|||
145574244|NCT02096835|524958208|FG000|Overall Study|Withdrawal by Subject|1|||
145339170|NCT04975191|524091051|FG003|Overall Study|Protocol Violation|2|||
145339171|NCT04975191|524091048|FG000|Overall Study|Lost to Follow-up|13|||
145339172|NCT04975191|524091049|FG001|Overall Study|Lost to Follow-up|3|||
145339173|NCT04975191|524091050|FG002|Overall Study|Lost to Follow-up|8|||
145339174|NCT04975191|524091051|FG003|Overall Study|Lost to Follow-up|8|||
145574245|NCT02096835|524958209|FG001|Overall Study|Withdrawal by Subject|0|||
145339175|NCT00761657|524091052|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
145339176|NCT00761657|524091053|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
145339177|NCT00761657|524091054|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
145339178|NCT00761657|524091055|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
145339179|NCT00761657|524091056|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
145339180|NCT00761657|524091057|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
145339181|NCT00761657|524091058|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
145339182|NCT00761657|524091059|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
145339183|NCT00761657|524091060|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
145339184|NCT00761657|524091052|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145622443|NCT01460381|525130088|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
145622444|NCT01460381|525130089|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
145622445|NCT01033643|525130091|FG000|Overall Study|Withdrew Consent|0|||
145622446|NCT01033643|525130092|FG001|Overall Study|Withdrew Consent|3|||
145622447|NCT01033643|525130093|FG002|Overall Study|Withdrew Consent|0|||
145622448|NCT01033643|525130094|FG003|Overall Study|Withdrew Consent|0|||
145622449|NCT01033643|525130095|FG004|Overall Study|Withdrew Consent|0|||
145622450|NCT01033643|525130096|FG005|Overall Study|Withdrew Consent|1|||
145622451|NCT02652130|525130103|FG000|Overall Study|Death|1|||
145622452|NCT02028884|525130104|FG000|Double-blind Period|Adverse Event|5|||
145622453|NCT02028884|525130105|FG001|Double-blind Period|Adverse Event|3|||
145622454|NCT02028884|525130106|FG002|Double-blind Period|Adverse Event|0|||
145622455|NCT02028884|525130104|FG000|Double-blind Period|Eligibility Violation|1|||
145622456|NCT02028884|525130105|FG001|Double-blind Period|Eligibility Violation|0|||
145622457|NCT02028884|525130106|FG002|Double-blind Period|Eligibility Violation|0|||
145622458|NCT02028884|525130104|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
145622459|NCT02028884|525130105|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
145622460|NCT02028884|525130106|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
145622461|NCT02028884|525130104|FG000|Double-blind Period|Withdrawal by Subject|2|||
145622462|NCT02028884|525130105|FG001|Double-blind Period|Withdrawal by Subject|0|||
145622463|NCT02028884|525130106|FG002|Double-blind Period|Withdrawal by Subject|0|||
145622464|NCT02028884|525130104|FG000|Open-label Extension Period|Adverse Event|3|||
145622465|NCT02028884|525130105|FG001|Open-label Extension Period|Adverse Event|1|||
145622466|NCT02028884|525130106|FG002|Open-label Extension Period|Adverse Event|0|||
145622467|NCT02028884|525130104|FG000|Open-label Extension Period|Lack of Efficacy|3|||
145622468|NCT02028884|525130105|FG001|Open-label Extension Period|Lack of Efficacy|0|||
145622469|NCT02028884|525130106|FG002|Open-label Extension Period|Lack of Efficacy|0|||
145622470|NCT02028884|525130104|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
145622471|NCT02028884|525130105|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
145622472|NCT02028884|525130106|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
145622473|NCT02028884|525130104|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
145622474|NCT02028884|525130105|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
145622475|NCT02028884|525130106|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
145622476|NCT02028884|525130104|FG000|Open-label Extension Period|Switched to another treatment option|3|||
145622477|NCT02028884|525130105|FG001|Open-label Extension Period|Switched to another treatment option|0|||
145622478|NCT02028884|525130106|FG002|Open-label Extension Period|Switched to another treatment option|0|||
145622479|NCT02403674|525130107|FG000|Base Study|Death|1|||
145622480|NCT02403674|525130108|FG001|Base Study|Death|4|||
145622481|NCT02403674|525130107|FG000|Base Study|Adverse Event|11|||
145622482|NCT02403674|525130108|FG001|Base Study|Adverse Event|26|||
145622483|NCT02403674|525130107|FG000|Base Study|Lack of Efficacy|31|||
145622484|NCT02403674|525130108|FG001|Base Study|Lack of Efficacy|23|||
145622485|NCT02403674|525130107|FG000|Base Study|Lost to Follow-up|6|||
145622486|NCT02403674|525130108|FG001|Base Study|Lost to Follow-up|8|||
145622487|NCT02403674|525130107|FG000|Base Study|Withdrawal by Subject|10|||
145622488|NCT02403674|525130108|FG001|Base Study|Withdrawal by Subject|17|||
145622489|NCT02403674|525130107|FG000|Base Study|Physician Decision|2|||
145622490|NCT02403674|525130108|FG001|Base Study|Physician Decision|2|||
145622491|NCT02403674|525130107|FG000|Base Study|Pregnancy|2|||
145622492|NCT02403674|525130108|FG001|Base Study|Pregnancy|2|||
145622493|NCT02403674|525130107|FG000|Base Study|Protocol Violation|8|||
145622494|NCT02403674|525130108|FG001|Base Study|Protocol Violation|4|||
145622495|NCT02403674|525130107|FG000|Base Study|Non-Compliance with study drug|1|||
145622496|NCT02403674|525130108|FG001|Base Study|Non-Compliance with study drug|4|||
145622497|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
145622498|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
145622499|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
145622500|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
145622501|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
145622502|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
145622503|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
145622504|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
145622505|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
145622506|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
145622507|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
145622508|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
145622509|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Death|1|||
145622510|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Death|0|||
145622511|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
145622512|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
145622513|NCT02403674|525130107|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
145622514|NCT02403674|525130108|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
145622515|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
145622516|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
145339185|NCT00761657|524091053|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339186|NCT00761657|524091054|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
145339187|NCT00761657|524091055|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
145339188|NCT00761657|524091056|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339189|NCT00761657|524091057|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339190|NCT00761657|524091058|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339191|NCT00761657|524091059|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339192|NCT00761657|524091060|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
145339193|NCT00761657|524091052|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
145339194|NCT00761657|524091053|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
145339195|NCT00761657|524091054|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
145339196|NCT00761657|524091055|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
145339197|NCT00761657|524091056|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
145339198|NCT00761657|524091057|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
145339199|NCT00761657|524091058|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
145339200|NCT00761657|524091059|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
145339201|NCT00761657|524091060|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
145339202|NCT00761657|524091052|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
145339203|NCT00761657|524091053|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
145339204|NCT00761657|524091054|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
145339205|NCT00761657|524091055|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
145339206|NCT00761657|524091056|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
145339207|NCT00761657|524091057|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
145339208|NCT00761657|524091058|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
145339209|NCT00761657|524091059|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
145339210|NCT00761657|524091060|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
145339211|NCT02929056|524091072|FG000|Overall Study|Lost to Follow-up|0|||
145339212|NCT02929056|524091073|FG001|Overall Study|Lost to Follow-up|1|||
145339213|NCT02245412|524091077|FG000|Treatment Period|Death|1|||
145339214|NCT02245412|524091078|FG001|Treatment Period|Death|1|||
145339215|NCT02245412|524091079|FG002|Treatment Period|Death|0|||
145339216|NCT02245412|524091077|FG000|Treatment Period|Physician Decision|1|||
145339217|NCT02245412|524091078|FG001|Treatment Period|Physician Decision|1|||
145339218|NCT02245412|524091079|FG002|Treatment Period|Physician Decision|0|||
145339219|NCT02245412|524091077|FG000|Treatment Period|Withdrawal by Subject|2|||
145339220|NCT02245412|524091078|FG001|Treatment Period|Withdrawal by Subject|1|||
145339221|NCT02245412|524091079|FG002|Treatment Period|Withdrawal by Subject|0|||
145339222|NCT02245412|524091077|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
145339223|NCT02245412|524091078|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
145339224|NCT02245412|524091079|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
145339225|NCT02245412|524091077|FG000|Follow-Up Period|Death|4|||
145339226|NCT02245412|524091078|FG001|Follow-Up Period|Death|2|||
145339227|NCT02245412|524091079|FG002|Follow-Up Period|Death|1|||
145339228|NCT02245412|524091077|FG000|Follow-Up Period|Physician Decision|1|||
145339229|NCT02245412|524091078|FG001|Follow-Up Period|Physician Decision|0|||
145339230|NCT02245412|524091079|FG002|Follow-Up Period|Physician Decision|0|||
145339231|NCT02245412|524091077|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
145339232|NCT02245412|524091078|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
145339233|NCT02245412|524091079|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
145339234|NCT02119819|524091083|FG000|Overall Study|Adverse Event|3|||
145339235|NCT02119819|524091084|FG001|Overall Study|Adverse Event|1|||
145339236|NCT02119819|524091085|FG002|Overall Study|Adverse Event|2|||
145339237|NCT02119819|524091086|FG003|Overall Study|Adverse Event|3|||
145339238|NCT02119819|524091087|FG004|Overall Study|Adverse Event|0|||
145339239|NCT02119819|524091088|FG005|Overall Study|Adverse Event|1|||
145339240|NCT02119819|524091083|FG000|Overall Study|Lack of Efficacy|0|||
145339241|NCT02119819|524091084|FG001|Overall Study|Lack of Efficacy|0|||
145339242|NCT02119819|524091085|FG002|Overall Study|Lack of Efficacy|0|||
145339243|NCT02119819|524091086|FG003|Overall Study|Lack of Efficacy|0|||
145339244|NCT02119819|524091087|FG004|Overall Study|Lack of Efficacy|0|||
145339245|NCT02119819|524091088|FG005|Overall Study|Lack of Efficacy|1|||
145339246|NCT02119819|524091083|FG000|Overall Study|Lost to Follow-up|0|||
145339247|NCT02119819|524091084|FG001|Overall Study|Lost to Follow-up|0|||
145339248|NCT02119819|524091085|FG002|Overall Study|Lost to Follow-up|1|||
145339249|NCT02119819|524091086|FG003|Overall Study|Lost to Follow-up|2|||
145339250|NCT02119819|524091087|FG004|Overall Study|Lost to Follow-up|1|||
145339251|NCT02119819|524091088|FG005|Overall Study|Lost to Follow-up|2|||
145339252|NCT02119819|524091083|FG000|Overall Study|Physician Decision|1|||
145339253|NCT02119819|524091084|FG001|Overall Study|Physician Decision|1|||
145339254|NCT02119819|524091085|FG002|Overall Study|Physician Decision|0|||
145339255|NCT02119819|524091086|FG003|Overall Study|Physician Decision|0|||
145339256|NCT02119819|524091087|FG004|Overall Study|Physician Decision|0|||
145339257|NCT02119819|524091088|FG005|Overall Study|Physician Decision|1|||
145339258|NCT02119819|524091083|FG000|Overall Study|Withdrawal by Subject|5|||
145339259|NCT02119819|524091084|FG001|Overall Study|Withdrawal by Subject|3|||
145339260|NCT02119819|524091085|FG002|Overall Study|Withdrawal by Subject|0|||
145339261|NCT02119819|524091086|FG003|Overall Study|Withdrawal by Subject|0|||
145339262|NCT02119819|524091087|FG004|Overall Study|Withdrawal by Subject|6|||
145339263|NCT02119819|524091088|FG005|Overall Study|Withdrawal by Subject|10|||
145339264|NCT02119819|524091083|FG000|Overall Study|Jury Duty|0|||
145339265|NCT02119819|524091084|FG001|Overall Study|Jury Duty|0|||
145339266|NCT02119819|524091085|FG002|Overall Study|Jury Duty|1|||
145339267|NCT02119819|524091086|FG003|Overall Study|Jury Duty|0|||
145339268|NCT02119819|524091087|FG004|Overall Study|Jury Duty|0|||
145339269|NCT02119819|524091088|FG005|Overall Study|Jury Duty|0|||
145339270|NCT02119819|524091083|FG000|Overall Study|Protocol Violation|0|||
145339271|NCT02119819|524091084|FG001|Overall Study|Protocol Violation|0|||
145339272|NCT02119819|524091085|FG002|Overall Study|Protocol Violation|0|||
145339273|NCT02119819|524091086|FG003|Overall Study|Protocol Violation|1|||
145339274|NCT02119819|524091087|FG004|Overall Study|Protocol Violation|0|||
145339275|NCT02119819|524091088|FG005|Overall Study|Protocol Violation|0|||
145339276|NCT02119819|524091083|FG000|Overall Study|Left the city to get a job|0|||
145339277|NCT02119819|524091084|FG001|Overall Study|Left the city to get a job|0|||
145339278|NCT02119819|524091085|FG002|Overall Study|Left the city to get a job|0|||
145339279|NCT02119819|524091086|FG003|Overall Study|Left the city to get a job|1|||
145339280|NCT02119819|524091087|FG004|Overall Study|Left the city to get a job|0|||
145339281|NCT02119819|524091088|FG005|Overall Study|Left the city to get a job|0|||
145339282|NCT01544179|524091089|FG000|Overall Study|Death|50|||
145339283|NCT01544179|524091090|FG001|Overall Study|Death|37|||
145339284|NCT01544179|524091089|FG000|Overall Study|Lost to Follow-up|0|||
145339285|NCT01544179|524091090|FG001|Overall Study|Lost to Follow-up|1|||
145339286|NCT01544179|524091089|FG000|Overall Study|Adverse Event|0|||
145339287|NCT01544179|524091090|FG001|Overall Study|Adverse Event|1|||
145339288|NCT01544179|524091089|FG000|Overall Study|Withdrawal by Subject|12|||
145339289|NCT01544179|524091090|FG001|Overall Study|Withdrawal by Subject|7|||
145339290|NCT01544179|524091089|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
145339291|NCT01544179|524091090|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145339292|NCT02045147|524091091|FG000|Overall Study|Withdrawal by Subject|2|||
145339293|NCT02045147|524091092|FG001|Overall Study|Withdrawal by Subject|0|||
145339294|NCT02045147|524091093|FG002|Overall Study|Withdrawal by Subject|0|||
145339295|NCT02045147|524091094|FG003|Overall Study|Withdrawal by Subject|0|||
145339296|NCT02045147|524091095|FG004|Overall Study|Withdrawal by Subject|0|||
145339297|NCT02045147|524091096|FG005|Overall Study|Withdrawal by Subject|0|||
145339298|NCT02045147|524091097|FG006|Overall Study|Withdrawal by Subject|0|||
145339299|NCT02045147|524091098|FG007|Overall Study|Withdrawal by Subject|1|||
145339300|NCT02045147|524091091|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
145339301|NCT02045147|524091092|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
145339302|NCT02045147|524091093|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
145339303|NCT02045147|524091094|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
145339304|NCT02045147|524091095|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
145339305|NCT02045147|524091096|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
145339306|NCT02045147|524091097|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
145339307|NCT02045147|524091098|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
145339308|NCT04839692|524091099|FG000|Overall Study|Withdrawal by Subject|0|||
145339309|NCT04839692|524091100|FG001|Overall Study|Withdrawal by Subject|3|||
145339310|NCT04839692|524091099|FG000|Overall Study|Physician Decision|1|||
145339311|NCT04839692|524091100|FG001|Overall Study|Physician Decision|0|||
145339312|NCT03146962|524091103|FG000|Overall Study|Lost to Follow-up|1|||
145339313|NCT03146962|524091104|FG001|Overall Study|Lost to Follow-up|1|||
145339314|NCT03146962|524091105|FG002|Overall Study|Lost to Follow-up|0|||
145339315|NCT03146962|524091106|FG003|Overall Study|Lost to Follow-up|0|||
145339316|NCT03146962|524091107|FG004|Overall Study|Lost to Follow-up|0|||
145339317|NCT03146962|524091108|FG005|Overall Study|Lost to Follow-up|0|||
145339318|NCT03146962|524091109|FG006|Overall Study|Lost to Follow-up|0|||
145339319|NCT03146962|524091110|FG007|Overall Study|Lost to Follow-up|0|||
145339320|NCT03146962|524091111|FG008|Overall Study|Lost to Follow-up|0|||
145339321|NCT03146962|524091112|FG009|Overall Study|Lost to Follow-up|0|||
145339322|NCT03146962|524091103|FG000|Overall Study|Adverse Event|0|||
145339323|NCT03146962|524091104|FG001|Overall Study|Adverse Event|3|||
145339324|NCT03146962|524091105|FG002|Overall Study|Adverse Event|0|||
145339325|NCT03146962|524091106|FG003|Overall Study|Adverse Event|0|||
145339326|NCT03146962|524091107|FG004|Overall Study|Adverse Event|0|||
145339327|NCT03146962|524091108|FG005|Overall Study|Adverse Event|0|||
145339328|NCT03146962|524091109|FG006|Overall Study|Adverse Event|0|||
145339329|NCT03146962|524091110|FG007|Overall Study|Adverse Event|1|||
145339330|NCT03146962|524091111|FG008|Overall Study|Adverse Event|0|||
145413361|NCT02337946|524367006|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
145622517|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
145339331|NCT03146962|524091112|FG009|Overall Study|Adverse Event|0|||
145339332|NCT03146962|524091103|FG000|Overall Study|Withdrawal by Subject|0|||
145339333|NCT03146962|524091104|FG001|Overall Study|Withdrawal by Subject|0|||
145339334|NCT03146962|524091105|FG002|Overall Study|Withdrawal by Subject|0|||
145339335|NCT03146962|524091106|FG003|Overall Study|Withdrawal by Subject|0|||
145413362|NCT05324371|524367008|FG000|Overall Study|Withdrawal by Subject|1|||
145413363|NCT05324371|524367008|FG000|Overall Study|Death|1|||
145413364|NCT01131585|524367009|FG000|Overall Study|Adverse Event|0|||
145413365|NCT01131585|524367010|FG001|Overall Study|Adverse Event|2|||
145413366|NCT01131585|524367009|FG000|Overall Study|Abnormal laboratory value|1|||
145413367|NCT01131585|524367010|FG001|Overall Study|Abnormal laboratory value|0|||
145413368|NCT01131585|524367009|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145413369|NCT01131585|524367010|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145413370|NCT01131585|524367009|FG000|Overall Study|Protocol Violation|2|||
145413371|NCT01131585|524367010|FG001|Overall Study|Protocol Violation|1|||
145413372|NCT01131585|524367009|FG000|Overall Study|Withdrawal by Subject|3|||
145413373|NCT01131585|524367010|FG001|Overall Study|Withdrawal by Subject|3|||
145413374|NCT01131585|524367009|FG000|Overall Study|Lost to Follow-up|0|||
145413375|NCT01131585|524367010|FG001|Overall Study|Lost to Follow-up|1|||
145413376|NCT01131585|524367009|FG000|Overall Study|Administrative problems|1|||
145413377|NCT01131585|524367010|FG001|Overall Study|Administrative problems|1|||
145413378|NCT01131585|524367009|FG000|Overall Study|Study termination|78|||
145413379|NCT01131585|524367010|FG001|Overall Study|Study termination|32|||
145413380|NCT01786109|524367011|FG000|Overall Study|fail manometry barostat tube placement|1|||
145413381|NCT01786109|524367012|FG001|Overall Study|fail manometry barostat tube placement|0|||
145413382|NCT01786109|524367013|FG002|Overall Study|fail manometry barostat tube placement|0|||
145413383|NCT01786109|524367011|FG000|Overall Study|unrelated illness|0|||
145574246|NCT02096835|524958210|FG002|Overall Study|Withdrawal by Subject|0|||
145574247|NCT02096835|524958208|FG000|Overall Study|converted to open procedures|1|||
145574248|NCT02096835|524958209|FG001|Overall Study|converted to open procedures|0|||
145574249|NCT02096835|524958210|FG002|Overall Study|converted to open procedures|0|||
145574250|NCT02096835|524958208|FG000|Overall Study|Lost to Follow-up|1|||
145574251|NCT02096835|524958209|FG001|Overall Study|Lost to Follow-up|0|||
145574252|NCT02096835|524958210|FG002|Overall Study|Lost to Follow-up|1|||
145574253|NCT00023673|524958212|FG000|Overall Study|Ineligible / no protocol treatment|0|||
145574254|NCT00023673|524958213|FG001|Overall Study|Ineligible / no protocol treatment|0|||
145574255|NCT00023673|524958214|FG002|Overall Study|Ineligible / no protocol treatment|0|||
145574256|NCT00023673|524958215|FG003|Overall Study|Ineligible / no protocol treatment|1|||
145574257|NCT00023673|524958212|FG000|Overall Study|Patient withdrew consent|0|||
145574258|NCT00023673|524958213|FG001|Overall Study|Patient withdrew consent|0|||
145574259|NCT00023673|524958214|FG002|Overall Study|Patient withdrew consent|0|||
145574260|NCT00023673|524958215|FG003|Overall Study|Patient withdrew consent|1|||
145574261|NCT02453594|524958216|FG000|Overall Study|Protocol Violation|0|||
145574262|NCT02453594|524958217|FG001|Overall Study|Protocol Violation|0|||
145574263|NCT02453594|524958218|FG002|Overall Study|Protocol Violation|1|||
145413384|NCT01786109|524367012|FG001|Overall Study|unrelated illness|0|||
145413385|NCT01786109|524367013|FG002|Overall Study|unrelated illness|1|||
145413386|NCT01786109|524367011|FG000|Overall Study|adverse effects colon preparation|0|||
145413387|NCT01786109|524367012|FG001|Overall Study|adverse effects colon preparation|0|||
145413388|NCT01786109|524367013|FG002|Overall Study|adverse effects colon preparation|1|||
145413389|NCT01068912|524367018|FG000|Overall Study|Adverse Event|2|||
145413390|NCT01068912|524367019|FG001|Overall Study|Adverse Event|3|||
145413391|NCT01068912|524367020|FG002|Overall Study|Adverse Event|2|||
145413392|NCT01068912|524367018|FG000|Overall Study|Withdrawal by Subject|5|||
145413393|NCT01068912|524367019|FG001|Overall Study|Withdrawal by Subject|6|||
145574264|NCT02453594|524958216|FG000|Overall Study|Cohort Was Closed|17|||
145574265|NCT02453594|524958217|FG001|Overall Study|Cohort Was Closed|21|||
145574266|NCT02453594|524958218|FG002|Overall Study|Cohort Was Closed|14|||
145574267|NCT02453594|524958216|FG000|Overall Study|Death|20|||
145574268|NCT02453594|524958217|FG001|Overall Study|Death|24|||
145574269|NCT02453594|524958218|FG002|Overall Study|Death|16|||
145574270|NCT02453594|524958216|FG000|Overall Study|Lost to Follow-up|6|||
145574271|NCT02453594|524958217|FG001|Overall Study|Lost to Follow-up|14|||
145574272|NCT02453594|524958218|FG002|Overall Study|Lost to Follow-up|2|||
145574273|NCT02453594|524958216|FG000|Overall Study|Physician Decision|2|||
145413394|NCT01068912|524367020|FG002|Overall Study|Withdrawal by Subject|6|||
145413395|NCT01068912|524367018|FG000|Overall Study|Lost to Follow-up|3|||
145413396|NCT01068912|524367019|FG001|Overall Study|Lost to Follow-up|7|||
145413397|NCT01068912|524367020|FG002|Overall Study|Lost to Follow-up|3|||
145413398|NCT01068912|524367018|FG000|Overall Study|Protocol Violation|0|||
145413399|NCT01068912|524367019|FG001|Overall Study|Protocol Violation|2|||
145574274|NCT02453594|524958217|FG001|Overall Study|Physician Decision|4|||
145574275|NCT02453594|524958218|FG002|Overall Study|Physician Decision|0|||
145574276|NCT02453594|524958216|FG000|Overall Study|Site Terminated by Sponsor|1|||
145574277|NCT02453594|524958217|FG001|Overall Study|Site Terminated by Sponsor|0|||
145574278|NCT02453594|524958218|FG002|Overall Study|Site Terminated by Sponsor|1|||
145574279|NCT02453594|524958216|FG000|Overall Study|Transitioned to Extension Study|16|||
145574280|NCT02453594|524958217|FG001|Overall Study|Transitioned to Extension Study|9|||
145574281|NCT02453594|524958218|FG002|Overall Study|Transitioned to Extension Study|16|||
145574282|NCT02453594|524958216|FG000|Overall Study|Withdrawal by Subject|7|||
145574283|NCT02453594|524958217|FG001|Overall Study|Withdrawal by Subject|9|||
145574284|NCT02453594|524958218|FG002|Overall Study|Withdrawal by Subject|11|||
145339336|NCT03146962|524091107|FG004|Overall Study|Withdrawal by Subject|1|||
145339337|NCT03146962|524091108|FG005|Overall Study|Withdrawal by Subject|0|||
145339338|NCT03146962|524091109|FG006|Overall Study|Withdrawal by Subject|0|||
145339339|NCT03146962|524091110|FG007|Overall Study|Withdrawal by Subject|0|||
145339340|NCT03146962|524091111|FG008|Overall Study|Withdrawal by Subject|0|||
145339341|NCT03146962|524091112|FG009|Overall Study|Withdrawal by Subject|0|||
145339342|NCT03146962|524091103|FG000|Overall Study|Death|0|||
145339343|NCT03146962|524091104|FG001|Overall Study|Death|1|||
145339344|NCT03146962|524091105|FG002|Overall Study|Death|0|||
145339345|NCT03146962|524091106|FG003|Overall Study|Death|0|||
145339346|NCT03146962|524091107|FG004|Overall Study|Death|0|||
145339347|NCT03146962|524091108|FG005|Overall Study|Death|0|||
145339348|NCT03146962|524091109|FG006|Overall Study|Death|0|||
145339349|NCT03146962|524091110|FG007|Overall Study|Death|0|||
145339350|NCT03146962|524091111|FG008|Overall Study|Death|0|||
145339351|NCT03146962|524091112|FG009|Overall Study|Death|0|||
145339352|NCT03146962|524091103|FG000|Overall Study|COVID Precautions|1|||
145339353|NCT03146962|524091104|FG001|Overall Study|COVID Precautions|0|||
145339354|NCT03146962|524091105|FG002|Overall Study|COVID Precautions|0|||
145339355|NCT03146962|524091106|FG003|Overall Study|COVID Precautions|0|||
145339356|NCT03146962|524091107|FG004|Overall Study|COVID Precautions|0|||
145339357|NCT03146962|524091108|FG005|Overall Study|COVID Precautions|0|||
145339358|NCT03146962|524091109|FG006|Overall Study|COVID Precautions|0|||
145339359|NCT03146962|524091110|FG007|Overall Study|COVID Precautions|0|||
145339360|NCT03146962|524091111|FG008|Overall Study|COVID Precautions|0|||
145339361|NCT03146962|524091112|FG009|Overall Study|COVID Precautions|0|||
145339362|NCT03146962|524091103|FG000|Overall Study|Physician Decision|0|||
145339363|NCT03146962|524091104|FG001|Overall Study|Physician Decision|0|||
145339364|NCT03146962|524091105|FG002|Overall Study|Physician Decision|0|||
145339365|NCT03146962|524091106|FG003|Overall Study|Physician Decision|0|||
145339366|NCT03146962|524091107|FG004|Overall Study|Physician Decision|0|||
145339367|NCT03146962|524091108|FG005|Overall Study|Physician Decision|0|||
145339368|NCT03146962|524091109|FG006|Overall Study|Physician Decision|0|||
145339369|NCT03146962|524091110|FG007|Overall Study|Physician Decision|0|||
145339370|NCT03146962|524091111|FG008|Overall Study|Physician Decision|0|||
145339371|NCT03146962|524091112|FG009|Overall Study|Physician Decision|1|||
145339372|NCT03146962|524091103|FG000|Overall Study|Started New Treatment|0|||
145339373|NCT03146962|524091104|FG001|Overall Study|Started New Treatment|1|||
145339374|NCT03146962|524091105|FG002|Overall Study|Started New Treatment|0|||
145339375|NCT03146962|524091106|FG003|Overall Study|Started New Treatment|0|||
145339376|NCT03146962|524091107|FG004|Overall Study|Started New Treatment|0|||
145339377|NCT03146962|524091108|FG005|Overall Study|Started New Treatment|0|||
145339378|NCT03146962|524091109|FG006|Overall Study|Started New Treatment|0|||
145339379|NCT03146962|524091110|FG007|Overall Study|Started New Treatment|0|||
145339380|NCT03146962|524091111|FG008|Overall Study|Started New Treatment|0|||
145339381|NCT03146962|524091112|FG009|Overall Study|Started New Treatment|0|||
145339382|NCT00049530|524091113|FG000|Overall Study|Lack of Efficacy|25|||
145339383|NCT00049530|524091113|FG000|Overall Study|Adverse Event|2|||
145339384|NCT00049530|524091113|FG000|Overall Study|Death|1|||
145339385|NCT00049530|524091113|FG000|Overall Study|symptomatic deterioration|1|||
145339386|NCT00049530|524091113|FG000|Overall Study|ineligible|3|||
145339387|NCT02383810|524091114|FG000|Overall Study|Physician Decision|1|||
145339388|NCT02383810|524091115|FG001|Overall Study|Physician Decision|1|||
145339389|NCT02383810|524091116|FG002|Overall Study|Physician Decision|0|||
145339390|NCT02383810|524091117|FG003|Overall Study|Physician Decision|0|||
145339391|NCT02383810|524091118|FG004|Overall Study|Physician Decision|0|||
145339392|NCT02383810|524091119|FG005|Overall Study|Physician Decision|0|||
145339393|NCT02383810|524091120|FG006|Overall Study|Physician Decision|0|||
145339394|NCT02383810|524091121|FG007|Overall Study|Physician Decision|0|||
145339395|NCT02383810|524091114|FG000|Overall Study|Withdrawal by Subject|2|||
145339396|NCT02383810|524091115|FG001|Overall Study|Withdrawal by Subject|3|||
145339397|NCT02383810|524091116|FG002|Overall Study|Withdrawal by Subject|3|||
145339398|NCT02383810|524091117|FG003|Overall Study|Withdrawal by Subject|3|||
145339399|NCT02383810|524091118|FG004|Overall Study|Withdrawal by Subject|0|||
145339400|NCT02383810|524091119|FG005|Overall Study|Withdrawal by Subject|0|||
145339401|NCT02383810|524091120|FG006|Overall Study|Withdrawal by Subject|0|||
145339402|NCT02383810|524091121|FG007|Overall Study|Withdrawal by Subject|0|||
145339403|NCT02383810|524091114|FG000|Overall Study|Adverse Event|0|||
145339404|NCT02383810|524091115|FG001|Overall Study|Adverse Event|2|||
145339405|NCT02383810|524091116|FG002|Overall Study|Adverse Event|4|||
145339406|NCT02383810|524091117|FG003|Overall Study|Adverse Event|5|||
145339407|NCT02383810|524091118|FG004|Overall Study|Adverse Event|0|||
145339408|NCT02383810|524091119|FG005|Overall Study|Adverse Event|1|||
145339409|NCT02383810|524091120|FG006|Overall Study|Adverse Event|1|||
145339410|NCT02383810|524091121|FG007|Overall Study|Adverse Event|0|||
145339411|NCT02383810|524091114|FG000|Overall Study|Lost to Follow-up|0|||
145339412|NCT02383810|524091115|FG001|Overall Study|Lost to Follow-up|1|||
145339413|NCT02383810|524091116|FG002|Overall Study|Lost to Follow-up|0|||
145339414|NCT02383810|524091117|FG003|Overall Study|Lost to Follow-up|1|||
145339415|NCT02383810|524091118|FG004|Overall Study|Lost to Follow-up|0|||
145622518|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
145574285|NCT02097134|524958219|FG000|Overall Study|Physician Decision|4|||
145622519|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
145622520|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
145622521|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
145622522|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
145622523|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
145622524|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
145622525|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Death|2|||
145622526|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Death|2|||
145622527|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
145622528|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
145622529|NCT02403674|525130107|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
145339416|NCT02383810|524091119|FG005|Overall Study|Lost to Follow-up|0|||
145339417|NCT02383810|524091120|FG006|Overall Study|Lost to Follow-up|0|||
145339418|NCT02383810|524091121|FG007|Overall Study|Lost to Follow-up|0|||
145339419|NCT02383810|524091114|FG000|Overall Study|other|0|||
145339420|NCT02383810|524091115|FG001|Overall Study|other|0|||
145339421|NCT02383810|524091116|FG002|Overall Study|other|0|||
145339422|NCT02383810|524091117|FG003|Overall Study|other|2|||
145339423|NCT02383810|524091118|FG004|Overall Study|other|0|||
145339424|NCT02383810|524091119|FG005|Overall Study|other|0|||
145339425|NCT02383810|524091120|FG006|Overall Study|other|0|||
145339426|NCT02383810|524091121|FG007|Overall Study|other|0|||
145339427|NCT02383810|524091114|FG000|Overall Study|subject did not receive study treatment|0|||
145339428|NCT02383810|524091115|FG001|Overall Study|subject did not receive study treatment|1|||
145339429|NCT02383810|524091116|FG002|Overall Study|subject did not receive study treatment|0|||
145339430|NCT02383810|524091117|FG003|Overall Study|subject did not receive study treatment|0|||
145339431|NCT02383810|524091118|FG004|Overall Study|subject did not receive study treatment|0|||
145339432|NCT02383810|524091119|FG005|Overall Study|subject did not receive study treatment|0|||
145339433|NCT02383810|524091120|FG006|Overall Study|subject did not receive study treatment|0|||
145339434|NCT02383810|524091121|FG007|Overall Study|subject did not receive study treatment|0|||
145339435|NCT03247816|524091126|FG000|Overall Study|Adverse Event|12|||
145339436|NCT03247816|524091126|FG000|Overall Study|Physician Decision|3|||
145339437|NCT03247816|524091126|FG000|Overall Study|Lack of Efficacy|1|||
145339438|NCT03247816|524091126|FG000|Overall Study|Lost to Follow-up|10|||
145339439|NCT03247816|524091126|FG000|Overall Study|Missing Feraccru stop date|3|||
145339440|NCT02861014|524091128|FG000|Primary Analysis|Adverse Event|7|||
145339441|NCT02861014|524091128|FG000|Primary Analysis|Death|1|||
145339442|NCT02861014|524091128|FG000|Primary Analysis|Lack of Efficacy|3|||
145339443|NCT02861014|524091128|FG000|Primary Analysis|Physician Decision|2|||
145339444|NCT02861014|524091128|FG000|Primary Analysis|Pregnancy|4|||
145339445|NCT02861014|524091128|FG000|Primary Analysis|Protocol Violation|2|||
145339446|NCT02861014|524091128|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
145339447|NCT02861014|524091128|FG000|Primary Analysis|Withdrawal by Subject|14|||
145339448|NCT02861014|524091128|FG000|Primary Analysis|Commercial ocrelizumab|3|||
145339449|NCT02861014|524091128|FG000|Safety Follow-up|Adverse Event|1|||
145339450|NCT02861014|524091128|FG000|Safety Follow-up|Pregnancy|1|||
145339451|NCT02861014|524091128|FG000|Safety Follow-up|Withdrawal by Subject|9|||
145339452|NCT02861014|524091128|FG000|Safety Follow-up|Study terminated by sponsor|1|||
145339453|NCT02861014|524091128|FG000|Safety Follow-up|Physician Decision|1|||
145339454|NCT02861014|524091128|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
145339455|NCT02861014|524091128|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
145339456|NCT01696058|524091131|FG000|Overall Study|Adverse Event|21|||
145339457|NCT01696058|524091132|FG001|Overall Study|Adverse Event|11|||
145339458|NCT01696058|524091131|FG000|Overall Study|Lack of Efficacy|2|||
145339459|NCT01696058|524091132|FG001|Overall Study|Lack of Efficacy|3|||
145339460|NCT01696058|524091131|FG000|Overall Study|Protocol Violation|9|||
145339461|NCT01696058|524091132|FG001|Overall Study|Protocol Violation|3|||
145574286|NCT02097134|524958219|FG000|Overall Study|Non-Protocol Therapy|1|||
145574287|NCT02097134|524958219|FG000|Overall Study|Progressive Disease|3|||
145574288|NCT02097134|524958219|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
145574289|NCT03285646|524958238|FG000|Overall Study|Adverse Event|1|||
145574290|NCT03285646|524958239|FG001|Overall Study|Adverse Event|0|||
145574291|NCT03285646|524958238|FG000|Overall Study|Withdrawal by Subject|10|||
145574292|NCT03285646|524958239|FG001|Overall Study|Withdrawal by Subject|2|||
145622530|NCT02403674|525130108|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
145339462|NCT01696058|524091131|FG000|Overall Study|Lost to Follow-up|2|||
145339463|NCT01696058|524091132|FG001|Overall Study|Lost to Follow-up|5|||
145339464|NCT01696058|524091131|FG000|Overall Study|Withdrawal by Subject|4|||
145339465|NCT01696058|524091132|FG001|Overall Study|Withdrawal by Subject|6|||
145339466|NCT01696058|524091131|FG000|Overall Study|Other reason prematurely discontinued|5|||
145339467|NCT01696058|524091132|FG001|Overall Study|Other reason prematurely discontinued|3|||
145339468|NCT02549027|524091134|FG000|Washout After Period 4|Withdrawal by Subject|0|||
145574293|NCT03285646|524958238|FG000|Overall Study|Lost to Follow-up|2|||
145574294|NCT03285646|524958239|FG001|Overall Study|Lost to Follow-up|1|||
145574295|NCT03285646|524958238|FG000|Overall Study|Investigator/Sponsor Decision|0|||
145574296|NCT03285646|524958239|FG001|Overall Study|Investigator/Sponsor Decision|1|||
145574297|NCT00306592|524958240|FG000|Overall Study|Adverse Event|8|||
145574298|NCT00306592|524958241|FG001|Overall Study|Adverse Event|15|||
145574299|NCT00306592|524958240|FG000|Overall Study|Lost to Follow-up|1|||
145574300|NCT00306592|524958241|FG001|Overall Study|Lost to Follow-up|0|||
145574301|NCT00306592|524958240|FG000|Overall Study|Noncompliance|0|||
145574302|NCT00306592|524958241|FG001|Overall Study|Noncompliance|2|||
145574303|NCT00306592|524958240|FG000|Overall Study|Persistent Antibodies|6|||
145574304|NCT00306592|524958241|FG001|Overall Study|Persistent Antibodies|3|||
145574305|NCT00306592|524958240|FG000|Overall Study|Voluntary|10|||
145574306|NCT00306592|524958241|FG001|Overall Study|Voluntary|6|||
145574307|NCT00306592|524958240|FG000|Overall Study|Other|5|||
145574308|NCT00306592|524958241|FG001|Overall Study|Other|10|||
145574309|NCT00306592|524958240|FG000|Overall Study|Other|1|||
145574310|NCT00306592|524958241|FG001|Overall Study|Other|2|||
145574311|NCT00306592|524958240|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
145574312|NCT00306592|524958241|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
145574313|NCT04101526|524958243|FG000|Overall Study|Did not complete all sleep diary entries|0|||
145574314|NCT04101526|524958244|FG001|Overall Study|Did not complete all sleep diary entries|1|||
145574315|NCT01023659|524958247|FG000|Overall Study|Lost to Follow-up|73|||
145574316|NCT01023659|524958248|FG001|Overall Study|Lost to Follow-up|228|||
145574317|NCT01023659|524958249|FG002|Overall Study|Lost to Follow-up|99|||
145574318|NCT01434823|524958250|FG000|Overall Study|Incomplete data in medical record|4|||
145574319|NCT01434823|524958251|FG001|Overall Study|Incomplete data in medical record|7|||
145574320|NCT02331446|524958252|FG000|Overall Study|Lost to Follow-up|2|||
145574321|NCT02331446|524958253|FG001|Overall Study|Lost to Follow-up|1|||
145574322|NCT02331446|524958254|FG002|Overall Study|Lost to Follow-up|0|||
145574323|NCT02331446|524958255|FG003|Overall Study|Lost to Follow-up|1|||
145574324|NCT02331446|524958252|FG000|Overall Study|Personal Problem|2|||
145574325|NCT02331446|524958253|FG001|Overall Study|Personal Problem|0|||
145574326|NCT02331446|524958254|FG002|Overall Study|Personal Problem|0|||
145574327|NCT02331446|524958255|FG003|Overall Study|Personal Problem|0|||
145574328|NCT02331446|524958252|FG000|Overall Study|Disease|0|||
145574329|NCT02331446|524958253|FG001|Overall Study|Disease|2|||
145574330|NCT02331446|524958254|FG002|Overall Study|Disease|2|||
145574331|NCT02331446|524958255|FG003|Overall Study|Disease|1|||
145574332|NCT02331446|524958252|FG000|Overall Study|Physician Decision|0|||
145574333|NCT02331446|524958253|FG001|Overall Study|Physician Decision|1|||
145574334|NCT02331446|524958254|FG002|Overall Study|Physician Decision|0|||
145574335|NCT02331446|524958255|FG003|Overall Study|Physician Decision|1|||
145574336|NCT02331446|524958252|FG000|Overall Study|Lost before baseline analysis|0|||
145574337|NCT02331446|524958253|FG001|Overall Study|Lost before baseline analysis|1|||
145574338|NCT02331446|524958254|FG002|Overall Study|Lost before baseline analysis|1|||
145574339|NCT02331446|524958255|FG003|Overall Study|Lost before baseline analysis|0|||
145574340|NCT01049919|524958257|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
145574341|NCT01049919|524958258|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
145574342|NCT01049919|524958257|FG000|Overall Study|Withdrawal by Subject|5|||
145574343|NCT01049919|524958258|FG001|Overall Study|Withdrawal by Subject|0|||
145574344|NCT01049919|524958257|FG000|Overall Study|Lost to Follow-up|6|||
145574345|NCT01049919|524958258|FG001|Overall Study|Lost to Follow-up|1|||
145574346|NCT01049919|524958257|FG000|Overall Study|Physician Decision|2|||
145574347|NCT01049919|524958258|FG001|Overall Study|Physician Decision|0|||
145339469|NCT02549027|524091135|FG001|Washout After Period 4|Withdrawal by Subject|1|||
145339470|NCT02549027|524091136|FG002|Washout After Period 4|Withdrawal by Subject|1|||
145339471|NCT02549027|524091137|FG003|Washout After Period 4|Withdrawal by Subject|1|||
145339472|NCT02549027|524091138|FG004|Washout After Period 4|Withdrawal by Subject|0|||
145339473|NCT02549027|524091139|FG005|Washout After Period 4|Withdrawal by Subject|0|||
145339474|NCT02549027|524091134|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145339475|NCT02549027|524091135|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145339476|NCT02549027|524091136|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145339477|NCT02549027|524091137|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145339478|NCT02549027|524091138|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
145339479|NCT02549027|524091139|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
145339480|NCT02186834|524091140|FG000|Dose Escalation|Death|0|||
145339481|NCT02186834|524091141|FG001|Dose Escalation|Death|0|||
145339482|NCT02186834|524091142|FG002|Dose Escalation|Death|0|||
145339483|NCT02186834|524091143|FG003|Dose Escalation|Death|1|||
145339484|NCT02186834|524091144|FG004|Dose Escalation|Death|0|||
145339485|NCT02186834|524091145|FG005|Dose Escalation|Death|0|||
145339486|NCT02186834|524091140|FG000|Treatment at RP2D|Died prior to treatment|0|||
145339487|NCT02186834|524091141|FG001|Treatment at RP2D|Died prior to treatment|0|||
145339488|NCT02186834|524091142|FG002|Treatment at RP2D|Died prior to treatment|0|||
145339489|NCT02186834|524091143|FG003|Treatment at RP2D|Died prior to treatment|0|||
145339490|NCT02186834|524091144|FG004|Treatment at RP2D|Died prior to treatment|0|||
145574348|NCT01049919|524958257|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
145339491|NCT02186834|524091145|FG005|Treatment at RP2D|Died prior to treatment|1|||
145339492|NCT05384171|524091149|FG000|Overall Study|Lost to Follow-up|9|||
145339493|NCT05384171|524091150|FG001|Overall Study|Lost to Follow-up|9|||
145339494|NCT05384171|524091149|FG000|Overall Study|Withdrawal by Subject|3|||
145339495|NCT05384171|524091150|FG001|Overall Study|Withdrawal by Subject|0|||
145339496|NCT00749892|524091151|FG000|Overall Study|Withdrawal by Subject|3|||
145339497|NCT04581369|524091152|FG000|Overall Study|Death|7|||
145339498|NCT04581369|524091153|FG001|Overall Study|Death|6|||
145339499|NCT04581369|524091154|FG002|Overall Study|Death|0|||
145339500|NCT04581369|524091152|FG000|Overall Study|Lost to Follow-up|7|||
145339501|NCT04581369|524091153|FG001|Overall Study|Lost to Follow-up|3|||
145339502|NCT04581369|524091154|FG002|Overall Study|Lost to Follow-up|0|||
145339503|NCT04581369|524091152|FG000|Overall Study|liver transplant|2|||
145339504|NCT04581369|524091153|FG001|Overall Study|liver transplant|2|||
145339505|NCT04581369|524091154|FG002|Overall Study|liver transplant|0|||
145339506|NCT04581369|524091152|FG000|Overall Study|transitioned to hospice care|0|||
145339507|NCT04581369|524091153|FG001|Overall Study|transitioned to hospice care|5|||
145339508|NCT04581369|524091154|FG002|Overall Study|transitioned to hospice care|0|||
145339509|NCT00780910|524091155|FG000|Overall Study|Adverse Event|2|||
145339510|NCT01111825|524091157|FG000|Overall Study|Withdrawal by Subject|0|||
145339511|NCT01111825|524091158|FG001|Overall Study|Withdrawal by Subject|0|||
145339512|NCT01111825|524091159|FG002|Overall Study|Withdrawal by Subject|1|||
145339513|NCT01111825|524091160|FG003|Overall Study|Withdrawal by Subject|0|||
145339514|NCT01111825|524091157|FG000|Overall Study|Lost to Follow-up|0|||
145339515|NCT01111825|524091158|FG001|Overall Study|Lost to Follow-up|0|||
145339516|NCT01111825|524091159|FG002|Overall Study|Lost to Follow-up|3|||
145339517|NCT01111825|524091160|FG003|Overall Study|Lost to Follow-up|1|||
145339518|NCT01111825|524091157|FG000|Overall Study|Adverse Event|2|||
145339519|NCT01111825|524091158|FG001|Overall Study|Adverse Event|1|||
145339520|NCT01111825|524091159|FG002|Overall Study|Adverse Event|4|||
145339521|NCT01111825|524091160|FG003|Overall Study|Adverse Event|0|||
145339522|NCT01111825|524091157|FG000|Overall Study|Disease Progression|1|||
145339523|NCT01111825|524091158|FG001|Overall Study|Disease Progression|0|||
145339524|NCT01111825|524091159|FG002|Overall Study|Disease Progression|0|||
145339525|NCT01111825|524091160|FG003|Overall Study|Disease Progression|0|||
145339526|NCT01111825|524091157|FG000|Overall Study|Discontinuation by Sponsor|0|||
145339527|NCT01111825|524091158|FG001|Overall Study|Discontinuation by Sponsor|0|||
145339528|NCT01111825|524091159|FG002|Overall Study|Discontinuation by Sponsor|0|||
145339529|NCT01111825|524091160|FG003|Overall Study|Discontinuation by Sponsor|20|||
145339530|NCT00106964|524091161|FG000|Overall Study|Lost to Follow-up|8|||
145339531|NCT00106964|524091162|FG001|Overall Study|Lost to Follow-up|6|||
145339532|NCT00106964|524091163|FG002|Overall Study|Lost to Follow-up|2|||
145339533|NCT00106964|524091161|FG000|Overall Study|Pregnancy|2|||
145339534|NCT00106964|524091162|FG001|Overall Study|Pregnancy|3|||
145339535|NCT00106964|524091163|FG002|Overall Study|Pregnancy|2|||
145339536|NCT00106964|524091161|FG000|Overall Study|Death|1|||
145339537|NCT00106964|524091162|FG001|Overall Study|Death|1|||
145339538|NCT00106964|524091163|FG002|Overall Study|Death|0|||
145339539|NCT00106964|524091161|FG000|Overall Study|Incarceration|0|||
145339540|NCT00106964|524091162|FG001|Overall Study|Incarceration|1|||
145339541|NCT00106964|524091163|FG002|Overall Study|Incarceration|0|||
145339542|NCT00106964|524091161|FG000|Overall Study|Site Funding Terminated|0|||
145339543|NCT00106964|524091162|FG001|Overall Study|Site Funding Terminated|1|||
145339544|NCT00106964|524091163|FG002|Overall Study|Site Funding Terminated|1|||
145339545|NCT00106964|524091161|FG000|Overall Study|Failure to adhere|2|||
145339546|NCT00106964|524091162|FG001|Overall Study|Failure to adhere|0|||
145339547|NCT00106964|524091163|FG002|Overall Study|Failure to adhere|0|||
145339548|NCT00106964|524091161|FG000|Overall Study|Did not meet eligibility criteria|0|||
145339549|NCT00106964|524091162|FG001|Overall Study|Did not meet eligibility criteria|2|||
145339550|NCT00106964|524091163|FG002|Overall Study|Did not meet eligibility criteria|2|||
145339551|NCT00106964|524091161|FG000|Overall Study|Required disallowed medication|0|||
145339552|NCT00106964|524091162|FG001|Overall Study|Required disallowed medication|1|||
145339553|NCT00106964|524091163|FG002|Overall Study|Required disallowed medication|0|||
145339554|NCT04746794|524091164|FG000|Overall Study|Did not complete any study assessment|50303|||
145339555|NCT04746794|524091165|FG001|Overall Study|Did not complete any study assessment|44997|||
145339556|NCT01422187|524091170|FG000|Overall Study|Personal reason|1|||
145339557|NCT01422187|524091171|FG001|Overall Study|Personal reason|0|||
145339558|NCT01422187|524091172|FG002|Overall Study|Personal reason|0|||
145339559|NCT01422187|524091170|FG000|Overall Study|Lost to Follow-up|0|||
145339560|NCT01422187|524091171|FG001|Overall Study|Lost to Follow-up|1|||
145339561|NCT01422187|524091172|FG002|Overall Study|Lost to Follow-up|0|||
145339562|NCT00168818|524091173|FG000|Overall Study|Adverse Event|23|||
145339563|NCT00168818|524091174|FG001|Overall Study|Adverse Event|29|||
145339564|NCT00168818|524091175|FG002|Overall Study|Adverse Event|31|||
145339565|NCT00168818|524091173|FG000|Overall Study|Protocol Violation|16|||
145339566|NCT00168818|524091174|FG001|Overall Study|Protocol Violation|11|||
145339567|NCT00168818|524091175|FG002|Overall Study|Protocol Violation|11|||
145339568|NCT00168818|524091173|FG000|Overall Study|Lost to Follow-up|13|||
145339569|NCT00168818|524091174|FG001|Overall Study|Lost to Follow-up|4|||
145339570|NCT00168818|524091175|FG002|Overall Study|Lost to Follow-up|15|||
145339571|NCT00168818|524091173|FG000|Overall Study|Withdrawal by Subject|43|||
145339572|NCT00168818|524091174|FG001|Overall Study|Withdrawal by Subject|41|||
145339573|NCT00168818|524091175|FG002|Overall Study|Withdrawal by Subject|37|||
145339574|NCT00168818|524091173|FG000|Overall Study|Other|22|||
145339575|NCT00168818|524091174|FG001|Overall Study|Other|24|||
145339576|NCT00168818|524091175|FG002|Overall Study|Other|30|||
145339577|NCT00168818|524091173|FG000|Treatment|Adverse Event|77|||
145339578|NCT00168818|524091174|FG001|Treatment|Adverse Event|89|||
145339579|NCT00168818|524091175|FG002|Treatment|Adverse Event|68|||
145339580|NCT00168818|524091173|FG000|Treatment|Protocol Violation|8|||
145339581|NCT00168818|524091174|FG001|Treatment|Protocol Violation|11|||
145339582|NCT00168818|524091175|FG002|Treatment|Protocol Violation|11|||
145339583|NCT00168818|524091173|FG000|Treatment|Lost to Follow-up|0|||
145339584|NCT00168818|524091174|FG001|Treatment|Lost to Follow-up|2|||
145339585|NCT00168818|524091175|FG002|Treatment|Lost to Follow-up|1|||
145339586|NCT00168818|524091173|FG000|Treatment|Withdrawal by Subject|25|||
145339587|NCT00168818|524091174|FG001|Treatment|Withdrawal by Subject|20|||
145339588|NCT00168818|524091175|FG002|Treatment|Withdrawal by Subject|22|||
145339589|NCT00168818|524091173|FG000|Treatment|Other|23|||
145339590|NCT00168818|524091174|FG001|Treatment|Other|29|||
145339591|NCT00168818|524091175|FG002|Treatment|Other|31|||
145339592|NCT02538965|524091182|FG000|Treatment Period|Other = Death due to disease progression|1|||
145339593|NCT02538965|524091182|FG000|Treatment Period|Adverse Event|2|||
145339594|NCT02538965|524091182|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
145339595|NCT02538965|524091182|FG000|Treatment Period|Treatment Failure|9|||
145339596|NCT02538965|524091182|FG000|Treatment Period|Disease Progression|1|||
145339597|NCT02538965|524091182|FG000|Treatment Period|Physician Decision|2|||
145339598|NCT02538965|524091182|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
145339599|NCT02538965|524091182|FG000|Follow-Up Period|Withdrawal by Parent|4|||
145339600|NCT00875797|524091183|FG000|Overall Study|Protocol Violation|6|||
145339601|NCT00875797|524091184|FG001|Overall Study|Protocol Violation|3|||
145339602|NCT00314951|524091189|FG000|Treatment|Didn't meet criteria for mITT population|16|||
145339603|NCT00314951|524091190|FG001|Treatment|Didn't meet criteria for mITT population|11|||
145574349|NCT01049919|524958258|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
145574350|NCT01049919|524958257|FG000|Overall Study|Early study termination by sponsor.|2|||
145574351|NCT01049919|524958258|FG001|Overall Study|Early study termination by sponsor.|0|||
145339604|NCT00314951|524091189|FG000|Follow-up|mITT failure|44|||
145339605|NCT00314951|524091190|FG001|Follow-up|mITT failure|34|||
145574352|NCT02984995|524958259|FG000|Overall Study|Required stem cell transplant|13|||
145574353|NCT02984995|524958260|FG001|Overall Study|Required stem cell transplant|2|||
145339606|NCT03503864|524091193|FG000|Overall Study|Protocol Violation|6|||
145339607|NCT03503864|524091193|FG000|Overall Study|Withdrawal by Subject|7|||
145339608|NCT00468650|524091194|FG000|Overall Study|Lost to Follow-up|4|||
145339609|NCT00468650|524091194|FG000|Overall Study|Withdrawal by Subject|2|||
145339610|NCT00468650|524091194|FG000|Overall Study|Protocol Violation|1|||
145339611|NCT02087189|524091195|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
145339612|NCT00642278|524091198|FG000|Overall Study|Adverse Event|2|||
145339613|NCT00642278|524091199|FG001|Overall Study|Adverse Event|1|||
145339614|NCT00642278|524091200|FG002|Overall Study|Adverse Event|3|||
145339615|NCT00642278|524091201|FG003|Overall Study|Adverse Event|1|||
145339616|NCT00642278|524091202|FG004|Overall Study|Adverse Event|2|||
145339617|NCT00642278|524091203|FG005|Overall Study|Adverse Event|2|||
145339618|NCT00642278|524091204|FG006|Overall Study|Adverse Event|0|||
145339619|NCT00642278|524091198|FG000|Overall Study|Lack of Efficacy|0|||
145339620|NCT00642278|524091199|FG001|Overall Study|Lack of Efficacy|1|||
145339621|NCT00642278|524091200|FG002|Overall Study|Lack of Efficacy|0|||
145339622|NCT00642278|524091201|FG003|Overall Study|Lack of Efficacy|0|||
145339623|NCT00642278|524091202|FG004|Overall Study|Lack of Efficacy|0|||
145339624|NCT00642278|524091203|FG005|Overall Study|Lack of Efficacy|0|||
145574354|NCT02984995|524958259|FG000|Overall Study|Progressive disease|11|||
145574355|NCT02984995|524958260|FG001|Overall Study|Progressive disease|1|||
145574356|NCT02984995|524958259|FG000|Overall Study|Adverse Event|1|||
145574357|NCT02984995|524958260|FG001|Overall Study|Adverse Event|0|||
145574358|NCT01401530|524958261|FG000|Overall Study|Disease Progression|1|||
145574359|NCT01401530|524958262|FG001|Overall Study|Disease Progression|2|||
145574360|NCT01401530|524958263|FG002|Overall Study|Disease Progression|1|||
145574361|NCT01401530|524958261|FG000|Overall Study|Adverse Event|1|||
145574362|NCT01401530|524958262|FG001|Overall Study|Adverse Event|1|||
145574363|NCT01401530|524958263|FG002|Overall Study|Adverse Event|1|||
145574364|NCT01401530|524958261|FG000|Overall Study|Participant Choice|1|||
145339625|NCT00642278|524091204|FG006|Overall Study|Lack of Efficacy|0|||
145574365|NCT01401530|524958262|FG001|Overall Study|Participant Choice|2|||
145574366|NCT01401530|524958263|FG002|Overall Study|Participant Choice|1|||
145339626|NCT00642278|524091198|FG000|Overall Study|Lost to Follow-up|5|||
145339627|NCT00642278|524091199|FG001|Overall Study|Lost to Follow-up|1|||
145339628|NCT00642278|524091200|FG002|Overall Study|Lost to Follow-up|0|||
145339629|NCT00642278|524091201|FG003|Overall Study|Lost to Follow-up|1|||
145339630|NCT00642278|524091202|FG004|Overall Study|Lost to Follow-up|0|||
145339631|NCT00642278|524091203|FG005|Overall Study|Lost to Follow-up|1|||
145339632|NCT00642278|524091204|FG006|Overall Study|Lost to Follow-up|1|||
145339633|NCT00642278|524091198|FG000|Overall Study|Physician Decision|0|||
145339634|NCT00642278|524091199|FG001|Overall Study|Physician Decision|0|||
145339635|NCT00642278|524091200|FG002|Overall Study|Physician Decision|0|||
145339636|NCT00642278|524091201|FG003|Overall Study|Physician Decision|1|||
145339637|NCT00642278|524091202|FG004|Overall Study|Physician Decision|0|||
145339638|NCT00642278|524091203|FG005|Overall Study|Physician Decision|0|||
145339639|NCT00642278|524091204|FG006|Overall Study|Physician Decision|0|||
145339640|NCT00642278|524091198|FG000|Overall Study|Protocol Violation|0|||
145339641|NCT00642278|524091199|FG001|Overall Study|Protocol Violation|0|||
145339642|NCT00642278|524091200|FG002|Overall Study|Protocol Violation|1|||
145339643|NCT00642278|524091201|FG003|Overall Study|Protocol Violation|1|||
145339644|NCT00642278|524091202|FG004|Overall Study|Protocol Violation|0|||
145339645|NCT00642278|524091203|FG005|Overall Study|Protocol Violation|1|||
145339646|NCT00642278|524091204|FG006|Overall Study|Protocol Violation|2|||
145339647|NCT00642278|524091198|FG000|Overall Study|Withdrawal by Subject|1|||
145339648|NCT00642278|524091199|FG001|Overall Study|Withdrawal by Subject|1|||
145339649|NCT00642278|524091200|FG002|Overall Study|Withdrawal by Subject|1|||
145339650|NCT00642278|524091201|FG003|Overall Study|Withdrawal by Subject|3|||
145339651|NCT00642278|524091202|FG004|Overall Study|Withdrawal by Subject|6|||
145339652|NCT00642278|524091203|FG005|Overall Study|Withdrawal by Subject|2|||
145339653|NCT00642278|524091204|FG006|Overall Study|Withdrawal by Subject|2|||
145339654|NCT00642278|524091198|FG000|Overall Study|Noncompliance with study drug regimen|0|||
145339655|NCT00642278|524091199|FG001|Overall Study|Noncompliance with study drug regimen|0|||
145339656|NCT00642278|524091200|FG002|Overall Study|Noncompliance with study drug regimen|0|||
145339657|NCT00642278|524091201|FG003|Overall Study|Noncompliance with study drug regimen|1|||
145339658|NCT00642278|524091202|FG004|Overall Study|Noncompliance with study drug regimen|0|||
145339659|NCT00642278|524091203|FG005|Overall Study|Noncompliance with study drug regimen|0|||
145339660|NCT00642278|524091204|FG006|Overall Study|Noncompliance with study drug regimen|0|||
145339661|NCT00642278|524091198|FG000|Overall Study|Other|2|||
145339662|NCT00642278|524091199|FG001|Overall Study|Other|1|||
145339663|NCT00642278|524091200|FG002|Overall Study|Other|0|||
145339664|NCT00642278|524091201|FG003|Overall Study|Other|1|||
145339665|NCT00642278|524091202|FG004|Overall Study|Other|0|||
145339666|NCT00642278|524091203|FG005|Overall Study|Other|1|||
145339667|NCT00642278|524091204|FG006|Overall Study|Other|0|||
145339668|NCT00090363|524091205|FG000|Overall Study|Lost to Follow-up|1|||
145339669|NCT00090363|524091206|FG001|Overall Study|Lost to Follow-up|2|||
145339670|NCT00090363|524091207|FG002|Overall Study|Lost to Follow-up|1|||
145339671|NCT00090363|524091205|FG000|Overall Study|Withdrawal by Subject|7|||
145339672|NCT00090363|524091206|FG001|Overall Study|Withdrawal by Subject|7|||
145339673|NCT00090363|524091207|FG002|Overall Study|Withdrawal by Subject|6|||
145339674|NCT00090363|524091205|FG000|Overall Study|Study-specific discontinuation criteria|75|||
145339675|NCT00090363|524091206|FG001|Overall Study|Study-specific discontinuation criteria|74|||
145339676|NCT00090363|524091207|FG002|Overall Study|Study-specific discontinuation criteria|62|||
145339677|NCT00090363|524091205|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145339678|NCT00090363|524091206|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145339679|NCT00090363|524091207|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145339680|NCT00090363|524091205|FG000|Overall Study|Consent expired|7|||
145339681|NCT00090363|524091206|FG001|Overall Study|Consent expired|10|||
145339682|NCT00090363|524091207|FG002|Overall Study|Consent expired|9|||
145339683|NCT00090363|524091205|FG000|Overall Study|Reasons not specified|2|||
145339684|NCT00090363|524091206|FG001|Overall Study|Reasons not specified|1|||
145339685|NCT00090363|524091207|FG002|Overall Study|Reasons not specified|1|||
145339686|NCT00090363|524091205|FG000|Overall Study|Continuing on study off treatment|14|||
145339687|NCT00090363|524091206|FG001|Overall Study|Continuing on study off treatment|13|||
145339688|NCT00090363|524091207|FG002|Overall Study|Continuing on study off treatment|16|||
145339689|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145339690|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145339691|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
145339692|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145413400|NCT01068912|524367020|FG002|Overall Study|Protocol Violation|0|||
145413401|NCT01068912|524367018|FG000|Overall Study|aggravation influenza|1|||
145339693|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145339694|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
145339695|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145339696|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145339697|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145339698|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145413402|NCT01068912|524367019|FG001|Overall Study|aggravation influenza|1|||
145413403|NCT01068912|524367020|FG002|Overall Study|aggravation influenza|1|||
145339699|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145339700|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145413404|NCT01068912|524367018|FG000|Overall Study|other underlying illness|0|||
145413405|NCT01068912|524367019|FG001|Overall Study|other underlying illness|3|||
145413406|NCT01068912|524367020|FG002|Overall Study|other underlying illness|3|||
145413407|NCT02762604|524367021|FG000|Overall Study|Lost to Follow-up|2|||
145413408|NCT02762604|524367022|FG001|Overall Study|Lost to Follow-up|7|||
145413409|NCT02762604|524367021|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
145413410|NCT02762604|524367022|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
145413411|NCT03442569|524367031|FG000|Overall Study|Subject was ineligible after enrollment|1|||
145413412|NCT00308685|524367036|FG000|Overall Study|Lost to Follow-up|1|||
145413413|NCT00308685|524367037|FG001|Overall Study|Lost to Follow-up|0|||
145413414|NCT00308685|524367036|FG000|Overall Study|Need to administer prohibited medication|1|||
145413415|NCT00308685|524367037|FG001|Overall Study|Need to administer prohibited medication|2|||
145413416|NCT00308685|524367036|FG000|Overall Study|Other than specified|1|||
145413417|NCT00308685|524367037|FG001|Overall Study|Other than specified|3|||
145413418|NCT03770455|524367038|FG000|Overall Study|Screen failures|3|||
145413419|NCT05399485|524368306|FG000|DBT Phase|Other|6|||
145413420|NCT05399485|524368307|FG001|DBT Phase|Other|5|||
145413421|NCT05399485|524368306|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
145574367|NCT01401530|524958261|FG000|Overall Study|Physician Decision|0|||
145339701|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
145339702|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
145339703|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
145339704|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145339705|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145339706|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145339707|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145339708|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145339709|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
145339710|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
145339711|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
145339712|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145339713|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145339714|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145339715|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145339716|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
145339717|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145339718|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
145339719|NCT03713619|524091210|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
145339720|NCT03713619|524091211|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
145339721|NCT03713619|524091212|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145339722|NCT03713619|524091213|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145339723|NCT03713619|524091214|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
145339724|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
145339725|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
145339726|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
145339727|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
145339728|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
145339729|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145339730|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145339731|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145339732|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145339733|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145339734|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
145413422|NCT05399485|524368307|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
145413423|NCT05399485|524368306|FG000|DBT Phase|Withdrawal by Subject|3|||
145574368|NCT01401530|524958262|FG001|Overall Study|Physician Decision|1|||
145574369|NCT01401530|524958263|FG002|Overall Study|Physician Decision|0|||
145574370|NCT00813124|524958269|FG000|Overall Study|Death|2|||
145574371|NCT00813124|524958269|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
145574372|NCT00813124|524958269|FG000|Overall Study|Withdrawal by Subject|1|||
145574373|NCT03969212|524958270|FG000|Overall Study|Adverse Event|1|||
145574374|NCT03969212|524958271|FG001|Overall Study|Adverse Event|0|||
145574375|NCT03969212|524958272|FG002|Overall Study|Adverse Event|0|||
145574376|NCT03969212|524958273|FG003|Overall Study|Adverse Event|0|||
145574377|NCT03969212|524958270|FG000|Overall Study|Lost to Follow-up|2|||
145574378|NCT03969212|524958271|FG001|Overall Study|Lost to Follow-up|2|||
145574379|NCT03969212|524958272|FG002|Overall Study|Lost to Follow-up|2|||
145574380|NCT03969212|524958273|FG003|Overall Study|Lost to Follow-up|2|||
145574381|NCT03969212|524958270|FG000|Overall Study|Protocol Violation|0|||
145574382|NCT03969212|524958271|FG001|Overall Study|Protocol Violation|0|||
145574383|NCT03969212|524958272|FG002|Overall Study|Protocol Violation|0|||
145574384|NCT03969212|524958273|FG003|Overall Study|Protocol Violation|1|||
145574385|NCT03969212|524958270|FG000|Overall Study|Withdrawal by Subject|7|||
145413424|NCT05399485|524368307|FG001|DBT Phase|Withdrawal by Subject|2|||
145413425|NCT05399485|524368306|FG000|DBT Phase|Protocol Violation|2|||
145413426|NCT05399485|524368307|FG001|DBT Phase|Protocol Violation|1|||
145413427|NCT05399485|524368306|FG000|DBT Phase|Physician Decision|0|||
145413428|NCT05399485|524368307|FG001|DBT Phase|Physician Decision|1|||
145413429|NCT05399485|524368306|FG000|DBT Phase|Adverse Event|2|||
145413430|NCT05399485|524368307|FG001|DBT Phase|Adverse Event|1|||
145413431|NCT05399485|524368306|FG000|OLE Phase|Protocol deviation|1|||
145413432|NCT05399485|524368307|FG001|OLE Phase|Protocol deviation|0|||
145413433|NCT05399485|524368306|FG000|OLE Phase|Other|5|||
145413434|NCT05399485|524368307|FG001|OLE Phase|Other|5|||
145413435|NCT05399485|524368306|FG000|OLE Phase|Withdrawal by Subject|12|||
145413436|NCT05399485|524368307|FG001|OLE Phase|Withdrawal by Subject|7|||
145413437|NCT05399485|524368306|FG000|OLE Phase|Pregnancy|0|||
145413438|NCT05399485|524368307|FG001|OLE Phase|Pregnancy|2|||
145413439|NCT05399485|524368306|FG000|OLE Phase|Physician Decision|3|||
145413440|NCT05399485|524368307|FG001|OLE Phase|Physician Decision|0|||
145413441|NCT05399485|524368306|FG000|OLE Phase|Adverse Event|2|||
145413442|NCT05399485|524368307|FG001|OLE Phase|Adverse Event|2|||
145413443|NCT04633447|524368310|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
145413444|NCT04633447|524368311|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
145413445|NCT04633447|524368310|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
145413446|NCT04633447|524368311|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
145413447|NCT04633447|524368310|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
145413448|NCT04633447|524368311|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
145413449|NCT04633447|524368310|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
145413450|NCT04633447|524368311|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
145413451|NCT04633447|524368310|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
145413452|NCT04633447|524368311|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
145413453|NCT04633447|524368310|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
145413454|NCT04633447|524368311|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
145413455|NCT01022580|524368314|FG000|Overall Study|Death|18|||
145413456|NCT01022580|524368315|FG001|Overall Study|Death|22|||
145413457|NCT03439839|524368316|FG000|Overall Study|Death|3|||
145413458|NCT03439839|524368317|FG001|Overall Study|Death|0|||
145413459|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145413460|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
145413461|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
145413462|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145413463|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145413464|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145413465|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
145339735|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
145339736|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
145339737|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
145339738|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
145339739|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
145339740|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
145339741|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
145339742|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
145339743|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
145339744|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
145339745|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
145339746|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145339747|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
145339748|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
145339749|NCT03713619|524091210|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145339750|NCT03713619|524091211|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145339751|NCT03713619|524091212|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145339752|NCT03713619|524091213|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145339753|NCT03713619|524091214|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145339754|NCT04642365|524091216|FG000|Overall Study|Death|3|||
145339755|NCT04642365|524091217|FG001|Overall Study|Death|2|||
145339756|NCT04642365|524091218|FG002|Overall Study|Death|4|||
145339757|NCT04642365|524091219|FG003|Overall Study|Death|5|||
145339758|NCT04642365|524091220|FG004|Overall Study|Death|5|||
145339759|NCT04642365|524091221|FG005|Overall Study|Death|3|||
145413466|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
145339760|NCT04642365|524091222|FG006|Overall Study|Death|2|||
145413467|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145413468|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
145413469|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145339761|NCT04642365|524091223|FG007|Overall Study|Death|1|||
145339762|NCT04642365|524091216|FG000|Overall Study|Physician Decision|1|||
145339763|NCT04642365|524091217|FG001|Overall Study|Physician Decision|0|||
145339764|NCT04642365|524091218|FG002|Overall Study|Physician Decision|0|||
145339765|NCT04642365|524091219|FG003|Overall Study|Physician Decision|0|||
145622531|NCT02403674|525130107|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
145622532|NCT02403674|525130108|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
145622533|NCT02403674|525130107|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
145622534|NCT02403674|525130108|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
145622535|NCT02403674|525130107|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
145622536|NCT02403674|525130108|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
145622537|NCT02403674|525130107|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
145622538|NCT02403674|525130108|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
145622539|NCT02403674|525130107|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
145339766|NCT04642365|524091220|FG004|Overall Study|Physician Decision|0|||
145339767|NCT04642365|524091221|FG005|Overall Study|Physician Decision|0|||
145339768|NCT04642365|524091222|FG006|Overall Study|Physician Decision|0|||
145339769|NCT04642365|524091223|FG007|Overall Study|Physician Decision|0|||
145339770|NCT04642365|524091216|FG000|Overall Study|Progressive Disease|1|||
145339771|NCT04642365|524091217|FG001|Overall Study|Progressive Disease|1|||
145339772|NCT04642365|524091218|FG002|Overall Study|Progressive Disease|1|||
145339773|NCT04642365|524091219|FG003|Overall Study|Progressive Disease|0|||
145339774|NCT04642365|524091220|FG004|Overall Study|Progressive Disease|0|||
145339775|NCT04642365|524091221|FG005|Overall Study|Progressive Disease|0|||
145339776|NCT04642365|524091222|FG006|Overall Study|Progressive Disease|1|||
145339777|NCT04642365|524091223|FG007|Overall Study|Progressive Disease|0|||
145339778|NCT04642365|524091216|FG000|Overall Study|Study Terminated By Sponsor|0|||
145339779|NCT04642365|524091217|FG001|Overall Study|Study Terminated By Sponsor|2|||
145339780|NCT04642365|524091218|FG002|Overall Study|Study Terminated By Sponsor|1|||
145339781|NCT04642365|524091219|FG003|Overall Study|Study Terminated By Sponsor|1|||
145339782|NCT04642365|524091220|FG004|Overall Study|Study Terminated By Sponsor|1|||
145339783|NCT04642365|524091221|FG005|Overall Study|Study Terminated By Sponsor|2|||
145339784|NCT04642365|524091222|FG006|Overall Study|Study Terminated By Sponsor|2|||
145339785|NCT04642365|524091223|FG007|Overall Study|Study Terminated By Sponsor|1|||
145339786|NCT04642365|524091216|FG000|Overall Study|Symptomatic Deterioration|1|||
145339787|NCT04642365|524091217|FG001|Overall Study|Symptomatic Deterioration|1|||
145339788|NCT04642365|524091218|FG002|Overall Study|Symptomatic Deterioration|0|||
145339789|NCT04642365|524091219|FG003|Overall Study|Symptomatic Deterioration|0|||
145339790|NCT04642365|524091220|FG004|Overall Study|Symptomatic Deterioration|0|||
145339791|NCT04642365|524091221|FG005|Overall Study|Symptomatic Deterioration|1|||
145339792|NCT04642365|524091222|FG006|Overall Study|Symptomatic Deterioration|0|||
145339793|NCT04642365|524091223|FG007|Overall Study|Symptomatic Deterioration|0|||
145339794|NCT04642365|524091216|FG000|Overall Study|Withdrawal by Subject|0|||
145339795|NCT04642365|524091217|FG001|Overall Study|Withdrawal by Subject|0|||
145339796|NCT04642365|524091218|FG002|Overall Study|Withdrawal by Subject|1|||
145339797|NCT04642365|524091219|FG003|Overall Study|Withdrawal by Subject|1|||
145339798|NCT04642365|524091220|FG004|Overall Study|Withdrawal by Subject|0|||
145339799|NCT04642365|524091221|FG005|Overall Study|Withdrawal by Subject|0|||
145339800|NCT04642365|524091222|FG006|Overall Study|Withdrawal by Subject|2|||
145339801|NCT04642365|524091223|FG007|Overall Study|Withdrawal by Subject|0|||
145339802|NCT04642365|524091216|FG000|Overall Study|Adverse Event|0|||
145339803|NCT04642365|524091217|FG001|Overall Study|Adverse Event|0|||
145339804|NCT04642365|524091218|FG002|Overall Study|Adverse Event|0|||
145339805|NCT04642365|524091219|FG003|Overall Study|Adverse Event|0|||
145339806|NCT04642365|524091220|FG004|Overall Study|Adverse Event|0|||
145339807|NCT04642365|524091221|FG005|Overall Study|Adverse Event|0|||
145339808|NCT04642365|524091222|FG006|Overall Study|Adverse Event|0|||
145339809|NCT04642365|524091223|FG007|Overall Study|Adverse Event|1|||
145339810|NCT00673387|524091225|FG000|Overall Study|Withdrawal by Subject|15|||
145339811|NCT00673387|524091226|FG001|Overall Study|Withdrawal by Subject|16|||
145339812|NCT00673387|524091227|FG002|Overall Study|Withdrawal by Subject|20|||
145339813|NCT00673387|524091228|FG003|Overall Study|Withdrawal by Subject|16|||
145339814|NCT00673387|524091229|FG004|Overall Study|Withdrawal by Subject|18|||
145339815|NCT00673387|524091230|FG005|Overall Study|Withdrawal by Subject|21|||
145339816|NCT00673387|524091231|FG006|Overall Study|Withdrawal by Subject|15|||
145339817|NCT00673387|524091232|FG007|Overall Study|Withdrawal by Subject|21|||
145339818|NCT00673387|524091225|FG000|Overall Study|Adverse Event|3|||
145339819|NCT00673387|524091226|FG001|Overall Study|Adverse Event|1|||
145339820|NCT00673387|524091227|FG002|Overall Study|Adverse Event|5|||
145339821|NCT00673387|524091228|FG003|Overall Study|Adverse Event|2|||
145339822|NCT00673387|524091229|FG004|Overall Study|Adverse Event|6|||
145339823|NCT00673387|524091230|FG005|Overall Study|Adverse Event|2|||
145339824|NCT00673387|524091231|FG006|Overall Study|Adverse Event|5|||
145339825|NCT00673387|524091232|FG007|Overall Study|Adverse Event|5|||
145622540|NCT02403674|525130108|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
145339826|NCT00673387|524091225|FG000|Overall Study|Physician Decision|0|||
145339827|NCT00673387|524091226|FG001|Overall Study|Physician Decision|0|||
145339828|NCT00673387|524091227|FG002|Overall Study|Physician Decision|0|||
145339829|NCT00673387|524091228|FG003|Overall Study|Physician Decision|0|||
145339830|NCT00673387|524091229|FG004|Overall Study|Physician Decision|0|||
145339831|NCT00673387|524091230|FG005|Overall Study|Physician Decision|5|||
145339832|NCT00673387|524091231|FG006|Overall Study|Physician Decision|1|||
145339833|NCT00673387|524091232|FG007|Overall Study|Physician Decision|1|||
145339834|NCT00673387|524091225|FG000|Overall Study|Protocol Violation|3|||
145339835|NCT00673387|524091226|FG001|Overall Study|Protocol Violation|0|||
145339836|NCT00673387|524091227|FG002|Overall Study|Protocol Violation|1|||
145339837|NCT00673387|524091228|FG003|Overall Study|Protocol Violation|2|||
145339838|NCT00673387|524091229|FG004|Overall Study|Protocol Violation|0|||
145339839|NCT00673387|524091230|FG005|Overall Study|Protocol Violation|1|||
145339840|NCT00673387|524091231|FG006|Overall Study|Protocol Violation|1|||
145339841|NCT00673387|524091232|FG007|Overall Study|Protocol Violation|3|||
145339842|NCT00673387|524091225|FG000|Overall Study|Lost to Follow-up|8|||
145339843|NCT00673387|524091226|FG001|Overall Study|Lost to Follow-up|6|||
145339844|NCT00673387|524091227|FG002|Overall Study|Lost to Follow-up|5|||
145339845|NCT00673387|524091228|FG003|Overall Study|Lost to Follow-up|6|||
145339846|NCT00673387|524091229|FG004|Overall Study|Lost to Follow-up|6|||
145339847|NCT00673387|524091230|FG005|Overall Study|Lost to Follow-up|5|||
145339848|NCT00673387|524091231|FG006|Overall Study|Lost to Follow-up|8|||
145339849|NCT00673387|524091232|FG007|Overall Study|Lost to Follow-up|5|||
145339850|NCT02533375|524091233|FG000|Overall Study|Lack of Efficacy|3|||
145339851|NCT02533375|524091233|FG000|Overall Study|Adverse Event|2|||
145339852|NCT00960115|524091234|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
145339853|NCT00960115|524091235|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
145339854|NCT00418821|524091236|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
145339855|NCT04619992|524091237|FG000|Overall Study|Withdrawal by Subject|1|||
145339856|NCT04619992|524091238|FG001|Overall Study|Withdrawal by Subject|0|||
145339857|NCT00270855|524092649|FG000|Overall Study|Withdrawal by Subject|8|||
145339858|NCT00270855|524092650|FG001|Overall Study|Withdrawal by Subject|8|||
145339859|NCT02618759|524092657|FG000|Overall Study|Lost to Follow-up|0|||
145339860|NCT02618759|524092658|FG001|Overall Study|Lost to Follow-up|1|||
145339861|NCT02618759|524092657|FG000|Overall Study|Withdrawal by Subject|1|||
145339862|NCT02618759|524092658|FG001|Overall Study|Withdrawal by Subject|0|||
145339863|NCT02618759|524092657|FG000|Overall Study|Other Reasons|1|||
145339864|NCT02618759|524092658|FG001|Overall Study|Other Reasons|4|||
145339865|NCT02152605|524092659|FG000|Overall Study|Adverse Event|6|||
145339866|NCT02152605|524092660|FG001|Overall Study|Adverse Event|8|||
145339867|NCT02152605|524092659|FG000|Overall Study|Lack of Efficacy|7|||
145339868|NCT02152605|524092660|FG001|Overall Study|Lack of Efficacy|4|||
145339869|NCT02152605|524092659|FG000|Overall Study|Protocol deviation|1|||
145339870|NCT02152605|524092660|FG001|Overall Study|Protocol deviation|4|||
145339871|NCT02152605|524092659|FG000|Overall Study|Lost to Follow-up|1|||
145339872|NCT02152605|524092660|FG001|Overall Study|Lost to Follow-up|0|||
145339873|NCT02152605|524092659|FG000|Overall Study|Withdrew consent|4|||
145339874|NCT02152605|524092660|FG001|Overall Study|Withdrew consent|2|||
145339875|NCT02500043|524092667|FG000|Overall Study|Randomized, but not Treated|2|||
145339876|NCT02500043|524092668|FG001|Overall Study|Randomized, but not Treated|2|||
145339877|NCT02500043|524092667|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
145339878|NCT02500043|524092668|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
145339879|NCT02500043|524092667|FG000|Overall Study|Adverse Event|33|||
145339880|NCT02500043|524092668|FG001|Overall Study|Adverse Event|11|||
145339881|NCT02500043|524092667|FG000|Overall Study|Clinical Progression|54|||
145339882|NCT02500043|524092668|FG001|Overall Study|Clinical Progression|35|||
145339883|NCT02500043|524092667|FG000|Overall Study|Radiological Progression|192|||
145339884|NCT02500043|524092668|FG001|Overall Study|Radiological Progression|110|||
145339885|NCT02500043|524092667|FG000|Overall Study|Physician's Decision|11|||
145339886|NCT02500043|524092668|FG001|Overall Study|Physician's Decision|3|||
145339887|NCT02500043|524092667|FG000|Overall Study|Withdrawal by Subject|14|||
145339888|NCT02500043|524092668|FG001|Overall Study|Withdrawal by Subject|4|||
145339889|NCT02500043|524092667|FG000|Overall Study|Death|11|||
145339890|NCT02500043|524092668|FG001|Overall Study|Death|2|||
145339891|NCT02500043|524092667|FG000|Overall Study|Protocol Deviation|1|||
145339892|NCT02500043|524092668|FG001|Overall Study|Protocol Deviation|0|||
145339893|NCT01371747|524092669|FG000|Overall Study|Adverse Event|4|||
145339894|NCT01371747|524092670|FG001|Overall Study|Adverse Event|2|||
145413470|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145413471|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145413472|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
145339895|NCT01371747|524092671|FG002|Overall Study|Adverse Event|7|||
145339896|NCT01371747|524092672|FG003|Overall Study|Adverse Event|2|||
145339897|NCT01371747|524092673|FG004|Overall Study|Adverse Event|2|||
145339898|NCT01371747|524092674|FG005|Overall Study|Adverse Event|2|||
145339899|NCT01371747|524092669|FG000|Overall Study|Death|1|||
145339900|NCT01371747|524092670|FG001|Overall Study|Death|0|||
145339901|NCT01371747|524092671|FG002|Overall Study|Death|4|||
145339902|NCT01371747|524092672|FG003|Overall Study|Death|1|||
145339903|NCT01371747|524092673|FG004|Overall Study|Death|2|||
145339904|NCT01371747|524092674|FG005|Overall Study|Death|0|||
145339905|NCT01371747|524092669|FG000|Overall Study|Abnormal Renal Function|0|||
145339906|NCT01371747|524092670|FG001|Overall Study|Abnormal Renal Function|2|||
145339907|NCT01371747|524092671|FG002|Overall Study|Abnormal Renal Function|0|||
145339908|NCT01371747|524092672|FG003|Overall Study|Abnormal Renal Function|1|||
145339909|NCT01371747|524092673|FG004|Overall Study|Abnormal Renal Function|0|||
145339910|NCT01371747|524092674|FG005|Overall Study|Abnormal Renal Function|1|||
145339911|NCT01371747|524092669|FG000|Overall Study|High Serum Potassium Results|1|||
145339912|NCT01371747|524092670|FG001|Overall Study|High Serum Potassium Results|1|||
145622541|NCT00826280|525130109|FG000|Overall Study|Randomized but drug not received|1|||
145622542|NCT00826280|525130110|FG001|Overall Study|Randomized but drug not received|0|||
145622543|NCT00826280|525130111|FG002|Overall Study|Randomized but drug not received|1|||
145339913|NCT01371747|524092671|FG002|Overall Study|High Serum Potassium Results|1|||
145339914|NCT01371747|524092672|FG003|Overall Study|High Serum Potassium Results|2|||
145339915|NCT01371747|524092673|FG004|Overall Study|High Serum Potassium Results|0|||
145339916|NCT01371747|524092674|FG005|Overall Study|High Serum Potassium Results|2|||
145339917|NCT01371747|524092669|FG000|Overall Study|Low Serum Potassium Results|1|||
145339918|NCT01371747|524092670|FG001|Overall Study|Low Serum Potassium Results|1|||
145339919|NCT01371747|524092671|FG002|Overall Study|Low Serum Potassium Results|1|||
145339920|NCT01371747|524092672|FG003|Overall Study|Low Serum Potassium Results|1|||
145339921|NCT01371747|524092673|FG004|Overall Study|Low Serum Potassium Results|0|||
145339922|NCT01371747|524092674|FG005|Overall Study|Low Serum Potassium Results|3|||
145339923|NCT01371747|524092669|FG000|Overall Study|Protocol Violation|0|||
145339924|NCT01371747|524092670|FG001|Overall Study|Protocol Violation|0|||
145339925|NCT01371747|524092671|FG002|Overall Study|Protocol Violation|1|||
145339926|NCT01371747|524092672|FG003|Overall Study|Protocol Violation|0|||
145339927|NCT01371747|524092673|FG004|Overall Study|Protocol Violation|0|||
145339928|NCT01371747|524092674|FG005|Overall Study|Protocol Violation|0|||
145339929|NCT01371747|524092669|FG000|Overall Study|Non-Compliance|3|||
145339930|NCT01371747|524092670|FG001|Overall Study|Non-Compliance|4|||
145339931|NCT01371747|524092671|FG002|Overall Study|Non-Compliance|3|||
145339932|NCT01371747|524092672|FG003|Overall Study|Non-Compliance|0|||
145339933|NCT01371747|524092673|FG004|Overall Study|Non-Compliance|0|||
145339934|NCT01371747|524092674|FG005|Overall Study|Non-Compliance|1|||
145339935|NCT01371747|524092669|FG000|Overall Study|Physician Decision|0|||
145339936|NCT01371747|524092670|FG001|Overall Study|Physician Decision|0|||
145339937|NCT01371747|524092671|FG002|Overall Study|Physician Decision|0|||
145339938|NCT01371747|524092672|FG003|Overall Study|Physician Decision|0|||
145339939|NCT01371747|524092673|FG004|Overall Study|Physician Decision|1|||
145339940|NCT01371747|524092674|FG005|Overall Study|Physician Decision|0|||
145339941|NCT01371747|524092669|FG000|Overall Study|Withdrawal by Subject|6|||
145339942|NCT01371747|524092670|FG001|Overall Study|Withdrawal by Subject|12|||
145339943|NCT01371747|524092671|FG002|Overall Study|Withdrawal by Subject|5|||
145339944|NCT01371747|524092672|FG003|Overall Study|Withdrawal by Subject|2|||
145339945|NCT01371747|524092673|FG004|Overall Study|Withdrawal by Subject|2|||
145339946|NCT01371747|524092674|FG005|Overall Study|Withdrawal by Subject|4|||
145339947|NCT01371747|524092669|FG000|Overall Study|Other Reasons|2|||
145339948|NCT01371747|524092670|FG001|Overall Study|Other Reasons|1|||
145339949|NCT01371747|524092671|FG002|Overall Study|Other Reasons|2|||
145339950|NCT01371747|524092672|FG003|Overall Study|Other Reasons|0|||
145339951|NCT01371747|524092673|FG004|Overall Study|Other Reasons|0|||
145339952|NCT01371747|524092674|FG005|Overall Study|Other Reasons|1|||
145339953|NCT02094417|524092675|FG000|Overall Study|Adverse Event|0|||
145339954|NCT02094417|524092676|FG001|Overall Study|Adverse Event|0|||
145339955|NCT02094417|524092677|FG002|Overall Study|Adverse Event|0|||
145339956|NCT02094417|524092678|FG003|Overall Study|Adverse Event|1|||
145339957|NCT02094417|524092675|FG000|Overall Study|Eligibility criteria|0|||
145339958|NCT02094417|524092676|FG001|Overall Study|Eligibility criteria|1|||
145339959|NCT02094417|524092677|FG002|Overall Study|Eligibility criteria|0|||
145339960|NCT02094417|524092678|FG003|Overall Study|Eligibility criteria|0|||
145339961|NCT02094417|524092675|FG000|Overall Study|No responder|4|||
145339962|NCT02094417|524092676|FG001|Overall Study|No responder|4|||
145339963|NCT02094417|524092677|FG002|Overall Study|No responder|4|||
145339964|NCT02094417|524092678|FG003|Overall Study|No responder|3|||
145339965|NCT02094417|524092675|FG000|Overall Study|Unable to conduct observations or assess|0|||
145339966|NCT02094417|524092676|FG001|Overall Study|Unable to conduct observations or assess|1|||
145339967|NCT02094417|524092677|FG002|Overall Study|Unable to conduct observations or assess|0|||
145339968|NCT02094417|524092678|FG003|Overall Study|Unable to conduct observations or assess|0|||
145339969|NCT02094417|524092675|FG000|Overall Study|Withdrawal by Subject|1|||
145339970|NCT02094417|524092676|FG001|Overall Study|Withdrawal by Subject|2|||
145339971|NCT02094417|524092677|FG002|Overall Study|Withdrawal by Subject|1|||
145339972|NCT02094417|524092678|FG003|Overall Study|Withdrawal by Subject|3|||
145339973|NCT03333941|524092679|FG000|Overall Study|Lost to Follow-up|10|||
145339974|NCT03333941|524092679|FG000|Overall Study|Death|2|||
145339975|NCT03333941|524092679|FG000|Overall Study|Adverse Event|1|||
145339976|NCT00509366|524092682|FG000|Overall Study|Not Treated (Screen Failure)|1|||
145339977|NCT00509366|524092683|FG001|Overall Study|Not Treated (Screen Failure)|1|||
145413473|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413474|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413475|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
145413476|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413477|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413478|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413479|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
145413480|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
145413481|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413482|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413483|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413484|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413485|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413486|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
145413487|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413488|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413489|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
145413490|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413491|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413492|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413493|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
145413494|NCT01807520|524368318|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
145413495|NCT01807520|524368319|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413496|NCT01807520|524368320|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413497|NCT01807520|524368321|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413498|NCT01807520|524368322|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413499|NCT01807520|524368323|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413500|NCT01807520|524368324|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
145413501|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
145413502|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
145413503|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145413504|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145413505|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
145413506|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145413507|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
145413508|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413509|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413510|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413511|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
145413512|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413513|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413514|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
145413515|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
145413516|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413517|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413518|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413519|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413520|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413521|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
145413522|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145413523|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
145413524|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145413525|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145413526|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145413527|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145413528|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
145339978|NCT00509366|524092684|FG002|Overall Study|Not Treated (Screen Failure)|1|||
145339979|NCT00509366|524092685|FG003|Overall Study|Not Treated (Screen Failure)|0|||
145339980|NCT00509366|524092686|FG004|Overall Study|Not Treated (Screen Failure)|0|||
145339981|NCT01473524|524092687|FG000|DB Phase|Adverse Event|4|||
145339982|NCT01473524|524092688|FG001|DB Phase|Adverse Event|8|||
145339983|NCT01473524|524092689|FG002|DB Phase|Adverse Event|2|||
145339984|NCT01473524|524092690|FG003|DB Phase|Adverse Event|0|||
145339985|NCT01473524|524092691|FG004|DB Phase|Adverse Event|0|||
145339986|NCT01473524|524092692|FG005|DB Phase|Adverse Event|0|||
145339987|NCT01473524|524092687|FG000|DB Phase|Death|1|||
145339988|NCT01473524|524092688|FG001|DB Phase|Death|0|||
145339989|NCT01473524|524092689|FG002|DB Phase|Death|0|||
145339990|NCT01473524|524092690|FG003|DB Phase|Death|0|||
145339991|NCT01473524|524092691|FG004|DB Phase|Death|0|||
145339992|NCT01473524|524092692|FG005|DB Phase|Death|0|||
145339993|NCT01473524|524092687|FG000|DB Phase|Withdrawal by Subject|2|||
145339994|NCT01473524|524092688|FG001|DB Phase|Withdrawal by Subject|1|||
145339995|NCT01473524|524092689|FG002|DB Phase|Withdrawal by Subject|1|||
145339996|NCT01473524|524092690|FG003|DB Phase|Withdrawal by Subject|0|||
145339997|NCT01473524|524092691|FG004|DB Phase|Withdrawal by Subject|0|||
145339998|NCT01473524|524092692|FG005|DB Phase|Withdrawal by Subject|0|||
145339999|NCT01473524|524092687|FG000|LTSE Phase|Withdrawal by Subject|0|||
145340000|NCT01473524|524092688|FG001|LTSE Phase|Withdrawal by Subject|0|||
145340001|NCT01473524|524092689|FG002|LTSE Phase|Withdrawal by Subject|0|||
145340002|NCT01473524|524092690|FG003|LTSE Phase|Withdrawal by Subject|3|||
145340003|NCT01473524|524092691|FG004|LTSE Phase|Withdrawal by Subject|3|||
145340004|NCT01473524|524092692|FG005|LTSE Phase|Withdrawal by Subject|6|||
145340005|NCT01473524|524092687|FG000|LTSE Phase|Death|0|||
145340006|NCT01473524|524092688|FG001|LTSE Phase|Death|0|||
145340007|NCT01473524|524092689|FG002|LTSE Phase|Death|0|||
145340008|NCT01473524|524092690|FG003|LTSE Phase|Death|0|||
145340009|NCT01473524|524092691|FG004|LTSE Phase|Death|1|||
145340010|NCT01473524|524092692|FG005|LTSE Phase|Death|0|||
145340011|NCT01473524|524092687|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
145340012|NCT01473524|524092688|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
145340013|NCT01473524|524092689|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
145340014|NCT01473524|524092690|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
145340015|NCT01473524|524092691|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
145340016|NCT01473524|524092692|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
145340017|NCT01473524|524092687|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
145340018|NCT01473524|524092688|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
145340019|NCT01473524|524092689|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
145340020|NCT01473524|524092690|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
145340021|NCT01473524|524092691|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
145340022|NCT01473524|524092692|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
145340023|NCT01473524|524092687|FG000|LTSE Phase|Lost to Follow-up|0|||
145340024|NCT01473524|524092688|FG001|LTSE Phase|Lost to Follow-up|0|||
145340025|NCT01473524|524092689|FG002|LTSE Phase|Lost to Follow-up|0|||
145340026|NCT01473524|524092690|FG003|LTSE Phase|Lost to Follow-up|1|||
145340027|NCT01473524|524092691|FG004|LTSE Phase|Lost to Follow-up|3|||
145340028|NCT01473524|524092692|FG005|LTSE Phase|Lost to Follow-up|2|||
145340029|NCT01473524|524092687|FG000|LTSE Phase|Principal Investigator Decision|0|||
145340030|NCT01473524|524092688|FG001|LTSE Phase|Principal Investigator Decision|0|||
145340031|NCT01473524|524092689|FG002|LTSE Phase|Principal Investigator Decision|0|||
145340032|NCT01473524|524092690|FG003|LTSE Phase|Principal Investigator Decision|1|||
145340033|NCT01473524|524092691|FG004|LTSE Phase|Principal Investigator Decision|1|||
145340034|NCT01473524|524092692|FG005|LTSE Phase|Principal Investigator Decision|3|||
145340035|NCT01473524|524092687|FG000|LTSE Phase|Liver Transplantation|0|||
145340036|NCT01473524|524092688|FG001|LTSE Phase|Liver Transplantation|0|||
145340037|NCT01473524|524092689|FG002|LTSE Phase|Liver Transplantation|0|||
145340038|NCT01473524|524092690|FG003|LTSE Phase|Liver Transplantation|0|||
145340039|NCT01473524|524092691|FG004|LTSE Phase|Liver Transplantation|0|||
145340040|NCT01473524|524092692|FG005|LTSE Phase|Liver Transplantation|1|||
145340041|NCT01473524|524092687|FG000|LTSE Phase|Pregnancy|0|||
145340042|NCT01473524|524092688|FG001|LTSE Phase|Pregnancy|0|||
145340043|NCT01473524|524092689|FG002|LTSE Phase|Pregnancy|0|||
145340044|NCT01473524|524092690|FG003|LTSE Phase|Pregnancy|1|||
145340045|NCT01473524|524092691|FG004|LTSE Phase|Pregnancy|0|||
145340046|NCT01473524|524092692|FG005|LTSE Phase|Pregnancy|0|||
145340047|NCT01473524|524092687|FG000|LTSE Phase|Protocol Violation|0|||
145340048|NCT01473524|524092688|FG001|LTSE Phase|Protocol Violation|0|||
145340049|NCT01473524|524092689|FG002|LTSE Phase|Protocol Violation|0|||
145340050|NCT01473524|524092690|FG003|LTSE Phase|Protocol Violation|0|||
145340051|NCT01473524|524092691|FG004|LTSE Phase|Protocol Violation|0|||
145340052|NCT01473524|524092692|FG005|LTSE Phase|Protocol Violation|1|||
145340053|NCT01590797|524092695|FG000|Overall Study|Adverse Event|4|||
145340054|NCT01590797|524092696|FG001|Overall Study|Adverse Event|3|||
145340055|NCT01590797|524092695|FG000|Overall Study|Lack of Efficacy|0|||
145413529|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
145413530|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145413531|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145413532|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
145340056|NCT01590797|524092696|FG001|Overall Study|Lack of Efficacy|2|||
145413533|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145622544|NCT00826280|525130109|FG000|Overall Study|Adverse Event|1|||
145340057|NCT01590797|524092695|FG000|Overall Study|Lost to Follow-up|0|||
145340058|NCT01590797|524092696|FG001|Overall Study|Lost to Follow-up|1|||
145340059|NCT01590797|524092695|FG000|Overall Study|Protocol Violation|4|||
145340060|NCT01590797|524092696|FG001|Overall Study|Protocol Violation|1|||
145340061|NCT01590797|524092695|FG000|Overall Study|Withdrawal by Subject|7|||
145340062|NCT01590797|524092696|FG001|Overall Study|Withdrawal by Subject|5|||
145340063|NCT01590797|524092695|FG000|Overall Study|Other Protocol Specified Criteria|2|||
145413534|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145413535|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
145413536|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
145413537|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
145413538|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145413539|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145413540|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
145413541|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145413542|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
145413543|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145413544|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145413545|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145413546|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
145413547|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145413548|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145413549|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
145413550|NCT01807520|524368318|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
145413551|NCT01807520|524368319|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
145413552|NCT01807520|524368320|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145413553|NCT01807520|524368321|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
145413554|NCT01807520|524368322|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
145413555|NCT01807520|524368323|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145413556|NCT01807520|524368324|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
145413557|NCT01807520|524368318|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413558|NCT01807520|524368319|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413559|NCT01807520|524368320|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413560|NCT01807520|524368321|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413561|NCT01807520|524368322|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413562|NCT01807520|524368323|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
145413563|NCT01807520|524368324|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
145413564|NCT01807520|524368318|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413565|NCT01807520|524368319|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413566|NCT01807520|524368320|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413567|NCT01807520|524368321|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413568|NCT01807520|524368322|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413569|NCT01807520|524368323|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
145413570|NCT01807520|524368324|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
145413571|NCT01807520|524368318|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145413572|NCT01807520|524368319|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145413573|NCT01807520|524368320|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145340064|NCT01590797|524092696|FG001|Overall Study|Other Protocol Specified Criteria|4|||
145340065|NCT00195338|524092704|FG000|Overall Study|Lost to Follow-up|2|||
145340066|NCT00195338|524092704|FG000|Overall Study|Adverse Event|5|||
145340067|NCT00195338|524092704|FG000|Overall Study|Lack of Efficacy|1|||
145340068|NCT00195338|524092704|FG000|Overall Study|Early closure of the site|4|||
145340069|NCT00811928|524092705|FG000|Overall Study|AEs and SAEs Including Death|7|||
145340070|NCT00811928|524092706|FG001|Overall Study|AEs and SAEs Including Death|11|||
145340071|NCT00811928|524092705|FG000|Overall Study|Withdrawal by Subject|18|||
145340072|NCT00811928|524092706|FG001|Overall Study|Withdrawal by Subject|12|||
145340073|NCT00811928|524092705|FG000|Overall Study|Did Not Take Study Drug|3|||
145340074|NCT00811928|524092706|FG001|Overall Study|Did Not Take Study Drug|0|||
145340075|NCT00811928|524092705|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
145340076|NCT00811928|524092706|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
145340077|NCT00811928|524092705|FG000|Overall Study|Investigator Decision|2|||
145340078|NCT00811928|524092706|FG001|Overall Study|Investigator Decision|1|||
145340079|NCT00811928|524092705|FG000|Overall Study|Poor Compliance|2|||
145340080|NCT00811928|524092706|FG001|Overall Study|Poor Compliance|5|||
145340081|NCT01085357|524092707|FG000|Overall Study|Adverse Event|1|||
145340082|NCT01085357|524092708|FG001|Overall Study|Adverse Event|1|||
145340083|NCT01085357|524092707|FG000|Overall Study|Subject Decision|4|||
145340084|NCT01085357|524092708|FG001|Overall Study|Subject Decision|3|||
145340085|NCT01085357|524092707|FG000|Overall Study|Investigator Decision|1|||
145413574|NCT01807520|524368321|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145413575|NCT01807520|524368322|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
145340086|NCT01085357|524092708|FG001|Overall Study|Investigator Decision|1|||
145340087|NCT01085357|524092707|FG000|Overall Study|Death|11|||
145340088|NCT01085357|524092708|FG001|Overall Study|Death|1|||
145413576|NCT01807520|524368323|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
145340089|NCT01085357|524092707|FG000|Overall Study|Lost to Follow-up|2|||
145622545|NCT00826280|525130110|FG001|Overall Study|Adverse Event|3|||
145340090|NCT01085357|524092708|FG001|Overall Study|Lost to Follow-up|0|||
145340091|NCT05320887|524092711|FG000|Overall Study|Lost to Follow-up|0|||
145340092|NCT05320887|524092712|FG001|Overall Study|Lost to Follow-up|3|||
145340093|NCT05320887|524092713|FG002|Overall Study|Lost to Follow-up|0|||
145340094|NCT05320887|524092714|FG003|Overall Study|Lost to Follow-up|0|||
145340095|NCT00920790|524092715|FG000|Overall Study|aggravation of general condition|14|||
145340096|NCT04411914|524092716|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
145340097|NCT04411914|524092717|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
145340098|NCT02015065|524092718|FG000|Overall Study|Death on study|1|||
145340099|NCT02015065|524092719|FG001|Overall Study|Death on study|2|||
145340100|NCT02015065|524092720|FG002|Overall Study|Death on study|1|||
145340101|NCT01860677|524092721|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
145340102|NCT01860677|524092722|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
145340103|NCT01144715|524092723|FG000|Overall Study|Lost to Follow-up|2|||
145340104|NCT01144715|524092724|FG001|Overall Study|Lost to Follow-up|1|||
145340105|NCT01144715|524092723|FG000|Overall Study|Withdrawal by Subject|2|||
145340106|NCT01144715|524092724|FG001|Overall Study|Withdrawal by Subject|1|||
145340107|NCT01144715|524092723|FG000|Overall Study|Adverse Event|0|||
145340108|NCT01144715|524092724|FG001|Overall Study|Adverse Event|1|||
145340109|NCT03553576|524092725|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
145340110|NCT03553576|524092726|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
145340111|NCT03553576|524092725|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
145340112|NCT03553576|524092726|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
145340113|NCT03553576|524092725|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
145340114|NCT03553576|524092726|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
145340115|NCT03553576|524092725|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
145340116|NCT03553576|524092726|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
145340117|NCT03553576|524092725|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
145340118|NCT03553576|524092726|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
145340119|NCT03553576|524092725|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
145340120|NCT03553576|524092726|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
145340121|NCT03553576|524092725|FG000|Overall Study|Physician Decision|2|||
145340122|NCT03553576|524092726|FG001|Overall Study|Physician Decision|5|||
145340123|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
145340124|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
145340125|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
145340126|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
145340127|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
145340128|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
145340129|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
145340130|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
145340131|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
145340132|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
145340133|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
145340134|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
145340135|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
145340136|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
145340137|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
145340138|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
145340139|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
145340140|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
145340141|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
145340142|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
145340143|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
145340144|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
145340145|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
145340146|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
145340147|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
145340148|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
145340149|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
145340150|NCT02552212|524092727|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
145340151|NCT02552212|524092728|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
145340152|NCT02552212|524092729|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
145340153|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
145340154|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
145340155|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
145340156|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
145340157|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
145340158|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
145340159|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
145340160|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
145340161|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
145340162|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
145340163|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
145340164|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
145340165|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
145340166|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
145340167|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
145340168|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
145340169|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
145340170|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
145340171|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
145340172|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
145340173|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
145340174|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
145340175|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
145340176|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
145340177|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
145340178|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
145340179|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
145340180|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
145340181|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
145340182|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
145340183|NCT02552212|524092727|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
145340184|NCT02552212|524092728|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
145340185|NCT02552212|524092729|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
145340186|NCT02728843|524092730|FG000|Overall Study|Adverse Event|0|||
145340187|NCT02728843|524092731|FG001|Overall Study|Adverse Event|2|||
145340188|NCT02728843|524092732|FG002|Overall Study|Adverse Event|3|||
145340189|NCT02728843|524092733|FG003|Overall Study|Adverse Event|1|||
145340190|NCT02728843|524092734|FG004|Overall Study|Adverse Event|2|||
145340191|NCT02728843|524092730|FG000|Overall Study|Lack of Efficacy|0|||
145340192|NCT02728843|524092731|FG001|Overall Study|Lack of Efficacy|1|||
145340193|NCT02728843|524092732|FG002|Overall Study|Lack of Efficacy|1|||
145340194|NCT02728843|524092733|FG003|Overall Study|Lack of Efficacy|0|||
145340195|NCT02728843|524092734|FG004|Overall Study|Lack of Efficacy|0|||
145340196|NCT02728843|524092730|FG000|Overall Study|Protocol Violation|2|||
145340197|NCT02728843|524092731|FG001|Overall Study|Protocol Violation|0|||
145340198|NCT02728843|524092732|FG002|Overall Study|Protocol Violation|4|||
145340199|NCT02728843|524092733|FG003|Overall Study|Protocol Violation|2|||
145340200|NCT02728843|524092734|FG004|Overall Study|Protocol Violation|2|||
145340201|NCT02728843|524092730|FG000|Overall Study|Withdrawal by Subject|1|||
145340202|NCT02728843|524092731|FG001|Overall Study|Withdrawal by Subject|0|||
145340203|NCT02728843|524092732|FG002|Overall Study|Withdrawal by Subject|0|||
145340204|NCT02728843|524092733|FG003|Overall Study|Withdrawal by Subject|1|||
145340205|NCT02728843|524092734|FG004|Overall Study|Withdrawal by Subject|0|||
145340206|NCT02728843|524092730|FG000|Overall Study|Use of rescue medication|0|||
145340207|NCT02728843|524092731|FG001|Overall Study|Use of rescue medication|2|||
145340208|NCT02728843|524092732|FG002|Overall Study|Use of rescue medication|0|||
145340209|NCT02728843|524092733|FG003|Overall Study|Use of rescue medication|2|||
145340210|NCT02728843|524092734|FG004|Overall Study|Use of rescue medication|1|||
145340211|NCT01671332|524092735|FG000|Overall Study|Withdrawal by Subject|1|||
145340212|NCT01671332|524092736|FG001|Overall Study|Withdrawal by Subject|1|||
145340213|NCT02056392|524092747|FG000|Overall Study|Lost to Follow-up|0|||
145340214|NCT02056392|524092748|FG001|Overall Study|Lost to Follow-up|1|||
145340215|NCT02056392|524092749|FG002|Overall Study|Lost to Follow-up|2|||
145340216|NCT02056392|524092750|FG003|Overall Study|Lost to Follow-up|0|||
145340217|NCT02056392|524092751|FG004|Overall Study|Lost to Follow-up|0|||
145340218|NCT02056392|524092752|FG005|Overall Study|Lost to Follow-up|0|||
145340219|NCT02056392|524092747|FG000|Overall Study|Protocol Violation|1|||
145340220|NCT02056392|524092748|FG001|Overall Study|Protocol Violation|0|||
145340221|NCT02056392|524092749|FG002|Overall Study|Protocol Violation|1|||
145340222|NCT02056392|524092750|FG003|Overall Study|Protocol Violation|0|||
145340223|NCT02056392|524092751|FG004|Overall Study|Protocol Violation|0|||
145622546|NCT00826280|525130111|FG002|Overall Study|Adverse Event|0|||
145340224|NCT02056392|524092752|FG005|Overall Study|Protocol Violation|0|||
145340225|NCT02056392|524092747|FG000|Overall Study|Withdrawal by Subject|1|||
145340226|NCT02056392|524092748|FG001|Overall Study|Withdrawal by Subject|0|||
145340227|NCT02056392|524092749|FG002|Overall Study|Withdrawal by Subject|0|||
145340228|NCT02056392|524092750|FG003|Overall Study|Withdrawal by Subject|0|||
145340229|NCT02056392|524092751|FG004|Overall Study|Withdrawal by Subject|1|||
145340230|NCT02056392|524092752|FG005|Overall Study|Withdrawal by Subject|0|||
145340231|NCT01806506|524092753|FG000|Overall Study|Lost to Follow-up|2|||
145340232|NCT01806506|524092754|FG001|Overall Study|Lost to Follow-up|1|||
145340233|NCT02092467|524092757|FG000|Overall Study|Death|49|||
145340234|NCT02092467|524092758|FG001|Overall Study|Death|66|||
145340235|NCT02092467|524092759|FG002|Overall Study|Death|38|||
145340236|NCT02092467|524092757|FG000|Overall Study|Lost to Follow-up|38|||
145340237|NCT02092467|524092758|FG001|Overall Study|Lost to Follow-up|35|||
145340238|NCT02092467|524092759|FG002|Overall Study|Lost to Follow-up|40|||
145340239|NCT02092467|524092757|FG000|Overall Study|Global Deterioration of Health Status|1|||
145340240|NCT02092467|524092758|FG001|Overall Study|Global Deterioration of Health Status|0|||
145340241|NCT02092467|524092759|FG002|Overall Study|Global Deterioration of Health Status|0|||
145340242|NCT02092467|524092757|FG000|Overall Study|Other|32|||
145340243|NCT02092467|524092758|FG001|Overall Study|Other|30|||
145340244|NCT02092467|524092759|FG002|Overall Study|Other|24|||
145340245|NCT02092467|524092757|FG000|Overall Study|Withdrawal by Subject|282|||
145340246|NCT02092467|524092758|FG001|Overall Study|Withdrawal by Subject|327|||
145340247|NCT02092467|524092759|FG002|Overall Study|Withdrawal by Subject|289|||
145340248|NCT02092467|524092757|FG000|Overall Study|Randomized but not treated|2|||
145340249|NCT02092467|524092758|FG001|Overall Study|Randomized but not treated|1|||
145340250|NCT02092467|524092759|FG002|Overall Study|Randomized but not treated|7|||
145340251|NCT02952898|524092764|FG000|Overall Study|Withdrawal by Subject|10|||
145340252|NCT02952898|524092765|FG001|Overall Study|Withdrawal by Subject|8|||
145340253|NCT02952898|524092766|FG002|Overall Study|Withdrawal by Subject|8|||
145340254|NCT02952898|524092764|FG000|Overall Study|Adverse Event|8|||
145340255|NCT02952898|524092765|FG001|Overall Study|Adverse Event|8|||
145340256|NCT02952898|524092766|FG002|Overall Study|Adverse Event|3|||
145340257|NCT02952898|524092764|FG000|Overall Study|Lost to Follow-up|3|||
145340258|NCT02952898|524092765|FG001|Overall Study|Lost to Follow-up|2|||
145340259|NCT02952898|524092766|FG002|Overall Study|Lost to Follow-up|2|||
145340260|NCT02952898|524092764|FG000|Overall Study|Non-compliance with study drug|1|||
145340261|NCT02952898|524092765|FG001|Overall Study|Non-compliance with study drug|1|||
145340262|NCT02952898|524092766|FG002|Overall Study|Non-compliance with study drug|2|||
145340263|NCT04844762|524092769|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340264|NCT04844762|524092770|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340265|NCT04844762|524092771|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
145340266|NCT04844762|524092772|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340267|NCT04844762|524092773|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340268|NCT04844762|524092774|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340269|NCT04844762|524092769|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145340270|NCT04844762|524092770|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145340271|NCT04844762|524092771|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145340272|NCT04844762|524092772|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145340273|NCT04844762|524092773|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
145340274|NCT04844762|524092774|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
145340275|NCT04844762|524092769|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340276|NCT04844762|524092770|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340277|NCT04844762|524092771|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145340278|NCT04844762|524092772|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
145340279|NCT04844762|524092773|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340280|NCT04844762|524092774|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145340281|NCT04844762|524092769|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340282|NCT04844762|524092770|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340283|NCT04844762|524092771|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145340284|NCT04844762|524092772|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145340285|NCT04844762|524092773|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
145340286|NCT04844762|524092774|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340287|NCT04844762|524092769|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
145340288|NCT04844762|524092770|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
145340289|NCT04844762|524092771|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340290|NCT04844762|524092772|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340291|NCT04844762|524092773|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340292|NCT04844762|524092774|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340293|NCT04844762|524092769|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145340294|NCT04844762|524092770|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340295|NCT04844762|524092771|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340296|NCT04844762|524092772|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340297|NCT04844762|524092773|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145622547|NCT00826280|525130109|FG000|Overall Study|Lost to Follow-up|0|||
145622548|NCT00826280|525130110|FG001|Overall Study|Lost to Follow-up|1|||
145622549|NCT00826280|525130111|FG002|Overall Study|Lost to Follow-up|0|||
145622550|NCT00826280|525130109|FG000|Overall Study|Sponsor discontinued subject or study|1|||
145622551|NCT00826280|525130110|FG001|Overall Study|Sponsor discontinued subject or study|0|||
145622552|NCT00826280|525130111|FG002|Overall Study|Sponsor discontinued subject or study|0|||
145622553|NCT00826280|525130109|FG000|Overall Study|Reversible ischemic defect not present|43|||
145622554|NCT00826280|525130110|FG001|Overall Study|Reversible ischemic defect not present|40|||
145622555|NCT00826280|525130111|FG002|Overall Study|Reversible ischemic defect not present|44|||
145622556|NCT00826280|525130109|FG000|Overall Study|Interpretation Failure|1|||
145622557|NCT00826280|525130110|FG001|Overall Study|Interpretation Failure|0|||
145622558|NCT00826280|525130111|FG002|Overall Study|Interpretation Failure|0|||
145622559|NCT00826280|525130109|FG000|Overall Study|Machine Failure|1|||
145622560|NCT00826280|525130110|FG001|Overall Study|Machine Failure|1|||
145622561|NCT00826280|525130111|FG002|Overall Study|Machine Failure|0|||
145622562|NCT00826280|525130109|FG000|Overall Study|One or more non-interpretable scan|0|||
145622563|NCT00826280|525130110|FG001|Overall Study|One or more non-interpretable scan|1|||
145622564|NCT00826280|525130111|FG002|Overall Study|One or more non-interpretable scan|1|||
145622565|NCT03487666|525130112|FG000|Overall Study|Disease progression|4|||
145622566|NCT03487666|525130113|FG001|Overall Study|Disease progression|2|||
145622567|NCT03487666|525130114|FG002|Overall Study|Disease progression|0|||
145622568|NCT03487666|525130112|FG000|Overall Study|Adverse Event|0|||
145622569|NCT03487666|525130113|FG001|Overall Study|Adverse Event|0|||
145622570|NCT03487666|525130114|FG002|Overall Study|Adverse Event|1|||
145622571|NCT03201757|525130115|FG000|Overall Study|Withdrawal by Subject|133|||
145622572|NCT03201757|525130115|FG000|Overall Study|Adverse Event|44|||
145622573|NCT03201757|525130115|FG000|Overall Study|Lost to Follow-up|37|||
145622574|NCT03201757|525130115|FG000|Overall Study|Pregnancy|2|||
145622575|NCT03201757|525130115|FG000|Overall Study|Lack of Efficacy|1|||
145622576|NCT03201757|525130115|FG000|Overall Study|Protocol Violation|20|||
145622577|NCT03201757|525130115|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
145622578|NCT03201757|525130115|FG000|Overall Study|Not Yet Determined|5|||
145622579|NCT03201757|525130115|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
145622580|NCT03201757|525130115|FG000|Overall Study|Other|20|||
145622581|NCT00765362|525130117|FG000|Overall Study|Death|9|||
145622582|NCT00765362|525130117|FG000|Overall Study|Adverse Event|2|||
145622583|NCT00765362|525130117|FG000|Overall Study|Protocol Violation|18|||
145622584|NCT00765362|525130117|FG000|Overall Study|Withdrawal by Subject|13|||
145622585|NCT00765362|525130117|FG000|Overall Study|Lost to Follow-up|95|||
145622586|NCT00557505|525130121|FG000|Overall Study|Death|0|||
145622587|NCT00557505|525130122|FG001|Overall Study|Death|0|||
145622588|NCT00557505|525130123|FG002|Overall Study|Death|0|||
145622589|NCT00557505|525130124|FG003|Overall Study|Death|0|||
145622590|NCT00557505|525130125|FG004|Overall Study|Death|0|||
145622591|NCT00557505|525130126|FG005|Overall Study|Death|0|||
145622592|NCT00557505|525130127|FG006|Overall Study|Death|0|||
145622593|NCT00557505|525130128|FG007|Overall Study|Death|0|||
145340298|NCT04844762|524092774|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340299|NCT04844762|524092769|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340300|NCT04844762|524092770|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340301|NCT04844762|524092771|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340302|NCT04844762|524092772|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340303|NCT04844762|524092773|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
145340304|NCT04844762|524092774|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
145340305|NCT04844762|524092769|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
145340306|NCT04844762|524092770|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340307|NCT04844762|524092771|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340308|NCT04844762|524092772|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340309|NCT04844762|524092773|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340310|NCT04844762|524092774|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
145340311|NCT04844762|524092769|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145340312|NCT04844762|524092770|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340313|NCT04844762|524092771|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340314|NCT04844762|524092772|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145340315|NCT04844762|524092773|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
145622594|NCT00557505|525130129|FG008|Overall Study|Death|1|||
145622595|NCT00557505|525130121|FG000|Overall Study|Adverse Event|0|||
145622596|NCT00557505|525130122|FG001|Overall Study|Adverse Event|0|||
145622597|NCT00557505|525130123|FG002|Overall Study|Adverse Event|1|||
145622598|NCT00557505|525130124|FG003|Overall Study|Adverse Event|0|||
145622599|NCT00557505|525130125|FG004|Overall Study|Adverse Event|0|||
145622600|NCT00557505|525130126|FG005|Overall Study|Adverse Event|0|||
145622601|NCT00557505|525130127|FG006|Overall Study|Adverse Event|1|||
145622602|NCT00557505|525130128|FG007|Overall Study|Adverse Event|0|||
145622603|NCT00557505|525130129|FG008|Overall Study|Adverse Event|0|||
145340316|NCT04844762|524092774|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
145340317|NCT04844762|524092769|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145340318|NCT04844762|524092770|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
145340319|NCT04844762|524092771|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145340320|NCT04844762|524092772|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145340321|NCT04844762|524092773|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145340322|NCT04844762|524092774|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
145340323|NCT04844762|524092769|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145340324|NCT04844762|524092770|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145340325|NCT04844762|524092771|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145340326|NCT04844762|524092772|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
145340327|NCT04844762|524092773|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145340328|NCT04844762|524092774|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
145340329|NCT04400682|524092775|FG000|Period 1|Withdrawal by Subject|1|||
145340330|NCT04400682|524092776|FG001|Period 1|Withdrawal by Subject|4|||
145340331|NCT02105974|524092777|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
145340332|NCT02105974|524092778|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
145340333|NCT02105974|524092779|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
145340334|NCT02105974|524092777|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
145340335|NCT02105974|524092778|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
145340336|NCT02105974|524092779|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
145340337|NCT02105974|524092777|FG000|2 Week Run-in Period|Adverse Event|6|||
145413577|NCT01807520|524368324|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
145413578|NCT00723944|524368330|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
145413579|NCT00723944|524368331|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
145413580|NCT00723944|524368330|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
145413581|NCT00723944|524368331|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
145413582|NCT00723944|524368330|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
145413583|NCT00723944|524368331|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
145413584|NCT01631188|524368332|FG000|Overall Study|Physician Decision|75|||
145413585|NCT03600350|524368335|FG000|Overall Study|Death|1|||
145413586|NCT03600350|524368335|FG000|Overall Study|On Follow Up|18|||
145413587|NCT04575324|524368336|FG000|Overall Study|Lost to Follow-up|29|||
145413588|NCT04575324|524368337|FG001|Overall Study|Lost to Follow-up|25|||
145413589|NCT04575324|524368336|FG000|Overall Study|Death|1|||
145413590|NCT04575324|524368337|FG001|Overall Study|Death|2|||
145413591|NCT04575324|524368336|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
145413592|NCT04575324|524368337|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
145413593|NCT01771913|524368343|FG000|Overall Study|Withdrawal by Subject|1|||
145413594|NCT01771913|524368344|FG001|Overall Study|Withdrawal by Subject|0|||
145413595|NCT01471574|524368350|FG000|Treatment Period|Lack of Efficacy|12|||
145413596|NCT01471574|524368351|FG001|Treatment Period|Lack of Efficacy|4|||
145413597|NCT01471574|524368352|FG002|Treatment Period|Lack of Efficacy|14|||
145413598|NCT01471574|524368353|FG003|Treatment Period|Lack of Efficacy|1|||
145413599|NCT01471574|524368350|FG000|Treatment Period|Adverse Event|7|||
145413600|NCT01471574|524368351|FG001|Treatment Period|Adverse Event|3|||
145413601|NCT01471574|524368352|FG002|Treatment Period|Adverse Event|6|||
145413602|NCT01471574|524368353|FG003|Treatment Period|Adverse Event|1|||
145413603|NCT01471574|524368350|FG000|Treatment Period|Withdrawal by Subject|5|||
145413604|NCT01471574|524368351|FG001|Treatment Period|Withdrawal by Subject|1|||
145413605|NCT01471574|524368352|FG002|Treatment Period|Withdrawal by Subject|1|||
145413606|NCT01471574|524368353|FG003|Treatment Period|Withdrawal by Subject|0|||
145413607|NCT01471574|524368350|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
145413608|NCT01471574|524368351|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
145413609|NCT01471574|524368352|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
145413610|NCT01471574|524368353|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
145413611|NCT01471574|524368350|FG000|Treatment Period|Lost to Follow-up|1|||
145413612|NCT01471574|524368351|FG001|Treatment Period|Lost to Follow-up|2|||
145413613|NCT01471574|524368352|FG002|Treatment Period|Lost to Follow-up|2|||
145413614|NCT01471574|524368353|FG003|Treatment Period|Lost to Follow-up|0|||
145413615|NCT01471574|524368350|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
145413616|NCT01471574|524368351|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145413617|NCT01471574|524368352|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145413618|NCT01471574|524368353|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
145413619|NCT01471574|524368350|FG000|Treatment Period|Other|1|||
145413620|NCT01471574|524368351|FG001|Treatment Period|Other|0|||
145413621|NCT01471574|524368352|FG002|Treatment Period|Other|0|||
145413622|NCT01471574|524368353|FG003|Treatment Period|Other|0|||
145413623|NCT01471574|524368350|FG000|Follow-up Period|Withdrawal by Subject|3|||
145413624|NCT01471574|524368351|FG001|Follow-up Period|Withdrawal by Subject|0|||
145413625|NCT01471574|524368352|FG002|Follow-up Period|Withdrawal by Subject|3|||
145413626|NCT01471574|524368353|FG003|Follow-up Period|Withdrawal by Subject|1|||
145340338|NCT02105974|524092778|FG001|2 Week Run-in Period|Adverse Event|0|||
145340339|NCT02105974|524092779|FG002|2 Week Run-in Period|Adverse Event|0|||
145340340|NCT02105974|524092777|FG000|2 Week Run-in Period|Study closed/terminated|1|||
145340341|NCT02105974|524092778|FG001|2 Week Run-in Period|Study closed/terminated|0|||
145340342|NCT02105974|524092779|FG002|2 Week Run-in Period|Study closed/terminated|0|||
145340343|NCT02105974|524092777|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
145340344|NCT02105974|524092778|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
145340345|NCT02105974|524092779|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
145340346|NCT02105974|524092777|FG000|2 Week Run-in Period|Withdrew consent|23|||
145340347|NCT02105974|524092778|FG001|2 Week Run-in Period|Withdrew consent|0|||
145340348|NCT02105974|524092779|FG002|2 Week Run-in Period|Withdrew consent|0|||
145340349|NCT02105974|524092777|FG000|2 Week Run-in Period|Investigator discretion|8|||
145340350|NCT02105974|524092778|FG001|2 Week Run-in Period|Investigator discretion|0|||
145340351|NCT02105974|524092779|FG002|2 Week Run-in Period|Investigator discretion|0|||
145340352|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
145340353|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
145340354|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
145340355|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
145340356|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
145340357|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
145340358|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
145340359|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
145340360|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
145340361|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
145340362|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
145340363|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
145340364|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
145340365|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
145340366|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
145340367|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
145340368|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
145340369|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
145340370|NCT02105974|524092777|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
145340371|NCT02105974|524092778|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
145340372|NCT02105974|524092779|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
145340373|NCT00477633|524092780|FG000|Overall Study|Did not receive treatment|23|||
145413627|NCT01471574|524368350|FG000|Follow-up Period|Lost to Follow-up|4|||
145340374|NCT00477633|524092780|FG000|Overall Study|Adverse Event|143|||
145340375|NCT00477633|524092780|FG000|Overall Study|Pregnancy|23|||
145413628|NCT01471574|524368351|FG001|Follow-up Period|Lost to Follow-up|1|||
145413629|NCT01471574|524368352|FG002|Follow-up Period|Lost to Follow-up|3|||
145413630|NCT01471574|524368353|FG003|Follow-up Period|Lost to Follow-up|2|||
145413631|NCT01471574|524368350|FG000|Follow-up Period|Death|0|||
145413632|NCT01471574|524368351|FG001|Follow-up Period|Death|0|||
145413633|NCT01471574|524368352|FG002|Follow-up Period|Death|1|||
145413634|NCT01471574|524368353|FG003|Follow-up Period|Death|0|||
145413635|NCT01471574|524368350|FG000|Follow-up Period|Follow-up no longer required|0|||
145413636|NCT01471574|524368351|FG001|Follow-up Period|Follow-up no longer required|1|||
145413637|NCT01471574|524368352|FG002|Follow-up Period|Follow-up no longer required|0|||
145413638|NCT01471574|524368353|FG003|Follow-up Period|Follow-up no longer required|0|||
145413639|NCT01137812|524368354|FG000|Overall Study|Adverse Event|21|||
145413640|NCT01137812|524368355|FG001|Overall Study|Adverse Event|14|||
145413641|NCT01137812|524368354|FG000|Overall Study|Lost to Follow-up|6|||
145413642|NCT01137812|524368355|FG001|Overall Study|Lost to Follow-up|8|||
145413643|NCT01137812|524368354|FG000|Overall Study|Physician Decision|25|||
145413644|NCT01137812|524368355|FG001|Overall Study|Physician Decision|17|||
145413645|NCT01137812|524368354|FG000|Overall Study|Protocol Violation|5|||
145340376|NCT00477633|524092780|FG000|Overall Study|Lost to Follow-up|271|||
145340377|NCT00477633|524092780|FG000|Overall Study|Withdrawal by Subject|149|||
145340378|NCT00477633|524092780|FG000|Overall Study|Protocol Violation|25|||
145340379|NCT00477633|524092780|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
145340380|NCT02968849|524092781|FG000|Overall Study|Death|8|||
145340381|NCT02968849|524092782|FG001|Overall Study|Death|10|||
145340382|NCT02968849|524092781|FG000|Overall Study|Lost to Follow-up|31|||
145340383|NCT02968849|524092782|FG001|Overall Study|Lost to Follow-up|29|||
145340384|NCT02968849|524092781|FG000|Overall Study|Withdrawal by Subject|73|||
145340385|NCT02968849|524092782|FG001|Overall Study|Withdrawal by Subject|64|||
145413646|NCT01137812|524368355|FG001|Overall Study|Protocol Violation|4|||
145413647|NCT01137812|524368354|FG000|Overall Study|Withdrawal by Subject|5|||
145413648|NCT01137812|524368355|FG001|Overall Study|Withdrawal by Subject|13|||
145340386|NCT02968849|524092781|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
145413649|NCT01137812|524368354|FG000|Overall Study|Death|2|||
145413650|NCT01137812|524368355|FG001|Overall Study|Death|0|||
145340387|NCT02968849|524092782|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
145340388|NCT02968849|524092781|FG000|Overall Study|Physician Decision|6|||
145340389|NCT02968849|524092782|FG001|Overall Study|Physician Decision|9|||
145340390|NCT02968849|524092781|FG000|Overall Study|Other|16|||
145340391|NCT02968849|524092782|FG001|Overall Study|Other|10|||
145340392|NCT00805467|524094502|FG000|Overall Study|Lack of Efficacy|0|||
145340393|NCT00805467|524094503|FG001|Overall Study|Lack of Efficacy|8|||
145340394|NCT00805467|524094504|FG002|Overall Study|Lack of Efficacy|13|||
145340395|NCT00805467|524094505|FG003|Overall Study|Lack of Efficacy|86|||
145340396|NCT00805467|524094502|FG000|Overall Study|Lost to Follow-up|0|||
145340397|NCT00805467|524094503|FG001|Overall Study|Lost to Follow-up|1|||
145340398|NCT00805467|524094504|FG002|Overall Study|Lost to Follow-up|7|||
145340399|NCT00805467|524094505|FG003|Overall Study|Lost to Follow-up|21|||
145340400|NCT00805467|524094502|FG000|Overall Study|Withdrawal by Subject|0|||
145340401|NCT00805467|524094503|FG001|Overall Study|Withdrawal by Subject|6|||
145340402|NCT00805467|524094504|FG002|Overall Study|Withdrawal by Subject|45|||
145340403|NCT00805467|524094505|FG003|Overall Study|Withdrawal by Subject|50|||
145340404|NCT00805467|524094502|FG000|Overall Study|Protocol Violation|0|||
145340405|NCT00805467|524094503|FG001|Overall Study|Protocol Violation|3|||
145340406|NCT00805467|524094504|FG002|Overall Study|Protocol Violation|0|||
145340407|NCT00805467|524094505|FG003|Overall Study|Protocol Violation|5|||
145340408|NCT00805467|524094502|FG000|Overall Study|Adverse Event|0|||
145340409|NCT00805467|524094503|FG001|Overall Study|Adverse Event|13|||
145340410|NCT00805467|524094504|FG002|Overall Study|Adverse Event|26|||
145340411|NCT00805467|524094505|FG003|Overall Study|Adverse Event|57|||
145340412|NCT00805467|524094502|FG000|Overall Study|Death|0|||
145340413|NCT00805467|524094503|FG001|Overall Study|Death|2|||
145340414|NCT00805467|524094504|FG002|Overall Study|Death|7|||
145340415|NCT00805467|524094505|FG003|Overall Study|Death|5|||
145340416|NCT00805467|524094502|FG000|Overall Study|Physician Decision|0|||
145340417|NCT00805467|524094503|FG001|Overall Study|Physician Decision|1|||
145340418|NCT00805467|524094504|FG002|Overall Study|Physician Decision|2|||
145340419|NCT00805467|524094505|FG003|Overall Study|Physician Decision|6|||
145340420|NCT00805467|524094502|FG000|Overall Study|Not reported|0|||
145340421|NCT00805467|524094503|FG001|Overall Study|Not reported|0|||
145340422|NCT00805467|524094504|FG002|Overall Study|Not reported|3|||
145340423|NCT00805467|524094505|FG003|Overall Study|Not reported|7|||
145340424|NCT00478244|524094510|FG000|Overall Study|Did not receive transplant|1|||
145340425|NCT00459043|524094511|FG000|Overall Study|Withdrawal by Subject|1|||
145340426|NCT00459043|524094512|FG001|Overall Study|Withdrawal by Subject|0|||
145340427|NCT01392963|524094513|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
145340428|NCT01392963|524094514|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
145340429|NCT01392963|524094513|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
145340430|NCT01392963|524094514|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
145340431|NCT01392963|524094513|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
145340432|NCT01392963|524094514|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
145340433|NCT03156504|524094518|FG000|Overall Study|Withdrawal by Subject|1|||
145340434|NCT02755649|524094519|FG000|Overall Study|Transitioned into OLE study|99|||
145340435|NCT02755649|524094520|FG001|Overall Study|Transitioned into OLE study|98|||
145340436|NCT02755649|524094521|FG002|Overall Study|Transitioned into OLE study|100|||
145340437|NCT02755649|524094519|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
145340438|NCT02755649|524094520|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
145340439|NCT02755649|524094521|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
145340440|NCT02755649|524094519|FG000|Overall Study|Physician Decision|0|||
145340441|NCT02755649|524094520|FG001|Overall Study|Physician Decision|0|||
145340442|NCT02755649|524094521|FG002|Overall Study|Physician Decision|2|||
145340443|NCT02755649|524094519|FG000|Overall Study|Withdrawal by Subject|0|||
145340444|NCT02755649|524094520|FG001|Overall Study|Withdrawal by Subject|1|||
145340445|NCT02755649|524094521|FG002|Overall Study|Withdrawal by Subject|0|||
145340446|NCT02755649|524094519|FG000|Overall Study|Undecided|1|||
145340447|NCT02755649|524094520|FG001|Overall Study|Undecided|0|||
145340448|NCT02755649|524094521|FG002|Overall Study|Undecided|0|||
145340449|NCT00580788|524094525|FG000|Overall Study|Adverse Event|0|||
145340450|NCT00580788|524094526|FG001|Overall Study|Adverse Event|0|||
145340451|NCT00580788|524094527|FG002|Overall Study|Adverse Event|0|||
145340452|NCT00580788|524094528|FG003|Overall Study|Adverse Event|1|||
145340453|NCT03301649|524094531|FG000|Overall Study|Need alternate therapy due to live lice|17|||
145340454|NCT03301649|524094532|FG001|Overall Study|Need alternate therapy due to live lice|25|||
145340455|NCT03301649|524094533|FG002|Overall Study|Need alternate therapy due to live lice|81|||
145340456|NCT03301649|524094531|FG000|Overall Study|Lost to Follow-up|11|||
145340457|NCT03301649|524094532|FG001|Overall Study|Lost to Follow-up|11|||
145340458|NCT03301649|524094533|FG002|Overall Study|Lost to Follow-up|3|||
145340459|NCT03301649|524094531|FG000|Overall Study|Protocol Violation|0|||
145340460|NCT03301649|524094532|FG001|Overall Study|Protocol Violation|1|||
145340461|NCT03301649|524094533|FG002|Overall Study|Protocol Violation|1|||
145340462|NCT03301649|524094531|FG000|Overall Study|Withdrawal by Subject|10|||
145340463|NCT03301649|524094532|FG001|Overall Study|Withdrawal by Subject|4|||
145340464|NCT03301649|524094533|FG002|Overall Study|Withdrawal by Subject|0|||
145413651|NCT01137812|524368354|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
145413652|NCT01137812|524368355|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
145413653|NCT01137812|524368354|FG000|Overall Study|Other|19|||
145340465|NCT03301649|524094531|FG000|Overall Study|Other than specified|5|||
145340466|NCT03301649|524094532|FG001|Overall Study|Other than specified|3|||
145340467|NCT03301649|524094533|FG002|Overall Study|Other than specified|0|||
145340468|NCT01403051|524094534|FG000|Overall Study|Protocol Violation|2|||
145340469|NCT01403051|524094535|FG001|Overall Study|Protocol Violation|0|||
145340470|NCT01403051|524094534|FG000|Overall Study|Death|1|||
145340471|NCT01403051|524094535|FG001|Overall Study|Death|0|||
145340472|NCT01403051|524094534|FG000|Overall Study|Withdrawal by Subject|2|||
145340473|NCT01403051|524094535|FG001|Overall Study|Withdrawal by Subject|1|||
145340474|NCT01403051|524094534|FG000|Overall Study|Lost to Follow-up|5|||
145340475|NCT01403051|524094535|FG001|Overall Study|Lost to Follow-up|5|||
145340476|NCT00887289|524094536|FG000|Overall Study|Lack of Efficacy|14|||
145340477|NCT00887289|524094536|FG000|Overall Study|Adverse Event|27|||
145340478|NCT00887289|524094536|FG000|Overall Study|Withdrawal by Subject|26|||
145340479|NCT00887289|524094536|FG000|Overall Study|Lost to Follow-up|8|||
145340480|NCT00887289|524094536|FG000|Overall Study|Other|20|||
145340481|NCT03022084|524094537|FG000|Overall Study|Lost to Follow-up|2|||
145340482|NCT03022084|524094538|FG001|Overall Study|Lost to Follow-up|3|||
145340483|NCT02932306|524094542|FG000|Overall Study|Withdrawal by Subject|16|||
145340484|NCT02932306|524094543|FG001|Overall Study|Withdrawal by Subject|25|||
145340485|NCT02932306|524094542|FG000|Overall Study|Adverse Event|3|||
145340486|NCT02932306|524094543|FG001|Overall Study|Adverse Event|0|||
145340487|NCT02932306|524094542|FG000|Overall Study|Pregnancy|2|||
145340488|NCT02932306|524094543|FG001|Overall Study|Pregnancy|0|||
145340489|NCT02932306|524094542|FG000|Overall Study|Protocol Violation|1|||
145340490|NCT02932306|524094543|FG001|Overall Study|Protocol Violation|1|||
145340491|NCT02932306|524094542|FG000|Overall Study|Noncompliance with Study Drug|1|||
145340492|NCT02932306|524094543|FG001|Overall Study|Noncompliance with Study Drug|1|||
145340493|NCT02932306|524094542|FG000|Overall Study|Lost to Follow-up|36|||
145340494|NCT02932306|524094543|FG001|Overall Study|Lost to Follow-up|40|||
145340495|NCT02932306|524094542|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
145340496|NCT02932306|524094543|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
145340497|NCT02932306|524094542|FG000|Overall Study|Lack of Efficacy|0|||
145340498|NCT02932306|524094543|FG001|Overall Study|Lack of Efficacy|2|||
145340499|NCT02932306|524094542|FG000|Overall Study|Worsening condition|2|||
145340500|NCT02932306|524094543|FG001|Overall Study|Worsening condition|0|||
145340501|NCT02932306|524094542|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
145340502|NCT02932306|524094543|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
145340503|NCT03559400|524094548|FG000|Overall Study|Lost to Follow-up|9|||
145340504|NCT03559400|524094549|FG001|Overall Study|Lost to Follow-up|7|||
145340505|NCT03559400|524094548|FG000|Overall Study|Death|0|||
145340506|NCT03559400|524094549|FG001|Overall Study|Death|2|||
145340507|NCT00282919|524094550|FG000|Overall Study|Lack of Efficacy|4|||
145340508|NCT00282919|524094550|FG000|Overall Study|Withdrawal by Subject|1|||
145340509|NCT00282919|524094550|FG000|Overall Study|Asymptomatic Parasitemia|2|||
145340510|NCT01433549|524094551|FG000|Phase 2: Second Study Product|Adverse Event|0|||
145340511|NCT01433549|524094552|FG001|Phase 2: Second Study Product|Adverse Event|1|||
145340512|NCT01438996|524094553|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
145340513|NCT01438996|524094554|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
145340514|NCT01438996|524094555|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
145340515|NCT04497948|524094558|FG000|Overall Study|Death|2|||
145340516|NCT00696787|524094559|FG000|Overall Study|Adverse Event|1|||
145340517|NCT00696787|524094560|FG001|Overall Study|Adverse Event|0|||
145340518|NCT00696787|524094561|FG002|Overall Study|Adverse Event|6|||
145340519|NCT00696787|524094559|FG000|Overall Study|Discontinuation by Sponsor|9|||
145340520|NCT00696787|524094560|FG001|Overall Study|Discontinuation by Sponsor|13|||
145340521|NCT00696787|524094561|FG002|Overall Study|Discontinuation by Sponsor|14|||
145340522|NCT00696787|524094559|FG000|Overall Study|Lack of Efficacy|0|||
145340523|NCT00696787|524094560|FG001|Overall Study|Lack of Efficacy|1|||
145340524|NCT00696787|524094561|FG002|Overall Study|Lack of Efficacy|0|||
145340525|NCT00696787|524094559|FG000|Overall Study|Lost to Follow-up|4|||
145340526|NCT00696787|524094560|FG001|Overall Study|Lost to Follow-up|0|||
145340527|NCT00696787|524094561|FG002|Overall Study|Lost to Follow-up|3|||
145340528|NCT00696787|524094559|FG000|Overall Study|Withdrawal by Subject|0|||
145413654|NCT01137812|524368355|FG001|Overall Study|Other|27|||
145413655|NCT00845182|524368356|FG000|Overall Study|Lost to Follow-up|3|||
145340529|NCT00696787|524094560|FG001|Overall Study|Withdrawal by Subject|3|||
145340530|NCT00696787|524094561|FG002|Overall Study|Withdrawal by Subject|2|||
145340531|NCT00696787|524094559|FG000|Overall Study|Failed to return|1|||
145340532|NCT00696787|524094560|FG001|Overall Study|Failed to return|3|||
145340533|NCT00696787|524094561|FG002|Overall Study|Failed to return|1|||
145340534|NCT03207243|524094568|FG000|Overall Study|Adverse Event|2|||
145340535|NCT03207243|524094569|FG001|Overall Study|Adverse Event|2|||
145340536|NCT03207243|524094568|FG000|Overall Study|Loss of Asthma Control|47|||
145413656|NCT00845182|524368357|FG001|Overall Study|Lost to Follow-up|3|||
145413657|NCT00845182|524368358|FG002|Overall Study|Lost to Follow-up|4|||
145413658|NCT00845182|524368356|FG000|Overall Study|Adverse Event|0|||
145413659|NCT00845182|524368357|FG001|Overall Study|Adverse Event|1|||
145413660|NCT00845182|524368358|FG002|Overall Study|Adverse Event|1|||
145413661|NCT00845182|524368356|FG000|Overall Study|Physician Decision|0|||
145413662|NCT00845182|524368357|FG001|Overall Study|Physician Decision|0|||
145413663|NCT00845182|524368358|FG002|Overall Study|Physician Decision|1|||
145413664|NCT04621760|524368359|FG000|Overall Study|Lost to Follow-up|2|||
145413665|NCT04621760|524368360|FG001|Overall Study|Lost to Follow-up|4|||
145413666|NCT04621760|524368359|FG000|Overall Study|Withdrawal by Subject|1|||
145413667|NCT04621760|524368360|FG001|Overall Study|Withdrawal by Subject|0|||
145413668|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
145413669|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
145413670|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
145413671|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
145413672|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
145413673|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
145413674|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
145413675|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
145413676|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
145413677|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
145413678|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
145413679|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
145413680|NCT00447278|524368361|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
145413681|NCT00447278|524368362|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
145413682|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
145413683|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
145413684|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
145413685|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
145413686|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
145413687|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
145413688|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
145413689|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
145413690|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
145413691|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
145413692|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
145413693|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
145413694|NCT00447278|524368361|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
145413695|NCT00447278|524368362|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
145413696|NCT03677401|524368363|FG000|Overall Study|Adverse Event|4|||
145413697|NCT03677401|524368364|FG001|Overall Study|Adverse Event|14|||
145413698|NCT03677401|524368363|FG000|Overall Study|Lack of Efficacy|3|||
145413699|NCT03677401|524368364|FG001|Overall Study|Lack of Efficacy|1|||
145413700|NCT03677401|524368363|FG000|Overall Study|Withdrawal by Subject|2|||
145413701|NCT03677401|524368364|FG001|Overall Study|Withdrawal by Subject|2|||
145413702|NCT03677401|524368363|FG000|Overall Study|Sponsor decision|0|||
145413703|NCT03677401|524368364|FG001|Overall Study|Sponsor decision|1|||
145413704|NCT03677401|524368363|FG000|Overall Study|Reason Unspecified|1|||
145413705|NCT03677401|524368364|FG001|Overall Study|Reason Unspecified|0|||
145413706|NCT05427916|524368370|FG000|Overall Study|Adverse Event|3|||
145413707|NCT05427916|524368371|FG001|Overall Study|Adverse Event|0|||
145413708|NCT05427916|524368370|FG000|Overall Study|Lack of Efficacy|6|||
145413709|NCT05427916|524368371|FG001|Overall Study|Lack of Efficacy|0|||
145413710|NCT05427916|524368370|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
145413711|NCT05427916|524368371|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
145413712|NCT06262607|524368374|FG000|Overall Study|Physician Decision|0|||
145413713|NCT06262607|524368375|FG001|Overall Study|Physician Decision|1|||
145413714|NCT06262607|524368374|FG000|Overall Study|Withdrawal by Subject|2|||
145574386|NCT03969212|524958271|FG001|Overall Study|Withdrawal by Subject|13|||
145574387|NCT03969212|524958272|FG002|Overall Study|Withdrawal by Subject|5|||
145574388|NCT03969212|524958273|FG003|Overall Study|Withdrawal by Subject|11|||
145574389|NCT03969212|524958270|FG000|Overall Study|Physician Decision|0|||
145574390|NCT03969212|524958271|FG001|Overall Study|Physician Decision|0|||
145413715|NCT06262607|524368375|FG001|Overall Study|Withdrawal by Subject|0|||
145413716|NCT05630755|524368377|FG000|Overall Study|Lost to Follow-up|7|||
145413717|NCT05630755|524368378|FG001|Overall Study|Lost to Follow-up|0|||
145413718|NCT05630755|524368377|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
145413719|NCT05630755|524368378|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
145413720|NCT05630755|524368377|FG000|Overall Study|Withdrawal by Subject|9|||
145413721|NCT05630755|524368378|FG001|Overall Study|Withdrawal by Subject|3|||
145574391|NCT03969212|524958272|FG002|Overall Study|Physician Decision|1|||
145574392|NCT03969212|524958273|FG003|Overall Study|Physician Decision|0|||
145574393|NCT03969212|524958270|FG000|Overall Study|Reason not Specified|22|||
145622604|NCT00557505|525130121|FG000|Overall Study|Global deterioration of health|1|||
145340537|NCT03207243|524094569|FG001|Overall Study|Loss of Asthma Control|31|||
145340538|NCT03207243|524094568|FG000|Overall Study|Withdrawal by Subject|2|||
145340539|NCT03207243|524094569|FG001|Overall Study|Withdrawal by Subject|4|||
145340540|NCT03207243|524094568|FG000|Overall Study|Physician Decision|1|||
145340541|NCT03207243|524094569|FG001|Overall Study|Physician Decision|1|||
145340542|NCT03207243|524094568|FG000|Overall Study|Lost to Follow-up|0|||
145340543|NCT03207243|524094569|FG001|Overall Study|Lost to Follow-up|1|||
145340544|NCT03207243|524094568|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
145340545|NCT03207243|524094569|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
145340546|NCT03207243|524094568|FG000|Overall Study|Protocol Violation|0|||
145340547|NCT03207243|524094569|FG001|Overall Study|Protocol Violation|3|||
145340548|NCT01377987|524094572|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
145340549|NCT01377987|524094573|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
145340550|NCT04893018|524094575|FG000|Overall Study|Lost to Follow-up|1|||
145622605|NCT00557505|525130122|FG001|Overall Study|Global deterioration of health|0|||
145622606|NCT00557505|525130123|FG002|Overall Study|Global deterioration of health|0|||
145622607|NCT00557505|525130124|FG003|Overall Study|Global deterioration of health|0|||
145622608|NCT00557505|525130125|FG004|Overall Study|Global deterioration of health|0|||
145622609|NCT00557505|525130126|FG005|Overall Study|Global deterioration of health|0|||
145622610|NCT00557505|525130127|FG006|Overall Study|Global deterioration of health|0|||
145622611|NCT00557505|525130128|FG007|Overall Study|Global deterioration of health|0|||
145622612|NCT00557505|525130129|FG008|Overall Study|Global deterioration of health|0|||
145622613|NCT00557505|525130121|FG000|Overall Study|Objective progression or relapse|2|||
145622614|NCT00557505|525130122|FG001|Overall Study|Objective progression or relapse|3|||
145622615|NCT00557505|525130123|FG002|Overall Study|Objective progression or relapse|3|||
145622616|NCT00557505|525130124|FG003|Overall Study|Objective progression or relapse|2|||
145622617|NCT00557505|525130125|FG004|Overall Study|Objective progression or relapse|2|||
145622618|NCT00557505|525130126|FG005|Overall Study|Objective progression or relapse|3|||
145622619|NCT00557505|525130127|FG006|Overall Study|Objective progression or relapse|2|||
145622620|NCT00557505|525130128|FG007|Overall Study|Objective progression or relapse|5|||
145622621|NCT00557505|525130129|FG008|Overall Study|Objective progression or relapse|15|||
145622622|NCT00557505|525130121|FG000|Overall Study|Withdrawal by Subject|0|||
145622623|NCT00557505|525130122|FG001|Overall Study|Withdrawal by Subject|0|||
145340551|NCT04893018|524094576|FG001|Overall Study|Lost to Follow-up|0|||
145340552|NCT04893018|524094575|FG000|Overall Study|Withdrawal by Subject|2|||
145340553|NCT04893018|524094576|FG001|Overall Study|Withdrawal by Subject|0|||
145340554|NCT04893018|524094575|FG000|Overall Study|Study Terminated|1|||
145340555|NCT04893018|524094576|FG001|Overall Study|Study Terminated|2|||
145340556|NCT02842073|524094580|FG000|Overall Study|Withdrawal by Subject|1|||
145340557|NCT01333397|524094583|FG000|Overall Study|Lost to Follow-up|1|||
145340558|NCT01333397|524094584|FG001|Overall Study|Lost to Follow-up|0|||
145340559|NCT01333397|524094585|FG002|Overall Study|Lost to Follow-up|0|||
145340560|NCT01333397|524094586|FG003|Overall Study|Lost to Follow-up|1|||
145340561|NCT01333397|524094587|FG004|Overall Study|Lost to Follow-up|0|||
145340562|NCT02910011|524094592|FG000|Overall Study|Physician Decision|2|||
145340563|NCT02460679|524094595|FG000|Overall Study|Investigator Decision|1|||
145340564|NCT02460679|524094595|FG000|Overall Study|Withdrawal by Subject|4|||
145340565|NCT00339144|524094603|FG000|Overall Study|Disease progression|5|||
145340566|NCT00339144|524094604|FG001|Overall Study|Disease progression|2|||
145340567|NCT00339144|524094605|FG002|Overall Study|Disease progression|2|||
145340568|NCT00339144|524094603|FG000|Overall Study|Study drug toxicity|3|||
145340569|NCT00339144|524094604|FG001|Overall Study|Study drug toxicity|1|||
145340570|NCT00339144|524094605|FG002|Overall Study|Study drug toxicity|1|||
145340571|NCT00339144|524094603|FG000|Overall Study|Participant's request to discontinuation|1|||
145340572|NCT00339144|524094604|FG001|Overall Study|Participant's request to discontinuation|0|||
145340573|NCT00339144|524094605|FG002|Overall Study|Participant's request to discontinuation|1|||
145340574|NCT00478426|524094607|FG000|Overall Study|Withdrawal by Subject|1|||
145340575|NCT00789737|524094612|FG000|Overall Study|Withdrawal by Subject|13|||
145340576|NCT00789737|524094613|FG001|Overall Study|Withdrawal by Subject|22|||
145340577|NCT00789737|524094612|FG000|Overall Study|Lost to Follow-up|10|||
145340578|NCT00789737|524094613|FG001|Overall Study|Lost to Follow-up|14|||
145622624|NCT00557505|525130123|FG002|Overall Study|Withdrawal by Subject|0|||
145622625|NCT00557505|525130124|FG003|Overall Study|Withdrawal by Subject|1|||
145622626|NCT00557505|525130125|FG004|Overall Study|Withdrawal by Subject|0|||
145622627|NCT00557505|525130126|FG005|Overall Study|Withdrawal by Subject|0|||
145340579|NCT00789737|524094612|FG000|Overall Study|Adverse Event|8|||
145340580|NCT00789737|524094613|FG001|Overall Study|Adverse Event|8|||
145340581|NCT00789737|524094612|FG000|Overall Study|Protocol Violation|3|||
145340582|NCT00789737|524094613|FG001|Overall Study|Protocol Violation|0|||
145340583|NCT00789737|524094612|FG000|Overall Study|Lack of Efficacy|3|||
145340584|NCT00789737|524094613|FG001|Overall Study|Lack of Efficacy|0|||
145622628|NCT00557505|525130127|FG006|Overall Study|Withdrawal by Subject|0|||
145340585|NCT00789737|524094612|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
145340586|NCT00789737|524094613|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
145574394|NCT03969212|524958271|FG001|Overall Study|Reason not Specified|23|||
145574395|NCT03969212|524958272|FG002|Overall Study|Reason not Specified|28|||
145574396|NCT03969212|524958273|FG003|Overall Study|Reason not Specified|26|||
145574397|NCT01302392|524958274|FG000|Overall Study|Lost to Follow-up|1|||
145574398|NCT01302392|524958275|FG001|Overall Study|Lost to Follow-up|0|||
145574399|NCT01302392|524958274|FG000|Overall Study|Withdrawal by Subject|6|||
145340587|NCT00789737|524094612|FG000|Overall Study|Other|11|||
145340588|NCT00789737|524094613|FG001|Overall Study|Other|7|||
145340589|NCT01189487|524094614|FG000|Overall Study|Lack of Efficacy|2|||
145340590|NCT01189487|524094614|FG000|Overall Study|Adverse Event|1|||
145340591|NCT04630158|524094615|FG000|Overall Study|Adverse Event|1|||
145340592|NCT04630158|524094616|FG001|Overall Study|Adverse Event|1|||
145340593|NCT04630158|524094617|FG002|Overall Study|Adverse Event|1|||
145340594|NCT04630158|524094615|FG000|Overall Study|Physician Decision|0|||
145340595|NCT04630158|524094616|FG001|Overall Study|Physician Decision|2|||
145340596|NCT04630158|524094617|FG002|Overall Study|Physician Decision|0|||
145340597|NCT04630158|524094615|FG000|Overall Study|Protocol Violation|1|||
145340598|NCT04630158|524094616|FG001|Overall Study|Protocol Violation|0|||
145340599|NCT04630158|524094617|FG002|Overall Study|Protocol Violation|1|||
145340600|NCT04630158|524094615|FG000|Overall Study|Withdrawal by Subject|2|||
145340601|NCT04630158|524094616|FG001|Overall Study|Withdrawal by Subject|1|||
145340602|NCT04630158|524094617|FG002|Overall Study|Withdrawal by Subject|2|||
145340603|NCT03485365|524094620|FG000|Overall Study|Protocol Violation|0|||
145340604|NCT03485365|524094621|FG001|Overall Study|Protocol Violation|0|||
145340605|NCT03485365|524094622|FG002|Overall Study|Protocol Violation|0|||
145340606|NCT03485365|524094623|FG003|Overall Study|Protocol Violation|1|||
145340607|NCT03485365|524094624|FG004|Overall Study|Protocol Violation|0|||
145340608|NCT03485365|524094625|FG005|Overall Study|Protocol Violation|0|||
145340609|NCT03485365|524094626|FG006|Overall Study|Protocol Violation|1|||
145340610|NCT03485365|524094627|FG007|Overall Study|Protocol Violation|0|||
145340611|NCT03485365|524094628|FG008|Overall Study|Protocol Violation|0|||
145340612|NCT03136965|524094630|FG000|Overall Study|Lost to Follow-up|0|||
145340613|NCT03136965|524094631|FG001|Overall Study|Lost to Follow-up|1|||
145340614|NCT03136965|524094632|FG002|Overall Study|Lost to Follow-up|0|||
145340615|NCT01210612|524094634|FG000|Overall Study|Withdrawal by Subject|0|||
145340616|NCT01210612|524094635|FG001|Overall Study|Withdrawal by Subject|2|||
145340617|NCT02290223|524094641|FG000|6 Months|Lost to Follow-up|9|||
145340618|NCT02290223|524094642|FG001|6 Months|Lost to Follow-up|6|||
145340619|NCT02290223|524094641|FG000|6 Months|Withdrawal by Subject|5|||
145340620|NCT02290223|524094642|FG001|6 Months|Withdrawal by Subject|0|||
145340621|NCT02290223|524094641|FG000|6 Months|deceased (not related to study)|2|||
145340622|NCT02290223|524094642|FG001|6 Months|deceased (not related to study)|0|||
145340623|NCT02290223|524094641|FG000|12 Months|Lost to Follow-up|16|||
145340624|NCT02290223|524094642|FG001|12 Months|Lost to Follow-up|10|||
145340625|NCT02290223|524094641|FG000|12 Months|Refusal|0|||
145340626|NCT02290223|524094642|FG001|12 Months|Refusal|1|||
145340627|NCT05293639|524094643|FG000|Overall Study|Withdrawal by Subject|1|||
145340628|NCT05293639|524094644|FG001|Overall Study|Withdrawal by Subject|1|||
145340629|NCT05293639|524094645|FG002|Overall Study|Withdrawal by Subject|2|||
145340630|NCT05293639|524094643|FG000|Overall Study|Death|0|||
145340631|NCT05293639|524094644|FG001|Overall Study|Death|1|||
145340632|NCT05293639|524094645|FG002|Overall Study|Death|0|||
145340633|NCT05293639|524094643|FG000|Overall Study|Lost to Follow-up|0|||
145340634|NCT05293639|524094644|FG001|Overall Study|Lost to Follow-up|0|||
145340635|NCT05293639|524094645|FG002|Overall Study|Lost to Follow-up|5|||
145340636|NCT05293639|524094643|FG000|Overall Study|Other|0|||
145340637|NCT05293639|524094644|FG001|Overall Study|Other|0|||
145340638|NCT05293639|524094645|FG002|Overall Study|Other|1|||
145340639|NCT00813800|524094651|FG000|Overall Study|Screen Failure after Consent|2|||
145340640|NCT00813800|524094651|FG000|Overall Study|Adverse Event|1|||
145340641|NCT00813800|524094651|FG000|Overall Study|Worsening of depression|2|||
145340642|NCT00813800|524094651|FG000|Overall Study|Physician Decision|1|||
145340643|NCT00351533|524094652|FG000|Overall Study|Extubated before first BAL|1|||
145340644|NCT00351533|524094653|FG001|Overall Study|Extubated before first BAL|0|||
145340645|NCT00351533|524094652|FG000|Overall Study|Lost to Follow-up|1|||
145340646|NCT00351533|524094653|FG001|Overall Study|Lost to Follow-up|3|||
145340647|NCT00351533|524094652|FG000|Overall Study|Physician Decision|0|||
145340648|NCT00351533|524094653|FG001|Overall Study|Physician Decision|1|||
145340649|NCT00351533|524094652|FG000|Overall Study|Withdrawal by Subject|0|||
145340650|NCT00351533|524094653|FG001|Overall Study|Withdrawal by Subject|1|||
145340651|NCT03185013|524094654|FG000|Overall Study|Withdrawal by Subject|5|||
145340652|NCT03185013|524094655|FG001|Overall Study|Withdrawal by Subject|3|||
145340653|NCT03185013|524094654|FG000|Overall Study|Adverse Event|1|||
145340654|NCT03185013|524094655|FG001|Overall Study|Adverse Event|0|||
145574400|NCT01302392|524958275|FG001|Overall Study|Withdrawal by Subject|1|||
145574401|NCT00670228|524958276|FG000|Overall Study|Adverse Event|1|||
145340655|NCT03185013|524094654|FG000|Overall Study|Progressive Disease|1|||
145340656|NCT03185013|524094655|FG001|Overall Study|Progressive Disease|0|||
145340657|NCT03185013|524094654|FG000|Overall Study|Lost to Follow-up|8|||
145340658|NCT03185013|524094655|FG001|Overall Study|Lost to Follow-up|2|||
145622629|NCT00557505|525130128|FG007|Overall Study|Withdrawal by Subject|0|||
145622630|NCT00557505|525130129|FG008|Overall Study|Withdrawal by Subject|1|||
145622631|NCT03019458|525130130|FG000|Overall Study|Death|0|||
145622632|NCT03019458|525130131|FG001|Overall Study|Death|1|||
145622633|NCT00031447|525130132|FG000|Overall Study|Lost to Follow-up|0|||
145622634|NCT00031447|525130133|FG001|Overall Study|Lost to Follow-up|1|||
145622635|NCT00031447|525130132|FG000|Overall Study|Non-compliant|1|||
145622636|NCT00031447|525130133|FG001|Overall Study|Non-compliant|1|||
145622637|NCT00031447|525130132|FG000|Overall Study|Re-activation of Disease|2|||
145622638|NCT00031447|525130133|FG001|Overall Study|Re-activation of Disease|1|||
145622639|NCT00031447|525130132|FG000|Overall Study|Disruption of blinded study drug supply|7|||
145622640|NCT00031447|525130133|FG001|Overall Study|Disruption of blinded study drug supply|4|||
145622641|NCT01636362|525130134|FG000|Overall Study|Physician Decision|6|||
145622642|NCT01636362|525130134|FG000|Overall Study|Subject healed, not returning|1|||
145622643|NCT01636362|525130134|FG000|Overall Study|Withdrawal by Subject|1|||
145622644|NCT00519779|525130137|FG000|Overall Study|Withdrawal by Subject|0|||
145622645|NCT00519779|525130138|FG001|Overall Study|Withdrawal by Subject|1|||
145622646|NCT01561079|525130139|FG000|Overall Study|Physician Decision|17|||
145622647|NCT01561079|525130139|FG000|Overall Study|Withdrawal by Subject|59|||
145622648|NCT01561079|525130139|FG000|Overall Study|Protocol Violation|2|||
145622649|NCT03330119|525130140|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
145622650|NCT03330119|525130141|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
145622651|NCT00664521|525130145|FG000|Overall Study|Adverse Event|4|||
145622652|NCT00664521|525130146|FG001|Overall Study|Adverse Event|1|||
145622653|NCT00664521|525130145|FG000|Overall Study|Lost to Follow-up|1|||
145622654|NCT00664521|525130146|FG001|Overall Study|Lost to Follow-up|0|||
145622655|NCT00664521|525130145|FG000|Overall Study|Other|1|||
145340659|NCT03185013|524094654|FG000|Overall Study|Physician Decision|1|||
145340660|NCT03185013|524094655|FG001|Overall Study|Physician Decision|0|||
145574402|NCT00670228|524958277|FG001|Overall Study|Adverse Event|0|||
145574403|NCT00670228|524958276|FG000|Overall Study|Death or MACE|0|||
145574404|NCT00670228|524958277|FG001|Overall Study|Death or MACE|1|||
145574405|NCT00670228|524958276|FG000|Overall Study|Not treated|2|||
145574406|NCT00670228|524958277|FG001|Overall Study|Not treated|2|||
145574407|NCT00670228|524958276|FG000|Overall Study|Not meeting the selection criteria|2|||
145574408|NCT00670228|524958277|FG001|Overall Study|Not meeting the selection criteria|0|||
145574409|NCT05267054|524958278|FG000|Overall Study|Death|13|||
145574410|NCT05267054|524958279|FG001|Overall Study|Death|14|||
145574411|NCT05267054|524958278|FG000|Overall Study|Study Ended by Sponsor|9|||
145574412|NCT05267054|524958279|FG001|Overall Study|Study Ended by Sponsor|13|||
145574413|NCT05267054|524958278|FG000|Overall Study|Lost to Follow-up|1|||
145574414|NCT05267054|524958279|FG001|Overall Study|Lost to Follow-up|1|||
145574415|NCT05267054|524958278|FG000|Overall Study|Withdrawal by Subject|1|||
145574416|NCT05267054|524958279|FG001|Overall Study|Withdrawal by Subject|1|||
145574417|NCT01552226|524958280|FG000|Overall Study|Withdrawal by Subject|4|||
145574418|NCT01552226|524958281|FG001|Overall Study|Withdrawal by Subject|4|||
145574419|NCT03604692|524958282|FG000|Overall Study|Investigator's Decision|0|||
145574420|NCT03604692|524958283|FG001|Overall Study|Investigator's Decision|0|||
145574421|NCT03604692|524958284|FG002|Overall Study|Investigator's Decision|0|||
145574422|NCT03604692|524958285|FG003|Overall Study|Investigator's Decision|1|||
145574423|NCT03604692|524958286|FG004|Overall Study|Investigator's Decision|0|||
145574424|NCT03604692|524958287|FG005|Overall Study|Investigator's Decision|7|||
145574425|NCT03604692|524958282|FG000|Overall Study|Withdrawal by Subject|0|||
145574426|NCT03604692|524958283|FG001|Overall Study|Withdrawal by Subject|0|||
145574427|NCT03604692|524958284|FG002|Overall Study|Withdrawal by Subject|0|||
145574428|NCT03604692|524958285|FG003|Overall Study|Withdrawal by Subject|0|||
145574429|NCT03604692|524958286|FG004|Overall Study|Withdrawal by Subject|0|||
145622656|NCT00664521|525130146|FG001|Overall Study|Other|0|||
145622657|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
145622658|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145340661|NCT03185013|524094654|FG000|Overall Study|Protocol Deviation|2|||
145340662|NCT03185013|524094655|FG001|Overall Study|Protocol Deviation|0|||
145340663|NCT03185013|524094654|FG000|Overall Study|Reason not Specified|3|||
145340664|NCT03185013|524094655|FG001|Overall Study|Reason not Specified|2|||
145340665|NCT03185013|524094654|FG000|Overall Study|Death|1|||
145340666|NCT03185013|524094655|FG001|Overall Study|Death|0|||
145340667|NCT00197496|524094656|FG000|Baseline to Discharge|not interested|1|||
145574430|NCT03604692|524958287|FG005|Overall Study|Withdrawal by Subject|2|||
145574431|NCT03604692|524958282|FG000|Overall Study|Progressive Disease|1|||
145574432|NCT03604692|524958283|FG001|Overall Study|Progressive Disease|0|||
145574433|NCT03604692|524958284|FG002|Overall Study|Progressive Disease|1|||
145574434|NCT03604692|524958285|FG003|Overall Study|Progressive Disease|0|||
145340668|NCT00197496|524094657|FG001|Baseline to Discharge|not interested|0|||
145574435|NCT03604692|524958286|FG004|Overall Study|Progressive Disease|3|||
145574436|NCT03604692|524958287|FG005|Overall Study|Progressive Disease|4|||
145574437|NCT03604692|524958282|FG000|Overall Study|Difficulty Coming into Site|0|||
145574438|NCT03604692|524958283|FG001|Overall Study|Difficulty Coming into Site|0|||
145340669|NCT00197496|524094656|FG000|Baseline to Discharge|MRSA|1|||
145340670|NCT00197496|524094657|FG001|Baseline to Discharge|MRSA|0|||
145340671|NCT00197496|524094656|FG000|Baseline to Discharge|Physician Decision|0|||
145340672|NCT00197496|524094657|FG001|Baseline to Discharge|Physician Decision|1|||
145340673|NCT00197496|524094656|FG000|Baseline to Discharge|Protocol Violation|0|||
145340674|NCT00197496|524094657|FG001|Baseline to Discharge|Protocol Violation|1|||
145340675|NCT00197496|524094656|FG000|Follow-up|Lost to Follow-up|2|||
145340676|NCT00197496|524094657|FG001|Follow-up|Lost to Follow-up|1|||
145340677|NCT00857584|524094660|FG000|Overall Study|Lack of Efficacy|1|||
145340678|NCT00857584|524094661|FG001|Overall Study|Lack of Efficacy|2|||
145340679|NCT00857584|524094660|FG000|Overall Study|Adverse Event|2|||
145340680|NCT00857584|524094661|FG001|Overall Study|Adverse Event|2|||
145340681|NCT00857584|524094660|FG000|Overall Study|Physician Decision|1|||
145340682|NCT00857584|524094661|FG001|Overall Study|Physician Decision|1|||
145340683|NCT02203331|524094665|FG000|Overall Study|Pregnancy|1|||
145340684|NCT02203331|524094666|FG001|Overall Study|Pregnancy|0|||
145340685|NCT02203331|524094667|FG002|Overall Study|Pregnancy|0|||
145340686|NCT02203331|524094668|FG003|Overall Study|Pregnancy|0|||
145340687|NCT02203331|524094669|FG004|Overall Study|Pregnancy|2|||
145340688|NCT02203331|524094670|FG005|Overall Study|Pregnancy|0|||
145340689|NCT02203331|524094665|FG000|Overall Study|Withdrawal by Subject|1|||
145340690|NCT02203331|524094666|FG001|Overall Study|Withdrawal by Subject|0|||
145340691|NCT02203331|524094667|FG002|Overall Study|Withdrawal by Subject|1|||
145340692|NCT02203331|524094668|FG003|Overall Study|Withdrawal by Subject|0|||
145340693|NCT02203331|524094669|FG004|Overall Study|Withdrawal by Subject|0|||
145340694|NCT02203331|524094670|FG005|Overall Study|Withdrawal by Subject|3|||
145340695|NCT02203331|524094665|FG000|Overall Study|Adverse Event|4|||
145340696|NCT02203331|524094666|FG001|Overall Study|Adverse Event|8|||
145340697|NCT02203331|524094667|FG002|Overall Study|Adverse Event|3|||
145340698|NCT02203331|524094668|FG003|Overall Study|Adverse Event|4|||
145340699|NCT02203331|524094669|FG004|Overall Study|Adverse Event|3|||
145340700|NCT02203331|524094670|FG005|Overall Study|Adverse Event|3|||
145340701|NCT02203331|524094665|FG000|Overall Study|Other Reasons|1|||
145340702|NCT02203331|524094666|FG001|Overall Study|Other Reasons|2|||
145340703|NCT02203331|524094667|FG002|Overall Study|Other Reasons|0|||
145340704|NCT02203331|524094668|FG003|Overall Study|Other Reasons|2|||
145340705|NCT02203331|524094669|FG004|Overall Study|Other Reasons|0|||
145340706|NCT02203331|524094670|FG005|Overall Study|Other Reasons|0|||
145340707|NCT02203331|524094665|FG000|Overall Study|Lack of Efficacy|0|||
145340708|NCT02203331|524094666|FG001|Overall Study|Lack of Efficacy|2|||
145340709|NCT02203331|524094667|FG002|Overall Study|Lack of Efficacy|1|||
145340710|NCT02203331|524094668|FG003|Overall Study|Lack of Efficacy|0|||
145340711|NCT02203331|524094669|FG004|Overall Study|Lack of Efficacy|0|||
145340712|NCT02203331|524094670|FG005|Overall Study|Lack of Efficacy|1|||
145340713|NCT02203331|524094665|FG000|Overall Study|Protocol Violation|0|||
145340714|NCT02203331|524094666|FG001|Overall Study|Protocol Violation|2|||
145340715|NCT02203331|524094667|FG002|Overall Study|Protocol Violation|0|||
145340716|NCT02203331|524094668|FG003|Overall Study|Protocol Violation|1|||
145340717|NCT02203331|524094669|FG004|Overall Study|Protocol Violation|1|||
145340718|NCT02203331|524094670|FG005|Overall Study|Protocol Violation|0|||
145340719|NCT02203331|524094665|FG000|Overall Study|Lost to Follow-up|0|||
145340720|NCT02203331|524094666|FG001|Overall Study|Lost to Follow-up|0|||
145340721|NCT02203331|524094667|FG002|Overall Study|Lost to Follow-up|0|||
145340722|NCT02203331|524094668|FG003|Overall Study|Lost to Follow-up|0|||
145340723|NCT02203331|524094669|FG004|Overall Study|Lost to Follow-up|1|||
145340724|NCT02203331|524094670|FG005|Overall Study|Lost to Follow-up|0|||
145340725|NCT03462459|524094676|FG000|Overall Study|Death|1|||
145340726|NCT03462459|524094677|FG001|Overall Study|Death|0|||
145340727|NCT03462459|524094676|FG000|Overall Study|Lack of Efficacy|2|||
145340728|NCT03462459|524094677|FG001|Overall Study|Lack of Efficacy|4|||
145340729|NCT03462459|524094676|FG000|Overall Study|Lost to Follow-up|1|||
145340730|NCT03462459|524094677|FG001|Overall Study|Lost to Follow-up|3|||
145340731|NCT03462459|524094676|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
145340732|NCT03462459|524094677|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
145340733|NCT03462459|524094676|FG000|Overall Study|Withdrawal by Subject|3|||
145340734|NCT03462459|524094677|FG001|Overall Study|Withdrawal by Subject|2|||
145340735|NCT03462459|524094676|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
145340736|NCT03462459|524094677|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
145340737|NCT01177059|524094679|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
145340738|NCT01177059|524094679|FG000|Overall Study|Withdrew consent|2|||
145340739|NCT01177059|524094679|FG000|Overall Study|Lost to Follow-up|18|||
145340740|NCT01200069|524096524|FG000|Overall Study|Withdrawal by Subject|0|||
145340741|NCT01200069|524096525|FG001|Overall Study|Withdrawal by Subject|1|||
145340742|NCT02899195|524096526|FG000|Concurrent Durvalumab|Adverse Event|4|||
145340743|NCT02899195|524096526|FG000|Concurrent Durvalumab|Physician Decision|1|||
145340744|NCT02899195|524096526|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
145340745|NCT02899195|524096526|FG000|Concurrent Durvalumab|Progressive Disease|5|||
145340746|NCT02899195|524096526|FG000|Maintenance Durvalumab|Adverse Event|1|||
145340747|NCT02899195|524096526|FG000|Maintenance Durvalumab|Physician Decision|1|||
145340748|NCT02899195|524096526|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
145340749|NCT02899195|524096526|FG000|Maintenance Durvalumab|Progressive Disease|31|||
145340750|NCT04778904|524096527|FG000|Overall Study|Protocol Violation|1|||
145340751|NCT04778904|524096528|FG001|Overall Study|Protocol Violation|0|||
145340752|NCT04778904|524096529|FG002|Overall Study|Protocol Violation|0|||
145340753|NCT04778904|524096530|FG003|Overall Study|Protocol Violation|0|||
145340754|NCT04778904|524096527|FG000|Overall Study|Withdrawal by Subject|0|||
145340755|NCT04778904|524096528|FG001|Overall Study|Withdrawal by Subject|0|||
145340756|NCT04778904|524096529|FG002|Overall Study|Withdrawal by Subject|1|||
145340757|NCT04778904|524096530|FG003|Overall Study|Withdrawal by Subject|0|||
145340758|NCT03452137|524096531|FG000|Overall Study|Death|67|||
145340759|NCT03452137|524096532|FG001|Overall Study|Death|70|||
145340760|NCT03452137|524096531|FG000|Overall Study|Lost to Follow-up|4|||
145340761|NCT03452137|524096532|FG001|Overall Study|Lost to Follow-up|2|||
145340762|NCT03452137|524096531|FG000|Overall Study|Physician Decision|0|||
145340763|NCT03452137|524096532|FG001|Overall Study|Physician Decision|1|||
145340764|NCT03452137|524096531|FG000|Overall Study|Study Terminated by Sponsor|120|||
145340765|NCT03452137|524096532|FG001|Overall Study|Study Terminated by Sponsor|121|||
145340766|NCT03452137|524096531|FG000|Overall Study|Withdrawal by Subject|12|||
145340767|NCT03452137|524096532|FG001|Overall Study|Withdrawal by Subject|9|||
145340768|NCT03772717|524096533|FG000|Overall Study|Withdrawal by Subject|2|||
145340769|NCT02856802|524096534|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
145340770|NCT02856802|524096535|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
145340771|NCT02856802|524096534|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
145340772|NCT02856802|524096535|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
145340773|NCT02856802|524096534|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
145340774|NCT02856802|524096535|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
145340775|NCT02856802|524096534|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
145340776|NCT02856802|524096535|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
145340777|NCT02856802|524096534|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
145340778|NCT02856802|524096535|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
145340779|NCT02856802|524096534|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
145340780|NCT02856802|524096535|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
145340781|NCT04138043|524096536|FG000|Overall Study|Withdrawal by Subject|0|||
145340782|NCT04138043|524096537|FG001|Overall Study|Withdrawal by Subject|1|||
145340783|NCT00587860|524096538|FG000|Overall Study|Lost to Follow-up|2|||
145340784|NCT00587860|524096539|FG001|Overall Study|Lost to Follow-up|2|||
145340785|NCT00587860|524096538|FG000|Overall Study|Withdrawal by Subject|3|||
145340786|NCT00587860|524096539|FG001|Overall Study|Withdrawal by Subject|3|||
145340787|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
145340788|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
145340789|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
145340790|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
145340791|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
145340792|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
145340793|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
145340794|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
145340795|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
145340796|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
145340797|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
145340798|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
145340799|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
145340800|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
145340801|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
145340802|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
145340803|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
145340804|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
145340805|NCT00261443|524096540|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
145340806|NCT00261443|524096541|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
145340807|NCT00261443|524096542|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
145340808|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
145340809|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
145340810|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
145340811|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
145340812|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
145340813|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
145340814|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
145340815|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
145340816|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
145574439|NCT03604692|524958284|FG002|Overall Study|Difficulty Coming into Site|0|||
145574440|NCT03604692|524958285|FG003|Overall Study|Difficulty Coming into Site|0|||
145574441|NCT03604692|524958286|FG004|Overall Study|Difficulty Coming into Site|0|||
145574442|NCT03604692|524958287|FG005|Overall Study|Difficulty Coming into Site|1|||
145413722|NCT05630755|524368377|FG000|Overall Study|Participant moved away from trial site|0|||
145413723|NCT05630755|524368378|FG001|Overall Study|Participant moved away from trial site|1|||
145413724|NCT05630755|524368377|FG000|Overall Study|Status not Recorded|316|||
145413725|NCT05630755|524368378|FG001|Overall Study|Status not Recorded|161|||
145413726|NCT05950906|524368379|FG000|Overall Study|Adverse Event|0|||
145413727|NCT05950906|524368380|FG001|Overall Study|Adverse Event|0|||
145413728|NCT05950906|524368381|FG002|Overall Study|Adverse Event|0|||
145413729|NCT05950906|524368382|FG003|Overall Study|Adverse Event|0|||
145413730|NCT05950906|524368383|FG004|Overall Study|Adverse Event|0|||
145413731|NCT05950906|524368384|FG005|Overall Study|Adverse Event|0|||
145413732|NCT05950906|524368385|FG006|Overall Study|Adverse Event|0|||
145574443|NCT03604692|524958282|FG000|Overall Study|Death|0|||
145574444|NCT03604692|524958283|FG001|Overall Study|Death|0|||
145340817|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
145340818|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
145340819|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
145340820|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
145340821|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
145340822|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
145340823|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
145340824|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
145340825|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
145340826|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
145340827|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
145340828|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
145340829|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
145340830|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
145340831|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
145340832|NCT00261443|524096540|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
145340833|NCT00261443|524096541|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
145340834|NCT00261443|524096542|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
145340835|NCT00261443|524096540|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
145340836|NCT00261443|524096541|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
145340837|NCT00261443|524096542|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
145340838|NCT00261443|524096540|FG000|3: Assessment of Relapse|Adverse Event|0|||
145340839|NCT00261443|524096541|FG001|3: Assessment of Relapse|Adverse Event|15|||
145340840|NCT00261443|524096542|FG002|3: Assessment of Relapse|Adverse Event|19|||
145340841|NCT00261443|524096540|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
145340842|NCT00261443|524096541|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
145340843|NCT00261443|524096542|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
145340844|NCT00261443|524096540|FG000|3: Assessment of Relapse|Death|0|||
145340845|NCT00261443|524096541|FG001|3: Assessment of Relapse|Death|0|||
145340846|NCT00261443|524096542|FG002|3: Assessment of Relapse|Death|1|||
145340847|NCT00261443|524096540|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
145340848|NCT00261443|524096541|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
145340849|NCT00261443|524096542|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
145340850|NCT00261443|524096540|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
145340851|NCT00261443|524096541|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
145340852|NCT00261443|524096542|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
145340853|NCT00261443|524096540|FG000|3: Assessment of Relapse|Pregnancy|0|||
145340854|NCT00261443|524096541|FG001|3: Assessment of Relapse|Pregnancy|2|||
145340855|NCT00261443|524096542|FG002|3: Assessment of Relapse|Pregnancy|1|||
145340856|NCT00261443|524096540|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
145340857|NCT00261443|524096541|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
145340858|NCT00261443|524096542|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
145340859|NCT00261443|524096540|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
145340860|NCT00261443|524096541|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
145413733|NCT05950906|524368386|FG007|Overall Study|Adverse Event|0|||
145574445|NCT03604692|524958284|FG002|Overall Study|Death|1|||
145574446|NCT03604692|524958285|FG003|Overall Study|Death|0|||
145574447|NCT03604692|524958286|FG004|Overall Study|Death|0|||
145413734|NCT05950906|524368387|FG008|Overall Study|Adverse Event|0|||
145413735|NCT05950906|524368388|FG009|Overall Study|Adverse Event|0|||
145574448|NCT03604692|524958287|FG005|Overall Study|Death|0|||
145574449|NCT03604692|524958282|FG000|Overall Study|Drug Intolerance|0|||
145574450|NCT03604692|524958283|FG001|Overall Study|Drug Intolerance|0|||
145574451|NCT03604692|524958284|FG002|Overall Study|Drug Intolerance|0|||
145340861|NCT00261443|524096542|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
145340862|NCT00261443|524096540|FG000|3: Assessment of Relapse|Other Reasons|0|||
145340863|NCT00261443|524096541|FG001|3: Assessment of Relapse|Other Reasons|4|||
145340864|NCT00261443|524096542|FG002|3: Assessment of Relapse|Other Reasons|3|||
145340865|NCT00261443|524096540|FG000|4: Extension Phase|Adverse Event|0|||
145340866|NCT00261443|524096541|FG001|4: Extension Phase|Adverse Event|1|||
145340867|NCT00261443|524096542|FG002|4: Extension Phase|Adverse Event|0|||
145340868|NCT00261443|524096540|FG000|4: Extension Phase|Withdrawal by Subject|0|||
145340869|NCT00261443|524096541|FG001|4: Extension Phase|Withdrawal by Subject|1|||
145340870|NCT00261443|524096542|FG002|4: Extension Phase|Withdrawal by Subject|2|||
145340871|NCT00261443|524096540|FG000|4: Extension Phase|Lost to Follow-up|0|||
145340872|NCT00261443|524096541|FG001|4: Extension Phase|Lost to Follow-up|1|||
145340873|NCT00261443|524096542|FG002|4: Extension Phase|Lost to Follow-up|0|||
145340874|NCT01286753|524096543|FG000|Overall Study|Adverse Event|7|||
145340875|NCT01286753|524096544|FG001|Overall Study|Adverse Event|6|||
145340876|NCT01286753|524096543|FG000|Overall Study|Progression|11|||
145340877|NCT01286753|524096544|FG001|Overall Study|Progression|13|||
145340878|NCT01286753|524096543|FG000|Overall Study|Refused Treatment|1|||
145340879|NCT01286753|524096544|FG001|Overall Study|Refused Treatment|0|||
145340880|NCT01286753|524096543|FG000|Overall Study|Withdrawal of Consent|0|||
145340881|NCT01286753|524096544|FG001|Overall Study|Withdrawal of Consent|2|||
145340882|NCT01286753|524096543|FG000|Overall Study|Discontinued to Join Extension Study|6|||
145340883|NCT01286753|524096544|FG001|Overall Study|Discontinued to Join Extension Study|4|||
145340884|NCT01286753|524096543|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
145340885|NCT01286753|524096544|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
145340886|NCT00923273|524096548|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145340887|NCT00923273|524096549|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145340888|NCT00923273|524096550|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145340889|NCT00923273|524096551|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
145340890|NCT00923273|524096552|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
145340891|NCT00923273|524096548|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145340892|NCT00923273|524096549|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145340893|NCT00923273|524096550|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145340894|NCT00923273|524096551|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
145340895|NCT00923273|524096552|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
145340896|NCT00605540|524096553|FG000|Overall Study|Death|15|||
145340897|NCT00605540|524096553|FG000|Overall Study|Lost to Follow-up|23|||
145340898|NCT02540850|524096554|FG000|Overall Study|Lost to Follow-up|69|||
145340899|NCT02540850|524096555|FG001|Overall Study|Lost to Follow-up|66|||
145340900|NCT02540850|524096556|FG002|Overall Study|Lost to Follow-up|34|||
145340901|NCT00264550|524096557|FG000|Overall Study|Death|0|||
145340902|NCT00264550|524096558|FG001|Overall Study|Death|3|||
145340903|NCT00264550|524096559|FG002|Overall Study|Death|0|||
145340904|NCT00264550|524096560|FG003|Overall Study|Death|0|||
145340905|NCT00264550|524096557|FG000|Overall Study|Lost to Follow-up|3|||
145340906|NCT00264550|524096558|FG001|Overall Study|Lost to Follow-up|1|||
145340907|NCT00264550|524096559|FG002|Overall Study|Lost to Follow-up|1|||
145340908|NCT00264550|524096560|FG003|Overall Study|Lost to Follow-up|1|||
145340909|NCT00264550|524096557|FG000|Overall Study|Adverse Event|23|||
145340910|NCT00264550|524096558|FG001|Overall Study|Adverse Event|18|||
145340911|NCT00264550|524096559|FG002|Overall Study|Adverse Event|9|||
145340912|NCT00264550|524096560|FG003|Overall Study|Adverse Event|14|||
145340913|NCT00264550|524096557|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145340914|NCT00264550|524096558|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
145340915|NCT00264550|524096559|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
145340916|NCT00264550|524096560|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
145340917|NCT00264550|524096557|FG000|Overall Study|Discontinued oral study agent|0|||
145340918|NCT00264550|524096558|FG001|Overall Study|Discontinued oral study agent|1|||
145340919|NCT00264550|524096559|FG002|Overall Study|Discontinued oral study agent|0|||
145340920|NCT00264550|524096560|FG003|Overall Study|Discontinued oral study agent|0|||
145340921|NCT00264550|524096557|FG000|Overall Study|Other|13|||
145340922|NCT00264550|524096558|FG001|Overall Study|Other|7|||
145340923|NCT00264550|524096559|FG002|Overall Study|Other|3|||
145340924|NCT00264550|524096560|FG003|Overall Study|Other|9|||
145340925|NCT02246114|524096561|FG000|Overall Study|miscarriage|1|||
145340926|NCT02246114|524096562|FG001|Overall Study|miscarriage|0|||
145340927|NCT00129389|524096570|FG000|Overall Study|Adverse Event|19|||
145574452|NCT03604692|524958285|FG003|Overall Study|Drug Intolerance|1|||
145574453|NCT03604692|524958286|FG004|Overall Study|Drug Intolerance|0|||
145574454|NCT03604692|524958287|FG005|Overall Study|Drug Intolerance|0|||
145340928|NCT00129389|524096571|FG001|Overall Study|Adverse Event|87|||
145340929|NCT00129389|524096570|FG000|Overall Study|Death|0|||
145340930|NCT00129389|524096571|FG001|Overall Study|Death|1|||
145340931|NCT00129389|524096570|FG000|Overall Study|Lost to Follow-up|2|||
145340932|NCT00129389|524096571|FG001|Overall Study|Lost to Follow-up|1|||
145574455|NCT03604692|524958282|FG000|Overall Study|Noncompliance with follow-up visit|0|||
145574456|NCT03604692|524958283|FG001|Overall Study|Noncompliance with follow-up visit|0|||
145574457|NCT03604692|524958284|FG002|Overall Study|Noncompliance with follow-up visit|0|||
145574458|NCT03604692|524958285|FG003|Overall Study|Noncompliance with follow-up visit|1|||
145574459|NCT03604692|524958286|FG004|Overall Study|Noncompliance with follow-up visit|0|||
145574460|NCT03604692|524958287|FG005|Overall Study|Noncompliance with follow-up visit|0|||
145574461|NCT03604692|524958282|FG000|Overall Study|Not Treated|0|||
145574462|NCT03604692|524958283|FG001|Overall Study|Not Treated|0|||
145574463|NCT03604692|524958284|FG002|Overall Study|Not Treated|0|||
145574464|NCT03604692|524958285|FG003|Overall Study|Not Treated|0|||
145574465|NCT03604692|524958286|FG004|Overall Study|Not Treated|1|||
145574466|NCT03604692|524958287|FG005|Overall Study|Not Treated|0|||
145574467|NCT00637195|524958288|FG000|Overall Study|Lost to Follow-up|1|||
145574468|NCT00637195|524958289|FG001|Overall Study|Lost to Follow-up|0|||
145574469|NCT00637195|524958288|FG000|Overall Study|Other|2|||
145574470|NCT00637195|524958289|FG001|Overall Study|Other|0|||
145574471|NCT00637195|524958288|FG000|Overall Study|Withdrawal by Subject|0|||
145574472|NCT00637195|524958289|FG001|Overall Study|Withdrawal by Subject|1|||
145574473|NCT01469065|524958290|FG000|Overall Study|Lack of Efficacy|0|||
145574474|NCT01469065|524958291|FG001|Overall Study|Lack of Efficacy|0|||
145574475|NCT01469065|524958292|FG002|Overall Study|Lack of Efficacy|0|||
145574476|NCT01469065|524958293|FG003|Overall Study|Lack of Efficacy|0|||
145574477|NCT01469065|524958294|FG004|Overall Study|Lack of Efficacy|1|||
145574478|NCT01469065|524958290|FG000|Overall Study|Other|0|||
145574479|NCT01469065|524958291|FG001|Overall Study|Other|1|||
145574480|NCT01469065|524958292|FG002|Overall Study|Other|0|||
145574481|NCT01469065|524958293|FG003|Overall Study|Other|0|||
145574482|NCT01469065|524958294|FG004|Overall Study|Other|0|||
145574483|NCT01020019|524958297|FG000|Overall Study|Lost to Follow-up|21|||
145574484|NCT01020019|524958298|FG001|Overall Study|Lost to Follow-up|18|||
145574485|NCT01020019|524958297|FG000|Overall Study|Adverse Event|1|||
145574486|NCT01020019|524958298|FG001|Overall Study|Adverse Event|5|||
145574487|NCT01020019|524958297|FG000|Overall Study|not interested in treatment|4|||
145574488|NCT01020019|524958298|FG001|Overall Study|not interested in treatment|4|||
145574489|NCT01020019|524958297|FG000|Overall Study|moving|0|||
145574490|NCT01020019|524958298|FG001|Overall Study|moving|2|||
145574491|NCT05091528|524958299|FG000|Overall Study|Study Termination by Sponsor|0|||
145574492|NCT05091528|524958300|FG001|Overall Study|Study Termination by Sponsor|1|||
145574493|NCT05091528|524958301|FG002|Overall Study|Study Termination by Sponsor|0|||
145574494|NCT05091528|524958302|FG003|Overall Study|Study Termination by Sponsor|1|||
145574495|NCT02115282|524958303|FG000|Overall Study|Disease progression during treatment|216|||
145574496|NCT02115282|524958304|FG001|Overall Study|Disease progression during treatment|229|||
145574497|NCT02115282|524958303|FG000|Overall Study|Adverse Event|49|||
145574498|NCT02115282|524958304|FG001|Overall Study|Adverse Event|23|||
145574499|NCT02115282|524958303|FG000|Overall Study|Death|1|||
145574500|NCT02115282|524958304|FG001|Overall Study|Death|3|||
145574501|NCT02115282|524958303|FG000|Overall Study|Alternative therapy|1|||
145574502|NCT02115282|524958304|FG001|Overall Study|Alternative therapy|1|||
145574503|NCT02115282|524958303|FG000|Overall Study|Complicating disease|0|||
145574504|NCT02115282|524958304|FG001|Overall Study|Complicating disease|3|||
145574505|NCT02115282|524958303|FG000|Overall Study|Withdrawal by Subject|12|||
145574506|NCT02115282|524958304|FG001|Overall Study|Withdrawal by Subject|10|||
145574507|NCT02115282|524958303|FG000|Overall Study|Symptomatic progression/deterioration|7|||
145574508|NCT02115282|524958304|FG001|Overall Study|Symptomatic progression/deterioration|18|||
145574509|NCT02115282|524958303|FG000|Overall Study|Non-compliance|5|||
145574510|NCT02115282|524958304|FG001|Overall Study|Non-compliance|1|||
145574511|NCT02115282|524958303|FG000|Overall Study|Protocol Violation|2|||
145574512|NCT02115282|524958304|FG001|Overall Study|Protocol Violation|2|||
145574513|NCT02115282|524958303|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
145574514|NCT02115282|524958304|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
145574515|NCT02115282|524958303|FG000|Overall Study|Not start protocol therapy|9|||
145574516|NCT02115282|524958304|FG001|Overall Study|Not start protocol therapy|10|||
145574517|NCT00006916|524958307|FG000|Overall Study|Device not inserted|4|||
145574518|NCT00006916|524958307|FG000|Overall Study|Complication of device insertion|1|||
145574519|NCT00558103|524958308|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
145574520|NCT00558103|524958309|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
145574521|NCT00558103|524958310|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
145574522|NCT00558103|524958311|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
145574523|NCT00558103|524958312|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
145574524|NCT00558103|524958313|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
145574525|NCT00558103|524958308|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
145574526|NCT00558103|524958309|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
145574527|NCT00558103|524958310|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
145574528|NCT00558103|524958311|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
145574529|NCT00558103|524958312|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
145574530|NCT00558103|524958313|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
145622659|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
145622660|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
145622661|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
145622662|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
145622663|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
145622664|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
145622665|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
145622666|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
145622667|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
145622668|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
145622669|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
145622670|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
145413736|NCT05950906|524368389|FG010|Overall Study|Adverse Event|0|||
145413737|NCT05950906|524368390|FG011|Overall Study|Adverse Event|0|||
145574531|NCT00558103|524958308|FG000|Randomized Treatment Phase|Disease Progression|1|||
145574532|NCT00558103|524958309|FG001|Randomized Treatment Phase|Disease Progression|0|||
145574533|NCT00558103|524958310|FG002|Randomized Treatment Phase|Disease Progression|1|||
145574534|NCT00558103|524958311|FG003|Randomized Treatment Phase|Disease Progression|0|||
145574535|NCT00558103|524958312|FG004|Randomized Treatment Phase|Disease Progression|0|||
145574536|NCT00558103|524958313|FG005|Randomized Treatment Phase|Disease Progression|0|||
145574537|NCT00558103|524958308|FG000|Randomized Treatment Phase|Adverse Event|0|||
145574538|NCT00558103|524958309|FG001|Randomized Treatment Phase|Adverse Event|0|||
145574539|NCT00558103|524958310|FG002|Randomized Treatment Phase|Adverse Event|0|||
145574540|NCT00558103|524958311|FG003|Randomized Treatment Phase|Adverse Event|1|||
145622671|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
145622672|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
145413738|NCT05950906|524368391|FG012|Overall Study|Adverse Event|1|||
145413739|NCT05950906|524368392|FG013|Overall Study|Adverse Event|0|||
145413740|NCT05950906|524368379|FG000|Overall Study|Physician Decision|0|||
145413741|NCT05950906|524368380|FG001|Overall Study|Physician Decision|0|||
145413742|NCT05950906|524368381|FG002|Overall Study|Physician Decision|0|||
145413743|NCT05950906|524368382|FG003|Overall Study|Physician Decision|0|||
145622673|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
145340933|NCT00129389|524096570|FG000|Overall Study|Physician Decision|0|||
145413744|NCT05950906|524368383|FG004|Overall Study|Physician Decision|0|||
145413745|NCT05950906|524368384|FG005|Overall Study|Physician Decision|0|||
145413746|NCT05950906|524368385|FG006|Overall Study|Physician Decision|0|||
145413747|NCT05950906|524368386|FG007|Overall Study|Physician Decision|0|||
145413748|NCT05950906|524368387|FG008|Overall Study|Physician Decision|0|||
145622674|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
145622675|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145340934|NCT00129389|524096571|FG001|Overall Study|Physician Decision|4|||
145340935|NCT00129389|524096570|FG000|Overall Study|Protocol Violation|0|||
145340936|NCT00129389|524096571|FG001|Overall Study|Protocol Violation|6|||
145340937|NCT00129389|524096570|FG000|Overall Study|Withdrawal by Subject|9|||
145340938|NCT00129389|524096571|FG001|Overall Study|Withdrawal by Subject|23|||
145340939|NCT00129389|524096570|FG000|Overall Study|Relapse|1|||
145340940|NCT00129389|524096571|FG001|Overall Study|Relapse|0|||
145340941|NCT00129389|524096570|FG000|Overall Study|Not eligible|1|||
145340942|NCT00129389|524096571|FG001|Overall Study|Not eligible|2|||
145340943|NCT00129389|524096570|FG000|Overall Study|Crossed to the other arm|1|||
145340944|NCT00129389|524096571|FG001|Overall Study|Crossed to the other arm|16|||
145340945|NCT02794246|524096573|FG000|Overall Study|Withdrawal by Subject|2|||
145340946|NCT02794246|524096573|FG000|Overall Study|Physician Decision|4|||
145340947|NCT00603837|524096574|FG000|Overall Study|Physician Decision|3|||
145340948|NCT00603837|524096575|FG001|Overall Study|Physician Decision|0|||
145340949|NCT04611529|524096576|FG000|2-day Follow up|Lost to Follow-up|5|||
145340950|NCT04611529|524096577|FG001|2-day Follow up|Lost to Follow-up|6|||
145340951|NCT04611529|524096578|FG002|2-day Follow up|Lost to Follow-up|3|||
145340952|NCT00741286|524096644|FG000|Overall Study|Lost to Follow-up|15|||
145340953|NCT00741286|524096645|FG001|Overall Study|Lost to Follow-up|10|||
145340954|NCT00741286|524096644|FG000|Overall Study|Adverse Event|1|||
145340955|NCT00741286|524096645|FG001|Overall Study|Adverse Event|6|||
145340956|NCT00741286|524096644|FG000|Overall Study|Protocol Violation|3|||
145340957|NCT00741286|524096645|FG001|Overall Study|Protocol Violation|2|||
145340958|NCT00741286|524096644|FG000|Overall Study|Primary Outcome|1|||
145413749|NCT05950906|524368388|FG009|Overall Study|Physician Decision|0|||
145413750|NCT05950906|524368389|FG010|Overall Study|Physician Decision|0|||
145413751|NCT05950906|524368390|FG011|Overall Study|Physician Decision|0|||
145413752|NCT05950906|524368391|FG012|Overall Study|Physician Decision|1|||
145574541|NCT00558103|524958312|FG004|Randomized Treatment Phase|Adverse Event|1|||
145340959|NCT00741286|524096645|FG001|Overall Study|Primary Outcome|1|||
145340960|NCT01831258|524096646|FG000|Overall Study|Withdrawal by Subject|2|||
145340961|NCT01831258|524096647|FG001|Overall Study|Withdrawal by Subject|1|||
145340962|NCT01831258|524096646|FG000|Overall Study|Lost to Follow-up|3|||
145340963|NCT01831258|524096647|FG001|Overall Study|Lost to Follow-up|2|||
145574542|NCT00558103|524958313|FG005|Randomized Treatment Phase|Adverse Event|0|||
145574543|NCT00558103|524958308|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
145574544|NCT00558103|524958309|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
145574545|NCT00558103|524958310|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
145574546|NCT00558103|524958311|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
145574547|NCT00558103|524958312|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
145574548|NCT00558103|524958313|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
145574549|NCT00558103|524958308|FG000|Monotherapy Extension Phase|Disease Progression|0|||
145574550|NCT00558103|524958309|FG001|Monotherapy Extension Phase|Disease Progression|0|||
145574551|NCT00558103|524958310|FG002|Monotherapy Extension Phase|Disease Progression|0|||
145574552|NCT00558103|524958311|FG003|Monotherapy Extension Phase|Disease Progression|0|||
145574553|NCT00558103|524958312|FG004|Monotherapy Extension Phase|Disease Progression|0|||
145574554|NCT00558103|524958313|FG005|Monotherapy Extension Phase|Disease Progression|8|||
145574555|NCT00308711|524958315|FG000|Overall Study|Withdrawal by Subject|1|||
145574556|NCT00308711|524958316|FG001|Overall Study|Withdrawal by Subject|0|||
145574557|NCT00308711|524958317|FG002|Overall Study|Withdrawal by Subject|1|||
145574558|NCT00308711|524958315|FG000|Overall Study|Protocol Violation|0|||
145574559|NCT00308711|524958316|FG001|Overall Study|Protocol Violation|1|||
145574560|NCT00308711|524958317|FG002|Overall Study|Protocol Violation|1|||
145574561|NCT00308711|524958315|FG000|Overall Study|Lost to Follow-up|0|||
145574562|NCT00308711|524958316|FG001|Overall Study|Lost to Follow-up|1|||
145574563|NCT00308711|524958317|FG002|Overall Study|Lost to Follow-up|0|||
145574564|NCT00308711|524958315|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
145574565|NCT00308711|524958316|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
145574566|NCT00308711|524958317|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
145574567|NCT00308711|524958315|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
145574568|NCT00308711|524958316|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
145574569|NCT00308711|524958317|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
145574570|NCT01420081|524958318|FG000|Overall Study|Death|1|||
145574571|NCT01420081|524958319|FG001|Overall Study|Death|0|||
145574572|NCT01420081|524958320|FG002|Overall Study|Death|8|||
145574573|NCT01420081|524958321|FG003|Overall Study|Death|0|||
145574574|NCT01420081|524958322|FG004|Overall Study|Death|7|||
145574575|NCT01420081|524958323|FG005|Overall Study|Death|12|||
145574576|NCT01420081|524958324|FG006|Overall Study|Death|0|||
145574577|NCT01420081|524958325|FG007|Overall Study|Death|1|||
145574578|NCT01420081|524958326|FG008|Overall Study|Death|1|||
145574579|NCT01420081|524958318|FG000|Overall Study|Lost to Follow-up|0|||
145574580|NCT01420081|524958319|FG001|Overall Study|Lost to Follow-up|0|||
145574581|NCT01420081|524958320|FG002|Overall Study|Lost to Follow-up|0|||
145574582|NCT01420081|524958321|FG003|Overall Study|Lost to Follow-up|0|||
145574583|NCT01420081|524958322|FG004|Overall Study|Lost to Follow-up|1|||
145574584|NCT01420081|524958323|FG005|Overall Study|Lost to Follow-up|1|||
145574585|NCT01420081|524958324|FG006|Overall Study|Lost to Follow-up|0|||
145574586|NCT01420081|524958325|FG007|Overall Study|Lost to Follow-up|0|||
145574587|NCT01420081|524958326|FG008|Overall Study|Lost to Follow-up|0|||
145574588|NCT01420081|524958318|FG000|Overall Study|Study Terminated by Sponsor|2|||
145574589|NCT01420081|524958319|FG001|Overall Study|Study Terminated by Sponsor|1|||
145574590|NCT01420081|524958320|FG002|Overall Study|Study Terminated by Sponsor|1|||
145574591|NCT01420081|524958321|FG003|Overall Study|Study Terminated by Sponsor|3|||
145574592|NCT01420081|524958322|FG004|Overall Study|Study Terminated by Sponsor|11|||
145574593|NCT01420081|524958323|FG005|Overall Study|Study Terminated by Sponsor|7|||
145574594|NCT01420081|524958324|FG006|Overall Study|Study Terminated by Sponsor|3|||
145574595|NCT01420081|524958325|FG007|Overall Study|Study Terminated by Sponsor|2|||
145574596|NCT01420081|524958326|FG008|Overall Study|Study Terminated by Sponsor|2|||
145574597|NCT01420081|524958318|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
145574598|NCT01420081|524958319|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
145574599|NCT01420081|524958320|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
145574600|NCT01420081|524958321|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
145622676|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145622677|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145340964|NCT00425373|524096656|FG000|Overall Study|Adverse Event|2|||
145340965|NCT00425373|524096657|FG001|Overall Study|Adverse Event|2|||
145574601|NCT01420081|524958322|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
145574602|NCT01420081|524958323|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
145574603|NCT01420081|524958324|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
145574604|NCT01420081|524958325|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
145574605|NCT01420081|524958326|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
145574606|NCT01420081|524958318|FG000|Overall Study|Other Reasons|0|||
145574607|NCT01420081|524958319|FG001|Overall Study|Other Reasons|0|||
145574608|NCT01420081|524958320|FG002|Overall Study|Other Reasons|1|||
145574609|NCT01420081|524958321|FG003|Overall Study|Other Reasons|0|||
145574610|NCT01420081|524958322|FG004|Overall Study|Other Reasons|0|||
145574611|NCT01420081|524958323|FG005|Overall Study|Other Reasons|0|||
145574612|NCT01420081|524958324|FG006|Overall Study|Other Reasons|0|||
145622678|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145622679|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
145622680|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
145622681|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145622682|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145622683|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145622684|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145622685|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145622686|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145622687|NCT01323660|525130149|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
145622688|NCT01323660|525130150|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145622689|NCT01323660|525130151|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
145622690|NCT01323660|525130152|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
145622691|NCT01323660|525130153|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
145622692|NCT01323660|525130154|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145622693|NCT01323660|525130149|FG000|Washout Period (14 Days)|Adverse Event|0|||
145622694|NCT01323660|525130150|FG001|Washout Period (14 Days)|Adverse Event|0|||
145622695|NCT01323660|525130151|FG002|Washout Period (14 Days)|Adverse Event|0|||
145622696|NCT01323660|525130152|FG003|Washout Period (14 Days)|Adverse Event|0|||
145622697|NCT01323660|525130153|FG004|Washout Period (14 Days)|Adverse Event|1|||
145622698|NCT01323660|525130154|FG005|Washout Period (14 Days)|Adverse Event|0|||
145622699|NCT01323660|525130149|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
145622700|NCT01323660|525130150|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
145622701|NCT01323660|525130151|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
145622702|NCT01323660|525130152|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
145622703|NCT01323660|525130153|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
145622704|NCT01323660|525130154|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
145622705|NCT01323660|525130149|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145622706|NCT01323660|525130150|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145622707|NCT01323660|525130151|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
145622708|NCT01323660|525130152|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145622709|NCT01323660|525130153|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
145622710|NCT01323660|525130154|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
145622711|NCT01323660|525130149|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
145622712|NCT01323660|525130150|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
145622713|NCT01323660|525130151|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
145622714|NCT01323660|525130152|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
145622715|NCT01323660|525130153|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
145622716|NCT01323660|525130154|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
145622717|NCT01323660|525130149|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
145622718|NCT01323660|525130150|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
145622719|NCT01323660|525130151|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
145622720|NCT01323660|525130152|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
145622721|NCT01323660|525130153|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
145622722|NCT01323660|525130154|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
145622723|NCT01323660|525130149|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
145622724|NCT01323660|525130150|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145622725|NCT01323660|525130151|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145574613|NCT01420081|524958325|FG007|Overall Study|Other Reasons|0|||
145574614|NCT01420081|524958326|FG008|Overall Study|Other Reasons|0|||
145574615|NCT02318693|524958328|FG000|Overall Study|Protocol Violation|0|||
145574616|NCT02318693|524958329|FG001|Overall Study|Protocol Violation|1|||
145574617|NCT00218543|524958330|FG000|Overall Study|Lost to Follow-up|8|||
145574618|NCT00218543|524958330|FG000|Overall Study|relocated|1|||
145574619|NCT00218543|524958330|FG000|Overall Study|Withdrawal by Subject|1|||
145574620|NCT00218543|524958330|FG000|Overall Study|Physician Decision|3|||
145574621|NCT00218543|524958330|FG000|Overall Study|Adverse Event|2|||
145622726|NCT01323660|525130152|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145622727|NCT01323660|525130153|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
145622728|NCT01323660|525130154|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
145622729|NCT01323660|525130149|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145622730|NCT01323660|525130150|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145340966|NCT00425373|524096658|FG002|Overall Study|Adverse Event|0|||
145340967|NCT00425373|524096659|FG003|Overall Study|Adverse Event|1|||
145574622|NCT02448875|524958331|FG000|Overall Study|Adverse Event|2|||
145340968|NCT00425373|524096660|FG004|Overall Study|Adverse Event|4|||
145574623|NCT02448875|524958332|FG001|Overall Study|Adverse Event|1|||
145574624|NCT02448875|524958333|FG002|Overall Study|Adverse Event|0|||
145340969|NCT00425373|524096661|FG005|Overall Study|Adverse Event|6|||
145574625|NCT02448875|524958331|FG000|Overall Study|Lost to Follow-up|1|||
145574626|NCT02448875|524958332|FG001|Overall Study|Lost to Follow-up|0|||
145574627|NCT02448875|524958333|FG002|Overall Study|Lost to Follow-up|0|||
145340970|NCT00425373|524096662|FG006|Overall Study|Adverse Event|2|||
145340971|NCT00425373|524096663|FG007|Overall Study|Adverse Event|3|||
145340972|NCT00425373|524096664|FG008|Overall Study|Adverse Event|8|||
145340973|NCT00425373|524096656|FG000|Overall Study|Lost to Follow-up|0|||
145340974|NCT00425373|524096657|FG001|Overall Study|Lost to Follow-up|1|||
145340975|NCT00425373|524096658|FG002|Overall Study|Lost to Follow-up|0|||
145340976|NCT00425373|524096659|FG003|Overall Study|Lost to Follow-up|0|||
145340977|NCT00425373|524096660|FG004|Overall Study|Lost to Follow-up|1|||
145340978|NCT00425373|524096661|FG005|Overall Study|Lost to Follow-up|0|||
145340979|NCT00425373|524096662|FG006|Overall Study|Lost to Follow-up|0|||
145340980|NCT00425373|524096663|FG007|Overall Study|Lost to Follow-up|0|||
145340981|NCT00425373|524096664|FG008|Overall Study|Lost to Follow-up|0|||
145340982|NCT00425373|524096656|FG000|Overall Study|Protocol Violation|1|||
145340983|NCT00425373|524096657|FG001|Overall Study|Protocol Violation|0|||
145340984|NCT00425373|524096658|FG002|Overall Study|Protocol Violation|1|||
145340985|NCT00425373|524096659|FG003|Overall Study|Protocol Violation|0|||
145340986|NCT00425373|524096660|FG004|Overall Study|Protocol Violation|0|||
145340987|NCT00425373|524096661|FG005|Overall Study|Protocol Violation|0|||
145340988|NCT00425373|524096662|FG006|Overall Study|Protocol Violation|0|||
145340989|NCT00425373|524096663|FG007|Overall Study|Protocol Violation|5|||
145340990|NCT00425373|524096664|FG008|Overall Study|Protocol Violation|3|||
145340991|NCT00425373|524096656|FG000|Overall Study|Withdrawal by Subject|2|||
145340992|NCT00425373|524096657|FG001|Overall Study|Withdrawal by Subject|0|||
145340993|NCT00425373|524096658|FG002|Overall Study|Withdrawal by Subject|2|||
145340994|NCT00425373|524096659|FG003|Overall Study|Withdrawal by Subject|1|||
145340995|NCT00425373|524096660|FG004|Overall Study|Withdrawal by Subject|4|||
145340996|NCT00425373|524096661|FG005|Overall Study|Withdrawal by Subject|0|||
145340997|NCT00425373|524096662|FG006|Overall Study|Withdrawal by Subject|2|||
145340998|NCT00425373|524096663|FG007|Overall Study|Withdrawal by Subject|2|||
145340999|NCT00425373|524096664|FG008|Overall Study|Withdrawal by Subject|2|||
145341000|NCT00425373|524096656|FG000|Overall Study|Lack of Efficacy|0|||
145341001|NCT00425373|524096657|FG001|Overall Study|Lack of Efficacy|0|||
145341002|NCT00425373|524096658|FG002|Overall Study|Lack of Efficacy|0|||
145341003|NCT00425373|524096659|FG003|Overall Study|Lack of Efficacy|0|||
145341004|NCT00425373|524096660|FG004|Overall Study|Lack of Efficacy|1|||
145341005|NCT00425373|524096661|FG005|Overall Study|Lack of Efficacy|3|||
145341006|NCT00425373|524096662|FG006|Overall Study|Lack of Efficacy|3|||
145341007|NCT00425373|524096663|FG007|Overall Study|Lack of Efficacy|0|||
145341008|NCT00425373|524096664|FG008|Overall Study|Lack of Efficacy|5|||
145341009|NCT02564887|524096665|FG000|Overall Study|Lost to Follow-up|6|||
145341010|NCT02564887|524096666|FG001|Overall Study|Lost to Follow-up|0|||
145341011|NCT01199016|524096667|FG000|Overall Study|No longer meets eligibility criteria|4|||
145341012|NCT01199016|524096667|FG000|Overall Study|Entrance criteria|5|||
145341013|NCT01199016|524096667|FG000|Overall Study|Protocol Violation|9|||
145341014|NCT01199016|524096667|FG000|Overall Study|Other|13|||
145341015|NCT01199016|524096667|FG000|Overall Study|Withdrawal by Subject|21|||
145341016|NCT01199016|524096667|FG000|Overall Study|Lost to Follow-up|25|||
145341017|NCT02960490|524096676|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
145341018|NCT02960490|524096677|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
145341019|NCT02960490|524096678|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341020|NCT02960490|524096679|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341021|NCT02960490|524096680|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341022|NCT02960490|524096681|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341023|NCT02960490|524096682|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341024|NCT02960490|524096683|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341025|NCT02960490|524096684|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341026|NCT02960490|524096685|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
145341027|NCT02960490|524096676|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341028|NCT02960490|524096677|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
145341029|NCT02960490|524096678|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341030|NCT02960490|524096679|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341031|NCT02960490|524096680|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341032|NCT02960490|524096681|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341033|NCT02960490|524096682|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341034|NCT02960490|524096683|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341035|NCT02960490|524096684|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341036|NCT02960490|524096685|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
145341037|NCT02960490|524096676|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
145341038|NCT02960490|524096677|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
145341039|NCT02960490|524096678|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341040|NCT02960490|524096679|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341041|NCT02960490|524096680|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341042|NCT02960490|524096681|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341043|NCT02960490|524096682|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341044|NCT02960490|524096683|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341045|NCT02960490|524096684|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341046|NCT02960490|524096685|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
145341047|NCT02960490|524096676|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
145341048|NCT02960490|524096677|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
145341049|NCT02960490|524096678|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341050|NCT02960490|524096679|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341051|NCT02960490|524096680|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341052|NCT02960490|524096681|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341053|NCT02960490|524096682|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341054|NCT02960490|524096683|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341055|NCT02960490|524096684|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341056|NCT02960490|524096685|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
145341057|NCT02960490|524096676|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341058|NCT02960490|524096677|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341059|NCT02960490|524096678|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
145341060|NCT02960490|524096679|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
145341061|NCT02960490|524096680|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341062|NCT02960490|524096681|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
145341063|NCT02960490|524096682|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341064|NCT02960490|524096683|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341065|NCT02960490|524096684|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341066|NCT02960490|524096685|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
145341067|NCT02960490|524096676|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341068|NCT02960490|524096677|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341069|NCT02960490|524096678|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
145341070|NCT02960490|524096679|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341071|NCT02960490|524096680|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
145341072|NCT02960490|524096681|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341073|NCT02960490|524096682|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341074|NCT02960490|524096683|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341075|NCT02960490|524096684|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341076|NCT02960490|524096685|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
145341077|NCT02960490|524096676|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
145341078|NCT02960490|524096677|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
145341079|NCT02960490|524096678|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
145341080|NCT02960490|524096679|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
145341081|NCT02960490|524096680|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
145341082|NCT02960490|524096681|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
145341083|NCT02960490|524096682|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
145341084|NCT02960490|524096683|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
145341085|NCT02960490|524096684|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
145341086|NCT02960490|524096685|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
145341087|NCT02960490|524096676|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341088|NCT02960490|524096677|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341089|NCT02960490|524096678|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341090|NCT02960490|524096679|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341091|NCT02960490|524096680|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341092|NCT02960490|524096681|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341093|NCT02960490|524096682|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
145341094|NCT02960490|524096683|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
145341095|NCT02960490|524096684|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
145341096|NCT02960490|524096685|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
145341097|NCT02960490|524096676|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341098|NCT02960490|524096677|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145574628|NCT02448875|524958331|FG000|Overall Study|Investigator Decision|3|||
145574629|NCT02448875|524958332|FG001|Overall Study|Investigator Decision|0|||
145574630|NCT02448875|524958333|FG002|Overall Study|Investigator Decision|1|||
145574631|NCT02448875|524958331|FG000|Overall Study|Withdrawal by Subject|1|||
145574632|NCT02448875|524958332|FG001|Overall Study|Withdrawal by Subject|0|||
145574633|NCT02448875|524958333|FG002|Overall Study|Withdrawal by Subject|0|||
145574634|NCT03337724|524958338|FG000|Overall Study|Reason not Specified|12|||
145574635|NCT03337724|524958339|FG001|Overall Study|Reason not Specified|21|||
145574636|NCT03337724|524958340|FG002|Overall Study|Reason not Specified|9|||
145574637|NCT03337724|524958341|FG003|Overall Study|Reason not Specified|9|||
145574638|NCT03337724|524958342|FG004|Overall Study|Reason not Specified|29|||
145574639|NCT03337724|524958338|FG000|Overall Study|Withdrawal by Subject|13|||
145574640|NCT03337724|524958339|FG001|Overall Study|Withdrawal by Subject|15|||
145574641|NCT03337724|524958340|FG002|Overall Study|Withdrawal by Subject|4|||
145574642|NCT03337724|524958341|FG003|Overall Study|Withdrawal by Subject|15|||
145574643|NCT03337724|524958342|FG004|Overall Study|Withdrawal by Subject|6|||
145574644|NCT03337724|524958338|FG000|Overall Study|Protocol Deviation|0|||
145574645|NCT03337724|524958339|FG001|Overall Study|Protocol Deviation|1|||
145574646|NCT03337724|524958340|FG002|Overall Study|Protocol Deviation|1|||
145574647|NCT03337724|524958341|FG003|Overall Study|Protocol Deviation|1|||
145574648|NCT03337724|524958342|FG004|Overall Study|Protocol Deviation|0|||
145574649|NCT03337724|524958338|FG000|Overall Study|Adverse Event|1|||
145574650|NCT03337724|524958339|FG001|Overall Study|Adverse Event|1|||
145574651|NCT03337724|524958340|FG002|Overall Study|Adverse Event|0|||
145574652|NCT03337724|524958341|FG003|Overall Study|Adverse Event|1|||
145574653|NCT03337724|524958342|FG004|Overall Study|Adverse Event|0|||
145574654|NCT03337724|524958338|FG000|Overall Study|Death|40|||
145574655|NCT03337724|524958339|FG001|Overall Study|Death|89|||
145574656|NCT03337724|524958340|FG002|Overall Study|Death|43|||
145574657|NCT03337724|524958341|FG003|Overall Study|Death|76|||
145574658|NCT03337724|524958342|FG004|Overall Study|Death|50|||
145574659|NCT03337724|524958338|FG000|Overall Study|Lost to Follow-up|5|||
145574660|NCT03337724|524958339|FG001|Overall Study|Lost to Follow-up|5|||
145574661|NCT03337724|524958340|FG002|Overall Study|Lost to Follow-up|4|||
145574662|NCT03337724|524958341|FG003|Overall Study|Lost to Follow-up|7|||
145574663|NCT03337724|524958342|FG004|Overall Study|Lost to Follow-up|4|||
145574664|NCT03337724|524958338|FG000|Overall Study|Physician Decision|16|||
145574665|NCT03337724|524958339|FG001|Overall Study|Physician Decision|34|||
145574666|NCT03337724|524958340|FG002|Overall Study|Physician Decision|14|||
145574667|NCT03337724|524958341|FG003|Overall Study|Physician Decision|34|||
145574668|NCT03337724|524958342|FG004|Overall Study|Physician Decision|13|||
145574669|NCT03337724|524958338|FG000|Overall Study|Progressive Disease|0|||
145574670|NCT03337724|524958339|FG001|Overall Study|Progressive Disease|2|||
145574671|NCT03337724|524958340|FG002|Overall Study|Progressive Disease|1|||
145574672|NCT03337724|524958341|FG003|Overall Study|Progressive Disease|2|||
145574673|NCT03337724|524958342|FG004|Overall Study|Progressive Disease|0|||
145574674|NCT03337724|524958338|FG000|Overall Study|Symptomatic Deterioration|0|||
145574675|NCT03337724|524958339|FG001|Overall Study|Symptomatic Deterioration|0|||
145574676|NCT03337724|524958340|FG002|Overall Study|Symptomatic Deterioration|0|||
145574677|NCT03337724|524958341|FG003|Overall Study|Symptomatic Deterioration|1|||
145574678|NCT03337724|524958342|FG004|Overall Study|Symptomatic Deterioration|0|||
145574679|NCT00773097|524958343|FG000|Overall Study|Withdrawal by Subject|1|||
145574680|NCT00773097|524958343|FG000|Overall Study|Physician Decision|6|||
145574681|NCT01038778|524958346|FG000|Overall Study|Withdrawal by Subject|0|||
145341099|NCT02960490|524096678|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341100|NCT02960490|524096679|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341101|NCT02960490|524096680|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341102|NCT02960490|524096681|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341103|NCT02960490|524096682|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341104|NCT02960490|524096683|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
145341105|NCT02960490|524096684|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341106|NCT02960490|524096685|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
145341107|NCT02960490|524096676|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145341108|NCT02960490|524096677|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145341109|NCT02960490|524096678|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145341110|NCT02960490|524096679|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145341111|NCT02960490|524096680|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145341112|NCT02960490|524096681|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
145574682|NCT01038778|524958347|FG001|Overall Study|Withdrawal by Subject|2|||
145574683|NCT01038778|524958348|FG002|Overall Study|Withdrawal by Subject|3|||
145574684|NCT02742103|524960048|FG000|Overall Study|Protocol Violation|1|||
145574685|NCT02742103|524960049|FG001|Overall Study|Protocol Violation|0|||
145574686|NCT02742103|524960048|FG000|Overall Study|Death|2|||
145574687|NCT02742103|524960049|FG001|Overall Study|Death|2|||
145574688|NCT02742103|524960048|FG000|Overall Study|Adverse Event|1|||
145574689|NCT02742103|524960049|FG001|Overall Study|Adverse Event|0|||
145574690|NCT02742103|524960048|FG000|Overall Study|Moved to another town|0|||
145574691|NCT02742103|524960049|FG001|Overall Study|Moved to another town|1|||
145574692|NCT02742103|524960048|FG000|Overall Study|Withdrawal by Subject|5|||
145574693|NCT02742103|524960049|FG001|Overall Study|Withdrawal by Subject|2|||
145574694|NCT04346615|524960052|FG000|Overall Study|Lost to Follow-up|0|||
145574695|NCT04346615|524960053|FG001|Overall Study|Lost to Follow-up|2|||
145574696|NCT04346615|524960052|FG000|Overall Study|Withdrawal by Subject|1|||
145574697|NCT04346615|524960053|FG001|Overall Study|Withdrawal by Subject|0|||
145574698|NCT04346615|524960052|FG000|Overall Study|Death|5|||
145574699|NCT04346615|524960053|FG001|Overall Study|Death|1|||
145574700|NCT04346615|524960052|FG000|Overall Study|Other|0|||
145622731|NCT01323660|525130151|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145622732|NCT01323660|525130152|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145622733|NCT01323660|525130153|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
145622734|NCT01323660|525130154|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145622735|NCT02886728|525130161|FG000|Overall Study|Withdrew Consent|31|||
145622736|NCT02886728|525130162|FG001|Overall Study|Withdrew Consent|13|||
145622737|NCT02886728|525130163|FG002|Overall Study|Withdrew Consent|11|||
145622738|NCT02886728|525130164|FG003|Overall Study|Withdrew Consent|47|||
145341113|NCT02960490|524096682|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
145574701|NCT04346615|524960053|FG001|Overall Study|Other|2|||
145574702|NCT04346615|524960052|FG000|Overall Study|Randomized not treated|1|||
145574703|NCT04346615|524960053|FG001|Overall Study|Randomized not treated|0|||
145574704|NCT00120042|524960056|FG000|Overall Study|all completed protocl|0|||
145574705|NCT00120042|524960057|FG001|Overall Study|all completed protocl|0|||
145574706|NCT00120042|524960058|FG002|Overall Study|all completed protocl|0|||
145574707|NCT03852316|524960059|FG000|Overall Study|Protocol Violation|1|||
145574708|NCT03852316|524960059|FG000|Overall Study|Withdrawal by Subject|2|||
145574709|NCT03852316|524960059|FG000|Overall Study|Enrolled but Device not Utilized|1|||
145574710|NCT04532112|524960060|FG000|Overall Study|Adverse Event|3|||
145574711|NCT04532112|524960061|FG001|Overall Study|Adverse Event|0|||
145574712|NCT03592641|524960062|FG000|Overall Study|Withdrawal by Subject|1|||
145574713|NCT00079274|524960066|FG000|Overall Study|Withdrawal by Subject|111|||
145574714|NCT00079274|524960067|FG001|Overall Study|Withdrawal by Subject|10|||
145574715|NCT00079274|524960068|FG002|Overall Study|Withdrawal by Subject|12|||
145574716|NCT00079274|524960069|FG003|Overall Study|Withdrawal by Subject|163|||
145574717|NCT00079274|524960070|FG004|Overall Study|Withdrawal by Subject|7|||
145574718|NCT00079274|524960071|FG005|Overall Study|Withdrawal by Subject|8|||
145574719|NCT00079274|524960072|FG006|Overall Study|Withdrawal by Subject|0|||
145574720|NCT00079274|524960066|FG000|Overall Study|Adverse Event|130|||
145574721|NCT00079274|524960067|FG001|Overall Study|Adverse Event|8|||
145574722|NCT00079274|524960068|FG002|Overall Study|Adverse Event|8|||
145574723|NCT00079274|524960069|FG003|Overall Study|Adverse Event|184|||
145574724|NCT00079274|524960070|FG004|Overall Study|Adverse Event|7|||
145574725|NCT00079274|524960071|FG005|Overall Study|Adverse Event|8|||
145574726|NCT00079274|524960072|FG006|Overall Study|Adverse Event|0|||
145622739|NCT02886728|525130161|FG000|Overall Study|Lost to Follow-up|12|||
145341114|NCT02960490|524096683|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
145341115|NCT02960490|524096684|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
145341116|NCT02960490|524096685|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
145341117|NCT02960490|524096676|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341118|NCT02960490|524096677|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341119|NCT02960490|524096678|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341120|NCT02960490|524096679|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341121|NCT02960490|524096680|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341122|NCT02960490|524096681|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341123|NCT02960490|524096682|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
145341124|NCT02960490|524096683|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341125|NCT02960490|524096684|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341126|NCT02960490|524096685|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
145341127|NCT02960490|524096676|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341128|NCT02960490|524096677|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341129|NCT02960490|524096678|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341130|NCT02960490|524096679|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341131|NCT02960490|524096680|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341132|NCT02960490|524096681|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341133|NCT02960490|524096682|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
145341134|NCT02960490|524096683|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
145341135|NCT02960490|524096684|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
145622740|NCT02886728|525130162|FG001|Overall Study|Lost to Follow-up|6|||
145622741|NCT02886728|525130163|FG002|Overall Study|Lost to Follow-up|13|||
145341136|NCT02960490|524096685|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
145574727|NCT00079274|524960066|FG000|Overall Study|Recurrence|21|||
145574728|NCT00079274|524960067|FG001|Overall Study|Recurrence|0|||
145574729|NCT00079274|524960068|FG002|Overall Study|Recurrence|1|||
145574730|NCT00079274|524960069|FG003|Overall Study|Recurrence|15|||
145574731|NCT00079274|524960070|FG004|Overall Study|Recurrence|0|||
145574732|NCT00079274|524960071|FG005|Overall Study|Recurrence|2|||
145574733|NCT00079274|524960072|FG006|Overall Study|Recurrence|0|||
145574734|NCT00079274|524960066|FG000|Overall Study|Alternate Treatment|6|||
145574735|NCT00079274|524960067|FG001|Overall Study|Alternate Treatment|1|||
145574736|NCT00079274|524960068|FG002|Overall Study|Alternate Treatment|0|||
145574737|NCT00079274|524960069|FG003|Overall Study|Alternate Treatment|3|||
145574738|NCT00079274|524960070|FG004|Overall Study|Alternate Treatment|0|||
145574739|NCT00079274|524960071|FG005|Overall Study|Alternate Treatment|0|||
145622742|NCT02886728|525130164|FG003|Overall Study|Lost to Follow-up|12|||
145622743|NCT02886728|525130161|FG000|Overall Study|Adverse Event|13|||
145622744|NCT02886728|525130162|FG001|Overall Study|Adverse Event|5|||
145622745|NCT02886728|525130163|FG002|Overall Study|Adverse Event|5|||
145622746|NCT02886728|525130164|FG003|Overall Study|Adverse Event|11|||
145622747|NCT02886728|525130161|FG000|Overall Study|Investigator's Discretion|11|||
145622748|NCT02886728|525130162|FG001|Overall Study|Investigator's Discretion|7|||
145622749|NCT02886728|525130163|FG002|Overall Study|Investigator's Discretion|5|||
145622750|NCT02886728|525130164|FG003|Overall Study|Investigator's Discretion|11|||
145622751|NCT02886728|525130161|FG000|Overall Study|Death|3|||
145622752|NCT02886728|525130162|FG001|Overall Study|Death|1|||
145622753|NCT02886728|525130163|FG002|Overall Study|Death|0|||
145622754|NCT02886728|525130164|FG003|Overall Study|Death|0|||
145622755|NCT02886728|525130161|FG000|Overall Study|Protocol Violation|0|||
145622756|NCT02886728|525130162|FG001|Overall Study|Protocol Violation|0|||
145622757|NCT02886728|525130163|FG002|Overall Study|Protocol Violation|0|||
145622758|NCT02886728|525130164|FG003|Overall Study|Protocol Violation|4|||
145622759|NCT02886728|525130161|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145622760|NCT02886728|525130162|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145622761|NCT02886728|525130163|FG002|Overall Study|Non-Compliance with Study Drug|1|||
145622762|NCT02886728|525130164|FG003|Overall Study|Non-Compliance with Study Drug|0|||
145622763|NCT02886728|525130161|FG000|Overall Study|Pregnancy|0|||
145622764|NCT02886728|525130162|FG001|Overall Study|Pregnancy|0|||
145622765|NCT02886728|525130163|FG002|Overall Study|Pregnancy|1|||
145622766|NCT02886728|525130164|FG003|Overall Study|Pregnancy|0|||
145622767|NCT02886728|525130161|FG000|Overall Study|Randomized but Not Dosed|1|||
145622768|NCT02886728|525130162|FG001|Overall Study|Randomized but Not Dosed|0|||
145622769|NCT02886728|525130163|FG002|Overall Study|Randomized but Not Dosed|0|||
145622770|NCT02886728|525130164|FG003|Overall Study|Randomized but Not Dosed|2|||
145622771|NCT04990440|525130167|FG000|Overall Study|Sponsor's Decision|0|||
145622772|NCT04990440|525130168|FG001|Overall Study|Sponsor's Decision|0|||
145622773|NCT04990440|525130169|FG002|Overall Study|Sponsor's Decision|1|||
145622774|NCT03712098|525130170|FG000|Overall Study|Lost to Follow-up|3|||
145622775|NCT03712098|525130171|FG001|Overall Study|Lost to Follow-up|7|||
145622776|NCT03712098|525130170|FG000|Overall Study|Withdrawal by Subject|9|||
145622777|NCT03712098|525130171|FG001|Overall Study|Withdrawal by Subject|4|||
145622778|NCT03712098|525130170|FG000|Overall Study|Protocol Violation|2|||
145622779|NCT03712098|525130171|FG001|Overall Study|Protocol Violation|1|||
145622780|NCT02954575|525130176|FG000|Overall Study|Withdrawal by Subject|2|||
145622781|NCT02954575|525130176|FG000|Overall Study|Adverse Event|1|||
145341137|NCT02368314|524096688|FG000|Overall Study|Withdrawal by Subject|2|||
145341138|NCT02368314|524096689|FG001|Overall Study|Withdrawal by Subject|1|||
145341139|NCT02368314|524096688|FG000|Overall Study|Adverse Event|1|||
145341140|NCT02368314|524096689|FG001|Overall Study|Adverse Event|2|||
145341141|NCT00863772|524096690|FG000|Overall Study|Adverse Event|1|||
145341142|NCT00863772|524096691|FG001|Overall Study|Adverse Event|4|||
145341143|NCT00863772|524096692|FG002|Overall Study|Adverse Event|0|||
145341144|NCT00863772|524096690|FG000|Overall Study|Lack of Efficacy|4|||
145341145|NCT00863772|524096691|FG001|Overall Study|Lack of Efficacy|2|||
145341146|NCT00863772|524096692|FG002|Overall Study|Lack of Efficacy|4|||
145341147|NCT00863772|524096690|FG000|Overall Study|Lost to Follow-up|5|||
145341148|NCT00863772|524096691|FG001|Overall Study|Lost to Follow-up|1|||
145341149|NCT00863772|524096692|FG002|Overall Study|Lost to Follow-up|1|||
145341150|NCT00863772|524096690|FG000|Overall Study|Protocol Violation|2|||
145341151|NCT00863772|524096691|FG001|Overall Study|Protocol Violation|0|||
145341152|NCT00863772|524096692|FG002|Overall Study|Protocol Violation|2|||
145341153|NCT00863772|524096690|FG000|Overall Study|Withdrawal by Subject|4|||
145341154|NCT00863772|524096691|FG001|Overall Study|Withdrawal by Subject|7|||
145341155|NCT00863772|524096692|FG002|Overall Study|Withdrawal by Subject|5|||
145341156|NCT00863772|524096690|FG000|Overall Study|Study terminated by sponsor|44|||
145341157|NCT00863772|524096691|FG001|Overall Study|Study terminated by sponsor|45|||
145341158|NCT00863772|524096692|FG002|Overall Study|Study terminated by sponsor|36|||
145341159|NCT00863772|524096690|FG000|Overall Study|Entered extension study|6|||
145341160|NCT00863772|524096691|FG001|Overall Study|Entered extension study|4|||
145341161|NCT00863772|524096692|FG002|Overall Study|Entered extension study|9|||
145341162|NCT00863772|524096690|FG000|Overall Study|Other|1|||
145341163|NCT00863772|524096691|FG001|Overall Study|Other|2|||
145622782|NCT01066156|525130178|FG000|Overall Study|ineligible|2|||
145622783|NCT01066156|525130178|FG000|Overall Study|Lost to Follow-up|7|||
145622784|NCT01066156|525130178|FG000|Overall Study|Withdrawal by Subject|1|||
145622785|NCT00570661|525130179|FG000|Overall Study|Disease worsening|5|||
145622786|NCT00570661|525130179|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
145622787|NCT00570661|525130179|FG000|Overall Study|Adverse Event|1|||
145622788|NCT01734382|525130183|FG000|Part 1|Adverse Event|2|||
145622789|NCT01734382|525130184|FG001|Part 1|Adverse Event|0|||
145622790|NCT01734382|525130185|FG002|Part 1|Adverse Event|0|||
145341164|NCT00863772|524096692|FG002|Overall Study|Other|4|||
145341165|NCT00863772|524096690|FG000|Overall Study|Randomized but not Treated|1|||
145622791|NCT01734382|525130183|FG000|Part 2|Adverse Event|0|||
145341166|NCT00863772|524096691|FG001|Overall Study|Randomized but not Treated|0|||
145622792|NCT01734382|525130184|FG001|Part 2|Adverse Event|0|||
145341167|NCT00863772|524096692|FG002|Overall Study|Randomized but not Treated|0|||
145341168|NCT00086281|524096693|FG000|Phase 1|Adverse Event|0|||
145341169|NCT00086281|524096694|FG001|Phase 1|Adverse Event|0|||
145341170|NCT00086281|524096695|FG002|Phase 1|Adverse Event|0|||
145341171|NCT00086281|524096696|FG003|Phase 1|Adverse Event|0|||
145341172|NCT00086281|524096697|FG004|Phase 1|Adverse Event|0|||
145341173|NCT00086281|524096698|FG005|Phase 1|Adverse Event|0|||
145341174|NCT00086281|524096699|FG006|Phase 1|Adverse Event|0|||
145341175|NCT00086281|524096700|FG007|Phase 1|Adverse Event|0|||
145574740|NCT00079274|524960072|FG006|Overall Study|Alternate Treatment|0|||
145574741|NCT00079274|524960066|FG000|Overall Study|Other Medical Problems|6|||
145574742|NCT00079274|524960067|FG001|Overall Study|Other Medical Problems|1|||
145574743|NCT00079274|524960068|FG002|Overall Study|Other Medical Problems|0|||
145574744|NCT00079274|524960069|FG003|Overall Study|Other Medical Problems|7|||
145574745|NCT00079274|524960070|FG004|Overall Study|Other Medical Problems|0|||
145574746|NCT00079274|524960071|FG005|Overall Study|Other Medical Problems|0|||
145574747|NCT00079274|524960072|FG006|Overall Study|Other Medical Problems|0|||
145574748|NCT00079274|524960066|FG000|Overall Study|Death|4|||
145574749|NCT00079274|524960067|FG001|Overall Study|Death|0|||
145574750|NCT00079274|524960068|FG002|Overall Study|Death|1|||
145574751|NCT00079274|524960069|FG003|Overall Study|Death|15|||
145574752|NCT00079274|524960070|FG004|Overall Study|Death|0|||
145574753|NCT00079274|524960071|FG005|Overall Study|Death|0|||
145574754|NCT00079274|524960072|FG006|Overall Study|Death|0|||
145574755|NCT00079274|524960066|FG000|Overall Study|Cytogenetic resistance|0|||
145574756|NCT00079274|524960067|FG001|Overall Study|Cytogenetic resistance|0|||
145574757|NCT00079274|524960068|FG002|Overall Study|Cytogenetic resistance|0|||
145574758|NCT00079274|524960069|FG003|Overall Study|Cytogenetic resistance|2|||
145622793|NCT01734382|525130185|FG002|Part 2|Adverse Event|1|||
145341176|NCT00086281|524096701|FG008|Phase 1|Adverse Event|0|||
145341177|NCT00086281|524096702|FG009|Phase 1|Adverse Event|1|||
145341178|NCT00086281|524096703|FG010|Phase 1|Adverse Event|2|||
145341179|NCT00086281|524096704|FG011|Phase 1|Adverse Event|1|||
145341180|NCT00086281|524096705|FG012|Phase 1|Adverse Event|1|||
145341181|NCT00086281|524096706|FG013|Phase 1|Adverse Event|1|||
145341182|NCT00086281|524096707|FG014|Phase 1|Adverse Event|2|||
145341183|NCT00086281|524096693|FG000|Phase 1|Protocol Violation|0|||
145341184|NCT00086281|524096694|FG001|Phase 1|Protocol Violation|0|||
145341185|NCT00086281|524096695|FG002|Phase 1|Protocol Violation|0|||
145341186|NCT00086281|524096696|FG003|Phase 1|Protocol Violation|0|||
145341187|NCT00086281|524096697|FG004|Phase 1|Protocol Violation|0|||
145341188|NCT00086281|524096698|FG005|Phase 1|Protocol Violation|0|||
145341189|NCT00086281|524096699|FG006|Phase 1|Protocol Violation|0|||
145341190|NCT00086281|524096700|FG007|Phase 1|Protocol Violation|0|||
145341191|NCT00086281|524096701|FG008|Phase 1|Protocol Violation|0|||
145341192|NCT00086281|524096702|FG009|Phase 1|Protocol Violation|0|||
145341193|NCT00086281|524096703|FG010|Phase 1|Protocol Violation|1|||
145341194|NCT00086281|524096704|FG011|Phase 1|Protocol Violation|0|||
145341195|NCT00086281|524096705|FG012|Phase 1|Protocol Violation|0|||
145341196|NCT00086281|524096706|FG013|Phase 1|Protocol Violation|0|||
145341197|NCT00086281|524096707|FG014|Phase 1|Protocol Violation|0|||
145341198|NCT00086281|524096693|FG000|Phase 1|Serious Adverse Event|0|||
145341199|NCT00086281|524096694|FG001|Phase 1|Serious Adverse Event|0|||
145341200|NCT00086281|524096695|FG002|Phase 1|Serious Adverse Event|0|||
145341201|NCT00086281|524096696|FG003|Phase 1|Serious Adverse Event|0|||
145341202|NCT00086281|524096697|FG004|Phase 1|Serious Adverse Event|0|||
145341203|NCT00086281|524096698|FG005|Phase 1|Serious Adverse Event|0|||
145341204|NCT00086281|524096699|FG006|Phase 1|Serious Adverse Event|0|||
145341205|NCT00086281|524096700|FG007|Phase 1|Serious Adverse Event|0|||
145341206|NCT00086281|524096701|FG008|Phase 1|Serious Adverse Event|0|||
145341207|NCT00086281|524096702|FG009|Phase 1|Serious Adverse Event|0|||
145341208|NCT00086281|524096703|FG010|Phase 1|Serious Adverse Event|0|||
145341209|NCT00086281|524096704|FG011|Phase 1|Serious Adverse Event|0|||
145341210|NCT00086281|524096705|FG012|Phase 1|Serious Adverse Event|0|||
145341211|NCT00086281|524096706|FG013|Phase 1|Serious Adverse Event|0|||
145341212|NCT00086281|524096707|FG014|Phase 1|Serious Adverse Event|1|||
145341213|NCT00086281|524096693|FG000|Phase 2|Adverse Event|0|||
145341214|NCT00086281|524096694|FG001|Phase 2|Adverse Event|0|||
145341215|NCT00086281|524096695|FG002|Phase 2|Adverse Event|0|||
145341216|NCT00086281|524096696|FG003|Phase 2|Adverse Event|0|||
145341217|NCT00086281|524096697|FG004|Phase 2|Adverse Event|0|||
145341218|NCT00086281|524096698|FG005|Phase 2|Adverse Event|0|||
145341219|NCT00086281|524096699|FG006|Phase 2|Adverse Event|0|||
145341220|NCT00086281|524096700|FG007|Phase 2|Adverse Event|0|||
145574759|NCT00079274|524960070|FG004|Overall Study|Cytogenetic resistance|0|||
145574760|NCT00079274|524960071|FG005|Overall Study|Cytogenetic resistance|0|||
145574761|NCT00079274|524960072|FG006|Overall Study|Cytogenetic resistance|0|||
145574762|NCT00079274|524960066|FG000|Overall Study|Other|43|||
145574763|NCT00079274|524960067|FG001|Overall Study|Other|7|||
145574764|NCT00079274|524960068|FG002|Overall Study|Other|5|||
145574765|NCT00079274|524960069|FG003|Overall Study|Other|55|||
145574766|NCT00079274|524960070|FG004|Overall Study|Other|1|||
145574767|NCT00079274|524960071|FG005|Overall Study|Other|2|||
145341221|NCT00086281|524096701|FG008|Phase 2|Adverse Event|0|||
145341222|NCT00086281|524096702|FG009|Phase 2|Adverse Event|0|||
145341223|NCT00086281|524096703|FG010|Phase 2|Adverse Event|0|||
145574768|NCT00079274|524960072|FG006|Overall Study|Other|0|||
145574769|NCT00767676|524960073|FG000|Overall Study|Investigator error|54|||
145574770|NCT00617240|524960076|FG000|Overall Study|Lack of Efficacy|1|||
145341224|NCT00086281|524096704|FG011|Phase 2|Adverse Event|0|||
145341225|NCT00086281|524096705|FG012|Phase 2|Adverse Event|1|||
145341226|NCT00086281|524096706|FG013|Phase 2|Adverse Event|1|||
145341227|NCT00086281|524096707|FG014|Phase 2|Adverse Event|0|||
145341228|NCT03456453|524096708|FG000|Overall Study|Withdrawal by Subject|2|||
145574771|NCT00617240|524960077|FG001|Overall Study|Lack of Efficacy|0|||
145574772|NCT01611259|524960078|FG000|Overall Study|Physician Decision|1|||
145574773|NCT01611259|524960078|FG000|Overall Study|Lack of Efficacy|2|||
145574774|NCT01611259|524960078|FG000|Overall Study|Adverse Event|4|||
145341229|NCT03456453|524096709|FG001|Overall Study|Withdrawal by Subject|0|||
145341230|NCT03456453|524096708|FG000|Overall Study|Not released to community|1|||
145341231|NCT03456453|524096709|FG001|Overall Study|Not released to community|5|||
145341232|NCT03456453|524096708|FG000|Overall Study|Lost to Follow-up|0|||
145341233|NCT03456453|524096709|FG001|Overall Study|Lost to Follow-up|2|||
145341234|NCT02785952|524096710|FG000|Overall Study|Adverse Event|31|||
145341235|NCT02785952|524096711|FG001|Overall Study|Adverse Event|19|||
145574775|NCT01611259|524960078|FG000|Overall Study|Withdrawal by Subject|7|||
145574776|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
145574777|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
145574778|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
145574779|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
145574780|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
145574781|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
145574782|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
145574783|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
145574784|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
145574785|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
145574786|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
145574787|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
145574788|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
145574789|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
145574790|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
145574791|NCT00280566|524960082|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
145574792|NCT00280566|524960083|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
145341236|NCT02785952|524096710|FG000|Overall Study|Refusal unrelated to adverse events|10|||
145341237|NCT02785952|524096711|FG001|Overall Study|Refusal unrelated to adverse events|5|||
145341238|NCT02785952|524096710|FG000|Overall Study|Disease progression/relapse|61|||
145341239|NCT02785952|524096711|FG001|Overall Study|Disease progression/relapse|89|||
145341240|NCT02785952|524096710|FG000|Overall Study|Death|11|||
145341241|NCT02785952|524096711|FG001|Overall Study|Death|7|||
145341242|NCT02785952|524096710|FG000|Overall Study|Other- not protocol specified|6|||
145341243|NCT02785952|524096711|FG001|Overall Study|Other- not protocol specified|4|||
145341244|NCT02785952|524096710|FG000|Overall Study|On protocol treatment|6|||
145341245|NCT02785952|524096711|FG001|Overall Study|On protocol treatment|3|||
145341246|NCT00896480|524096712|FG000|Overall Study|Disease progression/recurrence|21|||
145413753|NCT05950906|524368392|FG013|Overall Study|Physician Decision|0|||
145413754|NCT04868682|524368393|FG000|Post-treatment|Lost to Follow-up|1|||
145413755|NCT04868682|524368394|FG001|Post-treatment|Lost to Follow-up|1|||
145413756|NCT04868682|524368393|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
145413757|NCT04868682|524368394|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
145413758|NCT04868682|524368393|FG000|Six-month Assessment|Lost to Follow-up|1|||
145413759|NCT04868682|524368394|FG001|Six-month Assessment|Lost to Follow-up|0|||
145413760|NCT04868682|524368393|FG000|Six-month Assessment|Death|1|||
145413761|NCT04868682|524368394|FG001|Six-month Assessment|Death|0|||
145413762|NCT04868682|524368393|FG000|Six-month Assessment|Refused|0|||
145413763|NCT04868682|524368394|FG001|Six-month Assessment|Refused|1|||
145341247|NCT00205803|524096716|FG000|Infant Series|Lost to Follow-up|10|||
145413764|NCT04868682|524368393|FG000|12-month Assessment|Lost to Follow-up|2|||
145413765|NCT04868682|524368394|FG001|12-month Assessment|Lost to Follow-up|1|||
145574793|NCT00280566|524960084|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
145574794|NCT00280566|524960082|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
145574795|NCT00280566|524960083|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
145574796|NCT00280566|524960084|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
145574797|NCT00280566|524960082|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
145574798|NCT00280566|524960083|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
145574799|NCT00280566|524960084|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
145574800|NCT00280566|524960082|FG000|Period 2 Double Blind|Adverse Event|0|||
145574801|NCT00280566|524960083|FG001|Period 2 Double Blind|Adverse Event|11|||
145341248|NCT00205803|524096717|FG001|Infant Series|Lost to Follow-up|4|||
145341249|NCT00205803|524096716|FG000|Infant Series|Withdrawal by Subject|2|||
145341250|NCT00205803|524096717|FG001|Infant Series|Withdrawal by Subject|5|||
145341251|NCT00205803|524096716|FG000|Infant Series|Physician Decision|3|||
145341252|NCT00205803|524096717|FG001|Infant Series|Physician Decision|1|||
145341253|NCT00205803|524096716|FG000|Infant Series|Protocol Violation|1|||
145341254|NCT00205803|524096717|FG001|Infant Series|Protocol Violation|0|||
145341255|NCT00205803|524096716|FG000|Infant Series|Lost Kaiser coverage|0|||
145341256|NCT00205803|524096717|FG001|Infant Series|Lost Kaiser coverage|1|||
145341257|NCT00205803|524096716|FG000|Infant Series|Non-compliant|1|||
145341258|NCT00205803|524096717|FG001|Infant Series|Non-compliant|0|||
145341259|NCT00205803|524096716|FG000|Infant Series|Sponsor request|1|||
145341260|NCT00205803|524096717|FG001|Infant Series|Sponsor request|0|||
145341261|NCT00205803|524096716|FG000|After Infant Series|Adverse Event|1|||
145341262|NCT00205803|524096717|FG001|After Infant Series|Adverse Event|1|||
145341263|NCT00205803|524096716|FG000|After Infant Series|Protocol Violation|1|||
145341264|NCT00205803|524096717|FG001|After Infant Series|Protocol Violation|1|||
145341265|NCT00205803|524096716|FG000|After Infant Series|Lost to Follow-up|2|||
145341266|NCT00205803|524096717|FG001|After Infant Series|Lost to Follow-up|1|||
145341267|NCT00205803|524096716|FG000|After Infant Series|Physician Decision|3|||
145341268|NCT00205803|524096717|FG001|After Infant Series|Physician Decision|2|||
145341269|NCT00205803|524096716|FG000|After Infant Series|Withdrawal by Subject|1|||
145341270|NCT00205803|524096717|FG001|After Infant Series|Withdrawal by Subject|4|||
145341271|NCT00205803|524096716|FG000|After Infant Series|Other|10|||
145341272|NCT00205803|524096717|FG001|After Infant Series|Other|4|||
145341273|NCT00205803|524096716|FG000|Toddler Dose|Lost to Follow-up|2|||
145341274|NCT00205803|524096717|FG001|Toddler Dose|Lost to Follow-up|3|||
145341275|NCT01102374|524096719|FG000|Overall Study|Death|9|||
145341276|NCT01102374|524096720|FG001|Overall Study|Death|13|||
145341277|NCT01102374|524096719|FG000|Overall Study|Lost to Follow-up|7|||
145341278|NCT01102374|524096720|FG001|Overall Study|Lost to Follow-up|6|||
145341279|NCT01104792|524096721|FG000|Overall Study|Adverse Event|77|||
145341280|NCT01104792|524096721|FG000|Overall Study|Insufficient Therapeutic Response|22|||
145341281|NCT01104792|524096721|FG000|Overall Study|Protocol Violation|45|||
145341282|NCT01104792|524096721|FG000|Overall Study|Withdrawal of Consent|179|||
145341283|NCT01104792|524096721|FG000|Overall Study|Lost to Follow-up|43|||
145341284|NCT01104792|524096721|FG000|Overall Study|Reasons Not Specified|27|||
145341285|NCT01104792|524096721|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
145341286|NCT00658021|524096723|FG000|28-Week Treatment Period|Adverse Event|3|||
145341287|NCT00658021|524096724|FG001|28-Week Treatment Period|Adverse Event|1|||
145341288|NCT00658021|524096725|FG002|28-Week Treatment Period|Adverse Event|0|||
145341289|NCT00658021|524096723|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
145341290|NCT00658021|524096724|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
145341291|NCT00658021|524096725|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
145341292|NCT00658021|524096723|FG000|28-Week Treatment Period|Protocol Violation|0|||
145341293|NCT00658021|524096724|FG001|28-Week Treatment Period|Protocol Violation|2|||
145341294|NCT00658021|524096725|FG002|28-Week Treatment Period|Protocol Violation|1|||
145341295|NCT00658021|524096723|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
145341296|NCT00658021|524096724|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
145341297|NCT00658021|524096725|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
145341298|NCT00658021|524096723|FG000|28-Week Treatment Period|Physician Decision|1|||
145341299|NCT00658021|524096724|FG001|28-Week Treatment Period|Physician Decision|2|||
145341300|NCT00658021|524096725|FG002|28-Week Treatment Period|Physician Decision|1|||
145341301|NCT00658021|524096723|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145341302|NCT00658021|524096724|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145341303|NCT00658021|524096725|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
145341304|NCT00658021|524096723|FG000|28-Week Treatment Period|Loss of glucose control|1|||
145341305|NCT00658021|524096724|FG001|28-Week Treatment Period|Loss of glucose control|1|||
145341306|NCT00658021|524096725|FG002|28-Week Treatment Period|Loss of glucose control|10|||
145341307|NCT00658021|524096723|FG000|28-Week Treatment Period|Other|2|||
145341308|NCT00658021|524096724|FG001|28-Week Treatment Period|Other|3|||
145341309|NCT00658021|524096725|FG002|28-Week Treatment Period|Other|1|||
145341310|NCT00658021|524096723|FG000|28-Week Treatment Period|Did not receive treatment|2|||
145341311|NCT00658021|524096724|FG001|28-Week Treatment Period|Did not receive treatment|0|||
145341312|NCT00658021|524096725|FG002|28-Week Treatment Period|Did not receive treatment|0|||
145341313|NCT00658021|524096723|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
145341314|NCT00658021|524096724|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
145341315|NCT00658021|524096725|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
145341316|NCT00658021|524096723|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
145622794|NCT01734382|525130183|FG000|Part 2|Lack of Efficacy|0|||
145341317|NCT00658021|524096724|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
145341318|NCT00658021|524096725|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
145341319|NCT02551666|524096727|FG000|Overall Study|Withdrawal by Subject|1|||
145341320|NCT02551666|524096728|FG001|Overall Study|Withdrawal by Subject|3|||
145341321|NCT04051619|524096729|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
145341322|NCT04051619|524096730|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
145341323|NCT04051619|524096729|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
145341324|NCT04051619|524096730|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
145341325|NCT03408639|524098379|FG000|Overall Study|Death|5|||
145341326|NCT03408639|524098380|FG001|Overall Study|Death|5|||
145341327|NCT03408639|524098379|FG000|Overall Study|Lost to Follow-up|1|||
145341328|NCT03408639|524098380|FG001|Overall Study|Lost to Follow-up|4|||
145341329|NCT03408639|524098379|FG000|Overall Study|Withdrawal by Subject|2|||
145341330|NCT03408639|524098380|FG001|Overall Study|Withdrawal by Subject|7|||
145341331|NCT03408639|524098379|FG000|Overall Study|Physician Decision|3|||
145341332|NCT03408639|524098380|FG001|Overall Study|Physician Decision|6|||
145341333|NCT04998851|524098381|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
145341334|NCT04998851|524098382|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
145341335|NCT04998851|524098381|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
145341336|NCT04998851|524098382|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
145341337|NCT00070499|524098383|FG000|Overall Study|Adverse Event|6|||
145341338|NCT00070499|524098384|FG001|Overall Study|Adverse Event|6|||
145341339|NCT00070499|524098385|FG002|Overall Study|Adverse Event|19|||
145341340|NCT00070499|524098386|FG003|Overall Study|Adverse Event|15|||
145341341|NCT00070499|524098383|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
145341342|NCT00070499|524098384|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
145341343|NCT00070499|524098385|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
145341344|NCT00070499|524098386|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
145341345|NCT00070499|524098383|FG000|Overall Study|Progression/relapse|4|||
145341346|NCT00070499|524098384|FG001|Overall Study|Progression/relapse|2|||
145341347|NCT00070499|524098385|FG002|Overall Study|Progression/relapse|1|||
145341348|NCT00070499|524098386|FG003|Overall Study|Progression/relapse|4|||
145341349|NCT00070499|524098383|FG000|Overall Study|Death|1|||
145341350|NCT00070499|524098384|FG001|Overall Study|Death|1|||
145341351|NCT00070499|524098385|FG002|Overall Study|Death|1|||
145341352|NCT00070499|524098386|FG003|Overall Study|Death|2|||
145341353|NCT00070499|524098383|FG000|Overall Study|Other - not protocol specified|7|||
145341354|NCT00070499|524098384|FG001|Overall Study|Other - not protocol specified|3|||
145341355|NCT00070499|524098385|FG002|Overall Study|Other - not protocol specified|12|||
145341356|NCT00070499|524098386|FG003|Overall Study|Other - not protocol specified|20|||
145341357|NCT00070499|524098383|FG000|Overall Study|Still on protocol treatment|10|||
145341358|NCT00070499|524098384|FG001|Overall Study|Still on protocol treatment|4|||
145341359|NCT00070499|524098385|FG002|Overall Study|Still on protocol treatment|79|||
145341360|NCT00070499|524098386|FG003|Overall Study|Still on protocol treatment|57|||
145341361|NCT00070499|524098383|FG000|Overall Study|Did not start treatment|1|||
145341362|NCT00070499|524098384|FG001|Overall Study|Did not start treatment|0|||
145341363|NCT00070499|524098385|FG002|Overall Study|Did not start treatment|0|||
145341364|NCT00070499|524098386|FG003|Overall Study|Did not start treatment|2|||
145341365|NCT00070499|524098383|FG000|Overall Study|Not eligible|2|||
145341366|NCT00070499|524098384|FG001|Overall Study|Not eligible|5|||
145341367|NCT00070499|524098385|FG002|Overall Study|Not eligible|3|||
145413766|NCT04868682|524368393|FG000|12-month Assessment|Death|0|||
145413767|NCT04868682|524368394|FG001|12-month Assessment|Death|1|||
145413768|NCT02541903|524368395|FG000|Overall Study|Death|1|||
145413769|NCT03880565|524368396|FG000|Overall Study|Withdrawal by Subject|1|||
145413770|NCT03880565|524368397|FG001|Overall Study|Withdrawal by Subject|0|||
145413771|NCT02836769|524368398|FG000|Overall Study|Lost to Follow-up|10|||
145413772|NCT02836769|524368398|FG000|Overall Study|Medical withdrawal|2|||
145413773|NCT02836769|524368398|FG000|Overall Study|Withdrawal by Subject|3|||
145413774|NCT03142750|524368404|FG000|Overall Study|Lost to Follow-up|4|||
145413775|NCT03142750|524368405|FG001|Overall Study|Lost to Follow-up|1|||
145413776|NCT02942407|524368406|FG000|Overall Study|Lost to Follow-up|3|||
145413777|NCT02942407|524368407|FG001|Overall Study|Lost to Follow-up|2|||
145341368|NCT00070499|524098386|FG003|Overall Study|Not eligible|2|||
145341369|NCT01924754|524098387|FG000|Overall Study|Lost to Follow-up|1|||
145341370|NCT01924754|524098388|FG001|Overall Study|Lost to Follow-up|2|||
145341371|NCT01924754|524098389|FG002|Overall Study|Lost to Follow-up|1|||
145341372|NCT01924754|524098387|FG000|Overall Study|Pregnancy|0|||
145341373|NCT01924754|524098388|FG001|Overall Study|Pregnancy|1|||
145341374|NCT01924754|524098389|FG002|Overall Study|Pregnancy|2|||
145341375|NCT02925403|524098395|FG000|Overall Study|Lost to Follow-up|0|||
145341376|NCT02925403|524098396|FG001|Overall Study|Lost to Follow-up|1|||
145413778|NCT02942407|524368406|FG000|Overall Study|Withdrawal by Subject|7|||
145622795|NCT01734382|525130184|FG001|Part 2|Lack of Efficacy|1|||
145341377|NCT02135614|524098405|FG000|Overall Study|Randomized but Not Treated|2|||
145341378|NCT02135614|524098406|FG001|Overall Study|Randomized but Not Treated|1|||
145341379|NCT02135614|524098405|FG000|Overall Study|Adverse Event|0|||
145413779|NCT02942407|524368407|FG001|Overall Study|Withdrawal by Subject|9|||
145413780|NCT02942407|524368406|FG000|Overall Study|Death|16|||
145413781|NCT02942407|524368407|FG001|Overall Study|Death|13|||
145341380|NCT02135614|524098406|FG001|Overall Study|Adverse Event|1|||
145341381|NCT02135614|524098405|FG000|Overall Study|Death|1|||
145341382|NCT02135614|524098406|FG001|Overall Study|Death|0|||
145341383|NCT02135614|524098405|FG000|Overall Study|Investigator's Discretion|0|||
145341384|NCT02135614|524098406|FG001|Overall Study|Investigator's Discretion|1|||
145341385|NCT02135614|524098405|FG000|Overall Study|Withdrew Consent|2|||
145341386|NCT02135614|524098406|FG001|Overall Study|Withdrew Consent|2|||
145341387|NCT02135614|524098405|FG000|Overall Study|Lost to Follow-up|3|||
145341388|NCT02135614|524098406|FG001|Overall Study|Lost to Follow-up|0|||
145341389|NCT03743415|524098414|FG000|Overall Study|Death|5|||
145341390|NCT03743415|524098415|FG001|Overall Study|Death|3|||
145341391|NCT03743415|524098416|FG002|Overall Study|Death|1|||
145341392|NCT03743415|524098417|FG003|Overall Study|Death|4|||
145341393|NCT03743415|524098418|FG004|Overall Study|Death|0|||
145341394|NCT03743415|524098419|FG005|Overall Study|Death|0|||
145341395|NCT03743415|524098420|FG006|Overall Study|Death|0|||
145341396|NCT03743415|524098421|FG007|Overall Study|Death|0|||
145341397|NCT03743415|524098422|FG008|Overall Study|Death|1|||
145341398|NCT03743415|524098423|FG009|Overall Study|Death|0|||
145341399|NCT03743415|524098414|FG000|Overall Study|Withdrawal by Subject|1|||
145341400|NCT03743415|524098415|FG001|Overall Study|Withdrawal by Subject|0|||
145341401|NCT03743415|524098416|FG002|Overall Study|Withdrawal by Subject|4|||
145341402|NCT03743415|524098417|FG003|Overall Study|Withdrawal by Subject|5|||
145341403|NCT03743415|524098418|FG004|Overall Study|Withdrawal by Subject|5|||
145341404|NCT03743415|524098419|FG005|Overall Study|Withdrawal by Subject|2|||
145341405|NCT03743415|524098420|FG006|Overall Study|Withdrawal by Subject|2|||
145341406|NCT03743415|524098421|FG007|Overall Study|Withdrawal by Subject|5|||
145341407|NCT03743415|524098422|FG008|Overall Study|Withdrawal by Subject|9|||
145341408|NCT03743415|524098423|FG009|Overall Study|Withdrawal by Subject|10|||
145341409|NCT03743415|524098414|FG000|Overall Study|Lost to Follow-up|2|||
145341410|NCT03743415|524098415|FG001|Overall Study|Lost to Follow-up|0|||
145341411|NCT03743415|524098416|FG002|Overall Study|Lost to Follow-up|2|||
145341412|NCT03743415|524098417|FG003|Overall Study|Lost to Follow-up|1|||
145341413|NCT03743415|524098418|FG004|Overall Study|Lost to Follow-up|1|||
145341414|NCT03743415|524098419|FG005|Overall Study|Lost to Follow-up|0|||
145341415|NCT03743415|524098420|FG006|Overall Study|Lost to Follow-up|1|||
145341416|NCT03743415|524098421|FG007|Overall Study|Lost to Follow-up|4|||
145341417|NCT03743415|524098422|FG008|Overall Study|Lost to Follow-up|13|||
145341418|NCT03743415|524098423|FG009|Overall Study|Lost to Follow-up|13|||
145341419|NCT02679235|524098424|FG000|Overall Study|Withdrawal by Subject|3|||
145341420|NCT02679235|524098424|FG000|Overall Study|Adverse Event|1|||
145341421|NCT00094861|524098425|FG000|Overall Study|Adverse Event|5|||
145341422|NCT00094861|524098426|FG001|Overall Study|Adverse Event|2|||
145341423|NCT00094861|524098425|FG000|Overall Study|Withdrawal by Subject|5|||
145341424|NCT00094861|524098426|FG001|Overall Study|Withdrawal by Subject|3|||
145341425|NCT00094861|524098425|FG000|Overall Study|Physician Decision|1|||
145341426|NCT00094861|524098426|FG001|Overall Study|Physician Decision|1|||
145341427|NCT00094861|524098425|FG000|Overall Study|Lost to Follow-up|0|||
145341428|NCT00094861|524098426|FG001|Overall Study|Lost to Follow-up|1|||
145341429|NCT00094861|524098425|FG000|Overall Study|Death|4|||
145341430|NCT00094861|524098426|FG001|Overall Study|Death|2|||
145341431|NCT00094861|524098425|FG000|Overall Study|Other|3|||
145622796|NCT01734382|525130185|FG002|Part 2|Lack of Efficacy|1|||
145341432|NCT00094861|524098426|FG001|Overall Study|Other|0|||
145341433|NCT02648932|524098430|FG000|Overall Study|No transplant|3|||
145341434|NCT02648932|524098431|FG001|Overall Study|No transplant|1|||
145341435|NCT01994850|524098433|FG000|Overall Study|Physician Decision|1|||
145341436|NCT01994850|524098433|FG000|Overall Study|Withdrawal by Subject|1|||
145341437|NCT00182325|524098437|FG000|Overall Study|Lost to Follow-up|7|||
145341438|NCT00182325|524098438|FG001|Overall Study|Lost to Follow-up|7|||
145341439|NCT00182325|524098437|FG000|Overall Study|Miscarriage|5|||
145341440|NCT00182325|524098438|FG001|Overall Study|Miscarriage|3|||
145341441|NCT00182325|524098437|FG000|Overall Study|Did not complete survey|22|||
145341442|NCT00182325|524098438|FG001|Overall Study|Did not complete survey|43|||
145341443|NCT01420965|524098441|FG000|Overall Study|Withdrawal by Subject|1|||
145341444|NCT01420965|524098442|FG001|Overall Study|Withdrawal by Subject|0|||
145341445|NCT01420965|524098443|FG002|Overall Study|Withdrawal by Subject|0|||
145341446|NCT01420965|524098441|FG000|Overall Study|Adverse Event|0|||
145341447|NCT01420965|524098442|FG001|Overall Study|Adverse Event|1|||
145341448|NCT01420965|524098443|FG002|Overall Study|Adverse Event|0|||
145341449|NCT01890434|524098480|FG000|Overall Study|Adverse Event|8|||
145341450|NCT01890434|524098480|FG000|Overall Study|PCI at external hospital|1|||
145341451|NCT01890434|524098480|FG000|Overall Study|Assessment discrepancy|1|||
145341452|NCT01890434|524098480|FG000|Overall Study|CRC didn't contact participant for FU|1|||
145341453|NCT01890434|524098480|FG000|Overall Study|Could not get whole set of images|1|||
145341454|NCT01890434|524098480|FG000|Overall Study|Decline to return for GSPECT|1|||
145341455|NCT01890434|524098480|FG000|Overall Study|GSPECT at rest was not done|1|||
145341456|NCT01890434|524098480|FG000|Overall Study|Participant didn't complete MRI|1|||
145341457|NCT01890434|524098480|FG000|Overall Study|Uncontactable by phone|1|||
145341458|NCT01890434|524098480|FG000|Overall Study|Moved out of position|1|||
145341459|NCT01890434|524098480|FG000|Overall Study|Unable to contact|1|||
145341460|NCT01890434|524098480|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
145341461|NCT03280381|524098481|FG000|Overall Study|Physician Decision|0|||
145341462|NCT03280381|524098482|FG001|Overall Study|Physician Decision|2|||
145341463|NCT02655666|524098485|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
145341464|NCT01267994|524098486|FG000|Overall Study|Adverse Event|2|||
145341465|NCT00895414|524098489|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
145341466|NCT00895414|524098490|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
145341467|NCT00895414|524098489|FG000|First Intervention (14 Days)|Physician Decision|0|||
145341468|NCT00895414|524098490|FG001|First Intervention (14 Days)|Physician Decision|1|||
145341469|NCT05199090|524098495|FG000|Overall Study|Adverse Event|1|||
145341470|NCT05199090|524098496|FG001|Overall Study|Adverse Event|4|||
145341471|NCT05199090|524098497|FG002|Overall Study|Adverse Event|0|||
145341472|NCT05199090|524098498|FG003|Overall Study|Adverse Event|0|||
145341473|NCT05199090|524098499|FG004|Overall Study|Adverse Event|0|||
145341474|NCT05199090|524098500|FG005|Overall Study|Adverse Event|0|||
145341475|NCT05199090|524098495|FG000|Overall Study|Lost to Follow-up|1|||
145341476|NCT05199090|524098496|FG001|Overall Study|Lost to Follow-up|0|||
145341477|NCT05199090|524098497|FG002|Overall Study|Lost to Follow-up|1|||
145341478|NCT05199090|524098498|FG003|Overall Study|Lost to Follow-up|4|||
145341479|NCT05199090|524098499|FG004|Overall Study|Lost to Follow-up|0|||
145341480|NCT05199090|524098500|FG005|Overall Study|Lost to Follow-up|5|||
145341481|NCT05199090|524098495|FG000|Overall Study|Physician Decision|0|||
145341482|NCT05199090|524098496|FG001|Overall Study|Physician Decision|0|||
145341483|NCT05199090|524098497|FG002|Overall Study|Physician Decision|0|||
145341484|NCT05199090|524098498|FG003|Overall Study|Physician Decision|0|||
145341485|NCT05199090|524098499|FG004|Overall Study|Physician Decision|0|||
145341486|NCT05199090|524098500|FG005|Overall Study|Physician Decision|1|||
145341487|NCT05199090|524098495|FG000|Overall Study|Study terminated by sponsor|0|||
145341488|NCT05199090|524098496|FG001|Overall Study|Study terminated by sponsor|6|||
145341489|NCT05199090|524098497|FG002|Overall Study|Study terminated by sponsor|0|||
145341490|NCT05199090|524098498|FG003|Overall Study|Study terminated by sponsor|0|||
145341491|NCT05199090|524098499|FG004|Overall Study|Study terminated by sponsor|0|||
145341492|NCT05199090|524098500|FG005|Overall Study|Study terminated by sponsor|5|||
145341493|NCT05199090|524098495|FG000|Overall Study|Subject decision|0|||
145341494|NCT05199090|524098496|FG001|Overall Study|Subject decision|4|||
145341495|NCT05199090|524098497|FG002|Overall Study|Subject decision|0|||
145341496|NCT05199090|524098498|FG003|Overall Study|Subject decision|2|||
145341497|NCT05199090|524098499|FG004|Overall Study|Subject decision|5|||
145341498|NCT05199090|524098500|FG005|Overall Study|Subject decision|2|||
145341499|NCT03489109|524098501|FG000|Overall Study|Lost to Follow-up|1|||
145341500|NCT03489109|524098502|FG001|Overall Study|Lost to Follow-up|2|||
145341501|NCT02181790|524098503|FG000|Overall Study|study terminated|2|||
145341502|NCT02181790|524098504|FG001|Overall Study|study terminated|0|||
145341503|NCT03276078|524098505|FG000|Overall Study|Adverse Event|1|||
145341504|NCT02552732|524098506|FG000|Overall Study|Lost to Follow-up|2|||
145341505|NCT02552732|524098506|FG000|Overall Study|Physician Decision|1|||
145341506|NCT02552732|524098506|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
145341507|NCT02552732|524098506|FG000|Overall Study|Withdrawal by Subject|6|||
145341508|NCT01275430|524098508|FG000|Overall Study|Adverse Event|1|||
145341509|NCT01275430|524098508|FG000|Overall Study|No Contrast Injection|6|||
145341510|NCT01275430|524098508|FG000|Overall Study|Device Malfunction|1|||
145341511|NCT01275430|524098508|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
145341512|NCT04988087|524098509|FG000|Overall Study|Adverse Event|4|||
145341513|NCT04988087|524098510|FG001|Overall Study|Adverse Event|0|||
145341514|NCT04988087|524098511|FG002|Overall Study|Adverse Event|0|||
145341515|NCT04988087|524098512|FG003|Overall Study|Adverse Event|0|||
145341516|NCT04988087|524098509|FG000|Overall Study|Withdrawal by Subject|1|||
145341517|NCT04988087|524098510|FG001|Overall Study|Withdrawal by Subject|1|||
145341518|NCT04988087|524098511|FG002|Overall Study|Withdrawal by Subject|0|||
145341519|NCT04988087|524098512|FG003|Overall Study|Withdrawal by Subject|0|||
145341520|NCT04988087|524098509|FG000|Overall Study|Technical problems|7|||
145341521|NCT04988087|524098510|FG001|Overall Study|Technical problems|9|||
145341522|NCT04988087|524098511|FG002|Overall Study|Technical problems|1|||
145341523|NCT04988087|524098512|FG003|Overall Study|Technical problems|2|||
145341524|NCT02752087|524098513|FG000|Washout|Physician Decision|1|||
145341525|NCT02752087|524098514|FG001|Washout|Physician Decision|0|||
145341526|NCT02458287|524098515|FG000|Overall Study|Adverse Event|0|||
145341527|NCT02458287|524098516|FG001|Overall Study|Adverse Event|0|||
145341528|NCT02458287|524098517|FG002|Overall Study|Adverse Event|0|||
145341529|NCT02458287|524098518|FG003|Overall Study|Adverse Event|1|||
145341530|NCT02458287|524098515|FG000|Overall Study|Lost to Follow-up|0|||
145341531|NCT02458287|524098516|FG001|Overall Study|Lost to Follow-up|1|||
145341532|NCT02458287|524098517|FG002|Overall Study|Lost to Follow-up|1|||
145341533|NCT02458287|524098518|FG003|Overall Study|Lost to Follow-up|0|||
145341534|NCT02458287|524098515|FG000|Overall Study|Protocol Violation|0|||
145341535|NCT02458287|524098516|FG001|Overall Study|Protocol Violation|1|||
145341536|NCT02458287|524098517|FG002|Overall Study|Protocol Violation|0|||
145341537|NCT02458287|524098518|FG003|Overall Study|Protocol Violation|0|||
145341538|NCT02458287|524098515|FG000|Overall Study|Withdrawal by Subject|0|||
145341539|NCT02458287|524098516|FG001|Overall Study|Withdrawal by Subject|2|||
145341540|NCT02458287|524098517|FG002|Overall Study|Withdrawal by Subject|2|||
145341541|NCT02458287|524098518|FG003|Overall Study|Withdrawal by Subject|1|||
145341542|NCT02458287|524098515|FG000|Overall Study|Relocated Out of State|0|||
145341543|NCT02458287|524098516|FG001|Overall Study|Relocated Out of State|0|||
145341544|NCT02458287|524098517|FG002|Overall Study|Relocated Out of State|0|||
145341545|NCT02458287|524098518|FG003|Overall Study|Relocated Out of State|1|||
145341546|NCT02613182|524098519|FG000|Overall Study|Death|6|||
145341547|NCT02613182|524098519|FG000|Overall Study|Physician Decision|1|||
145341548|NCT02613182|524098519|FG000|Overall Study|Study Terminated by Sponsor|21|||
145341549|NCT02613182|524098519|FG000|Overall Study|Withdrawal by Subject|6|||
145341550|NCT00843635|524098520|FG000|Overall Study|Adverse Event|2|||
145341551|NCT00843635|524098521|FG001|Overall Study|Adverse Event|2|||
145341552|NCT00843635|524098522|FG002|Overall Study|Adverse Event|0|||
145341553|NCT01547130|524098523|FG000|Overall Study|Lost to Follow-up|9|||
145341554|NCT01547130|524098524|FG001|Overall Study|Lost to Follow-up|5|||
145341555|NCT03968978|524098525|FG000|Overall Study|Adverse Event|1|||
145413782|NCT00933166|524368408|FG000|Overall Study|Lost to Follow-up|4|||
145574802|NCT00280566|524960084|FG002|Period 2 Double Blind|Adverse Event|15|||
145574803|NCT00280566|524960082|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
145574804|NCT00280566|524960083|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
145574805|NCT00280566|524960084|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
145574806|NCT00280566|524960082|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
145574807|NCT00280566|524960083|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
145574808|NCT00280566|524960084|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
145574809|NCT00280566|524960082|FG000|Period 2 Double Blind|miscellaneous|0|||
145574810|NCT00280566|524960083|FG001|Period 2 Double Blind|miscellaneous|10|||
145574811|NCT00280566|524960084|FG002|Period 2 Double Blind|miscellaneous|5|||
145574812|NCT01147653|524960085|FG000|Year 2|Withdrawal by Subject|2|||
145574813|NCT01147653|524960086|FG001|Year 2|Withdrawal by Subject|3|||
145574814|NCT00353366|524960087|FG000|Overall Study|Adverse Event|8|||
145574815|NCT00353366|524960087|FG000|Overall Study|Protocol Violation|12|||
145574816|NCT00353366|524960087|FG000|Overall Study|Withdrawal by Subject|12|||
145574817|NCT00353366|524960087|FG000|Overall Study|Lost to Follow-up|92|||
145574818|NCT00353366|524960087|FG000|Overall Study|Other|19|||
145574819|NCT00259857|524960088|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
145574820|NCT00259857|524960089|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
145574821|NCT00259857|524960088|FG000|24 Months Treatment|Lost to Follow-up|0|||
145574822|NCT00259857|524960089|FG001|24 Months Treatment|Lost to Follow-up|3|||
145574823|NCT02375672|524960099|FG000|Overall Study|remain on follow up|20|||
145574824|NCT00094653|524960102|FG000|Overall Study|Death|306|||
145574825|NCT00094653|524960103|FG001|Overall Study|Death|100|||
145574826|NCT00094653|524960104|FG002|Overall Study|Death|119|||
145574827|NCT00094653|524960102|FG000|Overall Study|Subject Withdrew Consent|10|||
145574828|NCT00094653|524960103|FG001|Overall Study|Subject Withdrew Consent|2|||
145574829|NCT00094653|524960104|FG002|Overall Study|Subject Withdrew Consent|3|||
145574830|NCT00094653|524960102|FG000|Overall Study|Other|2|||
145574831|NCT00094653|524960103|FG001|Overall Study|Other|2|||
145574832|NCT00094653|524960104|FG002|Overall Study|Other|2|||
145574833|NCT00094653|524960102|FG000|Overall Study|Lost to Follow-up|3|||
145574834|NCT00094653|524960103|FG001|Overall Study|Lost to Follow-up|2|||
145574835|NCT00094653|524960104|FG002|Overall Study|Lost to Follow-up|1|||
145574836|NCT00094653|524960102|FG000|Overall Study|Protocol Violation|0|||
145574837|NCT00094653|524960103|FG001|Overall Study|Protocol Violation|0|||
145574838|NCT00094653|524960104|FG002|Overall Study|Protocol Violation|1|||
145574839|NCT03921411|524960105|FG000|Overall Study|Withdrawal by Subject|1|||
145574840|NCT03921411|524960105|FG000|Overall Study|Protocol Deviation|2|||
145574841|NCT03921411|524960105|FG000|Overall Study|Enrolled, but never treated|2|||
145574842|NCT03120013|524960109|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145574843|NCT03120013|524960110|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145574844|NCT02098109|524960111|FG000|Overall Study|Protocol Violation|3|||
145574845|NCT02098109|524960112|FG001|Overall Study|Protocol Violation|0|||
145574846|NCT01541826|524960113|FG000|Overall Study|Lost to Follow-up|2|||
145574847|NCT01541826|524960114|FG001|Overall Study|Lost to Follow-up|3|||
145574848|NCT01541826|524960115|FG002|Overall Study|Lost to Follow-up|0|||
145574849|NCT01541826|524960113|FG000|Overall Study|Withdrawal by Subject|2|||
145574850|NCT01541826|524960114|FG001|Overall Study|Withdrawal by Subject|0|||
145574851|NCT01541826|524960115|FG002|Overall Study|Withdrawal by Subject|0|||
145574852|NCT01565291|524960116|FG000|Overall Study|Withdrawal by Subject|1|||
145574853|NCT01565291|524960117|FG001|Overall Study|Withdrawal by Subject|0|||
145574854|NCT02143843|524960118|FG000|Overall Study|Adverse Event|8|||
145574855|NCT02143843|524960118|FG000|Overall Study|Lack of Efficacy|2|||
145574856|NCT02143843|524960118|FG000|Overall Study|Withdrawal by Subject|2|||
145574857|NCT02702401|524960123|FG000|Overall Study|Death|242|||
145574858|NCT02702401|524960124|FG001|Overall Study|Death|125|||
145574859|NCT02702401|524960123|FG000|Overall Study|Withdrawal by Subject|15|||
145574860|NCT02702401|524960124|FG001|Overall Study|Withdrawal by Subject|5|||
145574861|NCT02702401|524960123|FG000|Overall Study|Sponsor Decision|19|||
145341556|NCT03968978|524098526|FG001|Overall Study|Adverse Event|0|||
145341557|NCT02714426|524098530|FG000|Overall Study|Withdrawal by Subject|2|||
145341558|NCT02714426|524098531|FG001|Overall Study|Withdrawal by Subject|2|||
145341559|NCT00025259|524098533|FG000|Overall Study|Death|1|||
145341560|NCT00025259|524098534|FG001|Overall Study|Death|3|||
145341561|NCT00025259|524098535|FG002|Overall Study|Death|0|||
145341562|NCT00025259|524098536|FG003|Overall Study|Death|3|||
145341563|NCT00025259|524098537|FG004|Overall Study|Death|0|||
145341564|NCT00025259|524098538|FG005|Overall Study|Death|1|||
145341565|NCT00025259|524098539|FG006|Overall Study|Death|2|||
145341566|NCT00025259|524098533|FG000|Overall Study|Lack of Efficacy|2|||
145341567|NCT00025259|524098534|FG001|Overall Study|Lack of Efficacy|46|||
145341568|NCT00025259|524098535|FG002|Overall Study|Lack of Efficacy|60|||
145341569|NCT00025259|524098536|FG003|Overall Study|Lack of Efficacy|78|||
145341570|NCT00025259|524098537|FG004|Overall Study|Lack of Efficacy|11|||
145341571|NCT00025259|524098538|FG005|Overall Study|Lack of Efficacy|30|||
145341572|NCT00025259|524098539|FG006|Overall Study|Lack of Efficacy|38|||
145341573|NCT00025259|524098533|FG000|Overall Study|Lost to Follow-up|2|||
145341574|NCT00025259|524098534|FG001|Overall Study|Lost to Follow-up|9|||
145341575|NCT00025259|524098535|FG002|Overall Study|Lost to Follow-up|13|||
145341576|NCT00025259|524098536|FG003|Overall Study|Lost to Follow-up|13|||
145341577|NCT00025259|524098537|FG004|Overall Study|Lost to Follow-up|1|||
145341578|NCT00025259|524098538|FG005|Overall Study|Lost to Follow-up|3|||
145341579|NCT00025259|524098539|FG006|Overall Study|Lost to Follow-up|1|||
145341580|NCT00025259|524098533|FG000|Overall Study|Physician Decision|12|||
145341581|NCT00025259|524098534|FG001|Overall Study|Physician Decision|1|||
145341582|NCT00025259|524098535|FG002|Overall Study|Physician Decision|0|||
145341583|NCT00025259|524098536|FG003|Overall Study|Physician Decision|5|||
145341584|NCT00025259|524098537|FG004|Overall Study|Physician Decision|4|||
145341585|NCT00025259|524098538|FG005|Overall Study|Physician Decision|2|||
145341586|NCT00025259|524098539|FG006|Overall Study|Physician Decision|1|||
145341587|NCT00025259|524098533|FG000|Overall Study|Protocol Violation|3|||
145341588|NCT00025259|524098534|FG001|Overall Study|Protocol Violation|2|||
145341589|NCT00025259|524098535|FG002|Overall Study|Protocol Violation|2|||
145341590|NCT00025259|524098536|FG003|Overall Study|Protocol Violation|1|||
145341591|NCT00025259|524098537|FG004|Overall Study|Protocol Violation|2|||
145341592|NCT00025259|524098538|FG005|Overall Study|Protocol Violation|1|||
145341593|NCT00025259|524098539|FG006|Overall Study|Protocol Violation|3|||
145341594|NCT00025259|524098533|FG000|Overall Study|Withdrawal by Subject|9|||
145341595|NCT00025259|524098534|FG001|Overall Study|Withdrawal by Subject|27|||
145341596|NCT00025259|524098535|FG002|Overall Study|Withdrawal by Subject|6|||
145341597|NCT00025259|524098536|FG003|Overall Study|Withdrawal by Subject|14|||
145341598|NCT00025259|524098537|FG004|Overall Study|Withdrawal by Subject|11|||
145341599|NCT00025259|524098538|FG005|Overall Study|Withdrawal by Subject|8|||
145341600|NCT00025259|524098539|FG006|Overall Study|Withdrawal by Subject|3|||
145341601|NCT00025259|524098533|FG000|Overall Study|Ineligible|14|||
145341602|NCT00025259|524098534|FG001|Overall Study|Ineligible|1|||
145341603|NCT00025259|524098535|FG002|Overall Study|Ineligible|0|||
145341604|NCT00025259|524098536|FG003|Overall Study|Ineligible|0|||
145341605|NCT00025259|524098537|FG004|Overall Study|Ineligible|6|||
145341606|NCT00025259|524098538|FG005|Overall Study|Ineligible|0|||
145341607|NCT00025259|524098539|FG006|Overall Study|Ineligible|1|||
145341608|NCT00025259|524098533|FG000|Overall Study|Randomization error|1|||
145341609|NCT00025259|524098534|FG001|Overall Study|Randomization error|0|||
145341610|NCT00025259|524098535|FG002|Overall Study|Randomization error|0|||
145341611|NCT00025259|524098536|FG003|Overall Study|Randomization error|0|||
145341612|NCT00025259|524098537|FG004|Overall Study|Randomization error|1|||
145341613|NCT00025259|524098538|FG005|Overall Study|Randomization error|7|||
145341614|NCT00025259|524098539|FG006|Overall Study|Randomization error|2|||
145341615|NCT00025259|524098533|FG000|Overall Study|Adverse Event|1|||
145341616|NCT00025259|524098534|FG001|Overall Study|Adverse Event|0|||
145341617|NCT00025259|524098535|FG002|Overall Study|Adverse Event|0|||
145341618|NCT00025259|524098536|FG003|Overall Study|Adverse Event|0|||
145341619|NCT00025259|524098537|FG004|Overall Study|Adverse Event|0|||
145341620|NCT00025259|524098538|FG005|Overall Study|Adverse Event|0|||
145341621|NCT00025259|524098539|FG006|Overall Study|Adverse Event|0|||
145341622|NCT00908310|524098544|FG000|Overall Study|Death|37|||
145341623|NCT00908310|524098544|FG000|Overall Study|Withdrawal by Subject|7|||
145341624|NCT00908310|524098544|FG000|Overall Study|Lost to Follow-up|7|||
145341625|NCT00908310|524098544|FG000|Overall Study|Screening failure|5|||
145341626|NCT00908310|524098544|FG000|Overall Study|Other reasons|4|||
145341627|NCT02071849|524098548|FG000|6-month Primary Endpoint|Did not receive device|4|||
145341628|NCT02071849|524098548|FG000|6-month Primary Endpoint|Adverse Event|1|||
145341629|NCT02071849|524098548|FG000|2-year Extended Follow-up|Adverse Event|1|||
145341630|NCT03255655|524098549|FG000|Overall Study|Lost to Follow-up|7|||
145341631|NCT03255655|524098550|FG001|Overall Study|Lost to Follow-up|4|||
145341632|NCT00725205|524098553|FG000|Overall Study|Adverse Event|22|||
145341633|NCT00725205|524098553|FG000|Overall Study|Investigator Discontinued|1|||
145341634|NCT00725205|524098553|FG000|Overall Study|Non-compliance With Protocol|14|||
145341635|NCT00725205|524098553|FG000|Overall Study|Other|8|||
145341636|NCT00725205|524098553|FG000|Overall Study|Protocol Defined Clinical Event|1|||
145574862|NCT02702401|524960124|FG001|Overall Study|Sponsor Decision|3|||
145574863|NCT02702401|524960123|FG000|Overall Study|Physician Decision|1|||
145574864|NCT02702401|524960124|FG001|Overall Study|Physician Decision|2|||
145574865|NCT02702401|524960123|FG000|Overall Study|Lost to Follow-up|1|||
145574866|NCT02702401|524960124|FG001|Overall Study|Lost to Follow-up|0|||
145574867|NCT01462357|524960129|FG000|Overall Study|Death|0|||
145574868|NCT01462357|524960130|FG001|Overall Study|Death|0|||
145574869|NCT01462357|524960131|FG002|Overall Study|Death|1|||
145574870|NCT01462357|524960129|FG000|Overall Study|Withdrawal by Subject|3|||
145574871|NCT01462357|524960130|FG001|Overall Study|Withdrawal by Subject|11|||
145574872|NCT01462357|524960131|FG002|Overall Study|Withdrawal by Subject|3|||
145574873|NCT01462357|524960129|FG000|Overall Study|Migrated/moved from study area|2|||
145574874|NCT01462357|524960130|FG001|Overall Study|Migrated/moved from study area|3|||
145574875|NCT01462357|524960131|FG002|Overall Study|Migrated/moved from study area|1|||
145574876|NCT01462357|524960129|FG000|Overall Study|Lost to Follow-up|3|||
145574877|NCT01462357|524960130|FG001|Overall Study|Lost to Follow-up|5|||
145574878|NCT01462357|524960131|FG002|Overall Study|Lost to Follow-up|7|||
145574879|NCT04292730|524960132|FG000|Overall Study|Lost to Follow-up|8|||
145574880|NCT04292730|524960133|FG001|Overall Study|Lost to Follow-up|12|||
145574881|NCT04292730|524960134|FG002|Overall Study|Lost to Follow-up|12|||
145574882|NCT04292730|524960135|FG003|Overall Study|Lost to Follow-up|48|||
145574883|NCT04292730|524960132|FG000|Overall Study|Death|2|||
145574884|NCT04292730|524960133|FG001|Overall Study|Death|2|||
145574885|NCT04292730|524960134|FG002|Overall Study|Death|4|||
145574886|NCT04292730|524960135|FG003|Overall Study|Death|12|||
145574887|NCT04292730|524960132|FG000|Overall Study|Withdrew Consent|2|||
145574888|NCT04292730|524960133|FG001|Overall Study|Withdrew Consent|2|||
145574889|NCT04292730|524960134|FG002|Overall Study|Withdrew Consent|5|||
145574890|NCT04292730|524960135|FG003|Overall Study|Withdrew Consent|6|||
145574891|NCT04292730|524960132|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145574892|NCT04292730|524960133|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145574893|NCT04292730|524960134|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145574894|NCT04292730|524960135|FG003|Overall Study|Non-Compliance with Study Drug|0|||
145574895|NCT04292730|524960132|FG000|Overall Study|Protocol Violation|0|||
145574896|NCT04292730|524960133|FG001|Overall Study|Protocol Violation|0|||
145574897|NCT04292730|524960134|FG002|Overall Study|Protocol Violation|1|||
145574898|NCT04292730|524960135|FG003|Overall Study|Protocol Violation|0|||
145574899|NCT04292730|524960132|FG000|Overall Study|Randomized but not Treated|8|||
145574900|NCT04292730|524960133|FG001|Overall Study|Randomized but not Treated|4|||
145574901|NCT04292730|524960134|FG002|Overall Study|Randomized but not Treated|0|||
145574902|NCT04292730|524960135|FG003|Overall Study|Randomized but not Treated|14|||
145574903|NCT01527292|524960137|FG000|Overall Study|Physician Decision|0|||
145574904|NCT01527292|524960138|FG001|Overall Study|Physician Decision|3|||
145574905|NCT01482767|524960141|FG000|Overall Study|Death|1|||
145574906|NCT01482767|524960142|FG001|Overall Study|Death|1|||
145574907|NCT01482767|524960141|FG000|Overall Study|Withdrawal by Subject|7|||
145574908|NCT01482767|524960142|FG001|Overall Study|Withdrawal by Subject|5|||
145574909|NCT01482767|524960141|FG000|Overall Study|Lost to Follow-up|12|||
145574910|NCT01482767|524960142|FG001|Overall Study|Lost to Follow-up|6|||
145622797|NCT01734382|525130183|FG000|Part 2|Other|0|||
145622798|NCT01734382|525130184|FG001|Part 2|Other|0|||
145622799|NCT01734382|525130185|FG002|Part 2|Other|1|||
145622800|NCT01734382|525130183|FG000|Part 2|Physician Decision|0|||
145622801|NCT01734382|525130184|FG001|Part 2|Physician Decision|0|||
145622802|NCT01734382|525130185|FG002|Part 2|Physician Decision|3|||
145622803|NCT01734382|525130183|FG000|Part 2|Protocol Violation|0|||
145622804|NCT01734382|525130184|FG001|Part 2|Protocol Violation|1|||
145622805|NCT01734382|525130185|FG002|Part 2|Protocol Violation|0|||
145622806|NCT01734382|525130183|FG000|Part 2|Withdrawal by Subject|0|||
145622807|NCT01734382|525130184|FG001|Part 2|Withdrawal by Subject|0|||
145622808|NCT01734382|525130185|FG002|Part 2|Withdrawal by Subject|1|||
145574911|NCT01482767|524960141|FG000|Overall Study|Adverse Event|0|||
145574912|NCT01482767|524960142|FG001|Overall Study|Adverse Event|3|||
145574913|NCT01482767|524960141|FG000|Overall Study|Site closure|22|||
145574914|NCT01482767|524960142|FG001|Overall Study|Site closure|14|||
145574915|NCT01482767|524960141|FG000|Overall Study|Non-adherence to study requirements|4|||
145574916|NCT01482767|524960142|FG001|Overall Study|Non-adherence to study requirements|7|||
145574917|NCT01482767|524960141|FG000|Overall Study|Alternate HCV treatment|7|||
145574918|NCT01482767|524960142|FG001|Overall Study|Alternate HCV treatment|8|||
145574919|NCT01482767|524960141|FG000|Overall Study|Ineligible|0|||
145574920|NCT01482767|524960142|FG001|Overall Study|Ineligible|5|||
145574921|NCT01482767|524960141|FG000|Overall Study|Nurse error|1|||
145574922|NCT01482767|524960142|FG001|Overall Study|Nurse error|0|||
145574923|NCT01247090|524960145|FG000|Overall Study|Physician Decision|1|||
145574924|NCT01247090|524960146|FG001|Overall Study|Physician Decision|0|||
145574925|NCT01247090|524960147|FG002|Overall Study|Physician Decision|0|||
145574926|NCT01247090|524960145|FG000|Overall Study|Withdrawal by Subject|0|||
145574927|NCT01247090|524960146|FG001|Overall Study|Withdrawal by Subject|1|||
145574928|NCT01247090|524960147|FG002|Overall Study|Withdrawal by Subject|0|||
145574929|NCT02457325|524960153|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
145574930|NCT02457325|524960154|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
145574931|NCT03385239|524960155|FG000|Overall Study|Voluntary Withdrawal|2|||
145574932|NCT03385239|524960156|FG001|Overall Study|Voluntary Withdrawal|3|||
145574933|NCT03385239|524960157|FG002|Overall Study|Voluntary Withdrawal|2|||
145574934|NCT03385239|524960158|FG003|Overall Study|Voluntary Withdrawal|3|||
145574935|NCT03385239|524960159|FG004|Overall Study|Voluntary Withdrawal|0|||
145574936|NCT03385239|524960155|FG000|Overall Study|Adverse Event|0|||
145574937|NCT03385239|524960156|FG001|Overall Study|Adverse Event|0|||
145574938|NCT03385239|524960157|FG002|Overall Study|Adverse Event|1|||
145574939|NCT03385239|524960158|FG003|Overall Study|Adverse Event|0|||
145574940|NCT03385239|524960159|FG004|Overall Study|Adverse Event|0|||
145574941|NCT03385239|524960155|FG000|Overall Study|Other|0|||
145574942|NCT03385239|524960156|FG001|Overall Study|Other|0|||
145574943|NCT03385239|524960157|FG002|Overall Study|Other|0|||
145574944|NCT03385239|524960158|FG003|Overall Study|Other|1|||
145574945|NCT03385239|524960159|FG004|Overall Study|Other|0|||
145574946|NCT01574703|524960160|FG000|Overall Study|Adverse Event|0|||
145574947|NCT01574703|524960161|FG001|Overall Study|Adverse Event|2|||
145574948|NCT01574703|524960162|FG002|Overall Study|Adverse Event|1|||
145574949|NCT01574703|524960163|FG003|Overall Study|Adverse Event|1|||
145574950|NCT01574703|524960160|FG000|Overall Study|Protocol Violation|0|||
145574951|NCT01574703|524960161|FG001|Overall Study|Protocol Violation|0|||
145574952|NCT01574703|524960162|FG002|Overall Study|Protocol Violation|0|||
145574953|NCT01574703|524960163|FG003|Overall Study|Protocol Violation|1|||
145574954|NCT01574703|524960160|FG000|Overall Study|Unspecified Reason|27|||
145574955|NCT01574703|524960161|FG001|Overall Study|Unspecified Reason|15|||
145574956|NCT01574703|524960162|FG002|Overall Study|Unspecified Reason|20|||
145574957|NCT01574703|524960163|FG003|Overall Study|Unspecified Reason|16|||
145574958|NCT01574703|524960160|FG000|Overall Study|Withdrawal by Subject|53|||
145574959|NCT01574703|524960161|FG001|Overall Study|Withdrawal by Subject|52|||
145574960|NCT01574703|524960162|FG002|Overall Study|Withdrawal by Subject|36|||
145574961|NCT01574703|524960163|FG003|Overall Study|Withdrawal by Subject|61|||
145574962|NCT01574703|524960160|FG000|Overall Study|Met Withdrawal Criteria|0|||
145574963|NCT01574703|524960161|FG001|Overall Study|Met Withdrawal Criteria|1|||
145574964|NCT01574703|524960162|FG002|Overall Study|Met Withdrawal Criteria|1|||
145574965|NCT01574703|524960163|FG003|Overall Study|Met Withdrawal Criteria|0|||
145574966|NCT01574703|524960160|FG000|Overall Study|Lost to Follow-up|43|||
145574967|NCT01574703|524960161|FG001|Overall Study|Lost to Follow-up|41|||
145574968|NCT01574703|524960162|FG002|Overall Study|Lost to Follow-up|46|||
145574969|NCT01574703|524960163|FG003|Overall Study|Lost to Follow-up|35|||
145574970|NCT01574703|524960160|FG000|Overall Study|Death|2|||
145574971|NCT01574703|524960161|FG001|Overall Study|Death|1|||
145574972|NCT01574703|524960162|FG002|Overall Study|Death|1|||
145574973|NCT01574703|524960163|FG003|Overall Study|Death|0|||
145574974|NCT02751983|524960164|FG000|Treatment|Stopped ACT, but Remained in study|2|||
145574975|NCT02751983|524960165|FG001|Treatment|Stopped ACT, but Remained in study|0|||
145574976|NCT02751983|524960164|FG000|Treatment|Discharged prior to beginning ACT|2|||
145574977|NCT02751983|524960165|FG001|Treatment|Discharged prior to beginning ACT|0|||
145574978|NCT02751983|524960164|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
145574979|NCT02751983|524960165|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
145622809|NCT02015663|525130187|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
145622810|NCT02015663|525130188|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
145413783|NCT00933166|524368408|FG000|Overall Study|Lack of Efficacy|9|||
145413784|NCT00933166|524368408|FG000|Overall Study|Unavailable|4|||
145413785|NCT00933166|524368408|FG000|Overall Study|Withdrawal by Subject|1|||
145574980|NCT02751983|524960164|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
145574981|NCT02751983|524960165|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
145574982|NCT02751983|524960164|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
145574983|NCT02751983|524960165|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
145574984|NCT03139916|524960168|FG000|Overall Study|Withdrawal by Subject|2|||
145574985|NCT03139916|524960168|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
145574986|NCT03591575|524960169|FG000|Overall Study|Adverse Event|2|||
145574987|NCT03591575|524960170|FG001|Overall Study|Adverse Event|0|||
145574988|NCT03591575|524960169|FG000|Overall Study|Withdrawal by Subject|4|||
145574989|NCT03591575|524960170|FG001|Overall Study|Withdrawal by Subject|1|||
145574990|NCT00025883|524960171|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
145574991|NCT00025883|524960171|FG000|Overall Study|no baseline data|1|||
145574992|NCT00025883|524960171|FG000|Overall Study|Death|1|||
145574993|NCT00025883|524960171|FG000|Overall Study|Adverse Event|1|||
145574994|NCT00025883|524960171|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
145574995|NCT01282216|524960172|FG000|Overall Study|Graft failure|0|||
145574996|NCT01282216|524960173|FG001|Overall Study|Graft failure|0|||
145574997|NCT01282216|524960174|FG002|Overall Study|Graft failure|3|||
145574998|NCT01282216|524960175|FG003|Overall Study|Graft failure|2|||
145574999|NCT01282216|524960172|FG000|Overall Study|Physician Decision|0|||
145575000|NCT01282216|524960173|FG001|Overall Study|Physician Decision|0|||
145575001|NCT01282216|524960174|FG002|Overall Study|Physician Decision|11|||
145575002|NCT01282216|524960175|FG003|Overall Study|Physician Decision|0|||
145341637|NCT00725205|524098553|FG000|Overall Study|Treatment Failure|41|||
145341638|NCT05819203|524098555|FG000|Overall Study|Protocol Violation|1|||
145341639|NCT05819203|524098556|FG001|Overall Study|Protocol Violation|2|||
145341640|NCT05819203|524098555|FG000|Overall Study|Withdrawal by Subject|1|||
145341641|NCT05819203|524098556|FG001|Overall Study|Withdrawal by Subject|0|||
145341642|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
145341643|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
145341644|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341645|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341646|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341647|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341648|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341649|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341650|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341651|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
145341652|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
145341653|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
145341654|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341655|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341656|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341657|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341658|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341659|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341660|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341661|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
145341662|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341663|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
145341664|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341665|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341666|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341667|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341668|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341669|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341670|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341671|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
145341672|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
145341673|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341674|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341675|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341676|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341677|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341678|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341679|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341680|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341681|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
145341682|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
145341683|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
145341684|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341685|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145575003|NCT01282216|524960172|FG000|Overall Study|Relapse|0|||
145575004|NCT01282216|524960173|FG001|Overall Study|Relapse|0|||
145575005|NCT01282216|524960174|FG002|Overall Study|Relapse|17|||
145575006|NCT01282216|524960175|FG003|Overall Study|Relapse|6|||
145575007|NCT01282216|524960172|FG000|Overall Study|Death|0|||
145341686|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341687|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341688|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341689|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341690|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145341691|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
145413786|NCT04618471|524368409|FG000|Overall Study|Screen Failure|62|||
145413787|NCT04618471|524368409|FG000|Overall Study|Withdrawal by Subject|6|||
145413788|NCT04618471|524368409|FG000|Overall Study|Physician Decision|2|||
145575008|NCT01282216|524960173|FG001|Overall Study|Death|0|||
145575009|NCT01282216|524960174|FG002|Overall Study|Death|2|||
145575010|NCT01282216|524960175|FG003|Overall Study|Death|0|||
145575011|NCT02908529|524960178|FG000|Overall Study|Lost to Follow-up|0|||
145575012|NCT02908529|524960179|FG001|Overall Study|Lost to Follow-up|2|||
145575013|NCT04084769|524960186|FG000|Overall Study|Protocol Violation|1|||
145575014|NCT04084769|524960187|FG001|Overall Study|Protocol Violation|3|||
145575015|NCT04084769|524960188|FG002|Overall Study|Protocol Violation|0|||
145575016|NCT04084769|524960189|FG003|Overall Study|Protocol Violation|1|||
145575017|NCT04084769|524960186|FG000|Overall Study|Withdrawal by Subject|0|||
145575018|NCT04084769|524960187|FG001|Overall Study|Withdrawal by Subject|1|||
145575019|NCT04084769|524960188|FG002|Overall Study|Withdrawal by Subject|0|||
145575020|NCT04084769|524960189|FG003|Overall Study|Withdrawal by Subject|0|||
145575021|NCT04084769|524960186|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145575022|NCT04084769|524960187|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145575023|NCT04084769|524960188|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145575024|NCT04084769|524960189|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145575025|NCT04084769|524960186|FG000|Overall Study|Lost to Follow-up|2|||
145575026|NCT04084769|524960187|FG001|Overall Study|Lost to Follow-up|0|||
145575027|NCT04084769|524960188|FG002|Overall Study|Lost to Follow-up|0|||
145575028|NCT04084769|524960189|FG003|Overall Study|Lost to Follow-up|0|||
145575029|NCT01660412|524960190|FG000|Overall Study|Protocol Violation|0|||
145575030|NCT01660412|524960191|FG001|Overall Study|Protocol Violation|3|||
145575031|NCT03013491|524960192|FG000|Main Study|Death|2|||
145575032|NCT03013491|524960193|FG001|Main Study|Death|2|||
145575033|NCT03013491|524960194|FG002|Main Study|Death|5|||
145575034|NCT03013491|524960195|FG003|Main Study|Death|3|||
145575035|NCT03013491|524960196|FG004|Main Study|Death|9|||
145575036|NCT03013491|524960197|FG005|Main Study|Death|12|||
145575037|NCT03013491|524960198|FG006|Main Study|Death|3|||
145575038|NCT03013491|524960199|FG007|Main Study|Death|5|||
145575039|NCT03013491|524960200|FG008|Main Study|Death|1|||
145575040|NCT03013491|524960201|FG009|Main Study|Death|2|||
145575041|NCT03013491|524960202|FG010|Main Study|Death|4|||
145575042|NCT03013491|524960203|FG011|Main Study|Death|1|||
145575043|NCT03013491|524960204|FG012|Main Study|Death|1|||
145575044|NCT03013491|524960205|FG013|Main Study|Death|4|||
145575045|NCT03013491|524960206|FG014|Main Study|Death|0|||
145575046|NCT03013491|524960207|FG015|Main Study|Death|3|||
145575047|NCT03013491|524960208|FG016|Main Study|Death|5|||
145575048|NCT03013491|524960209|FG017|Main Study|Death|1|||
145575049|NCT03013491|524960210|FG018|Main Study|Death|47|||
145575050|NCT03013491|524960192|FG000|Main Study|Lost to Follow-up|0|||
145575051|NCT03013491|524960193|FG001|Main Study|Lost to Follow-up|0|||
145575052|NCT03013491|524960194|FG002|Main Study|Lost to Follow-up|1|||
145575053|NCT03013491|524960195|FG003|Main Study|Lost to Follow-up|0|||
145575054|NCT03013491|524960196|FG004|Main Study|Lost to Follow-up|1|||
145575055|NCT03013491|524960197|FG005|Main Study|Lost to Follow-up|0|||
145575056|NCT03013491|524960198|FG006|Main Study|Lost to Follow-up|0|||
145575057|NCT03013491|524960199|FG007|Main Study|Lost to Follow-up|0|||
145575058|NCT03013491|524960200|FG008|Main Study|Lost to Follow-up|0|||
145575059|NCT03013491|524960201|FG009|Main Study|Lost to Follow-up|0|||
145575060|NCT03013491|524960202|FG010|Main Study|Lost to Follow-up|0|||
145622811|NCT02015663|525130187|FG000|Overall Study|Withdrawal by Subject|1|||
145622812|NCT02015663|525130188|FG001|Overall Study|Withdrawal by Subject|0|||
145622813|NCT02015663|525130187|FG000|Overall Study|Protocol Violation|0|||
145341692|NCT04784533|524098559|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
145622814|NCT02015663|525130188|FG001|Overall Study|Protocol Violation|1|||
145622815|NCT02015663|525130187|FG000|Overall Study|Adverse Event|3|||
145341693|NCT04784533|524098560|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
145341694|NCT04784533|524098561|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341695|NCT04784533|524098562|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341696|NCT04784533|524098563|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341697|NCT04784533|524098564|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341698|NCT04784533|524098565|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341699|NCT04784533|524098566|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341700|NCT04784533|524098567|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341701|NCT04784533|524098568|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
145341702|NCT04784533|524098559|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341703|NCT04784533|524098560|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145413789|NCT04618471|524368409|FG000|Overall Study|Lost to Follow-up|1|||
145341704|NCT04784533|524098561|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
145413790|NCT04618471|524368409|FG000|Overall Study|Various other reasons|2|||
145575061|NCT03013491|524960203|FG011|Main Study|Lost to Follow-up|0|||
145575062|NCT03013491|524960204|FG012|Main Study|Lost to Follow-up|0|||
145575063|NCT03013491|524960205|FG013|Main Study|Lost to Follow-up|0|||
145575064|NCT03013491|524960206|FG014|Main Study|Lost to Follow-up|0|||
145575065|NCT03013491|524960207|FG015|Main Study|Lost to Follow-up|0|||
145575066|NCT03013491|524960208|FG016|Main Study|Lost to Follow-up|0|||
145575067|NCT03013491|524960209|FG017|Main Study|Lost to Follow-up|0|||
145575068|NCT03013491|524960210|FG018|Main Study|Lost to Follow-up|3|||
145575069|NCT03013491|524960192|FG000|Main Study|Termination of the study by Sponsor|0|||
145575070|NCT03013491|524960193|FG001|Main Study|Termination of the study by Sponsor|0|||
145341705|NCT04784533|524098562|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341706|NCT04784533|524098563|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341707|NCT04784533|524098564|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341708|NCT04784533|524098565|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341709|NCT04784533|524098566|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341710|NCT04784533|524098567|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341711|NCT04784533|524098568|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
145341712|NCT04784533|524098559|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341713|NCT04784533|524098560|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341714|NCT04784533|524098561|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341715|NCT04784533|524098562|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341716|NCT04784533|524098563|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341717|NCT04784533|524098564|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341718|NCT04784533|524098565|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341719|NCT04784533|524098566|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341720|NCT04784533|524098567|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
145341721|NCT04784533|524098568|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
145341722|NCT04784533|524098559|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341723|NCT04784533|524098560|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341724|NCT04784533|524098561|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341725|NCT04784533|524098562|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341726|NCT04784533|524098563|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341727|NCT04784533|524098564|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341728|NCT04784533|524098565|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341729|NCT04784533|524098566|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
145341730|NCT04784533|524098567|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
145341731|NCT04784533|524098568|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
145341732|NCT04123561|524098572|FG000|Overall Study|Lost to Follow-up|20|||
145341733|NCT04123561|524098573|FG001|Overall Study|Lost to Follow-up|12|||
145341734|NCT04123561|524098574|FG002|Overall Study|Lost to Follow-up|5|||
145341735|NCT04123561|524098572|FG000|Overall Study|Withdrawal by Subject|9|||
145341736|NCT04123561|524098573|FG001|Overall Study|Withdrawal by Subject|7|||
145341737|NCT04123561|524098574|FG002|Overall Study|Withdrawal by Subject|9|||
145341738|NCT04123561|524098572|FG000|Overall Study|Lack of Efficacy|7|||
145341739|NCT04123561|524098573|FG001|Overall Study|Lack of Efficacy|8|||
145341740|NCT04123561|524098574|FG002|Overall Study|Lack of Efficacy|6|||
145341741|NCT04123561|524098572|FG000|Overall Study|Adverse Event|5|||
145341742|NCT04123561|524098573|FG001|Overall Study|Adverse Event|2|||
145341743|NCT04123561|524098574|FG002|Overall Study|Adverse Event|3|||
145341744|NCT04123561|524098572|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
145341745|NCT04123561|524098573|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
145341746|NCT04123561|524098574|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
145341747|NCT04123561|524098572|FG000|Overall Study|Death|0|||
145341748|NCT04123561|524098573|FG001|Overall Study|Death|0|||
145341749|NCT04123561|524098574|FG002|Overall Study|Death|1|||
145341750|NCT04123561|524098572|FG000|Overall Study|Protocol Violation|0|||
145341751|NCT04123561|524098573|FG001|Overall Study|Protocol Violation|1|||
145341752|NCT04123561|524098574|FG002|Overall Study|Protocol Violation|0|||
145341753|NCT02542605|524098590|FG000|Part B: Challenge Phase|Sponsor decision|1|||
145341754|NCT02542605|524098591|FG001|Part B: Challenge Phase|Sponsor decision|0|||
145341755|NCT02542605|524098592|FG002|Part B: Challenge Phase|Sponsor decision|0|||
145341756|NCT02542605|524098590|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
145341757|NCT02542605|524098591|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
145341758|NCT02542605|524098592|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
145341759|NCT02682927|524098593|FG000|Overall Study|Adverse Event|0|||
145341760|NCT02682927|524098594|FG001|Overall Study|Adverse Event|0|||
145341761|NCT02682927|524098595|FG002|Overall Study|Adverse Event|5|||
145341762|NCT02682927|524098596|FG003|Overall Study|Adverse Event|1|||
145341763|NCT02682927|524098597|FG004|Overall Study|Adverse Event|0|||
145341764|NCT02682927|524098598|FG005|Overall Study|Adverse Event|2|||
145341765|NCT02682927|524098593|FG000|Overall Study|Death|0|||
145341766|NCT02682927|524098594|FG001|Overall Study|Death|0|||
145341767|NCT02682927|524098595|FG002|Overall Study|Death|0|||
145341768|NCT02682927|524098596|FG003|Overall Study|Death|1|||
145341769|NCT02682927|524098597|FG004|Overall Study|Death|0|||
145575071|NCT03013491|524960194|FG002|Main Study|Termination of the study by Sponsor|2|||
145341770|NCT02682927|524098598|FG005|Overall Study|Death|0|||
145341771|NCT02682927|524098593|FG000|Overall Study|Lack of Efficacy|1|||
145341772|NCT02682927|524098594|FG001|Overall Study|Lack of Efficacy|0|||
145341773|NCT02682927|524098595|FG002|Overall Study|Lack of Efficacy|0|||
145341774|NCT02682927|524098596|FG003|Overall Study|Lack of Efficacy|1|||
145341775|NCT02682927|524098597|FG004|Overall Study|Lack of Efficacy|0|||
145341776|NCT02682927|524098598|FG005|Overall Study|Lack of Efficacy|0|||
145341777|NCT02682927|524098593|FG000|Overall Study|Other|0|||
145575072|NCT03013491|524960195|FG003|Main Study|Termination of the study by Sponsor|0|||
145622816|NCT02015663|525130188|FG001|Overall Study|Adverse Event|0|||
145622817|NCT02015663|525130187|FG000|Overall Study|Administrative problems|10|||
145622818|NCT02015663|525130188|FG001|Overall Study|Administrative problems|11|||
145622819|NCT00146640|525130195|FG000|Overall Study|Adverse Event|12|||
145622820|NCT00146640|525130196|FG001|Overall Study|Adverse Event|10|||
145622821|NCT00146640|525130195|FG000|Overall Study|Medical Reasons|3|||
145622822|NCT00146640|525130196|FG001|Overall Study|Medical Reasons|0|||
145622823|NCT00146640|525130195|FG000|Overall Study|Non-Medical Reasons|8|||
145622824|NCT00146640|525130196|FG001|Overall Study|Non-Medical Reasons|4|||
145622825|NCT02059161|525130197|FG000|Overall Study|Pregnancy|0|||
145622826|NCT02059161|525130198|FG001|Overall Study|Pregnancy|2|||
145622827|NCT02059161|525130197|FG000|Overall Study|Adverse Event|2|||
145622828|NCT02059161|525130198|FG001|Overall Study|Adverse Event|6|||
145622829|NCT02059161|525130197|FG000|Overall Study|Lost to Follow-up|20|||
145622830|NCT02059161|525130198|FG001|Overall Study|Lost to Follow-up|12|||
145622831|NCT02059161|525130197|FG000|Overall Study|Physician Decision|4|||
145622832|NCT02059161|525130198|FG001|Overall Study|Physician Decision|4|||
145622833|NCT02059161|525130197|FG000|Overall Study|Protocol Violation|1|||
145622834|NCT02059161|525130198|FG001|Overall Study|Protocol Violation|1|||
145622835|NCT02059161|525130197|FG000|Overall Study|Withdrawal by Subject|16|||
145622836|NCT02059161|525130198|FG001|Overall Study|Withdrawal by Subject|13|||
145622837|NCT02059161|525130197|FG000|Overall Study|Randomized in error, no study drug|0|||
145622838|NCT02059161|525130198|FG001|Overall Study|Randomized in error, no study drug|1|||
145622839|NCT02059161|525130197|FG000|Overall Study|Non-compliance with study drug|6|||
145622840|NCT02059161|525130198|FG001|Overall Study|Non-compliance with study drug|2|||
145622841|NCT03293485|525130199|FG000|Overall Study|Death|1|||
145622842|NCT03293485|525130199|FG000|Overall Study|Screen Failure|2|||
145622843|NCT03293485|525130199|FG000|Overall Study|Withdrawal by Subject|2|||
145622844|NCT01723826|525130203|FG000|Overall Study|Adverse Event|4|||
145622845|NCT01723826|525130204|FG001|Overall Study|Adverse Event|1|||
145622846|NCT01723826|525130205|FG002|Overall Study|Adverse Event|4|||
145622847|NCT01723826|525130206|FG003|Overall Study|Adverse Event|5|||
145622848|NCT01723826|525130203|FG000|Overall Study|Death according to AE eCRF|2|||
145622849|NCT01723826|525130204|FG001|Overall Study|Death according to AE eCRF|3|||
145341778|NCT02682927|524098594|FG001|Overall Study|Other|0|||
145341779|NCT02682927|524098595|FG002|Overall Study|Other|0|||
145341780|NCT02682927|524098596|FG003|Overall Study|Other|2|||
145341781|NCT02682927|524098597|FG004|Overall Study|Other|0|||
145341782|NCT02682927|524098598|FG005|Overall Study|Other|0|||
145575073|NCT03013491|524960196|FG004|Main Study|Termination of the study by Sponsor|1|||
145575074|NCT03013491|524960197|FG005|Main Study|Termination of the study by Sponsor|2|||
145575075|NCT03013491|524960198|FG006|Main Study|Termination of the study by Sponsor|0|||
145575076|NCT03013491|524960199|FG007|Main Study|Termination of the study by Sponsor|0|||
145575077|NCT03013491|524960200|FG008|Main Study|Termination of the study by Sponsor|1|||
145575078|NCT03013491|524960201|FG009|Main Study|Termination of the study by Sponsor|1|||
145575079|NCT03013491|524960202|FG010|Main Study|Termination of the study by Sponsor|1|||
145575080|NCT03013491|524960203|FG011|Main Study|Termination of the study by Sponsor|2|||
145575081|NCT03013491|524960204|FG012|Main Study|Termination of the study by Sponsor|0|||
145575082|NCT03013491|524960205|FG013|Main Study|Termination of the study by Sponsor|0|||
145575083|NCT03013491|524960206|FG014|Main Study|Termination of the study by Sponsor|0|||
145575084|NCT03013491|524960207|FG015|Main Study|Termination of the study by Sponsor|0|||
145575085|NCT03013491|524960208|FG016|Main Study|Termination of the study by Sponsor|0|||
145575086|NCT03013491|524960209|FG017|Main Study|Termination of the study by Sponsor|1|||
145575087|NCT03013491|524960210|FG018|Main Study|Termination of the study by Sponsor|13|||
145575088|NCT03013491|524960192|FG000|Main Study|Withdrawal by Subject|0|||
145575089|NCT03013491|524960193|FG001|Main Study|Withdrawal by Subject|0|||
145575090|NCT03013491|524960194|FG002|Main Study|Withdrawal by Subject|0|||
145575091|NCT03013491|524960195|FG003|Main Study|Withdrawal by Subject|4|||
145575092|NCT03013491|524960196|FG004|Main Study|Withdrawal by Subject|2|||
145575093|NCT03013491|524960197|FG005|Main Study|Withdrawal by Subject|1|||
145575094|NCT03013491|524960198|FG006|Main Study|Withdrawal by Subject|0|||
145575095|NCT03013491|524960199|FG007|Main Study|Withdrawal by Subject|0|||
145575096|NCT03013491|524960200|FG008|Main Study|Withdrawal by Subject|0|||
145575097|NCT03013491|524960201|FG009|Main Study|Withdrawal by Subject|0|||
145575098|NCT03013491|524960202|FG010|Main Study|Withdrawal by Subject|1|||
145575099|NCT03013491|524960203|FG011|Main Study|Withdrawal by Subject|2|||
145575100|NCT03013491|524960204|FG012|Main Study|Withdrawal by Subject|0|||
145575101|NCT03013491|524960205|FG013|Main Study|Withdrawal by Subject|2|||
145575102|NCT03013491|524960206|FG014|Main Study|Withdrawal by Subject|0|||
145575103|NCT03013491|524960207|FG015|Main Study|Withdrawal by Subject|0|||
145575104|NCT03013491|524960208|FG016|Main Study|Withdrawal by Subject|0|||
145575105|NCT03013491|524960209|FG017|Main Study|Withdrawal by Subject|0|||
145575106|NCT03013491|524960210|FG018|Main Study|Withdrawal by Subject|18|||
145622850|NCT01723826|525130205|FG002|Overall Study|Death according to AE eCRF|3|||
145622851|NCT01723826|525130206|FG003|Overall Study|Death according to AE eCRF|7|||
145622852|NCT01723826|525130203|FG000|Overall Study|Lost to Follow-up|1|||
145575107|NCT03013491|524960192|FG000|Main Study|Disease progression|0|||
145575108|NCT03013491|524960193|FG001|Main Study|Disease progression|0|||
145413791|NCT04618471|524368409|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
145341783|NCT02682927|524098593|FG000|Overall Study|Withdrawal by Subject|2|||
145341784|NCT02682927|524098594|FG001|Overall Study|Withdrawal by Subject|0|||
145341785|NCT02682927|524098595|FG002|Overall Study|Withdrawal by Subject|1|||
145341786|NCT02682927|524098596|FG003|Overall Study|Withdrawal by Subject|0|||
145341787|NCT02682927|524098597|FG004|Overall Study|Withdrawal by Subject|1|||
145341788|NCT02682927|524098598|FG005|Overall Study|Withdrawal by Subject|1|||
145341789|NCT03654599|524098600|FG000|Overall Study|Lost to Follow-up|14|||
145341790|NCT03654599|524098601|FG001|Overall Study|Lost to Follow-up|12|||
145341791|NCT03654599|524098600|FG000|Overall Study|Death|8|||
145341792|NCT03654599|524098601|FG001|Overall Study|Death|6|||
145341793|NCT03654599|524098600|FG000|Overall Study|Withdrawal by Subject|6|||
145341794|NCT03654599|524098601|FG001|Overall Study|Withdrawal by Subject|4|||
145341795|NCT03132155|524099799|FG000|Overall Study|Lack of Efficacy|6|||
145341796|NCT03132155|524099799|FG000|Overall Study|Lost to Follow-up|1|||
145341797|NCT03132155|524099799|FG000|Overall Study|Withdrawal by Subject|1|||
145341798|NCT02126826|524099800|FG000|Overall Study|Withdrawal by Subject|0|||
145341799|NCT02126826|524099801|FG001|Overall Study|Withdrawal by Subject|0|||
145341800|NCT02126826|524099802|FG002|Overall Study|Withdrawal by Subject|0|||
145341801|NCT02126826|524099803|FG003|Overall Study|Withdrawal by Subject|1|||
145341802|NCT02126826|524099804|FG004|Overall Study|Withdrawal by Subject|0|||
145341803|NCT02126826|524099805|FG005|Overall Study|Withdrawal by Subject|0|||
145341804|NCT02126826|524099806|FG006|Overall Study|Withdrawal by Subject|0|||
145341805|NCT04971187|524099807|FG000|Overall Study|Screen failures|2|||
145341806|NCT00591773|524099808|FG000|Overall Study|Adverse Event|9|||
145341807|NCT00591773|524099809|FG001|Overall Study|Adverse Event|9|||
145341808|NCT00591773|524099810|FG002|Overall Study|Adverse Event|6|||
145341809|NCT00591773|524099808|FG000|Overall Study|Protocol Violation|2|||
145341810|NCT00591773|524099809|FG001|Overall Study|Protocol Violation|3|||
145341811|NCT00591773|524099810|FG002|Overall Study|Protocol Violation|0|||
145341812|NCT00591773|524099808|FG000|Overall Study|Lost to Follow-up|1|||
145413792|NCT05774977|524368412|FG000|Overall Study|Withdrawal by Subject|2|||
145413793|NCT00374868|524368413|FG000|Overall Study|Adverse Event|12|||
145413794|NCT00374868|524368413|FG000|Overall Study|Progressive Disease|7|||
145341813|NCT00591773|524099809|FG001|Overall Study|Lost to Follow-up|4|||
145341814|NCT00591773|524099810|FG002|Overall Study|Lost to Follow-up|1|||
145341815|NCT00591773|524099808|FG000|Overall Study|Withdrawal by Subject|2|||
145341816|NCT00591773|524099809|FG001|Overall Study|Withdrawal by Subject|5|||
145341817|NCT00591773|524099810|FG002|Overall Study|Withdrawal by Subject|3|||
145413795|NCT00374868|524368413|FG000|Overall Study|Physician Decision|13|||
145413796|NCT00374868|524368413|FG000|Overall Study|Lost to Follow-up|1|||
145575109|NCT03013491|524960194|FG002|Main Study|Disease progression|0|||
145575110|NCT03013491|524960195|FG003|Main Study|Disease progression|1|||
145575111|NCT03013491|524960196|FG004|Main Study|Disease progression|0|||
145575112|NCT03013491|524960197|FG005|Main Study|Disease progression|0|||
145575113|NCT03013491|524960198|FG006|Main Study|Disease progression|0|||
145575114|NCT03013491|524960199|FG007|Main Study|Disease progression|0|||
145575115|NCT03013491|524960200|FG008|Main Study|Disease progression|1|||
145575116|NCT03013491|524960201|FG009|Main Study|Disease progression|0|||
145575117|NCT03013491|524960202|FG010|Main Study|Disease progression|1|||
145575118|NCT03013491|524960203|FG011|Main Study|Disease progression|0|||
145575119|NCT03013491|524960204|FG012|Main Study|Disease progression|0|||
145575120|NCT03013491|524960205|FG013|Main Study|Disease progression|0|||
145575121|NCT03013491|524960206|FG014|Main Study|Disease progression|0|||
145575122|NCT03013491|524960207|FG015|Main Study|Disease progression|0|||
145575123|NCT03013491|524960208|FG016|Main Study|Disease progression|0|||
145575124|NCT03013491|524960209|FG017|Main Study|Disease progression|0|||
145575125|NCT03013491|524960210|FG018|Main Study|Disease progression|4|||
145575126|NCT03013491|524960192|FG000|Main Study|Symptomatic deterioration|0|||
145575127|NCT03013491|524960193|FG001|Main Study|Symptomatic deterioration|0|||
145575128|NCT03013491|524960194|FG002|Main Study|Symptomatic deterioration|0|||
145575129|NCT03013491|524960195|FG003|Main Study|Symptomatic deterioration|0|||
145575130|NCT03013491|524960196|FG004|Main Study|Symptomatic deterioration|0|||
145575131|NCT03013491|524960197|FG005|Main Study|Symptomatic deterioration|1|||
145575132|NCT03013491|524960198|FG006|Main Study|Symptomatic deterioration|0|||
145575133|NCT03013491|524960199|FG007|Main Study|Symptomatic deterioration|0|||
145575134|NCT03013491|524960200|FG008|Main Study|Symptomatic deterioration|0|||
145575135|NCT03013491|524960201|FG009|Main Study|Symptomatic deterioration|0|||
145575136|NCT03013491|524960202|FG010|Main Study|Symptomatic deterioration|0|||
145575137|NCT03013491|524960203|FG011|Main Study|Symptomatic deterioration|0|||
145575138|NCT03013491|524960204|FG012|Main Study|Symptomatic deterioration|0|||
145575139|NCT03013491|524960205|FG013|Main Study|Symptomatic deterioration|0|||
145575140|NCT03013491|524960206|FG014|Main Study|Symptomatic deterioration|0|||
145575141|NCT03013491|524960207|FG015|Main Study|Symptomatic deterioration|0|||
145575142|NCT03013491|524960208|FG016|Main Study|Symptomatic deterioration|0|||
145575143|NCT03013491|524960209|FG017|Main Study|Symptomatic deterioration|0|||
145575144|NCT03013491|524960210|FG018|Main Study|Symptomatic deterioration|0|||
145341818|NCT00591773|524099808|FG000|Overall Study|Lack of Efficacy|1|||
145341819|NCT00591773|524099809|FG001|Overall Study|Lack of Efficacy|2|||
145341820|NCT00591773|524099810|FG002|Overall Study|Lack of Efficacy|2|||
145341821|NCT00591773|524099808|FG000|Overall Study|Other|1|||
145341822|NCT00591773|524099809|FG001|Overall Study|Other|1|||
145341823|NCT00591773|524099810|FG002|Overall Study|Other|4|||
145341824|NCT01207583|524099811|FG000|Overall Study|Withdrawal by Subject|0|||
145341825|NCT01207583|524099812|FG001|Overall Study|Withdrawal by Subject|3|||
145341826|NCT01207583|524099813|FG002|Overall Study|Withdrawal by Subject|1|||
145341827|NCT01207583|524099811|FG000|Overall Study|Participant failed to return|1|||
145341828|NCT01207583|524099812|FG001|Overall Study|Participant failed to return|0|||
145341829|NCT01207583|524099813|FG002|Overall Study|Participant failed to return|0|||
145341830|NCT01207583|524099811|FG000|Overall Study|Lost to Follow-up|0|||
145341831|NCT01207583|524099812|FG001|Overall Study|Lost to Follow-up|2|||
145341832|NCT01207583|524099813|FG002|Overall Study|Lost to Follow-up|0|||
145341833|NCT02473523|524099814|FG000|Overall Study|Death|1|||
145341834|NCT02473523|524099814|FG000|Overall Study|Lost to Follow-up|1|||
145341835|NCT01191944|524099815|FG000|Overall Study|Adverse Event|11|||
145341836|NCT01191944|524099816|FG001|Overall Study|Adverse Event|12|||
145341837|NCT01191944|524099815|FG000|Overall Study|Protocol Violation|1|||
145341838|NCT01191944|524099816|FG001|Overall Study|Protocol Violation|2|||
145341839|NCT01191944|524099815|FG000|Overall Study|Withdrawal by Subject|4|||
145341840|NCT01191944|524099816|FG001|Overall Study|Withdrawal by Subject|2|||
145341841|NCT01191944|524099815|FG000|Overall Study|Other|1|||
145341842|NCT01191944|524099816|FG001|Overall Study|Other|3|||
145341843|NCT00253448|524099819|FG000|Overall Study|Withdrawal by Subject|1|||
145341844|NCT02052011|524099820|FG000|Overall Study|Lost to Follow-up|3|||
145341845|NCT02052011|524099821|FG001|Overall Study|Lost to Follow-up|0|||
145341846|NCT02052011|524099820|FG000|Overall Study|Withdrawal by Subject|1|||
145341847|NCT02052011|524099821|FG001|Overall Study|Withdrawal by Subject|2|||
145341848|NCT00000620|524099822|FG000|Overall Study|Death|86|||
145341849|NCT00000620|524099823|FG001|Overall Study|Death|67|||
145341850|NCT00000620|524099824|FG002|Overall Study|Death|112|||
145341851|NCT00000620|524099825|FG003|Overall Study|Death|126|||
145341852|NCT00000620|524099826|FG004|Overall Study|Death|64|||
145341853|NCT00000620|524099827|FG005|Overall Study|Death|77|||
145341854|NCT00000620|524099828|FG006|Overall Study|Death|91|||
145341855|NCT00000620|524099829|FG007|Overall Study|Death|95|||
145341856|NCT00000620|524099822|FG000|Overall Study|Lost to Follow-up|14|||
145341857|NCT00000620|524099823|FG001|Overall Study|Lost to Follow-up|14|||
145341858|NCT00000620|524099824|FG002|Overall Study|Lost to Follow-up|14|||
145341859|NCT00000620|524099825|FG003|Overall Study|Lost to Follow-up|14|||
145341860|NCT00000620|524099826|FG004|Overall Study|Lost to Follow-up|15|||
145341861|NCT00000620|524099827|FG005|Overall Study|Lost to Follow-up|15|||
145341862|NCT00000620|524099828|FG006|Overall Study|Lost to Follow-up|13|||
145575145|NCT03013491|524960192|FG000|Main Study|Protocol version 8.0 approval|0|||
145575146|NCT03013491|524960193|FG001|Main Study|Protocol version 8.0 approval|0|||
145575147|NCT03013491|524960194|FG002|Main Study|Protocol version 8.0 approval|0|||
145575148|NCT03013491|524960195|FG003|Main Study|Protocol version 8.0 approval|0|||
145575149|NCT03013491|524960196|FG004|Main Study|Protocol version 8.0 approval|0|||
145575150|NCT03013491|524960197|FG005|Main Study|Protocol version 8.0 approval|0|||
145575151|NCT03013491|524960198|FG006|Main Study|Protocol version 8.0 approval|0|||
145575152|NCT03013491|524960199|FG007|Main Study|Protocol version 8.0 approval|0|||
145575153|NCT03013491|524960200|FG008|Main Study|Protocol version 8.0 approval|0|||
145575154|NCT03013491|524960201|FG009|Main Study|Protocol version 8.0 approval|0|||
145575155|NCT03013491|524960202|FG010|Main Study|Protocol version 8.0 approval|1|||
145575156|NCT03013491|524960203|FG011|Main Study|Protocol version 8.0 approval|0|||
145575157|NCT03013491|524960204|FG012|Main Study|Protocol version 8.0 approval|0|||
145575158|NCT03013491|524960205|FG013|Main Study|Protocol version 8.0 approval|0|||
145575159|NCT03013491|524960206|FG014|Main Study|Protocol version 8.0 approval|0|||
145575160|NCT03013491|524960207|FG015|Main Study|Protocol version 8.0 approval|0|||
145575161|NCT03013491|524960208|FG016|Main Study|Protocol version 8.0 approval|0|||
145341863|NCT00000620|524099829|FG007|Overall Study|Lost to Follow-up|14|||
145341864|NCT00000620|524099822|FG000|Overall Study|Withdrawal by Subject|40|||
145575162|NCT03013491|524960209|FG017|Main Study|Protocol version 8.0 approval|0|||
145575163|NCT03013491|524960210|FG018|Main Study|Protocol version 8.0 approval|0|||
145341865|NCT00000620|524099823|FG001|Overall Study|Withdrawal by Subject|27|||
145341866|NCT00000620|524099824|FG002|Overall Study|Withdrawal by Subject|28|||
145341867|NCT00000620|524099825|FG003|Overall Study|Withdrawal by Subject|27|||
145341868|NCT00000620|524099826|FG004|Overall Study|Withdrawal by Subject|30|||
145341869|NCT00000620|524099827|FG005|Overall Study|Withdrawal by Subject|32|||
145341870|NCT00000620|524099828|FG006|Overall Study|Withdrawal by Subject|32|||
145341871|NCT00000620|524099829|FG007|Overall Study|Withdrawal by Subject|21|||
145341872|NCT00000620|524099822|FG000|Overall Study|missed closeout visit|22|||
145341873|NCT00000620|524099823|FG001|Overall Study|missed closeout visit|28|||
145575164|NCT03013491|524960192|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
145575165|NCT03013491|524960193|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
145575166|NCT03013491|524960194|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
145341874|NCT00000620|524099824|FG002|Overall Study|missed closeout visit|16|||
145341875|NCT00000620|524099825|FG003|Overall Study|missed closeout visit|11|||
145341876|NCT00000620|524099826|FG004|Overall Study|missed closeout visit|26|||
145341877|NCT00000620|524099827|FG005|Overall Study|missed closeout visit|28|||
145341878|NCT00000620|524099828|FG006|Overall Study|missed closeout visit|13|||
145341879|NCT00000620|524099829|FG007|Overall Study|missed closeout visit|16|||
145341880|NCT01851330|524099830|FG000|Overall Study|Lack of Efficacy|10|||
145341881|NCT01851330|524099831|FG001|Overall Study|Lack of Efficacy|9|||
145341882|NCT01851330|524099832|FG002|Overall Study|Lack of Efficacy|2|||
145341883|NCT01851330|524099830|FG000|Overall Study|Lost to Follow-up|1|||
145341884|NCT01851330|524099831|FG001|Overall Study|Lost to Follow-up|6|||
145341885|NCT01851330|524099832|FG002|Overall Study|Lost to Follow-up|9|||
145341886|NCT01851330|524099830|FG000|Overall Study|Withdrew Consent|2|||
145341887|NCT01851330|524099831|FG001|Overall Study|Withdrew Consent|1|||
145341888|NCT01851330|524099832|FG002|Overall Study|Withdrew Consent|0|||
145341889|NCT01851330|524099830|FG000|Overall Study|Investigator's Discretion|0|||
145341890|NCT01851330|524099831|FG001|Overall Study|Investigator's Discretion|0|||
145341891|NCT01851330|524099832|FG002|Overall Study|Investigator's Discretion|1|||
145341892|NCT01307111|524099835|FG000|IUD Insertion|Lost to Follow-up|2|||
145341893|NCT01307111|524099836|FG001|IUD Insertion|Lost to Follow-up|0|||
145341894|NCT01307111|524099835|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
145341895|NCT01307111|524099836|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
145341896|NCT01275729|524099840|FG000|Overall Study|Death|3|||
145341897|NCT01275729|524099840|FG000|Overall Study|Withdrawal by Subject|1|||
145341898|NCT02252406|524099841|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
145341899|NCT02252406|524099842|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
145341900|NCT02252406|524099841|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
145341901|NCT02252406|524099842|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
145341902|NCT02252406|524099841|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
145341903|NCT02252406|524099842|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
145341904|NCT02252406|524099841|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
145341905|NCT02252406|524099842|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
145341906|NCT02252406|524099841|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
145341907|NCT02252406|524099842|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
145341908|NCT01174043|524099843|FG000|Overall Study|Disease progression|5|||
145341909|NCT01174043|524099843|FG000|Overall Study|Adverse Event|3|||
145341910|NCT01174043|524099843|FG000|Overall Study|Death|1|||
145341911|NCT01174043|524099843|FG000|Overall Study|Withdrawal by Subject|2|||
145341912|NCT02047734|524099844|FG000|Overall Study|Adverse Event|18|||
145341913|NCT02047734|524099845|FG001|Overall Study|Adverse Event|13|||
145341914|NCT02047734|524099846|FG002|Overall Study|Adverse Event|13|||
145341915|NCT02047734|524099844|FG000|Overall Study|Lack of Efficacy|4|||
145341916|NCT02047734|524099845|FG001|Overall Study|Lack of Efficacy|5|||
145341917|NCT02047734|524099846|FG002|Overall Study|Lack of Efficacy|1|||
145341918|NCT02047734|524099844|FG000|Overall Study|Protocol Violation|3|||
145341919|NCT02047734|524099845|FG001|Overall Study|Protocol Violation|1|||
145341920|NCT02047734|524099846|FG002|Overall Study|Protocol Violation|1|||
145341921|NCT02047734|524099844|FG000|Overall Study|Lost to Follow-up|1|||
145341922|NCT02047734|524099845|FG001|Overall Study|Lost to Follow-up|4|||
145341923|NCT02047734|524099846|FG002|Overall Study|Lost to Follow-up|0|||
145341924|NCT02047734|524099844|FG000|Overall Study|Death|0|||
145341925|NCT02047734|524099845|FG001|Overall Study|Death|1|||
145341926|NCT02047734|524099846|FG002|Overall Study|Death|0|||
145341927|NCT02047734|524099844|FG000|Overall Study|Withdrawal by Subject|30|||
145341928|NCT02047734|524099845|FG001|Overall Study|Withdrawal by Subject|31|||
145341929|NCT02047734|524099846|FG002|Overall Study|Withdrawal by Subject|19|||
145341930|NCT02047734|524099844|FG000|Overall Study|Physician Decision|7|||
145341931|NCT02047734|524099845|FG001|Overall Study|Physician Decision|6|||
145341932|NCT02047734|524099846|FG002|Overall Study|Physician Decision|5|||
145341933|NCT02047734|524099844|FG000|Overall Study|Miscellaneous|2|||
145341934|NCT02047734|524099845|FG001|Overall Study|Miscellaneous|4|||
145341935|NCT02047734|524099846|FG002|Overall Study|Miscellaneous|6|||
145341936|NCT02047734|524099844|FG000|Overall Study|Did Not Receive Study Drug|2|||
145341937|NCT02047734|524099845|FG001|Overall Study|Did Not Receive Study Drug|4|||
145341938|NCT02047734|524099846|FG002|Overall Study|Did Not Receive Study Drug|1|||
145341939|NCT02289456|524099853|FG000|Induction Period|Death|2|||
145341940|NCT02289456|524099853|FG000|Induction Period|Adverse Event|11|||
145341941|NCT02289456|524099853|FG000|Induction Period|Progressive Disease (PD)|4|||
145341942|NCT02289456|524099853|FG000|Induction Period|Symptomatic Deterioration|4|||
145341943|NCT02289456|524099853|FG000|Induction Period|Withdrawal by Subject|2|||
145341944|NCT02289456|524099853|FG000|Induction Period|Miscellaneous|1|||
145341945|NCT02289456|524099853|FG000|Monotherapy Period|Death|1|||
145341946|NCT02289456|524099853|FG000|Monotherapy Period|Adverse Event|1|||
145341947|NCT02289456|524099853|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
145341948|NCT02289456|524099853|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
145341949|NCT02289456|524099853|FG000|Monotherapy Period|Withdrawal by Subject|2|||
145341950|NCT02289456|524099853|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
145341951|NCT02289456|524099853|FG000|Monotherapy Period|Miscellaneous|1|||
145341952|NCT02463357|524099854|FG000|Overall Study|Withdrawal by Subject|1|||
145341953|NCT02463357|524099855|FG001|Overall Study|Withdrawal by Subject|0|||
145341954|NCT02463357|524099856|FG002|Overall Study|Withdrawal by Subject|0|||
145341955|NCT02463357|524099857|FG003|Overall Study|Withdrawal by Subject|0|||
145341956|NCT02463357|524099858|FG004|Overall Study|Withdrawal by Subject|0|||
145341957|NCT02463357|524099854|FG000|Overall Study|Withdrawal by Subject|0|||
145341958|NCT02463357|524099855|FG001|Overall Study|Withdrawal by Subject|0|||
145341959|NCT02463357|524099856|FG002|Overall Study|Withdrawal by Subject|0|||
145341960|NCT02463357|524099857|FG003|Overall Study|Withdrawal by Subject|0|||
145341961|NCT02463357|524099858|FG004|Overall Study|Withdrawal by Subject|1|||
145341962|NCT01371539|524099861|FG000|Period One: One Week|Lost to Follow-up|0|||
145341963|NCT01371539|524099862|FG001|Period One: One Week|Lost to Follow-up|1|||
145341964|NCT01371539|524099861|FG000|Period Two: One Week|Lost to Follow-up|0|||
145341965|NCT01371539|524099862|FG001|Period Two: One Week|Lost to Follow-up|1|||
145341966|NCT01371539|524099861|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
145341967|NCT01371539|524099862|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
145341968|NCT01371539|524099861|FG000|Period Two: One Week|Time/job conflict|0|||
145341969|NCT01371539|524099862|FG001|Period Two: One Week|Time/job conflict|1|||
145341970|NCT01399658|524099863|FG000|Overall Study|Ineligible|1|||
145341971|NCT01399658|524099863|FG000|Overall Study|Machine Technical Issue|3|||
145341972|NCT01399658|524099863|FG000|Overall Study|Alternative therapy|1|||
145341973|NCT01399658|524099863|FG000|Overall Study|No reason given|1|||
145341974|NCT01721317|524099865|FG000|Overall Study|Study Closed / Terminated|2|||
145341975|NCT01721317|524099866|FG001|Overall Study|Study Closed / Terminated|2|||
145341976|NCT01721317|524099865|FG000|Overall Study|Physician Decision|0|||
145341977|NCT01721317|524099866|FG001|Overall Study|Physician Decision|1|||
145341978|NCT01721317|524099865|FG000|Overall Study|Withdrawal by Subject|0|||
145575167|NCT03013491|524960195|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
145575168|NCT03013491|524960196|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
145575169|NCT03013491|524960197|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
145575170|NCT03013491|524960198|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
145575171|NCT03013491|524960199|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
145575172|NCT03013491|524960200|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
145575173|NCT03013491|524960201|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
145575174|NCT03013491|524960202|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
145575175|NCT03013491|524960203|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
145575176|NCT03013491|524960204|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
145575177|NCT03013491|524960205|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
145575178|NCT03013491|524960206|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
145575179|NCT03013491|524960207|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
145575180|NCT03013491|524960208|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
145575181|NCT03013491|524960209|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
145575182|NCT03013491|524960210|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
145575183|NCT03013491|524960192|FG000|Main Study|Start of new anticancer therapy|0|||
145575184|NCT03013491|524960193|FG001|Main Study|Start of new anticancer therapy|0|||
145575185|NCT03013491|524960194|FG002|Main Study|Start of new anticancer therapy|0|||
145575186|NCT03013491|524960195|FG003|Main Study|Start of new anticancer therapy|0|||
145575187|NCT03013491|524960196|FG004|Main Study|Start of new anticancer therapy|0|||
145575188|NCT03013491|524960197|FG005|Main Study|Start of new anticancer therapy|0|||
145575189|NCT03013491|524960198|FG006|Main Study|Start of new anticancer therapy|0|||
145575190|NCT03013491|524960199|FG007|Main Study|Start of new anticancer therapy|0|||
145575191|NCT03013491|524960200|FG008|Main Study|Start of new anticancer therapy|0|||
145575192|NCT03013491|524960201|FG009|Main Study|Start of new anticancer therapy|0|||
145575193|NCT03013491|524960202|FG010|Main Study|Start of new anticancer therapy|0|||
145575194|NCT03013491|524960203|FG011|Main Study|Start of new anticancer therapy|0|||
145575195|NCT03013491|524960204|FG012|Main Study|Start of new anticancer therapy|0|||
145575196|NCT03013491|524960205|FG013|Main Study|Start of new anticancer therapy|0|||
145575197|NCT03013491|524960206|FG014|Main Study|Start of new anticancer therapy|0|||
145575198|NCT03013491|524960207|FG015|Main Study|Start of new anticancer therapy|0|||
145575199|NCT03013491|524960208|FG016|Main Study|Start of new anticancer therapy|0|||
145575200|NCT03013491|524960209|FG017|Main Study|Start of new anticancer therapy|0|||
145575201|NCT03013491|524960210|FG018|Main Study|Start of new anticancer therapy|2|||
145575202|NCT03013491|524960192|FG000|Long-term Extension|Disease progression|0|||
145575203|NCT03013491|524960193|FG001|Long-term Extension|Disease progression|0|||
145575204|NCT03013491|524960194|FG002|Long-term Extension|Disease progression|0|||
145575205|NCT03013491|524960195|FG003|Long-term Extension|Disease progression|1|||
145341979|NCT01721317|524099866|FG001|Overall Study|Withdrawal by Subject|1|||
145341980|NCT02806024|524099875|FG000|Overall Study|Night Delivery|1|||
145341981|NCT02806024|524099876|FG001|Overall Study|Night Delivery|1|||
145341982|NCT02806024|524099875|FG000|Overall Study|DVT during antepartum admission|0|||
145575206|NCT03013491|524960196|FG004|Long-term Extension|Disease progression|0|||
145575207|NCT03013491|524960197|FG005|Long-term Extension|Disease progression|0|||
145575208|NCT03013491|524960198|FG006|Long-term Extension|Disease progression|0|||
145575209|NCT03013491|524960199|FG007|Long-term Extension|Disease progression|0|||
145575210|NCT03013491|524960200|FG008|Long-term Extension|Disease progression|0|||
145575211|NCT03013491|524960201|FG009|Long-term Extension|Disease progression|0|||
145575212|NCT03013491|524960202|FG010|Long-term Extension|Disease progression|0|||
145575213|NCT03013491|524960203|FG011|Long-term Extension|Disease progression|0|||
145575214|NCT03013491|524960204|FG012|Long-term Extension|Disease progression|0|||
145575215|NCT03013491|524960205|FG013|Long-term Extension|Disease progression|0|||
145575216|NCT03013491|524960206|FG014|Long-term Extension|Disease progression|0|||
145575217|NCT03013491|524960207|FG015|Long-term Extension|Disease progression|0|||
145575218|NCT03013491|524960208|FG016|Long-term Extension|Disease progression|0|||
145575219|NCT03013491|524960209|FG017|Long-term Extension|Disease progression|0|||
145575220|NCT03013491|524960210|FG018|Long-term Extension|Disease progression|1|||
145575221|NCT03013491|524960192|FG000|Long-term Extension|Withdrawal by Subject|0|||
145575222|NCT03013491|524960193|FG001|Long-term Extension|Withdrawal by Subject|0|||
145575223|NCT03013491|524960194|FG002|Long-term Extension|Withdrawal by Subject|0|||
145575224|NCT03013491|524960195|FG003|Long-term Extension|Withdrawal by Subject|0|||
145575225|NCT03013491|524960196|FG004|Long-term Extension|Withdrawal by Subject|0|||
145575226|NCT03013491|524960197|FG005|Long-term Extension|Withdrawal by Subject|0|||
145575227|NCT03013491|524960198|FG006|Long-term Extension|Withdrawal by Subject|0|||
145575228|NCT03013491|524960199|FG007|Long-term Extension|Withdrawal by Subject|1|||
145575229|NCT03013491|524960200|FG008|Long-term Extension|Withdrawal by Subject|0|||
145575230|NCT03013491|524960201|FG009|Long-term Extension|Withdrawal by Subject|0|||
145575231|NCT03013491|524960202|FG010|Long-term Extension|Withdrawal by Subject|0|||
145575232|NCT03013491|524960203|FG011|Long-term Extension|Withdrawal by Subject|0|||
145575233|NCT03013491|524960204|FG012|Long-term Extension|Withdrawal by Subject|0|||
145575234|NCT03013491|524960205|FG013|Long-term Extension|Withdrawal by Subject|0|||
145575235|NCT03013491|524960206|FG014|Long-term Extension|Withdrawal by Subject|0|||
145575236|NCT03013491|524960207|FG015|Long-term Extension|Withdrawal by Subject|0|||
145575237|NCT03013491|524960208|FG016|Long-term Extension|Withdrawal by Subject|0|||
145575238|NCT03013491|524960209|FG017|Long-term Extension|Withdrawal by Subject|0|||
145575239|NCT03013491|524960210|FG018|Long-term Extension|Withdrawal by Subject|0|||
145575240|NCT03013491|524960192|FG000|Long-term Extension|Adverse Event|0|||
145575241|NCT03013491|524960193|FG001|Long-term Extension|Adverse Event|0|||
145575242|NCT03013491|524960194|FG002|Long-term Extension|Adverse Event|0|||
145575243|NCT03013491|524960195|FG003|Long-term Extension|Adverse Event|0|||
145575244|NCT03013491|524960196|FG004|Long-term Extension|Adverse Event|0|||
145575245|NCT03013491|524960197|FG005|Long-term Extension|Adverse Event|0|||
145575246|NCT03013491|524960198|FG006|Long-term Extension|Adverse Event|0|||
145575247|NCT03013491|524960199|FG007|Long-term Extension|Adverse Event|0|||
145575248|NCT03013491|524960200|FG008|Long-term Extension|Adverse Event|0|||
145575249|NCT03013491|524960201|FG009|Long-term Extension|Adverse Event|0|||
145575250|NCT03013491|524960202|FG010|Long-term Extension|Adverse Event|0|||
145575251|NCT03013491|524960203|FG011|Long-term Extension|Adverse Event|0|||
145575252|NCT03013491|524960204|FG012|Long-term Extension|Adverse Event|0|||
145575253|NCT03013491|524960205|FG013|Long-term Extension|Adverse Event|0|||
145575254|NCT03013491|524960206|FG014|Long-term Extension|Adverse Event|0|||
145575255|NCT03013491|524960207|FG015|Long-term Extension|Adverse Event|0|||
145575256|NCT03013491|524960208|FG016|Long-term Extension|Adverse Event|0|||
145575257|NCT03013491|524960209|FG017|Long-term Extension|Adverse Event|0|||
145575258|NCT03013491|524960210|FG018|Long-term Extension|Adverse Event|1|||
145575259|NCT03013491|524960192|FG000|Long-term Extension|Death|0|||
145575260|NCT03013491|524960193|FG001|Long-term Extension|Death|0|||
145575261|NCT03013491|524960194|FG002|Long-term Extension|Death|0|||
145575262|NCT03013491|524960195|FG003|Long-term Extension|Death|0|||
145575263|NCT03013491|524960196|FG004|Long-term Extension|Death|0|||
145575264|NCT03013491|524960197|FG005|Long-term Extension|Death|0|||
145575265|NCT03013491|524960198|FG006|Long-term Extension|Death|0|||
145575266|NCT03013491|524960199|FG007|Long-term Extension|Death|0|||
145575267|NCT03013491|524960200|FG008|Long-term Extension|Death|0|||
145575268|NCT03013491|524960201|FG009|Long-term Extension|Death|0|||
145575269|NCT03013491|524960202|FG010|Long-term Extension|Death|0|||
145575270|NCT03013491|524960203|FG011|Long-term Extension|Death|0|||
145575271|NCT03013491|524960204|FG012|Long-term Extension|Death|0|||
145575272|NCT03013491|524960205|FG013|Long-term Extension|Death|0|||
145575273|NCT03013491|524960206|FG014|Long-term Extension|Death|0|||
145575274|NCT03013491|524960207|FG015|Long-term Extension|Death|0|||
145575275|NCT03013491|524960208|FG016|Long-term Extension|Death|0|||
145575276|NCT03013491|524960209|FG017|Long-term Extension|Death|0|||
145575277|NCT03013491|524960210|FG018|Long-term Extension|Death|1|||
145575278|NCT03238911|524960213|FG000|Overall Study|Withdrawal by Subject|1|||
145575279|NCT03238911|524960214|FG001|Overall Study|Withdrawal by Subject|2|||
145575280|NCT03238911|524960213|FG000|Overall Study|Lost to Follow-up|2|||
145575281|NCT03238911|524960214|FG001|Overall Study|Lost to Follow-up|1|||
145575282|NCT02239536|524960215|FG000|Overall Study|Non-neoplastic polyp|23|||
145575283|NCT02239536|524960216|FG001|Overall Study|Non-neoplastic polyp|17|||
145575284|NCT04740034|524960222|FG000|Overall Study|Death|0|||
145575285|NCT04740034|524960223|FG001|Overall Study|Death|1|||
145341983|NCT02806024|524099876|FG001|Overall Study|DVT during antepartum admission|1|||
145341984|NCT02892149|524099877|FG000|Overall Study|Death|262|||
145341985|NCT02892149|524099878|FG001|Overall Study|Death|278|||
145341986|NCT02892149|524099877|FG000|Overall Study|Withdrawal by Subject|53|||
145341987|NCT02892149|524099878|FG001|Overall Study|Withdrawal by Subject|47|||
145341988|NCT02892149|524099877|FG000|Overall Study|Lost to Follow-up|37|||
145341989|NCT02892149|524099878|FG001|Overall Study|Lost to Follow-up|31|||
145341990|NCT04868968|524099886|FG000|Overall Study|Lost to Follow-up|1|||
145341991|NCT02996487|524099887|FG000|Overall Study|Lost to Follow-up|1|||
145341992|NCT02996487|524099888|FG001|Overall Study|Lost to Follow-up|1|||
145341993|NCT02996487|524099889|FG002|Overall Study|Lost to Follow-up|0|||
145575286|NCT04740034|524960224|FG002|Overall Study|Death|2|||
145575287|NCT04740034|524960225|FG003|Overall Study|Death|3|||
145575288|NCT04740034|524960226|FG004|Overall Study|Death|4|||
145575289|NCT04740034|524960227|FG005|Overall Study|Death|4|||
145575290|NCT04740034|524960228|FG006|Overall Study|Death|2|||
145575291|NCT04740034|524960229|FG007|Overall Study|Death|2|||
145575292|NCT04740034|524960230|FG008|Overall Study|Death|2|||
145575293|NCT04740034|524960231|FG009|Overall Study|Death|4|||
145575294|NCT04740034|524960232|FG010|Overall Study|Death|0|||
145575295|NCT04740034|524960222|FG000|Overall Study|Lost to Follow-up|0|||
145575296|NCT04740034|524960223|FG001|Overall Study|Lost to Follow-up|0|||
145575297|NCT04740034|524960224|FG002|Overall Study|Lost to Follow-up|0|||
145575298|NCT04740034|524960225|FG003|Overall Study|Lost to Follow-up|1|||
145575299|NCT04740034|524960226|FG004|Overall Study|Lost to Follow-up|2|||
145575300|NCT04740034|524960227|FG005|Overall Study|Lost to Follow-up|2|||
145575301|NCT04740034|524960228|FG006|Overall Study|Lost to Follow-up|0|||
145575302|NCT04740034|524960229|FG007|Overall Study|Lost to Follow-up|0|||
145575303|NCT04740034|524960230|FG008|Overall Study|Lost to Follow-up|0|||
145575304|NCT04740034|524960231|FG009|Overall Study|Lost to Follow-up|1|||
145575305|NCT04740034|524960232|FG010|Overall Study|Lost to Follow-up|0|||
145575306|NCT04740034|524960222|FG000|Overall Study|Withdrawal by Subject|1|||
145575307|NCT04740034|524960223|FG001|Overall Study|Withdrawal by Subject|0|||
145575308|NCT04740034|524960224|FG002|Overall Study|Withdrawal by Subject|0|||
145575309|NCT04740034|524960225|FG003|Overall Study|Withdrawal by Subject|0|||
145575310|NCT04740034|524960226|FG004|Overall Study|Withdrawal by Subject|0|||
145575311|NCT04740034|524960227|FG005|Overall Study|Withdrawal by Subject|0|||
145575312|NCT04740034|524960228|FG006|Overall Study|Withdrawal by Subject|0|||
145341994|NCT02996487|524099887|FG000|Overall Study|Death|0|||
145341995|NCT02996487|524099888|FG001|Overall Study|Death|1|||
145341996|NCT02996487|524099889|FG002|Overall Study|Death|0|||
145575313|NCT04740034|524960229|FG007|Overall Study|Withdrawal by Subject|1|||
145575314|NCT04740034|524960230|FG008|Overall Study|Withdrawal by Subject|0|||
145575315|NCT04740034|524960231|FG009|Overall Study|Withdrawal by Subject|1|||
145575316|NCT04740034|524960232|FG010|Overall Study|Withdrawal by Subject|0|||
145575317|NCT04740034|524960222|FG000|Overall Study|Decision by sponsor|0|||
145575318|NCT04740034|524960223|FG001|Overall Study|Decision by sponsor|0|||
145575319|NCT04740034|524960224|FG002|Overall Study|Decision by sponsor|1|||
145341997|NCT02996487|524099887|FG000|Overall Study|Withdrawal by Subject|2|||
145341998|NCT02996487|524099888|FG001|Overall Study|Withdrawal by Subject|3|||
145341999|NCT02996487|524099889|FG002|Overall Study|Withdrawal by Subject|0|||
145342000|NCT01004003|524099890|FG000|Overall Study|Progressive disease|2|||
145342001|NCT01004003|524099891|FG001|Overall Study|Progressive disease|1|||
145342002|NCT01004003|524099892|FG002|Overall Study|Progressive disease|1|||
145342003|NCT01004003|524099893|FG003|Overall Study|Progressive disease|0|||
145342004|NCT01004003|524099894|FG004|Overall Study|Progressive disease|2|||
145342005|NCT01004003|524099895|FG005|Overall Study|Progressive disease|1|||
145575320|NCT04740034|524960225|FG003|Overall Study|Decision by sponsor|0|||
145575321|NCT04740034|524960226|FG004|Overall Study|Decision by sponsor|0|||
145575322|NCT04740034|524960227|FG005|Overall Study|Decision by sponsor|0|||
145575323|NCT04740034|524960228|FG006|Overall Study|Decision by sponsor|1|||
145342006|NCT01004003|524099896|FG006|Overall Study|Progressive disease|1|||
145342007|NCT01004003|524099897|FG007|Overall Study|Progressive disease|39|||
145342008|NCT01004003|524099898|FG008|Overall Study|Progressive disease|22|||
145342009|NCT01004003|524099890|FG000|Overall Study|Adverse Event|4|||
145342010|NCT01004003|524099891|FG001|Overall Study|Adverse Event|2|||
145575324|NCT04740034|524960229|FG007|Overall Study|Decision by sponsor|2|||
145575325|NCT04740034|524960230|FG008|Overall Study|Decision by sponsor|1|||
145575326|NCT04740034|524960231|FG009|Overall Study|Decision by sponsor|1|||
145575327|NCT04740034|524960232|FG010|Overall Study|Decision by sponsor|2|||
145575328|NCT00991302|524962210|FG000|Overall Study|Death|0|||
145575329|NCT00991302|524962211|FG001|Overall Study|Death|1|||
145575330|NCT00991302|524962210|FG000|Overall Study|Lost to Follow-up|14|||
145575331|NCT00991302|524962211|FG001|Overall Study|Lost to Follow-up|12|||
145342011|NCT01004003|524099892|FG002|Overall Study|Adverse Event|3|||
145342012|NCT01004003|524099893|FG003|Overall Study|Adverse Event|3|||
145342013|NCT01004003|524099894|FG004|Overall Study|Adverse Event|2|||
145575332|NCT01709318|524962212|FG000|Overall Study|Adverse Event|3|||
145575333|NCT01709318|524962213|FG001|Overall Study|Adverse Event|4|||
145575334|NCT01709318|524962214|FG002|Overall Study|Adverse Event|2|||
145575335|NCT01709318|524962215|FG003|Overall Study|Adverse Event|2|||
145342014|NCT01004003|524099895|FG005|Overall Study|Adverse Event|2|||
145342015|NCT01004003|524099896|FG006|Overall Study|Adverse Event|7|||
145342016|NCT01004003|524099897|FG007|Overall Study|Adverse Event|21|||
145342017|NCT01004003|524099898|FG008|Overall Study|Adverse Event|6|||
145342018|NCT01004003|524099890|FG000|Overall Study|Refused to continue taking trial med.|0|||
145342019|NCT01004003|524099891|FG001|Overall Study|Refused to continue taking trial med.|0|||
145342020|NCT01004003|524099892|FG002|Overall Study|Refused to continue taking trial med.|0|||
145342021|NCT01004003|524099893|FG003|Overall Study|Refused to continue taking trial med.|0|||
145342022|NCT01004003|524099894|FG004|Overall Study|Refused to continue taking trial med.|0|||
145342023|NCT01004003|524099895|FG005|Overall Study|Refused to continue taking trial med.|0|||
145342024|NCT01004003|524099896|FG006|Overall Study|Refused to continue taking trial med.|0|||
145342025|NCT01004003|524099897|FG007|Overall Study|Refused to continue taking trial med.|0|||
145342026|NCT01004003|524099898|FG008|Overall Study|Refused to continue taking trial med.|2|||
145342027|NCT01004003|524099890|FG000|Overall Study|Other|0|||
145342028|NCT01004003|524099891|FG001|Overall Study|Other|0|||
145342029|NCT01004003|524099892|FG002|Overall Study|Other|0|||
145342030|NCT01004003|524099893|FG003|Overall Study|Other|0|||
145342031|NCT01004003|524099894|FG004|Overall Study|Other|0|||
145342032|NCT01004003|524099895|FG005|Overall Study|Other|1|||
145342033|NCT01004003|524099896|FG006|Overall Study|Other|0|||
145342034|NCT01004003|524099897|FG007|Overall Study|Other|0|||
145342035|NCT01004003|524099898|FG008|Overall Study|Other|0|||
145342036|NCT00259272|524099903|FG000|Overall Study|Adverse Event|2|||
145342037|NCT00259272|524099904|FG001|Overall Study|Adverse Event|1|||
145342038|NCT00259272|524099905|FG002|Overall Study|Adverse Event|0|||
145342039|NCT00259272|524099906|FG003|Overall Study|Adverse Event|3|||
145342040|NCT00259272|524099903|FG000|Overall Study|Lack of Efficacy|5|||
145342041|NCT00259272|524099904|FG001|Overall Study|Lack of Efficacy|1|||
145342042|NCT00259272|524099905|FG002|Overall Study|Lack of Efficacy|2|||
145342043|NCT00259272|524099906|FG003|Overall Study|Lack of Efficacy|6|||
145342044|NCT00259272|524099903|FG000|Overall Study|Physician Decision|1|||
145342045|NCT00259272|524099904|FG001|Overall Study|Physician Decision|2|||
145342046|NCT00259272|524099905|FG002|Overall Study|Physician Decision|1|||
145342047|NCT00259272|524099906|FG003|Overall Study|Physician Decision|3|||
145342048|NCT00259272|524099903|FG000|Overall Study|Protocol Violation|2|||
145342049|NCT00259272|524099904|FG001|Overall Study|Protocol Violation|0|||
145342050|NCT00259272|524099905|FG002|Overall Study|Protocol Violation|0|||
145342051|NCT00259272|524099906|FG003|Overall Study|Protocol Violation|1|||
145342052|NCT00259272|524099903|FG000|Overall Study|Sponsor Decision|0|||
145342053|NCT00259272|524099904|FG001|Overall Study|Sponsor Decision|1|||
145342054|NCT00259272|524099905|FG002|Overall Study|Sponsor Decision|0|||
145342055|NCT00259272|524099906|FG003|Overall Study|Sponsor Decision|0|||
145342056|NCT00259272|524099903|FG000|Overall Study|Withdrawal by Subject|4|||
145342057|NCT00259272|524099904|FG001|Overall Study|Withdrawal by Subject|2|||
145342058|NCT00259272|524099905|FG002|Overall Study|Withdrawal by Subject|2|||
145342059|NCT00259272|524099906|FG003|Overall Study|Withdrawal by Subject|7|||
145342060|NCT00259272|524099903|FG000|Overall Study|Lost to Follow-up|1|||
145575336|NCT01709318|524962216|FG004|Overall Study|Adverse Event|0|||
145342061|NCT00259272|524099904|FG001|Overall Study|Lost to Follow-up|0|||
145342062|NCT00259272|524099905|FG002|Overall Study|Lost to Follow-up|0|||
145342063|NCT00259272|524099906|FG003|Overall Study|Lost to Follow-up|1|||
145342064|NCT00103610|524099907|FG000|Overall Study|Entered Rescue Procedure|10|||
145342065|NCT00103610|524099908|FG001|Overall Study|Entered Rescue Procedure|52|||
145342066|NCT00103610|524099907|FG000|Overall Study|Death|16|||
145342067|NCT00103610|524099908|FG001|Overall Study|Death|12|||
145342068|NCT00103610|524099907|FG000|Overall Study|Elective Withdrawal|4|||
145342069|NCT00103610|524099908|FG001|Overall Study|Elective Withdrawal|0|||
145342070|NCT00103610|524099907|FG000|Overall Study|Lost to Follow-up|3|||
145342071|NCT00103610|524099908|FG001|Overall Study|Lost to Follow-up|1|||
145342072|NCT00103610|524099907|FG000|Overall Study|Adverse Event|2|||
145342073|NCT00103610|524099908|FG001|Overall Study|Adverse Event|2|||
145342074|NCT00103610|524099907|FG000|Overall Study|Other|2|||
145342075|NCT00103610|524099908|FG001|Overall Study|Other|7|||
145342076|NCT00103610|524099907|FG000|Overall Study|Failed mobilization|1|||
145575337|NCT01709318|524962217|FG005|Overall Study|Adverse Event|1|||
145342077|NCT00103610|524099908|FG001|Overall Study|Failed mobilization|5|||
145342078|NCT00103610|524099907|FG000|Overall Study|Noncompliance|0|||
145342079|NCT00103610|524099908|FG001|Overall Study|Noncompliance|1|||
145342080|NCT00315731|524099911|FG000|Overall Study|Lost to Follow-up|1|||
145342081|NCT00315731|524099911|FG000|Overall Study|Death|5|||
145342082|NCT04614246|524099912|FG000|Overall Study|Adverse Event|0|||
145342083|NCT04614246|524099913|FG001|Overall Study|Adverse Event|1|||
145342084|NCT04614246|524099914|FG002|Overall Study|Adverse Event|1|||
145342085|NCT04614246|524099915|FG003|Overall Study|Adverse Event|2|||
145342086|NCT04614246|524099916|FG004|Overall Study|Adverse Event|1|||
145342087|NCT04614246|524099912|FG000|Overall Study|Lost to Follow-up|0|||
145342088|NCT04614246|524099913|FG001|Overall Study|Lost to Follow-up|1|||
145342089|NCT04614246|524099914|FG002|Overall Study|Lost to Follow-up|0|||
145342090|NCT04614246|524099915|FG003|Overall Study|Lost to Follow-up|1|||
145575338|NCT01709318|524962218|FG006|Overall Study|Adverse Event|2|||
145342091|NCT04614246|524099916|FG004|Overall Study|Lost to Follow-up|3|||
145342092|NCT04614246|524099912|FG000|Overall Study|Other reason|0|||
145342093|NCT04614246|524099913|FG001|Overall Study|Other reason|1|||
145342094|NCT04614246|524099914|FG002|Overall Study|Other reason|2|||
145342095|NCT04614246|524099915|FG003|Overall Study|Other reason|0|||
145342096|NCT04614246|524099916|FG004|Overall Study|Other reason|0|||
145342097|NCT04614246|524099912|FG000|Overall Study|Withdrawal by Subject|4|||
145342098|NCT04614246|524099913|FG001|Overall Study|Withdrawal by Subject|2|||
145342099|NCT04614246|524099914|FG002|Overall Study|Withdrawal by Subject|4|||
145342100|NCT04614246|524099915|FG003|Overall Study|Withdrawal by Subject|3|||
145342101|NCT04614246|524099916|FG004|Overall Study|Withdrawal by Subject|4|||
145342102|NCT04614246|524099912|FG000|Overall Study|Physician Decision|0|||
145342103|NCT04614246|524099913|FG001|Overall Study|Physician Decision|2|||
145342104|NCT04614246|524099914|FG002|Overall Study|Physician Decision|1|||
145342105|NCT04614246|524099915|FG003|Overall Study|Physician Decision|0|||
145342106|NCT04614246|524099916|FG004|Overall Study|Physician Decision|0|||
145342107|NCT04614246|524099912|FG000|Overall Study|Study terminated by sponsor|10|||
145342108|NCT04614246|524099913|FG001|Overall Study|Study terminated by sponsor|15|||
145342109|NCT04614246|524099914|FG002|Overall Study|Study terminated by sponsor|12|||
145342110|NCT04614246|524099915|FG003|Overall Study|Study terminated by sponsor|13|||
145342111|NCT04614246|524099916|FG004|Overall Study|Study terminated by sponsor|9|||
145342112|NCT04614246|524099912|FG000|Overall Study|Pregnancy|2|||
145342113|NCT04614246|524099913|FG001|Overall Study|Pregnancy|0|||
145342114|NCT04614246|524099914|FG002|Overall Study|Pregnancy|1|||
145342115|NCT04614246|524099915|FG003|Overall Study|Pregnancy|0|||
145342116|NCT04614246|524099916|FG004|Overall Study|Pregnancy|0|||
145342117|NCT01680497|524099918|FG000|Overall Study|Lost to Follow-up|2|||
145342118|NCT03597464|524099921|FG000|Overall Study|Withdrawal by Subject|4|||
145342119|NCT03597464|524099922|FG001|Overall Study|Withdrawal by Subject|5|||
145342120|NCT03597464|524099921|FG000|Overall Study|Lost to Follow-up|3|||
145342121|NCT03597464|524099922|FG001|Overall Study|Lost to Follow-up|1|||
145342122|NCT03597464|524099921|FG000|Overall Study|Pregnancy|3|||
145342123|NCT03597464|524099922|FG001|Overall Study|Pregnancy|1|||
145342124|NCT03597464|524099921|FG000|Overall Study|Lack of Efficacy|2|||
145342125|NCT03597464|524099922|FG001|Overall Study|Lack of Efficacy|0|||
145342126|NCT03597464|524099921|FG000|Overall Study|Physician Decision|2|||
145342127|NCT03597464|524099922|FG001|Overall Study|Physician Decision|2|||
145342128|NCT03597464|524099921|FG000|Overall Study|Protocol Violation|1|||
145342129|NCT03597464|524099922|FG001|Overall Study|Protocol Violation|1|||
145342130|NCT03597464|524099921|FG000|Overall Study|Adverse Event|0|||
145342131|NCT03597464|524099922|FG001|Overall Study|Adverse Event|2|||
145342132|NCT03597464|524099921|FG000|Overall Study|Death|0|||
145342133|NCT03597464|524099922|FG001|Overall Study|Death|3|||
145342134|NCT00340678|524099929|FG000|Overall Study|Lost to Follow-up|1|||
145342135|NCT00340678|524099930|FG001|Overall Study|Lost to Follow-up|0|||
145342136|NCT00340678|524099931|FG002|Overall Study|Lost to Follow-up|0|||
145342137|NCT00340678|524099932|FG003|Overall Study|Lost to Follow-up|0|||
145342138|NCT00278889|524099933|FG000|Overall Study|Withdrawal by Subject|0|||
145342139|NCT00278889|524099934|FG001|Overall Study|Withdrawal by Subject|5|||
145342140|NCT00278889|524099935|FG002|Overall Study|Withdrawal by Subject|3|||
145342141|NCT00278889|524099933|FG000|Overall Study|Lost to Follow-up|1|||
145342142|NCT00278889|524099934|FG001|Overall Study|Lost to Follow-up|1|||
145342143|NCT00278889|524099935|FG002|Overall Study|Lost to Follow-up|0|||
145342144|NCT00278889|524099933|FG000|Overall Study|Death|24|||
145342145|NCT00278889|524099934|FG001|Overall Study|Death|21|||
145342146|NCT00278889|524099935|FG002|Overall Study|Death|17|||
145342147|NCT04042376|524099936|FG000|Overall Study|Withdrawal by Subject|1|||
145342148|NCT04042376|524099936|FG000|Overall Study|Death|3|||
145342149|NCT01243775|524099937|FG000|Overall Study|Withdrawal by Subject|2|||
145342150|NCT03092219|524102341|FG000|Overall Study|Protocol Violation|7|||
145342151|NCT03092219|524102342|FG001|Overall Study|Protocol Violation|4|||
145342152|NCT03278626|524102343|FG000|Overall Study|Death|2|||
145413797|NCT00374868|524368413|FG000|Overall Study|Death|2|||
145413798|NCT00374868|524368413|FG000|Overall Study|Other - Not Specified|1|||
145413799|NCT03188185|524368414|FG000|Stage 1|Adverse Event|4|||
145342153|NCT03278626|524102343|FG000|Overall Study|Toxicity|1|||
145342154|NCT03278626|524102343|FG000|Overall Study|Disease Progression|2|||
145342155|NCT05013008|524102345|FG000|Overall Study|Exclusion from mBFAS|5|||
145342156|NCT05013008|524102346|FG001|Overall Study|Exclusion from mBFAS|25|||
145342157|NCT01443728|524102347|FG000|Overall Study|Lost to Follow-up|2|||
145342158|NCT01443728|524102348|FG001|Overall Study|Lost to Follow-up|0|||
145342159|NCT01443728|524102347|FG000|Overall Study|Withdrawal by Subject|1|||
145413800|NCT03188185|524368415|FG001|Stage 1|Adverse Event|12|||
145342160|NCT01443728|524102348|FG001|Overall Study|Withdrawal by Subject|1|||
145413801|NCT03188185|524368416|FG002|Stage 1|Adverse Event|0|||
145413802|NCT03188185|524368417|FG003|Stage 1|Adverse Event|0|||
145342161|NCT01443728|524102347|FG000|Overall Study|Adverse Event|0|||
145342162|NCT01443728|524102348|FG001|Overall Study|Adverse Event|2|||
145342163|NCT04981717|524102349|FG000|Overall Study|Protocol Violation|0|||
145342164|NCT04981717|524102350|FG001|Overall Study|Protocol Violation|3|||
145413803|NCT03188185|524368414|FG000|Stage 1|Lack of Efficacy|0|||
145575339|NCT01709318|524962212|FG000|Overall Study|Lost to Follow-up|2|||
145575340|NCT01709318|524962213|FG001|Overall Study|Lost to Follow-up|0|||
145575341|NCT01709318|524962214|FG002|Overall Study|Lost to Follow-up|0|||
145575342|NCT01709318|524962215|FG003|Overall Study|Lost to Follow-up|0|||
145575343|NCT01709318|524962216|FG004|Overall Study|Lost to Follow-up|1|||
145575344|NCT01709318|524962217|FG005|Overall Study|Lost to Follow-up|1|||
145575345|NCT01709318|524962218|FG006|Overall Study|Lost to Follow-up|1|||
145575346|NCT01709318|524962212|FG000|Overall Study|Non-compliance with Study Drug|0|||
145575347|NCT01709318|524962213|FG001|Overall Study|Non-compliance with Study Drug|2|||
145575348|NCT01709318|524962214|FG002|Overall Study|Non-compliance with Study Drug|1|||
145575349|NCT01709318|524962215|FG003|Overall Study|Non-compliance with Study Drug|1|||
145575350|NCT01709318|524962216|FG004|Overall Study|Non-compliance with Study Drug|0|||
145575351|NCT01709318|524962217|FG005|Overall Study|Non-compliance with Study Drug|0|||
145575352|NCT01709318|524962218|FG006|Overall Study|Non-compliance with Study Drug|2|||
145575353|NCT01709318|524962212|FG000|Overall Study|Physician Decision|0|||
145575354|NCT01709318|524962213|FG001|Overall Study|Physician Decision|0|||
145575355|NCT01709318|524962214|FG002|Overall Study|Physician Decision|0|||
145575356|NCT01709318|524962215|FG003|Overall Study|Physician Decision|0|||
145575357|NCT01709318|524962216|FG004|Overall Study|Physician Decision|0|||
145575358|NCT01709318|524962217|FG005|Overall Study|Physician Decision|0|||
145575359|NCT01709318|524962218|FG006|Overall Study|Physician Decision|1|||
145575360|NCT01709318|524962212|FG000|Overall Study|Pregnancy|0|||
145575361|NCT01709318|524962213|FG001|Overall Study|Pregnancy|0|||
145575362|NCT01709318|524962214|FG002|Overall Study|Pregnancy|0|||
145575363|NCT01709318|524962215|FG003|Overall Study|Pregnancy|0|||
145575364|NCT01709318|524962216|FG004|Overall Study|Pregnancy|1|||
145575365|NCT01709318|524962217|FG005|Overall Study|Pregnancy|0|||
145575366|NCT01709318|524962218|FG006|Overall Study|Pregnancy|0|||
145575367|NCT01709318|524962212|FG000|Overall Study|Protocol Violation|0|||
145575368|NCT01709318|524962213|FG001|Overall Study|Protocol Violation|0|||
145575369|NCT01709318|524962214|FG002|Overall Study|Protocol Violation|0|||
145575370|NCT01709318|524962215|FG003|Overall Study|Protocol Violation|0|||
145575371|NCT01709318|524962216|FG004|Overall Study|Protocol Violation|2|||
145575372|NCT01709318|524962217|FG005|Overall Study|Protocol Violation|0|||
145575373|NCT01709318|524962218|FG006|Overall Study|Protocol Violation|1|||
145575374|NCT01709318|524962212|FG000|Overall Study|Technical Problems|1|||
145575375|NCT01709318|524962213|FG001|Overall Study|Technical Problems|0|||
145575376|NCT01709318|524962214|FG002|Overall Study|Technical Problems|0|||
145575377|NCT01709318|524962215|FG003|Overall Study|Technical Problems|0|||
145575378|NCT01709318|524962216|FG004|Overall Study|Technical Problems|0|||
145575379|NCT01709318|524962217|FG005|Overall Study|Technical Problems|0|||
145575380|NCT01709318|524962218|FG006|Overall Study|Technical Problems|0|||
145575381|NCT01709318|524962212|FG000|Overall Study|Withdrawal by Subject|3|||
145575382|NCT01709318|524962213|FG001|Overall Study|Withdrawal by Subject|0|||
145575383|NCT01709318|524962214|FG002|Overall Study|Withdrawal by Subject|3|||
145575384|NCT01709318|524962215|FG003|Overall Study|Withdrawal by Subject|3|||
145575385|NCT01709318|524962216|FG004|Overall Study|Withdrawal by Subject|0|||
145342165|NCT04981717|524102349|FG000|Overall Study|Adverse Event|1|||
145342166|NCT04981717|524102350|FG001|Overall Study|Adverse Event|3|||
145342167|NCT04981717|524102349|FG000|Overall Study|Pregnancy|1|||
145342168|NCT04981717|524102350|FG001|Overall Study|Pregnancy|0|||
145342169|NCT04981717|524102349|FG000|Overall Study|Physician Decision|1|||
145342170|NCT04981717|524102350|FG001|Overall Study|Physician Decision|0|||
145342171|NCT04981717|524102349|FG000|Overall Study|Sponsor Request|157|||
145342172|NCT04981717|524102350|FG001|Overall Study|Sponsor Request|172|||
145342173|NCT04981717|524102349|FG000|Overall Study|Lost to Follow-up|4|||
145342174|NCT04981717|524102350|FG001|Overall Study|Lost to Follow-up|5|||
145342175|NCT04981717|524102349|FG000|Overall Study|Withdrawal by Subject|50|||
145342176|NCT04981717|524102350|FG001|Overall Study|Withdrawal by Subject|37|||
145342177|NCT02640482|524102351|FG000|Overall Study|Lost to Follow-up|3|||
145342178|NCT02640482|524102352|FG001|Overall Study|Lost to Follow-up|0|||
145342179|NCT02129608|524102355|FG000|Overall Study|Lost to Follow-up|0|||
145342180|NCT02129608|524102356|FG001|Overall Study|Lost to Follow-up|1|||
145575386|NCT01709318|524962217|FG005|Overall Study|Withdrawal by Subject|2|||
145575387|NCT01709318|524962218|FG006|Overall Study|Withdrawal by Subject|4|||
145575388|NCT01709318|524962212|FG000|Overall Study|Other Protocol Specified Criteria|0|||
145575389|NCT01709318|524962213|FG001|Overall Study|Other Protocol Specified Criteria|1|||
145575390|NCT01709318|524962214|FG002|Overall Study|Other Protocol Specified Criteria|0|||
145575391|NCT01709318|524962215|FG003|Overall Study|Other Protocol Specified Criteria|0|||
145575392|NCT01709318|524962216|FG004|Overall Study|Other Protocol Specified Criteria|0|||
145575393|NCT01709318|524962217|FG005|Overall Study|Other Protocol Specified Criteria|0|||
145575394|NCT01709318|524962218|FG006|Overall Study|Other Protocol Specified Criteria|0|||
145342181|NCT02129608|524102357|FG002|Overall Study|Lost to Follow-up|1|||
145342182|NCT02129608|524102355|FG000|Overall Study|Withdrawal by Subject|0|||
145575395|NCT03370341|524962219|FG000|Overall Study|Lost to Follow-up|0|||
145575396|NCT03370341|524962220|FG001|Overall Study|Lost to Follow-up|1|||
145342183|NCT02129608|524102356|FG001|Overall Study|Withdrawal by Subject|0|||
145575397|NCT01707004|524962221|FG000|Overall Study|Physician Decision|3|||
145575398|NCT02573324|524962223|FG000|Overall Study|Withdrawal by Subject|26|||
145342184|NCT02129608|524102357|FG002|Overall Study|Withdrawal by Subject|2|||
145342185|NCT00451204|524102358|FG000|Overall Study|Adverse Event|4|||
145342186|NCT00451204|524102359|FG001|Overall Study|Adverse Event|6|||
145342187|NCT00451204|524102358|FG000|Overall Study|Lack of Efficacy|4|||
145342188|NCT00451204|524102359|FG001|Overall Study|Lack of Efficacy|4|||
145342189|NCT00451204|524102358|FG000|Overall Study|Lost to Follow-up|4|||
145342190|NCT00451204|524102359|FG001|Overall Study|Lost to Follow-up|4|||
145342191|NCT00451204|524102358|FG000|Overall Study|Protocol Violation|1|||
145342192|NCT00451204|524102359|FG001|Overall Study|Protocol Violation|0|||
145342193|NCT00451204|524102358|FG000|Overall Study|Patient refusal|8|||
145342194|NCT00451204|524102359|FG001|Overall Study|Patient refusal|4|||
145342195|NCT00451204|524102358|FG000|Overall Study|Other|1|||
145342196|NCT00451204|524102359|FG001|Overall Study|Other|2|||
145342197|NCT03760185|524102360|FG000|Overall Study|Lost to Follow-up|1|||
145342198|NCT03760185|524102361|FG001|Overall Study|Lost to Follow-up|1|||
145342199|NCT02242045|524102362|FG000|Overall Study|Investigator's Discretion|1|||
145342200|NCT02242045|524102362|FG000|Overall Study|Progressive Disease|2|||
145342201|NCT02242045|524102362|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
145342202|NCT02242045|524102362|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
145342203|NCT00976911|524102368|FG000|Overall Study|Withdrawal by Subject|4|||
145342204|NCT00976911|524102369|FG001|Overall Study|Withdrawal by Subject|6|||
145342205|NCT00976911|524102368|FG000|Overall Study|Death|138|||
145342206|NCT00976911|524102369|FG001|Overall Study|Death|126|||
145342207|NCT00976911|524102368|FG000|Overall Study|Adverse Event|0|||
145342208|NCT00976911|524102369|FG001|Overall Study|Adverse Event|1|||
145342209|NCT00976911|524102368|FG000|Overall Study|Protocol Violation|2|||
145342210|NCT00976911|524102369|FG001|Overall Study|Protocol Violation|0|||
145342211|NCT00976911|524102368|FG000|Overall Study|Other|8|||
145342212|NCT00976911|524102369|FG001|Overall Study|Other|9|||
145342213|NCT00976911|524102368|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
145342214|NCT00976911|524102369|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
145342215|NCT02954991|524102370|FG000|Overall Study|Death|92|||
145342216|NCT02954991|524102371|FG001|Overall Study|Death|11|||
145342217|NCT02954991|524102372|FG002|Overall Study|Death|2|||
145342218|NCT02954991|524102370|FG000|Overall Study|Lost to Follow-up|3|||
145342219|NCT02954991|524102371|FG001|Overall Study|Lost to Follow-up|2|||
145342220|NCT02954991|524102372|FG002|Overall Study|Lost to Follow-up|0|||
145342221|NCT02954991|524102370|FG000|Overall Study|Withdrawal by Subject|9|||
145342222|NCT02954991|524102371|FG001|Overall Study|Withdrawal by Subject|8|||
145342223|NCT02954991|524102372|FG002|Overall Study|Withdrawal by Subject|1|||
145342224|NCT02954991|524102370|FG000|Overall Study|Study Terminated by Sponsor|18|||
145342225|NCT02954991|524102371|FG001|Overall Study|Study Terminated by Sponsor|10|||
145342226|NCT02954991|524102372|FG002|Overall Study|Study Terminated by Sponsor|1|||
145342227|NCT02954991|524102370|FG000|Overall Study|Miscellaneous|2|||
145342228|NCT02954991|524102371|FG001|Overall Study|Miscellaneous|1|||
145342229|NCT02954991|524102372|FG002|Overall Study|Miscellaneous|1|||
145342230|NCT00576316|524102373|FG000|Overall Study|Adverse Event|9|||
145342231|NCT00576316|524102373|FG000|Overall Study|Withdrawal by Subject|2|||
145342232|NCT00576316|524102373|FG000|Overall Study|Protocol Violation|9|||
145575399|NCT02573324|524962224|FG001|Overall Study|Withdrawal by Subject|23|||
145575400|NCT02573324|524962225|FG002|Overall Study|Withdrawal by Subject|3|||
145575401|NCT02573324|524962223|FG000|Overall Study|Lost to Follow-up|4|||
145575402|NCT02573324|524962224|FG001|Overall Study|Lost to Follow-up|5|||
145575403|NCT02573324|524962225|FG002|Overall Study|Lost to Follow-up|0|||
145342233|NCT02552303|524102374|FG000|Allocation|Withdrawal by Subject|2|||
145342234|NCT02552303|524102375|FG001|Allocation|Withdrawal by Subject|1|||
145342235|NCT02552303|524102376|FG002|Allocation|Withdrawal by Subject|1|||
145342236|NCT02552303|524102377|FG003|Allocation|Withdrawal by Subject|1|||
145342237|NCT02552303|524102374|FG000|Allocation|ineligible|1|||
145342238|NCT02552303|524102375|FG001|Allocation|ineligible|1|||
145342239|NCT02552303|524102376|FG002|Allocation|ineligible|0|||
145342240|NCT02552303|524102377|FG003|Allocation|ineligible|0|||
145342241|NCT02552303|524102374|FG000|Follow-Up|Lost to Follow-up|0|||
145342242|NCT02552303|524102375|FG001|Follow-Up|Lost to Follow-up|0|||
145342243|NCT02552303|524102376|FG002|Follow-Up|Lost to Follow-up|1|||
145342244|NCT02552303|524102377|FG003|Follow-Up|Lost to Follow-up|0|||
145342245|NCT02552303|524102374|FG000|Follow-Up|ineligible|0|||
145342246|NCT02552303|524102375|FG001|Follow-Up|ineligible|2|||
145342247|NCT02552303|524102376|FG002|Follow-Up|ineligible|0|||
145342248|NCT02552303|524102377|FG003|Follow-Up|ineligible|0|||
145413804|NCT03188185|524368415|FG001|Stage 1|Lack of Efficacy|2|||
145342249|NCT04602546|524102382|FG000|Overall Study|Training|2|||
145342250|NCT04602546|524102383|FG001|Overall Study|Training|2|||
145342251|NCT04602546|524102384|FG002|Overall Study|Training|1|||
145575404|NCT02573324|524962223|FG000|Overall Study|Study Terminated by Sponsor|107|||
145342252|NCT04602546|524102385|FG003|Overall Study|Training|2|||
145342253|NCT04602546|524102386|FG004|Overall Study|Training|0|||
145342254|NCT04602546|524102382|FG000|Overall Study|Randomized with disqualified data|2|||
145342255|NCT04602546|524102383|FG001|Overall Study|Randomized with disqualified data|0|||
145342256|NCT04602546|524102384|FG002|Overall Study|Randomized with disqualified data|2|||
145342257|NCT04602546|524102385|FG003|Overall Study|Randomized with disqualified data|5|||
145342258|NCT04602546|524102386|FG004|Overall Study|Randomized with disqualified data|3|||
145342259|NCT01266031|524102387|FG000|Overall Study|Not treated|0|||
145342260|NCT01266031|524102388|FG001|Overall Study|Not treated|3|||
145342261|NCT01266031|524102389|FG002|Overall Study|Not treated|2|||
145342262|NCT03106987|524102390|FG000|Overall Study|Death|37|||
145342263|NCT03106987|524102391|FG001|Overall Study|Death|22|||
145575405|NCT02573324|524962224|FG001|Overall Study|Study Terminated by Sponsor|89|||
145575406|NCT02573324|524962225|FG002|Overall Study|Study Terminated by Sponsor|2|||
145575407|NCT02573324|524962223|FG000|Overall Study|Death|182|||
145575408|NCT02573324|524962224|FG001|Overall Study|Death|200|||
145575409|NCT02573324|524962225|FG002|Overall Study|Death|1|||
145575410|NCT02573324|524962223|FG000|Overall Study|Other, Not Specified|20|||
145575411|NCT02573324|524962224|FG001|Overall Study|Other, Not Specified|27|||
145575412|NCT02573324|524962225|FG002|Overall Study|Other, Not Specified|0|||
145575413|NCT02573324|524962223|FG000|Overall Study|Unknown Reason|2|||
145575414|NCT02573324|524962224|FG001|Overall Study|Unknown Reason|0|||
145575415|NCT02573324|524962225|FG002|Overall Study|Unknown Reason|0|||
145575416|NCT01607905|524962226|FG000|Overall Study|Withdrawal by participant|7|||
145575417|NCT01607905|524962227|FG001|Overall Study|Withdrawal by participant|2|||
145575418|NCT01607905|524962228|FG002|Overall Study|Withdrawal by participant|4|||
145575419|NCT01607905|524962229|FG003|Overall Study|Withdrawal by participant|6|||
145575420|NCT01607905|524962230|FG004|Overall Study|Withdrawal by participant|0|||
145575421|NCT01607905|524962231|FG005|Overall Study|Withdrawal by participant|4|||
145575422|NCT01607905|524962232|FG006|Overall Study|Withdrawal by participant|12|||
145575423|NCT01607905|524962226|FG000|Overall Study|Incidence or severity of AEs|5|||
145575424|NCT01607905|524962227|FG001|Overall Study|Incidence or severity of AEs|1|||
145575425|NCT01607905|524962228|FG002|Overall Study|Incidence or severity of AEs|1|||
145575426|NCT01607905|524962229|FG003|Overall Study|Incidence or severity of AEs|3|||
145575427|NCT01607905|524962230|FG004|Overall Study|Incidence or severity of AEs|0|||
145575428|NCT01607905|524962231|FG005|Overall Study|Incidence or severity of AEs|2|||
145575429|NCT01607905|524962232|FG006|Overall Study|Incidence or severity of AEs|8|||
145575430|NCT01607905|524962226|FG000|Overall Study|Disease progression|44|||
145575431|NCT01607905|524962227|FG001|Overall Study|Disease progression|16|||
145575432|NCT01607905|524962228|FG002|Overall Study|Disease progression|15|||
145575433|NCT01607905|524962229|FG003|Overall Study|Disease progression|11|||
145575434|NCT01607905|524962230|FG004|Overall Study|Disease progression|6|||
145575435|NCT01607905|524962231|FG005|Overall Study|Disease progression|7|||
145575436|NCT01607905|524962232|FG006|Overall Study|Disease progression|21|||
145575437|NCT01607905|524962226|FG000|Overall Study|Non-compliance with study procedures|0|||
145575438|NCT01607905|524962227|FG001|Overall Study|Non-compliance with study procedures|0|||
145575439|NCT01607905|524962228|FG002|Overall Study|Non-compliance with study procedures|0|||
145575440|NCT01607905|524962229|FG003|Overall Study|Non-compliance with study procedures|0|||
145575441|NCT01607905|524962230|FG004|Overall Study|Non-compliance with study procedures|0|||
145575442|NCT01607905|524962231|FG005|Overall Study|Non-compliance with study procedures|0|||
145575443|NCT01607905|524962232|FG006|Overall Study|Non-compliance with study procedures|1|||
145575444|NCT01607905|524962226|FG000|Overall Study|Death|1|||
145575445|NCT01607905|524962227|FG001|Overall Study|Death|1|||
145575446|NCT01607905|524962228|FG002|Overall Study|Death|1|||
145575447|NCT01607905|524962229|FG003|Overall Study|Death|1|||
145575448|NCT01607905|524962230|FG004|Overall Study|Death|0|||
145575449|NCT01607905|524962231|FG005|Overall Study|Death|0|||
145575450|NCT01607905|524962232|FG006|Overall Study|Death|3|||
145575451|NCT01607905|524962226|FG000|Overall Study|Other treatments become available|1|||
145575452|NCT01607905|524962227|FG001|Overall Study|Other treatments become available|0|||
145575453|NCT01607905|524962228|FG002|Overall Study|Other treatments become available|0|||
145575454|NCT01607905|524962229|FG003|Overall Study|Other treatments become available|0|||
145575455|NCT01607905|524962230|FG004|Overall Study|Other treatments become available|0|||
145342264|NCT03106987|524102392|FG002|Overall Study|Death|12|||
145413805|NCT03188185|524368416|FG002|Stage 1|Lack of Efficacy|0|||
145413806|NCT03188185|524368417|FG003|Stage 1|Lack of Efficacy|0|||
145342265|NCT03106987|524102393|FG003|Overall Study|Death|8|||
145342266|NCT03106987|524102390|FG000|Overall Study|Lost to Follow-up|2|||
145575456|NCT01607905|524962231|FG005|Overall Study|Other treatments become available|0|||
145575457|NCT01607905|524962232|FG006|Overall Study|Other treatments become available|1|||
145575458|NCT01607905|524962226|FG000|Overall Study|Investigator discretion|0|||
145575459|NCT01607905|524962227|FG001|Overall Study|Investigator discretion|0|||
145575460|NCT01607905|524962228|FG002|Overall Study|Investigator discretion|0|||
145575461|NCT01607905|524962229|FG003|Overall Study|Investigator discretion|0|||
145575462|NCT01607905|524962230|FG004|Overall Study|Investigator discretion|0|||
145575463|NCT01607905|524962231|FG005|Overall Study|Investigator discretion|1|||
145575464|NCT01607905|524962232|FG006|Overall Study|Investigator discretion|0|||
145575465|NCT01607905|524962226|FG000|Overall Study|Other|1|||
145342267|NCT03106987|524102391|FG001|Overall Study|Lost to Follow-up|0|||
145413807|NCT03188185|524368414|FG000|Stage 1|Lost to Follow-up|6|||
145575466|NCT01607905|524962227|FG001|Overall Study|Other|0|||
145575467|NCT01607905|524962228|FG002|Overall Study|Other|0|||
145575468|NCT01607905|524962229|FG003|Overall Study|Other|0|||
145575469|NCT01607905|524962230|FG004|Overall Study|Other|0|||
145342268|NCT03106987|524102392|FG002|Overall Study|Lost to Follow-up|2|||
145342269|NCT03106987|524102393|FG003|Overall Study|Lost to Follow-up|2|||
145342270|NCT03106987|524102390|FG000|Overall Study|Withdrawal by Subject|5|||
145342271|NCT03106987|524102391|FG001|Overall Study|Withdrawal by Subject|1|||
145342272|NCT03106987|524102392|FG002|Overall Study|Withdrawal by Subject|4|||
145342273|NCT03106987|524102393|FG003|Overall Study|Withdrawal by Subject|1|||
145342274|NCT03336528|524102394|FG000|Overall Study|Protocol Violation|1|||
145342275|NCT03336528|524102395|FG001|Overall Study|Protocol Violation|1|||
145342276|NCT03336528|524102394|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
145342277|NCT03336528|524102395|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
145342278|NCT03336528|524102394|FG000|Overall Study|Did not receive study medication|1|||
145342279|NCT03336528|524102395|FG001|Overall Study|Did not receive study medication|2|||
145342280|NCT02114385|524102398|FG000|Overall Study|Withdrawal by Subject|3|||
145342281|NCT02114385|524102399|FG001|Overall Study|Withdrawal by Subject|2|||
145342282|NCT02114385|524102398|FG000|Overall Study|Lost to Follow-up|0|||
145342283|NCT02114385|524102399|FG001|Overall Study|Lost to Follow-up|6|||
145342284|NCT01753297|524102403|FG000|Overall Study|Lost to Follow-up|7|||
145342285|NCT01753297|524102404|FG001|Overall Study|Lost to Follow-up|2|||
145342286|NCT01753297|524102403|FG000|Overall Study|Withdrawal by Subject|26|||
145342287|NCT01753297|524102404|FG001|Overall Study|Withdrawal by Subject|23|||
145342288|NCT01753297|524102403|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
145342289|NCT01753297|524102404|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
145342290|NCT01753297|524102403|FG000|Overall Study|Death|0|||
145342291|NCT01753297|524102404|FG001|Overall Study|Death|2|||
145342292|NCT01753297|524102403|FG000|Overall Study|Did not attend end of study visit|7|||
145342293|NCT01753297|524102404|FG001|Overall Study|Did not attend end of study visit|8|||
145342294|NCT00230178|524102405|FG000|Overall Study|Adverse Event|1|||
145342295|NCT00230178|524102406|FG001|Overall Study|Adverse Event|5|||
145342296|NCT00230178|524102407|FG002|Overall Study|Adverse Event|2|||
145342297|NCT00230178|524102405|FG000|Overall Study|Withdrawal by Subject|0|||
145342298|NCT00230178|524102406|FG001|Overall Study|Withdrawal by Subject|0|||
145342299|NCT00230178|524102407|FG002|Overall Study|Withdrawal by Subject|1|||
145342300|NCT00230178|524102405|FG000|Overall Study|Various other reasons|3|||
145342301|NCT00230178|524102406|FG001|Overall Study|Various other reasons|2|||
145342302|NCT00230178|524102407|FG002|Overall Study|Various other reasons|4|||
145342303|NCT02533180|524102410|FG000|Overall Study|Death|0|||
145342304|NCT02533180|524102411|FG001|Overall Study|Death|2|||
145342305|NCT02533180|524102410|FG000|Overall Study|Lost to Follow-up|0|||
145342306|NCT02533180|524102411|FG001|Overall Study|Lost to Follow-up|1|||
145342307|NCT02533180|524102410|FG000|Overall Study|Physician Decision|0|||
145342308|NCT02533180|524102411|FG001|Overall Study|Physician Decision|1|||
145342309|NCT02533180|524102410|FG000|Overall Study|Withdrawal by Subject|2|||
145342310|NCT02533180|524102411|FG001|Overall Study|Withdrawal by Subject|5|||
145342311|NCT02533180|524102410|FG000|Overall Study|Screen Failure|37|||
145342312|NCT02533180|524102411|FG001|Overall Study|Screen Failure|0|||
145342313|NCT02533180|524102410|FG000|Overall Study|Protocol Deviation|0|||
145342314|NCT02533180|524102411|FG001|Overall Study|Protocol Deviation|1|||
145342315|NCT02533180|524102410|FG000|Overall Study|Non-compliance|0|||
145342316|NCT02533180|524102411|FG001|Overall Study|Non-compliance|1|||
145342317|NCT00447876|524102412|FG000|Overall Study|Withdrawal by Subject|1|||
145342318|NCT00447876|524102413|FG001|Overall Study|Withdrawal by Subject|4|||
145342319|NCT00447876|524102412|FG000|Overall Study|Lost to Follow-up|1|||
145342320|NCT00447876|524102413|FG001|Overall Study|Lost to Follow-up|0|||
145342321|NCT00447876|524102412|FG000|Overall Study|Deterioration of symptomology|1|||
145342322|NCT00447876|524102413|FG001|Overall Study|Deterioration of symptomology|0|||
145342323|NCT00005957|524102414|FG000|Overall Study|No treated|3|||
145342324|NCT00005957|524102415|FG001|Overall Study|No treated|9|||
145575470|NCT01607905|524962231|FG005|Overall Study|Other|0|||
145575471|NCT01607905|524962232|FG006|Overall Study|Other|1|||
145575472|NCT01607905|524962226|FG000|Overall Study|Randomized but not treated|1|||
145575473|NCT01607905|524962227|FG001|Overall Study|Randomized but not treated|0|||
145575474|NCT01607905|524962228|FG002|Overall Study|Randomized but not treated|0|||
145342325|NCT00005957|524102414|FG000|Overall Study|Crossover to the other arm|5|||
145342326|NCT00005957|524102415|FG001|Overall Study|Crossover to the other arm|19|||
145342327|NCT00582010|524102417|FG000|Overall Study|Death|0|||
145342328|NCT00582010|524102418|FG001|Overall Study|Death|1|||
145342329|NCT02681510|524102422|FG000|Overall Study|Withdrawal by Subject|1|||
145342330|NCT02681510|524102422|FG000|Overall Study|Lost to Follow-up|9|||
145342331|NCT00958893|524102423|FG000|Overall Study|Study prematurely terminated|4|||
145342332|NCT00378573|524102424|FG000|Treatment Period|Adverse Event|9|||
145342333|NCT00378573|524102424|FG000|Treatment Period|Physician Decision|1|||
145342334|NCT00378573|524102424|FG000|Treatment Period|Withdrawal by Subject|2|||
145342335|NCT00378573|524102424|FG000|Treatment Period|Disease Progression|4|||
145575475|NCT01607905|524962229|FG003|Overall Study|Randomized but not treated|0|||
145342336|NCT00378573|524102424|FG000|Treatment Period|Sponsor decision to close study|1|||
145575476|NCT01607905|524962230|FG004|Overall Study|Randomized but not treated|1|||
145342337|NCT00378573|524102424|FG000|Follow-up|Death|12|||
145342338|NCT00378573|524102424|FG000|Follow-up|Lost to Follow-up|1|||
145342339|NCT00378573|524102424|FG000|Follow-up|Withdrawal by Subject|1|||
145342340|NCT03837743|524102427|FG000|Overall Study|Adverse Event|1|||
145342341|NCT03837743|524102427|FG000|Overall Study|Withdrawal by Subject|2|||
145342342|NCT00252239|524102428|FG000|Overall Study|Withdrawal by Subject|1|||
145342343|NCT00252239|524102429|FG001|Overall Study|Withdrawal by Subject|0|||
145342344|NCT00252239|524102430|FG002|Overall Study|Withdrawal by Subject|0|||
145342345|NCT00252239|524102431|FG003|Overall Study|Withdrawal by Subject|1|||
145342346|NCT00252239|524102428|FG000|Overall Study|Lost to Follow-up|0|||
145342347|NCT00252239|524102429|FG001|Overall Study|Lost to Follow-up|0|||
145342348|NCT00252239|524102430|FG002|Overall Study|Lost to Follow-up|2|||
145342349|NCT00252239|524102431|FG003|Overall Study|Lost to Follow-up|0|||
145342350|NCT02257385|524102433|FG000|Overall Study|Adverse Event|12|||
145342351|NCT02257385|524102434|FG001|Overall Study|Adverse Event|8|||
145342352|NCT02257385|524102433|FG000|Overall Study|Lack of Efficacy|1|||
145342353|NCT02257385|524102434|FG001|Overall Study|Lack of Efficacy|2|||
145342354|NCT02257385|524102433|FG000|Overall Study|Protocol Violation|5|||
145342355|NCT02257385|524102434|FG001|Overall Study|Protocol Violation|7|||
145342356|NCT02257385|524102433|FG000|Overall Study|Lost to Follow-up|0|||
145342357|NCT02257385|524102434|FG001|Overall Study|Lost to Follow-up|1|||
145342358|NCT02257385|524102433|FG000|Overall Study|Withdrawal by Subject|4|||
145342359|NCT02257385|524102434|FG001|Overall Study|Withdrawal by Subject|4|||
145342360|NCT01822366|524102441|FG000|Overall Study|Lost to Follow-up|5|||
145342361|NCT01822366|524102442|FG001|Overall Study|Lost to Follow-up|1|||
145342362|NCT01822366|524102443|FG002|Overall Study|Lost to Follow-up|5|||
145342363|NCT01822366|524102444|FG003|Overall Study|Lost to Follow-up|1|||
145342364|NCT01822366|524102441|FG000|Overall Study|Withdrawal by Subject|0|||
145342365|NCT01822366|524102442|FG001|Overall Study|Withdrawal by Subject|6|||
145342366|NCT01822366|524102443|FG002|Overall Study|Withdrawal by Subject|0|||
145342367|NCT01822366|524102444|FG003|Overall Study|Withdrawal by Subject|6|||
145342368|NCT01822366|524102441|FG000|Overall Study|Partial Intervention Completion|0|||
145342369|NCT01822366|524102442|FG001|Overall Study|Partial Intervention Completion|15|||
145342370|NCT01822366|524102443|FG002|Overall Study|Partial Intervention Completion|0|||
145342371|NCT01822366|524102444|FG003|Overall Study|Partial Intervention Completion|15|||
145342372|NCT00384930|524102447|FG000|Overall Study|Adverse Event|5|||
145342373|NCT00384930|524102448|FG001|Overall Study|Adverse Event|4|||
145342374|NCT00384930|524102449|FG002|Overall Study|Adverse Event|12|||
145342375|NCT00384930|524102450|FG003|Overall Study|Adverse Event|11|||
145342376|NCT00384930|524102451|FG004|Overall Study|Adverse Event|14|||
145342377|NCT00384930|524102447|FG000|Overall Study|Entry Criteria Not Met|2|||
145342378|NCT00384930|524102448|FG001|Overall Study|Entry Criteria Not Met|6|||
145342379|NCT00384930|524102449|FG002|Overall Study|Entry Criteria Not Met|7|||
145342380|NCT00384930|524102450|FG003|Overall Study|Entry Criteria Not Met|8|||
145342381|NCT00384930|524102451|FG004|Overall Study|Entry Criteria Not Met|4|||
145342382|NCT00384930|524102447|FG000|Overall Study|Lack of Efficacy|1|||
145342383|NCT00384930|524102448|FG001|Overall Study|Lack of Efficacy|1|||
145342384|NCT00384930|524102449|FG002|Overall Study|Lack of Efficacy|2|||
145342385|NCT00384930|524102450|FG003|Overall Study|Lack of Efficacy|1|||
145342386|NCT00384930|524102451|FG004|Overall Study|Lack of Efficacy|2|||
145342387|NCT00384930|524102447|FG000|Overall Study|Lost to Follow-up|5|||
145342388|NCT00384930|524102448|FG001|Overall Study|Lost to Follow-up|3|||
145342389|NCT00384930|524102449|FG002|Overall Study|Lost to Follow-up|0|||
145342390|NCT00384930|524102450|FG003|Overall Study|Lost to Follow-up|4|||
145413808|NCT03188185|524368415|FG001|Stage 1|Lost to Follow-up|1|||
145342391|NCT00384930|524102451|FG004|Overall Study|Lost to Follow-up|6|||
145413809|NCT03188185|524368416|FG002|Stage 1|Lost to Follow-up|0|||
145413810|NCT03188185|524368417|FG003|Stage 1|Lost to Follow-up|0|||
145413811|NCT03188185|524368414|FG000|Stage 1|Withdrawal by Subject|9|||
145413812|NCT03188185|524368415|FG001|Stage 1|Withdrawal by Subject|0|||
145413813|NCT03188185|524368416|FG002|Stage 1|Withdrawal by Subject|0|||
145413814|NCT03188185|524368417|FG003|Stage 1|Withdrawal by Subject|0|||
145342392|NCT00384930|524102447|FG000|Overall Study|Physician Decision|0|||
145342393|NCT00384930|524102448|FG001|Overall Study|Physician Decision|1|||
145342394|NCT00384930|524102449|FG002|Overall Study|Physician Decision|1|||
145342395|NCT00384930|524102450|FG003|Overall Study|Physician Decision|0|||
145342396|NCT00384930|524102451|FG004|Overall Study|Physician Decision|1|||
145342397|NCT00384930|524102447|FG000|Overall Study|Protocol Violation|1|||
145342398|NCT00384930|524102448|FG001|Overall Study|Protocol Violation|0|||
145342399|NCT00384930|524102449|FG002|Overall Study|Protocol Violation|1|||
145342400|NCT00384930|524102450|FG003|Overall Study|Protocol Violation|6|||
145342401|NCT00384930|524102451|FG004|Overall Study|Protocol Violation|4|||
145342402|NCT00384930|524102447|FG000|Overall Study|Sponsor Decision|3|||
145342403|NCT00384930|524102448|FG001|Overall Study|Sponsor Decision|4|||
145342404|NCT00384930|524102449|FG002|Overall Study|Sponsor Decision|0|||
145342405|NCT00384930|524102450|FG003|Overall Study|Sponsor Decision|5|||
145342406|NCT00384930|524102451|FG004|Overall Study|Sponsor Decision|0|||
145342407|NCT00384930|524102447|FG000|Overall Study|Withdrawal by Subject|9|||
145413815|NCT03188185|524368414|FG000|Stage 1|Identified as a professional patient|0|||
145342408|NCT00384930|524102448|FG001|Overall Study|Withdrawal by Subject|7|||
145342409|NCT00384930|524102449|FG002|Overall Study|Withdrawal by Subject|7|||
145342410|NCT00384930|524102450|FG003|Overall Study|Withdrawal by Subject|6|||
145342411|NCT00384930|524102451|FG004|Overall Study|Withdrawal by Subject|16|||
145342412|NCT00384930|524102447|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
145342413|NCT00384930|524102448|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
145342414|NCT00384930|524102449|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145342415|NCT00384930|524102450|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145342416|NCT00384930|524102451|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
145342417|NCT01449370|524102454|FG000|Overall Study|Disease Progression|5|||
145342418|NCT01449370|524102455|FG001|Overall Study|Disease Progression|4|||
145342419|NCT01449370|524102456|FG002|Overall Study|Disease Progression|8|||
145342420|NCT01449370|524102457|FG003|Overall Study|Disease Progression|3|||
145342421|NCT01449370|524102458|FG004|Overall Study|Disease Progression|3|||
145342422|NCT01449370|524102459|FG005|Overall Study|Disease Progression|3|||
145342423|NCT01449370|524102460|FG006|Overall Study|Disease Progression|3|||
145342424|NCT01449370|524102461|FG007|Overall Study|Disease Progression|2|||
145342425|NCT01449370|524102462|FG008|Overall Study|Disease Progression|9|||
145342426|NCT01449370|524102463|FG009|Overall Study|Disease Progression|1|||
145342427|NCT01449370|524102464|FG010|Overall Study|Disease Progression|3|||
145342428|NCT01449370|524102465|FG011|Overall Study|Disease Progression|3|||
145342429|NCT01449370|524102466|FG012|Overall Study|Disease Progression|2|||
145342430|NCT01449370|524102467|FG013|Overall Study|Disease Progression|8|||
145342431|NCT01449370|524102468|FG014|Overall Study|Disease Progression|3|||
145342432|NCT01449370|524102469|FG015|Overall Study|Disease Progression|1|||
145342433|NCT01449370|524102470|FG016|Overall Study|Disease Progression|4|||
145342434|NCT01449370|524102471|FG017|Overall Study|Disease Progression|3|||
145342435|NCT01449370|524102472|FG018|Overall Study|Disease Progression|1|||
145342436|NCT01449370|524102473|FG019|Overall Study|Disease Progression|2|||
145342437|NCT01449370|524102474|FG020|Overall Study|Disease Progression|5|||
145342438|NCT01449370|524102475|FG021|Overall Study|Disease Progression|2|||
145342439|NCT01449370|524102476|FG022|Overall Study|Disease Progression|3|||
145342440|NCT01449370|524102477|FG023|Overall Study|Disease Progression|7|||
145342441|NCT01449370|524102478|FG024|Overall Study|Disease Progression|3|||
145342442|NCT01449370|524102454|FG000|Overall Study|Adverse Event|1|||
145342443|NCT01449370|524102455|FG001|Overall Study|Adverse Event|2|||
145342444|NCT01449370|524102456|FG002|Overall Study|Adverse Event|0|||
145342445|NCT01449370|524102457|FG003|Overall Study|Adverse Event|1|||
145342446|NCT01449370|524102458|FG004|Overall Study|Adverse Event|0|||
145342447|NCT01449370|524102459|FG005|Overall Study|Adverse Event|0|||
145342448|NCT01449370|524102460|FG006|Overall Study|Adverse Event|0|||
145342449|NCT01449370|524102461|FG007|Overall Study|Adverse Event|0|||
145342450|NCT01449370|524102462|FG008|Overall Study|Adverse Event|1|||
145342451|NCT01449370|524102463|FG009|Overall Study|Adverse Event|1|||
145342452|NCT01449370|524102464|FG010|Overall Study|Adverse Event|0|||
145342453|NCT01449370|524102465|FG011|Overall Study|Adverse Event|0|||
145342454|NCT01449370|524102466|FG012|Overall Study|Adverse Event|0|||
145342455|NCT01449370|524102467|FG013|Overall Study|Adverse Event|2|||
145342456|NCT01449370|524102468|FG014|Overall Study|Adverse Event|0|||
145342457|NCT01449370|524102469|FG015|Overall Study|Adverse Event|1|||
145342458|NCT01449370|524102470|FG016|Overall Study|Adverse Event|0|||
145342459|NCT01449370|524102471|FG017|Overall Study|Adverse Event|0|||
145342460|NCT01449370|524102472|FG018|Overall Study|Adverse Event|1|||
145342461|NCT01449370|524102473|FG019|Overall Study|Adverse Event|1|||
145342462|NCT01449370|524102474|FG020|Overall Study|Adverse Event|0|||
145342463|NCT01449370|524102475|FG021|Overall Study|Adverse Event|1|||
145342464|NCT01449370|524102476|FG022|Overall Study|Adverse Event|0|||
145342465|NCT01449370|524102477|FG023|Overall Study|Adverse Event|1|||
145342466|NCT01449370|524102478|FG024|Overall Study|Adverse Event|3|||
145342467|NCT01449370|524102454|FG000|Overall Study|Participant Decision|0|||
145342468|NCT01449370|524102455|FG001|Overall Study|Participant Decision|0|||
145342469|NCT01449370|524102456|FG002|Overall Study|Participant Decision|0|||
145342470|NCT01449370|524102457|FG003|Overall Study|Participant Decision|0|||
145342471|NCT01449370|524102458|FG004|Overall Study|Participant Decision|0|||
145342472|NCT01449370|524102459|FG005|Overall Study|Participant Decision|0|||
145342473|NCT01449370|524102460|FG006|Overall Study|Participant Decision|0|||
145342474|NCT01449370|524102461|FG007|Overall Study|Participant Decision|1|||
145342475|NCT01449370|524102462|FG008|Overall Study|Participant Decision|1|||
145342476|NCT01449370|524102463|FG009|Overall Study|Participant Decision|0|||
145342477|NCT01449370|524102464|FG010|Overall Study|Participant Decision|0|||
145342478|NCT01449370|524102465|FG011|Overall Study|Participant Decision|0|||
145342479|NCT01449370|524102466|FG012|Overall Study|Participant Decision|1|||
145342480|NCT01449370|524102467|FG013|Overall Study|Participant Decision|1|||
145342481|NCT01449370|524102468|FG014|Overall Study|Participant Decision|0|||
145342482|NCT01449370|524102469|FG015|Overall Study|Participant Decision|1|||
145342483|NCT01449370|524102470|FG016|Overall Study|Participant Decision|3|||
145342484|NCT01449370|524102471|FG017|Overall Study|Participant Decision|0|||
145342485|NCT01449370|524102472|FG018|Overall Study|Participant Decision|1|||
145575477|NCT01607905|524962231|FG005|Overall Study|Randomized but not treated|1|||
145575478|NCT01607905|524962232|FG006|Overall Study|Randomized but not treated|0|||
145575479|NCT03892889|524962233|FG000|Overall Study|Adverse Event|17|||
145575480|NCT03892889|524962233|FG000|Overall Study|Lack of Efficacy|1|||
145575481|NCT03892889|524962233|FG000|Overall Study|Lost to Follow-up|46|||
145575482|NCT03892889|524962233|FG000|Overall Study|Non-compliance with study drug|22|||
145575483|NCT03892889|524962233|FG000|Overall Study|Pregnancy|1|||
145575484|NCT03892889|524962233|FG000|Overall Study|Protocol Deviation|3|||
145575485|NCT03892889|524962233|FG000|Overall Study|Withdrawal by Subject|50|||
145575486|NCT03892889|524962233|FG000|Overall Study|Withdrawal by Caregiver|1|||
145575487|NCT03892889|524962233|FG000|Overall Study|Study Terminated by Sponsor|50|||
145575488|NCT03892889|524962233|FG000|Overall Study|Physician Decision|8|||
145575489|NCT03892889|524962233|FG000|Overall Study|Reason not Specified|5|||
145342486|NCT01449370|524102473|FG019|Overall Study|Participant Decision|0|||
145342487|NCT01449370|524102474|FG020|Overall Study|Participant Decision|0|||
145342488|NCT01449370|524102475|FG021|Overall Study|Participant Decision|1|||
145342489|NCT01449370|524102476|FG022|Overall Study|Participant Decision|0|||
145342490|NCT01449370|524102477|FG023|Overall Study|Participant Decision|0|||
145342491|NCT01449370|524102478|FG024|Overall Study|Participant Decision|1|||
145342492|NCT01449370|524102454|FG000|Overall Study|Lost to Follow-up|0|||
145342493|NCT01449370|524102455|FG001|Overall Study|Lost to Follow-up|0|||
145342494|NCT01449370|524102456|FG002|Overall Study|Lost to Follow-up|0|||
145342495|NCT01449370|524102457|FG003|Overall Study|Lost to Follow-up|0|||
145342496|NCT01449370|524102458|FG004|Overall Study|Lost to Follow-up|0|||
145342497|NCT01449370|524102459|FG005|Overall Study|Lost to Follow-up|0|||
145342498|NCT01449370|524102460|FG006|Overall Study|Lost to Follow-up|0|||
145342499|NCT01449370|524102461|FG007|Overall Study|Lost to Follow-up|0|||
145342500|NCT01449370|524102462|FG008|Overall Study|Lost to Follow-up|0|||
145342501|NCT01449370|524102463|FG009|Overall Study|Lost to Follow-up|0|||
145342502|NCT01449370|524102464|FG010|Overall Study|Lost to Follow-up|0|||
145342503|NCT01449370|524102465|FG011|Overall Study|Lost to Follow-up|0|||
145342504|NCT01449370|524102466|FG012|Overall Study|Lost to Follow-up|0|||
145342505|NCT01449370|524102467|FG013|Overall Study|Lost to Follow-up|0|||
145342506|NCT01449370|524102468|FG014|Overall Study|Lost to Follow-up|0|||
145342507|NCT01449370|524102469|FG015|Overall Study|Lost to Follow-up|0|||
145342508|NCT01449370|524102470|FG016|Overall Study|Lost to Follow-up|0|||
145342509|NCT01449370|524102471|FG017|Overall Study|Lost to Follow-up|0|||
145342510|NCT01449370|524102472|FG018|Overall Study|Lost to Follow-up|0|||
145342511|NCT01449370|524102473|FG019|Overall Study|Lost to Follow-up|0|||
145342512|NCT01449370|524102474|FG020|Overall Study|Lost to Follow-up|1|||
145342513|NCT01449370|524102475|FG021|Overall Study|Lost to Follow-up|0|||
145342514|NCT01449370|524102476|FG022|Overall Study|Lost to Follow-up|0|||
145342515|NCT01449370|524102477|FG023|Overall Study|Lost to Follow-up|0|||
145342516|NCT01449370|524102478|FG024|Overall Study|Lost to Follow-up|0|||
145342517|NCT01449370|524102454|FG000|Overall Study|Other|0|||
145342518|NCT01449370|524102455|FG001|Overall Study|Other|0|||
145342519|NCT01449370|524102456|FG002|Overall Study|Other|0|||
145342520|NCT01449370|524102457|FG003|Overall Study|Other|0|||
145342521|NCT01449370|524102458|FG004|Overall Study|Other|0|||
145342522|NCT01449370|524102459|FG005|Overall Study|Other|0|||
145342523|NCT01449370|524102460|FG006|Overall Study|Other|0|||
145342524|NCT01449370|524102461|FG007|Overall Study|Other|0|||
145342525|NCT01449370|524102462|FG008|Overall Study|Other|1|||
145575490|NCT00679341|524962235|FG000|Overall Study|Disease progression|42|||
145575491|NCT00679341|524962236|FG001|Overall Study|Disease progression|36|||
145575492|NCT00679341|524962235|FG000|Overall Study|Adverse Event|5|||
145575493|NCT00679341|524962236|FG001|Overall Study|Adverse Event|6|||
145342526|NCT01449370|524102463|FG009|Overall Study|Other|1|||
145342527|NCT01449370|524102464|FG010|Overall Study|Other|0|||
145342528|NCT01449370|524102465|FG011|Overall Study|Other|0|||
145342529|NCT01449370|524102466|FG012|Overall Study|Other|0|||
145342530|NCT01449370|524102467|FG013|Overall Study|Other|0|||
145342531|NCT01449370|524102468|FG014|Overall Study|Other|0|||
145342532|NCT01449370|524102469|FG015|Overall Study|Other|0|||
145342533|NCT01449370|524102470|FG016|Overall Study|Other|0|||
145342534|NCT01449370|524102471|FG017|Overall Study|Other|0|||
145413816|NCT03188185|524368415|FG001|Stage 1|Identified as a professional patient|1|||
145413817|NCT03188185|524368416|FG002|Stage 1|Identified as a professional patient|0|||
145575494|NCT00679341|524962235|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
145342535|NCT01449370|524102472|FG018|Overall Study|Other|0|||
145342536|NCT01449370|524102473|FG019|Overall Study|Other|0|||
145342537|NCT01449370|524102474|FG020|Overall Study|Other|0|||
145342538|NCT01449370|524102475|FG021|Overall Study|Other|0|||
145342539|NCT01449370|524102476|FG022|Overall Study|Other|1|||
145575495|NCT00679341|524962236|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
145575496|NCT00679341|524962235|FG000|Overall Study|Death|1|||
145342540|NCT01449370|524102477|FG023|Overall Study|Other|1|||
145342541|NCT01449370|524102478|FG024|Overall Study|Other|0|||
145342542|NCT01449370|524102454|FG000|Overall Study|Medication Prohibited by Protocol|0|||
145342543|NCT01449370|524102455|FG001|Overall Study|Medication Prohibited by Protocol|0|||
145342544|NCT01449370|524102456|FG002|Overall Study|Medication Prohibited by Protocol|0|||
145575497|NCT00679341|524962236|FG001|Overall Study|Death|1|||
145575498|NCT00679341|524962235|FG000|Overall Study|Other|1|||
145575499|NCT00679341|524962236|FG001|Overall Study|Other|0|||
145575500|NCT00679341|524962235|FG000|Overall Study|Physician Decision|1|||
145342545|NCT01449370|524102457|FG003|Overall Study|Medication Prohibited by Protocol|0|||
145342546|NCT01449370|524102458|FG004|Overall Study|Medication Prohibited by Protocol|0|||
145342547|NCT01449370|524102459|FG005|Overall Study|Medication Prohibited by Protocol|0|||
145342548|NCT01449370|524102460|FG006|Overall Study|Medication Prohibited by Protocol|0|||
145575501|NCT00679341|524962236|FG001|Overall Study|Physician Decision|0|||
145575502|NCT00679341|524962235|FG000|Overall Study|Not treated|0|||
145575503|NCT00679341|524962236|FG001|Overall Study|Not treated|2|||
145575504|NCT00679341|524962235|FG000|Overall Study|Physician/patient decision to withdraw|0|||
145575505|NCT00679341|524962236|FG001|Overall Study|Physician/patient decision to withdraw|6|||
145575506|NCT02488629|524962239|FG000|Overall Study|Lack of Efficacy|3|||
145575507|NCT02488629|524962240|FG001|Overall Study|Lack of Efficacy|1|||
145575508|NCT02488629|524962241|FG002|Overall Study|Lack of Efficacy|0|||
145575509|NCT02488629|524962242|FG003|Overall Study|Lack of Efficacy|0|||
145575510|NCT02488629|524962239|FG000|Overall Study|Withdrawal by Subject|0|||
145575511|NCT02488629|524962240|FG001|Overall Study|Withdrawal by Subject|1|||
145575512|NCT02488629|524962241|FG002|Overall Study|Withdrawal by Subject|0|||
145575513|NCT02488629|524962242|FG003|Overall Study|Withdrawal by Subject|0|||
145575514|NCT02652624|524962243|FG000|Randomized Phase|Pregnancy|3|||
145575515|NCT02652624|524962244|FG001|Randomized Phase|Pregnancy|1|||
145575516|NCT02652624|524962243|FG000|Randomized Phase|Investigator's Discretion|0|||
145575517|NCT02652624|524962244|FG001|Randomized Phase|Investigator's Discretion|2|||
145575518|NCT02652624|524962243|FG000|Randomized Phase|Death|0|||
145575519|NCT02652624|524962244|FG001|Randomized Phase|Death|1|||
145575520|NCT02652624|524962243|FG000|Randomized Phase|Lost to Follow-up|0|||
145575521|NCT02652624|524962244|FG001|Randomized Phase|Lost to Follow-up|1|||
145575522|NCT02652624|524962243|FG000|Extension Phase|Lost to Follow-up|3|||
145575523|NCT02652624|524962244|FG001|Extension Phase|Lost to Follow-up|1|||
145575524|NCT02652624|524962243|FG000|Extension Phase|Pregnancy|1|||
145575525|NCT02652624|524962244|FG001|Extension Phase|Pregnancy|1|||
145575526|NCT02652624|524962243|FG000|Extension Phase|Adverse Event|0|||
145575527|NCT02652624|524962244|FG001|Extension Phase|Adverse Event|1|||
145575528|NCT02652624|524962243|FG000|Extension Phase|Withdrew Consent|0|||
145575529|NCT02652624|524962244|FG001|Extension Phase|Withdrew Consent|1|||
145575530|NCT00654628|524962245|FG000|6-week Active Treatment Period|Adverse Event|9|||
145575531|NCT00654628|524962245|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
145575532|NCT00654628|524962245|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
145342549|NCT01449370|524102461|FG007|Overall Study|Medication Prohibited by Protocol|0|||
145342550|NCT01449370|524102462|FG008|Overall Study|Medication Prohibited by Protocol|0|||
145342551|NCT01449370|524102463|FG009|Overall Study|Medication Prohibited by Protocol|0|||
145342552|NCT01449370|524102464|FG010|Overall Study|Medication Prohibited by Protocol|0|||
145342553|NCT01449370|524102465|FG011|Overall Study|Medication Prohibited by Protocol|0|||
145342554|NCT01449370|524102466|FG012|Overall Study|Medication Prohibited by Protocol|0|||
145342555|NCT01449370|524102467|FG013|Overall Study|Medication Prohibited by Protocol|0|||
145342556|NCT01449370|524102468|FG014|Overall Study|Medication Prohibited by Protocol|0|||
145342557|NCT01449370|524102469|FG015|Overall Study|Medication Prohibited by Protocol|0|||
145342558|NCT01449370|524102470|FG016|Overall Study|Medication Prohibited by Protocol|0|||
145342559|NCT01449370|524102471|FG017|Overall Study|Medication Prohibited by Protocol|0|||
145342560|NCT01449370|524102472|FG018|Overall Study|Medication Prohibited by Protocol|0|||
145342561|NCT01449370|524102473|FG019|Overall Study|Medication Prohibited by Protocol|0|||
145575533|NCT00654628|524962245|FG000|6-week Active Treatment Period|Out of window period|1|||
145575534|NCT00654628|524962245|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
145575535|NCT00654628|524962245|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
145575536|NCT00912405|524962248|FG000|Overall Study|Lost to Follow-up|5|||
145575537|NCT00953329|524962249|FG000|Overall Study|Lack of Efficacy|1|||
145342562|NCT01449370|524102474|FG020|Overall Study|Medication Prohibited by Protocol|0|||
145342563|NCT01449370|524102475|FG021|Overall Study|Medication Prohibited by Protocol|0|||
145413818|NCT03188185|524368417|FG003|Stage 1|Identified as a professional patient|0|||
145413819|NCT03188185|524368414|FG000|Stage 2|Adverse Event|0|||
145413820|NCT03188185|524368415|FG001|Stage 2|Adverse Event|0|||
145575538|NCT01797536|524962250|FG000|Overall Study|Adverse Event|0|||
145575539|NCT01797536|524962251|FG001|Overall Study|Adverse Event|1|||
145575540|NCT01797536|524962252|FG002|Overall Study|Adverse Event|0|||
145575541|NCT01797536|524962253|FG003|Overall Study|Adverse Event|0|||
145342564|NCT01449370|524102476|FG022|Overall Study|Medication Prohibited by Protocol|0|||
145342565|NCT01449370|524102477|FG023|Overall Study|Medication Prohibited by Protocol|1|||
145413821|NCT03188185|524368416|FG002|Stage 2|Adverse Event|2|||
145413822|NCT03188185|524368417|FG003|Stage 2|Adverse Event|4|||
145575542|NCT00796861|524962260|FG000|Overall Study|Withdrawal by Subject|2|||
145575543|NCT00796861|524962260|FG000|Overall Study|Death|2|||
145575544|NCT00529386|524962263|FG000|Overall Study|Lost to Follow-up|1|||
145575545|NCT00844545|524962267|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
145575546|NCT00844545|524962267|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
145342566|NCT01449370|524102478|FG024|Overall Study|Medication Prohibited by Protocol|0|||
145342567|NCT01449370|524102454|FG000|Overall Study|Death|0|||
145342568|NCT01449370|524102455|FG001|Overall Study|Death|0|||
145342569|NCT01449370|524102456|FG002|Overall Study|Death|0|||
145342570|NCT01449370|524102457|FG003|Overall Study|Death|0|||
145342571|NCT01449370|524102458|FG004|Overall Study|Death|0|||
145342572|NCT01449370|524102459|FG005|Overall Study|Death|0|||
145342573|NCT01449370|524102460|FG006|Overall Study|Death|0|||
145342574|NCT01449370|524102461|FG007|Overall Study|Death|0|||
145342575|NCT01449370|524102462|FG008|Overall Study|Death|0|||
145342576|NCT01449370|524102463|FG009|Overall Study|Death|0|||
145342577|NCT01449370|524102464|FG010|Overall Study|Death|0|||
145342578|NCT01449370|524102465|FG011|Overall Study|Death|0|||
145342579|NCT01449370|524102466|FG012|Overall Study|Death|0|||
145342580|NCT01449370|524102467|FG013|Overall Study|Death|0|||
145342581|NCT01449370|524102468|FG014|Overall Study|Death|0|||
145342582|NCT01449370|524102469|FG015|Overall Study|Death|0|||
145342583|NCT01449370|524102470|FG016|Overall Study|Death|0|||
145342584|NCT01449370|524102471|FG017|Overall Study|Death|0|||
145342585|NCT01449370|524102472|FG018|Overall Study|Death|0|||
145342586|NCT01449370|524102473|FG019|Overall Study|Death|0|||
145342587|NCT01449370|524102474|FG020|Overall Study|Death|0|||
145342588|NCT01449370|524102475|FG021|Overall Study|Death|0|||
145342589|NCT01449370|524102476|FG022|Overall Study|Death|0|||
145342590|NCT01449370|524102477|FG023|Overall Study|Death|0|||
145342591|NCT01449370|524102478|FG024|Overall Study|Death|1|||
145342592|NCT00534404|524102479|FG000|Overall Study|Death|0|||
145342593|NCT00534404|524102480|FG001|Overall Study|Death|0|||
145342594|NCT00534404|524102481|FG002|Overall Study|Death|2|||
145342595|NCT00534404|524102479|FG000|Overall Study|Withdrawal by Subject|8|||
145342596|NCT00534404|524102480|FG001|Overall Study|Withdrawal by Subject|2|||
145342597|NCT00534404|524102481|FG002|Overall Study|Withdrawal by Subject|38|||
145342598|NCT00534404|524102479|FG000|Overall Study|Removed by study staff|2|||
145342599|NCT00534404|524102480|FG001|Overall Study|Removed by study staff|3|||
145342600|NCT00534404|524102481|FG002|Overall Study|Removed by study staff|1|||
145342601|NCT00534404|524102479|FG000|Overall Study|Lost to Follow-up|170|||
145342602|NCT00534404|524102480|FG001|Overall Study|Lost to Follow-up|138|||
145342603|NCT00534404|524102481|FG002|Overall Study|Lost to Follow-up|201|||
145342604|NCT02027428|524102482|FG000|Induction|Never treated|7|||
145342605|NCT02027428|524102483|FG001|Induction|Never treated|0|||
145342606|NCT02027428|524102484|FG002|Induction|Never treated|0|||
145342607|NCT02027428|524102482|FG000|Induction|Progressive disease|77|||
145342608|NCT02027428|524102483|FG001|Induction|Progressive disease|0|||
145342609|NCT02027428|524102484|FG002|Induction|Progressive disease|0|||
145342610|NCT02027428|524102482|FG000|Induction|Adverse Event|51|||
145342611|NCT02027428|524102483|FG001|Induction|Adverse Event|0|||
145342612|NCT02027428|524102484|FG002|Induction|Adverse Event|0|||
145342613|NCT02027428|524102482|FG000|Induction|Withdrawal by Subject|22|||
145342614|NCT02027428|524102483|FG001|Induction|Withdrawal by Subject|0|||
145342615|NCT02027428|524102484|FG002|Induction|Withdrawal by Subject|0|||
145342616|NCT02027428|524102482|FG000|Induction|Death|21|||
145342617|NCT02027428|524102483|FG001|Induction|Death|0|||
145342618|NCT02027428|524102484|FG002|Induction|Death|0|||
145342619|NCT02027428|524102482|FG000|Induction|Symptomatic deterioration|16|||
145342620|NCT02027428|524102483|FG001|Induction|Symptomatic deterioration|0|||
145342621|NCT02027428|524102484|FG002|Induction|Symptomatic deterioration|0|||
145342622|NCT02027428|524102482|FG000|Induction|Study terminated by sponsor|12|||
145342623|NCT02027428|524102483|FG001|Induction|Study terminated by sponsor|0|||
145342624|NCT02027428|524102484|FG002|Induction|Study terminated by sponsor|0|||
145342625|NCT02027428|524102482|FG000|Induction|Protocol Violation|1|||
145342626|NCT02027428|524102483|FG001|Induction|Protocol Violation|0|||
145342627|NCT02027428|524102484|FG002|Induction|Protocol Violation|0|||
145342628|NCT02027428|524102482|FG000|Induction|Miscellaneous|14|||
145342629|NCT02027428|524102483|FG001|Induction|Miscellaneous|0|||
145342630|NCT02027428|524102484|FG002|Induction|Miscellaneous|0|||
145342631|NCT02027428|524102482|FG000|Induction|Induction Treatment Ongoing|4|||
145342632|NCT02027428|524102483|FG001|Induction|Induction Treatment Ongoing|0|||
145342633|NCT02027428|524102484|FG002|Induction|Induction Treatment Ongoing|0|||
145342634|NCT02027428|524102482|FG000|Maintenance|Death|0|||
145342635|NCT02027428|524102483|FG001|Maintenance|Death|3|||
145342636|NCT02027428|524102484|FG002|Maintenance|Death|2|||
145342637|NCT02027428|524102482|FG000|Maintenance|Adverse Event|0|||
145342638|NCT02027428|524102483|FG001|Maintenance|Adverse Event|21|||
145342639|NCT02027428|524102484|FG002|Maintenance|Adverse Event|1|||
145342640|NCT02027428|524102482|FG000|Maintenance|Progressive disease|0|||
145342641|NCT02027428|524102483|FG001|Maintenance|Progressive disease|84|||
145342642|NCT02027428|524102484|FG002|Maintenance|Progressive disease|47|||
145342643|NCT02027428|524102482|FG000|Maintenance|Symptomatic deterioration|0|||
145342644|NCT02027428|524102483|FG001|Maintenance|Symptomatic deterioration|4|||
145342645|NCT02027428|524102484|FG002|Maintenance|Symptomatic deterioration|1|||
145342646|NCT02027428|524102482|FG000|Maintenance|Withdrawal by Subject|0|||
145342647|NCT02027428|524102483|FG001|Maintenance|Withdrawal by Subject|6|||
145342648|NCT02027428|524102484|FG002|Maintenance|Withdrawal by Subject|5|||
145342649|NCT02027428|524102482|FG000|Maintenance|Protocol Violation|0|||
145342650|NCT02027428|524102483|FG001|Maintenance|Protocol Violation|0|||
145342651|NCT02027428|524102484|FG002|Maintenance|Protocol Violation|1|||
145342652|NCT02027428|524102482|FG000|Maintenance|Other|0|||
145342653|NCT02027428|524102483|FG001|Maintenance|Other|6|||
145342654|NCT02027428|524102484|FG002|Maintenance|Other|3|||
145342655|NCT02027428|524102482|FG000|Survival Follow-up|Death|0|||
145342656|NCT02027428|524102483|FG001|Survival Follow-up|Death|78|||
145342657|NCT02027428|524102484|FG002|Survival Follow-up|Death|45|||
145342658|NCT02027428|524102482|FG000|Survival Follow-up|Lost to Follow-up|0|||
145342659|NCT02027428|524102483|FG001|Survival Follow-up|Lost to Follow-up|1|||
145342660|NCT02027428|524102484|FG002|Survival Follow-up|Lost to Follow-up|1|||
145342661|NCT03097991|524102485|FG000|Overall Study|Didn't meet study criteria|8|||
145342662|NCT03097991|524102486|FG001|Overall Study|Didn't meet study criteria|0|||
145342663|NCT03097991|524102485|FG000|Overall Study|Withdrawal by Subject|12|||
145342664|NCT03097991|524102486|FG001|Overall Study|Withdrawal by Subject|6|||
145342665|NCT03097991|524102485|FG000|Overall Study|Death of Baby|3|||
145342666|NCT03097991|524102486|FG001|Overall Study|Death of Baby|1|||
145342667|NCT03097991|524102485|FG000|Overall Study|Lost to Follow-up|24|||
145342668|NCT03097991|524102486|FG001|Overall Study|Lost to Follow-up|38|||
145342669|NCT03097991|524102485|FG000|Overall Study|Adverse Event|3|||
145342670|NCT03097991|524102486|FG001|Overall Study|Adverse Event|5|||
145342671|NCT01098487|524102488|FG000|Overall Study|Adverse Event|22|||
145342672|NCT01098487|524102488|FG000|Overall Study|Lack of Efficacy|11|||
145342673|NCT01098487|524102488|FG000|Overall Study|Withdrawal by Subject|7|||
145342674|NCT01098487|524102488|FG000|Overall Study|Lost to Follow-up|3|||
145342675|NCT01098487|524102488|FG000|Overall Study|Physician Decision|1|||
145342676|NCT03301623|524102493|FG000|Overall Study|Death|3|||
145342677|NCT03301623|524102494|FG001|Overall Study|Death|1|||
145342678|NCT03301623|524102493|FG000|Overall Study|Withdrawal by Subject|11|||
145342679|NCT03301623|524102494|FG001|Overall Study|Withdrawal by Subject|13|||
145342680|NCT03301623|524102493|FG000|Overall Study|Lost to Follow-up|3|||
145342681|NCT03301623|524102494|FG001|Overall Study|Lost to Follow-up|1|||
145342682|NCT01374269|524102495|FG000|Overall Study|Withdrawal by Subject|4|||
145342683|NCT01374269|524102496|FG001|Overall Study|Withdrawal by Subject|0|||
145342684|NCT01374269|524102495|FG000|Overall Study|Lost to Follow-up|1|||
145342685|NCT01374269|524102496|FG001|Overall Study|Lost to Follow-up|3|||
145342686|NCT01374269|524102495|FG000|Overall Study|closed research|1|||
145342687|NCT01374269|524102496|FG001|Overall Study|closed research|2|||
145342688|NCT03316547|524102499|FG000|Overall Study|Death|3|||
145342689|NCT03316547|524102500|FG001|Overall Study|Death|1|||
145342690|NCT03316547|524102499|FG000|Overall Study|Lost to Follow-up|6|||
145342691|NCT03316547|524102500|FG001|Overall Study|Lost to Follow-up|6|||
145342692|NCT03316547|524102499|FG000|Overall Study|Withdrawal by Subject|3|||
145342693|NCT03316547|524102500|FG001|Overall Study|Withdrawal by Subject|2|||
145342694|NCT03316547|524102499|FG000|Overall Study|Transfer to another hospital|6|||
145342695|NCT03316547|524102500|FG001|Overall Study|Transfer to another hospital|4|||
145342696|NCT00996892|524102501|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
145342697|NCT00996892|524102502|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
145342698|NCT00996892|524102503|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
145342699|NCT00996892|524102504|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
145342700|NCT00996892|524102505|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
145342701|NCT00996892|524102506|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
145342702|NCT00996892|524102507|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
145342703|NCT00996892|524102508|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
145342704|NCT00996892|524102509|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
145342705|NCT00996892|524102510|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
145342706|NCT00996892|524102511|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
145342707|NCT00996892|524102512|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
145342708|NCT00996892|524102513|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
145342709|NCT00996892|524102514|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
145342710|NCT00996892|524102515|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
145342711|NCT00996892|524102516|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
145342712|NCT00996892|524102517|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
145342713|NCT00996892|524102518|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
145342714|NCT00996892|524102519|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
145342715|NCT00996892|524102520|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
145342716|NCT00996892|524102501|FG000|Dose-Escalation Stage 1|Death|1|||
145342717|NCT00996892|524102502|FG001|Dose-Escalation Stage 1|Death|0|||
145342718|NCT00996892|524102503|FG002|Dose-Escalation Stage 1|Death|0|||
145342719|NCT00996892|524102504|FG003|Dose-Escalation Stage 1|Death|0|||
145342720|NCT00996892|524102505|FG004|Dose-Escalation Stage 1|Death|0|||
145342721|NCT00996892|524102506|FG005|Dose-Escalation Stage 1|Death|1|||
145342722|NCT00996892|524102507|FG006|Dose-Escalation Stage 1|Death|0|||
145342723|NCT00996892|524102508|FG007|Dose-Escalation Stage 1|Death|0|||
145342724|NCT00996892|524102509|FG008|Dose-Escalation Stage 1|Death|0|||
145342725|NCT00996892|524102510|FG009|Dose-Escalation Stage 1|Death|0|||
145342726|NCT00996892|524102511|FG010|Dose-Escalation Stage 1|Death|0|||
145342727|NCT00996892|524102512|FG011|Dose-Escalation Stage 1|Death|0|||
145342728|NCT00996892|524102513|FG012|Dose-Escalation Stage 1|Death|0|||
145342729|NCT00996892|524102514|FG013|Dose-Escalation Stage 1|Death|0|||
145342730|NCT00996892|524102515|FG014|Dose-Escalation Stage 1|Death|0|||
145342731|NCT00996892|524102516|FG015|Dose-Escalation Stage 1|Death|0|||
145342732|NCT00996892|524102517|FG016|Dose-Escalation Stage 1|Death|0|||
145342733|NCT00996892|524102518|FG017|Dose-Escalation Stage 1|Death|0|||
145342734|NCT00996892|524102519|FG018|Dose-Escalation Stage 1|Death|0|||
145342735|NCT00996892|524102520|FG019|Dose-Escalation Stage 1|Death|0|||
145342736|NCT00996892|524102501|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
145342737|NCT00996892|524102502|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
145342738|NCT00996892|524102503|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
145342739|NCT00996892|524102504|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
145342740|NCT00996892|524102505|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
145342741|NCT00996892|524102506|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
145342742|NCT00996892|524102507|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
145342743|NCT00996892|524102508|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
145342744|NCT00996892|524102509|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
145342745|NCT00996892|524102510|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
145342746|NCT00996892|524102511|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
145342747|NCT00996892|524102512|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
145342748|NCT00996892|524102513|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
145342749|NCT00996892|524102514|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
145342750|NCT00996892|524102515|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
145342751|NCT00996892|524102516|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
145342752|NCT00996892|524102517|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
145342753|NCT00996892|524102518|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
145342754|NCT00996892|524102519|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
145342755|NCT00996892|524102520|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
145342756|NCT00996892|524102501|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342757|NCT00996892|524102502|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145342758|NCT00996892|524102503|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342759|NCT00996892|524102504|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
145342760|NCT00996892|524102505|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145342761|NCT00996892|524102506|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145342762|NCT00996892|524102507|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
145342763|NCT00996892|524102508|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342764|NCT00996892|524102509|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342765|NCT00996892|524102510|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342766|NCT00996892|524102511|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342767|NCT00996892|524102512|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342768|NCT00996892|524102513|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342769|NCT00996892|524102514|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342770|NCT00996892|524102515|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342771|NCT00996892|524102516|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342772|NCT00996892|524102517|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342773|NCT00996892|524102518|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342774|NCT00996892|524102519|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342775|NCT00996892|524102520|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
145342776|NCT00996892|524102501|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
145342777|NCT00996892|524102502|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
145342778|NCT00996892|524102503|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
145342779|NCT00996892|524102504|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
145342780|NCT00996892|524102505|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
145342781|NCT00996892|524102506|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
145342782|NCT00996892|524102507|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
145342783|NCT00996892|524102508|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
145342784|NCT00996892|524102509|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
145342785|NCT00996892|524102510|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
145342786|NCT00996892|524102511|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
145342787|NCT00996892|524102512|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
145342788|NCT00996892|524102513|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
145342789|NCT00996892|524102514|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
145342790|NCT00996892|524102515|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
145342791|NCT00996892|524102516|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
145342792|NCT00996892|524102517|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
145342793|NCT00996892|524102518|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
145342794|NCT00996892|524102519|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
145342795|NCT00996892|524102520|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
145342796|NCT00996892|524102501|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
145342797|NCT00996892|524102502|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
145342798|NCT00996892|524102503|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
145342799|NCT00996892|524102504|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
145342800|NCT00996892|524102505|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
145342801|NCT00996892|524102506|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
145342802|NCT00996892|524102507|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
145342803|NCT00996892|524102508|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
145342804|NCT00996892|524102509|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
145342805|NCT00996892|524102510|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
145342806|NCT00996892|524102511|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
145342807|NCT00996892|524102512|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
145342808|NCT00996892|524102513|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
145342809|NCT00996892|524102514|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
145342810|NCT00996892|524102515|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
145342811|NCT00996892|524102516|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
145342812|NCT00996892|524102517|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
145342813|NCT00996892|524102518|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
145342814|NCT00996892|524102519|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
145342815|NCT00996892|524102520|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
145342816|NCT00996892|524102501|FG000|Dose-Escalation Stage 1A|Death|0|||
145342817|NCT00996892|524102502|FG001|Dose-Escalation Stage 1A|Death|0|||
145342818|NCT00996892|524102503|FG002|Dose-Escalation Stage 1A|Death|0|||
145342819|NCT00996892|524102504|FG003|Dose-Escalation Stage 1A|Death|0|||
145342820|NCT00996892|524102505|FG004|Dose-Escalation Stage 1A|Death|0|||
145342821|NCT00996892|524102506|FG005|Dose-Escalation Stage 1A|Death|0|||
145342822|NCT00996892|524102507|FG006|Dose-Escalation Stage 1A|Death|0|||
145342823|NCT00996892|524102508|FG007|Dose-Escalation Stage 1A|Death|0|||
145342824|NCT00996892|524102509|FG008|Dose-Escalation Stage 1A|Death|0|||
145342825|NCT00996892|524102510|FG009|Dose-Escalation Stage 1A|Death|2|||
145342826|NCT00996892|524102511|FG010|Dose-Escalation Stage 1A|Death|0|||
145342827|NCT00996892|524102512|FG011|Dose-Escalation Stage 1A|Death|1|||
145342828|NCT00996892|524102513|FG012|Dose-Escalation Stage 1A|Death|1|||
145342829|NCT00996892|524102514|FG013|Dose-Escalation Stage 1A|Death|0|||
145342830|NCT00996892|524102515|FG014|Dose-Escalation Stage 1A|Death|0|||
145342831|NCT00996892|524102516|FG015|Dose-Escalation Stage 1A|Death|0|||
145342832|NCT00996892|524102517|FG016|Dose-Escalation Stage 1A|Death|0|||
145342833|NCT00996892|524102518|FG017|Dose-Escalation Stage 1A|Death|0|||
145342834|NCT00996892|524102519|FG018|Dose-Escalation Stage 1A|Death|0|||
145342835|NCT00996892|524102520|FG019|Dose-Escalation Stage 1A|Death|0|||
145342836|NCT00996892|524102501|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
145342837|NCT00996892|524102502|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
145342838|NCT00996892|524102503|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
145342839|NCT00996892|524102504|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
145342840|NCT00996892|524102505|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
145342841|NCT00996892|524102506|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
145342842|NCT00996892|524102507|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
145342843|NCT00996892|524102508|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
145342844|NCT00996892|524102509|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
145342845|NCT00996892|524102510|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
145342846|NCT00996892|524102511|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
145342847|NCT00996892|524102512|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
145342848|NCT00996892|524102513|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
145342849|NCT00996892|524102514|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
145342850|NCT00996892|524102515|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
145342851|NCT00996892|524102516|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
145342852|NCT00996892|524102517|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
145342853|NCT00996892|524102518|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
145342854|NCT00996892|524102519|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
145342855|NCT00996892|524102520|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
145342856|NCT00996892|524102501|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342857|NCT00996892|524102502|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342858|NCT00996892|524102503|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342859|NCT00996892|524102504|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342860|NCT00996892|524102505|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342861|NCT00996892|524102506|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145575547|NCT00844545|524962267|FG000|Extension Treatment Period|Adverse Event|2|||
145342862|NCT00996892|524102507|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342863|NCT00996892|524102508|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145575548|NCT00844545|524962267|FG000|Post Treatment Period|Withdrawal by Subject|1|||
145575549|NCT02039427|524962268|FG000|Overall Study|Duration of surgery > 3h|1|||
145342864|NCT00996892|524102509|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342865|NCT00996892|524102510|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145342866|NCT00996892|524102511|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145342867|NCT00996892|524102512|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145342868|NCT00996892|524102513|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
145342869|NCT00996892|524102514|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145575550|NCT02039427|524962269|FG001|Overall Study|Duration of surgery > 3h|1|||
145342870|NCT00996892|524102515|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342871|NCT00996892|524102516|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342872|NCT00996892|524102517|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342873|NCT00996892|524102518|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342874|NCT00996892|524102519|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342875|NCT00996892|524102520|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
145342876|NCT00996892|524102501|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
145342877|NCT00996892|524102502|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
145342878|NCT00996892|524102503|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
145342879|NCT00996892|524102504|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
145342880|NCT00996892|524102505|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
145342881|NCT00996892|524102506|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
145342882|NCT00996892|524102507|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
145342883|NCT00996892|524102508|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
145342884|NCT00996892|524102509|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
145342885|NCT00996892|524102510|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
145342886|NCT00996892|524102511|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
145342887|NCT00996892|524102512|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
145342888|NCT00996892|524102513|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
145342889|NCT00996892|524102514|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
145342890|NCT00996892|524102515|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
145342891|NCT00996892|524102516|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
145342892|NCT00996892|524102517|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
145342893|NCT00996892|524102518|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
145342894|NCT00996892|524102519|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
145342895|NCT00996892|524102520|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
145342896|NCT00996892|524102501|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
145342897|NCT00996892|524102502|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
145342898|NCT00996892|524102503|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
145342899|NCT00996892|524102504|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
145342900|NCT00996892|524102505|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
145342901|NCT00996892|524102506|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
145342902|NCT00996892|524102507|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
145342903|NCT00996892|524102508|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
145342904|NCT00996892|524102509|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
145342905|NCT00996892|524102510|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
145342906|NCT00996892|524102511|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
145342907|NCT00996892|524102512|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
145342908|NCT00996892|524102513|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
145342909|NCT00996892|524102514|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
145342910|NCT00996892|524102515|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
145342911|NCT00996892|524102516|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
145342912|NCT00996892|524102517|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
145342913|NCT00996892|524102518|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
145342914|NCT00996892|524102519|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
145342915|NCT00996892|524102520|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
145342916|NCT00996892|524102501|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
145342917|NCT00996892|524102502|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
145342918|NCT00996892|524102503|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
145342919|NCT00996892|524102504|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
145342920|NCT00996892|524102505|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
145342921|NCT00996892|524102506|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
145342922|NCT00996892|524102507|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
145342923|NCT00996892|524102508|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
145342924|NCT00996892|524102509|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
145342925|NCT00996892|524102510|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
145342926|NCT00996892|524102511|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
145342927|NCT00996892|524102512|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
145342928|NCT00996892|524102513|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
145342929|NCT00996892|524102514|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
145342930|NCT00996892|524102515|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
145342931|NCT00996892|524102516|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
145342932|NCT00996892|524102517|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
145342933|NCT00996892|524102518|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
145342934|NCT00996892|524102519|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
145342935|NCT00996892|524102520|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
145342936|NCT00996892|524102501|FG000|Expansion Stage 2|Adverse Event|0|||
145342937|NCT00996892|524102502|FG001|Expansion Stage 2|Adverse Event|0|||
145342938|NCT00996892|524102503|FG002|Expansion Stage 2|Adverse Event|0|||
145342939|NCT00996892|524102504|FG003|Expansion Stage 2|Adverse Event|0|||
145342940|NCT00996892|524102505|FG004|Expansion Stage 2|Adverse Event|0|||
145342941|NCT00996892|524102506|FG005|Expansion Stage 2|Adverse Event|0|||
145342942|NCT00996892|524102507|FG006|Expansion Stage 2|Adverse Event|0|||
145342943|NCT00996892|524102508|FG007|Expansion Stage 2|Adverse Event|0|||
145342944|NCT00996892|524102509|FG008|Expansion Stage 2|Adverse Event|0|||
145342945|NCT00996892|524102510|FG009|Expansion Stage 2|Adverse Event|0|||
145342946|NCT00996892|524102511|FG010|Expansion Stage 2|Adverse Event|0|||
145342947|NCT00996892|524102512|FG011|Expansion Stage 2|Adverse Event|0|||
145342948|NCT00996892|524102513|FG012|Expansion Stage 2|Adverse Event|0|||
145342949|NCT00996892|524102514|FG013|Expansion Stage 2|Adverse Event|0|||
145342950|NCT00996892|524102515|FG014|Expansion Stage 2|Adverse Event|0|||
145342951|NCT00996892|524102516|FG015|Expansion Stage 2|Adverse Event|0|||
145342952|NCT00996892|524102517|FG016|Expansion Stage 2|Adverse Event|0|||
145342953|NCT00996892|524102518|FG017|Expansion Stage 2|Adverse Event|0|||
145342954|NCT00996892|524102519|FG018|Expansion Stage 2|Adverse Event|3|||
145342955|NCT00996892|524102520|FG019|Expansion Stage 2|Adverse Event|0|||
145342956|NCT00996892|524102501|FG000|Expansion Stage 2|Death|0|||
145342957|NCT00996892|524102502|FG001|Expansion Stage 2|Death|0|||
145342958|NCT00996892|524102503|FG002|Expansion Stage 2|Death|0|||
145342959|NCT00996892|524102504|FG003|Expansion Stage 2|Death|0|||
145342960|NCT00996892|524102505|FG004|Expansion Stage 2|Death|0|||
145342961|NCT00996892|524102506|FG005|Expansion Stage 2|Death|0|||
145342962|NCT00996892|524102507|FG006|Expansion Stage 2|Death|0|||
145342963|NCT00996892|524102508|FG007|Expansion Stage 2|Death|0|||
145342964|NCT00996892|524102509|FG008|Expansion Stage 2|Death|0|||
145342965|NCT00996892|524102510|FG009|Expansion Stage 2|Death|0|||
145342966|NCT00996892|524102511|FG010|Expansion Stage 2|Death|0|||
145342967|NCT00996892|524102512|FG011|Expansion Stage 2|Death|0|||
145342968|NCT00996892|524102513|FG012|Expansion Stage 2|Death|0|||
145342969|NCT00996892|524102514|FG013|Expansion Stage 2|Death|0|||
145342970|NCT00996892|524102515|FG014|Expansion Stage 2|Death|0|||
145342971|NCT00996892|524102516|FG015|Expansion Stage 2|Death|0|||
145342972|NCT00996892|524102517|FG016|Expansion Stage 2|Death|0|||
145342973|NCT00996892|524102518|FG017|Expansion Stage 2|Death|0|||
145342974|NCT00996892|524102519|FG018|Expansion Stage 2|Death|2|||
145342975|NCT00996892|524102520|FG019|Expansion Stage 2|Death|0|||
145342976|NCT00996892|524102501|FG000|Expansion Stage 2|Physician Decision|0|||
145342977|NCT00996892|524102502|FG001|Expansion Stage 2|Physician Decision|0|||
145342978|NCT00996892|524102503|FG002|Expansion Stage 2|Physician Decision|0|||
145342979|NCT00996892|524102504|FG003|Expansion Stage 2|Physician Decision|0|||
145342980|NCT00996892|524102505|FG004|Expansion Stage 2|Physician Decision|0|||
145342981|NCT00996892|524102506|FG005|Expansion Stage 2|Physician Decision|0|||
145342982|NCT00996892|524102507|FG006|Expansion Stage 2|Physician Decision|0|||
145342983|NCT00996892|524102508|FG007|Expansion Stage 2|Physician Decision|0|||
145342984|NCT00996892|524102509|FG008|Expansion Stage 2|Physician Decision|0|||
145342985|NCT00996892|524102510|FG009|Expansion Stage 2|Physician Decision|0|||
145342986|NCT00996892|524102511|FG010|Expansion Stage 2|Physician Decision|0|||
145342987|NCT00996892|524102512|FG011|Expansion Stage 2|Physician Decision|0|||
145342988|NCT00996892|524102513|FG012|Expansion Stage 2|Physician Decision|0|||
145342989|NCT00996892|524102514|FG013|Expansion Stage 2|Physician Decision|0|||
145342990|NCT00996892|524102515|FG014|Expansion Stage 2|Physician Decision|0|||
145342991|NCT00996892|524102516|FG015|Expansion Stage 2|Physician Decision|0|||
145342992|NCT00996892|524102517|FG016|Expansion Stage 2|Physician Decision|0|||
145342993|NCT00996892|524102518|FG017|Expansion Stage 2|Physician Decision|0|||
145342994|NCT00996892|524102519|FG018|Expansion Stage 2|Physician Decision|1|||
145413823|NCT03188185|524368414|FG000|Stage 2|Lack of Efficacy|0|||
145413824|NCT03188185|524368415|FG001|Stage 2|Lack of Efficacy|0|||
145413825|NCT03188185|524368416|FG002|Stage 2|Lack of Efficacy|3|||
145413826|NCT03188185|524368417|FG003|Stage 2|Lack of Efficacy|0|||
145413827|NCT03188185|524368414|FG000|Stage 2|Lost to Follow-up|0|||
145413828|NCT03188185|524368415|FG001|Stage 2|Lost to Follow-up|0|||
145342995|NCT00996892|524102520|FG019|Expansion Stage 2|Physician Decision|0|||
145342996|NCT00996892|524102501|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
145342997|NCT00996892|524102502|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
145342998|NCT00996892|524102503|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
145342999|NCT00996892|524102504|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
145343000|NCT00996892|524102505|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
145343001|NCT00996892|524102506|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
145343002|NCT00996892|524102507|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
145343003|NCT00996892|524102508|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
145343004|NCT00996892|524102509|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
145343005|NCT00996892|524102510|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
145343006|NCT00996892|524102511|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
145343007|NCT00996892|524102512|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
145343008|NCT00996892|524102513|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
145343009|NCT00996892|524102514|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
145343010|NCT00996892|524102515|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
145343011|NCT00996892|524102516|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
145343012|NCT00996892|524102517|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
145343013|NCT00996892|524102518|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
145413829|NCT03188185|524368416|FG002|Stage 2|Lost to Follow-up|1|||
145343014|NCT00996892|524102519|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
145343015|NCT00996892|524102520|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
145343016|NCT00996892|524102501|FG000|Expansion Stage 2|Disease Progression|0|||
145343017|NCT00996892|524102502|FG001|Expansion Stage 2|Disease Progression|0|||
145343018|NCT00996892|524102503|FG002|Expansion Stage 2|Disease Progression|0|||
145343019|NCT00996892|524102504|FG003|Expansion Stage 2|Disease Progression|0|||
145343020|NCT00996892|524102505|FG004|Expansion Stage 2|Disease Progression|0|||
145343021|NCT00996892|524102506|FG005|Expansion Stage 2|Disease Progression|0|||
145343022|NCT00996892|524102507|FG006|Expansion Stage 2|Disease Progression|0|||
145343023|NCT00996892|524102508|FG007|Expansion Stage 2|Disease Progression|0|||
145343024|NCT00996892|524102509|FG008|Expansion Stage 2|Disease Progression|0|||
145343025|NCT00996892|524102510|FG009|Expansion Stage 2|Disease Progression|0|||
145343026|NCT00996892|524102511|FG010|Expansion Stage 2|Disease Progression|0|||
145343027|NCT00996892|524102512|FG011|Expansion Stage 2|Disease Progression|0|||
145343028|NCT00996892|524102513|FG012|Expansion Stage 2|Disease Progression|0|||
145343029|NCT00996892|524102514|FG013|Expansion Stage 2|Disease Progression|0|||
145343030|NCT00996892|524102515|FG014|Expansion Stage 2|Disease Progression|0|||
145343031|NCT00996892|524102516|FG015|Expansion Stage 2|Disease Progression|0|||
145343032|NCT00996892|524102517|FG016|Expansion Stage 2|Disease Progression|0|||
145343033|NCT00996892|524102518|FG017|Expansion Stage 2|Disease Progression|0|||
145343034|NCT00996892|524102519|FG018|Expansion Stage 2|Disease Progression|28|||
145343035|NCT00996892|524102520|FG019|Expansion Stage 2|Disease Progression|0|||
145343036|NCT00996892|524102501|FG000|Expansion Stage 2A|Adverse Event|0|||
145343037|NCT00996892|524102502|FG001|Expansion Stage 2A|Adverse Event|0|||
145343038|NCT00996892|524102503|FG002|Expansion Stage 2A|Adverse Event|0|||
145343039|NCT00996892|524102504|FG003|Expansion Stage 2A|Adverse Event|0|||
145343040|NCT00996892|524102505|FG004|Expansion Stage 2A|Adverse Event|0|||
145343041|NCT00996892|524102506|FG005|Expansion Stage 2A|Adverse Event|0|||
145343042|NCT00996892|524102507|FG006|Expansion Stage 2A|Adverse Event|0|||
145343043|NCT00996892|524102508|FG007|Expansion Stage 2A|Adverse Event|0|||
145343044|NCT00996892|524102509|FG008|Expansion Stage 2A|Adverse Event|0|||
145343045|NCT00996892|524102510|FG009|Expansion Stage 2A|Adverse Event|0|||
145343046|NCT00996892|524102511|FG010|Expansion Stage 2A|Adverse Event|0|||
145343047|NCT00996892|524102512|FG011|Expansion Stage 2A|Adverse Event|0|||
145343048|NCT00996892|524102513|FG012|Expansion Stage 2A|Adverse Event|0|||
145343049|NCT00996892|524102514|FG013|Expansion Stage 2A|Adverse Event|0|||
145343050|NCT00996892|524102515|FG014|Expansion Stage 2A|Adverse Event|0|||
145343051|NCT00996892|524102516|FG015|Expansion Stage 2A|Adverse Event|0|||
145343052|NCT00996892|524102517|FG016|Expansion Stage 2A|Adverse Event|0|||
145343053|NCT00996892|524102518|FG017|Expansion Stage 2A|Adverse Event|0|||
145343054|NCT00996892|524102519|FG018|Expansion Stage 2A|Adverse Event|0|||
145343055|NCT00996892|524102520|FG019|Expansion Stage 2A|Adverse Event|8|||
145343056|NCT00996892|524102501|FG000|Expansion Stage 2A|Physician Decision|0|||
145343057|NCT00996892|524102502|FG001|Expansion Stage 2A|Physician Decision|0|||
145343058|NCT00996892|524102503|FG002|Expansion Stage 2A|Physician Decision|0|||
145343059|NCT00996892|524102504|FG003|Expansion Stage 2A|Physician Decision|0|||
145413830|NCT03188185|524368417|FG003|Stage 2|Lost to Follow-up|0|||
145413831|NCT03188185|524368414|FG000|Stage 2|Physician Decision|0|||
145413832|NCT03188185|524368415|FG001|Stage 2|Physician Decision|0|||
145413833|NCT03188185|524368416|FG002|Stage 2|Physician Decision|0|||
145413834|NCT03188185|524368417|FG003|Stage 2|Physician Decision|1|||
145413835|NCT03188185|524368414|FG000|Stage 2|Withdrawal by Subject|0|||
145413836|NCT03188185|524368415|FG001|Stage 2|Withdrawal by Subject|0|||
145343060|NCT00996892|524102505|FG004|Expansion Stage 2A|Physician Decision|0|||
145343061|NCT00996892|524102506|FG005|Expansion Stage 2A|Physician Decision|0|||
145343062|NCT00996892|524102507|FG006|Expansion Stage 2A|Physician Decision|0|||
145343063|NCT00996892|524102508|FG007|Expansion Stage 2A|Physician Decision|0|||
145343064|NCT00996892|524102509|FG008|Expansion Stage 2A|Physician Decision|0|||
145343065|NCT00996892|524102510|FG009|Expansion Stage 2A|Physician Decision|0|||
145343066|NCT00996892|524102511|FG010|Expansion Stage 2A|Physician Decision|0|||
145343067|NCT00996892|524102512|FG011|Expansion Stage 2A|Physician Decision|0|||
145343068|NCT00996892|524102513|FG012|Expansion Stage 2A|Physician Decision|0|||
145343069|NCT00996892|524102514|FG013|Expansion Stage 2A|Physician Decision|0|||
145343070|NCT00996892|524102515|FG014|Expansion Stage 2A|Physician Decision|0|||
145343071|NCT00996892|524102516|FG015|Expansion Stage 2A|Physician Decision|0|||
145343072|NCT00996892|524102517|FG016|Expansion Stage 2A|Physician Decision|0|||
145413837|NCT03188185|524368416|FG002|Stage 2|Withdrawal by Subject|3|||
145343073|NCT00996892|524102518|FG017|Expansion Stage 2A|Physician Decision|0|||
145343074|NCT00996892|524102519|FG018|Expansion Stage 2A|Physician Decision|0|||
145343075|NCT00996892|524102520|FG019|Expansion Stage 2A|Physician Decision|2|||
145343076|NCT00996892|524102501|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
145343077|NCT00996892|524102502|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
145343078|NCT00996892|524102503|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
145343079|NCT00996892|524102504|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
145343080|NCT00996892|524102505|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
145343081|NCT00996892|524102506|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
145343082|NCT00996892|524102507|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
145413838|NCT03188185|524368417|FG003|Stage 2|Withdrawal by Subject|1|||
145413839|NCT00774748|524368418|FG000|Overall Study|Lost to Follow-up|3|||
145413840|NCT03412890|524368421|FG000|Overall Study|Adverse Event|5|||
145413841|NCT03412890|524368422|FG001|Overall Study|Adverse Event|5|||
145413842|NCT03412890|524368423|FG002|Overall Study|Adverse Event|9|||
145413843|NCT03412890|524368421|FG000|Overall Study|Protocol deviation|2|||
145413844|NCT03412890|524368422|FG001|Overall Study|Protocol deviation|1|||
145413845|NCT03412890|524368423|FG002|Overall Study|Protocol deviation|2|||
145413846|NCT03412890|524368421|FG000|Overall Study|Lost to Follow-up|7|||
145413847|NCT03412890|524368422|FG001|Overall Study|Lost to Follow-up|10|||
145413848|NCT03412890|524368423|FG002|Overall Study|Lost to Follow-up|10|||
145413849|NCT03412890|524368421|FG000|Overall Study|Withdrawal by Subject|9|||
145413850|NCT03412890|524368422|FG001|Overall Study|Withdrawal by Subject|12|||
145413851|NCT03412890|524368423|FG002|Overall Study|Withdrawal by Subject|11|||
145413852|NCT03412890|524368421|FG000|Overall Study|Lack of Efficacy|2|||
145413853|NCT03412890|524368422|FG001|Overall Study|Lack of Efficacy|7|||
145575551|NCT02039427|524962270|FG002|Overall Study|Duration of surgery > 3h|0|||
145575552|NCT02039427|524962271|FG003|Overall Study|Duration of surgery > 3h|0|||
145575553|NCT02039427|524962268|FG000|Overall Study|Withdrawal on concent|0|||
145575554|NCT02039427|524962269|FG001|Overall Study|Withdrawal on concent|0|||
145575555|NCT02039427|524962270|FG002|Overall Study|Withdrawal on concent|0|||
145575556|NCT02039427|524962271|FG003|Overall Study|Withdrawal on concent|1|||
145575557|NCT02039427|524962268|FG000|Overall Study|Cancellation of surgery|0|||
145575558|NCT02039427|524962269|FG001|Overall Study|Cancellation of surgery|0|||
145575559|NCT02039427|524962270|FG002|Overall Study|Cancellation of surgery|1|||
145575560|NCT02039427|524962271|FG003|Overall Study|Cancellation of surgery|0|||
145575561|NCT02039427|524962268|FG000|Overall Study|Loss of follow - up|1|||
145575562|NCT02039427|524962269|FG001|Overall Study|Loss of follow - up|0|||
145575563|NCT02039427|524962270|FG002|Overall Study|Loss of follow - up|2|||
145575564|NCT02039427|524962271|FG003|Overall Study|Loss of follow - up|4|||
145575565|NCT02039427|524962268|FG000|Overall Study|Steroid Use|1|||
145575566|NCT02039427|524962269|FG001|Overall Study|Steroid Use|0|||
145575567|NCT02039427|524962270|FG002|Overall Study|Steroid Use|0|||
145575568|NCT02039427|524962271|FG003|Overall Study|Steroid Use|0|||
145575569|NCT01532687|524962278|FG000|Overall Study|Death|2|||
145575570|NCT01532687|524962279|FG001|Overall Study|Death|0|||
145343083|NCT00996892|524102508|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
145343084|NCT00996892|524102509|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
145343085|NCT00996892|524102510|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
145343086|NCT00996892|524102511|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
145343087|NCT00996892|524102512|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
145343088|NCT00996892|524102513|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
145343089|NCT00996892|524102514|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
145343090|NCT00996892|524102515|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
145343091|NCT00996892|524102516|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
145343092|NCT00996892|524102517|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
145343093|NCT00996892|524102518|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
145343094|NCT00996892|524102519|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
145343095|NCT00996892|524102520|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
145343096|NCT00996892|524102501|FG000|Expansion Stage 2A|Disease Progression|0|||
145343097|NCT00996892|524102502|FG001|Expansion Stage 2A|Disease Progression|0|||
145343098|NCT00996892|524102503|FG002|Expansion Stage 2A|Disease Progression|0|||
145343099|NCT00996892|524102504|FG003|Expansion Stage 2A|Disease Progression|0|||
145343100|NCT00996892|524102505|FG004|Expansion Stage 2A|Disease Progression|0|||
145343101|NCT00996892|524102506|FG005|Expansion Stage 2A|Disease Progression|0|||
145343102|NCT00996892|524102507|FG006|Expansion Stage 2A|Disease Progression|0|||
145343103|NCT00996892|524102508|FG007|Expansion Stage 2A|Disease Progression|0|||
145413854|NCT03412890|524368423|FG002|Overall Study|Lack of Efficacy|5|||
145413855|NCT03412890|524368421|FG000|Overall Study|Other|5|||
145413856|NCT03412890|524368422|FG001|Overall Study|Other|6|||
145575571|NCT01532687|524962278|FG000|Overall Study|Adverse Event|6|||
145575572|NCT01532687|524962279|FG001|Overall Study|Adverse Event|1|||
145575573|NCT01532687|524962278|FG000|Overall Study|Withdrawal by Subject|1|||
145575574|NCT01532687|524962279|FG001|Overall Study|Withdrawal by Subject|0|||
145343104|NCT00996892|524102509|FG008|Expansion Stage 2A|Disease Progression|0|||
145343105|NCT00996892|524102510|FG009|Expansion Stage 2A|Disease Progression|0|||
145343106|NCT00996892|524102511|FG010|Expansion Stage 2A|Disease Progression|0|||
145343107|NCT00996892|524102512|FG011|Expansion Stage 2A|Disease Progression|0|||
145413857|NCT03412890|524368423|FG002|Overall Study|Other|5|||
145413858|NCT03412890|524368421|FG000|Overall Study|Participants who did not receive any study drug|0|||
145413859|NCT03412890|524368422|FG001|Overall Study|Participants who did not receive any study drug|1|||
145575575|NCT01532687|524962278|FG000|Overall Study|Physician Decision|2|||
145575576|NCT01532687|524962279|FG001|Overall Study|Physician Decision|1|||
145343108|NCT00996892|524102513|FG012|Expansion Stage 2A|Disease Progression|0|||
145343109|NCT00996892|524102514|FG013|Expansion Stage 2A|Disease Progression|0|||
145343110|NCT00996892|524102515|FG014|Expansion Stage 2A|Disease Progression|0|||
145575577|NCT01532687|524962278|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
145575578|NCT01532687|524962279|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
145343111|NCT00996892|524102516|FG015|Expansion Stage 2A|Disease Progression|0|||
145343112|NCT00996892|524102517|FG016|Expansion Stage 2A|Disease Progression|0|||
145343113|NCT00996892|524102518|FG017|Expansion Stage 2A|Disease Progression|0|||
145343114|NCT00996892|524102519|FG018|Expansion Stage 2A|Disease Progression|0|||
145343115|NCT00996892|524102520|FG019|Expansion Stage 2A|Disease Progression|31|||
145343116|NCT01653912|524102521|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145343117|NCT01653912|524102522|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
145343118|NCT01653912|524102523|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145343119|NCT01653912|524102524|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145343120|NCT01653912|524102525|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145343121|NCT01653912|524102526|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
145343122|NCT01653912|524102521|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145343123|NCT01653912|524102522|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145343124|NCT01653912|524102523|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
145343125|NCT01653912|524102524|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145343126|NCT01653912|524102525|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145343127|NCT01653912|524102526|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
145343128|NCT01653912|524102521|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145343129|NCT01653912|524102522|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145343130|NCT01653912|524102523|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145343131|NCT01653912|524102524|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
145343132|NCT01653912|524102525|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145343133|NCT01653912|524102526|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
145343134|NCT01653912|524102521|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343135|NCT01653912|524102522|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343136|NCT01653912|524102523|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343137|NCT01653912|524102524|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
145343138|NCT01653912|524102525|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343139|NCT01653912|524102526|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343140|NCT01653912|524102521|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145343141|NCT01653912|524102522|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145343142|NCT01653912|524102523|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145343143|NCT01653912|524102524|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145343144|NCT01653912|524102525|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
145343145|NCT01653912|524102526|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
145343146|NCT01653912|524102521|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145343147|NCT01653912|524102522|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145343148|NCT01653912|524102523|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145343149|NCT01653912|524102524|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145343150|NCT01653912|524102525|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
145343151|NCT01653912|524102526|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
145343152|NCT01653912|524102521|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343153|NCT01653912|524102522|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343154|NCT01653912|524102523|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343155|NCT01653912|524102524|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343156|NCT01653912|524102525|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
145343157|NCT01653912|524102526|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
145343158|NCT00708227|524102527|FG000|Overall Study|Physician Decision|0|||
145343159|NCT00708227|524102528|FG001|Overall Study|Physician Decision|3|||
145343160|NCT00708227|524102529|FG002|Overall Study|Physician Decision|1|||
145343161|NCT00708227|524102530|FG003|Overall Study|Physician Decision|2|||
145343162|NCT00708227|524102527|FG000|Overall Study|Withdrawal by Subject|1|||
145343163|NCT00708227|524102528|FG001|Overall Study|Withdrawal by Subject|2|||
145413860|NCT03412890|524368423|FG002|Overall Study|Participants who did not receive any study drug|0|||
145413861|NCT01529268|524368424|FG000|Overall Study|Lost to Follow-up|9|||
145413862|NCT01529268|524368425|FG001|Overall Study|Lost to Follow-up|3|||
145413863|NCT01529268|524368424|FG000|Overall Study|Moved|3|||
145413864|NCT01529268|524368425|FG001|Overall Study|Moved|0|||
145413865|NCT02315625|524368426|FG000|First Intervention|Disease Progression|1|||
145413866|NCT02315625|524368427|FG001|First Intervention|Disease Progression|0|||
145413867|NCT02315625|524368426|FG000|Second Intervention|Physician Decision|2|||
145413868|NCT02315625|524368427|FG001|Second Intervention|Physician Decision|1|||
145413869|NCT02315625|524368426|FG000|Second Intervention|Study closure|1|||
145413870|NCT02315625|524368427|FG001|Second Intervention|Study closure|0|||
145413871|NCT02315625|524368426|FG000|Second Intervention|Disease Progression|1|||
145413872|NCT02315625|524368427|FG001|Second Intervention|Disease Progression|0|||
145343164|NCT00708227|524102529|FG002|Overall Study|Withdrawal by Subject|0|||
145343165|NCT00708227|524102530|FG003|Overall Study|Withdrawal by Subject|1|||
145413873|NCT04439175|524369173|FG000|Overall Study|Never started treatment|4|||
145413874|NCT04439175|524369173|FG000|Overall Study|Ineligible|5|||
145413875|NCT04439175|524369173|FG000|Overall Study|Adverse Event|6|||
145413876|NCT04439175|524369173|FG000|Overall Study|Death|4|||
145575579|NCT00403455|524962280|FG000|Overall Study|Withdrawal by Subject|1|||
145575580|NCT03160703|524962281|FG000|Overall Study|Withdrawal by Subject|0|||
145575581|NCT03160703|524962282|FG001|Overall Study|Withdrawal by Subject|0|||
145575582|NCT03160703|524962283|FG002|Overall Study|Withdrawal by Subject|0|||
145575583|NCT03160703|524962284|FG003|Overall Study|Withdrawal by Subject|1|||
145575584|NCT00226941|524962291|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
145575585|NCT00226941|524962292|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
145575586|NCT00226941|524962293|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
145575587|NCT00226941|524962294|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
145575588|NCT00226941|524962291|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
145575589|NCT00226941|524962292|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
145575590|NCT00226941|524962293|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
145575591|NCT00226941|524962294|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
145575592|NCT01513291|524962295|FG000|Treatment Period|Adverse Event|8|||
145575593|NCT01513291|524962296|FG001|Treatment Period|Adverse Event|4|||
145575594|NCT01513291|524962297|FG002|Treatment Period|Adverse Event|0|||
145575595|NCT01513291|524962298|FG003|Treatment Period|Adverse Event|0|||
145575596|NCT01513291|524962299|FG004|Treatment Period|Adverse Event|0|||
145575597|NCT01513291|524962295|FG000|Treatment Period|Lack of Efficacy|3|||
145575598|NCT01513291|524962296|FG001|Treatment Period|Lack of Efficacy|0|||
145575599|NCT01513291|524962297|FG002|Treatment Period|Lack of Efficacy|0|||
145575600|NCT01513291|524962298|FG003|Treatment Period|Lack of Efficacy|0|||
145575601|NCT01513291|524962299|FG004|Treatment Period|Lack of Efficacy|0|||
145575602|NCT01513291|524962295|FG000|Treatment Period|Lost to Follow-up|2|||
145575603|NCT01513291|524962296|FG001|Treatment Period|Lost to Follow-up|3|||
145575604|NCT01513291|524962297|FG002|Treatment Period|Lost to Follow-up|0|||
145575605|NCT01513291|524962298|FG003|Treatment Period|Lost to Follow-up|0|||
145575606|NCT01513291|524962299|FG004|Treatment Period|Lost to Follow-up|0|||
145575607|NCT01513291|524962295|FG000|Treatment Period|Physician Decision|1|||
145575608|NCT01513291|524962296|FG001|Treatment Period|Physician Decision|0|||
145575609|NCT01513291|524962297|FG002|Treatment Period|Physician Decision|0|||
145575610|NCT01513291|524962298|FG003|Treatment Period|Physician Decision|0|||
145575611|NCT01513291|524962299|FG004|Treatment Period|Physician Decision|0|||
145575612|NCT01513291|524962295|FG000|Treatment Period|Protocol Violation|1|||
145575613|NCT01513291|524962296|FG001|Treatment Period|Protocol Violation|2|||
145575614|NCT01513291|524962297|FG002|Treatment Period|Protocol Violation|0|||
145575615|NCT01513291|524962298|FG003|Treatment Period|Protocol Violation|0|||
145575616|NCT01513291|524962299|FG004|Treatment Period|Protocol Violation|0|||
145575617|NCT01513291|524962295|FG000|Treatment Period|Withdrawal by Subject|8|||
145575618|NCT01513291|524962296|FG001|Treatment Period|Withdrawal by Subject|5|||
145343166|NCT04007991|524102531|FG000|Overall Study|Withdrawal by Subject|1|||
145343167|NCT04007991|524102532|FG001|Overall Study|Withdrawal by Subject|1|||
145343168|NCT04007991|524102531|FG000|Overall Study|Physician Decision|1|||
145343169|NCT04007991|524102532|FG001|Overall Study|Physician Decision|1|||
145343170|NCT04007991|524102531|FG000|Overall Study|Non-compliance with Study Drug|0|||
145343171|NCT04007991|524102532|FG001|Overall Study|Non-compliance with Study Drug|1|||
145343172|NCT04007991|524102531|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
145343173|NCT04007991|524102532|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
145343174|NCT04007991|524102531|FG000|Overall Study|Adverse event, non-fatal|5|||
145343175|NCT04007991|524102532|FG001|Overall Study|Adverse event, non-fatal|0|||
145343176|NCT04007991|524102531|FG000|Overall Study|Lost to Follow-up|2|||
145343177|NCT04007991|524102532|FG001|Overall Study|Lost to Follow-up|1|||
145343178|NCT01987479|524102533|FG000|Overall Study|Protocol Violation|1|||
145343179|NCT01987479|524102533|FG000|Overall Study|Physician Decision|2|||
145575619|NCT01513291|524962297|FG002|Treatment Period|Withdrawal by Subject|0|||
145575620|NCT01513291|524962298|FG003|Treatment Period|Withdrawal by Subject|0|||
145575621|NCT01513291|524962299|FG004|Treatment Period|Withdrawal by Subject|0|||
145575622|NCT01513291|524962295|FG000|Treatment Period|Randomized not treated|0|||
145575623|NCT01513291|524962296|FG001|Treatment Period|Randomized not treated|2|||
145575624|NCT01513291|524962297|FG002|Treatment Period|Randomized not treated|0|||
145575625|NCT01513291|524962298|FG003|Treatment Period|Randomized not treated|0|||
145575626|NCT01513291|524962299|FG004|Treatment Period|Randomized not treated|0|||
145575627|NCT01513291|524962295|FG000|Run-out Period|Lost to Follow-up|0|||
145575628|NCT01513291|524962296|FG001|Run-out Period|Lost to Follow-up|0|||
145575629|NCT01513291|524962297|FG002|Run-out Period|Lost to Follow-up|0|||
145575630|NCT01513291|524962298|FG003|Run-out Period|Lost to Follow-up|1|||
145575631|NCT01513291|524962299|FG004|Run-out Period|Lost to Follow-up|0|||
145575632|NCT01513291|524962295|FG000|Run-out Period|Withdrawal by Subject|0|||
145575633|NCT01513291|524962296|FG001|Run-out Period|Withdrawal by Subject|0|||
145575634|NCT01513291|524962297|FG002|Run-out Period|Withdrawal by Subject|0|||
145575635|NCT01513291|524962298|FG003|Run-out Period|Withdrawal by Subject|1|||
145575636|NCT01513291|524962299|FG004|Run-out Period|Withdrawal by Subject|0|||
145575637|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
145343180|NCT01987479|524102533|FG000|Overall Study|Participant/legal guardian decision|1|||
145343181|NCT01987479|524102533|FG000|Overall Study|Other|5|||
145343182|NCT01987479|524102533|FG000|Overall Study|Lost to Follow-up|1|||
145343183|NCT01987479|524102533|FG000|Overall Study|Adverse Event|7|||
145343184|NCT05314816|524102534|FG000|Overall Study|Lost to Follow-up|5|||
145343185|NCT05314816|524102535|FG001|Overall Study|Lost to Follow-up|0|||
145343186|NCT05314816|524102536|FG002|Overall Study|Lost to Follow-up|1|||
145343187|NCT05314816|524102534|FG000|Overall Study|Protocol Violation|13|||
145343188|NCT05314816|524102535|FG001|Overall Study|Protocol Violation|8|||
145343189|NCT05314816|524102536|FG002|Overall Study|Protocol Violation|0|||
145343190|NCT04324073|524104735|FG000|Overall Study|withdrew consent|0|||
145343191|NCT04324073|524104736|FG001|Overall Study|withdrew consent|4|||
145343192|NCT04324073|524104737|FG002|Overall Study|withdrew consent|2|||
145343193|NCT04324073|524104738|FG003|Overall Study|withdrew consent|8|||
145343194|NCT05833139|524104739|FG000|Study Period 2|Adverse Event|1|||
145343195|NCT02260570|524104744|FG000|Overall Study|Withdrawal by Subject|2|||
145343196|NCT02260570|524104745|FG001|Overall Study|Withdrawal by Subject|1|||
145343197|NCT02260570|524104744|FG000|Overall Study|Physician Decision|1|||
145343198|NCT02260570|524104745|FG001|Overall Study|Physician Decision|1|||
145343199|NCT03996447|524104746|FG000|First MRI Examination|Adverse Event|2|||
145575638|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
145575639|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
145575640|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
145575641|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
145575642|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
145575643|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
145575644|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
145575645|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
145575646|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
145575647|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
145575648|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
145575649|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
145575650|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
145575651|NCT03732638|524962300|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
145575652|NCT03732638|524962301|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
145575653|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
145575654|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
145575655|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
145575656|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
145575657|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
145575658|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
145575659|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
145575660|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
145575661|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
145575662|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
145575663|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
145575664|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
145575665|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
145575666|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
145575667|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
145575668|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
145575669|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
145575670|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
145575671|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
145575672|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
145575673|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
145575674|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
145575675|NCT03732638|524962300|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
145575676|NCT03732638|524962301|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
145575677|NCT03732638|524962300|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
145575678|NCT03732638|524962301|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
145343200|NCT03996447|524104747|FG001|First MRI Examination|Adverse Event|0|||
145343201|NCT03996447|524104746|FG000|First MRI Examination|Withdrawal by Subject|1|||
145575679|NCT03732638|524962300|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
145575680|NCT03732638|524962301|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
145575681|NCT03732638|524962300|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
145575682|NCT03732638|524962301|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
145575683|NCT03732638|524962300|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
145575684|NCT03732638|524962301|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
145575685|NCT01358981|524962302|FG000|Period 1|Withdrawal by Subject|0|||
145343202|NCT03996447|524104747|FG001|First MRI Examination|Withdrawal by Subject|2|||
145343203|NCT03996447|524104746|FG000|First MRI Examination|Protocol Violation|0|||
145343204|NCT03996447|524104747|FG001|First MRI Examination|Protocol Violation|1|||
145575686|NCT01358981|524962303|FG001|Period 1|Withdrawal by Subject|0|||
145575687|NCT01358981|524962304|FG002|Period 1|Withdrawal by Subject|0|||
145575688|NCT01358981|524962305|FG003|Period 1|Withdrawal by Subject|1|||
145343205|NCT03996447|524104746|FG000|Washout|Adverse Event|2|||
145343206|NCT03996447|524104747|FG001|Washout|Adverse Event|0|||
145343207|NCT03996447|524104746|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
145343208|NCT03996447|524104747|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
145343209|NCT03996447|524104746|FG000|Washout|Withdrawal by Subject|0|||
145343210|NCT03996447|524104747|FG001|Washout|Withdrawal by Subject|1|||
145343211|NCT03996447|524104746|FG000|Washout|Other reason|1|||
145343212|NCT03996447|524104747|FG001|Washout|Other reason|1|||
145343213|NCT01659125|524104756|FG000|Overall Study|Withdrawal by Subject|2|||
145343214|NCT01659125|524104756|FG000|Overall Study|Lost to Follow-up|7|||
145343215|NCT01659125|524104756|FG000|Overall Study|Technical Problem|1|||
145343216|NCT01659125|524104756|FG000|Overall Study|Time Constraints|2|||
145343217|NCT01659125|524104756|FG000|Overall Study|Failed to Start Treatment|2|||
145343218|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #1|24|||
145343219|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #1|0|||
145343220|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
145343221|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
145343222|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343223|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343224|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
145343225|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
145343226|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
145343227|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
145343228|NCT03888066|524104759|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343229|NCT03888066|524104760|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343230|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343231|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343232|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
145343233|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
145343234|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343235|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343236|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
145343237|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343238|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #2|5|||
145343239|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #2|0|||
145343240|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
145343241|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
145343242|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
145343243|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
145343244|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
145343245|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
145343246|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #3|11|||
145343247|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #3|0|||
145343248|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
145343249|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
145343250|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
145343251|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145343252|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343253|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343254|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #4|3|||
145343255|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #4|0|||
145343256|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
145343257|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
145343258|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
145343259|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
145343260|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
145575689|NCT01358981|524962306|FG004|Period 1|Withdrawal by Subject|0|||
145575690|NCT01358981|524962307|FG005|Period 1|Withdrawal by Subject|0|||
145575691|NCT01358981|524962308|FG006|Period 1|Withdrawal by Subject|0|||
145575692|NCT04354831|524962309|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
145575693|NCT04354831|524962310|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
145575694|NCT03728582|524962311|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
145575695|NCT03728582|524962312|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
145575696|NCT03728582|524962311|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
145343261|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145343262|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
145343263|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
145343264|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
145343265|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343266|NCT03888066|524104759|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
145343267|NCT03888066|524104760|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145343268|NCT03888066|524104759|FG000|Run-in Phase|AE (Adverse Event)|17|||
145343269|NCT03888066|524104760|FG001|Run-in Phase|AE (Adverse Event)|0|||
145343270|NCT03888066|524104759|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
145343271|NCT03888066|524104760|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
145343272|NCT03888066|524104759|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343273|NCT03888066|524104760|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343274|NCT03888066|524104759|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
145343275|NCT03888066|524104760|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343276|NCT03888066|524104759|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
145343277|NCT03888066|524104760|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145343278|NCT03888066|524104759|FG000|Run-in Phase|Withdrawal by Subject|43|||
145343279|NCT03888066|524104760|FG001|Run-in Phase|Withdrawal by Subject|0|||
145343280|NCT03888066|524104759|FG000|Run-in Phase|AE; Physician Decision|1|||
145343281|NCT03888066|524104760|FG001|Run-in Phase|AE; Physician Decision|0|||
145343282|NCT03888066|524104759|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
145343283|NCT03888066|524104760|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
145343284|NCT03888066|524104759|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
145343285|NCT03888066|524104760|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
145343286|NCT03888066|524104759|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
145343287|NCT03888066|524104760|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
145343288|NCT03888066|524104759|FG000|Run-in Phase|Death|1|||
145343289|NCT03888066|524104760|FG001|Run-in Phase|Death|0|||
145343290|NCT03888066|524104759|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
145343291|NCT03888066|524104760|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
145343292|NCT03888066|524104759|FG000|Run-in Phase|Physician Decision|1|||
145343293|NCT03888066|524104760|FG001|Run-in Phase|Physician Decision|0|||
145343294|NCT03888066|524104759|FG000|Run-in Phase|Protocol Violation|13|||
145343295|NCT03888066|524104760|FG001|Run-in Phase|Protocol Violation|0|||
145343296|NCT03888066|524104759|FG000|Run-in Phase|Sponsor Request|34|||
145343297|NCT03888066|524104760|FG001|Run-in Phase|Sponsor Request|0|||
145343298|NCT03888066|524104759|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
145343299|NCT03888066|524104760|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
145343300|NCT03888066|524104759|FG000|Run-in Phase|Withdrawal Of Consent|1|||
145343301|NCT03888066|524104760|FG001|Run-in Phase|Withdrawal Of Consent|0|||
145343302|NCT03888066|524104759|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
145343303|NCT03888066|524104760|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
145343304|NCT03888066|524104759|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
145343305|NCT03888066|524104760|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
145343306|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
145343307|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
145343308|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
145343309|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
145343310|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
145343311|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
145343312|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
145343313|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
145343314|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
145343315|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
145343316|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
145343317|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
145343318|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
145343319|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
145343320|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
145343321|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
145413877|NCT04439175|524369173|FG000|Overall Study|Disease progression|44|||
145343322|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
145413878|NCT04439175|524369173|FG000|Overall Study|Withdrawal by Subject|4|||
145413879|NCT04439175|524369173|FG000|Overall Study|Alternative Therapy|1|||
145413880|NCT04439175|524369173|FG000|Overall Study|Other|2|||
145343323|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
145343324|NCT03888066|524104759|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
145343325|NCT03888066|524104760|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
145343326|NCT02207634|524104761|FG000|Overall Study|Withdrawal by Subject|21|||
145343327|NCT02207634|524104762|FG001|Overall Study|Withdrawal by Subject|31|||
145343328|NCT02207634|524104761|FG000|Overall Study|Lost to Follow-up|1|||
145343329|NCT02207634|524104762|FG001|Overall Study|Lost to Follow-up|0|||
145343330|NCT00459355|524104763|FG000|Overall Study|Subject no longer met inc criteria|20|||
145343331|NCT00459355|524104764|FG001|Overall Study|Subject no longer met inc criteria|18|||
145343332|NCT00287586|524104765|FG000|Overall Study|Withdrew Consent|19|||
145343333|NCT00287586|524104766|FG001|Overall Study|Withdrew Consent|30|||
145343334|NCT00287586|524104765|FG000|Overall Study|Lost to Follow-up|5|||
145343335|NCT00287586|524104766|FG001|Overall Study|Lost to Follow-up|4|||
145343336|NCT00287586|524104765|FG000|Overall Study|Death|2|||
145343337|NCT00287586|524104766|FG001|Overall Study|Death|3|||
145343338|NCT00287586|524104765|FG000|Overall Study|Elevated Hematocrit|3|||
145343339|NCT00287586|524104766|FG001|Overall Study|Elevated Hematocrit|0|||
145343340|NCT00287586|524104765|FG000|Overall Study|Rash|3|||
145343341|NCT00287586|524104766|FG001|Overall Study|Rash|0|||
145343342|NCT00287586|524104765|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
145343343|NCT00287586|524104766|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
145343344|NCT00287586|524104765|FG000|Overall Study|Stroke|2|||
145413881|NCT01847209|524369174|FG000|Overall Study|Withdrawal by Subject|1|||
145413882|NCT01847209|524369174|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
145413883|NCT05278065|524369178|FG000|Overall Study|Withdrawal by Subject|1|||
145413884|NCT05278065|524369179|FG001|Overall Study|Withdrawal by Subject|0|||
145413885|NCT02691663|524369184|FG000|Overall Study|Screen failure after baseline|2|||
145413886|NCT02691663|524369185|FG001|Overall Study|Screen failure after baseline|2|||
145413887|NCT02691663|524369184|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
145413888|NCT02691663|524369185|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
145413889|NCT02691663|524369184|FG000|Overall Study|Withdrawn after Follow up 2|1|||
145413890|NCT02691663|524369185|FG001|Overall Study|Withdrawn after Follow up 2|1|||
145413891|NCT02691663|524369184|FG000|Overall Study|Lost to Follow-up|3|||
145413892|NCT02691663|524369185|FG001|Overall Study|Lost to Follow-up|2|||
145413893|NCT04425018|524369188|FG000|Overall Study|Withdrawal by Subject|1|||
145413894|NCT04425018|524369189|FG001|Overall Study|Withdrawal by Subject|2|||
145413895|NCT01944774|524369190|FG000|Overall Study|Withdrawal by Subject|2|||
145413896|NCT01944774|524369191|FG001|Overall Study|Withdrawal by Subject|3|||
145413897|NCT01944774|524369192|FG002|Overall Study|Withdrawal by Subject|3|||
145413898|NCT01944774|524369190|FG000|Overall Study|Adverse Event|3|||
145413899|NCT01944774|524369191|FG001|Overall Study|Adverse Event|2|||
145413900|NCT01944774|524369192|FG002|Overall Study|Adverse Event|3|||
145413901|NCT01944774|524369190|FG000|Overall Study|Lack of Efficacy|1|||
145413902|NCT01944774|524369191|FG001|Overall Study|Lack of Efficacy|2|||
145413903|NCT01944774|524369192|FG002|Overall Study|Lack of Efficacy|2|||
145413904|NCT01944774|524369190|FG000|Overall Study|Lost to Follow-up|0|||
145413905|NCT01944774|524369191|FG001|Overall Study|Lost to Follow-up|1|||
145413906|NCT01944774|524369192|FG002|Overall Study|Lost to Follow-up|0|||
145413907|NCT03325439|524369195|FG000|Overall Study|Ineligibility|3|||
145413908|NCT00812097|524369196|FG000|Overall Study|Death|3|||
145413909|NCT00812097|524369197|FG001|Overall Study|Death|10|||
145413910|NCT00812097|524369198|FG002|Overall Study|Death|3|||
145413911|NCT00812097|524369199|FG003|Overall Study|Death|3|||
145413912|NCT00812097|524369196|FG000|Overall Study|Withdrawal by Subject|14|||
145413913|NCT00812097|524369197|FG001|Overall Study|Withdrawal by Subject|12|||
145413914|NCT00812097|524369198|FG002|Overall Study|Withdrawal by Subject|8|||
145413915|NCT00812097|524369199|FG003|Overall Study|Withdrawal by Subject|2|||
145413916|NCT00812097|524369196|FG000|Overall Study|Lost to Follow-up|90|||
145413917|NCT00812097|524369197|FG001|Overall Study|Lost to Follow-up|14|||
145343345|NCT00287586|524104766|FG001|Overall Study|Stroke|0|||
145343346|NCT00287586|524104765|FG000|Overall Study|Myocardial Infarction|1|||
145413918|NCT00812097|524369198|FG002|Overall Study|Lost to Follow-up|17|||
145413919|NCT00812097|524369199|FG003|Overall Study|Lost to Follow-up|5|||
145413920|NCT00812097|524369196|FG000|Overall Study|Explantation of study device(s)|27|||
145413921|NCT00812097|524369197|FG001|Overall Study|Explantation of study device(s)|29|||
145413922|NCT00812097|524369198|FG002|Overall Study|Explantation of study device(s)|14|||
145413923|NCT00812097|524369199|FG003|Overall Study|Explantation of study device(s)|20|||
145413924|NCT00812097|524369196|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
145413925|NCT00812097|524369197|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
145343347|NCT00287586|524104766|FG001|Overall Study|Myocardial Infarction|0|||
145343348|NCT00287586|524104765|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
145413926|NCT00812097|524369198|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
145413927|NCT00812097|524369199|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
145413928|NCT00927082|524369200|FG000|Overall Study|Lost to Follow-up|9|||
145413929|NCT00927082|524369201|FG001|Overall Study|Lost to Follow-up|8|||
145413930|NCT00927082|524369202|FG002|Overall Study|Lost to Follow-up|12|||
145343349|NCT00287586|524104766|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
145343350|NCT00287586|524104765|FG000|Overall Study|Cognitive Impairment|1|||
145343351|NCT00287586|524104766|FG001|Overall Study|Cognitive Impairment|0|||
145343352|NCT00287586|524104765|FG000|Overall Study|Pancreatic Cancer|1|||
145343353|NCT00287586|524104766|FG001|Overall Study|Pancreatic Cancer|3|||
145343354|NCT00287586|524104765|FG000|Overall Study|Sleep Apnea|1|||
145343355|NCT00287586|524104766|FG001|Overall Study|Sleep Apnea|0|||
145343356|NCT00287586|524104765|FG000|Overall Study|Shoulder Pain|1|||
145343357|NCT00287586|524104766|FG001|Overall Study|Shoulder Pain|0|||
145343358|NCT00287586|524104765|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
145343359|NCT00287586|524104766|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
145343360|NCT00287586|524104765|FG000|Overall Study|Nonadherence|1|||
145343361|NCT00287586|524104766|FG001|Overall Study|Nonadherence|1|||
145343362|NCT00287586|524104765|FG000|Overall Study|Enrolled in Another Study|1|||
145343363|NCT00287586|524104766|FG001|Overall Study|Enrolled in Another Study|0|||
145343364|NCT00287586|524104765|FG000|Overall Study|Major Depression|0|||
145343365|NCT00287586|524104766|FG001|Overall Study|Major Depression|2|||
145343366|NCT00287586|524104765|FG000|Overall Study|Lung Cancer|0|||
145343367|NCT00287586|524104766|FG001|Overall Study|Lung Cancer|2|||
145575697|NCT03728582|524962312|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
145343368|NCT00287586|524104765|FG000|Overall Study|Elevated IPSS Score|0|||
145343369|NCT00287586|524104766|FG001|Overall Study|Elevated IPSS Score|1|||
145343370|NCT00287586|524104765|FG000|Overall Study|Retroperitoneal Cancer|0|||
145343371|NCT00287586|524104766|FG001|Overall Study|Retroperitoneal Cancer|1|||
145343372|NCT00287586|524104765|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
145343373|NCT00287586|524104766|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
145343374|NCT00287586|524104765|FG000|Overall Study|Mood Swings and Irritability|0|||
145343375|NCT00287586|524104766|FG001|Overall Study|Mood Swings and Irritability|1|||
145343376|NCT00287586|524104765|FG000|Overall Study|Bradycardia|0|||
145343377|NCT00287586|524104766|FG001|Overall Study|Bradycardia|1|||
145343378|NCT00287586|524104765|FG000|Overall Study|Itchy Swollen Eyes|0|||
145343379|NCT00287586|524104766|FG001|Overall Study|Itchy Swollen Eyes|1|||
145343380|NCT00287586|524104765|FG000|Overall Study|Recurrent Melanoma|0|||
145343381|NCT00287586|524104766|FG001|Overall Study|Recurrent Melanoma|1|||
145343382|NCT01145508|524104767|FG000|Overall Study|Adverse Event|1|||
145575698|NCT02732847|524962313|FG000|Overall Study|some filled early|42|||
145413931|NCT00927082|524369203|FG003|Overall Study|Lost to Follow-up|16|||
145413932|NCT00927082|524369200|FG000|Overall Study|Withdrawal by Subject|3|||
145575699|NCT02732847|524962314|FG001|Overall Study|some filled early|42|||
145575700|NCT01018264|524962315|FG000|Overall Study|Withdrawal by Subject|1|||
145575701|NCT01018264|524962316|FG001|Overall Study|Withdrawal by Subject|0|||
145575702|NCT01018264|524962315|FG000|Overall Study|Lost to Follow-up|0|||
145575703|NCT01018264|524962316|FG001|Overall Study|Lost to Follow-up|1|||
145575704|NCT02939404|524962318|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
145343383|NCT01145508|524104768|FG001|Overall Study|Adverse Event|0|||
145343384|NCT01145508|524104767|FG000|Overall Study|Death|1|||
145343385|NCT01145508|524104768|FG001|Overall Study|Death|0|||
145343386|NCT01145508|524104767|FG000|Overall Study|Physician Decision|2|||
145343387|NCT01145508|524104768|FG001|Overall Study|Physician Decision|1|||
145343388|NCT01145508|524104767|FG000|Overall Study|Never started treatment|1|||
145343389|NCT01145508|524104768|FG001|Overall Study|Never started treatment|1|||
145343390|NCT00799825|524104773|FG000|Overall Study|Adverse Event|1|||
145343391|NCT00799825|524104773|FG000|Overall Study|Withdrawal by Subject|6|||
145575705|NCT02939404|524962319|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
145575706|NCT02939404|524962318|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
145575707|NCT02939404|524962319|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
145343392|NCT00799825|524104773|FG000|Overall Study|Lost to Follow-up|38|||
145343393|NCT00799825|524104773|FG000|Overall Study|Pregnancy|3|||
145343394|NCT02640690|524104777|FG000|Overall Study|Lost to Follow-up|7|||
145343395|NCT02640690|524104778|FG001|Overall Study|Lost to Follow-up|7|||
145343396|NCT02640690|524104777|FG000|Overall Study|Withdrawal by Subject|16|||
145343397|NCT02640690|524104778|FG001|Overall Study|Withdrawal by Subject|20|||
145575708|NCT06640829|524962321|FG000|Overall Study|Withdrawal by Subject|1|||
145575709|NCT06640829|524962321|FG000|Overall Study|Lost to Follow-up|1|||
145575710|NCT01350128|524962324|FG000|Overall Study|Withdrawal by Subject|3|||
145575711|NCT01350128|524962324|FG000|Overall Study|Protocol discontinuation criteria|8|||
145575712|NCT01350128|524962324|FG000|Overall Study|Physician Decision|1|||
145575713|NCT01350128|524962324|FG000|Overall Study|Lost to Follow-up|2|||
145343398|NCT02640690|524104777|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
145343399|NCT02640690|524104778|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
145343400|NCT01520870|524104779|FG000|Overall Study|Withdrawal by Subject|2|||
145343401|NCT01118975|524104780|FG000|Overall Study|Adverse Event|0|||
145343402|NCT01118975|524104781|FG001|Overall Study|Adverse Event|1|||
145343403|NCT01645787|524104782|FG000|Washout (2 Weeks)|Adverse Event|1|||
145343404|NCT01645787|524104783|FG001|Washout (2 Weeks)|Adverse Event|0|||
145343405|NCT02620579|524104784|FG000|Overall Study|Physician Decision|0|||
145343406|NCT02620579|524104785|FG001|Overall Study|Physician Decision|0|||
145413933|NCT00927082|524369201|FG001|Overall Study|Withdrawal by Subject|2|||
145343407|NCT02620579|524104786|FG002|Overall Study|Physician Decision|0|||
145343408|NCT02620579|524104787|FG003|Overall Study|Physician Decision|1|||
145343409|NCT02620579|524104784|FG000|Overall Study|Withdrawal by Subject|0|||
145343410|NCT02620579|524104785|FG001|Overall Study|Withdrawal by Subject|1|||
145343411|NCT02620579|524104786|FG002|Overall Study|Withdrawal by Subject|1|||
145343412|NCT02620579|524104787|FG003|Overall Study|Withdrawal by Subject|0|||
145343413|NCT00796107|524104793|FG000|Overall Study|Lack of Efficacy|1|||
145343414|NCT00796107|524104793|FG000|Overall Study|Progressive Disease|5|||
145343415|NCT04315506|524104802|FG000|Overall Study|Lost to Follow-up|74|||
145343416|NCT04315506|524104803|FG001|Overall Study|Lost to Follow-up|82|||
145343417|NCT04315506|524104802|FG000|Overall Study|Withdrawal by Subject|8|||
145343418|NCT04315506|524104803|FG001|Overall Study|Withdrawal by Subject|8|||
145343419|NCT04315506|524104802|FG000|Overall Study|Physician Decision|0|||
145343420|NCT04315506|524104803|FG001|Overall Study|Physician Decision|1|||
145343421|NCT01098474|524104816|FG000|Active Phase|Other|0|||
145343422|NCT01098474|524104817|FG001|Active Phase|Other|0|||
145343423|NCT01098474|524104818|FG002|Active Phase|Other|3|||
145343424|NCT01098474|524104819|FG003|Active Phase|Other|0|||
145343425|NCT01098474|524104820|FG004|Active Phase|Other|0|||
145343426|NCT01098474|524104821|FG005|Active Phase|Other|0|||
145343427|NCT01098474|524104816|FG000|Active Phase|Withdrawal by Subject|1|||
145343428|NCT01098474|524104817|FG001|Active Phase|Withdrawal by Subject|1|||
145343429|NCT01098474|524104818|FG002|Active Phase|Withdrawal by Subject|2|||
145343430|NCT01098474|524104819|FG003|Active Phase|Withdrawal by Subject|0|||
145343431|NCT01098474|524104820|FG004|Active Phase|Withdrawal by Subject|0|||
145343432|NCT01098474|524104821|FG005|Active Phase|Withdrawal by Subject|0|||
145343433|NCT01098474|524104816|FG000|Active Phase|Lost to Follow-up|1|||
145343434|NCT01098474|524104817|FG001|Active Phase|Lost to Follow-up|0|||
145343435|NCT01098474|524104818|FG002|Active Phase|Lost to Follow-up|0|||
145343436|NCT01098474|524104819|FG003|Active Phase|Lost to Follow-up|0|||
145343437|NCT01098474|524104820|FG004|Active Phase|Lost to Follow-up|0|||
145343438|NCT01098474|524104821|FG005|Active Phase|Lost to Follow-up|0|||
145343439|NCT01098474|524104816|FG000|Follow Up Phase|Travelled out of study area|0|||
145343440|NCT01098474|524104817|FG001|Follow Up Phase|Travelled out of study area|0|||
145343441|NCT01098474|524104818|FG002|Follow Up Phase|Travelled out of study area|0|||
145343442|NCT01098474|524104819|FG003|Follow Up Phase|Travelled out of study area|0|||
145343443|NCT01098474|524104820|FG004|Follow Up Phase|Travelled out of study area|1|||
145343444|NCT01098474|524104821|FG005|Follow Up Phase|Travelled out of study area|0|||
145343445|NCT01098474|524104816|FG000|Follow Up Phase|Other|0|||
145343446|NCT01098474|524104817|FG001|Follow Up Phase|Other|0|||
145343447|NCT01098474|524104818|FG002|Follow Up Phase|Other|0|||
145343448|NCT01098474|524104819|FG003|Follow Up Phase|Other|0|||
145343449|NCT01098474|524104820|FG004|Follow Up Phase|Other|0|||
145343450|NCT01098474|524104821|FG005|Follow Up Phase|Other|4|||
145343451|NCT01098474|524104816|FG000|Follow Up Phase|Withdrawal by Subject|0|||
145343452|NCT01098474|524104817|FG001|Follow Up Phase|Withdrawal by Subject|0|||
145343453|NCT01098474|524104818|FG002|Follow Up Phase|Withdrawal by Subject|0|||
145343454|NCT01098474|524104819|FG003|Follow Up Phase|Withdrawal by Subject|2|||
145343455|NCT01098474|524104820|FG004|Follow Up Phase|Withdrawal by Subject|0|||
145343456|NCT01098474|524104821|FG005|Follow Up Phase|Withdrawal by Subject|1|||
145343457|NCT01098474|524104816|FG000|Follow Up Phase|Lost to Follow-up|0|||
145343458|NCT01098474|524104817|FG001|Follow Up Phase|Lost to Follow-up|0|||
145343459|NCT01098474|524104818|FG002|Follow Up Phase|Lost to Follow-up|0|||
145343460|NCT01098474|524104819|FG003|Follow Up Phase|Lost to Follow-up|0|||
145343461|NCT01098474|524104820|FG004|Follow Up Phase|Lost to Follow-up|1|||
145343462|NCT01098474|524104821|FG005|Follow Up Phase|Lost to Follow-up|0|||
145343463|NCT00626561|524104824|FG000|Overall Study|Withdrawal by Subject|2|||
145343464|NCT00626561|524104824|FG000|Overall Study|Disease Progression|2|||
145343465|NCT03993379|524104825|FG000|Overall Study|The study was terminated early due to business decision.|0|||
145343466|NCT03993379|524104826|FG001|Overall Study|The study was terminated early due to business decision.|2|||
145343467|NCT03993379|524104827|FG002|Overall Study|The study was terminated early due to business decision.|0|||
145343468|NCT03993379|524104828|FG003|Overall Study|The study was terminated early due to business decision.|0|||
145343469|NCT03993379|524104825|FG000|Overall Study|Withdrawal by Subject|0|||
145343470|NCT03993379|524104826|FG001|Overall Study|Withdrawal by Subject|1|||
145343471|NCT03993379|524104827|FG002|Overall Study|Withdrawal by Subject|0|||
145343472|NCT03993379|524104828|FG003|Overall Study|Withdrawal by Subject|0|||
145343473|NCT02604407|524104829|FG000|Overall Study|Adverse Event|0|||
145343474|NCT02604407|524104830|FG001|Overall Study|Adverse Event|7|||
145343475|NCT02604407|524104831|FG002|Overall Study|Adverse Event|5|||
145343476|NCT02604407|524104829|FG000|Overall Study|Protocol Violation|2|||
145343477|NCT02604407|524104830|FG001|Overall Study|Protocol Violation|0|||
145343478|NCT02604407|524104831|FG002|Overall Study|Protocol Violation|0|||
145343479|NCT02604407|524104829|FG000|Overall Study|Withdrawal by Subject|3|||
145343480|NCT02604407|524104830|FG001|Overall Study|Withdrawal by Subject|3|||
145343481|NCT02604407|524104831|FG002|Overall Study|Withdrawal by Subject|5|||
145343482|NCT02604407|524104829|FG000|Overall Study|Lost to Follow-up|2|||
145343483|NCT02604407|524104830|FG001|Overall Study|Lost to Follow-up|1|||
145343484|NCT02604407|524104831|FG002|Overall Study|Lost to Follow-up|2|||
145343485|NCT02604407|524104829|FG000|Overall Study|Lack of Efficacy|1|||
145343486|NCT02604407|524104830|FG001|Overall Study|Lack of Efficacy|0|||
145343487|NCT02604407|524104831|FG002|Overall Study|Lack of Efficacy|0|||
145343488|NCT02604407|524104829|FG000|Overall Study|Other|3|||
145343489|NCT02604407|524104830|FG001|Overall Study|Other|1|||
145343490|NCT02604407|524104831|FG002|Overall Study|Other|4|||
145343491|NCT00606632|524104834|FG000|Overall Study|Withdrawal by Subject|13|||
145343492|NCT00606632|524104834|FG000|Overall Study|Miscellaneous reasons|9|||
145343493|NCT00711880|524104837|FG000|Overall Study|Adverse Event|11|||
145343494|NCT00711880|524104838|FG001|Overall Study|Adverse Event|2|||
145343495|NCT00711880|524104837|FG000|Overall Study|Patient non-compliance|1|||
145343496|NCT00711880|524104838|FG001|Overall Study|Patient non-compliance|0|||
145343497|NCT00711880|524104837|FG000|Overall Study|Lack of Efficacy|1|||
145343498|NCT00711880|524104838|FG001|Overall Study|Lack of Efficacy|5|||
145343499|NCT00704132|524104839|FG000|Overall Study|Clinical Adverse Experience|1|||
145343500|NCT00704132|524104840|FG001|Overall Study|Clinical Adverse Experience|0|||
145343501|NCT00704132|524104839|FG000|Overall Study|Lack of Efficacy|0|||
145343502|NCT00704132|524104840|FG001|Overall Study|Lack of Efficacy|1|||
145343503|NCT00704132|524104839|FG000|Overall Study|Withdrawal by Subject|0|||
145343504|NCT00704132|524104840|FG001|Overall Study|Withdrawal by Subject|1|||
145343505|NCT03348163|524104841|FG000|Overall Study|Withdrawal by Subject|2|||
145343506|NCT03348163|524104842|FG001|Overall Study|Withdrawal by Subject|0|||
145343507|NCT02756208|524104843|FG000|Overall Study|Withdrawal by Subject|1|||
145343508|NCT02756208|524104844|FG001|Overall Study|Withdrawal by Subject|0|||
145343509|NCT02756208|524104845|FG002|Overall Study|Withdrawal by Subject|1|||
145343510|NCT02756208|524104846|FG003|Overall Study|Withdrawal by Subject|3|||
145343511|NCT02756208|524104843|FG000|Overall Study|Lost to Follow-up|3|||
145343512|NCT02756208|524104844|FG001|Overall Study|Lost to Follow-up|1|||
145343513|NCT02756208|524104845|FG002|Overall Study|Lost to Follow-up|1|||
145343514|NCT02756208|524104846|FG003|Overall Study|Lost to Follow-up|1|||
145343515|NCT02756208|524104843|FG000|Overall Study|Physician Decision|1|||
145343516|NCT02756208|524104844|FG001|Overall Study|Physician Decision|0|||
145343517|NCT02756208|524104845|FG002|Overall Study|Physician Decision|0|||
145343518|NCT02756208|524104846|FG003|Overall Study|Physician Decision|0|||
145343519|NCT02756208|524104843|FG000|Overall Study|Protocol Violation|0|||
145343520|NCT02756208|524104844|FG001|Overall Study|Protocol Violation|1|||
145343521|NCT02756208|524104845|FG002|Overall Study|Protocol Violation|0|||
145343522|NCT02756208|524104846|FG003|Overall Study|Protocol Violation|0|||
145343523|NCT02585778|524104847|FG000|Overall Study|Adverse Event|17|||
145343524|NCT02585778|524104848|FG001|Overall Study|Adverse Event|4|||
145343525|NCT02585778|524104847|FG000|Overall Study|Participant did not wish to continue|9|||
145343526|NCT02585778|524104848|FG001|Overall Study|Participant did not wish to continue|4|||
145343527|NCT02585778|524104847|FG000|Overall Study|Poor compliance to study protocol|0|||
145343528|NCT02585778|524104848|FG001|Overall Study|Poor compliance to study protocol|2|||
145343529|NCT02585778|524104847|FG000|Overall Study|Death|0|||
145343530|NCT02585778|524104848|FG001|Overall Study|Death|1|||
145343531|NCT02585778|524104847|FG000|Overall Study|Randomized but not treated|1|||
145343532|NCT02585778|524104848|FG001|Overall Study|Randomized but not treated|2|||
145343533|NCT02585778|524104847|FG000|Overall Study|Other than specified above|6|||
145343534|NCT02585778|524104848|FG001|Overall Study|Other than specified above|2|||
145343535|NCT04841577|524104849|FG000|Overall Study|Adverse Event|5|||
145343536|NCT04841577|524104850|FG001|Overall Study|Adverse Event|10|||
145343537|NCT04841577|524104849|FG000|Overall Study|Lost to Follow-up|8|||
145343538|NCT04841577|524104850|FG001|Overall Study|Lost to Follow-up|7|||
145343539|NCT04841577|524104849|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145343540|NCT04841577|524104850|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
145343541|NCT04841577|524104849|FG000|Overall Study|Other|0|||
145343542|NCT04841577|524104850|FG001|Overall Study|Other|1|||
145343543|NCT00356525|524104858|FG000|Overall Study|Progressive Disease|8|||
145343544|NCT00356525|524104859|FG001|Overall Study|Progressive Disease|5|||
145343545|NCT00356525|524104860|FG002|Overall Study|Progressive Disease|4|||
145343546|NCT00356525|524104861|FG003|Overall Study|Progressive Disease|2|||
145343547|NCT00356525|524104858|FG000|Overall Study|Adverse Event|1|||
145343548|NCT00356525|524104859|FG001|Overall Study|Adverse Event|3|||
145343549|NCT00356525|524104860|FG002|Overall Study|Adverse Event|1|||
145343550|NCT00356525|524104861|FG003|Overall Study|Adverse Event|1|||
145343551|NCT00356525|524104858|FG000|Overall Study|Lost to Follow-up|1|||
145343552|NCT00356525|524104859|FG001|Overall Study|Lost to Follow-up|0|||
145343553|NCT00356525|524104860|FG002|Overall Study|Lost to Follow-up|0|||
145343554|NCT00356525|524104861|FG003|Overall Study|Lost to Follow-up|0|||
145343555|NCT00356525|524104858|FG000|Overall Study|Physician Decision|2|||
145343556|NCT00356525|524104859|FG001|Overall Study|Physician Decision|2|||
145343557|NCT00356525|524104860|FG002|Overall Study|Physician Decision|2|||
145343558|NCT00356525|524104861|FG003|Overall Study|Physician Decision|1|||
145343559|NCT00356525|524104858|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
145343560|NCT00356525|524104859|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
145343561|NCT00356525|524104860|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
145343562|NCT00356525|524104861|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
145343563|NCT00356525|524104858|FG000|Overall Study|Withdrawal by Subject|1|||
145343564|NCT00356525|524104859|FG001|Overall Study|Withdrawal by Subject|1|||
145343565|NCT00356525|524104860|FG002|Overall Study|Withdrawal by Subject|0|||
145343566|NCT00356525|524104861|FG003|Overall Study|Withdrawal by Subject|3|||
145343567|NCT00356525|524104858|FG000|Overall Study|Death|0|||
145343568|NCT00356525|524104859|FG001|Overall Study|Death|0|||
145343569|NCT00356525|524104860|FG002|Overall Study|Death|0|||
145575714|NCT01859715|524962327|FG000|Overall Study|No 2nd VAS|16|||
145575715|NCT01859715|524962328|FG001|Overall Study|No 2nd VAS|8|||
145575716|NCT01859715|524962329|FG002|Overall Study|No 2nd VAS|23|||
145575717|NCT01252290|524962330|FG000|Overall Study|Withdrawal by Subject|1|||
145343570|NCT00356525|524104861|FG003|Overall Study|Death|1|||
145343571|NCT00356525|524104858|FG000|Overall Study|Sponsor Decision|0|||
145343572|NCT00356525|524104859|FG001|Overall Study|Sponsor Decision|0|||
145343573|NCT00356525|524104860|FG002|Overall Study|Sponsor Decision|0|||
145343574|NCT00356525|524104861|FG003|Overall Study|Sponsor Decision|1|||
145343575|NCT00652340|524104862|FG000|Overall Study|Had not progressed.|4|||
145343576|NCT00652340|524104863|FG001|Overall Study|Had not progressed.|3|||
145343577|NCT03682107|524104864|FG000|Overall Study|Withdrawal by Subject|0|||
145343578|NCT03682107|524104865|FG001|Overall Study|Withdrawal by Subject|1|||
145343579|NCT03682107|524104866|FG002|Overall Study|Withdrawal by Subject|0|||
145343580|NCT03682107|524104867|FG003|Overall Study|Withdrawal by Subject|0|||
145343581|NCT03682107|524104868|FG004|Overall Study|Withdrawal by Subject|0|||
145343582|NCT00214383|524104871|FG000|Overall Study|Lost to Follow-up|16|||
145343583|NCT00214383|524104872|FG001|Overall Study|Lost to Follow-up|26|||
145343584|NCT00879411|524104873|FG000|Overall Study|lost to follow-up (non-AE)|162|||
145343585|NCT01038297|524104874|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
145343586|NCT01038297|524104875|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
145343587|NCT01038297|524104876|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
145343588|NCT01589497|524104890|FG000|Overall Study|Withdrawal by Subject|0|||
145343589|NCT01589497|524104891|FG001|Overall Study|Withdrawal by Subject|1|||
145343590|NCT01589497|524104892|FG002|Overall Study|Withdrawal by Subject|0|||
145343591|NCT01589497|524104893|FG003|Overall Study|Withdrawal by Subject|1|||
145343592|NCT01589497|524104890|FG000|Overall Study|Death|1|||
145343593|NCT01589497|524104891|FG001|Overall Study|Death|0|||
145343594|NCT01589497|524104892|FG002|Overall Study|Death|0|||
145343595|NCT01589497|524104893|FG003|Overall Study|Death|0|||
145343596|NCT01589497|524104890|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145343597|NCT01589497|524104891|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145343598|NCT01589497|524104892|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
145343599|NCT01589497|524104893|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
145343600|NCT02516553|524104894|FG000|Overall Study|Progressive disease|2|||
145343601|NCT02516553|524104895|FG001|Overall Study|Progressive disease|2|||
145343602|NCT02516553|524104896|FG002|Overall Study|Progressive disease|3|||
145343603|NCT02516553|524104897|FG003|Overall Study|Progressive disease|5|||
145343604|NCT02516553|524104898|FG004|Overall Study|Progressive disease|3|||
145343605|NCT02516553|524104899|FG005|Overall Study|Progressive disease|0|||
145343606|NCT02516553|524104900|FG006|Overall Study|Progressive disease|5|||
145343607|NCT02516553|524104901|FG007|Overall Study|Progressive disease|5|||
145575718|NCT02075437|524962331|FG000|Overall Study|Withdrawal by Subject|5|||
145575719|NCT02075437|524962331|FG000|Overall Study|Lost to Follow-up|1|||
145575720|NCT04439240|524962332|FG000|Overall Study|Ineligible|2|||
145575721|NCT04439240|524962332|FG000|Overall Study|Never started treatment|2|||
145575722|NCT04439240|524962332|FG000|Overall Study|Adverse Event|12|||
145575723|NCT04439240|524962332|FG000|Overall Study|Death|2|||
145575724|NCT04439240|524962332|FG000|Overall Study|Disease progression|25|||
145343608|NCT02516553|524104902|FG008|Overall Study|Progressive disease|11|||
145343609|NCT02516553|524104903|FG009|Overall Study|Progressive disease|3|||
145343610|NCT02516553|524104904|FG010|Overall Study|Progressive disease|10|||
145343611|NCT02516553|524104905|FG011|Overall Study|Progressive disease|8|||
145343612|NCT02516553|524104906|FG012|Overall Study|Progressive disease|8|||
145575725|NCT04439240|524962332|FG000|Overall Study|Other diseases|2|||
145575726|NCT04439240|524962332|FG000|Overall Study|Withdrawal by Subject|3|||
145575727|NCT04439240|524962332|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
145575728|NCT04439240|524962332|FG000|Overall Study|Symptomatic decline|1|||
145343613|NCT02516553|524104907|FG013|Overall Study|Progressive disease|2|||
145343614|NCT02516553|524104908|FG014|Overall Study|Progressive disease|2|||
145343615|NCT02516553|524104909|FG015|Overall Study|Progressive disease|2|||
145343616|NCT02516553|524104910|FG016|Overall Study|Progressive disease|1|||
145343617|NCT02516553|524104911|FG017|Overall Study|Progressive disease|9|||
145343618|NCT02516553|524104912|FG018|Overall Study|Progressive disease|12|||
145343619|NCT02516553|524104913|FG019|Overall Study|Progressive disease|7|||
145343620|NCT02516553|524104914|FG020|Overall Study|Progressive disease|16|||
145343621|NCT02516553|524104915|FG021|Overall Study|Progressive disease|18|||
145343622|NCT02516553|524104894|FG000|Overall Study|Dose limiting toxicity|0|||
145343623|NCT02516553|524104895|FG001|Overall Study|Dose limiting toxicity|0|||
145343624|NCT02516553|524104896|FG002|Overall Study|Dose limiting toxicity|0|||
145575729|NCT04439240|524962332|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
145343625|NCT02516553|524104897|FG003|Overall Study|Dose limiting toxicity|0|||
145343626|NCT02516553|524104898|FG004|Overall Study|Dose limiting toxicity|3|||
145343627|NCT02516553|524104899|FG005|Overall Study|Dose limiting toxicity|1|||
145343628|NCT02516553|524104900|FG006|Overall Study|Dose limiting toxicity|1|||
145343629|NCT02516553|524104901|FG007|Overall Study|Dose limiting toxicity|0|||
145343630|NCT02516553|524104902|FG008|Overall Study|Dose limiting toxicity|1|||
145343631|NCT02516553|524104903|FG009|Overall Study|Dose limiting toxicity|0|||
145343632|NCT02516553|524104904|FG010|Overall Study|Dose limiting toxicity|0|||
145343633|NCT02516553|524104905|FG011|Overall Study|Dose limiting toxicity|1|||
145343634|NCT02516553|524104906|FG012|Overall Study|Dose limiting toxicity|0|||
145343635|NCT02516553|524104907|FG013|Overall Study|Dose limiting toxicity|1|||
145343636|NCT02516553|524104908|FG014|Overall Study|Dose limiting toxicity|0|||
145343637|NCT02516553|524104909|FG015|Overall Study|Dose limiting toxicity|0|||
145343638|NCT02516553|524104910|FG016|Overall Study|Dose limiting toxicity|1|||
145343639|NCT02516553|524104911|FG017|Overall Study|Dose limiting toxicity|1|||
145343640|NCT02516553|524104912|FG018|Overall Study|Dose limiting toxicity|0|||
145343641|NCT02516553|524104913|FG019|Overall Study|Dose limiting toxicity|2|||
145343642|NCT02516553|524104914|FG020|Overall Study|Dose limiting toxicity|0|||
145343643|NCT02516553|524104915|FG021|Overall Study|Dose limiting toxicity|0|||
145343644|NCT02516553|524104894|FG000|Overall Study|Other Adverse Events|0|||
145343645|NCT02516553|524104895|FG001|Overall Study|Other Adverse Events|0|||
145343646|NCT02516553|524104896|FG002|Overall Study|Other Adverse Events|0|||
145343647|NCT02516553|524104897|FG003|Overall Study|Other Adverse Events|1|||
145343648|NCT02516553|524104898|FG004|Overall Study|Other Adverse Events|0|||
145343649|NCT02516553|524104899|FG005|Overall Study|Other Adverse Events|1|||
145343650|NCT02516553|524104900|FG006|Overall Study|Other Adverse Events|0|||
145343651|NCT02516553|524104901|FG007|Overall Study|Other Adverse Events|0|||
145343652|NCT02516553|524104902|FG008|Overall Study|Other Adverse Events|0|||
145343653|NCT02516553|524104903|FG009|Overall Study|Other Adverse Events|1|||
145343654|NCT02516553|524104904|FG010|Overall Study|Other Adverse Events|3|||
145343655|NCT02516553|524104905|FG011|Overall Study|Other Adverse Events|2|||
145343656|NCT02516553|524104906|FG012|Overall Study|Other Adverse Events|0|||
145343657|NCT02516553|524104907|FG013|Overall Study|Other Adverse Events|1|||
145343658|NCT02516553|524104908|FG014|Overall Study|Other Adverse Events|0|||
145343659|NCT02516553|524104909|FG015|Overall Study|Other Adverse Events|0|||
145343660|NCT02516553|524104910|FG016|Overall Study|Other Adverse Events|0|||
145343661|NCT02516553|524104911|FG017|Overall Study|Other Adverse Events|2|||
145343662|NCT02516553|524104912|FG018|Overall Study|Other Adverse Events|1|||
145343663|NCT02516553|524104913|FG019|Overall Study|Other Adverse Events|2|||
145343664|NCT02516553|524104914|FG020|Overall Study|Other Adverse Events|2|||
145343665|NCT02516553|524104915|FG021|Overall Study|Other Adverse Events|1|||
145343666|NCT02516553|524104894|FG000|Overall Study|Refused to continue trial medication|0|||
145343667|NCT02516553|524104895|FG001|Overall Study|Refused to continue trial medication|0|||
145343668|NCT02516553|524104896|FG002|Overall Study|Refused to continue trial medication|0|||
145343669|NCT02516553|524104897|FG003|Overall Study|Refused to continue trial medication|0|||
145343670|NCT02516553|524104898|FG004|Overall Study|Refused to continue trial medication|0|||
145343671|NCT02516553|524104899|FG005|Overall Study|Refused to continue trial medication|0|||
145343672|NCT02516553|524104900|FG006|Overall Study|Refused to continue trial medication|0|||
145343673|NCT02516553|524104901|FG007|Overall Study|Refused to continue trial medication|0|||
145343674|NCT02516553|524104902|FG008|Overall Study|Refused to continue trial medication|0|||
145343675|NCT02516553|524104903|FG009|Overall Study|Refused to continue trial medication|0|||
145343676|NCT02516553|524104904|FG010|Overall Study|Refused to continue trial medication|1|||
145343677|NCT02516553|524104905|FG011|Overall Study|Refused to continue trial medication|0|||
145343678|NCT02516553|524104906|FG012|Overall Study|Refused to continue trial medication|0|||
145343679|NCT02516553|524104907|FG013|Overall Study|Refused to continue trial medication|0|||
145343680|NCT02516553|524104908|FG014|Overall Study|Refused to continue trial medication|0|||
145343681|NCT02516553|524104909|FG015|Overall Study|Refused to continue trial medication|0|||
145343682|NCT02516553|524104910|FG016|Overall Study|Refused to continue trial medication|0|||
145343683|NCT02516553|524104911|FG017|Overall Study|Refused to continue trial medication|0|||
145343684|NCT02516553|524104912|FG018|Overall Study|Refused to continue trial medication|1|||
145343685|NCT02516553|524104913|FG019|Overall Study|Refused to continue trial medication|0|||
145343686|NCT02516553|524104914|FG020|Overall Study|Refused to continue trial medication|0|||
145343687|NCT02516553|524104915|FG021|Overall Study|Refused to continue trial medication|1|||
145343688|NCT02516553|524104894|FG000|Overall Study|other reasons than listed|0|||
145343689|NCT02516553|524104895|FG001|Overall Study|other reasons than listed|0|||
145343690|NCT02516553|524104896|FG002|Overall Study|other reasons than listed|0|||
145343691|NCT02516553|524104897|FG003|Overall Study|other reasons than listed|0|||
145343692|NCT02516553|524104898|FG004|Overall Study|other reasons than listed|0|||
145343693|NCT02516553|524104899|FG005|Overall Study|other reasons than listed|0|||
145343694|NCT02516553|524104900|FG006|Overall Study|other reasons than listed|0|||
145343695|NCT02516553|524104901|FG007|Overall Study|other reasons than listed|1|||
145343696|NCT02516553|524104902|FG008|Overall Study|other reasons than listed|1|||
145343697|NCT02516553|524104903|FG009|Overall Study|other reasons than listed|0|||
145343698|NCT02516553|524104904|FG010|Overall Study|other reasons than listed|1|||
145343699|NCT02516553|524104905|FG011|Overall Study|other reasons than listed|1|||
145343700|NCT02516553|524104906|FG012|Overall Study|other reasons than listed|0|||
145343701|NCT02516553|524104907|FG013|Overall Study|other reasons than listed|0|||
145343702|NCT02516553|524104908|FG014|Overall Study|other reasons than listed|0|||
145343703|NCT02516553|524104909|FG015|Overall Study|other reasons than listed|0|||
145343704|NCT02516553|524104910|FG016|Overall Study|other reasons than listed|0|||
145343705|NCT02516553|524104911|FG017|Overall Study|other reasons than listed|0|||
145343706|NCT02516553|524104912|FG018|Overall Study|other reasons than listed|0|||
145343707|NCT02516553|524104913|FG019|Overall Study|other reasons than listed|0|||
145343708|NCT02516553|524104914|FG020|Overall Study|other reasons than listed|2|||
145343709|NCT02516553|524104915|FG021|Overall Study|other reasons than listed|2|||
145343710|NCT03052127|524104916|FG000|Overall Study|Withdrawal by Subject|0|||
145343711|NCT03052127|524104917|FG001|Overall Study|Withdrawal by Subject|0|||
145343712|NCT03052127|524104918|FG002|Overall Study|Withdrawal by Subject|0|||
145343713|NCT03052127|524104919|FG003|Overall Study|Withdrawal by Subject|0|||
145343714|NCT03052127|524104920|FG004|Overall Study|Withdrawal by Subject|0|||
145343715|NCT03052127|524104921|FG005|Overall Study|Withdrawal by Subject|0|||
145343716|NCT03052127|524104922|FG006|Overall Study|Withdrawal by Subject|0|||
145343717|NCT03052127|524104923|FG007|Overall Study|Withdrawal by Subject|1|||
145343718|NCT03052127|524104924|FG008|Overall Study|Withdrawal by Subject|1|||
145343719|NCT03052127|524104925|FG009|Overall Study|Withdrawal by Subject|1|||
145343720|NCT03052127|524104926|FG010|Overall Study|Withdrawal by Subject|0|||
145343721|NCT03052127|524104927|FG011|Overall Study|Withdrawal by Subject|0|||
145343722|NCT03052127|524104916|FG000|Overall Study|Discontinuation by Sponsor|0|||
145343723|NCT03052127|524104917|FG001|Overall Study|Discontinuation by Sponsor|0|||
145343724|NCT03052127|524104918|FG002|Overall Study|Discontinuation by Sponsor|0|||
145343725|NCT03052127|524104919|FG003|Overall Study|Discontinuation by Sponsor|0|||
145343726|NCT03052127|524104920|FG004|Overall Study|Discontinuation by Sponsor|0|||
145343727|NCT03052127|524104921|FG005|Overall Study|Discontinuation by Sponsor|0|||
145343728|NCT03052127|524104922|FG006|Overall Study|Discontinuation by Sponsor|0|||
145343729|NCT03052127|524104923|FG007|Overall Study|Discontinuation by Sponsor|0|||
145343730|NCT03052127|524104924|FG008|Overall Study|Discontinuation by Sponsor|4|||
145343731|NCT03052127|524104925|FG009|Overall Study|Discontinuation by Sponsor|2|||
145343732|NCT03052127|524104926|FG010|Overall Study|Discontinuation by Sponsor|5|||
145343733|NCT03052127|524104927|FG011|Overall Study|Discontinuation by Sponsor|13|||
145343734|NCT03052127|524104916|FG000|Overall Study|Inability to comply with trial requirements|0|||
145343735|NCT03052127|524104917|FG001|Overall Study|Inability to comply with trial requirements|0|||
145343736|NCT03052127|524104918|FG002|Overall Study|Inability to comply with trial requirements|1|||
145343737|NCT03052127|524104919|FG003|Overall Study|Inability to comply with trial requirements|0|||
145343738|NCT03052127|524104920|FG004|Overall Study|Inability to comply with trial requirements|0|||
145343739|NCT03052127|524104921|FG005|Overall Study|Inability to comply with trial requirements|0|||
145343740|NCT03052127|524104922|FG006|Overall Study|Inability to comply with trial requirements|0|||
145343741|NCT03052127|524104923|FG007|Overall Study|Inability to comply with trial requirements|0|||
145343742|NCT03052127|524104924|FG008|Overall Study|Inability to comply with trial requirements|0|||
145343743|NCT03052127|524104925|FG009|Overall Study|Inability to comply with trial requirements|0|||
145343744|NCT03052127|524104926|FG010|Overall Study|Inability to comply with trial requirements|0|||
145343745|NCT03052127|524104927|FG011|Overall Study|Inability to comply with trial requirements|0|||
145343746|NCT03052127|524104916|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145343747|NCT03052127|524104917|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343748|NCT03052127|524104918|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343749|NCT03052127|524104919|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343750|NCT03052127|524104920|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145343751|NCT03052127|524104921|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145343752|NCT03052127|524104922|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
145343753|NCT03052127|524104923|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343754|NCT03052127|524104924|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343755|NCT03052127|524104925|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343756|NCT03052127|524104926|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343757|NCT03052127|524104927|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
145343758|NCT00369486|524106925|FG000|4-Week Visit|Missed visit|2|||
145343759|NCT00369486|524106926|FG001|4-Week Visit|Missed visit|2|||
145343760|NCT00369486|524106927|FG002|4-Week Visit|Missed visit|0|||
145343761|NCT00369486|524106928|FG003|4-Week Visit|Missed visit|2|||
145343762|NCT00369486|524106929|FG004|4-Week Visit|Missed visit|1|||
145343763|NCT00369486|524106925|FG000|4-Week Visit|Dropped|0|||
145343764|NCT00369486|524106926|FG001|4-Week Visit|Dropped|0|||
145343765|NCT00369486|524106927|FG002|4-Week Visit|Dropped|1|||
145343766|NCT00369486|524106928|FG003|4-Week Visit|Dropped|0|||
145343767|NCT00369486|524106929|FG004|4-Week Visit|Dropped|0|||
145575730|NCT04439240|524962332|FG000|Overall Study|Clinical progression|1|||
145575731|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
145575732|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
145575733|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
145575734|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
145575735|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
145575736|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
145575737|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
145575738|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
145575739|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
145575740|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
145575741|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
145575742|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
145575743|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
145575744|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
145575745|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
145575746|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
145575747|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
145575748|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
145575749|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
145575750|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
145575751|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
145575752|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
145575753|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
145575754|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
145575755|NCT04542070|524962333|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
145575756|NCT04542070|524962334|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
145575757|NCT04542070|524962335|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
145575758|NCT04542070|524962336|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
145575759|NCT04542070|524962333|FG000|Maintenance + Extension Period|Adverse Event|10|||
145575760|NCT04542070|524962334|FG001|Maintenance + Extension Period|Adverse Event|2|||
145575761|NCT04542070|524962335|FG002|Maintenance + Extension Period|Adverse Event|0|||
145413934|NCT00927082|524369202|FG002|Overall Study|Withdrawal by Subject|7|||
145413935|NCT00927082|524369203|FG003|Overall Study|Withdrawal by Subject|2|||
145413936|NCT00927082|524369200|FG000|Overall Study|Death|0|||
145413937|NCT00927082|524369201|FG001|Overall Study|Death|0|||
145413938|NCT00927082|524369202|FG002|Overall Study|Death|1|||
145413939|NCT00927082|524369203|FG003|Overall Study|Death|0|||
145575762|NCT04542070|524962336|FG003|Maintenance + Extension Period|Adverse Event|0|||
145575763|NCT04542070|524962333|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
145575764|NCT04542070|524962334|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
145575765|NCT04542070|524962335|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
145575766|NCT04542070|524962336|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
145575767|NCT04542070|524962333|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
145575768|NCT04542070|524962334|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
145575769|NCT04542070|524962335|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
145575770|NCT04542070|524962336|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
145575771|NCT04542070|524962333|FG000|Maintenance + Extension Period|Physician Decision|1|||
145575772|NCT04542070|524962334|FG001|Maintenance + Extension Period|Physician Decision|1|||
145575773|NCT04542070|524962335|FG002|Maintenance + Extension Period|Physician Decision|0|||
145575774|NCT04542070|524962336|FG003|Maintenance + Extension Period|Physician Decision|0|||
145575775|NCT04542070|524962333|FG000|Maintenance + Extension Period|Protocol Violation|2|||
145575776|NCT04542070|524962334|FG001|Maintenance + Extension Period|Protocol Violation|5|||
145575777|NCT04542070|524962335|FG002|Maintenance + Extension Period|Protocol Violation|0|||
145575778|NCT04542070|524962336|FG003|Maintenance + Extension Period|Protocol Violation|0|||
145575779|NCT04542070|524962333|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
145575780|NCT04542070|524962334|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
145575781|NCT04542070|524962335|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
145575782|NCT04542070|524962336|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
145575783|NCT04542070|524962333|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
145575784|NCT04542070|524962334|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
145575785|NCT04542070|524962335|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
145413940|NCT00927082|524369200|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
145413941|NCT00927082|524369201|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
145413942|NCT00927082|524369202|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
145413943|NCT00927082|524369203|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
145413944|NCT03998462|524369206|FG000|Overall Study|Withdrawal by Subject|10|||
145575786|NCT04542070|524962336|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
145575787|NCT04542070|524962333|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
145575788|NCT04542070|524962334|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
145575789|NCT04542070|524962335|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
145575790|NCT04542070|524962336|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
145575791|NCT04542070|524962333|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
145575792|NCT04542070|524962334|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
145575793|NCT04542070|524962335|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
145575794|NCT04542070|524962336|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
145575795|NCT04542070|524962333|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
145575796|NCT04542070|524962334|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
145575797|NCT04542070|524962335|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
145575798|NCT04542070|524962336|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
145575799|NCT04542070|524962333|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
145575800|NCT04542070|524962334|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
145575801|NCT04542070|524962335|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
145575802|NCT04542070|524962336|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
145575803|NCT04542070|524962333|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
145575804|NCT04542070|524962334|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
145575805|NCT04542070|524962335|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
145575806|NCT04542070|524962336|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
145575807|NCT03049813|524962339|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
145343768|NCT00369486|524106925|FG000|8-Week Visit|Missed visit|0|||
145343769|NCT00369486|524106926|FG001|8-Week Visit|Missed visit|1|||
145343770|NCT00369486|524106927|FG002|8-Week Visit|Missed visit|0|||
145343771|NCT00369486|524106928|FG003|8-Week Visit|Missed visit|0|||
145343772|NCT00369486|524106929|FG004|8-Week Visit|Missed visit|1|||
145343773|NCT00369486|524106925|FG000|8-Week Visit|Dropped|0|||
145343774|NCT00369486|524106926|FG001|8-Week Visit|Dropped|0|||
145343775|NCT00369486|524106927|FG002|8-Week Visit|Dropped|0|||
145343776|NCT00369486|524106928|FG003|8-Week Visit|Dropped|1|||
145343777|NCT00369486|524106929|FG004|8-Week Visit|Dropped|0|||
145343778|NCT00369486|524106925|FG000|17-Week Visit|Missed visit|0|||
145343779|NCT00369486|524106926|FG001|17-Week Visit|Missed visit|0|||
145343780|NCT00369486|524106927|FG002|17-Week Visit|Missed visit|1|||
145343781|NCT00369486|524106928|FG003|17-Week Visit|Missed visit|1|||
145343782|NCT00369486|524106929|FG004|17-Week Visit|Missed visit|1|||
145343783|NCT00369486|524106925|FG000|34-Week Visit|Dropped|0|||
145343784|NCT00369486|524106926|FG001|34-Week Visit|Dropped|1|||
145343785|NCT00369486|524106927|FG002|34-Week Visit|Dropped|1|||
145343786|NCT00369486|524106928|FG003|34-Week Visit|Dropped|3|||
145343787|NCT00369486|524106929|FG004|34-Week Visit|Dropped|3|||
145343788|NCT01810302|524106930|FG000|Overall Study|Death|1|||
145343789|NCT01810302|524106931|FG001|Overall Study|Death|0|||
145343790|NCT01810302|524106930|FG000|Overall Study|Physician Decision|0|||
145343791|NCT01810302|524106931|FG001|Overall Study|Physician Decision|1|||
145343792|NCT02077140|524106935|FG000|Overall Study|Lost to Follow-up|4|||
145343793|NCT02077140|524106936|FG001|Overall Study|Lost to Follow-up|1|||
145343794|NCT02077140|524106937|FG002|Overall Study|Lost to Follow-up|2|||
145343795|NCT02077140|524106938|FG003|Overall Study|Lost to Follow-up|2|||
145343796|NCT02077140|524106939|FG004|Overall Study|Lost to Follow-up|3|||
145343797|NCT02077140|524106935|FG000|Overall Study|Withdrawal by Subject|0|||
145343798|NCT02077140|524106936|FG001|Overall Study|Withdrawal by Subject|1|||
145343799|NCT02077140|524106937|FG002|Overall Study|Withdrawal by Subject|0|||
145343800|NCT02077140|524106938|FG003|Overall Study|Withdrawal by Subject|2|||
145343801|NCT02077140|524106939|FG004|Overall Study|Withdrawal by Subject|2|||
145343802|NCT00974922|524106940|FG000|Overall Study|study terminated|24|||
145343803|NCT01762800|524106943|FG000|Overall Study|Adverse Event|8|||
145343804|NCT01762800|524106944|FG001|Overall Study|Adverse Event|13|||
145343805|NCT01762800|524106943|FG000|Overall Study|Lack of Efficacy|3|||
145575808|NCT03049813|524962340|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
145575809|NCT03049813|524962341|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
145575810|NCT03049813|524962342|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
145622853|NCT01723826|525130204|FG001|Overall Study|Lost to Follow-up|3|||
145343806|NCT01762800|524106944|FG001|Overall Study|Lack of Efficacy|2|||
145343807|NCT01762800|524106943|FG000|Overall Study|Study Closed/Terminated|0|||
145343808|NCT01762800|524106944|FG001|Overall Study|Study Closed/Terminated|1|||
145343809|NCT01762800|524106943|FG000|Overall Study|Physician Decision|1|||
145343810|NCT01762800|524106944|FG001|Overall Study|Physician Decision|1|||
145343811|NCT01762800|524106943|FG000|Overall Study|Withdrawal by Subject|7|||
145343812|NCT01762800|524106944|FG001|Overall Study|Withdrawal by Subject|4|||
145343813|NCT01173120|524106946|FG000|Overall Study|Lack of Efficacy|2|||
145343814|NCT01173120|524106946|FG000|Overall Study|Lost to Follow-up|1|||
145343815|NCT01173120|524106946|FG000|Overall Study|Participant Decision|2|||
145343816|NCT01173120|524106946|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
145343817|NCT01173120|524106946|FG000|Overall Study|Switch-Participant Decision|12|||
145343818|NCT01173120|524106946|FG000|Overall Study|Switch-Difficulty With Device|12|||
145343819|NCT00113763|524106947|FG000|Overall Study|Adverse Event|5|||
145343820|NCT00113763|524106948|FG001|Overall Study|Adverse Event|2|||
145343821|NCT00113763|524106947|FG000|Overall Study|Disease Progression|28|||
145343822|NCT00113763|524106948|FG001|Overall Study|Disease Progression|14|||
145343823|NCT00113763|524106947|FG000|Overall Study|Lost to Follow-up|10|||
145343824|NCT00113763|524106948|FG001|Overall Study|Lost to Follow-up|0|||
145343825|NCT00113763|524106947|FG000|Overall Study|Withdrawal by Subject|1|||
145343826|NCT00113763|524106948|FG001|Overall Study|Withdrawal by Subject|4|||
145343827|NCT00113763|524106947|FG000|Overall Study|Other|27|||
145343828|NCT00113763|524106948|FG001|Overall Study|Other|6|||
145343829|NCT00113763|524106947|FG000|Overall Study|Non-compliance|1|||
145343830|NCT00113763|524106948|FG001|Overall Study|Non-compliance|0|||
145343831|NCT00113763|524106947|FG000|Overall Study|Ongoing|1|||
145343832|NCT00113763|524106948|FG001|Overall Study|Ongoing|0|||
145343833|NCT00517881|524106949|FG000|Overall Study|Protocol Violation|2|||
145413945|NCT03998462|524369207|FG001|Overall Study|Withdrawal by Subject|4|||
145413946|NCT03998462|524369206|FG000|Overall Study|Lost to Follow-up|1|||
145413947|NCT03998462|524369207|FG001|Overall Study|Lost to Follow-up|0|||
145413948|NCT03998462|524369206|FG000|Overall Study|Technical Difficulties|1|||
145413949|NCT03998462|524369207|FG001|Overall Study|Technical Difficulties|2|||
145575811|NCT03049813|524962339|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
145575812|NCT03049813|524962340|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
145575813|NCT03049813|524962341|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
145575814|NCT03049813|524962342|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
145575815|NCT03049813|524962339|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
145575816|NCT03049813|524962340|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
145575817|NCT03049813|524962341|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
145575818|NCT03049813|524962342|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
145575819|NCT03049813|524962339|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
145575820|NCT03049813|524962340|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
145575821|NCT03049813|524962341|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
145575822|NCT03049813|524962342|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
145575823|NCT01813019|524962343|FG000|Overall Study|Adverse Event|0|||
145575824|NCT01813019|524962344|FG001|Overall Study|Adverse Event|3|||
145575825|NCT01813019|524962343|FG000|Overall Study|Withdrawal by Subject|3|||
145575826|NCT01813019|524962344|FG001|Overall Study|Withdrawal by Subject|2|||
145575827|NCT01813019|524962343|FG000|Overall Study|administrative problems|2|||
145575828|NCT01813019|524962344|FG001|Overall Study|administrative problems|0|||
145575829|NCT01813019|524962343|FG000|Overall Study|Protocol Deviation|2|||
145575830|NCT01813019|524962344|FG001|Overall Study|Protocol Deviation|1|||
145575831|NCT01696032|524962351|FG000|Overall Study|Withdrawal by Subject|0|||
145575832|NCT01696032|524962352|FG001|Overall Study|Withdrawal by Subject|0|||
145575833|NCT01696032|524962353|FG002|Overall Study|Withdrawal by Subject|1|||
145575834|NCT01696032|524962354|FG003|Overall Study|Withdrawal by Subject|2|||
145413950|NCT02965833|524369208|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
145413951|NCT02965833|524369209|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
145413952|NCT02965833|524369208|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
145413953|NCT02965833|524369209|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
145413954|NCT02965833|524369208|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
145413955|NCT02965833|524369209|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
145413956|NCT02965833|524369208|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
145413957|NCT02965833|524369209|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
145413958|NCT02965833|524369208|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
145575835|NCT01696032|524962351|FG000|Overall Study|Death|14|||
145343834|NCT00517881|524106949|FG000|Overall Study|Adverse Event|1|||
145343835|NCT00517881|524106949|FG000|Overall Study|Renal transplantation|2|||
145343836|NCT02847260|524106950|FG000|Overall Study|Adverse Event|3|||
145413959|NCT02965833|524369209|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
145413960|NCT03370302|524369214|FG000|Dose Escalation Phase|Other|0|||
145413961|NCT03370302|524369215|FG001|Dose Escalation Phase|Other|1|||
145413962|NCT03370302|524369216|FG002|Dose Escalation Phase|Other|1|||
145413963|NCT03370302|524369217|FG003|Dose Escalation Phase|Other|0|||
145575836|NCT01696032|524962352|FG001|Overall Study|Death|4|||
145575837|NCT01696032|524962353|FG002|Overall Study|Death|43|||
145575838|NCT01696032|524962354|FG003|Overall Study|Death|18|||
145575839|NCT01696032|524962351|FG000|Overall Study|Lost to Follow-up|0|||
145575840|NCT01696032|524962352|FG001|Overall Study|Lost to Follow-up|1|||
145575841|NCT01696032|524962353|FG002|Overall Study|Lost to Follow-up|0|||
145622854|NCT01723826|525130205|FG002|Overall Study|Lost to Follow-up|1|||
145622855|NCT01723826|525130206|FG003|Overall Study|Lost to Follow-up|1|||
145343837|NCT02847260|524106950|FG000|Overall Study|Withdrawal by Subject|2|||
145413964|NCT03370302|524369218|FG004|Dose Escalation Phase|Other|0|||
145413965|NCT03370302|524369219|FG005|Dose Escalation Phase|Other|0|||
145343838|NCT02847260|524106950|FG000|Overall Study|Clinical Deterioration|1|||
145343839|NCT02847260|524106950|FG000|Overall Study|Physician Decision|1|||
145343840|NCT02906358|524106953|FG000|Overall Study|Withdrawal by Subject|10|||
145343841|NCT02906358|524106954|FG001|Overall Study|Withdrawal by Subject|7|||
145343842|NCT02906358|524106953|FG000|Overall Study|Lost to Follow-up|12|||
145343843|NCT02906358|524106954|FG001|Overall Study|Lost to Follow-up|15|||
145343844|NCT02699684|524106955|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
145343845|NCT02699684|524106956|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
145343846|NCT02111603|524106965|FG000|Overall Study|Withdrawal by Subject|1|||
145343847|NCT01582152|524106966|FG000|Overall Study|Disease Progression|4|||
145343848|NCT01582152|524106967|FG001|Overall Study|Disease Progression|5|||
145343849|NCT01582152|524106966|FG000|Overall Study|Adverse Event|2|||
145343850|NCT01582152|524106967|FG001|Overall Study|Adverse Event|1|||
145343851|NCT01434810|524106968|FG000|Overall Study|Did not receive treatment|11|||
145343852|NCT01434810|524106969|FG001|Overall Study|Did not receive treatment|3|||
145343853|NCT01434810|524106968|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
145343854|NCT01434810|524106969|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
145343855|NCT01609023|524106973|FG000|Overall Study|Lack of Efficacy|3|||
145343856|NCT01609023|524106973|FG000|Overall Study|Withdrawal by Subject|4|||
145343857|NCT01609023|524106973|FG000|Overall Study|Lost to Follow-up|8|||
145343858|NCT01609023|524106973|FG000|Overall Study|Toxicity|3|||
145343859|NCT01609023|524106973|FG000|Overall Study|Disease progression|10|||
145343860|NCT01609023|524106973|FG000|Overall Study|Physician Decision|2|||
145343861|NCT01609023|524106973|FG000|Overall Study|Death|2|||
145343862|NCT01609023|524106973|FG000|Overall Study|Personal reasons|1|||
145343863|NCT04172597|524106978|FG000|Overall Study|Disease Progression|0|||
145343864|NCT04172597|524106979|FG001|Overall Study|Disease Progression|0|||
145343865|NCT04172597|524106980|FG002|Overall Study|Disease Progression|0|||
145343866|NCT04172597|524106981|FG003|Overall Study|Disease Progression|0|||
145343867|NCT04172597|524106982|FG004|Overall Study|Disease Progression|1|||
145343868|NCT00794339|524106983|FG000|Overall Study|Withdrawal by Subject|3|||
145343869|NCT00794339|524106983|FG000|Overall Study|Ineligible|4|||
145343870|NCT00794339|524106983|FG000|Overall Study|Tx prior to ATSM|3|||
145343871|NCT00794339|524106983|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
145343872|NCT00794339|524106983|FG000|Overall Study|Tx not per protocol|1|||
145343873|NCT01611857|524106984|FG000|Overall Study|Withdrawal by Subject|0|||
145343874|NCT01611857|524106985|FG001|Overall Study|Withdrawal by Subject|2|||
145343875|NCT02439970|524106986|FG000|Overall Study|Study Terminated|2|||
145343876|NCT02439970|524106987|FG001|Overall Study|Study Terminated|3|||
145343877|NCT02952586|524106990|FG000|Lead-In Phase (7 Days)|Death|0|||
145343878|NCT02952586|524106991|FG001|Lead-In Phase (7 Days)|Death|1|||
145343879|NCT02952586|524106990|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
145343880|NCT02952586|524106991|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
145343881|NCT02952586|524106990|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
145343882|NCT02952586|524106991|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
145343883|NCT02952586|524106990|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
145343884|NCT02952586|524106991|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
145343885|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
145343886|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
145343887|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
145343888|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
145343889|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
145343890|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
145343891|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
145343892|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
145343893|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
145343894|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
145343895|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
145343896|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
145343897|NCT02952586|524106990|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
145343898|NCT02952586|524106991|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
145343899|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Death|3|||
145343900|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Death|8|||
145343901|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
145343902|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
145343903|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
145343904|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
145343905|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
145343906|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
145343907|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
145343908|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
145343909|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
145343910|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
145413966|NCT03370302|524369214|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
145413967|NCT03370302|524369215|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
145413968|NCT03370302|524369216|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
145413969|NCT03370302|524369217|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145413970|NCT03370302|524369218|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
145413971|NCT03370302|524369219|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
145413972|NCT03370302|524369214|FG000|Dose Escalation Phase|Adverse Event|1|||
145413973|NCT03370302|524369215|FG001|Dose Escalation Phase|Adverse Event|0|||
145413974|NCT03370302|524369216|FG002|Dose Escalation Phase|Adverse Event|2|||
145413975|NCT03370302|524369217|FG003|Dose Escalation Phase|Adverse Event|0|||
145413976|NCT03370302|524369218|FG004|Dose Escalation Phase|Adverse Event|0|||
145413977|NCT03370302|524369219|FG005|Dose Escalation Phase|Adverse Event|0|||
145413978|NCT03370302|524369214|FG000|Dose Escalation Phase|Progressive Disease|2|||
145413979|NCT03370302|524369215|FG001|Dose Escalation Phase|Progressive Disease|4|||
145413980|NCT03370302|524369216|FG002|Dose Escalation Phase|Progressive Disease|2|||
145413981|NCT03370302|524369217|FG003|Dose Escalation Phase|Progressive Disease|0|||
145413982|NCT03370302|524369218|FG004|Dose Escalation Phase|Progressive Disease|3|||
145413983|NCT03370302|524369219|FG005|Dose Escalation Phase|Progressive Disease|1|||
145413984|NCT03370302|524369214|FG000|Dose Expansion Phase|Progressive Disease|0|||
145413985|NCT03370302|524369215|FG001|Dose Expansion Phase|Progressive Disease|0|||
145413986|NCT03370302|524369216|FG002|Dose Expansion Phase|Progressive Disease|0|||
145413987|NCT03370302|524369217|FG003|Dose Expansion Phase|Progressive Disease|6|||
145413988|NCT03370302|524369218|FG004|Dose Expansion Phase|Progressive Disease|0|||
145343911|NCT02952586|524106990|FG000|CRT for Cisplatin (63 Days)|Other|1|||
145343912|NCT02952586|524106991|FG001|CRT for Cisplatin (63 Days)|Other|1|||
145343913|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Death|5|||
145343914|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Death|8|||
145343915|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
145343916|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
145343917|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
145343918|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
145343919|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
145343920|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
145343921|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
145343922|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
145343923|NCT02952586|524106990|FG000|CRT for IMRT (63 Days)|Other|1|||
145343924|NCT02952586|524106991|FG001|CRT for IMRT (63 Days)|Other|0|||
145343925|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Death|17|||
145343926|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Death|11|||
145343927|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
145343928|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
145343929|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
145343930|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
145343931|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
145343932|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
145343933|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
145343934|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
145343935|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
145343936|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
145343937|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
145343938|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
145343939|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
145343940|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
145343941|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Other|2|||
145343942|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Other|1|||
145343943|NCT02952586|524106990|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
145343944|NCT02952586|524106991|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
145343945|NCT02952586|524106990|FG000|Follow-Up Phase (90 Days)|Death|12|||
145343946|NCT02952586|524106991|FG001|Follow-Up Phase (90 Days)|Death|10|||
145343947|NCT02952586|524106990|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
145343948|NCT02952586|524106991|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
145343949|NCT02952586|524106990|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
145343950|NCT02952586|524106991|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
145343951|NCT02952586|524106990|FG000|Follow-Up Phase (90 Days)|Other|7|||
145343952|NCT02952586|524106991|FG001|Follow-Up Phase (90 Days)|Other|5|||
145413989|NCT03370302|524369219|FG005|Dose Expansion Phase|Progressive Disease|0|||
145413990|NCT06061952|524369221|FG000|Overall Study|Withdrawal by Subject|1|||
145413991|NCT06061952|524369222|FG001|Overall Study|Withdrawal by Subject|2|||
145413992|NCT06061952|524369221|FG000|Overall Study|Lost to Follow-up|2|||
145413993|NCT06061952|524369222|FG001|Overall Study|Lost to Follow-up|2|||
145413994|NCT01685437|524369226|FG000|Overall Study|Withdrawal by Subject|22|||
145413995|NCT01685437|524369226|FG000|Overall Study|Lost to Follow-up|3|||
145622856|NCT01723826|525130203|FG000|Overall Study|Non-compliance|0|||
145413996|NCT01685437|524369226|FG000|Overall Study|Adverse Event|1|||
145413997|NCT01685437|524369226|FG000|Overall Study|Protocol Violation|4|||
145413998|NCT01685437|524369226|FG000|Overall Study|Unable to make visits due to work|1|||
145413999|NCT02369458|524369227|FG000|Overall Study|Determined to be not eligible|1|||
145414000|NCT02369458|524369228|FG001|Overall Study|Determined to be not eligible|0|||
145414001|NCT03853798|524369231|FG000|Overall Study|Death|0|||
145414002|NCT03853798|524369232|FG001|Overall Study|Death|0|||
145414003|NCT03853798|524369233|FG002|Overall Study|Death|0|||
145414004|NCT03853798|524369234|FG003|Overall Study|Death|0|||
145414005|NCT03853798|524369235|FG004|Overall Study|Death|0|||
145414006|NCT03853798|524369236|FG005|Overall Study|Death|1|||
145414007|NCT03853798|524369237|FG006|Overall Study|Death|0|||
145414008|NCT03853798|524369238|FG007|Overall Study|Death|0|||
145343953|NCT02952586|524106990|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
145343954|NCT02952586|524106991|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
145343955|NCT02952586|524106990|FG000|LT Follow-up (up to 45 Months)|Death|51|||
145343956|NCT02952586|524106991|FG001|LT Follow-up (up to 45 Months)|Death|31|||
145343957|NCT02952586|524106990|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
145343958|NCT02952586|524106991|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
145343959|NCT02952586|524106990|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
145343960|NCT02952586|524106991|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
145343961|NCT02952586|524106990|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
145343962|NCT02952586|524106991|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
145343963|NCT00492778|524106992|FG000|Overall Study|Ineligible by Pathology Review|8|||
145343964|NCT00492778|524106993|FG001|Overall Study|Ineligible by Pathology Review|1|||
145343965|NCT03717012|524107010|FG000|Overall Study|Due to trial termination|1|||
145343966|NCT03717012|524107011|FG001|Overall Study|Due to trial termination|2|||
145343967|NCT03717012|524107010|FG000|Overall Study|Protocol Violation|0|||
145343968|NCT03717012|524107011|FG001|Overall Study|Protocol Violation|2|||
145343969|NCT03717012|524107010|FG000|Overall Study|Adverse Event|0|||
145414009|NCT03853798|524369239|FG008|Overall Study|Death|0|||
145414010|NCT03853798|524369231|FG000|Overall Study|Adverse Event|0|||
145414011|NCT03853798|524369232|FG001|Overall Study|Adverse Event|0|||
145414012|NCT03853798|524369233|FG002|Overall Study|Adverse Event|2|||
145414013|NCT03853798|524369234|FG003|Overall Study|Adverse Event|0|||
145414014|NCT03853798|524369235|FG004|Overall Study|Adverse Event|0|||
145414015|NCT03853798|524369236|FG005|Overall Study|Adverse Event|0|||
145414016|NCT03853798|524369237|FG006|Overall Study|Adverse Event|0|||
145414017|NCT03853798|524369238|FG007|Overall Study|Adverse Event|0|||
145414018|NCT03853798|524369239|FG008|Overall Study|Adverse Event|0|||
145414019|NCT03853798|524369231|FG000|Overall Study|Withdrawal by Subject|0|||
145414020|NCT03853798|524369232|FG001|Overall Study|Withdrawal by Subject|1|||
145414021|NCT03853798|524369233|FG002|Overall Study|Withdrawal by Subject|4|||
145414022|NCT03853798|524369234|FG003|Overall Study|Withdrawal by Subject|0|||
145414023|NCT03853798|524369235|FG004|Overall Study|Withdrawal by Subject|0|||
145414024|NCT03853798|524369236|FG005|Overall Study|Withdrawal by Subject|5|||
145414025|NCT03853798|524369237|FG006|Overall Study|Withdrawal by Subject|0|||
145414026|NCT03853798|524369238|FG007|Overall Study|Withdrawal by Subject|0|||
145414027|NCT03853798|524369239|FG008|Overall Study|Withdrawal by Subject|4|||
145414028|NCT03853798|524369231|FG000|Overall Study|Physician Decision|1|||
145414029|NCT03853798|524369232|FG001|Overall Study|Physician Decision|0|||
145414030|NCT03853798|524369233|FG002|Overall Study|Physician Decision|0|||
145414031|NCT03853798|524369234|FG003|Overall Study|Physician Decision|0|||
145414032|NCT03853798|524369235|FG004|Overall Study|Physician Decision|0|||
145414033|NCT03853798|524369236|FG005|Overall Study|Physician Decision|0|||
145414034|NCT03853798|524369237|FG006|Overall Study|Physician Decision|0|||
145414035|NCT03853798|524369238|FG007|Overall Study|Physician Decision|0|||
145414036|NCT03853798|524369239|FG008|Overall Study|Physician Decision|1|||
145414037|NCT03853798|524369231|FG000|Overall Study|Lack of Efficacy|0|||
145414038|NCT03853798|524369232|FG001|Overall Study|Lack of Efficacy|0|||
145414039|NCT03853798|524369233|FG002|Overall Study|Lack of Efficacy|2|||
145414040|NCT03853798|524369234|FG003|Overall Study|Lack of Efficacy|0|||
145414041|NCT03853798|524369235|FG004|Overall Study|Lack of Efficacy|0|||
145414042|NCT03853798|524369236|FG005|Overall Study|Lack of Efficacy|0|||
145414043|NCT03853798|524369237|FG006|Overall Study|Lack of Efficacy|0|||
145414044|NCT03853798|524369238|FG007|Overall Study|Lack of Efficacy|0|||
145414045|NCT03853798|524369239|FG008|Overall Study|Lack of Efficacy|1|||
145414046|NCT03853798|524369231|FG000|Overall Study|Approved Drug Available for Indication|0|||
145343970|NCT03717012|524107011|FG001|Overall Study|Adverse Event|1|||
145343971|NCT03717012|524107010|FG000|Overall Study|Lung transplant|0|||
145414047|NCT03853798|524369232|FG001|Overall Study|Approved Drug Available for Indication|0|||
145414048|NCT03853798|524369233|FG002|Overall Study|Approved Drug Available for Indication|1|||
145414049|NCT03853798|524369234|FG003|Overall Study|Approved Drug Available for Indication|0|||
145414050|NCT03853798|524369235|FG004|Overall Study|Approved Drug Available for Indication|0|||
145414051|NCT03853798|524369236|FG005|Overall Study|Approved Drug Available for Indication|1|||
145575842|NCT01696032|524962354|FG003|Overall Study|Lost to Follow-up|0|||
145575843|NCT01696032|524962351|FG000|Overall Study|Database lock|0|||
145575844|NCT01696032|524962352|FG001|Overall Study|Database lock|1|||
145575845|NCT01696032|524962353|FG002|Overall Study|Database lock|7|||
145575846|NCT01696032|524962354|FG003|Overall Study|Database lock|2|||
145575847|NCT03025828|524962357|FG000|Overall Study|Lost to Follow-up|1|||
145575848|NCT02203591|524962358|FG000|Overall Study|Did not meet treatment day baseline|147|||
145575849|NCT02203591|524962359|FG001|Overall Study|Did not meet treatment day baseline|141|||
145575850|NCT02203591|524962360|FG002|Overall Study|Did not meet treatment day baseline|150|||
145575851|NCT02203591|524962361|FG003|Overall Study|Did not meet treatment day baseline|45|||
145575852|NCT02203591|524962362|FG004|Overall Study|Did not meet treatment day baseline|33|||
145575853|NCT02203591|524962363|FG005|Overall Study|Did not meet treatment day baseline|35|||
145575854|NCT02203591|524962364|FG006|Overall Study|Did not meet treatment day baseline|29|||
145575855|NCT02203591|524962365|FG007|Overall Study|Did not meet treatment day baseline|12|||
145575856|NCT02203591|524962358|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
145575857|NCT02203591|524962359|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
145575858|NCT02203591|524962360|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
145575859|NCT02203591|524962361|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
145343972|NCT03717012|524107011|FG001|Overall Study|Lung transplant|1|||
145343973|NCT00789035|524107012|FG000|Overall Study|Adverse Event|0|||
145343974|NCT00789035|524107013|FG001|Overall Study|Adverse Event|2|||
145343975|NCT00789035|524107014|FG002|Overall Study|Adverse Event|0|||
145343976|NCT00789035|524107015|FG003|Overall Study|Adverse Event|1|||
145343977|NCT00789035|524107016|FG004|Overall Study|Adverse Event|3|||
145343978|NCT00789035|524107012|FG000|Overall Study|Lack of Efficacy|3|||
145343979|NCT00789035|524107013|FG001|Overall Study|Lack of Efficacy|0|||
145343980|NCT00789035|524107014|FG002|Overall Study|Lack of Efficacy|0|||
145343981|NCT00789035|524107015|FG003|Overall Study|Lack of Efficacy|0|||
145343982|NCT00789035|524107016|FG004|Overall Study|Lack of Efficacy|2|||
145343983|NCT00789035|524107012|FG000|Overall Study|Protocol Violation|1|||
145343984|NCT00789035|524107013|FG001|Overall Study|Protocol Violation|0|||
145343985|NCT00789035|524107014|FG002|Overall Study|Protocol Violation|0|||
145343986|NCT00789035|524107015|FG003|Overall Study|Protocol Violation|0|||
145343987|NCT00789035|524107016|FG004|Overall Study|Protocol Violation|0|||
145343988|NCT00789035|524107012|FG000|Overall Study|Withdrawal by Subject|0|||
145343989|NCT00789035|524107013|FG001|Overall Study|Withdrawal by Subject|2|||
145343990|NCT00789035|524107014|FG002|Overall Study|Withdrawal by Subject|0|||
145343991|NCT00789035|524107015|FG003|Overall Study|Withdrawal by Subject|0|||
145343992|NCT00789035|524107016|FG004|Overall Study|Withdrawal by Subject|0|||
145343993|NCT00789035|524107012|FG000|Overall Study|Other reason not defined above|2|||
145343994|NCT00789035|524107013|FG001|Overall Study|Other reason not defined above|3|||
145343995|NCT00789035|524107014|FG002|Overall Study|Other reason not defined above|1|||
145343996|NCT00789035|524107015|FG003|Overall Study|Other reason not defined above|0|||
145343997|NCT00789035|524107016|FG004|Overall Study|Other reason not defined above|1|||
145343998|NCT04974749|524107017|FG000|Overall Study|Withdrawal by Subject|2|||
145343999|NCT04974749|524107017|FG000|Overall Study|Gestation|1|||
145344000|NCT00362336|524107018|FG000|Overall Study|Serious Adverse Event|1|||
145344001|NCT00362336|524107019|FG001|Overall Study|Serious Adverse Event|0|||
145344002|NCT00362336|524107020|FG002|Overall Study|Serious Adverse Event|1|||
145344003|NCT00362336|524107018|FG000|Overall Study|Protocol Violation|0|||
145344004|NCT00362336|524107019|FG001|Overall Study|Protocol Violation|0|||
145344005|NCT00362336|524107020|FG002|Overall Study|Protocol Violation|1|||
145344006|NCT00362336|524107018|FG000|Overall Study|Lost to Follow-up|6|||
145344007|NCT00362336|524107019|FG001|Overall Study|Lost to Follow-up|4|||
145344008|NCT00362336|524107020|FG002|Overall Study|Lost to Follow-up|0|||
145344009|NCT00362336|524107018|FG000|Overall Study|Withdrawal by Subject|3|||
145344010|NCT00362336|524107019|FG001|Overall Study|Withdrawal by Subject|3|||
145344011|NCT00362336|524107020|FG002|Overall Study|Withdrawal by Subject|1|||
145344012|NCT04414618|524107021|FG000|Overall Study|Death|3|||
145344013|NCT04414618|524107022|FG001|Overall Study|Death|3|||
145344014|NCT04414618|524107021|FG000|Overall Study|Withdrawal by Subject|2|||
145344015|NCT04414618|524107022|FG001|Overall Study|Withdrawal by Subject|1|||
145344016|NCT04414618|524107021|FG000|Overall Study|Lost to Follow-up|2|||
145344017|NCT04414618|524107022|FG001|Overall Study|Lost to Follow-up|3|||
145344018|NCT04414618|524107021|FG000|Overall Study|Physician Decision|1|||
145344019|NCT04414618|524107022|FG001|Overall Study|Physician Decision|0|||
145344020|NCT00658879|524107023|FG000|Overall Study|Protocol Violation|1|||
145344021|NCT02661217|524107030|FG000|Overall Study|Physician Decision|12|||
145575860|NCT02203591|524962362|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
145575861|NCT02203591|524962363|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
145575862|NCT02203591|524962364|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
145344022|NCT02661217|524107031|FG001|Overall Study|Physician Decision|15|||
145344023|NCT02661217|524107030|FG000|Overall Study|Lost to Follow-up|1|||
145344024|NCT02661217|524107031|FG001|Overall Study|Lost to Follow-up|4|||
145344025|NCT02661217|524107030|FG000|Overall Study|Protocol Deviation|0|||
145344026|NCT02661217|524107031|FG001|Overall Study|Protocol Deviation|4|||
145575863|NCT02203591|524962365|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
145575864|NCT03306264|524962368|FG000|Overall Study|Death|33|||
145575865|NCT03306264|524962369|FG001|Overall Study|Death|25|||
145575866|NCT03306264|524962370|FG002|Overall Study|Death|34|||
145575867|NCT03306264|524962371|FG003|Overall Study|Death|34|||
145344027|NCT02661217|524107030|FG000|Overall Study|Non-compliance with study treatment|5|||
145344028|NCT02661217|524107031|FG001|Overall Study|Non-compliance with study treatment|5|||
145344029|NCT02661217|524107030|FG000|Overall Study|Death|21|||
145344030|NCT02661217|524107031|FG001|Overall Study|Death|15|||
145344031|NCT02661217|524107030|FG000|Overall Study|Adverse Event|10|||
145344032|NCT02661217|524107031|FG001|Overall Study|Adverse Event|8|||
145344033|NCT02661217|524107030|FG000|Overall Study|Withdrawal by Subject|15|||
145344034|NCT02661217|524107031|FG001|Overall Study|Withdrawal by Subject|19|||
145344035|NCT02661217|524107030|FG000|Overall Study|Did not enter follow-up epoch|7|||
145344036|NCT02661217|524107031|FG001|Overall Study|Did not enter follow-up epoch|10|||
145344037|NCT02661217|524107030|FG000|Overall Study|Death - no study drug received|1|||
145344038|NCT02661217|524107031|FG001|Overall Study|Death - no study drug received|2|||
145344039|NCT02661217|524107030|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
145344040|NCT02661217|524107031|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
145344041|NCT02075515|524107032|FG000|Overall Study|Serious Adverse Event|1|||
145344042|NCT02075515|524107033|FG001|Overall Study|Serious Adverse Event|1|||
145344043|NCT02075515|524107034|FG002|Overall Study|Serious Adverse Event|1|||
145344044|NCT02075515|524107032|FG000|Overall Study|Non-Serious Adverse Event|0|||
145344045|NCT02075515|524107033|FG001|Overall Study|Non-Serious Adverse Event|1|||
145344046|NCT02075515|524107034|FG002|Overall Study|Non-Serious Adverse Event|0|||
145344047|NCT02075515|524107032|FG000|Overall Study|Withdrawal by Subject|2|||
145344048|NCT02075515|524107033|FG001|Overall Study|Withdrawal by Subject|0|||
145344049|NCT02075515|524107034|FG002|Overall Study|Withdrawal by Subject|1|||
145344050|NCT02075515|524107032|FG000|Overall Study|Lost to Follow-up|1|||
145344051|NCT02075515|524107033|FG001|Overall Study|Lost to Follow-up|3|||
145344052|NCT02075515|524107034|FG002|Overall Study|Lost to Follow-up|6|||
145344053|NCT00741338|524107037|FG000|Overall Study|Adverse Event|0|||
145344054|NCT00741338|524107038|FG001|Overall Study|Adverse Event|1|||
145344055|NCT03593395|524107039|FG000|Overall Study|Lost to Follow-up|48|||
145344056|NCT03593395|524107040|FG001|Overall Study|Lost to Follow-up|3|||
145344057|NCT03593395|524107039|FG000|Overall Study|Withdrawal by Subject|5|||
145344058|NCT03593395|524107040|FG001|Overall Study|Withdrawal by Subject|24|||
145344059|NCT03593395|524107039|FG000|Overall Study|Death|2|||
145344060|NCT03593395|524107040|FG001|Overall Study|Death|3|||
145344061|NCT03593395|524107039|FG000|Overall Study|Physician Decision|0|||
145344062|NCT03593395|524107040|FG001|Overall Study|Physician Decision|6|||
145344063|NCT03593395|524107039|FG000|Overall Study|Participant Relocated|19|||
145344064|NCT03593395|524107040|FG001|Overall Study|Participant Relocated|3|||
145344065|NCT03593395|524107039|FG000|Overall Study|No Information|1|||
145344066|NCT03593395|524107040|FG001|Overall Study|No Information|7|||
145344067|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
145344068|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
145344069|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
145344070|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145344071|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
145344072|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
145344073|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145344074|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
145344075|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145344076|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
145344077|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145344078|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145344079|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
145344080|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145344081|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
145344082|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
145344083|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145344084|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
145344085|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145344086|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
145344087|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145344088|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145344089|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
145344090|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145344091|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
145344092|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145344093|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145344094|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
145575868|NCT03306264|524962368|FG000|Overall Study|Complete Consent Withdrawal|4|||
145575869|NCT03306264|524962369|FG001|Overall Study|Complete Consent Withdrawal|4|||
145344095|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145344096|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
145344097|NCT03713632|524107041|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
145344098|NCT03713632|524107042|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145344099|NCT03713632|524107043|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145344100|NCT03713632|524107044|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145344101|NCT03713632|524107045|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
145344102|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
145344103|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
145344104|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
145344105|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
145575870|NCT03306264|524962370|FG002|Overall Study|Complete Consent Withdrawal|1|||
145575871|NCT03306264|524962371|FG003|Overall Study|Complete Consent Withdrawal|8|||
145575872|NCT03306264|524962368|FG000|Overall Study|Lost to Follow-up|1|||
145575873|NCT03306264|524962369|FG001|Overall Study|Lost to Follow-up|0|||
145575874|NCT03306264|524962370|FG002|Overall Study|Lost to Follow-up|1|||
145575875|NCT03306264|524962371|FG003|Overall Study|Lost to Follow-up|0|||
145575876|NCT03306264|524962368|FG000|Overall Study|Rollover to ASTX727-06|10|||
145575877|NCT03306264|524962369|FG001|Overall Study|Rollover to ASTX727-06|18|||
145575878|NCT03306264|524962370|FG002|Overall Study|Rollover to ASTX727-06|4|||
145575879|NCT03306264|524962371|FG003|Overall Study|Rollover to ASTX727-06|2|||
145575880|NCT03306264|524962368|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
145575881|NCT03306264|524962369|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
145575882|NCT03306264|524962370|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
145575883|NCT03306264|524962371|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
145575884|NCT00806546|524962379|FG000|Overall Study|Enrolled, not treated|35|||
145575885|NCT00806546|524962379|FG000|Overall Study|Lost to Follow-up|32|||
145575886|NCT00806546|524962379|FG000|Overall Study|Adverse Event|74|||
145575887|NCT00806546|524962379|FG000|Overall Study|Withdrawal by Subject|75|||
145575888|NCT00806546|524962379|FG000|Overall Study|Protocol Violation|49|||
145575889|NCT00806546|524962379|FG000|Overall Study|Various|42|||
145575890|NCT01466192|524962382|FG000|Overall Study|Physician Decision|1|||
145575891|NCT01466192|524962382|FG000|Overall Study|Withdrawal by Subject|3|||
145575892|NCT00700011|524962384|FG000|Overall Study|Death|0|||
145575893|NCT00700011|524962385|FG001|Overall Study|Death|1|||
145575894|NCT00678561|524962386|FG000|Overall Study|Adverse Event|0|||
145575895|NCT00678561|524962387|FG001|Overall Study|Adverse Event|1|||
145575896|NCT00678561|524962388|FG002|Overall Study|Adverse Event|1|||
145575897|NCT00678561|524962389|FG003|Overall Study|Adverse Event|0|||
145575898|NCT00678561|524962390|FG004|Overall Study|Adverse Event|1|||
145575899|NCT00678561|524962391|FG005|Overall Study|Adverse Event|0|||
145575900|NCT00678561|524962392|FG006|Overall Study|Adverse Event|0|||
145575901|NCT00678561|524962393|FG007|Overall Study|Adverse Event|0|||
145575902|NCT00678561|524962386|FG000|Overall Study|Protocol Violation|0|||
145575903|NCT00678561|524962387|FG001|Overall Study|Protocol Violation|0|||
145575904|NCT00678561|524962388|FG002|Overall Study|Protocol Violation|0|||
145575905|NCT00678561|524962389|FG003|Overall Study|Protocol Violation|0|||
145344106|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
145344107|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
145344108|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
145344109|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
145344110|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
145344111|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
145344112|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
145344113|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
145344114|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
145344115|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
145344116|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
145344117|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
145344118|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
145344119|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145575906|NCT00678561|524962390|FG004|Overall Study|Protocol Violation|1|||
145575907|NCT00678561|524962391|FG005|Overall Study|Protocol Violation|1|||
145575908|NCT00678561|524962392|FG006|Overall Study|Protocol Violation|0|||
145575909|NCT00678561|524962393|FG007|Overall Study|Protocol Violation|0|||
145575910|NCT00678561|524962386|FG000|Overall Study|Withdrawal by Subject|0|||
145575911|NCT00678561|524962387|FG001|Overall Study|Withdrawal by Subject|0|||
145575912|NCT00678561|524962388|FG002|Overall Study|Withdrawal by Subject|0|||
145575913|NCT00678561|524962389|FG003|Overall Study|Withdrawal by Subject|0|||
145575914|NCT00678561|524962390|FG004|Overall Study|Withdrawal by Subject|0|||
145575915|NCT00678561|524962391|FG005|Overall Study|Withdrawal by Subject|0|||
145575916|NCT00678561|524962392|FG006|Overall Study|Withdrawal by Subject|0|||
145575917|NCT00678561|524962393|FG007|Overall Study|Withdrawal by Subject|1|||
145575918|NCT00004031|524962394|FG000|Overall Study|Adverse Event|5|||
145344120|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
145344121|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
145344122|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
145344123|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145344124|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145344125|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
145344126|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
145344127|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
145344128|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145344129|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145344130|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145344131|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
145344132|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Death|0|||
145344133|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Death|1|||
145344134|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Death|0|||
145344135|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Death|0|||
145344136|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Death|0|||
145344137|NCT03713632|524107041|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145344138|NCT03713632|524107042|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
145344139|NCT03713632|524107043|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145344140|NCT03713632|524107044|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145344141|NCT03713632|524107045|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
145344142|NCT01524978|524107049|FG000|Overall Study|Other|16|||
145344143|NCT01524978|524107050|FG001|Overall Study|Other|2|||
145344144|NCT01524978|524107051|FG002|Overall Study|Other|1|||
145344145|NCT01524978|524107052|FG003|Overall Study|Other|2|||
145344146|NCT01524978|524107053|FG004|Overall Study|Other|1|||
145344147|NCT01524978|524107054|FG005|Overall Study|Other|3|||
145344148|NCT01524978|524107055|FG006|Overall Study|Other|17|||
145344149|NCT01524978|524107056|FG007|Overall Study|Other|1|||
145344150|NCT01524978|524107057|FG008|Overall Study|Other|2|||
145344151|NCT01524978|524107058|FG009|Overall Study|Other|2|||
145344152|NCT01524978|524107059|FG010|Overall Study|Other|5|||
145344153|NCT01524978|524107049|FG000|Overall Study|Withdrawal by Subject|12|||
145344154|NCT01524978|524107050|FG001|Overall Study|Withdrawal by Subject|0|||
145344155|NCT01524978|524107051|FG002|Overall Study|Withdrawal by Subject|1|||
145344156|NCT01524978|524107052|FG003|Overall Study|Withdrawal by Subject|1|||
145344157|NCT01524978|524107053|FG004|Overall Study|Withdrawal by Subject|3|||
145344158|NCT01524978|524107054|FG005|Overall Study|Withdrawal by Subject|1|||
145344159|NCT01524978|524107055|FG006|Overall Study|Withdrawal by Subject|6|||
145344160|NCT01524978|524107056|FG007|Overall Study|Withdrawal by Subject|2|||
145344161|NCT01524978|524107057|FG008|Overall Study|Withdrawal by Subject|4|||
145344162|NCT01524978|524107058|FG009|Overall Study|Withdrawal by Subject|0|||
145344163|NCT01524978|524107059|FG010|Overall Study|Withdrawal by Subject|5|||
145344164|NCT01524978|524107049|FG000|Overall Study|Lost to Follow-up|0|||
145344165|NCT01524978|524107050|FG001|Overall Study|Lost to Follow-up|0|||
145344166|NCT01524978|524107051|FG002|Overall Study|Lost to Follow-up|3|||
145344167|NCT01524978|524107052|FG003|Overall Study|Lost to Follow-up|0|||
145344168|NCT01524978|524107053|FG004|Overall Study|Lost to Follow-up|1|||
145344169|NCT01524978|524107054|FG005|Overall Study|Lost to Follow-up|1|||
145344170|NCT01524978|524107055|FG006|Overall Study|Lost to Follow-up|2|||
145344171|NCT01524978|524107056|FG007|Overall Study|Lost to Follow-up|0|||
145344172|NCT01524978|524107057|FG008|Overall Study|Lost to Follow-up|1|||
145344173|NCT01524978|524107058|FG009|Overall Study|Lost to Follow-up|1|||
145344174|NCT01524978|524107059|FG010|Overall Study|Lost to Follow-up|1|||
145344175|NCT01524978|524107049|FG000|Overall Study|Death|34|||
145344176|NCT01524978|524107050|FG001|Overall Study|Death|2|||
145344177|NCT01524978|524107051|FG002|Overall Study|Death|5|||
145344178|NCT01524978|524107052|FG003|Overall Study|Death|24|||
145344179|NCT01524978|524107053|FG004|Overall Study|Death|4|||
145344180|NCT01524978|524107054|FG005|Overall Study|Death|4|||
145344181|NCT01524978|524107055|FG006|Overall Study|Death|1|||
145344182|NCT01524978|524107056|FG007|Overall Study|Death|9|||
145344183|NCT01524978|524107057|FG008|Overall Study|Death|5|||
145344184|NCT01524978|524107058|FG009|Overall Study|Death|6|||
145344185|NCT01524978|524107059|FG010|Overall Study|Death|17|||
145344186|NCT02165735|524107067|FG000|Overall Study|Lost to Follow-up|12|||
145344187|NCT02165735|524107068|FG001|Overall Study|Lost to Follow-up|10|||
145344188|NCT02165735|524107067|FG000|Overall Study|Withdrawal by Subject|3|||
145344189|NCT02165735|524107068|FG001|Overall Study|Withdrawal by Subject|0|||
145344190|NCT02165735|524107067|FG000|Overall Study|Participant indicated lack of time|1|||
145344191|NCT02165735|524107068|FG001|Overall Study|Participant indicated lack of time|3|||
145344192|NCT02165735|524107067|FG000|Overall Study|Protocol Violation|0|||
145344193|NCT02165735|524107068|FG001|Overall Study|Protocol Violation|1|||
145344194|NCT03066258|524107069|FG000|Overall Study|Death|1|||
145344195|NCT03066258|524107070|FG001|Overall Study|Death|0|||
145344196|NCT03066258|524107071|FG002|Overall Study|Death|0|||
145344197|NCT03066258|524107072|FG003|Overall Study|Death|0|||
145575919|NCT00004031|524962395|FG001|Overall Study|Adverse Event|0|||
145575920|NCT00004031|524962394|FG000|Overall Study|Refusal unrelated to adverse events|2|||
145575921|NCT00004031|524962395|FG001|Overall Study|Refusal unrelated to adverse events|11|||
145575922|NCT00004031|524962394|FG000|Overall Study|Progression/relapse|9|||
145575923|NCT00004031|524962395|FG001|Overall Study|Progression/relapse|4|||
145575924|NCT00004031|524962394|FG000|Overall Study|Death|3|||
145575925|NCT00004031|524962395|FG001|Overall Study|Death|1|||
145575926|NCT00004031|524962394|FG000|Overall Study|Other- not protocol specified|3|||
145575927|NCT00004031|524962395|FG001|Overall Study|Other- not protocol specified|3|||
145575928|NCT00004031|524962394|FG000|Overall Study|Reason under review|3|||
145575929|NCT00004031|524962395|FG001|Overall Study|Reason under review|2|||
145575930|NCT01451424|524962396|FG000|Overall Study|Withdrawal by Subject|1|||
145575931|NCT01451424|524962397|FG001|Overall Study|Withdrawal by Subject|1|||
145575932|NCT01451424|524962398|FG002|Overall Study|Withdrawal by Subject|0|||
145575933|NCT01451424|524962399|FG003|Overall Study|Withdrawal by Subject|2|||
145575934|NCT01451424|524962396|FG000|Overall Study|Lost to Follow-up|0|||
145575935|NCT01451424|524962397|FG001|Overall Study|Lost to Follow-up|1|||
145575936|NCT01451424|524962398|FG002|Overall Study|Lost to Follow-up|0|||
145575937|NCT01451424|524962399|FG003|Overall Study|Lost to Follow-up|1|||
145575938|NCT01451424|524962396|FG000|Overall Study|Physician Decision|0|||
145575939|NCT01451424|524962397|FG001|Overall Study|Physician Decision|0|||
145575940|NCT01451424|524962398|FG002|Overall Study|Physician Decision|1|||
145575941|NCT01451424|524962399|FG003|Overall Study|Physician Decision|1|||
145575942|NCT01451424|524962396|FG000|Overall Study|Adverse Event|0|||
145575943|NCT01451424|524962397|FG001|Overall Study|Adverse Event|0|||
145575944|NCT01451424|524962398|FG002|Overall Study|Adverse Event|0|||
145344198|NCT03066258|524107073|FG004|Overall Study|Death|1|||
145344199|NCT02784795|524107074|FG000|Overall Study|Progressive Disease|2|||
145344200|NCT02784795|524107075|FG001|Overall Study|Progressive Disease|1|||
145344201|NCT02784795|524107076|FG002|Overall Study|Progressive Disease|1|||
145344202|NCT02784795|524107077|FG003|Overall Study|Progressive Disease|0|||
145344203|NCT02784795|524107078|FG004|Overall Study|Progressive Disease|2|||
145344204|NCT02784795|524107079|FG005|Overall Study|Progressive Disease|0|||
145344205|NCT02784795|524107080|FG006|Overall Study|Progressive Disease|2|||
145344206|NCT02784795|524107081|FG007|Overall Study|Progressive Disease|0|||
145344207|NCT02784795|524107082|FG008|Overall Study|Progressive Disease|0|||
145344208|NCT02784795|524107083|FG009|Overall Study|Progressive Disease|0|||
145344209|NCT02784795|524107084|FG010|Overall Study|Progressive Disease|1|||
145344210|NCT02784795|524107085|FG011|Overall Study|Progressive Disease|0|||
145344211|NCT02784795|524107074|FG000|Overall Study|Adverse Event|1|||
145344212|NCT02784795|524107075|FG001|Overall Study|Adverse Event|0|||
145344213|NCT02784795|524107076|FG002|Overall Study|Adverse Event|0|||
145344214|NCT02784795|524107077|FG003|Overall Study|Adverse Event|1|||
145344215|NCT02784795|524107078|FG004|Overall Study|Adverse Event|0|||
145344216|NCT02784795|524107079|FG005|Overall Study|Adverse Event|0|||
145344217|NCT02784795|524107080|FG006|Overall Study|Adverse Event|1|||
145344218|NCT02784795|524107081|FG007|Overall Study|Adverse Event|0|||
145344219|NCT02784795|524107082|FG008|Overall Study|Adverse Event|0|||
145344220|NCT02784795|524107083|FG009|Overall Study|Adverse Event|0|||
145344221|NCT02784795|524107084|FG010|Overall Study|Adverse Event|0|||
145344222|NCT02784795|524107085|FG011|Overall Study|Adverse Event|2|||
145344223|NCT02784795|524107074|FG000|Overall Study|Withdrawal by Subject|1|||
145344224|NCT02784795|524107075|FG001|Overall Study|Withdrawal by Subject|0|||
145344225|NCT02784795|524107076|FG002|Overall Study|Withdrawal by Subject|2|||
145344226|NCT02784795|524107077|FG003|Overall Study|Withdrawal by Subject|1|||
145344227|NCT02784795|524107078|FG004|Overall Study|Withdrawal by Subject|3|||
145344228|NCT02784795|524107079|FG005|Overall Study|Withdrawal by Subject|0|||
145344229|NCT02784795|524107080|FG006|Overall Study|Withdrawal by Subject|0|||
145344230|NCT02784795|524107081|FG007|Overall Study|Withdrawal by Subject|1|||
145344231|NCT02784795|524107082|FG008|Overall Study|Withdrawal by Subject|0|||
145344232|NCT02784795|524107083|FG009|Overall Study|Withdrawal by Subject|0|||
145344233|NCT02784795|524107084|FG010|Overall Study|Withdrawal by Subject|0|||
145575945|NCT01451424|524962399|FG003|Overall Study|Adverse Event|1|||
145575946|NCT02553421|524962402|FG000|Overall Study|Lost to Follow-up|21|||
145575947|NCT02553421|524962403|FG001|Overall Study|Lost to Follow-up|1|||
145575948|NCT02553421|524962402|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
145575949|NCT02553421|524962403|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
145575950|NCT02553421|524962402|FG000|Overall Study|Improper Device Placement|3|||
145575951|NCT02553421|524962403|FG001|Overall Study|Improper Device Placement|0|||
145575952|NCT04579679|524962405|FG000|Overall Study|New Antitumor Therapy|6|||
145575953|NCT04579679|524962406|FG001|Overall Study|New Antitumor Therapy|4|||
145575954|NCT04579679|524962407|FG002|Overall Study|New Antitumor Therapy|7|||
145344234|NCT02784795|524107085|FG011|Overall Study|Withdrawal by Subject|2|||
145344235|NCT02784795|524107074|FG000|Overall Study|Death|0|||
145344236|NCT02784795|524107075|FG001|Overall Study|Death|0|||
145344237|NCT02784795|524107076|FG002|Overall Study|Death|0|||
145344238|NCT02784795|524107077|FG003|Overall Study|Death|0|||
145344239|NCT02784795|524107078|FG004|Overall Study|Death|1|||
145344240|NCT02784795|524107079|FG005|Overall Study|Death|0|||
145344241|NCT02784795|524107080|FG006|Overall Study|Death|0|||
145344242|NCT02784795|524107081|FG007|Overall Study|Death|0|||
145344243|NCT02784795|524107082|FG008|Overall Study|Death|0|||
145344244|NCT02784795|524107083|FG009|Overall Study|Death|0|||
145344245|NCT02784795|524107084|FG010|Overall Study|Death|0|||
145344246|NCT02784795|524107085|FG011|Overall Study|Death|0|||
145344247|NCT02784795|524107074|FG000|Overall Study|Physician Decision|0|||
145344248|NCT02784795|524107075|FG001|Overall Study|Physician Decision|0|||
145344249|NCT02784795|524107076|FG002|Overall Study|Physician Decision|0|||
145344250|NCT02784795|524107077|FG003|Overall Study|Physician Decision|0|||
145344251|NCT02784795|524107078|FG004|Overall Study|Physician Decision|0|||
145344252|NCT02784795|524107079|FG005|Overall Study|Physician Decision|0|||
145344253|NCT02784795|524107080|FG006|Overall Study|Physician Decision|1|||
145344254|NCT02784795|524107081|FG007|Overall Study|Physician Decision|0|||
145344255|NCT02784795|524107082|FG008|Overall Study|Physician Decision|0|||
145344256|NCT02784795|524107083|FG009|Overall Study|Physician Decision|0|||
145344257|NCT02784795|524107084|FG010|Overall Study|Physician Decision|0|||
145344258|NCT02784795|524107085|FG011|Overall Study|Physician Decision|0|||
145344259|NCT02540083|524107088|FG000|Overall Study|Withdrawal by Subject|16|||
145344260|NCT00101283|524107089|FG000|Overall Study|Withdrawal by Subject|0|||
145344261|NCT00101283|524107090|FG001|Overall Study|Withdrawal by Subject|1|||
145344262|NCT00101283|524107089|FG000|Overall Study|Insurance Refusal|0|||
145344263|NCT00101283|524107090|FG001|Overall Study|Insurance Refusal|1|||
145344264|NCT00101283|524107089|FG000|Overall Study|Prostate Cancer Recurrence|0|||
145344265|NCT00101283|524107090|FG001|Overall Study|Prostate Cancer Recurrence|1|||
145344266|NCT02797171|524107091|FG000|Overall Study|Lost to Follow-up|2|||
145344267|NCT02797171|524107092|FG001|Overall Study|Lost to Follow-up|0|||
145344268|NCT02797171|524107093|FG002|Overall Study|Lost to Follow-up|2|||
145344269|NCT02797171|524107094|FG003|Overall Study|Lost to Follow-up|1|||
145344270|NCT02797171|524107095|FG004|Overall Study|Lost to Follow-up|2|||
145344271|NCT02797171|524107096|FG005|Overall Study|Lost to Follow-up|0|||
145344272|NCT02797171|524107091|FG000|Overall Study|Withdrawal by Subject|1|||
145344273|NCT02797171|524107092|FG001|Overall Study|Withdrawal by Subject|1|||
145344274|NCT02797171|524107093|FG002|Overall Study|Withdrawal by Subject|0|||
145344275|NCT02797171|524107094|FG003|Overall Study|Withdrawal by Subject|0|||
145344276|NCT02797171|524107095|FG004|Overall Study|Withdrawal by Subject|0|||
145344277|NCT02797171|524107096|FG005|Overall Study|Withdrawal by Subject|0|||
145344278|NCT02797171|524107091|FG000|Overall Study|Protocol Violation|1|||
145344279|NCT02797171|524107092|FG001|Overall Study|Protocol Violation|0|||
145344280|NCT02797171|524107093|FG002|Overall Study|Protocol Violation|0|||
145344281|NCT02797171|524107094|FG003|Overall Study|Protocol Violation|0|||
145344282|NCT02797171|524107095|FG004|Overall Study|Protocol Violation|0|||
145344283|NCT02797171|524107096|FG005|Overall Study|Protocol Violation|0|||
145344284|NCT02797171|524107091|FG000|Overall Study|Participant unable to adhere|0|||
145344285|NCT02797171|524107092|FG001|Overall Study|Participant unable to adhere|1|||
145344286|NCT02797171|524107093|FG002|Overall Study|Participant unable to adhere|0|||
145344287|NCT02797171|524107094|FG003|Overall Study|Participant unable to adhere|0|||
145344288|NCT02797171|524107095|FG004|Overall Study|Participant unable to adhere|0|||
145344289|NCT02797171|524107096|FG005|Overall Study|Participant unable to adhere|0|||
145344290|NCT02797171|524107091|FG000|Overall Study|Not Randomized|0|||
145344291|NCT02797171|524107092|FG001|Overall Study|Not Randomized|0|||
145344292|NCT02797171|524107093|FG002|Overall Study|Not Randomized|0|||
145344293|NCT02797171|524107094|FG003|Overall Study|Not Randomized|0|||
145344294|NCT02797171|524107095|FG004|Overall Study|Not Randomized|0|||
145344295|NCT02797171|524107096|FG005|Overall Study|Not Randomized|1|||
145344296|NCT00595309|524107097|FG000|Overall Study|Lost to Follow-up|1|||
145344297|NCT00595309|524107097|FG000|Overall Study|planned vaccination against yellow fever|1|||
145344298|NCT00595309|524107097|FG000|Overall Study|acute infection after V0|1|||
145344299|NCT00595309|524107097|FG000|Overall Study|personal reason|1|||
145344300|NCT01372748|524107100|FG000|Overall Study|Lost to Follow-up|16|||
145344301|NCT01372748|524107101|FG001|Overall Study|Lost to Follow-up|34|||
145344302|NCT01372748|524107100|FG000|Overall Study|Withdrawal by Subject|7|||
145344303|NCT01372748|524107101|FG001|Overall Study|Withdrawal by Subject|5|||
145344304|NCT00134901|524107102|FG000|Overall Study|Lost to Follow-up|5|||
145344305|NCT00134901|524107103|FG001|Overall Study|Lost to Follow-up|5|||
145344306|NCT00134901|524107102|FG000|Overall Study|discontinued intervention|12|||
145344307|NCT00134901|524107103|FG001|Overall Study|discontinued intervention|10|||
145344308|NCT02301390|524107106|FG000|Overall Study|Withdrawal by Subject|3|||
145344309|NCT02301390|524107107|FG001|Overall Study|Withdrawal by Subject|5|||
145344310|NCT02301390|524107106|FG000|Overall Study|Protocol Violation|1|||
145344311|NCT02301390|524107107|FG001|Overall Study|Protocol Violation|0|||
145344312|NCT02301390|524107106|FG000|Overall Study|Physician Decision|1|||
145344313|NCT02301390|524107107|FG001|Overall Study|Physician Decision|0|||
145344314|NCT02301390|524107106|FG000|Overall Study|Lost to Follow-up|0|||
145414052|NCT03853798|524369237|FG006|Overall Study|Approved Drug Available for Indication|0|||
145344315|NCT02301390|524107107|FG001|Overall Study|Lost to Follow-up|1|||
145344316|NCT02301390|524107106|FG000|Overall Study|Death|2|||
145344317|NCT02301390|524107107|FG001|Overall Study|Death|2|||
145344318|NCT02301390|524107106|FG000|Overall Study|Procedure not completed|0|||
145344319|NCT02301390|524107107|FG001|Overall Study|Procedure not completed|4|||
145344320|NCT02301390|524107106|FG000|Overall Study|Missed multiple visits|1|||
145344321|NCT02301390|524107107|FG001|Overall Study|Missed multiple visits|1|||
145344322|NCT02301390|524107106|FG000|Overall Study|study terminated|2|||
145344323|NCT02301390|524107107|FG001|Overall Study|study terminated|0|||
145344324|NCT00185588|524107108|FG000|Overall Study|Adverse Event|3|||
145344325|NCT00185588|524107109|FG001|Overall Study|Adverse Event|1|||
145344326|NCT00185588|524107110|FG002|Overall Study|Adverse Event|4|||
145344327|NCT00185588|524107111|FG003|Overall Study|Adverse Event|2|||
145344328|NCT00185588|524107108|FG000|Overall Study|Lost to Follow-up|0|||
145344329|NCT00185588|524107109|FG001|Overall Study|Lost to Follow-up|0|||
145344330|NCT00185588|524107110|FG002|Overall Study|Lost to Follow-up|1|||
145344331|NCT00185588|524107111|FG003|Overall Study|Lost to Follow-up|2|||
145344332|NCT00185588|524107108|FG000|Overall Study|Withdrawal by Subject|0|||
145344333|NCT00185588|524107109|FG001|Overall Study|Withdrawal by Subject|1|||
145344334|NCT00185588|524107110|FG002|Overall Study|Withdrawal by Subject|0|||
145344335|NCT00185588|524107111|FG003|Overall Study|Withdrawal by Subject|0|||
145344336|NCT00185588|524107108|FG000|Overall Study|Physician Decision|0|||
145344337|NCT00185588|524107109|FG001|Overall Study|Physician Decision|0|||
145344338|NCT00185588|524107110|FG002|Overall Study|Physician Decision|1|||
145344339|NCT00185588|524107111|FG003|Overall Study|Physician Decision|0|||
145344340|NCT00398866|524107112|FG000|Overall Study|Adverse Event|1|||
145344341|NCT00398866|524107113|FG001|Overall Study|Adverse Event|0|||
145344342|NCT00398866|524107114|FG002|Overall Study|Adverse Event|0|||
145344343|NCT00398866|524107112|FG000|Overall Study|Lack of Efficacy|0|||
145344344|NCT00398866|524107113|FG001|Overall Study|Lack of Efficacy|0|||
145344345|NCT00398866|524107114|FG002|Overall Study|Lack of Efficacy|1|||
145344346|NCT00398866|524107112|FG000|Overall Study|Lost to Follow-up|7|||
145344347|NCT00398866|524107113|FG001|Overall Study|Lost to Follow-up|6|||
145344348|NCT00398866|524107114|FG002|Overall Study|Lost to Follow-up|4|||
145344349|NCT00398866|524107112|FG000|Overall Study|Withdrawal by Subject|5|||
145344350|NCT00398866|524107113|FG001|Overall Study|Withdrawal by Subject|1|||
145344351|NCT00398866|524107114|FG002|Overall Study|Withdrawal by Subject|2|||
145344352|NCT00398866|524107112|FG000|Overall Study|Unable to complete requirements of study|1|||
145344353|NCT00398866|524107113|FG001|Overall Study|Unable to complete requirements of study|1|||
145344354|NCT00398866|524107114|FG002|Overall Study|Unable to complete requirements of study|1|||
145344355|NCT02481869|524107115|FG000|Overall Study|Lost to Follow-up|3|||
145344356|NCT02481869|524107116|FG001|Overall Study|Lost to Follow-up|4|||
145344357|NCT02481869|524107115|FG000|Overall Study|Withdrawal by Subject|2|||
145344358|NCT02481869|524107116|FG001|Overall Study|Withdrawal by Subject|0|||
145344359|NCT03908437|524107119|FG000|Overall Study|Death|0|||
145344360|NCT03908437|524107120|FG001|Overall Study|Death|1|||
145344361|NCT03908437|524107119|FG000|Overall Study|Lost to Follow-up|31|||
145344362|NCT03908437|524107120|FG001|Overall Study|Lost to Follow-up|24|||
145344363|NCT00442962|524107121|FG000|Overall Study|Pregnancy|1|||
145344364|NCT00442962|524107121|FG000|Overall Study|Lost to Follow-up|7|||
145344365|NCT04238650|524107122|FG000|Overall Study|Withdrawal by Subject|0|||
145344366|NCT04238650|524107123|FG001|Overall Study|Withdrawal by Subject|1|||
145344367|NCT03633825|524107124|FG000|Enrollment|Did not post on network|5066|||
145344368|NCT03633825|524107125|FG001|Enrollment|Did not post on network|5080|||
145344369|NCT03633825|524107124|FG000|Enrollment|Post not classified as crisis|13967|||
145344370|NCT03633825|524107125|FG001|Enrollment|Post not classified as crisis|13757|||
145344371|NCT03633825|524107124|FG000|Follow up|Lost to Follow-up|478|||
145344372|NCT03633825|524107125|FG001|Follow up|Lost to Follow-up|450|||
145344373|NCT00345631|524107128|FG000|Overall Study|Withdrawal by Subject|1|||
145344374|NCT00345631|524107129|FG001|Overall Study|Withdrawal by Subject|0|||
145344375|NCT00345631|524107130|FG002|Overall Study|Withdrawal by Subject|1|||
145575955|NCT04579679|524962408|FG003|Overall Study|New Antitumor Therapy|0|||
145575956|NCT04579679|524962405|FG000|Overall Study|Withdrawal of Consent|1|||
145575957|NCT04579679|524962406|FG001|Overall Study|Withdrawal of Consent|1|||
145575958|NCT04579679|524962407|FG002|Overall Study|Withdrawal of Consent|2|||
145344376|NCT00345631|524107128|FG000|Overall Study|Adverse Event|0|||
145344377|NCT00345631|524107129|FG001|Overall Study|Adverse Event|1|||
145344378|NCT00345631|524107130|FG002|Overall Study|Adverse Event|0|||
145344379|NCT00345631|524107128|FG000|Overall Study|Lost to Follow-up|3|||
145575959|NCT04579679|524962408|FG003|Overall Study|Withdrawal of Consent|4|||
145575960|NCT04579679|524962405|FG000|Overall Study|Death|2|||
145575961|NCT04579679|524962406|FG001|Overall Study|Death|2|||
145414053|NCT03853798|524369238|FG007|Overall Study|Approved Drug Available for Indication|0|||
145344380|NCT00345631|524107129|FG001|Overall Study|Lost to Follow-up|7|||
145344381|NCT00345631|524107130|FG002|Overall Study|Lost to Follow-up|4|||
145344382|NCT00345631|524107128|FG000|Overall Study|Other reasons|0|||
145344383|NCT00345631|524107129|FG001|Overall Study|Other reasons|0|||
145344384|NCT00345631|524107130|FG002|Overall Study|Other reasons|1|||
145344385|NCT01130597|524107138|FG000|Overall Study|Protocol-specified (High K+)|1|||
145344386|NCT01130597|524107138|FG000|Overall Study|Adverse Event|4|||
145344387|NCT01130597|524107138|FG000|Overall Study|Death|1|||
145575962|NCT04579679|524962407|FG002|Overall Study|Death|2|||
145575963|NCT04579679|524962408|FG003|Overall Study|Death|0|||
145344388|NCT01130597|524107138|FG000|Overall Study|Protocol Violation|1|||
145344389|NCT03371459|524107139|FG000|Washout|Lost to Follow-up|0|||
145344390|NCT03371459|524107140|FG001|Washout|Lost to Follow-up|1|||
145344391|NCT04458922|524109220|FG000|Overall Study|Withdrawal by Subject|1|||
145344392|NCT04458922|524109221|FG001|Overall Study|Withdrawal by Subject|0|||
145344393|NCT04458922|524109222|FG002|Overall Study|Withdrawal by Subject|2|||
145344394|NCT04458922|524109220|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
145344395|NCT04458922|524109221|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
145344396|NCT04458922|524109222|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
145344397|NCT04458922|524109220|FG000|Overall Study|Adverse Event|1|||
145344398|NCT04458922|524109221|FG001|Overall Study|Adverse Event|0|||
145344399|NCT04458922|524109222|FG002|Overall Study|Adverse Event|0|||
145344400|NCT04458922|524109220|FG000|Overall Study|Started new study|0|||
145344401|NCT04458922|524109221|FG001|Overall Study|Started new study|0|||
145344402|NCT04458922|524109222|FG002|Overall Study|Started new study|1|||
145344403|NCT04458922|524109220|FG000|Overall Study|Progressive disease|6|||
145344404|NCT04458922|524109221|FG001|Overall Study|Progressive disease|8|||
145344405|NCT04458922|524109222|FG002|Overall Study|Progressive disease|2|||
145344406|NCT04458922|524109220|FG000|Overall Study|Death|1|||
145344407|NCT04458922|524109221|FG001|Overall Study|Death|0|||
145344408|NCT04458922|524109222|FG002|Overall Study|Death|2|||
145344409|NCT04458922|524109220|FG000|Overall Study|Participant started chemotherapy|0|||
145344410|NCT04458922|524109221|FG001|Overall Study|Participant started chemotherapy|1|||
145344411|NCT04458922|524109222|FG002|Overall Study|Participant started chemotherapy|0|||
145344412|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
145344413|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
145344414|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
145344415|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
145344416|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
145344417|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
145344418|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
145344419|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
145344420|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
145344421|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
145344422|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
145344423|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
145575964|NCT04579679|524962405|FG000|Overall Study|Adverse Event|0|||
145575965|NCT04579679|524962406|FG001|Overall Study|Adverse Event|4|||
145344424|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
145344425|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
145344426|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
145575966|NCT04579679|524962407|FG002|Overall Study|Adverse Event|0|||
145575967|NCT04579679|524962408|FG003|Overall Study|Adverse Event|0|||
145575968|NCT04579679|524962405|FG000|Overall Study|Disease Progression|9|||
145575969|NCT04579679|524962406|FG001|Overall Study|Disease Progression|13|||
145575970|NCT04579679|524962407|FG002|Overall Study|Disease Progression|7|||
145575971|NCT04579679|524962408|FG003|Overall Study|Disease Progression|0|||
145575972|NCT04579679|524962405|FG000|Overall Study|Physician Decision|0|||
145575973|NCT04579679|524962406|FG001|Overall Study|Physician Decision|0|||
145575974|NCT04579679|524962407|FG002|Overall Study|Physician Decision|1|||
145575975|NCT04579679|524962408|FG003|Overall Study|Physician Decision|0|||
145344427|NCT04856930|524109223|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145344428|NCT04856930|524109224|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
145344429|NCT04856930|524109225|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145344430|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
145344431|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
145344432|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
145344433|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
145575976|NCT04579679|524962405|FG000|Overall Study|Study Terminated by Sponsor|2|||
145575977|NCT04579679|524962406|FG001|Overall Study|Study Terminated by Sponsor|7|||
145575978|NCT04579679|524962407|FG002|Overall Study|Study Terminated by Sponsor|1|||
145575979|NCT04579679|524962408|FG003|Overall Study|Study Terminated by Sponsor|0|||
145575980|NCT04524403|524964202|FG000|Overall Study|Withdrawal by Subject|10|||
145575981|NCT04524403|524964203|FG001|Overall Study|Withdrawal by Subject|3|||
145575982|NCT04524403|524964204|FG002|Overall Study|Withdrawal by Subject|8|||
145575983|NCT04524403|524964202|FG000|Overall Study|Lost to Follow-up|3|||
145575984|NCT04524403|524964203|FG001|Overall Study|Lost to Follow-up|4|||
145575985|NCT04524403|524964204|FG002|Overall Study|Lost to Follow-up|3|||
145344434|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
145344435|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
145575986|NCT04524403|524964202|FG000|Overall Study|Adverse Event|3|||
145344436|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
145344437|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
145344438|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
145344439|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
145344440|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
145344441|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
145344442|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
145344443|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145344444|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
145344445|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
145344446|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
145344447|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
145344448|NCT04856930|524109223|FG000|Extension Period (16 Weeks)|Other than specified|0|||
145344449|NCT04856930|524109224|FG001|Extension Period (16 Weeks)|Other than specified|0|||
145344450|NCT04856930|524109225|FG002|Extension Period (16 Weeks)|Other than specified|1|||
145344451|NCT04856930|524109223|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
145344452|NCT04856930|524109224|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
145344453|NCT04856930|524109225|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
145344454|NCT04856930|524109223|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
145344455|NCT04856930|524109224|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
145344456|NCT04856930|524109225|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
145344457|NCT04856930|524109223|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
145344458|NCT04856930|524109224|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
145344459|NCT04856930|524109225|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
145344460|NCT04856930|524109223|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
145344461|NCT04856930|524109224|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
145344462|NCT04856930|524109225|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
145344463|NCT04825912|524109226|FG000|Overall Study|Death|3|||
145344464|NCT04825912|524109226|FG000|Overall Study|Withdrawal by Subject|1|||
145344465|NCT01009814|524109229|FG000|Overall Study|No longer met study criteria|1|||
145344466|NCT01009814|524109230|FG001|Overall Study|No longer met study criteria|1|||
145344467|NCT01009814|524109231|FG002|Overall Study|No longer met study criteria|0|||
145344468|NCT01009814|524109232|FG003|Overall Study|No longer met study criteria|0|||
145344469|NCT01009814|524109233|FG004|Overall Study|No longer met study criteria|0|||
145344470|NCT00618371|524109234|FG000|Overall Study|Withdrawal by Subject|2|||
145344471|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
145344472|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
145344473|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
145344474|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
145344475|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
145344476|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
145344477|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
145344478|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
145344479|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
145344480|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
145344481|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
145344482|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
145344483|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
145344484|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
145344485|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
145344486|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145344487|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145344488|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145344489|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145344490|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
145344491|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
145344492|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
145344493|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
145344494|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
145344495|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
145344496|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145344497|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145344498|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145344499|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145344500|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
145344501|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
145344502|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
145414054|NCT03853798|524369239|FG008|Overall Study|Approved Drug Available for Indication|0|||
145344503|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
145344504|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
145344505|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
145344506|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145344507|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145344508|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145575987|NCT04524403|524964203|FG001|Overall Study|Adverse Event|1|||
145575988|NCT04524403|524964204|FG002|Overall Study|Adverse Event|4|||
145575989|NCT04524403|524964202|FG000|Overall Study|Non-compliant with study drug|1|||
145575990|NCT04524403|524964203|FG001|Overall Study|Non-compliant with study drug|2|||
145575991|NCT04524403|524964204|FG002|Overall Study|Non-compliant with study drug|3|||
145575992|NCT04524403|524964202|FG000|Overall Study|Moved|0|||
145575993|NCT04524403|524964203|FG001|Overall Study|Moved|1|||
145575994|NCT04524403|524964204|FG002|Overall Study|Moved|0|||
145575995|NCT02383758|524964205|FG000|Overall Study|Withdrawal by Subject|0|||
145575996|NCT02383758|524964206|FG001|Overall Study|Withdrawal by Subject|2|||
145575997|NCT03085927|524964211|FG000|Overall Study|Withdrawal by Subject|1|||
145575998|NCT03085927|524964212|FG001|Overall Study|Withdrawal by Subject|4|||
145575999|NCT03085927|524964211|FG000|Overall Study|Lost to Follow-up|3|||
145576000|NCT03085927|524964212|FG001|Overall Study|Lost to Follow-up|1|||
145576001|NCT03085927|524964211|FG000|Overall Study|Death|1|||
145576002|NCT03085927|524964212|FG001|Overall Study|Death|0|||
145576003|NCT03085927|524964211|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
145576004|NCT03085927|524964212|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
145576005|NCT03085927|524964211|FG000|Overall Study|Dyad Became Ineligible|0|||
145576006|NCT03085927|524964212|FG001|Overall Study|Dyad Became Ineligible|1|||
145622857|NCT01723826|525130204|FG001|Overall Study|Non-compliance|1|||
145344509|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145344510|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
145344511|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344512|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344513|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344514|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
145344515|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145576007|NCT00600821|524964213|FG000|Overall Study|Death|45|||
145576008|NCT00600821|524964214|FG001|Overall Study|Death|46|||
145576009|NCT00600821|524964213|FG000|Overall Study|Lost to Follow-up|2|||
145576010|NCT00600821|524964214|FG001|Overall Study|Lost to Follow-up|2|||
145576011|NCT00600821|524964213|FG000|Overall Study|Withdrawal by Subject|1|||
145576012|NCT00600821|524964214|FG001|Overall Study|Withdrawal by Subject|1|||
145576013|NCT00600821|524964213|FG000|Overall Study|Terminated by sponsor|8|||
145576014|NCT00600821|524964214|FG001|Overall Study|Terminated by sponsor|6|||
145576015|NCT00600821|524964213|FG000|Overall Study|Objective progression or relapse|0|||
145576016|NCT00600821|524964214|FG001|Overall Study|Objective progression or relapse|1|||
145344516|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344517|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344518|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344519|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344520|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
145344521|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
145344522|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
145344523|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
145344524|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
145344525|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
145344526|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
145344527|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
145344528|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
145344529|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
145344530|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
145344531|NCT03104400|524109235|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344532|NCT03104400|524109236|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344533|NCT03104400|524109237|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344534|NCT03104400|524109238|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
145576017|NCT00600821|524964213|FG000|Overall Study|Randomized but not treated|0|||
145576018|NCT00600821|524964214|FG001|Overall Study|Randomized but not treated|1|||
145576019|NCT00600821|524964213|FG000|Overall Study|Other|2|||
145576020|NCT00600821|524964214|FG001|Overall Study|Other|3|||
145576021|NCT00194012|524964215|FG000|Randomized Phase|Lack of Efficacy|8|||
145576022|NCT00194012|524964216|FG001|Randomized Phase|Lack of Efficacy|18|||
145576023|NCT00194012|524964215|FG000|Randomized Phase|Study nonadherence|2|||
145622858|NCT01723826|525130205|FG002|Overall Study|Non-compliance|3|||
145344535|NCT03104400|524109239|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344536|NCT03104400|524109240|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145576024|NCT00194012|524964216|FG001|Randomized Phase|Study nonadherence|1|||
145576025|NCT00194012|524964215|FG000|Randomized Phase|Withdrawal by Subject|3|||
145576026|NCT00194012|524964216|FG001|Randomized Phase|Withdrawal by Subject|3|||
145576027|NCT00194012|524964215|FG000|Randomized Phase|Adverse Event|2|||
145576028|NCT00194012|524964216|FG001|Randomized Phase|Adverse Event|1|||
145576029|NCT00194012|524964215|FG000|Randomized Phase|Participant reported having a rash|1|||
145344537|NCT03104400|524109241|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344538|NCT03104400|524109242|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344539|NCT03104400|524109243|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344540|NCT03104400|524109244|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
145344541|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
145344542|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
145344543|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
145344544|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
145344545|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
145344546|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
145344547|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
145344548|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
145344549|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
145344550|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
145344551|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145344552|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145344553|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145344554|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145344555|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
145344556|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
145344557|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
145344558|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
145344559|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
145344560|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
145344561|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145344562|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145344563|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145344564|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145344565|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
145344566|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
145344567|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
145344568|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
145344569|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
145344570|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
145344571|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145344572|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145344573|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145344574|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145344575|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
145344576|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
145344577|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
145344578|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
145344579|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
145344580|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
145344581|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344582|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344583|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344584|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344585|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344586|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344587|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
145344588|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
145344589|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
145344590|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
145344591|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344592|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344593|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344594|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344595|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344596|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344597|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344598|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
145344599|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
145344600|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
145344601|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
145344602|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
145344603|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
145344604|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
145344605|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
145344606|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
145344607|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
145344608|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
145344609|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
145344610|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
145344611|NCT03104400|524109235|FG000|Period 2 Week 56 - 260)|Other|0|||
145344612|NCT03104400|524109236|FG001|Period 2 Week 56 - 260)|Other|0|||
145344613|NCT03104400|524109237|FG002|Period 2 Week 56 - 260)|Other|0|||
145344614|NCT03104400|524109238|FG003|Period 2 Week 56 - 260)|Other|0|||
145344615|NCT03104400|524109239|FG004|Period 2 Week 56 - 260)|Other|0|||
145344616|NCT03104400|524109240|FG005|Period 2 Week 56 - 260)|Other|0|||
145344617|NCT03104400|524109241|FG006|Period 2 Week 56 - 260)|Other|0|||
145344618|NCT03104400|524109242|FG007|Period 2 Week 56 - 260)|Other|0|||
145344619|NCT03104400|524109243|FG008|Period 2 Week 56 - 260)|Other|1|||
145344620|NCT03104400|524109244|FG009|Period 2 Week 56 - 260)|Other|1|||
145344621|NCT02013817|524109245|FG000|Overall Study|Adverse Event|12|||
145344622|NCT02013817|524109245|FG000|Overall Study|Withdrawal by Subject|4|||
145344623|NCT02013817|524109245|FG000|Overall Study|Death|2|||
145344624|NCT02013817|524109245|FG000|Overall Study|Other|9|||
145344625|NCT00855894|524109246|FG000|Overall Study|Death|31|||
145344626|NCT00855894|524109246|FG000|Overall Study|Patient's decision|1|||
145344627|NCT00855894|524109246|FG000|Overall Study|Disease progression|1|||
145344628|NCT03055624|524109247|FG000|Overall Study|Study closed|9|||
145344629|NCT00191191|524109257|FG000|Overall Study|Entry Criteria Exclusion|2|||
145576030|NCT00194012|524964216|FG001|Randomized Phase|Participant reported having a rash|0|||
145344630|NCT00191191|524109258|FG001|Overall Study|Entry Criteria Exclusion|0|||
145344631|NCT00191191|524109257|FG000|Overall Study|Treated with Another Systemic Agent|1|||
145344632|NCT00191191|524109258|FG001|Overall Study|Treated with Another Systemic Agent|1|||
145344633|NCT00191191|524109257|FG000|Overall Study|Adverse Event|11|||
145344634|NCT00191191|524109258|FG001|Overall Study|Adverse Event|21|||
145344635|NCT00191191|524109257|FG000|Overall Study|Progressive Disease|84|||
145344636|NCT00191191|524109258|FG001|Overall Study|Progressive Disease|72|||
145344637|NCT00191191|524109257|FG000|Overall Study|Toxicity After Dose Reduction|7|||
145344638|NCT00191191|524109258|FG001|Overall Study|Toxicity After Dose Reduction|8|||
145344639|NCT00191191|524109257|FG000|Overall Study|Family/Caregiver Decision|5|||
145344640|NCT00191191|524109258|FG001|Overall Study|Family/Caregiver Decision|7|||
145344641|NCT00191191|524109257|FG000|Overall Study|Lost to Follow-up|1|||
145344642|NCT00191191|524109258|FG001|Overall Study|Lost to Follow-up|0|||
145344643|NCT00191191|524109257|FG000|Overall Study|Physician Decision|3|||
145344644|NCT00191191|524109258|FG001|Overall Study|Physician Decision|2|||
145344645|NCT00191191|524109257|FG000|Overall Study|Good Clinical Practice Violation|0|||
145344646|NCT00191191|524109258|FG001|Overall Study|Good Clinical Practice Violation|1|||
145344647|NCT05246670|524109259|FG000|Overall Study|Withdrawal by Subject|2|||
145344648|NCT05246670|524109260|FG001|Overall Study|Withdrawal by Subject|3|||
145344649|NCT05246670|524109261|FG002|Overall Study|Withdrawal by Subject|0|||
145344650|NCT05246670|524109262|FG003|Overall Study|Withdrawal by Subject|1|||
145576031|NCT00194012|524964215|FG000|Randomized Phase|Emesis and enuresis|0|||
145576032|NCT00194012|524964216|FG001|Randomized Phase|Emesis and enuresis|1|||
145576033|NCT00194012|524964215|FG000|Randomized Phase|Oral/nasal twitching|0|||
145576034|NCT00194012|524964216|FG001|Randomized Phase|Oral/nasal twitching|1|||
145576035|NCT00194012|524964215|FG000|Open Label Extension (OLE)|Weight Gain|1|||
145576036|NCT00194012|524964216|FG001|Open Label Extension (OLE)|Weight Gain|0|||
145576037|NCT00194012|524964215|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
145576038|NCT00194012|524964216|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
145576039|NCT00194012|524964215|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
145576040|NCT00194012|524964216|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
145576041|NCT00194012|524964215|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
145576042|NCT00194012|524964216|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
145576043|NCT01610700|524964217|FG000|Overall Study|Adverse Event|3|||
145576044|NCT01610700|524964218|FG001|Overall Study|Adverse Event|1|||
145576045|NCT01610700|524964217|FG000|Overall Study|Withdrawal by Subject|0|||
145576046|NCT01610700|524964218|FG001|Overall Study|Withdrawal by Subject|1|||
145576047|NCT01610700|524964217|FG000|Overall Study|subject took one dose of street cannabis|0|||
145576048|NCT01610700|524964218|FG001|Overall Study|subject took one dose of street cannabis|1|||
145576049|NCT02649972|524964219|FG000|Overall Study|Not treated|1|||
145344651|NCT05246670|524109259|FG000|Overall Study|Adverse Event|0|||
145344652|NCT05246670|524109260|FG001|Overall Study|Adverse Event|0|||
145344653|NCT05246670|524109261|FG002|Overall Study|Adverse Event|1|||
145344654|NCT05246670|524109262|FG003|Overall Study|Adverse Event|0|||
145344655|NCT05246670|524109259|FG000|Overall Study|Physician Decision|1|||
145344656|NCT05246670|524109260|FG001|Overall Study|Physician Decision|0|||
145344657|NCT05246670|524109261|FG002|Overall Study|Physician Decision|0|||
145344658|NCT05246670|524109262|FG003|Overall Study|Physician Decision|0|||
145344659|NCT05246670|524109259|FG000|Overall Study|Protocol Violation|1|||
145344660|NCT05246670|524109260|FG001|Overall Study|Protocol Violation|0|||
145344661|NCT05246670|524109261|FG002|Overall Study|Protocol Violation|0|||
145576050|NCT00436280|524964220|FG000|Period 1: Induction|Adverse Event|8|||
145576051|NCT00436280|524964220|FG000|Period 1: Induction|Progressive Disease|12|||
145576052|NCT00436280|524964220|FG000|Period 1: Induction|Stable Disease|6|||
145344662|NCT05246670|524109262|FG003|Overall Study|Protocol Violation|0|||
145344663|NCT04152291|524109263|FG000|Overall Study|Covid-19 restrictions|27|||
145344664|NCT04152291|524109263|FG000|Overall Study|Withdrawal by Subject|3|||
145344665|NCT03597295|524109264|FG000|Overall Study|Death|70|||
145344666|NCT03597295|524109264|FG000|Overall Study|Lost to Follow-up|7|||
145344667|NCT05124691|524109265|FG000|Phase II|Eligibility criteria|0|||
145344668|NCT05124691|524109266|FG001|Phase II|Eligibility criteria|1|||
145344669|NCT05124691|524109267|FG002|Phase II|Eligibility criteria|0|||
145344670|NCT05124691|524109265|FG000|Phase II|Withdrawal by Subject|6|||
145344671|NCT05124691|524109266|FG001|Phase II|Withdrawal by Subject|2|||
145344672|NCT05124691|524109267|FG002|Phase II|Withdrawal by Subject|3|||
145344673|NCT05124691|524109265|FG000|Phase III|Withdrawal by Subject|6|||
145344674|NCT05124691|524109266|FG001|Phase III|Withdrawal by Subject|4|||
145344675|NCT05124691|524109267|FG002|Phase III|Withdrawal by Subject|4|||
145344676|NCT05124691|524109265|FG000|Phase III|Lost to Follow-up|1|||
145344677|NCT05124691|524109266|FG001|Phase III|Lost to Follow-up|0|||
145344678|NCT05124691|524109267|FG002|Phase III|Lost to Follow-up|0|||
145344679|NCT05211726|524109268|FG000|Overall Study|Withdrawal by Subject|2|||
145344680|NCT05211726|524109269|FG001|Overall Study|Withdrawal by Subject|3|||
145344681|NCT05211726|524109268|FG000|Overall Study|Protocol Violation|0|||
145344682|NCT05211726|524109269|FG001|Overall Study|Protocol Violation|1|||
145344683|NCT03509467|524109270|FG000|Overall Study|Withdrawal by Subject|5|||
145344684|NCT03509467|524109271|FG001|Overall Study|Withdrawal by Subject|1|||
145344685|NCT03509467|524109272|FG002|Overall Study|Withdrawal by Subject|6|||
145344686|NCT03509467|524109273|FG003|Overall Study|Withdrawal by Subject|7|||
145344687|NCT03509467|524109274|FG004|Overall Study|Withdrawal by Subject|10|||
145344688|NCT03509467|524109275|FG005|Overall Study|Withdrawal by Subject|10|||
145344689|NCT03509467|524109276|FG006|Overall Study|Withdrawal by Subject|10|||
145414055|NCT03853798|524369231|FG000|Overall Study|Other un-specified|0|||
145414056|NCT03853798|524369232|FG001|Overall Study|Other un-specified|0|||
145414057|NCT03853798|524369233|FG002|Overall Study|Other un-specified|2|||
145414058|NCT03853798|524369234|FG003|Overall Study|Other un-specified|0|||
145414059|NCT03853798|524369235|FG004|Overall Study|Other un-specified|0|||
145414060|NCT03853798|524369236|FG005|Overall Study|Other un-specified|1|||
145414061|NCT03853798|524369237|FG006|Overall Study|Other un-specified|0|||
145414062|NCT03853798|524369238|FG007|Overall Study|Other un-specified|0|||
145414063|NCT03853798|524369239|FG008|Overall Study|Other un-specified|0|||
145414064|NCT02743494|524369240|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
145414065|NCT02743494|524369241|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
145414066|NCT02743494|524369240|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
145414067|NCT02743494|524369241|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
145414068|NCT02743494|524369240|FG000|Treatment Period|Disease recurrence|152|||
145414069|NCT02743494|524369241|FG001|Treatment Period|Disease recurrence|115|||
145414070|NCT02743494|524369240|FG000|Treatment Period|Study drug toxicity|56|||
145414071|NCT02743494|524369241|FG001|Treatment Period|Study drug toxicity|8|||
145414072|NCT02743494|524369240|FG000|Treatment Period|Death|1|||
145414073|NCT02743494|524369241|FG001|Treatment Period|Death|1|||
145414074|NCT02743494|524369240|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
145414075|NCT02743494|524369241|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
145414076|NCT02743494|524369240|FG000|Treatment Period|Participant request to discontinue treatment|31|||
145414077|NCT02743494|524369241|FG001|Treatment Period|Participant request to discontinue treatment|5|||
145414078|NCT02743494|524369240|FG000|Treatment Period|Participant withdrew consent|11|||
145414079|NCT02743494|524369241|FG001|Treatment Period|Participant withdrew consent|4|||
145414080|NCT02743494|524369240|FG000|Treatment Period|Lost to Follow-up|0|||
145414081|NCT02743494|524369241|FG001|Treatment Period|Lost to Follow-up|1|||
145414082|NCT02743494|524369240|FG000|Treatment Period|Poor/Non-compliance|2|||
145414083|NCT02743494|524369241|FG001|Treatment Period|Poor/Non-compliance|0|||
145414084|NCT02743494|524369240|FG000|Treatment Period|Other reasons|4|||
145414085|NCT02743494|524369241|FG001|Treatment Period|Other reasons|1|||
145414086|NCT02068794|524371161|FG000|Overall Study|Withdrawal by Subject|0|||
145414087|NCT02068794|524371162|FG001|Overall Study|Withdrawal by Subject|1|||
145414088|NCT02068794|524371163|FG002|Overall Study|Withdrawal by Subject|2|||
145414089|NCT02068794|524371161|FG000|Overall Study|Early Progression|1|||
145576053|NCT00436280|524964220|FG000|Period 1: Induction|Withdrawal by Subject|1|||
145576054|NCT00436280|524964220|FG000|Period 1: Induction|Death|1|||
145344690|NCT03509467|524109277|FG007|Overall Study|Withdrawal by Subject|10|||
145344691|NCT03509467|524109270|FG000|Overall Study|Death|0|||
145344692|NCT03509467|524109271|FG001|Overall Study|Death|0|||
145344693|NCT03509467|524109272|FG002|Overall Study|Death|2|||
145344694|NCT03509467|524109273|FG003|Overall Study|Death|2|||
145414090|NCT02068794|524371162|FG001|Overall Study|Early Progression|0|||
145414091|NCT02068794|524371163|FG002|Overall Study|Early Progression|1|||
145414092|NCT02068794|524371161|FG000|Overall Study|Ineligible|0|||
145414093|NCT02068794|524371162|FG001|Overall Study|Ineligible|0|||
145622859|NCT01723826|525130206|FG003|Overall Study|Non-compliance|3|||
145344695|NCT03509467|524109274|FG004|Overall Study|Death|1|||
145344696|NCT03509467|524109275|FG005|Overall Study|Death|0|||
145344697|NCT03509467|524109276|FG006|Overall Study|Death|1|||
145414094|NCT02068794|524371163|FG002|Overall Study|Ineligible|1|||
145344698|NCT03509467|524109277|FG007|Overall Study|Death|0|||
145344699|NCT03509467|524109270|FG000|Overall Study|Proxy Withdrawal|0|||
145344700|NCT03509467|524109271|FG001|Overall Study|Proxy Withdrawal|0|||
145344701|NCT03509467|524109272|FG002|Overall Study|Proxy Withdrawal|0|||
145344702|NCT03509467|524109273|FG003|Overall Study|Proxy Withdrawal|0|||
145344703|NCT03509467|524109274|FG004|Overall Study|Proxy Withdrawal|0|||
145344704|NCT03509467|524109275|FG005|Overall Study|Proxy Withdrawal|0|||
145344705|NCT03509467|524109276|FG006|Overall Study|Proxy Withdrawal|0|||
145344706|NCT03509467|524109277|FG007|Overall Study|Proxy Withdrawal|1|||
145344707|NCT00428116|524109278|FG000|Overall Study|Death|1|||
145344708|NCT00428116|524109279|FG001|Overall Study|Death|0|||
145344709|NCT00428116|524109278|FG000|Overall Study|Withdrawal by Subject|1|||
145344710|NCT00428116|524109279|FG001|Overall Study|Withdrawal by Subject|0|||
145344711|NCT00428116|524109278|FG000|Overall Study|Lost to Follow-up|1|||
145344712|NCT00428116|524109279|FG001|Overall Study|Lost to Follow-up|0|||
145344713|NCT01141205|524109280|FG000|Overall Study|Physician Decision|1|||
145344714|NCT01141205|524109281|FG001|Overall Study|Physician Decision|1|||
145344715|NCT01141205|524109280|FG000|Overall Study|Lost to Follow-up|1|||
145344716|NCT01141205|524109281|FG001|Overall Study|Lost to Follow-up|0|||
145344717|NCT01141205|524109280|FG000|Overall Study|Withdrawal by Subject|1|||
145344718|NCT01141205|524109281|FG001|Overall Study|Withdrawal by Subject|1|||
145344719|NCT01685840|524109284|FG000|Overall Study|Death|77|||
145344720|NCT01685840|524109285|FG001|Overall Study|Death|66|||
145344721|NCT01685840|524109284|FG000|Overall Study|Lost to Follow-up|27|||
145344722|NCT01685840|524109285|FG001|Overall Study|Lost to Follow-up|25|||
145414095|NCT01002105|524371164|FG000|Overall Study|Lost to Follow-up|10|||
145414096|NCT01002105|524371165|FG001|Overall Study|Lost to Follow-up|16|||
145414097|NCT01002105|524371164|FG000|Overall Study|non compliance|5|||
145414098|NCT01002105|524371165|FG001|Overall Study|non compliance|3|||
145414099|NCT01002105|524371164|FG000|Overall Study|condition worsened|4|||
145414100|NCT01002105|524371165|FG001|Overall Study|condition worsened|2|||
145414101|NCT00266812|524371167|FG000|Overall Study|Disease Progression|9|||
145414102|NCT00266812|524371168|FG001|Overall Study|Disease Progression|3|||
145414103|NCT00266812|524371167|FG000|Overall Study|Death|5|||
145414104|NCT00266812|524371168|FG001|Overall Study|Death|4|||
145414105|NCT00266812|524371167|FG000|Overall Study|Adverse Event|3|||
145414106|NCT00266812|524371168|FG001|Overall Study|Adverse Event|1|||
145414107|NCT00266812|524371167|FG000|Overall Study|Protocol Violation|0|||
145414108|NCT00266812|524371168|FG001|Overall Study|Protocol Violation|1|||
145414109|NCT00266812|524371167|FG000|Overall Study|Withdrawal by Subject|0|||
145414110|NCT00266812|524371168|FG001|Overall Study|Withdrawal by Subject|2|||
145414111|NCT00266812|524371167|FG000|Overall Study|Discontinued before starting study drug|4|||
145414112|NCT00266812|524371168|FG001|Overall Study|Discontinued before starting study drug|0|||
145414113|NCT03695094|524371169|FG000|Overall Study|Adverse Event|1|||
145414114|NCT03695094|524371170|FG001|Overall Study|Adverse Event|1|||
145414115|NCT03695094|524371169|FG000|Overall Study|Withdrawal by Subject|1|||
145414116|NCT03695094|524371170|FG001|Overall Study|Withdrawal by Subject|0|||
145414117|NCT00552058|524371175|FG000|Overall Study|Adverse Event|8|||
145414118|NCT00552058|524371176|FG001|Overall Study|Adverse Event|7|||
145414119|NCT00552058|524371175|FG000|Overall Study|Lack of Efficacy|1|||
145414120|NCT00552058|524371176|FG001|Overall Study|Lack of Efficacy|5|||
145414121|NCT00552058|524371175|FG000|Overall Study|Lost to Follow-up|1|||
145414122|NCT00552058|524371176|FG001|Overall Study|Lost to Follow-up|0|||
145414123|NCT00552058|524371175|FG000|Overall Study|Withdrawal by Subject|4|||
145414124|NCT00552058|524371176|FG001|Overall Study|Withdrawal by Subject|4|||
145414125|NCT00552058|524371175|FG000|Overall Study|Other: Protocol Violation|0|||
145414126|NCT00552058|524371176|FG001|Overall Study|Other: Protocol Violation|1|||
145414127|NCT00552058|524371175|FG000|Overall Study|Other: Non Compliance|1|||
145414128|NCT00552058|524371176|FG001|Overall Study|Other: Non Compliance|2|||
145576055|NCT00436280|524964220|FG000|Period 2: Consolidation|Adverse Event|1|||
145344723|NCT01685840|524109284|FG000|Overall Study|Physician Decision|3|||
145344724|NCT01685840|524109285|FG001|Overall Study|Physician Decision|7|||
145344725|NCT01685840|524109284|FG000|Overall Study|Withdrawal by Subject|14|||
145344726|NCT01685840|524109285|FG001|Overall Study|Withdrawal by Subject|17|||
145344727|NCT01685840|524109284|FG000|Overall Study|Futility|197|||
145344728|NCT01685840|524109285|FG001|Overall Study|Futility|200|||
145414129|NCT00552058|524371175|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
145414130|NCT00552058|524371176|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
145414131|NCT00552058|524371175|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
145414132|NCT00552058|524371176|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
145414133|NCT00552058|524371175|FG000|Overall Study|Other: Positive Stool Result|0|||
145414134|NCT00552058|524371176|FG001|Overall Study|Other: Positive Stool Result|1|||
145414135|NCT00552058|524371175|FG000|Overall Study|Other: Randomized in error|0|||
145344729|NCT01685840|524109284|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
145344730|NCT01685840|524109285|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
145344731|NCT00710866|524109286|FG000|Overall Study|Protocol Violation|5|||
145344732|NCT00710866|524109287|FG001|Overall Study|Protocol Violation|4|||
145576056|NCT00436280|524964220|FG000|Period 2: Consolidation|Progressive Disease|10|||
145576057|NCT00436280|524964220|FG000|Period 2: Consolidation|Stable Disease|1|||
145576058|NCT00436280|524964220|FG000|Period 2: Consolidation|Physician Decision|2|||
145576059|NCT00436280|524964220|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
145576060|NCT00436280|524964220|FG000|Period 2: Consolidation|Death|1|||
145576061|NCT00436280|524964220|FG000|Period 3: Maintenance|Adverse Event|6|||
145576062|NCT00436280|524964220|FG000|Period 3: Maintenance|Progressive Disease|12|||
145576063|NCT02738775|524964221|FG000|Overall Study|Withdrawal by Subject|0|||
145576064|NCT02738775|524964222|FG001|Overall Study|Withdrawal by Subject|1|||
145576065|NCT02738775|524964223|FG002|Overall Study|Withdrawal by Subject|0|||
145576066|NCT02738775|524964224|FG003|Overall Study|Withdrawal by Subject|0|||
145576067|NCT02738775|524964225|FG004|Overall Study|Withdrawal by Subject|0|||
145576068|NCT02738775|524964226|FG005|Overall Study|Withdrawal by Subject|0|||
145576069|NCT02738775|524964221|FG000|Overall Study|Adverse Event|0|||
145576070|NCT02738775|524964222|FG001|Overall Study|Adverse Event|0|||
145576071|NCT02738775|524964223|FG002|Overall Study|Adverse Event|0|||
145576072|NCT02738775|524964224|FG003|Overall Study|Adverse Event|1|||
145576073|NCT02738775|524964225|FG004|Overall Study|Adverse Event|0|||
145576074|NCT02738775|524964226|FG005|Overall Study|Adverse Event|0|||
145576075|NCT02738775|524964221|FG000|Overall Study|Pregnancy|0|||
145576076|NCT02738775|524964222|FG001|Overall Study|Pregnancy|1|||
145576077|NCT02738775|524964223|FG002|Overall Study|Pregnancy|0|||
145576078|NCT02738775|524964224|FG003|Overall Study|Pregnancy|0|||
145576079|NCT02738775|524964225|FG004|Overall Study|Pregnancy|0|||
145576080|NCT02738775|524964226|FG005|Overall Study|Pregnancy|0|||
145576081|NCT02738775|524964221|FG000|Overall Study|Missing|0|||
145576082|NCT02738775|524964222|FG001|Overall Study|Missing|0|||
145576083|NCT02738775|524964223|FG002|Overall Study|Missing|0|||
145576084|NCT02738775|524964224|FG003|Overall Study|Missing|0|||
145576085|NCT02738775|524964225|FG004|Overall Study|Missing|0|||
145576086|NCT02738775|524964226|FG005|Overall Study|Missing|1|||
145576087|NCT01785524|524964227|FG000|Overall Study|Withdrawal by Subject|2|||
145576088|NCT01785524|524964228|FG001|Overall Study|Withdrawal by Subject|2|||
145576089|NCT01060384|524964229|FG000|Overall Study|Withdrawal by Subject|0|||
145576090|NCT01060384|524964230|FG001|Overall Study|Withdrawal by Subject|1|||
145576091|NCT01060384|524964231|FG002|Overall Study|Withdrawal by Subject|0|||
145576092|NCT01060384|524964232|FG003|Overall Study|Withdrawal by Subject|0|||
145576093|NCT01060384|524964233|FG004|Overall Study|Withdrawal by Subject|0|||
145576094|NCT01060384|524964229|FG000|Overall Study|Death|0|||
145576095|NCT01060384|524964230|FG001|Overall Study|Death|0|||
145576096|NCT01060384|524964231|FG002|Overall Study|Death|0|||
145576097|NCT01060384|524964232|FG003|Overall Study|Death|0|||
145576098|NCT01060384|524964233|FG004|Overall Study|Death|1|||
145576099|NCT01060384|524964229|FG000|Overall Study|Intercurrent illness|0|||
145576100|NCT01060384|524964230|FG001|Overall Study|Intercurrent illness|0|||
145576101|NCT01060384|524964231|FG002|Overall Study|Intercurrent illness|0|||
145576102|NCT01060384|524964232|FG003|Overall Study|Intercurrent illness|0|||
145576103|NCT01060384|524964233|FG004|Overall Study|Intercurrent illness|1|||
145576104|NCT00812929|524964236|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
145576105|NCT00812929|524964237|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
145576106|NCT00812929|524964238|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
145576107|NCT00812929|524964239|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
145344733|NCT00710866|524109286|FG000|Overall Study|Withdrawal by Subject|2|||
145344734|NCT00710866|524109287|FG001|Overall Study|Withdrawal by Subject|1|||
145344735|NCT00710866|524109286|FG000|Overall Study|Lost to Follow-up|1|||
145344736|NCT00710866|524109287|FG001|Overall Study|Lost to Follow-up|0|||
145344737|NCT00710866|524109286|FG000|Overall Study|Failed to meet eligibility|1|||
145344738|NCT00710866|524109287|FG001|Overall Study|Failed to meet eligibility|1|||
145344739|NCT04759768|524109294|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
145344740|NCT04759768|524109295|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
145344741|NCT04759768|524109294|FG000|Washout (7 Days)|Physician Decision|0|||
145576108|NCT00812929|524964240|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
145576109|NCT00812929|524964241|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
145576110|NCT00812929|524964242|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
145576111|NCT00812929|524964243|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
145576112|NCT00812929|524964244|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
145576113|NCT00812929|524964245|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
145344742|NCT04759768|524109295|FG001|Washout (7 Days)|Physician Decision|1|||
145344743|NCT01128543|524109296|FG000|Overall Study|Withdrawal by Subject|3|||
145344744|NCT01128543|524109296|FG000|Overall Study|Protocol Violation|1|||
145344745|NCT02676765|524109297|FG000|Overall Study|Lost to Follow-up|0|||
145414136|NCT00552058|524371176|FG001|Overall Study|Other: Randomized in error|1|||
145414137|NCT00552058|524371175|FG000|Overall Study|Other: Sponsors Decision|0|||
145576114|NCT00812929|524964236|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
145576115|NCT00812929|524964237|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
145576116|NCT00812929|524964238|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
145576117|NCT00812929|524964239|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
145344746|NCT02676765|524109298|FG001|Overall Study|Lost to Follow-up|1|||
145344747|NCT03340974|524109299|FG000|Completion of Study -Long Term Follow up|Death|8|||
145344748|NCT03340974|524109300|FG001|Completion of Study -Long Term Follow up|Death|5|||
145344749|NCT03340974|524109301|FG002|Completion of Study -Long Term Follow up|Death|5|||
145344750|NCT03340974|524109302|FG003|Completion of Study -Long Term Follow up|Death|7|||
145344751|NCT03340974|524109299|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
145344752|NCT03340974|524109300|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
145344753|NCT03340974|524109301|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
145344754|NCT03340974|524109302|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
145344755|NCT03340974|524109299|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
145344756|NCT03340974|524109300|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
145344757|NCT03340974|524109301|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
145344758|NCT03340974|524109302|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
145344759|NCT03340974|524109299|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
145344760|NCT03340974|524109300|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
145344761|NCT03340974|524109301|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
145344762|NCT03340974|524109302|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
145344763|NCT02374346|524109303|FG000|Overall Study|operated or discharged during weekend|48|||
145344764|NCT00396565|524109312|FG000|Overall Study|Physician Decision|3|||
145344765|NCT00396565|524109313|FG001|Overall Study|Physician Decision|1|||
145344766|NCT00396565|524109314|FG002|Overall Study|Physician Decision|2|||
145344767|NCT00396565|524109312|FG000|Overall Study|Adverse Event|5|||
145344768|NCT00396565|524109313|FG001|Overall Study|Adverse Event|13|||
145344769|NCT00396565|524109314|FG002|Overall Study|Adverse Event|3|||
145344770|NCT00396565|524109312|FG000|Overall Study|Withdrawal by Subject|8|||
145344771|NCT00396565|524109313|FG001|Overall Study|Withdrawal by Subject|13|||
145344772|NCT00396565|524109314|FG002|Overall Study|Withdrawal by Subject|1|||
145344773|NCT00396565|524109312|FG000|Overall Study|Lack of Efficacy|32|||
145344774|NCT00396565|524109313|FG001|Overall Study|Lack of Efficacy|64|||
145344775|NCT00396565|524109314|FG002|Overall Study|Lack of Efficacy|11|||
145344776|NCT04487067|524109316|FG000|Overall Study|Adverse Event|3|||
145344777|NCT04487067|524109316|FG000|Overall Study|Death Other Than Progressive Disease|60|||
145344778|NCT04487067|524109316|FG000|Overall Study|Death Due To Progressive Disease|40|||
145344779|NCT04487067|524109316|FG000|Overall Study|Lost to Follow-up|3|||
145344780|NCT04487067|524109316|FG000|Overall Study|Progressive Disease|1|||
145344781|NCT04487067|524109316|FG000|Overall Study|Protocol Violation|3|||
145344782|NCT04487067|524109316|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
145344783|NCT04487067|524109316|FG000|Overall Study|Withdrawal by Subject|15|||
145344784|NCT04324021|524109317|FG000|Overall Study|Adverse Event|1|||
145344785|NCT04324021|524109318|FG001|Overall Study|Adverse Event|0|||
145344786|NCT04324021|524109319|FG002|Overall Study|Adverse Event|0|||
145344787|NCT04324021|524109317|FG000|Overall Study|Lack of Efficacy|0|||
145344788|NCT04324021|524109318|FG001|Overall Study|Lack of Efficacy|0|||
145344789|NCT04324021|524109319|FG002|Overall Study|Lack of Efficacy|1|||
145344790|NCT04324021|524109317|FG000|Overall Study|Death|1|||
145344791|NCT04324021|524109318|FG001|Overall Study|Death|1|||
145344792|NCT04324021|524109319|FG002|Overall Study|Death|0|||
145344793|NCT04877457|524109320|FG000|Overall Study|Early termination of study due to low enrollment|2|||
145344794|NCT04877457|524109321|FG001|Overall Study|Early termination of study due to low enrollment|1|||
145344795|NCT00246324|524109322|FG000|Overall Study|Withdrawal by Subject|1|||
145344796|NCT02006732|524109323|FG000|Overall Study|Adverse Event|10|||
145344797|NCT02006732|524109324|FG001|Overall Study|Adverse Event|7|||
145344798|NCT02006732|524109325|FG002|Overall Study|Adverse Event|4|||
145344799|NCT02006732|524109326|FG003|Overall Study|Adverse Event|2|||
145576118|NCT00812929|524964240|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
145576119|NCT00812929|524964241|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
145576120|NCT00812929|524964242|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
145576121|NCT00812929|524964243|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
145344800|NCT02006732|524109323|FG000|Overall Study|Lack of Efficacy|6|||
145344801|NCT02006732|524109324|FG001|Overall Study|Lack of Efficacy|3|||
145344802|NCT02006732|524109325|FG002|Overall Study|Lack of Efficacy|1|||
145344803|NCT02006732|524109326|FG003|Overall Study|Lack of Efficacy|1|||
145344804|NCT02006732|524109323|FG000|Overall Study|Protocol Violation|1|||
145344805|NCT02006732|524109324|FG001|Overall Study|Protocol Violation|1|||
145344806|NCT02006732|524109325|FG002|Overall Study|Protocol Violation|0|||
145344807|NCT02006732|524109326|FG003|Overall Study|Protocol Violation|0|||
145344808|NCT02006732|524109323|FG000|Overall Study|Lost to Follow-up|0|||
145344809|NCT02006732|524109324|FG001|Overall Study|Lost to Follow-up|1|||
145344810|NCT02006732|524109325|FG002|Overall Study|Lost to Follow-up|0|||
145344811|NCT02006732|524109326|FG003|Overall Study|Lost to Follow-up|0|||
145344812|NCT02006732|524109323|FG000|Overall Study|Withdrawal by Subject|3|||
145344813|NCT02006732|524109324|FG001|Overall Study|Withdrawal by Subject|0|||
145576122|NCT00812929|524964244|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
145576123|NCT00812929|524964245|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
145576124|NCT00812929|524964236|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
145576125|NCT00812929|524964237|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
145576126|NCT00812929|524964238|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
145576127|NCT00812929|524964239|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
145576128|NCT00812929|524964240|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
145576129|NCT00812929|524964241|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
145576130|NCT00812929|524964242|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
145576131|NCT00812929|524964243|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
145576132|NCT00812929|524964244|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
145576133|NCT00812929|524964245|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
145576134|NCT03217136|524964252|FG000|Overall Study|Lost to Follow-up|2|||
145576135|NCT03217136|524964253|FG001|Overall Study|Lost to Follow-up|1|||
145576136|NCT03217136|524964252|FG000|Overall Study|Site Randomized Participant in Error|0|||
145576137|NCT03217136|524964253|FG001|Overall Study|Site Randomized Participant in Error|1|||
145576138|NCT03217136|524964252|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
145576139|NCT03217136|524964253|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
145576140|NCT03217136|524964252|FG000|Overall Study|Dispensing Error|1|||
145576141|NCT03217136|524964253|FG001|Overall Study|Dispensing Error|0|||
145576142|NCT03217136|524964252|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145576143|NCT03217136|524964253|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145576144|NCT00678691|524964254|FG000|Overall Study|Adverse Event|6|||
145576145|NCT00678691|524964255|FG001|Overall Study|Adverse Event|4|||
145576146|NCT03296696|524964267|FG000|Overall Study|Started Other Antitumor Therapy|1|||
145576147|NCT03296696|524964268|FG001|Overall Study|Started Other Antitumor Therapy|2|||
145576148|NCT03296696|524964269|FG002|Overall Study|Started Other Antitumor Therapy|1|||
145576149|NCT03296696|524964270|FG003|Overall Study|Started Other Antitumor Therapy|2|||
145576150|NCT03296696|524964271|FG004|Overall Study|Started Other Antitumor Therapy|1|||
145576151|NCT03296696|524964272|FG005|Overall Study|Started Other Antitumor Therapy|1|||
145576152|NCT03296696|524964273|FG006|Overall Study|Started Other Antitumor Therapy|2|||
145576153|NCT03296696|524964274|FG007|Overall Study|Started Other Antitumor Therapy|3|||
145576154|NCT03296696|524964275|FG008|Overall Study|Started Other Antitumor Therapy|1|||
145576155|NCT03296696|524964276|FG009|Overall Study|Started Other Antitumor Therapy|0|||
145576156|NCT03296696|524964267|FG000|Overall Study|Death|0|||
145576157|NCT03296696|524964268|FG001|Overall Study|Death|1|||
145576158|NCT03296696|524964269|FG002|Overall Study|Death|1|||
145576159|NCT03296696|524964270|FG003|Overall Study|Death|2|||
145576160|NCT03296696|524964271|FG004|Overall Study|Death|2|||
145576161|NCT03296696|524964272|FG005|Overall Study|Death|3|||
145576162|NCT03296696|524964273|FG006|Overall Study|Death|1|||
145576163|NCT03296696|524964274|FG007|Overall Study|Death|2|||
145576164|NCT03296696|524964275|FG008|Overall Study|Death|0|||
145576165|NCT03296696|524964276|FG009|Overall Study|Death|0|||
145576166|NCT03296696|524964267|FG000|Overall Study|Withdrawal by Subject|0|||
145576167|NCT03296696|524964268|FG001|Overall Study|Withdrawal by Subject|0|||
145576168|NCT03296696|524964269|FG002|Overall Study|Withdrawal by Subject|1|||
145576169|NCT03296696|524964270|FG003|Overall Study|Withdrawal by Subject|0|||
145576170|NCT03296696|524964271|FG004|Overall Study|Withdrawal by Subject|1|||
145576171|NCT03296696|524964272|FG005|Overall Study|Withdrawal by Subject|0|||
145576172|NCT03296696|524964273|FG006|Overall Study|Withdrawal by Subject|0|||
145576173|NCT03296696|524964274|FG007|Overall Study|Withdrawal by Subject|0|||
145576174|NCT03296696|524964275|FG008|Overall Study|Withdrawal by Subject|0|||
145576175|NCT03296696|524964276|FG009|Overall Study|Withdrawal by Subject|1|||
145576176|NCT04694131|524964279|FG000|Overall Study|Withdrawal by Subject|7|||
145576177|NCT04694131|524964279|FG000|Overall Study|Screen Failure|1|||
145576178|NCT04694131|524964279|FG000|Overall Study|High stimulation threshold|3|||
145576179|NCT04456699|524964280|FG000|Overall Study|Death|48|||
145576180|NCT04456699|524964281|FG001|Overall Study|Death|50|||
145344814|NCT02006732|524109325|FG002|Overall Study|Withdrawal by Subject|4|||
145344815|NCT02006732|524109326|FG003|Overall Study|Withdrawal by Subject|1|||
145344816|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
145576181|NCT04456699|524964282|FG002|Overall Study|Death|52|||
145576182|NCT04456699|524964280|FG000|Overall Study|Physician Decision|0|||
145344817|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
145344818|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
145576183|NCT04456699|524964281|FG001|Overall Study|Physician Decision|0|||
145576184|NCT04456699|524964282|FG002|Overall Study|Physician Decision|2|||
145576185|NCT04456699|524964280|FG000|Overall Study|Sponsor Decision|55|||
145576186|NCT04456699|524964281|FG001|Overall Study|Sponsor Decision|61|||
145576187|NCT04456699|524964282|FG002|Overall Study|Sponsor Decision|50|||
145576188|NCT04456699|524964280|FG000|Overall Study|Withdrawal by Subject|8|||
145576189|NCT04456699|524964281|FG001|Overall Study|Withdrawal by Subject|4|||
145576190|NCT04456699|524964282|FG002|Overall Study|Withdrawal by Subject|5|||
145576191|NCT00261716|524964288|FG000|Overall Study|Withdrawal by Subject|6|||
145576192|NCT00261716|524964289|FG001|Overall Study|Withdrawal by Subject|8|||
145576193|NCT00261716|524964288|FG000|Overall Study|Lost to Follow-up|0|||
145576194|NCT00261716|524964289|FG001|Overall Study|Lost to Follow-up|2|||
145344819|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Death|1|||
145344820|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Death|3|||
145344821|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Death|1|||
145344822|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
145344823|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
145344824|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
145344825|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
145344826|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
145344827|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
145344828|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
145344829|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
145344830|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
145344831|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
145344832|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
145344833|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
145344834|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
145344835|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
145344836|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
145344837|NCT00299130|524109327|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
145344838|NCT00299130|524109328|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
145344839|NCT00299130|524109329|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
145344840|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
145344841|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
145344842|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
145344843|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
145344844|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
145344845|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
145344846|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
145344847|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
145344848|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
145344849|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
145344850|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
145344851|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
145344852|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
145344853|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
145344854|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
145344855|NCT00299130|524109327|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
145344856|NCT00299130|524109328|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
145344857|NCT00299130|524109329|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
145344858|NCT00299130|524109327|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
145344859|NCT00299130|524109328|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
145344860|NCT00299130|524109329|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
145344861|NCT00299130|524109327|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
145344862|NCT00299130|524109328|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
145344863|NCT00299130|524109329|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
145344864|NCT00299130|524109327|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
145344865|NCT00299130|524109328|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
145344866|NCT00299130|524109329|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
145344867|NCT02211417|524109330|FG000|Overall Study|Withdrawal by Subject|11|||
145344868|NCT02211417|524109331|FG001|Overall Study|Withdrawal by Subject|8|||
145344869|NCT02211417|524109330|FG000|Overall Study|Protocol Violation|1|||
145344870|NCT02211417|524109331|FG001|Overall Study|Protocol Violation|0|||
145344871|NCT02211417|524109330|FG000|Overall Study|Pregnancy|0|||
145344872|NCT02211417|524109331|FG001|Overall Study|Pregnancy|1|||
145344873|NCT02211417|524109330|FG000|Overall Study|Lost to Follow-up|2|||
145344874|NCT02211417|524109331|FG001|Overall Study|Lost to Follow-up|3|||
145414138|NCT00552058|524371176|FG001|Overall Study|Other: Sponsors Decision|1|||
145576195|NCT02047110|524964292|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
145344875|NCT02211417|524109330|FG000|Overall Study|Adverse Event|1|||
145344876|NCT02211417|524109331|FG001|Overall Study|Adverse Event|4|||
145344877|NCT01198132|524109332|FG000|Overall Study|Withdrawal by Subject|4|||
145344878|NCT01198132|524109333|FG001|Overall Study|Withdrawal by Subject|5|||
145344879|NCT01198132|524109332|FG000|Overall Study|Physician Decision|5|||
145344880|NCT01198132|524109333|FG001|Overall Study|Physician Decision|4|||
145344881|NCT01198132|524109332|FG000|Overall Study|Other Unspecified|3|||
145344882|NCT01198132|524109333|FG001|Overall Study|Other Unspecified|6|||
145344883|NCT01198132|524109332|FG000|Overall Study|Lack of Efficacy|2|||
145344884|NCT01198132|524109333|FG001|Overall Study|Lack of Efficacy|3|||
145344885|NCT01198132|524109332|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
145344886|NCT01198132|524109333|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
145344887|NCT01198132|524109332|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
145344888|NCT01198132|524109333|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
145344889|NCT01198132|524109332|FG000|Overall Study|Adverse Event|0|||
145344890|NCT01198132|524109333|FG001|Overall Study|Adverse Event|1|||
145344891|NCT01198132|524109332|FG000|Overall Study|Protocol Violation|1|||
145344892|NCT01198132|524109333|FG001|Overall Study|Protocol Violation|0|||
145344893|NCT01755091|524109334|FG000|Overall Study|Withdrawal by Subject|6|||
145344894|NCT01755091|524109335|FG001|Overall Study|Withdrawal by Subject|1|||
145344895|NCT01755091|524109336|FG002|Overall Study|Withdrawal by Subject|3|||
145344896|NCT01755091|524109334|FG000|Overall Study|Adverse Event|1|||
145344897|NCT01755091|524109335|FG001|Overall Study|Adverse Event|1|||
145344898|NCT01755091|524109336|FG002|Overall Study|Adverse Event|1|||
145344899|NCT01755091|524109334|FG000|Overall Study|Lost to Follow-up|1|||
145344900|NCT01755091|524109335|FG001|Overall Study|Lost to Follow-up|0|||
145344901|NCT01755091|524109336|FG002|Overall Study|Lost to Follow-up|1|||
145344902|NCT01755091|524109334|FG000|Overall Study|Physician Decision|1|||
145344903|NCT01755091|524109335|FG001|Overall Study|Physician Decision|1|||
145344904|NCT01755091|524109336|FG002|Overall Study|Physician Decision|2|||
145344905|NCT03516513|524109339|FG000|Overall Study|Withdrawal by Subject|2|||
145344906|NCT03516513|524109340|FG001|Overall Study|Withdrawal by Subject|2|||
145344907|NCT03516513|524109341|FG002|Overall Study|Withdrawal by Subject|0|||
145344908|NCT03516513|524109342|FG003|Overall Study|Withdrawal by Subject|0|||
145344909|NCT01885195|524109343|FG000|Overall Study|Adverse Event|29|||
145344910|NCT01885195|524109343|FG000|Overall Study|Death|1|||
145344911|NCT01885195|524109343|FG000|Overall Study|Disease Progression|67|||
145344912|NCT01885195|524109343|FG000|Overall Study|Protocol Deviation|2|||
145344913|NCT01885195|524109343|FG000|Overall Study|Physician Decision|3|||
145344914|NCT01885195|524109343|FG000|Overall Study|Patient/guardian decision|8|||
145344915|NCT03390426|524109344|FG000|Overall Study|Protocol Violation|0|||
145344916|NCT03390426|524109345|FG001|Overall Study|Protocol Violation|1|||
145344917|NCT00307437|524109350|FG000|Controlled Period|Adverse Event|7|||
145344918|NCT00307437|524109351|FG001|Controlled Period|Adverse Event|2|||
145344919|NCT00307437|524109352|FG002|Controlled Period|Adverse Event|5|||
145344920|NCT00307437|524109353|FG003|Controlled Period|Adverse Event|0|||
145344921|NCT00307437|524109354|FG004|Controlled Period|Adverse Event|0|||
145344922|NCT00307437|524109355|FG005|Controlled Period|Adverse Event|0|||
145344923|NCT00307437|524109356|FG006|Controlled Period|Adverse Event|0|||
145344924|NCT00307437|524109350|FG000|Controlled Period|Death|0|||
145344925|NCT00307437|524109351|FG001|Controlled Period|Death|0|||
145344926|NCT00307437|524109352|FG002|Controlled Period|Death|1|||
145344927|NCT00307437|524109353|FG003|Controlled Period|Death|0|||
145344928|NCT00307437|524109354|FG004|Controlled Period|Death|0|||
145344929|NCT00307437|524109355|FG005|Controlled Period|Death|0|||
145344930|NCT00307437|524109356|FG006|Controlled Period|Death|0|||
145344931|NCT00307437|524109350|FG000|Controlled Period|Lack of Efficacy|2|||
145344932|NCT00307437|524109351|FG001|Controlled Period|Lack of Efficacy|0|||
145344933|NCT00307437|524109352|FG002|Controlled Period|Lack of Efficacy|0|||
145344934|NCT00307437|524109353|FG003|Controlled Period|Lack of Efficacy|0|||
145344935|NCT00307437|524109354|FG004|Controlled Period|Lack of Efficacy|0|||
145344936|NCT00307437|524109355|FG005|Controlled Period|Lack of Efficacy|0|||
145344937|NCT00307437|524109356|FG006|Controlled Period|Lack of Efficacy|0|||
145344938|NCT00307437|524109350|FG000|Controlled Period|Lost to Follow-up|2|||
145344939|NCT00307437|524109351|FG001|Controlled Period|Lost to Follow-up|3|||
145344940|NCT00307437|524109352|FG002|Controlled Period|Lost to Follow-up|0|||
145344941|NCT00307437|524109353|FG003|Controlled Period|Lost to Follow-up|0|||
145344942|NCT00307437|524109354|FG004|Controlled Period|Lost to Follow-up|0|||
145344943|NCT00307437|524109355|FG005|Controlled Period|Lost to Follow-up|0|||
145344944|NCT00307437|524109356|FG006|Controlled Period|Lost to Follow-up|0|||
145344945|NCT00307437|524109350|FG000|Controlled Period|Other|5|||
145344946|NCT00307437|524109351|FG001|Controlled Period|Other|1|||
145344947|NCT00307437|524109352|FG002|Controlled Period|Other|3|||
145344948|NCT00307437|524109353|FG003|Controlled Period|Other|0|||
145344949|NCT00307437|524109354|FG004|Controlled Period|Other|0|||
145414139|NCT00552058|524371175|FG000|Overall Study|Other: Early Roll Over|1|||
145576196|NCT02047110|524964293|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
145344950|NCT00307437|524109355|FG005|Controlled Period|Other|0|||
145344951|NCT00307437|524109356|FG006|Controlled Period|Other|0|||
145344952|NCT00307437|524109350|FG000|After Controlled Period|Adverse Event|0|||
145344953|NCT00307437|524109351|FG001|After Controlled Period|Adverse Event|0|||
145344954|NCT00307437|524109352|FG002|After Controlled Period|Adverse Event|0|||
145344955|NCT00307437|524109353|FG003|After Controlled Period|Adverse Event|18|||
145344956|NCT00307437|524109354|FG004|After Controlled Period|Adverse Event|16|||
145344957|NCT00307437|524109355|FG005|After Controlled Period|Adverse Event|31|||
145344958|NCT00307437|524109356|FG006|After Controlled Period|Adverse Event|40|||
145344959|NCT00307437|524109350|FG000|After Controlled Period|Death|0|||
145344960|NCT00307437|524109351|FG001|After Controlled Period|Death|0|||
145344961|NCT00307437|524109352|FG002|After Controlled Period|Death|0|||
145344962|NCT00307437|524109353|FG003|After Controlled Period|Death|3|||
145576197|NCT02047110|524964294|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
145576198|NCT02047110|524964295|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
145576199|NCT02047110|524964292|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
145576200|NCT02047110|524964293|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
145576201|NCT02047110|524964294|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
145576202|NCT02047110|524964295|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
145576203|NCT02047110|524964292|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
145576204|NCT02047110|524964293|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
145576205|NCT02047110|524964294|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
145576206|NCT02047110|524964295|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
145576207|NCT02047110|524964292|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
145576208|NCT02047110|524964293|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
145576209|NCT02047110|524964294|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
145576210|NCT02047110|524964295|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
145576211|NCT02047110|524964292|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
145576212|NCT02047110|524964293|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
145576213|NCT02047110|524964294|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
145576214|NCT02047110|524964295|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
145576215|NCT02047110|524964292|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
145576216|NCT02047110|524964293|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
145576217|NCT02047110|524964294|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
145576218|NCT02047110|524964295|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
145576219|NCT02047110|524964292|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
145576220|NCT02047110|524964293|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
145576221|NCT02047110|524964294|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
145576222|NCT02047110|524964295|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
145576223|NCT02047110|524964292|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
145576224|NCT02047110|524964293|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
145576225|NCT02047110|524964294|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
145576226|NCT02047110|524964295|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
145576227|NCT02047110|524964292|FG000|Escape Treatment Period|Adverse Event|1|||
145576228|NCT02047110|524964293|FG001|Escape Treatment Period|Adverse Event|2|||
145576229|NCT02047110|524964294|FG002|Escape Treatment Period|Adverse Event|2|||
145576230|NCT02047110|524964295|FG003|Escape Treatment Period|Adverse Event|0|||
145576231|NCT02047110|524964292|FG000|Escape Treatment Period|Other than specified|1|||
145576232|NCT02047110|524964293|FG001|Escape Treatment Period|Other than specified|2|||
145576233|NCT02047110|524964294|FG002|Escape Treatment Period|Other than specified|0|||
145576234|NCT02047110|524964295|FG003|Escape Treatment Period|Other than specified|1|||
145576235|NCT02047110|524964292|FG000|OLE Treatment Period|Other than specified|0|||
145576236|NCT02047110|524964293|FG001|OLE Treatment Period|Other than specified|0|||
145576237|NCT02047110|524964294|FG002|OLE Treatment Period|Other than specified|1|||
145576238|NCT02047110|524964295|FG003|OLE Treatment Period|Other than specified|0|||
145576239|NCT01632800|524964298|FG000|Overall Study|Subject did not fit in apparatus|1|||
145576240|NCT01000051|524964299|FG000|Overall Study|Withdrawal by Subject|1|||
145576241|NCT01000051|524964300|FG001|Overall Study|Withdrawal by Subject|1|||
145576242|NCT01000051|524964299|FG000|Overall Study|Disease Progression|1|||
145576243|NCT01000051|524964300|FG001|Overall Study|Disease Progression|0|||
145344963|NCT00307437|524109354|FG004|After Controlled Period|Death|1|||
145344964|NCT00307437|524109355|FG005|After Controlled Period|Death|1|||
145344965|NCT00307437|524109356|FG006|After Controlled Period|Death|3|||
145344966|NCT00307437|524109350|FG000|After Controlled Period|Lack of Efficacy|0|||
145344967|NCT00307437|524109351|FG001|After Controlled Period|Lack of Efficacy|0|||
145344968|NCT00307437|524109352|FG002|After Controlled Period|Lack of Efficacy|0|||
145344969|NCT00307437|524109353|FG003|After Controlled Period|Lack of Efficacy|15|||
145344970|NCT00307437|524109354|FG004|After Controlled Period|Lack of Efficacy|17|||
145344971|NCT00307437|524109355|FG005|After Controlled Period|Lack of Efficacy|37|||
145344972|NCT00307437|524109356|FG006|After Controlled Period|Lack of Efficacy|24|||
145344973|NCT00307437|524109350|FG000|After Controlled Period|Lost to Follow-up|0|||
145344974|NCT00307437|524109351|FG001|After Controlled Period|Lost to Follow-up|0|||
145344975|NCT00307437|524109352|FG002|After Controlled Period|Lost to Follow-up|0|||
145344976|NCT00307437|524109353|FG003|After Controlled Period|Lost to Follow-up|7|||
145344977|NCT00307437|524109354|FG004|After Controlled Period|Lost to Follow-up|12|||
145344978|NCT00307437|524109355|FG005|After Controlled Period|Lost to Follow-up|13|||
145576244|NCT01000051|524964299|FG000|Overall Study|Serious noncompliance|1|||
145576245|NCT01000051|524964300|FG001|Overall Study|Serious noncompliance|0|||
145576246|NCT02247349|524964301|FG000|Overall Study|Disease Progression|7|||
145576247|NCT02247349|524964302|FG001|Overall Study|Disease Progression|4|||
145576248|NCT02247349|524964303|FG002|Overall Study|Disease Progression|26|||
145576249|NCT02247349|524964304|FG003|Overall Study|Disease Progression|31|||
145344979|NCT00307437|524109356|FG006|After Controlled Period|Lost to Follow-up|18|||
145344980|NCT00307437|524109350|FG000|After Controlled Period|Other|0|||
145344981|NCT00307437|524109351|FG001|After Controlled Period|Other|0|||
145576250|NCT02247349|524964305|FG004|Overall Study|Disease Progression|16|||
145576251|NCT02247349|524964306|FG005|Overall Study|Disease Progression|6|||
145576252|NCT02247349|524964301|FG000|Overall Study|Study drug toxicity|0|||
145576253|NCT02247349|524964302|FG001|Overall Study|Study drug toxicity|1|||
145576254|NCT02247349|524964303|FG002|Overall Study|Study drug toxicity|1|||
145576255|NCT02247349|524964304|FG003|Overall Study|Study drug toxicity|1|||
145576256|NCT02247349|524964305|FG004|Overall Study|Study drug toxicity|2|||
145576257|NCT02247349|524964306|FG005|Overall Study|Study drug toxicity|2|||
145576258|NCT02247349|524964301|FG000|Overall Study|Death|0|||
145576259|NCT02247349|524964302|FG001|Overall Study|Death|0|||
145576260|NCT02247349|524964303|FG002|Overall Study|Death|0|||
145576261|NCT02247349|524964304|FG003|Overall Study|Death|1|||
145576262|NCT02247349|524964305|FG004|Overall Study|Death|0|||
145576263|NCT02247349|524964306|FG005|Overall Study|Death|0|||
145576264|NCT02247349|524964301|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
145576265|NCT02247349|524964302|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
145576266|NCT02247349|524964303|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
145576267|NCT02247349|524964304|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
145576268|NCT02247349|524964305|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
145576269|NCT02247349|524964306|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
145576270|NCT02247349|524964301|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145576271|NCT02247349|524964302|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145576272|NCT02247349|524964303|FG002|Overall Study|Participant request to discontinue study treatment|1|||
145576273|NCT02247349|524964304|FG003|Overall Study|Participant request to discontinue study treatment|2|||
145576274|NCT02247349|524964305|FG004|Overall Study|Participant request to discontinue study treatment|1|||
145576275|NCT02247349|524964306|FG005|Overall Study|Participant request to discontinue study treatment|0|||
145576276|NCT02247349|524964301|FG000|Overall Study|Withdrawal by Subject|0|||
145576277|NCT02247349|524964302|FG001|Overall Study|Withdrawal by Subject|1|||
145576278|NCT02247349|524964303|FG002|Overall Study|Withdrawal by Subject|0|||
145576279|NCT02247349|524964304|FG003|Overall Study|Withdrawal by Subject|0|||
145576280|NCT02247349|524964305|FG004|Overall Study|Withdrawal by Subject|0|||
145576281|NCT02247349|524964306|FG005|Overall Study|Withdrawal by Subject|0|||
145576282|NCT02247349|524964301|FG000|Overall Study|Administrative reason by sponsor|0|||
145576283|NCT02247349|524964302|FG001|Overall Study|Administrative reason by sponsor|0|||
145576284|NCT02247349|524964303|FG002|Overall Study|Administrative reason by sponsor|0|||
145576285|NCT02247349|524964304|FG003|Overall Study|Administrative reason by sponsor|0|||
145576286|NCT02247349|524964305|FG004|Overall Study|Administrative reason by sponsor|1|||
145576287|NCT02247349|524964306|FG005|Overall Study|Administrative reason by sponsor|0|||
145576288|NCT02247349|524964301|FG000|Overall Study|Other reasons|0|||
145344982|NCT00307437|524109352|FG002|After Controlled Period|Other|0|||
145344983|NCT00307437|524109353|FG003|After Controlled Period|Other|15|||
145344984|NCT00307437|524109354|FG004|After Controlled Period|Other|9|||
145344985|NCT00307437|524109355|FG005|After Controlled Period|Other|40|||
145344986|NCT00307437|524109356|FG006|After Controlled Period|Other|28|||
145344987|NCT02521376|524109357|FG000|Overall Study|Enrolled, But Not Treated|1|||
145344988|NCT02521376|524109358|FG001|Overall Study|Enrolled, But Not Treated|0|||
145344989|NCT02521376|524109359|FG002|Overall Study|Enrolled, But Not Treated|0|||
145344990|NCT02521376|524109360|FG003|Overall Study|Enrolled, But Not Treated|0|||
145344991|NCT00143247|524109367|FG000|Overall Study|Death|8|||
145576289|NCT02247349|524964302|FG001|Overall Study|Other reasons|0|||
145576290|NCT02247349|524964303|FG002|Overall Study|Other reasons|1|||
145576291|NCT02247349|524964304|FG003|Overall Study|Other reasons|0|||
145576292|NCT02247349|524964305|FG004|Overall Study|Other reasons|0|||
145576293|NCT02247349|524964306|FG005|Overall Study|Other reasons|0|||
145576294|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Adverse Event|41|||
145576295|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Adverse Event|24|||
145576296|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
145576297|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
145576298|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
145576299|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
145576300|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Physician Decision|0|||
145576301|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Physician Decision|6|||
145576302|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
145576303|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
145576304|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
145576305|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
145576306|NCT00673452|524964307|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
145576307|NCT00673452|524964308|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
145344992|NCT00143247|524109367|FG000|Overall Study|Adverse Event|19|||
145344993|NCT00143247|524109367|FG000|Overall Study|Lack of Efficacy|3|||
145344994|NCT00143247|524109367|FG000|Overall Study|Withdrawal by Subject|55|||
145344995|NCT00143247|524109367|FG000|Overall Study|Study terminated by sponsor|31|||
145344996|NCT00143247|524109367|FG000|Overall Study|Protocol Violation|15|||
145344997|NCT00143247|524109367|FG000|Overall Study|Lost to Follow-up|12|||
145576308|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
145576309|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
145576310|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
145576311|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
145576312|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
145576313|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
145576314|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
145576315|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
145576316|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
145576317|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
145576318|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
145576319|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
145576320|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
145576321|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
145576322|NCT00673452|524964307|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
145576323|NCT00673452|524964308|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
145576324|NCT03495908|524964315|FG000|Overall Study|Withdrawal by Subject|3|||
145576325|NCT03495908|524964316|FG001|Overall Study|Withdrawal by Subject|1|||
145576326|NCT03495908|524964315|FG000|Overall Study|Lost to Follow-up|1|||
145576327|NCT03495908|524964316|FG001|Overall Study|Lost to Follow-up|4|||
145576328|NCT03495908|524964315|FG000|Overall Study|Adverse Event|0|||
145576329|NCT03495908|524964316|FG001|Overall Study|Adverse Event|2|||
145576330|NCT03495908|524964315|FG000|Overall Study|Death|1|||
145576331|NCT03495908|524964316|FG001|Overall Study|Death|0|||
145576332|NCT03495908|524964315|FG000|Overall Study|Physician Decision|5|||
145576333|NCT03495908|524964316|FG001|Overall Study|Physician Decision|4|||
145576334|NCT03495908|524964315|FG000|Overall Study|No documented reason|0|||
145576335|NCT03495908|524964316|FG001|Overall Study|No documented reason|2|||
145576336|NCT04936685|524964317|FG000|Overall Study|Protocol Violation|1|||
145576337|NCT04936685|524964318|FG001|Overall Study|Protocol Violation|0|||
145576338|NCT01193556|524964321|FG000|Overall Study|Study termination|26|||
145576339|NCT01193556|524964322|FG001|Overall Study|Study termination|25|||
145576340|NCT00813358|524964334|FG000|Overall Study|Death|32|||
145344998|NCT00143247|524109367|FG000|Overall Study|following inaccurate lab adverse event|1|||
145344999|NCT00143247|524109367|FG000|Overall Study|Other|12|||
145345000|NCT02933255|524109370|FG000|Overall Study|Discontinued due to study closure.|1|||
145345001|NCT02933255|524109371|FG001|Overall Study|Discontinued due to study closure.|0|||
145345002|NCT02766283|524109372|FG000|Overall Study|Lost to Follow-up|27|||
145345003|NCT04380961|524109373|FG000|Overall Study|Lost to Follow-up|17|||
145345004|NCT04380961|524109374|FG001|Overall Study|Lost to Follow-up|11|||
145345005|NCT04380961|524109373|FG000|Overall Study|Withdrawal by Subject|3|||
145345006|NCT04380961|524109374|FG001|Overall Study|Withdrawal by Subject|0|||
145345007|NCT04380961|524109373|FG000|Overall Study|Death|22|||
145345008|NCT04380961|524109374|FG001|Overall Study|Death|16|||
145345009|NCT04380961|524109373|FG000|Overall Study|Other|1|||
145345010|NCT04380961|524109374|FG001|Overall Study|Other|0|||
145345011|NCT04380961|524109373|FG000|Overall Study|Randomized but Not Treated|1|||
145345012|NCT04380961|524109374|FG001|Overall Study|Randomized but Not Treated|2|||
145345013|NCT00805961|524109375|FG000|Modality Therapy|Withdrawal by Subject|1|||
145345014|NCT00805961|524109375|FG000|Modality Therapy|Adverse Event|1|||
145345015|NCT00805961|524109375|FG000|Modality Therapy|Disease Progression|2|||
145345016|NCT00805961|524109375|FG000|Treatment-Free Interval|Adverse Event|3|||
145414140|NCT00552058|524371176|FG001|Overall Study|Other: Early Roll Over|0|||
145414141|NCT03520569|524371177|FG000|Overall Study|Withdrawal by Subject|1|||
145576341|NCT00813358|524964334|FG000|Overall Study|Lost to Follow-up|12|||
145576342|NCT00813358|524964334|FG000|Overall Study|other endpoints|5|||
145576343|NCT00813358|524964334|FG000|Overall Study|Withdrawal by Subject|20|||
145576344|NCT02920983|524964335|FG000|Dispense 1|Unacceptable Lens Fit|0|||
145576345|NCT02920983|524964336|FG001|Dispense 1|Unacceptable Lens Fit|0|||
145576346|NCT02920983|524964337|FG002|Dispense 1|Unacceptable Lens Fit|0|||
145576347|NCT02920983|524964338|FG003|Dispense 1|Unacceptable Lens Fit|0|||
145576348|NCT02920983|524964339|FG004|Dispense 1|Unacceptable Lens Fit|1|||
145576349|NCT02920983|524964340|FG005|Dispense 1|Unacceptable Lens Fit|0|||
145576350|NCT02920983|524964335|FG000|Dispense 2|Unscceptable lens fit|1|||
145576351|NCT02920983|524964336|FG001|Dispense 2|Unscceptable lens fit|0|||
145345017|NCT00805961|524109375|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
145345018|NCT00805961|524109375|FG000|Treatment-Free Interval|Physician Decision|1|||
145345019|NCT00805961|524109375|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
145345020|NCT00805961|524109375|FG000|Maintenance Treatment|Lack of Efficacy|13|||
145345021|NCT00805961|524109375|FG000|Maintenance Treatment|Intercurrent Illness|7|||
145576352|NCT02920983|524964337|FG002|Dispense 2|Unscceptable lens fit|0|||
145576353|NCT02920983|524964338|FG003|Dispense 2|Unscceptable lens fit|0|||
145576354|NCT02920983|524964339|FG004|Dispense 2|Unscceptable lens fit|1|||
145345022|NCT00805961|524109375|FG000|Maintenance Treatment|Adverse Event|6|||
145345023|NCT00805961|524109375|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
145414142|NCT02965716|524371179|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145576355|NCT02920983|524964340|FG005|Dispense 2|Unscceptable lens fit|0|||
145576356|NCT02920983|524964335|FG000|Dispense 3|Unacceptable Lens Fit|1|||
145576357|NCT02920983|524964336|FG001|Dispense 3|Unacceptable Lens Fit|1|||
145576358|NCT02920983|524964337|FG002|Dispense 3|Unacceptable Lens Fit|0|||
145576359|NCT02920983|524964338|FG003|Dispense 3|Unacceptable Lens Fit|0|||
145576360|NCT02920983|524964339|FG004|Dispense 3|Unacceptable Lens Fit|1|||
145576361|NCT02920983|524964340|FG005|Dispense 3|Unacceptable Lens Fit|0|||
145576362|NCT03665038|524964342|FG000|Overall Study|Lost to Follow-up|0|||
145576363|NCT03665038|524964343|FG001|Overall Study|Lost to Follow-up|0|||
145576364|NCT03665038|524964344|FG002|Overall Study|Lost to Follow-up|1|||
145576365|NCT03551210|524964345|FG000|Overall Study|Adverse Event|5|||
145576366|NCT03551210|524964346|FG001|Overall Study|Adverse Event|6|||
145576367|NCT03551210|524964345|FG000|Overall Study|Withdrawal by Subject|1|||
145576368|NCT03551210|524964346|FG001|Overall Study|Withdrawal by Subject|7|||
145576369|NCT03551210|524964345|FG000|Overall Study|Needed in other antibiotic treatment|2|||
145576370|NCT03551210|524964346|FG001|Overall Study|Needed in other antibiotic treatment|5|||
145576371|NCT03551210|524964345|FG000|Overall Study|Lost to Follow-up|1|||
145576372|NCT03551210|524964346|FG001|Overall Study|Lost to Follow-up|1|||
145576373|NCT03551210|524964345|FG000|Overall Study|Absence of visit 4 and 5|1|||
145576374|NCT03551210|524964346|FG001|Overall Study|Absence of visit 4 and 5|0|||
145576375|NCT03551210|524964345|FG000|Overall Study|No drug for dispensing|0|||
145576376|NCT03551210|524964346|FG001|Overall Study|No drug for dispensing|1|||
145576377|NCT03265119|524964347|FG000|Overall Study|Adverse Event|2|||
145576378|NCT03265119|524964348|FG001|Overall Study|Adverse Event|1|||
145576379|NCT03265119|524964347|FG000|Overall Study|Lack of Efficacy|3|||
145576380|NCT03265119|524964348|FG001|Overall Study|Lack of Efficacy|0|||
145576381|NCT03265119|524964347|FG000|Overall Study|Protocol Violation|1|||
145576382|NCT03265119|524964348|FG001|Overall Study|Protocol Violation|2|||
145576383|NCT03265119|524964347|FG000|Overall Study|Withdrawal by Subject|2|||
145576384|NCT03265119|524964348|FG001|Overall Study|Withdrawal by Subject|4|||
145576385|NCT03265119|524964347|FG000|Overall Study|Lost to Follow-up|1|||
145576386|NCT03265119|524964348|FG001|Overall Study|Lost to Follow-up|0|||
145576387|NCT03265119|524964347|FG000|Overall Study|Lack of Compliance|1|||
145576388|NCT03265119|524964348|FG001|Overall Study|Lack of Compliance|0|||
145576389|NCT03890367|524964354|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145576390|NCT03890367|524964355|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145576391|NCT03890367|524964356|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145576392|NCT03890367|524964354|FG000|Overall Study|Protocol deviation|2|||
145576393|NCT03890367|524964355|FG001|Overall Study|Protocol deviation|2|||
145576394|NCT03890367|524964356|FG002|Overall Study|Protocol deviation|1|||
145576395|NCT03890367|524964354|FG000|Overall Study|Lost to Follow-up|1|||
145576396|NCT03890367|524964355|FG001|Overall Study|Lost to Follow-up|1|||
145576397|NCT03890367|524964356|FG002|Overall Study|Lost to Follow-up|0|||
145576398|NCT00646958|524965839|FG000|Overall Study|Lack of Efficacy|1|||
145576399|NCT00646958|524965840|FG001|Overall Study|Lack of Efficacy|0|||
145576400|NCT00646958|524965841|FG002|Overall Study|Lack of Efficacy|0|||
145576401|NCT00646958|524965839|FG000|Overall Study|Adverse Event|4|||
145622860|NCT01723826|525130203|FG000|Overall Study|Non-compliance With Study Drug|0|||
145345024|NCT00805961|524109375|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
145345025|NCT00805961|524109375|FG000|Maintenance Treatment|Withdrawn Consent|1|||
145345026|NCT04803305|524109376|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
145345027|NCT04803305|524109377|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
145345028|NCT04803305|524109376|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
145345029|NCT04803305|524109377|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
145345030|NCT04803305|524109376|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
145345031|NCT04803305|524109377|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
145345032|NCT04803305|524109376|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
145345033|NCT04803305|524109377|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
145345034|NCT04803305|524109376|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
145345035|NCT04803305|524109377|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
145345036|NCT04803305|524109376|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
145345037|NCT04803305|524109377|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
145345038|NCT04803305|524109376|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
145345039|NCT04803305|524109377|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
145345040|NCT04803305|524109376|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
145345041|NCT04803305|524109377|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
145345042|NCT03922529|524111360|FG000|Overall Study|Withdrawal by Subject|13|||
145345043|NCT03922529|524111361|FG001|Overall Study|Withdrawal by Subject|12|||
145345044|NCT03922529|524111360|FG000|Overall Study|Death|7|||
145576402|NCT00646958|524965840|FG001|Overall Study|Adverse Event|0|||
145576403|NCT00646958|524965841|FG002|Overall Study|Adverse Event|0|||
145576404|NCT00646958|524965839|FG000|Overall Study|Lost to Follow-up|1|||
145576405|NCT00646958|524965840|FG001|Overall Study|Lost to Follow-up|5|||
145576406|NCT00646958|524965841|FG002|Overall Study|Lost to Follow-up|7|||
145576407|NCT00646958|524965839|FG000|Overall Study|Protocol Violation|1|||
145345045|NCT03922529|524111361|FG001|Overall Study|Death|12|||
145345046|NCT03922529|524111360|FG000|Overall Study|Lost to Follow-up|12|||
145345047|NCT03922529|524111361|FG001|Overall Study|Lost to Follow-up|19|||
145345048|NCT03922529|524111360|FG000|Overall Study|Adverse Event|1|||
145345049|NCT03922529|524111361|FG001|Overall Study|Adverse Event|0|||
145345050|NCT03922529|524111360|FG000|Overall Study|Death after withdrawal|1|||
145345051|NCT03922529|524111361|FG001|Overall Study|Death after withdrawal|0|||
145345052|NCT03922529|524111360|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
145345053|NCT03922529|524111361|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
145345054|NCT03922529|524111360|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
145576408|NCT00646958|524965840|FG001|Overall Study|Protocol Violation|1|||
145576409|NCT00646958|524965841|FG002|Overall Study|Protocol Violation|0|||
145576410|NCT00646958|524965839|FG000|Overall Study|Abnormal screening lab tests|1|||
145576411|NCT00646958|524965840|FG001|Overall Study|Abnormal screening lab tests|1|||
145345055|NCT03922529|524111361|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
145345056|NCT02017015|524111362|FG000|Overall Study|Adverse Event|9|||
145345057|NCT02017015|524111362|FG000|Overall Study|Withdrawal by Subject|21|||
145345058|NCT02017015|524111362|FG000|Overall Study|Death|4|||
145345059|NCT02017015|524111362|FG000|Overall Study|Progressive Disease|31|||
145345060|NCT02017015|524111362|FG000|Overall Study|Non-compliance with study drug|2|||
145345061|NCT02017015|524111362|FG000|Overall Study|Physician Decision|2|||
145345062|NCT01277601|524111365|FG000|Overall Study|Adverse Event|5|||
145345063|NCT01277601|524111366|FG001|Overall Study|Adverse Event|3|||
145345064|NCT01277601|524111367|FG002|Overall Study|Adverse Event|0|||
145345065|NCT01277601|524111368|FG003|Overall Study|Adverse Event|7|||
145345066|NCT01277601|524111365|FG000|Overall Study|Withdrawal by Subject|18|||
145345067|NCT01277601|524111366|FG001|Overall Study|Withdrawal by Subject|21|||
145345068|NCT01277601|524111367|FG002|Overall Study|Withdrawal by Subject|8|||
145345069|NCT01277601|524111368|FG003|Overall Study|Withdrawal by Subject|17|||
145345070|NCT01277601|524111365|FG000|Overall Study|Lost to Follow-up|7|||
145345071|NCT01277601|524111366|FG001|Overall Study|Lost to Follow-up|9|||
145345072|NCT01277601|524111367|FG002|Overall Study|Lost to Follow-up|4|||
145345073|NCT01277601|524111368|FG003|Overall Study|Lost to Follow-up|2|||
145345074|NCT01277601|524111365|FG000|Overall Study|Physician Decision|3|||
145345075|NCT01277601|524111366|FG001|Overall Study|Physician Decision|5|||
145345076|NCT01277601|524111367|FG002|Overall Study|Physician Decision|1|||
145345077|NCT01277601|524111368|FG003|Overall Study|Physician Decision|6|||
145345078|NCT01277601|524111365|FG000|Overall Study|Pregnancy|2|||
145345079|NCT01277601|524111366|FG001|Overall Study|Pregnancy|2|||
145345080|NCT01277601|524111367|FG002|Overall Study|Pregnancy|4|||
145345081|NCT01277601|524111368|FG003|Overall Study|Pregnancy|1|||
145345082|NCT01277601|524111365|FG000|Overall Study|Noncompliance with Study Drug|1|||
145345083|NCT01277601|524111366|FG001|Overall Study|Noncompliance with Study Drug|3|||
145345084|NCT01277601|524111367|FG002|Overall Study|Noncompliance with Study Drug|2|||
145345085|NCT01277601|524111368|FG003|Overall Study|Noncompliance with Study Drug|0|||
145345086|NCT01277601|524111365|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
145345087|NCT01277601|524111366|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
145345088|NCT01277601|524111367|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
145345089|NCT01277601|524111368|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
145345090|NCT01277601|524111365|FG000|Overall Study|Protocol Violation|0|||
145345091|NCT01277601|524111366|FG001|Overall Study|Protocol Violation|2|||
145345092|NCT01277601|524111367|FG002|Overall Study|Protocol Violation|5|||
145345093|NCT01277601|524111368|FG003|Overall Study|Protocol Violation|0|||
145345094|NCT01277601|524111365|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
145345095|NCT01277601|524111366|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
145345096|NCT01277601|524111367|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
145345097|NCT01277601|524111368|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
145345098|NCT04034927|524111369|FG000|Overall Study|Adverse Event|4|||
145345099|NCT04034927|524111370|FG001|Overall Study|Adverse Event|9|||
145345100|NCT04034927|524111369|FG000|Overall Study|Death|0|||
145345101|NCT04034927|524111370|FG001|Overall Study|Death|1|||
145345102|NCT04034927|524111369|FG000|Overall Study|Withdrawal by Subject|0|||
145576412|NCT00646958|524965841|FG002|Overall Study|Abnormal screening lab tests|0|||
145576413|NCT00646958|524965839|FG000|Overall Study|Withdrawal by Subject|1|||
145576414|NCT00646958|524965840|FG001|Overall Study|Withdrawal by Subject|2|||
145345103|NCT04034927|524111370|FG001|Overall Study|Withdrawal by Subject|3|||
145345104|NCT04034927|524111369|FG000|Overall Study|Still on Treatment|2|||
145345105|NCT04034927|524111370|FG001|Overall Study|Still on Treatment|1|||
145345106|NCT04034927|524111369|FG000|Overall Study|Other|1|||
145345107|NCT04034927|524111370|FG001|Overall Study|Other|1|||
145345108|NCT04158245|524111371|FG000|Overall Study|Lost to Follow-up|1|||
145345109|NCT02291510|524111372|FG000|Overall Study|Adverse Event|0|||
145345110|NCT02291510|524111373|FG001|Overall Study|Adverse Event|0|||
145345111|NCT02291510|524111374|FG002|Overall Study|Adverse Event|0|||
145345112|NCT02291510|524111375|FG003|Overall Study|Adverse Event|1|||
145345113|NCT01433055|524111379|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
145345114|NCT01433055|524111380|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
145345115|NCT01433055|524111379|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
145345116|NCT01433055|524111380|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
145345117|NCT02465398|524111385|FG000|Overall Study|Death|7|||
145345118|NCT02465398|524111385|FG000|Overall Study|Revision|7|||
145345119|NCT02465398|524111385|FG000|Overall Study|did not receive study device|1|||
145345120|NCT02465398|524111385|FG000|Overall Study|Withdrawal by Subject|1|||
145345121|NCT02465398|524111385|FG000|Overall Study|Lost to Follow-up|14|||
145345122|NCT00678210|524111386|FG000|Overall Study|Adverse Event|1|||
145345123|NCT00678210|524111387|FG001|Overall Study|Adverse Event|2|||
145345124|NCT00678210|524111388|FG002|Overall Study|Adverse Event|3|||
145345125|NCT00678210|524111389|FG003|Overall Study|Adverse Event|3|||
145345126|NCT00678210|524111386|FG000|Overall Study|Lack of Efficacy|2|||
145345127|NCT00678210|524111387|FG001|Overall Study|Lack of Efficacy|3|||
145345128|NCT00678210|524111388|FG002|Overall Study|Lack of Efficacy|1|||
145345129|NCT00678210|524111389|FG003|Overall Study|Lack of Efficacy|9|||
145345130|NCT00678210|524111386|FG000|Overall Study|Lost to Follow-up|4|||
145345131|NCT00678210|524111387|FG001|Overall Study|Lost to Follow-up|2|||
145345132|NCT00678210|524111388|FG002|Overall Study|Lost to Follow-up|0|||
145345133|NCT00678210|524111389|FG003|Overall Study|Lost to Follow-up|1|||
145345134|NCT00678210|524111386|FG000|Overall Study|Withdrawal by Subject|3|||
145345135|NCT00678210|524111387|FG001|Overall Study|Withdrawal by Subject|4|||
145345136|NCT00678210|524111388|FG002|Overall Study|Withdrawal by Subject|1|||
145345137|NCT00678210|524111389|FG003|Overall Study|Withdrawal by Subject|7|||
145345138|NCT00678210|524111386|FG000|Overall Study|Other|1|||
145345139|NCT00678210|524111387|FG001|Overall Study|Other|0|||
145345140|NCT00678210|524111388|FG002|Overall Study|Other|1|||
145345141|NCT00678210|524111389|FG003|Overall Study|Other|0|||
145345142|NCT03965689|524111390|FG000|Overall Study|Too sick to get study intervention|2|||
145345143|NCT01383707|524111393|FG000|Overall Study|Consent withdrawal|6|||
145345144|NCT01383707|524111393|FG000|Overall Study|Death|19|||
145345145|NCT01383707|524111393|FG000|Overall Study|Other|8|||
145345146|NCT01383707|524111393|FG000|Overall Study|Sponsor's decision|2|||
145345147|NCT01383707|524111393|FG000|Overall Study|Adverse Event|14|||
145345148|NCT01383707|524111393|FG000|Overall Study|Progressive disease|23|||
145345149|NCT02437903|524111396|FG000|Overall Study|Adverse Event|1|||
145345150|NCT02437903|524111396|FG000|Overall Study|Withdrawal by Subject|1|||
145345151|NCT02437903|524111396|FG000|Overall Study|Lost to Follow-up|3|||
145345152|NCT01121562|524111399|FG000|Overall Study|Objective progression or relapse|8|||
145345153|NCT01121562|524111399|FG000|Overall Study|Withdrawal by Subject|1|||
145345154|NCT01121562|524111399|FG000|Overall Study|Adverse Event|1|||
145345155|NCT01121562|524111399|FG000|Overall Study|Sponsor Decision|1|||
145345156|NCT01121562|524111399|FG000|Overall Study|Met study discontinuation criteria|1|||
145345157|NCT00616421|524111400|FG000|Overall Study|Withdrawal by Subject|9|||
145345158|NCT00616421|524111401|FG001|Overall Study|Withdrawal by Subject|11|||
145345159|NCT00616421|524111402|FG002|Overall Study|Withdrawal by Subject|8|||
145345160|NCT00616421|524111400|FG000|Overall Study|Lost to Follow-up|12|||
145345161|NCT00616421|524111401|FG001|Overall Study|Lost to Follow-up|26|||
145345162|NCT00616421|524111402|FG002|Overall Study|Lost to Follow-up|30|||
145345163|NCT00616421|524111400|FG000|Overall Study|Inappropriate enrollment|3|||
145345164|NCT00616421|524111401|FG001|Overall Study|Inappropriate enrollment|0|||
145345165|NCT00616421|524111402|FG002|Overall Study|Inappropriate enrollment|1|||
145345166|NCT00616421|524111400|FG000|Overall Study|Administrative reason|1|||
145345167|NCT00616421|524111401|FG001|Overall Study|Administrative reason|0|||
145345168|NCT00616421|524111402|FG002|Overall Study|Administrative reason|0|||
145345169|NCT00616421|524111400|FG000|Overall Study|Protocol Violation|0|||
145345170|NCT00616421|524111401|FG001|Overall Study|Protocol Violation|1|||
145345171|NCT00616421|524111402|FG002|Overall Study|Protocol Violation|2|||
145345172|NCT00616421|524111400|FG000|Overall Study|Unable to classify|1|||
145345173|NCT00616421|524111401|FG001|Overall Study|Unable to classify|0|||
145345174|NCT00616421|524111402|FG002|Overall Study|Unable to classify|0|||
145345175|NCT01427608|524111403|FG000|Overall Study|Death|1|||
145345176|NCT01427608|524111404|FG001|Overall Study|Death|0|||
145345177|NCT01427608|524111403|FG000|Overall Study|Withdrawal by Subject|7|||
145345178|NCT01427608|524111404|FG001|Overall Study|Withdrawal by Subject|3|||
145345179|NCT01427608|524111403|FG000|Overall Study|Relapsed-all cause|13|||
145345180|NCT01427608|524111404|FG001|Overall Study|Relapsed-all cause|34|||
145345181|NCT01427608|524111403|FG000|Overall Study|Events not attributed to study meds|0|||
145345182|NCT01427608|524111404|FG001|Overall Study|Events not attributed to study meds|1|||
145345183|NCT04071405|524111405|FG000|Overall Study|Protocol Violation|3|||
145345184|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
145345185|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
145345186|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
145345187|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
145345188|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
145345189|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
145345190|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
145345191|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
145345192|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
145345193|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
145345194|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
145345195|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
145345196|NCT02422797|524111406|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
145345197|NCT02422797|524111407|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
145345198|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
145345199|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
145345200|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
145345201|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
145345202|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
145345203|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
145345204|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
145345205|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
145345206|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
145345207|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
145345208|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
145345209|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
145345210|NCT02422797|524111406|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
145345211|NCT02422797|524111407|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
145345212|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
145345213|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
145345214|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
145345215|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
145345216|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
145345217|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
145345218|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
145345219|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
145345220|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
145345221|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
145345222|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
145345223|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
145345224|NCT02422797|524111406|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
145345225|NCT02422797|524111407|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
145345226|NCT05445492|524111410|FG000|Overall Study|Physician Decision|1|||
145345227|NCT04289363|524111414|FG000|Overall Study|Lost to Follow-up|14|||
145345228|NCT04289363|524111415|FG001|Overall Study|Lost to Follow-up|0|||
145345229|NCT03790657|524111416|FG000|Overall Study|Adverse Event|1|||
145345230|NCT03790657|524111417|FG001|Overall Study|Adverse Event|1|||
145345231|NCT03790657|524111416|FG000|Overall Study|Withdrawal by Subject|1|||
145345232|NCT03790657|524111417|FG001|Overall Study|Withdrawal by Subject|1|||
145345233|NCT03126435|524111418|FG000|Overall Study|Death|90|||
145345234|NCT03126435|524111419|FG001|Overall Study|Death|84|||
145345235|NCT03126435|524111418|FG000|Overall Study|Lost to Follow-up|4|||
145345236|NCT03126435|524111419|FG001|Overall Study|Lost to Follow-up|3|||
145345237|NCT03126435|524111418|FG000|Overall Study|Physician Decision|0|||
145345238|NCT03126435|524111419|FG001|Overall Study|Physician Decision|1|||
145345239|NCT03126435|524111418|FG000|Overall Study|Withdrawal by Subject|6|||
145345240|NCT03126435|524111419|FG001|Overall Study|Withdrawal by Subject|12|||
145345241|NCT03126435|524111418|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
145345242|NCT03126435|524111419|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
145345243|NCT03971474|524111420|FG000|Overall Study|Adverse Event|11|||
145345244|NCT03971474|524111421|FG001|Overall Study|Adverse Event|7|||
145345245|NCT03971474|524111420|FG000|Overall Study|Refusal unrelated to adverse event|5|||
145345246|NCT03971474|524111421|FG001|Overall Study|Refusal unrelated to adverse event|1|||
145345247|NCT03971474|524111420|FG000|Overall Study|Progression/relapse|40|||
145345248|NCT03971474|524111421|FG001|Overall Study|Progression/relapse|47|||
145345249|NCT03971474|524111420|FG000|Overall Study|Death|6|||
145345250|NCT03971474|524111421|FG001|Overall Study|Death|3|||
145345251|NCT03971474|524111420|FG000|Overall Study|Other - not protocol specified|5|||
145345252|NCT03971474|524111421|FG001|Overall Study|Other - not protocol specified|4|||
145345253|NCT03971474|524111420|FG000|Overall Study|On treatment|0|||
145345254|NCT03971474|524111421|FG001|Overall Study|On treatment|7|||
145345255|NCT01807065|524111422|FG000|Overall Study|Receive no sip-T due to IV access|1|||
145345256|NCT01807065|524111423|FG001|Overall Study|Receive no sip-T due to IV access|1|||
145345257|NCT01699815|524111425|FG000|Overall Study|Protocol Violation|4|||
145345258|NCT01699815|524111426|FG001|Overall Study|Protocol Violation|7|||
145345259|NCT01699815|524111425|FG000|Overall Study|record could not be located|1|||
145345260|NCT01699815|524111426|FG001|Overall Study|record could not be located|0|||
145576415|NCT00646958|524965841|FG002|Overall Study|Withdrawal by Subject|0|||
145345261|NCT01699815|524111425|FG000|Overall Study|Adverse Event|0|||
145345262|NCT01699815|524111426|FG001|Overall Study|Adverse Event|1|||
145345263|NCT01295320|524111427|FG000|Overall Study|Adverse Event|2|||
145345264|NCT01295320|524111427|FG000|Overall Study|Lost to Follow-up|4|||
145345265|NCT01295320|524111427|FG000|Overall Study|Withdrawal by Subject|2|||
145345266|NCT01295320|524111427|FG000|Overall Study|Subject was bedridden|1|||
145345267|NCT01295320|524111427|FG000|Overall Study|Unable to travel|1|||
145345268|NCT00699816|524111428|FG000|Overall Study|Protocol Violation|1|||
145345269|NCT00699816|524111429|FG001|Overall Study|Protocol Violation|3|||
145345270|NCT01569295|524111430|FG000|Overall Study|Progressive Disease|75|||
145345271|NCT01569295|524111431|FG001|Overall Study|Progressive Disease|139|||
145345272|NCT01569295|524111430|FG000|Overall Study|Adverse Event|39|||
145345273|NCT01569295|524111431|FG001|Overall Study|Adverse Event|14|||
145345274|NCT01569295|524111430|FG000|Overall Study|Withdrawal by Subject|25|||
145345275|NCT01569295|524111431|FG001|Overall Study|Withdrawal by Subject|12|||
145345276|NCT01569295|524111430|FG000|Overall Study|Death|19|||
145345277|NCT01569295|524111431|FG001|Overall Study|Death|15|||
145345278|NCT01569295|524111430|FG000|Overall Study|Physician Decision|13|||
145345279|NCT01569295|524111431|FG001|Overall Study|Physician Decision|18|||
145345280|NCT01569295|524111430|FG000|Overall Study|Study Terminated by Sponsor|24|||
145345281|NCT01569295|524111431|FG001|Overall Study|Study Terminated by Sponsor|2|||
145345282|NCT01569295|524111430|FG000|Overall Study|Other Reason not Specified|3|||
145345283|NCT01569295|524111431|FG001|Overall Study|Other Reason not Specified|5|||
145345284|NCT01569295|524111430|FG000|Overall Study|Non-Compliance with Study Drug|6|||
145345285|NCT01569295|524111431|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145345286|NCT01569295|524111430|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
145345287|NCT01569295|524111431|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
145345288|NCT01569295|524111430|FG000|Overall Study|Lost to Follow-up|1|||
145345289|NCT01569295|524111431|FG001|Overall Study|Lost to Follow-up|1|||
145345290|NCT02125877|524111432|FG000|Overall Study|Physician Decision|1|||
145345291|NCT02125877|524111433|FG001|Overall Study|Physician Decision|0|||
145345292|NCT02125877|524111432|FG000|Overall Study|Death|0|||
145345293|NCT02125877|524111433|FG001|Overall Study|Death|1|||
145345294|NCT02125877|524111432|FG000|Overall Study|Administrative problems|0|||
145345295|NCT02125877|524111433|FG001|Overall Study|Administrative problems|1|||
145345296|NCT02125877|524111432|FG000|Overall Study|Participant/guardian decision|0|||
145345297|NCT02125877|524111433|FG001|Overall Study|Participant/guardian decision|2|||
145345298|NCT02125877|524111432|FG000|Overall Study|Withdrawal by Subject|2|||
145345299|NCT02125877|524111433|FG001|Overall Study|Withdrawal by Subject|1|||
145345300|NCT02125877|524111432|FG000|Overall Study|Protocol deviation|4|||
145345301|NCT02125877|524111433|FG001|Overall Study|Protocol deviation|1|||
145345302|NCT02125877|524111432|FG000|Overall Study|Adverse Event|6|||
145345303|NCT02125877|524111433|FG001|Overall Study|Adverse Event|4|||
145345304|NCT01973595|524111434|FG000|Washout|Withdrawal by Subject|1|||
145345305|NCT01973595|524111435|FG001|Washout|Withdrawal by Subject|0|||
145345306|NCT01973595|524111436|FG002|Washout|Withdrawal by Subject|1|||
145345307|NCT01973595|524111437|FG003|Washout|Withdrawal by Subject|0|||
145345308|NCT02508935|524111438|FG000|Overall Study|Withdrawal by Subject|1|||
145345309|NCT02508935|524111438|FG000|Overall Study|Withdrawal by Caregiver|8|||
145345310|NCT02508935|524111438|FG000|Overall Study|Pain Score <4|1|||
145345311|NCT02508935|524111438|FG000|Overall Study|Emesis|3|||
145345312|NCT02508935|524111438|FG000|Overall Study|Adverse Event|3|||
145345313|NCT02508935|524111438|FG000|Overall Study|Protocol Violation|1|||
145345314|NCT02508935|524111438|FG000|Overall Study|Physician Decision|1|||
145345315|NCT02508935|524111438|FG000|Overall Study|Trial terminated by sponsor|5|||
145345316|NCT02800642|524111447|FG000|Overall Study|Death|3|||
145345317|NCT02800642|524111447|FG000|Overall Study|Other|10|||
145345318|NCT02800642|524111447|FG000|Overall Study|Physician Decision|2|||
145345319|NCT02800642|524111447|FG000|Overall Study|Adverse Event|6|||
145576416|NCT00646958|524965839|FG000|Overall Study|Did not receive study drug|2|||
145576417|NCT00646958|524965840|FG001|Overall Study|Did not receive study drug|0|||
145345320|NCT02800642|524111447|FG000|Overall Study|Withdrawal by Subject|3|||
145345321|NCT02800642|524111447|FG000|Overall Study|Lost to Follow-up|1|||
145345322|NCT04868500|524111448|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
145345323|NCT04868500|524111449|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
145345324|NCT04868500|524111448|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
145576418|NCT00646958|524965841|FG002|Overall Study|Did not receive study drug|2|||
145345325|NCT04868500|524111449|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
145345326|NCT01941498|524111453|FG000|Overall Study|Relocated out of state|1|||
145345327|NCT05299528|524111456|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145345328|NCT05299528|524111457|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
145345329|NCT05299528|524111458|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145345330|NCT05299528|524111459|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145345331|NCT05299528|524111460|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145414143|NCT02965716|524371180|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
145414144|NCT02965716|524371179|FG000|Overall Study|Progression/Relapse|8|||
145414145|NCT02965716|524371180|FG001|Overall Study|Progression/Relapse|16|||
145414146|NCT02965716|524371179|FG000|Overall Study|Death|1|||
145414147|NCT02965716|524371180|FG001|Overall Study|Death|0|||
145414148|NCT02965716|524371179|FG000|Overall Study|Not Protocol Specified|1|||
145414149|NCT02965716|524371180|FG001|Overall Study|Not Protocol Specified|3|||
145414150|NCT05558410|524371181|FG000|Overall Study|Adverse Event|1|||
145414151|NCT05558410|524371182|FG001|Overall Study|Adverse Event|2|||
145414152|NCT05558410|524371183|FG002|Overall Study|Adverse Event|0|||
145414153|NCT05558410|524371181|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
145414154|NCT05558410|524371182|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
145414155|NCT05558410|524371183|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
145414156|NCT05558410|524371181|FG000|Overall Study|Lost to Follow-up|10|||
145414157|NCT05558410|524371182|FG001|Overall Study|Lost to Follow-up|17|||
145414158|NCT05558410|524371183|FG002|Overall Study|Lost to Follow-up|19|||
145414159|NCT05558410|524371181|FG000|Overall Study|Death|1|||
145414160|NCT05558410|524371182|FG001|Overall Study|Death|0|||
145414161|NCT05558410|524371183|FG002|Overall Study|Death|0|||
145414162|NCT05558410|524371181|FG000|Overall Study|Other non-compliance|0|||
145414163|NCT05558410|524371182|FG001|Overall Study|Other non-compliance|1|||
145414164|NCT05558410|524371183|FG002|Overall Study|Other non-compliance|2|||
145414165|NCT05558410|524371181|FG000|Overall Study|Sponsor Decision|1|||
145414166|NCT05558410|524371182|FG001|Overall Study|Sponsor Decision|0|||
145414167|NCT05558410|524371183|FG002|Overall Study|Sponsor Decision|0|||
145414168|NCT05558410|524371181|FG000|Overall Study|Other|1|||
145414169|NCT05558410|524371182|FG001|Overall Study|Other|0|||
145414170|NCT05558410|524371183|FG002|Overall Study|Other|1|||
145414171|NCT02265744|524371186|FG000|Overall Study|Poor/Non-compliance|1|||
145414172|NCT02265744|524371187|FG001|Overall Study|Poor/Non-compliance|1|||
145414173|NCT02265744|524371188|FG002|Overall Study|Poor/Non-compliance|0|||
145414174|NCT02265744|524371189|FG003|Overall Study|Poor/Non-compliance|0|||
145414175|NCT02265744|524371190|FG004|Overall Study|Poor/Non-compliance|2|||
145414176|NCT02265744|524371186|FG000|Overall Study|Lost to Follow-up|0|||
145414177|NCT02265744|524371187|FG001|Overall Study|Lost to Follow-up|0|||
145414178|NCT02265744|524371188|FG002|Overall Study|Lost to Follow-up|0|||
145414179|NCT02265744|524371189|FG003|Overall Study|Lost to Follow-up|1|||
145345332|NCT05299528|524111461|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145345333|NCT05299528|524111462|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
145345334|NCT05299528|524111456|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145345335|NCT05299528|524111457|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145345336|NCT05299528|524111458|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145345337|NCT05299528|524111459|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145345338|NCT05299528|524111460|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145414180|NCT02265744|524371190|FG004|Overall Study|Lost to Follow-up|0|||
145414181|NCT02265744|524371186|FG000|Overall Study|Death|0|||
145414182|NCT02265744|524371187|FG001|Overall Study|Death|0|||
145414183|NCT02265744|524371188|FG002|Overall Study|Death|0|||
145414184|NCT02265744|524371189|FG003|Overall Study|Death|2|||
145414185|NCT02265744|524371190|FG004|Overall Study|Death|0|||
145414186|NCT02265744|524371186|FG000|Overall Study|Withdrawal by Subject|2|||
145414187|NCT02265744|524371187|FG001|Overall Study|Withdrawal by Subject|0|||
145414188|NCT02265744|524371188|FG002|Overall Study|Withdrawal by Subject|0|||
145414189|NCT02265744|524371189|FG003|Overall Study|Withdrawal by Subject|2|||
145414190|NCT02265744|524371190|FG004|Overall Study|Withdrawal by Subject|0|||
145414191|NCT02265744|524371186|FG000|Overall Study|Participant request to discontinue|2|||
145414192|NCT02265744|524371187|FG001|Overall Study|Participant request to discontinue|2|||
145414193|NCT02265744|524371188|FG002|Overall Study|Participant request to discontinue|2|||
145414194|NCT02265744|524371189|FG003|Overall Study|Participant request to discontinue|0|||
145414195|NCT02265744|524371190|FG004|Overall Study|Participant request to discontinue|0|||
145414196|NCT02265744|524371186|FG000|Overall Study|Adverse Event|8|||
145414197|NCT02265744|524371187|FG001|Overall Study|Adverse Event|4|||
145414198|NCT02265744|524371188|FG002|Overall Study|Adverse Event|9|||
145414199|NCT02265744|524371189|FG003|Overall Study|Adverse Event|8|||
145414200|NCT02265744|524371190|FG004|Overall Study|Adverse Event|2|||
145414201|NCT02265744|524371186|FG000|Overall Study|Lack of Efficacy|2|||
145414202|NCT02265744|524371187|FG001|Overall Study|Lack of Efficacy|4|||
145414203|NCT02265744|524371188|FG002|Overall Study|Lack of Efficacy|3|||
145414204|NCT02265744|524371189|FG003|Overall Study|Lack of Efficacy|4|||
145414205|NCT02265744|524371190|FG004|Overall Study|Lack of Efficacy|5|||
145414206|NCT02265744|524371186|FG000|Overall Study|Reason not provided by Investigator|1|||
145414207|NCT02265744|524371187|FG001|Overall Study|Reason not provided by Investigator|0|||
145414208|NCT02265744|524371188|FG002|Overall Study|Reason not provided by Investigator|0|||
145414209|NCT02265744|524371189|FG003|Overall Study|Reason not provided by Investigator|2|||
145414210|NCT02265744|524371190|FG004|Overall Study|Reason not provided by Investigator|0|||
145345339|NCT05299528|524111461|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
145345340|NCT05299528|524111462|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
145345341|NCT05299528|524111456|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
145345342|NCT05299528|524111457|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
145345343|NCT05299528|524111458|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
145345344|NCT05299528|524111459|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
145345345|NCT05299528|524111460|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
145576419|NCT02602288|524965845|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
145576420|NCT02602288|524965846|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
145576421|NCT02602288|524965845|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
145576422|NCT02602288|524965846|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
145576423|NCT02602288|524965845|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
145576424|NCT02602288|524965846|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
145576425|NCT02602288|524965845|FG000|12 Month Follow-up|Lost to Follow-up|0|||
145576426|NCT02602288|524965846|FG001|12 Month Follow-up|Lost to Follow-up|4|||
145576427|NCT02602288|524965845|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
145576428|NCT02602288|524965846|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
145576429|NCT02066298|524965852|FG000|Overall Study|Lost to Follow-up|3|||
145576430|NCT02066298|524965853|FG001|Overall Study|Lost to Follow-up|2|||
145576431|NCT02066298|524965854|FG002|Overall Study|Lost to Follow-up|3|||
145576432|NCT02066298|524965855|FG003|Overall Study|Lost to Follow-up|2|||
145576433|NCT02066298|524965856|FG004|Overall Study|Lost to Follow-up|3|||
145576434|NCT02066298|524965857|FG005|Overall Study|Lost to Follow-up|4|||
145345346|NCT05299528|524111461|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
145345347|NCT05299528|524111462|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
145345348|NCT00490841|524111463|FG000|Overall Study|Death|5|||
145345349|NCT00490841|524111463|FG000|Overall Study|Withdrawal by Subject|4|||
145345350|NCT00490841|524111463|FG000|Overall Study|Lost to Follow-up|1|||
145345351|NCT00490841|524111463|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
145345352|NCT04697069|524111464|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
145345353|NCT04697069|524111465|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
145345354|NCT04697069|524111464|FG000|Overall Study|Study termination|2|||
145345355|NCT04697069|524111465|FG001|Overall Study|Study termination|1|||
145345356|NCT02779855|524111466|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
145345357|NCT02779855|524111467|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
145345358|NCT02779855|524111468|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
145345359|NCT01301729|524111469|FG000|Overall Study|Withdrawal by Subject|2|||
145345360|NCT01301729|524111469|FG000|Overall Study|Participant did not Return for Treatment|1|||
145345361|NCT01301729|524111469|FG000|Overall Study|Violated Selection Criteria|1|||
145345362|NCT03071276|524111470|FG000|Overall Study|Adverse Event|1|||
145345363|NCT03071276|524111470|FG000|Overall Study|Lack of Efficacy|14|||
145345364|NCT05794503|524111471|FG000|Overall Study|Operation Cancelled|2|||
145345365|NCT05794503|524111472|FG001|Overall Study|Operation Cancelled|0|||
145345366|NCT05794503|524111471|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
145345367|NCT05794503|524111472|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
145345368|NCT05794503|524111471|FG000|Overall Study|Protocol Violation|1|||
145345369|NCT05794503|524111472|FG001|Overall Study|Protocol Violation|0|||
145345370|NCT03694327|524111473|FG000|Overall Study|Lost to Follow-up|13|||
145345371|NCT03694327|524111474|FG001|Overall Study|Lost to Follow-up|23|||
145345372|NCT00509795|524111480|FG000|Overall Study|Adverse Event|4|||
145345373|NCT00509795|524111481|FG001|Overall Study|Adverse Event|3|||
145345374|NCT00509795|524111482|FG002|Overall Study|Adverse Event|5|||
145345375|NCT00509795|524111483|FG003|Overall Study|Adverse Event|4|||
145345376|NCT00509795|524111480|FG000|Overall Study|Death|3|||
145345377|NCT00509795|524111481|FG001|Overall Study|Death|1|||
145345378|NCT00509795|524111482|FG002|Overall Study|Death|2|||
145345379|NCT00509795|524111483|FG003|Overall Study|Death|7|||
145576435|NCT02066298|524965852|FG000|Overall Study|Withdrawal by Subject|6|||
145576436|NCT02066298|524965853|FG001|Overall Study|Withdrawal by Subject|6|||
145576437|NCT02066298|524965854|FG002|Overall Study|Withdrawal by Subject|6|||
145576438|NCT02066298|524965855|FG003|Overall Study|Withdrawal by Subject|4|||
145345380|NCT00509795|524111480|FG000|Overall Study|Lack of Efficacy|0|||
145345381|NCT00509795|524111481|FG001|Overall Study|Lack of Efficacy|0|||
145345382|NCT00509795|524111482|FG002|Overall Study|Lack of Efficacy|2|||
145345383|NCT00509795|524111483|FG003|Overall Study|Lack of Efficacy|2|||
145345384|NCT00509795|524111480|FG000|Overall Study|Lost to Follow-up|1|||
145345385|NCT00509795|524111481|FG001|Overall Study|Lost to Follow-up|2|||
145345386|NCT00509795|524111482|FG002|Overall Study|Lost to Follow-up|4|||
145345387|NCT00509795|524111483|FG003|Overall Study|Lost to Follow-up|4|||
145345388|NCT00509795|524111480|FG000|Overall Study|OTHER|1|||
145345389|NCT00509795|524111481|FG001|Overall Study|OTHER|0|||
145345390|NCT00509795|524111482|FG002|Overall Study|OTHER|4|||
145345391|NCT00509795|524111483|FG003|Overall Study|OTHER|1|||
145345392|NCT00509795|524111480|FG000|Overall Study|Protocol Violation|3|||
145345393|NCT00509795|524111481|FG001|Overall Study|Protocol Violation|0|||
145345394|NCT00509795|524111482|FG002|Overall Study|Protocol Violation|3|||
145345395|NCT00509795|524111483|FG003|Overall Study|Protocol Violation|1|||
145345396|NCT00509795|524111480|FG000|Overall Study|Withdrawal by Subject|10|||
145345397|NCT00509795|524111481|FG001|Overall Study|Withdrawal by Subject|5|||
145345398|NCT00509795|524111482|FG002|Overall Study|Withdrawal by Subject|7|||
145345399|NCT00509795|524111483|FG003|Overall Study|Withdrawal by Subject|8|||
145345400|NCT00721227|524111484|FG000|Overall Study|Lost to Follow-up|3|||
145345401|NCT00721227|524111485|FG001|Overall Study|Lost to Follow-up|0|||
145345402|NCT00721227|524111484|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
145345403|NCT00721227|524111485|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
145345404|NCT03207867|524111486|FG000|Overall Study|Adverse Event|1|||
145345405|NCT03207867|524111487|FG001|Overall Study|Adverse Event|0|||
145345406|NCT03207867|524111488|FG002|Overall Study|Adverse Event|1|||
145345407|NCT03207867|524111489|FG003|Overall Study|Adverse Event|0|||
145345408|NCT03207867|524111490|FG004|Overall Study|Adverse Event|0|||
145345409|NCT03207867|524111491|FG005|Overall Study|Adverse Event|2|||
145345410|NCT03207867|524111492|FG006|Overall Study|Adverse Event|1|||
145414211|NCT02265744|524371186|FG000|Overall Study|Administrative reason by sponsor|3|||
145414212|NCT02265744|524371187|FG001|Overall Study|Administrative reason by sponsor|2|||
145414213|NCT02265744|524371188|FG002|Overall Study|Administrative reason by sponsor|2|||
145414214|NCT02265744|524371189|FG003|Overall Study|Administrative reason by sponsor|3|||
145414215|NCT02265744|524371190|FG004|Overall Study|Administrative reason by sponsor|3|||
145414216|NCT02265744|524371186|FG000|Overall Study|Subject no longer meets study criteria|0|||
145414217|NCT02265744|524371187|FG001|Overall Study|Subject no longer meets study criteria|0|||
145414218|NCT02265744|524371188|FG002|Overall Study|Subject no longer meets study criteria|0|||
145414219|NCT02265744|524371189|FG003|Overall Study|Subject no longer meets study criteria|0|||
145414220|NCT02265744|524371190|FG004|Overall Study|Subject no longer meets study criteria|1|||
145414221|NCT02265744|524371186|FG000|Overall Study|Pregnancy|1|||
145414222|NCT02265744|524371187|FG001|Overall Study|Pregnancy|2|||
145414223|NCT02265744|524371188|FG002|Overall Study|Pregnancy|1|||
145414224|NCT02265744|524371189|FG003|Overall Study|Pregnancy|1|||
145414225|NCT02265744|524371190|FG004|Overall Study|Pregnancy|0|||
145576439|NCT02066298|524965856|FG004|Overall Study|Withdrawal by Subject|5|||
145345411|NCT03207867|524111493|FG007|Overall Study|Adverse Event|1|||
145345412|NCT03207867|524111494|FG008|Overall Study|Adverse Event|2|||
145345413|NCT03207867|524111495|FG009|Overall Study|Adverse Event|2|||
145345414|NCT03207867|524111496|FG010|Overall Study|Adverse Event|0|||
145345415|NCT03207867|524111497|FG011|Overall Study|Adverse Event|0|||
145345416|NCT03207867|524111498|FG012|Overall Study|Adverse Event|0|||
145345417|NCT03207867|524111499|FG013|Overall Study|Adverse Event|0|||
145345418|NCT03207867|524111500|FG014|Overall Study|Adverse Event|0|||
145345419|NCT03207867|524111501|FG015|Overall Study|Adverse Event|0|||
145345420|NCT03207867|524111502|FG016|Overall Study|Adverse Event|3|||
145345421|NCT03207867|524111503|FG017|Overall Study|Adverse Event|1|||
145345422|NCT03207867|524111504|FG018|Overall Study|Adverse Event|2|||
145345423|NCT03207867|524111505|FG019|Overall Study|Adverse Event|1|||
145345424|NCT03207867|524111506|FG020|Overall Study|Adverse Event|0|||
145345425|NCT03207867|524111507|FG021|Overall Study|Adverse Event|0|||
145345426|NCT03207867|524111508|FG022|Overall Study|Adverse Event|0|||
145345427|NCT03207867|524111509|FG023|Overall Study|Adverse Event|0|||
145345428|NCT03207867|524111486|FG000|Overall Study|Death|0|||
145345429|NCT03207867|524111487|FG001|Overall Study|Death|0|||
145345430|NCT03207867|524111488|FG002|Overall Study|Death|0|||
145345431|NCT03207867|524111489|FG003|Overall Study|Death|0|||
145345432|NCT03207867|524111490|FG004|Overall Study|Death|0|||
145345433|NCT03207867|524111491|FG005|Overall Study|Death|1|||
145345434|NCT03207867|524111492|FG006|Overall Study|Death|0|||
145345435|NCT03207867|524111493|FG007|Overall Study|Death|3|||
145345436|NCT03207867|524111494|FG008|Overall Study|Death|1|||
145345437|NCT03207867|524111495|FG009|Overall Study|Death|2|||
145414226|NCT00574951|524371191|FG000|Overall Study|Ineligible - improper prior treatment|1|||
145345438|NCT03207867|524111496|FG010|Overall Study|Death|0|||
145345439|NCT03207867|524111497|FG011|Overall Study|Death|1|||
145345440|NCT03207867|524111498|FG012|Overall Study|Death|0|||
145345441|NCT03207867|524111499|FG013|Overall Study|Death|1|||
145345442|NCT03207867|524111500|FG014|Overall Study|Death|0|||
145345443|NCT03207867|524111501|FG015|Overall Study|Death|0|||
145345444|NCT03207867|524111502|FG016|Overall Study|Death|0|||
145345445|NCT03207867|524111503|FG017|Overall Study|Death|2|||
145345446|NCT03207867|524111504|FG018|Overall Study|Death|0|||
145345447|NCT03207867|524111505|FG019|Overall Study|Death|1|||
145345448|NCT03207867|524111506|FG020|Overall Study|Death|0|||
145345449|NCT03207867|524111507|FG021|Overall Study|Death|0|||
145345450|NCT03207867|524111508|FG022|Overall Study|Death|0|||
145345451|NCT03207867|524111509|FG023|Overall Study|Death|0|||
145345452|NCT03207867|524111486|FG000|Overall Study|Physician Decision|3|||
145345453|NCT03207867|524111487|FG001|Overall Study|Physician Decision|5|||
145345454|NCT03207867|524111488|FG002|Overall Study|Physician Decision|0|||
145345455|NCT03207867|524111489|FG003|Overall Study|Physician Decision|3|||
145345456|NCT03207867|524111490|FG004|Overall Study|Physician Decision|2|||
145576440|NCT02066298|524965857|FG005|Overall Study|Withdrawal by Subject|8|||
145576441|NCT02066298|524965852|FG000|Overall Study|Physician Decision|0|||
145576442|NCT02066298|524965853|FG001|Overall Study|Physician Decision|0|||
145576443|NCT02066298|524965854|FG002|Overall Study|Physician Decision|1|||
145576444|NCT02066298|524965855|FG003|Overall Study|Physician Decision|0|||
145576445|NCT02066298|524965856|FG004|Overall Study|Physician Decision|1|||
145576446|NCT02066298|524965857|FG005|Overall Study|Physician Decision|0|||
145576447|NCT04260191|524965858|FG000|Overall Study|Decision by Sponsor|0|||
145576448|NCT04260191|524965859|FG001|Overall Study|Decision by Sponsor|1|||
145576449|NCT04260191|524965860|FG002|Overall Study|Decision by Sponsor|0|||
145576450|NCT04260191|524965858|FG000|Overall Study|Withdrawal by Subject|1|||
145576451|NCT04260191|524965859|FG001|Overall Study|Withdrawal by Subject|0|||
145576452|NCT04260191|524965860|FG002|Overall Study|Withdrawal by Subject|3|||
145576453|NCT04260191|524965858|FG000|Overall Study|Death|4|||
145576454|NCT04260191|524965859|FG001|Overall Study|Death|3|||
145576455|NCT04260191|524965860|FG002|Overall Study|Death|2|||
145576456|NCT00630877|524965863|FG000|Overall Study|Adverse Event|11|||
145576457|NCT00630877|524965864|FG001|Overall Study|Adverse Event|8|||
145576458|NCT00630877|524965865|FG002|Overall Study|Adverse Event|7|||
145576459|NCT00630877|524965863|FG000|Overall Study|Withdrawal by Subject|3|||
145576460|NCT00630877|524965864|FG001|Overall Study|Withdrawal by Subject|4|||
145576461|NCT00630877|524965865|FG002|Overall Study|Withdrawal by Subject|0|||
145576462|NCT00630877|524965863|FG000|Overall Study|Lost to Follow-up|2|||
145576463|NCT00630877|524965864|FG001|Overall Study|Lost to Follow-up|0|||
145576464|NCT00630877|524965865|FG002|Overall Study|Lost to Follow-up|0|||
145576465|NCT00630877|524965863|FG000|Overall Study|Noncompliance|2|||
145576466|NCT00630877|524965864|FG001|Overall Study|Noncompliance|3|||
145576467|NCT00630877|524965865|FG002|Overall Study|Noncompliance|1|||
145576468|NCT00630877|524965863|FG000|Overall Study|Protocol violation|1|||
145576469|NCT00630877|524965864|FG001|Overall Study|Protocol violation|0|||
145576470|NCT00630877|524965865|FG002|Overall Study|Protocol violation|1|||
145576471|NCT00630877|524965863|FG000|Overall Study|Personal reasons|0|||
145576472|NCT00630877|524965864|FG001|Overall Study|Personal reasons|0|||
145576473|NCT00630877|524965865|FG002|Overall Study|Personal reasons|1|||
145576474|NCT01643473|524965866|FG000|Overall Study|Lost to Follow-up|1|||
145576475|NCT01643473|524965867|FG001|Overall Study|Lost to Follow-up|0|||
145576476|NCT01519518|524965868|FG000|Overall Study|Consent not available|7|||
145576477|NCT01519518|524965869|FG001|Overall Study|Consent not available|10|||
145576478|NCT02033889|524965870|FG000|Overall Study|Adverse Event|3|||
145576479|NCT02033889|524965871|FG001|Overall Study|Adverse Event|1|||
145576480|NCT02033889|524965872|FG002|Overall Study|Adverse Event|3|||
145576481|NCT02033889|524965870|FG000|Overall Study|Death|3|||
145345457|NCT03207867|524111491|FG005|Overall Study|Physician Decision|0|||
145345458|NCT03207867|524111492|FG006|Overall Study|Physician Decision|0|||
145345459|NCT03207867|524111493|FG007|Overall Study|Physician Decision|0|||
145576482|NCT02033889|524965871|FG001|Overall Study|Death|1|||
145576483|NCT02033889|524965872|FG002|Overall Study|Death|2|||
145576484|NCT02033889|524965870|FG000|Overall Study|Excluded Medication|1|||
145345460|NCT03207867|524111494|FG008|Overall Study|Physician Decision|4|||
145345461|NCT03207867|524111495|FG009|Overall Study|Physician Decision|2|||
145345462|NCT03207867|524111496|FG010|Overall Study|Physician Decision|0|||
145345463|NCT03207867|524111497|FG011|Overall Study|Physician Decision|4|||
145345464|NCT03207867|524111498|FG012|Overall Study|Physician Decision|0|||
145345465|NCT03207867|524111499|FG013|Overall Study|Physician Decision|0|||
145345466|NCT03207867|524111500|FG014|Overall Study|Physician Decision|2|||
145345467|NCT03207867|524111501|FG015|Overall Study|Physician Decision|1|||
145345468|NCT03207867|524111502|FG016|Overall Study|Physician Decision|1|||
145345469|NCT03207867|524111503|FG017|Overall Study|Physician Decision|2|||
145345470|NCT03207867|524111504|FG018|Overall Study|Physician Decision|1|||
145576485|NCT02033889|524965871|FG001|Overall Study|Excluded Medication|1|||
145576486|NCT02033889|524965872|FG002|Overall Study|Excluded Medication|0|||
145576487|NCT02033889|524965870|FG000|Overall Study|Lost to Follow-up|8|||
145576488|NCT02033889|524965871|FG001|Overall Study|Lost to Follow-up|5|||
145576489|NCT02033889|524965872|FG002|Overall Study|Lost to Follow-up|6|||
145622861|NCT01723826|525130204|FG001|Overall Study|Non-compliance With Study Drug|1|||
145622862|NCT01723826|525130205|FG002|Overall Study|Non-compliance With Study Drug|0|||
145345471|NCT03207867|524111505|FG019|Overall Study|Physician Decision|3|||
145345472|NCT03207867|524111506|FG020|Overall Study|Physician Decision|0|||
145345473|NCT03207867|524111507|FG021|Overall Study|Physician Decision|0|||
145345474|NCT03207867|524111508|FG022|Overall Study|Physician Decision|0|||
145345475|NCT03207867|524111509|FG023|Overall Study|Physician Decision|0|||
145345476|NCT03207867|524111486|FG000|Overall Study|Progressive Disease|7|||
145345477|NCT03207867|524111487|FG001|Overall Study|Progressive Disease|7|||
145345478|NCT03207867|524111488|FG002|Overall Study|Progressive Disease|9|||
145576490|NCT02033889|524965870|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145576491|NCT02033889|524965871|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145576492|NCT02033889|524965872|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145576493|NCT02033889|524965870|FG000|Overall Study|Physician Decision|0|||
145576494|NCT02033889|524965871|FG001|Overall Study|Physician Decision|1|||
145576495|NCT02033889|524965872|FG002|Overall Study|Physician Decision|1|||
145345479|NCT03207867|524111489|FG003|Overall Study|Progressive Disease|10|||
145345480|NCT03207867|524111490|FG004|Overall Study|Progressive Disease|11|||
145345481|NCT03207867|524111491|FG005|Overall Study|Progressive Disease|10|||
145345482|NCT03207867|524111492|FG006|Overall Study|Progressive Disease|9|||
145345483|NCT03207867|524111493|FG007|Overall Study|Progressive Disease|8|||
145345484|NCT03207867|524111494|FG008|Overall Study|Progressive Disease|19|||
145345485|NCT03207867|524111495|FG009|Overall Study|Progressive Disease|23|||
145345486|NCT03207867|524111496|FG010|Overall Study|Progressive Disease|2|||
145345487|NCT03207867|524111497|FG011|Overall Study|Progressive Disease|24|||
145345488|NCT03207867|524111498|FG012|Overall Study|Progressive Disease|3|||
145345489|NCT03207867|524111499|FG013|Overall Study|Progressive Disease|11|||
145345490|NCT03207867|524111500|FG014|Overall Study|Progressive Disease|9|||
145345491|NCT03207867|524111501|FG015|Overall Study|Progressive Disease|5|||
145345492|NCT03207867|524111502|FG016|Overall Study|Progressive Disease|10|||
145345493|NCT03207867|524111503|FG017|Overall Study|Progressive Disease|14|||
145345494|NCT03207867|524111504|FG018|Overall Study|Progressive Disease|13|||
145345495|NCT03207867|524111505|FG019|Overall Study|Progressive Disease|14|||
145345496|NCT03207867|524111506|FG020|Overall Study|Progressive Disease|6|||
145345497|NCT03207867|524111507|FG021|Overall Study|Progressive Disease|3|||
145345498|NCT03207867|524111508|FG022|Overall Study|Progressive Disease|3|||
145345499|NCT03207867|524111509|FG023|Overall Study|Progressive Disease|3|||
145345500|NCT03207867|524111486|FG000|Overall Study|Patient/guardian Decision|0|||
145345501|NCT03207867|524111487|FG001|Overall Study|Patient/guardian Decision|0|||
145345502|NCT03207867|524111488|FG002|Overall Study|Patient/guardian Decision|1|||
145345503|NCT03207867|524111489|FG003|Overall Study|Patient/guardian Decision|1|||
145345504|NCT03207867|524111490|FG004|Overall Study|Patient/guardian Decision|1|||
145345505|NCT03207867|524111491|FG005|Overall Study|Patient/guardian Decision|2|||
145345506|NCT03207867|524111492|FG006|Overall Study|Patient/guardian Decision|1|||
145345507|NCT03207867|524111493|FG007|Overall Study|Patient/guardian Decision|0|||
145345508|NCT03207867|524111494|FG008|Overall Study|Patient/guardian Decision|1|||
145345509|NCT03207867|524111495|FG009|Overall Study|Patient/guardian Decision|0|||
145345510|NCT03207867|524111496|FG010|Overall Study|Patient/guardian Decision|0|||
145345511|NCT03207867|524111497|FG011|Overall Study|Patient/guardian Decision|1|||
145345512|NCT03207867|524111498|FG012|Overall Study|Patient/guardian Decision|0|||
145345513|NCT03207867|524111499|FG013|Overall Study|Patient/guardian Decision|1|||
145345514|NCT03207867|524111500|FG014|Overall Study|Patient/guardian Decision|2|||
145345515|NCT03207867|524111501|FG015|Overall Study|Patient/guardian Decision|0|||
145345516|NCT03207867|524111502|FG016|Overall Study|Patient/guardian Decision|1|||
145345517|NCT03207867|524111503|FG017|Overall Study|Patient/guardian Decision|3|||
145345518|NCT03207867|524111504|FG018|Overall Study|Patient/guardian Decision|4|||
145345519|NCT03207867|524111505|FG019|Overall Study|Patient/guardian Decision|1|||
145345520|NCT03207867|524111506|FG020|Overall Study|Patient/guardian Decision|0|||
145345521|NCT03207867|524111507|FG021|Overall Study|Patient/guardian Decision|0|||
145345522|NCT03207867|524111508|FG022|Overall Study|Patient/guardian Decision|0|||
145345523|NCT03207867|524111509|FG023|Overall Study|Patient/guardian Decision|0|||
145345524|NCT00306995|524111510|FG000|Study Part I|Withdrawal by Subject|0|||
145345525|NCT00306995|524111511|FG001|Study Part I|Withdrawal by Subject|0|||
145345526|NCT00306995|524111512|FG002|Study Part I|Withdrawal by Subject|0|||
145345527|NCT00306995|524111513|FG003|Study Part I|Withdrawal by Subject|0|||
145345528|NCT00306995|524111514|FG004|Study Part I|Withdrawal by Subject|0|||
145345529|NCT00306995|524111515|FG005|Study Part I|Withdrawal by Subject|0|||
145345530|NCT00306995|524111516|FG006|Study Part I|Withdrawal by Subject|1|||
145345531|NCT00306995|524111510|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
145345532|NCT00306995|524111511|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
145345533|NCT00306995|524111512|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
145345534|NCT00306995|524111513|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
145345535|NCT00306995|524111514|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
145345536|NCT00306995|524111515|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
145345537|NCT00306995|524111516|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
145345538|NCT01769456|524113194|FG000|Overall Study|Lost to Follow-up|19|||
145345539|NCT01769456|524113194|FG000|Overall Study|Withdrawal by Subject|3|||
145345540|NCT01769456|524113194|FG000|Overall Study|Did not receive PCC intervention|6|||
145345541|NCT01769456|524113194|FG000|Overall Study|Moved out of the area|3|||
145345542|NCT01769456|524113194|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
145345543|NCT01769456|524113194|FG000|Overall Study|Parental request to youth to withdraw|1|||
145345544|NCT05244122|524113199|FG000|Overall Study|Withdrawal by Subject|318|||
145345545|NCT01214655|524113204|FG000|Part A|Progressive Disease|7|||
145345546|NCT01214655|524113205|FG001|Part A|Progressive Disease|0|||
145345547|NCT01214655|524113206|FG002|Part A|Progressive Disease|0|||
145345548|NCT01214655|524113204|FG000|Part A|Physician Decision|1|||
145345549|NCT01214655|524113205|FG001|Part A|Physician Decision|0|||
145345550|NCT01214655|524113206|FG002|Part A|Physician Decision|0|||
145345551|NCT01214655|524113204|FG000|Part B|Progressive disease|0|||
145345552|NCT01214655|524113205|FG001|Part B|Progressive disease|10|||
145345553|NCT01214655|524113206|FG002|Part B|Progressive disease|0|||
145345554|NCT01214655|524113204|FG000|Part B|Death|0|||
145345555|NCT01214655|524113205|FG001|Part B|Death|1|||
145345556|NCT01214655|524113206|FG002|Part B|Death|0|||
145345557|NCT01214655|524113204|FG000|Part B|Withdrawal by Subject|0|||
145345558|NCT01214655|524113205|FG001|Part B|Withdrawal by Subject|2|||
145345559|NCT01214655|524113206|FG002|Part B|Withdrawal by Subject|0|||
145345560|NCT01214655|524113204|FG000|Part C|Progressive Disease|0|||
145345561|NCT01214655|524113205|FG001|Part C|Progressive Disease|0|||
145345562|NCT01214655|524113206|FG002|Part C|Progressive Disease|5|||
145345563|NCT01214655|524113204|FG000|Part C|Death|0|||
145345564|NCT01214655|524113205|FG001|Part C|Death|0|||
145345565|NCT01214655|524113206|FG002|Part C|Death|1|||
145345566|NCT01214655|524113204|FG000|Part C|Physician Decision|0|||
145345567|NCT01214655|524113205|FG001|Part C|Physician Decision|0|||
145345568|NCT01214655|524113206|FG002|Part C|Physician Decision|1|||
145345569|NCT01977417|524113214|FG000|Overall Study|Adverse Event|1|||
145345570|NCT01977417|524113215|FG001|Overall Study|Adverse Event|0|||
145345571|NCT01977417|524113214|FG000|Overall Study|Withdrawal by Subject|2|||
145345572|NCT01977417|524113215|FG001|Overall Study|Withdrawal by Subject|4|||
145345573|NCT01977417|524113214|FG000|Overall Study|Female enrollment goal met|0|||
145345574|NCT01977417|524113215|FG001|Overall Study|Female enrollment goal met|2|||
145345575|NCT01692626|524113216|FG000|Overall Study|Death|0|||
145345576|NCT01692626|524113217|FG001|Overall Study|Death|1|||
145345577|NCT01692626|524113216|FG000|Overall Study|Adverse Event|2|||
145345578|NCT01692626|524113217|FG001|Overall Study|Adverse Event|3|||
145345579|NCT01692626|524113216|FG000|Overall Study|Protocol Violation|1|||
145345580|NCT01692626|524113217|FG001|Overall Study|Protocol Violation|2|||
145345581|NCT01692626|524113216|FG000|Overall Study|Withdrawal by Subject|1|||
145345582|NCT01692626|524113217|FG001|Overall Study|Withdrawal by Subject|0|||
145345583|NCT02794870|524113225|FG000|Overall Study|Withdrawal by Subject|2|||
145345584|NCT02794870|524113226|FG001|Overall Study|Withdrawal by Subject|0|||
145345585|NCT01495702|524113227|FG000|Randomized Phase|Randomized But Not Treated|1|||
145345586|NCT01495702|524113228|FG001|Randomized Phase|Randomized But Not Treated|4|||
145345587|NCT01495702|524113227|FG000|Randomized Phase|Adverse Event|2|||
145345588|NCT01495702|524113228|FG001|Randomized Phase|Adverse Event|2|||
145345589|NCT01495702|524113227|FG000|Randomized Phase|Death|1|||
145345590|NCT01495702|524113228|FG001|Randomized Phase|Death|0|||
145345591|NCT01495702|524113227|FG000|Randomized Phase|Lack of Efficacy|2|||
145345592|NCT01495702|524113228|FG001|Randomized Phase|Lack of Efficacy|0|||
145345593|NCT01495702|524113227|FG000|Randomized Phase|Investigators Discretion|2|||
145345594|NCT01495702|524113228|FG001|Randomized Phase|Investigators Discretion|0|||
145345595|NCT01495702|524113227|FG000|Randomized Phase|Withdrew Consent|10|||
145345596|NCT01495702|524113228|FG001|Randomized Phase|Withdrew Consent|18|||
145345597|NCT01495702|524113227|FG000|Randomized Phase|Lost to Follow-up|4|||
145345598|NCT01495702|524113228|FG001|Randomized Phase|Lost to Follow-up|3|||
145345599|NCT01495702|524113227|FG000|Randomized Phase|Participant Noncompliance|1|||
145345600|NCT01495702|524113228|FG001|Randomized Phase|Participant Noncompliance|0|||
145345601|NCT01495702|524113227|FG000|Randomized Phase|Protocol Violation|3|||
145345602|NCT01495702|524113228|FG001|Randomized Phase|Protocol Violation|1|||
145345603|NCT04152863|524113229|FG000|Overall Study|Death|13|||
145345604|NCT04152863|524113230|FG001|Overall Study|Death|12|||
145345605|NCT04152863|524113231|FG002|Overall Study|Death|7|||
145345606|NCT04152863|524113229|FG000|Overall Study|Physician Decision|1|||
145345607|NCT04152863|524113230|FG001|Overall Study|Physician Decision|1|||
145345608|NCT04152863|524113231|FG002|Overall Study|Physician Decision|1|||
145345609|NCT04152863|524113229|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
145345610|NCT04152863|524113230|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
145345611|NCT04152863|524113231|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
145345612|NCT04152863|524113229|FG000|Overall Study|Withdrawal by Subject|2|||
145345613|NCT04152863|524113230|FG001|Overall Study|Withdrawal by Subject|1|||
145345614|NCT04152863|524113231|FG002|Overall Study|Withdrawal by Subject|3|||
145345615|NCT02276807|524113235|FG000|Overall Study|Withdrawal by Subject|8|||
145345616|NCT02276807|524113236|FG001|Overall Study|Withdrawal by Subject|7|||
145345617|NCT02276807|524113235|FG000|Overall Study|Lost to Follow-up|10|||
145345618|NCT02276807|524113236|FG001|Overall Study|Lost to Follow-up|10|||
145576496|NCT02033889|524965870|FG000|Overall Study|Participant moved|0|||
145576497|NCT02033889|524965871|FG001|Overall Study|Participant moved|1|||
145576498|NCT02033889|524965872|FG002|Overall Study|Participant moved|0|||
145576499|NCT02033889|524965870|FG000|Overall Study|Withdrawal by Subject|18|||
145345619|NCT02370238|524113244|FG000|Overall Study|Death|42|||
145345620|NCT02370238|524113245|FG001|Overall Study|Death|35|||
145345621|NCT02370238|524113244|FG000|Overall Study|Lost to Follow-up|1|||
145345622|NCT02370238|524113245|FG001|Overall Study|Lost to Follow-up|3|||
145345623|NCT02370238|524113244|FG000|Overall Study|Withdrawal by Subject|2|||
145345624|NCT02370238|524113245|FG001|Overall Study|Withdrawal by Subject|6|||
145345625|NCT02370238|524113244|FG000|Overall Study|Other|2|||
145345626|NCT02370238|524113245|FG001|Overall Study|Other|1|||
145345627|NCT01153425|524113246|FG000|Overall Study|Withdrawal by Subject|3|||
145345628|NCT01153425|524113247|FG001|Overall Study|Withdrawal by Subject|3|||
145345629|NCT01937871|524113248|FG000|Overall Study|Adverse Event|6|||
145345630|NCT01937871|524113249|FG001|Overall Study|Adverse Event|6|||
145345631|NCT01937871|524113250|FG002|Overall Study|Adverse Event|2|||
145345632|NCT01937871|524113248|FG000|Overall Study|Lost to Follow-up|8|||
145345633|NCT01937871|524113249|FG001|Overall Study|Lost to Follow-up|2|||
145345634|NCT01937871|524113250|FG002|Overall Study|Lost to Follow-up|4|||
145345635|NCT01937871|524113248|FG000|Overall Study|Withdrawal by Subject|9|||
145345636|NCT01937871|524113249|FG001|Overall Study|Withdrawal by Subject|6|||
145345637|NCT01937871|524113250|FG002|Overall Study|Withdrawal by Subject|4|||
145345638|NCT01937871|524113248|FG000|Overall Study|Physician Decision|0|||
145345639|NCT01937871|524113249|FG001|Overall Study|Physician Decision|1|||
145345640|NCT01937871|524113250|FG002|Overall Study|Physician Decision|0|||
145345641|NCT01937871|524113248|FG000|Overall Study|Entry Criteria Not Met|1|||
145414227|NCT05161936|524371192|FG000|Overall Study|Study terminated by Sponsor|1|||
145414228|NCT05161936|524371193|FG001|Overall Study|Study terminated by Sponsor|0|||
145414229|NCT05161936|524371194|FG002|Overall Study|Study terminated by Sponsor|0|||
145576500|NCT02033889|524965871|FG001|Overall Study|Withdrawal by Subject|10|||
145576501|NCT02033889|524965872|FG002|Overall Study|Withdrawal by Subject|13|||
145576502|NCT02343458|524965876|FG000|Overall Study|Adverse Event|15|||
145576503|NCT02343458|524965877|FG001|Overall Study|Adverse Event|14|||
145576504|NCT02343458|524965878|FG002|Overall Study|Adverse Event|15|||
145576505|NCT02343458|524965879|FG003|Overall Study|Adverse Event|3|||
145576506|NCT02343458|524965876|FG000|Overall Study|Lack of Efficacy|3|||
145576507|NCT02343458|524965877|FG001|Overall Study|Lack of Efficacy|8|||
145576508|NCT02343458|524965878|FG002|Overall Study|Lack of Efficacy|4|||
145576509|NCT02343458|524965879|FG003|Overall Study|Lack of Efficacy|8|||
145576510|NCT02343458|524965876|FG000|Overall Study|Withdrawal by Subject|18|||
145576511|NCT02343458|524965877|FG001|Overall Study|Withdrawal by Subject|17|||
145576512|NCT02343458|524965878|FG002|Overall Study|Withdrawal by Subject|23|||
145576513|NCT02343458|524965879|FG003|Overall Study|Withdrawal by Subject|14|||
145576514|NCT02343458|524965876|FG000|Overall Study|Physician Decision|1|||
145576515|NCT02343458|524965877|FG001|Overall Study|Physician Decision|4|||
145576516|NCT02343458|524965878|FG002|Overall Study|Physician Decision|2|||
145576517|NCT02343458|524965879|FG003|Overall Study|Physician Decision|2|||
145576518|NCT02343458|524965876|FG000|Overall Study|Lost to Follow-up|5|||
145576519|NCT02343458|524965877|FG001|Overall Study|Lost to Follow-up|5|||
145414230|NCT05161936|524371192|FG000|Overall Study|Withdrawal by Subject|0|||
145414231|NCT05161936|524371193|FG001|Overall Study|Withdrawal by Subject|0|||
145414232|NCT05161936|524371194|FG002|Overall Study|Withdrawal by Subject|1|||
145576520|NCT02343458|524965878|FG002|Overall Study|Lost to Follow-up|3|||
145576521|NCT02343458|524965879|FG003|Overall Study|Lost to Follow-up|1|||
145576522|NCT02343458|524965876|FG000|Overall Study|Protocol Violation|2|||
145576523|NCT02343458|524965877|FG001|Overall Study|Protocol Violation|5|||
145576524|NCT02343458|524965878|FG002|Overall Study|Protocol Violation|2|||
145576525|NCT02343458|524965879|FG003|Overall Study|Protocol Violation|2|||
145576526|NCT02343458|524965876|FG000|Overall Study|Protocol Specified Criteria|17|||
145576527|NCT02343458|524965877|FG001|Overall Study|Protocol Specified Criteria|13|||
145576528|NCT02343458|524965878|FG002|Overall Study|Protocol Specified Criteria|14|||
145576529|NCT02343458|524965879|FG003|Overall Study|Protocol Specified Criteria|8|||
145576530|NCT01312909|524965880|FG000|Overall Study|Randomized but not treated|1|||
145576531|NCT01312909|524965881|FG001|Overall Study|Randomized but not treated|3|||
145576532|NCT01312909|524965882|FG002|Overall Study|Randomized but not treated|1|||
145576533|NCT01312909|524965880|FG000|Overall Study|Adverse Event|1|||
145576534|NCT01312909|524965881|FG001|Overall Study|Adverse Event|0|||
145576535|NCT01312909|524965882|FG002|Overall Study|Adverse Event|3|||
145576536|NCT01312909|524965880|FG000|Overall Study|Protocol Violation|2|||
145576537|NCT01312909|524965881|FG001|Overall Study|Protocol Violation|0|||
145576538|NCT01312909|524965882|FG002|Overall Study|Protocol Violation|2|||
145576539|NCT01312909|524965880|FG000|Overall Study|Other|9|||
145576540|NCT01312909|524965881|FG001|Overall Study|Other|6|||
145576541|NCT01312909|524965882|FG002|Overall Study|Other|11|||
145576542|NCT01312909|524965880|FG000|Overall Study|Withdrawal by Subject|8|||
145576543|NCT01312909|524965881|FG001|Overall Study|Withdrawal by Subject|10|||
145576544|NCT01312909|524965882|FG002|Overall Study|Withdrawal by Subject|7|||
145345642|NCT01937871|524113249|FG001|Overall Study|Entry Criteria Not Met|2|||
145414233|NCT02029443|524371195|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
145414234|NCT02029443|524371196|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
145576545|NCT01312909|524965880|FG000|Overall Study|Lost to Follow-up|21|||
145576546|NCT01312909|524965881|FG001|Overall Study|Lost to Follow-up|17|||
145576547|NCT01312909|524965882|FG002|Overall Study|Lost to Follow-up|20|||
145576548|NCT01312909|524965880|FG000|Overall Study|Insufficient clinical response|0|||
145576549|NCT01312909|524965881|FG001|Overall Study|Insufficient clinical response|0|||
145345643|NCT01937871|524113250|FG002|Overall Study|Entry Criteria Not Met|1|||
145345644|NCT01482312|524113251|FG000|Period 1, 90 Minutes of Wear|Other|1|||
145345645|NCT01482312|524113252|FG001|Period 1, 90 Minutes of Wear|Other|0|||
145576550|NCT01312909|524965882|FG002|Overall Study|Insufficient clinical response|1|||
145576551|NCT01312909|524965880|FG000|Overall Study|Entrance criteria not met|0|||
145576552|NCT01312909|524965881|FG001|Overall Study|Entrance criteria not met|0|||
145576553|NCT01312909|524965882|FG002|Overall Study|Entrance criteria not met|2|||
145576554|NCT01913041|524965883|FG000|Overall Study|Protocol Violation|35|||
145345646|NCT01482312|524113253|FG002|Period 1, 90 Minutes of Wear|Other|0|||
145345647|NCT01482312|524113251|FG000|Period 2, 90 Minutes of Wear|Other|1|||
145345648|NCT01482312|524113252|FG001|Period 2, 90 Minutes of Wear|Other|0|||
145345649|NCT01482312|524113253|FG002|Period 2, 90 Minutes of Wear|Other|0|||
145345650|NCT03154125|524113258|FG000|Overall Study|Lost to Follow-up|11|||
145345651|NCT03154125|524113259|FG001|Overall Study|Lost to Follow-up|11|||
145345652|NCT03154125|524113260|FG002|Overall Study|Lost to Follow-up|0|||
145345653|NCT03154125|524113258|FG000|Overall Study|Withdrawal by Subject|49|||
145345654|NCT03154125|524113259|FG001|Overall Study|Withdrawal by Subject|55|||
145345655|NCT03154125|524113260|FG002|Overall Study|Withdrawal by Subject|8|||
145345656|NCT03154125|524113258|FG000|Overall Study|Physician Decision|13|||
145345657|NCT03154125|524113259|FG001|Overall Study|Physician Decision|6|||
145345658|NCT03154125|524113260|FG002|Overall Study|Physician Decision|0|||
145345659|NCT03154125|524113258|FG000|Overall Study|Protocol Violation|3|||
145345660|NCT03154125|524113259|FG001|Overall Study|Protocol Violation|5|||
145345661|NCT03154125|524113260|FG002|Overall Study|Protocol Violation|0|||
145345662|NCT00799058|524113261|FG000|Overall Study|Withdrawal by Subject|2|||
145345663|NCT00799058|524113262|FG001|Overall Study|Withdrawal by Subject|2|||
145345664|NCT00799058|524113263|FG002|Overall Study|Withdrawal by Subject|2|||
145345665|NCT00799058|524113261|FG000|Overall Study|Lost to Follow-up|1|||
145345666|NCT00799058|524113262|FG001|Overall Study|Lost to Follow-up|2|||
145345667|NCT00799058|524113263|FG002|Overall Study|Lost to Follow-up|1|||
145345668|NCT00799058|524113261|FG000|Overall Study|Adverse Event|0|||
145345669|NCT00799058|524113262|FG001|Overall Study|Adverse Event|2|||
145345670|NCT00799058|524113263|FG002|Overall Study|Adverse Event|0|||
145345671|NCT00799058|524113261|FG000|Overall Study|Pregnancy|1|||
145345672|NCT00799058|524113262|FG001|Overall Study|Pregnancy|0|||
145345673|NCT00799058|524113263|FG002|Overall Study|Pregnancy|0|||
145345674|NCT00799058|524113261|FG000|Overall Study|Not adherent|3|||
145345675|NCT00799058|524113262|FG001|Overall Study|Not adherent|2|||
145345676|NCT00799058|524113263|FG002|Overall Study|Not adherent|1|||
145345677|NCT00799058|524113261|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
145345678|NCT00799058|524113262|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
145345679|NCT00799058|524113263|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
145345680|NCT00799058|524113261|FG000|Overall Study|IP dispensing error|1|||
145345681|NCT00799058|524113262|FG001|Overall Study|IP dispensing error|0|||
145345682|NCT00799058|524113263|FG002|Overall Study|IP dispensing error|0|||
145345683|NCT00799058|524113261|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
145345684|NCT00799058|524113262|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
145345685|NCT00799058|524113263|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
145345686|NCT00799058|524113261|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
145345687|NCT00799058|524113262|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
145345688|NCT00799058|524113263|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
145345689|NCT00799058|524113261|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
145345690|NCT00799058|524113262|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
145576555|NCT01913041|524965883|FG000|Overall Study|Withdrawal by Subject|3|||
145576556|NCT01913041|524965883|FG000|Overall Study|Physician Decision|1|||
145576557|NCT01513317|524965884|FG000|Overall Study|Withdrawal by Subject|15|||
145576558|NCT01513317|524965885|FG001|Overall Study|Withdrawal by Subject|4|||
145576559|NCT01513317|524965884|FG000|Overall Study|Death|1|||
145576560|NCT01513317|524965885|FG001|Overall Study|Death|1|||
145576561|NCT01513317|524965884|FG000|Overall Study|Study terminated by sponsor|18|||
145576562|NCT01513317|524965885|FG001|Overall Study|Study terminated by sponsor|18|||
145576563|NCT01513317|524965884|FG000|Overall Study|Other|0|||
145576564|NCT01513317|524965885|FG001|Overall Study|Other|1|||
145576565|NCT02564198|524965887|FG000|Overall Study|Withdrawal by Subject|2|||
145576566|NCT02564198|524965888|FG001|Overall Study|Withdrawal by Subject|4|||
145576567|NCT02564198|524965889|FG002|Overall Study|Withdrawal by Subject|0|||
145576568|NCT02564198|524965887|FG000|Overall Study|Adverse Event|0|||
145576569|NCT02564198|524965888|FG001|Overall Study|Adverse Event|1|||
145576570|NCT02564198|524965889|FG002|Overall Study|Adverse Event|0|||
145576571|NCT01639001|524965897|FG000|Overall Study|Refused further follow-up|9|||
145576572|NCT01639001|524965898|FG001|Overall Study|Refused further follow-up|12|||
145576573|NCT01639001|524965897|FG000|Overall Study|Lost to Follow-up|3|||
145576574|NCT01639001|524965898|FG001|Overall Study|Lost to Follow-up|0|||
145576575|NCT01639001|524965897|FG000|Overall Study|Death|62|||
145345691|NCT00799058|524113263|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
145345692|NCT00799058|524113261|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
145576576|NCT01639001|524965898|FG001|Overall Study|Death|61|||
145576577|NCT01639001|524965897|FG000|Overall Study|Randomized but not treated|0|||
145345693|NCT00799058|524113262|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
145345694|NCT00799058|524113263|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
145345695|NCT00810511|524113266|FG000|Overall Study|Protocol Violation|0|||
145345696|NCT00810511|524113267|FG001|Overall Study|Protocol Violation|1|||
145345697|NCT00810511|524113266|FG000|Overall Study|Lack of Efficacy|9|||
145345698|NCT00810511|524113267|FG001|Overall Study|Lack of Efficacy|1|||
145345699|NCT00810511|524113266|FG000|Overall Study|death in the family|0|||
145345700|NCT00810511|524113267|FG001|Overall Study|death in the family|1|||
145345701|NCT00810511|524113266|FG000|Overall Study|Lost to Follow-up|1|||
145345702|NCT00810511|524113267|FG001|Overall Study|Lost to Follow-up|0|||
145345703|NCT00810511|524113266|FG000|Overall Study|deposits on contact lens|0|||
145345704|NCT00810511|524113267|FG001|Overall Study|deposits on contact lens|1|||
145345705|NCT02088697|524113268|FG000|Period I|Physician Decision|1|||
145345706|NCT02088697|524113269|FG001|Period I|Physician Decision|4|||
145345707|NCT02088697|524113268|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
145345708|NCT02088697|524113269|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
145345709|NCT00462904|524113270|FG000|Overall Study|Lost to Follow-up|1|||
145345710|NCT02652949|524113271|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
145345711|NCT02652949|524113271|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
145345712|NCT02652949|524113271|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
145345713|NCT02652949|524113271|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
145345714|NCT02652949|524113271|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
145345715|NCT02652949|524113271|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
145345716|NCT02652949|524113271|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
145345717|NCT02652949|524113271|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
145345718|NCT02652949|524113271|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
145345719|NCT02652949|524113271|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
145345720|NCT02652949|524113271|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
145345721|NCT02652949|524113271|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
145345722|NCT02652949|524113271|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
145345723|NCT02652949|524113271|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
145345724|NCT02652949|524113271|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145345725|NCT02652949|524113271|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
145345726|NCT02652949|524113271|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
145345727|NCT04342819|524113272|FG000|Overall Study|Declined|4|||
145345728|NCT04342819|524113272|FG000|Overall Study|Not meeeting selection criteria|1|||
145345729|NCT02287922|524113273|FG000|Overall Study|Adverse Event|1|||
145345730|NCT02287922|524113274|FG001|Overall Study|Adverse Event|1|||
145345731|NCT02287922|524113275|FG002|Overall Study|Adverse Event|3|||
145345732|NCT02287922|524113276|FG003|Overall Study|Adverse Event|4|||
145345733|NCT02287922|524113273|FG000|Overall Study|Withdrawal by Subject|1|||
145345734|NCT02287922|524113274|FG001|Overall Study|Withdrawal by Subject|1|||
145345735|NCT02287922|524113275|FG002|Overall Study|Withdrawal by Subject|1|||
145345736|NCT02287922|524113276|FG003|Overall Study|Withdrawal by Subject|2|||
145345737|NCT02287922|524113273|FG000|Overall Study|Lost to Follow-up|0|||
145345738|NCT02287922|524113274|FG001|Overall Study|Lost to Follow-up|0|||
145345739|NCT02287922|524113275|FG002|Overall Study|Lost to Follow-up|1|||
145345740|NCT02287922|524113276|FG003|Overall Study|Lost to Follow-up|0|||
145345741|NCT02287922|524113273|FG000|Overall Study|Sponsor's decision|0|||
145345742|NCT02287922|524113274|FG001|Overall Study|Sponsor's decision|0|||
145345743|NCT02287922|524113275|FG002|Overall Study|Sponsor's decision|0|||
145345744|NCT02287922|524113276|FG003|Overall Study|Sponsor's decision|1|||
145345745|NCT02287922|524113273|FG000|Overall Study|Other|1|||
145345746|NCT02287922|524113274|FG001|Overall Study|Other|0|||
145345747|NCT02287922|524113275|FG002|Overall Study|Other|2|||
145345748|NCT02287922|524113276|FG003|Overall Study|Other|0|||
145345749|NCT04223752|524113282|FG000|Overall Study|Participant enrolled in error|0|||
145345750|NCT04223752|524113283|FG001|Overall Study|Participant enrolled in error|0|||
145345751|NCT04223752|524113284|FG002|Overall Study|Participant enrolled in error|0|||
145414235|NCT02029443|524371197|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
145414236|NCT02029443|524371198|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
145576578|NCT01639001|524965898|FG001|Overall Study|Randomized but not treated|2|||
145576579|NCT01639001|524965897|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
145576580|NCT01639001|524965898|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
145576581|NCT00424372|524965899|FG000|Overall Study|Death|1|||
145345752|NCT04223752|524113285|FG003|Overall Study|Participant enrolled in error|0|||
145345753|NCT04223752|524113286|FG004|Overall Study|Participant enrolled in error|1|||
145345754|NCT04223752|524113282|FG000|Overall Study|Death|0|||
145345755|NCT04223752|524113283|FG001|Overall Study|Death|0|||
145345756|NCT04223752|524113284|FG002|Overall Study|Death|0|||
145345757|NCT04223752|524113285|FG003|Overall Study|Death|2|||
145345758|NCT04223752|524113286|FG004|Overall Study|Death|1|||
145345759|NCT04759703|524113287|FG000|Overall Study|Withdrawal by Subject|4|||
145345760|NCT04759703|524113288|FG001|Overall Study|Withdrawal by Subject|9|||
145345761|NCT04759703|524113287|FG000|Overall Study|Adverse Event|1|||
145345762|NCT04759703|524113288|FG001|Overall Study|Adverse Event|0|||
145345763|NCT04759703|524113287|FG000|Overall Study|Lost to Follow-up|2|||
145345764|NCT04759703|524113288|FG001|Overall Study|Lost to Follow-up|0|||
145345765|NCT04186845|524113300|FG000|Overall Study|Death|2|||
145345766|NCT04186845|524113300|FG000|Overall Study|Lost to Follow-up|1|||
145345767|NCT04186845|524113300|FG000|Overall Study|Physician Decision|1|||
145345768|NCT04186845|524113300|FG000|Overall Study|Protocol Violation|1|||
145345769|NCT04186845|524113300|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
145345770|NCT04186845|524113300|FG000|Overall Study|Biopsy ordered but not done|1|||
145345771|NCT04186845|524113300|FG000|Overall Study|It was previously confirmed|1|||
145345772|NCT04186845|524113300|FG000|Overall Study|Patient cancelled scheduled scans|2|||
145345773|NCT04186845|524113300|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
145345774|NCT04186845|524113300|FG000|Overall Study|Subject refused confirmatory imaging|1|||
145345775|NCT04186845|524113300|FG000|Overall Study|Too small to biopsy|1|||
145345776|NCT05061420|524113301|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
145345777|NCT05061420|524113302|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145345778|NCT05061420|524113303|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145345779|NCT05061420|524113301|FG000|Overall Study|Progressive disease|11|||
145345780|NCT05061420|524113302|FG001|Overall Study|Progressive disease|15|||
145345781|NCT05061420|524113303|FG002|Overall Study|Progressive disease|14|||
145345782|NCT05061420|524113301|FG000|Overall Study|Withdrawal by Subject|2|||
145345783|NCT05061420|524113302|FG001|Overall Study|Withdrawal by Subject|0|||
145576582|NCT00424372|524965899|FG000|Overall Study|Adverse Event|18|||
145345784|NCT05061420|524113303|FG002|Overall Study|Withdrawal by Subject|1|||
145345785|NCT05061420|524113301|FG000|Overall Study|Not related to COVID-19|2|||
145345786|NCT05061420|524113302|FG001|Overall Study|Not related to COVID-19|0|||
145345787|NCT05061420|524113303|FG002|Overall Study|Not related to COVID-19|0|||
145345788|NCT00447993|524113306|FG000|Overall Study|Lost to Follow-up|0|||
145576583|NCT00424372|524965899|FG000|Overall Study|Lack of Efficacy|6|||
145576584|NCT00424372|524965899|FG000|Overall Study|Withdrawal by Subject|4|||
145576585|NCT00424372|524965899|FG000|Overall Study|Protocol Violation|1|||
145576586|NCT00424372|524965899|FG000|Overall Study|Health deterioration|1|||
145576587|NCT02167035|524965900|FG000|Overall Study|Adverse Event|2|||
145576588|NCT02167035|524965901|FG001|Overall Study|Adverse Event|2|||
145576589|NCT02167035|524965900|FG000|Overall Study|Lost to Follow-up|3|||
145345789|NCT00447993|524113307|FG001|Overall Study|Lost to Follow-up|0|||
145345790|NCT00447993|524113308|FG002|Overall Study|Lost to Follow-up|2|||
145345791|NCT00447993|524113309|FG003|Overall Study|Lost to Follow-up|2|||
145345792|NCT00447993|524113306|FG000|Overall Study|Withdrawal by Subject|0|||
145345793|NCT00447993|524113307|FG001|Overall Study|Withdrawal by Subject|0|||
145345794|NCT00447993|524113308|FG002|Overall Study|Withdrawal by Subject|2|||
145345795|NCT00447993|524113309|FG003|Overall Study|Withdrawal by Subject|2|||
145345796|NCT02503787|524113314|FG000|Enrollment|Withdrawal by Subject|6|||
145345797|NCT02503787|524113314|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
145345798|NCT02503787|524113314|FG000|Enrollment|Physician Decision|2|||
145345799|NCT02503787|524113314|FG000|Enrollment|Insurance issue|2|||
145345800|NCT02503787|524113314|FG000|Enrollment|Lost to Follow-up|1|||
145345801|NCT02503787|524113314|FG000|Enrollment|Study closure|1|||
145345802|NCT02503787|524113314|FG000|Enrollment|Adverse Event|1|||
145345803|NCT02503787|524113314|FG000|Enrollment|Protocol Violation|1|||
145345804|NCT02503787|524113314|FG000|Enrollment|Inability to implant system|1|||
145345805|NCT02503787|524113314|FG000|Enrollment|Unable to be programmed|1|||
145345806|NCT02503787|524113314|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
145345807|NCT02503787|524113314|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
145345808|NCT02503787|524113314|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
145345809|NCT02503787|524113314|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
145345810|NCT02503787|524113314|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
145345811|NCT02503787|524113314|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
145345812|NCT04700137|524113315|FG000|Overall Study|Lost to Follow-up|1|||
145345813|NCT04700137|524113316|FG001|Overall Study|Lost to Follow-up|6|||
145345814|NCT04700137|524113317|FG002|Overall Study|Lost to Follow-up|1|||
145576590|NCT02167035|524965901|FG001|Overall Study|Lost to Follow-up|3|||
145345815|NCT04700137|524113318|FG003|Overall Study|Lost to Follow-up|1|||
145345816|NCT04700137|524113315|FG000|Overall Study|Withdrawal by Subject|0|||
145345817|NCT04700137|524113316|FG001|Overall Study|Withdrawal by Subject|0|||
145622863|NCT01723826|525130206|FG003|Overall Study|Non-compliance With Study Drug|0|||
145622864|NCT01723826|525130203|FG000|Overall Study|Other Reason|8|||
145576591|NCT02167035|524965900|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
145576592|NCT02167035|524965901|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
145576593|NCT02148003|524965902|FG000|Overall Study|Failed inclusion criteria|1|||
145576594|NCT02148003|524965903|FG001|Overall Study|Failed inclusion criteria|0|||
145345818|NCT04700137|524113317|FG002|Overall Study|Withdrawal by Subject|1|||
145345819|NCT04700137|524113318|FG003|Overall Study|Withdrawal by Subject|0|||
145345820|NCT04700137|524113315|FG000|Overall Study|Death|0|||
145345821|NCT04700137|524113316|FG001|Overall Study|Death|0|||
145345822|NCT04700137|524113317|FG002|Overall Study|Death|1|||
145345823|NCT04700137|524113318|FG003|Overall Study|Death|0|||
145345824|NCT04787627|524113319|FG000|Overall Study|Withdrawal by Subject|3|||
145576595|NCT02148003|524965902|FG000|Overall Study|Met exclusion criteria|0|||
145576596|NCT02148003|524965903|FG001|Overall Study|Met exclusion criteria|1|||
145576597|NCT02148003|524965902|FG000|Overall Study|Withdrawal by Subject|0|||
145576598|NCT02148003|524965903|FG001|Overall Study|Withdrawal by Subject|1|||
145576599|NCT01034397|524965908|FG000|Overall Study|Lack of compliance|0|||
145576600|NCT01034397|524965909|FG001|Overall Study|Lack of compliance|1|||
145576601|NCT01034397|524965908|FG000|Overall Study|Lack of Efficacy|3|||
145576602|NCT01034397|524965909|FG001|Overall Study|Lack of Efficacy|0|||
145576603|NCT01034397|524965908|FG000|Overall Study|Adverse Event|4|||
145576604|NCT01034397|524965909|FG001|Overall Study|Adverse Event|0|||
145576605|NCT01034397|524965908|FG000|Overall Study|Other|0|||
145576606|NCT01034397|524965909|FG001|Overall Study|Other|1|||
145576607|NCT03192150|524965916|FG000|Overall Study|Adverse Event|14|||
145576608|NCT03192150|524965917|FG001|Overall Study|Adverse Event|12|||
145576609|NCT03192150|524965916|FG000|Overall Study|Lack of Efficacy|23|||
145576610|NCT03192150|524965917|FG001|Overall Study|Lack of Efficacy|30|||
145576611|NCT03192150|524965916|FG000|Overall Study|Lost to Follow-up|1|||
145576612|NCT03192150|524965917|FG001|Overall Study|Lost to Follow-up|1|||
145576613|NCT03192150|524965916|FG000|Overall Study|Withdrawal by Subject|4|||
145576614|NCT03192150|524965917|FG001|Overall Study|Withdrawal by Subject|2|||
145576615|NCT03192150|524965916|FG000|Overall Study|Protocol Violation|5|||
145576616|NCT03192150|524965917|FG001|Overall Study|Protocol Violation|2|||
145576617|NCT03192150|524965916|FG000|Overall Study|Surgery Canceled|6|||
145576618|NCT03192150|524965917|FG001|Overall Study|Surgery Canceled|2|||
145576619|NCT03192150|524965916|FG000|Overall Study|Other-Various Administrative Reasons|2|||
145576620|NCT03192150|524965917|FG001|Overall Study|Other-Various Administrative Reasons|5|||
145576621|NCT02579616|524965918|FG000|Overall Study|Participants did not receive treatment|3|||
145576622|NCT00482391|524965919|FG000|Overall Study|Withdrawal by Subject|1|||
145576623|NCT00482391|524965919|FG000|Overall Study|Adverse Event|1|||
145576624|NCT00482391|524965919|FG000|Overall Study|Death|1|||
145576625|NCT01448850|524965920|FG000|Overall Study|Death|3|||
145576626|NCT01448850|524965921|FG001|Overall Study|Death|6|||
145576627|NCT01448850|524965920|FG000|Overall Study|Withdrawal by Subject|13|||
145576628|NCT01448850|524965921|FG001|Overall Study|Withdrawal by Subject|21|||
145576629|NCT01448850|524965920|FG000|Overall Study|Lost to Follow-up|3|||
145576630|NCT01448850|524965921|FG001|Overall Study|Lost to Follow-up|1|||
145576631|NCT01448850|524965920|FG000|Overall Study|Other|15|||
145576632|NCT01448850|524965921|FG001|Overall Study|Other|12|||
145576633|NCT02664038|524965924|FG000|13 Week|Lost to Follow-up|7|||
145576634|NCT02664038|524965925|FG001|13 Week|Lost to Follow-up|14|||
145576635|NCT02664038|524965924|FG000|13 Week|Withdrawal by Subject|1|||
145576636|NCT02664038|524965925|FG001|13 Week|Withdrawal by Subject|0|||
145576637|NCT02664038|524965924|FG000|26 Week|Lost to Follow-up|5|||
145576638|NCT02664038|524965925|FG001|26 Week|Lost to Follow-up|4|||
145576639|NCT02606136|524965928|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
145576640|NCT02606136|524965928|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
145576641|NCT02606136|524965928|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
145576642|NCT02606136|524965928|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
145576643|NCT00086580|524965932|FG000|Treatment Period|Disease progression|9|||
145576644|NCT00086580|524965933|FG001|Treatment Period|Disease progression|8|||
145576645|NCT00086580|524965932|FG000|Treatment Period|Unable to comply with protocol|3|||
145576646|NCT00086580|524965933|FG001|Treatment Period|Unable to comply with protocol|1|||
145576647|NCT00086580|524965932|FG000|Treatment Period|Withdrawal by Subject|7|||
145576648|NCT00086580|524965933|FG001|Treatment Period|Withdrawal by Subject|8|||
145622865|NCT01723826|525130204|FG001|Overall Study|Other Reason|6|||
145345825|NCT04787627|524113320|FG001|Overall Study|Withdrawal by Subject|0|||
145345826|NCT04787627|524113319|FG000|Overall Study|Physician Decision|2|||
145345827|NCT04787627|524113320|FG001|Overall Study|Physician Decision|0|||
145345828|NCT04787627|524113319|FG000|Overall Study|Excluded|0|||
145345829|NCT04787627|524113320|FG001|Overall Study|Excluded|1|||
145345830|NCT00548093|524113321|FG000|Overall Study|Death|33|||
145345831|NCT00548093|524113322|FG001|Overall Study|Death|13|||
145345832|NCT00548093|524113321|FG000|Overall Study|Lost to Follow-up|3|||
145576649|NCT00086580|524965932|FG000|Treatment Period|Physician Decision|13|||
145576650|NCT00086580|524965933|FG001|Treatment Period|Physician Decision|7|||
145576651|NCT00086580|524965932|FG000|Treatment Period|AE - not treatment related|7|||
145576652|NCT00086580|524965933|FG001|Treatment Period|AE - not treatment related|7|||
145576653|NCT00086580|524965932|FG000|Treatment Period|Toxicity - treatment related|15|||
145576654|NCT00086580|524965933|FG001|Treatment Period|Toxicity - treatment related|15|||
145576655|NCT00086580|524965932|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
145576656|NCT00086580|524965933|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
145576657|NCT00086580|524965932|FG000|Treatment Period|Death|5|||
145576658|NCT00086580|524965933|FG001|Treatment Period|Death|7|||
145576659|NCT00086580|524965932|FG000|Treatment Period|Other|5|||
145576660|NCT00086580|524965933|FG001|Treatment Period|Other|3|||
145576661|NCT00086580|524965932|FG000|Follow-up Period|Disease progression|72|||
145576662|NCT00086580|524965933|FG001|Follow-up Period|Disease progression|99|||
145345833|NCT00548093|524113322|FG001|Overall Study|Lost to Follow-up|1|||
145576663|NCT00086580|524965932|FG000|Follow-up Period|Unable to comply with protocol|5|||
145576664|NCT00086580|524965933|FG001|Follow-up Period|Unable to comply with protocol|0|||
145576665|NCT00086580|524965932|FG000|Follow-up Period|Withdrawal by Subject|6|||
145345834|NCT00548093|524113321|FG000|Overall Study|Objective progression or relapse|1|||
145345835|NCT00548093|524113322|FG001|Overall Study|Objective progression or relapse|1|||
145345836|NCT00548093|524113321|FG000|Overall Study|Other|11|||
145345837|NCT00548093|524113322|FG001|Overall Study|Other|1|||
145345838|NCT00548093|524113321|FG000|Overall Study|Withdrawal by Subject|1|||
145345839|NCT00548093|524113322|FG001|Overall Study|Withdrawal by Subject|0|||
145345840|NCT00548093|524113321|FG000|Overall Study|Completed post-treatment follow-up|1|||
145345841|NCT00548093|524113322|FG001|Overall Study|Completed post-treatment follow-up|0|||
145345842|NCT02924727|524113327|FG000|Overall Study|Withdrawal by Subject|2|||
145345843|NCT02924727|524113328|FG001|Overall Study|Withdrawal by Subject|4|||
145345844|NCT02924727|524113327|FG000|Overall Study|Lost to Follow-up|2|||
145345845|NCT02924727|524113328|FG001|Overall Study|Lost to Follow-up|5|||
145345846|NCT02924727|524113327|FG000|Overall Study|Death|221|||
145345847|NCT02924727|524113328|FG001|Overall Study|Death|247|||
145345848|NCT02924727|524113327|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
145345849|NCT02924727|524113328|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
145345850|NCT01464931|524113329|FG000|Overall Study|Withdrawal by Subject|1|||
145345851|NCT01464931|524113330|FG001|Overall Study|Withdrawal by Subject|0|||
145345852|NCT01982812|524113333|FG000|Overall Study|Death|1|||
145345853|NCT01982812|524113334|FG001|Overall Study|Death|5|||
145345854|NCT01982812|524113333|FG000|Overall Study|Adverse Event|0|||
145345855|NCT01982812|524113334|FG001|Overall Study|Adverse Event|5|||
145345856|NCT00174954|524113335|FG000|Overall Study|Adverse Event|2|||
145345857|NCT00174954|524113335|FG000|Overall Study|No tophi found in MRI|1|||
145345858|NCT00174954|524113335|FG000|Overall Study|Physician Decision|1|||
145345859|NCT02185053|524113336|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
145345860|NCT02185053|524113337|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
145345861|NCT02185053|524113338|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
145345862|NCT02185053|524113336|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
145345863|NCT02185053|524113337|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145345864|NCT02185053|524113338|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145345865|NCT02185053|524113336|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
145345866|NCT02185053|524113337|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
145345867|NCT02185053|524113338|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
145345868|NCT02185053|524113336|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
145345869|NCT02185053|524113337|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
145345870|NCT02185053|524113338|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
145345871|NCT02185053|524113336|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145345872|NCT02185053|524113337|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
145345873|NCT02185053|524113338|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
145345874|NCT02185053|524113336|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
145345875|NCT02185053|524113337|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
145345876|NCT02185053|524113338|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
145345877|NCT02185053|524113336|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
145345878|NCT02185053|524113337|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
145345879|NCT02185053|524113338|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
145345880|NCT02185053|524113336|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
145345881|NCT02185053|524113337|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
145345882|NCT02185053|524113338|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
145345883|NCT00338728|524113339|FG000|Overall Study|Screen Failure|14|||
145345884|NCT01862484|524113340|FG000|Overall Study|Lack of Efficacy|1|||
145345885|NCT01862484|524113341|FG001|Overall Study|Lack of Efficacy|1|||
145345886|NCT01862484|524113340|FG000|Overall Study|Lost to Follow-up|1|||
145345887|NCT01862484|524113341|FG001|Overall Study|Lost to Follow-up|2|||
145345888|NCT01862484|524113340|FG000|Overall Study|Protocol Violation|0|||
145345889|NCT01862484|524113341|FG001|Overall Study|Protocol Violation|2|||
145345890|NCT01862484|524113340|FG000|Overall Study|Withdrawal by Subject|0|||
145345891|NCT01862484|524113341|FG001|Overall Study|Withdrawal by Subject|3|||
145345892|NCT00993421|524113342|FG000|Overall Study|Adverse Event|2|||
145345893|NCT00993421|524113343|FG001|Overall Study|Adverse Event|7|||
145345894|NCT00993421|524113344|FG002|Overall Study|Adverse Event|6|||
145345895|NCT00993421|524113345|FG003|Overall Study|Adverse Event|9|||
145345896|NCT00993421|524113346|FG004|Overall Study|Adverse Event|5|||
145345897|NCT00993421|524113347|FG005|Overall Study|Adverse Event|7|||
145414237|NCT02029443|524371199|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
145345898|NCT00993421|524113348|FG006|Overall Study|Adverse Event|1|||
145345899|NCT00993421|524113342|FG000|Overall Study|Sponsor Decision|36|||
145345900|NCT00993421|524113343|FG001|Overall Study|Sponsor Decision|31|||
145414238|NCT02029443|524371195|FG000|Overall Study|Death|13|||
145414239|NCT02029443|524371196|FG001|Overall Study|Death|2|||
145576666|NCT00086580|524965933|FG001|Follow-up Period|Withdrawal by Subject|6|||
145576667|NCT00086580|524965932|FG000|Follow-up Period|Physician Decision|0|||
145576668|NCT00086580|524965933|FG001|Follow-up Period|Physician Decision|1|||
145576669|NCT00086580|524965932|FG000|Follow-up Period|AE - not related|1|||
145576670|NCT00086580|524965933|FG001|Follow-up Period|AE - not related|0|||
145576671|NCT00086580|524965932|FG000|Follow-up Period|Death|13|||
145576672|NCT00086580|524965933|FG001|Follow-up Period|Death|7|||
145576673|NCT00086580|524965932|FG000|Follow-up Period|Other|7|||
145576674|NCT00086580|524965933|FG001|Follow-up Period|Other|6|||
145576675|NCT00086580|524965932|FG000|Observation Period|Unable to comply with protocol|1|||
145576676|NCT00086580|524965933|FG001|Observation Period|Unable to comply with protocol|1|||
145576677|NCT00086580|524965932|FG000|Observation Period|Withdrawal by Subject|4|||
145414240|NCT02029443|524371197|FG002|Overall Study|Death|2|||
145414241|NCT02029443|524371198|FG003|Overall Study|Death|11|||
145414242|NCT02029443|524371199|FG004|Overall Study|Death|2|||
145345901|NCT00993421|524113344|FG002|Overall Study|Sponsor Decision|28|||
145414243|NCT02029443|524371195|FG000|Overall Study|Lost to Follow-up|1|||
145414244|NCT02029443|524371196|FG001|Overall Study|Lost to Follow-up|0|||
145414245|NCT02029443|524371197|FG002|Overall Study|Lost to Follow-up|1|||
145414246|NCT02029443|524371198|FG003|Overall Study|Lost to Follow-up|1|||
145414247|NCT02029443|524371199|FG004|Overall Study|Lost to Follow-up|0|||
145414248|NCT02029443|524371195|FG000|Overall Study|Started other anti-cancer therapy|17|||
145414249|NCT02029443|524371196|FG001|Overall Study|Started other anti-cancer therapy|4|||
145576678|NCT00086580|524965933|FG001|Observation Period|Withdrawal by Subject|2|||
145345902|NCT00993421|524113345|FG003|Overall Study|Sponsor Decision|30|||
145345903|NCT00993421|524113346|FG004|Overall Study|Sponsor Decision|38|||
145345904|NCT00993421|524113347|FG005|Overall Study|Sponsor Decision|30|||
145576679|NCT00086580|524965932|FG000|Observation Period|Death|33|||
145576680|NCT00086580|524965933|FG001|Observation Period|Death|55|||
145576681|NCT00086580|524965932|FG000|Observation Period|Other|8|||
145576682|NCT00086580|524965933|FG001|Observation Period|Other|7|||
145576683|NCT02075320|524965937|FG000|Overall Study|Withdrawal by Subject|2|||
145576684|NCT02410811|524965938|FG000|Overall Study|Withdrawal by Subject|0|||
145576685|NCT02410811|524965939|FG001|Overall Study|Withdrawal by Subject|0|||
145576686|NCT02410811|524965940|FG002|Overall Study|Withdrawal by Subject|1|||
145576687|NCT02410811|524965941|FG003|Overall Study|Withdrawal by Subject|0|||
145576688|NCT02985736|524965944|FG000|Overall Study|Lost to Follow-up|3|||
145576689|NCT00382733|524965945|FG000|Overall Study|Withdrawal by Subject|0|||
145576690|NCT00382733|524965946|FG001|Overall Study|Withdrawal by Subject|1|||
145576691|NCT00382733|524965947|FG002|Overall Study|Withdrawal by Subject|0|||
145576692|NCT00382733|524965948|FG003|Overall Study|Withdrawal by Subject|0|||
145576693|NCT00382733|524965949|FG004|Overall Study|Withdrawal by Subject|0|||
145576694|NCT00550836|524965950|FG000|Overall Study|Withdrawal by Subject|3|||
145576695|NCT00550836|524965951|FG001|Overall Study|Withdrawal by Subject|9|||
145576696|NCT01458171|524965954|FG000|Overall Study|Adverse Event|1|||
145576697|NCT00578565|524965955|FG000|Overall Study|Adverse Event|3|||
145345905|NCT00993421|524113348|FG006|Overall Study|Sponsor Decision|29|||
145345906|NCT00993421|524113342|FG000|Overall Study|Lost to Follow-up|3|||
145345907|NCT00993421|524113343|FG001|Overall Study|Lost to Follow-up|5|||
145345908|NCT00993421|524113344|FG002|Overall Study|Lost to Follow-up|5|||
145345909|NCT00993421|524113345|FG003|Overall Study|Lost to Follow-up|0|||
145345910|NCT00993421|524113346|FG004|Overall Study|Lost to Follow-up|0|||
145345911|NCT00993421|524113347|FG005|Overall Study|Lost to Follow-up|0|||
145345912|NCT00993421|524113348|FG006|Overall Study|Lost to Follow-up|6|||
145345913|NCT00993421|524113342|FG000|Overall Study|Withdrawal by Subject|3|||
145576698|NCT01559311|524965956|FG000|Overall Study|Protocol Violation|0|||
145576699|NCT01559311|524965957|FG001|Overall Study|Protocol Violation|0|||
145576700|NCT01559311|524965958|FG002|Overall Study|Protocol Violation|2|||
145576701|NCT01559311|524965956|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
145576702|NCT01559311|524965957|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
145576703|NCT01559311|524965958|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
145576704|NCT01559311|524965956|FG000|Overall Study|Withdrawal by Subject|2|||
145576705|NCT01559311|524965957|FG001|Overall Study|Withdrawal by Subject|1|||
145345914|NCT00993421|524113343|FG001|Overall Study|Withdrawal by Subject|2|||
145414250|NCT02029443|524371197|FG002|Overall Study|Started other anti-cancer therapy|7|||
145414251|NCT02029443|524371198|FG003|Overall Study|Started other anti-cancer therapy|9|||
145414252|NCT02029443|524371199|FG004|Overall Study|Started other anti-cancer therapy|3|||
145414253|NCT02029443|524371195|FG000|Overall Study|Withdrawal by Subject|3|||
145576706|NCT01559311|524965958|FG002|Overall Study|Withdrawal by Subject|0|||
145576707|NCT01559311|524965956|FG000|Overall Study|Death|0|||
145576708|NCT01559311|524965957|FG001|Overall Study|Death|2|||
145576709|NCT01559311|524965958|FG002|Overall Study|Death|3|||
145576710|NCT01559311|524965956|FG000|Overall Study|Lost to Follow-up|0|||
145576711|NCT01559311|524965957|FG001|Overall Study|Lost to Follow-up|3|||
145576712|NCT01559311|524965958|FG002|Overall Study|Lost to Follow-up|2|||
145576713|NCT01559311|524965956|FG000|Overall Study|Adverse Event|0|||
145345915|NCT00993421|524113344|FG002|Overall Study|Withdrawal by Subject|3|||
145345916|NCT00993421|524113345|FG003|Overall Study|Withdrawal by Subject|3|||
145345917|NCT00993421|524113346|FG004|Overall Study|Withdrawal by Subject|3|||
145345918|NCT00993421|524113347|FG005|Overall Study|Withdrawal by Subject|5|||
145345919|NCT00993421|524113348|FG006|Overall Study|Withdrawal by Subject|3|||
145345920|NCT00993421|524113342|FG000|Overall Study|Death|0|||
145345921|NCT00993421|524113343|FG001|Overall Study|Death|0|||
145345922|NCT00993421|524113344|FG002|Overall Study|Death|0|||
145345923|NCT00993421|524113345|FG003|Overall Study|Death|0|||
145345924|NCT00993421|524113346|FG004|Overall Study|Death|0|||
145345925|NCT00993421|524113347|FG005|Overall Study|Death|0|||
145345926|NCT00993421|524113348|FG006|Overall Study|Death|1|||
145345927|NCT00993421|524113342|FG000|Overall Study|Entry Criteria Exclusion|0|||
145345928|NCT00993421|524113343|FG001|Overall Study|Entry Criteria Exclusion|0|||
145345929|NCT00993421|524113344|FG002|Overall Study|Entry Criteria Exclusion|1|||
145345930|NCT00993421|524113345|FG003|Overall Study|Entry Criteria Exclusion|3|||
145345931|NCT00993421|524113346|FG004|Overall Study|Entry Criteria Exclusion|0|||
145345932|NCT00993421|524113347|FG005|Overall Study|Entry Criteria Exclusion|1|||
145345933|NCT00993421|524113348|FG006|Overall Study|Entry Criteria Exclusion|0|||
145345934|NCT00993421|524113342|FG000|Overall Study|Physician Decision|0|||
145345935|NCT00993421|524113343|FG001|Overall Study|Physician Decision|0|||
145345936|NCT00993421|524113344|FG002|Overall Study|Physician Decision|0|||
145345937|NCT00993421|524113345|FG003|Overall Study|Physician Decision|0|||
145345938|NCT00993421|524113346|FG004|Overall Study|Physician Decision|0|||
145345939|NCT00993421|524113347|FG005|Overall Study|Physician Decision|1|||
145345940|NCT00993421|524113348|FG006|Overall Study|Physician Decision|1|||
145345941|NCT00993421|524113342|FG000|Overall Study|Protocol Violation|0|||
145345942|NCT00993421|524113343|FG001|Overall Study|Protocol Violation|0|||
145345943|NCT00993421|524113344|FG002|Overall Study|Protocol Violation|0|||
145345944|NCT00993421|524113345|FG003|Overall Study|Protocol Violation|0|||
145345945|NCT00993421|524113346|FG004|Overall Study|Protocol Violation|0|||
145345946|NCT00993421|524113347|FG005|Overall Study|Protocol Violation|2|||
145345947|NCT00993421|524113348|FG006|Overall Study|Protocol Violation|1|||
145345948|NCT02759692|524113349|FG000|Period 1|Test article no longer available|1|||
145345949|NCT02759692|524113350|FG001|Period 1|Test article no longer available|1|||
145345950|NCT02759692|524113349|FG000|Period 1|No longer meets eligibility criteria.|1|||
145345951|NCT02759692|524113350|FG001|Period 1|No longer meets eligibility criteria.|0|||
145345952|NCT02759692|524113349|FG000|Period 1|Miss-Randomized|1|||
145345953|NCT02759692|524113350|FG001|Period 1|Miss-Randomized|1|||
145345954|NCT02759692|524113349|FG000|Period 2|Lost to Follow-up|1|||
145345955|NCT02759692|524113350|FG001|Period 2|Lost to Follow-up|0|||
145345956|NCT02759692|524113349|FG000|Period 2|Test article no longer available|0|||
145345957|NCT02759692|524113350|FG001|Period 2|Test article no longer available|1|||
145345958|NCT01954745|524113351|FG000|Overall Study|Radiological Progression|11|||
145345959|NCT01954745|524113351|FG000|Overall Study|Clinical Progression|5|||
145345960|NCT01954745|524113351|FG000|Overall Study|Adverse Event|2|||
145345961|NCT01954745|524113351|FG000|Overall Study|Death|1|||
145345962|NCT03514017|524113354|FG000|Overall Study|Death|1|||
145345963|NCT03514017|524113354|FG000|Overall Study|Adverse Event|1|||
145345964|NCT02447744|524113358|FG000|Overall Study|Withdrawal by Subject|3|||
145576714|NCT01559311|524965957|FG001|Overall Study|Adverse Event|0|||
145576715|NCT01559311|524965958|FG002|Overall Study|Adverse Event|1|||
145576716|NCT05013905|524965959|FG000|Overall Study|Adverse Event|1|||
145576717|NCT05013905|524965959|FG000|Overall Study|Lack of Efficacy|1|||
145576718|NCT01849588|524965960|FG000|Overall Study|Lack of Efficacy|3|||
145576719|NCT00515827|524965961|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
145576720|NCT00515827|524965962|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
145576721|NCT00515827|524965961|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
145576722|NCT00515827|524965962|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
145576723|NCT00480779|524965968|FG000|Overall Study|Other|2|||
145576724|NCT00480779|524965969|FG001|Overall Study|Other|0|||
145576725|NCT00480779|524965968|FG000|Overall Study|Job and Health-related|0|||
145576726|NCT00480779|524965969|FG001|Overall Study|Job and Health-related|3|||
145345965|NCT02447744|524113359|FG001|Overall Study|Withdrawal by Subject|1|||
145345966|NCT02447744|524113358|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
145345967|NCT02447744|524113359|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
145345968|NCT00912912|524113360|FG000|Overall Study|Withdrawal by Subject|1|||
145345969|NCT00912912|524113360|FG000|Overall Study|Disease Progression|3|||
145345970|NCT05422625|524113361|FG000|Overall Study|Withdrawal by Subject|1|||
145345971|NCT05422625|524113362|FG001|Overall Study|Withdrawal by Subject|0|||
145345972|NCT01496976|524114694|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
145345973|NCT05938621|524114695|FG000|Overall Study|Lost to Follow-up|1|||
145576727|NCT00854581|524965974|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
145576728|NCT00854581|524965974|FG000|Induction (Up to Day 21)|Death|1|||
145576729|NCT00854581|524965974|FG000|Induction (Up to Day 21)|Physician Decision|1|||
145345974|NCT05938621|524114696|FG001|Overall Study|Lost to Follow-up|5|||
145345975|NCT05938621|524114697|FG002|Overall Study|Lost to Follow-up|2|||
145345976|NCT05938621|524114698|FG003|Overall Study|Lost to Follow-up|2|||
145345977|NCT04559347|524114700|FG000|Overall Study|Death|1|||
145345978|NCT04559347|524114701|FG001|Overall Study|Death|0|||
145345979|NCT04559347|524114700|FG000|Overall Study|Thoracotomy conversion|1|||
145345980|NCT04559347|524114701|FG001|Overall Study|Thoracotomy conversion|1|||
145345981|NCT04559347|524114700|FG000|Overall Study|Provider unavailable|2|||
145345982|NCT04559347|524114701|FG001|Overall Study|Provider unavailable|1|||
145345983|NCT04559347|524114700|FG000|Overall Study|Other|2|||
145345984|NCT04559347|524114701|FG001|Overall Study|Other|1|||
145345985|NCT00371033|524114702|FG000|Overall Study|Lost to Follow-up|3|||
145345986|NCT00371033|524114703|FG001|Overall Study|Lost to Follow-up|2|||
145345987|NCT00371033|524114702|FG000|Overall Study|No longer interested|2|||
145576730|NCT00854581|524965974|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
145576731|NCT01339390|524965975|FG000|Overall Study|Death|32|||
145576732|NCT01339390|524965976|FG001|Overall Study|Death|29|||
145576733|NCT01339390|524965975|FG000|Overall Study|Lost to Follow-up|125|||
145576734|NCT01339390|524965976|FG001|Overall Study|Lost to Follow-up|127|||
145576735|NCT00378703|524965979|FG000|Overall Study|Disease progression|59|||
145576736|NCT00378703|524965980|FG001|Overall Study|Disease progression|43|||
145576737|NCT00378703|524965981|FG002|Overall Study|Disease progression|48|||
145576738|NCT00378703|524965982|FG003|Overall Study|Disease progression|49|||
145576739|NCT00378703|524965979|FG000|Overall Study|Adverse Event|11|||
145576740|NCT00378703|524965980|FG001|Overall Study|Adverse Event|17|||
145576741|NCT00378703|524965981|FG002|Overall Study|Adverse Event|20|||
145576742|NCT00378703|524965982|FG003|Overall Study|Adverse Event|18|||
145576743|NCT00378703|524965979|FG000|Overall Study|Death|2|||
145576744|NCT00378703|524965980|FG001|Overall Study|Death|2|||
145576745|NCT00378703|524965981|FG002|Overall Study|Death|4|||
145576746|NCT00378703|524965982|FG003|Overall Study|Death|3|||
145576747|NCT00378703|524965979|FG000|Overall Study|Withdrawal by Subject|4|||
145576748|NCT00378703|524965980|FG001|Overall Study|Withdrawal by Subject|8|||
145576749|NCT00378703|524965981|FG002|Overall Study|Withdrawal by Subject|5|||
145576750|NCT00378703|524965982|FG003|Overall Study|Withdrawal by Subject|7|||
145576751|NCT00378703|524965979|FG000|Overall Study|Physician Decision|1|||
145576752|NCT00378703|524965980|FG001|Overall Study|Physician Decision|4|||
145576753|NCT00378703|524965981|FG002|Overall Study|Physician Decision|1|||
145576754|NCT00378703|524965982|FG003|Overall Study|Physician Decision|0|||
145576755|NCT00378703|524965979|FG000|Overall Study|Alternative therapy|4|||
145576756|NCT00378703|524965980|FG001|Overall Study|Alternative therapy|2|||
145576757|NCT00378703|524965981|FG002|Overall Study|Alternative therapy|0|||
145576758|NCT00378703|524965982|FG003|Overall Study|Alternative therapy|0|||
145576759|NCT00378703|524965979|FG000|Overall Study|Other complicated disease|0|||
145576760|NCT00378703|524965980|FG001|Overall Study|Other complicated disease|2|||
145576761|NCT00378703|524965981|FG002|Overall Study|Other complicated disease|2|||
145576762|NCT00378703|524965982|FG003|Overall Study|Other complicated disease|0|||
145576763|NCT00378703|524965979|FG000|Overall Study|Symptomatic deterioration|0|||
145576764|NCT00378703|524965980|FG001|Overall Study|Symptomatic deterioration|1|||
145576765|NCT00378703|524965981|FG002|Overall Study|Symptomatic deterioration|0|||
145345988|NCT00371033|524114703|FG001|Overall Study|No longer interested|0|||
145345989|NCT00371033|524114702|FG000|Overall Study|Uknown|3|||
145345990|NCT00371033|524114703|FG001|Overall Study|Uknown|1|||
145345991|NCT03816878|524114707|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
145345992|NCT03816878|524114708|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
145345993|NCT03816878|524114707|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
145345994|NCT03816878|524114708|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
145345995|NCT03355469|524114709|FG000|Overall Study|COVID-19|3|||
145345996|NCT03355469|524114710|FG001|Overall Study|COVID-19|2|||
145345997|NCT03355469|524114711|FG002|Overall Study|COVID-19|3|||
145345998|NCT03355469|524114712|FG003|Overall Study|COVID-19|3|||
145345999|NCT03355469|524114709|FG000|Overall Study|Lost to Follow-up|1|||
145346000|NCT03355469|524114710|FG001|Overall Study|Lost to Follow-up|0|||
145346001|NCT03355469|524114711|FG002|Overall Study|Lost to Follow-up|1|||
145346002|NCT03355469|524114712|FG003|Overall Study|Lost to Follow-up|0|||
145346003|NCT03355469|524114709|FG000|Overall Study|Withdrawal by Subject|2|||
145346004|NCT03355469|524114710|FG001|Overall Study|Withdrawal by Subject|1|||
145576766|NCT00378703|524965982|FG003|Overall Study|Symptomatic deterioration|2|||
145576767|NCT00378703|524965979|FG000|Overall Study|Surgery|1|||
145346005|NCT03355469|524114711|FG002|Overall Study|Withdrawal by Subject|0|||
145346006|NCT03355469|524114712|FG003|Overall Study|Withdrawal by Subject|3|||
145576768|NCT00378703|524965980|FG001|Overall Study|Surgery|0|||
145576769|NCT00378703|524965981|FG002|Overall Study|Surgery|0|||
145576770|NCT00378703|524965982|FG003|Overall Study|Surgery|1|||
145576771|NCT00378703|524965979|FG000|Overall Study|Joint decision of physician and patient|1|||
145576772|NCT00378703|524965980|FG001|Overall Study|Joint decision of physician and patient|0|||
145576773|NCT00378703|524965981|FG002|Overall Study|Joint decision of physician and patient|0|||
145346007|NCT02731638|524114713|FG000|Overall Study|Lost to Follow-up|6|||
145346008|NCT02731638|524114714|FG001|Overall Study|Lost to Follow-up|9|||
145346009|NCT05626231|524114715|FG000|Provider Enrollment|Worked part-time|4|||
145576774|NCT00378703|524965982|FG003|Overall Study|Joint decision of physician and patient|0|||
145576775|NCT00378703|524965979|FG000|Overall Study|Adverse events and progressive disease|0|||
145346010|NCT05626231|524114715|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
145346011|NCT05626231|524114715|FG000|Provider Enrollment|Non-clinical employee|1|||
145346012|NCT05626231|524114715|FG000|Provider Enrollment|Provider does not see clients|3|||
145346013|NCT05626231|524114715|FG000|Provider Enrollment|Other|5|||
145346014|NCT02454608|524114716|FG000|Double-Blind Period|Lack of Efficacy|0|||
145346015|NCT02454608|524114717|FG001|Double-Blind Period|Lack of Efficacy|2|||
145346016|NCT02454608|524114718|FG002|Double-Blind Period|Lack of Efficacy|0|||
145346017|NCT02454608|524114716|FG000|Open Label Period|Lost to Follow-up|0|||
145346018|NCT02454608|524114717|FG001|Open Label Period|Lost to Follow-up|0|||
145346019|NCT02454608|524114718|FG002|Open Label Period|Lost to Follow-up|11|||
145346020|NCT02454608|524114716|FG000|Open Label Period|Withdrawal by Subject|0|||
145346021|NCT02454608|524114717|FG001|Open Label Period|Withdrawal by Subject|0|||
145346022|NCT02454608|524114718|FG002|Open Label Period|Withdrawal by Subject|8|||
145346023|NCT03765788|524114721|FG000|Overall Study|Subject decision|2|||
145346024|NCT03765788|524114722|FG001|Overall Study|Subject decision|3|||
145346025|NCT03765788|524114721|FG000|Overall Study|Physician Decision|2|||
145346026|NCT03765788|524114722|FG001|Overall Study|Physician Decision|4|||
145346027|NCT03765788|524114721|FG000|Overall Study|Death|0|||
145346028|NCT03765788|524114722|FG001|Overall Study|Death|1|||
145346029|NCT03765788|524114721|FG000|Overall Study|Lost to Follow-up|1|||
145346030|NCT03765788|524114722|FG001|Overall Study|Lost to Follow-up|0|||
145346031|NCT03203850|524114723|FG000|Overall Study|Subject/guardian decision|4|||
145346032|NCT03203850|524114724|FG001|Overall Study|Subject/guardian decision|3|||
145346033|NCT03203850|524114723|FG000|Overall Study|Adverse Event|3|||
145346034|NCT03203850|524114724|FG001|Overall Study|Adverse Event|0|||
145346035|NCT03203850|524114723|FG000|Overall Study|Death|1|||
145346036|NCT03203850|524114724|FG001|Overall Study|Death|0|||
145346037|NCT02717455|524114725|FG000|Overall Study|Adverse Event|1|||
145346038|NCT02717455|524114726|FG001|Overall Study|Adverse Event|0|||
145346039|NCT02717455|524114727|FG002|Overall Study|Adverse Event|0|||
145346040|NCT02717455|524114728|FG003|Overall Study|Adverse Event|2|||
145346041|NCT02717455|524114729|FG004|Overall Study|Adverse Event|2|||
145346042|NCT02717455|524114730|FG005|Overall Study|Adverse Event|2|||
145346043|NCT02717455|524114725|FG000|Overall Study|Withdrawal by Subject|1|||
145346044|NCT02717455|524114726|FG001|Overall Study|Withdrawal by Subject|1|||
145346045|NCT02717455|524114727|FG002|Overall Study|Withdrawal by Subject|0|||
145346046|NCT02717455|524114728|FG003|Overall Study|Withdrawal by Subject|2|||
145346047|NCT02717455|524114729|FG004|Overall Study|Withdrawal by Subject|2|||
145346048|NCT02717455|524114730|FG005|Overall Study|Withdrawal by Subject|1|||
145346049|NCT02717455|524114725|FG000|Overall Study|Death|1|||
145346050|NCT02717455|524114726|FG001|Overall Study|Death|0|||
145346051|NCT02717455|524114727|FG002|Overall Study|Death|0|||
145346052|NCT02717455|524114728|FG003|Overall Study|Death|0|||
145346053|NCT02717455|524114729|FG004|Overall Study|Death|1|||
145346054|NCT02717455|524114730|FG005|Overall Study|Death|0|||
145346055|NCT02717455|524114725|FG000|Overall Study|Did not receive study drug|0|||
145346056|NCT02717455|524114726|FG001|Overall Study|Did not receive study drug|0|||
145346057|NCT02717455|524114727|FG002|Overall Study|Did not receive study drug|0|||
145346058|NCT02717455|524114728|FG003|Overall Study|Did not receive study drug|1|||
145346059|NCT02717455|524114729|FG004|Overall Study|Did not receive study drug|0|||
145346060|NCT02717455|524114730|FG005|Overall Study|Did not receive study drug|1|||
145346061|NCT02717455|524114725|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145346062|NCT02717455|524114726|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145346063|NCT02717455|524114727|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145346064|NCT02717455|524114728|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145346065|NCT02717455|524114729|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
145346066|NCT02717455|524114730|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
145346067|NCT02717455|524114725|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
145346068|NCT02717455|524114726|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
145346069|NCT02717455|524114727|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
145346070|NCT02717455|524114728|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
145346071|NCT02717455|524114729|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
145576776|NCT00378703|524965980|FG001|Overall Study|Adverse events and progressive disease|0|||
145346072|NCT02717455|524114730|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
145346073|NCT00733005|524114734|FG000|Overall Study|Adverse Event|0|||
145346074|NCT00733005|524114735|FG001|Overall Study|Adverse Event|1|||
145346075|NCT00733005|524114734|FG000|Overall Study|Treatment Failure|0|||
145576777|NCT00378703|524965981|FG002|Overall Study|Adverse events and progressive disease|0|||
145346076|NCT00733005|524114735|FG001|Overall Study|Treatment Failure|1|||
145346077|NCT00733005|524114734|FG000|Overall Study|Withdrawal by Subject|0|||
145346078|NCT00733005|524114735|FG001|Overall Study|Withdrawal by Subject|1|||
145576778|NCT00378703|524965982|FG003|Overall Study|Adverse events and progressive disease|1|||
145576779|NCT00378703|524965979|FG000|Overall Study|Relocation|0|||
145346079|NCT00733005|524114734|FG000|Overall Study|Protocol Violation|2|||
145346080|NCT00733005|524114735|FG001|Overall Study|Protocol Violation|0|||
145346081|NCT02969382|524114738|FG000|Overall Study|Adverse Event|8|||
145346082|NCT02969382|524114739|FG001|Overall Study|Adverse Event|10|||
145346083|NCT02969382|524114738|FG000|Overall Study|Lack of Efficacy|4|||
145346084|NCT02969382|524114739|FG001|Overall Study|Lack of Efficacy|5|||
145346085|NCT02969382|524114738|FG000|Overall Study|Death|0|||
145346086|NCT02969382|524114739|FG001|Overall Study|Death|1|||
145346087|NCT02969382|524114738|FG000|Overall Study|PROTOCOL DEVIATION|0|||
145346088|NCT02969382|524114739|FG001|Overall Study|PROTOCOL DEVIATION|1|||
145346089|NCT02969382|524114738|FG000|Overall Study|Withdrawal by Subject|14|||
145346090|NCT02969382|524114739|FG001|Overall Study|Withdrawal by Subject|9|||
145346091|NCT05223920|524114740|FG000|Overall Study|Adverse Event|6|||
145346092|NCT05223920|524114741|FG001|Overall Study|Adverse Event|3|||
145346093|NCT05223920|524114740|FG000|Overall Study|Death|2|||
145346094|NCT05223920|524114741|FG001|Overall Study|Death|0|||
145346095|NCT05223920|524114740|FG000|Overall Study|Disease Progression|1|||
145346096|NCT05223920|524114741|FG001|Overall Study|Disease Progression|2|||
145346097|NCT05223920|524114740|FG000|Overall Study|Physician Decision|1|||
145346098|NCT05223920|524114741|FG001|Overall Study|Physician Decision|2|||
145346099|NCT05223920|524114740|FG000|Overall Study|Sponsor decision|11|||
145346100|NCT05223920|524114741|FG001|Overall Study|Sponsor decision|9|||
145346101|NCT05223920|524114740|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
145346102|NCT05223920|524114741|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
145346103|NCT05223920|524114740|FG000|Overall Study|Subject decision|1|||
145346104|NCT05223920|524114741|FG001|Overall Study|Subject decision|0|||
145346105|NCT05223920|524114740|FG000|Overall Study|Withdrawal by Subject|1|||
145346106|NCT05223920|524114741|FG001|Overall Study|Withdrawal by Subject|6|||
145346107|NCT00261950|524114742|FG000|Overall Study|Lost to Follow-up|2|||
145346108|NCT00261950|524114742|FG000|Overall Study|Death|6|||
145346109|NCT00261950|524114742|FG000|Overall Study|Withdrawal by Subject|5|||
145346110|NCT00261950|524114742|FG000|Overall Study|Other|1|||
145346111|NCT00261950|524114742|FG000|Overall Study|Physician Decision|1|||
145346112|NCT00261950|524114742|FG000|Overall Study|Protocol specified Criteria|11|||
145346113|NCT01023035|524114743|FG000|Treatment Period|Adverse Event|27|||
145346114|NCT01023035|524114744|FG001|Treatment Period|Adverse Event|32|||
145346115|NCT01023035|524114745|FG002|Treatment Period|Adverse Event|50|||
145346116|NCT01023035|524114743|FG000|Treatment Period|Non-Medical Reasons|19|||
145346117|NCT01023035|524114744|FG001|Treatment Period|Non-Medical Reasons|22|||
145346118|NCT01023035|524114745|FG002|Treatment Period|Non-Medical Reasons|44|||
145346119|NCT01023035|524114743|FG000|Treatment Period|Treatment Failure|26|||
145346120|NCT01023035|524114744|FG001|Treatment Period|Treatment Failure|31|||
145346121|NCT01023035|524114745|FG002|Treatment Period|Treatment Failure|24|||
145346122|NCT01023035|524114743|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
145346123|NCT01023035|524114744|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
145346124|NCT01023035|524114745|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
145346125|NCT01023035|524114743|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
145346126|NCT01023035|524114744|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
145346127|NCT01023035|524114745|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
145346128|NCT00445432|524114750|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
145346129|NCT00445432|524114751|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
145346130|NCT00445432|524114752|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
145346131|NCT00445432|524114753|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
145346132|NCT00445432|524114750|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145346133|NCT00445432|524114751|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145346134|NCT00445432|524114752|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
145346135|NCT00445432|524114753|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
145346136|NCT00445432|524114750|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
145346137|NCT00445432|524114751|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
145346138|NCT00445432|524114752|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
145622866|NCT01723826|525130205|FG002|Overall Study|Other Reason|12|||
145346139|NCT00445432|524114753|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
145346140|NCT00445432|524114750|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
145346141|NCT00445432|524114751|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
145346142|NCT00445432|524114752|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
145346143|NCT00445432|524114753|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
145346144|NCT00445432|524114750|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145346145|NCT00445432|524114751|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145346146|NCT00445432|524114752|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
145346147|NCT00445432|524114753|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
145346148|NCT00445432|524114750|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145346149|NCT00445432|524114751|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145346150|NCT00445432|524114752|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
145346151|NCT00445432|524114753|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
145346152|NCT00445432|524114750|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
145346153|NCT00445432|524114751|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
145346154|NCT00445432|524114752|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
145346155|NCT00445432|524114753|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
145346156|NCT02789137|524114754|FG000|Overall Study|Dropped out/Died|58|||
145346157|NCT01090414|524114755|FG000|Study 101-99|Progressive Disease|28|||
145346158|NCT01090414|524114756|FG001|Study 101-99|Progressive Disease|48|||
145346159|NCT01090414|524114757|FG002|Study 101-99|Progressive Disease|10|||
145346160|NCT01090414|524114758|FG003|Study 101-99|Progressive Disease|4|||
145346161|NCT01090414|524114755|FG000|Study 101-99|Adverse Event|10|||
145346162|NCT01090414|524114756|FG001|Study 101-99|Adverse Event|28|||
145346163|NCT01090414|524114757|FG002|Study 101-99|Adverse Event|18|||
145346164|NCT01090414|524114758|FG003|Study 101-99|Adverse Event|0|||
145346165|NCT01090414|524114755|FG000|Study 101-99|Investigator Request|1|||
145346166|NCT01090414|524114756|FG001|Study 101-99|Investigator Request|11|||
145346167|NCT01090414|524114757|FG002|Study 101-99|Investigator Request|4|||
145346168|NCT01090414|524114758|FG003|Study 101-99|Investigator Request|0|||
145346169|NCT01090414|524114755|FG000|Study 101-99|Death|3|||
145346170|NCT01090414|524114756|FG001|Study 101-99|Death|8|||
145346171|NCT01090414|524114757|FG002|Study 101-99|Death|1|||
145346172|NCT01090414|524114758|FG003|Study 101-99|Death|0|||
145346173|NCT01090414|524114755|FG000|Study 101-99|Sponsor Discontinued Study|0|||
145346174|NCT01090414|524114756|FG001|Study 101-99|Sponsor Discontinued Study|7|||
145346175|NCT01090414|524114757|FG002|Study 101-99|Sponsor Discontinued Study|5|||
145346176|NCT01090414|524114758|FG003|Study 101-99|Sponsor Discontinued Study|0|||
145346177|NCT01090414|524114755|FG000|Study 101-99|Other (Unknown Reasons)|3|||
145346178|NCT01090414|524114756|FG001|Study 101-99|Other (Unknown Reasons)|3|||
145346179|NCT01090414|524114757|FG002|Study 101-99|Other (Unknown Reasons)|0|||
145346180|NCT01090414|524114758|FG003|Study 101-99|Other (Unknown Reasons)|0|||
145346181|NCT01090414|524114755|FG000|Study 101-99|Withdrew Consent|0|||
145346182|NCT01090414|524114756|FG001|Study 101-99|Withdrew Consent|2|||
145346183|NCT01090414|524114757|FG002|Study 101-99|Withdrew Consent|3|||
145346184|NCT01090414|524114758|FG003|Study 101-99|Withdrew Consent|1|||
145346185|NCT01090414|524114755|FG000|Study 101-99|Participant Request|3|||
145346186|NCT01090414|524114756|FG001|Study 101-99|Participant Request|1|||
145346187|NCT01090414|524114757|FG002|Study 101-99|Participant Request|0|||
145346188|NCT01090414|524114758|FG003|Study 101-99|Participant Request|0|||
145346189|NCT00247676|524114761|FG000|Overall Study|Death|5|||
145346190|NCT00247676|524114761|FG000|Overall Study|Adverse Event|11|||
145346191|NCT00247676|524114761|FG000|Overall Study|Lack of Efficacy|15|||
145346192|NCT00247676|524114761|FG000|Overall Study|Other|3|||
145346193|NCT00247676|524114761|FG000|Overall Study|Withdrawal by Subject|2|||
145346194|NCT00911300|524114762|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
145346195|NCT00911300|524114763|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
145346196|NCT00911300|524114762|FG000|Overall Study|Death|1|||
145346197|NCT00911300|524114763|FG001|Overall Study|Death|0|||
145346198|NCT00911300|524114762|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
145346199|NCT00911300|524114763|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
145346200|NCT00911300|524114762|FG000|Overall Study|Adverse Event|14|||
145346201|NCT00911300|524114763|FG001|Overall Study|Adverse Event|6|||
145346202|NCT00911300|524114762|FG000|Overall Study|Protocol Violation|3|||
145346203|NCT00911300|524114763|FG001|Overall Study|Protocol Violation|2|||
145346204|NCT00911300|524114762|FG000|Overall Study|Consent Withdrawn|4|||
145346205|NCT00911300|524114763|FG001|Overall Study|Consent Withdrawn|12|||
145346206|NCT00911300|524114762|FG000|Overall Study|Coronary Angiography Performed|1|||
145346207|NCT00911300|524114763|FG001|Overall Study|Coronary Angiography Performed|0|||
145346208|NCT00911300|524114762|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
145414254|NCT02029443|524371196|FG001|Overall Study|Withdrawal by Subject|1|||
145414255|NCT02029443|524371197|FG002|Overall Study|Withdrawal by Subject|1|||
145414256|NCT02029443|524371198|FG003|Overall Study|Withdrawal by Subject|1|||
145576780|NCT00378703|524965980|FG001|Overall Study|Relocation|0|||
145346209|NCT00911300|524114763|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
145346210|NCT00911300|524114762|FG000|Overall Study|Received Commercial Treatment|1|||
145346211|NCT00911300|524114763|FG001|Overall Study|Received Commercial Treatment|0|||
145346212|NCT00911300|524114762|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
145346213|NCT00911300|524114763|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
145346214|NCT00911300|524114762|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
145346215|NCT00911300|524114763|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
145346216|NCT00911300|524114762|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
145576781|NCT00378703|524965981|FG002|Overall Study|Relocation|1|||
145346217|NCT00911300|524114763|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
145346218|NCT00911300|524114762|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
145346219|NCT00911300|524114763|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
145346220|NCT00911300|524114762|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
145346221|NCT00911300|524114763|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
145346222|NCT00911300|524114762|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
145576782|NCT00378703|524965982|FG003|Overall Study|Relocation|0|||
145576783|NCT00378703|524965979|FG000|Overall Study|Ineligible|4|||
145576784|NCT00378703|524965980|FG001|Overall Study|Ineligible|7|||
145576785|NCT00378703|524965981|FG002|Overall Study|Ineligible|7|||
145576786|NCT00378703|524965982|FG003|Overall Study|Ineligible|7|||
145346223|NCT00911300|524114763|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
145346224|NCT00911300|524114762|FG000|Overall Study|International Normalized Ratio Too High|0|||
145346225|NCT00911300|524114763|FG001|Overall Study|International Normalized Ratio Too High|1|||
145346226|NCT00911300|524114762|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
145346227|NCT00911300|524114763|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
145346228|NCT00911300|524114762|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
145346229|NCT00911300|524114763|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
145346230|NCT00911300|524114762|FG000|Overall Study|Physician Decision|0|||
145346231|NCT00911300|524114763|FG001|Overall Study|Physician Decision|1|||
145346232|NCT00911300|524114762|FG000|Overall Study|Treatment Stopped by Mistake|0|||
145346233|NCT00911300|524114763|FG001|Overall Study|Treatment Stopped by Mistake|1|||
145346234|NCT00911300|524114762|FG000|Overall Study|Randomized; No Study Medication Received|0|||
145346235|NCT00911300|524114763|FG001|Overall Study|Randomized; No Study Medication Received|2|||
145346236|NCT00560391|524114768|FG000|Overall Study|Still on treatment|0|||
145346237|NCT00560391|524114769|FG001|Overall Study|Still on treatment|0|||
145346238|NCT00560391|524114770|FG002|Overall Study|Still on treatment|0|||
145346239|NCT00560391|524114771|FG003|Overall Study|Still on treatment|1|||
145346240|NCT00560391|524114772|FG004|Overall Study|Still on treatment|2|||
145346241|NCT03668808|524114773|FG000|First Intervention|Withdrawal by Subject|2|||
145346242|NCT03668808|524114774|FG001|First Intervention|Withdrawal by Subject|2|||
145346243|NCT00280735|524114775|FG000|Overall Study|Adverse Event|5|||
145346244|NCT00280735|524114775|FG000|Overall Study|Lack of Efficacy|3|||
145346245|NCT00280735|524114775|FG000|Overall Study|Withdrawal by Subject|8|||
145346246|NCT00280735|524114775|FG000|Overall Study|Intercurrent Illness|2|||
145346247|NCT03607487|524114785|FG000|Overall Study|Withdrawal by Subject|2|||
145346248|NCT03607487|524114786|FG001|Overall Study|Withdrawal by Subject|0|||
145346249|NCT03607487|524114787|FG002|Overall Study|Withdrawal by Subject|0|||
145346250|NCT03607487|524114788|FG003|Overall Study|Withdrawal by Subject|1|||
145346251|NCT01884337|524114789|FG000|Treatment|Adverse Event|2|||
145346252|NCT01884337|524114790|FG001|Treatment|Adverse Event|2|||
145346253|NCT01884337|524114789|FG000|Treatment|Subj. request to discont. treatment|2|||
145346254|NCT01884337|524114790|FG001|Treatment|Subj. request to discont. treatment|0|||
145346255|NCT01884337|524114789|FG000|Follow-up Period|Lost to Follow-up|1|||
145346256|NCT01884337|524114790|FG001|Follow-up Period|Lost to Follow-up|1|||
145346257|NCT02455518|524114791|FG000|Overall Study|Protocol Violation|0|||
145346258|NCT02455518|524114792|FG001|Overall Study|Protocol Violation|1|||
145346259|NCT02455518|524114793|FG002|Overall Study|Protocol Violation|1|||
145346260|NCT02455518|524114794|FG003|Overall Study|Protocol Violation|3|||
145346261|NCT01814553|524114795|FG000|Overall Study|PD per clinical progression|6|||
145346262|NCT01814553|524114796|FG001|Overall Study|PD per clinical progression|8|||
145346263|NCT01814553|524114795|FG000|Overall Study|Other Adverse Event|4|||
145346264|NCT01814553|524114796|FG001|Overall Study|Other Adverse Event|5|||
145414257|NCT02029443|524371199|FG004|Overall Study|Withdrawal by Subject|0|||
145414258|NCT02029443|524371195|FG000|Overall Study|Other|6|||
145414259|NCT02029443|524371196|FG001|Overall Study|Other|6|||
145576787|NCT00378703|524965979|FG000|Overall Study|Never started treatment|1|||
145576788|NCT00378703|524965980|FG001|Overall Study|Never started treatment|4|||
145576789|NCT00378703|524965981|FG002|Overall Study|Never started treatment|0|||
145576790|NCT00378703|524965982|FG003|Overall Study|Never started treatment|0|||
145576791|NCT00378703|524965979|FG000|Overall Study|Other|1|||
145576792|NCT00378703|524965980|FG001|Overall Study|Other|1|||
145576793|NCT00378703|524965981|FG002|Overall Study|Other|2|||
145576794|NCT00378703|524965982|FG003|Overall Study|Other|3|||
145576795|NCT01541930|524965990|FG000|Overall Study|Withdrawal by Subject|1|||
145576796|NCT01957475|524965991|FG000|Test Period 1|Withdrawal by Subject|1|||
145576797|NCT01957475|524965992|FG001|Test Period 1|Withdrawal by Subject|0|||
145414260|NCT02029443|524371197|FG002|Overall Study|Other|4|||
145576798|NCT01957475|524965991|FG000|Test Period 1|Other|1|||
145576799|NCT01957475|524965992|FG001|Test Period 1|Other|0|||
145576800|NCT01957475|524965991|FG000|Test Period 1|Lack of Efficacy|0|||
145414261|NCT02029443|524371198|FG003|Overall Study|Other|2|||
145346265|NCT01814553|524114795|FG000|Overall Study|Withdrawal by Subject|1|||
145346266|NCT01814553|524114796|FG001|Overall Study|Withdrawal by Subject|1|||
145346267|NCT01814553|524114795|FG000|Overall Study|Other than stated|7|||
145346268|NCT01814553|524114796|FG001|Overall Study|Other than stated|8|||
145346269|NCT04138823|524114800|FG000|Overall Study|Clinical disease progression|0|||
145346270|NCT04138823|524114801|FG001|Overall Study|Clinical disease progression|0|||
145346271|NCT04138823|524114802|FG002|Overall Study|Clinical disease progression|1|||
145346272|NCT04138823|524114800|FG000|Overall Study|Objective disease progression|3|||
145414262|NCT02029443|524371199|FG004|Overall Study|Other|0|||
145414263|NCT02639559|524371200|FG000|Overall Study|Mobilization failure|0|||
145576801|NCT01957475|524965992|FG001|Test Period 1|Lack of Efficacy|1|||
145576802|NCT01957475|524965991|FG000|Test Period 2|Adverse Event|1|||
145346273|NCT04138823|524114801|FG001|Overall Study|Objective disease progression|2|||
145346274|NCT04138823|524114802|FG002|Overall Study|Objective disease progression|5|||
145346275|NCT03138655|524114803|FG000|Overall Study|Adverse Event|2|||
145346276|NCT03138655|524114804|FG001|Overall Study|Adverse Event|1|||
145346277|NCT03138655|524114805|FG002|Overall Study|Adverse Event|2|||
145346278|NCT03138655|524114806|FG003|Overall Study|Adverse Event|1|||
145346279|NCT03138655|524114807|FG004|Overall Study|Adverse Event|1|||
145346280|NCT03138655|524114808|FG005|Overall Study|Adverse Event|4|||
145346281|NCT03138655|524114809|FG006|Overall Study|Adverse Event|2|||
145346282|NCT03138655|524114810|FG007|Overall Study|Adverse Event|2|||
145346283|NCT03138655|524114803|FG000|Overall Study|Withdrawal by Subject|0|||
145346284|NCT03138655|524114804|FG001|Overall Study|Withdrawal by Subject|1|||
145346285|NCT03138655|524114805|FG002|Overall Study|Withdrawal by Subject|0|||
145346286|NCT03138655|524114806|FG003|Overall Study|Withdrawal by Subject|0|||
145346287|NCT03138655|524114807|FG004|Overall Study|Withdrawal by Subject|0|||
145346288|NCT03138655|524114808|FG005|Overall Study|Withdrawal by Subject|0|||
145346289|NCT03138655|524114809|FG006|Overall Study|Withdrawal by Subject|1|||
145346290|NCT03138655|524114810|FG007|Overall Study|Withdrawal by Subject|0|||
145346291|NCT03138655|524114803|FG000|Overall Study|Reason not Specified|1|||
145346292|NCT03138655|524114804|FG001|Overall Study|Reason not Specified|0|||
145346293|NCT03138655|524114805|FG002|Overall Study|Reason not Specified|0|||
145346294|NCT03138655|524114806|FG003|Overall Study|Reason not Specified|2|||
145346295|NCT03138655|524114807|FG004|Overall Study|Reason not Specified|1|||
145346296|NCT03138655|524114808|FG005|Overall Study|Reason not Specified|1|||
145346297|NCT03138655|524114809|FG006|Overall Study|Reason not Specified|0|||
145346298|NCT03138655|524114810|FG007|Overall Study|Reason not Specified|0|||
145346299|NCT02859142|524114811|FG000|Overall Study|Adverse Event|1|||
145346300|NCT02859142|524114812|FG001|Overall Study|Adverse Event|2|||
145346301|NCT02859142|524114811|FG000|Overall Study|Lost to Follow-up|1|||
145346302|NCT02859142|524114812|FG001|Overall Study|Lost to Follow-up|4|||
145346303|NCT02859142|524114811|FG000|Overall Study|Withdrawal by Subject|2|||
145346304|NCT02859142|524114812|FG001|Overall Study|Withdrawal by Subject|0|||
145346305|NCT02859142|524114811|FG000|Overall Study|Scheduling difficulties|0|||
145346306|NCT02859142|524114812|FG001|Overall Study|Scheduling difficulties|3|||
145346307|NCT03290079|524114813|FG000|Overall Study|Death|2|||
145346308|NCT02466685|524114814|FG000|Overall Study|Adverse Event|5|||
145346309|NCT02466685|524114815|FG001|Overall Study|Adverse Event|2|||
145346310|NCT02466685|524114814|FG000|Overall Study|Lost to Follow-up|1|||
145346311|NCT02466685|524114815|FG001|Overall Study|Lost to Follow-up|1|||
145346312|NCT02466685|524114814|FG000|Overall Study|Withdrawal by Subject|1|||
145346313|NCT02466685|524114815|FG001|Overall Study|Withdrawal by Subject|0|||
145346314|NCT02466685|524114814|FG000|Overall Study|Physician Decision|1|||
145346315|NCT02466685|524114815|FG001|Overall Study|Physician Decision|1|||
145346316|NCT01277211|524114818|FG000|Overall Study|Adverse Event|60|||
145346317|NCT01277211|524114819|FG001|Overall Study|Adverse Event|22|||
145346318|NCT01277211|524114818|FG000|Overall Study|Pregnancy|9|||
145346319|NCT01277211|524114819|FG001|Overall Study|Pregnancy|4|||
145346320|NCT01277211|524114818|FG000|Overall Study|Lost to Follow-up|14|||
145346321|NCT01277211|524114819|FG001|Overall Study|Lost to Follow-up|9|||
145346322|NCT01277211|524114818|FG000|Overall Study|Did not wish to continue|17|||
145346323|NCT01277211|524114819|FG001|Overall Study|Did not wish to continue|0|||
145346324|NCT01277211|524114818|FG000|Overall Study|Withdrew Consent|9|||
145346325|NCT01277211|524114819|FG001|Overall Study|Withdrew Consent|9|||
145346326|NCT01277211|524114818|FG000|Overall Study|Non-compliance with protocol|13|||
145346327|NCT01277211|524114819|FG001|Overall Study|Non-compliance with protocol|4|||
145346328|NCT01277211|524114818|FG000|Overall Study|Did not meet protocol eligibility|1|||
145346329|NCT01277211|524114819|FG001|Overall Study|Did not meet protocol eligibility|0|||
145346330|NCT01277211|524114818|FG000|Overall Study|Administrative|3|||
145346331|NCT01277211|524114819|FG001|Overall Study|Administrative|0|||
145414264|NCT02639559|524371201|FG001|Overall Study|Mobilization failure|3|||
145346332|NCT01277211|524114818|FG000|Overall Study|Pregnancy wish|0|||
145346333|NCT01277211|524114819|FG001|Overall Study|Pregnancy wish|2|||
145346334|NCT01277211|524114818|FG000|Overall Study|Discontinued prior to treatment|24|||
145346335|NCT01277211|524114819|FG001|Overall Study|Discontinued prior to treatment|13|||
145346336|NCT03452943|524114820|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
145346337|NCT03452943|524114821|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
145346338|NCT03452943|524114820|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
145346339|NCT03452943|524114821|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
145346340|NCT03452943|524114820|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
145346341|NCT03452943|524114821|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
145346342|NCT03452943|524114820|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
145346343|NCT03452943|524114821|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
145346344|NCT03452943|524114820|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
145346345|NCT03452943|524114821|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
145346346|NCT03452943|524114820|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
145346347|NCT03452943|524114821|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
145346348|NCT02215967|524114831|FG000|Overall Study|Patient became ineligible for treatment|0|||
145346349|NCT02215967|524114832|FG001|Overall Study|Patient became ineligible for treatment|0|||
145346350|NCT02215967|524114833|FG002|Overall Study|Patient became ineligible for treatment|0|||
145346351|NCT02215967|524114834|FG003|Overall Study|Patient became ineligible for treatment|3|||
145346352|NCT02215967|524114831|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
145346353|NCT02215967|524114832|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
145346354|NCT02215967|524114833|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
145346355|NCT02215967|524114834|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
145346356|NCT00352417|524114835|FG000|Overall Study|Adverse Event|1|||
145346357|NCT00352417|524114836|FG001|Overall Study|Adverse Event|0|||
145346358|NCT00352417|524114835|FG000|Overall Study|Protocol Violation|0|||
145346359|NCT00352417|524114836|FG001|Overall Study|Protocol Violation|2|||
145346360|NCT00352417|524114835|FG000|Overall Study|Withdrawal by Subject|1|||
145346361|NCT00352417|524114836|FG001|Overall Study|Withdrawal by Subject|2|||
145346362|NCT00352417|524114835|FG000|Overall Study|Lost to Follow-up|1|||
145346363|NCT00352417|524114836|FG001|Overall Study|Lost to Follow-up|0|||
145346364|NCT00352417|524114835|FG000|Overall Study|Schedule Change|2|||
145346365|NCT00352417|524114836|FG001|Overall Study|Schedule Change|1|||
145346366|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
145346367|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
145346368|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
145346369|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145346370|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145346371|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
145346372|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
145346373|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
145346374|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
145346375|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
145346376|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
145346377|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
145346378|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145346379|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145346380|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145346381|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
145346382|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145346383|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
145346384|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
145346385|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
145346386|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
145346387|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346388|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346389|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346390|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346391|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346392|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
145346393|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
145346394|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
145346395|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
145346396|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346397|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346398|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346399|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346400|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346401|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
145346402|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
145346403|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
145346404|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
145346405|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145346406|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145346407|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145346408|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
145346409|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145346410|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
145346411|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
145346412|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346413|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346414|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346415|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145576803|NCT01957475|524965992|FG001|Test Period 2|Adverse Event|0|||
145346416|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346417|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346418|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346419|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
145346420|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346421|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
145346422|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346423|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346424|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346425|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346426|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346427|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346428|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346429|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346430|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346431|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
145346432|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346433|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346434|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346435|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346436|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346437|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
145346438|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
145346439|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346440|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346441|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346442|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346443|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346444|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346445|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346446|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
145346447|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
145346448|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346449|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346450|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346451|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346452|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346453|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346454|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346455|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
145346456|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
145346457|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346458|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346459|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346460|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346461|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346462|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346463|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346464|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
145346465|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346466|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
145346467|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
145346468|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346469|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346470|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346471|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346472|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145576804|NCT04497987|524965995|FG000|Overall Study|Adverse Event|1|||
145576805|NCT04497987|524965996|FG001|Overall Study|Adverse Event|0|||
145576806|NCT04497987|524965995|FG000|Overall Study|Death|21|||
145576807|NCT04497987|524965996|FG001|Overall Study|Death|13|||
145576808|NCT04497987|524965995|FG000|Overall Study|Lost to Follow-up|19|||
145346473|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
145346474|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
145346475|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
145346476|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346477|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346478|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346479|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346480|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346481|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346482|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
145346483|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346484|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
145346485|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346486|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346487|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346488|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346489|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346490|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346491|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
145346492|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346493|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
145346494|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346495|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346496|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346497|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346498|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346499|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346500|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
145346501|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346502|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346503|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
145346504|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346505|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346506|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346507|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346508|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346509|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
145346510|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346511|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346512|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
145346513|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346514|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346515|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346516|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145414265|NCT02639559|524371200|FG000|Overall Study|Issues with vascular acess|1|||
145414266|NCT02639559|524371201|FG001|Overall Study|Issues with vascular acess|0|||
145576809|NCT04497987|524965996|FG001|Overall Study|Lost to Follow-up|17|||
145576810|NCT04497987|524965995|FG000|Overall Study|Other - as reported by the investigator|22|||
145576811|NCT04497987|524965996|FG001|Overall Study|Other - as reported by the investigator|16|||
145576812|NCT04497987|524965995|FG000|Overall Study|Physician Decision|1|||
145576813|NCT04497987|524965996|FG001|Overall Study|Physician Decision|0|||
145576814|NCT04497987|524965995|FG000|Overall Study|Withdrawal by Subject|35|||
145576815|NCT04497987|524965996|FG001|Overall Study|Withdrawal by Subject|21|||
145576816|NCT02200042|524967934|FG000|Overall Study|Withdrawal by Subject|0|||
145576817|NCT02200042|524967935|FG001|Overall Study|Withdrawal by Subject|1|||
145576818|NCT01969838|524967936|FG000|Double-blind Phase|Adverse Event|10|||
145576819|NCT01969838|524967937|FG001|Double-blind Phase|Adverse Event|4|||
145576820|NCT01969838|524967938|FG002|Double-blind Phase|Adverse Event|0|||
145576821|NCT01969838|524967939|FG003|Double-blind Phase|Adverse Event|0|||
145576822|NCT01969838|524967936|FG000|Double-blind Phase|Death|5|||
145576823|NCT01969838|524967937|FG001|Double-blind Phase|Death|2|||
145576824|NCT01969838|524967938|FG002|Double-blind Phase|Death|0|||
145576825|NCT01969838|524967939|FG003|Double-blind Phase|Death|0|||
145576826|NCT01969838|524967936|FG000|Double-blind Phase|Physician Decision|5|||
145576827|NCT01969838|524967937|FG001|Double-blind Phase|Physician Decision|1|||
145576828|NCT01969838|524967938|FG002|Double-blind Phase|Physician Decision|0|||
145346517|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346518|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
145346519|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346520|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346521|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
145346522|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346523|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346524|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346525|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346526|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346527|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
145346528|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346529|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346530|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346531|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346532|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346533|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346534|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
145346535|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346536|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
145346537|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
145346538|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
145346539|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346540|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346541|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346542|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346543|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346544|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346545|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
145346546|NCT03598790|524116654|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346547|NCT03598790|524116655|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346548|NCT03598790|524116656|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
145346549|NCT03598790|524116657|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346550|NCT03598790|524116658|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346551|NCT03598790|524116659|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346552|NCT03598790|524116660|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346553|NCT03598790|524116661|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346554|NCT03598790|524116662|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
145346555|NCT03598790|524116654|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346556|NCT03598790|524116655|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346557|NCT03598790|524116656|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346558|NCT03598790|524116657|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
145346559|NCT03598790|524116658|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
145346560|NCT03598790|524116659|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
145346561|NCT03598790|524116660|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346562|NCT03598790|524116661|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346563|NCT03598790|524116662|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145346564|NCT03598790|524116654|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346565|NCT03598790|524116655|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346566|NCT03598790|524116656|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346567|NCT03598790|524116657|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
145346568|NCT03598790|524116658|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346569|NCT03598790|524116659|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346570|NCT03598790|524116660|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346571|NCT03598790|524116661|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346572|NCT03598790|524116662|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
145346573|NCT03598790|524116654|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346574|NCT03598790|524116655|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346575|NCT03598790|524116656|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346576|NCT03598790|524116657|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
145346577|NCT03598790|524116658|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346578|NCT03598790|524116659|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346579|NCT03598790|524116660|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346580|NCT03598790|524116661|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346581|NCT03598790|524116662|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145346582|NCT03598790|524116654|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346583|NCT03598790|524116655|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346584|NCT03598790|524116656|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346585|NCT03598790|524116657|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
145346586|NCT03598790|524116658|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
145346587|NCT03598790|524116659|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346588|NCT03598790|524116660|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346589|NCT03598790|524116661|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346590|NCT03598790|524116662|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
145346591|NCT03598790|524116654|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346592|NCT03598790|524116655|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145622867|NCT01723826|525130206|FG003|Overall Study|Other Reason|14|||
145622868|NCT01723826|525130203|FG000|Overall Study|Physician Decision|1|||
145622869|NCT01723826|525130204|FG001|Overall Study|Physician Decision|3|||
145622870|NCT01723826|525130205|FG002|Overall Study|Physician Decision|4|||
145622871|NCT01723826|525130206|FG003|Overall Study|Physician Decision|11|||
145622872|NCT01723826|525130203|FG000|Overall Study|Protocol Violation|1|||
145622873|NCT01723826|525130204|FG001|Overall Study|Protocol Violation|1|||
145622874|NCT01723826|525130205|FG002|Overall Study|Protocol Violation|3|||
145346593|NCT03598790|524116656|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346594|NCT03598790|524116657|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
145346595|NCT03598790|524116658|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346596|NCT03598790|524116659|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346597|NCT03598790|524116660|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346598|NCT03598790|524116661|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346599|NCT03598790|524116662|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
145346600|NCT05292183|524116663|FG000|Overall Study|Adverse Event|1|||
145346601|NCT01059786|524116664|FG000|Overall Study|Did not receive 6 cycles.|0|||
145346602|NCT01059786|524116665|FG001|Overall Study|Did not receive 6 cycles.|0|||
145346603|NCT01059786|524116666|FG002|Overall Study|Did not receive 6 cycles.|4|||
145346604|NCT01059786|524116667|FG003|Overall Study|Did not receive 6 cycles.|1|||
145346605|NCT01059786|524116668|FG004|Overall Study|Did not receive 6 cycles.|0|||
145346606|NCT04460885|524116669|FG000|Overall Study|Withdrawal by Subject|6|||
145346607|NCT04460885|524116670|FG001|Overall Study|Withdrawal by Subject|8|||
145346608|NCT04460885|524116669|FG000|Overall Study|Site closure|1|||
145346609|NCT04460885|524116670|FG001|Overall Study|Site closure|0|||
145346610|NCT04460885|524116669|FG000|Overall Study|Death|5|||
145346611|NCT04460885|524116670|FG001|Overall Study|Death|4|||
145346612|NCT04460885|524116669|FG000|Overall Study|Physician Decision|2|||
145346613|NCT04460885|524116670|FG001|Overall Study|Physician Decision|1|||
145346614|NCT04460885|524116669|FG000|Overall Study|Lost to Follow-up|4|||
145346615|NCT04460885|524116670|FG001|Overall Study|Lost to Follow-up|4|||
145346616|NCT04205812|524116671|FG000|Randomized Treatment Period|Ongoing|28|||
145346617|NCT04205812|524116672|FG001|Randomized Treatment Period|Ongoing|138|||
145346618|NCT04205812|524116671|FG000|Randomized Treatment Period|Death|94|||
145346619|NCT04205812|524116672|FG001|Randomized Treatment Period|Death|226|||
145346620|NCT04205812|524116671|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
145576829|NCT01969838|524967939|FG003|Double-blind Phase|Physician Decision|0|||
145576830|NCT01969838|524967936|FG000|Double-blind Phase|Subject Decision|4|||
145576831|NCT01969838|524967937|FG001|Double-blind Phase|Subject Decision|2|||
145576832|NCT01969838|524967938|FG002|Double-blind Phase|Subject Decision|0|||
145576833|NCT01969838|524967939|FG003|Double-blind Phase|Subject Decision|0|||
145576834|NCT01969838|524967936|FG000|Double-blind Phase|Disease Progression|2|||
145576835|NCT01969838|524967937|FG001|Double-blind Phase|Disease Progression|0|||
145622875|NCT01723826|525130206|FG003|Overall Study|Protocol Violation|1|||
145622876|NCT01723826|525130203|FG000|Overall Study|Withdrawal by Subject|10|||
145346621|NCT04205812|524116672|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
145346622|NCT04205812|524116671|FG000|Randomized Treatment Period|Physician Decision|1|||
145346623|NCT04205812|524116672|FG001|Randomized Treatment Period|Physician Decision|4|||
145576836|NCT01969838|524967938|FG002|Double-blind Phase|Disease Progression|0|||
145576837|NCT01969838|524967939|FG003|Double-blind Phase|Disease Progression|0|||
145622877|NCT01723826|525130204|FG001|Overall Study|Withdrawal by Subject|17|||
145622878|NCT01723826|525130205|FG002|Overall Study|Withdrawal by Subject|27|||
145622879|NCT01723826|525130206|FG003|Overall Study|Withdrawal by Subject|48|||
145346624|NCT04205812|524116671|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
145346625|NCT04205812|524116672|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
145346626|NCT04205812|524116671|FG000|Randomized Treatment Period|Progressive Disease|0|||
145346627|NCT04205812|524116672|FG001|Randomized Treatment Period|Progressive Disease|1|||
145346628|NCT04205812|524116671|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
145346629|NCT04205812|524116672|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
145346630|NCT04205812|524116671|FG000|Monotherapy Treatment Period|Ongoing|17|||
145346631|NCT04205812|524116672|FG001|Monotherapy Treatment Period|Ongoing|0|||
145346632|NCT04205812|524116671|FG000|Monotherapy Treatment Period|Death|39|||
145346633|NCT04205812|524116672|FG001|Monotherapy Treatment Period|Death|0|||
145346634|NCT04205812|524116671|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
145346635|NCT04205812|524116672|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
145346636|NCT04205812|524116671|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
145346637|NCT04205812|524116672|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
145346638|NCT05929651|524116677|FG000|Overall Study|Protocol Deviation|1|||
145346639|NCT05929651|524116677|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
145346640|NCT05026177|524116678|FG000|Overall Study|Adverse Event|33|||
145346641|NCT05026177|524116679|FG001|Overall Study|Adverse Event|33|||
145346642|NCT05026177|524116680|FG002|Overall Study|Adverse Event|17|||
145346643|NCT05026177|524116678|FG000|Overall Study|Lost to Follow-up|7|||
145346644|NCT05026177|524116679|FG001|Overall Study|Lost to Follow-up|6|||
145346645|NCT05026177|524116680|FG002|Overall Study|Lost to Follow-up|8|||
145346646|NCT05026177|524116678|FG000|Overall Study|Noncompliance with study drug|6|||
145346647|NCT05026177|524116679|FG001|Overall Study|Noncompliance with study drug|2|||
145346648|NCT05026177|524116680|FG002|Overall Study|Noncompliance with study drug|1|||
145346649|NCT05026177|524116678|FG000|Overall Study|Physician Decision|4|||
145346650|NCT05026177|524116679|FG001|Overall Study|Physician Decision|1|||
145346651|NCT05026177|524116680|FG002|Overall Study|Physician Decision|0|||
145346652|NCT05026177|524116678|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
145346653|NCT05026177|524116679|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
145346654|NCT05026177|524116680|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
145346655|NCT05026177|524116678|FG000|Overall Study|Withdrawal by Subject|53|||
145346656|NCT05026177|524116679|FG001|Overall Study|Withdrawal by Subject|51|||
145346657|NCT05026177|524116680|FG002|Overall Study|Withdrawal by Subject|55|||
145346658|NCT05026177|524116678|FG000|Overall Study|Protocol Violation|0|||
145346659|NCT05026177|524116679|FG001|Overall Study|Protocol Violation|1|||
145346660|NCT05026177|524116680|FG002|Overall Study|Protocol Violation|0|||
145346661|NCT05026177|524116678|FG000|Overall Study|Study terminated by sponsor|70|||
145346662|NCT05026177|524116679|FG001|Overall Study|Study terminated by sponsor|74|||
145346663|NCT05026177|524116680|FG002|Overall Study|Study terminated by sponsor|67|||
145346664|NCT05026177|524116678|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
145346665|NCT05026177|524116679|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
145346666|NCT05026177|524116680|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
145346667|NCT05026177|524116678|FG000|Overall Study|Starting alternative treatment|0|||
145346668|NCT05026177|524116679|FG001|Overall Study|Starting alternative treatment|1|||
145346669|NCT05026177|524116680|FG002|Overall Study|Starting alternative treatment|1|||
145346670|NCT05026177|524116678|FG000|Overall Study|Noncompliance with study procedures|0|||
145346671|NCT05026177|524116679|FG001|Overall Study|Noncompliance with study procedures|1|||
145346672|NCT05026177|524116680|FG002|Overall Study|Noncompliance with study procedures|1|||
145346673|NCT05026177|524116678|FG000|Overall Study|Met stopping criteria|0|||
145346674|NCT05026177|524116679|FG001|Overall Study|Met stopping criteria|0|||
145346675|NCT05026177|524116680|FG002|Overall Study|Met stopping criteria|1|||
145346676|NCT05026177|524116678|FG000|Overall Study|Health issues preventing continuation|0|||
145346677|NCT05026177|524116679|FG001|Overall Study|Health issues preventing continuation|0|||
145346678|NCT05026177|524116680|FG002|Overall Study|Health issues preventing continuation|1|||
145346679|NCT05026177|524116678|FG000|Overall Study|Randomized in error, not treated|0|||
145346680|NCT05026177|524116679|FG001|Overall Study|Randomized in error, not treated|0|||
145346681|NCT05026177|524116680|FG002|Overall Study|Randomized in error, not treated|2|||
145346682|NCT05256134|524116688|FG000|Overall Study|Study Terminated by Sponsor|11|||
145346683|NCT05256134|524116689|FG001|Overall Study|Study Terminated by Sponsor|10|||
145346684|NCT05256134|524116688|FG000|Overall Study|Withdrawal by Subject|1|||
145346685|NCT05256134|524116689|FG001|Overall Study|Withdrawal by Subject|3|||
145346686|NCT01625988|524116702|FG000|Overall Study|Lost to Follow-up|5|||
145346687|NCT01625988|524116703|FG001|Overall Study|Lost to Follow-up|6|||
145346688|NCT01625988|524116702|FG000|Overall Study|Withdrawal by Subject|8|||
145346689|NCT01625988|524116703|FG001|Overall Study|Withdrawal by Subject|3|||
145346690|NCT01625988|524116702|FG000|Overall Study|Adverse Event|0|||
145346691|NCT01625988|524116703|FG001|Overall Study|Adverse Event|1|||
145346692|NCT01625988|524116702|FG000|Overall Study|Lack of Efficacy|0|||
145346693|NCT01625988|524116703|FG001|Overall Study|Lack of Efficacy|1|||
145346694|NCT01625988|524116702|FG000|Overall Study|Randomized Inappropriately|1|||
145346695|NCT01625988|524116703|FG001|Overall Study|Randomized Inappropriately|0|||
145346696|NCT01625988|524116702|FG000|Overall Study|Protocol Violation|0|||
145346697|NCT01625988|524116703|FG001|Overall Study|Protocol Violation|2|||
145346698|NCT01644617|524116704|FG000|Overall Study|Withdrawal by Subject|3|||
145346699|NCT01644617|524116705|FG001|Overall Study|Withdrawal by Subject|4|||
145346700|NCT01644617|524116706|FG002|Overall Study|Withdrawal by Subject|1|||
145346701|NCT01644617|524116704|FG000|Overall Study|Lost to Follow-up|0|||
145346702|NCT01644617|524116705|FG001|Overall Study|Lost to Follow-up|1|||
145346703|NCT01644617|524116706|FG002|Overall Study|Lost to Follow-up|0|||
145346704|NCT01644617|524116704|FG000|Overall Study|Adverse Event|3|||
145346705|NCT01644617|524116705|FG001|Overall Study|Adverse Event|0|||
145346706|NCT01644617|524116706|FG002|Overall Study|Adverse Event|6|||
145346707|NCT00196326|524116707|FG000|Overall Study|Did not meet protocol requirements|64|||
145576838|NCT01969838|524967936|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
145576839|NCT01969838|524967937|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
145414267|NCT02969018|524371206|FG000|Overall Study|Adverse Event|2|||
145414268|NCT02969018|524371207|FG001|Overall Study|Adverse Event|4|||
145414269|NCT02969018|524371208|FG002|Overall Study|Adverse Event|1|||
145346708|NCT00196326|524116707|FG000|Overall Study|Non-compliance with the protocol|81|||
145346709|NCT00196326|524116707|FG000|Overall Study|Physician Decision|3|||
145346710|NCT00196326|524116707|FG000|Overall Study|Withdrawal by Subject|225|||
145346711|NCT00196326|524116707|FG000|Overall Study|Adverse Event|253|||
145346712|NCT00196326|524116707|FG000|Overall Study|Pregnancy|34|||
145346713|NCT00196326|524116707|FG000|Overall Study|Lost to Follow-up|304|||
145346714|NCT00196326|524116707|FG000|Overall Study|Other|22|||
145346715|NCT02964312|524116708|FG000|Overall Study|Lost to Follow-up|28|||
145346716|NCT02964312|524116708|FG000|Overall Study|Withdrawal by Subject|11|||
145346717|NCT02964312|524116708|FG000|Overall Study|Lack of Efficacy|10|||
145346718|NCT02964312|524116708|FG000|Overall Study|Did not consent to long-term FU|14|||
145346719|NCT02964312|524116708|FG000|Overall Study|Death|1|||
145346720|NCT02121652|524116711|FG000|Overall Study|Lost to Follow-up|2|||
145346721|NCT02121652|524116712|FG001|Overall Study|Lost to Follow-up|1|||
145346722|NCT02121652|524116711|FG000|Overall Study|Death|1|||
145346723|NCT02121652|524116712|FG001|Overall Study|Death|0|||
145346724|NCT02121652|524116711|FG000|Overall Study|Withdrawal by Subject|3|||
145346725|NCT02121652|524116712|FG001|Overall Study|Withdrawal by Subject|3|||
145346726|NCT03639779|524116719|FG000|Overall Study|Lost to Follow-up|1|||
145346727|NCT02413229|524116722|FG000|Overall Study|Adverse Event|0|||
145346728|NCT02413229|524116723|FG001|Overall Study|Adverse Event|0|||
145346729|NCT02413229|524116724|FG002|Overall Study|Adverse Event|0|||
145346730|NCT02413229|524116725|FG003|Overall Study|Adverse Event|1|||
145346731|NCT02413229|524116726|FG004|Overall Study|Adverse Event|0|||
145346732|NCT02413229|524116727|FG005|Overall Study|Adverse Event|0|||
145346733|NCT02413229|524116728|FG006|Overall Study|Adverse Event|0|||
145346734|NCT02413229|524116729|FG007|Overall Study|Adverse Event|1|||
145414270|NCT02969018|524371209|FG003|Overall Study|Adverse Event|2|||
145414271|NCT02969018|524371210|FG004|Overall Study|Adverse Event|0|||
145414272|NCT02969018|524371211|FG005|Overall Study|Adverse Event|1|||
145414273|NCT02969018|524371212|FG006|Overall Study|Adverse Event|2|||
145414274|NCT02969018|524371213|FG007|Overall Study|Adverse Event|0|||
145414275|NCT02969018|524371206|FG000|Overall Study|Lack of Efficacy|0|||
145414276|NCT02969018|524371207|FG001|Overall Study|Lack of Efficacy|1|||
145414277|NCT02969018|524371208|FG002|Overall Study|Lack of Efficacy|0|||
145414278|NCT02969018|524371209|FG003|Overall Study|Lack of Efficacy|0|||
145414279|NCT02969018|524371210|FG004|Overall Study|Lack of Efficacy|1|||
145414280|NCT02969018|524371211|FG005|Overall Study|Lack of Efficacy|1|||
145414281|NCT02969018|524371212|FG006|Overall Study|Lack of Efficacy|1|||
145414282|NCT02969018|524371213|FG007|Overall Study|Lack of Efficacy|1|||
145576840|NCT01969838|524967938|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
145576841|NCT01969838|524967939|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
145576842|NCT01969838|524967936|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
145576843|NCT01969838|524967937|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
145576844|NCT01969838|524967938|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
145576845|NCT01969838|524967939|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
145576846|NCT01969838|524967936|FG000|Open-label Phase|Adverse Event|0|||
145576847|NCT01969838|524967937|FG001|Open-label Phase|Adverse Event|0|||
145576848|NCT01969838|524967938|FG002|Open-label Phase|Adverse Event|37|||
145576849|NCT01969838|524967939|FG003|Open-label Phase|Adverse Event|49|||
145576850|NCT01969838|524967936|FG000|Open-label Phase|Disease Progression|0|||
145576851|NCT01969838|524967937|FG001|Open-label Phase|Disease Progression|0|||
145576852|NCT01969838|524967938|FG002|Open-label Phase|Disease Progression|26|||
145576853|NCT01969838|524967939|FG003|Open-label Phase|Disease Progression|27|||
145622880|NCT01627340|525130207|FG000|Overall Study|Adverse Event|1|||
145346735|NCT02413229|524116722|FG000|Overall Study|Lost to Follow-up|0|||
145346736|NCT02413229|524116723|FG001|Overall Study|Lost to Follow-up|0|||
145346737|NCT02413229|524116724|FG002|Overall Study|Lost to Follow-up|1|||
145346738|NCT02413229|524116725|FG003|Overall Study|Lost to Follow-up|0|||
145346739|NCT02413229|524116726|FG004|Overall Study|Lost to Follow-up|2|||
145346740|NCT02413229|524116727|FG005|Overall Study|Lost to Follow-up|0|||
145346741|NCT02413229|524116728|FG006|Overall Study|Lost to Follow-up|0|||
145414283|NCT02969018|524371206|FG000|Overall Study|Lost to Follow-up|1|||
145346742|NCT02413229|524116729|FG007|Overall Study|Lost to Follow-up|0|||
145346743|NCT02413229|524116722|FG000|Overall Study|Withdrawal by Subject|1|||
145346744|NCT02413229|524116723|FG001|Overall Study|Withdrawal by Subject|1|||
145346745|NCT02413229|524116724|FG002|Overall Study|Withdrawal by Subject|0|||
145346746|NCT02413229|524116725|FG003|Overall Study|Withdrawal by Subject|0|||
145346747|NCT02413229|524116726|FG004|Overall Study|Withdrawal by Subject|1|||
145346748|NCT02413229|524116727|FG005|Overall Study|Withdrawal by Subject|0|||
145346749|NCT02413229|524116728|FG006|Overall Study|Withdrawal by Subject|0|||
145346750|NCT02413229|524116729|FG007|Overall Study|Withdrawal by Subject|2|||
145346751|NCT02413229|524116722|FG000|Overall Study|Progressive Disease|0|||
145346752|NCT02413229|524116723|FG001|Overall Study|Progressive Disease|0|||
145346753|NCT02413229|524116724|FG002|Overall Study|Progressive Disease|0|||
145346754|NCT02413229|524116725|FG003|Overall Study|Progressive Disease|0|||
145346755|NCT02413229|524116726|FG004|Overall Study|Progressive Disease|0|||
145346756|NCT02413229|524116727|FG005|Overall Study|Progressive Disease|0|||
145346757|NCT02413229|524116728|FG006|Overall Study|Progressive Disease|0|||
145346758|NCT02413229|524116729|FG007|Overall Study|Progressive Disease|1|||
145346759|NCT03594071|524116730|FG000|Overall Study|Re-operation|3|||
145346760|NCT03594071|524116730|FG000|Overall Study|Missed visit|2|||
145346761|NCT05219448|524116731|FG000|Overall Study|Lost to Follow-up|9|||
145346762|NCT05219448|524116732|FG001|Overall Study|Lost to Follow-up|0|||
145346763|NCT03022370|524116734|FG000|Overall Study|Death|6|||
145346764|NCT03022370|524116735|FG001|Overall Study|Death|12|||
145346765|NCT03022370|524116734|FG000|Overall Study|Lost to Follow-up|174|||
145346766|NCT03022370|524116735|FG001|Overall Study|Lost to Follow-up|109|||
145346767|NCT00668317|524116736|FG000|Overall Study|Adverse Event|2|||
145346768|NCT01526655|524116740|FG000|Overall Study|Withdrawal by Subject|0|||
145346769|NCT01526655|524116741|FG001|Overall Study|Withdrawal by Subject|1|||
145346770|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
145346771|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Death|1|||
145346772|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
145346773|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
145346774|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
145346775|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
145346776|NCT02001987|524116743|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
145346777|NCT02001987|524116743|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
145346778|NCT02001987|524116743|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
145346779|NCT02001987|524116743|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
145346780|NCT02001987|524116743|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
145346781|NCT02001987|524116743|FG000|LTE Period (52 Weeks)|Other|3|||
145346782|NCT01965860|524116744|FG000|Overall Study|Pregnancy|1|||
145346783|NCT01965860|524116745|FG001|Overall Study|Pregnancy|0|||
145346784|NCT01965860|524116746|FG002|Overall Study|Pregnancy|1|||
145346785|NCT01965860|524116744|FG000|Overall Study|Logistics|1|||
145346786|NCT01965860|524116745|FG001|Overall Study|Logistics|0|||
145346787|NCT01965860|524116746|FG002|Overall Study|Logistics|0|||
145346788|NCT02064296|524116750|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
145346789|NCT02064296|524116751|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
145346790|NCT02064296|524116752|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
145346791|NCT02064296|524116750|FG000|Intervention|Withdrawal by Subject|0|||
145346792|NCT02064296|524116751|FG001|Intervention|Withdrawal by Subject|1|||
145346793|NCT02064296|524116752|FG002|Intervention|Withdrawal by Subject|2|||
145346794|NCT02288325|524116758|FG000|Run-in Period|Adverse Event|48|||
145346795|NCT02288325|524116759|FG001|Run-in Period|Adverse Event|0|||
145346796|NCT02288325|524116760|FG002|Run-in Period|Adverse Event|0|||
145346797|NCT02288325|524116758|FG000|Run-in Period|Lack of Efficacy|16|||
145346798|NCT02288325|524116759|FG001|Run-in Period|Lack of Efficacy|0|||
145346799|NCT02288325|524116760|FG002|Run-in Period|Lack of Efficacy|0|||
145346800|NCT02288325|524116758|FG000|Run-in Period|Withdrawal of Consent|28|||
145346801|NCT02288325|524116759|FG001|Run-in Period|Withdrawal of Consent|0|||
145346802|NCT02288325|524116760|FG002|Run-in Period|Withdrawal of Consent|0|||
145346803|NCT02288325|524116758|FG000|Run-in Period|Lost to Follow-up|25|||
145346804|NCT02288325|524116759|FG001|Run-in Period|Lost to Follow-up|0|||
145346805|NCT02288325|524116760|FG002|Run-in Period|Lost to Follow-up|0|||
145346806|NCT02288325|524116758|FG000|Run-in Period|Protocol Violation|17|||
145346807|NCT02288325|524116759|FG001|Run-in Period|Protocol Violation|0|||
145346808|NCT02288325|524116760|FG002|Run-in Period|Protocol Violation|0|||
145576854|NCT01969838|524967936|FG000|Open-label Phase|Lack of Efficacy|0|||
145346809|NCT02288325|524116758|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
145346810|NCT02288325|524116759|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
145346811|NCT02288325|524116760|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
145346812|NCT02288325|524116758|FG000|Run-in Period|Reason not Specified|8|||
145346813|NCT02288325|524116759|FG001|Run-in Period|Reason not Specified|0|||
145346814|NCT02288325|524116760|FG002|Run-in Period|Reason not Specified|0|||
145346815|NCT02288325|524116758|FG000|Stabilization Period|Adverse Event|13|||
145576855|NCT01969838|524967937|FG001|Open-label Phase|Lack of Efficacy|0|||
145576856|NCT01969838|524967938|FG002|Open-label Phase|Lack of Efficacy|17|||
145346816|NCT02288325|524116759|FG001|Stabilization Period|Adverse Event|0|||
145346817|NCT02288325|524116760|FG002|Stabilization Period|Adverse Event|0|||
145346818|NCT02288325|524116758|FG000|Stabilization Period|Lack of Efficacy|22|||
145346819|NCT02288325|524116759|FG001|Stabilization Period|Lack of Efficacy|0|||
145346820|NCT02288325|524116760|FG002|Stabilization Period|Lack of Efficacy|0|||
145346821|NCT02288325|524116758|FG000|Stabilization Period|Withdrawal of Consent|23|||
145346822|NCT02288325|524116759|FG001|Stabilization Period|Withdrawal of Consent|0|||
145346823|NCT02288325|524116760|FG002|Stabilization Period|Withdrawal of Consent|0|||
145346824|NCT02288325|524116758|FG000|Stabilization Period|Lost to Follow-up|12|||
145346825|NCT02288325|524116759|FG001|Stabilization Period|Lost to Follow-up|0|||
145346826|NCT02288325|524116760|FG002|Stabilization Period|Lost to Follow-up|0|||
145346827|NCT02288325|524116758|FG000|Stabilization Period|Protocol Violation|8|||
145346828|NCT02288325|524116759|FG001|Stabilization Period|Protocol Violation|0|||
145346829|NCT02288325|524116760|FG002|Stabilization Period|Protocol Violation|0|||
145346830|NCT02288325|524116758|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
145346831|NCT02288325|524116759|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
145346832|NCT02288325|524116760|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
145346833|NCT02288325|524116758|FG000|Stabilization Period|Reason not Specified|15|||
145346834|NCT02288325|524116759|FG001|Stabilization Period|Reason not Specified|0|||
145346835|NCT02288325|524116760|FG002|Stabilization Period|Reason not Specified|0|||
145346836|NCT02288325|524116758|FG000|Double-blind Treatment Period|Adverse Event|0|||
145346837|NCT02288325|524116759|FG001|Double-blind Treatment Period|Adverse Event|2|||
145346838|NCT02288325|524116760|FG002|Double-blind Treatment Period|Adverse Event|5|||
145346839|NCT02288325|524116758|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
145346840|NCT02288325|524116759|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
145346841|NCT02288325|524116760|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
145346842|NCT02288325|524116758|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145346843|NCT02288325|524116759|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
145346844|NCT02288325|524116760|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
145346845|NCT02288325|524116758|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145346846|NCT02288325|524116759|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145346847|NCT02288325|524116760|FG002|Double-blind Treatment Period|Protocol Violation|2|||
145346848|NCT02288325|524116758|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
145346849|NCT02288325|524116759|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
145346850|NCT02288325|524116760|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
145346851|NCT02288325|524116758|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
145346852|NCT02288325|524116759|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
145346853|NCT02288325|524116760|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
145346854|NCT03735121|524116763|FG000|Overall Study|Death|3|||
145346855|NCT03735121|524116764|FG001|Overall Study|Death|6|||
145346856|NCT03735121|524116765|FG002|Overall Study|Death|8|||
145346857|NCT03735121|524116766|FG003|Overall Study|Death|37|||
145346858|NCT03735121|524116767|FG004|Overall Study|Death|86|||
145346859|NCT03735121|524116763|FG000|Overall Study|Withdrawal by Subject|1|||
145346860|NCT03735121|524116764|FG001|Overall Study|Withdrawal by Subject|1|||
145346861|NCT03735121|524116765|FG002|Overall Study|Withdrawal by Subject|3|||
145346862|NCT03735121|524116766|FG003|Overall Study|Withdrawal by Subject|4|||
145346863|NCT03735121|524116767|FG004|Overall Study|Withdrawal by Subject|2|||
145576857|NCT01969838|524967939|FG003|Open-label Phase|Lack of Efficacy|19|||
145576858|NCT01969838|524967936|FG000|Open-label Phase|Subject Decision|0|||
145576859|NCT01969838|524967937|FG001|Open-label Phase|Subject Decision|0|||
145346864|NCT03735121|524116763|FG000|Overall Study|Progressive Disease|0|||
145346865|NCT03735121|524116764|FG001|Overall Study|Progressive Disease|0|||
145346866|NCT03735121|524116765|FG002|Overall Study|Progressive Disease|1|||
145346867|NCT03735121|524116766|FG003|Overall Study|Progressive Disease|0|||
145346868|NCT03735121|524116767|FG004|Overall Study|Progressive Disease|0|||
145346869|NCT03735121|524116763|FG000|Overall Study|Lost to Follow-up|0|||
145346870|NCT03735121|524116764|FG001|Overall Study|Lost to Follow-up|0|||
145346871|NCT03735121|524116765|FG002|Overall Study|Lost to Follow-up|0|||
145346872|NCT03735121|524116766|FG003|Overall Study|Lost to Follow-up|0|||
145346873|NCT03735121|524116767|FG004|Overall Study|Lost to Follow-up|1|||
145346874|NCT03735121|524116763|FG000|Overall Study|Ongoing|3|||
145346875|NCT03735121|524116764|FG001|Overall Study|Ongoing|3|||
145346876|NCT03735121|524116765|FG002|Overall Study|Ongoing|26|||
145346877|NCT03735121|524116766|FG003|Overall Study|Ongoing|83|||
145346878|NCT03735121|524116767|FG004|Overall Study|Ongoing|158|||
145346879|NCT04036110|524116775|FG000|Overall Study|Lost to Follow-up|3|||
145346880|NCT04036110|524116776|FG001|Overall Study|Lost to Follow-up|2|||
145346881|NCT04036110|524116777|FG002|Overall Study|Lost to Follow-up|1|||
145346882|NCT04036110|524116775|FG000|Overall Study|Study Suspended|4|||
145346883|NCT04036110|524116776|FG001|Overall Study|Study Suspended|5|||
145346884|NCT04036110|524116777|FG002|Overall Study|Study Suspended|1|||
145346885|NCT01107197|524116778|FG000|Overall Study|Death|12|||
145346886|NCT01107197|524116779|FG001|Overall Study|Death|10|||
145576860|NCT01969838|524967938|FG002|Open-label Phase|Subject Decision|14|||
145576861|NCT01969838|524967939|FG003|Open-label Phase|Subject Decision|15|||
145346887|NCT01107197|524116778|FG000|Overall Study|Lost to Follow-up|5|||
145346888|NCT01107197|524116779|FG001|Overall Study|Lost to Follow-up|8|||
145346889|NCT01107197|524116778|FG000|Overall Study|Withdrawal by Subject|3|||
145346890|NCT01107197|524116779|FG001|Overall Study|Withdrawal by Subject|5|||
145346891|NCT05180227|524116780|FG000|Overall Study|Hypertension at screening|1|||
145346892|NCT05180227|524116780|FG000|Overall Study|Lost to Follow-up|1|||
145346893|NCT02593110|524116781|FG000|Overall Study|Withdrawal by Subject|0|||
145346894|NCT02593110|524116782|FG001|Overall Study|Withdrawal by Subject|3|||
145346895|NCT02593110|524116783|FG002|Overall Study|Withdrawal by Subject|3|||
145346896|NCT02593110|524116784|FG003|Overall Study|Withdrawal by Subject|2|||
145346897|NCT02593110|524116781|FG000|Overall Study|Death|0|||
145346898|NCT02593110|524116782|FG001|Overall Study|Death|0|||
145346899|NCT02593110|524116783|FG002|Overall Study|Death|1|||
145346900|NCT02593110|524116784|FG003|Overall Study|Death|0|||
145346901|NCT03548337|524116785|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
145346902|NCT03548337|524116786|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
145346903|NCT03548337|524116785|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
145346904|NCT03548337|524116786|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
145346905|NCT03548337|524116785|FG000|Infant Series|Lost to Follow-up|2|||
145346906|NCT03548337|524116786|FG001|Infant Series|Lost to Follow-up|1|||
145346907|NCT03548337|524116785|FG000|Infant Series|Adverse Event|0|||
145346908|NCT03548337|524116786|FG001|Infant Series|Adverse Event|2|||
145346909|NCT03548337|524116785|FG000|Infant Series|Randomized but Not Vaccinated|1|||
145346910|NCT03548337|524116786|FG001|Infant Series|Randomized but Not Vaccinated|0|||
145346911|NCT03548337|524116785|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
145346912|NCT03548337|524116786|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
145346913|NCT01911273|524116789|FG000|Overall Study|Progression of Disease|1|||
145346914|NCT01911273|524116790|FG001|Overall Study|Progression of Disease|0|||
145346915|NCT01911273|524116789|FG000|Overall Study|Withdrawal by Subject|0|||
145346916|NCT01911273|524116790|FG001|Overall Study|Withdrawal by Subject|2|||
145346917|NCT02359994|524116795|FG000|Overall Population Study|Adverse Event|1|||
145346918|NCT02359994|524116796|FG001|Overall Population Study|Adverse Event|1|||
145346919|NCT02359994|524116795|FG000|Overall Population Study|Death|1|||
145346920|NCT02359994|524116796|FG001|Overall Population Study|Death|5|||
145346921|NCT02359994|524116795|FG000|Overall Population Study|Lost to Follow-up|1|||
145346922|NCT02359994|524116796|FG001|Overall Population Study|Lost to Follow-up|1|||
145346923|NCT02359994|524116795|FG000|Overall Population Study|Withdrawal by Subject|1|||
145346924|NCT02359994|524116796|FG001|Overall Population Study|Withdrawal by Subject|0|||
145346925|NCT02359994|524116795|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
145346926|NCT02359994|524116796|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
145346927|NCT02359994|524116795|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
145346928|NCT02359994|524116796|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
145346929|NCT02359994|524116795|FG000|Extended Oncology 24-Month Survival|Death|19|||
145576862|NCT01969838|524967936|FG000|Open-label Phase|Death|0|||
145576863|NCT01969838|524967937|FG001|Open-label Phase|Death|0|||
145576864|NCT01969838|524967938|FG002|Open-label Phase|Death|13|||
145576865|NCT01969838|524967939|FG003|Open-label Phase|Death|11|||
145576866|NCT01969838|524967936|FG000|Open-label Phase|Physician Decision|0|||
145576867|NCT01969838|524967937|FG001|Open-label Phase|Physician Decision|0|||
145576868|NCT01969838|524967938|FG002|Open-label Phase|Physician Decision|9|||
145576869|NCT01969838|524967939|FG003|Open-label Phase|Physician Decision|14|||
145576870|NCT01969838|524967936|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
145576871|NCT01969838|524967937|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
145346930|NCT02359994|524116796|FG001|Extended Oncology 24-Month Survival|Death|21|||
145346931|NCT02359994|524116795|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
145346932|NCT02359994|524116796|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
145346933|NCT04597632|524116797|FG000|Overall Study|Withdrawal by Subject|10|||
145346934|NCT04597632|524116797|FG000|Overall Study|Lost to Follow-up|1|||
145346935|NCT04597632|524116797|FG000|Overall Study|Death|1|||
145346936|NCT04597632|524116797|FG000|Overall Study|Adverse Event|5|||
145346937|NCT03017612|524116800|FG000|Overall Study|Adverse Event|2|||
145346938|NCT04895982|524116801|FG000|Overall Study|Withdrawal by Subject|0|||
145346939|NCT04895982|524116802|FG001|Overall Study|Withdrawal by Subject|0|||
145346940|NCT04895982|524116803|FG002|Overall Study|Withdrawal by Subject|0|||
145346941|NCT04895982|524116804|FG003|Overall Study|Withdrawal by Subject|0|||
145346942|NCT04895982|524116805|FG004|Overall Study|Withdrawal by Subject|0|||
145346943|NCT04895982|524116806|FG005|Overall Study|Withdrawal by Subject|1|||
145346944|NCT04895982|524116807|FG006|Overall Study|Withdrawal by Subject|1|||
145414284|NCT02969018|524371207|FG001|Overall Study|Lost to Follow-up|2|||
145414285|NCT02969018|524371208|FG002|Overall Study|Lost to Follow-up|2|||
145346945|NCT04895982|524116808|FG007|Overall Study|Withdrawal by Subject|0|||
145576872|NCT01969838|524967938|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
145576873|NCT01969838|524967939|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
145576874|NCT00408993|524967940|FG000|Overall Study|Adverse Event|15|||
145346946|NCT04895982|524116809|FG008|Overall Study|Withdrawal by Subject|0|||
145346947|NCT04895982|524116810|FG009|Overall Study|Withdrawal by Subject|1|||
145346948|NCT04895982|524116811|FG010|Overall Study|Withdrawal by Subject|0|||
145346949|NCT04895982|524116812|FG011|Overall Study|Withdrawal by Subject|1|||
145346950|NCT04895982|524116801|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145346951|NCT04895982|524116802|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145346952|NCT04895982|524116803|FG002|Overall Study|Withdrawal by parent/guardian|3|||
145346953|NCT04895982|524116804|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145346954|NCT04895982|524116805|FG004|Overall Study|Withdrawal by parent/guardian|3|||
145346955|NCT04895982|524116806|FG005|Overall Study|Withdrawal by parent/guardian|2|||
145346956|NCT04895982|524116807|FG006|Overall Study|Withdrawal by parent/guardian|1|||
145346957|NCT04895982|524116808|FG007|Overall Study|Withdrawal by parent/guardian|0|||
145346958|NCT04895982|524116809|FG008|Overall Study|Withdrawal by parent/guardian|3|||
145346959|NCT04895982|524116810|FG009|Overall Study|Withdrawal by parent/guardian|0|||
145346960|NCT04895982|524116811|FG010|Overall Study|Withdrawal by parent/guardian|0|||
145346961|NCT04895982|524116812|FG011|Overall Study|Withdrawal by parent/guardian|0|||
145346962|NCT04895982|524116801|FG000|Overall Study|Other|0|||
145346963|NCT04895982|524116802|FG001|Overall Study|Other|0|||
145346964|NCT04895982|524116803|FG002|Overall Study|Other|1|||
145346965|NCT04895982|524116804|FG003|Overall Study|Other|1|||
145346966|NCT04895982|524116805|FG004|Overall Study|Other|0|||
145346967|NCT04895982|524116806|FG005|Overall Study|Other|0|||
145346968|NCT04895982|524116807|FG006|Overall Study|Other|0|||
145346969|NCT04895982|524116808|FG007|Overall Study|Other|0|||
145346970|NCT04895982|524116809|FG008|Overall Study|Other|0|||
145346971|NCT04895982|524116810|FG009|Overall Study|Other|1|||
145346972|NCT04895982|524116811|FG010|Overall Study|Other|0|||
145346973|NCT04895982|524116812|FG011|Overall Study|Other|0|||
145346974|NCT04895982|524116801|FG000|Overall Study|Protocol Violation|0|||
145346975|NCT04895982|524116802|FG001|Overall Study|Protocol Violation|0|||
145346976|NCT04895982|524116803|FG002|Overall Study|Protocol Violation|1|||
145346977|NCT04895982|524116804|FG003|Overall Study|Protocol Violation|1|||
145346978|NCT04895982|524116805|FG004|Overall Study|Protocol Violation|1|||
145346979|NCT04895982|524116806|FG005|Overall Study|Protocol Violation|0|||
145346980|NCT04895982|524116807|FG006|Overall Study|Protocol Violation|0|||
145346981|NCT04895982|524116808|FG007|Overall Study|Protocol Violation|1|||
145346982|NCT04895982|524116809|FG008|Overall Study|Protocol Violation|0|||
145346983|NCT04895982|524116810|FG009|Overall Study|Protocol Violation|0|||
145346984|NCT04895982|524116811|FG010|Overall Study|Protocol Violation|0|||
145346985|NCT04895982|524116812|FG011|Overall Study|Protocol Violation|0|||
145346986|NCT04895982|524116801|FG000|Overall Study|Lost to Follow-up|0|||
145346987|NCT04895982|524116802|FG001|Overall Study|Lost to Follow-up|0|||
145346988|NCT04895982|524116803|FG002|Overall Study|Lost to Follow-up|1|||
145346989|NCT04895982|524116804|FG003|Overall Study|Lost to Follow-up|0|||
145346990|NCT04895982|524116805|FG004|Overall Study|Lost to Follow-up|0|||
145346991|NCT04895982|524116806|FG005|Overall Study|Lost to Follow-up|1|||
145346992|NCT04895982|524116807|FG006|Overall Study|Lost to Follow-up|0|||
145346993|NCT04895982|524116808|FG007|Overall Study|Lost to Follow-up|0|||
145346994|NCT04895982|524116809|FG008|Overall Study|Lost to Follow-up|1|||
145346995|NCT04895982|524116810|FG009|Overall Study|Lost to Follow-up|0|||
145346996|NCT04895982|524116811|FG010|Overall Study|Lost to Follow-up|0|||
145346997|NCT04895982|524116812|FG011|Overall Study|Lost to Follow-up|0|||
145414286|NCT02969018|524371209|FG003|Overall Study|Lost to Follow-up|0|||
145346998|NCT04895982|524116801|FG000|Overall Study|Refused further study procedures|0|||
145346999|NCT04895982|524116802|FG001|Overall Study|Refused further study procedures|0|||
145347000|NCT04895982|524116803|FG002|Overall Study|Refused further study procedures|1|||
145347001|NCT04895982|524116804|FG003|Overall Study|Refused further study procedures|0|||
145347002|NCT04895982|524116805|FG004|Overall Study|Refused further study procedures|0|||
145347003|NCT04895982|524116806|FG005|Overall Study|Refused further study procedures|0|||
145347004|NCT04895982|524116807|FG006|Overall Study|Refused further study procedures|0|||
145347005|NCT04895982|524116808|FG007|Overall Study|Refused further study procedures|0|||
145347006|NCT04895982|524116809|FG008|Overall Study|Refused further study procedures|0|||
145347007|NCT04895982|524116810|FG009|Overall Study|Refused further study procedures|0|||
145347008|NCT04895982|524116811|FG010|Overall Study|Refused further study procedures|0|||
145347009|NCT04895982|524116812|FG011|Overall Study|Refused further study procedures|0|||
145347010|NCT00919854|524116815|FG000|Overall Study|Adverse Event|1|||
145347011|NCT01893346|524116818|FG000|Overall Study|Lost to Follow-up|0|||
145347012|NCT01893346|524116819|FG001|Overall Study|Lost to Follow-up|1|||
145347013|NCT01893346|524116820|FG002|Overall Study|Lost to Follow-up|0|||
145347014|NCT01893346|524116821|FG003|Overall Study|Lost to Follow-up|0|||
145347015|NCT01893346|524116818|FG000|Overall Study|Protocol Violation|1|||
145347016|NCT01893346|524116819|FG001|Overall Study|Protocol Violation|0|||
145347017|NCT01893346|524116820|FG002|Overall Study|Protocol Violation|0|||
145347018|NCT01893346|524116821|FG003|Overall Study|Protocol Violation|0|||
145347019|NCT01893346|524116818|FG000|Overall Study|Withdrawal by Subject|2|||
145347020|NCT01893346|524116819|FG001|Overall Study|Withdrawal by Subject|0|||
145347021|NCT01893346|524116820|FG002|Overall Study|Withdrawal by Subject|0|||
145347022|NCT01893346|524116821|FG003|Overall Study|Withdrawal by Subject|0|||
145347023|NCT01377012|524116825|FG000|Core Study|Study terminated by Sponsor|47|||
145347024|NCT01377012|524116826|FG001|Core Study|Study terminated by Sponsor|54|||
145347025|NCT01377012|524116827|FG002|Core Study|Study terminated by Sponsor|46|||
145347026|NCT01377012|524116825|FG000|Core Study|Technical problems|1|||
145347027|NCT01377012|524116826|FG001|Core Study|Technical problems|0|||
145347028|NCT01377012|524116827|FG002|Core Study|Technical problems|0|||
145347029|NCT01377012|524116825|FG000|Core Study|Withdrawal by Subject|15|||
145347030|NCT01377012|524116826|FG001|Core Study|Withdrawal by Subject|23|||
145347031|NCT01377012|524116827|FG002|Core Study|Withdrawal by Subject|18|||
145347032|NCT01377012|524116825|FG000|Core Study|Protocol Violation|7|||
145347033|NCT01377012|524116826|FG001|Core Study|Protocol Violation|3|||
145347034|NCT01377012|524116827|FG002|Core Study|Protocol Violation|2|||
145347035|NCT01377012|524116825|FG000|Core Study|Pregnancy|0|||
145347036|NCT01377012|524116826|FG001|Core Study|Pregnancy|0|||
145347037|NCT01377012|524116827|FG002|Core Study|Pregnancy|1|||
145347038|NCT01377012|524116825|FG000|Core Study|Physician Decision|5|||
145347039|NCT01377012|524116826|FG001|Core Study|Physician Decision|4|||
145347040|NCT01377012|524116827|FG002|Core Study|Physician Decision|10|||
145347041|NCT01377012|524116825|FG000|Core Study|Non-Compliant with study treatment|0|||
145347042|NCT01377012|524116826|FG001|Core Study|Non-Compliant with study treatment|0|||
145347043|NCT01377012|524116827|FG002|Core Study|Non-Compliant with study treatment|1|||
145347044|NCT01377012|524116825|FG000|Core Study|No Longer require treatment|0|||
145347045|NCT01377012|524116826|FG001|Core Study|No Longer require treatment|0|||
145347046|NCT01377012|524116827|FG002|Core Study|No Longer require treatment|1|||
145347047|NCT01377012|524116825|FG000|Core Study|Lost to Follow-up|7|||
145347048|NCT01377012|524116826|FG001|Core Study|Lost to Follow-up|5|||
145347049|NCT01377012|524116827|FG002|Core Study|Lost to Follow-up|4|||
145347050|NCT01377012|524116825|FG000|Core Study|Lack of Efficacy|41|||
145347051|NCT01377012|524116826|FG001|Core Study|Lack of Efficacy|28|||
145347052|NCT01377012|524116827|FG002|Core Study|Lack of Efficacy|37|||
145347053|NCT01377012|524116825|FG000|Core Study|Death|1|||
145347054|NCT01377012|524116826|FG001|Core Study|Death|1|||
145347055|NCT01377012|524116827|FG002|Core Study|Death|1|||
145347056|NCT01377012|524116825|FG000|Core Study|Adverse Event|10|||
145347057|NCT01377012|524116826|FG001|Core Study|Adverse Event|14|||
145347058|NCT01377012|524116827|FG002|Core Study|Adverse Event|13|||
145347059|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
145347060|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
145347061|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
145347062|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
145347063|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
145347064|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
145347065|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
145347066|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
145347067|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
145347068|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
145347069|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
145347070|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
145347071|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
145347072|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
145347073|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
145347074|NCT01377012|524116825|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
145347075|NCT01377012|524116826|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
145347076|NCT01377012|524116827|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
145347077|NCT01632280|524116845|FG000|Overall Study|Withdrawal by Subject|1|||
145347078|NCT01632280|524116846|FG001|Overall Study|Withdrawal by Subject|0|||
145347079|NCT03736031|524116854|FG000|Overall Study|Death|2|||
145347080|NCT03736031|524116855|FG001|Overall Study|Death|4|||
145347081|NCT03736031|524116854|FG000|Overall Study|Lost to Follow-up|21|||
145347082|NCT03736031|524116855|FG001|Overall Study|Lost to Follow-up|2|||
145347083|NCT03736031|524116854|FG000|Overall Study|Withdrawal by Subject|9|||
145347084|NCT03736031|524116855|FG001|Overall Study|Withdrawal by Subject|0|||
145347085|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
145347086|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
145347087|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
145347088|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
145347089|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
145347090|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
145347091|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
145347092|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
145347093|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
145347094|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
145347095|NCT00451178|524116856|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
145347096|NCT00451178|524116857|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
145347097|NCT00451178|524116856|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
145347098|NCT00451178|524116857|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
145347099|NCT00451178|524116856|FG000|Prior to Maintenance Therapy|PD|2|||
145347100|NCT00451178|524116857|FG001|Prior to Maintenance Therapy|PD|0|||
145347101|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
145347102|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
145347103|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
145347104|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
145347105|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
145347106|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
145347107|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
145347108|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
145347109|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
145347110|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
145347111|NCT00451178|524116856|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
145347112|NCT00451178|524116857|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
145347113|NCT00451178|524116856|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
145347114|NCT00451178|524116857|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
145347115|NCT00233948|524119069|FG000|Overall Study|Adverse Event|1|||
145347116|NCT00233948|524119070|FG001|Overall Study|Adverse Event|0|||
145347117|NCT00233948|524119071|FG002|Overall Study|Adverse Event|0|||
145347118|NCT00233948|524119072|FG003|Overall Study|Adverse Event|0|||
145347119|NCT00233948|524119073|FG004|Overall Study|Adverse Event|0|||
145347120|NCT00233948|524119074|FG005|Overall Study|Adverse Event|0|||
145347121|NCT03573830|524119075|FG000|Overall Study|Dropped without completing treatment|0|||
145347122|NCT03573830|524119076|FG001|Overall Study|Dropped without completing treatment|7|||
145347123|NCT03573830|524119075|FG000|Overall Study|Lost to Follow-up|4|||
145347124|NCT03573830|524119076|FG001|Overall Study|Lost to Follow-up|0|||
145347125|NCT03284723|524119077|FG000|Overall Study|Death|0|||
145347126|NCT03284723|524119078|FG001|Overall Study|Death|0|||
145347127|NCT03284723|524119079|FG002|Overall Study|Death|0|||
145347128|NCT03284723|524119080|FG003|Overall Study|Death|1|||
145347129|NCT03284723|524119081|FG004|Overall Study|Death|0|||
145347130|NCT03284723|524119082|FG005|Overall Study|Death|0|||
145347131|NCT03284723|524119083|FG006|Overall Study|Death|1|||
145347132|NCT03284723|524119084|FG007|Overall Study|Death|0|||
145347133|NCT03284723|524119085|FG008|Overall Study|Death|0|||
145347134|NCT03284723|524119086|FG009|Overall Study|Death|2|||
145347135|NCT03284723|524119087|FG010|Overall Study|Death|1|||
145347136|NCT03284723|524119088|FG011|Overall Study|Death|0|||
145347137|NCT03284723|524119077|FG000|Overall Study|Lost to Follow-up|0|||
145347138|NCT03284723|524119078|FG001|Overall Study|Lost to Follow-up|0|||
145347139|NCT03284723|524119079|FG002|Overall Study|Lost to Follow-up|0|||
145347140|NCT03284723|524119080|FG003|Overall Study|Lost to Follow-up|0|||
145347141|NCT03284723|524119081|FG004|Overall Study|Lost to Follow-up|0|||
145347142|NCT03284723|524119082|FG005|Overall Study|Lost to Follow-up|2|||
145347143|NCT03284723|524119083|FG006|Overall Study|Lost to Follow-up|1|||
145347144|NCT03284723|524119084|FG007|Overall Study|Lost to Follow-up|0|||
145347145|NCT03284723|524119085|FG008|Overall Study|Lost to Follow-up|0|||
145347146|NCT03284723|524119086|FG009|Overall Study|Lost to Follow-up|2|||
145347147|NCT03284723|524119087|FG010|Overall Study|Lost to Follow-up|0|||
145347148|NCT03284723|524119088|FG011|Overall Study|Lost to Follow-up|0|||
145347149|NCT03284723|524119077|FG000|Overall Study|Study Terminated By Sponsor|0|||
145347150|NCT03284723|524119078|FG001|Overall Study|Study Terminated By Sponsor|0|||
145347151|NCT03284723|524119079|FG002|Overall Study|Study Terminated By Sponsor|0|||
145347152|NCT03284723|524119080|FG003|Overall Study|Study Terminated By Sponsor|0|||
145347153|NCT03284723|524119081|FG004|Overall Study|Study Terminated By Sponsor|1|||
145347154|NCT03284723|524119082|FG005|Overall Study|Study Terminated By Sponsor|0|||
145347155|NCT03284723|524119083|FG006|Overall Study|Study Terminated By Sponsor|0|||
145347156|NCT03284723|524119084|FG007|Overall Study|Study Terminated By Sponsor|0|||
145347157|NCT03284723|524119085|FG008|Overall Study|Study Terminated By Sponsor|1|||
145347158|NCT03284723|524119086|FG009|Overall Study|Study Terminated By Sponsor|1|||
145347159|NCT03284723|524119087|FG010|Overall Study|Study Terminated By Sponsor|1|||
145347160|NCT03284723|524119088|FG011|Overall Study|Study Terminated By Sponsor|1|||
145347161|NCT03284723|524119077|FG000|Overall Study|Withdrawal by Subject|0|||
145347162|NCT03284723|524119078|FG001|Overall Study|Withdrawal by Subject|0|||
145347163|NCT03284723|524119079|FG002|Overall Study|Withdrawal by Subject|0|||
145347164|NCT03284723|524119080|FG003|Overall Study|Withdrawal by Subject|0|||
145347165|NCT03284723|524119081|FG004|Overall Study|Withdrawal by Subject|5|||
145347166|NCT03284723|524119082|FG005|Overall Study|Withdrawal by Subject|3|||
145347167|NCT03284723|524119083|FG006|Overall Study|Withdrawal by Subject|1|||
145347168|NCT03284723|524119084|FG007|Overall Study|Withdrawal by Subject|0|||
145347169|NCT03284723|524119085|FG008|Overall Study|Withdrawal by Subject|6|||
145347170|NCT03284723|524119086|FG009|Overall Study|Withdrawal by Subject|0|||
145347171|NCT03284723|524119087|FG010|Overall Study|Withdrawal by Subject|3|||
145347172|NCT03284723|524119088|FG011|Overall Study|Withdrawal by Subject|1|||
145347173|NCT03284723|524119077|FG000|Overall Study|Other|1|||
145347174|NCT03284723|524119078|FG001|Overall Study|Other|0|||
145347175|NCT03284723|524119079|FG002|Overall Study|Other|1|||
145347176|NCT03284723|524119080|FG003|Overall Study|Other|0|||
145347177|NCT03284723|524119081|FG004|Overall Study|Other|1|||
145347178|NCT03284723|524119082|FG005|Overall Study|Other|0|||
145347179|NCT03284723|524119083|FG006|Overall Study|Other|0|||
145347180|NCT03284723|524119084|FG007|Overall Study|Other|0|||
145347181|NCT03284723|524119085|FG008|Overall Study|Other|0|||
145347182|NCT03284723|524119086|FG009|Overall Study|Other|0|||
145347183|NCT03284723|524119087|FG010|Overall Study|Other|1|||
145347184|NCT03284723|524119088|FG011|Overall Study|Other|0|||
145347185|NCT03284723|524119077|FG000|Overall Study|Adverse Event|0|||
145347186|NCT03284723|524119078|FG001|Overall Study|Adverse Event|0|||
145347187|NCT03284723|524119079|FG002|Overall Study|Adverse Event|0|||
145347188|NCT03284723|524119080|FG003|Overall Study|Adverse Event|0|||
145347189|NCT03284723|524119081|FG004|Overall Study|Adverse Event|0|||
145347190|NCT03284723|524119082|FG005|Overall Study|Adverse Event|0|||
145347191|NCT03284723|524119083|FG006|Overall Study|Adverse Event|0|||
145347192|NCT03284723|524119084|FG007|Overall Study|Adverse Event|0|||
145347193|NCT03284723|524119085|FG008|Overall Study|Adverse Event|1|||
145347194|NCT03284723|524119086|FG009|Overall Study|Adverse Event|0|||
145347195|NCT03284723|524119087|FG010|Overall Study|Adverse Event|0|||
145347196|NCT03284723|524119088|FG011|Overall Study|Adverse Event|0|||
145347197|NCT00064987|524119091|FG000|Overall Study|Physician Decision|3|||
145347198|NCT00064987|524119092|FG001|Overall Study|Physician Decision|0|||
145347199|NCT02090725|524119093|FG000|Overall Study|Withdrawal by Subject|1|||
145347200|NCT02090725|524119093|FG000|Overall Study|participants moved from area|3|||
145347201|NCT00764881|524119097|FG000|Overall Study|Adverse Event|5|||
145347202|NCT00764881|524119098|FG001|Overall Study|Adverse Event|1|||
145347203|NCT00764881|524119097|FG000|Overall Study|Withdrawal by Subject|1|||
145347204|NCT00764881|524119098|FG001|Overall Study|Withdrawal by Subject|3|||
145347205|NCT00764881|524119097|FG000|Overall Study|Protocol Violation|2|||
145347206|NCT00764881|524119098|FG001|Overall Study|Protocol Violation|2|||
145347207|NCT00764881|524119097|FG000|Overall Study|Lost to Follow-up|2|||
145347208|NCT00764881|524119098|FG001|Overall Study|Lost to Follow-up|0|||
145347209|NCT00764881|524119097|FG000|Overall Study|Noncompliant|1|||
145347210|NCT00764881|524119098|FG001|Overall Study|Noncompliant|0|||
145347211|NCT00764881|524119097|FG000|Overall Study|Accidentally discontinued study drug|1|||
145347212|NCT00764881|524119098|FG001|Overall Study|Accidentally discontinued study drug|0|||
145347213|NCT00764881|524119097|FG000|Overall Study|Wished to become pregnant|1|||
145347214|NCT00764881|524119098|FG001|Overall Study|Wished to become pregnant|0|||
145347215|NCT00764881|524119097|FG000|Overall Study|Carcinoma detected|1|||
145347216|NCT00764881|524119098|FG001|Overall Study|Carcinoma detected|0|||
145347217|NCT00764881|524119097|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
145347218|NCT00764881|524119098|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
145347219|NCT00764881|524119097|FG000|Overall Study|no treatment or no observation|2|||
145347220|NCT00764881|524119098|FG001|Overall Study|no treatment or no observation|2|||
145347221|NCT01567462|524119099|FG000|Overall Study|Withdrawal by Subject|4|||
145347222|NCT01567462|524119100|FG001|Overall Study|Withdrawal by Subject|7|||
145347223|NCT00886015|524119101|FG000|Overall Study|Death|0|||
145347224|NCT00886015|524119102|FG001|Overall Study|Death|2|||
145347225|NCT02548156|524119107|FG000|Washout Period 1|Lost to Follow-up|0|||
145347226|NCT02548156|524119108|FG001|Washout Period 1|Lost to Follow-up|0|||
145347227|NCT02548156|524119109|FG002|Washout Period 1|Lost to Follow-up|0|||
145414287|NCT02969018|524371210|FG004|Overall Study|Lost to Follow-up|1|||
145622881|NCT01627340|525130208|FG001|Overall Study|Adverse Event|0|||
145347228|NCT02548156|524119110|FG003|Washout Period 1|Lost to Follow-up|0|||
145347229|NCT02548156|524119111|FG004|Washout Period 1|Lost to Follow-up|1|||
145347230|NCT02548156|524119112|FG005|Washout Period 1|Lost to Follow-up|0|||
145347231|NCT00444587|524119119|FG000|Overall Study|Death|2|||
145347232|NCT00444587|524119120|FG001|Overall Study|Death|1|||
145347233|NCT00444587|524119119|FG000|Overall Study|Progression of the disease|73|||
145347234|NCT00444587|524119120|FG001|Overall Study|Progression of the disease|8|||
145347235|NCT00444587|524119119|FG000|Overall Study|Refused treatment/did not cooperate|4|||
145347236|NCT00444587|524119120|FG001|Overall Study|Refused treatment/did not cooperate|1|||
145347237|NCT00444587|524119119|FG000|Overall Study|Investigator decision|3|||
145347238|NCT00444587|524119120|FG001|Overall Study|Investigator decision|0|||
145347239|NCT00444587|524119119|FG000|Overall Study|Protocol Violation|1|||
145347240|NCT00444587|524119120|FG001|Overall Study|Protocol Violation|0|||
145347241|NCT00444587|524119119|FG000|Overall Study|Missing|0|||
145347242|NCT00444587|524119120|FG001|Overall Study|Missing|5|||
145347243|NCT01473407|524119123|FG000|Overall Study|Physician Decision|1|||
145347244|NCT01473407|524119124|FG001|Overall Study|Physician Decision|4|||
145347245|NCT01473407|524119123|FG000|Overall Study|Lost to Follow-up|10|||
145347246|NCT01473407|524119124|FG001|Overall Study|Lost to Follow-up|4|||
145347247|NCT01473407|524119123|FG000|Overall Study|Adverse Event|8|||
145347248|NCT01473407|524119124|FG001|Overall Study|Adverse Event|8|||
145347249|NCT01473407|524119123|FG000|Overall Study|Randomization Error|3|||
145347250|NCT01473407|524119124|FG001|Overall Study|Randomization Error|1|||
145414288|NCT02969018|524371211|FG005|Overall Study|Lost to Follow-up|1|||
145347251|NCT01473407|524119123|FG000|Overall Study|Withdrawal by Subject|4|||
145347252|NCT01473407|524119124|FG001|Overall Study|Withdrawal by Subject|7|||
145347253|NCT01473407|524119123|FG000|Overall Study|Kidney Transplant|7|||
145347254|NCT01473407|524119124|FG001|Overall Study|Kidney Transplant|6|||
145347255|NCT01473407|524119123|FG000|Overall Study|Vacation/Travel|1|||
145347256|NCT01473407|524119124|FG001|Overall Study|Vacation/Travel|1|||
145347257|NCT01473407|524119123|FG000|Overall Study|Elevated Hemoglobin|1|||
145347258|NCT01473407|524119124|FG001|Overall Study|Elevated Hemoglobin|0|||
145347259|NCT01473407|524119123|FG000|Overall Study|Patient Received Aranesp|1|||
145347260|NCT01473407|524119124|FG001|Overall Study|Patient Received Aranesp|0|||
145347261|NCT01473407|524119123|FG000|Overall Study|Patient Lost Green Card Status|1|||
145347262|NCT01473407|524119124|FG001|Overall Study|Patient Lost Green Card Status|0|||
145347263|NCT01473407|524119123|FG000|Overall Study|Temperature Excursion|2|||
145347264|NCT01473407|524119124|FG001|Overall Study|Temperature Excursion|3|||
145347265|NCT01473407|524119123|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
145347266|NCT01473407|524119124|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
145347267|NCT01473407|524119123|FG000|Overall Study|Sponsor's Decision|10|||
145347268|NCT01473407|524119124|FG001|Overall Study|Sponsor's Decision|10|||
145347269|NCT01473407|524119123|FG000|Overall Study|Site Closure|1|||
145347270|NCT01473407|524119124|FG001|Overall Study|Site Closure|0|||
145347271|NCT00369941|524119125|FG000|Overall Study|Never Treated|1|||
145347272|NCT00369941|524119126|FG001|Overall Study|Never Treated|2|||
145347273|NCT00369941|524119125|FG000|Overall Study|Adverse Event|14|||
145347274|NCT00369941|524119126|FG001|Overall Study|Adverse Event|28|||
145347275|NCT00369941|524119125|FG000|Overall Study|Lack of Efficacy|6|||
145347276|NCT00369941|524119126|FG001|Overall Study|Lack of Efficacy|10|||
145347277|NCT00369941|524119125|FG000|Overall Study|Lost to Follow-up|12|||
145347278|NCT00369941|524119126|FG001|Overall Study|Lost to Follow-up|22|||
145347279|NCT00369941|524119125|FG000|Overall Study|Protocol Violation|5|||
145347280|NCT00369941|524119126|FG001|Overall Study|Protocol Violation|3|||
145347281|NCT00369941|524119125|FG000|Overall Study|Withdrawal by Subject|5|||
145347282|NCT00369941|524119126|FG001|Overall Study|Withdrawal by Subject|18|||
145347283|NCT00369941|524119125|FG000|Overall Study|Pregnancy|4|||
145347284|NCT00369941|524119126|FG001|Overall Study|Pregnancy|2|||
145347285|NCT00369941|524119125|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
145347286|NCT00369941|524119126|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
145347287|NCT00369941|524119125|FG000|Overall Study|Moved|11|||
145347288|NCT00369941|524119126|FG001|Overall Study|Moved|5|||
145347289|NCT00369941|524119125|FG000|Overall Study|Treatment with Prohibited Medication|3|||
145347290|NCT00369941|524119126|FG001|Overall Study|Treatment with Prohibited Medication|1|||
145347291|NCT00369941|524119125|FG000|Overall Study|Employment Interfered with Study Visits|1|||
145347292|NCT00369941|524119126|FG001|Overall Study|Employment Interfered with Study Visits|0|||
145347293|NCT00369941|524119125|FG000|Overall Study|Study Site Terminated|2|||
145347294|NCT00369941|524119126|FG001|Overall Study|Study Site Terminated|0|||
145347295|NCT00369941|524119125|FG000|Overall Study|Miscellaneous|3|||
145347296|NCT00369941|524119126|FG001|Overall Study|Miscellaneous|3|||
145347297|NCT01027702|524119127|FG000|Overall Study|Received subsequent therapy|1|||
145347298|NCT01027702|524119128|FG001|Overall Study|Received subsequent therapy|2|||
145347299|NCT01027702|524119129|FG002|Overall Study|Received subsequent therapy|0|||
145347300|NCT01027702|524119130|FG003|Overall Study|Received subsequent therapy|4|||
145347301|NCT01027702|524119131|FG004|Overall Study|Received subsequent therapy|1|||
145347302|NCT01027702|524119132|FG005|Overall Study|Received subsequent therapy|0|||
145347303|NCT01027702|524119133|FG006|Overall Study|Received subsequent therapy|1|||
145347304|NCT01027702|524119127|FG000|Overall Study|Death|0|||
145347305|NCT01027702|524119128|FG001|Overall Study|Death|0|||
145347306|NCT01027702|524119129|FG002|Overall Study|Death|1|||
145347307|NCT01027702|524119130|FG003|Overall Study|Death|0|||
145347308|NCT01027702|524119131|FG004|Overall Study|Death|0|||
145347309|NCT01027702|524119132|FG005|Overall Study|Death|0|||
145347310|NCT01027702|524119133|FG006|Overall Study|Death|0|||
145347311|NCT00403585|524119134|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
145347312|NCT00403585|524119134|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
145347313|NCT00403585|524119134|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
145347314|NCT02862730|524119143|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347315|NCT02862730|524119144|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347316|NCT02862730|524119145|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
145347317|NCT02862730|524119146|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347318|NCT02862730|524119147|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347319|NCT02862730|524119148|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347320|NCT02862730|524119149|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
145347321|NCT02862730|524119143|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
145347322|NCT02862730|524119144|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347323|NCT02862730|524119145|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347324|NCT02862730|524119146|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347325|NCT02862730|524119147|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347326|NCT02862730|524119148|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347327|NCT02862730|524119149|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
145347328|NCT02862730|524119143|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145347329|NCT02862730|524119144|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145347330|NCT02862730|524119145|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
145347331|NCT02862730|524119146|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145347332|NCT02862730|524119147|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
145347333|NCT02862730|524119148|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145347334|NCT02862730|524119149|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
145347335|NCT02862730|524119143|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347336|NCT02862730|524119144|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347337|NCT02862730|524119145|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347338|NCT02862730|524119146|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
145347339|NCT02862730|524119147|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347340|NCT02862730|524119148|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347341|NCT02862730|524119149|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
145347342|NCT03685344|524119150|FG000|Overall Study|Withdrawal by Subject|1|||
145347343|NCT03685344|524119151|FG001|Overall Study|Withdrawal by Subject|1|||
145347344|NCT03685344|524119152|FG002|Overall Study|Withdrawal by Subject|2|||
145347345|NCT03685344|524119153|FG003|Overall Study|Withdrawal by Subject|0|||
145347346|NCT03685344|524119150|FG000|Overall Study|Physician Decision|1|||
145347347|NCT03685344|524119151|FG001|Overall Study|Physician Decision|1|||
145347348|NCT03685344|524119152|FG002|Overall Study|Physician Decision|5|||
145347349|NCT03685344|524119153|FG003|Overall Study|Physician Decision|0|||
145347350|NCT03685344|524119150|FG000|Overall Study|Death|1|||
145347351|NCT03685344|524119151|FG001|Overall Study|Death|1|||
145347352|NCT03685344|524119152|FG002|Overall Study|Death|0|||
145347353|NCT03685344|524119153|FG003|Overall Study|Death|0|||
145347354|NCT02932462|524119156|FG000|Overall Study|Adverse Event|1|||
145347355|NCT02932462|524119157|FG001|Overall Study|Adverse Event|2|||
145347356|NCT02932462|524119156|FG000|Overall Study|Lost to Follow-up|4|||
145347357|NCT02932462|524119157|FG001|Overall Study|Lost to Follow-up|1|||
145347358|NCT02932462|524119156|FG000|Overall Study|Protocol Violation|0|||
145347359|NCT02932462|524119157|FG001|Overall Study|Protocol Violation|5|||
145347360|NCT02932462|524119156|FG000|Overall Study|Withdrawal by Subject|1|||
145347361|NCT02932462|524119157|FG001|Overall Study|Withdrawal by Subject|4|||
145347362|NCT02932462|524119156|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145347363|NCT02932462|524119157|FG001|Overall Study|Non-Compliance With Study Drug|1|||
145347364|NCT02932462|524119156|FG000|Overall Study|Progressive Disease|1|||
145347365|NCT02932462|524119157|FG001|Overall Study|Progressive Disease|0|||
145347366|NCT01232452|524119158|FG000|Overall Study|Adverse Event|17|||
145347367|NCT01232452|524119159|FG001|Overall Study|Adverse Event|15|||
145347368|NCT01232452|524119158|FG000|Overall Study|Withdrawal by Subject|11|||
145347369|NCT01232452|524119159|FG001|Overall Study|Withdrawal by Subject|8|||
145347370|NCT01232452|524119158|FG000|Overall Study|Physician Decision|8|||
145347371|NCT01232452|524119159|FG001|Overall Study|Physician Decision|12|||
145347372|NCT01232452|524119158|FG000|Overall Study|Protocol entry criterion not met|0|||
145347373|NCT01232452|524119159|FG001|Overall Study|Protocol entry criterion not met|2|||
145347374|NCT01232452|524119158|FG000|Overall Study|Sponsor Decision|3|||
145347375|NCT01232452|524119159|FG001|Overall Study|Sponsor Decision|1|||
145347376|NCT01232452|524119158|FG000|Overall Study|Protocol Violation|0|||
145347377|NCT01232452|524119159|FG001|Overall Study|Protocol Violation|1|||
145347378|NCT02009722|524119160|FG000|Overall Study|Protocol Violation|1|||
145347379|NCT02009722|524119161|FG001|Overall Study|Protocol Violation|2|||
145347380|NCT02009722|524119160|FG000|Overall Study|Did not receive intervention|0|||
145347381|NCT02009722|524119161|FG001|Overall Study|Did not receive intervention|1|||
145347382|NCT02454933|524119168|FG000|Overall Study|Progressive disease|10|||
145347383|NCT02454933|524119169|FG001|Overall Study|Progressive disease|7|||
145347384|NCT02454933|524119168|FG000|Overall Study|Adverse Event|1|||
145347385|NCT02454933|524119169|FG001|Overall Study|Adverse Event|1|||
145347386|NCT02454933|524119168|FG000|Overall Study|Withdrawal by Subject|0|||
145347387|NCT02454933|524119169|FG001|Overall Study|Withdrawal by Subject|3|||
145347388|NCT02454933|524119168|FG000|Overall Study|Lost to Follow-up|1|||
145347389|NCT02454933|524119169|FG001|Overall Study|Lost to Follow-up|0|||
145347390|NCT02071225|524119170|FG000|Overall Study|Withdrawal of Consent|2|||
145347391|NCT02071225|524119170|FG000|Overall Study|Protocol Deviation|1|||
145347392|NCT02071225|524119170|FG000|Overall Study|Lost to Follow-up|2|||
145347393|NCT02071225|524119170|FG000|Overall Study|Death|25|||
145347394|NCT04753216|524119171|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
145347395|NCT04753216|524119171|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
145347396|NCT04753216|524119171|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
145347397|NCT01895777|524119172|FG000|Overall Study|Adverse Event|1|||
145347398|NCT01895777|524119173|FG001|Overall Study|Adverse Event|2|||
145347399|NCT01895777|524119172|FG000|Overall Study|Lost to Follow-up|2|||
145347400|NCT01895777|524119173|FG001|Overall Study|Lost to Follow-up|0|||
145347401|NCT01895777|524119172|FG000|Overall Study|Not treated|1|||
145347402|NCT01895777|524119173|FG001|Overall Study|Not treated|0|||
145347403|NCT01895777|524119172|FG000|Overall Study|Other reasons|3|||
145347404|NCT01895777|524119173|FG001|Overall Study|Other reasons|2|||
145347405|NCT01895777|524119172|FG000|Overall Study|Non-compliance with the CTP|2|||
145347406|NCT01895777|524119173|FG001|Overall Study|Non-compliance with the CTP|1|||
145347407|NCT01342081|524119174|FG000|Overall Study|Did not receive allocated intervention|0|||
145347408|NCT01342081|524119175|FG001|Overall Study|Did not receive allocated intervention|0|||
145347409|NCT01342081|524119176|FG002|Overall Study|Did not receive allocated intervention|1|||
145347410|NCT01342081|524119174|FG000|Overall Study|Adverse Event|1|||
145347411|NCT01342081|524119175|FG001|Overall Study|Adverse Event|0|||
145347412|NCT01342081|524119176|FG002|Overall Study|Adverse Event|0|||
145347413|NCT01342081|524119174|FG000|Overall Study|Physician Decision|0|||
145347414|NCT01342081|524119175|FG001|Overall Study|Physician Decision|1|||
145347415|NCT01342081|524119176|FG002|Overall Study|Physician Decision|0|||
145347416|NCT01342081|524119174|FG000|Overall Study|Withdrawal by Subject|1|||
145347417|NCT01342081|524119175|FG001|Overall Study|Withdrawal by Subject|1|||
145347418|NCT01342081|524119176|FG002|Overall Study|Withdrawal by Subject|0|||
145347419|NCT03571828|524119183|FG000|Overall Study|Withdrawal by Subject|1|||
145347420|NCT03571828|524119184|FG001|Overall Study|Withdrawal by Subject|0|||
145347421|NCT03571828|524119183|FG000|Overall Study|Decision by sponsor|5|||
145347422|NCT03571828|524119184|FG001|Overall Study|Decision by sponsor|1|||
145347423|NCT03571828|524119183|FG000|Overall Study|Death|2|||
145347424|NCT03571828|524119184|FG001|Overall Study|Death|0|||
145347425|NCT00666328|524119185|FG000|Overall Study|Death|2|||
145347426|NCT00666328|524119185|FG000|Overall Study|Lost to Follow-up|2|||
145347427|NCT00666328|524119185|FG000|Overall Study|No longer met eligibility criteria|1|||
145347428|NCT02829918|524119188|FG000|Overall Study|Death|2|||
145347429|NCT02829918|524119188|FG000|Overall Study|Withdrawal by Subject|4|||
145347430|NCT02829918|524119188|FG000|Overall Study|Adverse Event|1|||
145347431|NCT02829918|524119188|FG000|Overall Study|Progression|1|||
145347432|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
145347433|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Off-label use|283|||
145347434|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
145347435|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
145347436|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
145347437|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
145347438|NCT01070953|524119190|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
145347439|NCT01070953|524119190|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
145347440|NCT01070953|524119190|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
145347441|NCT01070953|524119190|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
145347442|NCT01957176|524119191|FG000|Overall Study|Adverse Event|2|||
145347443|NCT01957176|524119192|FG001|Overall Study|Adverse Event|0|||
145347444|NCT01957176|524119191|FG000|Overall Study|Physician Decision|2|||
145347445|NCT01957176|524119192|FG001|Overall Study|Physician Decision|1|||
145347446|NCT01957176|524119191|FG000|Overall Study|Withdrawal by Subject|1|||
145347447|NCT01957176|524119192|FG001|Overall Study|Withdrawal by Subject|0|||
145347448|NCT00839254|524119193|FG000|Overall Study|Protocol Violation|0|||
145347449|NCT00839254|524119194|FG001|Overall Study|Protocol Violation|1|||
145347450|NCT00839254|524119195|FG002|Overall Study|Protocol Violation|1|||
145347451|NCT00839254|524119196|FG003|Overall Study|Protocol Violation|1|||
145347452|NCT00839254|524119197|FG004|Overall Study|Protocol Violation|0|||
145347453|NCT00839254|524119198|FG005|Overall Study|Protocol Violation|0|||
145347454|NCT00839254|524119199|FG006|Overall Study|Protocol Violation|1|||
145347455|NCT00839254|524119200|FG007|Overall Study|Protocol Violation|2|||
145347456|NCT00839254|524119193|FG000|Overall Study|Physician Decision|0|||
145347457|NCT00839254|524119194|FG001|Overall Study|Physician Decision|1|||
145347458|NCT00839254|524119195|FG002|Overall Study|Physician Decision|0|||
145347459|NCT00839254|524119196|FG003|Overall Study|Physician Decision|0|||
145347460|NCT00839254|524119197|FG004|Overall Study|Physician Decision|0|||
145347461|NCT00839254|524119198|FG005|Overall Study|Physician Decision|0|||
145347462|NCT00839254|524119199|FG006|Overall Study|Physician Decision|0|||
145347463|NCT00839254|524119200|FG007|Overall Study|Physician Decision|1|||
145347464|NCT00839254|524119193|FG000|Overall Study|Wrong treatment number allocation|0|||
145347465|NCT00839254|524119194|FG001|Overall Study|Wrong treatment number allocation|1|||
145347466|NCT00839254|524119195|FG002|Overall Study|Wrong treatment number allocation|0|||
145347467|NCT00839254|524119196|FG003|Overall Study|Wrong treatment number allocation|0|||
145347468|NCT00839254|524119197|FG004|Overall Study|Wrong treatment number allocation|0|||
145347469|NCT00839254|524119198|FG005|Overall Study|Wrong treatment number allocation|1|||
145347470|NCT00839254|524119199|FG006|Overall Study|Wrong treatment number allocation|0|||
145347471|NCT00839254|524119200|FG007|Overall Study|Wrong treatment number allocation|0|||
145347472|NCT00839254|524119193|FG000|Overall Study|Adverse Event|12|||
145347473|NCT00839254|524119194|FG001|Overall Study|Adverse Event|6|||
145347474|NCT00839254|524119195|FG002|Overall Study|Adverse Event|3|||
145347475|NCT00839254|524119196|FG003|Overall Study|Adverse Event|5|||
145347476|NCT00839254|524119197|FG004|Overall Study|Adverse Event|2|||
145347477|NCT00839254|524119198|FG005|Overall Study|Adverse Event|1|||
145347478|NCT00839254|524119199|FG006|Overall Study|Adverse Event|0|||
145347479|NCT00839254|524119200|FG007|Overall Study|Adverse Event|1|||
145347480|NCT00839254|524119193|FG000|Overall Study|Withdrawal by Subject|87|||
145347481|NCT00839254|524119194|FG001|Overall Study|Withdrawal by Subject|53|||
145347482|NCT00839254|524119195|FG002|Overall Study|Withdrawal by Subject|54|||
145347483|NCT00839254|524119196|FG003|Overall Study|Withdrawal by Subject|32|||
145347484|NCT00839254|524119197|FG004|Overall Study|Withdrawal by Subject|27|||
145347485|NCT00839254|524119198|FG005|Overall Study|Withdrawal by Subject|15|||
145347486|NCT00839254|524119199|FG006|Overall Study|Withdrawal by Subject|22|||
145347487|NCT00839254|524119200|FG007|Overall Study|Withdrawal by Subject|9|||
145347488|NCT00839254|524119193|FG000|Overall Study|Wrong group allocation|0|||
145347489|NCT00839254|524119194|FG001|Overall Study|Wrong group allocation|0|||
145347490|NCT00839254|524119195|FG002|Overall Study|Wrong group allocation|0|||
145347491|NCT00839254|524119196|FG003|Overall Study|Wrong group allocation|0|||
145347492|NCT00839254|524119197|FG004|Overall Study|Wrong group allocation|0|||
145347493|NCT00839254|524119198|FG005|Overall Study|Wrong group allocation|0|||
145347494|NCT00839254|524119199|FG006|Overall Study|Wrong group allocation|1|||
145347495|NCT00839254|524119200|FG007|Overall Study|Wrong group allocation|0|||
145347496|NCT00839254|524119193|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
145347497|NCT00839254|524119194|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347498|NCT00839254|524119195|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347499|NCT00839254|524119196|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347500|NCT00839254|524119197|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347501|NCT00839254|524119198|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
145347502|NCT00839254|524119199|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347503|NCT00839254|524119200|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
145347504|NCT00839254|524119193|FG000|Overall Study|Withdrawn due to non-compliance|2|||
145347505|NCT00839254|524119194|FG001|Overall Study|Withdrawn due to non-compliance|0|||
145347506|NCT00839254|524119195|FG002|Overall Study|Withdrawn due to non-compliance|0|||
145347507|NCT00839254|524119196|FG003|Overall Study|Withdrawn due to non-compliance|0|||
145347508|NCT00839254|524119197|FG004|Overall Study|Withdrawn due to non-compliance|0|||
145347509|NCT00839254|524119198|FG005|Overall Study|Withdrawn due to non-compliance|0|||
145347510|NCT00839254|524119199|FG006|Overall Study|Withdrawn due to non-compliance|0|||
145347511|NCT00839254|524119200|FG007|Overall Study|Withdrawn due to non-compliance|0|||
145347512|NCT00839254|524119193|FG000|Overall Study|Lost to Follow-up|51|||
145347513|NCT00839254|524119194|FG001|Overall Study|Lost to Follow-up|30|||
145347514|NCT00839254|524119195|FG002|Overall Study|Lost to Follow-up|32|||
145347515|NCT00839254|524119196|FG003|Overall Study|Lost to Follow-up|24|||
145347516|NCT00839254|524119197|FG004|Overall Study|Lost to Follow-up|8|||
145347517|NCT00839254|524119198|FG005|Overall Study|Lost to Follow-up|8|||
145347518|NCT00839254|524119199|FG006|Overall Study|Lost to Follow-up|4|||
145347519|NCT00839254|524119200|FG007|Overall Study|Lost to Follow-up|2|||
145347520|NCT01823835|524119201|FG000|Overall Study|Adverse Event|0|||
145347521|NCT01823835|524119202|FG001|Overall Study|Adverse Event|0|||
145347522|NCT01823835|524119203|FG002|Overall Study|Adverse Event|0|||
145347523|NCT01823835|524119204|FG003|Overall Study|Adverse Event|0|||
145347524|NCT01823835|524119205|FG004|Overall Study|Adverse Event|1|||
145347525|NCT01823835|524119206|FG005|Overall Study|Adverse Event|0|||
145347526|NCT01823835|524119207|FG006|Overall Study|Adverse Event|1|||
145347527|NCT01823835|524119208|FG007|Overall Study|Adverse Event|0|||
145347528|NCT01823835|524119209|FG008|Overall Study|Adverse Event|0|||
145347529|NCT01823835|524119210|FG009|Overall Study|Adverse Event|0|||
145347530|NCT01823835|524119211|FG010|Overall Study|Adverse Event|1|||
145347531|NCT01823835|524119212|FG011|Overall Study|Adverse Event|2|||
145347532|NCT01823835|524119213|FG012|Overall Study|Adverse Event|0|||
145347533|NCT01823835|524119214|FG013|Overall Study|Adverse Event|0|||
145347534|NCT01823835|524119215|FG014|Overall Study|Adverse Event|0|||
145347535|NCT01823835|524119201|FG000|Overall Study|Physician Decision|0|||
145347536|NCT01823835|524119202|FG001|Overall Study|Physician Decision|0|||
145347537|NCT01823835|524119203|FG002|Overall Study|Physician Decision|0|||
145347538|NCT01823835|524119204|FG003|Overall Study|Physician Decision|0|||
145576875|NCT00408993|524967941|FG001|Overall Study|Adverse Event|4|||
145576876|NCT00408993|524967940|FG000|Overall Study|Protocol Violation|1|||
145347539|NCT01823835|524119205|FG004|Overall Study|Physician Decision|0|||
145347540|NCT01823835|524119206|FG005|Overall Study|Physician Decision|0|||
145576877|NCT00408993|524967941|FG001|Overall Study|Protocol Violation|6|||
145347541|NCT01823835|524119207|FG006|Overall Study|Physician Decision|0|||
145414289|NCT02969018|524371212|FG006|Overall Study|Lost to Follow-up|0|||
145414290|NCT02969018|524371213|FG007|Overall Study|Lost to Follow-up|1|||
145576878|NCT00408993|524967940|FG000|Overall Study|Lack of Efficacy|1|||
145576879|NCT00408993|524967941|FG001|Overall Study|Lack of Efficacy|4|||
145347542|NCT01823835|524119208|FG007|Overall Study|Physician Decision|0|||
145347543|NCT01823835|524119209|FG008|Overall Study|Physician Decision|0|||
145347544|NCT01823835|524119210|FG009|Overall Study|Physician Decision|0|||
145347545|NCT01823835|524119211|FG010|Overall Study|Physician Decision|0|||
145576880|NCT00408993|524967940|FG000|Overall Study|Withdrawal by Subject|2|||
145576881|NCT00408993|524967941|FG001|Overall Study|Withdrawal by Subject|3|||
145576882|NCT00298896|524967942|FG000|Overall Study|Death|3|||
145576883|NCT00298896|524967942|FG000|Overall Study|Physician Decision|2|||
145576884|NCT00298896|524967942|FG000|Overall Study|Intercurrent Illness|1|||
145576885|NCT00298896|524967942|FG000|Overall Study|Disease Progression|41|||
145576886|NCT00298896|524967942|FG000|Overall Study|Withdrawal by Subject|2|||
145576887|NCT00298896|524967942|FG000|Overall Study|Assigned to treatment in error|1|||
145576888|NCT02880371|524967943|FG000|Phase 1b|Lost to Follow-up|1|||
145576889|NCT02880371|524967944|FG001|Phase 1b|Lost to Follow-up|0|||
145576890|NCT02880371|524967945|FG002|Phase 1b|Lost to Follow-up|0|||
145576891|NCT02880371|524967946|FG003|Phase 1b|Lost to Follow-up|0|||
145576892|NCT02880371|524967947|FG004|Phase 1b|Lost to Follow-up|0|||
145576893|NCT02880371|524967948|FG005|Phase 1b|Lost to Follow-up|0|||
145576894|NCT02880371|524967949|FG006|Phase 1b|Lost to Follow-up|0|||
145576895|NCT02880371|524967950|FG007|Phase 1b|Lost to Follow-up|0|||
145576896|NCT02880371|524967943|FG000|Phase 1b|Participants terminated by Sponsor|1|||
145576897|NCT02880371|524967944|FG001|Phase 1b|Participants terminated by Sponsor|0|||
145576898|NCT02880371|524967945|FG002|Phase 1b|Participants terminated by Sponsor|0|||
145576899|NCT02880371|524967946|FG003|Phase 1b|Participants terminated by Sponsor|0|||
145576900|NCT02880371|524967947|FG004|Phase 1b|Participants terminated by Sponsor|0|||
145576901|NCT02880371|524967948|FG005|Phase 1b|Participants terminated by Sponsor|0|||
145576902|NCT02880371|524967949|FG006|Phase 1b|Participants terminated by Sponsor|0|||
145576903|NCT02880371|524967950|FG007|Phase 1b|Participants terminated by Sponsor|0|||
145576904|NCT02880371|524967943|FG000|Phase 1b|Withdrawal by Subject|0|||
145576905|NCT02880371|524967944|FG001|Phase 1b|Withdrawal by Subject|0|||
145576906|NCT02880371|524967945|FG002|Phase 1b|Withdrawal by Subject|1|||
145576907|NCT02880371|524967946|FG003|Phase 1b|Withdrawal by Subject|0|||
145576908|NCT02880371|524967947|FG004|Phase 1b|Withdrawal by Subject|0|||
145576909|NCT02880371|524967948|FG005|Phase 1b|Withdrawal by Subject|0|||
145576910|NCT02880371|524967949|FG006|Phase 1b|Withdrawal by Subject|0|||
145576911|NCT02880371|524967950|FG007|Phase 1b|Withdrawal by Subject|0|||
145576912|NCT02880371|524967943|FG000|Phase 1b|Death|4|||
145576913|NCT02880371|524967944|FG001|Phase 1b|Death|6|||
145576914|NCT02880371|524967945|FG002|Phase 1b|Death|5|||
145576915|NCT02880371|524967946|FG003|Phase 1b|Death|1|||
145576916|NCT02880371|524967947|FG004|Phase 1b|Death|0|||
145576917|NCT02880371|524967948|FG005|Phase 1b|Death|0|||
145576918|NCT02880371|524967949|FG006|Phase 1b|Death|0|||
145576919|NCT02880371|524967950|FG007|Phase 1b|Death|0|||
145576920|NCT02880371|524967943|FG000|Phase 1b|Enrolled but not Treated|0|||
145576921|NCT02880371|524967944|FG001|Phase 1b|Enrolled but not Treated|1|||
145576922|NCT02880371|524967945|FG002|Phase 1b|Enrolled but not Treated|0|||
145576923|NCT02880371|524967946|FG003|Phase 1b|Enrolled but not Treated|0|||
145576924|NCT02880371|524967947|FG004|Phase 1b|Enrolled but not Treated|0|||
145576925|NCT02880371|524967948|FG005|Phase 1b|Enrolled but not Treated|0|||
145576926|NCT02880371|524967949|FG006|Phase 1b|Enrolled but not Treated|0|||
145576927|NCT02880371|524967950|FG007|Phase 1b|Enrolled but not Treated|0|||
145576928|NCT02880371|524967943|FG000|Phase 2|Enrolled but not Treated|0|||
145576929|NCT02880371|524967944|FG001|Phase 2|Enrolled but not Treated|0|||
145576930|NCT02880371|524967945|FG002|Phase 2|Enrolled but not Treated|0|||
145576931|NCT02880371|524967946|FG003|Phase 2|Enrolled but not Treated|0|||
145576932|NCT02880371|524967947|FG004|Phase 2|Enrolled but not Treated|0|||
145576933|NCT02880371|524967948|FG005|Phase 2|Enrolled but not Treated|1|||
145576934|NCT02880371|524967949|FG006|Phase 2|Enrolled but not Treated|1|||
145576935|NCT02880371|524967950|FG007|Phase 2|Enrolled but not Treated|0|||
145576936|NCT02880371|524967943|FG000|Phase 2|Other|0|||
145576937|NCT02880371|524967944|FG001|Phase 2|Other|0|||
145576938|NCT02880371|524967945|FG002|Phase 2|Other|0|||
145576939|NCT02880371|524967946|FG003|Phase 2|Other|0|||
145576940|NCT02880371|524967947|FG004|Phase 2|Other|0|||
145576941|NCT02880371|524967948|FG005|Phase 2|Other|1|||
145622882|NCT01627340|525130207|FG000|Overall Study|Lost to Follow-up|8|||
145576942|NCT02880371|524967949|FG006|Phase 2|Other|2|||
145576943|NCT02880371|524967950|FG007|Phase 2|Other|1|||
145576944|NCT02880371|524967943|FG000|Phase 2|Participants terminated by Sponsor|0|||
145622883|NCT01627340|525130208|FG001|Overall Study|Lost to Follow-up|4|||
145622884|NCT01627340|525130207|FG000|Overall Study|Pregnancy|1|||
145622885|NCT01627340|525130208|FG001|Overall Study|Pregnancy|0|||
145576945|NCT02880371|524967944|FG001|Phase 2|Participants terminated by Sponsor|0|||
145576946|NCT02880371|524967945|FG002|Phase 2|Participants terminated by Sponsor|0|||
145576947|NCT02880371|524967946|FG003|Phase 2|Participants terminated by Sponsor|0|||
145576948|NCT02880371|524967947|FG004|Phase 2|Participants terminated by Sponsor|1|||
145576949|NCT02880371|524967948|FG005|Phase 2|Participants terminated by Sponsor|6|||
145576950|NCT02880371|524967949|FG006|Phase 2|Participants terminated by Sponsor|1|||
145576951|NCT02880371|524967950|FG007|Phase 2|Participants terminated by Sponsor|5|||
145576952|NCT02880371|524967943|FG000|Phase 2|Death|0|||
145576953|NCT02880371|524967944|FG001|Phase 2|Death|0|||
145576954|NCT02880371|524967945|FG002|Phase 2|Death|0|||
145576955|NCT02880371|524967946|FG003|Phase 2|Death|0|||
145576956|NCT02880371|524967947|FG004|Phase 2|Death|1|||
145576957|NCT02880371|524967948|FG005|Phase 2|Death|10|||
145576958|NCT02880371|524967949|FG006|Phase 2|Death|20|||
145576959|NCT02880371|524967950|FG007|Phase 2|Death|5|||
145576960|NCT02880371|524967943|FG000|Phase 2|Lost to Follow-up|0|||
145576961|NCT02880371|524967944|FG001|Phase 2|Lost to Follow-up|0|||
145576962|NCT02880371|524967945|FG002|Phase 2|Lost to Follow-up|0|||
145576963|NCT02880371|524967946|FG003|Phase 2|Lost to Follow-up|0|||
145576964|NCT02880371|524967947|FG004|Phase 2|Lost to Follow-up|0|||
145576965|NCT02880371|524967948|FG005|Phase 2|Lost to Follow-up|0|||
145576966|NCT02880371|524967949|FG006|Phase 2|Lost to Follow-up|3|||
145576967|NCT02880371|524967950|FG007|Phase 2|Lost to Follow-up|0|||
145576968|NCT02880371|524967943|FG000|Phase 2|Withdrawal by Subject|0|||
145576969|NCT02880371|524967944|FG001|Phase 2|Withdrawal by Subject|0|||
145576970|NCT02880371|524967945|FG002|Phase 2|Withdrawal by Subject|0|||
145576971|NCT02880371|524967946|FG003|Phase 2|Withdrawal by Subject|0|||
145576972|NCT02880371|524967947|FG004|Phase 2|Withdrawal by Subject|0|||
145576973|NCT02880371|524967948|FG005|Phase 2|Withdrawal by Subject|1|||
145576974|NCT02880371|524967949|FG006|Phase 2|Withdrawal by Subject|1|||
145576975|NCT02880371|524967950|FG007|Phase 2|Withdrawal by Subject|0|||
145576976|NCT02880371|524967943|FG000|Phase 2|End of Study page not completed by error|0|||
145576977|NCT02880371|524967944|FG001|Phase 2|End of Study page not completed by error|0|||
145576978|NCT02880371|524967945|FG002|Phase 2|End of Study page not completed by error|0|||
145576979|NCT02880371|524967946|FG003|Phase 2|End of Study page not completed by error|0|||
145576980|NCT02880371|524967947|FG004|Phase 2|End of Study page not completed by error|0|||
145576981|NCT02880371|524967948|FG005|Phase 2|End of Study page not completed by error|1|||
145576982|NCT02880371|524967949|FG006|Phase 2|End of Study page not completed by error|0|||
145576983|NCT02880371|524967950|FG007|Phase 2|End of Study page not completed by error|0|||
145576984|NCT02660359|524967951|FG000|Overall Study|Protocol Deviation|0|||
145576985|NCT02660359|524967952|FG001|Overall Study|Protocol Deviation|0|||
145347546|NCT01823835|524119212|FG011|Overall Study|Physician Decision|2|||
145347547|NCT01823835|524119213|FG012|Overall Study|Physician Decision|0|||
145347548|NCT01823835|524119214|FG013|Overall Study|Physician Decision|0|||
145347549|NCT01823835|524119215|FG014|Overall Study|Physician Decision|0|||
145347550|NCT01823835|524119201|FG000|Overall Study|Progressive Disease|3|||
145347551|NCT01823835|524119202|FG001|Overall Study|Progressive Disease|4|||
145347552|NCT01823835|524119203|FG002|Overall Study|Progressive Disease|3|||
145347553|NCT01823835|524119204|FG003|Overall Study|Progressive Disease|6|||
145347554|NCT01823835|524119205|FG004|Overall Study|Progressive Disease|4|||
145347555|NCT01823835|524119206|FG005|Overall Study|Progressive Disease|6|||
145347556|NCT01823835|524119207|FG006|Overall Study|Progressive Disease|5|||
145347557|NCT01823835|524119208|FG007|Overall Study|Progressive Disease|3|||
145347558|NCT01823835|524119209|FG008|Overall Study|Progressive Disease|3|||
145347559|NCT01823835|524119210|FG009|Overall Study|Progressive Disease|18|||
145347560|NCT01823835|524119211|FG010|Overall Study|Progressive Disease|8|||
145347561|NCT01823835|524119212|FG011|Overall Study|Progressive Disease|46|||
145347562|NCT01823835|524119213|FG012|Overall Study|Progressive Disease|18|||
145347563|NCT01823835|524119214|FG013|Overall Study|Progressive Disease|4|||
145347564|NCT01823835|524119215|FG014|Overall Study|Progressive Disease|6|||
145347565|NCT01823835|524119201|FG000|Overall Study|Study Termination|0|||
145347566|NCT01823835|524119202|FG001|Overall Study|Study Termination|0|||
145347567|NCT01823835|524119203|FG002|Overall Study|Study Termination|0|||
145347568|NCT01823835|524119204|FG003|Overall Study|Study Termination|0|||
145347569|NCT01823835|524119205|FG004|Overall Study|Study Termination|1|||
145347570|NCT01823835|524119206|FG005|Overall Study|Study Termination|0|||
145347571|NCT01823835|524119207|FG006|Overall Study|Study Termination|0|||
145347572|NCT01823835|524119208|FG007|Overall Study|Study Termination|0|||
145347573|NCT01823835|524119209|FG008|Overall Study|Study Termination|0|||
145347574|NCT01823835|524119210|FG009|Overall Study|Study Termination|0|||
145347575|NCT01823835|524119211|FG010|Overall Study|Study Termination|0|||
145576986|NCT02660359|524967953|FG002|Overall Study|Protocol Deviation|1|||
145576987|NCT02660359|524967951|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
145576988|NCT02660359|524967952|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
145576989|NCT02660359|524967953|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
145576990|NCT02660359|524967951|FG000|Overall Study|Lack of Efficacy|1|||
145576991|NCT02660359|524967952|FG001|Overall Study|Lack of Efficacy|1|||
145576992|NCT02660359|524967953|FG002|Overall Study|Lack of Efficacy|1|||
145347576|NCT01823835|524119212|FG011|Overall Study|Study Termination|1|||
145347577|NCT01823835|524119213|FG012|Overall Study|Study Termination|0|||
145576993|NCT02660359|524967951|FG000|Overall Study|Adverse Event|0|||
145576994|NCT02660359|524967952|FG001|Overall Study|Adverse Event|1|||
145576995|NCT02660359|524967953|FG002|Overall Study|Adverse Event|0|||
145576996|NCT02660359|524967951|FG000|Overall Study|Other|2|||
145576997|NCT02660359|524967952|FG001|Overall Study|Other|1|||
145347578|NCT01823835|524119214|FG013|Overall Study|Study Termination|0|||
145347579|NCT01823835|524119215|FG014|Overall Study|Study Termination|0|||
145347580|NCT01823835|524119201|FG000|Overall Study|Withdrawal by Subject|0|||
145347581|NCT01823835|524119202|FG001|Overall Study|Withdrawal by Subject|0|||
145576998|NCT02660359|524967953|FG002|Overall Study|Other|3|||
145347582|NCT01823835|524119203|FG002|Overall Study|Withdrawal by Subject|1|||
145347583|NCT01823835|524119204|FG003|Overall Study|Withdrawal by Subject|0|||
145576999|NCT02660359|524967951|FG000|Overall Study|Withdrawal by Subject|7|||
145347584|NCT01823835|524119205|FG004|Overall Study|Withdrawal by Subject|0|||
145347585|NCT01823835|524119206|FG005|Overall Study|Withdrawal by Subject|0|||
145347586|NCT01823835|524119207|FG006|Overall Study|Withdrawal by Subject|0|||
145347587|NCT01823835|524119208|FG007|Overall Study|Withdrawal by Subject|0|||
145347588|NCT01823835|524119209|FG008|Overall Study|Withdrawal by Subject|0|||
145347589|NCT01823835|524119210|FG009|Overall Study|Withdrawal by Subject|1|||
145347590|NCT01823835|524119211|FG010|Overall Study|Withdrawal by Subject|1|||
145347591|NCT01823835|524119212|FG011|Overall Study|Withdrawal by Subject|2|||
145347592|NCT01823835|524119213|FG012|Overall Study|Withdrawal by Subject|1|||
145347593|NCT01823835|524119214|FG013|Overall Study|Withdrawal by Subject|0|||
145347594|NCT01823835|524119215|FG014|Overall Study|Withdrawal by Subject|0|||
145347595|NCT01320150|524119216|FG000|Overall Study|Protocol Violation|15|||
145347596|NCT01320150|524119216|FG000|Overall Study|Withdrawal by Subject|5|||
145347597|NCT01320150|524119216|FG000|Overall Study|Death|2|||
145347598|NCT01320150|524119216|FG000|Overall Study|Lost to Follow-up|44|||
145347599|NCT00985491|524119217|FG000|Overall Study|Adverse Event|8|||
145347600|NCT00985491|524119217|FG000|Overall Study|device migration|7|||
145347601|NCT00985491|524119217|FG000|Overall Study|Withdrawal by Subject|1|||
145347602|NCT00985491|524119217|FG000|Overall Study|implant failure|3|||
145347603|NCT02296931|524119220|FG000|Overall Study|Protocol Violation|0|||
145347604|NCT02296931|524119221|FG001|Overall Study|Protocol Violation|2|||
145347605|NCT01590277|524119222|FG000|Overall Study|Withdrawal by Subject|3|||
145347606|NCT01590277|524119222|FG000|Overall Study|Withdrawal by Subject|2|||
145347607|NCT01590277|524119222|FG000|Overall Study|Withdrawal by Subject|1|||
145347608|NCT01590277|524119222|FG000|Overall Study|Withdrawal by Subject|1|||
145347609|NCT04386616|524119223|FG000|Overall Study|Death|22|||
145347610|NCT04386616|524119224|FG001|Overall Study|Death|22|||
145347611|NCT04386616|524119225|FG002|Overall Study|Death|21|||
145347612|NCT04386616|524119223|FG000|Overall Study|Lost to Follow-up|5|||
145347613|NCT04386616|524119224|FG001|Overall Study|Lost to Follow-up|8|||
145347614|NCT04386616|524119225|FG002|Overall Study|Lost to Follow-up|6|||
145347615|NCT04386616|524119223|FG000|Overall Study|Withdrawal by Subject|2|||
145347616|NCT04386616|524119224|FG001|Overall Study|Withdrawal by Subject|4|||
145347617|NCT04386616|524119225|FG002|Overall Study|Withdrawal by Subject|1|||
145347618|NCT04386616|524119223|FG000|Overall Study|Adverse Event|1|||
145347619|NCT04386616|524119224|FG001|Overall Study|Adverse Event|1|||
145347620|NCT04386616|524119225|FG002|Overall Study|Adverse Event|0|||
145347621|NCT03086551|524119226|FG000|First Intervention|Failure to meet inclusion criterion|1|||
145347622|NCT03086551|524119227|FG001|First Intervention|Failure to meet inclusion criterion|0|||
145347623|NCT03086551|524119226|FG000|First Intervention|Lost to Follow-up|0|||
145347624|NCT03086551|524119227|FG001|First Intervention|Lost to Follow-up|1|||
145347625|NCT03086551|524119226|FG000|Washout|Lost to Follow-up|1|||
145347626|NCT03086551|524119227|FG001|Washout|Lost to Follow-up|2|||
145347627|NCT03086551|524119226|FG000|Washout|Withdrawal by Subject|2|||
145347628|NCT03086551|524119227|FG001|Washout|Withdrawal by Subject|1|||
145347629|NCT01260701|524119228|FG000|Overall Study|Adverse Event|9|||
145347630|NCT01260701|524119228|FG000|Overall Study|Withdrawal by Subject|2|||
145347631|NCT01260701|524119228|FG000|Overall Study|Progression|53|||
145347632|NCT01260701|524119228|FG000|Overall Study|Death|2|||
145347633|NCT01260701|524119228|FG000|Overall Study|Not protocol specified|3|||
145347634|NCT01260701|524119228|FG000|Overall Study|Under review|1|||
145347635|NCT01260701|524119228|FG000|Overall Study|Ineligible|4|||
145347636|NCT01260701|524119228|FG000|Overall Study|Did not begin protocol therapy|1|||
145347637|NCT01290302|524121028|FG000|Overall Study|Adverse Event|2|||
145347638|NCT01290302|524121029|FG001|Overall Study|Adverse Event|0|||
145347639|NCT01290302|524121028|FG000|Overall Study|Withdrawal by Subject|1|||
145347640|NCT01290302|524121029|FG001|Overall Study|Withdrawal by Subject|0|||
145347641|NCT01290302|524121028|FG000|Overall Study|Physician Decision|0|||
145347642|NCT01290302|524121029|FG001|Overall Study|Physician Decision|2|||
145347643|NCT01290302|524121028|FG000|Overall Study|Expiration of time for screening window|1|||
145347644|NCT01290302|524121029|FG001|Overall Study|Expiration of time for screening window|0|||
145347645|NCT04856917|524121032|FG000|Overall Study|Withdrawal by Subject|4|||
145347646|NCT04856917|524121033|FG001|Overall Study|Withdrawal by Subject|3|||
145347647|NCT04856917|524121034|FG002|Overall Study|Withdrawal by Subject|1|||
145347648|NCT04856917|524121032|FG000|Overall Study|Lost to Follow-up|3|||
145347649|NCT04856917|524121033|FG001|Overall Study|Lost to Follow-up|1|||
145577000|NCT02660359|524967952|FG001|Overall Study|Withdrawal by Subject|5|||
145577001|NCT02660359|524967953|FG002|Overall Study|Withdrawal by Subject|8|||
145577002|NCT02660359|524967951|FG000|Overall Study|Lost to Follow-up|3|||
145577003|NCT02660359|524967952|FG001|Overall Study|Lost to Follow-up|3|||
145347650|NCT04856917|524121034|FG002|Overall Study|Lost to Follow-up|1|||
145347651|NCT04856917|524121032|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
145347652|NCT04856917|524121033|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
145347653|NCT04856917|524121034|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
145347654|NCT04856917|524121032|FG000|Overall Study|Other|1|||
145347655|NCT04856917|524121033|FG001|Overall Study|Other|1|||
145347656|NCT04856917|524121034|FG002|Overall Study|Other|0|||
145347657|NCT02498613|524121035|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
145347658|NCT02498613|524121036|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
145347659|NCT02498613|524121037|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
145347660|NCT02498613|524121038|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
145347661|NCT02498613|524121035|FG000|Overall Study|Withdrawal by Subject|3|||
145347662|NCT02498613|524121036|FG001|Overall Study|Withdrawal by Subject|1|||
145347663|NCT02498613|524121037|FG002|Overall Study|Withdrawal by Subject|0|||
145347664|NCT02498613|524121038|FG003|Overall Study|Withdrawal by Subject|0|||
145347665|NCT05109611|524121040|FG000|Overall Study|Adverse Event|13|||
145347666|NCT05109611|524121041|FG001|Overall Study|Adverse Event|10|||
145347667|NCT05109611|524121040|FG000|Overall Study|Withdrawal by Subject|1|||
145347668|NCT05109611|524121041|FG001|Overall Study|Withdrawal by Subject|0|||
145347669|NCT05109611|524121040|FG000|Overall Study|Lost to Follow-up|1|||
145347670|NCT05109611|524121041|FG001|Overall Study|Lost to Follow-up|2|||
145347671|NCT05109611|524121040|FG000|Overall Study|Protocol Violation|0|||
145347672|NCT05109611|524121041|FG001|Overall Study|Protocol Violation|4|||
145347673|NCT05109611|524121040|FG000|Overall Study|Information unavailable|1|||
145347674|NCT05109611|524121041|FG001|Overall Study|Information unavailable|1|||
145347675|NCT06195930|524121042|FG000|Overall Study|Adverse Event|4|||
145347676|NCT03631199|524121043|FG000|Overall Study|Progressive disease|9|||
145347677|NCT03631199|524121044|FG001|Overall Study|Progressive disease|5|||
145347678|NCT03631199|524121045|FG002|Overall Study|Progressive disease|5|||
145347679|NCT03631199|524121046|FG003|Overall Study|Progressive disease|149|||
145347680|NCT03631199|524121047|FG004|Overall Study|Progressive disease|148|||
145347681|NCT03631199|524121043|FG000|Overall Study|Physician Decision|0|||
145347682|NCT03631199|524121044|FG001|Overall Study|Physician Decision|2|||
145347683|NCT03631199|524121045|FG002|Overall Study|Physician Decision|3|||
145347684|NCT03631199|524121046|FG003|Overall Study|Physician Decision|19|||
145347685|NCT03631199|524121047|FG004|Overall Study|Physician Decision|13|||
145347686|NCT03631199|524121043|FG000|Overall Study|Adverse Event|1|||
145347687|NCT03631199|524121044|FG001|Overall Study|Adverse Event|1|||
145347688|NCT03631199|524121045|FG002|Overall Study|Adverse Event|0|||
145347689|NCT03631199|524121046|FG003|Overall Study|Adverse Event|28|||
145347690|NCT03631199|524121047|FG004|Overall Study|Adverse Event|29|||
145347691|NCT03631199|524121043|FG000|Overall Study|Death|0|||
145347692|NCT03631199|524121044|FG001|Overall Study|Death|1|||
145347693|NCT03631199|524121045|FG002|Overall Study|Death|0|||
145347694|NCT03631199|524121046|FG003|Overall Study|Death|35|||
145347695|NCT03631199|524121047|FG004|Overall Study|Death|48|||
145347696|NCT03631199|524121043|FG000|Overall Study|Subject decision|0|||
145347697|NCT03631199|524121044|FG001|Overall Study|Subject decision|1|||
145347698|NCT03631199|524121045|FG002|Overall Study|Subject decision|0|||
145347699|NCT03631199|524121046|FG003|Overall Study|Subject decision|12|||
145347700|NCT03631199|524121047|FG004|Overall Study|Subject decision|12|||
145347701|NCT03631199|524121043|FG000|Overall Study|No treated|0|||
145347702|NCT03631199|524121044|FG001|Overall Study|No treated|0|||
145347703|NCT03631199|524121045|FG002|Overall Study|No treated|0|||
145347704|NCT03631199|524121046|FG003|Overall Study|No treated|0|||
145347705|NCT03631199|524121047|FG004|Overall Study|No treated|1|||
145347706|NCT03631199|524121043|FG000|Overall Study|Treatment ongoing|0|||
145347707|NCT03631199|524121044|FG001|Overall Study|Treatment ongoing|1|||
145347708|NCT03631199|524121045|FG002|Overall Study|Treatment ongoing|1|||
145347709|NCT03631199|524121046|FG003|Overall Study|Treatment ongoing|76|||
145347710|NCT03631199|524121047|FG004|Overall Study|Treatment ongoing|71|||
145347711|NCT03631199|524121043|FG000|Overall Study|Guardian decision|0|||
145347712|NCT03631199|524121044|FG001|Overall Study|Guardian decision|0|||
145347713|NCT03631199|524121045|FG002|Overall Study|Guardian decision|0|||
145347714|NCT03631199|524121046|FG003|Overall Study|Guardian decision|1|||
145347715|NCT03631199|524121047|FG004|Overall Study|Guardian decision|1|||
145347716|NCT03999996|524121048|FG000|Prior to Booster|Adverse Event|2|||
145347717|NCT03999996|524121049|FG001|Prior to Booster|Adverse Event|0|||
145347718|NCT03999996|524121050|FG002|Prior to Booster|Adverse Event|0|||
145347719|NCT03999996|524121051|FG003|Prior to Booster|Adverse Event|0|||
145347720|NCT03999996|524121048|FG000|Prior to Booster|Lost to Follow-up|17|||
145347721|NCT03999996|524121049|FG001|Prior to Booster|Lost to Follow-up|22|||
145347722|NCT03999996|524121050|FG002|Prior to Booster|Lost to Follow-up|0|||
145347723|NCT03999996|524121051|FG003|Prior to Booster|Lost to Follow-up|0|||
145347724|NCT03999996|524121048|FG000|Prior to Booster|Withdrawal of Consent|51|||
145347725|NCT03999996|524121049|FG001|Prior to Booster|Withdrawal of Consent|8|||
145347726|NCT03999996|524121050|FG002|Prior to Booster|Withdrawal of Consent|0|||
145347727|NCT03999996|524121051|FG003|Prior to Booster|Withdrawal of Consent|0|||
145577004|NCT02660359|524967953|FG002|Overall Study|Lost to Follow-up|0|||
145347728|NCT03999996|524121048|FG000|Prior to Booster|Death|0|||
145347729|NCT03999996|524121049|FG001|Prior to Booster|Death|1|||
145347730|NCT03999996|524121050|FG002|Prior to Booster|Death|0|||
145347731|NCT03999996|524121051|FG003|Prior to Booster|Death|0|||
145347732|NCT03999996|524121048|FG000|Prior to Booster|Reason Not Specified|27|||
145347733|NCT03999996|524121049|FG001|Prior to Booster|Reason Not Specified|4|||
145347734|NCT03999996|524121050|FG002|Prior to Booster|Reason Not Specified|0|||
145347735|NCT03999996|524121051|FG003|Prior to Booster|Reason Not Specified|0|||
145347736|NCT03999996|524121048|FG000|Booster Phase|Lost to Follow-up|0|||
145577005|NCT03394391|524967957|FG000|Overall Study|Lost to Follow-up|1|||
145347737|NCT03999996|524121049|FG001|Booster Phase|Lost to Follow-up|0|||
145347738|NCT03999996|524121050|FG002|Booster Phase|Lost to Follow-up|3|||
145347739|NCT03999996|524121051|FG003|Booster Phase|Lost to Follow-up|3|||
145347740|NCT03999996|524121048|FG000|Booster Phase|Withdrawal of Consent|0|||
145347741|NCT03999996|524121049|FG001|Booster Phase|Withdrawal of Consent|0|||
145347742|NCT03999996|524121050|FG002|Booster Phase|Withdrawal of Consent|0|||
145347743|NCT03999996|524121051|FG003|Booster Phase|Withdrawal of Consent|1|||
145347744|NCT03999996|524121048|FG000|Booster Phase|Reason Not Specified|0|||
145347745|NCT03999996|524121049|FG001|Booster Phase|Reason Not Specified|0|||
145347746|NCT03999996|524121050|FG002|Booster Phase|Reason Not Specified|0|||
145347747|NCT03999996|524121051|FG003|Booster Phase|Reason Not Specified|1|||
145347748|NCT03690388|524121052|FG000|Overall Study|Adverse Event|8|||
145347749|NCT03690388|524121053|FG001|Overall Study|Adverse Event|1|||
145347750|NCT03690388|524121052|FG000|Overall Study|Radiographic Progression|14|||
145347751|NCT03690388|524121053|FG001|Overall Study|Radiographic Progression|29|||
145347752|NCT03690388|524121052|FG000|Overall Study|Clinical deterioration|10|||
145347753|NCT03690388|524121053|FG001|Overall Study|Clinical deterioration|6|||
145347754|NCT03690388|524121052|FG000|Overall Study|Withdrawal by Subject|2|||
145347755|NCT03690388|524121053|FG001|Overall Study|Withdrawal by Subject|0|||
145347756|NCT03690388|524121052|FG000|Overall Study|Lack of Efficacy|1|||
145347757|NCT03690388|524121053|FG001|Overall Study|Lack of Efficacy|0|||
145347758|NCT03690388|524121052|FG000|Overall Study|Lost to Follow-up|1|||
145347759|NCT03690388|524121053|FG001|Overall Study|Lost to Follow-up|0|||
145347760|NCT00615199|524121062|FG000|Overall Study|Adverse Event|3|||
145347761|NCT00615199|524121063|FG001|Overall Study|Adverse Event|1|||
145347762|NCT00615199|524121064|FG002|Overall Study|Adverse Event|1|||
145347763|NCT00615199|524121065|FG003|Overall Study|Adverse Event|0|||
145347764|NCT00615199|524121062|FG000|Overall Study|Lack of Efficacy|2|||
145347765|NCT00615199|524121063|FG001|Overall Study|Lack of Efficacy|0|||
145347766|NCT00615199|524121064|FG002|Overall Study|Lack of Efficacy|0|||
145347767|NCT00615199|524121065|FG003|Overall Study|Lack of Efficacy|1|||
145347768|NCT00615199|524121062|FG000|Overall Study|Lost to Follow-up|1|||
145347769|NCT00615199|524121063|FG001|Overall Study|Lost to Follow-up|0|||
145347770|NCT00615199|524121064|FG002|Overall Study|Lost to Follow-up|0|||
145347771|NCT00615199|524121065|FG003|Overall Study|Lost to Follow-up|0|||
145347772|NCT00615199|524121062|FG000|Overall Study|Other|0|||
145347773|NCT00615199|524121063|FG001|Overall Study|Other|0|||
145347774|NCT00615199|524121064|FG002|Overall Study|Other|0|||
145347775|NCT00615199|524121065|FG003|Overall Study|Other|1|||
145347776|NCT00615199|524121062|FG000|Overall Study|Withdrawal by Subject|2|||
145347777|NCT00615199|524121063|FG001|Overall Study|Withdrawal by Subject|1|||
145347778|NCT00615199|524121064|FG002|Overall Study|Withdrawal by Subject|0|||
145347779|NCT00615199|524121065|FG003|Overall Study|Withdrawal by Subject|0|||
145347780|NCT02653625|524121068|FG000|Overall Study|Adverse Event|1|||
145347781|NCT02653625|524121068|FG000|Overall Study|Non-compliance with Study Drug|1|||
145347782|NCT02653625|524121068|FG000|Overall Study|Protocol Violation|1|||
145347783|NCT02653625|524121068|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
145347784|NCT02738138|524121083|FG000|Overall Study|Adverse Event|0|||
145347785|NCT02738138|524121084|FG001|Overall Study|Adverse Event|1|||
145347786|NCT02738138|524121083|FG000|Overall Study|Lost to Follow-up|2|||
145347787|NCT02738138|524121084|FG001|Overall Study|Lost to Follow-up|0|||
145347788|NCT02738138|524121083|FG000|Overall Study|Other - not further specified|1|||
145577006|NCT03394391|524967958|FG001|Overall Study|Lost to Follow-up|2|||
145577007|NCT04622254|524967959|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
145577008|NCT04622254|524967960|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
145577009|NCT04622254|524967961|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
145577010|NCT04622254|524967962|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
145577011|NCT04622254|524967963|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
145577012|NCT04622254|524967964|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
145577013|NCT04622254|524967959|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
145577014|NCT04622254|524967960|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
145577015|NCT04622254|524967961|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
145577016|NCT04622254|524967962|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145577017|NCT04622254|524967963|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145347789|NCT02738138|524121084|FG001|Overall Study|Other - not further specified|0|||
145347790|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Other|34|||
145347791|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Other|0|||
145347792|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Other|0|||
145347793|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Other|0|||
145347794|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Death|14|||
145347795|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Death|0|||
145347796|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Death|0|||
145347797|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Death|0|||
145347798|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
145347799|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
145577018|NCT04622254|524967964|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
145577019|NCT04622254|524967959|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
145577020|NCT04622254|524967960|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
145577021|NCT04622254|524967961|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
145577022|NCT04622254|524967962|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
145577023|NCT04622254|524967963|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
145577024|NCT04622254|524967964|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
145414291|NCT02969018|524371206|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414292|NCT02969018|524371207|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414293|NCT02969018|524371208|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414294|NCT02969018|524371209|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414295|NCT02969018|524371210|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414296|NCT02969018|524371211|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
145577025|NCT04622254|524967959|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145577026|NCT04622254|524967960|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
145577027|NCT04622254|524967961|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
145577028|NCT04622254|524967962|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145577029|NCT04622254|524967963|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145577030|NCT04622254|524967964|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
145577031|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145577032|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145577033|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145577034|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
145577035|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145577036|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
145577037|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145577038|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145577039|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145577040|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
145577041|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
145577042|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
145577043|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145577044|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145577045|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145347800|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
145347801|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
145347802|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
145347803|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145347804|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145347805|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
145347806|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
145347807|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
145347808|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
145347809|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
145347810|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
145347811|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145347812|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145347813|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
145347814|NCT01995513|524121087|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
145347815|NCT01995513|524121088|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145347816|NCT01995513|524121089|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145347817|NCT01995513|524121090|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
145347818|NCT01995513|524121087|FG000|Period 1: Second Open Label Treatment|Other|0|||
145347819|NCT01995513|524121088|FG001|Period 1: Second Open Label Treatment|Other|2|||
145347820|NCT01995513|524121089|FG002|Period 1: Second Open Label Treatment|Other|0|||
145347821|NCT01995513|524121090|FG003|Period 1: Second Open Label Treatment|Other|0|||
145347822|NCT01995513|524121087|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
145347823|NCT01995513|524121088|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
145347824|NCT01995513|524121089|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
145347825|NCT01995513|524121090|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
145347826|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Death|0|||
145577046|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
145577047|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145622886|NCT01627340|525130207|FG000|Overall Study|Withdrawal by Subject|2|||
145347827|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Death|0|||
145347828|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Death|0|||
145577048|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
145577049|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145577050|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145577051|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145577052|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
145577053|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145577054|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
145577055|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145577056|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145577057|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
145577058|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
145577059|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
145577060|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
145577061|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145577062|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145577063|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
145577064|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
145577065|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
145577066|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
145577067|NCT04622254|524967959|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
145577068|NCT04622254|524967960|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
145577069|NCT04622254|524967961|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
145577070|NCT04622254|524967962|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
145577071|NCT04622254|524967963|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
145577072|NCT04622254|524967964|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
145577073|NCT00451282|524967967|FG000|Overall Study|Lost to Follow-up|6|||
145577074|NCT00451282|524967968|FG001|Overall Study|Lost to Follow-up|5|||
145577075|NCT00098839|524967969|FG000|Overall Study|Adverse Event|5|||
145577076|NCT00098839|524967970|FG001|Overall Study|Adverse Event|2|||
145577077|NCT00098839|524967969|FG000|Overall Study|Death|1|||
145577078|NCT00098839|524967970|FG001|Overall Study|Death|2|||
145577079|NCT00098839|524967969|FG000|Overall Study|Physician Decision|4|||
145577080|NCT00098839|524967970|FG001|Overall Study|Physician Decision|14|||
145577081|NCT00098839|524967969|FG000|Overall Study|Withdrawal by Subject|1|||
145577082|NCT00098839|524967970|FG001|Overall Study|Withdrawal by Subject|0|||
145577083|NCT00098839|524967969|FG000|Overall Study|Refusal of further protocol therapy|3|||
145577084|NCT00098839|524967970|FG001|Overall Study|Refusal of further protocol therapy|1|||
145577085|NCT00098839|524967969|FG000|Overall Study|Relapse|6|||
145577086|NCT00098839|524967970|FG001|Overall Study|Relapse|3|||
145577087|NCT00098839|524967969|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
145577088|NCT00098839|524967970|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
145577089|NCT00098839|524967969|FG000|Overall Study|Ineligible|2|||
145577090|NCT00098839|524967970|FG001|Overall Study|Ineligible|0|||
145577091|NCT03228680|524967972|FG000|Overall Study|Adverse Event|13|||
145577092|NCT03228680|524967973|FG001|Overall Study|Adverse Event|18|||
145577093|NCT03228680|524967972|FG000|Overall Study|Randomization failure|0|||
145347829|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Death|1|||
145347830|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Other|0|||
145347831|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Other|0|||
145347832|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Other|3|||
145347833|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Other|3|||
145347834|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
145577094|NCT03228680|524967973|FG001|Overall Study|Randomization failure|1|||
145577095|NCT03228680|524967972|FG000|Overall Study|Withdrawal by Subject|1|||
145577096|NCT03228680|524967973|FG001|Overall Study|Withdrawal by Subject|0|||
145577097|NCT03228680|524967972|FG000|Overall Study|Other|9|||
145577098|NCT03228680|524967973|FG001|Overall Study|Other|16|||
145577099|NCT02489981|524967974|FG000|Overall Study|Adverse Event|21|||
145577100|NCT02489981|524967974|FG000|Overall Study|Insufficient effectiveness|16|||
145577101|NCT02489981|524967974|FG000|Overall Study|Improved|31|||
145577102|NCT02489981|524967974|FG000|Overall Study|Lost to Follow-up|31|||
145577103|NCT02489981|524967974|FG000|Overall Study|Other than listed|28|||
145577104|NCT03348904|524967977|FG000|Overall Study|Administrative reason by the sponsor|0|||
145347835|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
145577105|NCT03348904|524967978|FG001|Overall Study|Administrative reason by the sponsor|1|||
145577106|NCT03348904|524967979|FG002|Overall Study|Administrative reason by the sponsor|0|||
145577107|NCT01743092|524967981|FG000|Overall Study|Lost to Follow-up|14|||
145577108|NCT01743092|524967982|FG001|Overall Study|Lost to Follow-up|15|||
145577109|NCT03586869|524967983|FG000|Overall Study|Progressive Disease|3|||
145577110|NCT00087568|524967984|FG000|Overall Study|Adverse Event|4|||
145577111|NCT00087568|524967985|FG001|Overall Study|Adverse Event|0|||
145577112|NCT00087568|524967984|FG000|Overall Study|Withdrawal by Subject|1|||
145577113|NCT00087568|524967985|FG001|Overall Study|Withdrawal by Subject|1|||
145347836|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
145347837|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
145347838|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
145347839|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
145347840|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
145347841|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
145347842|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
145347843|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
145347844|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
145347845|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
145347846|NCT01995513|524121087|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145347847|NCT01995513|524121088|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145347848|NCT01995513|524121089|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
145347849|NCT01995513|524121090|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
145347850|NCT01750190|524121091|FG000|Overall Study|Adverse Event|47|||
145347851|NCT01750190|524121092|FG001|Overall Study|Adverse Event|19|||
145347852|NCT01750190|524121091|FG000|Overall Study|Death|38|||
145347853|NCT01750190|524121092|FG001|Overall Study|Death|11|||
145347854|NCT01750190|524121091|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
145347855|NCT01750190|524121092|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
145347856|NCT01750190|524121091|FG000|Overall Study|Lost to Follow-up|28|||
145347857|NCT01750190|524121092|FG001|Overall Study|Lost to Follow-up|7|||
145347858|NCT01750190|524121091|FG000|Overall Study|Physician Decision|16|||
145347859|NCT01750190|524121092|FG001|Overall Study|Physician Decision|17|||
145347860|NCT01750190|524121091|FG000|Overall Study|Protocol Violation|6|||
145347861|NCT01750190|524121092|FG001|Overall Study|Protocol Violation|5|||
145347862|NCT01750190|524121091|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
145347863|NCT01750190|524121092|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
145347864|NCT01750190|524121091|FG000|Overall Study|Withdrawal by Subject|83|||
145347865|NCT01750190|524121092|FG001|Overall Study|Withdrawal by Subject|89|||
145347866|NCT01750190|524121091|FG000|Overall Study|Kidney Transplant|8|||
145347867|NCT01750190|524121092|FG001|Overall Study|Kidney Transplant|4|||
145347868|NCT01750190|524121091|FG000|Overall Study|Dialysis|22|||
145347869|NCT01750190|524121092|FG001|Overall Study|Dialysis|8|||
145347870|NCT01750190|524121091|FG000|Overall Study|Other than Specified|13|||
145347871|NCT01750190|524121092|FG001|Overall Study|Other than Specified|4|||
145347872|NCT02955212|524121099|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
145347873|NCT02955212|524121100|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
145347874|NCT02955212|524121099|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
145347875|NCT02955212|524121100|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
145347876|NCT02955212|524121099|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
145347877|NCT02955212|524121100|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
145347878|NCT02955212|524121099|FG000|Period 1: Double-blind Treatment Period|Other|3|||
145347879|NCT02955212|524121100|FG001|Period 1: Double-blind Treatment Period|Other|2|||
145347880|NCT02955212|524121099|FG000|Period 2: Open-label Extension|Adverse Event|11|||
145347881|NCT02955212|524121100|FG001|Period 2: Open-label Extension|Adverse Event|7|||
145347882|NCT02955212|524121099|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
145347883|NCT02955212|524121100|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
145347884|NCT02955212|524121099|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
145347885|NCT02955212|524121100|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
145347886|NCT02955212|524121099|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
145347887|NCT02955212|524121100|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
145347888|NCT02955212|524121099|FG000|Period 2: Open-label Extension|Other|2|||
145347889|NCT02955212|524121100|FG001|Period 2: Open-label Extension|Other|4|||
145347890|NCT04471428|524121112|FG000|Overall Study|Withdrawal by Subject|29|||
145347891|NCT04471428|524121113|FG001|Overall Study|Withdrawal by Subject|1|||
145347892|NCT04471428|524121112|FG000|Overall Study|Physician Decision|0|||
145347893|NCT04471428|524121113|FG001|Overall Study|Physician Decision|1|||
145347894|NCT04471428|524121112|FG000|Overall Study|Reason Not Specified|0|||
145347895|NCT04471428|524121113|FG001|Overall Study|Reason Not Specified|2|||
145347896|NCT04471428|524121112|FG000|Overall Study|Death|106|||
145347897|NCT04471428|524121113|FG001|Overall Study|Death|114|||
145347898|NCT04471428|524121112|FG000|Overall Study|Ongoing in the study|45|||
145347899|NCT04471428|524121113|FG001|Overall Study|Ongoing in the study|68|||
145347900|NCT00535405|524121114|FG000|Overall Study|Adverse Event|6|||
145347901|NCT00535405|524121115|FG001|Overall Study|Adverse Event|8|||
145347902|NCT00535405|524121116|FG002|Overall Study|Adverse Event|3|||
145347903|NCT00535405|524121117|FG003|Overall Study|Adverse Event|8|||
145347904|NCT00535405|524121118|FG004|Overall Study|Adverse Event|6|||
145347905|NCT00535405|524121114|FG000|Overall Study|Lost to Follow-up|1|||
145347906|NCT00535405|524121115|FG001|Overall Study|Lost to Follow-up|3|||
145347907|NCT00535405|524121116|FG002|Overall Study|Lost to Follow-up|3|||
145347908|NCT00535405|524121117|FG003|Overall Study|Lost to Follow-up|2|||
145347909|NCT00535405|524121118|FG004|Overall Study|Lost to Follow-up|1|||
145347910|NCT00535405|524121114|FG000|Overall Study|Physician Decision|3|||
145347911|NCT00535405|524121115|FG001|Overall Study|Physician Decision|2|||
145347912|NCT00535405|524121116|FG002|Overall Study|Physician Decision|0|||
145347913|NCT00535405|524121117|FG003|Overall Study|Physician Decision|1|||
145347914|NCT00535405|524121118|FG004|Overall Study|Physician Decision|1|||
145347915|NCT00535405|524121114|FG000|Overall Study|Protocol Violation|2|||
145347916|NCT00535405|524121115|FG001|Overall Study|Protocol Violation|2|||
145347917|NCT00535405|524121116|FG002|Overall Study|Protocol Violation|2|||
145347918|NCT00535405|524121117|FG003|Overall Study|Protocol Violation|1|||
145347919|NCT00535405|524121118|FG004|Overall Study|Protocol Violation|0|||
145347920|NCT00535405|524121114|FG000|Overall Study|Withdrawal by Subject|5|||
145347921|NCT00535405|524121115|FG001|Overall Study|Withdrawal by Subject|11|||
145347922|NCT00535405|524121116|FG002|Overall Study|Withdrawal by Subject|10|||
145347923|NCT00535405|524121117|FG003|Overall Study|Withdrawal by Subject|10|||
145347924|NCT00535405|524121118|FG004|Overall Study|Withdrawal by Subject|8|||
145347925|NCT03151304|524121119|FG000|Overall Study|Termination of study by Sponsor|23|||
145347926|NCT03151304|524121119|FG000|Overall Study|missing|3|||
145347927|NCT03151304|524121119|FG000|Overall Study|Withdrawal by Subject|8|||
145347928|NCT03151304|524121119|FG000|Overall Study|multiple reasons|30|||
145347929|NCT03519087|524121120|FG000|Clinic Evaluation|Physician Decision|15|||
145347930|NCT03519087|524121121|FG001|Clinic Evaluation|Physician Decision|18|||
145347931|NCT03519087|524121122|FG002|Clinic Evaluation|Physician Decision|0|||
145347932|NCT03519087|524121123|FG003|Clinic Evaluation|Physician Decision|0|||
145347933|NCT03519087|524121124|FG004|Clinic Evaluation|Physician Decision|0|||
145347934|NCT03519087|524121120|FG000|Clinic Evaluation|Protocol Violation|1|||
145347935|NCT03519087|524121121|FG001|Clinic Evaluation|Protocol Violation|0|||
145347936|NCT03519087|524121122|FG002|Clinic Evaluation|Protocol Violation|0|||
145347937|NCT03519087|524121123|FG003|Clinic Evaluation|Protocol Violation|0|||
145347938|NCT03519087|524121124|FG004|Clinic Evaluation|Protocol Violation|0|||
145347939|NCT03519087|524121120|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
145347940|NCT03519087|524121121|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
145347941|NCT03519087|524121122|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
145347942|NCT03519087|524121123|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
145347943|NCT03519087|524121124|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
145347944|NCT03519087|524121120|FG000|Re-randomization for Treatment|Not appropriate|2|||
145347945|NCT03519087|524121121|FG001|Re-randomization for Treatment|Not appropriate|3|||
145347946|NCT03519087|524121122|FG002|Re-randomization for Treatment|Not appropriate|0|||
145347947|NCT03519087|524121123|FG003|Re-randomization for Treatment|Not appropriate|0|||
145347948|NCT03519087|524121124|FG004|Re-randomization for Treatment|Not appropriate|0|||
145347949|NCT03519087|524121120|FG000|Laboratory Testing|Lost to Follow-up|0|||
145347950|NCT03519087|524121121|FG001|Laboratory Testing|Lost to Follow-up|0|||
145347951|NCT03519087|524121122|FG002|Laboratory Testing|Lost to Follow-up|2|||
145347952|NCT03519087|524121123|FG003|Laboratory Testing|Lost to Follow-up|3|||
145347953|NCT03519087|524121124|FG004|Laboratory Testing|Lost to Follow-up|6|||
145347954|NCT03519087|524121120|FG000|Laboratory Testing|Protocol Violation|0|||
145347955|NCT03519087|524121121|FG001|Laboratory Testing|Protocol Violation|0|||
145347956|NCT03519087|524121122|FG002|Laboratory Testing|Protocol Violation|0|||
145347957|NCT03519087|524121123|FG003|Laboratory Testing|Protocol Violation|1|||
145347958|NCT03519087|524121124|FG004|Laboratory Testing|Protocol Violation|0|||
145347959|NCT01137071|524121126|FG000|Overall Study|Disease Progression|11|||
145347960|NCT01137071|524121126|FG000|Overall Study|Withdrawal by Subject|2|||
145347961|NCT01137071|524121126|FG000|Overall Study|Wrongly Included|1|||
145347962|NCT02565511|524121127|FG000|Overall Study|Study terminated by Sponsor|35|||
145347963|NCT02565511|524121128|FG001|Overall Study|Study terminated by Sponsor|22|||
145347964|NCT02565511|524121129|FG002|Overall Study|Study terminated by Sponsor|235|||
145347965|NCT02565511|524121130|FG003|Overall Study|Study terminated by Sponsor|156|||
145347966|NCT02565511|524121127|FG000|Overall Study|Withdrawal by Subject|3|||
145347967|NCT02565511|524121128|FG001|Overall Study|Withdrawal by Subject|0|||
145347968|NCT02565511|524121129|FG002|Overall Study|Withdrawal by Subject|12|||
145347969|NCT02565511|524121130|FG003|Overall Study|Withdrawal by Subject|5|||
145347970|NCT02565511|524121127|FG000|Overall Study|Adverse Event|0|||
145347971|NCT02565511|524121128|FG001|Overall Study|Adverse Event|0|||
145347972|NCT02565511|524121129|FG002|Overall Study|Adverse Event|1|||
145347973|NCT02565511|524121130|FG003|Overall Study|Adverse Event|1|||
145347974|NCT02565511|524121127|FG000|Overall Study|Lost to Follow-up|4|||
145347975|NCT02565511|524121128|FG001|Overall Study|Lost to Follow-up|1|||
145347976|NCT02565511|524121129|FG002|Overall Study|Lost to Follow-up|0|||
145347977|NCT02565511|524121130|FG003|Overall Study|Lost to Follow-up|1|||
145347978|NCT02565511|524121127|FG000|Overall Study|Physician Decision|0|||
145347979|NCT02565511|524121128|FG001|Overall Study|Physician Decision|0|||
145347980|NCT02565511|524121129|FG002|Overall Study|Physician Decision|0|||
145347981|NCT02565511|524121130|FG003|Overall Study|Physician Decision|1|||
145347982|NCT02565511|524121127|FG000|Overall Study|Protocol deviation|0|||
145347983|NCT02565511|524121128|FG001|Overall Study|Protocol deviation|0|||
145347984|NCT02565511|524121129|FG002|Overall Study|Protocol deviation|3|||
145577114|NCT00087568|524967984|FG000|Overall Study|Lost to Follow-up|1|||
145577115|NCT00087568|524967985|FG001|Overall Study|Lost to Follow-up|0|||
145577116|NCT00087568|524967984|FG000|Overall Study|Lack of Efficacy|24|||
145577117|NCT00087568|524967985|FG001|Overall Study|Lack of Efficacy|1|||
145577118|NCT02992899|524967986|FG000|Overall Study|Withdrawal by Subject|1|||
145577119|NCT02992899|524967987|FG001|Overall Study|Withdrawal by Subject|0|||
145577120|NCT02992899|524967986|FG000|Overall Study|Lost to Follow-up|1|||
145577121|NCT02992899|524967987|FG001|Overall Study|Lost to Follow-up|3|||
145577122|NCT02370888|524967988|FG000|Overall Study|disease progression|2|||
145577123|NCT02370888|524967988|FG000|Overall Study|did not meet chimerism criteria|6|||
145577124|NCT01332305|524967989|FG000|Overall Study|Adverse Event|1|||
145577125|NCT01332305|524967990|FG001|Overall Study|Adverse Event|4|||
145577126|NCT01332305|524967991|FG002|Overall Study|Adverse Event|6|||
145577127|NCT01332305|524967992|FG003|Overall Study|Adverse Event|3|||
145577128|NCT01332305|524967993|FG004|Overall Study|Adverse Event|5|||
145577129|NCT01332305|524967989|FG000|Overall Study|Withdrawal by Subject|6|||
145577130|NCT01332305|524967990|FG001|Overall Study|Withdrawal by Subject|5|||
145577131|NCT01332305|524967991|FG002|Overall Study|Withdrawal by Subject|4|||
145577132|NCT01332305|524967992|FG003|Overall Study|Withdrawal by Subject|1|||
145577133|NCT01332305|524967993|FG004|Overall Study|Withdrawal by Subject|0|||
145347985|NCT02565511|524121130|FG003|Overall Study|Protocol deviation|0|||
145347986|NCT04807400|524121131|FG000|Overall Study|Adverse Event|2|||
145347987|NCT04807400|524121132|FG001|Overall Study|Adverse Event|3|||
145347988|NCT04807400|524121133|FG002|Overall Study|Adverse Event|3|||
145347989|NCT04807400|524121131|FG000|Overall Study|Death|2|||
145347990|NCT04807400|524121132|FG001|Overall Study|Death|0|||
145347991|NCT04807400|524121133|FG002|Overall Study|Death|0|||
145347992|NCT04807400|524121131|FG000|Overall Study|Lost to Follow-up|8|||
145347993|NCT04807400|524121132|FG001|Overall Study|Lost to Follow-up|6|||
145347994|NCT04807400|524121133|FG002|Overall Study|Lost to Follow-up|6|||
145347995|NCT04807400|524121131|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145347996|NCT04807400|524121132|FG001|Overall Study|Non-Compliance With Study Drug|4|||
145347997|NCT04807400|524121133|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145347998|NCT04807400|524121131|FG000|Overall Study|Participant Decision|20|||
145347999|NCT04807400|524121132|FG001|Overall Study|Participant Decision|19|||
145348000|NCT04807400|524121133|FG002|Overall Study|Participant Decision|26|||
145348001|NCT04807400|524121131|FG000|Overall Study|Physician Decision|0|||
145348002|NCT04807400|524121132|FG001|Overall Study|Physician Decision|1|||
145348003|NCT04807400|524121133|FG002|Overall Study|Physician Decision|0|||
145348004|NCT04807400|524121131|FG000|Overall Study|Protocol Violation|4|||
145348005|NCT04807400|524121132|FG001|Overall Study|Protocol Violation|3|||
145348006|NCT04807400|524121133|FG002|Overall Study|Protocol Violation|7|||
145348007|NCT04807400|524121131|FG000|Overall Study|Withdrawal by Subject|13|||
145348008|NCT04807400|524121132|FG001|Overall Study|Withdrawal by Subject|9|||
145348009|NCT04807400|524121133|FG002|Overall Study|Withdrawal by Subject|20|||
145348010|NCT04807400|524121131|FG000|Overall Study|Mis-randomized|1|||
145348011|NCT04807400|524121132|FG001|Overall Study|Mis-randomized|0|||
145348012|NCT04807400|524121133|FG002|Overall Study|Mis-randomized|0|||
145348013|NCT03656744|524121134|FG000|Overall Study|Adverse Event|1|||
145414297|NCT02969018|524371212|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
145414298|NCT02969018|524371213|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
145414299|NCT02969018|524371206|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145414300|NCT02969018|524371207|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145414301|NCT02969018|524371208|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145414302|NCT02969018|524371209|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145414303|NCT02969018|524371210|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145414304|NCT02969018|524371211|FG005|Overall Study|Non-Compliance With Study Drug|0|||
145414305|NCT02969018|524371212|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145414306|NCT02969018|524371213|FG007|Overall Study|Non-Compliance With Study Drug|0|||
145577134|NCT01332305|524967989|FG000|Overall Study|Lost to Follow-up|0|||
145577135|NCT01332305|524967990|FG001|Overall Study|Lost to Follow-up|2|||
145577136|NCT01332305|524967991|FG002|Overall Study|Lost to Follow-up|3|||
145414307|NCT02969018|524371206|FG000|Overall Study|Other|0|||
145414308|NCT02969018|524371207|FG001|Overall Study|Other|0|||
145414309|NCT02969018|524371208|FG002|Overall Study|Other|0|||
145414310|NCT02969018|524371209|FG003|Overall Study|Other|1|||
145414311|NCT02969018|524371210|FG004|Overall Study|Other|0|||
145414312|NCT02969018|524371211|FG005|Overall Study|Other|0|||
145414313|NCT02969018|524371212|FG006|Overall Study|Other|0|||
145414314|NCT02969018|524371213|FG007|Overall Study|Other|2|||
145414315|NCT02969018|524371206|FG000|Overall Study|Pregnancy|0|||
145577137|NCT01332305|524967992|FG003|Overall Study|Lost to Follow-up|2|||
145577138|NCT01332305|524967993|FG004|Overall Study|Lost to Follow-up|3|||
145577139|NCT01332305|524967989|FG000|Overall Study|Protocol Violation|1|||
145577140|NCT01332305|524967990|FG001|Overall Study|Protocol Violation|2|||
145577141|NCT01332305|524967991|FG002|Overall Study|Protocol Violation|1|||
145414316|NCT02969018|524371207|FG001|Overall Study|Pregnancy|0|||
145414317|NCT02969018|524371208|FG002|Overall Study|Pregnancy|0|||
145414318|NCT02969018|524371209|FG003|Overall Study|Pregnancy|0|||
145414319|NCT02969018|524371210|FG004|Overall Study|Pregnancy|0|||
145414320|NCT02969018|524371211|FG005|Overall Study|Pregnancy|1|||
145414321|NCT02969018|524371212|FG006|Overall Study|Pregnancy|0|||
145414322|NCT02969018|524371213|FG007|Overall Study|Pregnancy|0|||
145414323|NCT02969018|524371206|FG000|Overall Study|Protocol Violation|0|||
145414324|NCT02969018|524371207|FG001|Overall Study|Protocol Violation|0|||
145414325|NCT02969018|524371208|FG002|Overall Study|Protocol Violation|1|||
145414326|NCT02969018|524371209|FG003|Overall Study|Protocol Violation|1|||
145414327|NCT02969018|524371210|FG004|Overall Study|Protocol Violation|0|||
145414328|NCT02969018|524371211|FG005|Overall Study|Protocol Violation|0|||
145414329|NCT02969018|524371212|FG006|Overall Study|Protocol Violation|0|||
145414330|NCT02969018|524371213|FG007|Overall Study|Protocol Violation|0|||
145414331|NCT02969018|524371206|FG000|Overall Study|Withdrawal by Subject|0|||
145414332|NCT02969018|524371207|FG001|Overall Study|Withdrawal by Subject|1|||
145414333|NCT02969018|524371208|FG002|Overall Study|Withdrawal by Subject|2|||
145414334|NCT02969018|524371209|FG003|Overall Study|Withdrawal by Subject|1|||
145414335|NCT02969018|524371210|FG004|Overall Study|Withdrawal by Subject|0|||
145414336|NCT02969018|524371211|FG005|Overall Study|Withdrawal by Subject|4|||
145414337|NCT02969018|524371212|FG006|Overall Study|Withdrawal by Subject|4|||
145414338|NCT02969018|524371213|FG007|Overall Study|Withdrawal by Subject|3|||
145414339|NCT04999020|524371214|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
145414340|NCT04999020|524371215|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
145414341|NCT04999020|524371216|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
145414342|NCT04999020|524371217|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
145414343|NCT04999020|524371214|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
145414344|NCT04999020|524371215|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
145414345|NCT04999020|524371216|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
145414346|NCT04999020|524371217|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
145414347|NCT04999020|524371214|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
145414348|NCT04999020|524371215|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
145414349|NCT04999020|524371216|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
145414350|NCT04999020|524371217|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
145414351|NCT04999020|524371214|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145414352|NCT04999020|524371215|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145414353|NCT04999020|524371216|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
145414354|NCT04999020|524371217|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
145414355|NCT04999020|524371214|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
145414356|NCT04999020|524371215|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
145414357|NCT04999020|524371216|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
145414358|NCT04999020|524371217|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
145414359|NCT04999020|524371214|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
145414360|NCT04999020|524371215|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
145414361|NCT04999020|524371216|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
145414362|NCT04999020|524371217|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
145414363|NCT04999020|524371214|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145414364|NCT04999020|524371215|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145414365|NCT04999020|524371216|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
145414366|NCT04999020|524371217|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
145414367|NCT04999020|524371214|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
145414368|NCT04999020|524371215|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
145414369|NCT04999020|524371216|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
145414370|NCT04999020|524371217|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
145414371|NCT03925220|524371223|FG000|Overall Study|Withdrawal by Subject|4|||
145414372|NCT03925220|524371224|FG001|Overall Study|Withdrawal by Subject|4|||
145414373|NCT03925220|524371225|FG002|Overall Study|Withdrawal by Subject|4|||
145414374|NCT03925220|524371226|FG003|Overall Study|Withdrawal by Subject|4|||
145348014|NCT03656744|524121135|FG001|Overall Study|Adverse Event|4|||
145348015|NCT03656744|524121136|FG002|Overall Study|Adverse Event|1|||
145348016|NCT03656744|524121134|FG000|Overall Study|Protocol Violation|1|||
145348017|NCT03656744|524121135|FG001|Overall Study|Protocol Violation|0|||
145348018|NCT03656744|524121136|FG002|Overall Study|Protocol Violation|0|||
145348019|NCT03656744|524121134|FG000|Overall Study|Lost to Follow-up|2|||
145348020|NCT03656744|524121135|FG001|Overall Study|Lost to Follow-up|2|||
145348021|NCT03656744|524121136|FG002|Overall Study|Lost to Follow-up|0|||
145348022|NCT03656744|524121134|FG000|Overall Study|Withdrawal by Subject|0|||
145348023|NCT03656744|524121135|FG001|Overall Study|Withdrawal by Subject|1|||
145348024|NCT03656744|524121136|FG002|Overall Study|Withdrawal by Subject|0|||
145414375|NCT03925220|524371223|FG000|Overall Study|Lost to Follow-up|40|||
145414376|NCT03925220|524371224|FG001|Overall Study|Lost to Follow-up|46|||
145577142|NCT01332305|524967992|FG003|Overall Study|Protocol Violation|0|||
145414377|NCT03925220|524371225|FG002|Overall Study|Lost to Follow-up|37|||
145414378|NCT03925220|524371226|FG003|Overall Study|Lost to Follow-up|38|||
145414379|NCT04828486|524371227|FG000|Overall Study|Adverse Event|2|||
145348025|NCT03656744|524121134|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
145348026|NCT03656744|524121135|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
145348027|NCT03656744|524121136|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
145348028|NCT01332292|524121138|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
145348029|NCT01332292|524121139|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
145348030|NCT01332292|524121138|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145348031|NCT01332292|524121139|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
145348032|NCT01332292|524121138|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
145348033|NCT01332292|524121139|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
145348034|NCT03910673|524121141|FG000|Overall Study|Adverse Event|0|||
145348035|NCT03910673|524121142|FG001|Overall Study|Adverse Event|0|||
145348036|NCT03910673|524121143|FG002|Overall Study|Adverse Event|0|||
145348037|NCT03910673|524121144|FG003|Overall Study|Adverse Event|2|||
145348038|NCT03910673|524121145|FG004|Overall Study|Adverse Event|0|||
145348039|NCT00098774|524121146|FG000|Overall Study|Adverse Event|2|||
145348040|NCT00098774|524121146|FG000|Overall Study|Disease Progression|9|||
145348041|NCT00098774|524121146|FG000|Overall Study|Withdrawal by Subject|1|||
145348042|NCT00098774|524121146|FG000|Overall Study|Failed (to respond) during induction|4|||
145348043|NCT00098774|524121146|FG000|Overall Study|Physician Decision|2|||
145348044|NCT00796757|524121147|FG000|Overall Study|Withdrawal by Subject|14|||
145348045|NCT00796757|524121147|FG000|Overall Study|Death|61|||
145348046|NCT00796757|524121147|FG000|Overall Study|Protocol Violation|1|||
145348047|NCT00796757|524121147|FG000|Overall Study|Participant noncompliance|1|||
145348048|NCT00796757|524121147|FG000|Overall Study|Investigator's decision|2|||
145414380|NCT04828486|524371227|FG000|Overall Study|Death|1|||
145414381|NCT04828486|524371227|FG000|Overall Study|Disease Progression|8|||
145414382|NCT04828486|524371227|FG000|Overall Study|Other Complicating Disease|1|||
145414383|NCT04828486|524371227|FG000|Overall Study|Withdrawal by Subject|1|||
145414384|NCT00866320|524371228|FG000|Overall Study|Withdrawal by Subject|4|||
145414385|NCT00866320|524371228|FG000|Overall Study|Death|2|||
145414386|NCT00896233|524371229|FG000|Overall Study|Claustrophobia during MRI|1|||
145414387|NCT02965456|524371230|FG000|Overall Study|Lost to Follow-up|40|||
145414388|NCT02965456|524371231|FG001|Overall Study|Lost to Follow-up|18|||
145414389|NCT02965456|524371230|FG000|Overall Study|Subject Request|22|||
145414390|NCT02965456|524371231|FG001|Overall Study|Subject Request|13|||
145414391|NCT02965456|524371230|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
145414392|NCT02965456|524371231|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
145348049|NCT00796757|524121147|FG000|Overall Study|Other|7|||
145348050|NCT03142191|524121148|FG000|Placebo Controlled Period|Death|0|||
145348051|NCT03142191|524121149|FG001|Placebo Controlled Period|Death|1|||
145348052|NCT03142191|524121150|FG002|Placebo Controlled Period|Death|1|||
145348053|NCT03142191|524121151|FG003|Placebo Controlled Period|Death|0|||
145348054|NCT03142191|524121152|FG004|Placebo Controlled Period|Death|0|||
145348055|NCT03142191|524121148|FG000|Placebo Controlled Period|Adverse Event|4|||
145348056|NCT03142191|524121149|FG001|Placebo Controlled Period|Adverse Event|5|||
145348057|NCT03142191|524121150|FG002|Placebo Controlled Period|Adverse Event|1|||
145348058|NCT03142191|524121151|FG003|Placebo Controlled Period|Adverse Event|0|||
145348059|NCT03142191|524121152|FG004|Placebo Controlled Period|Adverse Event|0|||
145348060|NCT03142191|524121148|FG000|Placebo Controlled Period|Progressive Disease|1|||
145348061|NCT03142191|524121149|FG001|Placebo Controlled Period|Progressive Disease|0|||
145348062|NCT03142191|524121150|FG002|Placebo Controlled Period|Progressive Disease|1|||
145348063|NCT03142191|524121151|FG003|Placebo Controlled Period|Progressive Disease|0|||
145348064|NCT03142191|524121152|FG004|Placebo Controlled Period|Progressive Disease|0|||
145348065|NCT03142191|524121148|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
145348066|NCT03142191|524121149|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
145348067|NCT03142191|524121150|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
145348068|NCT03142191|524121151|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
145348069|NCT03142191|524121152|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
145348070|NCT03142191|524121148|FG000|Placebo Controlled Period|Other Reasons|1|||
145348071|NCT03142191|524121149|FG001|Placebo Controlled Period|Other Reasons|0|||
145348072|NCT03142191|524121150|FG002|Placebo Controlled Period|Other Reasons|0|||
145348073|NCT03142191|524121151|FG003|Placebo Controlled Period|Other Reasons|0|||
145348074|NCT03142191|524121152|FG004|Placebo Controlled Period|Other Reasons|0|||
145348075|NCT03142191|524121148|FG000|Active Treatment Extension Period|Death|2|||
145348076|NCT03142191|524121149|FG001|Active Treatment Extension Period|Death|1|||
145348077|NCT03142191|524121150|FG002|Active Treatment Extension Period|Death|1|||
145348078|NCT03142191|524121151|FG003|Active Treatment Extension Period|Death|1|||
145348079|NCT03142191|524121152|FG004|Active Treatment Extension Period|Death|0|||
145348080|NCT03142191|524121148|FG000|Active Treatment Extension Period|Adverse Event|6|||
145348081|NCT03142191|524121149|FG001|Active Treatment Extension Period|Adverse Event|5|||
145348082|NCT03142191|524121150|FG002|Active Treatment Extension Period|Adverse Event|4|||
145414393|NCT02965456|524371230|FG000|Overall Study|Adverse Event|3|||
145414394|NCT02965456|524371231|FG001|Overall Study|Adverse Event|0|||
145414395|NCT02965456|524371230|FG000|Overall Study|Noncompliance with Study Drug|1|||
145348083|NCT03142191|524121151|FG003|Active Treatment Extension Period|Adverse Event|1|||
145348084|NCT03142191|524121152|FG004|Active Treatment Extension Period|Adverse Event|0|||
145348085|NCT03142191|524121148|FG000|Active Treatment Extension Period|Progressive Disease|10|||
145348086|NCT03142191|524121149|FG001|Active Treatment Extension Period|Progressive Disease|5|||
145348087|NCT03142191|524121150|FG002|Active Treatment Extension Period|Progressive Disease|4|||
145348088|NCT03142191|524121151|FG003|Active Treatment Extension Period|Progressive Disease|1|||
145414396|NCT02965456|524371231|FG001|Overall Study|Noncompliance with Study Drug|1|||
145414397|NCT02965456|524371230|FG000|Overall Study|Worsening Condition|0|||
145414398|NCT02965456|524371231|FG001|Overall Study|Worsening Condition|2|||
145414399|NCT02965456|524371230|FG000|Overall Study|Lack of Efficacy|1|||
145414400|NCT02965456|524371231|FG001|Overall Study|Lack of Efficacy|0|||
145414401|NCT02965456|524371230|FG000|Overall Study|Physician Decision|0|||
145414402|NCT02965456|524371231|FG001|Overall Study|Physician Decision|1|||
145414403|NCT02965456|524371230|FG000|Overall Study|Pregnancy|1|||
145414404|NCT02965456|524371231|FG001|Overall Study|Pregnancy|0|||
145414405|NCT02965456|524371230|FG000|Overall Study|Protocol Violation|0|||
145414406|NCT02965456|524371231|FG001|Overall Study|Protocol Violation|1|||
145414407|NCT02965456|524371230|FG000|Overall Study|Participant ran out of study drug|0|||
145414408|NCT02965456|524371231|FG001|Overall Study|Participant ran out of study drug|1|||
145414409|NCT04465955|524371232|FG000|Overall Study|Withdrew consent|6|||
145414410|NCT04465955|524371233|FG001|Overall Study|Withdrew consent|10|||
145414411|NCT04465955|524371234|FG002|Overall Study|Withdrew consent|7|||
145414412|NCT04465955|524371232|FG000|Overall Study|Adverse Event|6|||
145414413|NCT04465955|524371233|FG001|Overall Study|Adverse Event|5|||
145414414|NCT04465955|524371234|FG002|Overall Study|Adverse Event|1|||
145414415|NCT04465955|524371232|FG000|Overall Study|Lost to Follow-up|2|||
145414416|NCT04465955|524371233|FG001|Overall Study|Lost to Follow-up|0|||
145414417|NCT04465955|524371234|FG002|Overall Study|Lost to Follow-up|3|||
145622887|NCT01627340|525130208|FG001|Overall Study|Withdrawal by Subject|0|||
145622888|NCT03633903|525130211|FG000|Overall Study|Withdrawal by Subject|1|||
145622889|NCT03633903|525130212|FG001|Overall Study|Withdrawal by Subject|2|||
145622890|NCT03633903|525130211|FG000|Overall Study|Lost to Follow-up|5|||
145622891|NCT03633903|525130212|FG001|Overall Study|Lost to Follow-up|5|||
145622892|NCT00419003|525130223|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
145622893|NCT00419003|525130224|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
145622894|NCT00419003|525130223|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
145622895|NCT00419003|525130224|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
145622896|NCT02687919|525130225|FG000|Overall Study|Withdrawal by Subject|6|||
145622897|NCT02687919|525130226|FG001|Overall Study|Withdrawal by Subject|6|||
145622898|NCT02687919|525130225|FG000|Overall Study|Protocol Violation|2|||
145622899|NCT02687919|525130226|FG001|Overall Study|Protocol Violation|0|||
145622900|NCT00131911|525130227|FG000|Overall Study|Withdrawal by Subject|1|||
145348089|NCT03142191|524121152|FG004|Active Treatment Extension Period|Progressive Disease|2|||
145348090|NCT03142191|524121148|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
145348091|NCT03142191|524121149|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
145348092|NCT03142191|524121150|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
145348093|NCT03142191|524121151|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
145348094|NCT03142191|524121152|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
145348095|NCT03142191|524121148|FG000|Active Treatment Extension Period|Physician Decision|2|||
145348096|NCT03142191|524121149|FG001|Active Treatment Extension Period|Physician Decision|0|||
145348097|NCT03142191|524121150|FG002|Active Treatment Extension Period|Physician Decision|0|||
145348098|NCT03142191|524121151|FG003|Active Treatment Extension Period|Physician Decision|0|||
145348099|NCT03142191|524121152|FG004|Active Treatment Extension Period|Physician Decision|0|||
145348100|NCT03142191|524121148|FG000|Active Treatment Extension Period|Other Reasons|3|||
145348101|NCT03142191|524121149|FG001|Active Treatment Extension Period|Other Reasons|3|||
145348102|NCT03142191|524121150|FG002|Active Treatment Extension Period|Other Reasons|3|||
145348103|NCT03142191|524121151|FG003|Active Treatment Extension Period|Other Reasons|8|||
145348104|NCT03142191|524121152|FG004|Active Treatment Extension Period|Other Reasons|3|||
145348105|NCT03142191|524121148|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
145348106|NCT03142191|524121149|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
145348107|NCT03142191|524121150|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
145414418|NCT04465955|524371232|FG000|Overall Study|Other|1|||
145414419|NCT04465955|524371233|FG001|Overall Study|Other|1|||
145622901|NCT00131911|525130228|FG001|Overall Study|Withdrawal by Subject|0|||
145622902|NCT02554513|525130229|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
145414420|NCT04465955|524371234|FG002|Overall Study|Other|3|||
145414421|NCT00387127|524371235|FG000|Overall Study|Lost to Follow-up|0|||
145622903|NCT02554513|525130230|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
145414422|NCT00387127|524371236|FG001|Overall Study|Lost to Follow-up|4|||
145414423|NCT00387127|524371235|FG000|Overall Study|Death|16|||
145414424|NCT00387127|524371236|FG001|Overall Study|Death|16|||
145622904|NCT01606189|525130233|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
145414425|NCT00387127|524371235|FG000|Overall Study|Physician Decision|0|||
145414426|NCT00387127|524371236|FG001|Overall Study|Physician Decision|1|||
145414427|NCT00387127|524371235|FG000|Overall Study|Withdrawal by Subject|3|||
145414428|NCT00387127|524371236|FG001|Overall Study|Withdrawal by Subject|2|||
145414429|NCT00387127|524371235|FG000|Overall Study|Required by Protocol Amendment #4|12|||
145414430|NCT00387127|524371236|FG001|Overall Study|Required by Protocol Amendment #4|10|||
145414431|NCT00387127|524371235|FG000|Overall Study|Serious Adverse Event|1|||
145414432|NCT00387127|524371236|FG001|Overall Study|Serious Adverse Event|1|||
145414433|NCT00387127|524371235|FG000|Overall Study|Sponsor Unblinded|1|||
145414434|NCT00387127|524371236|FG001|Overall Study|Sponsor Unblinded|0|||
145414435|NCT05101317|524371239|FG000|Week1-13|Adverse Event|0|||
145414436|NCT05101317|524371240|FG001|Week1-13|Adverse Event|1|||
145414437|NCT05101317|524371241|FG002|Week1-13|Adverse Event|0|||
145414438|NCT05101317|524371242|FG003|Week1-13|Adverse Event|0|||
145414439|NCT05101317|524371239|FG000|Week1-13|Withdrawal by Subject|0|||
145414440|NCT05101317|524371240|FG001|Week1-13|Withdrawal by Subject|2|||
145414441|NCT05101317|524371241|FG002|Week1-13|Withdrawal by Subject|0|||
145414442|NCT05101317|524371242|FG003|Week1-13|Withdrawal by Subject|0|||
145414443|NCT05101317|524371239|FG000|Week1-13|Early Withdrawl|0|||
145414444|NCT05101317|524371240|FG001|Week1-13|Early Withdrawl|0|||
145414445|NCT05101317|524371241|FG002|Week1-13|Early Withdrawl|0|||
145414446|NCT05101317|524371242|FG003|Week1-13|Early Withdrawl|1|||
145414447|NCT05101317|524371239|FG000|Week 13-25|Lost to Follow-up|0|||
145414448|NCT05101317|524371240|FG001|Week 13-25|Lost to Follow-up|0|||
145414449|NCT05101317|524371241|FG002|Week 13-25|Lost to Follow-up|1|||
145414450|NCT05101317|524371242|FG003|Week 13-25|Lost to Follow-up|0|||
145414451|NCT05101317|524371239|FG000|Week 13-25|Withdrawal by Subject|1|||
145414452|NCT05101317|524371240|FG001|Week 13-25|Withdrawal by Subject|1|||
145414453|NCT05101317|524371241|FG002|Week 13-25|Withdrawal by Subject|0|||
145414454|NCT05101317|524371242|FG003|Week 13-25|Withdrawal by Subject|0|||
145414455|NCT05101317|524371239|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
145414456|NCT05101317|524371240|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
145414457|NCT05101317|524371241|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
145414458|NCT05101317|524371242|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
145414459|NCT01327703|524371243|FG000|Second Treatment Period|Adverse Event|1|||
145414460|NCT01327703|524371244|FG001|Second Treatment Period|Adverse Event|1|||
145414461|NCT01327703|524371243|FG000|Second Treatment Period|Protocol Violation|0|||
145414462|NCT01327703|524371244|FG001|Second Treatment Period|Protocol Violation|1|||
145414463|NCT02513563|524371248|FG000|Overall Study|Death|4|||
145414464|NCT02513563|524371248|FG000|Overall Study|Withdrawal by Subject|4|||
145414465|NCT02513563|524371248|FG000|Overall Study|Physician Decision|1|||
145414466|NCT00317369|524371252|FG000|Overall Study|Adverse Event|2|||
145414467|NCT00317369|524371253|FG001|Overall Study|Adverse Event|1|||
145414468|NCT00317369|524371254|FG002|Overall Study|Adverse Event|0|||
145414469|NCT00317369|524371252|FG000|Overall Study|Lack of Efficacy|0|||
145414470|NCT00317369|524371253|FG001|Overall Study|Lack of Efficacy|1|||
145414471|NCT00317369|524371254|FG002|Overall Study|Lack of Efficacy|1|||
145414472|NCT00317369|524371252|FG000|Overall Study|Withdrawal by Subject|0|||
145414473|NCT00317369|524371253|FG001|Overall Study|Withdrawal by Subject|0|||
145414474|NCT00317369|524371254|FG002|Overall Study|Withdrawal by Subject|1|||
145414475|NCT06042855|524371258|FG000|Overall Study|No Receipt of Study Drug|48|||
145414476|NCT06042855|524371259|FG001|Overall Study|No Receipt of Study Drug|57|||
145414477|NCT06042855|524371258|FG000|Overall Study|Administratively Withdrawn|59|||
145414478|NCT06042855|524371259|FG001|Overall Study|Administratively Withdrawn|59|||
145414479|NCT03674411|524371260|FG000|Overall Study|Non-treatment|4|||
145414480|NCT06038643|524371263|FG000|Overall Study|Withdrawal by Subject|9|||
145414481|NCT06038643|524371264|FG001|Overall Study|Withdrawal by Subject|4|||
145414482|NCT06038643|524371263|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
145414483|NCT06038643|524371264|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
145414484|NCT02227199|524371265|FG000|Overall Study|Physician Decision|0|||
145414485|NCT02227199|524371266|FG001|Overall Study|Physician Decision|0|||
145414486|NCT02227199|524371267|FG002|Overall Study|Physician Decision|1|||
145577143|NCT01332305|524967993|FG004|Overall Study|Protocol Violation|3|||
145577144|NCT01332305|524967989|FG000|Overall Study|Withdrawal by Sponsor|1|||
145577145|NCT01332305|524967990|FG001|Overall Study|Withdrawal by Sponsor|0|||
145577146|NCT01332305|524967991|FG002|Overall Study|Withdrawal by Sponsor|0|||
145577147|NCT01332305|524967992|FG003|Overall Study|Withdrawal by Sponsor|1|||
145414487|NCT02227199|524371265|FG000|Overall Study|Adverse Event|0|||
145414488|NCT02227199|524371266|FG001|Overall Study|Adverse Event|0|||
145414489|NCT02227199|524371267|FG002|Overall Study|Adverse Event|3|||
145414490|NCT05710224|524371269|FG000|Overall Study|Death|1|||
145414491|NCT05710224|524371270|FG001|Overall Study|Death|0|||
145414492|NCT05710224|524371269|FG000|Overall Study|Lost to Follow-up|16|||
145414493|NCT05710224|524371270|FG001|Overall Study|Lost to Follow-up|7|||
145414494|NCT05710224|524371269|FG000|Overall Study|Withdrawal by Subject|4|||
145414495|NCT05710224|524371270|FG001|Overall Study|Withdrawal by Subject|6|||
145414496|NCT05710224|524371269|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145577148|NCT01332305|524967993|FG004|Overall Study|Withdrawal by Sponsor|1|||
145348108|NCT03142191|524121151|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
145348109|NCT03142191|524121152|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
145348110|NCT01130493|524121155|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
145348111|NCT01130493|524121156|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
145414497|NCT05710224|524371270|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145414498|NCT05710224|524371269|FG000|Overall Study|Participants Left The City|0|||
145414499|NCT05710224|524371270|FG001|Overall Study|Participants Left The City|2|||
145414500|NCT03369223|524371271|FG000|Overall Study|Lost to Follow-up|0|||
145414501|NCT03369223|524371272|FG001|Overall Study|Lost to Follow-up|0|||
145414502|NCT03369223|524371273|FG002|Overall Study|Lost to Follow-up|0|||
145414503|NCT03369223|524371274|FG003|Overall Study|Lost to Follow-up|0|||
145414504|NCT03369223|524371275|FG004|Overall Study|Lost to Follow-up|0|||
145414505|NCT03369223|524371276|FG005|Overall Study|Lost to Follow-up|0|||
145414506|NCT03369223|524371277|FG006|Overall Study|Lost to Follow-up|0|||
145414507|NCT03369223|524371278|FG007|Overall Study|Lost to Follow-up|0|||
145414508|NCT03369223|524371279|FG008|Overall Study|Lost to Follow-up|0|||
145414509|NCT03369223|524371280|FG009|Overall Study|Lost to Follow-up|0|||
145414510|NCT03369223|524371281|FG010|Overall Study|Lost to Follow-up|0|||
145414511|NCT03369223|524371282|FG011|Overall Study|Lost to Follow-up|0|||
145414512|NCT03369223|524371283|FG012|Overall Study|Lost to Follow-up|0|||
145414513|NCT03369223|524371284|FG013|Overall Study|Lost to Follow-up|0|||
145414514|NCT03369223|524371285|FG014|Overall Study|Lost to Follow-up|0|||
145414515|NCT03369223|524371286|FG015|Overall Study|Lost to Follow-up|0|||
145414516|NCT03369223|524371287|FG016|Overall Study|Lost to Follow-up|0|||
145414517|NCT03369223|524371288|FG017|Overall Study|Lost to Follow-up|0|||
145414518|NCT03369223|524371289|FG018|Overall Study|Lost to Follow-up|2|||
145414519|NCT03369223|524371290|FG019|Overall Study|Lost to Follow-up|1|||
145414520|NCT03369223|524371271|FG000|Overall Study|Participant no longer meets study criteria|0|||
145414521|NCT03369223|524371272|FG001|Overall Study|Participant no longer meets study criteria|0|||
145414522|NCT03369223|524371273|FG002|Overall Study|Participant no longer meets study criteria|0|||
145414523|NCT03369223|524371274|FG003|Overall Study|Participant no longer meets study criteria|0|||
145414524|NCT03369223|524371275|FG004|Overall Study|Participant no longer meets study criteria|0|||
145414525|NCT03369223|524371276|FG005|Overall Study|Participant no longer meets study criteria|0|||
145348112|NCT01130493|524121157|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
145348113|NCT01130493|524121155|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
145348114|NCT01130493|524121156|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
145348115|NCT01130493|524121157|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
145348116|NCT01130493|524121155|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
145348117|NCT01130493|524121156|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
145348118|NCT01130493|524121157|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
145348119|NCT01130493|524121155|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
145348120|NCT01130493|524121156|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
145348121|NCT01130493|524121157|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
145348122|NCT01130493|524121155|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
145348123|NCT01130493|524121156|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
145348124|NCT01130493|524121157|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
145348125|NCT01130493|524121155|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
145348126|NCT01130493|524121156|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
145348127|NCT01130493|524121157|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
145348128|NCT01130493|524121155|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
145348129|NCT01130493|524121156|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
145348130|NCT01130493|524121157|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
145348131|NCT01130493|524121155|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
145348132|NCT01130493|524121156|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
145348133|NCT01130493|524121157|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
145348134|NCT01130493|524121155|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
145348135|NCT01130493|524121156|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
145348136|NCT01130493|524121157|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
145348137|NCT01130493|524121155|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
145348138|NCT01130493|524121156|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
145577149|NCT01332305|524967989|FG000|Overall Study|Treatment Failure|1|||
145577150|NCT01332305|524967990|FG001|Overall Study|Treatment Failure|1|||
145577151|NCT01332305|524967991|FG002|Overall Study|Treatment Failure|0|||
145348139|NCT01130493|524121157|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
145348140|NCT01130493|524121155|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
145414526|NCT03369223|524371277|FG006|Overall Study|Participant no longer meets study criteria|0|||
145414527|NCT03369223|524371278|FG007|Overall Study|Participant no longer meets study criteria|0|||
145414528|NCT03369223|524371279|FG008|Overall Study|Participant no longer meets study criteria|0|||
145414529|NCT03369223|524371280|FG009|Overall Study|Participant no longer meets study criteria|0|||
145577152|NCT01332305|524967992|FG003|Overall Study|Treatment Failure|0|||
145348141|NCT01130493|524121156|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
145348142|NCT01130493|524121157|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
145348143|NCT01130493|524121155|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
145348144|NCT01130493|524121156|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
145348145|NCT01130493|524121157|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
145348146|NCT01130493|524121155|FG000|Part 2: OLE|Adverse Event|0|||
145348147|NCT01130493|524121156|FG001|Part 2: OLE|Adverse Event|2|||
145348148|NCT01130493|524121157|FG002|Part 2: OLE|Adverse Event|1|||
145348149|NCT01130493|524121155|FG000|Part 2: OLE|Withdrawal by Subject|0|||
145348150|NCT01130493|524121156|FG001|Part 2: OLE|Withdrawal by Subject|1|||
145348151|NCT01130493|524121157|FG002|Part 2: OLE|Withdrawal by Subject|4|||
145348152|NCT00879086|524121158|FG000|Overall Study|Adverse Event|3|||
145348153|NCT00879086|524121159|FG001|Overall Study|Adverse Event|15|||
145348154|NCT00879086|524121158|FG000|Overall Study|Participant choice|2|||
145348155|NCT00879086|524121159|FG001|Overall Study|Participant choice|2|||
145348156|NCT00879086|524121158|FG000|Overall Study|Progression of disease|40|||
145348157|NCT00879086|524121159|FG001|Overall Study|Progression of disease|26|||
145348158|NCT00879086|524121158|FG000|Overall Study|Withdrawal of consent|2|||
145348159|NCT00879086|524121159|FG001|Overall Study|Withdrawal of consent|1|||
145348160|NCT00879086|524121158|FG000|Overall Study|Other|4|||
145348161|NCT00879086|524121159|FG001|Overall Study|Other|6|||
145348162|NCT00879086|524121158|FG000|Overall Study|Death|1|||
145348163|NCT00879086|524121159|FG001|Overall Study|Death|2|||
145348164|NCT02969044|524121160|FG000|Overall Study|Withdrawal by Subject|2|||
145348165|NCT02969044|524121161|FG001|Overall Study|Withdrawal by Subject|6|||
145348166|NCT02969044|524121160|FG000|Overall Study|Adverse Event|3|||
145348167|NCT02969044|524121161|FG001|Overall Study|Adverse Event|0|||
145348168|NCT04728802|524121162|FG000|Overall Study|Withdrawal by Subject|4|||
145348169|NCT04728802|524121163|FG001|Overall Study|Withdrawal by Subject|20|||
145348170|NCT04728802|524121162|FG000|Overall Study|Physician Decision|7|||
145348171|NCT04728802|524121163|FG001|Overall Study|Physician Decision|7|||
145348172|NCT04728802|524121162|FG000|Overall Study|Protocol Violation|10|||
145348173|NCT04728802|524121163|FG001|Overall Study|Protocol Violation|4|||
145348174|NCT04728802|524121162|FG000|Overall Study|Transfer|1|||
145348175|NCT04728802|524121163|FG001|Overall Study|Transfer|0|||
145348176|NCT04728802|524121162|FG000|Overall Study|Death|4|||
145348177|NCT04728802|524121163|FG001|Overall Study|Death|5|||
145348178|NCT04728802|524121162|FG000|Overall Study|Other|3|||
145348179|NCT04728802|524121163|FG001|Overall Study|Other|0|||
145348180|NCT04650204|524121164|FG000|Overall Study|Study was Terminated|2|||
145414530|NCT03369223|524371281|FG010|Overall Study|Participant no longer meets study criteria|0|||
145414531|NCT03369223|524371282|FG011|Overall Study|Participant no longer meets study criteria|0|||
145414532|NCT03369223|524371283|FG012|Overall Study|Participant no longer meets study criteria|0|||
145414533|NCT03369223|524371284|FG013|Overall Study|Participant no longer meets study criteria|0|||
145414534|NCT03369223|524371285|FG014|Overall Study|Participant no longer meets study criteria|2|||
145414535|NCT03369223|524371286|FG015|Overall Study|Participant no longer meets study criteria|0|||
145414536|NCT03369223|524371287|FG016|Overall Study|Participant no longer meets study criteria|2|||
145414537|NCT03369223|524371288|FG017|Overall Study|Participant no longer meets study criteria|0|||
145414538|NCT03369223|524371289|FG018|Overall Study|Participant no longer meets study criteria|0|||
145414539|NCT03369223|524371290|FG019|Overall Study|Participant no longer meets study criteria|0|||
145414540|NCT03369223|524371271|FG000|Overall Study|Other reasons|0|||
145414541|NCT03369223|524371272|FG001|Overall Study|Other reasons|0|||
145414542|NCT03369223|524371273|FG002|Overall Study|Other reasons|0|||
145414543|NCT03369223|524371274|FG003|Overall Study|Other reasons|0|||
145414544|NCT03369223|524371275|FG004|Overall Study|Other reasons|0|||
145414545|NCT03369223|524371276|FG005|Overall Study|Other reasons|0|||
145414546|NCT03369223|524371277|FG006|Overall Study|Other reasons|0|||
145348181|NCT04650204|524121165|FG001|Overall Study|Study was Terminated|1|||
145348182|NCT01330303|524121166|FG000|Period 1|Adverse Event|1|||
145414547|NCT03369223|524371278|FG007|Overall Study|Other reasons|0|||
145348183|NCT01330303|524121167|FG001|Period 1|Adverse Event|0|||
145348184|NCT01330303|524121166|FG000|Period 1|Protocol Violation|0|||
145348185|NCT01330303|524121167|FG001|Period 1|Protocol Violation|1|||
145348186|NCT01330303|524121166|FG000|Period 1|Withdrawal by Subject|0|||
145348187|NCT01330303|524121167|FG001|Period 1|Withdrawal by Subject|1|||
145414548|NCT03369223|524371279|FG008|Overall Study|Other reasons|0|||
145414549|NCT03369223|524371280|FG009|Overall Study|Other reasons|0|||
145414550|NCT03369223|524371281|FG010|Overall Study|Other reasons|0|||
145577153|NCT01332305|524967993|FG004|Overall Study|Treatment Failure|0|||
145577154|NCT01332305|524967989|FG000|Overall Study|Physician Decision|0|||
145577155|NCT01332305|524967990|FG001|Overall Study|Physician Decision|0|||
145348188|NCT00489827|524121174|FG000|Overall Study|Intraoperative exclusion criteria|1|||
145348189|NCT00489827|524121175|FG001|Overall Study|Intraoperative exclusion criteria|1|||
145348190|NCT00489827|524121174|FG000|Overall Study|Intraoperative exclusion criteria|1|||
145348191|NCT00489827|524121175|FG001|Overall Study|Intraoperative exclusion criteria|1|||
145348192|NCT00625872|524121180|FG000|Overall Study|Withdrawal by Subject|1|||
145414551|NCT03369223|524371282|FG011|Overall Study|Other reasons|0|||
145348193|NCT00625872|524121181|FG001|Overall Study|Withdrawal by Subject|0|||
145348194|NCT00625872|524121180|FG000|Overall Study|Does not meet inclusion criteria|1|||
145348195|NCT00625872|524121181|FG001|Overall Study|Does not meet inclusion criteria|0|||
145348196|NCT00625872|524121180|FG000|Overall Study|Terminated by sponsor|2|||
145348197|NCT00625872|524121181|FG001|Overall Study|Terminated by sponsor|5|||
145348198|NCT00625872|524121180|FG000|Overall Study|Randomized but not treated|0|||
145348199|NCT00625872|524121181|FG001|Overall Study|Randomized but not treated|1|||
145348200|NCT01512160|524121182|FG000|Overall Study|Lost to Follow-up|1|||
145348201|NCT01512160|524121183|FG001|Overall Study|Lost to Follow-up|0|||
145348202|NCT01512160|524121184|FG002|Overall Study|Lost to Follow-up|0|||
145348203|NCT01512160|524121185|FG003|Overall Study|Lost to Follow-up|0|||
145348204|NCT01512160|524121182|FG000|Overall Study|Withdrawal by Subject|1|||
145348205|NCT01512160|524121183|FG001|Overall Study|Withdrawal by Subject|0|||
145348206|NCT01512160|524121184|FG002|Overall Study|Withdrawal by Subject|0|||
145348207|NCT01512160|524121185|FG003|Overall Study|Withdrawal by Subject|1|||
145348208|NCT03729596|524122360|FG000|Overall Study|Death|3|||
145348209|NCT03729596|524122361|FG001|Overall Study|Death|5|||
145348210|NCT03729596|524122362|FG002|Overall Study|Death|4|||
145348211|NCT03729596|524122363|FG003|Overall Study|Death|1|||
145348212|NCT03729596|524122364|FG004|Overall Study|Death|0|||
145348213|NCT03729596|524122365|FG005|Overall Study|Death|34|||
145348214|NCT03729596|524122366|FG006|Overall Study|Death|18|||
145348215|NCT03729596|524122367|FG007|Overall Study|Death|14|||
145348216|NCT03729596|524122368|FG008|Overall Study|Death|19|||
145348217|NCT03729596|524122369|FG009|Overall Study|Death|9|||
145348218|NCT03729596|524122360|FG000|Overall Study|Lost to Follow-up|0|||
145348219|NCT03729596|524122361|FG001|Overall Study|Lost to Follow-up|0|||
145348220|NCT03729596|524122362|FG002|Overall Study|Lost to Follow-up|0|||
145348221|NCT03729596|524122363|FG003|Overall Study|Lost to Follow-up|0|||
145348222|NCT03729596|524122364|FG004|Overall Study|Lost to Follow-up|0|||
145348223|NCT03729596|524122365|FG005|Overall Study|Lost to Follow-up|0|||
145348224|NCT03729596|524122366|FG006|Overall Study|Lost to Follow-up|1|||
145348225|NCT03729596|524122367|FG007|Overall Study|Lost to Follow-up|0|||
145348226|NCT03729596|524122368|FG008|Overall Study|Lost to Follow-up|0|||
145348227|NCT03729596|524122369|FG009|Overall Study|Lost to Follow-up|1|||
145348228|NCT03729596|524122360|FG000|Overall Study|protocol amendment|0|||
145348229|NCT03729596|524122361|FG001|Overall Study|protocol amendment|1|||
145348230|NCT03729596|524122362|FG002|Overall Study|protocol amendment|3|||
145348231|NCT03729596|524122363|FG003|Overall Study|protocol amendment|6|||
145348232|NCT03729596|524122364|FG004|Overall Study|protocol amendment|5|||
145348233|NCT03729596|524122365|FG005|Overall Study|protocol amendment|0|||
145348234|NCT03729596|524122366|FG006|Overall Study|protocol amendment|0|||
145348235|NCT03729596|524122367|FG007|Overall Study|protocol amendment|0|||
145348236|NCT03729596|524122368|FG008|Overall Study|protocol amendment|0|||
145348237|NCT03729596|524122369|FG009|Overall Study|protocol amendment|0|||
145348238|NCT03729596|524122360|FG000|Overall Study|Withdrawal by Subject|0|||
145348239|NCT03729596|524122361|FG001|Overall Study|Withdrawal by Subject|0|||
145348240|NCT03729596|524122362|FG002|Overall Study|Withdrawal by Subject|0|||
145348241|NCT03729596|524122363|FG003|Overall Study|Withdrawal by Subject|0|||
145348242|NCT03729596|524122364|FG004|Overall Study|Withdrawal by Subject|0|||
145348243|NCT03729596|524122365|FG005|Overall Study|Withdrawal by Subject|4|||
145348244|NCT03729596|524122366|FG006|Overall Study|Withdrawal by Subject|2|||
145348245|NCT03729596|524122367|FG007|Overall Study|Withdrawal by Subject|3|||
145348246|NCT03729596|524122368|FG008|Overall Study|Withdrawal by Subject|2|||
145348247|NCT03729596|524122369|FG009|Overall Study|Withdrawal by Subject|3|||
145348248|NCT03729596|524122360|FG000|Overall Study|study terminated by sponsor|0|||
145348249|NCT03729596|524122361|FG001|Overall Study|study terminated by sponsor|0|||
145348250|NCT03729596|524122362|FG002|Overall Study|study terminated by sponsor|0|||
145348251|NCT03729596|524122363|FG003|Overall Study|study terminated by sponsor|0|||
145348252|NCT03729596|524122364|FG004|Overall Study|study terminated by sponsor|1|||
145348253|NCT03729596|524122365|FG005|Overall Study|study terminated by sponsor|3|||
145348254|NCT03729596|524122366|FG006|Overall Study|study terminated by sponsor|0|||
145348255|NCT03729596|524122367|FG007|Overall Study|study terminated by sponsor|1|||
145348256|NCT03729596|524122368|FG008|Overall Study|study terminated by sponsor|0|||
145348257|NCT03729596|524122369|FG009|Overall Study|study terminated by sponsor|0|||
145348258|NCT03713593|524122370|FG000|Overall Study|Sponsor Decision|73|||
145348259|NCT03713593|524122371|FG001|Overall Study|Sponsor Decision|41|||
145348260|NCT03713593|524122370|FG000|Overall Study|Lost to Follow-up|2|||
145348261|NCT03713593|524122371|FG001|Overall Study|Lost to Follow-up|1|||
145348262|NCT03713593|524122370|FG000|Overall Study|Death|314|||
145348263|NCT03713593|524122371|FG001|Overall Study|Death|349|||
145348264|NCT03713593|524122370|FG000|Overall Study|Withdrawal by Subject|6|||
145348265|NCT03713593|524122371|FG001|Overall Study|Withdrawal by Subject|8|||
145348266|NCT06419907|524122372|FG000|Overall Study|Protocol Violation|0|||
145348267|NCT06419907|524122373|FG001|Overall Study|Protocol Violation|3|||
145348268|NCT06419907|524122374|FG002|Overall Study|Protocol Violation|0|||
145348269|NCT06419907|524122375|FG003|Overall Study|Protocol Violation|1|||
145348270|NCT06419907|524122372|FG000|Overall Study|Lost to Follow-up|0|||
145348271|NCT06419907|524122373|FG001|Overall Study|Lost to Follow-up|0|||
145348272|NCT06419907|524122374|FG002|Overall Study|Lost to Follow-up|2|||
145348273|NCT06419907|524122375|FG003|Overall Study|Lost to Follow-up|1|||
145348274|NCT03130777|524122376|FG000|Overall Study|Death|0|||
145348275|NCT03130777|524122377|FG001|Overall Study|Death|1|||
145348276|NCT03130777|524122376|FG000|Overall Study|Did not meet eligibility criteria|1|||
145348277|NCT03130777|524122377|FG001|Overall Study|Did not meet eligibility criteria|0|||
145348278|NCT02586688|524122379|FG000|Overall Study|Lost to Follow-up|2|||
145348279|NCT02586688|524122380|FG001|Overall Study|Lost to Follow-up|1|||
145348280|NCT02586688|524122379|FG000|Overall Study|Withdrawal by Subject|1|||
145348281|NCT02586688|524122380|FG001|Overall Study|Withdrawal by Subject|1|||
145348282|NCT02586688|524122379|FG000|Overall Study|Adverse Event|3|||
145348283|NCT02586688|524122380|FG001|Overall Study|Adverse Event|1|||
145348284|NCT03560037|524122381|FG000|Overall Study|Protocol Violation|1|||
145348285|NCT03560037|524122382|FG001|Overall Study|Protocol Violation|0|||
145348286|NCT03560037|524122381|FG000|Overall Study|Physician Decision|0|||
145348287|NCT03560037|524122382|FG001|Overall Study|Physician Decision|1|||
145348288|NCT03620708|524122383|FG000|Overall Study|Lost to Follow-up|1|||
145348289|NCT03620708|524122384|FG001|Overall Study|Lost to Follow-up|1|||
145348290|NCT03620708|524122385|FG002|Overall Study|Lost to Follow-up|2|||
145348291|NCT03620708|524122383|FG000|Overall Study|Withdrawal by Subject|0|||
145348292|NCT03620708|524122384|FG001|Overall Study|Withdrawal by Subject|0|||
145348293|NCT03620708|524122385|FG002|Overall Study|Withdrawal by Subject|1|||
145348294|NCT01720225|524122388|FG000|Overall Study|Withdrawal by Subject|0|||
145348295|NCT01720225|524122389|FG001|Overall Study|Withdrawal by Subject|1|||
145348296|NCT01720225|524122388|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
145348297|NCT01720225|524122389|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
145348298|NCT00661193|524122393|FG000|Overall Study|Adverse Event|2|||
145348299|NCT00661193|524122394|FG001|Overall Study|Adverse Event|1|||
145348300|NCT00661193|524122393|FG000|Overall Study|Withdrawal by Subject|3|||
145348301|NCT00661193|524122394|FG001|Overall Study|Withdrawal by Subject|1|||
145348302|NCT00661193|524122393|FG000|Overall Study|Progression|27|||
145348303|NCT00661193|524122394|FG001|Overall Study|Progression|24|||
145348304|NCT00661193|524122393|FG000|Overall Study|Not protocol specified|1|||
145348305|NCT00661193|524122394|FG001|Overall Study|Not protocol specified|0|||
145348306|NCT03280264|524122395|FG000|Overall Study|Adverse Event|1|||
145348307|NCT03280264|524122395|FG000|Overall Study|Physician Decision|1|||
145348308|NCT03280264|524122395|FG000|Overall Study|Withdrawal by Subject|1|||
145348309|NCT00524420|524122397|FG000|Overall Study|Lack of Efficacy|1|||
145348310|NCT00524420|524122398|FG001|Overall Study|Lack of Efficacy|0|||
145348311|NCT00577863|524122399|FG000|Overall Study|Adverse Event|4|||
145348312|NCT00577863|524122400|FG001|Overall Study|Adverse Event|2|||
145348313|NCT00577863|524122399|FG000|Overall Study|Death|1|||
145348314|NCT00577863|524122400|FG001|Overall Study|Death|0|||
145348315|NCT00577863|524122399|FG000|Overall Study|Lost to Follow-up|2|||
145348316|NCT00577863|524122400|FG001|Overall Study|Lost to Follow-up|2|||
145348317|NCT00577863|524122399|FG000|Overall Study|Entry Criteria Exclusion|1|||
145348318|NCT00577863|524122400|FG001|Overall Study|Entry Criteria Exclusion|0|||
145348319|NCT00577863|524122399|FG000|Overall Study|Withdrawal by Subject|0|||
145348320|NCT00577863|524122400|FG001|Overall Study|Withdrawal by Subject|2|||
145348321|NCT00577863|524122399|FG000|Overall Study|Sponsor Decision|2|||
145348322|NCT00577863|524122400|FG001|Overall Study|Sponsor Decision|7|||
145348323|NCT00577863|524122399|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
145348324|NCT00577863|524122400|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
145348325|NCT03934541|524122412|FG000|Overall Study|Study Terminated by Sponsor|0|||
145348326|NCT03934541|524122413|FG001|Overall Study|Study Terminated by Sponsor|1|||
145348327|NCT03934541|524122414|FG002|Overall Study|Study Terminated by Sponsor|0|||
145348328|NCT03934541|524122415|FG003|Overall Study|Study Terminated by Sponsor|0|||
145348329|NCT02673775|524122419|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
145348330|NCT02673775|524122420|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
145348331|NCT02673775|524122419|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
145348332|NCT02673775|524122420|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
145348333|NCT02673775|524122419|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
145348334|NCT02673775|524122420|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
145348335|NCT02673775|524122419|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
145348336|NCT02673775|524122420|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
145348337|NCT02441686|524122421|FG000|Induction|Adverse Event|4|||
145348338|NCT02441686|524122421|FG000|Induction|Complicating disease|1|||
145348339|NCT02441686|524122421|FG000|Induction|Physician Decision|1|||
145348340|NCT02441686|524122421|FG000|Induction|Withdrawal by Subject|1|||
145348341|NCT02441686|524122421|FG000|Induction|Did not receive treatment|1|||
145348342|NCT02441686|524122421|FG000|Maintenance|Remaining on Treatment|23|||
145348343|NCT02441686|524122421|FG000|Maintenance|Physician Decision|1|||
145348344|NCT02441686|524122421|FG000|Maintenance|Adverse Event|3|||
145348345|NCT02441686|524122421|FG000|Maintenance|Progressive Disease|10|||
145348346|NCT02441686|524122421|FG000|Maintenance|Withdrawal by Subject|1|||
145414552|NCT03369223|524371283|FG012|Overall Study|Other reasons|0|||
145348347|NCT03762239|524122422|FG000|Overall Study|Appointment to the doctor|1|||
145348348|NCT03762239|524122423|FG001|Overall Study|Appointment to the doctor|1|||
145348349|NCT04388553|524122430|FG000|Overall Study|Protocol Violation|1|||
145348350|NCT04388553|524122431|FG001|Overall Study|Protocol Violation|0|||
145348351|NCT02123446|524122432|FG000|Washout Period (1 Day)|Physician Decision|1|||
145348352|NCT02123446|524122433|FG001|Washout Period (1 Day)|Physician Decision|0|||
145348353|NCT02096744|524122437|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
145348354|NCT02096744|524122438|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
145348355|NCT02096744|524122437|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
145348356|NCT02096744|524122438|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
145348357|NCT02096744|524122437|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
145348358|NCT02096744|524122438|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
145348359|NCT02445963|524122441|FG000|Overall Study|Lost to Follow-up|1|||
145348360|NCT02445963|524122442|FG001|Overall Study|Lost to Follow-up|0|||
145348361|NCT02445963|524122443|FG002|Overall Study|Lost to Follow-up|0|||
145348362|NCT02445963|524122444|FG003|Overall Study|Lost to Follow-up|0|||
145348363|NCT02445963|524122441|FG000|Overall Study|Change in employment|1|||
145348364|NCT02445963|524122442|FG001|Overall Study|Change in employment|0|||
145348365|NCT02445963|524122443|FG002|Overall Study|Change in employment|0|||
145348366|NCT02445963|524122444|FG003|Overall Study|Change in employment|0|||
145348367|NCT02445963|524122441|FG000|Overall Study|Symptoms post-vaccination|0|||
145348368|NCT02445963|524122442|FG001|Overall Study|Symptoms post-vaccination|0|||
145348369|NCT02445963|524122443|FG002|Overall Study|Symptoms post-vaccination|1|||
145348370|NCT02445963|524122444|FG003|Overall Study|Symptoms post-vaccination|0|||
145348371|NCT02517463|524122448|FG000|Overall Study|Lost to Follow-up|5|||
145348372|NCT02517463|524122449|FG001|Overall Study|Lost to Follow-up|2|||
145348373|NCT03449446|524122450|FG000|Overall Study|Randomized but Never Treated|0|||
145348374|NCT03449446|524122451|FG001|Overall Study|Randomized but Never Treated|0|||
145348375|NCT03449446|524122452|FG002|Overall Study|Randomized but Never Treated|1|||
145348376|NCT03449446|524122453|FG003|Overall Study|Randomized but Never Treated|1|||
145348377|NCT03449446|524122454|FG004|Overall Study|Randomized but Never Treated|1|||
145348378|NCT03449446|524122455|FG005|Overall Study|Randomized but Never Treated|0|||
145348379|NCT03449446|524122456|FG006|Overall Study|Randomized but Never Treated|0|||
145348380|NCT03449446|524122450|FG000|Overall Study|Unknown Reason|33|||
145348381|NCT03449446|524122451|FG001|Overall Study|Unknown Reason|1|||
145348382|NCT03449446|524122452|FG002|Overall Study|Unknown Reason|1|||
145348383|NCT03449446|524122453|FG003|Overall Study|Unknown Reason|1|||
145348384|NCT03449446|524122454|FG004|Overall Study|Unknown Reason|2|||
145348385|NCT03449446|524122455|FG005|Overall Study|Unknown Reason|2|||
145348386|NCT03449446|524122456|FG006|Overall Study|Unknown Reason|0|||
145348387|NCT03449446|524122450|FG000|Overall Study|Withdrew Consent|1|||
145348388|NCT03449446|524122451|FG001|Overall Study|Withdrew Consent|3|||
145348389|NCT03449446|524122452|FG002|Overall Study|Withdrew Consent|1|||
145348390|NCT03449446|524122453|FG003|Overall Study|Withdrew Consent|4|||
145348391|NCT03449446|524122454|FG004|Overall Study|Withdrew Consent|4|||
145348392|NCT03449446|524122455|FG005|Overall Study|Withdrew Consent|4|||
145348393|NCT03449446|524122456|FG006|Overall Study|Withdrew Consent|1|||
145348394|NCT03449446|524122450|FG000|Overall Study|Adverse Event|1|||
145348395|NCT03449446|524122451|FG001|Overall Study|Adverse Event|2|||
145348396|NCT03449446|524122452|FG002|Overall Study|Adverse Event|1|||
145348397|NCT03449446|524122453|FG003|Overall Study|Adverse Event|0|||
145348398|NCT03449446|524122454|FG004|Overall Study|Adverse Event|0|||
145348399|NCT03449446|524122455|FG005|Overall Study|Adverse Event|2|||
145348400|NCT03449446|524122456|FG006|Overall Study|Adverse Event|0|||
145414553|NCT03369223|524371284|FG013|Overall Study|Other reasons|1|||
145414554|NCT03369223|524371285|FG014|Overall Study|Other reasons|2|||
145414555|NCT03369223|524371286|FG015|Overall Study|Other reasons|0|||
145414556|NCT03369223|524371287|FG016|Overall Study|Other reasons|1|||
145348401|NCT03449446|524122450|FG000|Overall Study|Lost to Follow-up|0|||
145348402|NCT03449446|524122451|FG001|Overall Study|Lost to Follow-up|0|||
145348403|NCT03449446|524122452|FG002|Overall Study|Lost to Follow-up|2|||
145348404|NCT03449446|524122453|FG003|Overall Study|Lost to Follow-up|1|||
145348405|NCT03449446|524122454|FG004|Overall Study|Lost to Follow-up|3|||
145348406|NCT03449446|524122455|FG005|Overall Study|Lost to Follow-up|0|||
145348407|NCT03449446|524122456|FG006|Overall Study|Lost to Follow-up|0|||
145348408|NCT03449446|524122450|FG000|Overall Study|Investigator's Discretion|0|||
145348409|NCT03449446|524122451|FG001|Overall Study|Investigator's Discretion|1|||
145348410|NCT03449446|524122452|FG002|Overall Study|Investigator's Discretion|1|||
145348411|NCT03449446|524122453|FG003|Overall Study|Investigator's Discretion|2|||
145414557|NCT03369223|524371288|FG017|Overall Study|Other reasons|0|||
145348412|NCT03449446|524122454|FG004|Overall Study|Investigator's Discretion|0|||
145348413|NCT03449446|524122455|FG005|Overall Study|Investigator's Discretion|0|||
145348414|NCT03449446|524122456|FG006|Overall Study|Investigator's Discretion|0|||
145348415|NCT03449446|524122450|FG000|Overall Study|Non Compliance with Study Drug|1|||
145348416|NCT03449446|524122451|FG001|Overall Study|Non Compliance with Study Drug|0|||
145348417|NCT03449446|524122452|FG002|Overall Study|Non Compliance with Study Drug|0|||
145348418|NCT03449446|524122453|FG003|Overall Study|Non Compliance with Study Drug|0|||
145348419|NCT03449446|524122454|FG004|Overall Study|Non Compliance with Study Drug|0|||
145348420|NCT03449446|524122455|FG005|Overall Study|Non Compliance with Study Drug|0|||
145348421|NCT03449446|524122456|FG006|Overall Study|Non Compliance with Study Drug|0|||
145348422|NCT03449446|524122450|FG000|Overall Study|Protocol Violation|0|||
145348423|NCT03449446|524122451|FG001|Overall Study|Protocol Violation|0|||
145348424|NCT03449446|524122452|FG002|Overall Study|Protocol Violation|0|||
145348425|NCT03449446|524122453|FG003|Overall Study|Protocol Violation|0|||
145348426|NCT03449446|524122454|FG004|Overall Study|Protocol Violation|1|||
145348427|NCT03449446|524122455|FG005|Overall Study|Protocol Violation|1|||
145348428|NCT03449446|524122456|FG006|Overall Study|Protocol Violation|0|||
145348429|NCT03449446|524122450|FG000|Overall Study|Death|0|||
145348430|NCT03449446|524122451|FG001|Overall Study|Death|0|||
145348431|NCT03449446|524122452|FG002|Overall Study|Death|0|||
145348432|NCT03449446|524122453|FG003|Overall Study|Death|0|||
145348433|NCT03449446|524122454|FG004|Overall Study|Death|1|||
145348434|NCT03449446|524122455|FG005|Overall Study|Death|0|||
145348435|NCT03449446|524122456|FG006|Overall Study|Death|0|||
145348436|NCT04208750|524122463|FG000|Overall Study|Lost to Follow-up|16|||
145348437|NCT04208750|524122464|FG001|Overall Study|Lost to Follow-up|15|||
145348438|NCT02201277|524122465|FG000|Overall Study|Death|3|||
145348439|NCT02201277|524122466|FG001|Overall Study|Death|4|||
145348440|NCT02201277|524122465|FG000|Overall Study|Lost to Follow-up|2|||
145348441|NCT02201277|524122466|FG001|Overall Study|Lost to Follow-up|1|||
145348442|NCT02201277|524122465|FG000|Overall Study|Failed retrieval|1|||
145348443|NCT02201277|524122466|FG001|Overall Study|Failed retrieval|0|||
145348444|NCT02201277|524122465|FG000|Overall Study|Physician Decision|1|||
145348445|NCT02201277|524122466|FG001|Overall Study|Physician Decision|0|||
145348446|NCT00866359|524122467|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
145348447|NCT00866359|524122468|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
145348448|NCT00866359|524122469|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
145348449|NCT00866359|524122470|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
145348450|NCT00866359|524122467|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
145348451|NCT00866359|524122468|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145348452|NCT00866359|524122469|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145348453|NCT00866359|524122470|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
145348454|NCT00866359|524122467|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
145348455|NCT00866359|524122468|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145348456|NCT00866359|524122469|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145348457|NCT00866359|524122470|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
145348458|NCT00866359|524122467|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
145348459|NCT00866359|524122468|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
145348460|NCT00866359|524122469|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
145348461|NCT00866359|524122470|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
145348462|NCT00866359|524122467|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
145348463|NCT00866359|524122468|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
145348464|NCT00866359|524122469|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
145348465|NCT00866359|524122470|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
145348466|NCT00866359|524122467|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
145348467|NCT00866359|524122468|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
145348468|NCT00866359|524122469|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
145348469|NCT00866359|524122470|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
145348470|NCT01625091|524122471|FG000|Intervention|Death|1|||
145348471|NCT01625091|524122472|FG001|Intervention|Death|1|||
145348472|NCT01625091|524122471|FG000|Intervention|Withdrawal by Subject|4|||
145348473|NCT01625091|524122472|FG001|Intervention|Withdrawal by Subject|1|||
145348474|NCT01625091|524122471|FG000|Intervention|Adverse Event|0|||
145348475|NCT01625091|524122472|FG001|Intervention|Adverse Event|2|||
145348476|NCT01625091|524122471|FG000|Intervention|Lost to Follow-up|4|||
145348477|NCT01625091|524122472|FG001|Intervention|Lost to Follow-up|4|||
145348478|NCT01625091|524122471|FG000|Intervention|Study termination|2|||
145348479|NCT01625091|524122472|FG001|Intervention|Study termination|3|||
145348480|NCT01625091|524122471|FG000|Post-intervention|Death|0|||
145348481|NCT01625091|524122472|FG001|Post-intervention|Death|1|||
145348482|NCT01625091|524122471|FG000|Post-intervention|Lost to Follow-up|2|||
145348483|NCT01625091|524122472|FG001|Post-intervention|Lost to Follow-up|0|||
145348484|NCT01625091|524122471|FG000|Post-intervention|Study termination|2|||
145348485|NCT01625091|524122472|FG001|Post-intervention|Study termination|1|||
145348486|NCT02163057|524122473|FG000|Overall Study|Participant Refusal to Continue|2|||
145348487|NCT02163057|524122474|FG001|Overall Study|Participant Refusal to Continue|2|||
145348488|NCT02163057|524122473|FG000|Overall Study|Participant Significant Noncompliance|0|||
145577156|NCT01332305|524967991|FG002|Overall Study|Physician Decision|0|||
145577157|NCT01332305|524967992|FG003|Overall Study|Physician Decision|1|||
145348489|NCT02163057|524122474|FG001|Overall Study|Participant Significant Noncompliance|1|||
145348490|NCT02163057|524122473|FG000|Overall Study|Progression of Disease|1|||
145348491|NCT02163057|524122474|FG001|Overall Study|Progression of Disease|2|||
145414558|NCT03369223|524371289|FG018|Overall Study|Other reasons|0|||
145348492|NCT00768248|524122478|FG000|Overall Study|Research coordinator didn't collect data|1|||
145348493|NCT00768248|524122479|FG001|Overall Study|Research coordinator didn't collect data|1|||
145348494|NCT01547390|524122483|FG000|Overall Study|Withdrawal by Subject|10|||
145348495|NCT01547390|524122484|FG001|Overall Study|Withdrawal by Subject|7|||
145348496|NCT01547390|524122483|FG000|Overall Study|termination of pregnancy|0|||
145348497|NCT01547390|524122484|FG001|Overall Study|termination of pregnancy|1|||
145348498|NCT01547390|524122483|FG000|Overall Study|Lost to Follow-up|0|||
145348499|NCT01547390|524122484|FG001|Overall Study|Lost to Follow-up|2|||
145348500|NCT01547390|524122483|FG000|Overall Study|Adverse Event|3|||
145348501|NCT01547390|524122484|FG001|Overall Study|Adverse Event|0|||
145348502|NCT01959295|524122487|FG000|Overall Study|Adverse Event|2|||
145348503|NCT01959295|524122488|FG001|Overall Study|Adverse Event|0|||
145348504|NCT01959295|524122487|FG000|Overall Study|Lost to Follow-up|0|||
145348505|NCT01959295|524122488|FG001|Overall Study|Lost to Follow-up|2|||
145348506|NCT01959295|524122487|FG000|Overall Study|Physician Decision|2|||
145348507|NCT01959295|524122488|FG001|Overall Study|Physician Decision|3|||
145348508|NCT01959295|524122487|FG000|Overall Study|Protocol Violation|16|||
145348509|NCT01959295|524122488|FG001|Overall Study|Protocol Violation|5|||
145348510|NCT01959295|524122487|FG000|Overall Study|Withdrawal by Subject|3|||
145348511|NCT01959295|524122488|FG001|Overall Study|Withdrawal by Subject|1|||
145348512|NCT01959295|524122487|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
145348513|NCT01959295|524122488|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
145348514|NCT01128179|524122489|FG000|Overall Study|Death|1|||
145348515|NCT01128179|524122490|FG001|Overall Study|Death|0|||
145348516|NCT01128179|524122489|FG000|Overall Study|Protocol Violation|1|||
145348517|NCT01128179|524122490|FG001|Overall Study|Protocol Violation|0|||
145348518|NCT00720382|524122494|FG000|Overall Study|Adverse Event|54|||
145348519|NCT00720382|524122495|FG001|Overall Study|Adverse Event|17|||
145348520|NCT00720382|524122494|FG000|Overall Study|Lack of Efficacy|18|||
145348521|NCT00720382|524122495|FG001|Overall Study|Lack of Efficacy|7|||
145348522|NCT00720382|524122494|FG000|Overall Study|Non-Compliance|15|||
145348523|NCT00720382|524122495|FG001|Overall Study|Non-Compliance|5|||
145348524|NCT00720382|524122494|FG000|Overall Study|Withdrawal by Subject|47|||
145348525|NCT00720382|524122495|FG001|Overall Study|Withdrawal by Subject|11|||
145348526|NCT00720382|524122494|FG000|Overall Study|Lost to Follow-up|28|||
145348527|NCT00720382|524122495|FG001|Overall Study|Lost to Follow-up|14|||
145348528|NCT00720382|524122494|FG000|Overall Study|administrative|14|||
145348529|NCT00720382|524122495|FG001|Overall Study|administrative|5|||
145348530|NCT05192889|524122496|FG000|Block 1: All Eligible Patients|Death|2|||
145348531|NCT05192889|524122497|FG001|Block 1: All Eligible Patients|Death|0|||
145348532|NCT05192889|524122498|FG002|Block 1: All Eligible Patients|Death|0|||
145348533|NCT05192889|524122496|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
145348534|NCT05192889|524122497|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
145348535|NCT05192889|524122498|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
145348536|NCT05192889|524122496|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
145348537|NCT05192889|524122497|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
145348538|NCT05192889|524122498|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
145348539|NCT05221320|524124941|FG000|Overall Study|Lack of Efficacy|3|||
145348540|NCT05221320|524124942|FG001|Overall Study|Lack of Efficacy|7|||
145348541|NCT05221320|524124943|FG002|Overall Study|Lack of Efficacy|10|||
145348542|NCT05221320|524124944|FG003|Overall Study|Lack of Efficacy|1|||
145348543|NCT05221320|524124945|FG004|Overall Study|Lack of Efficacy|0|||
145348544|NCT05221320|524124946|FG005|Overall Study|Lack of Efficacy|0|||
145348545|NCT05221320|524124941|FG000|Overall Study|Physician Decision|1|||
145348546|NCT05221320|524124942|FG001|Overall Study|Physician Decision|0|||
145348547|NCT05221320|524124943|FG002|Overall Study|Physician Decision|3|||
145348548|NCT05221320|524124944|FG003|Overall Study|Physician Decision|1|||
145348549|NCT05221320|524124945|FG004|Overall Study|Physician Decision|0|||
145348550|NCT05221320|524124946|FG005|Overall Study|Physician Decision|0|||
145348551|NCT05221320|524124941|FG000|Overall Study|Withdrawal by Subject|0|||
145414559|NCT03369223|524371290|FG019|Overall Study|Other reasons|2|||
145414560|NCT03369223|524371271|FG000|Overall Study|Death|0|||
145414561|NCT03369223|524371272|FG001|Overall Study|Death|0|||
145577158|NCT01332305|524967993|FG004|Overall Study|Physician Decision|0|||
145577159|NCT04027686|524967994|FG000|Overall Study|Lost to Follow-up|2|||
145577160|NCT04027686|524967995|FG001|Overall Study|Lost to Follow-up|0|||
145348552|NCT05221320|524124942|FG001|Overall Study|Withdrawal by Subject|3|||
145348553|NCT05221320|524124943|FG002|Overall Study|Withdrawal by Subject|1|||
145348554|NCT05221320|524124944|FG003|Overall Study|Withdrawal by Subject|0|||
145348555|NCT05221320|524124945|FG004|Overall Study|Withdrawal by Subject|0|||
145348556|NCT05221320|524124946|FG005|Overall Study|Withdrawal by Subject|0|||
145348557|NCT05221320|524124941|FG000|Overall Study|Death|0|||
145348558|NCT05221320|524124942|FG001|Overall Study|Death|5|||
145348559|NCT05221320|524124943|FG002|Overall Study|Death|6|||
145348560|NCT05221320|524124944|FG003|Overall Study|Death|0|||
145348561|NCT05221320|524124945|FG004|Overall Study|Death|1|||
145348562|NCT05221320|524124946|FG005|Overall Study|Death|0|||
145348563|NCT06473519|524124947|FG000|Overall Study|Lost to Follow-up|2|||
145348564|NCT06473519|524124948|FG001|Overall Study|Lost to Follow-up|5|||
145348565|NCT06473519|524124947|FG000|Overall Study|Withdrawal by Subject|1|||
145348566|NCT06473519|524124948|FG001|Overall Study|Withdrawal by Subject|4|||
145348567|NCT06473519|524124947|FG000|Overall Study|Randomized but not vaccinated|1|||
145348568|NCT06473519|524124948|FG001|Overall Study|Randomized but not vaccinated|2|||
145348569|NCT02514447|524124949|FG000|Overall Study|Withdrawal by Subject|3|||
145348570|NCT02514447|524124950|FG001|Overall Study|Withdrawal by Subject|1|||
145348571|NCT02514447|524124951|FG002|Overall Study|Withdrawal by Subject|1|||
145348572|NCT02514447|524124952|FG003|Overall Study|Withdrawal by Subject|0|||
145348573|NCT02514447|524124953|FG004|Overall Study|Withdrawal by Subject|0|||
145348574|NCT02514447|524124954|FG005|Overall Study|Withdrawal by Subject|0|||
145348575|NCT02514447|524124955|FG006|Overall Study|Withdrawal by Subject|0|||
145348576|NCT02514447|524124956|FG007|Overall Study|Withdrawal by Subject|1|||
145348577|NCT02514447|524124957|FG008|Overall Study|Withdrawal by Subject|1|||
145348578|NCT02514447|524124949|FG000|Overall Study|Death|24|||
145348579|NCT02514447|524124950|FG001|Overall Study|Death|28|||
145348580|NCT02514447|524124951|FG002|Overall Study|Death|29|||
145348581|NCT02514447|524124952|FG003|Overall Study|Death|0|||
145348582|NCT02514447|524124953|FG004|Overall Study|Death|3|||
145348583|NCT02514447|524124954|FG005|Overall Study|Death|4|||
145348584|NCT02514447|524124955|FG006|Overall Study|Death|8|||
145348585|NCT02514447|524124956|FG007|Overall Study|Death|6|||
145348586|NCT02514447|524124957|FG008|Overall Study|Death|5|||
145348587|NCT02514447|524124949|FG000|Overall Study|Lost to Follow-up|1|||
145348588|NCT02514447|524124950|FG001|Overall Study|Lost to Follow-up|0|||
145348589|NCT02514447|524124951|FG002|Overall Study|Lost to Follow-up|0|||
145348590|NCT02514447|524124952|FG003|Overall Study|Lost to Follow-up|0|||
145348591|NCT02514447|524124953|FG004|Overall Study|Lost to Follow-up|0|||
145348592|NCT02514447|524124954|FG005|Overall Study|Lost to Follow-up|0|||
145348593|NCT02514447|524124955|FG006|Overall Study|Lost to Follow-up|0|||
145348594|NCT02514447|524124956|FG007|Overall Study|Lost to Follow-up|0|||
145348595|NCT02514447|524124957|FG008|Overall Study|Lost to Follow-up|1|||
145348596|NCT02514447|524124949|FG000|Overall Study|Sponsor Termination of Study|0|||
145348597|NCT02514447|524124950|FG001|Overall Study|Sponsor Termination of Study|1|||
145348598|NCT02514447|524124951|FG002|Overall Study|Sponsor Termination of Study|1|||
145348599|NCT02514447|524124952|FG003|Overall Study|Sponsor Termination of Study|0|||
145348600|NCT02514447|524124953|FG004|Overall Study|Sponsor Termination of Study|0|||
145348601|NCT02514447|524124954|FG005|Overall Study|Sponsor Termination of Study|0|||
145348602|NCT02514447|524124955|FG006|Overall Study|Sponsor Termination of Study|0|||
145348603|NCT02514447|524124956|FG007|Overall Study|Sponsor Termination of Study|0|||
145348604|NCT02514447|524124957|FG008|Overall Study|Sponsor Termination of Study|0|||
145348605|NCT02514447|524124949|FG000|Overall Study|Study completion per Investigator|1|||
145348606|NCT02514447|524124950|FG001|Overall Study|Study completion per Investigator|0|||
145348607|NCT02514447|524124951|FG002|Overall Study|Study completion per Investigator|1|||
145348608|NCT02514447|524124952|FG003|Overall Study|Study completion per Investigator|2|||
145348609|NCT02514447|524124953|FG004|Overall Study|Study completion per Investigator|0|||
145348610|NCT02514447|524124954|FG005|Overall Study|Study completion per Investigator|0|||
145348611|NCT02514447|524124955|FG006|Overall Study|Study completion per Investigator|0|||
145348612|NCT02514447|524124956|FG007|Overall Study|Study completion per Investigator|0|||
145348613|NCT02514447|524124957|FG008|Overall Study|Study completion per Investigator|1|||
145348614|NCT03300817|524124959|FG000|Overall Study|Withdrawal by Subject|1|||
145348615|NCT03300817|524124959|FG000|Overall Study|Adverse Event|1|||
145348616|NCT03300817|524124959|FG000|Overall Study|Subject Found to be Ineligible|2|||
145348617|NCT00265759|524124960|FG000|Overall Study|Withdrawal by Subject|0|||
145348618|NCT00265759|524124961|FG001|Overall Study|Withdrawal by Subject|1|||
145348619|NCT00265759|524124962|FG002|Overall Study|Withdrawal by Subject|2|||
145348620|NCT00265759|524124963|FG003|Overall Study|Withdrawal by Subject|2|||
145348621|NCT00265759|524124960|FG000|Overall Study|Cancel|0|||
145348622|NCT00265759|524124961|FG001|Overall Study|Cancel|0|||
145348623|NCT00265759|524124962|FG002|Overall Study|Cancel|0|||
145348624|NCT00265759|524124963|FG003|Overall Study|Cancel|3|||
145348625|NCT00265759|524124960|FG000|Overall Study|Ineligible|0|||
145348626|NCT00265759|524124961|FG001|Overall Study|Ineligible|0|||
145348627|NCT00265759|524124962|FG002|Overall Study|Ineligible|0|||
145348628|NCT00265759|524124963|FG003|Overall Study|Ineligible|1|||
145348629|NCT00265759|524124960|FG000|Overall Study|Bilateral disease|0|||
145348630|NCT00265759|524124961|FG001|Overall Study|Bilateral disease|0|||
145348631|NCT00265759|524124962|FG002|Overall Study|Bilateral disease|0|||
145414562|NCT03369223|524371273|FG002|Overall Study|Death|0|||
145348632|NCT00265759|524124963|FG003|Overall Study|Bilateral disease|2|||
145348633|NCT00265759|524124960|FG000|Overall Study|Discontinued due to intolerability|0|||
145348634|NCT00265759|524124961|FG001|Overall Study|Discontinued due to intolerability|0|||
145348635|NCT00265759|524124962|FG002|Overall Study|Discontinued due to intolerability|0|||
145348636|NCT00265759|524124963|FG003|Overall Study|Discontinued due to intolerability|1|||
145348637|NCT05168202|524124964|FG000|Overall Study|Progressive Disease|4|||
145348638|NCT05168202|524124965|FG001|Overall Study|Progressive Disease|4|||
145348639|NCT05168202|524124966|FG002|Overall Study|Progressive Disease|2|||
145348640|NCT05168202|524124967|FG003|Overall Study|Progressive Disease|3|||
145414563|NCT03369223|524371274|FG003|Overall Study|Death|0|||
145414564|NCT03369223|524371275|FG004|Overall Study|Death|0|||
145414565|NCT03369223|524371276|FG005|Overall Study|Death|0|||
145414566|NCT03369223|524371277|FG006|Overall Study|Death|0|||
145348641|NCT05168202|524124968|FG004|Overall Study|Progressive Disease|2|||
145348642|NCT05168202|524124969|FG005|Overall Study|Progressive Disease|3|||
145348643|NCT05168202|524124970|FG006|Overall Study|Progressive Disease|2|||
145348644|NCT05168202|524124964|FG000|Overall Study|Adverse Event|2|||
145348645|NCT05168202|524124965|FG001|Overall Study|Adverse Event|1|||
145348646|NCT05168202|524124966|FG002|Overall Study|Adverse Event|4|||
145348647|NCT05168202|524124967|FG003|Overall Study|Adverse Event|4|||
145348648|NCT05168202|524124968|FG004|Overall Study|Adverse Event|3|||
145348649|NCT05168202|524124969|FG005|Overall Study|Adverse Event|2|||
145348650|NCT05168202|524124970|FG006|Overall Study|Adverse Event|0|||
145348651|NCT05168202|524124964|FG000|Overall Study|Lack of Efficacy|0|||
145348652|NCT05168202|524124965|FG001|Overall Study|Lack of Efficacy|1|||
145348653|NCT05168202|524124966|FG002|Overall Study|Lack of Efficacy|1|||
145348654|NCT05168202|524124967|FG003|Overall Study|Lack of Efficacy|0|||
145348655|NCT05168202|524124968|FG004|Overall Study|Lack of Efficacy|1|||
145348656|NCT05168202|524124969|FG005|Overall Study|Lack of Efficacy|2|||
145348657|NCT05168202|524124970|FG006|Overall Study|Lack of Efficacy|2|||
145348658|NCT05168202|524124964|FG000|Overall Study|Withdrawal by Subject|0|||
145348659|NCT05168202|524124965|FG001|Overall Study|Withdrawal by Subject|0|||
145348660|NCT05168202|524124966|FG002|Overall Study|Withdrawal by Subject|1|||
145348661|NCT05168202|524124967|FG003|Overall Study|Withdrawal by Subject|1|||
145348662|NCT05168202|524124968|FG004|Overall Study|Withdrawal by Subject|1|||
145348663|NCT05168202|524124969|FG005|Overall Study|Withdrawal by Subject|1|||
145348664|NCT05168202|524124970|FG006|Overall Study|Withdrawal by Subject|0|||
145348665|NCT05168202|524124964|FG000|Overall Study|Disease Relapse|0|||
145348666|NCT05168202|524124965|FG001|Overall Study|Disease Relapse|1|||
145348667|NCT05168202|524124966|FG002|Overall Study|Disease Relapse|0|||
145348668|NCT05168202|524124967|FG003|Overall Study|Disease Relapse|1|||
145348669|NCT05168202|524124968|FG004|Overall Study|Disease Relapse|1|||
145348670|NCT05168202|524124969|FG005|Overall Study|Disease Relapse|0|||
145348671|NCT05168202|524124970|FG006|Overall Study|Disease Relapse|0|||
145348672|NCT05168202|524124964|FG000|Overall Study|Other Reasons|0|||
145348673|NCT05168202|524124965|FG001|Overall Study|Other Reasons|0|||
145348674|NCT05168202|524124966|FG002|Overall Study|Other Reasons|0|||
145348675|NCT05168202|524124967|FG003|Overall Study|Other Reasons|0|||
145348676|NCT05168202|524124968|FG004|Overall Study|Other Reasons|0|||
145348677|NCT05168202|524124969|FG005|Overall Study|Other Reasons|2|||
145348678|NCT05168202|524124970|FG006|Overall Study|Other Reasons|1|||
145348679|NCT05168202|524124964|FG000|Overall Study|Physician Decision|0|||
145348680|NCT05168202|524124965|FG001|Overall Study|Physician Decision|1|||
145348681|NCT05168202|524124966|FG002|Overall Study|Physician Decision|1|||
145348682|NCT05168202|524124967|FG003|Overall Study|Physician Decision|0|||
145348683|NCT05168202|524124968|FG004|Overall Study|Physician Decision|0|||
145348684|NCT05168202|524124969|FG005|Overall Study|Physician Decision|0|||
145348685|NCT05168202|524124970|FG006|Overall Study|Physician Decision|0|||
145348686|NCT05168202|524124964|FG000|Overall Study|Study Terminated by Sponsor|0|||
145348687|NCT05168202|524124965|FG001|Overall Study|Study Terminated by Sponsor|0|||
145348688|NCT05168202|524124966|FG002|Overall Study|Study Terminated by Sponsor|0|||
145348689|NCT05168202|524124967|FG003|Overall Study|Study Terminated by Sponsor|1|||
145414567|NCT03369223|524371278|FG007|Overall Study|Death|0|||
145577161|NCT04027686|524967994|FG000|Overall Study|Withdrawal by Subject|0|||
145348690|NCT05168202|524124968|FG004|Overall Study|Study Terminated by Sponsor|0|||
145348691|NCT05168202|524124969|FG005|Overall Study|Study Terminated by Sponsor|0|||
145348692|NCT05168202|524124970|FG006|Overall Study|Study Terminated by Sponsor|0|||
145348693|NCT04011722|524124974|FG000|30 Days|Death|5|||
145348694|NCT04011722|524124975|FG001|30 Days|Death|1|||
145348695|NCT04011722|524124974|FG000|1 Year|Death|13|||
145348696|NCT04011722|524124975|FG001|1 Year|Death|5|||
145577162|NCT04027686|524967995|FG001|Overall Study|Withdrawal by Subject|1|||
145577163|NCT01263873|524967996|FG000|Overall Study|One provider unable to complete numbers|1|||
145348697|NCT04011722|524124974|FG000|1 Year|Withdrawal by Subject|8|||
145348698|NCT04011722|524124975|FG001|1 Year|Withdrawal by Subject|2|||
145348699|NCT04011722|524124974|FG000|1 Year|Missed Visit|6|||
145348700|NCT04011722|524124975|FG001|1 Year|Missed Visit|1|||
145348701|NCT04011722|524124974|FG000|1 Year|Pending Visit|0|||
145348702|NCT04011722|524124975|FG001|1 Year|Pending Visit|11|||
145348703|NCT04011722|524124974|FG000|1 Year|Not Yet Due|0|||
145348704|NCT04011722|524124975|FG001|1 Year|Not Yet Due|9|||
145348705|NCT04011722|524124974|FG000|2 Year|Death|16|||
145348706|NCT04011722|524124975|FG001|2 Year|Death|1|||
145348707|NCT04011722|524124974|FG000|2 Year|Withdrawal by Subject|10|||
145348708|NCT04011722|524124975|FG001|2 Year|Withdrawal by Subject|1|||
145348709|NCT04011722|524124974|FG000|2 Year|Missed Visit|9|||
145414568|NCT03369223|524371279|FG008|Overall Study|Death|0|||
145348710|NCT04011722|524124975|FG001|2 Year|Missed Visit|0|||
145348711|NCT04011722|524124974|FG000|2 Year|Visit Pending|1|||
145348712|NCT04011722|524124975|FG001|2 Year|Visit Pending|3|||
145348713|NCT04011722|524124974|FG000|2 Year|Not Yet Due|43|||
145414569|NCT03369223|524371280|FG009|Overall Study|Death|0|||
145414570|NCT03369223|524371281|FG010|Overall Study|Death|0|||
145414571|NCT03369223|524371282|FG011|Overall Study|Death|0|||
145414572|NCT03369223|524371283|FG012|Overall Study|Death|0|||
145414573|NCT03369223|524371284|FG013|Overall Study|Death|1|||
145414574|NCT03369223|524371285|FG014|Overall Study|Death|0|||
145414575|NCT03369223|524371286|FG015|Overall Study|Death|0|||
145414576|NCT03369223|524371287|FG016|Overall Study|Death|0|||
145414577|NCT03369223|524371288|FG017|Overall Study|Death|0|||
145414578|NCT03369223|524371289|FG018|Overall Study|Death|1|||
145414579|NCT03369223|524371290|FG019|Overall Study|Death|0|||
145414580|NCT03369223|524371271|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145414581|NCT03369223|524371272|FG001|Overall Study|Adverse event unrelated to study drug|0|||
145414582|NCT03369223|524371273|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145414583|NCT03369223|524371274|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145414584|NCT03369223|524371275|FG004|Overall Study|Adverse event unrelated to study drug|0|||
145414585|NCT03369223|524371276|FG005|Overall Study|Adverse event unrelated to study drug|0|||
145414586|NCT03369223|524371277|FG006|Overall Study|Adverse event unrelated to study drug|1|||
145414587|NCT03369223|524371278|FG007|Overall Study|Adverse event unrelated to study drug|0|||
145414588|NCT03369223|524371279|FG008|Overall Study|Adverse event unrelated to study drug|0|||
145414589|NCT03369223|524371280|FG009|Overall Study|Adverse event unrelated to study drug|1|||
145414590|NCT03369223|524371281|FG010|Overall Study|Adverse event unrelated to study drug|0|||
145414591|NCT03369223|524371282|FG011|Overall Study|Adverse event unrelated to study drug|0|||
145414592|NCT03369223|524371283|FG012|Overall Study|Adverse event unrelated to study drug|0|||
145414593|NCT03369223|524371284|FG013|Overall Study|Adverse event unrelated to study drug|4|||
145414594|NCT03369223|524371285|FG014|Overall Study|Adverse event unrelated to study drug|2|||
145414595|NCT03369223|524371286|FG015|Overall Study|Adverse event unrelated to study drug|0|||
145414596|NCT03369223|524371287|FG016|Overall Study|Adverse event unrelated to study drug|2|||
145414597|NCT03369223|524371288|FG017|Overall Study|Adverse event unrelated to study drug|1|||
145414598|NCT03369223|524371289|FG018|Overall Study|Adverse event unrelated to study drug|3|||
145414599|NCT03369223|524371290|FG019|Overall Study|Adverse event unrelated to study drug|2|||
145414600|NCT03369223|524371271|FG000|Overall Study|Disease progression|6|||
145414601|NCT03369223|524371272|FG001|Overall Study|Disease progression|8|||
145414602|NCT03369223|524371273|FG002|Overall Study|Disease progression|5|||
145414603|NCT03369223|524371274|FG003|Overall Study|Disease progression|1|||
145414604|NCT03369223|524371275|FG004|Overall Study|Disease progression|9|||
145414605|NCT03369223|524371276|FG005|Overall Study|Disease progression|9|||
145414606|NCT03369223|524371277|FG006|Overall Study|Disease progression|4|||
145414607|NCT03369223|524371278|FG007|Overall Study|Disease progression|6|||
145414608|NCT03369223|524371279|FG008|Overall Study|Disease progression|10|||
145414609|NCT03369223|524371280|FG009|Overall Study|Disease progression|7|||
145414610|NCT03369223|524371281|FG010|Overall Study|Disease progression|4|||
145414611|NCT03369223|524371282|FG011|Overall Study|Disease progression|1|||
145414612|NCT03369223|524371283|FG012|Overall Study|Disease progression|1|||
145414613|NCT03369223|524371284|FG013|Overall Study|Disease progression|25|||
145414614|NCT03369223|524371285|FG014|Overall Study|Disease progression|22|||
145414615|NCT03369223|524371286|FG015|Overall Study|Disease progression|2|||
145414616|NCT03369223|524371287|FG016|Overall Study|Disease progression|10|||
145414617|NCT03369223|524371288|FG017|Overall Study|Disease progression|1|||
145414618|NCT03369223|524371289|FG018|Overall Study|Disease progression|18|||
145414619|NCT03369223|524371290|FG019|Overall Study|Disease progression|28|||
145414620|NCT03369223|524371271|FG000|Overall Study|Study drug toxicity|0|||
145414621|NCT03369223|524371272|FG001|Overall Study|Study drug toxicity|1|||
145414622|NCT03369223|524371273|FG002|Overall Study|Study drug toxicity|4|||
145414623|NCT03369223|524371274|FG003|Overall Study|Study drug toxicity|0|||
145414624|NCT03369223|524371275|FG004|Overall Study|Study drug toxicity|1|||
145414625|NCT03369223|524371276|FG005|Overall Study|Study drug toxicity|2|||
145414626|NCT03369223|524371277|FG006|Overall Study|Study drug toxicity|4|||
145414627|NCT03369223|524371278|FG007|Overall Study|Study drug toxicity|2|||
145414628|NCT03369223|524371279|FG008|Overall Study|Study drug toxicity|2|||
145414629|NCT03369223|524371280|FG009|Overall Study|Study drug toxicity|0|||
145414630|NCT03369223|524371281|FG010|Overall Study|Study drug toxicity|6|||
145414631|NCT03369223|524371282|FG011|Overall Study|Study drug toxicity|1|||
145414632|NCT03369223|524371283|FG012|Overall Study|Study drug toxicity|2|||
145414633|NCT03369223|524371284|FG013|Overall Study|Study drug toxicity|19|||
145577164|NCT01263873|524967997|FG001|Overall Study|One provider unable to complete numbers|1|||
145414634|NCT03369223|524371285|FG014|Overall Study|Study drug toxicity|19|||
145414635|NCT03369223|524371286|FG015|Overall Study|Study drug toxicity|0|||
145414636|NCT03369223|524371287|FG016|Overall Study|Study drug toxicity|18|||
145414637|NCT03369223|524371288|FG017|Overall Study|Study drug toxicity|3|||
145414638|NCT03369223|524371289|FG018|Overall Study|Study drug toxicity|11|||
145414639|NCT03369223|524371290|FG019|Overall Study|Study drug toxicity|7|||
145414640|NCT03369223|524371271|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145414641|NCT03369223|524371272|FG001|Overall Study|Participant request to discontinue study treatment|1|||
145414642|NCT03369223|524371273|FG002|Overall Study|Participant request to discontinue study treatment|0|||
145414643|NCT03369223|524371274|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145348714|NCT04011722|524124975|FG001|2 Year|Not Yet Due|54|||
145348715|NCT04011722|524124974|FG000|3 Year|Death|10|||
145348716|NCT04011722|524124975|FG001|3 Year|Death|0|||
145348717|NCT04011722|524124974|FG000|3 Year|Withdrawal by Subject|2|||
145348718|NCT04011722|524124975|FG001|3 Year|Withdrawal by Subject|0|||
145348719|NCT04011722|524124974|FG000|3 Year|Missed Visit|2|||
145348720|NCT04011722|524124975|FG001|3 Year|Missed Visit|0|||
145348721|NCT04011722|524124974|FG000|3 Year|Pending Visit|34|||
145348722|NCT04011722|524124975|FG001|3 Year|Pending Visit|0|||
145348723|NCT04011722|524124974|FG000|3 Year|Not Yet Due|99|||
145348724|NCT04011722|524124975|FG001|3 Year|Not Yet Due|0|||
145348725|NCT05061134|524124978|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
145348726|NCT05061134|524124979|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
145348727|NCT05061134|524124980|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
145348728|NCT05061134|524124978|FG000|Overall Study|Subject not treated|0|||
145348729|NCT05061134|524124979|FG001|Overall Study|Subject not treated|0|||
145348730|NCT05061134|524124980|FG002|Overall Study|Subject not treated|2|||
145348731|NCT05061134|524124978|FG000|Overall Study|Other|0|||
145348732|NCT05061134|524124979|FG001|Overall Study|Other|0|||
145348733|NCT05061134|524124980|FG002|Overall Study|Other|9|||
145348734|NCT05061134|524124978|FG000|Overall Study|Withdrawal by Subject|9|||
145348735|NCT05061134|524124979|FG001|Overall Study|Withdrawal by Subject|8|||
145348736|NCT05061134|524124980|FG002|Overall Study|Withdrawal by Subject|5|||
145348737|NCT05061134|524124978|FG000|Overall Study|Study Terminated by Sponsor|22|||
145348738|NCT05061134|524124979|FG001|Overall Study|Study Terminated by Sponsor|14|||
145348739|NCT05061134|524124980|FG002|Overall Study|Study Terminated by Sponsor|7|||
145348740|NCT05061134|524124978|FG000|Overall Study|Progressive Disease|1|||
145348741|NCT05061134|524124979|FG001|Overall Study|Progressive Disease|2|||
145348742|NCT05061134|524124980|FG002|Overall Study|Progressive Disease|0|||
145348743|NCT05061134|524124978|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
145348744|NCT05061134|524124979|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
145348745|NCT05061134|524124980|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
145348746|NCT05061134|524124978|FG000|Overall Study|Lost to Follow-up|1|||
145348747|NCT05061134|524124979|FG001|Overall Study|Lost to Follow-up|0|||
145348748|NCT05061134|524124980|FG002|Overall Study|Lost to Follow-up|0|||
145348749|NCT05061134|524124978|FG000|Overall Study|Physician Decision|1|||
145348750|NCT05061134|524124979|FG001|Overall Study|Physician Decision|1|||
145348751|NCT05061134|524124980|FG002|Overall Study|Physician Decision|0|||
145348752|NCT05061134|524124978|FG000|Overall Study|Disease progression|1|||
145348753|NCT05061134|524124979|FG001|Overall Study|Disease progression|0|||
145348754|NCT05061134|524124980|FG002|Overall Study|Disease progression|0|||
145348755|NCT05061134|524124978|FG000|Overall Study|Death|43|||
145348756|NCT05061134|524124979|FG001|Overall Study|Death|23|||
145348757|NCT05061134|524124980|FG002|Overall Study|Death|14|||
145348758|NCT05061134|524124978|FG000|Overall Study|Database lock|2|||
145348759|NCT05061134|524124979|FG001|Overall Study|Database lock|0|||
145348760|NCT05061134|524124980|FG002|Overall Study|Database lock|0|||
145348761|NCT00266630|524124986|FG000|Overall Study|Adverse Event|8|||
145348762|NCT00266630|524124987|FG001|Overall Study|Adverse Event|6|||
145348763|NCT00266630|524124986|FG000|Overall Study|Lack of Efficacy|1|||
145348764|NCT00266630|524124987|FG001|Overall Study|Lack of Efficacy|4|||
145348765|NCT00266630|524124986|FG000|Overall Study|Entry Criteria not met|1|||
145348766|NCT00266630|524124987|FG001|Overall Study|Entry Criteria not met|0|||
145348767|NCT00266630|524124986|FG000|Overall Study|Protocol Violation|1|||
145348768|NCT00266630|524124987|FG001|Overall Study|Protocol Violation|3|||
145348769|NCT00266630|524124986|FG000|Overall Study|Physician Decision|1|||
145348770|NCT00266630|524124987|FG001|Overall Study|Physician Decision|2|||
145348771|NCT00266630|524124986|FG000|Overall Study|Withdrawal by Subject|10|||
145348772|NCT00266630|524124987|FG001|Overall Study|Withdrawal by Subject|2|||
145348773|NCT00266630|524124986|FG000|Overall Study|Lost to Follow-up|1|||
145348774|NCT00266630|524124987|FG001|Overall Study|Lost to Follow-up|0|||
145348775|NCT00266630|524124986|FG000|Overall Study|Other|19|||
145348776|NCT00266630|524124987|FG001|Overall Study|Other|11|||
145348777|NCT03410056|524124988|FG000|Overall Study|Decision by Sponsor|0|||
145348778|NCT03410056|524124989|FG001|Overall Study|Decision by Sponsor|0|||
145348779|NCT03410056|524124990|FG002|Overall Study|Decision by Sponsor|3|||
145348780|NCT03410056|524124991|FG003|Overall Study|Decision by Sponsor|0|||
145577165|NCT00642304|524967998|FG000|Overall Study|Adverse Event|1|||
145348781|NCT03410056|524124992|FG004|Overall Study|Decision by Sponsor|0|||
145348782|NCT03410056|524124993|FG005|Overall Study|Decision by Sponsor|0|||
145348783|NCT03410056|524124994|FG006|Overall Study|Decision by Sponsor|0|||
145348784|NCT03410056|524124988|FG000|Overall Study|Withdrawal by Subject|0|||
145348785|NCT03410056|524124989|FG001|Overall Study|Withdrawal by Subject|2|||
145348786|NCT03410056|524124990|FG002|Overall Study|Withdrawal by Subject|5|||
145414644|NCT03369223|524371275|FG004|Overall Study|Participant request to discontinue study treatment|1|||
145348787|NCT03410056|524124991|FG003|Overall Study|Withdrawal by Subject|5|||
145348788|NCT03410056|524124992|FG004|Overall Study|Withdrawal by Subject|0|||
145348789|NCT03410056|524124993|FG005|Overall Study|Withdrawal by Subject|0|||
145348790|NCT03410056|524124994|FG006|Overall Study|Withdrawal by Subject|0|||
145348791|NCT05377749|524124999|FG000|3 Weeks|Lost to Follow-up|2|||
145348792|NCT05377749|524125000|FG001|3 Weeks|Lost to Follow-up|4|||
145348793|NCT05377749|524124999|FG000|3 Weeks|Withdrawal by Subject|1|||
145348794|NCT05377749|524125000|FG001|3 Weeks|Withdrawal by Subject|1|||
145348795|NCT04909853|524125001|FG000|Part 1|Assigned but not treated|0|||
145348796|NCT04909853|524125002|FG001|Part 1|Assigned but not treated|0|||
145348797|NCT04909853|524125003|FG002|Part 1|Assigned but not treated|1|||
145348798|NCT04909853|524125004|FG003|Part 1|Assigned but not treated|0|||
145348799|NCT04909853|524125001|FG000|Part 2|Adverse Event|0|||
145348800|NCT04909853|524125002|FG001|Part 2|Adverse Event|0|||
145348801|NCT04909853|524125003|FG002|Part 2|Adverse Event|0|||
145348802|NCT04909853|524125004|FG003|Part 2|Adverse Event|1|||
145348803|NCT00077207|524125005|FG000|Overall Study|Adverse Event|5|||
145348804|NCT00077207|524125005|FG000|Overall Study|Lack of Efficacy|12|||
145348805|NCT00077207|524125005|FG000|Overall Study|Physician Decision|6|||
145348806|NCT00077207|524125005|FG000|Overall Study|Withdrawal by Subject|6|||
145348807|NCT00077207|524125005|FG000|Overall Study|Ineligible|1|||
145348808|NCT03288714|524125006|FG000|Overall Study|Lost to Follow-up|2|||
145348809|NCT03288714|524125007|FG001|Overall Study|Lost to Follow-up|1|||
145348810|NCT03288714|524125006|FG000|Overall Study|Non-compliance with study schedule|2|||
145348811|NCT03288714|524125007|FG001|Overall Study|Non-compliance with study schedule|0|||
145348812|NCT03288714|524125006|FG000|Overall Study|Withdrawal by Subject|3|||
145348813|NCT03288714|524125007|FG001|Overall Study|Withdrawal by Subject|1|||
145348814|NCT03288714|524125006|FG000|Overall Study|Clinical Worsening|2|||
145348815|NCT03288714|524125007|FG001|Overall Study|Clinical Worsening|1|||
145348816|NCT03288714|524125006|FG000|Overall Study|Adverse Event|1|||
145348817|NCT03288714|524125007|FG001|Overall Study|Adverse Event|0|||
145348818|NCT04882241|524125008|FG000|Overall Study|Ongoing in study|46|||
145348819|NCT04882241|524125009|FG001|Overall Study|Ongoing in study|48|||
145348820|NCT04882241|524125010|FG002|Overall Study|Ongoing in study|0|||
145348821|NCT04882241|524125011|FG003|Overall Study|Ongoing in study|0|||
145348822|NCT04882241|524125008|FG000|Overall Study|Death|13|||
145348823|NCT04882241|524125009|FG001|Overall Study|Death|13|||
145348824|NCT04882241|524125010|FG002|Overall Study|Death|0|||
145348825|NCT04882241|524125011|FG003|Overall Study|Death|0|||
145348826|NCT05024747|524125021|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
145348827|NCT05024747|524125022|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
145348828|NCT05024747|524125021|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
145348829|NCT05024747|524125022|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
145348830|NCT05024747|524125021|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
145348831|NCT05024747|524125022|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
145348832|NCT04428034|524125023|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
145348833|NCT02556801|524125024|FG000|Overall Study|Lost to Follow-up|1|||
145348834|NCT02556801|524125025|FG001|Overall Study|Lost to Follow-up|0|||
145348835|NCT02556801|524125026|FG002|Overall Study|Lost to Follow-up|2|||
145348836|NCT02556801|524125027|FG003|Overall Study|Lost to Follow-up|0|||
145348837|NCT02556801|524125024|FG000|Overall Study|Withdrawal by Subject|1|||
145348838|NCT02556801|524125025|FG001|Overall Study|Withdrawal by Subject|1|||
145348839|NCT02556801|524125026|FG002|Overall Study|Withdrawal by Subject|1|||
145348840|NCT02556801|524125027|FG003|Overall Study|Withdrawal by Subject|0|||
145348841|NCT02556801|524125024|FG000|Overall Study|Protocol Violation|0|||
145348842|NCT02556801|524125025|FG001|Overall Study|Protocol Violation|3|||
145348843|NCT02556801|524125026|FG002|Overall Study|Protocol Violation|1|||
145348844|NCT02556801|524125027|FG003|Overall Study|Protocol Violation|1|||
145348845|NCT02556801|524125024|FG000|Overall Study|Adverse Event|0|||
145348846|NCT02556801|524125025|FG001|Overall Study|Adverse Event|2|||
145348847|NCT02556801|524125026|FG002|Overall Study|Adverse Event|0|||
145348848|NCT02556801|524125027|FG003|Overall Study|Adverse Event|3|||
145348849|NCT02556801|524125024|FG000|Overall Study|Pregnancy|0|||
145348850|NCT02556801|524125025|FG001|Overall Study|Pregnancy|1|||
145348851|NCT02556801|524125026|FG002|Overall Study|Pregnancy|0|||
145348852|NCT02556801|524125027|FG003|Overall Study|Pregnancy|0|||
145348853|NCT02556801|524125024|FG000|Overall Study|Personal reasons patient|0|||
145348854|NCT02556801|524125025|FG001|Overall Study|Personal reasons patient|0|||
145348855|NCT02556801|524125026|FG002|Overall Study|Personal reasons patient|0|||
145348856|NCT02556801|524125027|FG003|Overall Study|Personal reasons patient|1|||
145348857|NCT01942993|524125028|FG000|Overall Study|Lost to Follow-up|1|||
145348858|NCT01942993|524125028|FG000|Overall Study|Physician Decision|1|||
145348859|NCT01350271|524125029|FG000|Overall Study|Lost to Follow-up|21|||
145348860|NCT01350271|524125030|FG001|Overall Study|Lost to Follow-up|17|||
145348861|NCT01350271|524125031|FG002|Overall Study|Lost to Follow-up|26|||
145348862|NCT02906670|524125035|FG000|Cohort 1, QW|Radiological Progression|1|||
145577166|NCT00642304|524967998|FG000|Overall Study|Death|1|||
145348863|NCT02906670|524125036|FG001|Cohort 1, QW|Radiological Progression|0|||
145348864|NCT02906670|524125037|FG002|Cohort 1, QW|Radiological Progression|0|||
145348865|NCT02906670|524125038|FG003|Cohort 1, QW|Radiological Progression|0|||
145348866|NCT02906670|524125039|FG004|Cohort 1, QW|Radiological Progression|0|||
145348867|NCT02906670|524125040|FG005|Cohort 1, QW|Radiological Progression|0|||
145348868|NCT02906670|524125041|FG006|Cohort 1, QW|Radiological Progression|0|||
145348869|NCT02906670|524125042|FG007|Cohort 1, QW|Radiological Progression|0|||
145348870|NCT02906670|524125043|FG008|Cohort 1, QW|Radiological Progression|0|||
145348871|NCT02906670|524125044|FG009|Cohort 1, QW|Radiological Progression|0|||
145348872|NCT02906670|524125035|FG000|Cohort 2, QW|Radiological Progression|0|||
145348873|NCT02906670|524125036|FG001|Cohort 2, QW|Radiological Progression|1|||
145348874|NCT02906670|524125037|FG002|Cohort 2, QW|Radiological Progression|0|||
145348875|NCT02906670|524125038|FG003|Cohort 2, QW|Radiological Progression|0|||
145348876|NCT02906670|524125039|FG004|Cohort 2, QW|Radiological Progression|0|||
145348877|NCT02906670|524125040|FG005|Cohort 2, QW|Radiological Progression|0|||
145348878|NCT02906670|524125041|FG006|Cohort 2, QW|Radiological Progression|0|||
145348879|NCT02906670|524125042|FG007|Cohort 2, QW|Radiological Progression|0|||
145348880|NCT02906670|524125043|FG008|Cohort 2, QW|Radiological Progression|0|||
145348881|NCT02906670|524125044|FG009|Cohort 2, QW|Radiological Progression|0|||
145348882|NCT02906670|524125035|FG000|Cohort 3, QW|Radiological Progression|0|||
145348883|NCT02906670|524125036|FG001|Cohort 3, QW|Radiological Progression|0|||
145348884|NCT02906670|524125037|FG002|Cohort 3, QW|Radiological Progression|2|||
145348885|NCT02906670|524125038|FG003|Cohort 3, QW|Radiological Progression|0|||
145348886|NCT02906670|524125039|FG004|Cohort 3, QW|Radiological Progression|0|||
145348887|NCT02906670|524125040|FG005|Cohort 3, QW|Radiological Progression|0|||
145348888|NCT02906670|524125041|FG006|Cohort 3, QW|Radiological Progression|0|||
145348889|NCT02906670|524125042|FG007|Cohort 3, QW|Radiological Progression|0|||
145348890|NCT02906670|524125043|FG008|Cohort 3, QW|Radiological Progression|0|||
145348891|NCT02906670|524125044|FG009|Cohort 3, QW|Radiological Progression|0|||
145348892|NCT02906670|524125035|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348893|NCT02906670|524125036|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348894|NCT02906670|524125037|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
145348895|NCT02906670|524125038|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348896|NCT02906670|524125039|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348897|NCT02906670|524125040|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348898|NCT02906670|524125041|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348899|NCT02906670|524125042|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348900|NCT02906670|524125043|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348901|NCT02906670|524125044|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
145348902|NCT02906670|524125035|FG000|Cohort 4, Q2W|Radiological Progression|0|||
145348903|NCT02906670|524125036|FG001|Cohort 4, Q2W|Radiological Progression|0|||
145348904|NCT02906670|524125037|FG002|Cohort 4, Q2W|Radiological Progression|0|||
145348905|NCT02906670|524125038|FG003|Cohort 4, Q2W|Radiological Progression|0|||
145348906|NCT02906670|524125039|FG004|Cohort 4, Q2W|Radiological Progression|0|||
145348907|NCT02906670|524125040|FG005|Cohort 4, Q2W|Radiological Progression|1|||
145348908|NCT02906670|524125041|FG006|Cohort 4, Q2W|Radiological Progression|0|||
145348909|NCT02906670|524125042|FG007|Cohort 4, Q2W|Radiological Progression|0|||
145348910|NCT02906670|524125043|FG008|Cohort 4, Q2W|Radiological Progression|0|||
145348911|NCT02906670|524125044|FG009|Cohort 4, Q2W|Radiological Progression|0|||
145348912|NCT02906670|524125035|FG000|Cohort 4, Q2W|Clinical Progression|0|||
145348913|NCT02906670|524125036|FG001|Cohort 4, Q2W|Clinical Progression|0|||
145348914|NCT02906670|524125037|FG002|Cohort 4, Q2W|Clinical Progression|0|||
145348915|NCT02906670|524125038|FG003|Cohort 4, Q2W|Clinical Progression|0|||
145348916|NCT02906670|524125039|FG004|Cohort 4, Q2W|Clinical Progression|0|||
145348917|NCT02906670|524125040|FG005|Cohort 4, Q2W|Clinical Progression|2|||
145348918|NCT02906670|524125041|FG006|Cohort 4, Q2W|Clinical Progression|0|||
145348919|NCT02906670|524125042|FG007|Cohort 4, Q2W|Clinical Progression|0|||
145348920|NCT02906670|524125043|FG008|Cohort 4, Q2W|Clinical Progression|0|||
145348921|NCT02906670|524125044|FG009|Cohort 4, Q2W|Clinical Progression|0|||
145348922|NCT02906670|524125035|FG000|Cohort 5, Q2W|Radiological Progression|0|||
145348923|NCT02906670|524125036|FG001|Cohort 5, Q2W|Radiological Progression|0|||
145348924|NCT02906670|524125037|FG002|Cohort 5, Q2W|Radiological Progression|0|||
145348925|NCT02906670|524125038|FG003|Cohort 5, Q2W|Radiological Progression|0|||
145348926|NCT02906670|524125039|FG004|Cohort 5, Q2W|Radiological Progression|0|||
145348927|NCT02906670|524125040|FG005|Cohort 5, Q2W|Radiological Progression|0|||
145348928|NCT02906670|524125041|FG006|Cohort 5, Q2W|Radiological Progression|4|||
145348929|NCT02906670|524125042|FG007|Cohort 5, Q2W|Radiological Progression|0|||
145348930|NCT02906670|524125043|FG008|Cohort 5, Q2W|Radiological Progression|0|||
145348931|NCT02906670|524125044|FG009|Cohort 5, Q2W|Radiological Progression|0|||
145348932|NCT02906670|524125035|FG000|Cohort 5, Q2W|Clinical Progression|0|||
145348933|NCT02906670|524125036|FG001|Cohort 5, Q2W|Clinical Progression|0|||
145348934|NCT02906670|524125037|FG002|Cohort 5, Q2W|Clinical Progression|0|||
145348935|NCT02906670|524125038|FG003|Cohort 5, Q2W|Clinical Progression|0|||
145348936|NCT02906670|524125039|FG004|Cohort 5, Q2W|Clinical Progression|0|||
145348937|NCT02906670|524125040|FG005|Cohort 5, Q2W|Clinical Progression|0|||
145348938|NCT02906670|524125041|FG006|Cohort 5, Q2W|Clinical Progression|1|||
145348939|NCT02906670|524125042|FG007|Cohort 5, Q2W|Clinical Progression|0|||
145348940|NCT02906670|524125043|FG008|Cohort 5, Q2W|Clinical Progression|0|||
145348941|NCT02906670|524125044|FG009|Cohort 5, Q2W|Clinical Progression|0|||
145348942|NCT02906670|524125035|FG000|Cohort 5, Q2W|Adverse Event|0|||
145348943|NCT02906670|524125036|FG001|Cohort 5, Q2W|Adverse Event|0|||
145348944|NCT02906670|524125037|FG002|Cohort 5, Q2W|Adverse Event|0|||
145348945|NCT02906670|524125038|FG003|Cohort 5, Q2W|Adverse Event|0|||
145348946|NCT02906670|524125039|FG004|Cohort 5, Q2W|Adverse Event|0|||
145348947|NCT02906670|524125040|FG005|Cohort 5, Q2W|Adverse Event|0|||
145348948|NCT02906670|524125041|FG006|Cohort 5, Q2W|Adverse Event|1|||
145348949|NCT02906670|524125042|FG007|Cohort 5, Q2W|Adverse Event|0|||
145348950|NCT02906670|524125043|FG008|Cohort 5, Q2W|Adverse Event|0|||
145348951|NCT02906670|524125044|FG009|Cohort 5, Q2W|Adverse Event|0|||
145348952|NCT02906670|524125035|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348953|NCT02906670|524125036|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348954|NCT02906670|524125037|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348955|NCT02906670|524125038|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348956|NCT02906670|524125039|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348957|NCT02906670|524125040|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348958|NCT02906670|524125041|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
145348959|NCT02906670|524125042|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348960|NCT02906670|524125043|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348961|NCT02906670|524125044|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
145348962|NCT02906670|524125035|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
145348963|NCT02906670|524125036|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
145348964|NCT02906670|524125037|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
145348965|NCT02906670|524125038|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
145348966|NCT02906670|524125039|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
145348967|NCT02906670|524125040|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
145348968|NCT02906670|524125041|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
145348969|NCT02906670|524125042|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
145348970|NCT02906670|524125043|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
145348971|NCT02906670|524125044|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
145348972|NCT02906670|524125035|FG000|Cohort 5P, Q2W|Adverse Event|0|||
145348973|NCT02906670|524125036|FG001|Cohort 5P, Q2W|Adverse Event|0|||
145348974|NCT02906670|524125037|FG002|Cohort 5P, Q2W|Adverse Event|0|||
145348975|NCT02906670|524125038|FG003|Cohort 5P, Q2W|Adverse Event|0|||
145348976|NCT02906670|524125039|FG004|Cohort 5P, Q2W|Adverse Event|0|||
145348977|NCT02906670|524125040|FG005|Cohort 5P, Q2W|Adverse Event|0|||
145348978|NCT02906670|524125041|FG006|Cohort 5P, Q2W|Adverse Event|0|||
145348979|NCT02906670|524125042|FG007|Cohort 5P, Q2W|Adverse Event|1|||
145348980|NCT02906670|524125043|FG008|Cohort 5P, Q2W|Adverse Event|0|||
145348981|NCT02906670|524125044|FG009|Cohort 5P, Q2W|Adverse Event|0|||
145348982|NCT02906670|524125035|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
145348983|NCT02906670|524125036|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
145348984|NCT02906670|524125037|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
145348985|NCT02906670|524125038|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
145348986|NCT02906670|524125039|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
145348987|NCT02906670|524125040|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
145348988|NCT02906670|524125041|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
145348989|NCT02906670|524125042|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
145348990|NCT02906670|524125043|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
145348991|NCT02906670|524125044|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
145348992|NCT02906670|524125035|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
145348993|NCT02906670|524125036|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
145348994|NCT02906670|524125037|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
145348995|NCT02906670|524125038|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
145348996|NCT02906670|524125039|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
145348997|NCT02906670|524125040|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
145348998|NCT02906670|524125041|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
145348999|NCT02906670|524125042|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
145349000|NCT02906670|524125043|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
145349001|NCT02906670|524125044|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
145349002|NCT02906670|524125035|FG000|Cohort 4P, QW|Radiological Progression|0|||
145349003|NCT02906670|524125036|FG001|Cohort 4P, QW|Radiological Progression|0|||
145349004|NCT02906670|524125037|FG002|Cohort 4P, QW|Radiological Progression|0|||
145349005|NCT02906670|524125038|FG003|Cohort 4P, QW|Radiological Progression|3|||
145349006|NCT02906670|524125039|FG004|Cohort 4P, QW|Radiological Progression|0|||
145349007|NCT02906670|524125040|FG005|Cohort 4P, QW|Radiological Progression|0|||
145349008|NCT02906670|524125041|FG006|Cohort 4P, QW|Radiological Progression|0|||
145349009|NCT02906670|524125042|FG007|Cohort 4P, QW|Radiological Progression|0|||
145349010|NCT02906670|524125043|FG008|Cohort 4P, QW|Radiological Progression|0|||
145349011|NCT02906670|524125044|FG009|Cohort 4P, QW|Radiological Progression|0|||
145349012|NCT02906670|524125035|FG000|Cohort 7P, Q2W|Adverse Event|0|||
145349013|NCT02906670|524125036|FG001|Cohort 7P, Q2W|Adverse Event|0|||
145349014|NCT02906670|524125037|FG002|Cohort 7P, Q2W|Adverse Event|0|||
145349015|NCT02906670|524125038|FG003|Cohort 7P, Q2W|Adverse Event|0|||
145349016|NCT02906670|524125039|FG004|Cohort 7P, Q2W|Adverse Event|0|||
145349017|NCT02906670|524125040|FG005|Cohort 7P, Q2W|Adverse Event|0|||
145349018|NCT02906670|524125041|FG006|Cohort 7P, Q2W|Adverse Event|0|||
145349019|NCT02906670|524125042|FG007|Cohort 7P, Q2W|Adverse Event|0|||
145349020|NCT02906670|524125043|FG008|Cohort 7P, Q2W|Adverse Event|0|||
145414645|NCT03369223|524371276|FG005|Overall Study|Participant request to discontinue study treatment|1|||
145414646|NCT03369223|524371277|FG006|Overall Study|Participant request to discontinue study treatment|1|||
145577167|NCT00642304|524967998|FG000|Overall Study|Blood transfusion|2|||
145349021|NCT02906670|524125044|FG009|Cohort 7P, Q2W|Adverse Event|1|||
145349022|NCT02906670|524125035|FG000|Cohort 7P, Q2W|Physician Decision|0|||
145349023|NCT02906670|524125036|FG001|Cohort 7P, Q2W|Physician Decision|0|||
145349024|NCT02906670|524125037|FG002|Cohort 7P, Q2W|Physician Decision|0|||
145349025|NCT02906670|524125038|FG003|Cohort 7P, Q2W|Physician Decision|0|||
145349026|NCT02906670|524125039|FG004|Cohort 7P, Q2W|Physician Decision|0|||
145349027|NCT02906670|524125040|FG005|Cohort 7P, Q2W|Physician Decision|0|||
145349028|NCT02906670|524125041|FG006|Cohort 7P, Q2W|Physician Decision|0|||
145349029|NCT02906670|524125042|FG007|Cohort 7P, Q2W|Physician Decision|0|||
145349030|NCT02906670|524125043|FG008|Cohort 7P, Q2W|Physician Decision|0|||
145349031|NCT02906670|524125044|FG009|Cohort 7P, Q2W|Physician Decision|1|||
145349032|NCT02906670|524125035|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349033|NCT02906670|524125036|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349034|NCT02906670|524125037|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349035|NCT02906670|524125038|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349036|NCT02906670|524125039|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349037|NCT02906670|524125040|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349038|NCT02906670|524125041|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349039|NCT02906670|524125042|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349040|NCT02906670|524125043|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
145349041|NCT02906670|524125044|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
145349042|NCT02906670|524125035|FG000|Cohort 5P, QW|Radiological Progression|0|||
145349043|NCT02906670|524125036|FG001|Cohort 5P, QW|Radiological Progression|0|||
145349044|NCT02906670|524125037|FG002|Cohort 5P, QW|Radiological Progression|0|||
145349045|NCT02906670|524125038|FG003|Cohort 5P, QW|Radiological Progression|0|||
145349046|NCT02906670|524125039|FG004|Cohort 5P, QW|Radiological Progression|3|||
145349047|NCT02906670|524125040|FG005|Cohort 5P, QW|Radiological Progression|0|||
145349048|NCT02906670|524125041|FG006|Cohort 5P, QW|Radiological Progression|0|||
145349049|NCT02906670|524125042|FG007|Cohort 5P, QW|Radiological Progression|0|||
145349050|NCT02906670|524125043|FG008|Cohort 5P, QW|Radiological Progression|0|||
145349051|NCT02906670|524125044|FG009|Cohort 5P, QW|Radiological Progression|0|||
145349052|NCT01349192|524125045|FG000|Overall Study|Protocol Violation|0|||
145349053|NCT01349192|524125046|FG001|Overall Study|Protocol Violation|1|||
145349054|NCT01349192|524125045|FG000|Overall Study|Withdrawal by Subject|0|||
145349055|NCT01349192|524125046|FG001|Overall Study|Withdrawal by Subject|2|||
145349056|NCT01349192|524125045|FG000|Overall Study|Lost to Follow-up|1|||
145349057|NCT01349192|524125046|FG001|Overall Study|Lost to Follow-up|3|||
145349058|NCT01349192|524125045|FG000|Overall Study|Failure to adhere to Protocol|2|||
145349059|NCT01349192|524125046|FG001|Overall Study|Failure to adhere to Protocol|0|||
145349060|NCT01973439|524125047|FG000|Overall Study|Lost samples from one PK Day|2|||
145349061|NCT01973439|524125047|FG000|Overall Study|Vomiting after commencing once daily|1|||
145349062|NCT01973439|524125047|FG000|Overall Study|PK curve incomplete|2|||
145349063|NCT02038010|524125048|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145349064|NCT02038010|524125049|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
145349065|NCT02038010|524125050|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145349066|NCT02038010|524125051|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
145349067|NCT02038010|524125048|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
145349068|NCT02038010|524125049|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145349069|NCT02038010|524125050|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145349070|NCT02038010|524125051|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
145349071|NCT02038010|524125048|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145349072|NCT02038010|524125049|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
145349073|NCT02038010|524125050|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145349074|NCT02038010|524125051|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
145349075|NCT02038010|524125048|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
145349076|NCT02038010|524125049|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
145349077|NCT02038010|524125050|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
145349078|NCT02038010|524125051|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
145349079|NCT02038010|524125048|FG000|Follow Up|Death|4|||
145349080|NCT02038010|524125049|FG001|Follow Up|Death|3|||
145349081|NCT02038010|524125050|FG002|Follow Up|Death|0|||
145349082|NCT02038010|524125051|FG003|Follow Up|Death|0|||
145349083|NCT02038010|524125048|FG000|Follow Up|Other|3|||
145349084|NCT02038010|524125049|FG001|Follow Up|Other|0|||
145349085|NCT02038010|524125050|FG002|Follow Up|Other|0|||
145349086|NCT02038010|524125051|FG003|Follow Up|Other|0|||
145349087|NCT02262325|524125056|FG000|Overall Study|Death|16|||
145349088|NCT02262325|524125056|FG000|Overall Study|Lost to Follow-up|1|||
145349089|NCT02815995|524125057|FG000|Overall Study|Disease Progression|3|||
145349090|NCT02815995|524125058|FG001|Overall Study|Disease Progression|7|||
145349091|NCT02815995|524125059|FG002|Overall Study|Disease Progression|2|||
145349092|NCT02815995|524125060|FG003|Overall Study|Disease Progression|4|||
145349093|NCT02815995|524125061|FG004|Overall Study|Disease Progression|3|||
145349094|NCT02815995|524125062|FG005|Overall Study|Disease Progression|9|||
145349095|NCT02815995|524125063|FG006|Overall Study|Disease Progression|3|||
145349096|NCT02815995|524125064|FG007|Overall Study|Disease Progression|1|||
145349097|NCT02815995|524125057|FG000|Overall Study|Adverse Event|1|||
145349098|NCT02815995|524125058|FG001|Overall Study|Adverse Event|2|||
145349099|NCT02815995|524125059|FG002|Overall Study|Adverse Event|2|||
145349100|NCT02815995|524125060|FG003|Overall Study|Adverse Event|0|||
145349101|NCT02815995|524125061|FG004|Overall Study|Adverse Event|0|||
145349102|NCT02815995|524125062|FG005|Overall Study|Adverse Event|1|||
145349103|NCT02815995|524125063|FG006|Overall Study|Adverse Event|0|||
145349104|NCT02815995|524125064|FG007|Overall Study|Adverse Event|0|||
145349105|NCT02815995|524125057|FG000|Overall Study|Pregnancy|0|||
145349106|NCT02815995|524125058|FG001|Overall Study|Pregnancy|0|||
145349107|NCT02815995|524125059|FG002|Overall Study|Pregnancy|0|||
145349108|NCT02815995|524125060|FG003|Overall Study|Pregnancy|0|||
145349109|NCT02815995|524125061|FG004|Overall Study|Pregnancy|0|||
145349110|NCT02815995|524125062|FG005|Overall Study|Pregnancy|0|||
145349111|NCT02815995|524125063|FG006|Overall Study|Pregnancy|1|||
145349112|NCT02815995|524125064|FG007|Overall Study|Pregnancy|0|||
145349113|NCT01071915|524125065|FG000|Overall Study|Adverse Event|3|||
145349114|NCT01071915|524125065|FG000|Overall Study|Physician Decision|2|||
145349115|NCT01071915|524125065|FG000|Overall Study|Withdrawal by Subject|2|||
145349116|NCT01071915|524125065|FG000|Overall Study|Miscellaneous Reasons|2|||
145349117|NCT00114140|524125066|FG000|Overall Study|Protocol Violation|7|||
145349118|NCT02536846|524125067|FG000|Overall Study|Withdrawal by Subject|1|||
145349119|NCT04604795|524125068|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
145349120|NCT04604795|524125069|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
145349121|NCT04604795|524125070|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349122|NCT04604795|524125071|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349123|NCT04604795|524125072|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349124|NCT04604795|524125073|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349125|NCT04604795|524125074|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349126|NCT04604795|524125075|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349127|NCT04604795|524125076|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349128|NCT04604795|524125077|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
145349129|NCT04604795|524125068|FG000|Part B: Up to Day 14|Adverse Event|0|||
145349130|NCT04604795|524125069|FG001|Part B: Up to Day 14|Adverse Event|0|||
145349131|NCT04604795|524125070|FG002|Part B: Up to Day 14|Adverse Event|0|||
145349132|NCT04604795|524125071|FG003|Part B: Up to Day 14|Adverse Event|0|||
145349133|NCT04604795|524125072|FG004|Part B: Up to Day 14|Adverse Event|2|||
145349134|NCT04604795|524125073|FG005|Part B: Up to Day 14|Adverse Event|1|||
145349135|NCT04604795|524125074|FG006|Part B: Up to Day 14|Adverse Event|0|||
145349136|NCT04604795|524125075|FG007|Part B: Up to Day 14|Adverse Event|0|||
145349137|NCT04604795|524125076|FG008|Part B: Up to Day 14|Adverse Event|0|||
145349138|NCT04604795|524125077|FG009|Part B: Up to Day 14|Adverse Event|0|||
145349139|NCT04604795|524125068|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349140|NCT04604795|524125069|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349141|NCT04604795|524125070|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349142|NCT04604795|524125071|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349143|NCT04604795|524125072|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349144|NCT04604795|524125073|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349145|NCT04604795|524125074|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349146|NCT04604795|524125075|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349147|NCT04604795|524125076|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
145349148|NCT04604795|524125077|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
145349149|NCT04604795|524125068|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349150|NCT04604795|524125069|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349151|NCT04604795|524125070|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349152|NCT04604795|524125071|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349153|NCT04604795|524125072|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349154|NCT04604795|524125073|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349155|NCT04604795|524125074|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349156|NCT04604795|524125075|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349157|NCT04604795|524125076|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
145349158|NCT04604795|524125077|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
145349159|NCT04604795|524125068|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145414647|NCT03369223|524371278|FG007|Overall Study|Participant request to discontinue study treatment|0|||
145414648|NCT03369223|524371279|FG008|Overall Study|Participant request to discontinue study treatment|0|||
145414649|NCT03369223|524371280|FG009|Overall Study|Participant request to discontinue study treatment|0|||
145414650|NCT03369223|524371281|FG010|Overall Study|Participant request to discontinue study treatment|0|||
145414651|NCT03369223|524371282|FG011|Overall Study|Participant request to discontinue study treatment|0|||
145414652|NCT03369223|524371283|FG012|Overall Study|Participant request to discontinue study treatment|0|||
145414653|NCT03369223|524371284|FG013|Overall Study|Participant request to discontinue study treatment|1|||
145414654|NCT03369223|524371285|FG014|Overall Study|Participant request to discontinue study treatment|1|||
145414655|NCT03369223|524371286|FG015|Overall Study|Participant request to discontinue study treatment|0|||
145414656|NCT03369223|524371287|FG016|Overall Study|Participant request to discontinue study treatment|0|||
145414657|NCT03369223|524371288|FG017|Overall Study|Participant request to discontinue study treatment|0|||
145414658|NCT03369223|524371289|FG018|Overall Study|Participant request to discontinue study treatment|1|||
145414659|NCT03369223|524371290|FG019|Overall Study|Participant request to discontinue study treatment|0|||
145414660|NCT03369223|524371271|FG000|Overall Study|Participant withdrew consent|0|||
145414661|NCT03369223|524371272|FG001|Overall Study|Participant withdrew consent|1|||
145414662|NCT03369223|524371273|FG002|Overall Study|Participant withdrew consent|1|||
145414663|NCT03369223|524371274|FG003|Overall Study|Participant withdrew consent|0|||
145414664|NCT03369223|524371275|FG004|Overall Study|Participant withdrew consent|0|||
145414665|NCT03369223|524371276|FG005|Overall Study|Participant withdrew consent|0|||
145414666|NCT03369223|524371277|FG006|Overall Study|Participant withdrew consent|1|||
145414667|NCT03369223|524371278|FG007|Overall Study|Participant withdrew consent|1|||
145414668|NCT03369223|524371279|FG008|Overall Study|Participant withdrew consent|1|||
145414669|NCT03369223|524371280|FG009|Overall Study|Participant withdrew consent|0|||
145414670|NCT03369223|524371281|FG010|Overall Study|Participant withdrew consent|0|||
145414671|NCT03369223|524371282|FG011|Overall Study|Participant withdrew consent|1|||
145414672|NCT03369223|524371283|FG012|Overall Study|Participant withdrew consent|0|||
145414673|NCT03369223|524371284|FG013|Overall Study|Participant withdrew consent|0|||
145414674|NCT03369223|524371285|FG014|Overall Study|Participant withdrew consent|3|||
145414675|NCT03369223|524371286|FG015|Overall Study|Participant withdrew consent|0|||
145414676|NCT03369223|524371287|FG016|Overall Study|Participant withdrew consent|1|||
145414677|NCT03369223|524371288|FG017|Overall Study|Participant withdrew consent|0|||
145414678|NCT03369223|524371289|FG018|Overall Study|Participant withdrew consent|4|||
145414679|NCT03369223|524371290|FG019|Overall Study|Participant withdrew consent|2|||
145414680|NCT03369223|524371271|FG000|Overall Study|Randomized but not treated|0|||
145414681|NCT03369223|524371272|FG001|Overall Study|Randomized but not treated|0|||
145414682|NCT03369223|524371273|FG002|Overall Study|Randomized but not treated|0|||
145414683|NCT03369223|524371274|FG003|Overall Study|Randomized but not treated|0|||
145414684|NCT03369223|524371275|FG004|Overall Study|Randomized but not treated|0|||
145414685|NCT03369223|524371276|FG005|Overall Study|Randomized but not treated|0|||
145414686|NCT03369223|524371277|FG006|Overall Study|Randomized but not treated|0|||
145414687|NCT03369223|524371278|FG007|Overall Study|Randomized but not treated|0|||
145414688|NCT03369223|524371279|FG008|Overall Study|Randomized but not treated|0|||
145414689|NCT03369223|524371280|FG009|Overall Study|Randomized but not treated|0|||
145414690|NCT03369223|524371281|FG010|Overall Study|Randomized but not treated|0|||
145414691|NCT03369223|524371282|FG011|Overall Study|Randomized but not treated|0|||
145414692|NCT03369223|524371283|FG012|Overall Study|Randomized but not treated|0|||
145414693|NCT03369223|524371284|FG013|Overall Study|Randomized but not treated|1|||
145414694|NCT03369223|524371285|FG014|Overall Study|Randomized but not treated|1|||
145414695|NCT03369223|524371286|FG015|Overall Study|Randomized but not treated|0|||
145414696|NCT03369223|524371287|FG016|Overall Study|Randomized but not treated|0|||
145414697|NCT03369223|524371288|FG017|Overall Study|Randomized but not treated|0|||
145414698|NCT03369223|524371289|FG018|Overall Study|Randomized but not treated|0|||
145414699|NCT03369223|524371290|FG019|Overall Study|Randomized but not treated|0|||
145414700|NCT03573882|524371291|FG000|Overall Study|Study Terminated by Sponsor|22|||
145414701|NCT03573882|524371292|FG001|Overall Study|Study Terminated by Sponsor|17|||
145414702|NCT03573882|524371293|FG002|Overall Study|Study Terminated by Sponsor|18|||
145414703|NCT03573882|524371291|FG000|Overall Study|Withdrawal by Subject|6|||
145414704|NCT03573882|524371292|FG001|Overall Study|Withdrawal by Subject|11|||
145414705|NCT03573882|524371293|FG002|Overall Study|Withdrawal by Subject|7|||
145414706|NCT03573882|524371291|FG000|Overall Study|Adverse Event|7|||
145414707|NCT03573882|524371292|FG001|Overall Study|Adverse Event|5|||
145414708|NCT03573882|524371293|FG002|Overall Study|Adverse Event|6|||
145414709|NCT03573882|524371291|FG000|Overall Study|Lost to Follow-up|2|||
145414710|NCT03573882|524371292|FG001|Overall Study|Lost to Follow-up|5|||
145577168|NCT00642304|524967998|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
145414711|NCT03573882|524371293|FG002|Overall Study|Lost to Follow-up|3|||
145414712|NCT03573882|524371291|FG000|Overall Study|Physician Decision|4|||
145414713|NCT03573882|524371292|FG001|Overall Study|Physician Decision|3|||
145414714|NCT03573882|524371293|FG002|Overall Study|Physician Decision|2|||
145414715|NCT03573882|524371291|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
145414716|NCT03573882|524371292|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
145414717|NCT03573882|524371293|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
145414718|NCT03573882|524371291|FG000|Overall Study|Pregnancy|1|||
145414719|NCT03573882|524371292|FG001|Overall Study|Pregnancy|2|||
145414720|NCT03573882|524371293|FG002|Overall Study|Pregnancy|0|||
145414721|NCT03573882|524371291|FG000|Overall Study|Other|4|||
145414722|NCT03573882|524371292|FG001|Overall Study|Other|2|||
145414723|NCT03573882|524371293|FG002|Overall Study|Other|2|||
145414724|NCT03407482|524371294|FG000|Overall Study|Adverse Event|12|||
145414725|NCT03407482|524371294|FG000|Overall Study|Disease Relapse|1|||
145414726|NCT03407482|524371294|FG000|Overall Study|Lost to Follow-up|1|||
145414727|NCT03407482|524371294|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145414728|NCT03407482|524371294|FG000|Overall Study|Pregnancy|2|||
145414729|NCT03407482|524371294|FG000|Overall Study|Protocol Violation|1|||
145414730|NCT03407482|524371294|FG000|Overall Study|Study Terminated By Sponsor|106|||
145414731|NCT03407482|524371294|FG000|Overall Study|Withdrawal by Subject|6|||
145414732|NCT03407482|524371294|FG000|Overall Study|Data Entry Error|1|||
145414733|NCT05942040|524371295|FG000|Overall Study|No longer employed at study site.|0|||
145414734|NCT05942040|524371296|FG001|Overall Study|No longer employed at study site.|0|||
145414735|NCT05942040|524371297|FG002|Overall Study|No longer employed at study site.|3|||
145414736|NCT03659916|524371298|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
145414737|NCT03659916|524371299|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
145414738|NCT03659916|524371300|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
145414739|NCT03659916|524371298|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
145414740|NCT03659916|524371299|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
145414741|NCT03659916|524371300|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
145414742|NCT03659916|524371298|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
145414743|NCT03659916|524371299|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
145414744|NCT03659916|524371300|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
145414745|NCT03659916|524371298|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
145414746|NCT03659916|524371299|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
145414747|NCT03659916|524371300|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
145414748|NCT03659916|524371298|FG000|Treatment Period (72 Weeks)|Other|1|||
145414749|NCT03659916|524371299|FG001|Treatment Period (72 Weeks)|Other|3|||
145414750|NCT03659916|524371300|FG002|Treatment Period (72 Weeks)|Other|9|||
145414751|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
145414752|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
145414753|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
145414754|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
145414755|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
145414756|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
145414757|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
145414758|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
145414759|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
145414760|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
145414761|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
145414762|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
145414763|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
145414764|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
145414765|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
145414766|NCT03659916|524371298|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
145414767|NCT03659916|524371299|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
145414768|NCT03659916|524371300|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
145414769|NCT04439123|524371304|FG000|Overall Study|Adverse Event|11|||
145414770|NCT04439123|524371304|FG000|Overall Study|Death|1|||
145414771|NCT04439123|524371304|FG000|Overall Study|Disease progression|19|||
145414772|NCT04439123|524371304|FG000|Overall Study|Withdrawal by Subject|2|||
145414773|NCT04439123|524371304|FG000|Overall Study|Still on treatment|2|||
145414774|NCT06375655|524371306|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
145414775|NCT06375655|524371307|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
145414776|NCT03011372|524371310|FG000|Overall Study|Death|16|||
145414777|NCT03011372|524371310|FG000|Overall Study|Lost to Follow-up|2|||
145414778|NCT03011372|524371310|FG000|Overall Study|Sponsor Decision|17|||
145414779|NCT03011372|524371310|FG000|Overall Study|Withdrawal by Subject|7|||
145414780|NCT03011372|524371310|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
145414781|NCT03011372|524371310|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
145414782|NCT03011372|524371310|FG000|Overall Study|Sponsor's Decision|2|||
145577169|NCT00642304|524967998|FG000|Overall Study|Transplantation|1|||
145577170|NCT01430585|524968001|FG000|Overall Study|Death|1|||
145414783|NCT03860584|524371311|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
145414784|NCT03860584|524371312|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
145414785|NCT03860584|524371311|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
145349160|NCT04604795|524125069|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349161|NCT04604795|524125070|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349162|NCT04604795|524125071|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349163|NCT04604795|524125072|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349164|NCT04604795|524125073|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349165|NCT04604795|524125074|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349166|NCT04604795|524125075|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349167|NCT04604795|524125076|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
145349168|NCT04604795|524125077|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
145349169|NCT04604795|524125068|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349170|NCT04604795|524125069|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349171|NCT04604795|524125070|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349172|NCT04604795|524125071|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349173|NCT04604795|524125072|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349174|NCT04604795|524125073|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349175|NCT04604795|524125074|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349176|NCT04604795|524125075|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349177|NCT04604795|524125076|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
145349178|NCT04604795|524125077|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
145349179|NCT00111241|524125083|FG000|Overall Study|Lost to Follow-up|1|||
145349180|NCT00111241|524125084|FG001|Overall Study|Lost to Follow-up|0|||
145349181|NCT00111241|524125083|FG000|Overall Study|Withdrawal by Subject|4|||
145349182|NCT00111241|524125084|FG001|Overall Study|Withdrawal by Subject|0|||
145349183|NCT00111241|524125083|FG000|Overall Study|Protocol Violation|9|||
145349184|NCT00111241|524125084|FG001|Overall Study|Protocol Violation|8|||
145349185|NCT00111241|524125083|FG000|Overall Study|Adverse Event|1|||
145349186|NCT00111241|524125084|FG001|Overall Study|Adverse Event|0|||
145349187|NCT01449812|524125085|FG000|Overall Study|Migrated/moved from study area|1|||
145349188|NCT01449812|524125086|FG001|Overall Study|Migrated/moved from study area|0|||
145349189|NCT01449812|524125087|FG002|Overall Study|Migrated/moved from study area|0|||
145349190|NCT01449812|524125085|FG000|Overall Study|Withdrawal by Subject|0|||
145349191|NCT01449812|524125086|FG001|Overall Study|Withdrawal by Subject|0|||
145349192|NCT01449812|524125087|FG002|Overall Study|Withdrawal by Subject|1|||
145349193|NCT01449812|524125085|FG000|Overall Study|Lost to Follow-up|1|||
145349194|NCT01449812|524125086|FG001|Overall Study|Lost to Follow-up|0|||
145349195|NCT01449812|524125087|FG002|Overall Study|Lost to Follow-up|0|||
145349196|NCT01855828|524125088|FG000|Overall Study|Adverse Event|1|||
145349197|NCT01855828|524125088|FG000|Overall Study|Withdrawal by Subject|1|||
145349198|NCT01866098|524125089|FG000|Overall Study|Lost to Follow-up|11|||
145349199|NCT01866098|524125090|FG001|Overall Study|Lost to Follow-up|18|||
145349200|NCT01866098|524125091|FG002|Overall Study|Lost to Follow-up|13|||
145349201|NCT01866098|524125089|FG000|Overall Study|Physician Decision|0|||
145349202|NCT01866098|524125090|FG001|Overall Study|Physician Decision|1|||
145349203|NCT01866098|524125091|FG002|Overall Study|Physician Decision|2|||
145349204|NCT01866098|524125089|FG000|Overall Study|Adverse Event|1|||
145349205|NCT01866098|524125090|FG001|Overall Study|Adverse Event|5|||
145349206|NCT01866098|524125091|FG002|Overall Study|Adverse Event|4|||
145349207|NCT01866098|524125089|FG000|Overall Study|Protocol Violation|1|||
145349208|NCT01866098|524125090|FG001|Overall Study|Protocol Violation|0|||
145349209|NCT01866098|524125091|FG002|Overall Study|Protocol Violation|0|||
145349210|NCT01866098|524125089|FG000|Overall Study|Withdrawal by Subject|1|||
145349211|NCT01866098|524125090|FG001|Overall Study|Withdrawal by Subject|2|||
145349212|NCT01866098|524125091|FG002|Overall Study|Withdrawal by Subject|0|||
145349213|NCT01866098|524125089|FG000|Overall Study|Unrelated Hospitalization|2|||
145349214|NCT01866098|524125090|FG001|Overall Study|Unrelated Hospitalization|0|||
145349215|NCT01866098|524125091|FG002|Overall Study|Unrelated Hospitalization|1|||
145349216|NCT01866098|524125089|FG000|Overall Study|Non-compliance|1|||
145349217|NCT01866098|524125090|FG001|Overall Study|Non-compliance|0|||
145349218|NCT01866098|524125091|FG002|Overall Study|Non-compliance|1|||
145349219|NCT01866098|524125089|FG000|Overall Study|Pregnancy|2|||
145349220|NCT01866098|524125090|FG001|Overall Study|Pregnancy|0|||
145349221|NCT01866098|524125091|FG002|Overall Study|Pregnancy|0|||
145349222|NCT01866098|524125089|FG000|Overall Study|Death|0|||
145349223|NCT01866098|524125090|FG001|Overall Study|Death|1|||
145349224|NCT01866098|524125091|FG002|Overall Study|Death|0|||
145349225|NCT04239027|524125096|FG000|Overall Study|Adverse Event|4|||
145349226|NCT04239027|524125096|FG000|Overall Study|Withdrawal by Subject|9|||
145349227|NCT04239027|524125096|FG000|Overall Study|Death|1|||
145349228|NCT04239027|524125096|FG000|Overall Study|Physician Decision|9|||
145349229|NCT04239027|524125096|FG000|Overall Study|Lost to Follow-up|2|||
145349230|NCT04239027|524125096|FG000|Overall Study|Lack of Efficacy|1|||
145349231|NCT03172494|524125103|FG000|Overall Study|Adverse Event|5|||
145349232|NCT03172494|524125104|FG001|Overall Study|Adverse Event|1|||
145349233|NCT03172494|524125105|FG002|Overall Study|Adverse Event|15|||
145349234|NCT03172494|524125103|FG000|Overall Study|Protocol Violation|3|||
145349235|NCT03172494|524125104|FG001|Overall Study|Protocol Violation|2|||
145349236|NCT03172494|524125105|FG002|Overall Study|Protocol Violation|1|||
145414786|NCT03860584|524371312|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
145414787|NCT03860584|524371311|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
145414788|NCT03860584|524371312|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
145414789|NCT03860584|524371311|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
145414790|NCT03860584|524371312|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
145349237|NCT03172494|524125103|FG000|Overall Study|Lack of Efficacy|0|||
145349238|NCT03172494|524125104|FG001|Overall Study|Lack of Efficacy|0|||
145349239|NCT03172494|524125105|FG002|Overall Study|Lack of Efficacy|4|||
145349240|NCT03172494|524125103|FG000|Overall Study|Pregnancy|0|||
145349241|NCT03172494|524125104|FG001|Overall Study|Pregnancy|1|||
145349242|NCT03172494|524125105|FG002|Overall Study|Pregnancy|0|||
145349243|NCT03172494|524125103|FG000|Overall Study|Withdrawal by Subject|10|||
145349244|NCT03172494|524125104|FG001|Overall Study|Withdrawal by Subject|8|||
145349245|NCT03172494|524125105|FG002|Overall Study|Withdrawal by Subject|8|||
145349246|NCT03172494|524125103|FG000|Overall Study|Severe hypoglycaemic episode|0|||
145349247|NCT03172494|524125104|FG001|Overall Study|Severe hypoglycaemic episode|0|||
145349248|NCT03172494|524125105|FG002|Overall Study|Severe hypoglycaemic episode|1|||
145349249|NCT03172494|524125103|FG000|Overall Study|Non-compliance towards treatment|2|||
145349250|NCT03172494|524125104|FG001|Overall Study|Non-compliance towards treatment|0|||
145349251|NCT03172494|524125105|FG002|Overall Study|Non-compliance towards treatment|0|||
145349252|NCT00143390|524125106|FG000|Overall Study|Death|2|||
145349253|NCT00143390|524125107|FG001|Overall Study|Death|0|||
145349254|NCT00143390|524125106|FG000|Overall Study|Not meeting entry criteria|2|||
145349255|NCT00143390|524125107|FG001|Overall Study|Not meeting entry criteria|5|||
145349256|NCT00143390|524125106|FG000|Overall Study|Withdrawal by Subject|4|||
145349257|NCT00143390|524125107|FG001|Overall Study|Withdrawal by Subject|4|||
145349258|NCT00143390|524125106|FG000|Overall Study|Progressive disease|119|||
145349259|NCT00143390|524125107|FG001|Overall Study|Progressive disease|115|||
145349260|NCT00143390|524125106|FG000|Overall Study|Protocol Violation|2|||
145349261|NCT00143390|524125107|FG001|Overall Study|Protocol Violation|0|||
145349262|NCT00143390|524125106|FG000|Overall Study|Study termination|10|||
145349263|NCT00143390|524125107|FG001|Overall Study|Study termination|15|||
145349264|NCT00143390|524125106|FG000|Overall Study|Adverse Event|9|||
145349265|NCT00143390|524125107|FG001|Overall Study|Adverse Event|8|||
145349266|NCT00143390|524125106|FG000|Overall Study|Other|1|||
145349267|NCT00143390|524125107|FG001|Overall Study|Other|2|||
145349268|NCT02764151|524125110|FG000|Overall Study|Subject refused further follow-up|0|||
145349269|NCT02764151|524125111|FG001|Overall Study|Subject refused further follow-up|0|||
145349270|NCT02764151|524125112|FG002|Overall Study|Subject refused further follow-up|0|||
145349271|NCT02764151|524125113|FG003|Overall Study|Subject refused further follow-up|1|||
145349272|NCT02764151|524125110|FG000|Overall Study|Other|0|||
145349273|NCT02764151|524125111|FG001|Overall Study|Other|0|||
145349274|NCT02764151|524125112|FG002|Overall Study|Other|0|||
145349275|NCT02764151|524125113|FG003|Overall Study|Other|2|||
145349276|NCT01450683|524125114|FG000|Overall Study|Adverse Event|2|||
145349277|NCT02108912|524125116|FG000|Overall Study|Lost to Follow-up|1|||
145349278|NCT02108912|524125117|FG001|Overall Study|Lost to Follow-up|1|||
145349279|NCT02108912|524125116|FG000|Overall Study|lack of transportation|1|||
145349280|NCT02108912|524125117|FG001|Overall Study|lack of transportation|0|||
145349281|NCT02108912|524125116|FG000|Overall Study|high blood pressure|1|||
145349282|NCT02108912|524125117|FG001|Overall Study|high blood pressure|0|||
145349283|NCT03180645|524125118|FG000|Overall Study|Adverse Event|0|||
145349284|NCT03180645|524125119|FG001|Overall Study|Adverse Event|1|||
145349285|NCT03180645|524125120|FG002|Overall Study|Adverse Event|2|||
145349286|NCT00852202|524125125|FG000|Overall Study|Adverse Event|2|||
145349287|NCT00852202|524125126|FG001|Overall Study|Adverse Event|3|||
145349288|NCT00852202|524125127|FG002|Overall Study|Adverse Event|7|||
145349289|NCT00852202|524125125|FG000|Overall Study|Lack of Efficacy|4|||
145414791|NCT00835978|524372282|FG000|Overall Study|Death|33|||
145414792|NCT00835978|524372283|FG001|Overall Study|Death|40|||
145414793|NCT00835978|524372284|FG002|Overall Study|Death|49|||
145414794|NCT00835978|524372285|FG003|Overall Study|Death|4|||
145577171|NCT01430585|524968001|FG000|Overall Study|Objective Progression or Relapse|3|||
145577172|NCT01430585|524968001|FG000|Overall Study|Study Terminated by Sponsor|3|||
145577173|NCT01430585|524968001|FG000|Overall Study|Other|7|||
145577174|NCT00779766|524968002|FG000|Month 24|Serious Adverse Event|2|||
145577175|NCT00779766|524968003|FG001|Month 24|Serious Adverse Event|3|||
145349290|NCT00852202|524125126|FG001|Overall Study|Lack of Efficacy|1|||
145349291|NCT00852202|524125127|FG002|Overall Study|Lack of Efficacy|2|||
145349292|NCT00852202|524125125|FG000|Overall Study|Protocol Violation|2|||
145349293|NCT00852202|524125126|FG001|Overall Study|Protocol Violation|2|||
145349294|NCT00852202|524125127|FG002|Overall Study|Protocol Violation|7|||
145349295|NCT00852202|524125125|FG000|Overall Study|Withdrawal by Subject|3|||
145349296|NCT00852202|524125126|FG001|Overall Study|Withdrawal by Subject|1|||
145349297|NCT00852202|524125127|FG002|Overall Study|Withdrawal by Subject|2|||
145349298|NCT00852202|524125125|FG000|Overall Study|Lost to Follow-up|5|||
145349299|NCT00852202|524125126|FG001|Overall Study|Lost to Follow-up|5|||
145349300|NCT00852202|524125127|FG002|Overall Study|Lost to Follow-up|6|||
145414795|NCT00835978|524372282|FG000|Overall Study|Lost to Follow-up|3|||
145414796|NCT00835978|524372283|FG001|Overall Study|Lost to Follow-up|4|||
145414797|NCT00835978|524372284|FG002|Overall Study|Lost to Follow-up|2|||
145414798|NCT00835978|524372285|FG003|Overall Study|Lost to Follow-up|1|||
145414799|NCT00835978|524372282|FG000|Overall Study|Other|5|||
145414800|NCT00835978|524372283|FG001|Overall Study|Other|1|||
145414801|NCT00835978|524372284|FG002|Overall Study|Other|8|||
145349301|NCT00852202|524125125|FG000|Overall Study|pregnancy,moving away and surgery|1|||
145349302|NCT00852202|524125126|FG001|Overall Study|pregnancy,moving away and surgery|0|||
145349303|NCT00852202|524125127|FG002|Overall Study|pregnancy,moving away and surgery|2|||
145349304|NCT05022212|524125132|FG000|Overall Study|Lost to Follow-up|0|||
145349305|NCT05022212|524125133|FG001|Overall Study|Lost to Follow-up|2|||
145349306|NCT02729909|524125134|FG000|Overall Study|Lost to Follow-up|0|||
145349307|NCT02729909|524125135|FG001|Overall Study|Lost to Follow-up|1|||
145349308|NCT02729909|524125134|FG000|Overall Study|Lack of Efficacy|0|||
145349309|NCT02729909|524125135|FG001|Overall Study|Lack of Efficacy|2|||
145349310|NCT02729909|524125134|FG000|Overall Study|Significant Protocol Deviation|0|||
145349311|NCT02729909|524125135|FG001|Overall Study|Significant Protocol Deviation|2|||
145349312|NCT02729909|524125134|FG000|Overall Study|Voluntary Withdrawal|1|||
145349313|NCT02729909|524125135|FG001|Overall Study|Voluntary Withdrawal|0|||
145349314|NCT04917861|524125138|FG000|Main Study (196 Days)|Adverse Event|0|||
145349315|NCT04917861|524125139|FG001|Main Study (196 Days)|Adverse Event|1|||
145349316|NCT04917861|524125140|FG002|Main Study (196 Days)|Adverse Event|0|||
145349317|NCT04917861|524125141|FG003|Main Study (196 Days)|Adverse Event|0|||
145349318|NCT04917861|524125138|FG000|Main Study (196 Days)|Death|0|||
145349319|NCT04917861|524125139|FG001|Main Study (196 Days)|Death|0|||
145349320|NCT04917861|524125140|FG002|Main Study (196 Days)|Death|0|||
145349321|NCT04917861|524125141|FG003|Main Study (196 Days)|Death|1|||
145349322|NCT04917861|524125138|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
145349323|NCT04917861|524125139|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
145349324|NCT04917861|524125140|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
145349325|NCT04917861|524125141|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
145349326|NCT04917861|524125138|FG000|Main Study (196 Days)|Physician Decision|0|||
145349327|NCT04917861|524125139|FG001|Main Study (196 Days)|Physician Decision|0|||
145349328|NCT04917861|524125140|FG002|Main Study (196 Days)|Physician Decision|0|||
145349329|NCT04917861|524125141|FG003|Main Study (196 Days)|Physician Decision|1|||
145349330|NCT04917861|524125138|FG000|Main Study (196 Days)|Pregnancy|1|||
145349331|NCT04917861|524125139|FG001|Main Study (196 Days)|Pregnancy|1|||
145349332|NCT04917861|524125140|FG002|Main Study (196 Days)|Pregnancy|0|||
145349333|NCT04917861|524125141|FG003|Main Study (196 Days)|Pregnancy|0|||
145349334|NCT04917861|524125138|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
145349335|NCT04917861|524125139|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
145414802|NCT00835978|524372285|FG003|Overall Study|Other|0|||
145414803|NCT00835978|524372282|FG000|Overall Study|Objective progression or relapse|2|||
145414804|NCT00835978|524372283|FG001|Overall Study|Objective progression or relapse|0|||
145414805|NCT00835978|524372284|FG002|Overall Study|Objective progression or relapse|1|||
145414806|NCT00835978|524372285|FG003|Overall Study|Objective progression or relapse|0|||
145414807|NCT00835978|524372282|FG000|Overall Study|Adverse Event|1|||
145414808|NCT00835978|524372283|FG001|Overall Study|Adverse Event|0|||
145414809|NCT00835978|524372284|FG002|Overall Study|Adverse Event|1|||
145414810|NCT00835978|524372285|FG003|Overall Study|Adverse Event|0|||
145414811|NCT00835978|524372282|FG000|Overall Study|Withdrawal by Subject|0|||
145414812|NCT00835978|524372283|FG001|Overall Study|Withdrawal by Subject|3|||
145414813|NCT00835978|524372284|FG002|Overall Study|Withdrawal by Subject|0|||
145414814|NCT00835978|524372285|FG003|Overall Study|Withdrawal by Subject|5|||
145414815|NCT00835978|524372282|FG000|Overall Study|Study terminated by sponsor|12|||
145414816|NCT00835978|524372283|FG001|Overall Study|Study terminated by sponsor|8|||
145414817|NCT00835978|524372284|FG002|Overall Study|Study terminated by sponsor|30|||
145414818|NCT00835978|524372285|FG003|Overall Study|Study terminated by sponsor|0|||
145414819|NCT02400736|524372288|FG000|Overall Study|Lost to Follow-up|6|||
145414820|NCT02400736|524372289|FG001|Overall Study|Lost to Follow-up|6|||
145414821|NCT02400736|524372288|FG000|Overall Study|Withdrawal by Subject|2|||
145414822|NCT02400736|524372289|FG001|Overall Study|Withdrawal by Subject|1|||
145414823|NCT02400736|524372288|FG000|Overall Study|Moved from the area|3|||
145414824|NCT02400736|524372289|FG001|Overall Study|Moved from the area|1|||
145349336|NCT04917861|524125140|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
145349337|NCT04917861|524125141|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
145349338|NCT04917861|524125138|FG000|Main Study (196 Days)|Other Than Specified|1|||
145349339|NCT04917861|524125139|FG001|Main Study (196 Days)|Other Than Specified|0|||
145414825|NCT02927145|524372291|FG000|Initial Recruitment|Withdrawal by Subject|0|||
145414826|NCT02927145|524372292|FG001|Initial Recruitment|Withdrawal by Subject|1|||
145414827|NCT02927145|524372293|FG002|Initial Recruitment|Withdrawal by Subject|1|||
145414828|NCT02927145|524372294|FG003|Initial Recruitment|Withdrawal by Subject|4|||
145414829|NCT02927145|524372295|FG004|Initial Recruitment|Withdrawal by Subject|1|||
145414830|NCT02927145|524372296|FG005|Initial Recruitment|Withdrawal by Subject|1|||
145414831|NCT02927145|524372297|FG006|Initial Recruitment|Withdrawal by Subject|0|||
145414832|NCT02927145|524372298|FG007|Initial Recruitment|Withdrawal by Subject|0|||
145577176|NCT00779766|524968002|FG000|Month 24|Adverse Event|3|||
145414833|NCT02927145|524372299|FG008|Initial Recruitment|Withdrawal by Subject|2|||
145414834|NCT02927145|524372291|FG000|Initial Recruitment|Adverse Event|0|||
145414835|NCT02927145|524372292|FG001|Initial Recruitment|Adverse Event|0|||
145414836|NCT02927145|524372293|FG002|Initial Recruitment|Adverse Event|0|||
145414837|NCT02927145|524372294|FG003|Initial Recruitment|Adverse Event|0|||
145414838|NCT02927145|524372295|FG004|Initial Recruitment|Adverse Event|2|||
145414839|NCT02927145|524372296|FG005|Initial Recruitment|Adverse Event|0|||
145414840|NCT02927145|524372297|FG006|Initial Recruitment|Adverse Event|0|||
145414841|NCT02927145|524372298|FG007|Initial Recruitment|Adverse Event|0|||
145414842|NCT02927145|524372299|FG008|Initial Recruitment|Adverse Event|0|||
145414843|NCT02927145|524372291|FG000|Invitation for Additional Challenge|Pregnancy|0|||
145414844|NCT02927145|524372292|FG001|Invitation for Additional Challenge|Pregnancy|0|||
145414845|NCT02927145|524372293|FG002|Invitation for Additional Challenge|Pregnancy|0|||
145414846|NCT02927145|524372294|FG003|Invitation for Additional Challenge|Pregnancy|0|||
145414847|NCT02927145|524372295|FG004|Invitation for Additional Challenge|Pregnancy|0|||
145414848|NCT02927145|524372296|FG005|Invitation for Additional Challenge|Pregnancy|0|||
145414849|NCT02927145|524372297|FG006|Invitation for Additional Challenge|Pregnancy|1|||
145414850|NCT02927145|524372298|FG007|Invitation for Additional Challenge|Pregnancy|0|||
145414851|NCT02927145|524372299|FG008|Invitation for Additional Challenge|Pregnancy|0|||
145414852|NCT01363440|524372300|FG000|Overall Study|Adverse Event|5|||
145414853|NCT01363440|524372301|FG001|Overall Study|Adverse Event|4|||
145414854|NCT01363440|524372302|FG002|Overall Study|Adverse Event|4|||
145414855|NCT01363440|524372300|FG000|Overall Study|Death|3|||
145414856|NCT01363440|524372301|FG001|Overall Study|Death|7|||
145414857|NCT01363440|524372302|FG002|Overall Study|Death|5|||
145414858|NCT01363440|524372300|FG000|Overall Study|Withdrawal by Subject|9|||
145414859|NCT01363440|524372301|FG001|Overall Study|Withdrawal by Subject|11|||
145414860|NCT01363440|524372302|FG002|Overall Study|Withdrawal by Subject|11|||
145414861|NCT01363440|524372300|FG000|Overall Study|Lost to Follow-up|2|||
145414862|NCT01363440|524372301|FG001|Overall Study|Lost to Follow-up|4|||
145414863|NCT01363440|524372302|FG002|Overall Study|Lost to Follow-up|5|||
145414864|NCT01363440|524372300|FG000|Overall Study|Other|4|||
145414865|NCT01363440|524372301|FG001|Overall Study|Other|5|||
145414866|NCT01363440|524372302|FG002|Overall Study|Other|2|||
145414867|NCT01166945|524372304|FG000|Randomized|diagnosed with Group A strep|4|||
145414868|NCT01166945|524372305|FG001|Randomized|diagnosed with Group A strep|4|||
145414869|NCT01166945|524372304|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
145414870|NCT01166945|524372305|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
145414871|NCT01166945|524372304|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
145414872|NCT01166945|524372305|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
145414873|NCT01166945|524372304|FG000|Day 30|Lost to Follow-up|4|||
145414874|NCT01166945|524372305|FG001|Day 30|Lost to Follow-up|3|||
145414875|NCT00923702|524372311|FG000|Overall Study|Ongoing enrollment|0|||
145349340|NCT04917861|524125140|FG002|Main Study (196 Days)|Other Than Specified|1|||
145349341|NCT04917861|524125141|FG003|Main Study (196 Days)|Other Than Specified|2|||
145349342|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
145349343|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
145349344|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
145349345|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
145349346|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145349347|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
145349348|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145349349|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
145349350|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145349351|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
145349352|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145349353|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
145349354|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
145349355|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
145349356|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
145349357|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
145349358|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145414876|NCT00923702|524372312|FG001|Overall Study|Ongoing enrollment|0|||
145414877|NCT00923702|524372313|FG002|Overall Study|Ongoing enrollment|0|||
145414878|NCT00923702|524372314|FG003|Overall Study|Ongoing enrollment|0|||
145414879|NCT00923702|524372315|FG004|Overall Study|Ongoing enrollment|354|||
145414880|NCT01158404|524372318|FG000|Overall Study|Withdrawal by Subject|0|||
145414881|NCT01158404|524372319|FG001|Overall Study|Withdrawal by Subject|1|||
145414882|NCT01158404|524372320|FG002|Overall Study|Withdrawal by Subject|0|||
145414883|NCT01158404|524372321|FG003|Overall Study|Withdrawal by Subject|0|||
145414884|NCT01158404|524372322|FG004|Overall Study|Withdrawal by Subject|3|||
145414885|NCT01158404|524372323|FG005|Overall Study|Withdrawal by Subject|1|||
145414886|NCT01158404|524372324|FG006|Overall Study|Withdrawal by Subject|0|||
145577177|NCT00779766|524968003|FG001|Month 24|Adverse Event|3|||
145577178|NCT00779766|524968002|FG000|Month 24|Protocol Violation|3|||
145349359|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
145349360|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145349361|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
145349362|NCT04917861|524125138|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
145349363|NCT04917861|524125139|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
145349364|NCT04917861|524125140|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
145349365|NCT04917861|524125141|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
145349366|NCT02694328|524125142|FG000|Overall Study|Adverse Event|27|||
145349367|NCT02694328|524125143|FG001|Overall Study|Adverse Event|33|||
145349368|NCT02694328|524125142|FG000|Overall Study|Withdrawal by Subject|27|||
145349369|NCT02694328|524125143|FG001|Overall Study|Withdrawal by Subject|23|||
145349370|NCT02694328|524125142|FG000|Overall Study|Lost to Follow-up|26|||
145349371|NCT02694328|524125143|FG001|Overall Study|Lost to Follow-up|22|||
145349372|NCT02694328|524125142|FG000|Overall Study|Noncompliant with study drug|11|||
145349373|NCT02694328|524125143|FG001|Overall Study|Noncompliant with study drug|8|||
145349374|NCT02694328|524125142|FG000|Overall Study|Incarceration|1|||
145349375|NCT02694328|524125143|FG001|Overall Study|Incarceration|1|||
145349376|NCT02694328|524125142|FG000|Overall Study|Lack of Efficacy|1|||
145349377|NCT02694328|524125143|FG001|Overall Study|Lack of Efficacy|2|||
145349378|NCT02694328|524125142|FG000|Overall Study|Pregnancy|1|||
145349379|NCT02694328|524125143|FG001|Overall Study|Pregnancy|1|||
145349380|NCT02694328|524125142|FG000|Overall Study|Protocol Violation|6|||
145349381|NCT02694328|524125143|FG001|Overall Study|Protocol Violation|5|||
145349382|NCT02694328|524125142|FG000|Overall Study|Abnormal Laboratory Value|0|||
145349383|NCT02694328|524125143|FG001|Overall Study|Abnormal Laboratory Value|3|||
145349384|NCT00001521|524127034|FG000|Overall Study|Withdrawal by Subject|3|||
145349385|NCT00001521|524127035|FG001|Overall Study|Withdrawal by Subject|3|||
145349386|NCT00001521|524127034|FG000|Overall Study|Physician Decision|1|||
145349387|NCT00001521|524127035|FG001|Overall Study|Physician Decision|1|||
145349388|NCT00001521|524127034|FG000|Overall Study|Noncompliant|6|||
145349389|NCT00001521|524127035|FG001|Overall Study|Noncompliant|3|||
145349390|NCT04848480|524127036|FG000|Main Phase (26 Weeks)|Death|1|||
145349391|NCT04848480|524127037|FG001|Main Phase (26 Weeks)|Death|0|||
145349392|NCT04848480|524127036|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
145349393|NCT04848480|524127037|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
145349394|NCT04848480|524127036|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
145349395|NCT04848480|524127037|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
145349396|NCT04848480|524127036|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
145349397|NCT04848480|524127037|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
145349398|NCT04848480|524127036|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
145349399|NCT04848480|524127037|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
145349400|NCT04848480|524127036|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
145349401|NCT04848480|524127037|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
145349402|NCT03176134|524127038|FG000|Overall Study|Lost to Follow-up|0|||
145349403|NCT03176134|524127039|FG001|Overall Study|Lost to Follow-up|2|||
145349404|NCT03176134|524127040|FG002|Overall Study|Lost to Follow-up|0|||
145349405|NCT03176134|524127041|FG003|Overall Study|Lost to Follow-up|0|||
145349406|NCT03176134|524127042|FG004|Overall Study|Lost to Follow-up|0|||
145349407|NCT03176134|524127043|FG005|Overall Study|Lost to Follow-up|0|||
145349408|NCT03176134|524127044|FG006|Overall Study|Lost to Follow-up|0|||
145349409|NCT03176134|524127045|FG007|Overall Study|Lost to Follow-up|0|||
145349410|NCT03176134|524127038|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145349411|NCT03176134|524127039|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145349412|NCT03176134|524127040|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145349413|NCT03176134|524127041|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145349414|NCT03176134|524127042|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
145349415|NCT03176134|524127043|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145349416|NCT03176134|524127044|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
145349417|NCT03176134|524127045|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
145349418|NCT01499095|524127048|FG000|Overall Study|Randomized But Not Treated|1|||
145349419|NCT01499095|524127049|FG001|Overall Study|Randomized But Not Treated|1|||
145349420|NCT01499095|524127048|FG000|Overall Study|Adverse Event|12|||
145349421|NCT01499095|524127049|FG001|Overall Study|Adverse Event|7|||
145349422|NCT01499095|524127048|FG000|Overall Study|Lack of Efficacy|2|||
145349423|NCT01499095|524127049|FG001|Overall Study|Lack of Efficacy|1|||
145349424|NCT01499095|524127048|FG000|Overall Study|Protocol Violation|6|||
145349425|NCT01499095|524127049|FG001|Overall Study|Protocol Violation|7|||
145349426|NCT01499095|524127048|FG000|Overall Study|Received Rescue Therapy|32|||
145349427|NCT01499095|524127049|FG001|Overall Study|Received Rescue Therapy|40|||
145349428|NCT01499095|524127048|FG000|Overall Study|Diverse Reasons|22|||
145349429|NCT01499095|524127049|FG001|Overall Study|Diverse Reasons|25|||
145349430|NCT01499095|524127048|FG000|Overall Study|Lost to Follow-up|6|||
145349431|NCT01499095|524127049|FG001|Overall Study|Lost to Follow-up|4|||
145349432|NCT01499095|524127048|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
145349433|NCT01499095|524127049|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
145349434|NCT01499095|524127048|FG000|Overall Study|Hypoglycemia|3|||
145349435|NCT01499095|524127049|FG001|Overall Study|Hypoglycemia|1|||
145349436|NCT01499095|524127048|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
145349437|NCT01499095|524127049|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
145349438|NCT01499095|524127048|FG000|Overall Study|Change in Injection Schedule|2|||
145349439|NCT01499095|524127049|FG001|Overall Study|Change in Injection Schedule|0|||
145349440|NCT01499095|524127048|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145349441|NCT01499095|524127049|FG001|Overall Study|Perceived Lack of Efficacy|1|||
145349442|NCT04358081|524127050|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
145349443|NCT04358081|524127051|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
145349444|NCT04358081|524127052|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
145349445|NCT04358081|524127050|FG000|Treatment Phase of Study|Adverse Event|1|||
145349446|NCT04358081|524127051|FG001|Treatment Phase of Study|Adverse Event|0|||
145349447|NCT04358081|524127052|FG002|Treatment Phase of Study|Adverse Event|1|||
145349448|NCT04358081|524127050|FG000|Treatment Phase of Study|Physician Decision|2|||
145349449|NCT04358081|524127051|FG001|Treatment Phase of Study|Physician Decision|0|||
145349450|NCT04358081|524127052|FG002|Treatment Phase of Study|Physician Decision|1|||
145349451|NCT04358081|524127050|FG000|Treatment Phase of Study|Protocol Violation|1|||
145349452|NCT04358081|524127051|FG001|Treatment Phase of Study|Protocol Violation|0|||
145349453|NCT04358081|524127052|FG002|Treatment Phase of Study|Protocol Violation|0|||
145349454|NCT04358081|524127050|FG000|Study Completion Phase|Death|0|||
145349455|NCT04358081|524127051|FG001|Study Completion Phase|Death|0|||
145349456|NCT04358081|524127052|FG002|Study Completion Phase|Death|1|||
145349457|NCT04358081|524127050|FG000|Study Completion Phase|Lost to Follow-up|1|||
145349458|NCT04358081|524127051|FG001|Study Completion Phase|Lost to Follow-up|0|||
145349459|NCT04358081|524127052|FG002|Study Completion Phase|Lost to Follow-up|1|||
145349460|NCT01368497|524127053|FG000|Overall Study|Lost to Follow-up|2|||
145349461|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
145349462|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
145349463|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
145349464|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
145349465|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
145349466|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
145349467|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
145349468|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
145349469|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
145349470|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
145349471|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
145349472|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
145349473|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
145349474|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
145349475|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
145349476|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
145414887|NCT01158404|524372325|FG007|Overall Study|Withdrawal by Subject|1|||
145414888|NCT01158404|524372318|FG000|Overall Study|Physician Decision|0|||
145414889|NCT01158404|524372319|FG001|Overall Study|Physician Decision|0|||
145414890|NCT01158404|524372320|FG002|Overall Study|Physician Decision|0|||
145414891|NCT01158404|524372321|FG003|Overall Study|Physician Decision|0|||
145414892|NCT01158404|524372322|FG004|Overall Study|Physician Decision|0|||
145414893|NCT01158404|524372323|FG005|Overall Study|Physician Decision|0|||
145414894|NCT01158404|524372324|FG006|Overall Study|Physician Decision|0|||
145414895|NCT01158404|524372325|FG007|Overall Study|Physician Decision|1|||
145414896|NCT01158404|524372318|FG000|Overall Study|Progressive Disease|0|||
145414897|NCT01158404|524372319|FG001|Overall Study|Progressive Disease|0|||
145414898|NCT01158404|524372320|FG002|Overall Study|Progressive Disease|0|||
145414899|NCT01158404|524372321|FG003|Overall Study|Progressive Disease|0|||
145414900|NCT01158404|524372322|FG004|Overall Study|Progressive Disease|0|||
145414901|NCT01158404|524372323|FG005|Overall Study|Progressive Disease|0|||
145414902|NCT01158404|524372324|FG006|Overall Study|Progressive Disease|1|||
145414903|NCT01158404|524372325|FG007|Overall Study|Progressive Disease|0|||
145414904|NCT00827242|524372327|FG000|Overall Study|Withdrawal by Subject|2|||
145414905|NCT00827242|524372328|FG001|Overall Study|Withdrawal by Subject|4|||
145414906|NCT00827242|524372327|FG000|Overall Study|Protocol Violation|1|||
145577179|NCT00779766|524968003|FG001|Month 24|Protocol Violation|1|||
145577180|NCT00779766|524968002|FG000|Month 24|Withdrawal by Subject|159|||
145349477|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
145349478|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
145349479|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
145414907|NCT00827242|524372328|FG001|Overall Study|Protocol Violation|3|||
145414908|NCT00827242|524372327|FG000|Overall Study|Lost to Follow-up|0|||
145414909|NCT00827242|524372328|FG001|Overall Study|Lost to Follow-up|3|||
145414910|NCT00827242|524372327|FG000|Overall Study|Adverse Event Excluding Death|2|||
145414911|NCT00827242|524372328|FG001|Overall Study|Adverse Event Excluding Death|1|||
145414912|NCT00827242|524372327|FG000|Overall Study|Entry Criteria Not Met|4|||
145414913|NCT00827242|524372328|FG001|Overall Study|Entry Criteria Not Met|1|||
145349480|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
145349481|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
145349482|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
145349483|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
145349484|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
145349485|NCT01130532|524127054|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
145349486|NCT01130532|524127055|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
145349487|NCT01130532|524127056|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
145349488|NCT01130532|524127057|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
145349489|NCT01130532|524127054|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
145349490|NCT01130532|524127055|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
145349491|NCT01130532|524127056|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
145349492|NCT01130532|524127057|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
145349493|NCT01130532|524127054|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145349494|NCT01130532|524127055|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145349495|NCT01130532|524127056|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
145349496|NCT01130532|524127057|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
145349497|NCT01130532|524127054|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145349498|NCT01130532|524127055|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145349499|NCT01130532|524127056|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
145349500|NCT01130532|524127057|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
145349501|NCT01130532|524127054|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145349502|NCT01130532|524127055|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145349503|NCT01130532|524127056|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
145349504|NCT01130532|524127057|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
145349505|NCT02762929|524127058|FG000|Overall Study|Adverse Event|0|||
145349506|NCT02762929|524127059|FG001|Overall Study|Adverse Event|0|||
145349507|NCT02762929|524127060|FG002|Overall Study|Adverse Event|0|||
145349508|NCT02762929|524127061|FG003|Overall Study|Adverse Event|1|||
145349509|NCT02762929|524127062|FG004|Overall Study|Adverse Event|0|||
145349510|NCT02762929|524127063|FG005|Overall Study|Adverse Event|0|||
145349511|NCT02762929|524127058|FG000|Overall Study|Lost to Follow-up|1|||
145349512|NCT02762929|524127059|FG001|Overall Study|Lost to Follow-up|2|||
145349513|NCT02762929|524127060|FG002|Overall Study|Lost to Follow-up|0|||
145349514|NCT02762929|524127061|FG003|Overall Study|Lost to Follow-up|1|||
145349515|NCT02762929|524127062|FG004|Overall Study|Lost to Follow-up|0|||
145349516|NCT02762929|524127063|FG005|Overall Study|Lost to Follow-up|0|||
145349517|NCT02762929|524127058|FG000|Overall Study|Withdrawal by Subject|0|||
145349518|NCT02762929|524127059|FG001|Overall Study|Withdrawal by Subject|1|||
145349519|NCT02762929|524127060|FG002|Overall Study|Withdrawal by Subject|0|||
145349520|NCT02762929|524127061|FG003|Overall Study|Withdrawal by Subject|0|||
145349521|NCT02762929|524127062|FG004|Overall Study|Withdrawal by Subject|0|||
145349522|NCT02762929|524127063|FG005|Overall Study|Withdrawal by Subject|0|||
145349523|NCT02762929|524127058|FG000|Overall Study|exclusionary medication disclosed late|0|||
145349524|NCT02762929|524127059|FG001|Overall Study|exclusionary medication disclosed late|0|||
145349525|NCT02762929|524127060|FG002|Overall Study|exclusionary medication disclosed late|0|||
145349526|NCT02762929|524127061|FG003|Overall Study|exclusionary medication disclosed late|1|||
145349527|NCT02762929|524127062|FG004|Overall Study|exclusionary medication disclosed late|0|||
145349528|NCT02762929|524127063|FG005|Overall Study|exclusionary medication disclosed late|0|||
145349529|NCT02656303|524127065|FG000|Overall Study|Adverse Event|3|||
145349530|NCT02656303|524127066|FG001|Overall Study|Adverse Event|2|||
145349531|NCT02656303|524127067|FG002|Overall Study|Adverse Event|0|||
145349532|NCT02656303|524127065|FG000|Overall Study|Death|12|||
145349533|NCT02656303|524127066|FG001|Overall Study|Death|4|||
145349534|NCT02656303|524127067|FG002|Overall Study|Death|1|||
145349535|NCT02656303|524127065|FG000|Overall Study|Lack of Efficacy|1|||
145349536|NCT02656303|524127066|FG001|Overall Study|Lack of Efficacy|0|||
145349537|NCT02656303|524127067|FG002|Overall Study|Lack of Efficacy|0|||
145349538|NCT02656303|524127065|FG000|Overall Study|Non-Compliance with Study|1|||
145349539|NCT02656303|524127066|FG001|Overall Study|Non-Compliance with Study|1|||
145349540|NCT02656303|524127067|FG002|Overall Study|Non-Compliance with Study|0|||
145349541|NCT02656303|524127065|FG000|Overall Study|Investigator Decision|2|||
145349542|NCT02656303|524127066|FG001|Overall Study|Investigator Decision|1|||
145349543|NCT02656303|524127067|FG002|Overall Study|Investigator Decision|0|||
145349544|NCT02656303|524127065|FG000|Overall Study|Progressive Disease|25|||
145349545|NCT02656303|524127066|FG001|Overall Study|Progressive Disease|14|||
145349546|NCT02656303|524127067|FG002|Overall Study|Progressive Disease|10|||
145349547|NCT02656303|524127065|FG000|Overall Study|Study Terminated by Sponsor|20|||
145349548|NCT02656303|524127066|FG001|Overall Study|Study Terminated by Sponsor|7|||
145349549|NCT02656303|524127067|FG002|Overall Study|Study Terminated by Sponsor|5|||
145349550|NCT02656303|524127065|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
145349551|NCT02656303|524127066|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
145349552|NCT02656303|524127067|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
145349553|NCT02656303|524127065|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
145349554|NCT02656303|524127066|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
145349555|NCT02656303|524127067|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
145349556|NCT02656303|524127065|FG000|Overall Study|Reason not Specified|1|||
145349557|NCT02656303|524127066|FG001|Overall Study|Reason not Specified|1|||
145349558|NCT02656303|524127067|FG002|Overall Study|Reason not Specified|2|||
145349559|NCT03041311|524127070|FG000|Overall Study|Death|39|||
145349560|NCT03041311|524127071|FG001|Overall Study|Death|42|||
145349561|NCT03041311|524127070|FG000|Overall Study|Lost to Follow-up|0|||
145349562|NCT03041311|524127071|FG001|Overall Study|Lost to Follow-up|1|||
145349563|NCT03041311|524127070|FG000|Overall Study|Withdrawal by Subject|8|||
145349564|NCT03041311|524127071|FG001|Overall Study|Withdrawal by Subject|5|||
145349565|NCT03041311|524127070|FG000|Overall Study|Sponsor Terminated Study|2|||
145349566|NCT03041311|524127071|FG001|Overall Study|Sponsor Terminated Study|4|||
145349567|NCT03041311|524127070|FG000|Overall Study|Disease Progression|3|||
145349568|NCT03041311|524127071|FG001|Overall Study|Disease Progression|1|||
145349569|NCT03041311|524127070|FG000|Overall Study|Randomized in error, did not receive drug|2|||
145349570|NCT03041311|524127071|FG001|Overall Study|Randomized in error, did not receive drug|0|||
145349571|NCT00443729|524127072|FG000|Overall Study|Never Treated|0|||
145349572|NCT00443729|524127073|FG001|Overall Study|Never Treated|1|||
145349573|NCT00443729|524127072|FG000|Overall Study|Lack of Efficacy|4|||
145349574|NCT00443729|524127073|FG001|Overall Study|Lack of Efficacy|2|||
145349575|NCT00443729|524127072|FG000|Overall Study|Lost to Follow-up|0|||
145349576|NCT00443729|524127073|FG001|Overall Study|Lost to Follow-up|1|||
145349577|NCT00443729|524127072|FG000|Overall Study|Physician Decision|2|||
145349578|NCT00443729|524127073|FG001|Overall Study|Physician Decision|1|||
145349579|NCT00443729|524127072|FG000|Overall Study|Protocol Violation|1|||
145349580|NCT00443729|524127073|FG001|Overall Study|Protocol Violation|1|||
145349581|NCT00443729|524127072|FG000|Overall Study|Withdrawal by Subject|3|||
145349582|NCT00443729|524127073|FG001|Overall Study|Withdrawal by Subject|1|||
145349583|NCT01842438|524127074|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
145349584|NCT01842438|524127075|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
145349585|NCT01842438|524127074|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
145349586|NCT01842438|524127075|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
145349587|NCT01842438|524127074|FG000|T2: 6month Follow-up|Death|0|||
145349588|NCT01842438|524127075|FG001|T2: 6month Follow-up|Death|1|||
145349589|NCT00782626|524127079|FG000|Overall Study|Adverse Event|1|||
145349590|NCT00782626|524127079|FG000|Overall Study|Progressive Disease|5|||
145349591|NCT00782626|524127079|FG000|Overall Study|Other Complicating Disease|1|||
145349592|NCT04054765|524127080|FG000|Baseline|Withdrawal by Subject|5|||
145349593|NCT04054765|524127081|FG001|Baseline|Withdrawal by Subject|3|||
145349594|NCT04054765|524127080|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
145349595|NCT04054765|524127081|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
145349596|NCT04054765|524127080|FG000|3-month Follow up|Withdrawal by Subject|0|||
145349597|NCT04054765|524127081|FG001|3-month Follow up|Withdrawal by Subject|3|||
145349598|NCT04054765|524127080|FG000|6-month Follow up|Lost to Follow-up|32|||
145349599|NCT04054765|524127081|FG001|6-month Follow up|Lost to Follow-up|32|||
145349600|NCT02366689|524127084|FG000|Overall Study|Withdrawal by Subject|1|||
145349601|NCT02366689|524127085|FG001|Overall Study|Withdrawal by Subject|0|||
145349602|NCT02366689|524127086|FG002|Overall Study|Withdrawal by Subject|1|||
145349603|NCT02366689|524127084|FG000|Overall Study|Lost to Follow-up|3|||
145349604|NCT02366689|524127085|FG001|Overall Study|Lost to Follow-up|2|||
145349605|NCT02366689|524127086|FG002|Overall Study|Lost to Follow-up|0|||
145349606|NCT02366689|524127084|FG000|Overall Study|Pregnancy|0|||
145349607|NCT02366689|524127085|FG001|Overall Study|Pregnancy|1|||
145349608|NCT02366689|524127086|FG002|Overall Study|Pregnancy|1|||
145349609|NCT01290068|524127087|FG000|Overall Study|Adverse Event|1|||
145349610|NCT01290068|524127088|FG001|Overall Study|Adverse Event|3|||
145349611|NCT01290068|524127087|FG000|Overall Study|Lost to Follow-up|3|||
145349612|NCT01290068|524127088|FG001|Overall Study|Lost to Follow-up|0|||
145349613|NCT01290068|524127087|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
145349614|NCT01290068|524127088|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
145349615|NCT01290068|524127087|FG000|Overall Study|Other|3|||
145349616|NCT01290068|524127088|FG001|Overall Study|Other|1|||
145349617|NCT03283566|524127091|FG000|Overall Study|Lost to Follow-up|1|||
145349618|NCT03283566|524127092|FG001|Overall Study|Lost to Follow-up|2|||
145349619|NCT03718832|524127093|FG000|Analysis Sample|Withdrawal by Subject|18|||
145349620|NCT03718832|524127094|FG001|Analysis Sample|Withdrawal by Subject|15|||
145414914|NCT00827242|524372327|FG000|Overall Study|Physician Decision|2|||
145349621|NCT03718832|524127093|FG000|Analysis Sample|Legal hold on data|1|||
145349622|NCT03718832|524127094|FG001|Analysis Sample|Legal hold on data|0|||
145349623|NCT03718832|524127093|FG000|Analysis Sample|Participant from treated household|0|||
145349624|NCT03718832|524127094|FG001|Analysis Sample|Participant from treated household|1|||
145349625|NCT03718832|524127093|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
145349626|NCT03718832|524127094|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
145349627|NCT01996241|524127096|FG000|Overall Study|Lost to Follow-up|252|||
145349628|NCT01996241|524127097|FG001|Overall Study|Lost to Follow-up|235|||
145349629|NCT03052751|524127098|FG000|Dosing Period 1|Adverse Event|0|||
145349630|NCT03052751|524127099|FG001|Dosing Period 1|Adverse Event|1|||
145349631|NCT03052751|524127100|FG002|Dosing Period 1|Adverse Event|0|||
145349632|NCT03052751|524127101|FG003|Dosing Period 1|Adverse Event|0|||
145349633|NCT03052751|524127102|FG004|Dosing Period 1|Adverse Event|0|||
145349634|NCT03052751|524127103|FG005|Dosing Period 1|Adverse Event|0|||
145349635|NCT03052751|524127098|FG000|Dosing Period 2|Adverse Event|0|||
145349636|NCT03052751|524127099|FG001|Dosing Period 2|Adverse Event|0|||
145349637|NCT03052751|524127100|FG002|Dosing Period 2|Adverse Event|3|||
145349638|NCT03052751|524127101|FG003|Dosing Period 2|Adverse Event|0|||
145349639|NCT03052751|524127102|FG004|Dosing Period 2|Adverse Event|0|||
145349640|NCT03052751|524127103|FG005|Dosing Period 2|Adverse Event|0|||
145349641|NCT03052751|524127098|FG000|Observation Period|Adverse Event|0|||
145349642|NCT03052751|524127099|FG001|Observation Period|Adverse Event|0|||
145349643|NCT03052751|524127100|FG002|Observation Period|Adverse Event|0|||
145349644|NCT03052751|524127101|FG003|Observation Period|Adverse Event|0|||
145349645|NCT03052751|524127102|FG004|Observation Period|Adverse Event|1|||
145349646|NCT03052751|524127103|FG005|Observation Period|Adverse Event|0|||
145349647|NCT01068262|524127106|FG000|Overall Study|Adverse Event|2|||
145349648|NCT01068262|524127107|FG001|Overall Study|Adverse Event|0|||
145349649|NCT01068262|524127108|FG002|Overall Study|Adverse Event|1|||
145349650|NCT01068262|524127109|FG003|Overall Study|Adverse Event|0|||
145349651|NCT01068262|524127106|FG000|Overall Study|Protocol Violation|1|||
145349652|NCT01068262|524127107|FG001|Overall Study|Protocol Violation|0|||
145349653|NCT01068262|524127108|FG002|Overall Study|Protocol Violation|0|||
145349654|NCT01068262|524127109|FG003|Overall Study|Protocol Violation|0|||
145349655|NCT01068262|524127106|FG000|Overall Study|Withdrawal by Subject|0|||
145349656|NCT01068262|524127107|FG001|Overall Study|Withdrawal by Subject|1|||
145349657|NCT01068262|524127108|FG002|Overall Study|Withdrawal by Subject|0|||
145349658|NCT01068262|524127109|FG003|Overall Study|Withdrawal by Subject|0|||
145349659|NCT04182490|524127110|FG000|Overall Study|Withdrawal by Subject|3|||
145349660|NCT04182490|524127111|FG001|Overall Study|Withdrawal by Subject|3|||
145349661|NCT04182490|524127110|FG000|Overall Study|Lost to Follow-up|0|||
145349662|NCT04182490|524127111|FG001|Overall Study|Lost to Follow-up|1|||
145349663|NCT04182490|524127110|FG000|Overall Study|Physician Decision|0|||
145349664|NCT04182490|524127111|FG001|Overall Study|Physician Decision|1|||
145349665|NCT00853099|524127112|FG000|Double-blind Period|Adverse Event|7|||
145349666|NCT00853099|524127113|FG001|Double-blind Period|Adverse Event|9|||
145349667|NCT00853099|524127114|FG002|Double-blind Period|Adverse Event|13|||
145349668|NCT00853099|524127115|FG003|Double-blind Period|Adverse Event|0|||
145349669|NCT00853099|524127112|FG000|Double-blind Period|Withdrawal by Subject|2|||
145349670|NCT00853099|524127113|FG001|Double-blind Period|Withdrawal by Subject|3|||
145349671|NCT00853099|524127114|FG002|Double-blind Period|Withdrawal by Subject|0|||
145349672|NCT00853099|524127115|FG003|Double-blind Period|Withdrawal by Subject|0|||
145349673|NCT00853099|524127112|FG000|Double-blind Period|Lack of Efficacy|14|||
145349674|NCT00853099|524127113|FG001|Double-blind Period|Lack of Efficacy|17|||
145349675|NCT00853099|524127114|FG002|Double-blind Period|Lack of Efficacy|16|||
145349676|NCT00853099|524127115|FG003|Double-blind Period|Lack of Efficacy|0|||
145349677|NCT00853099|524127112|FG000|Double-blind Period|Other|0|||
145349678|NCT00853099|524127113|FG001|Double-blind Period|Other|0|||
145349679|NCT00853099|524127114|FG002|Double-blind Period|Other|1|||
145349680|NCT00853099|524127115|FG003|Double-blind Period|Other|0|||
145349681|NCT00853099|524127112|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
145349682|NCT00853099|524127113|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
145349683|NCT00853099|524127114|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
145349684|NCT00853099|524127115|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
145349685|NCT00853099|524127112|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145349686|NCT00853099|524127113|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145349687|NCT00853099|524127114|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
145349688|NCT00853099|524127115|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
145349689|NCT00853099|524127112|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
145349690|NCT00853099|524127113|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
145349691|NCT00853099|524127114|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
145349692|NCT00853099|524127115|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
145349693|NCT00853099|524127112|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145349694|NCT00853099|524127113|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145349695|NCT00853099|524127114|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
145349696|NCT00853099|524127115|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
145349697|NCT00853099|524127112|FG000|Double-blind + Open-label Periods|Other|0|||
145349698|NCT00853099|524127113|FG001|Double-blind + Open-label Periods|Other|0|||
145349699|NCT00853099|524127114|FG002|Double-blind + Open-label Periods|Other|0|||
145349700|NCT00853099|524127115|FG003|Double-blind + Open-label Periods|Other|6|||
145349701|NCT01811472|524127118|FG000|Overall Study|Adverse Event|1|||
145349702|NCT01811472|524127119|FG001|Overall Study|Adverse Event|0|||
145349703|NCT01811472|524127120|FG002|Overall Study|Adverse Event|4|||
145349704|NCT01811472|524127118|FG000|Overall Study|Lost to Follow-up|0|||
145349705|NCT01811472|524127119|FG001|Overall Study|Lost to Follow-up|0|||
145349706|NCT01811472|524127120|FG002|Overall Study|Lost to Follow-up|1|||
145414915|NCT00827242|524372328|FG001|Overall Study|Physician Decision|0|||
145349707|NCT01811472|524127118|FG000|Overall Study|Subject/guardian decision|1|||
145349708|NCT01811472|524127119|FG001|Overall Study|Subject/guardian decision|0|||
145349709|NCT01811472|524127120|FG002|Overall Study|Subject/guardian decision|0|||
145349710|NCT04688671|524127124|FG000|Overall Study|Adverse Event|3|||
145349711|NCT04688671|524127125|FG001|Overall Study|Adverse Event|1|||
145349712|NCT04688671|524127124|FG000|Overall Study|Withdrawal by Subject|3|||
145349713|NCT04688671|524127125|FG001|Overall Study|Withdrawal by Subject|1|||
145349714|NCT04688671|524127124|FG000|Overall Study|Lack of Efficacy|1|||
145349715|NCT04688671|524127125|FG001|Overall Study|Lack of Efficacy|1|||
145349716|NCT04688671|524127124|FG000|Overall Study|Protocol Violation|1|||
145349717|NCT04688671|524127125|FG001|Overall Study|Protocol Violation|0|||
145349718|NCT04688671|524127124|FG000|Overall Study|Lost to Follow-up|0|||
145349719|NCT04688671|524127125|FG001|Overall Study|Lost to Follow-up|1|||
145349720|NCT01626690|524127126|FG000|Overall Study|Protocol Violation|1|||
145349721|NCT01626690|524127127|FG001|Overall Study|Protocol Violation|0|||
145349722|NCT01626690|524127126|FG000|Overall Study|Adverse Event|1|||
145349723|NCT01626690|524127127|FG001|Overall Study|Adverse Event|0|||
145349724|NCT04720053|524127128|FG000|Overall Study|Lost to Follow-up|12|||
145349725|NCT01960257|524127129|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
145349726|NCT01960257|524127130|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
145349727|NCT01960257|524127131|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
145349728|NCT01960257|524127129|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
145349729|NCT01960257|524127130|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
145349730|NCT01960257|524127131|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
145349731|NCT01960257|524127129|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
145349732|NCT01960257|524127130|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
145349733|NCT01960257|524127131|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
145349734|NCT03908125|524127132|FG000|Overall Study|Withdrawal by Subject|92|||
145349735|NCT03908125|524127132|FG000|Overall Study|Lost to Follow-up|8|||
145349736|NCT00110396|524127133|FG000|Overall Study|Adverse Event|15|||
145349737|NCT00110396|524127133|FG000|Overall Study|Lost to Follow-up|1|||
145349738|NCT00110396|524127133|FG000|Overall Study|Administration of plasmapheresis|1|||
145349739|NCT00110396|524127133|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
145349740|NCT00110396|524127133|FG000|Overall Study|Lack of Efficacy|1|||
145349741|NCT00110396|524127133|FG000|Overall Study|Decided not to continue treatment|1|||
145349742|NCT00110396|524127133|FG000|Overall Study|Patient non-compliance|1|||
145349743|NCT00110396|524127133|FG000|Overall Study|Patient refused to continue|1|||
145349744|NCT00110396|524127133|FG000|Overall Study|Patient refused to participate|1|||
145349745|NCT00110396|524127133|FG000|Overall Study|Patient will|1|||
145349746|NCT00110396|524127133|FG000|Overall Study|Patient's decision|1|||
145349747|NCT00110396|524127133|FG000|Overall Study|Participation in MS vaccine study|1|||
145349748|NCT00110396|524127133|FG000|Overall Study|Pregnancy|1|||
145349749|NCT00110396|524127133|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
145349750|NCT00110396|524127133|FG000|Overall Study|Protocol Violation|2|||
145349751|NCT00110396|524127133|FG000|Overall Study|Patient refused to come back|1|||
145349752|NCT00110396|524127133|FG000|Overall Study|The patient has refused|2|||
145349753|NCT00110396|524127133|FG000|Overall Study|The patient has refused to visit site|1|||
145349754|NCT00110396|524127133|FG000|Overall Study|Patient is to be administered copaxone|1|||
145349755|NCT02414958|524127136|FG000|Overall Study|Adverse Event|6|||
145349756|NCT02414958|524127137|FG001|Overall Study|Adverse Event|6|||
145349757|NCT02414958|524127138|FG002|Overall Study|Adverse Event|3|||
145349758|NCT02414958|524127136|FG000|Overall Study|Protocol Violation|10|||
145349759|NCT02414958|524127137|FG001|Overall Study|Protocol Violation|3|||
145349760|NCT02414958|524127138|FG002|Overall Study|Protocol Violation|1|||
145349761|NCT02414958|524127136|FG000|Overall Study|Lost to Follow-up|7|||
145349762|NCT02414958|524127137|FG001|Overall Study|Lost to Follow-up|4|||
145349763|NCT02414958|524127138|FG002|Overall Study|Lost to Follow-up|0|||
145349764|NCT02414958|524127136|FG000|Overall Study|Withdrawal by Subject|5|||
145349765|NCT02414958|524127137|FG001|Overall Study|Withdrawal by Subject|3|||
145349766|NCT02414958|524127138|FG002|Overall Study|Withdrawal by Subject|5|||
145349767|NCT02414958|524127136|FG000|Overall Study|Other than specified|4|||
145349768|NCT02414958|524127137|FG001|Overall Study|Other than specified|4|||
145349769|NCT02414958|524127138|FG002|Overall Study|Other than specified|5|||
145349770|NCT00245466|524127142|FG000|Overall Study|Adverse Event|2|||
145349771|NCT00245466|524127143|FG001|Overall Study|Adverse Event|8|||
145349772|NCT00245466|524127144|FG002|Overall Study|Adverse Event|4|||
145349773|NCT00245466|524127142|FG000|Overall Study|Low prostate specific antigen suppr|16|||
145349774|NCT00245466|524127143|FG001|Overall Study|Low prostate specific antigen suppr|14|||
145349775|NCT00245466|524127144|FG002|Overall Study|Low prostate specific antigen suppr|5|||
145349776|NCT00245466|524127142|FG000|Overall Study|Insufficient testosterone suppr|12|||
145349777|NCT00245466|524127143|FG001|Overall Study|Insufficient testosterone suppr|12|||
145349778|NCT00245466|524127144|FG002|Overall Study|Insufficient testosterone suppr|21|||
145349779|NCT00245466|524127142|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
145349780|NCT00245466|524127143|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
145349781|NCT00245466|524127144|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
145349782|NCT00245466|524127142|FG000|Overall Study|Withdrawal by Subject|2|||
145349783|NCT00245466|524127143|FG001|Overall Study|Withdrawal by Subject|2|||
145349784|NCT00245466|524127144|FG002|Overall Study|Withdrawal by Subject|1|||
145349785|NCT00245466|524127142|FG000|Overall Study|Lost to Follow-up|3|||
145349786|NCT00245466|524127143|FG001|Overall Study|Lost to Follow-up|0|||
145349787|NCT00245466|524127144|FG002|Overall Study|Lost to Follow-up|0|||
145349788|NCT00245466|524127142|FG000|Overall Study|Disease progression|0|||
145349789|NCT00245466|524127143|FG001|Overall Study|Disease progression|3|||
145349790|NCT00245466|524127144|FG002|Overall Study|Disease progression|1|||
145349791|NCT00245466|524127142|FG000|Overall Study|Protocol Violation|1|||
145349792|NCT00245466|524127143|FG001|Overall Study|Protocol Violation|2|||
145349793|NCT00245466|524127144|FG002|Overall Study|Protocol Violation|2|||
145349794|NCT00245466|524127142|FG000|Overall Study|Death|0|||
145349795|NCT00245466|524127143|FG001|Overall Study|Death|2|||
145349796|NCT00245466|524127144|FG002|Overall Study|Death|0|||
145349797|NCT00245466|524127142|FG000|Overall Study|Administrative reasons|0|||
145349798|NCT00245466|524127143|FG001|Overall Study|Administrative reasons|1|||
145349799|NCT00245466|524127144|FG002|Overall Study|Administrative reasons|0|||
145349800|NCT05064397|524127145|FG000|Overall Study|Adverse Event|4|||
145349801|NCT05064397|524127145|FG000|Overall Study|Lack of Efficacy|12|||
145349802|NCT05064397|524127145|FG000|Overall Study|Withdrawal by Subject|3|||
145349803|NCT05064397|524127145|FG000|Overall Study|Lost to Follow-up|1|||
145349804|NCT05064397|524127145|FG000|Overall Study|Other reasons|3|||
145349805|NCT00344448|524127146|FG000|Screening|Withdrawal by Subject|0|||
145349806|NCT00344448|524127147|FG001|Screening|Withdrawal by Subject|1|||
145349807|NCT00344448|524127146|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
145349808|NCT00344448|524127147|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
145349809|NCT00344448|524127146|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
145349810|NCT00344448|524127147|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
145349811|NCT00344448|524127146|FG000|Open Label|Withdrawal by Subject|1|||
145349812|NCT00344448|524127147|FG001|Open Label|Withdrawal by Subject|1|||
145349813|NCT00344448|524127146|FG000|Open Label|Study terminated|1|||
145349814|NCT00344448|524127147|FG001|Open Label|Study terminated|0|||
145349815|NCT04194645|524127152|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349816|NCT04194645|524127153|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349817|NCT04194645|524127154|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349818|NCT04194645|524127155|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349819|NCT04194645|524127156|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349820|NCT04194645|524127157|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349821|NCT04194645|524127158|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349822|NCT04194645|524127159|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349823|NCT04194645|524127160|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349824|NCT04194645|524127161|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
145349825|NCT04194645|524127162|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349826|NCT04194645|524127163|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349827|NCT04194645|524127164|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349828|NCT04194645|524127165|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349829|NCT04194645|524127166|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
145349830|NCT03076775|524127167|FG000|Overall Study|Lost to Follow-up|1|||
145349831|NCT03076775|524127168|FG001|Overall Study|Lost to Follow-up|0|||
145349832|NCT01783886|524127169|FG000|Overall Study|Lost to Follow-up|0|||
145349833|NCT01783886|524127170|FG001|Overall Study|Lost to Follow-up|3|||
145349834|NCT01783886|524127171|FG002|Overall Study|Lost to Follow-up|0|||
145349835|NCT01783886|524127169|FG000|Overall Study|Protocol deviation|0|||
145349836|NCT01783886|524127170|FG001|Overall Study|Protocol deviation|0|||
145349837|NCT01783886|524127171|FG002|Overall Study|Protocol deviation|2|||
145349838|NCT01783886|524127169|FG000|Overall Study|Withdrawal of consent by participant|1|||
145349839|NCT01783886|524127170|FG001|Overall Study|Withdrawal of consent by participant|3|||
145349840|NCT01783886|524127171|FG002|Overall Study|Withdrawal of consent by participant|4|||
145349841|NCT01783886|524127169|FG000|Overall Study|Adverse Event|4|||
145349842|NCT01783886|524127170|FG001|Overall Study|Adverse Event|5|||
145349843|NCT01783886|524127171|FG002|Overall Study|Adverse Event|4|||
145414916|NCT00827242|524372327|FG000|Overall Study|Death|1|||
145414917|NCT00827242|524372328|FG001|Overall Study|Death|0|||
145414918|NCT00827242|524372327|FG000|Overall Study|Lack of Efficacy|1|||
145349844|NCT04542057|524127172|FG000|Overall Study|Death|3|||
145349845|NCT04542057|524127173|FG001|Overall Study|Death|1|||
145414919|NCT00827242|524372328|FG001|Overall Study|Lack of Efficacy|0|||
145349846|NCT04542057|524127172|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
145349847|NCT04542057|524127173|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
145349848|NCT04542057|524127172|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
145349849|NCT04542057|524127173|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
145349850|NCT04542057|524127172|FG000|Overall Study|Adverse Event|15|||
145349851|NCT04542057|524127173|FG001|Overall Study|Adverse Event|6|||
145414920|NCT03670628|524372329|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
145577181|NCT00779766|524968003|FG001|Month 24|Withdrawal by Subject|127|||
145349852|NCT04542057|524127172|FG000|Overall Study|COVID-19 adverse event|6|||
145349853|NCT04542057|524127173|FG001|Overall Study|COVID-19 adverse event|4|||
145349854|NCT04542057|524127172|FG000|Overall Study|Lack of Efficacy|2|||
145349855|NCT04542057|524127173|FG001|Overall Study|Lack of Efficacy|5|||
145349856|NCT04542057|524127172|FG000|Overall Study|Study terminated by sponsor|1|||
145349857|NCT04542057|524127173|FG001|Overall Study|Study terminated by sponsor|0|||
145349858|NCT04542057|524127172|FG000|Overall Study|Investigator discretion|2|||
145349859|NCT04542057|524127173|FG001|Overall Study|Investigator discretion|1|||
145349860|NCT04542057|524127172|FG000|Overall Study|Withdrawal by Subject|52|||
145349861|NCT04542057|524127173|FG001|Overall Study|Withdrawal by Subject|30|||
145349862|NCT04542057|524127172|FG000|Overall Study|Lost to Follow-up|8|||
145349863|NCT04542057|524127173|FG001|Overall Study|Lost to Follow-up|11|||
145349864|NCT04542057|524127172|FG000|Overall Study|Other|2|||
145349865|NCT04542057|524127173|FG001|Overall Study|Other|2|||
145349866|NCT00104572|524127174|FG000|Overall Study|Withdrawal by Subject|3|||
145349867|NCT00104572|524127175|FG001|Overall Study|Withdrawal by Subject|3|||
145349868|NCT00104572|524127176|FG002|Overall Study|Withdrawal by Subject|0|||
145349869|NCT00940316|524127179|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
145349870|NCT00940316|524127180|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
145349871|NCT00940316|524127181|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
145349872|NCT00940316|524127179|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
145349873|NCT00940316|524127180|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
145349874|NCT00940316|524127181|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
145349875|NCT00940316|524127179|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
145349876|NCT00940316|524127180|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
145349877|NCT00940316|524127181|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
145349878|NCT00940316|524127179|FG000|Treated After Cycle 5|Adverse Event|0|||
145349879|NCT00940316|524127180|FG001|Treated After Cycle 5|Adverse Event|0|||
145349880|NCT00940316|524127181|FG002|Treated After Cycle 5|Adverse Event|1|||
145349881|NCT00940316|524127179|FG000|Treated After Cycle 5|Progressive disease|0|||
145349882|NCT00940316|524127180|FG001|Treated After Cycle 5|Progressive disease|1|||
145349883|NCT00940316|524127181|FG002|Treated After Cycle 5|Progressive disease|0|||
145349884|NCT03404674|524127183|FG000|Overall Study|Inability to Attend Future Visits|0|||
145349885|NCT03404674|524127184|FG001|Overall Study|Inability to Attend Future Visits|1|||
145349886|NCT03404674|524127185|FG002|Overall Study|Inability to Attend Future Visits|1|||
145349887|NCT03404674|524127186|FG003|Overall Study|Inability to Attend Future Visits|0|||
145349888|NCT03404674|524127187|FG004|Overall Study|Inability to Attend Future Visits|0|||
145349889|NCT03404674|524127188|FG005|Overall Study|Inability to Attend Future Visits|0|||
145349890|NCT03404674|524127183|FG000|Overall Study|Behavioral Problems|0|||
145349891|NCT03404674|524127184|FG001|Overall Study|Behavioral Problems|0|||
145349892|NCT03404674|524127185|FG002|Overall Study|Behavioral Problems|1|||
145349893|NCT03404674|524127186|FG003|Overall Study|Behavioral Problems|0|||
145349894|NCT03404674|524127187|FG004|Overall Study|Behavioral Problems|0|||
145349895|NCT03404674|524127188|FG005|Overall Study|Behavioral Problems|0|||
145349896|NCT03404674|524127183|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
145349897|NCT03404674|524127184|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
145349898|NCT03404674|524127185|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
145349899|NCT03404674|524127186|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
145349900|NCT03404674|524127187|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
145349901|NCT03404674|524127188|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
145349902|NCT02324582|524127189|FG000|Overall Study|Screen Failures|0|||
145349903|NCT02324582|524127190|FG001|Overall Study|Screen Failures|5|||
145349904|NCT02290405|524127193|FG000|Overall Study|Withdrawal by Subject|1|||
145349905|NCT02290405|524127194|FG001|Overall Study|Withdrawal by Subject|0|||
145349906|NCT02016183|524127195|FG000|Overall Study|Case Report Forms Uncollected|13|||
145349907|NCT02016183|524127195|FG000|Overall Study|Protocol Violation|52|||
145349908|NCT00996489|524127196|FG000|Overall Study|Device failure|45|||
145349909|NCT00996489|524127196|FG000|Overall Study|Discontinued|116|||
145349910|NCT00129545|524127210|FG000|Overall Study|Death|5|||
145349911|NCT00129545|524127211|FG001|Overall Study|Death|60|||
145349912|NCT00129545|524127212|FG002|Overall Study|Death|44|||
145349913|NCT00129545|524127210|FG000|Overall Study|Withdrawal by Subject|3|||
145349914|NCT00129545|524127211|FG001|Overall Study|Withdrawal by Subject|18|||
145349915|NCT00129545|524127212|FG002|Overall Study|Withdrawal by Subject|44|||
145349916|NCT00129545|524127210|FG000|Overall Study|Lost to Follow-up|2|||
145349917|NCT00129545|524127211|FG001|Overall Study|Lost to Follow-up|22|||
145349918|NCT00129545|524127212|FG002|Overall Study|Lost to Follow-up|13|||
145349919|NCT00129545|524127210|FG000|Overall Study|Physician Decision|0|||
145349920|NCT00129545|524127211|FG001|Overall Study|Physician Decision|3|||
145349921|NCT00129545|524127212|FG002|Overall Study|Physician Decision|10|||
145349922|NCT00129545|524127210|FG000|Overall Study|Device not implanted|16|||
145349923|NCT00129545|524127211|FG001|Overall Study|Device not implanted|61|||
145349924|NCT00129545|524127212|FG002|Overall Study|Device not implanted|0|||
145577182|NCT00779766|524968002|FG000|Month 24|Migrated/moved from study area|138|||
145349925|NCT00770328|524127213|FG000|Overall Study|Adverse Event|11|||
145349926|NCT00770328|524127214|FG001|Overall Study|Adverse Event|2|||
145349927|NCT00770328|524127213|FG000|Overall Study|Lost to Follow-up|2|||
145349928|NCT00770328|524127214|FG001|Overall Study|Lost to Follow-up|2|||
145349929|NCT03541317|524127222|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
145349930|NCT03541317|524127223|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145349931|NCT03541317|524127224|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145349932|NCT03541317|524127225|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145349933|NCT03541317|524127226|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145349934|NCT03541317|524127227|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
145349935|NCT03164616|524127232|FG000|Overall Study|Death|250|||
145349936|NCT03164616|524127233|FG001|Overall Study|Death|264|||
145349937|NCT03164616|524127234|FG002|Overall Study|Death|279|||
145349938|NCT03164616|524127232|FG000|Overall Study|Lost to Follow-up|2|||
145349939|NCT03164616|524127233|FG001|Overall Study|Lost to Follow-up|2|||
145349940|NCT03164616|524127234|FG002|Overall Study|Lost to Follow-up|2|||
145349941|NCT03164616|524127232|FG000|Overall Study|Withdrawal by Subject|6|||
145349942|NCT03164616|524127233|FG001|Overall Study|Withdrawal by Subject|7|||
145349943|NCT03164616|524127234|FG002|Overall Study|Withdrawal by Subject|16|||
145349944|NCT04502212|524127235|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
145349945|NCT04502212|524127235|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
145349946|NCT02905032|524127246|FG000|Overall Study|Withdrawal by Subject|2|||
145349947|NCT02905032|524127247|FG001|Overall Study|Withdrawal by Subject|0|||
145349948|NCT02905032|524127248|FG002|Overall Study|Withdrawal by Subject|0|||
145349949|NCT02905032|524127246|FG000|Overall Study|Protocol Violation|6|||
145349950|NCT02905032|524127247|FG001|Overall Study|Protocol Violation|12|||
145349951|NCT02905032|524127248|FG002|Overall Study|Protocol Violation|0|||
145349952|NCT00739063|524127249|FG000|Overall Study|Screen failures|8|||
145349953|NCT02603146|524129206|FG000|Overall Study|Lost to Follow-up|5|||
145349954|NCT02603146|524129207|FG001|Overall Study|Lost to Follow-up|6|||
145349955|NCT02603146|524129206|FG000|Overall Study|Withdrawal by Subject|8|||
145349956|NCT02603146|524129207|FG001|Overall Study|Withdrawal by Subject|10|||
145349957|NCT02603146|524129206|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
145349958|NCT02603146|524129207|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
145349959|NCT02603146|524129206|FG000|Overall Study|Participant moved|2|||
145349960|NCT02603146|524129207|FG001|Overall Study|Participant moved|0|||
145349961|NCT02603146|524129206|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
145349962|NCT02603146|524129207|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
145349963|NCT06082843|524129208|FG000|Overall Study|Withdrawal by Subject|0|||
145349964|NCT06082843|524129209|FG001|Overall Study|Withdrawal by Subject|2|||
145349965|NCT06082843|524129208|FG000|Overall Study|Study terminated by sponsor|12|||
145349966|NCT06082843|524129209|FG001|Overall Study|Study terminated by sponsor|8|||
145349967|NCT04123405|524129211|FG000|Overall Study|Adverse Event|1|||
145349968|NCT04123405|524129212|FG001|Overall Study|Adverse Event|2|||
145349969|NCT04123405|524129213|FG002|Overall Study|Adverse Event|3|||
145349970|NCT04123405|524129214|FG003|Overall Study|Adverse Event|3|||
145349971|NCT04123405|524129211|FG000|Overall Study|Exclusion criteria met|1|||
145349972|NCT04123405|524129212|FG001|Overall Study|Exclusion criteria met|2|||
145349973|NCT04123405|524129213|FG002|Overall Study|Exclusion criteria met|0|||
145349974|NCT04123405|524129214|FG003|Overall Study|Exclusion criteria met|2|||
145349975|NCT04123405|524129211|FG000|Overall Study|Withdrawal by Subject|1|||
145349976|NCT04123405|524129212|FG001|Overall Study|Withdrawal by Subject|3|||
145349977|NCT04123405|524129213|FG002|Overall Study|Withdrawal by Subject|0|||
145349978|NCT04123405|524129214|FG003|Overall Study|Withdrawal by Subject|2|||
145349979|NCT04123405|524129211|FG000|Overall Study|Contact to subject lost|0|||
145349980|NCT04123405|524129212|FG001|Overall Study|Contact to subject lost|0|||
145349981|NCT04123405|524129213|FG002|Overall Study|Contact to subject lost|0|||
145349982|NCT04123405|524129214|FG003|Overall Study|Contact to subject lost|1|||
145349983|NCT04123405|524129211|FG000|Overall Study|screening failure|1|||
145349984|NCT04123405|524129212|FG001|Overall Study|screening failure|0|||
145349985|NCT04123405|524129213|FG002|Overall Study|screening failure|0|||
145349986|NCT04123405|524129214|FG003|Overall Study|screening failure|0|||
145349987|NCT00545714|524129217|FG000|Induction Phase (6 Months)|Physician Decision|3|||
145349988|NCT00545714|524129217|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
145349989|NCT00545714|524129217|FG000|Induction Phase (6 Months)|Disease Progression|1|||
145349990|NCT00545714|524129217|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
145349991|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
145349992|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
145349993|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
145349994|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
145349995|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
145349996|NCT00545714|524129217|FG000|Maintenance Phase (36 Months)|Death|2|||
145349997|NCT02515331|524129228|FG000|Overall Study|Withdrawal by Subject|0|||
145349998|NCT02515331|524129229|FG001|Overall Study|Withdrawal by Subject|0|||
145349999|NCT02515331|524129230|FG002|Overall Study|Withdrawal by Subject|1|||
145350000|NCT02515331|524129228|FG000|Overall Study|Protocol deviation|0|||
145350001|NCT02515331|524129229|FG001|Overall Study|Protocol deviation|0|||
145350002|NCT02515331|524129230|FG002|Overall Study|Protocol deviation|3|||
145350003|NCT02515331|524129228|FG000|Overall Study|Adverse Event|2|||
145350004|NCT02515331|524129229|FG001|Overall Study|Adverse Event|0|||
145350005|NCT02515331|524129230|FG002|Overall Study|Adverse Event|0|||
145350006|NCT00124748|524129231|FG000|Overall Study|Adverse Event|8|||
145350007|NCT00124748|524129232|FG001|Overall Study|Adverse Event|39|||
145350008|NCT00124748|524129231|FG000|Overall Study|Abnormal laboratory Value|2|||
145350009|NCT00124748|524129232|FG001|Overall Study|Abnormal laboratory Value|2|||
145350010|NCT00124748|524129231|FG000|Overall Study|Abnormal Procedure|0|||
145350011|NCT00124748|524129232|FG001|Overall Study|Abnormal Procedure|1|||
145350012|NCT00124748|524129231|FG000|Overall Study|Lack of Efficacy|20|||
145350013|NCT00124748|524129232|FG001|Overall Study|Lack of Efficacy|41|||
145350014|NCT00124748|524129231|FG000|Overall Study|No longer requires study drug|1|||
145350015|NCT00124748|524129232|FG001|Overall Study|No longer requires study drug|1|||
145350016|NCT00124748|524129231|FG000|Overall Study|Protocol Violation|3|||
145350017|NCT00124748|524129232|FG001|Overall Study|Protocol Violation|1|||
145350018|NCT00124748|524129231|FG000|Overall Study|Withdrawal by Subject|5|||
145350019|NCT00124748|524129232|FG001|Overall Study|Withdrawal by Subject|15|||
145350020|NCT00124748|524129231|FG000|Overall Study|Lost to Follow-up|2|||
145350021|NCT00124748|524129232|FG001|Overall Study|Lost to Follow-up|7|||
145350022|NCT00124748|524129231|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
145350023|NCT00124748|524129232|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
145350024|NCT00124748|524129231|FG000|Overall Study|Death|1|||
145350025|NCT00124748|524129232|FG001|Overall Study|Death|3|||
145350026|NCT00322712|524129233|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
145350027|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
145350028|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
145350029|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
145350030|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350031|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
145350032|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
145350033|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350034|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350035|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350036|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350037|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350038|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350039|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350040|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350041|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350042|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350043|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
145350044|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145350045|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350046|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
145350047|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145350048|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
145350049|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
145350050|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350051|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350052|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350053|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350054|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350055|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350056|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350057|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350058|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350059|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350060|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
145350061|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
145350062|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145350063|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145577183|NCT00779766|524968003|FG001|Month 24|Migrated/moved from study area|162|||
145577184|NCT00779766|524968002|FG000|Month 24|Lost to Follow-up|9|||
145350064|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
145350065|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
145350066|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
145350067|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145577185|NCT00779766|524968003|FG001|Month 24|Lost to Follow-up|9|||
145350068|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350069|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350070|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350071|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350072|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350073|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350074|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350075|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350076|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350077|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
145350078|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350079|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
145350080|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
145350081|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350082|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
145350083|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
145350084|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350085|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350086|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350087|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350088|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350089|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350090|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350091|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350092|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350093|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350094|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
145350095|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350096|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350097|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
145350098|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
145350099|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350100|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350101|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350102|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350103|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350104|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350105|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350106|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350107|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350108|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350109|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350110|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350111|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
145350112|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350113|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350114|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350115|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350116|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
145350117|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350118|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350119|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350120|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350121|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350122|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350123|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350124|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350125|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350126|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350127|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350128|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
145350129|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145414921|NCT03670628|524372330|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
145414922|NCT03670628|524372329|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
145489783|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
145350130|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
145350131|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350132|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350133|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350134|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350135|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350136|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350137|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350138|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350139|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350140|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350141|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350142|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350143|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350144|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350145|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
145350146|NCT00758524|524129238|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350147|NCT00758524|524129239|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
145350148|NCT00758524|524129240|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350149|NCT00758524|524129241|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350150|NCT00758524|524129242|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350151|NCT00758524|524129243|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350152|NCT00758524|524129244|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350153|NCT00758524|524129245|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350154|NCT00758524|524129246|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350155|NCT00758524|524129247|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350156|NCT00758524|524129248|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350157|NCT00758524|524129249|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350158|NCT00758524|524129250|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350159|NCT00758524|524129251|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350160|NCT00758524|524129252|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350161|NCT00758524|524129253|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350162|NCT00758524|524129254|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
145350163|NCT00758524|524129238|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350164|NCT00758524|524129239|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350165|NCT00758524|524129240|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350166|NCT00758524|524129241|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350167|NCT00758524|524129242|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350168|NCT00758524|524129243|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350169|NCT00758524|524129244|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350170|NCT00758524|524129245|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350171|NCT00758524|524129246|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
145350172|NCT00758524|524129247|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350173|NCT00758524|524129248|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350174|NCT00758524|524129249|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350175|NCT00758524|524129250|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350176|NCT00758524|524129251|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350177|NCT00758524|524129252|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350178|NCT00758524|524129253|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350179|NCT00758524|524129254|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
145350180|NCT00758524|524129238|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350181|NCT00758524|524129239|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350182|NCT00758524|524129240|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350183|NCT00758524|524129241|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350184|NCT00758524|524129242|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350185|NCT00758524|524129243|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350186|NCT00758524|524129244|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
145350187|NCT00758524|524129245|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350188|NCT00758524|524129246|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350189|NCT00758524|524129247|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350190|NCT00758524|524129248|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350191|NCT00758524|524129249|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350192|NCT00758524|524129250|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145577186|NCT00779766|524968002|FG000|Month 24|Other|18|||
145577187|NCT00779766|524968003|FG001|Month 24|Other|27|||
145577188|NCT00779766|524968002|FG000|Month 48|Withdrawal by Subject|68|||
145577189|NCT00779766|524968003|FG001|Month 48|Withdrawal by Subject|63|||
145577190|NCT00779766|524968002|FG000|Month 48|Migrated/moved from study area|76|||
145350193|NCT00758524|524129251|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350194|NCT00758524|524129252|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350195|NCT00758524|524129253|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350196|NCT00758524|524129254|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
145350197|NCT04176250|524129255|FG000|Overall Study|Adverse Event|0|||
145350198|NCT04176250|524129256|FG001|Overall Study|Adverse Event|1|||
145350199|NCT04176250|524129257|FG002|Overall Study|Adverse Event|0|||
145350200|NCT04176250|524129258|FG003|Overall Study|Adverse Event|1|||
145350201|NCT04176250|524129259|FG004|Overall Study|Adverse Event|0|||
145350202|NCT04176250|524129260|FG005|Overall Study|Adverse Event|1|||
145414923|NCT03670628|524372330|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
145414924|NCT02063724|524372331|FG000|Overall Study|Disease progression|1|||
145414925|NCT01068249|524372336|FG000|Overall Study|Death|1|||
145414926|NCT01068249|524372336|FG000|Overall Study|Withdrawal by Subject|3|||
145414927|NCT04337021|524372342|FG000|Overall Study|Lost to Follow-up|54|||
145414928|NCT04337021|524372343|FG001|Overall Study|Lost to Follow-up|66|||
145414929|NCT01397747|524372352|FG000|Overall Study|Multitarget DNA test excluded|689|||
145414930|NCT01397747|524372352|FG000|Overall Study|Colonoscopy excluded|304|||
145414931|NCT01397747|524372352|FG000|Overall Study|FIT excluded|34|||
145414932|NCT03828383|524372355|FG000|Overall Study|Lost to Follow-up|3|||
145414933|NCT03828383|524372356|FG001|Overall Study|Lost to Follow-up|2|||
145414934|NCT03828383|524372355|FG000|Overall Study|Withdrawal by Subject|4|||
145414935|NCT03828383|524372356|FG001|Overall Study|Withdrawal by Subject|5|||
145414936|NCT00504309|524372357|FG000|Overall Study|Death|0|||
145414937|NCT00504309|524372358|FG001|Overall Study|Death|0|||
145414938|NCT00504309|524372359|FG002|Overall Study|Death|0|||
145414939|NCT00504309|524372360|FG003|Overall Study|Death|0|||
145414940|NCT00504309|524372361|FG004|Overall Study|Death|1|||
145414941|NCT00504309|524372362|FG005|Overall Study|Death|0|||
145414942|NCT00504309|524372357|FG000|Overall Study|Withdrawal by Subject|0|||
145414943|NCT00504309|524372358|FG001|Overall Study|Withdrawal by Subject|0|||
145414944|NCT00504309|524372359|FG002|Overall Study|Withdrawal by Subject|1|||
145414945|NCT00504309|524372360|FG003|Overall Study|Withdrawal by Subject|0|||
145414946|NCT00504309|524372361|FG004|Overall Study|Withdrawal by Subject|0|||
145414947|NCT00504309|524372362|FG005|Overall Study|Withdrawal by Subject|0|||
145414948|NCT03345095|524372364|FG000|Overall Study|Lack of Efficacy|184|||
145414949|NCT03345095|524372365|FG001|Overall Study|Lack of Efficacy|156|||
145414950|NCT03345095|524372364|FG000|Overall Study|Adverse Event|36|||
145414951|NCT03345095|524372365|FG001|Overall Study|Adverse Event|118|||
145414952|NCT03345095|524372364|FG000|Overall Study|Withdrawal by Subject|22|||
145414953|NCT03345095|524372365|FG001|Overall Study|Withdrawal by Subject|59|||
145414954|NCT03345095|524372364|FG000|Overall Study|Physician Decision|3|||
145414955|NCT03345095|524372365|FG001|Overall Study|Physician Decision|18|||
145414956|NCT03345095|524372364|FG000|Overall Study|Death|2|||
145414957|NCT03345095|524372365|FG001|Overall Study|Death|4|||
145414958|NCT03345095|524372364|FG000|Overall Study|Other reasons|2|||
145414959|NCT03345095|524372365|FG001|Overall Study|Other reasons|11|||
145414960|NCT03345095|524372364|FG000|Overall Study|Protocol Violation|0|||
145414961|NCT03345095|524372365|FG001|Overall Study|Protocol Violation|1|||
145414962|NCT01121575|524372366|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
145414963|NCT01121575|524372367|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
145414964|NCT01121575|524372368|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
145414965|NCT01121575|524372369|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
145414966|NCT01121575|524372370|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
145414967|NCT01121575|524372371|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
145414968|NCT01121575|524372366|FG000|Overall Study|Unspecified Reasons|8|||
145414969|NCT01121575|524372367|FG001|Overall Study|Unspecified Reasons|6|||
145414970|NCT01121575|524372368|FG002|Overall Study|Unspecified Reasons|7|||
145414971|NCT01121575|524372369|FG003|Overall Study|Unspecified Reasons|5|||
145577191|NCT00779766|524968003|FG001|Month 48|Migrated/moved from study area|75|||
145350203|NCT04176250|524129255|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145414972|NCT01121575|524372370|FG004|Overall Study|Unspecified Reasons|13|||
145414973|NCT01121575|524372371|FG005|Overall Study|Unspecified Reasons|10|||
145414974|NCT01121575|524372366|FG000|Overall Study|Death|6|||
145414975|NCT01121575|524372367|FG001|Overall Study|Death|0|||
145414976|NCT01121575|524372368|FG002|Overall Study|Death|0|||
145414977|NCT01121575|524372369|FG003|Overall Study|Death|1|||
145414978|NCT01121575|524372370|FG004|Overall Study|Death|7|||
145414979|NCT01121575|524372371|FG005|Overall Study|Death|1|||
145414980|NCT03158311|524372372|FG000|Overall Study|Subject/Guardian Decision|10|||
145577192|NCT00779766|524968002|FG000|Month 48|Lost to Follow-up|29|||
145577193|NCT00779766|524968003|FG001|Month 48|Lost to Follow-up|30|||
145414981|NCT03158311|524372373|FG001|Overall Study|Subject/Guardian Decision|6|||
145414982|NCT03158311|524372374|FG002|Overall Study|Subject/Guardian Decision|11|||
145414983|NCT03158311|524372372|FG000|Overall Study|Adverse Event|5|||
145414984|NCT03158311|524372373|FG001|Overall Study|Adverse Event|3|||
145414985|NCT03158311|524372374|FG002|Overall Study|Adverse Event|3|||
145414986|NCT03158311|524372372|FG000|Overall Study|Techinical Problems|3|||
145414987|NCT03158311|524372373|FG001|Overall Study|Techinical Problems|1|||
145414988|NCT03158311|524372374|FG002|Overall Study|Techinical Problems|5|||
145414989|NCT03158311|524372372|FG000|Overall Study|Physician Decision|2|||
145414990|NCT03158311|524372373|FG001|Overall Study|Physician Decision|3|||
145414991|NCT03158311|524372374|FG002|Overall Study|Physician Decision|7|||
145414992|NCT03158311|524372372|FG000|Overall Study|Lost to Follow-up|1|||
145414993|NCT03158311|524372373|FG001|Overall Study|Lost to Follow-up|1|||
145414994|NCT03158311|524372374|FG002|Overall Study|Lost to Follow-up|1|||
145414995|NCT03158311|524372372|FG000|Overall Study|Sponsor decision|1|||
145414996|NCT03158311|524372373|FG001|Overall Study|Sponsor decision|0|||
145414997|NCT03158311|524372374|FG002|Overall Study|Sponsor decision|0|||
145414998|NCT03158311|524372372|FG000|Overall Study|Pregnancy|0|||
145414999|NCT03158311|524372373|FG001|Overall Study|Pregnancy|2|||
145415000|NCT03158311|524372374|FG002|Overall Study|Pregnancy|0|||
145415001|NCT03158311|524372372|FG000|Overall Study|Randomized in error|0|||
145415002|NCT03158311|524372373|FG001|Overall Study|Randomized in error|0|||
145415003|NCT03158311|524372374|FG002|Overall Study|Randomized in error|1|||
145415004|NCT02665455|524372375|FG000|Overall Study|Withdrawal by Subject|6|||
145415005|NCT02665455|524372375|FG000|Overall Study|Lost to Follow-up|1|||
145415006|NCT02665455|524372375|FG000|Overall Study|Adverse Event|1|||
145415007|NCT02665455|524372375|FG000|Overall Study|Protocol Violation|1|||
145415008|NCT05865886|524372386|FG000|Overall Study|Serious adverse event|0|||
145415009|NCT05865886|524372387|FG001|Overall Study|Serious adverse event|1|||
145415010|NCT00504231|524374190|FG000|Overall Study|Discrepant chart documentation re route|0|||
145415011|NCT00504231|524374191|FG001|Overall Study|Discrepant chart documentation re route|0|||
145415012|NCT00504231|524374192|FG002|Overall Study|Discrepant chart documentation re route|1|||
145415013|NCT00504231|524374193|FG003|Overall Study|Discrepant chart documentation re route|0|||
145415014|NCT01105130|524374194|FG000|Overall Study|Withdrawal by Subject|4|||
145415015|NCT01105130|524374195|FG001|Overall Study|Withdrawal by Subject|6|||
145415016|NCT01105130|524374196|FG002|Overall Study|Withdrawal by Subject|2|||
145415017|NCT01105130|524374194|FG000|Overall Study|Never Started|2|||
145415018|NCT01105130|524374195|FG001|Overall Study|Never Started|2|||
145415019|NCT01105130|524374196|FG002|Overall Study|Never Started|4|||
145415020|NCT01105130|524374194|FG000|Overall Study|Toxicity|1|||
145415021|NCT01105130|524374195|FG001|Overall Study|Toxicity|3|||
145415022|NCT01105130|524374196|FG002|Overall Study|Toxicity|2|||
145415023|NCT01105130|524374194|FG000|Overall Study|Multiple Reasons|3|||
145415024|NCT01105130|524374195|FG001|Overall Study|Multiple Reasons|0|||
145415025|NCT01105130|524374196|FG002|Overall Study|Multiple Reasons|2|||
145415026|NCT00327171|524374197|FG000|Overall Study|Did not receive study medication|3|||
145415027|NCT00327171|524374198|FG001|Overall Study|Did not receive study medication|0|||
145415028|NCT00327171|524374197|FG000|Overall Study|Adverse Event|23|||
145415029|NCT00327171|524374198|FG001|Overall Study|Adverse Event|23|||
145415030|NCT00327171|524374197|FG000|Overall Study|Disease progression/lack of efficacy|68|||
145415031|NCT00327171|524374198|FG001|Overall Study|Disease progression/lack of efficacy|69|||
145415032|NCT00327171|524374197|FG000|Overall Study|Investigator/participant request|1|||
145415033|NCT00327171|524374198|FG001|Overall Study|Investigator/participant request|8|||
145415034|NCT00327171|524374197|FG000|Overall Study|Clinical progression|12|||
145415035|NCT00327171|524374198|FG001|Overall Study|Clinical progression|8|||
145415036|NCT00327171|524374197|FG000|Overall Study|Undisclosed history of ischemia|0|||
145415037|NCT00327171|524374198|FG001|Overall Study|Undisclosed history of ischemia|1|||
145415038|NCT00327171|524374197|FG000|Overall Study|Other|1|||
145415039|NCT00327171|524374198|FG001|Overall Study|Other|0|||
145415040|NCT02323334|524374199|FG000|Period 3|Lost to Follow-up|0|||
145577194|NCT00779766|524968002|FG000|Month 48|Other|1|||
145577195|NCT00779766|524968003|FG001|Month 48|Other|0|||
145415041|NCT02323334|524374200|FG001|Period 3|Lost to Follow-up|0|||
145415042|NCT02323334|524374201|FG002|Period 3|Lost to Follow-up|1|||
145415043|NCT02323334|524374202|FG003|Period 3|Lost to Follow-up|0|||
145415044|NCT02323334|524374203|FG004|Period 3|Lost to Follow-up|0|||
145415045|NCT02323334|524374204|FG005|Period 3|Lost to Follow-up|0|||
145577196|NCT00779766|524968002|FG000|Month 72|Withdrawal by Subject|55|||
145415046|NCT02323334|524374205|FG006|Period 3|Lost to Follow-up|0|||
145415047|NCT02323334|524374206|FG007|Period 3|Lost to Follow-up|0|||
145415048|NCT02323334|524374207|FG008|Period 3|Lost to Follow-up|0|||
145415049|NCT02323334|524374208|FG009|Period 3|Lost to Follow-up|0|||
145415050|NCT02323334|524374209|FG010|Period 3|Lost to Follow-up|0|||
145415051|NCT02323334|524374210|FG011|Period 3|Lost to Follow-up|0|||
145415052|NCT02323334|524374211|FG012|Period 3|Lost to Follow-up|0|||
145415053|NCT02323334|524374212|FG013|Period 3|Lost to Follow-up|0|||
145415054|NCT02323334|524374213|FG014|Period 3|Lost to Follow-up|0|||
145577197|NCT00779766|524968003|FG001|Month 72|Withdrawal by Subject|71|||
145577198|NCT00779766|524968002|FG000|Month 72|Migrated/moved from study area|124|||
145415055|NCT02323334|524374214|FG015|Period 3|Lost to Follow-up|0|||
145415056|NCT02323334|524374215|FG016|Period 3|Lost to Follow-up|0|||
145415057|NCT02323334|524374199|FG000|Period 3|Withdrawal by Subject|1|||
145415058|NCT02323334|524374200|FG001|Period 3|Withdrawal by Subject|0|||
145415059|NCT02323334|524374201|FG002|Period 3|Withdrawal by Subject|0|||
145415060|NCT02323334|524374202|FG003|Period 3|Withdrawal by Subject|0|||
145415061|NCT02323334|524374203|FG004|Period 3|Withdrawal by Subject|0|||
145415062|NCT02323334|524374204|FG005|Period 3|Withdrawal by Subject|0|||
145415063|NCT02323334|524374205|FG006|Period 3|Withdrawal by Subject|0|||
145415064|NCT02323334|524374206|FG007|Period 3|Withdrawal by Subject|0|||
145415065|NCT02323334|524374207|FG008|Period 3|Withdrawal by Subject|0|||
145415066|NCT02323334|524374208|FG009|Period 3|Withdrawal by Subject|0|||
145415067|NCT02323334|524374209|FG010|Period 3|Withdrawal by Subject|0|||
145415068|NCT02323334|524374210|FG011|Period 3|Withdrawal by Subject|0|||
145415069|NCT02323334|524374211|FG012|Period 3|Withdrawal by Subject|0|||
145415070|NCT02323334|524374212|FG013|Period 3|Withdrawal by Subject|0|||
145415071|NCT02323334|524374213|FG014|Period 3|Withdrawal by Subject|0|||
145415072|NCT02323334|524374214|FG015|Period 3|Withdrawal by Subject|0|||
145415073|NCT02323334|524374215|FG016|Period 3|Withdrawal by Subject|0|||
145350204|NCT04176250|524129256|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145350205|NCT04176250|524129257|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
145350206|NCT04176250|524129258|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
145350207|NCT04176250|524129259|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145350208|NCT04176250|524129260|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
145350209|NCT04176250|524129255|FG000|Overall Study|Withdrawal by Subject|0|||
145350210|NCT04176250|524129256|FG001|Overall Study|Withdrawal by Subject|0|||
145350211|NCT04176250|524129257|FG002|Overall Study|Withdrawal by Subject|0|||
145350212|NCT04176250|524129258|FG003|Overall Study|Withdrawal by Subject|0|||
145350213|NCT04176250|524129259|FG004|Overall Study|Withdrawal by Subject|0|||
145350214|NCT04176250|524129260|FG005|Overall Study|Withdrawal by Subject|1|||
145350215|NCT04176250|524129255|FG000|Overall Study|Randomized in error|0|||
145350216|NCT04176250|524129256|FG001|Overall Study|Randomized in error|0|||
145350217|NCT04176250|524129257|FG002|Overall Study|Randomized in error|0|||
145350218|NCT04176250|524129258|FG003|Overall Study|Randomized in error|0|||
145350219|NCT04176250|524129259|FG004|Overall Study|Randomized in error|1|||
145350220|NCT04176250|524129260|FG005|Overall Study|Randomized in error|0|||
145350221|NCT00276484|524129261|FG000|Overall Study|Adverse Event|4|||
145350222|NCT00276484|524129262|FG001|Overall Study|Adverse Event|7|||
145350223|NCT00276484|524129261|FG000|Overall Study|Lost to Follow-up|1|||
145350224|NCT00276484|524129262|FG001|Overall Study|Lost to Follow-up|1|||
145350225|NCT00276484|524129261|FG000|Overall Study|Protocol Violation|0|||
145350226|NCT00276484|524129262|FG001|Overall Study|Protocol Violation|1|||
145350227|NCT00276484|524129261|FG000|Overall Study|Withdrawal by Subject|4|||
145350228|NCT00276484|524129262|FG001|Overall Study|Withdrawal by Subject|3|||
145350229|NCT00276484|524129261|FG000|Overall Study|Could not take time off work|0|||
145350230|NCT00276484|524129262|FG001|Overall Study|Could not take time off work|1|||
145350231|NCT02790437|524129279|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
145350232|NCT02790437|524129280|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
145350233|NCT02790437|524129279|FG000|Overall Study|Adverse Event|1|||
145350234|NCT02790437|524129280|FG001|Overall Study|Adverse Event|0|||
145350235|NCT02790437|524129279|FG000|Overall Study|Withdrawal by Subject|1|||
145350236|NCT02790437|524129280|FG001|Overall Study|Withdrawal by Subject|0|||
145350237|NCT01125189|524129281|FG000|Treatment Period|Lack of Efficacy|15|||
145350238|NCT01125189|524129282|FG001|Treatment Period|Lack of Efficacy|18|||
145350239|NCT01125189|524129283|FG002|Treatment Period|Lack of Efficacy|25|||
145350240|NCT01125189|524129281|FG000|Treatment Period|Adverse Event|7|||
145350241|NCT01125189|524129282|FG001|Treatment Period|Adverse Event|8|||
145350242|NCT01125189|524129283|FG002|Treatment Period|Adverse Event|8|||
145350243|NCT01125189|524129281|FG000|Treatment Period|Withdrawal by Subject|3|||
145350244|NCT01125189|524129282|FG001|Treatment Period|Withdrawal by Subject|1|||
145350245|NCT01125189|524129283|FG002|Treatment Period|Withdrawal by Subject|1|||
145350246|NCT01125189|524129281|FG000|Treatment Period|Death|1|||
145350247|NCT01125189|524129282|FG001|Treatment Period|Death|0|||
145350248|NCT01125189|524129283|FG002|Treatment Period|Death|0|||
145350249|NCT01125189|524129281|FG000|Treatment Period|Lost to Follow-up|1|||
145350250|NCT01125189|524129282|FG001|Treatment Period|Lost to Follow-up|2|||
145350251|NCT01125189|524129283|FG002|Treatment Period|Lost to Follow-up|1|||
145350252|NCT01125189|524129281|FG000|Treatment Period|Poor compliance/noncompliance|0|||
145350253|NCT01125189|524129282|FG001|Treatment Period|Poor compliance/noncompliance|1|||
145350254|NCT01125189|524129283|FG002|Treatment Period|Poor compliance/noncompliance|0|||
145350255|NCT01125189|524129281|FG000|Treatment Period|Participants requested to discontinue|1|||
145415074|NCT00530075|524374216|FG000|Overall Study|Adverse Event|1|||
145415075|NCT00530075|524374216|FG000|Overall Study|Death|1|||
145415076|NCT00530075|524374216|FG000|Overall Study|Lack of Efficacy|3|||
145415077|NCT00530075|524374216|FG000|Overall Study|Protocol Violation|1|||
145415078|NCT00530075|524374216|FG000|Overall Study|Withdrawal by Subject|1|||
145415079|NCT03422718|524374217|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
145415080|NCT03422718|524374218|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
145415081|NCT03422718|524374219|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
145415082|NCT03422718|524374220|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
145415083|NCT03422718|524374221|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
145415084|NCT03422718|524374222|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
145415085|NCT03422718|524374223|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
145415086|NCT03422718|524374224|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
145415087|NCT03422718|524374217|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
145415088|NCT03422718|524374218|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
145415089|NCT03422718|524374219|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
145415090|NCT03422718|524374220|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
145415091|NCT03422718|524374221|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
145415092|NCT03422718|524374222|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
145415093|NCT03422718|524374223|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
145415094|NCT03422718|524374224|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
145415095|NCT03422718|524374217|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
145415096|NCT03422718|524374218|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
145415097|NCT03422718|524374219|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
145415098|NCT03422718|524374220|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145415099|NCT03422718|524374221|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
145415100|NCT03422718|524374222|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145415101|NCT03422718|524374223|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
145415102|NCT03422718|524374224|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
145415103|NCT03422718|524374217|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145415104|NCT03422718|524374218|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
145415105|NCT03422718|524374219|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145350256|NCT01125189|524129282|FG001|Treatment Period|Participants requested to discontinue|3|||
145350257|NCT01125189|524129283|FG002|Treatment Period|Participants requested to discontinue|4|||
145350258|NCT01125189|524129281|FG000|Treatment Period|Other reasons|1|||
145350259|NCT01125189|524129282|FG001|Treatment Period|Other reasons|1|||
145350260|NCT01125189|524129283|FG002|Treatment Period|Other reasons|0|||
145350261|NCT01125189|524129281|FG000|Treatment Period|Completed 24 week treatment period only|2|||
145350262|NCT01125189|524129282|FG001|Treatment Period|Completed 24 week treatment period only|1|||
145350263|NCT01125189|524129283|FG002|Treatment Period|Completed 24 week treatment period only|2|||
145350264|NCT01125189|524129281|FG000|Follow up Period|Withdrawal by Subject|3|||
145350265|NCT01125189|524129282|FG001|Follow up Period|Withdrawal by Subject|2|||
145415106|NCT03422718|524374220|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145415107|NCT03422718|524374221|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
145415108|NCT03422718|524374222|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
145415109|NCT03422718|524374223|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145415110|NCT03422718|524374224|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
145415111|NCT03422718|524374217|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
145415112|NCT03422718|524374218|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
145415113|NCT03422718|524374219|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
145415114|NCT03422718|524374220|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
145415115|NCT03422718|524374221|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
145415116|NCT03422718|524374222|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
145415117|NCT03422718|524374223|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
145415118|NCT03422718|524374224|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
145415119|NCT03422718|524374217|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
145415120|NCT03422718|524374218|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
145415121|NCT03422718|524374219|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
145415122|NCT03422718|524374220|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
145415123|NCT03422718|524374221|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
145415124|NCT03422718|524374222|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
145415125|NCT03422718|524374223|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
145415126|NCT03422718|524374224|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
145415127|NCT03309605|524374225|FG000|Overall Study|Adverse Event|0|||
145415128|NCT03309605|524374226|FG001|Overall Study|Adverse Event|0|||
145415129|NCT03309605|524374227|FG002|Overall Study|Adverse Event|0|||
145415130|NCT03309605|524374228|FG003|Overall Study|Adverse Event|1|||
145415131|NCT03309605|524374229|FG004|Overall Study|Adverse Event|0|||
145415132|NCT03309605|524374230|FG005|Overall Study|Adverse Event|0|||
145622905|NCT01606189|525130234|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
145350266|NCT01125189|524129283|FG002|Follow up Period|Withdrawal by Subject|5|||
145350267|NCT01125189|524129281|FG000|Follow up Period|Death|1|||
145350268|NCT01125189|524129282|FG001|Follow up Period|Death|0|||
145350269|NCT01125189|524129283|FG002|Follow up Period|Death|0|||
145350270|NCT01125189|524129281|FG000|Follow up Period|Lost to Follow-up|12|||
145350271|NCT01125189|524129282|FG001|Follow up Period|Lost to Follow-up|9|||
145350272|NCT01125189|524129283|FG002|Follow up Period|Lost to Follow-up|6|||
145350273|NCT01125189|524129281|FG000|Follow up Period|Other reasons|4|||
145350274|NCT01125189|524129282|FG001|Follow up Period|Other reasons|4|||
145350275|NCT01125189|524129283|FG002|Follow up Period|Other reasons|5|||
145350276|NCT00856193|524129285|FG000|Period 2|Abnormal test procedure results|0|||
145350277|NCT00856193|524129286|FG001|Period 2|Abnormal test procedure results|1|||
145350278|NCT00856193|524129285|FG000|Period 2|Lost to Follow-up|0|||
145350279|NCT00856193|524129286|FG001|Period 2|Lost to Follow-up|1|||
145350280|NCT03885661|524129287|FG000|Overall Study|Withdrawal by Subject|0|||
145415133|NCT03309605|524374231|FG006|Overall Study|Adverse Event|2|||
145415134|NCT03309605|524374232|FG007|Overall Study|Adverse Event|1|||
145415135|NCT03309605|524374225|FG000|Overall Study|Withdrawal by Subject|0|||
145415136|NCT03309605|524374226|FG001|Overall Study|Withdrawal by Subject|0|||
145415137|NCT03309605|524374227|FG002|Overall Study|Withdrawal by Subject|0|||
145415138|NCT03309605|524374228|FG003|Overall Study|Withdrawal by Subject|0|||
145415139|NCT03309605|524374229|FG004|Overall Study|Withdrawal by Subject|1|||
145415140|NCT03309605|524374230|FG005|Overall Study|Withdrawal by Subject|0|||
145415141|NCT03309605|524374231|FG006|Overall Study|Withdrawal by Subject|1|||
145415142|NCT03309605|524374232|FG007|Overall Study|Withdrawal by Subject|1|||
145415143|NCT01129284|524374233|FG000|Overall Study|Adverse Event|2|||
145415144|NCT01129284|524374234|FG001|Overall Study|Adverse Event|0|||
145415145|NCT01129284|524374235|FG002|Overall Study|Adverse Event|1|||
145415146|NCT00784927|524374238|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
145415147|NCT00784927|524374238|FG000|Overall Study|Protocol Violation|1|||
145415148|NCT00784927|524374238|FG000|Overall Study|Ineligible|1|||
145415149|NCT00422461|524374246|FG000|Overall Study|Adverse Event|1|||
145415150|NCT00422461|524374247|FG001|Overall Study|Adverse Event|2|||
145415151|NCT00422461|524374248|FG002|Overall Study|Adverse Event|1|||
145415152|NCT00422461|524374249|FG003|Overall Study|Adverse Event|1|||
145415153|NCT00422461|524374246|FG000|Overall Study|Other|0|||
145415154|NCT00422461|524374247|FG001|Overall Study|Other|0|||
145415155|NCT00422461|524374248|FG002|Overall Study|Other|0|||
145415156|NCT00422461|524374249|FG003|Overall Study|Other|2|||
145415157|NCT00422461|524374246|FG000|Overall Study|Participants no longer willing to participate in study|1|||
145415158|NCT00422461|524374247|FG001|Overall Study|Participants no longer willing to participate in study|0|||
145415159|NCT00422461|524374248|FG002|Overall Study|Participants no longer willing to participate in study|0|||
145415160|NCT00422461|524374249|FG003|Overall Study|Participants no longer willing to participate in study|0|||
145415161|NCT00422461|524374246|FG000|Overall Study|Randomized but not treated|1|||
145415162|NCT00422461|524374247|FG001|Overall Study|Randomized but not treated|1|||
145415163|NCT00422461|524374248|FG002|Overall Study|Randomized but not treated|0|||
145415164|NCT00422461|524374249|FG003|Overall Study|Randomized but not treated|0|||
145415165|NCT01795937|524374250|FG000|Overall Study|Withdrawal by Subject|1|||
145415166|NCT01795937|524374251|FG001|Overall Study|Withdrawal by Subject|0|||
145415167|NCT01795937|524374252|FG002|Overall Study|Withdrawal by Subject|0|||
145415168|NCT01795937|524374250|FG000|Overall Study|Physician Decision|0|||
145415169|NCT01795937|524374251|FG001|Overall Study|Physician Decision|1|||
145415170|NCT01795937|524374252|FG002|Overall Study|Physician Decision|0|||
145415171|NCT00245570|524374258|FG000|Washout Between Periods III and IV|Adverse Event|0|||
145415172|NCT00245570|524374259|FG001|Washout Between Periods III and IV|Adverse Event|1|||
145415173|NCT00245570|524374260|FG002|Washout Between Periods III and IV|Adverse Event|0|||
145415174|NCT00245570|524374261|FG003|Washout Between Periods III and IV|Adverse Event|0|||
145415175|NCT00245570|524374262|FG004|Washout Between Periods III and IV|Adverse Event|0|||
145415176|NCT00245570|524374263|FG005|Washout Between Periods III and IV|Adverse Event|0|||
145415177|NCT01913470|524374264|FG000|Overall Study|Lost to Follow-up|0|||
145415178|NCT01913470|524374265|FG001|Overall Study|Lost to Follow-up|1|||
145415179|NCT01913470|524374264|FG000|Overall Study|Physician Decision|0|||
145415180|NCT01913470|524374265|FG001|Overall Study|Physician Decision|1|||
145415181|NCT01913470|524374264|FG000|Overall Study|Withdrawal by Subject|0|||
145415182|NCT01913470|524374265|FG001|Overall Study|Withdrawal by Subject|1|||
145415183|NCT02384460|524374285|FG000|Overall Study|Protocol Violation|0|||
145415184|NCT02384460|524374286|FG001|Overall Study|Protocol Violation|1|||
145415185|NCT02384460|524374285|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
145415186|NCT02384460|524374286|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
145415187|NCT02384460|524374285|FG000|Overall Study|Adverse Event|5|||
145415188|NCT02384460|524374286|FG001|Overall Study|Adverse Event|2|||
145415189|NCT02384460|524374285|FG000|Overall Study|Withdrawal by Subject|0|||
145415190|NCT02384460|524374286|FG001|Overall Study|Withdrawal by Subject|3|||
145415191|NCT02384460|524374285|FG000|Overall Study|Elective medical treatment|1|||
145415192|NCT02384460|524374286|FG001|Overall Study|Elective medical treatment|0|||
145415193|NCT02384460|524374285|FG000|Overall Study|Non-compliance|1|||
145350281|NCT03885661|524129288|FG001|Overall Study|Withdrawal by Subject|1|||
145350282|NCT03885661|524129287|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
145350283|NCT03885661|524129288|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
145350284|NCT02232984|524129289|FG000|Overall Study|Withdrawal by Subject|5|||
145350285|NCT02232984|524129289|FG000|Overall Study|Death|1|||
145350286|NCT02232984|524129289|FG000|Overall Study|Investigator withdrawal|10|||
145350287|NCT02232984|524129289|FG000|Overall Study|Device implant unsuccessful|53|||
145350288|NCT02232984|524129289|FG000|Overall Study|not disclosed by site|7|||
145350289|NCT02232984|524129289|FG000|Overall Study|Protocol Violation|1|||
145350290|NCT00769379|524129292|FG000|Overall Study|No follow up data mapped to Other.|3|||
145350291|NCT00769379|524129293|FG001|Overall Study|No follow up data mapped to Other.|13|||
145350292|NCT02286843|524129298|FG000|Overall Study|Not Treated|4|||
145350293|NCT02286843|524129298|FG000|Overall Study|Protocol Violation|1|||
145350294|NCT02286843|524129298|FG000|Overall Study|Withdrawal by Subject|1|||
145350295|NCT00952731|524129305|FG000|Overall Study|Drug supply expired|1|||
145350296|NCT00952731|524129306|FG001|Overall Study|Drug supply expired|0|||
145350297|NCT01184079|524129307|FG000|Overall Study|Lost to Follow-up|14|||
145350298|NCT01184079|524129308|FG001|Overall Study|Lost to Follow-up|2|||
145350299|NCT04233073|524129309|FG000|Overall Study|Death|5|||
145350300|NCT00041132|524129310|FG000|Overall Study|Adverse Event|19|||
145350301|NCT00041132|524129310|FG000|Overall Study|Death|1|||
145350302|NCT00041132|524129310|FG000|Overall Study|Not Eligible|7|||
145350303|NCT00041132|524129310|FG000|Overall Study|Withdrawal by Subject|1|||
145350304|NCT00041132|524129310|FG000|Overall Study|Physician Decision|2|||
145350305|NCT00995774|524129315|FG000|Training Period 2|Withdrawal by Subject|2|||
145350306|NCT00995774|524129316|FG001|Training Period 2|Withdrawal by Subject|0|||
145350307|NCT01808573|524129317|FG000|Overall Study|Death|212|||
145350308|NCT01808573|524129318|FG001|Overall Study|Death|240|||
145350309|NCT01808573|524129317|FG000|Overall Study|Withdrawal by Subject|12|||
145350310|NCT01808573|524129318|FG001|Overall Study|Withdrawal by Subject|10|||
145350311|NCT01808573|524129317|FG000|Overall Study|Lost to Follow-up|3|||
145350312|NCT01808573|524129318|FG001|Overall Study|Lost to Follow-up|0|||
145350313|NCT01808573|524129317|FG000|Overall Study|Discontinuation of study by sponsor|79|||
145350314|NCT01808573|524129318|FG001|Overall Study|Discontinuation of study by sponsor|64|||
145350315|NCT01808573|524129317|FG000|Overall Study|Randomized in Error|1|||
145350316|NCT01808573|524129318|FG001|Overall Study|Randomized in Error|0|||
145350317|NCT01523002|524129321|FG000|Period 1|Withdrawal by Subject|1|||
145350318|NCT01523002|524129322|FG001|Period 1|Withdrawal by Subject|3|||
145350319|NCT01523002|524129321|FG000|Period 1|Lost to Follow-up|1|||
145350320|NCT01523002|524129322|FG001|Period 1|Lost to Follow-up|0|||
145350321|NCT01523002|524129321|FG000|Period 1|Adverse Event|0|||
145350322|NCT01523002|524129322|FG001|Period 1|Adverse Event|8|||
145350323|NCT01523002|524129321|FG000|Period 2|Withdrawal by Subject|4|||
145350324|NCT01523002|524129322|FG001|Period 2|Withdrawal by Subject|1|||
145350325|NCT01523002|524129321|FG000|Period 2|Adverse Event|2|||
145350326|NCT01523002|524129322|FG001|Period 2|Adverse Event|5|||
145350327|NCT01523002|524129321|FG000|Period 3|Withdrawal by Subject|1|||
145350328|NCT01523002|524129322|FG001|Period 3|Withdrawal by Subject|0|||
145350329|NCT01523002|524129321|FG000|Period 3|Adverse Event|3|||
145350330|NCT01523002|524129322|FG001|Period 3|Adverse Event|0|||
145350331|NCT01256502|524129323|FG000|Overall Study|Had scaffold removed|4|||
145350332|NCT01256502|524129323|FG000|Overall Study|Personal reasons|5|||
145350333|NCT01256502|524129323|FG000|Overall Study|Protocol deviation|1|||
145350334|NCT00489255|524129324|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
145350335|NCT00489255|524129325|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
145350336|NCT00489255|524129324|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
145350337|NCT00489255|524129325|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
145350338|NCT00489255|524129324|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
145350339|NCT00489255|524129325|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
145350340|NCT00489255|524129324|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
145350341|NCT00489255|524129325|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
145350342|NCT00489255|524129324|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
145350343|NCT00489255|524129325|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
145350344|NCT00489255|524129324|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
145415194|NCT02384460|524374286|FG001|Overall Study|Non-compliance|0|||
145350345|NCT00489255|524129325|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
145350346|NCT00489255|524129324|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
145622906|NCT01606189|525130235|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
145350347|NCT00489255|524129325|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
145350348|NCT00489255|524129324|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
145350349|NCT00489255|524129325|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
145350350|NCT00489255|524129324|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
145350351|NCT00489255|524129325|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
145415195|NCT01060111|524374287|FG000|Overall Study|Adverse Event|9|||
145350352|NCT00489255|524129324|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
145350353|NCT00489255|524129325|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
145350354|NCT03953612|524129326|FG000|Overall Study|Randomized but did not start|1|||
145577199|NCT00779766|524968003|FG001|Month 72|Migrated/moved from study area|109|||
145577200|NCT00779766|524968002|FG000|Month 72|Lost to Follow-up|6|||
145577201|NCT00779766|524968003|FG001|Month 72|Lost to Follow-up|8|||
145577202|NCT00779766|524968002|FG000|Month 72|Other|0|||
145577203|NCT00779766|524968003|FG001|Month 72|Other|1|||
145350355|NCT03953612|524129327|FG001|Overall Study|Randomized but did not start|1|||
145350356|NCT03953612|524129328|FG002|Overall Study|Randomized but did not start|1|||
145350357|NCT03953612|524129326|FG000|Overall Study|Withdrawal by Subject|2|||
145350358|NCT03953612|524129327|FG001|Overall Study|Withdrawal by Subject|1|||
145350359|NCT03953612|524129328|FG002|Overall Study|Withdrawal by Subject|0|||
145350360|NCT03485352|524129329|FG000|Overall Study|Lost to Follow-up|9|||
145350361|NCT04779879|524129345|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145350362|NCT04779879|524129346|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145350363|NCT04779879|524129347|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145350364|NCT04779879|524129348|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
145350365|NCT04779879|524129349|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145350366|NCT04779879|524129350|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
145350367|NCT04779879|524129345|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
145350368|NCT04779879|524129346|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
145350369|NCT04779879|524129347|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
145350370|NCT04779879|524129348|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
145350371|NCT04779879|524129349|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
145350372|NCT04779879|524129350|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
145350373|NCT04779879|524129345|FG000|Part C: Up to Week 36|Death|0|||
145350374|NCT04779879|524129346|FG001|Part C: Up to Week 36|Death|0|||
145350375|NCT04779879|524129347|FG002|Part C: Up to Week 36|Death|0|||
145350376|NCT04779879|524129348|FG003|Part C: Up to Week 36|Death|0|||
145350377|NCT04779879|524129349|FG004|Part C: Up to Week 36|Death|0|||
145350378|NCT04779879|524129350|FG005|Part C: Up to Week 36|Death|1|||
145350379|NCT04779879|524129345|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
145350380|NCT04779879|524129346|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
145350381|NCT04779879|524129347|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
145350382|NCT04779879|524129348|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
145350383|NCT04779879|524129349|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
145350384|NCT04779879|524129350|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
145350385|NCT05101343|524129351|FG000|Overall Study|Withdrawal by Subject|2|||
145350386|NCT05101343|524129352|FG001|Overall Study|Withdrawal by Subject|1|||
145350387|NCT02854527|524129353|FG000|Overall Study|Adverse Event|0|||
145350388|NCT02854527|524129354|FG001|Overall Study|Adverse Event|0|||
145350389|NCT02854527|524129355|FG002|Overall Study|Adverse Event|0|||
145350390|NCT02854527|524129356|FG003|Overall Study|Adverse Event|0|||
145350391|NCT02854527|524129357|FG004|Overall Study|Adverse Event|1|||
145350392|NCT02854527|524129358|FG005|Overall Study|Adverse Event|0|||
145350393|NCT02854527|524129359|FG006|Overall Study|Adverse Event|0|||
145350394|NCT02854527|524129360|FG007|Overall Study|Adverse Event|0|||
145350395|NCT02854527|524129361|FG008|Overall Study|Adverse Event|0|||
145350396|NCT02854527|524129362|FG009|Overall Study|Adverse Event|0|||
145350397|NCT02854527|524129353|FG000|Overall Study|Lost to Follow-up|0|||
145350398|NCT02854527|524129354|FG001|Overall Study|Lost to Follow-up|0|||
145350399|NCT02854527|524129355|FG002|Overall Study|Lost to Follow-up|0|||
145350400|NCT02854527|524129356|FG003|Overall Study|Lost to Follow-up|1|||
145350401|NCT02854527|524129357|FG004|Overall Study|Lost to Follow-up|0|||
145350402|NCT02854527|524129358|FG005|Overall Study|Lost to Follow-up|0|||
145350403|NCT02854527|524129359|FG006|Overall Study|Lost to Follow-up|0|||
145350404|NCT02854527|524129360|FG007|Overall Study|Lost to Follow-up|0|||
145350405|NCT02854527|524129361|FG008|Overall Study|Lost to Follow-up|0|||
145350406|NCT02854527|524129362|FG009|Overall Study|Lost to Follow-up|0|||
145350407|NCT01682811|524129366|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350408|NCT01682811|524129367|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350409|NCT01682811|524129368|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350410|NCT01682811|524129369|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350411|NCT01682811|524129370|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
145350412|NCT01682811|524129371|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350413|NCT01682811|524129372|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
145350414|NCT01682811|524129366|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
145350415|NCT01682811|524129367|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
145350416|NCT01682811|524129368|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
145350417|NCT01682811|524129369|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
145350418|NCT01682811|524129370|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
145350419|NCT01682811|524129371|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
145350420|NCT01682811|524129372|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
145350421|NCT01682811|524129366|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
145350422|NCT01682811|524129367|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
145350423|NCT01682811|524129368|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
145577204|NCT01412424|524968006|FG000|Core Treatment Period|Treatment Failure|24|||
145415196|NCT01060111|524374288|FG001|Overall Study|Adverse Event|5|||
145415197|NCT01060111|524374289|FG002|Overall Study|Adverse Event|18|||
145415198|NCT01060111|524374287|FG000|Overall Study|Lack of Efficacy|2|||
145415199|NCT01060111|524374288|FG001|Overall Study|Lack of Efficacy|1|||
145415200|NCT01060111|524374289|FG002|Overall Study|Lack of Efficacy|0|||
145415201|NCT01060111|524374287|FG000|Overall Study|Inappropriate participant|5|||
145415202|NCT01060111|524374288|FG001|Overall Study|Inappropriate participant|4|||
145415203|NCT01060111|524374289|FG002|Overall Study|Inappropriate participant|5|||
145415204|NCT01060111|524374287|FG000|Overall Study|Participants' evasion for hospital visit|0|||
145415205|NCT01060111|524374288|FG001|Overall Study|Participants' evasion for hospital visit|3|||
145415206|NCT01060111|524374289|FG002|Overall Study|Participants' evasion for hospital visit|2|||
145415207|NCT01060111|524374287|FG000|Overall Study|Participants' non-cooperation|8|||
145415208|NCT01060111|524374288|FG001|Overall Study|Participants' non-cooperation|6|||
145415209|NCT01060111|524374289|FG002|Overall Study|Participants' non-cooperation|6|||
145415210|NCT01060111|524374287|FG000|Overall Study|Adverse event and insufficient effect|0|||
145415211|NCT01060111|524374288|FG001|Overall Study|Adverse event and insufficient effect|1|||
145415212|NCT01060111|524374289|FG002|Overall Study|Adverse event and insufficient effect|0|||
145415213|NCT01060111|524374287|FG000|Overall Study|Participants' non-cooperation|1|||
145415214|NCT01060111|524374288|FG001|Overall Study|Participants' non-cooperation|0|||
145415215|NCT01060111|524374289|FG002|Overall Study|Participants' non-cooperation|0|||
145415216|NCT01060111|524374287|FG000|Overall Study|Other|2|||
145415217|NCT01060111|524374288|FG001|Overall Study|Other|3|||
145415218|NCT01060111|524374289|FG002|Overall Study|Other|4|||
145415219|NCT01336972|524374295|FG000|Overall Study|Adverse Event|1|||
145415220|NCT01336972|524374296|FG001|Overall Study|Adverse Event|1|||
145415221|NCT01336972|524374297|FG002|Overall Study|Adverse Event|0|||
145415222|NCT02441114|524374298|FG000|Washout2|Withdrawal by Subject|4|||
145415223|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
145415224|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
145415225|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
145415226|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
145415227|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
145415228|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
145415229|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
145415230|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
145415231|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
145415232|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
145415233|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
145415234|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
145415235|NCT03446573|524374300|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
145415236|NCT03446573|524374301|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
145415237|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
145415238|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
145415239|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
145415240|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
145415241|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
145415242|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
145415243|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
145415244|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
145415245|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
145415246|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
145415247|NCT03446573|524374300|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
145415248|NCT03446573|524374301|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
145415249|NCT00625378|524374306|FG000|Overall Study|Adverse Event|22|||
145415250|NCT00625378|524374307|FG001|Overall Study|Adverse Event|0|||
145415251|NCT00625378|524374306|FG000|Overall Study|Withdrawal by Subject|16|||
145415252|NCT00625378|524374307|FG001|Overall Study|Withdrawal by Subject|0|||
145415253|NCT00625378|524374306|FG000|Overall Study|Death|38|||
145415254|NCT00625378|524374307|FG001|Overall Study|Death|0|||
145415255|NCT00625378|524374306|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
145415256|NCT00625378|524374307|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
145415257|NCT00625378|524374306|FG000|Overall Study|Lost to Follow-up|17|||
145415258|NCT00625378|524374307|FG001|Overall Study|Lost to Follow-up|0|||
145415259|NCT00625378|524374306|FG000|Overall Study|Non-compliant with study medication|3|||
145415260|NCT00625378|524374307|FG001|Overall Study|Non-compliant with study medication|0|||
145415261|NCT00625378|524374306|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
145415262|NCT00625378|524374307|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
145415263|NCT00625378|524374306|FG000|Overall Study|Medical decision|1|||
145415264|NCT00625378|524374307|FG001|Overall Study|Medical decision|0|||
145415265|NCT00625378|524374306|FG000|Overall Study|Multiple toxicities|1|||
145577205|NCT01412424|524968006|FG000|Core Treatment Period|Adverse Event|21|||
145577206|NCT01412424|524968006|FG000|Core Treatment Period|Patient Request|5|||
145350424|NCT01682811|524129369|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
145350425|NCT01682811|524129370|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
145350426|NCT01682811|524129371|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
145350427|NCT01682811|524129372|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
145350428|NCT01682811|524129366|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350429|NCT01682811|524129367|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350430|NCT01682811|524129368|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350431|NCT01682811|524129369|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350432|NCT01682811|524129370|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350433|NCT01682811|524129371|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
145350434|NCT01682811|524129372|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
145350435|NCT05126693|524131234|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
145350436|NCT05126693|524131235|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
145350437|NCT05126693|524131234|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
145350438|NCT05126693|524131235|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
145350439|NCT05126693|524131234|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
145350440|NCT05126693|524131235|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
145350441|NCT05878093|524131236|FG000|Overall Study|Withdrawal by Subject|3|||
145350442|NCT05878093|524131237|FG001|Overall Study|Withdrawal by Subject|1|||
145350443|NCT04100018|524131243|FG000|Pre-Treatment Period|Not Reported|0|||
145350444|NCT04100018|524131244|FG001|Pre-Treatment Period|Not Reported|4|||
145350445|NCT04100018|524131243|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
145350446|NCT04100018|524131244|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
145350447|NCT04100018|524131243|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
145350448|NCT04100018|524131244|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
145350449|NCT04100018|524131243|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
145350450|NCT04100018|524131244|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145350451|NCT04100018|524131243|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
145350452|NCT04100018|524131244|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
145350453|NCT04100018|524131243|FG000|Treatment Period|Ongoing Treatment|1|||
145350454|NCT04100018|524131244|FG001|Treatment Period|Ongoing Treatment|0|||
145350455|NCT04100018|524131243|FG000|Treatment Period|Other Reason|26|||
145350456|NCT04100018|524131244|FG001|Treatment Period|Other Reason|37|||
145350457|NCT04100018|524131243|FG000|Treatment Period|Completed treatment as per protocol|1|||
145350458|NCT04100018|524131244|FG001|Treatment Period|Completed treatment as per protocol|2|||
145350459|NCT04100018|524131243|FG000|Treatment Period|Maximum clinical benefit|3|||
145350460|NCT04100018|524131244|FG001|Treatment Period|Maximum clinical benefit|0|||
145350461|NCT04100018|524131243|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
145350462|NCT04100018|524131244|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
145350463|NCT04100018|524131243|FG000|Treatment Period|Study drug toxicity|67|||
145350464|NCT04100018|524131244|FG001|Treatment Period|Study drug toxicity|28|||
145350465|NCT04100018|524131243|FG000|Treatment Period|Disease Progression|284|||
145350466|NCT04100018|524131244|FG001|Treatment Period|Disease Progression|327|||
145350467|NCT04100018|524131243|FG000|Treatment Period|Administrative reasons by sponsor|16|||
145350468|NCT04100018|524131244|FG001|Treatment Period|Administrative reasons by sponsor|30|||
145350469|NCT04100018|524131243|FG000|Treatment Period|Poor/Non-Compliance|1|||
145350470|NCT04100018|524131244|FG001|Treatment Period|Poor/Non-Compliance|0|||
145350471|NCT04100018|524131243|FG000|Treatment Period|Lost to Follow-up|2|||
145350472|NCT04100018|524131244|FG001|Treatment Period|Lost to Follow-up|2|||
145350473|NCT04100018|524131243|FG000|Treatment Period|Death|16|||
145350474|NCT04100018|524131244|FG001|Treatment Period|Death|11|||
145350475|NCT04100018|524131243|FG000|Treatment Period|Participant withdrew consent|10|||
145350476|NCT04100018|524131244|FG001|Treatment Period|Participant withdrew consent|10|||
145350477|NCT04100018|524131243|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
145350478|NCT04100018|524131244|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
145350479|NCT04100018|524131243|FG000|Treatment Period|Adverse Event|14|||
145350480|NCT04100018|524131244|FG001|Treatment Period|Adverse Event|6|||
145350481|NCT04100018|524131243|FG000|Treatment Period|Lack of Efficacy|4|||
145350482|NCT04100018|524131244|FG001|Treatment Period|Lack of Efficacy|2|||
145350483|NCT00118157|524131248|FG000|Overall Study|Adverse Event|2|||
145350484|NCT00118157|524131248|FG000|Overall Study|Death|8|||
145350485|NCT00118157|524131248|FG000|Overall Study|Withdrawal by Subject|2|||
145350486|NCT05989672|524131249|FG000|Overall Study|Adverse Event|3|||
145350487|NCT05989672|524131250|FG001|Overall Study|Adverse Event|0|||
145350488|NCT05989672|524131251|FG002|Overall Study|Adverse Event|0|||
145350489|NCT00696423|524131252|FG000|Overall Study|Lost to Follow-up|0|||
145350490|NCT00696423|524131253|FG001|Overall Study|Lost to Follow-up|5|||
145350491|NCT03989102|524131254|FG000|Year 1|Withdrawal by Subject|6|||
145350492|NCT03989102|524131255|FG001|Year 1|Withdrawal by Subject|2|||
145350493|NCT03989102|524131256|FG002|Year 1|Withdrawal by Subject|7|||
145350494|NCT03989102|524131254|FG000|Year 1|Lost to Follow-up|5|||
145350495|NCT03989102|524131255|FG001|Year 1|Lost to Follow-up|2|||
145350496|NCT03989102|524131256|FG002|Year 1|Lost to Follow-up|5|||
145350497|NCT03989102|524131254|FG000|Year 1|Subject met withdrawal criteria|1|||
145350498|NCT03989102|524131255|FG001|Year 1|Subject met withdrawal criteria|0|||
145350499|NCT03989102|524131256|FG002|Year 1|Subject met withdrawal criteria|1|||
145350500|NCT03989102|524131254|FG000|Year 2|Lost to Follow-up|7|||
145350501|NCT03989102|524131255|FG001|Year 2|Lost to Follow-up|3|||
145350502|NCT03989102|524131256|FG002|Year 2|Lost to Follow-up|4|||
145350503|NCT03989102|524131254|FG000|Year 2|Withdrawal by Subject|3|||
145350504|NCT03989102|524131255|FG001|Year 2|Withdrawal by Subject|1|||
145350505|NCT03989102|524131256|FG002|Year 2|Withdrawal by Subject|2|||
145350506|NCT03989102|524131254|FG000|Year 2|Subject non-compliant|3|||
145350507|NCT03989102|524131255|FG001|Year 2|Subject non-compliant|2|||
145350508|NCT03989102|524131256|FG002|Year 2|Subject non-compliant|0|||
145350509|NCT03989102|524131254|FG000|Year 2|Travel|1|||
145350510|NCT03989102|524131255|FG001|Year 2|Travel|0|||
145350511|NCT03989102|524131256|FG002|Year 2|Travel|1|||
145350512|NCT03989102|524131254|FG000|Year 2|P16 missing|4|||
145350513|NCT03989102|524131255|FG001|Year 2|P16 missing|2|||
145350514|NCT03989102|524131256|FG002|Year 2|P16 missing|1|||
145350515|NCT03989102|524131254|FG000|Year 2|P11 missing|1|||
145350516|NCT03989102|524131255|FG001|Year 2|P11 missing|3|||
145350517|NCT03989102|524131256|FG002|Year 2|P11 missing|7|||
145350518|NCT03989102|524131254|FG000|Year 2|Definitive displacement outside the study site|0|||
145350519|NCT03989102|524131255|FG001|Year 2|Definitive displacement outside the study site|1|||
145350520|NCT03989102|524131256|FG002|Year 2|Definitive displacement outside the study site|0|||
145350521|NCT03989102|524131254|FG000|Year 2|Subject missed last study visit|0|||
145350522|NCT03989102|524131255|FG001|Year 2|Subject missed last study visit|1|||
145350523|NCT03989102|524131256|FG002|Year 2|Subject missed last study visit|0|||
145350524|NCT03989102|524131254|FG000|Year 2|Death|0|||
145350525|NCT03989102|524131255|FG001|Year 2|Death|1|||
145350526|NCT03989102|524131256|FG002|Year 2|Death|0|||
145350527|NCT03989102|524131254|FG000|Year 2|Subject not reachable|0|||
145350528|NCT03989102|524131255|FG001|Year 2|Subject not reachable|0|||
145350529|NCT03989102|524131256|FG002|Year 2|Subject not reachable|1|||
145350530|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
145350531|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
145350532|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
145350533|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145350534|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145350535|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
145350536|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
145350537|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
145350538|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
145350539|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
145350540|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
145350541|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
145350542|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
145350543|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
145350544|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
145350545|NCT03989102|524131254|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
145350546|NCT03989102|524131255|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
145415266|NCT00625378|524374307|FG001|Overall Study|Multiple toxicities|0|||
145415267|NCT00625378|524374306|FG000|Overall Study|New cancer|1|||
145415268|NCT00625378|524374307|FG001|Overall Study|New cancer|0|||
145415269|NCT00625378|524374306|FG000|Overall Study|PTA program|2|||
145415270|NCT00625378|524374307|FG001|Overall Study|PTA program|0|||
145415271|NCT00625378|524374306|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
145350547|NCT03989102|524131256|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
145350548|NCT00818766|524131268|FG000|Overall Study|Could not be Contacted on Day 28|11|||
145350549|NCT00818766|524131269|FG001|Overall Study|Could not be Contacted on Day 28|10|||
145350550|NCT00818766|524131268|FG000|Overall Study|Death|1|||
145350551|NCT00818766|524131269|FG001|Overall Study|Death|0|||
145350552|NCT00818766|524131268|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
145350553|NCT00818766|524131269|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
145350554|NCT04515147|524131270|FG000|Overall Study|Withdrawal by Subject|1|||
145350555|NCT04515147|524131271|FG001|Overall Study|Withdrawal by Subject|0|||
145350556|NCT04515147|524131272|FG002|Overall Study|Withdrawal by Subject|10|||
145350557|NCT04515147|524131273|FG003|Overall Study|Withdrawal by Subject|18|||
145350558|NCT04515147|524131274|FG004|Overall Study|Withdrawal by Subject|1|||
145350559|NCT04515147|524131275|FG005|Overall Study|Withdrawal by Subject|8|||
145350560|NCT04515147|524131270|FG000|Overall Study|Lost to Follow-up|0|||
145350561|NCT04515147|524131271|FG001|Overall Study|Lost to Follow-up|1|||
145350562|NCT04515147|524131272|FG002|Overall Study|Lost to Follow-up|5|||
145350563|NCT04515147|524131273|FG003|Overall Study|Lost to Follow-up|6|||
145415272|NCT00625378|524374307|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
145415273|NCT00625378|524374306|FG000|Overall Study|Sponsor decision|1|||
145415274|NCT00625378|524374307|FG001|Overall Study|Sponsor decision|0|||
145415275|NCT00625378|524374306|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
145415276|NCT00625378|524374307|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
145415277|NCT00625378|524374306|FG000|Overall Study|Switch to commercial drug|6|||
145415278|NCT00625378|524374307|FG001|Overall Study|Switch to commercial drug|1|||
145415279|NCT00625378|524374306|FG000|Overall Study|Missing|2|||
145415280|NCT00625378|524374307|FG001|Overall Study|Missing|0|||
145415281|NCT00625378|524374306|FG000|Overall Study|End of treatment not available|2|||
145415282|NCT00625378|524374307|FG001|Overall Study|End of treatment not available|0|||
145415283|NCT00625378|524374306|FG000|Overall Study|Never treated|2|||
145415284|NCT00625378|524374307|FG001|Overall Study|Never treated|0|||
145415285|NCT04270760|524374308|FG000|Overall Study|Withdrawal by Subject|0|||
145415286|NCT04270760|524374309|FG001|Overall Study|Withdrawal by Subject|1|||
145415287|NCT04270760|524374310|FG002|Overall Study|Withdrawal by Subject|3|||
145415288|NCT04270760|524374311|FG003|Overall Study|Withdrawal by Subject|0|||
145415289|NCT04270760|524374312|FG004|Overall Study|Withdrawal by Subject|0|||
145415290|NCT04270760|524374308|FG000|Overall Study|Lost to Follow-up|1|||
145415291|NCT04270760|524374309|FG001|Overall Study|Lost to Follow-up|2|||
145415292|NCT04270760|524374310|FG002|Overall Study|Lost to Follow-up|1|||
145415293|NCT04270760|524374311|FG003|Overall Study|Lost to Follow-up|0|||
145415294|NCT04270760|524374312|FG004|Overall Study|Lost to Follow-up|0|||
145415295|NCT04270760|524374308|FG000|Overall Study|Death|0|||
145415296|NCT04270760|524374309|FG001|Overall Study|Death|0|||
145415297|NCT04270760|524374310|FG002|Overall Study|Death|0|||
145415298|NCT04270760|524374311|FG003|Overall Study|Death|0|||
145415299|NCT04270760|524374312|FG004|Overall Study|Death|1|||
145415300|NCT02070991|524374313|FG000|Overall Study|Death|2|||
145415301|NCT02070991|524374314|FG001|Overall Study|Death|0|||
145415302|NCT02070991|524374313|FG000|Overall Study|Withdrawal by Subject|1|||
145415303|NCT02070991|524374314|FG001|Overall Study|Withdrawal by Subject|0|||
145415304|NCT02448043|524374317|FG000|Overall Study|Withdrawal by Subject|2|||
145415305|NCT02448043|524374318|FG001|Overall Study|Withdrawal by Subject|2|||
145415306|NCT02448043|524374317|FG000|Overall Study|Protocol Violation|1|||
145415307|NCT02448043|524374318|FG001|Overall Study|Protocol Violation|2|||
145415308|NCT04790201|524374323|FG000|Overall Study|Lost to Follow-up|0|||
145415309|NCT04790201|524374324|FG001|Overall Study|Lost to Follow-up|0|||
145415310|NCT04790201|524374325|FG002|Overall Study|Lost to Follow-up|2|||
145415311|NCT04790201|524374323|FG000|Overall Study|Death|0|||
145415312|NCT04790201|524374324|FG001|Overall Study|Death|1|||
145415313|NCT04790201|524374325|FG002|Overall Study|Death|0|||
145415314|NCT04790201|524374323|FG000|Overall Study|Protocol Violation|1|||
145415315|NCT04790201|524374324|FG001|Overall Study|Protocol Violation|0|||
145415316|NCT04790201|524374325|FG002|Overall Study|Protocol Violation|1|||
145415317|NCT02609633|524374326|FG000|Overall Study|Consent Withdrawn|0|||
145415318|NCT02609633|524374327|FG001|Overall Study|Consent Withdrawn|1|||
145415319|NCT02609633|524374326|FG000|Overall Study|Protocol Deviation|1|||
145415320|NCT02609633|524374327|FG001|Overall Study|Protocol Deviation|0|||
145415321|NCT02609633|524374326|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
145415322|NCT02609633|524374327|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
145415323|NCT02609633|524374326|FG000|Overall Study|Reason not Specified|2|||
145415324|NCT02609633|524374327|FG001|Overall Study|Reason not Specified|1|||
145415325|NCT05762679|524374330|FG000|Overall Study|Withdrawal by Subject|1|||
145415326|NCT05762679|524374330|FG000|Overall Study|No analyzable imaging data|1|||
145415327|NCT00997126|524374331|FG000|Overall Study|Physician Decision|7|||
145415328|NCT00997126|524374332|FG001|Overall Study|Physician Decision|11|||
145415329|NCT00471107|524374333|FG000|Overall Study|Technical problems/data loss|3|||
145415330|NCT00471107|524374334|FG001|Overall Study|Technical problems/data loss|1|||
145415331|NCT00471107|524374335|FG002|Overall Study|Technical problems/data loss|3|||
145415332|NCT01769443|524374336|FG000|Overall Study|Study closure|1|||
145415333|NCT01769443|524374337|FG001|Overall Study|Study closure|0|||
145415334|NCT00699751|524374338|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
145415335|NCT00699751|524374339|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
145415336|NCT00699751|524374338|FG000|Period 1: Without/Before Drug Switch|Death|28|||
145415337|NCT00699751|524374339|FG001|Period 1: Without/Before Drug Switch|Death|29|||
145415338|NCT00699751|524374338|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
145415339|NCT00699751|524374339|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
145577207|NCT01412424|524968006|FG000|Core Treatment Period|Lost to Follow-up|2|||
145415340|NCT00699751|524374338|FG000|Period 1: Without/Before Drug Switch|Other|30|||
145415341|NCT00699751|524374339|FG001|Period 1: Without/Before Drug Switch|Other|20|||
145415342|NCT00699751|524374338|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
145415343|NCT00699751|524374339|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
145415344|NCT00699751|524374338|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
145415345|NCT00699751|524374339|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
145415346|NCT00699751|524374338|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
145415347|NCT00699751|524374339|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
145415348|NCT00699751|524374338|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
145415349|NCT00699751|524374339|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
145415350|NCT01947933|524374340|FG000|Overall Study|Withdrawal by Subject|0|||
145415351|NCT01947933|524374341|FG001|Overall Study|Withdrawal by Subject|0|||
145415352|NCT01947933|524374342|FG002|Overall Study|Withdrawal by Subject|1|||
145415353|NCT01947933|524374343|FG003|Overall Study|Withdrawal by Subject|0|||
145415354|NCT01947933|524374344|FG004|Overall Study|Withdrawal by Subject|0|||
145415355|NCT01947933|524374345|FG005|Overall Study|Withdrawal by Subject|0|||
145415356|NCT01947933|524374346|FG006|Overall Study|Withdrawal by Subject|0|||
145415357|NCT01947933|524374347|FG007|Overall Study|Withdrawal by Subject|0|||
145415358|NCT01947933|524374348|FG008|Overall Study|Withdrawal by Subject|0|||
145415359|NCT01947933|524374340|FG000|Overall Study|Lost to Follow-up|0|||
145415360|NCT01947933|524374341|FG001|Overall Study|Lost to Follow-up|0|||
145415361|NCT01947933|524374342|FG002|Overall Study|Lost to Follow-up|0|||
145415362|NCT01947933|524374343|FG003|Overall Study|Lost to Follow-up|0|||
145415363|NCT01947933|524374344|FG004|Overall Study|Lost to Follow-up|0|||
145415364|NCT01947933|524374345|FG005|Overall Study|Lost to Follow-up|0|||
145415365|NCT01947933|524374346|FG006|Overall Study|Lost to Follow-up|0|||
145415366|NCT01947933|524374347|FG007|Overall Study|Lost to Follow-up|0|||
145415367|NCT01947933|524374348|FG008|Overall Study|Lost to Follow-up|1|||
145415368|NCT00294398|524374349|FG000|Overall Study|Lost to Follow-up|21|||
145415369|NCT00294398|524374350|FG001|Overall Study|Lost to Follow-up|26|||
145415370|NCT01428128|524374351|FG000|Overall Study|Withdrawal by Subject|4|||
145415371|NCT01428128|524374351|FG000|Overall Study|Screen failure by p53|10|||
145415372|NCT01428128|524374351|FG000|Overall Study|Received Neulasta in one cycle|2|||
145415373|NCT01428128|524374351|FG000|Overall Study|Adverse Event|1|||
145415374|NCT00985790|524374353|FG000|Overall Study|Withdrawal by Subject|1|||
145415375|NCT00985790|524374354|FG001|Overall Study|Withdrawal by Subject|1|||
145415376|NCT00985790|524374353|FG000|Overall Study|Lost to Follow-up|6|||
145415377|NCT00985790|524374354|FG001|Overall Study|Lost to Follow-up|7|||
145415378|NCT00250718|524374355|FG000|Overall Study|Death|1|||
145415379|NCT00250718|524374355|FG000|Overall Study|Adverse Event|1|||
145415380|NCT00250718|524374355|FG000|Overall Study|Withdrawal by Subject|1|||
145415381|NCT05259033|524374361|FG000|Overall Study|Withdrawal by Subject|10|||
145415382|NCT05259033|524374362|FG001|Overall Study|Withdrawal by Subject|5|||
145415383|NCT05259033|524374361|FG000|Overall Study|Lost to Follow-up|1|||
145415384|NCT05259033|524374362|FG001|Overall Study|Lost to Follow-up|0|||
145415385|NCT05259033|524374361|FG000|Overall Study|Death|2|||
145415386|NCT05259033|524374362|FG001|Overall Study|Death|0|||
145415387|NCT01405911|524374363|FG000|Overall Study|Pre-treatment lab AE|0|||
145415388|NCT01405911|524374364|FG001|Overall Study|Pre-treatment lab AE|1|||
145415389|NCT01405911|524374365|FG002|Overall Study|Pre-treatment lab AE|0|||
145415390|NCT01405911|524374363|FG000|Overall Study|Lost to Follow-up|0|||
145415391|NCT01405911|524374364|FG001|Overall Study|Lost to Follow-up|1|||
145415392|NCT01405911|524374365|FG002|Overall Study|Lost to Follow-up|0|||
145415393|NCT01405911|524374363|FG000|Overall Study|Protocol Violation|1|||
145415394|NCT01405911|524374364|FG001|Overall Study|Protocol Violation|0|||
145415395|NCT01405911|524374365|FG002|Overall Study|Protocol Violation|0|||
145415396|NCT01405911|524374363|FG000|Overall Study|Withdrawal by Subject|3|||
145415397|NCT01405911|524374364|FG001|Overall Study|Withdrawal by Subject|1|||
145415398|NCT01405911|524374365|FG002|Overall Study|Withdrawal by Subject|1|||
145415399|NCT04124965|524374369|FG000|Overall Study|Adverse event, non-fatal|3|||
145415400|NCT04124965|524374370|FG001|Overall Study|Adverse event, non-fatal|1|||
145415401|NCT04124965|524374369|FG000|Overall Study|Withdrawal by Subject|1|||
145415402|NCT04124965|524374370|FG001|Overall Study|Withdrawal by Subject|1|||
145415403|NCT04124965|524374369|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
145415404|NCT04124965|524374370|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
145415405|NCT04124965|524374369|FG000|Overall Study|Pregnancy|1|||
145415406|NCT04124965|524374370|FG001|Overall Study|Pregnancy|0|||
145577208|NCT01412424|524968006|FG000|Core Treatment Period|Sponsor Request|1|||
145577209|NCT01412424|524968006|FG000|Extension Treatment Period|Adverse Event|2|||
145577210|NCT01412424|524968006|FG000|Extension Treatment Period|Treatment Failure|2|||
145577211|NCT01412424|524968006|FG000|Extension Treatment Period|Patient Request|2|||
145577212|NCT01274637|524968007|FG000|Overall Study|Withdrawal by Subject|0|||
145577213|NCT01274637|524968008|FG001|Overall Study|Withdrawal by Subject|1|||
145577214|NCT01274637|524968007|FG000|Overall Study|Lost to Follow-up|0|||
145577215|NCT01274637|524968008|FG001|Overall Study|Lost to Follow-up|1|||
145415407|NCT04124965|524374369|FG000|Overall Study|Sponsor and participant decision|0|||
145415408|NCT04124965|524374370|FG001|Overall Study|Sponsor and participant decision|1|||
145415409|NCT04124965|524374369|FG000|Overall Study|Personal surgery|0|||
145415410|NCT04124965|524374370|FG001|Overall Study|Personal surgery|1|||
145415411|NCT04124965|524374369|FG000|Overall Study|Physician Decision|0|||
145415412|NCT04124965|524374370|FG001|Overall Study|Physician Decision|1|||
145415413|NCT02184156|524374371|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
145415414|NCT02184156|524374372|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
145415415|NCT02184156|524374371|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
145415416|NCT02184156|524374372|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
145622907|NCT01606189|525130236|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
145622908|NCT01606189|525130237|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
145622909|NCT01606189|525130238|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
145622910|NCT01606189|525130233|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
145622911|NCT01606189|525130234|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
145350564|NCT04515147|524131274|FG004|Overall Study|Lost to Follow-up|2|||
145350565|NCT04515147|524131275|FG005|Overall Study|Lost to Follow-up|1|||
145350566|NCT04515147|524131270|FG000|Overall Study|Adverse Event|0|||
145350567|NCT04515147|524131271|FG001|Overall Study|Adverse Event|0|||
145350568|NCT04515147|524131272|FG002|Overall Study|Adverse Event|0|||
145350569|NCT04515147|524131273|FG003|Overall Study|Adverse Event|2|||
145350570|NCT04515147|524131274|FG004|Overall Study|Adverse Event|0|||
145350571|NCT04515147|524131275|FG005|Overall Study|Adverse Event|0|||
145350572|NCT04515147|524131270|FG000|Overall Study|Miscellaneous|0|||
145350573|NCT04515147|524131271|FG001|Overall Study|Miscellaneous|0|||
145350574|NCT04515147|524131272|FG002|Overall Study|Miscellaneous|0|||
145350575|NCT04515147|524131273|FG003|Overall Study|Miscellaneous|1|||
145350576|NCT04515147|524131274|FG004|Overall Study|Miscellaneous|0|||
145350577|NCT04515147|524131275|FG005|Overall Study|Miscellaneous|1|||
145350578|NCT02760004|524131279|FG000|Overall Study|Lost to Follow-up|13|||
145350579|NCT02760004|524131280|FG001|Overall Study|Lost to Follow-up|22|||
145350580|NCT00970593|524131283|FG000|Overall Study|Adverse Event|1|||
145350581|NCT00970593|524131284|FG001|Overall Study|Adverse Event|1|||
145350582|NCT00970593|524131285|FG002|Overall Study|Adverse Event|0|||
145350583|NCT00970593|524131286|FG003|Overall Study|Adverse Event|0|||
145350584|NCT00970593|524131287|FG004|Overall Study|Adverse Event|0|||
145350585|NCT00970593|524131288|FG005|Overall Study|Adverse Event|0|||
145350586|NCT00970593|524131289|FG006|Overall Study|Adverse Event|0|||
145350587|NCT00970593|524131283|FG000|Overall Study|Discontinuation of study by sponsor|0|||
145350588|NCT00970593|524131284|FG001|Overall Study|Discontinuation of study by sponsor|0|||
145350589|NCT00970593|524131285|FG002|Overall Study|Discontinuation of study by sponsor|5|||
145350590|NCT00970593|524131286|FG003|Overall Study|Discontinuation of study by sponsor|0|||
145350591|NCT00970593|524131287|FG004|Overall Study|Discontinuation of study by sponsor|0|||
145350592|NCT00970593|524131288|FG005|Overall Study|Discontinuation of study by sponsor|0|||
145350593|NCT00970593|524131289|FG006|Overall Study|Discontinuation of study by sponsor|2|||
145350594|NCT00970593|524131283|FG000|Overall Study|Withdrawal by Subject|0|||
145350595|NCT00970593|524131284|FG001|Overall Study|Withdrawal by Subject|0|||
145350596|NCT00970593|524131285|FG002|Overall Study|Withdrawal by Subject|1|||
145350597|NCT00970593|524131286|FG003|Overall Study|Withdrawal by Subject|0|||
145350598|NCT00970593|524131287|FG004|Overall Study|Withdrawal by Subject|0|||
145350599|NCT00970593|524131288|FG005|Overall Study|Withdrawal by Subject|0|||
145350600|NCT00970593|524131289|FG006|Overall Study|Withdrawal by Subject|0|||
145350601|NCT02719184|524131293|FG000|Overall Study|Other than listed|1|||
145350602|NCT02719184|524131294|FG001|Overall Study|Other than listed|12|||
145350603|NCT02719184|524131295|FG002|Overall Study|Other than listed|13|||
145350604|NCT02719184|524131296|FG003|Overall Study|Other than listed|22|||
145350605|NCT02719184|524131297|FG004|Overall Study|Other than listed|9|||
145350606|NCT02719184|524131293|FG000|Overall Study|Withdrawal by Subject|5|||
145350607|NCT02719184|524131294|FG001|Overall Study|Withdrawal by Subject|3|||
145350608|NCT02719184|524131295|FG002|Overall Study|Withdrawal by Subject|6|||
145350609|NCT02719184|524131296|FG003|Overall Study|Withdrawal by Subject|6|||
145350610|NCT02719184|524131297|FG004|Overall Study|Withdrawal by Subject|0|||
145350611|NCT02719184|524131293|FG000|Overall Study|Lost to Follow-up|0|||
145350612|NCT02719184|524131294|FG001|Overall Study|Lost to Follow-up|4|||
145350613|NCT02719184|524131295|FG002|Overall Study|Lost to Follow-up|1|||
145350614|NCT02719184|524131296|FG003|Overall Study|Lost to Follow-up|3|||
145350615|NCT02719184|524131297|FG004|Overall Study|Lost to Follow-up|0|||
145350616|NCT02719184|524131293|FG000|Overall Study|Protocol Violation|0|||
145350617|NCT02719184|524131294|FG001|Overall Study|Protocol Violation|3|||
145350618|NCT02719184|524131295|FG002|Overall Study|Protocol Violation|0|||
145350619|NCT02719184|524131296|FG003|Overall Study|Protocol Violation|2|||
145350620|NCT02719184|524131297|FG004|Overall Study|Protocol Violation|0|||
145350621|NCT02719184|524131293|FG000|Overall Study|Adverse Event|0|||
145350622|NCT02719184|524131294|FG001|Overall Study|Adverse Event|0|||
145350623|NCT02719184|524131295|FG002|Overall Study|Adverse Event|0|||
145350624|NCT02719184|524131296|FG003|Overall Study|Adverse Event|3|||
145350625|NCT02719184|524131297|FG004|Overall Study|Adverse Event|0|||
145350626|NCT00470535|524131301|FG000|Overall Study|Disease Progression|13|||
145350627|NCT00470535|524131301|FG000|Overall Study|Withdrawal by Subject|1|||
145350628|NCT00470535|524131301|FG000|Overall Study|Adverse Event|1|||
145350629|NCT00470535|524131301|FG000|Overall Study|Death|1|||
145350630|NCT00470535|524131301|FG000|Overall Study|Other|2|||
145350631|NCT04108299|524131303|FG000|Overall Study|Not interested in participating|2|||
145350632|NCT04108299|524131304|FG001|Overall Study|Not interested in participating|1|||
145350633|NCT04108299|524131305|FG002|Overall Study|Not interested in participating|2|||
145350634|NCT04108299|524131306|FG003|Overall Study|Not interested in participating|1|||
145350635|NCT00662649|524131310|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
145350636|NCT00662649|524131311|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
145350637|NCT00662649|524131312|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
145350638|NCT00662649|524131313|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
145350639|NCT00662649|524131314|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
145350640|NCT00662649|524131310|FG000|Core Study (24 Months)|Adverse Event|22|||
145350641|NCT00662649|524131311|FG001|Core Study (24 Months)|Adverse Event|13|||
145350642|NCT00662649|524131312|FG002|Core Study (24 Months)|Adverse Event|18|||
145350643|NCT00662649|524131313|FG003|Core Study (24 Months)|Adverse Event|0|||
145350644|NCT00662649|524131314|FG004|Core Study (24 Months)|Adverse Event|0|||
145350645|NCT00662649|524131310|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
145350646|NCT00662649|524131311|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
145350647|NCT00662649|524131312|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
145350648|NCT00662649|524131313|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
145350649|NCT00662649|524131314|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
145350650|NCT00662649|524131310|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
145350651|NCT00662649|524131311|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
145350652|NCT00662649|524131312|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
145350653|NCT00662649|524131313|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
145350654|NCT00662649|524131314|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
145350655|NCT00662649|524131310|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
145350656|NCT00662649|524131311|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
145350657|NCT00662649|524131312|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
145350658|NCT00662649|524131313|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
145350659|NCT00662649|524131314|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
145350660|NCT00662649|524131310|FG000|Core Study (24 Months)|Protocol Violation|5|||
145350661|NCT00662649|524131311|FG001|Core Study (24 Months)|Protocol Violation|5|||
145350662|NCT00662649|524131312|FG002|Core Study (24 Months)|Protocol Violation|4|||
145350663|NCT00662649|524131313|FG003|Core Study (24 Months)|Protocol Violation|0|||
145350664|NCT00662649|524131314|FG004|Core Study (24 Months)|Protocol Violation|0|||
145350665|NCT00662649|524131310|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
145350666|NCT00662649|524131311|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
145350667|NCT00662649|524131312|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
145350668|NCT00662649|524131313|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
145350669|NCT00662649|524131314|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
145350670|NCT00662649|524131310|FG000|Core Study (24 Months)|Death|1|||
145350671|NCT00662649|524131311|FG001|Core Study (24 Months)|Death|0|||
145350672|NCT00662649|524131312|FG002|Core Study (24 Months)|Death|2|||
145350673|NCT00662649|524131313|FG003|Core Study (24 Months)|Death|0|||
145350674|NCT00662649|524131314|FG004|Core Study (24 Months)|Death|0|||
145350675|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
145350676|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
145350677|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
145350678|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
145350679|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
145350680|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
145350681|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
145350682|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
145350683|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
145350684|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
145350685|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
145350686|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
145350687|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
145350688|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
145350689|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
145350690|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
145350691|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
145350692|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
145350693|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
145350694|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
145350695|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
145350696|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
145350697|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
145350698|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
145350699|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
145350700|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
145350701|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
145350702|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145350703|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145350704|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
145350705|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
145350706|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
145350707|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
145350708|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
145350709|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
145350710|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145350711|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
145350712|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145350713|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145350714|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
145350715|NCT00662649|524131310|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
145350716|NCT00662649|524131311|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
145350717|NCT00662649|524131312|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
145350718|NCT00662649|524131313|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
145350719|NCT00662649|524131314|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
145350720|NCT01026194|524131316|FG000|Period 1：Double Blind Period|Adverse Event|2|||
145350721|NCT01026194|524131317|FG001|Period 1：Double Blind Period|Adverse Event|1|||
145350722|NCT01026194|524131316|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
145350723|NCT01026194|524131317|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
145350724|NCT01026194|524131316|FG000|Period 1：Double Blind Period|Physician Decision|0|||
145350725|NCT01026194|524131317|FG001|Period 1：Double Blind Period|Physician Decision|4|||
145350726|NCT01026194|524131316|FG000|Period 2：Open-label Period|Adverse Event|4|||
145350727|NCT01026194|524131317|FG001|Period 2：Open-label Period|Adverse Event|5|||
145350728|NCT01026194|524131316|FG000|Period 2：Open-label Period|Physician Decision|3|||
145350729|NCT01026194|524131317|FG001|Period 2：Open-label Period|Physician Decision|1|||
145350730|NCT01026194|524131316|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
145350731|NCT01026194|524131317|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
145350732|NCT03889886|524131318|FG000|Overall Study|Other|0|||
145350733|NCT03889886|524131319|FG001|Overall Study|Other|1|||
145350734|NCT03889886|524131320|FG002|Overall Study|Other|0|||
145350735|NCT03889886|524131321|FG003|Overall Study|Other|1|||
145350736|NCT03889886|524131318|FG000|Overall Study|Withdrawal by Subject|0|||
145350737|NCT03889886|524131319|FG001|Overall Study|Withdrawal by Subject|0|||
145350738|NCT03889886|524131320|FG002|Overall Study|Withdrawal by Subject|1|||
145350739|NCT03889886|524131321|FG003|Overall Study|Withdrawal by Subject|0|||
145350740|NCT03889886|524131318|FG000|Overall Study|Adverse Event|0|||
145350741|NCT03889886|524131319|FG001|Overall Study|Adverse Event|0|||
145350742|NCT03889886|524131320|FG002|Overall Study|Adverse Event|0|||
145350743|NCT03889886|524131321|FG003|Overall Study|Adverse Event|6|||
145350744|NCT01431079|524131322|FG000|Overall Study|Lost to Follow-up|35|||
145350745|NCT01431079|524131323|FG001|Overall Study|Lost to Follow-up|39|||
145350746|NCT01202175|524131324|FG000|Overall Study|Lost to Follow-up|2|||
145350747|NCT01202175|524131324|FG000|Overall Study|Withdrawal by Subject|1|||
145350748|NCT01202175|524131324|FG000|Overall Study|Adverse Event|2|||
145350749|NCT04747470|524131325|FG000|Overall Study|Death|0|||
145350750|NCT04747470|524131326|FG001|Overall Study|Death|3|||
145350751|NCT04747470|524131327|FG002|Overall Study|Death|2|||
145350752|NCT04747470|524131328|FG003|Overall Study|Death|2|||
145350753|NCT04747470|524131329|FG004|Overall Study|Death|2|||
145350754|NCT04747470|524131330|FG005|Overall Study|Death|0|||
145350755|NCT04747470|524131331|FG006|Overall Study|Death|0|||
145350756|NCT04747470|524131332|FG007|Overall Study|Death|0|||
145350757|NCT04747470|524131333|FG008|Overall Study|Death|0|||
145622912|NCT01606189|525130235|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
145350758|NCT04747470|524131334|FG009|Overall Study|Death|0|||
145350759|NCT04747470|524131335|FG010|Overall Study|Death|0|||
145350760|NCT04747470|524131325|FG000|Overall Study|Withdrew Consent|0|||
145350761|NCT04747470|524131326|FG001|Overall Study|Withdrew Consent|0|||
145350762|NCT04747470|524131327|FG002|Overall Study|Withdrew Consent|0|||
145350763|NCT04747470|524131328|FG003|Overall Study|Withdrew Consent|1|||
145350764|NCT04747470|524131329|FG004|Overall Study|Withdrew Consent|0|||
145350765|NCT04747470|524131330|FG005|Overall Study|Withdrew Consent|0|||
145350766|NCT04747470|524131331|FG006|Overall Study|Withdrew Consent|0|||
145350767|NCT04747470|524131332|FG007|Overall Study|Withdrew Consent|0|||
145350768|NCT04747470|524131333|FG008|Overall Study|Withdrew Consent|0|||
145350769|NCT04747470|524131334|FG009|Overall Study|Withdrew Consent|0|||
145350770|NCT04747470|524131335|FG010|Overall Study|Withdrew Consent|0|||
145350771|NCT04747470|524131325|FG000|Overall Study|Study Terminated by Sponsor|0|||
145350772|NCT04747470|524131326|FG001|Overall Study|Study Terminated by Sponsor|0|||
145350773|NCT04747470|524131327|FG002|Overall Study|Study Terminated by Sponsor|1|||
145350774|NCT04747470|524131328|FG003|Overall Study|Study Terminated by Sponsor|0|||
145350775|NCT04747470|524131329|FG004|Overall Study|Study Terminated by Sponsor|2|||
145350776|NCT04747470|524131330|FG005|Overall Study|Study Terminated by Sponsor|0|||
145415417|NCT00002874|524374378|FG000|Overall Study|Withdrawal by Subject|1|||
145415418|NCT00002874|524374379|FG001|Overall Study|Withdrawal by Subject|1|||
145350777|NCT04747470|524131331|FG006|Overall Study|Study Terminated by Sponsor|0|||
145350778|NCT04747470|524131332|FG007|Overall Study|Study Terminated by Sponsor|0|||
145350779|NCT04747470|524131333|FG008|Overall Study|Study Terminated by Sponsor|0|||
145350780|NCT04747470|524131334|FG009|Overall Study|Study Terminated by Sponsor|0|||
145350781|NCT04747470|524131335|FG010|Overall Study|Study Terminated by Sponsor|0|||
145350782|NCT03749330|524131340|FG000|Overall Study|Clinicians left work in the CICU|0|||
145350783|NCT03749330|524131341|FG001|Overall Study|Clinicians left work in the CICU|2|||
145350784|NCT03749330|524131342|FG002|Overall Study|Clinicians left work in the CICU|0|||
145350785|NCT03749330|524131343|FG003|Overall Study|Clinicians left work in the CICU|0|||
145350786|NCT03749330|524131344|FG004|Overall Study|Clinicians left work in the CICU|0|||
145350787|NCT03749330|524131345|FG005|Overall Study|Clinicians left work in the CICU|0|||
145350788|NCT01518322|524131346|FG000|Overall Study|FeNO measurement was missing|13|||
145350789|NCT01269918|524131347|FG000|Overall Study|Did not receive study drug|0|||
145350790|NCT01269918|524131348|FG001|Overall Study|Did not receive study drug|3|||
145350791|NCT04660331|524131349|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
145350792|NCT04660331|524131350|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
145350793|NCT04660331|524131351|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
145350794|NCT01870778|524131352|FG000|Overall Study|Withdrawal by Subject|8|||
145350795|NCT01870778|524131353|FG001|Overall Study|Withdrawal by Subject|7|||
145350796|NCT01870778|524131352|FG000|Overall Study|Lost to Follow-up|0|||
145350797|NCT01870778|524131353|FG001|Overall Study|Lost to Follow-up|2|||
145350798|NCT00065156|524131354|FG000|Overall Study|Adverse Event|37|||
145350799|NCT00065156|524131354|FG000|Overall Study|Lack of Efficacy|52|||
145350800|NCT00065156|524131354|FG000|Overall Study|Withdrawal by Subject|8|||
145350801|NCT00065156|524131354|FG000|Overall Study|Lost to Follow-up|1|||
145350802|NCT00065156|524131354|FG000|Overall Study|Death|11|||
145350803|NCT00065156|524131354|FG000|Overall Study|Study Closed by Sponsor|2|||
145350804|NCT00065156|524131354|FG000|Overall Study|Disease Progression|7|||
145350805|NCT00065156|524131354|FG000|Overall Study|Investigator Decision|2|||
145350806|NCT00065156|524131354|FG000|Overall Study|Non-Compliance|2|||
145350807|NCT00065156|524131354|FG000|Overall Study|Loss of Response|1|||
145350808|NCT00065156|524131354|FG000|Overall Study|Secondary Malign Disease|1|||
145350809|NCT00100828|524131355|FG000|Overall Study|Physician Decision|6|||
145350810|NCT01176513|524131356|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
145350811|NCT02273388|524131367|FG000|Overall Study|Adverse Event|0|||
145350812|NCT02273388|524131368|FG001|Overall Study|Adverse Event|0|||
145350813|NCT02273388|524131369|FG002|Overall Study|Adverse Event|0|||
145350814|NCT02273388|524131370|FG003|Overall Study|Adverse Event|0|||
145350815|NCT02273388|524131371|FG004|Overall Study|Adverse Event|0|||
145350816|NCT02273388|524131372|FG005|Overall Study|Adverse Event|0|||
145350817|NCT02273388|524131373|FG006|Overall Study|Adverse Event|1|||
145350818|NCT02273388|524131374|FG007|Overall Study|Adverse Event|2|||
145350819|NCT02273388|524131375|FG008|Overall Study|Adverse Event|0|||
145415419|NCT00002874|524374378|FG000|Overall Study|Protocol Violation|44|||
145415420|NCT00002874|524374379|FG001|Overall Study|Protocol Violation|34|||
145415421|NCT02114684|524374382|FG000|Overall Study|Death|6|||
145415422|NCT02114684|524374383|FG001|Overall Study|Death|4|||
145415423|NCT02114684|524374382|FG000|Overall Study|Lost to Follow-up|1|||
145415424|NCT02114684|524374383|FG001|Overall Study|Lost to Follow-up|2|||
145415425|NCT02114684|524374382|FG000|Overall Study|Withdrawal by Subject|1|||
145415426|NCT02114684|524374383|FG001|Overall Study|Withdrawal by Subject|2|||
145415427|NCT02114684|524374382|FG000|Overall Study|Relocation|3|||
145415428|NCT02114684|524374383|FG001|Overall Study|Relocation|1|||
145415429|NCT02114684|524374382|FG000|Overall Study|Rifampicin resistant on culture|0|||
145415430|NCT02114684|524374383|FG001|Overall Study|Rifampicin resistant on culture|1|||
145577216|NCT03235024|524968021|FG000|Overall Study|Adverse Event|2|||
145577217|NCT03235024|524968022|FG001|Overall Study|Adverse Event|2|||
145577218|NCT03235024|524968021|FG000|Overall Study|Death|1|||
145577219|NCT03235024|524968022|FG001|Overall Study|Death|0|||
145577220|NCT03235024|524968021|FG000|Overall Study|Lost to Follow-up|2|||
145350820|NCT02273388|524131376|FG009|Overall Study|Adverse Event|0|||
145350821|NCT02273388|524131377|FG010|Overall Study|Adverse Event|0|||
145350822|NCT02273388|524131378|FG011|Overall Study|Adverse Event|0|||
145350823|NCT02273388|524131367|FG000|Overall Study|Adverse Event study disease worse|4|||
145350824|NCT02273388|524131368|FG001|Overall Study|Adverse Event study disease worse|3|||
145350825|NCT02273388|524131369|FG002|Overall Study|Adverse Event study disease worse|3|||
145350826|NCT02273388|524131370|FG003|Overall Study|Adverse Event study disease worse|2|||
145350827|NCT02273388|524131371|FG004|Overall Study|Adverse Event study disease worse|4|||
145350828|NCT02273388|524131372|FG005|Overall Study|Adverse Event study disease worse|3|||
145350829|NCT02273388|524131373|FG006|Overall Study|Adverse Event study disease worse|14|||
145350830|NCT02273388|524131374|FG007|Overall Study|Adverse Event study disease worse|6|||
145415431|NCT02114684|524374382|FG000|Overall Study|Patient Incarcerated|1|||
145415432|NCT02114684|524374383|FG001|Overall Study|Patient Incarcerated|0|||
145577221|NCT03235024|524968022|FG001|Overall Study|Lost to Follow-up|5|||
145577222|NCT03235024|524968021|FG000|Overall Study|Protocol Violation|1|||
145350831|NCT02273388|524131375|FG008|Overall Study|Adverse Event study disease worse|6|||
145350832|NCT02273388|524131376|FG009|Overall Study|Adverse Event study disease worse|5|||
145350833|NCT02273388|524131377|FG010|Overall Study|Adverse Event study disease worse|10|||
145350834|NCT02273388|524131378|FG011|Overall Study|Adverse Event study disease worse|1|||
145350835|NCT02273388|524131367|FG000|Overall Study|Sponsor decision|0|||
145350836|NCT02273388|524131368|FG001|Overall Study|Sponsor decision|0|||
145350837|NCT02273388|524131369|FG002|Overall Study|Sponsor decision|0|||
145350838|NCT02273388|524131370|FG003|Overall Study|Sponsor decision|0|||
145350839|NCT02273388|524131371|FG004|Overall Study|Sponsor decision|0|||
145350840|NCT02273388|524131372|FG005|Overall Study|Sponsor decision|0|||
145350841|NCT02273388|524131373|FG006|Overall Study|Sponsor decision|0|||
145350842|NCT02273388|524131374|FG007|Overall Study|Sponsor decision|0|||
145350843|NCT02273388|524131375|FG008|Overall Study|Sponsor decision|0|||
145350844|NCT02273388|524131376|FG009|Overall Study|Sponsor decision|0|||
145350845|NCT02273388|524131377|FG010|Overall Study|Sponsor decision|0|||
145350846|NCT02273388|524131378|FG011|Overall Study|Sponsor decision|1|||
145350847|NCT01042093|524131379|FG000|Overall Study|Protocol Violation|2|||
145350848|NCT01042093|524131380|FG001|Overall Study|Protocol Violation|2|||
145350849|NCT01042093|524131381|FG002|Overall Study|Protocol Violation|2|||
145350850|NCT01042093|524131382|FG003|Overall Study|Protocol Violation|3|||
145350851|NCT01042093|524131379|FG000|Overall Study|Withdrawal by Subject|0|||
145350852|NCT01042093|524131380|FG001|Overall Study|Withdrawal by Subject|0|||
145350853|NCT01042093|524131381|FG002|Overall Study|Withdrawal by Subject|0|||
145350854|NCT01042093|524131382|FG003|Overall Study|Withdrawal by Subject|1|||
145350855|NCT04331808|524131383|FG000|Overall Study|Withdrew consent|1|||
145415433|NCT02530242|524374389|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
145415434|NCT02530242|524374390|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
145415435|NCT00283959|524374391|FG000|Extension Period|Low Compliance|1|||
145415436|NCT01214720|524374392|FG000|Overall Study|Alive and still on treatment|34|||
145415437|NCT01214720|524374393|FG001|Overall Study|Alive and still on treatment|18|||
145415438|NCT01214720|524374392|FG000|Overall Study|Alive and in follow-up|45|||
145415439|NCT01214720|524374393|FG001|Overall Study|Alive and in follow-up|48|||
145415440|NCT01214720|524374392|FG000|Overall Study|Lost to Follow-up|6|||
145415441|NCT01214720|524374393|FG001|Overall Study|Lost to Follow-up|2|||
145415442|NCT05591755|524374394|FG000|Overall Study|Screen Failure|1|||
145415443|NCT05591755|524374395|FG001|Overall Study|Screen Failure|0|||
145415444|NCT05591755|524374396|FG002|Overall Study|Screen Failure|0|||
145415445|NCT05591755|524374397|FG003|Overall Study|Screen Failure|0|||
145415446|NCT05591755|524374394|FG000|Overall Study|Protocol Violation|0|||
145415447|NCT05591755|524374395|FG001|Overall Study|Protocol Violation|0|||
145415448|NCT05591755|524374396|FG002|Overall Study|Protocol Violation|2|||
145415449|NCT05591755|524374397|FG003|Overall Study|Protocol Violation|0|||
145415450|NCT05591755|524374394|FG000|Overall Study|Withdrawal by Subject|0|||
145415451|NCT05591755|524374395|FG001|Overall Study|Withdrawal by Subject|1|||
145415452|NCT05591755|524374396|FG002|Overall Study|Withdrawal by Subject|0|||
145415453|NCT05591755|524374397|FG003|Overall Study|Withdrawal by Subject|0|||
145415454|NCT02564978|524374398|FG000|Overall Study|Adverse Event|8|||
145415455|NCT02564978|524374398|FG000|Overall Study|Death|1|||
145415456|NCT02564978|524374398|FG000|Overall Study|Lost to Follow-up|1|||
145415457|NCT02564978|524374398|FG000|Overall Study|Withdrawal by Subject|15|||
145415458|NCT02564978|524374398|FG000|Overall Study|Early Study Closure|2|||
145415459|NCT02564978|524374398|FG000|Overall Study|Other Reason|5|||
145415460|NCT04971837|524376331|FG000|Overall Study|Long Term Illness|1|||
145415461|NCT04971837|524376331|FG000|Overall Study|BMI too low|9|||
145415462|NCT04971837|524376331|FG000|Overall Study|geographic location|1|||
145577223|NCT03235024|524968022|FG001|Overall Study|Protocol Violation|0|||
145577224|NCT03235024|524968021|FG000|Overall Study|Withdrawal by Subject|0|||
145577225|NCT03235024|524968022|FG001|Overall Study|Withdrawal by Subject|3|||
145350856|NCT04331808|524131384|FG001|Overall Study|Withdrew consent|0|||
145350857|NCT04331808|524131385|FG002|Overall Study|Withdrew consent|2|||
145350858|NCT04331808|524131386|FG003|Overall Study|Withdrew consent|3|||
145350859|NCT01329900|524131390|FG000|Overall Study|Elevated creatinine/renal function|1|||
145377834|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
145377835|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
145377836|NCT03191864|524233635|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
145377837|NCT03191864|524233636|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
145377838|NCT03191864|524233637|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
145377839|NCT03191864|524233638|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
145377840|NCT03191864|524233639|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
145377841|NCT03191864|524233640|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
145377842|NCT03191864|524233635|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145415463|NCT04971837|524376331|FG000|Overall Study|Discontinued scheduling conflict|1|||
145415464|NCT03022630|524376335|FG000|Overall Study|Death|9|||
145415465|NCT03022630|524376336|FG001|Overall Study|Death|7|||
145415466|NCT03022630|524376335|FG000|Overall Study|Withdrawal by Subject|0|||
145415467|NCT03022630|524376336|FG001|Overall Study|Withdrawal by Subject|5|||
145415468|NCT00884949|524376337|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
145415469|NCT00884949|524376337|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
145415470|NCT01734928|524376338|FG000|Randomization|Physician Decision|0|||
145415471|NCT01734928|524376339|FG001|Randomization|Physician Decision|1|||
145415472|NCT01734928|524376338|FG000|Randomization|clinical progression|0|||
145415473|NCT01734928|524376339|FG001|Randomization|clinical progression|1|||
145415474|NCT01734928|524376338|FG000|Randomization|progressive disease|0|||
145415475|NCT01734928|524376339|FG001|Randomization|progressive disease|2|||
145577226|NCT02357576|524968023|FG000|Treatment Period|Withdrawal by Subject|0|||
145577227|NCT02357576|524968024|FG001|Treatment Period|Withdrawal by Subject|1|||
145577228|NCT02357576|524968023|FG000|Treatment Period|Physician Decision|0|||
145577229|NCT02357576|524968024|FG001|Treatment Period|Physician Decision|1|||
145577230|NCT02357576|524968023|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
145350860|NCT03493685|524133473|FG000|Overall Study|Death|4|||
145350861|NCT03493685|524133474|FG001|Overall Study|Death|3|||
145350862|NCT03493685|524133473|FG000|Overall Study|Lost to Follow-up|3|||
145350863|NCT03493685|524133474|FG001|Overall Study|Lost to Follow-up|2|||
145350864|NCT03493685|524133473|FG000|Overall Study|Physician Decision|2|||
145350865|NCT03493685|524133474|FG001|Overall Study|Physician Decision|0|||
145350866|NCT03493685|524133473|FG000|Overall Study|Withdrawal by Subject|7|||
145350867|NCT03493685|524133474|FG001|Overall Study|Withdrawal by Subject|11|||
145350868|NCT04452669|524133475|FG000|Overall Study|Death|1|||
145350869|NCT04452669|524133476|FG001|Overall Study|Death|4|||
145350870|NCT04576507|524133477|FG000|Overall Study|Adverse Event|4|||
145350871|NCT04576507|524133477|FG000|Overall Study|Withdrawal by Subject|1|||
145350872|NCT04467840|524133478|FG000|Overall Study|Death|35|||
145350873|NCT04467840|524133479|FG001|Overall Study|Death|39|||
145350874|NCT04467840|524133478|FG000|Overall Study|Withdrawal by Subject|8|||
145350875|NCT04467840|524133479|FG001|Overall Study|Withdrawal by Subject|4|||
145350876|NCT04467840|524133478|FG000|Overall Study|Adverse Event|2|||
145350877|NCT04467840|524133479|FG001|Overall Study|Adverse Event|0|||
145350878|NCT04467840|524133478|FG000|Overall Study|Lost to Follow-up|1|||
145350879|NCT04467840|524133479|FG001|Overall Study|Lost to Follow-up|3|||
145350880|NCT04467840|524133478|FG000|Overall Study|Physician Decision|1|||
145350881|NCT04467840|524133479|FG001|Overall Study|Physician Decision|0|||
145350882|NCT04467840|524133478|FG000|Overall Study|Other|1|||
145350883|NCT04467840|524133479|FG001|Overall Study|Other|5|||
145350884|NCT04467840|524133478|FG000|Overall Study|Missing study completion status|3|||
145350885|NCT04467840|524133479|FG001|Overall Study|Missing study completion status|1|||
145350886|NCT05201794|524133484|FG000|Overall Study|Withdrawal by Subject|13|||
145350887|NCT05201794|524133485|FG001|Overall Study|Withdrawal by Subject|12|||
145350888|NCT05201794|524133486|FG002|Overall Study|Withdrawal by Subject|14|||
145350889|NCT05201794|524133487|FG003|Overall Study|Withdrawal by Subject|0|||
145350890|NCT05201794|524133484|FG000|Overall Study|Adverse Event|5|||
145350891|NCT05201794|524133485|FG001|Overall Study|Adverse Event|5|||
145350892|NCT05201794|524133486|FG002|Overall Study|Adverse Event|4|||
145350893|NCT05201794|524133487|FG003|Overall Study|Adverse Event|0|||
145350894|NCT05201794|524133484|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
145350895|NCT05201794|524133485|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145350896|NCT05201794|524133486|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
145350897|NCT05201794|524133487|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145350898|NCT05201794|524133484|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145350899|NCT05201794|524133485|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145350900|NCT05201794|524133486|FG002|Overall Study|Non-Compliance With Study Drug|3|||
145350901|NCT05201794|524133487|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145350902|NCT05201794|524133484|FG000|Overall Study|Physician Decision|1|||
145350903|NCT05201794|524133485|FG001|Overall Study|Physician Decision|3|||
145350904|NCT05201794|524133486|FG002|Overall Study|Physician Decision|2|||
145350905|NCT05201794|524133487|FG003|Overall Study|Physician Decision|0|||
145350906|NCT05201794|524133484|FG000|Overall Study|Lost to Follow-up|2|||
145350907|NCT05201794|524133485|FG001|Overall Study|Lost to Follow-up|2|||
145350908|NCT05201794|524133486|FG002|Overall Study|Lost to Follow-up|0|||
145350909|NCT05201794|524133487|FG003|Overall Study|Lost to Follow-up|0|||
145350910|NCT05201794|524133484|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
145350911|NCT05201794|524133485|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
145350912|NCT05201794|524133486|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
145350913|NCT05201794|524133487|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
145350914|NCT05201794|524133484|FG000|Overall Study|Protocol Violation|2|||
145350915|NCT05201794|524133485|FG001|Overall Study|Protocol Violation|0|||
145350916|NCT05201794|524133486|FG002|Overall Study|Protocol Violation|1|||
145350917|NCT05201794|524133487|FG003|Overall Study|Protocol Violation|0|||
145350918|NCT05201794|524133484|FG000|Overall Study|Death|1|||
145350919|NCT05201794|524133485|FG001|Overall Study|Death|0|||
145350920|NCT05201794|524133486|FG002|Overall Study|Death|0|||
145350921|NCT05201794|524133487|FG003|Overall Study|Death|0|||
145350922|NCT05201794|524133484|FG000|Overall Study|Site Terminated By Sponsor|0|||
145415476|NCT01734928|524376338|FG000|Randomization|Withdrew informed consent|0|||
145415477|NCT01734928|524376339|FG001|Randomization|Withdrew informed consent|4|||
145415478|NCT01734928|524376338|FG000|Randomization|Death|1|||
145415479|NCT01734928|524376339|FG001|Randomization|Death|0|||
145415480|NCT01734928|524376338|FG000|Randomization|Randomization error|1|||
145415481|NCT01734928|524376339|FG001|Randomization|Randomization error|0|||
145415482|NCT01734928|524376338|FG000|Randomization|Lost to Follow-up|1|||
145415483|NCT01734928|524376339|FG001|Randomization|Lost to Follow-up|0|||
145415484|NCT01734928|524376338|FG000|Treatment Period|Lost to Follow-up|0|||
145415485|NCT01734928|524376339|FG001|Treatment Period|Lost to Follow-up|2|||
145415486|NCT01734928|524376338|FG000|Treatment Period|Progressive Disease|167|||
145415487|NCT01734928|524376339|FG001|Treatment Period|Progressive Disease|165|||
145415488|NCT01734928|524376338|FG000|Treatment Period|Adverse Event|39|||
145415489|NCT01734928|524376339|FG001|Treatment Period|Adverse Event|52|||
145415490|NCT01734928|524376338|FG000|Treatment Period|Withdrawal of Consent|25|||
145415491|NCT01734928|524376339|FG001|Treatment Period|Withdrawal of Consent|22|||
145415492|NCT01734928|524376338|FG000|Treatment Period|Death|20|||
145415493|NCT01734928|524376339|FG001|Treatment Period|Death|9|||
145415494|NCT01734928|524376338|FG000|Treatment Period|Other Reasons|27|||
145415495|NCT01734928|524376339|FG001|Treatment Period|Other Reasons|19|||
145415496|NCT01734928|524376338|FG000|Treatment Period|Pregnancy|0|||
145415497|NCT01734928|524376339|FG001|Treatment Period|Pregnancy|1|||
145415498|NCT00620035|524376340|FG000|Overall Study|Adverse Event|106|||
145415499|NCT00620035|524376340|FG000|Overall Study|Withdrawal of Informed Consent|1|||
145415500|NCT00620035|524376340|FG000|Overall Study|Other Reason|38|||
145415501|NCT01778985|524376343|FG000|Overall Study|Lost to Follow-up|1|||
145415502|NCT01778985|524376344|FG001|Overall Study|Lost to Follow-up|0|||
145415503|NCT01778985|524376343|FG000|Overall Study|Physician Decision|2|||
145415504|NCT01778985|524376344|FG001|Overall Study|Physician Decision|2|||
145415505|NCT01778985|524376343|FG000|Overall Study|Protocol Violation|4|||
145415506|NCT01778985|524376344|FG001|Overall Study|Protocol Violation|1|||
145415507|NCT00088881|524376345|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
145415508|NCT00088881|524376345|FG000|Step 1 - R-CHOP|Adverse Event|1|||
145415509|NCT00088881|524376345|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
145415510|NCT00088881|524376345|FG000|Step 1 - R-CHOP|Physician Decision|1|||
145415511|NCT00088881|524376345|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
145415512|NCT00088881|524376345|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
145415513|NCT00088881|524376345|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
145415514|NCT00456612|524376346|FG000|Overall Study|Withdrawal by Subject|3|||
145415515|NCT00758043|524376349|FG000|Overall Study|Adverse Event|1|||
145415516|NCT00758043|524376350|FG001|Overall Study|Adverse Event|20|||
145577231|NCT02357576|524968024|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
145350923|NCT05201794|524133485|FG001|Overall Study|Site Terminated By Sponsor|1|||
145350924|NCT05201794|524133486|FG002|Overall Study|Site Terminated By Sponsor|0|||
145350925|NCT05201794|524133487|FG003|Overall Study|Site Terminated By Sponsor|0|||
145350926|NCT05201794|524133484|FG000|Overall Study|Other|3|||
145350927|NCT05201794|524133485|FG001|Overall Study|Other|3|||
145350928|NCT05201794|524133486|FG002|Overall Study|Other|3|||
145350929|NCT05201794|524133487|FG003|Overall Study|Other|0|||
145350930|NCT05201794|524133484|FG000|Overall Study|Randomized But Not Treated|1|||
145350931|NCT05201794|524133485|FG001|Overall Study|Randomized But Not Treated|2|||
145350932|NCT05201794|524133486|FG002|Overall Study|Randomized But Not Treated|1|||
145350933|NCT05201794|524133487|FG003|Overall Study|Randomized But Not Treated|0|||
145350934|NCT04653454|524133492|FG000|Overall Study|Withdrawal by Subject|1|||
145350935|NCT04653454|524133492|FG000|Overall Study|Physician Decision|40|||
145350936|NCT05525520|524133493|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
145350937|NCT05525520|524133494|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
145350938|NCT05525520|524133493|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
145350939|NCT05525520|524133494|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
145350940|NCT02721732|524133497|FG000|Overall Study|Adverse Event|2|||
145350941|NCT02721732|524133498|FG001|Overall Study|Adverse Event|0|||
145350942|NCT02721732|524133499|FG002|Overall Study|Adverse Event|2|||
145350943|NCT02721732|524133500|FG003|Overall Study|Adverse Event|0|||
145350944|NCT02721732|524133501|FG004|Overall Study|Adverse Event|1|||
145350945|NCT02721732|524133502|FG005|Overall Study|Adverse Event|0|||
145350946|NCT02721732|524133503|FG006|Overall Study|Adverse Event|1|||
145350947|NCT02721732|524133504|FG007|Overall Study|Adverse Event|0|||
145350948|NCT02721732|524133505|FG008|Overall Study|Adverse Event|1|||
145350949|NCT02721732|524133506|FG009|Overall Study|Adverse Event|1|||
145350950|NCT02721732|524133497|FG000|Overall Study|Death|0|||
145350951|NCT02721732|524133498|FG001|Overall Study|Death|0|||
145350952|NCT02721732|524133499|FG002|Overall Study|Death|0|||
145350953|NCT02721732|524133500|FG003|Overall Study|Death|0|||
145350954|NCT02721732|524133501|FG004|Overall Study|Death|1|||
145415517|NCT00758043|524376351|FG002|Overall Study|Adverse Event|12|||
145415518|NCT00758043|524376352|FG003|Overall Study|Adverse Event|62|||
145415519|NCT00758043|524376349|FG000|Overall Study|Lack of Efficacy|0|||
145415520|NCT00758043|524376350|FG001|Overall Study|Lack of Efficacy|6|||
145415521|NCT00758043|524376351|FG002|Overall Study|Lack of Efficacy|18|||
145415522|NCT00758043|524376352|FG003|Overall Study|Lack of Efficacy|12|||
145415523|NCT00758043|524376349|FG000|Overall Study|Refused Further Treatment|0|||
145350955|NCT02721732|524133502|FG005|Overall Study|Death|0|||
145350956|NCT02721732|524133503|FG006|Overall Study|Death|1|||
145350957|NCT02721732|524133504|FG007|Overall Study|Death|0|||
145350958|NCT02721732|524133505|FG008|Overall Study|Death|0|||
145350959|NCT02721732|524133506|FG009|Overall Study|Death|1|||
145350960|NCT02721732|524133497|FG000|Overall Study|Lack of Efficacy|12|||
145350961|NCT02721732|524133498|FG001|Overall Study|Lack of Efficacy|11|||
145350962|NCT02721732|524133499|FG002|Overall Study|Lack of Efficacy|18|||
145350963|NCT02721732|524133500|FG003|Overall Study|Lack of Efficacy|5|||
145350964|NCT02721732|524133501|FG004|Overall Study|Lack of Efficacy|21|||
145350965|NCT02721732|524133502|FG005|Overall Study|Lack of Efficacy|2|||
145350966|NCT02721732|524133503|FG006|Overall Study|Lack of Efficacy|8|||
145350967|NCT02721732|524133504|FG007|Overall Study|Lack of Efficacy|11|||
145350968|NCT02721732|524133505|FG008|Overall Study|Lack of Efficacy|10|||
145350969|NCT02721732|524133506|FG009|Overall Study|Lack of Efficacy|20|||
145350970|NCT02721732|524133497|FG000|Overall Study|Physician Decision|0|||
145350971|NCT02721732|524133498|FG001|Overall Study|Physician Decision|0|||
145350972|NCT02721732|524133499|FG002|Overall Study|Physician Decision|1|||
145350973|NCT02721732|524133500|FG003|Overall Study|Physician Decision|0|||
145350974|NCT02721732|524133501|FG004|Overall Study|Physician Decision|0|||
145350975|NCT02721732|524133502|FG005|Overall Study|Physician Decision|0|||
145350976|NCT02721732|524133503|FG006|Overall Study|Physician Decision|0|||
145350977|NCT02721732|524133504|FG007|Overall Study|Physician Decision|0|||
145350978|NCT02721732|524133505|FG008|Overall Study|Physician Decision|0|||
145350979|NCT02721732|524133506|FG009|Overall Study|Physician Decision|0|||
145350980|NCT02721732|524133497|FG000|Overall Study|Withdrawal by Subject|1|||
145350981|NCT02721732|524133498|FG001|Overall Study|Withdrawal by Subject|0|||
145350982|NCT02721732|524133499|FG002|Overall Study|Withdrawal by Subject|0|||
145350983|NCT02721732|524133500|FG003|Overall Study|Withdrawal by Subject|0|||
145350984|NCT02721732|524133501|FG004|Overall Study|Withdrawal by Subject|3|||
145350985|NCT02721732|524133502|FG005|Overall Study|Withdrawal by Subject|0|||
145350986|NCT02721732|524133503|FG006|Overall Study|Withdrawal by Subject|1|||
145350987|NCT02721732|524133504|FG007|Overall Study|Withdrawal by Subject|1|||
145350988|NCT02721732|524133505|FG008|Overall Study|Withdrawal by Subject|0|||
145350989|NCT02721732|524133506|FG009|Overall Study|Withdrawal by Subject|1|||
145350990|NCT02721732|524133497|FG000|Overall Study|Participant Choice|1|||
145350991|NCT02721732|524133498|FG001|Overall Study|Participant Choice|0|||
145350992|NCT02721732|524133499|FG002|Overall Study|Participant Choice|0|||
145350993|NCT02721732|524133500|FG003|Overall Study|Participant Choice|0|||
145350994|NCT02721732|524133501|FG004|Overall Study|Participant Choice|0|||
145350995|NCT02721732|524133502|FG005|Overall Study|Participant Choice|0|||
145350996|NCT02721732|524133503|FG006|Overall Study|Participant Choice|0|||
145350997|NCT02721732|524133504|FG007|Overall Study|Participant Choice|0|||
145350998|NCT02721732|524133505|FG008|Overall Study|Participant Choice|0|||
145350999|NCT02721732|524133506|FG009|Overall Study|Participant Choice|1|||
145351000|NCT02721732|524133497|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351001|NCT02721732|524133498|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351002|NCT02721732|524133499|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
145351003|NCT02721732|524133500|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351004|NCT02721732|524133501|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351005|NCT02721732|524133502|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351006|NCT02721732|524133503|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351007|NCT02721732|524133504|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351008|NCT02721732|524133505|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351009|NCT02721732|524133506|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
145351010|NCT02721732|524133497|FG000|Overall Study|Progression and withdrew consent|1|||
145351011|NCT02721732|524133498|FG001|Overall Study|Progression and withdrew consent|1|||
145351012|NCT02721732|524133499|FG002|Overall Study|Progression and withdrew consent|0|||
145351013|NCT02721732|524133500|FG003|Overall Study|Progression and withdrew consent|0|||
145351014|NCT02721732|524133501|FG004|Overall Study|Progression and withdrew consent|0|||
145351015|NCT02721732|524133502|FG005|Overall Study|Progression and withdrew consent|0|||
145351016|NCT02721732|524133503|FG006|Overall Study|Progression and withdrew consent|0|||
145351017|NCT02721732|524133504|FG007|Overall Study|Progression and withdrew consent|0|||
145351018|NCT02721732|524133505|FG008|Overall Study|Progression and withdrew consent|0|||
145351019|NCT02721732|524133506|FG009|Overall Study|Progression and withdrew consent|1|||
145351020|NCT02721732|524133497|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
145351021|NCT02721732|524133498|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
145351022|NCT02721732|524133499|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
145351023|NCT02721732|524133500|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
145351024|NCT02721732|524133501|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
145351025|NCT02721732|524133502|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
145351026|NCT02721732|524133503|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
145577232|NCT02357576|524968023|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
145577233|NCT02357576|524968024|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
145351027|NCT02721732|524133504|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
145351028|NCT02721732|524133505|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
145351029|NCT02721732|524133506|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
145351030|NCT02848001|524133507|FG000|Overall Study|other reasons|0|||
145351031|NCT02848001|524133508|FG001|Overall Study|other reasons|0|||
145351032|NCT02848001|524133509|FG002|Overall Study|other reasons|1|||
145351033|NCT02848001|524133510|FG003|Overall Study|other reasons|0|||
145351034|NCT02848001|524133511|FG004|Overall Study|other reasons|4|||
145351035|NCT02848001|524133512|FG005|Overall Study|other reasons|1|||
145351036|NCT02848001|524133513|FG006|Overall Study|other reasons|0|||
145351037|NCT02848001|524133514|FG007|Overall Study|other reasons|2|||
145351038|NCT02848001|524133515|FG008|Overall Study|other reasons|2|||
145351039|NCT02848001|524133516|FG009|Overall Study|other reasons|3|||
145351040|NCT02848001|524133517|FG010|Overall Study|other reasons|0|||
145351041|NCT02848001|524133518|FG011|Overall Study|other reasons|1|||
145351042|NCT02848001|524133519|FG012|Overall Study|other reasons|1|||
145351043|NCT02848001|524133520|FG013|Overall Study|other reasons|0|||
145351044|NCT02848001|524133521|FG014|Overall Study|other reasons|0|||
145351045|NCT02848001|524133522|FG015|Overall Study|other reasons|2|||
145351046|NCT02848001|524133523|FG016|Overall Study|other reasons|1|||
145351047|NCT02848001|524133507|FG000|Overall Study|Lack of Efficacy|0|||
145351048|NCT02848001|524133508|FG001|Overall Study|Lack of Efficacy|1|||
145351049|NCT02848001|524133509|FG002|Overall Study|Lack of Efficacy|1|||
145351050|NCT02848001|524133510|FG003|Overall Study|Lack of Efficacy|2|||
145351051|NCT02848001|524133511|FG004|Overall Study|Lack of Efficacy|3|||
145351052|NCT02848001|524133512|FG005|Overall Study|Lack of Efficacy|0|||
145351053|NCT02848001|524133513|FG006|Overall Study|Lack of Efficacy|1|||
145351054|NCT02848001|524133514|FG007|Overall Study|Lack of Efficacy|0|||
145351055|NCT02848001|524133515|FG008|Overall Study|Lack of Efficacy|0|||
145351056|NCT02848001|524133516|FG009|Overall Study|Lack of Efficacy|1|||
145351057|NCT02848001|524133517|FG010|Overall Study|Lack of Efficacy|0|||
145351058|NCT02848001|524133518|FG011|Overall Study|Lack of Efficacy|2|||
145351059|NCT02848001|524133519|FG012|Overall Study|Lack of Efficacy|0|||
145351060|NCT02848001|524133520|FG013|Overall Study|Lack of Efficacy|2|||
145351061|NCT02848001|524133521|FG014|Overall Study|Lack of Efficacy|2|||
145351062|NCT02848001|524133522|FG015|Overall Study|Lack of Efficacy|0|||
145351063|NCT02848001|524133523|FG016|Overall Study|Lack of Efficacy|0|||
145351064|NCT02848001|524133507|FG000|Overall Study|Progressive Disease|2|||
145351065|NCT02848001|524133508|FG001|Overall Study|Progressive Disease|1|||
145351066|NCT02848001|524133509|FG002|Overall Study|Progressive Disease|0|||
145351067|NCT02848001|524133510|FG003|Overall Study|Progressive Disease|4|||
145351068|NCT02848001|524133511|FG004|Overall Study|Progressive Disease|3|||
145351069|NCT02848001|524133512|FG005|Overall Study|Progressive Disease|0|||
145351070|NCT02848001|524133513|FG006|Overall Study|Progressive Disease|4|||
145351071|NCT02848001|524133514|FG007|Overall Study|Progressive Disease|1|||
145351072|NCT02848001|524133515|FG008|Overall Study|Progressive Disease|0|||
145351073|NCT02848001|524133516|FG009|Overall Study|Progressive Disease|2|||
145351074|NCT02848001|524133517|FG010|Overall Study|Progressive Disease|3|||
145351075|NCT02848001|524133518|FG011|Overall Study|Progressive Disease|2|||
145351076|NCT02848001|524133519|FG012|Overall Study|Progressive Disease|1|||
145351077|NCT02848001|524133520|FG013|Overall Study|Progressive Disease|0|||
145351078|NCT02848001|524133521|FG014|Overall Study|Progressive Disease|2|||
145351079|NCT02848001|524133522|FG015|Overall Study|Progressive Disease|4|||
145351080|NCT02848001|524133523|FG016|Overall Study|Progressive Disease|0|||
145351081|NCT02848001|524133507|FG000|Overall Study|Adverse Event|0|||
145351082|NCT02848001|524133508|FG001|Overall Study|Adverse Event|0|||
145351083|NCT02848001|524133509|FG002|Overall Study|Adverse Event|0|||
145351084|NCT02848001|524133510|FG003|Overall Study|Adverse Event|0|||
145351085|NCT02848001|524133511|FG004|Overall Study|Adverse Event|2|||
145577234|NCT02357576|524968023|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
145577235|NCT02357576|524968024|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
145577236|NCT02357576|524968023|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
145351086|NCT02848001|524133512|FG005|Overall Study|Adverse Event|0|||
145351087|NCT02848001|524133513|FG006|Overall Study|Adverse Event|0|||
145351088|NCT02848001|524133514|FG007|Overall Study|Adverse Event|0|||
145351089|NCT02848001|524133515|FG008|Overall Study|Adverse Event|0|||
145351090|NCT02848001|524133516|FG009|Overall Study|Adverse Event|1|||
145351091|NCT02848001|524133517|FG010|Overall Study|Adverse Event|0|||
145351092|NCT02848001|524133518|FG011|Overall Study|Adverse Event|1|||
145351093|NCT02848001|524133519|FG012|Overall Study|Adverse Event|1|||
145577237|NCT02357576|524968024|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
145351094|NCT02848001|524133520|FG013|Overall Study|Adverse Event|0|||
145351095|NCT02848001|524133521|FG014|Overall Study|Adverse Event|2|||
145351096|NCT02848001|524133522|FG015|Overall Study|Adverse Event|0|||
145351097|NCT02848001|524133523|FG016|Overall Study|Adverse Event|0|||
145351098|NCT02848001|524133507|FG000|Overall Study|Death|0|||
145577238|NCT00699699|524968025|FG000|Overall Study|Adverse Event|36|||
145351099|NCT02848001|524133508|FG001|Overall Study|Death|0|||
145351100|NCT02848001|524133509|FG002|Overall Study|Death|0|||
145351101|NCT02848001|524133510|FG003|Overall Study|Death|1|||
145351102|NCT02848001|524133511|FG004|Overall Study|Death|3|||
145351103|NCT02848001|524133512|FG005|Overall Study|Death|1|||
145351104|NCT02848001|524133513|FG006|Overall Study|Death|2|||
145351105|NCT02848001|524133514|FG007|Overall Study|Death|3|||
145351106|NCT02848001|524133515|FG008|Overall Study|Death|4|||
145351107|NCT02848001|524133516|FG009|Overall Study|Death|1|||
145351108|NCT02848001|524133517|FG010|Overall Study|Death|0|||
145351109|NCT02848001|524133518|FG011|Overall Study|Death|1|||
145351110|NCT02848001|524133519|FG012|Overall Study|Death|3|||
145351111|NCT02848001|524133520|FG013|Overall Study|Death|0|||
145351112|NCT02848001|524133521|FG014|Overall Study|Death|2|||
145351113|NCT02848001|524133522|FG015|Overall Study|Death|3|||
145351114|NCT02848001|524133523|FG016|Overall Study|Death|0|||
145351115|NCT02848001|524133507|FG000|Overall Study|Physician Decision|0|||
145351116|NCT02848001|524133508|FG001|Overall Study|Physician Decision|0|||
145351117|NCT02848001|524133509|FG002|Overall Study|Physician Decision|0|||
145351118|NCT02848001|524133510|FG003|Overall Study|Physician Decision|0|||
145351119|NCT02848001|524133511|FG004|Overall Study|Physician Decision|0|||
145351120|NCT02848001|524133512|FG005|Overall Study|Physician Decision|0|||
145351121|NCT02848001|524133513|FG006|Overall Study|Physician Decision|0|||
145351122|NCT02848001|524133514|FG007|Overall Study|Physician Decision|0|||
145351123|NCT02848001|524133515|FG008|Overall Study|Physician Decision|1|||
145351124|NCT02848001|524133516|FG009|Overall Study|Physician Decision|1|||
145351125|NCT02848001|524133517|FG010|Overall Study|Physician Decision|0|||
145351126|NCT02848001|524133518|FG011|Overall Study|Physician Decision|0|||
145351127|NCT02848001|524133519|FG012|Overall Study|Physician Decision|2|||
145351128|NCT02848001|524133520|FG013|Overall Study|Physician Decision|0|||
145351129|NCT02848001|524133521|FG014|Overall Study|Physician Decision|0|||
145351130|NCT02848001|524133522|FG015|Overall Study|Physician Decision|0|||
145351131|NCT02848001|524133523|FG016|Overall Study|Physician Decision|0|||
145351132|NCT02848001|524133507|FG000|Overall Study|Withdrawal by Subject|0|||
145351133|NCT02848001|524133508|FG001|Overall Study|Withdrawal by Subject|0|||
145351134|NCT02848001|524133509|FG002|Overall Study|Withdrawal by Subject|0|||
145351135|NCT02848001|524133510|FG003|Overall Study|Withdrawal by Subject|0|||
145351136|NCT02848001|524133511|FG004|Overall Study|Withdrawal by Subject|0|||
145351137|NCT02848001|524133512|FG005|Overall Study|Withdrawal by Subject|1|||
145351138|NCT02848001|524133513|FG006|Overall Study|Withdrawal by Subject|1|||
145351139|NCT02848001|524133514|FG007|Overall Study|Withdrawal by Subject|1|||
145351140|NCT02848001|524133515|FG008|Overall Study|Withdrawal by Subject|0|||
145351141|NCT02848001|524133516|FG009|Overall Study|Withdrawal by Subject|0|||
145351142|NCT02848001|524133517|FG010|Overall Study|Withdrawal by Subject|0|||
145351143|NCT02848001|524133518|FG011|Overall Study|Withdrawal by Subject|0|||
145351144|NCT02848001|524133519|FG012|Overall Study|Withdrawal by Subject|0|||
145351145|NCT02848001|524133520|FG013|Overall Study|Withdrawal by Subject|0|||
145351146|NCT02848001|524133521|FG014|Overall Study|Withdrawal by Subject|0|||
145351147|NCT02848001|524133522|FG015|Overall Study|Withdrawal by Subject|0|||
145351148|NCT02848001|524133523|FG016|Overall Study|Withdrawal by Subject|0|||
145351149|NCT00711243|524133524|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
145351150|NCT00711243|524133525|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
145351151|NCT00711243|524133526|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
145351152|NCT00711243|524133527|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
145351153|NCT00711243|524133528|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
145351154|NCT00711243|524133529|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
145351155|NCT00711243|524133524|FG000|Reached First Response/4 Cycles|Death|0|||
145351156|NCT00711243|524133525|FG001|Reached First Response/4 Cycles|Death|0|||
145351157|NCT00711243|524133526|FG002|Reached First Response/4 Cycles|Death|0|||
145577239|NCT00699699|524968025|FG000|Overall Study|Individual different reasons|21|||
145577240|NCT00705575|524968026|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145351158|NCT00711243|524133527|FG003|Reached First Response/4 Cycles|Death|0|||
145351159|NCT00711243|524133528|FG004|Reached First Response/4 Cycles|Death|0|||
145351160|NCT00711243|524133529|FG005|Reached First Response/4 Cycles|Death|2|||
145351161|NCT00711243|524133524|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
145351162|NCT00711243|524133525|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
145351163|NCT00711243|524133526|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
145415524|NCT00758043|524376350|FG001|Overall Study|Refused Further Treatment|11|||
145577241|NCT00705575|524968027|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145351164|NCT00711243|524133527|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
145351165|NCT00711243|524133528|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
145351166|NCT00711243|524133529|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
145351167|NCT00711243|524133524|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
145351168|NCT00711243|524133525|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
145415525|NCT00758043|524376351|FG002|Overall Study|Refused Further Treatment|5|||
145415526|NCT00758043|524376352|FG003|Overall Study|Refused Further Treatment|8|||
145415527|NCT00758043|524376349|FG000|Overall Study|Lost to Follow-up|0|||
145415528|NCT00758043|524376350|FG001|Overall Study|Lost to Follow-up|2|||
145415529|NCT00758043|524376351|FG002|Overall Study|Lost to Follow-up|2|||
145415530|NCT00758043|524376352|FG003|Overall Study|Lost to Follow-up|5|||
145415531|NCT00758043|524376349|FG000|Overall Study|Withdrawal by Subject|0|||
145415532|NCT00758043|524376350|FG001|Overall Study|Withdrawal by Subject|1|||
145415533|NCT00758043|524376351|FG002|Overall Study|Withdrawal by Subject|1|||
145415534|NCT00758043|524376352|FG003|Overall Study|Withdrawal by Subject|4|||
145415535|NCT00758043|524376349|FG000|Overall Study|Required Prohibited Medication|0|||
145415536|NCT00758043|524376350|FG001|Overall Study|Required Prohibited Medication|0|||
145415537|NCT00758043|524376351|FG002|Overall Study|Required Prohibited Medication|1|||
145415538|NCT00758043|524376352|FG003|Overall Study|Required Prohibited Medication|3|||
145415539|NCT00758043|524376349|FG000|Overall Study|Non-Compliant With study Drug|0|||
145415540|NCT00758043|524376350|FG001|Overall Study|Non-Compliant With study Drug|0|||
145415541|NCT00758043|524376351|FG002|Overall Study|Non-Compliant With study Drug|0|||
145415542|NCT00758043|524376352|FG003|Overall Study|Non-Compliant With study Drug|1|||
145415543|NCT00758043|524376349|FG000|Overall Study|Other Reasons|0|||
145415544|NCT00758043|524376350|FG001|Overall Study|Other Reasons|1|||
145415545|NCT00758043|524376351|FG002|Overall Study|Other Reasons|0|||
145415546|NCT00758043|524376352|FG003|Overall Study|Other Reasons|5|||
145415547|NCT05788328|524376361|FG000|Treatment Period 4 (5 Days)|Other|1|||
145415548|NCT05788328|524376361|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
145415549|NCT00145327|524376362|FG000|Overall Study|Withdrawal by Subject|77|||
145415550|NCT00145327|524376363|FG001|Overall Study|Withdrawal by Subject|72|||
145415551|NCT00145327|524376364|FG002|Overall Study|Withdrawal by Subject|164|||
145415552|NCT00145327|524376362|FG000|Overall Study|Death|26|||
145415553|NCT00145327|524376363|FG001|Overall Study|Death|18|||
145415554|NCT00145327|524376364|FG002|Overall Study|Death|30|||
145415555|NCT00145327|524376362|FG000|Overall Study|Adverse Event|14|||
145415556|NCT00145327|524376363|FG001|Overall Study|Adverse Event|11|||
145415557|NCT00145327|524376364|FG002|Overall Study|Adverse Event|22|||
145415558|NCT00145327|524376362|FG000|Overall Study|Lost to Follow-up|9|||
145415559|NCT00145327|524376363|FG001|Overall Study|Lost to Follow-up|14|||
145415560|NCT00145327|524376364|FG002|Overall Study|Lost to Follow-up|14|||
145415561|NCT00145327|524376362|FG000|Overall Study|Administrative problems|12|||
145415562|NCT00145327|524376363|FG001|Overall Study|Administrative problems|9|||
145415563|NCT00145327|524376364|FG002|Overall Study|Administrative problems|13|||
145415564|NCT00145327|524376362|FG000|Overall Study|Protocol Violation|2|||
145415565|NCT00145327|524376363|FG001|Overall Study|Protocol Violation|0|||
145415566|NCT00145327|524376364|FG002|Overall Study|Protocol Violation|2|||
145415567|NCT00145327|524376362|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145415568|NCT00145327|524376363|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145415569|NCT00145327|524376364|FG002|Overall Study|Abnormal laboratory value(s)|2|||
145415570|NCT00145327|524376362|FG000|Overall Study|Missing - not stated|1|||
145415571|NCT00145327|524376363|FG001|Overall Study|Missing - not stated|0|||
145622913|NCT01606189|525130236|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
145622914|NCT01606189|525130237|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
145415572|NCT00145327|524376364|FG002|Overall Study|Missing - not stated|1|||
145415573|NCT04027946|524376365|FG000|Overall Study|Screen failures|3|||
145415574|NCT01028053|524376370|FG000|Overall Study|Screen Failure|113|||
145415575|NCT01028053|524376370|FG000|Overall Study|Patient Request|11|||
145415576|NCT01028053|524376370|FG000|Overall Study|Protocol Violation|1|||
145415577|NCT01028053|524376370|FG000|Overall Study|Physician Decision|2|||
145415578|NCT01028053|524376370|FG000|Overall Study|Technical Problem|1|||
145415579|NCT01028053|524376370|FG000|Overall Study|Terminated by Sponsor|1|||
145415580|NCT01028053|524376370|FG000|Overall Study|Various reasons|4|||
145415581|NCT03315689|524376371|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
145415582|NCT03315689|524376372|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
145415583|NCT03315689|524376371|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
145415584|NCT03315689|524376372|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
145622915|NCT01606189|525130238|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
145622916|NCT01354938|525130239|FG000|Overall Study|Lost to Follow-up|1|||
145622917|NCT01167023|525130240|FG000|Overall Study|Lost to Follow-up|0|||
145415585|NCT03315689|524376371|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
145415586|NCT03315689|524376372|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
145415587|NCT00864513|524376374|FG000|Overall Study|Withdrawal by Subject|3|||
145415588|NCT03073109|524376375|FG000|Overall Study|Adverse Event|0|||
145415589|NCT03073109|524376376|FG001|Overall Study|Adverse Event|1|||
145415590|NCT03073109|524376375|FG000|Overall Study|Other|2|||
145415591|NCT03073109|524376376|FG001|Overall Study|Other|0|||
145415592|NCT03073109|524376375|FG000|Overall Study|Lost to Follow-up|8|||
145415593|NCT03073109|524376376|FG001|Overall Study|Lost to Follow-up|1|||
145415594|NCT01348698|524376377|FG000|Overall Study|Does not meet lesion size criteria|1|||
145415595|NCT01348698|524376377|FG000|Overall Study|Death|3|||
145415596|NCT01348698|524376377|FG000|Overall Study|PI decision to close study|68|||
145415597|NCT01297244|524376378|FG000|Overall Study|Progressive disease|22|||
145415598|NCT01297244|524376379|FG001|Overall Study|Progressive disease|3|||
145415599|NCT01297244|524376378|FG000|Overall Study|Adverse Event|9|||
145415600|NCT01297244|524376379|FG001|Overall Study|Adverse Event|1|||
145415601|NCT01297244|524376378|FG000|Overall Study|Death|1|||
145415602|NCT01297244|524376379|FG001|Overall Study|Death|1|||
145415603|NCT01297244|524376378|FG000|Overall Study|Clinical progression|1|||
145415604|NCT01297244|524376379|FG001|Overall Study|Clinical progression|1|||
145415605|NCT01297244|524376378|FG000|Overall Study|Withdrawal by Subject|2|||
145415606|NCT01297244|524376379|FG001|Overall Study|Withdrawal by Subject|0|||
145415607|NCT01875237|524376380|FG000|Overall Study|GVDH before DLI|1|||
145415608|NCT01875237|524376381|FG001|Overall Study|GVDH before DLI|0|||
145415609|NCT01875237|524376380|FG000|Overall Study|DLI cells could not be produced|1|||
145415610|NCT01875237|524376381|FG001|Overall Study|DLI cells could not be produced|0|||
145415611|NCT00875667|524376384|FG000|Overall Study|Adverse Event|29|||
145415612|NCT00875667|524376385|FG001|Overall Study|Adverse Event|10|||
145415613|NCT00875667|524376384|FG000|Overall Study|Withdrawal by Subject|17|||
145415614|NCT00875667|524376385|FG001|Overall Study|Withdrawal by Subject|5|||
145415615|NCT00875667|524376384|FG000|Overall Study|Death|7|||
145415616|NCT00875667|524376385|FG001|Overall Study|Death|2|||
145415617|NCT00875667|524376384|FG000|Overall Study|Protocol Violation|2|||
145415618|NCT00875667|524376385|FG001|Overall Study|Protocol Violation|0|||
145415619|NCT00875667|524376384|FG000|Overall Study|Disease Progression|100|||
145415620|NCT00875667|524376385|FG001|Overall Study|Disease Progression|49|||
145415621|NCT00875667|524376384|FG000|Overall Study|Miscellaneous|12|||
145415622|NCT00875667|524376385|FG001|Overall Study|Miscellaneous|6|||
145415623|NCT00875667|524376384|FG000|Overall Study|Randomized but no Study Drug Given|3|||
145415624|NCT00875667|524376385|FG001|Overall Study|Randomized but no Study Drug Given|1|||
145415625|NCT02400580|524376395|FG000|Overall Study|Withdrawal by Subject|1|||
145415626|NCT02400580|524376396|FG001|Overall Study|Withdrawal by Subject|1|||
145415627|NCT02400580|524376395|FG000|Overall Study|Adverse Event|1|||
145351169|NCT00711243|524133526|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
145351170|NCT00711243|524133527|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
145351171|NCT00711243|524133528|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
145351172|NCT00711243|524133529|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
145351173|NCT00711243|524133524|FG000|Treated Cycle 5 After First Response|Death|0|||
145351174|NCT00711243|524133525|FG001|Treated Cycle 5 After First Response|Death|0|||
145351175|NCT00711243|524133526|FG002|Treated Cycle 5 After First Response|Death|0|||
145351176|NCT00711243|524133527|FG003|Treated Cycle 5 After First Response|Death|0|||
145351177|NCT00711243|524133528|FG004|Treated Cycle 5 After First Response|Death|0|||
145351178|NCT00711243|524133529|FG005|Treated Cycle 5 After First Response|Death|2|||
145351179|NCT00711243|524133524|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
145351180|NCT00711243|524133525|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
145351181|NCT00711243|524133526|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
145351182|NCT00711243|524133527|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
145351183|NCT00711243|524133528|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
145351184|NCT00711243|524133529|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
145351185|NCT00711243|524133524|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145351186|NCT00711243|524133525|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145351187|NCT00711243|524133526|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145351188|NCT00711243|524133527|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145351189|NCT00711243|524133528|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
145351190|NCT00711243|524133529|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
145351191|NCT01962103|524133533|FG000|Phase 1|Adverse Event|4|||
145351192|NCT01962103|524133534|FG001|Phase 1|Adverse Event|0|||
145351193|NCT01962103|524133535|FG002|Phase 1|Adverse Event|2|||
145351194|NCT01962103|524133536|FG003|Phase 1|Adverse Event|1|||
145351195|NCT01962103|524133537|FG004|Phase 1|Adverse Event|2|||
145351196|NCT01962103|524133538|FG005|Phase 1|Adverse Event|2|||
145351197|NCT01962103|524133539|FG006|Phase 1|Adverse Event|0|||
145351198|NCT01962103|524133540|FG007|Phase 1|Adverse Event|0|||
145351199|NCT01962103|524133541|FG008|Phase 1|Adverse Event|0|||
145415628|NCT02400580|524376396|FG001|Overall Study|Adverse Event|0|||
145415629|NCT00965094|524376397|FG000|Overall Study|Adverse Event|5|||
145351200|NCT01962103|524133533|FG000|Phase 1|Progressive Disease|8|||
145351201|NCT01962103|524133534|FG001|Phase 1|Progressive Disease|6|||
145351202|NCT01962103|524133535|FG002|Phase 1|Progressive Disease|8|||
145415630|NCT00965094|524376398|FG001|Overall Study|Adverse Event|0|||
145415631|NCT00965094|524376397|FG000|Overall Study|Lost to Follow-up|0|||
145415632|NCT00965094|524376398|FG001|Overall Study|Lost to Follow-up|1|||
145415633|NCT04149353|524376413|FG000|Overall Study|Study terminated|1|||
145415634|NCT02068599|524376414|FG000|Overall Study|Adverse Event|4|||
145415635|NCT02068599|524376415|FG001|Overall Study|Adverse Event|1|||
145415636|NCT02068599|524376416|FG002|Overall Study|Adverse Event|1|||
145415637|NCT02068599|524376414|FG000|Overall Study|Withdrawal by Subject|2|||
145415638|NCT02068599|524376415|FG001|Overall Study|Withdrawal by Subject|7|||
145415639|NCT02068599|524376416|FG002|Overall Study|Withdrawal by Subject|5|||
145415640|NCT02068599|524376414|FG000|Overall Study|Protocol Violation|4|||
145415641|NCT02068599|524376415|FG001|Overall Study|Protocol Violation|2|||
145415642|NCT02068599|524376416|FG002|Overall Study|Protocol Violation|3|||
145415643|NCT02068599|524376414|FG000|Overall Study|Lost to Follow-up|1|||
145415644|NCT02068599|524376415|FG001|Overall Study|Lost to Follow-up|0|||
145415645|NCT02068599|524376416|FG002|Overall Study|Lost to Follow-up|0|||
145415646|NCT02068599|524376414|FG000|Overall Study|Lack of Efficacy|0|||
145415647|NCT02068599|524376415|FG001|Overall Study|Lack of Efficacy|0|||
145415648|NCT02068599|524376416|FG002|Overall Study|Lack of Efficacy|3|||
145415649|NCT02068599|524376414|FG000|Overall Study|Noncompliance|0|||
145415650|NCT02068599|524376415|FG001|Overall Study|Noncompliance|0|||
145415651|NCT02068599|524376416|FG002|Overall Study|Noncompliance|1|||
145415652|NCT01871727|524376417|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
145415653|NCT01871727|524376418|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
145415654|NCT01871727|524376419|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
145415655|NCT01871727|524376420|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
145415656|NCT01871727|524376421|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
145415657|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
145415658|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
145415659|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
145415660|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
145415661|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
145415662|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145415663|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145415664|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145415665|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
145415666|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
145415667|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145415668|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145415669|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145415670|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
145415671|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
145415672|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145415673|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145415674|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145415675|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
145415676|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
145415677|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145415678|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145415679|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145415680|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
145415681|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
145415682|NCT01871727|524376417|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
145415683|NCT01871727|524376418|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
145415684|NCT01871727|524376419|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
145415685|NCT01871727|524376420|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
145415686|NCT01871727|524376421|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
145415687|NCT01263028|524376422|FG000|Overall Study|Withdrawal by Subject|1|||
145351203|NCT01962103|524133536|FG003|Phase 1|Progressive Disease|4|||
145351204|NCT01962103|524133537|FG004|Phase 1|Progressive Disease|5|||
145351205|NCT01962103|524133538|FG005|Phase 1|Progressive Disease|4|||
145351206|NCT01962103|524133539|FG006|Phase 1|Progressive Disease|0|||
145351207|NCT01962103|524133540|FG007|Phase 1|Progressive Disease|0|||
145351208|NCT01962103|524133541|FG008|Phase 1|Progressive Disease|0|||
145351209|NCT01962103|524133533|FG000|Phase 1|Withdrawal by Subject|0|||
145351210|NCT01962103|524133534|FG001|Phase 1|Withdrawal by Subject|0|||
145351211|NCT01962103|524133535|FG002|Phase 1|Withdrawal by Subject|0|||
145351212|NCT01962103|524133536|FG003|Phase 1|Withdrawal by Subject|2|||
145351213|NCT01962103|524133537|FG004|Phase 1|Withdrawal by Subject|0|||
145351214|NCT01962103|524133538|FG005|Phase 1|Withdrawal by Subject|0|||
145351215|NCT01962103|524133539|FG006|Phase 1|Withdrawal by Subject|0|||
145351216|NCT01962103|524133540|FG007|Phase 1|Withdrawal by Subject|0|||
145351217|NCT01962103|524133541|FG008|Phase 1|Withdrawal by Subject|0|||
145351218|NCT01962103|524133533|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
145351219|NCT01962103|524133534|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
145415688|NCT01263028|524376422|FG000|Overall Study|Adverse Event|1|||
145415689|NCT01263028|524376422|FG000|Overall Study|Study terminated due to low enrollment.|4|||
145415690|NCT03019588|524376423|FG000|Overall Study|Death|44|||
145415691|NCT03019588|524376424|FG001|Overall Study|Death|46|||
145415692|NCT03019588|524376423|FG000|Overall Study|Study terminated by Sponsor|3|||
145415693|NCT03019588|524376424|FG001|Overall Study|Study terminated by Sponsor|1|||
145415694|NCT00887588|524376427|FG000|Core Period|Death|1|||
145351220|NCT01962103|524133535|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
145351221|NCT01962103|524133536|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
145351222|NCT01962103|524133537|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
145351223|NCT01962103|524133538|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
145351224|NCT01962103|524133539|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
145351225|NCT01962103|524133540|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
145351226|NCT01962103|524133541|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
145351227|NCT01962103|524133533|FG000|Phase 1|Physician Decision|0|||
145351228|NCT01962103|524133534|FG001|Phase 1|Physician Decision|0|||
145351229|NCT01962103|524133535|FG002|Phase 1|Physician Decision|0|||
145351230|NCT01962103|524133536|FG003|Phase 1|Physician Decision|1|||
145351231|NCT01962103|524133537|FG004|Phase 1|Physician Decision|0|||
145351232|NCT01962103|524133538|FG005|Phase 1|Physician Decision|0|||
145351233|NCT01962103|524133539|FG006|Phase 1|Physician Decision|0|||
145351234|NCT01962103|524133540|FG007|Phase 1|Physician Decision|0|||
145351235|NCT01962103|524133541|FG008|Phase 1|Physician Decision|0|||
145351236|NCT01962103|524133533|FG000|Phase 1|Symptomatic Deterioration|3|||
145351237|NCT01962103|524133534|FG001|Phase 1|Symptomatic Deterioration|2|||
145351238|NCT01962103|524133535|FG002|Phase 1|Symptomatic Deterioration|2|||
145351239|NCT01962103|524133536|FG003|Phase 1|Symptomatic Deterioration|2|||
145351240|NCT01962103|524133537|FG004|Phase 1|Symptomatic Deterioration|1|||
145351241|NCT01962103|524133538|FG005|Phase 1|Symptomatic Deterioration|1|||
145351242|NCT01962103|524133539|FG006|Phase 1|Symptomatic Deterioration|0|||
145351243|NCT01962103|524133540|FG007|Phase 1|Symptomatic Deterioration|0|||
145351244|NCT01962103|524133541|FG008|Phase 1|Symptomatic Deterioration|0|||
145351245|NCT01962103|524133533|FG000|Phase 1|Miscellaneous|1|||
145351246|NCT01962103|524133534|FG001|Phase 1|Miscellaneous|0|||
145351247|NCT01962103|524133535|FG002|Phase 1|Miscellaneous|0|||
145351248|NCT01962103|524133536|FG003|Phase 1|Miscellaneous|0|||
145351249|NCT01962103|524133537|FG004|Phase 1|Miscellaneous|0|||
145351250|NCT01962103|524133538|FG005|Phase 1|Miscellaneous|0|||
145351251|NCT01962103|524133539|FG006|Phase 1|Miscellaneous|0|||
145351252|NCT01962103|524133540|FG007|Phase 1|Miscellaneous|0|||
145351253|NCT01962103|524133541|FG008|Phase 1|Miscellaneous|0|||
145351254|NCT01962103|524133533|FG000|Phase 2|Adverse Event|0|||
145351255|NCT01962103|524133534|FG001|Phase 2|Adverse Event|0|||
145351256|NCT01962103|524133535|FG002|Phase 2|Adverse Event|0|||
145351257|NCT01962103|524133536|FG003|Phase 2|Adverse Event|0|||
145351258|NCT01962103|524133537|FG004|Phase 2|Adverse Event|0|||
145351259|NCT01962103|524133538|FG005|Phase 2|Adverse Event|0|||
145351260|NCT01962103|524133539|FG006|Phase 2|Adverse Event|1|||
145351261|NCT01962103|524133540|FG007|Phase 2|Adverse Event|0|||
145351262|NCT01962103|524133541|FG008|Phase 2|Adverse Event|3|||
145351263|NCT01962103|524133533|FG000|Phase 2|Progressive Disease|0|||
145351264|NCT01962103|524133534|FG001|Phase 2|Progressive Disease|0|||
145351265|NCT01962103|524133535|FG002|Phase 2|Progressive Disease|0|||
145351266|NCT01962103|524133536|FG003|Phase 2|Progressive Disease|0|||
145351267|NCT01962103|524133537|FG004|Phase 2|Progressive Disease|0|||
145351268|NCT01962103|524133538|FG005|Phase 2|Progressive Disease|0|||
145351269|NCT01962103|524133539|FG006|Phase 2|Progressive Disease|11|||
145351270|NCT01962103|524133540|FG007|Phase 2|Progressive Disease|12|||
145351271|NCT01962103|524133541|FG008|Phase 2|Progressive Disease|11|||
145351272|NCT01962103|524133533|FG000|Phase 2|Symptomatic Deterioration|0|||
145351273|NCT01962103|524133534|FG001|Phase 2|Symptomatic Deterioration|0|||
145351274|NCT01962103|524133535|FG002|Phase 2|Symptomatic Deterioration|0|||
145351275|NCT01962103|524133536|FG003|Phase 2|Symptomatic Deterioration|0|||
145351276|NCT01962103|524133537|FG004|Phase 2|Symptomatic Deterioration|0|||
145351277|NCT01962103|524133538|FG005|Phase 2|Symptomatic Deterioration|0|||
145351278|NCT01962103|524133539|FG006|Phase 2|Symptomatic Deterioration|2|||
145351279|NCT01962103|524133540|FG007|Phase 2|Symptomatic Deterioration|2|||
145351280|NCT01962103|524133541|FG008|Phase 2|Symptomatic Deterioration|0|||
145351281|NCT01321749|524133542|FG000|Overall Study|Lost to Follow-up|4|||
145351282|NCT01321749|524133543|FG001|Overall Study|Lost to Follow-up|11|||
145351283|NCT01321749|524133542|FG000|Overall Study|Protocol Violation|4|||
145351284|NCT01321749|524133543|FG001|Overall Study|Protocol Violation|7|||
145351285|NCT01321749|524133542|FG000|Overall Study|Withdrawal by Subject|5|||
145351286|NCT01321749|524133543|FG001|Overall Study|Withdrawal by Subject|4|||
145351287|NCT02763046|524133551|FG000|Overall Study|Adverse Event|5|||
145351288|NCT02763046|524133552|FG001|Overall Study|Adverse Event|4|||
145351289|NCT02763046|524133553|FG002|Overall Study|Adverse Event|0|||
145622918|NCT01167023|525130241|FG001|Overall Study|Lost to Follow-up|1|||
145351290|NCT02763046|524133551|FG000|Overall Study|Lack of Efficacy|1|||
145351291|NCT02763046|524133552|FG001|Overall Study|Lack of Efficacy|1|||
145351292|NCT02763046|524133553|FG002|Overall Study|Lack of Efficacy|3|||
145351293|NCT02763046|524133551|FG000|Overall Study|Physician Decision|1|||
145351294|NCT02763046|524133552|FG001|Overall Study|Physician Decision|0|||
145351295|NCT02763046|524133553|FG002|Overall Study|Physician Decision|1|||
145351296|NCT02763046|524133551|FG000|Overall Study|Subject/guardian decision|2|||
145351297|NCT02763046|524133552|FG001|Overall Study|Subject/guardian decision|0|||
145351298|NCT02763046|524133553|FG002|Overall Study|Subject/guardian decision|4|||
145351299|NCT02094300|524133564|FG000|Overall Study|Death|7|||
145351300|NCT02094300|524133564|FG000|Overall Study|Lost to Follow-up|10|||
145351301|NCT02094300|524133564|FG000|Overall Study|Still be eligible for follow-up|3|||
145351302|NCT00725491|524133567|FG000|Overall Study|Adverse Event|3|||
145351303|NCT00725491|524133568|FG001|Overall Study|Adverse Event|2|||
145351304|NCT00725491|524133567|FG000|Overall Study|Pregnancy|0|||
145351305|NCT00725491|524133568|FG001|Overall Study|Pregnancy|3|||
145351306|NCT00725491|524133567|FG000|Overall Study|Risk for hyperstimulation|2|||
145351307|NCT00725491|524133568|FG001|Overall Study|Risk for hyperstimulation|9|||
145351308|NCT00725491|524133567|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
145351309|NCT00725491|524133568|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
145351310|NCT00725491|524133567|FG000|Overall Study|Fertilization failure|0|||
145351311|NCT00725491|524133568|FG001|Overall Study|Fertilization failure|1|||
145351312|NCT00725491|524133567|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
145351313|NCT00725491|524133568|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
145351314|NCT01495000|524133571|FG000|Overall Study|Lost to Follow-up|2|||
145351315|NCT01495000|524133572|FG001|Overall Study|Lost to Follow-up|2|||
145351316|NCT01495000|524133571|FG000|Overall Study|Protocol Violation|1|||
145351317|NCT01495000|524133572|FG001|Overall Study|Protocol Violation|0|||
145351318|NCT01495000|524133571|FG000|Overall Study|Withdrawal by Subject|10|||
145351319|NCT01495000|524133572|FG001|Overall Study|Withdrawal by Subject|10|||
145351320|NCT02070965|524133573|FG000|Overall Study|Lost to Follow-up|0|||
145351321|NCT02070965|524133574|FG001|Overall Study|Lost to Follow-up|1|||
145351322|NCT02070965|524133575|FG002|Overall Study|Lost to Follow-up|0|||
145351323|NCT02070965|524133573|FG000|Overall Study|Withdrawal by Subject|1|||
145351324|NCT02070965|524133574|FG001|Overall Study|Withdrawal by Subject|1|||
145351325|NCT02070965|524133575|FG002|Overall Study|Withdrawal by Subject|1|||
145351326|NCT02070965|524133573|FG000|Overall Study|Subject moved|1|||
145351327|NCT02070965|524133574|FG001|Overall Study|Subject moved|0|||
145351328|NCT02070965|524133575|FG002|Overall Study|Subject moved|0|||
145351329|NCT00942357|524133578|FG000|Overall Study|Ineligible|37|||
145351330|NCT00942357|524133579|FG001|Overall Study|Ineligible|40|||
145351331|NCT02676882|524133585|FG000|Overall Study|Adverse Event|1|||
145351332|NCT02676882|524133586|FG001|Overall Study|Adverse Event|0|||
145351333|NCT02676882|524133585|FG000|Overall Study|Lost to Follow-up|1|||
145351334|NCT02676882|524133586|FG001|Overall Study|Lost to Follow-up|0|||
145351335|NCT02676882|524133585|FG000|Overall Study|Withdrawal by Subject|1|||
145351336|NCT02676882|524133586|FG001|Overall Study|Withdrawal by Subject|2|||
145351337|NCT00707239|524133597|FG000|Overall Study|Adverse Event|5|||
145351338|NCT00707239|524133598|FG001|Overall Study|Adverse Event|3|||
145351339|NCT00707239|524133599|FG002|Overall Study|Adverse Event|2|||
145351340|NCT00707239|524133597|FG000|Overall Study|Death|3|||
145351341|NCT00707239|524133598|FG001|Overall Study|Death|1|||
145351342|NCT00707239|524133599|FG002|Overall Study|Death|3|||
145351343|NCT00707239|524133597|FG000|Overall Study|Physician Decision|1|||
145351344|NCT00707239|524133598|FG001|Overall Study|Physician Decision|1|||
145351345|NCT00707239|524133599|FG002|Overall Study|Physician Decision|2|||
145351346|NCT00707239|524133597|FG000|Overall Study|Protocol Violation|0|||
145351347|NCT00707239|524133598|FG001|Overall Study|Protocol Violation|0|||
145351348|NCT00707239|524133599|FG002|Overall Study|Protocol Violation|1|||
145351349|NCT00707239|524133597|FG000|Overall Study|Lack of Efficacy|1|||
145351350|NCT00707239|524133598|FG001|Overall Study|Lack of Efficacy|2|||
145351351|NCT00707239|524133599|FG002|Overall Study|Lack of Efficacy|0|||
145351352|NCT00707239|524133597|FG000|Overall Study|Randomized, but not treated|1|||
145351353|NCT00707239|524133598|FG001|Overall Study|Randomized, but not treated|1|||
145351354|NCT00707239|524133599|FG002|Overall Study|Randomized, but not treated|1|||
145351355|NCT00707239|524133597|FG000|Overall Study|Other|8|||
145351356|NCT00707239|524133598|FG001|Overall Study|Other|3|||
145351357|NCT00707239|524133599|FG002|Overall Study|Other|5|||
145351358|NCT01778530|524133604|FG000|Overall Study|Progression on study|1|||
145351359|NCT01778530|524133604|FG000|Overall Study|Adverse event/side effect|1|||
145351360|NCT03472014|524133605|FG000|Overall Study|Lost to Follow-up|4|||
145351361|NCT03624192|524133608|FG000|Overall Study|Lost to Follow-up|1|||
145351362|NCT03624192|524133609|FG001|Overall Study|Lost to Follow-up|1|||
145351363|NCT01487525|524133612|FG000|Overall Study|Withdrawal by Subject|0|||
145351364|NCT01487525|524133613|FG001|Overall Study|Withdrawal by Subject|1|||
145351365|NCT01640249|524133614|FG000|Period 1|Withdrawal by Subject|1|||
145351366|NCT01640249|524133615|FG001|Period 1|Withdrawal by Subject|0|||
145351367|NCT01640249|524133616|FG002|Period 1|Withdrawal by Subject|0|||
145351368|NCT01640249|524133617|FG003|Period 1|Withdrawal by Subject|0|||
145351369|NCT01640249|524133618|FG004|Period 1|Withdrawal by Subject|0|||
145351370|NCT01640249|524133619|FG005|Period 1|Withdrawal by Subject|1|||
145351371|NCT01640249|524133620|FG006|Period 1|Withdrawal by Subject|0|||
145351372|NCT01215136|524133621|FG000|Overall Study|Adverse Event|2|||
145351373|NCT01215136|524133622|FG001|Overall Study|Adverse Event|9|||
145351374|NCT01215136|524133621|FG000|Overall Study|Disease Progression|3|||
145351375|NCT01215136|524133622|FG001|Overall Study|Disease Progression|14|||
145351376|NCT01215136|524133621|FG000|Overall Study|Symptomatic Deterioration|1|||
145351377|NCT01215136|524133622|FG001|Overall Study|Symptomatic Deterioration|1|||
145351378|NCT01215136|524133621|FG000|Overall Study|Death|0|||
145351379|NCT01215136|524133622|FG001|Overall Study|Death|2|||
145351380|NCT01215136|524133621|FG000|Overall Study|Withdrawal by Subject|0|||
145351381|NCT01215136|524133622|FG001|Overall Study|Withdrawal by Subject|1|||
145351382|NCT02308124|524133623|FG000|Overall Study|Lost to Follow-up|6|||
145351383|NCT02308124|524133624|FG001|Overall Study|Lost to Follow-up|6|||
145351384|NCT02308124|524133625|FG002|Overall Study|Lost to Follow-up|6|||
145351385|NCT02308124|524133623|FG000|Overall Study|Adverse Event|0|||
145351386|NCT02308124|524133624|FG001|Overall Study|Adverse Event|2|||
145351387|NCT02308124|524133625|FG002|Overall Study|Adverse Event|2|||
145351388|NCT01197911|524133626|FG000|Overall Study|Adverse Event|0|||
145351389|NCT01197911|524133627|FG001|Overall Study|Adverse Event|0|||
145351390|NCT01197911|524133628|FG002|Overall Study|Adverse Event|1|||
145351391|NCT01526057|524133629|FG000|Overall Study|Withdrawal by Subject|3|||
145351392|NCT01526057|524133630|FG001|Overall Study|Withdrawal by Subject|2|||
145351393|NCT01526057|524133631|FG002|Overall Study|Withdrawal by Subject|2|||
145351394|NCT01526057|524133629|FG000|Overall Study|Adverse Event|3|||
145351395|NCT01526057|524133630|FG001|Overall Study|Adverse Event|1|||
145351396|NCT01526057|524133631|FG002|Overall Study|Adverse Event|1|||
145351397|NCT01526057|524133629|FG000|Overall Study|Death|1|||
145351398|NCT01526057|524133630|FG001|Overall Study|Death|0|||
145351399|NCT01526057|524133631|FG002|Overall Study|Death|0|||
145351400|NCT01526057|524133629|FG000|Overall Study|Lost to Follow-up|1|||
145351401|NCT01526057|524133630|FG001|Overall Study|Lost to Follow-up|0|||
145351402|NCT01526057|524133631|FG002|Overall Study|Lost to Follow-up|1|||
145351403|NCT01526057|524133629|FG000|Overall Study|Other|1|||
145351404|NCT01526057|524133630|FG001|Overall Study|Other|0|||
145351405|NCT01526057|524133631|FG002|Overall Study|Other|1|||
145351406|NCT01526057|524133629|FG000|Overall Study|Protocol Violation|0|||
145351407|NCT01526057|524133630|FG001|Overall Study|Protocol Violation|0|||
145351408|NCT01526057|524133631|FG002|Overall Study|Protocol Violation|1|||
145351409|NCT02553772|524133635|FG000|Overall Study|Adverse Event|2|||
145351410|NCT02553772|524133636|FG001|Overall Study|Adverse Event|3|||
145351411|NCT02553772|524133635|FG000|Overall Study|Lost to Follow-up|2|||
145351412|NCT02553772|524133636|FG001|Overall Study|Lost to Follow-up|1|||
145351413|NCT02553772|524133635|FG000|Overall Study|Withdrawal of Consent|1|||
145351414|NCT02553772|524133636|FG001|Overall Study|Withdrawal of Consent|1|||
145351415|NCT02553772|524133635|FG000|Overall Study|Lack of Efficacy|1|||
145351416|NCT02553772|524133636|FG001|Overall Study|Lack of Efficacy|0|||
145351417|NCT02553772|524133635|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145351418|NCT02553772|524133636|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145351419|NCT05724589|524133637|FG000|Overall Study|Lost to Follow-up|1|||
145351420|NCT00610129|524133638|FG000|Overall Study|Not treated since patients ineligible|3|||
145351421|NCT00141778|524133639|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
145351422|NCT00141778|524133640|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
145351423|NCT00141778|524133641|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
145351424|NCT00141778|524133639|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
145351425|NCT00141778|524133640|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
145351426|NCT00141778|524133641|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
145351427|NCT00141778|524133639|FG000|Started Study Medication|Withdrawal by Subject|0|||
145415695|NCT00887588|524376428|FG001|Core Period|Death|1|||
145415696|NCT00887588|524376427|FG000|Core Period|Lost to Follow-up|3|||
145415697|NCT00887588|524376428|FG001|Core Period|Lost to Follow-up|1|||
145415698|NCT00887588|524376427|FG000|Core Period|Withdrawal by Subject|6|||
145415699|NCT00887588|524376428|FG001|Core Period|Withdrawal by Subject|8|||
145415700|NCT00887588|524376427|FG000|Core Period|Adverse Event|9|||
145415701|NCT00887588|524376428|FG001|Core Period|Adverse Event|11|||
145415702|NCT00887588|524376427|FG000|Extension Period|Adverse Event|4|||
145415703|NCT00887588|524376428|FG001|Extension Period|Adverse Event|4|||
145415704|NCT00887588|524376427|FG000|Extension Period|Death|0|||
145415705|NCT00887588|524376428|FG001|Extension Period|Death|1|||
145415706|NCT00887588|524376427|FG000|Extension Period|Protocol deviation|1|||
145415707|NCT00887588|524376428|FG001|Extension Period|Protocol deviation|0|||
145415708|NCT00887588|524376427|FG000|Extension Period|Lost to Follow-up|1|||
145415709|NCT00887588|524376428|FG001|Extension Period|Lost to Follow-up|0|||
145415710|NCT00366535|524376429|FG000|First Phase: 12 Weeks|Adverse Event|1|||
145415711|NCT00366535|524376430|FG001|First Phase: 12 Weeks|Adverse Event|3|||
145415712|NCT00366535|524376429|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
145415713|NCT00366535|524376430|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
145415714|NCT00366535|524376429|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
145415715|NCT00366535|524376430|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
145415716|NCT00366535|524376429|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
145415717|NCT00366535|524376430|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
145415718|NCT02958527|524376435|FG000|Overall Study|Not collected CRFs|12|||
145415719|NCT02691572|524376436|FG000|Overall Study|Withdrawal by Subject|1|||
145415720|NCT02691572|524376437|FG001|Overall Study|Withdrawal by Subject|0|||
145415721|NCT02691572|524376436|FG000|Overall Study|Protocol Violation|0|||
145415722|NCT02691572|524376437|FG001|Overall Study|Protocol Violation|1|||
145415723|NCT03753542|524376438|FG000|Overall Study|Lost to Follow-up|9|||
145415724|NCT03753542|524376439|FG001|Overall Study|Lost to Follow-up|14|||
145351428|NCT00141778|524133640|FG001|Started Study Medication|Withdrawal by Subject|2|||
145351429|NCT00141778|524133641|FG002|Started Study Medication|Withdrawal by Subject|0|||
145351430|NCT00141778|524133639|FG000|Started Study Medication|Difficulty Swallowing|0|||
145351431|NCT00141778|524133640|FG001|Started Study Medication|Difficulty Swallowing|1|||
145351432|NCT00141778|524133641|FG002|Started Study Medication|Difficulty Swallowing|0|||
145351433|NCT00141778|524133639|FG000|Started Study Medication|Chest Discomfort|0|||
145351434|NCT00141778|524133640|FG001|Started Study Medication|Chest Discomfort|0|||
145351435|NCT00141778|524133641|FG002|Started Study Medication|Chest Discomfort|1|||
145351436|NCT01982955|524133642|FG000|Overall Study|Randomized but not treated|0|||
145351437|NCT01982955|524133643|FG001|Overall Study|Randomized but not treated|0|||
145351438|NCT01982955|524133644|FG002|Overall Study|Randomized but not treated|0|||
145351439|NCT01982955|524133645|FG003|Overall Study|Randomized but not treated|1|||
145351440|NCT01982955|524133646|FG004|Overall Study|Randomized but not treated|0|||
145351441|NCT05655546|524134934|FG000|Overall Study|Withdrawal by Subject|2|||
145351442|NCT05655546|524134935|FG001|Overall Study|Withdrawal by Subject|4|||
145351443|NCT01067105|524134944|FG000|Overall Study|Adverse Event|14|||
145351444|NCT01067105|524134944|FG000|Overall Study|Protocol Violation|48|||
145351445|NCT01067105|524134944|FG000|Overall Study|Withdrawal by Subject|36|||
145351446|NCT01067105|524134944|FG000|Overall Study|Lost to Follow-up|6|||
145351447|NCT01067105|524134944|FG000|Overall Study|Physician Decision|6|||
145351448|NCT01067105|524134944|FG000|Overall Study|Other|31|||
145351449|NCT02203357|524134947|FG000|Overall Study|Lost to Follow-up|58|||
145351450|NCT02203357|524134948|FG001|Overall Study|Lost to Follow-up|66|||
145351451|NCT02203357|524134949|FG002|Overall Study|Lost to Follow-up|70|||
145351452|NCT02439216|524134950|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
145351453|NCT02439216|524134951|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351454|NCT02439216|524134952|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351455|NCT02439216|524134953|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351456|NCT02439216|524134954|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351457|NCT02439216|524134955|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351458|NCT02439216|524134956|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351459|NCT02439216|524134957|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351460|NCT02439216|524134958|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
145351461|NCT02439216|524134950|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351462|NCT02439216|524134951|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351463|NCT02439216|524134952|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351464|NCT02439216|524134953|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351465|NCT02439216|524134954|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351466|NCT02439216|524134955|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351467|NCT02439216|524134956|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351468|NCT02439216|524134957|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
145351469|NCT02439216|524134958|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
145351470|NCT02439216|524134950|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351471|NCT02439216|524134951|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351472|NCT02439216|524134952|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351473|NCT02439216|524134953|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351474|NCT02439216|524134954|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351475|NCT02439216|524134955|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351476|NCT02439216|524134956|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
145351477|NCT02439216|524134957|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
145351478|NCT02439216|524134958|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
145351479|NCT02439216|524134950|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351480|NCT02439216|524134951|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351481|NCT02439216|524134952|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351482|NCT02439216|524134953|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351483|NCT02439216|524134954|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351484|NCT02439216|524134955|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351485|NCT02439216|524134956|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351486|NCT02439216|524134957|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
145351487|NCT02439216|524134958|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
145351488|NCT02439216|524134950|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351489|NCT02439216|524134951|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351490|NCT02439216|524134952|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351491|NCT02439216|524134953|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351492|NCT02439216|524134954|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145377843|NCT03191864|524233636|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145415725|NCT06100250|524376440|FG000|Overall Study|Lost to Follow-up|5|||
145351493|NCT02439216|524134955|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351494|NCT02439216|524134956|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
145351495|NCT02439216|524134957|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
145351496|NCT02439216|524134958|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
145351497|NCT02493660|524134963|FG000|Overall Study|Physician Decision|0|||
145351498|NCT02493660|524134964|FG001|Overall Study|Physician Decision|1|||
145351499|NCT02493660|524134963|FG000|Overall Study|Adverse Event|4|||
145351500|NCT02493660|524134964|FG001|Overall Study|Adverse Event|2|||
145351501|NCT02493660|524134963|FG000|Overall Study|Withdrawal by Subject|2|||
145351502|NCT02493660|524134964|FG001|Overall Study|Withdrawal by Subject|3|||
145351503|NCT02493660|524134963|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
145351504|NCT02493660|524134964|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
145351505|NCT02493660|524134963|FG000|Overall Study|Protocol Violation|0|||
145351506|NCT02493660|524134964|FG001|Overall Study|Protocol Violation|1|||
145351507|NCT02493660|524134963|FG000|Overall Study|Death|0|||
145351508|NCT02493660|524134964|FG001|Overall Study|Death|1|||
145351509|NCT02493660|524134963|FG000|Overall Study|Lost to Follow-up|2|||
145351510|NCT02493660|524134964|FG001|Overall Study|Lost to Follow-up|4|||
145351511|NCT03347110|524134968|FG000|Overall Study|Other (Participant is incarcerated)|1|||
145351512|NCT03347110|524134968|FG000|Overall Study|Withdrawal by Subject|9|||
145351513|NCT03347110|524134968|FG000|Overall Study|Lost to Follow-up|1|||
145351514|NCT03347110|524134968|FG000|Overall Study|Lack of Efficacy|2|||
145351515|NCT03347110|524134968|FG000|Overall Study|Adverse Event, non-fatal|9|||
145351516|NCT02105467|524134971|FG000|Period 1|Lost to Follow-up|1|||
145351517|NCT02105467|524134972|FG001|Period 1|Lost to Follow-up|0|||
145351518|NCT02105467|524134971|FG000|Period 1|Death|1|||
145351519|NCT02105467|524134972|FG001|Period 1|Death|0|||
145351520|NCT02105467|524134971|FG000|Period 2|Lost to Follow-up|1|||
145351521|NCT02105467|524134972|FG001|Period 2|Lost to Follow-up|0|||
145351522|NCT02105467|524134971|FG000|Period 2|Death|1|||
145351523|NCT02105467|524134972|FG001|Period 2|Death|0|||
145351524|NCT02105467|524134971|FG000|Period 2|Withdrawal by Subject|0|||
145351525|NCT02105467|524134972|FG001|Period 2|Withdrawal by Subject|2|||
145351526|NCT02105467|524134971|FG000|Period 3|Lost to Follow-up|0|||
145351527|NCT02105467|524134972|FG001|Period 3|Lost to Follow-up|1|||
145351528|NCT00958828|524134973|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
145351529|NCT00958828|524134974|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
145351530|NCT00958828|524134973|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
145351531|NCT00958828|524134974|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
145351532|NCT02687451|524134975|FG000|Overall Study|Withdrawal by Subject|1|||
145351533|NCT02687451|524134976|FG001|Overall Study|Withdrawal by Subject|0|||
145351534|NCT02687451|524134977|FG002|Overall Study|Withdrawal by Subject|0|||
145351535|NCT02687451|524134978|FG003|Overall Study|Withdrawal by Subject|0|||
145351536|NCT02687451|524134979|FG004|Overall Study|Withdrawal by Subject|0|||
145351537|NCT02687451|524134980|FG005|Overall Study|Withdrawal by Subject|1|||
145351538|NCT00811733|524134981|FG000|Overall Study|Investigator Discretion|10|||
145351539|NCT00811733|524134982|FG001|Overall Study|Investigator Discretion|8|||
145351540|NCT00811733|524134981|FG000|Overall Study|Withdrawal by Subject|1|||
145351541|NCT00811733|524134982|FG001|Overall Study|Withdrawal by Subject|2|||
145351542|NCT00793871|524134983|FG000|Overall Study|Death|50|||
145351543|NCT00793871|524134983|FG000|Overall Study|Lost to Follow-up|3|||
145351544|NCT00793871|524134983|FG000|Overall Study|Study terminated by the Sponsor|7|||
145351545|NCT02500589|524134984|FG000|Overall Study|Withdrawal by Subject|11|||
145351546|NCT02500589|524134985|FG001|Overall Study|Withdrawal by Subject|14|||
145351547|NCT02500589|524134984|FG000|Overall Study|Lost to Follow-up|10|||
145351548|NCT02500589|524134985|FG001|Overall Study|Lost to Follow-up|12|||
145351549|NCT02500589|524134984|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
145351550|NCT02500589|524134985|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
145351551|NCT02500589|524134984|FG000|Overall Study|Death|7|||
145351552|NCT02500589|524134985|FG001|Overall Study|Death|5|||
145351553|NCT01958437|524134986|FG000|Overall Study|Incidental MRI findings|0|||
145351554|NCT01958437|524134987|FG001|Overall Study|Incidental MRI findings|0|||
145577242|NCT00705575|524968026|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145351555|NCT01958437|524134988|FG002|Overall Study|Incidental MRI findings|1|||
145351556|NCT01958437|524134989|FG003|Overall Study|Incidental MRI findings|1|||
145351557|NCT03442751|524134990|FG000|Overall Study|Withdrawal by Subject|3|||
145351558|NCT03442751|524134991|FG001|Overall Study|Withdrawal by Subject|1|||
145351559|NCT03442751|524134990|FG000|Overall Study|Lost to Follow-up|3|||
145351560|NCT03442751|524134991|FG001|Overall Study|Lost to Follow-up|0|||
145351561|NCT01841593|524134995|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
145351562|NCT01841593|524134996|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
145577243|NCT00705575|524968027|FG001|Overall Study|Abnormal test procedure result(s)|12|||
145351563|NCT01841593|524134995|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
145351564|NCT01841593|524134996|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
145351565|NCT03125798|524134998|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
145351566|NCT03125798|524134999|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
145351567|NCT03125798|524134998|FG000|Overall Study|Conversion to thoracotomy|7|||
145351568|NCT03125798|524134999|FG001|Overall Study|Conversion to thoracotomy|7|||
145351569|NCT02635984|524135000|FG000|Overall Study|Lost to Follow-up|2|||
145351570|NCT02635984|524135001|FG001|Overall Study|Lost to Follow-up|4|||
145351571|NCT02635984|524135000|FG000|Overall Study|Study Arm Closed|1|||
145351572|NCT02635984|524135001|FG001|Overall Study|Study Arm Closed|0|||
145351573|NCT00307086|524135002|FG000|Overall Study|ineligible|5|||
145351574|NCT00312338|524135007|FG000|Overall Study|Adverse Event|7|||
145351575|NCT00312338|524135008|FG001|Overall Study|Adverse Event|2|||
145351576|NCT00312338|524135007|FG000|Overall Study|Lost to Follow-up|9|||
145351577|NCT00312338|524135008|FG001|Overall Study|Lost to Follow-up|1|||
145351578|NCT00312338|524135007|FG000|Overall Study|Withdrawal by Subject|4|||
145351579|NCT00312338|524135008|FG001|Overall Study|Withdrawal by Subject|0|||
145351580|NCT00312338|524135007|FG000|Overall Study|Subsequent infection|2|||
145351581|NCT00312338|524135008|FG001|Overall Study|Subsequent infection|0|||
145351582|NCT00262028|524135009|FG000|Overall Study|Withdrawal by Subject|6|||
145351583|NCT00262028|524135010|FG001|Overall Study|Withdrawal by Subject|3|||
145351584|NCT00262028|524135011|FG002|Overall Study|Withdrawal by Subject|6|||
145351585|NCT00262028|524135012|FG003|Overall Study|Withdrawal by Subject|5|||
145351586|NCT00262028|524135013|FG004|Overall Study|Withdrawal by Subject|2|||
145351587|NCT00262028|524135014|FG005|Overall Study|Withdrawal by Subject|3|||
145351588|NCT00262028|524135015|FG006|Overall Study|Withdrawal by Subject|5|||
145351589|NCT00262028|524135016|FG007|Overall Study|Withdrawal by Subject|7|||
145351590|NCT00262028|524135017|FG008|Overall Study|Withdrawal by Subject|2|||
145351591|NCT00262028|524135009|FG000|Overall Study|Lost to Follow-up|7|||
145351592|NCT00262028|524135010|FG001|Overall Study|Lost to Follow-up|7|||
145351593|NCT00262028|524135011|FG002|Overall Study|Lost to Follow-up|5|||
145351594|NCT00262028|524135012|FG003|Overall Study|Lost to Follow-up|5|||
145351595|NCT00262028|524135013|FG004|Overall Study|Lost to Follow-up|4|||
145351596|NCT00262028|524135014|FG005|Overall Study|Lost to Follow-up|3|||
145351597|NCT00262028|524135015|FG006|Overall Study|Lost to Follow-up|3|||
145351598|NCT00262028|524135016|FG007|Overall Study|Lost to Follow-up|5|||
145351599|NCT00262028|524135017|FG008|Overall Study|Lost to Follow-up|6|||
145351600|NCT00262028|524135009|FG000|Overall Study|Administrative Reason|11|||
145351601|NCT00262028|524135010|FG001|Overall Study|Administrative Reason|14|||
145351602|NCT00262028|524135011|FG002|Overall Study|Administrative Reason|9|||
145351603|NCT00262028|524135012|FG003|Overall Study|Administrative Reason|12|||
145351604|NCT00262028|524135013|FG004|Overall Study|Administrative Reason|6|||
145351605|NCT00262028|524135014|FG005|Overall Study|Administrative Reason|7|||
145351606|NCT00262028|524135015|FG006|Overall Study|Administrative Reason|4|||
145351607|NCT00262028|524135016|FG007|Overall Study|Administrative Reason|6|||
145351608|NCT00262028|524135017|FG008|Overall Study|Administrative Reason|10|||
145351609|NCT00262028|524135009|FG000|Overall Study|Protocol Violation|0|||
145351610|NCT00262028|524135010|FG001|Overall Study|Protocol Violation|0|||
145351611|NCT00262028|524135011|FG002|Overall Study|Protocol Violation|0|||
145351612|NCT00262028|524135012|FG003|Overall Study|Protocol Violation|1|||
145351613|NCT00262028|524135013|FG004|Overall Study|Protocol Violation|0|||
145351614|NCT00262028|524135014|FG005|Overall Study|Protocol Violation|0|||
145351615|NCT00262028|524135015|FG006|Overall Study|Protocol Violation|0|||
145351616|NCT00262028|524135016|FG007|Overall Study|Protocol Violation|0|||
145351617|NCT00262028|524135017|FG008|Overall Study|Protocol Violation|0|||
145351618|NCT00262028|524135009|FG000|Overall Study|Unable to classify|0|||
145351619|NCT00262028|524135010|FG001|Overall Study|Unable to classify|3|||
145351620|NCT00262028|524135011|FG002|Overall Study|Unable to classify|0|||
145351621|NCT00262028|524135012|FG003|Overall Study|Unable to classify|0|||
145351622|NCT00262028|524135013|FG004|Overall Study|Unable to classify|0|||
145351623|NCT00262028|524135014|FG005|Overall Study|Unable to classify|0|||
145351624|NCT00262028|524135015|FG006|Overall Study|Unable to classify|0|||
145351625|NCT00262028|524135016|FG007|Overall Study|Unable to classify|0|||
145351626|NCT00262028|524135017|FG008|Overall Study|Unable to classify|1|||
145351627|NCT04583735|524135018|FG000|Double-masked Treatment Period|Adverse Event|0|||
145351628|NCT04583735|524135019|FG001|Double-masked Treatment Period|Adverse Event|1|||
145351629|NCT04583735|524135018|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
145351630|NCT04583735|524135019|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
145351631|NCT04583735|524135018|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
145351632|NCT04583735|524135019|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
145351633|NCT04583735|524135018|FG000|Open-label Treatment Period|Adverse Event|1|||
145351634|NCT04583735|524135019|FG001|Open-label Treatment Period|Adverse Event|1|||
145351635|NCT04583735|524135018|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
145351636|NCT04583735|524135019|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145351637|NCT04583735|524135018|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145351638|NCT04583735|524135019|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
145351639|NCT00613171|524135020|FG000|Overall Study|Adverse Event|7|||
145351640|NCT00613171|524135020|FG000|Overall Study|Withdrawal by Subject|3|||
145351641|NCT00613171|524135020|FG000|Overall Study|Reason not Specified|4|||
145351642|NCT01169350|524135023|FG000|Overall Study|Physician Decision|3|||
145415726|NCT05089357|524376443|FG000|Overall Study|Withdrawal by Subject|23|||
145351643|NCT01169350|524135023|FG000|Overall Study|Lost to Follow-up|2|||
145351644|NCT04870710|524135026|FG000|Overall Study|Lost to Follow-up|3|||
145351645|NCT00786409|524135027|FG000|Overall Study|Withdrawal by Subject|2|||
145351646|NCT00786409|524135027|FG000|Overall Study|Adverse Event|2|||
145351647|NCT00786409|524135027|FG000|Overall Study|Pregnancy|2|||
145351648|NCT00786409|524135027|FG000|Overall Study|Lost to Follow-up|1|||
145351649|NCT02189837|524135030|FG000|Overall Study|Withdrawal by Subject|2|||
145351650|NCT02189837|524135031|FG001|Overall Study|Withdrawal by Subject|1|||
145351651|NCT02189837|524135032|FG002|Overall Study|Withdrawal by Subject|3|||
145351652|NCT02189837|524135033|FG003|Overall Study|Withdrawal by Subject|1|||
145351653|NCT02189837|524135030|FG000|Overall Study|Sponsor Decision|0|||
145351654|NCT02189837|524135031|FG001|Overall Study|Sponsor Decision|0|||
145351655|NCT02189837|524135032|FG002|Overall Study|Sponsor Decision|0|||
145351656|NCT02189837|524135033|FG003|Overall Study|Sponsor Decision|1|||
145351657|NCT02198963|524135039|FG000|Overall Study|Adverse Event|1|||
145351658|NCT02198963|524135039|FG000|Overall Study|Withdrawal by Subject|6|||
145351659|NCT00243412|524135040|FG000|Overall Study|Death|0|||
145351660|NCT00243412|524135041|FG001|Overall Study|Death|1|||
145351661|NCT00243412|524135040|FG000|Overall Study|Adverse Event|4|||
145351662|NCT00243412|524135041|FG001|Overall Study|Adverse Event|2|||
145351663|NCT00243412|524135040|FG000|Overall Study|Lost to Follow-up|0|||
145351664|NCT00243412|524135041|FG001|Overall Study|Lost to Follow-up|1|||
145351665|NCT00243412|524135040|FG000|Overall Study|Physician Decision|1|||
145351666|NCT00243412|524135041|FG001|Overall Study|Physician Decision|1|||
145351667|NCT00243412|524135040|FG000|Overall Study|Withdrawal by Subject|4|||
145351668|NCT00243412|524135041|FG001|Overall Study|Withdrawal by Subject|5|||
145351669|NCT00243412|524135040|FG000|Overall Study|Other|1|||
145351670|NCT00243412|524135041|FG001|Overall Study|Other|1|||
145351671|NCT03629184|524135046|FG000|Overall Study|Withdrawal by Subject|2|||
145351672|NCT03629184|524135047|FG001|Overall Study|Withdrawal by Subject|1|||
145351673|NCT03629184|524135046|FG000|Overall Study|Physician Decision|1|||
145351674|NCT03629184|524135047|FG001|Overall Study|Physician Decision|0|||
145351675|NCT03447743|524135048|FG000|Overall Study|Withdrawal by Subject|2|||
145351676|NCT03447743|524135048|FG000|Overall Study|Lost to Follow-up|3|||
145351677|NCT03447743|524135048|FG000|Overall Study|Adverse Event|1|||
145351678|NCT03447743|524135048|FG000|Overall Study|Did not meet criteria to continue|1|||
145351679|NCT02046603|524135049|FG000|Overall Study|Other|11|||
145351680|NCT02046603|524135050|FG001|Overall Study|Other|66|||
145351681|NCT02046603|524135049|FG000|Overall Study|Protocol Violation|0|||
145351682|NCT02046603|524135050|FG001|Overall Study|Protocol Violation|1|||
145351683|NCT02046603|524135049|FG000|Overall Study|Participant/legal guardian decision|1|||
145351684|NCT02046603|524135050|FG001|Overall Study|Participant/legal guardian decision|3|||
145351685|NCT02046603|524135049|FG000|Overall Study|Physician Decision|2|||
145351686|NCT02046603|524135050|FG001|Overall Study|Physician Decision|1|||
145351687|NCT02046603|524135049|FG000|Overall Study|Lost to Follow-up|1|||
145351688|NCT02046603|524135050|FG001|Overall Study|Lost to Follow-up|2|||
145351689|NCT02046603|524135049|FG000|Overall Study|Death|0|||
145351690|NCT02046603|524135050|FG001|Overall Study|Death|1|||
145351691|NCT02046603|524135049|FG000|Overall Study|Adverse Event|0|||
145351692|NCT02046603|524135050|FG001|Overall Study|Adverse Event|1|||
145351693|NCT05620082|524135055|FG000|Overall Study|Discharged before study end|1|||
145351694|NCT05620082|524135056|FG001|Overall Study|Discharged before study end|4|||
145351695|NCT05620082|524135057|FG002|Overall Study|Discharged before study end|0|||
145351696|NCT05620082|524135055|FG000|Overall Study|Moved to a different ward|1|||
145351697|NCT05620082|524135056|FG001|Overall Study|Moved to a different ward|0|||
145351698|NCT05620082|524135057|FG002|Overall Study|Moved to a different ward|0|||
145415727|NCT05089357|524376443|FG000|Overall Study|Lost to Follow-up|6|||
145415728|NCT05089357|524376443|FG000|Overall Study|Medical reason|1|||
145415729|NCT05089357|524376443|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
145351699|NCT05620082|524135055|FG000|Overall Study|Feeling too unwell|1|||
145351700|NCT05620082|524135056|FG001|Overall Study|Feeling too unwell|0|||
145351701|NCT05620082|524135057|FG002|Overall Study|Feeling too unwell|0|||
145351702|NCT04179838|524136736|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
145415730|NCT05089357|524376443|FG000|Overall Study|Pregnancy|2|||
145351703|NCT04179838|524136737|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
145351704|NCT04179838|524136736|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
145351705|NCT04179838|524136737|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
145351706|NCT00086684|524136738|FG000|Overall Study|Adverse Event|12|||
145351707|NCT00086684|524136739|FG001|Overall Study|Adverse Event|17|||
145351708|NCT00086684|524136740|FG002|Overall Study|Adverse Event|14|||
145351709|NCT00086684|524136738|FG000|Overall Study|Lack of Efficacy|6|||
145351710|NCT00086684|524136739|FG001|Overall Study|Lack of Efficacy|6|||
145351711|NCT00086684|524136740|FG002|Overall Study|Lack of Efficacy|5|||
145351712|NCT00086684|524136738|FG000|Overall Study|Lost to Follow-up|15|||
145351713|NCT00086684|524136739|FG001|Overall Study|Lost to Follow-up|8|||
145351714|NCT00086684|524136740|FG002|Overall Study|Lost to Follow-up|10|||
145351715|NCT00086684|524136738|FG000|Overall Study|Protocol Violation|8|||
145415731|NCT04180696|524376444|FG000|Overall Study|Death|5|||
145622919|NCT01167023|525130242|FG002|Overall Study|Lost to Follow-up|1|||
145622920|NCT01167023|525130240|FG000|Overall Study|Screen Failure|0|||
145622921|NCT01167023|525130241|FG001|Overall Study|Screen Failure|1|||
145622922|NCT01167023|525130242|FG002|Overall Study|Screen Failure|0|||
145351716|NCT00086684|524136739|FG001|Overall Study|Protocol Violation|3|||
145351717|NCT00086684|524136740|FG002|Overall Study|Protocol Violation|0|||
145351718|NCT00086684|524136738|FG000|Overall Study|Withdrawal by Subject|0|||
145351719|NCT00086684|524136739|FG001|Overall Study|Withdrawal by Subject|4|||
145351720|NCT00086684|524136740|FG002|Overall Study|Withdrawal by Subject|10|||
145351721|NCT00086684|524136738|FG000|Overall Study|NONCOMPLIANCE|5|||
145351722|NCT00086684|524136739|FG001|Overall Study|NONCOMPLIANCE|7|||
145351723|NCT00086684|524136740|FG002|Overall Study|NONCOMPLIANCE|6|||
145351724|NCT00086684|524136738|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145351725|NCT00086684|524136739|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
145351726|NCT00086684|524136740|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
145351727|NCT00086684|524136738|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
145351728|NCT00086684|524136739|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
145351729|NCT00086684|524136740|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
145351730|NCT00086684|524136738|FG000|Overall Study|Other|4|||
145351731|NCT00086684|524136739|FG001|Overall Study|Other|2|||
145351732|NCT00086684|524136740|FG002|Overall Study|Other|3|||
145351733|NCT01050530|524136744|FG000|Overall Study|Adverse Event|6|||
145351734|NCT01050530|524136745|FG001|Overall Study|Adverse Event|3|||
145351735|NCT01050530|524136744|FG000|Overall Study|Lack of Efficacy|1|||
145351736|NCT01050530|524136745|FG001|Overall Study|Lack of Efficacy|4|||
145351737|NCT01050530|524136744|FG000|Overall Study|Withdrawal by Subject|0|||
145351738|NCT01050530|524136745|FG001|Overall Study|Withdrawal by Subject|3|||
145351739|NCT01050530|524136744|FG000|Overall Study|Protocol Violation|1|||
145351740|NCT01050530|524136745|FG001|Overall Study|Protocol Violation|0|||
145351741|NCT02288312|524136746|FG000|Overall Study|Pregnancy|1|||
145351742|NCT02288312|524136747|FG001|Overall Study|Pregnancy|0|||
145351743|NCT02288312|524136748|FG002|Overall Study|Pregnancy|0|||
145351744|NCT01276041|524136749|FG000|Overall Study|Adverse Event|2|||
145351745|NCT01276041|524136749|FG000|Overall Study|Protocol Violation|1|||
145351746|NCT00840749|524136753|FG000|Overall Study|Death|1|||
145351747|NCT00840749|524136754|FG001|Overall Study|Death|2|||
145351748|NCT00840749|524136753|FG000|Overall Study|not treated on study arm|11|||
145351749|NCT00840749|524136754|FG001|Overall Study|not treated on study arm|11|||
145351750|NCT00840749|524136753|FG000|Overall Study|study closed|19|||
145351751|NCT00840749|524136754|FG001|Overall Study|study closed|14|||
145351752|NCT01928472|524136755|FG000|Overall Study|Death|0|||
145351753|NCT01928472|524136756|FG001|Overall Study|Death|0|||
145351754|NCT01928472|524136757|FG002|Overall Study|Death|1|||
145351755|NCT01928472|524136758|FG003|Overall Study|Death|0|||
145351756|NCT01928472|524136755|FG000|Overall Study|Withdrawal by Subject|4|||
145351757|NCT01928472|524136756|FG001|Overall Study|Withdrawal by Subject|4|||
145351758|NCT01928472|524136757|FG002|Overall Study|Withdrawal by Subject|1|||
145351759|NCT01928472|524136758|FG003|Overall Study|Withdrawal by Subject|2|||
145351760|NCT01928472|524136755|FG000|Overall Study|Lost to Follow-up|2|||
145351761|NCT01928472|524136756|FG001|Overall Study|Lost to Follow-up|3|||
145351762|NCT01928472|524136757|FG002|Overall Study|Lost to Follow-up|4|||
145351763|NCT01928472|524136758|FG003|Overall Study|Lost to Follow-up|0|||
145351764|NCT01928472|524136755|FG000|Overall Study|Administrative Reason|2|||
145351765|NCT01928472|524136756|FG001|Overall Study|Administrative Reason|1|||
145351766|NCT01928472|524136757|FG002|Overall Study|Administrative Reason|0|||
145622923|NCT01167023|525130240|FG000|Overall Study|Sponsor Decision|0|||
145351767|NCT01928472|524136758|FG003|Overall Study|Administrative Reason|0|||
145351768|NCT01928472|524136755|FG000|Overall Study|Unclassified|0|||
145351769|NCT01928472|524136756|FG001|Overall Study|Unclassified|0|||
145351770|NCT01928472|524136757|FG002|Overall Study|Unclassified|1|||
145351771|NCT01928472|524136758|FG003|Overall Study|Unclassified|0|||
145351772|NCT02603887|524136760|FG000|Stage 1|Adverse Event|4|||
145351773|NCT02603887|524136760|FG000|Stage 1|Disease progression|1|||
145351774|NCT02603887|524136760|FG000|Stage 2|FDA guidance|1|||
145351775|NCT01308424|524136763|FG000|Baseline Eligibility|Screen Failures|71|||
145351776|NCT01308424|524136764|FG001|Baseline Eligibility|Screen Failures|0|||
145351777|NCT01308424|524136765|FG002|Baseline Eligibility|Screen Failures|0|||
145351778|NCT01308424|524136763|FG000|Randomization|Adverse Event|0|||
145351779|NCT01308424|524136764|FG001|Randomization|Adverse Event|1|||
145351780|NCT01308424|524136765|FG002|Randomization|Adverse Event|1|||
145351781|NCT01308424|524136763|FG000|Randomization|Lost to Follow-up|0|||
145351782|NCT01308424|524136764|FG001|Randomization|Lost to Follow-up|1|||
145351783|NCT01308424|524136765|FG002|Randomization|Lost to Follow-up|0|||
145622924|NCT01167023|525130241|FG001|Overall Study|Sponsor Decision|1|||
145622925|NCT01167023|525130242|FG002|Overall Study|Sponsor Decision|0|||
145351784|NCT01308424|524136763|FG000|Randomization|Physician Decision|0|||
145351785|NCT01308424|524136764|FG001|Randomization|Physician Decision|1|||
145351786|NCT01308424|524136765|FG002|Randomization|Physician Decision|1|||
145351787|NCT00948155|524136766|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
145351788|NCT00948155|524136767|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
145577244|NCT00705575|524968026|FG000|Overall Study|Adverse Event|11|||
145577245|NCT00705575|524968027|FG001|Overall Study|Adverse Event|15|||
145577246|NCT00705575|524968026|FG000|Overall Study|Lost to Follow-up|3|||
145577247|NCT00705575|524968027|FG001|Overall Study|Lost to Follow-up|4|||
145577248|NCT00705575|524968026|FG000|Overall Study|Protocol Violation|2|||
145577249|NCT00705575|524968027|FG001|Overall Study|Protocol Violation|2|||
145577250|NCT00705575|524968026|FG000|Overall Study|Withdrawal by Subject|5|||
145351789|NCT00948155|524136766|FG000|Washout 14 Days|Lost to Follow-up|1|||
145351790|NCT00948155|524136767|FG001|Washout 14 Days|Lost to Follow-up|2|||
145351791|NCT05767905|524136768|FG000|Overall Study|Adverse Event|0|||
145351792|NCT05767905|524136769|FG001|Overall Study|Adverse Event|0|||
145351793|NCT05767905|524136770|FG002|Overall Study|Adverse Event|1|||
145351794|NCT03535740|524136771|FG000|Overall Study|Death|44|||
145351795|NCT03535740|524136771|FG000|Overall Study|Lost to Follow-up|1|||
145351796|NCT03535740|524136771|FG000|Overall Study|Withdrawal by Subject|13|||
145351797|NCT03535740|524136771|FG000|Overall Study|Site terminated by Sponsor|45|||
145351798|NCT05198518|524136775|FG000|Screening Visit|Deemed unable to participate|58|||
145351799|NCT05198518|524136776|FG001|Screening Visit|Deemed unable to participate|0|||
145351800|NCT05198518|524136777|FG002|Screening Visit|Deemed unable to participate|0|||
145351801|NCT02766335|524136778|FG000|Initial Registration|Adverse Event|6|||
145351802|NCT02766335|524136779|FG001|Initial Registration|Adverse Event|3|||
145351803|NCT02766335|524136780|FG002|Initial Registration|Adverse Event|0|||
145351804|NCT02766335|524136778|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
145351805|NCT02766335|524136779|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
145351806|NCT02766335|524136780|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
145351807|NCT02766335|524136778|FG000|Initial Registration|Progression/relapse|49|||
145351808|NCT02766335|524136779|FG001|Initial Registration|Progression/relapse|15|||
145351809|NCT02766335|524136780|FG002|Initial Registration|Progression/relapse|0|||
145351810|NCT02766335|524136778|FG000|Initial Registration|Death|1|||
145351811|NCT02766335|524136779|FG001|Initial Registration|Death|3|||
145351812|NCT02766335|524136780|FG002|Initial Registration|Death|0|||
145351813|NCT02766335|524136778|FG000|Initial Registration|not protocol specified|1|||
145351814|NCT02766335|524136779|FG001|Initial Registration|not protocol specified|9|||
145351815|NCT02766335|524136780|FG002|Initial Registration|not protocol specified|0|||
145351816|NCT02766335|524136778|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
145351817|NCT02766335|524136779|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
145351818|NCT02766335|524136780|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
145351819|NCT02766335|524136778|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
145351820|NCT02766335|524136779|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
145351821|NCT02766335|524136780|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
145351822|NCT03645863|524136782|FG000|Overall Study|Withdrawal by Subject|1|||
145351823|NCT03645863|524136783|FG001|Overall Study|Withdrawal by Subject|0|||
145351824|NCT03645863|524136784|FG002|Overall Study|Withdrawal by Subject|0|||
145351825|NCT03518008|524136790|FG000|Period 2, Second Week of Wear|Family emergency|0|||
145351826|NCT03518008|524136791|FG001|Period 2, Second Week of Wear|Family emergency|1|||
145351827|NCT01515423|524136792|FG000|Open Label Phase|Adverse Event|57|||
145351828|NCT01515423|524136793|FG001|Open Label Phase|Adverse Event|0|||
145351829|NCT01515423|524136794|FG002|Open Label Phase|Adverse Event|0|||
145351830|NCT01515423|524136792|FG000|Open Label Phase|Death|2|||
145351831|NCT01515423|524136793|FG001|Open Label Phase|Death|0|||
145351832|NCT01515423|524136794|FG002|Open Label Phase|Death|0|||
145351833|NCT01515423|524136792|FG000|Open Label Phase|Lack of Efficacy|117|||
145351834|NCT01515423|524136793|FG001|Open Label Phase|Lack of Efficacy|0|||
145351835|NCT01515423|524136794|FG002|Open Label Phase|Lack of Efficacy|0|||
145351836|NCT01515423|524136792|FG000|Open Label Phase|Lost to Follow-up|21|||
145351837|NCT01515423|524136793|FG001|Open Label Phase|Lost to Follow-up|0|||
145351838|NCT01515423|524136794|FG002|Open Label Phase|Lost to Follow-up|0|||
145351839|NCT01515423|524136792|FG000|Open Label Phase|Withdrawal by Subject|118|||
145351840|NCT01515423|524136793|FG001|Open Label Phase|Withdrawal by Subject|0|||
145351841|NCT01515423|524136794|FG002|Open Label Phase|Withdrawal by Subject|0|||
145351842|NCT01515423|524136792|FG000|Open Label Phase|excluded from DB Phase|70|||
145351843|NCT01515423|524136793|FG001|Open Label Phase|excluded from DB Phase|0|||
145351844|NCT01515423|524136794|FG002|Open Label Phase|excluded from DB Phase|0|||
145351845|NCT01515423|524136792|FG000|Open Label Phase|Other|28|||
145351846|NCT01515423|524136793|FG001|Open Label Phase|Other|0|||
145351847|NCT01515423|524136794|FG002|Open Label Phase|Other|0|||
145577251|NCT00705575|524968027|FG001|Overall Study|Withdrawal by Subject|10|||
145351848|NCT01515423|524136792|FG000|DOUBLE BLIND|Adverse Event|0|||
145351849|NCT01515423|524136793|FG001|DOUBLE BLIND|Adverse Event|15|||
145351850|NCT01515423|524136794|FG002|DOUBLE BLIND|Adverse Event|13|||
145351851|NCT01515423|524136792|FG000|DOUBLE BLIND|Death|0|||
145351852|NCT01515423|524136793|FG001|DOUBLE BLIND|Death|1|||
145351853|NCT01515423|524136794|FG002|DOUBLE BLIND|Death|2|||
145351854|NCT01515423|524136792|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
145351855|NCT01515423|524136793|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
145351856|NCT01515423|524136794|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
145577252|NCT02170727|524968029|FG000|Overall Study|Lost to Follow-up|1|||
145351857|NCT01515423|524136792|FG000|DOUBLE BLIND|Pregnancy|0|||
145351858|NCT01515423|524136793|FG001|DOUBLE BLIND|Pregnancy|2|||
145351859|NCT01515423|524136794|FG002|DOUBLE BLIND|Pregnancy|0|||
145351860|NCT01515423|524136792|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
145351861|NCT01515423|524136793|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
145351862|NCT01515423|524136794|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
145351863|NCT01515423|524136792|FG000|DOUBLE BLIND|Other|0|||
145351864|NCT01515423|524136793|FG001|DOUBLE BLIND|Other|6|||
145351865|NCT01515423|524136794|FG002|DOUBLE BLIND|Other|12|||
145351866|NCT01515423|524136792|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
145351867|NCT01515423|524136793|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
145351868|NCT01515423|524136794|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
145351869|NCT01125917|524136803|FG000|Overall Study|Adverse Event|43|||
145351870|NCT01125917|524136803|FG000|Overall Study|Lost to Follow-up|23|||
145351871|NCT01125917|524136803|FG000|Overall Study|Withdrawal by Subject|31|||
145351872|NCT01125917|524136803|FG000|Overall Study|Administrative|223|||
145351873|NCT01125917|524136803|FG000|Overall Study|Lack of Efficacy|19|||
145351874|NCT04421131|524136807|FG000|Overall Study|Lost to Follow-up|1|||
145351875|NCT04421131|524136807|FG000|Overall Study|Protocol Violation|2|||
145351876|NCT04421131|524136807|FG000|Overall Study|App crashed|5|||
145351877|NCT00476190|524136811|FG000|Overall Study|Ineligible|1|||
145351878|NCT00476190|524136812|FG001|Overall Study|Ineligible|1|||
145351879|NCT00476190|524136811|FG000|Overall Study|Induction Death|2|||
145351880|NCT00476190|524136812|FG001|Overall Study|Induction Death|0|||
145351881|NCT00476190|524136811|FG000|Overall Study|Induction Failure|2|||
145351882|NCT00476190|524136812|FG001|Overall Study|Induction Failure|4|||
145351883|NCT00476190|524136811|FG000|Overall Study|Lost to Follow-up|1|||
145351884|NCT00476190|524136812|FG001|Overall Study|Lost to Follow-up|0|||
145351885|NCT00476190|524136811|FG000|Overall Study|Relapse/Progression|5|||
145351886|NCT00476190|524136812|FG001|Overall Study|Relapse/Progression|2|||
145351887|NCT00476190|524136811|FG000|Overall Study|Remission Death|0|||
145351888|NCT00476190|524136812|FG001|Overall Study|Remission Death|1|||
145351889|NCT00476190|524136811|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
145351890|NCT00476190|524136812|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
145351891|NCT00476190|524136811|FG000|Overall Study|Withdrawal by Subject|6|||
145351892|NCT00476190|524136812|FG001|Overall Study|Withdrawal by Subject|2|||
145351893|NCT00476190|524136811|FG000|Overall Study|Other|9|||
145351894|NCT00476190|524136812|FG001|Overall Study|Other|10|||
145351895|NCT00281957|524136814|FG000|Overall Study|Adverse Event|7|||
145351896|NCT00281957|524136815|FG001|Overall Study|Adverse Event|2|||
145351897|NCT00281957|524136814|FG000|Overall Study|Death|1|||
145351898|NCT00281957|524136815|FG001|Overall Study|Death|0|||
145351899|NCT00281957|524136814|FG000|Overall Study|Progression/relapse|47|||
145351900|NCT00281957|524136815|FG001|Overall Study|Progression/relapse|35|||
145351901|NCT00281957|524136814|FG000|Overall Study|Not protocol specified|8|||
145351902|NCT00281957|524136815|FG001|Overall Study|Not protocol specified|1|||
145351903|NCT00281957|524136814|FG000|Overall Study|Not eligible|1|||
145351904|NCT00281957|524136815|FG001|Overall Study|Not eligible|2|||
145351905|NCT00281957|524136814|FG000|Overall Study|Did not start treatment|3|||
145351906|NCT00281957|524136815|FG001|Overall Study|Did not start treatment|1|||
145351907|NCT00281957|524136814|FG000|Overall Study|Refusal unrelated to adverse events|0|||
145351908|NCT00281957|524136815|FG001|Overall Study|Refusal unrelated to adverse events|1|||
145351909|NCT01876446|524136816|FG000|Overall Study|Death|0|||
145351910|NCT01876446|524136817|FG001|Overall Study|Death|1|||
145351911|NCT01876446|524136816|FG000|Overall Study|Withdrawal by Subject|1|||
145351912|NCT01876446|524136817|FG001|Overall Study|Withdrawal by Subject|2|||
145351913|NCT01876446|524136816|FG000|Overall Study|Physician Decision|1|||
145351914|NCT01876446|524136817|FG001|Overall Study|Physician Decision|3|||
145351915|NCT00822692|524136827|FG000|Overall Study|Lost to Follow-up|17|||
145351916|NCT00822692|524136828|FG001|Overall Study|Lost to Follow-up|25|||
145351917|NCT03281876|524136830|FG000|Overall Study|Adverse Event|4|||
145351918|NCT03281876|524136831|FG001|Overall Study|Adverse Event|15|||
145351919|NCT03281876|524136830|FG000|Overall Study|Lost to Follow-up|1|||
145351920|NCT03281876|524136831|FG001|Overall Study|Lost to Follow-up|4|||
145351921|NCT03281876|524136830|FG000|Overall Study|Withdrawal by Subject|11|||
145577253|NCT02170727|524968030|FG001|Overall Study|Lost to Follow-up|0|||
145577254|NCT02170727|524968029|FG000|Overall Study|Withdrawal by Subject|2|||
145577255|NCT02170727|524968030|FG001|Overall Study|Withdrawal by Subject|0|||
145577256|NCT00414050|524968033|FG000|Overall Study|Adverse Event|1|||
145351922|NCT03281876|524136831|FG001|Overall Study|Withdrawal by Subject|15|||
145351923|NCT03281876|524136830|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
145351924|NCT03281876|524136831|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145351925|NCT03281876|524136830|FG000|Overall Study|OTHER|5|||
145351926|NCT03281876|524136831|FG001|Overall Study|OTHER|5|||
145351927|NCT02208089|524136832|FG000|Overall Study|Withdrawal by Subject|1|||
145351928|NCT02208089|524136833|FG001|Overall Study|Withdrawal by Subject|0|||
145351929|NCT02208089|524136832|FG000|Overall Study|Lost to Follow-up|6|||
145351930|NCT02208089|524136833|FG001|Overall Study|Lost to Follow-up|0|||
145351931|NCT02443740|524136834|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351932|NCT02443740|524136835|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351933|NCT02443740|524136836|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351934|NCT02443740|524136837|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351935|NCT02443740|524136838|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351936|NCT02443740|524136839|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
145351937|NCT02443740|524136840|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351938|NCT02443740|524136841|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351939|NCT02443740|524136842|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351940|NCT02443740|524136843|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351941|NCT02443740|524136844|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
145351942|NCT02443740|524136834|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
145351943|NCT02443740|524136835|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351944|NCT02443740|524136836|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351945|NCT02443740|524136837|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351946|NCT02443740|524136838|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351947|NCT02443740|524136839|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351948|NCT02443740|524136840|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
145351949|NCT02443740|524136841|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351950|NCT02443740|524136842|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351951|NCT02443740|524136843|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351952|NCT02443740|524136844|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
145351953|NCT02443740|524136834|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351954|NCT02443740|524136835|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351955|NCT02443740|524136836|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351956|NCT02443740|524136837|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351957|NCT02443740|524136838|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351958|NCT02443740|524136839|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
145351959|NCT02443740|524136840|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351960|NCT02443740|524136841|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351961|NCT02443740|524136842|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351962|NCT02443740|524136843|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351963|NCT02443740|524136844|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
145351964|NCT00456300|524136845|FG000|Overall Study|Adverse Event|1|||
145351965|NCT00456300|524136846|FG001|Overall Study|Adverse Event|0|||
145351966|NCT02452476|524136847|FG000|Overall Study|Death|4|||
145351967|NCT02452476|524136848|FG001|Overall Study|Death|7|||
145351968|NCT02452476|524136847|FG000|Overall Study|Lost to Follow-up|1|||
145351969|NCT02452476|524136848|FG001|Overall Study|Lost to Follow-up|1|||
145351970|NCT02452476|524136847|FG000|Overall Study|Physician Decision|1|||
145351971|NCT02452476|524136848|FG001|Overall Study|Physician Decision|1|||
145351972|NCT02452476|524136847|FG000|Overall Study|Not treated|5|||
145351973|NCT02452476|524136848|FG001|Overall Study|Not treated|1|||
145351974|NCT00683657|524136853|FG000|Overall Study|Adverse Event|0|||
145351975|NCT00683657|524136854|FG001|Overall Study|Adverse Event|1|||
145351976|NCT00683657|524136853|FG000|Overall Study|Subject Withdrew Consent|1|||
145351977|NCT00683657|524136854|FG001|Overall Study|Subject Withdrew Consent|0|||
145351978|NCT03200717|524136863|FG000|Overall Study|Progressive disease|24|||
145351979|NCT03200717|524136864|FG001|Overall Study|Progressive disease|5|||
145351980|NCT03200717|524136863|FG000|Overall Study|Adverse Event|11|||
145351981|NCT03200717|524136864|FG001|Overall Study|Adverse Event|8|||
145415732|NCT04180696|524376445|FG001|Overall Study|Death|6|||
145415733|NCT04180696|524376444|FG000|Overall Study|Lost to Follow-up|1|||
145415734|NCT04180696|524376445|FG001|Overall Study|Lost to Follow-up|0|||
145577257|NCT00414050|524968034|FG001|Overall Study|Adverse Event|1|||
145577258|NCT00414050|524968035|FG002|Overall Study|Adverse Event|1|||
145577259|NCT00414050|524968036|FG003|Overall Study|Adverse Event|1|||
145577260|NCT00414050|524968033|FG000|Overall Study|Lost to Follow-up|2|||
145577261|NCT00414050|524968034|FG001|Overall Study|Lost to Follow-up|2|||
145577262|NCT00414050|524968035|FG002|Overall Study|Lost to Follow-up|1|||
145577263|NCT00414050|524968036|FG003|Overall Study|Lost to Follow-up|1|||
145577264|NCT00414050|524968033|FG000|Overall Study|Withdrawal by Subject|5|||
145577265|NCT00414050|524968034|FG001|Overall Study|Withdrawal by Subject|3|||
145577266|NCT00414050|524968035|FG002|Overall Study|Withdrawal by Subject|2|||
145351982|NCT03200717|524136863|FG000|Overall Study|Physician Decision|3|||
145351983|NCT03200717|524136864|FG001|Overall Study|Physician Decision|2|||
145351984|NCT03200717|524136863|FG000|Overall Study|Death|2|||
145351985|NCT03200717|524136864|FG001|Overall Study|Death|0|||
145351986|NCT03200717|524136863|FG000|Overall Study|Subject/Guardian Decision|1|||
145351987|NCT03200717|524136864|FG001|Overall Study|Subject/Guardian Decision|0|||
145351988|NCT01461538|524136865|FG000|Overall Study|Death|15|||
145351989|NCT01461538|524136866|FG001|Overall Study|Death|6|||
145351990|NCT01461538|524136867|FG002|Overall Study|Death|2|||
145415735|NCT04180696|524376444|FG000|Overall Study|Withdrawal by Subject|0|||
145577267|NCT00414050|524968036|FG003|Overall Study|Withdrawal by Subject|4|||
145577268|NCT00414050|524968033|FG000|Overall Study|Subject discontinued for other reason|1|||
145351991|NCT01461538|524136865|FG000|Overall Study|Study Stopped by Sponsor|2|||
145351992|NCT01461538|524136866|FG001|Overall Study|Study Stopped by Sponsor|1|||
145351993|NCT01461538|524136867|FG002|Overall Study|Study Stopped by Sponsor|0|||
145351994|NCT01461538|524136865|FG000|Overall Study|Withdrawal by Subject|1|||
145351995|NCT01461538|524136866|FG001|Overall Study|Withdrawal by Subject|1|||
145351996|NCT01461538|524136867|FG002|Overall Study|Withdrawal by Subject|0|||
145351997|NCT03552380|524136869|FG000|Study Treatment|Disease Progression|3|||
145351998|NCT03552380|524136870|FG001|Study Treatment|Disease Progression|4|||
145351999|NCT03552380|524136869|FG000|Study Treatment|Adverse Event|2|||
145352000|NCT03552380|524136870|FG001|Study Treatment|Adverse Event|2|||
145352001|NCT03552380|524136869|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
145352002|NCT03552380|524136870|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
145352003|NCT03552380|524136869|FG000|Follow up|Death|3|||
145352004|NCT03552380|524136870|FG001|Follow up|Death|4|||
145352005|NCT03552380|524136869|FG000|Follow up|Site IRB terminated|0|||
145352006|NCT03552380|524136870|FG001|Follow up|Site IRB terminated|1|||
145352007|NCT02461160|524136871|FG000|Overall Study|Lost to Follow-up|0|||
145352008|NCT02461160|524136872|FG001|Overall Study|Lost to Follow-up|0|||
145352009|NCT02461160|524136873|FG002|Overall Study|Lost to Follow-up|0|||
145352010|NCT02461160|524136874|FG003|Overall Study|Lost to Follow-up|0|||
145352011|NCT02461160|524136875|FG004|Overall Study|Lost to Follow-up|0|||
145352012|NCT02461160|524136876|FG005|Overall Study|Lost to Follow-up|0|||
145352013|NCT02461160|524136877|FG006|Overall Study|Lost to Follow-up|0|||
145352014|NCT02461160|524136878|FG007|Overall Study|Lost to Follow-up|1|||
145352015|NCT02461160|524136879|FG008|Overall Study|Lost to Follow-up|0|||
145352016|NCT02461160|524136880|FG009|Overall Study|Lost to Follow-up|0|||
145352017|NCT02461160|524136881|FG010|Overall Study|Lost to Follow-up|0|||
145352018|NCT02461160|524136882|FG011|Overall Study|Lost to Follow-up|0|||
145352019|NCT02461160|524136883|FG012|Overall Study|Lost to Follow-up|0|||
145352020|NCT03567980|524136884|FG000|Overall Study|Adverse Event|1|||
145352021|NCT02633787|524136885|FG000|Overall Study|Withdrawal by Subject|1|||
145352022|NCT05373108|524136886|FG000|Overall Study|Withdrawal by Subject|2|||
145352023|NCT00349973|524136887|FG000|Overall Study|Adverse Event|3|||
145352024|NCT00349973|524136888|FG001|Overall Study|Adverse Event|3|||
145352025|NCT00349973|524136887|FG000|Overall Study|Withdrawal by Subject|1|||
145352026|NCT00349973|524136888|FG001|Overall Study|Withdrawal by Subject|0|||
145352027|NCT04871776|524136889|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
145352028|NCT04871776|524136890|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
145352029|NCT04871776|524136891|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
145352030|NCT04871776|524136889|FG000|Overall Study|Did not meet eligibility criteria|1|||
145352031|NCT04871776|524136890|FG001|Overall Study|Did not meet eligibility criteria|1|||
145352032|NCT04871776|524136891|FG002|Overall Study|Did not meet eligibility criteria|1|||
145352033|NCT06389487|524136897|FG000|Overall Study|Lost to Follow-up|9|||
145352034|NCT06389487|524136898|FG001|Overall Study|Lost to Follow-up|5|||
145352035|NCT06389487|524136899|FG002|Overall Study|Lost to Follow-up|13|||
145352036|NCT06389487|524136897|FG000|Overall Study|Protocol Violation|0|||
145352037|NCT06389487|524136898|FG001|Overall Study|Protocol Violation|0|||
145352038|NCT06389487|524136899|FG002|Overall Study|Protocol Violation|2|||
145352039|NCT06389487|524136897|FG000|Overall Study|Withdrawal by Subject|2|||
145352040|NCT06389487|524136898|FG001|Overall Study|Withdrawal by Subject|2|||
145352041|NCT06389487|524136899|FG002|Overall Study|Withdrawal by Subject|1|||
145352042|NCT06389487|524136897|FG000|Overall Study|Other|1|||
145352043|NCT06389487|524136898|FG001|Overall Study|Other|0|||
145352044|NCT06389487|524136899|FG002|Overall Study|Other|1|||
145352045|NCT04075487|524138466|FG000|Overall Study|Withdrawal by Subject|1|||
145352046|NCT05016960|524138469|FG000|Overall Study|Withdrawal by Subject|1|||
145352047|NCT05016960|524138470|FG001|Overall Study|Withdrawal by Subject|9|||
145352048|NCT00116779|524138473|FG000|Overall Study|Adverse Event|4|||
145352049|NCT00116779|524138474|FG001|Overall Study|Adverse Event|2|||
145352050|NCT00116779|524138473|FG000|Overall Study|Protocol Violation|1|||
145352051|NCT00116779|524138474|FG001|Overall Study|Protocol Violation|4|||
145352052|NCT00116779|524138473|FG000|Overall Study|Withdrawal by Subject|4|||
145352053|NCT00116779|524138474|FG001|Overall Study|Withdrawal by Subject|1|||
145352054|NCT00116779|524138473|FG000|Overall Study|Inadequate testosterone suppression|7|||
145352055|NCT00116779|524138474|FG001|Overall Study|Inadequate testosterone suppression|9|||
145352056|NCT00116779|524138473|FG000|Overall Study|Physician Decision|3|||
145352057|NCT00116779|524138474|FG001|Overall Study|Physician Decision|1|||
145352058|NCT00116779|524138473|FG000|Overall Study|Elevated PSA levels|2|||
145352059|NCT00116779|524138474|FG001|Overall Study|Elevated PSA levels|2|||
145352060|NCT01321879|524138475|FG000|Overall Study|Lack of Efficacy|5|||
145352061|NCT01321879|524138475|FG000|Overall Study|Adverse Event|5|||
145352062|NCT01321879|524138475|FG000|Overall Study|Death|3|||
145352063|NCT01321879|524138475|FG000|Overall Study|Withdrawal by Subject|1|||
145352064|NCT03743051|524138476|FG000|Overall Study|Adverse Event|5|||
145352065|NCT03743051|524138477|FG001|Overall Study|Adverse Event|9|||
145352066|NCT03743051|524138476|FG000|Overall Study|Death|27|||
145352067|NCT03743051|524138477|FG001|Overall Study|Death|26|||
145352068|NCT03743051|524138476|FG000|Overall Study|Lost to Follow-up|4|||
145352069|NCT03743051|524138477|FG001|Overall Study|Lost to Follow-up|8|||
145352070|NCT03743051|524138476|FG000|Overall Study|Withdrawal by Subject|32|||
145352071|NCT03743051|524138477|FG001|Overall Study|Withdrawal by Subject|19|||
145352072|NCT03743051|524138476|FG000|Overall Study|Physician Decision|10|||
145352073|NCT03743051|524138477|FG001|Overall Study|Physician Decision|15|||
145352074|NCT03743051|524138476|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
145352075|NCT03743051|524138477|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
145352076|NCT00711087|524138480|FG000|Overall Study|Lost to Follow-up|1|||
145352077|NCT00711087|524138481|FG001|Overall Study|Lost to Follow-up|0|||
145352078|NCT03652051|524138482|FG000|Stage 1|Adverse Event|0|||
145352079|NCT03652051|524138483|FG001|Stage 1|Adverse Event|5|||
145352080|NCT03652051|524138484|FG002|Stage 1|Adverse Event|7|||
145352081|NCT03652051|524138485|FG003|Stage 1|Adverse Event|1|||
145352082|NCT03652051|524138482|FG000|Stage 1|Withdrawal by Subject|0|||
145352083|NCT03652051|524138483|FG001|Stage 1|Withdrawal by Subject|0|||
145352084|NCT03652051|524138484|FG002|Stage 1|Withdrawal by Subject|1|||
145352085|NCT03652051|524138485|FG003|Stage 1|Withdrawal by Subject|0|||
145352086|NCT03652051|524138482|FG000|Stage 2|Adverse Event|0|||
145352087|NCT03652051|524138483|FG001|Stage 2|Adverse Event|2|||
145352088|NCT03652051|524138484|FG002|Stage 2|Adverse Event|1|||
145352089|NCT03652051|524138485|FG003|Stage 2|Adverse Event|0|||
145352090|NCT03652051|524138482|FG000|Stage 2|Protocol Violation|0|||
145352091|NCT03652051|524138483|FG001|Stage 2|Protocol Violation|1|||
145352092|NCT03652051|524138484|FG002|Stage 2|Protocol Violation|6|||
145352093|NCT03652051|524138485|FG003|Stage 2|Protocol Violation|0|||
145352094|NCT03652051|524138482|FG000|Stage 2|Lost to Follow-up|0|||
145352095|NCT03652051|524138483|FG001|Stage 2|Lost to Follow-up|2|||
145352096|NCT03652051|524138484|FG002|Stage 2|Lost to Follow-up|0|||
145352097|NCT03652051|524138485|FG003|Stage 2|Lost to Follow-up|3|||
145352098|NCT03652051|524138482|FG000|Stage 2|Withdrawal by Subject|0|||
145352099|NCT03652051|524138483|FG001|Stage 2|Withdrawal by Subject|11|||
145352100|NCT03652051|524138484|FG002|Stage 2|Withdrawal by Subject|9|||
145352101|NCT03652051|524138485|FG003|Stage 2|Withdrawal by Subject|3|||
145352102|NCT01113892|524138492|FG000|Overall Study|Lost to Follow-up|2|||
145352103|NCT01113892|524138493|FG001|Overall Study|Lost to Follow-up|2|||
145352104|NCT01113892|524138492|FG000|Overall Study|Withdrawal by Subject|1|||
145352105|NCT01113892|524138493|FG001|Overall Study|Withdrawal by Subject|1|||
145352106|NCT01113892|524138492|FG000|Overall Study|Death|2|||
145352107|NCT01113892|524138493|FG001|Overall Study|Death|4|||
145352108|NCT01113892|524138492|FG000|Overall Study|Graft no longer evaluable|9|||
145352109|NCT01113892|524138493|FG001|Overall Study|Graft no longer evaluable|9|||
145352110|NCT02394600|524138494|FG000|Overall Study|Adverse Event|3|||
145352111|NCT02394600|524138495|FG001|Overall Study|Adverse Event|0|||
145352112|NCT02394600|524138494|FG000|Overall Study|Lost to Follow-up|0|||
145352113|NCT02394600|524138495|FG001|Overall Study|Lost to Follow-up|1|||
145352114|NCT02394600|524138494|FG000|Overall Study|Withdrawal by Subject|0|||
145352115|NCT02394600|524138495|FG001|Overall Study|Withdrawal by Subject|1|||
145352116|NCT02394600|524138494|FG000|Overall Study|Protocol Violation|1|||
145352117|NCT02394600|524138495|FG001|Overall Study|Protocol Violation|0|||
145352118|NCT00428246|524138496|FG000|Overall Study|Withdrawal by Subject|0|||
145352119|NCT00428246|524138497|FG001|Overall Study|Withdrawal by Subject|0|||
145352120|NCT00428246|524138498|FG002|Overall Study|Withdrawal by Subject|1|||
145352121|NCT00428246|524138496|FG000|Overall Study|Adverse Event|1|||
145352122|NCT00428246|524138497|FG001|Overall Study|Adverse Event|0|||
145577269|NCT00414050|524968034|FG001|Overall Study|Subject discontinued for other reason|2|||
145352123|NCT00428246|524138498|FG002|Overall Study|Adverse Event|0|||
145352124|NCT02569801|524138499|FG000|Overall Study|Withdrawal by Subject|9|||
145352125|NCT02569801|524138500|FG001|Overall Study|Withdrawal by Subject|9|||
145352126|NCT02569801|524138499|FG000|Overall Study|Sponsor Decision|13|||
145352127|NCT02569801|524138500|FG001|Overall Study|Sponsor Decision|14|||
145352128|NCT02569801|524138499|FG000|Overall Study|Progressive Disease|2|||
145352129|NCT02569801|524138500|FG001|Overall Study|Progressive Disease|7|||
145577270|NCT00414050|524968035|FG002|Overall Study|Subject discontinued for other reason|2|||
145352130|NCT02569801|524138499|FG000|Overall Study|Lost to Follow-up|0|||
145352131|NCT02569801|524138500|FG001|Overall Study|Lost to Follow-up|1|||
145352132|NCT02569801|524138499|FG000|Overall Study|Death|12|||
145352133|NCT02569801|524138500|FG001|Overall Study|Death|4|||
145352134|NCT01960413|524138502|FG000|Overall Study|Withdrawal by Subject|1|||
145352135|NCT01960413|524138503|FG001|Overall Study|Withdrawal by Subject|1|||
145352136|NCT01960413|524138502|FG000|Overall Study|Physician Decision|1|||
145352137|NCT01960413|524138503|FG001|Overall Study|Physician Decision|0|||
145352138|NCT01960413|524138502|FG000|Overall Study|Lost to Follow-up|2|||
145352139|NCT01960413|524138503|FG001|Overall Study|Lost to Follow-up|0|||
145352140|NCT00791778|524138506|FG000|Double-blind Treatment|Adverse Event|49|||
145352141|NCT00791778|524138507|FG001|Double-blind Treatment|Adverse Event|9|||
145352142|NCT00791778|524138506|FG000|Double-blind Treatment|Physician Decision|6|||
145352143|NCT00791778|524138507|FG001|Double-blind Treatment|Physician Decision|26|||
145352144|NCT00791778|524138506|FG000|Double-blind Treatment|Protocol Violation|0|||
145352145|NCT00791778|524138507|FG001|Double-blind Treatment|Protocol Violation|4|||
145352146|NCT00791778|524138506|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
145352147|NCT00791778|524138507|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
145352148|NCT00791778|524138506|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
145352149|NCT00791778|524138507|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
145352150|NCT00791778|524138506|FG000|Follow-up|Withdrawal by Subject|3|||
145352151|NCT00791778|524138507|FG001|Follow-up|Withdrawal by Subject|0|||
145352152|NCT00791778|524138506|FG000|Follow-up|Lost to Follow-up|2|||
145352153|NCT00791778|524138507|FG001|Follow-up|Lost to Follow-up|1|||
145352154|NCT04886596|524138510|FG000|Overall Study|Adverse Event|442|||
145352155|NCT04886596|524138511|FG001|Overall Study|Adverse Event|441|||
145352156|NCT04886596|524138510|FG000|Overall Study|Lost to Follow-up|448|||
145352157|NCT04886596|524138511|FG001|Overall Study|Lost to Follow-up|465|||
145352158|NCT04886596|524138510|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
145352159|NCT04886596|524138511|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
145352160|NCT04886596|524138510|FG000|Overall Study|Migrated/moved from the study area|201|||
145352161|NCT04886596|524138511|FG001|Overall Study|Migrated/moved from the study area|184|||
145352162|NCT04886596|524138510|FG000|Overall Study|Other|298|||
145352163|NCT04886596|524138511|FG001|Overall Study|Other|326|||
145352164|NCT04620746|524138512|FG000|Overall Study|Adverse Event|2|||
145352165|NCT04620746|524138513|FG001|Overall Study|Adverse Event|0|||
145352166|NCT04620746|524138512|FG000|Overall Study|Uniterpretable skin test|1|||
145352167|NCT04620746|524138513|FG001|Overall Study|Uniterpretable skin test|0|||
145352168|NCT04620746|524138512|FG000|Overall Study|Withdrawal by Subject|0|||
145352169|NCT04620746|524138513|FG001|Overall Study|Withdrawal by Subject|1|||
145352170|NCT03473925|524138514|FG000|Overall Study|Death|48|||
145352171|NCT03473925|524138515|FG001|Overall Study|Death|44|||
145352172|NCT03473925|524138514|FG000|Overall Study|Sponsor Decision|2|||
145352173|NCT03473925|524138515|FG001|Overall Study|Sponsor Decision|7|||
145352174|NCT03473925|524138514|FG000|Overall Study|Withdrawal by Subject|1|||
145352175|NCT03473925|524138515|FG001|Overall Study|Withdrawal by Subject|3|||
145352176|NCT03473925|524138514|FG000|Overall Study|Not Treated|1|||
145352177|NCT03473925|524138515|FG001|Overall Study|Not Treated|1|||
145352178|NCT03411863|524138516|FG000|Overall Study|Withdrawal by Subject|3|||
145352179|NCT03411863|524138517|FG001|Overall Study|Withdrawal by Subject|1|||
145352180|NCT03411863|524138516|FG000|Overall Study|Physician Decision|0|||
145352181|NCT03411863|524138517|FG001|Overall Study|Physician Decision|1|||
145352182|NCT02756611|524138520|FG000|Overall Study|Death|70|||
145352183|NCT02756611|524138520|FG000|Overall Study|Withdrawal by Subject|2|||
145352184|NCT02756611|524138520|FG000|Overall Study|Lost to Follow-up|3|||
145352185|NCT02756611|524138520|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
145352186|NCT02756611|524138520|FG000|Overall Study|Other|10|||
145352187|NCT00124917|524138528|FG000|Overall Study|Physician Decision|3|||
145352188|NCT03164551|524138529|FG000|Overall Study|Imaging discontinued prior completion|8|||
145352189|NCT03164551|524138530|FG001|Overall Study|Imaging discontinued prior completion|0|||
145352190|NCT03164551|524138529|FG000|Overall Study|Participant was non-compliant|1|||
145352191|NCT03164551|524138530|FG001|Overall Study|Participant was non-compliant|0|||
145352192|NCT03164551|524138529|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
145352193|NCT03164551|524138530|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
145352194|NCT03164551|524138529|FG000|Overall Study|Other|8|||
145352195|NCT03164551|524138530|FG001|Overall Study|Other|2|||
145352196|NCT02501928|524138531|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145352197|NCT02501928|524138532|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
145352198|NCT02501928|524138533|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
145352199|NCT02501928|524138534|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
145352200|NCT02501928|524138535|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
145352201|NCT02501928|524138536|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
145352202|NCT00951496|524138543|FG000|Overall Study|Did not initiate study treatment|10|||
145352203|NCT00951496|524138544|FG001|Overall Study|Did not initiate study treatment|8|||
145352204|NCT00951496|524138545|FG002|Overall Study|Did not initiate study treatment|13|||
145352205|NCT00838526|524138546|FG000|Overall Study|Adverse Event|3|||
145352206|NCT00838526|524138547|FG001|Overall Study|Adverse Event|12|||
145352207|NCT00838526|524138546|FG000|Overall Study|Lost to Follow-up|4|||
145352208|NCT00838526|524138547|FG001|Overall Study|Lost to Follow-up|12|||
145352209|NCT00838526|524138546|FG000|Overall Study|Withdrawal by Subject|4|||
145352210|NCT00838526|524138547|FG001|Overall Study|Withdrawal by Subject|5|||
145352211|NCT00838526|524138546|FG000|Overall Study|Lack of Efficacy|2|||
145352212|NCT00838526|524138547|FG001|Overall Study|Lack of Efficacy|3|||
145352213|NCT00838526|524138546|FG000|Overall Study|Other|11|||
145352214|NCT00838526|524138547|FG001|Overall Study|Other|7|||
145352215|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
145352216|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
145352217|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
145352218|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
145352219|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
145352220|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
145352221|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
145352222|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
145352223|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
145352224|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
145352225|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
145352226|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
145352227|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
145352228|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
145352229|NCT04338022|524138556|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
145352230|NCT04338022|524138557|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
145352231|NCT04338022|524138556|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
145352232|NCT04338022|524138557|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
145352233|NCT04338022|524138556|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
145352234|NCT04338022|524138557|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
145352235|NCT04338022|524138556|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
145352236|NCT04338022|524138557|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
145352237|NCT04338022|524138556|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
145352238|NCT04338022|524138557|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
145352239|NCT04338022|524138556|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
145352240|NCT04338022|524138557|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
145352241|NCT04338022|524138556|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
145352242|NCT04338022|524138557|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
145352243|NCT04782076|524138560|FG000|Overall Study|Family Emergency|1|||
145352244|NCT02860546|524138565|FG000|Overall Study|Clinical Progression|6|||
145352245|NCT02860546|524138565|FG000|Overall Study|Radiological Progression|12|||
145352246|NCT02466321|524138566|FG000|Overall Study|Death|26|||
145352247|NCT02466321|524138566|FG000|Overall Study|Revision|6|||
145352248|NCT02466321|524138566|FG000|Overall Study|Lost to Follow-up|60|||
145352249|NCT02466321|524138566|FG000|Overall Study|Did not receive study device|1|||
145352250|NCT00193050|524138567|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
145352251|NCT00193050|524138567|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
145352252|NCT00193050|524138567|FG000|Neoadjuvant Treatment|Physician Decision|2|||
145352253|NCT00193050|524138567|FG000|Neoadjuvant Treatment|Adverse Event|2|||
145352254|NCT00193050|524138567|FG000|Adjuvant|Physician Decision|5|||
145352255|NCT00193050|524138567|FG000|Adjuvant|Intercurrent Hospitalization|3|||
145352256|NCT00193050|524138567|FG000|Adjuvant|Lack of Efficacy|2|||
145352257|NCT00061932|524138568|FG000|Overall Study|Withdrawal by Subject|13|||
145352258|NCT00061932|524138569|FG001|Overall Study|Withdrawal by Subject|4|||
145352259|NCT00916383|524138570|FG000|Overall Study|Adverse Event|1|||
145352260|NCT00916383|524138570|FG000|Overall Study|Death|1|||
145352261|NCT00916383|524138570|FG000|Overall Study|Protocol Violation|1|||
145352262|NCT02899962|524138571|FG000|Open-label Phase|Adverse Event|2|||
145352263|NCT02899962|524138572|FG001|Open-label Phase|Adverse Event|0|||
145352264|NCT02899962|524138573|FG002|Open-label Phase|Adverse Event|0|||
145352265|NCT02899962|524138571|FG000|Open-label Phase|Lost to Follow-up|9|||
145352266|NCT02899962|524138572|FG001|Open-label Phase|Lost to Follow-up|0|||
145352267|NCT02899962|524138573|FG002|Open-label Phase|Lost to Follow-up|0|||
145352268|NCT02899962|524138571|FG000|Open-label Phase|Other reasons|9|||
145352269|NCT02899962|524138572|FG001|Open-label Phase|Other reasons|0|||
145352270|NCT02899962|524138573|FG002|Open-label Phase|Other reasons|0|||
145352271|NCT02899962|524138571|FG000|Open-label Phase|Withdrawal by Subject|7|||
145352272|NCT02899962|524138572|FG001|Open-label Phase|Withdrawal by Subject|0|||
145352273|NCT02899962|524138573|FG002|Open-label Phase|Withdrawal by Subject|0|||
145352274|NCT02899962|524138571|FG000|Maintenance Phase|Adverse Event|0|||
145352275|NCT02899962|524138572|FG001|Maintenance Phase|Adverse Event|2|||
145352276|NCT02899962|524138573|FG002|Maintenance Phase|Adverse Event|1|||
145352277|NCT02899962|524138571|FG000|Maintenance Phase|Death|0|||
145352278|NCT02899962|524138572|FG001|Maintenance Phase|Death|0|||
145352279|NCT02899962|524138573|FG002|Maintenance Phase|Death|1|||
145352280|NCT02899962|524138571|FG000|Maintenance Phase|Lack of Efficacy|0|||
145352281|NCT02899962|524138572|FG001|Maintenance Phase|Lack of Efficacy|20|||
145352282|NCT02899962|524138573|FG002|Maintenance Phase|Lack of Efficacy|16|||
145352283|NCT02899962|524138571|FG000|Maintenance Phase|Lost to Follow-up|0|||
145352284|NCT02899962|524138572|FG001|Maintenance Phase|Lost to Follow-up|12|||
145352285|NCT02899962|524138573|FG002|Maintenance Phase|Lost to Follow-up|14|||
145352286|NCT02899962|524138571|FG000|Maintenance Phase|Other reasons|0|||
145352287|NCT02899962|524138572|FG001|Maintenance Phase|Other reasons|9|||
145352288|NCT02899962|524138573|FG002|Maintenance Phase|Other reasons|13|||
145352289|NCT02899962|524138571|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
145352290|NCT02899962|524138572|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
145352291|NCT02899962|524138573|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
145352292|NCT02899962|524138571|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
145415736|NCT04180696|524376445|FG001|Overall Study|Withdrawal by Subject|1|||
145415737|NCT05537571|524376446|FG000|Overall Study|Withdrawal by Subject|1|||
145415738|NCT05537571|524376447|FG001|Overall Study|Withdrawal by Subject|1|||
145415739|NCT05537571|524376448|FG002|Overall Study|Withdrawal by Subject|0|||
145415740|NCT05537571|524376449|FG003|Overall Study|Withdrawal by Subject|0|||
145415741|NCT05537571|524376450|FG004|Overall Study|Withdrawal by Subject|0|||
145415742|NCT05537571|524376446|FG000|Overall Study|Adverse Event|2|||
145415743|NCT05537571|524376447|FG001|Overall Study|Adverse Event|0|||
145415744|NCT05537571|524376448|FG002|Overall Study|Adverse Event|0|||
145415745|NCT05537571|524376449|FG003|Overall Study|Adverse Event|0|||
145415746|NCT05537571|524376450|FG004|Overall Study|Adverse Event|0|||
145415747|NCT05537571|524376446|FG000|Overall Study|Hepatitis A screening result|2|||
145415748|NCT05537571|524376447|FG001|Overall Study|Hepatitis A screening result|0|||
145415749|NCT05537571|524376448|FG002|Overall Study|Hepatitis A screening result|0|||
145415750|NCT05537571|524376449|FG003|Overall Study|Hepatitis A screening result|0|||
145415751|NCT05537571|524376450|FG004|Overall Study|Hepatitis A screening result|0|||
145415752|NCT05537571|524376446|FG000|Overall Study|Lost to Follow-up|0|||
145415753|NCT05537571|524376447|FG001|Overall Study|Lost to Follow-up|0|||
145415754|NCT05537571|524376448|FG002|Overall Study|Lost to Follow-up|1|||
145415755|NCT05537571|524376449|FG003|Overall Study|Lost to Follow-up|0|||
145415756|NCT05537571|524376450|FG004|Overall Study|Lost to Follow-up|1|||
145415757|NCT04210375|524376451|FG000|Overall Study|Death|0|||
145415758|NCT04210375|524376452|FG001|Overall Study|Death|1|||
145415759|NCT04210375|524376453|FG002|Overall Study|Death|0|||
145415760|NCT04210375|524376454|FG003|Overall Study|Death|0|||
145415761|NCT05752487|524376455|FG000|Overall Study|Enrolled, not treated|9|||
145415762|NCT05752487|524376455|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
145415763|NCT05752487|524376455|FG000|Overall Study|Withdrawal by Subject|2|||
145415764|NCT00424008|524376456|FG000|Overall Study|Adverse Event|8|||
145415765|NCT00424008|524376457|FG001|Overall Study|Adverse Event|6|||
145415766|NCT00424008|524376456|FG000|Overall Study|Lack of Efficacy|40|||
145415767|NCT00424008|524376457|FG001|Overall Study|Lack of Efficacy|34|||
145415768|NCT00424008|524376456|FG000|Overall Study|Lost to Follow-up|1|||
145415769|NCT00424008|524376457|FG001|Overall Study|Lost to Follow-up|2|||
145415770|NCT00424008|524376456|FG000|Overall Study|Withdrawal by Subject|5|||
145415771|NCT00424008|524376457|FG001|Overall Study|Withdrawal by Subject|8|||
145415772|NCT00424008|524376456|FG000|Overall Study|Noncompliance with protocol|13|||
145415773|NCT00424008|524376457|FG001|Overall Study|Noncompliance with protocol|7|||
145415774|NCT00424008|524376456|FG000|Overall Study|Did not meet protocol eligibility|16|||
145415775|NCT00424008|524376457|FG001|Overall Study|Did not meet protocol eligibility|21|||
145415776|NCT00424008|524376456|FG000|Overall Study|Administrative|266|||
145415777|NCT00424008|524376457|FG001|Overall Study|Administrative|257|||
145415778|NCT01860989|524376458|FG000|Overall Study|Unsatisfactory therapeutic|5|||
145415779|NCT02593864|524376459|FG000|Overall Study|Withdrawal by Subject|3|||
145415780|NCT02593864|524376459|FG000|Overall Study|Lost to Follow-up|3|||
145415781|NCT01018953|524376466|FG000|Overall Study|Adverse Event|2|||
145415782|NCT01018953|524376466|FG000|Overall Study|Withdrawal by Subject|1|||
145415783|NCT01018953|524376466|FG000|Overall Study|Study termination by sponsor|5|||
145415784|NCT01186419|524376469|FG000|Overall Study|Withdrawal by Subject|5|||
145415785|NCT01186419|524376470|FG001|Overall Study|Withdrawal by Subject|3|||
145415786|NCT01186419|524376469|FG000|Overall Study|Adverse Event|1|||
145415787|NCT01186419|524376470|FG001|Overall Study|Adverse Event|2|||
145415788|NCT01186419|524376469|FG000|Overall Study|Physician Decision|0|||
145415789|NCT01186419|524376470|FG001|Overall Study|Physician Decision|3|||
145415790|NCT01186419|524376469|FG000|Overall Study|Other|1|||
145415791|NCT01186419|524376470|FG001|Overall Study|Other|1|||
145415792|NCT01671059|524376471|FG000|Overall Study|Adverse Event|4|||
145415793|NCT01671059|524376471|FG000|Overall Study|Lack of Efficacy|1|||
145415794|NCT01033071|524376477|FG000|Overall Study|Adverse Event|28|||
145415795|NCT01033071|524376478|FG001|Overall Study|Adverse Event|51|||
145415796|NCT01033071|524376479|FG002|Overall Study|Adverse Event|26|||
145622926|NCT01167023|525130240|FG000|Overall Study|Withdrawal by Subject|0|||
145622927|NCT01167023|525130241|FG001|Overall Study|Withdrawal by Subject|0|||
145415797|NCT01033071|524376477|FG000|Overall Study|Protocol Violation|0|||
145415798|NCT01033071|524376478|FG001|Overall Study|Protocol Violation|2|||
145415799|NCT01033071|524376479|FG002|Overall Study|Protocol Violation|1|||
145415800|NCT01033071|524376477|FG000|Overall Study|Lost to Follow-up|4|||
145415801|NCT01033071|524376478|FG001|Overall Study|Lost to Follow-up|5|||
145415802|NCT01033071|524376479|FG002|Overall Study|Lost to Follow-up|5|||
145415803|NCT01033071|524376477|FG000|Overall Study|Withdrawal by Subject|17|||
145415804|NCT01033071|524376478|FG001|Overall Study|Withdrawal by Subject|14|||
145415805|NCT01033071|524376479|FG002|Overall Study|Withdrawal by Subject|11|||
145415806|NCT01033071|524376477|FG000|Overall Study|Lack of Efficacy|0|||
145415807|NCT01033071|524376478|FG001|Overall Study|Lack of Efficacy|1|||
145415808|NCT01033071|524376479|FG002|Overall Study|Lack of Efficacy|1|||
145415809|NCT01033071|524376477|FG000|Overall Study|Other|6|||
145415810|NCT01033071|524376478|FG001|Overall Study|Other|4|||
145415811|NCT01033071|524376479|FG002|Overall Study|Other|3|||
145415812|NCT03554473|524378545|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
145415813|NCT03554473|524378546|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
145577271|NCT00414050|524968036|FG003|Overall Study|Subject discontinued for other reason|1|||
145352293|NCT02899962|524138572|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
145352294|NCT02899962|524138573|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
145352295|NCT02899962|524138571|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145352296|NCT02899962|524138572|FG001|Maintenance Phase|Withdrawal by Subject|30|||
145352297|NCT02899962|524138573|FG002|Maintenance Phase|Withdrawal by Subject|36|||
145352298|NCT01112059|524138574|FG000|Overall Study|Withdrawal by Subject|1|||
145352299|NCT01112059|524138575|FG001|Overall Study|Withdrawal by Subject|0|||
145352300|NCT01245283|524138578|FG000|Overall Study|Lost to Follow-up|14|||
145352301|NCT01245283|524138579|FG001|Overall Study|Lost to Follow-up|11|||
145352302|NCT01245283|524138580|FG002|Overall Study|Lost to Follow-up|11|||
145352303|NCT01610492|524138591|FG000|Overall Study|Adverse Event|1|||
145352304|NCT01610492|524138591|FG000|Overall Study|Lack of Efficacy|3|||
145352305|NCT01610492|524138591|FG000|Overall Study|Other: Reached stopping criteria|1|||
145352306|NCT01610492|524138591|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
145352307|NCT03093259|524138593|FG000|Overall Study|Adverse Event|1|||
145352308|NCT03093259|524138594|FG001|Overall Study|Adverse Event|0|||
145352309|NCT03093259|524138593|FG000|Overall Study|Withdrawal by Subject|1|||
145352310|NCT03093259|524138594|FG001|Overall Study|Withdrawal by Subject|0|||
145352311|NCT02575833|524138595|FG000|Overall Study|Withdrawal by Subject|0|||
145352312|NCT02575833|524138596|FG001|Overall Study|Withdrawal by Subject|1|||
145352313|NCT02575833|524138595|FG000|Overall Study|Lost to Follow-up|1|||
145352314|NCT02575833|524138596|FG001|Overall Study|Lost to Follow-up|0|||
145352315|NCT01757275|524138597|FG000|Overall Study|Lost to Follow-up|1|||
145352316|NCT01757275|524138598|FG001|Overall Study|Lost to Follow-up|2|||
145352317|NCT01757275|524138597|FG000|Overall Study|Adverse Event|3|||
145352318|NCT01757275|524138598|FG001|Overall Study|Adverse Event|3|||
145352319|NCT01757275|524138597|FG000|Overall Study|Withdrawal by Subject|2|||
145352320|NCT01757275|524138598|FG001|Overall Study|Withdrawal by Subject|4|||
145352321|NCT01757275|524138597|FG000|Overall Study|Not treated|3|||
145352322|NCT01757275|524138598|FG001|Overall Study|Not treated|4|||
145352323|NCT01821807|524138601|FG000|Overall Study|Lost to Follow-up|3|||
145352324|NCT01821807|524138602|FG001|Overall Study|Lost to Follow-up|1|||
145352325|NCT02404805|524138603|FG000|Overall Study|Withdrawal by Subject|1|||
145352326|NCT02404805|524138604|FG001|Overall Study|Withdrawal by Subject|0|||
145352327|NCT02404805|524138605|FG002|Overall Study|Withdrawal by Subject|0|||
145352328|NCT02404805|524138606|FG003|Overall Study|Withdrawal by Subject|0|||
145352329|NCT02404805|524138607|FG004|Overall Study|Withdrawal by Subject|0|||
145352330|NCT02404805|524138608|FG005|Overall Study|Withdrawal by Subject|0|||
145352331|NCT01459783|524138609|FG000|Baseline to 6 Months|Death|1|||
145352332|NCT01459783|524138610|FG001|Baseline to 6 Months|Death|0|||
145352333|NCT01459783|524138609|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
145352334|NCT01459783|524138610|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
145352335|NCT01459783|524138609|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
145352336|NCT01459783|524138610|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
145352337|NCT01459783|524138609|FG000|6 Months to 12 Months|Death|0|||
145352338|NCT01459783|524138610|FG001|6 Months to 12 Months|Death|1|||
145352339|NCT01459783|524138609|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
145352340|NCT01459783|524138610|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
145352341|NCT01459783|524138609|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
145352342|NCT01459783|524138610|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
145352343|NCT01459783|524138609|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
145352344|NCT01459783|524138610|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
145352345|NCT04211831|524138611|FG000|Overall Study|Withdrawal by Subject|4|||
145352346|NCT04211831|524138612|FG001|Overall Study|Withdrawal by Subject|1|||
145352347|NCT04211831|524138613|FG002|Overall Study|Withdrawal by Subject|1|||
145352348|NCT04211831|524138611|FG000|Overall Study|Protocol Violation|0|||
145352349|NCT04211831|524138612|FG001|Overall Study|Protocol Violation|0|||
145352350|NCT04211831|524138613|FG002|Overall Study|Protocol Violation|1|||
145352351|NCT04211831|524138611|FG000|Overall Study|Adverse Event|0|||
145352352|NCT04211831|524138612|FG001|Overall Study|Adverse Event|1|||
145352353|NCT04211831|524138613|FG002|Overall Study|Adverse Event|0|||
145352354|NCT04211831|524138611|FG000|Overall Study|Lack of Efficacy|0|||
145352355|NCT04211831|524138612|FG001|Overall Study|Lack of Efficacy|0|||
145352356|NCT04211831|524138613|FG002|Overall Study|Lack of Efficacy|1|||
145352357|NCT04211831|524138611|FG000|Overall Study|Lost to Follow-up|0|||
145352358|NCT04211831|524138612|FG001|Overall Study|Lost to Follow-up|0|||
145352359|NCT04211831|524138613|FG002|Overall Study|Lost to Follow-up|2|||
145352360|NCT04211831|524138611|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
145352361|NCT04211831|524138612|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
145352362|NCT04211831|524138613|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
145352363|NCT04211831|524138611|FG000|Overall Study|Other|0|||
145352364|NCT04211831|524138612|FG001|Overall Study|Other|1|||
145352365|NCT04211831|524138613|FG002|Overall Study|Other|0|||
145415814|NCT03554473|524378547|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
145415815|NCT03554473|524378545|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
145415816|NCT03554473|524378546|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
145415817|NCT03554473|524378547|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
145415818|NCT03554473|524378545|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
145415819|NCT03554473|524378546|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
145415820|NCT03554473|524378547|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
145415821|NCT05206604|524378551|FG000|Overall Study|Non-compliance with study drug|0|||
145415822|NCT05206604|524378552|FG001|Overall Study|Non-compliance with study drug|0|||
145415823|NCT05206604|524378553|FG002|Overall Study|Non-compliance with study drug|0|||
145415824|NCT05206604|524378554|FG003|Overall Study|Non-compliance with study drug|0|||
145415825|NCT05206604|524378555|FG004|Overall Study|Non-compliance with study drug|0|||
145415826|NCT05206604|524378556|FG005|Overall Study|Non-compliance with study drug|1|||
145415827|NCT05206604|524378557|FG006|Overall Study|Non-compliance with study drug|0|||
145415828|NCT05206604|524378558|FG007|Overall Study|Non-compliance with study drug|0|||
145415829|NCT03735498|524378559|FG000|Overall Study|Withdrawal by Subject|3|||
145415830|NCT03735498|524378559|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
145415831|NCT00160615|524378560|FG000|Overall Study|Adverse Event|5|||
145415832|NCT00160615|524378561|FG001|Overall Study|Adverse Event|12|||
145415833|NCT00160615|524378560|FG000|Overall Study|Withdrawal by Subject|0|||
145415834|NCT00160615|524378561|FG001|Overall Study|Withdrawal by Subject|2|||
145415835|NCT00160615|524378560|FG000|Overall Study|Lack of Efficacy|11|||
145415836|NCT00160615|524378561|FG001|Overall Study|Lack of Efficacy|23|||
145415837|NCT00160615|524378560|FG000|Overall Study|Patient decision|1|||
145415838|NCT00160615|524378561|FG001|Overall Study|Patient decision|2|||
145415839|NCT00160615|524378560|FG000|Overall Study|Investigator decision|1|||
145415840|NCT00160615|524378561|FG001|Overall Study|Investigator decision|1|||
145415841|NCT00160615|524378560|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
145415842|NCT00160615|524378561|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
145415843|NCT00160615|524378560|FG000|Overall Study|Switch to surgical treatment|0|||
145415844|NCT00160615|524378561|FG001|Overall Study|Switch to surgical treatment|2|||
145415845|NCT00160615|524378560|FG000|Overall Study|Non-compliance was suspected|0|||
145415846|NCT00160615|524378561|FG001|Overall Study|Non-compliance was suspected|1|||
145415847|NCT00160615|524378560|FG000|Overall Study|Poor compliance|0|||
145415848|NCT00160615|524378561|FG001|Overall Study|Poor compliance|1|||
145352366|NCT00967330|524138614|FG000|Overall Study|Protocol Violation|3|||
145352367|NCT00967330|524138615|FG001|Overall Study|Protocol Violation|4|||
145352368|NCT00967330|524138614|FG000|Overall Study|Regular|10|||
145352369|NCT00967330|524138615|FG001|Overall Study|Regular|3|||
145352370|NCT00967330|524138614|FG000|Overall Study|Withdrawal by Subject|6|||
145352371|NCT00967330|524138615|FG001|Overall Study|Withdrawal by Subject|0|||
145352372|NCT00967330|524138614|FG000|Overall Study|Lost to Follow-up|1|||
145352373|NCT00967330|524138615|FG001|Overall Study|Lost to Follow-up|1|||
145352374|NCT00967330|524138614|FG000|Overall Study|Death|102|||
145352375|NCT00967330|524138615|FG001|Overall Study|Death|51|||
145352376|NCT00967330|524138614|FG000|Overall Study|Severe protocol deviation|0|||
145352377|NCT00967330|524138615|FG001|Overall Study|Severe protocol deviation|1|||
145352378|NCT02698163|524138616|FG000|Overall Study|Lost to Follow-up|0|||
145352379|NCT02698163|524138617|FG001|Overall Study|Lost to Follow-up|1|||
145352380|NCT01168232|524140676|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
145352381|NCT01168232|524140676|FG000|Overall Study|Ineligible- Wrong cell type|6|||
145352382|NCT01168232|524140676|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
145352383|NCT04510090|524140679|FG000|FE-HS|Withdrawal by Subject|0|||
145352384|NCT04510090|524140680|FG001|FE-HS|Withdrawal by Subject|0|||
145352385|NCT04510090|524140681|FG002|FE-HS|Withdrawal by Subject|0|||
145352386|NCT04510090|524140682|FG003|FE-HS|Withdrawal by Subject|0|||
145352387|NCT04510090|524140683|FG004|FE-HS|Withdrawal by Subject|1|||
145352388|NCT04510090|524140684|FG005|FE-HS|Withdrawal by Subject|0|||
145352389|NCT04510090|524140685|FG006|FE-HS|Withdrawal by Subject|0|||
145352390|NCT04510090|524140686|FG007|FE-HS|Withdrawal by Subject|0|||
145352391|NCT01749826|524140687|FG000|Overall Study|Study Terminated|20|||
145352392|NCT01749826|524140688|FG001|Overall Study|Study Terminated|0|||
145352393|NCT05085834|524140689|FG000|Overall Study|Lost to Follow-up|9|||
145352394|NCT05085834|524140690|FG001|Overall Study|Lost to Follow-up|2|||
145352395|NCT05085834|524140689|FG000|Overall Study|Adverse Event|6|||
145352396|NCT05085834|524140690|FG001|Overall Study|Adverse Event|0|||
145352397|NCT05085834|524140689|FG000|Overall Study|Death|1|||
145352398|NCT05085834|524140690|FG001|Overall Study|Death|0|||
145352399|NCT05085834|524140689|FG000|Overall Study|Inability to swallow the pill|0|||
145352400|NCT05085834|524140690|FG001|Overall Study|Inability to swallow the pill|1|||
145352401|NCT03657797|524140696|FG000|Overall Study|Lost to Follow-up|0|||
145415849|NCT03166631|524378562|FG000|Overall Study|Progressive disease|2|||
145415850|NCT03166631|524378563|FG001|Overall Study|Progressive disease|1|||
145415851|NCT03166631|524378564|FG002|Overall Study|Progressive disease|3|||
145415852|NCT03166631|524378565|FG003|Overall Study|Progressive disease|4|||
145415853|NCT03166631|524378566|FG004|Overall Study|Progressive disease|2|||
145415854|NCT03166631|524378567|FG005|Overall Study|Progressive disease|2|||
145415855|NCT03166631|524378568|FG006|Overall Study|Progressive disease|5|||
145415856|NCT03166631|524378569|FG007|Overall Study|Progressive disease|6|||
145415857|NCT03166631|524378570|FG008|Overall Study|Progressive disease|11|||
145415858|NCT03166631|524378571|FG009|Overall Study|Progressive disease|5|||
145415859|NCT03166631|524378572|FG010|Overall Study|Progressive disease|7|||
145415860|NCT03166631|524378562|FG000|Overall Study|Physician Decision|0|||
145415861|NCT03166631|524378563|FG001|Overall Study|Physician Decision|0|||
145415862|NCT03166631|524378564|FG002|Overall Study|Physician Decision|0|||
145415863|NCT03166631|524378565|FG003|Overall Study|Physician Decision|0|||
145415864|NCT03166631|524378566|FG004|Overall Study|Physician Decision|0|||
145415865|NCT03166631|524378567|FG005|Overall Study|Physician Decision|0|||
145415866|NCT03166631|524378568|FG006|Overall Study|Physician Decision|1|||
145415867|NCT03166631|524378569|FG007|Overall Study|Physician Decision|0|||
145415868|NCT03166631|524378570|FG008|Overall Study|Physician Decision|1|||
145415869|NCT03166631|524378571|FG009|Overall Study|Physician Decision|0|||
145415870|NCT03166631|524378572|FG010|Overall Study|Physician Decision|1|||
145415871|NCT03166631|524378562|FG000|Overall Study|Death|0|||
145415872|NCT03166631|524378563|FG001|Overall Study|Death|0|||
145415873|NCT03166631|524378564|FG002|Overall Study|Death|0|||
145415874|NCT03166631|524378565|FG003|Overall Study|Death|0|||
145415875|NCT03166631|524378566|FG004|Overall Study|Death|1|||
145415876|NCT03166631|524378567|FG005|Overall Study|Death|0|||
145415877|NCT03166631|524378568|FG006|Overall Study|Death|1|||
145415878|NCT03166631|524378569|FG007|Overall Study|Death|0|||
145415879|NCT03166631|524378570|FG008|Overall Study|Death|0|||
145415880|NCT03166631|524378571|FG009|Overall Study|Death|0|||
145415881|NCT03166631|524378572|FG010|Overall Study|Death|0|||
145415882|NCT03166631|524378562|FG000|Overall Study|Adverse Event|1|||
145415883|NCT03166631|524378563|FG001|Overall Study|Adverse Event|0|||
145415884|NCT03166631|524378564|FG002|Overall Study|Adverse Event|0|||
145352402|NCT03657797|524140697|FG001|Overall Study|Lost to Follow-up|1|||
145352403|NCT03657797|524140698|FG002|Overall Study|Lost to Follow-up|1|||
145352404|NCT03657797|524140699|FG003|Overall Study|Lost to Follow-up|0|||
145352405|NCT03657797|524140696|FG000|Overall Study|Physician Decision|0|||
145352406|NCT03657797|524140697|FG001|Overall Study|Physician Decision|1|||
145352407|NCT03657797|524140698|FG002|Overall Study|Physician Decision|0|||
145352408|NCT03657797|524140699|FG003|Overall Study|Physician Decision|0|||
145352409|NCT03657797|524140696|FG000|Overall Study|Withdrawal by Subject|0|||
145352410|NCT03657797|524140697|FG001|Overall Study|Withdrawal by Subject|1|||
145352411|NCT03657797|524140698|FG002|Overall Study|Withdrawal by Subject|2|||
145352412|NCT03657797|524140699|FG003|Overall Study|Withdrawal by Subject|0|||
145352413|NCT03657797|524140696|FG000|Overall Study|Adverse Event|0|||
145352414|NCT03657797|524140697|FG001|Overall Study|Adverse Event|0|||
145352415|NCT03657797|524140698|FG002|Overall Study|Adverse Event|2|||
145352416|NCT03657797|524140699|FG003|Overall Study|Adverse Event|0|||
145352417|NCT00725283|524140702|FG000|Overall Study|Missing Code|3|||
145352418|NCT00725283|524140702|FG000|Overall Study|Death|5|||
145352419|NCT00725283|524140702|FG000|Overall Study|Other|6|||
145415885|NCT03166631|524378565|FG003|Overall Study|Adverse Event|0|||
145415886|NCT03166631|524378566|FG004|Overall Study|Adverse Event|0|||
145415887|NCT03166631|524378567|FG005|Overall Study|Adverse Event|1|||
145415888|NCT03166631|524378568|FG006|Overall Study|Adverse Event|1|||
145415889|NCT03166631|524378569|FG007|Overall Study|Adverse Event|0|||
145577272|NCT00414050|524968033|FG000|Overall Study|Subject Moved|0|||
145577273|NCT00414050|524968034|FG001|Overall Study|Subject Moved|0|||
145577274|NCT00414050|524968035|FG002|Overall Study|Subject Moved|0|||
145352420|NCT00725283|524140702|FG000|Overall Study|Withdrawal by Subject|10|||
145352421|NCT02115269|524140703|FG000|Overall Study|Lost to Follow-up|43|||
145352422|NCT02115269|524140703|FG000|Overall Study|Did not complete patient diary|3|||
145352423|NCT02115269|524140703|FG000|Overall Study|Moved to another city|7|||
145352424|NCT02115269|524140703|FG000|Overall Study|Withdrawal by Subject|2|||
145577275|NCT00414050|524968036|FG003|Overall Study|Subject Moved|1|||
145352425|NCT02115269|524140703|FG000|Overall Study|Didn't take study drug|2|||
145352426|NCT01402570|524140706|FG000|Overall Study|Adverse Event|1|||
145352427|NCT03642262|524140707|FG000|Period 1|Withdrawal by Subject|1|||
145415890|NCT03166631|524378570|FG008|Overall Study|Adverse Event|1|||
145415891|NCT03166631|524378571|FG009|Overall Study|Adverse Event|2|||
145415892|NCT03166631|524378572|FG010|Overall Study|Adverse Event|1|||
145415893|NCT03166631|524378562|FG000|Overall Study|Withdrawal by Subject|0|||
145415894|NCT03166631|524378563|FG001|Overall Study|Withdrawal by Subject|0|||
145415895|NCT03166631|524378564|FG002|Overall Study|Withdrawal by Subject|0|||
145415896|NCT03166631|524378565|FG003|Overall Study|Withdrawal by Subject|0|||
145415897|NCT03166631|524378566|FG004|Overall Study|Withdrawal by Subject|0|||
145415898|NCT03166631|524378567|FG005|Overall Study|Withdrawal by Subject|0|||
145415899|NCT03166631|524378568|FG006|Overall Study|Withdrawal by Subject|0|||
145577276|NCT01959581|524968037|FG000|Overall Study|Lost to Follow-up|5|||
145352428|NCT03642262|524140708|FG001|Period 1|Withdrawal by Subject|1|||
145352429|NCT03642262|524140707|FG000|Period 1|Adverse Event|0|||
145352430|NCT03642262|524140708|FG001|Period 1|Adverse Event|1|||
145352431|NCT02572570|524140709|FG000|Overall Study|Study Terminated|27|||
145352432|NCT01417156|524140710|FG000|Overall Study|Adverse Event|12|||
145352433|NCT01417156|524140710|FG000|Overall Study|Protocol Violation|2|||
145352434|NCT01103180|524140711|FG000|Overall Study|Withdrawal by Subject|8|||
145352435|NCT01103180|524140712|FG001|Overall Study|Withdrawal by Subject|13|||
145352436|NCT01103180|524140711|FG000|Overall Study|Lost to Follow-up|13|||
145352437|NCT01103180|524140712|FG001|Overall Study|Lost to Follow-up|7|||
145352438|NCT01103180|524140711|FG000|Overall Study|Physician Decision|1|||
145352439|NCT01103180|524140712|FG001|Overall Study|Physician Decision|0|||
145352440|NCT01103180|524140711|FG000|Overall Study|Protocol Violation|0|||
145352441|NCT01103180|524140712|FG001|Overall Study|Protocol Violation|1|||
145352442|NCT00742209|524140715|FG000|Overall Study|Adverse Event|11|||
145352443|NCT00742209|524140716|FG001|Overall Study|Adverse Event|4|||
145352444|NCT00742209|524140717|FG002|Overall Study|Adverse Event|17|||
145352445|NCT00742209|524140718|FG003|Overall Study|Adverse Event|16|||
145352446|NCT00742209|524140719|FG004|Overall Study|Adverse Event|13|||
145352447|NCT00742209|524140715|FG000|Overall Study|Participant Withdrew Consent|8|||
145352448|NCT00742209|524140716|FG001|Overall Study|Participant Withdrew Consent|4|||
145352449|NCT00742209|524140717|FG002|Overall Study|Participant Withdrew Consent|14|||
145352450|NCT00742209|524140718|FG003|Overall Study|Participant Withdrew Consent|7|||
145352451|NCT00742209|524140719|FG004|Overall Study|Participant Withdrew Consent|4|||
145352452|NCT00742209|524140715|FG000|Overall Study|Protocol Violation|6|||
145352453|NCT00742209|524140716|FG001|Overall Study|Protocol Violation|5|||
145352454|NCT00742209|524140717|FG002|Overall Study|Protocol Violation|4|||
145352455|NCT00742209|524140718|FG003|Overall Study|Protocol Violation|5|||
145352456|NCT00742209|524140719|FG004|Overall Study|Protocol Violation|3|||
145352457|NCT00742209|524140715|FG000|Overall Study|Lost to Follow-up|3|||
145352458|NCT00742209|524140716|FG001|Overall Study|Lost to Follow-up|4|||
145352459|NCT00742209|524140717|FG002|Overall Study|Lost to Follow-up|5|||
145352460|NCT00742209|524140718|FG003|Overall Study|Lost to Follow-up|5|||
145352461|NCT00742209|524140719|FG004|Overall Study|Lost to Follow-up|3|||
145352462|NCT00742209|524140715|FG000|Overall Study|Lack of Efficacy|6|||
145352463|NCT00742209|524140716|FG001|Overall Study|Lack of Efficacy|1|||
145352464|NCT00742209|524140717|FG002|Overall Study|Lack of Efficacy|1|||
145352465|NCT00742209|524140718|FG003|Overall Study|Lack of Efficacy|3|||
145352466|NCT00742209|524140719|FG004|Overall Study|Lack of Efficacy|1|||
145352467|NCT00742209|524140715|FG000|Overall Study|Investigator Discretion|0|||
145352468|NCT00742209|524140716|FG001|Overall Study|Investigator Discretion|0|||
145352469|NCT00742209|524140717|FG002|Overall Study|Investigator Discretion|5|||
145352470|NCT00742209|524140718|FG003|Overall Study|Investigator Discretion|1|||
145352471|NCT00742209|524140719|FG004|Overall Study|Investigator Discretion|1|||
145352472|NCT03499067|524140722|FG000|First Intervention|Physician Decision|2|||
145352473|NCT03499067|524140723|FG001|First Intervention|Physician Decision|1|||
145352474|NCT03499067|524140722|FG000|First Intervention|Withdrawal by Subject|3|||
145352475|NCT03499067|524140723|FG001|First Intervention|Withdrawal by Subject|6|||
145352476|NCT02440464|524140724|FG000|Overall Study|Withdrawal by Subject|3|||
145352477|NCT02440464|524140725|FG001|Overall Study|Withdrawal by Subject|2|||
145352478|NCT03565900|524140726|FG000|Overall Study|Disposition Unknown|4|||
145352479|NCT03565900|524140727|FG001|Overall Study|Disposition Unknown|1|||
145352480|NCT03565900|524140726|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145352481|NCT03565900|524140727|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
145352482|NCT03565900|524140726|FG000|Overall Study|Withdrawal by Subject|4|||
145352483|NCT03565900|524140727|FG001|Overall Study|Withdrawal by Subject|5|||
145352484|NCT03565900|524140726|FG000|Overall Study|Randomized By Mistake|0|||
145352485|NCT03565900|524140727|FG001|Overall Study|Randomized By Mistake|2|||
145352486|NCT03565900|524140726|FG000|Overall Study|Physician Decision|7|||
145352487|NCT03565900|524140727|FG001|Overall Study|Physician Decision|11|||
145352488|NCT03565900|524140726|FG000|Overall Study|Death|9|||
145352489|NCT03565900|524140727|FG001|Overall Study|Death|7|||
145352490|NCT02058069|524140730|FG000|Overall Study|Exclusion due to implant size|5|||
145352491|NCT02058069|524140730|FG000|Overall Study|Withdrawal by Subject|6|||
145352492|NCT03359850|524140734|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
145352493|NCT03359850|524140735|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
145352494|NCT03359850|524140734|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
145352495|NCT03359850|524140735|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
145352496|NCT03359850|524140734|FG000|Extension Phase (Up to 28 Months)|Death|2|||
145352497|NCT03359850|524140735|FG001|Extension Phase (Up to 28 Months)|Death|4|||
145352498|NCT03359850|524140734|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
145352499|NCT03359850|524140735|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
145352500|NCT03359850|524140734|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
145352501|NCT03359850|524140735|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
145352502|NCT01074944|524140755|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
145352503|NCT01074944|524140756|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145352504|NCT01074944|524140757|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145352505|NCT01074944|524140758|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145352506|NCT01074944|524140759|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
145352507|NCT01074944|524140755|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
145352508|NCT01074944|524140756|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145352509|NCT01074944|524140757|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145352510|NCT01074944|524140758|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145352511|NCT01074944|524140759|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
145352512|NCT01074944|524140755|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
145352513|NCT01074944|524140756|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145352514|NCT01074944|524140757|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145352515|NCT01074944|524140758|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145352516|NCT01074944|524140759|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
145352517|NCT01074944|524140755|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
145352518|NCT01074944|524140756|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145352519|NCT01074944|524140757|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145352520|NCT01074944|524140758|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145352521|NCT01074944|524140759|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
145352522|NCT01074944|524140755|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145352523|NCT01074944|524140756|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
145352524|NCT01074944|524140757|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
145352525|NCT01074944|524140758|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145352526|NCT01074944|524140759|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
145352527|NCT01074944|524140755|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145352528|NCT01074944|524140756|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
145352529|NCT01074944|524140757|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
145352530|NCT01074944|524140758|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145352531|NCT01074944|524140759|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
145352532|NCT01074944|524140755|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145352533|NCT01074944|524140756|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
145352534|NCT01074944|524140757|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
145352535|NCT01074944|524140758|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145352536|NCT01074944|524140759|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
145352537|NCT01074944|524140755|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145352538|NCT01074944|524140756|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
145352539|NCT01074944|524140757|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145352540|NCT01074944|524140758|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145352541|NCT01074944|524140759|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
145352542|NCT01074944|524140755|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145352543|NCT01074944|524140756|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
145352544|NCT01074944|524140757|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
145352545|NCT01074944|524140758|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145352546|NCT01074944|524140759|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
145352547|NCT01074944|524140755|FG000|Long Term Treatment|Adverse Event|0|||
145352548|NCT01074944|524140756|FG001|Long Term Treatment|Adverse Event|0|||
145352549|NCT01074944|524140757|FG002|Long Term Treatment|Adverse Event|0|||
145352550|NCT01074944|524140758|FG003|Long Term Treatment|Adverse Event|3|||
145352551|NCT01074944|524140759|FG004|Long Term Treatment|Adverse Event|0|||
145352552|NCT01074944|524140755|FG000|Long Term Treatment|Lost to Follow-up|0|||
145352553|NCT01074944|524140756|FG001|Long Term Treatment|Lost to Follow-up|0|||
145352554|NCT01074944|524140757|FG002|Long Term Treatment|Lost to Follow-up|0|||
145352555|NCT01074944|524140758|FG003|Long Term Treatment|Lost to Follow-up|2|||
145352556|NCT01074944|524140759|FG004|Long Term Treatment|Lost to Follow-up|0|||
145352557|NCT01074944|524140755|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145352558|NCT01074944|524140756|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145352559|NCT01074944|524140757|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145352560|NCT01074944|524140758|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
145352561|NCT01074944|524140759|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
145352562|NCT01074944|524140755|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
145352563|NCT01074944|524140756|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
145352564|NCT01074944|524140757|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
145352565|NCT01074944|524140758|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
145352566|NCT01074944|524140759|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
145352567|NCT01074944|524140755|FG000|Long Term Treatment|Withdrawal by Subject|0|||
145352568|NCT01074944|524140756|FG001|Long Term Treatment|Withdrawal by Subject|0|||
145352569|NCT01074944|524140757|FG002|Long Term Treatment|Withdrawal by Subject|0|||
145352570|NCT01074944|524140758|FG003|Long Term Treatment|Withdrawal by Subject|2|||
145352571|NCT01074944|524140759|FG004|Long Term Treatment|Withdrawal by Subject|0|||
145415900|NCT03166631|524378569|FG007|Overall Study|Withdrawal by Subject|0|||
145415901|NCT03166631|524378570|FG008|Overall Study|Withdrawal by Subject|1|||
145415902|NCT03166631|524378571|FG009|Overall Study|Withdrawal by Subject|1|||
145415903|NCT03166631|524378572|FG010|Overall Study|Withdrawal by Subject|0|||
145415904|NCT03787212|524378576|FG000|Period 1|Study Termination|2|||
145415905|NCT03787212|524378577|FG001|Period 1|Study Termination|2|||
145415906|NCT02014103|524378578|FG000|Overall Study|Protocol Violation|7|||
145415907|NCT02014103|524378579|FG001|Overall Study|Protocol Violation|7|||
145415908|NCT02014103|524378578|FG000|Overall Study|Adverse Event|1|||
145415909|NCT02014103|524378579|FG001|Overall Study|Adverse Event|0|||
145415910|NCT02014103|524378578|FG000|Overall Study|Lost venous access|1|||
145415911|NCT02014103|524378579|FG001|Overall Study|Lost venous access|0|||
145415912|NCT02014103|524378578|FG000|Overall Study|Withdrawal by Subject|0|||
145415913|NCT02014103|524378579|FG001|Overall Study|Withdrawal by Subject|2|||
145415914|NCT05638737|524378580|FG000|Overall Study|Withdrawal by Subject|4|||
145415915|NCT05638737|524378581|FG001|Overall Study|Withdrawal by Subject|7|||
145415916|NCT00567580|524378582|FG000|Overall Study|Protocol Violation|28|||
145415917|NCT00567580|524378583|FG001|Overall Study|Protocol Violation|24|||
145415918|NCT00567580|524378584|FG002|Overall Study|Protocol Violation|24|||
145415919|NCT00382070|524378585|FG000|Overall Study|No follow up data mapped to Other|17|||
145415920|NCT00382070|524378586|FG001|Overall Study|No follow up data mapped to Other|19|||
145415921|NCT00382070|524378585|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
145415922|NCT00382070|524378586|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
145415923|NCT00382070|524378585|FG000|Overall Study|No clinical assessment|9|||
145415924|NCT00382070|524378586|FG001|Overall Study|No clinical assessment|11|||
145415925|NCT04289298|524378587|FG000|Overall Study|Lost to Follow-up|5|||
145415926|NCT04289298|524378588|FG001|Overall Study|Lost to Follow-up|0|||
145415927|NCT04289298|524378587|FG000|Overall Study|Withdrawal by Subject|2|||
145415928|NCT04289298|524378588|FG001|Overall Study|Withdrawal by Subject|0|||
145415929|NCT01629563|524378590|FG000|Overall Study|Adverse Event|16|||
145415930|NCT01629563|524378591|FG001|Overall Study|Adverse Event|16|||
145415931|NCT01629563|524378590|FG000|Overall Study|Death|2|||
145415932|NCT01629563|524378591|FG001|Overall Study|Death|0|||
145415933|NCT01629563|524378590|FG000|Overall Study|Lack of Efficacy|2|||
145415934|NCT01629563|524378591|FG001|Overall Study|Lack of Efficacy|3|||
145415935|NCT01629563|524378590|FG000|Overall Study|Lost to Follow-up|1|||
145415936|NCT01629563|524378591|FG001|Overall Study|Lost to Follow-up|0|||
145415937|NCT01629563|524378590|FG000|Overall Study|Pregnancy|1|||
145415938|NCT01629563|524378591|FG001|Overall Study|Pregnancy|2|||
145415939|NCT01629563|524378590|FG000|Overall Study|Protocol Violation|0|||
145415940|NCT01629563|524378591|FG001|Overall Study|Protocol Violation|1|||
145415941|NCT01629563|524378590|FG000|Overall Study|Withdrawal by Subject|27|||
145415942|NCT01629563|524378591|FG001|Overall Study|Withdrawal by Subject|20|||
145415943|NCT01629563|524378590|FG000|Overall Study|surgery|0|||
145415944|NCT01629563|524378591|FG001|Overall Study|surgery|3|||
145415945|NCT01629563|524378590|FG000|Overall Study|Lack of return of menses|12|||
145415946|NCT01629563|524378591|FG001|Overall Study|Lack of return of menses|7|||
145415947|NCT01629563|524378590|FG000|Overall Study|Protocol Violation|0|||
145415948|NCT01629563|524378591|FG001|Overall Study|Protocol Violation|1|||
145415949|NCT02370394|524378601|FG000|Overall Study|Lost to Follow-up|2|||
145415950|NCT02370394|524378602|FG001|Overall Study|Lost to Follow-up|1|||
145415951|NCT02370394|524378601|FG000|Overall Study|Withdrawal by Subject|0|||
145415952|NCT02370394|524378602|FG001|Overall Study|Withdrawal by Subject|1|||
145415953|NCT03684057|524378603|FG000|Overall Study|Withdrawal by Subject|4|||
145415954|NCT03684057|524378604|FG001|Overall Study|Withdrawal by Subject|5|||
145415955|NCT00983957|524378605|FG000|Overall Study|Adverse Event|1|||
145415956|NCT00983957|524378605|FG000|Overall Study|Personal Reasons|1|||
145415957|NCT03055195|524378606|FG000|Overall Study|Lack of Efficacy|1|||
145415958|NCT03055195|524378607|FG001|Overall Study|Lack of Efficacy|0|||
145415959|NCT03055195|524378606|FG000|Overall Study|Withdrawal by Subject|6|||
145415960|NCT03055195|524378607|FG001|Overall Study|Withdrawal by Subject|7|||
145415961|NCT03055195|524378606|FG000|Overall Study|Study Terminated by Sponsor|2|||
145415962|NCT03055195|524378607|FG001|Overall Study|Study Terminated by Sponsor|6|||
145415963|NCT03055195|524378606|FG000|Overall Study|Protocol Violation|2|||
145415964|NCT03055195|524378607|FG001|Overall Study|Protocol Violation|1|||
145415965|NCT03055195|524378606|FG000|Overall Study|Physician Decision|1|||
145415966|NCT03055195|524378607|FG001|Overall Study|Physician Decision|0|||
145415967|NCT00986232|524378608|FG000|Overall Study|Adverse Event|1|||
145415968|NCT00986232|524378609|FG001|Overall Study|Adverse Event|2|||
145415969|NCT00986232|524378610|FG002|Overall Study|Adverse Event|3|||
145415970|NCT00986232|524378611|FG003|Overall Study|Adverse Event|0|||
145415971|NCT00986232|524378608|FG000|Overall Study|Lost to Follow-up|19|||
145415972|NCT00986232|524378609|FG001|Overall Study|Lost to Follow-up|12|||
145415973|NCT00986232|524378610|FG002|Overall Study|Lost to Follow-up|12|||
145415974|NCT00986232|524378611|FG003|Overall Study|Lost to Follow-up|7|||
145415975|NCT00986232|524378608|FG000|Overall Study|Protocol Violation|2|||
145415976|NCT00986232|524378609|FG001|Overall Study|Protocol Violation|3|||
145415977|NCT00986232|524378610|FG002|Overall Study|Protocol Violation|0|||
145415978|NCT00986232|524378611|FG003|Overall Study|Protocol Violation|1|||
145622928|NCT01167023|525130242|FG002|Overall Study|Withdrawal by Subject|1|||
145622929|NCT00114959|525130255|FG000|Overall Study|Lack of Efficacy|6|||
145622930|NCT00114959|525130255|FG000|Overall Study|Physician Decision|1|||
145622931|NCT00114959|525130255|FG000|Overall Study|Death|1|||
145622932|NCT00394095|525131523|FG000|Screening|Withdrawal by Subject|1|||
145622933|NCT00394095|525131524|FG001|Screening|Withdrawal by Subject|0|||
145622934|NCT00394095|525131523|FG000|Randomized|Withdrawal by Subject|5|||
145622935|NCT00394095|525131524|FG001|Randomized|Withdrawal by Subject|1|||
145622936|NCT00394095|525131523|FG000|Randomized|Adverse Event|1|||
145622937|NCT00394095|525131524|FG001|Randomized|Adverse Event|1|||
145352572|NCT01074944|524140755|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145352573|NCT01074944|524140756|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145352574|NCT01074944|524140757|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145352575|NCT01074944|524140758|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
145352576|NCT01074944|524140759|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
145352577|NCT01074944|524140755|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145352578|NCT01074944|524140756|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145352579|NCT01074944|524140757|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145352580|NCT01074944|524140758|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
145352581|NCT01074944|524140759|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
145352582|NCT02348112|524140762|FG000|Overall Study|Withdrawal by Subject|32|||
145352583|NCT02348112|524140763|FG001|Overall Study|Withdrawal by Subject|29|||
145352584|NCT02348112|524140762|FG000|Overall Study|Lost to Follow-up|24|||
145352585|NCT02348112|524140763|FG001|Overall Study|Lost to Follow-up|20|||
145352586|NCT02348112|524140762|FG000|Overall Study|Physician Decision|17|||
145352587|NCT02348112|524140763|FG001|Overall Study|Physician Decision|15|||
145352588|NCT02348112|524140762|FG000|Overall Study|Site closed due to PI leaving|0|||
145352589|NCT02348112|524140763|FG001|Overall Study|Site closed due to PI leaving|30|||
145352590|NCT02348112|524140762|FG000|Overall Study|Sponsor withdrawal|0|||
145352591|NCT02348112|524140763|FG001|Overall Study|Sponsor withdrawal|7|||
145352592|NCT02348112|524140762|FG000|Overall Study|Death|0|||
145352593|NCT02348112|524140763|FG001|Overall Study|Death|1|||
145352594|NCT01408043|524140764|FG000|Overall Study|unable to collect cells|1|||
145352595|NCT01998841|524140769|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
145352596|NCT01998841|524140770|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
145352597|NCT01998841|524140771|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
145352598|NCT01998841|524140772|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145352599|NCT01998841|524140773|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145352600|NCT01998841|524140769|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145352601|NCT01998841|524140770|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145352602|NCT01998841|524140771|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
145352603|NCT01998841|524140772|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
145352604|NCT01998841|524140773|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
145352605|NCT00972595|524140774|FG000|Period 1|Adverse Event|1|||
145352606|NCT00972595|524140775|FG001|Period 1|Adverse Event|0|||
145352607|NCT02552121|524140776|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
145352608|NCT02552121|524140777|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352609|NCT02552121|524140778|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352610|NCT02552121|524140779|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352611|NCT02552121|524140780|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352612|NCT02552121|524140781|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352613|NCT02552121|524140782|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352614|NCT02552121|524140783|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
145352615|NCT02552121|524140776|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
145352616|NCT02552121|524140777|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352617|NCT02552121|524140778|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352618|NCT02552121|524140779|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352619|NCT02552121|524140780|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352620|NCT02552121|524140781|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352621|NCT02552121|524140782|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352622|NCT02552121|524140783|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
145352623|NCT02552121|524140776|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352624|NCT02552121|524140777|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
145352625|NCT02552121|524140778|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352626|NCT02552121|524140779|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352627|NCT02552121|524140780|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352628|NCT02552121|524140781|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145622938|NCT00394095|525131523|FG000|Randomized|Overdose|1|||
145622939|NCT00394095|525131524|FG001|Randomized|Overdose|0|||
145622940|NCT00394095|525131523|FG000|Randomized|Lost to Follow-up|1|||
145622941|NCT00394095|525131524|FG001|Randomized|Lost to Follow-up|2|||
145415979|NCT00986232|524378608|FG000|Overall Study|Withdrawal by Subject|13|||
145415980|NCT00986232|524378609|FG001|Overall Study|Withdrawal by Subject|16|||
145415981|NCT00986232|524378610|FG002|Overall Study|Withdrawal by Subject|12|||
145415982|NCT00986232|524378611|FG003|Overall Study|Withdrawal by Subject|3|||
145415983|NCT00986232|524378608|FG000|Overall Study|Missed one or more bleeds|13|||
145415984|NCT00986232|524378609|FG001|Overall Study|Missed one or more bleeds|10|||
145415985|NCT00986232|524378610|FG002|Overall Study|Missed one or more bleeds|6|||
145415986|NCT00986232|524378611|FG003|Overall Study|Missed one or more bleeds|7|||
145415987|NCT00986232|524378608|FG000|Overall Study|Incomplete safety follow-up|3|||
145415988|NCT00986232|524378609|FG001|Overall Study|Incomplete safety follow-up|7|||
145415989|NCT00986232|524378610|FG002|Overall Study|Incomplete safety follow-up|2|||
145415990|NCT00986232|524378611|FG003|Overall Study|Incomplete safety follow-up|2|||
145415991|NCT00790933|524378612|FG000|Overall Study|Adverse Event|94|||
145415992|NCT00790933|524378613|FG001|Overall Study|Adverse Event|119|||
145415993|NCT00790933|524378614|FG002|Overall Study|Adverse Event|65|||
145415994|NCT00790933|524378615|FG003|Overall Study|Adverse Event|5|||
145415995|NCT00790933|524378616|FG004|Overall Study|Adverse Event|69|||
145415996|NCT00790933|524378612|FG000|Overall Study|Protocol Violation(s)|8|||
145415997|NCT00790933|524378613|FG001|Overall Study|Protocol Violation(s)|18|||
145415998|NCT00790933|524378614|FG002|Overall Study|Protocol Violation(s)|7|||
145415999|NCT00790933|524378615|FG003|Overall Study|Protocol Violation(s)|0|||
145416000|NCT00790933|524378616|FG004|Overall Study|Protocol Violation(s)|12|||
145416001|NCT00790933|524378612|FG000|Overall Study|Lack of Efficacy|192|||
145416002|NCT00790933|524378613|FG001|Overall Study|Lack of Efficacy|176|||
145416003|NCT00790933|524378614|FG002|Overall Study|Lack of Efficacy|130|||
145416004|NCT00790933|524378615|FG003|Overall Study|Lack of Efficacy|1|||
145416005|NCT00790933|524378616|FG004|Overall Study|Lack of Efficacy|121|||
145416006|NCT00790933|524378612|FG000|Overall Study|Study Terminated by Sponsor|0|||
145416007|NCT00790933|524378613|FG001|Overall Study|Study Terminated by Sponsor|0|||
145416008|NCT00790933|524378614|FG002|Overall Study|Study Terminated by Sponsor|1|||
145416009|NCT00790933|524378615|FG003|Overall Study|Study Terminated by Sponsor|0|||
145416010|NCT00790933|524378616|FG004|Overall Study|Study Terminated by Sponsor|0|||
145416011|NCT00790933|524378612|FG000|Overall Study|Withdrawal by Subject|123|||
145416012|NCT00790933|524378613|FG001|Overall Study|Withdrawal by Subject|120|||
145416013|NCT00790933|524378614|FG002|Overall Study|Withdrawal by Subject|52|||
145416014|NCT00790933|524378615|FG003|Overall Study|Withdrawal by Subject|6|||
145416015|NCT00790933|524378616|FG004|Overall Study|Withdrawal by Subject|50|||
145416016|NCT00790933|524378612|FG000|Overall Study|Lost to Follow-up|13|||
145352629|NCT02552121|524140782|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352630|NCT02552121|524140783|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
145352631|NCT02552121|524140776|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352632|NCT02552121|524140777|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
145352633|NCT02552121|524140778|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352634|NCT02552121|524140779|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352635|NCT02552121|524140780|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352636|NCT02552121|524140781|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352637|NCT02552121|524140782|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352638|NCT02552121|524140783|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
145352639|NCT02552121|524140776|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352640|NCT02552121|524140777|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
145352641|NCT02552121|524140778|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352642|NCT02552121|524140779|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352643|NCT02552121|524140780|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352644|NCT02552121|524140781|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352645|NCT02552121|524140782|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352646|NCT02552121|524140783|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
145352647|NCT02552121|524140776|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145352648|NCT02552121|524140777|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
145352649|NCT02552121|524140778|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145352650|NCT02552121|524140779|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145416017|NCT00790933|524378613|FG001|Overall Study|Lost to Follow-up|31|||
145416018|NCT00790933|524378614|FG002|Overall Study|Lost to Follow-up|10|||
145352651|NCT02552121|524140780|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145352652|NCT02552121|524140781|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145416019|NCT00790933|524378615|FG003|Overall Study|Lost to Follow-up|1|||
145416020|NCT00790933|524378616|FG004|Overall Study|Lost to Follow-up|15|||
145416021|NCT00790933|524378612|FG000|Overall Study|Reason Not Specified|8|||
145416022|NCT00790933|524378613|FG001|Overall Study|Reason Not Specified|16|||
145416023|NCT00790933|524378614|FG002|Overall Study|Reason Not Specified|4|||
145416024|NCT00790933|524378615|FG003|Overall Study|Reason Not Specified|1|||
145416025|NCT00790933|524378616|FG004|Overall Study|Reason Not Specified|9|||
145416026|NCT00894647|524378617|FG000|Overall Study|Adverse Event|5|||
145416027|NCT00894647|524378618|FG001|Overall Study|Adverse Event|4|||
145416028|NCT00894647|524378617|FG000|Overall Study|Withdrawal by Subject|4|||
145416029|NCT00894647|524378618|FG001|Overall Study|Withdrawal by Subject|4|||
145416030|NCT00894647|524378617|FG000|Overall Study|Lost to Follow-up|0|||
145416031|NCT00894647|524378618|FG001|Overall Study|Lost to Follow-up|2|||
145416032|NCT00894647|524378617|FG000|Overall Study|Non-compliance with study procedures|0|||
145416033|NCT00894647|524378618|FG001|Overall Study|Non-compliance with study procedures|2|||
145416034|NCT00894647|524378617|FG000|Overall Study|Other, not due to AE|1|||
145416035|NCT00894647|524378618|FG001|Overall Study|Other, not due to AE|2|||
145416036|NCT01967277|524378619|FG000|Overall Study|Lost to Follow-up|1|||
145416037|NCT01967277|524378620|FG001|Overall Study|Lost to Follow-up|2|||
145416038|NCT01967277|524378619|FG000|Overall Study|Unrelated illness|0|||
145416039|NCT01967277|524378620|FG001|Overall Study|Unrelated illness|1|||
145416040|NCT02573467|524378621|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145416041|NCT02573467|524378622|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145416042|NCT02573467|524378623|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
145416043|NCT02573467|524378624|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
145416044|NCT02573467|524378621|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
145416045|NCT02573467|524378622|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
145416046|NCT02573467|524378623|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
145416047|NCT02573467|524378624|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
145416048|NCT02573467|524378621|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
145416049|NCT02573467|524378622|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
145416050|NCT02573467|524378623|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
145416051|NCT02573467|524378624|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
145416052|NCT02573467|524378621|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
145416053|NCT02573467|524378622|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
145416054|NCT02573467|524378623|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
145416055|NCT02573467|524378624|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
145416056|NCT02573467|524378621|FG000|Post-treatment Follow up Epoch|Death|1|||
145416057|NCT02573467|524378622|FG001|Post-treatment Follow up Epoch|Death|1|||
145416058|NCT02573467|524378623|FG002|Post-treatment Follow up Epoch|Death|0|||
145416059|NCT02573467|524378624|FG003|Post-treatment Follow up Epoch|Death|1|||
145416060|NCT02573467|524378621|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
145416061|NCT02573467|524378622|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
145416062|NCT02573467|524378623|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
145416063|NCT02573467|524378624|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
145416064|NCT02573467|524378621|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
145416065|NCT02573467|524378622|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
145416066|NCT02573467|524378623|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
145416067|NCT02573467|524378624|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
145416068|NCT01829165|524378625|FG000|Overall Study|Did not complete intervention|2|||
145416069|NCT01829165|524378626|FG001|Overall Study|Did not complete intervention|0|||
145416070|NCT00710970|524378629|FG000|Overall Study|Never took drug|3|||
145416071|NCT01028560|524378630|FG000|Overall Study|Lack of Efficacy|3|||
145622942|NCT01256476|525131526|FG000|Overall Study|Adverse Event|2|||
145352653|NCT02552121|524140782|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145352654|NCT02552121|524140783|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
145352655|NCT02552121|524140776|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
145352656|NCT02552121|524140777|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
145352657|NCT02552121|524140778|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
145352658|NCT02552121|524140779|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
145352659|NCT02552121|524140780|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
145352660|NCT02552121|524140781|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
145352661|NCT02552121|524140782|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
145352662|NCT02552121|524140783|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
145352663|NCT02552121|524140776|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
145352664|NCT02552121|524140777|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
145352665|NCT02552121|524140778|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
145352666|NCT02552121|524140779|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
145352667|NCT02552121|524140780|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
145352668|NCT02552121|524140781|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
145352669|NCT02552121|524140782|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
145352670|NCT02552121|524140783|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
145352671|NCT02552121|524140776|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
145352672|NCT02552121|524140777|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
145352673|NCT02552121|524140778|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
145416072|NCT01028560|524378631|FG001|Overall Study|Lack of Efficacy|6|||
145416073|NCT01028560|524378630|FG000|Overall Study|Withdrawal by Subject|7|||
145416074|NCT01028560|524378631|FG001|Overall Study|Withdrawal by Subject|12|||
145416075|NCT02153827|524378632|FG000|Overall Study|Lost to Follow-up|3|||
145416076|NCT02153827|524378633|FG001|Overall Study|Lost to Follow-up|9|||
145416077|NCT01960842|524378636|FG000|Overall Study|Adverse Event|1|||
145352674|NCT02552121|524140779|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
145352675|NCT02552121|524140780|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
145352676|NCT02552121|524140781|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
145352677|NCT02552121|524140782|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
145352678|NCT02552121|524140783|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
145352679|NCT02552121|524140776|FG000|Part 2: Cohort Expansion|Death|0|||
145352680|NCT02552121|524140777|FG001|Part 2: Cohort Expansion|Death|0|||
145352681|NCT02552121|524140778|FG002|Part 2: Cohort Expansion|Death|1|||
145352682|NCT02552121|524140779|FG003|Part 2: Cohort Expansion|Death|0|||
145352683|NCT02552121|524140780|FG004|Part 2: Cohort Expansion|Death|0|||
145352684|NCT02552121|524140781|FG005|Part 2: Cohort Expansion|Death|0|||
145352685|NCT02552121|524140782|FG006|Part 2: Cohort Expansion|Death|0|||
145352686|NCT02552121|524140783|FG007|Part 2: Cohort Expansion|Death|0|||
145352687|NCT02586155|524140784|FG000|Overall Study|Adverse Event|2|||
145352688|NCT02586155|524140785|FG001|Overall Study|Adverse Event|3|||
145352689|NCT02586155|524140784|FG000|Overall Study|Withdrawal by Subject|31|||
145352690|NCT02586155|524140785|FG001|Overall Study|Withdrawal by Subject|24|||
145352691|NCT02586155|524140784|FG000|Overall Study|Lost to Follow-up|7|||
145352692|NCT02586155|524140785|FG001|Overall Study|Lost to Follow-up|13|||
145352693|NCT02586155|524140784|FG000|Overall Study|Death|61|||
145352694|NCT02586155|524140785|FG001|Overall Study|Death|72|||
145352695|NCT02586155|524140784|FG000|Overall Study|Other reasons|26|||
145352696|NCT02586155|524140785|FG001|Overall Study|Other reasons|15|||
145352697|NCT01522456|524140787|FG000|Overall Study|Adverse Event|2|||
145352698|NCT01522456|524140787|FG000|Overall Study|Lost to Follow-up|2|||
145352699|NCT01522456|524140787|FG000|Overall Study|Withdrawal by Subject|2|||
145352700|NCT01522456|524140787|FG000|Overall Study|Pregnancy|1|||
145352701|NCT01522456|524140787|FG000|Overall Study|Tolerability Assessment|1|||
145352702|NCT04052620|524140788|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
145352703|NCT04052620|524140789|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
145352704|NCT04052620|524140788|FG000|Overall Study|Withdrawal by Subject|1|||
145352705|NCT04052620|524140789|FG001|Overall Study|Withdrawal by Subject|0|||
145352706|NCT04052620|524140788|FG000|Overall Study|Lost to Follow-up|1|||
145352707|NCT04052620|524140789|FG001|Overall Study|Lost to Follow-up|1|||
145352708|NCT04052620|524140788|FG000|Overall Study|Adverse Event|1|||
145352709|NCT04052620|524140789|FG001|Overall Study|Adverse Event|0|||
145352710|NCT04052620|524140788|FG000|Overall Study|Subject did not meet study Criteria|0|||
145352711|NCT04052620|524140789|FG001|Overall Study|Subject did not meet study Criteria|1|||
145352712|NCT04052620|524140788|FG000|Overall Study|Screened failure, randomized by mistake|0|||
145352713|NCT04052620|524140789|FG001|Overall Study|Screened failure, randomized by mistake|1|||
145352714|NCT04052620|524140788|FG000|Overall Study|Personal reasons|2|||
145352715|NCT04052620|524140789|FG001|Overall Study|Personal reasons|4|||
145352716|NCT04052620|524140788|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
145352717|NCT04052620|524140789|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
145352718|NCT02201784|524140791|FG000|Overall Study|Failure to achieve adequate block|2|||
145352719|NCT02201784|524140792|FG001|Overall Study|Failure to achieve adequate block|0|||
145352720|NCT02072980|524140793|FG000|Period 2, Second Wear|Adverse Event|0|||
145352721|NCT02072980|524140794|FG001|Period 2, Second Wear|Adverse Event|1|||
145352722|NCT02431364|524140795|FG000|Overall Study|Adverse Event|0|||
145352723|NCT02431364|524140796|FG001|Overall Study|Adverse Event|1|||
145352724|NCT02431364|524140797|FG002|Overall Study|Adverse Event|0|||
145352725|NCT02431364|524140798|FG003|Overall Study|Adverse Event|0|||
145352726|NCT02431364|524140799|FG004|Overall Study|Adverse Event|0|||
145352727|NCT02431364|524140795|FG000|Overall Study|Randomized but never treated|0|||
145352728|NCT02431364|524140796|FG001|Overall Study|Randomized but never treated|0|||
145352729|NCT02431364|524140797|FG002|Overall Study|Randomized but never treated|0|||
145352730|NCT02431364|524140798|FG003|Overall Study|Randomized but never treated|1|||
145352731|NCT02431364|524140799|FG004|Overall Study|Randomized but never treated|0|||
145352732|NCT00258960|524140800|FG000|Overall Study|Death|2|||
145352733|NCT00258960|524140800|FG000|Overall Study|Disease Progression|7|||
145352734|NCT00258960|524140800|FG000|Overall Study|Adverse Event|4|||
145352735|NCT00258960|524140800|FG000|Overall Study|Physician Decision|1|||
145352736|NCT00258960|524140800|FG000|Overall Study|Withdrawal by Subject|1|||
145352737|NCT00258960|524140800|FG000|Overall Study|Mistake|2|||
145352738|NCT00473590|524140801|FG000|Overall Study|Adverse Event|3|||
145352739|NCT00473590|524140802|FG001|Overall Study|Adverse Event|3|||
145416078|NCT01960842|524378636|FG000|Overall Study|Withdrawal by Subject|2|||
145577277|NCT03773757|524968039|FG000|Overall Study|Withdrawal by Subject|2|||
145577278|NCT03773757|524968040|FG001|Overall Study|Withdrawal by Subject|4|||
145352740|NCT00473590|524140801|FG000|Overall Study|Death|4|||
145352741|NCT00473590|524140802|FG001|Overall Study|Death|2|||
145352742|NCT00473590|524140801|FG000|Overall Study|Progression not resulting in death|24|||
145352743|NCT00473590|524140802|FG001|Overall Study|Progression not resulting in death|20|||
145352744|NCT00473590|524140801|FG000|Overall Study|Non-protocol-specified therapy|7|||
145352745|NCT00473590|524140802|FG001|Overall Study|Non-protocol-specified therapy|5|||
145577279|NCT00057746|524968041|FG000|Overall Study|Withdrawal by Subject|0|||
145416079|NCT00397930|524378637|FG000|Overall Study|Personal reasons|14|||
145416080|NCT00397930|524378638|FG001|Overall Study|Personal reasons|8|||
145416081|NCT00397930|524378637|FG000|Overall Study|Other medical|9|||
145416082|NCT00397930|524378638|FG001|Overall Study|Other medical|4|||
145416083|NCT00397930|524378637|FG000|Overall Study|Unknown reasons|9|||
145416084|NCT00397930|524378638|FG001|Overall Study|Unknown reasons|14|||
145416085|NCT00397930|524378637|FG000|Overall Study|Noncompliant|3|||
145416086|NCT00397930|524378638|FG001|Overall Study|Noncompliant|2|||
145416087|NCT00397930|524378637|FG000|Overall Study|Too time-consuming|2|||
145416088|NCT00397930|524378638|FG001|Overall Study|Too time-consuming|9|||
145416089|NCT00397930|524378637|FG000|Overall Study|Started own yoga program|1|||
145416090|NCT00397930|524378638|FG001|Overall Study|Started own yoga program|1|||
145416091|NCT00397930|524378637|FG000|Overall Study|Did not want to be in control group|0|||
145416092|NCT00397930|524378638|FG001|Overall Study|Did not want to be in control group|1|||
145416093|NCT00397930|524378637|FG000|Overall Study|Withdrawal by Subject|0|||
145416094|NCT00397930|524378638|FG001|Overall Study|Withdrawal by Subject|8|||
145416095|NCT00397930|524378637|FG000|Overall Study|Missing data|0|||
145416096|NCT00397930|524378638|FG001|Overall Study|Missing data|4|||
145416097|NCT02391584|524378639|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
145416098|NCT02391584|524378640|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
145416099|NCT02391584|524378639|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
145416100|NCT02391584|524378640|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
145416101|NCT02391584|524378639|FG000|3 Month|Lost to Follow-up|1|||
145416102|NCT02391584|524378640|FG001|3 Month|Lost to Follow-up|0|||
145416103|NCT02391584|524378639|FG000|6 Month|Withdrawal by Subject|1|||
145416104|NCT02391584|524378640|FG001|6 Month|Withdrawal by Subject|0|||
145416105|NCT02391584|524378639|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
145416106|NCT02391584|524378640|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
145416107|NCT04233580|524378654|FG000|Overall Study|Adverse Event|3|||
145416108|NCT04233580|524378655|FG001|Overall Study|Adverse Event|3|||
145416109|NCT04233580|524378654|FG000|Overall Study|Withdrawal by Subject|2|||
145416110|NCT04233580|524378655|FG001|Overall Study|Withdrawal by Subject|1|||
145416111|NCT01371565|524378656|FG000|Overall Study|Withdrawal by Subject|1|||
145416112|NCT01371565|524378656|FG000|Overall Study|Death|1|||
145416113|NCT01371565|524378656|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
145416114|NCT02061592|524378657|FG000|Period 1|Withdrawal by Subject|1|||
145416115|NCT02061592|524378658|FG001|Period 1|Withdrawal by Subject|0|||
145416116|NCT02061592|524378657|FG000|Period 1|Protocol Violation|1|||
145416117|NCT02061592|524378658|FG001|Period 1|Protocol Violation|0|||
145352746|NCT00473590|524140801|FG000|Overall Study|Physician Decision|2|||
145352747|NCT00473590|524140802|FG001|Overall Study|Physician Decision|4|||
145352748|NCT00473590|524140801|FG000|Overall Study|Withdrawal by Subject|5|||
145352749|NCT00473590|524140802|FG001|Overall Study|Withdrawal by Subject|3|||
145352750|NCT00473590|524140801|FG000|Overall Study|Other|0|||
145352751|NCT00473590|524140802|FG001|Overall Study|Other|1|||
145352752|NCT03367819|524140804|FG000|Overall Study|Adverse Event|4|||
145352753|NCT03367819|524140805|FG001|Overall Study|Adverse Event|4|||
145352754|NCT03367819|524140804|FG000|Overall Study|Progressive Disease|15|||
145352755|NCT03367819|524140805|FG001|Overall Study|Progressive Disease|13|||
145352756|NCT03367819|524140804|FG000|Overall Study|Withdrawal by Subject|1|||
145352757|NCT03367819|524140805|FG001|Overall Study|Withdrawal by Subject|0|||
145352758|NCT03367819|524140804|FG000|Overall Study|Other|4|||
145352759|NCT03367819|524140805|FG001|Overall Study|Other|2|||
145352760|NCT01401452|524140806|FG000|Overall Study|Adverse reaction|9|||
145352761|NCT01401452|524140806|FG000|Overall Study|Lost to Follow-up|12|||
145352762|NCT01401452|524140806|FG000|Overall Study|Lack of Efficacy|30|||
145352763|NCT01401452|524140806|FG000|Overall Study|Participant developed breast cancer|1|||
145352764|NCT01401452|524140806|FG000|Overall Study|Tx stopped due to financial reasons|1|||
145352765|NCT01401452|524140806|FG000|Overall Study|Tx stopped by psychiatrist|1|||
145352766|NCT01401452|524140806|FG000|Overall Study|No more visits within the 36 wk followup|4|||
145352767|NCT01401452|524140806|FG000|Overall Study|Subject did not come to follow up visits|2|||
145352768|NCT01401452|524140806|FG000|Overall Study|Subject didn't return for routine visits|1|||
145352769|NCT01401452|524140806|FG000|Overall Study|Subject moved to another city|1|||
145352770|NCT01401452|524140806|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
145352771|NCT01401452|524140806|FG000|Overall Study|Psoriatic arthritis|1|||
145352772|NCT01401452|524140806|FG000|Overall Study|Participant stopped Tx|2|||
145352773|NCT01401452|524140806|FG000|Overall Study|Discontinuation for personal reasons|1|||
145416118|NCT02061592|524378657|FG000|Period 2|Lost to Follow-up|0|||
145416119|NCT02061592|524378658|FG001|Period 2|Lost to Follow-up|1|||
145416120|NCT04996264|524378659|FG000|Overall Study|Lost to Follow-up|0|||
145416121|NCT04996264|524378660|FG001|Overall Study|Lost to Follow-up|1|||
145416122|NCT04996264|524378659|FG000|Overall Study|Withdrawal by Subject|4|||
145416123|NCT04996264|524378660|FG001|Overall Study|Withdrawal by Subject|3|||
145416124|NCT04996264|524378659|FG000|Overall Study|1 left AMA|0|||
145416125|NCT04996264|524378660|FG001|Overall Study|1 left AMA|1|||
145416126|NCT04996264|524378659|FG000|Overall Study|Subject changed hospitals|0|||
145416127|NCT04996264|524378660|FG001|Overall Study|Subject changed hospitals|1|||
145416128|NCT04996264|524378659|FG000|Overall Study|unable to complete due to work|0|||
145416129|NCT04996264|524378660|FG001|Overall Study|unable to complete due to work|1|||
145416130|NCT04433975|524378661|FG000|1-month Follow Up|Withdrawal by Subject|1|||
145416131|NCT04433975|524378662|FG001|1-month Follow Up|Withdrawal by Subject|1|||
145416132|NCT04433975|524378661|FG000|1-month Follow Up|Lost to Follow-up|21|||
145416133|NCT04433975|524378662|FG001|1-month Follow Up|Lost to Follow-up|25|||
145416134|NCT04433975|524378661|FG000|3-month Follow Up|Lost to Follow-up|20|||
145416135|NCT04433975|524378662|FG001|3-month Follow Up|Lost to Follow-up|24|||
145416136|NCT04433975|524378661|FG000|3-month Follow Up|Death|1|||
145416137|NCT04433975|524378662|FG001|3-month Follow Up|Death|0|||
145416138|NCT04433975|524378661|FG000|3-month Follow Up|Withdrawal by Subject|2|||
145416139|NCT04433975|524378662|FG001|3-month Follow Up|Withdrawal by Subject|0|||
145416140|NCT04433975|524378661|FG000|6-month Follow Up|Lost to Follow-up|23|||
145416141|NCT04433975|524378662|FG001|6-month Follow Up|Lost to Follow-up|28|||
145416142|NCT04433975|524378661|FG000|6-month Follow Up|Withdrawal by Subject|1|||
145416143|NCT04433975|524378662|FG001|6-month Follow Up|Withdrawal by Subject|1|||
145416144|NCT04433975|524378661|FG000|9-month Follow Up|Lost to Follow-up|27|||
145416145|NCT04433975|524378662|FG001|9-month Follow Up|Lost to Follow-up|36|||
145416146|NCT04433975|524378661|FG000|9-month Follow Up|Death|0|||
145416147|NCT04433975|524378662|FG001|9-month Follow Up|Death|1|||
145352774|NCT01401452|524140806|FG000|Overall Study|Treatment failure|1|||
145352775|NCT01401452|524140806|FG000|Overall Study|Unsatisfactory output|1|||
145352776|NCT01401452|524140806|FG000|Overall Study|Subject withdrew because of Tx success|1|||
145352777|NCT01401452|524140806|FG000|Overall Study|Subject chose to discontinue treatment|1|||
145352778|NCT01401452|524140806|FG000|Overall Study|Participant withdrew consent|1|||
145352779|NCT00550459|524140807|FG000|Overall Study|Adverse Event|0|||
145352780|NCT00550459|524140808|FG001|Overall Study|Adverse Event|2|||
145352781|NCT00550459|524140807|FG000|Overall Study|Withdrawal by Subject|1|||
145352782|NCT00550459|524140808|FG001|Overall Study|Withdrawal by Subject|1|||
145352783|NCT00584454|524140809|FG000|Overall Study|Adverse Event|1|||
145352784|NCT00584454|524140809|FG000|Overall Study|Relocation|1|||
145352785|NCT00584454|524140809|FG000|Overall Study|Clinical Hold|2|||
145352786|NCT01742897|524140810|FG000|Overall Study|Adverse Event|3|||
145352787|NCT01742897|524140810|FG000|Overall Study|Withdrawal by Subject|1|||
145352788|NCT01742897|524140810|FG000|Overall Study|Other|1|||
145352789|NCT02601014|524140814|FG000|Overall Study|Adverse Event|3|||
145352790|NCT02601014|524140815|FG001|Overall Study|Adverse Event|3|||
145352791|NCT02601014|524140814|FG000|Overall Study|Death|3|||
145352792|NCT02601014|524140815|FG001|Overall Study|Death|1|||
145352793|NCT02601014|524140814|FG000|Overall Study|Disease progression|4|||
145352794|NCT02601014|524140815|FG001|Overall Study|Disease progression|8|||
145352795|NCT01168427|524140816|FG000|Overall Study|Patient exited prior to implant|1|||
145352796|NCT00640315|524140819|FG000|Overall Study|Withdrawal by Subject|0|||
145352797|NCT00640315|524140820|FG001|Overall Study|Withdrawal by Subject|1|||
145352798|NCT00445146|524140821|FG000|Overall Study|Withdrew Consent|29|||
145352799|NCT00445146|524140821|FG000|Overall Study|Lack of Efficacy|28|||
145352800|NCT00445146|524140821|FG000|Overall Study|Investigator's Discretion|22|||
145352801|NCT00445146|524140821|FG000|Overall Study|Adverse Event|13|||
145352802|NCT00445146|524140821|FG000|Overall Study|Lost to Follow-up|13|||
145352803|NCT00445146|524140821|FG000|Overall Study|Death|9|||
145352804|NCT00445146|524140821|FG000|Overall Study|Protocol Violation|4|||
145352805|NCT00445146|524140821|FG000|Overall Study|Pregnancy|1|||
145352806|NCT01256879|524140822|FG000|Overall Study|Withdrawal by Subject|1|||
145352807|NCT00397514|524140823|FG000|Overall Study|Withdrawal by Subject|1|||
145352808|NCT00397514|524140823|FG000|Overall Study|Pacing wire malfunction|1|||
145352809|NCT00397514|524140823|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
145352810|NCT00397514|524140823|FG000|Overall Study|early extubation|2|||
145352811|NCT00397514|524140823|FG000|Overall Study|poor echocardiographic windows|1|||
145352812|NCT04720105|524140827|FG000|Overall Study|Lack of Efficacy|1|||
145352813|NCT04720105|524140827|FG000|Overall Study|Lost to Follow-up|1|||
145416148|NCT04433975|524378661|FG000|12-month Follow Up|Lost to Follow-up|27|||
145416149|NCT04433975|524378662|FG001|12-month Follow Up|Lost to Follow-up|31|||
145416150|NCT00685698|524378663|FG000|Overall Study|Withdrawal by Subject|1|||
145416151|NCT00685698|524378663|FG000|Overall Study|Protocol Violation|6|||
145416152|NCT00685698|524378663|FG000|Overall Study|Adverse Event|3|||
145352814|NCT04720105|524140827|FG000|Overall Study|Withdrawal by Subject|3|||
145352815|NCT02892331|524140830|FG000|Overall Study|Withdrawal by Subject|0|||
145352816|NCT02892331|524140831|FG001|Overall Study|Withdrawal by Subject|1|||
145352817|NCT02892331|524140832|FG002|Overall Study|Withdrawal by Subject|1|||
145352818|NCT02892331|524140830|FG000|Overall Study|Sick family member|0|||
145352819|NCT02892331|524140831|FG001|Overall Study|Sick family member|0|||
145352820|NCT02892331|524140832|FG002|Overall Study|Sick family member|1|||
145416153|NCT00685698|524378663|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
145416154|NCT00685698|524378663|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
145416155|NCT00685698|524378663|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
145416156|NCT04392635|524378664|FG000|Overall Study|Lost to Follow-up|0|||
145416157|NCT04392635|524378665|FG001|Overall Study|Lost to Follow-up|1|||
145416158|NCT02030418|524378667|FG000|Overall Study|Death|78|||
145577280|NCT00057746|524968042|FG001|Overall Study|Withdrawal by Subject|0|||
145352821|NCT02892331|524140830|FG000|Overall Study|Corona virus pandemic|1|||
145352822|NCT02892331|524140831|FG001|Overall Study|Corona virus pandemic|0|||
145352823|NCT02892331|524140832|FG002|Overall Study|Corona virus pandemic|1|||
145352824|NCT02892331|524140830|FG000|Overall Study|Lost to Follow-up|1|||
145352825|NCT02892331|524140831|FG001|Overall Study|Lost to Follow-up|0|||
145352826|NCT02892331|524140832|FG002|Overall Study|Lost to Follow-up|1|||
145352827|NCT02892331|524140830|FG000|Overall Study|Blood pressure was too elevated|0|||
145352828|NCT02892331|524140831|FG001|Overall Study|Blood pressure was too elevated|1|||
145352829|NCT02892331|524140832|FG002|Overall Study|Blood pressure was too elevated|0|||
145577281|NCT00057746|524968043|FG002|Overall Study|Withdrawal by Subject|1|||
145352830|NCT02892331|524140830|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
145352831|NCT02892331|524140831|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
145352832|NCT02892331|524140832|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
145352833|NCT01133067|524140833|FG000|Overall Study|Death|136|||
145352834|NCT01133067|524140833|FG000|Overall Study|Lost to Follow-up|3|||
145352835|NCT04135937|524140838|FG000|Overall Study|Lost to Follow-up|2|||
145352836|NCT04135937|524140838|FG000|Overall Study|Withdrawal by Subject|1|||
145352837|NCT02548143|524140839|FG000|Overall Study|Adverse Event|1|||
145352838|NCT02548143|524140840|FG001|Overall Study|Adverse Event|0|||
145352839|NCT02548143|524140839|FG000|Overall Study|Withdrawal by Subject|0|||
145352840|NCT02548143|524140840|FG001|Overall Study|Withdrawal by Subject|1|||
145352841|NCT06018129|524140842|FG000|Overall Study|Death|1|||
145352842|NCT06018129|524140843|FG001|Overall Study|Death|1|||
145352843|NCT06018129|524140844|FG002|Overall Study|Death|2|||
145352844|NCT06018129|524140842|FG000|Overall Study|Sponsor Decision|2|||
145352845|NCT06018129|524140843|FG001|Overall Study|Sponsor Decision|2|||
145352846|NCT06018129|524140844|FG002|Overall Study|Sponsor Decision|1|||
145352847|NCT00858273|524140845|FG000|Overall Study|Protocol Violation|3|||
145352848|NCT00858273|524140846|FG001|Overall Study|Protocol Violation|5|||
145352849|NCT00982657|524140847|FG000|Overall Study|Death|1|||
145352850|NCT00982657|524140848|FG001|Overall Study|Death|0|||
145352851|NCT00982657|524140849|FG002|Overall Study|Death|1|||
145352852|NCT00982657|524140850|FG003|Overall Study|Death|1|||
145352853|NCT00982657|524140847|FG000|Overall Study|Withdrawal by Subject|0|||
145352854|NCT00982657|524140848|FG001|Overall Study|Withdrawal by Subject|0|||
145352855|NCT00982657|524140849|FG002|Overall Study|Withdrawal by Subject|1|||
145352856|NCT00982657|524140850|FG003|Overall Study|Withdrawal by Subject|3|||
145352857|NCT00982657|524140847|FG000|Overall Study|Other|0|||
145352858|NCT00982657|524140848|FG001|Overall Study|Other|0|||
145352859|NCT00982657|524140849|FG002|Overall Study|Other|0|||
145352860|NCT00982657|524140850|FG003|Overall Study|Other|4|||
145352861|NCT00982657|524140847|FG000|Overall Study|On going at date of cut-off|0|||
145352862|NCT00982657|524140848|FG001|Overall Study|On going at date of cut-off|0|||
145352863|NCT00982657|524140849|FG002|Overall Study|On going at date of cut-off|0|||
145352864|NCT00982657|524140850|FG003|Overall Study|On going at date of cut-off|1|||
145352865|NCT00625820|524140851|FG000|Overall Study|Withdrawal by Subject|1|||
145352866|NCT00070564|524143157|FG000|Overall Study|Progression|2|||
145352867|NCT00070564|524143158|FG001|Overall Study|Progression|4|||
145352868|NCT00070564|524143159|FG002|Overall Study|Progression|7|||
145352869|NCT00070564|524143160|FG003|Overall Study|Progression|7|||
145352870|NCT00070564|524143161|FG004|Overall Study|Progression|1|||
145352871|NCT00070564|524143162|FG005|Overall Study|Progression|0|||
145352872|NCT00070564|524143157|FG000|Overall Study|Delinquent|1|||
145352873|NCT00070564|524143158|FG001|Overall Study|Delinquent|4|||
145352874|NCT00070564|524143159|FG002|Overall Study|Delinquent|2|||
145352875|NCT00070564|524143160|FG003|Overall Study|Delinquent|0|||
145352876|NCT00070564|524143161|FG004|Overall Study|Delinquent|0|||
145352877|NCT00070564|524143162|FG005|Overall Study|Delinquent|0|||
145352878|NCT00070564|524143157|FG000|Overall Study|Adverse Event|150|||
145352879|NCT00070564|524143158|FG001|Overall Study|Adverse Event|142|||
145352880|NCT00070564|524143159|FG002|Overall Study|Adverse Event|120|||
145352881|NCT00070564|524143160|FG003|Overall Study|Adverse Event|108|||
145352882|NCT00070564|524143161|FG004|Overall Study|Adverse Event|63|||
145352883|NCT00070564|524143162|FG005|Overall Study|Adverse Event|36|||
145352884|NCT00070564|524143157|FG000|Overall Study|Death|4|||
145352885|NCT00070564|524143158|FG001|Overall Study|Death|1|||
145352886|NCT00070564|524143159|FG002|Overall Study|Death|5|||
145352887|NCT00070564|524143160|FG003|Overall Study|Death|3|||
145352888|NCT00070564|524143161|FG004|Overall Study|Death|0|||
145352889|NCT00070564|524143162|FG005|Overall Study|Death|1|||
145352890|NCT00070564|524143157|FG000|Overall Study|Other, not protocol specified|17|||
145352891|NCT00070564|524143158|FG001|Overall Study|Other, not protocol specified|15|||
145352892|NCT00070564|524143159|FG002|Overall Study|Other, not protocol specified|14|||
145352893|NCT00070564|524143160|FG003|Overall Study|Other, not protocol specified|19|||
145352894|NCT00070564|524143161|FG004|Overall Study|Other, not protocol specified|6|||
145352895|NCT00070564|524143162|FG005|Overall Study|Other, not protocol specified|7|||
145577282|NCT01109316|524968044|FG000|Study Period 1|Adverse Event|0|||
145577283|NCT01109316|524968045|FG001|Study Period 1|Adverse Event|0|||
145352896|NCT00070564|524143157|FG000|Overall Study|Withdrawal by Subject|26|||
145352897|NCT00070564|524143158|FG001|Overall Study|Withdrawal by Subject|37|||
145352898|NCT00070564|524143159|FG002|Overall Study|Withdrawal by Subject|23|||
145352899|NCT00070564|524143160|FG003|Overall Study|Withdrawal by Subject|30|||
145352900|NCT00070564|524143161|FG004|Overall Study|Withdrawal by Subject|8|||
145352901|NCT00070564|524143162|FG005|Overall Study|Withdrawal by Subject|8|||
145352902|NCT00070564|524143157|FG000|Overall Study|Not reported|0|||
145352903|NCT00070564|524143158|FG001|Overall Study|Not reported|0|||
145352904|NCT00070564|524143159|FG002|Overall Study|Not reported|0|||
145352905|NCT00070564|524143160|FG003|Overall Study|Not reported|0|||
145352906|NCT00070564|524143161|FG004|Overall Study|Not reported|1|||
145352907|NCT00070564|524143162|FG005|Overall Study|Not reported|0|||
145352908|NCT05825404|524143166|FG000|First Intervention (Weeks 2-5)|Death|0|||
145352909|NCT05825404|524143167|FG001|First Intervention (Weeks 2-5)|Death|1|||
145352910|NCT05825404|524143166|FG000|Second Intervention (Weeks 8-11)|Death|0|||
145352911|NCT05825404|524143167|FG001|Second Intervention (Weeks 8-11)|Death|1|||
145352912|NCT01127256|524143168|FG000|Overall Study|Adverse Event|13|||
145352913|NCT01127256|524143169|FG001|Overall Study|Adverse Event|13|||
145352914|NCT01127256|524143168|FG000|Overall Study|Lack of Efficacy|4|||
145352915|NCT01127256|524143169|FG001|Overall Study|Lack of Efficacy|0|||
145352916|NCT01127256|524143168|FG000|Overall Study|Lost to Follow-up|16|||
145352917|NCT01127256|524143169|FG001|Overall Study|Lost to Follow-up|17|||
145352918|NCT01127256|524143168|FG000|Overall Study|Withdrawal by Subject|5|||
145352919|NCT01127256|524143169|FG001|Overall Study|Withdrawal by Subject|9|||
145352920|NCT01127256|524143168|FG000|Overall Study|Protocol Violation|1|||
145352921|NCT01127256|524143169|FG001|Overall Study|Protocol Violation|0|||
145352922|NCT00931528|524143170|FG000|Overall Study|Protocol Violation|9|||
145352923|NCT00931528|524143171|FG001|Overall Study|Protocol Violation|12|||
145352924|NCT00931528|524143170|FG000|Overall Study|Withdrawal by Subject|4|||
145352925|NCT00931528|524143171|FG001|Overall Study|Withdrawal by Subject|12|||
145352926|NCT00931528|524143170|FG000|Overall Study|Lost to Follow-up|6|||
145352927|NCT00931528|524143171|FG001|Overall Study|Lost to Follow-up|13|||
145352928|NCT00931528|524143170|FG000|Overall Study|Assessment outside of Time Frame|22|||
145352929|NCT00931528|524143171|FG001|Overall Study|Assessment outside of Time Frame|23|||
145352930|NCT01730053|524143172|FG000|Overall Study|Participant moved|0|||
145352931|NCT01730053|524143173|FG001|Overall Study|Participant moved|0|||
145352932|NCT01730053|524143174|FG002|Overall Study|Participant moved|1|||
145352933|NCT01730053|524143175|FG003|Overall Study|Participant moved|0|||
145352934|NCT01730053|524143176|FG004|Overall Study|Participant moved|0|||
145352935|NCT01730053|524143177|FG005|Overall Study|Participant moved|0|||
145352936|NCT01730053|524143172|FG000|Overall Study|Physician Decision|0|||
145352937|NCT01730053|524143173|FG001|Overall Study|Physician Decision|0|||
145352938|NCT01730053|524143174|FG002|Overall Study|Physician Decision|0|||
145352939|NCT01730053|524143175|FG003|Overall Study|Physician Decision|1|||
145352940|NCT01730053|524143176|FG004|Overall Study|Physician Decision|0|||
145352941|NCT01730053|524143177|FG005|Overall Study|Physician Decision|0|||
145352942|NCT01730053|524143172|FG000|Overall Study|Adverse Event|2|||
145352943|NCT01730053|524143173|FG001|Overall Study|Adverse Event|6|||
145352944|NCT01730053|524143174|FG002|Overall Study|Adverse Event|3|||
145352945|NCT01730053|524143175|FG003|Overall Study|Adverse Event|3|||
145352946|NCT01730053|524143176|FG004|Overall Study|Adverse Event|2|||
145352947|NCT01730053|524143177|FG005|Overall Study|Adverse Event|2|||
145352948|NCT01730053|524143172|FG000|Overall Study|Poor compliance to protocol|1|||
145352949|NCT01730053|524143173|FG001|Overall Study|Poor compliance to protocol|2|||
145352950|NCT01730053|524143174|FG002|Overall Study|Poor compliance to protocol|2|||
145352951|NCT01730053|524143175|FG003|Overall Study|Poor compliance to protocol|0|||
145352952|NCT01730053|524143176|FG004|Overall Study|Poor compliance to protocol|0|||
145352953|NCT01730053|524143177|FG005|Overall Study|Poor compliance to protocol|2|||
145352954|NCT01730053|524143172|FG000|Overall Study|Other than specified|2|||
145352955|NCT01730053|524143173|FG001|Overall Study|Other than specified|6|||
145352956|NCT01730053|524143174|FG002|Overall Study|Other than specified|5|||
145352957|NCT01730053|524143175|FG003|Overall Study|Other than specified|4|||
145352958|NCT01730053|524143176|FG004|Overall Study|Other than specified|7|||
145352959|NCT01730053|524143177|FG005|Overall Study|Other than specified|9|||
145352960|NCT01470248|524143178|FG000|Overall Study|Withdrawal by Subject|1|||
145352961|NCT05364931|524143183|FG000|Overall Study|Adverse Event|0|||
145352962|NCT05364931|524143184|FG001|Overall Study|Adverse Event|2|||
145352963|NCT05364931|524143185|FG002|Overall Study|Adverse Event|1|||
145352964|NCT05364931|524143186|FG003|Overall Study|Adverse Event|0|||
145352965|NCT05364931|524143183|FG000|Overall Study|Lost to Follow-up|1|||
145352966|NCT05364931|524143184|FG001|Overall Study|Lost to Follow-up|0|||
145352967|NCT05364931|524143185|FG002|Overall Study|Lost to Follow-up|0|||
145352968|NCT05364931|524143186|FG003|Overall Study|Lost to Follow-up|0|||
145352969|NCT05364931|524143183|FG000|Overall Study|Withdrawal by Subject|1|||
145352970|NCT05364931|524143184|FG001|Overall Study|Withdrawal by Subject|1|||
145352971|NCT05364931|524143185|FG002|Overall Study|Withdrawal by Subject|3|||
145352972|NCT05364931|524143186|FG003|Overall Study|Withdrawal by Subject|2|||
145352973|NCT05364931|524143183|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145416159|NCT02030418|524378667|FG000|Overall Study|Missed 12-Month Visit|9|||
145416160|NCT02030418|524378667|FG000|Overall Study|Withdrawn|57|||
145416161|NCT01179516|524378668|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
145416162|NCT01179516|524378669|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
145416163|NCT01179516|524378670|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
145416164|NCT01179516|524378668|FG000|Overall Study|Lack of Efficacy|4|||
145416165|NCT01179516|524378669|FG001|Overall Study|Lack of Efficacy|2|||
145416166|NCT01179516|524378670|FG002|Overall Study|Lack of Efficacy|0|||
145416167|NCT01179516|524378668|FG000|Overall Study|Noncompliance with Study Drug|2|||
145416168|NCT01179516|524378669|FG001|Overall Study|Noncompliance with Study Drug|0|||
145416169|NCT01179516|524378670|FG002|Overall Study|Noncompliance with Study Drug|1|||
145416170|NCT01179516|524378668|FG000|Overall Study|Protocol Deviations|4|||
145416171|NCT01179516|524378669|FG001|Overall Study|Protocol Deviations|3|||
145416172|NCT01179516|524378670|FG002|Overall Study|Protocol Deviations|3|||
145416173|NCT01179516|524378668|FG000|Overall Study|Withdrawal of Consent|2|||
145416174|NCT01179516|524378669|FG001|Overall Study|Withdrawal of Consent|6|||
145416175|NCT01179516|524378670|FG002|Overall Study|Withdrawal of Consent|10|||
145416176|NCT01179516|524378668|FG000|Overall Study|Lost to Follow-up|7|||
145416177|NCT01179516|524378669|FG001|Overall Study|Lost to Follow-up|7|||
145416178|NCT01179516|524378670|FG002|Overall Study|Lost to Follow-up|3|||
145416179|NCT01179516|524378668|FG000|Overall Study|Other|2|||
145416180|NCT01179516|524378669|FG001|Overall Study|Other|0|||
145416181|NCT01179516|524378670|FG002|Overall Study|Other|2|||
145416182|NCT02697422|524378676|FG000|Overall Study|Declined exit survey|9|||
145416183|NCT02697422|524378677|FG001|Overall Study|Declined exit survey|2|||
145416184|NCT02697422|524378676|FG000|Overall Study|Lost to Follow-up|13|||
145416185|NCT02697422|524378677|FG001|Overall Study|Lost to Follow-up|8|||
145416186|NCT02697422|524378676|FG000|Overall Study|Death|2|||
145416187|NCT02697422|524378677|FG001|Overall Study|Death|1|||
145416188|NCT02697422|524378676|FG000|Overall Study|Withdrawal by Subject|0|||
145416189|NCT02697422|524378677|FG001|Overall Study|Withdrawal by Subject|1|||
145416190|NCT02697422|524378676|FG000|Overall Study|Physician Decision|1|||
145416191|NCT02697422|524378677|FG001|Overall Study|Physician Decision|1|||
145416192|NCT02697422|524378676|FG000|Overall Study|Exit survey data lost|1|||
145416193|NCT02697422|524378677|FG001|Overall Study|Exit survey data lost|0|||
145416194|NCT03501277|524378678|FG000|Intervention Period 1 (4 Days)|Other|0|||
145416195|NCT03501277|524378679|FG001|Intervention Period 1 (4 Days)|Other|0|||
145416196|NCT03501277|524378680|FG002|Intervention Period 1 (4 Days)|Other|1|||
145416197|NCT03501277|524378681|FG003|Intervention Period 1 (4 Days)|Other|0|||
145416198|NCT03501277|524378678|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
145416199|NCT03501277|524378679|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
145416200|NCT03501277|524378680|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
145416201|NCT03501277|524378681|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
145416202|NCT03501277|524378678|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
145416203|NCT03501277|524378679|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
145416204|NCT03501277|524378680|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
145416205|NCT03501277|524378681|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
145416206|NCT03501277|524378678|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
145416207|NCT03501277|524378679|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
145416208|NCT03501277|524378680|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
145416209|NCT03501277|524378681|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
145416210|NCT03983109|524378682|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
145416211|NCT03983109|524378683|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
145416212|NCT04739709|524378689|FG000|Overall Study|Physician Decision|1|||
145416213|NCT04739709|524378690|FG001|Overall Study|Physician Decision|0|||
145416214|NCT00433290|524378691|FG000|Overall Study|Adverse Event|24|||
145416215|NCT00433290|524378692|FG001|Overall Study|Adverse Event|7|||
145416216|NCT00433290|524378691|FG000|Overall Study|Lack of Efficacy|1|||
145416217|NCT00433290|524378692|FG001|Overall Study|Lack of Efficacy|5|||
145416218|NCT00433290|524378691|FG000|Overall Study|Withdrawal by Subject|4|||
145416219|NCT00433290|524378692|FG001|Overall Study|Withdrawal by Subject|2|||
145622943|NCT01256476|525131527|FG001|Overall Study|Adverse Event|1|||
145416220|NCT00433290|524378691|FG000|Overall Study|Protocol Violation|3|||
145416221|NCT00433290|524378692|FG001|Overall Study|Protocol Violation|2|||
145416222|NCT00433290|524378691|FG000|Overall Study|Physician Decision|2|||
145416223|NCT00433290|524378692|FG001|Overall Study|Physician Decision|0|||
145416224|NCT00433290|524378691|FG000|Overall Study|Entry Criteria Not Met|0|||
145416225|NCT00433290|524378692|FG001|Overall Study|Entry Criteria Not Met|1|||
145416226|NCT00433290|524378691|FG000|Overall Study|Lost to Follow-up|1|||
145416227|NCT00433290|524378692|FG001|Overall Study|Lost to Follow-up|0|||
145416228|NCT00724503|524378694|FG000|Overall Study|Lost to Follow-up|4|||
145416229|NCT00724503|524378695|FG001|Overall Study|Lost to Follow-up|8|||
145416230|NCT00724503|524378694|FG000|Overall Study|Withdrawal by Subject|11|||
145416231|NCT00724503|524378695|FG001|Overall Study|Withdrawal by Subject|23|||
145416232|NCT00724503|524378694|FG000|Overall Study|Death|190|||
145416233|NCT00724503|524378695|FG001|Overall Study|Death|182|||
145416234|NCT00724503|524378694|FG000|Overall Study|Adverse Event|1|||
145352974|NCT05364931|524143184|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
145352975|NCT05364931|524143185|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145352976|NCT05364931|524143186|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
145352977|NCT05364931|524143183|FG000|Overall Study|Discontinued|1|||
145352978|NCT05364931|524143184|FG001|Overall Study|Discontinued|0|||
145352979|NCT05364931|524143185|FG002|Overall Study|Discontinued|0|||
145352980|NCT05364931|524143186|FG003|Overall Study|Discontinued|0|||
145352981|NCT05842967|524143187|FG000|Period 1: SSA|Adverse Event|1|||
145352982|NCT05842967|524143188|FG001|Period 1: SSA|Adverse Event|1|||
145352983|NCT05842967|524143189|FG002|Period 1: SSA|Adverse Event|0|||
145352984|NCT05842967|524143190|FG003|Period 1: SSA|Adverse Event|0|||
145352985|NCT05842967|524143187|FG000|Period 1: SSA|Death|1|||
145352986|NCT05842967|524143188|FG001|Period 1: SSA|Death|0|||
145352987|NCT05842967|524143189|FG002|Period 1: SSA|Death|0|||
145352988|NCT05842967|524143190|FG003|Period 1: SSA|Death|0|||
145352989|NCT05842967|524143187|FG000|Period 1: SSA|Lost to Follow-up|16|||
145352990|NCT05842967|524143188|FG001|Period 1: SSA|Lost to Follow-up|4|||
145352991|NCT05842967|524143189|FG002|Period 1: SSA|Lost to Follow-up|0|||
145352992|NCT05842967|524143190|FG003|Period 1: SSA|Lost to Follow-up|0|||
145352993|NCT05842967|524143187|FG000|Period 1: SSA|Physician Decision|1|||
145352994|NCT05842967|524143188|FG001|Period 1: SSA|Physician Decision|0|||
145352995|NCT05842967|524143189|FG002|Period 1: SSA|Physician Decision|0|||
145352996|NCT05842967|524143190|FG003|Period 1: SSA|Physician Decision|0|||
145352997|NCT05842967|524143187|FG000|Period 1: SSA|Withdrawal by Subject|2|||
145352998|NCT05842967|524143188|FG001|Period 1: SSA|Withdrawal by Subject|2|||
145352999|NCT05842967|524143189|FG002|Period 1: SSA|Withdrawal by Subject|0|||
145353000|NCT05842967|524143190|FG003|Period 1: SSA|Withdrawal by Subject|0|||
145353001|NCT05842967|524143187|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
145353002|NCT05842967|524143188|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
145353003|NCT05842967|524143189|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
145353004|NCT05842967|524143190|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
145353005|NCT05842967|524143187|FG000|Period 2: SSB|Adverse Event|0|||
145353006|NCT05842967|524143188|FG001|Period 2: SSB|Adverse Event|0|||
145353007|NCT05842967|524143189|FG002|Period 2: SSB|Adverse Event|2|||
145353008|NCT05842967|524143190|FG003|Period 2: SSB|Adverse Event|0|||
145353009|NCT05842967|524143187|FG000|Period 2: SSB|Lost to Follow-up|0|||
145353010|NCT05842967|524143188|FG001|Period 2: SSB|Lost to Follow-up|0|||
145353011|NCT05842967|524143189|FG002|Period 2: SSB|Lost to Follow-up|4|||
145353012|NCT05842967|524143190|FG003|Period 2: SSB|Lost to Follow-up|3|||
145353013|NCT05842967|524143187|FG000|Period 2: SSB|Withdrawal by Subject|0|||
145353014|NCT05842967|524143188|FG001|Period 2: SSB|Withdrawal by Subject|0|||
145353015|NCT05842967|524143189|FG002|Period 2: SSB|Withdrawal by Subject|1|||
145353016|NCT05842967|524143190|FG003|Period 2: SSB|Withdrawal by Subject|0|||
145353017|NCT05842967|524143187|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
145353018|NCT05842967|524143188|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
145353019|NCT05842967|524143189|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
145353020|NCT05842967|524143190|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
145353021|NCT05842967|524143187|FG000|Period 2: SSB|Protocol Violation|0|||
145353022|NCT05842967|524143188|FG001|Period 2: SSB|Protocol Violation|0|||
145353023|NCT05842967|524143189|FG002|Period 2: SSB|Protocol Violation|0|||
145353024|NCT05842967|524143190|FG003|Period 2: SSB|Protocol Violation|1|||
145353025|NCT00413699|524143191|FG000|Initial Period|Death|25|||
145353026|NCT00413699|524143192|FG001|Initial Period|Death|30|||
145353027|NCT00413699|524143193|FG002|Initial Period|Death|0|||
145353028|NCT00413699|524143191|FG000|Initial Period|Lack of Efficacy|59|||
145353029|NCT00413699|524143192|FG001|Initial Period|Lack of Efficacy|115|||
145353030|NCT00413699|524143193|FG002|Initial Period|Lack of Efficacy|0|||
145353031|NCT00413699|524143191|FG000|Initial Period|Lost to Follow-up|31|||
145353032|NCT00413699|524143192|FG001|Initial Period|Lost to Follow-up|101|||
145353033|NCT00413699|524143193|FG002|Initial Period|Lost to Follow-up|0|||
145353034|NCT00413699|524143191|FG000|Initial Period|Protocol Violation|38|||
145353035|NCT00413699|524143192|FG001|Initial Period|Protocol Violation|89|||
145353036|NCT00413699|524143193|FG002|Initial Period|Protocol Violation|0|||
145353037|NCT00413699|524143191|FG000|Initial Period|Pregnancy|10|||
145416235|NCT00724503|524378695|FG001|Overall Study|Adverse Event|0|||
145353038|NCT00413699|524143192|FG001|Initial Period|Pregnancy|8|||
145353039|NCT00413699|524143193|FG002|Initial Period|Pregnancy|0|||
145353040|NCT00413699|524143191|FG000|Initial Period|Did not meet entrance criteria|2|||
145353041|NCT00413699|524143192|FG001|Initial Period|Did not meet entrance criteria|2|||
145353042|NCT00413699|524143193|FG002|Initial Period|Did not meet entrance criteria|0|||
145353043|NCT00413699|524143191|FG000|Initial Period|Medication error without adverse event|0|||
145353044|NCT00413699|524143192|FG001|Initial Period|Medication error without adverse event|1|||
145353045|NCT00413699|524143193|FG002|Initial Period|Medication error without adverse event|0|||
145353046|NCT00413699|524143191|FG000|Initial Period|Study terminated by Sponsor|0|||
145353047|NCT00413699|524143192|FG001|Initial Period|Study terminated by Sponsor|1|||
145353048|NCT00413699|524143193|FG002|Initial Period|Study terminated by Sponsor|0|||
145353049|NCT00413699|524143191|FG000|Initial Period|Other|67|||
145353050|NCT00413699|524143192|FG001|Initial Period|Other|211|||
145353051|NCT00413699|524143193|FG002|Initial Period|Other|0|||
145353052|NCT00413699|524143191|FG000|Initial Period|Adverse event related to study drug|178|||
145353053|NCT00413699|524143192|FG001|Initial Period|Adverse event related to study drug|527|||
145353054|NCT00413699|524143193|FG002|Initial Period|Adverse event related to study drug|0|||
145353055|NCT00413699|524143191|FG000|Initial Period|Adverse event not related to study drug|113|||
145353056|NCT00413699|524143192|FG001|Initial Period|Adverse event not related to study drug|248|||
145353057|NCT00413699|524143193|FG002|Initial Period|Adverse event not related to study drug|0|||
145353058|NCT00413699|524143191|FG000|Initial Period|Missing end of study page|0|||
145353059|NCT00413699|524143192|FG001|Initial Period|Missing end of study page|4|||
145353060|NCT00413699|524143193|FG002|Initial Period|Missing end of study page|0|||
145353061|NCT00413699|524143191|FG000|Initial Period|No longer willing to participate|116|||
145353062|NCT00413699|524143192|FG001|Initial Period|No longer willing to participate|368|||
145353063|NCT00413699|524143193|FG002|Initial Period|No longer willing to participate|0|||
145353064|NCT00413699|524143191|FG000|Extension Period|No Longer Willing to Participate|0|||
145353065|NCT00413699|524143192|FG001|Extension Period|No Longer Willing to Participate|0|||
145353066|NCT00413699|524143193|FG002|Extension Period|No Longer Willing to Participate|2|||
145353067|NCT00413699|524143191|FG000|Extension Period|Protocol Violation|0|||
145353068|NCT00413699|524143192|FG001|Extension Period|Protocol Violation|0|||
145353069|NCT00413699|524143193|FG002|Extension Period|Protocol Violation|1|||
145353070|NCT00413699|524143191|FG000|Extension Period|Adverse Event|0|||
145353071|NCT00413699|524143192|FG001|Extension Period|Adverse Event|0|||
145353072|NCT00413699|524143193|FG002|Extension Period|Adverse Event|2|||
145353073|NCT03511105|524143195|FG000|Overall Study|Adverse Event|1|||
145353074|NCT03511105|524143196|FG001|Overall Study|Adverse Event|0|||
145353075|NCT03511105|524143195|FG000|Overall Study|Withdrew consent|1|||
145353076|NCT03511105|524143196|FG001|Overall Study|Withdrew consent|0|||
145353077|NCT00075816|524143197|FG000|Overall Study|Did not undergo transplantation|14|||
145353078|NCT00075816|524143198|FG001|Overall Study|Did not undergo transplantation|11|||
145353079|NCT02810457|524143199|FG000|Overall Study|Randomised but no treatment received|2|||
145353080|NCT02810457|524143200|FG001|Overall Study|Randomised but no treatment received|1|||
145353081|NCT02810457|524143199|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
145353082|NCT02810457|524143200|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
145353083|NCT02810457|524143199|FG000|Overall Study|Adverse Event|37|||
145353084|NCT02810457|524143200|FG001|Overall Study|Adverse Event|43|||
145353085|NCT02810457|524143199|FG000|Overall Study|Patient decision|31|||
145353086|NCT02810457|524143200|FG001|Overall Study|Patient decision|35|||
145353087|NCT02810457|524143199|FG000|Overall Study|Patient lost to follow-up|2|||
145353088|NCT02810457|524143200|FG001|Overall Study|Patient lost to follow-up|2|||
145353089|NCT02810457|524143199|FG000|Overall Study|Death|39|||
145353090|NCT02810457|524143200|FG001|Overall Study|Death|28|||
145353091|NCT02810457|524143199|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
145353092|NCT02810457|524143200|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
145353093|NCT02810457|524143199|FG000|Overall Study|Clinical progression|15|||
145353094|NCT02810457|524143200|FG001|Overall Study|Clinical progression|16|||
145353095|NCT02810457|524143199|FG000|Overall Study|Investigator decision|3|||
145353096|NCT02810457|524143200|FG001|Overall Study|Investigator decision|2|||
145353097|NCT02810457|524143199|FG000|Overall Study|Patient ineligibility|3|||
145353098|NCT02810457|524143200|FG001|Overall Study|Patient ineligibility|0|||
145353099|NCT02810457|524143199|FG000|Overall Study|Miscalculated PD|1|||
145353100|NCT02810457|524143200|FG001|Overall Study|Miscalculated PD|0|||
145353101|NCT02810457|524143199|FG000|Overall Study|Physician Decision|0|||
145353102|NCT02810457|524143200|FG001|Overall Study|Physician Decision|1|||
145353103|NCT01823328|524143201|FG000|Overall Study|Withdrawal by Subject|8|||
145353104|NCT01823328|524143202|FG001|Overall Study|Withdrawal by Subject|6|||
145353105|NCT01557504|524143203|FG000|Overall Study|Physician Decision|1|||
145353106|NCT01557504|524143204|FG001|Overall Study|Physician Decision|0|||
145353107|NCT02750618|524143207|FG000|Overall Study|Withdrawal by Subject|1|||
145353108|NCT03192488|524143208|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
145353109|NCT03192488|524143209|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
145353110|NCT03192488|524143210|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
145353111|NCT03192488|524143211|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
145353112|NCT03192488|524143212|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
145353113|NCT03192488|524143213|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
145353114|NCT03192488|524143208|FG000|Third Intervention (d1)|Adverse Event|0|||
145353115|NCT03192488|524143209|FG001|Third Intervention (d1)|Adverse Event|0|||
145353116|NCT03192488|524143210|FG002|Third Intervention (d1)|Adverse Event|0|||
145353117|NCT03192488|524143211|FG003|Third Intervention (d1)|Adverse Event|0|||
145353118|NCT03192488|524143212|FG004|Third Intervention (d1)|Adverse Event|1|||
145353119|NCT03192488|524143213|FG005|Third Intervention (d1)|Adverse Event|0|||
145353120|NCT03588910|524143215|FG000|Overall Study|Withdrawal by Subject|1|||
145353121|NCT03588910|524143216|FG001|Overall Study|Withdrawal by Subject|0|||
145353122|NCT03588910|524143215|FG000|Overall Study|Allergy|2|||
145353123|NCT03588910|524143216|FG001|Overall Study|Allergy|0|||
145353124|NCT03588910|524143215|FG000|Overall Study|Protocol Violation|0|||
145416236|NCT00724503|524378694|FG000|Overall Study|Not otherwise specified|4|||
145416237|NCT00724503|524378695|FG001|Overall Study|Not otherwise specified|7|||
145416238|NCT01928771|524378697|FG000|Overall Study|Adverse Event|6|||
145416239|NCT01928771|524378698|FG001|Overall Study|Adverse Event|5|||
145416240|NCT01928771|524378699|FG002|Overall Study|Adverse Event|1|||
145416241|NCT01928771|524378697|FG000|Overall Study|Death|2|||
145416242|NCT01928771|524378698|FG001|Overall Study|Death|2|||
145416243|NCT01928771|524378699|FG002|Overall Study|Death|2|||
145416244|NCT01928771|524378697|FG000|Overall Study|Lost to Follow-up|5|||
145416245|NCT01928771|524378698|FG001|Overall Study|Lost to Follow-up|6|||
145416246|NCT01928771|524378699|FG002|Overall Study|Lost to Follow-up|3|||
145416247|NCT01928771|524378697|FG000|Overall Study|Withdrawal by Subject|20|||
145416248|NCT01928771|524378698|FG001|Overall Study|Withdrawal by Subject|15|||
145416249|NCT01928771|524378699|FG002|Overall Study|Withdrawal by Subject|17|||
145416250|NCT01928771|524378697|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
145416251|NCT01928771|524378698|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145416252|NCT01928771|524378699|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
145416253|NCT01928771|524378697|FG000|Overall Study|Other Reasons|9|||
145416254|NCT01928771|524378698|FG001|Overall Study|Other Reasons|9|||
145416255|NCT01928771|524378699|FG002|Overall Study|Other Reasons|14|||
145416256|NCT01928771|524378697|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
145416257|NCT01928771|524378698|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
145416258|NCT01928771|524378699|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
145416259|NCT01937117|524378700|FG000|Overall Study|Disease Progression|7|||
145416260|NCT01937117|524378700|FG000|Overall Study|Physician Decision|4|||
145416261|NCT01937117|524378700|FG000|Overall Study|Adverse Event|2|||
145353125|NCT03588910|524143216|FG001|Overall Study|Protocol Violation|3|||
145353126|NCT03588910|524143215|FG000|Overall Study|Did not complete Day 1 Survey|5|||
145353127|NCT03588910|524143216|FG001|Overall Study|Did not complete Day 1 Survey|10|||
145353128|NCT03588910|524143215|FG000|Overall Study|Did not complete Day 7 Survey|5|||
145353129|NCT03588910|524143216|FG001|Overall Study|Did not complete Day 7 Survey|2|||
145353130|NCT02547428|524143226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
145353131|NCT02547428|524143227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
145353132|NCT02547428|524143226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
145353133|NCT02547428|524143227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
145353134|NCT02547428|524143226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
145353135|NCT02547428|524143227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
145353136|NCT02547428|524143226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
145353137|NCT02547428|524143227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
145353138|NCT02547428|524143226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
145416262|NCT01407367|524378703|FG000|Overall Study|Death|24|||
145416263|NCT01407367|524378704|FG001|Overall Study|Death|32|||
145416264|NCT01407367|524378703|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
145416265|NCT01407367|524378704|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
145416266|NCT01407367|524378703|FG000|Overall Study|Withdrawal by Subject|4|||
145416267|NCT01407367|524378704|FG001|Overall Study|Withdrawal by Subject|15|||
145416268|NCT01407367|524378703|FG000|Overall Study|Lost to Follow-up|0|||
145416269|NCT01407367|524378704|FG001|Overall Study|Lost to Follow-up|2|||
145416270|NCT01245062|524378707|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
145416271|NCT01245062|524378708|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
145416272|NCT01245062|524378709|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
145416273|NCT01245062|524378707|FG000|Randomization and Crossover Phase|Physician Decision|2|||
145416274|NCT01245062|524378708|FG001|Randomization and Crossover Phase|Physician Decision|4|||
145416275|NCT01245062|524378709|FG002|Randomization and Crossover Phase|Physician Decision|0|||
145416276|NCT01245062|524378707|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
145416277|NCT01245062|524378708|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
145416278|NCT01245062|524378709|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
145416279|NCT01245062|524378707|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
145416280|NCT01245062|524378708|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
145416281|NCT01245062|524378709|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
145416282|NCT01245062|524378707|FG000|Cross-over Phase|Lost to Follow-up|0|||
145416283|NCT01245062|524378708|FG001|Cross-over Phase|Lost to Follow-up|0|||
145416284|NCT01245062|524378709|FG002|Cross-over Phase|Lost to Follow-up|1|||
145416285|NCT01245062|524378707|FG000|Cross-over Phase|Physician Decision|0|||
145416286|NCT01245062|524378708|FG001|Cross-over Phase|Physician Decision|0|||
145416287|NCT01245062|524378709|FG002|Cross-over Phase|Physician Decision|1|||
145416288|NCT01245062|524378707|FG000|Cross-over Phase|Withdrew Consent|0|||
145416289|NCT01245062|524378708|FG001|Cross-over Phase|Withdrew Consent|0|||
145416290|NCT01245062|524378709|FG002|Cross-over Phase|Withdrew Consent|4|||
145353139|NCT02547428|524143227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
145416291|NCT01245062|524378707|FG000|Cross-over Phase|Study closed/ terminated|0|||
145577284|NCT01109316|524968046|FG002|Study Period 1|Adverse Event|1|||
145577285|NCT01109316|524968047|FG003|Study Period 1|Adverse Event|0|||
145353140|NCT02547428|524143226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
145353141|NCT02547428|524143227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
145353142|NCT02547428|524143226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
145353143|NCT02547428|524143227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
145353144|NCT02547428|524143226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
145353145|NCT02547428|524143227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
145353146|NCT01173523|524143228|FG000|Overall Study|Clinical Progression|1|||
145353147|NCT01173523|524143229|FG001|Overall Study|Clinical Progression|1|||
145353148|NCT01173523|524143228|FG000|Overall Study|Progressive Disease|10|||
145353149|NCT01173523|524143229|FG001|Overall Study|Progressive Disease|8|||
145353150|NCT01173523|524143228|FG000|Overall Study|Other|2|||
145353151|NCT01173523|524143229|FG001|Overall Study|Other|3|||
145353152|NCT02302833|524143234|FG000|Overall Study|Lost to Follow-up|3|||
145353153|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
145353154|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
145353155|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145353156|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145353157|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145353158|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
145353159|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
145353160|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
145353161|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
145353162|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
145353163|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
145353164|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
145353165|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
145353166|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
145353167|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
145353168|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145353169|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145353170|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
145353171|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
145353172|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
145353173|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
145353174|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145353175|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145353176|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
145353177|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
145353178|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
145353179|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
145353180|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145353181|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145353182|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
145353183|NCT04429503|524143235|FG000|Main Study (Up to Wk 96)|Death|9|||
145353184|NCT04429503|524143236|FG001|Main Study (Up to Wk 96)|Death|18|||
145353185|NCT04429503|524143237|FG002|Main Study (Up to Wk 96)|Death|5|||
145353186|NCT04429503|524143238|FG003|Main Study (Up to Wk 96)|Death|0|||
145353187|NCT04429503|524143239|FG004|Main Study (Up to Wk 96)|Death|0|||
145353188|NCT04429503|524143240|FG005|Main Study (Up to Wk 96)|Death|0|||
145353189|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145353190|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145353191|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145353192|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
145353193|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145353194|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
145353195|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145353196|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145353197|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
145353198|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145353199|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145353200|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
145353201|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145353202|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145353203|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145353204|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
145353205|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
145353206|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
145353207|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145353208|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145353209|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
145353210|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
145353211|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
145353212|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
145353213|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145353214|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145353215|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
145353216|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
145353217|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
145353218|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
145353219|NCT04429503|524143235|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145353220|NCT04429503|524143236|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145353221|NCT04429503|524143237|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
145353222|NCT04429503|524143238|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
145353223|NCT04429503|524143239|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
145353224|NCT04429503|524143240|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
145353225|NCT05516108|524143241|FG000|Overall Study|Time Commitment|3|||
145353226|NCT05516108|524143242|FG001|Overall Study|Time Commitment|1|||
145353227|NCT05516108|524143241|FG000|Overall Study|Reason Unknown|2|||
145353228|NCT05516108|524143242|FG001|Overall Study|Reason Unknown|4|||
145353229|NCT05017246|524143243|FG000|Overall Study|Withdrawal by Subject|5|||
145353230|NCT05017246|524143244|FG001|Overall Study|Withdrawal by Subject|3|||
145353231|NCT05017246|524143243|FG000|Overall Study|Determined to be ineligible|0|||
145353232|NCT05017246|524143244|FG001|Overall Study|Determined to be ineligible|1|||
145353233|NCT05017246|524143243|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
145353234|NCT05017246|524143244|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
145353235|NCT05017246|524143243|FG000|Overall Study|Technical failure|1|||
145353236|NCT05017246|524143244|FG001|Overall Study|Technical failure|3|||
145353237|NCT01866826|524143245|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
145353238|NCT01866826|524143246|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
145353239|NCT01866826|524143245|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
145353240|NCT01866826|524143246|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
145353241|NCT01866826|524143245|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
145353242|NCT01866826|524143246|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
145353243|NCT00485264|524143248|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
145353244|NCT00485264|524143249|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
145353245|NCT00485264|524143250|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
145353246|NCT00485264|524143251|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
145353247|NCT00485264|524143252|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
145353248|NCT00485264|524143253|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
145353249|NCT00485264|524143248|FG000|Overall Study|Death|1|||
145353250|NCT00485264|524143249|FG001|Overall Study|Death|0|||
145353251|NCT00485264|524143250|FG002|Overall Study|Death|0|||
145353252|NCT00485264|524143251|FG003|Overall Study|Death|0|||
145353253|NCT00485264|524143252|FG004|Overall Study|Death|1|||
145353254|NCT00485264|524143253|FG005|Overall Study|Death|0|||
145353255|NCT00485264|524143248|FG000|Overall Study|Adverse Event|1|||
145353256|NCT00485264|524143249|FG001|Overall Study|Adverse Event|0|||
145353257|NCT00485264|524143250|FG002|Overall Study|Adverse Event|2|||
145353258|NCT00485264|524143251|FG003|Overall Study|Adverse Event|3|||
145353259|NCT00485264|524143252|FG004|Overall Study|Adverse Event|1|||
145353260|NCT00485264|524143253|FG005|Overall Study|Adverse Event|3|||
145353261|NCT00485264|524143248|FG000|Overall Study|Pregnancy|4|||
145353262|NCT00485264|524143249|FG001|Overall Study|Pregnancy|0|||
145353263|NCT00485264|524143250|FG002|Overall Study|Pregnancy|0|||
145353264|NCT00485264|524143251|FG003|Overall Study|Pregnancy|0|||
145353265|NCT00485264|524143252|FG004|Overall Study|Pregnancy|0|||
145353266|NCT00485264|524143253|FG005|Overall Study|Pregnancy|0|||
145353267|NCT00485264|524143248|FG000|Overall Study|Disallowed Medication|0|||
145353268|NCT00485264|524143249|FG001|Overall Study|Disallowed Medication|0|||
145353269|NCT00485264|524143250|FG002|Overall Study|Disallowed Medication|0|||
145353270|NCT00485264|524143251|FG003|Overall Study|Disallowed Medication|0|||
145353271|NCT00485264|524143252|FG004|Overall Study|Disallowed Medication|0|||
145353272|NCT00485264|524143253|FG005|Overall Study|Disallowed Medication|1|||
145353273|NCT00485264|524143248|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
145353274|NCT00485264|524143249|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
145353275|NCT00485264|524143250|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
145353276|NCT00485264|524143251|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
145353277|NCT00485264|524143252|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
145353278|NCT00485264|524143253|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
145353279|NCT00485264|524143248|FG000|Overall Study|Lack of Efficacy|0|||
145353280|NCT00485264|524143249|FG001|Overall Study|Lack of Efficacy|1|||
145353281|NCT00485264|524143250|FG002|Overall Study|Lack of Efficacy|0|||
145416292|NCT01245062|524378708|FG001|Cross-over Phase|Study closed/ terminated|0|||
145416293|NCT01245062|524378709|FG002|Cross-over Phase|Study closed/ terminated|11|||
145416294|NCT01452347|524378710|FG000|Overall Study|Adverse Event|2|||
145416295|NCT01452347|524378711|FG001|Overall Study|Adverse Event|1|||
145416296|NCT01452347|524378710|FG000|Overall Study|Non compliance protocol|2|||
145416297|NCT01452347|524378711|FG001|Overall Study|Non compliance protocol|0|||
145416298|NCT01452347|524378710|FG000|Overall Study|Lost to Follow-up|2|||
145416299|NCT01452347|524378711|FG001|Overall Study|Lost to Follow-up|0|||
145416300|NCT01452347|524378710|FG000|Overall Study|Withdrawal by Subject|3|||
145416301|NCT01452347|524378711|FG001|Overall Study|Withdrawal by Subject|3|||
145416302|NCT01452347|524378710|FG000|Overall Study|Not treated|6|||
145416303|NCT01452347|524378711|FG001|Overall Study|Not treated|3|||
145416304|NCT01452347|524378710|FG000|Overall Study|Other reason not defined above|2|||
145416305|NCT01452347|524378711|FG001|Overall Study|Other reason not defined above|0|||
145416306|NCT00853047|524378712|FG000|Core Phase|Participant Request|0|||
145416307|NCT00853047|524378713|FG001|Core Phase|Participant Request|0|||
145416308|NCT00853047|524378714|FG002|Core Phase|Participant Request|0|||
145416309|NCT00853047|524378715|FG003|Core Phase|Participant Request|1|||
145416310|NCT00853047|524378716|FG004|Core Phase|Participant Request|0|||
145416311|NCT00853047|524378717|FG005|Core Phase|Participant Request|0|||
145416312|NCT00853047|524378712|FG000|Open-Label Extension Phase|Participant Request|0|||
145416313|NCT00853047|524378713|FG001|Open-Label Extension Phase|Participant Request|0|||
145416314|NCT00853047|524378714|FG002|Open-Label Extension Phase|Participant Request|0|||
145416315|NCT00853047|524378715|FG003|Open-Label Extension Phase|Participant Request|0|||
145416316|NCT00853047|524378716|FG004|Open-Label Extension Phase|Participant Request|0|||
145416317|NCT00853047|524378717|FG005|Open-Label Extension Phase|Participant Request|7|||
145416318|NCT00853047|524378712|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145416319|NCT00853047|524378713|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145416320|NCT00853047|524378714|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145416321|NCT00853047|524378715|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
145416322|NCT00853047|524378716|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
145416323|NCT00853047|524378717|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
145416324|NCT00853047|524378712|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145416325|NCT00853047|524378713|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145416326|NCT00853047|524378714|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145416327|NCT00853047|524378715|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145416328|NCT00853047|524378716|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
145416329|NCT00853047|524378717|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
145416330|NCT00853047|524378712|FG000|Open-Label Extension Phase|Investigator Decision|0|||
145416331|NCT00853047|524378713|FG001|Open-Label Extension Phase|Investigator Decision|0|||
145416332|NCT00853047|524378714|FG002|Open-Label Extension Phase|Investigator Decision|0|||
145416333|NCT00853047|524378715|FG003|Open-Label Extension Phase|Investigator Decision|0|||
145416334|NCT00853047|524378716|FG004|Open-Label Extension Phase|Investigator Decision|0|||
145416335|NCT00853047|524378717|FG005|Open-Label Extension Phase|Investigator Decision|1|||
145416336|NCT00853047|524378712|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
145416337|NCT00853047|524378713|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
145416338|NCT00853047|524378714|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
145416339|NCT00853047|524378715|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
145416340|NCT00853047|524378716|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
145416341|NCT00853047|524378717|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
145416342|NCT02724644|524380062|FG000|Overall Study|Adverse Event|7|||
145416343|NCT02724644|524380063|FG001|Overall Study|Adverse Event|1|||
145416344|NCT02724644|524380062|FG000|Overall Study|Lost to Follow-up|6|||
145416345|NCT02724644|524380063|FG001|Overall Study|Lost to Follow-up|2|||
145416346|NCT02724644|524380062|FG000|Overall Study|Withdrawal by Subject|7|||
145416347|NCT02724644|524380063|FG001|Overall Study|Withdrawal by Subject|1|||
145416348|NCT02724644|524380062|FG000|Overall Study|Administrative|1|||
145416349|NCT02724644|524380063|FG001|Overall Study|Administrative|0|||
145416350|NCT02316613|524380066|FG000|Overall Study|Death|63|||
145416351|NCT02316613|524380066|FG000|Overall Study|Lost to Follow-up|9|||
145416352|NCT02316613|524380066|FG000|Overall Study|Lymphoma transformation|2|||
145416353|NCT02316613|524380066|FG000|Overall Study|Participant moved/changed medical team|11|||
145416354|NCT02316613|524380066|FG000|Overall Study|No data and duplicate cases|5|||
145416355|NCT02316613|524380066|FG000|Overall Study|Did not met selection criteria|14|||
145416356|NCT01108796|524380067|FG000|Overall Study|Adverse Event|0|||
145416357|NCT01108796|524380068|FG001|Overall Study|Adverse Event|1|||
145416358|NCT01108796|524380067|FG000|Overall Study|Lost to Follow-up|7|||
145416359|NCT01108796|524380068|FG001|Overall Study|Lost to Follow-up|6|||
145416360|NCT02545127|524380071|FG000|Overall Study|Lost to Follow-up|1|||
145416361|NCT02545127|524380072|FG001|Overall Study|Lost to Follow-up|0|||
145416362|NCT03197935|524380073|FG000|Overall Study|Death due to any cause|26|||
145577286|NCT01109316|524968048|FG004|Study Period 1|Adverse Event|0|||
145577287|NCT01109316|524968049|FG005|Study Period 1|Adverse Event|0|||
145416363|NCT03197935|524380074|FG001|Overall Study|Death due to any cause|15|||
145577288|NCT01109316|524968044|FG000|Study Period 1|Lost to Follow-up|0|||
145416364|NCT03197935|524380073|FG000|Overall Study|Lost to Follow-up|3|||
145416365|NCT03197935|524380074|FG001|Overall Study|Lost to Follow-up|5|||
145416366|NCT03197935|524380073|FG000|Overall Study|Physician Decision|2|||
145416367|NCT03197935|524380074|FG001|Overall Study|Physician Decision|1|||
145416368|NCT03197935|524380073|FG000|Overall Study|Withdrawal by Subject|16|||
145416369|NCT03197935|524380074|FG001|Overall Study|Withdrawal by Subject|8|||
145416370|NCT00960856|524380076|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145416371|NCT00960856|524380077|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
145416372|NCT00960856|524380078|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
145416373|NCT00960856|524380079|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
145416374|NCT00960856|524380076|FG000|Washout Period of 7 Days|Adverse Event|0|||
145353282|NCT00485264|524143251|FG003|Overall Study|Lack of Efficacy|0|||
145353283|NCT00485264|524143252|FG004|Overall Study|Lack of Efficacy|0|||
145353284|NCT00485264|524143253|FG005|Overall Study|Lack of Efficacy|0|||
145353285|NCT00485264|524143248|FG000|Overall Study|Guardian Consent Withdrawn|1|||
145353286|NCT00485264|524143249|FG001|Overall Study|Guardian Consent Withdrawn|0|||
145353287|NCT00485264|524143250|FG002|Overall Study|Guardian Consent Withdrawn|0|||
145353288|NCT00485264|524143251|FG003|Overall Study|Guardian Consent Withdrawn|0|||
145353289|NCT00485264|524143252|FG004|Overall Study|Guardian Consent Withdrawn|1|||
145353290|NCT00485264|524143253|FG005|Overall Study|Guardian Consent Withdrawn|0|||
145353291|NCT00485264|524143248|FG000|Overall Study|Physician Decision|0|||
145353292|NCT00485264|524143249|FG001|Overall Study|Physician Decision|2|||
145353293|NCT00485264|524143250|FG002|Overall Study|Physician Decision|0|||
145416375|NCT00960856|524380077|FG001|Washout Period of 7 Days|Adverse Event|0|||
145416376|NCT00960856|524380078|FG002|Washout Period of 7 Days|Adverse Event|1|||
145416377|NCT00960856|524380079|FG003|Washout Period of 7 Days|Adverse Event|0|||
145416378|NCT05938010|524380080|FG000|Overall Study|Lost to Follow-up|2|||
145416379|NCT02595749|524380084|FG000|Overall Study|Withdrawal by Subject|12|||
145416380|NCT02595749|524380085|FG001|Overall Study|Withdrawal by Subject|7|||
145416381|NCT01562444|524380089|FG000|Overall Study|Did not meet entry criteria|2|||
145416382|NCT01562444|524380090|FG001|Overall Study|Did not meet entry criteria|0|||
145416383|NCT01562444|524380091|FG002|Overall Study|Did not meet entry criteria|3|||
145353294|NCT00485264|524143251|FG003|Overall Study|Physician Decision|0|||
145353295|NCT00485264|524143252|FG004|Overall Study|Physician Decision|0|||
145353296|NCT00485264|524143253|FG005|Overall Study|Physician Decision|0|||
145353297|NCT00485264|524143248|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145353298|NCT00485264|524143249|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145353299|NCT00485264|524143250|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
145353300|NCT00485264|524143251|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145353301|NCT00485264|524143252|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145353302|NCT00485264|524143253|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
145353303|NCT00485264|524143248|FG000|Overall Study|Not Able to Attend Clinic|5|||
145353304|NCT00485264|524143249|FG001|Overall Study|Not Able to Attend Clinic|0|||
145353305|NCT00485264|524143250|FG002|Overall Study|Not Able to Attend Clinic|0|||
145353306|NCT00485264|524143251|FG003|Overall Study|Not Able to Attend Clinic|1|||
145353307|NCT00485264|524143252|FG004|Overall Study|Not Able to Attend Clinic|1|||
145353308|NCT00485264|524143253|FG005|Overall Study|Not Able to Attend Clinic|2|||
145353309|NCT00485264|524143248|FG000|Overall Study|Non-Compliant|17|||
145353310|NCT00485264|524143249|FG001|Overall Study|Non-Compliant|2|||
145353311|NCT00485264|524143250|FG002|Overall Study|Non-Compliant|1|||
145353312|NCT00485264|524143251|FG003|Overall Study|Non-Compliant|0|||
145353313|NCT00485264|524143252|FG004|Overall Study|Non-Compliant|1|||
145353314|NCT00485264|524143253|FG005|Overall Study|Non-Compliant|0|||
145353315|NCT00485264|524143248|FG000|Overall Study|Lost to Follow-up|2|||
145353316|NCT00485264|524143249|FG001|Overall Study|Lost to Follow-up|1|||
145416384|NCT01562444|524380089|FG000|Overall Study|Did not comply with blood draw schedule|1|||
145416385|NCT01562444|524380090|FG001|Overall Study|Did not comply with blood draw schedule|0|||
145416386|NCT01562444|524380091|FG002|Overall Study|Did not comply with blood draw schedule|1|||
145416387|NCT01562444|524380089|FG000|Overall Study|Unavailable serological results|0|||
145416388|NCT01562444|524380090|FG001|Overall Study|Unavailable serological results|2|||
145416389|NCT01562444|524380091|FG002|Overall Study|Unavailable serological results|2|||
145416390|NCT01562444|524380089|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
145416391|NCT01562444|524380090|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
145416392|NCT01562444|524380091|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
145416393|NCT01562444|524380089|FG000|Overall Study|Protocol forbidden medication|1|||
145416394|NCT01562444|524380090|FG001|Overall Study|Protocol forbidden medication|0|||
145416395|NCT01562444|524380091|FG002|Overall Study|Protocol forbidden medication|0|||
145416396|NCT03387046|524380097|FG000|Overall Study|Adverse Event|1|||
145353317|NCT00485264|524143250|FG002|Overall Study|Lost to Follow-up|1|||
145353318|NCT00485264|524143251|FG003|Overall Study|Lost to Follow-up|0|||
145353319|NCT00485264|524143252|FG004|Overall Study|Lost to Follow-up|0|||
145353320|NCT00485264|524143253|FG005|Overall Study|Lost to Follow-up|1|||
145353321|NCT00485264|524143248|FG000|Overall Study|Other Reason|3|||
145353322|NCT00485264|524143249|FG001|Overall Study|Other Reason|0|||
145353323|NCT00485264|524143250|FG002|Overall Study|Other Reason|0|||
145416397|NCT03387046|524380098|FG001|Overall Study|Adverse Event|1|||
145416398|NCT03558672|524380099|FG000|Overall Study|Study Early Termination|10|||
145416399|NCT00421733|524380102|FG000|Overall Study|Adverse Event|4|||
145416400|NCT00421733|524380103|FG001|Overall Study|Adverse Event|9|||
145416401|NCT00421733|524380104|FG002|Overall Study|Adverse Event|2|||
145416402|NCT00421733|524380102|FG000|Overall Study|Lost to Follow-up|1|||
145416403|NCT00421733|524380103|FG001|Overall Study|Lost to Follow-up|2|||
145416404|NCT00421733|524380104|FG002|Overall Study|Lost to Follow-up|4|||
145416405|NCT00421733|524380102|FG000|Overall Study|Withdrawal by Subject|1|||
145416406|NCT00421733|524380103|FG001|Overall Study|Withdrawal by Subject|2|||
145416407|NCT00421733|524380104|FG002|Overall Study|Withdrawal by Subject|7|||
145416408|NCT00421733|524380102|FG000|Overall Study|Death|0|||
145416409|NCT00421733|524380103|FG001|Overall Study|Death|3|||
145416410|NCT00421733|524380104|FG002|Overall Study|Death|0|||
145416411|NCT00421733|524380102|FG000|Overall Study|Required dialysis|1|||
145416412|NCT00421733|524380103|FG001|Overall Study|Required dialysis|0|||
145416413|NCT00421733|524380104|FG002|Overall Study|Required dialysis|0|||
145416414|NCT00421733|524380102|FG000|Overall Study|Administrative|2|||
145416415|NCT00421733|524380103|FG001|Overall Study|Administrative|0|||
145416416|NCT00421733|524380104|FG002|Overall Study|Administrative|0|||
145416417|NCT00421733|524380102|FG000|Overall Study|Did not satisfy entry criteria|1|||
145416418|NCT00421733|524380103|FG001|Overall Study|Did not satisfy entry criteria|3|||
145416419|NCT00421733|524380104|FG002|Overall Study|Did not satisfy entry criteria|2|||
145416420|NCT00421733|524380102|FG000|Overall Study|Sponsor request|1|||
145416421|NCT00421733|524380103|FG001|Overall Study|Sponsor request|0|||
145416422|NCT00421733|524380104|FG002|Overall Study|Sponsor request|3|||
145416423|NCT00421733|524380102|FG000|Overall Study|Protocol deviation|4|||
145416424|NCT00421733|524380103|FG001|Overall Study|Protocol deviation|7|||
145416425|NCT00421733|524380104|FG002|Overall Study|Protocol deviation|2|||
145416426|NCT00103506|524380108|FG000|Overall Study|Study closed by sponsor|34|||
145416427|NCT00103506|524380109|FG001|Overall Study|Study closed by sponsor|37|||
145416428|NCT00103506|524380108|FG000|Overall Study|Death|257|||
145416429|NCT00103506|524380109|FG001|Overall Study|Death|253|||
145416430|NCT00103506|524380108|FG000|Overall Study|Lost to Follow-up|13|||
145416431|NCT00103506|524380109|FG001|Overall Study|Lost to Follow-up|13|||
145416432|NCT00103506|524380108|FG000|Overall Study|Withdrawal by Subject|18|||
145416433|NCT00103506|524380109|FG001|Overall Study|Withdrawal by Subject|21|||
145416434|NCT00585585|524380110|FG000|Overall Study|Adverse Event|1|||
145416435|NCT04676646|524380113|FG000|Open-label Run-in Phase|Adverse Event|3|||
145416436|NCT04676646|524380114|FG001|Open-label Run-in Phase|Adverse Event|0|||
145416437|NCT04676646|524380115|FG002|Open-label Run-in Phase|Adverse Event|0|||
145416438|NCT04676646|524380113|FG000|Open-label Run-in Phase|Death|3|||
145416439|NCT04676646|524380114|FG001|Open-label Run-in Phase|Death|0|||
145416440|NCT04676646|524380115|FG002|Open-label Run-in Phase|Death|0|||
145416441|NCT04676646|524380113|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
145416442|NCT04676646|524380114|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
145416443|NCT04676646|524380115|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
145416444|NCT04676646|524380113|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
145416445|NCT04676646|524380114|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
145416446|NCT04676646|524380115|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
145416447|NCT04676646|524380113|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
145416448|NCT04676646|524380114|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
145416449|NCT04676646|524380115|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
145416450|NCT04676646|524380113|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
145416451|NCT04676646|524380114|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
145416452|NCT04676646|524380115|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
145416453|NCT04676646|524380113|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
145416454|NCT04676646|524380114|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
145416455|NCT04676646|524380115|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
145416456|NCT04676646|524380113|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
145416457|NCT04676646|524380114|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
145416458|NCT04676646|524380115|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
145416459|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
145416460|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
145416461|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
145416462|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Death|0|||
145416463|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Death|1|||
145416464|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Death|2|||
145416465|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
145416466|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
145416467|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
145416468|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
145416469|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
145416470|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
145416471|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
145416472|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
145416473|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
145416474|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
145416475|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
145416476|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
145416477|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
145416478|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
145416479|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
145416480|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
145416481|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
145416482|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
145416483|NCT04676646|524380113|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
145416484|NCT04676646|524380114|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
145416485|NCT04676646|524380115|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
145416486|NCT02421510|524380116|FG000|Overall Study|Other|4|||
145416487|NCT02421510|524380117|FG001|Overall Study|Other|2|||
145416488|NCT02421510|524380118|FG002|Overall Study|Other|3|||
145416489|NCT02421510|524380116|FG000|Overall Study|Protocol Violation|1|||
145416490|NCT02421510|524380117|FG001|Overall Study|Protocol Violation|2|||
145416491|NCT02421510|524380118|FG002|Overall Study|Protocol Violation|0|||
145416492|NCT02421510|524380116|FG000|Overall Study|Death|1|||
145416493|NCT02421510|524380117|FG001|Overall Study|Death|0|||
145416494|NCT02421510|524380118|FG002|Overall Study|Death|0|||
145416495|NCT02421510|524380116|FG000|Overall Study|Noncompliance with study drug|1|||
145416496|NCT02421510|524380117|FG001|Overall Study|Noncompliance with study drug|0|||
145416497|NCT02421510|524380118|FG002|Overall Study|Noncompliance with study drug|0|||
145416498|NCT02421510|524380116|FG000|Overall Study|Physician Decision|1|||
145416499|NCT02421510|524380117|FG001|Overall Study|Physician Decision|1|||
145416500|NCT02421510|524380118|FG002|Overall Study|Physician Decision|3|||
145416501|NCT02421510|524380116|FG000|Overall Study|Adverse Event|9|||
145416502|NCT02421510|524380117|FG001|Overall Study|Adverse Event|10|||
145416503|NCT02421510|524380118|FG002|Overall Study|Adverse Event|18|||
145416504|NCT02421510|524380116|FG000|Overall Study|Pregnancy|1|||
145416505|NCT02421510|524380117|FG001|Overall Study|Pregnancy|1|||
145416506|NCT02421510|524380118|FG002|Overall Study|Pregnancy|0|||
145416507|NCT02421510|524380116|FG000|Overall Study|Withdrawal by Subject|14|||
145416508|NCT02421510|524380117|FG001|Overall Study|Withdrawal by Subject|18|||
145416509|NCT02421510|524380118|FG002|Overall Study|Withdrawal by Subject|12|||
145416510|NCT02421510|524380116|FG000|Overall Study|Lost to Follow-up|1|||
145416511|NCT02421510|524380117|FG001|Overall Study|Lost to Follow-up|1|||
145416512|NCT02421510|524380118|FG002|Overall Study|Lost to Follow-up|0|||
145416513|NCT02852434|524380119|FG000|Overall Study|Withdrawal by Subject|0|||
145416514|NCT02852434|524380120|FG001|Overall Study|Withdrawal by Subject|1|||
145416515|NCT02852434|524380119|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
145416516|NCT02852434|524380120|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
145416517|NCT05987540|524380122|FG000|Overall Study|Withdrawal by Subject|2|||
145416518|NCT05987540|524380122|FG000|Overall Study|Death|1|||
145416519|NCT05987540|524380122|FG000|Overall Study|Study Termination|1|||
145416520|NCT05987540|524380122|FG000|Overall Study|Adverse Event|2|||
145416521|NCT05061706|524380125|FG000|Overall Study|Adverse Event|29|||
145416522|NCT05061706|524380126|FG001|Overall Study|Adverse Event|1|||
145416523|NCT05061706|524380125|FG000|Overall Study|Lack of Efficacy|0|||
145416524|NCT05061706|524380126|FG001|Overall Study|Lack of Efficacy|1|||
145416525|NCT05061706|524380125|FG000|Overall Study|Lost to Follow-up|2|||
145416526|NCT05061706|524380126|FG001|Overall Study|Lost to Follow-up|2|||
145416527|NCT05061706|524380125|FG000|Overall Study|Protocol Violation|3|||
145416528|NCT05061706|524380126|FG001|Overall Study|Protocol Violation|1|||
145416529|NCT05061706|524380125|FG000|Overall Study|Withdrawal by Subject|3|||
145416530|NCT05061706|524380126|FG001|Overall Study|Withdrawal by Subject|9|||
145416531|NCT01149538|524380129|FG000|Overall Study|Lost to Follow-up|0|||
145416532|NCT01149538|524380130|FG001|Overall Study|Lost to Follow-up|1|||
145416533|NCT01149538|524380129|FG000|Overall Study|Withdrawal by Subject|5|||
145416534|NCT01149538|524380130|FG001|Overall Study|Withdrawal by Subject|3|||
145416535|NCT02336503|524380133|FG000|Overall Study|Lost to Follow-up|0|||
145416536|NCT02336503|524380134|FG001|Overall Study|Lost to Follow-up|3|||
145416537|NCT02336503|524380135|FG002|Overall Study|Lost to Follow-up|0|||
145416538|NCT02336503|524380136|FG003|Overall Study|Lost to Follow-up|2|||
145416539|NCT02336503|524380133|FG000|Overall Study|Withdrawal by Subject|2|||
145416540|NCT02336503|524380134|FG001|Overall Study|Withdrawal by Subject|0|||
145416541|NCT02336503|524380135|FG002|Overall Study|Withdrawal by Subject|0|||
145416542|NCT02336503|524380136|FG003|Overall Study|Withdrawal by Subject|4|||
145416543|NCT02336503|524380133|FG000|Overall Study|Adverse Event|0|||
145416544|NCT02336503|524380134|FG001|Overall Study|Adverse Event|0|||
145416545|NCT02336503|524380135|FG002|Overall Study|Adverse Event|1|||
145416546|NCT02336503|524380136|FG003|Overall Study|Adverse Event|0|||
145416547|NCT02583477|524380137|FG000|Overall Study|Adverse Event|0|||
145416548|NCT02583477|524380138|FG001|Overall Study|Adverse Event|2|||
145416549|NCT02583477|524380137|FG000|Overall Study|Death|1|||
145416550|NCT02583477|524380138|FG001|Overall Study|Death|16|||
145353324|NCT00485264|524143251|FG003|Overall Study|Other Reason|0|||
145353325|NCT00485264|524143252|FG004|Overall Study|Other Reason|0|||
145353326|NCT00485264|524143253|FG005|Overall Study|Other Reason|0|||
145353327|NCT01514461|524143254|FG000|Overall Study|Adverse Event|2|||
145353328|NCT01514461|524143255|FG001|Overall Study|Adverse Event|1|||
145353329|NCT01514461|524143256|FG002|Overall Study|Adverse Event|3|||
145353330|NCT01514461|524143254|FG000|Overall Study|Physician Decision|1|||
145353331|NCT01514461|524143255|FG001|Overall Study|Physician Decision|1|||
145353332|NCT01514461|524143256|FG002|Overall Study|Physician Decision|0|||
145353333|NCT01514461|524143254|FG000|Overall Study|Patient/guardian decision|1|||
145353334|NCT01514461|524143255|FG001|Overall Study|Patient/guardian decision|1|||
145353335|NCT01514461|524143256|FG002|Overall Study|Patient/guardian decision|1|||
145353336|NCT01514461|524143254|FG000|Overall Study|Death|1|||
145353337|NCT01514461|524143255|FG001|Overall Study|Death|0|||
145353338|NCT01514461|524143256|FG002|Overall Study|Death|0|||
145353339|NCT00654095|524143257|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
145353340|NCT00654095|524143257|FG000|Overall Study|Elevated triglyceride level (2)|1|||
145353341|NCT00654095|524143257|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
145353342|NCT00654095|524143257|FG000|Overall Study|Adverse Event|11|||
145353343|NCT00654095|524143257|FG000|Overall Study|Withdrawal by Subject|5|||
145353344|NCT00654095|524143257|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
145353345|NCT00654095|524143257|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
145353346|NCT00654095|524143257|FG000|Overall Study|Did not meet inclusion criteria|1|||
145353347|NCT02392481|524143263|FG000|Overall Study|Adverse Event|0|||
145353348|NCT02392481|524143264|FG001|Overall Study|Adverse Event|0|||
145353349|NCT02392481|524143265|FG002|Overall Study|Adverse Event|1|||
145353350|NCT02392481|524143266|FG003|Overall Study|Adverse Event|2|||
145353351|NCT02392481|524143263|FG000|Overall Study|Withdrawal by Subject|0|||
145353352|NCT02392481|524143264|FG001|Overall Study|Withdrawal by Subject|0|||
145353353|NCT02392481|524143265|FG002|Overall Study|Withdrawal by Subject|1|||
145353354|NCT02392481|524143266|FG003|Overall Study|Withdrawal by Subject|0|||
145353355|NCT02548832|524143268|FG000|Overall Study|Lost to Follow-up|2|||
145353356|NCT02548832|524143269|FG001|Overall Study|Lost to Follow-up|2|||
145353357|NCT02548832|524143270|FG002|Overall Study|Lost to Follow-up|2|||
145353358|NCT02222922|524143271|FG000|Overall Study|Death|0|||
145353359|NCT02222922|524143272|FG001|Overall Study|Death|0|||
145353360|NCT02222922|524143273|FG002|Overall Study|Death|0|||
145353361|NCT02222922|524143274|FG003|Overall Study|Death|0|||
145353362|NCT02222922|524143275|FG004|Overall Study|Death|13|||
145353363|NCT02222922|524143276|FG005|Overall Study|Death|0|||
145353364|NCT02222922|524143277|FG006|Overall Study|Death|0|||
145353365|NCT02222922|524143278|FG007|Overall Study|Death|0|||
145353366|NCT02222922|524143279|FG008|Overall Study|Death|2|||
145353367|NCT02222922|524143271|FG000|Overall Study|Lost to Follow-up|0|||
145353368|NCT02222922|524143272|FG001|Overall Study|Lost to Follow-up|0|||
145353369|NCT02222922|524143273|FG002|Overall Study|Lost to Follow-up|1|||
145353370|NCT02222922|524143274|FG003|Overall Study|Lost to Follow-up|0|||
145353371|NCT02222922|524143275|FG004|Overall Study|Lost to Follow-up|9|||
145416551|NCT02583477|524380137|FG000|Overall Study|Study terminated|2|||
145416552|NCT02583477|524380138|FG001|Overall Study|Study terminated|2|||
145416553|NCT01873833|524380144|FG000|Overall Study|Withdrawal by Subject|1|||
145416554|NCT02939781|524380147|FG000|Overall Study|Protocol Violation|8|||
145416555|NCT02939781|524380147|FG000|Overall Study|Withdrawal by Subject|1|||
145416556|NCT01740427|524380148|FG000|Overall Study|Objective Progression or Relapse|286|||
145416557|NCT01740427|524380149|FG001|Overall Study|Objective Progression or Relapse|172|||
145416558|NCT01740427|524380148|FG000|Overall Study|Adverse Event|32|||
145416559|NCT01740427|524380149|FG001|Overall Study|Adverse Event|9|||
145353372|NCT02222922|524143276|FG005|Overall Study|Lost to Follow-up|1|||
145353373|NCT02222922|524143277|FG006|Overall Study|Lost to Follow-up|0|||
145353374|NCT02222922|524143278|FG007|Overall Study|Lost to Follow-up|0|||
145353375|NCT02222922|524143279|FG008|Overall Study|Lost to Follow-up|0|||
145353376|NCT02222922|524143271|FG000|Overall Study|Other|0|||
145353377|NCT02222922|524143272|FG001|Overall Study|Other|0|||
145353378|NCT02222922|524143273|FG002|Overall Study|Other|0|||
145353379|NCT02222922|524143274|FG003|Overall Study|Other|2|||
145353380|NCT02222922|524143275|FG004|Overall Study|Other|10|||
145353381|NCT02222922|524143276|FG005|Overall Study|Other|2|||
145353382|NCT02222922|524143277|FG006|Overall Study|Other|2|||
145353383|NCT02222922|524143278|FG007|Overall Study|Other|4|||
145353384|NCT02222922|524143279|FG008|Overall Study|Other|1|||
145353385|NCT02222922|524143271|FG000|Overall Study|Participant refused further follow-up|1|||
145353386|NCT02222922|524143272|FG001|Overall Study|Participant refused further follow-up|0|||
145353387|NCT02222922|524143273|FG002|Overall Study|Participant refused further follow-up|0|||
145353388|NCT02222922|524143274|FG003|Overall Study|Participant refused further follow-up|1|||
145353389|NCT02222922|524143275|FG004|Overall Study|Participant refused further follow-up|6|||
145353390|NCT02222922|524143276|FG005|Overall Study|Participant refused further follow-up|0|||
145353391|NCT02222922|524143277|FG006|Overall Study|Participant refused further follow-up|0|||
145353392|NCT02222922|524143278|FG007|Overall Study|Participant refused further follow-up|0|||
145353393|NCT02222922|524143279|FG008|Overall Study|Participant refused further follow-up|3|||
145353394|NCT01254643|524143280|FG000|Overall Study|Withdrawal by Subject|1|||
145353395|NCT03817125|524143282|FG000|Overall Study|Adverse Event|1|||
145353396|NCT03817125|524143283|FG001|Overall Study|Adverse Event|0|||
145353397|NCT03817125|524143282|FG000|Overall Study|Physician Decision|0|||
145353398|NCT03817125|524143283|FG001|Overall Study|Physician Decision|1|||
145353399|NCT03817125|524143282|FG000|Overall Study|Lack of Efficacy|1|||
145353400|NCT03817125|524143283|FG001|Overall Study|Lack of Efficacy|5|||
145353401|NCT02002221|524143284|FG000|Overall Study|Adverse Event|2|||
145353402|NCT02002221|524143285|FG001|Overall Study|Adverse Event|1|||
145353403|NCT02002221|524143284|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145353404|NCT02002221|524143285|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145353405|NCT02002221|524143284|FG000|Overall Study|Patient withdrew consent|0|||
145353406|NCT02002221|524143285|FG001|Overall Study|Patient withdrew consent|1|||
145353407|NCT00942084|524143286|FG000|Overall Study|Death|2|||
145353408|NCT01998919|524143288|FG000|Overall Study|Death|2|||
145353409|NCT01998919|524143289|FG001|Overall Study|Death|2|||
145353410|NCT01998919|524143288|FG000|Overall Study|Adverse Event|0|||
145353411|NCT01998919|524143289|FG001|Overall Study|Adverse Event|5|||
145353412|NCT01998919|524143288|FG000|Overall Study|Disease progression|31|||
145353413|NCT01998919|524143289|FG001|Overall Study|Disease progression|22|||
145353414|NCT01998919|524143288|FG000|Overall Study|Withdrawal by Subject|2|||
145353415|NCT01998919|524143289|FG001|Overall Study|Withdrawal by Subject|4|||
145353416|NCT01998919|524143288|FG000|Overall Study|Lost to Follow-up|2|||
145353417|NCT01998919|524143289|FG001|Overall Study|Lost to Follow-up|0|||
145353418|NCT01998919|524143288|FG000|Overall Study|Other|5|||
145353419|NCT01998919|524143289|FG001|Overall Study|Other|2|||
145353420|NCT01037218|524143292|FG000|Overall Study|Adverse Event|4|||
145353421|NCT01037218|524143293|FG001|Overall Study|Adverse Event|2|||
145353422|NCT01037218|524143294|FG002|Overall Study|Adverse Event|2|||
145353423|NCT01037218|524143295|FG003|Overall Study|Adverse Event|1|||
145353424|NCT01037218|524143292|FG000|Overall Study|Lack of Efficacy|0|||
145353425|NCT01037218|524143293|FG001|Overall Study|Lack of Efficacy|2|||
145353426|NCT01037218|524143294|FG002|Overall Study|Lack of Efficacy|1|||
145353427|NCT01037218|524143295|FG003|Overall Study|Lack of Efficacy|5|||
145353428|NCT01037218|524143292|FG000|Overall Study|Lost to Follow-up|3|||
145353429|NCT01037218|524143293|FG001|Overall Study|Lost to Follow-up|5|||
145353430|NCT01037218|524143294|FG002|Overall Study|Lost to Follow-up|4|||
145353431|NCT01037218|524143295|FG003|Overall Study|Lost to Follow-up|2|||
145353432|NCT01037218|524143292|FG000|Overall Study|Withdrawal by Subject|6|||
145353433|NCT01037218|524143293|FG001|Overall Study|Withdrawal by Subject|7|||
145353434|NCT01037218|524143294|FG002|Overall Study|Withdrawal by Subject|7|||
145353435|NCT01037218|524143295|FG003|Overall Study|Withdrawal by Subject|4|||
145353436|NCT01037218|524143292|FG000|Overall Study|Partner Withdrew Consent|0|||
145353437|NCT01037218|524143293|FG001|Overall Study|Partner Withdrew Consent|3|||
145353438|NCT01037218|524143294|FG002|Overall Study|Partner Withdrew Consent|2|||
145353439|NCT01037218|524143295|FG003|Overall Study|Partner Withdrew Consent|1|||
145353440|NCT01037218|524143292|FG000|Overall Study|Protocol Violation|0|||
145353441|NCT01037218|524143293|FG001|Overall Study|Protocol Violation|0|||
145353442|NCT01037218|524143294|FG002|Overall Study|Protocol Violation|2|||
145353443|NCT01037218|524143295|FG003|Overall Study|Protocol Violation|2|||
145353444|NCT01037218|524143292|FG000|Overall Study|Various|3|||
145353445|NCT01037218|524143293|FG001|Overall Study|Various|2|||
145353446|NCT01037218|524143294|FG002|Overall Study|Various|3|||
145353447|NCT01037218|524143295|FG003|Overall Study|Various|1|||
145353448|NCT00897715|524143296|FG000|Overall Study|Lost to Follow-up|0|||
145353449|NCT00897715|524143297|FG001|Overall Study|Lost to Follow-up|1|||
145416560|NCT01740427|524380148|FG000|Overall Study|Global Deterioration of Health Status|28|||
145416561|NCT01740427|524380149|FG001|Overall Study|Global Deterioration of Health Status|12|||
145577289|NCT01109316|524968045|FG001|Study Period 1|Lost to Follow-up|0|||
145353450|NCT00897715|524143296|FG000|Overall Study|Physician Decision|1|||
145353451|NCT00897715|524143297|FG001|Overall Study|Physician Decision|0|||
145353452|NCT00897715|524143296|FG000|Overall Study|increased risk of infection|1|||
145353453|NCT00897715|524143297|FG001|Overall Study|increased risk of infection|0|||
145353454|NCT01199939|524143298|FG000|Overall Study|Adverse Event|4|||
145353455|NCT01199939|524143298|FG000|Overall Study|Protocol Violation|3|||
145353456|NCT01199939|524143298|FG000|Overall Study|Lost to Follow-up|2|||
145353457|NCT01199939|524143298|FG000|Overall Study|Reached a virologic endpoint|4|||
145353458|NCT02289729|524143299|FG000|Overall Study|Lack of Efficacy|3|||
145416562|NCT01740427|524380148|FG000|Overall Study|Participant Refused Continued Treatment|27|||
145416563|NCT01740427|524380149|FG001|Overall Study|Participant Refused Continued Treatment|15|||
145416564|NCT01740427|524380148|FG000|Overall Study|Unspecified reasons|52|||
145416565|NCT01740427|524380149|FG001|Overall Study|Unspecified reasons|8|||
145416566|NCT01740427|524380148|FG000|Overall Study|Death|10|||
145416567|NCT01740427|524380149|FG001|Overall Study|Death|3|||
145416568|NCT01740427|524380148|FG000|Overall Study|Protocol Violation|5|||
145416569|NCT01740427|524380149|FG001|Overall Study|Protocol Violation|3|||
145416570|NCT01740427|524380148|FG000|Overall Study|Lost to Follow-up|3|||
145416571|NCT01740427|524380149|FG001|Overall Study|Lost to Follow-up|0|||
145416572|NCT01740427|524380148|FG000|Overall Study|Site Terminated by Sponsor|1|||
145416573|NCT01740427|524380149|FG001|Overall Study|Site Terminated by Sponsor|0|||
145416574|NCT01980888|524380150|FG000|Overall Study|Study Terminated by Sponsor|116|||
145416575|NCT01980888|524380151|FG001|Overall Study|Study Terminated by Sponsor|122|||
145416576|NCT01980888|524380150|FG000|Overall Study|Withdrew Consent|17|||
145416577|NCT01980888|524380151|FG001|Overall Study|Withdrew Consent|6|||
145416578|NCT01980888|524380150|FG000|Overall Study|Investigator's Discretion|8|||
145416579|NCT01980888|524380151|FG001|Overall Study|Investigator's Discretion|3|||
145416580|NCT01980888|524380150|FG000|Overall Study|Non-Compliance with Study Drug|3|||
145416581|NCT01980888|524380151|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145416582|NCT04625972|524380153|FG000|Overall Study|Death|3|||
145416583|NCT04625972|524380154|FG001|Overall Study|Death|2|||
145416584|NCT04625972|524380153|FG000|Overall Study|Lost to Follow-up|82|||
145416585|NCT04625972|524380154|FG001|Overall Study|Lost to Follow-up|38|||
145416586|NCT04625972|524380153|FG000|Overall Study|Physician Decision|2|||
145416587|NCT04625972|524380154|FG001|Overall Study|Physician Decision|0|||
145416588|NCT04625972|524380153|FG000|Overall Study|Protocol Violation|0|||
145416589|NCT04625972|524380154|FG001|Overall Study|Protocol Violation|1|||
145416590|NCT04625972|524380153|FG000|Overall Study|Withdrawal by Subject|37|||
145416591|NCT04625972|524380154|FG001|Overall Study|Withdrawal by Subject|24|||
145416592|NCT04625972|524380153|FG000|Overall Study|Not specified elsewhere|8|||
145416593|NCT04625972|524380154|FG001|Overall Study|Not specified elsewhere|6|||
145416594|NCT01483651|524380155|FG000|Overall Study|Withdrawal by Subject|0|||
145416595|NCT01483651|524380156|FG001|Overall Study|Withdrawal by Subject|1|||
145416596|NCT01483651|524380157|FG002|Overall Study|Withdrawal by Subject|1|||
145416597|NCT01483651|524380158|FG003|Overall Study|Withdrawal by Subject|0|||
145416598|NCT01483651|524380159|FG004|Overall Study|Withdrawal by Subject|0|||
145416599|NCT01483651|524380160|FG005|Overall Study|Withdrawal by Subject|1|||
145416600|NCT06025695|524380162|FG000|Overall Study|Adverse Event|5|||
145416601|NCT06025695|524380163|FG001|Overall Study|Adverse Event|6|||
145416602|NCT06025695|524380162|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
145416603|NCT06025695|524380163|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
145416604|NCT06025695|524380162|FG000|Overall Study|Other|23|||
145416605|NCT06025695|524380163|FG001|Overall Study|Other|19|||
145416606|NCT06025695|524380162|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
145416607|NCT06025695|524380163|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
145416608|NCT05762744|524380164|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
145416609|NCT05762744|524380165|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
145416610|NCT05762744|524380164|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
145416611|NCT05762744|524380165|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
145416612|NCT01560416|524380169|FG000|Randomized Phase|Crossover Participants|7|||
145416613|NCT01560416|524380170|FG001|Randomized Phase|Crossover Participants|0|||
145416614|NCT01695772|524380174|FG000|Overall Study|Withdrawal by Subject|18|||
145416615|NCT01695772|524380174|FG000|Overall Study|Progressive Disease|8|||
145416616|NCT01695772|524380174|FG000|Overall Study|Investigator Decision|5|||
145416617|NCT01695772|524380174|FG000|Overall Study|Lost to Follow-up|4|||
145416618|NCT01695772|524380174|FG000|Overall Study|Protocol Violation|2|||
145416619|NCT01695772|524380174|FG000|Overall Study|Unspecified Reason|1|||
145416620|NCT00004859|524380177|FG000|Overall Study|Lack of Efficacy|43|||
145416621|NCT00004859|524380178|FG001|Overall Study|Lack of Efficacy|113|||
145416622|NCT00004859|524380177|FG000|Overall Study|Adverse Event|31|||
145416623|NCT00004859|524380178|FG001|Overall Study|Adverse Event|93|||
145416624|NCT00004859|524380177|FG000|Overall Study|Death|5|||
145416625|NCT00004859|524380178|FG001|Overall Study|Death|5|||
145416626|NCT00004859|524380177|FG000|Overall Study|Withdrawal by Subject|7|||
145416627|NCT00004859|524380178|FG001|Overall Study|Withdrawal by Subject|33|||
145416628|NCT00004859|524380177|FG000|Overall Study|Protocol Violation|2|||
145416629|NCT00004859|524380178|FG001|Overall Study|Protocol Violation|2|||
145416630|NCT00004859|524380177|FG000|Overall Study|other disease|0|||
145416631|NCT00004859|524380178|FG001|Overall Study|other disease|3|||
145416632|NCT00004859|524380177|FG000|Overall Study|error|3|||
145416633|NCT00004859|524380178|FG001|Overall Study|error|1|||
145416634|NCT00004859|524380177|FG000|Overall Study|missing data|14|||
145416635|NCT00004859|524380178|FG001|Overall Study|missing data|11|||
145416636|NCT00004859|524380177|FG000|Overall Study|Other|13|||
145416637|NCT00004859|524380178|FG001|Overall Study|Other|21|||
145416638|NCT04073407|524380179|FG000|Part 1|Withdrawal by Subject|1|||
145353459|NCT02289729|524143299|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
145353460|NCT02289729|524143299|FG000|Overall Study|Withdrawal by Subject|1|||
145353461|NCT02289729|524143299|FG000|Overall Study|Death|1|||
145353462|NCT00931411|524143300|FG000|First Intervention - 42 Days|Adverse Event|2|||
145353463|NCT00931411|524143301|FG001|First Intervention - 42 Days|Adverse Event|3|||
145353464|NCT00931411|524143300|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
145353465|NCT00931411|524143301|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
145353466|NCT00931411|524143300|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
145353467|NCT00931411|524143301|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
145353468|NCT01949662|524143302|FG000|Overall Study|Death|9|||
145353469|NCT01949662|524143303|FG001|Overall Study|Death|7|||
145353470|NCT01949662|524143302|FG000|Overall Study|Discharged before an agitation event|8|||
145353471|NCT01949662|524143303|FG001|Overall Study|Discharged before an agitation event|3|||
145353472|NCT01949662|524143302|FG000|Overall Study|Dropped out|1|||
145353473|NCT01949662|524143303|FG001|Overall Study|Dropped out|3|||
145353474|NCT01949662|524143302|FG000|Overall Study|Ineligible|0|||
145353475|NCT01949662|524143303|FG001|Overall Study|Ineligible|1|||
145353476|NCT02291237|524143304|FG000|Overall Study|Study Terminated by Sponsor|72|||
145353477|NCT02291237|524143305|FG001|Overall Study|Study Terminated by Sponsor|67|||
145353478|NCT02291237|524143304|FG000|Overall Study|Adverse Event|1|||
145353479|NCT02291237|524143305|FG001|Overall Study|Adverse Event|3|||
145353480|NCT02291237|524143304|FG000|Overall Study|Investigator's Discretion|0|||
145353481|NCT02291237|524143305|FG001|Overall Study|Investigator's Discretion|3|||
145353482|NCT02291237|524143304|FG000|Overall Study|Withdrew Consent|11|||
145353483|NCT02291237|524143305|FG001|Overall Study|Withdrew Consent|11|||
145353484|NCT02291237|524143304|FG000|Overall Study|Lost to Follow-up|0|||
145353485|NCT02291237|524143305|FG001|Overall Study|Lost to Follow-up|2|||
145353486|NCT02291237|524143304|FG000|Overall Study|Subject Required Prohibited Medication|2|||
145353487|NCT02291237|524143305|FG001|Overall Study|Subject Required Prohibited Medication|0|||
145353488|NCT00729937|524143308|FG000|Overall Study|Lost to Follow-up|49|||
145353489|NCT00729937|524143309|FG001|Overall Study|Lost to Follow-up|58|||
145353490|NCT00729937|524143310|FG002|Overall Study|Lost to Follow-up|18|||
145353491|NCT00729937|524143311|FG003|Overall Study|Lost to Follow-up|33|||
145353492|NCT00729937|524143312|FG004|Overall Study|Lost to Follow-up|18|||
145353493|NCT00729937|524143313|FG005|Overall Study|Lost to Follow-up|23|||
145353494|NCT00729937|524143308|FG000|Overall Study|Physician Decision|7|||
145353495|NCT00729937|524143309|FG001|Overall Study|Physician Decision|16|||
145353496|NCT00729937|524143310|FG002|Overall Study|Physician Decision|2|||
145353497|NCT00729937|524143311|FG003|Overall Study|Physician Decision|0|||
145353498|NCT00729937|524143312|FG004|Overall Study|Physician Decision|5|||
145353499|NCT00729937|524143313|FG005|Overall Study|Physician Decision|8|||
145353500|NCT00729937|524143308|FG000|Overall Study|Death|1|||
145353501|NCT00729937|524143309|FG001|Overall Study|Death|0|||
145353502|NCT00729937|524143310|FG002|Overall Study|Death|1|||
145353503|NCT00729937|524143311|FG003|Overall Study|Death|0|||
145353504|NCT00729937|524143312|FG004|Overall Study|Death|0|||
145353505|NCT00729937|524143313|FG005|Overall Study|Death|1|||
145353506|NCT00729937|524143308|FG000|Overall Study|Withdrawal by Subject|3|||
145353507|NCT00729937|524143309|FG001|Overall Study|Withdrawal by Subject|5|||
145353508|NCT00729937|524143310|FG002|Overall Study|Withdrawal by Subject|6|||
145353509|NCT00729937|524143311|FG003|Overall Study|Withdrawal by Subject|0|||
145353510|NCT00729937|524143312|FG004|Overall Study|Withdrawal by Subject|4|||
145353511|NCT00729937|524143313|FG005|Overall Study|Withdrawal by Subject|2|||
145353512|NCT00729937|524143308|FG000|Overall Study|Randomized but not treated|12|||
145353513|NCT00729937|524143309|FG001|Overall Study|Randomized but not treated|6|||
145353514|NCT00729937|524143310|FG002|Overall Study|Randomized but not treated|1|||
145353515|NCT00729937|524143311|FG003|Overall Study|Randomized but not treated|0|||
145353516|NCT00729937|524143312|FG004|Overall Study|Randomized but not treated|1|||
145353517|NCT00729937|524143313|FG005|Overall Study|Randomized but not treated|3|||
145353518|NCT00729937|524143308|FG000|Overall Study|Did not meet eligibility criteria|2|||
145577290|NCT01109316|524968046|FG002|Study Period 1|Lost to Follow-up|1|||
145577291|NCT01109316|524968047|FG003|Study Period 1|Lost to Follow-up|1|||
145577292|NCT01109316|524968048|FG004|Study Period 1|Lost to Follow-up|0|||
145353519|NCT00729937|524143309|FG001|Overall Study|Did not meet eligibility criteria|1|||
145353520|NCT00729937|524143310|FG002|Overall Study|Did not meet eligibility criteria|0|||
145353521|NCT00729937|524143311|FG003|Overall Study|Did not meet eligibility criteria|0|||
145353522|NCT00729937|524143312|FG004|Overall Study|Did not meet eligibility criteria|0|||
145353523|NCT00729937|524143313|FG005|Overall Study|Did not meet eligibility criteria|0|||
145353524|NCT00729937|524143308|FG000|Overall Study|Incarcerated|0|||
145353525|NCT00729937|524143309|FG001|Overall Study|Incarcerated|2|||
145353526|NCT00729937|524143310|FG002|Overall Study|Incarcerated|1|||
145353527|NCT00729937|524143311|FG003|Overall Study|Incarcerated|1|||
145353528|NCT00729937|524143312|FG004|Overall Study|Incarcerated|0|||
145353529|NCT00729937|524143313|FG005|Overall Study|Incarcerated|0|||
145353530|NCT01478373|524143315|FG000|Treatment Phase|Protocol Violation|1|||
145353531|NCT01478373|524143315|FG000|Survival Phase|Adverse Event|8|||
145577293|NCT01109316|524968049|FG005|Study Period 1|Lost to Follow-up|0|||
145416639|NCT04073407|524380180|FG001|Part 1|Withdrawal by Subject|0|||
145416640|NCT04073407|524380179|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
145416641|NCT04073407|524380180|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
145416642|NCT04073407|524380179|FG000|Part 2|Withdrawal by Subject|0|||
145416643|NCT04073407|524380180|FG001|Part 2|Withdrawal by Subject|1|||
145416644|NCT02082483|524381798|FG000|Overall Study|Lost to Follow-up|1|||
145416645|NCT02082483|524381799|FG001|Overall Study|Lost to Follow-up|1|||
145416646|NCT02082483|524381798|FG000|Overall Study|Withdrawal by Subject|2|||
145416647|NCT02082483|524381799|FG001|Overall Study|Withdrawal by Subject|1|||
145416648|NCT02082483|524381798|FG000|Overall Study|Physician Decision|1|||
145416649|NCT02082483|524381799|FG001|Overall Study|Physician Decision|1|||
145416650|NCT02082483|524381798|FG000|Overall Study|Death|2|||
145416651|NCT02082483|524381799|FG001|Overall Study|Death|3|||
145416652|NCT00762788|524381800|FG000|Overall Study|Lost to Follow-up|26|||
145416653|NCT00762788|524381801|FG001|Overall Study|Lost to Follow-up|37|||
145416654|NCT00762788|524381802|FG002|Overall Study|Lost to Follow-up|21|||
145416655|NCT00762788|524381803|FG003|Overall Study|Lost to Follow-up|26|||
145416656|NCT00762788|524381804|FG004|Overall Study|Lost to Follow-up|13|||
145416657|NCT00762788|524381805|FG005|Overall Study|Lost to Follow-up|21|||
145416658|NCT01783015|524381806|FG000|Blinded Treatment|Adverse Event|0|||
145416659|NCT01783015|524381807|FG001|Blinded Treatment|Adverse Event|1|||
145416660|NCT01783015|524381808|FG002|Blinded Treatment|Adverse Event|0|||
145416661|NCT01783015|524381806|FG000|Blinded Treatment|Protocol Violation|0|||
145416662|NCT01783015|524381807|FG001|Blinded Treatment|Protocol Violation|1|||
145416663|NCT01783015|524381808|FG002|Blinded Treatment|Protocol Violation|0|||
145416664|NCT01783015|524381806|FG000|Blinded Treatment|Withdrawal by Subject|0|||
145416665|NCT01783015|524381807|FG001|Blinded Treatment|Withdrawal by Subject|1|||
145416666|NCT01783015|524381808|FG002|Blinded Treatment|Withdrawal by Subject|0|||
145416667|NCT01783015|524381806|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
145416668|NCT01783015|524381807|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
145416669|NCT01783015|524381808|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
145416670|NCT01783015|524381806|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
145416671|NCT01783015|524381807|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
145416672|NCT01783015|524381808|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
145416673|NCT00985192|524381809|FG000|Overall Study|Withdrawal by Subject|1|||
145416674|NCT00985192|524381809|FG000|Overall Study|Disease Progression|1|||
145416675|NCT00985192|524381809|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
145416676|NCT00669331|524381810|FG000|Randomisation to First Dose|Adverse Event|1|||
145416677|NCT00669331|524381811|FG001|Randomisation to First Dose|Adverse Event|0|||
145416678|NCT00669331|524381810|FG000|Randomisation to First Dose|Protocol Violation|1|||
145416679|NCT00669331|524381811|FG001|Randomisation to First Dose|Protocol Violation|0|||
145416680|NCT00669331|524381810|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
145416681|NCT00669331|524381811|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
145416682|NCT00669331|524381810|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
145416683|NCT00669331|524381811|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
145416684|NCT00669331|524381810|FG000|Randomisation to First Dose|Death|1|||
145416685|NCT00669331|524381811|FG001|Randomisation to First Dose|Death|0|||
145416686|NCT00669331|524381810|FG000|Randomisation to First Dose|Sponsor decision|0|||
145416687|NCT00669331|524381811|FG001|Randomisation to First Dose|Sponsor decision|1|||
145416688|NCT00669331|524381810|FG000|Randomisation to First Dose|Randomised in error|3|||
145416689|NCT00669331|524381811|FG001|Randomisation to First Dose|Randomised in error|10|||
145416690|NCT00669331|524381810|FG000|Blinded Treatment Period|Adverse Event|16|||
145416691|NCT00669331|524381811|FG001|Blinded Treatment Period|Adverse Event|10|||
145416692|NCT00669331|524381810|FG000|Blinded Treatment Period|Protocol Violation|1|||
145416693|NCT00669331|524381811|FG001|Blinded Treatment Period|Protocol Violation|1|||
145416694|NCT00669331|524381810|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
145416695|NCT00669331|524381811|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
145416696|NCT00669331|524381810|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
145416697|NCT00669331|524381811|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
145577294|NCT01109316|524968044|FG000|Study Period 1|Withdrawal by Subject|0|||
145577295|NCT01109316|524968045|FG001|Study Period 1|Withdrawal by Subject|0|||
145577296|NCT01109316|524968046|FG002|Study Period 1|Withdrawal by Subject|1|||
145577297|NCT01109316|524968047|FG003|Study Period 1|Withdrawal by Subject|0|||
145577298|NCT01109316|524968048|FG004|Study Period 1|Withdrawal by Subject|2|||
145416698|NCT00669331|524381810|FG000|Blinded Treatment Period|Death|0|||
145416699|NCT00669331|524381811|FG001|Blinded Treatment Period|Death|2|||
145416700|NCT00669331|524381810|FG000|Blinded Treatment Period|Physician Decision|3|||
145416701|NCT00669331|524381811|FG001|Blinded Treatment Period|Physician Decision|3|||
145416702|NCT00669331|524381810|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
145416703|NCT00669331|524381811|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
145416704|NCT01454063|524381812|FG000|Randomized|Adverse Event|1|||
145416705|NCT01454063|524381813|FG001|Randomized|Adverse Event|1|||
145577299|NCT01109316|524968049|FG005|Study Period 1|Withdrawal by Subject|0|||
145577300|NCT01109316|524968044|FG000|Study Period 1|Sponsor Decision|0|||
145353532|NCT01478373|524143315|FG000|Survival Phase|Protocol Violation|1|||
145353533|NCT01478373|524143315|FG000|Survival Phase|crossover to another study|2|||
145353534|NCT01478373|524143315|FG000|Survival Phase|Progressive Disease|27|||
145353535|NCT00725920|524143317|FG000|Overall Study|Lack of Efficacy|3|||
145353536|NCT00725920|524143318|FG001|Overall Study|Lack of Efficacy|6|||
145353537|NCT02456740|524143319|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145353538|NCT02456740|524143320|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145353539|NCT02456740|524143321|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
145353540|NCT02456740|524143322|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353541|NCT02456740|524143323|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353542|NCT02456740|524143324|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353543|NCT02456740|524143325|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353544|NCT02456740|524143326|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353545|NCT02456740|524143327|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
145353546|NCT02456740|524143319|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
145353547|NCT02456740|524143320|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
145353548|NCT02456740|524143321|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
145353549|NCT02456740|524143322|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353550|NCT02456740|524143323|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353551|NCT02456740|524143324|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353552|NCT02456740|524143325|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353553|NCT02456740|524143326|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353554|NCT02456740|524143327|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
145353555|NCT02456740|524143319|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
145353556|NCT02456740|524143320|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
145353557|NCT02456740|524143321|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
145353558|NCT02456740|524143322|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353559|NCT02456740|524143323|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353560|NCT02456740|524143324|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353561|NCT02456740|524143325|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353562|NCT02456740|524143326|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353563|NCT02456740|524143327|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
145353564|NCT02456740|524143319|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353565|NCT02456740|524143320|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353566|NCT02456740|524143321|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353567|NCT02456740|524143322|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
145353568|NCT02456740|524143323|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
145353569|NCT02456740|524143324|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353570|NCT02456740|524143325|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353571|NCT02456740|524143326|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
145353572|NCT02456740|524143327|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
145353573|NCT02456740|524143319|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145353574|NCT02456740|524143320|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145353575|NCT02456740|524143321|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145353576|NCT02456740|524143322|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
145353577|NCT02456740|524143323|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
145353578|NCT02456740|524143324|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
145353579|NCT02456740|524143325|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
145353580|NCT02456740|524143326|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
145353581|NCT02456740|524143327|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
145353582|NCT02456740|524143319|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353583|NCT02456740|524143320|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353584|NCT02456740|524143321|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353585|NCT02456740|524143322|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353586|NCT02456740|524143323|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353587|NCT02456740|524143324|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353588|NCT02456740|524143325|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353589|NCT02456740|524143326|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
145353590|NCT02456740|524143327|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
145353591|NCT02456740|524143319|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145353592|NCT02456740|524143320|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145353593|NCT02456740|524143321|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145353594|NCT02456740|524143322|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
145353595|NCT02456740|524143323|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
145353596|NCT02456740|524143324|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
145353597|NCT02456740|524143325|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
145353598|NCT02456740|524143326|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
145353599|NCT02456740|524143327|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
145353600|NCT02623725|524143328|FG000|Overall Study|Non compliance with protocol|9|||
145353601|NCT02623725|524143329|FG001|Overall Study|Non compliance with protocol|3|||
145353602|NCT02623725|524143328|FG000|Overall Study|Serious adverse event|0|||
145353603|NCT02623725|524143329|FG001|Overall Study|Serious adverse event|2|||
145353604|NCT02623725|524143328|FG000|Overall Study|Withdrawal by Subject|7|||
145353605|NCT02623725|524143329|FG001|Overall Study|Withdrawal by Subject|1|||
145353606|NCT00752128|524143332|FG000|Overall Study|Withdrawal by Subject|4|||
145353607|NCT02286713|524143333|FG000|One Week Follow-Up|Death|1|||
145353608|NCT02286713|524143334|FG001|One Week Follow-Up|Death|0|||
145353609|NCT02286713|524143333|FG000|One Week Follow-Up|Lost to Follow-up|17|||
145353610|NCT02286713|524143334|FG001|One Week Follow-Up|Lost to Follow-up|21|||
145353611|NCT02286713|524143333|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
145353612|NCT02286713|524143334|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
145353613|NCT02286713|524143333|FG000|Three Month Follow-Up|Death|1|||
145353614|NCT02286713|524143334|FG001|Three Month Follow-Up|Death|1|||
145353615|NCT02286713|524143333|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
145353616|NCT02286713|524143334|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
145353617|NCT02286713|524143333|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
145353618|NCT02286713|524143334|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
145353619|NCT02286713|524143333|FG000|Six Month Follow-Up|Death|2|||
145353620|NCT02286713|524143334|FG001|Six Month Follow-Up|Death|0|||
145353621|NCT02286713|524143333|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
145353622|NCT02286713|524143334|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
145353623|NCT02654054|524143335|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
145353624|NCT02654054|524143336|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
145353625|NCT02654054|524143337|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
145353626|NCT02654054|524143335|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145353627|NCT02654054|524143336|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
145353628|NCT02654054|524143337|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
145353629|NCT02654054|524143335|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145353630|NCT02654054|524143336|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145353631|NCT02654054|524143337|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
145353632|NCT02654054|524143335|FG000|Post-Treatment Follow-Up Period|Other|1|||
145353633|NCT02654054|524143336|FG001|Post-Treatment Follow-Up Period|Other|0|||
145353634|NCT02654054|524143337|FG002|Post-Treatment Follow-Up Period|Other|4|||
145353635|NCT02654054|524143335|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145353636|NCT02654054|524143336|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145353637|NCT02654054|524143337|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
145353638|NCT02325973|524145414|FG000|Overall Study|Death|5|||
145353639|NCT02325973|524145414|FG000|Overall Study|Withdrawal by subject or investigator|16|||
145353640|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
145353641|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145353642|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145353643|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
145353644|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
145353645|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145353646|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145353647|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
145353648|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
145353649|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145353650|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145353651|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
145353652|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
145353653|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145353654|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145353655|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
145353656|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
145353657|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145353658|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145416706|NCT01454063|524381812|FG000|Randomized|Protocol Violation|0|||
145577301|NCT01109316|524968045|FG001|Study Period 1|Sponsor Decision|0|||
145577302|NCT01109316|524968046|FG002|Study Period 1|Sponsor Decision|0|||
145353659|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
145353660|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
145353661|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145353662|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145353663|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
145353664|NCT02513160|524145415|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
145353665|NCT02513160|524145416|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145353666|NCT02513160|524145417|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145353667|NCT02513160|524145418|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
145353668|NCT02513160|524145415|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
145353669|NCT02513160|524145416|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
145353670|NCT02513160|524145417|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
145353671|NCT02513160|524145418|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
145353672|NCT02513160|524145415|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
145353673|NCT02513160|524145416|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145353674|NCT02513160|524145417|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145353675|NCT02513160|524145418|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
145353676|NCT02513160|524145415|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
145353677|NCT02513160|524145416|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
145353678|NCT02513160|524145417|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
145353679|NCT02513160|524145418|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
145353680|NCT02513160|524145415|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
145353681|NCT02513160|524145416|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145353682|NCT02513160|524145417|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145353683|NCT02513160|524145418|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
145353684|NCT02513160|524145415|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145353685|NCT02513160|524145416|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
145353686|NCT02513160|524145417|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145353687|NCT02513160|524145418|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
145353688|NCT02861586|524145422|FG000|Overall Study|Withdrawal by Subject|1|||
145353689|NCT02861586|524145423|FG001|Overall Study|Withdrawal by Subject|2|||
145353690|NCT02861586|524145424|FG002|Overall Study|Withdrawal by Subject|0|||
145353691|NCT02861586|524145425|FG003|Overall Study|Withdrawal by Subject|0|||
145353692|NCT02861586|524145426|FG004|Overall Study|Withdrawal by Subject|0|||
145353693|NCT02861586|524145427|FG005|Overall Study|Withdrawal by Subject|1|||
145353694|NCT02861586|524145428|FG006|Overall Study|Withdrawal by Subject|1|||
145353695|NCT02861586|524145429|FG007|Overall Study|Withdrawal by Subject|0|||
145353696|NCT02861586|524145422|FG000|Overall Study|Lost to Follow-up|3|||
145353697|NCT02861586|524145423|FG001|Overall Study|Lost to Follow-up|1|||
145353698|NCT02861586|524145424|FG002|Overall Study|Lost to Follow-up|1|||
145353699|NCT02861586|524145425|FG003|Overall Study|Lost to Follow-up|0|||
145353700|NCT02861586|524145426|FG004|Overall Study|Lost to Follow-up|0|||
145353701|NCT02861586|524145427|FG005|Overall Study|Lost to Follow-up|3|||
145353702|NCT02861586|524145428|FG006|Overall Study|Lost to Follow-up|0|||
145353703|NCT02861586|524145429|FG007|Overall Study|Lost to Follow-up|0|||
145353704|NCT02861586|524145422|FG000|Overall Study|Adverse Event|0|||
145353705|NCT02861586|524145423|FG001|Overall Study|Adverse Event|0|||
145353706|NCT02861586|524145424|FG002|Overall Study|Adverse Event|0|||
145353707|NCT02861586|524145425|FG003|Overall Study|Adverse Event|0|||
145353708|NCT02861586|524145426|FG004|Overall Study|Adverse Event|0|||
145353709|NCT02861586|524145427|FG005|Overall Study|Adverse Event|1|||
145353710|NCT02861586|524145428|FG006|Overall Study|Adverse Event|0|||
145353711|NCT02861586|524145429|FG007|Overall Study|Adverse Event|0|||
145353712|NCT03428958|524145430|FG000|Overall Study|Adverse Event|0|||
145353713|NCT03428958|524145431|FG001|Overall Study|Adverse Event|0|||
145353714|NCT03428958|524145432|FG002|Overall Study|Adverse Event|0|||
145353715|NCT03428958|524145433|FG003|Overall Study|Adverse Event|1|||
145353716|NCT03428958|524145434|FG004|Overall Study|Adverse Event|0|||
145353717|NCT03428958|524145435|FG005|Overall Study|Adverse Event|2|||
145353718|NCT03428958|524145436|FG006|Overall Study|Adverse Event|1|||
145353719|NCT03428958|524145437|FG007|Overall Study|Adverse Event|0|||
145353720|NCT03428958|524145438|FG008|Overall Study|Adverse Event|0|||
145353721|NCT03428958|524145439|FG009|Overall Study|Adverse Event|0|||
145353722|NCT03428958|524145440|FG010|Overall Study|Adverse Event|0|||
145353723|NCT03428958|524145441|FG011|Overall Study|Adverse Event|0|||
145353724|NCT03428958|524145442|FG012|Overall Study|Adverse Event|0|||
145353725|NCT03428958|524145443|FG013|Overall Study|Adverse Event|0|||
145353726|NCT03428958|524145444|FG014|Overall Study|Adverse Event|0|||
145353727|NCT03428958|524145445|FG015|Overall Study|Adverse Event|0|||
145622944|NCT01256476|525131526|FG000|Overall Study|Withdrawal by Subject|2|||
145353728|NCT03428958|524145446|FG016|Overall Study|Adverse Event|0|||
145353729|NCT03428958|524145430|FG000|Overall Study|Clinical Progression|2|||
145353730|NCT03428958|524145431|FG001|Overall Study|Clinical Progression|3|||
145353731|NCT03428958|524145432|FG002|Overall Study|Clinical Progression|2|||
145353732|NCT03428958|524145433|FG003|Overall Study|Clinical Progression|1|||
145622945|NCT01256476|525131527|FG001|Overall Study|Withdrawal by Subject|1|||
145353733|NCT03428958|524145434|FG004|Overall Study|Clinical Progression|0|||
145353734|NCT03428958|524145435|FG005|Overall Study|Clinical Progression|2|||
145353735|NCT03428958|524145436|FG006|Overall Study|Clinical Progression|0|||
145353736|NCT03428958|524145437|FG007|Overall Study|Clinical Progression|0|||
145353737|NCT03428958|524145438|FG008|Overall Study|Clinical Progression|0|||
145353738|NCT03428958|524145439|FG009|Overall Study|Clinical Progression|0|||
145353739|NCT03428958|524145440|FG010|Overall Study|Clinical Progression|0|||
145353740|NCT03428958|524145441|FG011|Overall Study|Clinical Progression|0|||
145353741|NCT03428958|524145442|FG012|Overall Study|Clinical Progression|0|||
145353742|NCT03428958|524145443|FG013|Overall Study|Clinical Progression|0|||
145353743|NCT03428958|524145444|FG014|Overall Study|Clinical Progression|0|||
145353744|NCT03428958|524145445|FG015|Overall Study|Clinical Progression|0|||
145353745|NCT03428958|524145446|FG016|Overall Study|Clinical Progression|0|||
145353746|NCT03428958|524145430|FG000|Overall Study|Progression per RECIST|6|||
145353747|NCT03428958|524145431|FG001|Overall Study|Progression per RECIST|6|||
145353748|NCT03428958|524145432|FG002|Overall Study|Progression per RECIST|7|||
145353749|NCT03428958|524145433|FG003|Overall Study|Progression per RECIST|4|||
145353750|NCT03428958|524145434|FG004|Overall Study|Progression per RECIST|0|||
145353751|NCT03428958|524145435|FG005|Overall Study|Progression per RECIST|7|||
145353752|NCT03428958|524145436|FG006|Overall Study|Progression per RECIST|8|||
145353753|NCT03428958|524145437|FG007|Overall Study|Progression per RECIST|0|||
145353754|NCT03428958|524145438|FG008|Overall Study|Progression per RECIST|0|||
145353755|NCT03428958|524145439|FG009|Overall Study|Progression per RECIST|0|||
145353756|NCT03428958|524145440|FG010|Overall Study|Progression per RECIST|0|||
145353757|NCT03428958|524145441|FG011|Overall Study|Progression per RECIST|0|||
145353758|NCT03428958|524145442|FG012|Overall Study|Progression per RECIST|1|||
145353759|NCT03428958|524145443|FG013|Overall Study|Progression per RECIST|0|||
145353760|NCT03428958|524145444|FG014|Overall Study|Progression per RECIST|0|||
145353761|NCT03428958|524145445|FG015|Overall Study|Progression per RECIST|0|||
145353762|NCT03428958|524145446|FG016|Overall Study|Progression per RECIST|0|||
145353763|NCT03428958|524145430|FG000|Overall Study|Death|2|||
145353764|NCT03428958|524145431|FG001|Overall Study|Death|2|||
145353765|NCT03428958|524145432|FG002|Overall Study|Death|0|||
145353766|NCT03428958|524145433|FG003|Overall Study|Death|0|||
145353767|NCT03428958|524145434|FG004|Overall Study|Death|0|||
145353768|NCT03428958|524145435|FG005|Overall Study|Death|7|||
145353769|NCT03428958|524145436|FG006|Overall Study|Death|9|||
145353770|NCT03428958|524145437|FG007|Overall Study|Death|6|||
145353771|NCT03428958|524145438|FG008|Overall Study|Death|0|||
145353772|NCT03428958|524145439|FG009|Overall Study|Death|0|||
145353773|NCT03428958|524145440|FG010|Overall Study|Death|3|||
145353774|NCT03428958|524145441|FG011|Overall Study|Death|0|||
145353775|NCT03428958|524145442|FG012|Overall Study|Death|4|||
145353776|NCT03428958|524145443|FG013|Overall Study|Death|0|||
145353777|NCT03428958|524145444|FG014|Overall Study|Death|0|||
145353778|NCT03428958|524145445|FG015|Overall Study|Death|0|||
145353779|NCT03428958|524145446|FG016|Overall Study|Death|0|||
145353780|NCT03428958|524145430|FG000|Overall Study|Lost to Follow-up|0|||
145353781|NCT03428958|524145431|FG001|Overall Study|Lost to Follow-up|0|||
145353782|NCT03428958|524145432|FG002|Overall Study|Lost to Follow-up|0|||
145353783|NCT03428958|524145433|FG003|Overall Study|Lost to Follow-up|0|||
145353784|NCT03428958|524145434|FG004|Overall Study|Lost to Follow-up|0|||
145353785|NCT03428958|524145435|FG005|Overall Study|Lost to Follow-up|1|||
145353786|NCT03428958|524145436|FG006|Overall Study|Lost to Follow-up|1|||
145353787|NCT03428958|524145437|FG007|Overall Study|Lost to Follow-up|0|||
145353788|NCT03428958|524145438|FG008|Overall Study|Lost to Follow-up|0|||
145353789|NCT03428958|524145439|FG009|Overall Study|Lost to Follow-up|0|||
145353790|NCT03428958|524145440|FG010|Overall Study|Lost to Follow-up|0|||
145353791|NCT03428958|524145441|FG011|Overall Study|Lost to Follow-up|0|||
145353792|NCT03428958|524145442|FG012|Overall Study|Lost to Follow-up|0|||
145353793|NCT03428958|524145443|FG013|Overall Study|Lost to Follow-up|0|||
145353794|NCT03428958|524145444|FG014|Overall Study|Lost to Follow-up|0|||
145353795|NCT03428958|524145445|FG015|Overall Study|Lost to Follow-up|0|||
145353796|NCT03428958|524145446|FG016|Overall Study|Lost to Follow-up|0|||
145353797|NCT03428958|524145430|FG000|Overall Study|Physician/Sponsor Decision|1|||
145353798|NCT03428958|524145431|FG001|Overall Study|Physician/Sponsor Decision|0|||
145353799|NCT03428958|524145432|FG002|Overall Study|Physician/Sponsor Decision|1|||
145353800|NCT03428958|524145433|FG003|Overall Study|Physician/Sponsor Decision|0|||
145353801|NCT03428958|524145434|FG004|Overall Study|Physician/Sponsor Decision|0|||
145416707|NCT01454063|524381813|FG001|Randomized|Protocol Violation|1|||
145416708|NCT00509600|524381817|FG000|Overall Study|Adverse Event|1|||
145353802|NCT03428958|524145435|FG005|Overall Study|Physician/Sponsor Decision|2|||
145353803|NCT03428958|524145436|FG006|Overall Study|Physician/Sponsor Decision|2|||
145353804|NCT03428958|524145437|FG007|Overall Study|Physician/Sponsor Decision|2|||
145353805|NCT03428958|524145438|FG008|Overall Study|Physician/Sponsor Decision|0|||
145353806|NCT03428958|524145439|FG009|Overall Study|Physician/Sponsor Decision|0|||
145353807|NCT03428958|524145440|FG010|Overall Study|Physician/Sponsor Decision|2|||
145353808|NCT03428958|524145441|FG011|Overall Study|Physician/Sponsor Decision|0|||
145416709|NCT02568423|524381818|FG000|Overall Study|Lost to Follow-up|0|||
145416710|NCT02568423|524381819|FG001|Overall Study|Lost to Follow-up|2|||
145416711|NCT02568423|524381820|FG002|Overall Study|Lost to Follow-up|0|||
145416712|NCT02568423|524381821|FG003|Overall Study|Lost to Follow-up|0|||
145416713|NCT02568423|524381822|FG004|Overall Study|Lost to Follow-up|0|||
145416714|NCT02568423|524381823|FG005|Overall Study|Lost to Follow-up|0|||
145416715|NCT02568423|524381824|FG006|Overall Study|Lost to Follow-up|0|||
145416716|NCT02568423|524381825|FG007|Overall Study|Lost to Follow-up|0|||
145416717|NCT02568423|524381818|FG000|Overall Study|Physician Decision|0|||
145416718|NCT02568423|524381819|FG001|Overall Study|Physician Decision|0|||
145416719|NCT02568423|524381820|FG002|Overall Study|Physician Decision|0|||
145416720|NCT02568423|524381821|FG003|Overall Study|Physician Decision|0|||
145416721|NCT02568423|524381822|FG004|Overall Study|Physician Decision|0|||
145416722|NCT02568423|524381823|FG005|Overall Study|Physician Decision|1|||
145416723|NCT02568423|524381824|FG006|Overall Study|Physician Decision|0|||
145416724|NCT02568423|524381825|FG007|Overall Study|Physician Decision|0|||
145416725|NCT03794544|524381828|FG000|Overall Study|Withdrawal by Subject|1|||
145353809|NCT03428958|524145442|FG012|Overall Study|Physician/Sponsor Decision|4|||
145353810|NCT03428958|524145443|FG013|Overall Study|Physician/Sponsor Decision|0|||
145353811|NCT03428958|524145444|FG014|Overall Study|Physician/Sponsor Decision|0|||
145353812|NCT03428958|524145445|FG015|Overall Study|Physician/Sponsor Decision|0|||
145416726|NCT03794544|524381829|FG001|Overall Study|Withdrawal by Subject|1|||
145416727|NCT03794544|524381830|FG002|Overall Study|Withdrawal by Subject|0|||
145416728|NCT03794544|524381831|FG003|Overall Study|Withdrawal by Subject|0|||
145416729|NCT03794544|524381828|FG000|Overall Study|Death|0|||
145416730|NCT03794544|524381829|FG001|Overall Study|Death|0|||
145416731|NCT03794544|524381830|FG002|Overall Study|Death|0|||
145416732|NCT03794544|524381831|FG003|Overall Study|Death|1|||
145416733|NCT03794544|524381828|FG000|Overall Study|Lost to Follow-up|0|||
145416734|NCT03794544|524381829|FG001|Overall Study|Lost to Follow-up|1|||
145416735|NCT03794544|524381830|FG002|Overall Study|Lost to Follow-up|1|||
145416736|NCT03794544|524381831|FG003|Overall Study|Lost to Follow-up|0|||
145416737|NCT03794544|524381828|FG000|Overall Study|Other|0|||
145416738|NCT03794544|524381829|FG001|Overall Study|Other|1|||
145416739|NCT03794544|524381830|FG002|Overall Study|Other|0|||
145416740|NCT03794544|524381831|FG003|Overall Study|Other|0|||
145416741|NCT01027416|524381832|FG000|Overall Study|Withdrawal by Subject|0|||
145416742|NCT01027416|524381833|FG001|Overall Study|Withdrawal by Subject|1|||
145416743|NCT01027416|524381832|FG000|Overall Study|Physician Decision|1|||
145416744|NCT01027416|524381833|FG001|Overall Study|Physician Decision|4|||
145416745|NCT00120250|524381834|FG000|Overall Study|Lost to Follow-up|1|||
145416746|NCT00120250|524381835|FG001|Overall Study|Lost to Follow-up|1|||
145416747|NCT00120250|524381834|FG000|Overall Study|Protocol Violation|0|||
145416748|NCT00120250|524381835|FG001|Overall Study|Protocol Violation|1|||
145416749|NCT00720083|524381836|FG000|Overall Study|Ineligible|1|||
145416750|NCT00720083|524381837|FG001|Overall Study|Ineligible|2|||
145416751|NCT02056288|524381838|FG000|In-Hospital Data|Surgery cancelled|1|||
145416752|NCT02056288|524381839|FG001|In-Hospital Data|Surgery cancelled|0|||
145416753|NCT02056288|524381838|FG000|In-Hospital Data|Protocol Violation|3|||
145416754|NCT02056288|524381839|FG001|In-Hospital Data|Protocol Violation|0|||
145416755|NCT02056288|524381838|FG000|In-Hospital Data|Physician Decision|1|||
145416756|NCT02056288|524381839|FG001|In-Hospital Data|Physician Decision|0|||
145416757|NCT02056288|524381838|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
145416758|NCT02056288|524381839|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
145416759|NCT01433978|524381840|FG000|Core Study|Adverse Event, Non-Fatal|0|||
145416760|NCT01433978|524381841|FG001|Core Study|Adverse Event, Non-Fatal|1|||
145416761|NCT01433978|524381842|FG002|Core Study|Adverse Event, Non-Fatal|0|||
145416762|NCT01433978|524381840|FG000|Core Study|Lack of Efficacy|5|||
145577303|NCT01109316|524968047|FG003|Study Period 1|Sponsor Decision|0|||
145577304|NCT01109316|524968048|FG004|Study Period 1|Sponsor Decision|0|||
145577305|NCT01109316|524968049|FG005|Study Period 1|Sponsor Decision|2|||
145353813|NCT03428958|524145446|FG016|Overall Study|Physician/Sponsor Decision|0|||
145353814|NCT03428958|524145430|FG000|Overall Study|Withdrawal by Subject|0|||
145353815|NCT03428958|524145431|FG001|Overall Study|Withdrawal by Subject|0|||
145353816|NCT03428958|524145432|FG002|Overall Study|Withdrawal by Subject|2|||
145353817|NCT03428958|524145433|FG003|Overall Study|Withdrawal by Subject|0|||
145353818|NCT03428958|524145434|FG004|Overall Study|Withdrawal by Subject|0|||
145353819|NCT03428958|524145435|FG005|Overall Study|Withdrawal by Subject|2|||
145353820|NCT03428958|524145436|FG006|Overall Study|Withdrawal by Subject|4|||
145353821|NCT03428958|524145437|FG007|Overall Study|Withdrawal by Subject|1|||
145353822|NCT03428958|524145438|FG008|Overall Study|Withdrawal by Subject|0|||
145353823|NCT03428958|524145439|FG009|Overall Study|Withdrawal by Subject|0|||
145353824|NCT03428958|524145440|FG010|Overall Study|Withdrawal by Subject|0|||
145353825|NCT03428958|524145441|FG011|Overall Study|Withdrawal by Subject|0|||
145353826|NCT03428958|524145442|FG012|Overall Study|Withdrawal by Subject|0|||
145353827|NCT03428958|524145443|FG013|Overall Study|Withdrawal by Subject|0|||
145416763|NCT01433978|524381841|FG001|Core Study|Lack of Efficacy|1|||
145416764|NCT01433978|524381842|FG002|Core Study|Lack of Efficacy|0|||
145416765|NCT01433978|524381840|FG000|Core Study|Study Terminated by Sponsor|6|||
145416766|NCT01433978|524381841|FG001|Core Study|Study Terminated by Sponsor|9|||
145353828|NCT03428958|524145444|FG014|Overall Study|Withdrawal by Subject|0|||
145353829|NCT03428958|524145445|FG015|Overall Study|Withdrawal by Subject|0|||
145353830|NCT03428958|524145446|FG016|Overall Study|Withdrawal by Subject|0|||
145353831|NCT03874117|524145447|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
145353832|NCT03874117|524145448|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
145353833|NCT03874117|524145447|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
145353834|NCT03874117|524145448|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
145353835|NCT03874117|524145447|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145353836|NCT03874117|524145448|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145353837|NCT03874117|524145447|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
145353838|NCT03874117|524145448|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
145353839|NCT03874117|524145447|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145353840|NCT03874117|524145448|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145353841|NCT05012098|524145449|FG000|Overall Study|Disease progression|5|||
145353842|NCT05012098|524145450|FG001|Overall Study|Disease progression|2|||
145353843|NCT05012098|524145449|FG000|Overall Study|Adverse Event|1|||
145353844|NCT05012098|524145450|FG001|Overall Study|Adverse Event|0|||
145353845|NCT05012098|524145449|FG000|Overall Study|Withdrawal by Subject|1|||
145353846|NCT05012098|524145450|FG001|Overall Study|Withdrawal by Subject|0|||
145353847|NCT05012098|524145449|FG000|Overall Study|Discontinuation per protocol|1|||
145353848|NCT05012098|524145450|FG001|Overall Study|Discontinuation per protocol|0|||
145353849|NCT05258773|524145451|FG000|Overall Study|Screen Failure|1|||
145353850|NCT05258773|524145452|FG001|Overall Study|Screen Failure|1|||
145353851|NCT05258773|524145451|FG000|Overall Study|Adverse Event|1|||
145353852|NCT05258773|524145452|FG001|Overall Study|Adverse Event|0|||
145353853|NCT05258773|524145451|FG000|Overall Study|Withdrawal by Subject|0|||
145353854|NCT05258773|524145452|FG001|Overall Study|Withdrawal by Subject|1|||
145353855|NCT03018288|524145453|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
145353856|NCT03018288|524145454|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
145353857|NCT03018288|524145455|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
145353858|NCT03018288|524145456|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
145353859|NCT03018288|524145453|FG000|Overall Study|Participant withdrew consent.|0|||
145353860|NCT03018288|524145454|FG001|Overall Study|Participant withdrew consent.|0|||
145353861|NCT03018288|524145455|FG002|Overall Study|Participant withdrew consent.|1|||
145353862|NCT03018288|524145456|FG003|Overall Study|Participant withdrew consent.|0|||
145353863|NCT03018288|524145453|FG000|Overall Study|Switched to alternative treatment.|0|||
145353864|NCT03018288|524145454|FG001|Overall Study|Switched to alternative treatment.|0|||
145353865|NCT03018288|524145455|FG002|Overall Study|Switched to alternative treatment.|1|||
145353866|NCT03018288|524145456|FG003|Overall Study|Switched to alternative treatment.|0|||
145353867|NCT03018288|524145453|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
145353868|NCT03018288|524145454|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
145353869|NCT03018288|524145455|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
145353870|NCT03018288|524145456|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
145353871|NCT03018288|524145453|FG000|Overall Study|Screen failures|0|||
145353872|NCT03018288|524145454|FG001|Overall Study|Screen failures|0|||
145353873|NCT03018288|524145455|FG002|Overall Study|Screen failures|0|||
145353874|NCT03018288|524145456|FG003|Overall Study|Screen failures|51|||
145353875|NCT03018288|524145453|FG000|Overall Study|Chose treatment outside of UNC|0|||
145353876|NCT03018288|524145454|FG001|Overall Study|Chose treatment outside of UNC|0|||
145353877|NCT03018288|524145455|FG002|Overall Study|Chose treatment outside of UNC|0|||
145353878|NCT03018288|524145456|FG003|Overall Study|Chose treatment outside of UNC|1|||
145353879|NCT03018288|524145453|FG000|Overall Study|Unable to comply with protocol requirements|1|||
145353880|NCT03018288|524145454|FG001|Overall Study|Unable to comply with protocol requirements|1|||
145353881|NCT03018288|524145455|FG002|Overall Study|Unable to comply with protocol requirements|0|||
145353882|NCT03018288|524145456|FG003|Overall Study|Unable to comply with protocol requirements|1|||
145353883|NCT03018288|524145453|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
145353884|NCT03018288|524145454|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
145353885|NCT03018288|524145455|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
145353886|NCT03018288|524145456|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
145353887|NCT03018288|524145453|FG000|Overall Study|Physician Decision|0|||
145353888|NCT03018288|524145454|FG001|Overall Study|Physician Decision|0|||
145353889|NCT03018288|524145455|FG002|Overall Study|Physician Decision|0|||
145353890|NCT03018288|524145456|FG003|Overall Study|Physician Decision|1|||
145353891|NCT01490086|524145460|FG000|Overall Study|Consent withdrawn|4|||
145353892|NCT01490086|524145461|FG001|Overall Study|Consent withdrawn|4|||
145353893|NCT01490086|524145462|FG002|Overall Study|Consent withdrawn|3|||
145353894|NCT01490086|524145463|FG003|Overall Study|Consent withdrawn|0|||
145353895|NCT01490086|524145464|FG004|Overall Study|Consent withdrawn|1|||
145353896|NCT01490086|524145460|FG000|Overall Study|Non-compliance|0|||
145353897|NCT01490086|524145461|FG001|Overall Study|Non-compliance|1|||
145353898|NCT01490086|524145462|FG002|Overall Study|Non-compliance|0|||
145353899|NCT01490086|524145463|FG003|Overall Study|Non-compliance|0|||
145353900|NCT01490086|524145464|FG004|Overall Study|Non-compliance|0|||
145353901|NCT01490086|524145460|FG000|Overall Study|Abnormal laboratory findings|1|||
145353902|NCT01490086|524145461|FG001|Overall Study|Abnormal laboratory findings|0|||
145353903|NCT01490086|524145462|FG002|Overall Study|Abnormal laboratory findings|0|||
145353904|NCT01490086|524145463|FG003|Overall Study|Abnormal laboratory findings|0|||
145353905|NCT01490086|524145464|FG004|Overall Study|Abnormal laboratory findings|0|||
145353906|NCT01490086|524145460|FG000|Overall Study|Lost to Follow-up|0|||
145353907|NCT01490086|524145461|FG001|Overall Study|Lost to Follow-up|0|||
145353908|NCT01490086|524145462|FG002|Overall Study|Lost to Follow-up|0|||
145353909|NCT01490086|524145463|FG003|Overall Study|Lost to Follow-up|0|||
145353910|NCT01490086|524145464|FG004|Overall Study|Lost to Follow-up|1|||
145353911|NCT01490086|524145460|FG000|Overall Study|Physician Decision|3|||
145353912|NCT01490086|524145461|FG001|Overall Study|Physician Decision|4|||
145353913|NCT01490086|524145462|FG002|Overall Study|Physician Decision|2|||
145353914|NCT01490086|524145463|FG003|Overall Study|Physician Decision|3|||
145353915|NCT01490086|524145464|FG004|Overall Study|Physician Decision|1|||
145353916|NCT01490086|524145460|FG000|Overall Study|Adverse Event|0|||
145353917|NCT01490086|524145461|FG001|Overall Study|Adverse Event|0|||
145353918|NCT01490086|524145462|FG002|Overall Study|Adverse Event|1|||
145353919|NCT01490086|524145463|FG003|Overall Study|Adverse Event|2|||
145353920|NCT01490086|524145464|FG004|Overall Study|Adverse Event|0|||
145353921|NCT01490086|524145460|FG000|Overall Study|Lack of Efficacy|0|||
145353922|NCT01490086|524145461|FG001|Overall Study|Lack of Efficacy|3|||
145353923|NCT01490086|524145462|FG002|Overall Study|Lack of Efficacy|1|||
145353924|NCT01490086|524145463|FG003|Overall Study|Lack of Efficacy|0|||
145353925|NCT01490086|524145464|FG004|Overall Study|Lack of Efficacy|8|||
145353926|NCT01490086|524145460|FG000|Overall Study|Worsening of symptoms|0|||
145353927|NCT01490086|524145461|FG001|Overall Study|Worsening of symptoms|1|||
145353928|NCT01490086|524145462|FG002|Overall Study|Worsening of symptoms|0|||
145353929|NCT01490086|524145463|FG003|Overall Study|Worsening of symptoms|1|||
145353930|NCT01490086|524145464|FG004|Overall Study|Worsening of symptoms|0|||
145353931|NCT01490086|524145460|FG000|Overall Study|Subject uncontrollable and abusive|0|||
145353932|NCT01490086|524145461|FG001|Overall Study|Subject uncontrollable and abusive|1|||
145353933|NCT01490086|524145462|FG002|Overall Study|Subject uncontrollable and abusive|0|||
145353934|NCT01490086|524145463|FG003|Overall Study|Subject uncontrollable and abusive|0|||
145353935|NCT01490086|524145464|FG004|Overall Study|Subject uncontrollable and abusive|0|||
145353936|NCT01490086|524145460|FG000|Overall Study|Subject left hospital|0|||
145353937|NCT01490086|524145461|FG001|Overall Study|Subject left hospital|1|||
145353938|NCT01490086|524145462|FG002|Overall Study|Subject left hospital|0|||
145353939|NCT01490086|524145463|FG003|Overall Study|Subject left hospital|1|||
145353940|NCT01490086|524145464|FG004|Overall Study|Subject left hospital|0|||
145353941|NCT01922037|524145465|FG000|Overall Study|Withdrawal by Subject|2|||
145353942|NCT01922037|524145466|FG001|Overall Study|Withdrawal by Subject|44|||
145353943|NCT01922037|524145465|FG000|Overall Study|Adverse Event|1|||
145353944|NCT01922037|524145466|FG001|Overall Study|Adverse Event|7|||
145353945|NCT01922037|524145465|FG000|Overall Study|Death|0|||
145353946|NCT01922037|524145466|FG001|Overall Study|Death|5|||
145353947|NCT01922037|524145465|FG000|Overall Study|Pregnancy|0|||
145353948|NCT01922037|524145466|FG001|Overall Study|Pregnancy|2|||
145353949|NCT01922037|524145465|FG000|Overall Study|Participant non-compliance|4|||
145353950|NCT01922037|524145466|FG001|Overall Study|Participant non-compliance|46|||
145353951|NCT01922037|524145465|FG000|Overall Study|Investigator/Sponsor decision|1|||
145353952|NCT01922037|524145466|FG001|Overall Study|Investigator/Sponsor decision|4|||
145353953|NCT01922037|524145465|FG000|Overall Study|Other unspecified|2|||
145353954|NCT01922037|524145466|FG001|Overall Study|Other unspecified|66|||
145353955|NCT00679211|524145467|FG000|Overall Study|Progressive disease|82|||
145353956|NCT00679211|524145467|FG000|Overall Study|Adverse Event|7|||
145353957|NCT00679211|524145467|FG000|Overall Study|Withdrawal by Subject|2|||
145353958|NCT00679211|524145467|FG000|Overall Study|Physician Decision|5|||
145353959|NCT00679211|524145467|FG000|Overall Study|Refused to undergo protocol procedures|1|||
145353960|NCT00679211|524145467|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
145353961|NCT00679211|524145467|FG000|Overall Study|Other|1|||
145353962|NCT03103087|524145470|FG000|Overall Study|Did not receive any study drug|1|||
145353963|NCT03103087|524145471|FG001|Overall Study|Did not receive any study drug|0|||
145353964|NCT03103087|524145472|FG002|Overall Study|Did not receive any study drug|0|||
145353965|NCT03103087|524145470|FG000|Overall Study|Protocol Violation|1|||
145353966|NCT03103087|524145471|FG001|Overall Study|Protocol Violation|2|||
145353967|NCT03103087|524145472|FG002|Overall Study|Protocol Violation|1|||
145353968|NCT03103087|524145470|FG000|Overall Study|Lack of Efficacy|2|||
145353969|NCT03103087|524145471|FG001|Overall Study|Lack of Efficacy|1|||
145353970|NCT03103087|524145472|FG002|Overall Study|Lack of Efficacy|1|||
145353971|NCT03103087|524145470|FG000|Overall Study|Pregnancy|0|||
145353972|NCT03103087|524145471|FG001|Overall Study|Pregnancy|0|||
145353973|NCT03103087|524145472|FG002|Overall Study|Pregnancy|1|||
145353974|NCT03103087|524145470|FG000|Overall Study|Adverse Event|2|||
145353975|NCT03103087|524145471|FG001|Overall Study|Adverse Event|15|||
145416767|NCT01433978|524381842|FG002|Core Study|Study Terminated by Sponsor|0|||
145416768|NCT01433978|524381840|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
145416769|NCT01433978|524381841|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
145416770|NCT01433978|524381842|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
145416771|NCT01433978|524381840|FG000|Extension Phase|Lack of Efficacy|0|||
145416772|NCT01433978|524381841|FG001|Extension Phase|Lack of Efficacy|0|||
145416773|NCT01433978|524381842|FG002|Extension Phase|Lack of Efficacy|1|||
145416774|NCT01433978|524381840|FG000|Extension Phase|Study Terminated by Sponsor|0|||
145416775|NCT01433978|524381841|FG001|Extension Phase|Study Terminated by Sponsor|0|||
145416776|NCT01433978|524381842|FG002|Extension Phase|Study Terminated by Sponsor|4|||
145416777|NCT01441414|524381843|FG000|Overall Study|Participant died|9|||
145416778|NCT01441414|524381843|FG000|Overall Study|Other reasons|3|||
145416779|NCT01441414|524381843|FG000|Overall Study|Study terminated by sponsor|2|||
145416780|NCT01441414|524381843|FG000|Overall Study|Subject refused further follow-up|1|||
145416781|NCT01773889|524381844|FG000|Overall Study|lack of funding|2|||
145416782|NCT00500110|524381845|FG000|Overall Study|Withdrawal by Subject|3|||
145416783|NCT03954938|524381846|FG000|Overall Study|Withdrawal by Subject|2|||
145416784|NCT03954938|524381846|FG000|Overall Study|Adverse Event|1|||
145416785|NCT02565186|524381852|FG000|Overall Study|Adverse Event|113|||
145416786|NCT02565186|524381853|FG001|Overall Study|Adverse Event|148|||
145416787|NCT02565186|524381852|FG000|Overall Study|Lost to Follow-up|102|||
145416788|NCT02565186|524381853|FG001|Overall Study|Lost to Follow-up|93|||
145416789|NCT02565186|524381852|FG000|Overall Study|Non-Compliance|57|||
145416790|NCT02565186|524381853|FG001|Overall Study|Non-Compliance|55|||
145416791|NCT02565186|524381852|FG000|Overall Study|Withdrawal by Subject|229|||
145416792|NCT02565186|524381853|FG001|Overall Study|Withdrawal by Subject|214|||
145416793|NCT02565186|524381852|FG000|Overall Study|Physician Decision|18|||
145416794|NCT02565186|524381853|FG001|Overall Study|Physician Decision|16|||
145416795|NCT02565186|524381852|FG000|Overall Study|Sponsor Request|5|||
145416796|NCT02565186|524381853|FG001|Overall Study|Sponsor Request|9|||
145416797|NCT02565186|524381852|FG000|Overall Study|Missing|1|||
145416798|NCT02565186|524381853|FG001|Overall Study|Missing|0|||
145416799|NCT02565186|524381852|FG000|Overall Study|Did Not Receive Study Drug|55|||
145416800|NCT02565186|524381853|FG001|Overall Study|Did Not Receive Study Drug|86|||
145416801|NCT00617903|524381854|FG000|Overall Study|Withdrawal by Subject|2|||
145416802|NCT00617903|524381855|FG001|Overall Study|Withdrawal by Subject|3|||
145416803|NCT00617903|524381854|FG000|Overall Study|Lost to Follow-up|1|||
145416804|NCT00617903|524381855|FG001|Overall Study|Lost to Follow-up|1|||
145416805|NCT00617903|524381854|FG000|Overall Study|Lack of Efficacy|0|||
145416806|NCT00617903|524381855|FG001|Overall Study|Lack of Efficacy|1|||
145416807|NCT00617903|524381854|FG000|Overall Study|Adverse Event|0|||
145416808|NCT00617903|524381855|FG001|Overall Study|Adverse Event|1|||
145416809|NCT00617903|524381854|FG000|Overall Study|noncompliance|0|||
145416810|NCT00617903|524381855|FG001|Overall Study|noncompliance|1|||
145416811|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
145416812|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
145416813|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
145416814|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
145416815|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
145416816|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
145416817|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
145416818|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
145416819|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
145416820|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
145416821|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
145416822|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
145416823|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
145416824|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
145416825|NCT00976391|524381856|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
145416826|NCT00976391|524381857|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
145416827|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
145416828|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
145416829|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
145416830|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
145416831|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
145416832|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
145416833|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
145416834|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
145416835|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
145416836|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
145416837|NCT00976391|524381856|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
145416838|NCT00976391|524381857|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145416839|NCT02217982|524381858|FG000|Overall Study|Trial discontinued|1|||
145416840|NCT02217982|524381859|FG001|Overall Study|Trial discontinued|0|||
145416841|NCT02217982|524381858|FG000|Overall Study|Adverse Event|0|||
145416842|NCT02217982|524381859|FG001|Overall Study|Adverse Event|1|||
145416843|NCT05156125|524381860|FG000|Overall Study|Lack of Efficacy|1|||
145416844|NCT05156125|524381861|FG001|Overall Study|Lack of Efficacy|1|||
145416845|NCT05156125|524381862|FG002|Overall Study|Lack of Efficacy|1|||
145416846|NCT05156125|524381860|FG000|Overall Study|Physician Decision|0|||
145416847|NCT05156125|524381861|FG001|Overall Study|Physician Decision|0|||
145416848|NCT05156125|524381862|FG002|Overall Study|Physician Decision|1|||
145416849|NCT05156125|524381860|FG000|Overall Study|Non-compliance|0|||
145416850|NCT05156125|524381861|FG001|Overall Study|Non-compliance|1|||
145416851|NCT05156125|524381862|FG002|Overall Study|Non-compliance|1|||
145416852|NCT05156125|524381860|FG000|Overall Study|Withdrawal by Subject|0|||
145416853|NCT05156125|524381861|FG001|Overall Study|Withdrawal by Subject|0|||
145416854|NCT05156125|524381862|FG002|Overall Study|Withdrawal by Subject|1|||
145416855|NCT05156125|524381860|FG000|Overall Study|Adverse Event|2|||
145416856|NCT05156125|524381861|FG001|Overall Study|Adverse Event|1|||
145416857|NCT05156125|524381862|FG002|Overall Study|Adverse Event|0|||
145416858|NCT03123588|524381870|FG000|Overall Study|Study Terminated by Sponsor|2|||
145416859|NCT03123588|524381871|FG001|Overall Study|Study Terminated by Sponsor|5|||
145416860|NCT03123588|524381870|FG000|Overall Study|Withdrawal by Subject|1|||
145416861|NCT03123588|524381871|FG001|Overall Study|Withdrawal by Subject|0|||
145416862|NCT03123588|524381870|FG000|Overall Study|Adverse Event|1|||
145416863|NCT03123588|524381871|FG001|Overall Study|Adverse Event|0|||
145416864|NCT03123588|524381870|FG000|Overall Study|Physician Decision|2|||
145416865|NCT03123588|524381871|FG001|Overall Study|Physician Decision|1|||
145416866|NCT01717859|524381872|FG000|Overall Study|Adverse Event|5|||
145416867|NCT01717859|524381872|FG000|Overall Study|Moved out of state|1|||
145416868|NCT01717859|524381872|FG000|Overall Study|Patient concerned about mental health|1|||
145416869|NCT01717859|524381872|FG000|Overall Study|Lost to Follow-up|1|||
145416870|NCT01717859|524381872|FG000|Overall Study|Withdrawal by Subject|2|||
145416871|NCT01623752|524381873|FG000|Phase 1 (78 Weeks)|No Data|249|||
145416872|NCT01623752|524381874|FG001|Phase 1 (78 Weeks)|No Data|66|||
145416873|NCT01623752|524381875|FG002|Phase 1 (78 Weeks)|No Data|2|||
145416874|NCT01623752|524381873|FG000|Phase 1 (78 Weeks)|Other|33|||
145416875|NCT01623752|524381874|FG001|Phase 1 (78 Weeks)|Other|20|||
145416876|NCT01623752|524381875|FG002|Phase 1 (78 Weeks)|Other|0|||
145416877|NCT01623752|524381873|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
145416878|NCT01623752|524381874|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
145416879|NCT01623752|524381875|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
145416880|NCT01623752|524381873|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
145416881|NCT01623752|524381874|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
145416882|NCT01623752|524381875|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
145416883|NCT01623752|524381873|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
145416884|NCT01623752|524381874|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
145416885|NCT01623752|524381875|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
145416886|NCT01623752|524381873|FG000|Phase 2 (78 Weeks)|Other|5|||
145416887|NCT01623752|524381874|FG001|Phase 2 (78 Weeks)|Other|1|||
145416888|NCT01623752|524381875|FG002|Phase 2 (78 Weeks)|Other|0|||
145416889|NCT01623752|524381873|FG000|Phase 2 (78 Weeks)|No Data|43|||
145416890|NCT01623752|524381874|FG001|Phase 2 (78 Weeks)|No Data|11|||
145416891|NCT01623752|524381875|FG002|Phase 2 (78 Weeks)|No Data|0|||
145416892|NCT01623752|524381873|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
145416893|NCT01623752|524381874|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
145416894|NCT01623752|524381875|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
145416895|NCT01755637|524381876|FG000|Period 1|Adverse Event|0|||
145416896|NCT01755637|524381877|FG001|Period 1|Adverse Event|1|||
145416897|NCT01814332|524381878|FG000|Overall Study|Adverse Event|8|||
145416898|NCT01814332|524381879|FG001|Overall Study|Adverse Event|3|||
145416899|NCT01814332|524381878|FG000|Overall Study|Withdrawal by Subject|3|||
145416900|NCT01814332|524381879|FG001|Overall Study|Withdrawal by Subject|8|||
145416901|NCT01814332|524381878|FG000|Overall Study|Protocol Violation|0|||
145416902|NCT01814332|524381879|FG001|Overall Study|Protocol Violation|4|||
145416903|NCT01814332|524381878|FG000|Overall Study|Lost to Follow-up|5|||
145416904|NCT01814332|524381879|FG001|Overall Study|Lost to Follow-up|1|||
145622946|NCT01256476|525131526|FG000|Overall Study|Lost to Follow-up|1|||
145416905|NCT04389671|524381882|FG000|Overall Study|Death|7|||
145416906|NCT02287025|524381883|FG000|Overall Study|Not treated|2|||
145416907|NCT02287025|524381884|FG001|Overall Study|Not treated|0|||
145416908|NCT02287025|524381883|FG000|Overall Study|Progression of disease|3|||
145416909|NCT02287025|524381884|FG001|Overall Study|Progression of disease|2|||
145416910|NCT02287025|524381883|FG000|Overall Study|Adverse Event|2|||
145416911|NCT02287025|524381884|FG001|Overall Study|Adverse Event|4|||
145416912|NCT02287025|524381883|FG000|Overall Study|Withdrawal by Subject|2|||
145416913|NCT02287025|524381884|FG001|Overall Study|Withdrawal by Subject|2|||
145416914|NCT02287025|524381883|FG000|Overall Study|Screening failed|1|||
145416915|NCT02287025|524381884|FG001|Overall Study|Screening failed|1|||
145416916|NCT00899847|524381885|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
145416917|NCT04053452|524381886|FG000|Overall Study|Withdrawal by Subject|1|||
145416918|NCT04053452|524381887|FG001|Overall Study|Withdrawal by Subject|0|||
145416919|NCT04053452|524381886|FG000|Overall Study|Time restraint due to inpatient needs|1|||
145622947|NCT01256476|525131527|FG001|Overall Study|Lost to Follow-up|2|||
145416920|NCT04053452|524381887|FG001|Overall Study|Time restraint due to inpatient needs|2|||
145416921|NCT01421134|524381888|FG000|Overall Study|Adverse Event|3|||
145416922|NCT01421134|524381889|FG001|Overall Study|Adverse Event|5|||
145416923|NCT01421134|524381888|FG000|Overall Study|Lack of Efficacy|2|||
145416924|NCT01421134|524381889|FG001|Overall Study|Lack of Efficacy|4|||
145416925|NCT01421134|524381888|FG000|Overall Study|Protocol Violation|0|||
145416926|NCT01421134|524381889|FG001|Overall Study|Protocol Violation|3|||
145416927|NCT01421134|524381888|FG000|Overall Study|Withdrawal by Subject|1|||
145416928|NCT01421134|524381889|FG001|Overall Study|Withdrawal by Subject|1|||
145416929|NCT01421134|524381888|FG000|Overall Study|Administrative|0|||
145416930|NCT01421134|524381889|FG001|Overall Study|Administrative|1|||
145416931|NCT01421134|524381888|FG000|Overall Study|Lost to Follow-up|1|||
145416932|NCT01421134|524381889|FG001|Overall Study|Lost to Follow-up|1|||
145416933|NCT03528577|524381892|FG000|Sequence 1|Failed Spirometry|1|||
145416934|NCT03528577|524381892|FG000|Sequence 1|Restricted medication|1|||
145416935|NCT03528577|524381892|FG000|Sequence 2|Adverse Event|1|||
145416936|NCT03528577|524381892|FG000|Sequence 2|Withdrawal by Subject|1|||
145416937|NCT03528577|524381892|FG000|Sequence 2|Failed Spirometry|1|||
145416938|NCT03528577|524381892|FG000|Sequence 3|Failed Spirometry|1|||
145416939|NCT03528577|524381892|FG000|Sequence 4|Failed Spirometry|2|||
145416940|NCT03528577|524381892|FG000|Sequence 4|Adverse Event|1|||
145416941|NCT04882215|524381893|FG000|Overall Study|Withdrawal by Subject|5|||
145416942|NCT04882215|524381894|FG001|Overall Study|Withdrawal by Subject|0|||
145416943|NCT04098302|524381897|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
145416944|NCT04098302|524381898|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
145416945|NCT04098302|524381899|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
145416946|NCT04098302|524381900|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
145416947|NCT04098302|524381897|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
145416948|NCT04098302|524381898|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145416949|NCT04098302|524381899|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145416950|NCT04098302|524381900|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
145416951|NCT04098302|524381897|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
145416952|NCT04098302|524381898|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
145416953|NCT04098302|524381899|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
145416954|NCT04098302|524381900|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
145416955|NCT04098302|524381897|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
145416956|NCT04098302|524381898|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
145416957|NCT04098302|524381899|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
145416958|NCT04098302|524381900|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
145416959|NCT04098302|524381897|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
145416960|NCT04098302|524381898|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
145416961|NCT04098302|524381899|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
145416962|NCT04098302|524381900|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
145416963|NCT04098302|524381897|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145416964|NCT04098302|524381898|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145416965|NCT04098302|524381899|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
145416966|NCT04098302|524381900|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
145416967|NCT04098302|524381897|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145353976|NCT03103087|524145472|FG002|Overall Study|Adverse Event|6|||
145353977|NCT03103087|524145470|FG000|Overall Study|Withdrawal by Subject|13|||
145353978|NCT03103087|524145471|FG001|Overall Study|Withdrawal by Subject|6|||
145353979|NCT03103087|524145472|FG002|Overall Study|Withdrawal by Subject|6|||
145353980|NCT03103087|524145470|FG000|Overall Study|Lost to Follow-up|4|||
145353981|NCT03103087|524145471|FG001|Overall Study|Lost to Follow-up|2|||
145353982|NCT03103087|524145472|FG002|Overall Study|Lost to Follow-up|7|||
145353983|NCT03103087|524145470|FG000|Overall Study|Other reason not reported|1|||
145353984|NCT03103087|524145471|FG001|Overall Study|Other reason not reported|3|||
145353985|NCT03103087|524145472|FG002|Overall Study|Other reason not reported|5|||
145353986|NCT02019472|524145475|FG000|Overall Study|Adverse Event|14|||
145353987|NCT02019472|524145476|FG001|Overall Study|Adverse Event|23|||
145353988|NCT02019472|524145477|FG002|Overall Study|Adverse Event|17|||
145416968|NCT04098302|524381898|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145577306|NCT01109316|524968044|FG000|Study Period 2|Entry Criteria Not Met|0|||
145577307|NCT01109316|524968045|FG001|Study Period 2|Entry Criteria Not Met|1|||
145353989|NCT02019472|524145475|FG000|Overall Study|Death|0|||
145353990|NCT02019472|524145476|FG001|Overall Study|Death|1|||
145353991|NCT02019472|524145477|FG002|Overall Study|Death|1|||
145353992|NCT02019472|524145475|FG000|Overall Study|Lack of Efficacy|7|||
145416969|NCT04098302|524381899|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
145577308|NCT01109316|524968046|FG002|Study Period 2|Entry Criteria Not Met|0|||
145353993|NCT02019472|524145476|FG001|Overall Study|Lack of Efficacy|4|||
145577309|NCT01109316|524968047|FG003|Study Period 2|Entry Criteria Not Met|0|||
145353994|NCT02019472|524145477|FG002|Overall Study|Lack of Efficacy|4|||
145353995|NCT02019472|524145475|FG000|Overall Study|Lost to Follow-up|0|||
145353996|NCT02019472|524145476|FG001|Overall Study|Lost to Follow-up|2|||
145353997|NCT02019472|524145477|FG002|Overall Study|Lost to Follow-up|1|||
145353998|NCT02019472|524145475|FG000|Overall Study|Physician Decision|1|||
145353999|NCT02019472|524145476|FG001|Overall Study|Physician Decision|2|||
145354000|NCT02019472|524145477|FG002|Overall Study|Physician Decision|0|||
145354001|NCT02019472|524145475|FG000|Overall Study|Pregnancy|1|||
145354002|NCT02019472|524145476|FG001|Overall Study|Pregnancy|2|||
145354003|NCT02019472|524145477|FG002|Overall Study|Pregnancy|2|||
145354004|NCT02019472|524145475|FG000|Overall Study|Withdrawal by Subject|11|||
145354005|NCT02019472|524145476|FG001|Overall Study|Withdrawal by Subject|10|||
145354006|NCT02019472|524145477|FG002|Overall Study|Withdrawal by Subject|11|||
145354007|NCT02019472|524145475|FG000|Overall Study|Other|3|||
145416970|NCT04098302|524381900|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
145416971|NCT04098302|524381897|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145416972|NCT04098302|524381898|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145416973|NCT04098302|524381899|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
145416974|NCT04098302|524381900|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
145416975|NCT00724893|524381903|FG000|Overall Study|Adverse Event|76|||
145416976|NCT00724893|524381904|FG001|Overall Study|Adverse Event|142|||
145416977|NCT00724893|524381903|FG000|Overall Study|Withdrawal by Subject|0|||
145416978|NCT00724893|524381904|FG001|Overall Study|Withdrawal by Subject|1|||
145416979|NCT00724893|524381903|FG000|Overall Study|Lack of virologic response|94|||
145416980|NCT00724893|524381904|FG001|Overall Study|Lack of virologic response|202|||
145416981|NCT00724893|524381903|FG000|Overall Study|Reason not specified|193|||
145416982|NCT00724893|524381904|FG001|Overall Study|Reason not specified|7|||
145416983|NCT00724893|524381903|FG000|Overall Study|Patient choice|0|||
145416984|NCT00724893|524381904|FG001|Overall Study|Patient choice|26|||
145416985|NCT00724893|524381903|FG000|Overall Study|Geographic reasons|0|||
145416986|NCT00724893|524381904|FG001|Overall Study|Geographic reasons|11|||
145416987|NCT00724893|524381903|FG000|Overall Study|Incarceration|0|||
145416988|NCT00724893|524381904|FG001|Overall Study|Incarceration|9|||
145416989|NCT00724893|524381903|FG000|Overall Study|Substance abuse|0|||
145416990|NCT00724893|524381904|FG001|Overall Study|Substance abuse|3|||
145416991|NCT00724893|524381903|FG000|Overall Study|Financial reasons|0|||
145416992|NCT00724893|524381904|FG001|Overall Study|Financial reasons|2|||
145416993|NCT00724893|524381903|FG000|Overall Study|Assigned shorter treatment|0|||
145416994|NCT00724893|524381904|FG001|Overall Study|Assigned shorter treatment|2|||
145416995|NCT00724893|524381903|FG000|Overall Study|Lost to Follow-up|0|||
145416996|NCT00724893|524381904|FG001|Overall Study|Lost to Follow-up|52|||
145416997|NCT00724893|524381903|FG000|Overall Study|Unknown, missing data|1|||
145416998|NCT00724893|524381904|FG001|Overall Study|Unknown, missing data|1|||
145416999|NCT01290731|524381907|FG000|Overall Study|Withdrawal by Subject|1|||
145417000|NCT01279200|524381908|FG000|Overall Study|Withdrawal by Subject|1|||
145417001|NCT01279200|524381909|FG001|Overall Study|Withdrawal by Subject|3|||
145417002|NCT01279200|524381908|FG000|Overall Study|Patient withdrawal due to high cost|0|||
145417003|NCT01279200|524381909|FG001|Overall Study|Patient withdrawal due to high cost|1|||
145417004|NCT01279200|524381908|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
145417005|NCT01279200|524381909|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
145417006|NCT01279200|524381908|FG000|Overall Study|ultrasound screening failure|0|||
145417007|NCT01279200|524381909|FG001|Overall Study|ultrasound screening failure|1|||
145417008|NCT01279200|524381908|FG000|Overall Study|Lost to Follow-up|0|||
145417009|NCT01279200|524381909|FG001|Overall Study|Lost to Follow-up|1|||
145417010|NCT01279200|524381908|FG000|Overall Study|Adverse Event|1|||
145417011|NCT01279200|524381909|FG001|Overall Study|Adverse Event|0|||
145417012|NCT01399099|524381910|FG000|Overall Study|Lost to Follow-up|14|||
145417013|NCT01399099|524381910|FG000|Overall Study|Physician Decision|1|||
145417014|NCT01399099|524381910|FG000|Overall Study|Protocol Violation|1|||
145417015|NCT01399099|524381910|FG000|Overall Study|Skin Irritation|13|||
145417016|NCT01399099|524381910|FG000|Overall Study|Infection|1|||
145622948|NCT01256476|525131526|FG000|Overall Study|Persistent ALT or AST elevation|1|||
145622949|NCT01256476|525131527|FG001|Overall Study|Persistent ALT or AST elevation|0|||
145354008|NCT02019472|524145476|FG001|Overall Study|Other|8|||
145354009|NCT02019472|524145477|FG002|Overall Study|Other|6|||
145354010|NCT00513695|524145478|FG000|Overall Study|Discontinued therapy|2|||
145354011|NCT00513695|524145478|FG000|Overall Study|Progression prior to surgery|3|||
145622950|NCT01256476|525131526|FG000|Overall Study|Physician Decision|0|||
145354012|NCT02157935|524145479|FG000|Overall Study|Withdrawal by Subject|25|||
145354013|NCT02157935|524145480|FG001|Overall Study|Withdrawal by Subject|39|||
145354014|NCT02157935|524145479|FG000|Overall Study|Screen failure|1|||
145417017|NCT01399099|524381910|FG000|Overall Study|Miscellaneous|4|||
145417018|NCT01668537|524381912|FG000|Overall Study|Request to Discontinue Prematurely|1|||
145417019|NCT01668537|524381913|FG001|Overall Study|Request to Discontinue Prematurely|1|||
145417020|NCT01668537|524381912|FG000|Overall Study|Subject unwilling/unable to comply|5|||
145417021|NCT01668537|524381913|FG001|Overall Study|Subject unwilling/unable to comply|0|||
145622951|NCT01256476|525131527|FG001|Overall Study|Physician Decision|1|||
145354015|NCT02157935|524145480|FG001|Overall Study|Screen failure|2|||
145417022|NCT01668537|524381912|FG000|Overall Study|Reason Precludes Participation|1|||
145417023|NCT01668537|524381913|FG001|Overall Study|Reason Precludes Participation|0|||
145417024|NCT01668537|524381912|FG000|Overall Study|Lost to Follow-up|13|||
145417025|NCT01668537|524381913|FG001|Overall Study|Lost to Follow-up|6|||
145417026|NCT01668537|524381912|FG000|Overall Study|Other|2|||
145417027|NCT01668537|524381913|FG001|Overall Study|Other|3|||
145417028|NCT00888849|524381914|FG000|Overall Study|Death|4|||
145417029|NCT00888849|524381915|FG001|Overall Study|Death|7|||
145417030|NCT00888849|524381914|FG000|Overall Study|Lost to Follow-up|1|||
145417031|NCT00888849|524381915|FG001|Overall Study|Lost to Follow-up|2|||
145417032|NCT04576949|524381917|FG000|Overall Study|Adverse Event|1|||
145417033|NCT04576949|524381918|FG001|Overall Study|Adverse Event|3|||
145417034|NCT04576949|524381919|FG002|Overall Study|Adverse Event|2|||
145417035|NCT04576949|524381917|FG000|Overall Study|Withdrawal by Subject|41|||
145417036|NCT04576949|524381918|FG001|Overall Study|Withdrawal by Subject|26|||
145417037|NCT04576949|524381919|FG002|Overall Study|Withdrawal by Subject|18|||
145417038|NCT04576949|524381917|FG000|Overall Study|Physician Decision|3|||
145417039|NCT04576949|524381918|FG001|Overall Study|Physician Decision|0|||
145417040|NCT04576949|524381919|FG002|Overall Study|Physician Decision|0|||
145417041|NCT04576949|524381917|FG000|Overall Study|Death|0|||
145417042|NCT04576949|524381918|FG001|Overall Study|Death|1|||
145417043|NCT04576949|524381919|FG002|Overall Study|Death|0|||
145417044|NCT04576949|524381917|FG000|Overall Study|Lost to Follow-up|29|||
145417045|NCT04576949|524381918|FG001|Overall Study|Lost to Follow-up|37|||
145417046|NCT04576949|524381919|FG002|Overall Study|Lost to Follow-up|24|||
145417047|NCT04576949|524381917|FG000|Overall Study|Other, Not Specified|2|||
145417048|NCT04576949|524381918|FG001|Overall Study|Other, Not Specified|3|||
145417049|NCT04576949|524381919|FG002|Overall Study|Other, Not Specified|1|||
145417050|NCT04576949|524381917|FG000|Overall Study|Other|1|||
145417051|NCT04576949|524381918|FG001|Overall Study|Other|0|||
145417052|NCT04576949|524381919|FG002|Overall Study|Other|0|||
145417053|NCT04584554|524381920|FG000|Overall Study|Withdrawal by Subject|2|||
145417054|NCT04584554|524381921|FG001|Overall Study|Withdrawal by Subject|2|||
145417055|NCT01860404|524381922|FG000|Overall Study|Lost to Follow-up|3|||
145417056|NCT01860404|524381923|FG001|Overall Study|Lost to Follow-up|4|||
145417057|NCT01860404|524381924|FG002|Overall Study|Lost to Follow-up|1|||
145417058|NCT01860404|524381925|FG003|Overall Study|Lost to Follow-up|6|||
145417059|NCT01860404|524381926|FG004|Overall Study|Lost to Follow-up|4|||
145417060|NCT01860404|524381922|FG000|Overall Study|Withdrawal by Subject|0|||
145417061|NCT01860404|524381923|FG001|Overall Study|Withdrawal by Subject|0|||
145417062|NCT01860404|524381924|FG002|Overall Study|Withdrawal by Subject|4|||
145417063|NCT01860404|524381925|FG003|Overall Study|Withdrawal by Subject|0|||
145417064|NCT01860404|524381926|FG004|Overall Study|Withdrawal by Subject|0|||
145417065|NCT02187055|524381927|FG000|Overall Study|Lack of Efficacy|10|||
145417066|NCT02187055|524381928|FG001|Overall Study|Lack of Efficacy|3|||
145417067|NCT02187055|524381929|FG002|Overall Study|Lack of Efficacy|7|||
145417068|NCT02187055|524381927|FG000|Overall Study|Lost to Follow-up|2|||
145622952|NCT01256476|525131526|FG000|Overall Study|Subject non-compliance|0|||
145622953|NCT01256476|525131527|FG001|Overall Study|Subject non-compliance|1|||
145622954|NCT01256476|525131526|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
145622955|NCT01256476|525131527|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
145622956|NCT02401529|525131530|FG000|Overall Study|Lost to Follow-up|2|||
145622957|NCT02401529|525131531|FG001|Overall Study|Lost to Follow-up|1|||
145622958|NCT02401529|525131530|FG000|Overall Study|Physician Decision|2|||
145622959|NCT02401529|525131531|FG001|Overall Study|Physician Decision|6|||
145622960|NCT02401529|525131530|FG000|Overall Study|Protocol Violation|5|||
145622961|NCT02401529|525131531|FG001|Overall Study|Protocol Violation|0|||
145622962|NCT01598987|525131534|FG000|Baseline to Month 12|Administrative problems|2|||
145622963|NCT01598987|525131534|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
145622964|NCT01598987|525131534|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
145622965|NCT01598987|525131534|FG000|Baseline to 24 Month|Administrative problems|2|||
145622966|NCT01598987|525131534|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
145622967|NCT01450943|525131535|FG000|Overall Study|Screen failure, loss to follow-up|2|||
145622968|NCT01450943|525131536|FG001|Overall Study|Screen failure, loss to follow-up|7|||
145417069|NCT02187055|524381928|FG001|Overall Study|Lost to Follow-up|7|||
145417070|NCT02187055|524381929|FG002|Overall Study|Lost to Follow-up|3|||
145417071|NCT02187055|524381927|FG000|Overall Study|No longer meets eligibility criteria|0|||
145417072|NCT02187055|524381928|FG001|Overall Study|No longer meets eligibility criteria|2|||
145417073|NCT02187055|524381929|FG002|Overall Study|No longer meets eligibility criteria|0|||
145417074|NCT02187055|524381927|FG000|Overall Study|No longer willing to participate|6|||
145417075|NCT02187055|524381928|FG001|Overall Study|No longer willing to participate|8|||
145417076|NCT02187055|524381929|FG002|Overall Study|No longer willing to participate|10|||
145622969|NCT01450943|525131537|FG002|Overall Study|Screen failure, loss to follow-up|6|||
145417077|NCT02187055|524381927|FG000|Overall Study|Other|5|||
145417078|NCT02187055|524381928|FG001|Overall Study|Other|6|||
145417079|NCT02187055|524381929|FG002|Overall Study|Other|3|||
145417080|NCT02187055|524381927|FG000|Overall Study|Protocol Violation|9|||
145417081|NCT02187055|524381928|FG001|Overall Study|Protocol Violation|9|||
145417082|NCT02187055|524381929|FG002|Overall Study|Protocol Violation|4|||
145354016|NCT02157935|524145479|FG000|Overall Study|Protocol Violation|1|||
145354017|NCT02157935|524145480|FG001|Overall Study|Protocol Violation|0|||
145354018|NCT02157935|524145479|FG000|Overall Study|Progressive disease|0|||
145354019|NCT02157935|524145480|FG001|Overall Study|Progressive disease|2|||
145354020|NCT02157935|524145479|FG000|Overall Study|Other|5|||
145354021|NCT02157935|524145480|FG001|Overall Study|Other|12|||
145354022|NCT02157935|524145479|FG000|Overall Study|Lack of Efficacy|0|||
145354023|NCT02157935|524145480|FG001|Overall Study|Lack of Efficacy|1|||
145354024|NCT02157935|524145479|FG000|Overall Study|Death|4|||
145354025|NCT02157935|524145480|FG001|Overall Study|Death|4|||
145354026|NCT02157935|524145479|FG000|Overall Study|Adverse Event|3|||
145354027|NCT02157935|524145480|FG001|Overall Study|Adverse Event|5|||
145354028|NCT03664232|524145485|FG000|Overall Study|Withdrawal by Subject|0|||
145354029|NCT03664232|524145486|FG001|Overall Study|Withdrawal by Subject|1|||
145354030|NCT03664232|524145487|FG002|Overall Study|Withdrawal by Subject|0|||
145354031|NCT03664232|524145488|FG003|Overall Study|Withdrawal by Subject|1|||
145354032|NCT03664232|524145485|FG000|Overall Study|Adverse Event|0|||
145354033|NCT03664232|524145486|FG001|Overall Study|Adverse Event|0|||
145354034|NCT03664232|524145487|FG002|Overall Study|Adverse Event|1|||
145354035|NCT03664232|524145488|FG003|Overall Study|Adverse Event|0|||
145354036|NCT03664232|524145485|FG000|Overall Study|Other-Non-compliance with study drug|0|||
145354037|NCT03664232|524145486|FG001|Overall Study|Other-Non-compliance with study drug|1|||
145354038|NCT03664232|524145487|FG002|Overall Study|Other-Non-compliance with study drug|0|||
145354039|NCT03664232|524145488|FG003|Overall Study|Other-Non-compliance with study drug|2|||
145354040|NCT03664232|524145485|FG000|Overall Study|Other-Unspecified|0|||
145354041|NCT03664232|524145486|FG001|Overall Study|Other-Unspecified|3|||
145354042|NCT03664232|524145487|FG002|Overall Study|Other-Unspecified|0|||
145354043|NCT03664232|524145488|FG003|Overall Study|Other-Unspecified|1|||
145354044|NCT03664232|524145485|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
145354045|NCT03664232|524145486|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
145354046|NCT03664232|524145487|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
145354047|NCT03664232|524145488|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
145354048|NCT02717507|524145489|FG000|Overall Study|Lost to Follow-up|5|||
145354049|NCT02717507|524145490|FG001|Overall Study|Lost to Follow-up|8|||
145354050|NCT02717507|524145489|FG000|Overall Study|Pregnancy|1|||
145354051|NCT02717507|524145490|FG001|Overall Study|Pregnancy|1|||
145354052|NCT02717507|524145489|FG000|Overall Study|Protocol Violation|2|||
145354053|NCT02717507|524145490|FG001|Overall Study|Protocol Violation|2|||
145354054|NCT02717507|524145489|FG000|Overall Study|Withdrawal by Subject|20|||
145354055|NCT02717507|524145490|FG001|Overall Study|Withdrawal by Subject|20|||
145354056|NCT02717507|524145489|FG000|Overall Study|Relapse|1|||
145354057|NCT02717507|524145490|FG001|Overall Study|Relapse|1|||
145354058|NCT02717507|524145489|FG000|Overall Study|Cardiac Event|2|||
145354059|NCT02717507|524145490|FG001|Overall Study|Cardiac Event|6|||
145354060|NCT00709995|524145491|FG000|Overall Study|Adverse Event|4|||
145354061|NCT00709995|524145492|FG001|Overall Study|Adverse Event|2|||
145354062|NCT00709995|524145491|FG000|Overall Study|Withdrawal by Subject|1|||
145354063|NCT00709995|524145492|FG001|Overall Study|Withdrawal by Subject|3|||
145354064|NCT02003209|524145500|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
145354065|NCT02003209|524145501|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
145354066|NCT00638508|524145502|FG000|Overall Study|Physician Decision|5|||
145354067|NCT00638508|524145503|FG001|Overall Study|Physician Decision|2|||
145354068|NCT03500198|524145504|FG000|Overall Study|Lost to Follow-up|0|||
145354069|NCT03500198|524145505|FG001|Overall Study|Lost to Follow-up|1|||
145354070|NCT00595621|524145506|FG000|Open Label Run in|Adverse Event|1|||
145354071|NCT00595621|524145507|FG001|Open Label Run in|Adverse Event|0|||
145354072|NCT00595621|524145506|FG000|Open Label Run in|Physician Decision|1|||
145354073|NCT00595621|524145507|FG001|Open Label Run in|Physician Decision|0|||
145354074|NCT00595621|524145506|FG000|Open Label Run in|Withdrawal by Subject|1|||
145354075|NCT00595621|524145507|FG001|Open Label Run in|Withdrawal by Subject|0|||
145354076|NCT00595621|524145506|FG000|Randomization and Study|Adverse Event|2|||
145354077|NCT00595621|524145507|FG001|Randomization and Study|Adverse Event|0|||
145354078|NCT00595621|524145506|FG000|Randomization and Study|Withdrawal by Subject|0|||
145354079|NCT00595621|524145507|FG001|Randomization and Study|Withdrawal by Subject|1|||
145354080|NCT00324987|524145508|FG000|Overall Study|Adverse Event|2|||
145354081|NCT00324987|524145509|FG001|Overall Study|Adverse Event|1|||
145354082|NCT00324987|524145508|FG000|Overall Study|Withdrawal by Subject|1|||
145354083|NCT00324987|524145509|FG001|Overall Study|Withdrawal by Subject|1|||
145354084|NCT00324987|524145508|FG000|Overall Study|Progression|1|||
145354085|NCT00324987|524145509|FG001|Overall Study|Progression|1|||
145417083|NCT02187055|524381927|FG000|Overall Study|Pregnancy|3|||
145354086|NCT00324987|524145508|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
145354087|NCT00324987|524145509|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
145354088|NCT01068860|524145510|FG000|Overall Study|Withdrawal by Subject|0|||
145417084|NCT02187055|524381928|FG001|Overall Study|Pregnancy|1|||
145354089|NCT01068860|524145511|FG001|Overall Study|Withdrawal by Subject|0|||
145354090|NCT01068860|524145512|FG002|Overall Study|Withdrawal by Subject|0|||
145417085|NCT02187055|524381929|FG002|Overall Study|Pregnancy|0|||
145354091|NCT01068860|524145513|FG003|Overall Study|Withdrawal by Subject|0|||
145354092|NCT01068860|524145514|FG004|Overall Study|Withdrawal by Subject|0|||
145354093|NCT01068860|524145515|FG005|Overall Study|Withdrawal by Subject|2|||
145354094|NCT01068860|524145516|FG006|Overall Study|Withdrawal by Subject|0|||
145354095|NCT01068860|524145517|FG007|Overall Study|Withdrawal by Subject|0|||
145354096|NCT01068860|524145518|FG008|Overall Study|Withdrawal by Subject|0|||
145354097|NCT01068860|524145519|FG009|Overall Study|Withdrawal by Subject|3|||
145354098|NCT01068860|524145510|FG000|Overall Study|Administrative problems; misrandomized|0|||
145354099|NCT01068860|524145511|FG001|Overall Study|Administrative problems; misrandomized|0|||
145354100|NCT01068860|524145512|FG002|Overall Study|Administrative problems; misrandomized|0|||
145354101|NCT01068860|524145513|FG003|Overall Study|Administrative problems; misrandomized|1|||
145354102|NCT01068860|524145514|FG004|Overall Study|Administrative problems; misrandomized|0|||
145354103|NCT01068860|524145515|FG005|Overall Study|Administrative problems; misrandomized|0|||
145354104|NCT01068860|524145516|FG006|Overall Study|Administrative problems; misrandomized|0|||
145354105|NCT01068860|524145517|FG007|Overall Study|Administrative problems; misrandomized|0|||
145354106|NCT01068860|524145518|FG008|Overall Study|Administrative problems; misrandomized|0|||
145354107|NCT01068860|524145519|FG009|Overall Study|Administrative problems; misrandomized|1|||
145354108|NCT01068860|524145510|FG000|Overall Study|Lost to Follow-up|0|||
145354109|NCT01068860|524145511|FG001|Overall Study|Lost to Follow-up|1|||
145354110|NCT01068860|524145512|FG002|Overall Study|Lost to Follow-up|0|||
145354111|NCT01068860|524145513|FG003|Overall Study|Lost to Follow-up|0|||
145354112|NCT01068860|524145514|FG004|Overall Study|Lost to Follow-up|0|||
145354113|NCT01068860|524145515|FG005|Overall Study|Lost to Follow-up|0|||
145354114|NCT01068860|524145516|FG006|Overall Study|Lost to Follow-up|0|||
145354115|NCT01068860|524145517|FG007|Overall Study|Lost to Follow-up|0|||
145354116|NCT01068860|524145518|FG008|Overall Study|Lost to Follow-up|0|||
145354117|NCT01068860|524145519|FG009|Overall Study|Lost to Follow-up|0|||
145354118|NCT02568072|524145520|FG000|Overall Study|Unavailable for appointment|23|||
145354119|NCT02568072|524145520|FG000|Overall Study|Unable to contact|3|||
145354120|NCT02568072|524145520|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
145354121|NCT02568072|524145520|FG000|Overall Study|Withdrawal by Subject|1|||
145354122|NCT02568072|524145520|FG000|Overall Study|Sustained injury, marathon not run|24|||
145354123|NCT02714218|524145525|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145354124|NCT02714218|524145526|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145354125|NCT02714218|524145527|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145354126|NCT02714218|524145525|FG000|Pre-Treatment Period|Other reasons|0|||
145354127|NCT02714218|524145526|FG001|Pre-Treatment Period|Other reasons|1|||
145354128|NCT02714218|524145527|FG002|Pre-Treatment Period|Other reasons|0|||
145354129|NCT02714218|524145525|FG000|Treatment Period|Disease Progression|55|||
145354130|NCT02714218|524145526|FG001|Treatment Period|Disease Progression|52|||
145354131|NCT02714218|524145527|FG002|Treatment Period|Disease Progression|14|||
145354132|NCT02714218|524145525|FG000|Treatment Period|Study drug toxicity|46|||
145354133|NCT02714218|524145526|FG001|Treatment Period|Study drug toxicity|70|||
145354134|NCT02714218|524145527|FG002|Treatment Period|Study drug toxicity|6|||
145354135|NCT02714218|524145525|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
145354136|NCT02714218|524145526|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
145354137|NCT02714218|524145527|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
145354138|NCT02714218|524145525|FG000|Treatment Period|Request to discontinue treatment|1|||
145354139|NCT02714218|524145526|FG001|Treatment Period|Request to discontinue treatment|4|||
145354140|NCT02714218|524145527|FG002|Treatment Period|Request to discontinue treatment|1|||
145354141|NCT02714218|524145525|FG000|Treatment Period|Participant withdrew consent|2|||
145354142|NCT02714218|524145526|FG001|Treatment Period|Participant withdrew consent|2|||
145354143|NCT02714218|524145527|FG002|Treatment Period|Participant withdrew consent|0|||
145354144|NCT02714218|524145525|FG000|Treatment Period|Maximum clinical benefit|4|||
145354145|NCT02714218|524145526|FG001|Treatment Period|Maximum clinical benefit|2|||
145354146|NCT02714218|524145527|FG002|Treatment Period|Maximum clinical benefit|0|||
145354147|NCT02714218|524145525|FG000|Treatment Period|Administrative reason by sponsor|2|||
145354148|NCT02714218|524145526|FG001|Treatment Period|Administrative reason by sponsor|1|||
145354149|NCT02714218|524145527|FG002|Treatment Period|Administrative reason by sponsor|0|||
145354150|NCT02714218|524145525|FG000|Treatment Period|Other reasons|6|||
145354151|NCT02714218|524145526|FG001|Treatment Period|Other reasons|6|||
145354152|NCT02714218|524145527|FG002|Treatment Period|Other reasons|0|||
145354153|NCT02714218|524145525|FG000|Treatment Period|Completed treatment as per protocol|36|||
145354154|NCT02714218|524145526|FG001|Treatment Period|Completed treatment as per protocol|27|||
145354155|NCT02714218|524145527|FG002|Treatment Period|Completed treatment as per protocol|3|||
145354156|NCT02714218|524145525|FG000|Treatment Period|Not reported|9|||
145622970|NCT03303105|525131540|FG000|Overall Study|Adverse Event|0|||
145354157|NCT02714218|524145526|FG001|Treatment Period|Not reported|6|||
145354158|NCT02714218|524145527|FG002|Treatment Period|Not reported|0|||
145354159|NCT00882518|524145530|FG000|Overall Study|Adverse Event|9|||
145354160|NCT00882518|524145531|FG001|Overall Study|Adverse Event|18|||
145354161|NCT00882518|524145530|FG000|Overall Study|Withdrawal by Subject|9|||
145354162|NCT00882518|524145531|FG001|Overall Study|Withdrawal by Subject|13|||
145354163|NCT00882518|524145530|FG000|Overall Study|Lack of Efficacy|12|||
145354164|NCT00882518|524145531|FG001|Overall Study|Lack of Efficacy|9|||
145354165|NCT00882518|524145530|FG000|Overall Study|Severe non-compliance to protocol|3|||
145354166|NCT00882518|524145531|FG001|Overall Study|Severe non-compliance to protocol|1|||
145354167|NCT00882518|524145530|FG000|Overall Study|Incorrect enrolment|4|||
145354168|NCT00882518|524145531|FG001|Overall Study|Incorrect enrolment|2|||
145354169|NCT00882518|524145530|FG000|Overall Study|Central lab closure for National day|1|||
145354170|NCT00882518|524145531|FG001|Overall Study|Central lab closure for National day|0|||
145354171|NCT00882518|524145530|FG000|Overall Study|Allocating random number by mistake|0|||
145354172|NCT00882518|524145531|FG001|Overall Study|Allocating random number by mistake|1|||
145354173|NCT03238651|524145532|FG000|Overall Study|Other|0|||
145354174|NCT03238651|524145533|FG001|Overall Study|Other|0|||
145354175|NCT03238651|524145534|FG002|Overall Study|Other|0|||
145354176|NCT03238651|524145535|FG003|Overall Study|Other|0|||
145354177|NCT03238651|524145536|FG004|Overall Study|Other|1|||
145354178|NCT03238651|524145532|FG000|Overall Study|Progressive Disease|2|||
145354179|NCT03238651|524145533|FG001|Overall Study|Progressive Disease|2|||
145354180|NCT03238651|524145534|FG002|Overall Study|Progressive Disease|2|||
145354181|NCT03238651|524145535|FG003|Overall Study|Progressive Disease|2|||
145354182|NCT03238651|524145536|FG004|Overall Study|Progressive Disease|0|||
145354183|NCT03238651|524145532|FG000|Overall Study|Withdrawal by Subject|0|||
145354184|NCT03238651|524145533|FG001|Overall Study|Withdrawal by Subject|1|||
145354185|NCT03238651|524145534|FG002|Overall Study|Withdrawal by Subject|0|||
145354186|NCT03238651|524145535|FG003|Overall Study|Withdrawal by Subject|1|||
145354187|NCT03238651|524145536|FG004|Overall Study|Withdrawal by Subject|0|||
145354188|NCT03238651|524145532|FG000|Overall Study|Adverse Event|1|||
145354189|NCT03238651|524145533|FG001|Overall Study|Adverse Event|3|||
145354190|NCT03238651|524145534|FG002|Overall Study|Adverse Event|2|||
145354191|NCT03238651|524145535|FG003|Overall Study|Adverse Event|0|||
145354192|NCT03238651|524145536|FG004|Overall Study|Adverse Event|0|||
145354193|NCT03875508|524145539|FG000|Overall Study|Adverse Event|1|||
145354194|NCT03875508|524145539|FG000|Overall Study|Lost to Follow-up|8|||
145354195|NCT03875508|524145539|FG000|Overall Study|Lack of Efficacy|1|||
145354196|NCT03875508|524145539|FG000|Overall Study|Other, not specified|2|||
145354197|NCT02137252|524145540|FG000|Overall Study|trial terminated early|2|||
145354198|NCT02137252|524145541|FG001|Overall Study|trial terminated early|1|||
145354199|NCT04341363|524145543|FG000|Overall Study|Adverse Event|1|||
145354200|NCT04341363|524145543|FG000|Overall Study|Withdrawal by Subject|1|||
145354201|NCT00063934|524145544|FG000|Overall Study|Ineligible|1|||
145354202|NCT01930162|524145545|FG000|Overall Study|Abnormal test procedure result(s)|4|||
145354203|NCT01930162|524145545|FG000|Overall Study|Death|1|||
145354204|NCT03335475|524145546|FG000|Overall Study|Did not wear accelerometer|4|||
145354205|NCT03335475|524145547|FG001|Overall Study|Did not wear accelerometer|0|||
145354206|NCT03335475|524145546|FG000|Overall Study|Withdrawal by Subject|0|||
145354207|NCT03335475|524145547|FG001|Overall Study|Withdrawal by Subject|1|||
145354208|NCT06481709|524145548|FG000|Overall Study|Withdrawal by Subject|0|||
145354209|NCT06481709|524145549|FG001|Overall Study|Withdrawal by Subject|0|||
145354210|NCT06481709|524145550|FG002|Overall Study|Withdrawal by Subject|2|||
145354211|NCT06481709|524145551|FG003|Overall Study|Withdrawal by Subject|0|||
145354212|NCT00789854|524145552|FG000|Overall Study|Adverse Event|28|||
145354213|NCT00789854|524145553|FG001|Overall Study|Adverse Event|23|||
145354214|NCT00789854|524145554|FG002|Overall Study|Adverse Event|18|||
145354215|NCT00789854|524145552|FG000|Overall Study|Lost to Follow-up|1|||
145354216|NCT00789854|524145553|FG001|Overall Study|Lost to Follow-up|1|||
145354217|NCT00789854|524145554|FG002|Overall Study|Lost to Follow-up|4|||
145354218|NCT00789854|524145552|FG000|Overall Study|Withdrawal by Subject|9|||
145354219|NCT00789854|524145553|FG001|Overall Study|Withdrawal by Subject|6|||
145354220|NCT00789854|524145554|FG002|Overall Study|Withdrawal by Subject|17|||
145354221|NCT00789854|524145552|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145354222|NCT00789854|524145553|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
145354223|NCT00789854|524145554|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
145354224|NCT00789854|524145552|FG000|Overall Study|Severe non-compliance to the protocol|3|||
145354225|NCT00789854|524145553|FG001|Overall Study|Severe non-compliance to the protocol|0|||
145354226|NCT00789854|524145554|FG002|Overall Study|Severe non-compliance to the protocol|0|||
145354227|NCT00789854|524145552|FG000|Overall Study|Safety reasons|0|||
145354228|NCT00789854|524145553|FG001|Overall Study|Safety reasons|0|||
145354229|NCT00789854|524145554|FG002|Overall Study|Safety reasons|2|||
145354230|NCT00789854|524145552|FG000|Overall Study|Other|6|||
145354231|NCT00789854|524145553|FG001|Overall Study|Other|0|||
145354232|NCT00789854|524145554|FG002|Overall Study|Other|5|||
145354233|NCT05906628|524145555|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
145354234|NCT05906628|524145556|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
145354235|NCT05906628|524145555|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
145354236|NCT05906628|524145556|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
145354237|NCT05906628|524145555|FG000|16-Week DBVC Period|Protocol Violation|4|||
145354238|NCT05906628|524145556|FG001|16-Week DBVC Period|Protocol Violation|2|||
145354239|NCT05906628|524145555|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
145417086|NCT02187055|524381927|FG000|Overall Study|Withdrawal by Subject|11|||
145417087|NCT02187055|524381928|FG001|Overall Study|Withdrawal by Subject|11|||
145417088|NCT02187055|524381929|FG002|Overall Study|Withdrawal by Subject|11|||
145417089|NCT02187055|524381927|FG000|Overall Study|Adverse Event|21|||
145417090|NCT02187055|524381928|FG001|Overall Study|Adverse Event|26|||
145417091|NCT02187055|524381929|FG002|Overall Study|Adverse Event|36|||
145417092|NCT02187055|524381927|FG000|Overall Study|Death|2|||
145417093|NCT02187055|524381928|FG001|Overall Study|Death|0|||
145417094|NCT02187055|524381929|FG002|Overall Study|Death|0|||
145417095|NCT00421993|524381930|FG000|Overall Study|Withdrawal by Subject|22|||
145417096|NCT00421993|524381931|FG001|Overall Study|Withdrawal by Subject|23|||
145417097|NCT00421993|524381932|FG002|Overall Study|Withdrawal by Subject|23|||
145417098|NCT00421993|524381933|FG003|Overall Study|Withdrawal by Subject|24|||
145417099|NCT00421993|524381930|FG000|Overall Study|Lost to Follow-up|18|||
145417100|NCT00421993|524381931|FG001|Overall Study|Lost to Follow-up|19|||
145417101|NCT00421993|524381932|FG002|Overall Study|Lost to Follow-up|22|||
145417102|NCT00421993|524381933|FG003|Overall Study|Lost to Follow-up|20|||
145417103|NCT00421993|524381930|FG000|Overall Study|Adverse Event|11|||
145417104|NCT00421993|524381931|FG001|Overall Study|Adverse Event|1|||
145417105|NCT00421993|524381932|FG002|Overall Study|Adverse Event|6|||
145417106|NCT00421993|524381933|FG003|Overall Study|Adverse Event|4|||
145417107|NCT00421993|524381930|FG000|Overall Study|Protocol Violation|2|||
145417108|NCT00421993|524381931|FG001|Overall Study|Protocol Violation|2|||
145417109|NCT00421993|524381932|FG002|Overall Study|Protocol Violation|0|||
145417110|NCT00421993|524381933|FG003|Overall Study|Protocol Violation|1|||
145417111|NCT00421993|524381930|FG000|Overall Study|Lack of Efficacy|0|||
145417112|NCT00421993|524381931|FG001|Overall Study|Lack of Efficacy|3|||
145417113|NCT00421993|524381932|FG002|Overall Study|Lack of Efficacy|0|||
145417114|NCT00421993|524381933|FG003|Overall Study|Lack of Efficacy|5|||
145417115|NCT00421993|524381930|FG000|Overall Study|Pregnancy|0|||
145417116|NCT00421993|524381931|FG001|Overall Study|Pregnancy|1|||
145417117|NCT00421993|524381932|FG002|Overall Study|Pregnancy|1|||
145417118|NCT00421993|524381933|FG003|Overall Study|Pregnancy|2|||
145417119|NCT00421993|524381930|FG000|Overall Study|Subject transportation issues|0|||
145417120|NCT00421993|524381931|FG001|Overall Study|Subject transportation issues|0|||
145417121|NCT00421993|524381932|FG002|Overall Study|Subject transportation issues|0|||
145417122|NCT00421993|524381933|FG003|Overall Study|Subject transportation issues|1|||
145417123|NCT02015104|524381934|FG000|Overall Study|Withdrew consent after first dose drug|1|||
145417124|NCT02015104|524381935|FG001|Overall Study|Withdrew consent after first dose drug|0|||
145417125|NCT02015104|524381934|FG000|Overall Study|Withdrew consent prior to treatment|0|||
145417126|NCT02015104|524381935|FG001|Overall Study|Withdrew consent prior to treatment|1|||
145417127|NCT01301092|524381936|FG000|Overall Study|Lost to Follow-up|0|||
145417128|NCT01301092|524381937|FG001|Overall Study|Lost to Follow-up|0|||
145417129|NCT01301092|524381938|FG002|Overall Study|Lost to Follow-up|1|||
145417130|NCT03334175|524381939|FG000|Overall Study|Lost to Follow-up|0|||
145417131|NCT03334175|524381940|FG001|Overall Study|Lost to Follow-up|1|||
145417132|NCT01350973|524381941|FG000|Overall Study|Adverse Event|4|||
145417133|NCT01350973|524381942|FG001|Overall Study|Adverse Event|7|||
145417134|NCT01350973|524381943|FG002|Overall Study|Adverse Event|7|||
145417135|NCT01350973|524381941|FG000|Overall Study|Voluntary Withdrawal|2|||
145417136|NCT01350973|524381942|FG001|Overall Study|Voluntary Withdrawal|1|||
145417137|NCT01350973|524381943|FG002|Overall Study|Voluntary Withdrawal|1|||
145417138|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145417139|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
145417140|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
145417141|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
145417142|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
145417143|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
145417144|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
145417145|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
145417146|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
145417147|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
145417148|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
145417149|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
145417150|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
145417151|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145417152|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
145417153|NCT03738215|524381944|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145417154|NCT03738215|524381945|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
145417155|NCT03738215|524381946|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
145577310|NCT01109316|524968048|FG004|Study Period 2|Entry Criteria Not Met|0|||
145577311|NCT01109316|524968049|FG005|Study Period 2|Entry Criteria Not Met|0|||
145577312|NCT01109316|524968044|FG000|Study Period 2|Physician Decision|0|||
145577313|NCT01109316|524968045|FG001|Study Period 2|Physician Decision|0|||
145354240|NCT05906628|524145556|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
145354241|NCT05906628|524145555|FG000|16-Week OLE Period|Death|1|||
145354242|NCT05906628|524145556|FG001|16-Week OLE Period|Death|0|||
145354243|NCT05906628|524145555|FG000|16-Week OLE Period|Lost to Follow-up|1|||
145354244|NCT05906628|524145556|FG001|16-Week OLE Period|Lost to Follow-up|1|||
145354245|NCT05906628|524145555|FG000|16-Week OLE Period|Protocol Violation|0|||
145354246|NCT05906628|524145556|FG001|16-Week OLE Period|Protocol Violation|1|||
145354247|NCT05906628|524145555|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
145354248|NCT05906628|524145556|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
145354249|NCT01422213|524145557|FG000|Overall Study|Adverse Event|8|||
145354250|NCT01422213|524145558|FG001|Overall Study|Adverse Event|7|||
145354251|NCT01422213|524145559|FG002|Overall Study|Adverse Event|11|||
145354252|NCT01422213|524145557|FG000|Overall Study|Lack of Efficacy|10|||
145354253|NCT01422213|524145558|FG001|Overall Study|Lack of Efficacy|2|||
145354254|NCT01422213|524145559|FG002|Overall Study|Lack of Efficacy|2|||
145354255|NCT01422213|524145557|FG000|Overall Study|Non-compliance with study drug|0|||
145354256|NCT01422213|524145558|FG001|Overall Study|Non-compliance with study drug|1|||
145354257|NCT01422213|524145559|FG002|Overall Study|Non-compliance with study drug|0|||
145354258|NCT01422213|524145557|FG000|Overall Study|Protocol Violation|0|||
145354259|NCT01422213|524145558|FG001|Overall Study|Protocol Violation|2|||
145354260|NCT01422213|524145559|FG002|Overall Study|Protocol Violation|4|||
145354261|NCT01422213|524145557|FG000|Overall Study|Withdrawal of Consent|7|||
145354262|NCT01422213|524145558|FG001|Overall Study|Withdrawal of Consent|3|||
145354263|NCT01422213|524145559|FG002|Overall Study|Withdrawal of Consent|5|||
145354264|NCT01422213|524145557|FG000|Overall Study|Lost to Follow-up|3|||
145354265|NCT01422213|524145558|FG001|Overall Study|Lost to Follow-up|3|||
145354266|NCT01422213|524145559|FG002|Overall Study|Lost to Follow-up|5|||
145354267|NCT01422213|524145557|FG000|Overall Study|Administrative or Other Reason(s)|5|||
145354268|NCT01422213|524145558|FG001|Overall Study|Administrative or Other Reason(s)|4|||
145354269|NCT01422213|524145559|FG002|Overall Study|Administrative or Other Reason(s)|2|||
145354270|NCT02857816|524145560|FG000|Overall Study|Screen Failure|33|||
145354271|NCT02857816|524145560|FG000|Overall Study|Withdrawal by Subject|4|||
145354272|NCT02857816|524145560|FG000|Overall Study|Lost to Follow-up|1|||
145354273|NCT01320293|524145562|FG000|Overall Study|Lack of Efficacy|1|||
145354274|NCT01320293|524145562|FG000|Overall Study|Adverse Event|1|||
145354275|NCT00470470|524145563|FG000|Overall Study|Adverse Event|2|||
145354276|NCT00470470|524145563|FG000|Overall Study|Death|2|||
145354277|NCT00470470|524145563|FG000|Overall Study|Not treated|1|||
145354278|NCT03483012|524145564|FG000|Overall Study|Lack of Efficacy|6|||
145354279|NCT01149863|524145576|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
145354280|NCT03918629|524145577|FG000|Overall Study|Adverse Event|19|||
145354281|NCT03918629|524145578|FG001|Overall Study|Adverse Event|20|||
145354282|NCT03918629|524145577|FG000|Overall Study|Death|14|||
145354283|NCT03918629|524145578|FG001|Overall Study|Death|7|||
145354284|NCT03918629|524145577|FG000|Overall Study|Lost to Follow-up|36|||
145354285|NCT03918629|524145578|FG001|Overall Study|Lost to Follow-up|28|||
145354286|NCT03918629|524145577|FG000|Overall Study|Physician Decision|1|||
145354287|NCT03918629|524145578|FG001|Overall Study|Physician Decision|0|||
145354288|NCT03918629|524145577|FG000|Overall Study|Protocol Violation|7|||
145354289|NCT03918629|524145578|FG001|Overall Study|Protocol Violation|4|||
145354290|NCT03918629|524145577|FG000|Overall Study|Withdrawal by Subject|47|||
145354291|NCT03918629|524145578|FG001|Overall Study|Withdrawal by Subject|47|||
145354292|NCT03918629|524145577|FG000|Overall Study|Other|7|||
145354293|NCT03918629|524145578|FG001|Overall Study|Other|11|||
145354294|NCT03918629|524145577|FG000|Overall Study|Randomized but not vaccinated|2|||
145354295|NCT03918629|524145578|FG001|Overall Study|Randomized but not vaccinated|1|||
145354296|NCT01891864|524145580|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
145354297|NCT01891864|524145581|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
145354298|NCT01891864|524145582|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145354299|NCT01891864|524145583|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145354300|NCT01891864|524145584|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145417156|NCT03738215|524381944|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
145417157|NCT03738215|524381945|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
145354301|NCT01891864|524145585|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
145354302|NCT01891864|524145580|FG000|Treatment Period 1|Physician Decision|0|||
145354303|NCT01891864|524145581|FG001|Treatment Period 1|Physician Decision|1|||
145354304|NCT01891864|524145582|FG002|Treatment Period 1|Physician Decision|0|||
145354305|NCT01891864|524145583|FG003|Treatment Period 1|Physician Decision|0|||
145354306|NCT01891864|524145584|FG004|Treatment Period 1|Physician Decision|0|||
145354307|NCT01891864|524145585|FG005|Treatment Period 1|Physician Decision|0|||
145354308|NCT01891864|524145580|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145354309|NCT01891864|524145581|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
145354310|NCT01891864|524145582|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145354311|NCT01891864|524145583|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145354312|NCT01891864|524145584|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145577314|NCT01109316|524968046|FG002|Study Period 2|Physician Decision|0|||
145417158|NCT03738215|524381946|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
145417159|NCT03738215|524381944|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
145417160|NCT03738215|524381945|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
145417161|NCT03738215|524381946|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
145417162|NCT03738215|524381944|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
145417163|NCT03738215|524381945|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
145417164|NCT03738215|524381946|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
145417165|NCT03738215|524381944|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
145417166|NCT03738215|524381945|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
145417167|NCT03738215|524381946|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
145417168|NCT02638493|524381947|FG000|Overall Study|Inability to provide semen samples|2|||
145417169|NCT02638493|524381948|FG001|Overall Study|Inability to provide semen samples|0|||
145417170|NCT02638493|524381949|FG002|Overall Study|Inability to provide semen samples|0|||
145417171|NCT03882801|524383792|FG000|Period 1|Adverse Event|0|||
145417172|NCT03882801|524383793|FG001|Period 1|Adverse Event|1|||
145417173|NCT03882801|524383792|FG000|Period 1|Non-compliance with study drug|1|||
145417174|NCT03882801|524383793|FG001|Period 1|Non-compliance with study drug|1|||
145417175|NCT03882801|524383792|FG000|Period 1|Never treated with study drug|1|||
145417176|NCT03882801|524383793|FG001|Period 1|Never treated with study drug|0|||
145417177|NCT03882801|524383792|FG000|Washout Period|Physician Decision|0|||
145417178|NCT03882801|524383793|FG001|Washout Period|Physician Decision|1|||
145417179|NCT03882801|524383792|FG000|Period 2|Non-compliance with study drug|0|||
145417180|NCT03882801|524383793|FG001|Period 2|Non-compliance with study drug|1|||
145417181|NCT04193176|524383794|FG000|Overall Study|Withdrawal by Subject|6|||
145417182|NCT04193176|524383795|FG001|Overall Study|Withdrawal by Subject|10|||
145417183|NCT00944645|524383796|FG000|Period 2|Adverse Event|1|||
145417184|NCT00944645|524383797|FG001|Period 2|Adverse Event|0|||
145417185|NCT00944645|524383796|FG000|Period 2|Lost to Follow-up|0|||
145417186|NCT00944645|524383797|FG001|Period 2|Lost to Follow-up|3|||
145417187|NCT00944645|524383796|FG000|Period 2|Withdrawal by Subject|7|||
145417188|NCT00944645|524383797|FG001|Period 2|Withdrawal by Subject|6|||
145417189|NCT03928704|524383801|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145417190|NCT03928704|524383802|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
145417191|NCT03928704|524383803|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145417192|NCT03928704|524383804|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145417193|NCT03928704|524383805|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145417194|NCT03928704|524383806|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
145417195|NCT03928704|524383801|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
145417196|NCT03928704|524383802|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145417197|NCT03928704|524383803|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145417198|NCT03928704|524383804|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145417199|NCT03928704|524383805|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145417200|NCT03928704|524383806|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
145417201|NCT03928704|524383801|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
145417202|NCT03928704|524383802|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145417203|NCT03928704|524383803|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145417204|NCT03928704|524383804|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145417205|NCT03928704|524383805|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145417206|NCT03928704|524383806|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
145417207|NCT03928704|524383801|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
145417208|NCT03928704|524383802|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
145417209|NCT03928704|524383803|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145417210|NCT03928704|524383804|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145417211|NCT03928704|524383805|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145417212|NCT03928704|524383806|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
145417213|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145417214|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145417215|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
145417216|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145417217|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145417218|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
145417219|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145417220|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145417221|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
145417222|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145417223|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145417224|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
145622971|NCT03303105|525131541|FG001|Overall Study|Adverse Event|2|||
145354313|NCT01891864|524145585|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
145577315|NCT01109316|524968047|FG003|Study Period 2|Physician Decision|1|||
145577316|NCT01109316|524968048|FG004|Study Period 2|Physician Decision|0|||
145354314|NCT01891864|524145580|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
145354315|NCT01891864|524145581|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
145354316|NCT01891864|524145582|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145354317|NCT01891864|524145583|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145354318|NCT01891864|524145584|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145354319|NCT01891864|524145585|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
145354320|NCT01891864|524145580|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145354321|NCT01891864|524145581|FG001|Treatment Period 1|Withdrawal by Subject|5|||
145354322|NCT01891864|524145582|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145354323|NCT01891864|524145583|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145354324|NCT01891864|524145584|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145354325|NCT01891864|524145585|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145354326|NCT01891864|524145580|FG000|Treatment Period 1|Lost to Follow-up|1|||
145354327|NCT01891864|524145581|FG001|Treatment Period 1|Lost to Follow-up|0|||
145354328|NCT01891864|524145582|FG002|Treatment Period 1|Lost to Follow-up|0|||
145354329|NCT01891864|524145583|FG003|Treatment Period 1|Lost to Follow-up|0|||
145354330|NCT01891864|524145584|FG004|Treatment Period 1|Lost to Follow-up|0|||
145354331|NCT01891864|524145585|FG005|Treatment Period 1|Lost to Follow-up|0|||
145354332|NCT01891864|524145580|FG000|Treatment Period 2|Protocol Violation|0|||
145354333|NCT01891864|524145581|FG001|Treatment Period 2|Protocol Violation|0|||
145354334|NCT01891864|524145582|FG002|Treatment Period 2|Protocol Violation|0|||
145354335|NCT01891864|524145583|FG003|Treatment Period 2|Protocol Violation|1|||
145354336|NCT01891864|524145584|FG004|Treatment Period 2|Protocol Violation|0|||
145354337|NCT01891864|524145585|FG005|Treatment Period 2|Protocol Violation|0|||
145354338|NCT01891864|524145580|FG000|Treatment Period 2|Physician Decision|0|||
145354339|NCT01891864|524145581|FG001|Treatment Period 2|Physician Decision|0|||
145354340|NCT01891864|524145582|FG002|Treatment Period 2|Physician Decision|1|||
145354341|NCT01891864|524145583|FG003|Treatment Period 2|Physician Decision|0|||
145354342|NCT01891864|524145584|FG004|Treatment Period 2|Physician Decision|0|||
145354343|NCT01891864|524145585|FG005|Treatment Period 2|Physician Decision|0|||
145354344|NCT01891864|524145580|FG000|Treatment Period 2|Site Termination|0|||
145354345|NCT01891864|524145581|FG001|Treatment Period 2|Site Termination|0|||
145354346|NCT01891864|524145582|FG002|Treatment Period 2|Site Termination|1|||
145354347|NCT01891864|524145583|FG003|Treatment Period 2|Site Termination|2|||
145354348|NCT01891864|524145584|FG004|Treatment Period 2|Site Termination|0|||
145354349|NCT01891864|524145585|FG005|Treatment Period 2|Site Termination|0|||
145354350|NCT01891864|524145580|FG000|Treatment Period 2|Lack of Efficacy|0|||
145354351|NCT01891864|524145581|FG001|Treatment Period 2|Lack of Efficacy|0|||
145354352|NCT01891864|524145582|FG002|Treatment Period 2|Lack of Efficacy|1|||
145354353|NCT01891864|524145583|FG003|Treatment Period 2|Lack of Efficacy|0|||
145354354|NCT01891864|524145584|FG004|Treatment Period 2|Lack of Efficacy|1|||
145354355|NCT01891864|524145585|FG005|Treatment Period 2|Lack of Efficacy|0|||
145354356|NCT01891864|524145580|FG000|Treatment Period 2|Adverse Event|0|||
145354357|NCT01891864|524145581|FG001|Treatment Period 2|Adverse Event|0|||
145354358|NCT01891864|524145582|FG002|Treatment Period 2|Adverse Event|1|||
145354359|NCT01891864|524145583|FG003|Treatment Period 2|Adverse Event|2|||
145354360|NCT01891864|524145584|FG004|Treatment Period 2|Adverse Event|0|||
145354361|NCT01891864|524145585|FG005|Treatment Period 2|Adverse Event|4|||
145354362|NCT01891864|524145580|FG000|Treatment Period 2|Termination of Site|0|||
145354363|NCT01891864|524145581|FG001|Treatment Period 2|Termination of Site|0|||
145354364|NCT01891864|524145582|FG002|Treatment Period 2|Termination of Site|0|||
145354365|NCT01891864|524145583|FG003|Treatment Period 2|Termination of Site|0|||
145354366|NCT01891864|524145584|FG004|Treatment Period 2|Termination of Site|2|||
145354367|NCT01891864|524145585|FG005|Treatment Period 2|Termination of Site|0|||
145354368|NCT01891864|524145580|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145354369|NCT01891864|524145581|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145354370|NCT01891864|524145582|FG002|Treatment Period 2|Withdrawal by Subject|3|||
145354371|NCT01891864|524145583|FG003|Treatment Period 2|Withdrawal by Subject|4|||
145354372|NCT01891864|524145584|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145354373|NCT01891864|524145585|FG005|Treatment Period 2|Withdrawal by Subject|1|||
145577317|NCT01109316|524968049|FG005|Study Period 2|Physician Decision|0|||
145354374|NCT01891864|524145580|FG000|Extension Period|Lack of Efficacy|0|||
145354375|NCT01891864|524145581|FG001|Extension Period|Lack of Efficacy|0|||
145354376|NCT01891864|524145582|FG002|Extension Period|Lack of Efficacy|0|||
145354377|NCT01891864|524145583|FG003|Extension Period|Lack of Efficacy|1|||
145354378|NCT01891864|524145584|FG004|Extension Period|Lack of Efficacy|1|||
145354379|NCT01891864|524145585|FG005|Extension Period|Lack of Efficacy|0|||
145354380|NCT01891864|524145580|FG000|Extension Period|Pregnancy|0|||
145354381|NCT01891864|524145581|FG001|Extension Period|Pregnancy|0|||
145354382|NCT01891864|524145582|FG002|Extension Period|Pregnancy|1|||
145577318|NCT01109316|524968044|FG000|Study Period 2|Protocol Violation|1|||
145354383|NCT01891864|524145583|FG003|Extension Period|Pregnancy|0|||
145417225|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
145417226|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
145417227|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
145417228|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
145417229|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
145417230|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
145417231|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145417232|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145417233|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
145417234|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145417235|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145417236|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
145417237|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145417238|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145417239|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145417240|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145417241|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
145417242|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
145417243|NCT03928704|524383801|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
145417244|NCT03928704|524383802|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
145417245|NCT03928704|524383803|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
145417246|NCT03928704|524383804|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
145417247|NCT03928704|524383805|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
145417248|NCT03928704|524383806|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
145417249|NCT01245751|524383811|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
145417250|NCT01245751|524383812|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
145417251|NCT01245751|524383813|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
145417252|NCT01245751|524383814|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
145417253|NCT01245751|524383811|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145417254|NCT01245751|524383812|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145417255|NCT01245751|524383813|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
145417256|NCT01245751|524383814|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
145417257|NCT01245751|524383811|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145417258|NCT01245751|524383812|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
145417259|NCT01245751|524383813|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145417260|NCT01245751|524383814|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
145417261|NCT02181621|524383815|FG000|Overall Study|Adverse Event|1|||
145417262|NCT02181621|524383816|FG001|Overall Study|Adverse Event|0|||
145417263|NCT02181621|524383815|FG000|Overall Study|Previously Enrolled|0|||
145417264|NCT02181621|524383816|FG001|Overall Study|Previously Enrolled|1|||
145417265|NCT02181621|524383815|FG000|Overall Study|Enrollment Hold|1|||
145417266|NCT02181621|524383816|FG001|Overall Study|Enrollment Hold|1|||
145417267|NCT02959892|524383827|FG000|Overall Study|PET tracer synthesis failure|1|||
145417268|NCT02959892|524383828|FG001|Overall Study|PET tracer synthesis failure|0|||
145417269|NCT02959892|524383827|FG000|Overall Study|Study termination|0|||
145417270|NCT02959892|524383828|FG001|Overall Study|Study termination|1|||
145417271|NCT03338023|524383829|FG000|Overall Study|Withdrawal by Subject|3|||
145417272|NCT03338023|524383830|FG001|Overall Study|Withdrawal by Subject|4|||
145417273|NCT03338023|524383829|FG000|Overall Study|Protocol Violation|3|||
145417274|NCT03338023|524383830|FG001|Overall Study|Protocol Violation|3|||
145417275|NCT03338023|524383829|FG000|Overall Study|Lost to Follow-up|2|||
145417276|NCT03338023|524383830|FG001|Overall Study|Lost to Follow-up|1|||
145417277|NCT03338023|524383829|FG000|Overall Study|Physician Decision|1|||
145417278|NCT03338023|524383830|FG001|Overall Study|Physician Decision|2|||
145417279|NCT05064800|524383836|FG000|Period 3|Withdrawal by Subject|0|||
145417280|NCT05064800|524383837|FG001|Period 3|Withdrawal by Subject|0|||
145417281|NCT05064800|524383838|FG002|Period 3|Withdrawal by Subject|0|||
145417282|NCT05064800|524383839|FG003|Period 3|Withdrawal by Subject|0|||
145417283|NCT05064800|524383840|FG004|Period 3|Withdrawal by Subject|1|||
145417284|NCT05064800|524383841|FG005|Period 3|Withdrawal by Subject|0|||
145417285|NCT01181128|524383842|FG000|Overall Study|Withdrawal by Subject|2|||
145417286|NCT01181128|524383843|FG001|Overall Study|Withdrawal by Subject|2|||
145417287|NCT01181128|524383844|FG002|Overall Study|Withdrawal by Subject|0|||
145417288|NCT01181128|524383842|FG000|Overall Study|Death|1|||
145417289|NCT01181128|524383843|FG001|Overall Study|Death|0|||
145417290|NCT01181128|524383844|FG002|Overall Study|Death|0|||
145577319|NCT01109316|524968045|FG001|Study Period 2|Protocol Violation|0|||
145417291|NCT01181128|524383842|FG000|Overall Study|Physician Decision|2|||
145417292|NCT01181128|524383843|FG001|Overall Study|Physician Decision|0|||
145417293|NCT01181128|524383844|FG002|Overall Study|Physician Decision|0|||
145417294|NCT01181128|524383842|FG000|Overall Study|Adverse Event|0|||
145577320|NCT01109316|524968046|FG002|Study Period 2|Protocol Violation|0|||
145577321|NCT01109316|524968047|FG003|Study Period 2|Protocol Violation|0|||
145354384|NCT01891864|524145584|FG004|Extension Period|Pregnancy|0|||
145354385|NCT01891864|524145585|FG005|Extension Period|Pregnancy|0|||
145354386|NCT01891864|524145580|FG000|Extension Period|Adverse Event|0|||
145354387|NCT01891864|524145581|FG001|Extension Period|Adverse Event|0|||
145354388|NCT01891864|524145582|FG002|Extension Period|Adverse Event|4|||
145354389|NCT01891864|524145583|FG003|Extension Period|Adverse Event|2|||
145354390|NCT01891864|524145584|FG004|Extension Period|Adverse Event|2|||
145354391|NCT01891864|524145585|FG005|Extension Period|Adverse Event|0|||
145354392|NCT01891864|524145580|FG000|Extension Period|Withdrawal by Subject|0|||
145354393|NCT01891864|524145581|FG001|Extension Period|Withdrawal by Subject|0|||
145354394|NCT01891864|524145582|FG002|Extension Period|Withdrawal by Subject|1|||
145354395|NCT01891864|524145583|FG003|Extension Period|Withdrawal by Subject|2|||
145354396|NCT01891864|524145584|FG004|Extension Period|Withdrawal by Subject|4|||
145354397|NCT01891864|524145585|FG005|Extension Period|Withdrawal by Subject|0|||
145354398|NCT01891864|524145580|FG000|Extension Period|Lost to Follow-up|0|||
145354399|NCT01891864|524145581|FG001|Extension Period|Lost to Follow-up|0|||
145354400|NCT01891864|524145582|FG002|Extension Period|Lost to Follow-up|2|||
145354401|NCT01891864|524145583|FG003|Extension Period|Lost to Follow-up|0|||
145354402|NCT01891864|524145584|FG004|Extension Period|Lost to Follow-up|0|||
145354403|NCT01891864|524145585|FG005|Extension Period|Lost to Follow-up|0|||
145354404|NCT04314037|524145591|FG000|Treatment Period 2|Adverse Event|1|||
145354405|NCT04314037|524145592|FG001|Treatment Period 2|Adverse Event|0|||
145354406|NCT04314037|524145591|FG000|Treatment Period 3|Protocol Violation|1|||
145354407|NCT04314037|524145592|FG001|Treatment Period 3|Protocol Violation|0|||
145354408|NCT04314037|524145591|FG000|Treatment Period 3|Adverse Event|0|||
145354409|NCT04314037|524145592|FG001|Treatment Period 3|Adverse Event|1|||
145354410|NCT00273182|524145594|FG000|Overall Study|Death|450|||
145354411|NCT00273182|524145594|FG000|Overall Study|Lost to Follow-up|88|||
145354412|NCT00273182|524145594|FG000|Overall Study|Withdrawal by Subject|257|||
145354413|NCT00273182|524145594|FG000|Overall Study|Device/System Explant|154|||
145354414|NCT00273182|524145594|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
145354415|NCT00856492|524145597|FG000|Overall Study|Ineligible or withdrew consent|1|||
145354416|NCT00856492|524145598|FG001|Overall Study|Ineligible or withdrew consent|1|||
145354417|NCT00856492|524145599|FG002|Overall Study|Ineligible or withdrew consent|2|||
145354418|NCT03832686|524145600|FG000|Overall Study|Lost to Follow-up|6|||
145354419|NCT03832686|524145601|FG001|Overall Study|Lost to Follow-up|9|||
145354420|NCT03832686|524145600|FG000|Overall Study|Discontinued Intervention|5|||
145354421|NCT03832686|524145601|FG001|Overall Study|Discontinued Intervention|4|||
145354422|NCT02235454|524145602|FG000|Overall Study|Withdrawal by Subject|2|||
145354423|NCT04199104|524147206|FG000|Overall Study|Death|148|||
145354424|NCT04199104|524147207|FG001|Overall Study|Death|134|||
145354425|NCT04199104|524147206|FG000|Overall Study|Lost to Follow-up|1|||
145354426|NCT04199104|524147207|FG001|Overall Study|Lost to Follow-up|1|||
145354427|NCT04199104|524147206|FG000|Overall Study|Withdrawal by Subject|4|||
145354428|NCT04199104|524147207|FG001|Overall Study|Withdrawal by Subject|4|||
145354429|NCT04199104|524147206|FG000|Overall Study|Participants Ongoing|103|||
145354430|NCT04199104|524147207|FG001|Overall Study|Participants Ongoing|116|||
145354431|NCT04796961|524147210|FG000|Overall Study|Lost to Follow-up|10|||
145354432|NCT04796961|524147210|FG000|Overall Study|Withdrawal by Subject|3|||
145354433|NCT04796961|524147210|FG000|Overall Study|Left Organization|10|||
145354434|NCT01439802|524147211|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
145354435|NCT01439802|524147211|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
145354436|NCT02502149|524147212|FG000|Intermediate|Discontinued prematurely|1|||
145354437|NCT02502149|524147213|FG001|Intermediate|Discontinued prematurely|0|||
145354438|NCT02502149|524147214|FG002|Intermediate|Discontinued prematurely|0|||
145354439|NCT02502149|524147215|FG003|Intermediate|Discontinued prematurely|0|||
145354440|NCT02502149|524147216|FG004|Intermediate|Discontinued prematurely|0|||
145354441|NCT00513240|524147217|FG000|Overall Study|Did not have intended surgery|3|||
145354442|NCT00513240|524147218|FG001|Overall Study|Did not have intended surgery|0|||
145354443|NCT00513240|524147217|FG000|Overall Study|Death|3|||
145354444|NCT00513240|524147218|FG001|Overall Study|Death|3|||
145354445|NCT00513240|524147217|FG000|Overall Study|Withdrawal by Subject|7|||
145354446|NCT00513240|524147218|FG001|Overall Study|Withdrawal by Subject|4|||
145354447|NCT05263908|524147219|FG000|Overall Study|No informed consent for publication of study results|397|||
145354448|NCT05263908|524147219|FG000|Overall Study|CRF not collected|1|||
145354449|NCT01641640|524147227|FG000|Overall Study|Enrolled but not treated|1|||
145354450|NCT01641640|524147227|FG000|Overall Study|Efficacy failure|29|||
145354451|NCT01641640|524147227|FG000|Overall Study|Lost to Follow-up|3|||
145354452|NCT01641640|524147227|FG000|Overall Study|Withdrawal by Subject|2|||
145354453|NCT01641640|524147227|FG000|Overall Study|Adverse Event|1|||
145354454|NCT01433471|524147228|FG000|Overall Study|Withdrawal by Subject|0|||
145354455|NCT01433471|524147229|FG001|Overall Study|Withdrawal by Subject|1|||
145354456|NCT03711188|524147230|FG000|Overall Study|Disease progression|11|||
145354457|NCT03711188|524147230|FG000|Overall Study|Adverse Event|1|||
145354458|NCT02550561|524147231|FG000|Overall Study|Lost to Follow-up|5|||
145354459|NCT02550561|524147231|FG000|Overall Study|Withdrawal by Subject|1|||
145354460|NCT02570308|524147237|FG000|Overall Study|Death|1|||
145417295|NCT01181128|524383843|FG001|Overall Study|Adverse Event|2|||
145417296|NCT01181128|524383844|FG002|Overall Study|Adverse Event|0|||
145417297|NCT01181128|524383842|FG000|Overall Study|Other|1|||
145354461|NCT02570308|524147238|FG001|Overall Study|Death|5|||
145354462|NCT02570308|524147239|FG002|Overall Study|Death|4|||
145417298|NCT01181128|524383843|FG001|Overall Study|Other|1|||
145417299|NCT01181128|524383844|FG002|Overall Study|Other|1|||
145417300|NCT00629239|524383845|FG000|Overall Study|Adverse Event|7|||
145417301|NCT00629239|524383846|FG001|Overall Study|Adverse Event|4|||
145417302|NCT00629239|524383845|FG000|Overall Study|Physician Decision|1|||
145417303|NCT00629239|524383846|FG001|Overall Study|Physician Decision|0|||
145417304|NCT00183391|524383849|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
145417305|NCT00183391|524383850|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
145417306|NCT00183391|524383849|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
145417307|NCT00183391|524383850|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
145417308|NCT01543503|524383851|FG000|Overall Study|Lost to Follow-up|32|||
145417309|NCT01543503|524383852|FG001|Overall Study|Lost to Follow-up|36|||
145417310|NCT01543503|524383851|FG000|Overall Study|Adverse Event|9|||
145417311|NCT01543503|524383852|FG001|Overall Study|Adverse Event|13|||
145417312|NCT01543503|524383851|FG000|Overall Study|Lack of Efficacy|4|||
145417313|NCT01543503|524383852|FG001|Overall Study|Lack of Efficacy|16|||
145417314|NCT01543503|524383851|FG000|Overall Study|Participant withdrew informed consent|8|||
145417315|NCT01543503|524383852|FG001|Overall Study|Participant withdrew informed consent|10|||
145417316|NCT01543503|524383851|FG000|Overall Study|Change of jobs|0|||
145417317|NCT01543503|524383852|FG001|Overall Study|Change of jobs|1|||
145417318|NCT01543503|524383851|FG000|Overall Study|Intolerance to the biologic treatment|0|||
145417319|NCT01543503|524383852|FG001|Overall Study|Intolerance to the biologic treatment|1|||
145417320|NCT01543503|524383851|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
145417321|NCT01543503|524383852|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
145417322|NCT01543503|524383851|FG000|Overall Study|Participant did not complete last visit|0|||
145417323|NCT01543503|524383852|FG001|Overall Study|Participant did not complete last visit|2|||
145417324|NCT01543503|524383851|FG000|Overall Study|Refused to continue treatment|7|||
145417325|NCT01543503|524383852|FG001|Overall Study|Refused to continue treatment|0|||
145417326|NCT01543503|524383851|FG000|Overall Study|Incorrect medication received|1|||
145417327|NCT01543503|524383852|FG001|Overall Study|Incorrect medication received|0|||
145417328|NCT01543503|524383851|FG000|Overall Study|Participant moved to another city|2|||
145417329|NCT01543503|524383852|FG001|Overall Study|Participant moved to another city|0|||
145417330|NCT01543503|524383851|FG000|Overall Study|Participant will not return for visits|0|||
145354463|NCT02570308|524147240|FG003|Overall Study|Death|4|||
145354464|NCT02570308|524147241|FG004|Overall Study|Death|69|||
145354465|NCT02570308|524147237|FG000|Overall Study|Lost to Follow-up|0|||
145354466|NCT02570308|524147238|FG001|Overall Study|Lost to Follow-up|0|||
145354467|NCT02570308|524147239|FG002|Overall Study|Lost to Follow-up|0|||
145354468|NCT02570308|524147240|FG003|Overall Study|Lost to Follow-up|0|||
145354469|NCT02570308|524147241|FG004|Overall Study|Lost to Follow-up|2|||
145354470|NCT02570308|524147237|FG000|Overall Study|Withdrawal by Subject|0|||
145354471|NCT02570308|524147238|FG001|Overall Study|Withdrawal by Subject|0|||
145354472|NCT02570308|524147239|FG002|Overall Study|Withdrawal by Subject|0|||
145354473|NCT02570308|524147240|FG003|Overall Study|Withdrawal by Subject|0|||
145354474|NCT02570308|524147241|FG004|Overall Study|Withdrawal by Subject|1|||
145354475|NCT02570308|524147237|FG000|Overall Study|Other|0|||
145354476|NCT02570308|524147238|FG001|Overall Study|Other|0|||
145354477|NCT02570308|524147239|FG002|Overall Study|Other|0|||
145354478|NCT02570308|524147240|FG003|Overall Study|Other|0|||
145417331|NCT01543503|524383852|FG001|Overall Study|Participant will not return for visits|2|||
145417332|NCT01543503|524383851|FG000|Overall Study|Participant transferred to another city|1|||
145417333|NCT01543503|524383852|FG001|Overall Study|Participant transferred to another city|0|||
145417334|NCT01543503|524383851|FG000|Overall Study|Participant moved to Scotland|1|||
145417335|NCT01543503|524383852|FG001|Overall Study|Participant moved to Scotland|0|||
145417336|NCT01543503|524383851|FG000|Overall Study|Participant decision to stop treatment|1|||
145417337|NCT01543503|524383852|FG001|Overall Study|Participant decision to stop treatment|0|||
145417338|NCT01543503|524383851|FG000|Overall Study|Investigator did not wish to participate|1|||
145417339|NCT01543503|524383852|FG001|Overall Study|Investigator did not wish to participate|1|||
145354479|NCT02570308|524147241|FG004|Overall Study|Other|2|||
145354480|NCT02069015|524147243|FG000|Overall Study|Lost to Follow-up|39|||
145354481|NCT02069015|524147244|FG001|Overall Study|Lost to Follow-up|32|||
145354482|NCT02069015|524147243|FG000|Overall Study|Withdrawal by Subject|1|||
145417340|NCT01543503|524383851|FG000|Overall Study|Participant recruited after closing date|0|||
145417341|NCT01543503|524383852|FG001|Overall Study|Participant recruited after closing date|1|||
145417342|NCT01543503|524383851|FG000|Overall Study|Site stopped participation|5|||
145417343|NCT01543503|524383852|FG001|Overall Study|Site stopped participation|1|||
145417344|NCT01543503|524383851|FG000|Overall Study|Participant did not attend a visit|1|||
145354483|NCT02069015|524147244|FG001|Overall Study|Withdrawal by Subject|1|||
145354484|NCT02285361|524147245|FG000|Overall Study|Protocol Violation|43|||
145417345|NCT01543503|524383852|FG001|Overall Study|Participant did not attend a visit|0|||
145417346|NCT01543503|524383851|FG000|Overall Study|Moved to other rheumatologic site|0|||
145417347|NCT01543503|524383852|FG001|Overall Study|Moved to other rheumatologic site|1|||
145417348|NCT01543503|524383851|FG000|Overall Study|Participant consented to another study|0|||
145417349|NCT01543503|524383852|FG001|Overall Study|Participant consented to another study|2|||
145417350|NCT01543503|524383851|FG000|Overall Study|Participant went to United States|1|||
145417351|NCT01543503|524383852|FG001|Overall Study|Participant went to United States|0|||
145417352|NCT01543503|524383851|FG000|Overall Study|Screen failure|1|||
145417353|NCT01543503|524383852|FG001|Overall Study|Screen failure|0|||
145417354|NCT02460380|524383853|FG000|Overall Study|Withdrawal by Subject|10|||
145417355|NCT02460380|524383854|FG001|Overall Study|Withdrawal by Subject|5|||
145417356|NCT00052715|524383858|FG000|Overall Study|wrong histology|1|||
145417357|NCT01936974|524383859|FG000|Overall Study|Physician Decision|2|||
145417358|NCT01936974|524383860|FG001|Overall Study|Physician Decision|5|||
145417359|NCT05507450|524383862|FG000|Overall Study|Death|0|||
145417360|NCT05507450|524383863|FG001|Overall Study|Death|0|||
145417361|NCT05507450|524383864|FG002|Overall Study|Death|1|||
145417362|NCT05507450|524383865|FG003|Overall Study|Death|0|||
145417363|NCT05507450|524383862|FG000|Overall Study|Lost to Follow-up|22|||
145417364|NCT05507450|524383863|FG001|Overall Study|Lost to Follow-up|20|||
145417365|NCT05507450|524383864|FG002|Overall Study|Lost to Follow-up|20|||
145417366|NCT05507450|524383865|FG003|Overall Study|Lost to Follow-up|7|||
145417367|NCT05507450|524383862|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145417368|NCT05507450|524383863|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145417369|NCT05507450|524383864|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145417370|NCT05507450|524383865|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145417371|NCT05507450|524383862|FG000|Overall Study|Withdrawal by Subject|4|||
145417372|NCT05507450|524383863|FG001|Overall Study|Withdrawal by Subject|11|||
145417373|NCT05507450|524383864|FG002|Overall Study|Withdrawal by Subject|7|||
145417374|NCT05507450|524383865|FG003|Overall Study|Withdrawal by Subject|3|||
145417375|NCT05507450|524383862|FG000|Overall Study|Participant left the country|0|||
145417376|NCT05507450|524383863|FG001|Overall Study|Participant left the country|0|||
145417377|NCT05507450|524383864|FG002|Overall Study|Participant left the country|1|||
145417378|NCT05507450|524383865|FG003|Overall Study|Participant left the country|0|||
145417379|NCT01078545|524383866|FG000|Overall Study|Lost to Follow-up|13|||
145417380|NCT01078545|524383866|FG000|Overall Study|Physician Decision|6|||
145417381|NCT01078545|524383866|FG000|Overall Study|Withdrawal by Subject|3|||
145417382|NCT01078545|524383866|FG000|Overall Study|Death|3|||
145417383|NCT01078545|524383866|FG000|Overall Study|Participant moved to another physician|1|||
145417384|NCT02497755|524383867|FG000|Overall Study|Protocol Violation|1|||
145417385|NCT02497755|524383868|FG001|Overall Study|Protocol Violation|0|||
145417386|NCT01774370|524383869|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
145417387|NCT01774370|524383869|FG000|Overall Study|Administered prior to the contract date|4|||
145417388|NCT01774370|524383869|FG000|Overall Study|Subjects of contraindications|34|||
145417389|NCT01774370|524383869|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
145417390|NCT01774370|524383869|FG000|Overall Study|Follow-up failure|34|||
145577322|NCT01109316|524968048|FG004|Study Period 2|Protocol Violation|0|||
145577323|NCT01109316|524968049|FG005|Study Period 2|Protocol Violation|0|||
145577324|NCT01109316|524968044|FG000|Study Period 2|Withdrawal by Subject|0|||
145577325|NCT01109316|524968045|FG001|Study Period 2|Withdrawal by Subject|0|||
145577326|NCT01109316|524968046|FG002|Study Period 2|Withdrawal by Subject|1|||
145577327|NCT01109316|524968047|FG003|Study Period 2|Withdrawal by Subject|0|||
145577328|NCT01109316|524968048|FG004|Study Period 2|Withdrawal by Subject|0|||
145417391|NCT05436288|524383870|FG000|Overall Study|Lost to Follow-up|1|||
145417392|NCT05436288|524383870|FG000|Overall Study|Adverse Event|1|||
145417393|NCT00514917|524383874|FG000|Overall Study|Death|4|||
145417394|NCT00514917|524383875|FG001|Overall Study|Death|10|||
145417395|NCT00514917|524383874|FG000|Overall Study|Protocol Violation|1|||
145417396|NCT00514917|524383875|FG001|Overall Study|Protocol Violation|0|||
145417397|NCT00514917|524383874|FG000|Overall Study|Lost to Follow-up|4|||
145417398|NCT00514917|524383875|FG001|Overall Study|Lost to Follow-up|3|||
145417399|NCT00514917|524383874|FG000|Overall Study|Withdrawal by Subject|18|||
145417400|NCT00514917|524383875|FG001|Overall Study|Withdrawal by Subject|16|||
145417401|NCT00514917|524383874|FG000|Overall Study|Discontinued due to study closure|88|||
145577329|NCT01109316|524968049|FG005|Study Period 2|Withdrawal by Subject|1|||
145577330|NCT01109316|524968044|FG000|Study Period 3|Lost to Follow-up|0|||
145417402|NCT00514917|524383875|FG001|Overall Study|Discontinued due to study closure|81|||
145417403|NCT00514917|524383874|FG000|Overall Study|Undefined|11|||
145417404|NCT00514917|524383875|FG001|Overall Study|Undefined|5|||
145417405|NCT03767894|524383876|FG000|Overall Study|Withdrawal by Subject|1|||
145417406|NCT01436500|524383879|FG000|Overall Study|Death|1|||
145417407|NCT01436500|524383880|FG001|Overall Study|Death|0|||
145417408|NCT01436500|524383881|FG002|Overall Study|Death|0|||
145577331|NCT01109316|524968045|FG001|Study Period 3|Lost to Follow-up|0|||
145417409|NCT01436500|524383882|FG003|Overall Study|Death|0|||
145417410|NCT01436500|524383883|FG004|Overall Study|Death|0|||
145417411|NCT01436500|524383879|FG000|Overall Study|Adverse Event|0|||
145577332|NCT01109316|524968046|FG002|Study Period 3|Lost to Follow-up|0|||
145354485|NCT02285361|524147245|FG000|Overall Study|Lost to Follow-up|5|||
145354486|NCT02285361|524147245|FG000|Overall Study|Not taken GIOTRIF|2|||
145354487|NCT02285361|524147245|FG000|Overall Study|Consented prior to the contract date|1|||
145354488|NCT05506046|524147246|FG000|Overall Study|Lost to Follow-up|89|||
145354489|NCT05506046|524147247|FG001|Overall Study|Lost to Follow-up|101|||
145354490|NCT05506046|524147248|FG002|Overall Study|Lost to Follow-up|102|||
145354491|NCT05506046|524147249|FG003|Overall Study|Lost to Follow-up|99|||
145354492|NCT01283464|524147250|FG000|Overall Study|Lost to Follow-up|0|||
145354493|NCT01283464|524147251|FG001|Overall Study|Lost to Follow-up|1|||
145354494|NCT01283464|524147250|FG000|Overall Study|Withdrawal by Subject|1|||
145354495|NCT01283464|524147251|FG001|Overall Study|Withdrawal by Subject|0|||
145354496|NCT01283464|524147250|FG000|Overall Study|Physician Decision|1|||
145354497|NCT01283464|524147251|FG001|Overall Study|Physician Decision|0|||
145354498|NCT03051100|524147252|FG000|Overall Study|Withdrawal by Subject|1|||
145354499|NCT03051100|524147253|FG001|Overall Study|Withdrawal by Subject|0|||
145354500|NCT01778855|524147254|FG000|Overall Study|Death|0|||
145354501|NCT01778855|524147255|FG001|Overall Study|Death|1|||
145354502|NCT02059135|524147256|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
145354503|NCT02059135|524147257|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
145354504|NCT02059135|524147256|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
145354505|NCT02059135|524147257|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
145354506|NCT02059135|524147256|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
145354507|NCT02059135|524147257|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
145354508|NCT02059135|524147256|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
145354509|NCT02059135|524147257|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
145354510|NCT02059135|524147256|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
145354511|NCT02059135|524147257|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
145354512|NCT02059135|524147256|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
145354513|NCT02059135|524147257|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
145354514|NCT02059135|524147256|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
145354515|NCT02059135|524147257|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
145354516|NCT02059135|524147256|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
145354517|NCT02059135|524147257|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
145354518|NCT00191477|524147259|FG000|Overall Study|Tumor Recurrence|49|||
145354519|NCT00191477|524147260|FG001|Overall Study|Tumor Recurrence|48|||
145354520|NCT00191477|524147259|FG000|Overall Study|Death, Study Disease|1|||
145354521|NCT00191477|524147260|FG001|Overall Study|Death, Study Disease|1|||
145354522|NCT00191477|524147259|FG000|Overall Study|Death, Other Cause|3|||
145354523|NCT00191477|524147260|FG001|Overall Study|Death, Other Cause|6|||
145354524|NCT00191477|524147259|FG000|Overall Study|Lost to Follow-up|23|||
145354525|NCT00191477|524147260|FG001|Overall Study|Lost to Follow-up|21|||
145354526|NCT00191477|524147259|FG000|Overall Study|Protocol Violation|1|||
145354527|NCT00191477|524147260|FG001|Overall Study|Protocol Violation|1|||
145354528|NCT00191477|524147259|FG000|Overall Study|Treatment Change|2|||
145354529|NCT00191477|524147260|FG001|Overall Study|Treatment Change|0|||
145354530|NCT00191477|524147259|FG000|Overall Study|Withdrawal by Subject|2|||
145354531|NCT00191477|524147260|FG001|Overall Study|Withdrawal by Subject|0|||
145354532|NCT00191477|524147259|FG000|Overall Study|Other|2|||
145354533|NCT00191477|524147260|FG001|Overall Study|Other|0|||
145354534|NCT00191477|524147259|FG000|Overall Study|Not Eligible|41|||
145354535|NCT00191477|524147260|FG001|Overall Study|Not Eligible|38|||
145354536|NCT00191477|524147259|FG000|Overall Study|Pathological Specimen Lost|1|||
145354537|NCT00191477|524147260|FG001|Overall Study|Pathological Specimen Lost|0|||
145354538|NCT00191477|524147259|FG000|Overall Study|Discontinued Prior to Instillation|13|||
145354539|NCT00191477|524147260|FG001|Overall Study|Discontinued Prior to Instillation|14|||
145354540|NCT05921903|524147263|FG000|Overall Study|Unsolicited non-SAE|0|||
145354541|NCT05921903|524147264|FG001|Overall Study|Unsolicited non-SAE|1|||
145354542|NCT05921903|524147265|FG002|Overall Study|Unsolicited non-SAE|0|||
145354543|NCT05921903|524147263|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
145354544|NCT05921903|524147264|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
145354545|NCT05921903|524147265|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
145354546|NCT05921903|524147263|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
145354547|NCT05921903|524147264|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
145354548|NCT05921903|524147265|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
145354549|NCT00923013|524147268|FG000|Overall Study|Refused further treatment|0|||
145622972|NCT03303105|525131540|FG000|Overall Study|Lack of Efficacy|1|||
145417412|NCT01436500|524383880|FG001|Overall Study|Adverse Event|2|||
145354550|NCT00923013|524147269|FG001|Overall Study|Refused further treatment|1|||
145354551|NCT00923013|524147270|FG002|Overall Study|Refused further treatment|2|||
145354552|NCT00923013|524147271|FG003|Overall Study|Refused further treatment|0|||
145354553|NCT00923013|524147272|FG004|Overall Study|Refused further treatment|0|||
145354554|NCT00923013|524147273|FG005|Overall Study|Refused further treatment|0|||
145622973|NCT03303105|525131541|FG001|Overall Study|Lack of Efficacy|0|||
145622974|NCT03303105|525131540|FG000|Overall Study|Protocol Violation|1|||
145417413|NCT01436500|524383881|FG002|Overall Study|Adverse Event|2|||
145417414|NCT01436500|524383882|FG003|Overall Study|Adverse Event|0|||
145417415|NCT01436500|524383883|FG004|Overall Study|Adverse Event|1|||
145417416|NCT01436500|524383879|FG000|Overall Study|Withdrawal by Subject|0|||
145417417|NCT01436500|524383880|FG001|Overall Study|Withdrawal by Subject|0|||
145417418|NCT01436500|524383881|FG002|Overall Study|Withdrawal by Subject|2|||
145417419|NCT01436500|524383882|FG003|Overall Study|Withdrawal by Subject|0|||
145417420|NCT01436500|524383883|FG004|Overall Study|Withdrawal by Subject|2|||
145417421|NCT01436500|524383879|FG000|Overall Study|Physician Decision|0|||
145417422|NCT01436500|524383880|FG001|Overall Study|Physician Decision|0|||
145417423|NCT01436500|524383881|FG002|Overall Study|Physician Decision|1|||
145417424|NCT01436500|524383882|FG003|Overall Study|Physician Decision|0|||
145417425|NCT01436500|524383883|FG004|Overall Study|Physician Decision|0|||
145417426|NCT01436500|524383879|FG000|Overall Study|liver transplant|1|||
145417427|NCT01436500|524383880|FG001|Overall Study|liver transplant|0|||
145417428|NCT01436500|524383881|FG002|Overall Study|liver transplant|0|||
145354555|NCT00923013|524147268|FG000|Overall Study|Switched to alternative treatment|0|||
145354556|NCT00923013|524147269|FG001|Overall Study|Switched to alternative treatment|1|||
145354557|NCT00923013|524147270|FG002|Overall Study|Switched to alternative treatment|0|||
145354558|NCT00923013|524147271|FG003|Overall Study|Switched to alternative treatment|0|||
145354559|NCT00923013|524147272|FG004|Overall Study|Switched to alternative treatment|0|||
145354560|NCT00923013|524147273|FG005|Overall Study|Switched to alternative treatment|0|||
145354561|NCT00923013|524147268|FG000|Overall Study|Death on study|2|||
145354562|NCT00923013|524147269|FG001|Overall Study|Death on study|2|||
145354563|NCT00923013|524147270|FG002|Overall Study|Death on study|0|||
145354564|NCT00923013|524147271|FG003|Overall Study|Death on study|1|||
145354565|NCT00923013|524147272|FG004|Overall Study|Death on study|0|||
145354566|NCT00923013|524147273|FG005|Overall Study|Death on study|0|||
145354567|NCT05366010|524147275|FG000|Overall Study|Withdrawal by Subject|1|||
145354568|NCT05366010|524147275|FG000|Overall Study|Protocol Violation|1|||
145354569|NCT05366010|524147275|FG000|Overall Study|Lost to Follow-up|2|||
145354570|NCT05366010|524147275|FG000|Overall Study|Screen Failure|2|||
145354571|NCT01108718|524147276|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
145354572|NCT01108718|524147277|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
145354573|NCT05317312|524147278|FG000|Overall Study|Withdrawal by Subject|0|||
145354574|NCT05317312|524147279|FG001|Overall Study|Withdrawal by Subject|1|||
145354575|NCT05317312|524147280|FG002|Overall Study|Withdrawal by Subject|0|||
145354576|NCT05317312|524147281|FG003|Overall Study|Withdrawal by Subject|0|||
145354577|NCT05317312|524147278|FG000|Overall Study|Lost to Follow-up|0|||
145354578|NCT05317312|524147279|FG001|Overall Study|Lost to Follow-up|0|||
145354579|NCT05317312|524147280|FG002|Overall Study|Lost to Follow-up|0|||
145354580|NCT05317312|524147281|FG003|Overall Study|Lost to Follow-up|1|||
145354581|NCT05317312|524147278|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
145354582|NCT05317312|524147279|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
145354583|NCT05317312|524147280|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
145354584|NCT05317312|524147281|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
145354585|NCT01060072|524147282|FG000|Overall Study|Adverse Event|1|||
145354586|NCT01060072|524147283|FG001|Overall Study|Adverse Event|1|||
145354587|NCT01060072|524147282|FG000|Overall Study|Physician Decision|0|||
145354588|NCT01060072|524147283|FG001|Overall Study|Physician Decision|2|||
145354589|NCT01060072|524147282|FG000|Overall Study|Protocol Violation|0|||
145354590|NCT01060072|524147283|FG001|Overall Study|Protocol Violation|1|||
145354591|NCT01060072|524147282|FG000|Overall Study|Acute cholecystitis|1|||
145354592|NCT01060072|524147283|FG001|Overall Study|Acute cholecystitis|0|||
145354593|NCT01060072|524147282|FG000|Overall Study|Excluded Medications|0|||
145354594|NCT01060072|524147283|FG001|Overall Study|Excluded Medications|1|||
145354595|NCT00837148|524147284|FG000|Overall Study|Adverse Event|1|||
145354596|NCT00837148|524147284|FG000|Overall Study|Death|1|||
145354597|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
145354598|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
145417429|NCT01436500|524383882|FG003|Overall Study|liver transplant|0|||
145417430|NCT01436500|524383883|FG004|Overall Study|liver transplant|0|||
145417431|NCT01436500|524383879|FG000|Overall Study|initiation of dialysis|0|||
145622975|NCT03303105|525131541|FG001|Overall Study|Protocol Violation|0|||
145622976|NCT03303105|525131540|FG000|Overall Study|Withdrawal by Subject|0|||
145622977|NCT03303105|525131541|FG001|Overall Study|Withdrawal by Subject|2|||
145354599|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
145354600|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
145354601|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
145354602|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
145354603|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
145354604|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
145354605|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
145417432|NCT01436500|524383880|FG001|Overall Study|initiation of dialysis|0|||
145417433|NCT01436500|524383881|FG002|Overall Study|initiation of dialysis|0|||
145417434|NCT01436500|524383882|FG003|Overall Study|initiation of dialysis|0|||
145577333|NCT01109316|524968047|FG003|Study Period 3|Lost to Follow-up|0|||
145577334|NCT01109316|524968048|FG004|Study Period 3|Lost to Follow-up|1|||
145577335|NCT01109316|524968049|FG005|Study Period 3|Lost to Follow-up|0|||
145354606|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
145354607|NCT03762265|524147287|FG000|BT Period: Weeks 1 to 37|Other|0|||
145354608|NCT03762265|524147288|FG001|BT Period: Weeks 1 to 37|Other|1|||
145354609|NCT03762265|524147287|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
145354610|NCT03762265|524147288|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
145354611|NCT03762265|524147287|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
145354612|NCT03762265|524147288|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
145354613|NCT03762265|524147287|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
145354614|NCT03762265|524147288|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
145354615|NCT03762265|524147287|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
145354616|NCT03762265|524147288|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
145354617|NCT03762265|524147287|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
145354618|NCT03762265|524147288|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
145354619|NCT03762265|524147287|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
145354620|NCT03762265|524147288|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
145354621|NCT03762265|524147287|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
145354622|NCT03762265|524147288|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
145354623|NCT03762265|524147287|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
145354624|NCT03762265|524147288|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
145354625|NCT03762265|524147287|FG000|LTE Period: Weeks 61 to 109|Other|1|||
145354626|NCT03762265|524147288|FG001|LTE Period: Weeks 61 to 109|Other|0|||
145354627|NCT01532934|524147291|FG000|Overall Study|Lost to Follow-up|11|||
145354628|NCT01532934|524147292|FG001|Overall Study|Lost to Follow-up|11|||
145354629|NCT01532934|524147291|FG000|Overall Study|In controlled environment|3|||
145354630|NCT01532934|524147292|FG001|Overall Study|In controlled environment|2|||
145354631|NCT01597778|524147293|FG000|Overall Study|Death|7|||
145354632|NCT01597778|524147294|FG001|Overall Study|Death|10|||
145354633|NCT01597778|524147293|FG000|Overall Study|Withdrawal by Subject|3|||
145354634|NCT01597778|524147294|FG001|Overall Study|Withdrawal by Subject|4|||
145354635|NCT01597778|524147293|FG000|Overall Study|Adverse Event|1|||
145354636|NCT01597778|524147294|FG001|Overall Study|Adverse Event|1|||
145354637|NCT01597778|524147293|FG000|Overall Study|Protocol Violation|1|||
145354638|NCT01597778|524147294|FG001|Overall Study|Protocol Violation|11|||
145354639|NCT01597778|524147293|FG000|Overall Study|Transplanted off protocol|2|||
145354640|NCT01597778|524147294|FG001|Overall Study|Transplanted off protocol|3|||
145354641|NCT03326193|524147295|FG000|Overall Study|Sponsor decision|35|||
145354642|NCT01964976|524147298|FG000|Overall Study|Protocol Violation|31|||
145354643|NCT00699998|524147299|FG000|Overall Study|Withdrawal by Subject|194|||
145354644|NCT00699998|524147300|FG001|Overall Study|Withdrawal by Subject|83|||
145354645|NCT00699998|524147301|FG002|Overall Study|Withdrawal by Subject|202|||
145354646|NCT00699998|524147302|FG003|Overall Study|Withdrawal by Subject|80|||
145354647|NCT00699998|524147299|FG000|Overall Study|Physician Decision|3|||
145354648|NCT00699998|524147300|FG001|Overall Study|Physician Decision|2|||
145354649|NCT00699998|524147301|FG002|Overall Study|Physician Decision|1|||
145354650|NCT00699998|524147302|FG003|Overall Study|Physician Decision|1|||
145354651|NCT00699998|524147299|FG000|Overall Study|Lost to Follow-up|2|||
145354652|NCT00699998|524147300|FG001|Overall Study|Lost to Follow-up|1|||
145354653|NCT00699998|524147301|FG002|Overall Study|Lost to Follow-up|3|||
145354654|NCT00699998|524147302|FG003|Overall Study|Lost to Follow-up|1|||
145354655|NCT01406574|524147303|FG000|Overall Study|Adverse Event|0|||
145354656|NCT01406574|524147304|FG001|Overall Study|Adverse Event|0|||
145354657|NCT01406574|524147305|FG002|Overall Study|Adverse Event|1|||
145354658|NCT01406574|524147306|FG003|Overall Study|Adverse Event|3|||
145354659|NCT01406574|524147303|FG000|Overall Study|Physician Decision|0|||
145354660|NCT01406574|524147304|FG001|Overall Study|Physician Decision|0|||
145354661|NCT01406574|524147305|FG002|Overall Study|Physician Decision|0|||
145354662|NCT01406574|524147306|FG003|Overall Study|Physician Decision|1|||
145354663|NCT01406574|524147303|FG000|Overall Study|Withdrawal by Subject|0|||
145354664|NCT01406574|524147304|FG001|Overall Study|Withdrawal by Subject|1|||
145354665|NCT01406574|524147305|FG002|Overall Study|Withdrawal by Subject|0|||
145354666|NCT01406574|524147306|FG003|Overall Study|Withdrawal by Subject|0|||
145354667|NCT01406574|524147303|FG000|Overall Study|Definite progression of primary disease|1|||
145354668|NCT01406574|524147304|FG001|Overall Study|Definite progression of primary disease|0|||
145354669|NCT01406574|524147305|FG002|Overall Study|Definite progression of primary disease|0|||
145354670|NCT01406574|524147306|FG003|Overall Study|Definite progression of primary disease|0|||
145354671|NCT04616612|524147313|FG000|Overall Study|Lost to Follow-up|6|||
145354672|NCT04616612|524147314|FG001|Overall Study|Lost to Follow-up|3|||
145354673|NCT04740918|524147315|FG000|Overall Study|Study Terminated by Sponsor|41|||
145354674|NCT04740918|524147316|FG001|Overall Study|Study Terminated by Sponsor|32|||
145354675|NCT04740918|524147315|FG000|Overall Study|Death|3|||
145354676|NCT04740918|524147316|FG001|Overall Study|Death|6|||
145354677|NCT04740918|524147315|FG000|Overall Study|Withdrawal by Subject|5|||
145354678|NCT04740918|524147316|FG001|Overall Study|Withdrawal by Subject|4|||
145354679|NCT04740918|524147315|FG000|Overall Study|Lost to Follow-up|1|||
145354680|NCT04740918|524147316|FG001|Overall Study|Lost to Follow-up|3|||
145354681|NCT04740918|524147315|FG000|Overall Study|Progressive disease|0|||
145354682|NCT04740918|524147316|FG001|Overall Study|Progressive disease|1|||
145354683|NCT03759392|524147319|FG000|Overall Study|Adverse Event|12|||
145354684|NCT03759392|524147320|FG001|Overall Study|Adverse Event|4|||
145354685|NCT03759392|524147319|FG000|Overall Study|Death|2|||
145354686|NCT03759392|524147320|FG001|Overall Study|Death|1|||
145354687|NCT03759392|524147319|FG000|Overall Study|Withdrawal by Subject|2|||
145354688|NCT03759392|524147320|FG001|Overall Study|Withdrawal by Subject|0|||
145354689|NCT03759392|524147319|FG000|Overall Study|Protocol Violation|2|||
145354690|NCT03759392|524147320|FG001|Overall Study|Protocol Violation|0|||
145354691|NCT03759392|524147319|FG000|Overall Study|Physician Decision|0|||
145354692|NCT03759392|524147320|FG001|Overall Study|Physician Decision|1|||
145354693|NCT03759392|524147319|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
145354694|NCT03759392|524147320|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
145354695|NCT03759392|524147319|FG000|Overall Study|No longer able to take medicines|1|||
145354696|NCT03759392|524147320|FG001|Overall Study|No longer able to take medicines|0|||
145354697|NCT03759392|524147319|FG000|Overall Study|Stopped taking study drug|1|||
145354698|NCT03759392|524147320|FG001|Overall Study|Stopped taking study drug|0|||
145354699|NCT01709500|524147321|FG000|Overall Study|Randomized but not treated|0|||
145354700|NCT01709500|524147322|FG001|Overall Study|Randomized but not treated|1|||
145354701|NCT01709500|524147321|FG000|Overall Study|Adverse Event|5|||
145354702|NCT01709500|524147322|FG001|Overall Study|Adverse Event|1|||
145354703|NCT01709500|524147321|FG000|Overall Study|Poor compliance to protocol|2|||
145354704|NCT01709500|524147322|FG001|Overall Study|Poor compliance to protocol|1|||
145354705|NCT01709500|524147321|FG000|Overall Study|Other|3|||
145354706|NCT01709500|524147322|FG001|Overall Study|Other|1|||
145354707|NCT01709500|524147321|FG000|Overall Study|Related to IMP administration|1|||
145354708|NCT01709500|524147322|FG001|Overall Study|Related to IMP administration|0|||
145354709|NCT01709500|524147321|FG000|Overall Study|Treatment ongoing|156|||
145354710|NCT01709500|524147322|FG001|Overall Study|Treatment ongoing|78|||
145354711|NCT03170544|524147323|FG000|Part 1|Lost to Follow-up|1|||
145354712|NCT03170544|524147324|FG001|Part 1|Lost to Follow-up|0|||
145354713|NCT03170544|524147325|FG002|Part 1|Lost to Follow-up|0|||
145354714|NCT03170544|524147326|FG003|Part 1|Lost to Follow-up|0|||
145354715|NCT03170544|524147327|FG004|Part 1|Lost to Follow-up|0|||
145354716|NCT03170544|524147328|FG005|Part 1|Lost to Follow-up|0|||
145354717|NCT03170544|524147329|FG006|Part 1|Lost to Follow-up|0|||
145354718|NCT03170544|524147330|FG007|Part 1|Lost to Follow-up|0|||
145354719|NCT03170544|524147331|FG008|Part 1|Lost to Follow-up|0|||
145354720|NCT03170544|524147332|FG009|Part 1|Lost to Follow-up|0|||
145354721|NCT03170544|524147333|FG010|Part 1|Lost to Follow-up|0|||
145354722|NCT03170544|524147334|FG011|Part 1|Lost to Follow-up|0|||
145354723|NCT03170544|524147323|FG000|Part 1|Not treated|0|||
145354724|NCT03170544|524147324|FG001|Part 1|Not treated|0|||
145354725|NCT03170544|524147325|FG002|Part 1|Not treated|0|||
145354726|NCT03170544|524147326|FG003|Part 1|Not treated|1|||
145354727|NCT03170544|524147327|FG004|Part 1|Not treated|0|||
145354728|NCT03170544|524147328|FG005|Part 1|Not treated|0|||
145354729|NCT03170544|524147329|FG006|Part 1|Not treated|0|||
145354730|NCT03170544|524147330|FG007|Part 1|Not treated|0|||
145354731|NCT03170544|524147331|FG008|Part 1|Not treated|0|||
145354732|NCT03170544|524147332|FG009|Part 1|Not treated|0|||
145354733|NCT03170544|524147333|FG010|Part 1|Not treated|0|||
145354734|NCT03170544|524147334|FG011|Part 1|Not treated|0|||
145354735|NCT00420420|524147337|FG000|Overall Study|Adverse Event|5|||
145354736|NCT00420420|524147338|FG001|Overall Study|Adverse Event|3|||
145354737|NCT00420420|524147337|FG000|Overall Study|Protocol Violation|1|||
145354738|NCT00420420|524147338|FG001|Overall Study|Protocol Violation|1|||
145577336|NCT01109316|524968044|FG000|Study Period 3|Withdrawal by Subject|1|||
145577337|NCT01109316|524968045|FG001|Study Period 3|Withdrawal by Subject|0|||
145354739|NCT00420420|524147337|FG000|Overall Study|Withdrawal by Subject|1|||
145354740|NCT00420420|524147338|FG001|Overall Study|Withdrawal by Subject|0|||
145354741|NCT00420420|524147337|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
145354742|NCT00420420|524147338|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
145354743|NCT03323398|524147341|FG000|Overall Study|Other than Specified|0|||
145354744|NCT03323398|524147342|FG001|Overall Study|Other than Specified|1|||
145354745|NCT03323398|524147343|FG002|Overall Study|Other than Specified|2|||
145354746|NCT03323398|524147344|FG003|Overall Study|Other than Specified|0|||
145354747|NCT03323398|524147345|FG004|Overall Study|Other than Specified|0|||
145354748|NCT03323398|524147346|FG005|Overall Study|Other than Specified|0|||
145354749|NCT03323398|524147347|FG006|Overall Study|Other than Specified|1|||
145354750|NCT03323398|524147348|FG007|Overall Study|Other than Specified|0|||
145354751|NCT03323398|524147349|FG008|Overall Study|Other than Specified|2|||
145354752|NCT03323398|524147341|FG000|Overall Study|Lost to Follow-up|1|||
145354753|NCT03323398|524147342|FG001|Overall Study|Lost to Follow-up|2|||
145354754|NCT03323398|524147343|FG002|Overall Study|Lost to Follow-up|1|||
145354755|NCT03323398|524147344|FG003|Overall Study|Lost to Follow-up|0|||
145417435|NCT01436500|524383883|FG004|Overall Study|initiation of dialysis|1|||
145417436|NCT01436500|524383879|FG000|Overall Study|discontinued study drug|1|||
145417437|NCT01436500|524383880|FG001|Overall Study|discontinued study drug|0|||
145417438|NCT01436500|524383881|FG002|Overall Study|discontinued study drug|0|||
145417439|NCT01436500|524383882|FG003|Overall Study|discontinued study drug|0|||
145417440|NCT01436500|524383883|FG004|Overall Study|discontinued study drug|0|||
145417441|NCT01436500|524383879|FG000|Overall Study|Other|0|||
145417442|NCT01436500|524383880|FG001|Overall Study|Other|1|||
145417443|NCT01436500|524383881|FG002|Overall Study|Other|0|||
145417444|NCT01436500|524383882|FG003|Overall Study|Other|1|||
145417445|NCT01436500|524383883|FG004|Overall Study|Other|0|||
145417446|NCT00977561|524383884|FG000|Overall Study|Death|3|||
145417447|NCT00977561|524383885|FG001|Overall Study|Death|2|||
145417448|NCT00977561|524383884|FG000|Overall Study|Study terminated|0|||
145417449|NCT00977561|524383885|FG001|Overall Study|Study terminated|2|||
145417450|NCT00977561|524383884|FG000|Overall Study|Other|2|||
145417451|NCT00977561|524383885|FG001|Overall Study|Other|0|||
145417452|NCT00309244|524383896|FG000|Overall Study|Adverse Event|29|||
145417453|NCT00309244|524383897|FG001|Overall Study|Adverse Event|12|||
145417454|NCT00309244|524383896|FG000|Overall Study|Lost to Follow-up|6|||
145417455|NCT00309244|524383897|FG001|Overall Study|Lost to Follow-up|22|||
145417456|NCT00309244|524383896|FG000|Overall Study|Physician Decision|5|||
145417457|NCT00309244|524383897|FG001|Overall Study|Physician Decision|8|||
145417458|NCT00309244|524383896|FG000|Overall Study|Protocol Violation|6|||
145417459|NCT00309244|524383897|FG001|Overall Study|Protocol Violation|3|||
145417460|NCT00309244|524383896|FG000|Overall Study|Withdrawal by Subject|50|||
145417461|NCT00309244|524383897|FG001|Overall Study|Withdrawal by Subject|32|||
145417462|NCT00309244|524383896|FG000|Overall Study|Various|7|||
145417463|NCT00309244|524383897|FG001|Overall Study|Various|7|||
145417464|NCT00309244|524383896|FG000|Overall Study|Randomized but not dosed|11|||
145417465|NCT00309244|524383897|FG001|Overall Study|Randomized but not dosed|12|||
145577338|NCT01109316|524968046|FG002|Study Period 3|Withdrawal by Subject|0|||
145577339|NCT01109316|524968047|FG003|Study Period 3|Withdrawal by Subject|0|||
145577340|NCT01109316|524968048|FG004|Study Period 3|Withdrawal by Subject|1|||
145577341|NCT01109316|524968049|FG005|Study Period 3|Withdrawal by Subject|0|||
145354756|NCT03323398|524147345|FG004|Overall Study|Lost to Follow-up|0|||
145354757|NCT03323398|524147346|FG005|Overall Study|Lost to Follow-up|0|||
145354758|NCT03323398|524147347|FG006|Overall Study|Lost to Follow-up|0|||
145354759|NCT03323398|524147348|FG007|Overall Study|Lost to Follow-up|0|||
145354760|NCT03323398|524147349|FG008|Overall Study|Lost to Follow-up|0|||
145354761|NCT03323398|524147341|FG000|Overall Study|Death|4|||
145354762|NCT03323398|524147342|FG001|Overall Study|Death|6|||
145354763|NCT03323398|524147343|FG002|Overall Study|Death|2|||
145354764|NCT03323398|524147344|FG003|Overall Study|Death|2|||
145354765|NCT03323398|524147345|FG004|Overall Study|Death|1|||
145354766|NCT03323398|524147346|FG005|Overall Study|Death|2|||
145354767|NCT03323398|524147347|FG006|Overall Study|Death|0|||
145354768|NCT03323398|524147348|FG007|Overall Study|Death|0|||
145354769|NCT03323398|524147349|FG008|Overall Study|Death|6|||
145354770|NCT03323398|524147341|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
145354771|NCT03323398|524147342|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
145354772|NCT03323398|524147343|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
145354773|NCT03323398|524147344|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
145354774|NCT03323398|524147345|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
145354775|NCT03323398|524147346|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
145354776|NCT03323398|524147347|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
145354777|NCT03323398|524147348|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
145354778|NCT03323398|524147349|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
145354779|NCT03323398|524147341|FG000|Overall Study|Withdrawal by Subject|2|||
145354780|NCT03323398|524147342|FG001|Overall Study|Withdrawal by Subject|1|||
145417466|NCT00309244|524383896|FG000|Overall Study|Death|4|||
145417467|NCT00309244|524383897|FG001|Overall Study|Death|1|||
145417468|NCT00356421|524383898|FG000|Overall Study|Lack of Efficacy|3|||
145417469|NCT00356421|524383899|FG001|Overall Study|Lack of Efficacy|0|||
145417470|NCT00356421|524383898|FG000|Overall Study|Withdrawal by Subject|9|||
145417471|NCT00356421|524383899|FG001|Overall Study|Withdrawal by Subject|2|||
145417472|NCT00356421|524383898|FG000|Overall Study|Related to study drug|15|||
145417473|NCT00356421|524383899|FG001|Overall Study|Related to study drug|12|||
145354781|NCT03323398|524147343|FG002|Overall Study|Withdrawal by Subject|3|||
145417474|NCT00356421|524383898|FG000|Overall Study|Not related to study drug|5|||
145417475|NCT00356421|524383899|FG001|Overall Study|Not related to study drug|3|||
145417476|NCT04689009|524383900|FG000|Overall Study|Adverse Event|1|||
145417477|NCT04689009|524383901|FG001|Overall Study|Adverse Event|0|||
145354782|NCT03323398|524147344|FG003|Overall Study|Withdrawal by Subject|0|||
145417478|NCT04689009|524383900|FG000|Overall Study|Lost to Follow-up|1|||
145417479|NCT04689009|524383901|FG001|Overall Study|Lost to Follow-up|2|||
145417480|NCT04689009|524383900|FG000|Overall Study|Withdrawal by Subject|4|||
145417481|NCT04689009|524383901|FG001|Overall Study|Withdrawal by Subject|3|||
145417482|NCT04689009|524383900|FG000|Overall Study|Protocol Violation|1|||
145417483|NCT04689009|524383901|FG001|Overall Study|Protocol Violation|0|||
145354783|NCT03323398|524147345|FG004|Overall Study|Withdrawal by Subject|0|||
145354784|NCT03323398|524147346|FG005|Overall Study|Withdrawal by Subject|1|||
145354785|NCT03323398|524147347|FG006|Overall Study|Withdrawal by Subject|0|||
145354786|NCT03323398|524147348|FG007|Overall Study|Withdrawal by Subject|0|||
145354787|NCT03323398|524147349|FG008|Overall Study|Withdrawal by Subject|0|||
145354788|NCT03323398|524147341|FG000|Overall Study|Participant was Put on Hospice|0|||
145354789|NCT03323398|524147342|FG001|Overall Study|Participant was Put on Hospice|0|||
145354790|NCT03323398|524147343|FG002|Overall Study|Participant was Put on Hospice|0|||
145354791|NCT03323398|524147344|FG003|Overall Study|Participant was Put on Hospice|0|||
145354792|NCT03323398|524147345|FG004|Overall Study|Participant was Put on Hospice|0|||
145354793|NCT03323398|524147346|FG005|Overall Study|Participant was Put on Hospice|0|||
145354794|NCT03323398|524147347|FG006|Overall Study|Participant was Put on Hospice|1|||
145354795|NCT03323398|524147348|FG007|Overall Study|Participant was Put on Hospice|0|||
145354796|NCT03323398|524147349|FG008|Overall Study|Participant was Put on Hospice|0|||
145354797|NCT03323398|524147341|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
145354798|NCT03323398|524147342|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
145354799|NCT03323398|524147343|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
145354800|NCT03323398|524147344|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
145354801|NCT03323398|524147345|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
145354802|NCT03323398|524147346|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
145354803|NCT03323398|524147347|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
145354804|NCT03323398|524147348|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
145354805|NCT03323398|524147349|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
145354806|NCT03641469|524147350|FG000|Overall Study|Ineligible|2|||
145354807|NCT03641469|524147350|FG000|Overall Study|Withdrawal by Subject|5|||
145354808|NCT03641469|524147350|FG000|Overall Study|Physician Decision|1|||
145354809|NCT03641469|524147350|FG000|Overall Study|Protocol Violation|1|||
145354810|NCT03641469|524147350|FG000|Overall Study|Lost to Follow-up|2|||
145354811|NCT05479435|524147351|FG000|Overall Study|Withdrawal by Subject|1|||
145354812|NCT05479435|524147352|FG001|Overall Study|Withdrawal by Subject|0|||
145354813|NCT05479435|524147353|FG002|Overall Study|Withdrawal by Subject|0|||
145354814|NCT05479435|524147351|FG000|Overall Study|Covid 19|0|||
145354815|NCT05479435|524147352|FG001|Overall Study|Covid 19|0|||
145354816|NCT05479435|524147353|FG002|Overall Study|Covid 19|2|||
145354817|NCT00955617|524147357|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
145354818|NCT00955617|524147358|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
145354819|NCT00955617|524147357|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
145354820|NCT00955617|524147358|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
145354821|NCT00955617|524147357|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
145354822|NCT00955617|524147358|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
145354823|NCT00955617|524147357|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
145354824|NCT00955617|524147358|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
145354825|NCT04563754|524148992|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
145354826|NCT04563754|524148993|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
145354827|NCT04563754|524148994|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
145354828|NCT04563754|524148992|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
145354829|NCT04563754|524148993|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
145354830|NCT04563754|524148994|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
145354831|NCT04563754|524148992|FG000|Follow up|Lost to Follow-up|61|||
145354832|NCT04563754|524148993|FG001|Follow up|Lost to Follow-up|23|||
145354833|NCT04563754|524148994|FG002|Follow up|Lost to Follow-up|5|||
145354834|NCT04563754|524148992|FG000|Follow up|Death|0|||
145354835|NCT04563754|524148993|FG001|Follow up|Death|2|||
145354836|NCT04563754|524148994|FG002|Follow up|Death|0|||
145354837|NCT04563754|524148992|FG000|Follow up|Ongoing|0|||
145354838|NCT04563754|524148993|FG001|Follow up|Ongoing|28|||
145354839|NCT04563754|524148994|FG002|Follow up|Ongoing|0|||
145354840|NCT04023396|524148995|FG000|Overall Study|Adverse Event|16|||
145417484|NCT03336866|524383902|FG000|Overall Study|Lost to Follow-up|2|||
145417485|NCT03336866|524383903|FG001|Overall Study|Lost to Follow-up|0|||
145417486|NCT03336866|524383904|FG002|Overall Study|Lost to Follow-up|3|||
145354841|NCT04023396|524148995|FG000|Overall Study|Death|1|||
145354842|NCT04023396|524148995|FG000|Overall Study|Lost to Follow-up|1|||
145354843|NCT04023396|524148995|FG000|Overall Study|Withdrawal by Subject|14|||
145354844|NCT04023396|524148995|FG000|Overall Study|Pregnancy|4|||
145354845|NCT04023396|524148995|FG000|Overall Study|Lack of Efficacy|3|||
145417487|NCT03336866|524383902|FG000|Overall Study|Withdrawal by Subject|1|||
145417488|NCT03336866|524383903|FG001|Overall Study|Withdrawal by Subject|1|||
145417489|NCT03336866|524383904|FG002|Overall Study|Withdrawal by Subject|0|||
145577342|NCT03511560|524968055|FG000|Overall Study|Death|0|||
145354846|NCT04023396|524148995|FG000|Overall Study|Physician Decision|4|||
145622978|NCT04822298|525131544|FG000|Overall Study|Death|3|||
145354847|NCT04023396|524148995|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
145354848|NCT04075825|524148998|FG000|Overall Study|Withdrawal by Subject|6|||
145354849|NCT04075825|524148999|FG001|Overall Study|Withdrawal by Subject|8|||
145354850|NCT04075825|524148998|FG000|Overall Study|Physician Decision|3|||
145354851|NCT04075825|524148999|FG001|Overall Study|Physician Decision|1|||
145354852|NCT04075825|524148998|FG000|Overall Study|Lost to Follow-up|5|||
145354853|NCT04075825|524148999|FG001|Overall Study|Lost to Follow-up|1|||
145354854|NCT04075825|524148998|FG000|Overall Study|Participation in New Clinical Trial|1|||
145354855|NCT04075825|524148999|FG001|Overall Study|Participation in New Clinical Trial|1|||
145354856|NCT04075825|524148998|FG000|Overall Study|Reason Not Specified|2|||
145354857|NCT04075825|524148999|FG001|Overall Study|Reason Not Specified|2|||
145354858|NCT04581824|524149003|FG000|Overall Study|Lost to Follow-up|1|||
145354859|NCT04581824|524149004|FG001|Overall Study|Lost to Follow-up|0|||
145354860|NCT04581824|524149003|FG000|Overall Study|Withdrawal by Subject|2|||
145354861|NCT04581824|524149004|FG001|Overall Study|Withdrawal by Subject|7|||
145354862|NCT04581824|524149003|FG000|Overall Study|Study terminated by sponsor|37|||
145354863|NCT04581824|524149004|FG001|Overall Study|Study terminated by sponsor|23|||
145354864|NCT04796909|524149005|FG000|Overall Study|Withdrawal by Subject|1|||
145354865|NCT04796909|524149006|FG001|Overall Study|Withdrawal by Subject|1|||
145354866|NCT03879135|524149007|FG000|Overall Study|Physician Decision|0|||
145354867|NCT03879135|524149008|FG001|Overall Study|Physician Decision|0|||
145354868|NCT03879135|524149009|FG002|Overall Study|Physician Decision|0|||
145354869|NCT03879135|524149010|FG003|Overall Study|Physician Decision|1|||
145354870|NCT03879135|524149011|FG004|Overall Study|Physician Decision|0|||
145354871|NCT03879135|524149012|FG005|Overall Study|Physician Decision|0|||
145354872|NCT03879135|524149007|FG000|Overall Study|Withdrawal by Subject|0|||
145354873|NCT03879135|524149008|FG001|Overall Study|Withdrawal by Subject|0|||
145354874|NCT03879135|524149009|FG002|Overall Study|Withdrawal by Subject|0|||
145354875|NCT03879135|524149010|FG003|Overall Study|Withdrawal by Subject|0|||
145354876|NCT03879135|524149011|FG004|Overall Study|Withdrawal by Subject|0|||
145354877|NCT03879135|524149012|FG005|Overall Study|Withdrawal by Subject|1|||
145354878|NCT03879135|524149007|FG000|Overall Study|Site Closed by Sponsor|0|||
145354879|NCT03879135|524149008|FG001|Overall Study|Site Closed by Sponsor|0|||
145354880|NCT03879135|524149009|FG002|Overall Study|Site Closed by Sponsor|0|||
145354881|NCT03879135|524149010|FG003|Overall Study|Site Closed by Sponsor|1|||
145354882|NCT03879135|524149011|FG004|Overall Study|Site Closed by Sponsor|1|||
145354883|NCT03879135|524149012|FG005|Overall Study|Site Closed by Sponsor|0|||
145354884|NCT04162847|524149013|FG000|Overall Study|Withdrawal by Subject|7|||
145354885|NCT04162847|524149014|FG001|Overall Study|Withdrawal by Subject|1|||
145354886|NCT04815083|524149015|FG000|Overall Study|Physician Decision|1|||
145354887|NCT04815083|524149015|FG000|Overall Study|Study pause|2|||
145354888|NCT04815083|524149015|FG000|Overall Study|Screening failure|4|||
145354889|NCT02243605|524149016|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
145354890|NCT02243605|524149017|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
145354891|NCT02243605|524149016|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
145354892|NCT02243605|524149017|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
145354893|NCT02243605|524149016|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
145354894|NCT02243605|524149017|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
145354895|NCT02243605|524149016|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
145354896|NCT02243605|524149017|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
145354897|NCT02243605|524149016|FG000|Stage 2 - Final Analysis Population|Progression|0|||
145622979|NCT01333943|525131548|FG000|Overall Study|Known neuropathy|1|||
145622980|NCT01333943|525131549|FG001|Overall Study|Known neuropathy|0|||
145622981|NCT01789203|525131550|FG000|Overall Study|Adverse Event|2|||
145622982|NCT01789203|525131551|FG001|Overall Study|Adverse Event|2|||
145622983|NCT01789203|525131550|FG000|Overall Study|Withdrawal by Subject|1|||
145622984|NCT01789203|525131551|FG001|Overall Study|Withdrawal by Subject|0|||
145622985|NCT01789203|525131550|FG000|Overall Study|Death|1|||
145622986|NCT01789203|525131551|FG001|Overall Study|Death|0|||
145622987|NCT01789203|525131550|FG000|Overall Study|Protocol Violation|2|||
145622988|NCT01789203|525131551|FG001|Overall Study|Protocol Violation|1|||
145622989|NCT01789203|525131550|FG000|Overall Study|Other|1|||
145622990|NCT01789203|525131551|FG001|Overall Study|Other|1|||
145354898|NCT02243605|524149017|FG001|Stage 2 - Final Analysis Population|Progression|1|||
145354899|NCT02968576|524149018|FG000|Overall Study|Pregnancy|0|||
145622991|NCT01789203|525131550|FG000|Overall Study|patient non-adherent|2|||
145622992|NCT01789203|525131551|FG001|Overall Study|patient non-adherent|0|||
145622993|NCT01254305|525131558|FG000|Overall Study|Adverse Event|6|||
145354900|NCT02968576|524149019|FG001|Overall Study|Pregnancy|1|||
145622994|NCT01254305|525131559|FG001|Overall Study|Adverse Event|3|||
145622995|NCT01254305|525131560|FG002|Overall Study|Adverse Event|2|||
145354901|NCT01062425|524149025|FG000|Overall Study|Protocol Violation|3|||
145354902|NCT01062425|524149026|FG001|Overall Study|Protocol Violation|6|||
145354903|NCT02383017|524149027|FG000|Overall Study|Injury Sustained Outside Study|1|||
145354904|NCT02383017|524149028|FG001|Overall Study|Injury Sustained Outside Study|0|||
145622996|NCT01254305|525131558|FG000|Overall Study|Lack of Efficacy|1|||
145354905|NCT02383017|524149027|FG000|Overall Study|Compliance|3|||
145354906|NCT02383017|524149028|FG001|Overall Study|Compliance|2|||
145354907|NCT02383017|524149027|FG000|Overall Study|Found to be Hypogonadal|1|||
145354908|NCT02383017|524149028|FG001|Overall Study|Found to be Hypogonadal|0|||
145354909|NCT00927589|524149029|FG000|Overall Study|Death|1|||
145354910|NCT00927589|524149029|FG000|Overall Study|Physician Decision|1|||
145354911|NCT00927589|524149029|FG000|Overall Study|Withdrawal by Subject|3|||
145354912|NCT00927589|524149029|FG000|Overall Study|Adverse Event|2|||
145354913|NCT00927589|524149029|FG000|Overall Study|Disease Progression|8|||
145354914|NCT00927589|524149029|FG000|Overall Study|Non-compliance|1|||
145354915|NCT01651117|524149031|FG000|Overall Study|Death|2|||
145354916|NCT01651117|524149032|FG001|Overall Study|Death|3|||
145354917|NCT01651117|524149033|FG002|Overall Study|Death|2|||
145354918|NCT01651117|524149034|FG003|Overall Study|Death|2|||
145354919|NCT02088177|524149035|FG000|Overall Study|Lost to Follow-up|3|||
145354920|NCT00289848|524149037|FG000|Overall Study|Adverse Event|6|||
145354921|NCT00289848|524149038|FG001|Overall Study|Adverse Event|4|||
145354922|NCT00289848|524149037|FG000|Overall Study|Death|1|||
145354923|NCT00289848|524149038|FG001|Overall Study|Death|0|||
145354924|NCT00289848|524149037|FG000|Overall Study|Lack of Efficacy|20|||
145354925|NCT00289848|524149038|FG001|Overall Study|Lack of Efficacy|24|||
145354926|NCT00289848|524149037|FG000|Overall Study|Lost to Follow-up|3|||
145354927|NCT00289848|524149038|FG001|Overall Study|Lost to Follow-up|1|||
145354928|NCT00289848|524149037|FG000|Overall Study|Protocol Violation|5|||
145354929|NCT00289848|524149038|FG001|Overall Study|Protocol Violation|2|||
145354930|NCT00289848|524149037|FG000|Overall Study|Withdrawal by Subject|5|||
145354931|NCT00289848|524149038|FG001|Overall Study|Withdrawal by Subject|11|||
145354932|NCT00289848|524149037|FG000|Overall Study|Patient Moved|6|||
145354933|NCT00289848|524149038|FG001|Overall Study|Patient Moved|2|||
145354934|NCT00289848|524149037|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
145354935|NCT00289848|524149038|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
145354936|NCT01234350|524149039|FG000|Overall Study|Adverse Event|277|||
145354937|NCT01234350|524149040|FG001|Overall Study|Adverse Event|92|||
145354938|NCT01234350|524149039|FG000|Overall Study|Withdrawal by Subject|61|||
145354939|NCT01234350|524149040|FG001|Overall Study|Withdrawal by Subject|36|||
145354940|NCT01234350|524149039|FG000|Overall Study|Lost to Follow-up|115|||
145354941|NCT01234350|524149040|FG001|Overall Study|Lost to Follow-up|47|||
145354942|NCT01234350|524149039|FG000|Overall Study|Covers a diverse set of reasons|234|||
145354943|NCT01234350|524149040|FG001|Overall Study|Covers a diverse set of reasons|92|||
145354944|NCT01894919|524149048|FG000|Overall Study|Withdrawal by Subject|1|||
145354945|NCT01894919|524149049|FG001|Overall Study|Withdrawal by Subject|0|||
145354946|NCT01894919|524149050|FG002|Overall Study|Withdrawal by Subject|0|||
145354947|NCT01894919|524149051|FG003|Overall Study|Withdrawal by Subject|0|||
145354948|NCT01894919|524149052|FG004|Overall Study|Withdrawal by Subject|1|||
145354949|NCT01894919|524149053|FG005|Overall Study|Withdrawal by Subject|0|||
145354950|NCT01894919|524149054|FG006|Overall Study|Withdrawal by Subject|0|||
145354951|NCT01894919|524149055|FG007|Overall Study|Withdrawal by Subject|0|||
145354952|NCT01894919|524149056|FG008|Overall Study|Withdrawal by Subject|0|||
145354953|NCT01894919|524149057|FG009|Overall Study|Withdrawal by Subject|1|||
145354954|NCT01894919|524149058|FG010|Overall Study|Withdrawal by Subject|1|||
145354955|NCT01894919|524149059|FG011|Overall Study|Withdrawal by Subject|0|||
145354956|NCT01894919|524149060|FG012|Overall Study|Withdrawal by Subject|0|||
145354957|NCT01894919|524149048|FG000|Overall Study|Adverse Event|0|||
145354958|NCT01894919|524149049|FG001|Overall Study|Adverse Event|0|||
145354959|NCT01894919|524149050|FG002|Overall Study|Adverse Event|0|||
145354960|NCT01894919|524149051|FG003|Overall Study|Adverse Event|0|||
145354961|NCT01894919|524149052|FG004|Overall Study|Adverse Event|0|||
145354962|NCT01894919|524149053|FG005|Overall Study|Adverse Event|0|||
145354963|NCT01894919|524149054|FG006|Overall Study|Adverse Event|0|||
145354964|NCT01894919|524149055|FG007|Overall Study|Adverse Event|0|||
145354965|NCT01894919|524149056|FG008|Overall Study|Adverse Event|0|||
145354966|NCT01894919|524149057|FG009|Overall Study|Adverse Event|0|||
145354967|NCT01894919|524149058|FG010|Overall Study|Adverse Event|1|||
145354968|NCT01894919|524149059|FG011|Overall Study|Adverse Event|0|||
145354969|NCT01894919|524149060|FG012|Overall Study|Adverse Event|0|||
145354970|NCT01894919|524149048|FG000|Overall Study|Other-Unspecified|1|||
145354971|NCT01894919|524149049|FG001|Overall Study|Other-Unspecified|0|||
145354972|NCT01894919|524149050|FG002|Overall Study|Other-Unspecified|0|||
145354973|NCT01894919|524149051|FG003|Overall Study|Other-Unspecified|0|||
145417490|NCT03336866|524383902|FG000|Overall Study|Noncompliance with clinic house rules|0|||
145354974|NCT01894919|524149052|FG004|Overall Study|Other-Unspecified|0|||
145354975|NCT01894919|524149053|FG005|Overall Study|Other-Unspecified|0|||
145354976|NCT01894919|524149054|FG006|Overall Study|Other-Unspecified|0|||
145354977|NCT01894919|524149055|FG007|Overall Study|Other-Unspecified|0|||
145354978|NCT01894919|524149056|FG008|Overall Study|Other-Unspecified|0|||
145354979|NCT01894919|524149057|FG009|Overall Study|Other-Unspecified|0|||
145354980|NCT01894919|524149058|FG010|Overall Study|Other-Unspecified|0|||
145354981|NCT01894919|524149059|FG011|Overall Study|Other-Unspecified|0|||
145354982|NCT01894919|524149060|FG012|Overall Study|Other-Unspecified|0|||
145354983|NCT01894919|524149048|FG000|Overall Study|Lost to Follow-up|0|||
145354984|NCT01894919|524149049|FG001|Overall Study|Lost to Follow-up|0|||
145354985|NCT01894919|524149050|FG002|Overall Study|Lost to Follow-up|0|||
145354986|NCT01894919|524149051|FG003|Overall Study|Lost to Follow-up|0|||
145354987|NCT01894919|524149052|FG004|Overall Study|Lost to Follow-up|2|||
145354988|NCT01894919|524149053|FG005|Overall Study|Lost to Follow-up|0|||
145354989|NCT01894919|524149054|FG006|Overall Study|Lost to Follow-up|0|||
145354990|NCT01894919|524149055|FG007|Overall Study|Lost to Follow-up|0|||
145354991|NCT01894919|524149056|FG008|Overall Study|Lost to Follow-up|0|||
145354992|NCT01894919|524149057|FG009|Overall Study|Lost to Follow-up|0|||
145354993|NCT01894919|524149058|FG010|Overall Study|Lost to Follow-up|0|||
145354994|NCT01894919|524149059|FG011|Overall Study|Lost to Follow-up|0|||
145354995|NCT01894919|524149060|FG012|Overall Study|Lost to Follow-up|0|||
145354996|NCT02792517|524149061|FG000|Overall Study|Withdrawal by Subject|10|||
145354997|NCT02792517|524149061|FG000|Overall Study|Decision by Sponsor|7|||
145354998|NCT02792517|524149061|FG000|Overall Study|Lost to Follow-up|3|||
145354999|NCT03534687|524149067|FG000|Overall Study|Lost to Follow-up|7|||
145355000|NCT03534687|524149068|FG001|Overall Study|Lost to Follow-up|2|||
145355001|NCT03428152|524149069|FG000|Overall Study|Physician Decision|4|||
145355002|NCT03428152|524149070|FG001|Overall Study|Physician Decision|2|||
145355003|NCT03428152|524149069|FG000|Overall Study|Protocol Violation|3|||
145355004|NCT03428152|524149070|FG001|Overall Study|Protocol Violation|5|||
145355005|NCT03428152|524149069|FG000|Overall Study|Lack of Efficacy|0|||
145355006|NCT03428152|524149070|FG001|Overall Study|Lack of Efficacy|4|||
145355007|NCT00395629|524149071|FG000|Core Study|Adverse Event|0|||
145355008|NCT00395629|524149072|FG001|Core Study|Adverse Event|3|||
145355009|NCT00395629|524149073|FG002|Core Study|Adverse Event|4|||
145355010|NCT00395629|524149071|FG000|Core Study|Abnormal laboratory value(s)|0|||
145355011|NCT00395629|524149072|FG001|Core Study|Abnormal laboratory value(s)|0|||
145355012|NCT00395629|524149073|FG002|Core Study|Abnormal laboratory value(s)|1|||
145355013|NCT00395629|524149071|FG000|Core Study|Protocol Violation|1|||
145355014|NCT00395629|524149072|FG001|Core Study|Protocol Violation|0|||
145355015|NCT00395629|524149073|FG002|Core Study|Protocol Violation|0|||
145355016|NCT00395629|524149071|FG000|Core Study|Withdrawal by Subject|0|||
145355017|NCT00395629|524149072|FG001|Core Study|Withdrawal by Subject|1|||
145355018|NCT00395629|524149073|FG002|Core Study|Withdrawal by Subject|1|||
145355019|NCT00395629|524149071|FG000|Core Study|Lost to Follow-up|0|||
145355020|NCT00395629|524149072|FG001|Core Study|Lost to Follow-up|0|||
145355021|NCT00395629|524149073|FG002|Core Study|Lost to Follow-up|1|||
145355022|NCT00395629|524149071|FG000|Extension Study|Adverse Event|0|||
145355023|NCT00395629|524149072|FG001|Extension Study|Adverse Event|0|||
145355024|NCT00395629|524149073|FG002|Extension Study|Adverse Event|2|||
145355025|NCT00395629|524149071|FG000|Extension Study|Administrative problems|0|||
145355026|NCT00395629|524149072|FG001|Extension Study|Administrative problems|0|||
145355027|NCT00395629|524149073|FG002|Extension Study|Administrative problems|1|||
145355028|NCT01686373|524149074|FG000|Overall Study|Lost to Follow-up|3|||
145355029|NCT01686373|524149075|FG001|Overall Study|Lost to Follow-up|0|||
145355030|NCT01686373|524149074|FG000|Overall Study|Withdrawal by Subject|0|||
145355031|NCT01686373|524149075|FG001|Overall Study|Withdrawal by Subject|1|||
145355032|NCT01686373|524149074|FG000|Overall Study|Adverse Event|0|||
145355033|NCT01686373|524149075|FG001|Overall Study|Adverse Event|1|||
145355034|NCT01836471|524149082|FG000|Overall Study|Pregnancy|1|||
145355035|NCT01836471|524149083|FG001|Overall Study|Pregnancy|0|||
145355036|NCT01836471|524149084|FG002|Overall Study|Pregnancy|0|||
145355037|NCT01836471|524149085|FG003|Overall Study|Pregnancy|0|||
145355038|NCT01836471|524149086|FG004|Overall Study|Pregnancy|0|||
145355039|NCT01836471|524149082|FG000|Overall Study|Withdrawal by Subject|3|||
145355040|NCT01836471|524149083|FG001|Overall Study|Withdrawal by Subject|4|||
145355041|NCT01836471|524149084|FG002|Overall Study|Withdrawal by Subject|1|||
145355042|NCT01836471|524149085|FG003|Overall Study|Withdrawal by Subject|0|||
145355043|NCT01836471|524149086|FG004|Overall Study|Withdrawal by Subject|2|||
145355044|NCT01836471|524149082|FG000|Overall Study|Physician Decision|0|||
145355045|NCT01836471|524149083|FG001|Overall Study|Physician Decision|1|||
145355046|NCT01836471|524149084|FG002|Overall Study|Physician Decision|0|||
145355047|NCT01836471|524149085|FG003|Overall Study|Physician Decision|0|||
145355048|NCT01836471|524149086|FG004|Overall Study|Physician Decision|0|||
145355049|NCT01836471|524149082|FG000|Overall Study|Lost to Follow-up|0|||
145355050|NCT01836471|524149083|FG001|Overall Study|Lost to Follow-up|0|||
145355051|NCT01836471|524149084|FG002|Overall Study|Lost to Follow-up|0|||
145355052|NCT01836471|524149085|FG003|Overall Study|Lost to Follow-up|1|||
145355053|NCT01836471|524149086|FG004|Overall Study|Lost to Follow-up|1|||
145355054|NCT01836471|524149082|FG000|Overall Study|Adverse Event|6|||
145355055|NCT01836471|524149083|FG001|Overall Study|Adverse Event|3|||
145355056|NCT01836471|524149084|FG002|Overall Study|Adverse Event|1|||
145355057|NCT01836471|524149085|FG003|Overall Study|Adverse Event|1|||
145355058|NCT01836471|524149086|FG004|Overall Study|Adverse Event|2|||
145355059|NCT01836471|524149082|FG000|Overall Study|Non compliance with tx|1|||
145355060|NCT01836471|524149083|FG001|Overall Study|Non compliance with tx|1|||
145355061|NCT01836471|524149084|FG002|Overall Study|Non compliance with tx|0|||
145355062|NCT01836471|524149085|FG003|Overall Study|Non compliance with tx|0|||
145417491|NCT03336866|524383903|FG001|Overall Study|Noncompliance with clinic house rules|0|||
145417492|NCT03336866|524383904|FG002|Overall Study|Noncompliance with clinic house rules|1|||
145417493|NCT03462563|524383907|FG000|Overall Study|Death|1|||
145417494|NCT03462563|524383908|FG001|Overall Study|Death|1|||
145417495|NCT03462563|524383907|FG000|Overall Study|Termination of study|2|||
145417496|NCT03462563|524383908|FG001|Overall Study|Termination of study|1|||
145417497|NCT03462563|524383907|FG000|Overall Study|Adverse Event|1|||
145417498|NCT03462563|524383908|FG001|Overall Study|Adverse Event|3|||
145417499|NCT03462563|524383907|FG000|Overall Study|Unspecified reason|10|||
145417500|NCT03462563|524383908|FG001|Overall Study|Unspecified reason|12|||
145417501|NCT03462563|524383907|FG000|Overall Study|Physician Decision|1|||
145417502|NCT03462563|524383908|FG001|Overall Study|Physician Decision|0|||
145417503|NCT05737745|524383909|FG000|Overall Study|Withdrawal by Subject|0|||
145417504|NCT05737745|524383910|FG001|Overall Study|Withdrawal by Subject|6|||
145417505|NCT05737745|524383911|FG002|Overall Study|Withdrawal by Subject|1|||
145417506|NCT02021318|524383912|FG000|Overall Study|Adverse Event|2|||
145417507|NCT02021318|524383913|FG001|Overall Study|Adverse Event|1|||
145417508|NCT02021318|524383912|FG000|Overall Study|Death|33|||
145417509|NCT02021318|524383913|FG001|Overall Study|Death|34|||
145417510|NCT02021318|524383912|FG000|Overall Study|Lost to Follow-up|3|||
145417511|NCT02021318|524383913|FG001|Overall Study|Lost to Follow-up|3|||
145417512|NCT02021318|524383912|FG000|Overall Study|Progressive Disease|0|||
145417513|NCT02021318|524383913|FG001|Overall Study|Progressive Disease|1|||
145417514|NCT02021318|524383912|FG000|Overall Study|Withdrawal by Subject|30|||
145417515|NCT02021318|524383913|FG001|Overall Study|Withdrawal by Subject|18|||
145417516|NCT02021318|524383912|FG000|Overall Study|Physician Decision|3|||
145417517|NCT02021318|524383913|FG001|Overall Study|Physician Decision|3|||
145417518|NCT02021318|524383912|FG000|Overall Study|Miscellaneous|2|||
145417519|NCT02021318|524383913|FG001|Overall Study|Miscellaneous|3|||
145417520|NCT02569242|524383914|FG000|Overall Study|Death|1|||
145417521|NCT02569242|524383915|FG001|Overall Study|Death|0|||
145417522|NCT02569242|524383914|FG000|Overall Study|Withdrawal by Subject|0|||
145417523|NCT02569242|524383915|FG001|Overall Study|Withdrawal by Subject|1|||
145417524|NCT00689052|524383916|FG000|Overall Study|Adverse Event|4|||
145417525|NCT00689052|524383917|FG001|Overall Study|Adverse Event|6|||
145417526|NCT00689052|524383916|FG000|Overall Study|Protocol Violation|1|||
145417527|NCT00689052|524383917|FG001|Overall Study|Protocol Violation|0|||
145417528|NCT00689052|524383916|FG000|Overall Study|Lost to Follow-up|2|||
145417529|NCT00689052|524383917|FG001|Overall Study|Lost to Follow-up|0|||
145417530|NCT00689052|524383916|FG000|Overall Study|Withdrawal by Subject|2|||
145417531|NCT00689052|524383917|FG001|Overall Study|Withdrawal by Subject|0|||
145417532|NCT00689052|524383916|FG000|Overall Study|Early termination of the trial|22|||
145417533|NCT00689052|524383917|FG001|Overall Study|Early termination of the trial|24|||
145417534|NCT04796207|524383920|FG000|Overall Study|Lost to Follow-up|7|||
145417535|NCT04796207|524383921|FG001|Overall Study|Lost to Follow-up|2|||
145417536|NCT03003468|524383924|FG000|Overall Study|Withdrawal by Subject|0|||
145417537|NCT03003468|524383925|FG001|Overall Study|Withdrawal by Subject|0|||
145417538|NCT03003468|524383926|FG002|Overall Study|Withdrawal by Subject|1|||
145417539|NCT03003468|524383924|FG000|Overall Study|No measurable lesions|0|||
145417540|NCT03003468|524383925|FG001|Overall Study|No measurable lesions|0|||
145417541|NCT03003468|524383926|FG002|Overall Study|No measurable lesions|1|||
145417542|NCT02405962|524383927|FG000|Overall Study|Lost to Follow-up|1|||
145417543|NCT02405962|524383928|FG001|Overall Study|Lost to Follow-up|4|||
145417544|NCT02405962|524383927|FG000|Overall Study|A participant has moved to another place|0|||
145417545|NCT02405962|524383928|FG001|Overall Study|A participant has moved to another place|1|||
145417546|NCT00165698|524383929|FG000|Overall Study|Adverse Event|2|||
145417547|NCT00165698|524383930|FG001|Overall Study|Adverse Event|10|||
145417548|NCT00165698|524383929|FG000|Overall Study|Lost to Follow-up|2|||
145417549|NCT00165698|524383930|FG001|Overall Study|Lost to Follow-up|2|||
145417550|NCT00165698|524383929|FG000|Overall Study|Withdrawal by Subject|2|||
145417551|NCT00165698|524383930|FG001|Overall Study|Withdrawal by Subject|1|||
145417552|NCT00165698|524383929|FG000|Overall Study|Protocol Violation|1|||
145417553|NCT00165698|524383930|FG001|Overall Study|Protocol Violation|0|||
145417554|NCT00165698|524383929|FG000|Overall Study|Not Taken/Lost the medicine|1|||
145417555|NCT00165698|524383930|FG001|Overall Study|Not Taken/Lost the medicine|2|||
145417556|NCT01107457|524383931|FG000|Part A|Adverse Event|1|||
145417557|NCT01107457|524383932|FG001|Part A|Adverse Event|2|||
145417558|NCT01107457|524383933|FG002|Part A|Adverse Event|1|||
145417559|NCT01107457|524383934|FG003|Part A|Adverse Event|0|||
145417560|NCT01107457|524383935|FG004|Part A|Adverse Event|0|||
145417561|NCT01107457|524383936|FG005|Part A|Adverse Event|0|||
145417562|NCT01107457|524383931|FG000|Part A|Withdrawal by Subject|3|||
145417563|NCT01107457|524383932|FG001|Part A|Withdrawal by Subject|3|||
145417564|NCT01107457|524383933|FG002|Part A|Withdrawal by Subject|0|||
145417565|NCT01107457|524383934|FG003|Part A|Withdrawal by Subject|3|||
145417566|NCT01107457|524383935|FG004|Part A|Withdrawal by Subject|1|||
145417567|NCT01107457|524383936|FG005|Part A|Withdrawal by Subject|0|||
145417568|NCT01107457|524383931|FG000|Part A|Lost to Follow-up|0|||
145417569|NCT01107457|524383932|FG001|Part A|Lost to Follow-up|1|||
145355063|NCT01836471|524149086|FG004|Overall Study|Non compliance with tx|0|||
145355064|NCT03776357|524149092|FG000|Overall Study|Lost to Follow-up|3|||
145355065|NCT01286467|524149095|FG000|Overall Study|Death|1|||
145355066|NCT01286467|524149096|FG001|Overall Study|Death|1|||
145355067|NCT01286467|524149097|FG002|Overall Study|Death|1|||
145355068|NCT01286467|524149098|FG003|Overall Study|Death|0|||
145355069|NCT01286467|524149095|FG000|Overall Study|Lost to Follow-up|0|||
145355070|NCT01286467|524149096|FG001|Overall Study|Lost to Follow-up|0|||
145355071|NCT01286467|524149097|FG002|Overall Study|Lost to Follow-up|0|||
145355072|NCT01286467|524149098|FG003|Overall Study|Lost to Follow-up|1|||
145355073|NCT01286467|524149095|FG000|Overall Study|Withdrawal by Subject|0|||
145355074|NCT01286467|524149096|FG001|Overall Study|Withdrawal by Subject|0|||
145355075|NCT01286467|524149097|FG002|Overall Study|Withdrawal by Subject|1|||
145355076|NCT01286467|524149098|FG003|Overall Study|Withdrawal by Subject|0|||
145355077|NCT01286467|524149095|FG000|Overall Study|Physician Decision|0|||
145355078|NCT01286467|524149096|FG001|Overall Study|Physician Decision|0|||
145355079|NCT01286467|524149097|FG002|Overall Study|Physician Decision|0|||
145355080|NCT01286467|524149098|FG003|Overall Study|Physician Decision|1|||
145355081|NCT01286467|524149095|FG000|Overall Study|Disease progression|3|||
145355082|NCT01286467|524149096|FG001|Overall Study|Disease progression|2|||
145355083|NCT01286467|524149097|FG002|Overall Study|Disease progression|2|||
145355084|NCT01286467|524149098|FG003|Overall Study|Disease progression|3|||
145355085|NCT01286467|524149095|FG000|Overall Study|Adverse Event|0|||
145355086|NCT01286467|524149096|FG001|Overall Study|Adverse Event|1|||
145355087|NCT01286467|524149097|FG002|Overall Study|Adverse Event|2|||
145355088|NCT01286467|524149098|FG003|Overall Study|Adverse Event|3|||
145355089|NCT01286467|524149095|FG000|Overall Study|Study drug stop longer than 14 days|0|||
145355090|NCT01286467|524149096|FG001|Overall Study|Study drug stop longer than 14 days|0|||
145355091|NCT01286467|524149097|FG002|Overall Study|Study drug stop longer than 14 days|1|||
145355092|NCT01286467|524149098|FG003|Overall Study|Study drug stop longer than 14 days|0|||
145355093|NCT01058642|524149099|FG000|Treatment Period 1|Adverse Event|0|||
145355094|NCT01058642|524149100|FG001|Treatment Period 1|Adverse Event|1|||
145355095|NCT01058642|524149101|FG002|Treatment Period 1|Adverse Event|1|||
145355096|NCT01058642|524149102|FG003|Treatment Period 1|Adverse Event|0|||
145355097|NCT01058642|524149099|FG000|Treatment Period 1|Physician Decision|0|||
145355098|NCT01058642|524149100|FG001|Treatment Period 1|Physician Decision|0|||
145355099|NCT01058642|524149101|FG002|Treatment Period 1|Physician Decision|1|||
145355100|NCT01058642|524149102|FG003|Treatment Period 1|Physician Decision|0|||
145355101|NCT01058642|524149099|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145355102|NCT01058642|524149100|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145355103|NCT01058642|524149101|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145355104|NCT01058642|524149102|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145355105|NCT01058642|524149099|FG000|Treatment Period 1|Lack of Efficacy|0|||
145355106|NCT01058642|524149100|FG001|Treatment Period 1|Lack of Efficacy|0|||
145355107|NCT01058642|524149101|FG002|Treatment Period 1|Lack of Efficacy|0|||
145355108|NCT01058642|524149102|FG003|Treatment Period 1|Lack of Efficacy|1|||
145355109|NCT01058642|524149099|FG000|Treatment Period 1|Protocol Violation|0|||
145355110|NCT01058642|524149100|FG001|Treatment Period 1|Protocol Violation|0|||
145355111|NCT01058642|524149101|FG002|Treatment Period 1|Protocol Violation|0|||
145355112|NCT01058642|524149102|FG003|Treatment Period 1|Protocol Violation|1|||
145355113|NCT01058642|524149099|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
145355114|NCT01058642|524149100|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145355115|NCT01058642|524149101|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145355116|NCT01058642|524149102|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
145355117|NCT02411656|524149106|FG000|Overall Study|Adverse Event|4|||
145355118|NCT02411656|524149106|FG000|Overall Study|Clinical Progression|33|||
145355119|NCT03305848|524149107|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
145355120|NCT03305848|524149107|FG000|Overall Study|Physician Decision|2|||
145417570|NCT01107457|524383933|FG002|Part A|Lost to Follow-up|0|||
145417571|NCT01107457|524383934|FG003|Part A|Lost to Follow-up|0|||
145417572|NCT01107457|524383935|FG004|Part A|Lost to Follow-up|0|||
145417573|NCT01107457|524383936|FG005|Part A|Lost to Follow-up|0|||
145417574|NCT01107457|524383931|FG000|Part A|Lack of Efficacy|1|||
145417575|NCT01107457|524383932|FG001|Part A|Lack of Efficacy|0|||
145355121|NCT02224157|524149109|FG000|Overall Study|Severe non-compliance to protocol|2|||
145355122|NCT02224157|524149110|FG001|Overall Study|Severe non-compliance to protocol|2|||
145355123|NCT02224157|524149109|FG000|Overall Study|Other|13|||
145355124|NCT02224157|524149110|FG001|Overall Study|Other|10|||
145355125|NCT02224157|524149109|FG000|Overall Study|Subject decision|58|||
145355126|NCT02224157|524149110|FG001|Overall Study|Subject decision|50|||
145355127|NCT02224157|524149109|FG000|Overall Study|Prematurely closed site|4|||
145355128|NCT02224157|524149110|FG001|Overall Study|Prematurely closed site|2|||
145355129|NCT02224157|524149109|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
145355130|NCT02224157|524149110|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
145355131|NCT02224157|524149109|FG000|Overall Study|Lost to Follow-up|27|||
145417576|NCT01107457|524383933|FG002|Part A|Lack of Efficacy|0|||
145417577|NCT01107457|524383934|FG003|Part A|Lack of Efficacy|0|||
145417578|NCT01107457|524383935|FG004|Part A|Lack of Efficacy|0|||
145355132|NCT02224157|524149110|FG001|Overall Study|Lost to Follow-up|35|||
145355133|NCT02224157|524149109|FG000|Overall Study|Death|1|||
145355134|NCT02224157|524149110|FG001|Overall Study|Death|1|||
145355135|NCT02224157|524149109|FG000|Overall Study|Adverse Event|1|||
145355136|NCT02224157|524149110|FG001|Overall Study|Adverse Event|3|||
145355137|NCT04578535|524149113|FG000|Overall Study|Lost to Follow-up|1|||
145355138|NCT04578535|524149114|FG001|Overall Study|Lost to Follow-up|0|||
145355139|NCT04578535|524149115|FG002|Overall Study|Lost to Follow-up|0|||
145355140|NCT04578535|524149116|FG003|Overall Study|Lost to Follow-up|1|||
145355141|NCT04578535|524149117|FG004|Overall Study|Lost to Follow-up|0|||
145355142|NCT04578535|524149118|FG005|Overall Study|Lost to Follow-up|2|||
145355143|NCT04578535|524149113|FG000|Overall Study|Pregnancy|1|||
145355144|NCT04578535|524149114|FG001|Overall Study|Pregnancy|0|||
145355145|NCT04578535|524149115|FG002|Overall Study|Pregnancy|0|||
145355146|NCT04578535|524149116|FG003|Overall Study|Pregnancy|0|||
145355147|NCT04578535|524149117|FG004|Overall Study|Pregnancy|0|||
145355148|NCT04578535|524149118|FG005|Overall Study|Pregnancy|0|||
145355149|NCT04578535|524149113|FG000|Overall Study|Withdrawal by Subject|0|||
145355150|NCT04578535|524149114|FG001|Overall Study|Withdrawal by Subject|0|||
145355151|NCT04578535|524149115|FG002|Overall Study|Withdrawal by Subject|0|||
145355152|NCT04578535|524149116|FG003|Overall Study|Withdrawal by Subject|1|||
145355153|NCT04578535|524149117|FG004|Overall Study|Withdrawal by Subject|1|||
145355154|NCT04578535|524149118|FG005|Overall Study|Withdrawal by Subject|5|||
145355155|NCT04578535|524149113|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
145355156|NCT04578535|524149114|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
145355157|NCT04578535|524149115|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
145355158|NCT04578535|524149116|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
145577343|NCT03511560|524968056|FG001|Overall Study|Death|1|||
145577344|NCT03511560|524968055|FG000|Overall Study|Adverse Event|0|||
145577345|NCT03511560|524968056|FG001|Overall Study|Adverse Event|2|||
145577346|NCT03511560|524968055|FG000|Overall Study|Transplant cancelled|0|||
145577347|NCT03511560|524968056|FG001|Overall Study|Transplant cancelled|1|||
145355159|NCT04578535|524149117|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
145355160|NCT04578535|524149118|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
145355161|NCT00235755|524149121|FG000|4-Week Titration Phase|Adverse Event|6|||
145355162|NCT00235755|524149122|FG001|4-Week Titration Phase|Adverse Event|14|||
145355163|NCT00235755|524149123|FG002|4-Week Titration Phase|Adverse Event|20|||
145355164|NCT00235755|524149121|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
145355165|NCT00235755|524149122|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
145355166|NCT00235755|524149123|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
145355167|NCT00235755|524149121|FG000|4-Week Titration Phase|Protocol Violation|2|||
145355168|NCT00235755|524149122|FG001|4-Week Titration Phase|Protocol Violation|2|||
145355169|NCT00235755|524149123|FG002|4-Week Titration Phase|Protocol Violation|1|||
145355170|NCT00235755|524149121|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
145355171|NCT00235755|524149122|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
145355172|NCT00235755|524149123|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
145355173|NCT00235755|524149121|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145355174|NCT00235755|524149122|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
145577348|NCT03511560|524968055|FG000|Overall Study|Patient switched to another drug|1|||
145577349|NCT03511560|524968056|FG001|Overall Study|Patient switched to another drug|0|||
145577350|NCT00179413|524968061|FG000|Overall Study|Adverse Event|38|||
145577351|NCT00179413|524968062|FG001|Overall Study|Adverse Event|20|||
145577352|NCT00179413|524968061|FG000|Overall Study|Withdrawal by Subject|87|||
145577353|NCT00179413|524968062|FG001|Overall Study|Withdrawal by Subject|95|||
145577354|NCT00439140|524968063|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
145355175|NCT00235755|524149123|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
145355176|NCT00235755|524149121|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
145355177|NCT00235755|524149122|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
145355178|NCT00235755|524149123|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
145577355|NCT00439140|524968064|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
145355179|NCT00235755|524149121|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
145355180|NCT00235755|524149122|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
145577356|NCT00439140|524968065|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
145577357|NCT00439140|524968063|FG000|Treatment Cycle 1|Personal reasons|0|||
145577358|NCT00439140|524968064|FG001|Treatment Cycle 1|Personal reasons|2|||
145577359|NCT00439140|524968065|FG002|Treatment Cycle 1|Personal reasons|0|||
145577360|NCT00439140|524968063|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
145355181|NCT00235755|524149123|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
145355182|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Adverse Event|8|||
145355183|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Adverse Event|12|||
145355184|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Adverse Event|26|||
145355185|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
145577361|NCT00439140|524968064|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
145577362|NCT00439140|524968065|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
145577363|NCT00439140|524968063|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
145417579|NCT01107457|524383936|FG005|Part A|Lack of Efficacy|0|||
145417580|NCT01107457|524383931|FG000|Part A|Protocol Violation|0|||
145417581|NCT01107457|524383932|FG001|Part A|Protocol Violation|1|||
145417582|NCT01107457|524383933|FG002|Part A|Protocol Violation|0|||
145417583|NCT01107457|524383934|FG003|Part A|Protocol Violation|0|||
145417584|NCT01107457|524383935|FG004|Part A|Protocol Violation|0|||
145417585|NCT01107457|524383936|FG005|Part A|Protocol Violation|0|||
145417586|NCT01107457|524383931|FG000|Part B and C|Adverse Event|0|||
145417587|NCT01107457|524383932|FG001|Part B and C|Adverse Event|0|||
145417588|NCT01107457|524383933|FG002|Part B and C|Adverse Event|0|||
145417589|NCT01107457|524383934|FG003|Part B and C|Adverse Event|0|||
145417590|NCT01107457|524383935|FG004|Part B and C|Adverse Event|0|||
145417591|NCT01107457|524383936|FG005|Part B and C|Adverse Event|12|||
145417592|NCT01107457|524383931|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145417593|NCT01107457|524383932|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145417594|NCT01107457|524383933|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145417595|NCT01107457|524383934|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145417596|NCT01107457|524383935|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
145417597|NCT01107457|524383936|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
145417598|NCT01107457|524383931|FG000|Part B and C|Physician Decision|0|||
145417599|NCT01107457|524383932|FG001|Part B and C|Physician Decision|0|||
145417600|NCT01107457|524383933|FG002|Part B and C|Physician Decision|0|||
145417601|NCT01107457|524383934|FG003|Part B and C|Physician Decision|0|||
145417602|NCT01107457|524383935|FG004|Part B and C|Physician Decision|0|||
145417603|NCT01107457|524383936|FG005|Part B and C|Physician Decision|3|||
145417604|NCT01107457|524383931|FG000|Part B and C|Lack of Efficacy|0|||
145417605|NCT01107457|524383932|FG001|Part B and C|Lack of Efficacy|0|||
145417606|NCT01107457|524383933|FG002|Part B and C|Lack of Efficacy|0|||
145417607|NCT01107457|524383934|FG003|Part B and C|Lack of Efficacy|0|||
145417608|NCT01107457|524383935|FG004|Part B and C|Lack of Efficacy|0|||
145417609|NCT01107457|524383936|FG005|Part B and C|Lack of Efficacy|7|||
145417610|NCT01107457|524383931|FG000|Part B and C|Lost to Follow-up|0|||
145417611|NCT01107457|524383932|FG001|Part B and C|Lost to Follow-up|0|||
145417612|NCT01107457|524383933|FG002|Part B and C|Lost to Follow-up|0|||
145417613|NCT01107457|524383934|FG003|Part B and C|Lost to Follow-up|0|||
145417614|NCT01107457|524383935|FG004|Part B and C|Lost to Follow-up|0|||
145417615|NCT01107457|524383936|FG005|Part B and C|Lost to Follow-up|10|||
145417616|NCT01107457|524383931|FG000|Part B and C|Protocol Violation|0|||
145417617|NCT01107457|524383932|FG001|Part B and C|Protocol Violation|0|||
145417618|NCT01107457|524383933|FG002|Part B and C|Protocol Violation|0|||
145417619|NCT01107457|524383934|FG003|Part B and C|Protocol Violation|0|||
145417620|NCT01107457|524383935|FG004|Part B and C|Protocol Violation|0|||
145417621|NCT01107457|524383936|FG005|Part B and C|Protocol Violation|1|||
145417622|NCT01107457|524383931|FG000|Part B and C|Sponsor Decision|0|||
145417623|NCT01107457|524383932|FG001|Part B and C|Sponsor Decision|0|||
145417624|NCT01107457|524383933|FG002|Part B and C|Sponsor Decision|0|||
145417625|NCT01107457|524383934|FG003|Part B and C|Sponsor Decision|0|||
145417626|NCT01107457|524383935|FG004|Part B and C|Sponsor Decision|0|||
145417627|NCT01107457|524383936|FG005|Part B and C|Sponsor Decision|66|||
145417628|NCT01107457|524383931|FG000|Part B and C|Withdrawal by Subject|0|||
145417629|NCT01107457|524383932|FG001|Part B and C|Withdrawal by Subject|0|||
145417630|NCT01107457|524383933|FG002|Part B and C|Withdrawal by Subject|0|||
145417631|NCT01107457|524383934|FG003|Part B and C|Withdrawal by Subject|0|||
145417632|NCT01107457|524383935|FG004|Part B and C|Withdrawal by Subject|0|||
145417633|NCT01107457|524383936|FG005|Part B and C|Withdrawal by Subject|16|||
145417634|NCT01107457|524383931|FG000|Part B and C|Clinical Relapse|0|||
145417635|NCT01107457|524383932|FG001|Part B and C|Clinical Relapse|0|||
145417636|NCT01107457|524383933|FG002|Part B and C|Clinical Relapse|0|||
145417637|NCT01107457|524383934|FG003|Part B and C|Clinical Relapse|0|||
145417638|NCT01107457|524383935|FG004|Part B and C|Clinical Relapse|0|||
145577364|NCT00439140|524968064|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
145577365|NCT00439140|524968065|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
145577366|NCT00439140|524968063|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
145417639|NCT01107457|524383936|FG005|Part B and C|Clinical Relapse|4|||
145417640|NCT02547935|524383937|FG000|Overall Study|Other|0|||
145417641|NCT02547935|524383938|FG001|Overall Study|Other|1|||
145417642|NCT02547935|524383939|FG002|Overall Study|Other|0|||
145417643|NCT02547935|524383937|FG000|Overall Study|Withdrawal by Subject|2|||
145417644|NCT02547935|524383938|FG001|Overall Study|Withdrawal by Subject|3|||
145417645|NCT02547935|524383939|FG002|Overall Study|Withdrawal by Subject|4|||
145417646|NCT02547935|524383937|FG000|Overall Study|Screen Failure|2|||
145417647|NCT02547935|524383938|FG001|Overall Study|Screen Failure|0|||
145417648|NCT02547935|524383939|FG002|Overall Study|Screen Failure|0|||
145417649|NCT02547935|524383937|FG000|Overall Study|Physician Decision|0|||
145417650|NCT02547935|524383938|FG001|Overall Study|Physician Decision|1|||
145417651|NCT02547935|524383939|FG002|Overall Study|Physician Decision|0|||
145417652|NCT02547935|524383937|FG000|Overall Study|Lost to Follow-up|0|||
145417653|NCT02547935|524383938|FG001|Overall Study|Lost to Follow-up|2|||
145417654|NCT02547935|524383939|FG002|Overall Study|Lost to Follow-up|1|||
145417655|NCT02547935|524383937|FG000|Overall Study|Death|1|||
145622997|NCT01254305|525131559|FG001|Overall Study|Lack of Efficacy|0|||
145622998|NCT01254305|525131560|FG002|Overall Study|Lack of Efficacy|1|||
145355186|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
145355187|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
145355188|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
145355189|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
145355190|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
145355191|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
145355192|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
145355193|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
145355194|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
145355195|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
145355196|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
145355197|NCT00235755|524149121|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
145355198|NCT00235755|524149122|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
145355199|NCT00235755|524149123|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
145355200|NCT02301169|524149126|FG000|Overall Study|Adverse Event|1|||
145355201|NCT02301169|524149127|FG001|Overall Study|Adverse Event|0|||
145355202|NCT03839628|524149128|FG000|Overall Study|Withdrawal by Subject|1|||
145355203|NCT01147068|524149129|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
145355204|NCT01147068|524149130|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145355205|NCT01147068|524149131|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145355206|NCT01147068|524149132|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145355207|NCT01147068|524149133|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145355208|NCT01147068|524149134|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
145355209|NCT01147068|524149135|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
145355210|NCT01147068|524149129|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
145355211|NCT01147068|524149130|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
145355212|NCT01147068|524149131|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
145355213|NCT01147068|524149132|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
145355214|NCT01147068|524149133|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
145355215|NCT01147068|524149134|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
145355216|NCT01147068|524149135|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
145355217|NCT01147068|524149129|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
145355218|NCT01147068|524149130|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
145355219|NCT01147068|524149131|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
145355220|NCT01147068|524149132|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
145355221|NCT01147068|524149133|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
145355222|NCT01147068|524149134|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
145355223|NCT01147068|524149135|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
145355224|NCT01147068|524149129|FG000|Subjects That Received 2nd Dose|Other|0|||
145355225|NCT01147068|524149130|FG001|Subjects That Received 2nd Dose|Other|3|||
145355226|NCT01147068|524149131|FG002|Subjects That Received 2nd Dose|Other|3|||
145355227|NCT01147068|524149132|FG003|Subjects That Received 2nd Dose|Other|0|||
145355228|NCT01147068|524149133|FG004|Subjects That Received 2nd Dose|Other|1|||
145355229|NCT01147068|524149134|FG005|Subjects That Received 2nd Dose|Other|0|||
145355230|NCT01147068|524149135|FG006|Subjects That Received 2nd Dose|Other|0|||
145355231|NCT01147068|524149129|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145355232|NCT01147068|524149130|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145355233|NCT01147068|524149131|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145355234|NCT01147068|524149132|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145355235|NCT01147068|524149133|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
145355236|NCT01147068|524149134|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145355237|NCT01147068|524149135|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
145355238|NCT01147068|524149129|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355239|NCT01147068|524149130|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355240|NCT01147068|524149131|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355241|NCT01147068|524149132|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
145355242|NCT01147068|524149133|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355243|NCT01147068|524149134|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355244|NCT01147068|524149135|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
145355245|NCT01147068|524149129|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
145355246|NCT01147068|524149130|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
145355247|NCT01147068|524149131|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
145355248|NCT01147068|524149132|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
145355249|NCT01147068|524149133|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
145355250|NCT01147068|524149134|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
145577367|NCT00439140|524968064|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
145577368|NCT00439140|524968065|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
145355251|NCT01147068|524149135|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
145355252|NCT03181633|524149136|FG000|Overall Study|Withdrawal by Subject|1|||
145355253|NCT03181633|524149136|FG000|Overall Study|Missing follow-up visit|1|||
145355254|NCT01306305|524149139|FG000|Overall Study|Lost to Follow-up|1|||
145355255|NCT01306305|524149140|FG001|Overall Study|Lost to Follow-up|0|||
145355256|NCT01306305|524149139|FG000|Overall Study|Withdrew consent|1|||
145355257|NCT01306305|524149140|FG001|Overall Study|Withdrew consent|0|||
145355258|NCT01288079|524149141|FG000|Overall Study|Withdrawal by Subject|2|||
145355259|NCT01288079|524149142|FG001|Overall Study|Withdrawal by Subject|4|||
145355260|NCT01288079|524149143|FG002|Overall Study|Withdrawal by Subject|1|||
145355261|NCT01288079|524149144|FG003|Overall Study|Withdrawal by Subject|0|||
145355262|NCT01288079|524149141|FG000|Overall Study|Adverse Event|2|||
145355263|NCT01288079|524149142|FG001|Overall Study|Adverse Event|1|||
145355264|NCT01288079|524149143|FG002|Overall Study|Adverse Event|2|||
145355265|NCT01288079|524149144|FG003|Overall Study|Adverse Event|3|||
145355266|NCT01288079|524149141|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
145355267|NCT01288079|524149142|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
145355268|NCT01288079|524149143|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
145355269|NCT01288079|524149144|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
145355270|NCT01288079|524149141|FG000|Overall Study|Condition under Investigation Worsened|0|||
145355271|NCT01288079|524149142|FG001|Overall Study|Condition under Investigation Worsened|0|||
145355272|NCT01288079|524149143|FG002|Overall Study|Condition under Investigation Worsened|0|||
145355273|NCT01288079|524149144|FG003|Overall Study|Condition under Investigation Worsened|1|||
145355274|NCT01288079|524149141|FG000|Overall Study|Lack of Efficacy|2|||
145355275|NCT01288079|524149142|FG001|Overall Study|Lack of Efficacy|2|||
145355276|NCT01288079|524149143|FG002|Overall Study|Lack of Efficacy|0|||
145355277|NCT01288079|524149144|FG003|Overall Study|Lack of Efficacy|2|||
145355278|NCT01288079|524149141|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
145355279|NCT01288079|524149142|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145355280|NCT01288079|524149143|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
145355281|NCT01288079|524149144|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
145355282|NCT01288079|524149141|FG000|Overall Study|Lost to Follow-up|1|||
145355283|NCT01288079|524149142|FG001|Overall Study|Lost to Follow-up|1|||
145355284|NCT01288079|524149143|FG002|Overall Study|Lost to Follow-up|1|||
145355285|NCT01288079|524149144|FG003|Overall Study|Lost to Follow-up|0|||
145355286|NCT01288079|524149141|FG000|Overall Study|Other or Study Termination|11|||
145355287|NCT01288079|524149142|FG001|Overall Study|Other or Study Termination|15|||
145355288|NCT01288079|524149143|FG002|Overall Study|Other or Study Termination|14|||
145355289|NCT01288079|524149144|FG003|Overall Study|Other or Study Termination|8|||
145355290|NCT02387840|524149145|FG000|Overall Study|Death|0|||
145355291|NCT02387840|524149146|FG001|Overall Study|Death|0|||
145355292|NCT02387840|524149147|FG002|Overall Study|Death|0|||
145355293|NCT02387840|524149148|FG003|Overall Study|Death|0|||
145355294|NCT02387840|524149149|FG004|Overall Study|Death|0|||
145355295|NCT02387840|524149150|FG005|Overall Study|Death|1|||
145355296|NCT00868530|524149151|FG000|Overall Study|Adverse Event|3|||
145355297|NCT00868530|524149151|FG000|Overall Study|Lost to Follow-up|1|||
145355298|NCT01609790|524149152|FG000|Overall Study|Protocol Violation|1|||
145355299|NCT01609790|524149153|FG001|Overall Study|Protocol Violation|7|||
145355300|NCT01609790|524149154|FG002|Overall Study|Protocol Violation|8|||
145355301|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Adverse Event|7|||
145355302|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
145355303|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Non-compliance|3|||
145355304|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Other|17|||
145355305|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Physician Decision|2|||
145355306|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Pregnancy|1|||
145355307|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
145355308|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
145355309|NCT05207865|524150910|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
145355310|NCT05207865|524150910|FG000|Follow-up Phase|Lost to Follow-up|1|||
145355311|NCT05207865|524150910|FG000|Follow-up Phase|Non-compliance|1|||
145355312|NCT05207865|524150910|FG000|Follow-up Phase|Not reported|2|||
145355313|NCT05207865|524150910|FG000|Follow-up Phase|Not collected|11|||
145355314|NCT06025721|524150911|FG000|Overall Study|Physician Decision|1|||
145355315|NCT06025721|524150911|FG000|Overall Study|Protocol Violation|1|||
145355316|NCT06025721|524150911|FG000|Overall Study|Incarceration|1|||
145355317|NCT02068508|524150914|FG000|Overall Study|Case report forms uncollected|27|||
145355318|NCT02068508|524150914|FG000|Overall Study|Patient did not visit the study site|1|||
145355319|NCT02068508|524150914|FG000|Overall Study|Protocol Violation|4|||
145355320|NCT00813150|524150915|FG000|Treatment Period|Adverse Event|16|||
145355321|NCT00813150|524150916|FG001|Treatment Period|Adverse Event|15|||
145355322|NCT00813150|524150915|FG000|Treatment Period|Death|2|||
145355323|NCT00813150|524150916|FG001|Treatment Period|Death|0|||
145355324|NCT00813150|524150915|FG000|Treatment Period|Progressive disease|1|||
145622999|NCT01254305|525131558|FG000|Overall Study|Protocol Violation|1|||
145355325|NCT00813150|524150916|FG001|Treatment Period|Progressive disease|0|||
145355326|NCT00813150|524150915|FG000|Treatment Period|Complete response|0|||
145355327|NCT00813150|524150916|FG001|Treatment Period|Complete response|1|||
145355328|NCT00813150|524150915|FG000|Treatment Period|Stable disease|1|||
145355329|NCT00813150|524150916|FG001|Treatment Period|Stable disease|2|||
145355330|NCT00813150|524150915|FG000|Treatment Period|Protocol Violation|3|||
145355331|NCT00813150|524150916|FG001|Treatment Period|Protocol Violation|4|||
145355332|NCT00813150|524150915|FG000|Treatment Period|Withdrawal by Subject|5|||
145355333|NCT00813150|524150916|FG001|Treatment Period|Withdrawal by Subject|3|||
145355334|NCT00813150|524150915|FG000|Treatment Period|Non compliance|0|||
145355335|NCT00813150|524150916|FG001|Treatment Period|Non compliance|1|||
145355336|NCT00813150|524150915|FG000|Treatment Period|Reason not specified|3|||
145355337|NCT00813150|524150916|FG001|Treatment Period|Reason not specified|4|||
145355338|NCT00813150|524150915|FG000|Treatment Period|Data not available|1|||
145355339|NCT00813150|524150916|FG001|Treatment Period|Data not available|2|||
145355340|NCT00813150|524150915|FG000|Long Term Follow-up|Death|0|||
145355341|NCT00813150|524150916|FG001|Long Term Follow-up|Death|4|||
145355342|NCT00813150|524150915|FG000|Long Term Follow-up|Other|0|||
145355343|NCT00813150|524150916|FG001|Long Term Follow-up|Other|3|||
145355344|NCT00813150|524150915|FG000|Long Term Follow-up|Lost to Follow-up|2|||
145355345|NCT00813150|524150916|FG001|Long Term Follow-up|Lost to Follow-up|0|||
145355346|NCT00813150|524150915|FG000|Long Term Follow-up|Progression/Relapse|22|||
145355347|NCT00813150|524150916|FG001|Long Term Follow-up|Progression/Relapse|24|||
145355348|NCT05423093|524150924|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
145355349|NCT05423093|524150924|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
145355350|NCT05423093|524150924|FG000|Attended Intervention Session|Lost to Follow-up|3|||
145355351|NCT05423093|524150924|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
145355352|NCT05423093|524150924|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
145355353|NCT03593525|524150925|FG000|Overall Study|Withdrawal by Subject|1|||
145355354|NCT03593525|524150926|FG001|Overall Study|Withdrawal by Subject|0|||
145355355|NCT03593525|524150925|FG000|Overall Study|Lost to Follow-up|7|||
145355356|NCT03593525|524150926|FG001|Overall Study|Lost to Follow-up|5|||
145355357|NCT02832687|524150930|FG000|Overall Study|Adverse Event|0|||
145355358|NCT02832687|524150931|FG001|Overall Study|Adverse Event|2|||
145355359|NCT00210210|524150932|FG000|Overall Study|Withdrawal by Subject|3|||
145355360|NCT00210210|524150933|FG001|Overall Study|Withdrawal by Subject|2|||
145355361|NCT00210210|524150932|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
145355362|NCT00210210|524150933|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
145355363|NCT04231825|524150934|FG000|Overall Study|Protocol Violation|3|||
145355364|NCT04231825|524150935|FG001|Overall Study|Protocol Violation|3|||
145355365|NCT04231825|524150934|FG000|Overall Study|Lost to Follow-up|0|||
145355366|NCT04231825|524150935|FG001|Overall Study|Lost to Follow-up|1|||
145355367|NCT01662635|524150936|FG000|Overall Study|scarce samples for evaluation|30|||
145355368|NCT01217112|524150939|FG000|Overall Study|Adverse Event|0|||
145355369|NCT01217112|524150940|FG001|Overall Study|Adverse Event|2|||
145355370|NCT01217112|524150941|FG002|Overall Study|Adverse Event|0|||
145355371|NCT01217112|524150942|FG003|Overall Study|Adverse Event|2|||
145355372|NCT01217112|524150943|FG004|Overall Study|Adverse Event|0|||
145355373|NCT01217112|524150939|FG000|Overall Study|Withdrawal by Subject|0|||
145355374|NCT01217112|524150940|FG001|Overall Study|Withdrawal by Subject|0|||
145355375|NCT01217112|524150941|FG002|Overall Study|Withdrawal by Subject|1|||
145355376|NCT01217112|524150942|FG003|Overall Study|Withdrawal by Subject|0|||
145355377|NCT01217112|524150943|FG004|Overall Study|Withdrawal by Subject|0|||
145355378|NCT01217112|524150939|FG000|Overall Study|Physician Decision|0|||
145355379|NCT01217112|524150940|FG001|Overall Study|Physician Decision|0|||
145355380|NCT01217112|524150941|FG002|Overall Study|Physician Decision|0|||
145355381|NCT01217112|524150942|FG003|Overall Study|Physician Decision|0|||
145355382|NCT01217112|524150943|FG004|Overall Study|Physician Decision|1|||
145355383|NCT02596971|524150944|FG000|Overall Study|Death|5|||
145355384|NCT02596971|524150945|FG001|Overall Study|Death|1|||
145355385|NCT02596971|524150946|FG002|Overall Study|Death|5|||
145355386|NCT02596971|524150944|FG000|Overall Study|Withdrawal by Subject|5|||
145355387|NCT02596971|524150945|FG001|Overall Study|Withdrawal by Subject|1|||
145417656|NCT02547935|524383938|FG001|Overall Study|Death|1|||
145355388|NCT02596971|524150946|FG002|Overall Study|Withdrawal by Subject|4|||
145355389|NCT01401361|524150947|FG000|Overall Study|Withdrawal by Subject|16|||
145355390|NCT01401361|524150947|FG000|Overall Study|Lack of Efficacy|6|||
145355391|NCT01401361|524150947|FG000|Overall Study|Physician Decision|1|||
145355392|NCT01401361|524150947|FG000|Overall Study|Lost to Follow-up|3|||
145355393|NCT01401361|524150947|FG000|Overall Study|Subject/family decision post procedure|2|||
145355394|NCT00595920|524150948|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
145355395|NCT00351468|524150949|FG000|Overall Study|Adverse Event|42|||
145355396|NCT00351468|524150949|FG000|Overall Study|Withdrawal by Subject|39|||
145355397|NCT00351468|524150949|FG000|Overall Study|Various -follow up w clinical team|39|||
145355398|NCT00351468|524150949|FG000|Overall Study|Lack of Efficacy|32|||
145355399|NCT00351468|524150949|FG000|Overall Study|Non-compliance|8|||
145355400|NCT00351468|524150949|FG000|Overall Study|Lost to Follow-up|4|||
145355401|NCT00351468|524150949|FG000|Overall Study|Protocol Violation|3|||
145355402|NCT00611923|524150950|FG000|Overall Study|Withdrawal by Subject|2|||
145355403|NCT00611923|524150951|FG001|Overall Study|Withdrawal by Subject|2|||
145355404|NCT04565145|524150952|FG000|Overall Study|Withdrawal by Subject|1|||
145355405|NCT04565145|524150953|FG001|Overall Study|Withdrawal by Subject|1|||
145355406|NCT03096314|524150954|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
145355407|NCT03096314|524150955|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
145355408|NCT02764762|524150956|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145355409|NCT02764762|524150956|FG000|Overall Study|Lost to Follow-up|4|||
145355410|NCT02764762|524150956|FG000|Overall Study|Voluntary Withdrawal|8|||
145355411|NCT02764762|524150956|FG000|Overall Study|Site Termination|1|||
145355412|NCT02764762|524150956|FG000|Overall Study|Lack of Efficacy|16|||
145355413|NCT02764762|524150956|FG000|Overall Study|Reason not Specified|1|||
145355414|NCT03318861|524150960|FG000|Overall Study|Death|2|||
145355415|NCT03318861|524150961|FG001|Overall Study|Death|3|||
145355416|NCT03318861|524150962|FG002|Overall Study|Death|3|||
145355417|NCT03318861|524150963|FG003|Overall Study|Death|2|||
145355418|NCT03318861|524150964|FG004|Overall Study|Death|2|||
145355419|NCT03318861|524150960|FG000|Overall Study|Enrolled But Never Treated|0|||
145355420|NCT03318861|524150961|FG001|Overall Study|Enrolled But Never Treated|1|||
145355421|NCT03318861|524150962|FG002|Overall Study|Enrolled But Never Treated|0|||
145355422|NCT03318861|524150963|FG003|Overall Study|Enrolled But Never Treated|1|||
145355423|NCT03318861|524150964|FG004|Overall Study|Enrolled But Never Treated|1|||
145355424|NCT03318861|524150960|FG000|Overall Study|Informed Consent Withdraw|0|||
145355425|NCT03318861|524150961|FG001|Overall Study|Informed Consent Withdraw|0|||
145355426|NCT03318861|524150962|FG002|Overall Study|Informed Consent Withdraw|0|||
145355427|NCT03318861|524150963|FG003|Overall Study|Informed Consent Withdraw|1|||
145355428|NCT03318861|524150964|FG004|Overall Study|Informed Consent Withdraw|0|||
145355429|NCT03318861|524150960|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
145355430|NCT03318861|524150961|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145355431|NCT03318861|524150962|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145355432|NCT03318861|524150963|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145355433|NCT03318861|524150964|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
145355434|NCT00917852|524150965|FG000|Overall Study|Death|6|||
145355435|NCT00471081|524150966|FG000|Active Phase|Protocol Violation|1|||
145355436|NCT00471081|524150967|FG001|Active Phase|Protocol Violation|1|||
145355437|NCT00471081|524150966|FG000|Active Phase|Withdrawal by Subject|0|||
145355438|NCT00471081|524150967|FG001|Active Phase|Withdrawal by Subject|3|||
145355439|NCT00471081|524150966|FG000|Active Phase|Lost to Follow-up|0|||
145355440|NCT00471081|524150967|FG001|Active Phase|Lost to Follow-up|1|||
145355441|NCT00471081|524150966|FG000|Active Phase|Lost health plan/insurance|1|||
145355442|NCT00471081|524150967|FG001|Active Phase|Lost health plan/insurance|8|||
145355443|NCT00471081|524150966|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
145355444|NCT00471081|524150967|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
145355445|NCT00471081|524150966|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
145355446|NCT00471081|524150967|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
145355447|NCT00471081|524150966|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
145355448|NCT00471081|524150967|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
145355449|NCT02844933|524150968|FG000|Overall Study|Discontinued due to premature termination of study|3|||
145355450|NCT02844933|524150969|FG001|Overall Study|Discontinued due to premature termination of study|2|||
145355451|NCT01479465|524150970|FG000|Overall Study|Disease Progression|9|||
145355452|NCT01479465|524150971|FG001|Overall Study|Disease Progression|61|||
145355453|NCT01479465|524150972|FG002|Overall Study|Disease Progression|65|||
145355454|NCT01479465|524150973|FG003|Overall Study|Disease Progression|70|||
145355455|NCT01479465|524150970|FG000|Overall Study|Study Discontinued by Sponsor|0|||
145355456|NCT01479465|524150971|FG001|Overall Study|Study Discontinued by Sponsor|7|||
145355457|NCT01479465|524150972|FG002|Overall Study|Study Discontinued by Sponsor|5|||
145355458|NCT01479465|524150973|FG003|Overall Study|Study Discontinued by Sponsor|3|||
145355459|NCT01479465|524150970|FG000|Overall Study|Adverse Event|0|||
145355460|NCT01479465|524150971|FG001|Overall Study|Adverse Event|3|||
145355461|NCT01479465|524150972|FG002|Overall Study|Adverse Event|6|||
145355462|NCT01479465|524150973|FG003|Overall Study|Adverse Event|4|||
145355463|NCT01479465|524150970|FG000|Overall Study|Investigator Discretion|1|||
145355464|NCT01479465|524150971|FG001|Overall Study|Investigator Discretion|4|||
145355465|NCT01479465|524150972|FG002|Overall Study|Investigator Discretion|2|||
145355466|NCT01479465|524150973|FG003|Overall Study|Investigator Discretion|4|||
145355467|NCT01479465|524150970|FG000|Overall Study|Subject Request|1|||
145355468|NCT01479465|524150971|FG001|Overall Study|Subject Request|3|||
145355469|NCT01479465|524150972|FG002|Overall Study|Subject Request|4|||
145417657|NCT02547935|524383939|FG002|Overall Study|Death|0|||
145355470|NCT01479465|524150973|FG003|Overall Study|Subject Request|2|||
145355471|NCT01479465|524150970|FG000|Overall Study|Subject Withdrew Consent|0|||
145355472|NCT01479465|524150971|FG001|Overall Study|Subject Withdrew Consent|5|||
145417658|NCT00003474|524383943|FG000|Overall Study|Not Evaluable|14|||
145577369|NCT01192152|524968069|FG000|Period 1|left prematurely (while on treatment B)|0|||
145577370|NCT01192152|524968070|FG001|Period 1|left prematurely (while on treatment B)|1|||
145577371|NCT01192152|524968069|FG000|Period 3|family emergency|1|||
145577372|NCT01192152|524968070|FG001|Period 3|family emergency|0|||
145577373|NCT01009099|524968072|FG000|Overall Study|Lost to Follow-up|1|||
145355473|NCT01479465|524150972|FG002|Overall Study|Subject Withdrew Consent|2|||
145355474|NCT01479465|524150973|FG003|Overall Study|Subject Withdrew Consent|1|||
145355475|NCT01479465|524150970|FG000|Overall Study|Protocol Violation|0|||
145355476|NCT01479465|524150971|FG001|Overall Study|Protocol Violation|1|||
145355477|NCT01479465|524150972|FG002|Overall Study|Protocol Violation|1|||
145355478|NCT01479465|524150973|FG003|Overall Study|Protocol Violation|0|||
145355479|NCT01479465|524150970|FG000|Overall Study|Death|0|||
145355480|NCT01479465|524150971|FG001|Overall Study|Death|0|||
145355481|NCT01479465|524150972|FG002|Overall Study|Death|0|||
145355482|NCT01479465|524150973|FG003|Overall Study|Death|1|||
145355483|NCT01479465|524150970|FG000|Overall Study|Lost to Follow-up|0|||
145355484|NCT01479465|524150971|FG001|Overall Study|Lost to Follow-up|0|||
145355485|NCT01479465|524150972|FG002|Overall Study|Lost to Follow-up|1|||
145355486|NCT01479465|524150973|FG003|Overall Study|Lost to Follow-up|0|||
145355487|NCT01892501|524150974|FG000|Overall Study|Protocol Violation|2|||
145355488|NCT01892501|524150974|FG000|Overall Study|Puncture not carried out|9|||
145355489|NCT01892501|524150974|FG000|Overall Study|Radiological monitoring not carried out|5|||
145355490|NCT01892501|524150974|FG000|Overall Study|Non-contributory histological result|12|||
145355491|NCT02393950|524150979|FG000|Overall Study|Adverse Event|1|||
145355492|NCT02393950|524150980|FG001|Overall Study|Adverse Event|0|||
145355493|NCT02393950|524150979|FG000|Overall Study|Withdrawal by Subject|0|||
145355494|NCT02393950|524150980|FG001|Overall Study|Withdrawal by Subject|1|||
145355495|NCT04335123|524150982|FG000|Overall Study|Withdrawal by Subject|2|||
145355496|NCT04335123|524150983|FG001|Overall Study|Withdrawal by Subject|0|||
145355497|NCT04335123|524150982|FG000|Overall Study|Physician Decision|2|||
145355498|NCT04335123|524150983|FG001|Overall Study|Physician Decision|0|||
145355499|NCT05486091|524150984|FG000|Overall Study|Withdrawal by Subject|1|||
145355500|NCT05486091|524150984|FG000|Overall Study|Lost to Follow-up|2|||
145355501|NCT00370552|524150985|FG000|Overall Study|Adverse Event|2|||
145355502|NCT00370552|524150986|FG001|Overall Study|Adverse Event|2|||
145355503|NCT00370552|524150987|FG002|Overall Study|Adverse Event|2|||
145355504|NCT00370552|524150985|FG000|Overall Study|Disease progression|23|||
145355505|NCT00370552|524150986|FG001|Overall Study|Disease progression|23|||
145355506|NCT00370552|524150987|FG002|Overall Study|Disease progression|15|||
145355507|NCT00370552|524150985|FG000|Overall Study|Maximum clinical benefit|3|||
145355508|NCT00370552|524150986|FG001|Overall Study|Maximum clinical benefit|5|||
145355509|NCT00370552|524150987|FG002|Overall Study|Maximum clinical benefit|5|||
145355510|NCT00370552|524150985|FG000|Overall Study|Poor or noncompliance|0|||
145355511|NCT00370552|524150986|FG001|Overall Study|Poor or noncompliance|0|||
145355512|NCT00370552|524150987|FG002|Overall Study|Poor or noncompliance|1|||
145355513|NCT00370552|524150985|FG000|Overall Study|Study drug toxicity|11|||
145355514|NCT00370552|524150986|FG001|Overall Study|Study drug toxicity|8|||
145355515|NCT00370552|524150987|FG002|Overall Study|Study drug toxicity|6|||
145355516|NCT00370552|524150985|FG000|Overall Study|Withdrawal by Subject|2|||
145355517|NCT00370552|524150986|FG001|Overall Study|Withdrawal by Subject|0|||
145355518|NCT00370552|524150987|FG002|Overall Study|Withdrawal by Subject|1|||
145355519|NCT00370552|524150985|FG000|Overall Study|Still on treatment|1|||
145355520|NCT00370552|524150986|FG001|Overall Study|Still on treatment|3|||
145355521|NCT00370552|524150987|FG002|Overall Study|Still on treatment|2|||
145355522|NCT00370552|524150985|FG000|Overall Study|Never treated|1|||
145355523|NCT00370552|524150986|FG001|Overall Study|Never treated|0|||
145355524|NCT00370552|524150987|FG002|Overall Study|Never treated|0|||
145355525|NCT00370552|524150985|FG000|Overall Study|Physician Decision|1|||
145355526|NCT00370552|524150986|FG001|Overall Study|Physician Decision|1|||
145355527|NCT00370552|524150987|FG002|Overall Study|Physician Decision|0|||
145355528|NCT00370552|524150985|FG000|Overall Study|Investigator decision|2|||
145355529|NCT00370552|524150986|FG001|Overall Study|Investigator decision|1|||
145355530|NCT00370552|524150987|FG002|Overall Study|Investigator decision|0|||
145577374|NCT01009099|524968073|FG001|Overall Study|Lost to Follow-up|0|||
145577375|NCT01009099|524968072|FG000|Overall Study|Physician Decision|3|||
145577376|NCT01009099|524968073|FG001|Overall Study|Physician Decision|2|||
145355531|NCT00370552|524150985|FG000|Overall Study|High risk of allergic reaction|0|||
145355532|NCT00370552|524150986|FG001|Overall Study|High risk of allergic reaction|1|||
145355533|NCT00370552|524150987|FG002|Overall Study|High risk of allergic reaction|0|||
145355534|NCT00370552|524150985|FG000|Overall Study|Planned radiation for palliation|0|||
145577377|NCT01009099|524968072|FG000|Overall Study|Withdrawal by Subject|1|||
145355535|NCT00370552|524150986|FG001|Overall Study|Planned radiation for palliation|1|||
145355536|NCT00370552|524150987|FG002|Overall Study|Planned radiation for palliation|0|||
145355537|NCT00586703|524150992|FG000|Overall Study|Death|12|||
145355538|NCT00806403|524150993|FG000|Overall Study|Death|4|||
145355539|NCT00806403|524150994|FG001|Overall Study|Death|3|||
145355540|NCT00765102|524150995|FG000|Overall Study|Progressive disease|18|||
145577378|NCT01009099|524968073|FG001|Overall Study|Withdrawal by Subject|1|||
145623000|NCT01254305|525131559|FG001|Overall Study|Protocol Violation|7|||
145623001|NCT01254305|525131560|FG002|Overall Study|Protocol Violation|3|||
145623002|NCT01254305|525131558|FG000|Overall Study|Withdrawal by Subject|4|||
145355541|NCT00765102|524150995|FG000|Overall Study|Adverse Event|6|||
145355542|NCT00765102|524150995|FG000|Overall Study|Physician Decision|4|||
145355543|NCT00765102|524150995|FG000|Overall Study|Withdrawal by Subject|2|||
145355544|NCT00765102|524150995|FG000|Overall Study|Protocol Violation|1|||
145355545|NCT04383327|524151009|FG000|Overall Study|Lost to Follow-up|112|||
145355546|NCT04383327|524151010|FG001|Overall Study|Lost to Follow-up|14|||
145355547|NCT04383327|524151011|FG002|Overall Study|Lost to Follow-up|78|||
145355548|NCT04383327|524151012|FG003|Overall Study|Lost to Follow-up|13|||
145355549|NCT04383327|524151013|FG004|Overall Study|Lost to Follow-up|110|||
145355550|NCT04383327|524151014|FG005|Overall Study|Lost to Follow-up|13|||
145355551|NCT04383327|524151015|FG006|Overall Study|Lost to Follow-up|74|||
145355552|NCT04383327|524151016|FG007|Overall Study|Lost to Follow-up|13|||
145355553|NCT04383327|524151017|FG008|Overall Study|Lost to Follow-up|78|||
145355554|NCT04383327|524151018|FG009|Overall Study|Lost to Follow-up|10|||
145355555|NCT04383327|524151019|FG010|Overall Study|Lost to Follow-up|160|||
145355556|NCT04383327|524151020|FG011|Overall Study|Lost to Follow-up|13|||
145355557|NCT05271175|524151030|FG000|One Week Follow up|Lost to Follow-up|10|||
145355558|NCT05271175|524151031|FG001|One Week Follow up|Lost to Follow-up|7|||
145355559|NCT05271175|524151032|FG002|One Week Follow up|Lost to Follow-up|5|||
145355560|NCT05271175|524151030|FG000|One Month Follow up|Lost to Follow-up|12|||
145355561|NCT05271175|524151031|FG001|One Month Follow up|Lost to Follow-up|7|||
145355562|NCT05271175|524151032|FG002|One Month Follow up|Lost to Follow-up|9|||
145355563|NCT05271175|524151030|FG000|Six Months Follow up|Lost to Follow-up|8|||
145355564|NCT05271175|524151031|FG001|Six Months Follow up|Lost to Follow-up|2|||
145355565|NCT05271175|524151032|FG002|Six Months Follow up|Lost to Follow-up|2|||
145355566|NCT00991887|524151033|FG000|Overall Study|Lost to Follow-up|2|||
145355567|NCT00991887|524151034|FG001|Overall Study|Lost to Follow-up|1|||
145355568|NCT00226499|524151035|FG000|Overall Study|Adverse Event|10|||
145355569|NCT00226499|524151036|FG001|Overall Study|Adverse Event|6|||
145355570|NCT00226499|524151037|FG002|Overall Study|Adverse Event|3|||
145355571|NCT00226499|524151035|FG000|Overall Study|Others|1064|||
145355572|NCT00226499|524151036|FG001|Overall Study|Others|1066|||
145355573|NCT00226499|524151037|FG002|Overall Study|Others|356|||
145355574|NCT04030299|524151038|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
145355575|NCT04030299|524151038|FG000|Overall Study|Withdrawal by Subject|3|||
145355576|NCT00946920|524151039|FG000|Overall Study|Withdrawal by Subject|28|||
145355577|NCT00946920|524151040|FG001|Overall Study|Withdrawal by Subject|15|||
145355578|NCT00946920|524151039|FG000|Overall Study|Lost to Follow-up|2|||
145355579|NCT00946920|524151040|FG001|Overall Study|Lost to Follow-up|2|||
145355580|NCT00946920|524151039|FG000|Overall Study|Physician Decision|5|||
145355581|NCT00946920|524151040|FG001|Overall Study|Physician Decision|2|||
145355582|NCT00946920|524151039|FG000|Overall Study|Adverse Event|41|||
145355583|NCT00946920|524151040|FG001|Overall Study|Adverse Event|14|||
145355584|NCT00946920|524151039|FG000|Overall Study|Protocol Violation|16|||
145355585|NCT00946920|524151040|FG001|Overall Study|Protocol Violation|8|||
145355586|NCT00946920|524151039|FG000|Overall Study|Miscellaneous reasons|18|||
145355587|NCT00946920|524151040|FG001|Overall Study|Miscellaneous reasons|3|||
145355588|NCT02964247|524151041|FG000|Overall Study|Lost to Follow-up|2|||
145355589|NCT02964247|524151042|FG001|Overall Study|Lost to Follow-up|0|||
145355590|NCT02964247|524151041|FG000|Overall Study|Withdrawal by Subject|1|||
145355591|NCT02964247|524151042|FG001|Overall Study|Withdrawal by Subject|2|||
145355592|NCT01530464|524151043|FG000|Washout (24h)|Withdrawal by Subject|1|||
145355593|NCT01530464|524151044|FG001|Washout (24h)|Withdrawal by Subject|0|||
145355594|NCT01530464|524151043|FG000|Washout (24h)|Withdrawal by Subject|0|||
145417659|NCT02186171|524383944|FG000|Overall Study|Withdrawal by Subject|1|||
145417660|NCT02186171|524383945|FG001|Overall Study|Withdrawal by Subject|9|||
145417661|NCT02186171|524383944|FG000|Overall Study|Lost to Follow-up|2|||
145417662|NCT02186171|524383945|FG001|Overall Study|Lost to Follow-up|2|||
145417663|NCT02186171|524383944|FG000|Overall Study|Death|1|||
145417664|NCT02186171|524383945|FG001|Overall Study|Death|2|||
145417665|NCT02186171|524383944|FG000|Overall Study|Protocol-specified Criteria|0|||
145417666|NCT02186171|524383945|FG001|Overall Study|Protocol-specified Criteria|2|||
145417667|NCT01030900|524383947|FG000|Overall Study|Not treated due to congestive heart failure|1|||
145417668|NCT01030900|524383947|FG000|Overall Study|Not treated due to rapid disease|1|||
145355595|NCT01530464|524151044|FG001|Washout (24h)|Withdrawal by Subject|1|||
145355596|NCT03539302|524151049|FG000|Overall Study|Spontaneous cardio version|0|||
145355597|NCT03539302|524151050|FG001|Overall Study|Spontaneous cardio version|0|||
145355598|NCT03539302|524151051|FG002|Overall Study|Spontaneous cardio version|0|||
145355599|NCT03539302|524151052|FG003|Overall Study|Spontaneous cardio version|0|||
145355600|NCT03539302|524151053|FG004|Overall Study|Spontaneous cardio version|0|||
145355601|NCT03539302|524151054|FG005|Overall Study|Spontaneous cardio version|1|||
145355602|NCT03539302|524151055|FG006|Overall Study|Spontaneous cardio version|1|||
145355603|NCT02107131|524151060|FG000|Overall Study|Lost to Follow-up|4|||
145355604|NCT02107131|524151061|FG001|Overall Study|Lost to Follow-up|4|||
145355605|NCT02107131|524151060|FG000|Overall Study|Physician Decision|1|||
145355606|NCT02107131|524151061|FG001|Overall Study|Physician Decision|0|||
145355607|NCT02107131|524151060|FG000|Overall Study|Withdrawal by Subject|2|||
145355608|NCT02107131|524151061|FG001|Overall Study|Withdrawal by Subject|0|||
145355609|NCT02107131|524151060|FG000|Overall Study|mental instability|1|||
145355610|NCT02107131|524151061|FG001|Overall Study|mental instability|0|||
145355611|NCT02107131|524151060|FG000|Overall Study|Death|0|||
145355612|NCT02107131|524151061|FG001|Overall Study|Death|1|||
145355613|NCT02107131|524151060|FG000|Overall Study|Protocol Violation|0|||
145355614|NCT02107131|524151061|FG001|Overall Study|Protocol Violation|4|||
145355615|NCT02546986|524152202|FG000|Treatment Period|Progressive Disease|20|||
145355616|NCT02546986|524152203|FG001|Treatment Period|Progressive Disease|22|||
145355617|NCT02546986|524152202|FG000|Treatment Period|Adverse Event|14|||
145355618|NCT02546986|524152203|FG001|Treatment Period|Adverse Event|6|||
145355619|NCT02546986|524152202|FG000|Treatment Period|Symptomatic Deterioration|4|||
145355620|NCT02546986|524152203|FG001|Treatment Period|Symptomatic Deterioration|3|||
145355621|NCT02546986|524152202|FG000|Treatment Period|Death|3|||
145355622|NCT02546986|524152203|FG001|Treatment Period|Death|4|||
145355623|NCT02546986|524152202|FG000|Treatment Period|Physician Decision|1|||
145355624|NCT02546986|524152203|FG001|Treatment Period|Physician Decision|2|||
145355625|NCT02546986|524152202|FG000|Treatment Period|Protocol Violation|1|||
145355626|NCT02546986|524152203|FG001|Treatment Period|Protocol Violation|0|||
145355627|NCT02546986|524152202|FG000|Treatment Period|Withdrawal by Subject|1|||
145355628|NCT02546986|524152203|FG001|Treatment Period|Withdrawal by Subject|1|||
145355629|NCT02546986|524152202|FG000|Treatment Period|Non-compliance with Study Drug|0|||
145355630|NCT02546986|524152203|FG001|Treatment Period|Non-compliance with Study Drug|1|||
145355631|NCT02546986|524152202|FG000|Treatment Period|Study Terminated by Sponsor|0|||
145355632|NCT02546986|524152203|FG001|Treatment Period|Study Terminated by Sponsor|1|||
145355633|NCT02546986|524152202|FG000|Treatment Period|Miscellaneous|7|||
145355634|NCT02546986|524152203|FG001|Treatment Period|Miscellaneous|9|||
145355635|NCT02546986|524152202|FG000|Survival Follow-Up Phase|Missing Status|3|||
145355636|NCT02546986|524152203|FG001|Survival Follow-Up Phase|Missing Status|5|||
145355637|NCT02546986|524152202|FG000|Survival Follow-Up Phase|Death|18|||
145355638|NCT02546986|524152203|FG001|Survival Follow-Up Phase|Death|12|||
145355639|NCT02546986|524152202|FG000|Survival Follow-Up Phase|Alive|13|||
145355640|NCT02546986|524152203|FG001|Survival Follow-Up Phase|Alive|16|||
145355641|NCT02546986|524152202|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
145355642|NCT02546986|524152203|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
145355643|NCT00739882|524152204|FG000|Double-blind Period|Adverse Event|1|||
145355644|NCT00739882|524152205|FG001|Double-blind Period|Adverse Event|2|||
145355645|NCT00739882|524152204|FG000|Double-blind Period|Protocol Violation|1|||
145355646|NCT00739882|524152205|FG001|Double-blind Period|Protocol Violation|0|||
145355647|NCT00739882|524152204|FG000|Double-blind Period|Lack of Efficacy|1|||
145355648|NCT00739882|524152205|FG001|Double-blind Period|Lack of Efficacy|1|||
145355649|NCT00739882|524152204|FG000|Double-blind Period|Other|16|||
145355650|NCT00739882|524152205|FG001|Double-blind Period|Other|8|||
145355651|NCT00739882|524152204|FG000|Open-label Period|Adverse Event|1|||
145355652|NCT00739882|524152205|FG001|Open-label Period|Adverse Event|0|||
145355653|NCT00739882|524152204|FG000|Open-label Period|Other|9|||
145355654|NCT00739882|524152205|FG001|Open-label Period|Other|5|||
145355655|NCT04021914|524152206|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
145355656|NCT02844543|524152207|FG000|Overall Study|Withdrawal by Subject|4|||
145355657|NCT02844543|524152207|FG000|Overall Study|Did not meet eligibility criteria|1|||
145355658|NCT03985800|524152208|FG000|Overall Study|Death|1|||
145355659|NCT03985800|524152209|FG001|Overall Study|Death|2|||
145355660|NCT03985800|524152208|FG000|Overall Study|Withdrawal by Subject|3|||
145355661|NCT03985800|524152209|FG001|Overall Study|Withdrawal by Subject|6|||
145355662|NCT03985800|524152208|FG000|Overall Study|Protocol Violation|2|||
145355663|NCT03985800|524152209|FG001|Overall Study|Protocol Violation|0|||
145355664|NCT04173507|524152216|FG000|Overall Study|On Treatment|3|||
145355665|NCT04173507|524152216|FG000|Overall Study|Adverse Event|3|||
145355666|NCT04173507|524152216|FG000|Overall Study|Progression/Relapse|34|||
145355667|NCT04173507|524152216|FG000|Overall Study|Death|2|||
145355668|NCT02342678|524152224|FG000|Overall Study|Lost to Follow-up|0|||
145355669|NCT02342678|524152225|FG001|Overall Study|Lost to Follow-up|1|||
145417669|NCT01179399|524383948|FG000|Overall Study|Adverse Event|1|||
145355670|NCT02342678|524152224|FG000|Overall Study|Too busy to complete study|0|||
145355671|NCT02342678|524152225|FG001|Overall Study|Too busy to complete study|2|||
145355672|NCT02342678|524152224|FG000|Overall Study|Family illness/emergency|0|||
145355673|NCT02342678|524152225|FG001|Overall Study|Family illness/emergency|1|||
145355674|NCT02342678|524152224|FG000|Overall Study|Illness/medical reason|1|||
145355675|NCT02342678|524152225|FG001|Overall Study|Illness/medical reason|1|||
145355676|NCT00314340|524152227|FG000|Overall Study|lost interest|1|||
145355677|NCT00957801|524152228|FG000|Overall Study|Withdrawal by Subject|0|||
145355678|NCT00957801|524152229|FG001|Overall Study|Withdrawal by Subject|0|||
145355679|NCT00957801|524152230|FG002|Overall Study|Withdrawal by Subject|0|||
145355680|NCT00957801|524152231|FG003|Overall Study|Withdrawal by Subject|1|||
145355681|NCT02755103|524152239|FG000|Overall Study|Lost to Follow-up|17|||
145355682|NCT02755103|524152240|FG001|Overall Study|Lost to Follow-up|15|||
145417670|NCT01179399|524383948|FG000|Overall Study|Lack of Efficacy|30|||
145417671|NCT01179399|524383948|FG000|Overall Study|Withdrawal by Subject|1|||
145417672|NCT00441896|524383949|FG000|Overall Study|Withdrawal by Subject|0|||
145417673|NCT00441896|524383950|FG001|Overall Study|Withdrawal by Subject|0|||
145417674|NCT00441896|524383951|FG002|Overall Study|Withdrawal by Subject|0|||
145417675|NCT00441896|524383952|FG003|Overall Study|Withdrawal by Subject|1|||
145417676|NCT00441896|524383953|FG004|Overall Study|Withdrawal by Subject|0|||
145417677|NCT00441896|524383954|FG005|Overall Study|Withdrawal by Subject|0|||
145417678|NCT00441896|524383955|FG006|Overall Study|Withdrawal by Subject|0|||
145417679|NCT00441896|524383956|FG007|Overall Study|Withdrawal by Subject|0|||
145417680|NCT00441896|524383957|FG008|Overall Study|Withdrawal by Subject|0|||
145417681|NCT00441896|524383958|FG009|Overall Study|Withdrawal by Subject|0|||
145417682|NCT00441896|524383949|FG000|Overall Study|Other|0|||
145417683|NCT00441896|524383950|FG001|Overall Study|Other|0|||
145417684|NCT00441896|524383951|FG002|Overall Study|Other|0|||
145417685|NCT00441896|524383952|FG003|Overall Study|Other|0|||
145417686|NCT00441896|524383953|FG004|Overall Study|Other|1|||
145417687|NCT00441896|524383954|FG005|Overall Study|Other|0|||
145417688|NCT00441896|524383955|FG006|Overall Study|Other|0|||
145417689|NCT00441896|524383956|FG007|Overall Study|Other|0|||
145417690|NCT00441896|524383957|FG008|Overall Study|Other|0|||
145417691|NCT00441896|524383958|FG009|Overall Study|Other|0|||
145417692|NCT00289978|524386553|FG000|Overall Study|Withdrawal by Subject|31|||
145417693|NCT00289978|524386554|FG001|Overall Study|Withdrawal by Subject|17|||
145417694|NCT00289978|524386555|FG002|Overall Study|Withdrawal by Subject|28|||
145417695|NCT00289978|524386553|FG000|Overall Study|Adverse Event|22|||
145417696|NCT00289978|524386554|FG001|Overall Study|Adverse Event|13|||
145417697|NCT00289978|524386555|FG002|Overall Study|Adverse Event|18|||
145577379|NCT01009099|524968072|FG000|Overall Study|Death|0|||
145577380|NCT01009099|524968073|FG001|Overall Study|Death|1|||
145577381|NCT01552772|524968074|FG000|Overall Study|Lost to Follow-up|2|||
145577382|NCT01552772|524968074|FG000|Overall Study|Adverse Event|1|||
145577383|NCT01552772|524968074|FG000|Overall Study|Protocol Deviation|1|||
145577384|NCT04055116|524968081|FG000|First Intervention|Physician Decision|2|||
145577385|NCT04055116|524968082|FG001|First Intervention|Physician Decision|7|||
145577386|NCT02774681|524968083|FG000|Treatment on Study|Progressive Disease|7|||
145577387|NCT02774681|524968083|FG000|Follow-Up for 3 Years|Death|11|||
145577388|NCT02774681|524968083|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
145577389|NCT00512096|524968088|FG000|Overall Study|Adverse Event|2|||
145355683|NCT02755103|524152239|FG000|Overall Study|Death|0|||
145355684|NCT02755103|524152240|FG001|Overall Study|Death|1|||
145355685|NCT02755103|524152239|FG000|Overall Study|Physician Decision|0|||
145355686|NCT02755103|524152240|FG001|Overall Study|Physician Decision|1|||
145355687|NCT02755103|524152239|FG000|Overall Study|Pregnancy|0|||
145355688|NCT02755103|524152240|FG001|Overall Study|Pregnancy|1|||
145355689|NCT02755103|524152239|FG000|Overall Study|Withdrawal by Subject|3|||
145355690|NCT02755103|524152240|FG001|Overall Study|Withdrawal by Subject|0|||
145355691|NCT04177095|524152241|FG000|Overall Study|Withdrawal by Subject|3|||
145355692|NCT04177095|524152241|FG000|Overall Study|Screen Failure|3|||
145355693|NCT04177095|524152241|FG000|Overall Study|Problems with the Trugraf assay|1|||
145355694|NCT00777296|524152242|FG000|Overall Study|Adverse Event|0|||
145355695|NCT00777296|524152243|FG001|Overall Study|Adverse Event|1|||
145355696|NCT00777296|524152244|FG002|Overall Study|Adverse Event|0|||
145355697|NCT00777296|524152245|FG003|Overall Study|Adverse Event|1|||
145355698|NCT00777296|524152242|FG000|Overall Study|Withdrawal by Subject|1|||
145355699|NCT00777296|524152243|FG001|Overall Study|Withdrawal by Subject|0|||
145355700|NCT00777296|524152244|FG002|Overall Study|Withdrawal by Subject|0|||
145355701|NCT00777296|524152245|FG003|Overall Study|Withdrawal by Subject|0|||
145355702|NCT00777296|524152242|FG000|Overall Study|CRF form not completed|0|||
145355703|NCT00777296|524152243|FG001|Overall Study|CRF form not completed|0|||
145355704|NCT00777296|524152244|FG002|Overall Study|CRF form not completed|2|||
145355705|NCT00777296|524152245|FG003|Overall Study|CRF form not completed|0|||
145417698|NCT00289978|524386553|FG000|Overall Study|Lack of Efficacy|13|||
145417699|NCT00289978|524386554|FG001|Overall Study|Lack of Efficacy|6|||
145417700|NCT00289978|524386555|FG002|Overall Study|Lack of Efficacy|25|||
145417701|NCT00289978|524386553|FG000|Overall Study|Abnormal laboratory value(s)|20|||
145417702|NCT00289978|524386554|FG001|Overall Study|Abnormal laboratory value(s)|9|||
145417703|NCT00289978|524386555|FG002|Overall Study|Abnormal laboratory value(s)|1|||
145417704|NCT00289978|524386553|FG000|Overall Study|Lost to Follow-up|3|||
145417705|NCT00289978|524386554|FG001|Overall Study|Lost to Follow-up|5|||
145417706|NCT00289978|524386555|FG002|Overall Study|Lost to Follow-up|7|||
145417707|NCT00289978|524386553|FG000|Overall Study|Protocol Violation|5|||
145577390|NCT00512096|524968088|FG000|Overall Study|Withdrawal by Subject|2|||
145355706|NCT00658723|524152248|FG000|Overall Study|Lost to Follow-up|0|||
145355707|NCT00658723|524152249|FG001|Overall Study|Lost to Follow-up|2|||
145355708|NCT00658723|524152250|FG002|Overall Study|Lost to Follow-up|2|||
145417708|NCT00289978|524386554|FG001|Overall Study|Protocol Violation|5|||
145417709|NCT00289978|524386555|FG002|Overall Study|Protocol Violation|4|||
145417710|NCT00289978|524386553|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145355709|NCT00658723|524152248|FG000|Overall Study|Death|2|||
145355710|NCT00658723|524152249|FG001|Overall Study|Death|1|||
145355711|NCT00658723|524152250|FG002|Overall Study|Death|4|||
145355712|NCT00658723|524152248|FG000|Overall Study|Scheduling Issue|1|||
145355713|NCT00658723|524152249|FG001|Overall Study|Scheduling Issue|1|||
145355714|NCT00658723|524152250|FG002|Overall Study|Scheduling Issue|0|||
145355715|NCT00658723|524152248|FG000|Overall Study|Withdrawal by Subject|1|||
145355716|NCT00658723|524152249|FG001|Overall Study|Withdrawal by Subject|0|||
145355717|NCT00658723|524152250|FG002|Overall Study|Withdrawal by Subject|1|||
145355718|NCT03751098|524152252|FG000|Overall Study|Withdrawal by Subject|0|||
145355719|NCT03751098|524152253|FG001|Overall Study|Withdrawal by Subject|1|||
145355720|NCT01592786|524152254|FG000|Overall Study|Adverse Event|60|||
145355721|NCT01592786|524152254|FG000|Overall Study|Lack of Efficacy|19|||
145355722|NCT01592786|524152254|FG000|Overall Study|Protocol Violation|14|||
145355723|NCT01592786|524152254|FG000|Overall Study|Withdrawal by Subject|23|||
145355724|NCT01592786|524152254|FG000|Overall Study|Lost to Follow-up|19|||
145355725|NCT01592786|524152254|FG000|Overall Study|Other|3|||
145355726|NCT01909934|524152257|FG000|Overall Study|Withdrawal by Subject|3|||
145355727|NCT01909934|524152257|FG000|Overall Study|Lost to Follow-up|1|||
145355728|NCT01909934|524152257|FG000|Overall Study|Death|25|||
145355729|NCT01909934|524152257|FG000|Overall Study|Withdrawal of Informed Consent|1|||
145355730|NCT01909934|524152257|FG000|Overall Study|Reason Not Specified|1|||
145355731|NCT03810092|524152258|FG000|Overall Study|no ground support|17|||
145355732|NCT03810092|524152258|FG000|Overall Study|ADL not done at J0|16|||
145355733|NCT03810092|524152258|FG000|Overall Study|No hemoglobin measure at J5|27|||
145355734|NCT03380429|524152262|FG000|Overall Study|Physician Decision|0|||
145355735|NCT03380429|524152263|FG001|Overall Study|Physician Decision|1|||
145355736|NCT03380429|524152264|FG002|Overall Study|Physician Decision|0|||
145355737|NCT03380429|524152265|FG003|Overall Study|Physician Decision|1|||
145355738|NCT03380429|524152266|FG004|Overall Study|Physician Decision|1|||
145355739|NCT03380429|524152262|FG000|Overall Study|Withdrawal by Subject|3|||
145355740|NCT03380429|524152263|FG001|Overall Study|Withdrawal by Subject|3|||
145355741|NCT03380429|524152264|FG002|Overall Study|Withdrawal by Subject|5|||
145355742|NCT03380429|524152265|FG003|Overall Study|Withdrawal by Subject|2|||
145355743|NCT03380429|524152266|FG004|Overall Study|Withdrawal by Subject|1|||
145355744|NCT03380429|524152262|FG000|Overall Study|Lost to Follow-up|0|||
145355745|NCT03380429|524152263|FG001|Overall Study|Lost to Follow-up|2|||
145355746|NCT03380429|524152264|FG002|Overall Study|Lost to Follow-up|4|||
145355747|NCT03380429|524152265|FG003|Overall Study|Lost to Follow-up|3|||
145355748|NCT03380429|524152266|FG004|Overall Study|Lost to Follow-up|1|||
145355749|NCT03380429|524152262|FG000|Overall Study|Protocol Violation|1|||
145355750|NCT03380429|524152263|FG001|Overall Study|Protocol Violation|0|||
145355751|NCT03380429|524152264|FG002|Overall Study|Protocol Violation|1|||
145355752|NCT03380429|524152265|FG003|Overall Study|Protocol Violation|0|||
145355753|NCT03380429|524152266|FG004|Overall Study|Protocol Violation|1|||
145355754|NCT03380429|524152262|FG000|Overall Study|Lack of Efficacy|0|||
145355755|NCT03380429|524152263|FG001|Overall Study|Lack of Efficacy|0|||
145355756|NCT03380429|524152264|FG002|Overall Study|Lack of Efficacy|0|||
145355757|NCT03380429|524152265|FG003|Overall Study|Lack of Efficacy|2|||
145355758|NCT03380429|524152266|FG004|Overall Study|Lack of Efficacy|1|||
145355759|NCT03380429|524152262|FG000|Overall Study|Adverse Event|1|||
145355760|NCT03380429|524152263|FG001|Overall Study|Adverse Event|1|||
145355761|NCT03380429|524152264|FG002|Overall Study|Adverse Event|1|||
145355762|NCT03380429|524152265|FG003|Overall Study|Adverse Event|2|||
145355763|NCT03380429|524152266|FG004|Overall Study|Adverse Event|0|||
145355764|NCT01198470|524152267|FG000|Overall Study|Adverse Event|2|||
145355765|NCT04129125|524152270|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
145355766|NCT04129125|524152270|FG000|Overall Study|Study device was not used|3|||
145355767|NCT01827111|524152273|FG000|Overall Study|Disease Progression|1|||
145355768|NCT02962648|524152274|FG000|Overall Study|Withdrawal by Subject|3|||
145355769|NCT02962648|524152274|FG000|Overall Study|Lost to Follow-up|3|||
145355770|NCT02962648|524152274|FG000|Overall Study|Physician Decision|1|||
145355771|NCT02962648|524152274|FG000|Overall Study|Subject had problems with transportation|2|||
145355772|NCT02174627|524152276|FG000|Overall Study|Missing|0|||
145355773|NCT02174627|524152277|FG001|Overall Study|Missing|1|||
145355774|NCT02174627|524152276|FG000|Overall Study|Incorrect enrolment before randomization|0|||
145355775|NCT02174627|524152277|FG001|Overall Study|Incorrect enrolment before randomization|1|||
145355776|NCT02174627|524152276|FG000|Overall Study|Participant decision|84|||
145355777|NCT02174627|524152277|FG001|Overall Study|Participant decision|128|||
145355778|NCT04564092|524152278|FG000|Overall Study|Withdrawal by Subject|1|||
145355779|NCT02208362|524152280|FG000|Overall Study|Participant did not complete treatment|0|||
145355780|NCT02208362|524152281|FG001|Overall Study|Participant did not complete treatment|1|||
145355781|NCT02208362|524152282|FG002|Overall Study|Participant did not complete treatment|0|||
145355782|NCT02208362|524152283|FG003|Overall Study|Participant did not complete treatment|0|||
145355783|NCT02208362|524152284|FG004|Overall Study|Participant did not complete treatment|0|||
145355784|NCT02208362|524152285|FG005|Overall Study|Participant did not complete treatment|0|||
145355785|NCT02208362|524152286|FG006|Overall Study|Participant did not complete treatment|1|||
145355786|NCT02208362|524152287|FG007|Overall Study|Participant did not complete treatment|1|||
145355787|NCT02208362|524152288|FG008|Overall Study|Participant did not complete treatment|2|||
145355788|NCT02208362|524152289|FG009|Overall Study|Participant did not complete treatment|0|||
145355789|NCT02208362|524152290|FG010|Overall Study|Participant did not complete treatment|1|||
145355790|NCT02208362|524152291|FG011|Overall Study|Participant did not complete treatment|0|||
145355791|NCT02208362|524152280|FG000|Overall Study|Participant received disallowed treatment|0|||
145355792|NCT02208362|524152281|FG001|Overall Study|Participant received disallowed treatment|0|||
145355793|NCT02208362|524152282|FG002|Overall Study|Participant received disallowed treatment|0|||
145355794|NCT02208362|524152283|FG003|Overall Study|Participant received disallowed treatment|0|||
145355795|NCT02208362|524152284|FG004|Overall Study|Participant received disallowed treatment|0|||
145355796|NCT02208362|524152285|FG005|Overall Study|Participant received disallowed treatment|0|||
145355797|NCT02208362|524152286|FG006|Overall Study|Participant received disallowed treatment|0|||
145355798|NCT02208362|524152287|FG007|Overall Study|Participant received disallowed treatment|0|||
145355799|NCT02208362|524152288|FG008|Overall Study|Participant received disallowed treatment|1|||
145355800|NCT02208362|524152289|FG009|Overall Study|Participant received disallowed treatment|0|||
145355801|NCT02208362|524152290|FG010|Overall Study|Participant received disallowed treatment|0|||
145355802|NCT02208362|524152291|FG011|Overall Study|Participant received disallowed treatment|0|||
145355803|NCT03349060|524153824|FG000|Overall Study|Adverse Event|9|||
145355804|NCT03349060|524153825|FG001|Overall Study|Adverse Event|9|||
145355805|NCT03349060|524153826|FG002|Overall Study|Adverse Event|7|||
145355806|NCT03349060|524153824|FG000|Overall Study|Lack of Efficacy|1|||
145355807|NCT03349060|524153825|FG001|Overall Study|Lack of Efficacy|0|||
145355808|NCT03349060|524153826|FG002|Overall Study|Lack of Efficacy|2|||
145355809|NCT03349060|524153824|FG000|Overall Study|Lost to Follow-up|2|||
145355810|NCT03349060|524153825|FG001|Overall Study|Lost to Follow-up|1|||
145355811|NCT03349060|524153826|FG002|Overall Study|Lost to Follow-up|1|||
145355812|NCT03349060|524153824|FG000|Overall Study|Protocol Violation|2|||
145355813|NCT03349060|524153825|FG001|Overall Study|Protocol Violation|2|||
145355814|NCT03349060|524153826|FG002|Overall Study|Protocol Violation|1|||
145355815|NCT03349060|524153824|FG000|Overall Study|Withdrawal by Subject|5|||
145355816|NCT03349060|524153825|FG001|Overall Study|Withdrawal by Subject|3|||
145355817|NCT03349060|524153826|FG002|Overall Study|Withdrawal by Subject|4|||
145355818|NCT03349060|524153824|FG000|Overall Study|Medication error,no linked adverse event|0|||
145355819|NCT03349060|524153825|FG001|Overall Study|Medication error,no linked adverse event|0|||
145355820|NCT03349060|524153826|FG002|Overall Study|Medication error,no linked adverse event|1|||
145355821|NCT03349060|524153824|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
145355822|NCT03349060|524153825|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
145355823|NCT03349060|524153826|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
145355824|NCT03349060|524153824|FG000|Overall Study|Other|2|||
145355825|NCT03349060|524153825|FG001|Overall Study|Other|1|||
145355826|NCT03349060|524153826|FG002|Overall Study|Other|0|||
145355827|NCT00955409|524153827|FG000|Overall Study|Lack of Efficacy|1|||
145355828|NCT00955409|524153828|FG001|Overall Study|Lack of Efficacy|0|||
145355829|NCT00955409|524153829|FG002|Overall Study|Lack of Efficacy|0|||
145355830|NCT00955409|524153830|FG003|Overall Study|Lack of Efficacy|0|||
145355831|NCT00955409|524153831|FG004|Overall Study|Lack of Efficacy|0|||
145355832|NCT00955409|524153832|FG005|Overall Study|Lack of Efficacy|0|||
145355833|NCT00955409|524153833|FG006|Overall Study|Lack of Efficacy|0|||
145355834|NCT00955409|524153834|FG007|Overall Study|Lack of Efficacy|0|||
145355835|NCT00955409|524153835|FG008|Overall Study|Lack of Efficacy|0|||
145355836|NCT00955409|524153836|FG009|Overall Study|Lack of Efficacy|0|||
145355837|NCT00955409|524153827|FG000|Overall Study|Withdrawal by Subject|1|||
145355838|NCT00955409|524153828|FG001|Overall Study|Withdrawal by Subject|0|||
145355839|NCT00955409|524153829|FG002|Overall Study|Withdrawal by Subject|5|||
145355840|NCT00955409|524153830|FG003|Overall Study|Withdrawal by Subject|2|||
145355841|NCT00955409|524153831|FG004|Overall Study|Withdrawal by Subject|0|||
145355842|NCT00955409|524153832|FG005|Overall Study|Withdrawal by Subject|0|||
145355843|NCT00955409|524153833|FG006|Overall Study|Withdrawal by Subject|2|||
145355844|NCT00955409|524153834|FG007|Overall Study|Withdrawal by Subject|0|||
145355845|NCT00955409|524153835|FG008|Overall Study|Withdrawal by Subject|1|||
145355846|NCT00955409|524153836|FG009|Overall Study|Withdrawal by Subject|0|||
145355847|NCT00955409|524153827|FG000|Overall Study|Caregiver Request|2|||
145355848|NCT00955409|524153828|FG001|Overall Study|Caregiver Request|0|||
145577391|NCT00512096|524968088|FG000|Overall Study|Lack of Efficacy|3|||
145355849|NCT00955409|524153829|FG002|Overall Study|Caregiver Request|6|||
145355850|NCT00955409|524153830|FG003|Overall Study|Caregiver Request|5|||
145355851|NCT00955409|524153831|FG004|Overall Study|Caregiver Request|0|||
145355852|NCT00955409|524153832|FG005|Overall Study|Caregiver Request|2|||
145355853|NCT00955409|524153833|FG006|Overall Study|Caregiver Request|3|||
145355854|NCT00955409|524153834|FG007|Overall Study|Caregiver Request|1|||
145355855|NCT00955409|524153835|FG008|Overall Study|Caregiver Request|3|||
145355856|NCT00955409|524153836|FG009|Overall Study|Caregiver Request|0|||
145355857|NCT00955409|524153827|FG000|Overall Study|Investigator Request|0|||
145355858|NCT00955409|524153828|FG001|Overall Study|Investigator Request|0|||
145355859|NCT00955409|524153829|FG002|Overall Study|Investigator Request|1|||
145355860|NCT00955409|524153830|FG003|Overall Study|Investigator Request|0|||
145355861|NCT00955409|524153831|FG004|Overall Study|Investigator Request|0|||
145355862|NCT00955409|524153832|FG005|Overall Study|Investigator Request|0|||
145355863|NCT00955409|524153833|FG006|Overall Study|Investigator Request|0|||
145355864|NCT00955409|524153834|FG007|Overall Study|Investigator Request|0|||
145355865|NCT00955409|524153835|FG008|Overall Study|Investigator Request|0|||
145355866|NCT00955409|524153836|FG009|Overall Study|Investigator Request|0|||
145355867|NCT00955409|524153827|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
145355868|NCT00955409|524153828|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145355869|NCT00955409|524153829|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
145355870|NCT00955409|524153830|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145355871|NCT00955409|524153831|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
145355872|NCT00955409|524153832|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
145355873|NCT00955409|524153833|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
145355874|NCT00955409|524153834|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
145355875|NCT00955409|524153835|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
145355876|NCT00955409|524153836|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
145355877|NCT00955409|524153827|FG000|Overall Study|Lost to Follow-up|0|||
145355878|NCT00955409|524153828|FG001|Overall Study|Lost to Follow-up|0|||
145355879|NCT00955409|524153829|FG002|Overall Study|Lost to Follow-up|1|||
145355880|NCT00955409|524153830|FG003|Overall Study|Lost to Follow-up|0|||
145355881|NCT00955409|524153831|FG004|Overall Study|Lost to Follow-up|0|||
145355882|NCT00955409|524153832|FG005|Overall Study|Lost to Follow-up|0|||
145355883|NCT00955409|524153833|FG006|Overall Study|Lost to Follow-up|1|||
145355884|NCT00955409|524153834|FG007|Overall Study|Lost to Follow-up|0|||
145355885|NCT00955409|524153835|FG008|Overall Study|Lost to Follow-up|0|||
145355886|NCT00955409|524153836|FG009|Overall Study|Lost to Follow-up|0|||
145355887|NCT00955409|524153827|FG000|Overall Study|Failed to Return|2|||
145355888|NCT00955409|524153828|FG001|Overall Study|Failed to Return|0|||
145355889|NCT00955409|524153829|FG002|Overall Study|Failed to Return|0|||
145355890|NCT00955409|524153830|FG003|Overall Study|Failed to Return|0|||
145355891|NCT00955409|524153831|FG004|Overall Study|Failed to Return|0|||
145355892|NCT00955409|524153832|FG005|Overall Study|Failed to Return|0|||
145355893|NCT00955409|524153833|FG006|Overall Study|Failed to Return|0|||
145355894|NCT00955409|524153834|FG007|Overall Study|Failed to Return|2|||
145355895|NCT00955409|524153835|FG008|Overall Study|Failed to Return|0|||
145355896|NCT00955409|524153836|FG009|Overall Study|Failed to Return|0|||
145355897|NCT00955409|524153827|FG000|Overall Study|Adverse Event (AE)|2|||
145355898|NCT00955409|524153828|FG001|Overall Study|Adverse Event (AE)|0|||
145355899|NCT00955409|524153829|FG002|Overall Study|Adverse Event (AE)|0|||
145355900|NCT00955409|524153830|FG003|Overall Study|Adverse Event (AE)|0|||
145355901|NCT00955409|524153831|FG004|Overall Study|Adverse Event (AE)|0|||
145355902|NCT00955409|524153832|FG005|Overall Study|Adverse Event (AE)|1|||
145355903|NCT00955409|524153833|FG006|Overall Study|Adverse Event (AE)|2|||
145355904|NCT00955409|524153834|FG007|Overall Study|Adverse Event (AE)|0|||
145355905|NCT00955409|524153835|FG008|Overall Study|Adverse Event (AE)|2|||
145355906|NCT00955409|524153836|FG009|Overall Study|Adverse Event (AE)|0|||
145355907|NCT00955409|524153827|FG000|Overall Study|Reason not Specified|2|||
145355908|NCT00955409|524153828|FG001|Overall Study|Reason not Specified|1|||
145355909|NCT00955409|524153829|FG002|Overall Study|Reason not Specified|13|||
145355910|NCT00955409|524153830|FG003|Overall Study|Reason not Specified|1|||
145355911|NCT00955409|524153831|FG004|Overall Study|Reason not Specified|2|||
145355912|NCT00955409|524153832|FG005|Overall Study|Reason not Specified|0|||
145355913|NCT00955409|524153833|FG006|Overall Study|Reason not Specified|16|||
145355914|NCT00955409|524153834|FG007|Overall Study|Reason not Specified|0|||
145355915|NCT00955409|524153835|FG008|Overall Study|Reason not Specified|8|||
145355916|NCT00955409|524153836|FG009|Overall Study|Reason not Specified|1|||
145355917|NCT00485732|524153837|FG000|Overall Study|Protocol Violation|1|||
145355918|NCT00485732|524153838|FG001|Overall Study|Protocol Violation|3|||
145355919|NCT00485732|524153837|FG000|Overall Study|Withdrawal by Subject|5|||
145355920|NCT00485732|524153838|FG001|Overall Study|Withdrawal by Subject|4|||
145355921|NCT00485732|524153837|FG000|Overall Study|Lost to Follow-up|2|||
145355922|NCT00485732|524153838|FG001|Overall Study|Lost to Follow-up|2|||
145355923|NCT00803790|524153839|FG000|Period 1|Adverse Event|0|||
145355924|NCT00803790|524153840|FG001|Period 1|Adverse Event|1|||
145577392|NCT01069289|524968092|FG000|Overall Study|Withdrawal by Subject|15|||
145577393|NCT01069289|524968093|FG001|Overall Study|Withdrawal by Subject|26|||
145355925|NCT00803790|524153841|FG002|Period 1|Adverse Event|0|||
145355926|NCT00803790|524153842|FG003|Period 1|Adverse Event|0|||
145355927|NCT00803790|524153839|FG000|Period 1|Lost to Follow-up|1|||
145355928|NCT00803790|524153840|FG001|Period 1|Lost to Follow-up|2|||
145355929|NCT00803790|524153841|FG002|Period 1|Lost to Follow-up|0|||
145355930|NCT00803790|524153842|FG003|Period 1|Lost to Follow-up|0|||
145355931|NCT00803790|524153839|FG000|Period 1|Withdrawal by Subject|8|||
145355932|NCT00803790|524153840|FG001|Period 1|Withdrawal by Subject|6|||
145355933|NCT00803790|524153841|FG002|Period 1|Withdrawal by Subject|0|||
145355934|NCT00803790|524153842|FG003|Period 1|Withdrawal by Subject|0|||
145355935|NCT00803790|524153839|FG000|Period 1|positive drug screen or personal reasons|0|||
145417711|NCT00289978|524386554|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145417712|NCT00289978|524386555|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145417713|NCT00289978|524386553|FG000|Overall Study|Death|1|||
145417714|NCT00289978|524386554|FG001|Overall Study|Death|0|||
145417715|NCT00289978|524386555|FG002|Overall Study|Death|2|||
145355936|NCT00803790|524153840|FG001|Period 1|positive drug screen or personal reasons|3|||
145355937|NCT00803790|524153841|FG002|Period 1|positive drug screen or personal reasons|0|||
145355938|NCT00803790|524153842|FG003|Period 1|positive drug screen or personal reasons|4|||
145417716|NCT01524705|524386556|FG000|Overall Study|Adverse Event|2|||
145417717|NCT01524705|524386557|FG001|Overall Study|Adverse Event|0|||
145417718|NCT01524705|524386556|FG000|Overall Study|Death|1|||
145417719|NCT01524705|524386557|FG001|Overall Study|Death|0|||
145417720|NCT01524705|524386556|FG000|Overall Study|Lost to Follow-up|0|||
145417721|NCT01524705|524386557|FG001|Overall Study|Lost to Follow-up|1|||
145417722|NCT01524705|524386556|FG000|Overall Study|Withdrawal by Subject|0|||
145417723|NCT01524705|524386557|FG001|Overall Study|Withdrawal by Subject|1|||
145417724|NCT01524705|524386556|FG000|Overall Study|Pancreatic Cancer|0|||
145417725|NCT01524705|524386557|FG001|Overall Study|Pancreatic Cancer|1|||
145417726|NCT03055221|524386558|FG000|Overall Study|Adverse Event|2|||
145417727|NCT03055221|524386558|FG000|Overall Study|Withdrawal by Subject|4|||
145417728|NCT03055221|524386558|FG000|Overall Study|Death|6|||
145417729|NCT03055221|524386558|FG000|Overall Study|Physician Decision|1|||
145417730|NCT03055221|524386558|FG000|Overall Study|Study terminated by Sponsor|3|||
145417731|NCT03055221|524386558|FG000|Overall Study|Lost to Follow-up|4|||
145417732|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
145417733|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
145417734|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
145417735|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
145417736|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
145417737|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
145417738|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
145417739|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
145417740|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
145417741|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
145417742|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
145417743|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
145417744|NCT01243424|524386559|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
145417745|NCT01243424|524386560|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
145417746|NCT01243424|524386559|FG000|Discontinuation From Treatment|Not treated|5|||
145417747|NCT01243424|524386560|FG001|Discontinuation From Treatment|Not treated|4|||
145417748|NCT01243424|524386559|FG000|Discontinuation From Treatment|Adverse Event|457|||
145417749|NCT01243424|524386560|FG001|Discontinuation From Treatment|Adverse Event|523|||
145417750|NCT01243424|524386559|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
145417751|NCT01243424|524386560|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
145417752|NCT01243424|524386559|FG000|Discontinuation From Treatment|Protocol Violation|46|||
145417753|NCT01243424|524386560|FG001|Discontinuation From Treatment|Protocol Violation|47|||
145417754|NCT01243424|524386559|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
145417755|NCT01243424|524386560|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
145417756|NCT01243424|524386559|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
145417757|NCT01243424|524386560|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
145417758|NCT01243424|524386559|FG000|Discontinuation From Treatment|Other than listed above|230|||
145417759|NCT01243424|524386560|FG001|Discontinuation From Treatment|Other than listed above|211|||
145417760|NCT01160744|524386565|FG000|Overall Study|Withdrawal by Subject|11|||
145417761|NCT01160744|524386566|FG001|Overall Study|Withdrawal by Subject|5|||
145355939|NCT00803790|524153839|FG000|Period 1|Protocol Violation|0|||
145355940|NCT00803790|524153840|FG001|Period 1|Protocol Violation|0|||
145355941|NCT00803790|524153841|FG002|Period 1|Protocol Violation|1|||
145355942|NCT00803790|524153842|FG003|Period 1|Protocol Violation|0|||
145355943|NCT00803790|524153839|FG000|Period 2|Adverse Event|0|||
145355944|NCT00803790|524153840|FG001|Period 2|Adverse Event|0|||
145355945|NCT00803790|524153841|FG002|Period 2|Adverse Event|1|||
145417762|NCT01160744|524386567|FG002|Overall Study|Withdrawal by Subject|6|||
145355946|NCT00803790|524153842|FG003|Period 2|Adverse Event|1|||
145355947|NCT00803790|524153839|FG000|Period 2|Withdrawal by Subject|1|||
145355948|NCT00803790|524153840|FG001|Period 2|Withdrawal by Subject|0|||
145417763|NCT01160744|524386568|FG003|Overall Study|Withdrawal by Subject|4|||
145417764|NCT01160744|524386565|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
145417765|NCT01160744|524386566|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
145417766|NCT01160744|524386567|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
145577394|NCT01069289|524968092|FG000|Overall Study|Adverse Event|21|||
145355949|NCT00803790|524153841|FG002|Period 2|Withdrawal by Subject|0|||
145355950|NCT00803790|524153842|FG003|Period 2|Withdrawal by Subject|0|||
145355951|NCT00803790|524153839|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
145355952|NCT00803790|524153840|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
145355953|NCT00803790|524153841|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
145355954|NCT00803790|524153842|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
145355955|NCT04710576|524153843|FG000|Overall Study|Participants still in the study|73|||
145355956|NCT04710576|524153844|FG001|Overall Study|Participants still in the study|70|||
145355957|NCT04710576|524153845|FG002|Overall Study|Participants still in the study|60|||
145355958|NCT04710576|524153843|FG000|Overall Study|Death|2|||
145355959|NCT04710576|524153844|FG001|Overall Study|Death|7|||
145355960|NCT04710576|524153845|FG002|Overall Study|Death|12|||
145355961|NCT04710576|524153843|FG000|Overall Study|Withdrawal by Subject|4|||
145355962|NCT04710576|524153844|FG001|Overall Study|Withdrawal by Subject|3|||
145355963|NCT04710576|524153845|FG002|Overall Study|Withdrawal by Subject|7|||
145355964|NCT04710576|524153843|FG000|Overall Study|Sponsor decision|1|||
145355965|NCT04710576|524153844|FG001|Overall Study|Sponsor decision|0|||
145355966|NCT04710576|524153845|FG002|Overall Study|Sponsor decision|0|||
145355967|NCT01415518|524153848|FG000|Overall Study|Withdrawal by Subject|2|||
145355968|NCT01415518|524153849|FG001|Overall Study|Withdrawal by Subject|12|||
145355969|NCT01415518|524153848|FG000|Overall Study|Protocol Violation|6|||
145355970|NCT01415518|524153849|FG001|Overall Study|Protocol Violation|8|||
145355971|NCT01415518|524153848|FG000|Overall Study|Lost to Follow-up|3|||
145355972|NCT01415518|524153849|FG001|Overall Study|Lost to Follow-up|5|||
145355973|NCT01415518|524153848|FG000|Overall Study|Adverse Event|3|||
145355974|NCT01415518|524153849|FG001|Overall Study|Adverse Event|4|||
145355975|NCT01415518|524153848|FG000|Overall Study|Death|1|||
145355976|NCT01415518|524153849|FG001|Overall Study|Death|1|||
145355977|NCT01415518|524153848|FG000|Overall Study|Condition under Investigation Worsened|1|||
145355978|NCT01415518|524153849|FG001|Overall Study|Condition under Investigation Worsened|1|||
145355979|NCT02445248|524153851|FG000|Overall Study|Death|45|||
145355980|NCT02445248|524153852|FG001|Overall Study|Death|12|||
145355981|NCT02445248|524153851|FG000|Overall Study|Progressive disease|13|||
145355982|NCT02445248|524153852|FG001|Overall Study|Progressive disease|1|||
145355983|NCT02445248|524153851|FG000|Overall Study|Subject decision|8|||
145355984|NCT02445248|524153852|FG001|Overall Study|Subject decision|0|||
145355985|NCT02445248|524153851|FG000|Overall Study|Physician Decision|5|||
145355986|NCT02445248|524153852|FG001|Overall Study|Physician Decision|0|||
145355987|NCT02445248|524153851|FG000|Overall Study|Adverse Event|1|||
145355988|NCT02445248|524153852|FG001|Overall Study|Adverse Event|0|||
145355989|NCT02445248|524153851|FG000|Overall Study|Lost to Follow-up|1|||
145355990|NCT02445248|524153852|FG001|Overall Study|Lost to Follow-up|0|||
145355991|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
145355992|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
145355993|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
145355994|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
145355995|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
145355996|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
145355997|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
145355998|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
145355999|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
145356000|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
145356001|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
145356002|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
145356003|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145356004|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145356005|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
145356006|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
145623003|NCT01254305|525131559|FG001|Overall Study|Withdrawal by Subject|2|||
145356007|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
145356008|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
145356009|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
145356010|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
145356011|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
145356012|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
145356013|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
145356014|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
145356015|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
145356016|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
145356017|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
145356018|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
145356019|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
145356020|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
145356021|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
145356022|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
145356023|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145356024|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
145356025|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145356026|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
145356027|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145356028|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145356029|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
145356030|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
145356031|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
145356032|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145356033|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145356034|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
145356035|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
145356036|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
145356037|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
145356038|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
145356039|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145356040|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145356041|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
145356042|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
145356043|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Site closed|0|||
145356044|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Site closed|0|||
145356045|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Site closed|1|||
145356046|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Site closed|0|||
145356047|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
145356048|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145356049|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145356050|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
145356051|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
145356052|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
145356053|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
145356054|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
145356055|NCT00838903|524153857|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
145356056|NCT00838903|524153858|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145356057|NCT00838903|524153859|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145356058|NCT00838903|524153860|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
145356059|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
145356060|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
145356061|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
145356062|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
145356063|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
145356064|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
145356065|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
145356066|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
145356067|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
145356068|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
145356069|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
145356070|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
145356071|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
145356072|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
145356073|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
145356074|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
145356075|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
145356076|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
145356077|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
145356078|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
145356079|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
145356080|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
145356081|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
145356082|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
145356083|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
145356084|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145356085|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
145623004|NCT01254305|525131560|FG002|Overall Study|Withdrawal by Subject|4|||
145623005|NCT01254305|525131558|FG000|Overall Study|Lost to Follow-up|10|||
145356086|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
145356087|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145356088|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
145356089|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145356090|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
145356091|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145356092|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
145356093|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145356094|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
145356095|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145356096|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145356097|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
145356098|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
145356099|NCT00838903|524153857|FG000|Follow-up Period (8 Weeks)|Missing|1|||
145356100|NCT00838903|524153858|FG001|Follow-up Period (8 Weeks)|Missing|2|||
145356101|NCT00838903|524153859|FG002|Follow-up Period (8 Weeks)|Missing|1|||
145356102|NCT00838903|524153860|FG003|Follow-up Period (8 Weeks)|Missing|1|||
145356103|NCT04225715|524153861|FG000|Overall Study|Reason not Specified|1|||
145356104|NCT04225715|524153862|FG001|Overall Study|Reason not Specified|0|||
145356105|NCT04225715|524153863|FG002|Overall Study|Reason not Specified|0|||
145356106|NCT04225715|524153864|FG003|Overall Study|Reason not Specified|0|||
145356107|NCT04225715|524153865|FG004|Overall Study|Reason not Specified|0|||
145356108|NCT04225715|524153866|FG005|Overall Study|Reason not Specified|0|||
145356109|NCT04225715|524153867|FG006|Overall Study|Reason not Specified|0|||
145356110|NCT04225715|524153868|FG007|Overall Study|Reason not Specified|0|||
145356111|NCT04225715|524153869|FG008|Overall Study|Reason not Specified|0|||
145356112|NCT04225715|524153861|FG000|Overall Study|Protocol Violation|1|||
145356113|NCT04225715|524153862|FG001|Overall Study|Protocol Violation|0|||
145356114|NCT04225715|524153863|FG002|Overall Study|Protocol Violation|0|||
145356115|NCT04225715|524153864|FG003|Overall Study|Protocol Violation|0|||
145356116|NCT04225715|524153865|FG004|Overall Study|Protocol Violation|0|||
145356117|NCT04225715|524153866|FG005|Overall Study|Protocol Violation|9|||
145356118|NCT04225715|524153867|FG006|Overall Study|Protocol Violation|0|||
145356119|NCT04225715|524153868|FG007|Overall Study|Protocol Violation|0|||
145356120|NCT04225715|524153869|FG008|Overall Study|Protocol Violation|0|||
145356121|NCT04225715|524153861|FG000|Overall Study|Withdrawal by Subject|4|||
145356122|NCT04225715|524153862|FG001|Overall Study|Withdrawal by Subject|1|||
145356123|NCT04225715|524153863|FG002|Overall Study|Withdrawal by Subject|1|||
145356124|NCT04225715|524153864|FG003|Overall Study|Withdrawal by Subject|0|||
145356125|NCT04225715|524153865|FG004|Overall Study|Withdrawal by Subject|3|||
145356126|NCT04225715|524153866|FG005|Overall Study|Withdrawal by Subject|1|||
145356127|NCT04225715|524153867|FG006|Overall Study|Withdrawal by Subject|1|||
145356128|NCT04225715|524153868|FG007|Overall Study|Withdrawal by Subject|1|||
145356129|NCT04225715|524153869|FG008|Overall Study|Withdrawal by Subject|0|||
145356130|NCT04225715|524153861|FG000|Overall Study|Adverse Event|0|||
145356131|NCT04225715|524153862|FG001|Overall Study|Adverse Event|0|||
145356132|NCT04225715|524153863|FG002|Overall Study|Adverse Event|0|||
145356133|NCT04225715|524153864|FG003|Overall Study|Adverse Event|0|||
145356134|NCT04225715|524153865|FG004|Overall Study|Adverse Event|0|||
145356135|NCT04225715|524153866|FG005|Overall Study|Adverse Event|0|||
145356136|NCT04225715|524153867|FG006|Overall Study|Adverse Event|0|||
145356137|NCT04225715|524153868|FG007|Overall Study|Adverse Event|0|||
145356138|NCT04225715|524153869|FG008|Overall Study|Adverse Event|1|||
145356139|NCT04225715|524153861|FG000|Overall Study|Arm Terminated By Sponsor|0|||
145356140|NCT04225715|524153862|FG001|Overall Study|Arm Terminated By Sponsor|0|||
145356141|NCT04225715|524153863|FG002|Overall Study|Arm Terminated By Sponsor|0|||
145356142|NCT04225715|524153864|FG003|Overall Study|Arm Terminated By Sponsor|0|||
145356143|NCT04225715|524153865|FG004|Overall Study|Arm Terminated By Sponsor|0|||
145356144|NCT04225715|524153866|FG005|Overall Study|Arm Terminated By Sponsor|0|||
145356145|NCT04225715|524153867|FG006|Overall Study|Arm Terminated By Sponsor|0|||
145356146|NCT04225715|524153868|FG007|Overall Study|Arm Terminated By Sponsor|17|||
145356147|NCT04225715|524153869|FG008|Overall Study|Arm Terminated By Sponsor|18|||
145356148|NCT02512302|524153870|FG000|Period 1|Adverse Event|0|||
145356149|NCT02512302|524153871|FG001|Period 1|Adverse Event|1|||
145356150|NCT02512302|524153872|FG002|Period 1|Adverse Event|0|||
145356151|NCT02512302|524153873|FG003|Period 1|Adverse Event|0|||
145356152|NCT02512302|524153874|FG004|Period 1|Adverse Event|0|||
145356153|NCT02512302|524153875|FG005|Period 1|Adverse Event|0|||
145356154|NCT02512302|524153876|FG006|Period 1|Adverse Event|0|||
145356155|NCT02512302|524153877|FG007|Period 1|Adverse Event|0|||
145356156|NCT02512302|524153878|FG008|Period 1|Adverse Event|0|||
145356157|NCT02512302|524153879|FG009|Period 1|Adverse Event|0|||
145356158|NCT02512302|524153870|FG000|Period 2|Adverse Event|0|||
145356159|NCT02512302|524153871|FG001|Period 2|Adverse Event|0|||
145356160|NCT02512302|524153872|FG002|Period 2|Adverse Event|0|||
145356161|NCT02512302|524153873|FG003|Period 2|Adverse Event|0|||
145356162|NCT02512302|524153874|FG004|Period 2|Adverse Event|0|||
145356163|NCT02512302|524153875|FG005|Period 2|Adverse Event|0|||
145356164|NCT02512302|524153876|FG006|Period 2|Adverse Event|0|||
145356165|NCT02512302|524153877|FG007|Period 2|Adverse Event|0|||
145356166|NCT02512302|524153878|FG008|Period 2|Adverse Event|0|||
145356167|NCT02512302|524153879|FG009|Period 2|Adverse Event|1|||
145356168|NCT02512302|524153870|FG000|Period 3|Lost to Follow-up|0|||
145356169|NCT02512302|524153871|FG001|Period 3|Lost to Follow-up|0|||
145356170|NCT02512302|524153872|FG002|Period 3|Lost to Follow-up|1|||
145356171|NCT02512302|524153873|FG003|Period 3|Lost to Follow-up|0|||
145356172|NCT02512302|524153874|FG004|Period 3|Lost to Follow-up|0|||
145356173|NCT02512302|524153875|FG005|Period 3|Lost to Follow-up|0|||
145356174|NCT02512302|524153876|FG006|Period 3|Lost to Follow-up|0|||
145356175|NCT02512302|524153877|FG007|Period 3|Lost to Follow-up|0|||
145356176|NCT02512302|524153878|FG008|Period 3|Lost to Follow-up|0|||
145356177|NCT02512302|524153879|FG009|Period 3|Lost to Follow-up|0|||
145356178|NCT02512302|524153870|FG000|Period 4|Adverse Event|0|||
145356179|NCT02512302|524153871|FG001|Period 4|Adverse Event|0|||
145356180|NCT02512302|524153872|FG002|Period 4|Adverse Event|0|||
145356181|NCT02512302|524153873|FG003|Period 4|Adverse Event|0|||
145356182|NCT02512302|524153874|FG004|Period 4|Adverse Event|0|||
145623006|NCT01254305|525131559|FG001|Overall Study|Lost to Follow-up|6|||
145623007|NCT01254305|525131560|FG002|Overall Study|Lost to Follow-up|5|||
145623008|NCT01254305|525131558|FG000|Overall Study|Other Reasons|0|||
145623009|NCT01254305|525131559|FG001|Overall Study|Other Reasons|0|||
145623010|NCT01254305|525131560|FG002|Overall Study|Other Reasons|2|||
145623011|NCT00953160|525131565|FG000|Overall Study|Lost to Follow-up|23|||
145623012|NCT00953160|525131565|FG000|Overall Study|Withdrawal by Subject|4|||
145623013|NCT00425503|525131566|FG000|Overall Study|Adverse Event|2|||
145623014|NCT00425503|525131566|FG000|Overall Study|Protocol Violation|1|||
145623015|NCT02179918|525131567|FG000|Overall Study|Death|0|||
145623016|NCT02179918|525131568|FG001|Overall Study|Death|0|||
145623017|NCT02179918|525131569|FG002|Overall Study|Death|0|||
145623018|NCT02179918|525131570|FG003|Overall Study|Death|1|||
145356183|NCT02512302|524153875|FG005|Period 4|Adverse Event|0|||
145356184|NCT02512302|524153876|FG006|Period 4|Adverse Event|1|||
145356185|NCT02512302|524153877|FG007|Period 4|Adverse Event|0|||
145356186|NCT02512302|524153878|FG008|Period 4|Adverse Event|0|||
145356187|NCT02512302|524153879|FG009|Period 4|Adverse Event|0|||
145356188|NCT00471822|524153880|FG000|Overall Study|Protocol Violation|2|||
145356189|NCT00683618|524153881|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
145356190|NCT00683618|524153882|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
145356191|NCT00683618|524153883|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
145356192|NCT00683618|524153881|FG000|Randomised Treatment Period|Protocol Violation|0|||
145356193|NCT00683618|524153882|FG001|Randomised Treatment Period|Protocol Violation|1|||
145356194|NCT00683618|524153883|FG002|Randomised Treatment Period|Protocol Violation|0|||
145356195|NCT00683618|524153881|FG000|Randomised Treatment Period|Adverse Event|2|||
145356196|NCT00683618|524153882|FG001|Randomised Treatment Period|Adverse Event|0|||
145356197|NCT00683618|524153883|FG002|Randomised Treatment Period|Adverse Event|2|||
145356198|NCT00683618|524153881|FG000|Randomised Treatment Period|Reason not provided|0|||
145356199|NCT00683618|524153882|FG001|Randomised Treatment Period|Reason not provided|0|||
145356200|NCT00683618|524153883|FG002|Randomised Treatment Period|Reason not provided|2|||
145356201|NCT00683618|524153881|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
145356202|NCT00683618|524153882|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145356203|NCT00683618|524153883|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
145356204|NCT00683618|524153881|FG000|Extension Treatment Period|Adverse Event|1|||
145356205|NCT00683618|524153882|FG001|Extension Treatment Period|Adverse Event|0|||
145356206|NCT00683618|524153883|FG002|Extension Treatment Period|Adverse Event|0|||
145356207|NCT00683618|524153881|FG000|Extension Treatment Period|Protocol Violation|1|||
145356208|NCT00683618|524153882|FG001|Extension Treatment Period|Protocol Violation|0|||
145623019|NCT02179918|525131571|FG004|Overall Study|Death|0|||
145623020|NCT02179918|525131567|FG000|Overall Study|Lost to Follow-up|0|||
145623021|NCT02179918|525131568|FG001|Overall Study|Lost to Follow-up|0|||
145356209|NCT00683618|524153883|FG002|Extension Treatment Period|Protocol Violation|0|||
145356210|NCT04570670|524153884|FG000|Overall Study|Withdrawal by Subject|1|||
145356211|NCT04570670|524153885|FG001|Overall Study|Withdrawal by Subject|0|||
145356212|NCT01002989|524153886|FG000|Overall Study|exclusion criteria, no consent|5|||
145623022|NCT02179918|525131569|FG002|Overall Study|Lost to Follow-up|1|||
145623023|NCT02179918|525131570|FG003|Overall Study|Lost to Follow-up|0|||
145623024|NCT02179918|525131571|FG004|Overall Study|Lost to Follow-up|0|||
145356213|NCT05177484|524153888|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
145356214|NCT05177484|524153889|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
145356215|NCT05177484|524153888|FG000|Overall Study|Inadvertently withdrawn|3|||
145356216|NCT05177484|524153889|FG001|Overall Study|Inadvertently withdrawn|1|||
145356217|NCT05177484|524153888|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
145356218|NCT05177484|524153889|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
145356219|NCT02549859|524153890|FG000|Long-term 60 Hz DBS|Study Closed|1|||
145623025|NCT02179918|525131567|FG000|Overall Study|Progressive Disease|4|||
145623026|NCT02179918|525131568|FG001|Overall Study|Progressive Disease|1|||
145356220|NCT00729612|524153893|FG000|Overall Study|Non evaluable for response|10|||
145356221|NCT01082328|524153903|FG000|Overall Study|Adverse Event|1|||
145356222|NCT00031590|524153904|FG000|Overall Study|Adverse Event|1|||
145356223|NCT00031590|524153904|FG000|Overall Study|Withdrawal by parents|2|||
145356224|NCT01568892|524153907|FG000|Open-label Phase|Adverse Event|2|||
145356225|NCT01568892|524153908|FG001|Open-label Phase|Adverse Event|0|||
145356226|NCT01568892|524153907|FG000|Open-label Phase|Lack of Efficacy|4|||
145356227|NCT01568892|524153908|FG001|Open-label Phase|Lack of Efficacy|2|||
145356228|NCT01568892|524153907|FG000|Open-label Phase|Lost to Follow-up|0|||
145356229|NCT01568892|524153908|FG001|Open-label Phase|Lost to Follow-up|1|||
145356230|NCT01139125|524153909|FG000|Overall Study|Withdrawal by Subject|1|||
145356231|NCT02172664|524153917|FG000|Overall Study|Lost to Follow-up|4|||
145356232|NCT02172664|524153918|FG001|Overall Study|Lost to Follow-up|4|||
145356233|NCT02172664|524153917|FG000|Overall Study|Death|1|||
145356234|NCT02172664|524153918|FG001|Overall Study|Death|1|||
145356235|NCT02172664|524153917|FG000|Overall Study|Moved out of area|1|||
145356236|NCT02172664|524153918|FG001|Overall Study|Moved out of area|1|||
145356237|NCT00380874|524153919|FG000|Overall Study|Adverse Event|7|||
145356238|NCT00380874|524153920|FG001|Overall Study|Adverse Event|7|||
145356239|NCT00380874|524153919|FG000|Overall Study|Death|1|||
145356240|NCT00380874|524153920|FG001|Overall Study|Death|0|||
145356241|NCT00380874|524153919|FG000|Overall Study|Withdrawal by Subject|2|||
145356242|NCT00380874|524153920|FG001|Overall Study|Withdrawal by Subject|1|||
145356243|NCT00380874|524153919|FG000|Overall Study|Not related to study drug|3|||
145356244|NCT00380874|524153920|FG001|Overall Study|Not related to study drug|2|||
145356245|NCT01707290|524153921|FG000|Overall Study|Adverse event (AE)|1|||
145356246|NCT01707290|524153922|FG001|Overall Study|Adverse event (AE)|0|||
145356247|NCT01707290|524153921|FG000|Overall Study|Physician Decision|1|||
145356248|NCT01707290|524153922|FG001|Overall Study|Physician Decision|0|||
145356249|NCT01707290|524153921|FG000|Overall Study|Lost to Follow-up|3|||
145356250|NCT01707290|524153922|FG001|Overall Study|Lost to Follow-up|0|||
145356251|NCT01707290|524153921|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
145356252|NCT01707290|524153922|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
145356253|NCT01707290|524153921|FG000|Overall Study|Commercial drug available|60|||
145356254|NCT01707290|524153922|FG001|Overall Study|Commercial drug available|1|||
145356255|NCT01707290|524153921|FG000|Overall Study|Other unspecified|17|||
145356256|NCT01707290|524153922|FG001|Overall Study|Other unspecified|0|||
145356257|NCT02314026|524153923|FG000|Overall Study|Protocol Violation|28|||
145356258|NCT02949973|524153924|FG000|Overall Study|Physician Decision|1|||
145356259|NCT04760626|524153925|FG000|Overall Study|Withdrawal by Subject|24|||
145356260|NCT04760626|524153926|FG001|Overall Study|Withdrawal by Subject|20|||
145356261|NCT04760626|524153925|FG000|Overall Study|Lost to Follow-up|14|||
145356262|NCT04760626|524153926|FG001|Overall Study|Lost to Follow-up|19|||
145356263|NCT04760626|524153925|FG000|Overall Study|Physician Decision|3|||
145356264|NCT04760626|524153926|FG001|Overall Study|Physician Decision|5|||
145356265|NCT04760626|524153925|FG000|Overall Study|Death|3|||
145356266|NCT04760626|524153926|FG001|Overall Study|Death|6|||
145356267|NCT04760626|524153925|FG000|Overall Study|Site closure|1|||
145356268|NCT04760626|524153926|FG001|Overall Study|Site closure|0|||
145356269|NCT01882985|524153929|FG000|Overall Study|Lost to Follow-up|1|||
145356270|NCT01882985|524153929|FG000|Overall Study|Withdrawal by Subject|1|||
145356271|NCT03193853|524153930|FG000|Overall Study|Death|6|||
145356272|NCT03267212|524153931|FG000|First Intervention|Lost to Follow-up|0|||
145356273|NCT03267212|524153932|FG001|First Intervention|Lost to Follow-up|2|||
145356274|NCT03267212|524153931|FG000|First Intervention|Withdrawal by Subject|1|||
145356275|NCT03267212|524153932|FG001|First Intervention|Withdrawal by Subject|1|||
145417767|NCT01160744|524386568|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
145417768|NCT02301429|524386575|FG000|Overall Study|not acceptable vascular anatomy|3|||
145417769|NCT01502072|524386576|FG000|Overall Study|Withdrawal by Subject|1|||
145417770|NCT01502072|524386577|FG001|Overall Study|Withdrawal by Subject|0|||
145417771|NCT01502072|524386578|FG002|Overall Study|Withdrawal by Subject|0|||
145623027|NCT02179918|525131569|FG002|Overall Study|Progressive Disease|1|||
145623028|NCT02179918|525131570|FG003|Overall Study|Progressive Disease|2|||
145356276|NCT03267212|524153931|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
145356277|NCT03267212|524153932|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
145356278|NCT05303194|524153935|FG000|Overall Study|Lost to Follow-up|1|||
145356279|NCT05303194|524153936|FG001|Overall Study|Lost to Follow-up|1|||
145356280|NCT05303194|524153935|FG000|Overall Study|Withdrawal by Subject|0|||
145356281|NCT05303194|524153936|FG001|Overall Study|Withdrawal by Subject|1|||
145356282|NCT04837196|524153937|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145356283|NCT04837196|524153938|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
145356284|NCT04837196|524153939|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145356285|NCT04837196|524153940|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
145356286|NCT04837196|524153941|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
145356287|NCT04837196|524153937|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145356288|NCT04837196|524153938|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
145356289|NCT04837196|524153939|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
145356290|NCT04837196|524153940|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145356291|NCT04837196|524153941|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
145356292|NCT04837196|524153937|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145356293|NCT04837196|524153938|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
145356294|NCT04837196|524153939|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145356295|NCT04837196|524153940|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145356296|NCT04837196|524153941|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
145356297|NCT04837196|524153937|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145356298|NCT04837196|524153938|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145356299|NCT04837196|524153939|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
145356300|NCT04837196|524153940|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145356301|NCT04837196|524153941|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
145356302|NCT04837196|524153937|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145356303|NCT04837196|524153938|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145356304|NCT04837196|524153939|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
145356305|NCT04837196|524153940|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145356306|NCT04837196|524153941|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
145356307|NCT01289678|524153942|FG000|Overall Study|Physician Decision|6|||
145356308|NCT01597973|524153945|FG000|Overall Study|Found ineligible before study medication started|4|||
145356309|NCT01597973|524153946|FG001|Overall Study|Found ineligible before study medication started|2|||
145356310|NCT01597973|524153945|FG000|Overall Study|Eligible pathogen not confirmed|14|||
145356311|NCT01597973|524153946|FG001|Overall Study|Eligible pathogen not confirmed|15|||
145356312|NCT01597973|524153945|FG000|Overall Study|LAR not authorized to consent|0|||
145356313|NCT01597973|524153946|FG001|Overall Study|LAR not authorized to consent|1|||
145356314|NCT01597973|524153945|FG000|Overall Study|Ineligible due to early seizures|1|||
145356315|NCT01597973|524153946|FG001|Overall Study|Ineligible due to early seizures|0|||
145356316|NCT01597973|524153945|FG000|Overall Study|Ineligible due to non-target infection|1|||
145356317|NCT01597973|524153946|FG001|Overall Study|Ineligible due to non-target infection|1|||
145356318|NCT02723344|524153947|FG000|Overall Study|Lost to Follow-up|0|||
145356319|NCT02723344|524153948|FG001|Overall Study|Lost to Follow-up|4|||
145356320|NCT00908544|524153949|FG000|Overall Study|Withdrawal by Subject|2|||
145356321|NCT00908544|524153950|FG001|Overall Study|Withdrawal by Subject|4|||
145356322|NCT00908544|524153949|FG000|Overall Study|Lack of Efficacy|0|||
145356323|NCT00908544|524153950|FG001|Overall Study|Lack of Efficacy|1|||
145356324|NCT00908544|524153949|FG000|Overall Study|Pregnancy|1|||
145356325|NCT00908544|524153950|FG001|Overall Study|Pregnancy|0|||
145356326|NCT00908544|524153949|FG000|Overall Study|Relocation abroad|1|||
145356327|NCT00908544|524153950|FG001|Overall Study|Relocation abroad|1|||
145356328|NCT00908544|524153949|FG000|Overall Study|Unable to visit sutdy center|1|||
145356329|NCT00908544|524153950|FG001|Overall Study|Unable to visit sutdy center|0|||
145356330|NCT00740636|524153955|FG000|Overall Study|Adverse Event|0|||
145356331|NCT00740636|524153956|FG001|Overall Study|Adverse Event|2|||
145356332|NCT00740636|524153955|FG000|Overall Study|Patient Ineligible|0|||
145356333|NCT00740636|524153956|FG001|Overall Study|Patient Ineligible|1|||
145356334|NCT00740636|524153955|FG000|Overall Study|Patient Not Treated|0|||
145356335|NCT00740636|524153956|FG001|Overall Study|Patient Not Treated|1|||
145356336|NCT00740636|524153955|FG000|Overall Study|Progressive Disease|1|||
145356337|NCT00740636|524153956|FG001|Overall Study|Progressive Disease|0|||
145356338|NCT00740636|524153955|FG000|Overall Study|Death|1|||
145356339|NCT00740636|524153956|FG001|Overall Study|Death|0|||
145356340|NCT02362360|524153962|FG000|Period 1|Lack of Efficacy|1|||
145356341|NCT02362360|524153963|FG001|Period 1|Lack of Efficacy|0|||
145356342|NCT02362360|524153962|FG000|Period 1|Withdrawal by Subject|2|||
145356343|NCT02362360|524153963|FG001|Period 1|Withdrawal by Subject|1|||
145356344|NCT05573464|524155329|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
145356345|NCT05573464|524155330|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
145356346|NCT05573464|524155329|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
145356347|NCT05573464|524155330|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
145356348|NCT05573464|524155329|FG000|12-week Treatment Period|Protocol Violation|3|||
145356349|NCT05573464|524155330|FG001|12-week Treatment Period|Protocol Violation|1|||
145356350|NCT05573464|524155329|FG000|12-week Treatment Period|Physician Decision|1|||
145356351|NCT05573464|524155330|FG001|12-week Treatment Period|Physician Decision|2|||
145356352|NCT05573464|524155329|FG000|12-week Treatment Period|Lost to Follow-up|2|||
145356353|NCT05573464|524155330|FG001|12-week Treatment Period|Lost to Follow-up|0|||
145356354|NCT05573464|524155329|FG000|12-week Treatment Period|Adverse Event|20|||
145356355|NCT05573464|524155330|FG001|12-week Treatment Period|Adverse Event|9|||
145356356|NCT05573464|524155329|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
145356357|NCT05573464|524155330|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
145356358|NCT05573464|524155329|FG000|12-week Treatment Period|Randomised, not treated|0|||
145356359|NCT05573464|524155330|FG001|12-week Treatment Period|Randomised, not treated|1|||
145356360|NCT05573464|524155329|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
145356361|NCT05573464|524155330|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
145356362|NCT05573464|524155329|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
145356363|NCT05573464|524155330|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
145356364|NCT05573464|524155329|FG000|52-week Treatment Period|Protocol Violation|1|||
145356365|NCT05573464|524155330|FG001|52-week Treatment Period|Protocol Violation|1|||
145356366|NCT05573464|524155329|FG000|52-week Treatment Period|Physician Decision|2|||
145356367|NCT05573464|524155330|FG001|52-week Treatment Period|Physician Decision|2|||
145356368|NCT05573464|524155329|FG000|52-week Treatment Period|Lost to Follow-up|1|||
145356369|NCT05573464|524155330|FG001|52-week Treatment Period|Lost to Follow-up|1|||
145356370|NCT05573464|524155329|FG000|52-week Treatment Period|Adverse Event|11|||
145356371|NCT05573464|524155330|FG001|52-week Treatment Period|Adverse Event|8|||
145356372|NCT05573464|524155329|FG000|52-week Treatment Period|Death|1|||
145356373|NCT05573464|524155330|FG001|52-week Treatment Period|Death|1|||
145356374|NCT04632927|524155331|FG000|Overall Study|Adverse Event|0|||
145356375|NCT04632927|524155332|FG001|Overall Study|Adverse Event|1|||
145356376|NCT04632927|524155331|FG000|Overall Study|Lack of Efficacy|0|||
145356377|NCT04632927|524155332|FG001|Overall Study|Lack of Efficacy|4|||
145356378|NCT04632927|524155331|FG000|Overall Study|Loss of efficacy|0|||
145356379|NCT04632927|524155332|FG001|Overall Study|Loss of efficacy|1|||
145356380|NCT04632927|524155331|FG000|Overall Study|Non-compliance with study drug|0|||
145356381|NCT04632927|524155332|FG001|Overall Study|Non-compliance with study drug|1|||
145356382|NCT04632927|524155331|FG000|Overall Study|Physician Decision|0|||
145356383|NCT04632927|524155332|FG001|Overall Study|Physician Decision|1|||
145356384|NCT04632927|524155331|FG000|Overall Study|Subject decision|0|||
145356385|NCT04632927|524155332|FG001|Overall Study|Subject decision|1|||
145356386|NCT04632927|524155331|FG000|Overall Study|Withdrawal by Subject|0|||
145356387|NCT04632927|524155332|FG001|Overall Study|Withdrawal by Subject|1|||
145356388|NCT05734157|524155333|FG000|Overall Study|Death|3|||
145356389|NCT05734157|524155333|FG000|Overall Study|Withdrawal by Subject|2|||
145356390|NCT05734157|524155333|FG000|Overall Study|Lost to Follow-up|1|||
145356391|NCT05734157|524155333|FG000|Overall Study|Telephone call|3|||
145356392|NCT01611935|524155334|FG000|Overall Study|Family Declined Participation|1|||
145356393|NCT01611935|524155335|FG001|Overall Study|Family Declined Participation|0|||
145356394|NCT04067050|524155338|FG000|One Month|Lost to Follow-up|4|||
145356395|NCT04067050|524155339|FG001|One Month|Lost to Follow-up|0|||
145356396|NCT04067050|524155338|FG000|Two Month|Lost to Follow-up|1|||
145356397|NCT04067050|524155339|FG001|Two Month|Lost to Follow-up|0|||
145356398|NCT04067050|524155338|FG000|Two Month|Adverse Event|1|||
145356399|NCT04067050|524155339|FG001|Two Month|Adverse Event|0|||
145356400|NCT00460603|524155342|FG000|Phase 1|Death|1|||
145356401|NCT00460603|524155343|FG001|Phase 1|Death|0|||
145356402|NCT00460603|524155344|FG002|Phase 1|Death|0|||
145356403|NCT00460603|524155345|FG003|Phase 1|Death|2|||
145356404|NCT00460603|524155346|FG004|Phase 1|Death|0|||
145356405|NCT00460603|524155347|FG005|Phase 1|Death|0|||
145356406|NCT00460603|524155348|FG006|Phase 1|Death|0|||
145356407|NCT00460603|524155349|FG007|Phase 1|Death|0|||
145356408|NCT00460603|524155350|FG008|Phase 1|Death|1|||
145356409|NCT00460603|524155351|FG009|Phase 1|Death|0|||
145356410|NCT00460603|524155352|FG010|Phase 1|Death|0|||
145356411|NCT00460603|524155353|FG011|Phase 1|Death|0|||
145356412|NCT00460603|524155342|FG000|Phase 1|Adverse Event|3|||
145356413|NCT00460603|524155343|FG001|Phase 1|Adverse Event|1|||
145356414|NCT00460603|524155344|FG002|Phase 1|Adverse Event|1|||
145356415|NCT00460603|524155345|FG003|Phase 1|Adverse Event|2|||
145356416|NCT00460603|524155346|FG004|Phase 1|Adverse Event|0|||
145356417|NCT00460603|524155347|FG005|Phase 1|Adverse Event|0|||
145356418|NCT00460603|524155348|FG006|Phase 1|Adverse Event|3|||
145356419|NCT00460603|524155349|FG007|Phase 1|Adverse Event|0|||
145356420|NCT00460603|524155350|FG008|Phase 1|Adverse Event|4|||
145356421|NCT00460603|524155351|FG009|Phase 1|Adverse Event|0|||
145417772|NCT01502072|524386576|FG000|Overall Study|Death|0|||
145356422|NCT00460603|524155352|FG010|Phase 1|Adverse Event|0|||
145356423|NCT00460603|524155353|FG011|Phase 1|Adverse Event|0|||
145356424|NCT00460603|524155342|FG000|Phase 1|Lack of Efficacy|1|||
145356425|NCT00460603|524155343|FG001|Phase 1|Lack of Efficacy|0|||
145356426|NCT00460603|524155344|FG002|Phase 1|Lack of Efficacy|1|||
145356427|NCT00460603|524155345|FG003|Phase 1|Lack of Efficacy|2|||
145356428|NCT00460603|524155346|FG004|Phase 1|Lack of Efficacy|2|||
145356429|NCT00460603|524155347|FG005|Phase 1|Lack of Efficacy|2|||
145356430|NCT00460603|524155348|FG006|Phase 1|Lack of Efficacy|2|||
145356431|NCT00460603|524155349|FG007|Phase 1|Lack of Efficacy|2|||
145356432|NCT00460603|524155350|FG008|Phase 1|Lack of Efficacy|11|||
145356433|NCT00460603|524155351|FG009|Phase 1|Lack of Efficacy|0|||
145356434|NCT00460603|524155352|FG010|Phase 1|Lack of Efficacy|0|||
145356435|NCT00460603|524155353|FG011|Phase 1|Lack of Efficacy|0|||
145356436|NCT00460603|524155342|FG000|Phase 1|Withdrawal by Subject|1|||
145356437|NCT00460603|524155343|FG001|Phase 1|Withdrawal by Subject|2|||
145356438|NCT00460603|524155344|FG002|Phase 1|Withdrawal by Subject|1|||
145356439|NCT00460603|524155345|FG003|Phase 1|Withdrawal by Subject|1|||
145356440|NCT00460603|524155346|FG004|Phase 1|Withdrawal by Subject|3|||
145356441|NCT00460603|524155347|FG005|Phase 1|Withdrawal by Subject|0|||
145356442|NCT00460603|524155348|FG006|Phase 1|Withdrawal by Subject|1|||
145356443|NCT00460603|524155349|FG007|Phase 1|Withdrawal by Subject|0|||
145356444|NCT00460603|524155350|FG008|Phase 1|Withdrawal by Subject|2|||
145356445|NCT00460603|524155351|FG009|Phase 1|Withdrawal by Subject|0|||
145356446|NCT00460603|524155352|FG010|Phase 1|Withdrawal by Subject|0|||
145356447|NCT00460603|524155353|FG011|Phase 1|Withdrawal by Subject|0|||
145356448|NCT00460603|524155342|FG000|Phase 1|Other|0|||
145356449|NCT00460603|524155343|FG001|Phase 1|Other|3|||
145577395|NCT01069289|524968093|FG001|Overall Study|Adverse Event|28|||
145577396|NCT01069289|524968092|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145356450|NCT00460603|524155344|FG002|Phase 1|Other|1|||
145356451|NCT00460603|524155345|FG003|Phase 1|Other|1|||
145356452|NCT00460603|524155346|FG004|Phase 1|Other|1|||
145356453|NCT00460603|524155347|FG005|Phase 1|Other|2|||
145356454|NCT00460603|524155348|FG006|Phase 1|Other|0|||
145356455|NCT00460603|524155349|FG007|Phase 1|Other|1|||
145356456|NCT00460603|524155350|FG008|Phase 1|Other|0|||
145356457|NCT00460603|524155351|FG009|Phase 1|Other|0|||
145356458|NCT00460603|524155352|FG010|Phase 1|Other|0|||
145356459|NCT00460603|524155353|FG011|Phase 1|Other|0|||
145356460|NCT00460603|524155342|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356461|NCT00460603|524155343|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356462|NCT00460603|524155344|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356463|NCT00460603|524155345|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356464|NCT00460603|524155346|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356465|NCT00460603|524155347|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356466|NCT00460603|524155348|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356467|NCT00460603|524155349|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356468|NCT00460603|524155350|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356469|NCT00460603|524155351|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
145356470|NCT00460603|524155352|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356471|NCT00460603|524155353|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
145356472|NCT00460603|524155342|FG000|Phase 2|Adverse Event|0|||
145356473|NCT00460603|524155343|FG001|Phase 2|Adverse Event|0|||
145356474|NCT00460603|524155344|FG002|Phase 2|Adverse Event|0|||
145356475|NCT00460603|524155345|FG003|Phase 2|Adverse Event|0|||
145356476|NCT00460603|524155346|FG004|Phase 2|Adverse Event|0|||
145356477|NCT00460603|524155347|FG005|Phase 2|Adverse Event|0|||
145356478|NCT00460603|524155348|FG006|Phase 2|Adverse Event|0|||
145356479|NCT00460603|524155349|FG007|Phase 2|Adverse Event|0|||
145356480|NCT00460603|524155350|FG008|Phase 2|Adverse Event|0|||
145356481|NCT00460603|524155351|FG009|Phase 2|Adverse Event|12|||
145356482|NCT00460603|524155352|FG010|Phase 2|Adverse Event|9|||
145356483|NCT00460603|524155353|FG011|Phase 2|Adverse Event|10|||
145356484|NCT00460603|524155342|FG000|Phase 2|Death|0|||
145356485|NCT00460603|524155343|FG001|Phase 2|Death|0|||
145356486|NCT00460603|524155344|FG002|Phase 2|Death|0|||
145356487|NCT00460603|524155345|FG003|Phase 2|Death|0|||
145356488|NCT00460603|524155346|FG004|Phase 2|Death|0|||
145356489|NCT00460603|524155347|FG005|Phase 2|Death|0|||
145356490|NCT00460603|524155348|FG006|Phase 2|Death|0|||
145356491|NCT00460603|524155349|FG007|Phase 2|Death|0|||
145577397|NCT01069289|524968093|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145577398|NCT01069289|524968092|FG000|Overall Study|Severe non-compliance to protocol|3|||
145577399|NCT01069289|524968093|FG001|Overall Study|Severe non-compliance to protocol|2|||
145577400|NCT01069289|524968092|FG000|Overall Study|Due to deteriorating health condition|1|||
145356492|NCT00460603|524155350|FG008|Phase 2|Death|0|||
145356493|NCT00460603|524155351|FG009|Phase 2|Death|4|||
145356494|NCT00460603|524155352|FG010|Phase 2|Death|2|||
145356495|NCT00460603|524155353|FG011|Phase 2|Death|2|||
145356496|NCT00460603|524155342|FG000|Phase 2|Protocol Violation|0|||
145577401|NCT01069289|524968093|FG001|Overall Study|Due to deteriorating health condition|0|||
145356497|NCT00460603|524155343|FG001|Phase 2|Protocol Violation|0|||
145356498|NCT00460603|524155344|FG002|Phase 2|Protocol Violation|0|||
145356499|NCT00460603|524155345|FG003|Phase 2|Protocol Violation|0|||
145356500|NCT00460603|524155346|FG004|Phase 2|Protocol Violation|0|||
145356501|NCT00460603|524155347|FG005|Phase 2|Protocol Violation|0|||
145356502|NCT00460603|524155348|FG006|Phase 2|Protocol Violation|0|||
145356503|NCT00460603|524155349|FG007|Phase 2|Protocol Violation|0|||
145356504|NCT00460603|524155350|FG008|Phase 2|Protocol Violation|0|||
145356505|NCT00460603|524155351|FG009|Phase 2|Protocol Violation|1|||
145356506|NCT00460603|524155352|FG010|Phase 2|Protocol Violation|1|||
145356507|NCT00460603|524155353|FG011|Phase 2|Protocol Violation|0|||
145356508|NCT00460603|524155342|FG000|Phase 2|Lost to Follow-up|0|||
145356509|NCT00460603|524155343|FG001|Phase 2|Lost to Follow-up|0|||
145356510|NCT00460603|524155344|FG002|Phase 2|Lost to Follow-up|0|||
145356511|NCT00460603|524155345|FG003|Phase 2|Lost to Follow-up|0|||
145356512|NCT00460603|524155346|FG004|Phase 2|Lost to Follow-up|0|||
145356513|NCT00460603|524155347|FG005|Phase 2|Lost to Follow-up|0|||
145356514|NCT00460603|524155348|FG006|Phase 2|Lost to Follow-up|0|||
145356515|NCT00460603|524155349|FG007|Phase 2|Lost to Follow-up|0|||
145356516|NCT00460603|524155350|FG008|Phase 2|Lost to Follow-up|0|||
145356517|NCT00460603|524155351|FG009|Phase 2|Lost to Follow-up|1|||
145417773|NCT01502072|524386577|FG001|Overall Study|Death|1|||
145417774|NCT01502072|524386578|FG002|Overall Study|Death|0|||
145417775|NCT02018887|524386581|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
145417776|NCT02018887|524386582|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417777|NCT02018887|524386583|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417778|NCT02018887|524386584|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417779|NCT02018887|524386585|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417780|NCT02018887|524386586|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145356518|NCT00460603|524155352|FG010|Phase 2|Lost to Follow-up|0|||
145356519|NCT00460603|524155353|FG011|Phase 2|Lost to Follow-up|0|||
145356520|NCT00460603|524155342|FG000|Phase 2|Other|0|||
145356521|NCT00460603|524155343|FG001|Phase 2|Other|0|||
145356522|NCT00460603|524155344|FG002|Phase 2|Other|0|||
145356523|NCT00460603|524155345|FG003|Phase 2|Other|0|||
145356524|NCT00460603|524155346|FG004|Phase 2|Other|0|||
145356525|NCT00460603|524155347|FG005|Phase 2|Other|0|||
145356526|NCT00460603|524155348|FG006|Phase 2|Other|0|||
145356527|NCT00460603|524155349|FG007|Phase 2|Other|0|||
145356528|NCT00460603|524155350|FG008|Phase 2|Other|0|||
145356529|NCT00460603|524155351|FG009|Phase 2|Other|6|||
145356530|NCT00460603|524155352|FG010|Phase 2|Other|16|||
145356531|NCT00460603|524155353|FG011|Phase 2|Other|7|||
145356532|NCT00460603|524155342|FG000|Phase 2|Objective Progression or Relapse|0|||
145356533|NCT00460603|524155343|FG001|Phase 2|Objective Progression or Relapse|0|||
145356534|NCT00460603|524155344|FG002|Phase 2|Objective Progression or Relapse|0|||
145356535|NCT00460603|524155345|FG003|Phase 2|Objective Progression or Relapse|0|||
145356536|NCT00460603|524155346|FG004|Phase 2|Objective Progression or Relapse|0|||
145356537|NCT00460603|524155347|FG005|Phase 2|Objective Progression or Relapse|0|||
145356538|NCT00460603|524155348|FG006|Phase 2|Objective Progression or Relapse|0|||
145356539|NCT00460603|524155349|FG007|Phase 2|Objective Progression or Relapse|0|||
145356540|NCT00460603|524155350|FG008|Phase 2|Objective Progression or Relapse|0|||
145356541|NCT00460603|524155351|FG009|Phase 2|Objective Progression or Relapse|9|||
145356542|NCT00460603|524155352|FG010|Phase 2|Objective Progression or Relapse|10|||
145356543|NCT00460603|524155353|FG011|Phase 2|Objective Progression or Relapse|17|||
145356544|NCT00460603|524155342|FG000|Phase 2|Global Deterioration of Health Status|0|||
145356545|NCT00460603|524155343|FG001|Phase 2|Global Deterioration of Health Status|0|||
145356546|NCT00460603|524155344|FG002|Phase 2|Global Deterioration of Health Status|0|||
145356547|NCT00460603|524155345|FG003|Phase 2|Global Deterioration of Health Status|0|||
145356548|NCT00460603|524155346|FG004|Phase 2|Global Deterioration of Health Status|0|||
145356549|NCT00460603|524155347|FG005|Phase 2|Global Deterioration of Health Status|0|||
145356550|NCT00460603|524155348|FG006|Phase 2|Global Deterioration of Health Status|0|||
145356551|NCT00460603|524155349|FG007|Phase 2|Global Deterioration of Health Status|0|||
145356552|NCT00460603|524155350|FG008|Phase 2|Global Deterioration of Health Status|0|||
145356553|NCT00460603|524155351|FG009|Phase 2|Global Deterioration of Health Status|0|||
145356554|NCT00460603|524155352|FG010|Phase 2|Global Deterioration of Health Status|1|||
145356555|NCT00460603|524155353|FG011|Phase 2|Global Deterioration of Health Status|0|||
145356556|NCT00460603|524155342|FG000|Phase 2|Withdrawal by Subject|0|||
145356557|NCT00460603|524155343|FG001|Phase 2|Withdrawal by Subject|0|||
145356558|NCT00460603|524155344|FG002|Phase 2|Withdrawal by Subject|0|||
145356559|NCT00460603|524155345|FG003|Phase 2|Withdrawal by Subject|0|||
145356560|NCT00460603|524155346|FG004|Phase 2|Withdrawal by Subject|0|||
145356561|NCT00460603|524155347|FG005|Phase 2|Withdrawal by Subject|0|||
145356562|NCT00460603|524155348|FG006|Phase 2|Withdrawal by Subject|0|||
145356563|NCT00460603|524155349|FG007|Phase 2|Withdrawal by Subject|0|||
145356564|NCT00460603|524155350|FG008|Phase 2|Withdrawal by Subject|0|||
145356565|NCT00460603|524155351|FG009|Phase 2|Withdrawal by Subject|5|||
145417781|NCT02018887|524386587|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417782|NCT02018887|524386588|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417783|NCT02018887|524386589|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145356566|NCT00460603|524155352|FG010|Phase 2|Withdrawal by Subject|4|||
145356567|NCT00460603|524155353|FG011|Phase 2|Withdrawal by Subject|5|||
145356568|NCT00460603|524155342|FG000|Phase 2|Randomized, but not treated|0|||
145356569|NCT00460603|524155343|FG001|Phase 2|Randomized, but not treated|0|||
145356570|NCT00460603|524155344|FG002|Phase 2|Randomized, but not treated|0|||
145356571|NCT00460603|524155345|FG003|Phase 2|Randomized, but not treated|0|||
145356572|NCT00460603|524155346|FG004|Phase 2|Randomized, but not treated|0|||
145356573|NCT00460603|524155347|FG005|Phase 2|Randomized, but not treated|0|||
145356574|NCT00460603|524155348|FG006|Phase 2|Randomized, but not treated|0|||
145356575|NCT00460603|524155349|FG007|Phase 2|Randomized, but not treated|0|||
145356576|NCT00460603|524155350|FG008|Phase 2|Randomized, but not treated|0|||
145356577|NCT00460603|524155351|FG009|Phase 2|Randomized, but not treated|3|||
145356578|NCT00460603|524155352|FG010|Phase 2|Randomized, but not treated|0|||
145356579|NCT00460603|524155353|FG011|Phase 2|Randomized, but not treated|0|||
145577402|NCT01310413|524969407|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
145356580|NCT03003962|524155354|FG000|Overall Study|Withdrawal by Subject|5|||
145356581|NCT03003962|524155355|FG001|Overall Study|Withdrawal by Subject|17|||
145356582|NCT03003962|524155354|FG000|Overall Study|Death|274|||
145356583|NCT03003962|524155355|FG001|Overall Study|Death|277|||
145417784|NCT02018887|524386590|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417785|NCT02018887|524386591|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
145417786|NCT02018887|524386581|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417787|NCT02018887|524386582|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417788|NCT02018887|524386583|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417789|NCT02018887|524386584|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417790|NCT02018887|524386585|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
145417791|NCT02018887|524386586|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417792|NCT02018887|524386587|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
145417793|NCT02018887|524386588|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
145417794|NCT02018887|524386589|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417795|NCT02018887|524386590|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417796|NCT02018887|524386591|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
145417797|NCT02018887|524386581|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
145417798|NCT02018887|524386582|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
145417799|NCT02018887|524386583|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
145417800|NCT02018887|524386584|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
145417801|NCT02018887|524386585|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
145417802|NCT02018887|524386586|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
145417803|NCT02018887|524386587|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
145417804|NCT02018887|524386588|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
145417805|NCT02018887|524386589|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
145417806|NCT02018887|524386590|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
145417807|NCT02018887|524386591|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
145417808|NCT02018887|524386581|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
145417809|NCT02018887|524386582|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
145417810|NCT02018887|524386583|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
145417811|NCT02018887|524386584|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
145417812|NCT02018887|524386585|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
145417813|NCT02018887|524386586|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
145417814|NCT02018887|524386587|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
145417815|NCT02018887|524386588|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
145417816|NCT02018887|524386589|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
145417817|NCT02018887|524386590|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
145417818|NCT02018887|524386591|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
145417819|NCT01058005|524386592|FG000|Overall Study|Adverse Event|0|||
145417820|NCT01058005|524386593|FG001|Overall Study|Adverse Event|2|||
145417821|NCT01058005|524386594|FG002|Overall Study|Adverse Event|1|||
145417822|NCT01058005|524386592|FG000|Overall Study|Physician Decision|2|||
145417823|NCT01058005|524386593|FG001|Overall Study|Physician Decision|2|||
145417824|NCT01058005|524386594|FG002|Overall Study|Physician Decision|0|||
145417825|NCT01058005|524386592|FG000|Overall Study|Withdrawal by Subject|4|||
145417826|NCT01058005|524386593|FG001|Overall Study|Withdrawal by Subject|5|||
145417827|NCT01058005|524386594|FG002|Overall Study|Withdrawal by Subject|11|||
145417828|NCT01058005|524386592|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
145417829|NCT01058005|524386593|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
145417830|NCT01058005|524386594|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
145417831|NCT01058005|524386592|FG000|Overall Study|Reason Missing|5|||
145417832|NCT01058005|524386593|FG001|Overall Study|Reason Missing|3|||
145417833|NCT01058005|524386594|FG002|Overall Study|Reason Missing|1|||
145417834|NCT01145222|524386595|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
145417835|NCT01145222|524386596|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
145417836|NCT01145222|524386597|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
145417837|NCT01145222|524386598|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
145417838|NCT01145222|524386595|FG000|Overall Study|Poor bowel preparation|0|||
145417839|NCT01145222|524386596|FG001|Overall Study|Poor bowel preparation|0|||
145417840|NCT01145222|524386597|FG002|Overall Study|Poor bowel preparation|0|||
145417841|NCT01145222|524386598|FG003|Overall Study|Poor bowel preparation|1|||
145417842|NCT01698008|524386599|FG000|Overall Study|Withdrawal by Subject|1|||
145417843|NCT01698008|524386600|FG001|Overall Study|Withdrawal by Subject|2|||
145417844|NCT01011283|524386604|FG000|Overall Study|Adverse Event|4|||
145417845|NCT01011283|524386605|FG001|Overall Study|Adverse Event|2|||
145417846|NCT01011283|524386604|FG000|Overall Study|Progressive Disease|0|||
145417847|NCT01011283|524386605|FG001|Overall Study|Progressive Disease|2|||
145417848|NCT01011283|524386604|FG000|Overall Study|Terminated by Sponsor|5|||
145417849|NCT01011283|524386605|FG001|Overall Study|Terminated by Sponsor|5|||
145417850|NCT01011283|524386604|FG000|Overall Study|Other|2|||
145417851|NCT01011283|524386605|FG001|Overall Study|Other|2|||
145417852|NCT01096186|524386606|FG000|Overall Study|Adverse Event|16|||
145417853|NCT01096186|524386606|FG000|Overall Study|Death|4|||
145417854|NCT01096186|524386606|FG000|Overall Study|Lack of Efficacy|4|||
145417855|NCT01096186|524386606|FG000|Overall Study|Lost to Follow-up|2|||
145417856|NCT01096186|524386606|FG000|Overall Study|Withdrawal by Subject|22|||
145417857|NCT01096186|524386606|FG000|Overall Study|Physician Decision|1|||
145417858|NCT01096186|524386606|FG000|Overall Study|Noncompliance with study drug|1|||
145417859|NCT00122187|524386611|FG000|Overall Study|Withdrew because of resource limitations|2|||
145417860|NCT00122187|524386612|FG001|Overall Study|Withdrew because of resource limitations|2|||
145417861|NCT00799864|524386616|FG000|Overall Study|Participant reached a virologic endpoint|9|||
145417862|NCT00799864|524386617|FG001|Overall Study|Participant reached a virologic endpoint|2|||
145417863|NCT00799864|524386618|FG002|Overall Study|Participant reached a virologic endpoint|2|||
145417864|NCT00799864|524386619|FG003|Overall Study|Participant reached a virologic endpoint|0|||
145417865|NCT00799864|524386620|FG004|Overall Study|Participant reached a virologic endpoint|0|||
145417866|NCT00799864|524386616|FG000|Overall Study|Other|2|||
145417867|NCT00799864|524386617|FG001|Overall Study|Other|1|||
145417868|NCT00799864|524386618|FG002|Overall Study|Other|0|||
145417869|NCT00799864|524386619|FG003|Overall Study|Other|0|||
145417870|NCT00799864|524386620|FG004|Overall Study|Other|0|||
145417871|NCT04865978|524386621|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
145417872|NCT04865978|524386622|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
145417873|NCT04263532|524386625|FG000|Overall Study|Withdrawal by Subject|2|||
145417874|NCT04263532|524386626|FG001|Overall Study|Withdrawal by Subject|0|||
145417875|NCT02181738|524386636|FG000|Overall Study|Participant Withdrew Consent|2|||
145417876|NCT02181738|524386637|FG001|Overall Study|Participant Withdrew Consent|1|||
145417877|NCT02181738|524386638|FG002|Overall Study|Participant Withdrew Consent|1|||
145417878|NCT02181738|524386639|FG003|Overall Study|Participant Withdrew Consent|1|||
145417879|NCT02181738|524386636|FG000|Overall Study|Lost to Follow-up|1|||
145417880|NCT02181738|524386637|FG001|Overall Study|Lost to Follow-up|2|||
145417881|NCT02181738|524386638|FG002|Overall Study|Lost to Follow-up|1|||
145417882|NCT02181738|524386639|FG003|Overall Study|Lost to Follow-up|1|||
145417883|NCT02181738|524386636|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
145417884|NCT02181738|524386637|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
145417885|NCT02181738|524386638|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
145417886|NCT02181738|524386639|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
145417887|NCT02181738|524386636|FG000|Overall Study|Poor/Non-Compliance|1|||
145417888|NCT02181738|524386637|FG001|Overall Study|Poor/Non-Compliance|0|||
145417889|NCT02181738|524386638|FG002|Overall Study|Poor/Non-Compliance|2|||
145417890|NCT02181738|524386639|FG003|Overall Study|Poor/Non-Compliance|1|||
145417891|NCT02181738|524386636|FG000|Overall Study|Disease Progression|28|||
145417892|NCT02181738|524386637|FG001|Overall Study|Disease Progression|35|||
145417893|NCT02181738|524386638|FG002|Overall Study|Disease Progression|40|||
145417894|NCT02181738|524386639|FG003|Overall Study|Disease Progression|0|||
145417895|NCT02181738|524386636|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
145417896|NCT02181738|524386637|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
145417897|NCT02181738|524386638|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
145417898|NCT02181738|524386639|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
145417899|NCT02181738|524386636|FG000|Overall Study|Study Drug Toxicity|6|||
145417900|NCT02181738|524386637|FG001|Overall Study|Study Drug Toxicity|11|||
145417901|NCT02181738|524386638|FG002|Overall Study|Study Drug Toxicity|8|||
145417902|NCT02181738|524386639|FG003|Overall Study|Study Drug Toxicity|1|||
145417903|NCT02181738|524386636|FG000|Overall Study|Other Reasons|14|||
145417904|NCT02181738|524386637|FG001|Overall Study|Other Reasons|16|||
145417905|NCT02181738|524386638|FG002|Overall Study|Other Reasons|28|||
145417906|NCT02181738|524386639|FG003|Overall Study|Other Reasons|0|||
145417907|NCT02181738|524386636|FG000|Overall Study|Maximum Clinical Benefit|3|||
145417908|NCT02181738|524386637|FG001|Overall Study|Maximum Clinical Benefit|0|||
145417909|NCT02181738|524386638|FG002|Overall Study|Maximum Clinical Benefit|1|||
145417910|NCT02181738|524386639|FG003|Overall Study|Maximum Clinical Benefit|0|||
145417911|NCT02181738|524386636|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145417912|NCT02181738|524386637|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
145417913|NCT02181738|524386638|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
145417914|NCT02181738|524386639|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145417915|NCT04477486|524386640|FG000|Overall Study|Death|2|||
145417916|NCT04477486|524386640|FG000|Overall Study|Ongoing at Time of Analysis|11|||
145417917|NCT01851369|524386641|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417918|NCT01851369|524386642|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417919|NCT01851369|524386643|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417920|NCT01851369|524386644|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417921|NCT01851369|524386645|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417922|NCT01851369|524386646|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
145417923|NCT01851369|524386647|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417924|NCT01851369|524386648|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417925|NCT01851369|524386649|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145577403|NCT01310413|524969408|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
145577404|NCT01310413|524969409|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
145577405|NCT01310413|524969410|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
145356584|NCT03003962|524155354|FG000|Overall Study|Participants ongoing at DCO|55|||
145356585|NCT03003962|524155355|FG001|Overall Study|Participants ongoing at DCO|40|||
145356586|NCT03871543|524155356|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
145356587|NCT03871543|524155356|FG000|Period 1|Investigator Error|1|||
145356588|NCT03871543|524155356|FG000|Period 1|Protocol Violation|2|||
145356589|NCT03871543|524155356|FG000|Period 1|COVID-19 Related|1|||
145356590|NCT03871543|524155356|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
145356591|NCT03871543|524155356|FG000|Period 1|Withdrawal by Subject|10|||
145356592|NCT03871543|524155356|FG000|Period 2|Adverse Event|1|||
145356593|NCT03871543|524155356|FG000|Period 2|Withdrawal by Subject|1|||
145356594|NCT03802825|524155359|FG000|Overall Study|Lost to follow-up for intervention|12|||
145356595|NCT03802825|524155360|FG001|Overall Study|Lost to follow-up for intervention|3|||
145356596|NCT03802825|524155359|FG000|Overall Study|Received only 1 component of intervention|0|||
145356597|NCT03802825|524155360|FG001|Overall Study|Received only 1 component of intervention|13|||
145356598|NCT01051960|524155365|FG000|Overall Study|Adverse Event|1|||
145356599|NCT00360282|524155366|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
145356600|NCT00360282|524155367|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
145356601|NCT00360282|524155368|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
145356602|NCT00360282|524155369|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
145356603|NCT00360282|524155366|FG000|Second Intervention|Adverse Event|0|||
145356604|NCT00360282|524155367|FG001|Second Intervention|Adverse Event|1|||
145356605|NCT00360282|524155368|FG002|Second Intervention|Adverse Event|0|||
145356606|NCT00360282|524155369|FG003|Second Intervention|Adverse Event|0|||
145356607|NCT04537078|524155372|FG000|Overall Study|Protocol Violation|3|||
145356608|NCT04537078|524155373|FG001|Overall Study|Protocol Violation|2|||
145356609|NCT04537078|524155372|FG000|Overall Study|Lost to Follow-up|1|||
145356610|NCT04537078|524155373|FG001|Overall Study|Lost to Follow-up|0|||
145356611|NCT04537078|524155372|FG000|Overall Study|Withdrawal by Subject|0|||
145356612|NCT04537078|524155373|FG001|Overall Study|Withdrawal by Subject|1|||
145356613|NCT01293695|524155377|FG000|Overall Study|Withdrawal by Subject|7|||
145356614|NCT01293695|524155378|FG001|Overall Study|Withdrawal by Subject|1|||
145356615|NCT01293695|524155377|FG000|Overall Study|Lost to Follow-up|8|||
145356616|NCT01293695|524155378|FG001|Overall Study|Lost to Follow-up|6|||
145356617|NCT02626026|524155379|FG000|Overall Study|Randomized but Never Treated|0|||
145356618|NCT02626026|524155380|FG001|Overall Study|Randomized but Never Treated|0|||
145356619|NCT02626026|524155381|FG002|Overall Study|Randomized but Never Treated|0|||
145356620|NCT02626026|524155382|FG003|Overall Study|Randomized but Never Treated|0|||
145356621|NCT02626026|524155383|FG004|Overall Study|Randomized but Never Treated|1|||
145356622|NCT02626026|524155384|FG005|Overall Study|Randomized but Never Treated|0|||
145356623|NCT03922308|524155385|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
145356624|NCT03922308|524155386|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
145356625|NCT03922308|524155387|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
145356626|NCT03922308|524155385|FG000|Overall Study|Lost to Follow-up|1|||
145356627|NCT03922308|524155386|FG001|Overall Study|Lost to Follow-up|0|||
145356628|NCT03922308|524155387|FG002|Overall Study|Lost to Follow-up|0|||
145356629|NCT03922308|524155385|FG000|Overall Study|Reason not Specified|0|||
145356630|NCT03922308|524155386|FG001|Overall Study|Reason not Specified|2|||
145356631|NCT03922308|524155387|FG002|Overall Study|Reason not Specified|1|||
145356632|NCT01704495|524155388|FG000|Subjects Randomized|Other Reason|3|||
145356633|NCT01704495|524155389|FG001|Subjects Randomized|Other Reason|2|||
145356634|NCT01704495|524155390|FG002|Subjects Randomized|Other Reason|3|||
145356635|NCT01704495|524155391|FG003|Subjects Randomized|Other Reason|2|||
145356636|NCT01704495|524155388|FG000|Subjects Randomized|Discontinuation criteria met|4|||
145356637|NCT01704495|524155389|FG001|Subjects Randomized|Discontinuation criteria met|2|||
145356638|NCT01704495|524155390|FG002|Subjects Randomized|Discontinuation criteria met|2|||
145356639|NCT01704495|524155391|FG003|Subjects Randomized|Discontinuation criteria met|0|||
145356640|NCT01704495|524155388|FG000|Subjects Randomized|Adverse Event|8|||
145356641|NCT01704495|524155389|FG001|Subjects Randomized|Adverse Event|2|||
145356642|NCT01704495|524155390|FG002|Subjects Randomized|Adverse Event|0|||
145356643|NCT01704495|524155391|FG003|Subjects Randomized|Adverse Event|7|||
145356644|NCT01704495|524155388|FG000|Subjects Randomized|Withdrawal by Subject|5|||
145356645|NCT01704495|524155389|FG001|Subjects Randomized|Withdrawal by Subject|5|||
145356646|NCT01704495|524155390|FG002|Subjects Randomized|Withdrawal by Subject|5|||
145356647|NCT01704495|524155391|FG003|Subjects Randomized|Withdrawal by Subject|5|||
145356648|NCT01704495|524155388|FG000|Subjects Randomized|Protocol Violation|1|||
145356649|NCT01704495|524155389|FG001|Subjects Randomized|Protocol Violation|1|||
145356650|NCT01704495|524155390|FG002|Subjects Randomized|Protocol Violation|2|||
145356651|NCT01704495|524155391|FG003|Subjects Randomized|Protocol Violation|0|||
145356652|NCT01704495|524155388|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
145356653|NCT01704495|524155389|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
145356654|NCT01704495|524155390|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
145356655|NCT01704495|524155391|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
145417926|NCT01851369|524386650|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417927|NCT01851369|524386651|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145356656|NCT01704495|524155388|FG000|Optional Safety Extension|Adverse Event|0|||
145356657|NCT01704495|524155389|FG001|Optional Safety Extension|Adverse Event|4|||
145356658|NCT01704495|524155390|FG002|Optional Safety Extension|Adverse Event|0|||
145356659|NCT01704495|524155391|FG003|Optional Safety Extension|Adverse Event|1|||
145356660|NCT01704495|524155388|FG000|Optional Safety Extension|Other reason|27|||
145356661|NCT01704495|524155389|FG001|Optional Safety Extension|Other reason|29|||
145356662|NCT01704495|524155390|FG002|Optional Safety Extension|Other reason|30|||
145356663|NCT01704495|524155391|FG003|Optional Safety Extension|Other reason|28|||
145356664|NCT01704495|524155388|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
145356665|NCT01704495|524155389|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
145356666|NCT01704495|524155390|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
145356667|NCT01704495|524155391|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
145356668|NCT01256450|524155392|FG000|Open-label Titration|Adverse Event|39|||
145356669|NCT01256450|524155393|FG001|Open-label Titration|Adverse Event|0|||
145356670|NCT01256450|524155394|FG002|Open-label Titration|Adverse Event|0|||
145356671|NCT01256450|524155392|FG000|Open-label Titration|Lost to Follow-up|7|||
145356672|NCT01256450|524155393|FG001|Open-label Titration|Lost to Follow-up|0|||
145356673|NCT01256450|524155394|FG002|Open-label Titration|Lost to Follow-up|0|||
145356674|NCT01256450|524155392|FG000|Open-label Titration|Lack of analgesic effect|30|||
145356675|NCT01256450|524155393|FG001|Open-label Titration|Lack of analgesic effect|0|||
145356676|NCT01256450|524155394|FG002|Open-label Titration|Lack of analgesic effect|0|||
145356677|NCT01256450|524155392|FG000|Open-label Titration|Non-compliance|9|||
145356678|NCT01256450|524155393|FG001|Open-label Titration|Non-compliance|0|||
145356679|NCT01256450|524155394|FG002|Open-label Titration|Non-compliance|0|||
145356680|NCT01256450|524155392|FG000|Open-label Titration|Screen failure|1|||
145356681|NCT01256450|524155393|FG001|Open-label Titration|Screen failure|0|||
145356682|NCT01256450|524155394|FG002|Open-label Titration|Screen failure|0|||
145356683|NCT01256450|524155392|FG000|Open-label Titration|Other|13|||
145356684|NCT01256450|524155393|FG001|Open-label Titration|Other|0|||
145356685|NCT01256450|524155394|FG002|Open-label Titration|Other|0|||
145356686|NCT01256450|524155392|FG000|Double-blind Treatment|Adverse Event|0|||
145356687|NCT01256450|524155393|FG001|Double-blind Treatment|Adverse Event|8|||
145356688|NCT01256450|524155394|FG002|Double-blind Treatment|Adverse Event|6|||
145356689|NCT01256450|524155392|FG000|Double-blind Treatment|Lost to Follow-up|0|||
145356690|NCT01256450|524155393|FG001|Double-blind Treatment|Lost to Follow-up|1|||
145356691|NCT01256450|524155394|FG002|Double-blind Treatment|Lost to Follow-up|7|||
145356692|NCT01256450|524155392|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
145356693|NCT01256450|524155393|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
145356694|NCT01256450|524155394|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
145356695|NCT01256450|524155392|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
145356696|NCT01256450|524155393|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
145356697|NCT01256450|524155394|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
145356698|NCT01256450|524155392|FG000|Double-blind Treatment|Non-compliance|0|||
145356699|NCT01256450|524155393|FG001|Double-blind Treatment|Non-compliance|5|||
145356700|NCT01256450|524155394|FG002|Double-blind Treatment|Non-compliance|4|||
145356701|NCT01256450|524155392|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
145356702|NCT01256450|524155393|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
145356703|NCT01256450|524155394|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
145356704|NCT01256450|524155392|FG000|Double-blind Treatment|Other|0|||
145356705|NCT01256450|524155393|FG001|Double-blind Treatment|Other|9|||
145356706|NCT01256450|524155394|FG002|Double-blind Treatment|Other|12|||
145417928|NCT01851369|524386652|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145417929|NCT01851369|524386653|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
145356707|NCT02375971|524155395|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
145356708|NCT02375971|524155396|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
145356709|NCT02375971|524155397|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
145356710|NCT02375971|524155395|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145356711|NCT02375971|524155396|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145356712|NCT02375971|524155397|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
145356713|NCT02375971|524155395|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
145356714|NCT02375971|524155396|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
145356715|NCT02375971|524155397|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
145356716|NCT02375971|524155395|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
145356717|NCT02375971|524155396|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
145356718|NCT02375971|524155397|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
145356719|NCT02375971|524155395|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
145356720|NCT02375971|524155396|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
145356721|NCT02375971|524155397|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
145356722|NCT02375971|524155395|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
145356723|NCT02375971|524155396|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
145356724|NCT02375971|524155397|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
145356725|NCT02375971|524155395|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
145623029|NCT02179918|525131571|FG004|Overall Study|Progressive Disease|6|||
145623030|NCT02179918|525131567|FG000|Overall Study|Other|0|||
145623031|NCT02179918|525131568|FG001|Overall Study|Other|1|||
145623032|NCT02179918|525131569|FG002|Overall Study|Other|0|||
145623033|NCT02179918|525131570|FG003|Overall Study|Other|0|||
145356726|NCT02375971|524155396|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
145356727|NCT02375971|524155397|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
145356728|NCT02375971|524155395|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
145356729|NCT02375971|524155396|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
145356730|NCT02375971|524155397|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
145356731|NCT01139775|524155400|FG000|Overall Study|Adverse Event|0|||
145356732|NCT01139775|524155401|FG001|Overall Study|Adverse Event|6|||
145356733|NCT01139775|524155402|FG002|Overall Study|Adverse Event|2|||
145356734|NCT01139775|524155400|FG000|Overall Study|Protocol Violation|0|||
145356735|NCT01139775|524155401|FG001|Overall Study|Protocol Violation|5|||
145356736|NCT01139775|524155402|FG002|Overall Study|Protocol Violation|0|||
145356737|NCT01139775|524155400|FG000|Overall Study|Withdrawal by Subject|1|||
145356738|NCT01139775|524155401|FG001|Overall Study|Withdrawal by Subject|0|||
145356739|NCT01139775|524155402|FG002|Overall Study|Withdrawal by Subject|2|||
145356740|NCT01139775|524155400|FG000|Overall Study|Physician Decision|0|||
145356741|NCT01139775|524155401|FG001|Overall Study|Physician Decision|2|||
145356742|NCT01139775|524155402|FG002|Overall Study|Physician Decision|2|||
145356743|NCT01787292|524155403|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
145356744|NCT01787292|524155404|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
145356745|NCT01787292|524155403|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
145356746|NCT01787292|524155404|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
145356747|NCT01924689|524155405|FG000|Overall Study|Death|0|||
145356748|NCT01924689|524155406|FG001|Overall Study|Death|1|||
145356749|NCT01924689|524155407|FG002|Overall Study|Death|0|||
145356750|NCT01924689|524155408|FG003|Overall Study|Death|1|||
145356751|NCT01924689|524155409|FG004|Overall Study|Death|0|||
145356752|NCT01924689|524155410|FG005|Overall Study|Death|0|||
145356753|NCT01924689|524155405|FG000|Overall Study|Disease progression|0|||
145356754|NCT01924689|524155406|FG001|Overall Study|Disease progression|0|||
145356755|NCT01924689|524155407|FG002|Overall Study|Disease progression|2|||
145356756|NCT01924689|524155408|FG003|Overall Study|Disease progression|0|||
145356757|NCT01924689|524155409|FG004|Overall Study|Disease progression|3|||
145356758|NCT01924689|524155410|FG005|Overall Study|Disease progression|2|||
145356759|NCT01924689|524155405|FG000|Overall Study|New therapy or study|3|||
145356760|NCT01924689|524155406|FG001|Overall Study|New therapy or study|2|||
145356761|NCT01924689|524155407|FG002|Overall Study|New therapy or study|1|||
145356762|NCT01924689|524155408|FG003|Overall Study|New therapy or study|4|||
145356763|NCT01924689|524155409|FG004|Overall Study|New therapy or study|2|||
145356764|NCT01924689|524155410|FG005|Overall Study|New therapy or study|0|||
145356765|NCT01924689|524155405|FG000|Overall Study|Withdrawal of consent|0|||
145356766|NCT01924689|524155406|FG001|Overall Study|Withdrawal of consent|0|||
145356767|NCT01924689|524155407|FG002|Overall Study|Withdrawal of consent|1|||
145356768|NCT01924689|524155408|FG003|Overall Study|Withdrawal of consent|1|||
145356769|NCT01924689|524155409|FG004|Overall Study|Withdrawal of consent|0|||
145356770|NCT01924689|524155410|FG005|Overall Study|Withdrawal of consent|0|||
145356771|NCT01924689|524155405|FG000|Overall Study|Other|0|||
145356772|NCT01924689|524155406|FG001|Overall Study|Other|0|||
145356773|NCT01924689|524155407|FG002|Overall Study|Other|0|||
145356774|NCT01924689|524155408|FG003|Overall Study|Other|0|||
145356775|NCT01924689|524155409|FG004|Overall Study|Other|1|||
145356776|NCT01924689|524155410|FG005|Overall Study|Other|0|||
145356777|NCT04352101|524155411|FG000|Overall Study|Physician Decision|2|||
145356778|NCT04352101|524155412|FG001|Overall Study|Physician Decision|1|||
145356779|NCT04762160|524155416|FG000|Overall Study|Study terminated early due to business reasons|5|||
145356780|NCT01591096|524155418|FG000|Overall Study|Adverse Event|1|||
145356781|NCT01831635|524155419|FG000|Overall Study|Withdrawal by Subject|0|||
145356782|NCT01831635|524155420|FG001|Overall Study|Withdrawal by Subject|2|||
145356783|NCT01831635|524155421|FG002|Overall Study|Withdrawal by Subject|0|||
145356784|NCT02859337|524155422|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
145356785|NCT02859337|524155423|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
145623034|NCT02179918|525131571|FG004|Overall Study|Other|1|||
145356786|NCT02859337|524155424|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
145356787|NCT02859337|524155422|FG000|Overall Study|Withdrawal by Subject|3|||
145356788|NCT02859337|524155423|FG001|Overall Study|Withdrawal by Subject|1|||
145356789|NCT02859337|524155424|FG002|Overall Study|Withdrawal by Subject|0|||
145356790|NCT02859337|524155422|FG000|Overall Study|Lost to Follow-up|1|||
145356791|NCT02859337|524155423|FG001|Overall Study|Lost to Follow-up|0|||
145356792|NCT02859337|524155424|FG002|Overall Study|Lost to Follow-up|0|||
145356793|NCT04146012|524155427|FG000|Overall Study|Study Terminated|30|||
145356794|NCT04146012|524155428|FG001|Overall Study|Study Terminated|15|||
145356795|NCT01546025|524155429|FG000|Overall Study|Lost to Follow-up|0|||
145356796|NCT01546025|524155430|FG001|Overall Study|Lost to Follow-up|1|||
145356797|NCT02729025|524155431|FG000|Overall Study|Sponsor Decision|0|||
145356798|NCT02729025|524155432|FG001|Overall Study|Sponsor Decision|1|||
145356799|NCT02141438|524156808|FG000|Overall Study|Death|1308|||
145356800|NCT02141438|524156808|FG000|Overall Study|Lost to Follow-up|84|||
145356801|NCT02141438|524156808|FG000|Overall Study|Withdrawal by Subject|52|||
145356802|NCT02141438|524156808|FG000|Overall Study|Physician Decision|1|||
145356803|NCT02141438|524156808|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
145356804|NCT01880554|524156811|FG000|Overall Study|Protocol Violation|14|||
145356805|NCT01880554|524156811|FG000|Overall Study|Simon's design requirements|2|||
145356806|NCT05161481|524156812|FG000|Overall Study|Withdrawal of consent|0|||
145356807|NCT05161481|524156813|FG001|Overall Study|Withdrawal of consent|1|||
145356808|NCT05161481|524156814|FG002|Overall Study|Withdrawal of consent|1|||
145356809|NCT05161481|524156812|FG000|Overall Study|Study terminated by sponsor|3|||
145356810|NCT05161481|524156813|FG001|Overall Study|Study terminated by sponsor|3|||
145356811|NCT05161481|524156814|FG002|Overall Study|Study terminated by sponsor|2|||
145356812|NCT05161481|524156812|FG000|Overall Study|Adverse Event|3|||
145356813|NCT05161481|524156813|FG001|Overall Study|Adverse Event|0|||
145356814|NCT05161481|524156814|FG002|Overall Study|Adverse Event|6|||
145356815|NCT05161481|524156812|FG000|Overall Study|Randomised in error and was not treated|1|||
145356816|NCT05161481|524156813|FG001|Overall Study|Randomised in error and was not treated|0|||
145356817|NCT05161481|524156814|FG002|Overall Study|Randomised in error and was not treated|0|||
145356818|NCT05161481|524156812|FG000|Overall Study|Subject decision|0|||
145356819|NCT05161481|524156813|FG001|Overall Study|Subject decision|0|||
145356820|NCT05161481|524156814|FG002|Overall Study|Subject decision|1|||
145356821|NCT04846569|524156815|FG000|Overall Study|Withdrawal by Subject|3|||
145356822|NCT04846569|524156816|FG001|Overall Study|Withdrawal by Subject|1|||
145356823|NCT00444535|524156817|FG000|Overall Study|Withdrawal by Subject|5|||
145356824|NCT00444535|524156817|FG000|Overall Study|Physician Decision|5|||
145356825|NCT00444535|524156817|FG000|Overall Study|progressive disease|1|||
145356826|NCT00444535|524156817|FG000|Overall Study|Adverse Event|2|||
145356827|NCT03866512|524156818|FG000|Overall Study|Lost to Follow-up|1|||
145356828|NCT03866512|524156819|FG001|Overall Study|Lost to Follow-up|2|||
145356829|NCT03866512|524156820|FG002|Overall Study|Lost to Follow-up|1|||
145356830|NCT03866512|524156818|FG000|Overall Study|Cannulation issues|0|||
145356831|NCT03866512|524156819|FG001|Overall Study|Cannulation issues|1|||
145356832|NCT03866512|524156820|FG002|Overall Study|Cannulation issues|2|||
145356833|NCT00832455|524156825|FG000|Overall Study|Adverse Event|13|||
145356834|NCT00832455|524156825|FG000|Overall Study|Lost to Follow-up|26|||
145356835|NCT00832455|524156825|FG000|Overall Study|Protocol Violation|4|||
145356836|NCT00832455|524156825|FG000|Overall Study|Withdrawal by Subject|17|||
145356837|NCT00832455|524156825|FG000|Overall Study|Screening Failure|2|||
145356838|NCT00832455|524156825|FG000|Overall Study|Stopped Medication|4|||
145356839|NCT00832455|524156825|FG000|Overall Study|Parent misunderstood study|1|||
145356840|NCT00832455|524156825|FG000|Overall Study|Parent dissatisfied|1|||
145356841|NCT00832455|524156825|FG000|Overall Study|No improvement|3|||
145356842|NCT00832455|524156825|FG000|Overall Study|Patient moved|1|||
145356843|NCT03376789|524156829|FG000|Overall Study|Withdrawal by Subject|3|||
145356844|NCT03376789|524156830|FG001|Overall Study|Withdrawal by Subject|5|||
145356845|NCT03376789|524156829|FG000|Overall Study|Protocol Violation|0|||
145356846|NCT03376789|524156830|FG001|Overall Study|Protocol Violation|1|||
145356847|NCT03376789|524156829|FG000|Overall Study|Adverse Event|0|||
145356848|NCT03376789|524156830|FG001|Overall Study|Adverse Event|1|||
145356849|NCT03376789|524156829|FG000|Overall Study|Lost to Follow-up|1|||
145356850|NCT03376789|524156830|FG001|Overall Study|Lost to Follow-up|1|||
145356851|NCT03376789|524156829|FG000|Overall Study|Per sponsor due to noncompliance|1|||
145356852|NCT03376789|524156830|FG001|Overall Study|Per sponsor due to noncompliance|0|||
145356853|NCT03376789|524156829|FG000|Overall Study|Subject off study medication|0|||
145356854|NCT03376789|524156830|FG001|Overall Study|Subject off study medication|1|||
145356855|NCT03876743|524156838|FG000|Overall Study|Lost to Follow-up|6|||
145356856|NCT03876743|524156839|FG001|Overall Study|Lost to Follow-up|4|||
145356857|NCT03876743|524156840|FG002|Overall Study|Lost to Follow-up|4|||
145356858|NCT03876743|524156841|FG003|Overall Study|Lost to Follow-up|7|||
145356859|NCT03889418|524156842|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
145356860|NCT03889418|524156843|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145417930|NCT00395512|524386655|FG000|Overall Study|Adverse Event|3|||
145417931|NCT00395512|524386656|FG001|Overall Study|Adverse Event|8|||
145417932|NCT00395512|524386657|FG002|Overall Study|Adverse Event|6|||
145417933|NCT00395512|524386658|FG003|Overall Study|Adverse Event|6|||
145417934|NCT00395512|524386655|FG000|Overall Study|Protocol Violation|2|||
145417935|NCT00395512|524386656|FG001|Overall Study|Protocol Violation|3|||
145356861|NCT03889418|524156844|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356862|NCT03889418|524156845|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356863|NCT03889418|524156846|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356864|NCT03889418|524156847|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356865|NCT03889418|524156848|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356866|NCT03889418|524156849|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356867|NCT03889418|524156850|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145417936|NCT00395512|524386657|FG002|Overall Study|Protocol Violation|6|||
145417937|NCT00395512|524386658|FG003|Overall Study|Protocol Violation|7|||
145417938|NCT00395512|524386655|FG000|Overall Study|Lost to Follow-up|2|||
145417939|NCT00395512|524386656|FG001|Overall Study|Lost to Follow-up|6|||
145417940|NCT00395512|524386657|FG002|Overall Study|Lost to Follow-up|5|||
145417941|NCT00395512|524386658|FG003|Overall Study|Lost to Follow-up|5|||
145417942|NCT00395512|524386655|FG000|Overall Study|Withdrawal by Subject|6|||
145417943|NCT00395512|524386656|FG001|Overall Study|Withdrawal by Subject|5|||
145417944|NCT00395512|524386657|FG002|Overall Study|Withdrawal by Subject|5|||
145417945|NCT00395512|524386658|FG003|Overall Study|Withdrawal by Subject|12|||
145417946|NCT00395512|524386655|FG000|Overall Study|Physician Decision|6|||
145417947|NCT00395512|524386656|FG001|Overall Study|Physician Decision|4|||
145417948|NCT00395512|524386657|FG002|Overall Study|Physician Decision|2|||
145417949|NCT00395512|524386658|FG003|Overall Study|Physician Decision|2|||
145417950|NCT00395512|524386655|FG000|Overall Study|Other|1|||
145417951|NCT00395512|524386656|FG001|Overall Study|Other|1|||
145417952|NCT00395512|524386657|FG002|Overall Study|Other|0|||
145417953|NCT00395512|524386658|FG003|Overall Study|Other|0|||
145417954|NCT00395512|524386655|FG000|Overall Study|Hyperglycemic Rescue|18|||
145417955|NCT00395512|524386656|FG001|Overall Study|Hyperglycemic Rescue|10|||
145417956|NCT00395512|524386657|FG002|Overall Study|Hyperglycemic Rescue|4|||
145417957|NCT00395512|524386658|FG003|Overall Study|Hyperglycemic Rescue|6|||
145417958|NCT01478087|524386659|FG000|Overall Study|due to sponsor closing study|1|||
145417959|NCT01210443|524386665|FG000|Overall Study|Study terminated by sponsor|2|||
145417960|NCT02807181|524386668|FG000|Overall Study|Death|28|||
145417961|NCT02807181|524386669|FG001|Overall Study|Death|24|||
145417962|NCT02807181|524386668|FG000|Overall Study|Withdrawal by Subject|1|||
145417963|NCT02807181|524386669|FG001|Overall Study|Withdrawal by Subject|1|||
145417964|NCT02807181|524386668|FG000|Overall Study|Lost to Follow-up|0|||
145417965|NCT02807181|524386669|FG001|Overall Study|Lost to Follow-up|2|||
145417966|NCT02807181|524386668|FG000|Overall Study|Subject decision|1|||
145417967|NCT02807181|524386669|FG001|Overall Study|Subject decision|0|||
145417968|NCT02807181|524386668|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
145417969|NCT02807181|524386669|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
145417970|NCT02807181|524386668|FG000|Overall Study|In Study|3|||
145417971|NCT02807181|524386669|FG001|Overall Study|In Study|3|||
145417972|NCT02807181|524386668|FG000|Overall Study|Post Progression|3|||
145417973|NCT02807181|524386669|FG001|Overall Study|Post Progression|2|||
145417974|NCT00063999|524386670|FG000|Overall Study|Withdrawal by Subject|1|||
145417975|NCT00063999|524386671|FG001|Overall Study|Withdrawal by Subject|0|||
145417976|NCT00063999|524386670|FG000|Overall Study|Ineligible|44|||
145417977|NCT00063999|524386671|FG001|Overall Study|Ineligible|24|||
145417978|NCT02280499|524386673|FG000|Overall Study|Death|14|||
145356868|NCT03889418|524156851|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
145356869|NCT03889418|524156842|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356870|NCT03889418|524156843|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
145356871|NCT03889418|524156844|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
145356872|NCT03889418|524156845|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356873|NCT03889418|524156846|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356874|NCT03889418|524156847|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356875|NCT03889418|524156848|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356876|NCT03889418|524156849|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356877|NCT03889418|524156850|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356878|NCT03889418|524156851|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
145356879|NCT03889418|524156842|FG000|October-December 2019 (Month 7-9)|Death|0|||
145356880|NCT03889418|524156843|FG001|October-December 2019 (Month 7-9)|Death|0|||
145356881|NCT03889418|524156844|FG002|October-December 2019 (Month 7-9)|Death|0|||
145356882|NCT03889418|524156845|FG003|October-December 2019 (Month 7-9)|Death|0|||
145356883|NCT03889418|524156846|FG004|October-December 2019 (Month 7-9)|Death|0|||
145356884|NCT03889418|524156847|FG005|October-December 2019 (Month 7-9)|Death|0|||
145356885|NCT03889418|524156848|FG006|October-December 2019 (Month 7-9)|Death|0|||
145356886|NCT03889418|524156849|FG007|October-December 2019 (Month 7-9)|Death|0|||
145356887|NCT03889418|524156850|FG008|October-December 2019 (Month 7-9)|Death|1|||
145356888|NCT03889418|524156851|FG009|October-December 2019 (Month 7-9)|Death|0|||
145417979|NCT02280499|524386673|FG000|Overall Study|Lost to Follow-up|42|||
145417980|NCT02280499|524386673|FG000|Overall Study|Adverse Event|5|||
145417981|NCT03511066|524386683|FG000|Overall Study|Withdrawal by Subject|1|||
145417982|NCT03511066|524386684|FG001|Overall Study|Withdrawal by Subject|2|||
145417983|NCT03511066|524386685|FG002|Overall Study|Withdrawal by Subject|3|||
145356889|NCT03889418|524156842|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145417984|NCT03511066|524386683|FG000|Overall Study|Lost to Follow-up|2|||
145417985|NCT03511066|524386684|FG001|Overall Study|Lost to Follow-up|3|||
145417986|NCT03511066|524386685|FG002|Overall Study|Lost to Follow-up|0|||
145577406|NCT01310413|524969411|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
145356890|NCT03889418|524156843|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145417987|NCT04560309|524386687|FG000|Overall Study|Meet drop out criteria|1|||
145417988|NCT04560309|524386688|FG001|Overall Study|Meet drop out criteria|1|||
145356891|NCT03889418|524156844|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356892|NCT03889418|524156845|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
145356893|NCT03889418|524156846|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356894|NCT03889418|524156847|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356895|NCT03889418|524156848|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356896|NCT03889418|524156849|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
145356897|NCT03889418|524156850|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356898|NCT03889418|524156851|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
145356899|NCT03889418|524156842|FG000|April - June 2020 (Month 13-15)|Death|0|||
145356900|NCT03889418|524156843|FG001|April - June 2020 (Month 13-15)|Death|1|||
145356901|NCT03889418|524156844|FG002|April - June 2020 (Month 13-15)|Death|0|||
145356902|NCT03889418|524156845|FG003|April - June 2020 (Month 13-15)|Death|0|||
145356903|NCT03889418|524156846|FG004|April - June 2020 (Month 13-15)|Death|0|||
145356904|NCT03889418|524156847|FG005|April - June 2020 (Month 13-15)|Death|0|||
145356905|NCT03889418|524156848|FG006|April - June 2020 (Month 13-15)|Death|0|||
145356906|NCT03889418|524156849|FG007|April - June 2020 (Month 13-15)|Death|0|||
145356907|NCT03889418|524156850|FG008|April - June 2020 (Month 13-15)|Death|0|||
145356908|NCT03889418|524156851|FG009|April - June 2020 (Month 13-15)|Death|0|||
145356909|NCT03889418|524156842|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356910|NCT03889418|524156843|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356911|NCT03889418|524156844|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356912|NCT03889418|524156845|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
145356913|NCT03889418|524156846|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356914|NCT03889418|524156847|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356915|NCT03889418|524156848|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356916|NCT03889418|524156849|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356917|NCT03889418|524156850|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356918|NCT03889418|524156851|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
145356919|NCT03889418|524156842|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
145356920|NCT03889418|524156843|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356921|NCT03889418|524156844|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
145356922|NCT03889418|524156845|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
145356923|NCT03889418|524156846|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356924|NCT03889418|524156847|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356925|NCT03889418|524156848|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356926|NCT03889418|524156849|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
145356927|NCT03889418|524156850|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356928|NCT03889418|524156851|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
145356929|NCT03889418|524156842|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145356930|NCT03889418|524156843|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
145356931|NCT03889418|524156844|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
145356932|NCT03889418|524156845|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
145356933|NCT03889418|524156846|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145356934|NCT03889418|524156847|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145356935|NCT03889418|524156848|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145356936|NCT03889418|524156849|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
145356937|NCT03889418|524156850|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
145356938|NCT03889418|524156851|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
145356939|NCT00092118|524156853|FG000|Overall Study|Adverse Event|35|||
145356940|NCT00092118|524156854|FG001|Overall Study|Adverse Event|32|||
145356941|NCT00092118|524156853|FG000|Overall Study|Lack of Efficacy|12|||
145356942|NCT00092118|524156854|FG001|Overall Study|Lack of Efficacy|14|||
145356943|NCT00092118|524156853|FG000|Overall Study|Lost to Follow-up|4|||
145356944|NCT00092118|524156854|FG001|Overall Study|Lost to Follow-up|3|||
145356945|NCT00092118|524156853|FG000|Overall Study|Protocol Violation|23|||
145356946|NCT00092118|524156854|FG001|Overall Study|Protocol Violation|25|||
145356947|NCT00092118|524156853|FG000|Overall Study|Withdrawal by Subject|4|||
145356948|NCT00092118|524156854|FG001|Overall Study|Withdrawal by Subject|10|||
145356949|NCT00092118|524156853|FG000|Overall Study|Other|6|||
145356950|NCT00092118|524156854|FG001|Overall Study|Other|5|||
145356951|NCT02946463|524156855|FG000|Primary Evaluation Period|Physician Decision|0|||
145356952|NCT02946463|524156856|FG001|Primary Evaluation Period|Physician Decision|1|||
145356953|NCT02946463|524156857|FG002|Primary Evaluation Period|Physician Decision|0|||
145356954|NCT02946463|524156858|FG003|Primary Evaluation Period|Physician Decision|0|||
145356955|NCT02946463|524156855|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
145356956|NCT02946463|524156856|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
145356957|NCT02946463|524156857|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
145356958|NCT02946463|524156858|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
145356959|NCT02946463|524156855|FG000|Extension Period|Death|4|||
145356960|NCT02946463|524156856|FG001|Extension Period|Death|4|||
145356961|NCT02946463|524156857|FG002|Extension Period|Death|0|||
145417989|NCT05085405|524386689|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145417990|NCT05085405|524386690|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145356962|NCT02946463|524156858|FG003|Extension Period|Death|0|||
145356963|NCT02946463|524156855|FG000|Extension Period|Withdrawal by Subject|4|||
145356964|NCT02946463|524156856|FG001|Extension Period|Withdrawal by Subject|3|||
145356965|NCT02946463|524156857|FG002|Extension Period|Withdrawal by Subject|0|||
145356966|NCT02946463|524156858|FG003|Extension Period|Withdrawal by Subject|0|||
145356967|NCT02946463|524156855|FG000|Extension Period|Other than specified|2|||
145356968|NCT02946463|524156856|FG001|Extension Period|Other than specified|3|||
145356969|NCT02946463|524156857|FG002|Extension Period|Other than specified|2|||
145356970|NCT02946463|524156858|FG003|Extension Period|Other than specified|0|||
145356971|NCT02946463|524156855|FG000|Extension Period|Physician Decision|1|||
145356972|NCT02946463|524156856|FG001|Extension Period|Physician Decision|4|||
145356973|NCT02946463|524156857|FG002|Extension Period|Physician Decision|0|||
145356974|NCT02946463|524156858|FG003|Extension Period|Physician Decision|0|||
145356975|NCT02946463|524156855|FG000|Extension Period|Pregnancy|3|||
145356976|NCT02946463|524156856|FG001|Extension Period|Pregnancy|1|||
145356977|NCT02946463|524156857|FG002|Extension Period|Pregnancy|0|||
145356978|NCT02946463|524156858|FG003|Extension Period|Pregnancy|0|||
145356979|NCT02946463|524156855|FG000|Extension Period|Adverse Event|1|||
145356980|NCT02946463|524156856|FG001|Extension Period|Adverse Event|2|||
145356981|NCT02946463|524156857|FG002|Extension Period|Adverse Event|0|||
145356982|NCT02946463|524156858|FG003|Extension Period|Adverse Event|0|||
145356983|NCT02946463|524156855|FG000|Extension Period|Lost to Follow-up|1|||
145356984|NCT02946463|524156856|FG001|Extension Period|Lost to Follow-up|0|||
145356985|NCT02946463|524156857|FG002|Extension Period|Lost to Follow-up|0|||
145356986|NCT02946463|524156858|FG003|Extension Period|Lost to Follow-up|0|||
145356987|NCT05581641|524156862|FG000|Overall Study|Withdrawal by Subject|0|||
145356988|NCT05581641|524156863|FG001|Overall Study|Withdrawal by Subject|1|||
145356989|NCT05581641|524156864|FG002|Overall Study|Withdrawal by Subject|3|||
145356990|NCT05581641|524156865|FG003|Overall Study|Withdrawal by Subject|1|||
145356991|NCT05581641|524156862|FG000|Overall Study|Lost to Follow-up|0|||
145356992|NCT05581641|524156863|FG001|Overall Study|Lost to Follow-up|1|||
145356993|NCT05581641|524156864|FG002|Overall Study|Lost to Follow-up|0|||
145356994|NCT05581641|524156865|FG003|Overall Study|Lost to Follow-up|1|||
145356995|NCT05581641|524156862|FG000|Overall Study|Protocol Violation|1|||
145356996|NCT05581641|524156863|FG001|Overall Study|Protocol Violation|0|||
145356997|NCT05581641|524156864|FG002|Overall Study|Protocol Violation|0|||
145356998|NCT05581641|524156865|FG003|Overall Study|Protocol Violation|0|||
145356999|NCT05581641|524156862|FG000|Overall Study|Other|1|||
145357000|NCT05581641|524156863|FG001|Overall Study|Other|0|||
145357001|NCT05581641|524156864|FG002|Overall Study|Other|2|||
145357002|NCT05581641|524156865|FG003|Overall Study|Other|1|||
145357003|NCT05691712|524156866|FG000|Overall Study|Adverse Event|0|||
145357004|NCT05691712|524156867|FG001|Overall Study|Adverse Event|1|||
145357005|NCT05691712|524156868|FG002|Overall Study|Adverse Event|2|||
145357006|NCT05691712|524156869|FG003|Overall Study|Adverse Event|1|||
145357007|NCT05691712|524156866|FG000|Overall Study|Withdrawal by Subject|2|||
145357008|NCT05691712|524156867|FG001|Overall Study|Withdrawal by Subject|3|||
145357009|NCT05691712|524156868|FG002|Overall Study|Withdrawal by Subject|3|||
145357010|NCT05691712|524156869|FG003|Overall Study|Withdrawal by Subject|1|||
145357011|NCT05691712|524156866|FG000|Overall Study|Death|1|||
145357012|NCT05691712|524156867|FG001|Overall Study|Death|0|||
145417991|NCT05085405|524386691|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
145417992|NCT05085405|524386692|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
145417993|NCT05085405|524386693|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145417994|NCT05085405|524386694|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
145417995|NCT05085405|524386689|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145417996|NCT05085405|524386690|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145417997|NCT05085405|524386691|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145357013|NCT05691712|524156868|FG002|Overall Study|Death|0|||
145357014|NCT05691712|524156869|FG003|Overall Study|Death|0|||
145357015|NCT05691712|524156866|FG000|Overall Study|Pregnancy|0|||
145357016|NCT05691712|524156867|FG001|Overall Study|Pregnancy|1|||
145357017|NCT05691712|524156868|FG002|Overall Study|Pregnancy|0|||
145357018|NCT05691712|524156869|FG003|Overall Study|Pregnancy|0|||
145357019|NCT05691712|524156866|FG000|Overall Study|Assigned Treatment by Mistake|1|||
145357020|NCT05691712|524156867|FG001|Overall Study|Assigned Treatment by Mistake|0|||
145357021|NCT05691712|524156868|FG002|Overall Study|Assigned Treatment by Mistake|0|||
145357022|NCT05691712|524156869|FG003|Overall Study|Assigned Treatment by Mistake|1|||
145357023|NCT00468819|524156870|FG000|Overall Study|Withdrawal by Subject|4|||
145357024|NCT00468819|524156871|FG001|Overall Study|Withdrawal by Subject|0|||
145357025|NCT00468819|524156872|FG002|Overall Study|Withdrawal by Subject|1|||
145357026|NCT00468819|524156870|FG000|Overall Study|Lost to Follow-up|0|||
145357027|NCT00468819|524156871|FG001|Overall Study|Lost to Follow-up|0|||
145357028|NCT00468819|524156872|FG002|Overall Study|Lost to Follow-up|1|||
145357029|NCT00468819|524156870|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
145357030|NCT00468819|524156871|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
145357031|NCT00468819|524156872|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
145357032|NCT02492867|524156873|FG000|Overall Study|Alternate therapy|1|||
145357033|NCT02492867|524156873|FG000|Overall Study|Withdrawal by Subject|2|||
145357034|NCT02492867|524156873|FG000|Overall Study|Disease progression after treatment started|1|||
145357035|NCT02492867|524156873|FG000|Overall Study|Death|1|||
145357036|NCT03296527|524156874|FG000|Overall Study|Adverse Event|15|||
145357037|NCT03296527|524156875|FG001|Overall Study|Adverse Event|33|||
145357038|NCT03296527|524156874|FG000|Overall Study|Protocol Deviation|4|||
145357039|NCT03296527|524156875|FG001|Overall Study|Protocol Deviation|0|||
145357040|NCT03296527|524156874|FG000|Overall Study|Participant withdrew consent|3|||
145357041|NCT03296527|524156875|FG001|Overall Study|Participant withdrew consent|1|||
145357042|NCT03296527|524156874|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
145357043|NCT03296527|524156875|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
145357044|NCT03296527|524156874|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
145357045|NCT03296527|524156875|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
145357046|NCT03296527|524156874|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
145357047|NCT03296527|524156875|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
145357048|NCT03296527|524156874|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
145357049|NCT03296527|524156875|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
145357050|NCT03296527|524156874|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
145357051|NCT03296527|524156875|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
145357052|NCT01565889|524156876|FG000|Part A|Withdrawal by Subject|1|||
145357053|NCT01565889|524156877|FG001|Part A|Withdrawal by Subject|0|||
145357054|NCT01565889|524156878|FG002|Part A|Withdrawal by Subject|0|||
145357055|NCT01565889|524156879|FG003|Part A|Withdrawal by Subject|0|||
145357056|NCT01565889|524156880|FG004|Part A|Withdrawal by Subject|0|||
145357057|NCT01565889|524156881|FG005|Part A|Withdrawal by Subject|0|||
145357058|NCT01565889|524156876|FG000|Part B|Withdrawal by Subject|0|||
145357059|NCT01565889|524156877|FG001|Part B|Withdrawal by Subject|0|||
145357060|NCT01565889|524156878|FG002|Part B|Withdrawal by Subject|0|||
145357061|NCT01565889|524156879|FG003|Part B|Withdrawal by Subject|0|||
145357062|NCT01565889|524156880|FG004|Part B|Withdrawal by Subject|0|||
145357063|NCT01565889|524156881|FG005|Part B|Withdrawal by Subject|1|||
145357064|NCT01565889|524156876|FG000|Part B|Lack of Efficacy|0|||
145357065|NCT01565889|524156877|FG001|Part B|Lack of Efficacy|0|||
145357066|NCT01565889|524156878|FG002|Part B|Lack of Efficacy|0|||
145357067|NCT01565889|524156879|FG003|Part B|Lack of Efficacy|0|||
145357068|NCT01565889|524156880|FG004|Part B|Lack of Efficacy|0|||
145357069|NCT01565889|524156881|FG005|Part B|Lack of Efficacy|2|||
145357070|NCT01565889|524156876|FG000|Part B|Lost to Follow-up|0|||
145357071|NCT01565889|524156877|FG001|Part B|Lost to Follow-up|0|||
145357072|NCT01565889|524156878|FG002|Part B|Lost to Follow-up|0|||
145357073|NCT01565889|524156879|FG003|Part B|Lost to Follow-up|0|||
145357074|NCT01565889|524156880|FG004|Part B|Lost to Follow-up|0|||
145357075|NCT01565889|524156881|FG005|Part B|Lost to Follow-up|1|||
145357076|NCT01326845|524156883|FG000|Overall Study|Administrative Problems|5|||
145357077|NCT01326845|524156884|FG001|Overall Study|Administrative Problems|2|||
145357078|NCT01326845|524156883|FG000|Overall Study|Adverse Event|1|||
145357079|NCT01326845|524156884|FG001|Overall Study|Adverse Event|0|||
145357080|NCT01326845|524156883|FG000|Overall Study|Misisng|1|||
145357081|NCT01326845|524156884|FG001|Overall Study|Misisng|3|||
145357082|NCT02524847|524156885|FG000|Overall Study|Adverse Event|4|||
145357083|NCT02524847|524156885|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
145357084|NCT02524847|524156885|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
145357085|NCT02524847|524156885|FG000|Overall Study|Death|1|||
145357086|NCT02524847|524156885|FG000|Overall Study|Reason not Specified|1|||
145357087|NCT00122382|524156889|FG000|Double-Blind Study|Adverse Event|9|||
145357088|NCT00122382|524156890|FG001|Double-Blind Study|Adverse Event|11|||
145357089|NCT00122382|524156891|FG002|Double-Blind Study|Adverse Event|0|||
145357090|NCT00122382|524156889|FG000|Double-Blind Study|Death|2|||
145357091|NCT00122382|524156890|FG001|Double-Blind Study|Death|2|||
145577407|NCT01310413|524969412|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
145357092|NCT00122382|524156891|FG002|Double-Blind Study|Death|0|||
145357093|NCT00122382|524156889|FG000|Double-Blind Study|Lack of Efficacy|0|||
145357094|NCT00122382|524156890|FG001|Double-Blind Study|Lack of Efficacy|8|||
145577408|NCT01310413|524969413|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
145577409|NCT01310413|524969407|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
145577410|NCT01310413|524969408|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
145577411|NCT01310413|524969409|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
145357095|NCT00122382|524156891|FG002|Double-Blind Study|Lack of Efficacy|0|||
145357096|NCT00122382|524156889|FG000|Double-Blind Study|Lost to Follow-up|2|||
145357097|NCT00122382|524156890|FG001|Double-Blind Study|Lost to Follow-up|1|||
145357098|NCT00122382|524156891|FG002|Double-Blind Study|Lost to Follow-up|0|||
145417998|NCT05085405|524386692|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
145417999|NCT05085405|524386693|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145418000|NCT05085405|524386694|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
145418001|NCT04146909|524386695|FG000|Overall Study|Withdrawal by Subject|3|||
145418002|NCT04146909|524386695|FG000|Overall Study|Did not qualify after consented|1|||
145418003|NCT01663987|524386696|FG000|Overall Study|Adverse Event|7|||
145418004|NCT01663987|524386697|FG001|Overall Study|Adverse Event|2|||
145418005|NCT01663987|524386696|FG000|Overall Study|Lost to Follow-up|1|||
145418006|NCT01663987|524386697|FG001|Overall Study|Lost to Follow-up|1|||
145418007|NCT01663987|524386696|FG000|Overall Study|Withdrawal by Subject|2|||
145418008|NCT01663987|524386697|FG001|Overall Study|Withdrawal by Subject|3|||
145418009|NCT01663987|524386696|FG000|Overall Study|Other reason not defined above|3|||
145418010|NCT01663987|524386697|FG001|Overall Study|Other reason not defined above|0|||
145418011|NCT04193527|524386700|FG000|Overall Study|Other|1|||
145418012|NCT04193527|524386701|FG001|Overall Study|Other|1|||
145418013|NCT04193527|524386702|FG002|Overall Study|Other|0|||
145418014|NCT03808909|524386703|FG000|Overall Study|Lost to Follow-up|3|||
145418015|NCT03808909|524386704|FG001|Overall Study|Lost to Follow-up|0|||
145418016|NCT01827943|524386705|FG000|Overall Study|Protocol Violation|8|||
145418017|NCT01827943|524386705|FG000|Overall Study|Never treated because of an rapid progression|1|||
145418018|NCT00501085|524386707|FG000|Overall Study|Lost to Follow-up|195|||
145418019|NCT00501085|524386707|FG000|Overall Study|Withdrawal by Subject|34|||
145418020|NCT00501085|524386707|FG000|Overall Study|Subject Decision|1|||
145418021|NCT00501085|524386707|FG000|Overall Study|Revision Surgery|7|||
145418022|NCT00501085|524386707|FG000|Overall Study|Explantation Surgery|26|||
145418023|NCT00501085|524386707|FG000|Overall Study|Adverse Event|4|||
145418024|NCT00501085|524386707|FG000|Overall Study|Non-Compliance|24|||
145418025|NCT00501085|524386707|FG000|Overall Study|Study closed by sponsor|109|||
145418026|NCT00501085|524386707|FG000|Overall Study|Other loss to follow-up|32|||
145418027|NCT01487161|524386708|FG000|Overall Study|Adverse Event|1|||
145418028|NCT01487161|524386709|FG001|Overall Study|Adverse Event|0|||
145418029|NCT01487161|524386710|FG002|Overall Study|Adverse Event|0|||
145418030|NCT01487161|524386711|FG003|Overall Study|Adverse Event|0|||
145418031|NCT01487161|524386708|FG000|Overall Study|Withdrawal by Subject|1|||
145418032|NCT01487161|524386709|FG001|Overall Study|Withdrawal by Subject|1|||
145418033|NCT01487161|524386710|FG002|Overall Study|Withdrawal by Subject|1|||
145418034|NCT01487161|524386711|FG003|Overall Study|Withdrawal by Subject|2|||
145418035|NCT01487161|524386708|FG000|Overall Study|missing data|0|||
145418036|NCT01487161|524386709|FG001|Overall Study|missing data|1|||
145418037|NCT01487161|524386710|FG002|Overall Study|missing data|0|||
145418038|NCT01487161|524386711|FG003|Overall Study|missing data|0|||
145418039|NCT02945046|524386712|FG000|Overall Study|Adverse Event|1|||
145418040|NCT02945046|524386713|FG001|Overall Study|Adverse Event|0|||
145418041|NCT02945046|524386714|FG002|Overall Study|Adverse Event|2|||
145418042|NCT02945046|524386712|FG000|Overall Study|Withdrawal by Subject|3|||
145418043|NCT02945046|524386713|FG001|Overall Study|Withdrawal by Subject|3|||
145418044|NCT02945046|524386714|FG002|Overall Study|Withdrawal by Subject|3|||
145418045|NCT02945046|524386712|FG000|Overall Study|Protocol Violation|2|||
145418046|NCT02945046|524386713|FG001|Overall Study|Protocol Violation|3|||
145418047|NCT02945046|524386714|FG002|Overall Study|Protocol Violation|2|||
145418048|NCT02945046|524386712|FG000|Overall Study|Lost to Follow-up|1|||
145418049|NCT02945046|524386713|FG001|Overall Study|Lost to Follow-up|1|||
145418050|NCT02945046|524386714|FG002|Overall Study|Lost to Follow-up|0|||
145577412|NCT01310413|524969410|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
145577413|NCT01310413|524969411|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
145577414|NCT01310413|524969412|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
145357099|NCT00122382|524156889|FG000|Double-Blind Study|Pregnancy|2|||
145357100|NCT00122382|524156890|FG001|Double-Blind Study|Pregnancy|0|||
145357101|NCT00122382|524156891|FG002|Double-Blind Study|Pregnancy|0|||
145357102|NCT00122382|524156889|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
145357103|NCT00122382|524156890|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
145357104|NCT00122382|524156891|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
145357105|NCT00122382|524156889|FG000|Double-Blind Study|Withdrawal of Consent|7|||
145357106|NCT00122382|524156890|FG001|Double-Blind Study|Withdrawal of Consent|3|||
145357107|NCT00122382|524156891|FG002|Double-Blind Study|Withdrawal of Consent|0|||
145418051|NCT02945046|524386712|FG000|Overall Study|Lack of Efficacy|1|||
145418052|NCT02945046|524386713|FG001|Overall Study|Lack of Efficacy|2|||
145418053|NCT02945046|524386714|FG002|Overall Study|Lack of Efficacy|1|||
145418054|NCT02945046|524386712|FG000|Overall Study|Other than specified|5|||
145418055|NCT02945046|524386713|FG001|Overall Study|Other than specified|4|||
145418056|NCT02945046|524386714|FG002|Overall Study|Other than specified|7|||
145418057|NCT03113136|524386715|FG000|Overall Study|Lost to Follow-up|22|||
145418058|NCT03113136|524386716|FG001|Overall Study|Lost to Follow-up|47|||
145418059|NCT03113136|524386717|FG002|Overall Study|Lost to Follow-up|54|||
145418060|NCT03113136|524386715|FG000|Overall Study|Withdrawal by Subject|4|||
145418061|NCT03113136|524386716|FG001|Overall Study|Withdrawal by Subject|13|||
145418062|NCT03113136|524386717|FG002|Overall Study|Withdrawal by Subject|14|||
145418063|NCT03113136|524386715|FG000|Overall Study|Ineligible|0|||
145418064|NCT03113136|524386716|FG001|Overall Study|Ineligible|2|||
145418065|NCT03113136|524386717|FG002|Overall Study|Ineligible|1|||
145418066|NCT03113136|524386715|FG000|Overall Study|Study Team Decision|1|||
145418067|NCT03113136|524386716|FG001|Overall Study|Study Team Decision|4|||
145418068|NCT03113136|524386717|FG002|Overall Study|Study Team Decision|0|||
145418069|NCT02362412|524386722|FG000|Treatment Period III|Lost to Follow-up|0|||
145418070|NCT02362412|524386723|FG001|Treatment Period III|Lost to Follow-up|1|||
145418071|NCT00545948|524386725|FG000|Overall Study|Not Treated|1|||
145418072|NCT00545948|524386726|FG001|Overall Study|Not Treated|1|||
145418073|NCT00545948|524386727|FG002|Overall Study|Not Treated|7|||
145418074|NCT03467945|524386728|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145418075|NCT03467945|524386729|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145418076|NCT03467945|524386730|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145418077|NCT03467945|524386731|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145418078|NCT03467945|524386728|FG000|Treatment Period 3|Withdrawal by Subject|1|||
145418079|NCT03467945|524386729|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145418080|NCT03467945|524386730|FG002|Treatment Period 3|Withdrawal by Subject|2|||
145418081|NCT03467945|524386731|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145418082|NCT00541775|524386748|FG000|Overall Study|Adverse Event|3|||
145418083|NCT00541775|524386749|FG001|Overall Study|Adverse Event|2|||
145418084|NCT00541775|524386750|FG002|Overall Study|Adverse Event|1|||
145418085|NCT00541775|524386748|FG000|Overall Study|Lack of Efficacy|0|||
145418086|NCT00541775|524386749|FG001|Overall Study|Lack of Efficacy|0|||
145418087|NCT00541775|524386750|FG002|Overall Study|Lack of Efficacy|3|||
145418088|NCT00541775|524386748|FG000|Overall Study|Lost to Follow-up|0|||
145418089|NCT00541775|524386749|FG001|Overall Study|Lost to Follow-up|0|||
145418090|NCT00541775|524386750|FG002|Overall Study|Lost to Follow-up|2|||
145418091|NCT00541775|524386748|FG000|Overall Study|Protocol Violation|1|||
145418092|NCT00541775|524386749|FG001|Overall Study|Protocol Violation|0|||
145418093|NCT00541775|524386750|FG002|Overall Study|Protocol Violation|0|||
145418094|NCT00541775|524386748|FG000|Overall Study|Withdrawal by Subject and Other|5|||
145418095|NCT00541775|524386749|FG001|Overall Study|Withdrawal by Subject and Other|0|||
145418096|NCT00541775|524386750|FG002|Overall Study|Withdrawal by Subject and Other|2|||
145418097|NCT00032487|524386751|FG000|Overall Study|Withdrawal by Subject|67|||
145418098|NCT00032487|524386752|FG001|Overall Study|Withdrawal by Subject|43|||
145418099|NCT00032487|524386751|FG000|Overall Study|Adverse Event|3|||
145418100|NCT00032487|524386752|FG001|Overall Study|Adverse Event|7|||
145418101|NCT00032487|524386751|FG000|Overall Study|Lost to Follow-up|57|||
145418102|NCT00032487|524386752|FG001|Overall Study|Lost to Follow-up|58|||
145418103|NCT00032487|524386751|FG000|Overall Study|Had other reason|12|||
145418104|NCT00032487|524386752|FG001|Overall Study|Had other reason|12|||
145418105|NCT04913675|524386754|FG000|Main Study (Up to Week 36)|Death|0|||
145418106|NCT04913675|524386755|FG001|Main Study (Up to Week 36)|Death|2|||
145418107|NCT04913675|524386756|FG002|Main Study (Up to Week 36)|Death|2|||
145418108|NCT04913675|524386757|FG003|Main Study (Up to Week 36)|Death|0|||
145418109|NCT04913675|524386754|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
145418110|NCT04913675|524386755|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
145418111|NCT04913675|524386756|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
145418112|NCT04913675|524386757|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
145418113|NCT04913675|524386754|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
145418114|NCT04913675|524386755|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
145418115|NCT04913675|524386756|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
145418116|NCT04913675|524386757|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
145418117|NCT04913675|524386754|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
145418118|NCT04913675|524386755|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
145418119|NCT04913675|524386756|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
145418120|NCT04913675|524386757|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
145418121|NCT04913675|524386754|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145418122|NCT04913675|524386755|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145418123|NCT04913675|524386756|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
145418124|NCT04913675|524386757|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
145418125|NCT02975700|524386758|FG000|Overall Study|Adverse Event|1|||
145418126|NCT02975700|524386758|FG000|Overall Study|Progressive disease|3|||
145418127|NCT02975700|524386758|FG000|Overall Study|Failed screening criteria|2|||
145418128|NCT01541254|524386760|FG000|Overall Study|Withdrawal by Subject|1|||
145418129|NCT01541254|524386760|FG000|Overall Study|excluded - metal allergy|1|||
145418130|NCT01541254|524386760|FG000|Overall Study|enrolled after study closed|1|||
145418131|NCT01541254|524386760|FG000|Overall Study|GI bleed prior to procedure|1|||
145418132|NCT01541254|524386760|FG000|Overall Study|stent not required|1|||
145418133|NCT01541254|524386760|FG000|Overall Study|alternate stent used|1|||
145418134|NCT04518410|524386762|FG000|Overall Study|Lost to Follow-up|1|||
145418135|NCT04518410|524386763|FG001|Overall Study|Lost to Follow-up|1|||
145418136|NCT04518410|524386764|FG002|Overall Study|Lost to Follow-up|8|||
145623035|NCT02179918|525131567|FG000|Overall Study|Subject refused further follow-up|0|||
145418137|NCT04518410|524386765|FG003|Overall Study|Lost to Follow-up|5|||
145418138|NCT04518410|524386766|FG004|Overall Study|Lost to Follow-up|92|||
145357108|NCT00122382|524156889|FG000|Double-Blind Study|Protocol Violation|1|||
145357109|NCT00122382|524156890|FG001|Double-Blind Study|Protocol Violation|0|||
145357110|NCT00122382|524156891|FG002|Double-Blind Study|Protocol Violation|0|||
145357111|NCT00122382|524156889|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
145357112|NCT00122382|524156890|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
145357113|NCT00122382|524156891|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
145357114|NCT00122382|524156889|FG000|Double-Blind Study|Randomized but not treated|0|||
145357115|NCT00122382|524156890|FG001|Double-Blind Study|Randomized but not treated|2|||
145357116|NCT00122382|524156891|FG002|Double-Blind Study|Randomized but not treated|0|||
145357117|NCT00122382|524156889|FG000|Open-Label Study|Adverse Event|0|||
145357118|NCT00122382|524156890|FG001|Open-Label Study|Adverse Event|0|||
145357119|NCT00122382|524156891|FG002|Open-Label Study|Adverse Event|11|||
145357120|NCT00122382|524156889|FG000|Open-Label Study|Death|0|||
145357121|NCT00122382|524156890|FG001|Open-Label Study|Death|0|||
145357122|NCT00122382|524156891|FG002|Open-Label Study|Death|2|||
145357123|NCT00122382|524156889|FG000|Open-Label Study|Lack of Efficacy|0|||
145357124|NCT00122382|524156890|FG001|Open-Label Study|Lack of Efficacy|0|||
145357125|NCT00122382|524156891|FG002|Open-Label Study|Lack of Efficacy|3|||
145357126|NCT00122382|524156889|FG000|Open-Label Study|Lost to Follow-up|0|||
145357127|NCT00122382|524156890|FG001|Open-Label Study|Lost to Follow-up|0|||
145357128|NCT00122382|524156891|FG002|Open-Label Study|Lost to Follow-up|3|||
145357129|NCT00122382|524156889|FG000|Open-Label Study|Pregnancy|0|||
145357130|NCT00122382|524156890|FG001|Open-Label Study|Pregnancy|0|||
145357131|NCT00122382|524156891|FG002|Open-Label Study|Pregnancy|2|||
145357132|NCT00122382|524156889|FG000|Open-Label Study|Poor/Non-Compliance|0|||
145357133|NCT00122382|524156890|FG001|Open-Label Study|Poor/Non-Compliance|0|||
145357134|NCT00122382|524156891|FG002|Open-Label Study|Poor/Non-Compliance|1|||
145357135|NCT00122382|524156889|FG000|Open-Label Study|Withdrawal of Consent|0|||
145357136|NCT00122382|524156890|FG001|Open-Label Study|Withdrawal of Consent|0|||
145357137|NCT00122382|524156891|FG002|Open-Label Study|Withdrawal of Consent|4|||
145357138|NCT01213966|524156894|FG000|Overall Study|Protocol Violation|1|||
145357139|NCT01213966|524156895|FG001|Overall Study|Protocol Violation|0|||
145357140|NCT01213966|524156896|FG002|Overall Study|Protocol Violation|3|||
145357141|NCT01213966|524156897|FG003|Overall Study|Protocol Violation|1|||
145357142|NCT02166333|524156902|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
145357143|NCT02166333|524156903|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145357144|NCT02166333|524156904|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145357145|NCT02166333|524156905|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
145357146|NCT02166333|524156906|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
145357147|NCT02166333|524156907|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
145357148|NCT02166333|524156902|FG000|Stage 1|Death|4|||
145357149|NCT02166333|524156903|FG001|Stage 1|Death|0|||
145357150|NCT02166333|524156904|FG002|Stage 1|Death|2|||
145357151|NCT02166333|524156905|FG003|Stage 1|Death|0|||
145357152|NCT02166333|524156906|FG004|Stage 1|Death|3|||
145357153|NCT02166333|524156907|FG005|Stage 1|Death|2|||
145357154|NCT02166333|524156902|FG000|Stage 1|Lost to Follow-up|12|||
145357155|NCT02166333|524156903|FG001|Stage 1|Lost to Follow-up|0|||
145357156|NCT02166333|524156904|FG002|Stage 1|Lost to Follow-up|6|||
145357157|NCT02166333|524156905|FG003|Stage 1|Lost to Follow-up|0|||
145357158|NCT02166333|524156906|FG004|Stage 1|Lost to Follow-up|3|||
145357159|NCT02166333|524156907|FG005|Stage 1|Lost to Follow-up|3|||
145357160|NCT02166333|524156902|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
145357161|NCT02166333|524156903|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
145357162|NCT02166333|524156904|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
145357163|NCT02166333|524156905|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
145357164|NCT02166333|524156906|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
145357165|NCT02166333|524156907|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
145357166|NCT02166333|524156902|FG000|Stage 2|Death|4|||
145357167|NCT02166333|524156903|FG001|Stage 2|Death|2|||
145357168|NCT02166333|524156904|FG002|Stage 2|Death|1|||
145357169|NCT02166333|524156905|FG003|Stage 2|Death|0|||
145357170|NCT02166333|524156906|FG004|Stage 2|Death|0|||
145357171|NCT02166333|524156907|FG005|Stage 2|Death|1|||
145357172|NCT02166333|524156902|FG000|Stage 2|Lost to Follow-up|23|||
145357173|NCT02166333|524156903|FG001|Stage 2|Lost to Follow-up|4|||
145357174|NCT02166333|524156904|FG002|Stage 2|Lost to Follow-up|11|||
145357175|NCT02166333|524156905|FG003|Stage 2|Lost to Follow-up|9|||
145357176|NCT02166333|524156906|FG004|Stage 2|Lost to Follow-up|3|||
145357177|NCT02166333|524156907|FG005|Stage 2|Lost to Follow-up|6|||
145357178|NCT02269098|524156908|FG000|Overall Study|Lost to Follow-up|14|||
145357179|NCT02269098|524156909|FG001|Overall Study|Lost to Follow-up|9|||
145357180|NCT00682786|524156917|FG000|Overall Study|Withdrawal by Subject|2|||
145357181|NCT00682786|524156918|FG001|Overall Study|Withdrawal by Subject|2|||
145357182|NCT00682786|524156917|FG000|Overall Study|Did not receive irinotecan|0|||
145577415|NCT01310413|524969413|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
145577416|NCT01310413|524969407|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
145577417|NCT01310413|524969408|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
145577418|NCT01310413|524969409|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
145577419|NCT01310413|524969410|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
145577420|NCT01310413|524969411|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
145577421|NCT01310413|524969412|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
145577422|NCT01310413|524969413|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
145577423|NCT01310413|524969407|FG000|Day 0 to Day 385|Other|1|||
145623036|NCT02179918|525131568|FG001|Overall Study|Subject refused further follow-up|1|||
145357183|NCT00682786|524156918|FG001|Overall Study|Did not receive irinotecan|1|||
145357184|NCT00359424|524156921|FG000|Overall Study|Death|99|||
145357185|NCT00359424|524156922|FG001|Overall Study|Death|58|||
145357186|NCT00359424|524156921|FG000|Overall Study|Lost to Follow-up|19|||
145357187|NCT00359424|524156922|FG001|Overall Study|Lost to Follow-up|7|||
145357188|NCT00359424|524156921|FG000|Overall Study|Withdrawal by Subject|10|||
145357189|NCT00359424|524156922|FG001|Overall Study|Withdrawal by Subject|2|||
145357190|NCT00359424|524156921|FG000|Overall Study|follow up not conducted|2|||
145357191|NCT00359424|524156922|FG001|Overall Study|follow up not conducted|0|||
145357192|NCT02259010|524156925|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
145357193|NCT01445730|524156928|FG000|Overall Study|Adverse Event|1|||
145357194|NCT01445730|524156928|FG000|Overall Study|For the advice of a dentist|1|||
145357195|NCT01445730|524156928|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
145357196|NCT01167140|524156931|FG000|Overall Study|Withdrawal by Subject|1|||
145357197|NCT03805412|524156932|FG000|Overall Study|Lost to Follow-up|0|||
145357198|NCT03805412|524156933|FG001|Overall Study|Lost to Follow-up|1|||
145357199|NCT05514873|524156939|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
145357200|NCT05514873|524156939|FG000|Main Treatment Period|Adverse Event|2|||
145357201|NCT05514873|524156939|FG000|Extension Treatment Period|Lost to Follow-up|3|||
145357202|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
145357203|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
145357204|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
145357205|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
145357206|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
145357207|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
145357208|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
145357209|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145357210|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145357211|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
145357212|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
145357213|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
145357214|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
145357215|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
145357216|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
145357217|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
145357218|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
145357219|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
145357220|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
145357221|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
145357222|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
145357223|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
145357224|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
145357225|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
145357226|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
145357227|NCT03525678|524156943|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
145357228|NCT03525678|524156944|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
145357229|NCT03525678|524156945|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145357230|NCT03525678|524156946|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145357231|NCT03525678|524156947|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
145357232|NCT05966584|524156948|FG000|Overall Study|Lost to Follow-up|1|||
145357233|NCT05142722|524158792|FG000|Overall Study|Lost to Follow-up|16|||
145357234|NCT05142722|524158793|FG001|Overall Study|Lost to Follow-up|38|||
145357235|NCT05142722|524158792|FG000|Overall Study|Withdrawal by Subject|20|||
145357236|NCT05142722|524158793|FG001|Overall Study|Withdrawal by Subject|27|||
145357237|NCT05142722|524158792|FG000|Overall Study|Death|11|||
145357238|NCT05142722|524158793|FG001|Overall Study|Death|17|||
145357239|NCT05142722|524158792|FG000|Overall Study|Physician Decision|0|||
145357240|NCT05142722|524158793|FG001|Overall Study|Physician Decision|1|||
145357241|NCT05142722|524158792|FG000|Overall Study|Participant Moved Away|0|||
145357242|NCT05142722|524158793|FG001|Overall Study|Participant Moved Away|2|||
145357243|NCT05142722|524158792|FG000|Overall Study|Adverse Event|2|||
145577424|NCT01310413|524969408|FG001|Day 0 to Day 385|Other|0|||
145623037|NCT02179918|525131569|FG002|Overall Study|Subject refused further follow-up|0|||
145623038|NCT02179918|525131570|FG003|Overall Study|Subject refused further follow-up|0|||
145623039|NCT02179918|525131571|FG004|Overall Study|Subject refused further follow-up|1|||
145623040|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
145623041|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
145623042|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
145357244|NCT05142722|524158793|FG001|Overall Study|Adverse Event|1|||
145357245|NCT05086744|524158794|FG000|Part A|Adverse Event|0|||
145357246|NCT05086744|524158795|FG001|Part A|Adverse Event|1|||
145357247|NCT05086744|524158794|FG000|Part A|Lack of Efficacy|3|||
145357248|NCT05086744|524158795|FG001|Part A|Lack of Efficacy|0|||
145357249|NCT05086744|524158794|FG000|Part A|Protocol deviation|1|||
145357250|NCT05086744|524158795|FG001|Part A|Protocol deviation|0|||
145357251|NCT05086744|524158794|FG000|Part A|Subject decision|1|||
145357252|NCT05086744|524158795|FG001|Part A|Subject decision|0|||
145357253|NCT05086744|524158794|FG000|Part B|Adverse Event|0|||
145357254|NCT05086744|524158795|FG001|Part B|Adverse Event|1|||
145357255|NCT05086744|524158794|FG000|Part B|Lack of Efficacy|0|||
145357256|NCT05086744|524158795|FG001|Part B|Lack of Efficacy|1|||
145357257|NCT05086744|524158794|FG000|Part B|Study terminated by sponsor|1|||
145357258|NCT05086744|524158795|FG001|Part B|Study terminated by sponsor|6|||
145357259|NCT00437021|524158796|FG000|Overall Study|Adverse Event|0|||
145357260|NCT00437021|524158797|FG001|Overall Study|Adverse Event|0|||
145357261|NCT00437021|524158798|FG002|Overall Study|Adverse Event|0|||
145357262|NCT00437021|524158799|FG003|Overall Study|Adverse Event|0|||
145357263|NCT00437021|524158800|FG004|Overall Study|Adverse Event|0|||
145357264|NCT00437021|524158801|FG005|Overall Study|Adverse Event|0|||
145357265|NCT00437021|524158802|FG006|Overall Study|Adverse Event|1|||
145357266|NCT00437021|524158803|FG007|Overall Study|Adverse Event|0|||
145357267|NCT00437021|524158804|FG008|Overall Study|Adverse Event|0|||
145357268|NCT00437021|524158805|FG009|Overall Study|Adverse Event|0|||
145357269|NCT00437021|524158806|FG010|Overall Study|Adverse Event|0|||
145357270|NCT00437021|524158807|FG011|Overall Study|Adverse Event|0|||
145357271|NCT00437021|524158796|FG000|Overall Study|Lost to Follow-up|0|||
145357272|NCT00437021|524158797|FG001|Overall Study|Lost to Follow-up|3|||
145357273|NCT00437021|524158798|FG002|Overall Study|Lost to Follow-up|0|||
145357274|NCT00437021|524158799|FG003|Overall Study|Lost to Follow-up|0|||
145357275|NCT00437021|524158800|FG004|Overall Study|Lost to Follow-up|0|||
145357276|NCT00437021|524158801|FG005|Overall Study|Lost to Follow-up|2|||
145357277|NCT00437021|524158802|FG006|Overall Study|Lost to Follow-up|0|||
145357278|NCT00437021|524158803|FG007|Overall Study|Lost to Follow-up|1|||
145357279|NCT00437021|524158804|FG008|Overall Study|Lost to Follow-up|0|||
145357280|NCT00437021|524158805|FG009|Overall Study|Lost to Follow-up|0|||
145357281|NCT00437021|524158806|FG010|Overall Study|Lost to Follow-up|0|||
145357282|NCT00437021|524158807|FG011|Overall Study|Lost to Follow-up|0|||
145357283|NCT00437021|524158796|FG000|Overall Study|Withdrawal by Subject|2|||
145357284|NCT00437021|524158797|FG001|Overall Study|Withdrawal by Subject|1|||
145357285|NCT00437021|524158798|FG002|Overall Study|Withdrawal by Subject|0|||
145357286|NCT00437021|524158799|FG003|Overall Study|Withdrawal by Subject|0|||
145357287|NCT00437021|524158800|FG004|Overall Study|Withdrawal by Subject|0|||
145357288|NCT00437021|524158801|FG005|Overall Study|Withdrawal by Subject|0|||
145357289|NCT00437021|524158802|FG006|Overall Study|Withdrawal by Subject|0|||
145357290|NCT00437021|524158803|FG007|Overall Study|Withdrawal by Subject|0|||
145357291|NCT00437021|524158804|FG008|Overall Study|Withdrawal by Subject|0|||
145357292|NCT00437021|524158805|FG009|Overall Study|Withdrawal by Subject|0|||
145357293|NCT00437021|524158806|FG010|Overall Study|Withdrawal by Subject|0|||
145357294|NCT00437021|524158807|FG011|Overall Study|Withdrawal by Subject|0|||
145357295|NCT00536939|524158817|FG000|Overall Study|Withdrawal by Subject|1|||
145357296|NCT00536939|524158818|FG001|Overall Study|Withdrawal by Subject|0|||
145357297|NCT00536939|524158817|FG000|Overall Study|Other Complicating Disease|1|||
145357298|NCT00536939|524158818|FG001|Overall Study|Other Complicating Disease|0|||
145357299|NCT01894841|524158819|FG000|Overall Study|Withdrawal by Subject|9|||
145357300|NCT01894841|524158820|FG001|Overall Study|Withdrawal by Subject|4|||
145357301|NCT01894841|524158819|FG000|Overall Study|Withdrawn by investigator|2|||
145357302|NCT01894841|524158820|FG001|Overall Study|Withdrawn by investigator|2|||
145357303|NCT01894841|524158819|FG000|Overall Study|Lost to Follow-up|7|||
145357304|NCT01894841|524158820|FG001|Overall Study|Lost to Follow-up|3|||
145357305|NCT04227197|524158847|FG000|Randomization|Protocol Violation|1|||
145357306|NCT04227197|524158848|FG001|Randomization|Protocol Violation|0|||
145357307|NCT04227197|524158847|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
145357308|NCT04227197|524158848|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
145357309|NCT04227197|524158847|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
145357310|NCT04227197|524158848|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
145357311|NCT04227197|524158847|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
145357312|NCT04227197|524158848|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
145418139|NCT04518410|524386767|FG005|Overall Study|Lost to Follow-up|25|||
145418140|NCT04518410|524386768|FG006|Overall Study|Lost to Follow-up|25|||
145418141|NCT04518410|524386769|FG007|Overall Study|Lost to Follow-up|3|||
145623043|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
145623044|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
145623045|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
145623046|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
145623047|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
145623048|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
145623049|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
145623050|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
145623051|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
145623052|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
145623053|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
145623054|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
145623055|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
145623056|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
145623057|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
145623058|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
145623059|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
145623060|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
145357313|NCT04227197|524158847|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
145623061|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
145623062|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
145623063|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
145623064|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
145623065|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
145623066|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
145623067|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
145623068|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
145623069|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
145623070|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
145623071|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
145357314|NCT04227197|524158848|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
145357315|NCT04227197|524158847|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
145357316|NCT04227197|524158848|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
145357317|NCT04227197|524158847|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
145357318|NCT04227197|524158848|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
145357319|NCT01209949|524158858|FG000|Overall Study|Lost to Follow-up|3|||
145357320|NCT00708552|524158863|FG000|Overall Study|Adverse Event|10|||
145357321|NCT00708552|524158864|FG001|Overall Study|Adverse Event|3|||
145357322|NCT00708552|524158865|FG002|Overall Study|Adverse Event|4|||
145357323|NCT00708552|524158866|FG003|Overall Study|Adverse Event|6|||
145357324|NCT00708552|524158863|FG000|Overall Study|Lack of Efficacy|0|||
145357325|NCT00708552|524158864|FG001|Overall Study|Lack of Efficacy|4|||
145357326|NCT00708552|524158865|FG002|Overall Study|Lack of Efficacy|1|||
145357327|NCT00708552|524158866|FG003|Overall Study|Lack of Efficacy|0|||
145357328|NCT00708552|524158863|FG000|Overall Study|Protocol Violation|0|||
145357329|NCT00708552|524158864|FG001|Overall Study|Protocol Violation|0|||
145357330|NCT00708552|524158865|FG002|Overall Study|Protocol Violation|2|||
145357331|NCT00708552|524158866|FG003|Overall Study|Protocol Violation|4|||
145357332|NCT00708552|524158863|FG000|Overall Study|Lost to Follow-up|4|||
145357333|NCT00708552|524158864|FG001|Overall Study|Lost to Follow-up|2|||
145357334|NCT00708552|524158865|FG002|Overall Study|Lost to Follow-up|0|||
145357335|NCT00708552|524158866|FG003|Overall Study|Lost to Follow-up|1|||
145357336|NCT00708552|524158863|FG000|Overall Study|Physician Decision|1|||
145357337|NCT00708552|524158864|FG001|Overall Study|Physician Decision|2|||
145357338|NCT00708552|524158865|FG002|Overall Study|Physician Decision|0|||
145357339|NCT00708552|524158866|FG003|Overall Study|Physician Decision|0|||
145357340|NCT00708552|524158863|FG000|Overall Study|Withdrawal by Subject|12|||
145357341|NCT00708552|524158864|FG001|Overall Study|Withdrawal by Subject|7|||
145357342|NCT00708552|524158865|FG002|Overall Study|Withdrawal by Subject|8|||
145357343|NCT00708552|524158866|FG003|Overall Study|Withdrawal by Subject|10|||
145357344|NCT04878432|524158868|FG000|Overall Study|Adverse Event|1|||
145357345|NCT04878432|524158868|FG000|Overall Study|Death|2|||
145357346|NCT04878432|524158868|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145357347|NCT04878432|524158868|FG000|Overall Study|Withdrawal by Subject|6|||
145357348|NCT04878432|524158868|FG000|Overall Study|Progressive Disease|7|||
145357349|NCT04878432|524158868|FG000|Overall Study|New Therapy for Study Indication|7|||
145357350|NCT04878432|524158868|FG000|Overall Study|Physician Decision|11|||
145418142|NCT04518410|524386770|FG008|Overall Study|Lost to Follow-up|2|||
145418143|NCT04518410|524386771|FG009|Overall Study|Lost to Follow-up|13|||
145357351|NCT03971071|524158869|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145357352|NCT03971071|524158870|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
145357353|NCT03971071|524158871|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145357354|NCT03971071|524158872|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145357355|NCT03971071|524158873|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
145357356|NCT03971071|524158869|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
145357357|NCT03971071|524158870|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
145357358|NCT03971071|524158871|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
145357359|NCT03971071|524158872|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145357360|NCT03971071|524158873|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
145357361|NCT03971071|524158869|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
145357362|NCT03971071|524158870|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
145357363|NCT03971071|524158871|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
145357364|NCT03971071|524158872|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
145357365|NCT03971071|524158873|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
145357366|NCT03971071|524158869|FG000|Open-label Treatment Period|Sponsor decision|0|||
145357367|NCT03971071|524158870|FG001|Open-label Treatment Period|Sponsor decision|0|||
145357368|NCT03971071|524158871|FG002|Open-label Treatment Period|Sponsor decision|0|||
145357369|NCT03971071|524158872|FG003|Open-label Treatment Period|Sponsor decision|0|||
145357370|NCT03971071|524158873|FG004|Open-label Treatment Period|Sponsor decision|1|||
145357371|NCT03971071|524158869|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
145357372|NCT03971071|524158870|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145357373|NCT03971071|524158871|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
145357374|NCT03971071|524158872|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
145357375|NCT03971071|524158873|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
145357376|NCT03971071|524158869|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145357377|NCT03971071|524158870|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
145357378|NCT03971071|524158871|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
145357379|NCT03971071|524158872|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
145357380|NCT03971071|524158873|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
145357381|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
145357382|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
145357383|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
145357384|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
145357385|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
145357386|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357387|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357388|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357389|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357390|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357391|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357392|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357393|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357394|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357395|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
145357396|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
145357397|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
145357398|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
145357399|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
145357400|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
145357401|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357402|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357403|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357404|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357405|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357406|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357407|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357408|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357409|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357410|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
145357411|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
145357412|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
145357413|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
145357414|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
145357415|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
145357416|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357417|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357418|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357419|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357420|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357421|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357422|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357423|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357424|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357425|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
145357426|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
145357427|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
145357428|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
145357429|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
145357430|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
145357431|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357432|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357433|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357434|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357435|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357436|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357437|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357438|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357439|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357440|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
145357441|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
145357442|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357443|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
145357444|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
145357445|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
145357446|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357447|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357448|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357449|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357450|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357451|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357452|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357453|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357454|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357455|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
145357456|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357457|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357458|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357459|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
145357460|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357461|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357462|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357463|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357464|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357465|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357466|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357467|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357468|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357469|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357470|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
145357471|NCT03334435|524158878|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357472|NCT03334435|524158879|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
145357473|NCT03334435|524158880|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
145623072|NCT03890120|525131575|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
145623073|NCT03890120|525131576|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
145623074|NCT03890120|525131577|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
145623075|NCT03890120|525131578|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
145623076|NCT03890120|525131575|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
145623077|NCT03890120|525131576|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
145623078|NCT03890120|525131577|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
145623079|NCT03890120|525131578|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
145623080|NCT03890120|525131575|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
145623081|NCT03890120|525131576|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
145623082|NCT03890120|525131577|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
145623083|NCT03890120|525131578|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
145623084|NCT03890120|525131575|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
145623085|NCT03890120|525131576|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
145623086|NCT03890120|525131577|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
145623087|NCT03890120|525131578|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
145623088|NCT03890120|525131575|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
145623089|NCT03890120|525131576|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
145623090|NCT03890120|525131577|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
145623091|NCT03890120|525131578|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
145623092|NCT04003974|525131579|FG000|Overall Study|Missing|1|||
145623093|NCT04003974|525131580|FG001|Overall Study|Missing|0|||
145623094|NCT04003974|525131579|FG000|Overall Study|Withdrawal by Subject|0|||
145623095|NCT04003974|525131580|FG001|Overall Study|Withdrawal by Subject|2|||
145623096|NCT02400307|525131581|FG000|Overall Study|Enrolled and Never Dosed|1|||
145623097|NCT02400307|525131582|FG001|Overall Study|Enrolled and Never Dosed|0|||
145357474|NCT03334435|524158881|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
145357475|NCT03334435|524158882|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
145357476|NCT03334435|524158883|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357477|NCT03334435|524158884|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357478|NCT03334435|524158885|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357479|NCT03334435|524158886|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357480|NCT03334435|524158887|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357481|NCT03334435|524158888|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357482|NCT03334435|524158889|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357483|NCT03334435|524158890|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357484|NCT03334435|524158891|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357485|NCT03334435|524158892|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
145357486|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145357487|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145357488|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145357489|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145357490|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
145357491|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145357492|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
145357493|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145357494|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
145357495|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
145357496|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
145357497|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
145357498|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
145357499|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
145357500|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
145357501|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145623098|NCT01052662|525131585|FG000|Overall Study|Lost to Follow-up|15|||
145623099|NCT01052662|525131586|FG001|Overall Study|Lost to Follow-up|13|||
145623100|NCT01052662|525131587|FG002|Overall Study|Lost to Follow-up|18|||
145623101|NCT01052662|525131585|FG000|Overall Study|Withdrawal by Subject|3|||
145623102|NCT01052662|525131586|FG001|Overall Study|Withdrawal by Subject|2|||
145623103|NCT01052662|525131587|FG002|Overall Study|Withdrawal by Subject|1|||
145623104|NCT01052662|525131585|FG000|Overall Study|Pharmacy issue|1|||
145623105|NCT01052662|525131586|FG001|Overall Study|Pharmacy issue|3|||
145623106|NCT01052662|525131587|FG002|Overall Study|Pharmacy issue|3|||
145623107|NCT01052662|525131585|FG000|Overall Study|Adverse Event|1|||
145623108|NCT01052662|525131586|FG001|Overall Study|Adverse Event|1|||
145623109|NCT01052662|525131587|FG002|Overall Study|Adverse Event|0|||
145623110|NCT01052662|525131585|FG000|Overall Study|Legal Problem|2|||
145623111|NCT01052662|525131586|FG001|Overall Study|Legal Problem|0|||
145357502|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145357503|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145357504|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145357505|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
145357506|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
145357507|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
145357508|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
145357509|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
145357510|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
145357511|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
145357512|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
145357513|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
145357514|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
145357515|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
145357516|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357517|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357518|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357519|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357520|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357521|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
145357522|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
145357523|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
145357524|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
145357525|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
145357526|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
145357527|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
145357528|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
145357529|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
145357530|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
145357531|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145357532|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145357533|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145357534|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145357535|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
145357536|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
145357537|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
145357538|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145357539|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145357540|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
145357541|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
145357542|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
145357543|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
145357544|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
145357545|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
145357546|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357547|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357548|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357549|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357550|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357551|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357552|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
145357553|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
145357554|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
145357555|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145357556|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145357557|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
145357558|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
145357559|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
145357560|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
145357561|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357562|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357563|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145418144|NCT04518410|524386772|FG010|Overall Study|Lost to Follow-up|9|||
145577425|NCT01310413|524969409|FG002|Day 0 to Day 385|Other|3|||
145577426|NCT01310413|524969410|FG003|Day 0 to Day 385|Other|0|||
145357564|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357565|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357566|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357567|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357568|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357569|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357570|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357571|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357572|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
145357573|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357574|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
145357575|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
145357576|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357577|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357578|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357579|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357580|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357581|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
145357582|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357583|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357584|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357585|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357586|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357587|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357588|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357589|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
145357590|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
145357591|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357592|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357593|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357594|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357595|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357596|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357597|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357598|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357599|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357600|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
145357601|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357602|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
145357603|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357604|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357605|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
145357606|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357607|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357608|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357609|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357610|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357611|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145357612|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145357613|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357614|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357615|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357616|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
145357617|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145357618|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
145357619|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
145357620|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
145357621|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357622|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357623|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145418145|NCT04518410|524386773|FG011|Overall Study|Lost to Follow-up|13|||
145418146|NCT04518410|524386774|FG012|Overall Study|Lost to Follow-up|9|||
145357624|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357625|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357626|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145357627|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357628|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357629|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357630|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357631|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145357632|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357633|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357634|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
145357635|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
145357636|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357637|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357638|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357639|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357640|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357641|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357642|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357643|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145357644|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145357645|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357646|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145357647|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
145357648|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
145357649|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357650|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
145357651|NCT03334435|524158878|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357652|NCT03334435|524158879|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357653|NCT03334435|524158880|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357654|NCT03334435|524158881|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357655|NCT03334435|524158882|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357656|NCT03334435|524158883|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357657|NCT03334435|524158884|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357658|NCT03334435|524158885|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357659|NCT03334435|524158886|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357660|NCT03334435|524158887|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357661|NCT03334435|524158888|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357662|NCT03334435|524158889|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145357663|NCT03334435|524158890|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
145357664|NCT03334435|524158891|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145357665|NCT03334435|524158892|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
145357666|NCT03922321|524158893|FG000|Overall Study|Participant Moved|1|||
145357667|NCT03922321|524158893|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
145357668|NCT00350207|524158894|FG000|Overall Study|Adverse Event|5|||
145357669|NCT00350207|524158895|FG001|Overall Study|Adverse Event|2|||
145357670|NCT00350207|524158896|FG002|Overall Study|Adverse Event|2|||
145357671|NCT00350207|524158894|FG000|Overall Study|Lack of Efficacy|1|||
145357672|NCT00350207|524158895|FG001|Overall Study|Lack of Efficacy|0|||
145357673|NCT00350207|524158896|FG002|Overall Study|Lack of Efficacy|2|||
145357674|NCT00350207|524158894|FG000|Overall Study|Lost to Follow-up|1|||
145357675|NCT00350207|524158895|FG001|Overall Study|Lost to Follow-up|0|||
145357676|NCT00350207|524158896|FG002|Overall Study|Lost to Follow-up|1|||
145357677|NCT00350207|524158894|FG000|Overall Study|Withdrawal by Subject|0|||
145357678|NCT00350207|524158895|FG001|Overall Study|Withdrawal by Subject|1|||
145357679|NCT00350207|524158896|FG002|Overall Study|Withdrawal by Subject|1|||
145357680|NCT00350207|524158894|FG000|Overall Study|Other|1|||
145357681|NCT00350207|524158895|FG001|Overall Study|Other|3|||
145357682|NCT00350207|524158896|FG002|Overall Study|Other|1|||
145357683|NCT00495391|524158897|FG000|Overall Study|Lack of Efficacy|34|||
145357684|NCT00495391|524158898|FG001|Overall Study|Lack of Efficacy|18|||
145357685|NCT00495391|524158897|FG000|Overall Study|Withdrawal by Subject|2|||
145357686|NCT00495391|524158898|FG001|Overall Study|Withdrawal by Subject|3|||
145357687|NCT03214224|524158899|FG000|Overall Study|Protocol Violation|1|||
145357688|NCT03214224|524158899|FG000|Overall Study|Withdrawal by Subject|2|||
145357689|NCT03214224|524158899|FG000|Overall Study|Practice controls or therapists|6|||
145357690|NCT02712320|524158900|FG000|Overall Study|Lost to Follow-up|1|||
145357691|NCT02712320|524158900|FG000|Overall Study|Withdrawal by Subject|1|||
145357692|NCT02712320|524158900|FG000|Overall Study|Transferred to another facility|1|||
145357693|NCT02712320|524158900|FG000|Overall Study|Treating with the prohibited medications|2|||
145357694|NCT05266053|524158903|FG000|Overall Study|Withdrawal by Subject|8|||
145357695|NCT05266053|524158904|FG001|Overall Study|Withdrawal by Subject|4|||
145357696|NCT05005507|524158905|FG000|Overall Study|Premature termination of study|1|||
145357697|NCT03313180|524158910|FG000|Overall Study|Adverse Event|120|||
145357698|NCT03313180|524158910|FG000|Overall Study|Lost to Follow-up|3|||
145357699|NCT03313180|524158910|FG000|Overall Study|Withdrawal by Subject|39|||
145357700|NCT03313180|524158910|FG000|Overall Study|Other than listed above|15|||
145357701|NCT03313180|524158910|FG000|Overall Study|Covid-19 related|2|||
145357702|NCT01697748|524158911|FG000|Overall Study|ineligible skin incision|1|||
145357703|NCT01697748|524158912|FG001|Overall Study|ineligible skin incision|2|||
145357704|NCT01697748|524158911|FG000|Overall Study|ineligible uterine incision|4|||
145357705|NCT01697748|524158912|FG001|Overall Study|ineligible uterine incision|1|||
145357706|NCT01697748|524158911|FG000|Overall Study|Lost to Follow-up|53|||
145357707|NCT01697748|524158912|FG001|Overall Study|Lost to Follow-up|65|||
145357708|NCT02556775|524158914|FG000|Overall Study|Withdrawal by Subject|1|||
145357709|NCT02556775|524158915|FG001|Overall Study|Withdrawal by Subject|0|||
145357710|NCT02556775|524158916|FG002|Overall Study|Withdrawal by Subject|1|||
145357711|NCT02556775|524158917|FG003|Overall Study|Withdrawal by Subject|0|||
145357712|NCT02556775|524158914|FG000|Overall Study|Lost to Follow-up|1|||
145357713|NCT02556775|524158915|FG001|Overall Study|Lost to Follow-up|0|||
145357714|NCT02556775|524158916|FG002|Overall Study|Lost to Follow-up|0|||
145357715|NCT02556775|524158917|FG003|Overall Study|Lost to Follow-up|0|||
145357716|NCT02025725|524158920|FG000|Overall Study|Adverse Event|5|||
145357717|NCT02025725|524158921|FG001|Overall Study|Adverse Event|0|||
145357718|NCT02025725|524158920|FG000|Overall Study|Lost to Follow-up|2|||
145357719|NCT02025725|524158921|FG001|Overall Study|Lost to Follow-up|0|||
145357720|NCT02025725|524158920|FG000|Overall Study|Protocol Violation|1|||
145357721|NCT02025725|524158921|FG001|Overall Study|Protocol Violation|1|||
145357722|NCT02025725|524158920|FG000|Overall Study|Withdrawal by Subject|3|||
145357723|NCT02025725|524158921|FG001|Overall Study|Withdrawal by Subject|2|||
145357724|NCT02025725|524158920|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
145357725|NCT02025725|524158921|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
145357726|NCT01786993|524158922|FG000|Overall Study|Death|6|||
145357727|NCT01786993|524158923|FG001|Overall Study|Death|7|||
145357728|NCT01786993|524158922|FG000|Overall Study|Withdrawal by Subject|3|||
145357729|NCT01786993|524158923|FG001|Overall Study|Withdrawal by Subject|2|||
145357730|NCT01786993|524158922|FG000|Overall Study|Lost to Follow-up|0|||
145357731|NCT01786993|524158923|FG001|Overall Study|Lost to Follow-up|1|||
145357732|NCT01786993|524158922|FG000|Overall Study|Subject Non-Compliance|1|||
145357733|NCT01786993|524158923|FG001|Overall Study|Subject Non-Compliance|0|||
145357734|NCT01786993|524158922|FG000|Overall Study|System Explant|1|||
145357735|NCT01786993|524158923|FG001|Overall Study|System Explant|0|||
145357736|NCT01786993|524158922|FG000|Overall Study|Hospice Admission|1|||
145357737|NCT01786993|524158923|FG001|Overall Study|Hospice Admission|0|||
145357738|NCT00071110|524158924|FG000|Overall Study|Protocol Violation|0|||
145357739|NCT00071110|524158925|FG001|Overall Study|Protocol Violation|4|||
145357740|NCT03655405|524158926|FG000|Overall Study|Death after initial data collection|4|||
145357741|NCT03655405|524158927|FG001|Overall Study|Death after initial data collection|2|||
145357742|NCT03655405|524158926|FG000|Overall Study|Died before initial data collection|1|||
145357743|NCT03655405|524158927|FG001|Overall Study|Died before initial data collection|2|||
145357744|NCT03655405|524158926|FG000|Overall Study|Protocol Violation|0|||
145357745|NCT03655405|524158927|FG001|Overall Study|Protocol Violation|1|||
145357746|NCT00848718|524158930|FG000|Overall Study|Adverse Event|2|||
145357747|NCT00848718|524158931|FG001|Overall Study|Adverse Event|2|||
145357748|NCT00848718|524158932|FG002|Overall Study|Adverse Event|1|||
145357749|NCT00848718|524158933|FG003|Overall Study|Adverse Event|1|||
145357750|NCT00848718|524158934|FG004|Overall Study|Adverse Event|1|||
145357751|NCT00848718|524158935|FG005|Overall Study|Adverse Event|0|||
145357752|NCT00848718|524158936|FG006|Overall Study|Adverse Event|0|||
145357753|NCT00848718|524158937|FG007|Overall Study|Adverse Event|1|||
145357754|NCT00848718|524158938|FG008|Overall Study|Adverse Event|1|||
145357755|NCT00848718|524158939|FG009|Overall Study|Adverse Event|0|||
145357756|NCT00848718|524158940|FG010|Overall Study|Adverse Event|0|||
145357757|NCT00848718|524158941|FG011|Overall Study|Adverse Event|0|||
145357758|NCT00848718|524158942|FG012|Overall Study|Adverse Event|2|||
145357759|NCT00848718|524158930|FG000|Overall Study|Lack of Efficacy|0|||
145623112|NCT01052662|525131587|FG002|Overall Study|Legal Problem|0|||
145357760|NCT00848718|524158931|FG001|Overall Study|Lack of Efficacy|0|||
145623113|NCT01052662|525131585|FG000|Overall Study|Administrative|0|||
145357761|NCT00848718|524158932|FG002|Overall Study|Lack of Efficacy|1|||
145357762|NCT00848718|524158933|FG003|Overall Study|Lack of Efficacy|0|||
145623114|NCT01052662|525131586|FG001|Overall Study|Administrative|3|||
145357763|NCT00848718|524158934|FG004|Overall Study|Lack of Efficacy|0|||
145357764|NCT00848718|524158935|FG005|Overall Study|Lack of Efficacy|0|||
145357765|NCT00848718|524158936|FG006|Overall Study|Lack of Efficacy|1|||
145357766|NCT00848718|524158937|FG007|Overall Study|Lack of Efficacy|0|||
145357767|NCT00848718|524158938|FG008|Overall Study|Lack of Efficacy|0|||
145357768|NCT00848718|524158939|FG009|Overall Study|Lack of Efficacy|0|||
145357769|NCT00848718|524158940|FG010|Overall Study|Lack of Efficacy|0|||
145357770|NCT00848718|524158941|FG011|Overall Study|Lack of Efficacy|0|||
145357771|NCT00848718|524158942|FG012|Overall Study|Lack of Efficacy|0|||
145357772|NCT00848718|524158930|FG000|Overall Study|Physician Decision|0|||
145357773|NCT00848718|524158931|FG001|Overall Study|Physician Decision|1|||
145357774|NCT00848718|524158932|FG002|Overall Study|Physician Decision|0|||
145357775|NCT00848718|524158933|FG003|Overall Study|Physician Decision|0|||
145357776|NCT00848718|524158934|FG004|Overall Study|Physician Decision|1|||
145357777|NCT00848718|524158935|FG005|Overall Study|Physician Decision|1|||
145357778|NCT00848718|524158936|FG006|Overall Study|Physician Decision|0|||
145357779|NCT00848718|524158937|FG007|Overall Study|Physician Decision|0|||
145357780|NCT00848718|524158938|FG008|Overall Study|Physician Decision|1|||
145357781|NCT00848718|524158939|FG009|Overall Study|Physician Decision|2|||
145357782|NCT00848718|524158940|FG010|Overall Study|Physician Decision|0|||
145357783|NCT00848718|524158941|FG011|Overall Study|Physician Decision|0|||
145357784|NCT00848718|524158942|FG012|Overall Study|Physician Decision|1|||
145357785|NCT00848718|524158930|FG000|Overall Study|Progressive disease before treatment|1|||
145357786|NCT00848718|524158931|FG001|Overall Study|Progressive disease before treatment|5|||
145357787|NCT00848718|524158932|FG002|Overall Study|Progressive disease before treatment|1|||
145357788|NCT00848718|524158933|FG003|Overall Study|Progressive disease before treatment|3|||
145357789|NCT00848718|524158934|FG004|Overall Study|Progressive disease before treatment|4|||
145357790|NCT00848718|524158935|FG005|Overall Study|Progressive disease before treatment|4|||
145357791|NCT00848718|524158936|FG006|Overall Study|Progressive disease before treatment|2|||
145357792|NCT00848718|524158937|FG007|Overall Study|Progressive disease before treatment|1|||
145357793|NCT00848718|524158938|FG008|Overall Study|Progressive disease before treatment|2|||
145357794|NCT00848718|524158939|FG009|Overall Study|Progressive disease before treatment|7|||
145357795|NCT00848718|524158940|FG010|Overall Study|Progressive disease before treatment|3|||
145357796|NCT00848718|524158941|FG011|Overall Study|Progressive disease before treatment|6|||
145357797|NCT00848718|524158942|FG012|Overall Study|Progressive disease before treatment|2|||
145357798|NCT00848718|524158930|FG000|Overall Study|Protocol Violation|0|||
145357799|NCT00848718|524158931|FG001|Overall Study|Protocol Violation|1|||
145357800|NCT00848718|524158932|FG002|Overall Study|Protocol Violation|0|||
145357801|NCT00848718|524158933|FG003|Overall Study|Protocol Violation|0|||
145357802|NCT00848718|524158934|FG004|Overall Study|Protocol Violation|0|||
145357803|NCT00848718|524158935|FG005|Overall Study|Protocol Violation|0|||
145357804|NCT00848718|524158936|FG006|Overall Study|Protocol Violation|0|||
145357805|NCT00848718|524158937|FG007|Overall Study|Protocol Violation|1|||
145357806|NCT00848718|524158938|FG008|Overall Study|Protocol Violation|0|||
145357807|NCT00848718|524158939|FG009|Overall Study|Protocol Violation|0|||
145357808|NCT00848718|524158940|FG010|Overall Study|Protocol Violation|0|||
145577427|NCT01310413|524969411|FG004|Day 0 to Day 385|Other|0|||
145577428|NCT01310413|524969412|FG005|Day 0 to Day 385|Other|0|||
145577429|NCT01310413|524969413|FG006|Day 0 to Day 385|Other|0|||
145577430|NCT01310413|524969407|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577431|NCT01310413|524969408|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577432|NCT01310413|524969409|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577433|NCT01310413|524969410|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577434|NCT01310413|524969411|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577435|NCT01310413|524969412|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
145577436|NCT01310413|524969413|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
145577437|NCT01310413|524969407|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
145577438|NCT01310413|524969408|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
145577439|NCT01310413|524969409|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
145577440|NCT01310413|524969410|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
145577441|NCT01310413|524969411|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
145577442|NCT01310413|524969412|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
145577443|NCT01310413|524969413|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
145577444|NCT03019536|524969415|FG000|Overall Study|Withdrawal by Subject|1|||
145577445|NCT03019536|524969416|FG001|Overall Study|Withdrawal by Subject|1|||
145577446|NCT03019536|524969417|FG002|Overall Study|Withdrawal by Subject|0|||
145577447|NCT03019536|524969415|FG000|Overall Study|Adverse Event|0|||
145577448|NCT03019536|524969416|FG001|Overall Study|Adverse Event|0|||
145577449|NCT03019536|524969417|FG002|Overall Study|Adverse Event|2|||
145577450|NCT00182689|524969423|FG000|Overall Study|Adverse Event|8|||
145577451|NCT00182689|524969424|FG001|Overall Study|Adverse Event|11|||
145577452|NCT00182689|524969423|FG000|Overall Study|Withdrawal by Subject|2|||
145577453|NCT00182689|524969424|FG001|Overall Study|Withdrawal by Subject|2|||
145577454|NCT00182689|524969423|FG000|Overall Study|Progression|27|||
145577455|NCT00182689|524969424|FG001|Overall Study|Progression|29|||
145577456|NCT00182689|524969423|FG000|Overall Study|Death|1|||
145577457|NCT00182689|524969424|FG001|Overall Study|Death|0|||
145577458|NCT00182689|524969423|FG000|Overall Study|not protocol specified|0|||
145577459|NCT00182689|524969424|FG001|Overall Study|not protocol specified|3|||
145577460|NCT00182689|524969423|FG000|Overall Study|Ineligible|1|||
145577461|NCT00182689|524969424|FG001|Overall Study|Ineligible|4|||
145577462|NCT00182689|524969423|FG000|Overall Study|Never received treatment|1|||
145577463|NCT00182689|524969424|FG001|Overall Study|Never received treatment|0|||
145577464|NCT02391948|524969425|FG000|6-month Assessment|Death|0|||
145357809|NCT00848718|524158941|FG011|Overall Study|Protocol Violation|0|||
145357810|NCT00848718|524158942|FG012|Overall Study|Protocol Violation|1|||
145357811|NCT00848718|524158930|FG000|Overall Study|Withdrawal by Subject|1|||
145357812|NCT00848718|524158931|FG001|Overall Study|Withdrawal by Subject|0|||
145357813|NCT00848718|524158932|FG002|Overall Study|Withdrawal by Subject|0|||
145357814|NCT00848718|524158933|FG003|Overall Study|Withdrawal by Subject|1|||
145357815|NCT00848718|524158934|FG004|Overall Study|Withdrawal by Subject|0|||
145357816|NCT00848718|524158935|FG005|Overall Study|Withdrawal by Subject|0|||
145357817|NCT00848718|524158936|FG006|Overall Study|Withdrawal by Subject|0|||
145357818|NCT00848718|524158937|FG007|Overall Study|Withdrawal by Subject|0|||
145357819|NCT00848718|524158938|FG008|Overall Study|Withdrawal by Subject|0|||
145357820|NCT00848718|524158939|FG009|Overall Study|Withdrawal by Subject|0|||
145357821|NCT00848718|524158940|FG010|Overall Study|Withdrawal by Subject|1|||
145357822|NCT00848718|524158941|FG011|Overall Study|Withdrawal by Subject|0|||
145357823|NCT00848718|524158942|FG012|Overall Study|Withdrawal by Subject|0|||
145357824|NCT00848718|524158930|FG000|Overall Study|Progressive disease during treatment|3|||
145357825|NCT00848718|524158931|FG001|Overall Study|Progressive disease during treatment|0|||
145357826|NCT00848718|524158932|FG002|Overall Study|Progressive disease during treatment|3|||
145357827|NCT00848718|524158933|FG003|Overall Study|Progressive disease during treatment|0|||
145357828|NCT00848718|524158934|FG004|Overall Study|Progressive disease during treatment|0|||
145357829|NCT00848718|524158935|FG005|Overall Study|Progressive disease during treatment|0|||
145357830|NCT00848718|524158936|FG006|Overall Study|Progressive disease during treatment|0|||
145357831|NCT00848718|524158937|FG007|Overall Study|Progressive disease during treatment|2|||
145357832|NCT00848718|524158938|FG008|Overall Study|Progressive disease during treatment|0|||
145357833|NCT00848718|524158939|FG009|Overall Study|Progressive disease during treatment|0|||
145357834|NCT00848718|524158940|FG010|Overall Study|Progressive disease during treatment|0|||
145357835|NCT00848718|524158941|FG011|Overall Study|Progressive disease during treatment|0|||
145357836|NCT00848718|524158942|FG012|Overall Study|Progressive disease during treatment|2|||
145357837|NCT02389829|524158943|FG000|Overall Study|Lost to Follow-up|0|||
145357838|NCT02389829|524158944|FG001|Overall Study|Lost to Follow-up|1|||
145357839|NCT03817190|524158945|FG000|Overall Study|Early Termination|13|||
145357840|NCT03817190|524158946|FG001|Overall Study|Early Termination|20|||
145357841|NCT03817190|524158945|FG000|Overall Study|Adverse Event|10|||
145357842|NCT03817190|524158946|FG001|Overall Study|Adverse Event|17|||
145357843|NCT03817190|524158945|FG000|Overall Study|Withdrawal by Subject|12|||
145357844|NCT03817190|524158946|FG001|Overall Study|Withdrawal by Subject|8|||
145357845|NCT03817190|524158945|FG000|Overall Study|Lost to Follow-up|11|||
145357846|NCT03817190|524158946|FG001|Overall Study|Lost to Follow-up|7|||
145357847|NCT03817190|524158945|FG000|Overall Study|Lack of Efficacy|7|||
145357848|NCT03817190|524158946|FG001|Overall Study|Lack of Efficacy|5|||
145357849|NCT03817190|524158945|FG000|Overall Study|Investigator Decision|5|||
145357850|NCT03817190|524158946|FG001|Overall Study|Investigator Decision|1|||
145357851|NCT03817190|524158945|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
145357852|NCT03817190|524158946|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
145357853|NCT03817190|524158945|FG000|Overall Study|Lack of Contact|1|||
145357854|NCT03817190|524158946|FG001|Overall Study|Lack of Contact|0|||
145357855|NCT03817190|524158945|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
145357856|NCT03817190|524158946|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
145357857|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145357858|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145357859|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145357860|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145357861|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
145357862|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145357863|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145357864|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
145357865|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357866|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357867|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
145357868|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357869|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357870|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
145357871|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357872|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
145357873|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145357874|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145577465|NCT02391948|524969426|FG001|6-month Assessment|Death|0|||
145623115|NCT01052662|525131587|FG002|Overall Study|Administrative|0|||
145623116|NCT00479674|525131588|FG000|Overall Study|Adverse Event|18|||
145623117|NCT00479674|525131588|FG000|Overall Study|Withdrawal by Subject|6|||
145623118|NCT00479674|525131588|FG000|Overall Study|Physician Decision|14|||
145623119|NCT00479674|525131588|FG000|Overall Study|none provided|3|||
145623120|NCT03023332|525131589|FG000|Overall Study|Withdrawal by Subject|10|||
145623121|NCT03023332|525131590|FG001|Overall Study|Withdrawal by Subject|5|||
145623122|NCT03023332|525131591|FG002|Overall Study|Withdrawal by Subject|4|||
145623123|NCT03023332|525131592|FG003|Overall Study|Withdrawal by Subject|7|||
145623124|NCT03023332|525131589|FG000|Overall Study|Lost to Follow-up|13|||
145623125|NCT03023332|525131590|FG001|Overall Study|Lost to Follow-up|16|||
145623126|NCT03023332|525131591|FG002|Overall Study|Lost to Follow-up|8|||
145357875|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145357876|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145357877|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145357878|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145357879|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
145357880|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
145357881|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145357882|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145357883|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145357884|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145357885|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145357886|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
145357887|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145357888|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
145357889|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357890|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357891|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
145357892|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357893|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357894|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357895|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
145357896|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357897|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145357898|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145357899|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
145357900|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145357901|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145357902|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
145357903|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
145357904|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
145357905|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
145357906|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
145357907|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357908|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357909|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357910|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357911|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357912|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
145357913|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357914|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
145357915|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357916|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357917|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357918|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357919|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145623127|NCT03023332|525131592|FG003|Overall Study|Lost to Follow-up|13|||
145623128|NCT03023332|525131589|FG000|Overall Study|Death|1|||
145623129|NCT03023332|525131590|FG001|Overall Study|Death|0|||
145623130|NCT03023332|525131591|FG002|Overall Study|Death|0|||
145623131|NCT03023332|525131592|FG003|Overall Study|Death|0|||
145623132|NCT01272011|525131595|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
145418147|NCT04518410|524386775|FG013|Overall Study|Lost to Follow-up|13|||
145418148|NCT04518410|524386776|FG014|Overall Study|Lost to Follow-up|8|||
145418149|NCT04518410|524386777|FG015|Overall Study|Lost to Follow-up|10|||
145418150|NCT04518410|524386778|FG016|Overall Study|Lost to Follow-up|6|||
145418151|NCT04518410|524386779|FG017|Overall Study|Lost to Follow-up|13|||
145418152|NCT04518410|524386780|FG018|Overall Study|Lost to Follow-up|21|||
145418153|NCT04518410|524386781|FG019|Overall Study|Lost to Follow-up|6|||
145418154|NCT04518410|524386782|FG020|Overall Study|Lost to Follow-up|7|||
145418155|NCT04518410|524386783|FG021|Overall Study|Lost to Follow-up|21|||
145418156|NCT04518410|524386784|FG022|Overall Study|Lost to Follow-up|1|||
145418157|NCT04518410|524386785|FG023|Overall Study|Lost to Follow-up|7|||
145418158|NCT04518410|524386786|FG024|Overall Study|Lost to Follow-up|6|||
145418159|NCT04518410|524386762|FG000|Overall Study|Withdrawal by Subject|1|||
145418160|NCT04518410|524386763|FG001|Overall Study|Withdrawal by Subject|2|||
145418161|NCT04518410|524386764|FG002|Overall Study|Withdrawal by Subject|2|||
145418162|NCT04518410|524386765|FG003|Overall Study|Withdrawal by Subject|3|||
145418163|NCT04518410|524386766|FG004|Overall Study|Withdrawal by Subject|20|||
145418164|NCT04518410|524386767|FG005|Overall Study|Withdrawal by Subject|20|||
145418165|NCT04518410|524386768|FG006|Overall Study|Withdrawal by Subject|25|||
145418166|NCT04518410|524386769|FG007|Overall Study|Withdrawal by Subject|6|||
145418167|NCT04518410|524386770|FG008|Overall Study|Withdrawal by Subject|1|||
145418168|NCT04518410|524386771|FG009|Overall Study|Withdrawal by Subject|12|||
145418169|NCT04518410|524386772|FG010|Overall Study|Withdrawal by Subject|5|||
145418170|NCT04518410|524386773|FG011|Overall Study|Withdrawal by Subject|7|||
145418171|NCT04518410|524386774|FG012|Overall Study|Withdrawal by Subject|2|||
145418172|NCT04518410|524386775|FG013|Overall Study|Withdrawal by Subject|13|||
145418173|NCT04518410|524386776|FG014|Overall Study|Withdrawal by Subject|4|||
145418174|NCT04518410|524386777|FG015|Overall Study|Withdrawal by Subject|9|||
145418175|NCT04518410|524386778|FG016|Overall Study|Withdrawal by Subject|0|||
145418176|NCT04518410|524386779|FG017|Overall Study|Withdrawal by Subject|15|||
145418177|NCT04518410|524386780|FG018|Overall Study|Withdrawal by Subject|12|||
145418178|NCT04518410|524386781|FG019|Overall Study|Withdrawal by Subject|9|||
145418179|NCT04518410|524386782|FG020|Overall Study|Withdrawal by Subject|14|||
145418180|NCT04518410|524386783|FG021|Overall Study|Withdrawal by Subject|3|||
145418181|NCT04518410|524386784|FG022|Overall Study|Withdrawal by Subject|2|||
145418182|NCT04518410|524386785|FG023|Overall Study|Withdrawal by Subject|9|||
145418183|NCT04518410|524386786|FG024|Overall Study|Withdrawal by Subject|8|||
145418184|NCT04518410|524386762|FG000|Overall Study|Other|1|||
145418185|NCT04518410|524386763|FG001|Overall Study|Other|0|||
145418186|NCT04518410|524386764|FG002|Overall Study|Other|0|||
145418187|NCT04518410|524386765|FG003|Overall Study|Other|1|||
145418188|NCT04518410|524386766|FG004|Overall Study|Other|6|||
145418189|NCT04518410|524386767|FG005|Overall Study|Other|6|||
145418190|NCT04518410|524386768|FG006|Overall Study|Other|5|||
145418191|NCT04518410|524386769|FG007|Overall Study|Other|2|||
145577466|NCT02391948|524969427|FG002|6-month Assessment|Death|0|||
145577467|NCT02391948|524969428|FG003|6-month Assessment|Death|0|||
145577468|NCT02391948|524969429|FG004|6-month Assessment|Death|1|||
145577469|NCT02391948|524969425|FG000|6-month Assessment|Withdrawal by Subject|0|||
145577470|NCT02391948|524969426|FG001|6-month Assessment|Withdrawal by Subject|0|||
145577471|NCT02391948|524969427|FG002|6-month Assessment|Withdrawal by Subject|1|||
145577472|NCT02391948|524969428|FG003|6-month Assessment|Withdrawal by Subject|2|||
145577473|NCT02391948|524969429|FG004|6-month Assessment|Withdrawal by Subject|0|||
145577474|NCT02391948|524969425|FG000|6-month Assessment|Lost to Follow-up|4|||
145577475|NCT02391948|524969426|FG001|6-month Assessment|Lost to Follow-up|5|||
145577476|NCT02391948|524969427|FG002|6-month Assessment|Lost to Follow-up|2|||
145577477|NCT02391948|524969428|FG003|6-month Assessment|Lost to Follow-up|3|||
145577478|NCT02391948|524969429|FG004|6-month Assessment|Lost to Follow-up|1|||
145577479|NCT02391948|524969425|FG000|6-month Assessment|Medical issue/illness|1|||
145577480|NCT02391948|524969426|FG001|6-month Assessment|Medical issue/illness|1|||
145577481|NCT02391948|524969427|FG002|6-month Assessment|Medical issue/illness|0|||
145418192|NCT04518410|524386770|FG008|Overall Study|Other|0|||
145418193|NCT04518410|524386771|FG009|Overall Study|Other|1|||
145418194|NCT04518410|524386772|FG010|Overall Study|Other|0|||
145418195|NCT04518410|524386773|FG011|Overall Study|Other|2|||
145418196|NCT04518410|524386774|FG012|Overall Study|Other|0|||
145577482|NCT02391948|524969428|FG003|6-month Assessment|Medical issue/illness|0|||
145418197|NCT04518410|524386775|FG013|Overall Study|Other|0|||
145418198|NCT04518410|524386776|FG014|Overall Study|Other|0|||
145418199|NCT04518410|524386777|FG015|Overall Study|Other|3|||
145418200|NCT04518410|524386778|FG016|Overall Study|Other|1|||
145418201|NCT04518410|524386779|FG017|Overall Study|Other|1|||
145418202|NCT04518410|524386780|FG018|Overall Study|Other|1|||
145418203|NCT04518410|524386781|FG019|Overall Study|Other|0|||
145418204|NCT04518410|524386782|FG020|Overall Study|Other|1|||
145418205|NCT04518410|524386783|FG021|Overall Study|Other|0|||
145418206|NCT04518410|524386784|FG022|Overall Study|Other|1|||
145418207|NCT04518410|524386785|FG023|Overall Study|Other|2|||
145418208|NCT04518410|524386786|FG024|Overall Study|Other|2|||
145418209|NCT04518410|524386762|FG000|Overall Study|Protocol Violation|0|||
145418210|NCT04518410|524386763|FG001|Overall Study|Protocol Violation|0|||
145418211|NCT04518410|524386764|FG002|Overall Study|Protocol Violation|0|||
145418212|NCT04518410|524386765|FG003|Overall Study|Protocol Violation|2|||
145418213|NCT04518410|524386766|FG004|Overall Study|Protocol Violation|17|||
145418214|NCT04518410|524386767|FG005|Overall Study|Protocol Violation|1|||
145418215|NCT04518410|524386768|FG006|Overall Study|Protocol Violation|2|||
145418216|NCT04518410|524386769|FG007|Overall Study|Protocol Violation|1|||
145418217|NCT04518410|524386770|FG008|Overall Study|Protocol Violation|0|||
145418218|NCT04518410|524386771|FG009|Overall Study|Protocol Violation|0|||
145418219|NCT04518410|524386772|FG010|Overall Study|Protocol Violation|0|||
145418220|NCT04518410|524386773|FG011|Overall Study|Protocol Violation|0|||
145418221|NCT04518410|524386774|FG012|Overall Study|Protocol Violation|0|||
145418222|NCT04518410|524386775|FG013|Overall Study|Protocol Violation|0|||
145418223|NCT04518410|524386776|FG014|Overall Study|Protocol Violation|0|||
145418224|NCT04518410|524386777|FG015|Overall Study|Protocol Violation|0|||
145418225|NCT04518410|524386778|FG016|Overall Study|Protocol Violation|1|||
145418226|NCT04518410|524386779|FG017|Overall Study|Protocol Violation|1|||
145418227|NCT04518410|524386780|FG018|Overall Study|Protocol Violation|0|||
145418228|NCT04518410|524386781|FG019|Overall Study|Protocol Violation|0|||
145418229|NCT04518410|524386782|FG020|Overall Study|Protocol Violation|1|||
145418230|NCT04518410|524386783|FG021|Overall Study|Protocol Violation|2|||
145418231|NCT04518410|524386784|FG022|Overall Study|Protocol Violation|0|||
145418232|NCT04518410|524386785|FG023|Overall Study|Protocol Violation|3|||
145418233|NCT04518410|524386786|FG024|Overall Study|Protocol Violation|0|||
145418234|NCT04518410|524386762|FG000|Overall Study|Death|0|||
145418235|NCT04518410|524386763|FG001|Overall Study|Death|0|||
145418236|NCT04518410|524386764|FG002|Overall Study|Death|0|||
145357920|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
145357921|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357922|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357923|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357924|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357925|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
145357926|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357927|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357928|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
145357929|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357930|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357931|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357932|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357933|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357934|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
145357935|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357936|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
145357937|NCT03896503|524160485|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357938|NCT03896503|524160486|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357939|NCT03896503|524160487|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357940|NCT03896503|524160488|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357941|NCT03896503|524160489|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357942|NCT03896503|524160490|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
145357943|NCT03896503|524160491|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
145357944|NCT03896503|524160492|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
145357945|NCT01120184|524160495|FG000|Overall Study|Adverse Event|0|||
145357946|NCT01120184|524160496|FG001|Overall Study|Adverse Event|1|||
145357947|NCT01120184|524160497|FG002|Overall Study|Adverse Event|0|||
145357948|NCT01120184|524160495|FG000|Overall Study|Lost to Follow-up|13|||
145357949|NCT01120184|524160496|FG001|Overall Study|Lost to Follow-up|13|||
145357950|NCT01120184|524160497|FG002|Overall Study|Lost to Follow-up|11|||
145357951|NCT01120184|524160495|FG000|Overall Study|Physician Decision|9|||
145357952|NCT01120184|524160496|FG001|Overall Study|Physician Decision|1|||
145357953|NCT01120184|524160497|FG002|Overall Study|Physician Decision|3|||
145418237|NCT04518410|524386765|FG003|Overall Study|Death|0|||
145418238|NCT04518410|524386766|FG004|Overall Study|Death|12|||
145418239|NCT04518410|524386767|FG005|Overall Study|Death|2|||
145418240|NCT04518410|524386768|FG006|Overall Study|Death|11|||
145418241|NCT04518410|524386769|FG007|Overall Study|Death|0|||
145418242|NCT04518410|524386770|FG008|Overall Study|Death|1|||
145418243|NCT04518410|524386771|FG009|Overall Study|Death|0|||
145418244|NCT04518410|524386772|FG010|Overall Study|Death|0|||
145418245|NCT04518410|524386773|FG011|Overall Study|Death|0|||
145418246|NCT04518410|524386774|FG012|Overall Study|Death|0|||
145418247|NCT04518410|524386775|FG013|Overall Study|Death|1|||
145357954|NCT01120184|524160495|FG000|Overall Study|Reason not Specified|8|||
145357955|NCT01120184|524160496|FG001|Overall Study|Reason not Specified|3|||
145357956|NCT01120184|524160497|FG002|Overall Study|Reason not Specified|12|||
145357957|NCT01120184|524160495|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
145357958|NCT01120184|524160496|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
145357959|NCT01120184|524160497|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
145357960|NCT01120184|524160495|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
145357961|NCT01120184|524160496|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
145357962|NCT01120184|524160497|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
145357963|NCT01120184|524160495|FG000|Overall Study|Death|170|||
145357964|NCT01120184|524160496|FG001|Overall Study|Death|176|||
145357965|NCT01120184|524160497|FG002|Overall Study|Death|169|||
145357966|NCT00824772|524160498|FG000|Overall Study|Withdrawal by Subject|8|||
145357967|NCT00529087|524160504|FG000|Overall Study|Adverse Event|10|||
145357968|NCT00529087|524160505|FG001|Overall Study|Adverse Event|13|||
145357969|NCT00529087|524160506|FG002|Overall Study|Adverse Event|4|||
145357970|NCT00529087|524160504|FG000|Overall Study|Lost to Follow-up|6|||
145357971|NCT00529087|524160505|FG001|Overall Study|Lost to Follow-up|4|||
145357972|NCT00529087|524160506|FG002|Overall Study|Lost to Follow-up|1|||
145357973|NCT00529087|524160504|FG000|Overall Study|Protocol Violation|8|||
145357974|NCT00529087|524160505|FG001|Overall Study|Protocol Violation|7|||
145357975|NCT00529087|524160506|FG002|Overall Study|Protocol Violation|6|||
145357976|NCT00529087|524160504|FG000|Overall Study|Withdrawal by Subject|3|||
145357977|NCT00529087|524160505|FG001|Overall Study|Withdrawal by Subject|3|||
145357978|NCT00529087|524160506|FG002|Overall Study|Withdrawal by Subject|3|||
145357979|NCT00529087|524160504|FG000|Overall Study|Protocol deviation|1|||
145357980|NCT00529087|524160505|FG001|Overall Study|Protocol deviation|1|||
145357981|NCT00529087|524160506|FG002|Overall Study|Protocol deviation|2|||
145357982|NCT02954601|524160507|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
145357983|NCT02954601|524160508|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
145357984|NCT02954601|524160509|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
145357985|NCT02954601|524160510|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
145357986|NCT00318474|524160511|FG000|Overall Study|Adverse Event|1|||
145357987|NCT00318474|524160512|FG001|Overall Study|Adverse Event|1|||
145357988|NCT00318474|524160511|FG000|Overall Study|Lost to Follow-up|0|||
145357989|NCT00318474|524160512|FG001|Overall Study|Lost to Follow-up|1|||
145357990|NCT00318474|524160511|FG000|Overall Study|Pregnancy|0|||
145357991|NCT00318474|524160512|FG001|Overall Study|Pregnancy|2|||
145357992|NCT00318474|524160511|FG000|Overall Study|Protocol Violation|1|||
145357993|NCT00318474|524160512|FG001|Overall Study|Protocol Violation|0|||
145357994|NCT00318474|524160511|FG000|Overall Study|Withdrawal by Subject|3|||
145357995|NCT00318474|524160512|FG001|Overall Study|Withdrawal by Subject|2|||
145357996|NCT00318474|524160511|FG000|Overall Study|Fall in GFR|3|||
145357997|NCT00318474|524160512|FG001|Overall Study|Fall in GFR|3|||
145357998|NCT00318474|524160511|FG000|Overall Study|Post-therapy hyperflycemia|0|||
145357999|NCT00318474|524160512|FG001|Overall Study|Post-therapy hyperflycemia|1|||
145358000|NCT00318474|524160511|FG000|Overall Study|Trial terminated|10|||
145358001|NCT00318474|524160512|FG001|Overall Study|Trial terminated|7|||
145358002|NCT01735916|524160521|FG000|Overall Study|Subject not eligible to be randomized|11|||
145358003|NCT01735916|524160522|FG001|Overall Study|Subject not eligible to be randomized|0|||
145358004|NCT01735916|524160523|FG002|Overall Study|Subject not eligible to be randomized|0|||
145358005|NCT01735916|524160521|FG000|Overall Study|Early termination of study by sponsor|4|||
145358006|NCT01735916|524160522|FG001|Overall Study|Early termination of study by sponsor|19|||
145358007|NCT01735916|524160523|FG002|Overall Study|Early termination of study by sponsor|7|||
145358008|NCT01735916|524160521|FG000|Overall Study|Withdrawal by Subject|3|||
145358009|NCT01735916|524160522|FG001|Overall Study|Withdrawal by Subject|0|||
145358010|NCT01735916|524160523|FG002|Overall Study|Withdrawal by Subject|0|||
145358011|NCT02275546|524160529|FG000|Treatment Period 2|Withdrawal by Subject|2|||
145358012|NCT02275546|524160530|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145358013|NCT02275546|524160529|FG000|Treatment Period 2|Protocol Violation|0|||
145358014|NCT02275546|524160530|FG001|Treatment Period 2|Protocol Violation|1|||
145358015|NCT02955355|524160531|FG000|Overall Study|Adverse Event|4|||
145358016|NCT02955355|524160531|FG000|Overall Study|Death|1|||
145358017|NCT02955355|524160531|FG000|Overall Study|Physician Decision|21|||
145358018|NCT02955355|524160531|FG000|Overall Study|Site Terminated by Sponsor|35|||
145358019|NCT02955355|524160531|FG000|Overall Study|Withdrawal by Subject|19|||
145358020|NCT02955355|524160531|FG000|Overall Study|Reason Not Specified|5|||
145358021|NCT00333983|524160532|FG000|Overall Study|Lost to Follow-up|2|||
145358022|NCT00333983|524160533|FG001|Overall Study|Lost to Follow-up|1|||
145358023|NCT00333983|524160534|FG002|Overall Study|Lost to Follow-up|0|||
145358024|NCT00333983|524160532|FG000|Overall Study|Adverse Event|1|||
145358025|NCT00333983|524160533|FG001|Overall Study|Adverse Event|1|||
145358026|NCT00333983|524160534|FG002|Overall Study|Adverse Event|1|||
145358027|NCT00333983|524160532|FG000|Overall Study|Withdrawal by Subject|0|||
145358028|NCT00333983|524160533|FG001|Overall Study|Withdrawal by Subject|3|||
145577483|NCT02391948|524969429|FG004|6-month Assessment|Medical issue/illness|0|||
145418248|NCT04518410|524386776|FG014|Overall Study|Death|1|||
145418249|NCT04518410|524386777|FG015|Overall Study|Death|0|||
145418250|NCT04518410|524386778|FG016|Overall Study|Death|0|||
145418251|NCT04518410|524386779|FG017|Overall Study|Death|1|||
145418252|NCT04518410|524386780|FG018|Overall Study|Death|4|||
145418253|NCT04518410|524386781|FG019|Overall Study|Death|4|||
145418254|NCT04518410|524386782|FG020|Overall Study|Death|1|||
145418255|NCT04518410|524386783|FG021|Overall Study|Death|0|||
145418256|NCT04518410|524386784|FG022|Overall Study|Death|0|||
145418257|NCT04518410|524386785|FG023|Overall Study|Death|0|||
145418258|NCT04518410|524386786|FG024|Overall Study|Death|0|||
145418259|NCT04518410|524386762|FG000|Overall Study|Requirement to start alternative therapy|0|||
145418260|NCT04518410|524386763|FG001|Overall Study|Requirement to start alternative therapy|0|||
145418261|NCT04518410|524386764|FG002|Overall Study|Requirement to start alternative therapy|1|||
145418262|NCT04518410|524386765|FG003|Overall Study|Requirement to start alternative therapy|0|||
145418263|NCT04518410|524386766|FG004|Overall Study|Requirement to start alternative therapy|0|||
145418264|NCT04518410|524386767|FG005|Overall Study|Requirement to start alternative therapy|0|||
145418265|NCT04518410|524386768|FG006|Overall Study|Requirement to start alternative therapy|0|||
145418266|NCT04518410|524386769|FG007|Overall Study|Requirement to start alternative therapy|0|||
145418267|NCT04518410|524386770|FG008|Overall Study|Requirement to start alternative therapy|0|||
145418268|NCT04518410|524386771|FG009|Overall Study|Requirement to start alternative therapy|0|||
145418269|NCT04518410|524386772|FG010|Overall Study|Requirement to start alternative therapy|0|||
145418270|NCT04518410|524386773|FG011|Overall Study|Requirement to start alternative therapy|0|||
145418271|NCT04518410|524386774|FG012|Overall Study|Requirement to start alternative therapy|0|||
145418272|NCT04518410|524386775|FG013|Overall Study|Requirement to start alternative therapy|0|||
145418273|NCT04518410|524386776|FG014|Overall Study|Requirement to start alternative therapy|0|||
145418274|NCT04518410|524386777|FG015|Overall Study|Requirement to start alternative therapy|0|||
145418275|NCT04518410|524386778|FG016|Overall Study|Requirement to start alternative therapy|0|||
145418276|NCT04518410|524386779|FG017|Overall Study|Requirement to start alternative therapy|0|||
145418277|NCT04518410|524386780|FG018|Overall Study|Requirement to start alternative therapy|0|||
145418278|NCT04518410|524386781|FG019|Overall Study|Requirement to start alternative therapy|0|||
145418279|NCT04518410|524386782|FG020|Overall Study|Requirement to start alternative therapy|0|||
145418280|NCT04518410|524386783|FG021|Overall Study|Requirement to start alternative therapy|0|||
145418281|NCT04518410|524386784|FG022|Overall Study|Requirement to start alternative therapy|0|||
145418282|NCT04518410|524386785|FG023|Overall Study|Requirement to start alternative therapy|0|||
145418283|NCT04518410|524386786|FG024|Overall Study|Requirement to start alternative therapy|0|||
145418284|NCT04518410|524386762|FG000|Overall Study|Randomized but not treated|0|||
145418285|NCT04518410|524386763|FG001|Overall Study|Randomized but not treated|0|||
145418286|NCT04518410|524386764|FG002|Overall Study|Randomized but not treated|0|||
145418287|NCT04518410|524386765|FG003|Overall Study|Randomized but not treated|2|||
145418288|NCT04518410|524386766|FG004|Overall Study|Randomized but not treated|6|||
145418289|NCT04518410|524386767|FG005|Overall Study|Randomized but not treated|4|||
145418290|NCT04518410|524386768|FG006|Overall Study|Randomized but not treated|3|||
145418291|NCT04518410|524386769|FG007|Overall Study|Randomized but not treated|3|||
145418292|NCT04518410|524386770|FG008|Overall Study|Randomized but not treated|0|||
145418293|NCT04518410|524386771|FG009|Overall Study|Randomized but not treated|4|||
145418294|NCT04518410|524386772|FG010|Overall Study|Randomized but not treated|0|||
145418295|NCT04518410|524386773|FG011|Overall Study|Randomized but not treated|0|||
145418296|NCT04518410|524386774|FG012|Overall Study|Randomized but not treated|1|||
145418297|NCT04518410|524386775|FG013|Overall Study|Randomized but not treated|3|||
145418298|NCT04518410|524386776|FG014|Overall Study|Randomized but not treated|3|||
145418299|NCT04518410|524386777|FG015|Overall Study|Randomized but not treated|3|||
145418300|NCT04518410|524386778|FG016|Overall Study|Randomized but not treated|4|||
145418301|NCT04518410|524386779|FG017|Overall Study|Randomized but not treated|5|||
145418302|NCT04518410|524386780|FG018|Overall Study|Randomized but not treated|4|||
145418303|NCT04518410|524386781|FG019|Overall Study|Randomized but not treated|0|||
145418304|NCT04518410|524386782|FG020|Overall Study|Randomized but not treated|0|||
145418305|NCT04518410|524386783|FG021|Overall Study|Randomized but not treated|5|||
145418306|NCT04518410|524386784|FG022|Overall Study|Randomized but not treated|0|||
145418307|NCT04518410|524386785|FG023|Overall Study|Randomized but not treated|3|||
145418308|NCT04518410|524386786|FG024|Overall Study|Randomized but not treated|1|||
145577484|NCT02391948|524969425|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
145577485|NCT02391948|524969426|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
145418309|NCT04518410|524386762|FG000|Overall Study|Screen Fail but Randomized|0|||
145577486|NCT02391948|524969427|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
145577487|NCT02391948|524969428|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
145418310|NCT04518410|524386763|FG001|Overall Study|Screen Fail but Randomized|0|||
145418311|NCT04518410|524386764|FG002|Overall Study|Screen Fail but Randomized|0|||
145418312|NCT04518410|524386765|FG003|Overall Study|Screen Fail but Randomized|0|||
145418313|NCT04518410|524386766|FG004|Overall Study|Screen Fail but Randomized|2|||
145418314|NCT04518410|524386767|FG005|Overall Study|Screen Fail but Randomized|0|||
145418315|NCT04518410|524386768|FG006|Overall Study|Screen Fail but Randomized|0|||
145358029|NCT00333983|524160534|FG002|Overall Study|Withdrawal by Subject|1|||
145358030|NCT01379768|524160537|FG000|Overall Study|Adverse Event|1|||
145358031|NCT01379768|524160538|FG001|Overall Study|Adverse Event|1|||
145358032|NCT01379768|524160539|FG002|Overall Study|Adverse Event|0|||
145358033|NCT01379768|524160537|FG000|Overall Study|Lost to Follow-up|2|||
145358034|NCT01379768|524160538|FG001|Overall Study|Lost to Follow-up|0|||
145358035|NCT01379768|524160539|FG002|Overall Study|Lost to Follow-up|0|||
145358036|NCT02075203|524160544|FG000|Overall Study|Withdrawal by Subject|1|||
145358037|NCT02075203|524160545|FG001|Overall Study|Withdrawal by Subject|0|||
145358038|NCT02075203|524160546|FG002|Overall Study|Withdrawal by Subject|1|||
145358039|NCT02075203|524160544|FG000|Overall Study|Adverse Event|1|||
145358040|NCT02075203|524160545|FG001|Overall Study|Adverse Event|0|||
145358041|NCT02075203|524160546|FG002|Overall Study|Adverse Event|0|||
145358042|NCT02075203|524160544|FG000|Overall Study|participant refused to use contraception|1|||
145358043|NCT02075203|524160545|FG001|Overall Study|participant refused to use contraception|0|||
145358044|NCT02075203|524160546|FG002|Overall Study|participant refused to use contraception|0|||
145358045|NCT00568451|524160555|FG000|Overall Study|Disease Progression|0|||
145358046|NCT00568451|524160556|FG001|Overall Study|Disease Progression|0|||
145358047|NCT00568451|524160557|FG002|Overall Study|Disease Progression|2|||
145358048|NCT00568451|524160558|FG003|Overall Study|Disease Progression|7|||
145358049|NCT05344560|524160559|FG000|Period 1|Subject out of visit window|1|||
145358050|NCT05344560|524160560|FG001|Period 1|Subject out of visit window|1|||
145358051|NCT05344560|524160559|FG000|Period 2|Covid-19 Related|1|||
145358052|NCT05344560|524160560|FG001|Period 2|Covid-19 Related|0|||
145358053|NCT05344560|524160559|FG000|Period 2|Adverse Event|1|||
145358054|NCT05344560|524160560|FG001|Period 2|Adverse Event|0|||
145358055|NCT05344560|524160559|FG000|Period 2|Subject out of visit window|1|||
145358056|NCT05344560|524160560|FG001|Period 2|Subject out of visit window|1|||
145358057|NCT05344560|524160559|FG000|Period 3|Subject out of visit window|1|||
145358058|NCT05344560|524160560|FG001|Period 3|Subject out of visit window|0|||
145358059|NCT02996968|524160561|FG000|Overall Study|Withdrawal by Subject|1|||
145358060|NCT02996968|524160562|FG001|Overall Study|Withdrawal by Subject|0|||
145358061|NCT03817853|524160563|FG000|Induction Phase|Adverse Event|5|||
145358062|NCT03817853|524160564|FG001|Induction Phase|Adverse Event|0|||
145358063|NCT03817853|524160565|FG002|Induction Phase|Adverse Event|0|||
145358064|NCT03817853|524160563|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
145358065|NCT03817853|524160564|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
145358066|NCT03817853|524160565|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
145358067|NCT03817853|524160563|FG000|Induction Phase|Physician Decision|2|||
145358068|NCT03817853|524160564|FG001|Induction Phase|Physician Decision|0|||
145358069|NCT03817853|524160565|FG002|Induction Phase|Physician Decision|0|||
145358070|NCT03817853|524160563|FG000|Induction Phase|Progressive Disease|6|||
145358071|NCT03817853|524160564|FG001|Induction Phase|Progressive Disease|0|||
145358072|NCT03817853|524160565|FG002|Induction Phase|Progressive Disease|0|||
145358073|NCT03817853|524160563|FG000|Induction Phase|Withdrawal by Subject|4|||
145358074|NCT03817853|524160564|FG001|Induction Phase|Withdrawal by Subject|0|||
145358075|NCT03817853|524160565|FG002|Induction Phase|Withdrawal by Subject|0|||
145358076|NCT03817853|524160563|FG000|Maintenance Phase|Adverse Event|0|||
145358077|NCT03817853|524160564|FG001|Maintenance Phase|Adverse Event|8|||
145358078|NCT03817853|524160565|FG002|Maintenance Phase|Adverse Event|0|||
145358079|NCT03817853|524160563|FG000|Maintenance Phase|Death|0|||
145358080|NCT03817853|524160564|FG001|Maintenance Phase|Death|5|||
145358081|NCT03817853|524160565|FG002|Maintenance Phase|Death|0|||
145358082|NCT03817853|524160563|FG000|Maintenance Phase|Progressive Disease|0|||
145358083|NCT03817853|524160564|FG001|Maintenance Phase|Progressive Disease|7|||
145358084|NCT03817853|524160565|FG002|Maintenance Phase|Progressive Disease|0|||
145358085|NCT03817853|524160563|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145358086|NCT03817853|524160564|FG001|Maintenance Phase|Withdrawal by Subject|2|||
145358087|NCT03817853|524160565|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145418316|NCT04518410|524386769|FG007|Overall Study|Screen Fail but Randomized|0|||
145418317|NCT04518410|524386770|FG008|Overall Study|Screen Fail but Randomized|0|||
145418318|NCT04518410|524386771|FG009|Overall Study|Screen Fail but Randomized|0|||
145358088|NCT03817853|524160563|FG000|Maintenance Phase|Physician Decision|0|||
145358089|NCT03817853|524160564|FG001|Maintenance Phase|Physician Decision|1|||
145358090|NCT03817853|524160565|FG002|Maintenance Phase|Physician Decision|0|||
145358091|NCT03817853|524160563|FG000|Maintenance Phase|Various reasons|0|||
145358092|NCT03817853|524160564|FG001|Maintenance Phase|Various reasons|4|||
145358093|NCT03817853|524160565|FG002|Maintenance Phase|Various reasons|0|||
145358094|NCT03817853|524160563|FG000|Maintenance Phase|Protocol Deviation|0|||
145358095|NCT03817853|524160564|FG001|Maintenance Phase|Protocol Deviation|1|||
145358096|NCT03817853|524160565|FG002|Maintenance Phase|Protocol Deviation|0|||
145358097|NCT03817853|524160563|FG000|Follow-up Phase|Adverse Event|0|||
145358098|NCT03817853|524160564|FG001|Follow-up Phase|Adverse Event|0|||
145358099|NCT03817853|524160565|FG002|Follow-up Phase|Adverse Event|2|||
145358100|NCT03817853|524160563|FG000|Follow-up Phase|Death|0|||
145418319|NCT04518410|524386772|FG010|Overall Study|Screen Fail but Randomized|0|||
145358101|NCT03817853|524160564|FG001|Follow-up Phase|Death|0|||
145358102|NCT03817853|524160565|FG002|Follow-up Phase|Death|1|||
145358103|NCT03817853|524160563|FG000|Follow-up Phase|Progressive Disease|0|||
145358104|NCT03817853|524160564|FG001|Follow-up Phase|Progressive Disease|0|||
145358105|NCT03817853|524160565|FG002|Follow-up Phase|Progressive Disease|3|||
145358106|NCT03817853|524160563|FG000|Follow-up Phase|Withdrawal by Subject|0|||
145358107|NCT03817853|524160564|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145358108|NCT03817853|524160565|FG002|Follow-up Phase|Withdrawal by Subject|1|||
145358109|NCT00391768|524160566|FG000|Overall Study|Withdrawal by Subject|0|||
145358110|NCT00391768|524160567|FG001|Overall Study|Withdrawal by Subject|0|||
145358111|NCT00391768|524160568|FG002|Overall Study|Withdrawal by Subject|1|||
145358112|NCT00391768|524160569|FG003|Overall Study|Withdrawal by Subject|0|||
145358113|NCT00391768|524160570|FG004|Overall Study|Withdrawal by Subject|0|||
145358114|NCT00391768|524160571|FG005|Overall Study|Withdrawal by Subject|1|||
145358115|NCT00391768|524160572|FG006|Overall Study|Withdrawal by Subject|1|||
145358116|NCT00391768|524160566|FG000|Overall Study|Lost to Follow-up|0|||
145358117|NCT00391768|524160567|FG001|Overall Study|Lost to Follow-up|0|||
145358118|NCT00391768|524160568|FG002|Overall Study|Lost to Follow-up|0|||
145358119|NCT00391768|524160569|FG003|Overall Study|Lost to Follow-up|1|||
145358120|NCT00391768|524160570|FG004|Overall Study|Lost to Follow-up|2|||
145358121|NCT00391768|524160571|FG005|Overall Study|Lost to Follow-up|2|||
145358122|NCT00391768|524160572|FG006|Overall Study|Lost to Follow-up|3|||
145358123|NCT01620138|524160573|FG000|Overall Study|Withdrawal by Subject|3|||
145358124|NCT01620138|524160574|FG001|Overall Study|Withdrawal by Subject|0|||
145358125|NCT01620138|524160573|FG000|Overall Study|Lack of Efficacy|1|||
145358126|NCT01620138|524160574|FG001|Overall Study|Lack of Efficacy|0|||
145358127|NCT01620138|524160573|FG000|Overall Study|Adverse Event|2|||
145358128|NCT01620138|524160574|FG001|Overall Study|Adverse Event|0|||
145358129|NCT00449865|524160577|FG000|Overall Study|Withdrawal by Subject|110|||
145358130|NCT00449865|524160578|FG001|Overall Study|Withdrawal by Subject|110|||
145358131|NCT00449865|524160577|FG000|Overall Study|Lost to Follow-up|36|||
145358132|NCT00449865|524160578|FG001|Overall Study|Lost to Follow-up|37|||
145358133|NCT00449865|524160577|FG000|Overall Study|Physician Decision|13|||
145358134|NCT00449865|524160578|FG001|Overall Study|Physician Decision|12|||
145358135|NCT00449865|524160577|FG000|Overall Study|Death|31|||
145358136|NCT00449865|524160578|FG001|Overall Study|Death|40|||
145358137|NCT00449865|524160577|FG000|Overall Study|Protocol Violation|8|||
145358138|NCT00449865|524160578|FG001|Overall Study|Protocol Violation|7|||
145358139|NCT00449865|524160577|FG000|Overall Study|Study was stopped|324|||
145358140|NCT00449865|524160578|FG001|Overall Study|Study was stopped|328|||
145358141|NCT00406367|524160579|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
145358142|NCT00406367|524160580|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145358143|NCT00406367|524160579|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
145358144|NCT00406367|524160580|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
145358145|NCT00406367|524160579|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
145358146|NCT00406367|524160580|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
145358147|NCT00406367|524160579|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
145358148|NCT00406367|524160580|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
145358149|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
145358150|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
145358151|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
145358152|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
145358153|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
145358154|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
145358155|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
145358156|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
145358157|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
145358158|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
145358159|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
145358160|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
145358161|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
145358162|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
145358163|NCT00406367|524160579|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
145358164|NCT00406367|524160580|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
145358165|NCT00171210|524160581|FG000|Overall Study|Adverse Event|16|||
145358166|NCT00171210|524160582|FG001|Overall Study|Adverse Event|27|||
145358167|NCT00171210|524160581|FG000|Overall Study|Abnormal laboratory value(s)|6|||
145358168|NCT00171210|524160582|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145358169|NCT00171210|524160581|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145358170|NCT00171210|524160582|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145358171|NCT00171210|524160581|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
145358172|NCT00171210|524160582|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
145577488|NCT02391948|524969429|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
145577489|NCT02391948|524969425|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
145358173|NCT00171210|524160581|FG000|Overall Study|Protocol Violation|0|||
145358174|NCT00171210|524160582|FG001|Overall Study|Protocol Violation|2|||
145358175|NCT00171210|524160581|FG000|Overall Study|Withdrawal by Subject|32|||
145358176|NCT00171210|524160582|FG001|Overall Study|Withdrawal by Subject|30|||
145358177|NCT00171210|524160581|FG000|Overall Study|Lost to Follow-up|1|||
145358178|NCT00171210|524160582|FG001|Overall Study|Lost to Follow-up|0|||
145358179|NCT00171210|524160581|FG000|Overall Study|Administrative problems|1|||
145358180|NCT00171210|524160582|FG001|Overall Study|Administrative problems|1|||
145358181|NCT00171210|524160581|FG000|Overall Study|Death|2|||
145358182|NCT00171210|524160582|FG001|Overall Study|Death|3|||
145358183|NCT00171210|524160581|FG000|Overall Study|Stopped at end of core|0|||
145358184|NCT00171210|524160582|FG001|Overall Study|Stopped at end of core|32|||
145358185|NCT00171210|524160581|FG000|Overall Study|Stopped at end of extension 1|0|||
145358186|NCT00171210|524160582|FG001|Overall Study|Stopped at end of extension 1|1|||
145358187|NCT03187301|524160585|FG000|Titration Period|Adverse Event|0|||
145358188|NCT03187301|524160586|FG001|Titration Period|Adverse Event|0|||
145358189|NCT03187301|524160587|FG002|Titration Period|Adverse Event|0|||
145358190|NCT03187301|524160588|FG003|Titration Period|Adverse Event|0|||
145358191|NCT03187301|524160589|FG004|Titration Period|Adverse Event|0|||
145358192|NCT03187301|524160590|FG005|Titration Period|Adverse Event|0|||
145358193|NCT03187301|524160591|FG006|Titration Period|Adverse Event|5|||
145358194|NCT03187301|524160585|FG000|Titration Period|Withdrawal by Subject|0|||
145358195|NCT03187301|524160586|FG001|Titration Period|Withdrawal by Subject|0|||
145358196|NCT03187301|524160587|FG002|Titration Period|Withdrawal by Subject|0|||
145358197|NCT03187301|524160588|FG003|Titration Period|Withdrawal by Subject|0|||
145358198|NCT03187301|524160589|FG004|Titration Period|Withdrawal by Subject|0|||
145358199|NCT03187301|524160590|FG005|Titration Period|Withdrawal by Subject|0|||
145358200|NCT03187301|524160591|FG006|Titration Period|Withdrawal by Subject|1|||
145358201|NCT03187301|524160585|FG000|Titration Period|Exclusion Criteria Met|0|||
145358202|NCT03187301|524160586|FG001|Titration Period|Exclusion Criteria Met|0|||
145358203|NCT03187301|524160587|FG002|Titration Period|Exclusion Criteria Met|0|||
145358204|NCT03187301|524160588|FG003|Titration Period|Exclusion Criteria Met|0|||
145358205|NCT03187301|524160589|FG004|Titration Period|Exclusion Criteria Met|0|||
145358206|NCT03187301|524160590|FG005|Titration Period|Exclusion Criteria Met|0|||
145358207|NCT03187301|524160591|FG006|Titration Period|Exclusion Criteria Met|1|||
145358208|NCT03187301|524160585|FG000|Pre-Intervention|Withdrawal by Subject|1|||
145358209|NCT03187301|524160586|FG001|Pre-Intervention|Withdrawal by Subject|0|||
145358210|NCT03187301|524160587|FG002|Pre-Intervention|Withdrawal by Subject|0|||
145358211|NCT03187301|524160588|FG003|Pre-Intervention|Withdrawal by Subject|0|||
145358212|NCT03187301|524160589|FG004|Pre-Intervention|Withdrawal by Subject|0|||
145358213|NCT03187301|524160590|FG005|Pre-Intervention|Withdrawal by Subject|0|||
145358214|NCT03187301|524160591|FG006|Pre-Intervention|Withdrawal by Subject|0|||
145358215|NCT03252535|524160593|FG000|Overall Study|Withdrawal by Subject|1|||
145358216|NCT03252535|524160594|FG001|Overall Study|Withdrawal by Subject|0|||
145358217|NCT03252535|524160595|FG002|Overall Study|Withdrawal by Subject|0|||
145358218|NCT03252535|524160593|FG000|Overall Study|Physician Decision|0|||
145358219|NCT03252535|524160594|FG001|Overall Study|Physician Decision|1|||
145358220|NCT03252535|524160595|FG002|Overall Study|Physician Decision|0|||
145358221|NCT03252535|524160593|FG000|Overall Study|Met discontinuation criteria|0|||
145358222|NCT03252535|524160594|FG001|Overall Study|Met discontinuation criteria|1|||
145358223|NCT03252535|524160595|FG002|Overall Study|Met discontinuation criteria|0|||
145358224|NCT00461630|524160600|FG000|Overall Study|Death|798|||
145358225|NCT00461630|524160601|FG001|Overall Study|Death|732|||
145358226|NCT00461630|524160600|FG000|Overall Study|Lost to Follow-up|108|||
145358227|NCT00461630|524160601|FG001|Overall Study|Lost to Follow-up|95|||
145358228|NCT00442897|524160604|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
145358229|NCT00442897|524160605|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
145358230|NCT00442897|524160604|FG000|Base Study (12 Week Follow-up)|Death|0|||
145358231|NCT00442897|524160605|FG001|Base Study (12 Week Follow-up)|Death|1|||
145358232|NCT00442897|524160604|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
145358233|NCT00442897|524160605|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
145358234|NCT00442897|524160604|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
145358235|NCT00442897|524160605|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
145358236|NCT00442897|524160604|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
145358237|NCT00442897|524160605|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
145358238|NCT00442897|524160604|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
145358239|NCT00442897|524160605|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
145358240|NCT00442897|524160604|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
145358241|NCT00442897|524160605|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
145358242|NCT00442897|524160604|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
145358243|NCT00442897|524160605|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
145358244|NCT04498182|524160606|FG000|Overall Study|Adverse Event|2|||
145358245|NCT04498182|524160607|FG001|Overall Study|Adverse Event|3|||
145358246|NCT04498182|524160608|FG002|Overall Study|Adverse Event|2|||
145358247|NCT04498182|524160606|FG000|Overall Study|Withdrawal of Consent|3|||
145358248|NCT04498182|524160607|FG001|Overall Study|Withdrawal of Consent|4|||
145358249|NCT04498182|524160608|FG002|Overall Study|Withdrawal of Consent|3|||
145358250|NCT04498182|524160606|FG000|Overall Study|Non-Compliant|1|||
145358251|NCT04498182|524160607|FG001|Overall Study|Non-Compliant|0|||
145358252|NCT04498182|524160608|FG002|Overall Study|Non-Compliant|1|||
145358253|NCT04498182|524160606|FG000|Overall Study|Lost to Follow-up|0|||
145358254|NCT04498182|524160607|FG001|Overall Study|Lost to Follow-up|0|||
145358255|NCT04498182|524160608|FG002|Overall Study|Lost to Follow-up|1|||
145358256|NCT04498182|524160606|FG000|Overall Study|Investigator Decision|0|||
145358257|NCT04498182|524160607|FG001|Overall Study|Investigator Decision|0|||
145358258|NCT04498182|524160608|FG002|Overall Study|Investigator Decision|1|||
145358259|NCT04498182|524160606|FG000|Overall Study|Protocol Violation|1|||
145358260|NCT04498182|524160607|FG001|Overall Study|Protocol Violation|0|||
145358261|NCT04498182|524160608|FG002|Overall Study|Protocol Violation|2|||
145358262|NCT00997373|524160611|FG000|Overall Study|Withdrawal by Subject|5|||
145358263|NCT00997373|524160612|FG001|Overall Study|Withdrawal by Subject|0|||
145358264|NCT00997373|524160611|FG000|Overall Study|wrong tumor type|4|||
145358265|NCT00997373|524160612|FG001|Overall Study|wrong tumor type|0|||
145358266|NCT00997373|524160611|FG000|Overall Study|could not have hysterectomy|6|||
145358267|NCT00997373|524160612|FG001|Overall Study|could not have hysterectomy|0|||
145358268|NCT03809663|524160613|FG000|Overall Study|Decision by sponsor|24|||
145358269|NCT03809663|524160614|FG001|Overall Study|Decision by sponsor|18|||
145358270|NCT03809663|524160615|FG002|Overall Study|Decision by sponsor|20|||
145358271|NCT03809663|524160616|FG003|Overall Study|Decision by sponsor|20|||
145358272|NCT03809663|524160617|FG004|Overall Study|Decision by sponsor|0|||
145358273|NCT03809663|524160618|FG005|Overall Study|Decision by sponsor|0|||
145358274|NCT03809663|524160613|FG000|Overall Study|Withdrawal by Subject|26|||
145358275|NCT03809663|524160614|FG001|Overall Study|Withdrawal by Subject|22|||
145358276|NCT03809663|524160615|FG002|Overall Study|Withdrawal by Subject|27|||
145358277|NCT03809663|524160616|FG003|Overall Study|Withdrawal by Subject|26|||
145358278|NCT03809663|524160617|FG004|Overall Study|Withdrawal by Subject|0|||
145358279|NCT03809663|524160618|FG005|Overall Study|Withdrawal by Subject|0|||
145358280|NCT03809663|524160613|FG000|Overall Study|Lost to Follow-up|1|||
145358281|NCT03809663|524160614|FG001|Overall Study|Lost to Follow-up|4|||
145358282|NCT03809663|524160615|FG002|Overall Study|Lost to Follow-up|1|||
145358283|NCT03809663|524160616|FG003|Overall Study|Lost to Follow-up|1|||
145358284|NCT03809663|524160617|FG004|Overall Study|Lost to Follow-up|0|||
145358285|NCT03809663|524160618|FG005|Overall Study|Lost to Follow-up|0|||
145358286|NCT02275819|524160620|FG000|Overall Study|Adverse Event|0|||
145358287|NCT02275819|524160621|FG001|Overall Study|Adverse Event|1|||
145358288|NCT01346059|524160622|FG000|Overall Study|Withdrawal by Subject|1|||
145358289|NCT01346059|524160623|FG001|Overall Study|Withdrawal by Subject|0|||
145358290|NCT02792062|524160630|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
145358291|NCT02792062|524160631|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145358292|NCT02792062|524160632|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145358293|NCT02792062|524160633|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145358294|NCT02792062|524160634|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145358295|NCT02792062|524160635|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
145358296|NCT01464424|524160636|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
145358297|NCT01464424|524160637|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
145358298|NCT01464333|524160641|FG000|Overall Study|Adverse Event|34|||
145358299|NCT01464333|524160641|FG000|Overall Study|Lack of Efficacy|72|||
145358300|NCT01464333|524160641|FG000|Overall Study|Withdrawal by Subject|11|||
145358301|NCT01464333|524160641|FG000|Overall Study|Other|4|||
145358302|NCT01464333|524160641|FG000|Overall Study|No Hospital Visit|42|||
145358303|NCT00450437|524160642|FG000|Overall Study|Withdrawal by Subject|10|||
145358304|NCT00450437|524160643|FG001|Overall Study|Withdrawal by Subject|2|||
145418320|NCT04518410|524386773|FG011|Overall Study|Screen Fail but Randomized|0|||
145418321|NCT04518410|524386774|FG012|Overall Study|Screen Fail but Randomized|0|||
145358305|NCT00450437|524160644|FG002|Overall Study|Withdrawal by Subject|0|||
145358306|NCT00450437|524160645|FG003|Overall Study|Withdrawal by Subject|1|||
145358307|NCT00450437|524160642|FG000|Overall Study|Lost to Follow-up|31|||
145358308|NCT00450437|524160643|FG001|Overall Study|Lost to Follow-up|12|||
145358309|NCT00450437|524160644|FG002|Overall Study|Lost to Follow-up|19|||
145358310|NCT00450437|524160645|FG003|Overall Study|Lost to Follow-up|9|||
145358311|NCT00450437|524160642|FG000|Overall Study|Protocol Violation|0|||
145358312|NCT00450437|524160643|FG001|Overall Study|Protocol Violation|1|||
145358313|NCT00450437|524160644|FG002|Overall Study|Protocol Violation|0|||
145358314|NCT00450437|524160645|FG003|Overall Study|Protocol Violation|1|||
145358315|NCT00450437|524160642|FG000|Overall Study|Inappropriate enrollment|4|||
145358316|NCT00450437|524160643|FG001|Overall Study|Inappropriate enrollment|1|||
145358317|NCT00450437|524160644|FG002|Overall Study|Inappropriate enrollment|3|||
145358318|NCT00450437|524160645|FG003|Overall Study|Inappropriate enrollment|0|||
145358319|NCT00450437|524160642|FG000|Overall Study|Administrative reason|0|||
145358320|NCT00450437|524160643|FG001|Overall Study|Administrative reason|0|||
145358321|NCT00450437|524160644|FG002|Overall Study|Administrative reason|1|||
145358322|NCT00450437|524160645|FG003|Overall Study|Administrative reason|0|||
145358323|NCT00450437|524160642|FG000|Overall Study|Unable to Classify|1|||
145358324|NCT00450437|524160643|FG001|Overall Study|Unable to Classify|0|||
145358325|NCT00450437|524160644|FG002|Overall Study|Unable to Classify|1|||
145358326|NCT00450437|524160645|FG003|Overall Study|Unable to Classify|0|||
145358327|NCT02040805|524160646|FG000|Overall Study|Lost to Follow-up|14|||
145358328|NCT02040805|524160647|FG001|Overall Study|Lost to Follow-up|9|||
145358329|NCT02040805|524160646|FG000|Overall Study|Withdrawal by Subject|28|||
145358330|NCT02040805|524160647|FG001|Overall Study|Withdrawal by Subject|41|||
145358331|NCT00503698|524160649|FG000|Overall Study|Protocol Violation|5|||
145358332|NCT00503698|524160650|FG001|Overall Study|Protocol Violation|6|||
145358333|NCT00503698|524160649|FG000|Overall Study|Adverse Event|52|||
145358334|NCT00503698|524160650|FG001|Overall Study|Adverse Event|41|||
145358335|NCT00503698|524160649|FG000|Overall Study|Death|1|||
145358336|NCT00503698|524160650|FG001|Overall Study|Death|0|||
145358337|NCT00503698|524160649|FG000|Overall Study|Lack of Efficacy|3|||
145358338|NCT00503698|524160650|FG001|Overall Study|Lack of Efficacy|4|||
145358339|NCT00503698|524160649|FG000|Overall Study|Trial terminated|216|||
145358340|NCT00503698|524160650|FG001|Overall Study|Trial terminated|253|||
145358341|NCT00503698|524160649|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
145358342|NCT00503698|524160650|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
145358343|NCT00503698|524160649|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
145358344|NCT00503698|524160650|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
145358345|NCT00503698|524160649|FG000|Overall Study|Any condition in exclusion criteria|4|||
145358346|NCT00503698|524160650|FG001|Overall Study|Any condition in exclusion criteria|6|||
145358347|NCT00503698|524160649|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
145358348|NCT00503698|524160650|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
145358349|NCT00503698|524160649|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
145358350|NCT00503698|524160650|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
145358351|NCT00503698|524160649|FG000|Overall Study|Critically ill|2|||
145358352|NCT00503698|524160650|FG001|Overall Study|Critically ill|0|||
145358353|NCT00503698|524160649|FG000|Overall Study|Unclassified|48|||
145358354|NCT00503698|524160650|FG001|Overall Study|Unclassified|32|||
145358355|NCT00503698|524160649|FG000|Overall Study|Not exposed to trial drug|11|||
145358356|NCT00503698|524160650|FG001|Overall Study|Not exposed to trial drug|6|||
145358357|NCT02462603|524160652|FG000|Overall Study|Investigator Decision|1|||
145358358|NCT02462603|524160652|FG000|Overall Study|Non-Compliance|1|||
145358359|NCT02462603|524160652|FG000|Overall Study|Withdrawal by Subject|2|||
145358360|NCT00571727|524160653|FG000|Overall Study|Did not enter in this study|1|||
145358361|NCT00571727|524160653|FG000|Overall Study|Non-compliance|4|||
145358362|NCT00571727|524160653|FG000|Overall Study|Lost to Follow-up|30|||
145358363|NCT00571727|524160653|FG000|Overall Study|Poor growth|1|||
145358364|NCT00571727|524160653|FG000|Overall Study|Parent/patient decision|2|||
145358365|NCT00571727|524160653|FG000|Overall Study|Participant transferred to commercial drug|14|||
145358366|NCT00571727|524160653|FG000|Overall Study|Unable to provide study drug|6|||
145358367|NCT00571727|524160653|FG000|Overall Study|On-treatment at end of study|8|||
145358368|NCT04955691|524162317|FG000|Period 2|Discontinued intervention|1|||
145358369|NCT04955691|524162318|FG001|Period 2|Discontinued intervention|2|||
145358370|NCT03760744|524162319|FG000|Overall Study|Lost to Follow-up|3|||
145358371|NCT03760744|524162320|FG001|Overall Study|Lost to Follow-up|0|||
145358372|NCT01068678|524162321|FG000|Overall Study|Lack of Efficacy|3|||
145358373|NCT01068678|524162322|FG001|Overall Study|Lack of Efficacy|2|||
145358374|NCT01068678|524162321|FG000|Overall Study|Protocol Violation|5|||
145358375|NCT01068678|524162322|FG001|Overall Study|Protocol Violation|1|||
145358376|NCT01068678|524162321|FG000|Overall Study|Withdrawal criteria|12|||
145358377|NCT01068678|524162322|FG001|Overall Study|Withdrawal criteria|6|||
145358378|NCT01068678|524162321|FG000|Overall Study|Unclassified|18|||
145358379|NCT01068678|524162322|FG001|Overall Study|Unclassified|15|||
145358380|NCT03055338|524162325|FG000|Overall Study|Lost to Follow-up|9|||
145358381|NCT03055338|524162326|FG001|Overall Study|Lost to Follow-up|2|||
145358382|NCT03055338|524162327|FG002|Overall Study|Lost to Follow-up|3|||
145358383|NCT03055338|524162325|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
145358384|NCT03055338|524162326|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
145358385|NCT03055338|524162327|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
145358386|NCT03055338|524162325|FG000|Overall Study|Physician Decision|0|||
145358387|NCT03055338|524162326|FG001|Overall Study|Physician Decision|0|||
145358388|NCT03055338|524162327|FG002|Overall Study|Physician Decision|2|||
145358389|NCT03055338|524162325|FG000|Overall Study|Withdrawal by Subject|9|||
145358390|NCT03055338|524162326|FG001|Overall Study|Withdrawal by Subject|8|||
145358391|NCT03055338|524162327|FG002|Overall Study|Withdrawal by Subject|7|||
145358392|NCT03752970|524162336|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
145358393|NCT03752970|524162337|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
145358394|NCT03752970|524162338|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
145358395|NCT03752970|524162336|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
145358396|NCT03752970|524162337|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
145418322|NCT04518410|524386775|FG013|Overall Study|Screen Fail but Randomized|0|||
145418323|NCT04518410|524386776|FG014|Overall Study|Screen Fail but Randomized|0|||
145418324|NCT04518410|524386777|FG015|Overall Study|Screen Fail but Randomized|0|||
145418325|NCT04518410|524386778|FG016|Overall Study|Screen Fail but Randomized|0|||
145418326|NCT04518410|524386779|FG017|Overall Study|Screen Fail but Randomized|0|||
145418327|NCT04518410|524386780|FG018|Overall Study|Screen Fail but Randomized|0|||
145418328|NCT04518410|524386781|FG019|Overall Study|Screen Fail but Randomized|0|||
145418329|NCT04518410|524386782|FG020|Overall Study|Screen Fail but Randomized|0|||
145418330|NCT04518410|524386783|FG021|Overall Study|Screen Fail but Randomized|0|||
145418331|NCT04518410|524386784|FG022|Overall Study|Screen Fail but Randomized|0|||
145418332|NCT04518410|524386785|FG023|Overall Study|Screen Fail but Randomized|0|||
145418333|NCT04518410|524386786|FG024|Overall Study|Screen Fail but Randomized|0|||
145418334|NCT04518410|524386762|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418335|NCT04518410|524386763|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418336|NCT04518410|524386764|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418337|NCT04518410|524386765|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418338|NCT04518410|524386766|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
145418339|NCT04518410|524386767|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
145418340|NCT04518410|524386768|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
145418341|NCT04518410|524386769|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145418342|NCT04518410|524386770|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
145418343|NCT04518410|524386771|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
145418344|NCT04518410|524386772|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145418345|NCT04518410|524386773|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418346|NCT04518410|524386774|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418347|NCT04518410|524386775|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145418348|NCT04518410|524386776|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
145418349|NCT04518410|524386777|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
145418350|NCT04518410|524386778|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
145418351|NCT04518410|524386779|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
145418352|NCT04518410|524386780|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
145418353|NCT04518410|524386781|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
145418354|NCT04518410|524386782|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
145418355|NCT04518410|524386783|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
145418356|NCT04518410|524386784|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
145418357|NCT04518410|524386785|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
145418358|NCT04518410|524386786|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
145418359|NCT04518410|524386762|FG000|Overall Study|Dual Enrolled Subject|0|||
145418360|NCT04518410|524386763|FG001|Overall Study|Dual Enrolled Subject|0|||
145418361|NCT04518410|524386764|FG002|Overall Study|Dual Enrolled Subject|0|||
145418362|NCT04518410|524386765|FG003|Overall Study|Dual Enrolled Subject|0|||
145418363|NCT04518410|524386766|FG004|Overall Study|Dual Enrolled Subject|0|||
145418364|NCT04518410|524386767|FG005|Overall Study|Dual Enrolled Subject|0|||
145418365|NCT04518410|524386768|FG006|Overall Study|Dual Enrolled Subject|0|||
145418366|NCT04518410|524386769|FG007|Overall Study|Dual Enrolled Subject|0|||
145418367|NCT04518410|524386770|FG008|Overall Study|Dual Enrolled Subject|0|||
145418368|NCT04518410|524386771|FG009|Overall Study|Dual Enrolled Subject|0|||
145418369|NCT04518410|524386772|FG010|Overall Study|Dual Enrolled Subject|0|||
145577490|NCT02391948|524969426|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
145577491|NCT02391948|524969427|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
145577492|NCT02391948|524969428|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
145577493|NCT02391948|524969429|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
145577494|NCT02391948|524969425|FG000|12-month Assessment|Death|0|||
145577495|NCT02391948|524969426|FG001|12-month Assessment|Death|0|||
145577496|NCT02391948|524969427|FG002|12-month Assessment|Death|0|||
145577497|NCT02391948|524969428|FG003|12-month Assessment|Death|1|||
145577498|NCT02391948|524969429|FG004|12-month Assessment|Death|0|||
145577499|NCT02391948|524969425|FG000|12-month Assessment|Withdrawal by Subject|1|||
145577500|NCT02391948|524969426|FG001|12-month Assessment|Withdrawal by Subject|0|||
145358397|NCT03752970|524162338|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
145358398|NCT03752970|524162336|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
145358399|NCT03752970|524162337|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
145358400|NCT03752970|524162338|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
145358401|NCT03752970|524162336|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
145358402|NCT03752970|524162337|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
145358403|NCT03752970|524162338|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
145358404|NCT03752970|524162336|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
145358405|NCT03752970|524162337|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
145358406|NCT03752970|524162338|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
145358407|NCT04767282|524162339|FG000|Overall Study|Refused or did not begin surveys|6|||
145358408|NCT04767282|524162340|FG001|Overall Study|Refused or did not begin surveys|2|||
145358409|NCT04767282|524162341|FG002|Overall Study|Refused or did not begin surveys|2|||
145358410|NCT04767282|524162339|FG000|Overall Study|Duplicate household previously enrolled|2|||
145358411|NCT04767282|524162340|FG001|Overall Study|Duplicate household previously enrolled|0|||
145358412|NCT04767282|524162341|FG002|Overall Study|Duplicate household previously enrolled|8|||
145358413|NCT04767282|524162339|FG000|Overall Study|Unable to confirm legal guardian|0|||
145358414|NCT04767282|524162340|FG001|Overall Study|Unable to confirm legal guardian|2|||
145358415|NCT04767282|524162341|FG002|Overall Study|Unable to confirm legal guardian|8|||
145358416|NCT04767282|524162339|FG000|Overall Study|Withdrawal by Subject|0|||
145358417|NCT04767282|524162340|FG001|Overall Study|Withdrawal by Subject|0|||
145358418|NCT04767282|524162341|FG002|Overall Study|Withdrawal by Subject|6|||
145358419|NCT04767282|524162339|FG000|Overall Study|Survey comprehension challenges|4|||
145358420|NCT04767282|524162340|FG001|Overall Study|Survey comprehension challenges|0|||
145358421|NCT04767282|524162341|FG002|Overall Study|Survey comprehension challenges|0|||
145358422|NCT01467713|524162343|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
145358423|NCT01467713|524162344|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
145358424|NCT01467713|524162345|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
145358425|NCT01467713|524162346|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
145358426|NCT01467713|524162343|FG000|Overall Study|Major Protocol Deviation|2|||
145358427|NCT01467713|524162344|FG001|Overall Study|Major Protocol Deviation|4|||
145358428|NCT01467713|524162345|FG002|Overall Study|Major Protocol Deviation|4|||
145358429|NCT01467713|524162346|FG003|Overall Study|Major Protocol Deviation|1|||
145358430|NCT01467713|524162343|FG000|Overall Study|Lost to Follow-up|9|||
145358431|NCT01467713|524162344|FG001|Overall Study|Lost to Follow-up|12|||
145358432|NCT01467713|524162345|FG002|Overall Study|Lost to Follow-up|6|||
145358433|NCT01467713|524162346|FG003|Overall Study|Lost to Follow-up|9|||
145358434|NCT01467713|524162343|FG000|Overall Study|Voluntary Withdrawal|18|||
145358435|NCT01467713|524162344|FG001|Overall Study|Voluntary Withdrawal|14|||
145358436|NCT01467713|524162345|FG002|Overall Study|Voluntary Withdrawal|21|||
145358437|NCT01467713|524162346|FG003|Overall Study|Voluntary Withdrawal|20|||
145358438|NCT01467713|524162343|FG000|Overall Study|Study Termination|23|||
145358439|NCT01467713|524162344|FG001|Overall Study|Study Termination|33|||
145358440|NCT01467713|524162345|FG002|Overall Study|Study Termination|28|||
145358441|NCT01467713|524162346|FG003|Overall Study|Study Termination|29|||
145358442|NCT01467713|524162343|FG000|Overall Study|Pregnancy|0|||
145358443|NCT01467713|524162344|FG001|Overall Study|Pregnancy|1|||
145358444|NCT01467713|524162345|FG002|Overall Study|Pregnancy|1|||
145358445|NCT01467713|524162346|FG003|Overall Study|Pregnancy|3|||
145358446|NCT01467713|524162343|FG000|Overall Study|Relapse|35|||
145358447|NCT01467713|524162344|FG001|Overall Study|Relapse|25|||
145358448|NCT01467713|524162345|FG002|Overall Study|Relapse|28|||
145358449|NCT01467713|524162346|FG003|Overall Study|Relapse|35|||
145358450|NCT01467713|524162343|FG000|Overall Study|Reason not Specified|6|||
145358451|NCT01467713|524162344|FG001|Overall Study|Reason not Specified|11|||
145358452|NCT01467713|524162345|FG002|Overall Study|Reason not Specified|8|||
145358453|NCT01467713|524162346|FG003|Overall Study|Reason not Specified|7|||
145358454|NCT02525783|524162347|FG000|Overall Study|Lost to Follow-up|10|||
145358455|NCT00866281|524162348|FG000|Overall Study|Adverse Event|1|||
145358456|NCT00866281|524162349|FG001|Overall Study|Adverse Event|0|||
145358457|NCT00866281|524162348|FG000|Overall Study|Withdrawal by participants|3|||
145358458|NCT00866281|524162349|FG001|Overall Study|Withdrawal by participants|0|||
145358459|NCT00866281|524162348|FG000|Overall Study|Disease progression|3|||
145358460|NCT00866281|524162349|FG001|Overall Study|Disease progression|11|||
145358461|NCT00866281|524162348|FG000|Overall Study|New cancer therapy|0|||
145358462|NCT00866281|524162349|FG001|Overall Study|New cancer therapy|4|||
145358463|NCT01100086|524162350|FG000|Period 1|Withdrawal by Subject|1|||
145358464|NCT01100086|524162351|FG001|Period 1|Withdrawal by Subject|0|||
145358465|NCT02612623|524162357|FG000|Overall Study|Withdrawal by Subject|0|||
145358466|NCT02612623|524162358|FG001|Overall Study|Withdrawal by Subject|1|||
145358467|NCT02612623|524162359|FG002|Overall Study|Withdrawal by Subject|0|||
145358468|NCT02612623|524162360|FG003|Overall Study|Withdrawal by Subject|0|||
145358469|NCT02612623|524162357|FG000|Overall Study|Adverse Event|1|||
145358470|NCT02612623|524162358|FG001|Overall Study|Adverse Event|0|||
145418370|NCT04518410|524386773|FG011|Overall Study|Dual Enrolled Subject|0|||
145418371|NCT04518410|524386774|FG012|Overall Study|Dual Enrolled Subject|0|||
145418372|NCT04518410|524386775|FG013|Overall Study|Dual Enrolled Subject|0|||
145418373|NCT04518410|524386776|FG014|Overall Study|Dual Enrolled Subject|0|||
145418374|NCT04518410|524386777|FG015|Overall Study|Dual Enrolled Subject|0|||
145418375|NCT04518410|524386778|FG016|Overall Study|Dual Enrolled Subject|0|||
145418376|NCT04518410|524386779|FG017|Overall Study|Dual Enrolled Subject|1|||
145418377|NCT04518410|524386780|FG018|Overall Study|Dual Enrolled Subject|0|||
145418378|NCT04518410|524386781|FG019|Overall Study|Dual Enrolled Subject|0|||
145418379|NCT04518410|524386782|FG020|Overall Study|Dual Enrolled Subject|0|||
145418380|NCT04518410|524386783|FG021|Overall Study|Dual Enrolled Subject|0|||
145418381|NCT04518410|524386784|FG022|Overall Study|Dual Enrolled Subject|0|||
145418382|NCT04518410|524386785|FG023|Overall Study|Dual Enrolled Subject|0|||
145418383|NCT04518410|524386786|FG024|Overall Study|Dual Enrolled Subject|0|||
145418384|NCT01751685|524386787|FG000|6-mo Followup|Missed study visit|1|||
145418385|NCT01751685|524386788|FG001|6-mo Followup|Missed study visit|0|||
145418386|NCT01751685|524386787|FG000|6-mo Followup|Withdrawal by Subject|2|||
145418387|NCT01751685|524386788|FG001|6-mo Followup|Withdrawal by Subject|2|||
145418388|NCT01751685|524386787|FG000|6-mo Followup|Lost to Follow-up|0|||
145418389|NCT01751685|524386788|FG001|6-mo Followup|Lost to Follow-up|1|||
145418390|NCT01751685|524386787|FG000|12-mo Followup|Lost to Follow-up|5|||
145418391|NCT01751685|524386788|FG001|12-mo Followup|Lost to Follow-up|0|||
145418392|NCT01028391|524386789|FG000|Overall Study|Adverse Event|4|||
145418393|NCT01028391|524386790|FG001|Overall Study|Adverse Event|0|||
145418394|NCT01028391|524386789|FG000|Overall Study|Lack of Efficacy|0|||
145418395|NCT01028391|524386790|FG001|Overall Study|Lack of Efficacy|2|||
145418396|NCT01028391|524386789|FG000|Overall Study|Lost to Follow-up|3|||
145418397|NCT01028391|524386790|FG001|Overall Study|Lost to Follow-up|4|||
145418398|NCT01028391|524386789|FG000|Overall Study|Physician Decision|0|||
145418399|NCT01028391|524386790|FG001|Overall Study|Physician Decision|1|||
145418400|NCT01028391|524386789|FG000|Overall Study|Withdrawal by Subject|6|||
145418401|NCT01028391|524386790|FG001|Overall Study|Withdrawal by Subject|3|||
145418402|NCT01028391|524386789|FG000|Overall Study|Needed excluded medication|1|||
145418403|NCT01028391|524386790|FG001|Overall Study|Needed excluded medication|1|||
145418404|NCT00694161|524386791|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
145418405|NCT00694161|524386791|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
145418406|NCT00694161|524386791|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
145418407|NCT03601052|524386792|FG000|Overall Study|Lost to Follow-up|2|||
145418408|NCT01227395|524386793|FG000|Overall Study|Protocol Violation|0|||
145418409|NCT01227395|524386794|FG001|Overall Study|Protocol Violation|1|||
145418410|NCT03259308|524386795|FG000|Overall Study|Adverse Event|5|||
145418411|NCT03259308|524386796|FG001|Overall Study|Adverse Event|4|||
145418412|NCT03259308|524386797|FG002|Overall Study|Adverse Event|1|||
145418413|NCT03259308|524386795|FG000|Overall Study|Withdrawal by Subject|2|||
145418414|NCT03259308|524386796|FG001|Overall Study|Withdrawal by Subject|1|||
145418415|NCT03259308|524386797|FG002|Overall Study|Withdrawal by Subject|3|||
145418416|NCT03259308|524386795|FG000|Overall Study|Lost to Follow-up|0|||
145418417|NCT03259308|524386796|FG001|Overall Study|Lost to Follow-up|0|||
145418418|NCT03259308|524386797|FG002|Overall Study|Lost to Follow-up|1|||
145418419|NCT03259308|524386795|FG000|Overall Study|Pregnancy|0|||
145418420|NCT03259308|524386796|FG001|Overall Study|Pregnancy|0|||
145418421|NCT03259308|524386797|FG002|Overall Study|Pregnancy|1|||
145358471|NCT02612623|524162359|FG002|Overall Study|Adverse Event|1|||
145358472|NCT02612623|524162360|FG003|Overall Study|Adverse Event|0|||
145358473|NCT00570141|524162365|FG000|Overall Study|Adverse Event|1|||
145358474|NCT00570141|524162365|FG000|Overall Study|Missed visits|1|||
145358475|NCT00570141|524162365|FG000|Overall Study|Lost to Follow-up|1|||
145358476|NCT03270657|524162370|FG000|Overall Study|Withdrawal by Subject|1|||
145358477|NCT00455403|524162371|FG000|Overall Study|Lost to Follow-up|2|||
145358478|NCT00455403|524162372|FG001|Overall Study|Lost to Follow-up|1|||
145358479|NCT00455403|524162371|FG000|Overall Study|Withdrawal by Subject|1|||
145418422|NCT03259308|524386795|FG000|Overall Study|Protocol Deviation|0|||
145418423|NCT03259308|524386796|FG001|Overall Study|Protocol Deviation|3|||
145418424|NCT03259308|524386797|FG002|Overall Study|Protocol Deviation|0|||
145418425|NCT03259308|524386795|FG000|Overall Study|Lack of Efficacy|0|||
145358480|NCT00455403|524162372|FG001|Overall Study|Withdrawal by Subject|3|||
145418426|NCT03259308|524386796|FG001|Overall Study|Lack of Efficacy|0|||
145418427|NCT03259308|524386797|FG002|Overall Study|Lack of Efficacy|1|||
145418428|NCT03020888|524386798|FG000|Overall Study|Physician Decision|4|||
145418429|NCT03020888|524386798|FG000|Overall Study|Withdrawal by Subject|6|||
145418430|NCT03020888|524386798|FG000|Overall Study|Insurance coverage|2|||
145418431|NCT03020888|524386798|FG000|Overall Study|Lost to Follow-up|1|||
145418432|NCT01348490|524386799|FG000|Overall Study|Death|1|||
145418433|NCT01348490|524386799|FG000|Overall Study|Adverse Event|3|||
145418434|NCT01348490|524386799|FG000|Overall Study|Consent withdrawn|7|||
145418435|NCT01348490|524386799|FG000|Overall Study|Disease progression|3|||
145418436|NCT01348490|524386799|FG000|Overall Study|Lost to Follow-up|1|||
145418437|NCT01348490|524386799|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
145358481|NCT00455403|524162371|FG000|Overall Study|Protocol Violation|0|||
145358482|NCT00455403|524162372|FG001|Overall Study|Protocol Violation|2|||
145358483|NCT01812109|524162373|FG000|Overall Study|research personnel delay|16|||
145358484|NCT01812109|524162373|FG000|Overall Study|NIRS Unattainable|17|||
145358485|NCT02182843|524162375|FG000|Overall Study|Withdrawal by Subject|7|||
145358486|NCT02182843|524162375|FG000|Overall Study|Lost to Follow-up|2|||
145358487|NCT02182843|524162375|FG000|Overall Study|Adverse Event|1|||
145358488|NCT00891020|524162378|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
145358489|NCT00891020|524162379|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
145358490|NCT00891020|524162380|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
145358491|NCT00891020|524162378|FG000|24 Week Treatment Period|Death|0|||
145358492|NCT00891020|524162379|FG001|24 Week Treatment Period|Death|2|||
145358493|NCT00891020|524162380|FG002|24 Week Treatment Period|Death|0|||
145358494|NCT00891020|524162378|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
145358495|NCT00891020|524162379|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
145358496|NCT00891020|524162380|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
145358497|NCT00891020|524162378|FG000|24 Week Treatment Period|Failure to return|4|||
145358498|NCT00891020|524162379|FG001|24 Week Treatment Period|Failure to return|5|||
145358499|NCT00891020|524162380|FG002|24 Week Treatment Period|Failure to return|5|||
145358500|NCT00891020|524162378|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
145358501|NCT00891020|524162379|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
145358502|NCT00891020|524162380|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
145358503|NCT00891020|524162378|FG000|24 Week Treatment Period|Other protocol violation|1|||
145358504|NCT00891020|524162379|FG001|24 Week Treatment Period|Other protocol violation|1|||
145358505|NCT00891020|524162380|FG002|24 Week Treatment Period|Other protocol violation|2|||
145358506|NCT00891020|524162378|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
145358507|NCT00891020|524162379|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
145358508|NCT00891020|524162380|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
145358509|NCT00891020|524162378|FG000|24 Week Treatment Period|Withdrew consent|6|||
145358510|NCT00891020|524162379|FG001|24 Week Treatment Period|Withdrew consent|3|||
145358511|NCT00891020|524162380|FG002|24 Week Treatment Period|Withdrew consent|15|||
145358512|NCT00891020|524162378|FG000|24 Week Treatment Period|Administrative/Other|5|||
145358513|NCT00891020|524162379|FG001|24 Week Treatment Period|Administrative/Other|6|||
145358514|NCT00891020|524162380|FG002|24 Week Treatment Period|Administrative/Other|1|||
145358515|NCT00891020|524162378|FG000|Long-term Extension Period|Adverse Event|1|||
145358516|NCT00891020|524162379|FG001|Long-term Extension Period|Adverse Event|11|||
145358517|NCT00891020|524162380|FG002|Long-term Extension Period|Adverse Event|10|||
145358518|NCT00891020|524162378|FG000|Long-term Extension Period|Death|0|||
145358519|NCT00891020|524162379|FG001|Long-term Extension Period|Death|0|||
145358520|NCT00891020|524162380|FG002|Long-term Extension Period|Death|1|||
145358521|NCT00891020|524162378|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
145358522|NCT00891020|524162379|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
145358523|NCT00891020|524162380|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
145358524|NCT00891020|524162378|FG000|Long-term Extension Period|Protocol Violation|0|||
145358525|NCT00891020|524162379|FG001|Long-term Extension Period|Protocol Violation|1|||
145358526|NCT00891020|524162380|FG002|Long-term Extension Period|Protocol Violation|1|||
145358527|NCT00891020|524162378|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
145358528|NCT00891020|524162379|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
145358529|NCT00891020|524162380|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
145358530|NCT00891020|524162378|FG000|Long-term Extension Period|Failure to return|0|||
145358531|NCT00891020|524162379|FG001|Long-term Extension Period|Failure to return|2|||
145358532|NCT00891020|524162380|FG002|Long-term Extension Period|Failure to return|3|||
145358533|NCT00891020|524162378|FG000|Long-term Extension Period|Administrative|1|||
145358534|NCT00891020|524162379|FG001|Long-term Extension Period|Administrative|2|||
145358535|NCT00891020|524162380|FG002|Long-term Extension Period|Administrative|2|||
145358536|NCT00320710|524162383|FG000|Overall Study|Disease progression|24|||
145358537|NCT00320710|524162384|FG001|Overall Study|Disease progression|19|||
145358538|NCT00320710|524162385|FG002|Overall Study|Disease progression|2|||
145358539|NCT00320710|524162383|FG000|Overall Study|Death|10|||
145358540|NCT00320710|524162384|FG001|Overall Study|Death|7|||
145358541|NCT00320710|524162385|FG002|Overall Study|Death|1|||
145358542|NCT00320710|524162383|FG000|Overall Study|Administrative problems|1|||
145358543|NCT00320710|524162384|FG001|Overall Study|Administrative problems|2|||
145358544|NCT00320710|524162385|FG002|Overall Study|Administrative problems|0|||
145577501|NCT02391948|524969427|FG002|12-month Assessment|Withdrawal by Subject|0|||
145577502|NCT02391948|524969428|FG003|12-month Assessment|Withdrawal by Subject|1|||
145577503|NCT02391948|524969429|FG004|12-month Assessment|Withdrawal by Subject|0|||
145577504|NCT02391948|524969425|FG000|12-month Assessment|Lost to Follow-up|5|||
145358545|NCT00320710|524162383|FG000|Overall Study|Withdrawal by Subject|20|||
145358546|NCT00320710|524162384|FG001|Overall Study|Withdrawal by Subject|26|||
145358547|NCT00320710|524162385|FG002|Overall Study|Withdrawal by Subject|1|||
145358548|NCT00320710|524162383|FG000|Overall Study|Protocol Violation|6|||
145358549|NCT00320710|524162384|FG001|Overall Study|Protocol Violation|5|||
145358550|NCT00320710|524162385|FG002|Overall Study|Protocol Violation|0|||
145358551|NCT00320710|524162383|FG000|Overall Study|Abnormal test procedure result(s)|2|||
145358552|NCT00320710|524162384|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145358553|NCT00320710|524162385|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145358554|NCT00320710|524162383|FG000|Overall Study|Abnormal laboratory value(s)|12|||
145358555|NCT00320710|524162384|FG001|Overall Study|Abnormal laboratory value(s)|3|||
145358556|NCT00320710|524162385|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145358557|NCT00320710|524162383|FG000|Overall Study|Adverse Event|18|||
145358558|NCT00320710|524162384|FG001|Overall Study|Adverse Event|14|||
145358559|NCT00320710|524162385|FG002|Overall Study|Adverse Event|1|||
145358560|NCT00320710|524162383|FG000|Overall Study|Lost to Follow-up|1|||
145358561|NCT00320710|524162384|FG001|Overall Study|Lost to Follow-up|0|||
145358562|NCT00320710|524162385|FG002|Overall Study|Lost to Follow-up|0|||
145358563|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
145358564|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358565|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358566|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358567|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
145358568|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145358569|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145358570|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
145358571|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
145358572|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145358573|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145358574|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
145358575|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
145358576|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358577|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358578|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358579|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
145358580|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358581|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358582|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358583|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
145358584|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358585|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358586|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358587|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
145358588|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145358589|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145358590|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
145358591|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
145358592|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145358593|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145358594|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
145358595|NCT00506415|524162387|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
145358596|NCT00506415|524162388|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358597|NCT00506415|524162389|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358598|NCT00506415|524162390|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358599|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
145358600|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
145358601|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
145358602|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
145358603|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
145358604|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
145358605|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
145358606|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
145358607|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
145358608|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
145358609|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
145358610|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
145358611|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
145358612|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
145358613|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
145358614|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
145577505|NCT02391948|524969426|FG001|12-month Assessment|Lost to Follow-up|4|||
145577506|NCT02391948|524969427|FG002|12-month Assessment|Lost to Follow-up|4|||
145358615|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
145358616|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
145358617|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
145358618|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
145358619|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
145358620|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
145358621|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
145358622|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
145358623|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
145358624|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
145358625|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
145358626|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
145358627|NCT00506415|524162387|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145358628|NCT00506415|524162388|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145358629|NCT00506415|524162389|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
145358630|NCT00506415|524162390|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
145358631|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145358632|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145358633|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
145358634|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
145358635|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358636|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358637|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
145358638|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
145358639|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358640|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358641|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
145358642|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
145358643|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358644|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358645|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
145358646|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
145358647|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358648|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358649|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
145358650|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
145358651|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358652|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358653|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
145358654|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
145358655|NCT00506415|524162387|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145358656|NCT00506415|524162388|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145358657|NCT00506415|524162389|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
145358658|NCT00506415|524162390|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
145358659|NCT04578457|524162391|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
145358660|NCT04578457|524162391|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
145358661|NCT04578457|524162391|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
145358662|NCT04578457|524162391|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
145358663|NCT02841995|524162392|FG000|Overall Study|Disease progression|5|||
145358664|NCT02841995|524162393|FG001|Overall Study|Disease progression|11|||
145358665|NCT02841995|524162394|FG002|Overall Study|Disease progression|8|||
145358666|NCT02841995|524162392|FG000|Overall Study|Withdrawal by Subject|2|||
145358667|NCT02841995|524162393|FG001|Overall Study|Withdrawal by Subject|4|||
145358668|NCT02841995|524162394|FG002|Overall Study|Withdrawal by Subject|4|||
145358669|NCT02841995|524162392|FG000|Overall Study|Adverse Event|2|||
145358670|NCT02841995|524162393|FG001|Overall Study|Adverse Event|0|||
145358671|NCT02841995|524162394|FG002|Overall Study|Adverse Event|1|||
145358672|NCT02841995|524162392|FG000|Overall Study|Investigator decision|2|||
145358673|NCT02841995|524162393|FG001|Overall Study|Investigator decision|0|||
145577507|NCT02391948|524969428|FG003|12-month Assessment|Lost to Follow-up|4|||
145358674|NCT02841995|524162394|FG002|Overall Study|Investigator decision|1|||
145358675|NCT02841995|524162392|FG000|Overall Study|Death|0|||
145358676|NCT02841995|524162393|FG001|Overall Study|Death|0|||
145358677|NCT02841995|524162394|FG002|Overall Study|Death|2|||
145577508|NCT02391948|524969429|FG004|12-month Assessment|Lost to Follow-up|5|||
145577509|NCT02391948|524969425|FG000|12-month Assessment|Medical issue/illness|0|||
145358678|NCT02841995|524162392|FG000|Overall Study|Noncompliance to protocol|1|||
145358679|NCT02841995|524162393|FG001|Overall Study|Noncompliance to protocol|0|||
145358680|NCT02841995|524162394|FG002|Overall Study|Noncompliance to protocol|0|||
145358681|NCT02841995|524162392|FG000|Overall Study|Sponsor decision|1|||
145358682|NCT02841995|524162393|FG001|Overall Study|Sponsor decision|0|||
145358683|NCT02841995|524162394|FG002|Overall Study|Sponsor decision|0|||
145358684|NCT02841995|524162392|FG000|Overall Study|Other|4|||
145358685|NCT02841995|524162393|FG001|Overall Study|Other|1|||
145358686|NCT02841995|524162394|FG002|Overall Study|Other|5|||
145358687|NCT01703260|524162402|FG000|Overall Study|Adverse Event|1|||
145358688|NCT01703260|524162403|FG001|Overall Study|Adverse Event|2|||
145358689|NCT01703260|524162404|FG002|Overall Study|Adverse Event|2|||
145358690|NCT01703260|524162402|FG000|Overall Study|Lost to Follow-up|1|||
145358691|NCT01703260|524162403|FG001|Overall Study|Lost to Follow-up|0|||
145358692|NCT01703260|524162404|FG002|Overall Study|Lost to Follow-up|0|||
145358693|NCT01703260|524162402|FG000|Overall Study|Withdrawal by Subject|0|||
145358694|NCT01703260|524162403|FG001|Overall Study|Withdrawal by Subject|0|||
145358695|NCT01703260|524162404|FG002|Overall Study|Withdrawal by Subject|1|||
145358696|NCT01703260|524162402|FG000|Overall Study|Study Termination|1|||
145358697|NCT01703260|524162403|FG001|Overall Study|Study Termination|2|||
145358698|NCT01703260|524162404|FG002|Overall Study|Study Termination|0|||
145358699|NCT00561392|524162406|FG000|Overall Study|Adverse Event|38|||
145358700|NCT00561392|524162406|FG000|Overall Study|Lack of Efficacy|2|||
145358701|NCT00561392|524162406|FG000|Overall Study|Protocol Violation|1|||
145358702|NCT00561392|524162406|FG000|Overall Study|Withdrawal by Subject|8|||
145358703|NCT00561392|524162406|FG000|Overall Study|Administrative problems|4|||
145358704|NCT02632409|524162410|FG000|Randomized|AE unrelated to study Drug|0|||
145358705|NCT02632409|524162411|FG001|Randomized|AE unrelated to study Drug|1|||
145358706|NCT02632409|524162410|FG000|Randomized|Participant withdrew consent|2|||
145358707|NCT02632409|524162411|FG001|Randomized|Participant withdrew consent|1|||
145358708|NCT02632409|524162410|FG000|Randomized|No Longer meets study criteria|5|||
145358709|NCT02632409|524162411|FG001|Randomized|No Longer meets study criteria|0|||
145358710|NCT02632409|524162410|FG000|Randomized|other reasons|1|||
145358711|NCT02632409|524162411|FG001|Randomized|other reasons|0|||
145358712|NCT02632409|524162410|FG000|Treatment Period|Ongoing Treatment|20|||
145358713|NCT02632409|524162411|FG001|Treatment Period|Ongoing Treatment|21|||
145358714|NCT02632409|524162410|FG000|Treatment Period|Disease Recurrence|147|||
145358715|NCT02632409|524162411|FG001|Treatment Period|Disease Recurrence|90|||
145358716|NCT02632409|524162410|FG000|Treatment Period|Study Drug Toxicity|8|||
145418438|NCT01348490|524386799|FG000|Overall Study|Other Unspecified|8|||
145418439|NCT00300495|524386800|FG000|Overall Study|Protocol Violation|4|||
145418440|NCT00300495|524386801|FG001|Overall Study|Protocol Violation|1|||
145418441|NCT01567085|524388473|FG000|Overall Study|Death|6|||
145418442|NCT01567085|524388473|FG000|Overall Study|Adverse Event|6|||
145418443|NCT01567085|524388473|FG000|Overall Study|Lost to Follow-up|3|||
145418444|NCT01567085|524388473|FG000|Overall Study|Graft loss|2|||
145418445|NCT01567085|524388473|FG000|Overall Study|Renal transplantectomy|1|||
145418446|NCT01567085|524388473|FG000|Overall Study|Returned to chronic dialysis|1|||
145418447|NCT01567085|524388473|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
145418448|NCT03312114|524388479|FG000|Overall Study|All the five enrolled dropped out of the|5|||
145418449|NCT03537729|524388480|FG000|Overall Study|Death|2|||
145418450|NCT03537729|524388481|FG001|Overall Study|Death|2|||
145418451|NCT03537729|524388482|FG002|Overall Study|Death|7|||
145418452|NCT03537729|524388480|FG000|Overall Study|Withdrawal by Subject|3|||
145418453|NCT03537729|524388481|FG001|Overall Study|Withdrawal by Subject|3|||
145418454|NCT03537729|524388482|FG002|Overall Study|Withdrawal by Subject|0|||
145418455|NCT03537729|524388480|FG000|Overall Study|Subject Moved|8|||
145418456|NCT03537729|524388481|FG001|Overall Study|Subject Moved|5|||
145418457|NCT03537729|524388482|FG002|Overall Study|Subject Moved|4|||
145418458|NCT03537729|524388480|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
145418459|NCT03537729|524388481|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
145358717|NCT02632409|524162411|FG001|Treatment Period|Study Drug Toxicity|49|||
145358718|NCT02632409|524162410|FG000|Treatment Period|Death|1|||
145358719|NCT02632409|524162411|FG001|Treatment Period|Death|0|||
145358720|NCT02632409|524162410|FG000|Treatment Period|AE unrelated to study drug|15|||
145358721|NCT02632409|524162411|FG001|Treatment Period|AE unrelated to study drug|16|||
145358722|NCT02632409|524162410|FG000|Treatment Period|Request to discontinue treatment|4|||
145358723|NCT02632409|524162411|FG001|Treatment Period|Request to discontinue treatment|19|||
145358724|NCT02632409|524162410|FG000|Treatment Period|Participant withdrew consent|7|||
145358725|NCT02632409|524162411|FG001|Treatment Period|Participant withdrew consent|5|||
145358726|NCT02632409|524162410|FG000|Treatment Period|Lost to Follow-up|0|||
145358727|NCT02632409|524162411|FG001|Treatment Period|Lost to Follow-up|1|||
145418460|NCT03537729|524388482|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
145418461|NCT03537729|524388480|FG000|Overall Study|COVID-19 Site Restrictions|11|||
145418462|NCT03537729|524388481|FG001|Overall Study|COVID-19 Site Restrictions|15|||
145418463|NCT03537729|524388482|FG002|Overall Study|COVID-19 Site Restrictions|18|||
145358728|NCT02632409|524162410|FG000|Treatment Period|Maximum clinical benefit|1|||
145358729|NCT02632409|524162411|FG001|Treatment Period|Maximum clinical benefit|0|||
145358730|NCT02632409|524162410|FG000|Treatment Period|No longer meets study criteria|3|||
145358731|NCT02632409|524162411|FG001|Treatment Period|No longer meets study criteria|0|||
145358732|NCT02632409|524162410|FG000|Treatment Period|Administrative Reason by sponsor|0|||
145358733|NCT02632409|524162411|FG001|Treatment Period|Administrative Reason by sponsor|1|||
145358734|NCT02632409|524162410|FG000|Treatment Period|Other Reasons|10|||
145358735|NCT02632409|524162411|FG001|Treatment Period|Other Reasons|6|||
145358736|NCT05600283|524162412|FG000|Overall Study|Withdrawal by Subject|3|||
145358737|NCT05600283|524162413|FG001|Overall Study|Withdrawal by Subject|8|||
145358738|NCT05600283|524162412|FG000|Overall Study|invalid individual swab|1|||
145358739|NCT05600283|524162413|FG001|Overall Study|invalid individual swab|0|||
145358740|NCT05600283|524162412|FG000|Overall Study|missing clinician collection|3|||
145358741|NCT05600283|524162413|FG001|Overall Study|missing clinician collection|0|||
145358742|NCT05600283|524162412|FG000|Overall Study|screening failure|0|||
145358743|NCT05600283|524162413|FG001|Overall Study|screening failure|2|||
145358744|NCT02883062|524162414|FG000|Overall Study|Withdrawal by Subject|6|||
145358745|NCT02883062|524162415|FG001|Overall Study|Withdrawal by Subject|0|||
145358746|NCT04426006|524162416|FG000|Inclusion|Protocol Violation|1|||
145358747|NCT04426006|524162416|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
145358748|NCT04426006|524162416|FG000|Inclusion|Blood sample at inclusion not done|1|||
145358749|NCT04426006|524162416|FG000|3 Months|Lost to Follow-up|17|||
145358750|NCT04426006|524162416|FG000|12 Months|Lost to Follow-up|38|||
145358751|NCT00720213|524162419|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
145358752|NCT00720213|524162420|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
145358753|NCT00720213|524162421|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
145358754|NCT01808066|524162425|FG000|Overall Study|Withdrawal by Subject|15|||
145358755|NCT01420068|524162427|FG000|Overall Study|Administrative problems|1|||
145358756|NCT01420068|524162428|FG001|Overall Study|Administrative problems|3|||
145358757|NCT01420068|524162427|FG000|Overall Study|Withdrawal by Subject|1|||
145358758|NCT01420068|524162428|FG001|Overall Study|Withdrawal by Subject|2|||
145358759|NCT01252095|524162429|FG000|Overall Study|Disease progression|1|||
145358760|NCT01252095|524162430|FG001|Overall Study|Disease progression|0|||
145358761|NCT00745901|524162431|FG000|Overall Study|Adverse Event|3|||
145358762|NCT00745901|524162432|FG001|Overall Study|Adverse Event|4|||
145358763|NCT00745901|524162431|FG000|Overall Study|Protocol Violation|0|||
145358764|NCT00745901|524162432|FG001|Overall Study|Protocol Violation|1|||
145358765|NCT00745901|524162431|FG000|Overall Study|Withdrawal by Subject|1|||
145358766|NCT00745901|524162432|FG001|Overall Study|Withdrawal by Subject|0|||
145358767|NCT00745901|524162431|FG000|Overall Study|Lost to Follow-up|7|||
145358768|NCT00745901|524162432|FG001|Overall Study|Lost to Follow-up|4|||
145358769|NCT00745901|524162431|FG000|Overall Study|Pregnancy|2|||
145358770|NCT00745901|524162432|FG001|Overall Study|Pregnancy|4|||
145358771|NCT00745901|524162431|FG000|Overall Study|Lack of compliance|2|||
145358772|NCT00745901|524162432|FG001|Overall Study|Lack of compliance|2|||
145358773|NCT00745901|524162431|FG000|Overall Study|Patient's next menses did not start with|1|||
145358774|NCT00745901|524162432|FG001|Overall Study|Patient's next menses did not start with|0|||
145358775|NCT00745901|524162431|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
145358776|NCT00745901|524162432|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
145358777|NCT00745901|524162431|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
145358778|NCT00745901|524162432|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
145358779|NCT00745901|524162431|FG000|Overall Study|Patient didn't take any study medication|7|||
145358780|NCT00745901|524162432|FG001|Overall Study|Patient didn't take any study medication|3|||
145358781|NCT00884117|524162435|FG000|Overall Study|Adverse Event|2|||
145358782|NCT00884117|524162435|FG000|Overall Study|Withdrawal by Subject|89|||
145358783|NCT00884117|524162435|FG000|Overall Study|Death|3|||
145358784|NCT00884117|524162435|FG000|Overall Study|Lost to Follow-up|143|||
145358785|NCT00884117|524162435|FG000|Overall Study|Other|12|||
145358786|NCT01753310|524162436|FG000|Overall Study|Entered into open label extension study|25|||
145358787|NCT01753310|524162437|FG001|Overall Study|Entered into open label extension study|22|||
145358788|NCT01753310|524162436|FG000|Overall Study|Adverse Event|1|||
145358789|NCT01753310|524162437|FG001|Overall Study|Adverse Event|0|||
145358790|NCT01753310|524162436|FG000|Overall Study|Lost to Follow-up|2|||
145358791|NCT01753310|524162437|FG001|Overall Study|Lost to Follow-up|0|||
145358792|NCT01753310|524162436|FG000|Overall Study|Subject decision|2|||
145358793|NCT01753310|524162437|FG001|Overall Study|Subject decision|2|||
145358794|NCT01753310|524162436|FG000|Overall Study|Sponsor decision|1|||
145358795|NCT01753310|524162437|FG001|Overall Study|Sponsor decision|0|||
145358796|NCT01753310|524162436|FG000|Overall Study|Withdrawal by Subject|1|||
145358797|NCT01753310|524162437|FG001|Overall Study|Withdrawal by Subject|0|||
145418464|NCT03537729|524388480|FG000|Overall Study|Decline in Health|5|||
145358798|NCT00952068|524162439|FG000|Overall Study|Adverse Event|3|||
145358799|NCT00952068|524162439|FG000|Overall Study|Withdrawal by Subject|4|||
145358800|NCT02022202|524162440|FG000|Overall Study|Withdrawal by Subject|2|||
145358801|NCT02022202|524162440|FG000|Overall Study|Disease Progression|3|||
145418465|NCT03537729|524388481|FG001|Overall Study|Decline in Health|9|||
145418466|NCT03537729|524388482|FG002|Overall Study|Decline in Health|4|||
145418467|NCT03537729|524388480|FG000|Overall Study|Determined Ineligible|0|||
145418468|NCT03537729|524388481|FG001|Overall Study|Determined Ineligible|0|||
145418469|NCT03537729|524388482|FG002|Overall Study|Determined Ineligible|1|||
145418470|NCT00284934|524388483|FG000|Overall Study|Adverse Event|1|||
145418471|NCT00284934|524388484|FG001|Overall Study|Adverse Event|2|||
145418472|NCT00284934|524388483|FG000|Overall Study|Other reasons|3|||
145418473|NCT00284934|524388484|FG001|Overall Study|Other reasons|1|||
145418474|NCT00454142|524388485|FG000|Overall Study|Withdrawal by Subject|1|||
145418475|NCT00520572|524388493|FG000|Overall Study|Adverse Event|9|||
145418476|NCT00520572|524388494|FG001|Overall Study|Adverse Event|3|||
145418477|NCT00520572|524388495|FG002|Overall Study|Adverse Event|6|||
145418478|NCT00520572|524388496|FG003|Overall Study|Adverse Event|9|||
145418479|NCT00520572|524388497|FG004|Overall Study|Adverse Event|7|||
145418480|NCT00520572|524388498|FG005|Overall Study|Adverse Event|2|||
145418481|NCT00520572|524388493|FG000|Overall Study|Withdrawal by Subject|0|||
145418482|NCT00520572|524388494|FG001|Overall Study|Withdrawal by Subject|9|||
145418483|NCT00520572|524388495|FG002|Overall Study|Withdrawal by Subject|5|||
145418484|NCT00520572|524388496|FG003|Overall Study|Withdrawal by Subject|2|||
145418485|NCT00520572|524388497|FG004|Overall Study|Withdrawal by Subject|2|||
145418486|NCT00520572|524388498|FG005|Overall Study|Withdrawal by Subject|0|||
145418487|NCT00520572|524388493|FG000|Overall Study|Protocol Violation|0|||
145418488|NCT00520572|524388494|FG001|Overall Study|Protocol Violation|0|||
145418489|NCT00520572|524388495|FG002|Overall Study|Protocol Violation|1|||
145418490|NCT00520572|524388496|FG003|Overall Study|Protocol Violation|0|||
145418491|NCT00520572|524388497|FG004|Overall Study|Protocol Violation|0|||
145418492|NCT00520572|524388498|FG005|Overall Study|Protocol Violation|0|||
145418493|NCT00520572|524388493|FG000|Overall Study|Lack of Efficacy|1|||
145418494|NCT00520572|524388494|FG001|Overall Study|Lack of Efficacy|1|||
145418495|NCT00520572|524388495|FG002|Overall Study|Lack of Efficacy|1|||
145418496|NCT00520572|524388496|FG003|Overall Study|Lack of Efficacy|2|||
145418497|NCT00520572|524388497|FG004|Overall Study|Lack of Efficacy|1|||
145418498|NCT00520572|524388498|FG005|Overall Study|Lack of Efficacy|0|||
145418499|NCT00520572|524388493|FG000|Overall Study|Lost to Follow-up|0|||
145418500|NCT00520572|524388494|FG001|Overall Study|Lost to Follow-up|0|||
145418501|NCT00520572|524388495|FG002|Overall Study|Lost to Follow-up|0|||
145418502|NCT00520572|524388496|FG003|Overall Study|Lost to Follow-up|0|||
145418503|NCT00520572|524388497|FG004|Overall Study|Lost to Follow-up|1|||
145418504|NCT00520572|524388498|FG005|Overall Study|Lost to Follow-up|0|||
145418505|NCT00520572|524388493|FG000|Overall Study|Incorrect enrollment|1|||
145418506|NCT00520572|524388494|FG001|Overall Study|Incorrect enrollment|0|||
145418507|NCT00520572|524388495|FG002|Overall Study|Incorrect enrollment|1|||
145418508|NCT00520572|524388496|FG003|Overall Study|Incorrect enrollment|0|||
145418509|NCT00520572|524388497|FG004|Overall Study|Incorrect enrollment|1|||
145418510|NCT00520572|524388498|FG005|Overall Study|Incorrect enrollment|0|||
145418511|NCT00520572|524388493|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
145418512|NCT00520572|524388494|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
145418513|NCT00520572|524388495|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
145418514|NCT00520572|524388496|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
145418515|NCT00520572|524388497|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
145418516|NCT00520572|524388498|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
145418517|NCT00520572|524388493|FG000|Overall Study|Long break in taking Medication|0|||
145418518|NCT00520572|524388494|FG001|Overall Study|Long break in taking Medication|0|||
145418519|NCT00520572|524388495|FG002|Overall Study|Long break in taking Medication|0|||
145418520|NCT00520572|524388496|FG003|Overall Study|Long break in taking Medication|1|||
145418521|NCT00520572|524388497|FG004|Overall Study|Long break in taking Medication|0|||
145418522|NCT00520572|524388498|FG005|Overall Study|Long break in taking Medication|0|||
145418523|NCT00520572|524388493|FG000|Overall Study|Did not receive Treatment|1|||
145418524|NCT00520572|524388494|FG001|Overall Study|Did not receive Treatment|0|||
145418525|NCT00520572|524388495|FG002|Overall Study|Did not receive Treatment|1|||
145577510|NCT02391948|524969426|FG001|12-month Assessment|Medical issue/illness|1|||
145418526|NCT00520572|524388496|FG003|Overall Study|Did not receive Treatment|0|||
145418527|NCT00520572|524388497|FG004|Overall Study|Did not receive Treatment|0|||
145418528|NCT00520572|524388498|FG005|Overall Study|Did not receive Treatment|0|||
145418529|NCT02802865|524388501|FG000|Overall Study|Pregnancy|1|||
145418530|NCT02802865|524388502|FG001|Overall Study|Pregnancy|1|||
145418531|NCT02802865|524388501|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
145418532|NCT02802865|524388502|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
145418533|NCT01748552|524388506|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
145418534|NCT01748552|524388507|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
145418535|NCT01748552|524388508|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
145418536|NCT01748552|524388509|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
145418537|NCT01748552|524388510|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
145418538|NCT01748552|524388511|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
145358802|NCT02022202|524162440|FG000|Overall Study|Desire go to immediately to surgery|3|||
145358803|NCT04390763|524162442|FG000|Safety run-in Part|Adverse Event|4|||
145358804|NCT04390763|524162443|FG001|Safety run-in Part|Adverse Event|0|||
145358805|NCT04390763|524162444|FG002|Safety run-in Part|Adverse Event|0|||
145358806|NCT04390763|524162445|FG003|Safety run-in Part|Adverse Event|0|||
145358807|NCT04390763|524162442|FG000|Safety run-in Part|Physician Decision|1|||
145358808|NCT04390763|524162443|FG001|Safety run-in Part|Physician Decision|0|||
145358809|NCT04390763|524162444|FG002|Safety run-in Part|Physician Decision|0|||
145358810|NCT04390763|524162445|FG003|Safety run-in Part|Physician Decision|0|||
145358811|NCT04390763|524162442|FG000|Safety run-in Part|Progressive Disease|6|||
145358812|NCT04390763|524162443|FG001|Safety run-in Part|Progressive Disease|0|||
145358813|NCT04390763|524162444|FG002|Safety run-in Part|Progressive Disease|0|||
145358814|NCT04390763|524162445|FG003|Safety run-in Part|Progressive Disease|0|||
145358815|NCT04390763|524162442|FG000|Randomized Part|Adverse Event|0|||
145358816|NCT04390763|524162443|FG001|Randomized Part|Adverse Event|11|||
145358817|NCT04390763|524162444|FG002|Randomized Part|Adverse Event|5|||
145358818|NCT04390763|524162445|FG003|Randomized Part|Adverse Event|5|||
145358819|NCT04390763|524162442|FG000|Randomized Part|Death|0|||
145358820|NCT04390763|524162443|FG001|Randomized Part|Death|3|||
145358821|NCT04390763|524162444|FG002|Randomized Part|Death|4|||
145358822|NCT04390763|524162445|FG003|Randomized Part|Death|2|||
145358823|NCT04390763|524162442|FG000|Randomized Part|Physician Decision|0|||
145358824|NCT04390763|524162443|FG001|Randomized Part|Physician Decision|2|||
145358825|NCT04390763|524162444|FG002|Randomized Part|Physician Decision|2|||
145358826|NCT04390763|524162445|FG003|Randomized Part|Physician Decision|9|||
145358827|NCT04390763|524162442|FG000|Randomized Part|Progressive Disease|0|||
145358828|NCT04390763|524162443|FG001|Randomized Part|Progressive Disease|24|||
145358829|NCT04390763|524162444|FG002|Randomized Part|Progressive Disease|31|||
145358830|NCT04390763|524162445|FG003|Randomized Part|Progressive Disease|23|||
145358831|NCT04390763|524162442|FG000|Randomized Part|Study terminated by sponsor|0|||
145358832|NCT04390763|524162443|FG001|Randomized Part|Study terminated by sponsor|1|||
145358833|NCT04390763|524162444|FG002|Randomized Part|Study terminated by sponsor|0|||
145358834|NCT04390763|524162445|FG003|Randomized Part|Study terminated by sponsor|0|||
145358835|NCT04390763|524162442|FG000|Randomized Part|Participant Decision|0|||
145358836|NCT04390763|524162443|FG001|Randomized Part|Participant Decision|5|||
145358837|NCT04390763|524162444|FG002|Randomized Part|Participant Decision|7|||
145358838|NCT04390763|524162445|FG003|Randomized Part|Participant Decision|6|||
145358839|NCT04390763|524162442|FG000|Randomized Part|Not treated|0|||
145358840|NCT04390763|524162443|FG001|Randomized Part|Not treated|4|||
145358841|NCT04390763|524162444|FG002|Randomized Part|Not treated|2|||
145358842|NCT04390763|524162445|FG003|Randomized Part|Not treated|7|||
145358843|NCT04340843|524162446|FG000|Overall Study|Adverse Event|0|||
145358844|NCT04340843|524162447|FG001|Overall Study|Adverse Event|2|||
145358845|NCT04340843|524162446|FG000|Overall Study|Withdrawal by Subject|0|||
145358846|NCT04340843|524162447|FG001|Overall Study|Withdrawal by Subject|2|||
145358847|NCT01956773|524162454|FG000|Overall Study|Lost to Follow-up|628|||
145358848|NCT01956773|524162455|FG001|Overall Study|Lost to Follow-up|1|||
145358849|NCT01383174|524162456|FG000|3 Month Assessment|Death|0|||
145358850|NCT01383174|524162457|FG001|3 Month Assessment|Death|1|||
145358851|NCT01383174|524162456|FG000|3 Month Assessment|Lost to Follow-up|2|||
145358852|NCT01383174|524162457|FG001|3 Month Assessment|Lost to Follow-up|0|||
145358853|NCT01383174|524162456|FG000|3 Month Assessment|Refused to complete|4|||
145358854|NCT01383174|524162457|FG001|3 Month Assessment|Refused to complete|0|||
145358855|NCT01383174|524162456|FG000|6 Month Assessment|Lost to Follow-up|1|||
145358856|NCT01383174|524162457|FG001|6 Month Assessment|Lost to Follow-up|1|||
145358857|NCT01383174|524162456|FG000|6 Month Assessment|Refused to complete|4|||
145358858|NCT01383174|524162457|FG001|6 Month Assessment|Refused to complete|0|||
145358859|NCT01153815|524162458|FG000|Overall Study|Adverse Event|3|||
145358860|NCT01153815|524162459|FG001|Overall Study|Adverse Event|1|||
145358861|NCT01153815|524162458|FG000|Overall Study|Withdrawal by Subject|6|||
145358862|NCT01153815|524162459|FG001|Overall Study|Withdrawal by Subject|4|||
145358863|NCT01890122|524162462|FG000|Overall Study|Adverse Event|1|||
145358864|NCT01890122|524162463|FG001|Overall Study|Adverse Event|1|||
145358865|NCT01890122|524162464|FG002|Overall Study|Adverse Event|1|||
145577511|NCT02391948|524969427|FG002|12-month Assessment|Medical issue/illness|0|||
145358866|NCT01890122|524162465|FG003|Overall Study|Adverse Event|2|||
145358867|NCT01890122|524162462|FG000|Overall Study|Major Protocol Deviation|3|||
145358868|NCT01890122|524162463|FG001|Overall Study|Major Protocol Deviation|1|||
145358869|NCT01890122|524162464|FG002|Overall Study|Major Protocol Deviation|0|||
145358870|NCT01890122|524162465|FG003|Overall Study|Major Protocol Deviation|1|||
145577512|NCT02391948|524969428|FG003|12-month Assessment|Medical issue/illness|1|||
145358871|NCT01890122|524162462|FG000|Overall Study|Lost to Follow-up|0|||
145358872|NCT01890122|524162463|FG001|Overall Study|Lost to Follow-up|1|||
145358873|NCT01890122|524162464|FG002|Overall Study|Lost to Follow-up|2|||
145358874|NCT01890122|524162465|FG003|Overall Study|Lost to Follow-up|2|||
145358875|NCT01890122|524162462|FG000|Overall Study|Voluntary Withdrawal|8|||
145358876|NCT01890122|524162463|FG001|Overall Study|Voluntary Withdrawal|8|||
145358877|NCT01890122|524162464|FG002|Overall Study|Voluntary Withdrawal|2|||
145358878|NCT01890122|524162465|FG003|Overall Study|Voluntary Withdrawal|11|||
145358879|NCT01890122|524162462|FG000|Overall Study|Lack of Efficacy|14|||
145358880|NCT01890122|524162463|FG001|Overall Study|Lack of Efficacy|24|||
145358881|NCT01890122|524162464|FG002|Overall Study|Lack of Efficacy|7|||
145358882|NCT01890122|524162465|FG003|Overall Study|Lack of Efficacy|41|||
145358883|NCT01890122|524162462|FG000|Overall Study|Reason not Specified|0|||
145358884|NCT01890122|524162463|FG001|Overall Study|Reason not Specified|1|||
145358885|NCT01890122|524162464|FG002|Overall Study|Reason not Specified|1|||
145358886|NCT01890122|524162465|FG003|Overall Study|Reason not Specified|2|||
145358887|NCT01890122|524162462|FG000|Overall Study|Randomized but not Treated|1|||
145358888|NCT01890122|524162463|FG001|Overall Study|Randomized but not Treated|1|||
145358889|NCT01890122|524162464|FG002|Overall Study|Randomized but not Treated|0|||
145358890|NCT01890122|524162465|FG003|Overall Study|Randomized but not Treated|0|||
145358891|NCT03591874|524162467|FG000|Overall Study|Adverse Event|4|||
145358892|NCT03591874|524162468|FG001|Overall Study|Adverse Event|0|||
145358893|NCT03591874|524162467|FG000|Overall Study|Withdrawal by Subject|2|||
145358894|NCT03591874|524162468|FG001|Overall Study|Withdrawal by Subject|1|||
145358895|NCT03591874|524162467|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
145358896|NCT03591874|524162468|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
145358897|NCT03591874|524162467|FG000|Overall Study|On Study at Time of Study Termination|12|||
145358898|NCT03591874|524162468|FG001|Overall Study|On Study at Time of Study Termination|6|||
145358899|NCT04495829|524162471|FG000|Overall Study|Lost to Follow-up|2|||
145358900|NCT04495829|524162471|FG000|Overall Study|Inclusion criterion not met|3|||
145358901|NCT03644342|524162472|FG000|Overall Study|Adverse Event|2|||
145358902|NCT03644342|524162473|FG001|Overall Study|Adverse Event|0|||
145358903|NCT03644342|524162472|FG000|Overall Study|Protocol Violation|0|||
145358904|NCT03644342|524162473|FG001|Overall Study|Protocol Violation|1|||
145358905|NCT03194542|524162474|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
145358906|NCT03194542|524162475|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145358907|NCT03194542|524162476|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145358908|NCT03194542|524162477|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
145358909|NCT03194542|524162474|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
145358910|NCT03194542|524162475|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
145358911|NCT03194542|524162476|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
145358912|NCT03194542|524162477|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
145358913|NCT03194542|524162474|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
145358914|NCT03194542|524162475|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
145358915|NCT03194542|524162476|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
145358916|NCT03194542|524162477|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
145358917|NCT03194542|524162474|FG000|Overall Study|Loss of Response|4|||
145358918|NCT03194542|524162475|FG001|Overall Study|Loss of Response|2|||
145358919|NCT03194542|524162476|FG002|Overall Study|Loss of Response|3|||
145358920|NCT03194542|524162477|FG003|Overall Study|Loss of Response|4|||
145358921|NCT03194542|524162474|FG000|Overall Study|Physician Decision|0|||
145358922|NCT03194542|524162475|FG001|Overall Study|Physician Decision|1|||
145358923|NCT03194542|524162476|FG002|Overall Study|Physician Decision|0|||
145358924|NCT03194542|524162477|FG003|Overall Study|Physician Decision|0|||
145358925|NCT03194542|524162474|FG000|Overall Study|Lack of Efficacy|2|||
145358926|NCT03194542|524162475|FG001|Overall Study|Lack of Efficacy|2|||
145358927|NCT03194542|524162476|FG002|Overall Study|Lack of Efficacy|2|||
145358928|NCT03194542|524162477|FG003|Overall Study|Lack of Efficacy|6|||
145358929|NCT03194542|524162474|FG000|Overall Study|Withdrawal by Subject|2|||
145358930|NCT03194542|524162475|FG001|Overall Study|Withdrawal by Subject|1|||
145358931|NCT03194542|524162476|FG002|Overall Study|Withdrawal by Subject|5|||
145358932|NCT03194542|524162477|FG003|Overall Study|Withdrawal by Subject|4|||
145358933|NCT03194542|524162474|FG000|Overall Study|Progressive Disease|1|||
145358934|NCT03194542|524162475|FG001|Overall Study|Progressive Disease|0|||
145358935|NCT03194542|524162476|FG002|Overall Study|Progressive Disease|1|||
145358936|NCT03194542|524162477|FG003|Overall Study|Progressive Disease|1|||
145358937|NCT03194542|524162474|FG000|Overall Study|Adverse Event|1|||
145358938|NCT03194542|524162475|FG001|Overall Study|Adverse Event|2|||
145358939|NCT03194542|524162476|FG002|Overall Study|Adverse Event|0|||
145358940|NCT03194542|524162477|FG003|Overall Study|Adverse Event|5|||
145358941|NCT03194542|524162474|FG000|Overall Study|Death|1|||
145358942|NCT03194542|524162475|FG001|Overall Study|Death|2|||
145358943|NCT03194542|524162476|FG002|Overall Study|Death|0|||
145358944|NCT03194542|524162477|FG003|Overall Study|Death|5|||
145358945|NCT03194542|524162474|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
145418539|NCT01748552|524388512|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
145418540|NCT01748552|524388513|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
145358946|NCT03194542|524162475|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
145358947|NCT03194542|524162476|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
145358948|NCT03194542|524162477|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
145358949|NCT00030901|524162478|FG000|Initial Registration|Ineligible|167|||
145358950|NCT00030901|524162479|FG001|Initial Registration|Ineligible|0|||
145358951|NCT00030901|524162480|FG002|Initial Registration|Ineligible|0|||
145358952|NCT00030901|524162478|FG000|Randomization|Adverse Event|0|||
145358953|NCT00030901|524162479|FG001|Randomization|Adverse Event|11|||
145358954|NCT00030901|524162480|FG002|Randomization|Adverse Event|7|||
145358955|NCT00030901|524162478|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
145358956|NCT00030901|524162479|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
145358957|NCT00030901|524162480|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
145358958|NCT00030901|524162478|FG000|Randomization|Progression/Relapse|0|||
145358959|NCT00030901|524162479|FG001|Randomization|Progression/Relapse|22|||
145358960|NCT00030901|524162480|FG002|Randomization|Progression/Relapse|21|||
145358961|NCT00030901|524162478|FG000|Randomization|Death|0|||
145358962|NCT00030901|524162479|FG001|Randomization|Death|1|||
145358963|NCT00030901|524162480|FG002|Randomization|Death|3|||
145358964|NCT00030901|524162478|FG000|Randomization|Other|0|||
145358965|NCT00030901|524162479|FG001|Randomization|Other|36|||
145358966|NCT00030901|524162480|FG002|Randomization|Other|33|||
145358967|NCT00030901|524162478|FG000|Randomization|Ineligible|0|||
145358968|NCT00030901|524162479|FG001|Randomization|Ineligible|15|||
145358969|NCT00030901|524162480|FG002|Randomization|Ineligible|14|||
145358970|NCT01806051|524162481|FG000|Overall Study|Withdrawal by Subject|6|||
145358971|NCT02576847|524162482|FG000|Overall Study|Adverse Event|27|||
145358972|NCT02576847|524162482|FG000|Overall Study|Lost to Follow-up|22|||
145358973|NCT02576847|524162482|FG000|Overall Study|Physician Decision|1|||
145358974|NCT02576847|524162482|FG000|Overall Study|Pregnancy|1|||
145358975|NCT02576847|524162482|FG000|Overall Study|Protocol Violation|3|||
145358976|NCT02576847|524162482|FG000|Overall Study|Withdrawal by Subject|78|||
145358977|NCT02576847|524162482|FG000|Overall Study|Other|5|||
145358978|NCT02747108|524162485|FG000|Overall Study|Death|2|||
145358979|NCT02747108|524162486|FG001|Overall Study|Death|2|||
145358980|NCT02747108|524162485|FG000|Overall Study|Withdrawal by Subject|1|||
145358981|NCT02747108|524162486|FG001|Overall Study|Withdrawal by Subject|0|||
145358982|NCT02747108|524162485|FG000|Overall Study|Protocol Violation|2|||
145358983|NCT02747108|524162486|FG001|Overall Study|Protocol Violation|0|||
145358984|NCT05795153|524164579|FG000|Overall Study|Adverse Event|2|||
145358985|NCT05795153|524164579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145358986|NCT05795153|524164579|FG000|Overall Study|Lost to Follow-up|1|||
145358987|NCT05795153|524164579|FG000|Overall Study|Subject decision|2|||
145358988|NCT05336227|524164580|FG000|Overall Study|Adverse Event|1|||
145358989|NCT05336227|524164581|FG001|Overall Study|Adverse Event|0|||
145358990|NCT05336227|524164580|FG000|Overall Study|Lost to Follow-up|2|||
145358991|NCT05336227|524164581|FG001|Overall Study|Lost to Follow-up|0|||
145358992|NCT05336227|524164580|FG000|Overall Study|Withdrawal by Subject|1|||
145358993|NCT05336227|524164581|FG001|Overall Study|Withdrawal by Subject|0|||
145358994|NCT04050462|524164582|FG000|Overall Study|Withdrawal by Subject|1|||
145358995|NCT04050462|524164583|FG001|Overall Study|Withdrawal by Subject|0|||
145358996|NCT04050462|524164584|FG002|Overall Study|Withdrawal by Subject|0|||
145358997|NCT05151744|524164585|FG000|Overall Study|Adverse Event|6|||
145358998|NCT05151744|524164586|FG001|Overall Study|Adverse Event|2|||
145358999|NCT05151744|524164585|FG000|Overall Study|Death|1|||
145359000|NCT05151744|524164586|FG001|Overall Study|Death|2|||
145359001|NCT05151744|524164585|FG000|Overall Study|Lack of Efficacy|1|||
145359002|NCT05151744|524164586|FG001|Overall Study|Lack of Efficacy|1|||
145359003|NCT05151744|524164585|FG000|Overall Study|Lost to Follow-up|2|||
145359004|NCT05151744|524164586|FG001|Overall Study|Lost to Follow-up|2|||
145359005|NCT05151744|524164585|FG000|Overall Study|Need for Rescue Treatment|0|||
145359006|NCT05151744|524164586|FG001|Overall Study|Need for Rescue Treatment|1|||
145359007|NCT05151744|524164585|FG000|Overall Study|Non-compliance with Study Drug|0|||
145359008|NCT05151744|524164586|FG001|Overall Study|Non-compliance with Study Drug|1|||
145359009|NCT05151744|524164585|FG000|Overall Study|Reason not Specified|10|||
145359010|NCT05151744|524164586|FG001|Overall Study|Reason not Specified|0|||
145359011|NCT05151744|524164585|FG000|Overall Study|Physician Decision|2|||
145359012|NCT05151744|524164586|FG001|Overall Study|Physician Decision|1|||
145359013|NCT05151744|524164585|FG000|Overall Study|Protocol Violation|1|||
145359014|NCT05151744|524164586|FG001|Overall Study|Protocol Violation|0|||
145359015|NCT05151744|524164585|FG000|Overall Study|Withdrawal by Subject|6|||
145359016|NCT05151744|524164586|FG001|Overall Study|Withdrawal by Subject|3|||
145359017|NCT05228470|524164587|FG000|Overall Study|Death|6|||
145359018|NCT05228470|524164588|FG001|Overall Study|Death|11|||
145359019|NCT05228470|524164587|FG000|Overall Study|Withdrawal by Subject|1|||
145359020|NCT05228470|524164588|FG001|Overall Study|Withdrawal by Subject|8|||
145359021|NCT05228470|524164587|FG000|Overall Study|Ongoing|1|||
145359022|NCT05228470|524164588|FG001|Overall Study|Ongoing|11|||
145359023|NCT04053868|524164589|FG000|Overall Study|Withdrawal by Subject|1|||
145359024|NCT04053868|524164590|FG001|Overall Study|Withdrawal by Subject|0|||
145359025|NCT05731700|524164591|FG000|Overall Study|Death|1|||
145359026|NCT04010240|524164594|FG000|Overall Study|IHC not performed|2299|||
145359027|NCT00570687|524164603|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359028|NCT00570687|524164604|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145418541|NCT01748552|524388514|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
145418542|NCT01748552|524388515|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
145418543|NCT01748552|524388516|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
145418544|NCT01748552|524388517|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
145418545|NCT01748552|524388506|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418546|NCT01748552|524388507|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418547|NCT01748552|524388508|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418548|NCT01748552|524388509|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418549|NCT01748552|524388510|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418550|NCT01748552|524388511|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418551|NCT01748552|524388512|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145418552|NCT01748552|524388513|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145418553|NCT01748552|524388514|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
145359029|NCT00570687|524164605|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359030|NCT00570687|524164606|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359031|NCT00570687|524164607|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145359032|NCT00570687|524164608|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145359033|NCT00570687|524164609|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
145359034|NCT00570687|524164610|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145359035|NCT00570687|524164611|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
145359036|NCT00570687|524164612|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
145359037|NCT00570687|524164603|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359038|NCT00570687|524164604|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359039|NCT00570687|524164605|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359040|NCT00570687|524164606|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359041|NCT00570687|524164607|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359042|NCT00570687|524164608|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359043|NCT00570687|524164609|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359044|NCT00570687|524164610|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359045|NCT00570687|524164611|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
145359046|NCT00570687|524164612|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359047|NCT00570687|524164603|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359048|NCT00570687|524164604|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359049|NCT00570687|524164605|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359050|NCT00570687|524164606|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359051|NCT00570687|524164607|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359052|NCT00570687|524164608|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359053|NCT00570687|524164609|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
145359054|NCT00570687|524164610|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359055|NCT00570687|524164611|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359056|NCT00570687|524164612|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
145359057|NCT00975611|524164613|FG000|Overall Study|Screen Fail|16|||
145359058|NCT00975611|524164613|FG000|Overall Study|Physician Decision|1|||
145359059|NCT03058705|524164614|FG000|Overall Study|Withdrawal by Subject|2|||
145359060|NCT03058705|524164614|FG000|Overall Study|Physician Decision|2|||
145359061|NCT04623216|524164615|FG000|Overall Study|Death|5|||
145359062|NCT04623216|524164616|FG001|Overall Study|Death|2|||
145359063|NCT04623216|524164617|FG002|Overall Study|Death|0|||
145359064|NCT04623216|524164618|FG003|Overall Study|Death|0|||
145359065|NCT04623216|524164615|FG000|Overall Study|Terminated by Sponsor|3|||
145359066|NCT04623216|524164616|FG001|Overall Study|Terminated by Sponsor|2|||
145359067|NCT04623216|524164617|FG002|Overall Study|Terminated by Sponsor|2|||
145359068|NCT04623216|524164618|FG003|Overall Study|Terminated by Sponsor|0|||
145359069|NCT04623216|524164615|FG000|Overall Study|Physician Decision|1|||
145359070|NCT04623216|524164616|FG001|Overall Study|Physician Decision|0|||
145418554|NCT01748552|524388515|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145577513|NCT02391948|524969429|FG004|12-month Assessment|Medical issue/illness|0|||
145359071|NCT04623216|524164617|FG002|Overall Study|Physician Decision|0|||
145359072|NCT04623216|524164618|FG003|Overall Study|Physician Decision|0|||
145359073|NCT03521154|524164621|FG000|Overall Study|Ongoing study at data cut-off|111|||
145418555|NCT01748552|524388516|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418556|NCT01748552|524388517|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
145418557|NCT01529112|524388518|FG000|Overall Study|Adverse Event|2|||
145418558|NCT01529112|524388519|FG001|Overall Study|Adverse Event|0|||
145577514|NCT02391948|524969425|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
145359074|NCT03521154|524164622|FG001|Overall Study|Ongoing study at data cut-off|52|||
145359075|NCT05468164|524164623|FG000|Treatment Period 4|Adverse Event|0|||
145359076|NCT05468164|524164624|FG001|Treatment Period 4|Adverse Event|0|||
145359077|NCT05468164|524164625|FG002|Treatment Period 4|Adverse Event|0|||
145418559|NCT01529112|524388518|FG000|Overall Study|Death|59|||
145418560|NCT01529112|524388519|FG001|Overall Study|Death|38|||
145418561|NCT01529112|524388518|FG000|Overall Study|Protocol Violation|1|||
145418562|NCT01529112|524388519|FG001|Overall Study|Protocol Violation|0|||
145418563|NCT01529112|524388518|FG000|Overall Study|Withdrawal by Subject|7|||
145418564|NCT01529112|524388519|FG001|Overall Study|Withdrawal by Subject|3|||
145418565|NCT03607695|524388521|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
145418566|NCT03607695|524388521|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
145418567|NCT00676052|524388522|FG000|Overall Study|Adverse Event|0|||
145418568|NCT00676052|524388523|FG001|Overall Study|Adverse Event|1|||
145418569|NCT00676052|524388524|FG002|Overall Study|Adverse Event|1|||
145418570|NCT00676052|524388525|FG003|Overall Study|Adverse Event|2|||
145418571|NCT00676052|524388526|FG004|Overall Study|Adverse Event|2|||
145418572|NCT00676052|524388527|FG005|Overall Study|Adverse Event|2|||
145418573|NCT00676052|524388522|FG000|Overall Study|Lack of Efficacy|2|||
145418574|NCT00676052|524388523|FG001|Overall Study|Lack of Efficacy|2|||
145418575|NCT00676052|524388524|FG002|Overall Study|Lack of Efficacy|1|||
145418576|NCT00676052|524388525|FG003|Overall Study|Lack of Efficacy|1|||
145418577|NCT00676052|524388526|FG004|Overall Study|Lack of Efficacy|2|||
145418578|NCT00676052|524388527|FG005|Overall Study|Lack of Efficacy|1|||
145418579|NCT00676052|524388522|FG000|Overall Study|Protocol Violation|5|||
145418580|NCT00676052|524388523|FG001|Overall Study|Protocol Violation|3|||
145418581|NCT00676052|524388524|FG002|Overall Study|Protocol Violation|2|||
145418582|NCT00676052|524388525|FG003|Overall Study|Protocol Violation|2|||
145418583|NCT00676052|524388526|FG004|Overall Study|Protocol Violation|1|||
145418584|NCT00676052|524388527|FG005|Overall Study|Protocol Violation|2|||
145418585|NCT00676052|524388522|FG000|Overall Study|Lost to Follow-up|0|||
145418586|NCT00676052|524388523|FG001|Overall Study|Lost to Follow-up|0|||
145418587|NCT00676052|524388524|FG002|Overall Study|Lost to Follow-up|0|||
145418588|NCT00676052|524388525|FG003|Overall Study|Lost to Follow-up|0|||
145418589|NCT00676052|524388526|FG004|Overall Study|Lost to Follow-up|1|||
145418590|NCT00676052|524388527|FG005|Overall Study|Lost to Follow-up|0|||
145418591|NCT00676052|524388522|FG000|Overall Study|Physician Decision|1|||
145418592|NCT00676052|524388523|FG001|Overall Study|Physician Decision|1|||
145418593|NCT00676052|524388524|FG002|Overall Study|Physician Decision|1|||
145418594|NCT00676052|524388525|FG003|Overall Study|Physician Decision|0|||
145418595|NCT00676052|524388526|FG004|Overall Study|Physician Decision|0|||
145418596|NCT00676052|524388527|FG005|Overall Study|Physician Decision|1|||
145418597|NCT00676052|524388522|FG000|Overall Study|Withdrawal by Subject|1|||
145418598|NCT00676052|524388523|FG001|Overall Study|Withdrawal by Subject|0|||
145418599|NCT00676052|524388524|FG002|Overall Study|Withdrawal by Subject|1|||
145418600|NCT00676052|524388525|FG003|Overall Study|Withdrawal by Subject|0|||
145418601|NCT00676052|524388526|FG004|Overall Study|Withdrawal by Subject|0|||
145359078|NCT05468164|524164626|FG003|Treatment Period 4|Adverse Event|1|||
145359079|NCT05386680|524164627|FG000|Overall Study|Guardian decision|2|||
145359080|NCT03827291|524164628|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
145359081|NCT03827291|524164629|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
145359082|NCT04795466|524164630|FG000|Overall Study|Adverse Event|3|||
145359083|NCT04795466|524164631|FG001|Overall Study|Adverse Event|1|||
145359084|NCT04795466|524164630|FG000|Overall Study|Physician Decision|1|||
145359085|NCT04795466|524164631|FG001|Overall Study|Physician Decision|0|||
145359086|NCT04795466|524164630|FG000|Overall Study|Withdrawal by Subject|2|||
145359087|NCT04795466|524164631|FG001|Overall Study|Withdrawal by Subject|1|||
145359088|NCT04652726|524164632|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
145359089|NCT04652726|524164633|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
145359090|NCT04652726|524164634|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
145418602|NCT00676052|524388527|FG005|Overall Study|Withdrawal by Subject|0|||
145418603|NCT01428713|524388528|FG000|Overall Study|Non-compliance|2|||
145418604|NCT01428713|524388529|FG001|Overall Study|Non-compliance|2|||
145418605|NCT01428713|524388528|FG000|Overall Study|Withdrawal by Subject|1|||
145359091|NCT04652726|524164632|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
145359092|NCT04652726|524164633|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
145418606|NCT01428713|524388529|FG001|Overall Study|Withdrawal by Subject|1|||
145418607|NCT01428713|524388528|FG000|Overall Study|Adverse Event|0|||
145418608|NCT01428713|524388529|FG001|Overall Study|Adverse Event|2|||
145418609|NCT00585169|524388532|FG000|Overall Study|Withdrawal by Subject|1|||
145418610|NCT01093885|524388551|FG000|Overall Study|Adverse Event|4|||
145418611|NCT01093885|524388551|FG000|Overall Study|Lost to Follow-up|1|||
145418612|NCT00710554|524388552|FG000|Overall Study|Adverse Event|24|||
145418613|NCT00710554|524388553|FG001|Overall Study|Adverse Event|7|||
145418614|NCT00710554|524388552|FG000|Overall Study|Withdrawal by Subject|7|||
145418615|NCT00710554|524388553|FG001|Overall Study|Withdrawal by Subject|3|||
145359093|NCT04652726|524164634|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
145418616|NCT00710554|524388552|FG000|Overall Study|Lost to Follow-up|7|||
145418617|NCT00710554|524388553|FG001|Overall Study|Lost to Follow-up|1|||
145418618|NCT00710554|524388552|FG000|Overall Study|Lack of Efficacy|11|||
145418619|NCT00710554|524388553|FG001|Overall Study|Lack of Efficacy|12|||
145359094|NCT01102257|524164643|FG000|Overall Study|Adverse Event|1|||
145359095|NCT01102257|524164644|FG001|Overall Study|Adverse Event|0|||
145359096|NCT01102257|524164643|FG000|Overall Study|Adverse Event|1|||
145359097|NCT01102257|524164644|FG001|Overall Study|Adverse Event|0|||
145359098|NCT04066244|524164645|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
145359099|NCT04066244|524164646|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
145359100|NCT04066244|524164647|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
145359101|NCT04066244|524164648|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
145359102|NCT04066244|524164649|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
145359103|NCT04066244|524164650|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
145359104|NCT04066244|524164645|FG000|Part 2 (Cohort 5)|Death|0|||
145359105|NCT04066244|524164646|FG001|Part 2 (Cohort 5)|Death|0|||
145359106|NCT04066244|524164647|FG002|Part 2 (Cohort 5)|Death|0|||
145359107|NCT04066244|524164648|FG003|Part 2 (Cohort 5)|Death|0|||
145359108|NCT04066244|524164649|FG004|Part 2 (Cohort 5)|Death|0|||
145359109|NCT04066244|524164650|FG005|Part 2 (Cohort 5)|Death|2|||
145359110|NCT04066244|524164645|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145359111|NCT04066244|524164646|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145359112|NCT04066244|524164647|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145359113|NCT04066244|524164648|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145359114|NCT04066244|524164649|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
145359115|NCT04066244|524164650|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
145359116|NCT04066244|524164645|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145359117|NCT04066244|524164646|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145359118|NCT04066244|524164647|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145359119|NCT04066244|524164648|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145359120|NCT04066244|524164649|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
145359121|NCT04066244|524164650|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
145359122|NCT03976362|524164651|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
145359123|NCT03976362|524164652|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145359124|NCT03976362|524164653|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145359125|NCT03976362|524164651|FG000|Induction Phase|Death|62|||
145359126|NCT03976362|524164652|FG001|Induction Phase|Death|0|||
145359127|NCT03976362|524164653|FG002|Induction Phase|Death|0|||
145359128|NCT03976362|524164651|FG000|Maintenance Phase|Participants Ongoing|0|||
145359129|NCT03976362|524164652|FG001|Maintenance Phase|Participants Ongoing|106|||
145359130|NCT03976362|524164653|FG002|Maintenance Phase|Participants Ongoing|103|||
145359131|NCT03976362|524164651|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145359132|NCT03976362|524164652|FG001|Maintenance Phase|Withdrawal by Subject|4|||
145359133|NCT03976362|524164653|FG002|Maintenance Phase|Withdrawal by Subject|4|||
145359134|NCT03976362|524164651|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
145359135|NCT03976362|524164652|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
145359136|NCT03976362|524164653|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
145359137|NCT03976362|524164651|FG000|Maintenance Phase|Death|0|||
145359138|NCT03976362|524164652|FG001|Maintenance Phase|Death|186|||
145359139|NCT03976362|524164653|FG002|Maintenance Phase|Death|187|||
145359140|NCT04509076|524164654|FG000|Overall Study|Withdrawal by Subject|1|||
145359141|NCT04509076|524164655|FG001|Overall Study|Withdrawal by Subject|2|||
145359142|NCT04509076|524164654|FG000|Overall Study|Lost to Follow-up|1|||
145359143|NCT04509076|524164655|FG001|Overall Study|Lost to Follow-up|2|||
145359144|NCT01343043|524164658|FG000|Overall Study|Disease progression before treatment|1|||
145359145|NCT01343043|524164659|FG001|Overall Study|Disease progression before treatment|0|||
145359146|NCT01343043|524164660|FG002|Overall Study|Disease progression before treatment|0|||
145359147|NCT01343043|524164661|FG003|Overall Study|Disease progression before treatment|0|||
145359148|NCT01343043|524164658|FG000|Overall Study|Withdrawal by Subject|1|||
145359149|NCT01343043|524164659|FG001|Overall Study|Withdrawal by Subject|0|||
145359150|NCT01343043|524164660|FG002|Overall Study|Withdrawal by Subject|0|||
145359151|NCT01343043|524164661|FG003|Overall Study|Withdrawal by Subject|0|||
145359152|NCT01343043|524164658|FG000|Overall Study|Death|1|||
145359153|NCT01343043|524164659|FG001|Overall Study|Death|1|||
145359154|NCT01343043|524164660|FG002|Overall Study|Death|0|||
145359155|NCT01343043|524164661|FG003|Overall Study|Death|1|||
145359156|NCT00925704|524164662|FG000|First Intervention|Withdrew consent|0|||
145418620|NCT00710554|524388552|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
145359157|NCT00925704|524164663|FG001|First Intervention|Withdrew consent|0|||
145359158|NCT00925704|524164664|FG002|First Intervention|Withdrew consent|0|||
145359159|NCT00925704|524164665|FG003|First Intervention|Withdrew consent|1|||
145359160|NCT00925704|524164666|FG004|First Intervention|Withdrew consent|1|||
145359161|NCT00925704|524164667|FG005|First Intervention|Withdrew consent|0|||
145359162|NCT00925704|524164662|FG000|Second Intervention|Withdrawal by Subject|1|||
145359163|NCT00925704|524164663|FG001|Second Intervention|Withdrawal by Subject|0|||
145359164|NCT00925704|524164664|FG002|Second Intervention|Withdrawal by Subject|0|||
145359165|NCT00925704|524164665|FG003|Second Intervention|Withdrawal by Subject|0|||
145359166|NCT00925704|524164666|FG004|Second Intervention|Withdrawal by Subject|1|||
145359167|NCT00925704|524164667|FG005|Second Intervention|Withdrawal by Subject|0|||
145418621|NCT00710554|524388553|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
145359168|NCT00925704|524164662|FG000|Third Intervention|Withdrew consent|0|||
145359169|NCT00925704|524164663|FG001|Third Intervention|Withdrew consent|0|||
145359170|NCT00925704|524164664|FG002|Third Intervention|Withdrew consent|0|||
145359171|NCT00925704|524164665|FG003|Third Intervention|Withdrew consent|0|||
145359172|NCT00925704|524164666|FG004|Third Intervention|Withdrew consent|0|||
145359173|NCT00925704|524164667|FG005|Third Intervention|Withdrew consent|1|||
145359174|NCT00502242|524164675|FG000|Overall Study|Lack of Efficacy|1|||
145359175|NCT00502242|524164676|FG001|Overall Study|Lack of Efficacy|11|||
145359176|NCT00502242|524164675|FG000|Overall Study|Adverse Event|31|||
145359177|NCT00502242|524164676|FG001|Overall Study|Adverse Event|20|||
145359178|NCT00502242|524164675|FG000|Overall Study|Physician Decision|2|||
145359179|NCT00502242|524164676|FG001|Overall Study|Physician Decision|3|||
145359180|NCT00502242|524164675|FG000|Overall Study|Other - Unspecified|8|||
145359181|NCT00502242|524164676|FG001|Overall Study|Other - Unspecified|14|||
145359182|NCT00502242|524164675|FG000|Overall Study|Protocol Violation|3|||
145359183|NCT00502242|524164676|FG001|Overall Study|Protocol Violation|1|||
145359184|NCT00502242|524164675|FG000|Overall Study|Withdrawal by Subject|6|||
145359185|NCT00502242|524164676|FG001|Overall Study|Withdrawal by Subject|7|||
145359186|NCT03207815|524164677|FG000|Overall Study|Protocol Violation|3|||
145359187|NCT03207815|524164678|FG001|Overall Study|Protocol Violation|1|||
145359188|NCT03207815|524164677|FG000|Overall Study|Adverse Event|1|||
145359189|NCT03207815|524164678|FG001|Overall Study|Adverse Event|2|||
145359190|NCT03207815|524164677|FG000|Overall Study|Lost to Follow-up|1|||
145359191|NCT03207815|524164678|FG001|Overall Study|Lost to Follow-up|2|||
145359192|NCT03207815|524164677|FG000|Overall Study|Investigator's Discretion|1|||
145359193|NCT03207815|524164678|FG001|Overall Study|Investigator's Discretion|1|||
145359194|NCT03207815|524164677|FG000|Overall Study|Lack of Efficacy|0|||
145359195|NCT03207815|524164678|FG001|Overall Study|Lack of Efficacy|1|||
145359196|NCT03207815|524164677|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
145359197|NCT03207815|524164678|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
145359198|NCT03207815|524164677|FG000|Overall Study|Withdrew Consent|1|||
145359199|NCT03207815|524164678|FG001|Overall Study|Withdrew Consent|0|||
145359200|NCT01671007|524164679|FG000|Overall Study|Other reasons than listed|166|||
145359201|NCT01671007|524164680|FG001|Overall Study|Other reasons than listed|373|||
145359202|NCT01671007|524164681|FG002|Overall Study|Other reasons than listed|197|||
145359203|NCT01671007|524164682|FG003|Overall Study|Other reasons than listed|228|||
145359204|NCT01671007|524164683|FG004|Overall Study|Other reasons than listed|14|||
145359205|NCT01671007|524164684|FG005|Overall Study|Other reasons than listed|71|||
145418622|NCT01301001|524388554|FG000|First Intervention|Lost to Follow-up|4|||
145418623|NCT01301001|524388555|FG001|First Intervention|Lost to Follow-up|4|||
145418624|NCT01301001|524388554|FG000|First Intervention|Withdrawal by Subject|1|||
145418625|NCT01301001|524388555|FG001|First Intervention|Withdrawal by Subject|4|||
145418626|NCT01301001|524388554|FG000|First Intervention|Adverse Event|5|||
145418627|NCT01301001|524388555|FG001|First Intervention|Adverse Event|0|||
145418628|NCT01301001|524388554|FG000|First Intervention|Protocol Violation|0|||
145418629|NCT01301001|524388555|FG001|First Intervention|Protocol Violation|1|||
145418630|NCT01301001|524388554|FG000|Second Intervention|Adverse Event|2|||
145418631|NCT01301001|524388555|FG001|Second Intervention|Adverse Event|0|||
145418632|NCT01301001|524388554|FG000|Second Intervention|Withdrawal by Subject|2|||
145418633|NCT01301001|524388555|FG001|Second Intervention|Withdrawal by Subject|0|||
145418634|NCT01560988|524388556|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
145418635|NCT01560988|524388557|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
145418636|NCT01560988|524388556|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
145418637|NCT01560988|524388557|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
145418638|NCT01560988|524388556|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
145418639|NCT01560988|524388557|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
145418640|NCT04243837|524388561|FG000|Overall Study|Adverse Event|2|||
145418641|NCT04243837|524388562|FG001|Overall Study|Adverse Event|1|||
145418642|NCT04243837|524388561|FG000|Overall Study|Withdrawal by Subject|4|||
145418643|NCT04243837|524388562|FG001|Overall Study|Withdrawal by Subject|2|||
145418644|NCT04243837|524388561|FG000|Overall Study|Covid-19 lock down|1|||
145359206|NCT01671007|524164685|FG006|Overall Study|Other reasons than listed|17|||
145359207|NCT01671007|524164686|FG007|Overall Study|Other reasons than listed|66|||
145359208|NCT01671007|524164687|FG008|Overall Study|Other reasons than listed|0|||
145359209|NCT01671007|524164679|FG000|Overall Study|Withdrawal by Subject|36|||
145359210|NCT01671007|524164680|FG001|Overall Study|Withdrawal by Subject|59|||
145359211|NCT01671007|524164681|FG002|Overall Study|Withdrawal by Subject|53|||
145418645|NCT04243837|524388562|FG001|Overall Study|Covid-19 lock down|0|||
145359212|NCT01671007|524164682|FG003|Overall Study|Withdrawal by Subject|58|||
145359213|NCT01671007|524164683|FG004|Overall Study|Withdrawal by Subject|4|||
145359214|NCT01671007|524164684|FG005|Overall Study|Withdrawal by Subject|15|||
145359215|NCT01671007|524164685|FG006|Overall Study|Withdrawal by Subject|1|||
145359216|NCT01671007|524164686|FG007|Overall Study|Withdrawal by Subject|19|||
145359217|NCT01671007|524164687|FG008|Overall Study|Withdrawal by Subject|0|||
145359218|NCT01671007|524164679|FG000|Overall Study|Lost to Follow-up|93|||
145418646|NCT04243837|524388561|FG000|Overall Study|Study Terminated by Sponsor|11|||
145359219|NCT01671007|524164680|FG001|Overall Study|Lost to Follow-up|142|||
145418647|NCT04243837|524388562|FG001|Overall Study|Study Terminated by Sponsor|12|||
145418648|NCT02829957|524388565|FG000|Overall Study|Lost to Follow-up|2|||
145418649|NCT02829957|524388566|FG001|Overall Study|Lost to Follow-up|1|||
145418650|NCT00455455|524388572|FG000|Washout|Withdrawal by Subject|0|||
145418651|NCT00455455|524388573|FG001|Washout|Withdrawal by Subject|1|||
145418652|NCT00455455|524388572|FG000|Washout|Withdrawal by Subject|1|||
145418653|NCT00455455|524388573|FG001|Washout|Withdrawal by Subject|0|||
145418654|NCT01370538|524388574|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
145418655|NCT01370538|524388575|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
145418656|NCT01370538|524388574|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145418657|NCT01370538|524388575|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145418658|NCT01370538|524388574|FG000|Overall Study|Adverse Event|1|||
145418659|NCT01370538|524388575|FG001|Overall Study|Adverse Event|0|||
145418660|NCT01370538|524388574|FG000|Overall Study|Protocol Violation|8|||
145418661|NCT01370538|524388575|FG001|Overall Study|Protocol Violation|5|||
145418662|NCT01370538|524388574|FG000|Overall Study|Development of study specific withdrawal|1|||
145418663|NCT01370538|524388575|FG001|Overall Study|Development of study specific withdrawal|1|||
145418664|NCT01370538|524388574|FG000|Overall Study|Lost to follow up|6|||
145418665|NCT01370538|524388575|FG001|Overall Study|Lost to follow up|10|||
145418666|NCT00676689|524388576|FG000|Overall Study|Screen Failure|2|||
145418667|NCT00676689|524388576|FG000|Overall Study|Death|2|||
145418668|NCT00676689|524388576|FG000|Overall Study|Lost to Follow-up|4|||
145418669|NCT00676689|524388576|FG000|Overall Study|Physician Decision|1|||
145418670|NCT00676689|524388576|FG000|Overall Study|Withdrawal by Subject|3|||
145418671|NCT00676689|524388576|FG000|Overall Study|Continuing FU|49|||
145418672|NCT00663351|524388577|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
145418673|NCT00663351|524388578|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
145418674|NCT00663351|524388577|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
145418675|NCT00663351|524388578|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
145418676|NCT00663351|524388577|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
145418677|NCT00663351|524388578|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
145418678|NCT00663351|524388577|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
145418679|NCT00663351|524388578|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
145418680|NCT00663351|524388577|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
145418681|NCT00663351|524388578|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
145418682|NCT00663351|524388577|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
145418683|NCT00663351|524388578|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
145418684|NCT00567112|524388579|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
145418685|NCT00567112|524388580|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
145418686|NCT00567112|524388581|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
145418687|NCT00567112|524388579|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
145418688|NCT00567112|524388580|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
145418689|NCT00567112|524388581|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
145418690|NCT00567112|524388579|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
145418691|NCT00567112|524388580|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
145418692|NCT00567112|524388581|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
145418693|NCT02675452|524388583|FG000|Overall Study|Sponsor decision|0|||
145418694|NCT02675452|524388584|FG001|Overall Study|Sponsor decision|0|||
145418695|NCT02675452|524388585|FG002|Overall Study|Sponsor decision|0|||
145418696|NCT02675452|524388586|FG003|Overall Study|Sponsor decision|0|||
145418697|NCT02675452|524388587|FG004|Overall Study|Sponsor decision|0|||
145418698|NCT02675452|524388588|FG005|Overall Study|Sponsor decision|0|||
145418699|NCT02675452|524388589|FG006|Overall Study|Sponsor decision|0|||
145418700|NCT02675452|524388590|FG007|Overall Study|Sponsor decision|0|||
145418701|NCT02675452|524388591|FG008|Overall Study|Sponsor decision|0|||
145418702|NCT02675452|524388592|FG009|Overall Study|Sponsor decision|1|||
145418703|NCT02675452|524388593|FG010|Overall Study|Sponsor decision|0|||
145418704|NCT02675452|524388594|FG011|Overall Study|Sponsor decision|0|||
145418705|NCT02675452|524388595|FG012|Overall Study|Sponsor decision|0|||
145418706|NCT02675452|524388596|FG013|Overall Study|Sponsor decision|2|||
145418707|NCT02675452|524388597|FG014|Overall Study|Sponsor decision|1|||
145418708|NCT02675452|524388598|FG015|Overall Study|Sponsor decision|0|||
145418709|NCT02675452|524388599|FG016|Overall Study|Sponsor decision|1|||
145418710|NCT02675452|524388600|FG017|Overall Study|Sponsor decision|0|||
145418711|NCT02675452|524388601|FG018|Overall Study|Sponsor decision|0|||
145418712|NCT02675452|524388602|FG019|Overall Study|Sponsor decision|0|||
145418713|NCT02675452|524388603|FG020|Overall Study|Sponsor decision|0|||
145418714|NCT02675452|524388604|FG021|Overall Study|Sponsor decision|0|||
145418715|NCT02675452|524388605|FG022|Overall Study|Sponsor decision|0|||
145418716|NCT02675452|524388606|FG023|Overall Study|Sponsor decision|0|||
145418717|NCT02675452|524388607|FG024|Overall Study|Sponsor decision|0|||
145418718|NCT02675452|524388608|FG025|Overall Study|Sponsor decision|0|||
145418719|NCT02675452|524388609|FG026|Overall Study|Sponsor decision|2|||
145418720|NCT02675452|524388610|FG027|Overall Study|Sponsor decision|0|||
145418721|NCT02675452|524388611|FG028|Overall Study|Sponsor decision|0|||
145418722|NCT02675452|524388583|FG000|Overall Study|Withdrawal by Subject|0|||
145418723|NCT02675452|524388584|FG001|Overall Study|Withdrawal by Subject|0|||
145418724|NCT02675452|524388585|FG002|Overall Study|Withdrawal by Subject|0|||
145418725|NCT02675452|524388586|FG003|Overall Study|Withdrawal by Subject|0|||
145418726|NCT02675452|524388587|FG004|Overall Study|Withdrawal by Subject|0|||
145418727|NCT02675452|524388588|FG005|Overall Study|Withdrawal by Subject|0|||
145418728|NCT02675452|524388589|FG006|Overall Study|Withdrawal by Subject|0|||
145418729|NCT02675452|524388590|FG007|Overall Study|Withdrawal by Subject|0|||
145418730|NCT02675452|524388591|FG008|Overall Study|Withdrawal by Subject|0|||
145418731|NCT02675452|524388592|FG009|Overall Study|Withdrawal by Subject|1|||
145418732|NCT02675452|524388593|FG010|Overall Study|Withdrawal by Subject|0|||
145418733|NCT02675452|524388594|FG011|Overall Study|Withdrawal by Subject|1|||
145418734|NCT02675452|524388595|FG012|Overall Study|Withdrawal by Subject|0|||
145418735|NCT02675452|524388596|FG013|Overall Study|Withdrawal by Subject|1|||
145418736|NCT02675452|524388597|FG014|Overall Study|Withdrawal by Subject|1|||
145418737|NCT02675452|524388598|FG015|Overall Study|Withdrawal by Subject|0|||
145418738|NCT02675452|524388599|FG016|Overall Study|Withdrawal by Subject|2|||
145418739|NCT02675452|524388600|FG017|Overall Study|Withdrawal by Subject|0|||
145418740|NCT02675452|524388601|FG018|Overall Study|Withdrawal by Subject|0|||
145418741|NCT02675452|524388602|FG019|Overall Study|Withdrawal by Subject|0|||
145418742|NCT02675452|524388603|FG020|Overall Study|Withdrawal by Subject|0|||
145418743|NCT02675452|524388604|FG021|Overall Study|Withdrawal by Subject|0|||
145418744|NCT02675452|524388605|FG022|Overall Study|Withdrawal by Subject|3|||
145418745|NCT02675452|524388606|FG023|Overall Study|Withdrawal by Subject|0|||
145418746|NCT02675452|524388607|FG024|Overall Study|Withdrawal by Subject|1|||
145418747|NCT02675452|524388608|FG025|Overall Study|Withdrawal by Subject|0|||
145418748|NCT02675452|524388609|FG026|Overall Study|Withdrawal by Subject|1|||
145418749|NCT02675452|524388610|FG027|Overall Study|Withdrawal by Subject|3|||
145418750|NCT02675452|524388611|FG028|Overall Study|Withdrawal by Subject|4|||
145359220|NCT01671007|524164681|FG002|Overall Study|Lost to Follow-up|91|||
145359221|NCT01671007|524164682|FG003|Overall Study|Lost to Follow-up|63|||
145359222|NCT01671007|524164683|FG004|Overall Study|Lost to Follow-up|7|||
145359223|NCT01671007|524164684|FG005|Overall Study|Lost to Follow-up|20|||
145359224|NCT01671007|524164685|FG006|Overall Study|Lost to Follow-up|2|||
145359225|NCT01671007|524164686|FG007|Overall Study|Lost to Follow-up|28|||
145359226|NCT01671007|524164687|FG008|Overall Study|Lost to Follow-up|0|||
145359227|NCT01671007|524164679|FG000|Overall Study|No end of study case report form|3|||
145359228|NCT01671007|524164680|FG001|Overall Study|No end of study case report form|1|||
145359229|NCT01671007|524164681|FG002|Overall Study|No end of study case report form|0|||
145359230|NCT01671007|524164682|FG003|Overall Study|No end of study case report form|2|||
145418751|NCT02675452|524388583|FG000|Overall Study|Death|0|||
145418752|NCT02675452|524388584|FG001|Overall Study|Death|0|||
145418753|NCT02675452|524388585|FG002|Overall Study|Death|1|||
145418754|NCT02675452|524388586|FG003|Overall Study|Death|0|||
145418755|NCT02675452|524388587|FG004|Overall Study|Death|0|||
145418756|NCT02675452|524388588|FG005|Overall Study|Death|1|||
145418757|NCT02675452|524388589|FG006|Overall Study|Death|0|||
145418758|NCT02675452|524388590|FG007|Overall Study|Death|0|||
145418759|NCT02675452|524388591|FG008|Overall Study|Death|1|||
145418760|NCT02675452|524388592|FG009|Overall Study|Death|0|||
145418761|NCT02675452|524388593|FG010|Overall Study|Death|0|||
145418762|NCT02675452|524388594|FG011|Overall Study|Death|0|||
145418763|NCT02675452|524388595|FG012|Overall Study|Death|1|||
145418764|NCT02675452|524388596|FG013|Overall Study|Death|0|||
145418765|NCT02675452|524388597|FG014|Overall Study|Death|0|||
145418766|NCT02675452|524388598|FG015|Overall Study|Death|2|||
145418767|NCT02675452|524388599|FG016|Overall Study|Death|0|||
145418768|NCT02675452|524388600|FG017|Overall Study|Death|0|||
145418769|NCT02675452|524388601|FG018|Overall Study|Death|4|||
145359231|NCT01671007|524164683|FG004|Overall Study|No end of study case report form|0|||
145359232|NCT01671007|524164684|FG005|Overall Study|No end of study case report form|0|||
145359233|NCT01671007|524164685|FG006|Overall Study|No end of study case report form|0|||
145359234|NCT01671007|524164686|FG007|Overall Study|No end of study case report form|0|||
145418770|NCT02675452|524388602|FG019|Overall Study|Death|3|||
145418771|NCT02675452|524388603|FG020|Overall Study|Death|3|||
145418772|NCT02675452|524388604|FG021|Overall Study|Death|3|||
145418773|NCT02675452|524388605|FG022|Overall Study|Death|7|||
145418774|NCT02675452|524388606|FG023|Overall Study|Death|5|||
145359235|NCT01671007|524164687|FG008|Overall Study|No end of study case report form|0|||
145418775|NCT02675452|524388607|FG024|Overall Study|Death|3|||
145359236|NCT01671007|524164679|FG000|Overall Study|Not eligible|23|||
145359237|NCT01671007|524164680|FG001|Overall Study|Not eligible|76|||
145359238|NCT01671007|524164681|FG002|Overall Study|Not eligible|25|||
145359239|NCT01671007|524164682|FG003|Overall Study|Not eligible|17|||
145418776|NCT02675452|524388608|FG025|Overall Study|Death|4|||
145418777|NCT02675452|524388609|FG026|Overall Study|Death|7|||
145359240|NCT01671007|524164683|FG004|Overall Study|Not eligible|0|||
145418778|NCT02675452|524388610|FG027|Overall Study|Death|6|||
145418779|NCT02675452|524388611|FG028|Overall Study|Death|9|||
145418780|NCT02675452|524388583|FG000|Overall Study|Lost to Follow-up|0|||
145418781|NCT02675452|524388584|FG001|Overall Study|Lost to Follow-up|1|||
145418782|NCT02675452|524388585|FG002|Overall Study|Lost to Follow-up|0|||
145418783|NCT02675452|524388586|FG003|Overall Study|Lost to Follow-up|0|||
145418784|NCT02675452|524388587|FG004|Overall Study|Lost to Follow-up|0|||
145623133|NCT01272011|525131596|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
145623134|NCT01272011|525131597|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
145623135|NCT02240680|525131598|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
145623136|NCT02240680|525131599|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
145623137|NCT02240680|525131600|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
145359241|NCT01671007|524164684|FG005|Overall Study|Not eligible|6|||
145418785|NCT02675452|524388588|FG005|Overall Study|Lost to Follow-up|0|||
145418786|NCT02675452|524388589|FG006|Overall Study|Lost to Follow-up|0|||
145418787|NCT02675452|524388590|FG007|Overall Study|Lost to Follow-up|0|||
145359242|NCT01671007|524164685|FG006|Overall Study|Not eligible|1|||
145359243|NCT01671007|524164686|FG007|Overall Study|Not eligible|19|||
145359244|NCT01671007|524164687|FG008|Overall Study|Not eligible|0|||
145359245|NCT03877068|524164688|FG000|Overall Study|Physician Decision|9|||
145359246|NCT03877068|524164689|FG001|Overall Study|Physician Decision|3|||
145359247|NCT01966120|524164690|FG000|Overall Study|Withdrawal by Subject|0|||
145359248|NCT01966120|524164691|FG001|Overall Study|Withdrawal by Subject|5|||
145359249|NCT01966120|524164690|FG000|Overall Study|Lost to Follow-up|1|||
145359250|NCT01966120|524164691|FG001|Overall Study|Lost to Follow-up|1|||
145359251|NCT04630002|524164692|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
145359252|NCT04630002|524164693|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145359253|NCT04630002|524164694|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145359254|NCT04630002|524164692|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
145359255|NCT04630002|524164693|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145359256|NCT04630002|524164694|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145359257|NCT04630002|524164692|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
145359258|NCT04630002|524164693|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145359259|NCT04630002|524164694|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145359260|NCT04630002|524164692|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145359261|NCT04630002|524164693|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
145359262|NCT04630002|524164694|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
145359263|NCT04630002|524164692|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145359264|NCT04630002|524164693|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
145359265|NCT04630002|524164694|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
145359266|NCT04630002|524164692|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145359267|NCT04630002|524164693|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
145359268|NCT04630002|524164694|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
145359269|NCT04630002|524164692|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
145359270|NCT04630002|524164693|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
145359271|NCT04630002|524164694|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
145359272|NCT04630002|524164692|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
145359273|NCT04630002|524164693|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
145359274|NCT04630002|524164694|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
145359275|NCT02588612|524164704|FG000|Overall Study|Physician Decision|1|||
145359276|NCT02588612|524164704|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
145359277|NCT02588612|524164704|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
145359278|NCT02588612|524164704|FG000|Overall Study|Death prior to T-cell infusion|1|||
145359279|NCT03448419|524164714|FG000|Overall Study|Adverse Event|10|||
145359280|NCT03448419|524164715|FG001|Overall Study|Adverse Event|9|||
145359281|NCT03448419|524164714|FG000|Overall Study|Lost to Follow-up|0|||
145359282|NCT03448419|524164715|FG001|Overall Study|Lost to Follow-up|2|||
145359283|NCT03448419|524164714|FG000|Overall Study|Withdrawal by Subject|3|||
145359284|NCT03448419|524164715|FG001|Overall Study|Withdrawal by Subject|1|||
145359285|NCT03448419|524164714|FG000|Overall Study|Not treated|0|||
145359286|NCT03448419|524164715|FG001|Overall Study|Not treated|1|||
145359287|NCT03448419|524164714|FG000|Overall Study|Patient did not attend all visits|0|||
145359288|NCT03448419|524164715|FG001|Overall Study|Patient did not attend all visits|2|||
145359289|NCT03448419|524164714|FG000|Overall Study|Withdrawn by Sponsor|0|||
145418788|NCT02675452|524388591|FG008|Overall Study|Lost to Follow-up|0|||
145418789|NCT02675452|524388592|FG009|Overall Study|Lost to Follow-up|0|||
145418790|NCT02675452|524388593|FG010|Overall Study|Lost to Follow-up|0|||
145359290|NCT03448419|524164715|FG001|Overall Study|Withdrawn by Sponsor|1|||
145359291|NCT00630825|524164717|FG000|Overall Study|Adverse Event|4|||
145359292|NCT00630825|524164718|FG001|Overall Study|Adverse Event|4|||
145359293|NCT00630825|524164719|FG002|Overall Study|Adverse Event|3|||
145418791|NCT02675452|524388594|FG011|Overall Study|Lost to Follow-up|0|||
145418792|NCT02675452|524388595|FG012|Overall Study|Lost to Follow-up|1|||
145418793|NCT02675452|524388596|FG013|Overall Study|Lost to Follow-up|0|||
145418794|NCT02675452|524388597|FG014|Overall Study|Lost to Follow-up|0|||
145418795|NCT02675452|524388598|FG015|Overall Study|Lost to Follow-up|0|||
145418796|NCT02675452|524388599|FG016|Overall Study|Lost to Follow-up|0|||
145418797|NCT02675452|524388600|FG017|Overall Study|Lost to Follow-up|0|||
145418798|NCT02675452|524388601|FG018|Overall Study|Lost to Follow-up|0|||
145418799|NCT02675452|524388602|FG019|Overall Study|Lost to Follow-up|0|||
145418800|NCT02675452|524388603|FG020|Overall Study|Lost to Follow-up|0|||
145418801|NCT02675452|524388604|FG021|Overall Study|Lost to Follow-up|0|||
145418802|NCT02675452|524388605|FG022|Overall Study|Lost to Follow-up|0|||
145418803|NCT02675452|524388606|FG023|Overall Study|Lost to Follow-up|0|||
145418804|NCT02675452|524388607|FG024|Overall Study|Lost to Follow-up|0|||
145418805|NCT02675452|524388608|FG025|Overall Study|Lost to Follow-up|0|||
145418806|NCT02675452|524388609|FG026|Overall Study|Lost to Follow-up|1|||
145418807|NCT02675452|524388610|FG027|Overall Study|Lost to Follow-up|0|||
145418808|NCT02675452|524388611|FG028|Overall Study|Lost to Follow-up|0|||
145418809|NCT02675452|524388583|FG000|Overall Study|Other|0|||
145418810|NCT02675452|524388584|FG001|Overall Study|Other|0|||
145418811|NCT02675452|524388585|FG002|Overall Study|Other|0|||
145418812|NCT02675452|524388586|FG003|Overall Study|Other|0|||
145418813|NCT02675452|524388587|FG004|Overall Study|Other|0|||
145418814|NCT02675452|524388588|FG005|Overall Study|Other|0|||
145418815|NCT02675452|524388589|FG006|Overall Study|Other|0|||
145418816|NCT02675452|524388590|FG007|Overall Study|Other|0|||
145418817|NCT02675452|524388591|FG008|Overall Study|Other|0|||
145418818|NCT02675452|524388592|FG009|Overall Study|Other|0|||
145418819|NCT02675452|524388593|FG010|Overall Study|Other|0|||
145418820|NCT02675452|524388594|FG011|Overall Study|Other|0|||
145418821|NCT02675452|524388595|FG012|Overall Study|Other|0|||
145418822|NCT02675452|524388596|FG013|Overall Study|Other|0|||
145418823|NCT02675452|524388597|FG014|Overall Study|Other|0|||
145418824|NCT02675452|524388598|FG015|Overall Study|Other|0|||
145418825|NCT02675452|524388599|FG016|Overall Study|Other|0|||
145418826|NCT02675452|524388600|FG017|Overall Study|Other|0|||
145418827|NCT02675452|524388601|FG018|Overall Study|Other|0|||
145418828|NCT02675452|524388602|FG019|Overall Study|Other|0|||
145418829|NCT02675452|524388603|FG020|Overall Study|Other|0|||
145418830|NCT02675452|524388604|FG021|Overall Study|Other|0|||
145418831|NCT02675452|524388605|FG022|Overall Study|Other|0|||
145418832|NCT02675452|524388606|FG023|Overall Study|Other|0|||
145418833|NCT02675452|524388607|FG024|Overall Study|Other|0|||
145418834|NCT02675452|524388608|FG025|Overall Study|Other|0|||
145418835|NCT02675452|524388609|FG026|Overall Study|Other|1|||
145418836|NCT02675452|524388610|FG027|Overall Study|Other|0|||
145418837|NCT02675452|524388611|FG028|Overall Study|Other|0|||
145418838|NCT01666314|524388612|FG000|Overall Study|Adverse Event|3|||
145418839|NCT01666314|524388613|FG001|Overall Study|Adverse Event|13|||
145418840|NCT01666314|524388614|FG002|Overall Study|Adverse Event|7|||
145418841|NCT01666314|524388615|FG003|Overall Study|Adverse Event|7|||
145418842|NCT01666314|524388612|FG000|Overall Study|Progressive Disease|11|||
145418843|NCT01666314|524388613|FG001|Overall Study|Progressive Disease|9|||
145418844|NCT01666314|524388614|FG002|Overall Study|Progressive Disease|19|||
145418845|NCT01666314|524388615|FG003|Overall Study|Progressive Disease|20|||
145418846|NCT01666314|524388612|FG000|Overall Study|Symptomatic Deterioration|1|||
145418847|NCT01666314|524388613|FG001|Overall Study|Symptomatic Deterioration|0|||
145418848|NCT01666314|524388614|FG002|Overall Study|Symptomatic Deterioration|2|||
145418849|NCT01666314|524388615|FG003|Overall Study|Symptomatic Deterioration|0|||
145418850|NCT01666314|524388612|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
145418851|NCT01666314|524388613|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
145418852|NCT01666314|524388614|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
145418853|NCT01666314|524388615|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
145418854|NCT01666314|524388612|FG000|Overall Study|Withdrawal by Subject|1|||
145418855|NCT01666314|524388613|FG001|Overall Study|Withdrawal by Subject|1|||
145418856|NCT01666314|524388614|FG002|Overall Study|Withdrawal by Subject|2|||
145418857|NCT01666314|524388615|FG003|Overall Study|Withdrawal by Subject|3|||
145418858|NCT01666314|524388612|FG000|Overall Study|Reason not Specified|10|||
145418859|NCT01666314|524388613|FG001|Overall Study|Reason not Specified|7|||
145418860|NCT01666314|524388614|FG002|Overall Study|Reason not Specified|5|||
145418861|NCT01666314|524388615|FG003|Overall Study|Reason not Specified|5|||
145418862|NCT05660538|524388616|FG000|Overall Study|Adverse Event|0|||
145418863|NCT05660538|524388617|FG001|Overall Study|Adverse Event|0|||
145418864|NCT05660538|524388618|FG002|Overall Study|Adverse Event|1|||
145418865|NCT05660538|524388619|FG003|Overall Study|Adverse Event|0|||
145418866|NCT05660538|524388616|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145418867|NCT05660538|524388617|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
145418868|NCT05660538|524388618|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
145418869|NCT05660538|524388619|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
145418870|NCT05660538|524388616|FG000|Overall Study|Lost to Follow-up|0|||
145418871|NCT05660538|524388617|FG001|Overall Study|Lost to Follow-up|0|||
145418872|NCT05660538|524388618|FG002|Overall Study|Lost to Follow-up|1|||
145418873|NCT05660538|524388619|FG003|Overall Study|Lost to Follow-up|1|||
145418874|NCT05660538|524388616|FG000|Overall Study|Death|0|||
145418875|NCT05660538|524388617|FG001|Overall Study|Death|0|||
145359294|NCT00630825|524164720|FG003|Overall Study|Adverse Event|1|||
145359295|NCT00630825|524164717|FG000|Overall Study|Entry Criteria Not Met|1|||
145359296|NCT00630825|524164718|FG001|Overall Study|Entry Criteria Not Met|0|||
145359297|NCT00630825|524164719|FG002|Overall Study|Entry Criteria Not Met|2|||
145359298|NCT00630825|524164720|FG003|Overall Study|Entry Criteria Not Met|1|||
145359299|NCT00630825|524164717|FG000|Overall Study|Lost to Follow-up|1|||
145359300|NCT00630825|524164718|FG001|Overall Study|Lost to Follow-up|1|||
145359301|NCT00630825|524164719|FG002|Overall Study|Lost to Follow-up|1|||
145359302|NCT00630825|524164720|FG003|Overall Study|Lost to Follow-up|1|||
145359303|NCT00630825|524164717|FG000|Overall Study|Physician Decision|1|||
145359304|NCT00630825|524164718|FG001|Overall Study|Physician Decision|0|||
145359305|NCT00630825|524164719|FG002|Overall Study|Physician Decision|0|||
145359306|NCT00630825|524164720|FG003|Overall Study|Physician Decision|0|||
145359307|NCT00630825|524164717|FG000|Overall Study|Withdrawal by Subject|2|||
145359308|NCT00630825|524164718|FG001|Overall Study|Withdrawal by Subject|2|||
145359309|NCT00630825|524164719|FG002|Overall Study|Withdrawal by Subject|2|||
145359310|NCT00630825|524164720|FG003|Overall Study|Withdrawal by Subject|3|||
145359311|NCT02211209|524164723|FG000|Overall Study|Investigator judgment|0|||
145359312|NCT02211209|524164724|FG001|Overall Study|Investigator judgment|1|||
145359313|NCT02211209|524164723|FG000|Overall Study|Voluntary withdrawal|1|||
145359314|NCT02211209|524164724|FG001|Overall Study|Voluntary withdrawal|4|||
145359315|NCT02211209|524164723|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145359316|NCT02211209|524164724|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
145359317|NCT02211209|524164723|FG000|Overall Study|Reason Not Specified|1|||
145359318|NCT02211209|524164724|FG001|Overall Study|Reason Not Specified|0|||
145359319|NCT02230904|524164727|FG000|Overall Study|Safety follow up could not take place|0|||
145359320|NCT02230904|524164728|FG001|Overall Study|Safety follow up could not take place|1|||
145359321|NCT01681212|524164729|FG000|Overall Study|No longer met study criteria|5|||
145359322|NCT01681212|524164729|FG000|Overall Study|Administrative reason by sponsor|1|||
145359323|NCT05047211|524164730|FG000|Overall Study|Lost to Follow-up|8|||
145359324|NCT05047211|524164731|FG001|Overall Study|Lost to Follow-up|5|||
145359325|NCT02187198|524164734|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
145359326|NCT02187198|524164735|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
145359327|NCT02187198|524164734|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
145359328|NCT02187198|524164735|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
145359329|NCT03321968|524164736|FG000|Overall Study|Withdrawal by Subject|1|||
145359330|NCT03321968|524164737|FG001|Overall Study|Withdrawal by Subject|2|||
145359331|NCT03321968|524164738|FG002|Overall Study|Withdrawal by Subject|1|||
145359332|NCT03321968|524164736|FG000|Overall Study|Lost to Follow-up|2|||
145359333|NCT03321968|524164737|FG001|Overall Study|Lost to Follow-up|0|||
145359334|NCT03321968|524164738|FG002|Overall Study|Lost to Follow-up|1|||
145359335|NCT03321968|524164736|FG000|Overall Study|Other than specified|0|||
145359336|NCT03321968|524164737|FG001|Overall Study|Other than specified|0|||
145359337|NCT03321968|524164738|FG002|Overall Study|Other than specified|1|||
145359338|NCT03822468|524164739|FG000|Treatment Period|Progressive disease|98|||
145359339|NCT03822468|524164740|FG001|Treatment Period|Progressive disease|94|||
145359340|NCT03822468|524164739|FG000|Treatment Period|Adverse Event|21|||
145359341|NCT03822468|524164740|FG001|Treatment Period|Adverse Event|24|||
145359342|NCT03822468|524164739|FG000|Treatment Period|Withdrawal by Subject|9|||
145359343|NCT03822468|524164740|FG001|Treatment Period|Withdrawal by Subject|5|||
145359344|NCT03822468|524164739|FG000|Treatment Period|Physician Decision|9|||
145359345|NCT03822468|524164740|FG001|Treatment Period|Physician Decision|7|||
145359346|NCT03822468|524164739|FG000|Treatment Period|Protocol Violation|2|||
145359347|NCT03822468|524164740|FG001|Treatment Period|Protocol Violation|1|||
145359348|NCT03822468|524164739|FG000|Treatment Period|Death|2|||
145359349|NCT03822468|524164740|FG001|Treatment Period|Death|3|||
145359350|NCT03822468|524164739|FG000|Treatment Period|Lost to Follow-up|1|||
145359351|NCT03822468|524164740|FG001|Treatment Period|Lost to Follow-up|1|||
145359352|NCT03822468|524164739|FG000|Treatment Period|Sponsor decision|46|||
145359353|NCT03822468|524164740|FG001|Treatment Period|Sponsor decision|53|||
145359354|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
145359355|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
145359356|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
145359357|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
145359358|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Death|1|||
145359359|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Death|0|||
145359360|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145359361|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145359362|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
145577515|NCT02391948|524969426|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
145577516|NCT02391948|524969427|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
145577517|NCT02391948|524969428|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
145359363|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145359364|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
145359365|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145359366|NCT03822468|524164739|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
145359367|NCT03822468|524164740|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
145359368|NCT01532518|524164741|FG000|Overall Study|Withdrawal by Subject|0|||
145359369|NCT01532518|524164742|FG001|Overall Study|Withdrawal by Subject|0|||
145359370|NCT01532518|524164743|FG002|Overall Study|Withdrawal by Subject|1|||
145359371|NCT01575834|524164744|FG000|Overall Study|Withdrawal by Subject|352|||
145359372|NCT01575834|524164745|FG001|Overall Study|Withdrawal by Subject|390|||
145359373|NCT01575834|524164744|FG000|Overall Study|Death|81|||
145359374|NCT01575834|524164745|FG001|Overall Study|Death|74|||
145359375|NCT01575834|524164744|FG000|Overall Study|Other|70|||
145359376|NCT01575834|524164745|FG001|Overall Study|Other|70|||
145359377|NCT01575834|524164744|FG000|Overall Study|Adverse Event|63|||
145359378|NCT01575834|524164745|FG001|Overall Study|Adverse Event|61|||
145359379|NCT01575834|524164744|FG000|Overall Study|Lost to Follow-up|55|||
145359380|NCT01575834|524164745|FG001|Overall Study|Lost to Follow-up|68|||
145359381|NCT01575834|524164744|FG000|Overall Study|Noncompliance|52|||
145359382|NCT01575834|524164745|FG001|Overall Study|Noncompliance|27|||
145359383|NCT01575834|524164744|FG000|Overall Study|Administrative decision|15|||
145359384|NCT01575834|524164745|FG001|Overall Study|Administrative decision|33|||
145359385|NCT01575834|524164744|FG000|Overall Study|Ineligibility Determined|5|||
145359386|NCT01575834|524164745|FG001|Overall Study|Ineligibility Determined|8|||
145359387|NCT01575834|524164744|FG000|Overall Study|Protocol Deviation|4|||
145359388|NCT01575834|524164745|FG001|Overall Study|Protocol Deviation|3|||
145359389|NCT01575834|524164744|FG000|Overall Study|Requirement for Alternative Therapy|2|||
145359390|NCT01575834|524164745|FG001|Overall Study|Requirement for Alternative Therapy|4|||
145359391|NCT02155283|524164746|FG000|Overall Study|Lost to Follow-up|3|||
145359392|NCT02155283|524164746|FG000|Overall Study|Withdrawal by Subject|1|||
145359393|NCT02155283|524164746|FG000|Overall Study|Protocol Violation|3|||
145359394|NCT01741688|524164748|FG000|Overall Study|Lack of insurance coverage|2|||
145359395|NCT01741688|524164748|FG000|Overall Study|Withdrawal by Subject|1|||
145359396|NCT02282813|524164753|FG000|Overall Study|Withdrawal by Subject|4|||
145359397|NCT02282813|524164754|FG001|Overall Study|Withdrawal by Subject|5|||
145359398|NCT02282813|524164755|FG002|Overall Study|Withdrawal by Subject|0|||
145359399|NCT02282813|524164753|FG000|Overall Study|Adverse Event|3|||
145359400|NCT02282813|524164754|FG001|Overall Study|Adverse Event|10|||
145359401|NCT02282813|524164755|FG002|Overall Study|Adverse Event|1|||
145359402|NCT02282813|524164753|FG000|Overall Study|Subject non-compliance|1|||
145359403|NCT02282813|524164754|FG001|Overall Study|Subject non-compliance|4|||
145359404|NCT02282813|524164755|FG002|Overall Study|Subject non-compliance|0|||
145359405|NCT02282813|524164753|FG000|Overall Study|Physician Decision|0|||
145359406|NCT02282813|524164754|FG001|Overall Study|Physician Decision|3|||
145359407|NCT02282813|524164755|FG002|Overall Study|Physician Decision|1|||
145359408|NCT02282813|524164753|FG000|Overall Study|Lost to Follow-up|2|||
145359409|NCT02282813|524164754|FG001|Overall Study|Lost to Follow-up|0|||
145359410|NCT02282813|524164755|FG002|Overall Study|Lost to Follow-up|1|||
145359411|NCT02282813|524164753|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
145359412|NCT02282813|524164754|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
145359413|NCT02282813|524164755|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
145359414|NCT02282813|524164753|FG000|Overall Study|Lack of Efficacy|1|||
145359415|NCT02282813|524164754|FG001|Overall Study|Lack of Efficacy|0|||
145359416|NCT02282813|524164755|FG002|Overall Study|Lack of Efficacy|0|||
145359417|NCT02282813|524164753|FG000|Overall Study|Administrative reasons|0|||
145359418|NCT02282813|524164754|FG001|Overall Study|Administrative reasons|1|||
145359419|NCT02282813|524164755|FG002|Overall Study|Administrative reasons|0|||
145359420|NCT00463047|524164757|FG000|Titration Period 1|Adverse Event|10|||
145359421|NCT00463047|524164758|FG001|Titration Period 1|Adverse Event|8|||
145359422|NCT00463047|524164757|FG000|Titration Period 1|Lack of Efficacy|10|||
145359423|NCT00463047|524164758|FG001|Titration Period 1|Lack of Efficacy|4|||
145359424|NCT00463047|524164757|FG000|Titration Period 1|Lost to Follow-up|2|||
145359425|NCT00463047|524164758|FG001|Titration Period 1|Lost to Follow-up|0|||
145359426|NCT00463047|524164757|FG000|Titration Period 1|Non-compliance with study medication|3|||
145359427|NCT00463047|524164758|FG001|Titration Period 1|Non-compliance with study medication|5|||
145359428|NCT00463047|524164757|FG000|Titration Period 1|Protocol Violation|5|||
145359429|NCT00463047|524164758|FG001|Titration Period 1|Protocol Violation|5|||
145359430|NCT00463047|524164757|FG000|Titration Period 1|Withdrawal by Subject|3|||
145359431|NCT00463047|524164758|FG001|Titration Period 1|Withdrawal by Subject|5|||
145359432|NCT00463047|524164757|FG000|Titration Period 1|Non-compliance procedures|4|||
145418876|NCT05660538|524388618|FG002|Overall Study|Death|1|||
145359433|NCT00463047|524164758|FG001|Titration Period 1|Non-compliance procedures|10|||
145359434|NCT00463047|524164757|FG000|Titration Period 1|Other|0|||
145359435|NCT00463047|524164758|FG001|Titration Period 1|Other|2|||
145359436|NCT00463047|524164757|FG000|Titration Period 2|Adverse Event|9|||
145359437|NCT00463047|524164758|FG001|Titration Period 2|Adverse Event|9|||
145359438|NCT00463047|524164757|FG000|Titration Period 2|Lack of Efficacy|6|||
145359439|NCT00463047|524164758|FG001|Titration Period 2|Lack of Efficacy|4|||
145359440|NCT00463047|524164757|FG000|Titration Period 2|Withdrawal by Subject|1|||
145359441|NCT00463047|524164758|FG001|Titration Period 2|Withdrawal by Subject|0|||
145359442|NCT00463047|524164757|FG000|Titration Period 2|Protocol Violation|2|||
145359443|NCT00463047|524164758|FG001|Titration Period 2|Protocol Violation|3|||
145359444|NCT00463047|524164757|FG000|Titration Period 2|Lost to Follow-up|1|||
145359445|NCT00463047|524164758|FG001|Titration Period 2|Lost to Follow-up|2|||
145359446|NCT00463047|524164757|FG000|Titration Period 2|Non-compliance study medication|4|||
145359447|NCT00463047|524164758|FG001|Titration Period 2|Non-compliance study medication|2|||
145359448|NCT00463047|524164757|FG000|Titration Period 2|Non-compliance procedures|4|||
145359449|NCT00463047|524164758|FG001|Titration Period 2|Non-compliance procedures|1|||
145359450|NCT00463047|524164757|FG000|Titration Period 2|Other|3|||
145359451|NCT00463047|524164758|FG001|Titration Period 2|Other|2|||
145359452|NCT00463047|524164757|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
145359453|NCT00463047|524164758|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
145359454|NCT00463047|524164757|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
145359455|NCT00463047|524164758|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
145359456|NCT00463047|524164757|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
145359457|NCT00463047|524164758|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
145359458|NCT00463047|524164757|FG000|Double-Blind Treatment Period 1|Other|1|||
145359459|NCT00463047|524164758|FG001|Double-Blind Treatment Period 1|Other|0|||
145359460|NCT00463047|524164757|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
145359461|NCT00463047|524164758|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
145359462|NCT00463047|524164757|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
145359463|NCT00463047|524164758|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
145359464|NCT00463047|524164757|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
145359465|NCT00463047|524164758|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
145359466|NCT00739661|524164762|FG000|Overall Study|Adverse Event|2|||
145359467|NCT00739661|524164763|FG001|Overall Study|Adverse Event|0|||
145359468|NCT00739661|524164762|FG000|Overall Study|Physician decision to withdraw patient|1|||
145359469|NCT00739661|524164763|FG001|Overall Study|Physician decision to withdraw patient|0|||
145359470|NCT00739661|524164762|FG000|Overall Study|Patient decision to withdraw|9|||
145359471|NCT00739661|524164763|FG001|Overall Study|Patient decision to withdraw|4|||
145359472|NCT00739661|524164762|FG000|Overall Study|Disease progression, radiographic|33|||
145359473|NCT00739661|524164763|FG001|Overall Study|Disease progression, radiographic|37|||
145359474|NCT00739661|524164762|FG000|Overall Study|Reason for discontinuation not available|1|||
145359475|NCT00739661|524164763|FG001|Overall Study|Reason for discontinuation not available|1|||
145359476|NCT00410813|524164764|FG000|Overall Study|Adverse Event|6|||
145359477|NCT00410813|524164765|FG001|Overall Study|Adverse Event|11|||
145359478|NCT00410813|524164764|FG000|Overall Study|Progression|32|||
145359479|NCT00410813|524164765|FG001|Overall Study|Progression|21|||
145359480|NCT00410813|524164764|FG000|Overall Study|Not protocol specified|3|||
145359481|NCT00410813|524164765|FG001|Overall Study|Not protocol specified|4|||
145359482|NCT00410813|524164764|FG000|Overall Study|Ineligible|2|||
145359483|NCT00410813|524164765|FG001|Overall Study|Ineligible|4|||
145359484|NCT00410813|524164764|FG000|Overall Study|Death|0|||
145359485|NCT00410813|524164765|FG001|Overall Study|Death|2|||
145359486|NCT02198664|524164766|FG000|Overall Study|Adverse Event|2|||
145359487|NCT02198664|524164767|FG001|Overall Study|Adverse Event|0|||
145359488|NCT02198664|524164766|FG000|Overall Study|Withdrawal by Subject|11|||
145359489|NCT02198664|524164767|FG001|Overall Study|Withdrawal by Subject|8|||
145359490|NCT02198664|524164766|FG000|Overall Study|Failure to tolerate|2|||
145359491|NCT02198664|524164767|FG001|Overall Study|Failure to tolerate|0|||
145359492|NCT02198664|524164766|FG000|Overall Study|Not stated|1|||
145359493|NCT02198664|524164767|FG001|Overall Study|Not stated|0|||
145359494|NCT01991743|524164769|FG000|Overall Study|external cephalic version not performed|0|||
145359495|NCT01991743|524164770|FG001|Overall Study|external cephalic version not performed|0|||
145359496|NCT01991743|524164771|FG002|Overall Study|external cephalic version not performed|1|||
145359497|NCT01991743|524164772|FG003|Overall Study|external cephalic version not performed|0|||
145359498|NCT01611883|524164773|FG000|Overall Study|Adverse Event|1|||
145359499|NCT01611883|524164774|FG001|Overall Study|Adverse Event|1|||
145359500|NCT00734994|524164777|FG000|Overall Study|Withdrawal by Subject|1|||
145359501|NCT01622673|524164778|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145359502|NCT01622673|524164779|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145359503|NCT01622673|524164780|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145359504|NCT01622673|524164781|FG003|Treatment Period 1|Withdrawal by Subject|1|||
145359505|NCT01622673|524164782|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145359506|NCT01622673|524164783|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145359507|NCT01622673|524164778|FG000|Treatment Period 1|Protocol Violation|0|||
145359508|NCT01622673|524164779|FG001|Treatment Period 1|Protocol Violation|1|||
145359509|NCT01622673|524164780|FG002|Treatment Period 1|Protocol Violation|0|||
145359510|NCT01622673|524164781|FG003|Treatment Period 1|Protocol Violation|0|||
145359511|NCT01622673|524164782|FG004|Treatment Period 1|Protocol Violation|0|||
145359512|NCT01622673|524164783|FG005|Treatment Period 1|Protocol Violation|0|||
145359513|NCT01622673|524164778|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145623138|NCT02240680|525131601|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
145359514|NCT01622673|524164779|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145359515|NCT01622673|524164780|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145359516|NCT01622673|524164781|FG003|Treatment Period 2|Withdrawal by Subject|1|||
145359517|NCT01622673|524164782|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145359518|NCT01622673|524164783|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145359519|NCT01622673|524164778|FG000|Treatment Period 3|Protocol Violation|0|||
145359520|NCT01622673|524164779|FG001|Treatment Period 3|Protocol Violation|1|||
145359521|NCT01622673|524164780|FG002|Treatment Period 3|Protocol Violation|0|||
145359522|NCT01622673|524164781|FG003|Treatment Period 3|Protocol Violation|0|||
145359523|NCT01622673|524164782|FG004|Treatment Period 3|Protocol Violation|0|||
145359524|NCT01622673|524164783|FG005|Treatment Period 3|Protocol Violation|0|||
145359525|NCT03668119|524166423|FG000|Pre-treatment|Disease Progression|1|||
145359526|NCT03668119|524166424|FG001|Pre-treatment|Disease Progression|0|||
145359527|NCT03668119|524166423|FG000|Treatment|Disease Progression|76|||
145359528|NCT03668119|524166424|FG001|Treatment|Disease Progression|57|||
145359529|NCT03668119|524166423|FG000|Treatment|Study drug toxicity|19|||
145359530|NCT03668119|524166424|FG001|Treatment|Study drug toxicity|1|||
145359531|NCT03668119|524166423|FG000|Treatment|Death|3|||
145359532|NCT03668119|524166424|FG001|Treatment|Death|0|||
145359533|NCT03668119|524166423|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
145359534|NCT03668119|524166424|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
145359535|NCT03668119|524166423|FG000|Treatment|Withdrawal by Subject|1|||
145359536|NCT03668119|524166424|FG001|Treatment|Withdrawal by Subject|1|||
145359537|NCT03668119|524166423|FG000|Treatment|Participant request to discontinue study treatment|3|||
145359538|NCT03668119|524166424|FG001|Treatment|Participant request to discontinue study treatment|1|||
145359539|NCT03668119|524166423|FG000|Treatment|Maximum Clinical Benefit|0|||
145359540|NCT03668119|524166424|FG001|Treatment|Maximum Clinical Benefit|1|||
145359541|NCT03668119|524166423|FG000|Treatment|Participants completed treatment|27|||
145359542|NCT03668119|524166424|FG001|Treatment|Participants completed treatment|11|||
145359543|NCT03668119|524166423|FG000|Treatment|Other reasons|2|||
145359544|NCT03668119|524166424|FG001|Treatment|Other reasons|1|||
145359545|NCT03769168|524166425|FG000|Overall Study|Adverse Event|0|||
145359546|NCT03769168|524166426|FG001|Overall Study|Adverse Event|1|||
145359547|NCT03769168|524166425|FG000|Overall Study|Lack of Efficacy|2|||
145359548|NCT03769168|524166426|FG001|Overall Study|Lack of Efficacy|4|||
145359549|NCT03769168|524166425|FG000|Overall Study|Post study access to treatment|3|||
145359550|NCT03769168|524166426|FG001|Overall Study|Post study access to treatment|11|||
145359551|NCT03769168|524166425|FG000|Overall Study|Physician Decision|1|||
145359552|NCT03769168|524166426|FG001|Overall Study|Physician Decision|4|||
145359553|NCT03769168|524166425|FG000|Overall Study|Subject Decision|2|||
145359554|NCT03769168|524166426|FG001|Overall Study|Subject Decision|4|||
145359555|NCT03769168|524166425|FG000|Overall Study|Guardian decision|1|||
145359556|NCT03769168|524166426|FG001|Overall Study|Guardian decision|0|||
145359557|NCT03771898|524166429|FG000|Overall Study|Adverse Event|1|||
145359558|NCT03771898|524166430|FG001|Overall Study|Adverse Event|0|||
145359559|NCT03771898|524166431|FG002|Overall Study|Adverse Event|0|||
145359560|NCT03771898|524166432|FG003|Overall Study|Adverse Event|0|||
145359561|NCT03771898|524166433|FG004|Overall Study|Adverse Event|0|||
145359562|NCT03771898|524166429|FG000|Overall Study|Lost to Follow-up|1|||
145359563|NCT03771898|524166430|FG001|Overall Study|Lost to Follow-up|1|||
145359564|NCT03771898|524166431|FG002|Overall Study|Lost to Follow-up|1|||
145359565|NCT03771898|524166432|FG003|Overall Study|Lost to Follow-up|0|||
145359566|NCT03771898|524166433|FG004|Overall Study|Lost to Follow-up|0|||
145359567|NCT03771898|524166429|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145359568|NCT03771898|524166430|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145359569|NCT03771898|524166431|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145359570|NCT03771898|524166432|FG003|Overall Study|Withdrawal by parent/guardian|0|||
145359571|NCT03771898|524166433|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145359572|NCT03771898|524166429|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145359573|NCT03771898|524166430|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145418877|NCT05660538|524388619|FG003|Overall Study|Death|0|||
145359574|NCT03771898|524166431|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145418878|NCT05660538|524388616|FG000|Overall Study|Physician Decision|0|||
145418879|NCT05660538|524388617|FG001|Overall Study|Physician Decision|0|||
145359575|NCT03771898|524166432|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
145359576|NCT03771898|524166433|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
145359577|NCT01780038|524166439|FG000|Overall Study|Lost to Follow-up|4|||
145359578|NCT01780038|524166440|FG001|Overall Study|Lost to Follow-up|1|||
145359579|NCT03168711|524166441|FG000|Overall Study|Adverse Event|2|||
145359580|NCT03168711|524166442|FG001|Overall Study|Adverse Event|0|||
145359581|NCT03168711|524166441|FG000|Overall Study|Withdrawal by Subject|0|||
145359582|NCT03168711|524166442|FG001|Overall Study|Withdrawal by Subject|1|||
145359583|NCT03168711|524166441|FG000|Overall Study|Death|0|||
145359584|NCT03168711|524166442|FG001|Overall Study|Death|1|||
145359585|NCT01346696|524166443|FG000|Overall Study|Death|1|||
145359586|NCT04548193|524166446|FG000|Overall Study|Lost to Follow-up|0|||
145359587|NCT04548193|524166447|FG001|Overall Study|Lost to Follow-up|1|||
145359588|NCT04548193|524166446|FG000|Overall Study|Death|0|||
145359589|NCT04548193|524166447|FG001|Overall Study|Death|1|||
145359590|NCT04548193|524166446|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
145359591|NCT04548193|524166447|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
145359592|NCT04548193|524166446|FG000|Overall Study|Withdrawal by Subject|2|||
145359593|NCT04548193|524166447|FG001|Overall Study|Withdrawal by Subject|2|||
145359594|NCT02042014|524166448|FG000|Overall Study|Adverse Event|1|||
145359595|NCT02042014|524166448|FG000|Overall Study|Physician Decision|7|||
145359596|NCT03123393|524166451|FG000|Overall Study|Study Terminated by Sponsor|6|||
145359597|NCT03123393|524166452|FG001|Overall Study|Study Terminated by Sponsor|9|||
145359598|NCT03123393|524166451|FG000|Overall Study|Withdrawal by Subject|2|||
145359599|NCT03123393|524166452|FG001|Overall Study|Withdrawal by Subject|1|||
145359600|NCT03123393|524166451|FG000|Overall Study|Reason not Specified|13|||
145359601|NCT03123393|524166452|FG001|Overall Study|Reason not Specified|13|||
145359602|NCT00558701|524166454|FG000|Overall Study|Protocol Deviations|1|||
145359603|NCT00558701|524166455|FG001|Overall Study|Protocol Deviations|4|||
145359604|NCT00427648|524166456|FG000|Overall Study|Protocol Violation|1|||
145359605|NCT00427648|524166457|FG001|Overall Study|Protocol Violation|2|||
145359606|NCT00427648|524166456|FG000|Overall Study|Adverse Event|0|||
145359607|NCT00427648|524166457|FG001|Overall Study|Adverse Event|1|||
145359608|NCT04278417|524166458|FG000|Overall Study|Withdrawal by Subject|20|||
145359609|NCT04278417|524166459|FG001|Overall Study|Withdrawal by Subject|20|||
145359610|NCT04278417|524166458|FG000|Overall Study|Progressive disease|0|||
145359611|NCT04278417|524166459|FG001|Overall Study|Progressive disease|2|||
145359612|NCT04278417|524166458|FG000|Overall Study|Physician Decision|4|||
145359613|NCT04278417|524166459|FG001|Overall Study|Physician Decision|6|||
145359614|NCT04278417|524166458|FG000|Overall Study|Lost to Follow-up|11|||
145359615|NCT04278417|524166459|FG001|Overall Study|Lost to Follow-up|13|||
145359616|NCT04278417|524166458|FG000|Overall Study|Death|8|||
145359617|NCT04278417|524166459|FG001|Overall Study|Death|9|||
145359618|NCT04278417|524166458|FG000|Overall Study|Adverse Event|3|||
145359619|NCT04278417|524166459|FG001|Overall Study|Adverse Event|5|||
145359620|NCT06509438|524166460|FG000|Overall Study|Adverse Event|1|||
145359621|NCT06509438|524166460|FG000|Overall Study|Lost to Follow-up|3|||
145359622|NCT02867592|524166461|FG000|Overall Study|Adverse Event|3|||
145359623|NCT02867592|524166462|FG001|Overall Study|Adverse Event|0|||
145359624|NCT02867592|524166463|FG002|Overall Study|Adverse Event|2|||
145359625|NCT02867592|524166464|FG003|Overall Study|Adverse Event|1|||
145359626|NCT02867592|524166465|FG004|Overall Study|Adverse Event|1|||
145359627|NCT02867592|524166466|FG005|Overall Study|Adverse Event|5|||
145359628|NCT02867592|524166461|FG000|Overall Study|Death|0|||
145359629|NCT02867592|524166462|FG001|Overall Study|Death|0|||
145359630|NCT02867592|524166463|FG002|Overall Study|Death|0|||
145359631|NCT02867592|524166464|FG003|Overall Study|Death|1|||
145359632|NCT02867592|524166465|FG004|Overall Study|Death|0|||
145359633|NCT02867592|524166466|FG005|Overall Study|Death|1|||
145359634|NCT02867592|524166461|FG000|Overall Study|Lack of Efficacy|8|||
145359635|NCT02867592|524166462|FG001|Overall Study|Lack of Efficacy|10|||
145359636|NCT02867592|524166463|FG002|Overall Study|Lack of Efficacy|8|||
145359637|NCT02867592|524166464|FG003|Overall Study|Lack of Efficacy|8|||
145359638|NCT02867592|524166465|FG004|Overall Study|Lack of Efficacy|12|||
145359639|NCT02867592|524166466|FG005|Overall Study|Lack of Efficacy|17|||
145359640|NCT02867592|524166461|FG000|Overall Study|Physician Decision|1|||
145359641|NCT02867592|524166462|FG001|Overall Study|Physician Decision|2|||
145359642|NCT02867592|524166463|FG002|Overall Study|Physician Decision|2|||
145359643|NCT02867592|524166464|FG003|Overall Study|Physician Decision|0|||
145359644|NCT02867592|524166465|FG004|Overall Study|Physician Decision|5|||
145359645|NCT02867592|524166466|FG005|Overall Study|Physician Decision|1|||
145359646|NCT02867592|524166461|FG000|Overall Study|Protocol Violation|0|||
145359647|NCT02867592|524166462|FG001|Overall Study|Protocol Violation|0|||
145359648|NCT02867592|524166463|FG002|Overall Study|Protocol Violation|0|||
145359649|NCT02867592|524166464|FG003|Overall Study|Protocol Violation|0|||
145623139|NCT02240680|525131598|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
145359650|NCT02867592|524166465|FG004|Overall Study|Protocol Violation|1|||
145359651|NCT02867592|524166466|FG005|Overall Study|Protocol Violation|1|||
145359652|NCT02867592|524166461|FG000|Overall Study|Withdrawal by Subject|0|||
145359653|NCT02867592|524166462|FG001|Overall Study|Withdrawal by Subject|1|||
145359654|NCT02867592|524166463|FG002|Overall Study|Withdrawal by Subject|0|||
145359655|NCT02867592|524166464|FG003|Overall Study|Withdrawal by Subject|1|||
145359656|NCT02867592|524166465|FG004|Overall Study|Withdrawal by Subject|3|||
145359657|NCT02867592|524166466|FG005|Overall Study|Withdrawal by Subject|3|||
145359658|NCT02867592|524166461|FG000|Overall Study|Ineligible|1|||
145359659|NCT02867592|524166462|FG001|Overall Study|Ineligible|1|||
145359660|NCT02867592|524166463|FG002|Overall Study|Ineligible|0|||
145359661|NCT02867592|524166464|FG003|Overall Study|Ineligible|0|||
145359662|NCT02867592|524166465|FG004|Overall Study|Ineligible|2|||
145359663|NCT02867592|524166466|FG005|Overall Study|Ineligible|0|||
145359664|NCT02867592|524166461|FG000|Overall Study|No Treatment|1|||
145359665|NCT02867592|524166462|FG001|Overall Study|No Treatment|0|||
145359666|NCT02867592|524166463|FG002|Overall Study|No Treatment|0|||
145577518|NCT02391948|524969429|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
145577519|NCT02391948|524969425|FG000|18-month Assessment|Death|0|||
145577520|NCT02391948|524969426|FG001|18-month Assessment|Death|0|||
145577521|NCT02391948|524969427|FG002|18-month Assessment|Death|0|||
145359667|NCT02867592|524166464|FG003|Overall Study|No Treatment|0|||
145359668|NCT02867592|524166465|FG004|Overall Study|No Treatment|0|||
145359669|NCT02867592|524166466|FG005|Overall Study|No Treatment|0|||
145359670|NCT02867592|524166461|FG000|Overall Study|Still on Therapy|0|||
145359671|NCT02867592|524166462|FG001|Overall Study|Still on Therapy|0|||
145359672|NCT02867592|524166463|FG002|Overall Study|Still on Therapy|0|||
145359673|NCT02867592|524166464|FG003|Overall Study|Still on Therapy|0|||
145359674|NCT02867592|524166465|FG004|Overall Study|Still on Therapy|1|||
145359675|NCT02867592|524166466|FG005|Overall Study|Still on Therapy|0|||
145359676|NCT02867592|524166461|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
145359677|NCT02867592|524166462|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
145359678|NCT02867592|524166463|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
145359679|NCT02867592|524166464|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
145359680|NCT02867592|524166465|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
145359681|NCT02867592|524166466|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
145359682|NCT02867592|524166461|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
145359683|NCT02867592|524166462|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
145359684|NCT02867592|524166463|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
145359685|NCT02867592|524166464|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
145359686|NCT02867592|524166465|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
145359687|NCT02867592|524166466|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
145359688|NCT01262872|524166468|FG000|Step 2|Death|0|||
145359689|NCT01262872|524166469|FG001|Step 2|Death|0|||
145359690|NCT01262872|524166470|FG002|Step 2|Death|0|||
145359691|NCT01262872|524166471|FG003|Step 2|Death|1|||
145359692|NCT01262872|524166472|FG004|Step 2|Death|0|||
145359693|NCT01262872|524166473|FG005|Step 2|Death|2|||
145359694|NCT01262872|524166474|FG006|Step 2|Death|2|||
145359695|NCT01262872|524166475|FG007|Step 2|Death|1|||
145359696|NCT01262872|524166468|FG000|Step 2|Protocol Violation|0|||
145359697|NCT01262872|524166469|FG001|Step 2|Protocol Violation|0|||
145359698|NCT01262872|524166470|FG002|Step 2|Protocol Violation|1|||
145359699|NCT01262872|524166471|FG003|Step 2|Protocol Violation|0|||
145359700|NCT01262872|524166472|FG004|Step 2|Protocol Violation|0|||
145359701|NCT01262872|524166473|FG005|Step 2|Protocol Violation|0|||
145359702|NCT01262872|524166474|FG006|Step 2|Protocol Violation|3|||
145359703|NCT01262872|524166475|FG007|Step 2|Protocol Violation|1|||
145359704|NCT01262872|524166468|FG000|Step 2|Withdrawal by Subject|0|||
145359705|NCT01262872|524166469|FG001|Step 2|Withdrawal by Subject|0|||
145359706|NCT01262872|524166470|FG002|Step 2|Withdrawal by Subject|4|||
145359707|NCT01262872|524166471|FG003|Step 2|Withdrawal by Subject|6|||
145359708|NCT01262872|524166472|FG004|Step 2|Withdrawal by Subject|3|||
145359709|NCT01262872|524166473|FG005|Step 2|Withdrawal by Subject|1|||
145359710|NCT01262872|524166474|FG006|Step 2|Withdrawal by Subject|2|||
145359711|NCT01262872|524166475|FG007|Step 2|Withdrawal by Subject|1|||
145359712|NCT01262872|524166468|FG000|Step 2|Migrated/moved from study area|0|||
145359713|NCT01262872|524166469|FG001|Step 2|Migrated/moved from study area|0|||
145359714|NCT01262872|524166470|FG002|Step 2|Migrated/moved from study area|4|||
145359715|NCT01262872|524166471|FG003|Step 2|Migrated/moved from study area|3|||
145359716|NCT01262872|524166472|FG004|Step 2|Migrated/moved from study area|2|||
145359717|NCT01262872|524166473|FG005|Step 2|Migrated/moved from study area|6|||
145359718|NCT01262872|524166474|FG006|Step 2|Migrated/moved from study area|2|||
145359719|NCT01262872|524166475|FG007|Step 2|Migrated/moved from study area|3|||
145418880|NCT05660538|524388618|FG002|Overall Study|Physician Decision|0|||
145577522|NCT02391948|524969428|FG003|18-month Assessment|Death|1|||
145577523|NCT02391948|524969429|FG004|18-month Assessment|Death|1|||
145359720|NCT01000155|524166476|FG000|Overall Study|Withdrawal by Subject|1|||
145359721|NCT01000155|524166476|FG000|Overall Study|Adverse Event|1|||
145359722|NCT00365794|524166478|FG000|Overall Study|Withdrawal by Subject|2|||
145359723|NCT02554682|524166479|FG000|Overall Study|Lost to Follow-up|11|||
145359724|NCT02554682|524166480|FG001|Overall Study|Lost to Follow-up|9|||
145359725|NCT02554682|524166481|FG002|Overall Study|Lost to Follow-up|4|||
145359726|NCT02554682|524166482|FG003|Overall Study|Lost to Follow-up|3|||
145359727|NCT02554682|524166483|FG004|Overall Study|Lost to Follow-up|2|||
145359728|NCT02554682|524166484|FG005|Overall Study|Lost to Follow-up|1|||
145418881|NCT05660538|524388619|FG003|Overall Study|Physician Decision|1|||
145359729|NCT02554682|524166485|FG006|Overall Study|Lost to Follow-up|6|||
145577524|NCT02391948|524969425|FG000|18-month Assessment|Withdrawal by Subject|1|||
145577525|NCT02391948|524969426|FG001|18-month Assessment|Withdrawal by Subject|0|||
145359730|NCT02554682|524166486|FG007|Overall Study|Lost to Follow-up|6|||
145359731|NCT02554682|524166487|FG008|Overall Study|Lost to Follow-up|2|||
145359732|NCT02554682|524166488|FG009|Overall Study|Lost to Follow-up|2|||
145359733|NCT02554682|524166479|FG000|Overall Study|Withdrawal by Subject|2|||
145359734|NCT02554682|524166480|FG001|Overall Study|Withdrawal by Subject|1|||
145359735|NCT02554682|524166481|FG002|Overall Study|Withdrawal by Subject|0|||
145359736|NCT02554682|524166482|FG003|Overall Study|Withdrawal by Subject|0|||
145359737|NCT02554682|524166483|FG004|Overall Study|Withdrawal by Subject|0|||
145359738|NCT02554682|524166484|FG005|Overall Study|Withdrawal by Subject|0|||
145359739|NCT02554682|524166485|FG006|Overall Study|Withdrawal by Subject|0|||
145359740|NCT02554682|524166486|FG007|Overall Study|Withdrawal by Subject|0|||
145359741|NCT02554682|524166487|FG008|Overall Study|Withdrawal by Subject|0|||
145359742|NCT02554682|524166488|FG009|Overall Study|Withdrawal by Subject|0|||
145359743|NCT02554682|524166479|FG000|Overall Study|Physician Decision|2|||
145359744|NCT02554682|524166480|FG001|Overall Study|Physician Decision|2|||
145359745|NCT02554682|524166481|FG002|Overall Study|Physician Decision|0|||
145359746|NCT02554682|524166482|FG003|Overall Study|Physician Decision|0|||
145359747|NCT02554682|524166483|FG004|Overall Study|Physician Decision|0|||
145359748|NCT02554682|524166484|FG005|Overall Study|Physician Decision|0|||
145359749|NCT02554682|524166485|FG006|Overall Study|Physician Decision|0|||
145359750|NCT02554682|524166486|FG007|Overall Study|Physician Decision|0|||
145359751|NCT02554682|524166487|FG008|Overall Study|Physician Decision|0|||
145359752|NCT02554682|524166488|FG009|Overall Study|Physician Decision|0|||
145359753|NCT04526288|524166489|FG000|Overall Study|Disease Progression|1|||
145359754|NCT04526288|524166490|FG001|Overall Study|Disease Progression|0|||
145359755|NCT00594165|524166491|FG000|Overall Study|Major protocol violation|1|||
145359756|NCT00594165|524166491|FG000|Overall Study|Lack of Efficacy|12|||
145359757|NCT00594165|524166491|FG000|Overall Study|Adverse Event|52|||
145359758|NCT00594165|524166491|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
145359759|NCT00594165|524166491|FG000|Overall Study|Subject withdrew consent|27|||
145359760|NCT00594165|524166491|FG000|Overall Study|Study ended per sponsor|102|||
145359761|NCT00594165|524166491|FG000|Overall Study|Lost to Follow-up|4|||
145359762|NCT00594165|524166491|FG000|Overall Study|Other: PI discretion|5|||
145359763|NCT00594165|524166491|FG000|Overall Study|Other: Subject moving|3|||
145359764|NCT00594165|524166491|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
145359765|NCT00594165|524166491|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
145359766|NCT00594165|524166491|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
145359767|NCT00594165|524166491|FG000|Overall Study|Other: Site terminated participation|2|||
145359768|NCT02169271|524166492|FG000|Overall Study|Protocol Violation|1|||
145359769|NCT02169271|524166493|FG001|Overall Study|Protocol Violation|2|||
145359770|NCT04926831|524166494|FG000|Overall Study|Withdrawal by Subject|2|||
145359771|NCT04926831|524166494|FG000|Overall Study|Adverse Event|2|||
145359772|NCT03482635|524166495|FG000|Overall Study|Lack of Efficacy|0|||
145359773|NCT03482635|524166496|FG001|Overall Study|Lack of Efficacy|0|||
145359774|NCT03482635|524166497|FG002|Overall Study|Lack of Efficacy|1|||
145359775|NCT03482635|524166498|FG003|Overall Study|Lack of Efficacy|3|||
145359776|NCT03482635|524166495|FG000|Overall Study|Adverse Event|2|||
145359777|NCT03482635|524166496|FG001|Overall Study|Adverse Event|2|||
145359778|NCT03482635|524166497|FG002|Overall Study|Adverse Event|0|||
145359779|NCT03482635|524166498|FG003|Overall Study|Adverse Event|3|||
145359780|NCT03482635|524166495|FG000|Overall Study|Withdrawal by Subject|2|||
145359781|NCT03482635|524166496|FG001|Overall Study|Withdrawal by Subject|1|||
145359782|NCT03482635|524166497|FG002|Overall Study|Withdrawal by Subject|0|||
145359783|NCT03482635|524166498|FG003|Overall Study|Withdrawal by Subject|1|||
145359784|NCT03482635|524166495|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
145359785|NCT03482635|524166496|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
145359786|NCT03482635|524166497|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
145359787|NCT03482635|524166498|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
145359788|NCT03482635|524166495|FG000|Overall Study|Not treated|0|||
145359789|NCT03482635|524166496|FG001|Overall Study|Not treated|0|||
145359790|NCT03482635|524166497|FG002|Overall Study|Not treated|0|||
145359791|NCT03482635|524166498|FG003|Overall Study|Not treated|1|||
145359792|NCT02712554|524166510|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
145359793|NCT02712554|524166511|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
145418882|NCT05660538|524388616|FG000|Overall Study|Sponsor Decision|1|||
145418883|NCT05660538|524388617|FG001|Overall Study|Sponsor Decision|0|||
145359794|NCT02712554|524166510|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
145359795|NCT02712554|524166511|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
145359796|NCT02712554|524166510|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
145359797|NCT02712554|524166511|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
145359798|NCT02712554|524166510|FG000|Part B: Qualification Phase|Adverse Event|0|||
145359799|NCT02712554|524166511|FG001|Part B: Qualification Phase|Adverse Event|1|||
145359800|NCT02712554|524166510|FG000|Part B: Treatment Phase|Adverse Event|0|||
145359801|NCT02712554|524166511|FG001|Part B: Treatment Phase|Adverse Event|1|||
145418884|NCT05660538|524388618|FG002|Overall Study|Sponsor Decision|0|||
145418885|NCT05660538|524388619|FG003|Overall Study|Sponsor Decision|0|||
145418886|NCT05660538|524388616|FG000|Overall Study|Other|1|||
145359802|NCT02712554|524166510|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
145359803|NCT02712554|524166511|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
145359804|NCT02712554|524166510|FG000|Part B: Treatment Phase|Other|0|||
145359805|NCT02712554|524166511|FG001|Part B: Treatment Phase|Other|1|||
145359806|NCT02503540|524166513|FG000|Overall Study|Death|2|||
145359807|NCT02503540|524166513|FG000|Overall Study|Withdrawal by Subject|1|||
145359808|NCT01662492|524166514|FG000|Overall Study|Other miscellaneous reasons.|1|||
145359809|NCT01662492|524166515|FG001|Overall Study|Other miscellaneous reasons.|0|||
145359810|NCT01662492|524166516|FG002|Overall Study|Other miscellaneous reasons.|1|||
145359811|NCT01662492|524166514|FG000|Overall Study|Withdrawal by Subject|0|||
145359812|NCT01662492|524166515|FG001|Overall Study|Withdrawal by Subject|0|||
145359813|NCT01662492|524166516|FG002|Overall Study|Withdrawal by Subject|1|||
145359814|NCT01662492|524166514|FG000|Overall Study|Protocol Violation|1|||
145359815|NCT01662492|524166515|FG001|Overall Study|Protocol Violation|0|||
145359816|NCT01662492|524166516|FG002|Overall Study|Protocol Violation|0|||
145359817|NCT01662492|524166514|FG000|Overall Study|Lost to Follow-up|0|||
145359818|NCT01662492|524166515|FG001|Overall Study|Lost to Follow-up|0|||
145359819|NCT01662492|524166516|FG002|Overall Study|Lost to Follow-up|2|||
145359820|NCT01662492|524166514|FG000|Overall Study|Lack of Efficacy|1|||
145359821|NCT01662492|524166515|FG001|Overall Study|Lack of Efficacy|1|||
145359822|NCT01662492|524166516|FG002|Overall Study|Lack of Efficacy|2|||
145359823|NCT00979654|524166517|FG000|Overall Study|Lost to Follow-up|1|||
145359824|NCT00979654|524166517|FG000|Overall Study|Withdrawal by Subject|22|||
145359825|NCT00979654|524166517|FG000|Overall Study|Death|1|||
145359826|NCT00979654|524166517|FG000|Overall Study|Lack of Efficacy|6|||
145359827|NCT00979654|524166517|FG000|Overall Study|Adverse Event|1|||
145359828|NCT00979654|524166517|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
145359829|NCT00979654|524166517|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
145359830|NCT00979654|524166517|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
145359831|NCT00979654|524166517|FG000|Overall Study|Serious Adverse Event|1|||
145359832|NCT00979654|524166517|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
145359833|NCT01804946|524166520|FG000|Overall Study|Protocol Violation|1|||
145359834|NCT01804946|524166521|FG001|Overall Study|Protocol Violation|0|||
145359835|NCT01804946|524166520|FG000|Overall Study|Adverse Event|0|||
145359836|NCT01804946|524166521|FG001|Overall Study|Adverse Event|1|||
145359837|NCT01804946|524166520|FG000|Overall Study|Insufficient data available|0|||
145359838|NCT01804946|524166521|FG001|Overall Study|Insufficient data available|1|||
145359839|NCT01804946|524166520|FG000|Overall Study|Do not meet inclusion criteria|1|||
145359840|NCT01804946|524166521|FG001|Overall Study|Do not meet inclusion criteria|2|||
145359841|NCT03830333|524166522|FG000|Overall Study|Death|0|||
145359842|NCT03830333|524166523|FG001|Overall Study|Death|1|||
145359843|NCT03830333|524166522|FG000|Overall Study|Withdrawal by Subject|5|||
145359844|NCT03830333|524166523|FG001|Overall Study|Withdrawal by Subject|1|||
145359845|NCT03830333|524166522|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
145359846|NCT03830333|524166523|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
145359847|NCT00722137|524166524|FG000|Overall Study|Overt Disease Progression|5|||
145359848|NCT00722137|524166525|FG001|Overall Study|Overt Disease Progression|4|||
145359849|NCT00722137|524166524|FG000|Overall Study|Adverse Event|17|||
145359850|NCT00722137|524166525|FG001|Overall Study|Adverse Event|21|||
145359851|NCT00722137|524166524|FG000|Overall Study|Death|12|||
145359852|NCT00722137|524166525|FG001|Overall Study|Death|7|||
145359853|NCT00722137|524166524|FG000|Overall Study|Withdrawal by Subject|6|||
145359854|NCT00722137|524166525|FG001|Overall Study|Withdrawal by Subject|9|||
145359855|NCT00722137|524166524|FG000|Overall Study|Other Reason Unknown|3|||
145359856|NCT00722137|524166525|FG001|Overall Study|Other Reason Unknown|4|||
145359857|NCT00722137|524166524|FG000|Overall Study|Randomized But Not Treated|2|||
145359858|NCT00722137|524166525|FG001|Overall Study|Randomized But Not Treated|3|||
145359859|NCT01129557|524166526|FG000|Overall Study|Adverse Event|1|||
145359860|NCT01129557|524166527|FG001|Overall Study|Adverse Event|2|||
145359861|NCT01129557|524166528|FG002|Overall Study|Adverse Event|2|||
145359862|NCT01129557|524166526|FG000|Overall Study|Novartis terminated study early|3|||
145359863|NCT01129557|524166527|FG001|Overall Study|Novartis terminated study early|3|||
145359864|NCT01129557|524166528|FG002|Overall Study|Novartis terminated study early|2|||
145359865|NCT01486446|524166529|FG000|Overall Study|Adverse Event|1|||
145359866|NCT01486446|524166530|FG001|Overall Study|Adverse Event|0|||
145359867|NCT00985504|524166535|FG000|Acute Treatment Period|Adverse Event|3|||
145359868|NCT00985504|524166536|FG001|Acute Treatment Period|Adverse Event|4|||
145359869|NCT00985504|524166535|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
145359870|NCT00985504|524166536|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
145359871|NCT00985504|524166535|FG000|Acute Treatment Period|Protocol Violation|2|||
145359872|NCT00985504|524166536|FG001|Acute Treatment Period|Protocol Violation|0|||
145359873|NCT00985504|524166535|FG000|Acute Treatment Period|Sponsor Decision|0|||
145359874|NCT00985504|524166536|FG001|Acute Treatment Period|Sponsor Decision|1|||
145359875|NCT00985504|524166535|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
145359876|NCT00985504|524166536|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
145359877|NCT00985504|524166535|FG000|Optimization Period|Adverse Event|7|||
145359878|NCT00985504|524166536|FG001|Optimization Period|Adverse Event|9|||
145359879|NCT00985504|524166535|FG000|Optimization Period|Death|0|||
145359880|NCT00985504|524166536|FG001|Optimization Period|Death|1|||
145359881|NCT00985504|524166535|FG000|Optimization Period|Lack of Efficacy|5|||
145359882|NCT00985504|524166536|FG001|Optimization Period|Lack of Efficacy|3|||
145359883|NCT00985504|524166535|FG000|Optimization Period|Lost to Follow-up|0|||
145359884|NCT00985504|524166536|FG001|Optimization Period|Lost to Follow-up|1|||
145359885|NCT00985504|524166535|FG000|Optimization Period|Physician Decision|1|||
145359886|NCT00985504|524166536|FG001|Optimization Period|Physician Decision|0|||
145359887|NCT00985504|524166535|FG000|Optimization Period|Protocol Violation|3|||
145359888|NCT00985504|524166536|FG001|Optimization Period|Protocol Violation|1|||
145359889|NCT00985504|524166535|FG000|Optimization Period|Withdrawal by Subject|10|||
145359890|NCT00985504|524166536|FG001|Optimization Period|Withdrawal by Subject|8|||
145359891|NCT04390113|524166541|FG000|Overall Study|Not Treated|0|||
145359892|NCT04390113|524166542|FG001|Overall Study|Not Treated|1|||
145359893|NCT04390113|524166541|FG000|Overall Study|Adverse Event|1|||
145359894|NCT04390113|524166542|FG001|Overall Study|Adverse Event|0|||
145359895|NCT04390113|524166541|FG000|Overall Study|Death|2|||
145359896|NCT04390113|524166542|FG001|Overall Study|Death|1|||
145359897|NCT04390113|524166541|FG000|Overall Study|Physician Decision|1|||
145359898|NCT04390113|524166542|FG001|Overall Study|Physician Decision|3|||
145359899|NCT04390113|524166541|FG000|Overall Study|Study Terminated by Sponsor|5|||
145359900|NCT04390113|524166542|FG001|Overall Study|Study Terminated by Sponsor|3|||
145359901|NCT04390113|524166541|FG000|Overall Study|Withdrawal by Subject|10|||
145359902|NCT04390113|524166542|FG001|Overall Study|Withdrawal by Subject|5|||
145359903|NCT04390113|524166541|FG000|Overall Study|Other|1|||
145359904|NCT04390113|524166542|FG001|Overall Study|Other|0|||
145359905|NCT04390113|524166541|FG000|Overall Study|Missing|0|||
145359906|NCT04390113|524166542|FG001|Overall Study|Missing|1|||
145359907|NCT03474965|524166545|FG000|Overall Study|Pregnancy|1|||
145359908|NCT03474965|524166546|FG001|Overall Study|Pregnancy|0|||
145359909|NCT03474965|524166547|FG002|Overall Study|Pregnancy|0|||
145359910|NCT03474965|524166548|FG003|Overall Study|Pregnancy|0|||
145359911|NCT03474965|524166545|FG000|Overall Study|Lost to Follow-up|0|||
145359912|NCT03474965|524166546|FG001|Overall Study|Lost to Follow-up|0|||
145359913|NCT03474965|524166547|FG002|Overall Study|Lost to Follow-up|1|||
145359914|NCT03474965|524166548|FG003|Overall Study|Lost to Follow-up|0|||
145359915|NCT03474965|524166545|FG000|Overall Study|Death|1|||
145359916|NCT03474965|524166546|FG001|Overall Study|Death|0|||
145359917|NCT03474965|524166547|FG002|Overall Study|Death|0|||
145359918|NCT03474965|524166548|FG003|Overall Study|Death|0|||
145359919|NCT03474965|524166545|FG000|Overall Study|Adverse Event|1|||
145359920|NCT03474965|524166546|FG001|Overall Study|Adverse Event|0|||
145359921|NCT03474965|524166547|FG002|Overall Study|Adverse Event|0|||
145359922|NCT03474965|524166548|FG003|Overall Study|Adverse Event|1|||
145359923|NCT03474965|524166545|FG000|Overall Study|Physician Decision|3|||
145359924|NCT03474965|524166546|FG001|Overall Study|Physician Decision|1|||
145359925|NCT03474965|524166547|FG002|Overall Study|Physician Decision|2|||
145359926|NCT03474965|524166548|FG003|Overall Study|Physician Decision|0|||
145359927|NCT03474965|524166545|FG000|Overall Study|Participant Decision|7|||
145359928|NCT03474965|524166546|FG001|Overall Study|Participant Decision|0|||
145359929|NCT03474965|524166547|FG002|Overall Study|Participant Decision|1|||
145359930|NCT03474965|524166548|FG003|Overall Study|Participant Decision|0|||
145359931|NCT03474965|524166545|FG000|Overall Study|Guardian Decision|4|||
145359932|NCT03474965|524166546|FG001|Overall Study|Guardian Decision|2|||
145359933|NCT03474965|524166547|FG002|Overall Study|Guardian Decision|7|||
145359934|NCT03474965|524166548|FG003|Overall Study|Guardian Decision|2|||
145359935|NCT05400655|524168359|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
145359936|NCT05400655|524168360|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
145359937|NCT05400655|524168361|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
145359938|NCT05400655|524168362|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
145359939|NCT05400655|524168363|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
145359940|NCT05400655|524168364|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
145359941|NCT05400655|524168365|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
145359942|NCT05400655|524168366|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
145359943|NCT05400655|524168367|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
145359944|NCT05400655|524168368|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
145359945|NCT05400655|524168369|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
145359946|NCT05400655|524168370|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
145359947|NCT05400655|524168371|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
145359948|NCT05400655|524168372|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
145359949|NCT05400655|524168373|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
145359950|NCT05400655|524168374|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
145359951|NCT05400655|524168375|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
145359952|NCT05400655|524168376|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
145359953|NCT05400655|524168377|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
145359954|NCT05400655|524168378|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
145418887|NCT05660538|524388617|FG001|Overall Study|Other|0|||
145359955|NCT05400655|524168379|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
145359956|NCT05400655|524168380|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
145359957|NCT05400655|524168359|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359958|NCT05400655|524168360|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359959|NCT05400655|524168361|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359960|NCT05400655|524168362|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359961|NCT05400655|524168363|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359962|NCT05400655|524168364|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359963|NCT05400655|524168365|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359964|NCT05400655|524168366|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359965|NCT05400655|524168367|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359966|NCT05400655|524168368|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359967|NCT05400655|524168369|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359968|NCT05400655|524168370|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359969|NCT05400655|524168371|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145359970|NCT05400655|524168372|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359971|NCT05400655|524168373|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359972|NCT05400655|524168374|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359973|NCT05400655|524168375|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145359974|NCT05400655|524168376|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359975|NCT05400655|524168377|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
145359976|NCT05400655|524168378|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
145359977|NCT05400655|524168379|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359978|NCT05400655|524168380|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
145359979|NCT05400655|524168359|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359980|NCT05400655|524168360|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359981|NCT05400655|524168361|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359982|NCT05400655|524168362|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359983|NCT05400655|524168363|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359984|NCT05400655|524168364|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359985|NCT05400655|524168365|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359986|NCT05400655|524168366|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359987|NCT05400655|524168367|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359988|NCT05400655|524168368|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359989|NCT05400655|524168369|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359990|NCT05400655|524168370|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359991|NCT05400655|524168371|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359992|NCT05400655|524168372|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
145359993|NCT05400655|524168373|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359994|NCT05400655|524168374|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359995|NCT05400655|524168375|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
145359996|NCT05400655|524168376|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359997|NCT05400655|524168377|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
145359998|NCT05400655|524168378|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145359999|NCT05400655|524168379|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145360000|NCT05400655|524168380|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
145360001|NCT05400655|524168359|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360002|NCT05400655|524168360|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360003|NCT05400655|524168361|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360004|NCT05400655|524168362|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360005|NCT05400655|524168363|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360006|NCT05400655|524168364|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360007|NCT05400655|524168365|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360008|NCT05400655|524168366|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360009|NCT05400655|524168367|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360010|NCT05400655|524168368|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360011|NCT05400655|524168369|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360012|NCT05400655|524168370|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360013|NCT05400655|524168371|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360014|NCT05400655|524168372|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360015|NCT05400655|524168373|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360016|NCT05400655|524168374|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360017|NCT05400655|524168375|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145360018|NCT05400655|524168376|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145360019|NCT05400655|524168377|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
145360020|NCT05400655|524168378|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
145360021|NCT05400655|524168379|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
145360022|NCT05400655|524168380|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
145360023|NCT05400655|524168359|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360024|NCT05400655|524168360|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360025|NCT05400655|524168361|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360026|NCT05400655|524168362|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360027|NCT05400655|524168363|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360028|NCT05400655|524168364|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360029|NCT05400655|524168365|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360030|NCT05400655|524168366|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360031|NCT05400655|524168367|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360032|NCT05400655|524168368|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360033|NCT05400655|524168369|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360034|NCT05400655|524168370|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360035|NCT05400655|524168371|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360036|NCT05400655|524168372|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360037|NCT05400655|524168373|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360038|NCT05400655|524168374|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360039|NCT05400655|524168375|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360040|NCT05400655|524168376|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
145360041|NCT05400655|524168377|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
145360042|NCT05400655|524168378|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360043|NCT05400655|524168379|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360044|NCT05400655|524168380|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
145360045|NCT05400655|524168359|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360046|NCT05400655|524168360|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360047|NCT05400655|524168361|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360048|NCT05400655|524168362|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360049|NCT05400655|524168363|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360050|NCT05400655|524168364|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360051|NCT05400655|524168365|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360052|NCT05400655|524168366|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360053|NCT05400655|524168367|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360054|NCT05400655|524168368|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360055|NCT05400655|524168369|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360056|NCT05400655|524168370|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360057|NCT05400655|524168371|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360058|NCT05400655|524168372|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360059|NCT05400655|524168373|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360060|NCT05400655|524168374|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360061|NCT05400655|524168375|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145360062|NCT05400655|524168376|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
145360063|NCT05400655|524168377|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145360064|NCT05400655|524168378|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
145360065|NCT05400655|524168379|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
145360066|NCT05400655|524168380|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
145360067|NCT01682226|524168381|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
145360068|NCT01682226|524168381|FG000|Overall Study|Participants did not receive treatment|2|||
145360069|NCT01682226|524168381|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
145360070|NCT03263936|524168382|FG000|Overall Study|Adverse Event|0|||
145360071|NCT03263936|524168383|FG001|Overall Study|Adverse Event|1|||
145360072|NCT03263936|524168384|FG002|Overall Study|Adverse Event|0|||
145360073|NCT03263936|524168382|FG000|Overall Study|Death|0|||
145360074|NCT03263936|524168383|FG001|Overall Study|Death|1|||
145360075|NCT03263936|524168384|FG002|Overall Study|Death|0|||
145360076|NCT05343000|524168385|FG000|Overall Study|Physician Decision|2|||
145360077|NCT03123120|524168386|FG000|Overall Study|Lost to Follow-up|0|||
145360078|NCT03123120|524168387|FG001|Overall Study|Lost to Follow-up|1|||
145360079|NCT03123120|524168386|FG000|Overall Study|Withdrawal by Subject|0|||
145360080|NCT03123120|524168387|FG001|Overall Study|Withdrawal by Subject|1|||
145360081|NCT03135548|524168388|FG000|Overall Study|Lost to Follow-up|3|||
145360082|NCT03135548|524168389|FG001|Overall Study|Lost to Follow-up|0|||
145360083|NCT03135548|524168390|FG002|Overall Study|Lost to Follow-up|0|||
145360084|NCT03135548|524168388|FG000|Overall Study|Withdrawal by Subject|2|||
145418888|NCT05660538|524388618|FG002|Overall Study|Other|0|||
145418889|NCT05660538|524388619|FG003|Overall Study|Other|1|||
145360085|NCT03135548|524168389|FG001|Overall Study|Withdrawal by Subject|2|||
145360086|NCT03135548|524168390|FG002|Overall Study|Withdrawal by Subject|1|||
145360087|NCT03135548|524168388|FG000|Overall Study|Other than listed|0|||
145360088|NCT03135548|524168389|FG001|Overall Study|Other than listed|2|||
145360089|NCT03135548|524168390|FG002|Overall Study|Other than listed|2|||
145360090|NCT02632175|524168391|FG000|Overall Study|Withdrawal by Subject|6|||
145360091|NCT02632175|524168391|FG000|Overall Study|Lost to Follow-up|1|||
145418890|NCT05660538|524388616|FG000|Overall Study|Randomized but did not receive study drug|1|||
145418891|NCT05660538|524388617|FG001|Overall Study|Randomized but did not receive study drug|0|||
145418892|NCT05660538|524388618|FG002|Overall Study|Randomized but did not receive study drug|0|||
145360092|NCT02632175|524168391|FG000|Overall Study|Lack of Efficacy|18|||
145360093|NCT02632175|524168391|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
145360094|NCT02632175|524168391|FG000|Overall Study|Subject noncompliance|3|||
145360095|NCT02632175|524168391|FG000|Overall Study|other|2|||
145360096|NCT02088554|524168392|FG000|Overall Study|Exited before procedure|130|||
145360097|NCT02088554|524168392|FG000|Overall Study|Attempted but not implanted|31|||
145360098|NCT02088554|524168392|FG000|Overall Study|Implant not attempted|19|||
145360099|NCT02088554|524168392|FG000|Overall Study|Pending next visit|532|||
145360100|NCT02088554|524168392|FG000|Overall Study|Death|170|||
145360101|NCT02088554|524168392|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
145360102|NCT02088554|524168392|FG000|Overall Study|Lost to Follow-up|23|||
145360103|NCT02088554|524168392|FG000|Overall Study|Explanted|32|||
145360104|NCT02088554|524168392|FG000|Overall Study|Any other reason not covered by previous categories|11|||
145360105|NCT02283268|524168410|FG000|Overall Study|Withdrawal by Subject|1|||
145360106|NCT00454246|524168411|FG000|Overall Study|Adverse Event|2|||
145360107|NCT00454246|524168412|FG001|Overall Study|Adverse Event|2|||
145360108|NCT00454246|524168413|FG002|Overall Study|Adverse Event|0|||
145360109|NCT00454246|524168411|FG000|Overall Study|Violation of selection criteria at entry|6|||
145360110|NCT00454246|524168412|FG001|Overall Study|Violation of selection criteria at entry|0|||
145360111|NCT00454246|524168413|FG002|Overall Study|Violation of selection criteria at entry|0|||
145360112|NCT00454246|524168411|FG000|Overall Study|Protocol Violation|1|||
145360113|NCT00454246|524168412|FG001|Overall Study|Protocol Violation|0|||
145360114|NCT00454246|524168413|FG002|Overall Study|Protocol Violation|0|||
145360115|NCT00454246|524168411|FG000|Overall Study|Refused Treatment|1|||
145360116|NCT00454246|524168412|FG001|Overall Study|Refused Treatment|1|||
145360117|NCT00454246|524168413|FG002|Overall Study|Refused Treatment|0|||
145360118|NCT00454246|524168411|FG000|Overall Study|Failure to return|1|||
145360119|NCT00454246|524168412|FG001|Overall Study|Failure to return|0|||
145360120|NCT00454246|524168413|FG002|Overall Study|Failure to return|0|||
145360121|NCT00454246|524168411|FG000|Overall Study|Early termination of study|62|||
145360122|NCT00454246|524168412|FG001|Overall Study|Early termination of study|26|||
145360123|NCT00454246|524168413|FG002|Overall Study|Early termination of study|9|||
145360124|NCT05326529|524168414|FG000|Overall Study|Lack of Efficacy|0|||
145360125|NCT05326529|524168415|FG001|Overall Study|Lack of Efficacy|1|||
145360126|NCT05326529|524168416|FG002|Overall Study|Lack of Efficacy|0|||
145360127|NCT05326529|524168414|FG000|Overall Study|Physician Decision|0|||
145360128|NCT05326529|524168415|FG001|Overall Study|Physician Decision|0|||
145360129|NCT05326529|524168416|FG002|Overall Study|Physician Decision|2|||
145360130|NCT02126579|524168417|FG000|Overall Study|disease progression|0|||
145360131|NCT02126579|524168418|FG001|Overall Study|disease progression|0|||
145360132|NCT02126579|524168419|FG002|Overall Study|disease progression|0|||
145360133|NCT02126579|524168420|FG003|Overall Study|disease progression|1|||
145360134|NCT02126579|524168421|FG004|Overall Study|disease progression|0|||
145360135|NCT02126579|524168422|FG005|Overall Study|disease progression|0|||
145360136|NCT02126579|524168423|FG006|Overall Study|disease progression|1|||
145360137|NCT02309411|524168425|FG000|Overall Study|Physician Decision|1|||
145360138|NCT02309411|524168426|FG001|Overall Study|Physician Decision|0|||
145360139|NCT02309411|524168427|FG002|Overall Study|Physician Decision|0|||
145360140|NCT02309411|524168425|FG000|Overall Study|Withdrawal by Subject|1|||
145360141|NCT02309411|524168426|FG001|Overall Study|Withdrawal by Subject|1|||
145360142|NCT02309411|524168427|FG002|Overall Study|Withdrawal by Subject|0|||
145360143|NCT01609010|524168430|FG000|Overall Study|Stable disease (SD)|22|||
145360144|NCT01609010|524168431|FG001|Overall Study|Stable disease (SD)|16|||
145360145|NCT01609010|524168430|FG000|Overall Study|Progressive disease (PD)|8|||
145360146|NCT01609010|524168431|FG001|Overall Study|Progressive disease (PD)|10|||
145360147|NCT01609010|524168430|FG000|Overall Study|Adverse Event|3|||
145360148|NCT01609010|524168431|FG001|Overall Study|Adverse Event|6|||
145360149|NCT01609010|524168430|FG000|Overall Study|Withdrawal by Subject|2|||
145360150|NCT01609010|524168431|FG001|Overall Study|Withdrawal by Subject|2|||
145360151|NCT01609010|524168430|FG000|Overall Study|Other|2|||
145360152|NCT01609010|524168431|FG001|Overall Study|Other|0|||
145360153|NCT01609010|524168430|FG000|Overall Study|Other malignancy|1|||
145360154|NCT01609010|524168431|FG001|Overall Study|Other malignancy|0|||
145360155|NCT01609010|524168430|FG000|Overall Study|Pathology review|2|||
145360156|NCT01609010|524168431|FG001|Overall Study|Pathology review|1|||
145418893|NCT05660538|524388619|FG003|Overall Study|Randomized but did not receive study drug|1|||
145418894|NCT05660538|524388616|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145623140|NCT02240680|525131599|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
145360157|NCT01609010|524168430|FG000|Overall Study|Protocol Violation|1|||
145360158|NCT01609010|524168431|FG001|Overall Study|Protocol Violation|1|||
145360159|NCT01609010|524168430|FG000|Overall Study|New cancer|1|||
145360160|NCT01609010|524168431|FG001|Overall Study|New cancer|0|||
145623141|NCT02240680|525131600|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
145360161|NCT01609010|524168430|FG000|Overall Study|Lost to Follow-up|1|||
145360162|NCT01609010|524168431|FG001|Overall Study|Lost to Follow-up|1|||
145360163|NCT02770170|524168435|FG000|Overall Study|Withdrawal by Subject|0|||
145360164|NCT02770170|524168436|FG001|Overall Study|Withdrawal by Subject|0|||
145360165|NCT02770170|524168437|FG002|Overall Study|Withdrawal by Subject|0|||
145360166|NCT02770170|524168438|FG003|Overall Study|Withdrawal by Subject|2|||
145360167|NCT02770170|524168435|FG000|Overall Study|due to pregnancy|1|||
145360168|NCT02770170|524168436|FG001|Overall Study|due to pregnancy|0|||
145360169|NCT02770170|524168437|FG002|Overall Study|due to pregnancy|0|||
145360170|NCT02770170|524168438|FG003|Overall Study|due to pregnancy|0|||
145360171|NCT02770170|524168435|FG000|Overall Study|Lack of Efficacy|2|||
145360172|NCT02770170|524168436|FG001|Overall Study|Lack of Efficacy|0|||
145360173|NCT02770170|524168437|FG002|Overall Study|Lack of Efficacy|0|||
145360174|NCT02770170|524168438|FG003|Overall Study|Lack of Efficacy|1|||
145360175|NCT02770170|524168435|FG000|Overall Study|Adverse Event|4|||
145360176|NCT02770170|524168436|FG001|Overall Study|Adverse Event|3|||
145360177|NCT02770170|524168437|FG002|Overall Study|Adverse Event|5|||
145360178|NCT02770170|524168438|FG003|Overall Study|Adverse Event|3|||
145360179|NCT02770170|524168435|FG000|Overall Study|due to disease worsening|0|||
145360180|NCT02770170|524168436|FG001|Overall Study|due to disease worsening|0|||
145360181|NCT02770170|524168437|FG002|Overall Study|due to disease worsening|0|||
145360182|NCT02770170|524168438|FG003|Overall Study|due to disease worsening|1|||
145360183|NCT03581123|524168441|FG000|2-month Follow-up|Withdrawal by Subject|5|||
145360184|NCT03581123|524168442|FG001|2-month Follow-up|Withdrawal by Subject|4|||
145360185|NCT03581123|524168443|FG002|2-month Follow-up|Withdrawal by Subject|6|||
145360186|NCT03581123|524168444|FG003|2-month Follow-up|Withdrawal by Subject|4|||
145360187|NCT03581123|524168441|FG000|2-month Follow-up|Lost to Follow-up|8|||
145360188|NCT03581123|524168442|FG001|2-month Follow-up|Lost to Follow-up|1|||
145360189|NCT03581123|524168443|FG002|2-month Follow-up|Lost to Follow-up|2|||
145360190|NCT03581123|524168444|FG003|2-month Follow-up|Lost to Follow-up|2|||
145360191|NCT03581123|524168441|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
145360192|NCT03581123|524168442|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
145360193|NCT03581123|524168443|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
145360194|NCT03581123|524168444|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
145360195|NCT03581123|524168441|FG000|6-Month Follow-up|Lost to Follow-up|3|||
145360196|NCT03581123|524168442|FG001|6-Month Follow-up|Lost to Follow-up|3|||
145360197|NCT03581123|524168443|FG002|6-Month Follow-up|Lost to Follow-up|1|||
145360198|NCT03581123|524168444|FG003|6-Month Follow-up|Lost to Follow-up|1|||
145360199|NCT03581123|524168441|FG000|12-Month Follow-up|Lost to Follow-up|4|||
145360200|NCT03581123|524168442|FG001|12-Month Follow-up|Lost to Follow-up|3|||
145360201|NCT03581123|524168443|FG002|12-Month Follow-up|Lost to Follow-up|4|||
145360202|NCT03581123|524168444|FG003|12-Month Follow-up|Lost to Follow-up|5|||
145360203|NCT00162981|524168445|FG000|Overall Study|Adverse Event|2|||
145360204|NCT00162981|524168446|FG001|Overall Study|Adverse Event|5|||
145360205|NCT00162981|524168445|FG000|Overall Study|Withdrawal by Subject|1|||
145360206|NCT00162981|524168446|FG001|Overall Study|Withdrawal by Subject|1|||
145360207|NCT00162981|524168445|FG000|Overall Study|Physician Decision|1|||
145360208|NCT00162981|524168446|FG001|Overall Study|Physician Decision|0|||
145360209|NCT04195685|524168447|FG000|Overall Study|Withdrawal by Subject|6|||
145360210|NCT04195685|524168448|FG001|Overall Study|Withdrawal by Subject|2|||
145360211|NCT04195685|524168447|FG000|Overall Study|Lost to Follow-up|1|||
145360212|NCT04195685|524168448|FG001|Overall Study|Lost to Follow-up|4|||
145360213|NCT03351608|524168455|FG000|Overall Study|Lost to Follow-up|0|||
145360214|NCT03351608|524168456|FG001|Overall Study|Lost to Follow-up|1|||
145360215|NCT03351608|524168457|FG002|Overall Study|Lost to Follow-up|1|||
145360216|NCT03351608|524168458|FG003|Overall Study|Lost to Follow-up|1|||
145360217|NCT03351608|524168459|FG004|Overall Study|Lost to Follow-up|1|||
145360218|NCT03351608|524168455|FG000|Overall Study|Physician Decision|1|||
145360219|NCT03351608|524168456|FG001|Overall Study|Physician Decision|0|||
145360220|NCT03351608|524168457|FG002|Overall Study|Physician Decision|0|||
145360221|NCT03351608|524168458|FG003|Overall Study|Physician Decision|2|||
145360222|NCT03351608|524168459|FG004|Overall Study|Physician Decision|1|||
145360223|NCT03351608|524168455|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
145360224|NCT03351608|524168456|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
145360225|NCT03351608|524168457|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
145360226|NCT03351608|524168458|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
145360227|NCT03351608|524168459|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
145418895|NCT05660538|524388617|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
145360228|NCT03351608|524168455|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145360229|NCT03351608|524168456|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145360230|NCT03351608|524168457|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145360231|NCT03351608|524168458|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145360232|NCT03351608|524168459|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145418896|NCT05660538|524388618|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145360233|NCT03351608|524168455|FG000|Overall Study|Other|0|||
145360234|NCT03351608|524168456|FG001|Overall Study|Other|1|||
145360235|NCT03351608|524168457|FG002|Overall Study|Other|1|||
145360236|NCT03351608|524168458|FG003|Overall Study|Other|3|||
145360237|NCT03351608|524168459|FG004|Overall Study|Other|0|||
145360238|NCT02877004|524168460|FG000|Overall Study|Pregnancy|0|||
145360239|NCT02877004|524168461|FG001|Overall Study|Pregnancy|0|||
145360240|NCT02877004|524168462|FG002|Overall Study|Pregnancy|1|||
145360241|NCT02044302|524168464|FG000|Overall Study|study terminated|2|||
145360242|NCT02044302|524168465|FG001|Overall Study|study terminated|0|||
145360243|NCT02019264|524168468|FG000|Overall Study|Not treated|6|||
145360244|NCT02019264|524168469|FG001|Overall Study|Not treated|4|||
145360245|NCT02019264|524168468|FG000|Overall Study|Lost to Follow-up|50|||
145360246|NCT02019264|524168469|FG001|Overall Study|Lost to Follow-up|47|||
145360247|NCT02019264|524168468|FG000|Overall Study|Withdrawal by Subject|142|||
145360248|NCT02019264|524168469|FG001|Overall Study|Withdrawal by Subject|117|||
145360249|NCT02019264|524168468|FG000|Overall Study|Administrative reason|36|||
145360250|NCT02019264|524168469|FG001|Overall Study|Administrative reason|28|||
145360251|NCT02019264|524168468|FG000|Overall Study|Missing|14|||
145360252|NCT02019264|524168469|FG001|Overall Study|Missing|11|||
145360253|NCT01297517|524168475|FG000|Overall Study|Adverse Event|21|||
145360254|NCT01297517|524168476|FG001|Overall Study|Adverse Event|7|||
145360255|NCT01297517|524168477|FG002|Overall Study|Adverse Event|16|||
145360256|NCT01297517|524168475|FG000|Overall Study|Lost to Follow-up|1|||
145360257|NCT01297517|524168476|FG001|Overall Study|Lost to Follow-up|0|||
145360258|NCT01297517|524168477|FG002|Overall Study|Lost to Follow-up|1|||
145360259|NCT01297517|524168475|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
145360260|NCT01297517|524168476|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
145360261|NCT01297517|524168477|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
145360262|NCT01297517|524168475|FG000|Overall Study|Noncompliance|1|||
145360263|NCT01297517|524168476|FG001|Overall Study|Noncompliance|0|||
145360264|NCT01297517|524168477|FG002|Overall Study|Noncompliance|0|||
145360265|NCT01297517|524168475|FG000|Overall Study|Protocol Violation|1|||
145360266|NCT01297517|524168476|FG001|Overall Study|Protocol Violation|1|||
145360267|NCT01297517|524168477|FG002|Overall Study|Protocol Violation|1|||
145360268|NCT01297517|524168475|FG000|Overall Study|Inadequate Control of IOP|1|||
145360269|NCT01297517|524168476|FG001|Overall Study|Inadequate Control of IOP|1|||
145360270|NCT01297517|524168477|FG002|Overall Study|Inadequate Control of IOP|2|||
145360271|NCT01609296|524168478|FG000|Overall Study|Death|253|||
145360272|NCT01609296|524168478|FG000|Overall Study|Withdrawal by Subject|151|||
145360273|NCT01609296|524168478|FG000|Overall Study|Lost to Follow-up|21|||
145360274|NCT01609296|524168478|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
145360275|NCT01609296|524168478|FG000|Overall Study|missed visit but known to be alive|28|||
145360276|NCT00386360|524168479|FG000|Overall Study|Adverse Event|4|||
145360277|NCT00386360|524168480|FG001|Overall Study|Adverse Event|2|||
145360278|NCT00386360|524168479|FG000|Overall Study|Physician Decision|2|||
145360279|NCT00386360|524168480|FG001|Overall Study|Physician Decision|2|||
145360280|NCT00386360|524168479|FG000|Overall Study|Lost to Follow-up|0|||
145360281|NCT00386360|524168480|FG001|Overall Study|Lost to Follow-up|2|||
145360282|NCT00386360|524168479|FG000|Overall Study|Protocol Violation|0|||
145360283|NCT00386360|524168480|FG001|Overall Study|Protocol Violation|3|||
145360284|NCT00386360|524168479|FG000|Overall Study|Withdrawal by Subject|3|||
145360285|NCT00386360|524168480|FG001|Overall Study|Withdrawal by Subject|6|||
145360286|NCT00386360|524168479|FG000|Overall Study|Did not take any study medication|0|||
145360287|NCT00386360|524168480|FG001|Overall Study|Did not take any study medication|2|||
145360288|NCT00628212|524168481|FG000|Overall Study|Adverse Event|2|||
145360289|NCT00628212|524168482|FG001|Overall Study|Adverse Event|0|||
145360290|NCT00628212|524168483|FG002|Overall Study|Adverse Event|1|||
145360291|NCT00628212|524168484|FG003|Overall Study|Adverse Event|2|||
145360292|NCT00628212|524168481|FG000|Overall Study|Physician Decision|1|||
145360293|NCT00628212|524168482|FG001|Overall Study|Physician Decision|1|||
145360294|NCT00628212|524168483|FG002|Overall Study|Physician Decision|2|||
145360295|NCT00628212|524168484|FG003|Overall Study|Physician Decision|3|||
145360296|NCT00546377|524168485|FG000|Overall Study|Deemed ineligible|1|||
145360297|NCT00546377|524168485|FG000|Overall Study|Adverse Event|6|||
145360298|NCT02220764|524168487|FG000|Overall Study|Lost to Follow-up|3|||
145360299|NCT02220764|524168488|FG001|Overall Study|Lost to Follow-up|1|||
145360300|NCT02220764|524168487|FG000|Overall Study|Death|1|||
145360301|NCT02220764|524168488|FG001|Overall Study|Death|0|||
145360302|NCT05000164|524168489|FG000|Overall Study|Adverse Event|1|||
145360303|NCT05000164|524168489|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145360304|NCT05000164|524168489|FG000|Overall Study|Lens Discomfort|3|||
145360305|NCT05000164|524168489|FG000|Overall Study|Withdrew Consent during Study|2|||
145360306|NCT05000164|524168489|FG000|Overall Study|Subject Withdrawn by PI|2|||
145360307|NCT05000164|524168489|FG000|Overall Study|Other Fractured Test Article|1|||
145360308|NCT03020992|524168490|FG000|Overall Study|Adverse Event|5|||
145360309|NCT03020992|524168490|FG000|Overall Study|Withdrawal by Subject|1|||
145360310|NCT02861807|524168491|FG000|Overall Study|Lost to Follow-up|7|||
145360311|NCT02861807|524168492|FG001|Overall Study|Lost to Follow-up|6|||
145360312|NCT02861807|524168491|FG000|Overall Study|Withdrawal by Subject|5|||
145360313|NCT02861807|524168492|FG001|Overall Study|Withdrawal by Subject|8|||
145360314|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
145360315|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
145360316|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
145360317|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
145360318|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Pregnancy|0|||
145360319|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Pregnancy|1|||
145360320|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
145360321|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
145360322|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
145360323|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
145360324|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
145360325|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
145360326|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Other|3|||
145360327|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Other|0|||
145360328|NCT01006122|524168493|FG000|First Double-blind Intervention Period|Adverse Event|0|||
145360329|NCT01006122|524168494|FG001|First Double-blind Intervention Period|Adverse Event|4|||
145360330|NCT01006122|524168493|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
145360331|NCT01006122|524168494|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
145360332|NCT01006122|524168493|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
145360333|NCT01006122|524168494|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
145360334|NCT01006122|524168493|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
145360335|NCT01006122|524168494|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
145360336|NCT01006122|524168493|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
145360337|NCT01006122|524168494|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
145360338|NCT01006122|524168493|FG000|Second Double-blind Intervention Period|Death|0|||
145360339|NCT01006122|524168494|FG001|Second Double-blind Intervention Period|Death|1|||
145360340|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
145360341|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
145360342|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
145360343|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
145360344|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
145360345|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
145360346|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
145360347|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
145360348|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
145360349|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
145360350|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
145360351|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
145360352|NCT03493854|524168495|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
145360353|NCT03493854|524168496|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
145360354|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
145360355|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
145360356|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
145360357|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
145360358|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
145360359|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
145360360|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
145360361|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
145360362|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
145360363|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
145360364|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
145360365|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
145360366|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
145360367|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
145360368|NCT03493854|524168495|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
145360369|NCT03493854|524168496|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
145360370|NCT03493854|524168495|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
145360371|NCT03493854|524168496|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
145360372|NCT03493854|524168495|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
145360373|NCT03493854|524168496|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
145360374|NCT03493854|524168495|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
145360375|NCT03493854|524168496|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
145360376|NCT02062450|524168511|FG000|Overall Study|No follow-up visit|124|||
145360377|NCT04025879|524168512|FG000|Randomization|Participant withdrew consent|0|||
145360378|NCT04025879|524168513|FG001|Randomization|Participant withdrew consent|1|||
145360379|NCT04025879|524168512|FG000|Randomization|Participant no longer met study criteria|1|||
145360380|NCT04025879|524168513|FG001|Randomization|Participant no longer met study criteria|1|||
145360381|NCT04025879|524168512|FG000|Treatment|Ongoing treatment|10|||
145577526|NCT02391948|524969427|FG002|18-month Assessment|Withdrawal by Subject|0|||
145577527|NCT02391948|524969428|FG003|18-month Assessment|Withdrawal by Subject|1|||
145577528|NCT02391948|524969429|FG004|18-month Assessment|Withdrawal by Subject|0|||
145577529|NCT02391948|524969425|FG000|18-month Assessment|Lost to Follow-up|2|||
145577530|NCT02391948|524969426|FG001|18-month Assessment|Lost to Follow-up|6|||
145577531|NCT02391948|524969427|FG002|18-month Assessment|Lost to Follow-up|2|||
145577532|NCT02391948|524969428|FG003|18-month Assessment|Lost to Follow-up|2|||
145623142|NCT02240680|525131601|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
145360382|NCT04025879|524168513|FG001|Treatment|Ongoing treatment|8|||
145360383|NCT04025879|524168512|FG000|Treatment|Disease progression/recurrence|36|||
145360384|NCT04025879|524168513|FG001|Treatment|Disease progression/recurrence|72|||
145360385|NCT04025879|524168512|FG000|Treatment|Study drug toxicity|36|||
145360386|NCT04025879|524168513|FG001|Treatment|Study drug toxicity|13|||
145360387|NCT04025879|524168512|FG000|Treatment|Death|2|||
145360388|NCT04025879|524168513|FG001|Treatment|Death|0|||
145360389|NCT04025879|524168512|FG000|Treatment|Adverse event unrelated to study drug|21|||
145360390|NCT04025879|524168513|FG001|Treatment|Adverse event unrelated to study drug|14|||
145360391|NCT04025879|524168512|FG000|Treatment|Participant request to discontinue study treatment|16|||
145360392|NCT04025879|524168513|FG001|Treatment|Participant request to discontinue study treatment|8|||
145360393|NCT04025879|524168512|FG000|Treatment|Participant withdrew consent|1|||
145360394|NCT04025879|524168513|FG001|Treatment|Participant withdrew consent|3|||
145360395|NCT04025879|524168512|FG000|Treatment|Participant no longer meets study criteria|3|||
145360396|NCT04025879|524168513|FG001|Treatment|Participant no longer meets study criteria|2|||
145360397|NCT04025879|524168512|FG000|Treatment|Lost to Follow-up|1|||
145360398|NCT04025879|524168513|FG001|Treatment|Lost to Follow-up|0|||
145360399|NCT04025879|524168512|FG000|Treatment|Other reasons|15|||
145360400|NCT04025879|524168513|FG001|Treatment|Other reasons|17|||
145360401|NCT04025879|524168512|FG000|Treatment|Administrative reason by sponsor|0|||
145360402|NCT04025879|524168513|FG001|Treatment|Administrative reason by sponsor|1|||
145360403|NCT04025879|524168512|FG000|Treatment|Not reported|2|||
145360404|NCT04025879|524168513|FG001|Treatment|Not reported|0|||
145360405|NCT03859427|524168514|FG000|Overall Study|Withdrawal by Subject|4|||
145360406|NCT03859427|524168515|FG001|Overall Study|Withdrawal by Subject|7|||
145360407|NCT03859427|524168514|FG000|Overall Study|Decision by sponsor|0|||
145360408|NCT03859427|524168515|FG001|Overall Study|Decision by sponsor|3|||
145360409|NCT03859427|524168514|FG000|Overall Study|Lost to Follow-up|3|||
145360410|NCT03859427|524168515|FG001|Overall Study|Lost to Follow-up|2|||
145360411|NCT03859427|524168514|FG000|Overall Study|Death|22|||
145360412|NCT03859427|524168515|FG001|Overall Study|Death|25|||
145360413|NCT01367886|524168521|FG000|Overall Study|Lost to Follow-up|4|||
145360414|NCT01367886|524168521|FG000|Overall Study|Lack of Efficacy|2|||
145360415|NCT01367886|524168521|FG000|Overall Study|Death|1|||
145360416|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
145360417|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
145360418|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
145360419|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
145360420|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
145360421|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
145360422|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
145360423|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
145360424|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
145360425|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
145360426|NCT03711786|524168522|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
145360427|NCT03711786|524168523|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
145360428|NCT03379727|524168524|FG000|Overall Study|Lack of Efficacy|73|||
145360429|NCT03379727|524168524|FG000|Overall Study|Adverse Event|32|||
145360430|NCT03379727|524168524|FG000|Overall Study|Death|18|||
145360431|NCT03379727|524168524|FG000|Overall Study|Patient/guardian decision|17|||
145360432|NCT03379727|524168524|FG000|Overall Study|Physician Decision|104|||
145360433|NCT03379727|524168524|FG000|Overall Study|Protocol Violation|4|||
145360434|NCT03379727|524168524|FG000|Overall Study|Lost to Follow-up|1|||
145360435|NCT02418182|524168527|FG000|Overall Study|Unable to re-consent|18|||
145360436|NCT02418182|524168528|FG001|Overall Study|Unable to re-consent|15|||
145360437|NCT02418182|524168527|FG000|Overall Study|Lost to Follow-up|0|||
145623143|NCT02240680|525131598|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
145360438|NCT02418182|524168528|FG001|Overall Study|Lost to Follow-up|2|||
145360439|NCT02431676|524168529|FG000|Overall Study|no lab obtained|0|||
145360440|NCT02431676|524168530|FG001|Overall Study|no lab obtained|1|||
145360441|NCT02431676|524168531|FG002|Overall Study|no lab obtained|2|||
145360442|NCT03103152|524168532|FG000|Overall Study|Physician Decision|5|||
145360443|NCT03103152|524168533|FG001|Overall Study|Physician Decision|2|||
145360444|NCT03103152|524168534|FG002|Overall Study|Physician Decision|6|||
145360445|NCT03103152|524168535|FG003|Overall Study|Physician Decision|3|||
145360446|NCT03103152|524168536|FG004|Overall Study|Physician Decision|3|||
145577533|NCT02391948|524969429|FG004|18-month Assessment|Lost to Follow-up|3|||
145360447|NCT03103152|524168537|FG005|Overall Study|Physician Decision|1|||
145360448|NCT03103152|524168532|FG000|Overall Study|Protocol Violation|2|||
145360449|NCT03103152|524168533|FG001|Overall Study|Protocol Violation|2|||
145360450|NCT03103152|524168534|FG002|Overall Study|Protocol Violation|1|||
145360451|NCT03103152|524168535|FG003|Overall Study|Protocol Violation|2|||
145360452|NCT03103152|524168536|FG004|Overall Study|Protocol Violation|1|||
145360453|NCT03103152|524168537|FG005|Overall Study|Protocol Violation|1|||
145360454|NCT03103152|524168532|FG000|Overall Study|Inter-current illness|0|||
145360455|NCT03103152|524168533|FG001|Overall Study|Inter-current illness|0|||
145360456|NCT03103152|524168534|FG002|Overall Study|Inter-current illness|1|||
145360457|NCT03103152|524168535|FG003|Overall Study|Inter-current illness|0|||
145360458|NCT03103152|524168536|FG004|Overall Study|Inter-current illness|0|||
145360459|NCT03103152|524168537|FG005|Overall Study|Inter-current illness|0|||
145360460|NCT03103152|524168532|FG000|Overall Study|Death|0|||
145360461|NCT03103152|524168533|FG001|Overall Study|Death|1|||
145360462|NCT03103152|524168534|FG002|Overall Study|Death|0|||
145360463|NCT03103152|524168535|FG003|Overall Study|Death|0|||
145360464|NCT03103152|524168536|FG004|Overall Study|Death|0|||
145360465|NCT03103152|524168537|FG005|Overall Study|Death|0|||
145360466|NCT03103152|524168532|FG000|Overall Study|Adverse Event|0|||
145360467|NCT03103152|524168533|FG001|Overall Study|Adverse Event|0|||
145360468|NCT03103152|524168534|FG002|Overall Study|Adverse Event|1|||
145360469|NCT03103152|524168535|FG003|Overall Study|Adverse Event|0|||
145360470|NCT03103152|524168536|FG004|Overall Study|Adverse Event|0|||
145360471|NCT03103152|524168537|FG005|Overall Study|Adverse Event|1|||
145360472|NCT03103152|524168532|FG000|Overall Study|Withdrawal by Subject|1|||
145360473|NCT03103152|524168533|FG001|Overall Study|Withdrawal by Subject|0|||
145360474|NCT03103152|524168534|FG002|Overall Study|Withdrawal by Subject|1|||
145360475|NCT03103152|524168535|FG003|Overall Study|Withdrawal by Subject|1|||
145360476|NCT03103152|524168536|FG004|Overall Study|Withdrawal by Subject|1|||
145360477|NCT03103152|524168537|FG005|Overall Study|Withdrawal by Subject|1|||
145360478|NCT03103152|524168532|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
145360479|NCT03103152|524168533|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
145360480|NCT03103152|524168534|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
145360481|NCT03103152|524168535|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
145360482|NCT03103152|524168536|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
145360483|NCT03103152|524168537|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
145360484|NCT03103152|524168532|FG000|Overall Study|Unacceptable side effects|0|||
145360485|NCT03103152|524168533|FG001|Overall Study|Unacceptable side effects|0|||
145360486|NCT03103152|524168534|FG002|Overall Study|Unacceptable side effects|0|||
145360487|NCT03103152|524168535|FG003|Overall Study|Unacceptable side effects|0|||
145360488|NCT03103152|524168536|FG004|Overall Study|Unacceptable side effects|0|||
145360489|NCT03103152|524168537|FG005|Overall Study|Unacceptable side effects|1|||
145360490|NCT03103152|524168532|FG000|Overall Study|Lost to Follow-up|0|||
145360491|NCT03103152|524168533|FG001|Overall Study|Lost to Follow-up|1|||
145360492|NCT03103152|524168534|FG002|Overall Study|Lost to Follow-up|0|||
145360493|NCT03103152|524168535|FG003|Overall Study|Lost to Follow-up|1|||
145360494|NCT03103152|524168536|FG004|Overall Study|Lost to Follow-up|0|||
145360495|NCT03103152|524168537|FG005|Overall Study|Lost to Follow-up|1|||
145360496|NCT03103152|524168532|FG000|Overall Study|Testicular pain|0|||
145360497|NCT03103152|524168533|FG001|Overall Study|Testicular pain|0|||
145360498|NCT03103152|524168534|FG002|Overall Study|Testicular pain|0|||
145360499|NCT03103152|524168535|FG003|Overall Study|Testicular pain|1|||
145360500|NCT03103152|524168536|FG004|Overall Study|Testicular pain|0|||
145360501|NCT03103152|524168537|FG005|Overall Study|Testicular pain|0|||
145360502|NCT03100903|524170496|FG000|Overall Study|Withdrawal by Subject|0|||
145360503|NCT03100903|524170497|FG001|Overall Study|Withdrawal by Subject|0|||
145360504|NCT03100903|524170498|FG002|Overall Study|Withdrawal by Subject|1|||
145360505|NCT04659993|524170499|FG000|Overall Study|Withdrawal by Subject|2|||
145360506|NCT04659993|524170499|FG000|Overall Study|Lost to Follow-up|2|||
145360507|NCT00298272|524170500|FG000|Double-blind Phase|Adverse Event|2|||
145360508|NCT00298272|524170501|FG001|Double-blind Phase|Adverse Event|0|||
145360509|NCT00298272|524170500|FG000|Double-blind Phase|Failure to Return|2|||
145577534|NCT02391948|524969425|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
145360510|NCT00298272|524170501|FG001|Double-blind Phase|Failure to Return|0|||
145360511|NCT00298272|524170500|FG000|Double-blind Phase|Protocol Violation|2|||
145360512|NCT00298272|524170501|FG001|Double-blind Phase|Protocol Violation|0|||
145360513|NCT00298272|524170500|FG000|Double-blind Phase|Withdrawal by Subject|2|||
145360514|NCT00298272|524170501|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145360515|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Adverse Event|1|||
145360516|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Adverse Event|2|||
145360517|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
145360518|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
145360519|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Failure to Return|1|||
145360520|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Failure to Return|0|||
145360521|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
145360522|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
145360523|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
145360524|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
145360525|NCT00298272|524170500|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
145360526|NCT00298272|524170501|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
145360527|NCT00298272|524170500|FG000|Safety Follow-up Phase|Failure to Return|1|||
145360528|NCT00298272|524170501|FG001|Safety Follow-up Phase|Failure to Return|1|||
145360529|NCT00298272|524170500|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
145360530|NCT00298272|524170501|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
145360531|NCT00298272|524170500|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
145360532|NCT00298272|524170501|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
145360533|NCT00915018|524170502|FG000|Overall Study|Death|75|||
145360534|NCT00915018|524170503|FG001|Overall Study|Death|70|||
145360535|NCT00915018|524170502|FG000|Overall Study|Lost to Follow-up|10|||
145360536|NCT00915018|524170503|FG001|Overall Study|Lost to Follow-up|5|||
145360537|NCT00915018|524170502|FG000|Overall Study|Withdrawal by Subject|38|||
145360538|NCT00915018|524170503|FG001|Overall Study|Withdrawal by Subject|27|||
145360539|NCT00915018|524170502|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
145360540|NCT00915018|524170503|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
145360541|NCT00457002|524170504|FG000|Overall Study|Death|40|||
145360542|NCT00457002|524170505|FG001|Overall Study|Death|47|||
145360543|NCT00457002|524170504|FG000|Overall Study|Adverse Event|284|||
145360544|NCT00457002|524170505|FG001|Overall Study|Adverse Event|260|||
145360545|NCT00457002|524170504|FG000|Overall Study|Withdrawal by Subject|299|||
145360546|NCT00457002|524170505|FG001|Overall Study|Withdrawal by Subject|271|||
145360547|NCT00457002|524170504|FG000|Overall Study|Lost to Follow-up|72|||
145360548|NCT00457002|524170505|FG001|Overall Study|Lost to Follow-up|71|||
145360549|NCT00457002|524170504|FG000|Overall Study|Poor/Non-compliance|46|||
145360550|NCT00457002|524170505|FG001|Overall Study|Poor/Non-compliance|33|||
145360551|NCT00457002|524170504|FG000|Overall Study|No longer met criteria|41|||
145360552|NCT00457002|524170505|FG001|Overall Study|No longer met criteria|37|||
145360553|NCT00457002|524170504|FG000|Overall Study|Administrative reason by Sponsor|1|||
145360554|NCT00457002|524170505|FG001|Overall Study|Administrative reason by Sponsor|0|||
145360555|NCT00457002|524170504|FG000|Overall Study|non-specified|29|||
145360556|NCT00457002|524170505|FG001|Overall Study|non-specified|38|||
145360557|NCT00457002|524170504|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
145360558|NCT00457002|524170505|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
145360559|NCT04168112|524170506|FG000|Overall Study|Lost to Follow-up|1|||
145360560|NCT04168112|524170507|FG001|Overall Study|Lost to Follow-up|0|||
145360561|NCT04168112|524170506|FG000|Overall Study|Withdrawal by Subject|1|||
145360562|NCT04168112|524170507|FG001|Overall Study|Withdrawal by Subject|0|||
145360563|NCT00833105|524170508|FG000|Overall Study|Withdrawal by Subject|1|||
145360564|NCT00833105|524170508|FG000|Overall Study|Adverse Event|2|||
145360565|NCT02898597|524170509|FG000|Overall Study|Protocol Violation|4|||
145360566|NCT02898597|524170510|FG001|Overall Study|Protocol Violation|2|||
145360567|NCT02898597|524170509|FG000|Overall Study|Lost to Follow-up|0|||
145360568|NCT02898597|524170510|FG001|Overall Study|Lost to Follow-up|9|||
145360569|NCT02898597|524170509|FG000|Overall Study|Death|0|||
145360570|NCT02898597|524170510|FG001|Overall Study|Death|1|||
145360571|NCT03656068|524170511|FG000|Overall Study|Withdrawal by Subject|4|||
145360572|NCT03656068|524170511|FG000|Overall Study|Adverse Event|1|||
145360573|NCT00154284|524170512|FG000|Overall Study|Adverse Event|6|||
145360574|NCT00154284|524170513|FG001|Overall Study|Adverse Event|9|||
145360575|NCT00154284|524170512|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145360576|NCT00154284|524170513|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145360577|NCT00154284|524170512|FG000|Overall Study|Lack of Efficacy|1|||
145360578|NCT00154284|524170513|FG001|Overall Study|Lack of Efficacy|2|||
145360579|NCT00154284|524170512|FG000|Overall Study|Protocol Violation|0|||
145360580|NCT00154284|524170513|FG001|Overall Study|Protocol Violation|1|||
145360581|NCT00326716|524170514|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
145360582|NCT00326716|524170515|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
145360583|NCT00326716|524170516|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
145360584|NCT00326716|524170517|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
145360585|NCT00684411|524170518|FG000|Overall Study|New Primary Cancer|1|||
145360586|NCT00684411|524170518|FG000|Overall Study|Disease Progression|10|||
145623144|NCT02240680|525131599|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
145360587|NCT00684411|524170518|FG000|Overall Study|Adverse Event|1|||
145623145|NCT02240680|525131600|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
145360588|NCT05253573|524170519|FG000|Overall Study|Death|1|||
145360589|NCT05253573|524170520|FG001|Overall Study|Death|0|||
145360590|NCT01344824|524170521|FG000|Overall Study|Adverse Event|15|||
145360591|NCT01344824|524170521|FG000|Overall Study|Withdrawal by Subject|6|||
145360592|NCT01344824|524170521|FG000|Overall Study|Other complicating disease|1|||
145360593|NCT01344824|524170521|FG000|Overall Study|Progression|15|||
145360594|NCT01085630|524170526|FG000|Overall Study|Insufficient data|1|||
145360595|NCT01085630|524170527|FG001|Overall Study|Insufficient data|0|||
145360596|NCT01085630|524170526|FG000|Overall Study|Ineligible|3|||
145360597|NCT01085630|524170527|FG001|Overall Study|Ineligible|0|||
145360598|NCT02366637|524170533|FG000|First Intervention Period|Adverse Event|0|||
145360599|NCT02366637|524170534|FG001|First Intervention Period|Adverse Event|1|||
145360600|NCT02366637|524170533|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
145360601|NCT02366637|524170534|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
145360602|NCT02366637|524170533|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
145360603|NCT02366637|524170534|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
145360604|NCT02609607|524170535|FG000|Overall Study|Lost to Follow-up|0|||
145360605|NCT02609607|524170536|FG001|Overall Study|Lost to Follow-up|1|||
145360606|NCT02027545|524170542|FG000|Overall Study|Failed to sign HIPAA|0|||
145360607|NCT02027545|524170543|FG001|Overall Study|Failed to sign HIPAA|2|||
145360608|NCT02027545|524170542|FG000|Overall Study|Failed to attend study visit|2|||
145360609|NCT02027545|524170543|FG001|Overall Study|Failed to attend study visit|0|||
145360610|NCT02027545|524170542|FG000|Overall Study|Protocol Violation|1|||
145360611|NCT02027545|524170543|FG001|Overall Study|Protocol Violation|0|||
145360612|NCT02356588|524170549|FG000|Overall Study|Lack of Efficacy|4|||
145360613|NCT02356588|524170550|FG001|Overall Study|Lack of Efficacy|10|||
145360614|NCT02356588|524170549|FG000|Overall Study|Adverse Event|0|||
145360615|NCT02356588|524170550|FG001|Overall Study|Adverse Event|2|||
145360616|NCT02356588|524170549|FG000|Overall Study|Withdrawal by Subject|1|||
145360617|NCT02356588|524170550|FG001|Overall Study|Withdrawal by Subject|0|||
145360618|NCT02356588|524170549|FG000|Overall Study|Protocol Violation|0|||
145360619|NCT02356588|524170550|FG001|Overall Study|Protocol Violation|1|||
145360620|NCT01418378|524170551|FG000|Overall Study|Death|1|||
145360621|NCT01418378|524170552|FG001|Overall Study|Death|2|||
145360622|NCT01418378|524170551|FG000|Overall Study|Physician Decision|0|||
145360623|NCT01418378|524170552|FG001|Overall Study|Physician Decision|1|||
145360624|NCT01418378|524170551|FG000|Overall Study|ligament imbalance|0|||
145360625|NCT01418378|524170552|FG001|Overall Study|ligament imbalance|1|||
145360626|NCT01418378|524170551|FG000|Overall Study|developed chronic myopathy|0|||
145360627|NCT01418378|524170552|FG001|Overall Study|developed chronic myopathy|1|||
145360628|NCT03150719|524170555|FG000|Overall Study|Adverse Event|0|||
145360629|NCT03150719|524170556|FG001|Overall Study|Adverse Event|1|||
145360630|NCT03150719|524170555|FG000|Overall Study|Death|0|||
145360631|NCT03150719|524170556|FG001|Overall Study|Death|1|||
145360632|NCT03150719|524170555|FG000|Overall Study|Other|1|||
145360633|NCT03150719|524170556|FG001|Overall Study|Other|0|||
145360634|NCT01790984|524170557|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
145360635|NCT01790984|524170558|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
145360636|NCT01790984|524170559|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
145360637|NCT01790984|524170560|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
145360638|NCT01051791|524170564|FG000|Overall Study|Failed screening|3|||
145360639|NCT01051791|524170564|FG000|Overall Study|Withdrawal by Subject|1|||
145360640|NCT00288626|524170571|FG000|Overall Study|Death|3|||
145360641|NCT00288626|524170571|FG000|Overall Study|Withdrawal by Subject|4|||
145360642|NCT04610346|524170573|FG000|Overall Study|Withdrawal by Subject|1|||
145360643|NCT04610346|524170574|FG001|Overall Study|Withdrawal by Subject|1|||
145360644|NCT04610346|524170573|FG000|Overall Study|did not complete shelter onboarding|2|||
145360645|NCT04610346|524170574|FG001|Overall Study|did not complete shelter onboarding|1|||
145360646|NCT00558467|524170576|FG000|Overall Study|Adverse Event|1|||
145360647|NCT00558467|524170577|FG001|Overall Study|Adverse Event|2|||
145360648|NCT00558467|524170576|FG000|Overall Study|Lack of Efficacy|0|||
145360649|NCT00558467|524170577|FG001|Overall Study|Lack of Efficacy|1|||
145360650|NCT00558467|524170576|FG000|Overall Study|Patient moving out of state|0|||
145360651|NCT00558467|524170577|FG001|Overall Study|Patient moving out of state|1|||
145360652|NCT00931255|524170578|FG000|Overall Study|Follow up biopsy not done|2|||
145360653|NCT00931255|524170579|FG001|Overall Study|Follow up biopsy not done|3|||
145360654|NCT01372995|524170580|FG000|Overall Study|Spouse withdrew participant from study|0|||
145360655|NCT01372995|524170581|FG001|Overall Study|Spouse withdrew participant from study|1|||
145360656|NCT01372995|524170582|FG002|Overall Study|Spouse withdrew participant from study|0|||
145360657|NCT01372995|524170580|FG000|Overall Study|Physician Decision|0|||
145360658|NCT01372995|524170581|FG001|Overall Study|Physician Decision|0|||
145360659|NCT01372995|524170582|FG002|Overall Study|Physician Decision|1|||
145360660|NCT01684423|524170594|FG000|Overall Study|Withdrawal by Subject|0|||
145360661|NCT01684423|524170595|FG001|Overall Study|Withdrawal by Subject|0|||
145360662|NCT01684423|524170596|FG002|Overall Study|Withdrawal by Subject|1|||
145360663|NCT01684423|524170597|FG003|Overall Study|Withdrawal by Subject|0|||
145360664|NCT01684423|524170598|FG004|Overall Study|Withdrawal by Subject|0|||
145360665|NCT04157348|524170601|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
145360666|NCT04157348|524170602|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
145360667|NCT04157348|524170601|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145360668|NCT04157348|524170602|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145360669|NCT04157348|524170601|FG000|Double-blind Treatment Period|Adverse Event|0|||
145360670|NCT04157348|524170602|FG001|Double-blind Treatment Period|Adverse Event|1|||
145360671|NCT04157348|524170601|FG000|Open-label Extension Period|Adverse Event|1|||
145360672|NCT04157348|524170602|FG001|Open-label Extension Period|Adverse Event|1|||
145360673|NCT04157348|524170601|FG000|Open-label Extension Period|Death|0|||
145360674|NCT04157348|524170602|FG001|Open-label Extension Period|Death|1|||
145360675|NCT04157348|524170601|FG000|Open-label Extension Period|Lack of Efficacy|2|||
145360676|NCT04157348|524170602|FG001|Open-label Extension Period|Lack of Efficacy|2|||
145360677|NCT04157348|524170601|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
145360678|NCT04157348|524170602|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
145360679|NCT04157348|524170601|FG000|Open-label Extension Period|Ongoing|60|||
145360680|NCT04157348|524170602|FG001|Open-label Extension Period|Ongoing|57|||
145360681|NCT04157348|524170601|FG000|Open-label Extension Period|other reasons|1|||
145360682|NCT04157348|524170602|FG001|Open-label Extension Period|other reasons|1|||
145360683|NCT00568061|524170603|FG000|Overall Study|Inclusion / exclusion criteria|5|||
145360684|NCT00568061|524170604|FG001|Overall Study|Inclusion / exclusion criteria|1|||
145360685|NCT00568061|524170603|FG000|Overall Study|Adverse Event|0|||
145360686|NCT00568061|524170604|FG001|Overall Study|Adverse Event|1|||
145360687|NCT00529308|524170606|FG000|Overall Study|Withdrawal by Subject|1|||
145360688|NCT00529308|524170607|FG001|Overall Study|Withdrawal by Subject|1|||
145360689|NCT02693002|524170608|FG000|Overall Study|Withdrawal by Subject|1|||
145360690|NCT02693002|524170609|FG001|Overall Study|Withdrawal by Subject|0|||
145360691|NCT00812981|524170610|FG000|Overall Study|Other|0|||
145360692|NCT00812981|524170611|FG001|Overall Study|Other|1|||
145360693|NCT04666259|524170614|FG000|Treatment Phase|Physician Decision|9|||
145360694|NCT04666259|524170615|FG001|Treatment Phase|Physician Decision|3|||
145360695|NCT04666259|524170616|FG002|Treatment Phase|Physician Decision|3|||
145360696|NCT04666259|524170614|FG000|Treatment Phase|Adverse Event|3|||
145360697|NCT04666259|524170615|FG001|Treatment Phase|Adverse Event|1|||
145360698|NCT04666259|524170616|FG002|Treatment Phase|Adverse Event|0|||
145360699|NCT04666259|524170614|FG000|Treatment Phase|Subject decision|1|||
145360700|NCT04666259|524170615|FG001|Treatment Phase|Subject decision|2|||
145360701|NCT04666259|524170616|FG002|Treatment Phase|Subject decision|0|||
145360702|NCT04666259|524170614|FG000|Treatment Phase|Progressive disease|0|||
145360703|NCT04666259|524170615|FG001|Treatment Phase|Progressive disease|1|||
145360704|NCT04666259|524170616|FG002|Treatment Phase|Progressive disease|0|||
145360705|NCT04666259|524170614|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
145360706|NCT04666259|524170615|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
145360707|NCT04666259|524170616|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
145360708|NCT04666259|524170614|FG000|Safety Follow-up Phase|Physician Decision|2|||
145360709|NCT04666259|524170615|FG001|Safety Follow-up Phase|Physician Decision|0|||
145360710|NCT04666259|524170616|FG002|Safety Follow-up Phase|Physician Decision|0|||
145360711|NCT04666259|524170614|FG000|Safety Follow-up Phase|Subject decision|1|||
145360712|NCT04666259|524170615|FG001|Safety Follow-up Phase|Subject decision|0|||
145360713|NCT04666259|524170616|FG002|Safety Follow-up Phase|Subject decision|0|||
145360714|NCT04666259|524170614|FG000|Safety Follow-up Phase|Death|0|||
145360715|NCT04666259|524170615|FG001|Safety Follow-up Phase|Death|1|||
145360716|NCT04666259|524170616|FG002|Safety Follow-up Phase|Death|0|||
145360717|NCT02677922|524170617|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
145360718|NCT02677922|524170618|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
145360719|NCT02677922|524170619|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
145360720|NCT02677922|524170620|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
145360721|NCT02677922|524170621|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
145360722|NCT02677922|524170622|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
145360723|NCT02677922|524170617|FG000|Treatment Period|Adverse Event|0|||
145360724|NCT02677922|524170618|FG001|Treatment Period|Adverse Event|0|||
145360725|NCT02677922|524170619|FG002|Treatment Period|Adverse Event|1|||
145360726|NCT02677922|524170620|FG003|Treatment Period|Adverse Event|3|||
145360727|NCT02677922|524170621|FG004|Treatment Period|Adverse Event|5|||
145360728|NCT02677922|524170622|FG005|Treatment Period|Adverse Event|2|||
145360729|NCT02677922|524170617|FG000|Treatment Period|Progressive Disease|1|||
145360730|NCT02677922|524170618|FG001|Treatment Period|Progressive Disease|1|||
145360731|NCT02677922|524170619|FG002|Treatment Period|Progressive Disease|0|||
145360732|NCT02677922|524170620|FG003|Treatment Period|Progressive Disease|0|||
145360733|NCT02677922|524170621|FG004|Treatment Period|Progressive Disease|8|||
145360734|NCT02677922|524170622|FG005|Treatment Period|Progressive Disease|7|||
145360735|NCT02677922|524170617|FG000|Treatment Period|Lack of Efficacy|0|||
145360736|NCT02677922|524170618|FG001|Treatment Period|Lack of Efficacy|0|||
145418897|NCT05660538|524388619|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
145360737|NCT02677922|524170619|FG002|Treatment Period|Lack of Efficacy|0|||
145360738|NCT02677922|524170620|FG003|Treatment Period|Lack of Efficacy|1|||
145360739|NCT02677922|524170621|FG004|Treatment Period|Lack of Efficacy|1|||
145360740|NCT02677922|524170622|FG005|Treatment Period|Lack of Efficacy|6|||
145360741|NCT02677922|524170617|FG000|Treatment Period|Withdrawal by Subject|0|||
145360742|NCT02677922|524170618|FG001|Treatment Period|Withdrawal by Subject|0|||
145360743|NCT02677922|524170619|FG002|Treatment Period|Withdrawal by Subject|1|||
145360744|NCT02677922|524170620|FG003|Treatment Period|Withdrawal by Subject|3|||
145360745|NCT02677922|524170621|FG004|Treatment Period|Withdrawal by Subject|5|||
145360746|NCT02677922|524170622|FG005|Treatment Period|Withdrawal by Subject|5|||
145360747|NCT02677922|524170617|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
145360748|NCT02677922|524170618|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
145360749|NCT02677922|524170619|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
145360750|NCT02677922|524170620|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
145360751|NCT02677922|524170621|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
145360752|NCT02677922|524170622|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
145360753|NCT02677922|524170617|FG000|Treatment Period|Disease Relapse|0|||
145360754|NCT02677922|524170618|FG001|Treatment Period|Disease Relapse|0|||
145360755|NCT02677922|524170619|FG002|Treatment Period|Disease Relapse|0|||
145360756|NCT02677922|524170620|FG003|Treatment Period|Disease Relapse|3|||
145360757|NCT02677922|524170621|FG004|Treatment Period|Disease Relapse|6|||
145360758|NCT02677922|524170622|FG005|Treatment Period|Disease Relapse|1|||
145360759|NCT02677922|524170617|FG000|Treatment Period|Allogeneic HSCT|1|||
145360760|NCT02677922|524170618|FG001|Treatment Period|Allogeneic HSCT|0|||
145360761|NCT02677922|524170619|FG002|Treatment Period|Allogeneic HSCT|0|||
145360762|NCT02677922|524170620|FG003|Treatment Period|Allogeneic HSCT|1|||
145360763|NCT02677922|524170621|FG004|Treatment Period|Allogeneic HSCT|4|||
145360764|NCT02677922|524170622|FG005|Treatment Period|Allogeneic HSCT|1|||
145360765|NCT02677922|524170617|FG000|Treatment Period|Other Reasons|0|||
145360766|NCT02677922|524170618|FG001|Treatment Period|Other Reasons|0|||
145360767|NCT02677922|524170619|FG002|Treatment Period|Other Reasons|0|||
145360768|NCT02677922|524170620|FG003|Treatment Period|Other Reasons|1|||
145360769|NCT02677922|524170621|FG004|Treatment Period|Other Reasons|3|||
145360770|NCT02677922|524170622|FG005|Treatment Period|Other Reasons|5|||
145360771|NCT02677922|524170617|FG000|Treatment Period|Death|0|||
145360772|NCT02677922|524170618|FG001|Treatment Period|Death|0|||
145360773|NCT02677922|524170619|FG002|Treatment Period|Death|0|||
145360774|NCT02677922|524170620|FG003|Treatment Period|Death|0|||
145360775|NCT02677922|524170621|FG004|Treatment Period|Death|12|||
145360776|NCT02677922|524170622|FG005|Treatment Period|Death|1|||
145360777|NCT02677922|524170617|FG000|Treatment Period|Non-compliance with Study Drug|0|||
145360778|NCT02677922|524170618|FG001|Treatment Period|Non-compliance with Study Drug|0|||
145360779|NCT02677922|524170619|FG002|Treatment Period|Non-compliance with Study Drug|0|||
145360780|NCT02677922|524170620|FG003|Treatment Period|Non-compliance with Study Drug|0|||
145360781|NCT02677922|524170621|FG004|Treatment Period|Non-compliance with Study Drug|1|||
145360782|NCT02677922|524170622|FG005|Treatment Period|Non-compliance with Study Drug|0|||
145360783|NCT02677922|524170617|FG000|Treatment Period|Physician Decision|0|||
145360784|NCT02677922|524170618|FG001|Treatment Period|Physician Decision|0|||
145360785|NCT02677922|524170619|FG002|Treatment Period|Physician Decision|0|||
145360786|NCT02677922|524170620|FG003|Treatment Period|Physician Decision|0|||
145360787|NCT02677922|524170621|FG004|Treatment Period|Physician Decision|0|||
145360788|NCT02677922|524170622|FG005|Treatment Period|Physician Decision|1|||
145360789|NCT02677922|524170617|FG000|Treatment Period|Symptomatic Deterioration|0|||
145360790|NCT02677922|524170618|FG001|Treatment Period|Symptomatic Deterioration|0|||
145360791|NCT02677922|524170619|FG002|Treatment Period|Symptomatic Deterioration|0|||
145360792|NCT02677922|524170620|FG003|Treatment Period|Symptomatic Deterioration|0|||
145360793|NCT02677922|524170621|FG004|Treatment Period|Symptomatic Deterioration|1|||
145360794|NCT02677922|524170622|FG005|Treatment Period|Symptomatic Deterioration|0|||
145360795|NCT05343364|524170624|FG000|Overall Study|Miscellaneous|0|||
145360796|NCT05343364|524170625|FG001|Overall Study|Miscellaneous|1|||
145360797|NCT03331796|524170626|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
145360798|NCT03331796|524170627|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
145360799|NCT03331796|524170628|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
145360800|NCT03331796|524170626|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
145360801|NCT03331796|524170627|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
145360802|NCT03331796|524170628|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
145360803|NCT03331796|524170626|FG000|Extended Follow-up|Adverse Event|1|||
145577535|NCT02391948|524969426|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
145577536|NCT02391948|524969427|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
145577537|NCT02391948|524969428|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
145577538|NCT02391948|524969429|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
145360804|NCT03331796|524170627|FG001|Extended Follow-up|Adverse Event|0|||
145360805|NCT03331796|524170628|FG002|Extended Follow-up|Adverse Event|1|||
145360806|NCT03331796|524170626|FG000|Extended Follow-up|Lost to Follow-up|0|||
145360807|NCT03331796|524170627|FG001|Extended Follow-up|Lost to Follow-up|0|||
145360808|NCT03331796|524170628|FG002|Extended Follow-up|Lost to Follow-up|1|||
145360809|NCT03331796|524170626|FG000|Extended Follow-up|Withdrawal by Subject|1|||
145360810|NCT03331796|524170627|FG001|Extended Follow-up|Withdrawal by Subject|0|||
145360811|NCT03331796|524170628|FG002|Extended Follow-up|Withdrawal by Subject|0|||
145360812|NCT03331796|524170626|FG000|Extended Follow-up|Termination of Funding|0|||
145360813|NCT03331796|524170627|FG001|Extended Follow-up|Termination of Funding|1|||
145360814|NCT03331796|524170628|FG002|Extended Follow-up|Termination of Funding|0|||
145360815|NCT00996125|524170633|FG000|Overall Study|Adverse Event|0|||
145360816|NCT00996125|524170634|FG001|Overall Study|Adverse Event|2|||
145360817|NCT00996125|524170633|FG000|Overall Study|Lost to Follow-up|1|||
145360818|NCT00996125|524170634|FG001|Overall Study|Lost to Follow-up|6|||
145360819|NCT00996125|524170633|FG000|Overall Study|Withdrawal by Subject|4|||
145360820|NCT00996125|524170634|FG001|Overall Study|Withdrawal by Subject|3|||
145360821|NCT00488644|524170636|FG000|Overall Study|Not Eligible|1|||
145360822|NCT00488644|524170636|FG000|Overall Study|Not Evaluable|1|||
145360823|NCT04331067|524170637|FG000|Overall Study|Adverse Event|1|||
145360824|NCT04331067|524170638|FG001|Overall Study|Adverse Event|3|||
145360825|NCT04331067|524170639|FG002|Overall Study|Adverse Event|1|||
145360826|NCT04331067|524170637|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
145360827|NCT04331067|524170638|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
145360828|NCT04331067|524170639|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
145360829|NCT04745689|524170644|FG000|Overall Study|Death|9|||
145360830|NCT04745689|524170645|FG001|Overall Study|Death|6|||
145360831|NCT04745689|524170644|FG000|Overall Study|Lost to Follow-up|1|||
145360832|NCT04745689|524170645|FG001|Overall Study|Lost to Follow-up|0|||
145360833|NCT04745689|524170644|FG000|Overall Study|Withdrawal by Subject|2|||
145360834|NCT04745689|524170645|FG001|Overall Study|Withdrawal by Subject|0|||
145360835|NCT04745689|524170644|FG000|Overall Study|Study terminated by sponsor|10|||
145360836|NCT04745689|524170645|FG001|Overall Study|Study terminated by sponsor|3|||
145360837|NCT00153179|524170646|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
145360838|NCT00153179|524170647|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
145360839|NCT00153179|524170648|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
145360840|NCT00153179|524170649|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
145360841|NCT01408303|524170650|FG000|Overall Study|Adverse Event|3|||
145360842|NCT01408303|524170651|FG001|Overall Study|Adverse Event|7|||
145360843|NCT01408303|524170652|FG002|Overall Study|Adverse Event|2|||
145360844|NCT01408303|524170650|FG000|Overall Study|Lost to Follow-up|0|||
145360845|NCT01408303|524170651|FG001|Overall Study|Lost to Follow-up|1|||
145360846|NCT01408303|524170652|FG002|Overall Study|Lost to Follow-up|2|||
145360847|NCT01408303|524170650|FG000|Overall Study|Withdrawal by Subject|2|||
145360848|NCT01408303|524170651|FG001|Overall Study|Withdrawal by Subject|3|||
145360849|NCT01408303|524170652|FG002|Overall Study|Withdrawal by Subject|1|||
145360850|NCT01408303|524170650|FG000|Overall Study|Protocol Violation|0|||
145360851|NCT01408303|524170651|FG001|Overall Study|Protocol Violation|1|||
145360852|NCT01408303|524170652|FG002|Overall Study|Protocol Violation|0|||
145360853|NCT01408303|524170650|FG000|Overall Study|Noncompliance|1|||
145360854|NCT01408303|524170651|FG001|Overall Study|Noncompliance|0|||
145360855|NCT01408303|524170652|FG002|Overall Study|Noncompliance|1|||
145360856|NCT00669669|524170653|FG000|Overall Study|To late to start treatment|1|||
145360857|NCT01205776|524170657|FG000|Overall Study|Lost to Follow-up|53|||
145360858|NCT01205776|524170658|FG001|Overall Study|Lost to Follow-up|61|||
145360859|NCT01205776|524170657|FG000|Overall Study|Withdrawal by Subject|11|||
145360860|NCT01205776|524170658|FG001|Overall Study|Withdrawal by Subject|34|||
145360861|NCT04031846|524170659|FG000|Overall Study|Lost to Follow-up|4|||
145360862|NCT04031846|524170660|FG001|Overall Study|Lost to Follow-up|4|||
145360863|NCT04031846|524170659|FG000|Overall Study|Physician Decision|0|||
145360864|NCT04031846|524170660|FG001|Overall Study|Physician Decision|1|||
145360865|NCT04031846|524170659|FG000|Overall Study|Protocol Violation|1|||
145360866|NCT04031846|524170660|FG001|Overall Study|Protocol Violation|1|||
145360867|NCT04031846|524170659|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
145360868|NCT04031846|524170660|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
145360869|NCT03782792|524172550|FG000|Overall Study|Patient left the country|0|||
145360870|NCT03782792|524172551|FG001|Overall Study|Patient left the country|1|||
145360871|NCT03782792|524172550|FG000|Overall Study|Withdrawal by Subject|1|||
145360872|NCT03782792|524172551|FG001|Overall Study|Withdrawal by Subject|2|||
145360873|NCT05271370|524172552|FG000|Overall Study|Study early termination|8|||
145360874|NCT05271370|524172553|FG001|Overall Study|Study early termination|16|||
145418898|NCT01125748|524388621|FG000|Overall Study|Adverse Event|0|||
145623146|NCT02240680|525131601|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
145360875|NCT05271370|524172554|FG002|Overall Study|Study early termination|29|||
145360876|NCT03048747|524172556|FG000|Overall Study|Adverse Event|2|||
145360877|NCT03048747|524172556|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
145360878|NCT03048747|524172556|FG000|Overall Study|Physician Decision|1|||
145360879|NCT01295671|524172563|FG000|Overall Study|Lost to Follow-up|4|||
145360880|NCT01295671|524172564|FG001|Overall Study|Lost to Follow-up|6|||
145360881|NCT01295671|524172565|FG002|Overall Study|Lost to Follow-up|3|||
145360882|NCT01295671|524172563|FG000|Overall Study|Withdrawal by Subject|3|||
145360883|NCT01295671|524172564|FG001|Overall Study|Withdrawal by Subject|1|||
145360884|NCT01295671|524172565|FG002|Overall Study|Withdrawal by Subject|0|||
145360885|NCT01436370|524172568|FG000|Overall Study|Lost to Follow-up|0|||
145360886|NCT01436370|524172569|FG001|Overall Study|Lost to Follow-up|0|||
145360887|NCT01436370|524172570|FG002|Overall Study|Lost to Follow-up|0|||
145360888|NCT01436370|524172571|FG003|Overall Study|Lost to Follow-up|0|||
145360889|NCT01436370|524172572|FG004|Overall Study|Lost to Follow-up|1|||
145360890|NCT01436370|524172573|FG005|Overall Study|Lost to Follow-up|0|||
145360891|NCT01436370|524172574|FG006|Overall Study|Lost to Follow-up|0|||
145360892|NCT01436370|524172575|FG007|Overall Study|Lost to Follow-up|0|||
145360893|NCT02395848|524172576|FG000|Overall Study|Lost to Follow-up|2|||
145360894|NCT02276560|524172577|FG000|Overall Study|Adverse Event|1|||
145360895|NCT02276560|524172578|FG001|Overall Study|Adverse Event|0|||
145360896|NCT02276560|524172579|FG002|Overall Study|Adverse Event|0|||
145360897|NCT01754129|524172580|FG000|Overall Study|Death|13|||
145360898|NCT01754129|524172580|FG000|Overall Study|Duodopa discontinuation|9|||
145360899|NCT01754129|524172580|FG000|Overall Study|Lost to Follow-up|7|||
145360900|NCT01754129|524172580|FG000|Overall Study|Withdrew consent|1|||
145360901|NCT01754129|524172580|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
145360902|NCT00651261|524172582|FG000|Overall Study|Adverse Event|32|||
145360903|NCT00651261|524172583|FG001|Overall Study|Adverse Event|22|||
145360904|NCT00651261|524172582|FG000|Overall Study|Death|18|||
145360905|NCT00651261|524172583|FG001|Overall Study|Death|18|||
145360906|NCT00651261|524172582|FG000|Overall Study|Withdrawal by Subject|22|||
145360907|NCT00651261|524172583|FG001|Overall Study|Withdrawal by Subject|40|||
145360908|NCT00651261|524172582|FG000|Overall Study|Induction failure|24|||
145360909|NCT00651261|524172583|FG001|Overall Study|Induction failure|35|||
145360910|NCT00651261|524172582|FG000|Overall Study|Disease progression|58|||
145360911|NCT00651261|524172583|FG001|Overall Study|Disease progression|58|||
145360912|NCT00651261|524172582|FG000|Overall Study|Alternative therapy|109|||
145360913|NCT00651261|524172583|FG001|Overall Study|Alternative therapy|107|||
145360914|NCT00651261|524172582|FG000|Overall Study|Other disease or participant decisions|23|||
145360915|NCT00651261|524172583|FG001|Overall Study|Other disease or participant decisions|23|||
145360916|NCT00651261|524172582|FG000|Overall Study|Never treated|5|||
145360917|NCT00651261|524172583|FG001|Overall Study|Never treated|3|||
145360918|NCT00687271|524172584|FG000|Overall Study|Adverse Event|1|||
145360919|NCT00687271|524172585|FG001|Overall Study|Adverse Event|3|||
145360920|NCT00687271|524172586|FG002|Overall Study|Adverse Event|1|||
145360921|NCT00687271|524172587|FG003|Overall Study|Adverse Event|0|||
145360922|NCT00687271|524172584|FG000|Overall Study|Lost to Follow-up|0|||
145360923|NCT00687271|524172585|FG001|Overall Study|Lost to Follow-up|1|||
145360924|NCT00687271|524172586|FG002|Overall Study|Lost to Follow-up|0|||
145360925|NCT00687271|524172587|FG003|Overall Study|Lost to Follow-up|0|||
145360926|NCT00687271|524172584|FG000|Overall Study|Protocol Violation|2|||
145360927|NCT00687271|524172585|FG001|Overall Study|Protocol Violation|1|||
145360928|NCT00687271|524172586|FG002|Overall Study|Protocol Violation|1|||
145360929|NCT00687271|524172587|FG003|Overall Study|Protocol Violation|0|||
145360930|NCT00687271|524172584|FG000|Overall Study|Withdrawal by Subject|0|||
145360931|NCT00687271|524172585|FG001|Overall Study|Withdrawal by Subject|1|||
145360932|NCT00687271|524172586|FG002|Overall Study|Withdrawal by Subject|3|||
145360933|NCT00687271|524172587|FG003|Overall Study|Withdrawal by Subject|0|||
145360934|NCT01134107|524172588|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
145360935|NCT01134107|524172589|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
145360936|NCT01134107|524172588|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
145360937|NCT01134107|524172589|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
145360938|NCT01134107|524172588|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
145360939|NCT01134107|524172589|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
145360940|NCT01134107|524172588|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
145360941|NCT01134107|524172589|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
145360942|NCT01134107|524172588|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
145360943|NCT01134107|524172589|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
145360944|NCT01134107|524172588|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
145360945|NCT01134107|524172589|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
145360946|NCT01134107|524172588|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
145360947|NCT01134107|524172589|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
145360948|NCT05483686|524172591|FG000|Overall Study|Lost to Follow-up|5|||
145360949|NCT05483686|524172592|FG001|Overall Study|Lost to Follow-up|7|||
145360950|NCT05780983|524172593|FG000|Overall Study|Withdrawal by Subject|1|||
145360951|NCT04541589|524172594|FG000|Treatment Period|Adverse Event|8|||
145360952|NCT04541589|524172595|FG001|Treatment Period|Adverse Event|2|||
145360953|NCT04541589|524172594|FG000|Treatment Period|Physician Decision|3|||
145360954|NCT04541589|524172595|FG001|Treatment Period|Physician Decision|1|||
145360955|NCT04541589|524172594|FG000|Treatment Period|Subject decision|7|||
145360956|NCT04541589|524172595|FG001|Treatment Period|Subject decision|4|||
145360957|NCT04541589|524172594|FG000|Treatment Period|Withdrawal by Subject|1|||
145360958|NCT04541589|524172595|FG001|Treatment Period|Withdrawal by Subject|0|||
145360959|NCT04541589|524172594|FG000|Safety Follow-up Period|Adverse Event|2|||
145360960|NCT04541589|524172595|FG001|Safety Follow-up Period|Adverse Event|1|||
145360961|NCT04541589|524172594|FG000|Safety Follow-up Period|Physician Decision|1|||
145360962|NCT04541589|524172595|FG001|Safety Follow-up Period|Physician Decision|0|||
145418899|NCT01125748|524388622|FG001|Overall Study|Adverse Event|2|||
145360963|NCT04541589|524172594|FG000|Safety Follow-up Period|Subject decision|5|||
145360964|NCT04541589|524172595|FG001|Safety Follow-up Period|Subject decision|3|||
145360965|NCT04541589|524172594|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
145360966|NCT04541589|524172595|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
145360967|NCT02727478|524172596|FG000|Overall Study|Withdrawal by Subject|8|||
145360968|NCT02727478|524172597|FG001|Overall Study|Withdrawal by Subject|10|||
145360969|NCT02633293|524172598|FG000|Overall Study|Death|56|||
145360970|NCT02633293|524172598|FG000|Overall Study|Progressive Disease|12|||
145360971|NCT02633293|524172598|FG000|Overall Study|Adverse Event|29|||
145360972|NCT02633293|524172598|FG000|Overall Study|Withdrawal by Subject|41|||
145360973|NCT02633293|524172598|FG000|Overall Study|Protocol Violation|1|||
145360974|NCT02633293|524172598|FG000|Overall Study|Lost to Follow-up|1|||
145360975|NCT02633293|524172598|FG000|Overall Study|Study Terminated by Sponsor|24|||
145360976|NCT02633293|524172598|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
145360977|NCT02633293|524172598|FG000|Overall Study|Lung Transplant|5|||
145360978|NCT02633293|524172598|FG000|Overall Study|Lack of Efficacy|2|||
145360979|NCT02633293|524172598|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
145360980|NCT01017874|524172599|FG000|Overall Study|Withdrawal by Subject|23|||
145360981|NCT01017874|524172600|FG001|Overall Study|Withdrawal by Subject|20|||
145360982|NCT01017874|524172599|FG000|Overall Study|Sponsor decision|3|||
145360983|NCT01017874|524172600|FG001|Overall Study|Sponsor decision|1|||
145360984|NCT01017874|524172599|FG000|Overall Study|Lost to Follow-up|3|||
145360985|NCT01017874|524172600|FG001|Overall Study|Lost to Follow-up|2|||
145360986|NCT01017874|524172599|FG000|Overall Study|Physician Decision|1|||
145360987|NCT01017874|524172600|FG001|Overall Study|Physician Decision|3|||
145360988|NCT00808210|524172601|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
145360989|NCT00808210|524172602|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
145360990|NCT00808210|524172601|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
145360991|NCT00808210|524172602|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
145360992|NCT00808210|524172601|FG000|Double-Blind TX Period|Adverse Event|0|||
145360993|NCT00808210|524172602|FG001|Double-Blind TX Period|Adverse Event|1|||
145360994|NCT00808210|524172601|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
145360995|NCT00808210|524172602|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
145360996|NCT00808210|524172601|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
145360997|NCT00808210|524172602|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
145360998|NCT00808210|524172601|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
145360999|NCT00808210|524172602|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
145361000|NCT00778817|524172607|FG000|Overall Study|Adverse Event|2|||
145361001|NCT00778817|524172607|FG000|Overall Study|Withdrawal by Subject|2|||
145361002|NCT01372618|524172608|FG000|Overall Study|PI Died. Study Terminated|9|||
145361003|NCT00507455|524172609|FG000|Overall Study|Adverse Event|3|||
145361004|NCT00507455|524172610|FG001|Overall Study|Adverse Event|3|||
145361005|NCT00507455|524172611|FG002|Overall Study|Adverse Event|6|||
145361006|NCT00507455|524172609|FG000|Overall Study|Withdrawal by Subject|2|||
145361007|NCT00507455|524172610|FG001|Overall Study|Withdrawal by Subject|1|||
145361008|NCT00507455|524172611|FG002|Overall Study|Withdrawal by Subject|2|||
145361009|NCT00507455|524172609|FG000|Overall Study|Protocol Violation|4|||
145361010|NCT00507455|524172610|FG001|Overall Study|Protocol Violation|1|||
145361011|NCT00507455|524172611|FG002|Overall Study|Protocol Violation|1|||
145361012|NCT00507455|524172609|FG000|Overall Study|Lost to Follow-up|2|||
145361013|NCT00507455|524172610|FG001|Overall Study|Lost to Follow-up|0|||
145361014|NCT00507455|524172611|FG002|Overall Study|Lost to Follow-up|2|||
145361015|NCT00507455|524172609|FG000|Overall Study|Lack of Efficacy|0|||
145361016|NCT00507455|524172610|FG001|Overall Study|Lack of Efficacy|1|||
145361017|NCT00507455|524172611|FG002|Overall Study|Lack of Efficacy|0|||
145361018|NCT00507455|524172609|FG000|Overall Study|Other - miscellaneous reason|1|||
145361019|NCT00507455|524172610|FG001|Overall Study|Other - miscellaneous reason|0|||
145361020|NCT00507455|524172611|FG002|Overall Study|Other - miscellaneous reason|1|||
145361021|NCT03309943|524172612|FG000|Overall Study|Withdrawal by Subject|0|||
145361022|NCT03309943|524172613|FG001|Overall Study|Withdrawal by Subject|1|||
145361023|NCT03309943|524172612|FG000|Overall Study|Inappropriate behavior towards staff|0|||
145361024|NCT03309943|524172613|FG001|Overall Study|Inappropriate behavior towards staff|1|||
145361025|NCT02914613|524172618|FG000|Overall Study|Withdrawal by Subject|1|||
145361026|NCT02914613|524172619|FG001|Overall Study|Withdrawal by Subject|2|||
145361027|NCT02914613|524172618|FG000|Overall Study|Adverse Event|1|||
145623147|NCT02240680|525131598|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
145361028|NCT02914613|524172619|FG001|Overall Study|Adverse Event|0|||
145361029|NCT03363776|524172627|FG000|Overall Study|Progressive disease|2|||
145361030|NCT03363776|524172628|FG001|Overall Study|Progressive disease|3|||
145361031|NCT03363776|524172629|FG002|Overall Study|Progressive disease|1|||
145361032|NCT03363776|524172627|FG000|Overall Study|Study drug toxicity|0|||
145361033|NCT03363776|524172628|FG001|Overall Study|Study drug toxicity|0|||
145361034|NCT03363776|524172629|FG002|Overall Study|Study drug toxicity|1|||
145361035|NCT03363776|524172627|FG000|Overall Study|Death|1|||
145361036|NCT03363776|524172628|FG001|Overall Study|Death|0|||
145361037|NCT03363776|524172629|FG002|Overall Study|Death|0|||
145361038|NCT05027451|524172630|FG000|Overall Study|Lost to Follow-up|1|||
145361039|NCT05027451|524172631|FG001|Overall Study|Lost to Follow-up|1|||
145361040|NCT04178122|524172632|FG000|Overall Study|Withdrawal by Subject|1|||
145361041|NCT04178122|524172633|FG001|Overall Study|Withdrawal by Subject|1|||
145361042|NCT04178122|524172632|FG000|Overall Study|Death|2|||
145361043|NCT04178122|524172633|FG001|Overall Study|Death|0|||
145361044|NCT04178122|524172632|FG000|Overall Study|Did not complete testing|3|||
145361045|NCT04178122|524172633|FG001|Overall Study|Did not complete testing|13|||
145361046|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
145361047|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145361048|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145361049|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145361050|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145361051|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
145361052|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
145361053|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
145361054|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145361055|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145361056|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145361057|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
145361058|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
145361059|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
145361060|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361061|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361062|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361063|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361064|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145361065|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145361066|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361067|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361068|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361069|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361070|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
145361071|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
145361072|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145361073|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145361074|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145361075|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
145361076|NCT02105987|524172640|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145361077|NCT02105987|524172641|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
145361078|NCT02105987|524172642|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145361079|NCT02105987|524172643|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145361080|NCT02105987|524172644|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145361081|NCT02105987|524172645|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
145361082|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145361083|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145361084|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
145361085|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
145361086|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145361087|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
145361088|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145361089|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145361090|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
145361091|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
145361092|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145361093|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
145361094|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361095|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361096|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
145418900|NCT01125748|524388621|FG000|Overall Study|Lost to Follow-up|0|||
145418901|NCT01125748|524388622|FG001|Overall Study|Lost to Follow-up|1|||
145418902|NCT01125748|524388621|FG000|Overall Study|Physician Decision|8|||
145361097|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
145361098|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145418903|NCT01125748|524388622|FG001|Overall Study|Physician Decision|7|||
145418904|NCT01125748|524388621|FG000|Overall Study|Patient Decision to Withdraw|2|||
145361099|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
145361100|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145418905|NCT01125748|524388622|FG001|Overall Study|Patient Decision to Withdraw|4|||
145361101|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361102|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
145361103|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
145361104|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361105|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
145361106|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145361107|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145361108|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
145361109|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145361110|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145361111|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
145361112|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145361113|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145361114|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145361115|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
145361116|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145361117|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
145361118|NCT02105987|524172640|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145361119|NCT02105987|524172641|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145361120|NCT02105987|524172642|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
145361121|NCT02105987|524172643|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145361122|NCT02105987|524172644|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145361123|NCT02105987|524172645|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
145361124|NCT02105987|524172640|FG000|Continuation Phase|Protocol Violation|0|||
145361125|NCT02105987|524172641|FG001|Continuation Phase|Protocol Violation|0|||
145361126|NCT02105987|524172642|FG002|Continuation Phase|Protocol Violation|0|||
145361127|NCT02105987|524172643|FG003|Continuation Phase|Protocol Violation|0|||
145361128|NCT02105987|524172644|FG004|Continuation Phase|Protocol Violation|1|||
145361129|NCT02105987|524172645|FG005|Continuation Phase|Protocol Violation|0|||
145361130|NCT01753570|524172646|FG000|Overall Study|Adverse Event|1|||
145361131|NCT01753570|524172647|FG001|Overall Study|Adverse Event|0|||
145361132|NCT01753570|524172648|FG002|Overall Study|Adverse Event|1|||
145361133|NCT01753570|524172646|FG000|Overall Study|Physician Decision|0|||
145361134|NCT01753570|524172647|FG001|Overall Study|Physician Decision|1|||
145361135|NCT01753570|524172648|FG002|Overall Study|Physician Decision|0|||
145361136|NCT01753570|524172646|FG000|Overall Study|Withdrawal by Subject|1|||
145361137|NCT01753570|524172647|FG001|Overall Study|Withdrawal by Subject|4|||
145361138|NCT01753570|524172648|FG002|Overall Study|Withdrawal by Subject|0|||
145361139|NCT01791894|524172649|FG000|Overall Study|Adverse Event|1|||
145361140|NCT02268916|524172660|FG000|Overall Study|Lost to Follow-up|1|||
145361141|NCT02268916|524172661|FG001|Overall Study|Lost to Follow-up|1|||
145361142|NCT02268916|524172660|FG000|Overall Study|Withdrawal by Subject|6|||
145361143|NCT02268916|524172661|FG001|Overall Study|Withdrawal by Subject|5|||
145361144|NCT02268916|524172660|FG000|Overall Study|Participant did not have diabetes|1|||
145361145|NCT02268916|524172661|FG001|Overall Study|Participant did not have diabetes|0|||
145361146|NCT02268916|524172660|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
145361147|NCT02268916|524172661|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
145361148|NCT03926117|524172662|FG000|Overall Study|Unclassified|1|||
145361149|NCT03926117|524172663|FG001|Overall Study|Unclassified|4|||
145361150|NCT03926117|524172664|FG002|Overall Study|Unclassified|1|||
145361151|NCT03926117|524172665|FG003|Overall Study|Unclassified|4|||
145361152|NCT03926117|524172662|FG000|Overall Study|Withdrawal by Subject|3|||
145361153|NCT03926117|524172663|FG001|Overall Study|Withdrawal by Subject|0|||
145361154|NCT03926117|524172664|FG002|Overall Study|Withdrawal by Subject|1|||
145361155|NCT03926117|524172665|FG003|Overall Study|Withdrawal by Subject|1|||
145361156|NCT03926117|524172662|FG000|Overall Study|Lost to Follow-up|0|||
145361157|NCT03926117|524172663|FG001|Overall Study|Lost to Follow-up|2|||
145361158|NCT03926117|524172664|FG002|Overall Study|Lost to Follow-up|1|||
145361159|NCT03926117|524172665|FG003|Overall Study|Lost to Follow-up|0|||
145361160|NCT03926117|524172662|FG000|Overall Study|Adverse Event|1|||
145361161|NCT03926117|524172663|FG001|Overall Study|Adverse Event|2|||
145361162|NCT03926117|524172664|FG002|Overall Study|Adverse Event|3|||
145361163|NCT03926117|524172665|FG003|Overall Study|Adverse Event|1|||
145361164|NCT03926117|524172662|FG000|Overall Study|Randomized but not treated|1|||
145361165|NCT03926117|524172663|FG001|Overall Study|Randomized but not treated|1|||
145361166|NCT03926117|524172664|FG002|Overall Study|Randomized but not treated|0|||
145361167|NCT03926117|524172665|FG003|Overall Study|Randomized but not treated|1|||
145361168|NCT04830969|524172675|FG000|Overall Study|Withdrawal by Subject|6|||
145361169|NCT04830969|524172676|FG001|Overall Study|Withdrawal by Subject|2|||
145361170|NCT04830969|524172675|FG000|Overall Study|Protocol Violation|3|||
145361171|NCT04830969|524172676|FG001|Overall Study|Protocol Violation|9|||
145361172|NCT04830969|524172675|FG000|Overall Study|Lost to Follow-up|4|||
145361173|NCT04830969|524172676|FG001|Overall Study|Lost to Follow-up|4|||
145361174|NCT01422889|524172677|FG000|Overall Study|No Data Entered for Study Stent|9|||
145361175|NCT01580670|524172678|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
145361176|NCT01580670|524172678|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
145361177|NCT02748356|524172679|FG000|Overall Study|Withdrawal by Subject|1|||
145361178|NCT05870371|524172680|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
145361179|NCT05870371|524172681|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
145361180|NCT02203721|524172683|FG000|Overall Study|Lost to Follow-up|1|||
145361181|NCT02203721|524172684|FG001|Overall Study|Lost to Follow-up|0|||
145361182|NCT02203721|524172683|FG000|Overall Study|Death|0|||
145361183|NCT02203721|524172684|FG001|Overall Study|Death|2|||
145361184|NCT02203721|524172683|FG000|Overall Study|Illness|0|||
145361185|NCT02203721|524172684|FG001|Overall Study|Illness|1|||
145361186|NCT04495751|524172687|FG000|Overall Study|Withdrawal by Subject|1|||
145361187|NCT04495751|524172688|FG001|Overall Study|Withdrawal by Subject|0|||
145361188|NCT04495751|524172687|FG000|Overall Study|Lost to Follow-up|1|||
145361189|NCT04495751|524172688|FG001|Overall Study|Lost to Follow-up|0|||
145361190|NCT03289754|524172689|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
145361191|NCT03584854|524172690|FG000|Overall Study|Primary outcome not measured|1|||
145361192|NCT03584854|524172691|FG001|Overall Study|Primary outcome not measured|2|||
145361193|NCT04639219|524172692|FG000|Overall Study|Withdrawal by Subject|8|||
145361194|NCT04639219|524172692|FG000|Overall Study|Lost to Follow-up|6|||
145361195|NCT04639219|524172692|FG000|Overall Study|Death|55|||
145361196|NCT04681066|524172693|FG000|Overall Study|Lost to Follow-up|3|||
145361197|NCT04681066|524172694|FG001|Overall Study|Lost to Follow-up|1|||
145361198|NCT04681066|524172695|FG002|Overall Study|Lost to Follow-up|2|||
145361199|NCT04681066|524172696|FG003|Overall Study|Lost to Follow-up|1|||
145361200|NCT04681066|524172693|FG000|Overall Study|Withdrawal by Subject|2|||
145361201|NCT04681066|524172694|FG001|Overall Study|Withdrawal by Subject|1|||
145361202|NCT04681066|524172695|FG002|Overall Study|Withdrawal by Subject|0|||
145361203|NCT04681066|524172696|FG003|Overall Study|Withdrawal by Subject|3|||
145361204|NCT04681066|524172693|FG000|Overall Study|Death|0|||
145361205|NCT04681066|524172694|FG001|Overall Study|Death|1|||
145361206|NCT04681066|524172695|FG002|Overall Study|Death|0|||
145361207|NCT04681066|524172696|FG003|Overall Study|Death|0|||
145361208|NCT00564850|524172704|FG000|Overall Study|Protocol Violation|2|||
145361209|NCT00314327|524172705|FG000|Overall Study|Withdrawal by Subject|1|||
145361210|NCT01205269|524172706|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145361211|NCT01205269|524172707|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145361212|NCT01205269|524172708|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145361213|NCT01205269|524172709|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
145361214|NCT01205269|524172710|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145361215|NCT01205269|524172711|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
145361216|NCT00433511|524174520|FG000|Step 1|Adverse Event|50|||
145361217|NCT00433511|524174521|FG001|Step 1|Adverse Event|157|||
145361218|NCT00433511|524174522|FG002|Step 1|Adverse Event|153|||
145361219|NCT00433511|524174520|FG000|Step 1|Withdrawal by Subject|45|||
145361220|NCT00433511|524174521|FG001|Step 1|Withdrawal by Subject|143|||
145361221|NCT00433511|524174522|FG002|Step 1|Withdrawal by Subject|154|||
145361222|NCT00433511|524174520|FG000|Step 1|Death|3|||
145361223|NCT00433511|524174521|FG001|Step 1|Death|1|||
145361224|NCT00433511|524174522|FG002|Step 1|Death|1|||
145361225|NCT00433511|524174520|FG000|Step 1|Physician Decision|1|||
145577539|NCT02391948|524969425|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
145577540|NCT02391948|524969426|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
145577541|NCT02391948|524969427|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
145577542|NCT02391948|524969428|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
145361226|NCT00433511|524174521|FG001|Step 1|Physician Decision|4|||
145361227|NCT00433511|524174522|FG002|Step 1|Physician Decision|3|||
145577543|NCT02391948|524969429|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
145361228|NCT00433511|524174520|FG000|Step 1|Never started protocol therapy|28|||
145361229|NCT00433511|524174521|FG001|Step 1|Never started protocol therapy|64|||
145361230|NCT00433511|524174522|FG002|Step 1|Never started protocol therapy|66|||
145577544|NCT02391948|524969425|FG000|24-month Assessment|Death|0|||
145623148|NCT02240680|525131599|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
145361231|NCT00433511|524174520|FG000|Step 1|Alternative therapy|2|||
145361232|NCT00433511|524174521|FG001|Step 1|Alternative therapy|1|||
145361233|NCT00433511|524174522|FG002|Step 1|Alternative therapy|3|||
145361234|NCT00433511|524174520|FG000|Step 1|Disease progression, relapse|5|||
145361235|NCT00433511|524174521|FG001|Step 1|Disease progression, relapse|3|||
145361236|NCT00433511|524174522|FG002|Step 1|Disease progression, relapse|3|||
145361237|NCT00433511|524174520|FG000|Step 1|Other complicating disease|2|||
145361238|NCT00433511|524174521|FG001|Step 1|Other complicating disease|6|||
145577545|NCT02391948|524969426|FG001|24-month Assessment|Death|0|||
145361239|NCT00433511|524174522|FG002|Step 1|Other complicating disease|3|||
145361240|NCT00433511|524174520|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
145361241|NCT00433511|524174521|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
145361242|NCT00433511|524174522|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
145361243|NCT00433511|524174520|FG000|Step 1|Suspected recurrence|0|||
145361244|NCT00433511|524174521|FG001|Step 1|Suspected recurrence|1|||
145361245|NCT00433511|524174522|FG002|Step 1|Suspected recurrence|0|||
145361246|NCT00433511|524174520|FG000|Step 1|Insurance/drug distribution issues|0|||
145361247|NCT00433511|524174521|FG001|Step 1|Insurance/drug distribution issues|1|||
145361248|NCT00433511|524174522|FG002|Step 1|Insurance/drug distribution issues|2|||
145361249|NCT00433511|524174520|FG000|Step 1|Patient moved|0|||
145361250|NCT00433511|524174521|FG001|Step 1|Patient moved|0|||
145361251|NCT00433511|524174522|FG002|Step 1|Patient moved|1|||
145361252|NCT00433511|524174520|FG000|Step 2 (Arm D)|Adverse Event|0|||
145361253|NCT00433511|524174521|FG001|Step 2 (Arm D)|Adverse Event|0|||
145361254|NCT00433511|524174522|FG002|Step 2 (Arm D)|Adverse Event|135|||
145361255|NCT00433511|524174520|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
145361256|NCT00433511|524174521|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
145361257|NCT00433511|524174522|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
145361258|NCT00433511|524174520|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
145361259|NCT00433511|524174521|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
145361260|NCT00433511|524174522|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
145361261|NCT00433511|524174520|FG000|Step 2 (Arm D)|Physician Decision|0|||
145361262|NCT00433511|524174521|FG001|Step 2 (Arm D)|Physician Decision|0|||
145361263|NCT00433511|524174522|FG002|Step 2 (Arm D)|Physician Decision|9|||
145361264|NCT00433511|524174520|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
145361265|NCT00433511|524174521|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
145361266|NCT00433511|524174522|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
145361267|NCT00433511|524174520|FG000|Step 2 (Arm D)|Other complicating disease|0|||
145361268|NCT00433511|524174521|FG001|Step 2 (Arm D)|Other complicating disease|0|||
145361269|NCT00433511|524174522|FG002|Step 2 (Arm D)|Other complicating disease|3|||
145361270|NCT00433511|524174520|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
145361271|NCT00433511|524174521|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
145361272|NCT00433511|524174522|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
145361273|NCT00433511|524174520|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
145361274|NCT00433511|524174521|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
145361275|NCT00433511|524174522|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
145361276|NCT00433511|524174520|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
145361277|NCT00433511|524174521|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
145361278|NCT00433511|524174522|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
145361279|NCT00433511|524174520|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
145361280|NCT00433511|524174521|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
145361281|NCT00433511|524174522|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
145361282|NCT02151851|524174525|FG000|Overall Study|Lack of Efficacy|67|||
145361283|NCT02151851|524174526|FG001|Overall Study|Lack of Efficacy|94|||
145361284|NCT02151851|524174525|FG000|Overall Study|Protocol Violation|0|||
145361285|NCT02151851|524174526|FG001|Overall Study|Protocol Violation|1|||
145361286|NCT02151851|524174525|FG000|Overall Study|Withdrawal by Subject|2|||
145361287|NCT02151851|524174526|FG001|Overall Study|Withdrawal by Subject|5|||
145361288|NCT02151851|524174525|FG000|Overall Study|Medical impairment|1|||
145361289|NCT02151851|524174526|FG001|Overall Study|Medical impairment|0|||
145361290|NCT02151851|524174525|FG000|Overall Study|Low compliance to study visits|0|||
145361291|NCT02151851|524174526|FG001|Overall Study|Low compliance to study visits|1|||
145361292|NCT02151851|524174525|FG000|Overall Study|Subject entered into study in error|0|||
145361293|NCT02151851|524174526|FG001|Overall Study|Subject entered into study in error|1|||
145361294|NCT02151851|524174525|FG000|Overall Study|Adverse Event|6|||
145361295|NCT02151851|524174526|FG001|Overall Study|Adverse Event|28|||
145361296|NCT02159053|524174527|FG000|Overall Study|Death|2|||
145361297|NCT02159053|524174528|FG001|Overall Study|Death|0|||
145361298|NCT02159053|524174529|FG002|Overall Study|Death|1|||
145361299|NCT02159053|524174527|FG000|Overall Study|Physician Decision|0|||
145361300|NCT02159053|524174528|FG001|Overall Study|Physician Decision|1|||
145361301|NCT02159053|524174529|FG002|Overall Study|Physician Decision|1|||
145361302|NCT02159053|524174527|FG000|Overall Study|Lack of Efficacy|3|||
145361303|NCT02159053|524174528|FG001|Overall Study|Lack of Efficacy|4|||
145361304|NCT02159053|524174529|FG002|Overall Study|Lack of Efficacy|7|||
145361305|NCT02159053|524174527|FG000|Overall Study|Adverse Event|7|||
145361306|NCT02159053|524174528|FG001|Overall Study|Adverse Event|6|||
145361307|NCT02159053|524174529|FG002|Overall Study|Adverse Event|5|||
145361308|NCT02159053|524174527|FG000|Overall Study|Participants/guardian decision|8|||
145361309|NCT02159053|524174528|FG001|Overall Study|Participants/guardian decision|10|||
145361310|NCT02159053|524174529|FG002|Overall Study|Participants/guardian decision|6|||
145361311|NCT01540487|524174530|FG000|Overall Study|Protocol Violation|1|||
145361312|NCT01540487|524174531|FG001|Overall Study|Protocol Violation|0|||
145361313|NCT00617890|524174532|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
145361314|NCT00617890|524174533|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
145361315|NCT00617890|524174534|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
145361316|NCT00617890|524174535|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
145361317|NCT00617890|524174532|FG000|Overall Study|Lack of Efficacy|23|||
145361318|NCT00617890|524174533|FG001|Overall Study|Lack of Efficacy|26|||
145361319|NCT00617890|524174534|FG002|Overall Study|Lack of Efficacy|30|||
145361320|NCT00617890|524174535|FG003|Overall Study|Lack of Efficacy|97|||
145361321|NCT00617890|524174532|FG000|Overall Study|Lost to Follow-up|0|||
145361322|NCT00617890|524174533|FG001|Overall Study|Lost to Follow-up|0|||
145361323|NCT00617890|524174534|FG002|Overall Study|Lost to Follow-up|1|||
145361324|NCT00617890|524174535|FG003|Overall Study|Lost to Follow-up|2|||
145361325|NCT00617890|524174532|FG000|Overall Study|Withdrawal by Subject|4|||
145361326|NCT00617890|524174533|FG001|Overall Study|Withdrawal by Subject|1|||
145361327|NCT00617890|524174534|FG002|Overall Study|Withdrawal by Subject|0|||
145361328|NCT00617890|524174535|FG003|Overall Study|Withdrawal by Subject|2|||
145361329|NCT00617890|524174532|FG000|Overall Study|Protocol Violation|2|||
145361330|NCT00617890|524174533|FG001|Overall Study|Protocol Violation|1|||
145361331|NCT00617890|524174534|FG002|Overall Study|Protocol Violation|0|||
145361332|NCT00617890|524174535|FG003|Overall Study|Protocol Violation|0|||
145361333|NCT00617890|524174532|FG000|Overall Study|Adverse Event|1|||
145361334|NCT00617890|524174533|FG001|Overall Study|Adverse Event|0|||
145361335|NCT00617890|524174534|FG002|Overall Study|Adverse Event|3|||
145361336|NCT00617890|524174535|FG003|Overall Study|Adverse Event|8|||
145361337|NCT00617890|524174532|FG000|Overall Study|Not treated|1|||
145361338|NCT00617890|524174533|FG001|Overall Study|Not treated|0|||
145361339|NCT00617890|524174534|FG002|Overall Study|Not treated|1|||
145361340|NCT00617890|524174535|FG003|Overall Study|Not treated|1|||
145361341|NCT03503370|524174536|FG000|Overall Study|Death|3|||
145361342|NCT03503370|524174537|FG001|Overall Study|Death|1|||
145361343|NCT03483961|524174538|FG000|Overall Study|Lost to Follow-up|7|||
145361344|NCT03483961|524174539|FG001|Overall Study|Lost to Follow-up|6|||
145361345|NCT03483961|524174540|FG002|Overall Study|Lost to Follow-up|6|||
145361346|NCT03483961|524174541|FG003|Overall Study|Lost to Follow-up|6|||
145361347|NCT03483961|524174542|FG004|Overall Study|Lost to Follow-up|6|||
145361348|NCT03483961|524174543|FG005|Overall Study|Lost to Follow-up|4|||
145361349|NCT03483961|524174544|FG006|Overall Study|Lost to Follow-up|4|||
145361350|NCT03483961|524174545|FG007|Overall Study|Lost to Follow-up|11|||
145361351|NCT03483961|524174546|FG008|Overall Study|Lost to Follow-up|1|||
145361352|NCT03483961|524174547|FG009|Overall Study|Lost to Follow-up|0|||
145361353|NCT03483961|524174538|FG000|Overall Study|Withdrawal by Subject|3|||
145361354|NCT03483961|524174539|FG001|Overall Study|Withdrawal by Subject|4|||
145361355|NCT03483961|524174540|FG002|Overall Study|Withdrawal by Subject|5|||
145361356|NCT03483961|524174541|FG003|Overall Study|Withdrawal by Subject|3|||
145361357|NCT03483961|524174542|FG004|Overall Study|Withdrawal by Subject|4|||
145361358|NCT03483961|524174543|FG005|Overall Study|Withdrawal by Subject|2|||
145361359|NCT03483961|524174544|FG006|Overall Study|Withdrawal by Subject|1|||
145361360|NCT03483961|524174545|FG007|Overall Study|Withdrawal by Subject|2|||
145361361|NCT03483961|524174546|FG008|Overall Study|Withdrawal by Subject|1|||
145361362|NCT03483961|524174547|FG009|Overall Study|Withdrawal by Subject|0|||
145361363|NCT03483961|524174538|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
145361364|NCT03483961|524174539|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361365|NCT03483961|524174540|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361366|NCT03483961|524174541|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361367|NCT03483961|524174542|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361368|NCT03483961|524174543|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361369|NCT03483961|524174544|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361370|NCT03483961|524174545|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361371|NCT03483961|524174546|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361372|NCT03483961|524174547|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
145361373|NCT03483961|524174538|FG000|Overall Study|Adverse Event|0|||
145361374|NCT03483961|524174539|FG001|Overall Study|Adverse Event|0|||
145361375|NCT03483961|524174540|FG002|Overall Study|Adverse Event|1|||
145361376|NCT03483961|524174541|FG003|Overall Study|Adverse Event|0|||
145361377|NCT03483961|524174542|FG004|Overall Study|Adverse Event|0|||
145361378|NCT03483961|524174543|FG005|Overall Study|Adverse Event|0|||
145361379|NCT03483961|524174544|FG006|Overall Study|Adverse Event|0|||
145361380|NCT03483961|524174545|FG007|Overall Study|Adverse Event|0|||
145361381|NCT03483961|524174546|FG008|Overall Study|Adverse Event|0|||
145361382|NCT03483961|524174547|FG009|Overall Study|Adverse Event|0|||
145361383|NCT02640950|524174548|FG000|Overall Study|Adverse Event|1|||
145361384|NCT02640950|524174548|FG000|Overall Study|Withdrawal by Subject|1|||
145361385|NCT04545489|524174549|FG000|Overall Study|Withdrawal by Subject|12|||
145361386|NCT04545489|524174550|FG001|Overall Study|Withdrawal by Subject|4|||
145361387|NCT04545489|524174549|FG000|Overall Study|Lost to Follow-up|17|||
145361388|NCT04545489|524174550|FG001|Overall Study|Lost to Follow-up|18|||
145361389|NCT04545489|524174549|FG000|Overall Study|12month BP not collected|4|||
145361390|NCT04545489|524174550|FG001|Overall Study|12month BP not collected|4|||
145361391|NCT00652626|524174551|FG000|Initial Treatment Phase|Adverse Event|0|||
145361392|NCT00652626|524174552|FG001|Initial Treatment Phase|Adverse Event|0|||
145361393|NCT00652626|524174553|FG002|Initial Treatment Phase|Adverse Event|0|||
145361394|NCT00652626|524174554|FG003|Initial Treatment Phase|Adverse Event|0|||
145361395|NCT00652626|524174555|FG004|Initial Treatment Phase|Adverse Event|1|||
145361396|NCT00652626|524174556|FG005|Initial Treatment Phase|Adverse Event|0|||
145361397|NCT00652626|524174557|FG006|Initial Treatment Phase|Adverse Event|0|||
145361398|NCT00652626|524174551|FG000|Initial Treatment Phase|Protocol Violation|0|||
145361399|NCT00652626|524174552|FG001|Initial Treatment Phase|Protocol Violation|0|||
145361400|NCT00652626|524174553|FG002|Initial Treatment Phase|Protocol Violation|0|||
145361401|NCT00652626|524174554|FG003|Initial Treatment Phase|Protocol Violation|1|||
145361402|NCT00652626|524174555|FG004|Initial Treatment Phase|Protocol Violation|0|||
145361403|NCT00652626|524174556|FG005|Initial Treatment Phase|Protocol Violation|0|||
145361404|NCT00652626|524174557|FG006|Initial Treatment Phase|Protocol Violation|0|||
145361405|NCT00652626|524174551|FG000|Initial Treatment Phase|Physician Decision|0|||
145361406|NCT00652626|524174552|FG001|Initial Treatment Phase|Physician Decision|0|||
145361407|NCT00652626|524174553|FG002|Initial Treatment Phase|Physician Decision|0|||
145361408|NCT00652626|524174554|FG003|Initial Treatment Phase|Physician Decision|0|||
145361409|NCT00652626|524174555|FG004|Initial Treatment Phase|Physician Decision|1|||
145361410|NCT00652626|524174556|FG005|Initial Treatment Phase|Physician Decision|0|||
145361411|NCT00652626|524174557|FG006|Initial Treatment Phase|Physician Decision|0|||
145361412|NCT00652626|524174551|FG000|Initial Treatment Phase|Sponsor Request|0|||
145361413|NCT00652626|524174552|FG001|Initial Treatment Phase|Sponsor Request|0|||
145361414|NCT00652626|524174553|FG002|Initial Treatment Phase|Sponsor Request|1|||
145361415|NCT00652626|524174554|FG003|Initial Treatment Phase|Sponsor Request|0|||
145361416|NCT00652626|524174555|FG004|Initial Treatment Phase|Sponsor Request|0|||
145361417|NCT00652626|524174556|FG005|Initial Treatment Phase|Sponsor Request|0|||
145361418|NCT00652626|524174557|FG006|Initial Treatment Phase|Sponsor Request|0|||
145361419|NCT00652626|524174551|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
145361420|NCT00652626|524174552|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
145361421|NCT00652626|524174553|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
145361422|NCT00652626|524174554|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
145361423|NCT00652626|524174555|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
145361424|NCT00652626|524174556|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
145361425|NCT00652626|524174557|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
145361426|NCT00652626|524174551|FG000|Extension Phase|Withdrawal by Subject|0|||
145361427|NCT00652626|524174552|FG001|Extension Phase|Withdrawal by Subject|0|||
145361428|NCT00652626|524174553|FG002|Extension Phase|Withdrawal by Subject|0|||
145361429|NCT00652626|524174554|FG003|Extension Phase|Withdrawal by Subject|0|||
145361430|NCT00652626|524174555|FG004|Extension Phase|Withdrawal by Subject|0|||
145361431|NCT00652626|524174556|FG005|Extension Phase|Withdrawal by Subject|2|||
145361432|NCT00652626|524174557|FG006|Extension Phase|Withdrawal by Subject|0|||
145361433|NCT00652626|524174551|FG000|Extension Phase|Adverse Event|0|||
145361434|NCT00652626|524174552|FG001|Extension Phase|Adverse Event|0|||
145361435|NCT00652626|524174553|FG002|Extension Phase|Adverse Event|0|||
145361436|NCT00652626|524174554|FG003|Extension Phase|Adverse Event|0|||
145361437|NCT00652626|524174555|FG004|Extension Phase|Adverse Event|0|||
145361438|NCT00652626|524174556|FG005|Extension Phase|Adverse Event|2|||
145361439|NCT00652626|524174557|FG006|Extension Phase|Adverse Event|1|||
145361440|NCT00652626|524174551|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145361441|NCT00652626|524174552|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145361442|NCT00652626|524174553|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145361443|NCT00652626|524174554|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145418906|NCT00837330|524388623|FG000|Overall Study|Lost to Follow-up|1|||
145418907|NCT00837330|524388624|FG001|Overall Study|Lost to Follow-up|3|||
145418908|NCT00694122|524388639|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
145418909|NCT00694122|524388640|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
145418910|NCT00694122|524388639|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
145418911|NCT00694122|524388640|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
145418912|NCT00694122|524388639|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
145418913|NCT00694122|524388640|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
145418914|NCT00105508|524388641|FG000|Overall Study|Prephase Dropout|1|||
145418915|NCT00105508|524388642|FG001|Overall Study|Prephase Dropout|0|||
145418916|NCT00105508|524388641|FG000|Overall Study|Adverse Event|16|||
145623149|NCT02240680|525131600|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
145361444|NCT00652626|524174555|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145361445|NCT00652626|524174556|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
145361446|NCT00652626|524174557|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
145361447|NCT00652626|524174551|FG000|Extension Phase|Physician Decision|0|||
145361448|NCT00652626|524174552|FG001|Extension Phase|Physician Decision|0|||
145361449|NCT00652626|524174553|FG002|Extension Phase|Physician Decision|0|||
145361450|NCT00652626|524174554|FG003|Extension Phase|Physician Decision|0|||
145361451|NCT00652626|524174555|FG004|Extension Phase|Physician Decision|0|||
145361452|NCT00652626|524174556|FG005|Extension Phase|Physician Decision|1|||
145361453|NCT00652626|524174557|FG006|Extension Phase|Physician Decision|1|||
145361454|NCT00652626|524174551|FG000|Extension Phase|Death|0|||
145361455|NCT00652626|524174552|FG001|Extension Phase|Death|0|||
145361456|NCT00652626|524174553|FG002|Extension Phase|Death|0|||
145361457|NCT00652626|524174554|FG003|Extension Phase|Death|0|||
145361458|NCT00652626|524174555|FG004|Extension Phase|Death|0|||
145361459|NCT00652626|524174556|FG005|Extension Phase|Death|1|||
145361460|NCT00652626|524174557|FG006|Extension Phase|Death|1|||
145361461|NCT04003636|524174558|FG000|Overall Study|Death|409|||
145361462|NCT04003636|524174559|FG001|Overall Study|Death|443|||
145361463|NCT04003636|524174558|FG000|Overall Study|Lost to Follow-up|0|||
145361464|NCT04003636|524174559|FG001|Overall Study|Lost to Follow-up|1|||
145361465|NCT04003636|524174558|FG000|Overall Study|Withdrawal by Subject|5|||
145361466|NCT04003636|524174559|FG001|Overall Study|Withdrawal by Subject|2|||
145361467|NCT04003636|524174558|FG000|Overall Study|Participant On-going|119|||
145361468|NCT04003636|524174559|FG001|Overall Study|Participant On-going|90|||
145361469|NCT02693106|524174563|FG000|Overall Study|No time|3|||
145361470|NCT06028438|524174572|FG000|Overall Study|Adverse Event|3|||
145361471|NCT06028438|524174573|FG001|Overall Study|Adverse Event|9|||
145361472|NCT06028438|524174572|FG000|Overall Study|Lack of Efficacy|1|||
145361473|NCT06028438|524174573|FG001|Overall Study|Lack of Efficacy|1|||
145361474|NCT06028438|524174572|FG000|Overall Study|Lost to Follow-up|1|||
145361475|NCT06028438|524174573|FG001|Overall Study|Lost to Follow-up|0|||
145361476|NCT06028438|524174572|FG000|Overall Study|Withdrawal by Subject|1|||
145361477|NCT06028438|524174573|FG001|Overall Study|Withdrawal by Subject|0|||
145361478|NCT06028438|524174572|FG000|Overall Study|Other|3|||
145361479|NCT06028438|524174573|FG001|Overall Study|Other|3|||
145361480|NCT05625802|524174574|FG000|Overall Study|Lost to Follow-up|1|||
145361481|NCT05625802|524174575|FG001|Overall Study|Lost to Follow-up|0|||
145361482|NCT01954056|524174577|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
145361483|NCT01954056|524174578|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
145361484|NCT01081769|524174582|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
145361485|NCT01081769|524174583|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
145361486|NCT01081769|524174582|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
145361487|NCT01081769|524174583|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
145361488|NCT01081769|524174582|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
145361489|NCT01081769|524174583|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
145361490|NCT01081769|524174582|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
145361491|NCT01081769|524174583|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
145361492|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Adverse Event|14|||
145361493|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Adverse Event|11|||
145361494|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Death|1|||
145361495|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Death|1|||
145361496|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
145361497|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
145361498|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
145361499|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
145361500|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Pregnancy|1|||
145361501|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Pregnancy|0|||
145361502|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
145361503|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
145361504|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
145577546|NCT02391948|524969427|FG002|24-month Assessment|Death|0|||
145577547|NCT02391948|524969428|FG003|24-month Assessment|Death|0|||
145361505|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
145361506|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Other|0|||
145361507|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Other|1|||
145361508|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Ineligibility|3|||
145361509|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Ineligibility|4|||
145361510|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
145361511|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
145577548|NCT02391948|524969429|FG004|24-month Assessment|Death|1|||
145418917|NCT00105508|524388642|FG001|Overall Study|Adverse Event|19|||
145361512|NCT01081769|524174582|FG000|CORE Intent-To-Treat|Patient Moved|2|||
145361513|NCT01081769|524174583|FG001|CORE Intent-To-Treat|Patient Moved|2|||
145361514|NCT00105079|524174584|FG000|Overall Study|Adverse Event|5|||
145361515|NCT00105079|524174585|FG001|Overall Study|Adverse Event|12|||
145577549|NCT02391948|524969425|FG000|24-month Assessment|Withdrawal by Subject|1|||
145577550|NCT02391948|524969426|FG001|24-month Assessment|Withdrawal by Subject|1|||
145361516|NCT00105079|524174584|FG000|Overall Study|Death|3|||
145361517|NCT00105079|524174585|FG001|Overall Study|Death|1|||
145361518|NCT00105079|524174584|FG000|Overall Study|Lost to Follow-up|12|||
145361519|NCT00105079|524174585|FG001|Overall Study|Lost to Follow-up|12|||
145361520|NCT00105079|524174584|FG000|Overall Study|Lack of Efficacy|9|||
145418918|NCT00105508|524388641|FG000|Overall Study|Insufficient Efficacy|1|||
145577551|NCT02391948|524969427|FG002|24-month Assessment|Withdrawal by Subject|0|||
145361521|NCT00105079|524174585|FG001|Overall Study|Lack of Efficacy|3|||
145361522|NCT00105079|524174584|FG000|Overall Study|Refused treatment|6|||
145361523|NCT00105079|524174585|FG001|Overall Study|Refused treatment|4|||
145361524|NCT00105079|524174584|FG000|Overall Study|Violation of selection criteria at entry|0|||
145361525|NCT00105079|524174585|FG001|Overall Study|Violation of selection criteria at entry|2|||
145361526|NCT00105079|524174584|FG000|Overall Study|Protocol Violation|1|||
145361527|NCT00105079|524174585|FG001|Overall Study|Protocol Violation|0|||
145361528|NCT00105079|524174584|FG000|Overall Study|Other|3|||
145361529|NCT00105079|524174585|FG001|Overall Study|Other|1|||
145361530|NCT01464593|524174586|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
145361531|NCT00789373|524174594|FG000|Induction|Adverse Event|64|||
145361532|NCT00789373|524174595|FG001|Induction|Adverse Event|0|||
145361533|NCT00789373|524174596|FG002|Induction|Adverse Event|0|||
145361534|NCT00789373|524174594|FG000|Induction|Death Due to study disease|24|||
145361535|NCT00789373|524174595|FG001|Induction|Death Due to study disease|0|||
145361536|NCT00789373|524174596|FG002|Induction|Death Due to study disease|0|||
145361537|NCT00789373|524174594|FG000|Induction|Death due to adverse event|19|||
145361538|NCT00789373|524174595|FG001|Induction|Death due to adverse event|0|||
145361539|NCT00789373|524174596|FG002|Induction|Death due to adverse event|0|||
145361540|NCT00789373|524174594|FG000|Induction|Death due to toxicity|11|||
145361541|NCT00789373|524174595|FG001|Induction|Death due to toxicity|0|||
145361542|NCT00789373|524174596|FG002|Induction|Death due to toxicity|0|||
145361543|NCT00789373|524174594|FG000|Induction|Death due to procedure|1|||
145361544|NCT00789373|524174595|FG001|Induction|Death due to procedure|0|||
145361545|NCT00789373|524174596|FG002|Induction|Death due to procedure|0|||
145361546|NCT00789373|524174594|FG000|Induction|Investigator decision|7|||
145361547|NCT00789373|524174595|FG001|Induction|Investigator decision|0|||
145361548|NCT00789373|524174596|FG002|Induction|Investigator decision|0|||
145361549|NCT00789373|524174594|FG000|Induction|Protocol entry criteria not met|9|||
145361550|NCT00789373|524174595|FG001|Induction|Protocol entry criteria not met|0|||
145361551|NCT00789373|524174596|FG002|Induction|Protocol entry criteria not met|0|||
145361552|NCT00789373|524174594|FG000|Induction|Lost to Follow-up|6|||
145361553|NCT00789373|524174595|FG001|Induction|Lost to Follow-up|0|||
145361554|NCT00789373|524174596|FG002|Induction|Lost to Follow-up|0|||
145361555|NCT00789373|524174594|FG000|Induction|Protocol Violation|1|||
145361556|NCT00789373|524174595|FG001|Induction|Protocol Violation|0|||
145361557|NCT00789373|524174596|FG002|Induction|Protocol Violation|0|||
145361558|NCT00789373|524174594|FG000|Induction|Progressive Disease|220|||
145361559|NCT00789373|524174595|FG001|Induction|Progressive Disease|0|||
145361560|NCT00789373|524174596|FG002|Induction|Progressive Disease|0|||
145361561|NCT00789373|524174594|FG000|Induction|Withdrawal by Subject|37|||
145361562|NCT00789373|524174595|FG001|Induction|Withdrawal by Subject|0|||
145361563|NCT00789373|524174596|FG002|Induction|Withdrawal by Subject|0|||
145361564|NCT00789373|524174594|FG000|Maintenance|Adverse Event|0|||
145361565|NCT00789373|524174595|FG001|Maintenance|Adverse Event|65|||
145361566|NCT00789373|524174596|FG002|Maintenance|Adverse Event|12|||
145361567|NCT00789373|524174594|FG000|Maintenance|Death due to study disease|0|||
145361568|NCT00789373|524174595|FG001|Maintenance|Death due to study disease|3|||
145361569|NCT00789373|524174596|FG002|Maintenance|Death due to study disease|1|||
145361570|NCT00789373|524174594|FG000|Maintenance|Death due to adverse event|0|||
145361571|NCT00789373|524174595|FG001|Maintenance|Death due to adverse event|4|||
145361572|NCT00789373|524174596|FG002|Maintenance|Death due to adverse event|1|||
145361573|NCT00789373|524174594|FG000|Maintenance|Death due to toxicity|0|||
145361574|NCT00789373|524174595|FG001|Maintenance|Death due to toxicity|1|||
145361575|NCT00789373|524174596|FG002|Maintenance|Death due to toxicity|2|||
145361576|NCT00789373|524174594|FG000|Maintenance|Investigator Decision|0|||
145361577|NCT00789373|524174595|FG001|Maintenance|Investigator Decision|4|||
145361578|NCT00789373|524174596|FG002|Maintenance|Investigator Decision|2|||
145577552|NCT02391948|524969428|FG003|24-month Assessment|Withdrawal by Subject|0|||
145577553|NCT02391948|524969429|FG004|24-month Assessment|Withdrawal by Subject|1|||
145577554|NCT02391948|524969425|FG000|24-month Assessment|Lost to Follow-up|5|||
145577555|NCT02391948|524969426|FG001|24-month Assessment|Lost to Follow-up|4|||
145418919|NCT00105508|524388642|FG001|Overall Study|Insufficient Efficacy|0|||
145361579|NCT00789373|524174594|FG000|Maintenance|Protocol entry criteria not met|0|||
145361580|NCT00789373|524174595|FG001|Maintenance|Protocol entry criteria not met|2|||
145361581|NCT00789373|524174596|FG002|Maintenance|Protocol entry criteria not met|0|||
145361582|NCT00789373|524174594|FG000|Maintenance|Lost to Follow-up|0|||
145361583|NCT00789373|524174595|FG001|Maintenance|Lost to Follow-up|2|||
145361584|NCT00789373|524174596|FG002|Maintenance|Lost to Follow-up|0|||
145361585|NCT00789373|524174594|FG000|Maintenance|Progressive Disease|0|||
145361586|NCT00789373|524174595|FG001|Maintenance|Progressive Disease|253|||
145361587|NCT00789373|524174596|FG002|Maintenance|Progressive Disease|152|||
145361588|NCT00789373|524174594|FG000|Maintenance|Withdrawal by Subject|0|||
145361589|NCT00789373|524174595|FG001|Maintenance|Withdrawal by Subject|21|||
145361590|NCT00789373|524174596|FG002|Maintenance|Withdrawal by Subject|8|||
145361591|NCT00789373|524174594|FG000|Maintenance|Sponsor Decision|0|||
145361592|NCT00789373|524174595|FG001|Maintenance|Sponsor Decision|0|||
145577556|NCT02391948|524969427|FG002|24-month Assessment|Lost to Follow-up|0|||
145577557|NCT02391948|524969428|FG003|24-month Assessment|Lost to Follow-up|0|||
145361593|NCT00789373|524174596|FG002|Maintenance|Sponsor Decision|2|||
145361594|NCT00789373|524174594|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
145361595|NCT00789373|524174595|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
145361596|NCT00789373|524174596|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
145361597|NCT01964222|524174602|FG000|Overall Study|Lost to Follow-up|7|||
145361598|NCT01964222|524174603|FG001|Overall Study|Lost to Follow-up|5|||
145361599|NCT01964222|524174602|FG000|Overall Study|Withdrawal by Subject|6|||
145361600|NCT01964222|524174603|FG001|Overall Study|Withdrawal by Subject|6|||
145361601|NCT01964222|524174602|FG000|Overall Study|Screening Failure|2|||
145361602|NCT01964222|524174603|FG001|Overall Study|Screening Failure|0|||
145361603|NCT00026494|524174610|FG000|Overall Study|Withdrawal by Subject|1|||
145361604|NCT00026494|524174611|FG001|Overall Study|Withdrawal by Subject|0|||
145361605|NCT00026494|524174612|FG002|Overall Study|Withdrawal by Subject|1|||
145361606|NCT00026494|524174613|FG003|Overall Study|Withdrawal by Subject|0|||
145361607|NCT00026494|524174610|FG000|Overall Study|Patient non-compliance|1|||
145361608|NCT00026494|524174611|FG001|Overall Study|Patient non-compliance|0|||
145361609|NCT00026494|524174612|FG002|Overall Study|Patient non-compliance|0|||
145361610|NCT00026494|524174613|FG003|Overall Study|Patient non-compliance|0|||
145361611|NCT00026494|524174610|FG000|Overall Study|Patient not treated|0|||
145361612|NCT00026494|524174611|FG001|Overall Study|Patient not treated|0|||
145361613|NCT00026494|524174612|FG002|Overall Study|Patient not treated|2|||
145361614|NCT00026494|524174613|FG003|Overall Study|Patient not treated|0|||
145361615|NCT00026494|524174610|FG000|Overall Study|Clinical progression|0|||
145361616|NCT00026494|524174611|FG001|Overall Study|Clinical progression|0|||
145361617|NCT00026494|524174612|FG002|Overall Study|Clinical progression|3|||
145361618|NCT00026494|524174613|FG003|Overall Study|Clinical progression|0|||
145361619|NCT01455597|524174614|FG000|Overall Study|Adverse Event|7|||
145361620|NCT01455597|524174615|FG001|Overall Study|Adverse Event|0|||
145361621|NCT01455597|524174616|FG002|Overall Study|Adverse Event|5|||
145361622|NCT01455597|524174617|FG003|Overall Study|Adverse Event|1|||
145361623|NCT01455597|524174614|FG000|Overall Study|Lack of Efficacy|0|||
145361624|NCT01455597|524174615|FG001|Overall Study|Lack of Efficacy|1|||
145361625|NCT01455597|524174616|FG002|Overall Study|Lack of Efficacy|2|||
145361626|NCT01455597|524174617|FG003|Overall Study|Lack of Efficacy|0|||
145361627|NCT01455597|524174614|FG000|Overall Study|Lost to Follow-up|3|||
145361628|NCT01455597|524174615|FG001|Overall Study|Lost to Follow-up|0|||
145361629|NCT01455597|524174616|FG002|Overall Study|Lost to Follow-up|2|||
145361630|NCT01455597|524174617|FG003|Overall Study|Lost to Follow-up|1|||
145361631|NCT01455597|524174614|FG000|Overall Study|Withdrew Consent|6|||
145361632|NCT01455597|524174615|FG001|Overall Study|Withdrew Consent|5|||
145361633|NCT01455597|524174616|FG002|Overall Study|Withdrew Consent|8|||
145361634|NCT01455597|524174617|FG003|Overall Study|Withdrew Consent|5|||
145361635|NCT01455597|524174614|FG000|Overall Study|Reason not Specified|1|||
145361636|NCT01455597|524174615|FG001|Overall Study|Reason not Specified|2|||
145361637|NCT01455597|524174616|FG002|Overall Study|Reason not Specified|3|||
145361638|NCT01455597|524174617|FG003|Overall Study|Reason not Specified|3|||
145361639|NCT00441129|524174618|FG000|Overall Study|Withdrawal by Subject|6|||
145361640|NCT00441129|524174619|FG001|Overall Study|Withdrawal by Subject|14|||
145361641|NCT03850496|524174622|FG000|Overall Study|Withdrawal by Subject|1|||
145361642|NCT03850496|524174623|FG001|Overall Study|Withdrawal by Subject|0|||
145361643|NCT03850496|524174624|FG002|Overall Study|Withdrawal by Subject|0|||
145361644|NCT03850496|524174622|FG000|Overall Study|Lost to Follow-up|0|||
145361645|NCT03850496|524174623|FG001|Overall Study|Lost to Follow-up|1|||
145361646|NCT03850496|524174624|FG002|Overall Study|Lost to Follow-up|4|||
145361647|NCT00656292|524174625|FG000|Overall Study|Withdrawal by Subject|2|||
145361648|NCT00656292|524174626|FG001|Overall Study|Withdrawal by Subject|3|||
145361649|NCT00656292|524174625|FG000|Overall Study|Screen failure|1|||
145361650|NCT00656292|524174626|FG001|Overall Study|Screen failure|2|||
145361651|NCT03674112|524174627|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
145361652|NCT03674112|524174628|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
145361653|NCT03674112|524174627|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
145361654|NCT03674112|524174628|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
145361655|NCT03674112|524174627|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
145361656|NCT03674112|524174628|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
145623150|NCT02240680|525131601|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
145623151|NCT02240680|525131598|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
145361657|NCT03674112|524174627|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
145361658|NCT03674112|524174628|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
145361659|NCT03674112|524174627|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
145361660|NCT03674112|524174628|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
145361661|NCT03674112|524174627|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
145361662|NCT03674112|524174628|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
145361663|NCT03674112|524174627|FG000|Follow-Up Period (≥3 Years)|Death|2|||
145361664|NCT03674112|524174628|FG001|Follow-Up Period (≥3 Years)|Death|0|||
145361665|NCT03674112|524174627|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
145361666|NCT03674112|524174628|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
145361667|NCT02527434|524174633|FG000|Overall Study|Lost to Follow-up|2|||
145361668|NCT02527434|524174634|FG001|Overall Study|Lost to Follow-up|2|||
145361669|NCT02527434|524174635|FG002|Overall Study|Lost to Follow-up|0|||
145361670|NCT02527434|524174633|FG000|Overall Study|Death|19|||
145361671|NCT02527434|524174634|FG001|Overall Study|Death|6|||
145361672|NCT02527434|524174635|FG002|Overall Study|Death|17|||
145361673|NCT02527434|524174633|FG000|Overall Study|Withdrawal by Subject|5|||
145361674|NCT02527434|524174634|FG001|Overall Study|Withdrawal by Subject|3|||
145361675|NCT02527434|524174635|FG002|Overall Study|Withdrawal by Subject|3|||
145361676|NCT02527434|524174633|FG000|Overall Study|Reason Not Specified|1|||
145361677|NCT02527434|524174634|FG001|Overall Study|Reason Not Specified|0|||
145361678|NCT02527434|524174635|FG002|Overall Study|Reason Not Specified|0|||
145361679|NCT02527434|524174633|FG000|Overall Study|Site closure|1|||
145361680|NCT02527434|524174634|FG001|Overall Study|Site closure|0|||
145361681|NCT02527434|524174635|FG002|Overall Study|Site closure|0|||
145361682|NCT05107492|524174642|FG000|Overall Study|Lost to Follow-up|1|||
145361683|NCT05107492|524174643|FG001|Overall Study|Lost to Follow-up|0|||
145361684|NCT05236764|524174644|FG000|Overall Study|In follow up (ongoing)|1|||
145361685|NCT05236764|524174644|FG000|Overall Study|Taken off study - secondary graft failure|1|||
145361686|NCT05236764|524174644|FG000|Overall Study|Death|1|||
145361687|NCT02670525|524174645|FG000|Overall Study|Death|94|||
145361688|NCT02670525|524174646|FG001|Overall Study|Death|14|||
145361689|NCT02670525|524174645|FG000|Overall Study|Lost to Follow-up|4|||
145361690|NCT02670525|524174646|FG001|Overall Study|Lost to Follow-up|1|||
145361691|NCT02670525|524174645|FG000|Overall Study|Subject withdrew consent|1|||
145361692|NCT02670525|524174646|FG001|Overall Study|Subject withdrew consent|0|||
145361693|NCT02670525|524174645|FG000|Overall Study|Unknown, data entry delayed|123|||
145361694|NCT02670525|524174646|FG001|Overall Study|Unknown, data entry delayed|78|||
145361695|NCT01796392|524174647|FG000|Overall Study|Withdrawal by Subject|2|||
145361696|NCT01796392|524174648|FG001|Overall Study|Withdrawal by Subject|0|||
145361697|NCT01796392|524174647|FG000|Overall Study|Death|5|||
145361698|NCT01796392|524174648|FG001|Overall Study|Death|1|||
145361699|NCT01796392|524174647|FG000|Overall Study|Excluded for medical reasons|1|||
145361700|NCT01796392|524174648|FG001|Overall Study|Excluded for medical reasons|2|||
145361701|NCT01796392|524174647|FG000|Overall Study|Lost to Follow-up|1|||
145361702|NCT01796392|524174648|FG001|Overall Study|Lost to Follow-up|0|||
145361703|NCT02505217|524174649|FG000|Overall Study|Withdrawal by Subject|1|||
145361704|NCT02505217|524174650|FG001|Overall Study|Withdrawal by Subject|2|||
145361705|NCT03517540|524174656|FG000|Overall Study|Protocol Violation|2|||
145361706|NCT03517540|524174657|FG001|Overall Study|Protocol Violation|0|||
145361707|NCT03517540|524174658|FG002|Overall Study|Protocol Violation|0|||
145361708|NCT03517540|524174659|FG003|Overall Study|Protocol Violation|1|||
145361709|NCT03517540|524174656|FG000|Overall Study|Adverse Event|9|||
145361710|NCT03517540|524174657|FG001|Overall Study|Adverse Event|3|||
145361711|NCT03517540|524174658|FG002|Overall Study|Adverse Event|8|||
145361712|NCT03517540|524174659|FG003|Overall Study|Adverse Event|1|||
145361713|NCT03517540|524174656|FG000|Overall Study|Withdrawal by Subject|3|||
145418920|NCT00105508|524388641|FG000|Overall Study|Withdrawal by Subject|10|||
145361714|NCT03517540|524174657|FG001|Overall Study|Withdrawal by Subject|4|||
145361715|NCT03517540|524174658|FG002|Overall Study|Withdrawal by Subject|1|||
145361716|NCT03517540|524174659|FG003|Overall Study|Withdrawal by Subject|3|||
145361717|NCT02640664|524174660|FG000|Epoch 1|Withdrawal of informed consent|1|||
145361718|NCT02640664|524174661|FG001|Epoch 1|Withdrawal of informed consent|0|||
145361719|NCT02640664|524174662|FG002|Epoch 1|Withdrawal of informed consent|0|||
145418921|NCT00105508|524388642|FG001|Overall Study|Withdrawal by Subject|6|||
145418922|NCT00105508|524388641|FG000|Overall Study|Lost to Follow-up|3|||
145418923|NCT00105508|524388642|FG001|Overall Study|Lost to Follow-up|0|||
145418924|NCT00105508|524388641|FG000|Overall Study|Protocol Violation|1|||
145418925|NCT00105508|524388642|FG001|Overall Study|Protocol Violation|2|||
145361720|NCT02640664|524174660|FG000|Epoch 1|Death|0|||
145361721|NCT02640664|524174661|FG001|Epoch 1|Death|0|||
145361722|NCT02640664|524174662|FG002|Epoch 1|Death|1|||
145361723|NCT02640664|524174660|FG000|Epoch 2|Withdrawal of informed consent|3|||
145418926|NCT00105508|524388641|FG000|Overall Study|Other|8|||
145577558|NCT02391948|524969429|FG004|24-month Assessment|Lost to Follow-up|0|||
145577559|NCT02391948|524969425|FG000|24-month Assessment|Medical issue/illness|0|||
145361724|NCT02640664|524174661|FG001|Epoch 2|Withdrawal of informed consent|4|||
145577560|NCT02391948|524969426|FG001|24-month Assessment|Medical issue/illness|0|||
145577561|NCT02391948|524969427|FG002|24-month Assessment|Medical issue/illness|1|||
145361725|NCT02640664|524174662|FG002|Epoch 2|Withdrawal of informed consent|2|||
145361726|NCT02640664|524174660|FG000|Epoch 2|Subject/guardian decision|0|||
145361727|NCT02640664|524174661|FG001|Epoch 2|Subject/guardian decision|2|||
145361728|NCT02640664|524174662|FG002|Epoch 2|Subject/guardian decision|2|||
145361729|NCT02640664|524174660|FG000|Epoch 2|Lost to Follow-up|3|||
145361730|NCT02640664|524174661|FG001|Epoch 2|Lost to Follow-up|4|||
145361731|NCT02640664|524174662|FG002|Epoch 2|Lost to Follow-up|1|||
145577562|NCT02391948|524969428|FG003|24-month Assessment|Medical issue/illness|0|||
145577563|NCT02391948|524969429|FG004|24-month Assessment|Medical issue/illness|0|||
145418927|NCT00105508|524388642|FG001|Overall Study|Other|9|||
145418928|NCT00086307|524388643|FG000|Overall Study|Lack of Efficacy|1|||
145418929|NCT00086307|524388644|FG001|Overall Study|Lack of Efficacy|1|||
145418930|NCT00086307|524388645|FG002|Overall Study|Lack of Efficacy|2|||
145418931|NCT00086307|524388643|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
145418932|NCT00086307|524388644|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
145418933|NCT00086307|524388645|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
145418934|NCT00086307|524388643|FG000|Overall Study|Nausea and headaches|0|||
145418935|NCT00086307|524388644|FG001|Overall Study|Nausea and headaches|0|||
145418936|NCT00086307|524388645|FG002|Overall Study|Nausea and headaches|1|||
145418937|NCT00086307|524388643|FG000|Overall Study|Constipation and sleepiness|0|||
145418938|NCT00086307|524388644|FG001|Overall Study|Constipation and sleepiness|0|||
145418939|NCT00086307|524388645|FG002|Overall Study|Constipation and sleepiness|1|||
145418940|NCT00086307|524388643|FG000|Overall Study|Suicidal ideation|0|||
145418941|NCT00086307|524388644|FG001|Overall Study|Suicidal ideation|0|||
145418942|NCT00086307|524388645|FG002|Overall Study|Suicidal ideation|1|||
145418943|NCT00086307|524388643|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
145418944|NCT00086307|524388644|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
145418945|NCT00086307|524388645|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
145418946|NCT00086307|524388643|FG000|Overall Study|Withdrawal by Subject|0|||
145418947|NCT00086307|524388644|FG001|Overall Study|Withdrawal by Subject|0|||
145361732|NCT02640664|524174660|FG000|Epoch 2|Death|0|||
145361733|NCT02640664|524174661|FG001|Epoch 2|Death|0|||
145361734|NCT02640664|524174662|FG002|Epoch 2|Death|1|||
145361735|NCT01207687|524174663|FG000|Overall Study|Adverse Event|1|||
145361736|NCT01207687|524174663|FG000|Overall Study|Withdrawal by Subject|1|||
145361737|NCT00987337|524174664|FG000|Overall Study|Adverse Event|10|||
145361738|NCT00987337|524174665|FG001|Overall Study|Adverse Event|9|||
145361739|NCT00987337|524174666|FG002|Overall Study|Adverse Event|8|||
145361740|NCT00987337|524174664|FG000|Overall Study|Insufficient Virologic Response|10|||
145361741|NCT00987337|524174665|FG001|Overall Study|Insufficient Virologic Response|7|||
145361742|NCT00987337|524174666|FG002|Overall Study|Insufficient Virologic Response|12|||
145361743|NCT00987337|524174664|FG000|Overall Study|Virologic Breakthrough|2|||
145361744|NCT00987337|524174665|FG001|Overall Study|Virologic Breakthrough|2|||
145361745|NCT00987337|524174666|FG002|Overall Study|Virologic Breakthrough|8|||
145361746|NCT00987337|524174664|FG000|Overall Study|Lost to Follow-up|10|||
145361747|NCT00987337|524174665|FG001|Overall Study|Lost to Follow-up|6|||
145361748|NCT00987337|524174666|FG002|Overall Study|Lost to Follow-up|2|||
145361749|NCT00987337|524174664|FG000|Overall Study|Withdrawal by Subject|6|||
145361750|NCT00987337|524174665|FG001|Overall Study|Withdrawal by Subject|9|||
145361751|NCT00987337|524174666|FG002|Overall Study|Withdrawal by Subject|9|||
145361752|NCT00987337|524174664|FG000|Overall Study|Other|0|||
145361753|NCT00987337|524174665|FG001|Overall Study|Other|2|||
145361754|NCT00987337|524174666|FG002|Overall Study|Other|5|||
145361755|NCT00987337|524174664|FG000|Overall Study|Protocol Violation|1|||
145361756|NCT00987337|524174665|FG001|Overall Study|Protocol Violation|0|||
145361757|NCT00987337|524174666|FG002|Overall Study|Protocol Violation|2|||
145361758|NCT00987337|524174664|FG000|Overall Study|Participant Relapsed|18|||
145361759|NCT00987337|524174665|FG001|Overall Study|Participant Relapsed|20|||
145361760|NCT00987337|524174666|FG002|Overall Study|Participant Relapsed|5|||
145361761|NCT01801865|524174668|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
145361762|NCT01801865|524174668|FG000|Overall Study|Physician Decision|7|||
145361763|NCT06868654|524174673|FG000|Overall Study|Death|4|||
145361764|NCT06868654|524174674|FG001|Overall Study|Death|14|||
145361765|NCT06868654|524174673|FG000|Overall Study|Lost to Follow-up|0|||
145361766|NCT06868654|524174674|FG001|Overall Study|Lost to Follow-up|1|||
145361767|NCT06868654|524174673|FG000|Overall Study|Withdrawal by Subject|5|||
145361768|NCT06868654|524174674|FG001|Overall Study|Withdrawal by Subject|3|||
145361769|NCT06868654|524174673|FG000|Overall Study|Physician Decision|0|||
145361770|NCT06868654|524174674|FG001|Overall Study|Physician Decision|1|||
145361771|NCT06868654|524174673|FG000|Overall Study|Ongoing|23|||
145361772|NCT06868654|524174674|FG001|Overall Study|Ongoing|21|||
145361773|NCT02134015|524174677|FG000|Overall Study|Protocol Violation|0|||
145361774|NCT02134015|524174678|FG001|Overall Study|Protocol Violation|1|||
145361775|NCT02134015|524174677|FG000|Overall Study|Death|2|||
145361776|NCT02134015|524174678|FG001|Overall Study|Death|1|||
145361777|NCT02134015|524174677|FG000|Overall Study|Reason not provided|1|||
145361778|NCT02134015|524174678|FG001|Overall Study|Reason not provided|2|||
145418948|NCT00086307|524388645|FG002|Overall Study|Withdrawal by Subject|2|||
145418949|NCT00683384|524388646|FG000|Overall Study|Death|1|||
145577564|NCT02391948|524969425|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
145361779|NCT02134015|524174677|FG000|Overall Study|Clinical progression|14|||
145361780|NCT02134015|524174678|FG001|Overall Study|Clinical progression|7|||
145361781|NCT02134015|524174677|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
145361782|NCT02134015|524174678|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
145361783|NCT02134015|524174677|FG000|Overall Study|Study terminated by sponsor|2|||
145418950|NCT00683384|524388646|FG000|Overall Study|Adverse Event|1|||
145418951|NCT00120874|524388647|FG000|Overall Study|Death|0|||
145577565|NCT02391948|524969426|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
145361784|NCT02134015|524174678|FG001|Overall Study|Study terminated by sponsor|3|||
145361785|NCT02134015|524174677|FG000|Overall Study|Adverse Event|9|||
145361786|NCT02134015|524174678|FG001|Overall Study|Adverse Event|10|||
145361787|NCT02134015|524174677|FG000|Overall Study|Withdrawal by Subject|3|||
145361788|NCT02134015|524174678|FG001|Overall Study|Withdrawal by Subject|7|||
145361789|NCT03867201|524174679|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
145361790|NCT03867201|524174680|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
145361791|NCT03867201|524174679|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
145361792|NCT03867201|524174680|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
145361793|NCT03867201|524174679|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
145361794|NCT03867201|524174680|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
145361795|NCT03867201|524174679|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
145361796|NCT03867201|524174680|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
145361797|NCT03867201|524174679|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
145361798|NCT03867201|524174680|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
145361799|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Adverse Event|5|||
145361800|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Adverse Event|11|||
145361801|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
145361802|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
145361803|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Physician Decision|6|||
145361804|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Physician Decision|3|||
145361805|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Pregnancy|2|||
145361806|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Pregnancy|2|||
145361807|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
145361808|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
145361809|NCT03867201|524174679|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
145361810|NCT03867201|524174680|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
145361811|NCT03867201|524174679|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
145361812|NCT03867201|524174680|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
145361813|NCT03867201|524174679|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
145361814|NCT03867201|524174680|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
145361815|NCT05763875|524174681|FG000|Overall Study|Subject decision|5|||
145361816|NCT05763875|524174682|FG001|Overall Study|Subject decision|2|||
145361817|NCT05763875|524174683|FG002|Overall Study|Subject decision|1|||
145361818|NCT05763875|524174681|FG000|Overall Study|Lost to Follow-up|4|||
145361819|NCT05763875|524174682|FG001|Overall Study|Lost to Follow-up|1|||
145361820|NCT05763875|524174683|FG002|Overall Study|Lost to Follow-up|2|||
145361821|NCT05763875|524174681|FG000|Overall Study|Adverse Event|1|||
145361822|NCT05763875|524174682|FG001|Overall Study|Adverse Event|0|||
145361823|NCT05763875|524174683|FG002|Overall Study|Adverse Event|0|||
145361824|NCT01777282|524174684|FG000|Overall Study|Persistent Hyperglycemia|0|||
145361825|NCT01777282|524174685|FG001|Overall Study|Persistent Hyperglycemia|0|||
145361826|NCT01777282|524174686|FG002|Overall Study|Persistent Hyperglycemia|1|||
145361827|NCT01777282|524174687|FG003|Overall Study|Persistent Hyperglycemia|0|||
145361828|NCT01777282|524174688|FG004|Overall Study|Persistent Hyperglycemia|0|||
145361829|NCT01777282|524174684|FG000|Overall Study|New Antidiabetic Medication|0|||
145361830|NCT01777282|524174685|FG001|Overall Study|New Antidiabetic Medication|0|||
145361831|NCT01777282|524174686|FG002|Overall Study|New Antidiabetic Medication|1|||
145361832|NCT01777282|524174687|FG003|Overall Study|New Antidiabetic Medication|0|||
145361833|NCT01777282|524174688|FG004|Overall Study|New Antidiabetic Medication|0|||
145361834|NCT01777282|524174684|FG000|Overall Study|Adverse Event|4|||
145361835|NCT01777282|524174685|FG001|Overall Study|Adverse Event|4|||
145361836|NCT01777282|524174686|FG002|Overall Study|Adverse Event|2|||
145361837|NCT01777282|524174687|FG003|Overall Study|Adverse Event|1|||
145361838|NCT01777282|524174688|FG004|Overall Study|Adverse Event|3|||
145361839|NCT01777282|524174684|FG000|Overall Study|Withdrawal by Subject|4|||
145361840|NCT01777282|524174685|FG001|Overall Study|Withdrawal by Subject|0|||
145361841|NCT01777282|524174686|FG002|Overall Study|Withdrawal by Subject|0|||
145361842|NCT01777282|524174687|FG003|Overall Study|Withdrawal by Subject|1|||
145361843|NCT01777282|524174688|FG004|Overall Study|Withdrawal by Subject|2|||
145361844|NCT01777282|524174684|FG000|Overall Study|Protocol Violation|2|||
145361845|NCT01777282|524174685|FG001|Overall Study|Protocol Violation|0|||
145361846|NCT01777282|524174686|FG002|Overall Study|Protocol Violation|1|||
145361847|NCT01777282|524174687|FG003|Overall Study|Protocol Violation|0|||
145361848|NCT01777282|524174688|FG004|Overall Study|Protocol Violation|2|||
145361849|NCT01777282|524174684|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
145361850|NCT01777282|524174685|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145361851|NCT01777282|524174686|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
145361852|NCT01777282|524174687|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145361853|NCT01777282|524174688|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
145361854|NCT00932373|524176201|FG000|Overall Study|Progressive disease|3|||
145361855|NCT00932373|524176202|FG001|Overall Study|Progressive disease|1|||
145418952|NCT00120874|524388648|FG001|Overall Study|Death|1|||
145418953|NCT01727154|524388649|FG000|Overall Study|Death|17|||
145418954|NCT01727154|524388649|FG000|Overall Study|Withdrawal by Subject|14|||
145418955|NCT01727154|524388649|FG000|Overall Study|Subject Withdrew Consent|18|||
145418956|NCT01727154|524388649|FG000|Overall Study|Study Terminated|6|||
145418957|NCT01727154|524388649|FG000|Overall Study|No Discontinuation Documentation|4|||
145418958|NCT01184118|524388660|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
145418959|NCT01184118|524388660|FG000|Overall Study|No physiologic confirmation of asthma|8|||
145418960|NCT01184118|524388660|FG000|Overall Study|FEV1 <60% predicted|2|||
145418961|NCT01184118|524388660|FG000|Overall Study|Exclusionary medical condition|2|||
145418962|NCT01184118|524388660|FG000|Overall Study|Withdrawal by Subject|5|||
145418963|NCT01049828|524388665|FG000|Overall Study|Claustrophibia and Frustration|2|||
145418964|NCT01198548|524388666|FG000|Overall Study|Disease Progression|9|||
145418965|NCT01198548|524388666|FG000|Overall Study|Administrative Decision|1|||
145418966|NCT00290238|524388667|FG000|Overall Study|Study terminated|27|||
145418967|NCT00290238|524388668|FG001|Overall Study|Study terminated|27|||
145418968|NCT00290238|524388667|FG000|Overall Study|Lost to Follow-up|0|||
145418969|NCT00290238|524388668|FG001|Overall Study|Lost to Follow-up|1|||
145418970|NCT00290238|524388667|FG000|Overall Study|Withdrawal by Subject|15|||
145418971|NCT00290238|524388668|FG001|Overall Study|Withdrawal by Subject|13|||
145418972|NCT03834883|524388669|FG000|Second Treatment|Withdrawal by Subject|1|||
145418973|NCT03834883|524388670|FG001|Second Treatment|Withdrawal by Subject|0|||
145418974|NCT03834883|524388671|FG002|Second Treatment|Withdrawal by Subject|0|||
145418975|NCT03834883|524388672|FG003|Second Treatment|Withdrawal by Subject|0|||
145418976|NCT03834883|524388669|FG000|Second Treatment|COVID-19 pandemic|1|||
145418977|NCT03834883|524388670|FG001|Second Treatment|COVID-19 pandemic|0|||
145418978|NCT03834883|524388671|FG002|Second Treatment|COVID-19 pandemic|1|||
145418979|NCT03834883|524388672|FG003|Second Treatment|COVID-19 pandemic|1|||
145418980|NCT01793129|524390580|FG000|Overall Study|Lost to Follow-up|3|||
145418981|NCT01793129|524390581|FG001|Overall Study|Lost to Follow-up|7|||
145418982|NCT01793129|524390580|FG000|Overall Study|Withdrawal by Subject|0|||
145418983|NCT01793129|524390581|FG001|Overall Study|Withdrawal by Subject|2|||
145418984|NCT03931785|524390584|FG000|Overall Study|Lost to Follow-up|4|||
145418985|NCT03931785|524390585|FG001|Overall Study|Lost to Follow-up|1|||
145418986|NCT03931785|524390586|FG002|Overall Study|Lost to Follow-up|4|||
145418987|NCT03931785|524390587|FG003|Overall Study|Lost to Follow-up|3|||
145418988|NCT03931785|524390584|FG000|Overall Study|Adverse Event|1|||
145418989|NCT03931785|524390585|FG001|Overall Study|Adverse Event|0|||
145418990|NCT03931785|524390586|FG002|Overall Study|Adverse Event|3|||
145418991|NCT03931785|524390587|FG003|Overall Study|Adverse Event|4|||
145418992|NCT03931785|524390584|FG000|Overall Study|Protocol Violation|0|||
145418993|NCT03931785|524390585|FG001|Overall Study|Protocol Violation|1|||
145418994|NCT03931785|524390586|FG002|Overall Study|Protocol Violation|0|||
145418995|NCT03931785|524390587|FG003|Overall Study|Protocol Violation|0|||
145418996|NCT03931785|524390584|FG000|Overall Study|Noncompliance With Study drug|0|||
145418997|NCT03931785|524390585|FG001|Overall Study|Noncompliance With Study drug|1|||
145418998|NCT03931785|524390586|FG002|Overall Study|Noncompliance With Study drug|0|||
145418999|NCT03931785|524390587|FG003|Overall Study|Noncompliance With Study drug|0|||
145419000|NCT03931785|524390584|FG000|Overall Study|Other Not specified|0|||
145419001|NCT03931785|524390585|FG001|Overall Study|Other Not specified|2|||
145419002|NCT03931785|524390586|FG002|Overall Study|Other Not specified|2|||
145419003|NCT03931785|524390587|FG003|Overall Study|Other Not specified|2|||
145419004|NCT03931785|524390584|FG000|Overall Study|Withdrawal by Subject|0|||
145419005|NCT03931785|524390585|FG001|Overall Study|Withdrawal by Subject|2|||
145419006|NCT03931785|524390586|FG002|Overall Study|Withdrawal by Subject|4|||
145419007|NCT03931785|524390587|FG003|Overall Study|Withdrawal by Subject|1|||
145577566|NCT02391948|524969427|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
145577567|NCT02391948|524969428|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
145577568|NCT02391948|524969429|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
145577569|NCT02866682|524969432|FG000|Overall Study|Death|0|||
145577570|NCT02866682|524969433|FG001|Overall Study|Death|1|||
145577571|NCT02866682|524969432|FG000|Overall Study|Lost to Follow-up|0|||
145577572|NCT02866682|524969433|FG001|Overall Study|Lost to Follow-up|4|||
145577573|NCT02866682|524969432|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
145623152|NCT02240680|525131599|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
145623153|NCT02240680|525131600|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
145419008|NCT03931785|524390584|FG000|Overall Study|Pregnancy|0|||
145419009|NCT03931785|524390585|FG001|Overall Study|Pregnancy|0|||
145419010|NCT03931785|524390586|FG002|Overall Study|Pregnancy|0|||
145419011|NCT03931785|524390587|FG003|Overall Study|Pregnancy|1|||
145419012|NCT03548415|524390588|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
145419013|NCT03548415|524390589|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145419014|NCT03548415|524390590|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
145577574|NCT02866682|524969433|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
145577575|NCT02866682|524969432|FG000|Overall Study|Other|0|||
145577576|NCT02866682|524969433|FG001|Overall Study|Other|1|||
145361856|NCT00932373|524176203|FG002|Overall Study|Progressive disease|0|||
145361857|NCT00932373|524176204|FG003|Overall Study|Progressive disease|0|||
145361858|NCT00932373|524176205|FG004|Overall Study|Progressive disease|10|||
145361859|NCT00932373|524176206|FG005|Overall Study|Progressive disease|1|||
145361860|NCT00932373|524176207|FG006|Overall Study|Progressive disease|0|||
145361861|NCT00932373|524176208|FG007|Overall Study|Progressive disease|2|||
145361862|NCT00932373|524176209|FG008|Overall Study|Progressive disease|1|||
145361863|NCT00932373|524176210|FG009|Overall Study|Progressive disease|9|||
145361864|NCT00932373|524176211|FG010|Overall Study|Progressive disease|2|||
145361865|NCT00932373|524176201|FG000|Overall Study|Adverse Event|0|||
145361866|NCT00932373|524176202|FG001|Overall Study|Adverse Event|0|||
145361867|NCT00932373|524176203|FG002|Overall Study|Adverse Event|0|||
145361868|NCT00932373|524176204|FG003|Overall Study|Adverse Event|0|||
145361869|NCT00932373|524176205|FG004|Overall Study|Adverse Event|2|||
145361870|NCT00932373|524176206|FG005|Overall Study|Adverse Event|1|||
145361871|NCT00932373|524176207|FG006|Overall Study|Adverse Event|0|||
145361872|NCT00932373|524176208|FG007|Overall Study|Adverse Event|1|||
145361873|NCT00932373|524176209|FG008|Overall Study|Adverse Event|0|||
145361874|NCT00932373|524176210|FG009|Overall Study|Adverse Event|2|||
145361875|NCT00932373|524176211|FG010|Overall Study|Adverse Event|1|||
145361876|NCT00932373|524176201|FG000|Overall Study|Physician Decision|0|||
145361877|NCT00932373|524176202|FG001|Overall Study|Physician Decision|0|||
145361878|NCT00932373|524176203|FG002|Overall Study|Physician Decision|1|||
145361879|NCT00932373|524176204|FG003|Overall Study|Physician Decision|0|||
145361880|NCT00932373|524176205|FG004|Overall Study|Physician Decision|2|||
145361881|NCT00932373|524176206|FG005|Overall Study|Physician Decision|0|||
145361882|NCT00932373|524176207|FG006|Overall Study|Physician Decision|0|||
145361883|NCT00932373|524176208|FG007|Overall Study|Physician Decision|0|||
145361884|NCT00932373|524176209|FG008|Overall Study|Physician Decision|0|||
145361885|NCT00932373|524176210|FG009|Overall Study|Physician Decision|1|||
145361886|NCT00932373|524176211|FG010|Overall Study|Physician Decision|0|||
145361887|NCT00932373|524176201|FG000|Overall Study|Dose limiting toxicity|0|||
145361888|NCT00932373|524176202|FG001|Overall Study|Dose limiting toxicity|0|||
145361889|NCT00932373|524176203|FG002|Overall Study|Dose limiting toxicity|0|||
145361890|NCT00932373|524176204|FG003|Overall Study|Dose limiting toxicity|0|||
145361891|NCT00932373|524176205|FG004|Overall Study|Dose limiting toxicity|0|||
145361892|NCT00932373|524176206|FG005|Overall Study|Dose limiting toxicity|1|||
145361893|NCT00932373|524176207|FG006|Overall Study|Dose limiting toxicity|0|||
145361894|NCT00932373|524176208|FG007|Overall Study|Dose limiting toxicity|0|||
145361895|NCT00932373|524176209|FG008|Overall Study|Dose limiting toxicity|0|||
145361896|NCT00932373|524176210|FG009|Overall Study|Dose limiting toxicity|0|||
145361897|NCT00932373|524176211|FG010|Overall Study|Dose limiting toxicity|0|||
145361898|NCT00932373|524176201|FG000|Overall Study|Withdrawal by Subject|0|||
145361899|NCT00932373|524176202|FG001|Overall Study|Withdrawal by Subject|0|||
145361900|NCT00932373|524176203|FG002|Overall Study|Withdrawal by Subject|0|||
145361901|NCT00932373|524176204|FG003|Overall Study|Withdrawal by Subject|0|||
145361902|NCT00932373|524176205|FG004|Overall Study|Withdrawal by Subject|0|||
145361903|NCT00932373|524176206|FG005|Overall Study|Withdrawal by Subject|0|||
145361904|NCT00932373|524176207|FG006|Overall Study|Withdrawal by Subject|0|||
145361905|NCT00932373|524176208|FG007|Overall Study|Withdrawal by Subject|0|||
145361906|NCT00932373|524176209|FG008|Overall Study|Withdrawal by Subject|1|||
145361907|NCT00932373|524176210|FG009|Overall Study|Withdrawal by Subject|0|||
145361908|NCT00932373|524176211|FG010|Overall Study|Withdrawal by Subject|0|||
145361909|NCT00932373|524176201|FG000|Overall Study|Clinical progression|0|||
145361910|NCT00932373|524176202|FG001|Overall Study|Clinical progression|0|||
145361911|NCT00932373|524176203|FG002|Overall Study|Clinical progression|0|||
145361912|NCT00932373|524176204|FG003|Overall Study|Clinical progression|0|||
145361913|NCT00932373|524176205|FG004|Overall Study|Clinical progression|0|||
145361914|NCT00932373|524176206|FG005|Overall Study|Clinical progression|0|||
145361915|NCT00932373|524176207|FG006|Overall Study|Clinical progression|1|||
145361916|NCT00932373|524176208|FG007|Overall Study|Clinical progression|0|||
145361917|NCT00932373|524176209|FG008|Overall Study|Clinical progression|0|||
145361918|NCT00932373|524176210|FG009|Overall Study|Clinical progression|0|||
145361919|NCT00932373|524176211|FG010|Overall Study|Clinical progression|0|||
145361920|NCT00932373|524176201|FG000|Overall Study|Lack of Efficacy|0|||
145361921|NCT00932373|524176202|FG001|Overall Study|Lack of Efficacy|0|||
145361922|NCT00932373|524176203|FG002|Overall Study|Lack of Efficacy|0|||
145361923|NCT00932373|524176204|FG003|Overall Study|Lack of Efficacy|0|||
145361924|NCT00932373|524176205|FG004|Overall Study|Lack of Efficacy|0|||
145361925|NCT00932373|524176206|FG005|Overall Study|Lack of Efficacy|0|||
145361926|NCT00932373|524176207|FG006|Overall Study|Lack of Efficacy|0|||
145361927|NCT00932373|524176208|FG007|Overall Study|Lack of Efficacy|0|||
145361928|NCT00932373|524176209|FG008|Overall Study|Lack of Efficacy|0|||
145361929|NCT00932373|524176210|FG009|Overall Study|Lack of Efficacy|1|||
145361930|NCT00932373|524176211|FG010|Overall Study|Lack of Efficacy|0|||
145361931|NCT00459290|524176215|FG000|Overall Study|Adverse Event|3|||
145361932|NCT00459290|524176215|FG000|Overall Study|Ineligible|2|||
145361933|NCT06152224|524176216|FG000|Overall Study|Withdrawal by Subject|1|||
145361934|NCT06152224|524176217|FG001|Overall Study|Withdrawal by Subject|0|||
145361935|NCT06152224|524176216|FG000|Overall Study|Lost to Follow-up|0|||
145361936|NCT06152224|524176217|FG001|Overall Study|Lost to Follow-up|1|||
145361937|NCT06152224|524176216|FG000|Overall Study|On Follow Up|18|||
145361938|NCT06152224|524176217|FG001|Overall Study|On Follow Up|18|||
145361939|NCT03337113|524176224|FG000|Overall Study|Adverse Event|1|||
145361940|NCT03337113|524176225|FG001|Overall Study|Adverse Event|1|||
145361941|NCT03337113|524176226|FG002|Overall Study|Adverse Event|0|||
145361942|NCT03337113|524176227|FG003|Overall Study|Adverse Event|1|||
145361943|NCT03337113|524176224|FG000|Overall Study|Physician Decision|0|||
145361944|NCT03337113|524176225|FG001|Overall Study|Physician Decision|2|||
145361945|NCT03337113|524176226|FG002|Overall Study|Physician Decision|0|||
145361946|NCT03337113|524176227|FG003|Overall Study|Physician Decision|1|||
145361947|NCT03337113|524176224|FG000|Overall Study|Withdrawal by Subject|0|||
145361948|NCT03337113|524176225|FG001|Overall Study|Withdrawal by Subject|0|||
145361949|NCT03337113|524176226|FG002|Overall Study|Withdrawal by Subject|1|||
145361950|NCT03337113|524176227|FG003|Overall Study|Withdrawal by Subject|0|||
145361951|NCT02476578|524176236|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
145361952|NCT02476578|524176237|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
145361953|NCT02476578|524176236|FG000|Overall Study|Lost to Follow-up|6|||
145361954|NCT02476578|524176237|FG001|Overall Study|Lost to Follow-up|13|||
145361955|NCT03491462|524176238|FG000|Overall Study|Lost to Follow-up|2|||
145361956|NCT03491462|524176239|FG001|Overall Study|Lost to Follow-up|0|||
145361957|NCT03491462|524176238|FG000|Overall Study|Adverse Event|11|||
145361958|NCT03491462|524176239|FG001|Overall Study|Adverse Event|1|||
145361959|NCT03491462|524176238|FG000|Overall Study|Physician Decision|3|||
145361960|NCT03491462|524176239|FG001|Overall Study|Physician Decision|0|||
145361961|NCT03491462|524176238|FG000|Overall Study|Withdrawal by Subject|22|||
145361962|NCT03491462|524176239|FG001|Overall Study|Withdrawal by Subject|15|||
145361963|NCT04938180|524176240|FG000|Overall Study|Adverse Event|1|||
145361964|NCT01019694|524176241|FG000|Overall Study|Adverse Event|12|||
145361965|NCT01019694|524176242|FG001|Overall Study|Adverse Event|16|||
145361966|NCT01019694|524176243|FG002|Overall Study|Adverse Event|19|||
145361967|NCT01019694|524176241|FG000|Overall Study|Protocol Violation|2|||
145361968|NCT01019694|524176242|FG001|Overall Study|Protocol Violation|6|||
145361969|NCT01019694|524176243|FG002|Overall Study|Protocol Violation|4|||
145361970|NCT01019694|524176241|FG000|Overall Study|Lost to Follow-up|5|||
145361971|NCT01019694|524176242|FG001|Overall Study|Lost to Follow-up|3|||
145361972|NCT01019694|524176243|FG002|Overall Study|Lost to Follow-up|3|||
145361973|NCT01019694|524176241|FG000|Overall Study|Withdrawal by Subject|4|||
145361974|NCT01019694|524176242|FG001|Overall Study|Withdrawal by Subject|6|||
145361975|NCT01019694|524176243|FG002|Overall Study|Withdrawal by Subject|12|||
145361976|NCT01019694|524176241|FG000|Overall Study|Not treated|0|||
145361977|NCT01019694|524176242|FG001|Overall Study|Not treated|2|||
145361978|NCT01019694|524176243|FG002|Overall Study|Not treated|3|||
145361979|NCT01019694|524176241|FG000|Overall Study|Other reason (not specified)|1|||
145361980|NCT01019694|524176242|FG001|Overall Study|Other reason (not specified)|5|||
145361981|NCT01019694|524176243|FG002|Overall Study|Other reason (not specified)|6|||
145361982|NCT01737710|524176248|FG000|Overall Study|Lost to Follow-up|0|||
145361983|NCT01737710|524176249|FG001|Overall Study|Lost to Follow-up|2|||
145361984|NCT01737710|524176250|FG002|Overall Study|Lost to Follow-up|2|||
145361985|NCT01737710|524176251|FG003|Overall Study|Lost to Follow-up|0|||
145361986|NCT01737710|524176252|FG004|Overall Study|Lost to Follow-up|0|||
145361987|NCT01737710|524176248|FG000|Overall Study|Withdrawal by Subject|1|||
145361988|NCT01737710|524176249|FG001|Overall Study|Withdrawal by Subject|1|||
145361989|NCT01737710|524176250|FG002|Overall Study|Withdrawal by Subject|1|||
145361990|NCT01737710|524176251|FG003|Overall Study|Withdrawal by Subject|0|||
145361991|NCT01737710|524176252|FG004|Overall Study|Withdrawal by Subject|0|||
145361992|NCT01737710|524176248|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
145361993|NCT01737710|524176249|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
145361994|NCT01737710|524176250|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
145361995|NCT01737710|524176251|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
145361996|NCT01737710|524176252|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
145361997|NCT04747886|524176253|FG000|Overall Study|Withdrawal by Subject|1|||
145361998|NCT04747886|524176254|FG001|Overall Study|Withdrawal by Subject|4|||
145361999|NCT03777436|524176258|FG000|Placebo-controlled Phase|Adverse Event|8|||
145577577|NCT00201006|524969434|FG000|Overall Study|Withdrawal by Subject|7|||
145362000|NCT03777436|524176259|FG001|Placebo-controlled Phase|Adverse Event|10|||
145362001|NCT03777436|524176260|FG002|Placebo-controlled Phase|Adverse Event|0|||
145362002|NCT03777436|524176258|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
145362003|NCT03777436|524176259|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
145362004|NCT03777436|524176260|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
145362005|NCT03777436|524176258|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
145362006|NCT03777436|524176259|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
145362007|NCT03777436|524176260|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
145577578|NCT00201006|524969435|FG001|Overall Study|Withdrawal by Subject|2|||
145577579|NCT00201006|524969436|FG002|Overall Study|Withdrawal by Subject|3|||
145419015|NCT03548415|524390591|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
145419016|NCT03548415|524390592|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
145419017|NCT04605588|524390593|FG000|Overall Study|Withdrawal by Subject|1|||
145419018|NCT04605588|524390594|FG001|Overall Study|Withdrawal by Subject|0|||
145419019|NCT01230814|524390595|FG000|Overall Study|Lost to Follow-up|11|||
145419020|NCT01230814|524390596|FG001|Overall Study|Lost to Follow-up|3|||
145362008|NCT03777436|524176258|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
145362009|NCT03777436|524176259|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
145362010|NCT03777436|524176260|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
145362011|NCT03777436|524176258|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
145362012|NCT03777436|524176259|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
145362013|NCT03777436|524176260|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
145362014|NCT03777436|524176258|FG000|Placebo-controlled Phase|Physician Decision|0|||
145362015|NCT03777436|524176259|FG001|Placebo-controlled Phase|Physician Decision|1|||
145362016|NCT03777436|524176260|FG002|Placebo-controlled Phase|Physician Decision|0|||
145362017|NCT03777436|524176258|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
145362018|NCT03777436|524176259|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
145362019|NCT03777436|524176260|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
145362020|NCT03777436|524176258|FG000|Apremilast Extension Phase|Adverse Event|0|||
145362021|NCT03777436|524176259|FG001|Apremilast Extension Phase|Adverse Event|0|||
145362022|NCT03777436|524176260|FG002|Apremilast Extension Phase|Adverse Event|6|||
145362023|NCT03777436|524176258|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
145362024|NCT03777436|524176259|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
145362025|NCT03777436|524176260|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
145362026|NCT03777436|524176258|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
145362027|NCT03777436|524176259|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
145362028|NCT03777436|524176260|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
145362029|NCT03777436|524176258|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
145362030|NCT03777436|524176259|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
145362031|NCT03777436|524176260|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
145362032|NCT03777436|524176258|FG000|Apremilast Extension Phase|Miscellaneous|0|||
145362033|NCT03777436|524176259|FG001|Apremilast Extension Phase|Miscellaneous|0|||
145362034|NCT03777436|524176260|FG002|Apremilast Extension Phase|Miscellaneous|1|||
145362035|NCT00869999|524176263|FG000|Overall Study|Withdrawal by Subject|1|||
145362036|NCT00869999|524176263|FG000|Overall Study|removed prior to starting therapy|1|||
145362037|NCT00685399|524176264|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145362038|NCT00685399|524176265|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145362039|NCT00685399|524176266|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145362040|NCT00685399|524176267|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145362041|NCT00685399|524176268|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145362042|NCT00685399|524176269|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145362043|NCT00685399|524176270|FG006|Treatment Period 1|Withdrawal by Subject|0|||
145362044|NCT00685399|524176271|FG007|Treatment Period 1|Withdrawal by Subject|0|||
145362045|NCT00685399|524176264|FG000|Treatment Period 1|Protocol Violation|1|||
145362046|NCT00685399|524176265|FG001|Treatment Period 1|Protocol Violation|0|||
145362047|NCT00685399|524176266|FG002|Treatment Period 1|Protocol Violation|0|||
145362048|NCT00685399|524176267|FG003|Treatment Period 1|Protocol Violation|0|||
145362049|NCT00685399|524176268|FG004|Treatment Period 1|Protocol Violation|0|||
145362050|NCT00685399|524176269|FG005|Treatment Period 1|Protocol Violation|0|||
145362051|NCT00685399|524176270|FG006|Treatment Period 1|Protocol Violation|0|||
145362052|NCT00685399|524176271|FG007|Treatment Period 1|Protocol Violation|0|||
145362053|NCT00685399|524176264|FG000|Treatment Period 1|Administrative|2|||
145362054|NCT00685399|524176265|FG001|Treatment Period 1|Administrative|0|||
145362055|NCT00685399|524176266|FG002|Treatment Period 1|Administrative|0|||
145362056|NCT00685399|524176267|FG003|Treatment Period 1|Administrative|0|||
145362057|NCT00685399|524176268|FG004|Treatment Period 1|Administrative|0|||
145362058|NCT00685399|524176269|FG005|Treatment Period 1|Administrative|0|||
145362059|NCT00685399|524176270|FG006|Treatment Period 1|Administrative|0|||
145362060|NCT00685399|524176271|FG007|Treatment Period 1|Administrative|0|||
145419021|NCT01230814|524390595|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
145419022|NCT01230814|524390596|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
145419023|NCT01803737|524390599|FG000|Overall Study|Lack of Time|1|||
145419024|NCT01803737|524390600|FG001|Overall Study|Lack of Time|0|||
145419025|NCT01803737|524390599|FG000|Overall Study|Medical Reason|0|||
145419026|NCT01803737|524390600|FG001|Overall Study|Medical Reason|1|||
145419027|NCT01803737|524390599|FG000|Overall Study|Lost to Follow-up|0|||
145362061|NCT00685399|524176264|FG000|Treatment Period 1|Lack of Efficacy|1|||
145362062|NCT00685399|524176265|FG001|Treatment Period 1|Lack of Efficacy|0|||
145362063|NCT00685399|524176266|FG002|Treatment Period 1|Lack of Efficacy|0|||
145362064|NCT00685399|524176267|FG003|Treatment Period 1|Lack of Efficacy|0|||
145362065|NCT00685399|524176268|FG004|Treatment Period 1|Lack of Efficacy|0|||
145362066|NCT00685399|524176269|FG005|Treatment Period 1|Lack of Efficacy|0|||
145362067|NCT00685399|524176270|FG006|Treatment Period 1|Lack of Efficacy|0|||
145362068|NCT00685399|524176271|FG007|Treatment Period 1|Lack of Efficacy|0|||
145362069|NCT00685399|524176264|FG000|Treatment Period 2|Administrative Problems|0|||
145362070|NCT00685399|524176265|FG001|Treatment Period 2|Administrative Problems|2|||
145362071|NCT00685399|524176266|FG002|Treatment Period 2|Administrative Problems|1|||
145362072|NCT00685399|524176267|FG003|Treatment Period 2|Administrative Problems|0|||
145577580|NCT00201006|524969434|FG000|Overall Study|Adverse Event|1|||
145577581|NCT00201006|524969435|FG001|Overall Study|Adverse Event|0|||
145577582|NCT00201006|524969436|FG002|Overall Study|Adverse Event|1|||
145577583|NCT00938431|524969440|FG000|Overall Study|Adverse Event|5|||
145362073|NCT00685399|524176268|FG004|Treatment Period 2|Administrative Problems|0|||
145362074|NCT00685399|524176269|FG005|Treatment Period 2|Administrative Problems|0|||
145362075|NCT00685399|524176270|FG006|Treatment Period 2|Administrative Problems|0|||
145362076|NCT00685399|524176271|FG007|Treatment Period 2|Administrative Problems|0|||
145362077|NCT00685399|524176264|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145362078|NCT00685399|524176265|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145362079|NCT00685399|524176266|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145362080|NCT00685399|524176267|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145362081|NCT00685399|524176268|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145362082|NCT00685399|524176269|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145362083|NCT00685399|524176270|FG006|Treatment Period 2|Withdrawal by Subject|0|||
145362084|NCT00685399|524176271|FG007|Treatment Period 2|Withdrawal by Subject|2|||
145362085|NCT00685399|524176264|FG000|Treatment Period 2|Adverse Event|0|||
145362086|NCT00685399|524176265|FG001|Treatment Period 2|Adverse Event|0|||
145362087|NCT00685399|524176266|FG002|Treatment Period 2|Adverse Event|0|||
145362088|NCT00685399|524176267|FG003|Treatment Period 2|Adverse Event|0|||
145362089|NCT00685399|524176268|FG004|Treatment Period 2|Adverse Event|0|||
145362090|NCT00685399|524176269|FG005|Treatment Period 2|Adverse Event|1|||
145362091|NCT00685399|524176270|FG006|Treatment Period 2|Adverse Event|0|||
145362092|NCT00685399|524176271|FG007|Treatment Period 2|Adverse Event|0|||
145362093|NCT00685399|524176264|FG000|Treatment Period 2|Lack of Efficacy|0|||
145362094|NCT00685399|524176265|FG001|Treatment Period 2|Lack of Efficacy|10|||
145362095|NCT00685399|524176266|FG002|Treatment Period 2|Lack of Efficacy|2|||
145362096|NCT00685399|524176267|FG003|Treatment Period 2|Lack of Efficacy|0|||
145362097|NCT00685399|524176268|FG004|Treatment Period 2|Lack of Efficacy|0|||
145362098|NCT00685399|524176269|FG005|Treatment Period 2|Lack of Efficacy|1|||
145362099|NCT00685399|524176270|FG006|Treatment Period 2|Lack of Efficacy|0|||
145362100|NCT00685399|524176271|FG007|Treatment Period 2|Lack of Efficacy|0|||
145362101|NCT00685399|524176264|FG000|Extension|Administrative Issues|0|||
145419028|NCT01803737|524390600|FG001|Overall Study|Lost to Follow-up|2|||
145419029|NCT00504556|524390603|FG000|Overall Study|Adverse Event|11|||
145419030|NCT00504556|524390604|FG001|Overall Study|Adverse Event|11|||
145419031|NCT00504556|524390605|FG002|Overall Study|Adverse Event|14|||
145419032|NCT00504556|524390606|FG003|Overall Study|Adverse Event|13|||
145419033|NCT00504556|524390607|FG004|Overall Study|Adverse Event|5|||
145419034|NCT00504556|524390603|FG000|Overall Study|Death|3|||
145419035|NCT00504556|524390604|FG001|Overall Study|Death|3|||
145419036|NCT00504556|524390605|FG002|Overall Study|Death|1|||
145419037|NCT00504556|524390606|FG003|Overall Study|Death|0|||
145419038|NCT00504556|524390607|FG004|Overall Study|Death|2|||
145419039|NCT00504556|524390603|FG000|Overall Study|Protocol Violation|1|||
145419040|NCT00504556|524390604|FG001|Overall Study|Protocol Violation|3|||
145419041|NCT00504556|524390605|FG002|Overall Study|Protocol Violation|2|||
145419042|NCT00504556|524390606|FG003|Overall Study|Protocol Violation|1|||
145419043|NCT00504556|524390607|FG004|Overall Study|Protocol Violation|2|||
145419044|NCT00504556|524390603|FG000|Overall Study|Lost to Follow-up|0|||
145419045|NCT00504556|524390604|FG001|Overall Study|Lost to Follow-up|0|||
145419046|NCT00504556|524390605|FG002|Overall Study|Lost to Follow-up|1|||
145419047|NCT00504556|524390606|FG003|Overall Study|Lost to Follow-up|1|||
145419048|NCT00504556|524390607|FG004|Overall Study|Lost to Follow-up|1|||
145419049|NCT00504556|524390603|FG000|Overall Study|Withdrawal by Subject|16|||
145577584|NCT00938431|524969441|FG001|Overall Study|Adverse Event|8|||
145577585|NCT00938431|524969442|FG002|Overall Study|Adverse Event|6|||
145577586|NCT00938431|524969440|FG000|Overall Study|Lack of Efficacy|0|||
145577587|NCT00938431|524969441|FG001|Overall Study|Lack of Efficacy|1|||
145362102|NCT00685399|524176265|FG001|Extension|Administrative Issues|0|||
145362103|NCT00685399|524176266|FG002|Extension|Administrative Issues|0|||
145362104|NCT00685399|524176267|FG003|Extension|Administrative Issues|1|||
145362105|NCT00685399|524176268|FG004|Extension|Administrative Issues|0|||
145362106|NCT00685399|524176269|FG005|Extension|Administrative Issues|0|||
145362107|NCT00685399|524176270|FG006|Extension|Administrative Issues|0|||
145362108|NCT00685399|524176271|FG007|Extension|Administrative Issues|0|||
145419050|NCT00504556|524390604|FG001|Overall Study|Withdrawal by Subject|16|||
145419051|NCT00504556|524390605|FG002|Overall Study|Withdrawal by Subject|7|||
145419052|NCT00504556|524390606|FG003|Overall Study|Withdrawal by Subject|8|||
145419053|NCT00504556|524390607|FG004|Overall Study|Withdrawal by Subject|12|||
145419054|NCT00504556|524390603|FG000|Overall Study|administrative reasons|0|||
145419055|NCT00504556|524390604|FG001|Overall Study|administrative reasons|2|||
145577588|NCT00938431|524969442|FG002|Overall Study|Lack of Efficacy|0|||
145577589|NCT00938431|524969440|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
145577590|NCT00938431|524969441|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
145577591|NCT00938431|524969442|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
145577592|NCT00938431|524969440|FG000|Overall Study|Dosing compliance issue|0|||
145577593|NCT00938431|524969441|FG001|Overall Study|Dosing compliance issue|0|||
145362109|NCT00685399|524176264|FG000|Extension|Withdrawal by Subject|0|||
145362110|NCT00685399|524176265|FG001|Extension|Withdrawal by Subject|0|||
145362111|NCT00685399|524176266|FG002|Extension|Withdrawal by Subject|0|||
145362112|NCT00685399|524176267|FG003|Extension|Withdrawal by Subject|1|||
145362113|NCT00685399|524176268|FG004|Extension|Withdrawal by Subject|0|||
145362114|NCT00685399|524176269|FG005|Extension|Withdrawal by Subject|0|||
145362115|NCT00685399|524176270|FG006|Extension|Withdrawal by Subject|0|||
145362116|NCT00685399|524176271|FG007|Extension|Withdrawal by Subject|0|||
145362117|NCT00685399|524176264|FG000|Extension|Protocol Violation|0|||
145362118|NCT00685399|524176265|FG001|Extension|Protocol Violation|0|||
145362119|NCT00685399|524176266|FG002|Extension|Protocol Violation|0|||
145362120|NCT00685399|524176267|FG003|Extension|Protocol Violation|1|||
145362121|NCT00685399|524176268|FG004|Extension|Protocol Violation|0|||
145362122|NCT00685399|524176269|FG005|Extension|Protocol Violation|0|||
145362123|NCT00685399|524176270|FG006|Extension|Protocol Violation|0|||
145362124|NCT00685399|524176271|FG007|Extension|Protocol Violation|0|||
145362125|NCT00685399|524176264|FG000|Extension|Lack of Efficacy|0|||
145362126|NCT00685399|524176265|FG001|Extension|Lack of Efficacy|0|||
145362127|NCT00685399|524176266|FG002|Extension|Lack of Efficacy|0|||
145362128|NCT00685399|524176267|FG003|Extension|Lack of Efficacy|2|||
145362129|NCT00685399|524176268|FG004|Extension|Lack of Efficacy|0|||
145362130|NCT00685399|524176269|FG005|Extension|Lack of Efficacy|0|||
145362131|NCT00685399|524176270|FG006|Extension|Lack of Efficacy|0|||
145362132|NCT00685399|524176271|FG007|Extension|Lack of Efficacy|0|||
145362133|NCT00685399|524176264|FG000|Extension|Adverse Event|0|||
145362134|NCT00685399|524176265|FG001|Extension|Adverse Event|0|||
145362135|NCT00685399|524176266|FG002|Extension|Adverse Event|0|||
145362136|NCT00685399|524176267|FG003|Extension|Adverse Event|2|||
145362137|NCT00685399|524176268|FG004|Extension|Adverse Event|0|||
145362138|NCT00685399|524176269|FG005|Extension|Adverse Event|0|||
145362139|NCT00685399|524176270|FG006|Extension|Adverse Event|0|||
145362140|NCT00685399|524176271|FG007|Extension|Adverse Event|0|||
145362141|NCT02684097|524176278|FG000|Overall Study|Lack of Efficacy|13|||
145362142|NCT02684097|524176279|FG001|Overall Study|Lack of Efficacy|6|||
145362143|NCT00462709|524176280|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
145362144|NCT00462709|524176280|FG000|Overall Study|Lost to Follow-up|10|||
145362145|NCT00462709|524176280|FG000|Overall Study|Withdrawal by Subject|8|||
145362146|NCT00462709|524176280|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
145362147|NCT00462709|524176280|FG000|Overall Study|Death|2|||
145362148|NCT00462709|524176280|FG000|Overall Study|Logistical reasons|2|||
145362149|NCT00462709|524176280|FG000|Overall Study|Physician Decision|1|||
145362150|NCT00462709|524176280|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
145362151|NCT02064816|524176281|FG000|Overall Study|Adverse Event|3|||
145362152|NCT02064816|524176282|FG001|Overall Study|Adverse Event|2|||
145362153|NCT02064816|524176281|FG000|Overall Study|Withdrawal by Subject|2|||
145362154|NCT02064816|524176282|FG001|Overall Study|Withdrawal by Subject|1|||
145362155|NCT02064816|524176281|FG000|Overall Study|Lost to Follow-up|2|||
145362156|NCT02064816|524176282|FG001|Overall Study|Lost to Follow-up|1|||
145362157|NCT02064816|524176281|FG000|Overall Study|Therapeutic failure|0|||
145362158|NCT02064816|524176282|FG001|Overall Study|Therapeutic failure|1|||
145362159|NCT02064816|524176281|FG000|Overall Study|Other|1|||
145362160|NCT02064816|524176282|FG001|Overall Study|Other|3|||
145362161|NCT04468347|524176283|FG000|Overall Study|Withdrawal by Subject|0|||
145362162|NCT04468347|524176284|FG001|Overall Study|Withdrawal by Subject|1|||
145362163|NCT04468347|524176285|FG002|Overall Study|Withdrawal by Subject|3|||
145362164|NCT04468347|524176286|FG003|Overall Study|Withdrawal by Subject|3|||
145362165|NCT04468347|524176283|FG000|Overall Study|Lost to Follow-up|0|||
145362166|NCT04468347|524176284|FG001|Overall Study|Lost to Follow-up|0|||
145362167|NCT04468347|524176285|FG002|Overall Study|Lost to Follow-up|1|||
145362168|NCT04468347|524176286|FG003|Overall Study|Lost to Follow-up|1|||
145362169|NCT04468347|524176283|FG000|Overall Study|Physician Decision|1|||
145362170|NCT04468347|524176284|FG001|Overall Study|Physician Decision|0|||
145362171|NCT04468347|524176285|FG002|Overall Study|Physician Decision|2|||
145362172|NCT04468347|524176286|FG003|Overall Study|Physician Decision|0|||
145362173|NCT04468347|524176283|FG000|Overall Study|Protocol Violation|1|||
145577594|NCT00938431|524969442|FG002|Overall Study|Dosing compliance issue|1|||
145577595|NCT00938431|524969440|FG000|Overall Study|Reached maximum dose early|0|||
145577596|NCT00938431|524969441|FG001|Overall Study|Reached maximum dose early|0|||
145362174|NCT04468347|524176284|FG001|Overall Study|Protocol Violation|0|||
145362175|NCT04468347|524176285|FG002|Overall Study|Protocol Violation|0|||
145362176|NCT04468347|524176286|FG003|Overall Study|Protocol Violation|0|||
145362177|NCT01732458|524176287|FG000|Overall Study|Lost to Follow-up|0|||
145362178|NCT01732458|524176288|FG001|Overall Study|Lost to Follow-up|2|||
145577597|NCT00938431|524969442|FG002|Overall Study|Reached maximum dose early|1|||
145362179|NCT01732458|524176289|FG002|Overall Study|Lost to Follow-up|0|||
145362180|NCT01732458|524176290|FG003|Overall Study|Lost to Follow-up|0|||
145419056|NCT00504556|524390605|FG002|Overall Study|administrative reasons|2|||
145419057|NCT00504556|524390606|FG003|Overall Study|administrative reasons|1|||
145419058|NCT00504556|524390607|FG004|Overall Study|administrative reasons|2|||
145362181|NCT01732458|524176287|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145362182|NCT01732458|524176288|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145362183|NCT01732458|524176289|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145362184|NCT01732458|524176290|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145362185|NCT01732458|524176287|FG000|Overall Study|Physician Decision|1|||
145362186|NCT01732458|524176288|FG001|Overall Study|Physician Decision|2|||
145362187|NCT01732458|524176289|FG002|Overall Study|Physician Decision|2|||
145362188|NCT01732458|524176290|FG003|Overall Study|Physician Decision|0|||
145362189|NCT01732458|524176287|FG000|Overall Study|Protocol Violation|2|||
145362190|NCT01732458|524176288|FG001|Overall Study|Protocol Violation|0|||
145362191|NCT01732458|524176289|FG002|Overall Study|Protocol Violation|0|||
145362192|NCT01732458|524176290|FG003|Overall Study|Protocol Violation|2|||
145362193|NCT01732458|524176287|FG000|Overall Study|Screen Failure|0|||
145362194|NCT01732458|524176288|FG001|Overall Study|Screen Failure|1|||
145362195|NCT01732458|524176289|FG002|Overall Study|Screen Failure|0|||
145362196|NCT01732458|524176290|FG003|Overall Study|Screen Failure|0|||
145362197|NCT00237458|524176291|FG000|Overall Study|Lack of Efficacy|1|||
145362198|NCT00237458|524176291|FG000|Overall Study|Adverse Event|1|||
145362199|NCT00237458|524176291|FG000|Overall Study|Withdrawal by Subject|1|||
145362200|NCT04339062|524176292|FG000|Overall Study|Death|0|||
145362201|NCT04339062|524176293|FG001|Overall Study|Death|1|||
145362202|NCT03218826|524176294|FG000|Overall Study|Non-compliance with protocol|1|||
145362203|NCT03218826|524176295|FG001|Overall Study|Non-compliance with protocol|0|||
145362204|NCT03218826|524176296|FG002|Overall Study|Non-compliance with protocol|2|||
145362205|NCT03218826|524176297|FG003|Overall Study|Non-compliance with protocol|1|||
145362206|NCT03218826|524176298|FG004|Overall Study|Non-compliance with protocol|1|||
145362207|NCT01197534|524176299|FG000|Overall Study|Not reported|16|||
145362208|NCT01197534|524176300|FG001|Overall Study|Not reported|10|||
145362209|NCT01197534|524176301|FG002|Overall Study|Not reported|16|||
145362210|NCT01197534|524176299|FG000|Overall Study|Enrolment in long term extension|57|||
145362211|NCT01197534|524176300|FG001|Overall Study|Enrolment in long term extension|66|||
145362212|NCT01197534|524176301|FG002|Overall Study|Enrolment in long term extension|119|||
145362213|NCT01197534|524176299|FG000|Overall Study|Severe non-compliance to protocol|3|||
145362214|NCT01197534|524176300|FG001|Overall Study|Severe non-compliance to protocol|4|||
145362215|NCT01197534|524176301|FG002|Overall Study|Severe non-compliance to protocol|1|||
145362216|NCT01197534|524176299|FG000|Overall Study|Lack of therapeutic response|9|||
145362217|NCT01197534|524176300|FG001|Overall Study|Lack of therapeutic response|4|||
145362218|NCT01197534|524176301|FG002|Overall Study|Lack of therapeutic response|9|||
145362219|NCT01197534|524176299|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
145362220|NCT01197534|524176300|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
145362221|NCT01197534|524176301|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
145362222|NCT01197534|524176299|FG000|Overall Study|Lost to Follow-up|1|||
145362223|NCT01197534|524176300|FG001|Overall Study|Lost to Follow-up|4|||
145362224|NCT01197534|524176301|FG002|Overall Study|Lost to Follow-up|2|||
145362225|NCT01197534|524176299|FG000|Overall Study|Adverse Event|35|||
145362226|NCT01197534|524176300|FG001|Overall Study|Adverse Event|36|||
145362227|NCT01197534|524176301|FG002|Overall Study|Adverse Event|24|||
145362228|NCT00703157|524176306|FG000|Overall Study|Lost to Follow-up|0|||
145362229|NCT00703157|524176307|FG001|Overall Study|Lost to Follow-up|1|||
145362230|NCT00703157|524176306|FG000|Overall Study|source data permanently lost/ other|4|||
145362231|NCT00703157|524176307|FG001|Overall Study|source data permanently lost/ other|1|||
145362232|NCT05868577|524176308|FG000|Overall Study|Lost to Follow-up|5|||
145362233|NCT05868577|524176309|FG001|Overall Study|Lost to Follow-up|5|||
145362234|NCT02522884|524176310|FG000|Overall Study|Withdrawal by Subject|6|||
145362235|NCT02522884|524176310|FG000|Overall Study|Death|3|||
145362236|NCT02522884|524176310|FG000|Overall Study|Missed 12-month Follow-up|9|||
145362237|NCT04873934|524176311|FG000|Overall Study|Adverse Event|0|||
145362238|NCT04873934|524176312|FG001|Overall Study|Adverse Event|1|||
145362239|NCT04873934|524176311|FG000|Overall Study|Death|0|||
145419059|NCT00504556|524390603|FG000|Overall Study|did not meet entry criteria|2|||
145419060|NCT00504556|524390604|FG001|Overall Study|did not meet entry criteria|0|||
145362240|NCT04873934|524176312|FG001|Overall Study|Death|2|||
145362241|NCT04873934|524176311|FG000|Overall Study|Lost to Follow-up|13|||
145362242|NCT04873934|524176312|FG001|Overall Study|Lost to Follow-up|9|||
145362243|NCT04873934|524176311|FG000|Overall Study|Physician Decision|1|||
145419061|NCT00504556|524390605|FG002|Overall Study|did not meet entry criteria|1|||
145362244|NCT04873934|524176312|FG001|Overall Study|Physician Decision|1|||
145362245|NCT04873934|524176311|FG000|Overall Study|Protocol deviation|2|||
145362246|NCT04873934|524176312|FG001|Overall Study|Protocol deviation|1|||
145362247|NCT04873934|524176311|FG000|Overall Study|Subject decision|1|||
145362248|NCT04873934|524176312|FG001|Overall Study|Subject decision|8|||
145362249|NCT04873934|524176311|FG000|Overall Study|Withdrew consent|0|||
145362250|NCT04873934|524176312|FG001|Overall Study|Withdrew consent|4|||
145419062|NCT00504556|524390606|FG003|Overall Study|did not meet entry criteria|1|||
145419063|NCT00504556|524390607|FG004|Overall Study|did not meet entry criteria|0|||
145419064|NCT00504556|524390603|FG000|Overall Study|data monitor committee decision|0|||
145419065|NCT00504556|524390604|FG001|Overall Study|data monitor committee decision|0|||
145419066|NCT00504556|524390605|FG002|Overall Study|data monitor committee decision|0|||
145419067|NCT00504556|524390606|FG003|Overall Study|data monitor committee decision|100|||
145419068|NCT00504556|524390607|FG004|Overall Study|data monitor committee decision|0|||
145419069|NCT00504556|524390603|FG000|Overall Study|Other|2|||
145419070|NCT00504556|524390604|FG001|Overall Study|Other|2|||
145419071|NCT00504556|524390605|FG002|Overall Study|Other|2|||
145419072|NCT00504556|524390606|FG003|Overall Study|Other|3|||
145419073|NCT00504556|524390607|FG004|Overall Study|Other|0|||
145419074|NCT00504556|524390603|FG000|Overall Study|not in safety analysis set|0|||
145419075|NCT00504556|524390604|FG001|Overall Study|not in safety analysis set|1|||
145419076|NCT00504556|524390605|FG002|Overall Study|not in safety analysis set|1|||
145419077|NCT00504556|524390606|FG003|Overall Study|not in safety analysis set|0|||
145419078|NCT00504556|524390607|FG004|Overall Study|not in safety analysis set|1|||
145419079|NCT02741193|524390610|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
145419080|NCT02741193|524390610|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
145419081|NCT02502383|524390611|FG000|Overall Study|Lost to Follow-up|130|||
145419082|NCT02502383|524390612|FG001|Overall Study|Lost to Follow-up|131|||
145419083|NCT02502383|524390611|FG000|Overall Study|Withdrawal by Subject|31|||
145419084|NCT02502383|524390612|FG001|Overall Study|Withdrawal by Subject|24|||
145419085|NCT02930941|524390613|FG000|Overall Study|Lost to Follow-up|1|||
145419086|NCT02930941|524390614|FG001|Overall Study|Lost to Follow-up|2|||
145419087|NCT00903344|524390615|FG000|Overall Study|Pregnancy|2|||
145419088|NCT00903344|524390616|FG001|Overall Study|Pregnancy|3|||
145419089|NCT00903344|524390615|FG000|Overall Study|Lost to Follow-up|3|||
145419090|NCT00903344|524390616|FG001|Overall Study|Lost to Follow-up|0|||
145419091|NCT01530256|524390619|FG000|Overall Study|Death|2|||
145419092|NCT00527748|524390621|FG000|Overall Study|Other|3|||
145419093|NCT01964560|524390624|FG000|Overall Study|Adverse Event|23|||
145419094|NCT01964560|524390624|FG000|Overall Study|Lack of Efficacy|46|||
145419095|NCT01964560|524390624|FG000|Overall Study|Protocol deviation|2|||
145419096|NCT01964560|524390624|FG000|Overall Study|Lost to Follow-up|4|||
145419097|NCT01964560|524390624|FG000|Overall Study|Withdrawal by Subject|64|||
145419098|NCT01964560|524390624|FG000|Overall Study|Surgery-hemispherotomy|1|||
145419099|NCT01964560|524390624|FG000|Overall Study|Surgery|1|||
145419100|NCT01964560|524390624|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
145419101|NCT01964560|524390624|FG000|Overall Study|Patient and Investigator choice|1|||
145419102|NCT01964560|524390624|FG000|Overall Study|Patient was prescribed CBD|1|||
145419103|NCT01964560|524390624|FG000|Overall Study|Participant moved to another country|1|||
145419104|NCT00292370|524390625|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
145419105|NCT00292370|524390626|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
145419106|NCT00292370|524390627|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
145419107|NCT00292370|524390625|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
145362251|NCT04873934|524176311|FG000|Overall Study|Missing|1|||
145362252|NCT04873934|524176312|FG001|Overall Study|Missing|0|||
145362253|NCT00708461|524176316|FG000|Overall Study|Lost to Follow-up|18|||
145362254|NCT00708461|524176317|FG001|Overall Study|Lost to Follow-up|11|||
145362255|NCT00708461|524176316|FG000|Overall Study|Withdrawal by Subject|8|||
145362256|NCT00708461|524176317|FG001|Overall Study|Withdrawal by Subject|9|||
145362257|NCT00708461|524176316|FG000|Overall Study|left workforce|115|||
145362258|NCT00708461|524176317|FG001|Overall Study|left workforce|180|||
145362259|NCT02907177|524176320|FG000|Overall Study|Death|0|||
145362260|NCT02907177|524176321|FG001|Overall Study|Death|1|||
145362261|NCT02907177|524176320|FG000|Overall Study|Physician Decision|3|||
145362262|NCT02907177|524176321|FG001|Overall Study|Physician Decision|3|||
145362263|NCT02907177|524176320|FG000|Overall Study|Withdrawal by Subject|15|||
145362264|NCT02907177|524176321|FG001|Overall Study|Withdrawal by Subject|7|||
145362265|NCT02907177|524176320|FG000|Overall Study|Sponsor's Decision|50|||
145362266|NCT02907177|524176321|FG001|Overall Study|Sponsor's Decision|57|||
145362267|NCT02968173|524176324|FG000|Overall Study|Withdrawal by Subject|1|||
145362268|NCT04586244|524176325|FG000|Overall Study|Lost to Follow-up|1|||
145362269|NCT04586244|524176326|FG001|Overall Study|Lost to Follow-up|0|||
145362270|NCT04586244|524176327|FG002|Overall Study|Lost to Follow-up|0|||
145362271|NCT04586244|524176328|FG003|Overall Study|Lost to Follow-up|1|||
145419108|NCT00292370|524390626|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
145419109|NCT00292370|524390627|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
145419110|NCT00292370|524390625|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
145362272|NCT04586244|524176329|FG004|Overall Study|Lost to Follow-up|0|||
145419111|NCT00292370|524390626|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
145419112|NCT00292370|524390627|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
145419113|NCT00292370|524390625|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
145419114|NCT00292370|524390626|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
145419115|NCT00292370|524390627|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
145362273|NCT04586244|524176325|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145362274|NCT04586244|524176326|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
145362275|NCT04586244|524176327|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145362276|NCT04586244|524176328|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145362277|NCT04586244|524176329|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
145362278|NCT03564119|524176332|FG000|Overall Study|Adverse Event|4|||
145362279|NCT03564119|524176333|FG001|Overall Study|Adverse Event|0|||
145362280|NCT03564119|524176332|FG000|Overall Study|Lost to Follow-up|1|||
145362281|NCT03564119|524176333|FG001|Overall Study|Lost to Follow-up|4|||
145362282|NCT03564119|524176332|FG000|Overall Study|Protocol Violation|1|||
145362283|NCT03564119|524176333|FG001|Overall Study|Protocol Violation|0|||
145362284|NCT03564119|524176332|FG000|Overall Study|Withdrawal by Subject|9|||
145362285|NCT03564119|524176333|FG001|Overall Study|Withdrawal by Subject|4|||
145362286|NCT03564119|524176332|FG000|Overall Study|Other Than Specified|0|||
145362287|NCT03564119|524176333|FG001|Overall Study|Other Than Specified|1|||
145362288|NCT00634036|524176334|FG000|Overall Study|Lost to Follow-up|1|||
145362289|NCT00634036|524176335|FG001|Overall Study|Lost to Follow-up|1|||
145362290|NCT00634036|524176334|FG000|Overall Study|Withdrawal by Subject|1|||
145362291|NCT00634036|524176335|FG001|Overall Study|Withdrawal by Subject|1|||
145362292|NCT03896022|524176340|FG000|Overall Study|Withdrawal by Subject|1|||
145362293|NCT03896022|524176341|FG001|Overall Study|Withdrawal by Subject|0|||
145362294|NCT03896022|524176342|FG002|Overall Study|Withdrawal by Subject|0|||
145362295|NCT03896022|524176340|FG000|Overall Study|Did not have procedure|3|||
145362296|NCT03896022|524176341|FG001|Overall Study|Did not have procedure|0|||
145362297|NCT03896022|524176342|FG002|Overall Study|Did not have procedure|0|||
145362298|NCT04015518|524176343|FG000|Overall Study|Adverse Event|6|||
145362299|NCT04015518|524176344|FG001|Overall Study|Adverse Event|1|||
145362300|NCT04015518|524176345|FG002|Overall Study|Adverse Event|1|||
145362301|NCT04015518|524176346|FG003|Overall Study|Adverse Event|3|||
145362302|NCT04015518|524176347|FG004|Overall Study|Adverse Event|3|||
145362303|NCT04015518|524176343|FG000|Overall Study|Lack of Efficacy|1|||
145362304|NCT04015518|524176344|FG001|Overall Study|Lack of Efficacy|0|||
145362305|NCT04015518|524176345|FG002|Overall Study|Lack of Efficacy|1|||
145362306|NCT04015518|524176346|FG003|Overall Study|Lack of Efficacy|0|||
145362307|NCT04015518|524176347|FG004|Overall Study|Lack of Efficacy|4|||
145362308|NCT04015518|524176343|FG000|Overall Study|Lost to Follow-up|0|||
145362309|NCT04015518|524176344|FG001|Overall Study|Lost to Follow-up|0|||
145362310|NCT04015518|524176345|FG002|Overall Study|Lost to Follow-up|0|||
145362311|NCT04015518|524176346|FG003|Overall Study|Lost to Follow-up|0|||
145362312|NCT04015518|524176347|FG004|Overall Study|Lost to Follow-up|1|||
145362313|NCT04015518|524176343|FG000|Overall Study|Withdrawal by Subject|0|||
145362314|NCT04015518|524176344|FG001|Overall Study|Withdrawal by Subject|1|||
145362315|NCT04015518|524176345|FG002|Overall Study|Withdrawal by Subject|0|||
145362316|NCT04015518|524176346|FG003|Overall Study|Withdrawal by Subject|1|||
145362317|NCT04015518|524176347|FG004|Overall Study|Withdrawal by Subject|1|||
145362318|NCT04015518|524176343|FG000|Overall Study|Patient did not come for consecutive visits|0|||
145362319|NCT04015518|524176344|FG001|Overall Study|Patient did not come for consecutive visits|1|||
145362320|NCT04015518|524176345|FG002|Overall Study|Patient did not come for consecutive visits|0|||
145362321|NCT04015518|524176346|FG003|Overall Study|Patient did not come for consecutive visits|0|||
145362322|NCT04015518|524176347|FG004|Overall Study|Patient did not come for consecutive visits|0|||
145362323|NCT04015518|524176343|FG000|Overall Study|not willing to travel due to Covid-19|0|||
145362324|NCT04015518|524176344|FG001|Overall Study|not willing to travel due to Covid-19|0|||
145362325|NCT04015518|524176345|FG002|Overall Study|not willing to travel due to Covid-19|1|||
145362326|NCT04015518|524176346|FG003|Overall Study|not willing to travel due to Covid-19|0|||
145362327|NCT04015518|524176347|FG004|Overall Study|not willing to travel due to Covid-19|0|||
145362328|NCT04015518|524176343|FG000|Overall Study|Patient wants to discontinue treatment|0|||
145362329|NCT04015518|524176344|FG001|Overall Study|Patient wants to discontinue treatment|0|||
145362330|NCT04015518|524176345|FG002|Overall Study|Patient wants to discontinue treatment|0|||
145362331|NCT04015518|524176346|FG003|Overall Study|Patient wants to discontinue treatment|1|||
145362332|NCT04015518|524176347|FG004|Overall Study|Patient wants to discontinue treatment|0|||
145362333|NCT04015518|524176343|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
145362334|NCT04015518|524176344|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
145362335|NCT04015518|524176345|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
145362336|NCT04015518|524176346|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
145362337|NCT04015518|524176347|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
145362338|NCT04015518|524176343|FG000|Overall Study|Pregnancy|0|||
145362339|NCT04015518|524176344|FG001|Overall Study|Pregnancy|0|||
145362340|NCT04015518|524176345|FG002|Overall Study|Pregnancy|0|||
145362341|NCT04015518|524176346|FG003|Overall Study|Pregnancy|0|||
145362342|NCT04015518|524176347|FG004|Overall Study|Pregnancy|1|||
145362343|NCT04015518|524176343|FG000|Overall Study|Personal reasons|1|||
145362344|NCT04015518|524176344|FG001|Overall Study|Personal reasons|0|||
145362345|NCT04015518|524176345|FG002|Overall Study|Personal reasons|0|||
145362346|NCT04015518|524176346|FG003|Overall Study|Personal reasons|0|||
145362347|NCT04015518|524176347|FG004|Overall Study|Personal reasons|1|||
145362348|NCT04015518|524176343|FG000|Overall Study|Withdrew consent|1|||
145362349|NCT04015518|524176344|FG001|Overall Study|Withdrew consent|0|||
145362350|NCT04015518|524176345|FG002|Overall Study|Withdrew consent|0|||
145362351|NCT04015518|524176346|FG003|Overall Study|Withdrew consent|0|||
145362352|NCT04015518|524176347|FG004|Overall Study|Withdrew consent|0|||
145362353|NCT04015518|524176343|FG000|Overall Study|Prostate carcinoma|1|||
145362354|NCT04015518|524176344|FG001|Overall Study|Prostate carcinoma|0|||
145362355|NCT04015518|524176345|FG002|Overall Study|Prostate carcinoma|0|||
145362356|NCT04015518|524176346|FG003|Overall Study|Prostate carcinoma|0|||
145362357|NCT04015518|524176347|FG004|Overall Study|Prostate carcinoma|0|||
145362358|NCT04015518|524176343|FG000|Overall Study|Could not keep appointments due to work|1|||
145362359|NCT04015518|524176344|FG001|Overall Study|Could not keep appointments due to work|0|||
145362360|NCT04015518|524176345|FG002|Overall Study|Could not keep appointments due to work|0|||
145362361|NCT04015518|524176346|FG003|Overall Study|Could not keep appointments due to work|0|||
145362362|NCT04015518|524176347|FG004|Overall Study|Could not keep appointments due to work|0|||
145362363|NCT00550745|524176348|FG000|Overall Study|Death|20|||
145362364|NCT00550745|524176349|FG001|Overall Study|Death|16|||
145362365|NCT00550745|524176348|FG000|Overall Study|Lost to Follow-up|45|||
145362366|NCT00550745|524176349|FG001|Overall Study|Lost to Follow-up|30|||
145362367|NCT00550745|524176348|FG000|Overall Study|Physician Decision|0|||
145362368|NCT00550745|524176349|FG001|Overall Study|Physician Decision|2|||
145362369|NCT00550745|524176348|FG000|Overall Study|Protocol Violation|4|||
145362370|NCT00550745|524176349|FG001|Overall Study|Protocol Violation|2|||
145362371|NCT00550745|524176348|FG000|Overall Study|Withdrawal by Subject|17|||
145362372|NCT00550745|524176349|FG001|Overall Study|Withdrawal by Subject|10|||
145362373|NCT00550745|524176348|FG000|Overall Study|Screen failure|1|||
145362374|NCT00550745|524176349|FG001|Overall Study|Screen failure|0|||
145362375|NCT00764660|524176350|FG000|Overall Study|Adverse Event|6|||
145362376|NCT00764660|524176351|FG001|Overall Study|Adverse Event|3|||
145362377|NCT00764660|524176350|FG000|Overall Study|Lost to Follow-up|3|||
145362378|NCT00764660|524176351|FG001|Overall Study|Lost to Follow-up|4|||
145362379|NCT00764660|524176350|FG000|Overall Study|Withdrawal by Subject|7|||
145362380|NCT00764660|524176351|FG001|Overall Study|Withdrawal by Subject|3|||
145362381|NCT00764660|524176350|FG000|Overall Study|Noncompliance With Protocol|5|||
145362382|NCT00764660|524176351|FG001|Overall Study|Noncompliance With Protocol|1|||
145362383|NCT00764660|524176350|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
145362384|NCT00764660|524176351|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
145362385|NCT01131455|524176352|FG000|Overall Study|Death of PI|6|||
145362386|NCT01131455|524176353|FG001|Overall Study|Death of PI|4|||
145362387|NCT01131455|524176354|FG002|Overall Study|Death of PI|0|||
145362388|NCT02186873|524178081|FG000|Overall Study|Adverse Event|1|||
145362389|NCT02186873|524178082|FG001|Overall Study|Adverse Event|3|||
145362390|NCT02186873|524178081|FG000|Overall Study|Lack of Efficacy|0|||
145362391|NCT02186873|524178082|FG001|Overall Study|Lack of Efficacy|1|||
145362392|NCT02186873|524178081|FG000|Overall Study|Lost to Follow-up|1|||
145362393|NCT02186873|524178082|FG001|Overall Study|Lost to Follow-up|2|||
145362394|NCT02186873|524178081|FG000|Overall Study|Withdrawal by Subject|7|||
145362395|NCT02186873|524178082|FG001|Overall Study|Withdrawal by Subject|2|||
145362396|NCT00347958|524178083|FG000|Overall Study|Adverse Event|1|||
145362397|NCT00347958|524178083|FG000|Overall Study|Protocol Violation|2|||
145362398|NCT00347958|524178083|FG000|Overall Study|Withdrawal by Subject|1|||
145362399|NCT01623310|524178086|FG000|Overall Study|Adverse Event|21|||
145362400|NCT01623310|524178086|FG000|Overall Study|Lost to Follow-up|18|||
145362401|NCT01623310|524178086|FG000|Overall Study|Lack of Efficacy|6|||
145362402|NCT01623310|524178086|FG000|Overall Study|Protocol Violation|6|||
145362403|NCT01623310|524178086|FG000|Overall Study|Withdrawal by Subject|25|||
145362404|NCT01623310|524178086|FG000|Overall Study|Became potentially child-bearing|1|||
145362405|NCT01623310|524178086|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
145362406|NCT01623310|524178086|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
145362407|NCT00356603|524178087|FG000|Overall Study|Other|6|||
145362408|NCT00356603|524178088|FG001|Overall Study|Other|3|||
145362409|NCT00734162|524178090|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
145362410|NCT00734162|524178091|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
145362411|NCT00734162|524178092|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
145362412|NCT00734162|524178093|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
145362413|NCT00734162|524178090|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145362414|NCT00734162|524178091|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145362415|NCT00734162|524178092|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
145362416|NCT00734162|524178093|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
145362417|NCT00734162|524178090|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
145362418|NCT00734162|524178091|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145362419|NCT00734162|524178092|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145577598|NCT02086591|524969443|FG000|Overall Study|Adverse Event|1|||
145419116|NCT00292370|524390625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
145419117|NCT00292370|524390626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
145419118|NCT00292370|524390627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
145419119|NCT00292370|524390625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
145419120|NCT00292370|524390626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
145419121|NCT00292370|524390627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
145419122|NCT01346709|524390628|FG000|Overall Study|Protocol Violation|35|||
145419123|NCT01346709|524390628|FG000|Overall Study|Lost to Follow-up|31|||
145419124|NCT01346709|524390628|FG000|Overall Study|Missing data in candidate risk factor|285|||
145419125|NCT00605657|524390631|FG000|Overall Study|Adverse Event|1|||
145419126|NCT00605657|524390631|FG000|Overall Study|Protocol Violation|1|||
145419127|NCT00458705|524390632|FG000|Overall Study|Adverse Event|4|||
145419128|NCT00458705|524390632|FG000|Overall Study|Not Treated|1|||
145419129|NCT00378560|524390635|FG000|Overall Study|Adverse Event|1|||
145419130|NCT00378560|524390636|FG001|Overall Study|Adverse Event|0|||
145419131|NCT00378560|524390635|FG000|Overall Study|Lost to Follow-up|24|||
145419132|NCT00378560|524390636|FG001|Overall Study|Lost to Follow-up|29|||
145419133|NCT00378560|524390635|FG000|Overall Study|Protocol Violation|2|||
145419134|NCT00378560|524390636|FG001|Overall Study|Protocol Violation|0|||
145419135|NCT00378560|524390635|FG000|Overall Study|Withdrawal by Subject|17|||
145419136|NCT00378560|524390636|FG001|Overall Study|Withdrawal by Subject|21|||
145419137|NCT00378560|524390635|FG000|Overall Study|Moved|4|||
145577599|NCT02086591|524969443|FG000|Overall Study|Withdrawal by Subject|1|||
145577600|NCT02086591|524969443|FG000|Overall Study|protocol terminated|3|||
145577601|NCT03738865|524969444|FG000|Overall Study|Withdrawal by Subject|3|||
145577602|NCT03738865|524969445|FG001|Overall Study|Withdrawal by Subject|3|||
145577603|NCT03738865|524969444|FG000|Overall Study|Adverse Event|2|||
145577604|NCT03738865|524969445|FG001|Overall Study|Adverse Event|0|||
145577605|NCT03738865|524969444|FG000|Overall Study|Physician Decision|0|||
145362420|NCT00734162|524178093|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
145362421|NCT00734162|524178090|FG000|Open-Label Phase|Withdrew Consent|1|||
145362422|NCT00734162|524178091|FG001|Open-Label Phase|Withdrew Consent|0|||
145362423|NCT00734162|524178092|FG002|Open-Label Phase|Withdrew Consent|1|||
145362424|NCT00734162|524178093|FG003|Open-Label Phase|Withdrew Consent|1|||
145362425|NCT00734162|524178090|FG000|Open-Label Phase|Lost to Follow-up|1|||
145362426|NCT00734162|524178091|FG001|Open-Label Phase|Lost to Follow-up|2|||
145362427|NCT00734162|524178092|FG002|Open-Label Phase|Lost to Follow-up|0|||
145362428|NCT00734162|524178093|FG003|Open-Label Phase|Lost to Follow-up|1|||
145362429|NCT00734162|524178090|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145362430|NCT00734162|524178091|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145362431|NCT00734162|524178092|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
145362432|NCT00734162|524178093|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
145362433|NCT00566020|524178094|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
145362434|NCT00566020|524178095|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
145362435|NCT00566020|524178094|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
145362436|NCT00566020|524178095|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
145362437|NCT00566020|524178094|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
145362438|NCT00566020|524178095|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
145362439|NCT00566020|524178094|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
145362440|NCT00566020|524178095|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
145362441|NCT00566020|524178094|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
145362442|NCT00566020|524178095|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
145362443|NCT00566020|524178094|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
145362444|NCT00566020|524178095|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
145362445|NCT06098339|524178096|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
145362446|NCT06098339|524178097|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
145362447|NCT06098339|524178096|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
145362448|NCT06098339|524178097|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
145362449|NCT03831113|524178100|FG000|Overall Study|Withdrawal by Subject|0|||
145362450|NCT03831113|524178101|FG001|Overall Study|Withdrawal by Subject|2|||
145362451|NCT03831113|524178100|FG000|Overall Study|Protocol Violation|0|||
145362452|NCT03831113|524178101|FG001|Overall Study|Protocol Violation|9|||
145362453|NCT00300885|524178102|FG000|Treatment|Adverse Event|134|||
145362454|NCT00300885|524178103|FG001|Treatment|Adverse Event|82|||
145362455|NCT00300885|524178102|FG000|Treatment|Death|20|||
145362456|NCT00300885|524178103|FG001|Treatment|Death|7|||
145362457|NCT00300885|524178102|FG000|Treatment|Lack of Efficacy|1|||
145419138|NCT00378560|524390636|FG001|Overall Study|Moved|3|||
145419139|NCT00378560|524390635|FG000|Overall Study|Pregnancy|7|||
145419140|NCT00378560|524390636|FG001|Overall Study|Pregnancy|5|||
145419141|NCT00378560|524390635|FG000|Overall Study|Laboratory test values abnormal|1|||
145419142|NCT00378560|524390636|FG001|Overall Study|Laboratory test values abnormal|0|||
145577606|NCT03738865|524969445|FG001|Overall Study|Physician Decision|1|||
145419143|NCT02773537|524390637|FG000|Overall Study|Lost to Follow-up|0|||
145419144|NCT02773537|524390638|FG001|Overall Study|Lost to Follow-up|1|||
145419145|NCT02773537|524390639|FG002|Overall Study|Lost to Follow-up|4|||
145419146|NCT01975285|524390654|FG000|Overall Study|Failed Block and follow up|2|||
145419147|NCT01975285|524390655|FG001|Overall Study|Failed Block and follow up|2|||
145419148|NCT04535362|524390656|FG000|Overall Study|Lost to Follow-up|3|||
145419149|NCT04535362|524390657|FG001|Overall Study|Lost to Follow-up|1|||
145419150|NCT03791060|524390658|FG000|Overall Study|Withdrawal by Subject|1|||
145419151|NCT03774810|524390659|FG000|Phase 1|Lack of Efficacy|21|||
145419152|NCT03774810|524390660|FG001|Phase 1|Lack of Efficacy|0|||
145419153|NCT03774810|524390661|FG002|Phase 1|Lack of Efficacy|0|||
145419154|NCT03774810|524390662|FG003|Phase 1|Lack of Efficacy|0|||
145419155|NCT03774810|524390663|FG004|Phase 1|Lack of Efficacy|0|||
145419156|NCT03774810|524390659|FG000|Phase 1|Withdrawal by Subject|9|||
145419157|NCT03774810|524390660|FG001|Phase 1|Withdrawal by Subject|0|||
145419158|NCT03774810|524390661|FG002|Phase 1|Withdrawal by Subject|0|||
145419159|NCT03774810|524390662|FG003|Phase 1|Withdrawal by Subject|0|||
145419160|NCT03774810|524390663|FG004|Phase 1|Withdrawal by Subject|0|||
145419161|NCT03774810|524390659|FG000|Phase 1|Lost to Follow-up|2|||
145419162|NCT03774810|524390660|FG001|Phase 1|Lost to Follow-up|0|||
145419163|NCT03774810|524390661|FG002|Phase 1|Lost to Follow-up|0|||
145419164|NCT03774810|524390662|FG003|Phase 1|Lost to Follow-up|0|||
145419165|NCT03774810|524390663|FG004|Phase 1|Lost to Follow-up|0|||
145419166|NCT03774810|524390659|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
145419167|NCT03774810|524390660|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
145419168|NCT03774810|524390661|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
145419169|NCT03774810|524390662|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
145419170|NCT03774810|524390663|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
145419171|NCT03774810|524390659|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
145419172|NCT03774810|524390660|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
145419173|NCT03774810|524390661|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
145419174|NCT03774810|524390662|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
145419175|NCT03774810|524390663|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
145419176|NCT03774810|524390659|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
145419177|NCT03774810|524390660|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
145419178|NCT03774810|524390661|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
145419179|NCT03774810|524390662|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
145419180|NCT03774810|524390663|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
145419181|NCT03774810|524390659|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
145419182|NCT03774810|524390660|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
145419183|NCT03774810|524390661|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
145419184|NCT03774810|524390662|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
145419185|NCT03774810|524390663|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
145419186|NCT03774810|524390659|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
145419187|NCT03774810|524390660|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
145419188|NCT03774810|524390661|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
145419189|NCT03774810|524390662|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
145419190|NCT03774810|524390663|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
145419191|NCT03774810|524390659|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145419192|NCT03774810|524390660|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145419193|NCT03774810|524390661|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
145419194|NCT03774810|524390662|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
145419195|NCT03774810|524390663|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
145419196|NCT01174459|524390667|FG000|Overall Study|case report form (CRF) not collected|5|||
145419197|NCT00927186|524390668|FG000|12 Months Primary Study|Adverse Event|5|||
145419198|NCT00927186|524390669|FG001|12 Months Primary Study|Adverse Event|2|||
145419199|NCT00927186|524390668|FG000|12 Months Primary Study|Lost to Follow-up|1|||
145419200|NCT00927186|524390669|FG001|12 Months Primary Study|Lost to Follow-up|0|||
145419201|NCT00927186|524390668|FG000|12 Months Primary Study|Protocol Violation|0|||
145419202|NCT00927186|524390669|FG001|12 Months Primary Study|Protocol Violation|1|||
145419203|NCT00927186|524390668|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
145419204|NCT00927186|524390669|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
145419205|NCT00604383|524390670|FG000|Overall Study|Withdrawal by Subject|33|||
145419206|NCT00604383|524390671|FG001|Overall Study|Withdrawal by Subject|31|||
145419207|NCT00604383|524390670|FG000|Overall Study|Lost to Follow-up|24|||
145419208|NCT00604383|524390671|FG001|Overall Study|Lost to Follow-up|19|||
145419209|NCT00604383|524390670|FG000|Overall Study|Death|14|||
145419210|NCT00604383|524390671|FG001|Overall Study|Death|22|||
145419211|NCT00604383|524390670|FG000|Overall Study|Adverse Event|16|||
145419212|NCT00604383|524390671|FG001|Overall Study|Adverse Event|9|||
145419213|NCT00604383|524390670|FG000|Overall Study|Physician Decision|0|||
145419214|NCT00604383|524390671|FG001|Overall Study|Physician Decision|3|||
145419215|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
145419216|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
145419217|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
145419218|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
145362458|NCT00300885|524178103|FG001|Treatment|Lack of Efficacy|1|||
145362459|NCT00300885|524178102|FG000|Treatment|Lost to Follow-up|3|||
145362460|NCT00300885|524178103|FG001|Treatment|Lost to Follow-up|2|||
145362461|NCT00300885|524178102|FG000|Treatment|Physician Decision|4|||
145362462|NCT00300885|524178103|FG001|Treatment|Physician Decision|5|||
145419219|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
145419220|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
145362463|NCT00300885|524178102|FG000|Treatment|Protocol Violation|11|||
145362464|NCT00300885|524178103|FG001|Treatment|Protocol Violation|11|||
145362465|NCT00300885|524178102|FG000|Treatment|Withdrawal by Subject|26|||
145362466|NCT00300885|524178103|FG001|Treatment|Withdrawal by Subject|23|||
145362467|NCT00300885|524178102|FG000|Treatment|Disease progression|171|||
145362468|NCT00300885|524178103|FG001|Treatment|Disease progression|238|||
145362469|NCT00300885|524178102|FG000|Treatment|Random code broken (subject died)|0|||
145362470|NCT00300885|524178103|FG001|Treatment|Random code broken (subject died)|1|||
145362471|NCT00300885|524178102|FG000|Treatment|Non-compliant with study medication|3|||
145362472|NCT00300885|524178103|FG001|Treatment|Non-compliant with study medication|4|||
145362473|NCT00300885|524178102|FG000|Follow-up|Death|141|||
145362474|NCT00300885|524178103|FG001|Follow-up|Death|163|||
145362475|NCT00300885|524178102|FG000|Follow-up|Lost to Follow-up|11|||
145419221|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
145419222|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
145419223|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
145419224|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
145419225|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
145419226|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
145419227|NCT00290758|524390678|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
145419228|NCT00290758|524390679|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
145419229|NCT00290758|524390678|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
145419230|NCT00290758|524390679|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
145419231|NCT03994120|524390681|FG000|Overall Study|Lost to Follow-up|3|||
145419232|NCT03994120|524390682|FG001|Overall Study|Lost to Follow-up|1|||
145419233|NCT01111292|524390683|FG000|Treatment|Physician Decision|1|||
145419234|NCT01111292|524390684|FG001|Treatment|Physician Decision|1|||
145419235|NCT02619812|524390685|FG000|Overall Study|Withdrawal by Subject|0|||
145419236|NCT02619812|524390686|FG001|Overall Study|Withdrawal by Subject|0|||
145419237|NCT02619812|524390687|FG002|Overall Study|Withdrawal by Subject|1|||
145362476|NCT00300885|524178103|FG001|Follow-up|Lost to Follow-up|7|||
145362477|NCT00300885|524178102|FG000|Follow-up|Withdrawal by Subject|26|||
145362478|NCT00300885|524178103|FG001|Follow-up|Withdrawal by Subject|25|||
145362479|NCT02058537|524178104|FG000|Overall Study|Withdrawal by Subject|1|||
145362480|NCT02582242|524178105|FG000|Overall Study|Adverse Event|4|||
145362481|NCT02582242|524178106|FG001|Overall Study|Adverse Event|3|||
145362482|NCT02582242|524178105|FG000|Overall Study|Protocol Violation|3|||
145362483|NCT02582242|524178106|FG001|Overall Study|Protocol Violation|1|||
145362484|NCT02582242|524178105|FG000|Overall Study|Lost to Follow-up|0|||
145362485|NCT02582242|524178106|FG001|Overall Study|Lost to Follow-up|1|||
145362486|NCT02582242|524178105|FG000|Overall Study|Withdrawal by Subject|11|||
145362487|NCT02582242|524178106|FG001|Overall Study|Withdrawal by Subject|11|||
145362488|NCT02582242|524178105|FG000|Overall Study|Unclassified|2|||
145362489|NCT02582242|524178106|FG001|Overall Study|Unclassified|1|||
145362490|NCT03691207|524178107|FG000|Overall Study|Death|41|||
145362491|NCT03691207|524178108|FG001|Overall Study|Death|26|||
145362492|NCT03691207|524178107|FG000|Overall Study|Lost to Follow-up|1|||
145362493|NCT03691207|524178108|FG001|Overall Study|Lost to Follow-up|1|||
145362494|NCT03691207|524178107|FG000|Overall Study|Withdrawal by Subject|2|||
145362495|NCT03691207|524178108|FG001|Overall Study|Withdrawal by Subject|8|||
145362496|NCT03691207|524178107|FG000|Overall Study|Sponsor decision|1|||
145362497|NCT03691207|524178108|FG001|Overall Study|Sponsor decision|7|||
145419238|NCT02619812|524390688|FG003|Overall Study|Withdrawal by Subject|2|||
145419239|NCT05587998|524390694|FG000|Overall Study|Withdrawal by Subject|1|||
145419240|NCT05587998|524390695|FG001|Overall Study|Withdrawal by Subject|1|||
145419241|NCT05587998|524390694|FG000|Overall Study|Not treated|3|||
145419242|NCT05587998|524390695|FG001|Overall Study|Not treated|1|||
145419243|NCT05587998|524390694|FG000|Overall Study|Non-compliance with study procedures|0|||
145419244|NCT05587998|524390695|FG001|Overall Study|Non-compliance with study procedures|1|||
145419245|NCT03892915|524390696|FG000|Overall Study|Lost to Follow-up|6|||
145419246|NCT03892915|524390697|FG001|Overall Study|Lost to Follow-up|12|||
145419247|NCT03892915|524390696|FG000|Overall Study|Death|0|||
145419248|NCT03892915|524390697|FG001|Overall Study|Death|2|||
145419249|NCT03892915|524390696|FG000|Overall Study|Withdrawal by Subject|1|||
145362498|NCT03412734|524178116|FG000|Overall Study|Incorrect labeling of samples|2|||
145362499|NCT03412734|524178117|FG001|Overall Study|Incorrect labeling of samples|0|||
145362500|NCT03412734|524178116|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
145362501|NCT03412734|524178117|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
145362502|NCT00423332|524178118|FG000|Overall Study|Adverse Event|6|||
145362503|NCT00423332|524178119|FG001|Overall Study|Adverse Event|2|||
145362504|NCT00423332|524178118|FG000|Overall Study|Withdrawal by Subject|1|||
145362505|NCT00423332|524178119|FG001|Overall Study|Withdrawal by Subject|0|||
145362506|NCT00423332|524178118|FG000|Overall Study|Condition under investigation worsened|1|||
145362507|NCT00423332|524178119|FG001|Overall Study|Condition under investigation worsened|1|||
145362508|NCT00423332|524178118|FG000|Overall Study|Progressive at Week 6|0|||
145362509|NCT00423332|524178119|FG001|Overall Study|Progressive at Week 6|1|||
145362510|NCT00423332|524178118|FG000|Overall Study|Unblinded before 12 weeks|1|||
145362511|NCT00423332|524178119|FG001|Overall Study|Unblinded before 12 weeks|3|||
145362512|NCT02035202|524178121|FG000|Overall Study|Lost to Follow-up|8|||
145362513|NCT02035202|524178122|FG001|Overall Study|Lost to Follow-up|16|||
145362514|NCT02035202|524178123|FG002|Overall Study|Lost to Follow-up|2|||
145362515|NCT00644917|524178124|FG000|Overall Study|Withdrawal by Subject|2|||
145362516|NCT00758485|524178125|FG000|Overall Study|Lost to Follow-up|0|||
145362517|NCT00758485|524178126|FG001|Overall Study|Lost to Follow-up|1|||
145362518|NCT00758485|524178125|FG000|Overall Study|Not Treated|1|||
145362519|NCT00758485|524178126|FG001|Overall Study|Not Treated|2|||
145362520|NCT00921557|524178127|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
145362521|NCT00921557|524178128|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
145362522|NCT00921557|524178129|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
145362523|NCT00921557|524178127|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
145362524|NCT00921557|524178128|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
145362525|NCT00921557|524178129|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
145362526|NCT00921557|524178127|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
145362527|NCT00921557|524178128|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
145362528|NCT00921557|524178129|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
145362529|NCT00921557|524178127|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
145362530|NCT00921557|524178128|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
145362531|NCT00921557|524178129|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
145362532|NCT00921557|524178127|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
145362533|NCT00921557|524178128|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
145362534|NCT00921557|524178129|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
145362535|NCT03259425|524178139|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
145362536|NCT02097238|524178149|FG000|Overall Study|Death|1|||
145362537|NCT02097238|524178149|FG000|Overall Study|Physician Decision|1|||
145362538|NCT02097238|524178149|FG000|Overall Study|Progressive Disease|17|||
145362539|NCT01106911|524178150|FG000|Overall Study|Physician Decision|2|||
145362540|NCT01106911|524178150|FG000|Overall Study|deemed ineligible after screening|3|||
145362541|NCT01282372|524178152|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
145362542|NCT01282372|524178152|FG000|Overall Study|Lost to Follow-up|23|||
145362543|NCT01282372|524178152|FG000|Overall Study|Withdrawal by Subject|11|||
145362544|NCT01282372|524178152|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
145362545|NCT01282372|524178152|FG000|Overall Study|Death|1|||
145362546|NCT01282372|524178152|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
145362547|NCT01282372|524178152|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
145362548|NCT01282372|524178152|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
145362549|NCT01282372|524178152|FG000|Overall Study|Adverse Event|12|||
145362550|NCT01814696|524178153|FG000|Overall Study|Withdrawal by Subject|1|||
145362551|NCT01814696|524178154|FG001|Overall Study|Withdrawal by Subject|0|||
145362552|NCT01814696|524178153|FG000|Overall Study|Randomized to wrong group|1|||
145362553|NCT01814696|524178154|FG001|Overall Study|Randomized to wrong group|0|||
145362554|NCT00713258|524178155|FG000|Overall Study|Adverse Event|2|||
145362555|NCT00713258|524178156|FG001|Overall Study|Adverse Event|4|||
145362556|NCT00713258|524178155|FG000|Overall Study|Non-Compliance|2|||
145362557|NCT00713258|524178156|FG001|Overall Study|Non-Compliance|1|||
145362558|NCT00713258|524178155|FG000|Overall Study|Other|1|||
145419250|NCT03892915|524390697|FG001|Overall Study|Withdrawal by Subject|1|||
145419251|NCT03892915|524390696|FG000|Overall Study|unsuccessful delivery|13|||
145419252|NCT03892915|524390697|FG001|Overall Study|unsuccessful delivery|18|||
145362559|NCT00713258|524178156|FG001|Overall Study|Other|1|||
145362560|NCT01322490|524178157|FG000|Treatment Period|Adverse Event|12|||
145419253|NCT00191152|524390698|FG000|Initial Treatment|Adverse Event|43|||
145419254|NCT00191152|524390699|FG001|Initial Treatment|Adverse Event|67|||
145577607|NCT01565993|524969447|FG000|Overall Study|Physician Decision|0|||
145577608|NCT01565993|524969448|FG001|Overall Study|Physician Decision|3|||
145362561|NCT01322490|524178158|FG001|Treatment Period|Adverse Event|18|||
145362562|NCT01322490|524178159|FG002|Treatment Period|Adverse Event|15|||
145362563|NCT01322490|524178157|FG000|Treatment Period|Death|5|||
145362564|NCT01322490|524178158|FG001|Treatment Period|Death|7|||
145362565|NCT01322490|524178159|FG002|Treatment Period|Death|3|||
145362566|NCT01322490|524178157|FG000|Treatment Period|Lack of Efficacy|89|||
145419255|NCT00191152|524390698|FG000|Initial Treatment|Physician Decision|40|||
145419256|NCT00191152|524390699|FG001|Initial Treatment|Physician Decision|31|||
145419257|NCT00191152|524390698|FG000|Initial Treatment|Withdrawal by Subject|40|||
145419258|NCT00191152|524390699|FG001|Initial Treatment|Withdrawal by Subject|28|||
145419259|NCT00191152|524390698|FG000|Initial Treatment|Lost to Follow-up|0|||
145419260|NCT00191152|524390699|FG001|Initial Treatment|Lost to Follow-up|6|||
145419261|NCT00191152|524390698|FG000|Initial Treatment|Other|18|||
145419262|NCT00191152|524390699|FG001|Initial Treatment|Other|21|||
145419263|NCT00191152|524390698|FG000|Crossover Treatment|Adverse Event|8|||
145419264|NCT00191152|524390699|FG001|Crossover Treatment|Adverse Event|8|||
145419265|NCT00191152|524390698|FG000|Crossover Treatment|Physician Decision|7|||
145419266|NCT00191152|524390699|FG001|Crossover Treatment|Physician Decision|7|||
145419267|NCT00191152|524390698|FG000|Crossover Treatment|Withdrawal by Subject|6|||
145419268|NCT00191152|524390699|FG001|Crossover Treatment|Withdrawal by Subject|9|||
145419269|NCT00191152|524390698|FG000|Crossover Treatment|Lost to Follow-up|2|||
145419270|NCT00191152|524390699|FG001|Crossover Treatment|Lost to Follow-up|1|||
145419271|NCT00191152|524390698|FG000|Crossover Treatment|Other|4|||
145419272|NCT00191152|524390699|FG001|Crossover Treatment|Other|3|||
145419273|NCT00114777|524390700|FG000|Randomization to Month 36|Death|10|||
145419274|NCT00114777|524390701|FG001|Randomization to Month 36|Death|4|||
145419275|NCT00114777|524390702|FG002|Randomization to Month 36|Death|3|||
145419276|NCT00114777|524390700|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
145419277|NCT00114777|524390701|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
145419278|NCT00114777|524390702|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
145419279|NCT00114777|524390700|FG000|Randomization to Month 36|Lack of Efficacy|19|||
145419280|NCT00114777|524390701|FG001|Randomization to Month 36|Lack of Efficacy|15|||
145419281|NCT00114777|524390702|FG002|Randomization to Month 36|Lack of Efficacy|17|||
145419282|NCT00114777|524390700|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
145419283|NCT00114777|524390701|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
145419284|NCT00114777|524390702|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
145419285|NCT00114777|524390700|FG000|Randomization to Month 36|Adverse Event|34|||
145419286|NCT00114777|524390701|FG001|Randomization to Month 36|Adverse Event|35|||
145419287|NCT00114777|524390702|FG002|Randomization to Month 36|Adverse Event|44|||
145419288|NCT00114777|524390700|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
145419289|NCT00114777|524390701|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
145419290|NCT00114777|524390702|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
145419291|NCT00114777|524390700|FG000|Randomization to Month 36|Other|9|||
145419292|NCT00114777|524390701|FG001|Randomization to Month 36|Other|3|||
145419293|NCT00114777|524390702|FG002|Randomization to Month 36|Other|12|||
145419294|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Death|8|||
145419295|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Death|13|||
145419296|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Death|7|||
145419297|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
145419298|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
145419299|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
145419300|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
145419301|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
145419302|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
145419303|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
145419304|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
145419305|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
145419306|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
145419307|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
145419308|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
145419309|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
145419310|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
145419311|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
145419312|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
145419313|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
145419314|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
145419315|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
145419316|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
145419317|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
145419318|NCT00114777|524390700|FG000|Long-Term Extension to Month 84|Other|2|||
145419319|NCT00114777|524390701|FG001|Long-Term Extension to Month 84|Other|0|||
145419320|NCT00114777|524390702|FG002|Long-Term Extension to Month 84|Other|2|||
145419321|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Adverse Event|14|||
145419322|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Adverse Event|27|||
145419323|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Adverse Event|60|||
145419324|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Adverse Event|0|||
145419325|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Adverse Event|0|||
145419326|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Pregnancy|0|||
145419327|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Pregnancy|7|||
145419328|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Pregnancy|9|||
145362567|NCT01322490|524178158|FG001|Treatment Period|Lack of Efficacy|100|||
145362568|NCT01322490|524178159|FG002|Treatment Period|Lack of Efficacy|112|||
145362569|NCT01322490|524178157|FG000|Treatment Period|Physician Decision|0|||
145362570|NCT01322490|524178158|FG001|Treatment Period|Physician Decision|2|||
145362571|NCT01322490|524178159|FG002|Treatment Period|Physician Decision|1|||
145362572|NCT01322490|524178157|FG000|Treatment Period|Protocol Violation|7|||
145362573|NCT01322490|524178158|FG001|Treatment Period|Protocol Violation|5|||
145362574|NCT01322490|524178159|FG002|Treatment Period|Protocol Violation|4|||
145362575|NCT01322490|524178157|FG000|Treatment Period|Withdrawal by Subject|14|||
145362576|NCT01322490|524178158|FG001|Treatment Period|Withdrawal by Subject|16|||
145362577|NCT01322490|524178159|FG002|Treatment Period|Withdrawal by Subject|11|||
145362578|NCT01322490|524178157|FG000|Treatment Period|Non-compliance with study drug|0|||
145362579|NCT01322490|524178158|FG001|Treatment Period|Non-compliance with study drug|0|||
145362580|NCT01322490|524178159|FG002|Treatment Period|Non-compliance with study drug|1|||
145362581|NCT01322490|524178157|FG000|Treatment Period|Other per report|2|||
145362582|NCT01322490|524178158|FG001|Treatment Period|Other per report|2|||
145362583|NCT01322490|524178159|FG002|Treatment Period|Other per report|1|||
145362584|NCT01322490|524178157|FG000|Treatment Period|Randomized but Not Treated|3|||
145362585|NCT01322490|524178158|FG001|Treatment Period|Randomized but Not Treated|3|||
145362586|NCT01322490|524178159|FG002|Treatment Period|Randomized but Not Treated|5|||
145362587|NCT01322490|524178157|FG000|Long Term Follow-up Period|Death|235|||
145362588|NCT01322490|524178158|FG001|Long Term Follow-up Period|Death|239|||
145362589|NCT01322490|524178159|FG002|Long Term Follow-up Period|Death|236|||
145362590|NCT01322490|524178157|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
145362591|NCT01322490|524178158|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
145362592|NCT01322490|524178159|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
145362593|NCT01322490|524178157|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
145362594|NCT01322490|524178158|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
145362595|NCT01322490|524178159|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
145362596|NCT01322490|524178157|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
145362597|NCT01322490|524178158|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
145362598|NCT01322490|524178159|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
145362599|NCT01322490|524178157|FG000|Long Term Follow-up Period|Other per report|3|||
145362600|NCT01322490|524178158|FG001|Long Term Follow-up Period|Other per report|2|||
145362601|NCT01322490|524178159|FG002|Long Term Follow-up Period|Other per report|2|||
145362602|NCT01322490|524178157|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
145362603|NCT01322490|524178158|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
145362604|NCT01322490|524178159|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
145362605|NCT02199795|524178161|FG000|Overall Study|no longer met inclusion criteria|1|||
145362606|NCT02199795|524178162|FG001|Overall Study|no longer met inclusion criteria|0|||
145362607|NCT02199795|524178161|FG000|Overall Study|withdrew due to shoulder pain|1|||
145362608|NCT02199795|524178162|FG001|Overall Study|withdrew due to shoulder pain|0|||
145362609|NCT05310071|524178179|FG000|Overall Study|Death|0|||
145362610|NCT05310071|524178180|FG001|Overall Study|Death|3|||
145362611|NCT05310071|524178179|FG000|Overall Study|Adverse Event|4|||
145362612|NCT05310071|524178180|FG001|Overall Study|Adverse Event|31|||
145362613|NCT05310071|524178179|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
145362614|NCT05310071|524178180|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
145362615|NCT05310071|524178179|FG000|Overall Study|Protocol Deviation|2|||
145362616|NCT05310071|524178180|FG001|Overall Study|Protocol Deviation|0|||
145362617|NCT05310071|524178179|FG000|Overall Study|Randomized by Mistake|0|||
145362618|NCT05310071|524178180|FG001|Overall Study|Randomized by Mistake|1|||
145362619|NCT05310071|524178179|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
145362620|NCT05310071|524178180|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
145362621|NCT05310071|524178179|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
145362622|NCT05310071|524178180|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
145362623|NCT05310071|524178179|FG000|Overall Study|Site Terminated by Sponsor|0|||
145362624|NCT05310071|524178180|FG001|Overall Study|Site Terminated by Sponsor|2|||
145362625|NCT05310071|524178179|FG000|Overall Study|Study Terminated by Sponsor|282|||
145362626|NCT05310071|524178180|FG001|Overall Study|Study Terminated by Sponsor|559|||
145362627|NCT05310071|524178179|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
145362628|NCT05310071|524178180|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
145362629|NCT05310071|524178179|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
145362630|NCT05310071|524178180|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
145362631|NCT05310071|524178179|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
145362632|NCT05310071|524178180|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
145362633|NCT05310071|524178179|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
145362634|NCT05310071|524178180|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
145362635|NCT05310071|524178179|FG000|Overall Study|Withdrawal by Participant - Other|25|||
145362636|NCT05310071|524178180|FG001|Overall Study|Withdrawal by Participant - Other|30|||
145362637|NCT05310071|524178179|FG000|Overall Study|Lost to Follow-up|2|||
145362638|NCT05310071|524178180|FG001|Overall Study|Lost to Follow-up|4|||
145362639|NCT05310071|524178179|FG000|Overall Study|Reason Not Specified|1|||
145362640|NCT05310071|524178180|FG001|Overall Study|Reason Not Specified|3|||
145362641|NCT02418949|524178181|FG000|Overall Study|Withdrawal by Subject|1|||
145362642|NCT02418949|524178182|FG001|Overall Study|Withdrawal by Subject|0|||
145362643|NCT02418949|524178183|FG002|Overall Study|Withdrawal by Subject|1|||
145362644|NCT02418949|524178184|FG003|Overall Study|Withdrawal by Subject|1|||
145362645|NCT02418949|524178181|FG000|Overall Study|Lost to Follow-up|1|||
145362646|NCT02418949|524178182|FG001|Overall Study|Lost to Follow-up|0|||
145362647|NCT02418949|524178183|FG002|Overall Study|Lost to Follow-up|1|||
145362648|NCT02418949|524178184|FG003|Overall Study|Lost to Follow-up|0|||
145362649|NCT02418949|524178181|FG000|Overall Study|Physician Decision|1|||
145362650|NCT02418949|524178182|FG001|Overall Study|Physician Decision|1|||
145362651|NCT02418949|524178183|FG002|Overall Study|Physician Decision|1|||
145362652|NCT02418949|524178184|FG003|Overall Study|Physician Decision|0|||
145362653|NCT00984542|524178189|FG000|Overall Study|disease progression|19|||
145362654|NCT00984542|524178189|FG000|Overall Study|toxicity|7|||
145362655|NCT00984542|524178189|FG000|Overall Study|Death|7|||
145362656|NCT00984542|524178189|FG000|Overall Study|complicating disease|3|||
145362657|NCT00984542|524178189|FG000|Overall Study|Withdrawal by Subject|3|||
145362658|NCT00984542|524178189|FG000|Overall Study|clinical deterioration|2|||
145362659|NCT02343939|524178190|FG000|Overall Study|Death|0|||
145362660|NCT02343939|524178191|FG001|Overall Study|Death|15|||
145362661|NCT02343939|524178192|FG002|Overall Study|Death|4|||
145362662|NCT02343939|524178193|FG003|Overall Study|Death|2|||
145362663|NCT02343939|524178194|FG004|Overall Study|Death|5|||
145362664|NCT02343939|524178195|FG005|Overall Study|Death|11|||
145362665|NCT02343939|524178196|FG006|Overall Study|Death|8|||
145362666|NCT02343939|524178197|FG007|Overall Study|Death|22|||
145362667|NCT02343939|524178198|FG008|Overall Study|Death|1|||
145362668|NCT02343939|524178190|FG000|Overall Study|Study terminated by sponsor|0|||
145362669|NCT02343939|524178191|FG001|Overall Study|Study terminated by sponsor|27|||
145362670|NCT02343939|524178192|FG002|Overall Study|Study terminated by sponsor|0|||
145362671|NCT02343939|524178193|FG003|Overall Study|Study terminated by sponsor|1|||
145362672|NCT02343939|524178194|FG004|Overall Study|Study terminated by sponsor|1|||
145362673|NCT02343939|524178195|FG005|Overall Study|Study terminated by sponsor|5|||
145362674|NCT02343939|524178196|FG006|Overall Study|Study terminated by sponsor|3|||
145362675|NCT02343939|524178197|FG007|Overall Study|Study terminated by sponsor|4|||
145362676|NCT02343939|524178198|FG008|Overall Study|Study terminated by sponsor|0|||
145362677|NCT02343939|524178190|FG000|Overall Study|Withdrew consent|3|||
145362678|NCT02343939|524178191|FG001|Overall Study|Withdrew consent|6|||
145362679|NCT02343939|524178192|FG002|Overall Study|Withdrew consent|1|||
145362680|NCT02343939|524178193|FG003|Overall Study|Withdrew consent|2|||
145362681|NCT02343939|524178194|FG004|Overall Study|Withdrew consent|2|||
145362682|NCT02343939|524178195|FG005|Overall Study|Withdrew consent|0|||
145362683|NCT02343939|524178196|FG006|Overall Study|Withdrew consent|0|||
145362684|NCT02343939|524178197|FG007|Overall Study|Withdrew consent|8|||
145362685|NCT02343939|524178198|FG008|Overall Study|Withdrew consent|6|||
145362686|NCT02343939|524178190|FG000|Overall Study|Treatment failure|0|||
145362687|NCT02343939|524178191|FG001|Overall Study|Treatment failure|0|||
145362688|NCT02343939|524178192|FG002|Overall Study|Treatment failure|0|||
145362689|NCT02343939|524178193|FG003|Overall Study|Treatment failure|0|||
145362690|NCT02343939|524178194|FG004|Overall Study|Treatment failure|0|||
145362691|NCT02343939|524178195|FG005|Overall Study|Treatment failure|0|||
145362692|NCT02343939|524178196|FG006|Overall Study|Treatment failure|2|||
145362693|NCT02343939|524178197|FG007|Overall Study|Treatment failure|1|||
145362694|NCT02343939|524178198|FG008|Overall Study|Treatment failure|0|||
145362695|NCT02343939|524178190|FG000|Overall Study|Investigator's discretion|0|||
145362696|NCT02343939|524178191|FG001|Overall Study|Investigator's discretion|0|||
145362697|NCT02343939|524178192|FG002|Overall Study|Investigator's discretion|0|||
145362698|NCT02343939|524178193|FG003|Overall Study|Investigator's discretion|1|||
145362699|NCT02343939|524178194|FG004|Overall Study|Investigator's discretion|0|||
145362700|NCT02343939|524178195|FG005|Overall Study|Investigator's discretion|0|||
145362701|NCT02343939|524178196|FG006|Overall Study|Investigator's discretion|1|||
145362702|NCT02343939|524178197|FG007|Overall Study|Investigator's discretion|0|||
145362703|NCT02343939|524178198|FG008|Overall Study|Investigator's discretion|0|||
145362704|NCT02343939|524178190|FG000|Overall Study|Adverse Event|0|||
145362705|NCT02343939|524178191|FG001|Overall Study|Adverse Event|0|||
145362706|NCT02343939|524178192|FG002|Overall Study|Adverse Event|0|||
145419329|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Pregnancy|0|||
145362707|NCT02343939|524178193|FG003|Overall Study|Adverse Event|0|||
145419330|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Pregnancy|0|||
145362708|NCT02343939|524178194|FG004|Overall Study|Adverse Event|0|||
145362709|NCT02343939|524178195|FG005|Overall Study|Adverse Event|1|||
145362710|NCT02343939|524178196|FG006|Overall Study|Adverse Event|0|||
145362711|NCT02343939|524178197|FG007|Overall Study|Adverse Event|0|||
145362712|NCT02343939|524178198|FG008|Overall Study|Adverse Event|0|||
145362713|NCT02343939|524178190|FG000|Overall Study|Never Treated With ENTO|0|||
145362714|NCT02343939|524178191|FG001|Overall Study|Never Treated With ENTO|0|||
145362715|NCT02343939|524178192|FG002|Overall Study|Never Treated With ENTO|0|||
145362716|NCT02343939|524178193|FG003|Overall Study|Never Treated With ENTO|0|||
145362717|NCT02343939|524178194|FG004|Overall Study|Never Treated With ENTO|0|||
145362718|NCT02343939|524178195|FG005|Overall Study|Never Treated With ENTO|0|||
145362719|NCT02343939|524178196|FG006|Overall Study|Never Treated With ENTO|1|||
145362720|NCT02343939|524178197|FG007|Overall Study|Never Treated With ENTO|2|||
145362721|NCT02343939|524178198|FG008|Overall Study|Never Treated With ENTO|0|||
145362722|NCT00460811|524178199|FG000|Overall Study|Adverse Event|4|||
145362723|NCT00460811|524178200|FG001|Overall Study|Adverse Event|6|||
145362724|NCT00460811|524178201|FG002|Overall Study|Adverse Event|3|||
145362725|NCT00460811|524178202|FG003|Overall Study|Adverse Event|10|||
145362726|NCT00460811|524178203|FG004|Overall Study|Adverse Event|2|||
145362727|NCT00460811|524178199|FG000|Overall Study|Noncompliance|1|||
145362728|NCT00460811|524178200|FG001|Overall Study|Noncompliance|0|||
145362729|NCT00460811|524178201|FG002|Overall Study|Noncompliance|0|||
145362730|NCT00460811|524178202|FG003|Overall Study|Noncompliance|2|||
145362731|NCT00460811|524178203|FG004|Overall Study|Noncompliance|1|||
145362732|NCT00460811|524178199|FG000|Overall Study|Withdrawal by Subject|7|||
145362733|NCT00460811|524178200|FG001|Overall Study|Withdrawal by Subject|7|||
145362734|NCT00460811|524178201|FG002|Overall Study|Withdrawal by Subject|6|||
145362735|NCT00460811|524178202|FG003|Overall Study|Withdrawal by Subject|3|||
145362736|NCT00460811|524178203|FG004|Overall Study|Withdrawal by Subject|11|||
145362737|NCT00460811|524178199|FG000|Overall Study|Physician Decision|1|||
145362738|NCT00460811|524178200|FG001|Overall Study|Physician Decision|0|||
145362739|NCT00460811|524178201|FG002|Overall Study|Physician Decision|0|||
145362740|NCT00460811|524178202|FG003|Overall Study|Physician Decision|0|||
145362741|NCT00460811|524178203|FG004|Overall Study|Physician Decision|0|||
145362742|NCT00460811|524178199|FG000|Overall Study|Lost to Follow-up|3|||
145362743|NCT00460811|524178200|FG001|Overall Study|Lost to Follow-up|2|||
145362744|NCT00460811|524178201|FG002|Overall Study|Lost to Follow-up|5|||
145362745|NCT00460811|524178202|FG003|Overall Study|Lost to Follow-up|3|||
145362746|NCT00460811|524178203|FG004|Overall Study|Lost to Follow-up|6|||
145362747|NCT02097745|524178204|FG000|Overall Study|Adverse Event|25|||
145362748|NCT02097745|524178204|FG000|Overall Study|Death|16|||
145362749|NCT02097745|524178204|FG000|Overall Study|Failure to Return|14|||
145362750|NCT02097745|524178204|FG000|Overall Study|Administrative/Other|27|||
145362751|NCT02097745|524178204|FG000|Overall Study|Reason Not Specified|96|||
145362752|NCT00425750|524178210|FG000|Overall Study|Death|1|||
145362753|NCT00425750|524178210|FG000|Overall Study|Withdrawal by Subject|3|||
145362754|NCT00425750|524178210|FG000|Overall Study|Adverse Event|3|||
145362755|NCT00425750|524178210|FG000|Overall Study|Progression of disease|18|||
145362756|NCT02099110|524178211|FG000|Overall Study|Protocol Violation|2|||
145362757|NCT02099110|524178212|FG001|Overall Study|Protocol Violation|1|||
145362758|NCT02099110|524178213|FG002|Overall Study|Protocol Violation|0|||
145362759|NCT02099110|524178214|FG003|Overall Study|Protocol Violation|3|||
145362760|NCT02099110|524178215|FG004|Overall Study|Protocol Violation|1|||
145362761|NCT02099110|524178211|FG000|Overall Study|Participant moved|1|||
145362762|NCT02099110|524178212|FG001|Overall Study|Participant moved|1|||
145362763|NCT02099110|524178213|FG002|Overall Study|Participant moved|1|||
145362764|NCT02099110|524178214|FG003|Overall Study|Participant moved|0|||
145362765|NCT02099110|524178215|FG004|Overall Study|Participant moved|2|||
145362766|NCT02099110|524178211|FG000|Overall Study|Withdrawal by Subject|7|||
145362767|NCT02099110|524178212|FG001|Overall Study|Withdrawal by Subject|11|||
145362768|NCT02099110|524178213|FG002|Overall Study|Withdrawal by Subject|13|||
145362769|NCT02099110|524178214|FG003|Overall Study|Withdrawal by Subject|9|||
145362770|NCT02099110|524178215|FG004|Overall Study|Withdrawal by Subject|13|||
145362771|NCT02099110|524178211|FG000|Overall Study|Adverse Event|3|||
145362772|NCT02099110|524178212|FG001|Overall Study|Adverse Event|5|||
145362773|NCT02099110|524178213|FG002|Overall Study|Adverse Event|2|||
145362774|NCT02099110|524178214|FG003|Overall Study|Adverse Event|3|||
145419331|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
145623154|NCT02240680|525131601|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
145362775|NCT02099110|524178215|FG004|Overall Study|Adverse Event|2|||
145362776|NCT02099110|524178211|FG000|Overall Study|Lost to Follow-up|6|||
145362777|NCT02099110|524178212|FG001|Overall Study|Lost to Follow-up|12|||
145362778|NCT02099110|524178213|FG002|Overall Study|Lost to Follow-up|11|||
145362779|NCT02099110|524178214|FG003|Overall Study|Lost to Follow-up|5|||
145623155|NCT02240680|525131598|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
145623156|NCT02240680|525131599|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
145623157|NCT02240680|525131600|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
145623158|NCT02240680|525131601|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
145623159|NCT02240680|525131598|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
145623160|NCT02240680|525131599|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
145362780|NCT02099110|524178215|FG004|Overall Study|Lost to Follow-up|6|||
145362781|NCT02099110|524178211|FG000|Overall Study|Death|0|||
145362782|NCT02099110|524178212|FG001|Overall Study|Death|1|||
145362783|NCT02099110|524178213|FG002|Overall Study|Death|0|||
145362784|NCT02099110|524178214|FG003|Overall Study|Death|0|||
145623161|NCT02240680|525131600|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
145623162|NCT02240680|525131601|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
145623163|NCT02240680|525131598|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
145623164|NCT02240680|525131599|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
145623165|NCT02240680|525131600|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
145623166|NCT02240680|525131601|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
145623167|NCT01657032|525131602|FG000|Overall Study|Lost to Follow-up|0|||
145623168|NCT01657032|525131603|FG001|Overall Study|Lost to Follow-up|7|||
145623169|NCT05968482|525131604|FG000|First Crossover Period|Withdrawal by Subject|0|||
145623170|NCT05968482|525131605|FG001|First Crossover Period|Withdrawal by Subject|0|||
145623171|NCT05968482|525131606|FG002|First Crossover Period|Withdrawal by Subject|1|||
145623172|NCT05968482|525131607|FG003|First Crossover Period|Withdrawal by Subject|0|||
145623173|NCT05968482|525131608|FG004|First Crossover Period|Withdrawal by Subject|0|||
145623174|NCT05968482|525131609|FG005|First Crossover Period|Withdrawal by Subject|0|||
145623175|NCT05968482|525131604|FG000|First Crossover Period|Adverse Event|0|||
145623176|NCT05968482|525131605|FG001|First Crossover Period|Adverse Event|0|||
145623177|NCT05968482|525131606|FG002|First Crossover Period|Adverse Event|0|||
145623178|NCT05968482|525131607|FG003|First Crossover Period|Adverse Event|0|||
145362785|NCT02099110|524178215|FG004|Overall Study|Death|0|||
145362786|NCT02099110|524178211|FG000|Overall Study|Screen failure|0|||
145362787|NCT02099110|524178212|FG001|Overall Study|Screen failure|0|||
145362788|NCT02099110|524178213|FG002|Overall Study|Screen failure|0|||
145362789|NCT02099110|524178214|FG003|Overall Study|Screen failure|0|||
145362790|NCT02099110|524178215|FG004|Overall Study|Screen failure|1|||
145362791|NCT02099110|524178211|FG000|Overall Study|Non-compliance with study drug|2|||
145362792|NCT02099110|524178212|FG001|Overall Study|Non-compliance with study drug|0|||
145362793|NCT02099110|524178213|FG002|Overall Study|Non-compliance with study drug|0|||
145362794|NCT02099110|524178214|FG003|Overall Study|Non-compliance with study drug|0|||
145362795|NCT02099110|524178215|FG004|Overall Study|Non-compliance with study drug|1|||
145362796|NCT02099110|524178211|FG000|Overall Study|Physician Decision|3|||
145362797|NCT02099110|524178212|FG001|Overall Study|Physician Decision|0|||
145362798|NCT02099110|524178213|FG002|Overall Study|Physician Decision|1|||
145362799|NCT02099110|524178214|FG003|Overall Study|Physician Decision|2|||
145362800|NCT02099110|524178215|FG004|Overall Study|Physician Decision|1|||
145362801|NCT01757184|524178222|FG000|Double-blind Period|Adverse Event|1|||
145362802|NCT01757184|524178223|FG001|Double-blind Period|Adverse Event|0|||
145362803|NCT01757184|524178224|FG002|Double-blind Period|Adverse Event|0|||
145362804|NCT01757184|524178225|FG003|Double-blind Period|Adverse Event|0|||
145362805|NCT01757184|524178222|FG000|Open-label Period|Lost to Follow-up|0|||
145362806|NCT01757184|524178223|FG001|Open-label Period|Lost to Follow-up|0|||
145362807|NCT01757184|524178224|FG002|Open-label Period|Lost to Follow-up|2|||
145362808|NCT01757184|524178225|FG003|Open-label Period|Lost to Follow-up|0|||
145362809|NCT01757184|524178222|FG000|Open-label Period|Withdrawal by Subject|0|||
145362810|NCT01757184|524178223|FG001|Open-label Period|Withdrawal by Subject|0|||
145362811|NCT01757184|524178224|FG002|Open-label Period|Withdrawal by Subject|1|||
145362812|NCT01757184|524178225|FG003|Open-label Period|Withdrawal by Subject|1|||
145362813|NCT01757184|524178222|FG000|Open-label Period|Discontinued by Sponsor|0|||
145362814|NCT01757184|524178223|FG001|Open-label Period|Discontinued by Sponsor|0|||
145362815|NCT01757184|524178224|FG002|Open-label Period|Discontinued by Sponsor|1|||
145362816|NCT01757184|524178225|FG003|Open-label Period|Discontinued by Sponsor|2|||
145362817|NCT03515811|524178228|FG000|Overall Study|Lost to Follow-up|2|||
145362818|NCT03515811|524178229|FG001|Overall Study|Lost to Follow-up|1|||
145362819|NCT03515811|524178228|FG000|Overall Study|Protocol Violation|1|||
145362820|NCT03515811|524178229|FG001|Overall Study|Protocol Violation|1|||
145362821|NCT03515811|524178228|FG000|Overall Study|Death|1|||
145362822|NCT03515811|524178229|FG001|Overall Study|Death|1|||
145362823|NCT03515811|524178228|FG000|Overall Study|Withdrawal by Subject|0|||
145362824|NCT03515811|524178229|FG001|Overall Study|Withdrawal by Subject|2|||
145362825|NCT03515811|524178228|FG000|Overall Study|Technical Problems|1|||
145362826|NCT03515811|524178229|FG001|Overall Study|Technical Problems|0|||
145362827|NCT03515811|524178228|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
145362828|NCT03515811|524178229|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
145362829|NCT03515811|524178228|FG000|Overall Study|COVID-19|0|||
145362830|NCT03515811|524178229|FG001|Overall Study|COVID-19|1|||
145362831|NCT02977572|524178230|FG000|Overall Study|Exclusion criterion|2|||
145362832|NCT02977572|524178231|FG001|Overall Study|Exclusion criterion|2|||
145362833|NCT02589639|524178243|FG000|Overall Study|Lost to Follow-up|1|||
145362834|NCT02589639|524178244|FG001|Overall Study|Lost to Follow-up|0|||
145362835|NCT02589639|524178245|FG002|Overall Study|Lost to Follow-up|0|||
145362836|NCT02589639|524178243|FG000|Overall Study|Protocol Violation|1|||
145362837|NCT02589639|524178244|FG001|Overall Study|Protocol Violation|0|||
145419332|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
145419333|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
145362838|NCT02589639|524178245|FG002|Overall Study|Protocol Violation|0|||
145362839|NCT02589639|524178243|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
145362840|NCT02589639|524178244|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
145362841|NCT02589639|524178245|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
145362842|NCT02589639|524178243|FG000|Overall Study|Adverse Event|4|||
145362843|NCT02589639|524178244|FG001|Overall Study|Adverse Event|5|||
145362844|NCT02589639|524178245|FG002|Overall Study|Adverse Event|3|||
145362845|NCT02589639|524178243|FG000|Overall Study|Other reason than specified above|1|||
145362846|NCT02589639|524178244|FG001|Overall Study|Other reason than specified above|2|||
145362847|NCT02589639|524178245|FG002|Overall Study|Other reason than specified above|1|||
145362848|NCT02589639|524178243|FG000|Overall Study|Not Treated|0|||
145362849|NCT02589639|524178244|FG001|Overall Study|Not Treated|3|||
145362850|NCT02589639|524178245|FG002|Overall Study|Not Treated|0|||
145362851|NCT01276756|524178246|FG000|Overall Study|Lost to Follow-up|2|||
145362852|NCT01276756|524178247|FG001|Overall Study|Lost to Follow-up|0|||
145362853|NCT01276756|524178246|FG000|Overall Study|Adverse Event|3|||
145362854|NCT01276756|524178247|FG001|Overall Study|Adverse Event|2|||
145362855|NCT00347009|524178248|FG000|Overall Study|Death|1|||
145362856|NCT00347009|524178248|FG000|Overall Study|Adverse Event|6|||
145362857|NCT00347009|524178248|FG000|Overall Study|Withdrawal by Subject|3|||
145362858|NCT00347009|524178248|FG000|Overall Study|Physician Decision|5|||
145362859|NCT00347009|524178248|FG000|Overall Study|Lost to Follow-up|4|||
145362860|NCT00347009|524178248|FG000|Overall Study|Protocol Violation|2|||
145362861|NCT00347009|524178248|FG000|Overall Study|Adverse Laboratory Experience|1|||
145362862|NCT00347009|524178248|FG000|Overall Study|Insufficient Viral Suppression|3|||
145362863|NCT00347009|524178248|FG000|Overall Study|Increased ALT/HBV DNA|1|||
145362864|NCT00347009|524178248|FG000|Overall Study|Serious Adverse Event|1|||
145362865|NCT02630251|524178249|FG000|Overall Study|Physician Decision|0|||
145362866|NCT02630251|524178250|FG001|Overall Study|Physician Decision|0|||
145362867|NCT02630251|524178251|FG002|Overall Study|Physician Decision|1|||
145362868|NCT02630251|524178252|FG003|Overall Study|Physician Decision|0|||
145362869|NCT01500382|524178253|FG000|Washout Period|Study site went out of business|0|||
145362870|NCT01500382|524178254|FG001|Washout Period|Study site went out of business|0|||
145362871|NCT01500382|524178255|FG002|Washout Period|Study site went out of business|1|||
145362872|NCT01500382|524178256|FG003|Washout Period|Study site went out of business|0|||
145362873|NCT03694002|524179825|FG000|Overall Study|Progression|4|||
145362874|NCT03694002|524179826|FG001|Overall Study|Progression|2|||
145362875|NCT03694002|524179825|FG000|Overall Study|Adverse Event|2|||
145362876|NCT03694002|524179826|FG001|Overall Study|Adverse Event|0|||
145362877|NCT03694002|524179825|FG000|Overall Study|Other not protocol specified|1|||
145362878|NCT03694002|524179826|FG001|Overall Study|Other not protocol specified|0|||
145362879|NCT03694002|524179825|FG000|Overall Study|Ineligible|0|||
145362880|NCT03694002|524179826|FG001|Overall Study|Ineligible|1|||
145362881|NCT03694002|524179825|FG000|Overall Study|Withdrew consent before starting treatment|0|||
145362882|NCT03694002|524179826|FG001|Overall Study|Withdrew consent before starting treatment|3|||
145362883|NCT05678959|524179827|FG000|Overall Study|Study Terminated by Sponsor|76|||
145362884|NCT05678959|524179828|FG001|Overall Study|Study Terminated by Sponsor|76|||
145362885|NCT05678959|524179827|FG000|Overall Study|Physician Decision|2|||
145362886|NCT05678959|524179828|FG001|Overall Study|Physician Decision|3|||
145362887|NCT05678959|524179827|FG000|Overall Study|Adverse Event|1|||
145362888|NCT05678959|524179828|FG001|Overall Study|Adverse Event|1|||
145362889|NCT05678959|524179827|FG000|Overall Study|Guardian Decision|1|||
145362890|NCT05678959|524179828|FG001|Overall Study|Guardian Decision|0|||
145362891|NCT05678959|524179827|FG000|Overall Study|Protocol Deviation|0|||
145362892|NCT05678959|524179828|FG001|Overall Study|Protocol Deviation|1|||
145362893|NCT05678959|524179827|FG000|Overall Study|Subject Decision|1|||
145362894|NCT05678959|524179828|FG001|Overall Study|Subject Decision|0|||
145362895|NCT05678959|524179827|FG000|Overall Study|Technical Problem|0|||
145362896|NCT05678959|524179828|FG001|Overall Study|Technical Problem|1|||
145362897|NCT06360588|524179829|FG000|Overall Study|Adverse Event|3|||
145362898|NCT06360588|524179829|FG000|Overall Study|Death|2|||
145362899|NCT06360588|524179829|FG000|Overall Study|Disease Progression|14|||
145362900|NCT06360588|524179829|FG000|Overall Study|Withdrawal by Subject|1|||
145362901|NCT06360588|524179829|FG000|Overall Study|Lack of Efficacy|1|||
145362902|NCT06360588|524179829|FG000|Overall Study|Ineligible|1|||
145362903|NCT01481766|524179830|FG000|4 months|Lost to Follow-up|3|||
145362904|NCT01481766|524179831|FG001|4 months|Lost to Follow-up|2|||
145362905|NCT01481766|524179832|FG002|4 months|Lost to Follow-up|1|||
145362906|NCT01481766|524179833|FG003|4 months|Lost to Follow-up|5|||
145362907|NCT01481766|524179830|FG000|12 months|Lost to Follow-up|7|||
145362908|NCT01481766|524179831|FG001|12 months|Lost to Follow-up|8|||
145362909|NCT01481766|524179832|FG002|12 months|Lost to Follow-up|5|||
145362910|NCT01481766|524179833|FG003|12 months|Lost to Follow-up|3|||
145362911|NCT00754234|524179834|FG000|Overall Study|Withdrawal by Subject|3|||
145362912|NCT03868930|524179835|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
145362913|NCT03868930|524179836|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
145362914|NCT03868930|524179835|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
145362915|NCT03868930|524179836|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
145362916|NCT03868930|524179835|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
145419334|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
145419335|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
145419336|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
145419337|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
145419338|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
145419339|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
145419340|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
145419341|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Death|1|||
145419342|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Death|2|||
145419343|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Death|2|||
145419344|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Death|0|||
145419345|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Death|0|||
145419346|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
145419347|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
145419348|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
145419349|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
145419350|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
145419351|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
145419352|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
145419353|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
145419354|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
145419355|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
145419356|NCT00098293|524390705|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
145419357|NCT00098293|524390706|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
145419358|NCT00098293|524390707|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
145419359|NCT00098293|524390708|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
145419360|NCT00098293|524390709|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
145419361|NCT00098293|524390705|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145419362|NCT00098293|524390706|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145419363|NCT00098293|524390707|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
145419364|NCT00098293|524390708|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145419365|NCT00098293|524390709|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
145419366|NCT00098293|524390705|FG000|Open-label (OL) Phase|Adverse Event|0|||
145419367|NCT00098293|524390706|FG001|Open-label (OL) Phase|Adverse Event|3|||
145419368|NCT00098293|524390707|FG002|Open-label (OL) Phase|Adverse Event|7|||
145419369|NCT00098293|524390708|FG003|Open-label (OL) Phase|Adverse Event|6|||
145419370|NCT00098293|524390709|FG004|Open-label (OL) Phase|Adverse Event|0|||
145419371|NCT00098293|524390705|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
145419372|NCT00098293|524390706|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
145419373|NCT00098293|524390707|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
145419374|NCT00098293|524390708|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
145419375|NCT00098293|524390709|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
145419376|NCT00098293|524390705|FG000|Open-label (OL) Phase|Pregnancy|0|||
145419377|NCT00098293|524390706|FG001|Open-label (OL) Phase|Pregnancy|1|||
145419378|NCT00098293|524390707|FG002|Open-label (OL) Phase|Pregnancy|0|||
145419379|NCT00098293|524390708|FG003|Open-label (OL) Phase|Pregnancy|3|||
145419380|NCT00098293|524390709|FG004|Open-label (OL) Phase|Pregnancy|0|||
145419381|NCT00098293|524390705|FG000|Open-label (OL) Phase|Protocol Violation|0|||
145419382|NCT00098293|524390706|FG001|Open-label (OL) Phase|Protocol Violation|6|||
145419383|NCT00098293|524390707|FG002|Open-label (OL) Phase|Protocol Violation|13|||
145419384|NCT00098293|524390708|FG003|Open-label (OL) Phase|Protocol Violation|16|||
145419385|NCT00098293|524390709|FG004|Open-label (OL) Phase|Protocol Violation|0|||
145419386|NCT00098293|524390705|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
145419387|NCT00098293|524390706|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
145419388|NCT00098293|524390707|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
145419389|NCT00098293|524390708|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
145419390|NCT00098293|524390709|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
145419391|NCT00098293|524390705|FG000|Open-label (OL) Phase|Death|0|||
145419392|NCT00098293|524390706|FG001|Open-label (OL) Phase|Death|2|||
145419393|NCT00098293|524390707|FG002|Open-label (OL) Phase|Death|3|||
145419394|NCT00098293|524390708|FG003|Open-label (OL) Phase|Death|0|||
145419395|NCT00098293|524390709|FG004|Open-label (OL) Phase|Death|0|||
145419396|NCT00098293|524390705|FG000|Supplemental Phase (SP)|Death|0|||
145419397|NCT00098293|524390706|FG001|Supplemental Phase (SP)|Death|0|||
145419398|NCT00098293|524390707|FG002|Supplemental Phase (SP)|Death|0|||
145419399|NCT00098293|524390708|FG003|Supplemental Phase (SP)|Death|0|||
145419400|NCT00098293|524390709|FG004|Supplemental Phase (SP)|Death|1|||
145419401|NCT00098293|524390705|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
145419402|NCT00098293|524390706|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
145419403|NCT00098293|524390707|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
145419404|NCT00098293|524390708|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
145419405|NCT00098293|524390709|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
145419406|NCT00098293|524390705|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145419407|NCT00098293|524390706|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145419408|NCT00098293|524390707|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145419409|NCT00098293|524390708|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
145419410|NCT00098293|524390709|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
145419411|NCT00098293|524390705|FG000|Supplemental Phase (SP)|Other|0|||
145419412|NCT00098293|524390706|FG001|Supplemental Phase (SP)|Other|0|||
145419413|NCT00098293|524390707|FG002|Supplemental Phase (SP)|Other|0|||
145419414|NCT00098293|524390708|FG003|Supplemental Phase (SP)|Other|0|||
145419415|NCT00098293|524390709|FG004|Supplemental Phase (SP)|Other|22|||
145419416|NCT01968785|524390710|FG000|Overall Study|Withdrawal by Subject|1|||
145419417|NCT01968785|524390711|FG001|Overall Study|Withdrawal by Subject|0|||
145419418|NCT00754559|524390714|FG000|Overall Study|Adverse Event|15|||
145419419|NCT00754559|524390714|FG000|Overall Study|Protocol Violation|11|||
145419420|NCT00754559|524390714|FG000|Overall Study|Lack of Efficacy|10|||
145419421|NCT00754559|524390714|FG000|Overall Study|Lost to Follow-up|2|||
145419422|NCT00754559|524390714|FG000|Overall Study|Administrative reason|1|||
145419423|NCT00754559|524390714|FG000|Overall Study|Other|5|||
145419424|NCT00754559|524390714|FG000|Overall Study|Withdrawal by Subject|3|||
145419425|NCT04000724|524390715|FG000|Overall Study|Withdrawal by Subject|5|||
145419426|NCT04000724|524390716|FG001|Overall Study|Withdrawal by Subject|3|||
145419427|NCT04000724|524390717|FG002|Overall Study|Withdrawal by Subject|4|||
145419428|NCT04000724|524390715|FG000|Overall Study|Lost to Follow-up|11|||
145419429|NCT04000724|524390716|FG001|Overall Study|Lost to Follow-up|7|||
145419430|NCT04000724|524390717|FG002|Overall Study|Lost to Follow-up|13|||
145419431|NCT04595370|524390718|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
145419432|NCT04595370|524390719|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145419433|NCT04595370|524390720|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145419434|NCT04595370|524390721|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145419435|NCT04595370|524390722|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145419436|NCT04595370|524390723|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
145419437|NCT04595370|524390718|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145419438|NCT04595370|524390719|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145419439|NCT04595370|524390720|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
145419440|NCT04595370|524390721|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145419441|NCT04595370|524390722|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145419442|NCT04595370|524390723|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
145419443|NCT04595370|524390718|FG000|Overall Study|Adverse Event|0|||
145419444|NCT04595370|524390719|FG001|Overall Study|Adverse Event|4|||
145419445|NCT04595370|524390720|FG002|Overall Study|Adverse Event|3|||
145419446|NCT04595370|524390721|FG003|Overall Study|Adverse Event|1|||
145419447|NCT04595370|524390722|FG004|Overall Study|Adverse Event|1|||
145419448|NCT04595370|524390723|FG005|Overall Study|Adverse Event|1|||
145419449|NCT04595370|524390718|FG000|Overall Study|Withdrawal of Consent|1|||
145419450|NCT04595370|524390719|FG001|Overall Study|Withdrawal of Consent|1|||
145419451|NCT04595370|524390720|FG002|Overall Study|Withdrawal of Consent|1|||
145419452|NCT04595370|524390721|FG003|Overall Study|Withdrawal of Consent|0|||
145419453|NCT04595370|524390722|FG004|Overall Study|Withdrawal of Consent|0|||
145419454|NCT04595370|524390723|FG005|Overall Study|Withdrawal of Consent|0|||
145419455|NCT04595370|524390718|FG000|Overall Study|Death|0|||
145419456|NCT04595370|524390719|FG001|Overall Study|Death|1|||
145419457|NCT04595370|524390720|FG002|Overall Study|Death|0|||
145419458|NCT04595370|524390721|FG003|Overall Study|Death|0|||
145419459|NCT04595370|524390722|FG004|Overall Study|Death|1|||
145419460|NCT04595370|524390723|FG005|Overall Study|Death|0|||
145419461|NCT04595370|524390718|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145419462|NCT04595370|524390719|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145419463|NCT04595370|524390720|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145419464|NCT04595370|524390721|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145419465|NCT04595370|524390722|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145419466|NCT04595370|524390723|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145419467|NCT04595370|524390718|FG000|Overall Study|Withdrawal by Subject|0|||
145419468|NCT04595370|524390719|FG001|Overall Study|Withdrawal by Subject|0|||
145419469|NCT04595370|524390720|FG002|Overall Study|Withdrawal by Subject|1|||
145419470|NCT04595370|524390721|FG003|Overall Study|Withdrawal by Subject|0|||
145419471|NCT04595370|524390722|FG004|Overall Study|Withdrawal by Subject|2|||
145419472|NCT04595370|524390723|FG005|Overall Study|Withdrawal by Subject|0|||
145419473|NCT04595370|524390718|FG000|Overall Study|Lost to Follow-up|0|||
145419474|NCT04595370|524390719|FG001|Overall Study|Lost to Follow-up|0|||
145419475|NCT04595370|524390720|FG002|Overall Study|Lost to Follow-up|0|||
145419476|NCT04595370|524390721|FG003|Overall Study|Lost to Follow-up|0|||
145419477|NCT04595370|524390722|FG004|Overall Study|Lost to Follow-up|1|||
145419478|NCT04595370|524390723|FG005|Overall Study|Lost to Follow-up|0|||
145419479|NCT04595370|524390718|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145419480|NCT04595370|524390719|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
145362917|NCT03868930|524179836|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
145362918|NCT03868930|524179835|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
145362919|NCT03868930|524179836|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
145362920|NCT03868930|524179835|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
145362921|NCT03868930|524179836|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
145362922|NCT04432831|524179837|FG000|Overall Study|Withdrawal by Subject|24|||
145362923|NCT04432831|524179838|FG001|Overall Study|Withdrawal by Subject|28|||
145362924|NCT04432831|524179839|FG002|Overall Study|Withdrawal by Subject|21|||
145362925|NCT04432831|524179837|FG000|Overall Study|Death|23|||
145362926|NCT04432831|524179838|FG001|Overall Study|Death|23|||
145362927|NCT04432831|524179839|FG002|Overall Study|Death|17|||
145362928|NCT04432831|524179837|FG000|Overall Study|Lost to Follow-up|15|||
145362929|NCT04432831|524179838|FG001|Overall Study|Lost to Follow-up|15|||
145362930|NCT04432831|524179839|FG002|Overall Study|Lost to Follow-up|12|||
145362931|NCT04432831|524179837|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
145362932|NCT04432831|524179838|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
145362933|NCT04432831|524179839|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
145362934|NCT04432831|524179837|FG000|Overall Study|Reason Not Specified|7|||
145362935|NCT04432831|524179838|FG001|Overall Study|Reason Not Specified|11|||
145362936|NCT04432831|524179839|FG002|Overall Study|Reason Not Specified|9|||
145362937|NCT04432831|524179837|FG000|Overall Study|Adverse Event|7|||
145362938|NCT04432831|524179838|FG001|Overall Study|Adverse Event|7|||
145362939|NCT04432831|524179839|FG002|Overall Study|Adverse Event|7|||
145362940|NCT04432831|524179837|FG000|Overall Study|Physician Decision|1|||
145362941|NCT04432831|524179838|FG001|Overall Study|Physician Decision|3|||
145362942|NCT04432831|524179839|FG002|Overall Study|Physician Decision|6|||
145362943|NCT04432831|524179837|FG000|Overall Study|Protocol Violation|1|||
145362944|NCT04432831|524179838|FG001|Overall Study|Protocol Violation|0|||
145362945|NCT04432831|524179839|FG002|Overall Study|Protocol Violation|2|||
145362946|NCT04432831|524179837|FG000|Overall Study|Pregnancy|0|||
145362947|NCT04432831|524179838|FG001|Overall Study|Pregnancy|1|||
145362948|NCT04432831|524179839|FG002|Overall Study|Pregnancy|0|||
145362949|NCT04432831|524179837|FG000|Overall Study|Lack of Efficacy|0|||
145362950|NCT04432831|524179838|FG001|Overall Study|Lack of Efficacy|0|||
145362951|NCT04432831|524179839|FG002|Overall Study|Lack of Efficacy|2|||
145362952|NCT01262287|524179842|FG000|Overall Study|Lost to Follow-up|2|||
145362953|NCT01262287|524179843|FG001|Overall Study|Lost to Follow-up|1|||
145362954|NCT00596687|524179844|FG000|Overall Study|< 24 hours of insulin treatment|8|||
145362955|NCT00596687|524179845|FG001|Overall Study|< 24 hours of insulin treatment|6|||
145362956|NCT00596687|524179844|FG000|Overall Study|continuous insulin infusion during TPN|2|||
145362957|NCT00596687|524179845|FG001|Overall Study|continuous insulin infusion during TPN|1|||
145362958|NCT00596687|524179844|FG000|Overall Study|Withdrawal by Subject|3|||
145362959|NCT00596687|524179845|FG001|Overall Study|Withdrawal by Subject|1|||
145362960|NCT00596687|524179844|FG000|Overall Study|cancelled surgery|1|||
145362961|NCT00596687|524179845|FG001|Overall Study|cancelled surgery|1|||
145362962|NCT04134767|524179846|FG000|Overall Study|Death|0|||
145362963|NCT04134767|524179847|FG001|Overall Study|Death|1|||
145362964|NCT04134767|524179846|FG000|Overall Study|Removed for harassing staff|0|||
145362965|NCT04134767|524179847|FG001|Overall Study|Removed for harassing staff|1|||
145362966|NCT04134767|524179846|FG000|Overall Study|Lost to Follow-up|44|||
145362967|NCT04134767|524179847|FG001|Overall Study|Lost to Follow-up|40|||
145362968|NCT00638404|524179848|FG000|Overall Study|Physician Decision|8|||
145362969|NCT00638404|524179849|FG001|Overall Study|Physician Decision|0|||
145362970|NCT02492984|524179850|FG000|Overall Study|Adverse Event|1|||
145362971|NCT02492984|524179851|FG001|Overall Study|Adverse Event|0|||
145362972|NCT02492984|524179850|FG000|Overall Study|Protocol Violation|1|||
145362973|NCT02492984|524179851|FG001|Overall Study|Protocol Violation|0|||
145362974|NCT02492984|524179850|FG000|Overall Study|Withdrawal by Subject|1|||
145362975|NCT02492984|524179851|FG001|Overall Study|Withdrawal by Subject|0|||
145362976|NCT02101736|524179852|FG000|Overall Study|Protocol Violation|3|||
145362977|NCT02101736|524179853|FG001|Overall Study|Protocol Violation|0|||
145362978|NCT02101736|524179852|FG000|Overall Study|Withdrawal by Subject|1|||
145362979|NCT02101736|524179853|FG001|Overall Study|Withdrawal by Subject|1|||
145362980|NCT02282631|524179854|FG000|Overall Study|Lost to Follow-up|2|||
145362981|NCT02282631|524179855|FG001|Overall Study|Lost to Follow-up|0|||
145362982|NCT01515865|524179857|FG000|Part A (Open-label)|Other|3|||
145362983|NCT01515865|524179858|FG001|Part A (Open-label)|Other|0|||
145362984|NCT01515865|524179859|FG002|Part A (Open-label)|Other|0|||
145362985|NCT01515865|524179857|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
145362986|NCT01515865|524179858|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
145362987|NCT01515865|524179859|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
145362988|NCT01515865|524179857|FG000|Part B (Open-label)|Other|1|||
145362989|NCT01515865|524179858|FG001|Part B (Open-label)|Other|0|||
145362990|NCT01515865|524179859|FG002|Part B (Open-label)|Other|0|||
145419481|NCT04595370|524390720|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
145362991|NCT02453334|524179860|FG000|Overall Study|Death|15|||
145362992|NCT02453334|524179861|FG001|Overall Study|Death|13|||
145362993|NCT02453334|524179860|FG000|Overall Study|Adverse Event|2|||
145362994|NCT02453334|524179861|FG001|Overall Study|Adverse Event|1|||
145362995|NCT02453334|524179860|FG000|Overall Study|Lost to Follow-up|5|||
145362996|NCT02453334|524179861|FG001|Overall Study|Lost to Follow-up|9|||
145362997|NCT02453334|524179860|FG000|Overall Study|Physician Decision|1|||
145362998|NCT02453334|524179861|FG001|Overall Study|Physician Decision|0|||
145362999|NCT02453334|524179860|FG000|Overall Study|Withdrawal by Subject|17|||
145363000|NCT02453334|524179861|FG001|Overall Study|Withdrawal by Subject|13|||
145363001|NCT02453334|524179860|FG000|Overall Study|Other reason|1|||
145363002|NCT02453334|524179861|FG001|Overall Study|Other reason|4|||
145363003|NCT03981900|524179863|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
145363004|NCT03981900|524179863|FG000|Overall Study|Adverse Event|5|||
145363005|NCT03981900|524179863|FG000|Overall Study|Protocol Violation|1|||
145363006|NCT03981900|524179863|FG000|Overall Study|Withdrawal by Subject|7|||
145363007|NCT03981900|524179863|FG000|Overall Study|Lost to Follow-up|46|||
145363008|NCT03981900|524179863|FG000|Overall Study|Decision of the researcher|3|||
145363009|NCT03981900|524179863|FG000|Overall Study|Death|3|||
145363010|NCT03981900|524179863|FG000|Overall Study|Other|5|||
145363011|NCT02509507|524179869|FG000|Overall Study|Death|21|||
145363012|NCT02509507|524179870|FG001|Overall Study|Death|3|||
145363013|NCT02509507|524179871|FG002|Overall Study|Death|22|||
145363014|NCT02509507|524179872|FG003|Overall Study|Death|14|||
145363015|NCT02509507|524179873|FG004|Overall Study|Death|8|||
145363016|NCT02509507|524179874|FG005|Overall Study|Death|12|||
145363017|NCT02509507|524179875|FG006|Overall Study|Death|5|||
145363018|NCT02509507|524179876|FG007|Overall Study|Death|4|||
145363019|NCT02509507|524179877|FG008|Overall Study|Death|8|||
145363020|NCT02509507|524179869|FG000|Overall Study|Lost to Follow-up|0|||
145363021|NCT02509507|524179870|FG001|Overall Study|Lost to Follow-up|1|||
145363022|NCT02509507|524179871|FG002|Overall Study|Lost to Follow-up|0|||
145363023|NCT02509507|524179872|FG003|Overall Study|Lost to Follow-up|0|||
145363024|NCT02509507|524179873|FG004|Overall Study|Lost to Follow-up|0|||
145363025|NCT02509507|524179874|FG005|Overall Study|Lost to Follow-up|2|||
145363026|NCT02509507|524179875|FG006|Overall Study|Lost to Follow-up|0|||
145363027|NCT02509507|524179876|FG007|Overall Study|Lost to Follow-up|0|||
145363028|NCT02509507|524179877|FG008|Overall Study|Lost to Follow-up|0|||
145363029|NCT02509507|524179869|FG000|Overall Study|Withdrawal by Subject|2|||
145363030|NCT02509507|524179870|FG001|Overall Study|Withdrawal by Subject|0|||
145363031|NCT02509507|524179871|FG002|Overall Study|Withdrawal by Subject|1|||
145363032|NCT02509507|524179872|FG003|Overall Study|Withdrawal by Subject|4|||
145363033|NCT02509507|524179873|FG004|Overall Study|Withdrawal by Subject|1|||
145363034|NCT02509507|524179874|FG005|Overall Study|Withdrawal by Subject|3|||
145363035|NCT02509507|524179875|FG006|Overall Study|Withdrawal by Subject|4|||
145363036|NCT02509507|524179876|FG007|Overall Study|Withdrawal by Subject|0|||
145363037|NCT02509507|524179877|FG008|Overall Study|Withdrawal by Subject|1|||
145363038|NCT02510664|524179885|FG000|Overall Study|Transferred Care|9|||
145363039|NCT02510664|524179886|FG001|Overall Study|Transferred Care|9|||
145363040|NCT02510664|524179887|FG002|Overall Study|Transferred Care|0|||
145363041|NCT02510664|524179885|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
145363042|NCT02510664|524179886|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
145363043|NCT02510664|524179887|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
145363044|NCT02510664|524179885|FG000|Overall Study|Time Constraints|1|||
145363045|NCT02510664|524179886|FG001|Overall Study|Time Constraints|1|||
145363046|NCT02510664|524179887|FG002|Overall Study|Time Constraints|0|||
145363047|NCT02801617|524179889|FG000|Overall Study|Protocol Violation|2|||
145363048|NCT02801617|524179890|FG001|Overall Study|Protocol Violation|6|||
145363049|NCT04090060|524179896|FG000|Overall Study|Lost to Follow-up|76|||
145363050|NCT04090060|524179897|FG001|Overall Study|Lost to Follow-up|77|||
145363051|NCT02490371|524179898|FG000|Overall Study|Lost to Follow-up|1|||
145363052|NCT02490371|524179899|FG001|Overall Study|Lost to Follow-up|1|||
145363053|NCT01163851|524179900|FG000|Overall Study|Site Closure|0|||
145363054|NCT01163851|524179901|FG001|Overall Study|Site Closure|1|||
145363055|NCT01163851|524179900|FG000|Overall Study|Enrolled but not treated|1|||
145363056|NCT01163851|524179901|FG001|Overall Study|Enrolled but not treated|0|||
145363057|NCT00179660|524179902|FG000|Overall Study|Adverse Event|7|||
145363058|NCT00179660|524179902|FG000|Overall Study|Lack of therapeutic effect|28|||
145363059|NCT00179660|524179902|FG000|Overall Study|Withdrawal by Subject|2|||
145363060|NCT00179660|524179902|FG000|Overall Study|Lost to Follow-up|1|||
145363061|NCT00179660|524179902|FG000|Overall Study|Death|3|||
145363062|NCT00179660|524179902|FG000|Overall Study|Other - Unspecified|9|||
145363063|NCT00183885|524179914|FG000|Overall Study|Adverse Event|11|||
145363064|NCT00183885|524179914|FG000|Overall Study|Death|1|||
145363065|NCT00183885|524179914|FG000|Overall Study|Lost to Follow-up|3|||
145363066|NCT00183885|524179914|FG000|Overall Study|Physician Decision|6|||
145363067|NCT00183885|524179914|FG000|Overall Study|Withdrawal by Subject|5|||
145363068|NCT00183885|524179914|FG000|Overall Study|Switched to alternative treatment|8|||
145363069|NCT00183885|524179914|FG000|Overall Study|Treatment delayed too long|4|||
145363070|NCT00183885|524179914|FG000|Overall Study|Developed second malignancy|1|||
145363071|NCT00014495|524179915|FG000|Overall Study|Death|0|||
145363072|NCT00014495|524179916|FG001|Overall Study|Death|0|||
145363073|NCT00014495|524179917|FG002|Overall Study|Death|1|||
145363074|NCT00014495|524179918|FG003|Overall Study|Death|0|||
145363075|NCT00014495|524179915|FG000|Overall Study|Clinical deterioration|0|||
145363076|NCT00014495|524179916|FG001|Overall Study|Clinical deterioration|0|||
145363077|NCT00014495|524179917|FG002|Overall Study|Clinical deterioration|0|||
145363078|NCT00014495|524179918|FG003|Overall Study|Clinical deterioration|1|||
145363079|NCT02091089|524179952|FG000|Overall Study|Lost to Follow-up|2|||
145363080|NCT01303172|524179953|FG000|Overall Study|Physician Decision|9|||
145363081|NCT01303172|524179954|FG001|Overall Study|Physician Decision|6|||
145363082|NCT01303172|524179953|FG000|Overall Study|Adverse Event|5|||
145363083|NCT01303172|524179954|FG001|Overall Study|Adverse Event|2|||
145363084|NCT01303172|524179953|FG000|Overall Study|Withdrawal by Subject|4|||
145363085|NCT01303172|524179954|FG001|Overall Study|Withdrawal by Subject|2|||
145363086|NCT01303172|524179953|FG000|Overall Study|Death|20|||
145363087|NCT01303172|524179954|FG001|Overall Study|Death|7|||
145363088|NCT01303172|524179953|FG000|Overall Study|Lack of Efficacy|25|||
145363089|NCT01303172|524179954|FG001|Overall Study|Lack of Efficacy|17|||
145363090|NCT00591565|524179959|FG000|Overall Study|lost follow up, withdrawn|5|||
145363091|NCT01863667|524179961|FG000|Overall Study|Adverse Event|1|||
145363092|NCT01863667|524179962|FG001|Overall Study|Adverse Event|0|||
145363093|NCT01863667|524179961|FG000|Overall Study|Study terminated by Sponsor|30|||
145363094|NCT01863667|524179962|FG001|Overall Study|Study terminated by Sponsor|30|||
145363095|NCT01863667|524179961|FG000|Overall Study|Withdrawal by Subject|2|||
145363096|NCT01863667|524179962|FG001|Overall Study|Withdrawal by Subject|2|||
145363097|NCT03627546|524179965|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
145363098|NCT03627546|524179966|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
145363099|NCT03627546|524179967|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
145363100|NCT03627546|524179965|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
145363101|NCT03627546|524179966|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
145363102|NCT03627546|524179967|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
145363103|NCT00615550|524179968|FG000|Overall Study|Lost to Follow-up|6|||
145363104|NCT00615550|524179969|FG001|Overall Study|Lost to Follow-up|1|||
145363105|NCT01537042|524179970|FG000|Overall Study|Adverse Event|0|||
145363106|NCT01537042|524179971|FG001|Overall Study|Adverse Event|2|||
145363107|NCT01537042|524179970|FG000|Overall Study|Lack of Efficacy|0|||
145363108|NCT01537042|524179971|FG001|Overall Study|Lack of Efficacy|1|||
145363109|NCT01537042|524179970|FG000|Overall Study|Protocol Violation|0|||
145363110|NCT01537042|524179971|FG001|Overall Study|Protocol Violation|1|||
145363111|NCT01537042|524179970|FG000|Overall Study|Other|0|||
145363112|NCT01537042|524179971|FG001|Overall Study|Other|1|||
145363113|NCT02741076|524179972|FG000|Overall Study|Adverse Event|0|||
145363114|NCT02741076|524179973|FG001|Overall Study|Adverse Event|1|||
145363115|NCT02741076|524179974|FG002|Overall Study|Adverse Event|1|||
145363116|NCT02741076|524179975|FG003|Overall Study|Adverse Event|0|||
145363117|NCT02741076|524179972|FG000|Overall Study|Lack of Efficacy|1|||
145363118|NCT02741076|524179973|FG001|Overall Study|Lack of Efficacy|0|||
145363119|NCT02741076|524179974|FG002|Overall Study|Lack of Efficacy|0|||
145363120|NCT02741076|524179975|FG003|Overall Study|Lack of Efficacy|0|||
145363121|NCT02741076|524179972|FG000|Overall Study|Withdrawal by Subject|0|||
145363122|NCT02741076|524179973|FG001|Overall Study|Withdrawal by Subject|1|||
145363123|NCT02741076|524179974|FG002|Overall Study|Withdrawal by Subject|0|||
145363124|NCT02741076|524179975|FG003|Overall Study|Withdrawal by Subject|0|||
145363125|NCT02741076|524179972|FG000|Overall Study|Sponsor Request|2|||
145363126|NCT02741076|524179973|FG001|Overall Study|Sponsor Request|3|||
145363127|NCT02741076|524179974|FG002|Overall Study|Sponsor Request|0|||
145363128|NCT02741076|524179975|FG003|Overall Study|Sponsor Request|1|||
145363129|NCT02741076|524179972|FG000|Overall Study|No additional information available|0|||
145363130|NCT02741076|524179973|FG001|Overall Study|No additional information available|0|||
145363131|NCT02741076|524179974|FG002|Overall Study|No additional information available|1|||
145363132|NCT02741076|524179975|FG003|Overall Study|No additional information available|1|||
145363133|NCT02965573|524179976|FG000|Overall Study|Lack of Efficacy|1|||
145363134|NCT02965573|524179977|FG001|Overall Study|Lack of Efficacy|0|||
145363135|NCT01779440|524179978|FG000|Overall Study|Withdrawal by Subject|3|||
145363136|NCT01779440|524179979|FG001|Overall Study|Withdrawal by Subject|5|||
145363137|NCT00315458|524179983|FG000|Overall Study|Administrative|0|||
145363138|NCT00315458|524179984|FG001|Overall Study|Administrative|3|||
145363139|NCT00315458|524179985|FG002|Overall Study|Administrative|8|||
145363140|NCT00315458|524179986|FG003|Overall Study|Administrative|21|||
145363141|NCT00315458|524179983|FG000|Overall Study|Adverse Event|2|||
145577609|NCT01824303|524969449|FG000|Randomized Study|Withdrawal by Subject|1|||
145363142|NCT00315458|524179984|FG001|Overall Study|Adverse Event|4|||
145363143|NCT00315458|524179985|FG002|Overall Study|Adverse Event|23|||
145363144|NCT00315458|524179986|FG003|Overall Study|Adverse Event|3|||
145363145|NCT00315458|524179983|FG000|Overall Study|Lost to Follow-up|1|||
145363146|NCT00315458|524179984|FG001|Overall Study|Lost to Follow-up|2|||
145363147|NCT00315458|524179985|FG002|Overall Study|Lost to Follow-up|0|||
145363148|NCT00315458|524179986|FG003|Overall Study|Lost to Follow-up|2|||
145363149|NCT00315458|524179983|FG000|Overall Study|Withdrawal by Subject|0|||
145363150|NCT00315458|524179984|FG001|Overall Study|Withdrawal by Subject|3|||
145363151|NCT00315458|524179985|FG002|Overall Study|Withdrawal by Subject|0|||
145363152|NCT00315458|524179986|FG003|Overall Study|Withdrawal by Subject|2|||
145363153|NCT00315458|524179983|FG000|Overall Study|Lack of Efficacy|0|||
145363154|NCT00315458|524179984|FG001|Overall Study|Lack of Efficacy|0|||
145363155|NCT00315458|524179985|FG002|Overall Study|Lack of Efficacy|20|||
145363156|NCT00315458|524179986|FG003|Overall Study|Lack of Efficacy|1|||
145363157|NCT00315458|524179983|FG000|Overall Study|Did not qualify|0|||
145363158|NCT00315458|524179984|FG001|Overall Study|Did not qualify|0|||
145363159|NCT00315458|524179985|FG002|Overall Study|Did not qualify|1|||
145363160|NCT00315458|524179986|FG003|Overall Study|Did not qualify|0|||
145363161|NCT00523848|524179987|FG000|Overall Study|Adverse Event|11|||
145363162|NCT00523848|524179987|FG000|Overall Study|Withdrawal by Subject|2|||
145363163|NCT00523848|524179987|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
145363164|NCT00523848|524179987|FG000|Overall Study|Disease Progression|5|||
145363165|NCT00523848|524179987|FG000|Overall Study|Other, unspecified|4|||
145363166|NCT00086619|524179988|FG000|Overall Study|Withdrawal by Subject|6|||
145363167|NCT00086619|524179989|FG001|Overall Study|Withdrawal by Subject|6|||
145363168|NCT00086619|524179988|FG000|Overall Study|Adverse Event|8|||
145363169|NCT00086619|524179989|FG001|Overall Study|Adverse Event|10|||
145363170|NCT00086619|524179988|FG000|Overall Study|Protocol Violation|1|||
145363171|NCT00086619|524179989|FG001|Overall Study|Protocol Violation|1|||
145363172|NCT00489918|524179990|FG000|Overall Study|Withdrawal by Subject|2|||
145363173|NCT00489918|524179991|FG001|Overall Study|Withdrawal by Subject|1|||
145363174|NCT00489918|524179992|FG002|Overall Study|Withdrawal by Subject|1|||
145363175|NCT00489918|524179993|FG003|Overall Study|Withdrawal by Subject|0|||
145363176|NCT00489918|524179994|FG004|Overall Study|Withdrawal by Subject|1|||
145363177|NCT00489918|524179990|FG000|Overall Study|Adverse Event|0|||
145363178|NCT00489918|524179991|FG001|Overall Study|Adverse Event|1|||
145363179|NCT00489918|524179992|FG002|Overall Study|Adverse Event|1|||
145363180|NCT00489918|524179993|FG003|Overall Study|Adverse Event|0|||
145363181|NCT00489918|524179994|FG004|Overall Study|Adverse Event|0|||
145363182|NCT00489918|524179990|FG000|Overall Study|Lost to Follow-up|0|||
145363183|NCT00489918|524179991|FG001|Overall Study|Lost to Follow-up|0|||
145363184|NCT00489918|524179992|FG002|Overall Study|Lost to Follow-up|1|||
145363185|NCT00489918|524179993|FG003|Overall Study|Lost to Follow-up|1|||
145363186|NCT00489918|524179994|FG004|Overall Study|Lost to Follow-up|0|||
145363187|NCT00489918|524179990|FG000|Overall Study|Physician Decision|0|||
145363188|NCT00489918|524179991|FG001|Overall Study|Physician Decision|0|||
145363189|NCT00489918|524179992|FG002|Overall Study|Physician Decision|1|||
145363190|NCT00489918|524179993|FG003|Overall Study|Physician Decision|0|||
145363191|NCT00489918|524179994|FG004|Overall Study|Physician Decision|0|||
145363192|NCT02748213|524179995|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
145363193|NCT02748213|524179996|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
145363194|NCT02748213|524179995|FG000|Overall Study|Abnormal Laboratory Test|1|||
145363195|NCT02748213|524179996|FG001|Overall Study|Abnormal Laboratory Test|0|||
145363196|NCT02748213|524179995|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
145363197|NCT02748213|524179996|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
145363198|NCT02748213|524179995|FG000|Overall Study|Death|5|||
145363199|NCT02748213|524179996|FG001|Overall Study|Death|3|||
145363200|NCT02748213|524179995|FG000|Overall Study|Insufficient Therapeutic Response|56|||
145363201|NCT02748213|524179996|FG001|Overall Study|Insufficient Therapeutic Response|57|||
145363202|NCT02748213|524179995|FG000|Overall Study|Violation of Selection Criteria|2|||
145363203|NCT02748213|524179996|FG001|Overall Study|Violation of Selection Criteria|0|||
145363204|NCT02748213|524179995|FG000|Overall Study|Protocol Violation|6|||
145363205|NCT02748213|524179996|FG001|Overall Study|Protocol Violation|4|||
145363206|NCT02748213|524179995|FG000|Overall Study|Refused Treatment*|6|||
145363207|NCT02748213|524179996|FG001|Overall Study|Refused Treatment*|6|||
145363208|NCT02748213|524179995|FG000|Overall Study|Failure to Return|1|||
145363209|NCT02748213|524179996|FG001|Overall Study|Failure to Return|0|||
145363210|NCT02748213|524179995|FG000|Overall Study|Other|30|||
145363211|NCT02748213|524179996|FG001|Overall Study|Other|29|||
145363212|NCT00961350|524179998|FG000|Overall Study|Adverse Event|18|||
145363213|NCT00961350|524179999|FG001|Overall Study|Adverse Event|33|||
145363214|NCT00961350|524179998|FG000|Overall Study|Withdrawal by Subject|10|||
145363215|NCT00961350|524179999|FG001|Overall Study|Withdrawal by Subject|10|||
145363216|NCT00961350|524179998|FG000|Overall Study|Lost to Follow-up|3|||
145363217|NCT00961350|524179999|FG001|Overall Study|Lost to Follow-up|3|||
145363218|NCT00961350|524179998|FG000|Overall Study|Misc|16|||
145363219|NCT00961350|524179999|FG001|Overall Study|Misc|21|||
145363220|NCT04284774|524180002|FG000|Overall Study|Progressive disease|5|||
145363221|NCT01760655|524181508|FG000|Overall Study|Death|18|||
145363222|NCT01760655|524181508|FG000|Overall Study|Physician Decision|1|||
145363223|NCT03056638|524181521|FG000|Overall Study|Death|1|||
145363224|NCT03056638|524181522|FG001|Overall Study|Death|0|||
145363225|NCT02530125|524181523|FG000|Completed Treatment|Early termination of study|1|||
145363226|NCT02530125|524181523|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
145363227|NCT00468481|524181524|FG000|Overall Study|Adverse Event|13|||
145363228|NCT00468481|524181525|FG001|Overall Study|Adverse Event|3|||
145419482|NCT04595370|524390721|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145419483|NCT04595370|524390722|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
145419484|NCT04595370|524390723|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
145419485|NCT03572218|524390724|FG000|Overall Study|Lost to Follow-up|3|||
145419486|NCT03572218|524390725|FG001|Overall Study|Lost to Follow-up|2|||
145419487|NCT03572218|524390724|FG000|Overall Study|No longer available for study visits|2|||
145419488|NCT03572218|524390725|FG001|Overall Study|No longer available for study visits|1|||
145419489|NCT03572218|524390724|FG000|Overall Study|No longer interested|1|||
145419490|NCT03572218|524390725|FG001|Overall Study|No longer interested|2|||
145419491|NCT02487199|524390726|FG000|Overall Study|Withdrew Consent|0|||
145419492|NCT02487199|524390727|FG001|Overall Study|Withdrew Consent|1|||
145419493|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
145419494|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145419495|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145419496|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145419497|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145419498|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
145419499|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
145419500|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
145419501|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145419502|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
145419503|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145419504|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145419505|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145419506|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
145419507|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
145419508|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419509|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419510|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419511|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419512|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419513|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
145419514|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
145363229|NCT00468481|524181524|FG000|Overall Study|Lost to Follow-up|25|||
145363230|NCT00468481|524181525|FG001|Overall Study|Lost to Follow-up|8|||
145363231|NCT00468481|524181524|FG000|Overall Study|Pregnancy|2|||
145363232|NCT00468481|524181525|FG001|Overall Study|Pregnancy|0|||
145363233|NCT00468481|524181524|FG000|Overall Study|Protocol Violation|18|||
145363234|NCT00468481|524181525|FG001|Overall Study|Protocol Violation|8|||
145363235|NCT00468481|524181524|FG000|Overall Study|Withdrawal by Subject|12|||
145363236|NCT00468481|524181525|FG001|Overall Study|Withdrawal by Subject|3|||
145363237|NCT00468481|524181524|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
145363238|NCT00468481|524181525|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
145363239|NCT00468481|524181524|FG000|Overall Study|Prohibited Medication|1|||
145363240|NCT00468481|524181525|FG001|Overall Study|Prohibited Medication|1|||
145363241|NCT00468481|524181524|FG000|Overall Study|Egg Donor|1|||
145363242|NCT00468481|524181525|FG001|Overall Study|Egg Donor|0|||
145363243|NCT00468481|524181524|FG000|Overall Study|Moved out of area|4|||
145363244|NCT00468481|524181525|FG001|Overall Study|Moved out of area|1|||
145363245|NCT00468481|524181524|FG000|Overall Study|Non-Compliance|5|||
145363246|NCT00468481|524181525|FG001|Overall Study|Non-Compliance|0|||
145363247|NCT00468481|524181524|FG000|Overall Study|Other|6|||
145363248|NCT00468481|524181525|FG001|Overall Study|Other|0|||
145363249|NCT01568034|524181526|FG000|Overall Study|Withdrawal by Subject|1|||
145363250|NCT01568034|524181527|FG001|Overall Study|Withdrawal by Subject|0|||
145363251|NCT01568034|524181528|FG002|Overall Study|Withdrawal by Subject|0|||
145363252|NCT01568034|524181529|FG003|Overall Study|Withdrawal by Subject|0|||
145363253|NCT00728468|524181530|FG000|Overall Study|Enrolled but not treated|1|||
145363254|NCT00728468|524181530|FG000|Overall Study|Death|1|||
145363255|NCT00728468|524181530|FG000|Overall Study|Protocol Violation|4|||
145419515|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145419516|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145419517|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145363256|NCT00728468|524181530|FG000|Overall Study|Objective progression or relapse|9|||
145363257|NCT00728468|524181530|FG000|Overall Study|Study terminated by sponsor|1|||
145363258|NCT05656534|524181533|FG000|Overall Study|Withdrawal by Subject|1|||
145577610|NCT01824303|524969450|FG001|Randomized Study|Withdrawal by Subject|1|||
145363259|NCT05656534|524181534|FG001|Overall Study|Withdrawal by Subject|1|||
145363260|NCT05656534|524181535|FG002|Overall Study|Withdrawal by Subject|0|||
145363261|NCT05656534|524181536|FG003|Overall Study|Withdrawal by Subject|0|||
145419518|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145419519|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
145363262|NCT05656534|524181533|FG000|Overall Study|Physician Decision|1|||
145363263|NCT05656534|524181534|FG001|Overall Study|Physician Decision|1|||
145363264|NCT05656534|524181535|FG002|Overall Study|Physician Decision|0|||
145363265|NCT05656534|524181536|FG003|Overall Study|Physician Decision|0|||
145363266|NCT02176655|524181540|FG000|Overall Study|Subjects did not treat|6|||
145363267|NCT06110494|524181541|FG000|Overall Study|Protocol Violation|2|||
145363268|NCT06110494|524181542|FG001|Overall Study|Protocol Violation|0|||
145363269|NCT06110494|524181543|FG002|Overall Study|Protocol Violation|1|||
145363270|NCT06110494|524181541|FG000|Overall Study|Dixon's test for outlier analysis|1|||
145363271|NCT06110494|524181542|FG001|Overall Study|Dixon's test for outlier analysis|1|||
145363272|NCT06110494|524181543|FG002|Overall Study|Dixon's test for outlier analysis|0|||
145363273|NCT00302328|524181544|FG000|Overall Study|Physician Decision|0|||
145363274|NCT00302328|524181545|FG001|Overall Study|Physician Decision|1|||
145363275|NCT00302328|524181546|FG002|Overall Study|Physician Decision|0|||
145363276|NCT01288937|524181549|FG000|Overall Study|Adverse Event|1|||
145363277|NCT01288937|524181550|FG001|Overall Study|Adverse Event|0|||
145363278|NCT01718535|524181551|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
145363279|NCT01718535|524181552|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
145363280|NCT01718535|524181553|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
145363281|NCT01718535|524181554|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
145363282|NCT01718535|524181555|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
145363283|NCT01718535|524181556|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
145363284|NCT01718535|524181557|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
145363285|NCT01718535|524181558|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
145363286|NCT01718535|524181559|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
145363287|NCT01718535|524181560|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
145363288|NCT01073605|524181566|FG000|Overall Study|Ongoing at Cutoff Date|1|||
145363289|NCT01073605|524181567|FG001|Overall Study|Ongoing at Cutoff Date|1|||
145363290|NCT01073605|524181568|FG002|Overall Study|Ongoing at Cutoff Date|0|||
145363291|NCT01073605|524181566|FG000|Overall Study|Adverse Event|2|||
145363292|NCT01073605|524181567|FG001|Overall Study|Adverse Event|1|||
145363293|NCT01073605|524181568|FG002|Overall Study|Adverse Event|0|||
145363294|NCT01073605|524181566|FG000|Overall Study|Lost to Follow-up|3|||
145363295|NCT01073605|524181567|FG001|Overall Study|Lost to Follow-up|4|||
145363296|NCT01073605|524181568|FG002|Overall Study|Lost to Follow-up|9|||
145363297|NCT01073605|524181566|FG000|Overall Study|Other|25|||
145363298|NCT01073605|524181567|FG001|Overall Study|Other|21|||
145363299|NCT01073605|524181568|FG002|Overall Study|Other|29|||
145363300|NCT01073605|524181566|FG000|Overall Study|Withdrawal by Subject|31|||
145363301|NCT01073605|524181567|FG001|Overall Study|Withdrawal by Subject|39|||
145363302|NCT01073605|524181568|FG002|Overall Study|Withdrawal by Subject|22|||
145363303|NCT01073605|524181566|FG000|Overall Study|Randomized But Not Treated|0|||
145363304|NCT01073605|524181567|FG001|Overall Study|Randomized But Not Treated|1|||
145363305|NCT01073605|524181568|FG002|Overall Study|Randomized But Not Treated|1|||
145363306|NCT03018080|524181569|FG000|Overall Study|Death|12|||
145363307|NCT03018080|524181570|FG001|Overall Study|Death|19|||
145363308|NCT00740792|524181571|FG000|Overall Study|Adverse Event|3|||
145363309|NCT00740792|524181572|FG001|Overall Study|Adverse Event|1|||
145363310|NCT00740792|524181573|FG002|Overall Study|Adverse Event|1|||
145363311|NCT00740792|524181574|FG003|Overall Study|Adverse Event|3|||
145363312|NCT00740792|524181571|FG000|Overall Study|Lack of Efficacy|1|||
145363313|NCT00740792|524181572|FG001|Overall Study|Lack of Efficacy|1|||
145363314|NCT00740792|524181573|FG002|Overall Study|Lack of Efficacy|0|||
145363315|NCT00740792|524181574|FG003|Overall Study|Lack of Efficacy|3|||
145363316|NCT00740792|524181571|FG000|Overall Study|Lost to Follow-up|2|||
145363317|NCT00740792|524181572|FG001|Overall Study|Lost to Follow-up|1|||
145363318|NCT00740792|524181573|FG002|Overall Study|Lost to Follow-up|0|||
145363319|NCT00740792|524181574|FG003|Overall Study|Lost to Follow-up|0|||
145363320|NCT00740792|524181571|FG000|Overall Study|Protocol Violation|0|||
145363321|NCT00740792|524181572|FG001|Overall Study|Protocol Violation|1|||
145363322|NCT00740792|524181573|FG002|Overall Study|Protocol Violation|0|||
145363323|NCT00740792|524181574|FG003|Overall Study|Protocol Violation|2|||
145363324|NCT00740792|524181571|FG000|Overall Study|Withdrawal by Subject|1|||
145363325|NCT00740792|524181572|FG001|Overall Study|Withdrawal by Subject|1|||
145363326|NCT00740792|524181573|FG002|Overall Study|Withdrawal by Subject|0|||
145363327|NCT00740792|524181574|FG003|Overall Study|Withdrawal by Subject|0|||
145419520|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
145623179|NCT05968482|525131608|FG004|First Crossover Period|Adverse Event|0|||
145363328|NCT00740792|524181571|FG000|Overall Study|administrative|3|||
145363329|NCT00740792|524181572|FG001|Overall Study|administrative|3|||
145363330|NCT00740792|524181573|FG002|Overall Study|administrative|8|||
145363331|NCT00740792|524181574|FG003|Overall Study|administrative|2|||
145363332|NCT00912743|524181579|FG000|Overall Study|Adverse Event|3|||
145363333|NCT00912743|524181580|FG001|Overall Study|Adverse Event|1|||
145363334|NCT00912743|524181579|FG000|Overall Study|Lack of Efficacy|9|||
145363335|NCT00912743|524181580|FG001|Overall Study|Lack of Efficacy|18|||
145363336|NCT00912743|524181579|FG000|Overall Study|Toxicity|0|||
145363337|NCT00912743|524181580|FG001|Overall Study|Toxicity|1|||
145363338|NCT00912743|524181579|FG000|Overall Study|End of treatment form was not collected|1|||
145363339|NCT00912743|524181580|FG001|Overall Study|End of treatment form was not collected|0|||
145363340|NCT04478695|524181592|FG000|Overall Study|Death|1|||
145363341|NCT04478695|524181593|FG001|Overall Study|Death|0|||
145363342|NCT00402688|524181594|FG000|Overall Study|Adverse Event|12|||
145363343|NCT00402688|524181595|FG001|Overall Study|Adverse Event|9|||
145363344|NCT00402688|524181596|FG002|Overall Study|Adverse Event|3|||
145363345|NCT00402688|524181594|FG000|Overall Study|Withdrawal by Subject|3|||
145363346|NCT00402688|524181595|FG001|Overall Study|Withdrawal by Subject|1|||
145363347|NCT00402688|524181596|FG002|Overall Study|Withdrawal by Subject|1|||
145363348|NCT00402688|524181594|FG000|Overall Study|Physician Decision|0|||
145363349|NCT00402688|524181595|FG001|Overall Study|Physician Decision|0|||
145363350|NCT00402688|524181596|FG002|Overall Study|Physician Decision|1|||
145363351|NCT00402688|524181594|FG000|Overall Study|Lack of Efficacy|4|||
145363352|NCT00402688|524181595|FG001|Overall Study|Lack of Efficacy|4|||
145363353|NCT00402688|524181596|FG002|Overall Study|Lack of Efficacy|5|||
145363354|NCT00402688|524181594|FG000|Overall Study|Protocol Violation|1|||
145363355|NCT00402688|524181595|FG001|Overall Study|Protocol Violation|1|||
145363356|NCT00402688|524181596|FG002|Overall Study|Protocol Violation|1|||
145363357|NCT00402688|524181594|FG000|Overall Study|Lost to Follow-up|1|||
145363358|NCT00402688|524181595|FG001|Overall Study|Lost to Follow-up|0|||
145363359|NCT00402688|524181596|FG002|Overall Study|Lost to Follow-up|2|||
145363360|NCT00402688|524181594|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
145363361|NCT00402688|524181595|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
145363362|NCT00402688|524181596|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
145363363|NCT00402688|524181594|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
145363364|NCT00402688|524181595|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
145363365|NCT00402688|524181596|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
145363366|NCT00402688|524181594|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
145363367|NCT00402688|524181595|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
145363368|NCT00402688|524181596|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
145363369|NCT01431716|524181609|FG000|Overall Study|Withdrawal of consent|1|||
145363370|NCT01053663|524181610|FG000|Overall Study|Death|2|||
145363371|NCT01053663|524181610|FG000|Overall Study|Lost to Follow-up|1|||
145363372|NCT01053663|524181610|FG000|Overall Study|Poor IV Access|1|||
145363373|NCT01053663|524181610|FG000|Overall Study|Transferred to Another Hospital|1|||
145363374|NCT01053663|524181610|FG000|Overall Study|Negative Influenza Diagnosis|1|||
145363375|NCT02737930|524181611|FG000|Overall Study|Withdrawal by Subject|0|||
145363376|NCT02737930|524181612|FG001|Overall Study|Withdrawal by Subject|1|||
145363377|NCT00708214|524181615|FG000|Overall Study|Other Adverse Event|3|||
145363378|NCT00708214|524181616|FG001|Overall Study|Other Adverse Event|6|||
145363379|NCT00708214|524181617|FG002|Overall Study|Other Adverse Event|2|||
145363380|NCT00708214|524181615|FG000|Overall Study|Other|0|||
145363381|NCT00708214|524181616|FG001|Overall Study|Other|1|||
145363382|NCT00708214|524181617|FG002|Overall Study|Other|1|||
145363383|NCT00708214|524181615|FG000|Overall Study|Progressive Disease|4|||
145363384|NCT00708214|524181616|FG001|Overall Study|Progressive Disease|6|||
145363385|NCT00708214|524181617|FG002|Overall Study|Progressive Disease|5|||
145363386|NCT03852264|524181618|FG000|Third Research Visit|Lost to Follow-up|1|||
145363387|NCT03852264|524181619|FG001|Third Research Visit|Lost to Follow-up|0|||
145363388|NCT04481789|524181620|FG000|Period 1|Withdrawal by Subject|1|||
145363389|NCT04481789|524181621|FG001|Period 1|Withdrawal by Subject|0|||
145363390|NCT04481789|524181622|FG002|Period 1|Withdrawal by Subject|0|||
145363391|NCT04481789|524181623|FG003|Period 1|Withdrawal by Subject|0|||
145363392|NCT04481789|524181624|FG004|Period 1|Withdrawal by Subject|0|||
145363393|NCT04481789|524181625|FG005|Period 1|Withdrawal by Subject|0|||
145363394|NCT05708976|524181626|FG000|Overall Study|Withdrawal by Subject|0|||
145363395|NCT05708976|524181627|FG001|Overall Study|Withdrawal by Subject|1|||
145363396|NCT02929589|524181629|FG000|Overall Study|Withdrawal by Subject|1|||
145363397|NCT02929589|524181630|FG001|Overall Study|Withdrawal by Subject|0|||
145363398|NCT02929589|524181631|FG002|Overall Study|Withdrawal by Subject|0|||
145623180|NCT05968482|525131609|FG005|First Crossover Period|Adverse Event|1|||
145623181|NCT05968482|525131604|FG000|Second Crossover Period|Withdrawal by Subject|0|||
145363399|NCT02929589|524181632|FG003|Overall Study|Withdrawal by Subject|0|||
145363400|NCT02929589|524181629|FG000|Overall Study|Physician Decision|2|||
145363401|NCT02929589|524181630|FG001|Overall Study|Physician Decision|0|||
145363402|NCT02929589|524181631|FG002|Overall Study|Physician Decision|0|||
145363403|NCT02929589|524181632|FG003|Overall Study|Physician Decision|0|||
145363404|NCT00994461|524181641|FG000|Overall Study|Adverse Event|2|||
145363405|NCT00994461|524181642|FG001|Overall Study|Adverse Event|1|||
145363406|NCT00994461|524181643|FG002|Overall Study|Adverse Event|0|||
145363407|NCT02837731|524181649|FG000|Allocation|Admitted to General Floor|3|||
145363408|NCT02837731|524181650|FG001|Allocation|Admitted to General Floor|4|||
145419521|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419522|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
145419523|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419524|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419525|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419526|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419527|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
145419528|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145419529|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145419530|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145419531|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145419532|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
145419533|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
145419534|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
145419535|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145419536|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145419537|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145419538|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145419539|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145419540|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
145419541|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
145419542|NCT01557244|524392870|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
145419543|NCT01557244|524392871|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145419544|NCT01557244|524392872|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
145419545|NCT01557244|524392873|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145419546|NCT01557244|524392874|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145419547|NCT01557244|524392875|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145419548|NCT01557244|524392876|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
145419549|NCT01557244|524392870|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145419550|NCT01557244|524392871|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145419551|NCT01557244|524392872|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145419552|NCT01557244|524392873|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145419553|NCT01557244|524392874|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145419554|NCT01557244|524392875|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
145419555|NCT01557244|524392876|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
145419556|NCT01557244|524392870|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
145419557|NCT01557244|524392871|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
145419558|NCT01557244|524392872|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145419559|NCT01557244|524392873|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145419560|NCT01557244|524392874|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145419561|NCT01557244|524392875|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145419562|NCT01557244|524392876|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
145419563|NCT01557244|524392870|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145419564|NCT01557244|524392871|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145419565|NCT01557244|524392872|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145419566|NCT01557244|524392873|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
145419567|NCT01557244|524392874|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145363409|NCT02837731|524181649|FG000|Allocation|Immediate surgery/withdrew|2|||
145363410|NCT02837731|524181650|FG001|Allocation|Immediate surgery/withdrew|0|||
145363411|NCT02837731|524181649|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
145363412|NCT02837731|524181650|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
145363413|NCT02837731|524181649|FG000|Allocation|Withdrawal by Subject|2|||
145363414|NCT02837731|524181650|FG001|Allocation|Withdrawal by Subject|0|||
145363415|NCT02837731|524181649|FG000|Allocation|Device not available|1|||
145363416|NCT02837731|524181650|FG001|Allocation|Device not available|0|||
145363417|NCT02837731|524181649|FG000|Allocation|Protocol not implemented|7|||
145363418|NCT02837731|524181650|FG001|Allocation|Protocol not implemented|0|||
145363419|NCT02837731|524181649|FG000|Allocation|Moribund/Do not resuscitate|2|||
145363420|NCT02837731|524181650|FG001|Allocation|Moribund/Do not resuscitate|0|||
145363421|NCT02837731|524181649|FG000|Allocation|Did not meet sepsis criteria|1|||
145363422|NCT02837731|524181650|FG001|Allocation|Did not meet sepsis criteria|2|||
145363423|NCT02837731|524181649|FG000|Allocation|Known aortic abnormalities|0|||
145363424|NCT02837731|524181650|FG001|Allocation|Known aortic abnormalities|1|||
145419568|NCT01557244|524392875|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145419569|NCT01557244|524392876|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
145419570|NCT01557244|524392870|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
145419571|NCT01557244|524392871|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
145419572|NCT01557244|524392872|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145419573|NCT01557244|524392873|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145419574|NCT01557244|524392874|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145419575|NCT01557244|524392875|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145419576|NCT01557244|524392876|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
145419577|NCT01313676|524392877|FG000|Overall Study|Adverse Event|395|||
145419578|NCT01313676|524392878|FG001|Overall Study|Adverse Event|365|||
145419579|NCT01313676|524392879|FG002|Overall Study|Adverse Event|372|||
145419580|NCT01313676|524392880|FG003|Overall Study|Adverse Event|333|||
145419581|NCT01313676|524392877|FG000|Overall Study|Lack of Efficacy|98|||
145419582|NCT01313676|524392878|FG001|Overall Study|Lack of Efficacy|90|||
145419583|NCT01313676|524392879|FG002|Overall Study|Lack of Efficacy|65|||
145419584|NCT01313676|524392880|FG003|Overall Study|Lack of Efficacy|46|||
145419585|NCT01313676|524392877|FG000|Overall Study|Protocol Violation|37|||
145419586|NCT01313676|524392878|FG001|Overall Study|Protocol Violation|44|||
145419587|NCT01313676|524392879|FG002|Overall Study|Protocol Violation|46|||
145419588|NCT01313676|524392880|FG003|Overall Study|Protocol Violation|44|||
145419589|NCT01313676|524392877|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
145419590|NCT01313676|524392878|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
145419591|NCT01313676|524392879|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
145419592|NCT01313676|524392880|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
145419593|NCT01313676|524392877|FG000|Overall Study|Study Closed/terminated|7|||
145419594|NCT01313676|524392878|FG001|Overall Study|Study Closed/terminated|6|||
145419595|NCT01313676|524392879|FG002|Overall Study|Study Closed/terminated|9|||
145419596|NCT01313676|524392880|FG003|Overall Study|Study Closed/terminated|9|||
145419597|NCT01313676|524392877|FG000|Overall Study|Lost to Follow-up|0|||
145419598|NCT01313676|524392878|FG001|Overall Study|Lost to Follow-up|0|||
145363425|NCT01209520|524181652|FG000|Overall Study|Withdrawal by Subject|3|||
145363426|NCT03850483|524181656|FG000|Treatment for Stage 1|Adverse Event|1|||
145363427|NCT03850483|524181657|FG001|Treatment for Stage 1|Adverse Event|1|||
145363428|NCT03850483|524181658|FG002|Treatment for Stage 1|Adverse Event|3|||
145363429|NCT03850483|524181659|FG003|Treatment for Stage 1|Adverse Event|0|||
145363430|NCT03850483|524181660|FG004|Treatment for Stage 1|Adverse Event|2|||
145363431|NCT03850483|524181661|FG005|Treatment for Stage 1|Adverse Event|0|||
145363432|NCT03850483|524181662|FG006|Treatment for Stage 1|Adverse Event|2|||
145363433|NCT03850483|524181663|FG007|Treatment for Stage 1|Adverse Event|2|||
145363434|NCT03850483|524181664|FG008|Treatment for Stage 1|Adverse Event|0|||
145363435|NCT03850483|524181665|FG009|Treatment for Stage 1|Adverse Event|0|||
145363436|NCT03850483|524181656|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
145363437|NCT03850483|524181657|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
145363438|NCT03850483|524181658|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
145363439|NCT03850483|524181659|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
145363440|NCT03850483|524181660|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
145363441|NCT03850483|524181661|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
145363442|NCT03850483|524181662|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
145363443|NCT03850483|524181663|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
145363444|NCT03850483|524181664|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
145363445|NCT03850483|524181665|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
145363446|NCT03850483|524181656|FG000|Treatment for Stage 1|Protocol Violation|1|||
145363447|NCT03850483|524181657|FG001|Treatment for Stage 1|Protocol Violation|0|||
145363448|NCT03850483|524181658|FG002|Treatment for Stage 1|Protocol Violation|0|||
145419599|NCT01313676|524392879|FG002|Overall Study|Lost to Follow-up|1|||
145419600|NCT01313676|524392880|FG003|Overall Study|Lost to Follow-up|0|||
145419601|NCT01313676|524392877|FG000|Overall Study|Physician Decision|53|||
145419602|NCT01313676|524392878|FG001|Overall Study|Physician Decision|64|||
145419603|NCT01313676|524392879|FG002|Overall Study|Physician Decision|62|||
145419604|NCT01313676|524392880|FG003|Overall Study|Physician Decision|48|||
145419605|NCT01313676|524392877|FG000|Overall Study|Decision by Participant or Proxy|643|||
145419606|NCT01313676|524392878|FG001|Overall Study|Decision by Participant or Proxy|527|||
145419607|NCT01313676|524392879|FG002|Overall Study|Decision by Participant or Proxy|515|||
145419608|NCT01313676|524392880|FG003|Overall Study|Decision by Participant or Proxy|492|||
145419609|NCT01313676|524392877|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
145419610|NCT01313676|524392878|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
145419611|NCT01313676|524392879|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
145363449|NCT03850483|524181659|FG003|Treatment for Stage 1|Protocol Violation|0|||
145363450|NCT03850483|524181660|FG004|Treatment for Stage 1|Protocol Violation|0|||
145363451|NCT03850483|524181661|FG005|Treatment for Stage 1|Protocol Violation|0|||
145363452|NCT03850483|524181662|FG006|Treatment for Stage 1|Protocol Violation|1|||
145419612|NCT01313676|524392880|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
145363453|NCT03850483|524181663|FG007|Treatment for Stage 1|Protocol Violation|0|||
145363454|NCT03850483|524181664|FG008|Treatment for Stage 1|Protocol Violation|0|||
145363455|NCT03850483|524181665|FG009|Treatment for Stage 1|Protocol Violation|0|||
145363456|NCT03850483|524181656|FG000|Treatment for Stage 1|Physician Decision|0|||
145363457|NCT03850483|524181657|FG001|Treatment for Stage 1|Physician Decision|0|||
145363458|NCT03850483|524181658|FG002|Treatment for Stage 1|Physician Decision|0|||
145363459|NCT03850483|524181659|FG003|Treatment for Stage 1|Physician Decision|0|||
145363460|NCT03850483|524181660|FG004|Treatment for Stage 1|Physician Decision|0|||
145363461|NCT03850483|524181661|FG005|Treatment for Stage 1|Physician Decision|1|||
145363462|NCT03850483|524181662|FG006|Treatment for Stage 1|Physician Decision|0|||
145363463|NCT03850483|524181663|FG007|Treatment for Stage 1|Physician Decision|0|||
145363464|NCT03850483|524181664|FG008|Treatment for Stage 1|Physician Decision|0|||
145363465|NCT03850483|524181665|FG009|Treatment for Stage 1|Physician Decision|0|||
145363466|NCT03850483|524181656|FG000|Treatment for Stage 1|Other|0|||
145363467|NCT03850483|524181657|FG001|Treatment for Stage 1|Other|0|||
145363468|NCT03850483|524181658|FG002|Treatment for Stage 1|Other|0|||
145363469|NCT03850483|524181659|FG003|Treatment for Stage 1|Other|0|||
145363470|NCT03850483|524181660|FG004|Treatment for Stage 1|Other|2|||
145363471|NCT03850483|524181661|FG005|Treatment for Stage 1|Other|1|||
145363472|NCT03850483|524181662|FG006|Treatment for Stage 1|Other|0|||
145363473|NCT03850483|524181663|FG007|Treatment for Stage 1|Other|0|||
145363474|NCT03850483|524181664|FG008|Treatment for Stage 1|Other|0|||
145363475|NCT03850483|524181665|FG009|Treatment for Stage 1|Other|0|||
145363476|NCT03850483|524181656|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363477|NCT03850483|524181657|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363478|NCT03850483|524181658|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
145363479|NCT03850483|524181659|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363480|NCT03850483|524181660|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363481|NCT03850483|524181661|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363482|NCT03850483|524181662|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363483|NCT03850483|524181663|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363484|NCT03850483|524181664|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363485|NCT03850483|524181665|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
145363486|NCT03850483|524181656|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363487|NCT03850483|524181657|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363488|NCT03850483|524181658|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363489|NCT03850483|524181659|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363490|NCT03850483|524181660|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363491|NCT03850483|524181661|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
145363492|NCT03850483|524181662|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363493|NCT03850483|524181663|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363494|NCT03850483|524181664|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363495|NCT03850483|524181665|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
145363496|NCT03850483|524181656|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
145363497|NCT03850483|524181657|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
145363498|NCT03850483|524181658|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
145363499|NCT03850483|524181659|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
145363500|NCT03850483|524181660|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
145363501|NCT03850483|524181661|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
145363502|NCT03850483|524181662|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
145363503|NCT03850483|524181663|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
145363504|NCT03850483|524181664|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
145363505|NCT03850483|524181665|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
145363506|NCT03850483|524181656|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
145363507|NCT03850483|524181657|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
145363508|NCT03850483|524181658|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
145363509|NCT03850483|524181659|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
145363510|NCT03850483|524181660|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
145363511|NCT03850483|524181661|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
145363512|NCT03850483|524181662|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
145363513|NCT03850483|524181663|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
145363514|NCT03850483|524181664|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
145363515|NCT03850483|524181665|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
145363516|NCT03850483|524181656|FG000|Treatment for Stage 1|Death|0|||
145363517|NCT03850483|524181657|FG001|Treatment for Stage 1|Death|0|||
145363518|NCT03850483|524181658|FG002|Treatment for Stage 1|Death|0|||
145363519|NCT03850483|524181659|FG003|Treatment for Stage 1|Death|0|||
145363520|NCT03850483|524181660|FG004|Treatment for Stage 1|Death|0|||
145363521|NCT03850483|524181661|FG005|Treatment for Stage 1|Death|1|||
145363522|NCT03850483|524181662|FG006|Treatment for Stage 1|Death|0|||
145363523|NCT03850483|524181663|FG007|Treatment for Stage 1|Death|0|||
145363524|NCT03850483|524181664|FG008|Treatment for Stage 1|Death|0|||
145363525|NCT03850483|524181665|FG009|Treatment for Stage 1|Death|0|||
145363526|NCT03850483|524181656|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
145419613|NCT01313676|524392877|FG000|Overall Study|Investigator Site Closed|12|||
145419614|NCT01313676|524392878|FG001|Overall Study|Investigator Site Closed|11|||
145419615|NCT01313676|524392879|FG002|Overall Study|Investigator Site Closed|15|||
145419616|NCT01313676|524392880|FG003|Overall Study|Investigator Site Closed|10|||
145419617|NCT01313676|524392877|FG000|Overall Study|Missing|1|||
145419618|NCT01313676|524392878|FG001|Overall Study|Missing|1|||
145419619|NCT01313676|524392879|FG002|Overall Study|Missing|1|||
145419620|NCT01313676|524392880|FG003|Overall Study|Missing|0|||
145419621|NCT04621786|524392882|FG000|Overall Study|Lost to Follow-up|9|||
145419622|NCT04621786|524392882|FG000|Overall Study|Protocol Violation|3|||
145419623|NCT02533674|524392883|FG000|Dose Level I|Progressive disease|1|||
145419624|NCT02533674|524392884|FG001|Dose Level I|Progressive disease|0|||
145419625|NCT02533674|524392885|FG002|Dose Level I|Progressive disease|0|||
145419626|NCT02533674|524392886|FG003|Dose Level I|Progressive disease|0|||
145419627|NCT02533674|524392887|FG004|Dose Level I|Progressive disease|0|||
145419628|NCT02533674|524392888|FG005|Dose Level I|Progressive disease|0|||
145419629|NCT02533674|524392889|FG006|Dose Level I|Progressive disease|0|||
145419630|NCT02533674|524392890|FG007|Dose Level I|Progressive disease|0|||
145419631|NCT02533674|524392883|FG000|Dose Level I|Withdrawal by Subject|1|||
145419632|NCT02533674|524392884|FG001|Dose Level I|Withdrawal by Subject|0|||
145419633|NCT02533674|524392885|FG002|Dose Level I|Withdrawal by Subject|0|||
145419634|NCT02533674|524392886|FG003|Dose Level I|Withdrawal by Subject|0|||
145419635|NCT02533674|524392887|FG004|Dose Level I|Withdrawal by Subject|0|||
145419636|NCT02533674|524392888|FG005|Dose Level I|Withdrawal by Subject|0|||
145419637|NCT02533674|524392889|FG006|Dose Level I|Withdrawal by Subject|0|||
145419638|NCT02533674|524392890|FG007|Dose Level I|Withdrawal by Subject|0|||
145419639|NCT02533674|524392883|FG000|Dose Level I|Physician Decision|1|||
145419640|NCT02533674|524392884|FG001|Dose Level I|Physician Decision|0|||
145419641|NCT02533674|524392885|FG002|Dose Level I|Physician Decision|0|||
145419642|NCT02533674|524392886|FG003|Dose Level I|Physician Decision|0|||
145419643|NCT02533674|524392887|FG004|Dose Level I|Physician Decision|0|||
145419644|NCT02533674|524392888|FG005|Dose Level I|Physician Decision|0|||
145419645|NCT02533674|524392889|FG006|Dose Level I|Physician Decision|0|||
145419646|NCT02533674|524392890|FG007|Dose Level I|Physician Decision|0|||
145419647|NCT02533674|524392883|FG000|Dose Level I|Death|1|||
145419648|NCT02533674|524392884|FG001|Dose Level I|Death|0|||
145419649|NCT02533674|524392885|FG002|Dose Level I|Death|0|||
145419650|NCT02533674|524392886|FG003|Dose Level I|Death|0|||
145419651|NCT02533674|524392887|FG004|Dose Level I|Death|0|||
145419652|NCT02533674|524392888|FG005|Dose Level I|Death|0|||
145419653|NCT02533674|524392889|FG006|Dose Level I|Death|0|||
145419654|NCT02533674|524392890|FG007|Dose Level I|Death|0|||
145419655|NCT02533674|524392883|FG000|Dose Level I|Never Treated|1|||
145419656|NCT02533674|524392884|FG001|Dose Level I|Never Treated|0|||
145419657|NCT02533674|524392885|FG002|Dose Level I|Never Treated|0|||
145419658|NCT02533674|524392886|FG003|Dose Level I|Never Treated|0|||
145419659|NCT02533674|524392887|FG004|Dose Level I|Never Treated|0|||
145419660|NCT02533674|524392888|FG005|Dose Level I|Never Treated|0|||
145419661|NCT02533674|524392889|FG006|Dose Level I|Never Treated|0|||
145419662|NCT02533674|524392890|FG007|Dose Level I|Never Treated|0|||
145419663|NCT02533674|524392883|FG000|Dose Level II|Progressive disease|0|||
145419664|NCT02533674|524392884|FG001|Dose Level II|Progressive disease|3|||
145419665|NCT02533674|524392885|FG002|Dose Level II|Progressive disease|0|||
145419666|NCT02533674|524392886|FG003|Dose Level II|Progressive disease|0|||
145419667|NCT02533674|524392887|FG004|Dose Level II|Progressive disease|0|||
145419668|NCT02533674|524392888|FG005|Dose Level II|Progressive disease|0|||
145577611|NCT01824303|524969449|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
145577612|NCT01824303|524969450|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
145577613|NCT04086472|524969451|FG000|Overall Study|Lost to Follow-up|1|||
145577614|NCT04086472|524969452|FG001|Overall Study|Lost to Follow-up|0|||
145363527|NCT03850483|524181657|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
145363528|NCT03850483|524181658|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
145363529|NCT03850483|524181659|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
145363530|NCT03850483|524181660|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
145363531|NCT03850483|524181661|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
145363532|NCT03850483|524181662|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
145363533|NCT03850483|524181663|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
145363534|NCT03850483|524181664|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
145363535|NCT03850483|524181665|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
145363536|NCT03850483|524181656|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
145363537|NCT03850483|524181657|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
145363538|NCT03850483|524181658|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
145363539|NCT03850483|524181659|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
145363540|NCT03850483|524181660|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
145363541|NCT03850483|524181661|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
145363542|NCT03850483|524181662|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
145363543|NCT03850483|524181663|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
145419669|NCT02533674|524392889|FG006|Dose Level II|Progressive disease|0|||
145419670|NCT02533674|524392890|FG007|Dose Level II|Progressive disease|0|||
145419671|NCT02533674|524392883|FG000|Dose Level II|Withdrawal by Subject|0|||
145419672|NCT02533674|524392884|FG001|Dose Level II|Withdrawal by Subject|1|||
145419673|NCT02533674|524392885|FG002|Dose Level II|Withdrawal by Subject|0|||
145419674|NCT02533674|524392886|FG003|Dose Level II|Withdrawal by Subject|0|||
145419675|NCT02533674|524392887|FG004|Dose Level II|Withdrawal by Subject|0|||
145419676|NCT02533674|524392888|FG005|Dose Level II|Withdrawal by Subject|0|||
145419677|NCT02533674|524392889|FG006|Dose Level II|Withdrawal by Subject|0|||
145419678|NCT02533674|524392890|FG007|Dose Level II|Withdrawal by Subject|0|||
145419679|NCT02533674|524392883|FG000|Dose Level II|Treatment-related AE|0|||
145419680|NCT02533674|524392884|FG001|Dose Level II|Treatment-related AE|1|||
145419681|NCT02533674|524392885|FG002|Dose Level II|Treatment-related AE|0|||
145419682|NCT02533674|524392886|FG003|Dose Level II|Treatment-related AE|0|||
145419683|NCT02533674|524392887|FG004|Dose Level II|Treatment-related AE|0|||
145419684|NCT02533674|524392888|FG005|Dose Level II|Treatment-related AE|0|||
145419685|NCT02533674|524392889|FG006|Dose Level II|Treatment-related AE|0|||
145419686|NCT02533674|524392890|FG007|Dose Level II|Treatment-related AE|0|||
145419687|NCT02533674|524392883|FG000|Dose Level II|Physician Decision|0|||
145419688|NCT02533674|524392884|FG001|Dose Level II|Physician Decision|1|||
145419689|NCT02533674|524392885|FG002|Dose Level II|Physician Decision|0|||
145419690|NCT02533674|524392886|FG003|Dose Level II|Physician Decision|0|||
145419691|NCT02533674|524392887|FG004|Dose Level II|Physician Decision|0|||
145419692|NCT02533674|524392888|FG005|Dose Level II|Physician Decision|0|||
145419693|NCT02533674|524392889|FG006|Dose Level II|Physician Decision|0|||
145419694|NCT02533674|524392890|FG007|Dose Level II|Physician Decision|0|||
145419695|NCT02533674|524392883|FG000|Dose Level II|Non-treatment-related AE|0|||
145419696|NCT02533674|524392884|FG001|Dose Level II|Non-treatment-related AE|1|||
145419697|NCT02533674|524392885|FG002|Dose Level II|Non-treatment-related AE|0|||
145419698|NCT02533674|524392886|FG003|Dose Level II|Non-treatment-related AE|0|||
145419699|NCT02533674|524392887|FG004|Dose Level II|Non-treatment-related AE|0|||
145419700|NCT02533674|524392888|FG005|Dose Level II|Non-treatment-related AE|0|||
145419701|NCT02533674|524392889|FG006|Dose Level II|Non-treatment-related AE|0|||
145419702|NCT02533674|524392890|FG007|Dose Level II|Non-treatment-related AE|0|||
145419703|NCT02533674|524392883|FG000|Dose Level III|Progressive disease|0|||
145419704|NCT02533674|524392884|FG001|Dose Level III|Progressive disease|0|||
145419705|NCT02533674|524392885|FG002|Dose Level III|Progressive disease|2|||
145419706|NCT02533674|524392886|FG003|Dose Level III|Progressive disease|0|||
145419707|NCT02533674|524392887|FG004|Dose Level III|Progressive disease|0|||
145419708|NCT02533674|524392888|FG005|Dose Level III|Progressive disease|0|||
145419709|NCT02533674|524392889|FG006|Dose Level III|Progressive disease|0|||
145419710|NCT02533674|524392890|FG007|Dose Level III|Progressive disease|0|||
145419711|NCT02533674|524392883|FG000|Dose Level III|Withdrawal by Subject|0|||
145419712|NCT02533674|524392884|FG001|Dose Level III|Withdrawal by Subject|0|||
145419713|NCT02533674|524392885|FG002|Dose Level III|Withdrawal by Subject|1|||
145419714|NCT02533674|524392886|FG003|Dose Level III|Withdrawal by Subject|0|||
145363544|NCT03850483|524181664|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
145363545|NCT03850483|524181665|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
145363546|NCT03850483|524181656|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363547|NCT03850483|524181657|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363548|NCT03850483|524181658|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363549|NCT03850483|524181659|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363550|NCT03850483|524181660|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363551|NCT03850483|524181661|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363552|NCT03850483|524181662|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
145363553|NCT03850483|524181663|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
145363554|NCT03850483|524181664|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363555|NCT03850483|524181665|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
145363556|NCT03850483|524181656|FG000|Follow-up for Stage 1|Physician Decision|0|||
145363557|NCT03850483|524181657|FG001|Follow-up for Stage 1|Physician Decision|0|||
145363558|NCT03850483|524181658|FG002|Follow-up for Stage 1|Physician Decision|0|||
145363559|NCT03850483|524181659|FG003|Follow-up for Stage 1|Physician Decision|0|||
145363560|NCT03850483|524181660|FG004|Follow-up for Stage 1|Physician Decision|1|||
145363561|NCT03850483|524181661|FG005|Follow-up for Stage 1|Physician Decision|0|||
145363562|NCT03850483|524181662|FG006|Follow-up for Stage 1|Physician Decision|1|||
145363563|NCT03850483|524181663|FG007|Follow-up for Stage 1|Physician Decision|0|||
145363564|NCT03850483|524181664|FG008|Follow-up for Stage 1|Physician Decision|0|||
145363565|NCT03850483|524181665|FG009|Follow-up for Stage 1|Physician Decision|0|||
145363566|NCT03850483|524181656|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
145363567|NCT03850483|524181657|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
145419715|NCT02533674|524392887|FG004|Dose Level III|Withdrawal by Subject|0|||
145419716|NCT02533674|524392888|FG005|Dose Level III|Withdrawal by Subject|0|||
145419717|NCT02533674|524392889|FG006|Dose Level III|Withdrawal by Subject|0|||
145419718|NCT02533674|524392890|FG007|Dose Level III|Withdrawal by Subject|0|||
145419719|NCT02533674|524392883|FG000|Dose Level III|Treatment-related AE|0|||
145419720|NCT02533674|524392884|FG001|Dose Level III|Treatment-related AE|0|||
145363568|NCT03850483|524181658|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
145363569|NCT03850483|524181659|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
145363570|NCT03850483|524181660|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
145363571|NCT03850483|524181661|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
145363572|NCT03850483|524181662|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
145363573|NCT03850483|524181663|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
145363574|NCT03850483|524181664|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
145363575|NCT03850483|524181665|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
145363576|NCT03850483|524181656|FG000|Follow-up for Stage 1|Adverse Event|0|||
145363577|NCT03850483|524181657|FG001|Follow-up for Stage 1|Adverse Event|0|||
145363578|NCT03850483|524181658|FG002|Follow-up for Stage 1|Adverse Event|1|||
145363579|NCT03850483|524181659|FG003|Follow-up for Stage 1|Adverse Event|0|||
145363580|NCT03850483|524181660|FG004|Follow-up for Stage 1|Adverse Event|0|||
145363581|NCT03850483|524181661|FG005|Follow-up for Stage 1|Adverse Event|1|||
145363582|NCT03850483|524181662|FG006|Follow-up for Stage 1|Adverse Event|0|||
145363583|NCT03850483|524181663|FG007|Follow-up for Stage 1|Adverse Event|0|||
145363584|NCT03850483|524181664|FG008|Follow-up for Stage 1|Adverse Event|0|||
145363585|NCT03850483|524181665|FG009|Follow-up for Stage 1|Adverse Event|0|||
145363586|NCT03850483|524181656|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363587|NCT03850483|524181657|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
145363588|NCT03850483|524181658|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363589|NCT03850483|524181659|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363590|NCT03850483|524181660|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
145363591|NCT03850483|524181661|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
145363592|NCT03850483|524181662|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363593|NCT03850483|524181663|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363594|NCT03850483|524181664|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363595|NCT03850483|524181665|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
145363596|NCT03850483|524181656|FG000|Follow-up for Stage 1|Other|0|||
145363597|NCT03850483|524181657|FG001|Follow-up for Stage 1|Other|2|||
145363598|NCT03850483|524181658|FG002|Follow-up for Stage 1|Other|0|||
145363599|NCT03850483|524181659|FG003|Follow-up for Stage 1|Other|2|||
145363600|NCT03850483|524181660|FG004|Follow-up for Stage 1|Other|0|||
145363601|NCT03850483|524181661|FG005|Follow-up for Stage 1|Other|1|||
145363602|NCT03850483|524181662|FG006|Follow-up for Stage 1|Other|0|||
145363603|NCT03850483|524181663|FG007|Follow-up for Stage 1|Other|0|||
145363604|NCT03850483|524181664|FG008|Follow-up for Stage 1|Other|0|||
145363605|NCT03850483|524181665|FG009|Follow-up for Stage 1|Other|0|||
145363606|NCT03850483|524181656|FG000|Treatment for Stage 2|Adverse Event|0|||
145363607|NCT03850483|524181657|FG001|Treatment for Stage 2|Adverse Event|0|||
145363608|NCT03850483|524181658|FG002|Treatment for Stage 2|Adverse Event|0|||
145363609|NCT03850483|524181659|FG003|Treatment for Stage 2|Adverse Event|0|||
145363610|NCT03850483|524181660|FG004|Treatment for Stage 2|Adverse Event|0|||
145363611|NCT03850483|524181661|FG005|Treatment for Stage 2|Adverse Event|0|||
145363612|NCT03850483|524181662|FG006|Treatment for Stage 2|Adverse Event|0|||
145363613|NCT03850483|524181663|FG007|Treatment for Stage 2|Adverse Event|0|||
145363614|NCT03850483|524181664|FG008|Treatment for Stage 2|Adverse Event|0|||
145363615|NCT03850483|524181665|FG009|Treatment for Stage 2|Adverse Event|1|||
145363616|NCT03850483|524181656|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
145363617|NCT03850483|524181657|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
145363618|NCT03850483|524181658|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
145363619|NCT03850483|524181659|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
145363620|NCT03850483|524181660|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
145363621|NCT03850483|524181661|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
145363622|NCT03850483|524181662|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
145363623|NCT03850483|524181663|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
145363624|NCT03850483|524181664|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
145363625|NCT03850483|524181665|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
145363626|NCT03850483|524181656|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
145363627|NCT03850483|524181657|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
145363628|NCT03850483|524181658|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
145363629|NCT03850483|524181659|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
145363630|NCT03850483|524181660|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
145363631|NCT03850483|524181661|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
145363632|NCT03850483|524181662|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
145363633|NCT03850483|524181663|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
145363634|NCT03850483|524181664|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
145363635|NCT03850483|524181665|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
145363636|NCT03850483|524181656|FG000|Treatment for Stage 2|Physician Decision|0|||
145363637|NCT03850483|524181657|FG001|Treatment for Stage 2|Physician Decision|0|||
145363638|NCT03850483|524181658|FG002|Treatment for Stage 2|Physician Decision|0|||
145363639|NCT03850483|524181659|FG003|Treatment for Stage 2|Physician Decision|0|||
145363640|NCT03850483|524181660|FG004|Treatment for Stage 2|Physician Decision|0|||
145363641|NCT03850483|524181661|FG005|Treatment for Stage 2|Physician Decision|0|||
145363642|NCT03850483|524181662|FG006|Treatment for Stage 2|Physician Decision|0|||
145363643|NCT03850483|524181663|FG007|Treatment for Stage 2|Physician Decision|0|||
145363644|NCT03850483|524181664|FG008|Treatment for Stage 2|Physician Decision|0|||
145363645|NCT03850483|524181665|FG009|Treatment for Stage 2|Physician Decision|1|||
145363646|NCT03850483|524181656|FG000|Treatment for Stage 2|Protocol Violation|0|||
145363647|NCT03850483|524181657|FG001|Treatment for Stage 2|Protocol Violation|0|||
145363648|NCT03850483|524181658|FG002|Treatment for Stage 2|Protocol Violation|0|||
145363649|NCT03850483|524181659|FG003|Treatment for Stage 2|Protocol Violation|0|||
145363650|NCT03850483|524181660|FG004|Treatment for Stage 2|Protocol Violation|0|||
145363651|NCT03850483|524181661|FG005|Treatment for Stage 2|Protocol Violation|0|||
145363652|NCT03850483|524181662|FG006|Treatment for Stage 2|Protocol Violation|0|||
145363653|NCT03850483|524181663|FG007|Treatment for Stage 2|Protocol Violation|0|||
145363654|NCT03850483|524181664|FG008|Treatment for Stage 2|Protocol Violation|1|||
145363655|NCT03850483|524181665|FG009|Treatment for Stage 2|Protocol Violation|0|||
145363656|NCT03850483|524181656|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
145363657|NCT03850483|524181657|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
145363658|NCT03850483|524181658|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
145363659|NCT03850483|524181659|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
145363660|NCT03850483|524181660|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
145363661|NCT03850483|524181661|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
145363662|NCT03850483|524181662|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
145363663|NCT03850483|524181663|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
145363664|NCT03850483|524181664|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
145363665|NCT03850483|524181665|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
145363666|NCT03850483|524181656|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363667|NCT03850483|524181657|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363668|NCT03850483|524181658|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363669|NCT03850483|524181659|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363670|NCT03850483|524181660|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363671|NCT03850483|524181661|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363672|NCT03850483|524181662|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363673|NCT03850483|524181663|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363674|NCT03850483|524181664|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
145363675|NCT03850483|524181665|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
145363676|NCT03850483|524181656|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
145363677|NCT03850483|524181657|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
145363678|NCT03850483|524181658|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
145363679|NCT03850483|524181659|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
145363680|NCT03850483|524181660|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
145363681|NCT03850483|524181661|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
145363682|NCT03850483|524181662|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
145363683|NCT03850483|524181663|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
145363684|NCT03850483|524181664|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
145363685|NCT03850483|524181665|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
145363686|NCT03850483|524181656|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
145363687|NCT03850483|524181657|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
145363688|NCT03850483|524181658|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
145363689|NCT03850483|524181659|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
145363690|NCT03850483|524181660|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
145363691|NCT03850483|524181661|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
145363692|NCT03850483|524181662|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
145363693|NCT03850483|524181663|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
145363694|NCT03850483|524181664|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
145363695|NCT03850483|524181665|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
145363696|NCT03850483|524181656|FG000|Follow-up For Stage 2|Other|0|||
145363697|NCT03850483|524181657|FG001|Follow-up For Stage 2|Other|0|||
145363698|NCT03850483|524181658|FG002|Follow-up For Stage 2|Other|0|||
145363699|NCT03850483|524181659|FG003|Follow-up For Stage 2|Other|0|||
145419721|NCT02533674|524392885|FG002|Dose Level III|Treatment-related AE|1|||
145419722|NCT02533674|524392886|FG003|Dose Level III|Treatment-related AE|0|||
145419723|NCT02533674|524392887|FG004|Dose Level III|Treatment-related AE|0|||
145419724|NCT02533674|524392888|FG005|Dose Level III|Treatment-related AE|0|||
145419725|NCT02533674|524392889|FG006|Dose Level III|Treatment-related AE|0|||
145419726|NCT02533674|524392890|FG007|Dose Level III|Treatment-related AE|0|||
145419727|NCT02533674|524392883|FG000|Dose Level IV|Progressive disease|0|||
145419728|NCT02533674|524392884|FG001|Dose Level IV|Progressive disease|0|||
145419729|NCT02533674|524392885|FG002|Dose Level IV|Progressive disease|0|||
145419730|NCT02533674|524392886|FG003|Dose Level IV|Progressive disease|3|||
145419731|NCT02533674|524392887|FG004|Dose Level IV|Progressive disease|0|||
145419732|NCT02533674|524392888|FG005|Dose Level IV|Progressive disease|0|||
145419733|NCT02533674|524392889|FG006|Dose Level IV|Progressive disease|0|||
145363700|NCT03850483|524181660|FG004|Follow-up For Stage 2|Other|0|||
145363701|NCT03850483|524181661|FG005|Follow-up For Stage 2|Other|0|||
145363702|NCT03850483|524181662|FG006|Follow-up For Stage 2|Other|0|||
145363703|NCT03850483|524181663|FG007|Follow-up For Stage 2|Other|0|||
145363704|NCT03850483|524181664|FG008|Follow-up For Stage 2|Other|0|||
145363705|NCT03850483|524181665|FG009|Follow-up For Stage 2|Other|1|||
145363706|NCT01637922|524183207|FG000|Overall Study|Adverse Event|0|||
145363707|NCT01637922|524183208|FG001|Overall Study|Adverse Event|1|||
145363708|NCT01637922|524183207|FG000|Overall Study|Protocol Violation|0|||
145363709|NCT01637922|524183208|FG001|Overall Study|Protocol Violation|1|||
145363710|NCT01637922|524183207|FG000|Overall Study|Withdrawal by Subject|0|||
145363711|NCT01637922|524183208|FG001|Overall Study|Withdrawal by Subject|3|||
145363712|NCT01637922|524183207|FG000|Overall Study|Lost to Follow-up|2|||
145363713|NCT01637922|524183208|FG001|Overall Study|Lost to Follow-up|0|||
145363714|NCT02498444|524183209|FG000|Overall Study|Withdrawal by Subject|3|||
145363715|NCT02498444|524183210|FG001|Overall Study|Withdrawal by Subject|0|||
145363716|NCT02498444|524183209|FG000|Overall Study|Physician Decision|1|||
145363717|NCT02498444|524183210|FG001|Overall Study|Physician Decision|0|||
145363718|NCT03656692|524183211|FG000|Overall Study|Worsening of disease activity|2|||
145363719|NCT03656692|524183211|FG000|Overall Study|Physician Decision|1|||
145363720|NCT01841762|524183212|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
145363721|NCT01841762|524183212|FG000|Treatment Period|Adverse Event|16|||
145363722|NCT01841762|524183212|FG000|Treatment Period|Death|1|||
145363723|NCT01841762|524183212|FG000|Treatment Period|Withdrawal by Subject|7|||
145363724|NCT01841762|524183212|FG000|Treatment Period|Lost to Follow-up|1|||
145363725|NCT01841762|524183212|FG000|Treatment Period|Physician Decision|2|||
145363726|NCT01841762|524183212|FG000|Treatment Period|Other, including non-compliance|5|||
145363727|NCT01841762|524183212|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
145363728|NCT01841762|524183212|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
145363729|NCT01841762|524183212|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
145363730|NCT01841762|524183212|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
145363731|NCT01270464|524183213|FG000|Overall Study|Protocol Violation|4|||
145363732|NCT01270464|524183214|FG001|Overall Study|Protocol Violation|3|||
145363733|NCT01270464|524183215|FG002|Overall Study|Protocol Violation|2|||
145363734|NCT01270464|524183213|FG000|Overall Study|Lack of Efficacy|2|||
145363735|NCT01270464|524183214|FG001|Overall Study|Lack of Efficacy|3|||
145363736|NCT01270464|524183215|FG002|Overall Study|Lack of Efficacy|1|||
145363737|NCT01270464|524183213|FG000|Overall Study|Adverse Event|9|||
145363738|NCT01270464|524183214|FG001|Overall Study|Adverse Event|1|||
145363739|NCT01270464|524183215|FG002|Overall Study|Adverse Event|7|||
145363740|NCT01270464|524183213|FG000|Overall Study|Withdrawal by Subject|2|||
145363741|NCT01270464|524183214|FG001|Overall Study|Withdrawal by Subject|1|||
145363742|NCT01270464|524183215|FG002|Overall Study|Withdrawal by Subject|4|||
145363743|NCT01270464|524183213|FG000|Overall Study|Lost to Follow-up|2|||
145363744|NCT01270464|524183214|FG001|Overall Study|Lost to Follow-up|3|||
145363745|NCT01270464|524183215|FG002|Overall Study|Lost to Follow-up|1|||
145363746|NCT01270464|524183213|FG000|Overall Study|Other|1|||
145363747|NCT01270464|524183214|FG001|Overall Study|Other|1|||
145363748|NCT01270464|524183215|FG002|Overall Study|Other|3|||
145363749|NCT02448537|524183216|FG000|Overall Study|Withdrawal by Subject|1|||
145363750|NCT02448537|524183217|FG001|Overall Study|Withdrawal by Subject|1|||
145363751|NCT02448537|524183218|FG002|Overall Study|Withdrawal by Subject|1|||
145363752|NCT04725812|524183219|FG000|Overall Study|Withdrawal by Subject|1|||
145363753|NCT00839800|524183222|FG000|Overall Study|Adverse Event|8|||
145363754|NCT00839800|524183223|FG001|Overall Study|Adverse Event|12|||
145363755|NCT00839800|524183222|FG000|Overall Study|Lost to Follow-up|31|||
145363756|NCT00839800|524183223|FG001|Overall Study|Lost to Follow-up|26|||
145363757|NCT00839800|524183222|FG000|Overall Study|Withdrawal by Subject|28|||
145363758|NCT00839800|524183223|FG001|Overall Study|Withdrawal by Subject|34|||
145363759|NCT00839800|524183222|FG000|Overall Study|Incorrect Enrolment|3|||
145363760|NCT00839800|524183223|FG001|Overall Study|Incorrect Enrolment|3|||
145363761|NCT00839800|524183222|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
145363762|NCT00839800|524183223|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
145363763|NCT00839800|524183222|FG000|Overall Study|Safety Reasons|2|||
145363764|NCT00839800|524183223|FG001|Overall Study|Safety Reasons|1|||
145363765|NCT00839800|524183222|FG000|Overall Study|Other|8|||
145363766|NCT00839800|524183223|FG001|Overall Study|Other|14|||
145363767|NCT00839800|524183222|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
145363768|NCT00839800|524183223|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
145363769|NCT01164579|524183224|FG000|Overall Study|Lack of Efficacy|0|||
145363770|NCT01164579|524183225|FG001|Overall Study|Lack of Efficacy|0|||
145363771|NCT01164579|524183226|FG002|Overall Study|Lack of Efficacy|6|||
145363772|NCT01164579|524183224|FG000|Overall Study|Lost to Follow-up|1|||
145363773|NCT01164579|524183225|FG001|Overall Study|Lost to Follow-up|1|||
145363774|NCT01164579|524183226|FG002|Overall Study|Lost to Follow-up|0|||
145363775|NCT01164579|524183224|FG000|Overall Study|Withdrawal by Subject|2|||
145363776|NCT01164579|524183225|FG001|Overall Study|Withdrawal by Subject|5|||
145363777|NCT01164579|524183226|FG002|Overall Study|Withdrawal by Subject|3|||
145419734|NCT02533674|524392890|FG007|Dose Level IV|Progressive disease|0|||
145419735|NCT02533674|524392883|FG000|Dose Level IV|Withdrawal by Subject|0|||
145419736|NCT02533674|524392884|FG001|Dose Level IV|Withdrawal by Subject|0|||
145419737|NCT02533674|524392885|FG002|Dose Level IV|Withdrawal by Subject|0|||
145419738|NCT02533674|524392886|FG003|Dose Level IV|Withdrawal by Subject|1|||
145419739|NCT02533674|524392887|FG004|Dose Level IV|Withdrawal by Subject|0|||
145419740|NCT02533674|524392888|FG005|Dose Level IV|Withdrawal by Subject|0|||
145419741|NCT02533674|524392889|FG006|Dose Level IV|Withdrawal by Subject|0|||
145419742|NCT02533674|524392890|FG007|Dose Level IV|Withdrawal by Subject|0|||
145419743|NCT02533674|524392883|FG000|Dose Level IV|Physician Decision|0|||
145419744|NCT02533674|524392884|FG001|Dose Level IV|Physician Decision|0|||
145419745|NCT02533674|524392885|FG002|Dose Level IV|Physician Decision|0|||
145419746|NCT02533674|524392886|FG003|Dose Level IV|Physician Decision|1|||
145419747|NCT02533674|524392887|FG004|Dose Level IV|Physician Decision|0|||
145419748|NCT02533674|524392888|FG005|Dose Level IV|Physician Decision|0|||
145419749|NCT02533674|524392889|FG006|Dose Level IV|Physician Decision|0|||
145419750|NCT02533674|524392890|FG007|Dose Level IV|Physician Decision|0|||
145419751|NCT02533674|524392883|FG000|Dose Level V|Progressive disease|0|||
145419752|NCT02533674|524392884|FG001|Dose Level V|Progressive disease|0|||
145419753|NCT02533674|524392885|FG002|Dose Level V|Progressive disease|0|||
145419754|NCT02533674|524392886|FG003|Dose Level V|Progressive disease|0|||
145419755|NCT02533674|524392887|FG004|Dose Level V|Progressive disease|3|||
145363778|NCT01164579|524183224|FG000|Overall Study|Protocol Violation|0|||
145419756|NCT02533674|524392888|FG005|Dose Level V|Progressive disease|0|||
145419757|NCT02533674|524392889|FG006|Dose Level V|Progressive disease|0|||
145363779|NCT01164579|524183225|FG001|Overall Study|Protocol Violation|1|||
145363780|NCT01164579|524183226|FG002|Overall Study|Protocol Violation|2|||
145363781|NCT01164579|524183224|FG000|Overall Study|Adverse Event|4|||
145363782|NCT01164579|524183225|FG001|Overall Study|Adverse Event|2|||
145363783|NCT01164579|524183226|FG002|Overall Study|Adverse Event|5|||
145363784|NCT01164579|524183224|FG000|Overall Study|Reason not specified|1|||
145363785|NCT01164579|524183225|FG001|Overall Study|Reason not specified|0|||
145363786|NCT01164579|524183226|FG002|Overall Study|Reason not specified|0|||
145363787|NCT01136356|524183231|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
145363788|NCT01136356|524183232|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
145363789|NCT01136356|524183231|FG000|First 18-day Withdrawal|Physician Decision|1|||
145363790|NCT01136356|524183232|FG001|First 18-day Withdrawal|Physician Decision|0|||
145363791|NCT01136356|524183231|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
145363792|NCT01136356|524183232|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
145363793|NCT02347774|524183233|FG000|Study Participation|Lost to Follow-up|3|||
145363794|NCT02347774|524183234|FG001|Study Participation|Lost to Follow-up|6|||
145363795|NCT02347774|524183235|FG002|Study Participation|Lost to Follow-up|2|||
145363796|NCT02347774|524183233|FG000|Study Participation|Withdrawal by Subject|8|||
145363797|NCT02347774|524183234|FG001|Study Participation|Withdrawal by Subject|9|||
145363798|NCT02347774|524183235|FG002|Study Participation|Withdrawal by Subject|15|||
145363799|NCT02347774|524183233|FG000|Study Participation|Adverse Event|1|||
145363800|NCT02347774|524183234|FG001|Study Participation|Adverse Event|4|||
145363801|NCT02347774|524183235|FG002|Study Participation|Adverse Event|6|||
145363802|NCT02347774|524183233|FG000|Study Participation|withdrew consent|1|||
145363803|NCT02347774|524183234|FG001|Study Participation|withdrew consent|1|||
145363804|NCT02347774|524183235|FG002|Study Participation|withdrew consent|1|||
145363805|NCT02347774|524183233|FG000|Study Participation|Met Prolonged QT criteria|1|||
145363806|NCT02347774|524183234|FG001|Study Participation|Met Prolonged QT criteria|0|||
145363807|NCT02347774|524183235|FG002|Study Participation|Met Prolonged QT criteria|0|||
145363808|NCT02347774|524183233|FG000|Study Participation|non-compliance with study drug|0|||
145363809|NCT02347774|524183234|FG001|Study Participation|non-compliance with study drug|1|||
145363810|NCT02347774|524183235|FG002|Study Participation|non-compliance with study drug|0|||
145363811|NCT02347774|524183233|FG000|Study Participation|incarceration|1|||
145363812|NCT02347774|524183234|FG001|Study Participation|incarceration|0|||
145363813|NCT02347774|524183235|FG002|Study Participation|incarceration|0|||
145363814|NCT02347774|524183233|FG000|Study Participation|randomized in error|0|||
145363815|NCT02347774|524183234|FG001|Study Participation|randomized in error|0|||
145363816|NCT02347774|524183235|FG002|Study Participation|randomized in error|1|||
145363817|NCT02347774|524183233|FG000|On Study Treatment|Adverse Event|9|||
145363818|NCT02347774|524183234|FG001|On Study Treatment|Adverse Event|15|||
145363819|NCT02347774|524183235|FG002|On Study Treatment|Adverse Event|19|||
145363820|NCT02347774|524183233|FG000|On Study Treatment|Lack of Efficacy|3|||
145363821|NCT02347774|524183234|FG001|On Study Treatment|Lack of Efficacy|0|||
145363822|NCT02347774|524183235|FG002|On Study Treatment|Lack of Efficacy|2|||
145419758|NCT02533674|524392890|FG007|Dose Level V|Progressive disease|0|||
145419759|NCT02533674|524392883|FG000|Dose Level V|Withdrawal by Subject|0|||
145419760|NCT02533674|524392884|FG001|Dose Level V|Withdrawal by Subject|0|||
145419761|NCT02533674|524392885|FG002|Dose Level V|Withdrawal by Subject|0|||
145419762|NCT02533674|524392886|FG003|Dose Level V|Withdrawal by Subject|0|||
145419763|NCT02533674|524392887|FG004|Dose Level V|Withdrawal by Subject|1|||
145419764|NCT02533674|524392888|FG005|Dose Level V|Withdrawal by Subject|0|||
145363823|NCT02347774|524183233|FG000|On Study Treatment|non-complicance with study medication|0|||
145363824|NCT02347774|524183234|FG001|On Study Treatment|non-complicance with study medication|2|||
145363825|NCT02347774|524183235|FG002|On Study Treatment|non-complicance with study medication|0|||
145363826|NCT02347774|524183233|FG000|On Study Treatment|Protocol Violation|0|||
145363827|NCT02347774|524183234|FG001|On Study Treatment|Protocol Violation|0|||
145363828|NCT02347774|524183235|FG002|On Study Treatment|Protocol Violation|1|||
145363829|NCT02347774|524183233|FG000|On Study Treatment|withdrew consent|9|||
145363830|NCT02347774|524183234|FG001|On Study Treatment|withdrew consent|8|||
145363831|NCT02347774|524183235|FG002|On Study Treatment|withdrew consent|12|||
145363832|NCT02347774|524183233|FG000|On Study Treatment|Lost to Follow-up|2|||
145363833|NCT02347774|524183234|FG001|On Study Treatment|Lost to Follow-up|6|||
145363834|NCT02347774|524183235|FG002|On Study Treatment|Lost to Follow-up|1|||
145363835|NCT02347774|524183233|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
145363836|NCT02347774|524183234|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
145363837|NCT02347774|524183235|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
145363838|NCT02347774|524183233|FG000|On Study Treatment|ranomized in error|0|||
145363839|NCT02347774|524183234|FG001|On Study Treatment|ranomized in error|0|||
145363840|NCT02347774|524183235|FG002|On Study Treatment|ranomized in error|1|||
145363841|NCT00927862|524183236|FG000|Overall Study|Missing data needed for endpt analyses|27|||
145363842|NCT00927862|524183237|FG001|Overall Study|Missing data needed for endpt analyses|45|||
145363843|NCT00820248|524183239|FG000|Overall Study|No treated|4|||
145363844|NCT00820248|524183240|FG001|Overall Study|No treated|1|||
145363845|NCT04157296|524183241|FG000|Overall Study|Withdrawal by Subject|0|||
145363846|NCT04157296|524183242|FG001|Overall Study|Withdrawal by Subject|1|||
145363847|NCT04157296|524183241|FG000|Overall Study|Did not obtain second fMRI.|0|||
145363848|NCT04157296|524183242|FG001|Overall Study|Did not obtain second fMRI.|1|||
145363849|NCT04157296|524183241|FG000|Overall Study|MRI failed/no second fMRI|0|||
145363850|NCT04157296|524183242|FG001|Overall Study|MRI failed/no second fMRI|1|||
145363851|NCT02237196|524183243|FG000|Overall Study|Adverse Event|0|||
145363852|NCT02237196|524183244|FG001|Overall Study|Adverse Event|1|||
145363853|NCT02237196|524183245|FG002|Overall Study|Adverse Event|1|||
145363854|NCT02237196|524183246|FG003|Overall Study|Adverse Event|0|||
145363855|NCT02237196|524183243|FG000|Overall Study|Lost to Follow-up|4|||
145363856|NCT02237196|524183244|FG001|Overall Study|Lost to Follow-up|2|||
145363857|NCT02237196|524183245|FG002|Overall Study|Lost to Follow-up|4|||
145363858|NCT02237196|524183246|FG003|Overall Study|Lost to Follow-up|6|||
145363859|NCT02237196|524183243|FG000|Overall Study|Physician Decision|2|||
145363860|NCT02237196|524183244|FG001|Overall Study|Physician Decision|0|||
145363861|NCT02237196|524183245|FG002|Overall Study|Physician Decision|0|||
145363862|NCT02237196|524183246|FG003|Overall Study|Physician Decision|1|||
145363863|NCT02237196|524183243|FG000|Overall Study|Pregnancy|0|||
145363864|NCT02237196|524183244|FG001|Overall Study|Pregnancy|0|||
145363865|NCT02237196|524183245|FG002|Overall Study|Pregnancy|1|||
145363866|NCT02237196|524183246|FG003|Overall Study|Pregnancy|1|||
145363867|NCT02237196|524183243|FG000|Overall Study|Withdrawal by Subject|1|||
145363868|NCT02237196|524183244|FG001|Overall Study|Withdrawal by Subject|1|||
145363869|NCT02237196|524183245|FG002|Overall Study|Withdrawal by Subject|4|||
145363870|NCT02237196|524183246|FG003|Overall Study|Withdrawal by Subject|1|||
145363871|NCT02237196|524183243|FG000|Overall Study|Site Error|1|||
145363872|NCT02237196|524183244|FG001|Overall Study|Site Error|2|||
145363873|NCT02237196|524183245|FG002|Overall Study|Site Error|0|||
145363874|NCT02237196|524183246|FG003|Overall Study|Site Error|2|||
145363875|NCT00267969|524183249|FG000|Controlled Period|Adverse Event|6|||
145363876|NCT00267969|524183250|FG001|Controlled Period|Adverse Event|0|||
145363877|NCT00267969|524183251|FG002|Controlled Period|Adverse Event|2|||
145363878|NCT00267969|524183252|FG003|Controlled Period|Adverse Event|0|||
145363879|NCT00267969|524183253|FG004|Controlled Period|Adverse Event|0|||
145363880|NCT00267969|524183254|FG005|Controlled Period|Adverse Event|0|||
145363881|NCT00267969|524183255|FG006|Controlled Period|Adverse Event|0|||
145363882|NCT00267969|524183249|FG000|Controlled Period|Lack of Efficacy|3|||
145419765|NCT02533674|524392889|FG006|Dose Level V|Withdrawal by Subject|0|||
145363883|NCT00267969|524183250|FG001|Controlled Period|Lack of Efficacy|0|||
145363884|NCT00267969|524183251|FG002|Controlled Period|Lack of Efficacy|1|||
145363885|NCT00267969|524183252|FG003|Controlled Period|Lack of Efficacy|0|||
145363886|NCT00267969|524183253|FG004|Controlled Period|Lack of Efficacy|0|||
145363887|NCT00267969|524183254|FG005|Controlled Period|Lack of Efficacy|0|||
145363888|NCT00267969|524183255|FG006|Controlled Period|Lack of Efficacy|0|||
145363889|NCT00267969|524183249|FG000|Controlled Period|Lost to Follow-up|1|||
145419766|NCT02533674|524392890|FG007|Dose Level V|Withdrawal by Subject|0|||
145363890|NCT00267969|524183250|FG001|Controlled Period|Lost to Follow-up|0|||
145363891|NCT00267969|524183251|FG002|Controlled Period|Lost to Follow-up|1|||
145577615|NCT04086472|524969453|FG002|Overall Study|Lost to Follow-up|0|||
145363892|NCT00267969|524183252|FG003|Controlled Period|Lost to Follow-up|0|||
145363893|NCT00267969|524183253|FG004|Controlled Period|Lost to Follow-up|0|||
145363894|NCT00267969|524183254|FG005|Controlled Period|Lost to Follow-up|0|||
145363895|NCT00267969|524183255|FG006|Controlled Period|Lost to Follow-up|0|||
145363896|NCT00267969|524183249|FG000|Controlled Period|Randomized but not treated|0|||
145363897|NCT00267969|524183250|FG001|Controlled Period|Randomized but not treated|0|||
145363898|NCT00267969|524183251|FG002|Controlled Period|Randomized but not treated|1|||
145363899|NCT00267969|524183252|FG003|Controlled Period|Randomized but not treated|0|||
145363900|NCT00267969|524183253|FG004|Controlled Period|Randomized but not treated|0|||
145363901|NCT00267969|524183254|FG005|Controlled Period|Randomized but not treated|0|||
145363902|NCT00267969|524183255|FG006|Controlled Period|Randomized but not treated|0|||
145363903|NCT00267969|524183249|FG000|Controlled Period|Other|2|||
145363904|NCT00267969|524183250|FG001|Controlled Period|Other|1|||
145363905|NCT00267969|524183251|FG002|Controlled Period|Other|6|||
145363906|NCT00267969|524183252|FG003|Controlled Period|Other|0|||
145363907|NCT00267969|524183253|FG004|Controlled Period|Other|0|||
145363908|NCT00267969|524183254|FG005|Controlled Period|Other|0|||
145363909|NCT00267969|524183255|FG006|Controlled Period|Other|0|||
145363910|NCT00267969|524183249|FG000|After Controlled Period|Adverse Event|0|||
145363911|NCT00267969|524183250|FG001|After Controlled Period|Adverse Event|0|||
145363912|NCT00267969|524183251|FG002|After Controlled Period|Adverse Event|0|||
145363913|NCT00267969|524183252|FG003|After Controlled Period|Adverse Event|7|||
145363914|NCT00267969|524183253|FG004|After Controlled Period|Adverse Event|8|||
145363915|NCT00267969|524183254|FG005|After Controlled Period|Adverse Event|23|||
145363916|NCT00267969|524183255|FG006|After Controlled Period|Adverse Event|21|||
145363917|NCT00267969|524183249|FG000|After Controlled Period|Death|0|||
145363918|NCT00267969|524183250|FG001|After Controlled Period|Death|0|||
145363919|NCT00267969|524183251|FG002|After Controlled Period|Death|0|||
145363920|NCT00267969|524183252|FG003|After Controlled Period|Death|1|||
145363921|NCT00267969|524183253|FG004|After Controlled Period|Death|2|||
145363922|NCT00267969|524183254|FG005|After Controlled Period|Death|0|||
145363923|NCT00267969|524183255|FG006|After Controlled Period|Death|1|||
145363924|NCT00267969|524183249|FG000|After Controlled Period|Lack of Efficacy|0|||
145363925|NCT00267969|524183250|FG001|After Controlled Period|Lack of Efficacy|0|||
145363926|NCT00267969|524183251|FG002|After Controlled Period|Lack of Efficacy|0|||
145363927|NCT00267969|524183252|FG003|After Controlled Period|Lack of Efficacy|10|||
145363928|NCT00267969|524183253|FG004|After Controlled Period|Lack of Efficacy|6|||
145363929|NCT00267969|524183254|FG005|After Controlled Period|Lack of Efficacy|28|||
145363930|NCT00267969|524183255|FG006|After Controlled Period|Lack of Efficacy|15|||
145363931|NCT00267969|524183249|FG000|After Controlled Period|Lost to Follow-up|0|||
145363932|NCT00267969|524183250|FG001|After Controlled Period|Lost to Follow-up|0|||
145363933|NCT00267969|524183251|FG002|After Controlled Period|Lost to Follow-up|0|||
145363934|NCT00267969|524183252|FG003|After Controlled Period|Lost to Follow-up|5|||
145363935|NCT00267969|524183253|FG004|After Controlled Period|Lost to Follow-up|8|||
145363936|NCT00267969|524183254|FG005|After Controlled Period|Lost to Follow-up|9|||
145363937|NCT00267969|524183255|FG006|After Controlled Period|Lost to Follow-up|10|||
145363938|NCT00267969|524183249|FG000|After Controlled Period|Other|0|||
145363939|NCT00267969|524183250|FG001|After Controlled Period|Other|0|||
145363940|NCT00267969|524183251|FG002|After Controlled Period|Other|0|||
145363941|NCT00267969|524183252|FG003|After Controlled Period|Other|13|||
145363942|NCT00267969|524183253|FG004|After Controlled Period|Other|11|||
145363943|NCT00267969|524183254|FG005|After Controlled Period|Other|22|||
145363944|NCT00267969|524183255|FG006|After Controlled Period|Other|25|||
145363945|NCT04075682|524183256|FG000|Overall Study|Lost to Follow-up|5|||
145363946|NCT04075682|524183257|FG001|Overall Study|Lost to Follow-up|5|||
145363947|NCT04075682|524183258|FG002|Overall Study|Lost to Follow-up|2|||
145363948|NCT04075682|524183259|FG003|Overall Study|Lost to Follow-up|2|||
145363949|NCT04075682|524183256|FG000|Overall Study|Withdrawal by Subject|1|||
145363950|NCT04075682|524183257|FG001|Overall Study|Withdrawal by Subject|0|||
145363951|NCT04075682|524183258|FG002|Overall Study|Withdrawal by Subject|1|||
145363952|NCT04075682|524183259|FG003|Overall Study|Withdrawal by Subject|0|||
145363953|NCT04075682|524183256|FG000|Overall Study|Protocol Violation|0|||
145363954|NCT04075682|524183257|FG001|Overall Study|Protocol Violation|1|||
145363955|NCT04075682|524183258|FG002|Overall Study|Protocol Violation|1|||
145363956|NCT04075682|524183259|FG003|Overall Study|Protocol Violation|0|||
145363957|NCT04075682|524183256|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
145363958|NCT04075682|524183257|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
145363959|NCT04075682|524183258|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
145363960|NCT04075682|524183259|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
145363961|NCT04075682|524183256|FG000|Overall Study|Lost study phone the first day of study participation|0|||
145363962|NCT04075682|524183257|FG001|Overall Study|Lost study phone the first day of study participation|1|||
145363963|NCT04075682|524183258|FG002|Overall Study|Lost study phone the first day of study participation|0|||
145363964|NCT04075682|524183259|FG003|Overall Study|Lost study phone the first day of study participation|0|||
145363965|NCT00862823|524183262|FG000|First Intervention|Withdrawal by Subject|1|||
145363966|NCT00862823|524183263|FG001|First Intervention|Withdrawal by Subject|1|||
145363967|NCT00887315|524183264|FG000|Overall Study|Study termination|7|||
145363968|NCT00887315|524183265|FG001|Overall Study|Study termination|4|||
145363969|NCT00619892|524183270|FG000|Overall Study|Adverse Event|3|||
145363970|NCT00619892|524183271|FG001|Overall Study|Adverse Event|0|||
145363971|NCT00619892|524183270|FG000|Overall Study|Lost to Follow-up|0|||
145419767|NCT02533674|524392883|FG000|Dose Level V|Physician Decision|0|||
145419768|NCT02533674|524392884|FG001|Dose Level V|Physician Decision|0|||
145419769|NCT02533674|524392885|FG002|Dose Level V|Physician Decision|0|||
145419770|NCT02533674|524392886|FG003|Dose Level V|Physician Decision|0|||
145419771|NCT02533674|524392887|FG004|Dose Level V|Physician Decision|1|||
145419772|NCT02533674|524392888|FG005|Dose Level V|Physician Decision|0|||
145419773|NCT02533674|524392889|FG006|Dose Level V|Physician Decision|0|||
145419774|NCT02533674|524392890|FG007|Dose Level V|Physician Decision|0|||
145419775|NCT02533674|524392883|FG000|Dose Level VI|Progressive disease|0|||
145419776|NCT02533674|524392884|FG001|Dose Level VI|Progressive disease|0|||
145419777|NCT02533674|524392885|FG002|Dose Level VI|Progressive disease|0|||
145419778|NCT02533674|524392886|FG003|Dose Level VI|Progressive disease|0|||
145419779|NCT02533674|524392887|FG004|Dose Level VI|Progressive disease|0|||
145419780|NCT02533674|524392888|FG005|Dose Level VI|Progressive disease|7|||
145419781|NCT02533674|524392889|FG006|Dose Level VI|Progressive disease|0|||
145419782|NCT02533674|524392890|FG007|Dose Level VI|Progressive disease|0|||
145419783|NCT02533674|524392883|FG000|Dose Level VI|Withdrawal by Subject|0|||
145419784|NCT02533674|524392884|FG001|Dose Level VI|Withdrawal by Subject|0|||
145419785|NCT02533674|524392885|FG002|Dose Level VI|Withdrawal by Subject|0|||
145419786|NCT02533674|524392886|FG003|Dose Level VI|Withdrawal by Subject|0|||
145419787|NCT02533674|524392887|FG004|Dose Level VI|Withdrawal by Subject|0|||
145419788|NCT02533674|524392888|FG005|Dose Level VI|Withdrawal by Subject|1|||
145419789|NCT02533674|524392889|FG006|Dose Level VI|Withdrawal by Subject|0|||
145419790|NCT02533674|524392890|FG007|Dose Level VI|Withdrawal by Subject|0|||
145419791|NCT02533674|524392883|FG000|Dose Level VI|Treatment-related AE|0|||
145419792|NCT02533674|524392884|FG001|Dose Level VI|Treatment-related AE|0|||
145419793|NCT02533674|524392885|FG002|Dose Level VI|Treatment-related AE|0|||
145419794|NCT02533674|524392886|FG003|Dose Level VI|Treatment-related AE|0|||
145419795|NCT02533674|524392887|FG004|Dose Level VI|Treatment-related AE|0|||
145419796|NCT02533674|524392888|FG005|Dose Level VI|Treatment-related AE|1|||
145419797|NCT02533674|524392889|FG006|Dose Level VI|Treatment-related AE|0|||
145419798|NCT02533674|524392890|FG007|Dose Level VI|Treatment-related AE|0|||
145419799|NCT02533674|524392883|FG000|Dose Level VII|Progressive disease|0|||
145419800|NCT02533674|524392884|FG001|Dose Level VII|Progressive disease|0|||
145419801|NCT02533674|524392885|FG002|Dose Level VII|Progressive disease|0|||
145419802|NCT02533674|524392886|FG003|Dose Level VII|Progressive disease|0|||
145419803|NCT02533674|524392887|FG004|Dose Level VII|Progressive disease|0|||
145419804|NCT02533674|524392888|FG005|Dose Level VII|Progressive disease|0|||
145419805|NCT02533674|524392889|FG006|Dose Level VII|Progressive disease|10|||
145419806|NCT02533674|524392890|FG007|Dose Level VII|Progressive disease|0|||
145419807|NCT02533674|524392883|FG000|Dose Level VII|Withdrawal by Subject|0|||
145419808|NCT02533674|524392884|FG001|Dose Level VII|Withdrawal by Subject|0|||
145419809|NCT02533674|524392885|FG002|Dose Level VII|Withdrawal by Subject|0|||
145419810|NCT02533674|524392886|FG003|Dose Level VII|Withdrawal by Subject|0|||
145419811|NCT02533674|524392887|FG004|Dose Level VII|Withdrawal by Subject|0|||
145419812|NCT02533674|524392888|FG005|Dose Level VII|Withdrawal by Subject|0|||
145419813|NCT02533674|524392889|FG006|Dose Level VII|Withdrawal by Subject|3|||
145419814|NCT02533674|524392890|FG007|Dose Level VII|Withdrawal by Subject|0|||
145419815|NCT02533674|524392883|FG000|Dose Level VII|Treatment-related AE|0|||
145419816|NCT02533674|524392884|FG001|Dose Level VII|Treatment-related AE|0|||
145419817|NCT02533674|524392885|FG002|Dose Level VII|Treatment-related AE|0|||
145419818|NCT02533674|524392886|FG003|Dose Level VII|Treatment-related AE|0|||
145577616|NCT04086472|524969454|FG003|Overall Study|Lost to Follow-up|0|||
145577617|NCT04086472|524969455|FG004|Overall Study|Lost to Follow-up|1|||
145577618|NCT04086472|524969451|FG000|Overall Study|Physician Decision|0|||
145577619|NCT04086472|524969452|FG001|Overall Study|Physician Decision|1|||
145577620|NCT04086472|524969453|FG002|Overall Study|Physician Decision|1|||
145577621|NCT04086472|524969454|FG003|Overall Study|Physician Decision|0|||
145363972|NCT00619892|524183271|FG001|Overall Study|Lost to Follow-up|1|||
145363973|NCT00619892|524183270|FG000|Overall Study|Intercurrent illness|0|||
145363974|NCT00619892|524183271|FG001|Overall Study|Intercurrent illness|1|||
145363975|NCT01562782|524183274|FG000|Overall Study|Withdrawal by Subject|3|||
145363976|NCT01562782|524183275|FG001|Overall Study|Withdrawal by Subject|3|||
145363977|NCT01562782|524183274|FG000|Overall Study|screen failure|1|||
145363978|NCT01562782|524183275|FG001|Overall Study|screen failure|2|||
145363979|NCT00857896|524183279|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
145363980|NCT02308540|524183280|FG000|Overall Study|Lost to Follow-up|0|||
145363981|NCT02308540|524183281|FG001|Overall Study|Lost to Follow-up|0|||
145363982|NCT02308540|524183282|FG002|Overall Study|Lost to Follow-up|0|||
145363983|NCT02308540|524183283|FG003|Overall Study|Lost to Follow-up|0|||
145419819|NCT02533674|524392887|FG004|Dose Level VII|Treatment-related AE|0|||
145419820|NCT02533674|524392888|FG005|Dose Level VII|Treatment-related AE|0|||
145419821|NCT02533674|524392889|FG006|Dose Level VII|Treatment-related AE|1|||
145419822|NCT02533674|524392890|FG007|Dose Level VII|Treatment-related AE|0|||
145419823|NCT02533674|524392883|FG000|Dose Level VII|Death|0|||
145419824|NCT02533674|524392884|FG001|Dose Level VII|Death|0|||
145419825|NCT02533674|524392885|FG002|Dose Level VII|Death|0|||
145419826|NCT02533674|524392886|FG003|Dose Level VII|Death|0|||
145419827|NCT02533674|524392887|FG004|Dose Level VII|Death|0|||
145419828|NCT02533674|524392888|FG005|Dose Level VII|Death|0|||
145419829|NCT02533674|524392889|FG006|Dose Level VII|Death|2|||
145419830|NCT02533674|524392890|FG007|Dose Level VII|Death|0|||
145419831|NCT02533674|524392883|FG000|Dose Level VIII|Progressive disease|0|||
145419832|NCT02533674|524392884|FG001|Dose Level VIII|Progressive disease|0|||
145419833|NCT02533674|524392885|FG002|Dose Level VIII|Progressive disease|0|||
145419834|NCT02533674|524392886|FG003|Dose Level VIII|Progressive disease|0|||
145419835|NCT02533674|524392887|FG004|Dose Level VIII|Progressive disease|0|||
145419836|NCT02533674|524392888|FG005|Dose Level VIII|Progressive disease|0|||
145419837|NCT02533674|524392889|FG006|Dose Level VIII|Progressive disease|0|||
145419838|NCT02533674|524392890|FG007|Dose Level VIII|Progressive disease|3|||
145419839|NCT02533674|524392883|FG000|Dose Level VIII|Withdrawal by Subject|0|||
145419840|NCT02533674|524392884|FG001|Dose Level VIII|Withdrawal by Subject|0|||
145419841|NCT02533674|524392885|FG002|Dose Level VIII|Withdrawal by Subject|0|||
145577622|NCT04086472|524969455|FG004|Overall Study|Physician Decision|0|||
145577623|NCT04086472|524969451|FG000|Overall Study|Withdrawal by Subject|1|||
145577624|NCT04086472|524969452|FG001|Overall Study|Withdrawal by Subject|1|||
145577625|NCT04086472|524969453|FG002|Overall Study|Withdrawal by Subject|1|||
145577626|NCT04086472|524969454|FG003|Overall Study|Withdrawal by Subject|0|||
145363984|NCT02308540|524183284|FG004|Overall Study|Lost to Follow-up|0|||
145363985|NCT02308540|524183285|FG005|Overall Study|Lost to Follow-up|1|||
145363986|NCT04109391|524183286|FG000|Overall Study|Adverse Event|2|||
145363987|NCT04109391|524183287|FG001|Overall Study|Adverse Event|2|||
145363988|NCT04109391|524183288|FG002|Overall Study|Adverse Event|0|||
145363989|NCT04109391|524183286|FG000|Overall Study|Withdrawal by Subject|2|||
145363990|NCT04109391|524183287|FG001|Overall Study|Withdrawal by Subject|0|||
145363991|NCT04109391|524183288|FG002|Overall Study|Withdrawal by Subject|0|||
145363992|NCT04109391|524183286|FG000|Overall Study|Pregnancy|1|||
145363993|NCT04109391|524183287|FG001|Overall Study|Pregnancy|0|||
145363994|NCT04109391|524183288|FG002|Overall Study|Pregnancy|0|||
145363995|NCT04109391|524183286|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
145363996|NCT04109391|524183287|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
145363997|NCT04109391|524183288|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
145363998|NCT04109391|524183286|FG000|Overall Study|Lost to Follow-up|0|||
145363999|NCT04109391|524183287|FG001|Overall Study|Lost to Follow-up|0|||
145364000|NCT04109391|524183288|FG002|Overall Study|Lost to Follow-up|1|||
145364001|NCT04109391|524183286|FG000|Overall Study|Lack of Efficacy|2|||
145364002|NCT04109391|524183287|FG001|Overall Study|Lack of Efficacy|2|||
145364003|NCT04109391|524183288|FG002|Overall Study|Lack of Efficacy|3|||
145364004|NCT00443079|524183297|FG000|Overall Study|Lost to Follow-up|0|||
145364005|NCT00443079|524183298|FG001|Overall Study|Lost to Follow-up|1|||
145364006|NCT02049814|524183299|FG000|Overall Study|Reason not Specified|4|||
145364007|NCT02049814|524183300|FG001|Overall Study|Reason not Specified|3|||
145364008|NCT02049814|524183299|FG000|Overall Study|Pregnancy|1|||
145364009|NCT02049814|524183300|FG001|Overall Study|Pregnancy|0|||
145364010|NCT02049814|524183299|FG000|Overall Study|Lost to Follow-up|2|||
145364011|NCT02049814|524183300|FG001|Overall Study|Lost to Follow-up|3|||
145364012|NCT02049814|524183299|FG000|Overall Study|Serious Protocol Violation|5|||
145364013|NCT02049814|524183300|FG001|Overall Study|Serious Protocol Violation|7|||
145364014|NCT02049814|524183299|FG000|Overall Study|Study Termination|0|||
145364015|NCT02049814|524183300|FG001|Overall Study|Study Termination|1|||
145364016|NCT02049814|524183299|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
145364017|NCT02049814|524183300|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
145364018|NCT02049814|524183299|FG000|Overall Study|Voluntary withdrawal|9|||
145364019|NCT02049814|524183300|FG001|Overall Study|Voluntary withdrawal|8|||
145364020|NCT02993250|524183301|FG000|Overall Study|Lost to Follow-up|0|||
145364021|NCT02993250|524183302|FG001|Overall Study|Lost to Follow-up|1|||
145364022|NCT00954941|524183304|FG000|Overall Study|Received treatment at home|1|||
145364023|NCT00954941|524183305|FG001|Overall Study|Received treatment at home|0|||
145364024|NCT00954941|524183304|FG000|Overall Study|Withdrawal by Subject|1|||
145364025|NCT00954941|524183305|FG001|Overall Study|Withdrawal by Subject|0|||
145419842|NCT02533674|524392886|FG003|Dose Level VIII|Withdrawal by Subject|0|||
145419843|NCT02533674|524392887|FG004|Dose Level VIII|Withdrawal by Subject|0|||
145419844|NCT02533674|524392888|FG005|Dose Level VIII|Withdrawal by Subject|0|||
145419845|NCT02533674|524392889|FG006|Dose Level VIII|Withdrawal by Subject|0|||
145419846|NCT02533674|524392890|FG007|Dose Level VIII|Withdrawal by Subject|1|||
145419847|NCT02533674|524392883|FG000|Dose Level VIII|Treatment-related AE|0|||
145419848|NCT02533674|524392884|FG001|Dose Level VIII|Treatment-related AE|0|||
145577627|NCT04086472|524969455|FG004|Overall Study|Withdrawal by Subject|0|||
145364026|NCT00954941|524183304|FG000|Overall Study|Insurance Denial|2|||
145364027|NCT00954941|524183305|FG001|Overall Study|Insurance Denial|2|||
145364028|NCT00954941|524183304|FG000|Overall Study|Physician Decision|2|||
145364029|NCT00954941|524183305|FG001|Overall Study|Physician Decision|2|||
145364030|NCT00954941|524183304|FG000|Overall Study|Ineligible|2|||
145364031|NCT00954941|524183305|FG001|Overall Study|Ineligible|2|||
145364032|NCT00954941|524183304|FG000|Overall Study|Adverse Event|0|||
145577628|NCT04086472|524969451|FG000|Overall Study|Various reasons|2|||
145577629|NCT04086472|524969452|FG001|Overall Study|Various reasons|0|||
145577630|NCT04086472|524969453|FG002|Overall Study|Various reasons|0|||
145577631|NCT04086472|524969454|FG003|Overall Study|Various reasons|3|||
145577632|NCT04086472|524969455|FG004|Overall Study|Various reasons|1|||
145577633|NCT04116229|524969456|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
145364033|NCT00954941|524183305|FG001|Overall Study|Adverse Event|1|||
145364034|NCT00356148|524183308|FG000|Overall Study|Reoperation within 30 days|2|||
145364035|NCT00356148|524183309|FG001|Overall Study|Reoperation within 30 days|1|||
145364036|NCT02484456|524183310|FG000|Washout Period|Withdrawal by Subject|0|||
145364037|NCT02484456|524183311|FG001|Washout Period|Withdrawal by Subject|1|||
145364038|NCT02484456|524183310|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
145364039|NCT02484456|524183311|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
145364040|NCT02484456|524183310|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
145364041|NCT02484456|524183311|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
145364042|NCT02484456|524183310|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
145364043|NCT02484456|524183311|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
145364044|NCT02865499|524183317|FG000|Baseline|Adverse Event|1|||
145364045|NCT02865499|524183317|FG000|Baseline|Withdrawal by Subject|1|||
145364046|NCT02792192|524183318|FG000|Overall Study|Death|1|||
145364047|NCT02792192|524183319|FG001|Overall Study|Death|0|||
145364048|NCT02792192|524183320|FG002|Overall Study|Death|0|||
145364049|NCT02792192|524183321|FG003|Overall Study|Death|0|||
145364050|NCT02792192|524183318|FG000|Overall Study|Informed Consent Withdrawn|4|||
145364051|NCT02792192|524183319|FG001|Overall Study|Informed Consent Withdrawn|0|||
145364052|NCT02792192|524183320|FG002|Overall Study|Informed Consent Withdrawn|0|||
145364053|NCT02792192|524183321|FG003|Overall Study|Informed Consent Withdrawn|0|||
145364054|NCT02792192|524183318|FG000|Overall Study|Physician Decision|1|||
145364055|NCT02792192|524183319|FG001|Overall Study|Physician Decision|0|||
145364056|NCT02792192|524183320|FG002|Overall Study|Physician Decision|0|||
145364057|NCT02792192|524183321|FG003|Overall Study|Physician Decision|0|||
145364058|NCT02792192|524183318|FG000|Overall Study|Progressive Disease|0|||
145364059|NCT02792192|524183319|FG001|Overall Study|Progressive Disease|1|||
145364060|NCT02792192|524183320|FG002|Overall Study|Progressive Disease|0|||
145364061|NCT02792192|524183321|FG003|Overall Study|Progressive Disease|0|||
145364062|NCT02792192|524183318|FG000|Overall Study|Study Terminated By Sponsor|6|||
145364063|NCT02792192|524183319|FG001|Overall Study|Study Terminated By Sponsor|10|||
145364064|NCT02792192|524183320|FG002|Overall Study|Study Terminated By Sponsor|0|||
145364065|NCT02792192|524183321|FG003|Overall Study|Study Terminated By Sponsor|0|||
145364066|NCT02247440|524183322|FG000|Overall Study|Withdrawal by Subject|1|||
145364067|NCT02247440|524183322|FG000|Overall Study|Lack of Efficacy|3|||
145364068|NCT00661609|524183323|FG000|Overall Study|Adverse Event|4|||
145364069|NCT00661609|524183323|FG000|Overall Study|Death|20|||
145364070|NCT00661609|524183323|FG000|Overall Study|Withdrawal by Subject|2|||
145364071|NCT00661609|524183323|FG000|Overall Study|PI Decision|1|||
145364072|NCT00661609|524183323|FG000|Overall Study|Survival follow up stage discontinued|11|||
145364073|NCT00661609|524183323|FG000|Overall Study|Disease progression|3|||
145364074|NCT00396656|524183325|FG000|First Treatment Period|Withdrawal by Subject|0|||
145364075|NCT00396656|524183326|FG001|First Treatment Period|Withdrawal by Subject|2|||
145364076|NCT00396656|524183325|FG000|Second Treatment Period|Adverse Event|0|||
145364077|NCT00396656|524183326|FG001|Second Treatment Period|Adverse Event|1|||
145364078|NCT00554515|524183327|FG000|Overall Study|Withdrawal by Subject|3|||
145364079|NCT00554515|524183327|FG000|Overall Study|Disease progression|52|||
145364080|NCT00554515|524183327|FG000|Overall Study|Physician Decision|18|||
145364081|NCT00554515|524183327|FG000|Overall Study|Withdrawal by Subject|11|||
145364082|NCT00554515|524183327|FG000|Overall Study|Adverse Event|9|||
145364083|NCT00554515|524183327|FG000|Overall Study|Death|2|||
145364084|NCT00554515|524183327|FG000|Overall Study|Achieved Stable Disease|7|||
145364085|NCT00554515|524183327|FG000|Overall Study|Other|1|||
145364086|NCT00554515|524183327|FG000|Overall Study|Misc|15|||
145364087|NCT02593097|524183335|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
145364088|NCT02593097|524183336|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
145364089|NCT02593097|524183335|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145364090|NCT02593097|524183336|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
145364091|NCT02593097|524183335|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
145364092|NCT02593097|524183336|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
145364093|NCT02593097|524183335|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
145364094|NCT02593097|524183336|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
145364095|NCT02593097|524183335|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
145364096|NCT02593097|524183336|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
145364097|NCT03759587|524183337|FG000|Overall Study|Adverse Event|5|||
145577634|NCT04116229|524969457|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
145577635|NCT04116229|524969456|FG000|Overall Study|Scheduling not possible.|0|||
145577636|NCT04116229|524969457|FG001|Overall Study|Scheduling not possible.|1|||
145364098|NCT03759587|524183337|FG000|Overall Study|Progressive Disease|10|||
145364099|NCT03759587|524183337|FG000|Overall Study|Site Terminated by Sponsor|3|||
145419849|NCT02533674|524392885|FG002|Dose Level VIII|Treatment-related AE|0|||
145419850|NCT02533674|524392886|FG003|Dose Level VIII|Treatment-related AE|0|||
145419851|NCT02533674|524392887|FG004|Dose Level VIII|Treatment-related AE|0|||
145419852|NCT02533674|524392888|FG005|Dose Level VIII|Treatment-related AE|0|||
145419853|NCT02533674|524392889|FG006|Dose Level VIII|Treatment-related AE|0|||
145419854|NCT02533674|524392890|FG007|Dose Level VIII|Treatment-related AE|1|||
145419855|NCT02533674|524392883|FG000|Dose Level VIII|Never treated|0|||
145419856|NCT02533674|524392884|FG001|Dose Level VIII|Never treated|0|||
145419857|NCT02533674|524392885|FG002|Dose Level VIII|Never treated|0|||
145419858|NCT02533674|524392886|FG003|Dose Level VIII|Never treated|0|||
145419859|NCT02533674|524392887|FG004|Dose Level VIII|Never treated|0|||
145419860|NCT02533674|524392888|FG005|Dose Level VIII|Never treated|0|||
145419861|NCT02533674|524392889|FG006|Dose Level VIII|Never treated|0|||
145419862|NCT02533674|524392890|FG007|Dose Level VIII|Never treated|1|||
145419863|NCT02365064|524392897|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
145419864|NCT02365064|524392898|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
145419865|NCT02365064|524392897|FG000|Overall Study|Withdrawal by Subject|6|||
145419866|NCT02365064|524392898|FG001|Overall Study|Withdrawal by Subject|9|||
145419867|NCT02365064|524392897|FG000|Overall Study|Treatment intolerance|2|||
145419868|NCT02365064|524392898|FG001|Overall Study|Treatment intolerance|4|||
145419869|NCT04821245|524392903|FG000|Overall Study|Withdrawal by Subject|3|||
145419870|NCT04821245|524392903|FG000|Overall Study|Physician Decision|1|||
145419871|NCT04821245|524392903|FG000|Overall Study|Protocol Violation|5|||
145419872|NCT02123511|524392904|FG000|Overall Study|Cancelled treatment|1|||
145419873|NCT02123511|524392905|FG001|Overall Study|Cancelled treatment|0|||
145419874|NCT02123511|524392904|FG000|Overall Study|Incomplete data|1|||
145419875|NCT02123511|524392905|FG001|Overall Study|Incomplete data|3|||
145419876|NCT02123511|524392904|FG000|Overall Study|Ineligible|0|||
145419877|NCT02123511|524392905|FG001|Overall Study|Ineligible|1|||
145419878|NCT00397046|524392908|FG000|Overall Study|Disease Progression|3|||
145419879|NCT00397046|524392909|FG001|Overall Study|Disease Progression|3|||
145419880|NCT00397046|524392910|FG002|Overall Study|Disease Progression|10|||
145419881|NCT00397046|524392911|FG003|Overall Study|Disease Progression|5|||
145419882|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
145419883|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
145419884|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
145419885|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
145419886|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145419887|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
145419888|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
145419889|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
145419890|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
145419891|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
145419892|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
145419893|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
145419894|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Other|6|||
145577637|NCT04574362|524969460|FG000|Overall Study|Other|0|||
145577638|NCT04574362|524969461|FG001|Overall Study|Other|5|||
145577639|NCT04574362|524969460|FG000|Overall Study|COVID-19|0|||
145577640|NCT04574362|524969461|FG001|Overall Study|COVID-19|1|||
145419895|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Other|3|||
145419896|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Other|0|||
145419897|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
145419898|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145419899|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
145419900|NCT03636269|524392913|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
145419901|NCT03636269|524392914|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
145419902|NCT03636269|524392915|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
145419903|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Adverse Event|0|||
145419904|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Adverse Event|0|||
145577641|NCT04574362|524969460|FG000|Overall Study|Adverse Event|1|||
145577642|NCT04574362|524969461|FG001|Overall Study|Adverse Event|1|||
145577643|NCT04574362|524969460|FG000|Overall Study|Withdrawal by Subject|2|||
145577644|NCT04574362|524969461|FG001|Overall Study|Withdrawal by Subject|4|||
145577645|NCT04574362|524969460|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
145419905|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Adverse Event|21|||
145419906|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
145419907|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
145419908|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
145419909|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
145419910|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
145419911|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
145419912|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
145419913|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
145419914|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
145419915|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Administrative|0|||
145419916|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Administrative|0|||
145419917|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Administrative|36|||
145419918|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Other|0|||
145419919|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Other|0|||
145419920|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Other|9|||
145419921|NCT03636269|524392913|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
145419922|NCT03636269|524392914|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
145419923|NCT03636269|524392915|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
145419924|NCT00493285|524392924|FG000|Overall Study|Lost to Follow-up|0|||
145419925|NCT00493285|524392925|FG001|Overall Study|Lost to Follow-up|0|||
145419926|NCT00493285|524392926|FG002|Overall Study|Lost to Follow-up|0|||
145419927|NCT00493285|524392927|FG003|Overall Study|Lost to Follow-up|0|||
145419928|NCT00493285|524392928|FG004|Overall Study|Lost to Follow-up|1|||
145419929|NCT00493285|524392929|FG005|Overall Study|Lost to Follow-up|0|||
145419930|NCT03021005|524392930|FG000|Overall Study|Lost to Follow-up|39|||
145419931|NCT03021005|524392931|FG001|Overall Study|Lost to Follow-up|26|||
145419932|NCT00337194|524392932|FG000|Overall Study|Adverse Event|5|||
145419933|NCT00337194|524392933|FG001|Overall Study|Adverse Event|1|||
145419934|NCT00337194|524392932|FG000|Overall Study|Death|2|||
145419935|NCT00337194|524392933|FG001|Overall Study|Death|0|||
145419936|NCT00337194|524392932|FG000|Overall Study|Withdrawal by Subject|1|||
145419937|NCT00337194|524392933|FG001|Overall Study|Withdrawal by Subject|0|||
145419938|NCT00337194|524392932|FG000|Overall Study|Disease progression|1|||
145419939|NCT00337194|524392933|FG001|Overall Study|Disease progression|2|||
145419940|NCT00337194|524392932|FG000|Overall Study|Subsequent non-protocol therapy|3|||
145419941|NCT00337194|524392933|FG001|Overall Study|Subsequent non-protocol therapy|1|||
145419942|NCT03188705|524392934|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
145419943|NCT03188705|524392934|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
145419944|NCT00981175|524392941|FG000|Primary Dose Vaccination|Adverse Event|1|||
145419945|NCT00981175|524392942|FG001|Primary Dose Vaccination|Adverse Event|0|||
145419946|NCT00981175|524392941|FG000|Primary Dose Vaccination|Protocol Violation|0|||
145419947|NCT00981175|524392942|FG001|Primary Dose Vaccination|Protocol Violation|1|||
145419948|NCT00981175|524392941|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
145419949|NCT00981175|524392942|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
145419950|NCT00981175|524392941|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
145419951|NCT00981175|524392942|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
145419952|NCT01750281|524392943|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
145419953|NCT01750281|524392944|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
145419954|NCT01750281|524392945|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
145419955|NCT01750281|524392943|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
145419956|NCT01750281|524392944|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
145419957|NCT01750281|524392945|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
145419958|NCT01750281|524392943|FG000|Overall Study|Did not receive treatment|0|||
145419959|NCT01750281|524392944|FG001|Overall Study|Did not receive treatment|1|||
145419960|NCT01750281|524392945|FG002|Overall Study|Did not receive treatment|0|||
145419961|NCT04189588|524392946|FG000|Overall Study|Death|0|||
145419962|NCT04189588|524392947|FG001|Overall Study|Death|1|||
145419963|NCT04189588|524392946|FG000|Overall Study|Lost to Follow-up|0|||
145419964|NCT04189588|524392947|FG001|Overall Study|Lost to Follow-up|1|||
145577646|NCT04574362|524969461|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
145419965|NCT03757715|524392949|FG000|Overall Study|Lost to Follow-up|4|||
145419966|NCT03757715|524392950|FG001|Overall Study|Lost to Follow-up|9|||
145419967|NCT03757715|524392949|FG000|Overall Study|Withdrawal by Subject|1|||
145419968|NCT03757715|524392950|FG001|Overall Study|Withdrawal by Subject|1|||
145419969|NCT03156621|524392951|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
145419970|NCT03156621|524392952|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
145419971|NCT03156621|524392951|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
145419972|NCT03156621|524392952|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
145419973|NCT03302936|524392953|FG000|Overall Study|Protocol Violation|3|||
145577647|NCT04574362|524969460|FG000|Overall Study|Participant refused to come to the hospital|1|||
145419974|NCT03302936|524392954|FG001|Overall Study|Protocol Violation|4|||
145419975|NCT01122680|524392955|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
145419976|NCT01122680|524392956|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
145419977|NCT01122680|524392957|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
145419978|NCT01122680|524392958|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
145419979|NCT01122680|524392955|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
145419980|NCT01122680|524392956|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
145419981|NCT01122680|524392957|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
145419982|NCT01122680|524392958|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
145419983|NCT01122680|524392955|FG000|Period 1 (4 Weeks)|Other|1|||
145419984|NCT01122680|524392956|FG001|Period 1 (4 Weeks)|Other|1|||
145419985|NCT01122680|524392957|FG002|Period 1 (4 Weeks)|Other|0|||
145364100|NCT03759587|524183337|FG000|Overall Study|Withdrawal by Subject|1|||
145364101|NCT00665431|524183339|FG000|Overall Study|Adverse Event|16|||
145364102|NCT00665431|524183340|FG001|Overall Study|Adverse Event|22|||
145364103|NCT00665431|524183341|FG002|Overall Study|Adverse Event|6|||
145364104|NCT00665431|524183339|FG000|Overall Study|Withdrawal by Subject|17|||
145364105|NCT00665431|524183340|FG001|Overall Study|Withdrawal by Subject|25|||
145364106|NCT00665431|524183341|FG002|Overall Study|Withdrawal by Subject|15|||
145364107|NCT00665431|524183339|FG000|Overall Study|Lost to Follow-up|3|||
145364108|NCT00665431|524183340|FG001|Overall Study|Lost to Follow-up|3|||
145364109|NCT00665431|524183341|FG002|Overall Study|Lost to Follow-up|1|||
145364110|NCT00665431|524183339|FG000|Overall Study|Other|4|||
145364111|NCT00665431|524183340|FG001|Overall Study|Other|7|||
145364112|NCT00665431|524183341|FG002|Overall Study|Other|2|||
145364113|NCT03340454|524183344|FG000|Overall Study|Lost to Follow-up|0|||
145364114|NCT03340454|524183345|FG001|Overall Study|Lost to Follow-up|4|||
145364115|NCT01464164|524183346|FG000|Overall Study|Screen failure|0|||
145364116|NCT01464164|524183347|FG001|Overall Study|Screen failure|1|||
145364117|NCT01464164|524183348|FG002|Overall Study|Screen failure|2|||
145364118|NCT01464164|524183349|FG003|Overall Study|Screen failure|0|||
145364119|NCT01464164|524183350|FG004|Overall Study|Screen failure|0|||
145364120|NCT01464164|524183351|FG005|Overall Study|Screen failure|0|||
145364121|NCT01464164|524183352|FG006|Overall Study|Screen failure|0|||
145364122|NCT01464164|524183346|FG000|Overall Study|Physician Decision|0|||
145364123|NCT01464164|524183347|FG001|Overall Study|Physician Decision|1|||
145364124|NCT01464164|524183348|FG002|Overall Study|Physician Decision|0|||
145364125|NCT01464164|524183349|FG003|Overall Study|Physician Decision|0|||
145364126|NCT01464164|524183350|FG004|Overall Study|Physician Decision|0|||
145364127|NCT01464164|524183351|FG005|Overall Study|Physician Decision|0|||
145364128|NCT01464164|524183352|FG006|Overall Study|Physician Decision|2|||
145364129|NCT03682848|524183353|FG000|Overall Study|Withdrawal by Subject|2|||
145364130|NCT03682848|524183353|FG000|Overall Study|Site closed|5|||
145364131|NCT03682848|524183353|FG000|Overall Study|Protocol Deviation|1|||
145364132|NCT03682848|524183353|FG000|Overall Study|Adverse Event|1|||
145364133|NCT00454363|524183354|FG000|Overall Study|Adverse Event|1|||
145364134|NCT00454363|524183355|FG001|Overall Study|Adverse Event|2|||
145364135|NCT00454363|524183354|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
145364136|NCT00454363|524183355|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
145364137|NCT01578239|524183356|FG000|Treatment Period|Progressive Disease|19|||
145364138|NCT01578239|524183357|FG001|Treatment Period|Progressive Disease|64|||
145364139|NCT01578239|524183356|FG000|Treatment Period|Physician Decision|17|||
145364140|NCT01578239|524183357|FG001|Treatment Period|Physician Decision|17|||
145364141|NCT01578239|524183356|FG000|Treatment Period|Adverse Event|13|||
145364142|NCT01578239|524183357|FG001|Treatment Period|Adverse Event|10|||
145364143|NCT01578239|524183356|FG000|Treatment Period|Non-compliance|2|||
145364144|NCT01578239|524183357|FG001|Treatment Period|Non-compliance|0|||
145364145|NCT01578239|524183356|FG000|Treatment Period|Withdrawal by Subject|10|||
145364146|NCT01578239|524183357|FG001|Treatment Period|Withdrawal by Subject|9|||
145364147|NCT01578239|524183356|FG000|Treatment Period|Other|6|||
145364148|NCT01578239|524183357|FG001|Treatment Period|Other|1|||
145364149|NCT01578239|524183356|FG000|Long-term Follow-Up Period|Death|69|||
145364150|NCT01578239|524183357|FG001|Long-term Follow-Up Period|Death|64|||
145364151|NCT01578239|524183356|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
145364152|NCT01578239|524183357|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
145364153|NCT01578239|524183356|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
145364154|NCT01578239|524183357|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
145364155|NCT01578239|524183356|FG000|Long-term Follow-Up Period|Other|2|||
145364156|NCT01578239|524183357|FG001|Long-term Follow-Up Period|Other|2|||
145364157|NCT02347813|524183358|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
145364158|NCT02347813|524183359|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
145364159|NCT02347813|524183358|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
145364160|NCT02347813|524183359|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
145364161|NCT01119859|524183360|FG000|Overall Study|Adverse Event|9|||
145364162|NCT01119859|524183361|FG001|Overall Study|Adverse Event|10|||
145364163|NCT01119859|524183360|FG000|Overall Study|Death|2|||
145364164|NCT01119859|524183361|FG001|Overall Study|Death|0|||
145364165|NCT01119859|524183360|FG000|Overall Study|Insufficient therapeutic response|7|||
145364166|NCT01119859|524183361|FG001|Overall Study|Insufficient therapeutic response|14|||
145364167|NCT01119859|524183360|FG000|Overall Study|Refused treatment|3|||
145364168|NCT01119859|524183361|FG001|Overall Study|Refused treatment|6|||
145364169|NCT01119859|524183360|FG000|Overall Study|Failure to return|3|||
145364170|NCT01119859|524183361|FG001|Overall Study|Failure to return|0|||
145364171|NCT03817229|524183362|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
145364172|NCT03817229|524183363|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
145364173|NCT03817229|524183364|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
145364174|NCT03817229|524183365|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
145364175|NCT03817229|524183362|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145364176|NCT03817229|524183363|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
145419986|NCT01122680|524392958|FG003|Period 1 (4 Weeks)|Other|0|||
145577648|NCT04574362|524969461|FG001|Overall Study|Participant refused to come to the hospital|0|||
145577649|NCT04574362|524969460|FG000|Overall Study|Participant refused the visit|1|||
145577650|NCT04574362|524969461|FG001|Overall Study|Participant refused the visit|0|||
145577651|NCT04574362|524969460|FG000|Overall Study|Participant quit early because of business trip|1|||
145577652|NCT04574362|524969461|FG001|Overall Study|Participant quit early because of business trip|0|||
145577653|NCT01600040|524969463|FG000|Overall Study|Withdrawal by Subject|1|||
145364177|NCT03817229|524183364|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145364178|NCT03817229|524183365|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
145364179|NCT03817229|524183362|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
145364180|NCT03817229|524183363|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
145364181|NCT03817229|524183364|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
145364182|NCT03817229|524183365|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
145364183|NCT03817229|524183362|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
145364184|NCT03817229|524183363|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
145364185|NCT03817229|524183364|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
145364186|NCT03817229|524183365|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
145364187|NCT03817229|524183362|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145364188|NCT03817229|524183363|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145364189|NCT03817229|524183364|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
145364190|NCT03817229|524183365|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
145364191|NCT03817229|524183362|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
145364192|NCT03817229|524183363|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
145364193|NCT03817229|524183364|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
145364194|NCT03817229|524183365|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
145364195|NCT03817229|524183362|FG000|Post-Intervention|Withdrawal by Subject|6|||
145364196|NCT03817229|524183363|FG001|Post-Intervention|Withdrawal by Subject|0|||
145364197|NCT03817229|524183364|FG002|Post-Intervention|Withdrawal by Subject|2|||
145364198|NCT03817229|524183365|FG003|Post-Intervention|Withdrawal by Subject|2|||
145364199|NCT03817229|524183362|FG000|Post-Intervention|Withdrawal by Study Team|3|||
145364200|NCT03817229|524183363|FG001|Post-Intervention|Withdrawal by Study Team|1|||
145364201|NCT03817229|524183364|FG002|Post-Intervention|Withdrawal by Study Team|1|||
145364202|NCT03817229|524183365|FG003|Post-Intervention|Withdrawal by Study Team|4|||
145364203|NCT03817229|524183362|FG000|Post-Intervention|Weaned from medication|3|||
145364204|NCT03817229|524183363|FG001|Post-Intervention|Weaned from medication|0|||
145364205|NCT03817229|524183364|FG002|Post-Intervention|Weaned from medication|2|||
145364206|NCT03817229|524183365|FG003|Post-Intervention|Weaned from medication|1|||
145364207|NCT03817229|524183362|FG000|Post-Intervention|Transferred care to another institution|1|||
145364208|NCT03817229|524183363|FG001|Post-Intervention|Transferred care to another institution|0|||
145364209|NCT03817229|524183364|FG002|Post-Intervention|Transferred care to another institution|0|||
145364210|NCT03817229|524183365|FG003|Post-Intervention|Transferred care to another institution|0|||
145364211|NCT03817229|524183362|FG000|Post-Intervention|Change in parental guardianship|0|||
145364212|NCT03817229|524183363|FG001|Post-Intervention|Change in parental guardianship|0|||
145364213|NCT03817229|524183364|FG002|Post-Intervention|Change in parental guardianship|1|||
145364214|NCT03817229|524183365|FG003|Post-Intervention|Change in parental guardianship|0|||
145364215|NCT03817229|524183362|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
145364216|NCT03817229|524183363|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
145364217|NCT03817229|524183364|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
145364218|NCT03817229|524183365|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
145364219|NCT03817229|524183362|FG000|Follow-up 1|Withdrawal by Subject|1|||
145364220|NCT03817229|524183363|FG001|Follow-up 1|Withdrawal by Subject|2|||
145364221|NCT03817229|524183364|FG002|Follow-up 1|Withdrawal by Subject|0|||
145364222|NCT03817229|524183365|FG003|Follow-up 1|Withdrawal by Subject|0|||
145364223|NCT03817229|524183362|FG000|Follow-up 1|Withdrawal by Study Team|3|||
145364224|NCT03817229|524183363|FG001|Follow-up 1|Withdrawal by Study Team|1|||
145364225|NCT03817229|524183364|FG002|Follow-up 1|Withdrawal by Study Team|0|||
145364226|NCT03817229|524183365|FG003|Follow-up 1|Withdrawal by Study Team|0|||
145364227|NCT03817229|524183362|FG000|Follow-up 1|Wean from medication|3|||
145364228|NCT03817229|524183363|FG001|Follow-up 1|Wean from medication|4|||
145364229|NCT03817229|524183364|FG002|Follow-up 1|Wean from medication|0|||
145364230|NCT03817229|524183365|FG003|Follow-up 1|Wean from medication|1|||
145364231|NCT03817229|524183362|FG000|Follow-up 1|Transferred care to another hospital|1|||
145364232|NCT03817229|524183363|FG001|Follow-up 1|Transferred care to another hospital|0|||
145364233|NCT03817229|524183364|FG002|Follow-up 1|Transferred care to another hospital|0|||
145364234|NCT03817229|524183365|FG003|Follow-up 1|Transferred care to another hospital|0|||
145364235|NCT03817229|524183362|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
145364236|NCT03817229|524183363|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
145364237|NCT03817229|524183364|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
145377844|NCT03191864|524233637|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145577654|NCT00047463|524969464|FG000|Overall Study|Withdrawal by Subject|0|||
145364238|NCT03817229|524183365|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
145364239|NCT03817229|524183362|FG000|Follow-up 2|Withdrawal by Subject|2|||
145364240|NCT03817229|524183363|FG001|Follow-up 2|Withdrawal by Subject|0|||
145364241|NCT03817229|524183364|FG002|Follow-up 2|Withdrawal by Subject|1|||
145364242|NCT03817229|524183365|FG003|Follow-up 2|Withdrawal by Subject|1|||
145364243|NCT03817229|524183362|FG000|Follow-up 2|Withdrawal by Study Team|2|||
145364244|NCT03817229|524183363|FG001|Follow-up 2|Withdrawal by Study Team|0|||
145364245|NCT03817229|524183364|FG002|Follow-up 2|Withdrawal by Study Team|1|||
145364246|NCT03817229|524183365|FG003|Follow-up 2|Withdrawal by Study Team|0|||
145364247|NCT03817229|524183362|FG000|Follow-up 2|Wean from medication|1|||
145364248|NCT03817229|524183363|FG001|Follow-up 2|Wean from medication|0|||
145364249|NCT03817229|524183364|FG002|Follow-up 2|Wean from medication|0|||
145364250|NCT03817229|524183365|FG003|Follow-up 2|Wean from medication|0|||
145364251|NCT03817229|524183362|FG000|Follow-up 2|Transferred care|0|||
145364252|NCT03817229|524183363|FG001|Follow-up 2|Transferred care|0|||
145364253|NCT03817229|524183364|FG002|Follow-up 2|Transferred care|1|||
145364254|NCT03817229|524183365|FG003|Follow-up 2|Transferred care|0|||
145364255|NCT04402138|524185229|FG000|Overall Study|Progressive Disease|2|||
145364256|NCT04402138|524185229|FG000|Overall Study|Adverse Event|1|||
145364257|NCT04390503|524185231|FG000|Overall Study|Physician Decision|2|||
145364258|NCT04390503|524185232|FG001|Overall Study|Physician Decision|1|||
145364259|NCT04390503|524185231|FG000|Overall Study|Adverse Event|1|||
145364260|NCT04390503|524185232|FG001|Overall Study|Adverse Event|0|||
145364261|NCT03508726|524185233|FG000|Overall Study|Withdrawal by Subject|0|||
145364262|NCT03508726|524185234|FG001|Overall Study|Withdrawal by Subject|1|||
145364263|NCT02875613|524185238|FG000|Overall Study|Withdrawal by Subject|1|||
145364264|NCT02875613|524185238|FG000|Overall Study|Screen Failure|1|||
145364265|NCT01057810|524185239|FG000|Overall Study|Disease progression|156|||
145364266|NCT01057810|524185240|FG001|Overall Study|Disease progression|197|||
145364267|NCT01057810|524185239|FG000|Overall Study|Study drug toxicity|5|||
145364268|NCT01057810|524185240|FG001|Overall Study|Study drug toxicity|114|||
145364269|NCT01057810|524185239|FG000|Overall Study|Adverse event unrelated to study drug|13|||
145364270|NCT01057810|524185240|FG001|Overall Study|Adverse event unrelated to study drug|29|||
145364271|NCT01057810|524185239|FG000|Overall Study|Withdrawal by Subject|10|||
145364272|NCT01057810|524185240|FG001|Overall Study|Withdrawal by Subject|25|||
145364273|NCT01057810|524185239|FG000|Overall Study|Death|2|||
145364274|NCT01057810|524185240|FG001|Overall Study|Death|12|||
145364275|NCT01057810|524185239|FG000|Overall Study|Maximum clinical benefit|5|||
145364276|NCT01057810|524185240|FG001|Overall Study|Maximum clinical benefit|5|||
145364277|NCT01057810|524185239|FG000|Overall Study|Poor/non-compliance|0|||
145364278|NCT01057810|524185240|FG001|Overall Study|Poor/non-compliance|1|||
145364279|NCT01057810|524185239|FG000|Overall Study|No longer met study criteria|0|||
145364280|NCT01057810|524185240|FG001|Overall Study|No longer met study criteria|1|||
145364281|NCT01057810|524185239|FG000|Overall Study|Other|7|||
145364282|NCT01057810|524185240|FG001|Overall Study|Other|14|||
145364283|NCT02088905|524185241|FG000|Overall Study|Withdrawal by Subject|5|||
145364284|NCT02088905|524185242|FG001|Overall Study|Withdrawal by Subject|1|||
145364285|NCT01091662|524185244|FG000|Overall Study|Adverse Event|1|||
145364286|NCT01091662|524185245|FG001|Overall Study|Adverse Event|9|||
145364287|NCT01091662|524185244|FG000|Overall Study|Physician Decision|1|||
145364288|NCT01091662|524185245|FG001|Overall Study|Physician Decision|1|||
145364289|NCT01091662|524185244|FG000|Overall Study|Withdrawal by Subject|7|||
145364290|NCT01091662|524185245|FG001|Overall Study|Withdrawal by Subject|6|||
145364291|NCT01091662|524185244|FG000|Overall Study|met exit criteria|7|||
145364292|NCT01091662|524185245|FG001|Overall Study|met exit criteria|13|||
145364293|NCT01091662|524185244|FG000|Overall Study|met exclusion criteria|1|||
145364294|NCT01091662|524185245|FG001|Overall Study|met exclusion criteria|0|||
145364295|NCT01091662|524185244|FG000|Overall Study|Lost to Follow-up|0|||
145364296|NCT01091662|524185245|FG001|Overall Study|Lost to Follow-up|1|||
145364297|NCT01091662|524185244|FG000|Overall Study|Pregnancy|0|||
145364298|NCT01091662|524185245|FG001|Overall Study|Pregnancy|1|||
145364299|NCT01091662|524185244|FG000|Overall Study|Protocol Violation|0|||
145364300|NCT01091662|524185245|FG001|Overall Study|Protocol Violation|2|||
145364301|NCT01091662|524185244|FG000|Overall Study|unable to swallow capsule|0|||
145364302|NCT01091662|524185245|FG001|Overall Study|unable to swallow capsule|1|||
145364303|NCT02714595|524185246|FG000|Overall Study|Lost to Follow-up|1|||
145364304|NCT02714595|524185247|FG001|Overall Study|Lost to Follow-up|0|||
145364305|NCT02714595|524185246|FG000|Overall Study|Withdrawal by Subject|1|||
145364306|NCT02714595|524185247|FG001|Overall Study|Withdrawal by Subject|2|||
145364307|NCT02714595|524185246|FG000|Overall Study|Lack of Efficacy|0|||
145364308|NCT02714595|524185247|FG001|Overall Study|Lack of Efficacy|1|||
145364309|NCT02714595|524185246|FG000|Overall Study|Death|30|||
145364310|NCT02714595|524185247|FG001|Overall Study|Death|9|||
145364311|NCT02714595|524185246|FG000|Overall Study|Other-Miscellaneous|0|||
145364312|NCT02714595|524185247|FG001|Overall Study|Other-Miscellaneous|1|||
145364313|NCT04606394|524185250|FG000|Overall Study|Withdrawal by Subject|3|||
145364314|NCT04606394|524185250|FG000|Overall Study|Exclusion criteria screen failure|12|||
145364315|NCT01896128|524185251|FG000|Overall Study|Withdrawal by Subject|3|||
145577655|NCT00047463|524969465|FG001|Overall Study|Withdrawal by Subject|3|||
145577656|NCT02178475|524969469|FG000|Overall Study|Withdrawal by Subject|7|||
145577657|NCT02178475|524969469|FG000|Overall Study|Lost to Follow-up|10|||
145577658|NCT02178475|524969469|FG000|Overall Study|Death|13|||
145577659|NCT02178475|524969469|FG000|Overall Study|Protocol-specified Criteria|99|||
145577660|NCT01706250|524969477|FG000|Overall Study|Lost to Follow-up|2|||
145577661|NCT03286140|524969478|FG000|Overall Study|Withdrawal by Subject|10|||
145364316|NCT01896128|524185252|FG001|Overall Study|Withdrawal by Subject|3|||
145364317|NCT00955955|524185253|FG000|Overall Study|Lost to Follow-up|2|||
145419987|NCT01122680|524392955|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
145419988|NCT01122680|524392956|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
145419989|NCT01122680|524392957|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
145419990|NCT01122680|524392958|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
145419991|NCT01122680|524392955|FG000|Period 2 (4 Weeks)|Other|1|||
145419992|NCT01122680|524392956|FG001|Period 2 (4 Weeks)|Other|0|||
145419993|NCT01122680|524392957|FG002|Period 2 (4 Weeks)|Other|0|||
145419994|NCT01122680|524392958|FG003|Period 2 (4 Weeks)|Other|0|||
145419995|NCT01122680|524392955|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
145419996|NCT01122680|524392956|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
145419997|NCT01122680|524392957|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
145419998|NCT01122680|524392958|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
145419999|NCT01122680|524392955|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145420000|NCT01122680|524392956|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
145420001|NCT01122680|524392957|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145420002|NCT01122680|524392958|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
145364318|NCT00955955|524185254|FG001|Overall Study|Lost to Follow-up|0|||
145364319|NCT00955955|524185255|FG002|Overall Study|Lost to Follow-up|0|||
145364320|NCT01996254|524185257|FG000|Overall Study|Change in Eligibility|0|||
145364321|NCT01996254|524185258|FG001|Overall Study|Change in Eligibility|2|||
145364322|NCT01996254|524185259|FG002|Overall Study|Change in Eligibility|0|||
145364323|NCT01996254|524185257|FG000|Overall Study|Withdrawal by Subject|0|||
145364324|NCT01996254|524185258|FG001|Overall Study|Withdrawal by Subject|3|||
145364325|NCT01996254|524185259|FG002|Overall Study|Withdrawal by Subject|4|||
145364326|NCT01996254|524185257|FG000|Overall Study|Lost to Follow-up|1|||
145364327|NCT01996254|524185258|FG001|Overall Study|Lost to Follow-up|0|||
145364328|NCT01996254|524185259|FG002|Overall Study|Lost to Follow-up|4|||
145364329|NCT03423173|524185260|FG000|Overall Study|Randomized but not vaccinated|1|||
145364330|NCT03423173|524185261|FG001|Overall Study|Randomized but not vaccinated|0|||
145364331|NCT03423173|524185262|FG002|Overall Study|Randomized but not vaccinated|2|||
145364332|NCT03423173|524185263|FG003|Overall Study|Randomized but not vaccinated|1|||
145364333|NCT03423173|524185260|FG000|Overall Study|Adverse Event|1|||
145364334|NCT03423173|524185261|FG001|Overall Study|Adverse Event|1|||
145364335|NCT03423173|524185262|FG002|Overall Study|Adverse Event|1|||
145364336|NCT03423173|524185263|FG003|Overall Study|Adverse Event|1|||
145364337|NCT03423173|524185260|FG000|Overall Study|Lost to Follow-up|10|||
145364338|NCT03423173|524185261|FG001|Overall Study|Lost to Follow-up|19|||
145364339|NCT03423173|524185262|FG002|Overall Study|Lost to Follow-up|17|||
145364340|NCT03423173|524185263|FG003|Overall Study|Lost to Follow-up|22|||
145364341|NCT03423173|524185260|FG000|Overall Study|Withdrawal of consent|4|||
145364342|NCT03423173|524185261|FG001|Overall Study|Withdrawal of consent|10|||
145364343|NCT03423173|524185262|FG002|Overall Study|Withdrawal of consent|4|||
145364344|NCT03423173|524185263|FG003|Overall Study|Withdrawal of consent|5|||
145364345|NCT03423173|524185260|FG000|Overall Study|Death|1|||
145364346|NCT03423173|524185261|FG001|Overall Study|Death|0|||
145364347|NCT03423173|524185262|FG002|Overall Study|Death|0|||
145364348|NCT03423173|524185263|FG003|Overall Study|Death|0|||
145364349|NCT03423173|524185260|FG000|Overall Study|Reason not Specified|2|||
145364350|NCT03423173|524185261|FG001|Overall Study|Reason not Specified|5|||
145364351|NCT03423173|524185262|FG002|Overall Study|Reason not Specified|3|||
145364352|NCT03423173|524185263|FG003|Overall Study|Reason not Specified|1|||
145364353|NCT03348930|524185264|FG000|Washout (1 Week)|Lost to Follow-up|1|||
145364354|NCT03348930|524185265|FG001|Washout (1 Week)|Lost to Follow-up|1|||
145420003|NCT03016403|524392961|FG000|Baseline|Death|5|||
145420004|NCT03016403|524392962|FG001|Baseline|Death|8|||
145420005|NCT03016403|524392963|FG002|Baseline|Death|1|||
145420006|NCT03016403|524392964|FG003|Baseline|Death|0|||
145364355|NCT03533114|524185266|FG000|Overall|Adverse Event|16|||
145364356|NCT03533114|524185267|FG001|Overall|Adverse Event|11|||
145364357|NCT03533114|524185266|FG000|Overall|Consent Withdrawal by Participant|7|||
145364358|NCT03533114|524185267|FG001|Overall|Consent Withdrawal by Participant|6|||
145364359|NCT03533114|524185266|FG000|Overall|Lack of Efficacy|5|||
145364360|NCT03533114|524185267|FG001|Overall|Lack of Efficacy|3|||
145364361|NCT03533114|524185266|FG000|Overall|Lost to Follow-up|1|||
145420007|NCT03016403|524392961|FG000|Baseline|Withdrawal by Subject|2|||
145420008|NCT03016403|524392962|FG001|Baseline|Withdrawal by Subject|8|||
145364362|NCT03533114|524185267|FG001|Overall|Lost to Follow-up|1|||
145364363|NCT03533114|524185266|FG000|Overall|Physician Decision|0|||
145577662|NCT03286140|524969479|FG001|Overall Study|Withdrawal by Subject|5|||
145420009|NCT03016403|524392963|FG002|Baseline|Withdrawal by Subject|4|||
145420010|NCT03016403|524392964|FG003|Baseline|Withdrawal by Subject|10|||
145420011|NCT03016403|524392961|FG000|Baseline|Lost to Follow-up|9|||
145420012|NCT03016403|524392962|FG001|Baseline|Lost to Follow-up|11|||
145420013|NCT03016403|524392963|FG002|Baseline|Lost to Follow-up|6|||
145420014|NCT03016403|524392964|FG003|Baseline|Lost to Follow-up|24|||
145420015|NCT03016403|524392961|FG000|6-week Follow-up|Death|1|||
145420016|NCT03016403|524392962|FG001|6-week Follow-up|Death|4|||
145420017|NCT03016403|524392963|FG002|6-week Follow-up|Death|0|||
145420018|NCT03016403|524392964|FG003|6-week Follow-up|Death|0|||
145420019|NCT03016403|524392961|FG000|6-week Follow-up|Lost to Follow-up|2|||
145420020|NCT03016403|524392962|FG001|6-week Follow-up|Lost to Follow-up|7|||
145420021|NCT03016403|524392963|FG002|6-week Follow-up|Lost to Follow-up|4|||
145420022|NCT03016403|524392964|FG003|6-week Follow-up|Lost to Follow-up|8|||
145420023|NCT03016403|524392961|FG000|6-week Follow-up|Withdrawal by Subject|0|||
145420024|NCT03016403|524392962|FG001|6-week Follow-up|Withdrawal by Subject|2|||
145420025|NCT03016403|524392963|FG002|6-week Follow-up|Withdrawal by Subject|0|||
145420026|NCT03016403|524392964|FG003|6-week Follow-up|Withdrawal by Subject|1|||
145420027|NCT03016403|524392961|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
145420028|NCT03016403|524392962|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
145420029|NCT03016403|524392963|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
145420030|NCT03016403|524392964|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
145420031|NCT03016403|524392961|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
145420032|NCT03016403|524392962|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
145420033|NCT03016403|524392963|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
145420034|NCT03016403|524392964|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
145420035|NCT03016403|524392961|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145420036|NCT03016403|524392962|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145420037|NCT03016403|524392963|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
145420038|NCT03016403|524392964|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
145420039|NCT05463705|524392965|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
145420040|NCT05463705|524392966|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
145420041|NCT05463705|524392967|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
145420042|NCT05463705|524392968|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
145420043|NCT05463705|524392969|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
145420044|NCT05463705|524392970|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
145420045|NCT00576407|524392971|FG000|Overall Study|Death|7|||
145420046|NCT00576407|524392971|FG000|Overall Study|Physician Decision|1|||
145420047|NCT00621322|524392972|FG000|Overall Study|Lost to Follow-up|0|||
145420048|NCT00621322|524392973|FG001|Overall Study|Lost to Follow-up|0|||
145420049|NCT00621322|524392974|FG002|Overall Study|Lost to Follow-up|0|||
145420050|NCT00621322|524392975|FG003|Overall Study|Lost to Follow-up|0|||
145420051|NCT00621322|524392976|FG004|Overall Study|Lost to Follow-up|1|||
145420052|NCT00621322|524392977|FG005|Overall Study|Lost to Follow-up|0|||
145420053|NCT00621322|524392972|FG000|Overall Study|Physician Decision|0|||
145420054|NCT00621322|524392973|FG001|Overall Study|Physician Decision|0|||
145420055|NCT00621322|524392974|FG002|Overall Study|Physician Decision|1|||
145420056|NCT00621322|524392975|FG003|Overall Study|Physician Decision|1|||
145420057|NCT00621322|524392976|FG004|Overall Study|Physician Decision|0|||
145420058|NCT00621322|524392977|FG005|Overall Study|Physician Decision|0|||
145364364|NCT03533114|524185267|FG001|Overall|Physician Decision|2|||
145364365|NCT03533114|524185266|FG000|Overall|Protocol deviation|1|||
145364366|NCT03533114|524185267|FG001|Overall|Protocol deviation|1|||
145364367|NCT03533114|524185266|FG000|Overall|Failure to meet randomization criteria|1|||
145364368|NCT03533114|524185267|FG001|Overall|Failure to meet randomization criteria|2|||
145364369|NCT03533114|524185266|FG000|Overall|Non-Compliance with study drug|0|||
145364370|NCT03533114|524185267|FG001|Overall|Non-Compliance with study drug|1|||
145364371|NCT03533114|524185266|FG000|Overall|Other|0|||
145364372|NCT03533114|524185267|FG001|Overall|Other|1|||
145364373|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Adverse Event|11|||
145364374|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Adverse Event|8|||
145420059|NCT00621322|524392972|FG000|Overall Study|Withdrawal by Subject|0|||
145364375|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
145364376|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
145364377|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
145420060|NCT00621322|524392973|FG001|Overall Study|Withdrawal by Subject|0|||
145420061|NCT00621322|524392974|FG002|Overall Study|Withdrawal by Subject|0|||
145420062|NCT00621322|524392975|FG003|Overall Study|Withdrawal by Subject|1|||
145420063|NCT00621322|524392976|FG004|Overall Study|Withdrawal by Subject|0|||
145420064|NCT00621322|524392977|FG005|Overall Study|Withdrawal by Subject|2|||
145364378|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
145364379|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
145364380|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
145420065|NCT00621322|524392972|FG000|Overall Study|Migrated/moved from study area|1|||
145577663|NCT03286140|524969478|FG000|Overall Study|Lost to Follow-up|5|||
145420066|NCT00621322|524392973|FG001|Overall Study|Migrated/moved from study area|0|||
145420067|NCT00621322|524392974|FG002|Overall Study|Migrated/moved from study area|1|||
145420068|NCT00621322|524392975|FG003|Overall Study|Migrated/moved from study area|1|||
145420069|NCT00621322|524392976|FG004|Overall Study|Migrated/moved from study area|0|||
145420070|NCT00621322|524392977|FG005|Overall Study|Migrated/moved from study area|2|||
145420071|NCT02346370|524392978|FG000|Overall Study|Not treated|1|||
145420072|NCT02346370|524392979|FG001|Overall Study|Not treated|0|||
145420073|NCT02346370|524392980|FG002|Overall Study|Not treated|0|||
145420074|NCT02346370|524392978|FG000|Overall Study|Withdrawal of consent|1|||
145420075|NCT02346370|524392979|FG001|Overall Study|Withdrawal of consent|0|||
145420076|NCT02346370|524392980|FG002|Overall Study|Withdrawal of consent|0|||
145577664|NCT03286140|524969479|FG001|Overall Study|Lost to Follow-up|10|||
145577665|NCT03286140|524969478|FG000|Overall Study|Failure to comply|0|||
145577666|NCT03286140|524969479|FG001|Overall Study|Failure to comply|1|||
145577667|NCT01826825|524969480|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
145577668|NCT01826825|524969481|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
145577669|NCT03254134|524969482|FG000|Overall Study|Not eligible patients|599|||
145577670|NCT03254134|524969483|FG001|Overall Study|Not eligible patients|3630|||
145577671|NCT02563028|524969484|FG000|Overall Study|Lack of equipment|1|||
145577672|NCT02563028|524969484|FG000|Overall Study|Unable to elicit VEP post induction|1|||
145577673|NCT03181542|524969485|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
145577674|NCT03181542|524969486|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
145577675|NCT01856543|524969487|FG000|Overall Study|Treatment discontinued|6|||
145577676|NCT01856543|524969488|FG001|Overall Study|Treatment discontinued|3|||
145420077|NCT02346370|524392978|FG000|Overall Study|Death|1|||
145420078|NCT02346370|524392979|FG001|Overall Study|Death|3|||
145420079|NCT02346370|524392980|FG002|Overall Study|Death|1|||
145420080|NCT02346370|524392978|FG000|Overall Study|Sponsor discontinued study|5|||
145420081|NCT02346370|524392979|FG001|Overall Study|Sponsor discontinued study|0|||
145420082|NCT02346370|524392980|FG002|Overall Study|Sponsor discontinued study|2|||
145420083|NCT02346370|524392978|FG000|Overall Study|Radiologic progression|0|||
145420084|NCT02346370|524392979|FG001|Overall Study|Radiologic progression|0|||
145420085|NCT02346370|524392980|FG002|Overall Study|Radiologic progression|1|||
145420086|NCT02346370|524392978|FG000|Overall Study|Physician Decision|0|||
145420087|NCT02346370|524392979|FG001|Overall Study|Physician Decision|1|||
145420088|NCT02346370|524392980|FG002|Overall Study|Physician Decision|0|||
145420089|NCT01217047|524392981|FG000|Overall Study|Lost to Follow-up|0|||
145420090|NCT01217047|524392982|FG001|Overall Study|Lost to Follow-up|1|||
145420091|NCT01217047|524392983|FG002|Overall Study|Lost to Follow-up|0|||
145420092|NCT06399471|524392984|FG000|Overall Study|Withdrawal by Subject|1|||
145420093|NCT05529173|524392985|FG000|Overall Study|Physician Decision|3|||
145420094|NCT05529173|524392986|FG001|Overall Study|Physician Decision|6|||
145420095|NCT05529173|524392985|FG000|Overall Study|Sample shipment delay more than one day|4|||
145420096|NCT05529173|524392986|FG001|Overall Study|Sample shipment delay more than one day|0|||
145420097|NCT03835117|524392987|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
145420098|NCT03835117|524392988|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
145420099|NCT01362270|524392990|FG000|Overall Study|Withdrawal by Subject|1|||
145420100|NCT01362270|524392991|FG001|Overall Study|Withdrawal by Subject|0|||
145420101|NCT01362270|524392990|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
145420102|NCT01362270|524392991|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
145420103|NCT01362270|524392990|FG000|Overall Study|Met excl. criteria before 1st session|1|||
145420104|NCT01362270|524392991|FG001|Overall Study|Met excl. criteria before 1st session|1|||
145420105|NCT02318277|524392992|FG000|Overall Study|Physician Decision|0|||
145420106|NCT02318277|524392993|FG001|Overall Study|Physician Decision|0|||
145420107|NCT02318277|524392994|FG002|Overall Study|Physician Decision|0|||
145420108|NCT02318277|524392995|FG003|Overall Study|Physician Decision|0|||
145420109|NCT02318277|524392996|FG004|Overall Study|Physician Decision|0|||
145420110|NCT02318277|524392997|FG005|Overall Study|Physician Decision|0|||
145577677|NCT01856543|524969487|FG000|Overall Study|Withdrawn before start|7|||
145577678|NCT01856543|524969488|FG001|Overall Study|Withdrawn before start|3|||
145577679|NCT01848990|524969489|FG000|Overall Study|Adverse Event|6|||
145577680|NCT01848990|524969490|FG001|Overall Study|Adverse Event|2|||
145577681|NCT01848990|524969491|FG002|Overall Study|Adverse Event|0|||
145577682|NCT01848990|524969489|FG000|Overall Study|Lost to Follow-up|6|||
145577683|NCT01848990|524969490|FG001|Overall Study|Lost to Follow-up|2|||
145420111|NCT02318277|524392998|FG006|Overall Study|Physician Decision|0|||
145420112|NCT02318277|524392999|FG007|Overall Study|Physician Decision|1|||
145420113|NCT02318277|524392992|FG000|Overall Study|Other|0|||
145420114|NCT02318277|524392993|FG001|Overall Study|Other|0|||
145420115|NCT02318277|524392994|FG002|Overall Study|Other|0|||
145577684|NCT01848990|524969491|FG002|Overall Study|Lost to Follow-up|2|||
145420116|NCT02318277|524392995|FG003|Overall Study|Other|0|||
145420117|NCT02318277|524392996|FG004|Overall Study|Other|0|||
145420118|NCT02318277|524392997|FG005|Overall Study|Other|0|||
145420119|NCT02318277|524392998|FG006|Overall Study|Other|1|||
145420120|NCT02318277|524392999|FG007|Overall Study|Other|0|||
145420121|NCT02318277|524392992|FG000|Overall Study|Withdrawal by Subject|0|||
145420122|NCT02318277|524392993|FG001|Overall Study|Withdrawal by Subject|0|||
145420123|NCT02318277|524392994|FG002|Overall Study|Withdrawal by Subject|1|||
145420124|NCT02318277|524392995|FG003|Overall Study|Withdrawal by Subject|0|||
145420125|NCT02318277|524392996|FG004|Overall Study|Withdrawal by Subject|1|||
145420126|NCT02318277|524392997|FG005|Overall Study|Withdrawal by Subject|1|||
145420127|NCT02318277|524392998|FG006|Overall Study|Withdrawal by Subject|6|||
145420128|NCT02318277|524392999|FG007|Overall Study|Withdrawal by Subject|14|||
145420129|NCT02318277|524392992|FG000|Overall Study|Participant trial terminated by sponsor|0|||
145420130|NCT02318277|524392993|FG001|Overall Study|Participant trial terminated by sponsor|0|||
145420131|NCT02318277|524392994|FG002|Overall Study|Participant trial terminated by sponsor|1|||
145420132|NCT02318277|524392995|FG003|Overall Study|Participant trial terminated by sponsor|0|||
145420133|NCT02318277|524392996|FG004|Overall Study|Participant trial terminated by sponsor|1|||
145420134|NCT02318277|524392997|FG005|Overall Study|Participant trial terminated by sponsor|2|||
145420135|NCT02318277|524392998|FG006|Overall Study|Participant trial terminated by sponsor|5|||
145420136|NCT02318277|524392999|FG007|Overall Study|Participant trial terminated by sponsor|16|||
145420137|NCT02318277|524392992|FG000|Overall Study|Lost to Follow-up|1|||
145420138|NCT02318277|524392993|FG001|Overall Study|Lost to Follow-up|0|||
145420139|NCT02318277|524392994|FG002|Overall Study|Lost to Follow-up|1|||
145420140|NCT02318277|524392995|FG003|Overall Study|Lost to Follow-up|0|||
145420141|NCT02318277|524392996|FG004|Overall Study|Lost to Follow-up|0|||
145420142|NCT02318277|524392997|FG005|Overall Study|Lost to Follow-up|0|||
145420143|NCT02318277|524392998|FG006|Overall Study|Lost to Follow-up|3|||
145420144|NCT02318277|524392999|FG007|Overall Study|Lost to Follow-up|4|||
145420145|NCT02318277|524392992|FG000|Overall Study|Death|5|||
145420146|NCT02318277|524392993|FG001|Overall Study|Death|3|||
145420147|NCT02318277|524392994|FG002|Overall Study|Death|1|||
145420148|NCT02318277|524392995|FG003|Overall Study|Death|4|||
145420149|NCT02318277|524392996|FG004|Overall Study|Death|6|||
145420150|NCT02318277|524392997|FG005|Overall Study|Death|5|||
145420151|NCT02318277|524392998|FG006|Overall Study|Death|34|||
145420152|NCT02318277|524392999|FG007|Overall Study|Death|58|||
145420153|NCT02318277|524392992|FG000|Overall Study|Transitioned to Hospice|0|||
145420154|NCT02318277|524392993|FG001|Overall Study|Transitioned to Hospice|0|||
145420155|NCT02318277|524392994|FG002|Overall Study|Transitioned to Hospice|0|||
145420156|NCT02318277|524392995|FG003|Overall Study|Transitioned to Hospice|0|||
145420157|NCT02318277|524392996|FG004|Overall Study|Transitioned to Hospice|0|||
145420158|NCT02318277|524392997|FG005|Overall Study|Transitioned to Hospice|1|||
145420159|NCT02318277|524392998|FG006|Overall Study|Transitioned to Hospice|0|||
145420160|NCT02318277|524392999|FG007|Overall Study|Transitioned to Hospice|0|||
145420161|NCT03364686|524393000|FG000|Overall Study|Physician Decision|2|||
145420162|NCT01986751|524393007|FG000|Overall Study|improperly consented|10|||
145420163|NCT01986751|524393008|FG001|Overall Study|improperly consented|2|||
145420164|NCT03566550|524393009|FG000|Overall Study|Withdrawal by Subject|0|||
145420165|NCT03566550|524393010|FG001|Overall Study|Withdrawal by Subject|1|||
145420166|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
145420167|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
145420168|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
145420169|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
145420170|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
145364381|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
145364382|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
145364383|NCT03533114|524185266|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
145364384|NCT03533114|524185267|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
145364385|NCT03533114|524185266|FG000|Stable Dose|Adverse Event|0|||
145364386|NCT03533114|524185267|FG001|Stable Dose|Adverse Event|2|||
145364387|NCT03533114|524185266|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
145364388|NCT03533114|524185267|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
145364389|NCT03533114|524185266|FG000|Stable Dose|Lack of Efficacy|1|||
145364390|NCT03533114|524185267|FG001|Stable Dose|Lack of Efficacy|0|||
145420171|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
145420172|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145364391|NCT03533114|524185266|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
145420173|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145420174|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
145364392|NCT03533114|524185267|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
145420175|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
145420176|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
145420177|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
145420178|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145420179|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
145420180|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
145420181|NCT00407030|524393015|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
145364393|NCT03533114|524185266|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
145364394|NCT03533114|524185267|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
145364395|NCT03533114|524185266|FG000|Open-Label Safety Extension|Adverse Event|3|||
145364396|NCT03533114|524185267|FG001|Open-Label Safety Extension|Adverse Event|0|||
145364397|NCT03533114|524185266|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
145364398|NCT03533114|524185267|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
145364399|NCT03533114|524185266|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
145364400|NCT03533114|524185267|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
145364401|NCT03533114|524185266|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
145364402|NCT03533114|524185267|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
145364403|NCT03533114|524185266|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
145364404|NCT03533114|524185267|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
145364405|NCT02411396|524185270|FG000|Overall Study|Lost to Follow-up|31|||
145364406|NCT02411396|524185270|FG000|Overall Study|Death|10|||
145364407|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
145364408|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
145364409|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
145364410|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
145364411|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
145364412|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
145364413|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
145364414|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
145364415|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
145364416|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
145364417|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
145364418|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
145364419|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
145364420|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
145364421|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145364422|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145364423|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145364424|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
145364425|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
145364426|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
145364427|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
145364428|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
145364429|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
145364430|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
145364431|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
145364432|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
145364433|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
145364434|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
145364435|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
145364436|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
145364437|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
145364438|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
145364439|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145364440|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145364441|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145364442|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
145364443|NCT02016105|524185277|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
145364444|NCT02016105|524185278|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
145364445|NCT02016105|524185279|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145364446|NCT02016105|524185280|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145364447|NCT02016105|524185281|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145364448|NCT02016105|524185282|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
145364449|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
145364450|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
145364451|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
145364452|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
145364453|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
145364454|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
145364455|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
145364456|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
145364457|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
145364458|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
145364459|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
145420182|NCT00407030|524393016|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
145364460|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
145364461|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
145364462|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
145364463|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
145364464|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
145364465|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
145420183|NCT00407030|524393017|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
145420184|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
145420185|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
145420186|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
145420187|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
145420188|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
145420189|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
145420190|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
145420191|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
145420192|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
145420193|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
145420194|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
145420195|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
145420196|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
145420197|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
145420198|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
145420199|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
145420200|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
145420201|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
145420202|NCT00407030|524393015|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
145420203|NCT00407030|524393016|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
145420204|NCT00407030|524393017|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
145420205|NCT03722030|524393018|FG000|Overall Study|Withdrawal by Subject|1|||
145420206|NCT03722030|524393019|FG001|Overall Study|Withdrawal by Subject|0|||
145420207|NCT01489358|524393020|FG000|Overall Study|Lost to Follow-up|0|||
145420208|NCT01489358|524393021|FG001|Overall Study|Lost to Follow-up|0|||
145420209|NCT01489358|524393022|FG002|Overall Study|Lost to Follow-up|2|||
145420210|NCT00736476|524393023|FG000|Overall Study|Adverse Event|1|||
145420211|NCT00736476|524393024|FG001|Overall Study|Adverse Event|0|||
145420212|NCT03518203|524393025|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
145420213|NCT03518203|524393025|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
145420214|NCT00345592|524393026|FG000|Overall Study|Death|14|||
145420215|NCT00345592|524393027|FG001|Overall Study|Death|16|||
145420216|NCT00345592|524393026|FG000|Overall Study|Withdrawal by Subject|11|||
145420217|NCT00345592|524393027|FG001|Overall Study|Withdrawal by Subject|8|||
145420218|NCT01084135|524393029|FG000|20 Week|Physician Decision|0|||
145420219|NCT01084135|524393030|FG001|20 Week|Physician Decision|1|||
145420220|NCT03335566|524393031|FG000|Overall Study|Adverse Event|0|||
145420221|NCT03335566|524393032|FG001|Overall Study|Adverse Event|1|||
145420222|NCT03335566|524393031|FG000|Overall Study|Lost to Follow-up|1|||
145420223|NCT03335566|524393032|FG001|Overall Study|Lost to Follow-up|0|||
145420224|NCT03335566|524393031|FG000|Overall Study|Technical Problems|1|||
145420225|NCT03335566|524393032|FG001|Overall Study|Technical Problems|0|||
145420226|NCT03335566|524393031|FG000|Overall Study|Protocol Violation|1|||
145420227|NCT03335566|524393032|FG001|Overall Study|Protocol Violation|0|||
145420228|NCT03335566|524393031|FG000|Overall Study|Other than specified above|1|||
145420229|NCT03335566|524393032|FG001|Overall Study|Other than specified above|2|||
145420230|NCT01016015|524393033|FG000|Overall Study|Not Treated|3|||
145420231|NCT01016015|524393033|FG000|Overall Study|Withdrawal by Subject|1|||
145420232|NCT01016015|524393033|FG000|Overall Study|Adverse Event|15|||
145420233|NCT02218268|524393034|FG000|24 Hour Washout|Physician Decision|11|||
145420234|NCT02218268|524393035|FG001|24 Hour Washout|Physician Decision|9|||
145420235|NCT03651336|524393036|FG000|Overall Study|Withdrawal by Subject|4|||
145420236|NCT01341990|524393037|FG000|Overall Study|Adverse Event|0|||
145577685|NCT01848990|524969489|FG000|Overall Study|Protocol Violation|1|||
145577686|NCT01848990|524969490|FG001|Overall Study|Protocol Violation|1|||
145577687|NCT01848990|524969491|FG002|Overall Study|Protocol Violation|0|||
145577688|NCT01848990|524969489|FG000|Overall Study|Withdrawal by Subject|29|||
145577689|NCT01848990|524969490|FG001|Overall Study|Withdrawal by Subject|10|||
145577690|NCT01848990|524969491|FG002|Overall Study|Withdrawal by Subject|11|||
145577691|NCT01848990|524969489|FG000|Overall Study|Physician Decision|1|||
145577692|NCT01848990|524969490|FG001|Overall Study|Physician Decision|1|||
145420237|NCT01341990|524393038|FG001|Overall Study|Adverse Event|1|||
145577693|NCT01848990|524969491|FG002|Overall Study|Physician Decision|0|||
145577694|NCT01848990|524969489|FG000|Overall Study|Non Compliance|1|||
145420238|NCT01341990|524393037|FG000|Overall Study|Torn Study Lens|1|||
145420239|NCT01341990|524393038|FG001|Overall Study|Torn Study Lens|0|||
145420240|NCT01341990|524393037|FG000|Overall Study|Withdrawal by Subject|2|||
145420241|NCT01341990|524393038|FG001|Overall Study|Withdrawal by Subject|0|||
145420242|NCT03632720|524393040|FG000|Overall Study|Adverse Event|2|||
145420243|NCT03632720|524393041|FG001|Overall Study|Adverse Event|0|||
145420244|NCT03632720|524393042|FG002|Overall Study|Adverse Event|0|||
145577695|NCT01848990|524969490|FG001|Overall Study|Non Compliance|0|||
145577696|NCT01848990|524969491|FG002|Overall Study|Non Compliance|0|||
145420245|NCT03632720|524393040|FG000|Overall Study|Lost to Follow-up|0|||
145420246|NCT03632720|524393041|FG001|Overall Study|Lost to Follow-up|1|||
145420247|NCT03632720|524393042|FG002|Overall Study|Lost to Follow-up|0|||
145420248|NCT03632720|524393040|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
145420249|NCT03632720|524393041|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
145420250|NCT03632720|524393042|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
145420251|NCT03632720|524393040|FG000|Overall Study|Screen failure|0|||
145420252|NCT03632720|524393041|FG001|Overall Study|Screen failure|1|||
145420253|NCT03632720|524393042|FG002|Overall Study|Screen failure|0|||
145420254|NCT00682435|524393043|FG000|Overall Study|Insufficient data|5|||
145420255|NCT00682435|524393043|FG000|Overall Study|Erroneously enrolled twice|2|||
145420256|NCT01117350|524393044|FG000|Comparative Period|Not Treated|5|||
145420257|NCT01117350|524393045|FG001|Comparative Period|Not Treated|8|||
145420258|NCT01117350|524393044|FG000|Comparative Period|Adverse Event|6|||
145420259|NCT01117350|524393045|FG001|Comparative Period|Adverse Event|33|||
145420260|NCT01117350|524393044|FG000|Comparative Period|Lost to Follow-up|11|||
145420261|NCT01117350|524393045|FG001|Comparative Period|Lost to Follow-up|7|||
145420262|NCT01117350|524393044|FG000|Comparative Period|Withdrawal by Subject|9|||
145420263|NCT01117350|524393045|FG001|Comparative Period|Withdrawal by Subject|13|||
145420264|NCT01117350|524393044|FG000|Comparative Period|Protocol Violation|8|||
145420265|NCT01117350|524393045|FG001|Comparative Period|Protocol Violation|12|||
145420266|NCT01117350|524393044|FG000|Comparative Period|Lack of Efficacy|1|||
145420267|NCT01117350|524393045|FG001|Comparative Period|Lack of Efficacy|0|||
145420268|NCT01117350|524393044|FG000|Comparative Period|Physician Decision|0|||
145420269|NCT01117350|524393045|FG001|Comparative Period|Physician Decision|1|||
145420270|NCT01117350|524393044|FG000|Comparative Period|Move to another city/country|2|||
145420271|NCT01117350|524393045|FG001|Comparative Period|Move to another city/country|1|||
145420272|NCT01117350|524393044|FG000|Extension Period|Not included in extension, not treated|0|||
145420273|NCT01117350|524393045|FG001|Extension Period|Not included in extension, not treated|50|||
145420274|NCT01117350|524393044|FG000|Extension Period|Adverse Event|0|||
145420275|NCT01117350|524393045|FG001|Extension Period|Adverse Event|2|||
145420276|NCT01117350|524393044|FG000|Extension Period|Protocol Violation|0|||
145420277|NCT01117350|524393045|FG001|Extension Period|Protocol Violation|2|||
145420278|NCT01117350|524393044|FG000|Extension Period|Lost to Follow-up|0|||
145420279|NCT01117350|524393045|FG001|Extension Period|Lost to Follow-up|2|||
145420280|NCT01117350|524393044|FG000|Extension Period|Withdrawal by Subject|0|||
145420281|NCT01117350|524393045|FG001|Extension Period|Withdrawal by Subject|3|||
145420282|NCT01117350|524393044|FG000|Extension Period|Lack of Efficacy|0|||
145420283|NCT01117350|524393045|FG001|Extension Period|Lack of Efficacy|2|||
145420284|NCT01117350|524393044|FG000|Extension Period|Inclusion criteria not respected|0|||
145420285|NCT01117350|524393045|FG001|Extension Period|Inclusion criteria not respected|1|||
145420286|NCT01117350|524393044|FG000|Extension Period|Prohibited medication|0|||
145420287|NCT01117350|524393045|FG001|Extension Period|Prohibited medication|1|||
145420288|NCT00286455|524393050|FG000|Overall Study|Hyperglycemia rescue|19|||
145420289|NCT00286455|524393051|FG001|Overall Study|Hyperglycemia rescue|13|||
145420290|NCT00286455|524393052|FG002|Overall Study|Hyperglycemia rescue|10|||
145420291|NCT00286455|524393050|FG000|Overall Study|Adverse Event|1|||
145420292|NCT00286455|524393051|FG001|Overall Study|Adverse Event|3|||
145420293|NCT00286455|524393052|FG002|Overall Study|Adverse Event|2|||
145420294|NCT00286455|524393050|FG000|Overall Study|Lost to Follow-up|0|||
145420295|NCT00286455|524393051|FG001|Overall Study|Lost to Follow-up|3|||
145623182|NCT05968482|525131605|FG001|Second Crossover Period|Withdrawal by Subject|0|||
145623183|NCT05968482|525131606|FG002|Second Crossover Period|Withdrawal by Subject|0|||
145420296|NCT00286455|524393052|FG002|Overall Study|Lost to Follow-up|3|||
145420297|NCT00286455|524393050|FG000|Overall Study|Physician Decision|3|||
145420298|NCT00286455|524393051|FG001|Overall Study|Physician Decision|0|||
145420299|NCT00286455|524393052|FG002|Overall Study|Physician Decision|2|||
145420300|NCT00286455|524393050|FG000|Overall Study|Protocol Violation|1|||
145420301|NCT00286455|524393051|FG001|Overall Study|Protocol Violation|1|||
145420302|NCT00286455|524393052|FG002|Overall Study|Protocol Violation|0|||
145420303|NCT00286455|524393050|FG000|Overall Study|Participant Non-compliance|1|||
145420304|NCT00286455|524393051|FG001|Overall Study|Participant Non-compliance|0|||
145420305|NCT00286455|524393052|FG002|Overall Study|Participant Non-compliance|0|||
145623184|NCT05968482|525131607|FG003|Second Crossover Period|Withdrawal by Subject|0|||
145420306|NCT00286455|524393050|FG000|Overall Study|Withdrawal by Subject|0|||
145420307|NCT00286455|524393051|FG001|Overall Study|Withdrawal by Subject|8|||
145420308|NCT00286455|524393052|FG002|Overall Study|Withdrawal by Subject|7|||
145420309|NCT04495478|524393053|FG000|Overall Study|Withdrawal by Subject|0|||
145420310|NCT04495478|524393054|FG001|Overall Study|Withdrawal by Subject|0|||
145420311|NCT04495478|524393055|FG002|Overall Study|Withdrawal by Subject|0|||
145420312|NCT04495478|524393056|FG003|Overall Study|Withdrawal by Subject|1|||
145420313|NCT04495478|524393057|FG004|Overall Study|Withdrawal by Subject|0|||
145420314|NCT04495478|524393058|FG005|Overall Study|Withdrawal by Subject|0|||
145420315|NCT04495478|524393059|FG006|Overall Study|Withdrawal by Subject|0|||
145420316|NCT04495478|524393053|FG000|Overall Study|Physician Decision|0|||
145420317|NCT04495478|524393054|FG001|Overall Study|Physician Decision|1|||
145420318|NCT04495478|524393055|FG002|Overall Study|Physician Decision|0|||
145420319|NCT04495478|524393056|FG003|Overall Study|Physician Decision|0|||
145420320|NCT04495478|524393057|FG004|Overall Study|Physician Decision|1|||
145420321|NCT04495478|524393058|FG005|Overall Study|Physician Decision|0|||
145420322|NCT04495478|524393059|FG006|Overall Study|Physician Decision|0|||
145420323|NCT01213251|524394423|FG000|Overall Study|Death|2|||
145420324|NCT01213251|524394424|FG001|Overall Study|Death|1|||
145420325|NCT01213251|524394425|FG002|Overall Study|Death|2|||
145420326|NCT01213251|524394423|FG000|Overall Study|Exit|3|||
145420327|NCT01213251|524394424|FG001|Overall Study|Exit|2|||
145420328|NCT01213251|524394425|FG002|Overall Study|Exit|8|||
145420329|NCT01213251|524394423|FG000|Overall Study|Protocol Violation|1|||
145420330|NCT01213251|524394424|FG001|Overall Study|Protocol Violation|1|||
145420331|NCT01213251|524394425|FG002|Overall Study|Protocol Violation|0|||
145420332|NCT01213251|524394423|FG000|Overall Study|Missed 18-Month Follow-up|0|||
145420333|NCT01213251|524394424|FG001|Overall Study|Missed 18-Month Follow-up|0|||
145420334|NCT01213251|524394425|FG002|Overall Study|Missed 18-Month Follow-up|1|||
145420335|NCT01862029|524394430|FG000|Overall Study|Physician Decision|1|||
145420336|NCT02004275|524394437|FG000|Phase 1|Ineligible|0|||
145420337|NCT02004275|524394438|FG001|Phase 1|Ineligible|0|||
145420338|NCT02004275|524394439|FG002|Phase 1|Ineligible|0|||
145420339|NCT02004275|524394440|FG003|Phase 1|Ineligible|1|||
145420340|NCT02004275|524394441|FG004|Phase 1|Ineligible|1|||
145420341|NCT02004275|524394442|FG005|Phase 1|Ineligible|0|||
145420342|NCT02004275|524394437|FG000|Phase 1|Protocol Violation|0|||
145420343|NCT02004275|524394438|FG001|Phase 1|Protocol Violation|0|||
145420344|NCT02004275|524394439|FG002|Phase 1|Protocol Violation|0|||
145420345|NCT02004275|524394440|FG003|Phase 1|Protocol Violation|1|||
145420346|NCT02004275|524394441|FG004|Phase 1|Protocol Violation|0|||
145420347|NCT02004275|524394442|FG005|Phase 1|Protocol Violation|5|||
145420348|NCT02004275|524394437|FG000|Phase 2 Part 1|Ineligible|6|||
145420349|NCT02004275|524394438|FG001|Phase 2 Part 1|Ineligible|9|||
145420350|NCT02004275|524394439|FG002|Phase 2 Part 1|Ineligible|0|||
145420351|NCT02004275|524394440|FG003|Phase 2 Part 1|Ineligible|0|||
145420352|NCT02004275|524394441|FG004|Phase 2 Part 1|Ineligible|0|||
145420353|NCT02004275|524394442|FG005|Phase 2 Part 1|Ineligible|0|||
145420354|NCT02004275|524394437|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
145420355|NCT02004275|524394438|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
145420356|NCT02004275|524394439|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
145420357|NCT02004275|524394440|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
145420358|NCT02004275|524394441|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
145420359|NCT02004275|524394442|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
145420360|NCT01840163|524394443|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
145420361|NCT01840163|524394444|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
145420362|NCT01840163|524394443|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
145420363|NCT01840163|524394444|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
145420364|NCT01840163|524394443|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
145420365|NCT01840163|524394444|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
145420366|NCT00662038|524394445|FG000|Overall Study|Reason not specified|3|||
145420367|NCT00662038|524394445|FG000|Overall Study|Withdrawn consent|22|||
145420368|NCT00662038|524394445|FG000|Overall Study|Withdrawal by Subject|83|||
145420369|NCT00662038|524394445|FG000|Overall Study|Sponsor decision|1|||
145420370|NCT00662038|524394445|FG000|Overall Study|Physician Decision|19|||
145420371|NCT00662038|524394445|FG000|Overall Study|Lung transplantation|44|||
145420372|NCT00662038|524394445|FG000|Overall Study|Lost to Follow-up|1|||
145420373|NCT00662038|524394445|FG000|Overall Study|Death|95|||
145420374|NCT00662038|524394445|FG000|Overall Study|Adverse Event|358|||
145420375|NCT00662038|524394445|FG000|Overall Study|Continued treatment|5|||
145420376|NCT04914000|524394446|FG000|Overall Study|Lost to Follow-up|8|||
145420377|NCT04914000|524394446|FG000|Overall Study|Withdrawal by Subject|1|||
145420378|NCT01658735|524394453|FG000|Overall Study|Lack of Efficacy|1|||
145420379|NCT01658735|524394454|FG001|Overall Study|Lack of Efficacy|0|||
145420380|NCT01658735|524394455|FG002|Overall Study|Lack of Efficacy|1|||
145420381|NCT01658735|524394453|FG000|Overall Study|Lost to Follow-up|1|||
145420382|NCT01658735|524394454|FG001|Overall Study|Lost to Follow-up|1|||
145577697|NCT01848990|524969489|FG000|Overall Study|Death|1|||
145420383|NCT01658735|524394455|FG002|Overall Study|Lost to Follow-up|0|||
145420384|NCT01658735|524394453|FG000|Overall Study|Protocol Violation|0|||
145420385|NCT01658735|524394454|FG001|Overall Study|Protocol Violation|1|||
145420386|NCT01658735|524394455|FG002|Overall Study|Protocol Violation|0|||
145420387|NCT01658735|524394453|FG000|Overall Study|Withdrawal by Subject|3|||
145420388|NCT01658735|524394454|FG001|Overall Study|Withdrawal by Subject|5|||
145420389|NCT01658735|524394455|FG002|Overall Study|Withdrawal by Subject|3|||
145420390|NCT01379937|524394456|FG000|Overall Study|Protocol Violation|0|||
145420391|NCT01379937|524394457|FG001|Overall Study|Protocol Violation|0|||
145420392|NCT01379937|524394458|FG002|Overall Study|Protocol Violation|0|||
145420393|NCT01379937|524394459|FG003|Overall Study|Protocol Violation|1|||
145420394|NCT01379937|524394456|FG000|Overall Study|Consent withdrawal|0|||
145420395|NCT01379937|524394457|FG001|Overall Study|Consent withdrawal|1|||
145577698|NCT01848990|524969490|FG001|Overall Study|Death|0|||
145364466|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
145364467|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Death|0|||
145364468|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Death|0|||
145364469|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Death|0|||
145364470|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Death|0|||
145364471|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Death|0|||
145364472|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Death|1|||
145364473|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
145364474|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
145364475|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
145364476|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
145364477|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
145364478|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
145364479|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
145364480|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
145364481|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
145364482|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
145364483|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
145364484|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
145364485|NCT02016105|524185277|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145364486|NCT02016105|524185278|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145364487|NCT02016105|524185279|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
145364488|NCT02016105|524185280|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145364489|NCT02016105|524185281|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
145364490|NCT02016105|524185282|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
145364491|NCT02016105|524185277|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
145364492|NCT02016105|524185278|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
145364493|NCT02016105|524185279|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
145364494|NCT02016105|524185280|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
145364495|NCT02016105|524185281|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
145364496|NCT02016105|524185282|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
145364497|NCT02016105|524185277|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
145364498|NCT02016105|524185278|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
145364499|NCT02016105|524185279|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
145364500|NCT02016105|524185280|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
145364501|NCT02016105|524185281|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
145364502|NCT02016105|524185282|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
145364503|NCT02016105|524185277|FG000|EXTENSION PERIOD|Adverse Event|0|||
145364504|NCT02016105|524185278|FG001|EXTENSION PERIOD|Adverse Event|0|||
145364505|NCT02016105|524185279|FG002|EXTENSION PERIOD|Adverse Event|2|||
145364506|NCT02016105|524185280|FG003|EXTENSION PERIOD|Adverse Event|0|||
145364507|NCT02016105|524185281|FG004|EXTENSION PERIOD|Adverse Event|1|||
145364508|NCT02016105|524185282|FG005|EXTENSION PERIOD|Adverse Event|0|||
145364509|NCT02016105|524185277|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
145364510|NCT02016105|524185278|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
145364511|NCT02016105|524185279|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
145364512|NCT02016105|524185280|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
145364513|NCT02016105|524185281|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
145364514|NCT02016105|524185282|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
145364515|NCT02016105|524185277|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
145364516|NCT02016105|524185278|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
145364517|NCT02016105|524185279|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
145364518|NCT02016105|524185280|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
145364519|NCT02016105|524185281|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
145364520|NCT02016105|524185282|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
145364521|NCT02016105|524185277|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
145364522|NCT02016105|524185278|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
145364523|NCT02016105|524185279|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
145364524|NCT02016105|524185280|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
145364525|NCT02016105|524185281|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
145364526|NCT02016105|524185282|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
145364527|NCT02320058|524185283|FG000|Overall Study|Death|25|||
145364528|NCT02320058|524185284|FG001|Overall Study|Death|10|||
145364529|NCT02320058|524185283|FG000|Overall Study|Lost to Follow-up|4|||
145364530|NCT02320058|524185284|FG001|Overall Study|Lost to Follow-up|0|||
145364531|NCT02320058|524185283|FG000|Overall Study|Other reasons|4|||
145364532|NCT02320058|524185284|FG001|Overall Study|Other reasons|1|||
145364533|NCT02320058|524185283|FG000|Overall Study|Withdrawal by Subject|8|||
145364534|NCT02320058|524185284|FG001|Overall Study|Withdrawal by Subject|2|||
145364535|NCT02320058|524185283|FG000|Overall Study|Not reported|1|||
145623185|NCT05968482|525131608|FG004|Second Crossover Period|Withdrawal by Subject|1|||
145364536|NCT02320058|524185284|FG001|Overall Study|Not reported|0|||
145364537|NCT01430403|524185285|FG000|Overall Study|Lost to Follow-up|5|||
145364538|NCT01430403|524185286|FG001|Overall Study|Lost to Follow-up|5|||
145364539|NCT01430403|524185287|FG002|Overall Study|Lost to Follow-up|3|||
145364540|NCT01430403|524185285|FG000|Overall Study|Physician Decision|1|||
145364541|NCT01430403|524185286|FG001|Overall Study|Physician Decision|0|||
145420396|NCT01379937|524394458|FG002|Overall Study|Consent withdrawal|0|||
145420397|NCT01379937|524394459|FG003|Overall Study|Consent withdrawal|0|||
145420398|NCT01379937|524394456|FG000|Overall Study|Lost to Follow-up|1|||
145364542|NCT01430403|524185287|FG002|Overall Study|Physician Decision|0|||
145364543|NCT01430403|524185285|FG000|Overall Study|Protocol Violation|2|||
145364544|NCT01430403|524185286|FG001|Overall Study|Protocol Violation|3|||
145364545|NCT01430403|524185287|FG002|Overall Study|Protocol Violation|2|||
145364546|NCT01430403|524185285|FG000|Overall Study|Withdrawal by Subject|9|||
145364547|NCT01430403|524185286|FG001|Overall Study|Withdrawal by Subject|1|||
145364548|NCT01430403|524185287|FG002|Overall Study|Withdrawal by Subject|3|||
145364549|NCT01855243|524185290|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
145364550|NCT01855243|524185291|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
145364551|NCT01855243|524185292|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
145364552|NCT03124407|524185295|FG000|Overall Study|Lost to Follow-up|1|||
145364553|NCT03124407|524185296|FG001|Overall Study|Lost to Follow-up|0|||
145364554|NCT03124407|524185297|FG002|Overall Study|Lost to Follow-up|0|||
145364555|NCT03124407|524185298|FG003|Overall Study|Lost to Follow-up|0|||
145364556|NCT03124407|524185295|FG000|Overall Study|Adverse Event|0|||
145364557|NCT03124407|524185296|FG001|Overall Study|Adverse Event|0|||
145364558|NCT03124407|524185297|FG002|Overall Study|Adverse Event|1|||
145364559|NCT03124407|524185298|FG003|Overall Study|Adverse Event|0|||
145364560|NCT01860040|524185301|FG000|Overall Study|Withdrawal by Subject|1|||
145364561|NCT01860040|524185302|FG001|Overall Study|Withdrawal by Subject|0|||
145364562|NCT01931995|524185303|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
145364563|NCT01931995|524185304|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
145364564|NCT01931995|524185303|FG000|First Intervention (1 Day)|Physician Decision|1|||
145364565|NCT01931995|524185304|FG001|First Intervention (1 Day)|Physician Decision|1|||
145364566|NCT01931995|524185303|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
145364567|NCT01931995|524185304|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
145364568|NCT02477826|524185323|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
145364569|NCT02477826|524185324|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
145364570|NCT02477826|524185325|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
145364571|NCT02477826|524185326|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
145364572|NCT02477826|524185327|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
145364573|NCT02477826|524185328|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
145364574|NCT02477826|524185329|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
145364575|NCT02477826|524185330|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
145364576|NCT02477826|524185331|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
145364577|NCT02477826|524185332|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
145364578|NCT02477826|524185323|FG000|Pre-Treatment|Other reasons|4|||
145364579|NCT02477826|524185324|FG001|Pre-Treatment|Other reasons|1|||
145364580|NCT02477826|524185325|FG002|Pre-Treatment|Other reasons|4|||
145364581|NCT02477826|524185326|FG003|Pre-Treatment|Other reasons|1|||
145364582|NCT02477826|524185327|FG004|Pre-Treatment|Other reasons|4|||
145364583|NCT02477826|524185328|FG005|Pre-Treatment|Other reasons|2|||
145364584|NCT02477826|524185329|FG006|Pre-Treatment|Other reasons|0|||
145364585|NCT02477826|524185330|FG007|Pre-Treatment|Other reasons|0|||
145364586|NCT02477826|524185331|FG008|Pre-Treatment|Other reasons|0|||
145364587|NCT02477826|524185332|FG009|Pre-Treatment|Other reasons|0|||
145364588|NCT02477826|524185323|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
145364589|NCT02477826|524185324|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
145364590|NCT02477826|524185325|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
145364591|NCT02477826|524185326|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
145364592|NCT02477826|524185327|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
145364593|NCT02477826|524185328|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
145364594|NCT02477826|524185329|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
145364595|NCT02477826|524185330|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
145364596|NCT02477826|524185331|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
145364597|NCT02477826|524185332|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
145364598|NCT02477826|524185323|FG000|Pre-Treatment|Subject withdrew consent|0|||
145364599|NCT02477826|524185324|FG001|Pre-Treatment|Subject withdrew consent|0|||
145364600|NCT02477826|524185325|FG002|Pre-Treatment|Subject withdrew consent|3|||
145364601|NCT02477826|524185326|FG003|Pre-Treatment|Subject withdrew consent|0|||
145364602|NCT02477826|524185327|FG004|Pre-Treatment|Subject withdrew consent|0|||
145364603|NCT02477826|524185328|FG005|Pre-Treatment|Subject withdrew consent|1|||
145364604|NCT02477826|524185329|FG006|Pre-Treatment|Subject withdrew consent|0|||
145364605|NCT02477826|524185330|FG007|Pre-Treatment|Subject withdrew consent|1|||
145364606|NCT02477826|524185331|FG008|Pre-Treatment|Subject withdrew consent|0|||
145364607|NCT02477826|524185332|FG009|Pre-Treatment|Subject withdrew consent|3|||
145364608|NCT02477826|524185323|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
145420399|NCT01379937|524394457|FG001|Overall Study|Lost to Follow-up|2|||
145623186|NCT05968482|525131609|FG005|Second Crossover Period|Withdrawal by Subject|0|||
145420400|NCT01379937|524394458|FG002|Overall Study|Lost to Follow-up|2|||
145420401|NCT01379937|524394459|FG003|Overall Study|Lost to Follow-up|0|||
145420402|NCT04985682|524394460|FG000|Overall Study|Withdrawal by Subject|1|||
145420403|NCT00225758|524394465|FG000|Overall Study|Adverse Event|4|||
145420404|NCT00079781|524394466|FG000|Pre-implant Period|Withdrawal by Subject|2|||
145577699|NCT01848990|524969491|FG002|Overall Study|Death|1|||
145577700|NCT01848990|524969489|FG000|Overall Study|Other|1|||
145364609|NCT02477826|524185324|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
145364610|NCT02477826|524185325|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364611|NCT02477826|524185326|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364612|NCT02477826|524185327|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364613|NCT02477826|524185328|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364614|NCT02477826|524185329|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364615|NCT02477826|524185330|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364616|NCT02477826|524185331|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
145364617|NCT02477826|524185332|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
145364618|NCT02477826|524185323|FG000|Pre-Treatment|Death|0|||
145364619|NCT02477826|524185324|FG001|Pre-Treatment|Death|0|||
145364620|NCT02477826|524185325|FG002|Pre-Treatment|Death|0|||
145364621|NCT02477826|524185326|FG003|Pre-Treatment|Death|0|||
145364622|NCT02477826|524185327|FG004|Pre-Treatment|Death|0|||
145364623|NCT02477826|524185328|FG005|Pre-Treatment|Death|0|||
145364624|NCT02477826|524185329|FG006|Pre-Treatment|Death|1|||
145364625|NCT02477826|524185330|FG007|Pre-Treatment|Death|0|||
145364626|NCT02477826|524185331|FG008|Pre-Treatment|Death|0|||
145364627|NCT02477826|524185332|FG009|Pre-Treatment|Death|0|||
145364628|NCT02477826|524185323|FG000|Treatment Period|Not reported|8|||
145364629|NCT02477826|524185324|FG001|Treatment Period|Not reported|6|||
145364630|NCT02477826|524185325|FG002|Treatment Period|Not reported|4|||
145364631|NCT02477826|524185326|FG003|Treatment Period|Not reported|4|||
145364632|NCT02477826|524185327|FG004|Treatment Period|Not reported|2|||
145364633|NCT02477826|524185328|FG005|Treatment Period|Not reported|1|||
145364634|NCT02477826|524185329|FG006|Treatment Period|Not reported|14|||
145364635|NCT02477826|524185330|FG007|Treatment Period|Not reported|8|||
145364636|NCT02477826|524185331|FG008|Treatment Period|Not reported|5|||
145364637|NCT02477826|524185332|FG009|Treatment Period|Not reported|2|||
145364638|NCT02477826|524185323|FG000|Treatment Period|Other reasons|5|||
145364639|NCT02477826|524185324|FG001|Treatment Period|Other reasons|6|||
145364640|NCT02477826|524185325|FG002|Treatment Period|Other reasons|12|||
145364641|NCT02477826|524185326|FG003|Treatment Period|Other reasons|7|||
145364642|NCT02477826|524185327|FG004|Treatment Period|Other reasons|5|||
145364643|NCT02477826|524185328|FG005|Treatment Period|Other reasons|1|||
145364644|NCT02477826|524185329|FG006|Treatment Period|Other reasons|8|||
145364645|NCT02477826|524185330|FG007|Treatment Period|Other reasons|8|||
145364646|NCT02477826|524185331|FG008|Treatment Period|Other reasons|21|||
145364647|NCT02477826|524185332|FG009|Treatment Period|Other reasons|1|||
145364648|NCT02477826|524185323|FG000|Treatment Period|Administrative reason by sponsor|0|||
145364649|NCT02477826|524185324|FG001|Treatment Period|Administrative reason by sponsor|3|||
145364650|NCT02477826|524185325|FG002|Treatment Period|Administrative reason by sponsor|0|||
145364651|NCT02477826|524185326|FG003|Treatment Period|Administrative reason by sponsor|0|||
145364652|NCT02477826|524185327|FG004|Treatment Period|Administrative reason by sponsor|0|||
145364653|NCT02477826|524185328|FG005|Treatment Period|Administrative reason by sponsor|0|||
145364654|NCT02477826|524185329|FG006|Treatment Period|Administrative reason by sponsor|0|||
145364655|NCT02477826|524185330|FG007|Treatment Period|Administrative reason by sponsor|0|||
145364656|NCT02477826|524185331|FG008|Treatment Period|Administrative reason by sponsor|0|||
145364657|NCT02477826|524185332|FG009|Treatment Period|Administrative reason by sponsor|0|||
145364658|NCT02477826|524185323|FG000|Treatment Period|Participant meet no longer study criteria|1|||
145364659|NCT02477826|524185324|FG001|Treatment Period|Participant meet no longer study criteria|1|||
145364660|NCT02477826|524185325|FG002|Treatment Period|Participant meet no longer study criteria|0|||
145364661|NCT02477826|524185326|FG003|Treatment Period|Participant meet no longer study criteria|0|||
145364662|NCT02477826|524185327|FG004|Treatment Period|Participant meet no longer study criteria|1|||
145577701|NCT01848990|524969490|FG001|Overall Study|Other|4|||
145364663|NCT02477826|524185328|FG005|Treatment Period|Participant meet no longer study criteria|1|||
145364664|NCT02477826|524185329|FG006|Treatment Period|Participant meet no longer study criteria|0|||
145420405|NCT00079781|524394467|FG001|Pre-implant Period|Withdrawal by Subject|0|||
145364665|NCT02477826|524185330|FG007|Treatment Period|Participant meet no longer study criteria|1|||
145364666|NCT02477826|524185331|FG008|Treatment Period|Participant meet no longer study criteria|0|||
145364667|NCT02477826|524185332|FG009|Treatment Period|Participant meet no longer study criteria|0|||
145364668|NCT02477826|524185323|FG000|Treatment Period|Poor/Non Compliance|1|||
145364669|NCT02477826|524185324|FG001|Treatment Period|Poor/Non Compliance|0|||
145364670|NCT02477826|524185325|FG002|Treatment Period|Poor/Non Compliance|2|||
145364671|NCT02477826|524185326|FG003|Treatment Period|Poor/Non Compliance|0|||
145420406|NCT00079781|524394468|FG002|Pre-implant Period|Withdrawal by Subject|0|||
145577702|NCT01848990|524969491|FG002|Overall Study|Other|2|||
145577703|NCT01712984|524969492|FG000|Overall Study|Adverse Event|0|||
145577704|NCT01712984|524969493|FG001|Overall Study|Adverse Event|0|||
145577705|NCT01712984|524969494|FG002|Overall Study|Adverse Event|1|||
145577706|NCT01712984|524969492|FG000|Overall Study|Protocol Violation|2|||
145577707|NCT01712984|524969493|FG001|Overall Study|Protocol Violation|0|||
145577708|NCT01712984|524969494|FG002|Overall Study|Protocol Violation|1|||
145577709|NCT01712984|524969492|FG000|Overall Study|Lost to Follow-up|8|||
145577710|NCT01712984|524969493|FG001|Overall Study|Lost to Follow-up|10|||
145577711|NCT01712984|524969494|FG002|Overall Study|Lost to Follow-up|1|||
145577712|NCT01712984|524969492|FG000|Overall Study|Withdrawal by Subject|6|||
145577713|NCT01712984|524969493|FG001|Overall Study|Withdrawal by Subject|6|||
145577714|NCT01712984|524969494|FG002|Overall Study|Withdrawal by Subject|7|||
145577715|NCT00096044|524969497|FG000|Overall Study|Withdrawal by Subject|9|||
145364672|NCT02477826|524185327|FG004|Treatment Period|Poor/Non Compliance|0|||
145364673|NCT02477826|524185328|FG005|Treatment Period|Poor/Non Compliance|1|||
145364674|NCT02477826|524185329|FG006|Treatment Period|Poor/Non Compliance|1|||
145364675|NCT02477826|524185330|FG007|Treatment Period|Poor/Non Compliance|0|||
145364676|NCT02477826|524185331|FG008|Treatment Period|Poor/Non Compliance|0|||
145364677|NCT02477826|524185332|FG009|Treatment Period|Poor/Non Compliance|1|||
145364678|NCT02477826|524185323|FG000|Treatment Period|Maximum Clinical Benefit|3|||
145364679|NCT02477826|524185324|FG001|Treatment Period|Maximum Clinical Benefit|3|||
145364680|NCT02477826|524185325|FG002|Treatment Period|Maximum Clinical Benefit|1|||
145364681|NCT02477826|524185326|FG003|Treatment Period|Maximum Clinical Benefit|1|||
145364682|NCT02477826|524185327|FG004|Treatment Period|Maximum Clinical Benefit|3|||
145364683|NCT02477826|524185328|FG005|Treatment Period|Maximum Clinical Benefit|0|||
145364684|NCT02477826|524185329|FG006|Treatment Period|Maximum Clinical Benefit|3|||
145364685|NCT02477826|524185330|FG007|Treatment Period|Maximum Clinical Benefit|2|||
145364686|NCT02477826|524185331|FG008|Treatment Period|Maximum Clinical Benefit|2|||
145364687|NCT02477826|524185332|FG009|Treatment Period|Maximum Clinical Benefit|2|||
145364688|NCT02477826|524185323|FG000|Treatment Period|Lost to Follow-up|0|||
145364689|NCT02477826|524185324|FG001|Treatment Period|Lost to Follow-up|0|||
145364690|NCT02477826|524185325|FG002|Treatment Period|Lost to Follow-up|1|||
145364691|NCT02477826|524185326|FG003|Treatment Period|Lost to Follow-up|1|||
145364692|NCT02477826|524185327|FG004|Treatment Period|Lost to Follow-up|0|||
145364693|NCT02477826|524185328|FG005|Treatment Period|Lost to Follow-up|0|||
145364694|NCT02477826|524185329|FG006|Treatment Period|Lost to Follow-up|2|||
145364695|NCT02477826|524185330|FG007|Treatment Period|Lost to Follow-up|2|||
145364696|NCT02477826|524185331|FG008|Treatment Period|Lost to Follow-up|0|||
145364697|NCT02477826|524185332|FG009|Treatment Period|Lost to Follow-up|0|||
145364698|NCT02477826|524185323|FG000|Treatment Period|Participant withdrew Consent|5|||
145364699|NCT02477826|524185324|FG001|Treatment Period|Participant withdrew Consent|5|||
145364700|NCT02477826|524185325|FG002|Treatment Period|Participant withdrew Consent|3|||
145364701|NCT02477826|524185326|FG003|Treatment Period|Participant withdrew Consent|3|||
145364702|NCT02477826|524185327|FG004|Treatment Period|Participant withdrew Consent|1|||
145364703|NCT02477826|524185328|FG005|Treatment Period|Participant withdrew Consent|3|||
145364704|NCT02477826|524185329|FG006|Treatment Period|Participant withdrew Consent|3|||
145364705|NCT02477826|524185330|FG007|Treatment Period|Participant withdrew Consent|3|||
145364706|NCT02477826|524185331|FG008|Treatment Period|Participant withdrew Consent|2|||
145364707|NCT02477826|524185332|FG009|Treatment Period|Participant withdrew Consent|3|||
145364708|NCT02477826|524185323|FG000|Treatment Period|Participant request to discontinue treatment|5|||
145364709|NCT02477826|524185324|FG001|Treatment Period|Participant request to discontinue treatment|3|||
145364710|NCT02477826|524185325|FG002|Treatment Period|Participant request to discontinue treatment|15|||
145364711|NCT02477826|524185326|FG003|Treatment Period|Participant request to discontinue treatment|5|||
145364712|NCT02477826|524185327|FG004|Treatment Period|Participant request to discontinue treatment|3|||
145364713|NCT02477826|524185328|FG005|Treatment Period|Participant request to discontinue treatment|6|||
145364714|NCT02477826|524185329|FG006|Treatment Period|Participant request to discontinue treatment|13|||
145364715|NCT02477826|524185330|FG007|Treatment Period|Participant request to discontinue treatment|15|||
145364716|NCT02477826|524185331|FG008|Treatment Period|Participant request to discontinue treatment|4|||
145364717|NCT02477826|524185332|FG009|Treatment Period|Participant request to discontinue treatment|18|||
145420407|NCT00079781|524394466|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
145577716|NCT00096044|524969497|FG000|Overall Study|Adverse Event|21|||
145577717|NCT00096044|524969497|FG000|Overall Study|Disease Progression|4|||
145364718|NCT02477826|524185323|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
145364719|NCT02477826|524185324|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
145420408|NCT00079781|524394467|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
145577718|NCT02442830|524969498|FG000|Overall Study|Technical Failure|0|||
145577719|NCT02442830|524969499|FG001|Overall Study|Technical Failure|1|||
145577720|NCT04587193|524969500|FG000|Overall Study|Screen failure after consent|3|||
145577721|NCT04587193|524969501|FG001|Overall Study|Screen failure after consent|0|||
145577722|NCT04587193|524969500|FG000|Overall Study|Device broke during study|3|||
145364720|NCT02477826|524185325|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
145420409|NCT00079781|524394468|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
145577723|NCT04587193|524969501|FG001|Overall Study|Device broke during study|2|||
145420410|NCT00079781|524394466|FG000|Follow-up Period|Withdrawal by Subject|3|||
145420411|NCT00079781|524394467|FG001|Follow-up Period|Withdrawal by Subject|0|||
145420412|NCT00079781|524394468|FG002|Follow-up Period|Withdrawal by Subject|1|||
145420413|NCT00079781|524394466|FG000|Follow-up Period|Lost to Follow-up|1|||
145420414|NCT00079781|524394467|FG001|Follow-up Period|Lost to Follow-up|0|||
145420415|NCT00079781|524394468|FG002|Follow-up Period|Lost to Follow-up|0|||
145420416|NCT00079781|524394466|FG000|Follow-up Period|Death|0|||
145420417|NCT00079781|524394467|FG001|Follow-up Period|Death|0|||
145420418|NCT00079781|524394468|FG002|Follow-up Period|Death|1|||
145420419|NCT04641975|524394469|FG000|Overall Study|Protocol Violation|1|||
145420420|NCT04641975|524394470|FG001|Overall Study|Protocol Violation|2|||
145420421|NCT04641975|524394471|FG002|Overall Study|Protocol Violation|0|||
145420422|NCT04641975|524394472|FG003|Overall Study|Protocol Violation|0|||
145420423|NCT04641975|524394469|FG000|Overall Study|Adverse Event|0|||
145420424|NCT04641975|524394470|FG001|Overall Study|Adverse Event|0|||
145420425|NCT04641975|524394471|FG002|Overall Study|Adverse Event|1|||
145420426|NCT04641975|524394472|FG003|Overall Study|Adverse Event|1|||
145420427|NCT04641975|524394469|FG000|Overall Study|Withdrawal by Subject|1|||
145420428|NCT04641975|524394470|FG001|Overall Study|Withdrawal by Subject|0|||
145420429|NCT04641975|524394471|FG002|Overall Study|Withdrawal by Subject|0|||
145420430|NCT04641975|524394472|FG003|Overall Study|Withdrawal by Subject|0|||
145420431|NCT01259024|524394476|FG000|Overall Study|Physician Decision|1|||
145420432|NCT01657500|524394477|FG000|Overall Study|set impropperly matched|3|||
145420433|NCT01657500|524394478|FG001|Overall Study|set impropperly matched|3|||
145420434|NCT01657500|524394477|FG000|Overall Study|Lost to Follow-up|2|||
145420435|NCT01657500|524394478|FG001|Overall Study|Lost to Follow-up|2|||
145420436|NCT00756444|524394481|FG000|Overall Study|Adverse Event|1|||
145420437|NCT00756444|524394482|FG001|Overall Study|Adverse Event|1|||
145420438|NCT00756444|524394481|FG000|Overall Study|Withdrawal by Subject|6|||
145420439|NCT00756444|524394482|FG001|Overall Study|Withdrawal by Subject|8|||
145420440|NCT00756444|524394481|FG000|Overall Study|Lost to Follow-up|0|||
145577724|NCT03878134|524969504|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
145577725|NCT03851016|524969505|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145420441|NCT00756444|524394482|FG001|Overall Study|Lost to Follow-up|1|||
145420442|NCT00756444|524394481|FG000|Overall Study|Death|5|||
145420443|NCT00756444|524394482|FG001|Overall Study|Death|4|||
145420444|NCT00756444|524394481|FG000|Overall Study|Disease Progression|2|||
145420445|NCT00756444|524394482|FG001|Overall Study|Disease Progression|7|||
145420446|NCT00756444|524394481|FG000|Overall Study|Ineligibility Determined|1|||
145420447|NCT00756444|524394482|FG001|Overall Study|Ineligibility Determined|0|||
145420448|NCT00564070|524394483|FG000|Overall Study|Lost to Follow-up|9|||
145420449|NCT00564070|524394484|FG001|Overall Study|Lost to Follow-up|7|||
145420450|NCT00564070|524394483|FG000|Overall Study|Worsening depression, referred to care|3|||
145420451|NCT00564070|524394484|FG001|Overall Study|Worsening depression, referred to care|0|||
145420452|NCT02264821|524394486|FG000|Overall Study|Protocol Violation|1|||
145420453|NCT02264821|524394487|FG001|Overall Study|Protocol Violation|3|||
145420454|NCT02264821|524394488|FG002|Overall Study|Protocol Violation|6|||
145420455|NCT00552279|524394489|FG000|Overall Study|Adverse Event|0|||
145420456|NCT00552279|524394490|FG001|Overall Study|Adverse Event|1|||
145420457|NCT00552279|524394489|FG000|Overall Study|Withdrawal by Subject|12|||
145420458|NCT00552279|524394490|FG001|Overall Study|Withdrawal by Subject|1|||
145420459|NCT00552279|524394489|FG000|Overall Study|Lost to Follow-up|1|||
145420460|NCT00552279|524394490|FG001|Overall Study|Lost to Follow-up|0|||
145420461|NCT00552279|524394489|FG000|Overall Study|Other|1|||
145420462|NCT00552279|524394490|FG001|Overall Study|Other|1|||
145420463|NCT03142334|524394492|FG000|Overall Study|Death|18|||
145420464|NCT03142334|524394493|FG001|Overall Study|Death|33|||
145420465|NCT03142334|524394492|FG000|Overall Study|Withdrawal by Subject|15|||
145420466|NCT03142334|524394493|FG001|Overall Study|Withdrawal by Subject|11|||
145420467|NCT03142334|524394492|FG000|Overall Study|Ongoing on trial follow up|463|||
145577726|NCT03851016|524969506|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
145577727|NCT00853658|524969507|FG000|Overall Study|Death|713|||
145577728|NCT00853658|524969508|FG001|Overall Study|Death|768|||
145577729|NCT00853658|524969509|FG002|Overall Study|Death|753|||
145420468|NCT03142334|524394493|FG001|Overall Study|Ongoing on trial follow up|454|||
145420469|NCT01655069|524394494|FG000|Overall Study|Physician Decision|0|||
145420470|NCT01655069|524394495|FG001|Overall Study|Physician Decision|0|||
145420471|NCT01655069|524394496|FG002|Overall Study|Physician Decision|0|||
145420472|NCT01655069|524394497|FG003|Overall Study|Physician Decision|1|||
145420473|NCT01655069|524394494|FG000|Overall Study|Adverse Event|6|||
145420474|NCT01655069|524394495|FG001|Overall Study|Adverse Event|7|||
145420475|NCT01655069|524394496|FG002|Overall Study|Adverse Event|2|||
145420476|NCT01655069|524394497|FG003|Overall Study|Adverse Event|3|||
145420477|NCT01655069|524394494|FG000|Overall Study|Lack of Efficacy|0|||
145420478|NCT01655069|524394495|FG001|Overall Study|Lack of Efficacy|1|||
145420479|NCT01655069|524394496|FG002|Overall Study|Lack of Efficacy|0|||
145420480|NCT01655069|524394497|FG003|Overall Study|Lack of Efficacy|0|||
145420481|NCT01655069|524394494|FG000|Overall Study|No Treatment Needed|0|||
145420482|NCT01655069|524394495|FG001|Overall Study|No Treatment Needed|1|||
145420483|NCT01655069|524394496|FG002|Overall Study|No Treatment Needed|0|||
145420484|NCT01655069|524394497|FG003|Overall Study|No Treatment Needed|0|||
145420485|NCT01655069|524394494|FG000|Overall Study|Withdrawal by Subject|2|||
145420486|NCT01655069|524394495|FG001|Overall Study|Withdrawal by Subject|3|||
145420487|NCT01655069|524394496|FG002|Overall Study|Withdrawal by Subject|0|||
145420488|NCT01655069|524394497|FG003|Overall Study|Withdrawal by Subject|0|||
145420489|NCT06083493|524394498|FG000|Overall Study|Technical issues with the interventional device|2|||
145420490|NCT06083493|524394499|FG001|Overall Study|Technical issues with the interventional device|2|||
145420491|NCT06083493|524394498|FG000|Overall Study|Performed incorrect visual task|1|||
145420492|NCT06083493|524394499|FG001|Overall Study|Performed incorrect visual task|0|||
145420493|NCT06083493|524394498|FG000|Overall Study|Insufficient baseline performance|0|||
145420494|NCT06083493|524394499|FG001|Overall Study|Insufficient baseline performance|1|||
145420495|NCT04034056|524394500|FG000|Overall Study|Withdrawal by Subject|2|||
145420496|NCT04034056|524394500|FG000|Overall Study|Reason Not Specified|13|||
145420497|NCT04034056|524394500|FG000|Overall Study|Adverse Event|56|||
145420498|NCT03225989|524394501|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
145420499|NCT03225989|524394502|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
145420500|NCT03225989|524394503|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
145420501|NCT03225989|524394501|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
145420502|NCT03225989|524394502|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
145420503|NCT03225989|524394503|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
145420504|NCT03225989|524394501|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
145420505|NCT03225989|524394502|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
145420506|NCT03225989|524394503|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
145420507|NCT03225989|524394501|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
145420508|NCT03225989|524394502|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
145420509|NCT03225989|524394503|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
145420510|NCT03225989|524394501|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
145420511|NCT03225989|524394502|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
145420512|NCT03225989|524394503|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
145420513|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
145420514|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
145420515|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
145420516|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
145420517|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
145420518|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
145420519|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
145420520|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
145420521|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
145420522|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
145420523|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
145420524|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
145420525|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
145420526|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
145420527|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
145420528|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
145420529|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
145420530|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
145420531|NCT03225989|524394501|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
145420532|NCT03225989|524394502|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
145420533|NCT03225989|524394503|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
145420534|NCT03093870|524394504|FG000|Overall Study|Withdrawal by Subject|2|||
145420535|NCT03093870|524394505|FG001|Overall Study|Withdrawal by Subject|6|||
145420536|NCT03093870|524394506|FG002|Overall Study|Withdrawal by Subject|5|||
145420537|NCT03093870|524394504|FG000|Overall Study|Death|1|||
145420538|NCT03093870|524394505|FG001|Overall Study|Death|35|||
145420539|NCT03093870|524394506|FG002|Overall Study|Death|35|||
145420540|NCT03093870|524394504|FG000|Overall Study|Radiographic disease progression|10|||
145420541|NCT03093870|524394505|FG001|Overall Study|Radiographic disease progression|0|||
145420542|NCT03093870|524394506|FG002|Overall Study|Radiographic disease progression|0|||
145623187|NCT05968482|525131604|FG000|Third Crossover Period|Adverse Event|0|||
145623188|NCT05968482|525131605|FG001|Third Crossover Period|Adverse Event|0|||
145623189|NCT05968482|525131606|FG002|Third Crossover Period|Adverse Event|0|||
145420543|NCT03093870|524394504|FG000|Overall Study|Clinical disease progression|1|||
145420544|NCT03093870|524394505|FG001|Overall Study|Clinical disease progression|0|||
145420545|NCT03093870|524394506|FG002|Overall Study|Clinical disease progression|0|||
145420546|NCT03093870|524394504|FG000|Overall Study|Physician Decision|2|||
145623190|NCT05968482|525131607|FG003|Third Crossover Period|Adverse Event|0|||
145623191|NCT05968482|525131608|FG004|Third Crossover Period|Adverse Event|1|||
145420547|NCT03093870|524394505|FG001|Overall Study|Physician Decision|0|||
145420548|NCT03093870|524394506|FG002|Overall Study|Physician Decision|0|||
145420549|NCT03093870|524394504|FG000|Overall Study|Adverse Event|7|||
145420550|NCT03093870|524394505|FG001|Overall Study|Adverse Event|0|||
145420551|NCT03093870|524394506|FG002|Overall Study|Adverse Event|0|||
145420552|NCT03093870|524394504|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
145420553|NCT03093870|524394505|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
145420554|NCT03093870|524394506|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
145420555|NCT03093870|524394504|FG000|Overall Study|Lost to Follow-up|0|||
145420556|NCT03093870|524394505|FG001|Overall Study|Lost to Follow-up|0|||
145420557|NCT03093870|524394506|FG002|Overall Study|Lost to Follow-up|1|||
145420558|NCT00601107|524394507|FG000|Overall Study|Adverse Event|0|||
145420559|NCT00601107|524394508|FG001|Overall Study|Adverse Event|1|||
145420560|NCT00601107|524394509|FG002|Overall Study|Adverse Event|3|||
145420561|NCT00601107|524394510|FG003|Overall Study|Adverse Event|0|||
145420562|NCT00601107|524394507|FG000|Overall Study|Withdrawal by Subject|5|||
145420563|NCT00601107|524394508|FG001|Overall Study|Withdrawal by Subject|4|||
145420564|NCT00601107|524394509|FG002|Overall Study|Withdrawal by Subject|7|||
145420565|NCT00601107|524394510|FG003|Overall Study|Withdrawal by Subject|4|||
145420566|NCT00601107|524394507|FG000|Overall Study|Lost to Follow-up|3|||
145420567|NCT00601107|524394508|FG001|Overall Study|Lost to Follow-up|3|||
145420568|NCT00601107|524394509|FG002|Overall Study|Lost to Follow-up|0|||
145420569|NCT00601107|524394510|FG003|Overall Study|Lost to Follow-up|3|||
145420570|NCT00601107|524394507|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145420571|NCT00601107|524394508|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145420572|NCT00601107|524394509|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
145420573|NCT00601107|524394510|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
145420574|NCT00601107|524394507|FG000|Overall Study|Worsening of Psoriasis|4|||
145420575|NCT00601107|524394508|FG001|Overall Study|Worsening of Psoriasis|1|||
145420576|NCT00601107|524394509|FG002|Overall Study|Worsening of Psoriasis|1|||
145420577|NCT00601107|524394510|FG003|Overall Study|Worsening of Psoriasis|4|||
145420578|NCT00601107|524394507|FG000|Overall Study|Undefined|1|||
145420579|NCT00601107|524394508|FG001|Overall Study|Undefined|0|||
145420580|NCT00601107|524394509|FG002|Overall Study|Undefined|1|||
145420581|NCT00601107|524394510|FG003|Overall Study|Undefined|0|||
145420582|NCT01530997|524394511|FG000|Overall Study|Physician Decision|1|||
145420583|NCT01530997|524394511|FG000|Overall Study|Withdrawal by Subject|1|||
145420584|NCT00609973|524394512|FG000|Overall Study|Adverse Event|2|||
145420585|NCT00609973|524394513|FG001|Overall Study|Adverse Event|1|||
145420586|NCT00609973|524394512|FG000|Overall Study|Protocol Violation|4|||
145420587|NCT00609973|524394513|FG001|Overall Study|Protocol Violation|3|||
145420588|NCT00609973|524394512|FG000|Overall Study|Lost to Follow-up|2|||
145420589|NCT00609973|524394513|FG001|Overall Study|Lost to Follow-up|1|||
145420590|NCT00609973|524394512|FG000|Overall Study|Withdrawal by Subject|0|||
145420591|NCT00609973|524394513|FG001|Overall Study|Withdrawal by Subject|1|||
145420592|NCT02453191|524394515|FG000|Overall Study|Withdrawal by Subject|1|||
145420593|NCT01520714|524394516|FG000|Overall Study|Protocol Violation|0|||
145420594|NCT01520714|524394517|FG001|Overall Study|Protocol Violation|3|||
145420595|NCT01520714|524394516|FG000|Overall Study|Adverse Event|0|||
145420596|NCT01520714|524394517|FG001|Overall Study|Adverse Event|2|||
145420597|NCT01520714|524394516|FG000|Overall Study|Lack of Efficacy|0|||
145420598|NCT01520714|524394517|FG001|Overall Study|Lack of Efficacy|1|||
145420599|NCT01063881|524394519|FG000|Overall Study|Adverse Event|12|||
145420600|NCT01063881|524394520|FG001|Overall Study|Adverse Event|2|||
145420601|NCT01063881|524394521|FG002|Overall Study|Adverse Event|0|||
145420602|NCT01063881|524394519|FG000|Overall Study|Lost to Follow-up|13|||
145420603|NCT01063881|524394520|FG001|Overall Study|Lost to Follow-up|7|||
145420604|NCT01063881|524394521|FG002|Overall Study|Lost to Follow-up|1|||
145420605|NCT01063881|524394519|FG000|Overall Study|Withdrawal by Subject|25|||
145420606|NCT01063881|524394520|FG001|Overall Study|Withdrawal by Subject|1|||
145420607|NCT01063881|524394521|FG002|Overall Study|Withdrawal by Subject|0|||
145420608|NCT01063881|524394519|FG000|Overall Study|Reason for not completed not specified|5|||
145420609|NCT01063881|524394520|FG001|Overall Study|Reason for not completed not specified|1|||
145420610|NCT01063881|524394521|FG002|Overall Study|Reason for not completed not specified|0|||
145420611|NCT01309100|524394522|FG000|Overall Study|Protocol Violation|1|||
145420612|NCT01309100|524394522|FG000|Overall Study|Positive Slit lamp finding|1|||
145420613|NCT01340170|524394523|FG000|Overall Study|Lost to Follow-up|2|||
145420614|NCT01340170|524394524|FG001|Overall Study|Lost to Follow-up|4|||
145420615|NCT01340170|524394525|FG002|Overall Study|Lost to Follow-up|0|||
145420616|NCT01340170|524394523|FG000|Overall Study|Implant failure|1|||
145420617|NCT01340170|524394524|FG001|Overall Study|Implant failure|3|||
145420618|NCT01340170|524394525|FG002|Overall Study|Implant failure|0|||
145420619|NCT01927861|524394526|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
145420620|NCT01927861|524394527|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
145420621|NCT01927861|524394526|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
145623192|NCT05968482|525131609|FG005|Third Crossover Period|Adverse Event|0|||
145420622|NCT01927861|524394527|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
145420623|NCT01248468|524394528|FG000|Overall Study|Administrative problem|1|||
145420624|NCT01248468|524394529|FG001|Overall Study|Administrative problem|0|||
145420625|NCT01248468|524394530|FG002|Overall Study|Administrative problem|0|||
145420626|NCT01248468|524394528|FG000|Overall Study|Lost to Follow-up|9|||
145420627|NCT01248468|524394529|FG001|Overall Study|Lost to Follow-up|12|||
145420628|NCT01248468|524394530|FG002|Overall Study|Lost to Follow-up|4|||
145420629|NCT01248468|524394528|FG000|Overall Study|Pregnancy|1|||
145420630|NCT01248468|524394529|FG001|Overall Study|Pregnancy|0|||
145420631|NCT01248468|524394530|FG002|Overall Study|Pregnancy|0|||
145420632|NCT01248468|524394528|FG000|Overall Study|Withdrawal by Subject|4|||
145420633|NCT01248468|524394529|FG001|Overall Study|Withdrawal by Subject|2|||
145420634|NCT01248468|524394530|FG002|Overall Study|Withdrawal by Subject|0|||
145420635|NCT02006654|524394531|FG000|Overall Study|Withdrawal before treatment|4|||
145420636|NCT02006654|524394532|FG001|Overall Study|Withdrawal before treatment|2|||
145420637|NCT02006654|524394531|FG000|Overall Study|Adverse Event|16|||
145420638|NCT02006654|524394532|FG001|Overall Study|Adverse Event|17|||
145420639|NCT02006654|524394531|FG000|Overall Study|Death|1|||
145420640|NCT02006654|524394532|FG001|Overall Study|Death|0|||
145420641|NCT02006654|524394531|FG000|Overall Study|Withdrawal by Subject|14|||
145420642|NCT02006654|524394532|FG001|Overall Study|Withdrawal by Subject|12|||
145420643|NCT02006654|524394531|FG000|Overall Study|Protocol Violation|5|||
145420644|NCT02006654|524394532|FG001|Overall Study|Protocol Violation|8|||
145420645|NCT02006654|524394531|FG000|Overall Study|Lost to Follow-up|1|||
145420646|NCT02006654|524394532|FG001|Overall Study|Lost to Follow-up|0|||
145420647|NCT02006654|524394531|FG000|Overall Study|patient's will|2|||
145420648|NCT02006654|524394532|FG001|Overall Study|patient's will|1|||
145420649|NCT02006654|524394531|FG000|Overall Study|insufficient compliance|1|||
145420650|NCT02006654|524394532|FG001|Overall Study|insufficient compliance|0|||
145420651|NCT02006654|524394531|FG000|Overall Study|worsening cognitive condition|0|||
145420652|NCT02006654|524394532|FG001|Overall Study|worsening cognitive condition|1|||
145420653|NCT02006654|524394531|FG000|Overall Study|faecal incontinence|0|||
145420654|NCT02006654|524394532|FG001|Overall Study|faecal incontinence|1|||
145420655|NCT02006654|524394531|FG000|Overall Study|mood disorder|0|||
145420656|NCT02006654|524394532|FG001|Overall Study|mood disorder|1|||
145420657|NCT02006654|524394531|FG000|Overall Study|disallowed medication|1|||
145420658|NCT02006654|524394532|FG001|Overall Study|disallowed medication|0|||
145420659|NCT02006654|524394531|FG000|Overall Study|moving out of state|0|||
145420660|NCT02006654|524394532|FG001|Overall Study|moving out of state|1|||
145420661|NCT02366130|524394533|FG000|Overall Study|Withdrawal by Subject|3|||
145420662|NCT02366130|524394533|FG000|Overall Study|Ineligible|6|||
145420663|NCT01065766|524394534|FG000|Overall Study|Assessed before the contracted date|1|||
145420664|NCT01065766|524394534|FG000|Overall Study|Contraindication to administration|6|||
145420665|NCT01065766|524394534|FG000|Overall Study|Violated dosage/administration|25|||
145420666|NCT04223687|524394538|FG000|Overall Study|Missing primary outcome|1|||
145420667|NCT04223687|524394539|FG001|Overall Study|Missing primary outcome|0|||
145420668|NCT01608308|524394543|FG000|Overall Study|pretreatment medical and billing reasons|0|||
145420669|NCT01608308|524394544|FG001|Overall Study|pretreatment medical and billing reasons|2|||
145420670|NCT04128228|524394545|FG000|Overall Study|Withdrawal by Subject|3|||
145420671|NCT04128228|524394546|FG001|Overall Study|Withdrawal by Subject|3|||
145420672|NCT04128228|524394547|FG002|Overall Study|Withdrawal by Subject|0|||
145420673|NCT04128228|524394548|FG003|Overall Study|Withdrawal by Subject|0|||
145420674|NCT04128228|524394545|FG000|Overall Study|noncompliance|2|||
145420675|NCT04128228|524394546|FG001|Overall Study|noncompliance|2|||
145420676|NCT04128228|524394547|FG002|Overall Study|noncompliance|0|||
145420677|NCT04128228|524394548|FG003|Overall Study|noncompliance|0|||
145420678|NCT01945242|524394549|FG000|Overall Study|Physician Decision|3|||
145420679|NCT01945242|524394550|FG001|Overall Study|Physician Decision|3|||
145420680|NCT02057666|524394553|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
145420681|NCT02057666|524394554|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
145420682|NCT02057666|524394553|FG000|Double Blind Treatment Period|Poor tolerability|7|||
145420683|NCT02057666|524394554|FG001|Double Blind Treatment Period|Poor tolerability|2|||
145420684|NCT02057666|524394553|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
145420685|NCT02057666|524394554|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
145577730|NCT00853658|524969507|FG000|Overall Study|Lost to Follow-up|11|||
145420686|NCT02057666|524394553|FG000|Double Blind Treatment Period|Physician Decision|1|||
145420687|NCT02057666|524394554|FG001|Double Blind Treatment Period|Physician Decision|0|||
145420688|NCT02057666|524394553|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
145577731|NCT00853658|524969508|FG001|Overall Study|Lost to Follow-up|6|||
145420689|NCT02057666|524394554|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
145420690|NCT02057666|524394553|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
145420691|NCT02057666|524394554|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
145420692|NCT02057666|524394553|FG000|Double Blind Treatment Period|Sponsor's request|70|||
145420693|NCT02057666|524394554|FG001|Double Blind Treatment Period|Sponsor's request|34|||
145420694|NCT02057666|524394553|FG000|Open-Label Treatment Period|Poor tolerability|0|||
145577732|NCT00853658|524969509|FG002|Overall Study|Lost to Follow-up|11|||
145577733|NCT00853658|524969507|FG000|Overall Study|H.A. Request|26|||
145577734|NCT00853658|524969508|FG001|Overall Study|H.A. Request|23|||
145577735|NCT00853658|524969509|FG002|Overall Study|H.A. Request|19|||
145577736|NCT00853658|524969507|FG000|Overall Study|IRB request|0|||
145577737|NCT00853658|524969508|FG001|Overall Study|IRB request|0|||
145577738|NCT00853658|524969509|FG002|Overall Study|IRB request|2|||
145577739|NCT00853658|524969507|FG000|Overall Study|Vital Status known (alive) at study end|2|||
145577740|NCT00853658|524969508|FG001|Overall Study|Vital Status known (alive) at study end|3|||
145623193|NCT05968482|525131604|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
145623194|NCT05968482|525131605|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
145364721|NCT02477826|524185326|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
145364722|NCT02477826|524185327|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
145364723|NCT02477826|524185328|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
145364724|NCT02477826|524185329|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
145364725|NCT02477826|524185330|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
145364726|NCT02477826|524185331|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
145364727|NCT02477826|524185332|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
145364728|NCT02477826|524185323|FG000|Treatment Period|Death|4|||
145364729|NCT02477826|524185324|FG001|Treatment Period|Death|7|||
145364730|NCT02477826|524185325|FG002|Treatment Period|Death|0|||
145364731|NCT02477826|524185326|FG003|Treatment Period|Death|0|||
145364732|NCT02477826|524185327|FG004|Treatment Period|Death|1|||
145364733|NCT02477826|524185328|FG005|Treatment Period|Death|2|||
145364734|NCT02477826|524185329|FG006|Treatment Period|Death|6|||
145364735|NCT02477826|524185330|FG007|Treatment Period|Death|5|||
145364736|NCT02477826|524185331|FG008|Treatment Period|Death|9|||
145364737|NCT02477826|524185332|FG009|Treatment Period|Death|0|||
145364738|NCT02477826|524185323|FG000|Treatment Period|Study Drug Toxicity|79|||
145364739|NCT02477826|524185324|FG001|Treatment Period|Study Drug Toxicity|51|||
145364740|NCT02477826|524185325|FG002|Treatment Period|Study Drug Toxicity|31|||
145364741|NCT02477826|524185326|FG003|Treatment Period|Study Drug Toxicity|39|||
145364742|NCT02477826|524185327|FG004|Treatment Period|Study Drug Toxicity|12|||
145364743|NCT02477826|524185328|FG005|Treatment Period|Study Drug Toxicity|25|||
145364744|NCT02477826|524185329|FG006|Treatment Period|Study Drug Toxicity|52|||
145364745|NCT02477826|524185330|FG007|Treatment Period|Study Drug Toxicity|30|||
145364746|NCT02477826|524185331|FG008|Treatment Period|Study Drug Toxicity|20|||
145364747|NCT02477826|524185332|FG009|Treatment Period|Study Drug Toxicity|9|||
145364748|NCT02477826|524185323|FG000|Treatment Period|Disease progression|212|||
145364749|NCT02477826|524185324|FG001|Treatment Period|Disease progression|240|||
145364750|NCT02477826|524185325|FG002|Treatment Period|Disease progression|202|||
145364751|NCT02477826|524185326|FG003|Treatment Period|Disease progression|93|||
145364752|NCT02477826|524185327|FG004|Treatment Period|Disease progression|113|||
145364753|NCT02477826|524185328|FG005|Treatment Period|Disease progression|96|||
145364754|NCT02477826|524185329|FG006|Treatment Period|Disease progression|208|||
145364755|NCT02477826|524185330|FG007|Treatment Period|Disease progression|195|||
145364756|NCT02477826|524185331|FG008|Treatment Period|Disease progression|59|||
145364757|NCT02477826|524185332|FG009|Treatment Period|Disease progression|46|||
145364758|NCT02477826|524185323|FG000|Treatment Period|Pregnancy|0|||
145364759|NCT02477826|524185324|FG001|Treatment Period|Pregnancy|0|||
145364760|NCT02477826|524185325|FG002|Treatment Period|Pregnancy|0|||
145364761|NCT02477826|524185326|FG003|Treatment Period|Pregnancy|0|||
145364762|NCT02477826|524185327|FG004|Treatment Period|Pregnancy|0|||
145364763|NCT02477826|524185328|FG005|Treatment Period|Pregnancy|0|||
145364764|NCT02477826|524185329|FG006|Treatment Period|Pregnancy|0|||
145364765|NCT02477826|524185330|FG007|Treatment Period|Pregnancy|0|||
145364766|NCT02477826|524185331|FG008|Treatment Period|Pregnancy|0|||
145364767|NCT02477826|524185332|FG009|Treatment Period|Pregnancy|1|||
145364768|NCT02477826|524185323|FG000|Treatment Period|Other|0|||
145364769|NCT02477826|524185324|FG001|Treatment Period|Other|0|||
145364770|NCT02477826|524185325|FG002|Treatment Period|Other|0|||
145364771|NCT02477826|524185326|FG003|Treatment Period|Other|0|||
145364772|NCT02477826|524185327|FG004|Treatment Period|Other|0|||
145364773|NCT02477826|524185328|FG005|Treatment Period|Other|0|||
145364774|NCT02477826|524185329|FG006|Treatment Period|Other|0|||
145364775|NCT02477826|524185330|FG007|Treatment Period|Other|0|||
145364776|NCT02477826|524185331|FG008|Treatment Period|Other|0|||
145364777|NCT02477826|524185332|FG009|Treatment Period|Other|1|||
145364778|NCT00828568|524185333|FG000|Randomized|Withdrawal by Subject|1|||
145364779|NCT00828568|524185334|FG001|Randomized|Withdrawal by Subject|0|||
145364780|NCT00828568|524185335|FG002|Randomized|Withdrawal by Subject|2|||
145364781|NCT00828568|524185333|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
145577741|NCT00853658|524969509|FG002|Overall Study|Vital Status known (alive) at study end|3|||
145577742|NCT00853658|524969507|FG000|Overall Study|Vital Status unknown at study end|1|||
145364782|NCT00828568|524185334|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
145364783|NCT00828568|524185335|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
145364784|NCT00828568|524185333|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
145577743|NCT00853658|524969508|FG001|Overall Study|Vital Status unknown at study end|1|||
145577744|NCT00853658|524969509|FG002|Overall Study|Vital Status unknown at study end|0|||
145577745|NCT00853658|524969507|FG000|Overall Study|Vital Status at study end N/A|8|||
145577746|NCT00853658|524969508|FG001|Overall Study|Vital Status at study end N/A|10|||
145577747|NCT00853658|524969509|FG002|Overall Study|Vital Status at study end N/A|10|||
145577748|NCT00853658|524969507|FG000|Overall Study|Patient's request|21|||
145420695|NCT02057666|524394554|FG001|Open-Label Treatment Period|Poor tolerability|1|||
145420696|NCT02057666|524394553|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
145420697|NCT02057666|524394554|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
145420698|NCT02057666|524394553|FG000|Open-Label Treatment Period|Sponsor's request|0|||
145420699|NCT02057666|524394554|FG001|Open-Label Treatment Period|Sponsor's request|4|||
145420700|NCT05661734|524394555|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
145420701|NCT05661734|524394555|FG000|Overall Study|Lost to Follow-up|13|||
145420702|NCT05661734|524394555|FG000|Overall Study|Enrolled but not dosed|2|||
145420703|NCT00362609|524394556|FG000|Overall Study|Withdrawal by Subject|0|||
145420704|NCT00362609|524394557|FG001|Overall Study|Withdrawal by Subject|1|||
145420705|NCT00362609|524394556|FG000|Overall Study|Protocol Violation|0|||
145420706|NCT00362609|524394557|FG001|Overall Study|Protocol Violation|1|||
145420707|NCT01800058|524394558|FG000|Overall Study|Lost to Follow-up|1|||
145420708|NCT00450749|524394559|FG000|Overall Study|Withdrawal by Subject|0|||
145420709|NCT00450749|524394560|FG001|Overall Study|Withdrawal by Subject|0|||
145420710|NCT00450749|524394561|FG002|Overall Study|Withdrawal by Subject|2|||
145420711|NCT00450749|524394559|FG000|Overall Study|Noncompliant|0|||
145420712|NCT00450749|524394560|FG001|Overall Study|Noncompliant|1|||
145420713|NCT00450749|524394561|FG002|Overall Study|Noncompliant|0|||
145577749|NCT00853658|524969508|FG001|Overall Study|Patient's request|17|||
145577750|NCT00853658|524969509|FG002|Overall Study|Patient's request|11|||
145577751|NCT00853658|524969507|FG000|Overall Study|Missing study completion information|5|||
145577752|NCT00853658|524969508|FG001|Overall Study|Missing study completion information|4|||
145577753|NCT00853658|524969509|FG002|Overall Study|Missing study completion information|6|||
145364785|NCT00828568|524185334|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
145364786|NCT00828568|524185335|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
145364787|NCT00828568|524185333|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
145364788|NCT00828568|524185334|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
145364789|NCT00828568|524185335|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
145364790|NCT00828568|524185333|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
145364791|NCT00828568|524185334|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
145364792|NCT00828568|524185335|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
145364793|NCT00403481|524185337|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
145364794|NCT00403481|524185337|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
145364795|NCT00403481|524185337|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
145364796|NCT00403481|524185337|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
145364797|NCT00403481|524185337|FG000|Olm 40 mg|Adverse Event|2|||
145364798|NCT00403481|524185337|FG000|Olm 40 mg|Protocol Violation|1|||
145364799|NCT00403481|524185337|FG000|Olm 40 mg|Withdrawal by Subject|1|||
145364800|NCT00403481|524185337|FG000|Olm 40 mg|Other|1|||
145364801|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
145364802|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
145364803|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
145364804|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
145364805|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
145364806|NCT00403481|524185337|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
145364807|NCT02821754|524185338|FG000|Overall Study|Procedure not required prior to amendment change|13|||
145364808|NCT02821754|524185339|FG001|Overall Study|Procedure not required prior to amendment change|11|||
145364809|NCT02821754|524185340|FG002|Overall Study|Procedure not required prior to amendment change|0|||
145364810|NCT02821754|524185338|FG000|Overall Study|Participant's Clinical status|2|||
145364811|NCT02821754|524185339|FG001|Overall Study|Participant's Clinical status|0|||
145364812|NCT02821754|524185340|FG002|Overall Study|Participant's Clinical status|0|||
145364813|NCT02821754|524185338|FG000|Overall Study|Participant removed for noncompliance|1|||
145364814|NCT02821754|524185339|FG001|Overall Study|Participant removed for noncompliance|0|||
145364815|NCT02821754|524185340|FG002|Overall Study|Participant removed for noncompliance|0|||
145364816|NCT02821754|524185338|FG000|Overall Study|Drug not available.|0|||
145364817|NCT02821754|524185339|FG001|Overall Study|Drug not available.|0|||
145364818|NCT02821754|524185340|FG002|Overall Study|Drug not available.|1|||
145420714|NCT03178942|524394562|FG000|Overall Study|Withdrawal by Subject|2|||
145577754|NCT00586469|524969511|FG000|Overall Study|Adverse Event|0|||
145577755|NCT00586469|524969512|FG001|Overall Study|Adverse Event|1|||
145364819|NCT02821754|524185338|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
145420715|NCT03178942|524394563|FG001|Overall Study|Withdrawal by Subject|0|||
145420716|NCT03178942|524394562|FG000|Overall Study|Lost to Follow-up|1|||
145420717|NCT03178942|524394563|FG001|Overall Study|Lost to Follow-up|2|||
145577756|NCT01227512|524969515|FG000|Overall Study|Physician Decision|6|||
145577757|NCT01227512|524969516|FG001|Overall Study|Physician Decision|6|||
145577758|NCT01227512|524969515|FG000|Overall Study|Adverse Event|4|||
145577759|NCT01227512|524969516|FG001|Overall Study|Adverse Event|3|||
145577760|NCT01227512|524969515|FG000|Overall Study|Withdrawal by Subject|3|||
145577761|NCT01227512|524969516|FG001|Overall Study|Withdrawal by Subject|0|||
145577762|NCT01227512|524969515|FG000|Overall Study|Participant met withdrawal criteria|0|||
145577763|NCT01227512|524969516|FG001|Overall Study|Participant met withdrawal criteria|1|||
145577764|NCT00298038|524969517|FG000|Overall Study|Lost to Follow-up|0|||
145577765|NCT00298038|524969518|FG001|Overall Study|Lost to Follow-up|1|||
145577766|NCT00298038|524969517|FG000|Overall Study|Liver Transplant|0|||
145577767|NCT00298038|524969518|FG001|Overall Study|Liver Transplant|1|||
145577768|NCT00298038|524969517|FG000|Overall Study|Protocol Violation|1|||
145577769|NCT00298038|524969518|FG001|Overall Study|Protocol Violation|3|||
145577770|NCT00298038|524969517|FG000|Overall Study|Death|6|||
145577771|NCT00298038|524969518|FG001|Overall Study|Death|3|||
145577772|NCT00298038|524969517|FG000|Overall Study|Withdrawal by Subject|6|||
145577773|NCT00298038|524969518|FG001|Overall Study|Withdrawal by Subject|9|||
145577774|NCT00298038|524969517|FG000|Overall Study|Adverse Event|8|||
145577775|NCT00298038|524969518|FG001|Overall Study|Adverse Event|7|||
145577776|NCT00298038|524969517|FG000|Overall Study|Breakthrough overt HE episode|28|||
145577777|NCT00298038|524969518|FG001|Overall Study|Breakthrough overt HE episode|69|||
145577778|NCT00298038|524969517|FG000|Overall Study|Noncompliance|1|||
145577779|NCT00298038|524969518|FG001|Overall Study|Noncompliance|0|||
145577780|NCT00298038|524969517|FG000|Overall Study|Cocaine Abuse|1|||
145577781|NCT00298038|524969518|FG001|Overall Study|Cocaine Abuse|0|||
145577782|NCT00298038|524969517|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
145577783|NCT00298038|524969518|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
145577784|NCT02696096|524969519|FG000|Overall Study|ruled out at screening|1|||
145577785|NCT02696096|524969519|FG000|Overall Study|did not attend second fMRI|1|||
145577786|NCT02707640|524969520|FG000|Overall Study|Adverse Event|4|||
145577787|NCT02707640|524969521|FG001|Overall Study|Adverse Event|2|||
145577788|NCT02707640|524969520|FG000|Overall Study|Death|1|||
145577789|NCT02707640|524969521|FG001|Overall Study|Death|2|||
145577790|NCT02707640|524969520|FG000|Overall Study|Physician Decision|2|||
145577791|NCT02707640|524969521|FG001|Overall Study|Physician Decision|0|||
145577792|NCT02707640|524969520|FG000|Overall Study|Withdrawal by Subject|0|||
145577793|NCT02707640|524969521|FG001|Overall Study|Withdrawal by Subject|1|||
145577794|NCT02707640|524969520|FG000|Overall Study|Participant's Personal Decision|1|||
145577795|NCT02707640|524969521|FG001|Overall Study|Participant's Personal Decision|2|||
145577796|NCT02707640|524969520|FG000|Overall Study|Sponsor Discretion|1|||
145577797|NCT02707640|524969521|FG001|Overall Study|Sponsor Discretion|0|||
145577798|NCT02556710|524971297|FG000|Overall Study|Surgical treatment|3|||
145577799|NCT02556710|524971298|FG001|Overall Study|Surgical treatment|0|||
145577800|NCT02556710|524971297|FG000|Overall Study|Required proscribed pain medication|2|||
145577801|NCT02556710|524971298|FG001|Overall Study|Required proscribed pain medication|1|||
145577802|NCT02556710|524971297|FG000|Overall Study|Lack of Efficacy|1|||
145577803|NCT02556710|524971298|FG001|Overall Study|Lack of Efficacy|0|||
145577804|NCT02556710|524971297|FG000|Overall Study|Worsening osteoarthritis|1|||
145577805|NCT02556710|524971298|FG001|Overall Study|Worsening osteoarthritis|0|||
145577806|NCT02556710|524971297|FG000|Overall Study|Moved out of state|1|||
145577807|NCT02556710|524971298|FG001|Overall Study|Moved out of state|0|||
145577808|NCT02556710|524971297|FG000|Overall Study|Missing reason|3|||
145577809|NCT02556710|524971298|FG001|Overall Study|Missing reason|1|||
145577810|NCT02556710|524971297|FG000|Overall Study|Pain as lack of efficacy|0|||
145577811|NCT02556710|524971298|FG001|Overall Study|Pain as lack of efficacy|4|||
145364820|NCT02821754|524185339|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
145364821|NCT02821754|524185340|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
145364822|NCT02477332|524185348|FG000|Overall Study|Adverse Event|0|||
145364823|NCT02477332|524185349|FG001|Overall Study|Adverse Event|1|||
145364824|NCT02477332|524185350|FG002|Overall Study|Adverse Event|1|||
145364825|NCT02477332|524185351|FG003|Overall Study|Adverse Event|2|||
145364826|NCT02477332|524185352|FG004|Overall Study|Adverse Event|1|||
145364827|NCT02477332|524185353|FG005|Overall Study|Adverse Event|2|||
145364828|NCT02477332|524185348|FG000|Overall Study|Lack of Efficacy|1|||
145364829|NCT02477332|524185349|FG001|Overall Study|Lack of Efficacy|2|||
145364830|NCT02477332|524185350|FG002|Overall Study|Lack of Efficacy|1|||
145577812|NCT02564471|524971299|FG000|Overall Study|Adverse Event|1|||
145577813|NCT02564471|524971300|FG001|Overall Study|Adverse Event|0|||
145577814|NCT02564471|524971301|FG002|Overall Study|Adverse Event|0|||
145577815|NCT02564471|524971302|FG003|Overall Study|Adverse Event|0|||
145623195|NCT05968482|525131606|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
145364831|NCT02477332|524185351|FG003|Overall Study|Lack of Efficacy|2|||
145364832|NCT02477332|524185352|FG004|Overall Study|Lack of Efficacy|1|||
145577816|NCT02564471|524971299|FG000|Overall Study|Withdrawal by Subject|2|||
145577817|NCT02564471|524971300|FG001|Overall Study|Withdrawal by Subject|1|||
145577818|NCT02564471|524971301|FG002|Overall Study|Withdrawal by Subject|3|||
145420718|NCT03071965|524396019|FG000|Overall Study|Adverse Event|0|||
145420719|NCT03071965|524396020|FG001|Overall Study|Adverse Event|0|||
145420720|NCT03071965|524396021|FG002|Overall Study|Adverse Event|1|||
145420721|NCT03071965|524396022|FG003|Overall Study|Adverse Event|0|||
145420722|NCT03071965|524396019|FG000|Overall Study|Death|0|||
145420723|NCT03071965|524396020|FG001|Overall Study|Death|0|||
145420724|NCT03071965|524396021|FG002|Overall Study|Death|1|||
145420725|NCT03071965|524396022|FG003|Overall Study|Death|1|||
145420726|NCT03071965|524396019|FG000|Overall Study|COVID-19|0|||
145420727|NCT03071965|524396020|FG001|Overall Study|COVID-19|1|||
145420728|NCT03071965|524396021|FG002|Overall Study|COVID-19|0|||
145420729|NCT03071965|524396022|FG003|Overall Study|COVID-19|1|||
145420730|NCT03071965|524396019|FG000|Overall Study|Other Health Reason|0|||
145420731|NCT03071965|524396020|FG001|Overall Study|Other Health Reason|0|||
145420732|NCT03071965|524396021|FG002|Overall Study|Other Health Reason|0|||
145420733|NCT03071965|524396022|FG003|Overall Study|Other Health Reason|1|||
145420734|NCT00986102|524396023|FG000|Overall Study|Lost to Follow-up|0|||
145420735|NCT00986102|524396024|FG001|Overall Study|Lost to Follow-up|1|||
145420736|NCT00986102|524396025|FG002|Overall Study|Lost to Follow-up|0|||
145420737|NCT00986102|524396026|FG003|Overall Study|Lost to Follow-up|1|||
145420738|NCT00986102|524396023|FG000|Overall Study|Withdrawal by Subject|1|||
145420739|NCT00986102|524396024|FG001|Overall Study|Withdrawal by Subject|1|||
145420740|NCT00986102|524396025|FG002|Overall Study|Withdrawal by Subject|0|||
145420741|NCT00986102|524396026|FG003|Overall Study|Withdrawal by Subject|0|||
145420742|NCT01691482|524396029|FG000|Treatment Period 2|Adverse Event|0|||
145420743|NCT01691482|524396030|FG001|Treatment Period 2|Adverse Event|1|||
145420744|NCT01691482|524396029|FG000|Treatment Period 2|Protocol Violation|1|||
145420745|NCT01691482|524396030|FG001|Treatment Period 2|Protocol Violation|1|||
145420746|NCT01392495|524396031|FG000|Overall Study|Death|3|||
145420747|NCT01392495|524396031|FG000|Overall Study|Administrative problems|8|||
145420748|NCT01392495|524396031|FG000|Overall Study|Withdrawal by Subject|2|||
145420749|NCT01392495|524396031|FG000|Overall Study|Adverse Event|3|||
145420750|NCT01452789|524396038|FG000|Overall Study|Withdrawal by Subject|3|||
145420751|NCT01452789|524396039|FG001|Overall Study|Withdrawal by Subject|2|||
145420752|NCT01796470|524396042|FG000|Overall Study|Adverse Event|4|||
145420753|NCT01796470|524396043|FG001|Overall Study|Adverse Event|2|||
145420754|NCT01796470|524396044|FG002|Overall Study|Adverse Event|2|||
145420755|NCT01796470|524396045|FG003|Overall Study|Adverse Event|1|||
145420756|NCT01796470|524396046|FG004|Overall Study|Adverse Event|3|||
145420757|NCT01796470|524396042|FG000|Overall Study|Death|2|||
145420758|NCT01796470|524396043|FG001|Overall Study|Death|0|||
145420759|NCT01796470|524396044|FG002|Overall Study|Death|0|||
145420760|NCT01796470|524396045|FG003|Overall Study|Death|0|||
145420761|NCT01796470|524396046|FG004|Overall Study|Death|1|||
145420762|NCT01796470|524396042|FG000|Overall Study|Initiated New Therapy|9|||
145420763|NCT01796470|524396043|FG001|Overall Study|Initiated New Therapy|0|||
145420764|NCT01796470|524396044|FG002|Overall Study|Initiated New Therapy|0|||
145420765|NCT01796470|524396045|FG003|Overall Study|Initiated New Therapy|0|||
145420766|NCT01796470|524396046|FG004|Overall Study|Initiated New Therapy|2|||
145420767|NCT01796470|524396042|FG000|Overall Study|Lost to Follow-up|0|||
145420768|NCT01796470|524396043|FG001|Overall Study|Lost to Follow-up|1|||
145420769|NCT01796470|524396044|FG002|Overall Study|Lost to Follow-up|0|||
145420770|NCT01796470|524396045|FG003|Overall Study|Lost to Follow-up|0|||
145420771|NCT01796470|524396046|FG004|Overall Study|Lost to Follow-up|0|||
145577819|NCT02564471|524971302|FG003|Overall Study|Withdrawal by Subject|0|||
145577820|NCT02564471|524971299|FG000|Overall Study|Lost to Follow-up|0|||
145577821|NCT02564471|524971300|FG001|Overall Study|Lost to Follow-up|2|||
145577822|NCT02564471|524971301|FG002|Overall Study|Lost to Follow-up|0|||
145577823|NCT02564471|524971302|FG003|Overall Study|Lost to Follow-up|0|||
145420772|NCT01796470|524396042|FG000|Overall Study|Physician Decision|5|||
145420773|NCT01796470|524396043|FG001|Overall Study|Physician Decision|4|||
145420774|NCT01796470|524396044|FG002|Overall Study|Physician Decision|1|||
145420775|NCT01796470|524396045|FG003|Overall Study|Physician Decision|0|||
145420776|NCT01796470|524396046|FG004|Overall Study|Physician Decision|1|||
145420777|NCT01796470|524396042|FG000|Overall Study|Progressive Disease|7|||
145420778|NCT01796470|524396043|FG001|Overall Study|Progressive Disease|7|||
145420779|NCT01796470|524396044|FG002|Overall Study|Progressive Disease|3|||
145577824|NCT00941733|524971303|FG000|Overall Study|Death|24|||
145577825|NCT00941733|524971304|FG001|Overall Study|Death|10|||
145577826|NCT00941733|524971303|FG000|Overall Study|Withdrawal by Subject|14|||
145420780|NCT01796470|524396045|FG003|Overall Study|Progressive Disease|2|||
145577827|NCT00941733|524971304|FG001|Overall Study|Withdrawal by Subject|6|||
145420781|NCT01796470|524396046|FG004|Overall Study|Progressive Disease|0|||
145420782|NCT01796470|524396042|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
145420783|NCT01796470|524396043|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
145420784|NCT01796470|524396044|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
145420785|NCT01796470|524396045|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
145420786|NCT01796470|524396046|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
145420787|NCT01796470|524396042|FG000|Overall Study|Withdrawal by Subject|7|||
145420788|NCT01796470|524396043|FG001|Overall Study|Withdrawal by Subject|0|||
145364833|NCT02477332|524185353|FG005|Overall Study|Lack of Efficacy|1|||
145364834|NCT02477332|524185348|FG000|Overall Study|Non-compliance with study treatment|0|||
145364835|NCT02477332|524185349|FG001|Overall Study|Non-compliance with study treatment|1|||
145364836|NCT02477332|524185350|FG002|Overall Study|Non-compliance with study treatment|2|||
145364837|NCT02477332|524185351|FG003|Overall Study|Non-compliance with study treatment|0|||
145364838|NCT02477332|524185352|FG004|Overall Study|Non-compliance with study treatment|0|||
145364839|NCT02477332|524185353|FG005|Overall Study|Non-compliance with study treatment|0|||
145364840|NCT02477332|524185348|FG000|Overall Study|Pregnancy|0|||
145364841|NCT02477332|524185349|FG001|Overall Study|Pregnancy|0|||
145364842|NCT02477332|524185350|FG002|Overall Study|Pregnancy|0|||
145364843|NCT02477332|524185351|FG003|Overall Study|Pregnancy|1|||
145364844|NCT02477332|524185352|FG004|Overall Study|Pregnancy|0|||
145364845|NCT02477332|524185353|FG005|Overall Study|Pregnancy|0|||
145364846|NCT02477332|524185348|FG000|Overall Study|Protocol Violation|2|||
145364847|NCT02477332|524185349|FG001|Overall Study|Protocol Violation|0|||
145364848|NCT02477332|524185350|FG002|Overall Study|Protocol Violation|3|||
145364849|NCT02477332|524185351|FG003|Overall Study|Protocol Violation|3|||
145364850|NCT02477332|524185352|FG004|Overall Study|Protocol Violation|1|||
145364851|NCT02477332|524185353|FG005|Overall Study|Protocol Violation|1|||
145364852|NCT02477332|524185348|FG000|Overall Study|Technical problems|0|||
145364853|NCT02477332|524185349|FG001|Overall Study|Technical problems|0|||
145364854|NCT02477332|524185350|FG002|Overall Study|Technical problems|1|||
145364855|NCT02477332|524185351|FG003|Overall Study|Technical problems|0|||
145364856|NCT02477332|524185352|FG004|Overall Study|Technical problems|0|||
145364857|NCT02477332|524185353|FG005|Overall Study|Technical problems|0|||
145364858|NCT02477332|524185348|FG000|Overall Study|Lost to Follow-up|0|||
145364859|NCT02477332|524185349|FG001|Overall Study|Lost to Follow-up|0|||
145364860|NCT02477332|524185350|FG002|Overall Study|Lost to Follow-up|2|||
145364861|NCT02477332|524185351|FG003|Overall Study|Lost to Follow-up|0|||
145364862|NCT02477332|524185352|FG004|Overall Study|Lost to Follow-up|0|||
145364863|NCT02477332|524185353|FG005|Overall Study|Lost to Follow-up|0|||
145364864|NCT02477332|524185348|FG000|Overall Study|Physician Decision|0|||
145364865|NCT02477332|524185349|FG001|Overall Study|Physician Decision|0|||
145364866|NCT02477332|524185350|FG002|Overall Study|Physician Decision|1|||
145364867|NCT02477332|524185351|FG003|Overall Study|Physician Decision|3|||
145364868|NCT02477332|524185352|FG004|Overall Study|Physician Decision|0|||
145364869|NCT02477332|524185353|FG005|Overall Study|Physician Decision|1|||
145364870|NCT02477332|524185348|FG000|Overall Study|Withdrawal by Subject|0|||
145364871|NCT02477332|524185349|FG001|Overall Study|Withdrawal by Subject|3|||
145364872|NCT02477332|524185350|FG002|Overall Study|Withdrawal by Subject|1|||
145364873|NCT02477332|524185351|FG003|Overall Study|Withdrawal by Subject|2|||
145364874|NCT02477332|524185352|FG004|Overall Study|Withdrawal by Subject|1|||
145364875|NCT02477332|524185353|FG005|Overall Study|Withdrawal by Subject|0|||
145364876|NCT04087720|524185354|FG000|Overall Study|Withdrawal by Subject|2|||
145364877|NCT04087720|524185354|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
145364878|NCT00900159|524185359|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
145364879|NCT00900159|524185360|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
145364880|NCT01166438|524185361|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
145364881|NCT01166438|524185362|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
145364882|NCT01166438|524185361|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
145364883|NCT01166438|524185362|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
145364884|NCT01166438|524185361|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
145364885|NCT01166438|524185362|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
145364886|NCT01166438|524185361|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
145364887|NCT01166438|524185362|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
145364888|NCT01166438|524185361|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
145364889|NCT01166438|524185362|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
145364890|NCT01166438|524185361|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
145364891|NCT01166438|524185362|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
145364892|NCT01075256|524185363|FG000|Overall Study|Withdrawal by Subject|1|||
145364893|NCT01075256|524185364|FG001|Overall Study|Withdrawal by Subject|0|||
145364894|NCT01075256|524185365|FG002|Overall Study|Withdrawal by Subject|0|||
145364895|NCT02644668|524185375|FG000|Overall Study|Adverse Event|2|||
145364896|NCT02644668|524185376|FG001|Overall Study|Adverse Event|0|||
145364897|NCT02644668|524185377|FG002|Overall Study|Adverse Event|1|||
145364898|NCT02644668|524185375|FG000|Overall Study|Protocol Violation|0|||
145364899|NCT02644668|524185376|FG001|Overall Study|Protocol Violation|0|||
145364900|NCT02644668|524185377|FG002|Overall Study|Protocol Violation|1|||
145364901|NCT02644668|524185375|FG000|Overall Study|Withdrawal by Subject|0|||
145364902|NCT02644668|524185376|FG001|Overall Study|Withdrawal by Subject|0|||
145364903|NCT02644668|524185377|FG002|Overall Study|Withdrawal by Subject|1|||
145420789|NCT01796470|524396044|FG002|Overall Study|Withdrawal by Subject|0|||
145364904|NCT01134939|524185378|FG000|Overall Study|Adverse Event|9|||
145364905|NCT01134939|524185379|FG001|Overall Study|Adverse Event|3|||
145364906|NCT01134939|524185380|FG002|Overall Study|Adverse Event|4|||
145364907|NCT01134939|524185381|FG003|Overall Study|Adverse Event|5|||
145420790|NCT01796470|524396045|FG003|Overall Study|Withdrawal by Subject|0|||
145420791|NCT01796470|524396046|FG004|Overall Study|Withdrawal by Subject|1|||
145420792|NCT00147537|524396047|FG000|Phase 1b|Death|0|||
145420793|NCT00147537|524396048|FG001|Phase 1b|Death|1|||
145420794|NCT00147537|524396049|FG002|Phase 1b|Death|2|||
145420795|NCT00147537|524396050|FG003|Phase 1b|Death|1|||
145420796|NCT00147537|524396051|FG004|Phase 1b|Death|2|||
145420797|NCT00147537|524396052|FG005|Phase 1b|Death|2|||
145420798|NCT00147537|524396053|FG006|Phase 1b|Death|1|||
145420799|NCT00147537|524396054|FG007|Phase 1b|Death|3|||
145420800|NCT00147537|524396055|FG008|Phase 1b|Death|9|||
145420801|NCT00147537|524396056|FG009|Phase 1b|Death|0|||
145420802|NCT00147537|524396057|FG010|Phase 1b|Death|0|||
145420803|NCT00147537|524396047|FG000|Phase 1b|Lost to Follow-up|2|||
145420804|NCT00147537|524396048|FG001|Phase 1b|Lost to Follow-up|1|||
145420805|NCT00147537|524396049|FG002|Phase 1b|Lost to Follow-up|0|||
145420806|NCT00147537|524396050|FG003|Phase 1b|Lost to Follow-up|0|||
145420807|NCT00147537|524396051|FG004|Phase 1b|Lost to Follow-up|0|||
145420808|NCT00147537|524396052|FG005|Phase 1b|Lost to Follow-up|0|||
145420809|NCT00147537|524396053|FG006|Phase 1b|Lost to Follow-up|2|||
145420810|NCT00147537|524396054|FG007|Phase 1b|Lost to Follow-up|0|||
145420811|NCT00147537|524396055|FG008|Phase 1b|Lost to Follow-up|1|||
145420812|NCT00147537|524396056|FG009|Phase 1b|Lost to Follow-up|0|||
145420813|NCT00147537|524396057|FG010|Phase 1b|Lost to Follow-up|0|||
145420814|NCT00147537|524396047|FG000|Phase 1b|Other|0|||
145364908|NCT01134939|524185382|FG004|Overall Study|Adverse Event|5|||
145364909|NCT01134939|524185383|FG005|Overall Study|Adverse Event|5|||
145364910|NCT01134939|524185384|FG006|Overall Study|Adverse Event|1|||
145364911|NCT01134939|524185385|FG007|Overall Study|Adverse Event|0|||
145364912|NCT01134939|524185378|FG000|Overall Study|Lack of Efficacy|2|||
145364913|NCT01134939|524185379|FG001|Overall Study|Lack of Efficacy|5|||
145364914|NCT01134939|524185380|FG002|Overall Study|Lack of Efficacy|1|||
145364915|NCT01134939|524185381|FG003|Overall Study|Lack of Efficacy|0|||
145364916|NCT01134939|524185382|FG004|Overall Study|Lack of Efficacy|3|||
145364917|NCT01134939|524185383|FG005|Overall Study|Lack of Efficacy|0|||
145364918|NCT01134939|524185384|FG006|Overall Study|Lack of Efficacy|1|||
145364919|NCT01134939|524185385|FG007|Overall Study|Lack of Efficacy|0|||
145364920|NCT01134939|524185378|FG000|Overall Study|Lost to Follow-up|2|||
145364921|NCT01134939|524185379|FG001|Overall Study|Lost to Follow-up|3|||
145364922|NCT01134939|524185380|FG002|Overall Study|Lost to Follow-up|0|||
145364923|NCT01134939|524185381|FG003|Overall Study|Lost to Follow-up|1|||
145364924|NCT01134939|524185382|FG004|Overall Study|Lost to Follow-up|2|||
145364925|NCT01134939|524185383|FG005|Overall Study|Lost to Follow-up|1|||
145364926|NCT01134939|524185384|FG006|Overall Study|Lost to Follow-up|0|||
145364927|NCT01134939|524185385|FG007|Overall Study|Lost to Follow-up|0|||
145364928|NCT01134939|524185378|FG000|Overall Study|Death|0|||
145364929|NCT01134939|524185379|FG001|Overall Study|Death|1|||
145364930|NCT01134939|524185380|FG002|Overall Study|Death|0|||
145364931|NCT01134939|524185381|FG003|Overall Study|Death|0|||
145364932|NCT01134939|524185382|FG004|Overall Study|Death|0|||
145364933|NCT01134939|524185383|FG005|Overall Study|Death|0|||
145364934|NCT01134939|524185384|FG006|Overall Study|Death|0|||
145364935|NCT01134939|524185385|FG007|Overall Study|Death|0|||
145364936|NCT01134939|524185378|FG000|Overall Study|Termination page not available|4|||
145364937|NCT01134939|524185379|FG001|Overall Study|Termination page not available|6|||
145364938|NCT01134939|524185380|FG002|Overall Study|Termination page not available|5|||
145364939|NCT01134939|524185381|FG003|Overall Study|Termination page not available|8|||
145364940|NCT01134939|524185382|FG004|Overall Study|Termination page not available|0|||
145364941|NCT01134939|524185383|FG005|Overall Study|Termination page not available|3|||
145364942|NCT01134939|524185384|FG006|Overall Study|Termination page not available|7|||
145364943|NCT01134939|524185385|FG007|Overall Study|Termination page not available|0|||
145420815|NCT00147537|524396048|FG001|Phase 1b|Other|0|||
145420816|NCT00147537|524396049|FG002|Phase 1b|Other|2|||
145420817|NCT00147537|524396050|FG003|Phase 1b|Other|1|||
145420818|NCT00147537|524396051|FG004|Phase 1b|Other|1|||
145420819|NCT00147537|524396052|FG005|Phase 1b|Other|1|||
145420820|NCT00147537|524396053|FG006|Phase 1b|Other|14|||
145420821|NCT00147537|524396054|FG007|Phase 1b|Other|4|||
145420822|NCT00147537|524396055|FG008|Phase 1b|Other|4|||
145420823|NCT00147537|524396056|FG009|Phase 1b|Other|0|||
145420824|NCT00147537|524396057|FG010|Phase 1b|Other|0|||
145420825|NCT00147537|524396047|FG000|Phase 1b|Withdrawal by Subject|0|||
145420826|NCT00147537|524396048|FG001|Phase 1b|Withdrawal by Subject|0|||
145420827|NCT00147537|524396049|FG002|Phase 1b|Withdrawal by Subject|0|||
145420828|NCT00147537|524396050|FG003|Phase 1b|Withdrawal by Subject|0|||
145420829|NCT00147537|524396051|FG004|Phase 1b|Withdrawal by Subject|0|||
145420830|NCT00147537|524396052|FG005|Phase 1b|Withdrawal by Subject|0|||
145364944|NCT02547220|524185388|FG000|Overall Study|Withdrawal by Subject|1|||
145420831|NCT00147537|524396053|FG006|Phase 1b|Withdrawal by Subject|0|||
145420832|NCT00147537|524396054|FG007|Phase 1b|Withdrawal by Subject|0|||
145420833|NCT00147537|524396055|FG008|Phase 1b|Withdrawal by Subject|2|||
145420834|NCT00147537|524396056|FG009|Phase 1b|Withdrawal by Subject|0|||
145420835|NCT00147537|524396057|FG010|Phase 1b|Withdrawal by Subject|0|||
145420836|NCT00147537|524396047|FG000|Phase 1b|Randomized but not treated|0|||
145420837|NCT00147537|524396048|FG001|Phase 1b|Randomized but not treated|0|||
145420838|NCT00147537|524396049|FG002|Phase 1b|Randomized but not treated|0|||
145420839|NCT00147537|524396050|FG003|Phase 1b|Randomized but not treated|0|||
145420840|NCT00147537|524396051|FG004|Phase 1b|Randomized but not treated|0|||
145420841|NCT00147537|524396052|FG005|Phase 1b|Randomized but not treated|0|||
145420842|NCT00147537|524396053|FG006|Phase 1b|Randomized but not treated|1|||
145420843|NCT00147537|524396054|FG007|Phase 1b|Randomized but not treated|0|||
145420844|NCT00147537|524396055|FG008|Phase 1b|Randomized but not treated|1|||
145420845|NCT00147537|524396056|FG009|Phase 1b|Randomized but not treated|0|||
145420846|NCT00147537|524396057|FG010|Phase 1b|Randomized but not treated|0|||
145420847|NCT00147537|524396047|FG000|Phase 2|Death|0|||
145420848|NCT00147537|524396048|FG001|Phase 2|Death|0|||
145420849|NCT00147537|524396049|FG002|Phase 2|Death|0|||
145420850|NCT00147537|524396050|FG003|Phase 2|Death|0|||
145420851|NCT00147537|524396051|FG004|Phase 2|Death|0|||
145420852|NCT00147537|524396052|FG005|Phase 2|Death|0|||
145420853|NCT00147537|524396053|FG006|Phase 2|Death|0|||
145420854|NCT00147537|524396054|FG007|Phase 2|Death|0|||
145420855|NCT00147537|524396055|FG008|Phase 2|Death|0|||
145420856|NCT00147537|524396056|FG009|Phase 2|Death|85|||
145420857|NCT00147537|524396057|FG010|Phase 2|Death|31|||
145420858|NCT00147537|524396047|FG000|Phase 2|Lost to Follow-up|0|||
145420859|NCT00147537|524396048|FG001|Phase 2|Lost to Follow-up|0|||
145420860|NCT00147537|524396049|FG002|Phase 2|Lost to Follow-up|0|||
145420861|NCT00147537|524396050|FG003|Phase 2|Lost to Follow-up|0|||
145420862|NCT00147537|524396051|FG004|Phase 2|Lost to Follow-up|0|||
145420863|NCT00147537|524396052|FG005|Phase 2|Lost to Follow-up|0|||
145420864|NCT00147537|524396053|FG006|Phase 2|Lost to Follow-up|0|||
145420865|NCT00147537|524396054|FG007|Phase 2|Lost to Follow-up|0|||
145420866|NCT00147537|524396055|FG008|Phase 2|Lost to Follow-up|0|||
145420867|NCT00147537|524396056|FG009|Phase 2|Lost to Follow-up|12|||
145364945|NCT02547220|524185389|FG001|Overall Study|Withdrawal by Subject|0|||
145364946|NCT02547220|524185388|FG000|Overall Study|Study terminated by sponsor|18|||
145364947|NCT02547220|524185389|FG001|Overall Study|Study terminated by sponsor|20|||
145364948|NCT01186692|524185390|FG000|Overall Study|Not Catheterized|11|||
145364949|NCT01186692|524185390|FG000|Overall Study|Futher testing contraindicated implant|19|||
145364950|NCT01186692|524185390|FG000|Overall Study|Adverse Event|2|||
145364951|NCT02195869|524185391|FG000|Overall Study|cGVHD Progression|5|||
145364952|NCT02195869|524185391|FG000|Overall Study|Malignancy Progression/relapse|2|||
145364953|NCT02195869|524185391|FG000|Overall Study|Adverse Event|15|||
145364954|NCT02195869|524185391|FG000|Overall Study|Withdrawal by Subject|7|||
145364955|NCT02195869|524185391|FG000|Overall Study|Physician Decision|4|||
145364956|NCT02195869|524185391|FG000|Overall Study|Study Terminated by Sponsor|7|||
145364957|NCT02195869|524185391|FG000|Overall Study|Noncompliance with study drug|2|||
145364958|NCT03319732|524185395|FG000|Overall Study|Adverse Event|40|||
145364959|NCT03319732|524185395|FG000|Overall Study|Withdrawal by Subject|50|||
145364960|NCT03319732|524185395|FG000|Overall Study|MS relapse|10|||
145364961|NCT03319732|524185395|FG000|Overall Study|reason not specified|5|||
145364962|NCT00757042|524185396|FG000|Overall Study|Lost to Follow-up|0|||
145364963|NCT00757042|524185397|FG001|Overall Study|Lost to Follow-up|0|||
145364964|NCT00757042|524185398|FG002|Overall Study|Lost to Follow-up|0|||
145364965|NCT00757042|524185399|FG003|Overall Study|Lost to Follow-up|0|||
145364966|NCT00757042|524185400|FG004|Overall Study|Lost to Follow-up|0|||
145364967|NCT00757042|524185401|FG005|Overall Study|Lost to Follow-up|0|||
145420868|NCT00147537|524396057|FG010|Phase 2|Lost to Follow-up|4|||
145420869|NCT00147537|524396047|FG000|Phase 2|Other|0|||
145420870|NCT00147537|524396048|FG001|Phase 2|Other|0|||
145420871|NCT00147537|524396049|FG002|Phase 2|Other|0|||
145420872|NCT00147537|524396050|FG003|Phase 2|Other|0|||
145420873|NCT00147537|524396051|FG004|Phase 2|Other|0|||
145420874|NCT00147537|524396052|FG005|Phase 2|Other|0|||
145420875|NCT00147537|524396053|FG006|Phase 2|Other|0|||
145420876|NCT00147537|524396054|FG007|Phase 2|Other|0|||
145420877|NCT00147537|524396055|FG008|Phase 2|Other|0|||
145420878|NCT00147537|524396056|FG009|Phase 2|Other|47|||
145364968|NCT00757042|524185402|FG006|Overall Study|Lost to Follow-up|0|||
145364969|NCT00757042|524185403|FG007|Overall Study|Lost to Follow-up|0|||
145420879|NCT00147537|524396057|FG010|Phase 2|Other|12|||
145420880|NCT00147537|524396047|FG000|Phase 2|Withdrawal by Subject|0|||
145420881|NCT00147537|524396048|FG001|Phase 2|Withdrawal by Subject|0|||
145364970|NCT00757042|524185404|FG008|Overall Study|Lost to Follow-up|1|||
145364971|NCT00757042|524185405|FG009|Overall Study|Lost to Follow-up|0|||
145364972|NCT00757042|524185406|FG010|Overall Study|Lost to Follow-up|0|||
145364973|NCT00757042|524185396|FG000|Overall Study|Ineligibility Determined|0|||
145420882|NCT00147537|524396049|FG002|Phase 2|Withdrawal by Subject|0|||
145420883|NCT00147537|524396050|FG003|Phase 2|Withdrawal by Subject|0|||
145420884|NCT00147537|524396051|FG004|Phase 2|Withdrawal by Subject|0|||
145420885|NCT00147537|524396052|FG005|Phase 2|Withdrawal by Subject|0|||
145420886|NCT00147537|524396053|FG006|Phase 2|Withdrawal by Subject|0|||
145420887|NCT00147537|524396054|FG007|Phase 2|Withdrawal by Subject|0|||
145420888|NCT00147537|524396055|FG008|Phase 2|Withdrawal by Subject|0|||
145420889|NCT00147537|524396056|FG009|Phase 2|Withdrawal by Subject|16|||
145420890|NCT00147537|524396057|FG010|Phase 2|Withdrawal by Subject|4|||
145420891|NCT00147537|524396047|FG000|Phase 2|Randomized but not treated|0|||
145420892|NCT00147537|524396048|FG001|Phase 2|Randomized but not treated|0|||
145420893|NCT00147537|524396049|FG002|Phase 2|Randomized but not treated|0|||
145420894|NCT00147537|524396050|FG003|Phase 2|Randomized but not treated|0|||
145420895|NCT00147537|524396051|FG004|Phase 2|Randomized but not treated|0|||
145420896|NCT00147537|524396052|FG005|Phase 2|Randomized but not treated|0|||
145420897|NCT00147537|524396053|FG006|Phase 2|Randomized but not treated|0|||
145420898|NCT00147537|524396054|FG007|Phase 2|Randomized but not treated|0|||
145420899|NCT00147537|524396055|FG008|Phase 2|Randomized but not treated|0|||
145420900|NCT00147537|524396056|FG009|Phase 2|Randomized but not treated|1|||
145420901|NCT00147537|524396057|FG010|Phase 2|Randomized but not treated|1|||
145420902|NCT01089543|524396058|FG000|Overall Study|Withdrawal by Subject|2|||
145420903|NCT01089543|524396059|FG001|Overall Study|Withdrawal by Subject|3|||
145420904|NCT01089543|524396060|FG002|Overall Study|Withdrawal by Subject|3|||
145420905|NCT01089543|524396061|FG003|Overall Study|Withdrawal by Subject|1|||
145420906|NCT01089543|524396058|FG000|Overall Study|Physician Decision|1|||
145420907|NCT01089543|524396059|FG001|Overall Study|Physician Decision|0|||
145420908|NCT01089543|524396060|FG002|Overall Study|Physician Decision|0|||
145420909|NCT01089543|524396061|FG003|Overall Study|Physician Decision|1|||
145420910|NCT01089543|524396058|FG000|Overall Study|Adverse Event|0|||
145420911|NCT01089543|524396059|FG001|Overall Study|Adverse Event|1|||
145420912|NCT01089543|524396060|FG002|Overall Study|Adverse Event|0|||
145420913|NCT01089543|524396061|FG003|Overall Study|Adverse Event|0|||
145420914|NCT00468546|524396064|FG000|Week 24 Analysis|Lack of Efficacy|83|||
145420915|NCT00468546|524396065|FG001|Week 24 Analysis|Lack of Efficacy|37|||
145420916|NCT00468546|524396064|FG000|Week 24 Analysis|Refused treatment|5|||
145420917|NCT00468546|524396065|FG001|Week 24 Analysis|Refused treatment|5|||
145420918|NCT00468546|524396064|FG000|Week 24 Analysis|Adverse Event|1|||
145420919|NCT00468546|524396065|FG001|Week 24 Analysis|Adverse Event|8|||
145420920|NCT00468546|524396064|FG000|Week 24 Analysis|Failure to return|3|||
145420921|NCT00468546|524396065|FG001|Week 24 Analysis|Failure to return|4|||
145420922|NCT00468546|524396064|FG000|Week 24 Analysis|Rescue therapy|2|||
145420923|NCT00468546|524396065|FG001|Week 24 Analysis|Rescue therapy|0|||
145420924|NCT00468546|524396064|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
145420925|NCT00468546|524396065|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
145420926|NCT00468546|524396064|FG000|Week 24 Analysis|Due to clinical hold|1|||
145420927|NCT00468546|524396065|FG001|Week 24 Analysis|Due to clinical hold|0|||
145420928|NCT00468546|524396064|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
145420929|NCT00468546|524396065|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
145420930|NCT00468546|524396064|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
145420931|NCT00468546|524396065|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
145420932|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
145420933|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
145420934|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Death|1|||
145420935|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Death|0|||
145420936|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
145364974|NCT00757042|524185397|FG001|Overall Study|Ineligibility Determined|0|||
145364975|NCT00757042|524185398|FG002|Overall Study|Ineligibility Determined|0|||
145364976|NCT00757042|524185399|FG003|Overall Study|Ineligibility Determined|0|||
145364977|NCT00757042|524185400|FG004|Overall Study|Ineligibility Determined|0|||
145364978|NCT00757042|524185401|FG005|Overall Study|Ineligibility Determined|0|||
145364979|NCT00757042|524185402|FG006|Overall Study|Ineligibility Determined|0|||
145364980|NCT00757042|524185403|FG007|Overall Study|Ineligibility Determined|0|||
145364981|NCT00757042|524185404|FG008|Overall Study|Ineligibility Determined|0|||
145364982|NCT00757042|524185405|FG009|Overall Study|Ineligibility Determined|0|||
145364983|NCT00757042|524185406|FG010|Overall Study|Ineligibility Determined|1|||
145364984|NCT00757042|524185396|FG000|Overall Study|Withdrawal by Subject|0|||
145364985|NCT00757042|524185397|FG001|Overall Study|Withdrawal by Subject|0|||
145364986|NCT00757042|524185398|FG002|Overall Study|Withdrawal by Subject|0|||
145364987|NCT00757042|524185399|FG003|Overall Study|Withdrawal by Subject|0|||
145364988|NCT00757042|524185400|FG004|Overall Study|Withdrawal by Subject|0|||
145364989|NCT00757042|524185401|FG005|Overall Study|Withdrawal by Subject|0|||
145364990|NCT00757042|524185402|FG006|Overall Study|Withdrawal by Subject|0|||
145364991|NCT00757042|524185403|FG007|Overall Study|Withdrawal by Subject|0|||
145364992|NCT00757042|524185404|FG008|Overall Study|Withdrawal by Subject|0|||
145364993|NCT00757042|524185405|FG009|Overall Study|Withdrawal by Subject|1|||
145364994|NCT00757042|524185406|FG010|Overall Study|Withdrawal by Subject|0|||
145364995|NCT02654977|524185407|FG000|Overall Study|Death|1|||
145420937|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
145420938|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
145364996|NCT02654977|524185407|FG000|Overall Study|Lost to Follow-up|1|||
145420939|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
145420940|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
145420941|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
145420942|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
145420943|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
145623196|NCT05968482|525131607|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
145623197|NCT05968482|525131608|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
145623198|NCT05968482|525131609|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
145623199|NCT01925170|525131612|FG000|Overall Study|Unverified cancer status|53|||
145364997|NCT02654977|524185407|FG000|Overall Study|Adverse Event|1|||
145364998|NCT02654977|524185407|FG000|Overall Study|Withdrawal by Subject|1|||
145364999|NCT02654977|524185407|FG000|Overall Study|Lack of Efficacy|3|||
145365000|NCT01921101|524185409|FG000|Overall Study|Death|16|||
145365001|NCT01921101|524185410|FG001|Overall Study|Death|6|||
145365002|NCT00767455|524185411|FG000|Overall Study|Investigator error|19|||
145365003|NCT01266291|524185412|FG000|Overall Study|Adverse Event|1|||
145365004|NCT03291431|524185413|FG000|Overall Study|Protocol Violation|2|||
145365005|NCT03291431|524185414|FG001|Overall Study|Protocol Violation|1|||
145365006|NCT03291431|524185413|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
145365007|NCT03291431|524185414|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
145365008|NCT03291431|524185413|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
145365009|NCT03291431|524185414|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
145365010|NCT04925557|524186641|FG000|Overall Study|Study closed|5|||
145365011|NCT04925557|524186642|FG001|Overall Study|Study closed|3|||
145365012|NCT05488470|524186643|FG000|Overall Study|Physician Decision|2|||
145365013|NCT05488470|524186643|FG000|Overall Study|Withdrawal by Subject|1|||
145365014|NCT05488470|524186643|FG000|Overall Study|Death|1|||
145365015|NCT00068393|524186648|FG000|Overall Study|Adverse Event|2|||
145365016|NCT00068393|524186648|FG000|Overall Study|Death|3|||
145365017|NCT00068393|524186648|FG000|Overall Study|Withdrawal by Subject|3|||
145365018|NCT00068393|524186648|FG000|Overall Study|Alternative treatment|1|||
145365019|NCT00068393|524186648|FG000|Overall Study|Quality of life worsening|1|||
145365020|NCT01108341|524186653|FG000|Overall Study|Death|2|||
145365021|NCT01108341|524186653|FG000|Overall Study|Withdrawal by Subject|1|||
145365022|NCT01108341|524186653|FG000|Overall Study|Lost to Follow-up|1|||
145365023|NCT01108341|524186653|FG000|Overall Study|Other|1|||
145365024|NCT01068730|524186654|FG000|Period 3|Personal reason|1|||
145365025|NCT01068730|524186655|FG001|Period 3|Personal reason|0|||
145365026|NCT01068730|524186656|FG002|Period 3|Personal reason|0|||
145365027|NCT01068730|524186657|FG003|Period 3|Personal reason|0|||
145365028|NCT01068730|524186654|FG000|Period 4|Family emergency|0|||
145365029|NCT01068730|524186655|FG001|Period 4|Family emergency|1|||
145365030|NCT01068730|524186656|FG002|Period 4|Family emergency|0|||
145365031|NCT01068730|524186657|FG003|Period 4|Family emergency|0|||
145365032|NCT00178685|524186659|FG000|Overall Study|Death|3|||
145365033|NCT00178685|524186660|FG001|Overall Study|Death|3|||
145365034|NCT00178685|524186661|FG002|Overall Study|Death|6|||
145365035|NCT00178685|524186659|FG000|Overall Study|Lost to Follow-up|100|||
145365036|NCT00178685|524186660|FG001|Overall Study|Lost to Follow-up|187|||
145365037|NCT00178685|524186661|FG002|Overall Study|Lost to Follow-up|183|||
145365038|NCT00178685|524186659|FG000|Overall Study|Withdrawal by Subject|8|||
145365039|NCT00178685|524186660|FG001|Overall Study|Withdrawal by Subject|14|||
145365040|NCT00178685|524186661|FG002|Overall Study|Withdrawal by Subject|7|||
145365041|NCT04112043|524186662|FG000|Overall Study|Withdrawal by Subject|1|||
145365042|NCT04112043|524186663|FG001|Overall Study|Withdrawal by Subject|1|||
145365043|NCT04112043|524186664|FG002|Overall Study|Withdrawal by Subject|1|||
145365044|NCT04112043|524186662|FG000|Overall Study|Taking NR supplement|1|||
145365045|NCT04112043|524186663|FG001|Overall Study|Taking NR supplement|0|||
145365046|NCT04112043|524186664|FG002|Overall Study|Taking NR supplement|0|||
145365047|NCT04112043|524186662|FG000|Overall Study|Adverse Event|0|||
145365048|NCT04112043|524186663|FG001|Overall Study|Adverse Event|1|||
145365049|NCT04112043|524186664|FG002|Overall Study|Adverse Event|0|||
145365050|NCT01750697|524186667|FG000|Overall Study|Transferred Back to Local Hospital|1|||
145365051|NCT01750697|524186667|FG000|Overall Study|Physician and Family Decision|1|||
145365052|NCT01750697|524186667|FG000|Overall Study|Transferred to Adult Services|5|||
145365053|NCT01750697|524186667|FG000|Overall Study|Physician Decision|1|||
145365054|NCT01750697|524186667|FG000|Overall Study|Withdrawal by Subject|1|||
145365055|NCT00384839|524186670|FG000|Overall Study|Adverse Event|4|||
145365056|NCT00384839|524186670|FG000|Overall Study|Investigator Request|1|||
145365057|NCT00384839|524186670|FG000|Overall Study|Patient Request|1|||
145365058|NCT00384839|524186670|FG000|Overall Study|Ineligible|2|||
145365059|NCT01421225|524186671|FG000|Overall Study|Withdrawal by Subject|0|||
145365060|NCT01421225|524186672|FG001|Overall Study|Withdrawal by Subject|1|||
145365061|NCT02649439|524186673|FG000|Overall Study|Switched to alternative treatment|6|||
145365062|NCT02649439|524186674|FG001|Overall Study|Switched to alternative treatment|4|||
145365063|NCT02649439|524186673|FG000|Overall Study|Patient decision|1|||
145365064|NCT02649439|524186674|FG001|Overall Study|Patient decision|0|||
145365065|NCT02649439|524186673|FG000|Overall Study|Patient going out of country|1|||
145365066|NCT02649439|524186674|FG001|Overall Study|Patient going out of country|0|||
145365067|NCT02649439|524186673|FG000|Overall Study|To start finasteride|1|||
145365068|NCT02649439|524186674|FG001|Overall Study|To start finasteride|0|||
145365069|NCT02649439|524186673|FG000|Overall Study|Physician Decision|1|||
145365070|NCT02649439|524186674|FG001|Overall Study|Physician Decision|0|||
145365071|NCT02649439|524186673|FG000|Overall Study|Disease progression on study|12|||
145365072|NCT02649439|524186674|FG001|Overall Study|Disease progression on study|13|||
145365073|NCT02649439|524186673|FG000|Overall Study|Refused further treatment|1|||
145365074|NCT02649439|524186674|FG001|Overall Study|Refused further treatment|0|||
145365075|NCT02649439|524186673|FG000|Overall Study|Refused further follow up|2|||
145365076|NCT02649439|524186674|FG001|Overall Study|Refused further follow up|7|||
145365077|NCT02649439|524186673|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
145365078|NCT02649439|524186674|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
145365079|NCT02649439|524186673|FG000|Overall Study|No treatment, per protocol|1|||
145365080|NCT02649439|524186674|FG001|Overall Study|No treatment, per protocol|0|||
145365081|NCT02649439|524186673|FG000|Overall Study|PSA DT makes ineligible|0|||
145365082|NCT02649439|524186674|FG001|Overall Study|PSA DT makes ineligible|1|||
145365083|NCT02649439|524186673|FG000|Overall Study|Rising PSA No Mets|0|||
145365084|NCT02649439|524186674|FG001|Overall Study|Rising PSA No Mets|1|||
145365085|NCT02649439|524186673|FG000|Overall Study|Rising PSA|0|||
145365086|NCT02649439|524186674|FG001|Overall Study|Rising PSA|1|||
145365087|NCT02649439|524186673|FG000|Overall Study|Signed follow up protocol|0|||
145365088|NCT02649439|524186674|FG001|Overall Study|Signed follow up protocol|1|||
145365089|NCT02257489|524186679|FG000|Overall Study|Withdrawal by Subject|0|||
145365090|NCT02257489|524186680|FG001|Overall Study|Withdrawal by Subject|0|||
145365091|NCT02257489|524186681|FG002|Overall Study|Withdrawal by Subject|0|||
145365092|NCT02257489|524186682|FG003|Overall Study|Withdrawal by Subject|1|||
145420944|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
145420945|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
145420946|NCT00468546|524396064|FG000|Week 24 to Week 104 Analysis|Other|17|||
145420947|NCT00468546|524396065|FG001|Week 24 to Week 104 Analysis|Other|14|||
145420948|NCT00472641|524396067|FG000|Overall Study|Lack of Efficacy|3|||
145420949|NCT00472641|524396067|FG000|Overall Study|Adverse Event|3|||
145420950|NCT00472641|524396067|FG000|Overall Study|Lost to Follow-up|1|||
145420951|NCT01905267|524396070|FG000|Overall Study|Physician Decision|2|||
145420952|NCT01905267|524396071|FG001|Overall Study|Physician Decision|2|||
145420953|NCT03438656|524396072|FG000|Overall Study|Lost to Follow-up|2|||
145420954|NCT02991859|524396075|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420955|NCT02991859|524396076|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
145420956|NCT02991859|524396077|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420957|NCT02991859|524396078|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420958|NCT02991859|524396079|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
145420959|NCT02991859|524396080|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420960|NCT02991859|524396081|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420961|NCT02991859|524396082|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420962|NCT02991859|524396083|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420963|NCT02991859|524396084|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420964|NCT02991859|524396085|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420965|NCT02991859|524396086|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420966|NCT02991859|524396087|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420967|NCT02991859|524396088|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420968|NCT02991859|524396089|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420969|NCT02991859|524396090|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420970|NCT02991859|524396091|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
145420971|NCT02991859|524396075|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420972|NCT02991859|524396076|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420973|NCT02991859|524396077|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420974|NCT02991859|524396078|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420975|NCT02991859|524396079|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420976|NCT02991859|524396080|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420977|NCT02991859|524396081|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420978|NCT02991859|524396082|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420979|NCT02991859|524396083|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420980|NCT02991859|524396084|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420981|NCT02991859|524396085|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420982|NCT02991859|524396086|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420983|NCT02991859|524396087|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
145577828|NCT00941733|524971303|FG000|Overall Study|Adverse Event|20|||
145365093|NCT02257489|524186683|FG004|Overall Study|Withdrawal by Subject|0|||
145365094|NCT02257489|524186684|FG005|Overall Study|Withdrawal by Subject|0|||
145365095|NCT02257489|524186685|FG006|Overall Study|Withdrawal by Subject|0|||
145577829|NCT00941733|524971304|FG001|Overall Study|Adverse Event|4|||
145577830|NCT00941733|524971303|FG000|Overall Study|Lost to Follow-up|1|||
145577831|NCT00941733|524971304|FG001|Overall Study|Lost to Follow-up|2|||
145577832|NCT00941733|524971303|FG000|Overall Study|Protocol Violation|15|||
145577833|NCT00941733|524971304|FG001|Overall Study|Protocol Violation|6|||
145577834|NCT01076400|524971306|FG000|Overall Study|Adverse Event|2|||
145577835|NCT01076400|524971307|FG001|Overall Study|Adverse Event|0|||
145577836|NCT01076400|524971308|FG002|Overall Study|Adverse Event|0|||
145577837|NCT01076400|524971306|FG000|Overall Study|Progressive Disease|5|||
145577838|NCT01076400|524971307|FG001|Overall Study|Progressive Disease|0|||
145577839|NCT01076400|524971308|FG002|Overall Study|Progressive Disease|0|||
145577840|NCT01265953|524971314|FG000|Overall Study|Non compliance|5|||
145577841|NCT01265953|524971315|FG001|Overall Study|Non compliance|3|||
145577842|NCT00659646|524971316|FG000|Overall Study|Protocol Violation|12|||
145577843|NCT00659646|524971317|FG001|Overall Study|Protocol Violation|8|||
145577844|NCT00659646|524971316|FG000|Overall Study|Adverse Event|1|||
145577845|NCT00659646|524971317|FG001|Overall Study|Adverse Event|0|||
145577846|NCT00659646|524971316|FG000|Overall Study|Lost to Follow-up|1|||
145577847|NCT00659646|524971317|FG001|Overall Study|Lost to Follow-up|0|||
145577848|NCT00659646|524971316|FG000|Overall Study|protocol noncompliance after randomized|1|||
145577849|NCT00659646|524971317|FG001|Overall Study|protocol noncompliance after randomized|0|||
145577850|NCT01640301|524971318|FG000|Overall Study|Death|0|||
145577851|NCT01640301|524971319|FG001|Overall Study|Death|8|||
145577852|NCT02348489|524971321|FG000|Overall Study|Death|336|||
145577853|NCT02348489|524971322|FG001|Overall Study|Death|335|||
145577854|NCT02348489|524971321|FG000|Overall Study|Withdrawal by Subject|14|||
145577855|NCT02348489|524971322|FG001|Overall Study|Withdrawal by Subject|27|||
145577856|NCT02348489|524971321|FG000|Overall Study|Lost to Follow-up|3|||
145577857|NCT02348489|524971322|FG001|Overall Study|Lost to Follow-up|5|||
145577858|NCT04193202|524971329|FG000|Overall Study|Adverse Event|2|||
145577859|NCT04193202|524971330|FG001|Overall Study|Adverse Event|1|||
145577860|NCT04193202|524971329|FG000|Overall Study|Death|0|||
145577861|NCT04193202|524971330|FG001|Overall Study|Death|1|||
145577862|NCT04193202|524971329|FG000|Overall Study|Physician Decision|1|||
145577863|NCT04193202|524971330|FG001|Overall Study|Physician Decision|1|||
145577864|NCT04193202|524971329|FG000|Overall Study|Protocol Violation|2|||
145577865|NCT04193202|524971330|FG001|Overall Study|Protocol Violation|2|||
145577866|NCT04193202|524971329|FG000|Overall Study|Withdrawal by Subject|11|||
145577867|NCT04193202|524971330|FG001|Overall Study|Withdrawal by Subject|5|||
145577868|NCT02212730|524971331|FG000|Overall Study|Tumor not of the required cell histology|1|||
145577869|NCT02212730|524971332|FG001|Overall Study|Tumor not of the required cell histology|0|||
145577870|NCT02212730|524971331|FG000|Overall Study|Withdrawal by Subject|1|||
145577871|NCT02212730|524971332|FG001|Overall Study|Withdrawal by Subject|0|||
145365096|NCT02257489|524186686|FG007|Overall Study|Withdrawal by Subject|0|||
145365097|NCT02257489|524186687|FG008|Overall Study|Withdrawal by Subject|0|||
145365098|NCT01028014|524186689|FG000|Overall Study|Lost to Follow-up|1|||
145365099|NCT01028014|524186690|FG001|Overall Study|Lost to Follow-up|2|||
145365100|NCT01028014|524186691|FG002|Overall Study|Lost to Follow-up|0|||
145365101|NCT01028014|524186692|FG003|Overall Study|Lost to Follow-up|1|||
145365102|NCT01028014|524186693|FG004|Overall Study|Lost to Follow-up|1|||
145365103|NCT01028014|524186694|FG005|Overall Study|Lost to Follow-up|2|||
145577872|NCT02212730|524971331|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
145577873|NCT02212730|524971332|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
145577874|NCT01694706|524971333|FG000|Overall Study|Adverse Event|0|||
145577875|NCT01694706|524971334|FG001|Overall Study|Adverse Event|1|||
145577876|NCT01694706|524971335|FG002|Overall Study|Adverse Event|0|||
145577877|NCT01694706|524971333|FG000|Overall Study|other reason not defined above|1|||
145365104|NCT02071706|524186695|FG000|Overall Study|Adverse Event|1|||
145577878|NCT01694706|524971334|FG001|Overall Study|other reason not defined above|0|||
145577879|NCT01694706|524971335|FG002|Overall Study|other reason not defined above|0|||
145577880|NCT00975975|524971336|FG000|Overall Study|Death|6|||
145577881|NCT01923181|524971337|FG000|Overall Study|Protocol Violation|2|||
145577882|NCT01923181|524971338|FG001|Overall Study|Protocol Violation|2|||
145577883|NCT01923181|524971339|FG002|Overall Study|Protocol Violation|0|||
145577884|NCT01923181|524971340|FG003|Overall Study|Protocol Violation|2|||
145577885|NCT01923181|524971341|FG004|Overall Study|Protocol Violation|2|||
145577886|NCT01923181|524971342|FG005|Overall Study|Protocol Violation|1|||
145577887|NCT01923181|524971343|FG006|Overall Study|Protocol Violation|1|||
145577888|NCT01923181|524971344|FG007|Overall Study|Protocol Violation|2|||
145577889|NCT01923181|524971345|FG008|Overall Study|Protocol Violation|1|||
145577890|NCT01923181|524971337|FG000|Overall Study|Withdrawal by Subject|0|||
145577891|NCT01923181|524971338|FG001|Overall Study|Withdrawal by Subject|1|||
145577892|NCT01923181|524971339|FG002|Overall Study|Withdrawal by Subject|0|||
145577893|NCT01923181|524971340|FG003|Overall Study|Withdrawal by Subject|1|||
145577894|NCT01923181|524971341|FG004|Overall Study|Withdrawal by Subject|4|||
145365105|NCT02071706|524186695|FG000|Overall Study|Withdrawal by Subject|2|||
145365106|NCT01908829|524186696|FG000|Overall Study|Adverse Event|13|||
145577895|NCT01923181|524971342|FG005|Overall Study|Withdrawal by Subject|2|||
145577896|NCT01923181|524971343|FG006|Overall Study|Withdrawal by Subject|4|||
145365107|NCT01908829|524186697|FG001|Overall Study|Adverse Event|11|||
145365108|NCT01908829|524186698|FG002|Overall Study|Adverse Event|13|||
145365109|NCT01908829|524186696|FG000|Overall Study|Lost to Follow-up|4|||
145365110|NCT01908829|524186697|FG001|Overall Study|Lost to Follow-up|2|||
145365111|NCT01908829|524186698|FG002|Overall Study|Lost to Follow-up|1|||
145365112|NCT01908829|524186696|FG000|Overall Study|Randomized no double-blind drug received|1|||
145365113|NCT01908829|524186697|FG001|Overall Study|Randomized no double-blind drug received|0|||
145365114|NCT01908829|524186698|FG002|Overall Study|Randomized no double-blind drug received|1|||
145365115|NCT01908829|524186696|FG000|Overall Study|Discontinued (no EoT page)|2|||
145365116|NCT01908829|524186697|FG001|Overall Study|Discontinued (no EoT page)|0|||
145365117|NCT01908829|524186698|FG002|Overall Study|Discontinued (no EoT page)|0|||
145365118|NCT01908829|524186696|FG000|Overall Study|Miscellaneous|0|||
145365119|NCT01908829|524186697|FG001|Overall Study|Miscellaneous|2|||
145365120|NCT01908829|524186698|FG002|Overall Study|Miscellaneous|0|||
145365121|NCT01908829|524186696|FG000|Overall Study|Protocol Violation|2|||
145365122|NCT01908829|524186697|FG001|Overall Study|Protocol Violation|2|||
145365123|NCT01908829|524186698|FG002|Overall Study|Protocol Violation|0|||
145365124|NCT01908829|524186696|FG000|Overall Study|Lack of Efficacy|1|||
145365125|NCT01908829|524186697|FG001|Overall Study|Lack of Efficacy|3|||
145365126|NCT01908829|524186698|FG002|Overall Study|Lack of Efficacy|2|||
145365127|NCT01908829|524186696|FG000|Overall Study|Withdrawal by Subject|26|||
145365128|NCT01908829|524186697|FG001|Overall Study|Withdrawal by Subject|29|||
145365129|NCT01908829|524186698|FG002|Overall Study|Withdrawal by Subject|22|||
145365130|NCT01339923|524186699|FG000|Overall Study|Adverse Event|1|||
145365131|NCT01339923|524186700|FG001|Overall Study|Adverse Event|1|||
145365132|NCT01339923|524186701|FG002|Overall Study|Adverse Event|1|||
145365133|NCT01339923|524186702|FG003|Overall Study|Adverse Event|0|||
145365134|NCT01339923|524186703|FG004|Overall Study|Adverse Event|0|||
145365135|NCT01339923|524186704|FG005|Overall Study|Adverse Event|0|||
145365136|NCT01339923|524186705|FG006|Overall Study|Adverse Event|1|||
145365137|NCT01339923|524186699|FG000|Overall Study|Inappropriate Enrollment|1|||
145365138|NCT01339923|524186700|FG001|Overall Study|Inappropriate Enrollment|0|||
145365139|NCT01339923|524186701|FG002|Overall Study|Inappropriate Enrollment|0|||
145365140|NCT01339923|524186702|FG003|Overall Study|Inappropriate Enrollment|0|||
145365141|NCT01339923|524186703|FG004|Overall Study|Inappropriate Enrollment|0|||
145365142|NCT01339923|524186704|FG005|Overall Study|Inappropriate Enrollment|1|||
145365143|NCT01339923|524186705|FG006|Overall Study|Inappropriate Enrollment|0|||
145365144|NCT01339923|524186699|FG000|Overall Study|Lost to Follow-up|4|||
145365145|NCT01339923|524186700|FG001|Overall Study|Lost to Follow-up|4|||
145365146|NCT01339923|524186701|FG002|Overall Study|Lost to Follow-up|0|||
145365147|NCT01339923|524186702|FG003|Overall Study|Lost to Follow-up|3|||
145365148|NCT01339923|524186703|FG004|Overall Study|Lost to Follow-up|1|||
145365149|NCT01339923|524186704|FG005|Overall Study|Lost to Follow-up|1|||
145365150|NCT01339923|524186705|FG006|Overall Study|Lost to Follow-up|5|||
145365151|NCT01339923|524186699|FG000|Overall Study|Protocol Violation|0|||
145365152|NCT01339923|524186700|FG001|Overall Study|Protocol Violation|0|||
145365153|NCT01339923|524186701|FG002|Overall Study|Protocol Violation|0|||
145365154|NCT01339923|524186702|FG003|Overall Study|Protocol Violation|0|||
145365155|NCT01339923|524186703|FG004|Overall Study|Protocol Violation|0|||
145365156|NCT01339923|524186704|FG005|Overall Study|Protocol Violation|3|||
145365157|NCT01339923|524186705|FG006|Overall Study|Protocol Violation|1|||
145365158|NCT01339923|524186699|FG000|Overall Study|Unable to Classify|1|||
145365159|NCT01339923|524186700|FG001|Overall Study|Unable to Classify|0|||
145365160|NCT01339923|524186701|FG002|Overall Study|Unable to Classify|1|||
145365161|NCT01339923|524186702|FG003|Overall Study|Unable to Classify|0|||
145365162|NCT01339923|524186703|FG004|Overall Study|Unable to Classify|0|||
145365163|NCT01339923|524186704|FG005|Overall Study|Unable to Classify|1|||
145365164|NCT01339923|524186705|FG006|Overall Study|Unable to Classify|5|||
145365165|NCT01339923|524186699|FG000|Overall Study|Withdrawal by Subject|7|||
145365166|NCT01339923|524186700|FG001|Overall Study|Withdrawal by Subject|11|||
145365167|NCT01339923|524186701|FG002|Overall Study|Withdrawal by Subject|6|||
145365168|NCT01339923|524186702|FG003|Overall Study|Withdrawal by Subject|1|||
145365169|NCT01339923|524186703|FG004|Overall Study|Withdrawal by Subject|4|||
145365170|NCT01339923|524186704|FG005|Overall Study|Withdrawal by Subject|3|||
145365171|NCT01339923|524186705|FG006|Overall Study|Withdrawal by Subject|2|||
145365172|NCT00766636|524186709|FG000|Overall Study|Withdrawal by Subject|1|||
145365173|NCT00766636|524186710|FG001|Overall Study|Withdrawal by Subject|1|||
145365174|NCT00766636|524186709|FG000|Overall Study|Incomplete Treatment|0|||
145365175|NCT00766636|524186710|FG001|Overall Study|Incomplete Treatment|1|||
145365176|NCT00766636|524186709|FG000|Overall Study|Adverse Event|1|||
145365177|NCT00766636|524186710|FG001|Overall Study|Adverse Event|0|||
145365178|NCT00766636|524186709|FG000|Overall Study|Disease Progression|1|||
145365179|NCT00766636|524186710|FG001|Overall Study|Disease Progression|0|||
145365180|NCT04657198|524186711|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
145365181|NCT04657198|524186712|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145365182|NCT04657198|524186713|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
145365183|NCT03793842|524186714|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
145623200|NCT01077024|525131613|FG000|Overall Study|Lost to Follow-up|20|||
145365184|NCT03793842|524186715|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
145365185|NCT03793842|524186714|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
145365186|NCT03793842|524186715|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
145365187|NCT00520533|524186716|FG000|Overall Study|Death|1|||
145365188|NCT00520533|524186716|FG000|Overall Study|Suspension of the study for safety reasons|1|||
145365189|NCT00520533|524186716|FG000|Overall Study|Withdrawal by Subject|1|||
145365190|NCT00520533|524186716|FG000|Overall Study|Physician Decision|1|||
145365191|NCT01377922|524186717|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
145365192|NCT01377922|524186718|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
145365193|NCT02157376|524186719|FG000|Overall Study|Death|10|||
145365194|NCT02157376|524186720|FG001|Overall Study|Death|4|||
145365195|NCT02157376|524186719|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145365196|NCT02157376|524186720|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145365197|NCT02157376|524186719|FG000|Overall Study|Withdrawal by Subject|3|||
145365198|NCT02157376|524186720|FG001|Overall Study|Withdrawal by Subject|8|||
145365199|NCT02157376|524186719|FG000|Overall Study|Not treated|8|||
145365200|NCT02157376|524186720|FG001|Overall Study|Not treated|3|||
145365201|NCT02157376|524186719|FG000|Overall Study|Investigator's misjudgement|1|||
145365202|NCT02157376|524186720|FG001|Overall Study|Investigator's misjudgement|2|||
145365203|NCT00529373|524186721|FG000|Base Study|Adverse Event|525|||
145365204|NCT00529373|524186722|FG001|Base Study|Adverse Event|470|||
145365205|NCT00529373|524186721|FG000|Base Study|Lack of Efficacy|16|||
145365206|NCT00529373|524186722|FG001|Base Study|Lack of Efficacy|75|||
145365207|NCT00529373|524186721|FG000|Base Study|Lost to Follow-up|221|||
145365208|NCT00529373|524186722|FG001|Base Study|Lost to Follow-up|208|||
145365209|NCT00529373|524186721|FG000|Base Study|Other Protocol Specified Criteria|19|||
145365210|NCT00529373|524186722|FG001|Base Study|Other Protocol Specified Criteria|20|||
145365211|NCT00529373|524186721|FG000|Base Study|Physician Decision|60|||
145365212|NCT00529373|524186722|FG001|Base Study|Physician Decision|52|||
145365213|NCT00529373|524186721|FG000|Base Study|Protocol Violation|48|||
145365214|NCT00529373|524186722|FG001|Base Study|Protocol Violation|38|||
145365215|NCT00529373|524186721|FG000|Base Study|Withdrawal by Subject|1062|||
145365216|NCT00529373|524186722|FG001|Base Study|Withdrawal by Subject|967|||
145365217|NCT00529373|524186721|FG000|Base Study|Did not continue into Extension|1795|||
145365218|NCT00529373|524186722|FG001|Base Study|Did not continue into Extension|2238|||
145365219|NCT00529373|524186721|FG000|First Extension Study|Adverse Event|162|||
145365220|NCT00529373|524186722|FG001|First Extension Study|Adverse Event|142|||
145365221|NCT00529373|524186721|FG000|First Extension Study|Lack of Efficacy|65|||
145365222|NCT00529373|524186722|FG001|First Extension Study|Lack of Efficacy|427|||
145365223|NCT00529373|524186721|FG000|First Extension Study|Lost to Follow-up|41|||
145365224|NCT00529373|524186722|FG001|First Extension Study|Lost to Follow-up|37|||
145365225|NCT00529373|524186721|FG000|First Extension Study|Other|27|||
145365226|NCT00529373|524186722|FG001|First Extension Study|Other|47|||
145365227|NCT00529373|524186721|FG000|First Extension Study|Physician Decision|50|||
145365228|NCT00529373|524186722|FG001|First Extension Study|Physician Decision|45|||
145365229|NCT00529373|524186721|FG000|First Extension Study|Protocol Violation|16|||
145365230|NCT00529373|524186722|FG001|First Extension Study|Protocol Violation|13|||
145365231|NCT00529373|524186721|FG000|First Extension Study|Withdrawal by Subject|296|||
145365232|NCT00529373|524186722|FG001|First Extension Study|Withdrawal by Subject|287|||
145365233|NCT00529373|524186721|FG000|First Extension Study|Disposition record non-existing|0|||
145365234|NCT00529373|524186722|FG001|First Extension Study|Disposition record non-existing|1|||
145365235|NCT00529373|524186721|FG000|First Extension Study|Discontinued after 5 years completion|208|||
145365236|NCT00529373|524186722|FG001|First Extension Study|Discontinued after 5 years completion|346|||
145365237|NCT00529373|524186721|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
145365238|NCT00529373|524186722|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
145365239|NCT00529373|524186721|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
145365240|NCT00529373|524186722|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
145365241|NCT00529373|524186721|FG000|Second Extension Study|Adverse Event|101|||
145365242|NCT00529373|524186722|FG001|Second Extension Study|Adverse Event|51|||
145365243|NCT00529373|524186721|FG000|Second Extension Study|Lack of Efficacy|7|||
145365244|NCT00529373|524186722|FG001|Second Extension Study|Lack of Efficacy|15|||
145365245|NCT00529373|524186721|FG000|Second Extension Study|Lost to Follow-up|18|||
145577897|NCT01923181|524971344|FG007|Overall Study|Withdrawal by Subject|3|||
145577898|NCT01923181|524971345|FG008|Overall Study|Withdrawal by Subject|1|||
145365246|NCT00529373|524186722|FG001|Second Extension Study|Lost to Follow-up|12|||
145365247|NCT00529373|524186721|FG000|Second Extension Study|Other|7|||
145365248|NCT00529373|524186722|FG001|Second Extension Study|Other|12|||
145365249|NCT00529373|524186721|FG000|Second Extension Study|Physician Decision|63|||
145365250|NCT00529373|524186722|FG001|Second Extension Study|Physician Decision|26|||
145365251|NCT00529373|524186721|FG000|Second Extension Study|Protocol Violation|2|||
145365252|NCT00529373|524186722|FG001|Second Extension Study|Protocol Violation|1|||
145365253|NCT00529373|524186721|FG000|Second Extension Study|Withdrawal by Subject|97|||
145577899|NCT01923181|524971337|FG000|Overall Study|Other|1|||
145577900|NCT01923181|524971338|FG001|Overall Study|Other|0|||
145365254|NCT00529373|524186722|FG001|Second Extension Study|Withdrawal by Subject|75|||
145365255|NCT00529373|524186721|FG000|Second Extension Study|Status Missing|5|||
145365256|NCT00529373|524186722|FG001|Second Extension Study|Status Missing|5|||
145365257|NCT01074268|524186729|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
145365258|NCT01074268|524186730|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
145365259|NCT01074268|524186729|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
145365260|NCT01074268|524186730|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
145365261|NCT01074268|524186729|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
145365262|NCT01074268|524186730|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
145365263|NCT01074268|524186729|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
145365264|NCT01074268|524186730|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
145365265|NCT01074268|524186729|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
145365266|NCT01074268|524186730|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
145365267|NCT01074268|524186729|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
145365268|NCT01074268|524186730|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
145365269|NCT01074268|524186729|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
145365270|NCT01074268|524186730|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
145365271|NCT01074268|524186729|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
145365272|NCT01074268|524186730|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
145365273|NCT01074268|524186729|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
145365274|NCT01074268|524186730|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
145365275|NCT04200651|524186731|FG000|Overall Study|Moved to another country during follow-up|2|||
145365276|NCT04200651|524186732|FG001|Overall Study|Moved to another country during follow-up|2|||
145365277|NCT04200651|524186731|FG000|Overall Study|Lost to Follow-up|1|||
145365278|NCT04200651|524186732|FG001|Overall Study|Lost to Follow-up|3|||
145365279|NCT00733421|524186733|FG000|Overall Study|Withdrawal by Subject|1|||
145365280|NCT00733421|524186734|FG001|Overall Study|Withdrawal by Subject|1|||
145365281|NCT04185220|524186735|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
145365282|NCT04185220|524186736|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
145365283|NCT04185220|524186735|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
145365284|NCT04185220|524186736|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
145365285|NCT01031680|524186737|FG000|Overall Study|Adverse Event|8|||
145365286|NCT01031680|524186738|FG001|Overall Study|Adverse Event|3|||
145365287|NCT01031680|524186737|FG000|Overall Study|Lost to Follow-up|2|||
145365288|NCT01031680|524186738|FG001|Overall Study|Lost to Follow-up|10|||
145365289|NCT01031680|524186737|FG000|Overall Study|Withdrawal by Subject|12|||
145365290|NCT01031680|524186738|FG001|Overall Study|Withdrawal by Subject|16|||
145365291|NCT01031680|524186737|FG000|Overall Study|Death|2|||
145365292|NCT01031680|524186738|FG001|Overall Study|Death|1|||
145365293|NCT01031680|524186737|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
145365294|NCT01031680|524186738|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
145365295|NCT01031680|524186737|FG000|Overall Study|Poor/Non-compliance|5|||
145365296|NCT01031680|524186738|FG001|Overall Study|Poor/Non-compliance|6|||
145365297|NCT01031680|524186737|FG000|Overall Study|Safety|1|||
145365298|NCT01031680|524186738|FG001|Overall Study|Safety|0|||
145365299|NCT01031680|524186737|FG000|Overall Study|Incorrect Enrolment|1|||
145365300|NCT01031680|524186738|FG001|Overall Study|Incorrect Enrolment|2|||
145365301|NCT01031680|524186737|FG000|Overall Study|Administrative Reason by Sponsor|0|||
145365302|NCT01031680|524186738|FG001|Overall Study|Administrative Reason by Sponsor|1|||
145365303|NCT01031680|524186737|FG000|Overall Study|Various|0|||
145365304|NCT01031680|524186738|FG001|Overall Study|Various|2|||
145365305|NCT01029782|524186741|FG000|Overall Study|Lost to Follow-up|2|||
145365306|NCT01029782|524186742|FG001|Overall Study|Lost to Follow-up|2|||
145365307|NCT01029782|524186741|FG000|Overall Study|Diagnosis changed|1|||
145365308|NCT01029782|524186742|FG001|Overall Study|Diagnosis changed|1|||
145365309|NCT01029782|524186741|FG000|Overall Study|Adverse Event|0|||
145365310|NCT01029782|524186742|FG001|Overall Study|Adverse Event|1|||
145365311|NCT01029782|524186741|FG000|Overall Study|Physician Decision|0|||
145365312|NCT01029782|524186742|FG001|Overall Study|Physician Decision|1|||
145365313|NCT01029782|524186741|FG000|Overall Study|Protocol Violation|0|||
145365314|NCT01029782|524186742|FG001|Overall Study|Protocol Violation|2|||
145365315|NCT01029782|524186741|FG000|Overall Study|Withdrawal by Subject|0|||
145365316|NCT01029782|524186742|FG001|Overall Study|Withdrawal by Subject|1|||
145365317|NCT03232931|524188190|FG000|Overall Study|Physician Decision|1|||
145365318|NCT03232931|524188191|FG001|Overall Study|Physician Decision|1|||
145365319|NCT03232931|524188190|FG000|Overall Study|Withdrawal by Subject|6|||
145365320|NCT03232931|524188191|FG001|Overall Study|Withdrawal by Subject|0|||
145365321|NCT03232931|524188190|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
145365322|NCT03232931|524188191|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
145365323|NCT03232931|524188190|FG000|Overall Study|Parent did not record voice|1|||
145365324|NCT03232931|524188191|FG001|Overall Study|Parent did not record voice|2|||
145365325|NCT03232931|524188190|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
145365326|NCT03232931|524188191|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
145365327|NCT01190410|524188192|FG000|Overall Study|Adverse Event|0|||
145365328|NCT01190410|524188193|FG001|Overall Study|Adverse Event|3|||
145365329|NCT01190410|524188192|FG000|Overall Study|Lack of Efficacy|0|||
145365330|NCT01190410|524188193|FG001|Overall Study|Lack of Efficacy|2|||
145365331|NCT01190410|524188192|FG000|Overall Study|Withdrawal by Subject|0|||
145365332|NCT01190410|524188193|FG001|Overall Study|Withdrawal by Subject|2|||
145365333|NCT01190410|524188192|FG000|Overall Study|Administrative decision|1|||
145365334|NCT01190410|524188193|FG001|Overall Study|Administrative decision|0|||
145365335|NCT01190410|524188192|FG000|Overall Study|PI discretion|0|||
145365336|NCT01190410|524188193|FG001|Overall Study|PI discretion|2|||
145365337|NCT03300505|524188198|FG000|Overall Study|Death|0|||
145365338|NCT03300505|524188199|FG001|Overall Study|Death|1|||
145365339|NCT03300505|524188200|FG002|Overall Study|Death|0|||
145365340|NCT03300505|524188198|FG000|Overall Study|Withdrawal by Subject|0|||
145365341|NCT03300505|524188199|FG001|Overall Study|Withdrawal by Subject|1|||
145365342|NCT03300505|524188200|FG002|Overall Study|Withdrawal by Subject|1|||
145365343|NCT03300505|524188198|FG000|Overall Study|Sponsor Termination|0|||
145365344|NCT03300505|524188199|FG001|Overall Study|Sponsor Termination|1|||
145365345|NCT03300505|524188200|FG002|Overall Study|Sponsor Termination|0|||
145365346|NCT03300505|524188198|FG000|Overall Study|Adverse Event|0|||
145365347|NCT03300505|524188199|FG001|Overall Study|Adverse Event|0|||
145365348|NCT03300505|524188200|FG002|Overall Study|Adverse Event|2|||
145365349|NCT05088603|524188201|FG000|Overall Study|Protocol Violation|6|||
145365350|NCT05088603|524188202|FG001|Overall Study|Protocol Violation|1|||
145365351|NCT03233529|524188208|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
145365352|NCT03233529|524188208|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
145365353|NCT03260244|524188209|FG000|Overall Study|Death|19|||
145365354|NCT03260244|524188209|FG000|Overall Study|Lost to Follow-up|60|||
145365355|NCT03260244|524188209|FG000|Overall Study|Withdrawal by Subject|48|||
145365356|NCT03260244|524188209|FG000|Overall Study|Procedure Not Performed|21|||
145365357|NCT03260244|524188209|FG000|Overall Study|Enrollment Criteria Not Met|31|||
145365358|NCT03260244|524188209|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
145365359|NCT03260244|524188209|FG000|Overall Study|Subject Noncompliance|6|||
145365360|NCT03260244|524188209|FG000|Overall Study|No inducible Arrhythmia|2|||
145365361|NCT03260244|524188209|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
145365362|NCT03260244|524188209|FG000|Overall Study|Screen Failure|2|||
145365363|NCT03260244|524188209|FG000|Overall Study|Treated Off Label|69|||
145365364|NCT03260244|524188209|FG000|Overall Study|No Radiofrequency Ablation|14|||
145365365|NCT00594100|524188216|FG000|Procedure|Technical Failure|9|||
145365366|NCT00594100|524188216|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
145365367|NCT00594100|524188216|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
145365368|NCT00594100|524188216|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
145365369|NCT00610155|524188221|FG000|Period 1|Withdrawal by Subject|0|||
145365370|NCT00610155|524188222|FG001|Period 1|Withdrawal by Subject|0|||
145365371|NCT00610155|524188223|FG002|Period 1|Withdrawal by Subject|1|||
145365372|NCT00610155|524188224|FG003|Period 1|Withdrawal by Subject|0|||
145365373|NCT00610155|524188225|FG004|Period 1|Withdrawal by Subject|0|||
145365374|NCT00610155|524188226|FG005|Period 1|Withdrawal by Subject|0|||
145365375|NCT00610155|524188221|FG000|Period 3|Adverse Event|1|||
145365376|NCT00610155|524188222|FG001|Period 3|Adverse Event|0|||
145365377|NCT00610155|524188223|FG002|Period 3|Adverse Event|0|||
145365378|NCT00610155|524188224|FG003|Period 3|Adverse Event|0|||
145365379|NCT00610155|524188225|FG004|Period 3|Adverse Event|0|||
145365380|NCT00610155|524188226|FG005|Period 3|Adverse Event|0|||
145365381|NCT01284348|524188227|FG000|Overall Study|Death|1|||
145365382|NCT01284348|524188228|FG001|Overall Study|Death|1|||
145365383|NCT01284348|524188227|FG000|Overall Study|Withdrew consent|0|||
145365384|NCT01284348|524188228|FG001|Overall Study|Withdrew consent|1|||
145365385|NCT01284348|524188227|FG000|Overall Study|Status not recorded|9|||
145365386|NCT01284348|524188228|FG001|Overall Study|Status not recorded|10|||
145365387|NCT00083759|524188231|FG000|Overall Study|Adverse Event|5|||
145365388|NCT00083759|524188232|FG001|Overall Study|Adverse Event|3|||
145365389|NCT00083759|524188231|FG000|Overall Study|Lost to Follow-up|1|||
145365390|NCT00083759|524188232|FG001|Overall Study|Lost to Follow-up|0|||
145365391|NCT00083759|524188231|FG000|Overall Study|Death|1|||
145365392|NCT00083759|524188232|FG001|Overall Study|Death|1|||
145365393|NCT00083759|524188231|FG000|Overall Study|Inadequate Therapeutic Response|32|||
145365394|NCT00083759|524188232|FG001|Overall Study|Inadequate Therapeutic Response|35|||
145420984|NCT02991859|524396088|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
145420985|NCT02991859|524396089|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420986|NCT02991859|524396090|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145365395|NCT00083759|524188231|FG000|Overall Study|Subject Withdrew Consent|2|||
145365396|NCT00083759|524188232|FG001|Overall Study|Subject Withdrew Consent|2|||
145365397|NCT00083759|524188231|FG000|Overall Study|Non-Compliance|1|||
145420987|NCT02991859|524396091|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
145420988|NCT02991859|524396075|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145623201|NCT01077024|525131614|FG001|Overall Study|Lost to Follow-up|14|||
145623202|NCT01077024|525131613|FG000|Overall Study|Withdrawal by Subject|0|||
145623203|NCT01077024|525131614|FG001|Overall Study|Withdrawal by Subject|2|||
145365398|NCT00083759|524188232|FG001|Overall Study|Non-Compliance|0|||
145365399|NCT00083759|524188231|FG000|Overall Study|Sponsor's Discretion|28|||
145365400|NCT00083759|524188232|FG001|Overall Study|Sponsor's Discretion|29|||
145365401|NCT00083759|524188231|FG000|Overall Study|Other|14|||
145365402|NCT00083759|524188232|FG001|Overall Study|Other|13|||
145365403|NCT03645395|524188233|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
145365404|NCT03645395|524188234|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
145365405|NCT03645395|524188235|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
145365406|NCT03645395|524188236|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
145365407|NCT03645395|524188233|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
145365408|NCT03645395|524188234|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
145365409|NCT03645395|524188235|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
145365410|NCT03645395|524188236|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
145365411|NCT03645395|524188233|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145365412|NCT03645395|524188234|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145365413|NCT03645395|524188235|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
145365414|NCT03645395|524188236|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
145365415|NCT03645395|524188233|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
145365416|NCT03645395|524188234|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
145365417|NCT03645395|524188235|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
145365418|NCT03645395|524188236|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
145365419|NCT02564900|524188237|FG000|Dose Escalation|Progressive disease per RECIST|2|||
145365420|NCT02564900|524188238|FG001|Dose Escalation|Progressive disease per RECIST|3|||
145365421|NCT02564900|524188239|FG002|Dose Escalation|Progressive disease per RECIST|3|||
145365422|NCT02564900|524188240|FG003|Dose Escalation|Progressive disease per RECIST|3|||
145365423|NCT02564900|524188241|FG004|Dose Escalation|Progressive disease per RECIST|3|||
145365424|NCT02564900|524188242|FG005|Dose Escalation|Progressive disease per RECIST|1|||
145365425|NCT02564900|524188243|FG006|Dose Escalation|Progressive disease per RECIST|0|||
145365426|NCT02564900|524188244|FG007|Dose Escalation|Progressive disease per RECIST|0|||
145365427|NCT02564900|524188245|FG008|Dose Escalation|Progressive disease per RECIST|0|||
145365428|NCT02564900|524188246|FG009|Dose Escalation|Progressive disease per RECIST|0|||
145365429|NCT02564900|524188247|FG010|Dose Escalation|Progressive disease per RECIST|0|||
145365430|NCT02564900|524188248|FG011|Dose Escalation|Progressive disease per RECIST|0|||
145365431|NCT02564900|524188249|FG012|Dose Escalation|Progressive disease per RECIST|0|||
145365432|NCT02564900|524188250|FG013|Dose Escalation|Progressive disease per RECIST|0|||
145365433|NCT02564900|524188251|FG014|Dose Escalation|Progressive disease per RECIST|0|||
145365434|NCT02564900|524188237|FG000|Dose Escalation|Ongoing|1|||
145365435|NCT02564900|524188238|FG001|Dose Escalation|Ongoing|0|||
145365436|NCT02564900|524188239|FG002|Dose Escalation|Ongoing|0|||
145365437|NCT02564900|524188240|FG003|Dose Escalation|Ongoing|2|||
145365438|NCT02564900|524188241|FG004|Dose Escalation|Ongoing|2|||
145365439|NCT02564900|524188242|FG005|Dose Escalation|Ongoing|2|||
145365440|NCT02564900|524188243|FG006|Dose Escalation|Ongoing|0|||
145365441|NCT02564900|524188244|FG007|Dose Escalation|Ongoing|0|||
145365442|NCT02564900|524188245|FG008|Dose Escalation|Ongoing|0|||
145365443|NCT02564900|524188246|FG009|Dose Escalation|Ongoing|0|||
145365444|NCT02564900|524188247|FG010|Dose Escalation|Ongoing|0|||
145365445|NCT02564900|524188248|FG011|Dose Escalation|Ongoing|0|||
145365446|NCT02564900|524188249|FG012|Dose Escalation|Ongoing|0|||
145365447|NCT02564900|524188250|FG013|Dose Escalation|Ongoing|0|||
145365448|NCT02564900|524188251|FG014|Dose Escalation|Ongoing|0|||
145365449|NCT02564900|524188237|FG000|Dose Escalation|Adverse Event|0|||
145365450|NCT02564900|524188238|FG001|Dose Escalation|Adverse Event|0|||
145365451|NCT02564900|524188239|FG002|Dose Escalation|Adverse Event|0|||
145420989|NCT02991859|524396076|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420990|NCT02991859|524396077|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420991|NCT02991859|524396078|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420992|NCT02991859|524396079|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420993|NCT02991859|524396080|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
145420994|NCT02991859|524396081|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420995|NCT02991859|524396082|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420996|NCT02991859|524396083|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145365452|NCT02564900|524188240|FG003|Dose Escalation|Adverse Event|1|||
145365453|NCT02564900|524188241|FG004|Dose Escalation|Adverse Event|1|||
145365454|NCT02564900|524188242|FG005|Dose Escalation|Adverse Event|3|||
145365455|NCT02564900|524188243|FG006|Dose Escalation|Adverse Event|0|||
145365456|NCT02564900|524188244|FG007|Dose Escalation|Adverse Event|0|||
145365457|NCT02564900|524188245|FG008|Dose Escalation|Adverse Event|0|||
145365458|NCT02564900|524188246|FG009|Dose Escalation|Adverse Event|0|||
145420997|NCT02991859|524396084|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145365459|NCT02564900|524188247|FG010|Dose Escalation|Adverse Event|0|||
145365460|NCT02564900|524188248|FG011|Dose Escalation|Adverse Event|0|||
145365461|NCT02564900|524188249|FG012|Dose Escalation|Adverse Event|0|||
145365462|NCT02564900|524188250|FG013|Dose Escalation|Adverse Event|0|||
145365463|NCT02564900|524188251|FG014|Dose Escalation|Adverse Event|0|||
145365464|NCT02564900|524188237|FG000|Dose Expansion|Progressive disease per RECIST|0|||
145365465|NCT02564900|524188238|FG001|Dose Expansion|Progressive disease per RECIST|0|||
145365466|NCT02564900|524188239|FG002|Dose Expansion|Progressive disease per RECIST|0|||
145365467|NCT02564900|524188240|FG003|Dose Expansion|Progressive disease per RECIST|0|||
145365468|NCT02564900|524188241|FG004|Dose Expansion|Progressive disease per RECIST|0|||
145365469|NCT02564900|524188242|FG005|Dose Expansion|Progressive disease per RECIST|0|||
145365470|NCT02564900|524188243|FG006|Dose Expansion|Progressive disease per RECIST|19|||
145365471|NCT02564900|524188244|FG007|Dose Expansion|Progressive disease per RECIST|17|||
145365472|NCT02564900|524188245|FG008|Dose Expansion|Progressive disease per RECIST|8|||
145365473|NCT02564900|524188246|FG009|Dose Expansion|Progressive disease per RECIST|16|||
145365474|NCT02564900|524188247|FG010|Dose Expansion|Progressive disease per RECIST|13|||
145365475|NCT02564900|524188248|FG011|Dose Expansion|Progressive disease per RECIST|19|||
145365476|NCT02564900|524188249|FG012|Dose Expansion|Progressive disease per RECIST|10|||
145365477|NCT02564900|524188250|FG013|Dose Expansion|Progressive disease per RECIST|13|||
145365478|NCT02564900|524188251|FG014|Dose Expansion|Progressive disease per RECIST|11|||
145365479|NCT02564900|524188237|FG000|Dose Expansion|Clinical progression|0|||
145365480|NCT02564900|524188238|FG001|Dose Expansion|Clinical progression|0|||
145365481|NCT02564900|524188239|FG002|Dose Expansion|Clinical progression|0|||
145365482|NCT02564900|524188240|FG003|Dose Expansion|Clinical progression|0|||
145365483|NCT02564900|524188241|FG004|Dose Expansion|Clinical progression|0|||
145365484|NCT02564900|524188242|FG005|Dose Expansion|Clinical progression|0|||
145365485|NCT02564900|524188243|FG006|Dose Expansion|Clinical progression|5|||
145365486|NCT02564900|524188244|FG007|Dose Expansion|Clinical progression|12|||
145365487|NCT02564900|524188245|FG008|Dose Expansion|Clinical progression|0|||
145365488|NCT02564900|524188246|FG009|Dose Expansion|Clinical progression|3|||
145365489|NCT02564900|524188247|FG010|Dose Expansion|Clinical progression|2|||
145365490|NCT02564900|524188248|FG011|Dose Expansion|Clinical progression|0|||
145365491|NCT02564900|524188249|FG012|Dose Expansion|Clinical progression|1|||
145365492|NCT02564900|524188250|FG013|Dose Expansion|Clinical progression|3|||
145365493|NCT02564900|524188251|FG014|Dose Expansion|Clinical progression|1|||
145365494|NCT02564900|524188237|FG000|Dose Expansion|Adverse Event|0|||
145365495|NCT02564900|524188238|FG001|Dose Expansion|Adverse Event|0|||
145365496|NCT02564900|524188239|FG002|Dose Expansion|Adverse Event|0|||
145365497|NCT02564900|524188240|FG003|Dose Expansion|Adverse Event|0|||
145365498|NCT02564900|524188241|FG004|Dose Expansion|Adverse Event|0|||
145365499|NCT02564900|524188242|FG005|Dose Expansion|Adverse Event|0|||
145365500|NCT02564900|524188243|FG006|Dose Expansion|Adverse Event|9|||
145365501|NCT02564900|524188244|FG007|Dose Expansion|Adverse Event|22|||
145365502|NCT02564900|524188245|FG008|Dose Expansion|Adverse Event|0|||
145365503|NCT02564900|524188246|FG009|Dose Expansion|Adverse Event|11|||
145365504|NCT02564900|524188247|FG010|Dose Expansion|Adverse Event|0|||
145365505|NCT02564900|524188248|FG011|Dose Expansion|Adverse Event|5|||
145365506|NCT02564900|524188249|FG012|Dose Expansion|Adverse Event|2|||
145365507|NCT02564900|524188250|FG013|Dose Expansion|Adverse Event|2|||
145365508|NCT02564900|524188251|FG014|Dose Expansion|Adverse Event|1|||
145365509|NCT02564900|524188237|FG000|Dose Expansion|Ongoing|0|||
145365510|NCT02564900|524188238|FG001|Dose Expansion|Ongoing|0|||
145365511|NCT02564900|524188239|FG002|Dose Expansion|Ongoing|0|||
145365512|NCT02564900|524188240|FG003|Dose Expansion|Ongoing|0|||
145365513|NCT02564900|524188241|FG004|Dose Expansion|Ongoing|0|||
145365514|NCT02564900|524188242|FG005|Dose Expansion|Ongoing|0|||
145365515|NCT02564900|524188243|FG006|Dose Expansion|Ongoing|9|||
145365516|NCT02564900|524188244|FG007|Dose Expansion|Ongoing|10|||
145365517|NCT02564900|524188245|FG008|Dose Expansion|Ongoing|11|||
145365518|NCT02564900|524188246|FG009|Dose Expansion|Ongoing|3|||
145365519|NCT02564900|524188247|FG010|Dose Expansion|Ongoing|0|||
145365520|NCT02564900|524188248|FG011|Dose Expansion|Ongoing|0|||
145365521|NCT02564900|524188249|FG012|Dose Expansion|Ongoing|4|||
145365522|NCT02564900|524188250|FG013|Dose Expansion|Ongoing|0|||
145577901|NCT01923181|524971339|FG002|Overall Study|Other|0|||
145577902|NCT01923181|524971340|FG003|Overall Study|Other|1|||
145365523|NCT02564900|524188251|FG014|Dose Expansion|Ongoing|6|||
145365524|NCT02564900|524188237|FG000|Dose Expansion|Death|0|||
145577903|NCT01923181|524971341|FG004|Overall Study|Other|0|||
145365525|NCT02564900|524188238|FG001|Dose Expansion|Death|0|||
145365526|NCT02564900|524188239|FG002|Dose Expansion|Death|0|||
145365527|NCT02564900|524188240|FG003|Dose Expansion|Death|0|||
145365528|NCT02564900|524188241|FG004|Dose Expansion|Death|0|||
145365529|NCT02564900|524188242|FG005|Dose Expansion|Death|0|||
145365530|NCT02564900|524188243|FG006|Dose Expansion|Death|1|||
145365531|NCT02564900|524188244|FG007|Dose Expansion|Death|0|||
145365532|NCT02564900|524188245|FG008|Dose Expansion|Death|0|||
145365533|NCT02564900|524188246|FG009|Dose Expansion|Death|0|||
145365534|NCT02564900|524188247|FG010|Dose Expansion|Death|1|||
145365535|NCT02564900|524188248|FG011|Dose Expansion|Death|0|||
145365536|NCT02564900|524188249|FG012|Dose Expansion|Death|1|||
145365537|NCT02564900|524188250|FG013|Dose Expansion|Death|1|||
145365538|NCT02564900|524188251|FG014|Dose Expansion|Death|0|||
145365539|NCT02564900|524188237|FG000|Dose Expansion|Withdrawal by Subject|0|||
145365540|NCT02564900|524188238|FG001|Dose Expansion|Withdrawal by Subject|0|||
145365541|NCT02564900|524188239|FG002|Dose Expansion|Withdrawal by Subject|0|||
145365542|NCT02564900|524188240|FG003|Dose Expansion|Withdrawal by Subject|0|||
145365543|NCT02564900|524188241|FG004|Dose Expansion|Withdrawal by Subject|0|||
145365544|NCT02564900|524188242|FG005|Dose Expansion|Withdrawal by Subject|0|||
145365545|NCT02564900|524188243|FG006|Dose Expansion|Withdrawal by Subject|4|||
145365546|NCT02564900|524188244|FG007|Dose Expansion|Withdrawal by Subject|0|||
145365547|NCT02564900|524188245|FG008|Dose Expansion|Withdrawal by Subject|0|||
145365548|NCT02564900|524188246|FG009|Dose Expansion|Withdrawal by Subject|0|||
145365549|NCT02564900|524188247|FG010|Dose Expansion|Withdrawal by Subject|1|||
145365550|NCT02564900|524188248|FG011|Dose Expansion|Withdrawal by Subject|0|||
145365551|NCT02564900|524188249|FG012|Dose Expansion|Withdrawal by Subject|0|||
145365552|NCT02564900|524188250|FG013|Dose Expansion|Withdrawal by Subject|1|||
145365553|NCT02564900|524188251|FG014|Dose Expansion|Withdrawal by Subject|1|||
145365554|NCT02564900|524188237|FG000|Dose Expansion|Other|0|||
145365555|NCT02564900|524188238|FG001|Dose Expansion|Other|0|||
145365556|NCT02564900|524188239|FG002|Dose Expansion|Other|0|||
145365557|NCT02564900|524188240|FG003|Dose Expansion|Other|0|||
145365558|NCT02564900|524188241|FG004|Dose Expansion|Other|0|||
145365559|NCT02564900|524188242|FG005|Dose Expansion|Other|0|||
145365560|NCT02564900|524188243|FG006|Dose Expansion|Other|1|||
145365561|NCT02564900|524188244|FG007|Dose Expansion|Other|0|||
145365562|NCT02564900|524188245|FG008|Dose Expansion|Other|1|||
145365563|NCT02564900|524188246|FG009|Dose Expansion|Other|0|||
145365564|NCT02564900|524188247|FG010|Dose Expansion|Other|0|||
145365565|NCT02564900|524188248|FG011|Dose Expansion|Other|0|||
145365566|NCT02564900|524188249|FG012|Dose Expansion|Other|0|||
145365567|NCT02564900|524188250|FG013|Dose Expansion|Other|0|||
145365568|NCT02564900|524188251|FG014|Dose Expansion|Other|1|||
145365569|NCT02564900|524188237|FG000|Dose Expansion|Did not receive treatment|0|||
145365570|NCT02564900|524188238|FG001|Dose Expansion|Did not receive treatment|0|||
145365571|NCT02564900|524188239|FG002|Dose Expansion|Did not receive treatment|0|||
145365572|NCT02564900|524188240|FG003|Dose Expansion|Did not receive treatment|0|||
145365573|NCT02564900|524188241|FG004|Dose Expansion|Did not receive treatment|0|||
145365574|NCT02564900|524188242|FG005|Dose Expansion|Did not receive treatment|0|||
145365575|NCT02564900|524188243|FG006|Dose Expansion|Did not receive treatment|1|||
145365576|NCT02564900|524188244|FG007|Dose Expansion|Did not receive treatment|1|||
145365577|NCT02564900|524188245|FG008|Dose Expansion|Did not receive treatment|0|||
145365578|NCT02564900|524188246|FG009|Dose Expansion|Did not receive treatment|0|||
145365579|NCT02564900|524188247|FG010|Dose Expansion|Did not receive treatment|0|||
145365580|NCT02564900|524188248|FG011|Dose Expansion|Did not receive treatment|0|||
145365581|NCT02564900|524188249|FG012|Dose Expansion|Did not receive treatment|0|||
145365582|NCT02564900|524188250|FG013|Dose Expansion|Did not receive treatment|0|||
145365583|NCT02564900|524188251|FG014|Dose Expansion|Did not receive treatment|1|||
145365584|NCT00892151|524188252|FG000|Overall Study|Protocol Violation|1|||
145365585|NCT00379080|524188255|FG000|Overall Study|Withdrawal by Subject|0|||
145365586|NCT00379080|524188256|FG001|Overall Study|Withdrawal by Subject|4|||
145365587|NCT00379080|524188257|FG002|Overall Study|Withdrawal by Subject|0|||
145365588|NCT01222520|524188258|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
145365589|NCT01222520|524188259|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
145365590|NCT01222520|524188258|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
145365591|NCT01222520|524188259|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
145365592|NCT01222520|524188258|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
145365593|NCT01222520|524188259|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
145365594|NCT01222520|524188258|FG000|Double-blind Period|Adverse Event|0|||
145365595|NCT01222520|524188259|FG001|Double-blind Period|Adverse Event|1|||
145365596|NCT01222520|524188258|FG000|Double-blind Period|Lack of Efficacy|0|||
145365597|NCT01222520|524188259|FG001|Double-blind Period|Lack of Efficacy|1|||
145365598|NCT01222520|524188258|FG000|Double-blind Period|Study medication stolen|1|||
145365599|NCT01222520|524188259|FG001|Double-blind Period|Study medication stolen|0|||
145365600|NCT02285166|524188260|FG000|Overall Study|Case Report Forms Uncollected|564|||
145365601|NCT02285166|524188260|FG000|Overall Study|Protocol Deviation|402|||
145365602|NCT01089608|524188261|FG000|Overall Study|Adverse Event|0|||
145365603|NCT01089608|524188262|FG001|Overall Study|Adverse Event|4|||
145365604|NCT01089608|524188261|FG000|Overall Study|Lost to Follow-up|0|||
145365605|NCT01089608|524188262|FG001|Overall Study|Lost to Follow-up|2|||
145365606|NCT02920008|524188263|FG000|Overall Study|Death|117|||
145365607|NCT02920008|524188264|FG001|Overall Study|Death|127|||
145365608|NCT02920008|524188263|FG000|Overall Study|Withdrawal by Subject|3|||
145365609|NCT02920008|524188264|FG001|Overall Study|Withdrawal by Subject|6|||
145365610|NCT02920008|524188263|FG000|Overall Study|Lost to Follow-up|0|||
145365611|NCT02920008|524188264|FG001|Overall Study|Lost to Follow-up|1|||
145365612|NCT01862250|524188265|FG000|Overall Study|Adverse Event|4|||
145365613|NCT00090493|524188266|FG000|Overall Study|Physician Decision|2|||
145420998|NCT02991859|524396085|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145420999|NCT02991859|524396086|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421000|NCT02991859|524396087|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421001|NCT02991859|524396088|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421002|NCT02991859|524396089|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421003|NCT02991859|524396090|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421004|NCT02991859|524396091|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
145421005|NCT02991859|524396075|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421006|NCT02991859|524396076|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421007|NCT02991859|524396077|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421008|NCT02991859|524396078|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421009|NCT02991859|524396079|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421010|NCT02991859|524396080|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421011|NCT02991859|524396081|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421012|NCT02991859|524396082|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421013|NCT02991859|524396083|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421014|NCT02991859|524396084|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
145421015|NCT02991859|524396085|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421016|NCT02991859|524396086|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421017|NCT02991859|524396087|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421018|NCT02991859|524396088|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421019|NCT02991859|524396089|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421020|NCT02991859|524396090|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421021|NCT02991859|524396091|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
145421022|NCT02991859|524396075|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421023|NCT02991859|524396076|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421024|NCT02991859|524396077|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421025|NCT02991859|524396078|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421026|NCT02991859|524396079|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421027|NCT02991859|524396080|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421028|NCT02991859|524396081|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421029|NCT02991859|524396082|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421030|NCT02991859|524396083|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
145421031|NCT02991859|524396084|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421032|NCT02991859|524396085|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421033|NCT02991859|524396086|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421034|NCT02991859|524396087|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421035|NCT02991859|524396088|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421036|NCT02991859|524396089|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421037|NCT02991859|524396090|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421038|NCT02991859|524396091|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
145421039|NCT05652140|524396093|FG000|Overall Study|Lost to Follow-up|7|||
145421040|NCT05652140|524396094|FG001|Overall Study|Lost to Follow-up|16|||
145421041|NCT05652140|524396095|FG002|Overall Study|Lost to Follow-up|22|||
145421042|NCT05652140|524396096|FG003|Overall Study|Lost to Follow-up|31|||
145421043|NCT03163264|524396098|FG000|Overall Study|Withdrawal by Subject|13|||
145421044|NCT03163264|524396099|FG001|Overall Study|Withdrawal by Subject|3|||
145421045|NCT03163264|524396100|FG002|Overall Study|Withdrawal by Subject|4|||
145421046|NCT03163264|524396101|FG003|Overall Study|Withdrawal by Subject|2|||
145421047|NCT03163264|524396098|FG000|Overall Study|Lost to Follow-up|17|||
145421048|NCT03163264|524396099|FG001|Overall Study|Lost to Follow-up|20|||
145421049|NCT03163264|524396100|FG002|Overall Study|Lost to Follow-up|0|||
145421050|NCT03163264|524396101|FG003|Overall Study|Lost to Follow-up|0|||
145421051|NCT03163264|524396098|FG000|Overall Study|Death|0|||
145421052|NCT03163264|524396099|FG001|Overall Study|Death|2|||
145421053|NCT03163264|524396100|FG002|Overall Study|Death|0|||
145421054|NCT03163264|524396101|FG003|Overall Study|Death|0|||
145421055|NCT04648241|524396102|FG000|Overall Study|Lost to Follow-up|1|||
145421056|NCT04648241|524396103|FG001|Overall Study|Lost to Follow-up|0|||
145421057|NCT04401293|524396107|FG000|Overall Study|Withdrawal by Subject|1|||
145421058|NCT04401293|524396108|FG001|Overall Study|Withdrawal by Subject|3|||
145421059|NCT03679884|524396109|FG000|Overall Study|Other|12|||
145421060|NCT03679884|524396110|FG001|Overall Study|Other|12|||
145421061|NCT03679884|524396111|FG002|Overall Study|Other|12|||
145421062|NCT03679884|524396112|FG003|Overall Study|Other|7|||
145421063|NCT03679884|524396113|FG004|Overall Study|Other|8|||
145421064|NCT03679884|524396109|FG000|Overall Study|Lack of Efficacy|15|||
145421065|NCT03679884|524396110|FG001|Overall Study|Lack of Efficacy|29|||
145421066|NCT03679884|524396111|FG002|Overall Study|Lack of Efficacy|13|||
145421067|NCT03679884|524396112|FG003|Overall Study|Lack of Efficacy|29|||
145421068|NCT03679884|524396113|FG004|Overall Study|Lack of Efficacy|10|||
145421069|NCT03679884|524396109|FG000|Overall Study|Death|1|||
145421070|NCT03679884|524396110|FG001|Overall Study|Death|0|||
145421071|NCT03679884|524396111|FG002|Overall Study|Death|0|||
145365614|NCT00637000|524188269|FG000|Overall Study|Withdrawal by Subject|4|||
145365615|NCT00637000|524188270|FG001|Overall Study|Withdrawal by Subject|3|||
145365616|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
145577904|NCT01923181|524971342|FG005|Overall Study|Other|0|||
145577905|NCT01923181|524971343|FG006|Overall Study|Other|0|||
145577906|NCT01923181|524971344|FG007|Overall Study|Other|0|||
145577907|NCT01923181|524971345|FG008|Overall Study|Other|0|||
145577908|NCT01923181|524971337|FG000|Overall Study|Lost to Follow-up|0|||
145577909|NCT01923181|524971338|FG001|Overall Study|Lost to Follow-up|3|||
145577910|NCT01923181|524971339|FG002|Overall Study|Lost to Follow-up|2|||
145577911|NCT01923181|524971340|FG003|Overall Study|Lost to Follow-up|1|||
145577912|NCT01923181|524971341|FG004|Overall Study|Lost to Follow-up|2|||
145577913|NCT01923181|524971342|FG005|Overall Study|Lost to Follow-up|1|||
145577914|NCT01923181|524971343|FG006|Overall Study|Lost to Follow-up|3|||
145577915|NCT01923181|524971344|FG007|Overall Study|Lost to Follow-up|3|||
145577916|NCT01923181|524971345|FG008|Overall Study|Lost to Follow-up|1|||
145577917|NCT02944578|524971346|FG000|Overall Study|Physician Decision|1|||
145577918|NCT02944578|524971347|FG001|Overall Study|Physician Decision|0|||
145577919|NCT00577122|524971351|FG000|Overall Study|Adverse Event|0|||
145577920|NCT00577122|524971352|FG001|Overall Study|Adverse Event|2|||
145577921|NCT00577122|524971351|FG000|Overall Study|Progression, relapse during active trt|6|||
145577922|NCT00577122|524971352|FG001|Overall Study|Progression, relapse during active trt|8|||
145577923|NCT00577122|524971351|FG000|Overall Study|Prog, refract disease during active trt|8|||
145577924|NCT00577122|524971352|FG001|Overall Study|Prog, refract disease during active trt|5|||
145577925|NCT00577122|524971351|FG000|Overall Study|Alternative Therapy|0|||
145577926|NCT00577122|524971352|FG001|Overall Study|Alternative Therapy|1|||
145577927|NCT00440271|524971354|FG000|Overall Study|Protocol Violation|1|||
145577928|NCT00440271|524971355|FG001|Overall Study|Protocol Violation|1|||
145577929|NCT00440271|524971354|FG000|Overall Study|Adverse Event|0|||
145577930|NCT00440271|524971355|FG001|Overall Study|Adverse Event|1|||
145577931|NCT00440271|524971354|FG000|Overall Study|Lost to Follow-up|1|||
145577932|NCT00440271|524971355|FG001|Overall Study|Lost to Follow-up|0|||
145577933|NCT00440271|524971354|FG000|Overall Study|Withdrawal by Subject|0|||
145577934|NCT00440271|524971355|FG001|Overall Study|Withdrawal by Subject|2|||
145577935|NCT00440271|524971354|FG000|Overall Study|Lack of Efficacy|0|||
145577936|NCT00440271|524971355|FG001|Overall Study|Lack of Efficacy|1|||
145577937|NCT00440271|524971354|FG000|Overall Study|Due to closure of trial|8|||
145577938|NCT00440271|524971355|FG001|Overall Study|Due to closure of trial|10|||
145577939|NCT00440271|524971354|FG000|Overall Study|Other|2|||
145577940|NCT00440271|524971355|FG001|Overall Study|Other|0|||
145577941|NCT00456092|524971356|FG000|Extension Phase|Grade 2 or Greater AE|2|||
145577942|NCT00456092|524971357|FG001|Extension Phase|Grade 2 or Greater AE|2|||
145577943|NCT00456092|524971358|FG002|Extension Phase|Grade 2 or Greater AE|0|||
145577944|NCT00456092|524971359|FG003|Extension Phase|Grade 2 or Greater AE|0|||
145577945|NCT00456092|524971360|FG004|Extension Phase|Grade 2 or Greater AE|2|||
145577946|NCT00456092|524971356|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
145577947|NCT00456092|524971357|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
145577948|NCT00456092|524971358|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
145577949|NCT00456092|524971359|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
145577950|NCT00456092|524971360|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
145577951|NCT00456092|524971356|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
145577952|NCT00456092|524971357|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
145577953|NCT00456092|524971358|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
145577954|NCT00456092|524971359|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
145577955|NCT00456092|524971360|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
145577956|NCT00456092|524971356|FG000|Extension Phase|Withdrew Consent|2|||
145577957|NCT00456092|524971357|FG001|Extension Phase|Withdrew Consent|0|||
145577958|NCT00456092|524971358|FG002|Extension Phase|Withdrew Consent|0|||
145577959|NCT00456092|524971359|FG003|Extension Phase|Withdrew Consent|0|||
145365617|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
145577960|NCT00456092|524971360|FG004|Extension Phase|Withdrew Consent|0|||
145577961|NCT00456092|524971356|FG000|Extension Phase|Lost to Follow-up|1|||
145577962|NCT00456092|524971357|FG001|Extension Phase|Lost to Follow-up|1|||
145577963|NCT00456092|524971358|FG002|Extension Phase|Lost to Follow-up|0|||
145577964|NCT00456092|524971359|FG003|Extension Phase|Lost to Follow-up|0|||
145577965|NCT00456092|524971360|FG004|Extension Phase|Lost to Follow-up|1|||
145577966|NCT00456092|524971356|FG000|Extension Phase|Other|2|||
145577967|NCT00456092|524971357|FG001|Extension Phase|Other|0|||
145577968|NCT00456092|524971358|FG002|Extension Phase|Other|0|||
145577969|NCT00456092|524971359|FG003|Extension Phase|Other|1|||
145577970|NCT00456092|524971360|FG004|Extension Phase|Other|1|||
145577971|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
145577972|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
145577973|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
145577974|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
145577975|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
145421072|NCT03679884|524396112|FG003|Overall Study|Death|0|||
145421073|NCT03679884|524396113|FG004|Overall Study|Death|0|||
145421074|NCT03679884|524396109|FG000|Overall Study|Adverse Event|2|||
145421075|NCT03679884|524396110|FG001|Overall Study|Adverse Event|10|||
145421076|NCT03679884|524396111|FG002|Overall Study|Adverse Event|9|||
145421077|NCT03679884|524396112|FG003|Overall Study|Adverse Event|6|||
145421078|NCT03679884|524396113|FG004|Overall Study|Adverse Event|6|||
145421079|NCT03679884|524396109|FG000|Overall Study|Withdrawal by Subject|12|||
145421080|NCT03679884|524396110|FG001|Overall Study|Withdrawal by Subject|23|||
145421081|NCT03679884|524396111|FG002|Overall Study|Withdrawal by Subject|8|||
145421082|NCT03679884|524396112|FG003|Overall Study|Withdrawal by Subject|8|||
145421083|NCT03679884|524396113|FG004|Overall Study|Withdrawal by Subject|9|||
145421084|NCT03679884|524396109|FG000|Overall Study|Lost to Follow-up|1|||
145421085|NCT03679884|524396110|FG001|Overall Study|Lost to Follow-up|4|||
145421086|NCT03679884|524396111|FG002|Overall Study|Lost to Follow-up|2|||
145421087|NCT03679884|524396112|FG003|Overall Study|Lost to Follow-up|0|||
145421088|NCT03679884|524396113|FG004|Overall Study|Lost to Follow-up|3|||
145421089|NCT01026038|524396114|FG000|Overall Study|Lost to Follow-up|1|||
145421090|NCT01026038|524396115|FG001|Overall Study|Lost to Follow-up|1|||
145421091|NCT01026038|524396116|FG002|Overall Study|Lost to Follow-up|0|||
145421092|NCT02774278|524396117|FG000|Overall Study|Lack of Efficacy|199|||
145421093|NCT02774278|524396117|FG000|Overall Study|Death|29|||
145421094|NCT02774278|524396117|FG000|Overall Study|Adverse event/intercurrent illness|16|||
145421095|NCT02774278|524396117|FG000|Overall Study|Refused treatment/did not cooperate|9|||
145421096|NCT02774278|524396117|FG000|Overall Study|Administrative reasons|6|||
145421097|NCT02774278|524396117|FG000|Overall Study|Withdrawal by Subject|3|||
145421098|NCT02774278|524396117|FG000|Overall Study|Protocol Violation|2|||
145421099|NCT01108055|524396127|FG000|Overall Study|Ineligible|11|||
145421100|NCT01108055|524396127|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
145421101|NCT03339453|524396129|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
145421102|NCT03339453|524396130|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
145421103|NCT00236197|524396134|FG000|Overall Study|Withdrawal by Subject|3|||
145421104|NCT00236197|524396135|FG001|Overall Study|Withdrawal by Subject|2|||
145421105|NCT00236197|524396134|FG000|Overall Study|Lost to Follow-up|1|||
145421106|NCT00236197|524396135|FG001|Overall Study|Lost to Follow-up|5|||
145421107|NCT00236197|524396134|FG000|Overall Study|Protocol Violation|0|||
145421108|NCT00236197|524396135|FG001|Overall Study|Protocol Violation|3|||
145421109|NCT00236197|524396134|FG000|Overall Study|Medication non-compliance|1|||
145421110|NCT00236197|524396135|FG001|Overall Study|Medication non-compliance|2|||
145421111|NCT00236197|524396134|FG000|Overall Study|Other|0|||
145421112|NCT00236197|524396135|FG001|Overall Study|Other|2|||
145421113|NCT03760666|524396138|FG000|Overall Study|Adverse Event|2|||
145421114|NCT03760666|524396139|FG001|Overall Study|Adverse Event|4|||
145421115|NCT03760666|524396140|FG002|Overall Study|Adverse Event|1|||
145421116|NCT03760666|524396138|FG000|Overall Study|AML Disease Progression|3|||
145421117|NCT03760666|524396139|FG001|Overall Study|AML Disease Progression|3|||
145421118|NCT03760666|524396140|FG002|Overall Study|AML Disease Progression|0|||
145421119|NCT03760666|524396138|FG000|Overall Study|Physician Decision|0|||
145421120|NCT03760666|524396139|FG001|Overall Study|Physician Decision|3|||
145421121|NCT03760666|524396140|FG002|Overall Study|Physician Decision|0|||
145421122|NCT03760666|524396138|FG000|Overall Study|Withdrawal by Subject|0|||
145421123|NCT03760666|524396139|FG001|Overall Study|Withdrawal by Subject|1|||
145421124|NCT03760666|524396140|FG002|Overall Study|Withdrawal by Subject|0|||
145421125|NCT00800384|524396146|FG000|Overall Study|Withdrawal by Subject|24|||
145421126|NCT00800384|524396147|FG001|Overall Study|Withdrawal by Subject|17|||
145421127|NCT00800384|524396146|FG000|Overall Study|Lost to Follow-up|17|||
145421128|NCT00800384|524396147|FG001|Overall Study|Lost to Follow-up|26|||
145421129|NCT02946996|524396148|FG000|Overall Study|non-evaluable|3|||
145421130|NCT02946996|524396149|FG001|Overall Study|non-evaluable|6|||
145421131|NCT02946996|524396150|FG002|Overall Study|non-evaluable|5|||
145421132|NCT01245049|524396151|FG000|Overall Study|Migrated/moved from study area|0|||
145421133|NCT01245049|524396152|FG001|Overall Study|Migrated/moved from study area|1|||
145421134|NCT01245049|524396151|FG000|Overall Study|Withdrawal by Subject|0|||
145421135|NCT01245049|524396152|FG001|Overall Study|Withdrawal by Subject|1|||
145421136|NCT01245049|524396151|FG000|Overall Study|Lost to Follow-up|1|||
145421137|NCT01245049|524396152|FG001|Overall Study|Lost to Follow-up|2|||
145421138|NCT02151604|524396153|FG000|Overall Study|Lost to Follow-up|3|||
145421139|NCT02151604|524396153|FG000|Overall Study|Withdrawal by Subject|2|||
145421140|NCT02151604|524396153|FG000|Overall Study|Physician Decision|3|||
145421141|NCT02151604|524396153|FG000|Overall Study|Death|1|||
145421142|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
145421143|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
145421144|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
145421145|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Adverse Event|5|||
145421146|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Adverse Event|1|||
145421147|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Adverse Event|0|||
145421148|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
145421149|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
145577976|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
145577977|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
145577978|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
145577979|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
145577980|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
145577981|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
145577982|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
145577983|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
145577984|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
145577985|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
145577986|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
145365618|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
145365619|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
145365620|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
145365621|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
145365622|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
145365623|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
145365624|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
145365625|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
145365626|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
145365627|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
145365628|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
145365629|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
145365630|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
145365631|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
145365632|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
145365633|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
145365634|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
145365635|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
145365636|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
145365637|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
145365638|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
145365639|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
145365640|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
145365641|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
145365642|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
145365643|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
145365644|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145365645|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
145365646|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
145365647|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
145365648|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
145365649|NCT00839527|524188273|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
145365650|NCT00839527|524188274|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
145365651|NCT00839527|524188275|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
145365652|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145365653|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
145365654|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
145365655|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
145365656|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
145365657|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
145365658|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
145365659|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
145365660|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
145365661|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
145365662|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
145365663|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
145365664|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
145365665|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
145577987|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
145577988|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
145577989|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
145623204|NCT01077024|525131613|FG000|Overall Study|Incarcerated|7|||
145365666|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
145365667|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
145365668|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
145421150|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
145421151|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Death|8|||
145421152|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Death|24|||
145421153|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Death|0|||
145421154|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
145421155|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
145421156|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
145421157|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
145421158|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
145421159|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
145421160|NCT02931539|524396155|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
145421161|NCT02931539|524396156|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
145421162|NCT02931539|524396157|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
145421163|NCT02931539|524396155|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
145421164|NCT02931539|524396156|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
145421165|NCT02931539|524396157|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
145421166|NCT00655746|524396158|FG000|Overall Study|Withdrawal by Subject|1|||
145421167|NCT06097273|524396159|FG000|Overall Study|Death|2|||
145421168|NCT06097273|524396160|FG001|Overall Study|Death|1|||
145421169|NCT06097273|524396161|FG002|Overall Study|Death|2|||
145421170|NCT06097273|524396162|FG003|Overall Study|Death|2|||
145421171|NCT06097273|524396159|FG000|Overall Study|Lost to Follow-up|27|||
145421172|NCT06097273|524396160|FG001|Overall Study|Lost to Follow-up|18|||
145421173|NCT06097273|524396161|FG002|Overall Study|Lost to Follow-up|36|||
145421174|NCT06097273|524396162|FG003|Overall Study|Lost to Follow-up|31|||
145421175|NCT06097273|524396159|FG000|Overall Study|Physician Decision|0|||
145421176|NCT06097273|524396160|FG001|Overall Study|Physician Decision|1|||
145421177|NCT06097273|524396161|FG002|Overall Study|Physician Decision|0|||
145421178|NCT06097273|524396162|FG003|Overall Study|Physician Decision|3|||
145421179|NCT06097273|524396159|FG000|Overall Study|Protocol Violation|1|||
145421180|NCT06097273|524396160|FG001|Overall Study|Protocol Violation|1|||
145421181|NCT06097273|524396161|FG002|Overall Study|Protocol Violation|2|||
145421182|NCT06097273|524396162|FG003|Overall Study|Protocol Violation|1|||
145421183|NCT06097273|524396159|FG000|Overall Study|Withdrawal by Subject|14|||
145421184|NCT06097273|524396160|FG001|Overall Study|Withdrawal by Subject|11|||
145421185|NCT06097273|524396161|FG002|Overall Study|Withdrawal by Subject|14|||
145421186|NCT06097273|524396162|FG003|Overall Study|Withdrawal by Subject|15|||
145421187|NCT06097273|524396159|FG000|Overall Study|Other Than Specified|7|||
145421188|NCT06097273|524396160|FG001|Overall Study|Other Than Specified|3|||
145421189|NCT06097273|524396161|FG002|Overall Study|Other Than Specified|11|||
145421190|NCT06097273|524396162|FG003|Overall Study|Other Than Specified|6|||
145421191|NCT03004183|524397743|FG000|Overall Study|Adverse Event|7|||
145421192|NCT03004183|524397743|FG000|Overall Study|Lost to Follow-up|1|||
145421193|NCT03004183|524397743|FG000|Overall Study|Physician Decision|40|||
145421194|NCT03004183|524397743|FG000|Overall Study|Withdrawal by Subject|1|||
145421195|NCT03004183|524397743|FG000|Overall Study|COVID-19|1|||
145421196|NCT02529488|524397744|FG000|Overall Study|Adverse Event|1|||
145421197|NCT02529488|524397744|FG000|Overall Study|Death|3|||
145421198|NCT02698787|524397745|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
145421199|NCT02698787|524397746|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
145421200|NCT01699685|524397752|FG000|Period 1|Adverse Event|1|||
145421201|NCT01699685|524397753|FG001|Period 1|Adverse Event|1|||
145421202|NCT01699685|524397752|FG000|Period 1|Medical or ethical, noncompliance|2|||
145421203|NCT01699685|524397753|FG001|Period 1|Medical or ethical, noncompliance|0|||
145421204|NCT01699685|524397752|FG000|Period 1|Other|0|||
145421205|NCT01699685|524397753|FG001|Period 1|Other|1|||
145421206|NCT01699685|524397752|FG000|Period 1|Patient request|0|||
145421207|NCT01699685|524397753|FG001|Period 1|Patient request|1|||
145421208|NCT01699685|524397752|FG000|Period 2|Lost to Follow-up|1|||
145421209|NCT01699685|524397753|FG001|Period 2|Lost to Follow-up|0|||
145421210|NCT03635996|524397754|FG000|Overall Study|Study terminated by Sponsor|94|||
145577990|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
145577991|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
145421211|NCT03635996|524397754|FG000|Overall Study|Withdrawal by Subject|20|||
145577992|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
145421212|NCT03635996|524397754|FG000|Overall Study|Ablation|26|||
145421213|NCT03635996|524397754|FG000|Overall Study|Adverse Event|7|||
145421214|NCT03635996|524397754|FG000|Overall Study|Physician Decision|3|||
145421215|NCT03635996|524397754|FG000|Overall Study|Prohibited medication|5|||
145421216|NCT03635996|524397754|FG000|Overall Study|Did not meet eligibility criteria|5|||
145421217|NCT03635996|524397754|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
145421218|NCT03635996|524397754|FG000|Overall Study|Protocol Violation|1|||
145421219|NCT03635996|524397754|FG000|Overall Study|Lost to Follow-up|1|||
145421220|NCT02821000|524397755|FG000|Overall Study|Death|89|||
145577993|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
145623205|NCT01077024|525131614|FG001|Overall Study|Incarcerated|8|||
145577994|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
145577995|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
145577996|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
145577997|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
145577998|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
145577999|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
145578000|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
145578001|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
145578002|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
145578003|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
145578004|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
145578005|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
145578006|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145578007|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145578008|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145578009|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145578010|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145578011|NCT00456092|524971356|FG000|Treatment Phase (12 Weeks)|Other|1|||
145578012|NCT00456092|524971357|FG001|Treatment Phase (12 Weeks)|Other|0|||
145578013|NCT00456092|524971358|FG002|Treatment Phase (12 Weeks)|Other|1|||
145578014|NCT00456092|524971359|FG003|Treatment Phase (12 Weeks)|Other|0|||
145578015|NCT00456092|524971360|FG004|Treatment Phase (12 Weeks)|Other|0|||
145578016|NCT00723801|524971367|FG000|Overall Study|Lost to Follow-up|1|||
145578017|NCT00723801|524971368|FG001|Overall Study|Lost to Follow-up|2|||
145578018|NCT00723801|524971367|FG000|Overall Study|Protocol Violation|2|||
145578019|NCT00723801|524971368|FG001|Overall Study|Protocol Violation|1|||
145578020|NCT02252081|524971382|FG000|Overall Study|Withdrawal by Subject|2|||
145578021|NCT02252081|524971383|FG001|Overall Study|Withdrawal by Subject|1|||
145578022|NCT02252081|524971382|FG000|Overall Study|Adverse Event|4|||
145578023|NCT02252081|524971383|FG001|Overall Study|Adverse Event|1|||
145578024|NCT02252081|524971382|FG000|Overall Study|non compliance & others|0|||
145578025|NCT02252081|524971383|FG001|Overall Study|non compliance & others|2|||
145578026|NCT00048724|524971384|FG000|Overall Study|Adverse Event|53|||
145578027|NCT00048724|524971385|FG001|Overall Study|Adverse Event|12|||
145578028|NCT00048724|524971384|FG000|Overall Study|Withdrawal by Subject|34|||
145578029|NCT00048724|524971385|FG001|Overall Study|Withdrawal by Subject|54|||
145578030|NCT00048724|524971384|FG000|Overall Study|Lost to Follow-up|5|||
145578031|NCT00048724|524971385|FG001|Overall Study|Lost to Follow-up|5|||
145578032|NCT00048724|524971384|FG000|Overall Study|Protocol-defined Clinical Event|17|||
145578033|NCT00048724|524971385|FG001|Overall Study|Protocol-defined Clinical Event|32|||
145578034|NCT00048724|524971384|FG000|Overall Study|Noncompliance With Protocol|4|||
145578035|NCT00048724|524971385|FG001|Overall Study|Noncompliance With Protocol|12|||
145578036|NCT00048724|524971384|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
145578037|NCT00048724|524971385|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
145578038|NCT00048724|524971384|FG000|Overall Study|Administrative|1|||
145578039|NCT00048724|524971385|FG001|Overall Study|Administrative|1|||
145578040|NCT02809976|524971386|FG000|Overall Study|Lost to Follow-up|1|||
145578041|NCT02809976|524971386|FG000|Overall Study|Withdrawal by Subject|1|||
145578042|NCT00211081|524971387|FG000|Overall Study|Withdrawal by Subject|2|||
145578043|NCT00113516|524971388|FG000|Part 1|Adverse Event|6|||
145578044|NCT00113516|524971389|FG001|Part 1|Adverse Event|0|||
145578045|NCT00113516|524971388|FG000|Part 1|Death|3|||
145365669|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
145365670|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
145578046|NCT00113516|524971389|FG001|Part 1|Death|0|||
145578047|NCT00113516|524971388|FG000|Part 1|Other|3|||
145578048|NCT00113516|524971389|FG001|Part 1|Other|0|||
145578049|NCT00113516|524971388|FG000|Part 1|Withdrawal by Subject|2|||
145578050|NCT00113516|524971389|FG001|Part 1|Withdrawal by Subject|0|||
145578051|NCT00113516|524971388|FG000|Part 1|Lack of Efficacy|2|||
145578052|NCT00113516|524971389|FG001|Part 1|Lack of Efficacy|0|||
145578053|NCT00113516|524971388|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
145578054|NCT00113516|524971389|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
145578055|NCT00113516|524971388|FG000|Part 1|Laboratory Abnormality|1|||
145578056|NCT00113516|524971389|FG001|Part 1|Laboratory Abnormality|0|||
145578057|NCT00113516|524971388|FG000|Part 1|Ongoing|1|||
145578058|NCT00113516|524971389|FG001|Part 1|Ongoing|0|||
145578059|NCT00113516|524971388|FG000|Part 1|Missing|65|||
145578060|NCT00113516|524971389|FG001|Part 1|Missing|0|||
145578061|NCT00113516|524971388|FG000|Part 2|Adverse Event|0|||
145578062|NCT00113516|524971389|FG001|Part 2|Adverse Event|16|||
145578063|NCT00113516|524971388|FG000|Part 2|Death|0|||
145578064|NCT00113516|524971389|FG001|Part 2|Death|5|||
145578065|NCT00113516|524971388|FG000|Part 2|Lack of Efficacy|0|||
145578066|NCT00113516|524971389|FG001|Part 2|Lack of Efficacy|37|||
145578067|NCT00113516|524971388|FG000|Part 2|Withdrawal by Subject|0|||
145578068|NCT00113516|524971389|FG001|Part 2|Withdrawal by Subject|3|||
145421221|NCT02821000|524397755|FG000|Overall Study|Sponsor Decision|12|||
145421222|NCT02821000|524397755|FG000|Overall Study|Withdrawal by Subject|2|||
145421223|NCT00326495|524397756|FG000|Overall Study|Switched to alternative treatment|1|||
145421224|NCT00326495|524397756|FG000|Overall Study|Disease progression before treatment|1|||
145421225|NCT00326495|524397756|FG000|Overall Study|Refused further treatment|2|||
145421226|NCT00326495|524397756|FG000|Overall Study|Subject off study before assessment|1|||
145421227|NCT02933151|524397757|FG000|Overall Study|Lost to Follow-up|19|||
145421228|NCT02933151|524397758|FG001|Overall Study|Lost to Follow-up|18|||
145421229|NCT02933151|524397757|FG000|Overall Study|Death|1732|||
145421230|NCT02933151|524397758|FG001|Overall Study|Death|1827|||
145421231|NCT02933151|524397757|FG000|Overall Study|Transplant|210|||
145421232|NCT02933151|524397758|FG001|Overall Study|Transplant|278|||
145421233|NCT02933151|524397757|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
145421234|NCT02933151|524397758|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
145421235|NCT02933151|524397757|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
145421236|NCT02933151|524397758|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
145421237|NCT02933151|524397757|FG000|Overall Study|Recovered Kidney Function|47|||
145421238|NCT02933151|524397758|FG001|Overall Study|Recovered Kidney Function|29|||
145421239|NCT00394472|524397759|FG000|Overall Study|Protocol Violation|1|||
145421240|NCT00394472|524397760|FG001|Overall Study|Protocol Violation|3|||
145421241|NCT00394472|524397759|FG000|Overall Study|incorrect enrolment|4|||
145421242|NCT00394472|524397760|FG001|Overall Study|incorrect enrolment|2|||
145421243|NCT00394472|524397759|FG000|Overall Study|Adverse Event|4|||
145421244|NCT00394472|524397760|FG001|Overall Study|Adverse Event|2|||
145421245|NCT00394472|524397759|FG000|Overall Study|Withdrawal by Subject|0|||
145421246|NCT00394472|524397760|FG001|Overall Study|Withdrawal by Subject|2|||
145421247|NCT00394472|524397759|FG000|Overall Study|Physician Decision|0|||
145421248|NCT00394472|524397760|FG001|Overall Study|Physician Decision|1|||
145421249|NCT00394472|524397759|FG000|Overall Study|Lost to Follow-up|0|||
145421250|NCT00394472|524397760|FG001|Overall Study|Lost to Follow-up|1|||
145421251|NCT04359680|524397761|FG000|Overall Study|Withdrawal by Subject|29|||
145421252|NCT04359680|524397762|FG001|Overall Study|Withdrawal by Subject|24|||
145421253|NCT04359680|524397761|FG000|Overall Study|Adverse Event|6|||
145421254|NCT04359680|524397762|FG001|Overall Study|Adverse Event|2|||
145421255|NCT04359680|524397761|FG000|Overall Study|Lost to Follow-up|56|||
145421256|NCT04359680|524397762|FG001|Overall Study|Lost to Follow-up|59|||
145421257|NCT04359680|524397761|FG000|Overall Study|Protocol Violation|3|||
145421258|NCT04359680|524397762|FG001|Overall Study|Protocol Violation|5|||
145421259|NCT04359680|524397761|FG000|Overall Study|Physician Decision|1|||
145421260|NCT04359680|524397762|FG001|Overall Study|Physician Decision|1|||
145421261|NCT04359680|524397761|FG000|Overall Study|Sponsor Decision|0|||
145421262|NCT04359680|524397762|FG001|Overall Study|Sponsor Decision|1|||
145421263|NCT01654250|524397763|FG000|Overall Study|Lost to Follow-up|1|||
145421264|NCT01654250|524397764|FG001|Overall Study|Lost to Follow-up|0|||
145421265|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
145421266|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
145421267|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
145421268|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
145421269|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
145421270|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
145421271|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
145421272|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
145421273|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145421274|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145421275|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
145421276|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
145421277|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
145421278|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
145421279|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
145421280|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
145421281|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
145421282|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
145421283|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
145421284|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
145421285|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
145421286|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
145421287|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
145421288|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
145421289|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
145421290|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145421291|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145421292|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
145421293|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
145421294|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
145421295|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
145421296|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
145421297|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
145421298|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
145421299|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
145421300|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
145421301|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145421302|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145421303|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
145421304|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
145421305|NCT02596893|524397765|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
145421306|NCT02596893|524397766|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
145421307|NCT02596893|524397767|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
145421308|NCT02596893|524397768|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
145421309|NCT03280615|524397769|FG000|Overall Study|Lost to Follow-up|1|||
145421310|NCT03280615|524397770|FG001|Overall Study|Lost to Follow-up|2|||
145421311|NCT03280615|524397769|FG000|Overall Study|Adverse Event|1|||
145421312|NCT03280615|524397770|FG001|Overall Study|Adverse Event|1|||
145421313|NCT03280615|524397769|FG000|Overall Study|Withdrawal by Subject|2|||
145421314|NCT03280615|524397770|FG001|Overall Study|Withdrawal by Subject|2|||
145421315|NCT00004228|524397773|FG000|Overall Study|Adverse Event|0|||
145421316|NCT00004228|524397774|FG001|Overall Study|Adverse Event|1|||
145421317|NCT00004228|524397775|FG002|Overall Study|Adverse Event|0|||
145421318|NCT00004228|524397776|FG003|Overall Study|Adverse Event|0|||
145421319|NCT00004228|524397777|FG004|Overall Study|Adverse Event|1|||
145421320|NCT00004228|524397778|FG005|Overall Study|Adverse Event|0|||
145421321|NCT00004228|524397779|FG006|Overall Study|Adverse Event|0|||
145421322|NCT00004228|524397773|FG000|Overall Study|Death|0|||
145421323|NCT00004228|524397774|FG001|Overall Study|Death|1|||
145421324|NCT00004228|524397775|FG002|Overall Study|Death|2|||
145421325|NCT00004228|524397776|FG003|Overall Study|Death|0|||
145421326|NCT00004228|524397777|FG004|Overall Study|Death|1|||
145421327|NCT00004228|524397778|FG005|Overall Study|Death|0|||
145421328|NCT00004228|524397779|FG006|Overall Study|Death|0|||
145421329|NCT00004228|524397773|FG000|Overall Study|Lack of Efficacy|1|||
145421330|NCT00004228|524397774|FG001|Overall Study|Lack of Efficacy|6|||
145421331|NCT00004228|524397775|FG002|Overall Study|Lack of Efficacy|5|||
145421332|NCT00004228|524397776|FG003|Overall Study|Lack of Efficacy|3|||
145421333|NCT00004228|524397777|FG004|Overall Study|Lack of Efficacy|9|||
145421334|NCT00004228|524397778|FG005|Overall Study|Lack of Efficacy|8|||
145421335|NCT00004228|524397779|FG006|Overall Study|Lack of Efficacy|4|||
145421336|NCT00004228|524397773|FG000|Overall Study|Lost to Follow-up|0|||
145421337|NCT00004228|524397774|FG001|Overall Study|Lost to Follow-up|0|||
145421338|NCT00004228|524397775|FG002|Overall Study|Lost to Follow-up|1|||
145421339|NCT00004228|524397776|FG003|Overall Study|Lost to Follow-up|0|||
145421340|NCT00004228|524397777|FG004|Overall Study|Lost to Follow-up|0|||
145421341|NCT00004228|524397778|FG005|Overall Study|Lost to Follow-up|0|||
145421342|NCT00004228|524397779|FG006|Overall Study|Lost to Follow-up|0|||
145421343|NCT00004228|524397773|FG000|Overall Study|Physician Decision|1|||
145421344|NCT00004228|524397774|FG001|Overall Study|Physician Decision|0|||
145421345|NCT00004228|524397775|FG002|Overall Study|Physician Decision|3|||
145421346|NCT00004228|524397776|FG003|Overall Study|Physician Decision|2|||
145421347|NCT00004228|524397777|FG004|Overall Study|Physician Decision|1|||
145421348|NCT00004228|524397778|FG005|Overall Study|Physician Decision|1|||
145421349|NCT00004228|524397779|FG006|Overall Study|Physician Decision|1|||
145421350|NCT00004228|524397773|FG000|Overall Study|Protocol Violation|0|||
145421351|NCT00004228|524397774|FG001|Overall Study|Protocol Violation|5|||
145421352|NCT00004228|524397775|FG002|Overall Study|Protocol Violation|2|||
145421353|NCT00004228|524397776|FG003|Overall Study|Protocol Violation|1|||
145421354|NCT00004228|524397777|FG004|Overall Study|Protocol Violation|1|||
145421355|NCT00004228|524397778|FG005|Overall Study|Protocol Violation|2|||
145421356|NCT00004228|524397779|FG006|Overall Study|Protocol Violation|0|||
145421357|NCT00004228|524397773|FG000|Overall Study|Withdrawal by Subject|3|||
145421358|NCT00004228|524397774|FG001|Overall Study|Withdrawal by Subject|0|||
145421359|NCT00004228|524397775|FG002|Overall Study|Withdrawal by Subject|1|||
145421360|NCT00004228|524397776|FG003|Overall Study|Withdrawal by Subject|0|||
145421361|NCT00004228|524397777|FG004|Overall Study|Withdrawal by Subject|2|||
145421362|NCT00004228|524397778|FG005|Overall Study|Withdrawal by Subject|1|||
145421363|NCT00004228|524397779|FG006|Overall Study|Withdrawal by Subject|2|||
145421364|NCT00004228|524397773|FG000|Overall Study|Other|0|||
145421365|NCT00004228|524397774|FG001|Overall Study|Other|0|||
145421366|NCT00004228|524397775|FG002|Overall Study|Other|1|||
145421367|NCT00004228|524397776|FG003|Overall Study|Other|0|||
145421368|NCT00004228|524397777|FG004|Overall Study|Other|0|||
145421369|NCT00004228|524397778|FG005|Overall Study|Other|0|||
145421370|NCT00004228|524397779|FG006|Overall Study|Other|0|||
145421371|NCT00004228|524397773|FG000|Overall Study|ineligible|4|||
145421372|NCT00004228|524397774|FG001|Overall Study|ineligible|2|||
145421373|NCT00004228|524397775|FG002|Overall Study|ineligible|4|||
145421374|NCT00004228|524397776|FG003|Overall Study|ineligible|1|||
145421375|NCT00004228|524397777|FG004|Overall Study|ineligible|1|||
145421376|NCT00004228|524397778|FG005|Overall Study|ineligible|2|||
145421377|NCT00004228|524397779|FG006|Overall Study|ineligible|5|||
145421378|NCT02255279|524397782|FG000|Overall Study|Lost to Follow-up|2|||
145421379|NCT02255279|524397783|FG001|Overall Study|Lost to Follow-up|2|||
145421380|NCT02255279|524397782|FG000|Overall Study|Protocol Violation|0|||
145421381|NCT02255279|524397783|FG001|Overall Study|Protocol Violation|1|||
145421382|NCT02255279|524397782|FG000|Overall Study|Withdrawal by Subject|3|||
145421383|NCT02255279|524397783|FG001|Overall Study|Withdrawal by Subject|6|||
145421384|NCT01013870|524397784|FG000|Overall Study|Lost to Follow-up|1|||
145421385|NCT01013870|524397785|FG001|Overall Study|Lost to Follow-up|3|||
145421386|NCT01386645|524397786|FG000|Overall Study|Physician Decision|0|||
145421387|NCT01386645|524397787|FG001|Overall Study|Physician Decision|0|||
145421388|NCT01386645|524397788|FG002|Overall Study|Physician Decision|1|||
145421389|NCT01386645|524397786|FG000|Overall Study|Withdrawal by Subject|0|||
145421390|NCT01386645|524397787|FG001|Overall Study|Withdrawal by Subject|1|||
145421391|NCT01386645|524397788|FG002|Overall Study|Withdrawal by Subject|1|||
145421392|NCT00432991|524397789|FG000|Overall Study|Protocol Violation|7|||
145421393|NCT00432991|524397790|FG001|Overall Study|Protocol Violation|12|||
145421394|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
145421395|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
145421396|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
145421397|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
145421398|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
145421399|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
145421400|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
145421401|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
145421402|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
145421403|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
145421404|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
145421405|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
145421406|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
145421407|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
145421408|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
145421409|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
145421410|NCT01755156|524397800|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
145365671|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
145365672|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
145365673|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
145365674|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
145365675|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
145365676|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
145365677|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
145365678|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
145365679|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
145365680|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
145365681|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
145365682|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
145365683|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
145365684|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
145365685|NCT00839527|524188273|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
145365686|NCT00839527|524188274|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
145365687|NCT00839527|524188275|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
145365688|NCT02751450|524188276|FG000|Overall Study|Adverse Event|1|||
145365689|NCT02751450|524188277|FG001|Overall Study|Adverse Event|0|||
145365690|NCT01598090|524188278|FG000|Treatment Period|Poor/non-compliance|0|||
145365691|NCT01598090|524188279|FG001|Treatment Period|Poor/non-compliance|2|||
145421411|NCT01755156|524397801|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
145421412|NCT01755156|524397800|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
145421413|NCT01755156|524397801|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
145421414|NCT01755156|524397800|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
145421415|NCT01755156|524397801|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
145421416|NCT03048019|524397802|FG000|Overall Study|Adverse Event|1|||
145421417|NCT03048019|524397803|FG001|Overall Study|Adverse Event|0|||
145421418|NCT00382863|524397804|FG000|Overall Study|Death|9|||
145421419|NCT00382863|524397805|FG001|Overall Study|Death|9|||
145421420|NCT00382863|524397804|FG000|Overall Study|Lost to Follow-up|1|||
145421421|NCT00382863|524397805|FG001|Overall Study|Lost to Follow-up|2|||
145365692|NCT01598090|524188280|FG002|Treatment Period|Poor/non-compliance|0|||
145365693|NCT01598090|524188278|FG000|Treatment Period|No longer meet study criteria|0|||
145365694|NCT01598090|524188279|FG001|Treatment Period|No longer meet study criteria|1|||
145365695|NCT01598090|524188280|FG002|Treatment Period|No longer meet study criteria|0|||
145365696|NCT01598090|524188278|FG000|Treatment Period|Lack of Efficacy|5|||
145365697|NCT01598090|524188279|FG001|Treatment Period|Lack of Efficacy|14|||
145365698|NCT01598090|524188280|FG002|Treatment Period|Lack of Efficacy|6|||
145365699|NCT01598090|524188278|FG000|Treatment Period|Adverse Event|2|||
145365700|NCT01598090|524188279|FG001|Treatment Period|Adverse Event|33|||
145365701|NCT01598090|524188280|FG002|Treatment Period|Adverse Event|17|||
145365702|NCT01598090|524188278|FG000|Treatment Period|Other reasons|0|||
145365703|NCT01598090|524188279|FG001|Treatment Period|Other reasons|4|||
145365704|NCT01598090|524188280|FG002|Treatment Period|Other reasons|1|||
145365705|NCT01598090|524188278|FG000|Treatment Period|Withdrawal by Subject|3|||
145365706|NCT01598090|524188279|FG001|Treatment Period|Withdrawal by Subject|13|||
145365707|NCT01598090|524188280|FG002|Treatment Period|Withdrawal by Subject|10|||
145365708|NCT01598090|524188278|FG000|Treatment Period|Lost to Follow-up|1|||
145365709|NCT01598090|524188279|FG001|Treatment Period|Lost to Follow-up|5|||
145365710|NCT01598090|524188280|FG002|Treatment Period|Lost to Follow-up|1|||
145365711|NCT01598090|524188278|FG000|Follow-up Period|Death|0|||
145365712|NCT01598090|524188279|FG001|Follow-up Period|Death|1|||
145365713|NCT01598090|524188280|FG002|Follow-up Period|Death|0|||
145365714|NCT01598090|524188278|FG000|Follow-up Period|No longer required per protocol|1|||
145365715|NCT01598090|524188279|FG001|Follow-up Period|No longer required per protocol|3|||
145365716|NCT01598090|524188280|FG002|Follow-up Period|No longer required per protocol|2|||
145365717|NCT01598090|524188278|FG000|Follow-up Period|Not reported|0|||
145365718|NCT01598090|524188279|FG001|Follow-up Period|Not reported|10|||
145365719|NCT01598090|524188280|FG002|Follow-up Period|Not reported|4|||
145365720|NCT01598090|524188278|FG000|Follow-up Period|Withdrawal by Subject|0|||
145365721|NCT01598090|524188279|FG001|Follow-up Period|Withdrawal by Subject|3|||
145365722|NCT01598090|524188280|FG002|Follow-up Period|Withdrawal by Subject|2|||
145365723|NCT01598090|524188278|FG000|Follow-up Period|Other reasons|2|||
145365724|NCT01598090|524188279|FG001|Follow-up Period|Other reasons|8|||
145365725|NCT01598090|524188280|FG002|Follow-up Period|Other reasons|8|||
145365726|NCT01598090|524188278|FG000|Follow-up Period|Lost to Follow-up|2|||
145365727|NCT01598090|524188279|FG001|Follow-up Period|Lost to Follow-up|10|||
145365728|NCT01598090|524188280|FG002|Follow-up Period|Lost to Follow-up|12|||
145365729|NCT02549287|524188281|FG000|Overall Study|Lost to Follow-up|65|||
145365730|NCT02549287|524188282|FG001|Overall Study|Lost to Follow-up|26|||
145365731|NCT02549287|524188281|FG000|Overall Study|Withdrawal by Subject|15|||
145365732|NCT02549287|524188282|FG001|Overall Study|Withdrawal by Subject|6|||
145365733|NCT00427921|524188286|FG000|Overall Study|Adverse Event|26|||
145365734|NCT00427921|524188286|FG000|Overall Study|Withdrawal by Subject|4|||
145365735|NCT00427921|524188286|FG000|Overall Study|Lost to Follow-up|2|||
145365736|NCT00427921|524188286|FG000|Overall Study|Other reason not specified|10|||
145365737|NCT00427921|524188286|FG000|Overall Study|Adverse Event + Hospitalization|1|||
145365738|NCT00427921|524188286|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
145365739|NCT00427921|524188286|FG000|Overall Study|Adverse Event + No Response|1|||
145365740|NCT00427921|524188286|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
145365741|NCT00427921|524188286|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
145365742|NCT00427921|524188286|FG000|Overall Study|Adverse Event + Lost Response|1|||
145365743|NCT00427921|524188286|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
145365744|NCT00427921|524188286|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
145365745|NCT03502070|524188287|FG000|Overall Study|Withdrawal by Subject|1|||
145365746|NCT03502070|524188287|FG000|Overall Study|Screen Failure|1|||
145365747|NCT01218087|524188288|FG000|Overall Study|Death|2|||
145365748|NCT01218087|524188289|FG001|Overall Study|Death|1|||
145365749|NCT01218087|524188288|FG000|Overall Study|Withdrawal by Subject|5|||
145365750|NCT01218087|524188289|FG001|Overall Study|Withdrawal by Subject|0|||
145365751|NCT01218087|524188288|FG000|Overall Study|Transferred|8|||
145365752|NCT01218087|524188289|FG001|Overall Study|Transferred|5|||
145365753|NCT04615403|524188292|FG000|Overall Study|Death|1|||
145365754|NCT03170362|524188293|FG000|Overall Study|Death|2|||
145365755|NCT03170362|524188294|FG001|Overall Study|Death|2|||
145365756|NCT03170362|524188293|FG000|Overall Study|Withdrawal by Subject|23|||
145365757|NCT03170362|524188294|FG001|Overall Study|Withdrawal by Subject|22|||
145365758|NCT03170362|524188293|FG000|Overall Study|Lost to Follow-up|187|||
145365759|NCT03170362|524188294|FG001|Overall Study|Lost to Follow-up|167|||
145365760|NCT00603473|524188299|FG000|Overall Study|Adverse Event|4|||
145365761|NCT00603473|524188299|FG000|Overall Study|Lack of Efficacy|4|||
145365762|NCT00603473|524188299|FG000|Overall Study|Protocol Violation|1|||
145365763|NCT02887183|524188310|FG000|Overall Study|Adverse Event|44|||
145421422|NCT00382863|524397804|FG000|Overall Study|Withdrawal by Subject|5|||
145365764|NCT02887183|524188310|FG000|Overall Study|Death|30|||
145365765|NCT02887183|524188310|FG000|Overall Study|Pregnancy|1|||
145365766|NCT02887183|524188310|FG000|Overall Study|Protocol Violation|6|||
145365767|NCT02887183|524188310|FG000|Overall Study|Technical Problems|2|||
145365768|NCT02887183|524188310|FG000|Overall Study|Lost to Follow-up|13|||
145421423|NCT00382863|524397805|FG001|Overall Study|Withdrawal by Subject|25|||
145421424|NCT02168439|524397806|FG000|Overall Study|Protocol Violation|0|||
145421425|NCT02168439|524397807|FG001|Overall Study|Protocol Violation|2|||
145421426|NCT01292473|524397810|FG000|Overall Study|Adverse Event|1|||
145421427|NCT01292473|524397811|FG001|Overall Study|Adverse Event|0|||
145421428|NCT01292473|524397812|FG002|Overall Study|Adverse Event|1|||
145421429|NCT01292473|524397813|FG003|Overall Study|Adverse Event|1|||
145421430|NCT01292473|524397810|FG000|Overall Study|Lost to Follow-up|1|||
145421431|NCT01292473|524397811|FG001|Overall Study|Lost to Follow-up|1|||
145421432|NCT01292473|524397812|FG002|Overall Study|Lost to Follow-up|2|||
145421433|NCT01292473|524397813|FG003|Overall Study|Lost to Follow-up|2|||
145421434|NCT01292473|524397810|FG000|Overall Study|Withdrawal by Subject|3|||
145421435|NCT01292473|524397811|FG001|Overall Study|Withdrawal by Subject|4|||
145421436|NCT01292473|524397812|FG002|Overall Study|Withdrawal by Subject|3|||
145421437|NCT01292473|524397813|FG003|Overall Study|Withdrawal by Subject|3|||
145421438|NCT01292473|524397810|FG000|Overall Study|Physician Decision|0|||
145421439|NCT01292473|524397811|FG001|Overall Study|Physician Decision|1|||
145421440|NCT01292473|524397812|FG002|Overall Study|Physician Decision|0|||
145421441|NCT01292473|524397813|FG003|Overall Study|Physician Decision|0|||
145421442|NCT01292473|524397810|FG000|Overall Study|Disease Progression|0|||
145421443|NCT01292473|524397811|FG001|Overall Study|Disease Progression|1|||
145421444|NCT01292473|524397812|FG002|Overall Study|Disease Progression|3|||
145421445|NCT01292473|524397813|FG003|Overall Study|Disease Progression|6|||
145421446|NCT04432298|524397814|FG000|Overall Study|Other than specified|1|||
145421447|NCT04432298|524397815|FG001|Overall Study|Other than specified|0|||
145421448|NCT04432298|524397814|FG000|Overall Study|Lost to Follow-up|0|||
145421449|NCT04432298|524397815|FG001|Overall Study|Lost to Follow-up|1|||
145421450|NCT04432298|524397814|FG000|Overall Study|Death|3|||
145421451|NCT04432298|524397815|FG001|Overall Study|Death|2|||
145421452|NCT04432298|524397814|FG000|Overall Study|Withdrawal by Subject|2|||
145421453|NCT04432298|524397815|FG001|Overall Study|Withdrawal by Subject|0|||
145421454|NCT02451007|524397816|FG000|Overall Study|Withdrawal by Subject|4|||
145421455|NCT02451007|524397816|FG000|Overall Study|Adverse Event|1|||
145421456|NCT02451007|524397816|FG000|Overall Study|Disease Progression|2|||
145421457|NCT00348374|524397817|FG000|Overall Study|Adverse Event|1|||
145421458|NCT00348374|524397818|FG001|Overall Study|Adverse Event|4|||
145421459|NCT00348374|524397817|FG000|Overall Study|Lost to Follow-up|1|||
145421460|NCT00348374|524397818|FG001|Overall Study|Lost to Follow-up|3|||
145421461|NCT00348374|524397817|FG000|Overall Study|Withdrawal by Subject|5|||
145421462|NCT00348374|524397818|FG001|Overall Study|Withdrawal by Subject|5|||
145421463|NCT00348374|524397817|FG000|Overall Study|Other|11|||
145421464|NCT00348374|524397818|FG001|Overall Study|Other|12|||
145421465|NCT00348374|524397817|FG000|Overall Study|ongoing at date of cutoff|1|||
145421466|NCT00348374|524397818|FG001|Overall Study|ongoing at date of cutoff|1|||
145421467|NCT00348374|524397817|FG000|Overall Study|randomized but did not receive treatment|0|||
145421468|NCT00348374|524397818|FG001|Overall Study|randomized but did not receive treatment|7|||
145421469|NCT00661687|524397826|FG000|Overall Study|Study related symptoms and complaints|5|||
145421470|NCT00661687|524397826|FG000|Overall Study|Positive slit lamp findings|4|||
145578069|NCT00113516|524971388|FG000|Part 2|Other|0|||
145578070|NCT00113516|524971389|FG001|Part 2|Other|3|||
145578071|NCT00113516|524971388|FG000|Part 2|Laboratory Abnormality|0|||
145578072|NCT00113516|524971389|FG001|Part 2|Laboratory Abnormality|1|||
145578073|NCT00113516|524971388|FG000|Part 2|Ongoing|0|||
145578074|NCT00113516|524971389|FG001|Part 2|Ongoing|1|||
145578075|NCT03755765|524971394|FG000|Overall Study|Withdrawal by Subject|2|||
145578076|NCT03755765|524971395|FG001|Overall Study|Withdrawal by Subject|4|||
145578077|NCT03755765|524971396|FG002|Overall Study|Withdrawal by Subject|4|||
145578078|NCT02104557|524971397|FG000|Overall Study|Adverse Event|24|||
145578079|NCT02104557|524971397|FG000|Overall Study|Lost to Follow-up|34|||
145578080|NCT02104557|524971397|FG000|Overall Study|Violated the usage and dosage|14|||
145578081|NCT02104557|524971397|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
145578082|NCT02104557|524971397|FG000|Overall Study|Administered Sayana prior to the contract|1|||
145578083|NCT02104557|524971397|FG000|Overall Study|Other|17|||
145578084|NCT02104557|524971397|FG000|Overall Study|Change to other contraception methods|5|||
145578085|NCT02104557|524971397|FG000|Overall Study|Discontinuation due to no pain|1|||
145578086|NCT02104557|524971397|FG000|Overall Study|Withdrawal consent|2|||
145578087|NCT02104557|524971397|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
145578088|NCT02104557|524971397|FG000|Overall Study|Discontinuation of contraception|9|||
145421471|NCT00661687|524397826|FG000|Overall Study|Inability to maintain wearing schedule|3|||
145421472|NCT00661687|524397826|FG000|Overall Study|Physician Decision|1|||
145421473|NCT00661687|524397826|FG000|Overall Study|Adverse Event|2|||
145421474|NCT01362530|524397832|FG000|Base Study (Cycle 1)|Adverse Event|2|||
145421475|NCT01362530|524397833|FG001|Base Study (Cycle 1)|Adverse Event|0|||
145421476|NCT01362530|524397832|FG000|Base Study (Cycle 1)|Physician Decision|0|||
145421477|NCT01362530|524397833|FG001|Base Study (Cycle 1)|Physician Decision|1|||
145578089|NCT01490060|524971403|FG000|Cycle 1|Change of Treatment|0|||
145578090|NCT01490060|524971404|FG001|Cycle 1|Change of Treatment|1|||
145578091|NCT01490060|524971405|FG002|Cycle 1|Change of Treatment|1|||
145365769|NCT02887183|524188310|FG000|Overall Study|Physician Decision|10|||
145365770|NCT02887183|524188310|FG000|Overall Study|Withdrawal by Subject|35|||
145365771|NCT00789698|524188314|FG000|Overall Study|Lack of Efficacy|10|||
145365772|NCT00789698|524188315|FG001|Overall Study|Lack of Efficacy|4|||
145365773|NCT00789698|524188316|FG002|Overall Study|Lack of Efficacy|5|||
145365774|NCT00789698|524188317|FG003|Overall Study|Lack of Efficacy|18|||
145365775|NCT00789698|524188314|FG000|Overall Study|Adverse Event|5|||
145365776|NCT00789698|524188315|FG001|Overall Study|Adverse Event|5|||
145365777|NCT00789698|524188316|FG002|Overall Study|Adverse Event|3|||
145365778|NCT00789698|524188317|FG003|Overall Study|Adverse Event|4|||
145365779|NCT00789698|524188314|FG000|Overall Study|Lost to Follow-up|5|||
145365780|NCT00789698|524188315|FG001|Overall Study|Lost to Follow-up|5|||
145365781|NCT00789698|524188316|FG002|Overall Study|Lost to Follow-up|2|||
145365782|NCT00789698|524188317|FG003|Overall Study|Lost to Follow-up|9|||
145365783|NCT00789698|524188314|FG000|Overall Study|Protocol Violation|6|||
145365784|NCT00789698|524188315|FG001|Overall Study|Protocol Violation|1|||
145365785|NCT00789698|524188316|FG002|Overall Study|Protocol Violation|2|||
145365786|NCT00789698|524188317|FG003|Overall Study|Protocol Violation|1|||
145365787|NCT00789698|524188314|FG000|Overall Study|Withdrawal by Subject|14|||
145365788|NCT00789698|524188315|FG001|Overall Study|Withdrawal by Subject|15|||
145365789|NCT00789698|524188316|FG002|Overall Study|Withdrawal by Subject|12|||
145365790|NCT00789698|524188317|FG003|Overall Study|Withdrawal by Subject|19|||
145365791|NCT00789698|524188314|FG000|Overall Study|Administrative|0|||
145365792|NCT00789698|524188315|FG001|Overall Study|Administrative|3|||
145365793|NCT00789698|524188316|FG002|Overall Study|Administrative|3|||
145365794|NCT00789698|524188317|FG003|Overall Study|Administrative|1|||
145365795|NCT01870973|524188318|FG000|Overall Study|Lost to Follow-up|10|||
145365796|NCT01870973|524188319|FG001|Overall Study|Lost to Follow-up|3|||
145365797|NCT02729051|524188322|FG000|Overall Study|Adverse Event|21|||
145365798|NCT02729051|524188323|FG001|Overall Study|Adverse Event|11|||
145365799|NCT02729051|524188322|FG000|Overall Study|Lack of Efficacy|1|||
145365800|NCT02729051|524188323|FG001|Overall Study|Lack of Efficacy|1|||
145365801|NCT02729051|524188322|FG000|Overall Study|Lost to Follow-up|1|||
145365802|NCT02729051|524188323|FG001|Overall Study|Lost to Follow-up|2|||
145365803|NCT02729051|524188322|FG000|Overall Study|Physician Decision|1|||
145365804|NCT02729051|524188323|FG001|Overall Study|Physician Decision|1|||
145365805|NCT02729051|524188322|FG000|Overall Study|Withdrawal by Subject|6|||
145365806|NCT02729051|524188323|FG001|Overall Study|Withdrawal by Subject|17|||
145365807|NCT02702388|524188324|FG000|Overall Study|Disease Progression|18|||
145365808|NCT02702388|524188325|FG001|Overall Study|Disease Progression|25|||
145365809|NCT02702388|524188324|FG000|Overall Study|Withdrawal by Subject|9|||
145365810|NCT02702388|524188325|FG001|Overall Study|Withdrawal by Subject|7|||
145365811|NCT02702388|524188324|FG000|Overall Study|Adverse Event|11|||
145365812|NCT02702388|524188325|FG001|Overall Study|Adverse Event|15|||
145365813|NCT02702388|524188324|FG000|Overall Study|Other|2|||
145365814|NCT02702388|524188325|FG001|Overall Study|Other|4|||
145365815|NCT00596817|524188326|FG000|Open-label Period|Adverse Event|0|||
145365816|NCT00596817|524188327|FG001|Open-label Period|Adverse Event|49|||
145365817|NCT00596817|524188326|FG000|Open-label Period|Lack of Efficacy|0|||
145365818|NCT00596817|524188327|FG001|Open-label Period|Lack of Efficacy|33|||
145365819|NCT00596817|524188326|FG000|Open-label Period|Other Reasons|0|||
145365820|NCT00596817|524188327|FG001|Open-label Period|Other Reasons|65|||
145365821|NCT00596817|524188326|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
145365822|NCT00596817|524188327|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
145365823|NCT00596817|524188326|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
145365824|NCT00596817|524188327|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
145365825|NCT00596817|524188326|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
145365826|NCT00596817|524188327|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
145365827|NCT00596817|524188326|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
145365828|NCT00596817|524188327|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
145365829|NCT00596817|524188326|FG000|Double-blind Period|Adverse Event|5|||
145365830|NCT00596817|524188327|FG001|Double-blind Period|Adverse Event|16|||
145365831|NCT00596817|524188326|FG000|Double-blind Period|Lack of Efficacy|52|||
145365832|NCT00596817|524188327|FG001|Double-blind Period|Lack of Efficacy|28|||
145421478|NCT01362530|524397832|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
145421479|NCT01362530|524397833|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
145365833|NCT00596817|524188326|FG000|Double-blind Period|Non-compliance With Study Product|3|||
145365834|NCT00596817|524188327|FG001|Double-blind Period|Non-compliance With Study Product|4|||
145365835|NCT00596817|524188326|FG000|Double-blind Period|Protocol Violation|11|||
145421480|NCT01362530|524397832|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
145421481|NCT01362530|524397833|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
145365836|NCT00596817|524188327|FG001|Double-blind Period|Protocol Violation|8|||
145365837|NCT00596817|524188326|FG000|Double-blind Period|Withdrawal of Consent|7|||
145365838|NCT00596817|524188327|FG001|Double-blind Period|Withdrawal of Consent|3|||
145365839|NCT00596817|524188326|FG000|Double-blind Period|Lost to Follow-up|0|||
145365840|NCT00596817|524188327|FG001|Double-blind Period|Lost to Follow-up|2|||
145365841|NCT00596817|524188326|FG000|Double-blind Period|Other Reasons|10|||
145578092|NCT01490060|524971406|FG003|Cycle 1|Change of Treatment|1|||
145578093|NCT01490060|524971403|FG000|Cycle 1|Insurance Denied|0|||
145578094|NCT01490060|524971404|FG001|Cycle 1|Insurance Denied|0|||
145578095|NCT01490060|524971405|FG002|Cycle 1|Insurance Denied|2|||
145578096|NCT01490060|524971406|FG003|Cycle 1|Insurance Denied|0|||
145578097|NCT01490060|524971403|FG000|Cycle 1|Withdrawal by Subject|0|||
145578098|NCT01490060|524971404|FG001|Cycle 1|Withdrawal by Subject|0|||
145578099|NCT01490060|524971405|FG002|Cycle 1|Withdrawal by Subject|0|||
145578100|NCT01490060|524971406|FG003|Cycle 1|Withdrawal by Subject|1|||
145578101|NCT01490060|524971403|FG000|Cycle 1|Treatment at Another Facility|0|||
145578102|NCT01490060|524971404|FG001|Cycle 1|Treatment at Another Facility|0|||
145578103|NCT01490060|524971405|FG002|Cycle 1|Treatment at Another Facility|0|||
145578104|NCT01490060|524971406|FG003|Cycle 1|Treatment at Another Facility|1|||
145578105|NCT01490060|524971403|FG000|Cycle 2|Change of Treatment|1|||
145578106|NCT01490060|524971404|FG001|Cycle 2|Change of Treatment|1|||
145578107|NCT01490060|524971405|FG002|Cycle 2|Change of Treatment|0|||
145578108|NCT01490060|524971406|FG003|Cycle 2|Change of Treatment|0|||
145578109|NCT01490060|524971403|FG000|Cycle 2|Non-Compliance|0|||
145578110|NCT01490060|524971404|FG001|Cycle 2|Non-Compliance|0|||
145578111|NCT01490060|524971405|FG002|Cycle 2|Non-Compliance|1|||
145578112|NCT01490060|524971406|FG003|Cycle 2|Non-Compliance|0|||
145365842|NCT00596817|524188327|FG001|Double-blind Period|Other Reasons|18|||
145365843|NCT03225105|524188330|FG000|Overall Study|Withdrawal by Subject|1|||
145365844|NCT03225105|524188331|FG001|Overall Study|Withdrawal by Subject|0|||
145365845|NCT03225105|524188332|FG002|Overall Study|Withdrawal by Subject|0|||
145365846|NCT03225105|524188333|FG003|Overall Study|Withdrawal by Subject|0|||
145365847|NCT03225105|524188330|FG000|Overall Study|Death|0|||
145365848|NCT03225105|524188331|FG001|Overall Study|Death|4|||
145365849|NCT03225105|524188332|FG002|Overall Study|Death|2|||
145365850|NCT03225105|524188333|FG003|Overall Study|Death|0|||
145365851|NCT03225105|524188330|FG000|Overall Study|Study termination per Sponsor Decision|2|||
145365852|NCT03225105|524188331|FG001|Overall Study|Study termination per Sponsor Decision|0|||
145365853|NCT03225105|524188332|FG002|Overall Study|Study termination per Sponsor Decision|3|||
145365854|NCT03225105|524188333|FG003|Overall Study|Study termination per Sponsor Decision|3|||
145365855|NCT05119595|524190068|FG000|Overall Study|Death|1|||
145365856|NCT05119595|524190068|FG000|Overall Study|Lost to Follow-up|7|||
145365857|NCT01283334|524190073|FG000|Overall Study|Withdrawal by Subject|1|||
145365858|NCT01283334|524190073|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
145365859|NCT01283334|524190073|FG000|Overall Study|Adverse Event|4|||
145365860|NCT01283334|524190073|FG000|Overall Study|Physician Decision|1|||
145365861|NCT03467217|524190074|FG000|Overall Study|Trial stopped early|5|||
145365862|NCT03467217|524190075|FG001|Overall Study|Trial stopped early|2|||
145365863|NCT03467217|524190074|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
145365864|NCT03467217|524190075|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
145365865|NCT03467217|524190074|FG000|Overall Study|Lost to Follow-up|0|||
145365866|NCT03467217|524190075|FG001|Overall Study|Lost to Follow-up|2|||
145365867|NCT04981470|524190076|FG000|Overall Study|Device failure in all 4 patients|4|||
145365868|NCT00784238|524190077|FG000|Overall Study|Adverse Event|14|||
145365869|NCT00784238|524190077|FG000|Overall Study|Death|2|||
145365870|NCT00784238|524190077|FG000|Overall Study|Lack of Efficacy|33|||
145365871|NCT00784238|524190077|FG000|Overall Study|Lost to Follow-up|29|||
145365872|NCT00784238|524190077|FG000|Overall Study|Pregnancy|1|||
145365873|NCT00784238|524190077|FG000|Overall Study|Withdrawal by Subject|26|||
145365874|NCT00784238|524190077|FG000|Overall Study|Other|14|||
145365875|NCT03806933|524190078|FG000|Main Period|Physician Decision|0|||
145365876|NCT03806933|524190079|FG001|Main Period|Physician Decision|0|||
145365877|NCT03806933|524190080|FG002|Main Period|Physician Decision|0|||
145365878|NCT03806933|524190081|FG003|Main Period|Physician Decision|1|||
145365879|NCT03806933|524190078|FG000|Main Period|Pregnancy|0|||
145365880|NCT03806933|524190079|FG001|Main Period|Pregnancy|0|||
145365881|NCT03806933|524190080|FG002|Main Period|Pregnancy|1|||
145365882|NCT03806933|524190081|FG003|Main Period|Pregnancy|0|||
145365883|NCT03806933|524190078|FG000|Main Period|Withdrawal by Subject|2|||
145365884|NCT03806933|524190079|FG001|Main Period|Withdrawal by Subject|1|||
145365885|NCT03806933|524190080|FG002|Main Period|Withdrawal by Subject|1|||
145365886|NCT03806933|524190081|FG003|Main Period|Withdrawal by Subject|2|||
145365887|NCT03806933|524190078|FG000|Main Period|Lost to Follow-up|2|||
145365888|NCT03806933|524190079|FG001|Main Period|Lost to Follow-up|2|||
145365889|NCT03806933|524190080|FG002|Main Period|Lost to Follow-up|0|||
145365890|NCT03806933|524190081|FG003|Main Period|Lost to Follow-up|0|||
145365891|NCT03806933|524190078|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145365892|NCT03806933|524190079|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145578113|NCT01490060|524971403|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
145578114|NCT01490060|524971404|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
145578115|NCT01490060|524971405|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
145578116|NCT01490060|524971406|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
145578117|NCT02863354|524971409|FG000|Year 1|Lost to Follow-up|1|||
145578118|NCT02863354|524971410|FG001|Year 1|Lost to Follow-up|1|||
145578119|NCT02863354|524971409|FG000|Year 1|Withdrawal by Subject|3|||
145578120|NCT02863354|524971410|FG001|Year 1|Withdrawal by Subject|0|||
145578121|NCT02863354|524971409|FG000|Year 1|Death|0|||
145578122|NCT02863354|524971410|FG001|Year 1|Death|1|||
145578123|NCT02863354|524971409|FG000|Year 2|Lost to Follow-up|2|||
145578124|NCT02863354|524971410|FG001|Year 2|Lost to Follow-up|2|||
145578125|NCT03698773|524971411|FG000|Overall Study|Lost to Follow-up|2|||
145578126|NCT03698773|524971412|FG001|Overall Study|Lost to Follow-up|1|||
145578127|NCT00724451|524971413|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
145578128|NCT00724451|524971413|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
145578129|NCT00724451|524971413|FG000|Overall Study|Not Eligible for Treatment|431|||
145578130|NCT00724451|524971413|FG000|Overall Study|Participant Refused Treatment|89|||
145578131|NCT00724451|524971413|FG000|Overall Study|Never Started Treatment|89|||
145578132|NCT00724451|524971413|FG000|Overall Study|Unknown; No Data Sources Available|9|||
145578133|NCT00724451|524971413|FG000|Overall Study|Physician Decision|116|||
145578134|NCT00724451|524971413|FG000|Overall Study|Withdrawal by Subject|45|||
145578135|NCT00724451|524971413|FG000|Overall Study|Investigator + Participant Decision|13|||
145578136|NCT01599650|524971414|FG000|Overall Study|Administrative issue|1|||
145578137|NCT01599650|524971415|FG001|Overall Study|Administrative issue|0|||
145578138|NCT01599650|524971416|FG002|Overall Study|Administrative issue|1|||
145578139|NCT01599650|524971414|FG000|Overall Study|Physician Decision|2|||
145578140|NCT01599650|524971415|FG001|Overall Study|Physician Decision|0|||
145578141|NCT01599650|524971416|FG002|Overall Study|Physician Decision|7|||
145578142|NCT01599650|524971414|FG000|Overall Study|Protocol Violation|0|||
145578143|NCT01599650|524971415|FG001|Overall Study|Protocol Violation|3|||
145578144|NCT01599650|524971416|FG002|Overall Study|Protocol Violation|0|||
145578145|NCT01599650|524971414|FG000|Overall Study|Death|2|||
145578146|NCT01599650|524971415|FG001|Overall Study|Death|1|||
145578147|NCT01599650|524971416|FG002|Overall Study|Death|2|||
145578148|NCT01599650|524971414|FG000|Overall Study|Lost to Follow-up|3|||
145578149|NCT01599650|524971415|FG001|Overall Study|Lost to Follow-up|3|||
145578150|NCT01599650|524971416|FG002|Overall Study|Lost to Follow-up|3|||
145578151|NCT01599650|524971414|FG000|Overall Study|Withdrawal by Subject|11|||
145578152|NCT01599650|524971415|FG001|Overall Study|Withdrawal by Subject|11|||
145578153|NCT01599650|524971416|FG002|Overall Study|Withdrawal by Subject|10|||
145578154|NCT01599650|524971414|FG000|Overall Study|Adverse Event|3|||
145578155|NCT01599650|524971415|FG001|Overall Study|Adverse Event|8|||
145578156|NCT01599650|524971416|FG002|Overall Study|Adverse Event|4|||
145578157|NCT00720876|524971417|FG000|Overall Study|found to be ineligible after starting tx|2|||
145578158|NCT03304379|524971419|FG000|Overall Study|Protocol Violation|8|||
145578159|NCT03304379|524971420|FG001|Overall Study|Protocol Violation|10|||
145578160|NCT03304379|524971421|FG002|Overall Study|Protocol Violation|5|||
145578161|NCT03304379|524971422|FG003|Overall Study|Protocol Violation|0|||
145578162|NCT03304379|524971423|FG004|Overall Study|Protocol Violation|2|||
145578163|NCT03304379|524971419|FG000|Overall Study|Adverse Event|4|||
145578164|NCT03304379|524971420|FG001|Overall Study|Adverse Event|20|||
145578165|NCT03304379|524971421|FG002|Overall Study|Adverse Event|17|||
145578166|NCT03304379|524971422|FG003|Overall Study|Adverse Event|1|||
145578167|NCT03304379|524971423|FG004|Overall Study|Adverse Event|0|||
145365893|NCT03806933|524190080|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
145365894|NCT03806933|524190081|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
145365895|NCT00078767|524190082|FG000|Overall Study|Withdrawal by Subject|1|||
145365896|NCT00078767|524190083|FG001|Overall Study|Withdrawal by Subject|1|||
145365897|NCT03528369|524190086|FG000|Overall Study|Withdrawal by Subject|2|||
145365898|NCT03528369|524190087|FG001|Overall Study|Withdrawal by Subject|0|||
145365899|NCT03528369|524190088|FG002|Overall Study|Withdrawal by Subject|0|||
145365900|NCT03528369|524190086|FG000|Overall Study|Lost to Follow-up|1|||
145365901|NCT03528369|524190087|FG001|Overall Study|Lost to Follow-up|0|||
145365902|NCT03528369|524190088|FG002|Overall Study|Lost to Follow-up|0|||
145365903|NCT03528369|524190086|FG000|Overall Study|Adverse Event|0|||
145365904|NCT03528369|524190087|FG001|Overall Study|Adverse Event|1|||
145578168|NCT03304379|524971419|FG000|Overall Study|Lack of Efficacy|17|||
145578169|NCT03304379|524971420|FG001|Overall Study|Lack of Efficacy|16|||
145578170|NCT03304379|524971421|FG002|Overall Study|Lack of Efficacy|20|||
145578171|NCT03304379|524971422|FG003|Overall Study|Lack of Efficacy|0|||
145578172|NCT03304379|524971423|FG004|Overall Study|Lack of Efficacy|0|||
145365905|NCT03528369|524190088|FG002|Overall Study|Adverse Event|0|||
145578173|NCT03304379|524971419|FG000|Overall Study|Physician Decision|6|||
145578174|NCT03304379|524971420|FG001|Overall Study|Physician Decision|10|||
145578175|NCT03304379|524971421|FG002|Overall Study|Physician Decision|6|||
145578176|NCT03304379|524971422|FG003|Overall Study|Physician Decision|9|||
145365906|NCT02162719|524190089|FG000|Overall Study|Death|41|||
145365907|NCT02162719|524190090|FG001|Overall Study|Death|46|||
145365908|NCT02162719|524190089|FG000|Overall Study|Lost to Follow-up|1|||
145578177|NCT03304379|524971423|FG004|Overall Study|Physician Decision|10|||
145623206|NCT01077024|525131613|FG000|Overall Study|Other|4|||
145578178|NCT03304379|524971419|FG000|Overall Study|Withdrawal by Subject|26|||
145578179|NCT03304379|524971420|FG001|Overall Study|Withdrawal by Subject|58|||
145578180|NCT03304379|524971421|FG002|Overall Study|Withdrawal by Subject|66|||
145578181|NCT03304379|524971422|FG003|Overall Study|Withdrawal by Subject|3|||
145578182|NCT03304379|524971423|FG004|Overall Study|Withdrawal by Subject|5|||
145578183|NCT03304379|524971419|FG000|Overall Study|Lost to Follow-up|8|||
145578184|NCT03304379|524971420|FG001|Overall Study|Lost to Follow-up|24|||
145578185|NCT03304379|524971421|FG002|Overall Study|Lost to Follow-up|35|||
145578186|NCT03304379|524971422|FG003|Overall Study|Lost to Follow-up|4|||
145578187|NCT03304379|524971423|FG004|Overall Study|Lost to Follow-up|0|||
145578188|NCT03304379|524971419|FG000|Overall Study|Death|1|||
145365909|NCT02162719|524190090|FG001|Overall Study|Lost to Follow-up|3|||
145365910|NCT02162719|524190089|FG000|Overall Study|Disease Progression|2|||
145365911|NCT02162719|524190090|FG001|Overall Study|Disease Progression|1|||
145365912|NCT02162719|524190089|FG000|Overall Study|Withdrawal by Subject|8|||
145365913|NCT02162719|524190090|FG001|Overall Study|Withdrawal by Subject|2|||
145365914|NCT02162719|524190089|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
145365915|NCT02162719|524190090|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
145365916|NCT03555565|524190091|FG000|Overall Study|Case Report Forms Uncollected|2|||
145365917|NCT03555565|524190091|FG000|Overall Study|Protocol Deviation|13|||
145365918|NCT00076752|524190095|FG000|Overall Study|Death|2|||
145365919|NCT00076752|524190095|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
145365920|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
145365921|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
145365922|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
145365923|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
145365924|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
145365925|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
145365926|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
145365927|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
145365928|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Death|0|||
145365929|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Death|1|||
145365930|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
145365931|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
145365932|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
145365933|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
145365934|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
145365935|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
145365936|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
145365937|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
145365938|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
145365939|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
145365940|NCT00394836|524190098|FG000|Teatment or Follow-up Phase|Non compliance|0|||
145365941|NCT00394836|524190099|FG001|Teatment or Follow-up Phase|Non compliance|1|||
145365942|NCT00394836|524190098|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
145365943|NCT00394836|524190099|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
145365944|NCT00394836|524190098|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
145365945|NCT00394836|524190099|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
145365946|NCT00394836|524190098|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
145365947|NCT00394836|524190099|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
145365948|NCT00394836|524190098|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
145365949|NCT00394836|524190099|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
145365950|NCT04696055|524190102|FG000|Overall Study|Adverse Event|10|||
145365951|NCT04696055|524190103|FG001|Overall Study|Adverse Event|2|||
145365952|NCT04696055|524190102|FG000|Overall Study|Death|4|||
145365953|NCT04696055|524190103|FG001|Overall Study|Death|0|||
145365954|NCT04696055|524190102|FG000|Overall Study|Other|7|||
145365955|NCT04696055|524190103|FG001|Overall Study|Other|2|||
145365956|NCT04696055|524190102|FG000|Overall Study|Physician Decision|3|||
145365957|NCT04696055|524190103|FG001|Overall Study|Physician Decision|0|||
145365958|NCT04696055|524190102|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
145365959|NCT04696055|524190103|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
145365960|NCT04696055|524190102|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
145365961|NCT04696055|524190103|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
145365962|NCT04696055|524190102|FG000|Overall Study|Subject Decision|1|||
145365963|NCT04696055|524190103|FG001|Overall Study|Subject Decision|2|||
145365964|NCT03969901|524190104|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145365965|NCT03969901|524190105|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145365966|NCT03969901|524190106|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145365967|NCT03969901|524190107|FG003|Overall Study|Withdrawal by parent/guardian|0|||
145365968|NCT03969901|524190108|FG004|Overall Study|Withdrawal by parent/guardian|1|||
145365969|NCT03969901|524190109|FG005|Overall Study|Withdrawal by parent/guardian|0|||
145365970|NCT03969901|524190110|FG006|Overall Study|Withdrawal by parent/guardian|0|||
145578189|NCT03304379|524971420|FG001|Overall Study|Death|2|||
145578190|NCT03304379|524971421|FG002|Overall Study|Death|0|||
145578191|NCT03304379|524971422|FG003|Overall Study|Death|0|||
145365971|NCT03969901|524190111|FG007|Overall Study|Withdrawal by parent/guardian|1|||
145421482|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
145421483|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
145421484|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
145421485|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
145421486|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
145421487|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
145421488|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
145421489|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
145421490|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
145421491|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
145421492|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
145421493|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
145365972|NCT03969901|524190112|FG008|Overall Study|Withdrawal by parent/guardian|1|||
145365973|NCT03969901|524190113|FG009|Overall Study|Withdrawal by parent/guardian|0|||
145365974|NCT04411810|524190114|FG000|Overall Study|Screen failure|1|||
145365975|NCT04411810|524190114|FG000|Overall Study|Withdrawal by Subject|1|||
145365976|NCT01920958|524190115|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
145365977|NCT02028767|524190118|FG000|Treatment Period 2|Non compliant with protocol|1|||
145365978|NCT02028767|524190119|FG001|Treatment Period 2|Non compliant with protocol|0|||
145365979|NCT02028767|524190118|FG000|Treatment Period 2|Reason other than those specified above|1|||
145365980|NCT02028767|524190119|FG001|Treatment Period 2|Reason other than those specified above|0|||
145365981|NCT03192306|524190122|FG000|Overall Study|Did not treat cold sore during study|149|||
145365982|NCT03192306|524190123|FG001|Overall Study|Did not treat cold sore during study|143|||
145365983|NCT03192306|524190122|FG000|Overall Study|Withdrawal by Subject|1|||
145365984|NCT03192306|524190123|FG001|Overall Study|Withdrawal by Subject|1|||
145365985|NCT03192306|524190122|FG000|Overall Study|Lost to Follow-up|1|||
145365986|NCT03192306|524190123|FG001|Overall Study|Lost to Follow-up|0|||
145365987|NCT03192306|524190122|FG000|Overall Study|Protocol Violation|1|||
145365988|NCT03192306|524190123|FG001|Overall Study|Protocol Violation|1|||
145365989|NCT01127451|524190133|FG000|Overall Study|Other|2|||
145365990|NCT01127451|524190134|FG001|Overall Study|Other|1|||
145365991|NCT01127451|524190133|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
145365992|NCT01127451|524190134|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
145365993|NCT01127451|524190133|FG000|Overall Study|Death|22|||
145365994|NCT01127451|524190134|FG001|Overall Study|Death|17|||
145365995|NCT01127451|524190133|FG000|Overall Study|Lost to Follow-up|3|||
145365996|NCT01127451|524190134|FG001|Overall Study|Lost to Follow-up|0|||
145365997|NCT01127451|524190133|FG000|Overall Study|Administrative Reason by Sponsor|2|||
145365998|NCT01127451|524190134|FG001|Overall Study|Administrative Reason by Sponsor|2|||
145365999|NCT02111577|524190135|FG000|Overall Study|Protocol Violation|2|||
145366000|NCT02111577|524190136|FG001|Overall Study|Protocol Violation|0|||
145366001|NCT02111577|524190135|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
145366002|NCT02111577|524190136|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
145366003|NCT02111577|524190135|FG000|Overall Study|Failure to produce study treatment|6|||
145366004|NCT02111577|524190136|FG001|Overall Study|Failure to produce study treatment|0|||
145366005|NCT02111577|524190135|FG000|Overall Study|Death|518|||
145366006|NCT02111577|524190136|FG001|Overall Study|Death|254|||
145366007|NCT02111577|524190135|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
145366008|NCT02111577|524190136|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
145366009|NCT02111577|524190135|FG000|Overall Study|Adverse Event|1|||
145366010|NCT02111577|524190136|FG001|Overall Study|Adverse Event|1|||
145366011|NCT02111577|524190135|FG000|Overall Study|Withdrawal by Subject|51|||
145366012|NCT02111577|524190136|FG001|Overall Study|Withdrawal by Subject|23|||
145366013|NCT02111577|524190135|FG000|Overall Study|Disease progression|0|||
145366014|NCT02111577|524190136|FG001|Overall Study|Disease progression|1|||
145366015|NCT02111577|524190135|FG000|Overall Study|Lost to Follow-up|19|||
145366016|NCT02111577|524190136|FG001|Overall Study|Lost to Follow-up|10|||
145366017|NCT00886743|524190137|FG000|Overall Study|Adverse Event|3|||
145366018|NCT00886743|524190137|FG000|Overall Study|Other|1|||
145366019|NCT02429778|524190139|FG000|Overall Study|Lost to Follow-up|2|||
145366020|NCT02429778|524190140|FG001|Overall Study|Lost to Follow-up|0|||
145366021|NCT02429778|524190139|FG000|Overall Study|Withdrawal by Subject|5|||
145366022|NCT02429778|524190140|FG001|Overall Study|Withdrawal by Subject|0|||
145366023|NCT02475265|524190141|FG000|Overall Study|Physician Decision|1|||
145366024|NCT02475265|524190141|FG000|Overall Study|Withdrawal by Subject|2|||
145366025|NCT02587598|524190142|FG000|Overall Study|Death|4|||
145366026|NCT02587598|524190143|FG001|Overall Study|Death|8|||
145366027|NCT02587598|524190144|FG002|Overall Study|Death|4|||
145366028|NCT02587598|524190145|FG003|Overall Study|Death|16|||
145366029|NCT02587598|524190146|FG004|Overall Study|Death|9|||
145366030|NCT02587598|524190147|FG005|Overall Study|Death|4|||
145366031|NCT02587598|524190148|FG006|Overall Study|Death|6|||
145366032|NCT02587598|524190149|FG007|Overall Study|Death|7|||
145421494|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
145421495|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
145421496|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
145421497|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
145421498|NCT01362530|524397832|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
145421499|NCT01362530|524397833|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
145421500|NCT01133977|524397834|FG000|Overall Study|Adverse Event|0|||
145421501|NCT01133977|524397835|FG001|Overall Study|Adverse Event|0|||
145421502|NCT01133977|524397836|FG002|Overall Study|Adverse Event|1|||
145421503|NCT01133977|524397837|FG003|Overall Study|Adverse Event|0|||
145421504|NCT01133977|524397838|FG004|Overall Study|Adverse Event|0|||
145421505|NCT01133977|524397834|FG000|Overall Study|Death|1|||
145421506|NCT01133977|524397835|FG001|Overall Study|Death|1|||
145421507|NCT01133977|524397836|FG002|Overall Study|Death|1|||
145421508|NCT01133977|524397837|FG003|Overall Study|Death|7|||
145421509|NCT01133977|524397838|FG004|Overall Study|Death|3|||
145421510|NCT01133977|524397834|FG000|Overall Study|Started a New Line of Therapy|2|||
145421511|NCT01133977|524397835|FG001|Overall Study|Started a New Line of Therapy|6|||
145421512|NCT01133977|524397836|FG002|Overall Study|Started a New Line of Therapy|4|||
145421513|NCT01133977|524397837|FG003|Overall Study|Started a New Line of Therapy|25|||
145421514|NCT01133977|524397838|FG004|Overall Study|Started a New Line of Therapy|33|||
145421515|NCT01133977|524397834|FG000|Overall Study|Lost to Follow-up|0|||
145421516|NCT01133977|524397835|FG001|Overall Study|Lost to Follow-up|0|||
145421517|NCT01133977|524397836|FG002|Overall Study|Lost to Follow-up|0|||
145421518|NCT01133977|524397837|FG003|Overall Study|Lost to Follow-up|2|||
145421519|NCT01133977|524397838|FG004|Overall Study|Lost to Follow-up|1|||
145421520|NCT01133977|524397834|FG000|Overall Study|Withdrawal by Subject|0|||
145421521|NCT01133977|524397835|FG001|Overall Study|Withdrawal by Subject|0|||
145421522|NCT01133977|524397836|FG002|Overall Study|Withdrawal by Subject|0|||
145421523|NCT01133977|524397837|FG003|Overall Study|Withdrawal by Subject|5|||
145421524|NCT01133977|524397838|FG004|Overall Study|Withdrawal by Subject|1|||
145421525|NCT02105012|524397843|FG000|Overall Study|Withdrawal by Subject|11|||
145421526|NCT02105012|524397843|FG000|Overall Study|Protocol Specified Criteria|9|||
145421527|NCT02105012|524397843|FG000|Overall Study|Lost to Follow-up|4|||
145421528|NCT02105012|524397843|FG000|Overall Study|Protocol Violation|4|||
145421529|NCT02105012|524397843|FG000|Overall Study|Physician Decision|3|||
145421530|NCT02105012|524397843|FG000|Overall Study|Adverse Event|1|||
145421531|NCT02105012|524397843|FG000|Overall Study|Lack of Efficacy|1|||
145421532|NCT00474968|524397850|FG000|Overall Study|Withdrawal by Subject|8|||
145421533|NCT00474968|524397851|FG001|Overall Study|Withdrawal by Subject|7|||
145421534|NCT00474968|524397850|FG000|Overall Study|Protocol Violation|9|||
145421535|NCT00474968|524397851|FG001|Overall Study|Protocol Violation|8|||
145421536|NCT00474968|524397850|FG000|Overall Study|Sample not collected|1|||
145421537|NCT00474968|524397851|FG001|Overall Study|Sample not collected|1|||
145421538|NCT00215553|524397852|FG000|Overall Study|Adverse Event|0|||
145421539|NCT00215553|524397853|FG001|Overall Study|Adverse Event|1|||
145421540|NCT00215553|524397854|FG002|Overall Study|Adverse Event|2|||
145421541|NCT00215553|524397855|FG003|Overall Study|Adverse Event|1|||
145421542|NCT00215553|524397856|FG004|Overall Study|Adverse Event|2|||
145421543|NCT00215553|524397857|FG005|Overall Study|Adverse Event|6|||
145421544|NCT00215553|524397858|FG006|Overall Study|Adverse Event|0|||
145421545|NCT01429623|524397859|FG000|Overall Study|Death|1|||
145421546|NCT01429623|524397860|FG001|Overall Study|Death|0|||
145421547|NCT01429623|524397859|FG000|Overall Study|Adverse Event|7|||
145421548|NCT01429623|524397860|FG001|Overall Study|Adverse Event|14|||
145421549|NCT01429623|524397859|FG000|Overall Study|Withdrawal by Subject|19|||
145421550|NCT01429623|524397860|FG001|Overall Study|Withdrawal by Subject|13|||
145421551|NCT01429623|524397859|FG000|Overall Study|Physician Decision|2|||
145421552|NCT01429623|524397860|FG001|Overall Study|Physician Decision|3|||
145421553|NCT01429623|524397859|FG000|Overall Study|Protocol Violation|3|||
145421554|NCT01429623|524397860|FG001|Overall Study|Protocol Violation|2|||
145421555|NCT01429623|524397859|FG000|Overall Study|Assorted|1|||
145421556|NCT01429623|524397860|FG001|Overall Study|Assorted|2|||
145421557|NCT01429623|524397859|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
145421558|NCT01429623|524397860|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
145421559|NCT01429623|524397859|FG000|Overall Study|No post baseline data|4|||
145421560|NCT01429623|524397860|FG001|Overall Study|No post baseline data|4|||
145421561|NCT05345405|524397861|FG000|Overall Study|Withdrawal by Subject|2|||
145421562|NCT05345405|524397862|FG001|Overall Study|Withdrawal by Subject|0|||
145421563|NCT05345405|524397863|FG002|Overall Study|Withdrawal by Subject|0|||
145421564|NCT05345405|524397861|FG000|Overall Study|Did not meet eligibility criteria|0|||
145421565|NCT05345405|524397862|FG001|Overall Study|Did not meet eligibility criteria|2|||
145421566|NCT05345405|524397863|FG002|Overall Study|Did not meet eligibility criteria|0|||
145421567|NCT05345405|524397861|FG000|Overall Study|Lost to Follow-up|0|||
145421568|NCT05345405|524397862|FG001|Overall Study|Lost to Follow-up|0|||
145421569|NCT05345405|524397863|FG002|Overall Study|Lost to Follow-up|1|||
145421570|NCT01550965|524397867|FG000|Overall Study|Adverse Event|26|||
145421571|NCT01550965|524397867|FG000|Overall Study|Withdrawal by Subject|10|||
145421572|NCT01550965|524397867|FG000|Overall Study|Lost to Follow-up|2|||
145421573|NCT01550965|524397867|FG000|Overall Study|Lack of Efficacy|59|||
145421574|NCT01550965|524397867|FG000|Overall Study|Other|13|||
145421575|NCT04135352|524397872|FG000|Overall Study|Not treated-randomization error|0|||
145421576|NCT04135352|524397873|FG001|Overall Study|Not treated-randomization error|0|||
145421577|NCT04135352|524397874|FG002|Overall Study|Not treated-randomization error|1|||
145421578|NCT04135352|524397875|FG003|Overall Study|Not treated-randomization error|0|||
145421579|NCT04135352|524397876|FG004|Overall Study|Not treated-randomization error|0|||
145421580|NCT04135352|524397877|FG005|Overall Study|Not treated-randomization error|0|||
145421581|NCT04135352|524397878|FG006|Overall Study|Not treated-randomization error|0|||
145421582|NCT04135352|524397879|FG007|Overall Study|Not treated-randomization error|0|||
145421583|NCT04135352|524397872|FG000|Overall Study|Withdrawal by Subject|0|||
145421584|NCT04135352|524397873|FG001|Overall Study|Withdrawal by Subject|0|||
145421585|NCT04135352|524397874|FG002|Overall Study|Withdrawal by Subject|2|||
145421586|NCT04135352|524397875|FG003|Overall Study|Withdrawal by Subject|0|||
145421587|NCT04135352|524397876|FG004|Overall Study|Withdrawal by Subject|0|||
145421588|NCT04135352|524397877|FG005|Overall Study|Withdrawal by Subject|0|||
145421589|NCT04135352|524397878|FG006|Overall Study|Withdrawal by Subject|0|||
145421590|NCT04135352|524397879|FG007|Overall Study|Withdrawal by Subject|0|||
145421591|NCT04135352|524397872|FG000|Overall Study|Sponsor Decision|0|||
145421592|NCT04135352|524397873|FG001|Overall Study|Sponsor Decision|0|||
145421593|NCT04135352|524397874|FG002|Overall Study|Sponsor Decision|2|||
145421594|NCT04135352|524397875|FG003|Overall Study|Sponsor Decision|5|||
145421595|NCT04135352|524397876|FG004|Overall Study|Sponsor Decision|1|||
145421596|NCT04135352|524397877|FG005|Overall Study|Sponsor Decision|4|||
145421597|NCT04135352|524397878|FG006|Overall Study|Sponsor Decision|0|||
145421598|NCT04135352|524397879|FG007|Overall Study|Sponsor Decision|0|||
145421599|NCT04135352|524397872|FG000|Overall Study|Physician Decision|0|||
145421600|NCT04135352|524397873|FG001|Overall Study|Physician Decision|0|||
145421601|NCT04135352|524397874|FG002|Overall Study|Physician Decision|1|||
145421602|NCT04135352|524397875|FG003|Overall Study|Physician Decision|0|||
145421603|NCT04135352|524397876|FG004|Overall Study|Physician Decision|1|||
145421604|NCT04135352|524397877|FG005|Overall Study|Physician Decision|0|||
145421605|NCT04135352|524397878|FG006|Overall Study|Physician Decision|0|||
145421606|NCT04135352|524397879|FG007|Overall Study|Physician Decision|0|||
145421607|NCT04135352|524397872|FG000|Overall Study|Death|3|||
145421608|NCT04135352|524397873|FG001|Overall Study|Death|4|||
145421609|NCT04135352|524397874|FG002|Overall Study|Death|7|||
145421610|NCT04135352|524397875|FG003|Overall Study|Death|0|||
145421611|NCT04135352|524397876|FG004|Overall Study|Death|3|||
145421612|NCT04135352|524397877|FG005|Overall Study|Death|1|||
145421613|NCT04135352|524397878|FG006|Overall Study|Death|0|||
145421614|NCT04135352|524397879|FG007|Overall Study|Death|0|||
145421615|NCT01696214|524397881|FG000|Overall Study|Lost to Follow-up|1|||
145421616|NCT01696214|524397882|FG001|Overall Study|Lost to Follow-up|0|||
145421617|NCT01696214|524397883|FG002|Overall Study|Lost to Follow-up|0|||
145421618|NCT01696214|524397884|FG003|Overall Study|Lost to Follow-up|0|||
145623207|NCT01077024|525131614|FG001|Overall Study|Other|4|||
145366033|NCT02587598|524190150|FG008|Overall Study|Death|9|||
145366034|NCT02587598|524190151|FG009|Overall Study|Death|1|||
145366035|NCT02587598|524190152|FG010|Overall Study|Death|3|||
145366036|NCT02587598|524190142|FG000|Overall Study|Study Terminated by the Sponsor|0|||
145366037|NCT02587598|524190143|FG001|Overall Study|Study Terminated by the Sponsor|1|||
145366038|NCT02587598|524190144|FG002|Overall Study|Study Terminated by the Sponsor|0|||
145366039|NCT02587598|524190145|FG003|Overall Study|Study Terminated by the Sponsor|3|||
145366040|NCT02587598|524190146|FG004|Overall Study|Study Terminated by the Sponsor|0|||
145366041|NCT02587598|524190147|FG005|Overall Study|Study Terminated by the Sponsor|1|||
145366042|NCT02587598|524190148|FG006|Overall Study|Study Terminated by the Sponsor|0|||
145366043|NCT02587598|524190149|FG007|Overall Study|Study Terminated by the Sponsor|0|||
145366044|NCT02587598|524190150|FG008|Overall Study|Study Terminated by the Sponsor|0|||
145366045|NCT02587598|524190151|FG009|Overall Study|Study Terminated by the Sponsor|1|||
145366046|NCT02587598|524190152|FG010|Overall Study|Study Terminated by the Sponsor|6|||
145366047|NCT02587598|524190142|FG000|Overall Study|Reason for study withdrawal not specified|0|||
145366048|NCT02587598|524190143|FG001|Overall Study|Reason for study withdrawal not specified|1|||
145366049|NCT02587598|524190144|FG002|Overall Study|Reason for study withdrawal not specified|0|||
145421619|NCT00819832|524397887|FG000|Overall Study|Sponsor Termination of Study|3|||
145421620|NCT00819832|524397888|FG001|Overall Study|Sponsor Termination of Study|0|||
145421621|NCT00819832|524397889|FG002|Overall Study|Sponsor Termination of Study|0|||
145421622|NCT00819832|524397890|FG003|Overall Study|Sponsor Termination of Study|0|||
145421623|NCT00819832|524397891|FG004|Overall Study|Sponsor Termination of Study|0|||
145421624|NCT00819832|524397892|FG005|Overall Study|Sponsor Termination of Study|0|||
145421625|NCT00066170|524397897|FG000|Overall Study|Adverse Event|2|||
145421626|NCT00066170|524397898|FG001|Overall Study|Adverse Event|4|||
145421627|NCT00066170|524397899|FG002|Overall Study|Adverse Event|1|||
145421628|NCT00066170|524397900|FG003|Overall Study|Adverse Event|7|||
145421629|NCT00066170|524397897|FG000|Overall Study|Serious Adverse Event|0|||
145421630|NCT00066170|524397898|FG001|Overall Study|Serious Adverse Event|0|||
145421631|NCT00066170|524397899|FG002|Overall Study|Serious Adverse Event|1|||
145421632|NCT00066170|524397900|FG003|Overall Study|Serious Adverse Event|1|||
145421633|NCT00066170|524397897|FG000|Overall Study|Lost to Follow-up|0|||
145421634|NCT00066170|524397898|FG001|Overall Study|Lost to Follow-up|1|||
145421635|NCT00066170|524397899|FG002|Overall Study|Lost to Follow-up|0|||
145421636|NCT00066170|524397900|FG003|Overall Study|Lost to Follow-up|0|||
145421637|NCT00066170|524397897|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
145421638|NCT00066170|524397898|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
145421639|NCT00066170|524397899|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
145421640|NCT00066170|524397900|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
145421641|NCT00066170|524397897|FG000|Overall Study|Protocol Violation|3|||
145421642|NCT00066170|524397898|FG001|Overall Study|Protocol Violation|0|||
145578192|NCT03304379|524971423|FG004|Overall Study|Death|0|||
145578193|NCT03304379|524971419|FG000|Overall Study|Other|0|||
145578194|NCT03304379|524971420|FG001|Overall Study|Other|1|||
145366050|NCT02587598|524190145|FG003|Overall Study|Reason for study withdrawal not specified|0|||
145366051|NCT02587598|524190146|FG004|Overall Study|Reason for study withdrawal not specified|0|||
145366052|NCT02587598|524190147|FG005|Overall Study|Reason for study withdrawal not specified|0|||
145366053|NCT02587598|524190148|FG006|Overall Study|Reason for study withdrawal not specified|0|||
145366054|NCT02587598|524190149|FG007|Overall Study|Reason for study withdrawal not specified|0|||
145366055|NCT02587598|524190150|FG008|Overall Study|Reason for study withdrawal not specified|0|||
145366056|NCT02587598|524190151|FG009|Overall Study|Reason for study withdrawal not specified|0|||
145366057|NCT02587598|524190152|FG010|Overall Study|Reason for study withdrawal not specified|0|||
145366058|NCT02587598|524190142|FG000|Overall Study|Withdrawal by Subject|0|||
145366059|NCT02587598|524190143|FG001|Overall Study|Withdrawal by Subject|1|||
145366060|NCT02587598|524190144|FG002|Overall Study|Withdrawal by Subject|0|||
145366061|NCT02587598|524190145|FG003|Overall Study|Withdrawal by Subject|2|||
145366062|NCT02587598|524190146|FG004|Overall Study|Withdrawal by Subject|3|||
145366063|NCT02587598|524190147|FG005|Overall Study|Withdrawal by Subject|1|||
145366064|NCT02587598|524190148|FG006|Overall Study|Withdrawal by Subject|0|||
145366065|NCT02587598|524190149|FG007|Overall Study|Withdrawal by Subject|0|||
145366066|NCT02587598|524190150|FG008|Overall Study|Withdrawal by Subject|0|||
145366067|NCT02587598|524190151|FG009|Overall Study|Withdrawal by Subject|1|||
145366068|NCT02587598|524190152|FG010|Overall Study|Withdrawal by Subject|2|||
145366069|NCT02587598|524190142|FG000|Overall Study|Physician Decision|0|||
145366070|NCT02587598|524190143|FG001|Overall Study|Physician Decision|0|||
145366071|NCT02587598|524190144|FG002|Overall Study|Physician Decision|0|||
145366072|NCT02587598|524190145|FG003|Overall Study|Physician Decision|0|||
145366073|NCT02587598|524190146|FG004|Overall Study|Physician Decision|0|||
145366074|NCT02587598|524190147|FG005|Overall Study|Physician Decision|0|||
145366075|NCT02587598|524190148|FG006|Overall Study|Physician Decision|0|||
145366076|NCT02587598|524190149|FG007|Overall Study|Physician Decision|0|||
145366077|NCT02587598|524190150|FG008|Overall Study|Physician Decision|0|||
145366078|NCT02587598|524190151|FG009|Overall Study|Physician Decision|0|||
145366079|NCT02587598|524190152|FG010|Overall Study|Physician Decision|3|||
145366080|NCT01704651|524190159|FG000|Overall Study|Pre-op withdrawal by subject|1|||
145366081|NCT01704651|524190160|FG001|Overall Study|Pre-op withdrawal by subject|1|||
145366082|NCT01704651|524190159|FG000|Overall Study|Pre-op change in treatment plan|1|||
145366083|NCT01704651|524190160|FG001|Overall Study|Pre-op change in treatment plan|4|||
145366084|NCT01704651|524190159|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
145366085|NCT01704651|524190160|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
145366086|NCT01704651|524190159|FG000|Overall Study|Post-op did not have laparotomy|2|||
145366087|NCT01704651|524190160|FG001|Overall Study|Post-op did not have laparotomy|1|||
145366088|NCT03474731|524190163|FG000|Overall Study|Withdrawal by Subject|36|||
145366089|NCT03474731|524190164|FG001|Overall Study|Withdrawal by Subject|29|||
145366090|NCT03474731|524190165|FG002|Overall Study|Withdrawal by Subject|11|||
145366091|NCT03474731|524190166|FG003|Overall Study|Withdrawal by Subject|27|||
145366092|NCT03474731|524190163|FG000|Overall Study|COVID|0|||
145366093|NCT03474731|524190164|FG001|Overall Study|COVID|23|||
145366094|NCT03474731|524190165|FG002|Overall Study|COVID|0|||
145366095|NCT03474731|524190166|FG003|Overall Study|COVID|0|||
145421643|NCT00066170|524397899|FG002|Overall Study|Protocol Violation|0|||
145421644|NCT00066170|524397900|FG003|Overall Study|Protocol Violation|0|||
145366096|NCT03474731|524190163|FG000|Overall Study|Participant moved from area|1|||
145366097|NCT03474731|524190164|FG001|Overall Study|Participant moved from area|0|||
145366098|NCT03474731|524190165|FG002|Overall Study|Participant moved from area|0|||
145366099|NCT03474731|524190166|FG003|Overall Study|Participant moved from area|0|||
145366100|NCT03474731|524190163|FG000|Overall Study|Lost to Follow-up|11|||
145366101|NCT03474731|524190164|FG001|Overall Study|Lost to Follow-up|3|||
145366102|NCT03474731|524190165|FG002|Overall Study|Lost to Follow-up|18|||
145421645|NCT00066170|524397897|FG000|Overall Study|Other|1|||
145421646|NCT00066170|524397898|FG001|Overall Study|Other|5|||
145421647|NCT00066170|524397899|FG002|Overall Study|Other|2|||
145421648|NCT00066170|524397900|FG003|Overall Study|Other|0|||
145578195|NCT03304379|524971421|FG002|Overall Study|Other|0|||
145366103|NCT03474731|524190166|FG003|Overall Study|Lost to Follow-up|17|||
145366104|NCT03474731|524190163|FG000|Overall Study|Death|0|||
145366105|NCT03474731|524190164|FG001|Overall Study|Death|1|||
145366106|NCT03474731|524190165|FG002|Overall Study|Death|0|||
145366107|NCT03474731|524190166|FG003|Overall Study|Death|0|||
145366108|NCT03474731|524190163|FG000|Overall Study|Participant Removed|0|||
145366109|NCT03474731|524190164|FG001|Overall Study|Participant Removed|0|||
145366110|NCT03474731|524190165|FG002|Overall Study|Participant Removed|0|||
145366111|NCT03474731|524190166|FG003|Overall Study|Participant Removed|1|||
145366112|NCT02887248|524190170|FG000|Overall Study|Withdrawal by Subject|1|||
145366113|NCT02887248|524190170|FG000|Overall Study|Adverse Event|1|||
145366114|NCT02887248|524190170|FG000|Overall Study|Progressive Disease|1|||
145366115|NCT00765336|524190171|FG000|Overall Study|Protocol Violation|4|||
145366116|NCT00765336|524190172|FG001|Overall Study|Protocol Violation|2|||
145366117|NCT00765336|524190171|FG000|Overall Study|Withdrawal by Subject|6|||
145366118|NCT00765336|524190172|FG001|Overall Study|Withdrawal by Subject|4|||
145366119|NCT00765336|524190171|FG000|Overall Study|Lost to Follow-up|7|||
145366120|NCT00765336|524190172|FG001|Overall Study|Lost to Follow-up|9|||
145366121|NCT00765336|524190171|FG000|Overall Study|Adverse Event|2|||
145366122|NCT00765336|524190172|FG001|Overall Study|Adverse Event|1|||
145366123|NCT00478777|524190173|FG000|Overall Study|Adverse Event|29|||
145366124|NCT00478777|524190173|FG000|Overall Study|Lack of Efficacy|23|||
145366125|NCT00478777|524190173|FG000|Overall Study|Withdrawal by Subject|4|||
145366126|NCT00478777|524190173|FG000|Overall Study|Death|3|||
145366127|NCT00478777|524190173|FG000|Overall Study|Protocol Violation|3|||
145366128|NCT00478777|524190173|FG000|Overall Study|Lost to Follow-up|3|||
145366129|NCT00478777|524190173|FG000|Overall Study|Physician Decision|1|||
145366130|NCT00478777|524190173|FG000|Overall Study|Intolerance of therapy|1|||
145366131|NCT00478777|524190173|FG000|Overall Study|Lack of compliance|1|||
145366132|NCT00478777|524190173|FG000|Overall Study|Lymphocytes infusion|1|||
145366133|NCT00478777|524190173|FG000|Overall Study|End of therapy|2|||
145366134|NCT00478777|524190173|FG000|Overall Study|Not treated with lenalidomide|6|||
145366135|NCT04105218|524190179|FG000|Overall Study|Withdrawal by Subject|3|||
145366136|NCT04105218|524190180|FG001|Overall Study|Withdrawal by Subject|2|||
145366137|NCT04105218|524190179|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
145366138|NCT04105218|524190180|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
145366139|NCT04105218|524190179|FG000|Overall Study|Failed screening tests|2|||
145366140|NCT04105218|524190180|FG001|Overall Study|Failed screening tests|1|||
145366141|NCT02858583|524190183|FG000|Overall Study|Declined consent|1|||
145366142|NCT02858583|524190184|FG001|Overall Study|Declined consent|1|||
145366143|NCT01323387|524190189|FG000|Overall Study|Withdrawal by Subject|41|||
145366144|NCT01323387|524190189|FG000|Overall Study|Radiographic Data Unavailable|1|||
145366145|NCT01323387|524190189|FG000|Overall Study|Revision|14|||
145366146|NCT01323387|524190189|FG000|Overall Study|Protocol Violation|12|||
145366147|NCT01323387|524190189|FG000|Overall Study|Randomized but Never Treated|16|||
145366148|NCT01972438|524190190|FG000|Baseline-Month 3 Crossover Period|Death|1|||
145366149|NCT01972438|524190191|FG001|Baseline-Month 3 Crossover Period|Death|0|||
145366150|NCT01972438|524190190|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
145366151|NCT01972438|524190191|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
145366152|NCT01972438|524190190|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
145366153|NCT01972438|524190191|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
145366154|NCT01972438|524190190|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
145366155|NCT01972438|524190191|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
145366156|NCT01972438|524190190|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
145366157|NCT01972438|524190191|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
145366158|NCT01972438|524190190|FG000|Months 6-12 Study Period|Death|1|||
145366159|NCT01972438|524190191|FG001|Months 6-12 Study Period|Death|0|||
145578196|NCT03304379|524971422|FG003|Overall Study|Other|0|||
145578197|NCT03304379|524971423|FG004|Overall Study|Other|0|||
145366160|NCT01972438|524190190|FG000|Months 6-12 Study Period|Early Study Closure|2|||
145366161|NCT01972438|524190191|FG001|Months 6-12 Study Period|Early Study Closure|2|||
145366162|NCT01972438|524190190|FG000|Post Month 12 Study Period|Early Study Closure|3|||
145366163|NCT01972438|524190191|FG001|Post Month 12 Study Period|Early Study Closure|4|||
145366164|NCT00570063|524190199|FG000|Overall Study|Adverse Event|4|||
145366165|NCT00570063|524190200|FG001|Overall Study|Adverse Event|1|||
145366166|NCT00570063|524190199|FG000|Overall Study|Lack of Efficacy|0|||
145366167|NCT00570063|524190200|FG001|Overall Study|Lack of Efficacy|1|||
145366168|NCT00570063|524190199|FG000|Overall Study|Withdrawal by Subject|4|||
145366169|NCT00570063|524190200|FG001|Overall Study|Withdrawal by Subject|3|||
145366170|NCT00570063|524190199|FG000|Overall Study|Sponsor's Decision|7|||
145366171|NCT00570063|524190200|FG001|Overall Study|Sponsor's Decision|3|||
145366172|NCT00697463|524190201|FG000|Overall Study|Withdrawal by Subject|1|||
145366173|NCT03307252|524190202|FG000|Part 2, Period 1|Treatment not received|0|||
145366174|NCT03307252|524190203|FG001|Part 2, Period 1|Treatment not received|0|||
145578198|NCT02802345|524971437|FG000|Overall Study|Not Treated|0|||
145578199|NCT02802345|524971438|FG001|Overall Study|Not Treated|1|||
145366175|NCT03307252|524190204|FG002|Part 2, Period 1|Treatment not received|0|||
145366176|NCT03307252|524190205|FG003|Part 2, Period 1|Treatment not received|0|||
145366177|NCT03307252|524190206|FG004|Part 2, Period 1|Treatment not received|0|||
145366178|NCT03307252|524190207|FG005|Part 2, Period 1|Treatment not received|1|||
145366179|NCT03307252|524190208|FG006|Part 2, Period 1|Treatment not received|0|||
145366180|NCT03307252|524190209|FG007|Part 2, Period 1|Treatment not received|0|||
145366181|NCT03307252|524190210|FG008|Part 2, Period 1|Treatment not received|0|||
145366182|NCT03307252|524190211|FG009|Part 2, Period 1|Treatment not received|0|||
145366183|NCT03307252|524190212|FG010|Part 2, Period 1|Treatment not received|0|||
145366184|NCT03307252|524190202|FG000|Part 2, Period 3|Other than listed|0|||
145366185|NCT03307252|524190203|FG001|Part 2, Period 3|Other than listed|0|||
145366186|NCT03307252|524190204|FG002|Part 2, Period 3|Other than listed|0|||
145366187|NCT03307252|524190205|FG003|Part 2, Period 3|Other than listed|0|||
145366188|NCT03307252|524190206|FG004|Part 2, Period 3|Other than listed|1|||
145366189|NCT03307252|524190207|FG005|Part 2, Period 3|Other than listed|0|||
145366190|NCT03307252|524190208|FG006|Part 2, Period 3|Other than listed|0|||
145366191|NCT03307252|524190209|FG007|Part 2, Period 3|Other than listed|0|||
145366192|NCT03307252|524190210|FG008|Part 2, Period 3|Other than listed|0|||
145366193|NCT03307252|524190211|FG009|Part 2, Period 3|Other than listed|0|||
145366194|NCT03307252|524190212|FG010|Part 2, Period 3|Other than listed|0|||
145366195|NCT03307252|524190202|FG000|Part 2, Period 4|Other than listed|0|||
145366196|NCT03307252|524190203|FG001|Part 2, Period 4|Other than listed|0|||
145366197|NCT03307252|524190204|FG002|Part 2, Period 4|Other than listed|0|||
145366198|NCT03307252|524190205|FG003|Part 2, Period 4|Other than listed|0|||
145366199|NCT03307252|524190206|FG004|Part 2, Period 4|Other than listed|0|||
145366200|NCT03307252|524190207|FG005|Part 2, Period 4|Other than listed|0|||
145366201|NCT03307252|524190208|FG006|Part 2, Period 4|Other than listed|1|||
145366202|NCT03307252|524190209|FG007|Part 2, Period 4|Other than listed|0|||
145366203|NCT03307252|524190210|FG008|Part 2, Period 4|Other than listed|0|||
145366204|NCT03307252|524190211|FG009|Part 2, Period 4|Other than listed|0|||
145366205|NCT03307252|524190212|FG010|Part 2, Period 4|Other than listed|0|||
145366206|NCT03307252|524190202|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366207|NCT03307252|524190203|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366208|NCT03307252|524190204|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366209|NCT03307252|524190205|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366210|NCT03307252|524190206|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366211|NCT03307252|524190207|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366212|NCT03307252|524190208|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366213|NCT03307252|524190209|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366214|NCT03307252|524190210|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366215|NCT03307252|524190211|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
145366216|NCT03307252|524190212|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
145366217|NCT03482453|524190213|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366218|NCT03482453|524190214|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366219|NCT03482453|524190215|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366220|NCT03482453|524190216|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366221|NCT03482453|524190217|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366222|NCT03482453|524190218|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366223|NCT03482453|524190219|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366224|NCT03482453|524190220|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366225|NCT03482453|524190221|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366226|NCT03482453|524190222|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366227|NCT03482453|524190223|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
145366228|NCT03482453|524190224|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
145366229|NCT02568189|524190225|FG000|Overall Study|Protocol Violation|0|||
145366230|NCT02568189|524190226|FG001|Overall Study|Protocol Violation|0|||
145366231|NCT02568189|524190227|FG002|Overall Study|Protocol Violation|19|||
145366232|NCT02568189|524190228|FG003|Overall Study|Protocol Violation|18|||
145366233|NCT01554527|524190229|FG000|Overall Study|Withdrawal by Subject|1|||
145366234|NCT01554527|524190230|FG001|Overall Study|Withdrawal by Subject|0|||
145366235|NCT01554527|524190231|FG002|Overall Study|Withdrawal by Subject|3|||
145366236|NCT01554527|524190229|FG000|Overall Study|Lost to Follow-up|0|||
145366237|NCT01554527|524190230|FG001|Overall Study|Lost to Follow-up|0|||
145366238|NCT01554527|524190231|FG002|Overall Study|Lost to Follow-up|4|||
145366239|NCT01554527|524190229|FG000|Overall Study|Physician Decision|0|||
145366240|NCT01554527|524190230|FG001|Overall Study|Physician Decision|0|||
145366241|NCT01554527|524190231|FG002|Overall Study|Physician Decision|1|||
145366242|NCT01052480|524190232|FG000|Overall Study|Lost to Follow-up|3|||
145421649|NCT03520387|524397902|FG000|Pre-Randomization|Withdrawal by Subject|1|||
145421650|NCT03520387|524397903|FG001|Pre-Randomization|Withdrawal by Subject|0|||
145623208|NCT02034435|525131615|FG000|Overall Study|Withdrawal by Subject|1|||
145578200|NCT02802345|524971437|FG000|Overall Study|Adverse Event|28|||
145578201|NCT02802345|524971438|FG001|Overall Study|Adverse Event|20|||
145578202|NCT02802345|524971437|FG000|Overall Study|Withdrawal by Subject|3|||
145578203|NCT02802345|524971438|FG001|Overall Study|Withdrawal by Subject|3|||
145578204|NCT02802345|524971437|FG000|Overall Study|Protocol Violation|0|||
145578205|NCT02802345|524971438|FG001|Overall Study|Protocol Violation|1|||
145578206|NCT02802345|524971437|FG000|Overall Study|Other than listed|1|||
145578207|NCT02802345|524971438|FG001|Overall Study|Other than listed|5|||
145366243|NCT01052480|524190233|FG001|Overall Study|Lost to Follow-up|3|||
145366244|NCT01052480|524190232|FG000|Overall Study|Protocol Violation|1|||
145366245|NCT01052480|524190233|FG001|Overall Study|Protocol Violation|0|||
145366246|NCT01052480|524190232|FG000|Overall Study|Withdrawal by Subject|3|||
145366247|NCT01052480|524190233|FG001|Overall Study|Withdrawal by Subject|7|||
145366248|NCT01052480|524190232|FG000|Overall Study|Physician Decision|0|||
145366249|NCT01052480|524190233|FG001|Overall Study|Physician Decision|2|||
145366250|NCT01052480|524190232|FG000|Overall Study|Death|1|||
145366251|NCT01052480|524190233|FG001|Overall Study|Death|5|||
145366252|NCT02073929|524190236|FG000|Overall Study|Lost to Follow-up|2|||
145366253|NCT02073929|524190237|FG001|Overall Study|Lost to Follow-up|1|||
145366254|NCT02073929|524190236|FG000|Overall Study|Adverse Event|2|||
145366255|NCT02073929|524190237|FG001|Overall Study|Adverse Event|1|||
145366256|NCT02073929|524190236|FG000|Overall Study|Withdrawal by Subject|0|||
145366257|NCT02073929|524190237|FG001|Overall Study|Withdrawal by Subject|1|||
145366258|NCT01314872|524190240|FG000|Treatment Period 1|Protocol Violation|2|||
145366259|NCT01314872|524190241|FG001|Treatment Period 1|Protocol Violation|1|||
145366260|NCT01314872|524190242|FG002|Treatment Period 1|Protocol Violation|1|||
145366261|NCT01314872|524190243|FG003|Treatment Period 1|Protocol Violation|0|||
145366262|NCT01314872|524190244|FG004|Treatment Period 1|Protocol Violation|1|||
145366263|NCT01314872|524190245|FG005|Treatment Period 1|Protocol Violation|0|||
145366264|NCT01314872|524190246|FG006|Treatment Period 1|Protocol Violation|0|||
145366265|NCT01314872|524190247|FG007|Treatment Period 1|Protocol Violation|0|||
145366266|NCT01314872|524190248|FG008|Treatment Period 1|Protocol Violation|0|||
145366267|NCT01314872|524190249|FG009|Treatment Period 1|Protocol Violation|1|||
145366268|NCT01314872|524190250|FG010|Treatment Period 1|Protocol Violation|1|||
145366269|NCT01314872|524190251|FG011|Treatment Period 1|Protocol Violation|0|||
145366270|NCT01314872|524190252|FG012|Treatment Period 1|Protocol Violation|0|||
145366271|NCT01314872|524190253|FG013|Treatment Period 1|Protocol Violation|0|||
145366272|NCT01314872|524190254|FG014|Treatment Period 1|Protocol Violation|0|||
145366273|NCT01314872|524190240|FG000|Treatment Period 1|Physician Decision|0|||
145366274|NCT01314872|524190241|FG001|Treatment Period 1|Physician Decision|1|||
145366275|NCT01314872|524190242|FG002|Treatment Period 1|Physician Decision|0|||
145366276|NCT01314872|524190243|FG003|Treatment Period 1|Physician Decision|1|||
145366277|NCT01314872|524190244|FG004|Treatment Period 1|Physician Decision|0|||
145366278|NCT01314872|524190245|FG005|Treatment Period 1|Physician Decision|0|||
145366279|NCT01314872|524190246|FG006|Treatment Period 1|Physician Decision|0|||
145366280|NCT01314872|524190247|FG007|Treatment Period 1|Physician Decision|0|||
145366281|NCT01314872|524190248|FG008|Treatment Period 1|Physician Decision|0|||
145366282|NCT01314872|524190249|FG009|Treatment Period 1|Physician Decision|1|||
145366283|NCT01314872|524190250|FG010|Treatment Period 1|Physician Decision|0|||
145366284|NCT01314872|524190251|FG011|Treatment Period 1|Physician Decision|0|||
145366285|NCT01314872|524190252|FG012|Treatment Period 1|Physician Decision|0|||
145366286|NCT01314872|524190253|FG013|Treatment Period 1|Physician Decision|0|||
145366287|NCT01314872|524190254|FG014|Treatment Period 1|Physician Decision|0|||
145366288|NCT01314872|524190240|FG000|Treatment Period 1|Lack of Efficacy|1|||
145366289|NCT01314872|524190241|FG001|Treatment Period 1|Lack of Efficacy|0|||
145366290|NCT01314872|524190242|FG002|Treatment Period 1|Lack of Efficacy|0|||
145366291|NCT01314872|524190243|FG003|Treatment Period 1|Lack of Efficacy|0|||
145366292|NCT01314872|524190244|FG004|Treatment Period 1|Lack of Efficacy|0|||
145366293|NCT01314872|524190245|FG005|Treatment Period 1|Lack of Efficacy|1|||
145366294|NCT01314872|524190246|FG006|Treatment Period 1|Lack of Efficacy|0|||
145366295|NCT01314872|524190247|FG007|Treatment Period 1|Lack of Efficacy|2|||
145366296|NCT01314872|524190248|FG008|Treatment Period 1|Lack of Efficacy|0|||
145366297|NCT01314872|524190249|FG009|Treatment Period 1|Lack of Efficacy|0|||
145366298|NCT01314872|524190250|FG010|Treatment Period 1|Lack of Efficacy|0|||
145366299|NCT01314872|524190251|FG011|Treatment Period 1|Lack of Efficacy|0|||
145366300|NCT01314872|524190252|FG012|Treatment Period 1|Lack of Efficacy|0|||
145366301|NCT01314872|524190253|FG013|Treatment Period 1|Lack of Efficacy|0|||
145366302|NCT01314872|524190254|FG014|Treatment Period 1|Lack of Efficacy|0|||
145366303|NCT01314872|524190240|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
145366304|NCT01314872|524190241|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
145366305|NCT01314872|524190242|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
145366306|NCT01314872|524190243|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
145366307|NCT01314872|524190244|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
145578208|NCT03075644|524971443|FG000|Overall Study|Withdrawal by Subject|1|||
145578209|NCT03075644|524971444|FG001|Overall Study|Withdrawal by Subject|1|||
145578210|NCT02486406|524971453|FG000|Overall Study|Withdrew consent|1|||
145578211|NCT02486406|524971454|FG001|Overall Study|Withdrew consent|0|||
145366308|NCT01314872|524190245|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
145366309|NCT01314872|524190246|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
145366310|NCT01314872|524190247|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
145366311|NCT01314872|524190248|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
145366312|NCT01314872|524190249|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
145366313|NCT01314872|524190250|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
145366314|NCT01314872|524190251|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
145366315|NCT01314872|524190252|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
145366316|NCT01314872|524190253|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
145366317|NCT01314872|524190254|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
145366318|NCT01314872|524190240|FG000|Treatment Period 1|Withdrawal by Subject|3|||
145366319|NCT01314872|524190241|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145366320|NCT01314872|524190242|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145366321|NCT01314872|524190243|FG003|Treatment Period 1|Withdrawal by Subject|2|||
145366322|NCT01314872|524190244|FG004|Treatment Period 1|Withdrawal by Subject|3|||
145366323|NCT01314872|524190245|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145366324|NCT01314872|524190246|FG006|Treatment Period 1|Withdrawal by Subject|3|||
145366325|NCT01314872|524190247|FG007|Treatment Period 1|Withdrawal by Subject|2|||
145366326|NCT01314872|524190248|FG008|Treatment Period 1|Withdrawal by Subject|2|||
145366327|NCT01314872|524190249|FG009|Treatment Period 1|Withdrawal by Subject|2|||
145366328|NCT01314872|524190250|FG010|Treatment Period 1|Withdrawal by Subject|1|||
145366329|NCT01314872|524190251|FG011|Treatment Period 1|Withdrawal by Subject|0|||
145366330|NCT01314872|524190252|FG012|Treatment Period 1|Withdrawal by Subject|0|||
145366331|NCT01314872|524190253|FG013|Treatment Period 1|Withdrawal by Subject|0|||
145366332|NCT01314872|524190254|FG014|Treatment Period 1|Withdrawal by Subject|0|||
145366333|NCT01314872|524190240|FG000|Treatment Period 1|Lost to Follow-up|0|||
145366334|NCT01314872|524190241|FG001|Treatment Period 1|Lost to Follow-up|1|||
145366335|NCT01314872|524190242|FG002|Treatment Period 1|Lost to Follow-up|2|||
145366336|NCT01314872|524190243|FG003|Treatment Period 1|Lost to Follow-up|2|||
145366337|NCT01314872|524190244|FG004|Treatment Period 1|Lost to Follow-up|1|||
145366338|NCT01314872|524190245|FG005|Treatment Period 1|Lost to Follow-up|1|||
145366339|NCT01314872|524190246|FG006|Treatment Period 1|Lost to Follow-up|1|||
145366340|NCT01314872|524190247|FG007|Treatment Period 1|Lost to Follow-up|1|||
145366341|NCT01314872|524190248|FG008|Treatment Period 1|Lost to Follow-up|1|||
145366342|NCT01314872|524190249|FG009|Treatment Period 1|Lost to Follow-up|0|||
145366343|NCT01314872|524190250|FG010|Treatment Period 1|Lost to Follow-up|0|||
145366344|NCT01314872|524190251|FG011|Treatment Period 1|Lost to Follow-up|0|||
145366345|NCT01314872|524190252|FG012|Treatment Period 1|Lost to Follow-up|0|||
145366346|NCT01314872|524190253|FG013|Treatment Period 1|Lost to Follow-up|0|||
145366347|NCT01314872|524190254|FG014|Treatment Period 1|Lost to Follow-up|0|||
145366348|NCT01314872|524190240|FG000|Period 2|Protocol Violation|0|||
145366349|NCT01314872|524190241|FG001|Period 2|Protocol Violation|0|||
145366350|NCT01314872|524190242|FG002|Period 2|Protocol Violation|0|||
145366351|NCT01314872|524190243|FG003|Period 2|Protocol Violation|0|||
145366352|NCT01314872|524190244|FG004|Period 2|Protocol Violation|0|||
145366353|NCT01314872|524190245|FG005|Period 2|Protocol Violation|0|||
145366354|NCT01314872|524190246|FG006|Period 2|Protocol Violation|0|||
145366355|NCT01314872|524190247|FG007|Period 2|Protocol Violation|0|||
145366356|NCT01314872|524190248|FG008|Period 2|Protocol Violation|0|||
145366357|NCT01314872|524190249|FG009|Period 2|Protocol Violation|0|||
145366358|NCT01314872|524190250|FG010|Period 2|Protocol Violation|0|||
145366359|NCT01314872|524190251|FG011|Period 2|Protocol Violation|3|||
145366360|NCT01314872|524190252|FG012|Period 2|Protocol Violation|3|||
145366361|NCT01314872|524190253|FG013|Period 2|Protocol Violation|2|||
145366362|NCT01314872|524190254|FG014|Period 2|Protocol Violation|0|||
145366363|NCT01314872|524190240|FG000|Period 2|Non-compliance with study drug|0|||
145366364|NCT01314872|524190241|FG001|Period 2|Non-compliance with study drug|0|||
145366365|NCT01314872|524190242|FG002|Period 2|Non-compliance with study drug|0|||
145366366|NCT01314872|524190243|FG003|Period 2|Non-compliance with study drug|0|||
145366367|NCT01314872|524190244|FG004|Period 2|Non-compliance with study drug|0|||
145366368|NCT01314872|524190245|FG005|Period 2|Non-compliance with study drug|0|||
145366369|NCT01314872|524190246|FG006|Period 2|Non-compliance with study drug|0|||
145366370|NCT01314872|524190247|FG007|Period 2|Non-compliance with study drug|0|||
145366371|NCT01314872|524190248|FG008|Period 2|Non-compliance with study drug|0|||
145366372|NCT01314872|524190249|FG009|Period 2|Non-compliance with study drug|0|||
145366373|NCT01314872|524190250|FG010|Period 2|Non-compliance with study drug|0|||
145366374|NCT01314872|524190251|FG011|Period 2|Non-compliance with study drug|3|||
145366375|NCT01314872|524190252|FG012|Period 2|Non-compliance with study drug|3|||
145366376|NCT01314872|524190253|FG013|Period 2|Non-compliance with study drug|1|||
145366377|NCT01314872|524190254|FG014|Period 2|Non-compliance with study drug|2|||
145366378|NCT01314872|524190240|FG000|Period 2|Lack of Efficacy|0|||
145366379|NCT01314872|524190241|FG001|Period 2|Lack of Efficacy|0|||
145366380|NCT01314872|524190242|FG002|Period 2|Lack of Efficacy|0|||
145366381|NCT01314872|524190243|FG003|Period 2|Lack of Efficacy|0|||
145366382|NCT01314872|524190244|FG004|Period 2|Lack of Efficacy|0|||
145366383|NCT01314872|524190245|FG005|Period 2|Lack of Efficacy|0|||
145366384|NCT01314872|524190246|FG006|Period 2|Lack of Efficacy|0|||
145366385|NCT01314872|524190247|FG007|Period 2|Lack of Efficacy|0|||
145366386|NCT01314872|524190248|FG008|Period 2|Lack of Efficacy|0|||
145366387|NCT01314872|524190249|FG009|Period 2|Lack of Efficacy|0|||
145366388|NCT01314872|524190250|FG010|Period 2|Lack of Efficacy|0|||
145366389|NCT01314872|524190251|FG011|Period 2|Lack of Efficacy|7|||
145366390|NCT01314872|524190252|FG012|Period 2|Lack of Efficacy|12|||
145366391|NCT01314872|524190253|FG013|Period 2|Lack of Efficacy|9|||
145366392|NCT01314872|524190254|FG014|Period 2|Lack of Efficacy|2|||
145366393|NCT01314872|524190240|FG000|Period 2|Pregnancy|0|||
145366394|NCT01314872|524190241|FG001|Period 2|Pregnancy|0|||
145366395|NCT01314872|524190242|FG002|Period 2|Pregnancy|0|||
145366396|NCT01314872|524190243|FG003|Period 2|Pregnancy|0|||
145366397|NCT01314872|524190244|FG004|Period 2|Pregnancy|0|||
145366398|NCT01314872|524190245|FG005|Period 2|Pregnancy|0|||
145366399|NCT01314872|524190246|FG006|Period 2|Pregnancy|0|||
145366400|NCT01314872|524190247|FG007|Period 2|Pregnancy|0|||
145366401|NCT01314872|524190248|FG008|Period 2|Pregnancy|0|||
145366402|NCT01314872|524190249|FG009|Period 2|Pregnancy|0|||
145366403|NCT01314872|524190250|FG010|Period 2|Pregnancy|0|||
145366404|NCT01314872|524190251|FG011|Period 2|Pregnancy|0|||
145366405|NCT01314872|524190252|FG012|Period 2|Pregnancy|0|||
145366406|NCT01314872|524190253|FG013|Period 2|Pregnancy|0|||
145366407|NCT01314872|524190254|FG014|Period 2|Pregnancy|1|||
145366408|NCT01314872|524190240|FG000|Period 2|Study terminated by Sponsor|0|||
145366409|NCT01314872|524190241|FG001|Period 2|Study terminated by Sponsor|0|||
145366410|NCT01314872|524190242|FG002|Period 2|Study terminated by Sponsor|0|||
145366411|NCT01314872|524190243|FG003|Period 2|Study terminated by Sponsor|0|||
145366412|NCT01314872|524190244|FG004|Period 2|Study terminated by Sponsor|0|||
145366413|NCT01314872|524190245|FG005|Period 2|Study terminated by Sponsor|0|||
145366414|NCT01314872|524190246|FG006|Period 2|Study terminated by Sponsor|0|||
145366415|NCT01314872|524190247|FG007|Period 2|Study terminated by Sponsor|0|||
145366416|NCT01314872|524190248|FG008|Period 2|Study terminated by Sponsor|0|||
145366417|NCT01314872|524190249|FG009|Period 2|Study terminated by Sponsor|0|||
145366418|NCT01314872|524190250|FG010|Period 2|Study terminated by Sponsor|0|||
145366419|NCT01314872|524190251|FG011|Period 2|Study terminated by Sponsor|2|||
145366420|NCT01314872|524190252|FG012|Period 2|Study terminated by Sponsor|2|||
145366421|NCT01314872|524190253|FG013|Period 2|Study terminated by Sponsor|3|||
145366422|NCT01314872|524190254|FG014|Period 2|Study terminated by Sponsor|0|||
145366423|NCT01314872|524190240|FG000|Period 2|Adverse event, non-fatal|0|||
145366424|NCT01314872|524190241|FG001|Period 2|Adverse event, non-fatal|0|||
145366425|NCT01314872|524190242|FG002|Period 2|Adverse event, non-fatal|0|||
145366426|NCT01314872|524190243|FG003|Period 2|Adverse event, non-fatal|0|||
145366427|NCT01314872|524190244|FG004|Period 2|Adverse event, non-fatal|0|||
145366428|NCT01314872|524190245|FG005|Period 2|Adverse event, non-fatal|0|||
145366429|NCT01314872|524190246|FG006|Period 2|Adverse event, non-fatal|0|||
145366430|NCT01314872|524190247|FG007|Period 2|Adverse event, non-fatal|0|||
145366431|NCT01314872|524190248|FG008|Period 2|Adverse event, non-fatal|0|||
145366432|NCT01314872|524190249|FG009|Period 2|Adverse event, non-fatal|0|||
145366433|NCT01314872|524190250|FG010|Period 2|Adverse event, non-fatal|0|||
145366434|NCT01314872|524190251|FG011|Period 2|Adverse event, non-fatal|13|||
145366435|NCT01314872|524190252|FG012|Period 2|Adverse event, non-fatal|16|||
145366436|NCT01314872|524190253|FG013|Period 2|Adverse event, non-fatal|24|||
145366437|NCT01314872|524190254|FG014|Period 2|Adverse event, non-fatal|9|||
145366438|NCT01314872|524190240|FG000|Period 2|Withdrawal by Subject|0|||
145366439|NCT01314872|524190241|FG001|Period 2|Withdrawal by Subject|0|||
145366440|NCT01314872|524190242|FG002|Period 2|Withdrawal by Subject|0|||
145366441|NCT01314872|524190243|FG003|Period 2|Withdrawal by Subject|0|||
145366442|NCT01314872|524190244|FG004|Period 2|Withdrawal by Subject|0|||
145366443|NCT01314872|524190245|FG005|Period 2|Withdrawal by Subject|0|||
145366444|NCT01314872|524190246|FG006|Period 2|Withdrawal by Subject|0|||
145366445|NCT01314872|524190247|FG007|Period 2|Withdrawal by Subject|0|||
145366446|NCT01314872|524190248|FG008|Period 2|Withdrawal by Subject|0|||
145366447|NCT01314872|524190249|FG009|Period 2|Withdrawal by Subject|0|||
145366448|NCT01314872|524190250|FG010|Period 2|Withdrawal by Subject|0|||
145366449|NCT01314872|524190251|FG011|Period 2|Withdrawal by Subject|14|||
145366450|NCT01314872|524190252|FG012|Period 2|Withdrawal by Subject|17|||
145366451|NCT01314872|524190253|FG013|Period 2|Withdrawal by Subject|12|||
145366452|NCT01314872|524190254|FG014|Period 2|Withdrawal by Subject|4|||
145366453|NCT01314872|524190240|FG000|Period 2|Lost to Follow-up|0|||
145366454|NCT01314872|524190241|FG001|Period 2|Lost to Follow-up|0|||
145366455|NCT01314872|524190242|FG002|Period 2|Lost to Follow-up|0|||
145366456|NCT01314872|524190243|FG003|Period 2|Lost to Follow-up|0|||
145421651|NCT03520387|524397904|FG002|Pre-Randomization|Withdrawal by Subject|0|||
145421652|NCT03520387|524397905|FG003|Pre-Randomization|Withdrawal by Subject|0|||
145366457|NCT01314872|524190244|FG004|Period 2|Lost to Follow-up|0|||
145366458|NCT01314872|524190245|FG005|Period 2|Lost to Follow-up|0|||
145366459|NCT01314872|524190246|FG006|Period 2|Lost to Follow-up|0|||
145366460|NCT01314872|524190247|FG007|Period 2|Lost to Follow-up|0|||
145366461|NCT01314872|524190248|FG008|Period 2|Lost to Follow-up|0|||
145366462|NCT01314872|524190249|FG009|Period 2|Lost to Follow-up|0|||
145366463|NCT01314872|524190250|FG010|Period 2|Lost to Follow-up|0|||
145366464|NCT01314872|524190251|FG011|Period 2|Lost to Follow-up|6|||
145366465|NCT01314872|524190252|FG012|Period 2|Lost to Follow-up|7|||
145366466|NCT01314872|524190253|FG013|Period 2|Lost to Follow-up|2|||
145366467|NCT01314872|524190254|FG014|Period 2|Lost to Follow-up|6|||
145366468|NCT01399047|524191717|FG000|Overall Study|Withdrawal by Subject|0|||
145366469|NCT01399047|524191718|FG001|Overall Study|Withdrawal by Subject|1|||
145366470|NCT03652636|524191726|FG000|Overall Study|Withdrawal by Subject|7|||
145366471|NCT00679029|524191727|FG000|Overall Study|Adverse Event|3|||
145366472|NCT00679029|524191727|FG000|Overall Study|Withdrawal by Subject|1|||
145366473|NCT00679029|524191727|FG000|Overall Study|Lost to Follow-up|1|||
145366474|NCT00809471|524191731|FG000|Overall Study|Protocol non-compliance|15|||
145366475|NCT00809471|524191732|FG001|Overall Study|Protocol non-compliance|15|||
145366476|NCT00809471|524191733|FG002|Overall Study|Protocol non-compliance|6|||
145366477|NCT00809471|524191731|FG000|Overall Study|Lost to Follow-up|4|||
145366478|NCT00809471|524191732|FG001|Overall Study|Lost to Follow-up|2|||
145366479|NCT00809471|524191733|FG002|Overall Study|Lost to Follow-up|9|||
145366480|NCT00809471|524191731|FG000|Overall Study|Adverse Event|0|||
145366481|NCT00809471|524191732|FG001|Overall Study|Adverse Event|2|||
145366482|NCT00809471|524191733|FG002|Overall Study|Adverse Event|2|||
145366483|NCT00809471|524191731|FG000|Overall Study|Requirement for restricted medication|1|||
145366484|NCT00809471|524191732|FG001|Overall Study|Requirement for restricted medication|1|||
145366485|NCT00809471|524191733|FG002|Overall Study|Requirement for restricted medication|0|||
145366486|NCT01736397|524191734|FG000|Overall Study|Lack of Efficacy|1|||
145366487|NCT01736397|524191735|FG001|Overall Study|Lack of Efficacy|11|||
145366488|NCT01736397|524191734|FG000|Overall Study|Withdrawal by Subject|6|||
145366489|NCT01736397|524191735|FG001|Overall Study|Withdrawal by Subject|5|||
145366490|NCT01736397|524191734|FG000|Overall Study|Lost to Follow-up|0|||
145366491|NCT01736397|524191735|FG001|Overall Study|Lost to Follow-up|1|||
145366492|NCT01736397|524191734|FG000|Overall Study|Adverse Event|6|||
145366493|NCT01736397|524191735|FG001|Overall Study|Adverse Event|3|||
145366494|NCT01736397|524191734|FG000|Overall Study|Not stated|1|||
145366495|NCT01736397|524191735|FG001|Overall Study|Not stated|4|||
145366496|NCT01868438|524191736|FG000|First Intervention|Withdrawal by Subject|5|||
145366497|NCT01868438|524191737|FG001|First Intervention|Withdrawal by Subject|1|||
145366498|NCT01868438|524191736|FG000|First Intervention|Lost to Follow-up|2|||
145366499|NCT01868438|524191737|FG001|First Intervention|Lost to Follow-up|3|||
145366500|NCT01868438|524191736|FG000|First Intervention|Meeting the non-redosing criteria|0|||
145366501|NCT01868438|524191737|FG001|First Intervention|Meeting the non-redosing criteria|1|||
145366502|NCT01868438|524191736|FG000|Second Intervention|Adverse Event|3|||
145366503|NCT01868438|524191737|FG001|Second Intervention|Adverse Event|3|||
145366504|NCT01177293|524191738|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
145366505|NCT01177293|524191739|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
145366506|NCT00956592|524191740|FG000|Overall Study|Protocol Violation|1|||
145366507|NCT00956592|524191741|FG001|Overall Study|Protocol Violation|3|||
145366508|NCT00748189|524191742|FG000|Overall Study|Death|99|||
145366509|NCT00748189|524191743|FG001|Overall Study|Death|84|||
145366510|NCT00748189|524191742|FG000|Overall Study|Withdrawal by Subject|23|||
145366511|NCT00748189|524191743|FG001|Overall Study|Withdrawal by Subject|29|||
145366512|NCT00748189|524191742|FG000|Overall Study|Physician Decision|16|||
145366513|NCT00748189|524191743|FG001|Overall Study|Physician Decision|5|||
145366514|NCT00748189|524191742|FG000|Overall Study|Lost to Follow-up|8|||
145366515|NCT00748189|524191743|FG001|Overall Study|Lost to Follow-up|15|||
145366516|NCT00748189|524191742|FG000|Overall Study|Study terminated by Sponsor|70|||
145366517|NCT00748189|524191743|FG001|Overall Study|Study terminated by Sponsor|79|||
145366518|NCT04481191|524191744|FG000|Overall Study|Withdrawn by parent/guardian|15|||
145366519|NCT04481191|524191745|FG001|Overall Study|Withdrawn by parent/guardian|10|||
145366520|NCT02589626|524191746|FG000|Overall Study|Other than the reason specified|1|||
145366521|NCT02589626|524191747|FG001|Overall Study|Other than the reason specified|0|||
145366522|NCT02589626|524191746|FG000|Overall Study|Withdrawal by Subject|1|||
145366523|NCT02589626|524191747|FG001|Overall Study|Withdrawal by Subject|1|||
145366524|NCT02589626|524191746|FG000|Overall Study|Adverse Event|1|||
145366525|NCT02589626|524191747|FG001|Overall Study|Adverse Event|1|||
145366526|NCT04292912|524191752|FG000|Overall Study|Physician Decision|1|||
145366527|NCT04292912|524191752|FG000|Overall Study|Protocol Violation|6|||
145366528|NCT00280397|524191753|FG000|Overall Study|Adverse Event|1|||
145366529|NCT05338502|524191761|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
145366530|NCT05338502|524191762|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
145366531|NCT05338502|524191763|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
145366532|NCT05338502|524191761|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
145366533|NCT05338502|524191762|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
145366534|NCT05338502|524191763|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
145366535|NCT03575793|524191766|FG000|Overall Study|Withdrawal by Subject|0|||
145366536|NCT03575793|524191767|FG001|Overall Study|Withdrawal by Subject|1|||
145366537|NCT03575793|524191766|FG000|Overall Study|Never Treated|0|||
145366538|NCT03575793|524191767|FG001|Overall Study|Never Treated|2|||
145366539|NCT01250873|524191768|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
145421653|NCT03520387|524397906|FG004|Pre-Randomization|Withdrawal by Subject|0|||
145421654|NCT03520387|524397902|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
145421655|NCT03520387|524397903|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145421656|NCT03520387|524397904|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145421657|NCT03520387|524397905|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145421658|NCT03520387|524397906|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
145421659|NCT02489045|524397907|FG000|Overall Study|unable to collect usable data|53|||
145421660|NCT02489045|524397907|FG000|Follow-up|Lost to Follow-up|10|||
145421661|NCT00930176|524397908|FG000|Overall Study|Death|1|||
145421662|NCT05486065|524397912|FG000|Overall Study|Withdrawal by Subject|1|||
145421663|NCT05486065|524397913|FG001|Overall Study|Withdrawal by Subject|5|||
145421664|NCT05486065|524397914|FG002|Overall Study|Withdrawal by Subject|4|||
145421665|NCT05486065|524397915|FG003|Overall Study|Withdrawal by Subject|3|||
145421666|NCT05486065|524397912|FG000|Overall Study|Lost to Follow-up|4|||
145421667|NCT05486065|524397913|FG001|Overall Study|Lost to Follow-up|2|||
145421668|NCT05486065|524397914|FG002|Overall Study|Lost to Follow-up|2|||
145421669|NCT05486065|524397915|FG003|Overall Study|Lost to Follow-up|2|||
145421670|NCT05486065|524397912|FG000|Overall Study|Physician Decision|0|||
145421671|NCT05486065|524397913|FG001|Overall Study|Physician Decision|1|||
145421672|NCT05486065|524397914|FG002|Overall Study|Physician Decision|1|||
145421673|NCT05486065|524397915|FG003|Overall Study|Physician Decision|0|||
145421674|NCT05486065|524397912|FG000|Overall Study|Failure to meet randomization criteria|0|||
145421675|NCT05486065|524397913|FG001|Overall Study|Failure to meet randomization criteria|0|||
145421676|NCT05486065|524397914|FG002|Overall Study|Failure to meet randomization criteria|0|||
145421677|NCT05486065|524397915|FG003|Overall Study|Failure to meet randomization criteria|1|||
145421678|NCT01064622|524397916|FG000|Randomized Phase II|Withdrawal by Subject|2|||
145421679|NCT01064622|524397917|FG001|Randomized Phase II|Withdrawal by Subject|2|||
145421680|NCT01064622|524397916|FG000|Randomized Phase II|Protocol Violation|0|||
145421681|NCT01064622|524397917|FG001|Randomized Phase II|Protocol Violation|1|||
145421682|NCT06868667|524397920|FG000|Overall Study|Death|0|||
145421683|NCT06868667|524397921|FG001|Overall Study|Death|4|||
145421684|NCT06868667|524397920|FG000|Overall Study|Lost to Follow-up|0|||
145421685|NCT06868667|524397921|FG001|Overall Study|Lost to Follow-up|1|||
145421686|NCT06868667|524397920|FG000|Overall Study|Withdrawal by Subject|1|||
145421687|NCT06868667|524397921|FG001|Overall Study|Withdrawal by Subject|0|||
145421688|NCT06868667|524397920|FG000|Overall Study|Ongoing|9|||
145421689|NCT06868667|524397921|FG001|Overall Study|Ongoing|9|||
145421690|NCT05330429|524397924|FG000|Overall Study|Study Terminated by Sponsor|4|||
145421691|NCT05330429|524397925|FG001|Overall Study|Study Terminated by Sponsor|33|||
145421692|NCT05330429|524397926|FG002|Overall Study|Study Terminated by Sponsor|12|||
145421693|NCT05330429|524397924|FG000|Overall Study|Death|5|||
145421694|NCT05330429|524397925|FG001|Overall Study|Death|2|||
145421695|NCT05330429|524397926|FG002|Overall Study|Death|4|||
145421696|NCT05330429|524397924|FG000|Overall Study|Withdrew Consent|0|||
145421697|NCT05330429|524397925|FG001|Overall Study|Withdrew Consent|5|||
145421698|NCT05330429|524397926|FG002|Overall Study|Withdrew Consent|4|||
145421699|NCT05330429|524397924|FG000|Overall Study|Investigator's Discretion|0|||
145421700|NCT05330429|524397925|FG001|Overall Study|Investigator's Discretion|1|||
145421701|NCT05330429|524397926|FG002|Overall Study|Investigator's Discretion|3|||
145421702|NCT05330429|524397924|FG000|Overall Study|Subject Decision|1|||
145421703|NCT05330429|524397925|FG001|Overall Study|Subject Decision|2|||
145421704|NCT05330429|524397926|FG002|Overall Study|Subject Decision|0|||
145421705|NCT05330429|524397924|FG000|Overall Study|Lost to Follow-up|0|||
145421706|NCT05330429|524397925|FG001|Overall Study|Lost to Follow-up|1|||
145421707|NCT05330429|524397926|FG002|Overall Study|Lost to Follow-up|0|||
145421708|NCT01569763|524400080|FG000|Overall Study|Lack of Efficacy|2|||
145421709|NCT01569763|524400081|FG001|Overall Study|Lack of Efficacy|7|||
145421710|NCT01569763|524400080|FG000|Overall Study|Adverse Event|1|||
145421711|NCT01569763|524400081|FG001|Overall Study|Adverse Event|0|||
145421712|NCT01926509|524400082|FG000|Overall Study|vital sign met discontinuation criteria|1|||
145421713|NCT01926509|524400083|FG001|Overall Study|vital sign met discontinuation criteria|0|||
145421714|NCT01926509|524400084|FG002|Overall Study|vital sign met discontinuation criteria|0|||
145421715|NCT01926509|524400085|FG003|Overall Study|vital sign met discontinuation criteria|0|||
145421716|NCT02730169|524400086|FG000|Overall Study|Protocol Violation|1|||
145421717|NCT02730169|524400087|FG001|Overall Study|Protocol Violation|0|||
145421718|NCT02730169|524400088|FG002|Overall Study|Protocol Violation|0|||
145421719|NCT02730169|524400089|FG003|Overall Study|Protocol Violation|1|||
145421720|NCT02730169|524400086|FG000|Overall Study|Adverse Event|2|||
145421721|NCT02730169|524400087|FG001|Overall Study|Adverse Event|3|||
145421722|NCT02730169|524400088|FG002|Overall Study|Adverse Event|3|||
145421723|NCT02730169|524400089|FG003|Overall Study|Adverse Event|0|||
145421724|NCT02730169|524400086|FG000|Overall Study|Adverse Event of Special Interest|0|||
145421725|NCT02730169|524400087|FG001|Overall Study|Adverse Event of Special Interest|1|||
145421726|NCT02730169|524400088|FG002|Overall Study|Adverse Event of Special Interest|2|||
145421727|NCT02730169|524400089|FG003|Overall Study|Adverse Event of Special Interest|0|||
145421728|NCT02730169|524400086|FG000|Overall Study|Withdrawal by Subject|6|||
145421729|NCT02730169|524400087|FG001|Overall Study|Withdrawal by Subject|11|||
145421730|NCT02730169|524400088|FG002|Overall Study|Withdrawal by Subject|6|||
145421731|NCT02730169|524400089|FG003|Overall Study|Withdrawal by Subject|8|||
145421732|NCT02730169|524400086|FG000|Overall Study|Lost to Follow-up|5|||
145421733|NCT02730169|524400087|FG001|Overall Study|Lost to Follow-up|6|||
145421734|NCT02730169|524400088|FG002|Overall Study|Lost to Follow-up|5|||
145421735|NCT02730169|524400089|FG003|Overall Study|Lost to Follow-up|6|||
145421736|NCT02730169|524400086|FG000|Overall Study|Other|0|||
145421737|NCT02730169|524400087|FG001|Overall Study|Other|0|||
145421738|NCT02730169|524400088|FG002|Overall Study|Other|1|||
145623209|NCT02034435|525131616|FG001|Overall Study|Withdrawal by Subject|0|||
145623210|NCT02034435|525131617|FG002|Overall Study|Withdrawal by Subject|0|||
145623211|NCT02034435|525131618|FG003|Overall Study|Withdrawal by Subject|0|||
145623212|NCT02034435|525131615|FG000|Overall Study|Illness|0|||
145623213|NCT02034435|525131616|FG001|Overall Study|Illness|2|||
145366540|NCT01250873|524191768|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
145366541|NCT02278939|524191769|FG000|Overall Study|lack of time|1|||
145421739|NCT02730169|524400089|FG003|Overall Study|Other|1|||
145421740|NCT03681093|524400090|FG000|Overall Study|Subject decision|0|||
145421741|NCT03681093|524400091|FG001|Overall Study|Subject decision|2|||
145421742|NCT03681093|524400092|FG002|Overall Study|Subject decision|1|||
145421743|NCT01027754|524400093|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
145421744|NCT01027754|524400094|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
145421745|NCT01027754|524400093|FG000|Overall Study|Withdrawal by Subject|0|||
145421746|NCT01027754|524400094|FG001|Overall Study|Withdrawal by Subject|5|||
145421747|NCT01882829|524400095|FG000|Overall Study|Adverse Event|4|||
145366542|NCT02278939|524191770|FG001|Overall Study|lack of time|0|||
145366543|NCT02278939|524191769|FG000|Overall Study|Lost to Follow-up|1|||
145366544|NCT02278939|524191770|FG001|Overall Study|Lost to Follow-up|1|||
145366545|NCT02278939|524191769|FG000|Overall Study|death in family|1|||
145366546|NCT02278939|524191770|FG001|Overall Study|death in family|0|||
145366547|NCT02278939|524191769|FG000|Overall Study|family emergency unable to commit|2|||
145366548|NCT02278939|524191770|FG001|Overall Study|family emergency unable to commit|0|||
145366549|NCT02423343|524191771|FG000|Overall Study|Withdrawal by Subject|0|||
145366550|NCT02423343|524191772|FG001|Overall Study|Withdrawal by Subject|1|||
145366551|NCT02423343|524191773|FG002|Overall Study|Withdrawal by Subject|0|||
145366552|NCT02423343|524191774|FG003|Overall Study|Withdrawal by Subject|0|||
145366553|NCT02423343|524191775|FG004|Overall Study|Withdrawal by Subject|0|||
145366554|NCT02423343|524191776|FG005|Overall Study|Withdrawal by Subject|0|||
145366555|NCT02423343|524191771|FG000|Overall Study|Progressive Disease|0|||
145366556|NCT02423343|524191772|FG001|Overall Study|Progressive Disease|0|||
145366557|NCT02423343|524191773|FG002|Overall Study|Progressive Disease|0|||
145366558|NCT02423343|524191774|FG003|Overall Study|Progressive Disease|0|||
145366559|NCT02423343|524191775|FG004|Overall Study|Progressive Disease|2|||
145366560|NCT02423343|524191776|FG005|Overall Study|Progressive Disease|0|||
145366561|NCT02423343|524191771|FG000|Overall Study|Adverse Event|0|||
145366562|NCT02423343|524191772|FG001|Overall Study|Adverse Event|0|||
145366563|NCT02423343|524191773|FG002|Overall Study|Adverse Event|0|||
145366564|NCT02423343|524191774|FG003|Overall Study|Adverse Event|0|||
145366565|NCT02423343|524191775|FG004|Overall Study|Adverse Event|2|||
145366566|NCT02423343|524191776|FG005|Overall Study|Adverse Event|0|||
145366567|NCT02423343|524191771|FG000|Overall Study|Death|0|||
145366568|NCT02423343|524191772|FG001|Overall Study|Death|0|||
145366569|NCT02423343|524191773|FG002|Overall Study|Death|0|||
145366570|NCT02423343|524191774|FG003|Overall Study|Death|0|||
145366571|NCT02423343|524191775|FG004|Overall Study|Death|1|||
145366572|NCT02423343|524191776|FG005|Overall Study|Death|0|||
145366573|NCT00930774|524191779|FG000|Overall Study|Withdrawal by Subject|1|||
145366574|NCT00930774|524191780|FG001|Overall Study|Withdrawal by Subject|9|||
145366575|NCT00930774|524191781|FG002|Overall Study|Withdrawal by Subject|2|||
145366576|NCT00930774|524191782|FG003|Overall Study|Withdrawal by Subject|0|||
145366577|NCT02042950|524191783|FG000|Overall Study|Progressive Disease|4|||
145366578|NCT01014988|524191784|FG000|Overall Study|Adverse Event|20|||
145366579|NCT01014988|524191785|FG001|Overall Study|Adverse Event|0|||
145366580|NCT01014988|524191786|FG002|Overall Study|Adverse Event|1|||
145421748|NCT01882829|524400095|FG000|Overall Study|Protocol Violation|1|||
145421749|NCT01882829|524400095|FG000|Overall Study|Withdrawal by Subject|1|||
145421750|NCT02469961|524400102|FG000|Overall Study|Physician Decision|4|||
145421751|NCT02469961|524400103|FG001|Overall Study|Physician Decision|1|||
145421752|NCT02562040|524400107|FG000|Overall Study|Lost to Follow-up|20|||
145421753|NCT02562040|524400108|FG001|Overall Study|Lost to Follow-up|28|||
145421754|NCT02562040|524400107|FG000|Overall Study|Withdrawal by Subject|8|||
145421755|NCT02562040|524400108|FG001|Overall Study|Withdrawal by Subject|7|||
145421756|NCT02562040|524400107|FG000|Overall Study|Adverse Event|1|||
145421757|NCT02562040|524400108|FG001|Overall Study|Adverse Event|0|||
145421758|NCT00368849|524400110|FG000|Overall Study|Withdrawal by Subject|0|||
145421759|NCT00368849|524400111|FG001|Overall Study|Withdrawal by Subject|1|||
145421760|NCT00368849|524400110|FG000|Overall Study|Physician Decision|0|||
145623214|NCT02034435|525131617|FG002|Overall Study|Illness|0|||
145421761|NCT00368849|524400111|FG001|Overall Study|Physician Decision|1|||
145421762|NCT01902303|524400115|FG000|Overall Study|Adverse Event|0|||
145421763|NCT01902303|524400116|FG001|Overall Study|Adverse Event|1|||
145366581|NCT01014988|524191787|FG003|Overall Study|Adverse Event|0|||
145421764|NCT01902303|524400115|FG000|Overall Study|Lost to Follow-up|0|||
145421765|NCT01902303|524400116|FG001|Overall Study|Lost to Follow-up|1|||
145421766|NCT01902303|524400115|FG000|Overall Study|Protocol Violation|2|||
145421767|NCT01902303|524400116|FG001|Overall Study|Protocol Violation|2|||
145421768|NCT01902303|524400115|FG000|Overall Study|subject lost investigational product|0|||
145421769|NCT01902303|524400116|FG001|Overall Study|subject lost investigational product|1|||
145421770|NCT01902303|524400115|FG000|Overall Study|Did not develop a cold sore|21|||
145421771|NCT01902303|524400116|FG001|Overall Study|Did not develop a cold sore|19|||
145421772|NCT03211858|524400117|FG000|Overall Study|Adverse Event|8|||
145421773|NCT03211858|524400118|FG001|Overall Study|Adverse Event|6|||
145421774|NCT03211858|524400117|FG000|Overall Study|Lack of Efficacy|0|||
145421775|NCT03211858|524400118|FG001|Overall Study|Lack of Efficacy|4|||
145421776|NCT03211858|524400117|FG000|Overall Study|Poor compliance to protocol|6|||
145421777|NCT03211858|524400118|FG001|Overall Study|Poor compliance to protocol|2|||
145421778|NCT03211858|524400117|FG000|Overall Study|Non-serious Hypoglycemia|1|||
145421779|NCT03211858|524400118|FG001|Overall Study|Non-serious Hypoglycemia|0|||
145366582|NCT01014988|524191788|FG004|Overall Study|Adverse Event|1|||
145366583|NCT01014988|524191789|FG005|Overall Study|Adverse Event|3|||
145366584|NCT01014988|524191784|FG000|Overall Study|Lost to Follow-up|1|||
145366585|NCT01014988|524191785|FG001|Overall Study|Lost to Follow-up|0|||
145366586|NCT01014988|524191786|FG002|Overall Study|Lost to Follow-up|1|||
145366587|NCT01014988|524191787|FG003|Overall Study|Lost to Follow-up|0|||
145366588|NCT01014988|524191788|FG004|Overall Study|Lost to Follow-up|0|||
145366589|NCT01014988|524191789|FG005|Overall Study|Lost to Follow-up|0|||
145366590|NCT01014988|524191784|FG000|Overall Study|Physician Decision|1|||
145366591|NCT01014988|524191785|FG001|Overall Study|Physician Decision|0|||
145366592|NCT01014988|524191786|FG002|Overall Study|Physician Decision|0|||
145366593|NCT01014988|524191787|FG003|Overall Study|Physician Decision|0|||
145366594|NCT01014988|524191788|FG004|Overall Study|Physician Decision|0|||
145366595|NCT01014988|524191789|FG005|Overall Study|Physician Decision|0|||
145366596|NCT01014988|524191784|FG000|Overall Study|Withdrawal by Subject|1|||
145366597|NCT01014988|524191785|FG001|Overall Study|Withdrawal by Subject|0|||
145366598|NCT01014988|524191786|FG002|Overall Study|Withdrawal by Subject|0|||
145366599|NCT01014988|524191787|FG003|Overall Study|Withdrawal by Subject|0|||
145366600|NCT01014988|524191788|FG004|Overall Study|Withdrawal by Subject|0|||
145366601|NCT01014988|524191789|FG005|Overall Study|Withdrawal by Subject|0|||
145366602|NCT00729157|524191790|FG000|Overall Study|Withdrawal by Subject|1|||
145366603|NCT02217410|524191791|FG000|Overall Study|Graft Loss|0|||
145366604|NCT02217410|524191792|FG001|Overall Study|Graft Loss|0|||
145366605|NCT02217410|524191793|FG002|Overall Study|Graft Loss|2|||
145366606|NCT02217410|524191791|FG000|Overall Study|Withdrawal by Subject|0|||
145366607|NCT02217410|524191792|FG001|Overall Study|Withdrawal by Subject|0|||
145366608|NCT02217410|524191793|FG002|Overall Study|Withdrawal by Subject|2|||
145366609|NCT02217410|524191791|FG000|Overall Study|Lost to Follow-up|0|||
145366610|NCT02217410|524191792|FG001|Overall Study|Lost to Follow-up|0|||
145366611|NCT02217410|524191793|FG002|Overall Study|Lost to Follow-up|1|||
145366612|NCT02217410|524191791|FG000|Overall Study|Lack of Efficacy|0|||
145366613|NCT02217410|524191792|FG001|Overall Study|Lack of Efficacy|1|||
145366614|NCT02217410|524191793|FG002|Overall Study|Lack of Efficacy|0|||
145366615|NCT02217410|524191791|FG000|Overall Study|Physician Decision|1|||
145366616|NCT02217410|524191792|FG001|Overall Study|Physician Decision|3|||
145366617|NCT02217410|524191793|FG002|Overall Study|Physician Decision|0|||
145366618|NCT03521115|524191797|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
145366619|NCT03521115|524191798|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
145366620|NCT03521115|524191797|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
145366621|NCT03521115|524191798|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
145366622|NCT03063086|524191802|FG000|Overall Study|technical problems|1|||
145366623|NCT03063086|524191803|FG001|Overall Study|technical problems|0|||
145366624|NCT03063086|524191804|FG002|Overall Study|technical problems|0|||
145421780|NCT03211858|524400117|FG000|Overall Study|Other than specified above|22|||
145421781|NCT03211858|524400118|FG001|Overall Study|Other than specified above|21|||
145421782|NCT03142451|524400119|FG000|Overall Study|Adverse Event|5|||
145421783|NCT03142451|524400120|FG001|Overall Study|Adverse Event|2|||
145421784|NCT03142451|524400119|FG000|Overall Study|Lost to Follow-up|25|||
145421785|NCT03142451|524400120|FG001|Overall Study|Lost to Follow-up|8|||
145421786|NCT03142451|524400119|FG000|Overall Study|Participant request|24|||
145421787|NCT03142451|524400120|FG001|Overall Study|Participant request|12|||
145421788|NCT03142451|524400119|FG000|Overall Study|Protocol Violation|3|||
145421789|NCT03142451|524400120|FG001|Overall Study|Protocol Violation|1|||
145421790|NCT03142451|524400119|FG000|Overall Study|Other|1|||
145421791|NCT03142451|524400120|FG001|Overall Study|Other|1|||
145421792|NCT00862277|524400121|FG000|Overall Study|Protocol Violation|1|||
145421793|NCT00862277|524400122|FG001|Overall Study|Protocol Violation|2|||
145421794|NCT00862277|524400123|FG002|Overall Study|Protocol Violation|5|||
145366625|NCT03063086|524191805|FG003|Overall Study|technical problems|0|||
145366626|NCT03063086|524191806|FG004|Overall Study|technical problems|0|||
145366627|NCT03063086|524191807|FG005|Overall Study|technical problems|0|||
145366628|NCT03063086|524191802|FG000|Overall Study|Adverse Event|1|||
145366629|NCT03063086|524191803|FG001|Overall Study|Adverse Event|1|||
145366630|NCT03063086|524191804|FG002|Overall Study|Adverse Event|1|||
145366631|NCT03063086|524191805|FG003|Overall Study|Adverse Event|1|||
145366632|NCT03063086|524191806|FG004|Overall Study|Adverse Event|0|||
145366633|NCT03063086|524191807|FG005|Overall Study|Adverse Event|0|||
145366634|NCT03063086|524191802|FG000|Overall Study|subject/guardian decision|1|||
145578212|NCT02486406|524971455|FG002|Overall Study|Withdrew consent|0|||
145578213|NCT02486406|524971456|FG003|Overall Study|Withdrew consent|1|||
145578214|NCT02486406|524971453|FG000|Overall Study|Lost to Follow-up|1|||
145366635|NCT03063086|524191803|FG001|Overall Study|subject/guardian decision|0|||
145366636|NCT03063086|524191804|FG002|Overall Study|subject/guardian decision|0|||
145366637|NCT03063086|524191805|FG003|Overall Study|subject/guardian decision|0|||
145366638|NCT03063086|524191806|FG004|Overall Study|subject/guardian decision|0|||
145366639|NCT03063086|524191807|FG005|Overall Study|subject/guardian decision|0|||
145366640|NCT03063086|524191802|FG000|Overall Study|Non-compliance with study treatment|0|||
145366641|NCT03063086|524191803|FG001|Overall Study|Non-compliance with study treatment|0|||
145366642|NCT03063086|524191804|FG002|Overall Study|Non-compliance with study treatment|0|||
145366643|NCT03063086|524191805|FG003|Overall Study|Non-compliance with study treatment|1|||
145366644|NCT03063086|524191806|FG004|Overall Study|Non-compliance with study treatment|0|||
145366645|NCT03063086|524191807|FG005|Overall Study|Non-compliance with study treatment|1|||
145366646|NCT03063086|524191802|FG000|Overall Study|Physician Decision|0|||
145366647|NCT03063086|524191803|FG001|Overall Study|Physician Decision|0|||
145366648|NCT03063086|524191804|FG002|Overall Study|Physician Decision|0|||
145366649|NCT03063086|524191805|FG003|Overall Study|Physician Decision|1|||
145366650|NCT03063086|524191806|FG004|Overall Study|Physician Decision|0|||
145366651|NCT03063086|524191807|FG005|Overall Study|Physician Decision|0|||
145366652|NCT04590586|524191808|FG000|Overall Study|Death|7|||
145366653|NCT04590586|524191809|FG001|Overall Study|Death|1|||
145366654|NCT04590586|524191810|FG002|Overall Study|Death|37|||
145366655|NCT04590586|524191811|FG003|Overall Study|Death|34|||
145366656|NCT04590586|524191812|FG004|Overall Study|Death|19|||
145366657|NCT04590586|524191813|FG005|Overall Study|Death|3|||
145366658|NCT04590586|524191808|FG000|Overall Study|Lost to Follow-up|3|||
145366659|NCT04590586|524191809|FG001|Overall Study|Lost to Follow-up|0|||
145366660|NCT04590586|524191810|FG002|Overall Study|Lost to Follow-up|11|||
145366661|NCT04590586|524191811|FG003|Overall Study|Lost to Follow-up|11|||
145366662|NCT04590586|524191812|FG004|Overall Study|Lost to Follow-up|6|||
145366663|NCT04590586|524191813|FG005|Overall Study|Lost to Follow-up|0|||
145366664|NCT04590586|524191808|FG000|Overall Study|Withdrawal by Subject|0|||
145366665|NCT04590586|524191809|FG001|Overall Study|Withdrawal by Subject|0|||
145366666|NCT04590586|524191810|FG002|Overall Study|Withdrawal by Subject|6|||
145366667|NCT04590586|524191811|FG003|Overall Study|Withdrawal by Subject|0|||
145366668|NCT04590586|524191812|FG004|Overall Study|Withdrawal by Subject|3|||
145366669|NCT04590586|524191813|FG005|Overall Study|Withdrawal by Subject|0|||
145366670|NCT04590586|524191808|FG000|Overall Study|Other|3|||
145366671|NCT04590586|524191809|FG001|Overall Study|Other|0|||
145366672|NCT04590586|524191810|FG002|Overall Study|Other|1|||
145366673|NCT04590586|524191811|FG003|Overall Study|Other|1|||
145366674|NCT04590586|524191812|FG004|Overall Study|Other|2|||
145366675|NCT04590586|524191813|FG005|Overall Study|Other|1|||
145366676|NCT02244463|524191814|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
145366677|NCT02244463|524191815|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145366678|NCT02244463|524191816|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145366679|NCT02244463|524191817|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145366680|NCT02244463|524191818|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145366681|NCT02244463|524191819|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
145366682|NCT02244463|524191814|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
145366683|NCT02244463|524191815|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
145366684|NCT02244463|524191816|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
145366685|NCT02244463|524191817|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
145366686|NCT02244463|524191818|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
145366687|NCT02244463|524191819|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
145366688|NCT02244463|524191814|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145366689|NCT02244463|524191815|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
145366690|NCT02244463|524191816|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145366691|NCT02244463|524191817|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145366692|NCT02244463|524191818|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145366693|NCT02244463|524191819|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
145366694|NCT02244463|524191814|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145366695|NCT02244463|524191815|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145366696|NCT02244463|524191816|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
145366697|NCT02244463|524191817|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145578215|NCT02486406|524971454|FG001|Overall Study|Lost to Follow-up|3|||
145578216|NCT02486406|524971455|FG002|Overall Study|Lost to Follow-up|1|||
145578217|NCT02486406|524971456|FG003|Overall Study|Lost to Follow-up|3|||
145578218|NCT02486406|524971453|FG000|Overall Study|Other, not specified|0|||
145578219|NCT02486406|524971454|FG001|Overall Study|Other, not specified|0|||
145578220|NCT02486406|524971455|FG002|Overall Study|Other, not specified|1|||
145366698|NCT02244463|524191818|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145366699|NCT02244463|524191819|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
145578221|NCT02486406|524971456|FG003|Overall Study|Other, not specified|0|||
145578222|NCT01858194|524971457|FG000|Overall Study|Total Artificial Heart Implant|0|||
145366700|NCT02244463|524191814|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145366701|NCT02244463|524191815|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145366702|NCT02244463|524191816|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145366703|NCT02244463|524191817|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
145366704|NCT02244463|524191818|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145366705|NCT02244463|524191819|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
145366706|NCT02244463|524191814|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145366707|NCT02244463|524191815|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145366708|NCT02244463|524191816|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145366709|NCT02244463|524191817|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
145366710|NCT02244463|524191818|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145366711|NCT02244463|524191819|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
145366712|NCT02244463|524191814|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145366713|NCT02244463|524191815|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145366714|NCT02244463|524191816|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145366715|NCT02244463|524191817|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
145366716|NCT02244463|524191818|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145366717|NCT02244463|524191819|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
145366718|NCT02244463|524191814|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145366719|NCT02244463|524191815|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145366720|NCT02244463|524191816|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145366721|NCT02244463|524191817|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
145366722|NCT02244463|524191818|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145366723|NCT02244463|524191819|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
145366724|NCT02244463|524191814|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145366725|NCT02244463|524191815|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145366726|NCT02244463|524191816|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145366727|NCT02244463|524191817|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
145366728|NCT02244463|524191818|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145366729|NCT02244463|524191819|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
145366730|NCT02244463|524191814|FG000|Period 5: Phase II|Disease Progression|0|||
145366731|NCT02244463|524191815|FG001|Period 5: Phase II|Disease Progression|0|||
145366732|NCT02244463|524191816|FG002|Period 5: Phase II|Disease Progression|0|||
145366733|NCT02244463|524191817|FG003|Period 5: Phase II|Disease Progression|0|||
145366734|NCT02244463|524191818|FG004|Period 5: Phase II|Disease Progression|10|||
145366735|NCT02244463|524191819|FG005|Period 5: Phase II|Disease Progression|11|||
145366736|NCT02244463|524191814|FG000|Period 5: Phase II|Physician Decision|0|||
145366737|NCT02244463|524191815|FG001|Period 5: Phase II|Physician Decision|0|||
145366738|NCT02244463|524191816|FG002|Period 5: Phase II|Physician Decision|0|||
145366739|NCT02244463|524191817|FG003|Period 5: Phase II|Physician Decision|0|||
145366740|NCT02244463|524191818|FG004|Period 5: Phase II|Physician Decision|3|||
145366741|NCT02244463|524191819|FG005|Period 5: Phase II|Physician Decision|2|||
145366742|NCT02244463|524191814|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
145366743|NCT02244463|524191815|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
145366744|NCT02244463|524191816|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
145366745|NCT02244463|524191817|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
145366746|NCT02244463|524191818|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
145366747|NCT02244463|524191819|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
145366748|NCT02244463|524191814|FG000|Period 5: Phase II|Intercurrent Illness|0|||
145366749|NCT02244463|524191815|FG001|Period 5: Phase II|Intercurrent Illness|0|||
145366750|NCT02244463|524191816|FG002|Period 5: Phase II|Intercurrent Illness|0|||
145366751|NCT02244463|524191817|FG003|Period 5: Phase II|Intercurrent Illness|0|||
145366752|NCT02244463|524191818|FG004|Period 5: Phase II|Intercurrent Illness|2|||
145578223|NCT01858194|524971458|FG001|Overall Study|Total Artificial Heart Implant|1|||
145578224|NCT01858194|524971457|FG000|Overall Study|Lost to Follow-up|0|||
145623215|NCT02034435|525131618|FG003|Overall Study|Illness|0|||
145366753|NCT02244463|524191819|FG005|Period 5: Phase II|Intercurrent Illness|0|||
145366754|NCT02244463|524191814|FG000|Period 5: Phase II|Adverse Event|0|||
145578225|NCT01858194|524971458|FG001|Overall Study|Lost to Follow-up|1|||
145578226|NCT03509948|524971462|FG000|Overall Study|Protocol Violation|0|||
145578227|NCT03509948|524971463|FG001|Overall Study|Protocol Violation|1|||
145578228|NCT03221257|524971464|FG000|Overall Study|Lost to Follow-up|0|||
145421795|NCT01052428|524400124|FG000|Overall Study|Death|1|||
145421796|NCT01052428|524400125|FG001|Overall Study|Death|0|||
145421797|NCT01052428|524400124|FG000|Overall Study|Withdrawal by Subject|0|||
145421798|NCT01052428|524400125|FG001|Overall Study|Withdrawal by Subject|1|||
145421799|NCT00871000|524400126|FG000|Overall Study|Withdrawal by Subject|1|||
145421800|NCT00871000|524400127|FG001|Overall Study|Withdrawal by Subject|0|||
145421801|NCT03400787|524400128|FG000|Overall Study|Lost to Follow-up|1|||
145421802|NCT03400787|524400129|FG001|Overall Study|Lost to Follow-up|0|||
145421803|NCT03400787|524400128|FG000|Overall Study|Death|1|||
145421804|NCT03400787|524400129|FG001|Overall Study|Death|0|||
145421805|NCT03400787|524400128|FG000|Overall Study|Protocol Violation|0|||
145421806|NCT03400787|524400129|FG001|Overall Study|Protocol Violation|2|||
145421807|NCT03400787|524400128|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
145421808|NCT03400787|524400129|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
145421809|NCT02402907|524400134|FG000|Overall Study|Delivered vaginally|9|||
145421810|NCT02402907|524400135|FG001|Overall Study|Delivered vaginally|3|||
145421811|NCT02402907|524400134|FG000|Overall Study|Delivered outside of Sinai|1|||
145421812|NCT02402907|524400135|FG001|Overall Study|Delivered outside of Sinai|1|||
145421813|NCT02402907|524400134|FG000|Overall Study|Lost to follow up after C-Section|10|||
145421814|NCT02402907|524400135|FG001|Overall Study|Lost to follow up after C-Section|23|||
145421815|NCT01716559|524400138|FG000|Overall Study|Adverse Event|11|||
145421816|NCT01716559|524400138|FG000|Overall Study|Death|21|||
145421817|NCT01716559|524400138|FG000|Overall Study|Withdrawal by Subject|4|||
145421818|NCT01716559|524400138|FG000|Overall Study|Other withdrawal reason|75|||
145421819|NCT02595437|524400142|FG000|Triferic Via IV|Withdrawal by Subject|1|||
145421820|NCT01423084|524400146|FG000|Overall Study|Adverse Event|0|||
145421821|NCT01423084|524400147|FG001|Overall Study|Adverse Event|1|||
145421822|NCT01423084|524400146|FG000|Overall Study|Withdrawal by Subject|2|||
145421823|NCT01423084|524400147|FG001|Overall Study|Withdrawal by Subject|3|||
145421824|NCT02180672|524400148|FG000|Overall Study|Lost to Follow-up|5|||
145421825|NCT02180672|524400149|FG001|Overall Study|Lost to Follow-up|7|||
145421826|NCT03574389|524400151|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
145421827|NCT03574389|524400152|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
145421828|NCT03574389|524400153|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
145421829|NCT03574389|524400154|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
145421830|NCT03574389|524400155|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
145421831|NCT03574389|524400156|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
145421832|NCT03574389|524400157|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
145421833|NCT03574389|524400151|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
145421834|NCT03574389|524400152|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
145421835|NCT03574389|524400153|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
145421836|NCT03574389|524400154|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
145421837|NCT03574389|524400155|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
145421838|NCT03574389|524400156|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
145421839|NCT03574389|524400157|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
145421840|NCT03574389|524400151|FG000|Vaccination Period|Other|6|||
145421841|NCT03574389|524400152|FG001|Vaccination Period|Other|0|||
145421842|NCT03574389|524400153|FG002|Vaccination Period|Other|0|||
145421843|NCT03574389|524400154|FG003|Vaccination Period|Other|0|||
145421844|NCT03574389|524400155|FG004|Vaccination Period|Other|0|||
145421845|NCT03574389|524400156|FG005|Vaccination Period|Other|0|||
145421846|NCT03574389|524400157|FG006|Vaccination Period|Other|0|||
145421847|NCT03574389|524400151|FG000|Vaccination Period|Adverse Event|0|||
145421848|NCT03574389|524400152|FG001|Vaccination Period|Adverse Event|1|||
145421849|NCT03574389|524400153|FG002|Vaccination Period|Adverse Event|0|||
145421850|NCT03574389|524400154|FG003|Vaccination Period|Adverse Event|0|||
145421851|NCT03574389|524400155|FG004|Vaccination Period|Adverse Event|0|||
145421852|NCT03574389|524400156|FG005|Vaccination Period|Adverse Event|0|||
145421853|NCT03574389|524400157|FG006|Vaccination Period|Adverse Event|0|||
145623216|NCT02034435|525131615|FG000|Overall Study|Inadequate IV access|1|||
145623217|NCT02034435|525131616|FG001|Overall Study|Inadequate IV access|0|||
145421854|NCT03574389|524400151|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
145421855|NCT03574389|524400152|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
145421856|NCT03574389|524400153|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
145421857|NCT03574389|524400154|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
145421858|NCT03574389|524400155|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
145421859|NCT03574389|524400156|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
145421860|NCT03574389|524400157|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
145421861|NCT02837952|524400161|FG000|Overall Study|Adverse Event|0|||
145421862|NCT02837952|524400162|FG001|Overall Study|Adverse Event|1|||
145421863|NCT02837952|524400161|FG000|Overall Study|Withdrawal by Subject|4|||
145421864|NCT02837952|524400162|FG001|Overall Study|Withdrawal by Subject|5|||
145421865|NCT02837952|524400161|FG000|Overall Study|Medication Error|1|||
145421866|NCT02837952|524400162|FG001|Overall Study|Medication Error|0|||
145421867|NCT02070380|524400163|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
145578229|NCT03221257|524971465|FG001|Overall Study|Lost to Follow-up|1|||
145578230|NCT03221257|524971464|FG000|Overall Study|Withdrawal by Subject|1|||
145578231|NCT03221257|524971465|FG001|Overall Study|Withdrawal by Subject|1|||
145578232|NCT00799617|524971471|FG000|Main Testosterone Trial|Randomized in error|1|||
145578233|NCT00799617|524971472|FG001|Main Testosterone Trial|Randomized in error|1|||
145578234|NCT00799617|524971471|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
145578235|NCT00799617|524971472|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
145578236|NCT00799617|524971471|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
145578237|NCT00799617|524971472|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
145578238|NCT00799617|524971471|FG000|Sexual Funtion Trial|No Baseline Data|4|||
145578239|NCT00799617|524971472|FG001|Sexual Funtion Trial|No Baseline Data|7|||
145578240|NCT00799617|524971471|FG000|Physical Function Trial|Lost to Follow-up|6|||
145578241|NCT00799617|524971472|FG001|Physical Function Trial|Lost to Follow-up|11|||
145578242|NCT00799617|524971471|FG000|Vitality Trial|Lost to Follow-up|7|||
145578243|NCT00799617|524971472|FG001|Vitality Trial|Lost to Follow-up|22|||
145578244|NCT00799617|524971471|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
145578245|NCT00799617|524971472|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
145578246|NCT00799617|524971471|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
145578247|NCT00799617|524971472|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
145578248|NCT00799617|524971471|FG000|Bone Trial|Month 12 scan not available|6|||
145578249|NCT00799617|524971472|FG001|Bone Trial|Month 12 scan not available|16|||
145578250|NCT00799617|524971471|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
145578251|NCT00799617|524971472|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
145578252|NCT00799617|524971471|FG000|Anemia Trial|Withdrawal by Subject|3|||
145578253|NCT00799617|524971472|FG001|Anemia Trial|Withdrawal by Subject|3|||
145578254|NCT04545515|524971473|FG000|Overall Study|Adverse Event|1|||
145578255|NCT04545515|524971473|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
145578256|NCT04545515|524971473|FG000|Overall Study|Commercial drug is available for participant|7|||
145578257|NCT02501096|524971474|FG000|Overall Study|Lost to Follow-up|0|||
145578258|NCT02501096|524971475|FG001|Overall Study|Lost to Follow-up|0|||
145578259|NCT02501096|524971476|FG002|Overall Study|Lost to Follow-up|0|||
145578260|NCT02501096|524971477|FG003|Overall Study|Lost to Follow-up|0|||
145578261|NCT02501096|524971478|FG004|Overall Study|Lost to Follow-up|1|||
145578262|NCT02501096|524971479|FG005|Overall Study|Lost to Follow-up|1|||
145578263|NCT02501096|524971480|FG006|Overall Study|Lost to Follow-up|3|||
145578264|NCT02501096|524971481|FG007|Overall Study|Lost to Follow-up|0|||
145578265|NCT02501096|524971482|FG008|Overall Study|Lost to Follow-up|0|||
145578266|NCT02501096|524971474|FG000|Overall Study|Withdrawal by Subject|1|||
145578267|NCT02501096|524971475|FG001|Overall Study|Withdrawal by Subject|0|||
145578268|NCT02501096|524971476|FG002|Overall Study|Withdrawal by Subject|7|||
145578269|NCT02501096|524971477|FG003|Overall Study|Withdrawal by Subject|13|||
145578270|NCT02501096|524971478|FG004|Overall Study|Withdrawal by Subject|2|||
145623218|NCT02034435|525131617|FG002|Overall Study|Inadequate IV access|0|||
145366755|NCT02244463|524191815|FG001|Period 5: Phase II|Adverse Event|0|||
145366756|NCT02244463|524191816|FG002|Period 5: Phase II|Adverse Event|0|||
145366757|NCT02244463|524191817|FG003|Period 5: Phase II|Adverse Event|0|||
145366758|NCT02244463|524191818|FG004|Period 5: Phase II|Adverse Event|0|||
145366759|NCT02244463|524191819|FG005|Period 5: Phase II|Adverse Event|2|||
145366760|NCT02244463|524191814|FG000|Period 5: Phase II|Still On treatment|0|||
145366761|NCT02244463|524191815|FG001|Period 5: Phase II|Still On treatment|0|||
145366762|NCT02244463|524191816|FG002|Period 5: Phase II|Still On treatment|0|||
145366763|NCT02244463|524191817|FG003|Period 5: Phase II|Still On treatment|0|||
145366764|NCT02244463|524191818|FG004|Period 5: Phase II|Still On treatment|0|||
145366765|NCT02244463|524191819|FG005|Period 5: Phase II|Still On treatment|3|||
145366766|NCT05481125|524191820|FG000|Overall Study|Adverse Event|1|||
145421868|NCT02070380|524400164|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
145578271|NCT02501096|524971479|FG005|Overall Study|Withdrawal by Subject|2|||
145578272|NCT02501096|524971480|FG006|Overall Study|Withdrawal by Subject|2|||
145578273|NCT02501096|524971481|FG007|Overall Study|Withdrawal by Subject|3|||
145578274|NCT02501096|524971482|FG008|Overall Study|Withdrawal by Subject|0|||
145578275|NCT02501096|524971474|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
145578276|NCT02501096|524971475|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
145578277|NCT02501096|524971476|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
145578278|NCT02501096|524971477|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
145578279|NCT02501096|524971478|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
145578280|NCT02501096|524971479|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
145366767|NCT05481125|524191821|FG001|Overall Study|Adverse Event|0|||
145366768|NCT05481125|524191820|FG000|Overall Study|Lost to Follow-up|0|||
145366769|NCT05481125|524191821|FG001|Overall Study|Lost to Follow-up|1|||
145421869|NCT02070380|524400165|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
145578281|NCT02501096|524971480|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
145623219|NCT02034435|525131618|FG003|Overall Study|Inadequate IV access|1|||
145578282|NCT02501096|524971481|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
145578283|NCT02501096|524971482|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
145421870|NCT02070380|524400166|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
145421871|NCT02070380|524400163|FG000|Second Injection|Image sets missing or technically inadeq|0|||
145421872|NCT02070380|524400164|FG001|Second Injection|Image sets missing or technically inadeq|1|||
145421873|NCT02070380|524400165|FG002|Second Injection|Image sets missing or technically inadeq|0|||
145421874|NCT02070380|524400166|FG003|Second Injection|Image sets missing or technically inadeq|0|||
145421875|NCT02070380|524400163|FG000|Second Injection|Protocol Violation|0|||
145421876|NCT02070380|524400164|FG001|Second Injection|Protocol Violation|1|||
145421877|NCT02070380|524400165|FG002|Second Injection|Protocol Violation|1|||
145421878|NCT02070380|524400166|FG003|Second Injection|Protocol Violation|5|||
145421879|NCT01682603|524400177|FG000|Overall Study|Lost to Follow-up|3|||
145421880|NCT01908699|524400178|FG000|Overall Study|Adverse Event|8|||
145421881|NCT01908699|524400179|FG001|Overall Study|Adverse Event|12|||
145421882|NCT01908699|524400178|FG000|Overall Study|Lack of Efficacy|2|||
145421883|NCT01908699|524400179|FG001|Overall Study|Lack of Efficacy|2|||
145421884|NCT01908699|524400178|FG000|Overall Study|Lost to Follow-up|2|||
145421885|NCT01908699|524400179|FG001|Overall Study|Lost to Follow-up|4|||
145421886|NCT01908699|524400178|FG000|Overall Study|Physician Decision|8|||
145421887|NCT01908699|524400179|FG001|Overall Study|Physician Decision|8|||
145421888|NCT01908699|524400178|FG000|Overall Study|Withdrawal by Subject|15|||
145421889|NCT01908699|524400179|FG001|Overall Study|Withdrawal by Subject|10|||
145421890|NCT01908699|524400178|FG000|Overall Study|Pregnancy|0|||
145421891|NCT01908699|524400179|FG001|Overall Study|Pregnancy|1|||
145421892|NCT01908699|524400178|FG000|Overall Study|Randomized in Error|1|||
145421893|NCT01908699|524400179|FG001|Overall Study|Randomized in Error|0|||
145421894|NCT01908699|524400178|FG000|Overall Study|Death|9|||
145421895|NCT01908699|524400179|FG001|Overall Study|Death|12|||
145421896|NCT01908699|524400178|FG000|Overall Study|Progressive Disease|30|||
145421897|NCT01908699|524400179|FG001|Overall Study|Progressive Disease|29|||
145421898|NCT02242903|524400180|FG000|Overall Study|Withdrawal by Subject|1|||
145421899|NCT02242903|524400181|FG001|Overall Study|Withdrawal by Subject|0|||
145421900|NCT02242903|524400182|FG002|Overall Study|Withdrawal by Subject|0|||
145421901|NCT02242903|524400183|FG003|Overall Study|Withdrawal by Subject|0|||
145421902|NCT02242903|524400184|FG004|Overall Study|Withdrawal by Subject|0|||
145421903|NCT02242903|524400185|FG005|Overall Study|Withdrawal by Subject|0|||
145421904|NCT02242903|524400186|FG006|Overall Study|Withdrawal by Subject|0|||
145421905|NCT01896986|524400189|FG000|Overall Study|samples lost|14|||
145421906|NCT01896986|524400190|FG001|Overall Study|samples lost|23|||
145578284|NCT02501096|524971474|FG000|Overall Study|Death|1|||
145578285|NCT02501096|524971475|FG001|Overall Study|Death|1|||
145578286|NCT02501096|524971476|FG002|Overall Study|Death|88|||
145578287|NCT02501096|524971477|FG003|Overall Study|Death|74|||
145578288|NCT02501096|524971478|FG004|Overall Study|Death|15|||
145578289|NCT02501096|524971479|FG005|Overall Study|Death|16|||
145578290|NCT02501096|524971480|FG006|Overall Study|Death|15|||
145578291|NCT02501096|524971481|FG007|Overall Study|Death|16|||
145578292|NCT02501096|524971482|FG008|Overall Study|Death|1|||
145578293|NCT03149237|524971483|FG000|Overall Study|Withdrawal by Subject|4|||
145578294|NCT03149237|524971484|FG001|Overall Study|Withdrawal by Subject|5|||
145578295|NCT00437034|524971485|FG000|Overall Study|Adverse Event|1|||
145578296|NCT00437034|524971485|FG000|Overall Study|Disease progression during treatment|5|||
145578297|NCT01976845|524971488|FG000|Overall Study|Physician Decision|8|||
145578298|NCT01976845|524971489|FG001|Overall Study|Physician Decision|8|||
145578299|NCT01976845|524971490|FG002|Overall Study|Physician Decision|3|||
145623220|NCT02839681|525131621|FG000|Overall Study|Death|2|||
145421907|NCT00281580|524400192|FG000|Overall Study|Adverse Event|2|||
145421908|NCT00281580|524400193|FG001|Overall Study|Adverse Event|0|||
145421909|NCT00281580|524400194|FG002|Overall Study|Adverse Event|2|||
145623221|NCT02300311|525131622|FG000|Overall Study|Other than the reason specified|1|||
145421910|NCT00281580|524400195|FG003|Overall Study|Adverse Event|4|||
145421911|NCT00281580|524400196|FG004|Overall Study|Adverse Event|1|||
145421912|NCT00281580|524400197|FG005|Overall Study|Adverse Event|0|||
145623222|NCT02300311|525131623|FG001|Overall Study|Other than the reason specified|0|||
145421913|NCT00281580|524400198|FG006|Overall Study|Adverse Event|1|||
145421914|NCT00281580|524400199|FG007|Overall Study|Adverse Event|0|||
145623223|NCT02300311|525131622|FG000|Overall Study|Refused to continue taking medication|18|||
145421915|NCT00281580|524400200|FG008|Overall Study|Adverse Event|1|||
145421916|NCT00281580|524400201|FG009|Overall Study|Adverse Event|6|||
145421917|NCT00281580|524400202|FG010|Overall Study|Adverse Event|0|||
145623224|NCT02300311|525131623|FG001|Overall Study|Refused to continue taking medication|0|||
145623225|NCT00772928|525131624|FG000|Overall Study|Lost to Follow-up|9|||
145623226|NCT00772928|525131625|FG001|Overall Study|Lost to Follow-up|6|||
145623227|NCT00772928|525131624|FG000|Overall Study|Protocol Violation|10|||
145421918|NCT00281580|524400203|FG011|Overall Study|Adverse Event|5|||
145421919|NCT00281580|524400204|FG012|Overall Study|Adverse Event|8|||
145421920|NCT00281580|524400205|FG013|Overall Study|Adverse Event|2|||
145421921|NCT00281580|524400206|FG014|Overall Study|Adverse Event|3|||
145421922|NCT00281580|524400207|FG015|Overall Study|Adverse Event|3|||
145421923|NCT00281580|524400192|FG000|Overall Study|Protocol Violation|0|||
145421924|NCT00281580|524400193|FG001|Overall Study|Protocol Violation|0|||
145421925|NCT00281580|524400194|FG002|Overall Study|Protocol Violation|1|||
145421926|NCT00281580|524400195|FG003|Overall Study|Protocol Violation|1|||
145421927|NCT00281580|524400196|FG004|Overall Study|Protocol Violation|0|||
145421928|NCT00281580|524400197|FG005|Overall Study|Protocol Violation|0|||
145421929|NCT00281580|524400198|FG006|Overall Study|Protocol Violation|1|||
145421930|NCT00281580|524400199|FG007|Overall Study|Protocol Violation|0|||
145421931|NCT00281580|524400200|FG008|Overall Study|Protocol Violation|2|||
145421932|NCT00281580|524400201|FG009|Overall Study|Protocol Violation|0|||
145421933|NCT00281580|524400202|FG010|Overall Study|Protocol Violation|1|||
145421934|NCT00281580|524400203|FG011|Overall Study|Protocol Violation|2|||
145421935|NCT00281580|524400204|FG012|Overall Study|Protocol Violation|0|||
145421936|NCT00281580|524400205|FG013|Overall Study|Protocol Violation|1|||
145421937|NCT00281580|524400206|FG014|Overall Study|Protocol Violation|1|||
145421938|NCT00281580|524400207|FG015|Overall Study|Protocol Violation|3|||
145421939|NCT00281580|524400192|FG000|Overall Study|Withdrawal by Subject|3|||
145421940|NCT00281580|524400193|FG001|Overall Study|Withdrawal by Subject|0|||
145421941|NCT00281580|524400194|FG002|Overall Study|Withdrawal by Subject|1|||
145421942|NCT00281580|524400195|FG003|Overall Study|Withdrawal by Subject|1|||
145421943|NCT00281580|524400196|FG004|Overall Study|Withdrawal by Subject|1|||
145421944|NCT00281580|524400197|FG005|Overall Study|Withdrawal by Subject|2|||
145421945|NCT00281580|524400198|FG006|Overall Study|Withdrawal by Subject|2|||
145421946|NCT00281580|524400199|FG007|Overall Study|Withdrawal by Subject|0|||
145421947|NCT00281580|524400200|FG008|Overall Study|Withdrawal by Subject|1|||
145421948|NCT00281580|524400201|FG009|Overall Study|Withdrawal by Subject|4|||
145421949|NCT00281580|524400202|FG010|Overall Study|Withdrawal by Subject|1|||
145421950|NCT00281580|524400203|FG011|Overall Study|Withdrawal by Subject|1|||
145421951|NCT00281580|524400204|FG012|Overall Study|Withdrawal by Subject|2|||
145421952|NCT00281580|524400205|FG013|Overall Study|Withdrawal by Subject|2|||
145421953|NCT00281580|524400206|FG014|Overall Study|Withdrawal by Subject|1|||
145421954|NCT00281580|524400207|FG015|Overall Study|Withdrawal by Subject|5|||
145421955|NCT00281580|524400192|FG000|Overall Study|Lack of Efficacy|2|||
145421956|NCT00281580|524400193|FG001|Overall Study|Lack of Efficacy|1|||
145421957|NCT00281580|524400194|FG002|Overall Study|Lack of Efficacy|1|||
145421958|NCT00281580|524400195|FG003|Overall Study|Lack of Efficacy|6|||
145421959|NCT00281580|524400196|FG004|Overall Study|Lack of Efficacy|2|||
145421960|NCT00281580|524400197|FG005|Overall Study|Lack of Efficacy|0|||
145421961|NCT00281580|524400198|FG006|Overall Study|Lack of Efficacy|0|||
145421962|NCT00281580|524400199|FG007|Overall Study|Lack of Efficacy|0|||
145421963|NCT00281580|524400200|FG008|Overall Study|Lack of Efficacy|0|||
145578300|NCT00827372|524973632|FG000|Overall Study|Adverse Event|5|||
145578301|NCT00827372|524973632|FG000|Overall Study|Lack of Efficacy|3|||
145578302|NCT02293005|524973633|FG000|Overall Study|Adverse Event|2|||
145578303|NCT02293005|524973633|FG000|Overall Study|Death|4|||
145578304|NCT02293005|524973633|FG000|Overall Study|Lost to Follow-up|1|||
145578305|NCT02293005|524973633|FG000|Overall Study|Withdrawal by Subject|2|||
145578306|NCT02293005|524973633|FG000|Overall Study|Progression|17|||
145578307|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
145578308|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145578309|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145578310|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145578311|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145578312|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
145578313|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
145578314|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145578315|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145578316|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145578317|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145578318|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
145578319|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
145578320|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145578321|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145578322|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145578323|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145578324|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
145578325|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
145578326|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145421964|NCT00281580|524400201|FG009|Overall Study|Lack of Efficacy|0|||
145421965|NCT00281580|524400202|FG010|Overall Study|Lack of Efficacy|0|||
145421966|NCT00281580|524400203|FG011|Overall Study|Lack of Efficacy|1|||
145421967|NCT00281580|524400204|FG012|Overall Study|Lack of Efficacy|0|||
145421968|NCT00281580|524400205|FG013|Overall Study|Lack of Efficacy|2|||
145578327|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145578328|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145421969|NCT00281580|524400206|FG014|Overall Study|Lack of Efficacy|1|||
145421970|NCT00281580|524400207|FG015|Overall Study|Lack of Efficacy|0|||
145421971|NCT00281580|524400192|FG000|Overall Study|Lost to Follow-up|0|||
145421972|NCT00281580|524400193|FG001|Overall Study|Lost to Follow-up|0|||
145421973|NCT00281580|524400194|FG002|Overall Study|Lost to Follow-up|0|||
145421974|NCT00281580|524400195|FG003|Overall Study|Lost to Follow-up|3|||
145421975|NCT00281580|524400196|FG004|Overall Study|Lost to Follow-up|0|||
145421976|NCT00281580|524400197|FG005|Overall Study|Lost to Follow-up|1|||
145421977|NCT00281580|524400198|FG006|Overall Study|Lost to Follow-up|0|||
145421978|NCT00281580|524400199|FG007|Overall Study|Lost to Follow-up|1|||
145421979|NCT00281580|524400200|FG008|Overall Study|Lost to Follow-up|2|||
145421980|NCT00281580|524400201|FG009|Overall Study|Lost to Follow-up|1|||
145421981|NCT00281580|524400202|FG010|Overall Study|Lost to Follow-up|1|||
145421982|NCT00281580|524400203|FG011|Overall Study|Lost to Follow-up|0|||
145421983|NCT00281580|524400204|FG012|Overall Study|Lost to Follow-up|1|||
145421984|NCT00281580|524400205|FG013|Overall Study|Lost to Follow-up|0|||
145421985|NCT00281580|524400206|FG014|Overall Study|Lost to Follow-up|0|||
145421986|NCT00281580|524400207|FG015|Overall Study|Lost to Follow-up|0|||
145421987|NCT00281580|524400192|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
145421988|NCT00281580|524400193|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
145421989|NCT00281580|524400194|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
145421990|NCT00281580|524400195|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
145421991|NCT00281580|524400196|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
145421992|NCT00281580|524400197|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
145421993|NCT00281580|524400198|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
145421994|NCT00281580|524400199|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
145421995|NCT00281580|524400200|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
145421996|NCT00281580|524400201|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
145421997|NCT00281580|524400202|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
145421998|NCT00281580|524400203|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
145421999|NCT00281580|524400204|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
145422000|NCT00281580|524400205|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
145422001|NCT00281580|524400206|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
145422002|NCT00281580|524400207|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
145422003|NCT02771145|524400211|FG000|Overall Study|Adverse Event|3|||
145422004|NCT02771145|524400211|FG000|Overall Study|Lost to Follow-up|1|||
145422005|NCT02067156|524400219|FG000|Overall Study|Lost to Follow-up|4|||
145422006|NCT03596983|524400220|FG000|Overall Study|Withdrawal by Subject|3|||
145422007|NCT01370642|524400221|FG000|Overall Study|Adverse Event|2|||
145422008|NCT01370642|524400222|FG001|Overall Study|Adverse Event|1|||
145422009|NCT01370642|524400223|FG002|Overall Study|Adverse Event|1|||
145422010|NCT01370642|524400221|FG000|Overall Study|Detectable HCV RNA|0|||
145422011|NCT01370642|524400222|FG001|Overall Study|Detectable HCV RNA|0|||
145422012|NCT01370642|524400223|FG002|Overall Study|Detectable HCV RNA|22|||
145422013|NCT01370642|524400221|FG000|Overall Study|Lost to Follow-up|0|||
145422014|NCT01370642|524400222|FG001|Overall Study|Lost to Follow-up|0|||
145422015|NCT01370642|524400223|FG002|Overall Study|Lost to Follow-up|1|||
145422016|NCT01370642|524400221|FG000|Overall Study|Physician Decision|4|||
145422017|NCT01370642|524400222|FG001|Overall Study|Physician Decision|1|||
145422018|NCT01370642|524400223|FG002|Overall Study|Physician Decision|2|||
145422019|NCT01370642|524400221|FG000|Overall Study|Withdrawal by Subject|2|||
145422020|NCT01370642|524400222|FG001|Overall Study|Withdrawal by Subject|4|||
145422021|NCT01370642|524400223|FG002|Overall Study|Withdrawal by Subject|3|||
145422022|NCT00987935|524400230|FG000|Overall Study|Progressive disease|3|||
145422023|NCT00987935|524400231|FG001|Overall Study|Progressive disease|2|||
145422024|NCT00987935|524400232|FG002|Overall Study|Progressive disease|3|||
145422025|NCT00987935|524400233|FG003|Overall Study|Progressive disease|2|||
145422026|NCT00987935|524400234|FG004|Overall Study|Progressive disease|5|||
145422027|NCT00987935|524400235|FG005|Overall Study|Progressive disease|3|||
145422028|NCT00987935|524400236|FG006|Overall Study|Progressive disease|9|||
145422029|NCT00987935|524400237|FG007|Overall Study|Progressive disease|48|||
145422030|NCT00987935|524400238|FG008|Overall Study|Progressive disease|23|||
145422031|NCT00987935|524400230|FG000|Overall Study|Adverse Event|0|||
145422032|NCT00987935|524400231|FG001|Overall Study|Adverse Event|1|||
145422033|NCT00987935|524400232|FG002|Overall Study|Adverse Event|0|||
145422034|NCT00987935|524400233|FG003|Overall Study|Adverse Event|1|||
145422035|NCT00987935|524400234|FG004|Overall Study|Adverse Event|1|||
145422036|NCT00987935|524400235|FG005|Overall Study|Adverse Event|0|||
145422037|NCT00987935|524400236|FG006|Overall Study|Adverse Event|2|||
145422038|NCT00987935|524400237|FG007|Overall Study|Adverse Event|10|||
145422039|NCT00987935|524400238|FG008|Overall Study|Adverse Event|6|||
145422040|NCT00987935|524400230|FG000|Overall Study|Refused to continue taking trial med.|1|||
145422041|NCT00987935|524400231|FG001|Overall Study|Refused to continue taking trial med.|0|||
145422042|NCT00987935|524400232|FG002|Overall Study|Refused to continue taking trial med.|0|||
145422043|NCT00987935|524400233|FG003|Overall Study|Refused to continue taking trial med.|0|||
145422044|NCT00987935|524400234|FG004|Overall Study|Refused to continue taking trial med.|1|||
145422045|NCT00987935|524400235|FG005|Overall Study|Refused to continue taking trial med.|0|||
145366770|NCT05481125|524191820|FG000|Overall Study|Withdrawal by Subject|0|||
145366771|NCT05481125|524191821|FG001|Overall Study|Withdrawal by Subject|1|||
145366772|NCT01769508|524191822|FG000|Overall Study|Death|3|||
145366773|NCT01769508|524191822|FG000|Overall Study|Withdrawal by Subject|1|||
145366774|NCT01769508|524191822|FG000|Overall Study|Adverse Event|1|||
145366775|NCT01769508|524191822|FG000|Overall Study|Lost to Follow-up|1|||
145366776|NCT01290679|524191823|FG000|Overall Study|Adverse Event|2|||
145366777|NCT01290679|524191824|FG001|Overall Study|Adverse Event|0|||
145366778|NCT01290679|524191823|FG000|Overall Study|Lost to Follow-up|8|||
145366779|NCT01290679|524191824|FG001|Overall Study|Lost to Follow-up|10|||
145366780|NCT01290679|524191823|FG000|Overall Study|Protocol Violation|0|||
145366781|NCT01290679|524191824|FG001|Overall Study|Protocol Violation|1|||
145366782|NCT01290679|524191823|FG000|Overall Study|Withdrawal by Subject|6|||
145366783|NCT01290679|524191824|FG001|Overall Study|Withdrawal by Subject|5|||
145366784|NCT01290679|524191823|FG000|Overall Study|Subject Entered Another Trial|0|||
145366785|NCT01290679|524191824|FG001|Overall Study|Subject Entered Another Trial|5|||
145366786|NCT00562302|524191825|FG000|Overall Study|Lost to Follow-up|3|||
145366787|NCT00562302|524191826|FG001|Overall Study|Lost to Follow-up|3|||
145366788|NCT00562302|524191825|FG000|Overall Study|Adverse Event|0|||
145366789|NCT00562302|524191826|FG001|Overall Study|Adverse Event|6|||
145366790|NCT00562302|524191825|FG000|Overall Study|Non-compliance|1|||
145366791|NCT00562302|524191826|FG001|Overall Study|Non-compliance|2|||
145366792|NCT00562302|524191825|FG000|Overall Study|Withdrawal by Subject|7|||
145366793|NCT00562302|524191826|FG001|Overall Study|Withdrawal by Subject|8|||
145366794|NCT00562302|524191825|FG000|Overall Study|Death|1|||
145366795|NCT00562302|524191826|FG001|Overall Study|Death|2|||
145366796|NCT00562302|524191825|FG000|Overall Study|Lung resection prior to study completion|7|||
145366797|NCT00562302|524191826|FG001|Overall Study|Lung resection prior to study completion|7|||
145366798|NCT00562302|524191825|FG000|Overall Study|Not stated|1|||
145366799|NCT00562302|524191826|FG001|Overall Study|Not stated|4|||
145366800|NCT03615144|524191827|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
145366801|NCT03615144|524191828|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
145366802|NCT04791319|524191829|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
145366803|NCT04791319|524191830|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
145366804|NCT04791319|524191831|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
145366805|NCT04791319|524191832|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
145366806|NCT04791319|524191833|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366807|NCT04791319|524191834|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366808|NCT04791319|524191835|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366809|NCT04791319|524191836|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366810|NCT04791319|524191837|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366811|NCT04791319|524191838|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366812|NCT04791319|524191839|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
145366813|NCT04791319|524191829|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
145366814|NCT04791319|524191830|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366815|NCT04791319|524191831|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
145366816|NCT04791319|524191832|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
145366817|NCT04791319|524191833|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366818|NCT04791319|524191834|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366819|NCT04791319|524191835|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366820|NCT04791319|524191836|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366821|NCT04791319|524191837|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366822|NCT04791319|524191838|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366823|NCT04791319|524191839|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
145366824|NCT04791319|524191829|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
145366825|NCT04791319|524191830|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
145366826|NCT04791319|524191831|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
145366827|NCT04791319|524191832|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
145366828|NCT04791319|524191833|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366829|NCT04791319|524191834|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366830|NCT04791319|524191835|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366831|NCT04791319|524191836|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366832|NCT04791319|524191837|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366833|NCT04791319|524191838|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366834|NCT04791319|524191839|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
145366835|NCT04791319|524191829|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
145366836|NCT04791319|524191830|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
145366837|NCT04791319|524191831|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
145366838|NCT04791319|524191832|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
145578329|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145578330|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
145578331|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
145578332|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145578333|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145578334|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145578335|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145578336|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
145578337|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
145578338|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
145578339|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
145366839|NCT04791319|524191833|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366840|NCT04791319|524191834|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366841|NCT04791319|524191835|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366842|NCT04791319|524191836|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366843|NCT04791319|524191837|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366844|NCT04791319|524191838|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366845|NCT04791319|524191839|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
145366846|NCT04791319|524191829|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366847|NCT04791319|524191830|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145578340|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
145578341|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
145623228|NCT00772928|525131625|FG001|Overall Study|Protocol Violation|12|||
145366848|NCT04791319|524191831|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366849|NCT04791319|524191832|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
145366850|NCT04791319|524191833|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366851|NCT04791319|524191834|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366852|NCT04791319|524191835|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366853|NCT04791319|524191836|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366854|NCT04791319|524191837|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366855|NCT04791319|524191838|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366856|NCT04791319|524191839|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
145366857|NCT04791319|524191829|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366858|NCT04791319|524191830|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366859|NCT04791319|524191831|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366860|NCT04791319|524191832|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366861|NCT04791319|524191833|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
145366862|NCT04791319|524191834|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
145366863|NCT04791319|524191835|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
145366864|NCT04791319|524191836|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366865|NCT04791319|524191837|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366866|NCT04791319|524191838|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
145366867|NCT04791319|524191839|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
145366868|NCT04791319|524191829|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366869|NCT04791319|524191830|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366870|NCT04791319|524191831|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366871|NCT04791319|524191832|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366872|NCT04791319|524191833|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366873|NCT04791319|524191834|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366874|NCT04791319|524191835|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366875|NCT04791319|524191836|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366876|NCT04791319|524191837|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366877|NCT04791319|524191838|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
145366878|NCT04791319|524191839|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
145366879|NCT04791319|524191829|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145366880|NCT04791319|524191830|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145366881|NCT04791319|524191831|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145366882|NCT04791319|524191832|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145366883|NCT04791319|524191833|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
145366884|NCT04791319|524191834|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
145366885|NCT04791319|524191835|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
145578342|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
145578343|NCT02139644|524973634|FG000|Run-In Period (Pre-assignment)|Other|6|||
145422046|NCT00987935|524400236|FG006|Overall Study|Refused to continue taking trial med.|4|||
145422047|NCT00987935|524400237|FG007|Overall Study|Refused to continue taking trial med.|4|||
145422048|NCT00987935|524400238|FG008|Overall Study|Refused to continue taking trial med.|2|||
145422049|NCT00987935|524400230|FG000|Overall Study|Reason other than those specified above|0|||
145422050|NCT00987935|524400231|FG001|Overall Study|Reason other than those specified above|0|||
145422051|NCT00987935|524400232|FG002|Overall Study|Reason other than those specified above|0|||
145422052|NCT00987935|524400233|FG003|Overall Study|Reason other than those specified above|0|||
145422053|NCT00987935|524400234|FG004|Overall Study|Reason other than those specified above|0|||
145422054|NCT00987935|524400235|FG005|Overall Study|Reason other than those specified above|0|||
145623229|NCT00772928|525131624|FG000|Overall Study|Withdrawal by Subject|25|||
145623230|NCT00772928|525131625|FG001|Overall Study|Withdrawal by Subject|22|||
145623231|NCT00772928|525131624|FG000|Overall Study|Did not receive vaccine|0|||
145623232|NCT00772928|525131625|FG001|Overall Study|Did not receive vaccine|1|||
145623233|NCT00801242|525131630|FG000|Overall Study|Adverse Event|10|||
145623234|NCT00801242|525131630|FG000|Overall Study|Withdrawal by Subject|13|||
145623235|NCT00801242|525131630|FG000|Overall Study|Protocol Violation|5|||
145623236|NCT00801242|525131630|FG000|Overall Study|Physician Decision|3|||
145623237|NCT00801242|525131630|FG000|Overall Study|Lost to Follow-up|1|||
145623238|NCT00801242|525131630|FG000|Overall Study|Miscellaneous reasons|20|||
145623239|NCT02015195|525131632|FG000|Overall Study|Adverse Event|0|||
145623240|NCT02015195|525131633|FG001|Overall Study|Adverse Event|0|||
145623241|NCT02015195|525131634|FG002|Overall Study|Adverse Event|0|||
145623242|NCT02015195|525131635|FG003|Overall Study|Adverse Event|1|||
145623243|NCT02015195|525131636|FG004|Overall Study|Adverse Event|0|||
145623244|NCT02015195|525131637|FG005|Overall Study|Adverse Event|0|||
145623245|NCT02015195|525131638|FG006|Overall Study|Adverse Event|0|||
145623246|NCT01318811|525131639|FG000|Overall Study|Physician Decision|1|||
145623247|NCT01318811|525131640|FG001|Overall Study|Physician Decision|1|||
145623248|NCT01318811|525131639|FG000|Overall Study|CRRT stopped for head CT|0|||
145623249|NCT01318811|525131640|FG001|Overall Study|CRRT stopped for head CT|1|||
145623250|NCT01318811|525131639|FG000|Overall Study|Death|0|||
145623251|NCT01318811|525131640|FG001|Overall Study|Death|1|||
145623252|NCT01318811|525131639|FG000|Overall Study|CRRT stopped for head MRI|0|||
145623253|NCT01318811|525131640|FG001|Overall Study|CRRT stopped for head MRI|1|||
145623254|NCT00577629|525131641|FG000|Treatment Period|Death|1|||
145623255|NCT00577629|525131641|FG000|Long Term Follow-Up|Death|15|||
145623256|NCT00577629|525131641|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
145623257|NCT00577629|525131641|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
145623258|NCT00577629|525131641|FG000|Long Term Follow-Up|Physician Decision|1|||
145366886|NCT04791319|524191836|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
145366887|NCT04791319|524191837|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
145366888|NCT04791319|524191838|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
145366889|NCT04791319|524191839|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
145366890|NCT04791319|524191829|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145366891|NCT04791319|524191830|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145366892|NCT04791319|524191831|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145366893|NCT04791319|524191832|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
145366894|NCT04791319|524191833|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
145366895|NCT04791319|524191834|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
145366896|NCT04791319|524191835|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
145366897|NCT04791319|524191836|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
145366898|NCT04791319|524191837|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
145366899|NCT04791319|524191838|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
145366900|NCT04791319|524191839|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
145366901|NCT00791661|524191840|FG000|7 Day Wash-out|Adverse Event|0|||
145366902|NCT00791661|524191841|FG001|7 Day Wash-out|Adverse Event|0|||
145366903|NCT00791661|524191842|FG002|7 Day Wash-out|Adverse Event|1|||
145366904|NCT00791661|524191840|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
145366905|NCT00791661|524191841|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
145366906|NCT00791661|524191842|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
145366907|NCT03605862|524191843|FG000|Overall Study|Withdrawal by Subject|12|||
145366908|NCT03605862|524191844|FG001|Overall Study|Withdrawal by Subject|9|||
145422055|NCT00987935|524400236|FG006|Overall Study|Reason other than those specified above|0|||
145623259|NCT01449721|525131643|FG000|Overall Study|Physician Decision|0|||
145422056|NCT00987935|524400237|FG007|Overall Study|Reason other than those specified above|0|||
145422057|NCT00987935|524400238|FG008|Overall Study|Reason other than those specified above|1|||
145623260|NCT01449721|525131644|FG001|Overall Study|Physician Decision|1|||
145623261|NCT01449721|525131643|FG000|Overall Study|Physician Decision|0|||
145623262|NCT01449721|525131644|FG001|Overall Study|Physician Decision|1|||
145623263|NCT03212365|525131656|FG000|Overall Study|Discharged prior to Xa level|12|||
145578344|NCT02139644|524973635|FG001|Run-In Period (Pre-assignment)|Other|0|||
145578345|NCT02139644|524973636|FG002|Run-In Period (Pre-assignment)|Other|0|||
145578346|NCT02139644|524973637|FG003|Run-In Period (Pre-assignment)|Other|0|||
145578347|NCT02139644|524973638|FG004|Run-In Period (Pre-assignment)|Other|0|||
145578348|NCT02139644|524973639|FG005|Run-In Period (Pre-assignment)|Other|0|||
145578349|NCT02139644|524973634|FG000|Treatment Period|Adverse Event|0|||
145578350|NCT02139644|524973635|FG001|Treatment Period|Adverse Event|0|||
145578351|NCT02139644|524973636|FG002|Treatment Period|Adverse Event|3|||
145578352|NCT02139644|524973637|FG003|Treatment Period|Adverse Event|2|||
145578353|NCT02139644|524973638|FG004|Treatment Period|Adverse Event|1|||
145578354|NCT02139644|524973639|FG005|Treatment Period|Adverse Event|6|||
145578355|NCT02139644|524973634|FG000|Treatment Period|Withdrawal by Subject|0|||
145578356|NCT02139644|524973635|FG001|Treatment Period|Withdrawal by Subject|0|||
145578357|NCT02139644|524973636|FG002|Treatment Period|Withdrawal by Subject|2|||
145578358|NCT02139644|524973637|FG003|Treatment Period|Withdrawal by Subject|2|||
145578359|NCT02139644|524973638|FG004|Treatment Period|Withdrawal by Subject|3|||
145578360|NCT02139644|524973639|FG005|Treatment Period|Withdrawal by Subject|2|||
145578361|NCT02139644|524973634|FG000|Treatment Period|Non-compliance|0|||
145623264|NCT03212365|525131657|FG001|Overall Study|Discharged prior to Xa level|8|||
145366909|NCT03605862|524191843|FG000|Overall Study|Adverse Event|2|||
145366910|NCT03605862|524191844|FG001|Overall Study|Adverse Event|1|||
145366911|NCT03605862|524191843|FG000|Overall Study|Physician Decision|3|||
145366912|NCT03605862|524191844|FG001|Overall Study|Physician Decision|1|||
145366913|NCT03605862|524191843|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
145366914|NCT03605862|524191844|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
145366915|NCT00937040|524191845|FG000|Overall Study|Adverse Event|5|||
145366916|NCT00937040|524191846|FG001|Overall Study|Adverse Event|8|||
145366917|NCT00937040|524191845|FG000|Overall Study|Lost to Follow-up|12|||
145366918|NCT00937040|524191846|FG001|Overall Study|Lost to Follow-up|12|||
145366919|NCT00937040|524191845|FG000|Overall Study|Protocol Violation|3|||
145366920|NCT00937040|524191846|FG001|Overall Study|Protocol Violation|0|||
145366921|NCT00937040|524191845|FG000|Overall Study|Withdrawal by Subject|13|||
145366922|NCT00937040|524191846|FG001|Overall Study|Withdrawal by Subject|7|||
145366923|NCT00937040|524191845|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
145366924|NCT00937040|524191846|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
145366925|NCT00937040|524191845|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
145366926|NCT00937040|524191846|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
145366927|NCT00634803|524191849|FG000|Overall Study|Lost to Follow-up|6|||
145366928|NCT00634803|524191850|FG001|Overall Study|Lost to Follow-up|7|||
145366929|NCT00634803|524191851|FG002|Overall Study|Lost to Follow-up|7|||
145366930|NCT00364923|524191852|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
145366931|NCT00364923|524191852|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
145366932|NCT00550043|524191859|FG000|Overall Study|Adverse Event|0|||
145366933|NCT00550043|524191860|FG001|Overall Study|Adverse Event|0|||
145366934|NCT00550043|524191861|FG002|Overall Study|Adverse Event|0|||
145366935|NCT00550043|524191862|FG003|Overall Study|Adverse Event|1|||
145366936|NCT00550043|524191863|FG004|Overall Study|Adverse Event|1|||
145366937|NCT00550043|524191859|FG000|Overall Study|Subject Withdrew Consent|0|||
145366938|NCT00550043|524191860|FG001|Overall Study|Subject Withdrew Consent|2|||
145366939|NCT00550043|524191861|FG002|Overall Study|Subject Withdrew Consent|1|||
145366940|NCT00550043|524191862|FG003|Overall Study|Subject Withdrew Consent|0|||
145366941|NCT00550043|524191863|FG004|Overall Study|Subject Withdrew Consent|0|||
145366942|NCT00550043|524191859|FG000|Overall Study|Other Reasons- Unspecified|0|||
145366943|NCT00550043|524191860|FG001|Overall Study|Other Reasons- Unspecified|1|||
145366944|NCT00550043|524191861|FG002|Overall Study|Other Reasons- Unspecified|0|||
145366945|NCT00550043|524191862|FG003|Overall Study|Other Reasons- Unspecified|1|||
145366946|NCT00550043|524191863|FG004|Overall Study|Other Reasons- Unspecified|0|||
145366947|NCT01483027|524191864|FG000|Overall Study|Administrative Reasons|2|||
145366948|NCT01483027|524191865|FG001|Overall Study|Administrative Reasons|1|||
145366949|NCT01483027|524191864|FG000|Overall Study|Withdrawal by Subject|21|||
145366950|NCT01483027|524191865|FG001|Overall Study|Withdrawal by Subject|32|||
145366951|NCT01483027|524191864|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
145366952|NCT01483027|524191865|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
145366953|NCT01483027|524191864|FG000|Overall Study|Lost to Follow-up|1|||
145366954|NCT01483027|524191865|FG001|Overall Study|Lost to Follow-up|1|||
145366955|NCT01483027|524191864|FG000|Overall Study|Adverse Event|0|||
145366956|NCT01483027|524191865|FG001|Overall Study|Adverse Event|1|||
145366957|NCT01483027|524191864|FG000|Overall Study|Withdrawal by Subject|0|||
145366958|NCT01483027|524191865|FG001|Overall Study|Withdrawal by Subject|1|||
145366959|NCT01806961|524193249|FG000|Overall Study|sponsor decision|16|||
145578362|NCT02139644|524973635|FG001|Treatment Period|Non-compliance|0|||
145578363|NCT02139644|524973636|FG002|Treatment Period|Non-compliance|0|||
145578364|NCT02139644|524973637|FG003|Treatment Period|Non-compliance|1|||
145578365|NCT02139644|524973638|FG004|Treatment Period|Non-compliance|0|||
145578366|NCT02139644|524973639|FG005|Treatment Period|Non-compliance|0|||
145366960|NCT00769067|524193253|FG000|Overall Study|Death|89|||
145366961|NCT00769067|524193254|FG001|Overall Study|Death|86|||
145366962|NCT00769067|524193253|FG000|Overall Study|Lost to Follow-up|3|||
145366963|NCT00769067|524193254|FG001|Overall Study|Lost to Follow-up|1|||
145366964|NCT00769067|524193253|FG000|Overall Study|Study terminated by sponsor|1|||
145366965|NCT00769067|524193254|FG001|Overall Study|Study terminated by sponsor|3|||
145366966|NCT00769067|524193253|FG000|Overall Study|Other|1|||
145366967|NCT00769067|524193254|FG001|Overall Study|Other|3|||
145366968|NCT00769067|524193253|FG000|Overall Study|Withdrawal by Subject|0|||
145366969|NCT00769067|524193254|FG001|Overall Study|Withdrawal by Subject|1|||
145366970|NCT00831311|524193257|FG000|Overall Study|Definitive Contraindication|3|||
145366971|NCT00831311|524193258|FG001|Overall Study|Definitive Contraindication|3|||
145366972|NCT00831311|524193257|FG000|Overall Study|Lost to Follow-up|3|||
145366973|NCT00831311|524193258|FG001|Overall Study|Lost to Follow-up|0|||
145366974|NCT00831311|524193257|FG000|Overall Study|Physician Decision|0|||
145366975|NCT00831311|524193258|FG001|Overall Study|Physician Decision|1|||
145366976|NCT00831311|524193257|FG000|Overall Study|Withdrawal by Subject|6|||
145366977|NCT00831311|524193258|FG001|Overall Study|Withdrawal by Subject|4|||
145366978|NCT00160706|524193264|FG000|Overall Study|Adverse Event|53|||
145366979|NCT00160706|524193264|FG000|Overall Study|Adverse Event and Other Reason|105|||
145366980|NCT00160706|524193264|FG000|Overall Study|Protocol Violation|3|||
145366981|NCT00160706|524193264|FG000|Overall Study|Withdrawal by Subject|41|||
145366982|NCT00160706|524193264|FG000|Overall Study|Withdrawal by Subject and Other|12|||
145366983|NCT00160706|524193264|FG000|Overall Study|Physician Decision|10|||
145366984|NCT00160706|524193264|FG000|Overall Study|Physician Decision and Other|3|||
145366985|NCT00160706|524193264|FG000|Overall Study|Lost to Follow-up|4|||
145366986|NCT00160706|524193264|FG000|Overall Study|Lost to Follow-up and Other|1|||
145366987|NCT00160706|524193264|FG000|Overall Study|Lack of Efficacy|42|||
145366988|NCT00160706|524193264|FG000|Overall Study|Lack of Efficacy and Other|1|||
145366989|NCT00160706|524193264|FG000|Overall Study|Other Reason|11|||
145366990|NCT03214380|524193265|FG000|Lead-in|Adverse Event|3|||
145366991|NCT03214380|524193266|FG001|Lead-in|Adverse Event|0|||
145366992|NCT03214380|524193267|FG002|Lead-in|Adverse Event|0|||
145366993|NCT03214380|524193268|FG003|Lead-in|Adverse Event|1|||
145366994|NCT03214380|524193269|FG004|Lead-in|Adverse Event|0|||
145366995|NCT03214380|524193270|FG005|Lead-in|Adverse Event|0|||
145366996|NCT03214380|524193265|FG000|Lead-in|Lost to Follow-up|4|||
145366997|NCT03214380|524193266|FG001|Lead-in|Lost to Follow-up|0|||
145366998|NCT03214380|524193267|FG002|Lead-in|Lost to Follow-up|0|||
145366999|NCT03214380|524193268|FG003|Lead-in|Lost to Follow-up|1|||
145367000|NCT03214380|524193269|FG004|Lead-in|Lost to Follow-up|0|||
145367001|NCT03214380|524193270|FG005|Lead-in|Lost to Follow-up|0|||
145367002|NCT03214380|524193265|FG000|Lead-in|Eligibility Criteria|3|||
145367003|NCT03214380|524193266|FG001|Lead-in|Eligibility Criteria|0|||
145367004|NCT03214380|524193267|FG002|Lead-in|Eligibility Criteria|0|||
145367005|NCT03214380|524193268|FG003|Lead-in|Eligibility Criteria|0|||
145367006|NCT03214380|524193269|FG004|Lead-in|Eligibility Criteria|0|||
145367007|NCT03214380|524193270|FG005|Lead-in|Eligibility Criteria|0|||
145367008|NCT03214380|524193265|FG000|Lead-in|Physician Decision|6|||
145367009|NCT03214380|524193266|FG001|Lead-in|Physician Decision|0|||
145367010|NCT03214380|524193267|FG002|Lead-in|Physician Decision|0|||
145367011|NCT03214380|524193268|FG003|Lead-in|Physician Decision|0|||
145367012|NCT03214380|524193269|FG004|Lead-in|Physician Decision|0|||
145367013|NCT03214380|524193270|FG005|Lead-in|Physician Decision|0|||
145367014|NCT03214380|524193265|FG000|Lead-in|Protocol Deviation|7|||
145367015|NCT03214380|524193266|FG001|Lead-in|Protocol Deviation|0|||
145367016|NCT03214380|524193267|FG002|Lead-in|Protocol Deviation|0|||
145367017|NCT03214380|524193268|FG003|Lead-in|Protocol Deviation|3|||
145367018|NCT03214380|524193269|FG004|Lead-in|Protocol Deviation|0|||
145367019|NCT03214380|524193270|FG005|Lead-in|Protocol Deviation|0|||
145367020|NCT03214380|524193265|FG000|Lead-in|Withdrawal by Subject|41|||
145367021|NCT03214380|524193266|FG001|Lead-in|Withdrawal by Subject|0|||
145422058|NCT00452530|524400239|FG000|Overall Study|Death|1|||
145422059|NCT00452530|524400240|FG001|Overall Study|Death|0|||
145422060|NCT00452530|524400239|FG000|Overall Study|Adverse Event|40|||
145422061|NCT00452530|524400240|FG001|Overall Study|Adverse Event|44|||
145422062|NCT00452530|524400239|FG000|Overall Study|Withdrawal by Subject|68|||
145578367|NCT02139644|524973634|FG000|Treatment Period|Protocol Violation|0|||
145367022|NCT03214380|524193267|FG002|Lead-in|Withdrawal by Subject|0|||
145367023|NCT03214380|524193268|FG003|Lead-in|Withdrawal by Subject|14|||
145367024|NCT03214380|524193269|FG004|Lead-in|Withdrawal by Subject|0|||
145367025|NCT03214380|524193270|FG005|Lead-in|Withdrawal by Subject|0|||
145367026|NCT03214380|524193265|FG000|Lead-in|Family Emergency|1|||
145422063|NCT00452530|524400240|FG001|Overall Study|Withdrawal by Subject|57|||
145578368|NCT02139644|524973635|FG001|Treatment Period|Protocol Violation|0|||
145367027|NCT03214380|524193266|FG001|Lead-in|Family Emergency|0|||
145367028|NCT03214380|524193267|FG002|Lead-in|Family Emergency|0|||
145367029|NCT03214380|524193268|FG003|Lead-in|Family Emergency|0|||
145367030|NCT03214380|524193269|FG004|Lead-in|Family Emergency|0|||
145367031|NCT03214380|524193270|FG005|Lead-in|Family Emergency|0|||
145367032|NCT03214380|524193265|FG000|Lead-in|Natural Disaster|9|||
145367033|NCT03214380|524193266|FG001|Lead-in|Natural Disaster|0|||
145367034|NCT03214380|524193267|FG002|Lead-in|Natural Disaster|0|||
145367035|NCT03214380|524193268|FG003|Lead-in|Natural Disaster|0|||
145367036|NCT03214380|524193269|FG004|Lead-in|Natural Disaster|0|||
145367037|NCT03214380|524193270|FG005|Lead-in|Natural Disaster|0|||
145367038|NCT03214380|524193265|FG000|Lead-in|Non Compliance|1|||
145367039|NCT03214380|524193266|FG001|Lead-in|Non Compliance|0|||
145367040|NCT03214380|524193267|FG002|Lead-in|Non Compliance|0|||
145367041|NCT03214380|524193268|FG003|Lead-in|Non Compliance|0|||
145367042|NCT03214380|524193269|FG004|Lead-in|Non Compliance|0|||
145367043|NCT03214380|524193270|FG005|Lead-in|Non Compliance|0|||
145367044|NCT03214380|524193265|FG000|Lead-in|Participant Schedule|2|||
145367045|NCT03214380|524193266|FG001|Lead-in|Participant Schedule|0|||
145367046|NCT03214380|524193267|FG002|Lead-in|Participant Schedule|0|||
145367047|NCT03214380|524193268|FG003|Lead-in|Participant Schedule|0|||
145367048|NCT03214380|524193269|FG004|Lead-in|Participant Schedule|0|||
145367049|NCT03214380|524193270|FG005|Lead-in|Participant Schedule|0|||
145367050|NCT03214380|524193265|FG000|Treatment Period|Adverse Event|0|||
145367051|NCT03214380|524193266|FG001|Treatment Period|Adverse Event|1|||
145367052|NCT03214380|524193267|FG002|Treatment Period|Adverse Event|1|||
145367053|NCT03214380|524193268|FG003|Treatment Period|Adverse Event|0|||
145367054|NCT03214380|524193269|FG004|Treatment Period|Adverse Event|1|||
145367055|NCT03214380|524193270|FG005|Treatment Period|Adverse Event|0|||
145367056|NCT03214380|524193265|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
145367057|NCT03214380|524193266|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
145367058|NCT03214380|524193267|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
145367059|NCT03214380|524193268|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
145367060|NCT03214380|524193269|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
145367061|NCT03214380|524193270|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
145367062|NCT03214380|524193265|FG000|Treatment Period|Withdrawal by Subject|0|||
145367063|NCT03214380|524193266|FG001|Treatment Period|Withdrawal by Subject|10|||
145367064|NCT03214380|524193267|FG002|Treatment Period|Withdrawal by Subject|8|||
145367065|NCT03214380|524193268|FG003|Treatment Period|Withdrawal by Subject|0|||
145367066|NCT03214380|524193269|FG004|Treatment Period|Withdrawal by Subject|7|||
145367067|NCT03214380|524193270|FG005|Treatment Period|Withdrawal by Subject|11|||
145367068|NCT03214380|524193265|FG000|Treatment Period|Death|0|||
145367069|NCT03214380|524193266|FG001|Treatment Period|Death|1|||
145367070|NCT03214380|524193267|FG002|Treatment Period|Death|2|||
145367071|NCT03214380|524193268|FG003|Treatment Period|Death|0|||
145367072|NCT03214380|524193269|FG004|Treatment Period|Death|0|||
145367073|NCT03214380|524193270|FG005|Treatment Period|Death|0|||
145367074|NCT03214380|524193265|FG000|Treatment Period|Lost to Follow-up|0|||
145367075|NCT03214380|524193266|FG001|Treatment Period|Lost to Follow-up|6|||
145367076|NCT03214380|524193267|FG002|Treatment Period|Lost to Follow-up|3|||
145367077|NCT03214380|524193268|FG003|Treatment Period|Lost to Follow-up|0|||
145367078|NCT03214380|524193269|FG004|Treatment Period|Lost to Follow-up|0|||
145367079|NCT03214380|524193270|FG005|Treatment Period|Lost to Follow-up|0|||
145367080|NCT03214380|524193265|FG000|Treatment Period|Participant schedule|0|||
145367081|NCT03214380|524193266|FG001|Treatment Period|Participant schedule|0|||
145367082|NCT03214380|524193267|FG002|Treatment Period|Participant schedule|1|||
145367083|NCT03214380|524193268|FG003|Treatment Period|Participant schedule|0|||
145367084|NCT03214380|524193269|FG004|Treatment Period|Participant schedule|0|||
145367085|NCT03214380|524193270|FG005|Treatment Period|Participant schedule|0|||
145367086|NCT03214380|524193265|FG000|Treatment Period|Treatment Interruption|0|||
145367087|NCT03214380|524193266|FG001|Treatment Period|Treatment Interruption|0|||
145367088|NCT03214380|524193267|FG002|Treatment Period|Treatment Interruption|1|||
145367089|NCT03214380|524193268|FG003|Treatment Period|Treatment Interruption|0|||
145367090|NCT03214380|524193269|FG004|Treatment Period|Treatment Interruption|0|||
145367091|NCT03214380|524193270|FG005|Treatment Period|Treatment Interruption|0|||
145367092|NCT03692325|524193274|FG000|Overall Study|Adverse Event|2|||
145367093|NCT03692325|524193274|FG000|Overall Study|Progression/Recurrence|2|||
145367094|NCT03200704|524193280|FG000|Overall Study|Withdrawal by Subject|1|||
145367095|NCT00654875|524193281|FG000|Overall Study|Adverse Event|5|||
145367096|NCT00654875|524193282|FG001|Overall Study|Adverse Event|5|||
145367097|NCT00654875|524193281|FG000|Overall Study|Withdrawal by Subject|4|||
145367098|NCT00654875|524193282|FG001|Overall Study|Withdrawal by Subject|4|||
145367099|NCT00654875|524193281|FG000|Overall Study|Protocol Violation|3|||
145367100|NCT00654875|524193282|FG001|Overall Study|Protocol Violation|3|||
145422064|NCT00452530|524400239|FG000|Overall Study|Lost to Follow-up|1|||
145422065|NCT00452530|524400240|FG001|Overall Study|Lost to Follow-up|0|||
145367101|NCT00654875|524193281|FG000|Overall Study|Lack of Efficacy|2|||
145367102|NCT00654875|524193282|FG001|Overall Study|Lack of Efficacy|2|||
145367103|NCT00654875|524193281|FG000|Overall Study|Lost to Follow-up|1|||
145367104|NCT00654875|524193282|FG001|Overall Study|Lost to Follow-up|3|||
145367105|NCT00654875|524193281|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
145367106|NCT00654875|524193282|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145367107|NCT00654875|524193281|FG000|Overall Study|Administrative Problems|1|||
145367108|NCT00654875|524193282|FG001|Overall Study|Administrative Problems|0|||
145367109|NCT01683266|524193289|FG000|Overall Study|Adverse Event|5|||
145367110|NCT01683266|524193290|FG001|Overall Study|Adverse Event|4|||
145367111|NCT01683266|524193289|FG000|Overall Study|Lack of Efficacy|5|||
145367112|NCT01683266|524193290|FG001|Overall Study|Lack of Efficacy|2|||
145367113|NCT01683266|524193289|FG000|Overall Study|Protocol Violation|13|||
145367114|NCT01683266|524193290|FG001|Overall Study|Protocol Violation|6|||
145367115|NCT01683266|524193289|FG000|Overall Study|Personal Reason|17|||
145367116|NCT01683266|524193290|FG001|Overall Study|Personal Reason|25|||
145367117|NCT01683266|524193289|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
145367118|NCT01683266|524193290|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
145367119|NCT01683266|524193289|FG000|Overall Study|Lost to Follow-up|5|||
145367120|NCT01683266|524193290|FG001|Overall Study|Lost to Follow-up|0|||
145367121|NCT01683266|524193289|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
145367122|NCT01683266|524193290|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
145367123|NCT01683266|524193289|FG000|Overall Study|Nonserious Hypoglycemia|0|||
145367124|NCT01683266|524193290|FG001|Overall Study|Nonserious Hypoglycemia|3|||
145367125|NCT01683266|524193289|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145367126|NCT01683266|524193290|FG001|Overall Study|Perceived Lack of Efficacy|1|||
145367127|NCT01683266|524193289|FG000|Overall Study|Possibly Hypoglycemia|1|||
145367128|NCT01683266|524193290|FG001|Overall Study|Possibly Hypoglycemia|0|||
145367129|NCT01683266|524193289|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
145367130|NCT01683266|524193290|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
145367131|NCT00626821|524193293|FG000|Overall Study|Adverse Event|44|||
145367132|NCT00626821|524193293|FG000|Overall Study|Protocol Violation|33|||
145367133|NCT00626821|524193293|FG000|Overall Study|Withdrawal by Subject|10|||
145367134|NCT00626821|524193293|FG000|Overall Study|Physician Decision|9|||
145367135|NCT00626821|524193293|FG000|Overall Study|Product dysfunction|21|||
145367136|NCT00626821|524193293|FG000|Overall Study|other/unknown reason|104|||
145422066|NCT00452530|524400239|FG000|Overall Study|Poor compliance/noncompliance|1|||
145422067|NCT00452530|524400240|FG001|Overall Study|Poor compliance/noncompliance|2|||
145422068|NCT00452530|524400239|FG000|Overall Study|No longer met study criteria|18|||
145578369|NCT02139644|524973636|FG002|Treatment Period|Protocol Violation|0|||
145578370|NCT02139644|524973637|FG003|Treatment Period|Protocol Violation|1|||
145578371|NCT02139644|524973638|FG004|Treatment Period|Protocol Violation|1|||
145578372|NCT02139644|524973639|FG005|Treatment Period|Protocol Violation|1|||
145578373|NCT02139644|524973634|FG000|Treatment Period|Disease progression|0|||
145578374|NCT02139644|524973635|FG001|Treatment Period|Disease progression|0|||
145578375|NCT02139644|524973636|FG002|Treatment Period|Disease progression|0|||
145578376|NCT02139644|524973637|FG003|Treatment Period|Disease progression|1|||
145578377|NCT02139644|524973638|FG004|Treatment Period|Disease progression|1|||
145578378|NCT02139644|524973639|FG005|Treatment Period|Disease progression|2|||
145578379|NCT02139644|524973634|FG000|Treatment Period|Lost to Follow-up|0|||
145578380|NCT02139644|524973635|FG001|Treatment Period|Lost to Follow-up|0|||
145578381|NCT02139644|524973636|FG002|Treatment Period|Lost to Follow-up|1|||
145578382|NCT02139644|524973637|FG003|Treatment Period|Lost to Follow-up|1|||
145578383|NCT02139644|524973638|FG004|Treatment Period|Lost to Follow-up|1|||
145578384|NCT02139644|524973639|FG005|Treatment Period|Lost to Follow-up|1|||
145578385|NCT02139644|524973634|FG000|Treatment Period|Lack of Efficacy|0|||
145578386|NCT02139644|524973635|FG001|Treatment Period|Lack of Efficacy|0|||
145578387|NCT02139644|524973636|FG002|Treatment Period|Lack of Efficacy|1|||
145578388|NCT02139644|524973637|FG003|Treatment Period|Lack of Efficacy|0|||
145578389|NCT02139644|524973638|FG004|Treatment Period|Lack of Efficacy|1|||
145578390|NCT02139644|524973639|FG005|Treatment Period|Lack of Efficacy|4|||
145578391|NCT02139644|524973634|FG000|Treatment Period|Other|0|||
145578392|NCT02139644|524973635|FG001|Treatment Period|Other|3|||
145578393|NCT02139644|524973636|FG002|Treatment Period|Other|1|||
145578394|NCT02139644|524973637|FG003|Treatment Period|Other|1|||
145578395|NCT02139644|524973638|FG004|Treatment Period|Other|0|||
145578396|NCT02139644|524973639|FG005|Treatment Period|Other|1|||
145578397|NCT03328897|524973640|FG000|Randomized-treatment Epoch|Adverse Event|4|||
145367137|NCT01940887|524193298|FG000|Year 1|Protocol Violation|0|||
145422069|NCT00452530|524400240|FG001|Overall Study|No longer met study criteria|22|||
145578398|NCT03328897|524973641|FG001|Randomized-treatment Epoch|Adverse Event|1|||
145578399|NCT03328897|524973642|FG002|Randomized-treatment Epoch|Adverse Event|1|||
145578400|NCT03328897|524973640|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
145578401|NCT03328897|524973641|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
145578402|NCT03328897|524973642|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
145623265|NCT03212365|525131656|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
145367138|NCT01940887|524193299|FG001|Year 1|Protocol Violation|1|||
145367139|NCT01940887|524193298|FG000|Year 1|Physician Decision|7|||
145367140|NCT01940887|524193299|FG001|Year 1|Physician Decision|3|||
145367141|NCT01940887|524193298|FG000|Year 1|Death|5|||
145422070|NCT00452530|524400239|FG000|Overall Study|Other|7|||
145422071|NCT00452530|524400240|FG001|Overall Study|Other|11|||
145578403|NCT03328897|524973640|FG000|Randomized-treatment Epoch|Pregnancy|3|||
145578404|NCT03328897|524973641|FG001|Randomized-treatment Epoch|Pregnancy|0|||
145578405|NCT03328897|524973642|FG002|Randomized-treatment Epoch|Pregnancy|0|||
145578406|NCT03328897|524973640|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
145578407|NCT03328897|524973641|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
145578408|NCT03328897|524973642|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
145578409|NCT03328897|524973640|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
145578410|NCT03328897|524973641|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
145578411|NCT03328897|524973642|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
145578412|NCT03328897|524973640|FG000|Follow-up Epoch|Adverse Event|4|||
145578413|NCT03328897|524973641|FG001|Follow-up Epoch|Adverse Event|0|||
145578414|NCT03328897|524973642|FG002|Follow-up Epoch|Adverse Event|1|||
145623266|NCT03212365|525131657|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
145623267|NCT03212365|525131656|FG000|Overall Study|Refused study medication|3|||
145367142|NCT01940887|524193299|FG001|Year 1|Death|3|||
145367143|NCT01940887|524193298|FG000|Year 1|Adverse Event|7|||
145367144|NCT01940887|524193299|FG001|Year 1|Adverse Event|6|||
145367145|NCT01940887|524193298|FG000|Year 1|Withdrawal by Subject|18|||
145367146|NCT01940887|524193299|FG001|Year 1|Withdrawal by Subject|9|||
145367147|NCT01940887|524193298|FG000|Year 1|Lost to Follow-up|2|||
145367148|NCT01940887|524193299|FG001|Year 1|Lost to Follow-up|1|||
145367149|NCT01940887|524193298|FG000|Year 2|Physician Decision|8|||
145367150|NCT01940887|524193299|FG001|Year 2|Physician Decision|1|||
145367151|NCT01940887|524193298|FG000|Year 2|Death|0|||
145367152|NCT01940887|524193299|FG001|Year 2|Death|2|||
145367153|NCT01940887|524193298|FG000|Year 2|Sponsor Decision, early termination|192|||
145367154|NCT01940887|524193299|FG001|Year 2|Sponsor Decision, early termination|203|||
145367155|NCT01940887|524193298|FG000|Year 2|Adverse Event|8|||
145367156|NCT01940887|524193299|FG001|Year 2|Adverse Event|2|||
145367157|NCT01940887|524193298|FG000|Year 2|Withdrawal by Subject|8|||
145367158|NCT01940887|524193299|FG001|Year 2|Withdrawal by Subject|8|||
145367159|NCT01940887|524193298|FG000|Year 2|Lost to Follow-up|1|||
145367160|NCT01940887|524193299|FG001|Year 2|Lost to Follow-up|6|||
145367161|NCT01062113|524193300|FG000|Overall Study|Adverse Event|1|||
145367162|NCT01062113|524193301|FG001|Overall Study|Adverse Event|0|||
145367163|NCT01062113|524193302|FG002|Overall Study|Adverse Event|0|||
145367164|NCT01062113|524193300|FG000|Overall Study|Lack of Efficacy|38|||
145367165|NCT01062113|524193301|FG001|Overall Study|Lack of Efficacy|22|||
145367166|NCT01062113|524193302|FG002|Overall Study|Lack of Efficacy|31|||
145367167|NCT01062113|524193300|FG000|Overall Study|Withdrawal by Subject|1|||
145367168|NCT01062113|524193301|FG001|Overall Study|Withdrawal by Subject|0|||
145367169|NCT01062113|524193302|FG002|Overall Study|Withdrawal by Subject|0|||
145367170|NCT03655470|524193308|FG000|Overall Study|Lost to Follow-up|6|||
145367171|NCT03655470|524193309|FG001|Overall Study|Lost to Follow-up|7|||
145367172|NCT01893281|524193311|FG000|Overall Study|Adverse Event|1|||
145367173|NCT01893281|524193311|FG000|Overall Study|Protocol Violation|1|||
145367174|NCT01893281|524193311|FG000|Overall Study|Withdrawal by Subject|1|||
145367175|NCT00679289|524193317|FG000|Overall Study|Progressive disease|4|||
145367176|NCT00679289|524193318|FG001|Overall Study|Progressive disease|5|||
145367177|NCT00679289|524193319|FG002|Overall Study|Progressive disease|18|||
145367178|NCT00679289|524193317|FG000|Overall Study|Withdrawal by Subject|0|||
145367179|NCT00679289|524193318|FG001|Overall Study|Withdrawal by Subject|1|||
145367180|NCT00679289|524193319|FG002|Overall Study|Withdrawal by Subject|1|||
145367181|NCT00679289|524193317|FG000|Overall Study|Adverse Event|0|||
145367182|NCT00679289|524193318|FG001|Overall Study|Adverse Event|0|||
145367183|NCT00679289|524193319|FG002|Overall Study|Adverse Event|3|||
145367184|NCT00679289|524193317|FG000|Overall Study|Physician Decision|1|||
145367185|NCT00679289|524193318|FG001|Overall Study|Physician Decision|0|||
145367186|NCT00679289|524193319|FG002|Overall Study|Physician Decision|1|||
145367187|NCT00552396|524193325|FG000|Overall Study|protocol withdrawal criteria|3|||
145367188|NCT00552396|524193326|FG001|Overall Study|protocol withdrawal criteria|3|||
145367189|NCT00552396|524193327|FG002|Overall Study|protocol withdrawal criteria|3|||
145367190|NCT00552396|524193328|FG003|Overall Study|protocol withdrawal criteria|6|||
145367191|NCT00552396|524193329|FG004|Overall Study|protocol withdrawal criteria|3|||
145367192|NCT00552396|524193330|FG005|Overall Study|protocol withdrawal criteria|3|||
145367193|NCT00552396|524193331|FG006|Overall Study|protocol withdrawal criteria|9|||
145367194|NCT02553499|524193338|FG000|Overall Study|Adverse Event|0|||
145367195|NCT02553499|524193339|FG001|Overall Study|Adverse Event|0|||
145367196|NCT02553499|524193340|FG002|Overall Study|Adverse Event|0|||
145367197|NCT02553499|524193341|FG003|Overall Study|Adverse Event|0|||
145578415|NCT03328897|524973640|FG000|Follow-up Epoch|Lack of Efficacy|1|||
145623268|NCT03212365|525131657|FG001|Overall Study|Refused study medication|0|||
145623269|NCT03212365|525131656|FG000|Overall Study|Initiated heparin infusion on floor|1|||
145623270|NCT03212365|525131657|FG001|Overall Study|Initiated heparin infusion on floor|1|||
145623271|NCT03212365|525131656|FG000|Overall Study|Unexpected return to OR|1|||
145367198|NCT02553499|524193342|FG004|Overall Study|Adverse Event|0|||
145367199|NCT02553499|524193343|FG005|Overall Study|Adverse Event|0|||
145367200|NCT02553499|524193344|FG006|Overall Study|Adverse Event|1|||
145367201|NCT02553499|524193345|FG007|Overall Study|Adverse Event|1|||
145367202|NCT02553499|524193346|FG008|Overall Study|Adverse Event|0|||
145367203|NCT02553499|524193347|FG009|Overall Study|Adverse Event|0|||
145578416|NCT03328897|524973641|FG001|Follow-up Epoch|Lack of Efficacy|1|||
145578417|NCT03328897|524973642|FG002|Follow-up Epoch|Lack of Efficacy|1|||
145623272|NCT03212365|525131657|FG001|Overall Study|Unexpected return to OR|1|||
145422072|NCT03888482|524400241|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
145422073|NCT03888482|524400242|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
145422074|NCT03888482|524400241|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
145422075|NCT03888482|524400242|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
145422076|NCT01189227|524400243|FG000|Overall Study|Study terminated due to low accrual|6|||
145422077|NCT01189227|524400244|FG001|Overall Study|Study terminated due to low accrual|3|||
145422078|NCT00563316|524400245|FG000|Overall Study|Adverse Event|2|||
145422079|NCT00563316|524400245|FG000|Overall Study|Physician Decision|1|||
145422080|NCT00563316|524400245|FG000|Overall Study|Lost to Follow-up|2|||
145422081|NCT00563316|524400245|FG000|Overall Study|Death|1|||
145422082|NCT00563316|524400245|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
145422083|NCT00563316|524400245|FG000|Overall Study|Other|1|||
145422084|NCT00425854|524400247|FG000|Overall Study|Progressive Disease|19|||
145422085|NCT00425854|524400248|FG001|Overall Study|Progressive Disease|12|||
145422086|NCT00425854|524400247|FG000|Overall Study|Dose reduction toxicity AE|8|||
145422087|NCT00425854|524400248|FG001|Overall Study|Dose reduction toxicity AE|7|||
145422088|NCT00425854|524400247|FG000|Overall Study|Other Adverse Event|2|||
145422089|NCT00425854|524400248|FG001|Overall Study|Other Adverse Event|2|||
145422090|NCT01630811|524400254|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
145422091|NCT01630811|524400255|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145422092|NCT04818086|524400258|FG000|Overall Study|Physician Decision|1|||
145422093|NCT04818086|524400259|FG001|Overall Study|Physician Decision|0|||
145422094|NCT04818086|524400258|FG000|Overall Study|Withdrawal by Subject|0|||
145422095|NCT04818086|524400259|FG001|Overall Study|Withdrawal by Subject|1|||
145422096|NCT00954538|524400275|FG000|Part III|Withdrawal by Subject|0|||
145422097|NCT00954538|524400276|FG001|Part III|Withdrawal by Subject|0|||
145422098|NCT00954538|524400277|FG002|Part III|Withdrawal by Subject|0|||
145422099|NCT00954538|524400278|FG003|Part III|Withdrawal by Subject|0|||
145422100|NCT00954538|524400279|FG004|Part III|Withdrawal by Subject|1|||
145422101|NCT00954538|524400280|FG005|Part III|Withdrawal by Subject|0|||
145422102|NCT01905683|524400281|FG000|Overall Study|Protocol Violation|1|||
145422103|NCT01905683|524400281|FG000|Overall Study|Re-injection criteria not met; others|13|||
145422104|NCT01905683|524400281|FG000|Overall Study|Physician Decision|1|||
145422105|NCT01905683|524400281|FG000|Overall Study|Lack of Efficacy|8|||
145422106|NCT01905683|524400281|FG000|Overall Study|Withdrawal by Subject|20|||
145422107|NCT01905683|524400281|FG000|Overall Study|Adverse Event|4|||
145422108|NCT01905683|524400281|FG000|Overall Study|Lost to Follow-up|4|||
145422109|NCT00537082|524400286|FG000|Overall Study|Adverse Event|6|||
145422110|NCT00537082|524400287|FG001|Overall Study|Adverse Event|6|||
145422111|NCT00537082|524400288|FG002|Overall Study|Adverse Event|3|||
145422112|NCT00537082|524400286|FG000|Overall Study|Protocol Violation|0|||
145422113|NCT00537082|524400287|FG001|Overall Study|Protocol Violation|2|||
145422114|NCT00537082|524400288|FG002|Overall Study|Protocol Violation|1|||
145422115|NCT00537082|524400286|FG000|Overall Study|Lack of Efficacy|0|||
145422116|NCT00537082|524400287|FG001|Overall Study|Lack of Efficacy|0|||
145422117|NCT00537082|524400288|FG002|Overall Study|Lack of Efficacy|2|||
145422118|NCT00537082|524400286|FG000|Overall Study|Withdrawal by Subject|0|||
145422119|NCT00537082|524400287|FG001|Overall Study|Withdrawal by Subject|1|||
145422120|NCT00537082|524400288|FG002|Overall Study|Withdrawal by Subject|0|||
145422121|NCT00537082|524400286|FG000|Overall Study|Discontinued before initiating treatment|3|||
145422122|NCT00537082|524400287|FG001|Overall Study|Discontinued before initiating treatment|0|||
145422123|NCT00537082|524400288|FG002|Overall Study|Discontinued before initiating treatment|0|||
145422124|NCT02568254|524400289|FG000|Period 2|Adverse Event|0|||
145422125|NCT02568254|524400290|FG001|Period 2|Adverse Event|0|||
145422126|NCT02568254|524400291|FG002|Period 2|Adverse Event|1|||
145422127|NCT02568254|524400292|FG003|Period 2|Adverse Event|0|||
145422128|NCT02568254|524400293|FG004|Period 2|Adverse Event|0|||
145422129|NCT02568254|524400294|FG005|Period 2|Adverse Event|0|||
145422130|NCT02568254|524400289|FG000|Period 3|Unstatisfactory Lens fitting|0|||
145422131|NCT02568254|524400290|FG001|Period 3|Unstatisfactory Lens fitting|0|||
145422132|NCT02568254|524400291|FG002|Period 3|Unstatisfactory Lens fitting|0|||
145422133|NCT02568254|524400292|FG003|Period 3|Unstatisfactory Lens fitting|0|||
145422134|NCT02568254|524400293|FG004|Period 3|Unstatisfactory Lens fitting|1|||
145422135|NCT02568254|524400294|FG005|Period 3|Unstatisfactory Lens fitting|0|||
145578418|NCT03328897|524973640|FG000|Follow-up Epoch|Lost to Follow-up|0|||
145422136|NCT03061214|524400299|FG000|Overall Study|Withdrawal by Subject|21|||
145422137|NCT03061214|524400300|FG001|Overall Study|Withdrawal by Subject|26|||
145422138|NCT03061214|524400301|FG002|Overall Study|Withdrawal by Subject|9|||
145422139|NCT03061214|524400299|FG000|Overall Study|Lost to Follow-up|3|||
145422140|NCT03061214|524400300|FG001|Overall Study|Lost to Follow-up|1|||
145422141|NCT03061214|524400301|FG002|Overall Study|Lost to Follow-up|1|||
145422142|NCT03061214|524400299|FG000|Overall Study|Death|1|||
145422143|NCT03061214|524400300|FG001|Overall Study|Death|1|||
145422144|NCT03061214|524400301|FG002|Overall Study|Death|0|||
145422145|NCT05058456|524401984|FG000|Overall Study|Death|1|||
145422146|NCT05058456|524401984|FG000|Overall Study|End of Study data not yet due for release|34|||
145422147|NCT01832038|524401985|FG000|Overall Study|Death|5|||
145422148|NCT01832038|524401985|FG000|Overall Study|Adverse Event|50|||
145367204|NCT02553499|524193348|FG010|Overall Study|Adverse Event|0|||
145367205|NCT02553499|524193349|FG011|Overall Study|Adverse Event|0|||
145367206|NCT02553499|524193350|FG012|Overall Study|Adverse Event|0|||
145367207|NCT02553499|524193351|FG013|Overall Study|Adverse Event|1|||
145367208|NCT02553499|524193338|FG000|Overall Study|Death|0|||
145367209|NCT02553499|524193339|FG001|Overall Study|Death|1|||
145367210|NCT02553499|524193340|FG002|Overall Study|Death|1|||
145367211|NCT02553499|524193341|FG003|Overall Study|Death|0|||
145367212|NCT02553499|524193342|FG004|Overall Study|Death|1|||
145367213|NCT02553499|524193343|FG005|Overall Study|Death|2|||
145367214|NCT02553499|524193344|FG006|Overall Study|Death|0|||
145367215|NCT02553499|524193345|FG007|Overall Study|Death|0|||
145367216|NCT02553499|524193346|FG008|Overall Study|Death|0|||
145367217|NCT02553499|524193347|FG009|Overall Study|Death|0|||
145367218|NCT02553499|524193348|FG010|Overall Study|Death|1|||
145367219|NCT02553499|524193349|FG011|Overall Study|Death|0|||
145367220|NCT02553499|524193350|FG012|Overall Study|Death|0|||
145367221|NCT02553499|524193351|FG013|Overall Study|Death|0|||
145367222|NCT02553499|524193338|FG000|Overall Study|Lost to Follow-up|0|||
145367223|NCT02553499|524193339|FG001|Overall Study|Lost to Follow-up|0|||
145367224|NCT02553499|524193340|FG002|Overall Study|Lost to Follow-up|0|||
145367225|NCT02553499|524193341|FG003|Overall Study|Lost to Follow-up|0|||
145367226|NCT02553499|524193342|FG004|Overall Study|Lost to Follow-up|0|||
145367227|NCT02553499|524193343|FG005|Overall Study|Lost to Follow-up|0|||
145367228|NCT02553499|524193344|FG006|Overall Study|Lost to Follow-up|1|||
145367229|NCT02553499|524193345|FG007|Overall Study|Lost to Follow-up|0|||
145367230|NCT02553499|524193346|FG008|Overall Study|Lost to Follow-up|0|||
145367231|NCT02553499|524193347|FG009|Overall Study|Lost to Follow-up|0|||
145367232|NCT02553499|524193348|FG010|Overall Study|Lost to Follow-up|0|||
145367233|NCT02553499|524193349|FG011|Overall Study|Lost to Follow-up|0|||
145367234|NCT02553499|524193350|FG012|Overall Study|Lost to Follow-up|0|||
145367235|NCT02553499|524193351|FG013|Overall Study|Lost to Follow-up|0|||
145367236|NCT02553499|524193338|FG000|Overall Study|Physician Decision|0|||
145367237|NCT02553499|524193339|FG001|Overall Study|Physician Decision|1|||
145367238|NCT02553499|524193340|FG002|Overall Study|Physician Decision|1|||
145367239|NCT02553499|524193341|FG003|Overall Study|Physician Decision|0|||
145367240|NCT02553499|524193342|FG004|Overall Study|Physician Decision|1|||
145367241|NCT02553499|524193343|FG005|Overall Study|Physician Decision|0|||
145367242|NCT02553499|524193344|FG006|Overall Study|Physician Decision|0|||
145367243|NCT02553499|524193345|FG007|Overall Study|Physician Decision|1|||
145367244|NCT02553499|524193346|FG008|Overall Study|Physician Decision|1|||
145367245|NCT02553499|524193347|FG009|Overall Study|Physician Decision|2|||
145367246|NCT02553499|524193348|FG010|Overall Study|Physician Decision|1|||
145367247|NCT02553499|524193349|FG011|Overall Study|Physician Decision|3|||
145367248|NCT02553499|524193350|FG012|Overall Study|Physician Decision|1|||
145367249|NCT02553499|524193351|FG013|Overall Study|Physician Decision|0|||
145367250|NCT02553499|524193338|FG000|Overall Study|Progressive Disease|0|||
145367251|NCT02553499|524193339|FG001|Overall Study|Progressive Disease|0|||
145367252|NCT02553499|524193340|FG002|Overall Study|Progressive Disease|0|||
145367253|NCT02553499|524193341|FG003|Overall Study|Progressive Disease|2|||
145367254|NCT02553499|524193342|FG004|Overall Study|Progressive Disease|1|||
145367255|NCT02553499|524193343|FG005|Overall Study|Progressive Disease|1|||
145367256|NCT02553499|524193344|FG006|Overall Study|Progressive Disease|1|||
145367257|NCT02553499|524193345|FG007|Overall Study|Progressive Disease|0|||
145367258|NCT02553499|524193346|FG008|Overall Study|Progressive Disease|0|||
145367259|NCT02553499|524193347|FG009|Overall Study|Progressive Disease|1|||
145367260|NCT02553499|524193348|FG010|Overall Study|Progressive Disease|0|||
145367261|NCT02553499|524193349|FG011|Overall Study|Progressive Disease|0|||
145367262|NCT02553499|524193350|FG012|Overall Study|Progressive Disease|2|||
145367263|NCT02553499|524193351|FG013|Overall Study|Progressive Disease|1|||
145367264|NCT02553499|524193338|FG000|Overall Study|Study Terminated by Sponsor|0|||
145367265|NCT02553499|524193339|FG001|Overall Study|Study Terminated by Sponsor|0|||
145367266|NCT02553499|524193340|FG002|Overall Study|Study Terminated by Sponsor|0|||
145367267|NCT02553499|524193341|FG003|Overall Study|Study Terminated by Sponsor|0|||
145367268|NCT02553499|524193342|FG004|Overall Study|Study Terminated by Sponsor|0|||
145367269|NCT02553499|524193343|FG005|Overall Study|Study Terminated by Sponsor|0|||
145367270|NCT02553499|524193344|FG006|Overall Study|Study Terminated by Sponsor|0|||
145367271|NCT02553499|524193345|FG007|Overall Study|Study Terminated by Sponsor|0|||
145367272|NCT02553499|524193346|FG008|Overall Study|Study Terminated by Sponsor|1|||
145367273|NCT02553499|524193347|FG009|Overall Study|Study Terminated by Sponsor|0|||
145367274|NCT02553499|524193348|FG010|Overall Study|Study Terminated by Sponsor|0|||
145367275|NCT02553499|524193349|FG011|Overall Study|Study Terminated by Sponsor|0|||
145367276|NCT02553499|524193350|FG012|Overall Study|Study Terminated by Sponsor|0|||
145367277|NCT02553499|524193351|FG013|Overall Study|Study Terminated by Sponsor|0|||
145367278|NCT02553499|524193338|FG000|Overall Study|Withdrawal by Subject|2|||
145367279|NCT02553499|524193339|FG001|Overall Study|Withdrawal by Subject|0|||
145367280|NCT02553499|524193340|FG002|Overall Study|Withdrawal by Subject|0|||
145367281|NCT02553499|524193341|FG003|Overall Study|Withdrawal by Subject|0|||
145367282|NCT02553499|524193342|FG004|Overall Study|Withdrawal by Subject|0|||
145367283|NCT02553499|524193343|FG005|Overall Study|Withdrawal by Subject|0|||
145367284|NCT02553499|524193344|FG006|Overall Study|Withdrawal by Subject|0|||
145367285|NCT02553499|524193345|FG007|Overall Study|Withdrawal by Subject|1|||
145367286|NCT02553499|524193346|FG008|Overall Study|Withdrawal by Subject|1|||
145367287|NCT02553499|524193347|FG009|Overall Study|Withdrawal by Subject|0|||
145367288|NCT02553499|524193348|FG010|Overall Study|Withdrawal by Subject|1|||
145367289|NCT02553499|524193349|FG011|Overall Study|Withdrawal by Subject|0|||
145367290|NCT02553499|524193350|FG012|Overall Study|Withdrawal by Subject|0|||
145367291|NCT02553499|524193351|FG013|Overall Study|Withdrawal by Subject|0|||
145367292|NCT01582178|524193352|FG000|Overall Study|Physician Decision|6|||
145367293|NCT01582178|524193353|FG001|Overall Study|Physician Decision|5|||
145367294|NCT01726270|524193354|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
145367295|NCT01726270|524193354|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
145367296|NCT01726270|524193354|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
145367297|NCT01726270|524193354|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
145367298|NCT01726270|524193354|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
145367299|NCT01726270|524193354|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
145367300|NCT00582608|524193356|FG000|Overall Study|Not Treated|7|||
145367301|NCT00582608|524193356|FG000|Overall Study|Patient Ineligible|1|||
145367302|NCT00582608|524193356|FG000|Overall Study|Lack of accrual|4|||
145367303|NCT03478644|524193360|FG000|Phase 2|Withdrawal by Subject|2|||
145367304|NCT03478644|524193361|FG001|Phase 2|Withdrawal by Subject|1|||
145367305|NCT03478644|524193360|FG000|Phase 2|Lost to Follow-up|1|||
145367306|NCT03478644|524193361|FG001|Phase 2|Lost to Follow-up|0|||
145367307|NCT04152837|524193364|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
145367308|NCT04152837|524193364|FG000|Maintenance Period|Adverse Event|1|||
145367309|NCT04152837|524193364|FG000|Maintenance Period|Withdrawal by Subject|1|||
145367310|NCT04152837|524193364|FG000|Maintenance Period|Sponsor Termination of Study|2|||
145367311|NCT00586820|524193365|FG000|Overall Study|Unsuccessful PCI|1|||
145367312|NCT00586820|524193366|FG001|Overall Study|Unsuccessful PCI|0|||
145367313|NCT04463251|524193369|FG000|Overall Study|Death|1|||
145367314|NCT04463251|524193370|FG001|Overall Study|Death|0|||
145367315|NCT04463251|524193371|FG002|Overall Study|Death|1|||
145367316|NCT04463251|524193369|FG000|Overall Study|Adverse Event|0|||
145367317|NCT04463251|524193370|FG001|Overall Study|Adverse Event|1|||
145367318|NCT04463251|524193371|FG002|Overall Study|Adverse Event|0|||
145367319|NCT04463251|524193369|FG000|Overall Study|Lost to Follow-up|0|||
145367320|NCT04463251|524193370|FG001|Overall Study|Lost to Follow-up|1|||
145367321|NCT04463251|524193371|FG002|Overall Study|Lost to Follow-up|0|||
145367322|NCT04463251|524193369|FG000|Overall Study|Withdrawal by Subject|0|||
145367323|NCT04463251|524193370|FG001|Overall Study|Withdrawal by Subject|2|||
145367324|NCT04463251|524193371|FG002|Overall Study|Withdrawal by Subject|2|||
145367325|NCT00101166|524193372|FG000|Overall Study|progressive disease|10|||
145367326|NCT00686829|524193375|FG000|Overall Study|Adverse Event|5|||
145367327|NCT00686829|524193375|FG000|Overall Study|Lack of Efficacy|6|||
145367328|NCT00686829|524193375|FG000|Overall Study|Lost to Follow-up|4|||
145367329|NCT00686829|524193375|FG000|Overall Study|Withdrawal by Subject|14|||
145367330|NCT00686829|524193375|FG000|Overall Study|Protocol Violation|3|||
145367331|NCT00686829|524193375|FG000|Overall Study|Sponsor discontinued VCV|47|||
145367332|NCT01827267|524193376|FG000|Overall Study|Did not receive study drug|1|||
145367333|NCT01827267|524193377|FG001|Overall Study|Did not receive study drug|1|||
145367334|NCT01827267|524193376|FG000|Overall Study|Physician Decision|1|||
145367335|NCT01827267|524193377|FG001|Overall Study|Physician Decision|0|||
145367336|NCT01827267|524193376|FG000|Overall Study|Disease Progression|1|||
145367337|NCT01827267|524193377|FG001|Overall Study|Disease Progression|1|||
145367338|NCT01827267|524193376|FG000|Overall Study|Sponsor Discontinued Study|2|||
145367339|NCT01827267|524193377|FG001|Overall Study|Sponsor Discontinued Study|8|||
145367340|NCT01827267|524193376|FG000|Overall Study|Still on study|0|||
145367341|NCT01827267|524193377|FG001|Overall Study|Still on study|2|||
145367342|NCT01732640|524193378|FG000|Overall Study|Adverse Event|0|||
145367343|NCT01732640|524193379|FG001|Overall Study|Adverse Event|1|||
145367344|NCT01732640|524193378|FG000|Overall Study|Death|0|||
145367345|NCT01732640|524193379|FG001|Overall Study|Death|1|||
145367346|NCT03070002|524193382|FG000|Follow up for 2 Years|Death|1|||
145367347|NCT00712543|524193385|FG000|Day 8-14|Lost to Follow-up|0|||
145367348|NCT00712543|524193386|FG001|Day 8-14|Lost to Follow-up|2|||
145422149|NCT01832038|524401985|FG000|Overall Study|Lack of Efficacy|81|||
145367349|NCT04520997|524193398|FG000|Overall Study|Lost to Follow-up|1|||
145367350|NCT04520997|524193399|FG001|Overall Study|Lost to Follow-up|1|||
145367351|NCT04520997|524193398|FG000|Overall Study|Withdrawal by Subject|1|||
145367352|NCT04520997|524193399|FG001|Overall Study|Withdrawal by Subject|0|||
145367353|NCT04520997|524193398|FG000|Overall Study|Not Treated|0|||
145367354|NCT04520997|524193399|FG001|Overall Study|Not Treated|1|||
145367355|NCT03689374|524193400|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
145367356|NCT03689374|524193401|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
145367357|NCT03689374|524193402|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
145367358|NCT03689374|524193400|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
145367359|NCT03689374|524193401|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
145367360|NCT03689374|524193402|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
145367361|NCT03689374|524193400|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
145367362|NCT03689374|524193401|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
145367363|NCT03689374|524193402|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
145367364|NCT03689374|524193400|FG000|Treatment Period (Week 0 to 52)|Death|0|||
145367365|NCT03689374|524193401|FG001|Treatment Period (Week 0 to 52)|Death|11|||
145367366|NCT03689374|524193402|FG002|Treatment Period (Week 0 to 52)|Death|1|||
145367367|NCT05367973|524193403|FG000|Overall Study|Adverse Event|0|||
145367368|NCT05367973|524193404|FG001|Overall Study|Adverse Event|2|||
145367369|NCT00972816|524194877|FG000|Overall Study|Adverse Event|0|||
145367370|NCT00972816|524194878|FG001|Overall Study|Adverse Event|0|||
145367371|NCT00972816|524194879|FG002|Overall Study|Adverse Event|1|||
145367372|NCT00972816|524194880|FG003|Overall Study|Adverse Event|0|||
145367373|NCT00972816|524194881|FG004|Overall Study|Adverse Event|0|||
145367374|NCT00972816|524194882|FG005|Overall Study|Adverse Event|0|||
145367375|NCT00972816|524194883|FG006|Overall Study|Adverse Event|0|||
145367376|NCT00972816|524194884|FG007|Overall Study|Adverse Event|0|||
145367377|NCT00972816|524194877|FG000|Overall Study|Withdrawal by Subject|4|||
145367378|NCT00972816|524194878|FG001|Overall Study|Withdrawal by Subject|2|||
145367379|NCT00972816|524194879|FG002|Overall Study|Withdrawal by Subject|1|||
145367380|NCT00972816|524194880|FG003|Overall Study|Withdrawal by Subject|3|||
145367381|NCT00972816|524194881|FG004|Overall Study|Withdrawal by Subject|0|||
145367382|NCT00972816|524194882|FG005|Overall Study|Withdrawal by Subject|1|||
145367383|NCT00972816|524194883|FG006|Overall Study|Withdrawal by Subject|1|||
145367384|NCT00972816|524194884|FG007|Overall Study|Withdrawal by Subject|2|||
145367385|NCT00972816|524194877|FG000|Overall Study|Lost to Follow-up|11|||
145367386|NCT00972816|524194878|FG001|Overall Study|Lost to Follow-up|9|||
145367387|NCT00972816|524194879|FG002|Overall Study|Lost to Follow-up|7|||
145367388|NCT00972816|524194880|FG003|Overall Study|Lost to Follow-up|5|||
145367389|NCT00972816|524194881|FG004|Overall Study|Lost to Follow-up|11|||
145367390|NCT00972816|524194882|FG005|Overall Study|Lost to Follow-up|10|||
145367391|NCT00972816|524194883|FG006|Overall Study|Lost to Follow-up|7|||
145367392|NCT00972816|524194884|FG007|Overall Study|Lost to Follow-up|7|||
145367393|NCT00972816|524194877|FG000|Overall Study|Inappropriate enrolment|0|||
145367394|NCT00972816|524194878|FG001|Overall Study|Inappropriate enrolment|0|||
145367395|NCT00972816|524194879|FG002|Overall Study|Inappropriate enrolment|0|||
145367396|NCT00972816|524194880|FG003|Overall Study|Inappropriate enrolment|0|||
145367397|NCT00972816|524194881|FG004|Overall Study|Inappropriate enrolment|0|||
145367398|NCT00972816|524194882|FG005|Overall Study|Inappropriate enrolment|0|||
145367399|NCT00972816|524194883|FG006|Overall Study|Inappropriate enrolment|2|||
145367400|NCT00972816|524194884|FG007|Overall Study|Inappropriate enrolment|0|||
145367401|NCT00972816|524194877|FG000|Overall Study|Unable to classify|2|||
145367402|NCT00972816|524194878|FG001|Overall Study|Unable to classify|0|||
145367403|NCT00972816|524194879|FG002|Overall Study|Unable to classify|0|||
145367404|NCT00972816|524194880|FG003|Overall Study|Unable to classify|0|||
145367405|NCT00972816|524194881|FG004|Overall Study|Unable to classify|1|||
145367406|NCT00972816|524194882|FG005|Overall Study|Unable to classify|0|||
145367407|NCT00972816|524194883|FG006|Overall Study|Unable to classify|0|||
145367408|NCT00972816|524194884|FG007|Overall Study|Unable to classify|0|||
145367409|NCT00593684|524194887|FG000|Overall Study|Death|2|||
145367410|NCT00593684|524194888|FG001|Overall Study|Death|1|||
145367411|NCT03625466|524194889|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
145367412|NCT03625466|524194890|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
145367413|NCT03625466|524194891|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
145367414|NCT03625466|524194889|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145367415|NCT03625466|524194890|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
145367416|NCT03625466|524194891|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145367417|NCT03625466|524194889|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145377845|NCT03191864|524233638|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145377846|NCT03191864|524233639|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
145377847|NCT03191864|524233640|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
145377848|NCT03191864|524233635|FG000|Baseline Symptom Assessment|Adverse Event|0|||
145377849|NCT03191864|524233636|FG001|Baseline Symptom Assessment|Adverse Event|0|||
145377850|NCT03191864|524233637|FG002|Baseline Symptom Assessment|Adverse Event|0|||
145377851|NCT03191864|524233638|FG003|Baseline Symptom Assessment|Adverse Event|0|||
145377852|NCT03191864|524233639|FG004|Baseline Symptom Assessment|Adverse Event|0|||
145377853|NCT03191864|524233640|FG005|Baseline Symptom Assessment|Adverse Event|2|||
145377854|NCT03191864|524233635|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145377855|NCT03191864|524233636|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145377856|NCT03191864|524233637|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145377857|NCT03191864|524233638|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145377858|NCT03191864|524233639|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
145377859|NCT03191864|524233640|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
145377860|NCT03191864|524233635|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145377861|NCT03191864|524233636|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145422150|NCT01832038|524401985|FG000|Overall Study|Protocol Violation|7|||
145422151|NCT01832038|524401985|FG000|Overall Study|Lost to Follow-up|10|||
145422152|NCT01832038|524401985|FG000|Overall Study|Withdrawal by Subject|49|||
145422153|NCT01832038|524401985|FG000|Overall Study|Visit non-compliance|2|||
145422154|NCT01832038|524401985|FG000|Overall Study|Subject refused to return visit|2|||
145422155|NCT01832038|524401985|FG000|Overall Study|Not convenient to come back to site|2|||
145422156|NCT01832038|524401985|FG000|Overall Study|Participant was asked to quit|5|||
145422157|NCT01832038|524401985|FG000|Overall Study|Back home|1|||
145422158|NCT01832038|524401985|FG000|Overall Study|Pregnancy|1|||
145422159|NCT01832038|524401985|FG000|Overall Study|Low compliance|3|||
145422160|NCT01832038|524401985|FG000|Overall Study|Prohibit procedure|2|||
145422161|NCT01832038|524401985|FG000|Overall Study|Not possible to visit the hospital|1|||
145422162|NCT01832038|524401985|FG000|Overall Study|Changes of implementation system|3|||
145422163|NCT01832038|524401985|FG000|Overall Study|Plan to pregnancy|7|||
145422164|NCT01832038|524401985|FG000|Overall Study|Bad mood and has suicidal thought|1|||
145422165|NCT01832038|524401985|FG000|Overall Study|Prohibited concomitant medication|1|||
145422166|NCT01832038|524401985|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
145422167|NCT01832038|524401985|FG000|Overall Study|Subject considered the efficacy was poor|1|||
145422168|NCT02457546|524401997|FG000|Overall Study|Other reasons|4|||
145422169|NCT02457546|524401998|FG001|Overall Study|Other reasons|1|||
145422170|NCT02457546|524401997|FG000|Overall Study|Refused to complete study/procedures|1|||
145422171|NCT02457546|524401998|FG001|Overall Study|Refused to complete study/procedures|1|||
145422172|NCT02457546|524401997|FG000|Overall Study|Lost to Follow-up|4|||
145422173|NCT02457546|524401998|FG001|Overall Study|Lost to Follow-up|1|||
145422174|NCT02457546|524401997|FG000|Overall Study|Adverse Event|0|||
145422175|NCT02457546|524401998|FG001|Overall Study|Adverse Event|1|||
145422176|NCT01897896|524401999|FG000|Overall Study|Death|1|||
145422177|NCT01897896|524402000|FG001|Overall Study|Death|0|||
145422178|NCT01897896|524401999|FG000|Overall Study|Adverse Event|11|||
145422179|NCT01897896|524402000|FG001|Overall Study|Adverse Event|1|||
145422180|NCT01897896|524401999|FG000|Overall Study|Lost to Follow-up|1|||
145623273|NCT03212365|525131656|FG000|Overall Study|Medication distribution error|1|||
145623274|NCT03212365|525131657|FG001|Overall Study|Medication distribution error|0|||
145623275|NCT03212365|525131656|FG000|Overall Study|Required epidural placement|1|||
145367418|NCT03625466|524194890|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
145367419|NCT03625466|524194891|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
145367420|NCT00546117|524194893|FG000|Overall Study|Withdrawal by Subject|3|||
145367421|NCT00546117|524194894|FG001|Overall Study|Withdrawal by Subject|0|||
145367422|NCT00546117|524194893|FG000|Overall Study|Inability to schedule follow-up visit|1|||
145367423|NCT00546117|524194894|FG001|Overall Study|Inability to schedule follow-up visit|0|||
145367424|NCT01560234|524194897|FG000|Overall Study|Lost to Follow-up|3|||
145367425|NCT01560234|524194898|FG001|Overall Study|Lost to Follow-up|0|||
145367426|NCT01560234|524194899|FG002|Overall Study|Lost to Follow-up|1|||
145367427|NCT01560234|524194900|FG003|Overall Study|Lost to Follow-up|0|||
145367428|NCT01560234|524194901|FG004|Overall Study|Lost to Follow-up|0|||
145367429|NCT01560234|524194902|FG005|Overall Study|Lost to Follow-up|2|||
145367430|NCT01560234|524194903|FG006|Overall Study|Lost to Follow-up|0|||
145367431|NCT01560234|524194904|FG007|Overall Study|Lost to Follow-up|2|||
145367432|NCT01289639|524194905|FG000|Overall Study|Lost to Follow-up|1|||
145367433|NCT01289639|524194906|FG001|Overall Study|Lost to Follow-up|0|||
145367434|NCT01289639|524194907|FG002|Overall Study|Lost to Follow-up|0|||
145367435|NCT02780713|524194908|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145367436|NCT02780713|524194909|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145367437|NCT02780713|524194910|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
145623276|NCT03212365|525131657|FG001|Overall Study|Required epidural placement|0|||
145367438|NCT02780713|524194911|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145367439|NCT02780713|524194912|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
145367440|NCT01931475|524194913|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
145367441|NCT01931475|524194914|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
145367442|NCT01931475|524194913|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
145367443|NCT01931475|524194914|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
145367444|NCT01931475|524194913|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
145367445|NCT01931475|524194914|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
145367446|NCT01931475|524194913|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
145367447|NCT01931475|524194914|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
145367448|NCT01931475|524194913|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
145367449|NCT01931475|524194914|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
145367450|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
145367451|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
145367452|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
145367453|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
145422181|NCT01897896|524402000|FG001|Overall Study|Lost to Follow-up|0|||
145422182|NCT01897896|524401999|FG000|Overall Study|Non-compliance with study drug dosing|1|||
145367454|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
145367455|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
145367456|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
145367457|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
145367458|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
145367459|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
145367460|NCT01931475|524194913|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
145367461|NCT01931475|524194914|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
145367462|NCT00425061|524194918|FG000|Overall Study|Adverse Event|1|||
145367463|NCT00425061|524194919|FG001|Overall Study|Adverse Event|0|||
145367464|NCT00425061|524194920|FG002|Overall Study|Adverse Event|0|||
145367465|NCT00425061|524194921|FG003|Overall Study|Adverse Event|2|||
145367466|NCT00425061|524194922|FG004|Overall Study|Adverse Event|2|||
145367467|NCT00425061|524194923|FG005|Overall Study|Adverse Event|0|||
145367468|NCT00425061|524194924|FG006|Overall Study|Adverse Event|0|||
145367469|NCT00425061|524194918|FG000|Overall Study|Lost to Follow-up|0|||
145367470|NCT00425061|524194919|FG001|Overall Study|Lost to Follow-up|1|||
145367471|NCT00425061|524194920|FG002|Overall Study|Lost to Follow-up|0|||
145367472|NCT00425061|524194921|FG003|Overall Study|Lost to Follow-up|0|||
145367473|NCT00425061|524194922|FG004|Overall Study|Lost to Follow-up|0|||
145367474|NCT00425061|524194923|FG005|Overall Study|Lost to Follow-up|0|||
145367475|NCT00425061|524194924|FG006|Overall Study|Lost to Follow-up|0|||
145367476|NCT00425061|524194918|FG000|Overall Study|Protocol Violation|1|||
145367477|NCT00425061|524194919|FG001|Overall Study|Protocol Violation|0|||
145367478|NCT00425061|524194920|FG002|Overall Study|Protocol Violation|0|||
145367479|NCT00425061|524194921|FG003|Overall Study|Protocol Violation|0|||
145367480|NCT00425061|524194922|FG004|Overall Study|Protocol Violation|0|||
145367481|NCT00425061|524194923|FG005|Overall Study|Protocol Violation|0|||
145367482|NCT00425061|524194924|FG006|Overall Study|Protocol Violation|0|||
145367483|NCT00425061|524194918|FG000|Overall Study|Withdrawal by Subject|0|||
145367484|NCT00425061|524194919|FG001|Overall Study|Withdrawal by Subject|1|||
145367485|NCT00425061|524194920|FG002|Overall Study|Withdrawal by Subject|0|||
145367486|NCT00425061|524194921|FG003|Overall Study|Withdrawal by Subject|0|||
145367487|NCT00425061|524194922|FG004|Overall Study|Withdrawal by Subject|1|||
145367488|NCT00425061|524194923|FG005|Overall Study|Withdrawal by Subject|0|||
145367489|NCT00425061|524194924|FG006|Overall Study|Withdrawal by Subject|3|||
145367490|NCT00425061|524194918|FG000|Overall Study|Sponsor's request|0|||
145367491|NCT00425061|524194919|FG001|Overall Study|Sponsor's request|0|||
145367492|NCT00425061|524194920|FG002|Overall Study|Sponsor's request|0|||
145367493|NCT00425061|524194921|FG003|Overall Study|Sponsor's request|0|||
145367494|NCT00425061|524194922|FG004|Overall Study|Sponsor's request|19|||
145367495|NCT00425061|524194923|FG005|Overall Study|Sponsor's request|4|||
145367496|NCT00425061|524194924|FG006|Overall Study|Sponsor's request|15|||
145367497|NCT00425061|524194918|FG000|Overall Study|Physician Decision|0|||
145367498|NCT00425061|524194919|FG001|Overall Study|Physician Decision|0|||
145367499|NCT00425061|524194920|FG002|Overall Study|Physician Decision|0|||
145367500|NCT00425061|524194921|FG003|Overall Study|Physician Decision|0|||
145367501|NCT00425061|524194922|FG004|Overall Study|Physician Decision|1|||
145367502|NCT00425061|524194923|FG005|Overall Study|Physician Decision|0|||
145367503|NCT00425061|524194924|FG006|Overall Study|Physician Decision|0|||
145367504|NCT00425061|524194918|FG000|Overall Study|Other|0|||
145367505|NCT00425061|524194919|FG001|Overall Study|Other|0|||
145367506|NCT00425061|524194920|FG002|Overall Study|Other|0|||
145367507|NCT00425061|524194921|FG003|Overall Study|Other|0|||
145367508|NCT00425061|524194922|FG004|Overall Study|Other|3|||
145367509|NCT00425061|524194923|FG005|Overall Study|Other|0|||
145367510|NCT00425061|524194924|FG006|Overall Study|Other|1|||
145367511|NCT03436693|524194925|FG000|Overall Study|Adverse Event|22|||
145367512|NCT03436693|524194926|FG001|Overall Study|Adverse Event|10|||
145367513|NCT03436693|524194925|FG000|Overall Study|Physician Decision|3|||
145367514|NCT03436693|524194926|FG001|Overall Study|Physician Decision|3|||
145367515|NCT03436693|524194925|FG000|Overall Study|Withdrawal by Subject|4|||
145367516|NCT03436693|524194926|FG001|Overall Study|Withdrawal by Subject|13|||
145367517|NCT03436693|524194925|FG000|Overall Study|Progressive Disease|1|||
145367518|NCT03436693|524194926|FG001|Overall Study|Progressive Disease|1|||
145367519|NCT01680861|524194927|FG000|Early Post-transplant Period|Protocol Violation|1|||
145367520|NCT01680861|524194928|FG001|Early Post-transplant Period|Protocol Violation|1|||
145367521|NCT04967885|524194931|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
145367522|NCT04967885|524194932|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
145367523|NCT04967885|524194931|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
145367524|NCT04967885|524194932|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
145367525|NCT04967885|524194931|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
145367526|NCT04967885|524194932|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
145367527|NCT04967885|524194931|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
145367528|NCT04967885|524194932|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
145367529|NCT04967885|524194931|FG000|EMI-II Intervention|Lost to Follow-up|14|||
145367530|NCT04967885|524194932|FG001|EMI-II Intervention|Lost to Follow-up|10|||
145367531|NCT01011465|524194933|FG000|Overall Study|Withdrawal by Subject|2|||
145367532|NCT01011465|524194934|FG001|Overall Study|Withdrawal by Subject|1|||
145367533|NCT01011465|524194935|FG002|Overall Study|Withdrawal by Subject|0|||
145367534|NCT01011465|524194936|FG003|Overall Study|Withdrawal by Subject|0|||
145367535|NCT01011465|524194937|FG004|Overall Study|Withdrawal by Subject|1|||
145367536|NCT01011465|524194938|FG005|Overall Study|Withdrawal by Subject|0|||
145367537|NCT01011465|524194939|FG006|Overall Study|Withdrawal by Subject|1|||
145367538|NCT01011465|524194940|FG007|Overall Study|Withdrawal by Subject|0|||
145367539|NCT00723008|524194941|FG000|Enrollment|Lost to Follow-up|1|||
145367540|NCT00723008|524194942|FG001|Enrollment|Lost to Follow-up|0|||
145367541|NCT00723008|524194941|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
145367542|NCT00723008|524194942|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
145367543|NCT00723008|524194941|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
145422183|NCT01897896|524402000|FG001|Overall Study|Non-compliance with study drug dosing|1|||
145422184|NCT01897896|524401999|FG000|Overall Study|Withdrawal by Subject|7|||
145422185|NCT01897896|524402000|FG001|Overall Study|Withdrawal by Subject|1|||
145422186|NCT01897896|524401999|FG000|Overall Study|Require drug that interfere with study|1|||
145422187|NCT01897896|524402000|FG001|Overall Study|Require drug that interfere with study|4|||
145422188|NCT01897896|524401999|FG000|Overall Study|Protocol Violation|1|||
145422189|NCT01897896|524402000|FG001|Overall Study|Protocol Violation|1|||
145422190|NCT01897896|524401999|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
145422191|NCT01897896|524402000|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
145422192|NCT01897896|524401999|FG000|Overall Study|Caregiver can no longer participate|0|||
145422193|NCT01897896|524402000|FG001|Overall Study|Caregiver can no longer participate|2|||
145422194|NCT01897896|524401999|FG000|Overall Study|Other than specified|2|||
145422195|NCT01897896|524402000|FG001|Overall Study|Other than specified|1|||
145422196|NCT00363467|524402001|FG000|Overall Study|Physician Decision|1|||
145422197|NCT05069415|524402004|FG000|Overall Study|Withdrawal by Subject|2|||
145422198|NCT05069415|524402005|FG001|Overall Study|Withdrawal by Subject|0|||
145422199|NCT05069415|524402004|FG000|Overall Study|Adverse Event|2|||
145422200|NCT05069415|524402005|FG001|Overall Study|Adverse Event|0|||
145422201|NCT03160573|524402006|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
145422202|NCT03160573|524402007|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
145422203|NCT03160573|524402008|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
145422204|NCT03160573|524402009|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
145422205|NCT00101400|524402010|FG000|Survival Follow-Up|Alive|7|||
145422206|NCT00090402|524402014|FG000|Overall Study|Death|1|||
145422207|NCT00090402|524402015|FG001|Overall Study|Death|1|||
145422208|NCT00090402|524402016|FG002|Overall Study|Death|0|||
145422209|NCT00090402|524402014|FG000|Overall Study|subject moved|0|||
145422210|NCT00090402|524402015|FG001|Overall Study|subject moved|1|||
145422211|NCT00090402|524402016|FG002|Overall Study|subject moved|0|||
145422212|NCT00090402|524402014|FG000|Overall Study|stopped taking study medication|1|||
145422213|NCT00090402|524402015|FG001|Overall Study|stopped taking study medication|0|||
145422214|NCT00090402|524402016|FG002|Overall Study|stopped taking study medication|1|||
145422215|NCT01730729|524402019|FG000|Overall Study|Adverse Event|1|||
145422216|NCT01730729|524402019|FG000|Overall Study|Death|1|||
145422217|NCT01730729|524402019|FG000|Overall Study|Progressive Disease|12|||
145422218|NCT02462057|524402022|FG000|Overall Study|Left Vitality|32|||
145422219|NCT02462057|524402023|FG001|Overall Study|Left Vitality|27|||
145422220|NCT02462057|524402024|FG002|Overall Study|Left Vitality|23|||
145422221|NCT02462057|524402025|FG003|Overall Study|Left Vitality|35|||
145422222|NCT02462057|524402026|FG004|Overall Study|Left Vitality|33|||
145422223|NCT02462057|524402022|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
145422224|NCT02462057|524402023|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
145422225|NCT02462057|524402024|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
145422226|NCT02462057|524402025|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
145422227|NCT02462057|524402026|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
145422228|NCT01791205|524402028|FG000|Phase II|Lack of Efficacy|6|||
145422229|NCT01791205|524402029|FG001|Phase II|Lack of Efficacy|0|||
145422230|NCT01791205|524402028|FG000|Phase II|Adverse Event|2|||
145422231|NCT01791205|524402029|FG001|Phase II|Adverse Event|0|||
145422232|NCT01791205|524402028|FG000|Phase II|Safety|1|||
145422233|NCT01791205|524402029|FG001|Phase II|Safety|0|||
145422234|NCT01791205|524402028|FG000|Phase II|Lost to Follow-up|1|||
145422235|NCT01791205|524402029|FG001|Phase II|Lost to Follow-up|0|||
145422236|NCT01791205|524402028|FG000|Phase II|Remission of disease|1|||
145422237|NCT01791205|524402029|FG001|Phase II|Remission of disease|0|||
145422238|NCT01791205|524402028|FG000|Phase II|Physician's decision|1|||
145422239|NCT01791205|524402029|FG001|Phase II|Physician's decision|0|||
145367544|NCT00723008|524194942|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
145367545|NCT00723008|524194941|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
145422240|NCT01697501|524402030|FG000|Overall Study|Protocol Violation|2|||
145422241|NCT03436420|524402031|FG000|Overall Study|Lack of Efficacy|3|||
145422242|NCT01061710|524402032|FG000|Overall Study|Protocol Violation|14|||
145422243|NCT03473301|524402035|FG000|Overall Study|Protocol Violation|4|||
145422244|NCT03473301|524402036|FG001|Overall Study|Protocol Violation|0|||
145422245|NCT03473301|524402037|FG002|Overall Study|Protocol Violation|0|||
145367546|NCT00723008|524194942|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
145367547|NCT00723008|524194941|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
145367548|NCT00723008|524194942|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
145367549|NCT00723008|524194941|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
145367550|NCT00723008|524194942|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
145367551|NCT05835011|524194943|FG000|Overall Study|Study Terminated by the Sponsor|1|||
145367552|NCT05835011|524194943|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
145367553|NCT00526669|524194946|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
145367554|NCT00526669|524194947|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
145367555|NCT00526669|524194946|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
145367556|NCT00526669|524194947|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
145367557|NCT00526669|524194946|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
145367558|NCT00526669|524194947|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
145367559|NCT00526669|524194946|FG000|Combined Treatment Phase|Death|0|||
145367560|NCT00526669|524194947|FG001|Combined Treatment Phase|Death|2|||
145367561|NCT01981954|524194948|FG000|Titration Period|Protocol Deviation|1|||
145367562|NCT01981954|524194948|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
145367563|NCT01137110|524194957|FG000|Overall Study|Protocol Violation|1|||
145367564|NCT01137110|524194958|FG001|Overall Study|Protocol Violation|0|||
145367565|NCT00355147|524194963|FG000|Overall Study|Lost to Follow-up|10|||
145367566|NCT00355147|524194964|FG001|Overall Study|Lost to Follow-up|8|||
145367567|NCT00355147|524194963|FG000|Overall Study|Withdrawal by Subject|8|||
145367568|NCT00355147|524194964|FG001|Overall Study|Withdrawal by Subject|12|||
145367569|NCT00638443|524194971|FG000|First Intervention|Adverse Event|2|||
145367570|NCT00638443|524194972|FG001|First Intervention|Adverse Event|1|||
145367571|NCT01355575|524194976|FG000|Overall Study|Withdrawal by Subject|2|||
145367572|NCT02438826|524194980|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
145367573|NCT02438826|524194981|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
145367574|NCT02438826|524194982|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145367575|NCT02438826|524194983|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145367576|NCT02438826|524194980|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
145367577|NCT02438826|524194981|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145367578|NCT02438826|524194982|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145367579|NCT02438826|524194983|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145367580|NCT02438826|524194980|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
145367581|NCT02438826|524194981|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
145367582|NCT02438826|524194982|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145367583|NCT02438826|524194983|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145367584|NCT02438826|524194980|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
145367585|NCT02438826|524194981|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
145367586|NCT02438826|524194982|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145367587|NCT02438826|524194983|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
145367588|NCT02438826|524194980|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
145367589|NCT02438826|524194981|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
145367590|NCT02438826|524194982|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
145367591|NCT02438826|524194983|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
145367592|NCT02438826|524194980|FG000|Open-Label Treatment Phase|Adverse Event|11|||
145367593|NCT02438826|524194981|FG001|Open-Label Treatment Phase|Adverse Event|6|||
145367594|NCT02438826|524194982|FG002|Open-Label Treatment Phase|Adverse Event|0|||
145367595|NCT02438826|524194983|FG003|Open-Label Treatment Phase|Adverse Event|0|||
145367596|NCT02438826|524194980|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
145367597|NCT02438826|524194981|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
145367598|NCT02438826|524194982|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
145367599|NCT02438826|524194983|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
145367600|NCT02438826|524194980|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
145367601|NCT02438826|524194981|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
145367602|NCT02438826|524194982|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
145367603|NCT02438826|524194983|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
145367604|NCT02438826|524194980|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
145367605|NCT02438826|524194981|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
145367606|NCT02438826|524194982|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
145367607|NCT02438826|524194983|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
145367608|NCT02438826|524194980|FG000|Post-Treatment Phase|Adverse Event|3|||
145623277|NCT03212365|525131656|FG000|Overall Study|Withdrawal by Subject|0|||
145623278|NCT03212365|525131657|FG001|Overall Study|Withdrawal by Subject|1|||
145367609|NCT02438826|524194981|FG001|Post-Treatment Phase|Adverse Event|0|||
145367610|NCT02438826|524194982|FG002|Post-Treatment Phase|Adverse Event|0|||
145367611|NCT02438826|524194983|FG003|Post-Treatment Phase|Adverse Event|0|||
145367612|NCT02438826|524194980|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
145367613|NCT02438826|524194981|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
145367614|NCT02438826|524194982|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
145367615|NCT02438826|524194983|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
145367616|NCT02438826|524194980|FG000|Post-Treatment Phase|Physician Decision|1|||
145367617|NCT02438826|524194981|FG001|Post-Treatment Phase|Physician Decision|0|||
145367618|NCT02438826|524194982|FG002|Post-Treatment Phase|Physician Decision|0|||
145367619|NCT02438826|524194983|FG003|Post-Treatment Phase|Physician Decision|0|||
145367620|NCT02438826|524194980|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
145367621|NCT02438826|524194981|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
145367622|NCT02438826|524194982|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
145367623|NCT02438826|524194983|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
145367624|NCT00675428|524194987|FG000|Overall Study|Disease Progression|2|||
145367625|NCT00675428|524194988|FG001|Overall Study|Disease Progression|2|||
145367626|NCT00675428|524194987|FG000|Overall Study|No Disease Response After Cycle 6|0|||
145367627|NCT00675428|524194988|FG001|Overall Study|No Disease Response After Cycle 6|1|||
145367628|NCT00675428|524194987|FG000|Overall Study|Physician Decision|1|||
145367629|NCT00675428|524194988|FG001|Overall Study|Physician Decision|0|||
145367630|NCT04740827|524194997|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
145367631|NCT04740827|524194998|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
145367632|NCT04740827|524194997|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
145367633|NCT04740827|524194998|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
145367634|NCT04740827|524194997|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
145367635|NCT04740827|524194998|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
145367636|NCT04740827|524194997|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
145367637|NCT04740827|524194998|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
145367638|NCT04740827|524194997|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
145367639|NCT04740827|524194998|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
145367640|NCT04740827|524194997|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
145367641|NCT04740827|524194998|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
145367642|NCT02147158|524194999|FG000|Treatment Course 1|Adverse Event|1|||
145367643|NCT02147158|524195000|FG001|Treatment Course 1|Adverse Event|4|||
145367644|NCT02147158|524195001|FG002|Treatment Course 1|Adverse Event|3|||
145367645|NCT02147158|524195002|FG003|Treatment Course 1|Adverse Event|4|||
145367646|NCT02147158|524195003|FG004|Treatment Course 1|Adverse Event|1|||
145367647|NCT02147158|524195004|FG005|Treatment Course 1|Adverse Event|2|||
145367648|NCT02147158|524194999|FG000|Treatment Course 1|Lost to Follow-up|2|||
145367649|NCT02147158|524195000|FG001|Treatment Course 1|Lost to Follow-up|4|||
145367650|NCT02147158|524195001|FG002|Treatment Course 1|Lost to Follow-up|3|||
145367651|NCT02147158|524195002|FG003|Treatment Course 1|Lost to Follow-up|3|||
145367652|NCT02147158|524195003|FG004|Treatment Course 1|Lost to Follow-up|2|||
145367653|NCT02147158|524195004|FG005|Treatment Course 1|Lost to Follow-up|4|||
145367654|NCT02147158|524194999|FG000|Treatment Course 1|Protocol Violation|0|||
145367655|NCT02147158|524195000|FG001|Treatment Course 1|Protocol Violation|0|||
145367656|NCT02147158|524195001|FG002|Treatment Course 1|Protocol Violation|1|||
145367657|NCT02147158|524195002|FG003|Treatment Course 1|Protocol Violation|1|||
145367658|NCT02147158|524195003|FG004|Treatment Course 1|Protocol Violation|0|||
145367659|NCT02147158|524195004|FG005|Treatment Course 1|Protocol Violation|0|||
145367660|NCT02147158|524194999|FG000|Treatment Course 1|Withdrawal of Consent|1|||
145367661|NCT02147158|524195000|FG001|Treatment Course 1|Withdrawal of Consent|1|||
145367662|NCT02147158|524195001|FG002|Treatment Course 1|Withdrawal of Consent|1|||
145367663|NCT02147158|524195002|FG003|Treatment Course 1|Withdrawal of Consent|5|||
145367664|NCT02147158|524195003|FG004|Treatment Course 1|Withdrawal of Consent|3|||
145367665|NCT02147158|524195004|FG005|Treatment Course 1|Withdrawal of Consent|2|||
145367666|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Adverse Event|1|||
145367667|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Adverse Event|0|||
145367668|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Adverse Event|0|||
145367669|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Adverse Event|1|||
145367670|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Adverse Event|0|||
145367671|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Adverse Event|0|||
145367672|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
145367673|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
145367674|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
145367675|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
145623279|NCT03212365|525131656|FG000|Overall Study|developed acute renal failure|0|||
145367676|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
145367677|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
145367678|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
145367679|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
145367680|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
145367681|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
145367682|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
145367683|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
145367684|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
145367685|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
145367686|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
145367687|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
145367688|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
145367689|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
145367690|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
145367691|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
145367692|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
145367693|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
145367694|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
145367695|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
145367696|NCT02147158|524194999|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
145367697|NCT02147158|524195000|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145367698|NCT02147158|524195001|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
145367699|NCT02147158|524195002|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
145367700|NCT02147158|524195003|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145367701|NCT02147158|524195004|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
145422246|NCT03473301|524402035|FG000|Overall Study|Withdrawal by Subject|0|||
145422247|NCT03473301|524402036|FG001|Overall Study|Withdrawal by Subject|1|||
145422248|NCT03473301|524402037|FG002|Overall Study|Withdrawal by Subject|0|||
145422249|NCT03473301|524402035|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
145422250|NCT03473301|524402036|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
145422251|NCT03473301|524402037|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
145422252|NCT05287685|524402038|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
145422253|NCT05287685|524402039|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
145422254|NCT05287685|524402038|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
145422255|NCT05287685|524402039|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
145367702|NCT02147158|524194999|FG000|Treatment Course 2|Adverse Event|0|||
145367703|NCT02147158|524195000|FG001|Treatment Course 2|Adverse Event|4|||
145367704|NCT02147158|524195001|FG002|Treatment Course 2|Adverse Event|2|||
145367705|NCT02147158|524195002|FG003|Treatment Course 2|Adverse Event|1|||
145367706|NCT02147158|524195003|FG004|Treatment Course 2|Adverse Event|0|||
145367707|NCT02147158|524195004|FG005|Treatment Course 2|Adverse Event|1|||
145367708|NCT02147158|524194999|FG000|Treatment Course 2|Withdrawal of Consent|0|||
145367709|NCT02147158|524195000|FG001|Treatment Course 2|Withdrawal of Consent|1|||
145367710|NCT02147158|524195001|FG002|Treatment Course 2|Withdrawal of Consent|2|||
145367711|NCT02147158|524195002|FG003|Treatment Course 2|Withdrawal of Consent|3|||
145367712|NCT02147158|524195003|FG004|Treatment Course 2|Withdrawal of Consent|0|||
145367713|NCT02147158|524195004|FG005|Treatment Course 2|Withdrawal of Consent|0|||
145367714|NCT02147158|524194999|FG000|Treatment Course 2|Lost to Follow-up|1|||
145367715|NCT02147158|524195000|FG001|Treatment Course 2|Lost to Follow-up|0|||
145367716|NCT02147158|524195001|FG002|Treatment Course 2|Lost to Follow-up|1|||
145367717|NCT02147158|524195002|FG003|Treatment Course 2|Lost to Follow-up|1|||
145367718|NCT02147158|524195003|FG004|Treatment Course 2|Lost to Follow-up|0|||
145367719|NCT02147158|524195004|FG005|Treatment Course 2|Lost to Follow-up|1|||
145367720|NCT02147158|524194999|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
145367721|NCT02147158|524195000|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
145367722|NCT02147158|524195001|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
145367723|NCT02147158|524195002|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
145367724|NCT02147158|524195003|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
145367725|NCT02147158|524195004|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
145367726|NCT02147158|524194999|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
145367727|NCT02147158|524195000|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
145367728|NCT02147158|524195001|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
145367729|NCT02147158|524195002|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
145367730|NCT02147158|524195003|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
145367731|NCT02147158|524195004|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
145367732|NCT02147158|524194999|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
145367733|NCT02147158|524195000|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
145367734|NCT02147158|524195001|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
145422256|NCT02314247|524402040|FG000|Overall Study|Adverse Event|2|||
145422257|NCT02314247|524402041|FG001|Overall Study|Adverse Event|1|||
145422258|NCT02314247|524402042|FG002|Overall Study|Adverse Event|0|||
145422259|NCT02314247|524402040|FG000|Overall Study|Withdrawal by Subject|1|||
145422260|NCT02314247|524402041|FG001|Overall Study|Withdrawal by Subject|3|||
145422261|NCT02314247|524402042|FG002|Overall Study|Withdrawal by Subject|1|||
145367735|NCT02147158|524195002|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
145367736|NCT02147158|524195003|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
145367737|NCT02147158|524195004|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
145367738|NCT02147158|524194999|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
145367739|NCT02147158|524195000|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
145422262|NCT02314247|524402040|FG000|Overall Study|Progression of Disease|6|||
145422263|NCT02314247|524402041|FG001|Overall Study|Progression of Disease|2|||
145422264|NCT02314247|524402042|FG002|Overall Study|Progression of Disease|0|||
145367740|NCT02147158|524195001|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
145367741|NCT02147158|524195002|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
145367742|NCT02147158|524195003|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
145367743|NCT02147158|524195004|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
145367744|NCT02147158|524194999|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
145367745|NCT02147158|524195000|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
145367746|NCT02147158|524195001|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
145367747|NCT02147158|524195002|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
145367748|NCT02147158|524195003|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
145367749|NCT02147158|524195004|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
145367750|NCT02981082|524195006|FG000|Overall Study|Withdrawal by Subject|2|||
145367751|NCT02981082|524195007|FG001|Overall Study|Withdrawal by Subject|0|||
145367752|NCT02981082|524195006|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
145367753|NCT02981082|524195007|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
145367754|NCT02981082|524195006|FG000|Overall Study|Adverse Event|0|||
145367755|NCT02981082|524195007|FG001|Overall Study|Adverse Event|1|||
145367756|NCT01082211|524195008|FG000|Overall Study|Protocol Violation|4|||
145367757|NCT01082211|524195008|FG000|Overall Study|No protocol treatment received|3|||
145367758|NCT01905553|524198419|FG000|Period 2|Adverse Event|1|||
145367759|NCT01905553|524198420|FG001|Period 2|Adverse Event|0|||
145367760|NCT02656290|524198430|FG000|Overall Study|Lost to Follow-up|1|||
145367761|NCT02656290|524198430|FG000|Overall Study|Reintervention|3|||
145367762|NCT01608087|524198431|FG000|Overall Study|Lost to Follow-up|0|||
145367763|NCT01608087|524198432|FG001|Overall Study|Lost to Follow-up|1|||
145367764|NCT01608087|524198433|FG002|Overall Study|Lost to Follow-up|0|||
145367765|NCT01608087|524198431|FG000|Overall Study|Other Reason|0|||
145367766|NCT01608087|524198432|FG001|Overall Study|Other Reason|1|||
145367767|NCT01608087|524198433|FG002|Overall Study|Other Reason|0|||
145367768|NCT02817516|524198434|FG000|Overall Study|Other|0|||
145367769|NCT02817516|524198435|FG001|Overall Study|Other|0|||
145367770|NCT02817516|524198436|FG002|Overall Study|Other|1|||
145367771|NCT02817516|524198437|FG003|Overall Study|Other|0|||
145367772|NCT00664859|524198438|FG000|Overall Study|Adverse Event|2|||
145367773|NCT00664859|524198439|FG001|Overall Study|Adverse Event|1|||
145367774|NCT00664859|524198440|FG002|Overall Study|Adverse Event|3|||
145367775|NCT00664859|524198438|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
145367776|NCT00664859|524198439|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
145367777|NCT00664859|524198440|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
145367778|NCT00664859|524198438|FG000|Overall Study|Noncompliance with protocol|1|||
145367779|NCT00664859|524198439|FG001|Overall Study|Noncompliance with protocol|0|||
145367780|NCT00664859|524198440|FG002|Overall Study|Noncompliance with protocol|4|||
145367781|NCT00664859|524198438|FG000|Overall Study|Laboratory abnormality|2|||
145367782|NCT00664859|524198439|FG001|Overall Study|Laboratory abnormality|1|||
145367783|NCT00664859|524198440|FG002|Overall Study|Laboratory abnormality|4|||
145367784|NCT00664859|524198438|FG000|Overall Study|Withdrawal by Subject|4|||
145367785|NCT00664859|524198439|FG001|Overall Study|Withdrawal by Subject|1|||
145367786|NCT00664859|524198440|FG002|Overall Study|Withdrawal by Subject|3|||
145367787|NCT00664859|524198438|FG000|Overall Study|Lost to Follow-up|2|||
145367788|NCT00664859|524198439|FG001|Overall Study|Lost to Follow-up|2|||
145367789|NCT00664859|524198440|FG002|Overall Study|Lost to Follow-up|1|||
145367790|NCT00664859|524198438|FG000|Overall Study|Other|0|||
145367791|NCT00664859|524198439|FG001|Overall Study|Other|1|||
145367792|NCT00664859|524198440|FG002|Overall Study|Other|2|||
145367793|NCT00348595|524198441|FG000|Overall Study|Adverse Event|5|||
145367794|NCT00348595|524198442|FG001|Overall Study|Adverse Event|8|||
145367795|NCT01943851|524198443|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367796|NCT01943851|524198444|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367797|NCT01943851|524198445|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367798|NCT01943851|524198446|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145367799|NCT01943851|524198447|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367800|NCT01943851|524198448|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367801|NCT01943851|524198449|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145367802|NCT01943851|524198450|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145367803|NCT01943851|524198451|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
145367804|NCT01943851|524198452|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367805|NCT01943851|524198453|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367806|NCT01943851|524198454|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367807|NCT01943851|524198455|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367808|NCT01943851|524198456|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145623280|NCT03212365|525131657|FG001|Overall Study|developed acute renal failure|1|||
145367809|NCT01943851|524198457|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367810|NCT01943851|524198458|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367811|NCT01943851|524198459|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367812|NCT01943851|524198460|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
145367813|NCT01943851|524198443|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367814|NCT01943851|524198444|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367815|NCT01943851|524198445|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367816|NCT01943851|524198446|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367817|NCT01943851|524198447|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
145367818|NCT01943851|524198448|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367819|NCT01943851|524198449|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367820|NCT01943851|524198450|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
145367821|NCT01943851|524198451|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367822|NCT01943851|524198452|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367823|NCT01943851|524198453|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367824|NCT01943851|524198454|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367825|NCT01943851|524198455|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367826|NCT01943851|524198456|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367827|NCT01943851|524198457|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367828|NCT01943851|524198458|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367829|NCT01943851|524198459|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367830|NCT01943851|524198460|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
145367831|NCT01943851|524198443|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367832|NCT01943851|524198444|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367833|NCT01943851|524198445|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367834|NCT01943851|524198446|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367835|NCT01943851|524198447|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367836|NCT01943851|524198448|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367837|NCT01943851|524198449|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367838|NCT01943851|524198450|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367839|NCT01943851|524198451|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367840|NCT01943851|524198452|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367841|NCT01943851|524198453|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367842|NCT01943851|524198454|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367843|NCT01943851|524198455|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367844|NCT01943851|524198456|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
145367845|NCT01943851|524198457|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367846|NCT01943851|524198458|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367847|NCT01943851|524198459|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367848|NCT01943851|524198460|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
145367849|NCT01943851|524198443|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367850|NCT01943851|524198444|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367851|NCT01943851|524198445|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367852|NCT01943851|524198446|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367853|NCT01943851|524198447|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367854|NCT01943851|524198448|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367855|NCT01943851|524198449|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367856|NCT01943851|524198450|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367857|NCT01943851|524198451|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367858|NCT01943851|524198452|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367859|NCT01943851|524198453|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367860|NCT01943851|524198454|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367861|NCT01943851|524198455|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367862|NCT01943851|524198456|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367863|NCT01943851|524198457|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367864|NCT01943851|524198458|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
145367865|NCT01943851|524198459|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367866|NCT01943851|524198460|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
145367867|NCT01943851|524198443|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367868|NCT01943851|524198444|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367869|NCT01943851|524198445|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367870|NCT01943851|524198446|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367871|NCT01943851|524198447|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367872|NCT01943851|524198448|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367873|NCT01943851|524198449|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367874|NCT01943851|524198450|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367875|NCT01943851|524198451|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367876|NCT01943851|524198452|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367877|NCT01943851|524198453|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367878|NCT01943851|524198454|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367879|NCT01943851|524198455|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367880|NCT01943851|524198456|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367881|NCT01943851|524198457|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
145367882|NCT01943851|524198458|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
145422265|NCT01953354|524402043|FG000|Overall Study|Withdrawal by Subject|0|||
145422266|NCT01953354|524402044|FG001|Overall Study|Withdrawal by Subject|1|||
145422267|NCT01953354|524402043|FG000|Overall Study|Decision of Sponsor|0|||
145422268|NCT01953354|524402044|FG001|Overall Study|Decision of Sponsor|1|||
145422269|NCT01953354|524402043|FG000|Overall Study|Disease Exacerbation|1|||
145422270|NCT01953354|524402044|FG001|Overall Study|Disease Exacerbation|0|||
145422271|NCT01570192|524402045|FG000|Overall Study|no qualifying organism|6|||
145422272|NCT01570192|524402046|FG001|Overall Study|no qualifying organism|12|||
145422273|NCT01570192|524402045|FG000|Overall Study|changed to palliative care|1|||
145422274|NCT01570192|524402046|FG001|Overall Study|changed to palliative care|0|||
145422275|NCT01570192|524402045|FG000|Overall Study|Physician Decision|0|||
145422276|NCT01570192|524402046|FG001|Overall Study|Physician Decision|1|||
145422277|NCT02134028|524402047|FG000|Overall Study|Lack of Efficacy|1|||
145422278|NCT02134028|524402048|FG001|Overall Study|Lack of Efficacy|0|||
145422279|NCT02134028|524402049|FG002|Overall Study|Lack of Efficacy|3|||
145578419|NCT03328897|524973641|FG001|Follow-up Epoch|Lost to Follow-up|1|||
145578420|NCT03328897|524973642|FG002|Follow-up Epoch|Lost to Follow-up|0|||
145367883|NCT01943851|524198459|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
145367884|NCT01943851|524198460|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
145367885|NCT04720911|524198461|FG000|Overall Study|Withdrawal by Subject|0|||
145367886|NCT04720911|524198462|FG001|Overall Study|Withdrawal by Subject|1|||
145367887|NCT04720911|524198463|FG002|Overall Study|Withdrawal by Subject|0|||
145367888|NCT00090220|524198464|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
145367889|NCT00090220|524198465|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
145367890|NCT00090220|524198466|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145367891|NCT00090220|524198467|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145367892|NCT00090220|524198468|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145367893|NCT00090220|524198469|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145367894|NCT00090220|524198464|FG000|Base Study Vaccination Period|Adverse Event|6|||
145367895|NCT00090220|524198465|FG001|Base Study Vaccination Period|Adverse Event|1|||
145367896|NCT00090220|524198466|FG002|Base Study Vaccination Period|Adverse Event|0|||
145367897|NCT00090220|524198467|FG003|Base Study Vaccination Period|Adverse Event|0|||
145367898|NCT00090220|524198468|FG004|Base Study Vaccination Period|Adverse Event|0|||
145367899|NCT00090220|524198469|FG005|Base Study Vaccination Period|Adverse Event|0|||
145367900|NCT00090220|524198464|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
145367901|NCT00090220|524198465|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
145367902|NCT00090220|524198466|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
145367903|NCT00090220|524198467|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
145367904|NCT00090220|524198468|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
145367905|NCT00090220|524198469|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
145367906|NCT00090220|524198464|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
145367907|NCT00090220|524198465|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
145367908|NCT00090220|524198466|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
145367909|NCT00090220|524198467|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
145367910|NCT00090220|524198468|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
145367911|NCT00090220|524198469|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
145367912|NCT00090220|524198464|FG000|Base Study Vaccination Period|Patient Moved|6|||
145367913|NCT00090220|524198465|FG001|Base Study Vaccination Period|Patient Moved|2|||
145367914|NCT00090220|524198466|FG002|Base Study Vaccination Period|Patient Moved|0|||
145367915|NCT00090220|524198467|FG003|Base Study Vaccination Period|Patient Moved|0|||
145367916|NCT00090220|524198468|FG004|Base Study Vaccination Period|Patient Moved|0|||
145367917|NCT00090220|524198469|FG005|Base Study Vaccination Period|Patient Moved|0|||
145367918|NCT00090220|524198464|FG000|Base Study Vaccination Period|Other|4|||
145367919|NCT00090220|524198465|FG001|Base Study Vaccination Period|Other|4|||
145367920|NCT00090220|524198466|FG002|Base Study Vaccination Period|Other|0|||
145367921|NCT00090220|524198467|FG003|Base Study Vaccination Period|Other|0|||
145367922|NCT00090220|524198468|FG004|Base Study Vaccination Period|Other|0|||
145367923|NCT00090220|524198469|FG005|Base Study Vaccination Period|Other|0|||
145367924|NCT00090220|524198464|FG000|Base Study Follow-up Period|Adverse Event|6|||
145367925|NCT00090220|524198465|FG001|Base Study Follow-up Period|Adverse Event|1|||
145367926|NCT00090220|524198466|FG002|Base Study Follow-up Period|Adverse Event|0|||
145367927|NCT00090220|524198467|FG003|Base Study Follow-up Period|Adverse Event|0|||
145367928|NCT00090220|524198468|FG004|Base Study Follow-up Period|Adverse Event|0|||
145367929|NCT00090220|524198469|FG005|Base Study Follow-up Period|Adverse Event|0|||
145367930|NCT00090220|524198464|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
145367931|NCT00090220|524198465|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
145422280|NCT02134028|524402050|FG003|Overall Study|Lack of Efficacy|2|||
145422281|NCT02134028|524402051|FG004|Overall Study|Lack of Efficacy|1|||
145422282|NCT02134028|524402052|FG005|Overall Study|Lack of Efficacy|2|||
145578421|NCT03328897|524973640|FG000|Follow-up Epoch|Pregnancy|1|||
145422283|NCT02134028|524402053|FG006|Overall Study|Lack of Efficacy|1|||
145578422|NCT03328897|524973641|FG001|Follow-up Epoch|Pregnancy|0|||
145578423|NCT03328897|524973642|FG002|Follow-up Epoch|Pregnancy|0|||
145578424|NCT03328897|524973640|FG000|Follow-up Epoch|Patient/guardian decision|2|||
145367932|NCT00090220|524198466|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
145367933|NCT00090220|524198467|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
145367934|NCT00090220|524198468|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
145367935|NCT00090220|524198469|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
145367936|NCT00090220|524198464|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
145367937|NCT00090220|524198465|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
145367938|NCT00090220|524198466|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
145367939|NCT00090220|524198467|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
145367940|NCT00090220|524198468|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
145367941|NCT00090220|524198469|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
145367942|NCT00090220|524198464|FG000|Base Study Follow-up Period|Patient Moved|20|||
145367943|NCT00090220|524198465|FG001|Base Study Follow-up Period|Patient Moved|28|||
145367944|NCT00090220|524198466|FG002|Base Study Follow-up Period|Patient Moved|0|||
145367945|NCT00090220|524198467|FG003|Base Study Follow-up Period|Patient Moved|0|||
145367946|NCT00090220|524198468|FG004|Base Study Follow-up Period|Patient Moved|0|||
145367947|NCT00090220|524198469|FG005|Base Study Follow-up Period|Patient Moved|0|||
145367948|NCT00090220|524198464|FG000|Base Study Follow-up Period|Other|19|||
145367949|NCT00090220|524198465|FG001|Base Study Follow-up Period|Other|21|||
145367950|NCT00090220|524198466|FG002|Base Study Follow-up Period|Other|0|||
145367951|NCT00090220|524198467|FG003|Base Study Follow-up Period|Other|0|||
145367952|NCT00090220|524198468|FG004|Base Study Follow-up Period|Other|0|||
145367953|NCT00090220|524198469|FG005|Base Study Follow-up Period|Other|0|||
145367954|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Adverse Event|0|||
145367955|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Adverse Event|0|||
145367956|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Adverse Event|4|||
145367957|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Adverse Event|0|||
145367958|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Adverse Event|0|||
145367959|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Adverse Event|0|||
145367960|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
145367961|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
145367962|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
145367963|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
145367964|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
145367965|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
145367966|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Moved|0|||
145367967|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Moved|0|||
145367968|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Moved|2|||
145367969|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Moved|1|||
145367970|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Moved|0|||
145367971|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Moved|0|||
145367972|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145367973|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145367974|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
145367975|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145367976|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145367977|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
145367978|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
145367979|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
145367980|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
145367981|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
145367982|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
145367983|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
145367984|NCT00090220|524198464|FG000|Extension 1 (EXT1)|Other reason|0|||
145367985|NCT00090220|524198465|FG001|Extension 1 (EXT1)|Other reason|0|||
145367986|NCT00090220|524198466|FG002|Extension 1 (EXT1)|Other reason|2|||
145367987|NCT00090220|524198467|FG003|Extension 1 (EXT1)|Other reason|0|||
145367988|NCT00090220|524198468|FG004|Extension 1 (EXT1)|Other reason|0|||
145367989|NCT00090220|524198469|FG005|Extension 1 (EXT1)|Other reason|0|||
145367990|NCT00090220|524198464|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145367991|NCT00090220|524198465|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145367992|NCT00090220|524198466|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145367993|NCT00090220|524198467|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
145367994|NCT00090220|524198468|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
145367995|NCT00090220|524198469|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
145578425|NCT03328897|524973641|FG001|Follow-up Epoch|Patient/guardian decision|1|||
145578426|NCT03328897|524973642|FG002|Follow-up Epoch|Patient/guardian decision|0|||
145578427|NCT00608829|524973644|FG000|Overall Study|Death|6|||
145578428|NCT00608829|524973644|FG000|Overall Study|Withdrawal by Subject|4|||
145367996|NCT00090220|524198464|FG000|Long-term Follow-up (EXT2)|Death|0|||
145367997|NCT00090220|524198465|FG001|Long-term Follow-up (EXT2)|Death|0|||
145367998|NCT00090220|524198466|FG002|Long-term Follow-up (EXT2)|Death|0|||
145367999|NCT00090220|524198467|FG003|Long-term Follow-up (EXT2)|Death|0|||
145368000|NCT00090220|524198468|FG004|Long-term Follow-up (EXT2)|Death|1|||
145368001|NCT00090220|524198469|FG005|Long-term Follow-up (EXT2)|Death|1|||
145422284|NCT02134028|524402054|FG007|Overall Study|Lack of Efficacy|0|||
145578429|NCT00608829|524973644|FG000|Overall Study|Subject refuses to follow up or return.|5|||
145578430|NCT02766608|524973645|FG000|Overall Study|Adverse Event|27|||
145578431|NCT02766608|524973646|FG001|Overall Study|Adverse Event|22|||
145368002|NCT00090220|524198464|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145368003|NCT00090220|524198465|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145368004|NCT00090220|524198466|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145368005|NCT00090220|524198467|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
145368006|NCT00090220|524198468|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
145368007|NCT00090220|524198469|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
145368008|NCT00090220|524198464|FG000|Long-term Follow-up (EXT2)|Other|0|||
145368009|NCT00090220|524198465|FG001|Long-term Follow-up (EXT2)|Other|0|||
145368010|NCT00090220|524198466|FG002|Long-term Follow-up (EXT2)|Other|0|||
145368011|NCT00090220|524198467|FG003|Long-term Follow-up (EXT2)|Other|0|||
145368012|NCT00090220|524198468|FG004|Long-term Follow-up (EXT2)|Other|1|||
145368013|NCT00090220|524198469|FG005|Long-term Follow-up (EXT2)|Other|0|||
145368014|NCT00941863|524198470|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
145368015|NCT00941863|524198471|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
145368016|NCT00941863|524198472|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
145368017|NCT00941863|524198473|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
145368018|NCT00941863|524198474|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
145368019|NCT00941863|524198470|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
145368020|NCT00941863|524198471|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
145368021|NCT00941863|524198472|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
145368022|NCT00941863|524198473|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
145368023|NCT00941863|524198474|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
145368024|NCT00941863|524198470|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145368025|NCT00941863|524198471|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145368026|NCT00941863|524198472|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
145368027|NCT00941863|524198473|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
145368028|NCT00941863|524198474|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
145368029|NCT00941863|524198470|FG000|Until Primary Completion Date (PCD)|Death|0|||
145368030|NCT00941863|524198471|FG001|Until Primary Completion Date (PCD)|Death|0|||
145368031|NCT00941863|524198472|FG002|Until Primary Completion Date (PCD)|Death|1|||
145368032|NCT00941863|524198473|FG003|Until Primary Completion Date (PCD)|Death|2|||
145368033|NCT00941863|524198474|FG004|Until Primary Completion Date (PCD)|Death|7|||
145368034|NCT00941863|524198470|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
145368035|NCT00941863|524198471|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
145368036|NCT00941863|524198472|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
145368037|NCT00941863|524198473|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
145368038|NCT00941863|524198474|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
145368039|NCT00941863|524198470|FG000|Continued After PCD|Withdrawal by Subject|0|||
145368040|NCT00941863|524198471|FG001|Continued After PCD|Withdrawal by Subject|0|||
145368041|NCT00941863|524198472|FG002|Continued After PCD|Withdrawal by Subject|0|||
145368042|NCT00941863|524198473|FG003|Continued After PCD|Withdrawal by Subject|0|||
145368043|NCT00941863|524198474|FG004|Continued After PCD|Withdrawal by Subject|1|||
145368044|NCT00941863|524198470|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
145368045|NCT00941863|524198471|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
145368046|NCT00941863|524198472|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
145368047|NCT00941863|524198473|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
145368048|NCT00941863|524198474|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
145368049|NCT01867710|524198477|FG000|Overall Study|Death|25|||
145368050|NCT01867710|524198478|FG001|Overall Study|Death|15|||
145368051|NCT01867710|524198479|FG002|Overall Study|Death|27|||
145368052|NCT01867710|524198480|FG003|Overall Study|Death|20|||
145368053|NCT01867710|524198477|FG000|Overall Study|Lost to Follow-up|3|||
145368054|NCT01867710|524198478|FG001|Overall Study|Lost to Follow-up|4|||
145368055|NCT01867710|524198479|FG002|Overall Study|Lost to Follow-up|3|||
145368056|NCT01867710|524198480|FG003|Overall Study|Lost to Follow-up|2|||
145368057|NCT01867710|524198477|FG000|Overall Study|Withdrawal of consent|2|||
145368058|NCT01867710|524198478|FG001|Overall Study|Withdrawal of consent|5|||
145422285|NCT02134028|524402047|FG000|Overall Study|Poor compliance to protocol|1|||
145422286|NCT02134028|524402048|FG001|Overall Study|Poor compliance to protocol|1|||
145422287|NCT02134028|524402049|FG002|Overall Study|Poor compliance to protocol|3|||
145578432|NCT02766608|524973647|FG002|Overall Study|Adverse Event|17|||
145578433|NCT02766608|524973648|FG003|Overall Study|Adverse Event|13|||
145368059|NCT01867710|524198479|FG002|Overall Study|Withdrawal of consent|1|||
145368060|NCT01867710|524198480|FG003|Overall Study|Withdrawal of consent|2|||
145368061|NCT01867710|524198477|FG000|Overall Study|Study Terminated by Sponsor|9|||
145368062|NCT01867710|524198478|FG001|Overall Study|Study Terminated by Sponsor|13|||
145422288|NCT02134028|524402050|FG003|Overall Study|Poor compliance to protocol|7|||
145368063|NCT01867710|524198479|FG002|Overall Study|Study Terminated by Sponsor|8|||
145368064|NCT01867710|524198480|FG003|Overall Study|Study Terminated by Sponsor|16|||
145368065|NCT01867710|524198477|FG000|Overall Study|Biochemical progression|0|||
145422289|NCT02134028|524402051|FG004|Overall Study|Poor compliance to protocol|1|||
145368066|NCT01867710|524198478|FG001|Overall Study|Biochemical progression|1|||
145368067|NCT01867710|524198479|FG002|Overall Study|Biochemical progression|0|||
145368068|NCT01867710|524198480|FG003|Overall Study|Biochemical progression|0|||
145368069|NCT01867710|524198477|FG000|Overall Study|Clinical progression|0|||
145368070|NCT01867710|524198478|FG001|Overall Study|Clinical progression|0|||
145368071|NCT01867710|524198479|FG002|Overall Study|Clinical progression|1|||
145578434|NCT02766608|524973649|FG004|Overall Study|Adverse Event|12|||
145578435|NCT02766608|524973645|FG000|Overall Study|Withdrawal by Subject|21|||
145578436|NCT02766608|524973646|FG001|Overall Study|Withdrawal by Subject|20|||
145578437|NCT02766608|524973647|FG002|Overall Study|Withdrawal by Subject|24|||
145578438|NCT02766608|524973648|FG003|Overall Study|Withdrawal by Subject|13|||
145578439|NCT02766608|524973649|FG004|Overall Study|Withdrawal by Subject|10|||
145578440|NCT02766608|524973645|FG000|Overall Study|Lack of Efficacy|16|||
145578441|NCT02766608|524973646|FG001|Overall Study|Lack of Efficacy|15|||
145578442|NCT02766608|524973647|FG002|Overall Study|Lack of Efficacy|32|||
145578443|NCT02766608|524973648|FG003|Overall Study|Lack of Efficacy|8|||
145578444|NCT02766608|524973649|FG004|Overall Study|Lack of Efficacy|2|||
145578445|NCT02766608|524973645|FG000|Overall Study|Lost to Follow-up|6|||
145578446|NCT02766608|524973646|FG001|Overall Study|Lost to Follow-up|3|||
145578447|NCT02766608|524973647|FG002|Overall Study|Lost to Follow-up|5|||
145578448|NCT02766608|524973648|FG003|Overall Study|Lost to Follow-up|2|||
145578449|NCT02766608|524973649|FG004|Overall Study|Lost to Follow-up|2|||
145578450|NCT02766608|524973645|FG000|Overall Study|Physician Decision|3|||
145578451|NCT02766608|524973646|FG001|Overall Study|Physician Decision|2|||
145578452|NCT02766608|524973647|FG002|Overall Study|Physician Decision|3|||
145578453|NCT02766608|524973648|FG003|Overall Study|Physician Decision|1|||
145578454|NCT02766608|524973649|FG004|Overall Study|Physician Decision|2|||
145578455|NCT02766608|524973645|FG000|Overall Study|Protocol disc criteria|3|||
145578456|NCT02766608|524973646|FG001|Overall Study|Protocol disc criteria|3|||
145578457|NCT02766608|524973647|FG002|Overall Study|Protocol disc criteria|4|||
145578458|NCT02766608|524973648|FG003|Overall Study|Protocol disc criteria|0|||
145578459|NCT02766608|524973649|FG004|Overall Study|Protocol disc criteria|0|||
145578460|NCT02766608|524973645|FG000|Overall Study|Protocol Violation|0|||
145578461|NCT02766608|524973646|FG001|Overall Study|Protocol Violation|4|||
145578462|NCT02766608|524973647|FG002|Overall Study|Protocol Violation|4|||
145578463|NCT02766608|524973648|FG003|Overall Study|Protocol Violation|0|||
145578464|NCT02766608|524973649|FG004|Overall Study|Protocol Violation|1|||
145578465|NCT02766608|524973645|FG000|Overall Study|Administrative Reasons|3|||
145578466|NCT02766608|524973646|FG001|Overall Study|Administrative Reasons|1|||
145578467|NCT02766608|524973647|FG002|Overall Study|Administrative Reasons|1|||
145578468|NCT02766608|524973648|FG003|Overall Study|Administrative Reasons|0|||
145578469|NCT02766608|524973649|FG004|Overall Study|Administrative Reasons|0|||
145578470|NCT00612066|524973650|FG000|Overall Study|Adverse Event|1|||
145578471|NCT02080091|524973651|FG000|Overall Study|Study Terminated|22|||
145578472|NCT02080091|524973651|FG000|Overall Study|Death|1|||
145578473|NCT02080091|524973651|FG000|Overall Study|Withdrawal by Subject|1|||
145578474|NCT02080091|524973651|FG000|Overall Study|Other|1|||
145578475|NCT02648698|524973655|FG000|Overall Study|Protocol Violation|1|||
145578476|NCT02648698|524973656|FG001|Overall Study|Protocol Violation|5|||
145578477|NCT03143829|524973657|FG000|Overall Study|Withdrawal by Subject|2|||
145578478|NCT03143829|524973658|FG001|Overall Study|Withdrawal by Subject|5|||
145578479|NCT03143829|524973657|FG000|Overall Study|Lost to Follow-up|0|||
145578480|NCT03143829|524973658|FG001|Overall Study|Lost to Follow-up|2|||
145578481|NCT03143829|524973657|FG000|Overall Study|Death|1|||
145578482|NCT03143829|524973658|FG001|Overall Study|Death|1|||
145578483|NCT03143829|524973657|FG000|Overall Study|changed treatment, no longer eligible|2|||
145578484|NCT03143829|524973658|FG001|Overall Study|changed treatment, no longer eligible|2|||
145578485|NCT01750268|524973661|FG000|Overall Study|Lost to Follow-up|0|||
145578486|NCT01750268|524973662|FG001|Overall Study|Lost to Follow-up|2|||
145578487|NCT01750268|524973661|FG000|Overall Study|Physician Decision|0|||
145578488|NCT01750268|524973662|FG001|Overall Study|Physician Decision|3|||
145578489|NCT01750268|524973661|FG000|Overall Study|Withdrawal by Subject|2|||
145578490|NCT01750268|524973662|FG001|Overall Study|Withdrawal by Subject|0|||
145578491|NCT00966940|524973663|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
145578492|NCT00966940|524973664|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
145578493|NCT00966940|524973663|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
145578494|NCT00966940|524973664|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
145578495|NCT01529645|524973665|FG000|Overall Study|Lost to Follow-up|0|||
145578496|NCT01529645|524973666|FG001|Overall Study|Lost to Follow-up|1|||
145578497|NCT01529645|524973667|FG002|Overall Study|Lost to Follow-up|1|||
145578498|NCT01529645|524973668|FG003|Overall Study|Lost to Follow-up|1|||
145578499|NCT01529645|524973669|FG004|Overall Study|Lost to Follow-up|1|||
145578500|NCT01529645|524973670|FG005|Overall Study|Lost to Follow-up|0|||
145578501|NCT01529645|524973671|FG006|Overall Study|Lost to Follow-up|2|||
145578502|NCT01529645|524973672|FG007|Overall Study|Lost to Follow-up|0|||
145578503|NCT01529645|524973673|FG008|Overall Study|Lost to Follow-up|1|||
145578504|NCT01529645|524973674|FG009|Overall Study|Lost to Follow-up|0|||
145578505|NCT01529645|524973665|FG000|Overall Study|SAE - Premature contractions|0|||
145578506|NCT01529645|524973666|FG001|Overall Study|SAE - Premature contractions|0|||
145623281|NCT00333138|525131658|FG000|Core Study (6 Months)|Adverse Event|4|||
145623282|NCT00333138|525131659|FG001|Core Study (6 Months)|Adverse Event|5|||
145623283|NCT00333138|525131660|FG002|Core Study (6 Months)|Adverse Event|8|||
145623284|NCT00333138|525131658|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
145623285|NCT00333138|525131659|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
145623286|NCT00333138|525131660|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
145623287|NCT00333138|525131658|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
145623288|NCT00333138|525131659|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
145623289|NCT00333138|525131660|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
145623290|NCT00333138|525131658|FG000|Core Study (6 Months)|Protocol Violation|1|||
145623291|NCT00333138|525131659|FG001|Core Study (6 Months)|Protocol Violation|0|||
145623292|NCT00333138|525131660|FG002|Core Study (6 Months)|Protocol Violation|1|||
145623293|NCT00333138|525131658|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
145623294|NCT00333138|525131659|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
145623295|NCT00333138|525131660|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
145623296|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
145623297|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
145623298|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
145623299|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
145623300|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
145623301|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
145623302|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
145623303|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
145623304|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
145623305|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
145623306|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
145623307|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
145623308|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
145623309|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
145623310|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
145623311|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
145623312|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
145623313|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
145623314|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
145623315|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
145623316|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
145623317|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
145623318|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
145623319|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
145623320|NCT00333138|525131658|FG000|Extension Study (Month6 to End of Study)|Death|0|||
145623321|NCT00333138|525131659|FG001|Extension Study (Month6 to End of Study)|Death|1|||
145623322|NCT00333138|525131660|FG002|Extension Study (Month6 to End of Study)|Death|0|||
145623323|NCT01342887|525131662|FG000|Overall Study|Death|2|||
145623324|NCT04880161|525131664|FG000|Overall Study|Withdrawal by Subject|1|||
145623325|NCT04880161|525131665|FG001|Overall Study|Withdrawal by Subject|0|||
145623326|NCT04880161|525131664|FG000|Overall Study|Lack of Compliance|1|||
145623327|NCT04880161|525131665|FG001|Overall Study|Lack of Compliance|1|||
145623328|NCT04880161|525131664|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
145623329|NCT04880161|525131665|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
145623330|NCT04880161|525131664|FG000|Overall Study|Screen Failure|0|||
145623331|NCT04880161|525131665|FG001|Overall Study|Screen Failure|1|||
145623332|NCT01354106|525131666|FG000|Overall Study|Withdrawal by Subject|2|||
145623333|NCT02491411|525133862|FG000|Overall Study|Physician Decision|4|||
145623334|NCT04034238|525133863|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
145578507|NCT01529645|524973667|FG002|Overall Study|SAE - Premature contractions|1|||
145578508|NCT01529645|524973668|FG003|Overall Study|SAE - Premature contractions|0|||
145578509|NCT01529645|524973669|FG004|Overall Study|SAE - Premature contractions|0|||
145578510|NCT01529645|524973670|FG005|Overall Study|SAE - Premature contractions|0|||
145578511|NCT01529645|524973671|FG006|Overall Study|SAE - Premature contractions|0|||
145578512|NCT01529645|524973672|FG007|Overall Study|SAE - Premature contractions|0|||
145578513|NCT01529645|524973673|FG008|Overall Study|SAE - Premature contractions|0|||
145623335|NCT04034238|525133864|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
145623336|NCT04034238|525133865|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
145623337|NCT04034238|525133866|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145623338|NCT04034238|525133863|FG000|Dose Escalation Phase|Screen failures|0|||
145623339|NCT04034238|525133864|FG001|Dose Escalation Phase|Screen failures|0|||
145623340|NCT04034238|525133865|FG002|Dose Escalation Phase|Screen failures|0|||
145578514|NCT01529645|524973674|FG009|Overall Study|SAE - Premature contractions|0|||
145578515|NCT01529645|524973665|FG000|Overall Study|Withdrawal by Subject|2|||
145578516|NCT01529645|524973666|FG001|Overall Study|Withdrawal by Subject|0|||
145578517|NCT01529645|524973667|FG002|Overall Study|Withdrawal by Subject|0|||
145422290|NCT02134028|524402052|FG005|Overall Study|Poor compliance to protocol|1|||
145578518|NCT01529645|524973668|FG003|Overall Study|Withdrawal by Subject|1|||
145578519|NCT01529645|524973669|FG004|Overall Study|Withdrawal by Subject|1|||
145578520|NCT01529645|524973670|FG005|Overall Study|Withdrawal by Subject|1|||
145578521|NCT01529645|524973671|FG006|Overall Study|Withdrawal by Subject|0|||
145578522|NCT01529645|524973672|FG007|Overall Study|Withdrawal by Subject|0|||
145578523|NCT01529645|524973673|FG008|Overall Study|Withdrawal by Subject|0|||
145578524|NCT01529645|524973674|FG009|Overall Study|Withdrawal by Subject|0|||
145578525|NCT00274716|524973679|FG000|Phase A|Other non-reported reason|4|||
145578526|NCT00274716|524973680|FG001|Phase A|Other non-reported reason|2|||
145578527|NCT00274716|524973681|FG002|Phase A|Other non-reported reason|1|||
145578528|NCT00274716|524973682|FG003|Phase A|Other non-reported reason|2|||
145578529|NCT00274716|524973683|FG004|Phase A|Other non-reported reason|0|||
145578530|NCT00274716|524973684|FG005|Phase A|Other non-reported reason|1|||
145578531|NCT00274716|524973679|FG000|Phase A|Participant moved|0|||
145578532|NCT00274716|524973680|FG001|Phase A|Participant moved|0|||
145578533|NCT00274716|524973681|FG002|Phase A|Participant moved|1|||
145578534|NCT00274716|524973682|FG003|Phase A|Participant moved|0|||
145578535|NCT00274716|524973683|FG004|Phase A|Participant moved|0|||
145578536|NCT00274716|524973684|FG005|Phase A|Participant moved|1|||
145578537|NCT00274716|524973679|FG000|Phase A|Site Terminated|0|||
145578538|NCT00274716|524973680|FG001|Phase A|Site Terminated|0|||
145578539|NCT00274716|524973681|FG002|Phase A|Site Terminated|0|||
145578540|NCT00274716|524973682|FG003|Phase A|Site Terminated|1|||
145578541|NCT00274716|524973683|FG004|Phase A|Site Terminated|0|||
145578542|NCT00274716|524973684|FG005|Phase A|Site Terminated|0|||
145578543|NCT00274716|524973679|FG000|Phase A|Protocol Violation|1|||
145578544|NCT00274716|524973680|FG001|Phase A|Protocol Violation|0|||
145578545|NCT00274716|524973681|FG002|Phase A|Protocol Violation|0|||
145578546|NCT00274716|524973682|FG003|Phase A|Protocol Violation|1|||
145578547|NCT00274716|524973683|FG004|Phase A|Protocol Violation|0|||
145578548|NCT00274716|524973684|FG005|Phase A|Protocol Violation|0|||
145578549|NCT00274716|524973679|FG000|Phase A|Met criteria for discontinuation|1|||
145578550|NCT00274716|524973680|FG001|Phase A|Met criteria for discontinuation|1|||
145578551|NCT00274716|524973681|FG002|Phase A|Met criteria for discontinuation|0|||
145578552|NCT00274716|524973682|FG003|Phase A|Met criteria for discontinuation|0|||
145578553|NCT00274716|524973683|FG004|Phase A|Met criteria for discontinuation|0|||
145578554|NCT00274716|524973684|FG005|Phase A|Met criteria for discontinuation|0|||
145578555|NCT00274716|524973679|FG000|Phase A|Withdrawal by Subject|2|||
145578556|NCT00274716|524973680|FG001|Phase A|Withdrawal by Subject|2|||
145578557|NCT00274716|524973681|FG002|Phase A|Withdrawal by Subject|1|||
145578558|NCT00274716|524973682|FG003|Phase A|Withdrawal by Subject|3|||
145578559|NCT00274716|524973683|FG004|Phase A|Withdrawal by Subject|0|||
145578560|NCT00274716|524973684|FG005|Phase A|Withdrawal by Subject|1|||
145578561|NCT00274716|524973679|FG000|Phase A|Adverse Event|2|||
145578562|NCT00274716|524973680|FG001|Phase A|Adverse Event|3|||
145578563|NCT00274716|524973681|FG002|Phase A|Adverse Event|3|||
145578564|NCT00274716|524973682|FG003|Phase A|Adverse Event|0|||
145578565|NCT00274716|524973683|FG004|Phase A|Adverse Event|2|||
145578566|NCT00274716|524973684|FG005|Phase A|Adverse Event|0|||
145578567|NCT00274716|524973679|FG000|Phase A|Completed but did not enter Phase B|1|||
145578568|NCT00274716|524973680|FG001|Phase A|Completed but did not enter Phase B|2|||
145578569|NCT00274716|524973681|FG002|Phase A|Completed but did not enter Phase B|2|||
145578570|NCT00274716|524973682|FG003|Phase A|Completed but did not enter Phase B|2|||
145578571|NCT00274716|524973683|FG004|Phase A|Completed but did not enter Phase B|1|||
145578572|NCT00274716|524973684|FG005|Phase A|Completed but did not enter Phase B|1|||
145578573|NCT00274716|524973679|FG000|Phase B|Adverse Event|0|||
145578574|NCT00274716|524973680|FG001|Phase B|Adverse Event|0|||
145578575|NCT00274716|524973681|FG002|Phase B|Adverse Event|2|||
145578576|NCT00274716|524973682|FG003|Phase B|Adverse Event|0|||
145578577|NCT00274716|524973683|FG004|Phase B|Adverse Event|0|||
145578578|NCT00274716|524973684|FG005|Phase B|Adverse Event|1|||
145578579|NCT00274716|524973679|FG000|Phase B|Protocol Violation|0|||
145578580|NCT00274716|524973680|FG001|Phase B|Protocol Violation|2|||
145578581|NCT00274716|524973681|FG002|Phase B|Protocol Violation|0|||
145578582|NCT00274716|524973682|FG003|Phase B|Protocol Violation|0|||
145578583|NCT00274716|524973683|FG004|Phase B|Protocol Violation|0|||
145578584|NCT00274716|524973684|FG005|Phase B|Protocol Violation|0|||
145578585|NCT00274716|524973679|FG000|Phase B|Withdrawal by Subject|0|||
145578586|NCT00274716|524973680|FG001|Phase B|Withdrawal by Subject|1|||
145578587|NCT00274716|524973681|FG002|Phase B|Withdrawal by Subject|0|||
145422291|NCT02134028|524402053|FG006|Overall Study|Poor compliance to protocol|0|||
145578588|NCT00274716|524973682|FG003|Phase B|Withdrawal by Subject|0|||
145578589|NCT00274716|524973683|FG004|Phase B|Withdrawal by Subject|0|||
145578590|NCT00274716|524973684|FG005|Phase B|Withdrawal by Subject|0|||
145578591|NCT00274716|524973679|FG000|Phase B|Participant moved|1|||
145578592|NCT00274716|524973680|FG001|Phase B|Participant moved|0|||
145578593|NCT00274716|524973681|FG002|Phase B|Participant moved|0|||
145578594|NCT00274716|524973682|FG003|Phase B|Participant moved|0|||
145578595|NCT00274716|524973683|FG004|Phase B|Participant moved|0|||
145578596|NCT00274716|524973684|FG005|Phase B|Participant moved|0|||
145578597|NCT00274716|524973679|FG000|Phase B|Other non-reported reason|0|||
145578598|NCT00274716|524973680|FG001|Phase B|Other non-reported reason|0|||
145578599|NCT00274716|524973681|FG002|Phase B|Other non-reported reason|1|||
145578600|NCT00274716|524973682|FG003|Phase B|Other non-reported reason|1|||
145578601|NCT00274716|524973683|FG004|Phase B|Other non-reported reason|0|||
145578602|NCT00274716|524973684|FG005|Phase B|Other non-reported reason|0|||
145578603|NCT00274716|524973679|FG000|Phase B|Lost to Follow-up|0|||
145578604|NCT00274716|524973680|FG001|Phase B|Lost to Follow-up|1|||
145578605|NCT00274716|524973681|FG002|Phase B|Lost to Follow-up|0|||
145578606|NCT00274716|524973682|FG003|Phase B|Lost to Follow-up|0|||
145578607|NCT00274716|524973683|FG004|Phase B|Lost to Follow-up|0|||
145578608|NCT00274716|524973684|FG005|Phase B|Lost to Follow-up|0|||
145578609|NCT01774903|524973685|FG000|Overall Study|Adverse Event|7|||
145578610|NCT01774903|524973685|FG000|Overall Study|Withdrawal by Subject|2|||
145578611|NCT01774903|524973685|FG000|Overall Study|Lack of Efficacy|1|||
145578612|NCT01774903|524973685|FG000|Overall Study|Ineligible to continue the trial|1|||
145578613|NCT00924950|524973686|FG000|Overall Study|Lost to Follow-up|2|||
145578614|NCT01602315|524973687|FG000|Overall Study|Protocol Violation|0|||
145578615|NCT01602315|524973688|FG001|Overall Study|Protocol Violation|0|||
145578616|NCT01602315|524973689|FG002|Overall Study|Protocol Violation|0|||
145623341|NCT04034238|525133866|FG003|Dose Escalation Phase|Screen failures|2|||
145623342|NCT04034238|525133863|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
145623343|NCT04034238|525133864|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
145623344|NCT04034238|525133865|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
145623345|NCT04034238|525133866|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
145623346|NCT04034238|525133863|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
145623347|NCT04034238|525133864|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
145623348|NCT04034238|525133865|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
145623349|NCT04034238|525133866|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
145623350|NCT00465361|525133867|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
145623351|NCT01511536|525133868|FG000|Phase 1|Other|0|||
145623352|NCT01511536|525133869|FG001|Phase 1|Other|1|||
145623353|NCT01511536|525133870|FG002|Phase 1|Other|0|||
145623354|NCT01511536|525133868|FG000|Phase 2|Other|0|||
145623355|NCT01511536|525133869|FG001|Phase 2|Other|0|||
145623356|NCT01511536|525133870|FG002|Phase 2|Other|9|||
145623357|NCT02297503|525133874|FG000|Overall Study|Withdrawal by Subject|1|||
145623358|NCT02297503|525133875|FG001|Overall Study|Withdrawal by Subject|1|||
145623359|NCT02297503|525133874|FG000|Overall Study|Protocol Violation|1|||
145623360|NCT02297503|525133875|FG001|Overall Study|Protocol Violation|0|||
145623361|NCT02297503|525133874|FG000|Overall Study|Pregnancy|0|||
145623362|NCT02297503|525133875|FG001|Overall Study|Pregnancy|1|||
145623363|NCT02297503|525133874|FG000|Overall Study|Lost to Follow-up|0|||
145623364|NCT02297503|525133875|FG001|Overall Study|Lost to Follow-up|1|||
145623365|NCT02297503|525133874|FG000|Overall Study|Medical reason|0|||
145623366|NCT02297503|525133875|FG001|Overall Study|Medical reason|1|||
145623367|NCT02703532|525133877|FG000|Overall Study|Withdrawal by Subject|0|||
145623368|NCT02703532|525133878|FG001|Overall Study|Withdrawal by Subject|1|||
145623369|NCT02703532|525133879|FG002|Overall Study|Withdrawal by Subject|0|||
145623370|NCT02703532|525133880|FG003|Overall Study|Withdrawal by Subject|1|||
145623371|NCT02703532|525133877|FG000|Overall Study|Lost to Follow-up|2|||
145623372|NCT02703532|525133878|FG001|Overall Study|Lost to Follow-up|0|||
145623373|NCT02703532|525133879|FG002|Overall Study|Lost to Follow-up|2|||
145623374|NCT02703532|525133880|FG003|Overall Study|Lost to Follow-up|0|||
145623375|NCT03738241|525133884|FG000|Overall Study|Withdrawal by Subject|0|||
145623376|NCT03738241|525133885|FG001|Overall Study|Withdrawal by Subject|0|||
145623377|NCT03738241|525133886|FG002|Overall Study|Withdrawal by Subject|0|||
145578617|NCT01602315|524973690|FG003|Overall Study|Protocol Violation|0|||
145578618|NCT01602315|524973691|FG004|Overall Study|Protocol Violation|0|||
145623378|NCT03738241|525133887|FG003|Overall Study|Withdrawal by Subject|0|||
145623379|NCT03738241|525133888|FG004|Overall Study|Withdrawal by Subject|0|||
145623380|NCT03738241|525133889|FG005|Overall Study|Withdrawal by Subject|0|||
145623381|NCT03738241|525133890|FG006|Overall Study|Withdrawal by Subject|0|||
145623382|NCT03738241|525133891|FG007|Overall Study|Withdrawal by Subject|0|||
145623383|NCT03738241|525133892|FG008|Overall Study|Withdrawal by Subject|0|||
145623384|NCT03738241|525133893|FG009|Overall Study|Withdrawal by Subject|1|||
145623385|NCT03738241|525133884|FG000|Overall Study|Physician Decision|0|||
145623386|NCT03738241|525133885|FG001|Overall Study|Physician Decision|0|||
145623387|NCT03738241|525133886|FG002|Overall Study|Physician Decision|0|||
145623388|NCT03738241|525133887|FG003|Overall Study|Physician Decision|0|||
145623389|NCT03738241|525133888|FG004|Overall Study|Physician Decision|0|||
145578619|NCT01602315|524973692|FG005|Overall Study|Protocol Violation|1|||
145578620|NCT01602315|524973693|FG006|Overall Study|Protocol Violation|0|||
145578621|NCT01602315|524973687|FG000|Overall Study|Physician Decision|2|||
145422292|NCT02134028|524402054|FG007|Overall Study|Poor compliance to protocol|0|||
145422293|NCT02134028|524402047|FG000|Overall Study|Other unspecified|4|||
145422294|NCT02134028|524402048|FG001|Overall Study|Other unspecified|22|||
145422295|NCT02134028|524402049|FG002|Overall Study|Other unspecified|33|||
145422296|NCT02134028|524402050|FG003|Overall Study|Other unspecified|64|||
145422297|NCT02134028|524402051|FG004|Overall Study|Other unspecified|8|||
145422298|NCT02134028|524402052|FG005|Overall Study|Other unspecified|6|||
145422299|NCT02134028|524402053|FG006|Overall Study|Other unspecified|2|||
145578622|NCT01602315|524973688|FG001|Overall Study|Physician Decision|0|||
145578623|NCT01602315|524973689|FG002|Overall Study|Physician Decision|0|||
145578624|NCT01602315|524973690|FG003|Overall Study|Physician Decision|0|||
145422300|NCT02134028|524402054|FG007|Overall Study|Other unspecified|1|||
145422301|NCT02134028|524402047|FG000|Overall Study|Adverse Event|3|||
145422302|NCT02134028|524402048|FG001|Overall Study|Adverse Event|19|||
145578625|NCT01602315|524973691|FG004|Overall Study|Physician Decision|2|||
145578626|NCT01602315|524973692|FG005|Overall Study|Physician Decision|1|||
145578627|NCT01602315|524973693|FG006|Overall Study|Physician Decision|1|||
145578628|NCT01602315|524973687|FG000|Overall Study|Disease progression|6|||
145578629|NCT01602315|524973688|FG001|Overall Study|Disease progression|3|||
145578630|NCT01602315|524973689|FG002|Overall Study|Disease progression|10|||
145578631|NCT01602315|524973690|FG003|Overall Study|Disease progression|1|||
145578632|NCT01602315|524973691|FG004|Overall Study|Disease progression|41|||
145578633|NCT01602315|524973692|FG005|Overall Study|Disease progression|12|||
145578634|NCT01602315|524973693|FG006|Overall Study|Disease progression|15|||
145578635|NCT01602315|524973687|FG000|Overall Study|Death|1|||
145578636|NCT01602315|524973688|FG001|Overall Study|Death|1|||
145578637|NCT01602315|524973689|FG002|Overall Study|Death|1|||
145578638|NCT01602315|524973690|FG003|Overall Study|Death|1|||
145578639|NCT01602315|524973691|FG004|Overall Study|Death|7|||
145578640|NCT01602315|524973692|FG005|Overall Study|Death|2|||
145578641|NCT01602315|524973693|FG006|Overall Study|Death|2|||
145578642|NCT01602315|524973687|FG000|Overall Study|Withdrawal by Subject|2|||
145578643|NCT01602315|524973688|FG001|Overall Study|Withdrawal by Subject|0|||
145578644|NCT01602315|524973689|FG002|Overall Study|Withdrawal by Subject|2|||
145578645|NCT01602315|524973690|FG003|Overall Study|Withdrawal by Subject|0|||
145578646|NCT01602315|524973691|FG004|Overall Study|Withdrawal by Subject|6|||
145578647|NCT01602315|524973692|FG005|Overall Study|Withdrawal by Subject|0|||
145578648|NCT01602315|524973693|FG006|Overall Study|Withdrawal by Subject|1|||
145578649|NCT01602315|524973687|FG000|Overall Study|Adverse Event|5|||
145578650|NCT01602315|524973688|FG001|Overall Study|Adverse Event|1|||
145578651|NCT01602315|524973689|FG002|Overall Study|Adverse Event|5|||
145578652|NCT01602315|524973690|FG003|Overall Study|Adverse Event|4|||
145578653|NCT01602315|524973691|FG004|Overall Study|Adverse Event|15|||
145578654|NCT01602315|524973692|FG005|Overall Study|Adverse Event|3|||
145578655|NCT01602315|524973693|FG006|Overall Study|Adverse Event|9|||
145578656|NCT01602315|524973687|FG000|Overall Study|Subject/guardian decision|0|||
145578657|NCT01602315|524973688|FG001|Overall Study|Subject/guardian decision|0|||
145578658|NCT01602315|524973689|FG002|Overall Study|Subject/guardian decision|0|||
145578659|NCT01602315|524973690|FG003|Overall Study|Subject/guardian decision|0|||
145578660|NCT01602315|524973691|FG004|Overall Study|Subject/guardian decision|0|||
145578661|NCT01602315|524973692|FG005|Overall Study|Subject/guardian decision|0|||
145578662|NCT01602315|524973693|FG006|Overall Study|Subject/guardian decision|1|||
145578663|NCT01602315|524973687|FG000|Overall Study|Cross-over patients to combo treatment|0|||
145578664|NCT01602315|524973688|FG001|Overall Study|Cross-over patients to combo treatment|0|||
145578665|NCT01602315|524973689|FG002|Overall Study|Cross-over patients to combo treatment|0|||
145578666|NCT01602315|524973690|FG003|Overall Study|Cross-over patients to combo treatment|0|||
145578667|NCT01602315|524973691|FG004|Overall Study|Cross-over patients to combo treatment|0|||
145578668|NCT01602315|524973692|FG005|Overall Study|Cross-over patients to combo treatment|16|||
145578669|NCT01602315|524973693|FG006|Overall Study|Cross-over patients to combo treatment|0|||
145578670|NCT01777997|524973698|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
145578671|NCT01777997|524973698|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
145578672|NCT01777997|524973698|FG000|Weeks 48 to 72/96 on ART|Death|1|||
145578673|NCT01777997|524973698|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
145578674|NCT00961259|524973703|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
145578675|NCT00961259|524973704|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
145578676|NCT00961259|524973705|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
145578677|NCT01252251|524973706|FG000|Overall Study|Withdrawal by Subject|1|||
145578678|NCT01324024|524973707|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
145578679|NCT01324024|524973708|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145578680|NCT02691455|524973709|FG000|Overall Study|Withdrawal by Subject|1|||
145578681|NCT02691455|524973710|FG001|Overall Study|Withdrawal by Subject|2|||
145578682|NCT02691455|524973709|FG000|Overall Study|Lost to Follow-up|15|||
145578683|NCT02691455|524973710|FG001|Overall Study|Lost to Follow-up|15|||
145578684|NCT02932891|524973711|FG000|Overall Study|Lost to Follow-up|2|||
145578685|NCT02932891|524973711|FG000|Overall Study|HPA Suppress|2|||
145422303|NCT02134028|524402049|FG002|Overall Study|Adverse Event|13|||
145422304|NCT02134028|524402050|FG003|Overall Study|Adverse Event|32|||
145422305|NCT02134028|524402051|FG004|Overall Study|Adverse Event|4|||
145422306|NCT02134028|524402052|FG005|Overall Study|Adverse Event|5|||
145422307|NCT02134028|524402053|FG006|Overall Study|Adverse Event|1|||
145422308|NCT02134028|524402054|FG007|Overall Study|Adverse Event|2|||
145422309|NCT02965976|524402055|FG000|Overall Study|Withdrawal by Subject|2|||
145422310|NCT02965976|524402056|FG001|Overall Study|Withdrawal by Subject|0|||
145422311|NCT00806026|524402057|FG000|Overall Study|Death|0|||
145422312|NCT00806026|524402058|FG001|Overall Study|Death|0|||
145422313|NCT00806026|524402059|FG002|Overall Study|Death|0|||
145422314|NCT00806026|524402060|FG003|Overall Study|Death|1|||
145422315|NCT00806026|524402061|FG004|Overall Study|Death|0|||
145422316|NCT00806026|524402062|FG005|Overall Study|Death|0|||
145422317|NCT00806026|524402057|FG000|Overall Study|Did not meet entrance criteria|4|||
145422318|NCT00806026|524402058|FG001|Overall Study|Did not meet entrance criteria|1|||
145422319|NCT00806026|524402059|FG002|Overall Study|Did not meet entrance criteria|2|||
145422320|NCT00806026|524402060|FG003|Overall Study|Did not meet entrance criteria|1|||
145422321|NCT00806026|524402061|FG004|Overall Study|Did not meet entrance criteria|0|||
145422322|NCT00806026|524402062|FG005|Overall Study|Did not meet entrance criteria|0|||
145422323|NCT00806026|524402057|FG000|Overall Study|Lack of Efficacy|5|||
145422324|NCT00806026|524402058|FG001|Overall Study|Lack of Efficacy|18|||
145422325|NCT00806026|524402059|FG002|Overall Study|Lack of Efficacy|13|||
145422326|NCT00806026|524402060|FG003|Overall Study|Lack of Efficacy|4|||
145422327|NCT00806026|524402061|FG004|Overall Study|Lack of Efficacy|8|||
145422328|NCT00806026|524402062|FG005|Overall Study|Lack of Efficacy|7|||
145422329|NCT00806026|524402057|FG000|Overall Study|Lost to Follow-up|8|||
145422330|NCT00806026|524402058|FG001|Overall Study|Lost to Follow-up|15|||
145422331|NCT00806026|524402059|FG002|Overall Study|Lost to Follow-up|8|||
145422332|NCT00806026|524402060|FG003|Overall Study|Lost to Follow-up|2|||
145422333|NCT00806026|524402061|FG004|Overall Study|Lost to Follow-up|6|||
145422334|NCT00806026|524402062|FG005|Overall Study|Lost to Follow-up|6|||
145422335|NCT00806026|524402057|FG000|Overall Study|Withdrawal by Subject|14|||
145422336|NCT00806026|524402058|FG001|Overall Study|Withdrawal by Subject|17|||
145422337|NCT00806026|524402059|FG002|Overall Study|Withdrawal by Subject|9|||
145422338|NCT00806026|524402060|FG003|Overall Study|Withdrawal by Subject|2|||
145422339|NCT00806026|524402061|FG004|Overall Study|Withdrawal by Subject|5|||
145422340|NCT00806026|524402062|FG005|Overall Study|Withdrawal by Subject|3|||
145422341|NCT00806026|524402057|FG000|Overall Study|Other|3|||
145422342|NCT00806026|524402058|FG001|Overall Study|Other|6|||
145422343|NCT00806026|524402059|FG002|Overall Study|Other|8|||
145422344|NCT00806026|524402060|FG003|Overall Study|Other|2|||
145422345|NCT00806026|524402061|FG004|Overall Study|Other|0|||
145422346|NCT00806026|524402062|FG005|Overall Study|Other|4|||
145422347|NCT00806026|524402057|FG000|Overall Study|Protocol Violation|6|||
145578686|NCT02057757|524973712|FG000|Overall Study|Withdrawal by Subject|3|||
145578687|NCT02057757|524973713|FG001|Overall Study|Withdrawal by Subject|5|||
145578688|NCT02057757|524973712|FG000|Overall Study|Death|2|||
145578689|NCT02057757|524973713|FG001|Overall Study|Death|0|||
145578690|NCT02057757|524973712|FG000|Overall Study|Lost to Follow-up|8|||
145578691|NCT02057757|524973713|FG001|Overall Study|Lost to Follow-up|3|||
145578692|NCT02057757|524973712|FG000|Overall Study|Non-compliance|1|||
145578693|NCT02057757|524973713|FG001|Overall Study|Non-compliance|0|||
145578694|NCT00563797|524973714|FG000|Overall Study|Lost to Follow-up|7|||
145578695|NCT00563797|524973715|FG001|Overall Study|Lost to Follow-up|2|||
145578696|NCT00530023|524973716|FG000|Overall Study|Withdrawal by Subject|0|||
145578697|NCT00530023|524973717|FG001|Overall Study|Withdrawal by Subject|1|||
145578698|NCT01158222|524973718|FG000|Overall Study|Not eligible for intermediate phase|17|||
145578699|NCT00111228|524973719|FG000|Overall Study|Withdrawal by Subject|5|||
145578700|NCT00111228|524973720|FG001|Overall Study|Withdrawal by Subject|1|||
145578701|NCT00111228|524973721|FG002|Overall Study|Withdrawal by Subject|0|||
145578702|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
145578703|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
145578704|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
145578705|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
145578706|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
145578707|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
145578708|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
145623390|NCT03738241|525133889|FG005|Overall Study|Physician Decision|0|||
145422348|NCT00806026|524402058|FG001|Overall Study|Protocol Violation|9|||
145422349|NCT00806026|524402059|FG002|Overall Study|Protocol Violation|9|||
145422350|NCT00806026|524402060|FG003|Overall Study|Protocol Violation|0|||
145422351|NCT00806026|524402061|FG004|Overall Study|Protocol Violation|2|||
145422352|NCT00806026|524402062|FG005|Overall Study|Protocol Violation|3|||
145422353|NCT00806026|524402057|FG000|Overall Study|Adverse Event|52|||
145422354|NCT00806026|524402058|FG001|Overall Study|Adverse Event|35|||
145422355|NCT00806026|524402059|FG002|Overall Study|Adverse Event|44|||
145422356|NCT00806026|524402060|FG003|Overall Study|Adverse Event|17|||
145422357|NCT00806026|524402061|FG004|Overall Study|Adverse Event|9|||
145422358|NCT00806026|524402062|FG005|Overall Study|Adverse Event|9|||
145623391|NCT03738241|525133890|FG006|Overall Study|Physician Decision|0|||
145623392|NCT03738241|525133891|FG007|Overall Study|Physician Decision|0|||
145623393|NCT03738241|525133892|FG008|Overall Study|Physician Decision|1|||
145623394|NCT03738241|525133893|FG009|Overall Study|Physician Decision|0|||
145623395|NCT03738241|525133884|FG000|Overall Study|Adverse Event|1|||
145623396|NCT03738241|525133885|FG001|Overall Study|Adverse Event|0|||
145623397|NCT03738241|525133886|FG002|Overall Study|Adverse Event|0|||
145623398|NCT03738241|525133887|FG003|Overall Study|Adverse Event|0|||
145623399|NCT03738241|525133888|FG004|Overall Study|Adverse Event|0|||
145623400|NCT03738241|525133889|FG005|Overall Study|Adverse Event|0|||
145623401|NCT03738241|525133890|FG006|Overall Study|Adverse Event|0|||
145623402|NCT03738241|525133891|FG007|Overall Study|Adverse Event|0|||
145623403|NCT03738241|525133892|FG008|Overall Study|Adverse Event|0|||
145623404|NCT03738241|525133893|FG009|Overall Study|Adverse Event|0|||
145623405|NCT01244763|525133894|FG000|Overall Study|Adverse Event|1|||
145623406|NCT01244763|525133895|FG001|Overall Study|Adverse Event|0|||
145623407|NCT01244763|525133896|FG002|Overall Study|Adverse Event|0|||
145623408|NCT01244763|525133897|FG003|Overall Study|Adverse Event|0|||
145623409|NCT01244763|525133898|FG004|Overall Study|Adverse Event|0|||
145623410|NCT01244763|525133899|FG005|Overall Study|Adverse Event|1|||
145623411|NCT01244763|525133894|FG000|Overall Study|Death|1|||
145623412|NCT01244763|525133895|FG001|Overall Study|Death|0|||
145623413|NCT01244763|525133896|FG002|Overall Study|Death|1|||
145623414|NCT01244763|525133897|FG003|Overall Study|Death|0|||
145623415|NCT01244763|525133898|FG004|Overall Study|Death|2|||
145368072|NCT01867710|524198480|FG003|Overall Study|Clinical progression|0|||
145368073|NCT01867710|524198477|FG000|Overall Study|Disease progression|1|||
145368074|NCT01867710|524198478|FG001|Overall Study|Disease progression|0|||
145368075|NCT01867710|524198479|FG002|Overall Study|Disease progression|0|||
145368076|NCT01867710|524198480|FG003|Overall Study|Disease progression|0|||
145368077|NCT01867710|524198477|FG000|Overall Study|Patient decision|0|||
145368078|NCT01867710|524198478|FG001|Overall Study|Patient decision|0|||
145368079|NCT01867710|524198479|FG002|Overall Study|Patient decision|0|||
145368080|NCT01867710|524198480|FG003|Overall Study|Patient decision|1|||
145368081|NCT01867710|524198477|FG000|Overall Study|Patient to follow subsequent treatment|0|||
145368082|NCT01867710|524198478|FG001|Overall Study|Patient to follow subsequent treatment|1|||
145368083|NCT01867710|524198479|FG002|Overall Study|Patient to follow subsequent treatment|0|||
145368084|NCT01867710|524198480|FG003|Overall Study|Patient to follow subsequent treatment|0|||
145368085|NCT01867710|524198477|FG000|Overall Study|Progressive disease|1|||
145368086|NCT01867710|524198478|FG001|Overall Study|Progressive disease|0|||
145368087|NCT01867710|524198479|FG002|Overall Study|Progressive disease|0|||
145368088|NCT01867710|524198480|FG003|Overall Study|Progressive disease|0|||
145368089|NCT01867710|524198477|FG000|Overall Study|Protocol Violation|0|||
145368090|NCT01867710|524198478|FG001|Overall Study|Protocol Violation|0|||
145368091|NCT01867710|524198479|FG002|Overall Study|Protocol Violation|0|||
145368092|NCT01867710|524198480|FG003|Overall Study|Protocol Violation|1|||
145368093|NCT01867710|524198477|FG000|Overall Study|PSA-progression|0|||
145368094|NCT01867710|524198478|FG001|Overall Study|PSA-progression|1|||
145368095|NCT01867710|524198479|FG002|Overall Study|PSA-progression|0|||
145368096|NCT01867710|524198480|FG003|Overall Study|PSA-progression|0|||
145368097|NCT01867710|524198477|FG000|Overall Study|Study medication no longer effective|0|||
145368098|NCT01867710|524198478|FG001|Overall Study|Study medication no longer effective|1|||
145368099|NCT01867710|524198479|FG002|Overall Study|Study medication no longer effective|0|||
145368100|NCT01867710|524198480|FG003|Overall Study|Study medication no longer effective|0|||
145368101|NCT01471340|524198484|FG000|Overall Study|Death|5|||
145368102|NCT01471340|524198485|FG001|Overall Study|Death|4|||
145368103|NCT01471340|524198484|FG000|Overall Study|Lost to Follow-up|0|||
145368104|NCT01471340|524198485|FG001|Overall Study|Lost to Follow-up|1|||
145368105|NCT01471340|524198484|FG000|Overall Study|Investigational site closure|0|||
145368106|NCT01471340|524198485|FG001|Overall Study|Investigational site closure|1|||
145368107|NCT01471340|524198484|FG000|Overall Study|Invalid informed consent|1|||
145368108|NCT01471340|524198485|FG001|Overall Study|Invalid informed consent|0|||
145368109|NCT03499899|524198486|FG000|Overall Study|Adverse Event|2|||
145368110|NCT03499899|524198487|FG001|Overall Study|Adverse Event|3|||
145368111|NCT03499899|524198488|FG002|Overall Study|Adverse Event|3|||
145368112|NCT03499899|524198486|FG000|Overall Study|Death|0|||
145368113|NCT03499899|524198487|FG001|Overall Study|Death|0|||
145368114|NCT03499899|524198488|FG002|Overall Study|Death|1|||
145368115|NCT03499899|524198486|FG000|Overall Study|Physician Decision|3|||
145368116|NCT03499899|524198487|FG001|Overall Study|Physician Decision|6|||
145368117|NCT03499899|524198488|FG002|Overall Study|Physician Decision|6|||
145368118|NCT03499899|524198486|FG000|Overall Study|Progressive disease|15|||
145368119|NCT03499899|524198487|FG001|Overall Study|Progressive disease|23|||
145368120|NCT03499899|524198488|FG002|Overall Study|Progressive disease|23|||
145368121|NCT03499899|524198486|FG000|Overall Study|Patient decision|0|||
145368122|NCT03499899|524198487|FG001|Overall Study|Patient decision|1|||
145623416|NCT01244763|525133899|FG005|Overall Study|Death|0|||
145623417|NCT01244763|525133894|FG000|Overall Study|Physician Decision|0|||
145623418|NCT01244763|525133895|FG001|Overall Study|Physician Decision|0|||
145623419|NCT01244763|525133896|FG002|Overall Study|Physician Decision|1|||
145422359|NCT01260311|524402066|FG000|Overall Study|Adverse Event|11|||
145422360|NCT01260311|524402066|FG000|Overall Study|Lack of Efficacy|4|||
145422361|NCT01260311|524402066|FG000|Overall Study|Lost to Follow-up|25|||
145422362|NCT01260311|524402066|FG000|Overall Study|Withdrawal by Subject|6|||
145422363|NCT01260311|524402066|FG000|Overall Study|Financial Constraints|77|||
145422364|NCT01260311|524402066|FG000|Overall Study|Gone to Province|2|||
145422365|NCT01260311|524402066|FG000|Overall Study|Medication Stopped|1|||
145422366|NCT01260311|524402066|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
145422367|NCT01714063|524402069|FG000|Overall Study|Equipment malfunction|2|||
145422368|NCT06048705|524402076|FG000|Overall Study|Physician Decision|1|||
145422369|NCT06048705|524402077|FG001|Overall Study|Physician Decision|0|||
145422370|NCT06048705|524402078|FG002|Overall Study|Physician Decision|0|||
145422371|NCT06048705|524402076|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
145422372|NCT06048705|524402077|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
145422373|NCT06048705|524402078|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
145422374|NCT06048705|524402076|FG000|Overall Study|Death prior to lymphodepletion|0|||
145578709|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
145578710|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
145368123|NCT03499899|524198488|FG002|Overall Study|Patient decision|1|||
145368124|NCT03499899|524198486|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
145368125|NCT03499899|524198487|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
145368126|NCT03499899|524198488|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
145368127|NCT01609543|524198493|FG000|Overall Study|Disease Progression|28|||
145368128|NCT01609543|524198493|FG000|Overall Study|Adverse Event|5|||
145368129|NCT01609543|524198493|FG000|Overall Study|Withdrawal by Subject|1|||
145368130|NCT01609543|524198493|FG000|Overall Study|Protocol Violation|1|||
145368131|NCT01609543|524198493|FG000|Overall Study|Death|7|||
145368132|NCT02218736|524198494|FG000|Overall Study|Withdrawal by Subject|10|||
145368133|NCT02218736|524198495|FG001|Overall Study|Withdrawal by Subject|9|||
145368134|NCT02218736|524198494|FG000|Overall Study|Protocol Violation|2|||
145368135|NCT02218736|524198495|FG001|Overall Study|Protocol Violation|0|||
145368136|NCT03702010|524198502|FG000|Follow-up (30days)|Lack of Efficacy|2|||
145368137|NCT03702010|524198503|FG001|Follow-up (30days)|Lack of Efficacy|2|||
145368138|NCT01254318|524198504|FG000|Overall Study|Lost to Follow-up|5|||
145368139|NCT01254318|524198504|FG000|Overall Study|Death|47|||
145368140|NCT02295020|524198517|FG000|Overall Study|Adverse Event|0|||
145368141|NCT02295020|524198518|FG001|Overall Study|Adverse Event|1|||
145368142|NCT02295020|524198517|FG000|Overall Study|Withdrawal by Subject|3|||
145368143|NCT02295020|524198518|FG001|Overall Study|Withdrawal by Subject|2|||
145368144|NCT03557931|524198519|FG000|Overall Study|Adverse Event|4|||
145368145|NCT03557931|524198520|FG001|Overall Study|Adverse Event|6|||
145368146|NCT03557931|524198521|FG002|Overall Study|Adverse Event|1|||
145368147|NCT03557931|524198519|FG000|Overall Study|Lost to Follow-up|4|||
145368148|NCT03557931|524198520|FG001|Overall Study|Lost to Follow-up|4|||
145368149|NCT03557931|524198521|FG002|Overall Study|Lost to Follow-up|1|||
145368150|NCT03557931|524198519|FG000|Overall Study|Protocol Violation|1|||
145368151|NCT03557931|524198520|FG001|Overall Study|Protocol Violation|4|||
145368152|NCT03557931|524198521|FG002|Overall Study|Protocol Violation|1|||
145368153|NCT03557931|524198519|FG000|Overall Study|Withdrawal by Subject|14|||
145368154|NCT03557931|524198520|FG001|Overall Study|Withdrawal by Subject|0|||
145368155|NCT03557931|524198521|FG002|Overall Study|Withdrawal by Subject|7|||
145368156|NCT03557931|524198519|FG000|Overall Study|Miscellaneous|8|||
145368157|NCT03557931|524198520|FG001|Overall Study|Miscellaneous|5|||
145368158|NCT03557931|524198521|FG002|Overall Study|Miscellaneous|3|||
145368159|NCT02394340|524198524|FG000|Overall Study|Failed drug screen test|1|||
145368160|NCT02394340|524198524|FG000|Overall Study|Adverse Event|1|||
145368161|NCT03315286|524198525|FG000|Overall Study|Lost to Follow-up|0|||
145368162|NCT03315286|524198526|FG001|Overall Study|Lost to Follow-up|3|||
145368163|NCT03315286|524198525|FG000|Overall Study|Withdrawal by Subject|1|||
145422375|NCT06048705|524402077|FG001|Overall Study|Death prior to lymphodepletion|0|||
145422376|NCT06048705|524402078|FG002|Overall Study|Death prior to lymphodepletion|1|||
145422377|NCT02971137|524402079|FG000|Overall Study|Lost to Follow-up|44|||
145422378|NCT02971137|524402080|FG001|Overall Study|Lost to Follow-up|56|||
145422379|NCT00215657|524402081|FG000|Overall Study|Adverse Event|5|||
145422380|NCT00215657|524402082|FG001|Overall Study|Adverse Event|1|||
145623420|NCT01244763|525133897|FG003|Overall Study|Physician Decision|0|||
145368164|NCT03315286|524198526|FG001|Overall Study|Withdrawal by Subject|0|||
145368165|NCT03315286|524198525|FG000|Overall Study|Protocol Violation|0|||
145368166|NCT03315286|524198526|FG001|Overall Study|Protocol Violation|1|||
145368167|NCT02828124|524198527|FG000|Overall Study|Disease Progression|1|||
145368168|NCT02828124|524198528|FG001|Overall Study|Disease Progression|2|||
145368169|NCT02828124|524198529|FG002|Overall Study|Disease Progression|1|||
145422381|NCT00215657|524402083|FG002|Overall Study|Adverse Event|3|||
145422382|NCT00215657|524402084|FG003|Overall Study|Adverse Event|0|||
145422383|NCT00215657|524402085|FG004|Overall Study|Adverse Event|3|||
145422384|NCT00215657|524402086|FG005|Overall Study|Adverse Event|1|||
145422385|NCT00215657|524402087|FG006|Overall Study|Adverse Event|0|||
145368170|NCT02828124|524198530|FG003|Overall Study|Disease Progression|4|||
145368171|NCT02828124|524198527|FG000|Overall Study|AE Unrelated to Study Drug|0|||
145368172|NCT02828124|524198528|FG001|Overall Study|AE Unrelated to Study Drug|0|||
145368173|NCT02828124|524198529|FG002|Overall Study|AE Unrelated to Study Drug|0|||
145368174|NCT02828124|524198530|FG003|Overall Study|AE Unrelated to Study Drug|1|||
145368175|NCT02828124|524198527|FG000|Overall Study|Subject Withdrew Consent|0|||
145368176|NCT02828124|524198528|FG001|Overall Study|Subject Withdrew Consent|0|||
145368177|NCT02828124|524198529|FG002|Overall Study|Subject Withdrew Consent|0|||
145368178|NCT02828124|524198530|FG003|Overall Study|Subject Withdrew Consent|1|||
145368179|NCT00747474|524198531|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368180|NCT00747474|524198532|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368181|NCT00747474|524198533|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368182|NCT00747474|524198534|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368183|NCT00747474|524198535|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368184|NCT00747474|524198536|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368185|NCT00747474|524198537|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368186|NCT00747474|524198538|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
145368187|NCT00747474|524198539|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368188|NCT00747474|524198540|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368189|NCT00747474|524198541|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368190|NCT00747474|524198542|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
145368191|NCT02829723|524198544|FG000|Overall Study|Adverse Event|0|||
145368192|NCT02829723|524198545|FG001|Overall Study|Adverse Event|0|||
145368193|NCT02829723|524198546|FG002|Overall Study|Adverse Event|1|||
145368194|NCT02829723|524198547|FG003|Overall Study|Adverse Event|1|||
145368195|NCT02829723|524198548|FG004|Overall Study|Adverse Event|0|||
145368196|NCT02829723|524198549|FG005|Overall Study|Adverse Event|0|||
145368197|NCT02829723|524198550|FG006|Overall Study|Adverse Event|0|||
145368198|NCT02829723|524198551|FG007|Overall Study|Adverse Event|1|||
145368199|NCT02829723|524198552|FG008|Overall Study|Adverse Event|0|||
145368200|NCT02829723|524198553|FG009|Overall Study|Adverse Event|0|||
145368201|NCT02829723|524198554|FG010|Overall Study|Adverse Event|0|||
145368202|NCT02829723|524198555|FG011|Overall Study|Adverse Event|0|||
145368203|NCT02829723|524198556|FG012|Overall Study|Adverse Event|0|||
145368204|NCT02829723|524198557|FG013|Overall Study|Adverse Event|0|||
145368205|NCT02829723|524198558|FG014|Overall Study|Adverse Event|1|||
145368206|NCT02829723|524198559|FG015|Overall Study|Adverse Event|1|||
145368207|NCT02829723|524198560|FG016|Overall Study|Adverse Event|1|||
145368208|NCT02829723|524198561|FG017|Overall Study|Adverse Event|2|||
145368209|NCT02829723|524198562|FG018|Overall Study|Adverse Event|1|||
145368210|NCT02829723|524198563|FG019|Overall Study|Adverse Event|1|||
145368211|NCT02829723|524198564|FG020|Overall Study|Adverse Event|3|||
145368212|NCT02829723|524198565|FG021|Overall Study|Adverse Event|0|||
145368213|NCT02829723|524198566|FG022|Overall Study|Adverse Event|0|||
145368214|NCT02829723|524198567|FG023|Overall Study|Adverse Event|1|||
145368215|NCT02829723|524198568|FG024|Overall Study|Adverse Event|1|||
145368216|NCT02829723|524198569|FG025|Overall Study|Adverse Event|3|||
145368217|NCT02829723|524198570|FG026|Overall Study|Adverse Event|5|||
145368218|NCT02829723|524198544|FG000|Overall Study|Death|1|||
145368219|NCT02829723|524198545|FG001|Overall Study|Death|0|||
145368220|NCT02829723|524198546|FG002|Overall Study|Death|1|||
145368221|NCT02829723|524198547|FG003|Overall Study|Death|1|||
145368222|NCT02829723|524198548|FG004|Overall Study|Death|0|||
145368223|NCT02829723|524198549|FG005|Overall Study|Death|0|||
145368224|NCT02829723|524198550|FG006|Overall Study|Death|2|||
145368225|NCT02829723|524198551|FG007|Overall Study|Death|0|||
145368226|NCT02829723|524198552|FG008|Overall Study|Death|1|||
145368227|NCT02829723|524198553|FG009|Overall Study|Death|0|||
145368228|NCT02829723|524198554|FG010|Overall Study|Death|0|||
145368229|NCT02829723|524198555|FG011|Overall Study|Death|0|||
145368230|NCT02829723|524198556|FG012|Overall Study|Death|2|||
145368231|NCT02829723|524198557|FG013|Overall Study|Death|1|||
145368232|NCT02829723|524198558|FG014|Overall Study|Death|0|||
145368233|NCT02829723|524198559|FG015|Overall Study|Death|0|||
145368234|NCT02829723|524198560|FG016|Overall Study|Death|0|||
145368235|NCT02829723|524198561|FG017|Overall Study|Death|0|||
145368236|NCT02829723|524198562|FG018|Overall Study|Death|0|||
145368237|NCT02829723|524198563|FG019|Overall Study|Death|0|||
145368238|NCT02829723|524198564|FG020|Overall Study|Death|0|||
145368239|NCT02829723|524198565|FG021|Overall Study|Death|2|||
145368240|NCT02829723|524198566|FG022|Overall Study|Death|0|||
145368241|NCT02829723|524198567|FG023|Overall Study|Death|0|||
145368242|NCT02829723|524198568|FG024|Overall Study|Death|0|||
145368243|NCT02829723|524198569|FG025|Overall Study|Death|1|||
145368244|NCT02829723|524198570|FG026|Overall Study|Death|2|||
145368245|NCT02829723|524198544|FG000|Overall Study|Physician Decision|0|||
145368246|NCT02829723|524198545|FG001|Overall Study|Physician Decision|0|||
145368247|NCT02829723|524198546|FG002|Overall Study|Physician Decision|0|||
145368248|NCT02829723|524198547|FG003|Overall Study|Physician Decision|0|||
145422386|NCT00215657|524402088|FG007|Overall Study|Adverse Event|3|||
145422387|NCT00215657|524402081|FG000|Overall Study|Withdrawal by Subject|6|||
145422388|NCT00215657|524402082|FG001|Overall Study|Withdrawal by Subject|3|||
145422389|NCT00215657|524402083|FG002|Overall Study|Withdrawal by Subject|3|||
145422390|NCT00215657|524402084|FG003|Overall Study|Withdrawal by Subject|1|||
145422391|NCT00215657|524402085|FG004|Overall Study|Withdrawal by Subject|6|||
145368249|NCT02829723|524198548|FG004|Overall Study|Physician Decision|0|||
145368250|NCT02829723|524198549|FG005|Overall Study|Physician Decision|0|||
145368251|NCT02829723|524198550|FG006|Overall Study|Physician Decision|0|||
145368252|NCT02829723|524198551|FG007|Overall Study|Physician Decision|0|||
145368253|NCT02829723|524198552|FG008|Overall Study|Physician Decision|0|||
145368254|NCT02829723|524198553|FG009|Overall Study|Physician Decision|1|||
145368255|NCT02829723|524198554|FG010|Overall Study|Physician Decision|1|||
145368256|NCT02829723|524198555|FG011|Overall Study|Physician Decision|0|||
145368257|NCT02829723|524198556|FG012|Overall Study|Physician Decision|0|||
145368258|NCT02829723|524198557|FG013|Overall Study|Physician Decision|1|||
145368259|NCT02829723|524198558|FG014|Overall Study|Physician Decision|0|||
145368260|NCT02829723|524198559|FG015|Overall Study|Physician Decision|0|||
145368261|NCT02829723|524198560|FG016|Overall Study|Physician Decision|2|||
145368262|NCT02829723|524198561|FG017|Overall Study|Physician Decision|0|||
145368263|NCT02829723|524198562|FG018|Overall Study|Physician Decision|0|||
145368264|NCT02829723|524198563|FG019|Overall Study|Physician Decision|0|||
145368265|NCT02829723|524198564|FG020|Overall Study|Physician Decision|0|||
145368266|NCT02829723|524198565|FG021|Overall Study|Physician Decision|0|||
145368267|NCT02829723|524198566|FG022|Overall Study|Physician Decision|1|||
145368268|NCT02829723|524198567|FG023|Overall Study|Physician Decision|1|||
145368269|NCT02829723|524198568|FG024|Overall Study|Physician Decision|1|||
145368270|NCT02829723|524198569|FG025|Overall Study|Physician Decision|1|||
145368271|NCT02829723|524198570|FG026|Overall Study|Physician Decision|3|||
145368272|NCT02829723|524198544|FG000|Overall Study|Progressive disease|4|||
145368273|NCT02829723|524198545|FG001|Overall Study|Progressive disease|6|||
145368274|NCT02829723|524198546|FG002|Overall Study|Progressive disease|3|||
145368275|NCT02829723|524198547|FG003|Overall Study|Progressive disease|3|||
145368276|NCT02829723|524198548|FG004|Overall Study|Progressive disease|3|||
145368277|NCT02829723|524198549|FG005|Overall Study|Progressive disease|5|||
145368278|NCT02829723|524198550|FG006|Overall Study|Progressive disease|4|||
145368279|NCT02829723|524198551|FG007|Overall Study|Progressive disease|6|||
145368280|NCT02829723|524198552|FG008|Overall Study|Progressive disease|8|||
145368281|NCT02829723|524198553|FG009|Overall Study|Progressive disease|4|||
145368282|NCT02829723|524198554|FG010|Overall Study|Progressive disease|9|||
145368283|NCT02829723|524198555|FG011|Overall Study|Progressive disease|0|||
145368284|NCT02829723|524198556|FG012|Overall Study|Progressive disease|3|||
145368285|NCT02829723|524198557|FG013|Overall Study|Progressive disease|4|||
145368286|NCT02829723|524198558|FG014|Overall Study|Progressive disease|2|||
145368287|NCT02829723|524198559|FG015|Overall Study|Progressive disease|4|||
145368288|NCT02829723|524198560|FG016|Overall Study|Progressive disease|5|||
145368289|NCT02829723|524198561|FG017|Overall Study|Progressive disease|3|||
145368290|NCT02829723|524198562|FG018|Overall Study|Progressive disease|4|||
145368291|NCT02829723|524198563|FG019|Overall Study|Progressive disease|4|||
145368292|NCT02829723|524198564|FG020|Overall Study|Progressive disease|7|||
145368293|NCT02829723|524198565|FG021|Overall Study|Progressive disease|6|||
145368294|NCT02829723|524198566|FG022|Overall Study|Progressive disease|3|||
145368295|NCT02829723|524198567|FG023|Overall Study|Progressive disease|3|||
145368296|NCT02829723|524198568|FG024|Overall Study|Progressive disease|3|||
145368297|NCT02829723|524198569|FG025|Overall Study|Progressive disease|16|||
145368298|NCT02829723|524198570|FG026|Overall Study|Progressive disease|10|||
145368299|NCT02829723|524198544|FG000|Overall Study|Subject/guardian decision|0|||
145368300|NCT02829723|524198545|FG001|Overall Study|Subject/guardian decision|1|||
145368301|NCT02829723|524198546|FG002|Overall Study|Subject/guardian decision|0|||
145368302|NCT02829723|524198547|FG003|Overall Study|Subject/guardian decision|1|||
145368303|NCT02829723|524198548|FG004|Overall Study|Subject/guardian decision|0|||
145368304|NCT02829723|524198549|FG005|Overall Study|Subject/guardian decision|0|||
145368305|NCT02829723|524198550|FG006|Overall Study|Subject/guardian decision|0|||
145368306|NCT02829723|524198551|FG007|Overall Study|Subject/guardian decision|1|||
145368307|NCT02829723|524198552|FG008|Overall Study|Subject/guardian decision|0|||
145422392|NCT00215657|524402086|FG005|Overall Study|Withdrawal by Subject|1|||
145368308|NCT02829723|524198553|FG009|Overall Study|Subject/guardian decision|0|||
145368309|NCT02829723|524198554|FG010|Overall Study|Subject/guardian decision|0|||
145368310|NCT02829723|524198555|FG011|Overall Study|Subject/guardian decision|0|||
145368311|NCT02829723|524198556|FG012|Overall Study|Subject/guardian decision|0|||
145368312|NCT02829723|524198557|FG013|Overall Study|Subject/guardian decision|0|||
145368313|NCT02829723|524198558|FG014|Overall Study|Subject/guardian decision|1|||
145368314|NCT02829723|524198559|FG015|Overall Study|Subject/guardian decision|0|||
145368315|NCT02829723|524198560|FG016|Overall Study|Subject/guardian decision|1|||
145368316|NCT02829723|524198561|FG017|Overall Study|Subject/guardian decision|0|||
145368317|NCT02829723|524198562|FG018|Overall Study|Subject/guardian decision|1|||
145368318|NCT02829723|524198563|FG019|Overall Study|Subject/guardian decision|0|||
145368319|NCT02829723|524198564|FG020|Overall Study|Subject/guardian decision|1|||
145422393|NCT00215657|524402087|FG006|Overall Study|Withdrawal by Subject|10|||
145368320|NCT02829723|524198565|FG021|Overall Study|Subject/guardian decision|0|||
145368321|NCT02829723|524198566|FG022|Overall Study|Subject/guardian decision|0|||
145368322|NCT02829723|524198567|FG023|Overall Study|Subject/guardian decision|1|||
145368323|NCT02829723|524198568|FG024|Overall Study|Subject/guardian decision|0|||
145368324|NCT02829723|524198569|FG025|Overall Study|Subject/guardian decision|1|||
145368325|NCT02829723|524198570|FG026|Overall Study|Subject/guardian decision|1|||
145368326|NCT02829723|524198544|FG000|Overall Study|Study terminated by sponsor|0|||
145368327|NCT02829723|524198545|FG001|Overall Study|Study terminated by sponsor|0|||
145368328|NCT02829723|524198546|FG002|Overall Study|Study terminated by sponsor|0|||
145368329|NCT02829723|524198547|FG003|Overall Study|Study terminated by sponsor|0|||
145368330|NCT02829723|524198548|FG004|Overall Study|Study terminated by sponsor|0|||
145368331|NCT02829723|524198549|FG005|Overall Study|Study terminated by sponsor|0|||
145368332|NCT02829723|524198550|FG006|Overall Study|Study terminated by sponsor|0|||
145368333|NCT02829723|524198551|FG007|Overall Study|Study terminated by sponsor|0|||
145368334|NCT02829723|524198552|FG008|Overall Study|Study terminated by sponsor|0|||
145368335|NCT02829723|524198553|FG009|Overall Study|Study terminated by sponsor|0|||
145368336|NCT02829723|524198554|FG010|Overall Study|Study terminated by sponsor|0|||
145368337|NCT02829723|524198555|FG011|Overall Study|Study terminated by sponsor|0|||
145368338|NCT02829723|524198556|FG012|Overall Study|Study terminated by sponsor|0|||
145368339|NCT02829723|524198557|FG013|Overall Study|Study terminated by sponsor|0|||
145368340|NCT02829723|524198558|FG014|Overall Study|Study terminated by sponsor|0|||
145368341|NCT02829723|524198559|FG015|Overall Study|Study terminated by sponsor|0|||
145368342|NCT02829723|524198560|FG016|Overall Study|Study terminated by sponsor|0|||
145368343|NCT02829723|524198561|FG017|Overall Study|Study terminated by sponsor|0|||
145368344|NCT02829723|524198562|FG018|Overall Study|Study terminated by sponsor|0|||
145368345|NCT02829723|524198563|FG019|Overall Study|Study terminated by sponsor|0|||
145368346|NCT02829723|524198564|FG020|Overall Study|Study terminated by sponsor|0|||
145368347|NCT02829723|524198565|FG021|Overall Study|Study terminated by sponsor|1|||
145368348|NCT02829723|524198566|FG022|Overall Study|Study terminated by sponsor|0|||
145368349|NCT02829723|524198567|FG023|Overall Study|Study terminated by sponsor|0|||
145368350|NCT02829723|524198568|FG024|Overall Study|Study terminated by sponsor|0|||
145368351|NCT02829723|524198569|FG025|Overall Study|Study terminated by sponsor|0|||
145368352|NCT02829723|524198570|FG026|Overall Study|Study terminated by sponsor|0|||
145368353|NCT02989649|524198571|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
145368354|NCT02989649|524198571|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
145368355|NCT02989649|524198571|FG000|Overall Study|Lost For Observation During Study|3|||
145368356|NCT02989649|524198571|FG000|Overall Study|Reason Not Specified|13|||
145368357|NCT00256854|524198572|FG000|Overall Study|Withdrawal by Subject|2|||
145368358|NCT00256854|524198573|FG001|Overall Study|Withdrawal by Subject|3|||
145368359|NCT00256854|524198574|FG002|Overall Study|Withdrawal by Subject|0|||
145368360|NCT00256854|524198575|FG003|Overall Study|Withdrawal by Subject|0|||
145368361|NCT00256854|524198576|FG004|Overall Study|Withdrawal by Subject|0|||
145368362|NCT00256854|524198577|FG005|Overall Study|Withdrawal by Subject|0|||
145368363|NCT00256854|524198572|FG000|Overall Study|Lack of Efficacy|1|||
145368364|NCT00256854|524198573|FG001|Overall Study|Lack of Efficacy|0|||
145368365|NCT00256854|524198574|FG002|Overall Study|Lack of Efficacy|0|||
145368366|NCT00256854|524198575|FG003|Overall Study|Lack of Efficacy|0|||
145368367|NCT00256854|524198576|FG004|Overall Study|Lack of Efficacy|0|||
145368368|NCT00256854|524198577|FG005|Overall Study|Lack of Efficacy|0|||
145368369|NCT00256854|524198572|FG000|Overall Study|Protocol Violation|0|||
145368370|NCT00256854|524198573|FG001|Overall Study|Protocol Violation|1|||
145368371|NCT00256854|524198574|FG002|Overall Study|Protocol Violation|1|||
145368372|NCT00256854|524198575|FG003|Overall Study|Protocol Violation|1|||
145368373|NCT00256854|524198576|FG004|Overall Study|Protocol Violation|0|||
145368374|NCT00256854|524198577|FG005|Overall Study|Protocol Violation|0|||
145368375|NCT00256854|524198572|FG000|Overall Study|Adverse Event|0|||
145368376|NCT00256854|524198573|FG001|Overall Study|Adverse Event|0|||
145368377|NCT00256854|524198574|FG002|Overall Study|Adverse Event|2|||
145368378|NCT00256854|524198575|FG003|Overall Study|Adverse Event|2|||
145368379|NCT00256854|524198576|FG004|Overall Study|Adverse Event|0|||
145368380|NCT00256854|524198577|FG005|Overall Study|Adverse Event|1|||
145368381|NCT00256854|524198572|FG000|Overall Study|Not compliant with the study drug|0|||
145368382|NCT00256854|524198573|FG001|Overall Study|Not compliant with the study drug|0|||
145368383|NCT00256854|524198574|FG002|Overall Study|Not compliant with the study drug|0|||
145368384|NCT00256854|524198575|FG003|Overall Study|Not compliant with the study drug|0|||
145368385|NCT00256854|524198576|FG004|Overall Study|Not compliant with the study drug|1|||
145368386|NCT00256854|524198577|FG005|Overall Study|Not compliant with the study drug|0|||
145368387|NCT02353442|524198578|FG000|Overall Study|Withdrawal by Subject|3|||
145368388|NCT02353442|524198579|FG001|Overall Study|Withdrawal by Subject|4|||
145368389|NCT03990571|524198581|FG000|Overall Study|Withdrawal by Subject|1|||
145368390|NCT03990571|524198581|FG000|Overall Study|Insurance Issues|3|||
145368391|NCT03990571|524198581|FG000|Overall Study|Covid Restrictions|2|||
145368392|NCT03514485|524198582|FG000|Overall Study|Lost to Follow-up|5|||
145368393|NCT03514485|524198583|FG001|Overall Study|Lost to Follow-up|3|||
145422394|NCT00215657|524402088|FG007|Overall Study|Withdrawal by Subject|3|||
145623421|NCT01244763|525133898|FG004|Overall Study|Physician Decision|0|||
145422395|NCT00215657|524402081|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
145368394|NCT03514485|524198584|FG002|Overall Study|Lost to Follow-up|2|||
145368395|NCT03514485|524198585|FG003|Overall Study|Lost to Follow-up|0|||
145368396|NCT03514485|524198586|FG004|Overall Study|Lost to Follow-up|1|||
145368397|NCT03514485|524198587|FG005|Overall Study|Lost to Follow-up|4|||
145368398|NCT03514485|524198582|FG000|Overall Study|Withdrawal by Subject|0|||
145368399|NCT03514485|524198583|FG001|Overall Study|Withdrawal by Subject|1|||
145368400|NCT03514485|524198584|FG002|Overall Study|Withdrawal by Subject|3|||
145422396|NCT00215657|524402082|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
145422397|NCT00215657|524402083|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
145422398|NCT00215657|524402084|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
145422399|NCT00215657|524402085|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
145368401|NCT03514485|524198585|FG003|Overall Study|Withdrawal by Subject|1|||
145368402|NCT03514485|524198586|FG004|Overall Study|Withdrawal by Subject|2|||
145368403|NCT03514485|524198587|FG005|Overall Study|Withdrawal by Subject|1|||
145368404|NCT03075891|524198589|FG000|Overall Study|Withdrawal by Subject|3|||
145368405|NCT03075891|524198590|FG001|Overall Study|Withdrawal by Subject|6|||
145368406|NCT03075891|524198589|FG000|Overall Study|Lost to Follow-up|1|||
145368407|NCT03075891|524198590|FG001|Overall Study|Lost to Follow-up|0|||
145368408|NCT03075891|524198589|FG000|Overall Study|Pregnancy|3|||
145368409|NCT03075891|524198590|FG001|Overall Study|Pregnancy|1|||
145368410|NCT03075891|524198589|FG000|Overall Study|visits not performed (no time)|1|||
145368411|NCT03075891|524198590|FG001|Overall Study|visits not performed (no time)|0|||
145368412|NCT03075891|524198589|FG000|Overall Study|Drug abuse relapse issue|0|||
145368413|NCT03075891|524198590|FG001|Overall Study|Drug abuse relapse issue|1|||
145368414|NCT03075891|524198589|FG000|Overall Study|Participant requiring study withdrawal|0|||
145368415|NCT03075891|524198590|FG001|Overall Study|Participant requiring study withdrawal|1|||
145368416|NCT03075891|524198589|FG000|Overall Study|Adverse event, non-fatal|1|||
145368417|NCT03075891|524198590|FG001|Overall Study|Adverse event, non-fatal|4|||
145368418|NCT02004886|524198591|FG000|Overall Study|Adverse Event|0|||
145368419|NCT02004886|524198592|FG001|Overall Study|Adverse Event|1|||
145368420|NCT02004886|524198593|FG002|Overall Study|Adverse Event|0|||
145368421|NCT02004886|524198594|FG003|Overall Study|Adverse Event|0|||
145368422|NCT02004886|524198591|FG000|Overall Study|Unable to attend future visits|1|||
145368423|NCT02004886|524198592|FG001|Overall Study|Unable to attend future visits|0|||
145368424|NCT02004886|524198593|FG002|Overall Study|Unable to attend future visits|0|||
145368425|NCT02004886|524198594|FG003|Overall Study|Unable to attend future visits|0|||
145368426|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
145368427|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
145368428|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
145368429|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
145368430|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
145368431|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
145368432|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
145368433|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
145368434|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
145368435|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
145368436|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Death|1|||
145368437|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Death|0|||
145368438|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
145368439|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
145368440|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
145368441|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
145368442|NCT01876784|524198595|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
145422400|NCT00215657|524402086|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
145422401|NCT00215657|524402087|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
145422402|NCT00215657|524402088|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
145422403|NCT00215657|524402081|FG000|Overall Study|Insufficient testosterone response|5|||
145422404|NCT00215657|524402082|FG001|Overall Study|Insufficient testosterone response|4|||
145422405|NCT00215657|524402083|FG002|Overall Study|Insufficient testosterone response|1|||
145368443|NCT01876784|524198596|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
145368444|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
145368445|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
145368446|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Adverse Event|2|||
145368447|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Adverse Event|6|||
145422406|NCT00215657|524402084|FG003|Overall Study|Insufficient testosterone response|12|||
145422407|NCT00215657|524402085|FG004|Overall Study|Insufficient testosterone response|8|||
145368448|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
145422408|NCT00215657|524402086|FG005|Overall Study|Insufficient testosterone response|12|||
145578711|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
145578712|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
145578713|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
145368449|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
145578714|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
145578715|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
145578716|NCT02464969|524973724|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
145578717|NCT02464969|524973725|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
145578718|NCT02464969|524973724|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
145578719|NCT02464969|524973725|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
145578720|NCT02464969|524973724|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
145578721|NCT02464969|524973725|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
145578722|NCT02464969|524973724|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
145578723|NCT02464969|524973725|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
145578724|NCT02399085|524973726|FG000|Overall Study|Adverse Event|16|||
145578725|NCT02399085|524973726|FG000|Overall Study|Death|2|||
145578726|NCT02399085|524973726|FG000|Overall Study|Withdrawal by Subject|8|||
145578727|NCT02399085|524973726|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
145578728|NCT02399085|524973726|FG000|Overall Study|Physician Decision|5|||
145578729|NCT02480621|524973730|FG000|Randomization|Withdrawal by Subject|1|||
145578730|NCT02480621|524973731|FG001|Randomization|Withdrawal by Subject|0|||
145578731|NCT02480621|524973730|FG000|Randomization|Surgeon did not give intervention|0|||
145578732|NCT02480621|524973731|FG001|Randomization|Surgeon did not give intervention|1|||
145578733|NCT02480621|524973730|FG000|Follow Up|Lost to Follow-up|4|||
145578734|NCT02480621|524973731|FG001|Follow Up|Lost to Follow-up|2|||
145578735|NCT04632940|524973734|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
145578736|NCT04632940|524973735|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
145578737|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
145578738|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
145578739|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
145578740|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
145578741|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
145578742|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
145578743|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
145578744|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
145578745|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
145578746|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
145578747|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Other than specified|0|||
145578748|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Other than specified|1|||
145368450|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Progressive disease|4|||
145368451|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Progressive disease|35|||
145368452|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
145368453|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
145368454|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
145368455|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
145368456|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Death|0|||
145368457|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Death|1|||
145368458|NCT01876784|524198595|FG000|Open-label Period (31 Months)|Other than specified above|9|||
145368459|NCT01876784|524198596|FG001|Open-label Period (31 Months)|Other than specified above|18|||
145368460|NCT01878084|524198597|FG000|Overall Study|Physician Decision|2|||
145368461|NCT03891862|524198599|FG000|Open-label Period|Adverse Event|2|||
145368462|NCT03891862|524198600|FG001|Open-label Period|Adverse Event|0|||
145368463|NCT03891862|524198601|FG002|Open-label Period|Adverse Event|0|||
145368464|NCT03891862|524198599|FG000|Open-label Period|Protocol Violation|5|||
145368465|NCT03891862|524198600|FG001|Open-label Period|Protocol Violation|0|||
145368466|NCT03891862|524198601|FG002|Open-label Period|Protocol Violation|0|||
145368467|NCT03891862|524198599|FG000|Open-label Period|Withdrawal by Subject|6|||
145368468|NCT03891862|524198600|FG001|Open-label Period|Withdrawal by Subject|0|||
145578749|NCT04632940|524973734|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
145578750|NCT04632940|524973735|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
145578751|NCT02520531|524973738|FG000|Overall Study|Revision of study device components|2|||
145578752|NCT02520531|524973739|FG001|Overall Study|Revision of study device components|2|||
145578753|NCT02520531|524973738|FG000|Overall Study|Death|1|||
145578754|NCT02520531|524973739|FG001|Overall Study|Death|2|||
145578755|NCT02520531|524973738|FG000|Overall Study|Lost to Follow-up|1|||
145578756|NCT02520531|524973739|FG001|Overall Study|Lost to Follow-up|1|||
145578757|NCT02520531|524973738|FG000|Overall Study|Meet exclusion criterion|0|||
145578758|NCT02520531|524973739|FG001|Overall Study|Meet exclusion criterion|1|||
145578759|NCT02520531|524973738|FG000|Overall Study|Withdrawal by Subject|1|||
145578760|NCT02520531|524973739|FG001|Overall Study|Withdrawal by Subject|0|||
145368469|NCT03891862|524198601|FG002|Open-label Period|Withdrawal by Subject|0|||
145422409|NCT00215657|524402087|FG006|Overall Study|Insufficient testosterone response|4|||
145422410|NCT00215657|524402088|FG007|Overall Study|Insufficient testosterone response|7|||
145422411|NCT00215657|524402081|FG000|Overall Study|Other|3|||
145422412|NCT00215657|524402082|FG001|Overall Study|Other|1|||
145368470|NCT03891862|524198599|FG000|Open-label Period|Death|1|||
145368471|NCT03891862|524198600|FG001|Open-label Period|Death|0|||
145422413|NCT00215657|524402083|FG002|Overall Study|Other|2|||
145422414|NCT00215657|524402084|FG003|Overall Study|Other|3|||
145422415|NCT00215657|524402085|FG004|Overall Study|Other|5|||
145422416|NCT00215657|524402086|FG005|Overall Study|Other|4|||
145422417|NCT00215657|524402087|FG006|Overall Study|Other|6|||
145422418|NCT00215657|524402088|FG007|Overall Study|Other|1|||
145422419|NCT02614066|524402089|FG000|Overall Study|Death|6|||
145422420|NCT02614066|524402090|FG001|Overall Study|Death|14|||
145422421|NCT02614066|524402091|FG002|Overall Study|Death|11|||
145422422|NCT02614066|524402092|FG003|Overall Study|Death|29|||
145422423|NCT02614066|524402089|FG000|Overall Study|Full consent withdrawn|0|||
145422424|NCT02614066|524402090|FG001|Overall Study|Full consent withdrawn|1|||
145422425|NCT02614066|524402091|FG002|Overall Study|Full consent withdrawn|0|||
145422426|NCT02614066|524402092|FG003|Overall Study|Full consent withdrawn|8|||
145422427|NCT02614066|524402089|FG000|Overall Study|Lost to Follow-up|0|||
145422428|NCT02614066|524402090|FG001|Overall Study|Lost to Follow-up|2|||
145422429|NCT02614066|524402091|FG002|Overall Study|Lost to Follow-up|2|||
145422430|NCT02614066|524402092|FG003|Overall Study|Lost to Follow-up|2|||
145422431|NCT02614066|524402089|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
145422432|NCT02614066|524402090|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
145422433|NCT02614066|524402091|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
145368472|NCT03891862|524198601|FG002|Open-label Period|Death|0|||
145368473|NCT03891862|524198599|FG000|Open-label Period|Lost to Follow-up|2|||
145368474|NCT03891862|524198600|FG001|Open-label Period|Lost to Follow-up|0|||
145368475|NCT03891862|524198601|FG002|Open-label Period|Lost to Follow-up|0|||
145368476|NCT03891862|524198599|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
145368477|NCT03891862|524198600|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
145368478|NCT03891862|524198601|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
145368479|NCT03891862|524198599|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
145368480|NCT03891862|524198600|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
145368481|NCT03891862|524198601|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
145368482|NCT03891862|524198599|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
145368483|NCT03891862|524198600|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
145368484|NCT03891862|524198601|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
145368485|NCT03891862|524198599|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
145368486|NCT03891862|524198600|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
145368487|NCT03891862|524198601|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
145368488|NCT01194531|524198602|FG000|Overall Study|Withdrawal by Subject|1|||
145368489|NCT01194531|524198603|FG001|Overall Study|Withdrawal by Subject|0|||
145368490|NCT01194531|524198602|FG000|Overall Study|Protocol Violation|4|||
145368491|NCT01194531|524198603|FG001|Overall Study|Protocol Violation|1|||
145368492|NCT01194531|524198602|FG000|Overall Study|Physician Decision|0|||
145368493|NCT01194531|524198603|FG001|Overall Study|Physician Decision|2|||
145368494|NCT01500187|524198605|FG000|Overall Study|Lost to Follow-up|6|||
145368495|NCT01500187|524198606|FG001|Overall Study|Lost to Follow-up|0|||
145368496|NCT01435460|524198614|FG000|Overall Study|Adverse Event|2|||
145368497|NCT01435460|524198615|FG001|Overall Study|Adverse Event|1|||
145368498|NCT01435460|524198614|FG000|Overall Study|Lost to Follow-up|6|||
145368499|NCT01435460|524198615|FG001|Overall Study|Lost to Follow-up|1|||
145368500|NCT01435460|524198614|FG000|Overall Study|Withdrawal by Subject|1|||
145368501|NCT01435460|524198615|FG001|Overall Study|Withdrawal by Subject|3|||
145368502|NCT01435460|524198614|FG000|Overall Study|Protocol Violation|0|||
145368503|NCT01435460|524198615|FG001|Overall Study|Protocol Violation|1|||
145368504|NCT01435460|524198614|FG000|Overall Study|Did not meet eligibility criteria|2|||
145368505|NCT01435460|524198615|FG001|Overall Study|Did not meet eligibility criteria|0|||
145368506|NCT01706939|524198616|FG000|Pre Randomization|Screen Failure|1|||
145368507|NCT01706939|524198617|FG001|Pre Randomization|Screen Failure|0|||
145368508|NCT01706939|524198618|FG002|Pre Randomization|Screen Failure|0|||
145368509|NCT01706939|524198616|FG000|Pre Randomization|Ineligible for Randomization|1|||
145422434|NCT02614066|524402092|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
145422435|NCT02614066|524402089|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
145422436|NCT02614066|524402090|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
145422437|NCT02614066|524402091|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
145422438|NCT02614066|524402092|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
145368510|NCT01706939|524198617|FG001|Pre Randomization|Ineligible for Randomization|0|||
145368511|NCT01706939|524198618|FG002|Pre Randomization|Ineligible for Randomization|0|||
145422439|NCT02614066|524402089|FG000|Overall Study|Reason not specified|0|||
145422440|NCT02614066|524402090|FG001|Overall Study|Reason not specified|2|||
145368512|NCT01706939|524198616|FG000|Pre Randomization|Withdrawal by Subject|1|||
145368513|NCT01706939|524198617|FG001|Pre Randomization|Withdrawal by Subject|0|||
145368514|NCT01706939|524198618|FG002|Pre Randomization|Withdrawal by Subject|0|||
145368515|NCT01706939|524198616|FG000|Randomization|Insufficient QoL survey compliance|0|||
145368516|NCT01706939|524198617|FG001|Randomization|Insufficient QoL survey compliance|1|||
145368517|NCT01706939|524198618|FG002|Randomization|Insufficient QoL survey compliance|1|||
145368518|NCT01706939|524198616|FG000|Randomization|Progression of disease|0|||
145368519|NCT01706939|524198617|FG001|Randomization|Progression of disease|2|||
145368520|NCT01706939|524198618|FG002|Randomization|Progression of disease|1|||
145368521|NCT01046903|524198619|FG000|Overall Study|Lost to Follow-up|16|||
145368522|NCT01046903|524198619|FG000|Overall Study|Adverse Event|4|||
145368523|NCT01046903|524198619|FG000|Overall Study|Withdrawal by Subject|3|||
145368524|NCT01046903|524198619|FG000|Overall Study|Other|5|||
145368525|NCT01343277|524198620|FG000|Overall Study|Other|3|||
145368526|NCT01343277|524198621|FG001|Overall Study|Other|3|||
145368527|NCT01343277|524198620|FG000|Overall Study|Withdrawal by Subject|18|||
145368528|NCT01343277|524198621|FG001|Overall Study|Withdrawal by Subject|13|||
145368529|NCT01343277|524198620|FG000|Overall Study|Physician Decision|1|||
145368530|NCT01343277|524198621|FG001|Overall Study|Physician Decision|2|||
145368531|NCT01343277|524198620|FG000|Overall Study|Death|10|||
145368532|NCT01343277|524198621|FG001|Overall Study|Death|1|||
145368533|NCT01343277|524198620|FG000|Overall Study|Adverse Event|67|||
145368534|NCT01343277|524198621|FG001|Overall Study|Adverse Event|13|||
145368535|NCT01343277|524198620|FG000|Overall Study|Disease progression|270|||
145368536|NCT01343277|524198621|FG001|Overall Study|Disease progression|138|||
145368537|NCT01343277|524198620|FG000|Overall Study|Randomized not treated|6|||
145368538|NCT01343277|524198621|FG001|Overall Study|Randomized not treated|21|||
145368539|NCT01343277|524198620|FG000|Overall Study|Treatment ongoing|8|||
145368540|NCT01343277|524198621|FG001|Overall Study|Treatment ongoing|2|||
145368541|NCT01343277|524198620|FG000|Overall Study|Subsequent anticancer therapy|1|||
145368542|NCT01343277|524198621|FG001|Overall Study|Subsequent anticancer therapy|0|||
145368543|NCT01894100|524198622|FG000|Overall Study|Lost to Follow-up|0|||
145368544|NCT01894100|524198623|FG001|Overall Study|Lost to Follow-up|1|||
145368545|NCT01894100|524198622|FG000|Overall Study|Withdrawal by Subject|3|||
145368546|NCT01894100|524198623|FG001|Overall Study|Withdrawal by Subject|0|||
145368547|NCT01094301|524198624|FG000|Trial Stage|Withdrawal by Subject|1|||
145368548|NCT01094301|524198624|FG000|Implant Stage|Adverse Event|1|||
145368549|NCT01094301|524198624|FG000|Implant Stage|Protocol Violation|1|||
145368550|NCT01094301|524198624|FG000|Implant Stage|Withdrawal by Subject|2|||
145368551|NCT01094301|524198624|FG000|Implant Stage|No return of pain|4|||
145368552|NCT00135512|524198625|FG000|Overall Study|Adverse Event|56|||
145368553|NCT00135512|524198625|FG000|Overall Study|Lack of Efficacy|25|||
145368554|NCT00135512|524198625|FG000|Overall Study|Other|42|||
145368555|NCT04013672|524198627|FG000|Overall Study|Withdrawal by Subject|3|||
145368556|NCT04013672|524198628|FG001|Overall Study|Withdrawal by Subject|0|||
145368557|NCT04013672|524198627|FG000|Overall Study|Death|1|||
145368558|NCT04013672|524198628|FG001|Overall Study|Death|0|||
145368559|NCT04013672|524198627|FG000|Overall Study|Physician Decision|5|||
145368560|NCT04013672|524198628|FG001|Overall Study|Physician Decision|0|||
145368561|NCT00430573|524198629|FG000|Overall Study|Withdrawal by Subject|5|||
145368562|NCT05020665|524198632|FG000|Overall Study|Study terminated by Sponsor|5|||
145368563|NCT05020665|524198633|FG001|Overall Study|Study terminated by Sponsor|4|||
145368564|NCT05020665|524198632|FG000|Overall Study|Death|2|||
145368565|NCT05020665|524198633|FG001|Overall Study|Death|1|||
145368566|NCT05020665|524198632|FG000|Overall Study|Physician Decision|0|||
145368567|NCT05020665|524198633|FG001|Overall Study|Physician Decision|1|||
145368568|NCT05020665|524198632|FG000|Overall Study|Withdrawal by Subject|0|||
145368569|NCT05020665|524198633|FG001|Overall Study|Withdrawal by Subject|1|||
145368570|NCT05020665|524198632|FG000|Overall Study|Reason not specified|1|||
145368571|NCT05020665|524198633|FG001|Overall Study|Reason not specified|0|||
145368572|NCT01868022|524198634|FG000|Overall Study|Withdrawal by Subject|0|||
145368573|NCT01868022|524198635|FG001|Overall Study|Withdrawal by Subject|0|||
145368574|NCT01868022|524198636|FG002|Overall Study|Withdrawal by Subject|1|||
145368575|NCT01868022|524198637|FG003|Overall Study|Withdrawal by Subject|1|||
145368576|NCT01868022|524198638|FG004|Overall Study|Withdrawal by Subject|0|||
145578761|NCT02520531|524973738|FG000|Overall Study|Not study device|1|||
145368577|NCT01868022|524198639|FG005|Overall Study|Withdrawal by Subject|0|||
145368578|NCT01868022|524198640|FG006|Overall Study|Withdrawal by Subject|0|||
145368579|NCT01868022|524198641|FG007|Overall Study|Withdrawal by Subject|1|||
145368580|NCT01868022|524198642|FG008|Overall Study|Withdrawal by Subject|0|||
145368581|NCT01868022|524198634|FG000|Overall Study|Adverse Event|0|||
145368582|NCT01868022|524198635|FG001|Overall Study|Adverse Event|0|||
145368583|NCT01868022|524198636|FG002|Overall Study|Adverse Event|0|||
145368584|NCT01868022|524198637|FG003|Overall Study|Adverse Event|0|||
145368585|NCT01868022|524198638|FG004|Overall Study|Adverse Event|2|||
145368586|NCT01868022|524198639|FG005|Overall Study|Adverse Event|0|||
145368587|NCT01868022|524198640|FG006|Overall Study|Adverse Event|0|||
145368588|NCT01868022|524198641|FG007|Overall Study|Adverse Event|2|||
145578762|NCT02520531|524973739|FG001|Overall Study|Not study device|0|||
145368589|NCT01868022|524198642|FG008|Overall Study|Adverse Event|2|||
145368590|NCT01868022|524198634|FG000|Overall Study|Physician Decision|0|||
145368591|NCT01868022|524198635|FG001|Overall Study|Physician Decision|0|||
145368592|NCT01868022|524198636|FG002|Overall Study|Physician Decision|0|||
145368593|NCT01868022|524198637|FG003|Overall Study|Physician Decision|0|||
145368594|NCT01868022|524198638|FG004|Overall Study|Physician Decision|0|||
145368595|NCT01868022|524198639|FG005|Overall Study|Physician Decision|1|||
145368596|NCT01868022|524198640|FG006|Overall Study|Physician Decision|0|||
145368597|NCT01868022|524198641|FG007|Overall Study|Physician Decision|2|||
145368598|NCT01868022|524198642|FG008|Overall Study|Physician Decision|0|||
145368599|NCT01868022|524198634|FG000|Overall Study|Study closed/terminated|0|||
145368600|NCT01868022|524198635|FG001|Overall Study|Study closed/terminated|0|||
145368601|NCT01868022|524198636|FG002|Overall Study|Study closed/terminated|0|||
145368602|NCT01868022|524198637|FG003|Overall Study|Study closed/terminated|0|||
145368603|NCT01868022|524198638|FG004|Overall Study|Study closed/terminated|0|||
145368604|NCT01868022|524198639|FG005|Overall Study|Study closed/terminated|0|||
145368605|NCT01868022|524198640|FG006|Overall Study|Study closed/terminated|0|||
145368606|NCT01868022|524198641|FG007|Overall Study|Study closed/terminated|1|||
145368607|NCT01868022|524198642|FG008|Overall Study|Study closed/terminated|0|||
145368608|NCT01868022|524198634|FG000|Overall Study|Ongoing|0|||
145368609|NCT01868022|524198635|FG001|Overall Study|Ongoing|0|||
145368610|NCT01868022|524198636|FG002|Overall Study|Ongoing|0|||
145368611|NCT01868022|524198637|FG003|Overall Study|Ongoing|0|||
145368612|NCT01868022|524198638|FG004|Overall Study|Ongoing|0|||
145368613|NCT01868022|524198639|FG005|Overall Study|Ongoing|0|||
145368614|NCT01868022|524198640|FG006|Overall Study|Ongoing|0|||
145368615|NCT01868022|524198641|FG007|Overall Study|Ongoing|3|||
145368616|NCT01868022|524198642|FG008|Overall Study|Ongoing|0|||
145368617|NCT04999163|524198653|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
145368618|NCT04999163|524198654|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
145368619|NCT04999163|524198653|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
145368620|NCT04999163|524198654|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
145368621|NCT04999163|524198653|FG000|Overall Study|Withdrawal by Subject|1|||
145368622|NCT04999163|524198654|FG001|Overall Study|Withdrawal by Subject|0|||
145368623|NCT00199797|524200444|FG000|Overall Study|Progressive Disease|1|||
145368624|NCT00199797|524200444|FG000|Overall Study|Adverse Event|1|||
145368625|NCT00199797|524200444|FG000|Overall Study|Physician Decision|1|||
145368626|NCT04250350|524200446|FG000|Overall Study|Withdrawal by Subject|13|||
145368627|NCT04250350|524200446|FG000|Overall Study|Lost to Follow-up|8|||
145368628|NCT04250350|524200446|FG000|Overall Study|Adverse Event|5|||
145368629|NCT04250350|524200446|FG000|Overall Study|Lack of Efficacy|4|||
145368630|NCT04250350|524200446|FG000|Overall Study|Physician Decision|1|||
145368631|NCT04250350|524200446|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
145368632|NCT00504725|524200451|FG000|Overall Study|Protocol Violation|1|||
145368633|NCT00504725|524200452|FG001|Overall Study|Protocol Violation|0|||
145368634|NCT01435018|524200453|FG000|Overall Study|Death|37|||
145368635|NCT01435018|524200454|FG001|Overall Study|Death|18|||
145368636|NCT01435018|524200455|FG002|Overall Study|Death|25|||
145368637|NCT01435018|524200453|FG000|Overall Study|Site is closing|4|||
145368638|NCT01435018|524200454|FG001|Overall Study|Site is closing|9|||
145368639|NCT01435018|524200455|FG002|Overall Study|Site is closing|7|||
145368640|NCT01435018|524200453|FG000|Overall Study|Withdrew consent|0|||
145368641|NCT01435018|524200454|FG001|Overall Study|Withdrew consent|3|||
145368642|NCT01435018|524200455|FG002|Overall Study|Withdrew consent|1|||
145368643|NCT01435018|524200453|FG000|Overall Study|Not willing to adhere to requirements|0|||
145368644|NCT01435018|524200454|FG001|Overall Study|Not willing to adhere to requirements|2|||
145368645|NCT01435018|524200455|FG002|Overall Study|Not willing to adhere to requirements|3|||
145368646|NCT01435018|524200453|FG000|Overall Study|Not able to get to clinic|2|||
145368647|NCT01435018|524200454|FG001|Overall Study|Not able to get to clinic|0|||
145368648|NCT01435018|524200455|FG002|Overall Study|Not able to get to clinic|2|||
145368649|NCT01435018|524200453|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145368650|NCT01435018|524200454|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145368651|NCT01435018|524200455|FG002|Overall Study|Severe debilitation, unable to continue|1|||
145368652|NCT01435018|524200453|FG000|Overall Study|Unable to contact participant/parent|1|||
145422441|NCT02614066|524402091|FG002|Overall Study|Reason not specified|1|||
145368653|NCT01435018|524200454|FG001|Overall Study|Unable to contact participant/parent|1|||
145368654|NCT01435018|524200455|FG002|Overall Study|Unable to contact participant/parent|1|||
145368655|NCT01435018|524200453|FG000|Overall Study|Enrollment Violation|0|||
145368656|NCT01435018|524200454|FG001|Overall Study|Enrollment Violation|1|||
145368657|NCT01435018|524200455|FG002|Overall Study|Enrollment Violation|0|||
145368658|NCT01435018|524200453|FG000|Overall Study|Never started chemotherapy|3|||
145368659|NCT01435018|524200454|FG001|Overall Study|Never started chemotherapy|0|||
145368660|NCT01435018|524200455|FG002|Overall Study|Never started chemotherapy|1|||
145368661|NCT00378508|524200456|FG000|Overall Study|Withdrawal by Subject|1|||
145368662|NCT00378508|524200457|FG001|Overall Study|Withdrawal by Subject|3|||
145368663|NCT00378508|524200456|FG000|Overall Study|Lost to Follow-up|1|||
145578763|NCT02550652|524973740|FG000|Overall Study|Death|1|||
145578764|NCT02550652|524973741|FG001|Overall Study|Death|4|||
145578765|NCT02550652|524973740|FG000|Overall Study|Lack of Efficacy|1|||
145578766|NCT02550652|524973741|FG001|Overall Study|Lack of Efficacy|0|||
145368664|NCT00378508|524200457|FG001|Overall Study|Lost to Follow-up|0|||
145368665|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
145368666|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
145368667|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
145368668|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
145368669|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Death|0|||
145368670|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Death|0|||
145368671|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Death|1|||
145368672|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Death|0|||
145368673|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
145368674|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145368675|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145368676|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
145368677|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
145368678|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
145368679|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
145368680|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
145368681|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
145368682|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
145368683|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
145368684|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
145368685|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
145368686|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
145368687|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
145368688|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
145368689|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
145368690|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
145368691|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
145368692|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
145368693|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
145368694|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
145368695|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
145368696|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
145368697|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
145368698|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
145368699|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145368700|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
145368701|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
145368702|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
145368703|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
145368704|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
145368705|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
145368706|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
145368707|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
145368708|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
145368709|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Other|8|||
145368710|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Other|14|||
145578767|NCT02550652|524973740|FG000|Overall Study|Withdrawal by Subject|4|||
145578768|NCT02550652|524973741|FG001|Overall Study|Withdrawal by Subject|7|||
145578769|NCT02550652|524973740|FG000|Overall Study|Post Trial Access|1|||
145578770|NCT02550652|524973741|FG001|Overall Study|Post Trial Access|0|||
145578771|NCT02550652|524973740|FG000|Overall Study|Lost to Follow-up|1|||
145578772|NCT02550652|524973741|FG001|Overall Study|Lost to Follow-up|3|||
145578773|NCT02550652|524973740|FG000|Overall Study|Physician Decision|0|||
145578774|NCT02550652|524973741|FG001|Overall Study|Physician Decision|2|||
145578775|NCT02550652|524973740|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
145578776|NCT02550652|524973741|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
145578777|NCT05402995|524973742|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
145578778|NCT05402995|524973743|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
145578779|NCT05402995|524973744|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
145578780|NCT05402995|524973745|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
145578781|NCT00205712|524973746|FG000|Overall Study|Lost to Follow-up|0|||
145578782|NCT00205712|524973747|FG001|Overall Study|Lost to Follow-up|1|||
145578783|NCT01071512|524973748|FG000|Overall Study|Adverse Event|1|||
145578784|NCT01071512|524973748|FG000|Overall Study|Development of antibodies to drug|2|||
145578785|NCT01071512|524973748|FG000|Overall Study|positive anti-JC virus antibody test|2|||
145578786|NCT02188485|524973749|FG000|Overall Study|Withdrawal by Subject|2|||
145578787|NCT02188485|524973750|FG001|Overall Study|Withdrawal by Subject|1|||
145578788|NCT02188485|524973749|FG000|Overall Study|PI withdrew, lack of capacity|0|||
145578789|NCT02188485|524973750|FG001|Overall Study|PI withdrew, lack of capacity|2|||
145578790|NCT02316717|524973753|FG000|Overall Study|Adverse Event|2|||
145623422|NCT01244763|525133899|FG005|Overall Study|Physician Decision|0|||
145368711|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Other|8|||
145368712|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Other|23|||
145368713|NCT01106677|524200458|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
145368714|NCT01106677|524200459|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
145368715|NCT01106677|524200460|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
145368716|NCT01106677|524200461|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
145368717|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145368718|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
145368719|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
145368720|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
145368721|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Death|0|||
145368722|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Death|0|||
145368723|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Death|0|||
145368724|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Death|1|||
145368725|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
145368726|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
145368727|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
145368728|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
145368729|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
145368730|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145368731|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145368732|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
145368733|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145368734|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
145368735|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
145368736|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
145368737|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
145368738|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145368739|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145368740|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
145368741|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145368742|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
145368743|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
145368744|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
145368745|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
145368746|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
145368747|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
145368748|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
145368749|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145368750|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145368751|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
145368752|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
145368753|NCT01106677|524200458|FG000|Extension Period: Week 26 to Week 52|Other|6|||
145368754|NCT01106677|524200459|FG001|Extension Period: Week 26 to Week 52|Other|5|||
145368755|NCT01106677|524200460|FG002|Extension Period: Week 26 to Week 52|Other|8|||
145368756|NCT01106677|524200461|FG003|Extension Period: Week 26 to Week 52|Other|5|||
145368757|NCT03875092|524200462|FG000|Overall Study|Adverse Event|2|||
145368758|NCT03875092|524200463|FG001|Overall Study|Adverse Event|5|||
145368759|NCT03875092|524200462|FG000|Overall Study|Death|44|||
145368760|NCT03875092|524200463|FG001|Overall Study|Death|51|||
145368761|NCT03875092|524200462|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
145368762|NCT03875092|524200463|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
145368763|NCT03205761|524200464|FG000|Overall Study|Withdrawal by Subject|1|||
145368764|NCT03205761|524200464|FG000|Overall Study|Progressive Disease|10|||
145368765|NCT00452673|524200472|FG000|Dose Escalation Period|Disease Progression|6|||
145368766|NCT00452673|524200473|FG001|Dose Escalation Period|Disease Progression|6|||
145578791|NCT02316717|524973754|FG001|Overall Study|Adverse Event|2|||
145623423|NCT01244763|525133894|FG000|Overall Study|Withdrawal by Subject|1|||
145623424|NCT01244763|525133895|FG001|Overall Study|Withdrawal by Subject|2|||
145422442|NCT02614066|524402092|FG003|Overall Study|Reason not specified|1|||
145368767|NCT00452673|524200474|FG002|Dose Escalation Period|Disease Progression|2|||
145368768|NCT00452673|524200475|FG003|Dose Escalation Period|Disease Progression|6|||
145368769|NCT00452673|524200476|FG004|Dose Escalation Period|Disease Progression|0|||
145368770|NCT00452673|524200472|FG000|Dose Escalation Period|study drug toxicity|1|||
145368771|NCT00452673|524200473|FG001|Dose Escalation Period|study drug toxicity|3|||
145368772|NCT00452673|524200474|FG002|Dose Escalation Period|study drug toxicity|3|||
145368773|NCT00452673|524200475|FG003|Dose Escalation Period|study drug toxicity|1|||
145368774|NCT00452673|524200476|FG004|Dose Escalation Period|study drug toxicity|0|||
145368775|NCT00452673|524200472|FG000|Dose Escalation Period|Other|0|||
145368776|NCT00452673|524200473|FG001|Dose Escalation Period|Other|0|||
145368777|NCT00452673|524200474|FG002|Dose Escalation Period|Other|1|||
145368778|NCT00452673|524200475|FG003|Dose Escalation Period|Other|0|||
145368779|NCT00452673|524200476|FG004|Dose Escalation Period|Other|0|||
145368780|NCT00452673|524200472|FG000|Dose Escalation Period|Adverse Event|0|||
145368781|NCT00452673|524200473|FG001|Dose Escalation Period|Adverse Event|0|||
145368782|NCT00452673|524200474|FG002|Dose Escalation Period|Adverse Event|0|||
145368783|NCT00452673|524200475|FG003|Dose Escalation Period|Adverse Event|1|||
145368784|NCT00452673|524200476|FG004|Dose Escalation Period|Adverse Event|0|||
145368785|NCT00452673|524200472|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
145368786|NCT00452673|524200473|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
145368787|NCT00452673|524200474|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
145368788|NCT00452673|524200475|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
145368789|NCT00452673|524200476|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
145368790|NCT00452673|524200472|FG000|Dose Expansion Period|Disease Progression|0|||
145368791|NCT00452673|524200473|FG001|Dose Expansion Period|Disease Progression|0|||
145368792|NCT00452673|524200474|FG002|Dose Expansion Period|Disease Progression|0|||
145368793|NCT00452673|524200475|FG003|Dose Expansion Period|Disease Progression|0|||
145368794|NCT00452673|524200476|FG004|Dose Expansion Period|Disease Progression|19|||
145368795|NCT00452673|524200472|FG000|Dose Expansion Period|Other|0|||
145368796|NCT00452673|524200473|FG001|Dose Expansion Period|Other|0|||
145368797|NCT00452673|524200474|FG002|Dose Expansion Period|Other|0|||
145368798|NCT00452673|524200475|FG003|Dose Expansion Period|Other|0|||
145368799|NCT00452673|524200476|FG004|Dose Expansion Period|Other|2|||
145368800|NCT02461524|524200478|FG000|Overall Study|Death|16|||
145368801|NCT02461524|524200478|FG000|Overall Study|Withdrawal by Subject|4|||
145368802|NCT02461524|524200478|FG000|Overall Study|Device Explanted|5|||
145368803|NCT02461524|524200478|FG000|Overall Study|Missed Visit|6|||
145368804|NCT00843037|524200488|FG000|Overall Study|Lost to Follow-up|1|||
145368805|NCT04984278|524200489|FG000|Period 1|Withdrawal by Subject|1|||
145368806|NCT04984278|524200490|FG001|Period 1|Withdrawal by Subject|0|||
145368807|NCT04984278|524200489|FG000|Period 1|Other|0|||
145368808|NCT04984278|524200490|FG001|Period 1|Other|1|||
145368809|NCT04984278|524200489|FG000|Period 2|Adverse Event|1|||
145368810|NCT04984278|524200490|FG001|Period 2|Adverse Event|0|||
145368811|NCT04984278|524200489|FG000|Period 2|Other|0|||
145368812|NCT04984278|524200490|FG001|Period 2|Other|1|||
145368813|NCT03535194|524200491|FG000|Induction Period|Adverse Event|2|||
145368814|NCT03535194|524200492|FG001|Induction Period|Adverse Event|2|||
145368815|NCT03535194|524200493|FG002|Induction Period|Adverse Event|1|||
145368816|NCT03535194|524200494|FG003|Induction Period|Adverse Event|3|||
145368817|NCT03535194|524200495|FG004|Induction Period|Adverse Event|0|||
145368818|NCT03535194|524200491|FG000|Induction Period|Death|0|||
145368819|NCT03535194|524200492|FG001|Induction Period|Death|1|||
145368820|NCT03535194|524200493|FG002|Induction Period|Death|0|||
145368821|NCT03535194|524200494|FG003|Induction Period|Death|0|||
145368822|NCT03535194|524200495|FG004|Induction Period|Death|0|||
145368823|NCT03535194|524200491|FG000|Induction Period|Lack of Efficacy|1|||
145368824|NCT03535194|524200492|FG001|Induction Period|Lack of Efficacy|3|||
145368825|NCT03535194|524200493|FG002|Induction Period|Lack of Efficacy|2|||
145578792|NCT02316717|524973755|FG002|Overall Study|Adverse Event|0|||
145578793|NCT02316717|524973753|FG000|Overall Study|Lost to Follow-up|1|||
145578794|NCT02316717|524973754|FG001|Overall Study|Lost to Follow-up|2|||
145368826|NCT03535194|524200494|FG003|Induction Period|Lack of Efficacy|2|||
145368827|NCT03535194|524200495|FG004|Induction Period|Lack of Efficacy|0|||
145368828|NCT03535194|524200491|FG000|Induction Period|Lost to Follow-up|3|||
145368829|NCT03535194|524200492|FG001|Induction Period|Lost to Follow-up|5|||
145368830|NCT03535194|524200493|FG002|Induction Period|Lost to Follow-up|2|||
145368831|NCT03535194|524200494|FG003|Induction Period|Lost to Follow-up|3|||
145368832|NCT03535194|524200495|FG004|Induction Period|Lost to Follow-up|0|||
145368833|NCT03535194|524200491|FG000|Induction Period|Physician Decision|1|||
145368834|NCT03535194|524200492|FG001|Induction Period|Physician Decision|1|||
145368835|NCT03535194|524200493|FG002|Induction Period|Physician Decision|0|||
145578795|NCT02316717|524973755|FG002|Overall Study|Lost to Follow-up|1|||
145578796|NCT02316717|524973753|FG000|Overall Study|Non compliance|3|||
145368836|NCT03535194|524200494|FG003|Induction Period|Physician Decision|0|||
145368837|NCT03535194|524200495|FG004|Induction Period|Physician Decision|0|||
145578797|NCT02316717|524973754|FG001|Overall Study|Non compliance|1|||
145578798|NCT02316717|524973755|FG002|Overall Study|Non compliance|0|||
145368838|NCT03535194|524200491|FG000|Induction Period|Protocol Violation|1|||
145368839|NCT03535194|524200492|FG001|Induction Period|Protocol Violation|0|||
145368840|NCT03535194|524200493|FG002|Induction Period|Protocol Violation|0|||
145368841|NCT03535194|524200494|FG003|Induction Period|Protocol Violation|1|||
145368842|NCT03535194|524200495|FG004|Induction Period|Protocol Violation|0|||
145368843|NCT03535194|524200491|FG000|Induction Period|Screen Failure|0|||
145368844|NCT03535194|524200492|FG001|Induction Period|Screen Failure|1|||
145368845|NCT03535194|524200493|FG002|Induction Period|Screen Failure|0|||
145368846|NCT03535194|524200494|FG003|Induction Period|Screen Failure|0|||
145368847|NCT03535194|524200495|FG004|Induction Period|Screen Failure|0|||
145368848|NCT03535194|524200491|FG000|Induction Period|Withdrawal by Subject|3|||
145368849|NCT03535194|524200492|FG001|Induction Period|Withdrawal by Subject|4|||
145368850|NCT03535194|524200493|FG002|Induction Period|Withdrawal by Subject|3|||
145368851|NCT03535194|524200494|FG003|Induction Period|Withdrawal by Subject|2|||
145368852|NCT03535194|524200495|FG004|Induction Period|Withdrawal by Subject|0|||
145368853|NCT03535194|524200491|FG000|Maintenance Period|Adverse Event|6|||
145368854|NCT03535194|524200492|FG001|Maintenance Period|Adverse Event|5|||
145368855|NCT03535194|524200493|FG002|Maintenance Period|Adverse Event|1|||
145368856|NCT03535194|524200494|FG003|Maintenance Period|Adverse Event|11|||
145368857|NCT03535194|524200495|FG004|Maintenance Period|Adverse Event|4|||
145368858|NCT03535194|524200491|FG000|Maintenance Period|Lack of Efficacy|3|||
145368859|NCT03535194|524200492|FG001|Maintenance Period|Lack of Efficacy|2|||
145368860|NCT03535194|524200493|FG002|Maintenance Period|Lack of Efficacy|5|||
145368861|NCT03535194|524200494|FG003|Maintenance Period|Lack of Efficacy|9|||
145368862|NCT03535194|524200495|FG004|Maintenance Period|Lack of Efficacy|0|||
145368863|NCT03535194|524200491|FG000|Maintenance Period|Lost to Follow-up|4|||
145368864|NCT03535194|524200492|FG001|Maintenance Period|Lost to Follow-up|2|||
145368865|NCT03535194|524200493|FG002|Maintenance Period|Lost to Follow-up|1|||
145368866|NCT03535194|524200494|FG003|Maintenance Period|Lost to Follow-up|5|||
145368867|NCT03535194|524200495|FG004|Maintenance Period|Lost to Follow-up|2|||
145368868|NCT03535194|524200491|FG000|Maintenance Period|Other|1|||
145368869|NCT03535194|524200492|FG001|Maintenance Period|Other|2|||
145368870|NCT03535194|524200493|FG002|Maintenance Period|Other|0|||
145368871|NCT03535194|524200494|FG003|Maintenance Period|Other|0|||
145368872|NCT03535194|524200495|FG004|Maintenance Period|Other|0|||
145368873|NCT03535194|524200491|FG000|Maintenance Period|Physician Decision|1|||
145368874|NCT03535194|524200492|FG001|Maintenance Period|Physician Decision|2|||
145368875|NCT03535194|524200493|FG002|Maintenance Period|Physician Decision|0|||
145368876|NCT03535194|524200494|FG003|Maintenance Period|Physician Decision|2|||
145368877|NCT03535194|524200495|FG004|Maintenance Period|Physician Decision|0|||
145368878|NCT03535194|524200491|FG000|Maintenance Period|Pregnancy|0|||
145368879|NCT03535194|524200492|FG001|Maintenance Period|Pregnancy|0|||
145422443|NCT01185366|524402093|FG000|First Line Therapy|Insurance Coverage Denied|1|||
145422444|NCT01185366|524402094|FG001|First Line Therapy|Insurance Coverage Denied|1|||
145422445|NCT01185366|524402093|FG000|First Line Therapy|Withdrawal by Subject|1|||
145422446|NCT01185366|524402094|FG001|First Line Therapy|Withdrawal by Subject|0|||
145422447|NCT01185366|524402093|FG000|First Line Therapy|Lack of Metastatic Site|1|||
145422448|NCT01185366|524402094|FG001|First Line Therapy|Lack of Metastatic Site|0|||
145422449|NCT01185366|524402093|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
145422450|NCT01185366|524402094|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
145422451|NCT01185366|524402093|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
145422452|NCT01185366|524402094|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
145422453|NCT01185366|524402093|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
145422454|NCT01185366|524402094|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
145422455|NCT01185366|524402093|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
145422456|NCT01185366|524402094|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
145422457|NCT00127933|524402099|FG000|Overall Study|Randomized but not dosed|1|||
145368880|NCT03535194|524200493|FG002|Maintenance Period|Pregnancy|0|||
145368881|NCT03535194|524200494|FG003|Maintenance Period|Pregnancy|2|||
145368882|NCT03535194|524200495|FG004|Maintenance Period|Pregnancy|0|||
145368883|NCT03535194|524200491|FG000|Maintenance Period|Protocol Violation|0|||
145422458|NCT00127933|524402100|FG001|Overall Study|Randomized but not dosed|0|||
145422459|NCT01783938|524402106|FG000|Overall Study|Disease Progression|18|||
145422460|NCT01783938|524402107|FG001|Overall Study|Disease Progression|41|||
145422461|NCT01783938|524402106|FG000|Overall Study|Study Drug Toxicity|27|||
145368884|NCT03535194|524200492|FG001|Maintenance Period|Protocol Violation|1|||
145368885|NCT03535194|524200493|FG002|Maintenance Period|Protocol Violation|0|||
145368886|NCT03535194|524200494|FG003|Maintenance Period|Protocol Violation|0|||
145368887|NCT03535194|524200495|FG004|Maintenance Period|Protocol Violation|0|||
145368888|NCT03535194|524200491|FG000|Maintenance Period|Withdrawal by Subject|7|||
145368889|NCT03535194|524200492|FG001|Maintenance Period|Withdrawal by Subject|2|||
145368890|NCT03535194|524200493|FG002|Maintenance Period|Withdrawal by Subject|1|||
145368891|NCT03535194|524200494|FG003|Maintenance Period|Withdrawal by Subject|8|||
145368892|NCT03535194|524200495|FG004|Maintenance Period|Withdrawal by Subject|0|||
145422462|NCT01783938|524402107|FG001|Overall Study|Study Drug Toxicity|14|||
145422463|NCT01783938|524402106|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
145422464|NCT01783938|524402107|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
145422465|NCT01783938|524402106|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
145422466|NCT01783938|524402107|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
145422467|NCT01783938|524402106|FG000|Overall Study|Participant Withdrew Consent|2|||
145422468|NCT01783938|524402107|FG001|Overall Study|Participant Withdrew Consent|0|||
145422469|NCT01783938|524402106|FG000|Overall Study|Maximum Clinical Benefit|1|||
145422470|NCT01783938|524402107|FG001|Overall Study|Maximum Clinical Benefit|0|||
145422471|NCT01783938|524402106|FG000|Overall Study|Other Reasons|3|||
145422472|NCT01783938|524402107|FG001|Overall Study|Other Reasons|1|||
145422473|NCT03111732|524402111|FG000|Overall Study|Enrolled in different study|1|||
145422474|NCT03111732|524402111|FG000|Overall Study|Progressive disease|3|||
145422475|NCT03111732|524402111|FG000|Overall Study|Withdrawal by Subject|1|||
145422476|NCT03072875|524402112|FG000|Overall Study|Lost to Follow-up|1|||
145422477|NCT00401830|524402113|FG000|Overall Study|Adverse Event|10|||
145422478|NCT00401830|524402114|FG001|Overall Study|Adverse Event|18|||
145422479|NCT00401830|524402113|FG000|Overall Study|Lack of Efficacy|11|||
145422480|NCT00401830|524402114|FG001|Overall Study|Lack of Efficacy|5|||
145422481|NCT00401830|524402113|FG000|Overall Study|Withdrawal by Subject|4|||
145422482|NCT00401830|524402114|FG001|Overall Study|Withdrawal by Subject|3|||
145422483|NCT00401830|524402113|FG000|Overall Study|Protocol Violation|3|||
145422484|NCT00401830|524402114|FG001|Overall Study|Protocol Violation|3|||
145422485|NCT00401830|524402113|FG000|Overall Study|Non-compliance with drug study|1|||
145422486|NCT00401830|524402114|FG001|Overall Study|Non-compliance with drug study|0|||
145422487|NCT00401830|524402113|FG000|Overall Study|Lost to Follow-up|1|||
145422488|NCT00401830|524402114|FG001|Overall Study|Lost to Follow-up|3|||
145422489|NCT00401830|524402113|FG000|Overall Study|Other: Personal / Family problems|1|||
145422490|NCT00401830|524402114|FG001|Overall Study|Other: Personal / Family problems|0|||
145422491|NCT01943825|524402117|FG000|Overall Study|Lost to Follow-up|9|||
145422492|NCT01943825|524402118|FG001|Overall Study|Lost to Follow-up|3|||
145422493|NCT01943825|524402119|FG002|Overall Study|Lost to Follow-up|12|||
145422494|NCT01943825|524402120|FG003|Overall Study|Lost to Follow-up|8|||
145422495|NCT01943825|524402117|FG000|Overall Study|Withdrawal by Subject|1|||
145422496|NCT01943825|524402118|FG001|Overall Study|Withdrawal by Subject|0|||
145422497|NCT01943825|524402119|FG002|Overall Study|Withdrawal by Subject|3|||
145422498|NCT01943825|524402120|FG003|Overall Study|Withdrawal by Subject|2|||
145422499|NCT01943825|524402117|FG000|Overall Study|Other than specified above|0|||
145422500|NCT01943825|524402118|FG001|Overall Study|Other than specified above|1|||
145422501|NCT01943825|524402119|FG002|Overall Study|Other than specified above|0|||
145422502|NCT01943825|524402120|FG003|Overall Study|Other than specified above|1|||
145422503|NCT01539525|524402123|FG000|Overall Study|Lost to Follow-up|19|||
145422504|NCT01539525|524402124|FG001|Overall Study|Lost to Follow-up|12|||
145422505|NCT01539525|524402125|FG002|Overall Study|Lost to Follow-up|11|||
145422506|NCT01539525|524402123|FG000|Overall Study|Withdrawal by Subject|0|||
145422507|NCT01539525|524402124|FG001|Overall Study|Withdrawal by Subject|3|||
145422508|NCT01539525|524402125|FG002|Overall Study|Withdrawal by Subject|2|||
145422509|NCT01539525|524402123|FG000|Overall Study|Protocol Violation|1|||
145422510|NCT01539525|524402124|FG001|Overall Study|Protocol Violation|1|||
145422511|NCT01539525|524402125|FG002|Overall Study|Protocol Violation|4|||
145422512|NCT02205359|524402126|FG000|Overall Study|Death|293|||
145422513|NCT02205359|524402127|FG001|Overall Study|Death|327|||
145422514|NCT02205359|524402126|FG000|Overall Study|Lost to Follow-up|182|||
145422515|NCT02205359|524402127|FG001|Overall Study|Lost to Follow-up|162|||
145422516|NCT02205359|524402126|FG000|Overall Study|Physician Decision|51|||
145368893|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Adverse Event|4|||
145368894|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Adverse Event|5|||
145368895|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Adverse Event|1|||
145368896|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Adverse Event|8|||
145368897|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Adverse Event|0|||
145368898|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
145368899|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
145368900|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
145368901|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
145368902|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
145368903|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
145368904|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
145368905|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
145368906|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
145368907|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
145422517|NCT02205359|524402127|FG001|Overall Study|Physician Decision|53|||
145422518|NCT02205359|524402126|FG000|Overall Study|Withdrawal by Subject|167|||
145422519|NCT02205359|524402127|FG001|Overall Study|Withdrawal by Subject|169|||
145422520|NCT02792257|524402130|FG000|Overall Study|Lost to Follow-up|3|||
145422521|NCT02792257|524402131|FG001|Overall Study|Lost to Follow-up|4|||
145422522|NCT02792257|524402130|FG000|Overall Study|Allergy|0|||
145422523|NCT02792257|524402131|FG001|Overall Study|Allergy|1|||
145422524|NCT02792257|524402130|FG000|Overall Study|Protocol Violation|2|||
145422525|NCT02792257|524402131|FG001|Overall Study|Protocol Violation|0|||
145422526|NCT02792257|524402130|FG000|Overall Study|Excessive Agitation|0|||
145422527|NCT02792257|524402131|FG001|Overall Study|Excessive Agitation|1|||
145422528|NCT02792257|524402130|FG000|Overall Study|Not Feeling Well|0|||
145578799|NCT02316717|524973753|FG000|Overall Study|Protocol Violation|2|||
145578800|NCT02316717|524973754|FG001|Overall Study|Protocol Violation|0|||
145368908|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Other|1|||
145368909|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Other|0|||
145368910|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Other|0|||
145368911|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Other|5|||
145368912|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Other|0|||
145368913|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Physician Decision|0|||
145368914|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Physician Decision|2|||
145368915|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Physician Decision|1|||
145368916|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Physician Decision|1|||
145368917|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Physician Decision|0|||
145368918|NCT03535194|524200491|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
145368919|NCT03535194|524200492|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
145368920|NCT03535194|524200493|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
145368921|NCT03535194|524200494|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
145368922|NCT03535194|524200495|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145368923|NCT03991299|524200498|FG000|Overall Study|Study closed, sponsor decision|3|||
145368924|NCT03991299|524200498|FG000|Overall Study|Withdrawal by Subject|1|||
145368925|NCT04429555|524200506|FG000|Overall Study|Death|0|||
145368926|NCT04429555|524200507|FG001|Overall Study|Death|2|||
145368927|NCT04429555|524200506|FG000|Overall Study|Other|2|||
145368928|NCT04429555|524200507|FG001|Overall Study|Other|0|||
145368929|NCT04470544|524200510|FG000|Overall Study|Withdrawal by Subject|4|||
145368930|NCT04470544|524200511|FG001|Overall Study|Withdrawal by Subject|6|||
145368931|NCT00712881|524200512|FG000|Overall Study|Adverse Event|3|||
145368932|NCT00712881|524200513|FG001|Overall Study|Adverse Event|3|||
145368933|NCT00712881|524200512|FG000|Overall Study|Withdrawal by Subject|1|||
145368934|NCT00712881|524200513|FG001|Overall Study|Withdrawal by Subject|1|||
145368935|NCT00712881|524200512|FG000|Overall Study|Disease Progression|2|||
145368936|NCT00712881|524200513|FG001|Overall Study|Disease Progression|1|||
145368937|NCT00712881|524200512|FG000|Overall Study|Lost to Follow-up|1|||
145368938|NCT00712881|524200513|FG001|Overall Study|Lost to Follow-up|1|||
145368939|NCT00712881|524200512|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
145368940|NCT00712881|524200513|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
145368941|NCT00712881|524200512|FG000|Overall Study|Protocol Violation|1|||
145368942|NCT00712881|524200513|FG001|Overall Study|Protocol Violation|1|||
145368943|NCT00712881|524200512|FG000|Overall Study|Randomized but not treated|1|||
145368944|NCT00712881|524200513|FG001|Overall Study|Randomized but not treated|0|||
145368945|NCT05113979|524200517|FG000|Overall Study|Death|2|||
145368946|NCT05113979|524200517|FG000|Overall Study|Lost to Follow-up|1|||
145368947|NCT00968981|524200518|FG000|Overall Study|Adverse Event|2|||
145368948|NCT00968981|524200519|FG001|Overall Study|Adverse Event|0|||
145368949|NCT00968981|524200520|FG002|Overall Study|Adverse Event|0|||
145368950|NCT00968981|524200518|FG000|Overall Study|Disease Progression|14|||
145368951|NCT00968981|524200519|FG001|Overall Study|Disease Progression|16|||
145368952|NCT00968981|524200520|FG002|Overall Study|Disease Progression|13|||
145368953|NCT00968981|524200518|FG000|Overall Study|Lost to Follow-up|0|||
145368954|NCT00968981|524200519|FG001|Overall Study|Lost to Follow-up|0|||
145368955|NCT00968981|524200520|FG002|Overall Study|Lost to Follow-up|1|||
145368956|NCT00968981|524200518|FG000|Overall Study|Physician Decision|5|||
145368957|NCT00968981|524200519|FG001|Overall Study|Physician Decision|3|||
145368958|NCT00968981|524200520|FG002|Overall Study|Physician Decision|5|||
145368959|NCT00968981|524200518|FG000|Overall Study|Withdrawal by Subject|1|||
145368960|NCT00968981|524200519|FG001|Overall Study|Withdrawal by Subject|3|||
145368961|NCT00968981|524200520|FG002|Overall Study|Withdrawal by Subject|3|||
145368962|NCT04016779|524200526|FG000|Overall Study|Adverse Event|9|||
145368963|NCT04016779|524200527|FG001|Overall Study|Adverse Event|17|||
145368964|NCT04016779|524200526|FG000|Overall Study|Lack of Efficacy|4|||
145368965|NCT04016779|524200527|FG001|Overall Study|Lack of Efficacy|1|||
145368966|NCT04016779|524200526|FG000|Overall Study|Lost to Follow-up|5|||
145368967|NCT04016779|524200527|FG001|Overall Study|Lost to Follow-up|14|||
145422529|NCT02792257|524402131|FG001|Overall Study|Not Feeling Well|1|||
145578801|NCT02316717|524973755|FG002|Overall Study|Protocol Violation|0|||
145578802|NCT02316717|524973753|FG000|Overall Study|Withdrawal by Subject|2|||
145368968|NCT04016779|524200526|FG000|Overall Study|Physician Decision|1|||
145368969|NCT04016779|524200527|FG001|Overall Study|Physician Decision|3|||
145368970|NCT04016779|524200526|FG000|Overall Study|Withdrawal by Subject|6|||
145368971|NCT04016779|524200527|FG001|Overall Study|Withdrawal by Subject|8|||
145368972|NCT04016779|524200526|FG000|Overall Study|Non-compliance with Study Drug|2|||
145368973|NCT04016779|524200527|FG001|Overall Study|Non-compliance with Study Drug|3|||
145368974|NCT04016779|524200526|FG000|Overall Study|Other, Multiple categories|17|||
145422530|NCT00553475|524402132|FG000|Overall Study|Adverse Event|7|||
145368975|NCT04016779|524200527|FG001|Overall Study|Other, Multiple categories|17|||
145368976|NCT00330343|524200528|FG000|Overall Study|Lost to Follow-up|5|||
145368977|NCT00281632|524200529|FG000|Overall Study|Adverse Event|7|||
145368978|NCT00281632|524200529|FG000|Overall Study|Withdrawal by Subject|2|||
145368979|NCT00281632|524200529|FG000|Overall Study|Disease Progression|22|||
145368980|NCT00281632|524200529|FG000|Overall Study|Death|1|||
145368981|NCT00281632|524200529|FG000|Overall Study|Physician Decision|1|||
145368982|NCT00281632|524200529|FG000|Overall Study|Ongoing|3|||
145368983|NCT06586788|524200530|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
145368984|NCT02691936|524200534|FG000|Overall Study|Withdrawal by Subject|2|||
145368985|NCT02691936|524200535|FG001|Overall Study|Withdrawal by Subject|5|||
145368986|NCT03696108|524200536|FG000|Overall Study|Physician Decision|1|||
145368987|NCT03696108|524200537|FG001|Overall Study|Physician Decision|0|||
145368988|NCT03696108|524200536|FG000|Overall Study|Withdrawal by Subject|3|||
145368989|NCT03696108|524200537|FG001|Overall Study|Withdrawal by Subject|6|||
145368990|NCT05239494|524200538|FG000|Overall Study|Lost to Follow-up|1|||
145368991|NCT01053962|524200541|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145368992|NCT01053962|524200542|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145368993|NCT01053962|524200543|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
145368994|NCT01053962|524200544|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
145368995|NCT01053962|524200545|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
145368996|NCT01053962|524200541|FG000|Pretreatment Period|Venipuncture Failure|0|||
145368997|NCT01053962|524200542|FG001|Pretreatment Period|Venipuncture Failure|0|||
145368998|NCT01053962|524200543|FG002|Pretreatment Period|Venipuncture Failure|1|||
145368999|NCT01053962|524200544|FG003|Pretreatment Period|Venipuncture Failure|0|||
145369000|NCT01053962|524200545|FG004|Pretreatment Period|Venipuncture Failure|0|||
145369001|NCT01053962|524200541|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145369002|NCT01053962|524200542|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
145369003|NCT01053962|524200543|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145369004|NCT01053962|524200544|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145369005|NCT01053962|524200545|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
145369006|NCT01053962|524200541|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145369007|NCT01053962|524200542|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145369008|NCT01053962|524200543|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145369009|NCT01053962|524200544|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
145369010|NCT01053962|524200545|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
145369011|NCT01053962|524200541|FG000|Treatment Period|Lack of Efficacy|0|||
145369012|NCT01053962|524200542|FG001|Treatment Period|Lack of Efficacy|0|||
145369013|NCT01053962|524200543|FG002|Treatment Period|Lack of Efficacy|0|||
145369014|NCT01053962|524200544|FG003|Treatment Period|Lack of Efficacy|0|||
145369015|NCT01053962|524200545|FG004|Treatment Period|Lack of Efficacy|1|||
145369016|NCT01053962|524200541|FG000|Treatment Period|Adverse Event|0|||
145369017|NCT01053962|524200542|FG001|Treatment Period|Adverse Event|0|||
145369018|NCT01053962|524200543|FG002|Treatment Period|Adverse Event|0|||
145369019|NCT01053962|524200544|FG003|Treatment Period|Adverse Event|0|||
145369020|NCT01053962|524200545|FG004|Treatment Period|Adverse Event|1|||
145369021|NCT01053962|524200541|FG000|Treatment Period|Withdrawal by Subject|0|||
145369022|NCT01053962|524200542|FG001|Treatment Period|Withdrawal by Subject|0|||
145369023|NCT01053962|524200543|FG002|Treatment Period|Withdrawal by Subject|0|||
145369024|NCT01053962|524200544|FG003|Treatment Period|Withdrawal by Subject|0|||
145369025|NCT01053962|524200545|FG004|Treatment Period|Withdrawal by Subject|1|||
145369026|NCT01053962|524200541|FG000|Treatment Period|Noncompliance with protocol|1|||
145369027|NCT01053962|524200542|FG001|Treatment Period|Noncompliance with protocol|0|||
145369028|NCT01053962|524200543|FG002|Treatment Period|Noncompliance with protocol|0|||
145369029|NCT01053962|524200544|FG003|Treatment Period|Noncompliance with protocol|0|||
145369030|NCT01053962|524200545|FG004|Treatment Period|Noncompliance with protocol|0|||
145369031|NCT02892422|524200546|FG000|Overall Study|Enrolled not treated|4|||
145369032|NCT02892422|524200546|FG000|Overall Study|Adverse Event|38|||
145369033|NCT02892422|524200546|FG000|Overall Study|Lack of Efficacy|32|||
145369034|NCT02892422|524200546|FG000|Overall Study|Non-compliance with study drug|11|||
145369035|NCT02892422|524200546|FG000|Overall Study|Protocol Violation|4|||
145369036|NCT02892422|524200546|FG000|Overall Study|Withdrawal by Subject|56|||
145369037|NCT02892422|524200546|FG000|Overall Study|Lost to Follow-up|5|||
145369038|NCT02892422|524200546|FG000|Overall Study|sponsor information 16159A results|21|||
145369039|NCT02892422|524200546|FG000|Overall Study|withdrawal of consent|13|||
145369040|NCT02892422|524200546|FG000|Overall Study|exclusion criteria met|3|||
145369041|NCT02892422|524200546|FG000|Overall Study|moving elsewhere|4|||
145369042|NCT02892422|524200546|FG000|Overall Study|non-compliance|10|||
145369043|NCT02892422|524200546|FG000|Overall Study|patient legally incapable|1|||
145369044|NCT02892422|524200546|FG000|Overall Study|patient decision|7|||
145369045|NCT02892422|524200546|FG000|Overall Study|Investigator decision|1|||
145369046|NCT03089697|524200547|FG000|Overall Study|Adverse Event|1|||
145369047|NCT03089697|524200548|FG001|Overall Study|Adverse Event|2|||
145369048|NCT03089697|524200547|FG000|Overall Study|Withdrawal by Subject|1|||
145369049|NCT03089697|524200548|FG001|Overall Study|Withdrawal by Subject|0|||
145369050|NCT02693171|524200560|FG000|Overall Study|Adverse Event|1|||
145369051|NCT02693171|524200560|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
145369052|NCT00595517|524200561|FG000|Overall Study|Adverse Event|6|||
145369053|NCT00595517|524200561|FG000|Overall Study|Withdrawal by Subject|4|||
145369054|NCT00595517|524200561|FG000|Overall Study|Protocol Violation|2|||
145369055|NCT00595517|524200561|FG000|Overall Study|Recurrence of ulcer|5|||
145369056|NCT00595517|524200561|FG000|Overall Study|usage of prohibited treatment|1|||
145369057|NCT00595517|524200561|FG000|Overall Study|No intention to attend regularly|1|||
145369058|NCT01167881|524200562|FG000|Overall Study|Adverse Event|47|||
145369059|NCT01167881|524200563|FG001|Overall Study|Adverse Event|51|||
145369060|NCT01167881|524200562|FG000|Overall Study|Lack of Efficacy|4|||
145369061|NCT01167881|524200563|FG001|Overall Study|Lack of Efficacy|7|||
145369062|NCT01167881|524200562|FG000|Overall Study|Non compliant with protocol|9|||
145369063|NCT01167881|524200563|FG001|Overall Study|Non compliant with protocol|18|||
145369064|NCT01167881|524200562|FG000|Overall Study|Lost to Follow-up|19|||
145369065|NCT01167881|524200563|FG001|Overall Study|Lost to Follow-up|20|||
145369066|NCT01167881|524200562|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
145369067|NCT01167881|524200563|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
145369068|NCT01167881|524200562|FG000|Overall Study|Not treated|4|||
145369069|NCT01167881|524200563|FG001|Overall Study|Not treated|0|||
145369070|NCT01167881|524200562|FG000|Overall Study|Other not defined above|31|||
145369071|NCT01167881|524200563|FG001|Overall Study|Other not defined above|55|||
145369072|NCT01992653|524200564|FG000|Overall Study|Death|0|||
145369073|NCT01992653|524200565|FG001|Overall Study|Death|0|||
145369074|NCT01992653|524200566|FG002|Overall Study|Death|1|||
145369075|NCT01992653|524200567|FG003|Overall Study|Death|0|||
145369076|NCT01992653|524200568|FG004|Overall Study|Death|1|||
145369077|NCT01992653|524200569|FG005|Overall Study|Death|0|||
145369078|NCT01992653|524200570|FG006|Overall Study|Death|4|||
145369079|NCT01992653|524200571|FG007|Overall Study|Death|2|||
145369080|NCT01992653|524200564|FG000|Overall Study|Lost to Follow-up|0|||
145369081|NCT01992653|524200565|FG001|Overall Study|Lost to Follow-up|0|||
145369082|NCT01992653|524200566|FG002|Overall Study|Lost to Follow-up|0|||
145369083|NCT01992653|524200567|FG003|Overall Study|Lost to Follow-up|0|||
145369084|NCT01992653|524200568|FG004|Overall Study|Lost to Follow-up|0|||
145369085|NCT01992653|524200569|FG005|Overall Study|Lost to Follow-up|0|||
145369086|NCT01992653|524200570|FG006|Overall Study|Lost to Follow-up|0|||
145369087|NCT01992653|524200571|FG007|Overall Study|Lost to Follow-up|1|||
145369088|NCT01992653|524200564|FG000|Overall Study|Study Completed|0|||
145369089|NCT01992653|524200565|FG001|Overall Study|Study Completed|0|||
145369090|NCT01992653|524200566|FG002|Overall Study|Study Completed|0|||
145369091|NCT01992653|524200567|FG003|Overall Study|Study Completed|0|||
145369092|NCT01992653|524200568|FG004|Overall Study|Study Completed|0|||
145369093|NCT01992653|524200569|FG005|Overall Study|Study Completed|0|||
145369094|NCT01992653|524200570|FG006|Overall Study|Study Completed|0|||
145369095|NCT01992653|524200571|FG007|Overall Study|Study Completed|1|||
145369096|NCT01992653|524200564|FG000|Overall Study|Disease Progression|0|||
145369097|NCT01992653|524200565|FG001|Overall Study|Disease Progression|0|||
145369098|NCT01992653|524200566|FG002|Overall Study|Disease Progression|0|||
145369099|NCT01992653|524200567|FG003|Overall Study|Disease Progression|0|||
145369100|NCT01992653|524200568|FG004|Overall Study|Disease Progression|0|||
145369101|NCT01992653|524200569|FG005|Overall Study|Disease Progression|0|||
145369102|NCT01992653|524200570|FG006|Overall Study|Disease Progression|4|||
145369103|NCT01992653|524200571|FG007|Overall Study|Disease Progression|0|||
145369104|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
145369105|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
145369106|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
145369107|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
145369108|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145369109|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145369110|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
145369111|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
145369112|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
145369113|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145369114|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145369115|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
145369116|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
145369117|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
145369118|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
145369119|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
145369120|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145369121|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
145369122|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145369123|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
145369124|NCT00556933|524200579|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145369125|NCT00556933|524200580|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
145369126|NCT00556933|524200581|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145369127|NCT00556933|524200582|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
145369128|NCT00556933|524200579|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
145369129|NCT00556933|524200580|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
145369130|NCT00556933|524200581|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
145369131|NCT00556933|524200582|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
145369132|NCT00556933|524200579|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
145369133|NCT00556933|524200580|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
145369134|NCT00556933|524200581|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
145369135|NCT00556933|524200582|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
145369136|NCT00556933|524200579|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
145369137|NCT00556933|524200580|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
145369138|NCT00556933|524200581|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
145369139|NCT00556933|524200582|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
145369140|NCT00556933|524200579|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
145369141|NCT00556933|524200580|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
145369142|NCT00556933|524200581|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
145369143|NCT00556933|524200582|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
145369144|NCT00556933|524200579|FG000|CNI Withdrawal vs. Minimization|Death|0|||
145369145|NCT00556933|524200580|FG001|CNI Withdrawal vs. Minimization|Death|0|||
145369146|NCT00556933|524200581|FG002|CNI Withdrawal vs. Minimization|Death|0|||
145369147|NCT00556933|524200582|FG003|CNI Withdrawal vs. Minimization|Death|1|||
145369148|NCT03887442|524200583|FG000|Overall Study|Adverse Event|1|||
145369149|NCT03887442|524200584|FG001|Overall Study|Adverse Event|0|||
145369150|NCT01628198|524200588|FG000|Overall Study|Lost to Follow-up|7|||
145369151|NCT01628198|524200588|FG000|Overall Study|Withdrawal by Subject|10|||
145369152|NCT01628198|524200588|FG000|Overall Study|Screen failure|1|||
145369153|NCT00022698|524200589|FG000|Overall Study|Adverse Event|5|||
145369154|NCT00022698|524200590|FG001|Overall Study|Adverse Event|9|||
145369155|NCT00022698|524200589|FG000|Overall Study|Death|0|||
145369156|NCT00022698|524200590|FG001|Overall Study|Death|2|||
145369157|NCT00022698|524200589|FG000|Overall Study|Failure to return|0|||
145369158|NCT00022698|524200590|FG001|Overall Study|Failure to return|1|||
145369159|NCT00022698|524200589|FG000|Overall Study|Refused treatment|0|||
145369160|NCT00022698|524200590|FG001|Overall Study|Refused treatment|2|||
145369161|NCT00022698|524200589|FG000|Overall Study|Insufficient therapeutic response|2|||
145369162|NCT00022698|524200590|FG001|Overall Study|Insufficient therapeutic response|14|||
145369163|NCT00022698|524200589|FG000|Overall Study|Administrative /other|1|||
145369164|NCT00022698|524200590|FG001|Overall Study|Administrative /other|7|||
145369165|NCT02504827|524200591|FG000|Overall Study|Could not produce sputum|1|||
145369166|NCT01743560|524200592|FG000|Overall Study|Disease progression|26|||
145369167|NCT01743560|524200592|FG000|Overall Study|Adverse Event|8|||
145369168|NCT01743560|524200592|FG000|Overall Study|Death|3|||
145369169|NCT01743560|524200592|FG000|Overall Study|Withdrawal by Subject|2|||
145369170|NCT01743560|524200592|FG000|Overall Study|Protocol Violation|1|||
145369171|NCT01743560|524200592|FG000|Overall Study|>1 dose of study drug|3|||
145369172|NCT03386994|524200593|FG000|Overall Study|Lung transplant|1|||
145369173|NCT03386994|524200593|FG000|Overall Study|Adverse Event|14|||
145369174|NCT03386994|524200593|FG000|Overall Study|Lost to Follow-up|4|||
145369175|NCT03386994|524200593|FG000|Overall Study|Withdrawal by Subject|3|||
145369176|NCT03386994|524200593|FG000|Overall Study|Death|16|||
145369177|NCT03425396|524200595|FG000|Overall Study|Lost to Follow-up|2|||
145369178|NCT03425396|524200596|FG001|Overall Study|Lost to Follow-up|5|||
145369179|NCT03425396|524200597|FG002|Overall Study|Lost to Follow-up|2|||
145369180|NCT03425396|524200598|FG003|Overall Study|Lost to Follow-up|0|||
145369181|NCT03425396|524200599|FG004|Overall Study|Lost to Follow-up|0|||
145369182|NCT03425396|524200595|FG000|Overall Study|Withdrawal by Subject|0|||
145369183|NCT03425396|524200596|FG001|Overall Study|Withdrawal by Subject|1|||
145369184|NCT03425396|524200597|FG002|Overall Study|Withdrawal by Subject|0|||
145369185|NCT03425396|524200598|FG003|Overall Study|Withdrawal by Subject|1|||
145369186|NCT03425396|524200599|FG004|Overall Study|Withdrawal by Subject|0|||
145369187|NCT03425396|524200595|FG000|Overall Study|Other|0|||
145369188|NCT03425396|524200596|FG001|Overall Study|Other|1|||
145369189|NCT03425396|524200597|FG002|Overall Study|Other|1|||
145369190|NCT03425396|524200598|FG003|Overall Study|Other|0|||
145369191|NCT03425396|524200599|FG004|Overall Study|Other|1|||
145369192|NCT03033602|524200600|FG000|Overall Study|Withdrawal by Subject|11|||
145369193|NCT03033602|524200601|FG001|Overall Study|Withdrawal by Subject|21|||
145369194|NCT03033602|524200600|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
145369195|NCT03033602|524200601|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
145369196|NCT01441765|524200602|FG000|Overall Study|Death|1|||
145369197|NCT01441765|524200603|FG001|Overall Study|Death|0|||
145369198|NCT00940823|524200604|FG000|Overall Study|Death|8|||
145369199|NCT00940823|524200605|FG001|Overall Study|Death|12|||
145369200|NCT00940823|524200604|FG000|Overall Study|Lost to Follow-up|27|||
145369201|NCT00940823|524200605|FG001|Overall Study|Lost to Follow-up|20|||
145369202|NCT03937908|524202319|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
145369203|NCT03937908|524202320|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
145369204|NCT00636194|524202321|FG000|Overall Study|Study related symptoms and complaints|1|||
145369205|NCT00636194|524202322|FG001|Overall Study|Study related symptoms and complaints|0|||
145369206|NCT00636194|524202321|FG000|Overall Study|Protocol Violation|2|||
145369207|NCT00636194|524202322|FG001|Overall Study|Protocol Violation|0|||
145369208|NCT04114357|524202323|FG000|Baseline-Randomization|Adverse Event|2|||
145369209|NCT04114357|524202324|FG001|Baseline-Randomization|Adverse Event|1|||
145369210|NCT04114357|524202323|FG000|Baseline-Randomization|Lost to Follow-up|1|||
145369211|NCT04114357|524202324|FG001|Baseline-Randomization|Lost to Follow-up|1|||
145369212|NCT04114357|524202323|FG000|Cross-over|Adverse Event|0|||
145369213|NCT04114357|524202324|FG001|Cross-over|Adverse Event|1|||
145369214|NCT02163226|524202325|FG000|Overall Study|Death|2|||
145369215|NCT02163226|524202326|FG001|Overall Study|Death|1|||
145369216|NCT02163226|524202325|FG000|Overall Study|Withdrawal by Subject|5|||
145369217|NCT02163226|524202326|FG001|Overall Study|Withdrawal by Subject|2|||
145369218|NCT02163226|524202325|FG000|Overall Study|Returned home, local radiotherapy|3|||
145369219|NCT02163226|524202326|FG001|Overall Study|Returned home, local radiotherapy|0|||
145369220|NCT02163226|524202325|FG000|Overall Study|Repeat imaging showed no disease|2|||
145369221|NCT02163226|524202326|FG001|Overall Study|Repeat imaging showed no disease|0|||
145369222|NCT02163226|524202325|FG000|Overall Study|Incomplete radiotherapy|3|||
145369223|NCT02163226|524202326|FG001|Overall Study|Incomplete radiotherapy|0|||
145369224|NCT02163226|524202325|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
145369225|NCT02163226|524202326|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
145369226|NCT02163226|524202325|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
145369227|NCT02163226|524202326|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
145369228|NCT02163226|524202325|FG000|Overall Study|ineligible|0|||
145369229|NCT02163226|524202326|FG001|Overall Study|ineligible|3|||
145369230|NCT03693612|524202328|FG000|Overall Study|Lost to Follow-up|0|||
145369231|NCT03693612|524202329|FG001|Overall Study|Lost to Follow-up|0|||
145369232|NCT03693612|524202330|FG002|Overall Study|Lost to Follow-up|0|||
145369233|NCT03693612|524202331|FG003|Overall Study|Lost to Follow-up|0|||
145369234|NCT03693612|524202332|FG004|Overall Study|Lost to Follow-up|1|||
145369235|NCT03693612|524202333|FG005|Overall Study|Lost to Follow-up|0|||
145369236|NCT03693612|524202334|FG006|Overall Study|Lost to Follow-up|0|||
145369237|NCT03693612|524202328|FG000|Overall Study|Withdrawal by Subject|0|||
145369238|NCT03693612|524202329|FG001|Overall Study|Withdrawal by Subject|0|||
145369239|NCT03693612|524202330|FG002|Overall Study|Withdrawal by Subject|1|||
145369240|NCT03693612|524202331|FG003|Overall Study|Withdrawal by Subject|0|||
145369241|NCT03693612|524202332|FG004|Overall Study|Withdrawal by Subject|2|||
145369242|NCT03693612|524202333|FG005|Overall Study|Withdrawal by Subject|0|||
145369243|NCT03693612|524202334|FG006|Overall Study|Withdrawal by Subject|0|||
145369244|NCT03693612|524202328|FG000|Overall Study|Study Terminated by Sponsor|0|||
145369245|NCT03693612|524202329|FG001|Overall Study|Study Terminated by Sponsor|1|||
145369246|NCT03693612|524202330|FG002|Overall Study|Study Terminated by Sponsor|0|||
145369247|NCT03693612|524202331|FG003|Overall Study|Study Terminated by Sponsor|0|||
145369248|NCT03693612|524202332|FG004|Overall Study|Study Terminated by Sponsor|3|||
145369249|NCT03693612|524202333|FG005|Overall Study|Study Terminated by Sponsor|0|||
145369250|NCT03693612|524202334|FG006|Overall Study|Study Terminated by Sponsor|0|||
145369251|NCT05318092|524202335|FG000|Overall Study|Lost to Follow-up|3|||
145369252|NCT05318092|524202335|FG000|Overall Study|Withdrawal by Subject|1|||
145369253|NCT04304235|524202336|FG000|Overall Study|incomplete triage data|0|||
145369254|NCT04304235|524202337|FG001|Overall Study|incomplete triage data|69|||
145369255|NCT04304235|524202338|FG002|Overall Study|incomplete triage data|0|||
145369256|NCT04304235|524202339|FG003|Overall Study|incomplete triage data|0|||
145369257|NCT04304235|524202340|FG004|Overall Study|incomplete triage data|289|||
145369258|NCT04304235|524202341|FG005|Overall Study|incomplete triage data|123|||
145369259|NCT04304235|524202342|FG006|Overall Study|incomplete triage data|65|||
145369260|NCT02048826|524202345|FG000|Overall Study|Withdrawal by Subject|1|||
145369261|NCT02048826|524202346|FG001|Overall Study|Withdrawal by Subject|0|||
145369262|NCT02222545|524202348|FG000|Overall Study|Adverse Event|1|||
145369263|NCT02222545|524202349|FG001|Overall Study|Adverse Event|0|||
145369264|NCT02222545|524202350|FG002|Overall Study|Adverse Event|2|||
145369265|NCT02222545|524202348|FG000|Overall Study|Death|0|||
145369266|NCT02222545|524202349|FG001|Overall Study|Death|0|||
145369267|NCT02222545|524202350|FG002|Overall Study|Death|9|||
145578803|NCT02316717|524973754|FG001|Overall Study|Withdrawal by Subject|1|||
145369268|NCT02222545|524202348|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
145578804|NCT02316717|524973755|FG002|Overall Study|Withdrawal by Subject|1|||
145578805|NCT02316717|524973753|FG000|Overall Study|Death|0|||
145369269|NCT02222545|524202349|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
145369270|NCT02222545|524202350|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
145369271|NCT02222545|524202348|FG000|Overall Study|Withdrawal by Subject|0|||
145369272|NCT02222545|524202349|FG001|Overall Study|Withdrawal by Subject|0|||
145369273|NCT02222545|524202350|FG002|Overall Study|Withdrawal by Subject|3|||
145369274|NCT02222545|524202348|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
145369275|NCT02222545|524202349|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
145369276|NCT02222545|524202350|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
145369277|NCT02651155|524202352|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145369278|NCT02651155|524202353|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
145369279|NCT02651155|524202352|FG000|Overall Study|Voluntary Withdrawal|5|||
145369280|NCT02651155|524202353|FG001|Overall Study|Voluntary Withdrawal|0|||
145369281|NCT00537316|524202354|FG000|Part 1|Adverse Event|7|||
145369282|NCT00537316|524202355|FG001|Part 1|Adverse Event|11|||
145369283|NCT00537316|524202356|FG002|Part 1|Adverse Event|8|||
145369284|NCT00537316|524202357|FG003|Part 1|Adverse Event|0|||
145369285|NCT00537316|524202358|FG004|Part 1|Adverse Event|0|||
145369286|NCT00537316|524202359|FG005|Part 1|Adverse Event|0|||
145369287|NCT00537316|524202360|FG006|Part 1|Adverse Event|0|||
145369288|NCT00537316|524202354|FG000|Part 1|Protocol defined clinical event|1|||
145369289|NCT00537316|524202355|FG001|Part 1|Protocol defined clinical event|0|||
145369290|NCT00537316|524202356|FG002|Part 1|Protocol defined clinical event|0|||
145369291|NCT00537316|524202357|FG003|Part 1|Protocol defined clinical event|0|||
145369292|NCT00537316|524202358|FG004|Part 1|Protocol defined clinical event|0|||
145369293|NCT00537316|524202359|FG005|Part 1|Protocol defined clinical event|0|||
145369294|NCT00537316|524202360|FG006|Part 1|Protocol defined clinical event|0|||
145369295|NCT00537316|524202354|FG000|Part 1|Lost to Follow-up|1|||
145369296|NCT00537316|524202355|FG001|Part 1|Lost to Follow-up|0|||
145369297|NCT00537316|524202356|FG002|Part 1|Lost to Follow-up|0|||
145369298|NCT00537316|524202357|FG003|Part 1|Lost to Follow-up|0|||
145369299|NCT00537316|524202358|FG004|Part 1|Lost to Follow-up|0|||
145369300|NCT00537316|524202359|FG005|Part 1|Lost to Follow-up|0|||
145369301|NCT00537316|524202360|FG006|Part 1|Lost to Follow-up|0|||
145369302|NCT00537316|524202354|FG000|Part 1|Withdrawal by Subject|3|||
145369303|NCT00537316|524202355|FG001|Part 1|Withdrawal by Subject|8|||
145369304|NCT00537316|524202356|FG002|Part 1|Withdrawal by Subject|4|||
145369305|NCT00537316|524202357|FG003|Part 1|Withdrawal by Subject|0|||
145369306|NCT00537316|524202358|FG004|Part 1|Withdrawal by Subject|0|||
145369307|NCT00537316|524202359|FG005|Part 1|Withdrawal by Subject|0|||
145369308|NCT00537316|524202360|FG006|Part 1|Withdrawal by Subject|0|||
145369309|NCT00537316|524202354|FG000|Part 1|Protocol Violation|1|||
145369310|NCT00537316|524202355|FG001|Part 1|Protocol Violation|5|||
145369311|NCT00537316|524202356|FG002|Part 1|Protocol Violation|1|||
145369312|NCT00537316|524202357|FG003|Part 1|Protocol Violation|0|||
145369313|NCT00537316|524202358|FG004|Part 1|Protocol Violation|0|||
145369314|NCT00537316|524202359|FG005|Part 1|Protocol Violation|0|||
145369315|NCT00537316|524202360|FG006|Part 1|Protocol Violation|0|||
145369316|NCT00537316|524202354|FG000|Part 1|Did not meet protocol eligibility|1|||
145369317|NCT00537316|524202355|FG001|Part 1|Did not meet protocol eligibility|3|||
145369318|NCT00537316|524202356|FG002|Part 1|Did not meet protocol eligibility|2|||
145369319|NCT00537316|524202357|FG003|Part 1|Did not meet protocol eligibility|0|||
145369320|NCT00537316|524202358|FG004|Part 1|Did not meet protocol eligibility|0|||
145369321|NCT00537316|524202359|FG005|Part 1|Did not meet protocol eligibility|0|||
145369322|NCT00537316|524202360|FG006|Part 1|Did not meet protocol eligibility|0|||
145369323|NCT00537316|524202354|FG000|Part 1|Administrative|0|||
145369324|NCT00537316|524202355|FG001|Part 1|Administrative|0|||
145369325|NCT00537316|524202356|FG002|Part 1|Administrative|2|||
145369326|NCT00537316|524202357|FG003|Part 1|Administrative|0|||
145369327|NCT00537316|524202358|FG004|Part 1|Administrative|0|||
145369328|NCT00537316|524202359|FG005|Part 1|Administrative|0|||
145369329|NCT00537316|524202360|FG006|Part 1|Administrative|0|||
145369330|NCT00537316|524202354|FG000|Part 2|Never entered follow-up|0|||
145369331|NCT00537316|524202355|FG001|Part 2|Never entered follow-up|0|||
145369332|NCT00537316|524202356|FG002|Part 2|Never entered follow-up|0|||
145369333|NCT00537316|524202357|FG003|Part 2|Never entered follow-up|0|||
145369334|NCT00537316|524202358|FG004|Part 2|Never entered follow-up|0|||
145369335|NCT00537316|524202359|FG005|Part 2|Never entered follow-up|0|||
145369336|NCT00537316|524202360|FG006|Part 2|Never entered follow-up|1|||
145369337|NCT00537316|524202354|FG000|Part 2|Adverse Event|4|||
145369338|NCT00537316|524202355|FG001|Part 2|Adverse Event|0|||
145369339|NCT00537316|524202356|FG002|Part 2|Adverse Event|2|||
145369340|NCT00537316|524202357|FG003|Part 2|Adverse Event|0|||
145369341|NCT00537316|524202358|FG004|Part 2|Adverse Event|0|||
145369342|NCT00537316|524202359|FG005|Part 2|Adverse Event|0|||
145369343|NCT00537316|524202360|FG006|Part 2|Adverse Event|0|||
145369344|NCT00537316|524202354|FG000|Part 2|Lost to Follow-up|1|||
145369345|NCT00537316|524202355|FG001|Part 2|Lost to Follow-up|0|||
145369346|NCT00537316|524202356|FG002|Part 2|Lost to Follow-up|2|||
145369347|NCT00537316|524202357|FG003|Part 2|Lost to Follow-up|0|||
145369348|NCT00537316|524202358|FG004|Part 2|Lost to Follow-up|0|||
145369349|NCT00537316|524202359|FG005|Part 2|Lost to Follow-up|0|||
145369350|NCT00537316|524202360|FG006|Part 2|Lost to Follow-up|0|||
145369351|NCT00537316|524202354|FG000|Part 2|Withdrawal by Subject|5|||
145369352|NCT00537316|524202355|FG001|Part 2|Withdrawal by Subject|1|||
145369353|NCT00537316|524202356|FG002|Part 2|Withdrawal by Subject|4|||
145369354|NCT00537316|524202357|FG003|Part 2|Withdrawal by Subject|0|||
145369355|NCT00537316|524202358|FG004|Part 2|Withdrawal by Subject|0|||
145369356|NCT00537316|524202359|FG005|Part 2|Withdrawal by Subject|0|||
145369357|NCT00537316|524202360|FG006|Part 2|Withdrawal by Subject|0|||
145369358|NCT00537316|524202354|FG000|Part 2|Administrative|16|||
145369359|NCT00537316|524202355|FG001|Part 2|Administrative|8|||
145369360|NCT00537316|524202356|FG002|Part 2|Administrative|24|||
145369361|NCT00537316|524202357|FG003|Part 2|Administrative|3|||
145369362|NCT00537316|524202358|FG004|Part 2|Administrative|1|||
145369363|NCT00537316|524202359|FG005|Part 2|Administrative|4|||
145369364|NCT00537316|524202360|FG006|Part 2|Administrative|1|||
145369365|NCT04533412|524202361|FG000|Overall Study|Withdrawal by Subject|1|||
145369366|NCT04533412|524202362|FG001|Overall Study|Withdrawal by Subject|1|||
145369367|NCT04533412|524202361|FG000|Overall Study|Lost to Follow-up|1|||
145369368|NCT04533412|524202362|FG001|Overall Study|Lost to Follow-up|4|||
145369369|NCT03452488|524202364|FG000|Overall Study|Adverse Event|4|||
145369370|NCT03452488|524202365|FG001|Overall Study|Adverse Event|6|||
145369371|NCT03452488|524202366|FG002|Overall Study|Adverse Event|1|||
145369372|NCT03452488|524202364|FG000|Overall Study|Death|0|||
145369373|NCT03452488|524202365|FG001|Overall Study|Death|0|||
145369374|NCT03452488|524202366|FG002|Overall Study|Death|1|||
145369375|NCT03452488|524202364|FG000|Overall Study|Lost to Follow-up|1|||
145369376|NCT03452488|524202365|FG001|Overall Study|Lost to Follow-up|2|||
145369377|NCT03452488|524202366|FG002|Overall Study|Lost to Follow-up|0|||
145369378|NCT03452488|524202364|FG000|Overall Study|PI Decision|1|||
145369379|NCT03452488|524202365|FG001|Overall Study|PI Decision|0|||
145369380|NCT03452488|524202366|FG002|Overall Study|PI Decision|0|||
145369381|NCT03452488|524202364|FG000|Overall Study|Withdrew consent|4|||
145369382|NCT03452488|524202365|FG001|Overall Study|Withdrew consent|2|||
145369383|NCT03452488|524202366|FG002|Overall Study|Withdrew consent|2|||
145369384|NCT03452488|524202364|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
145369385|NCT03452488|524202365|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
145369386|NCT03452488|524202366|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
145369387|NCT03452488|524202364|FG000|Overall Study|Other|0|||
145369388|NCT03452488|524202365|FG001|Overall Study|Other|2|||
145369389|NCT03452488|524202366|FG002|Overall Study|Other|2|||
145369390|NCT02980341|524202369|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145369391|NCT02980341|524202370|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145369392|NCT02980341|524202371|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
145369393|NCT02980341|524202372|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
145369394|NCT02980341|524202373|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
145369395|NCT02980341|524202374|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369396|NCT02980341|524202375|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369397|NCT02980341|524202376|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369398|NCT02980341|524202377|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369399|NCT02980341|524202378|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369400|NCT02980341|524202379|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
145369401|NCT02980341|524202369|FG000|Dose Escalation|Clinical progression|0|||
145369402|NCT02980341|524202370|FG001|Dose Escalation|Clinical progression|0|||
145369403|NCT02980341|524202371|FG002|Dose Escalation|Clinical progression|2|||
145369404|NCT02980341|524202372|FG003|Dose Escalation|Clinical progression|1|||
145369405|NCT02980341|524202373|FG004|Dose Escalation|Clinical progression|0|||
145369406|NCT02980341|524202374|FG005|Dose Escalation|Clinical progression|0|||
145369407|NCT02980341|524202375|FG006|Dose Escalation|Clinical progression|0|||
145369408|NCT02980341|524202376|FG007|Dose Escalation|Clinical progression|0|||
145369409|NCT02980341|524202377|FG008|Dose Escalation|Clinical progression|0|||
145369410|NCT02980341|524202378|FG009|Dose Escalation|Clinical progression|0|||
145369411|NCT02980341|524202379|FG010|Dose Escalation|Clinical progression|0|||
145369412|NCT02980341|524202369|FG000|Dose Escalation|Adverse Event|0|||
145369413|NCT02980341|524202370|FG001|Dose Escalation|Adverse Event|0|||
145369414|NCT02980341|524202371|FG002|Dose Escalation|Adverse Event|1|||
145369415|NCT02980341|524202372|FG003|Dose Escalation|Adverse Event|2|||
145369416|NCT02980341|524202373|FG004|Dose Escalation|Adverse Event|2|||
145422531|NCT00553475|524402133|FG001|Overall Study|Adverse Event|17|||
145422532|NCT00553475|524402134|FG002|Overall Study|Adverse Event|13|||
145422533|NCT00553475|524402132|FG000|Overall Study|Lack of Efficacy|7|||
145369417|NCT02980341|524202374|FG005|Dose Escalation|Adverse Event|0|||
145369418|NCT02980341|524202375|FG006|Dose Escalation|Adverse Event|0|||
145369419|NCT02980341|524202376|FG007|Dose Escalation|Adverse Event|0|||
145369420|NCT02980341|524202377|FG008|Dose Escalation|Adverse Event|0|||
145369421|NCT02980341|524202378|FG009|Dose Escalation|Adverse Event|0|||
145369422|NCT02980341|524202379|FG010|Dose Escalation|Adverse Event|0|||
145369423|NCT02980341|524202369|FG000|Dose Escalation|Withdrawal by Subject|0|||
145369424|NCT02980341|524202370|FG001|Dose Escalation|Withdrawal by Subject|0|||
145369425|NCT02980341|524202371|FG002|Dose Escalation|Withdrawal by Subject|1|||
145369426|NCT02980341|524202372|FG003|Dose Escalation|Withdrawal by Subject|0|||
145369427|NCT02980341|524202373|FG004|Dose Escalation|Withdrawal by Subject|0|||
145422534|NCT00553475|524402133|FG001|Overall Study|Lack of Efficacy|1|||
145369428|NCT02980341|524202374|FG005|Dose Escalation|Withdrawal by Subject|0|||
145369429|NCT02980341|524202375|FG006|Dose Escalation|Withdrawal by Subject|0|||
145369430|NCT02980341|524202376|FG007|Dose Escalation|Withdrawal by Subject|0|||
145369431|NCT02980341|524202377|FG008|Dose Escalation|Withdrawal by Subject|0|||
145369432|NCT02980341|524202378|FG009|Dose Escalation|Withdrawal by Subject|0|||
145369433|NCT02980341|524202379|FG010|Dose Escalation|Withdrawal by Subject|0|||
145369434|NCT02980341|524202369|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369435|NCT02980341|524202370|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369436|NCT02980341|524202371|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369437|NCT02980341|524202372|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
145369438|NCT02980341|524202373|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369439|NCT02980341|524202374|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369440|NCT02980341|524202375|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369441|NCT02980341|524202376|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369442|NCT02980341|524202377|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369443|NCT02980341|524202378|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369444|NCT02980341|524202379|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
145369445|NCT02980341|524202369|FG000|Dose Escalation|Due to investigator's decision|0|||
145369446|NCT02980341|524202370|FG001|Dose Escalation|Due to investigator's decision|0|||
145369447|NCT02980341|524202371|FG002|Dose Escalation|Due to investigator's decision|0|||
145369448|NCT02980341|524202372|FG003|Dose Escalation|Due to investigator's decision|0|||
145369449|NCT02980341|524202373|FG004|Dose Escalation|Due to investigator's decision|1|||
145369450|NCT02980341|524202374|FG005|Dose Escalation|Due to investigator's decision|0|||
145369451|NCT02980341|524202375|FG006|Dose Escalation|Due to investigator's decision|0|||
145369452|NCT02980341|524202376|FG007|Dose Escalation|Due to investigator's decision|0|||
145369453|NCT02980341|524202377|FG008|Dose Escalation|Due to investigator's decision|0|||
145369454|NCT02980341|524202378|FG009|Dose Escalation|Due to investigator's decision|0|||
145369455|NCT02980341|524202379|FG010|Dose Escalation|Due to investigator's decision|0|||
145369456|NCT02980341|524202369|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369457|NCT02980341|524202370|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369458|NCT02980341|524202371|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369459|NCT02980341|524202372|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369460|NCT02980341|524202373|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369461|NCT02980341|524202374|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
145369462|NCT02980341|524202375|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
145369463|NCT02980341|524202376|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369464|NCT02980341|524202377|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369465|NCT02980341|524202378|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369466|NCT02980341|524202379|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
145369467|NCT02980341|524202369|FG000|Dose Finding|Adverse Event|0|||
145369468|NCT02980341|524202370|FG001|Dose Finding|Adverse Event|0|||
145369469|NCT02980341|524202371|FG002|Dose Finding|Adverse Event|0|||
145369470|NCT02980341|524202372|FG003|Dose Finding|Adverse Event|0|||
145369471|NCT02980341|524202373|FG004|Dose Finding|Adverse Event|0|||
145369472|NCT02980341|524202374|FG005|Dose Finding|Adverse Event|3|||
145369473|NCT02980341|524202375|FG006|Dose Finding|Adverse Event|0|||
145369474|NCT02980341|524202376|FG007|Dose Finding|Adverse Event|0|||
145369475|NCT02980341|524202377|FG008|Dose Finding|Adverse Event|0|||
145369476|NCT02980341|524202378|FG009|Dose Finding|Adverse Event|0|||
145369477|NCT02980341|524202379|FG010|Dose Finding|Adverse Event|0|||
145369478|NCT02980341|524202369|FG000|Dose Finding|Withdrawal by Subject|0|||
145369479|NCT02980341|524202370|FG001|Dose Finding|Withdrawal by Subject|0|||
145369480|NCT02980341|524202371|FG002|Dose Finding|Withdrawal by Subject|0|||
145369481|NCT02980341|524202372|FG003|Dose Finding|Withdrawal by Subject|0|||
145369482|NCT02980341|524202373|FG004|Dose Finding|Withdrawal by Subject|0|||
145369483|NCT02980341|524202374|FG005|Dose Finding|Withdrawal by Subject|1|||
145369484|NCT02980341|524202375|FG006|Dose Finding|Withdrawal by Subject|1|||
145369485|NCT02980341|524202376|FG007|Dose Finding|Withdrawal by Subject|0|||
145369486|NCT02980341|524202377|FG008|Dose Finding|Withdrawal by Subject|0|||
145369487|NCT02980341|524202378|FG009|Dose Finding|Withdrawal by Subject|0|||
145369488|NCT02980341|524202379|FG010|Dose Finding|Withdrawal by Subject|0|||
145369489|NCT02980341|524202369|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369490|NCT02980341|524202370|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369491|NCT02980341|524202371|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369492|NCT02980341|524202372|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369493|NCT02980341|524202373|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369494|NCT02980341|524202374|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369495|NCT02980341|524202375|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
145369496|NCT02980341|524202376|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
145369497|NCT02980341|524202377|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
145422535|NCT00553475|524402134|FG002|Overall Study|Lack of Efficacy|0|||
145369498|NCT02980341|524202378|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
145369499|NCT02980341|524202379|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
145369500|NCT02980341|524202369|FG000|Dose Expansion|Clinical progression|0|||
145369501|NCT02980341|524202370|FG001|Dose Expansion|Clinical progression|0|||
145369502|NCT02980341|524202371|FG002|Dose Expansion|Clinical progression|0|||
145369503|NCT02980341|524202372|FG003|Dose Expansion|Clinical progression|0|||
145369504|NCT02980341|524202373|FG004|Dose Expansion|Clinical progression|0|||
145369505|NCT02980341|524202374|FG005|Dose Expansion|Clinical progression|0|||
145369506|NCT02980341|524202375|FG006|Dose Expansion|Clinical progression|0|||
145369507|NCT02980341|524202376|FG007|Dose Expansion|Clinical progression|4|||
145369508|NCT02980341|524202377|FG008|Dose Expansion|Clinical progression|3|||
145369509|NCT02980341|524202378|FG009|Dose Expansion|Clinical progression|1|||
145369510|NCT02980341|524202379|FG010|Dose Expansion|Clinical progression|4|||
145369511|NCT02980341|524202369|FG000|Dose Expansion|Adverse Event|0|||
145369512|NCT02980341|524202370|FG001|Dose Expansion|Adverse Event|0|||
145369513|NCT02980341|524202371|FG002|Dose Expansion|Adverse Event|0|||
145369514|NCT02980341|524202372|FG003|Dose Expansion|Adverse Event|0|||
145369515|NCT02980341|524202373|FG004|Dose Expansion|Adverse Event|0|||
145369516|NCT02980341|524202374|FG005|Dose Expansion|Adverse Event|0|||
145369517|NCT02980341|524202375|FG006|Dose Expansion|Adverse Event|0|||
145369518|NCT02980341|524202376|FG007|Dose Expansion|Adverse Event|3|||
145369519|NCT02980341|524202377|FG008|Dose Expansion|Adverse Event|0|||
145369520|NCT02980341|524202378|FG009|Dose Expansion|Adverse Event|1|||
145369521|NCT02980341|524202379|FG010|Dose Expansion|Adverse Event|3|||
145369522|NCT02980341|524202369|FG000|Dose Expansion|Death|0|||
145369523|NCT02980341|524202370|FG001|Dose Expansion|Death|0|||
145369524|NCT02980341|524202371|FG002|Dose Expansion|Death|0|||
145369525|NCT02980341|524202372|FG003|Dose Expansion|Death|0|||
145369526|NCT02980341|524202373|FG004|Dose Expansion|Death|0|||
145369527|NCT02980341|524202374|FG005|Dose Expansion|Death|0|||
145369528|NCT02980341|524202375|FG006|Dose Expansion|Death|0|||
145369529|NCT02980341|524202376|FG007|Dose Expansion|Death|0|||
145369530|NCT02980341|524202377|FG008|Dose Expansion|Death|2|||
145369531|NCT02980341|524202378|FG009|Dose Expansion|Death|1|||
145369532|NCT02980341|524202379|FG010|Dose Expansion|Death|0|||
145369533|NCT02980341|524202369|FG000|Dose Expansion|Withdrawal by Subject|0|||
145369534|NCT02980341|524202370|FG001|Dose Expansion|Withdrawal by Subject|0|||
145369535|NCT02980341|524202371|FG002|Dose Expansion|Withdrawal by Subject|0|||
145369536|NCT02980341|524202372|FG003|Dose Expansion|Withdrawal by Subject|0|||
145369537|NCT02980341|524202373|FG004|Dose Expansion|Withdrawal by Subject|0|||
145369538|NCT02980341|524202374|FG005|Dose Expansion|Withdrawal by Subject|0|||
145369539|NCT02980341|524202375|FG006|Dose Expansion|Withdrawal by Subject|0|||
145369540|NCT02980341|524202376|FG007|Dose Expansion|Withdrawal by Subject|2|||
145369541|NCT02980341|524202377|FG008|Dose Expansion|Withdrawal by Subject|0|||
145369542|NCT02980341|524202378|FG009|Dose Expansion|Withdrawal by Subject|1|||
145369543|NCT02980341|524202379|FG010|Dose Expansion|Withdrawal by Subject|0|||
145369544|NCT02980341|524202369|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369545|NCT02980341|524202370|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369546|NCT02980341|524202371|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369547|NCT02980341|524202372|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369548|NCT02980341|524202373|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369549|NCT02980341|524202374|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369550|NCT02980341|524202375|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369551|NCT02980341|524202376|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
145369552|NCT02980341|524202377|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369553|NCT02980341|524202378|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369554|NCT02980341|524202379|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
145369555|NCT02980341|524202369|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369556|NCT02980341|524202370|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369557|NCT02980341|524202371|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369558|NCT02980341|524202372|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369559|NCT02980341|524202373|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369560|NCT02980341|524202374|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369561|NCT02980341|524202375|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369562|NCT02980341|524202376|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369563|NCT02980341|524202377|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
145369564|NCT02980341|524202378|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369565|NCT02980341|524202379|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
145369566|NCT02980341|524202369|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369567|NCT02980341|524202370|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369568|NCT02980341|524202371|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369569|NCT02980341|524202372|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369570|NCT02980341|524202373|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369571|NCT02980341|524202374|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369572|NCT02980341|524202375|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369573|NCT02980341|524202376|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369574|NCT02980341|524202377|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
145369575|NCT02980341|524202378|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369576|NCT02980341|524202379|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
145369577|NCT02980341|524202369|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369578|NCT02980341|524202370|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369579|NCT02980341|524202371|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369580|NCT02980341|524202372|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369581|NCT02980341|524202373|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369582|NCT02980341|524202374|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369583|NCT02980341|524202375|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369584|NCT02980341|524202376|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369585|NCT02980341|524202377|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369586|NCT02980341|524202378|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
145369587|NCT02980341|524202379|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
145369588|NCT00749684|524202382|FG000|Overall Study|Death|1|||
145369589|NCT00749684|524202382|FG000|Overall Study|Adverse Event|27|||
145369590|NCT00749684|524202382|FG000|Overall Study|Participant's Wish|10|||
145369591|NCT00749684|524202382|FG000|Overall Study|Not Documented|1|||
145369592|NCT00749684|524202382|FG000|Overall Study|Progressive Desease|31|||
145369593|NCT00749684|524202382|FG000|Overall Study|Therapy according to protocol + AE|2|||
145369594|NCT00749684|524202382|FG000|Overall Study|AE+discontinuation on participants wish|1|||
145369595|NCT00749684|524202382|FG000|Overall Study|Missing|9|||
145369596|NCT04603482|524202383|FG000|Overall Study|Lost to Follow-up|15|||
145369597|NCT04603482|524202384|FG001|Overall Study|Lost to Follow-up|15|||
145369598|NCT04603482|524202385|FG002|Overall Study|Lost to Follow-up|15|||
145369599|NCT01054196|524202389|FG000|Overall Study|Physician Decision|0|||
145369600|NCT01054196|524202390|FG001|Overall Study|Physician Decision|0|||
145369601|NCT01054196|524202391|FG002|Overall Study|Physician Decision|0|||
145369602|NCT01054196|524202392|FG003|Overall Study|Physician Decision|1|||
145369603|NCT01054196|524202393|FG004|Overall Study|Physician Decision|0|||
145369604|NCT01054196|524202394|FG005|Overall Study|Physician Decision|0|||
145369605|NCT01054196|524202395|FG006|Overall Study|Physician Decision|1|||
145369606|NCT00179673|524202397|FG000|Overall Study|Adverse Event|7|||
145369607|NCT00179673|524202397|FG000|Overall Study|Lack of Efficacy|15|||
145369608|NCT00179673|524202397|FG000|Overall Study|Withdrawal by Subject|3|||
145369609|NCT00179673|524202397|FG000|Overall Study|Death|4|||
145369610|NCT00179673|524202397|FG000|Overall Study|Other Observations and options|14|||
145369611|NCT00492648|524202398|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
145369612|NCT00492648|524202399|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
145369613|NCT00282113|524202400|FG000|Overall Study|Removed at parents request|1|||
145369614|NCT00282113|524202401|FG001|Overall Study|Removed at parents request|0|||
145369615|NCT00282113|524202402|FG002|Overall Study|Removed at parents request|0|||
145369616|NCT03382834|524202403|FG000|Step 1|Lost to Follow-up|0|||
145369617|NCT03382834|524202404|FG001|Step 1|Lost to Follow-up|1|||
145369618|NCT03382834|524202403|FG000|Step 2|Death|1|||
145369619|NCT03382834|524202404|FG001|Step 2|Death|0|||
145369620|NCT03382834|524202403|FG000|Step 2|Lost to Follow-up|2|||
145369621|NCT03382834|524202404|FG001|Step 2|Lost to Follow-up|2|||
145369622|NCT03382834|524202403|FG000|Step 2|Site Terminated by Sponsor|1|||
145369623|NCT03382834|524202404|FG001|Step 2|Site Terminated by Sponsor|0|||
145369624|NCT02387957|524202405|FG000|Overall Study|The study was discontinued|21|||
145369625|NCT02387957|524202406|FG001|Overall Study|The study was discontinued|21|||
145369626|NCT02387957|524202407|FG002|Overall Study|The study was discontinued|20|||
145369627|NCT02294396|524202408|FG000|Overall Study|Adverse Event|26|||
145369628|NCT02294396|524202409|FG001|Overall Study|Adverse Event|25|||
145369629|NCT02294396|524202410|FG002|Overall Study|Adverse Event|21|||
145369630|NCT02294396|524202411|FG003|Overall Study|Adverse Event|24|||
145369631|NCT02294396|524202408|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
145369632|NCT02294396|524202409|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
145369633|NCT02294396|524202410|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
145369634|NCT02294396|524202411|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
145369635|NCT02294396|524202408|FG000|Overall Study|Withdrawal by Subject|8|||
145369636|NCT02294396|524202409|FG001|Overall Study|Withdrawal by Subject|6|||
145369637|NCT02294396|524202410|FG002|Overall Study|Withdrawal by Subject|6|||
145369638|NCT02294396|524202411|FG003|Overall Study|Withdrawal by Subject|8|||
145369639|NCT02294396|524202408|FG000|Overall Study|Lost to Follow-up|0|||
145369640|NCT02294396|524202409|FG001|Overall Study|Lost to Follow-up|0|||
145369641|NCT02294396|524202410|FG002|Overall Study|Lost to Follow-up|1|||
145369642|NCT02294396|524202411|FG003|Overall Study|Lost to Follow-up|1|||
145369643|NCT02294396|524202408|FG000|Overall Study|Protocol Deviation|3|||
145369644|NCT02294396|524202409|FG001|Overall Study|Protocol Deviation|2|||
145369645|NCT02294396|524202410|FG002|Overall Study|Protocol Deviation|2|||
145369646|NCT02294396|524202411|FG003|Overall Study|Protocol Deviation|1|||
145369647|NCT02294396|524202408|FG000|Overall Study|Miscellaneous|2|||
145369648|NCT02294396|524202409|FG001|Overall Study|Miscellaneous|0|||
145369649|NCT02294396|524202410|FG002|Overall Study|Miscellaneous|5|||
145369650|NCT02294396|524202411|FG003|Overall Study|Miscellaneous|2|||
145369651|NCT02949843|524202412|FG000|Overall Study|Withdrawal by Subject|0|||
145369652|NCT02949843|524202413|FG001|Overall Study|Withdrawal by Subject|1|||
145369653|NCT02949843|524202414|FG002|Overall Study|Withdrawal by Subject|1|||
145369654|NCT02120833|524202415|FG000|Overall Study|Adverse Event|1|||
145369655|NCT02120833|524202416|FG001|Overall Study|Adverse Event|0|||
145369656|NCT02120833|524202415|FG000|Overall Study|Withdrawal by Subject|2|||
145369657|NCT02120833|524202416|FG001|Overall Study|Withdrawal by Subject|0|||
145369658|NCT02120833|524202415|FG000|Overall Study|Lost to Follow-up|1|||
145369659|NCT02120833|524202416|FG001|Overall Study|Lost to Follow-up|1|||
145369660|NCT03613649|524202417|FG000|Second Treatment|Lost to Follow-up|0|||
145369661|NCT03613649|524202418|FG001|Second Treatment|Lost to Follow-up|0|||
145369662|NCT03613649|524202419|FG002|Second Treatment|Lost to Follow-up|1|||
145369663|NCT03613649|524202420|FG003|Second Treatment|Lost to Follow-up|0|||
145369664|NCT03613649|524202421|FG004|Second Treatment|Lost to Follow-up|0|||
145369665|NCT03613649|524202422|FG005|Second Treatment|Lost to Follow-up|0|||
145369666|NCT03613649|524202423|FG006|Second Treatment|Lost to Follow-up|0|||
145369667|NCT03613649|524202424|FG007|Second Treatment|Lost to Follow-up|0|||
145369668|NCT03613649|524202425|FG008|Second Treatment|Lost to Follow-up|0|||
145369669|NCT03613649|524202426|FG009|Second Treatment|Lost to Follow-up|0|||
145369670|NCT03613649|524202427|FG010|Second Treatment|Lost to Follow-up|0|||
145369671|NCT03613649|524202428|FG011|Second Treatment|Lost to Follow-up|0|||
145369672|NCT03613649|524202417|FG000|Second Treatment|Withdrawal by Subject|0|||
145369673|NCT03613649|524202418|FG001|Second Treatment|Withdrawal by Subject|0|||
145369674|NCT03613649|524202419|FG002|Second Treatment|Withdrawal by Subject|0|||
145369675|NCT03613649|524202420|FG003|Second Treatment|Withdrawal by Subject|0|||
145369676|NCT03613649|524202421|FG004|Second Treatment|Withdrawal by Subject|1|||
145369677|NCT03613649|524202422|FG005|Second Treatment|Withdrawal by Subject|0|||
145369678|NCT03613649|524202423|FG006|Second Treatment|Withdrawal by Subject|0|||
145369679|NCT03613649|524202424|FG007|Second Treatment|Withdrawal by Subject|0|||
145369680|NCT03613649|524202425|FG008|Second Treatment|Withdrawal by Subject|0|||
145369681|NCT03613649|524202426|FG009|Second Treatment|Withdrawal by Subject|0|||
145369682|NCT03613649|524202427|FG010|Second Treatment|Withdrawal by Subject|0|||
145369683|NCT03613649|524202428|FG011|Second Treatment|Withdrawal by Subject|0|||
145369684|NCT03613649|524202417|FG000|Third Treatment|Lost to Follow-up|0|||
145369685|NCT03613649|524202418|FG001|Third Treatment|Lost to Follow-up|0|||
145369686|NCT03613649|524202419|FG002|Third Treatment|Lost to Follow-up|0|||
145369687|NCT03613649|524202420|FG003|Third Treatment|Lost to Follow-up|0|||
145369688|NCT03613649|524202421|FG004|Third Treatment|Lost to Follow-up|1|||
145369689|NCT03613649|524202422|FG005|Third Treatment|Lost to Follow-up|0|||
145369690|NCT03613649|524202423|FG006|Third Treatment|Lost to Follow-up|0|||
145369691|NCT03613649|524202424|FG007|Third Treatment|Lost to Follow-up|0|||
145369692|NCT03613649|524202425|FG008|Third Treatment|Lost to Follow-up|0|||
145369693|NCT03613649|524202426|FG009|Third Treatment|Lost to Follow-up|0|||
145369694|NCT03613649|524202427|FG010|Third Treatment|Lost to Follow-up|0|||
145369695|NCT03613649|524202428|FG011|Third Treatment|Lost to Follow-up|1|||
145369696|NCT03613649|524202417|FG000|Third Treatment|Protocol Violation|0|||
145369697|NCT03613649|524202418|FG001|Third Treatment|Protocol Violation|0|||
145369698|NCT03613649|524202419|FG002|Third Treatment|Protocol Violation|0|||
145369699|NCT03613649|524202420|FG003|Third Treatment|Protocol Violation|0|||
145369700|NCT03613649|524202421|FG004|Third Treatment|Protocol Violation|0|||
145369701|NCT03613649|524202422|FG005|Third Treatment|Protocol Violation|0|||
145369702|NCT03613649|524202423|FG006|Third Treatment|Protocol Violation|1|||
145369703|NCT03613649|524202424|FG007|Third Treatment|Protocol Violation|0|||
145369704|NCT03613649|524202425|FG008|Third Treatment|Protocol Violation|0|||
145369705|NCT03613649|524202426|FG009|Third Treatment|Protocol Violation|0|||
145369706|NCT03613649|524202427|FG010|Third Treatment|Protocol Violation|0|||
145369707|NCT03613649|524202428|FG011|Third Treatment|Protocol Violation|1|||
145369708|NCT03613649|524202417|FG000|Fourth Treatment|Protocol Violation|1|||
145369709|NCT03613649|524202418|FG001|Fourth Treatment|Protocol Violation|0|||
145369710|NCT03613649|524202419|FG002|Fourth Treatment|Protocol Violation|0|||
145369711|NCT03613649|524202420|FG003|Fourth Treatment|Protocol Violation|0|||
145422536|NCT00553475|524402132|FG000|Overall Study|Withdrawal by Subject|1|||
145422537|NCT00553475|524402133|FG001|Overall Study|Withdrawal by Subject|1|||
145422538|NCT00553475|524402134|FG002|Overall Study|Withdrawal by Subject|0|||
145422539|NCT00553475|524402132|FG000|Overall Study|Physician Decision|1|||
145422540|NCT00553475|524402133|FG001|Overall Study|Physician Decision|0|||
145422541|NCT00553475|524402134|FG002|Overall Study|Physician Decision|0|||
145422542|NCT00553475|524402132|FG000|Overall Study|Due to moving|0|||
145422543|NCT00553475|524402133|FG001|Overall Study|Due to moving|1|||
145422544|NCT00553475|524402134|FG002|Overall Study|Due to moving|0|||
145422545|NCT03810495|524402135|FG000|Overall Study|Lost to Follow-up|2|||
145422546|NCT03810495|524402135|FG000|Overall Study|Withdrawal by Subject|1|||
145422547|NCT00107614|524404142|FG000|Overall Study|Physician Decision|10|||
145422548|NCT00107614|524404142|FG000|Overall Study|Death|2|||
145422549|NCT00449787|524404145|FG000|Overall Study|Lost to Follow-up|10|||
145422550|NCT00449787|524404146|FG001|Overall Study|Lost to Follow-up|8|||
145422551|NCT00449787|524404145|FG000|Overall Study|Did not require medication|95|||
145422552|NCT00449787|524404146|FG001|Overall Study|Did not require medication|92|||
145422553|NCT01633112|524404147|FG000|Overall Study|Lack of Efficacy|1|||
145422554|NCT01633112|524404148|FG001|Overall Study|Lack of Efficacy|6|||
145578806|NCT02316717|524973754|FG001|Overall Study|Death|0|||
145578807|NCT02316717|524973755|FG002|Overall Study|Death|1|||
145578808|NCT02316717|524973753|FG000|Overall Study|Physician Decision|0|||
145578809|NCT02316717|524973754|FG001|Overall Study|Physician Decision|1|||
145578810|NCT02316717|524973755|FG002|Overall Study|Physician Decision|0|||
145578811|NCT02316717|524973753|FG000|Overall Study|TBC|1|||
145578812|NCT02316717|524973754|FG001|Overall Study|TBC|0|||
145578813|NCT02316717|524973755|FG002|Overall Study|TBC|0|||
145578814|NCT02296112|524973756|FG000|Overall Study|Disease progression|7|||
145578815|NCT02296112|524973756|FG000|Overall Study|Toxicity|1|||
145578816|NCT02296112|524973756|FG000|Overall Study|Began an alternate therapy|1|||
145578817|NCT01720069|524973757|FG000|Overall Study|Could not use e-diary correctly|0|||
145578818|NCT01720069|524973758|FG001|Overall Study|Could not use e-diary correctly|1|||
145578819|NCT01720069|524973759|FG002|Overall Study|Could not use e-diary correctly|1|||
145578820|NCT01720069|524973757|FG000|Overall Study|Randomised without baseline values|0|||
145578821|NCT01720069|524973758|FG001|Overall Study|Randomised without baseline values|0|||
145578822|NCT01720069|524973759|FG002|Overall Study|Randomised without baseline values|1|||
145578823|NCT01720069|524973757|FG000|Overall Study|Adverse Event|0|||
145578824|NCT01720069|524973758|FG001|Overall Study|Adverse Event|0|||
145578825|NCT01720069|524973759|FG002|Overall Study|Adverse Event|1|||
145578826|NCT01720069|524973757|FG000|Overall Study|Lack of Efficacy|0|||
145578827|NCT01720069|524973758|FG001|Overall Study|Lack of Efficacy|4|||
145578828|NCT01720069|524973759|FG002|Overall Study|Lack of Efficacy|0|||
145578829|NCT01720069|524973757|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
145578830|NCT01720069|524973758|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
145578831|NCT01720069|524973759|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
145578832|NCT01720069|524973757|FG000|Overall Study|Withdrawal by Subject|0|||
145578833|NCT01720069|524973758|FG001|Overall Study|Withdrawal by Subject|2|||
145578834|NCT01720069|524973759|FG002|Overall Study|Withdrawal by Subject|1|||
145578835|NCT01720069|524973757|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
145578836|NCT01720069|524973758|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
145578837|NCT01720069|524973759|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
145578838|NCT01720069|524973757|FG000|Overall Study|Non-compliance on using e-diary|0|||
145578839|NCT01720069|524973758|FG001|Overall Study|Non-compliance on using e-diary|0|||
145578840|NCT01720069|524973759|FG002|Overall Study|Non-compliance on using e-diary|1|||
145578841|NCT01720069|524973757|FG000|Overall Study|Lost to Follow-up|0|||
145578842|NCT01720069|524973758|FG001|Overall Study|Lost to Follow-up|0|||
145578843|NCT01720069|524973759|FG002|Overall Study|Lost to Follow-up|1|||
145578844|NCT00508742|524973760|FG000|Period 1: Infant Series|Adverse Event|5|||
145578845|NCT00508742|524973761|FG001|Period 1: Infant Series|Adverse Event|4|||
145578846|NCT00508742|524973760|FG000|Period 1: Infant Series|Protocol Violation|1|||
145578847|NCT00508742|524973761|FG001|Period 1: Infant Series|Protocol Violation|0|||
145578848|NCT00508742|524973760|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
145578849|NCT00508742|524973761|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
145422555|NCT01633112|524404149|FG002|Overall Study|Lack of Efficacy|13|||
145422556|NCT01633112|524404147|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145578850|NCT00508742|524973760|FG000|Period 1: Infant Series|Physician Decision|1|||
145578851|NCT00508742|524973761|FG001|Period 1: Infant Series|Physician Decision|0|||
145578852|NCT00508742|524973760|FG000|Period 1: Infant Series|Other|4|||
145578853|NCT00508742|524973761|FG001|Period 1: Infant Series|Other|1|||
145578854|NCT00508742|524973760|FG000|Period 2: After Infant Series|Adverse Event|2|||
145578855|NCT00508742|524973761|FG001|Period 2: After Infant Series|Adverse Event|6|||
145422557|NCT01633112|524404148|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145422558|NCT01633112|524404149|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145422559|NCT01633112|524404147|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145422560|NCT01633112|524404148|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145422561|NCT01633112|524404149|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145369712|NCT03613649|524202421|FG004|Fourth Treatment|Protocol Violation|1|||
145369713|NCT03613649|524202422|FG005|Fourth Treatment|Protocol Violation|0|||
145369714|NCT03613649|524202423|FG006|Fourth Treatment|Protocol Violation|0|||
145369715|NCT03613649|524202424|FG007|Fourth Treatment|Protocol Violation|0|||
145369716|NCT03613649|524202425|FG008|Fourth Treatment|Protocol Violation|0|||
145369717|NCT03613649|524202426|FG009|Fourth Treatment|Protocol Violation|0|||
145369718|NCT03613649|524202427|FG010|Fourth Treatment|Protocol Violation|0|||
145369719|NCT03613649|524202428|FG011|Fourth Treatment|Protocol Violation|0|||
145369720|NCT03613649|524202417|FG000|Fourth Treatment|Physician Decision|0|||
145369721|NCT03613649|524202418|FG001|Fourth Treatment|Physician Decision|0|||
145369722|NCT03613649|524202419|FG002|Fourth Treatment|Physician Decision|0|||
145369723|NCT03613649|524202420|FG003|Fourth Treatment|Physician Decision|0|||
145369724|NCT03613649|524202421|FG004|Fourth Treatment|Physician Decision|0|||
145369725|NCT03613649|524202422|FG005|Fourth Treatment|Physician Decision|0|||
145369726|NCT03613649|524202423|FG006|Fourth Treatment|Physician Decision|1|||
145369727|NCT03613649|524202424|FG007|Fourth Treatment|Physician Decision|0|||
145369728|NCT03613649|524202425|FG008|Fourth Treatment|Physician Decision|0|||
145369729|NCT03613649|524202426|FG009|Fourth Treatment|Physician Decision|0|||
145369730|NCT03613649|524202427|FG010|Fourth Treatment|Physician Decision|0|||
145369731|NCT03613649|524202428|FG011|Fourth Treatment|Physician Decision|0|||
145369732|NCT03429244|524202429|FG000|Overall Study|Withdrawal by Subject|2|||
145369733|NCT03429244|524202430|FG001|Overall Study|Withdrawal by Subject|1|||
145369734|NCT03429244|524202431|FG002|Overall Study|Withdrawal by Subject|1|||
145369735|NCT00750139|524202432|FG000|Overall Study|Adverse Event|1|||
145369736|NCT00750139|524202433|FG001|Overall Study|Adverse Event|2|||
145369737|NCT00750139|524202434|FG002|Overall Study|Adverse Event|0|||
145369738|NCT00750139|524202435|FG003|Overall Study|Adverse Event|1|||
145369739|NCT00750139|524202432|FG000|Overall Study|Lost to Follow-up|17|||
145369740|NCT00750139|524202433|FG001|Overall Study|Lost to Follow-up|12|||
145369741|NCT00750139|524202434|FG002|Overall Study|Lost to Follow-up|15|||
145369742|NCT00750139|524202435|FG003|Overall Study|Lost to Follow-up|6|||
145369743|NCT00750139|524202432|FG000|Overall Study|Withdrawal by Subject|3|||
145369744|NCT00750139|524202433|FG001|Overall Study|Withdrawal by Subject|2|||
145369745|NCT00750139|524202434|FG002|Overall Study|Withdrawal by Subject|6|||
145369746|NCT00750139|524202435|FG003|Overall Study|Withdrawal by Subject|2|||
145369747|NCT00750139|524202432|FG000|Overall Study|Physician Decision|1|||
145369748|NCT00750139|524202433|FG001|Overall Study|Physician Decision|1|||
145369749|NCT00750139|524202434|FG002|Overall Study|Physician Decision|0|||
145369750|NCT00750139|524202435|FG003|Overall Study|Physician Decision|0|||
145369751|NCT00750139|524202432|FG000|Overall Study|Non-compliance|1|||
145369752|NCT00750139|524202433|FG001|Overall Study|Non-compliance|0|||
145369753|NCT00750139|524202434|FG002|Overall Study|Non-compliance|1|||
145369754|NCT00750139|524202435|FG003|Overall Study|Non-compliance|3|||
145369755|NCT00750139|524202432|FG000|Overall Study|Termination by sponsor|4|||
145369756|NCT00750139|524202433|FG001|Overall Study|Termination by sponsor|0|||
145369757|NCT00750139|524202434|FG002|Overall Study|Termination by sponsor|0|||
145369758|NCT00750139|524202435|FG003|Overall Study|Termination by sponsor|1|||
145369759|NCT00750139|524202432|FG000|Overall Study|Non-specific|62|||
145369760|NCT00750139|524202433|FG001|Overall Study|Non-specific|42|||
145369761|NCT00750139|524202434|FG002|Overall Study|Non-specific|79|||
145369762|NCT00750139|524202435|FG003|Overall Study|Non-specific|33|||
145369763|NCT00658775|524202436|FG000|Overall Study|Adverse Event|4|||
145369764|NCT00658775|524202437|FG001|Overall Study|Adverse Event|6|||
145369765|NCT00658775|524202436|FG000|Overall Study|Lost to Follow-up|17|||
145578856|NCT00508742|524973760|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
145369766|NCT00658775|524202437|FG001|Overall Study|Lost to Follow-up|18|||
145369767|NCT00658775|524202436|FG000|Overall Study|Withdrawal by Subject|6|||
145369768|NCT00658775|524202437|FG001|Overall Study|Withdrawal by Subject|4|||
145369769|NCT00658775|524202436|FG000|Overall Study|Withdrawal of consent|8|||
145369770|NCT00658775|524202437|FG001|Overall Study|Withdrawal of consent|7|||
145369771|NCT00658775|524202436|FG000|Overall Study|Other|7|||
145369772|NCT00658775|524202437|FG001|Overall Study|Other|8|||
145369773|NCT00977314|524202438|FG000|Overall Study|Withdrawal by Subject|1|||
145369774|NCT00977314|524202439|FG001|Overall Study|Withdrawal by Subject|0|||
145369775|NCT00977314|524202438|FG000|Overall Study|Physician Decision|1|||
145369776|NCT00977314|524202439|FG001|Overall Study|Physician Decision|0|||
145369777|NCT02107859|524202442|FG000|Overall Study|Withdrawal by Subject|14|||
145369778|NCT02107859|524202442|FG000|Overall Study|Adverse Event|3|||
145369779|NCT02107859|524202442|FG000|Overall Study|Study closure|41|||
145369780|NCT02107859|524202442|FG000|Overall Study|Other than specified|3|||
145369781|NCT00877487|524202445|FG000|Open-label Treatment Phase|Adverse Event|1|||
145369782|NCT00877487|524202446|FG001|Open-label Treatment Phase|Adverse Event|0|||
145369783|NCT00877487|524202445|FG000|Open-label Treatment Phase|Protocol Violation|3|||
145369784|NCT00877487|524202446|FG001|Open-label Treatment Phase|Protocol Violation|0|||
145369785|NCT00877487|524202445|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
145369786|NCT00877487|524202446|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
145369787|NCT00877487|524202445|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
145422562|NCT01633112|524404147|FG000|Overall Study|Administrative problems|1|||
145422563|NCT01633112|524404148|FG001|Overall Study|Administrative problems|2|||
145422564|NCT01633112|524404149|FG002|Overall Study|Administrative problems|5|||
145422565|NCT01633112|524404147|FG000|Overall Study|Adverse Event|16|||
145422566|NCT01633112|524404148|FG001|Overall Study|Adverse Event|18|||
145422567|NCT01633112|524404149|FG002|Overall Study|Adverse Event|20|||
145422568|NCT01633112|524404147|FG000|Overall Study|Lost to Follow-up|7|||
145422569|NCT01633112|524404148|FG001|Overall Study|Lost to Follow-up|19|||
145422570|NCT01633112|524404149|FG002|Overall Study|Lost to Follow-up|6|||
145422571|NCT01633112|524404147|FG000|Overall Study|Protocol Violation|4|||
145422572|NCT01633112|524404148|FG001|Overall Study|Protocol Violation|0|||
145422573|NCT01633112|524404149|FG002|Overall Study|Protocol Violation|2|||
145422574|NCT01633112|524404147|FG000|Overall Study|Subject no longer requires study drug|0|||
145422575|NCT01633112|524404148|FG001|Overall Study|Subject no longer requires study drug|0|||
145422576|NCT01633112|524404149|FG002|Overall Study|Subject no longer requires study drug|1|||
145422577|NCT01633112|524404147|FG000|Overall Study|Withdrawal by Subject|20|||
145422578|NCT01633112|524404148|FG001|Overall Study|Withdrawal by Subject|12|||
145422579|NCT01633112|524404149|FG002|Overall Study|Withdrawal by Subject|41|||
145422580|NCT01633112|524404147|FG000|Overall Study|missing Study Completion CRF|1|||
145422581|NCT01633112|524404148|FG001|Overall Study|missing Study Completion CRF|1|||
145422582|NCT01633112|524404149|FG002|Overall Study|missing Study Completion CRF|4|||
145422583|NCT01959919|524404150|FG000|Overall Study|Did not meet the eligibility criteria|2|||
145422584|NCT03439072|524404151|FG000|Overall Study|Withdrawal by Subject|2|||
145422585|NCT03439072|524404152|FG001|Overall Study|Withdrawal by Subject|3|||
145422586|NCT03439072|524404151|FG000|Overall Study|Physician Decision|0|||
145422587|NCT03439072|524404152|FG001|Overall Study|Physician Decision|1|||
145422588|NCT02094885|524404154|FG000|Overall Study|Death|1|||
145422589|NCT02094885|524404155|FG001|Overall Study|Death|5|||
145422590|NCT02094885|524404154|FG000|Overall Study|Withdrawn due to age|1|||
145422591|NCT02094885|524404155|FG001|Overall Study|Withdrawn due to age|0|||
145422592|NCT02003898|524404156|FG000|Overall Study|Death|3|||
145422593|NCT02003898|524404156|FG000|Overall Study|Lost to Follow-up|12|||
145422594|NCT02003898|524404156|FG000|Overall Study|Withdrawal by Subject|52|||
145422595|NCT01537432|524404157|FG000|Overall Study|Lost to Follow-up|3|||
145422596|NCT01537432|524404158|FG001|Overall Study|Lost to Follow-up|1|||
145422597|NCT01537432|524404157|FG000|Overall Study|Withdrawal by Subject|0|||
145422598|NCT01537432|524404158|FG001|Overall Study|Withdrawal by Subject|1|||
145422599|NCT01537432|524404157|FG000|Overall Study|Administrative problems|1|||
145422600|NCT01537432|524404158|FG001|Overall Study|Administrative problems|0|||
145422601|NCT01537432|524404157|FG000|Overall Study|Adverse Event|1|||
145422602|NCT01537432|524404158|FG001|Overall Study|Adverse Event|0|||
145422603|NCT01537432|524404157|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145422604|NCT01537432|524404158|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145422605|NCT05166902|524404159|FG000|First Intervention|Lost to Follow-up|0|||
145422606|NCT05166902|524404160|FG001|First Intervention|Lost to Follow-up|1|||
145422607|NCT01998477|524404161|FG000|Overall Study|Lost to Follow-up|4|||
145422608|NCT01998477|524404162|FG001|Overall Study|Lost to Follow-up|5|||
145422609|NCT01998477|524404161|FG000|Overall Study|Withdrawal by Subject|6|||
145422610|NCT01998477|524404162|FG001|Overall Study|Withdrawal by Subject|0|||
145422611|NCT00779909|524404163|FG000|Overall Study|Lost to Follow-up|1|||
145422612|NCT00779909|524404164|FG001|Overall Study|Lost to Follow-up|0|||
145422613|NCT00779909|524404165|FG002|Overall Study|Lost to Follow-up|0|||
145422614|NCT00779909|524404166|FG003|Overall Study|Lost to Follow-up|1|||
145422615|NCT00779909|524404163|FG000|Overall Study|Withdrawal by Subject|0|||
145422616|NCT00779909|524404164|FG001|Overall Study|Withdrawal by Subject|1|||
145422617|NCT00779909|524404165|FG002|Overall Study|Withdrawal by Subject|0|||
145422618|NCT00779909|524404166|FG003|Overall Study|Withdrawal by Subject|0|||
145422619|NCT00128492|524404167|FG000|Overall Study|AE unrelated to study|2|||
145422620|NCT00128492|524404168|FG001|Overall Study|AE unrelated to study|9|||
145422621|NCT00128492|524404167|FG000|Overall Study|Study drug intolerance (AE)|2|||
145422622|NCT00128492|524404168|FG001|Overall Study|Study drug intolerance (AE)|8|||
145422623|NCT00128492|524404167|FG000|Overall Study|AE related to study|1|||
145422624|NCT00128492|524404168|FG001|Overall Study|AE related to study|4|||
145578857|NCT00508742|524973761|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
145422625|NCT00128492|524404167|FG000|Overall Study|Death|1|||
145422626|NCT00128492|524404168|FG001|Overall Study|Death|0|||
145422627|NCT00128492|524404167|FG000|Overall Study|Lost to Follow-up|1|||
145422628|NCT00128492|524404168|FG001|Overall Study|Lost to Follow-up|5|||
145422629|NCT00128492|524404167|FG000|Overall Study|Noncompliance|0|||
145422630|NCT00128492|524404168|FG001|Overall Study|Noncompliance|5|||
145422631|NCT00128492|524404167|FG000|Overall Study|Personal or administrative|10|||
145422632|NCT00128492|524404168|FG001|Overall Study|Personal or administrative|22|||
145422633|NCT00128492|524404167|FG000|Overall Study|Withdrawal by Subject|3|||
145422634|NCT00128492|524404168|FG001|Overall Study|Withdrawal by Subject|5|||
145422635|NCT00128492|524404167|FG000|Overall Study|Pregnancy|0|||
145422636|NCT00128492|524404168|FG001|Overall Study|Pregnancy|1|||
145422637|NCT00159874|524404169|FG000|Overall Study|Adverse Event|2|||
145369788|NCT00877487|524202446|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
145369789|NCT00877487|524202445|FG000|Open-label Treatment Phase|Out of country for business|1|||
145369790|NCT00877487|524202446|FG001|Open-label Treatment Phase|Out of country for business|0|||
145369791|NCT00877487|524202445|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
145369792|NCT00877487|524202446|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
145369793|NCT00877487|524202445|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
145369794|NCT00877487|524202446|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
145369795|NCT00877487|524202445|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
145369796|NCT00877487|524202446|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
145369797|NCT00877487|524202445|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
145369798|NCT00877487|524202446|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
145369799|NCT01516008|524202447|FG000|Overall Study|Adverse Event|0|||
145369800|NCT01516008|524202448|FG001|Overall Study|Adverse Event|2|||
145369801|NCT01516008|524202449|FG002|Overall Study|Adverse Event|7|||
145369802|NCT01516008|524202447|FG000|Overall Study|Lack of Efficacy|44|||
145369803|NCT01516008|524202448|FG001|Overall Study|Lack of Efficacy|14|||
145369804|NCT01516008|524202449|FG002|Overall Study|Lack of Efficacy|10|||
145369805|NCT01516008|524202447|FG000|Overall Study|Protocol Violation|1|||
145369806|NCT01516008|524202448|FG001|Overall Study|Protocol Violation|0|||
145369807|NCT01516008|524202449|FG002|Overall Study|Protocol Violation|0|||
145369808|NCT01516008|524202447|FG000|Overall Study|Reason not specified|0|||
145369809|NCT01516008|524202448|FG001|Overall Study|Reason not specified|0|||
145369810|NCT01516008|524202449|FG002|Overall Study|Reason not specified|1|||
145369811|NCT01217476|524202452|FG000|Overall Study|Adverse Event|6|||
145369812|NCT01217476|524202453|FG001|Overall Study|Adverse Event|1|||
145369813|NCT01217476|524202452|FG000|Overall Study|Physician Decision|0|||
145369814|NCT01217476|524202453|FG001|Overall Study|Physician Decision|1|||
145369815|NCT01217476|524202452|FG000|Overall Study|Withdrawal by Subject|3|||
145369816|NCT01217476|524202453|FG001|Overall Study|Withdrawal by Subject|3|||
145369817|NCT01217476|524202452|FG000|Overall Study|Surgery on the Target Limb|0|||
145369818|NCT01217476|524202453|FG001|Overall Study|Surgery on the Target Limb|2|||
145369819|NCT01217476|524202452|FG000|Overall Study|Protocol Deviation|1|||
145369820|NCT01217476|524202453|FG001|Overall Study|Protocol Deviation|0|||
145369821|NCT01217476|524202452|FG000|Overall Study|Other|2|||
145369822|NCT01217476|524202453|FG001|Overall Study|Other|0|||
145369823|NCT00986921|524202456|FG000|Overall Study|Physician Decision|1|||
145369824|NCT00986921|524202457|FG001|Overall Study|Physician Decision|0|||
145369825|NCT00813813|524202458|FG000|Overall Study|Withdrawal by Subject|1|||
145369826|NCT00813813|524202459|FG001|Overall Study|Withdrawal by Subject|1|||
145369827|NCT00813813|524202458|FG000|Overall Study|Lost to Follow-up|2|||
145369828|NCT00813813|524202459|FG001|Overall Study|Lost to Follow-up|7|||
145369829|NCT00813813|524202458|FG000|Overall Study|Other|0|||
145369830|NCT00813813|524202459|FG001|Overall Study|Other|1|||
145369831|NCT04445714|524202460|FG000|Overall Study|Discontinuation of the study|14|||
145369832|NCT04445714|524202460|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
145369833|NCT04445714|524202460|FG000|Overall Study|Withdrawal of Informed Consent|8|||
145369834|NCT02805660|524202461|FG000|Overall Study|Death|5|||
145369835|NCT02805660|524202462|FG001|Overall Study|Death|2|||
145369836|NCT02805660|524202463|FG002|Overall Study|Death|9|||
145369837|NCT02805660|524202464|FG003|Overall Study|Death|5|||
145369838|NCT02805660|524202465|FG004|Overall Study|Death|0|||
145369839|NCT02805660|524202466|FG005|Overall Study|Death|14|||
145369840|NCT02805660|524202467|FG006|Overall Study|Death|12|||
145369841|NCT02805660|524202461|FG000|Overall Study|Lost to Follow-up|0|||
145369842|NCT02805660|524202462|FG001|Overall Study|Lost to Follow-up|1|||
145369843|NCT02805660|524202463|FG002|Overall Study|Lost to Follow-up|1|||
145369844|NCT02805660|524202464|FG003|Overall Study|Lost to Follow-up|2|||
145369845|NCT02805660|524202465|FG004|Overall Study|Lost to Follow-up|0|||
145369846|NCT02805660|524202466|FG005|Overall Study|Lost to Follow-up|0|||
145369847|NCT02805660|524202467|FG006|Overall Study|Lost to Follow-up|0|||
145369848|NCT02805660|524202461|FG000|Overall Study|Withdrawal by Subject|0|||
145369849|NCT02805660|524202462|FG001|Overall Study|Withdrawal by Subject|0|||
145422638|NCT00159874|524404170|FG001|Overall Study|Adverse Event|2|||
145578858|NCT00508742|524973760|FG000|Period 2: After Infant Series|Protocol Violation|1|||
145578859|NCT00508742|524973761|FG001|Period 2: After Infant Series|Protocol Violation|0|||
145369850|NCT02805660|524202463|FG002|Overall Study|Withdrawal by Subject|0|||
145369851|NCT02805660|524202464|FG003|Overall Study|Withdrawal by Subject|3|||
145369852|NCT02805660|524202465|FG004|Overall Study|Withdrawal by Subject|1|||
145369853|NCT02805660|524202466|FG005|Overall Study|Withdrawal by Subject|0|||
145369854|NCT02805660|524202467|FG006|Overall Study|Withdrawal by Subject|2|||
145369855|NCT02805660|524202461|FG000|Overall Study|Study terminated by Sponsor|0|||
145369856|NCT02805660|524202462|FG001|Overall Study|Study terminated by Sponsor|0|||
145369857|NCT02805660|524202463|FG002|Overall Study|Study terminated by Sponsor|1|||
145369858|NCT02805660|524202464|FG003|Overall Study|Study terminated by Sponsor|4|||
145369859|NCT02805660|524202465|FG004|Overall Study|Study terminated by Sponsor|2|||
145422639|NCT00159874|524404171|FG002|Overall Study|Adverse Event|5|||
145369860|NCT02805660|524202466|FG005|Overall Study|Study terminated by Sponsor|3|||
145369861|NCT02805660|524202467|FG006|Overall Study|Study terminated by Sponsor|1|||
145369862|NCT02805660|524202461|FG000|Overall Study|Miscellaneous|0|||
145369863|NCT02805660|524202462|FG001|Overall Study|Miscellaneous|1|||
145369864|NCT02805660|524202463|FG002|Overall Study|Miscellaneous|0|||
145369865|NCT02805660|524202464|FG003|Overall Study|Miscellaneous|4|||
145369866|NCT02805660|524202465|FG004|Overall Study|Miscellaneous|0|||
145369867|NCT02805660|524202466|FG005|Overall Study|Miscellaneous|6|||
145369868|NCT02805660|524202467|FG006|Overall Study|Miscellaneous|4|||
145369869|NCT02778074|524202468|FG000|Overall Study|Lost to Follow-up|7|||
145369870|NCT02778074|524202469|FG001|Overall Study|Lost to Follow-up|10|||
145369871|NCT01684943|524202470|FG000|Overall Study|Inadequate Venous Access|3|||
145369872|NCT01684943|524202471|FG001|Overall Study|Inadequate Venous Access|0|||
145369873|NCT01684943|524202472|FG002|Overall Study|Inadequate Venous Access|0|||
145369874|NCT01684943|524202470|FG000|Overall Study|Principal Investigator Determination|1|||
145369875|NCT01684943|524202471|FG001|Overall Study|Principal Investigator Determination|0|||
145369876|NCT01684943|524202472|FG002|Overall Study|Principal Investigator Determination|0|||
145369877|NCT01684943|524202470|FG000|Overall Study|Excluded from Analysis|1|||
145369878|NCT01684943|524202471|FG001|Overall Study|Excluded from Analysis|1|||
145369879|NCT01684943|524202472|FG002|Overall Study|Excluded from Analysis|1|||
145369880|NCT01684943|524202470|FG000|Overall Study|Lost to Follow-up|3|||
145369881|NCT01684943|524202471|FG001|Overall Study|Lost to Follow-up|0|||
145369882|NCT01684943|524202472|FG002|Overall Study|Lost to Follow-up|0|||
145369883|NCT01684943|524202470|FG000|Overall Study|Planning Pregnancy|1|||
145369884|NCT01684943|524202471|FG001|Overall Study|Planning Pregnancy|0|||
145369885|NCT01684943|524202472|FG002|Overall Study|Planning Pregnancy|0|||
145369886|NCT03963232|524202476|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145369887|NCT03963232|524202477|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
145369888|NCT03963232|524202476|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
145369889|NCT03963232|524202477|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145369890|NCT03963232|524202476|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
145369891|NCT03963232|524202477|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
145369892|NCT03963232|524202476|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
145369893|NCT03963232|524202477|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
145369894|NCT03963232|524202476|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
145369895|NCT03963232|524202477|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
145369896|NCT03963232|524202476|FG000|Open-Label Treatment Phase|Adverse Event|1|||
145369897|NCT03963232|524202477|FG001|Open-Label Treatment Phase|Adverse Event|2|||
145369898|NCT03963232|524202476|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
145369899|NCT03963232|524202477|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
145369900|NCT03963232|524202476|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
145369901|NCT03963232|524202477|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
145369902|NCT03963232|524202476|FG000|Open-Label Treatment Phase|Pregnancy|1|||
145369903|NCT03963232|524202477|FG001|Open-Label Treatment Phase|Pregnancy|0|||
145369904|NCT03963232|524202476|FG000|Follow-up Phase|Withdrawal by Subject|7|||
145369905|NCT03963232|524202477|FG001|Follow-up Phase|Withdrawal by Subject|5|||
145369906|NCT03963232|524202476|FG000|Follow-up Phase|Protocol Violation|0|||
145369907|NCT03963232|524202477|FG001|Follow-up Phase|Protocol Violation|2|||
145369908|NCT03963232|524202476|FG000|Follow-up Phase|Adverse Event|0|||
145369909|NCT03963232|524202477|FG001|Follow-up Phase|Adverse Event|1|||
145369910|NCT03963232|524202476|FG000|Follow-up Phase|Lost to Follow-up|0|||
145369911|NCT03963232|524202477|FG001|Follow-up Phase|Lost to Follow-up|1|||
145369912|NCT03512210|524202479|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
145369913|NCT03512210|524202479|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
145369914|NCT03512210|524202479|FG000|Step 2:Post-MINMON|Death|2|||
145369915|NCT03512210|524202479|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
145369916|NCT03512210|524202479|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
145369917|NCT01672710|524202482|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
145369918|NCT01672710|524202483|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
145369919|NCT01672710|524202482|FG000|3 Month Follow up|Lost to Follow-up|2|||
145369920|NCT01672710|524202483|FG001|3 Month Follow up|Lost to Follow-up|3|||
145369921|NCT01672710|524202482|FG000|3 Month Follow up|follow up due after termination date|4|||
145369922|NCT01672710|524202483|FG001|3 Month Follow up|follow up due after termination date|1|||
145369923|NCT02122887|524202484|FG000|Overall Study|Withdrawal by Subject|20|||
145369924|NCT02122887|524202485|FG001|Overall Study|Withdrawal by Subject|2|||
145369925|NCT03725761|524202486|FG000|Overall Study|still on study|1|||
145369926|NCT02836236|524204663|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
145369927|NCT02836236|524204664|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
145369928|NCT02836236|524204665|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
145369929|NCT02836236|524204666|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145369930|NCT02836236|524204663|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
145369931|NCT02836236|524204664|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
145369932|NCT02836236|524204665|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145369933|NCT02836236|524204666|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
145369934|NCT02836236|524204663|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145369935|NCT02836236|524204664|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
145369936|NCT02836236|524204665|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145369937|NCT02836236|524204666|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
145369938|NCT02836236|524204663|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
145369939|NCT02836236|524204664|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145369940|NCT02836236|524204665|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145369941|NCT02836236|524204666|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145369942|NCT02836236|524204663|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145369943|NCT02836236|524204664|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145369944|NCT02836236|524204665|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
145369945|NCT02836236|524204666|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
145369946|NCT02836236|524204663|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145369947|NCT02836236|524204664|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145369948|NCT02836236|524204665|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
145369949|NCT02836236|524204666|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
145369950|NCT02836236|524204663|FG000|Open-Label TAF Treatment Phase|Death|0|||
145369951|NCT02836236|524204664|FG001|Open-Label TAF Treatment Phase|Death|0|||
145369952|NCT02836236|524204665|FG002|Open-Label TAF Treatment Phase|Death|1|||
145369953|NCT02836236|524204666|FG003|Open-Label TAF Treatment Phase|Death|1|||
145369954|NCT02836236|524204663|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145369955|NCT02836236|524204664|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145369956|NCT02836236|524204665|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
145369957|NCT02836236|524204666|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
145369958|NCT01669174|524204674|FG000|Overall Study|Subject withdrew consent|2|||
145369959|NCT01669174|524204675|FG001|Overall Study|Subject withdrew consent|2|||
145369960|NCT01669174|524204674|FG000|Overall Study|Lost to Follow-up|1|||
145369961|NCT01669174|524204675|FG001|Overall Study|Lost to Follow-up|0|||
145369962|NCT01669174|524204674|FG000|Overall Study|Adverse Event|2|||
145369963|NCT01669174|524204675|FG001|Overall Study|Adverse Event|2|||
145369964|NCT01669174|524204674|FG000|Overall Study|Administrative problems|1|||
145369965|NCT01669174|524204675|FG001|Overall Study|Administrative problems|2|||
145369966|NCT01953601|524204676|FG000|Part 1 (Base Study)|Adverse Event|24|||
145369967|NCT01953601|524204677|FG001|Part 1 (Base Study)|Adverse Event|37|||
145369968|NCT01953601|524204678|FG002|Part 1 (Base Study)|Adverse Event|15|||
145369969|NCT01953601|524204676|FG000|Part 1 (Base Study)|Death|2|||
145369970|NCT01953601|524204677|FG001|Part 1 (Base Study)|Death|0|||
145369971|NCT01953601|524204678|FG002|Part 1 (Base Study)|Death|3|||
145369972|NCT01953601|524204676|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
145369973|NCT01953601|524204677|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
145369974|NCT01953601|524204678|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
145369975|NCT01953601|524204676|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
145369976|NCT01953601|524204677|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
145369977|NCT01953601|524204678|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
145369978|NCT01953601|524204676|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
145369979|NCT01953601|524204677|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
145369980|NCT01953601|524204678|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
145369981|NCT01953601|524204676|FG000|Part 1 (Base Study)|Physician Decision|3|||
145369982|NCT01953601|524204677|FG001|Part 1 (Base Study)|Physician Decision|7|||
145369983|NCT01953601|524204678|FG002|Part 1 (Base Study)|Physician Decision|4|||
145369984|NCT01953601|524204676|FG000|Part 1 (Base Study)|Screen failure|1|||
145369985|NCT01953601|524204677|FG001|Part 1 (Base Study)|Screen failure|0|||
145369986|NCT01953601|524204678|FG002|Part 1 (Base Study)|Screen failure|1|||
145369987|NCT01953601|524204676|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
145369988|NCT01953601|524204677|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
145369989|NCT01953601|524204678|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
145369990|NCT01953601|524204676|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
145369991|NCT01953601|524204677|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
145369992|NCT01953601|524204678|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
145369993|NCT01953601|524204676|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
145369994|NCT01953601|524204677|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
145369995|NCT01953601|524204678|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
145369996|NCT01953601|524204676|FG000|Part 1 (Base Study)|Subject moved|2|||
145369997|NCT01953601|524204677|FG001|Part 1 (Base Study)|Subject moved|2|||
145369998|NCT01953601|524204678|FG002|Part 1 (Base Study)|Subject moved|1|||
145369999|NCT01953601|524204676|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
145370000|NCT01953601|524204677|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
145370001|NCT01953601|524204678|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
145370002|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Adverse Event|1|||
145370003|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Adverse Event|1|||
145370004|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Adverse Event|10|||
145370005|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Death|0|||
145370006|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Death|3|||
145370007|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Death|0|||
145370008|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
145370009|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
145370010|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
145370011|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
145370012|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
145370013|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
145370014|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Physician Decision|2|||
145370015|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Physician Decision|0|||
145370016|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Physician Decision|2|||
145370017|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
145370018|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
145370019|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
145370020|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
145370021|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
145370022|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
145370023|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
145370024|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
145370025|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
145370026|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Subject moved|0|||
145370027|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Subject moved|0|||
145370028|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Subject moved|1|||
145370029|NCT01953601|524204676|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
145370030|NCT01953601|524204677|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
145370031|NCT01953601|524204678|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
145370032|NCT00723255|524204685|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
145370033|NCT00723255|524204685|FG000|Overall Study|Ineligible: Second primary|1|||
145370034|NCT00723255|524204685|FG000|Overall Study|Ineligible: Wrong Primary|2|||
145370035|NCT00614523|524204686|FG000|Overall Study|Adverse Event|4|||
145370036|NCT00614523|524204687|FG001|Overall Study|Adverse Event|20|||
145370037|NCT00614523|524204686|FG000|Overall Study|Death|5|||
145370038|NCT00614523|524204687|FG001|Overall Study|Death|8|||
145370039|NCT00614523|524204686|FG000|Overall Study|Lack of Efficacy|9|||
145370040|NCT00614523|524204687|FG001|Overall Study|Lack of Efficacy|11|||
145370041|NCT00614523|524204686|FG000|Overall Study|Lost to Follow-up|0|||
145370042|NCT00614523|524204687|FG001|Overall Study|Lost to Follow-up|1|||
145370043|NCT00614523|524204686|FG000|Overall Study|Protocol Violation|3|||
145370044|NCT00614523|524204687|FG001|Overall Study|Protocol Violation|2|||
145370045|NCT00614523|524204686|FG000|Overall Study|Withdrawal by Subject|12|||
145370046|NCT00614523|524204687|FG001|Overall Study|Withdrawal by Subject|22|||
145370047|NCT00614523|524204686|FG000|Overall Study|Other|6|||
145370048|NCT00614523|524204687|FG001|Overall Study|Other|11|||
145370049|NCT00614523|524204686|FG000|Overall Study|Ineligibility Determined|1|||
145370050|NCT00614523|524204687|FG001|Overall Study|Ineligibility Determined|2|||
145370051|NCT00614523|524204686|FG000|Overall Study|Disease Progression|0|||
145370052|NCT00614523|524204687|FG001|Overall Study|Disease Progression|8|||
145370053|NCT00614523|524204686|FG000|Overall Study|Administrative Decision|23|||
145370054|NCT00614523|524204687|FG001|Overall Study|Administrative Decision|46|||
145370055|NCT03962790|524204688|FG000|Period 1|Adverse Event|0|||
145370056|NCT03962790|524204689|FG001|Period 1|Adverse Event|1|||
145370057|NCT03962790|524204688|FG000|Period 1|Failed to meet all eligibility criteria|1|||
145370058|NCT03962790|524204689|FG001|Period 1|Failed to meet all eligibility criteria|1|||
145370059|NCT03962790|524204688|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
145370060|NCT03962790|524204689|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
145370061|NCT03962790|524204688|FG000|Period 1|Withdrawal by Subject|1|||
145370062|NCT03962790|524204689|FG001|Period 1|Withdrawal by Subject|0|||
145370063|NCT03854370|524204696|FG000|Overall Study|samples not collected|1|||
145370064|NCT03854370|524204697|FG001|Overall Study|samples not collected|1|||
145370065|NCT03854370|524204698|FG002|Overall Study|samples not collected|1|||
145370066|NCT03854370|524204699|FG003|Overall Study|samples not collected|1|||
145370067|NCT01300338|524204710|FG000|Overall Study|Lost to Follow-up|5|||
145370068|NCT01300338|524204711|FG001|Overall Study|Lost to Follow-up|0|||
145370069|NCT00900757|524204712|FG000|Overall Study|screen failure|19|||
145370070|NCT00381238|524204717|FG000|Overall Study|Adverse Event|3|||
145370071|NCT00381238|524204717|FG000|Overall Study|Protocol Violation|1|||
145370072|NCT00381238|524204717|FG000|Overall Study|Withdrawal by Subject|4|||
145370073|NCT00381238|524204717|FG000|Overall Study|Lack of Efficacy|2|||
145370074|NCT00381238|524204717|FG000|Overall Study|Withdrew by physician|1|||
145370075|NCT00381238|524204717|FG000|Overall Study|Disease progression|1|||
145370076|NCT00401544|524204721|FG000|Overall Study|Adverse Event|5|||
145370077|NCT00401544|524204722|FG001|Overall Study|Adverse Event|1|||
145370078|NCT00401544|524204723|FG002|Overall Study|Adverse Event|1|||
145578860|NCT00508742|524973760|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
145578861|NCT00508742|524973761|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
145578862|NCT00508742|524973760|FG000|Period 2: After Infant Series|Failed to Return|1|||
145578863|NCT00508742|524973761|FG001|Period 2: After Infant Series|Failed to Return|0|||
145578864|NCT00508742|524973760|FG000|Period 2: After Infant Series|Other|2|||
145578865|NCT00508742|524973761|FG001|Period 2: After Infant Series|Other|1|||
145578866|NCT00508742|524973760|FG000|Period 3: Toddler Dose|Adverse Event|1|||
145578867|NCT00508742|524973761|FG001|Period 3: Toddler Dose|Adverse Event|0|||
145578868|NCT00508742|524973760|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
145578869|NCT00508742|524973761|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
145578870|NCT00508742|524973760|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
145578871|NCT00508742|524973761|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
145578872|NCT00508742|524973760|FG000|Period 3: Toddler Dose|Other|5|||
145578873|NCT00508742|524973761|FG001|Period 3: Toddler Dose|Other|4|||
145578874|NCT02460224|524973768|FG000|Overall Study|Adverse Event|0|||
145578875|NCT02460224|524973769|FG001|Overall Study|Adverse Event|0|||
145578876|NCT02460224|524973770|FG002|Overall Study|Adverse Event|0|||
145578877|NCT02460224|524973771|FG003|Overall Study|Adverse Event|0|||
145578878|NCT02460224|524973772|FG004|Overall Study|Adverse Event|0|||
145578879|NCT02460224|524973773|FG005|Overall Study|Adverse Event|0|||
145370079|NCT00401544|524204724|FG003|Overall Study|Adverse Event|1|||
145370080|NCT00401544|524204721|FG000|Overall Study|Death|3|||
145370081|NCT00401544|524204722|FG001|Overall Study|Death|6|||
145370082|NCT00401544|524204723|FG002|Overall Study|Death|2|||
145370083|NCT00401544|524204724|FG003|Overall Study|Death|5|||
145370084|NCT00401544|524204721|FG000|Overall Study|Lost to Follow-up|2|||
145370085|NCT00401544|524204722|FG001|Overall Study|Lost to Follow-up|0|||
145370086|NCT00401544|524204723|FG002|Overall Study|Lost to Follow-up|1|||
145370087|NCT00401544|524204724|FG003|Overall Study|Lost to Follow-up|1|||
145370088|NCT00401544|524204721|FG000|Overall Study|Withdrawal by Subject|7|||
145370089|NCT00401544|524204722|FG001|Overall Study|Withdrawal by Subject|6|||
145370090|NCT00401544|524204723|FG002|Overall Study|Withdrawal by Subject|6|||
145370091|NCT00401544|524204724|FG003|Overall Study|Withdrawal by Subject|5|||
145370092|NCT00401544|524204721|FG000|Overall Study|Physician Decision|1|||
145370093|NCT00401544|524204722|FG001|Overall Study|Physician Decision|3|||
145370094|NCT00401544|524204723|FG002|Overall Study|Physician Decision|0|||
145370095|NCT00401544|524204724|FG003|Overall Study|Physician Decision|0|||
145370096|NCT00401544|524204721|FG000|Overall Study|Ineligibility determined|0|||
145370097|NCT00401544|524204722|FG001|Overall Study|Ineligibility determined|1|||
145370098|NCT00401544|524204723|FG002|Overall Study|Ineligibility determined|0|||
145370099|NCT00401544|524204724|FG003|Overall Study|Ineligibility determined|2|||
145370100|NCT00401544|524204721|FG000|Overall Study|Disease progression|0|||
145370101|NCT00401544|524204722|FG001|Overall Study|Disease progression|1|||
145370102|NCT00401544|524204723|FG002|Overall Study|Disease progression|0|||
145370103|NCT00401544|524204724|FG003|Overall Study|Disease progression|0|||
145370104|NCT00401544|524204721|FG000|Overall Study|Other|0|||
145370105|NCT00401544|524204722|FG001|Overall Study|Other|0|||
145370106|NCT00401544|524204723|FG002|Overall Study|Other|2|||
145370107|NCT00401544|524204724|FG003|Overall Study|Other|2|||
145370108|NCT02703272|524204725|FG000|Overall Study|Death|4|||
145370109|NCT02703272|524204726|FG001|Overall Study|Death|9|||
145370110|NCT02703272|524204727|FG002|Overall Study|Death|19|||
145370111|NCT02703272|524204728|FG003|Overall Study|Death|10|||
145370112|NCT02703272|524204725|FG000|Overall Study|Withdrawal by Subject|0|||
145370113|NCT02703272|524204726|FG001|Overall Study|Withdrawal by Subject|0|||
145370114|NCT02703272|524204727|FG002|Overall Study|Withdrawal by Subject|4|||
145370115|NCT02703272|524204728|FG003|Overall Study|Withdrawal by Subject|2|||
145370116|NCT02703272|524204725|FG000|Overall Study|Study Terminated by Sponsor|6|||
145370117|NCT02703272|524204726|FG001|Overall Study|Study Terminated by Sponsor|1|||
145370118|NCT02703272|524204727|FG002|Overall Study|Study Terminated by Sponsor|12|||
145370119|NCT02703272|524204728|FG003|Overall Study|Study Terminated by Sponsor|4|||
145370120|NCT02703272|524204725|FG000|Overall Study|Other|1|||
145370121|NCT02703272|524204726|FG001|Overall Study|Other|0|||
145370122|NCT02703272|524204727|FG002|Overall Study|Other|0|||
145370123|NCT02703272|524204728|FG003|Overall Study|Other|0|||
145370124|NCT00976820|524204730|FG000|Overall Study|Lost to Follow-up|5|||
145370125|NCT00976820|524204731|FG001|Overall Study|Lost to Follow-up|16|||
145370126|NCT00976820|524204732|FG002|Overall Study|Lost to Follow-up|2|||
145370127|NCT00976820|524204733|FG003|Overall Study|Lost to Follow-up|3|||
145370128|NCT00976820|524204730|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
145370129|NCT00976820|524204731|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
145370130|NCT00976820|524204732|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
145370131|NCT00976820|524204733|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
145370132|NCT00976820|524204730|FG000|Overall Study|Withdrawal by Subject|2|||
145370133|NCT00976820|524204731|FG001|Overall Study|Withdrawal by Subject|4|||
145370134|NCT00976820|524204732|FG002|Overall Study|Withdrawal by Subject|1|||
145370135|NCT00976820|524204733|FG003|Overall Study|Withdrawal by Subject|4|||
145370136|NCT01489254|524204736|FG000|Double-blind Part|Adverse Event|7|||
145370137|NCT01489254|524204737|FG001|Double-blind Part|Adverse Event|2|||
145370138|NCT01489254|524204738|FG002|Double-blind Part|Adverse Event|2|||
145370139|NCT01489254|524204739|FG003|Double-blind Part|Adverse Event|0|||
145370140|NCT01489254|524204736|FG000|Double-blind Part|Pregnancy|1|||
145370141|NCT01489254|524204737|FG001|Double-blind Part|Pregnancy|3|||
145370142|NCT01489254|524204738|FG002|Double-blind Part|Pregnancy|0|||
145370143|NCT01489254|524204739|FG003|Double-blind Part|Pregnancy|0|||
145370144|NCT01489254|524204736|FG000|Double-blind Part|Withdrawal by Subject|12|||
145370145|NCT01489254|524204737|FG001|Double-blind Part|Withdrawal by Subject|20|||
145370146|NCT01489254|524204738|FG002|Double-blind Part|Withdrawal by Subject|1|||
145370147|NCT01489254|524204739|FG003|Double-blind Part|Withdrawal by Subject|0|||
145370148|NCT01489254|524204736|FG000|Double-blind Part|Lost to Follow-up|1|||
145370149|NCT01489254|524204737|FG001|Double-blind Part|Lost to Follow-up|2|||
145370150|NCT01489254|524204738|FG002|Double-blind Part|Lost to Follow-up|0|||
145370151|NCT01489254|524204739|FG003|Double-blind Part|Lost to Follow-up|0|||
145370152|NCT01489254|524204736|FG000|Double-blind Part|Other reasons for not completing study|4|||
145370153|NCT01489254|524204737|FG001|Double-blind Part|Other reasons for not completing study|6|||
145370154|NCT01489254|524204738|FG002|Double-blind Part|Other reasons for not completing study|0|||
145370155|NCT01489254|524204739|FG003|Double-blind Part|Other reasons for not completing study|0|||
145370156|NCT01489254|524204736|FG000|Open-label Extension Part|Adverse Event|0|||
145370157|NCT01489254|524204737|FG001|Open-label Extension Part|Adverse Event|0|||
145370158|NCT01489254|524204738|FG002|Open-label Extension Part|Adverse Event|0|||
145370159|NCT01489254|524204739|FG003|Open-label Extension Part|Adverse Event|10|||
145578880|NCT02460224|524973774|FG006|Overall Study|Adverse Event|1|||
145578881|NCT02460224|524973775|FG007|Overall Study|Adverse Event|0|||
145578882|NCT02460224|524973776|FG008|Overall Study|Adverse Event|0|||
145578883|NCT02460224|524973777|FG009|Overall Study|Adverse Event|0|||
145578884|NCT02460224|524973778|FG010|Overall Study|Adverse Event|0|||
145578885|NCT02460224|524973779|FG011|Overall Study|Adverse Event|0|||
145578886|NCT02460224|524973780|FG012|Overall Study|Adverse Event|1|||
145578887|NCT02460224|524973781|FG013|Overall Study|Adverse Event|0|||
145578888|NCT02460224|524973782|FG014|Overall Study|Adverse Event|0|||
145578889|NCT02460224|524973783|FG015|Overall Study|Adverse Event|0|||
145578890|NCT02460224|524973784|FG016|Overall Study|Adverse Event|1|||
145578891|NCT02460224|524973785|FG017|Overall Study|Adverse Event|0|||
145578892|NCT02460224|524973786|FG018|Overall Study|Adverse Event|1|||
145578893|NCT02460224|524973787|FG019|Overall Study|Adverse Event|0|||
145578894|NCT02460224|524973788|FG020|Overall Study|Adverse Event|1|||
145578895|NCT02460224|524973789|FG021|Overall Study|Adverse Event|1|||
145578896|NCT02460224|524973790|FG022|Overall Study|Adverse Event|1|||
145578897|NCT02460224|524973791|FG023|Overall Study|Adverse Event|0|||
145578898|NCT02460224|524973792|FG024|Overall Study|Adverse Event|0|||
145578899|NCT02460224|524973793|FG025|Overall Study|Adverse Event|0|||
145578900|NCT02460224|524973794|FG026|Overall Study|Adverse Event|11|||
145370160|NCT01489254|524204736|FG000|Open-label Extension Part|Pregnancy|0|||
145370161|NCT01489254|524204737|FG001|Open-label Extension Part|Pregnancy|0|||
145370162|NCT01489254|524204738|FG002|Open-label Extension Part|Pregnancy|0|||
145370163|NCT01489254|524204739|FG003|Open-label Extension Part|Pregnancy|3|||
145370164|NCT01489254|524204736|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
145370165|NCT01489254|524204737|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
145370166|NCT01489254|524204738|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
145370167|NCT01489254|524204739|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
145370168|NCT01489254|524204736|FG000|Open-label Extension Part|Protocol Violation|0|||
145370169|NCT01489254|524204737|FG001|Open-label Extension Part|Protocol Violation|0|||
145370170|NCT01489254|524204738|FG002|Open-label Extension Part|Protocol Violation|0|||
145370171|NCT01489254|524204739|FG003|Open-label Extension Part|Protocol Violation|1|||
145370172|NCT01489254|524204736|FG000|Open-label Extension Part|Lost to Follow-up|0|||
145370173|NCT01489254|524204737|FG001|Open-label Extension Part|Lost to Follow-up|0|||
145370174|NCT01489254|524204738|FG002|Open-label Extension Part|Lost to Follow-up|0|||
145578901|NCT02460224|524973795|FG027|Overall Study|Adverse Event|1|||
145578902|NCT02460224|524973796|FG028|Overall Study|Adverse Event|6|||
145578903|NCT02460224|524973768|FG000|Overall Study|Death|0|||
145578904|NCT02460224|524973769|FG001|Overall Study|Death|0|||
145623425|NCT01244763|525133896|FG002|Overall Study|Withdrawal by Subject|0|||
145623426|NCT01244763|525133897|FG003|Overall Study|Withdrawal by Subject|1|||
145623427|NCT01244763|525133898|FG004|Overall Study|Withdrawal by Subject|1|||
145623428|NCT01244763|525133899|FG005|Overall Study|Withdrawal by Subject|2|||
145623429|NCT01244763|525133894|FG000|Overall Study|Lost to Follow-up|0|||
145623430|NCT01244763|525133895|FG001|Overall Study|Lost to Follow-up|1|||
145370175|NCT01489254|524204739|FG003|Open-label Extension Part|Lost to Follow-up|9|||
145578905|NCT02460224|524973770|FG002|Overall Study|Death|0|||
145578906|NCT02460224|524973771|FG003|Overall Study|Death|0|||
145578907|NCT02460224|524973772|FG004|Overall Study|Death|0|||
145578908|NCT02460224|524973773|FG005|Overall Study|Death|2|||
145578909|NCT02460224|524973774|FG006|Overall Study|Death|1|||
145578910|NCT02460224|524973775|FG007|Overall Study|Death|0|||
145623431|NCT01244763|525133896|FG002|Overall Study|Lost to Follow-up|0|||
145578911|NCT02460224|524973776|FG008|Overall Study|Death|0|||
145578912|NCT02460224|524973777|FG009|Overall Study|Death|1|||
145623432|NCT01244763|525133897|FG003|Overall Study|Lost to Follow-up|0|||
145623433|NCT01244763|525133898|FG004|Overall Study|Lost to Follow-up|0|||
145623434|NCT01244763|525133899|FG005|Overall Study|Lost to Follow-up|0|||
145623435|NCT01244763|525133894|FG000|Overall Study|Enrolled into the Extension Study|0|||
145623436|NCT01244763|525133895|FG001|Overall Study|Enrolled into the Extension Study|0|||
145623437|NCT01244763|525133896|FG002|Overall Study|Enrolled into the Extension Study|0|||
145623438|NCT01244763|525133897|FG003|Overall Study|Enrolled into the Extension Study|0|||
145623439|NCT01244763|525133898|FG004|Overall Study|Enrolled into the Extension Study|0|||
145623440|NCT01244763|525133899|FG005|Overall Study|Enrolled into the Extension Study|1|||
145623441|NCT02788656|525133900|FG000|Overall Study|Withdrawal by Subject|1|||
145623442|NCT02788656|525133901|FG001|Overall Study|Withdrawal by Subject|0|||
145623443|NCT03169361|525133902|FG000|Overall Study|Protocol Violation|32|||
145623444|NCT02263885|525133903|FG000|Overall Study|Withdrawal by Subject|7|||
145623445|NCT02263885|525133903|FG000|Overall Study|Alternative Treatment|3|||
145623446|NCT02459964|525133914|FG000|Overall Study|Withdrawal by Subject|0|||
145623447|NCT02459964|525133915|FG001|Overall Study|Withdrawal by Subject|0|||
145623448|NCT02459964|525133916|FG002|Overall Study|Withdrawal by Subject|1|||
145623449|NCT02459964|525133914|FG000|Overall Study|Abnormal EKG changes|0|||
145623450|NCT02459964|525133915|FG001|Overall Study|Abnormal EKG changes|0|||
145623451|NCT02459964|525133916|FG002|Overall Study|Abnormal EKG changes|1|||
145623452|NCT00550732|525133917|FG000|Overall Study|Death|4|||
145623453|NCT00550732|525133917|FG000|Overall Study|Withdrawal by Subject|2|||
145623454|NCT00550732|525133917|FG000|Overall Study|Physician Decision|2|||
145623455|NCT00550732|525133917|FG000|Overall Study|Lost to Follow-up|1|||
145623456|NCT00550732|525133917|FG000|Overall Study|Palliative care|1|||
145623457|NCT00550732|525133917|FG000|Overall Study|Adverse Event|1|||
145623458|NCT00751790|525133923|FG000|Overall Study|Lost to Follow-up|1|||
145623459|NCT00751790|525133923|FG000|Overall Study|Death|3|||
145623460|NCT00751790|525133923|FG000|Overall Study|Withdrawal by Subject|1|||
145623461|NCT03302910|525133924|FG000|Overall Study|Protocol Violation|1|||
145623462|NCT03302910|525133925|FG001|Overall Study|Protocol Violation|0|||
145623463|NCT00761774|525133932|FG000|Overall Study|Adverse Event|17|||
145623464|NCT00761774|525133932|FG000|Overall Study|Lack of Efficacy|37|||
145623465|NCT00761774|525133932|FG000|Overall Study|Lost to Follow-up|2|||
145623466|NCT00761774|525133932|FG000|Overall Study|Withdrawal by Subject|9|||
145370176|NCT01489254|524204736|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
145370177|NCT01489254|524204737|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
145370178|NCT01489254|524204738|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
145370179|NCT01489254|524204739|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
145370180|NCT00373958|524204741|FG000|Infant Series|Withdrawal by Subject|13|||
145370181|NCT00373958|524204742|FG001|Infant Series|Withdrawal by Subject|15|||
145370182|NCT00373958|524204741|FG000|Infant Series|Failed to return|8|||
145370183|NCT00373958|524204742|FG001|Infant Series|Failed to return|13|||
145370184|NCT00373958|524204741|FG000|Infant Series|Lost to Follow-up|6|||
145370185|NCT00373958|524204742|FG001|Infant Series|Lost to Follow-up|5|||
145370186|NCT00373958|524204741|FG000|Infant Series|Protocol Violation|3|||
145370187|NCT00373958|524204742|FG001|Infant Series|Protocol Violation|7|||
145370188|NCT00373958|524204741|FG000|Infant Series|Lost Kaiser coverage|4|||
145370189|NCT00373958|524204742|FG001|Infant Series|Lost Kaiser coverage|0|||
145370190|NCT00373958|524204741|FG000|Infant Series|Child relocated|1|||
145370191|NCT00373958|524204742|FG001|Infant Series|Child relocated|0|||
145370192|NCT00373958|524204741|FG000|Infant Series|Consent was not received|1|||
145370193|NCT00373958|524204742|FG001|Infant Series|Consent was not received|0|||
145370194|NCT00373958|524204741|FG000|Infant Series|Adverse Event|3|||
145370195|NCT00373958|524204742|FG001|Infant Series|Adverse Event|1|||
145370196|NCT00373958|524204741|FG000|Infant Series|Physician Decision|1|||
145370197|NCT00373958|524204742|FG001|Infant Series|Physician Decision|1|||
145370198|NCT00373958|524204741|FG000|Toddler Dose|Lost to Follow-up|5|||
145370199|NCT00373958|524204742|FG001|Toddler Dose|Lost to Follow-up|8|||
145370200|NCT00373958|524204741|FG000|Toddler Dose|Withdrawal by Subject|2|||
145370201|NCT00373958|524204742|FG001|Toddler Dose|Withdrawal by Subject|2|||
145370202|NCT00373958|524204741|FG000|Toddler Dose|Failed to return|1|||
145578913|NCT02460224|524973778|FG010|Overall Study|Death|0|||
145370203|NCT00373958|524204742|FG001|Toddler Dose|Failed to return|2|||
145578914|NCT02460224|524973779|FG011|Overall Study|Death|0|||
145578915|NCT02460224|524973780|FG012|Overall Study|Death|0|||
145578916|NCT02460224|524973781|FG013|Overall Study|Death|1|||
145623467|NCT00761774|525133932|FG000|Overall Study|Non-compliance|4|||
145623468|NCT00761774|525133932|FG000|Overall Study|End of study|2|||
145623469|NCT00761774|525133932|FG000|Overall Study|Reclassification of seizures|1|||
145578917|NCT02460224|524973782|FG014|Overall Study|Death|0|||
145578918|NCT02460224|524973783|FG015|Overall Study|Death|0|||
145578919|NCT02460224|524973784|FG016|Overall Study|Death|2|||
145623470|NCT00761774|525133932|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
145623471|NCT00761774|525133932|FG000|Overall Study|Sponsor decision|1|||
145623472|NCT00761774|525133932|FG000|Overall Study|Investigator clinical judgement|1|||
145370204|NCT00373958|524204741|FG000|Toddler Dose|Protocol Violation|0|||
145370205|NCT00373958|524204742|FG001|Toddler Dose|Protocol Violation|1|||
145370206|NCT00373958|524204741|FG000|Toddler Dose|Withdrawn after infant series|22|||
145370207|NCT00373958|524204742|FG001|Toddler Dose|Withdrawn after infant series|25|||
145370208|NCT04240457|524204743|FG000|Overall Study|Lost to Follow-up|5|||
145370209|NCT04240457|524204744|FG001|Overall Study|Lost to Follow-up|1|||
145370210|NCT01820572|524204751|FG000|Randomization|Not Treated|2|||
145370211|NCT01820572|524204752|FG001|Randomization|Not Treated|1|||
145370212|NCT01820572|524204751|FG000|Treatment Period|Adverse Event|12|||
145370213|NCT01820572|524204752|FG001|Treatment Period|Adverse Event|7|||
145370214|NCT01820572|524204751|FG000|Treatment Period|Death|3|||
145370215|NCT01820572|524204752|FG001|Treatment Period|Death|3|||
145370216|NCT01820572|524204751|FG000|Treatment Period|Lack of Efficacy|1|||
145370217|NCT01820572|524204752|FG001|Treatment Period|Lack of Efficacy|0|||
145370218|NCT01820572|524204751|FG000|Treatment Period|poor/non compliance|0|||
145370219|NCT01820572|524204752|FG001|Treatment Period|poor/non compliance|3|||
145370220|NCT01820572|524204751|FG000|Treatment Period|request to discontinue|6|||
145370221|NCT01820572|524204752|FG001|Treatment Period|request to discontinue|11|||
145370222|NCT01820572|524204751|FG000|Treatment Period|No longer meets study criteria|3|||
145370223|NCT01820572|524204752|FG001|Treatment Period|No longer meets study criteria|10|||
145370224|NCT01820572|524204751|FG000|Treatment Period|withdrew consent|1|||
145370225|NCT01820572|524204752|FG001|Treatment Period|withdrew consent|2|||
145370226|NCT04439214|524204758|FG000|Overall Study|Adverse Event|13|||
145370227|NCT04439214|524204758|FG000|Overall Study|Disease progression|16|||
145370228|NCT04439214|524204758|FG000|Overall Study|Death|1|||
145370229|NCT04439214|524204758|FG000|Overall Study|Withdrawal by Subject|2|||
145370230|NCT04439214|524204758|FG000|Overall Study|Declining health|1|||
145370231|NCT04439214|524204758|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
145370232|NCT04439214|524204758|FG000|Overall Study|Ineligible|5|||
145370233|NCT02235077|524204759|FG000|Overall Study|Death|5|||
145370234|NCT02235077|524204760|FG001|Overall Study|Death|7|||
145370235|NCT02235077|524204759|FG000|Overall Study|Lost to Follow-up|5|||
145370236|NCT02235077|524204760|FG001|Overall Study|Lost to Follow-up|6|||
145370237|NCT02235077|524204759|FG000|Overall Study|Withdrawal by Subject|8|||
145370238|NCT02235077|524204760|FG001|Overall Study|Withdrawal by Subject|5|||
145370239|NCT02235077|524204759|FG000|Overall Study|Physician Decision|0|||
145370240|NCT02235077|524204760|FG001|Overall Study|Physician Decision|1|||
145370241|NCT03852628|524204761|FG000|Overall Study|Lost to Follow-up|7|||
145370242|NCT03852628|524204762|FG001|Overall Study|Lost to Follow-up|6|||
145370243|NCT03852628|524204761|FG000|Overall Study|Lack of Efficacy|6|||
145370244|NCT03852628|524204762|FG001|Overall Study|Lack of Efficacy|6|||
145370245|NCT02964208|524204763|FG000|Overall Study|Death|103|||
145370246|NCT02964208|524204763|FG000|Overall Study|Withdrawal by Subject|6|||
145370247|NCT02964208|524204763|FG000|Overall Study|Lost to Follow-up|6|||
145370248|NCT02964208|524204763|FG000|Overall Study|Unsuccessful Procedure|5|||
145370249|NCT02964208|524204763|FG000|Overall Study|Device Explant|1|||
145370250|NCT02964208|524204763|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
145370251|NCT01295827|524204774|FG000|Overall Study|Adverse Event|1|||
145370252|NCT01295827|524204775|FG001|Overall Study|Adverse Event|2|||
145370253|NCT01295827|524204776|FG002|Overall Study|Adverse Event|2|||
145370254|NCT01295827|524204777|FG003|Overall Study|Adverse Event|1|||
145370255|NCT01295827|524204778|FG004|Overall Study|Adverse Event|1|||
145370256|NCT01295827|524204779|FG005|Overall Study|Adverse Event|4|||
145370257|NCT01295827|524204780|FG006|Overall Study|Adverse Event|15|||
145370258|NCT01295827|524204781|FG007|Overall Study|Adverse Event|49|||
145370259|NCT01295827|524204782|FG008|Overall Study|Adverse Event|22|||
145370260|NCT01295827|524204783|FG009|Overall Study|Adverse Event|7|||
145370261|NCT01295827|524204784|FG010|Overall Study|Adverse Event|50|||
145370262|NCT01295827|524204785|FG011|Overall Study|Adverse Event|21|||
145370263|NCT01295827|524204786|FG012|Overall Study|Adverse Event|0|||
145370264|NCT01295827|524204787|FG013|Overall Study|Adverse Event|0|||
145370265|NCT01295827|524204788|FG014|Overall Study|Adverse Event|0|||
145370266|NCT01295827|524204774|FG000|Overall Study|Lost to Follow-up|0|||
145370267|NCT01295827|524204775|FG001|Overall Study|Lost to Follow-up|0|||
145370268|NCT01295827|524204776|FG002|Overall Study|Lost to Follow-up|3|||
145370269|NCT01295827|524204777|FG003|Overall Study|Lost to Follow-up|0|||
145370270|NCT01295827|524204778|FG004|Overall Study|Lost to Follow-up|1|||
145370271|NCT01295827|524204779|FG005|Overall Study|Lost to Follow-up|0|||
145370272|NCT01295827|524204780|FG006|Overall Study|Lost to Follow-up|4|||
145370273|NCT01295827|524204781|FG007|Overall Study|Lost to Follow-up|8|||
145370274|NCT01295827|524204782|FG008|Overall Study|Lost to Follow-up|7|||
145370275|NCT01295827|524204783|FG009|Overall Study|Lost to Follow-up|4|||
145370276|NCT01295827|524204784|FG010|Overall Study|Lost to Follow-up|7|||
145370277|NCT01295827|524204785|FG011|Overall Study|Lost to Follow-up|3|||
145370278|NCT01295827|524204786|FG012|Overall Study|Lost to Follow-up|0|||
145370279|NCT01295827|524204787|FG013|Overall Study|Lost to Follow-up|0|||
145370280|NCT01295827|524204788|FG014|Overall Study|Lost to Follow-up|0|||
145370281|NCT01295827|524204774|FG000|Overall Study|Not Reported|0|||
145370282|NCT01295827|524204775|FG001|Overall Study|Not Reported|0|||
145578920|NCT02460224|524973785|FG017|Overall Study|Death|1|||
145578921|NCT02460224|524973786|FG018|Overall Study|Death|0|||
145578922|NCT02460224|524973787|FG019|Overall Study|Death|2|||
145578923|NCT02460224|524973788|FG020|Overall Study|Death|0|||
145578924|NCT02460224|524973789|FG021|Overall Study|Death|0|||
145370283|NCT01295827|524204776|FG002|Overall Study|Not Reported|0|||
145370284|NCT01295827|524204777|FG003|Overall Study|Not Reported|1|||
145370285|NCT01295827|524204778|FG004|Overall Study|Not Reported|0|||
145370286|NCT01295827|524204779|FG005|Overall Study|Not Reported|0|||
145370287|NCT01295827|524204780|FG006|Overall Study|Not Reported|24|||
145370288|NCT01295827|524204781|FG007|Overall Study|Not Reported|58|||
145370289|NCT01295827|524204782|FG008|Overall Study|Not Reported|41|||
145370290|NCT01295827|524204783|FG009|Overall Study|Not Reported|2|||
145370291|NCT01295827|524204784|FG010|Overall Study|Not Reported|23|||
145370292|NCT01295827|524204785|FG011|Overall Study|Not Reported|13|||
145370293|NCT01295827|524204786|FG012|Overall Study|Not Reported|0|||
145370294|NCT01295827|524204787|FG013|Overall Study|Not Reported|0|||
145370295|NCT01295827|524204788|FG014|Overall Study|Not Reported|0|||
145370296|NCT01295827|524204774|FG000|Overall Study|Progressive Disease|2|||
145370297|NCT01295827|524204775|FG001|Overall Study|Progressive Disease|1|||
145370298|NCT01295827|524204776|FG002|Overall Study|Progressive Disease|5|||
145370299|NCT01295827|524204777|FG003|Overall Study|Progressive Disease|2|||
145370300|NCT01295827|524204778|FG004|Overall Study|Progressive Disease|0|||
145370301|NCT01295827|524204779|FG005|Overall Study|Progressive Disease|1|||
145370302|NCT01295827|524204780|FG006|Overall Study|Progressive Disease|87|||
145370303|NCT01295827|524204781|FG007|Overall Study|Progressive Disease|144|||
145370304|NCT01295827|524204782|FG008|Overall Study|Progressive Disease|85|||
145370305|NCT01295827|524204783|FG009|Overall Study|Progressive Disease|40|||
145370306|NCT01295827|524204784|FG010|Overall Study|Progressive Disease|175|||
145370307|NCT01295827|524204785|FG011|Overall Study|Progressive Disease|136|||
145370308|NCT01295827|524204786|FG012|Overall Study|Progressive Disease|0|||
145370309|NCT01295827|524204787|FG013|Overall Study|Progressive Disease|0|||
145370310|NCT01295827|524204788|FG014|Overall Study|Progressive Disease|0|||
145370311|NCT01295827|524204774|FG000|Overall Study|Screen Failure|0|||
145370312|NCT01295827|524204775|FG001|Overall Study|Screen Failure|0|||
145370313|NCT01295827|524204776|FG002|Overall Study|Screen Failure|0|||
145370314|NCT01295827|524204777|FG003|Overall Study|Screen Failure|0|||
145370315|NCT01295827|524204778|FG004|Overall Study|Screen Failure|0|||
145370316|NCT01295827|524204779|FG005|Overall Study|Screen Failure|0|||
145370317|NCT01295827|524204780|FG006|Overall Study|Screen Failure|2|||
145370318|NCT01295827|524204781|FG007|Overall Study|Screen Failure|2|||
145370319|NCT01295827|524204782|FG008|Overall Study|Screen Failure|2|||
145370320|NCT01295827|524204783|FG009|Overall Study|Screen Failure|0|||
145370321|NCT01295827|524204784|FG010|Overall Study|Screen Failure|1|||
145370322|NCT01295827|524204785|FG011|Overall Study|Screen Failure|0|||
145370323|NCT01295827|524204786|FG012|Overall Study|Screen Failure|0|||
145370324|NCT01295827|524204787|FG013|Overall Study|Screen Failure|0|||
145370325|NCT01295827|524204788|FG014|Overall Study|Screen Failure|0|||
145370326|NCT01295827|524204774|FG000|Overall Study|Withdrawal by Subject|1|||
145370327|NCT01295827|524204775|FG001|Overall Study|Withdrawal by Subject|0|||
145370328|NCT01295827|524204776|FG002|Overall Study|Withdrawal by Subject|2|||
145370329|NCT01295827|524204777|FG003|Overall Study|Withdrawal by Subject|0|||
145370330|NCT01295827|524204778|FG004|Overall Study|Withdrawal by Subject|0|||
145370331|NCT01295827|524204779|FG005|Overall Study|Withdrawal by Subject|1|||
145370332|NCT01295827|524204780|FG006|Overall Study|Withdrawal by Subject|13|||
145370333|NCT01295827|524204781|FG007|Overall Study|Withdrawal by Subject|35|||
145370334|NCT01295827|524204782|FG008|Overall Study|Withdrawal by Subject|11|||
145370335|NCT01295827|524204783|FG009|Overall Study|Withdrawal by Subject|2|||
145370336|NCT01295827|524204784|FG010|Overall Study|Withdrawal by Subject|18|||
145370337|NCT01295827|524204785|FG011|Overall Study|Withdrawal by Subject|13|||
145370338|NCT01295827|524204786|FG012|Overall Study|Withdrawal by Subject|0|||
145370339|NCT01295827|524204787|FG013|Overall Study|Withdrawal by Subject|0|||
145370340|NCT01295827|524204788|FG014|Overall Study|Withdrawal by Subject|0|||
145370341|NCT01295827|524204774|FG000|Overall Study|Other|0|||
145370342|NCT01295827|524204775|FG001|Overall Study|Other|0|||
145370343|NCT01295827|524204776|FG002|Overall Study|Other|0|||
145370344|NCT01295827|524204777|FG003|Overall Study|Other|0|||
145370345|NCT01295827|524204778|FG004|Overall Study|Other|0|||
145370346|NCT01295827|524204779|FG005|Overall Study|Other|0|||
145370347|NCT01295827|524204780|FG006|Overall Study|Other|1|||
145370348|NCT01295827|524204781|FG007|Overall Study|Other|1|||
145370349|NCT01295827|524204782|FG008|Overall Study|Other|1|||
145578925|NCT02460224|524973790|FG022|Overall Study|Death|0|||
145370350|NCT01295827|524204783|FG009|Overall Study|Other|0|||
145370351|NCT01295827|524204784|FG010|Overall Study|Other|2|||
145370352|NCT01295827|524204785|FG011|Overall Study|Other|0|||
145370353|NCT01295827|524204786|FG012|Overall Study|Other|0|||
145370354|NCT01295827|524204787|FG013|Overall Study|Other|0|||
145370355|NCT01295827|524204788|FG014|Overall Study|Other|0|||
145370356|NCT01668173|524204789|FG000|Overall Study|Adverse Event|3|||
145578926|NCT02460224|524973791|FG023|Overall Study|Death|0|||
145578927|NCT02460224|524973792|FG024|Overall Study|Death|1|||
145370357|NCT01668173|524204789|FG000|Overall Study|Trial suspension|4|||
145370358|NCT00072280|524204790|FG000|Treatment|Found ineligible|1|||
145370359|NCT00072280|524204791|FG001|Treatment|Found ineligible|2|||
145370360|NCT00072280|524204790|FG000|Follow-up|Early termination of study|2|||
145370361|NCT00072280|524204791|FG001|Follow-up|Early termination of study|2|||
145370362|NCT00746564|524204792|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
145370363|NCT03226769|524204795|FG000|Overall Study|Withdrawal by Subject|0|||
145370364|NCT03226769|524204796|FG001|Overall Study|Withdrawal by Subject|1|||
145370365|NCT02640677|524204799|FG000|Overall Study|Lost to Follow-up|1|||
145370366|NCT02640677|524204799|FG000|Overall Study|Withdrawal by Subject|1|||
145370367|NCT00957268|524204809|FG000|Overall Study|Voluntary Withdrawal|0|||
145370368|NCT00957268|524204810|FG001|Overall Study|Voluntary Withdrawal|0|||
145370369|NCT00957268|524204811|FG002|Overall Study|Voluntary Withdrawal|1|||
145370370|NCT00957268|524204812|FG003|Overall Study|Voluntary Withdrawal|0|||
145370371|NCT00957268|524204813|FG004|Overall Study|Voluntary Withdrawal|0|||
145370372|NCT01758731|524204814|FG000|Overall Study|Physician Decision|1|||
145370373|NCT02396420|524204816|FG000|Overall Study|Death|1|||
145370374|NCT01493284|524204821|FG000|Overall Study|Death|29|||
145370375|NCT01493284|524204821|FG000|Overall Study|Withdrawal by Subject|32|||
145370376|NCT00325156|524204822|FG000|Overall Study|Protocol Violation|8|||
145370377|NCT00325156|524204822|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
145370378|NCT00325156|524204822|FG000|Overall Study|Migrated/moved from study area|12|||
145370379|NCT00325156|524204822|FG000|Overall Study|Adverse event, non-fatal|3|||
145370380|NCT00325156|524204822|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
145370381|NCT00325156|524204822|FG000|Overall Study|Other|1|||
145370382|NCT00325156|524204822|FG000|Overall Study|Withdrawal by Subject|31|||
145370383|NCT03489707|524204823|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
145370384|NCT03489707|524204824|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
145370385|NCT03489707|524204823|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
145370386|NCT03489707|524204824|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
145370387|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
145370388|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
145370389|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
145370390|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145370391|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145370392|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145370393|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
145370394|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145370395|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
145370396|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
145370397|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145370398|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145370399|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145370400|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
145370401|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
145370402|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
145370403|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145370404|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145370405|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145370406|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145370407|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
145370408|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370409|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
145370410|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370411|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370412|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370413|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370414|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
145370415|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
145370416|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145370417|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
145370418|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145370419|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145370420|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145578928|NCT02460224|524973793|FG025|Overall Study|Death|1|||
145578929|NCT02460224|524973794|FG026|Overall Study|Death|5|||
145578930|NCT02460224|524973795|FG027|Overall Study|Death|0|||
145578931|NCT02460224|524973796|FG028|Overall Study|Death|1|||
145370421|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
145370422|NCT03395184|524204825|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
145370423|NCT03395184|524204826|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
145370424|NCT03395184|524204827|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
145370425|NCT03395184|524204828|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
145370426|NCT03395184|524204829|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
145370427|NCT03395184|524204830|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
145370428|NCT03395184|524204831|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
145370429|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
145370430|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
145370431|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
145370432|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
145370433|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
145370434|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
145370435|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
145370436|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145370437|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145370438|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
145370439|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
145370440|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
145370441|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
145370442|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
145370443|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370444|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370445|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370446|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370447|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
145370448|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370449|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
145370450|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145370451|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145370452|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
145370453|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
145370454|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
145370455|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
145370456|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
145370457|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145370458|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145370459|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145370460|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
145370461|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145370462|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
145370463|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
145370464|NCT03395184|524204825|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145370465|NCT03395184|524204826|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145370466|NCT03395184|524204827|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
145370467|NCT03395184|524204828|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
145370468|NCT03395184|524204829|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
145370469|NCT03395184|524204830|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
145370470|NCT03395184|524204831|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
145370471|NCT01817582|524204832|FG000|Overall Study|Withdrawal by Subject|0|||
145370472|NCT01817582|524204833|FG001|Overall Study|Withdrawal by Subject|1|||
145370473|NCT01817582|524204834|FG002|Overall Study|Withdrawal by Subject|0|||
145370474|NCT01817582|524204832|FG000|Overall Study|Participant revealed masked treatment|1|||
145370475|NCT01817582|524204833|FG001|Overall Study|Participant revealed masked treatment|0|||
145370476|NCT01817582|524204834|FG002|Overall Study|Participant revealed masked treatment|0|||
145370477|NCT01817582|524204832|FG000|Overall Study|Randomized but exclusion criteria met|1|||
145370478|NCT01817582|524204833|FG001|Overall Study|Randomized but exclusion criteria met|0|||
145370479|NCT01817582|524204834|FG002|Overall Study|Randomized but exclusion criteria met|0|||
145370480|NCT00356135|524204837|FG000|Overall Study|Protocol Violation|1|||
145370481|NCT00356135|524204838|FG001|Overall Study|Protocol Violation|0|||
145370482|NCT00356135|524204839|FG002|Overall Study|Protocol Violation|0|||
145370483|NCT00356135|524204837|FG000|Overall Study|Adverse Event|1|||
145370484|NCT00356135|524204838|FG001|Overall Study|Adverse Event|0|||
145370485|NCT00356135|524204839|FG002|Overall Study|Adverse Event|0|||
145370486|NCT00356135|524204837|FG000|Overall Study|Lost to Follow-up|0|||
145370487|NCT00356135|524204838|FG001|Overall Study|Lost to Follow-up|0|||
145370488|NCT00356135|524204839|FG002|Overall Study|Lost to Follow-up|1|||
145370489|NCT00356135|524204837|FG000|Overall Study|Physician Decision|1|||
145370490|NCT00356135|524204838|FG001|Overall Study|Physician Decision|1|||
145370491|NCT00356135|524204839|FG002|Overall Study|Physician Decision|1|||
145370492|NCT00356135|524204837|FG000|Overall Study|Subject non-compliance|1|||
145578932|NCT02460224|524973768|FG000|Overall Study|Lost to Follow-up|0|||
145578933|NCT02460224|524973769|FG001|Overall Study|Lost to Follow-up|0|||
145578934|NCT02460224|524973770|FG002|Overall Study|Lost to Follow-up|0|||
145578935|NCT02460224|524973771|FG003|Overall Study|Lost to Follow-up|0|||
145578936|NCT02460224|524973772|FG004|Overall Study|Lost to Follow-up|0|||
145578937|NCT02460224|524973773|FG005|Overall Study|Lost to Follow-up|0|||
145578938|NCT02460224|524973774|FG006|Overall Study|Lost to Follow-up|0|||
145578939|NCT02460224|524973775|FG007|Overall Study|Lost to Follow-up|0|||
145578940|NCT02460224|524973776|FG008|Overall Study|Lost to Follow-up|0|||
145578941|NCT02460224|524973777|FG009|Overall Study|Lost to Follow-up|0|||
145578942|NCT02460224|524973778|FG010|Overall Study|Lost to Follow-up|0|||
145578943|NCT02460224|524973779|FG011|Overall Study|Lost to Follow-up|0|||
145578944|NCT02460224|524973780|FG012|Overall Study|Lost to Follow-up|0|||
145578945|NCT02460224|524973781|FG013|Overall Study|Lost to Follow-up|0|||
145578946|NCT02460224|524973782|FG014|Overall Study|Lost to Follow-up|0|||
145578947|NCT02460224|524973783|FG015|Overall Study|Lost to Follow-up|0|||
145578948|NCT02460224|524973784|FG016|Overall Study|Lost to Follow-up|0|||
145578949|NCT02460224|524973785|FG017|Overall Study|Lost to Follow-up|0|||
145578950|NCT02460224|524973786|FG018|Overall Study|Lost to Follow-up|0|||
145578951|NCT02460224|524973787|FG019|Overall Study|Lost to Follow-up|0|||
145578952|NCT02460224|524973788|FG020|Overall Study|Lost to Follow-up|0|||
145578953|NCT02460224|524973789|FG021|Overall Study|Lost to Follow-up|0|||
145578954|NCT02460224|524973790|FG022|Overall Study|Lost to Follow-up|1|||
145578955|NCT02460224|524973791|FG023|Overall Study|Lost to Follow-up|0|||
145578956|NCT02460224|524973792|FG024|Overall Study|Lost to Follow-up|0|||
145578957|NCT02460224|524973793|FG025|Overall Study|Lost to Follow-up|0|||
145370493|NCT00356135|524204838|FG001|Overall Study|Subject non-compliance|1|||
145370494|NCT00356135|524204839|FG002|Overall Study|Subject non-compliance|3|||
145370495|NCT03617770|524204840|FG000|Overall Study|Lost to Follow-up|1|||
145370496|NCT03617770|524204841|FG001|Overall Study|Lost to Follow-up|0|||
145370497|NCT03634033|524206502|FG000|Overall Study|Did not have a post-assessment|384|||
145370498|NCT03634033|524206503|FG001|Overall Study|Did not have a post-assessment|291|||
145370499|NCT03634033|524206504|FG002|Overall Study|Did not have a post-assessment|114|||
145370500|NCT03634033|524206505|FG003|Overall Study|Did not have a post-assessment|161|||
145370501|NCT03634033|524206506|FG004|Overall Study|Did not have a post-assessment|5|||
145370502|NCT03634033|524206507|FG005|Overall Study|Did not have a post-assessment|0|||
145370503|NCT03634033|524206508|FG006|Overall Study|Did not have a post-assessment|0|||
145370504|NCT03634033|524206502|FG000|Overall Study|Death|0|||
145370505|NCT03634033|524206503|FG001|Overall Study|Death|0|||
145370506|NCT03634033|524206504|FG002|Overall Study|Death|0|||
145370507|NCT03634033|524206505|FG003|Overall Study|Death|0|||
145370508|NCT03634033|524206506|FG004|Overall Study|Death|0|||
145370509|NCT03634033|524206507|FG005|Overall Study|Death|7|||
145370510|NCT03634033|524206508|FG006|Overall Study|Death|7|||
145370511|NCT03634033|524206502|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145370512|NCT03634033|524206503|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145370513|NCT03634033|524206504|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145370514|NCT03634033|524206505|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145370515|NCT03634033|524206506|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
145370516|NCT03634033|524206507|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
145370517|NCT03634033|524206508|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
145370518|NCT03634033|524206502|FG000|Overall Study|Lost to Follow-up|0|||
145370519|NCT03634033|524206503|FG001|Overall Study|Lost to Follow-up|0|||
145370520|NCT03634033|524206504|FG002|Overall Study|Lost to Follow-up|0|||
145578958|NCT02460224|524973794|FG026|Overall Study|Lost to Follow-up|0|||
145578959|NCT02460224|524973795|FG027|Overall Study|Lost to Follow-up|0|||
145578960|NCT02460224|524973796|FG028|Overall Study|Lost to Follow-up|0|||
145578961|NCT02460224|524973768|FG000|Overall Study|Physician Decision|0|||
145370521|NCT03634033|524206505|FG003|Overall Study|Lost to Follow-up|0|||
145370522|NCT03634033|524206506|FG004|Overall Study|Lost to Follow-up|0|||
145370523|NCT03634033|524206507|FG005|Overall Study|Lost to Follow-up|1|||
145370524|NCT03634033|524206508|FG006|Overall Study|Lost to Follow-up|2|||
145370525|NCT03634033|524206502|FG000|Overall Study|Withdrawal by Subject|0|||
145370526|NCT03634033|524206503|FG001|Overall Study|Withdrawal by Subject|0|||
145370527|NCT03634033|524206504|FG002|Overall Study|Withdrawal by Subject|0|||
145370528|NCT03634033|524206505|FG003|Overall Study|Withdrawal by Subject|0|||
145370529|NCT03634033|524206506|FG004|Overall Study|Withdrawal by Subject|0|||
145370530|NCT03634033|524206507|FG005|Overall Study|Withdrawal by Subject|0|||
145578962|NCT02460224|524973769|FG001|Overall Study|Physician Decision|1|||
145578963|NCT02460224|524973770|FG002|Overall Study|Physician Decision|0|||
145578964|NCT02460224|524973771|FG003|Overall Study|Physician Decision|0|||
145578965|NCT02460224|524973772|FG004|Overall Study|Physician Decision|1|||
145370531|NCT03634033|524206508|FG006|Overall Study|Withdrawal by Subject|1|||
145578966|NCT02460224|524973773|FG005|Overall Study|Physician Decision|0|||
145578967|NCT02460224|524973774|FG006|Overall Study|Physician Decision|0|||
145578968|NCT02460224|524973775|FG007|Overall Study|Physician Decision|1|||
145370532|NCT06366087|524206509|FG000|Overall Study|Withdrawal by Subject|0|||
145578969|NCT02460224|524973776|FG008|Overall Study|Physician Decision|0|||
145422640|NCT00159874|524404172|FG003|Overall Study|Adverse Event|1|||
145422641|NCT00159874|524404173|FG004|Overall Study|Adverse Event|1|||
145422642|NCT00159874|524404174|FG005|Overall Study|Adverse Event|2|||
145422643|NCT00159874|524404175|FG006|Overall Study|Adverse Event|0|||
145422644|NCT00159874|524404169|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
145422645|NCT00159874|524404170|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
145422646|NCT00159874|524404171|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
145422647|NCT00159874|524404172|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
145422648|NCT00159874|524404173|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
145422649|NCT00159874|524404174|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
145422650|NCT00159874|524404175|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
145422651|NCT00159874|524404169|FG000|Overall Study|Lack of Efficacy|2|||
145422652|NCT00159874|524404170|FG001|Overall Study|Lack of Efficacy|0|||
145422653|NCT00159874|524404171|FG002|Overall Study|Lack of Efficacy|1|||
145422654|NCT00159874|524404172|FG003|Overall Study|Lack of Efficacy|1|||
145422655|NCT00159874|524404173|FG004|Overall Study|Lack of Efficacy|0|||
145422656|NCT00159874|524404174|FG005|Overall Study|Lack of Efficacy|3|||
145422657|NCT00159874|524404175|FG006|Overall Study|Lack of Efficacy|0|||
145422658|NCT00159874|524404169|FG000|Overall Study|Lost to Follow-up|1|||
145422659|NCT00159874|524404170|FG001|Overall Study|Lost to Follow-up|0|||
145422660|NCT00159874|524404171|FG002|Overall Study|Lost to Follow-up|3|||
145422661|NCT00159874|524404172|FG003|Overall Study|Lost to Follow-up|0|||
145422662|NCT00159874|524404173|FG004|Overall Study|Lost to Follow-up|1|||
145422663|NCT00159874|524404174|FG005|Overall Study|Lost to Follow-up|2|||
145422664|NCT00159874|524404175|FG006|Overall Study|Lost to Follow-up|1|||
145422665|NCT00159874|524404169|FG000|Overall Study|Other|8|||
145422666|NCT00159874|524404170|FG001|Overall Study|Other|8|||
145422667|NCT00159874|524404171|FG002|Overall Study|Other|8|||
145422668|NCT00159874|524404172|FG003|Overall Study|Other|0|||
145422669|NCT00159874|524404173|FG004|Overall Study|Other|2|||
145422670|NCT00159874|524404174|FG005|Overall Study|Other|1|||
145422671|NCT00159874|524404175|FG006|Overall Study|Other|3|||
145422672|NCT00159874|524404169|FG000|Overall Study|Protocol Violation|0|||
145422673|NCT00159874|524404170|FG001|Overall Study|Protocol Violation|5|||
145422674|NCT00159874|524404171|FG002|Overall Study|Protocol Violation|2|||
145422675|NCT00159874|524404172|FG003|Overall Study|Protocol Violation|0|||
145422676|NCT00159874|524404173|FG004|Overall Study|Protocol Violation|0|||
145422677|NCT00159874|524404174|FG005|Overall Study|Protocol Violation|0|||
145422678|NCT00159874|524404175|FG006|Overall Study|Protocol Violation|0|||
145422679|NCT00159874|524404169|FG000|Overall Study|Death|3|||
145422680|NCT00159874|524404170|FG001|Overall Study|Death|8|||
145422681|NCT00159874|524404171|FG002|Overall Study|Death|15|||
145422682|NCT00159874|524404172|FG003|Overall Study|Death|0|||
145422683|NCT00159874|524404173|FG004|Overall Study|Death|1|||
145422684|NCT00159874|524404174|FG005|Overall Study|Death|2|||
145422685|NCT00159874|524404175|FG006|Overall Study|Death|0|||
145422686|NCT00159874|524404169|FG000|Overall Study|Withdrawal by Subject|2|||
145422687|NCT00159874|524404170|FG001|Overall Study|Withdrawal by Subject|6|||
145422688|NCT00159874|524404171|FG002|Overall Study|Withdrawal by Subject|8|||
145422689|NCT00159874|524404172|FG003|Overall Study|Withdrawal by Subject|4|||
145422690|NCT00159874|524404173|FG004|Overall Study|Withdrawal by Subject|3|||
145422691|NCT00159874|524404174|FG005|Overall Study|Withdrawal by Subject|2|||
145422692|NCT00159874|524404175|FG006|Overall Study|Withdrawal by Subject|1|||
145422693|NCT00159874|524404169|FG000|Overall Study|Pregnancy|1|||
145422694|NCT00159874|524404170|FG001|Overall Study|Pregnancy|1|||
145422695|NCT00159874|524404171|FG002|Overall Study|Pregnancy|0|||
145422696|NCT00159874|524404172|FG003|Overall Study|Pregnancy|0|||
145422697|NCT00159874|524404173|FG004|Overall Study|Pregnancy|0|||
145422698|NCT00159874|524404174|FG005|Overall Study|Pregnancy|0|||
145422699|NCT00159874|524404175|FG006|Overall Study|Pregnancy|0|||
145422700|NCT01104870|524404177|FG000|Overall Study|Adverse Event|1|||
145422701|NCT01104870|524404178|FG001|Overall Study|Adverse Event|1|||
145422702|NCT01104870|524404179|FG002|Overall Study|Adverse Event|0|||
145422703|NCT01104870|524404177|FG000|Overall Study|Death|0|||
145422704|NCT01104870|524404178|FG001|Overall Study|Death|0|||
145623473|NCT00761774|525133932|FG000|Overall Study|Patient moved out of study area|1|||
145623474|NCT00761774|525133932|FG000|Overall Study|Coordinator leaving site|1|||
145422705|NCT01104870|524404179|FG002|Overall Study|Death|1|||
145422706|NCT01104870|524404177|FG000|Overall Study|Withdrawal by Subject|0|||
145422707|NCT01104870|524404178|FG001|Overall Study|Withdrawal by Subject|0|||
145422708|NCT01104870|524404179|FG002|Overall Study|Withdrawal by Subject|1|||
145422709|NCT00276380|524404187|FG000|Overall Study|Adverse Event|5|||
145422710|NCT00276380|524404188|FG001|Overall Study|Adverse Event|3|||
145422711|NCT00276380|524404187|FG000|Overall Study|Lost to Follow-up|1|||
145422712|NCT00276380|524404188|FG001|Overall Study|Lost to Follow-up|1|||
145422713|NCT00276380|524404187|FG000|Overall Study|Withdrawal by Subject|3|||
145422714|NCT00276380|524404188|FG001|Overall Study|Withdrawal by Subject|6|||
145422715|NCT00276380|524404187|FG000|Overall Study|Death|5|||
145422716|NCT00276380|524404188|FG001|Overall Study|Death|3|||
145422717|NCT00276380|524404187|FG000|Overall Study|Abnormal aPPT Levels|0|||
145422718|NCT00276380|524404188|FG001|Overall Study|Abnormal aPPT Levels|1|||
145578970|NCT02460224|524973777|FG009|Overall Study|Physician Decision|0|||
145370533|NCT06366087|524206510|FG001|Overall Study|Withdrawal by Subject|1|||
145370534|NCT01397786|524206515|FG000|Phase A|Lost to Follow-up|0|||
145370535|NCT01397786|524206516|FG001|Phase A|Lost to Follow-up|0|||
145370536|NCT01397786|524206517|FG002|Phase A|Lost to Follow-up|6|||
145370537|NCT01397786|524206515|FG000|Phase A|Adverse Event|0|||
145370538|NCT01397786|524206516|FG001|Phase A|Adverse Event|0|||
145370539|NCT01397786|524206517|FG002|Phase A|Adverse Event|8|||
145370540|NCT01397786|524206515|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
145370541|NCT01397786|524206516|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
145370542|NCT01397786|524206517|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
145370543|NCT01397786|524206515|FG000|Phase A|Physician Decision|0|||
145370544|NCT01397786|524206516|FG001|Phase A|Physician Decision|0|||
145370545|NCT01397786|524206517|FG002|Phase A|Physician Decision|1|||
145370546|NCT01397786|524206515|FG000|Phase A|Withdrawal by Subject|0|||
145370547|NCT01397786|524206516|FG001|Phase A|Withdrawal by Subject|0|||
145370548|NCT01397786|524206517|FG002|Phase A|Withdrawal by Subject|5|||
145370549|NCT01397786|524206515|FG000|Phase A|Lack of Efficacy|0|||
145370550|NCT01397786|524206516|FG001|Phase A|Lack of Efficacy|0|||
145370551|NCT01397786|524206517|FG002|Phase A|Lack of Efficacy|1|||
145370552|NCT01397786|524206515|FG000|Phase B|Lost to Follow-up|22|||
145370553|NCT01397786|524206516|FG001|Phase B|Lost to Follow-up|12|||
145370554|NCT01397786|524206517|FG002|Phase B|Lost to Follow-up|22|||
145370555|NCT01397786|524206515|FG000|Phase B|Adverse Event|109|||
145370556|NCT01397786|524206516|FG001|Phase B|Adverse Event|23|||
145370557|NCT01397786|524206517|FG002|Phase B|Adverse Event|27|||
145370558|NCT01397786|524206515|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
145370559|NCT01397786|524206516|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
145370560|NCT01397786|524206517|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
145370561|NCT01397786|524206515|FG000|Phase B|Physician Decision|9|||
145370562|NCT01397786|524206516|FG001|Phase B|Physician Decision|1|||
145370563|NCT01397786|524206517|FG002|Phase B|Physician Decision|3|||
145370564|NCT01397786|524206515|FG000|Phase B|Withdrawal by Subject|102|||
145370565|NCT01397786|524206516|FG001|Phase B|Withdrawal by Subject|45|||
145370566|NCT01397786|524206517|FG002|Phase B|Withdrawal by Subject|30|||
145370567|NCT01397786|524206515|FG000|Phase B|Protocol Deviation|1|||
145370568|NCT01397786|524206516|FG001|Phase B|Protocol Deviation|2|||
145370569|NCT01397786|524206517|FG002|Phase B|Protocol Deviation|4|||
145370570|NCT01397786|524206515|FG000|Phase B|Lack of Efficacy|22|||
145370571|NCT01397786|524206516|FG001|Phase B|Lack of Efficacy|7|||
145370572|NCT01397786|524206517|FG002|Phase B|Lack of Efficacy|14|||
145370573|NCT00784550|524206521|FG000|Overall Study|Adverse Event|12|||
145370574|NCT00784550|524206522|FG001|Overall Study|Adverse Event|10|||
145370575|NCT00784550|524206521|FG000|Overall Study|Lack of Efficacy|0|||
145370576|NCT00784550|524206522|FG001|Overall Study|Lack of Efficacy|1|||
145370577|NCT00784550|524206521|FG000|Overall Study|Protocol Violation|10|||
145370578|NCT00784550|524206522|FG001|Overall Study|Protocol Violation|10|||
145370579|NCT00784550|524206521|FG000|Overall Study|Lost to Follow-up|8|||
145370580|NCT00784550|524206522|FG001|Overall Study|Lost to Follow-up|5|||
145370581|NCT00784550|524206521|FG000|Overall Study|Physician Decision|2|||
145370582|NCT00784550|524206522|FG001|Overall Study|Physician Decision|3|||
145370583|NCT00784550|524206521|FG000|Overall Study|Withdrawal by Subject|4|||
145370584|NCT00784550|524206522|FG001|Overall Study|Withdrawal by Subject|13|||
145370585|NCT01275755|524206525|FG000|Double-blind Treatment Period|Adverse Event|0|||
145370586|NCT01275755|524206526|FG001|Double-blind Treatment Period|Adverse Event|2|||
145370587|NCT01275755|524206525|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
145370588|NCT01275755|524206526|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
145370589|NCT01275755|524206525|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145370590|NCT01275755|524206526|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145370591|NCT01275755|524206525|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
145370592|NCT01275755|524206526|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
145370593|NCT00174967|524206529|FG000|Overall Study|Adverse Event|1|||
145578971|NCT02460224|524973778|FG010|Overall Study|Physician Decision|0|||
145370594|NCT00174967|524206530|FG001|Overall Study|Adverse Event|2|||
145370595|NCT00174967|524206531|FG002|Overall Study|Adverse Event|2|||
145370596|NCT00174967|524206532|FG003|Overall Study|Adverse Event|1|||
145370597|NCT00174967|524206529|FG000|Overall Study|Gout Flare|0|||
145370598|NCT00174967|524206530|FG001|Overall Study|Gout Flare|0|||
145370599|NCT00174967|524206531|FG002|Overall Study|Gout Flare|0|||
145370600|NCT00174967|524206532|FG003|Overall Study|Gout Flare|1|||
145370601|NCT00174967|524206529|FG000|Overall Study|Other|0|||
145370602|NCT00174967|524206530|FG001|Overall Study|Other|1|||
145370603|NCT00174967|524206531|FG002|Overall Study|Other|0|||
145578972|NCT02460224|524973779|FG011|Overall Study|Physician Decision|1|||
145370604|NCT00174967|524206532|FG003|Overall Study|Other|0|||
145370605|NCT04420585|524206533|FG000|Overall Study|Adverse Event|1|||
145578973|NCT02460224|524973780|FG012|Overall Study|Physician Decision|0|||
145370606|NCT04420585|524206533|FG000|Overall Study|Never initiated medication|2|||
145370607|NCT00477750|524206534|FG000|Overall Study|Currently Receiving Treatment|11|||
145370608|NCT03558152|524206535|FG000|Overall Study|Adverse Event|0|||
145370609|NCT03558152|524206536|FG001|Overall Study|Adverse Event|0|||
145370610|NCT03558152|524206537|FG002|Overall Study|Adverse Event|1|||
145370611|NCT03558152|524206538|FG003|Overall Study|Adverse Event|1|||
145370612|NCT03558152|524206539|FG004|Overall Study|Adverse Event|2|||
145370613|NCT03558152|524206540|FG005|Overall Study|Adverse Event|1|||
145370614|NCT03558152|524206541|FG006|Overall Study|Adverse Event|1|||
145370615|NCT03558152|524206542|FG007|Overall Study|Adverse Event|0|||
145370616|NCT03558152|524206535|FG000|Overall Study|Death|0|||
145370617|NCT03558152|524206536|FG001|Overall Study|Death|0|||
145370618|NCT03558152|524206537|FG002|Overall Study|Death|0|||
145370619|NCT03558152|524206538|FG003|Overall Study|Death|0|||
145370620|NCT03558152|524206539|FG004|Overall Study|Death|1|||
145370621|NCT03558152|524206540|FG005|Overall Study|Death|0|||
145370622|NCT03558152|524206541|FG006|Overall Study|Death|0|||
145370623|NCT03558152|524206542|FG007|Overall Study|Death|0|||
145370624|NCT03558152|524206535|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
145370625|NCT03558152|524206536|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370626|NCT03558152|524206537|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370627|NCT03558152|524206538|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370628|NCT03558152|524206539|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370629|NCT03558152|524206540|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370630|NCT03558152|524206541|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370631|NCT03558152|524206542|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
145370632|NCT03558152|524206535|FG000|Overall Study|Miscalculation in mmcs|0|||
145370633|NCT03558152|524206536|FG001|Overall Study|Miscalculation in mmcs|0|||
145370634|NCT03558152|524206537|FG002|Overall Study|Miscalculation in mmcs|0|||
145370635|NCT03558152|524206538|FG003|Overall Study|Miscalculation in mmcs|0|||
145370636|NCT03558152|524206539|FG004|Overall Study|Miscalculation in mmcs|0|||
145370637|NCT03558152|524206540|FG005|Overall Study|Miscalculation in mmcs|0|||
145370638|NCT03558152|524206541|FG006|Overall Study|Miscalculation in mmcs|1|||
145370639|NCT03558152|524206542|FG007|Overall Study|Miscalculation in mmcs|0|||
145370640|NCT03558152|524206535|FG000|Overall Study|Mistake in calculation|0|||
145370641|NCT03558152|524206536|FG001|Overall Study|Mistake in calculation|0|||
145370642|NCT03558152|524206537|FG002|Overall Study|Mistake in calculation|0|||
145370643|NCT03558152|524206538|FG003|Overall Study|Mistake in calculation|1|||
145370644|NCT03558152|524206539|FG004|Overall Study|Mistake in calculation|0|||
145370645|NCT03558152|524206540|FG005|Overall Study|Mistake in calculation|0|||
145370646|NCT03558152|524206541|FG006|Overall Study|Mistake in calculation|0|||
145370647|NCT03558152|524206542|FG007|Overall Study|Mistake in calculation|0|||
145370648|NCT03558152|524206535|FG000|Overall Study|Mistake in evaluation of disease status|0|||
145370649|NCT03558152|524206536|FG001|Overall Study|Mistake in evaluation of disease status|0|||
145370650|NCT03558152|524206537|FG002|Overall Study|Mistake in evaluation of disease status|0|||
145370651|NCT03558152|524206538|FG003|Overall Study|Mistake in evaluation of disease status|0|||
145370652|NCT03558152|524206539|FG004|Overall Study|Mistake in evaluation of disease status|0|||
145370653|NCT03558152|524206540|FG005|Overall Study|Mistake in evaluation of disease status|0|||
145370654|NCT03558152|524206541|FG006|Overall Study|Mistake in evaluation of disease status|0|||
145370655|NCT03558152|524206542|FG007|Overall Study|Mistake in evaluation of disease status|1|||
145370656|NCT03558152|524206535|FG000|Overall Study|Physician Decision|0|||
145370657|NCT03558152|524206536|FG001|Overall Study|Physician Decision|0|||
145370658|NCT03558152|524206537|FG002|Overall Study|Physician Decision|0|||
145578974|NCT02460224|524973781|FG013|Overall Study|Physician Decision|1|||
145578975|NCT02460224|524973782|FG014|Overall Study|Physician Decision|0|||
145370659|NCT03558152|524206538|FG003|Overall Study|Physician Decision|0|||
145370660|NCT03558152|524206539|FG004|Overall Study|Physician Decision|0|||
145370661|NCT03558152|524206540|FG005|Overall Study|Physician Decision|0|||
145370662|NCT03558152|524206541|FG006|Overall Study|Physician Decision|1|||
145370663|NCT03558152|524206542|FG007|Overall Study|Physician Decision|0|||
145370664|NCT03558152|524206535|FG000|Overall Study|Withdrawal by Subject|2|||
145370665|NCT03558152|524206536|FG001|Overall Study|Withdrawal by Subject|3|||
145422719|NCT02150863|524404189|FG000|Overall Study|Lost to Follow-up|0|||
145422720|NCT02150863|524404190|FG001|Overall Study|Lost to Follow-up|1|||
145422721|NCT02150863|524404191|FG002|Overall Study|Lost to Follow-up|0|||
145422722|NCT01651208|524404192|FG000|Overall Study|Lost to Follow-up|14|||
145422723|NCT01651208|524404193|FG001|Overall Study|Lost to Follow-up|16|||
145422724|NCT04829214|524404194|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
145422725|NCT04829214|524404195|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
145422726|NCT04829214|524404194|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
145422727|NCT04829214|524404195|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
145422728|NCT00835549|524404198|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
145422729|NCT00835549|524404199|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145422730|NCT04008069|524404200|FG000|Open-Label Period|Adverse Event|1|||
145422731|NCT04008069|524404201|FG001|Open-Label Period|Adverse Event|0|||
145422732|NCT04008069|524404202|FG002|Open-Label Period|Adverse Event|0|||
145422733|NCT04008069|524404200|FG000|Open-Label Period|Lack of Efficacy|4|||
145422734|NCT04008069|524404201|FG001|Open-Label Period|Lack of Efficacy|0|||
145422735|NCT04008069|524404202|FG002|Open-Label Period|Lack of Efficacy|0|||
145578976|NCT02460224|524973783|FG015|Overall Study|Physician Decision|0|||
145578977|NCT02460224|524973784|FG016|Overall Study|Physician Decision|2|||
145578978|NCT02460224|524973785|FG017|Overall Study|Physician Decision|1|||
145578979|NCT02460224|524973786|FG018|Overall Study|Physician Decision|1|||
145578980|NCT02460224|524973787|FG019|Overall Study|Physician Decision|2|||
145578981|NCT02460224|524973788|FG020|Overall Study|Physician Decision|1|||
145578982|NCT02460224|524973789|FG021|Overall Study|Physician Decision|1|||
145578983|NCT02460224|524973790|FG022|Overall Study|Physician Decision|0|||
145578984|NCT02460224|524973791|FG023|Overall Study|Physician Decision|0|||
145578985|NCT02460224|524973792|FG024|Overall Study|Physician Decision|1|||
145578986|NCT02460224|524973793|FG025|Overall Study|Physician Decision|0|||
145578987|NCT02460224|524973794|FG026|Overall Study|Physician Decision|14|||
145578988|NCT02460224|524973795|FG027|Overall Study|Physician Decision|1|||
145578989|NCT02460224|524973796|FG028|Overall Study|Physician Decision|6|||
145578990|NCT02460224|524973768|FG000|Overall Study|Progressive disease|15|||
145578991|NCT02460224|524973769|FG001|Overall Study|Progressive disease|11|||
145578992|NCT02460224|524973770|FG002|Overall Study|Progressive disease|5|||
145578993|NCT02460224|524973771|FG003|Overall Study|Progressive disease|6|||
145578994|NCT02460224|524973772|FG004|Overall Study|Progressive disease|3|||
145578995|NCT02460224|524973773|FG005|Overall Study|Progressive disease|26|||
145578996|NCT02460224|524973774|FG006|Overall Study|Progressive disease|28|||
145578997|NCT02460224|524973775|FG007|Overall Study|Progressive disease|4|||
145578998|NCT02460224|524973776|FG008|Overall Study|Progressive disease|5|||
145578999|NCT02460224|524973777|FG009|Overall Study|Progressive disease|9|||
145579000|NCT02460224|524973778|FG010|Overall Study|Progressive disease|5|||
145579001|NCT02460224|524973779|FG011|Overall Study|Progressive disease|4|||
145579002|NCT02460224|524973780|FG012|Overall Study|Progressive disease|5|||
145579003|NCT02460224|524973781|FG013|Overall Study|Progressive disease|4|||
145579004|NCT02460224|524973782|FG014|Overall Study|Progressive disease|5|||
145579005|NCT02460224|524973783|FG015|Overall Study|Progressive disease|5|||
145579006|NCT02460224|524973784|FG016|Overall Study|Progressive disease|15|||
145579007|NCT02460224|524973785|FG017|Overall Study|Progressive disease|3|||
145579008|NCT02460224|524973786|FG018|Overall Study|Progressive disease|8|||
145579009|NCT02460224|524973787|FG019|Overall Study|Progressive disease|3|||
145579010|NCT02460224|524973788|FG020|Overall Study|Progressive disease|4|||
145579011|NCT02460224|524973789|FG021|Overall Study|Progressive disease|9|||
145579012|NCT02460224|524973790|FG022|Overall Study|Progressive disease|4|||
145579013|NCT02460224|524973791|FG023|Overall Study|Progressive disease|11|||
145579014|NCT02460224|524973792|FG024|Overall Study|Progressive disease|4|||
145579015|NCT02460224|524973793|FG025|Overall Study|Progressive disease|5|||
145579016|NCT02460224|524973794|FG026|Overall Study|Progressive disease|85|||
145579017|NCT02460224|524973795|FG027|Overall Study|Progressive disease|17|||
145579018|NCT02460224|524973796|FG028|Overall Study|Progressive disease|77|||
145579019|NCT02460224|524973768|FG000|Overall Study|Subject/guardian decision|2|||
145579020|NCT02460224|524973769|FG001|Overall Study|Subject/guardian decision|0|||
145370666|NCT03558152|524206537|FG002|Overall Study|Withdrawal by Subject|2|||
145370667|NCT03558152|524206538|FG003|Overall Study|Withdrawal by Subject|1|||
145370668|NCT03558152|524206539|FG004|Overall Study|Withdrawal by Subject|1|||
145370669|NCT03558152|524206540|FG005|Overall Study|Withdrawal by Subject|1|||
145370670|NCT03558152|524206541|FG006|Overall Study|Withdrawal by Subject|3|||
145370671|NCT03558152|524206542|FG007|Overall Study|Withdrawal by Subject|2|||
145370672|NCT03558152|524206535|FG000|Overall Study|Lack of Efficacy|11|||
145370673|NCT03558152|524206536|FG001|Overall Study|Lack of Efficacy|11|||
145370674|NCT03558152|524206537|FG002|Overall Study|Lack of Efficacy|10|||
145370675|NCT03558152|524206538|FG003|Overall Study|Lack of Efficacy|11|||
145370676|NCT03558152|524206539|FG004|Overall Study|Lack of Efficacy|14|||
145370677|NCT03558152|524206540|FG005|Overall Study|Lack of Efficacy|12|||
145370678|NCT03558152|524206541|FG006|Overall Study|Lack of Efficacy|14|||
145370679|NCT03558152|524206542|FG007|Overall Study|Lack of Efficacy|13|||
145370680|NCT03558152|524206535|FG000|Overall Study|Protocol Violation|1|||
145370681|NCT03558152|524206536|FG001|Overall Study|Protocol Violation|1|||
145579021|NCT02460224|524973770|FG002|Overall Study|Subject/guardian decision|1|||
145579022|NCT02460224|524973771|FG003|Overall Study|Subject/guardian decision|0|||
145579023|NCT02460224|524973772|FG004|Overall Study|Subject/guardian decision|2|||
145579024|NCT02460224|524973773|FG005|Overall Study|Subject/guardian decision|2|||
145370682|NCT03558152|524206537|FG002|Overall Study|Protocol Violation|0|||
145579025|NCT02460224|524973774|FG006|Overall Study|Subject/guardian decision|0|||
145579026|NCT02460224|524973775|FG007|Overall Study|Subject/guardian decision|0|||
145579027|NCT02460224|524973776|FG008|Overall Study|Subject/guardian decision|1|||
145579028|NCT02460224|524973777|FG009|Overall Study|Subject/guardian decision|1|||
145579029|NCT02460224|524973778|FG010|Overall Study|Subject/guardian decision|0|||
145579030|NCT02460224|524973779|FG011|Overall Study|Subject/guardian decision|1|||
145579031|NCT02460224|524973780|FG012|Overall Study|Subject/guardian decision|0|||
145370683|NCT03558152|524206538|FG003|Overall Study|Protocol Violation|1|||
145370684|NCT03558152|524206539|FG004|Overall Study|Protocol Violation|1|||
145370685|NCT03558152|524206540|FG005|Overall Study|Protocol Violation|0|||
145370686|NCT03558152|524206541|FG006|Overall Study|Protocol Violation|2|||
145579032|NCT02460224|524973781|FG013|Overall Study|Subject/guardian decision|0|||
145579033|NCT02460224|524973782|FG014|Overall Study|Subject/guardian decision|0|||
145370687|NCT03558152|524206542|FG007|Overall Study|Protocol Violation|0|||
145579034|NCT02460224|524973783|FG015|Overall Study|Subject/guardian decision|1|||
145579035|NCT02460224|524973784|FG016|Overall Study|Subject/guardian decision|0|||
145579036|NCT02460224|524973785|FG017|Overall Study|Subject/guardian decision|1|||
145579037|NCT02460224|524973786|FG018|Overall Study|Subject/guardian decision|2|||
145370688|NCT00601172|524206543|FG000|Overall Study|Adverse Event|43|||
145370689|NCT00601172|524206544|FG001|Overall Study|Adverse Event|32|||
145370690|NCT00601172|524206543|FG000|Overall Study|Lack of Efficacy|11|||
145370691|NCT00601172|524206544|FG001|Overall Study|Lack of Efficacy|12|||
145370692|NCT00601172|524206543|FG000|Overall Study|Protocol Violation|2|||
145370693|NCT00601172|524206544|FG001|Overall Study|Protocol Violation|5|||
145370694|NCT00601172|524206543|FG000|Overall Study|Lost to Follow-up|4|||
145370695|NCT00601172|524206544|FG001|Overall Study|Lost to Follow-up|3|||
145370696|NCT00601172|524206543|FG000|Overall Study|Physician Decision|27|||
145370697|NCT00601172|524206544|FG001|Overall Study|Physician Decision|28|||
145370698|NCT00601172|524206543|FG000|Overall Study|Withdrawal by Subject|35|||
145370699|NCT00601172|524206544|FG001|Overall Study|Withdrawal by Subject|27|||
145370700|NCT00601172|524206543|FG000|Overall Study|Did not meet continuation criteria|19|||
145370701|NCT00601172|524206544|FG001|Overall Study|Did not meet continuation criteria|20|||
145370702|NCT04434469|524206548|FG000|Overall Study|Death|2|||
145370703|NCT04434469|524206549|FG001|Overall Study|Death|3|||
145370704|NCT04434469|524206550|FG002|Overall Study|Death|2|||
145370705|NCT04434469|524206551|FG003|Overall Study|Death|2|||
145370706|NCT04434469|524206552|FG004|Overall Study|Death|2|||
145370707|NCT04434469|524206553|FG005|Overall Study|Death|0|||
145370708|NCT04434469|524206548|FG000|Overall Study|Lost to Follow-up|0|||
145370709|NCT04434469|524206549|FG001|Overall Study|Lost to Follow-up|0|||
145370710|NCT04434469|524206550|FG002|Overall Study|Lost to Follow-up|0|||
145370711|NCT04434469|524206551|FG003|Overall Study|Lost to Follow-up|1|||
145370712|NCT04434469|524206552|FG004|Overall Study|Lost to Follow-up|1|||
145370713|NCT04434469|524206553|FG005|Overall Study|Lost to Follow-up|0|||
145370714|NCT04434469|524206548|FG000|Overall Study|Study terminated by sponsor|1|||
145370715|NCT04434469|524206549|FG001|Overall Study|Study terminated by sponsor|1|||
145370716|NCT04434469|524206550|FG002|Overall Study|Study terminated by sponsor|1|||
145370717|NCT04434469|524206551|FG003|Overall Study|Study terminated by sponsor|2|||
145370718|NCT04434469|524206552|FG004|Overall Study|Study terminated by sponsor|3|||
145370719|NCT04434469|524206553|FG005|Overall Study|Study terminated by sponsor|3|||
145370720|NCT04434469|524206548|FG000|Overall Study|Withdrawal by Subject|0|||
145370721|NCT04434469|524206549|FG001|Overall Study|Withdrawal by Subject|0|||
145370722|NCT04434469|524206550|FG002|Overall Study|Withdrawal by Subject|1|||
145370723|NCT04434469|524206551|FG003|Overall Study|Withdrawal by Subject|0|||
145370724|NCT04434469|524206552|FG004|Overall Study|Withdrawal by Subject|0|||
145370725|NCT04434469|524206553|FG005|Overall Study|Withdrawal by Subject|0|||
145370726|NCT01154296|524206554|FG000|Randomization and Intervention|Decided to decline|1|||
145370727|NCT01154296|524206555|FG001|Randomization and Intervention|Decided to decline|1|||
145370728|NCT01154296|524206554|FG000|Randomization and Intervention|Declined by staff|1|||
145370729|NCT01154296|524206555|FG001|Randomization and Intervention|Declined by staff|0|||
145370730|NCT01154296|524206554|FG000|Randomization and Intervention|Did not return|1|||
145370731|NCT01154296|524206555|FG001|Randomization and Intervention|Did not return|0|||
145370732|NCT01154296|524206554|FG000|Randomization and Intervention|Left before test|0|||
145370733|NCT01154296|524206555|FG001|Randomization and Intervention|Left before test|1|||
145370734|NCT01154296|524206554|FG000|Randomization and Intervention|Left clinic early|2|||
145370735|NCT01154296|524206555|FG001|Randomization and Intervention|Left clinic early|0|||
145370736|NCT01154296|524206554|FG000|6-month Follow-up|Lost contact|269|||
145370737|NCT01154296|524206555|FG001|6-month Follow-up|Lost contact|275|||
145370738|NCT01154296|524206554|FG000|6-month Follow-up|Incarcerated|37|||
145370739|NCT01154296|524206555|FG001|6-month Follow-up|Incarcerated|32|||
145370740|NCT01154296|524206554|FG000|6-month Follow-up|Withdrew consent|14|||
145370741|NCT01154296|524206555|FG001|6-month Follow-up|Withdrew consent|15|||
145370742|NCT01154296|524206554|FG000|6-month Follow-up|Death|3|||
145370743|NCT01154296|524206555|FG001|6-month Follow-up|Death|2|||
145370744|NCT01154296|524206554|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
145370745|NCT01154296|524206555|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
145370746|NCT04310397|524206557|FG000|Overall Study|Lack of Efficacy|3|||
145370747|NCT04310397|524206557|FG000|Overall Study|Withdrawal by Subject|1|||
145370748|NCT01936181|524206561|FG000|Randomised, Double-blind|Adverse Event|27|||
145370749|NCT01936181|524206562|FG001|Randomised, Double-blind|Adverse Event|21|||
145370750|NCT01936181|524206563|FG002|Randomised, Double-blind|Adverse Event|0|||
145370751|NCT01936181|524206564|FG003|Randomised, Double-blind|Adverse Event|0|||
145370752|NCT01936181|524206561|FG000|Randomised, Double-blind|Protocol Violation|1|||
145579038|NCT02460224|524973787|FG019|Overall Study|Subject/guardian decision|0|||
145370753|NCT01936181|524206562|FG001|Randomised, Double-blind|Protocol Violation|5|||
145370754|NCT01936181|524206563|FG002|Randomised, Double-blind|Protocol Violation|0|||
145370755|NCT01936181|524206564|FG003|Randomised, Double-blind|Protocol Violation|0|||
145370756|NCT01936181|524206561|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
145579039|NCT02460224|524973788|FG020|Overall Study|Subject/guardian decision|0|||
145370757|NCT01936181|524206562|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
145370758|NCT01936181|524206563|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
145370759|NCT01936181|524206564|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
145370760|NCT01936181|524206561|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
145370761|NCT01936181|524206562|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
145370762|NCT01936181|524206563|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
145370763|NCT01936181|524206564|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
145370764|NCT01936181|524206561|FG000|Randomised, Double-blind|Pregnancy|0|||
145370765|NCT01936181|524206562|FG001|Randomised, Double-blind|Pregnancy|1|||
145370766|NCT01936181|524206563|FG002|Randomised, Double-blind|Pregnancy|0|||
145370767|NCT01936181|524206564|FG003|Randomised, Double-blind|Pregnancy|0|||
145370768|NCT01936181|524206561|FG000|Randomised, Double-blind|Physician Decision|4|||
145370769|NCT01936181|524206562|FG001|Randomised, Double-blind|Physician Decision|4|||
145370770|NCT01936181|524206563|FG002|Randomised, Double-blind|Physician Decision|0|||
145370771|NCT01936181|524206564|FG003|Randomised, Double-blind|Physician Decision|0|||
145370772|NCT01936181|524206561|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
145370773|NCT01936181|524206562|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
145370774|NCT01936181|524206563|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
145370775|NCT01936181|524206564|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
145370776|NCT01936181|524206561|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
145370777|NCT01936181|524206562|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
145370778|NCT01936181|524206563|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
145370779|NCT01936181|524206564|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
145370780|NCT01936181|524206561|FG000|Transition-extension|Adverse Event|3|||
145370781|NCT01936181|524206562|FG001|Transition-extension|Adverse Event|0|||
145370782|NCT01936181|524206563|FG002|Transition-extension|Adverse Event|3|||
145370783|NCT01936181|524206564|FG003|Transition-extension|Adverse Event|1|||
145370784|NCT01936181|524206561|FG000|Transition-extension|Lost to Follow-up|3|||
145370785|NCT01936181|524206562|FG001|Transition-extension|Lost to Follow-up|0|||
145370786|NCT01936181|524206563|FG002|Transition-extension|Lost to Follow-up|1|||
145370787|NCT01936181|524206564|FG003|Transition-extension|Lost to Follow-up|2|||
145370788|NCT01936181|524206561|FG000|Transition-extension|Physician Decision|2|||
145370789|NCT01936181|524206562|FG001|Transition-extension|Physician Decision|0|||
145370790|NCT01936181|524206563|FG002|Transition-extension|Physician Decision|0|||
145370791|NCT01936181|524206564|FG003|Transition-extension|Physician Decision|1|||
145370792|NCT01936181|524206561|FG000|Transition-extension|Withdrawal by Subject|7|||
145370793|NCT01936181|524206562|FG001|Transition-extension|Withdrawal by Subject|0|||
145370794|NCT01936181|524206563|FG002|Transition-extension|Withdrawal by Subject|2|||
145370795|NCT01936181|524206564|FG003|Transition-extension|Withdrawal by Subject|1|||
145370796|NCT00970632|524206569|FG000|Overall Study|Adverse Event|2|||
145370797|NCT00970632|524206570|FG001|Overall Study|Adverse Event|2|||
145370798|NCT00970632|524206571|FG002|Overall Study|Adverse Event|1|||
145370799|NCT00970632|524206569|FG000|Overall Study|Lack of Efficacy|3|||
145370800|NCT00970632|524206570|FG001|Overall Study|Lack of Efficacy|0|||
145370801|NCT00970632|524206571|FG002|Overall Study|Lack of Efficacy|0|||
145370802|NCT00970632|524206569|FG000|Overall Study|Lost to Follow-up|3|||
145370803|NCT00970632|524206570|FG001|Overall Study|Lost to Follow-up|0|||
145370804|NCT00970632|524206571|FG002|Overall Study|Lost to Follow-up|2|||
145370805|NCT00970632|524206569|FG000|Overall Study|Protocol Violation|8|||
145370806|NCT00970632|524206570|FG001|Overall Study|Protocol Violation|5|||
145370807|NCT00970632|524206571|FG002|Overall Study|Protocol Violation|8|||
145370808|NCT00970632|524206569|FG000|Overall Study|Withdrawal by Subject|7|||
145370809|NCT00970632|524206570|FG001|Overall Study|Withdrawal by Subject|6|||
145370810|NCT00970632|524206571|FG002|Overall Study|Withdrawal by Subject|4|||
145370811|NCT00970632|524206569|FG000|Overall Study|Entry criteria not met|0|||
145370812|NCT00970632|524206570|FG001|Overall Study|Entry criteria not met|2|||
145370813|NCT00970632|524206571|FG002|Overall Study|Entry criteria not met|2|||
145370814|NCT00970632|524206569|FG000|Overall Study|Sponsor decision|1|||
145370815|NCT00970632|524206570|FG001|Overall Study|Sponsor decision|0|||
145370816|NCT00970632|524206571|FG002|Overall Study|Sponsor decision|1|||
145370817|NCT03320850|524206574|FG000|Overall Study|Lost to Follow-up|0|||
145370818|NCT03320850|524206575|FG001|Overall Study|Lost to Follow-up|0|||
145370819|NCT03320850|524206576|FG002|Overall Study|Lost to Follow-up|0|||
145370820|NCT03320850|524206577|FG003|Overall Study|Lost to Follow-up|0|||
145370821|NCT03320850|524206578|FG004|Overall Study|Lost to Follow-up|1|||
145370822|NCT03320850|524206579|FG005|Overall Study|Lost to Follow-up|2|||
145370823|NCT03320850|524206580|FG006|Overall Study|Lost to Follow-up|2|||
145370824|NCT03320850|524206581|FG007|Overall Study|Lost to Follow-up|0|||
145370825|NCT03320850|524206582|FG008|Overall Study|Lost to Follow-up|6|||
145370826|NCT03320850|524206583|FG009|Overall Study|Lost to Follow-up|4|||
145370827|NCT03320850|524206574|FG000|Overall Study|Withdrawal by Subject|0|||
145370828|NCT03320850|524206575|FG001|Overall Study|Withdrawal by Subject|0|||
145370829|NCT03320850|524206576|FG002|Overall Study|Withdrawal by Subject|0|||
145370830|NCT03320850|524206577|FG003|Overall Study|Withdrawal by Subject|0|||
145370831|NCT03320850|524206578|FG004|Overall Study|Withdrawal by Subject|1|||
145370832|NCT03320850|524206579|FG005|Overall Study|Withdrawal by Subject|2|||
145579040|NCT02460224|524973789|FG021|Overall Study|Subject/guardian decision|1|||
145370833|NCT03320850|524206580|FG006|Overall Study|Withdrawal by Subject|4|||
145370834|NCT03320850|524206581|FG007|Overall Study|Withdrawal by Subject|5|||
145370835|NCT03320850|524206582|FG008|Overall Study|Withdrawal by Subject|2|||
145370836|NCT03320850|524206583|FG009|Overall Study|Withdrawal by Subject|1|||
145370837|NCT03320850|524206574|FG000|Overall Study|Lack of Efficacy|0|||
145370838|NCT03320850|524206575|FG001|Overall Study|Lack of Efficacy|0|||
145370839|NCT03320850|524206576|FG002|Overall Study|Lack of Efficacy|0|||
145370840|NCT03320850|524206577|FG003|Overall Study|Lack of Efficacy|1|||
145370841|NCT03320850|524206578|FG004|Overall Study|Lack of Efficacy|0|||
145370842|NCT03320850|524206579|FG005|Overall Study|Lack of Efficacy|1|||
145370843|NCT03320850|524206580|FG006|Overall Study|Lack of Efficacy|0|||
145370844|NCT03320850|524206581|FG007|Overall Study|Lack of Efficacy|2|||
145370845|NCT03320850|524206582|FG008|Overall Study|Lack of Efficacy|0|||
145370846|NCT03320850|524206583|FG009|Overall Study|Lack of Efficacy|3|||
145370847|NCT03320850|524206574|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145370848|NCT03320850|524206575|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145370849|NCT03320850|524206576|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145370850|NCT03320850|524206577|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
145370851|NCT03320850|524206578|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
145370852|NCT03320850|524206579|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
145370853|NCT03320850|524206580|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
145370854|NCT03320850|524206581|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
145370855|NCT03320850|524206582|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
145370856|NCT03320850|524206583|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
145370857|NCT03320850|524206574|FG000|Overall Study|Adverse Event|0|||
145370858|NCT03320850|524206575|FG001|Overall Study|Adverse Event|0|||
145370859|NCT03320850|524206576|FG002|Overall Study|Adverse Event|0|||
145370860|NCT03320850|524206577|FG003|Overall Study|Adverse Event|0|||
145370861|NCT03320850|524206578|FG004|Overall Study|Adverse Event|0|||
145370862|NCT03320850|524206579|FG005|Overall Study|Adverse Event|2|||
145370863|NCT03320850|524206580|FG006|Overall Study|Adverse Event|1|||
145370864|NCT03320850|524206581|FG007|Overall Study|Adverse Event|0|||
145370865|NCT03320850|524206582|FG008|Overall Study|Adverse Event|2|||
145370866|NCT03320850|524206583|FG009|Overall Study|Adverse Event|0|||
145370867|NCT03320850|524206574|FG000|Overall Study|Reason Not Specified|0|||
145370868|NCT03320850|524206575|FG001|Overall Study|Reason Not Specified|0|||
145370869|NCT03320850|524206576|FG002|Overall Study|Reason Not Specified|0|||
145370870|NCT03320850|524206577|FG003|Overall Study|Reason Not Specified|0|||
145370871|NCT03320850|524206578|FG004|Overall Study|Reason Not Specified|0|||
145370872|NCT03320850|524206579|FG005|Overall Study|Reason Not Specified|1|||
145370873|NCT03320850|524206580|FG006|Overall Study|Reason Not Specified|0|||
145370874|NCT03320850|524206581|FG007|Overall Study|Reason Not Specified|0|||
145370875|NCT03320850|524206582|FG008|Overall Study|Reason Not Specified|0|||
145370876|NCT03320850|524206583|FG009|Overall Study|Reason Not Specified|1|||
145370877|NCT01424514|524206590|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
145370878|NCT01424514|524206591|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
145370879|NCT01424514|524206590|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
145370880|NCT01424514|524206591|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
145370881|NCT01286168|524206592|FG000|Overall Study|Withdrawal by Subject|1|||
145370882|NCT01286168|524206592|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
145370883|NCT02002533|524206595|FG000|Overall Study|Withdrawal by Subject|6|||
145370884|NCT02002533|524206596|FG001|Overall Study|Withdrawal by Subject|13|||
145370885|NCT02002533|524206595|FG000|Overall Study|Protocol Violation|0|||
145370886|NCT02002533|524206596|FG001|Overall Study|Protocol Violation|1|||
145370887|NCT02002533|524206595|FG000|Overall Study|Adverse Event|0|||
145370888|NCT02002533|524206596|FG001|Overall Study|Adverse Event|3|||
145370889|NCT02002533|524206595|FG000|Overall Study|Lost to Follow-up|0|||
145370890|NCT02002533|524206596|FG001|Overall Study|Lost to Follow-up|1|||
145370891|NCT04598451|524206597|FG000|Overall Study|Adverse Event|3|||
145370892|NCT04598451|524206598|FG001|Overall Study|Adverse Event|2|||
145370893|NCT04598451|524206597|FG000|Overall Study|Withdrawal by Subject|3|||
145370894|NCT04598451|524206598|FG001|Overall Study|Withdrawal by Subject|7|||
145370895|NCT04598451|524206597|FG000|Overall Study|Lost to Follow-up|2|||
145579041|NCT02460224|524973790|FG022|Overall Study|Subject/guardian decision|0|||
145370896|NCT04598451|524206598|FG001|Overall Study|Lost to Follow-up|0|||
145370897|NCT04598451|524206597|FG000|Overall Study|Physician Decision|4|||
145370898|NCT04598451|524206598|FG001|Overall Study|Physician Decision|1|||
145370899|NCT04598451|524206597|FG000|Overall Study|Requires Prohibited Medication|1|||
145370900|NCT04598451|524206598|FG001|Overall Study|Requires Prohibited Medication|0|||
145370901|NCT04598451|524206597|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
145370902|NCT04598451|524206598|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
145579042|NCT02460224|524973791|FG023|Overall Study|Subject/guardian decision|0|||
145370903|NCT02653170|524206599|FG000|Overall Study|Withdrawal by Subject|3|||
145422736|NCT04008069|524404200|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
145422737|NCT04008069|524404201|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
145422738|NCT04008069|524404202|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
145422739|NCT04008069|524404200|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
145422740|NCT04008069|524404201|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
145422741|NCT04008069|524404202|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
145422742|NCT00511199|524404204|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
145422743|NCT00511199|524404205|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
145422744|NCT00511199|524404204|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
145422745|NCT00511199|524404205|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
145422746|NCT00511199|524404204|FG000|Overall Study|Withdrawal of Informed Consent|19|||
145422747|NCT00511199|524404205|FG001|Overall Study|Withdrawal of Informed Consent|4|||
145422748|NCT00511199|524404204|FG000|Overall Study|Pregnancy|6|||
145422749|NCT00511199|524404205|FG001|Overall Study|Pregnancy|3|||
145422750|NCT00511199|524404204|FG000|Overall Study|Pregnancy Wish|16|||
145422751|NCT00511199|524404205|FG001|Overall Study|Pregnancy Wish|8|||
145422752|NCT00511199|524404204|FG000|Overall Study|Lost to Follow-up|40|||
145422753|NCT00511199|524404205|FG001|Overall Study|Lost to Follow-up|17|||
145422754|NCT00511199|524404204|FG000|Overall Study|Other Reason|78|||
145422755|NCT00511199|524404205|FG001|Overall Study|Other Reason|37|||
145422756|NCT02571244|524404206|FG000|Overall Study|Lost to Follow-up|0|||
145422757|NCT02571244|524404207|FG001|Overall Study|Lost to Follow-up|1|||
145422758|NCT02571244|524404206|FG000|Overall Study|Unable to reach out post discharge|3|||
145422759|NCT02571244|524404207|FG001|Overall Study|Unable to reach out post discharge|0|||
145422760|NCT01687595|524404208|FG000|Overall Study|Withdrawal by Subject|8|||
145422761|NCT01687595|524404209|FG001|Overall Study|Withdrawal by Subject|0|||
145422762|NCT01687595|524404208|FG000|Overall Study|Lost to Follow-up|3|||
145422763|NCT01687595|524404209|FG001|Overall Study|Lost to Follow-up|1|||
145422764|NCT01687595|524404208|FG000|Overall Study|Investigator's decision|1|||
145422765|NCT01687595|524404209|FG001|Overall Study|Investigator's decision|0|||
145422766|NCT01687595|524404208|FG000|Overall Study|Sponsor's decision|1|||
145422767|NCT01687595|524404209|FG001|Overall Study|Sponsor's decision|0|||
145422768|NCT01687595|524404208|FG000|Overall Study|Noncompliance|1|||
145422769|NCT01687595|524404209|FG001|Overall Study|Noncompliance|2|||
145370904|NCT02653170|524206600|FG001|Overall Study|Withdrawal by Subject|8|||
145370905|NCT02653170|524206601|FG002|Overall Study|Withdrawal by Subject|3|||
145370906|NCT02653170|524206599|FG000|Overall Study|withdrawn by study team|2|||
145370907|NCT02653170|524206600|FG001|Overall Study|withdrawn by study team|4|||
145370908|NCT02653170|524206601|FG002|Overall Study|withdrawn by study team|5|||
145370909|NCT02653170|524206599|FG000|Overall Study|Lost to Follow-up|12|||
145370910|NCT02653170|524206600|FG001|Overall Study|Lost to Follow-up|4|||
145370911|NCT02653170|524206601|FG002|Overall Study|Lost to Follow-up|10|||
145370912|NCT02086448|524206607|FG000|Overall Study|Withdrawal by Subject|1|||
145579043|NCT02460224|524973792|FG024|Overall Study|Subject/guardian decision|0|||
145579044|NCT02460224|524973793|FG025|Overall Study|Subject/guardian decision|0|||
145370913|NCT02086448|524206608|FG001|Overall Study|Withdrawal by Subject|0|||
145370914|NCT02086448|524206609|FG002|Overall Study|Withdrawal by Subject|0|||
145370915|NCT02086448|524206610|FG003|Overall Study|Withdrawal by Subject|2|||
145370916|NCT01482065|524206633|FG000|Overall Study|Withdrawal by Subject|0|||
145370917|NCT01482065|524206634|FG001|Overall Study|Withdrawal by Subject|1|||
145370918|NCT01942486|524206635|FG000|Overall Study|Lost to Follow-up|27|||
145370919|NCT03728426|524206636|FG000|Overall Study|Death|3|||
145370920|NCT00231114|524206637|FG000|Randomized|Withdrawal by Subject|6|||
145370921|NCT00231114|524206638|FG001|Randomized|Withdrawal by Subject|3|||
145370922|NCT00231114|524206637|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
145422770|NCT01687595|524404208|FG000|Overall Study|Other than specified|56|||
145422771|NCT01687595|524404209|FG001|Overall Study|Other than specified|7|||
145422772|NCT00489359|524404210|FG000|Overall Study|Death|0|||
145422773|NCT00489359|524404211|FG001|Overall Study|Death|2|||
145422774|NCT00489359|524404210|FG000|Overall Study|Progressive Disease|5|||
145579045|NCT02460224|524973794|FG026|Overall Study|Subject/guardian decision|6|||
145579046|NCT02460224|524973795|FG027|Overall Study|Subject/guardian decision|2|||
145370923|NCT00231114|524206638|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
145370924|NCT00231114|524206637|FG000|Post-Treatment Period|Lost to Follow-up|6|||
145370925|NCT00231114|524206638|FG001|Post-Treatment Period|Lost to Follow-up|1|||
145370926|NCT00231114|524206637|FG000|Post-Treatment Period|Physician Decision|1|||
145370927|NCT00231114|524206638|FG001|Post-Treatment Period|Physician Decision|0|||
145370928|NCT00231114|524206637|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
145370929|NCT00231114|524206638|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
145370930|NCT02005692|524206639|FG000|Overall Study|Protocol Violation|1|||
145422775|NCT00489359|524404211|FG001|Overall Study|Progressive Disease|6|||
145422776|NCT00489359|524404210|FG000|Overall Study|Lost to Follow-up|1|||
145422777|NCT00489359|524404211|FG001|Overall Study|Lost to Follow-up|0|||
145422778|NCT00489359|524404210|FG000|Overall Study|Withdrawal by Subject|1|||
145422779|NCT00489359|524404211|FG001|Overall Study|Withdrawal by Subject|5|||
145422780|NCT00489359|524404210|FG000|Overall Study|Adverse Event|0|||
145370931|NCT02005692|524206639|FG000|Overall Study|Withdrawal by Subject|1|||
145370932|NCT02005692|524206639|FG000|Overall Study|Discharged earlier than anticipated|5|||
145370933|NCT01194999|524206640|FG000|Overall Study|Lost to Follow-up|17|||
145370934|NCT05139303|524206641|FG000|Overall Study|Lost to Follow-up|3|||
145370935|NCT05139303|524206642|FG001|Overall Study|Lost to Follow-up|0|||
145370936|NCT05139303|524206641|FG000|Overall Study|Adverse Event|1|||
145370937|NCT05139303|524206642|FG001|Overall Study|Adverse Event|0|||
145370938|NCT00507819|524206645|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
145370939|NCT00507819|524206646|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
145370940|NCT03261674|524206649|FG000|Overall Study|Lost to Follow-up|6|||
145370941|NCT03261674|524206650|FG001|Overall Study|Lost to Follow-up|7|||
145370942|NCT03261674|524206649|FG000|Overall Study|Protocol Violation|1|||
145370943|NCT03261674|524206650|FG001|Overall Study|Protocol Violation|4|||
145370944|NCT03261674|524206649|FG000|Overall Study|Withdrawal by Subject|1|||
145370945|NCT03261674|524206650|FG001|Overall Study|Withdrawal by Subject|4|||
145370946|NCT03261674|524206649|FG000|Overall Study|Physician Decision|1|||
145370947|NCT03261674|524206650|FG001|Overall Study|Physician Decision|0|||
145370948|NCT01075646|524206653|FG000|Overall Study|Lost to Follow-up|4|||
145370949|NCT01075646|524206654|FG001|Overall Study|Lost to Follow-up|3|||
145370950|NCT01075646|524206655|FG002|Overall Study|Lost to Follow-up|1|||
145370951|NCT01075646|524206656|FG003|Overall Study|Lost to Follow-up|2|||
145370952|NCT00732758|524206657|FG000|Overall Study|Lost to Follow-up|8|||
145370953|NCT00732758|524206658|FG001|Overall Study|Lost to Follow-up|16|||
145370954|NCT01552915|524206659|FG000|Overall Study|Adverse Event|3|||
145370955|NCT01552915|524206660|FG001|Overall Study|Adverse Event|14|||
145370956|NCT01552915|524206661|FG002|Overall Study|Adverse Event|3|||
145370957|NCT01552915|524206659|FG000|Overall Study|Lost to Follow-up|4|||
145370958|NCT01552915|524206660|FG001|Overall Study|Lost to Follow-up|6|||
145370959|NCT01552915|524206661|FG002|Overall Study|Lost to Follow-up|5|||
145370960|NCT01552915|524206659|FG000|Overall Study|Withdrawal by Subject|6|||
145370961|NCT01552915|524206660|FG001|Overall Study|Withdrawal by Subject|4|||
145370962|NCT01552915|524206661|FG002|Overall Study|Withdrawal by Subject|5|||
145370963|NCT01552915|524206659|FG000|Overall Study|Protocol Violation|0|||
145370964|NCT01552915|524206660|FG001|Overall Study|Protocol Violation|4|||
145370965|NCT01552915|524206661|FG002|Overall Study|Protocol Violation|4|||
145370966|NCT01552915|524206659|FG000|Overall Study|Lack of Efficacy|8|||
145370967|NCT01552915|524206660|FG001|Overall Study|Lack of Efficacy|1|||
145370968|NCT01552915|524206661|FG002|Overall Study|Lack of Efficacy|4|||
145370969|NCT01552915|524206659|FG000|Overall Study|Other|2|||
145370970|NCT01552915|524206660|FG001|Overall Study|Other|0|||
145370971|NCT01552915|524206661|FG002|Overall Study|Other|6|||
145370972|NCT00844480|524206665|FG000|Overall Study|Withdrawal by Subject|2|||
145370973|NCT00844480|524206666|FG001|Overall Study|Withdrawal by Subject|3|||
145370974|NCT02858180|524206667|FG000|Overall Study|Lost to Follow-up|0|||
145370975|NCT02858180|524206668|FG001|Overall Study|Lost to Follow-up|2|||
145370976|NCT00979420|524206669|FG000|Overall Study|Adverse Event|1|||
145370977|NCT00979420|524206670|FG001|Overall Study|Adverse Event|0|||
145370978|NCT00979420|524206671|FG002|Overall Study|Adverse Event|0|||
145370979|NCT00979420|524206672|FG003|Overall Study|Adverse Event|0|||
145370980|NCT00979420|524206669|FG000|Overall Study|Lack of Efficacy|3|||
145370981|NCT00979420|524206670|FG001|Overall Study|Lack of Efficacy|0|||
145370982|NCT00979420|524206671|FG002|Overall Study|Lack of Efficacy|1|||
145370983|NCT00979420|524206672|FG003|Overall Study|Lack of Efficacy|1|||
145370984|NCT00979420|524206669|FG000|Overall Study|Other reasons not related to Viramune|3|||
145370985|NCT00979420|524206670|FG001|Overall Study|Other reasons not related to Viramune|0|||
145370986|NCT00979420|524206671|FG002|Overall Study|Other reasons not related to Viramune|0|||
145370987|NCT00979420|524206672|FG003|Overall Study|Other reasons not related to Viramune|1|||
145370988|NCT00319592|524206676|FG000|Overall Study|Protocol Violation|1|||
145370989|NCT00319592|524206677|FG001|Overall Study|Protocol Violation|0|||
145370990|NCT00319592|524206676|FG000|Overall Study|Physician Decision|0|||
145370991|NCT00319592|524206677|FG001|Overall Study|Physician Decision|1|||
145370992|NCT02572076|524206678|FG000|Overall Study|Protocol Violation|1|||
145370993|NCT01273623|524206685|FG000|Overall Study|did not meet IVUS criteria|29|||
145370994|NCT00519428|524206688|FG000|Overall Study|Adverse Event|5|||
145370995|NCT00519428|524206689|FG001|Overall Study|Adverse Event|2|||
145370996|NCT00519428|524206690|FG002|Overall Study|Adverse Event|10|||
145370997|NCT00519428|524206688|FG000|Overall Study|Lost to Follow-up|7|||
145370998|NCT00519428|524206689|FG001|Overall Study|Lost to Follow-up|7|||
145370999|NCT00519428|524206690|FG002|Overall Study|Lost to Follow-up|6|||
145371000|NCT00519428|524206688|FG000|Overall Study|Withdrawal by Subject|8|||
145371001|NCT00519428|524206689|FG001|Overall Study|Withdrawal by Subject|3|||
145371002|NCT00519428|524206690|FG002|Overall Study|Withdrawal by Subject|7|||
145371003|NCT00519428|524206688|FG000|Overall Study|unstated|1|||
145371004|NCT00519428|524206689|FG001|Overall Study|unstated|3|||
145371005|NCT00519428|524206690|FG002|Overall Study|unstated|2|||
145371006|NCT04064411|524206691|FG000|Overall Study|Adverse Event|29|||
145371007|NCT04064411|524206692|FG001|Overall Study|Adverse Event|19|||
145371008|NCT04064411|524206691|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
145422781|NCT00489359|524404211|FG001|Overall Study|Adverse Event|16|||
145579047|NCT02460224|524973796|FG028|Overall Study|Subject/guardian decision|3|||
145579048|NCT03146650|524973797|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
145579049|NCT03146650|524973797|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
145579050|NCT03146650|524973797|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
145579051|NCT03146650|524973797|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
145579052|NCT03146650|524973797|FG000|2 Year Follow-up|Death|11|||
145579053|NCT03146650|524973797|FG000|2 Year Follow-up|Still in follow-up|7|||
145579054|NCT03146650|524973797|FG000|2 Year Follow-up|Lost to Follow-up|1|||
145579055|NCT02517905|524973798|FG000|Overall Study|Lost to Follow-up|4|||
145371009|NCT04064411|524206692|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
145371010|NCT04064411|524206691|FG000|Overall Study|Protocol Deviation|0|||
145371011|NCT04064411|524206692|FG001|Overall Study|Protocol Deviation|2|||
145371012|NCT04064411|524206691|FG000|Overall Study|Withdrawal by Subject|25|||
145371013|NCT04064411|524206692|FG001|Overall Study|Withdrawal by Subject|29|||
145371014|NCT04064411|524206691|FG000|Overall Study|Lost to Follow-up|5|||
145371015|NCT04064411|524206692|FG001|Overall Study|Lost to Follow-up|2|||
145371016|NCT04064411|524206691|FG000|Overall Study|Other than Specified|4|||
145371017|NCT04064411|524206692|FG001|Overall Study|Other than Specified|1|||
145371018|NCT04064411|524206691|FG000|Overall Study|Death|1|||
145371019|NCT04064411|524206692|FG001|Overall Study|Death|0|||
145371020|NCT03053063|524206693|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
145371021|NCT03053063|524206694|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
145371022|NCT03053063|524206695|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
145371023|NCT03053063|524206696|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
145371024|NCT03053063|524206693|FG000|Randomized Phase|Withdrew consent|8|||
145371025|NCT03053063|524206694|FG001|Randomized Phase|Withdrew consent|11|||
145371026|NCT03053063|524206695|FG002|Randomized Phase|Withdrew consent|5|||
145371027|NCT03053063|524206696|FG003|Randomized Phase|Withdrew consent|0|||
145371028|NCT03053063|524206693|FG000|Randomized Phase|Investigator's Discretion|8|||
145371029|NCT03053063|524206694|FG001|Randomized Phase|Investigator's Discretion|6|||
145371030|NCT03053063|524206695|FG002|Randomized Phase|Investigator's Discretion|2|||
145371031|NCT03053063|524206696|FG003|Randomized Phase|Investigator's Discretion|0|||
145371032|NCT03053063|524206693|FG000|Randomized Phase|Lost to Follow-up|3|||
145371033|NCT03053063|524206694|FG001|Randomized Phase|Lost to Follow-up|5|||
145371034|NCT03053063|524206695|FG002|Randomized Phase|Lost to Follow-up|1|||
145371035|NCT03053063|524206696|FG003|Randomized Phase|Lost to Follow-up|0|||
145371036|NCT03053063|524206693|FG000|Randomized Phase|Adverse Event|0|||
145371037|NCT03053063|524206694|FG001|Randomized Phase|Adverse Event|1|||
145371038|NCT03053063|524206695|FG002|Randomized Phase|Adverse Event|0|||
145371039|NCT03053063|524206696|FG003|Randomized Phase|Adverse Event|0|||
145371040|NCT03053063|524206693|FG000|Randomized Phase|Randomized but Never Treated|1|||
145371041|NCT03053063|524206694|FG001|Randomized Phase|Randomized but Never Treated|3|||
145371042|NCT03053063|524206695|FG002|Randomized Phase|Randomized but Never Treated|2|||
145371043|NCT03053063|524206696|FG003|Randomized Phase|Randomized but Never Treated|0|||
145371044|NCT03053063|524206693|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
145371045|NCT03053063|524206694|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
145371046|NCT03053063|524206695|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
145371047|NCT03053063|524206696|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
145371048|NCT03053063|524206693|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
145371049|NCT03053063|524206694|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
145371050|NCT03053063|524206695|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
145371051|NCT03053063|524206696|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
145371052|NCT03053063|524206693|FG000|Open-Label Phase|Death|0|||
145371053|NCT03053063|524206694|FG001|Open-Label Phase|Death|0|||
145371054|NCT03053063|524206695|FG002|Open-Label Phase|Death|0|||
145371055|NCT03053063|524206696|FG003|Open-Label Phase|Death|2|||
145371056|NCT03053063|524206693|FG000|Open-Label Phase|Investigator's discretion|0|||
145371057|NCT03053063|524206694|FG001|Open-Label Phase|Investigator's discretion|0|||
145371058|NCT03053063|524206695|FG002|Open-Label Phase|Investigator's discretion|0|||
145371059|NCT03053063|524206696|FG003|Open-Label Phase|Investigator's discretion|2|||
145371060|NCT05033262|524206698|FG000|Overall Study|Lost to Follow-up|1|||
145371061|NCT05033262|524206699|FG001|Overall Study|Lost to Follow-up|0|||
145371062|NCT05033262|524206700|FG002|Overall Study|Lost to Follow-up|0|||
145371063|NCT05033262|524206701|FG003|Overall Study|Lost to Follow-up|1|||
145371064|NCT05270395|524206702|FG000|Overall Study|Lost to Follow-up|2|||
145371065|NCT05270395|524206703|FG001|Overall Study|Lost to Follow-up|2|||
145371066|NCT05270395|524206702|FG000|Overall Study|Death|1|||
145371067|NCT05270395|524206703|FG001|Overall Study|Death|2|||
145371068|NCT05270395|524206702|FG000|Overall Study|Study Team Withdrew|1|||
145371069|NCT05270395|524206703|FG001|Overall Study|Study Team Withdrew|0|||
145371070|NCT00860249|524209011|FG000|Overall Study|trial was terminated prior to completion|21|||
145371071|NCT00860249|524209012|FG001|Overall Study|trial was terminated prior to completion|18|||
145371072|NCT00860249|524209013|FG002|Overall Study|trial was terminated prior to completion|21|||
145579056|NCT02517905|524973799|FG001|Overall Study|Lost to Follow-up|0|||
145371073|NCT00743288|524209014|FG000|Overall Study|Adverse Event|1|||
145371074|NCT00743288|524209015|FG001|Overall Study|Adverse Event|1|||
145371075|NCT00743288|524209016|FG002|Overall Study|Adverse Event|2|||
145371076|NCT00743288|524209017|FG003|Overall Study|Adverse Event|2|||
145371077|NCT00743288|524209018|FG004|Overall Study|Adverse Event|1|||
145371078|NCT00743288|524209019|FG005|Overall Study|Adverse Event|1|||
145371079|NCT00743288|524209020|FG006|Overall Study|Adverse Event|2|||
145371080|NCT00743288|524209014|FG000|Overall Study|Withdrawal by Subject|0|||
145371081|NCT00743288|524209015|FG001|Overall Study|Withdrawal by Subject|0|||
145371082|NCT00743288|524209016|FG002|Overall Study|Withdrawal by Subject|1|||
145371083|NCT00743288|524209017|FG003|Overall Study|Withdrawal by Subject|0|||
145371084|NCT00743288|524209018|FG004|Overall Study|Withdrawal by Subject|0|||
145371085|NCT00743288|524209019|FG005|Overall Study|Withdrawal by Subject|1|||
145371086|NCT00743288|524209020|FG006|Overall Study|Withdrawal by Subject|1|||
145371087|NCT00743288|524209014|FG000|Overall Study|Progressive disease (PD)|2|||
145371088|NCT00743288|524209015|FG001|Overall Study|Progressive disease (PD)|0|||
145371089|NCT00743288|524209016|FG002|Overall Study|Progressive disease (PD)|1|||
145371090|NCT00743288|524209017|FG003|Overall Study|Progressive disease (PD)|4|||
145371091|NCT00743288|524209018|FG004|Overall Study|Progressive disease (PD)|5|||
145371092|NCT00743288|524209019|FG005|Overall Study|Progressive disease (PD)|3|||
145371093|NCT00743288|524209020|FG006|Overall Study|Progressive disease (PD)|6|||
145371094|NCT00743288|524209014|FG000|Overall Study|Worsening of condition (Not PD)|0|||
145371095|NCT00743288|524209015|FG001|Overall Study|Worsening of condition (Not PD)|2|||
145371096|NCT00743288|524209016|FG002|Overall Study|Worsening of condition (Not PD)|1|||
145371097|NCT00743288|524209017|FG003|Overall Study|Worsening of condition (Not PD)|1|||
145371098|NCT00743288|524209018|FG004|Overall Study|Worsening of condition (Not PD)|0|||
145371099|NCT00743288|524209019|FG005|Overall Study|Worsening of condition (Not PD)|0|||
145371100|NCT00743288|524209020|FG006|Overall Study|Worsening of condition (Not PD)|0|||
145371101|NCT05903924|524209021|FG000|Overall Study|Lost to Follow-up|1|||
145371102|NCT05903924|524209022|FG001|Overall Study|Lost to Follow-up|0|||
145371103|NCT05903924|524209023|FG002|Overall Study|Lost to Follow-up|0|||
145371104|NCT00688701|524209024|FG000|Overall Study|Adverse Event|1|||
145371105|NCT00688701|524209025|FG001|Overall Study|Adverse Event|0|||
145371106|NCT00688701|524209026|FG002|Overall Study|Adverse Event|5|||
145371107|NCT00688701|524209027|FG003|Overall Study|Adverse Event|3|||
145371108|NCT00688701|524209024|FG000|Overall Study|Lack of Efficacy|0|||
145371109|NCT00688701|524209025|FG001|Overall Study|Lack of Efficacy|1|||
145371110|NCT00688701|524209026|FG002|Overall Study|Lack of Efficacy|0|||
145371111|NCT00688701|524209027|FG003|Overall Study|Lack of Efficacy|0|||
145371112|NCT00688701|524209024|FG000|Overall Study|Withdrawal by Subject|3|||
145371113|NCT00688701|524209025|FG001|Overall Study|Withdrawal by Subject|3|||
145371114|NCT00688701|524209026|FG002|Overall Study|Withdrawal by Subject|4|||
145371115|NCT00688701|524209027|FG003|Overall Study|Withdrawal by Subject|8|||
145371116|NCT00688701|524209024|FG000|Overall Study|Poor compliance to protocol|0|||
145371117|NCT00688701|524209025|FG001|Overall Study|Poor compliance to protocol|1|||
145371118|NCT00688701|524209026|FG002|Overall Study|Poor compliance to protocol|1|||
145371119|NCT00688701|524209027|FG003|Overall Study|Poor compliance to protocol|0|||
145371120|NCT03917472|524209037|FG000|Overall Study|Physician Decision|4|||
145371121|NCT03917472|524209038|FG001|Overall Study|Physician Decision|0|||
145371122|NCT03917472|524209037|FG000|Overall Study|Adverse Event|3|||
145371123|NCT03917472|524209038|FG001|Overall Study|Adverse Event|1|||
145371124|NCT03917472|524209037|FG000|Overall Study|Death|7|||
145371125|NCT03917472|524209038|FG001|Overall Study|Death|5|||
145371126|NCT03917472|524209037|FG000|Overall Study|Withdrawal by Subject|11|||
145371127|NCT03917472|524209038|FG001|Overall Study|Withdrawal by Subject|4|||
145371128|NCT03917472|524209037|FG000|Overall Study|Lost to Follow-up|10|||
145371129|NCT03917472|524209038|FG001|Overall Study|Lost to Follow-up|5|||
145371130|NCT02706886|524209039|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
145371131|NCT02706886|524209040|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
145371132|NCT02706886|524209041|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
145371133|NCT02706886|524209042|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
145371134|NCT02706886|524209043|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
145371135|NCT02706886|524209044|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
145371136|NCT02706886|524209045|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
145371137|NCT02706886|524209046|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
145371138|NCT02706886|524209047|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
145371139|NCT02759055|524209048|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
145371140|NCT02759055|524209049|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
145422782|NCT03180138|524404212|FG000|Overall Study|Mobile-phone could not be verified|2|||
145371141|NCT04934189|524209050|FG000|Overall Study|Lost to Follow-up|4|||
145371142|NCT04934189|524209050|FG000|Overall Study|Withdrawal by Subject|17|||
145371143|NCT02487771|524209052|FG000|Overall Study|Lost to Follow-up|2|||
145371144|NCT02487771|524209053|FG001|Overall Study|Lost to Follow-up|3|||
145371145|NCT02487771|524209052|FG000|Overall Study|Moved out of area|5|||
145371146|NCT02487771|524209053|FG001|Overall Study|Moved out of area|6|||
145371147|NCT02487771|524209052|FG000|Overall Study|Withdrawal by Subject|3|||
145422783|NCT03180138|524404213|FG001|Overall Study|Mobile-phone could not be verified|13|||
145422784|NCT03180138|524404214|FG002|Overall Study|Mobile-phone could not be verified|15|||
145422785|NCT03180138|524404212|FG000|Overall Study|No prior immunization records|17|||
145422786|NCT03180138|524404213|FG001|Overall Study|No prior immunization records|0|||
145422787|NCT03180138|524404214|FG002|Overall Study|No prior immunization records|6|||
145422788|NCT03180138|524404212|FG000|Overall Study|Found to be >24 mon after randomization|3|||
145422789|NCT03180138|524404213|FG001|Overall Study|Found to be >24 mon after randomization|0|||
145422790|NCT03180138|524404214|FG002|Overall Study|Found to be >24 mon after randomization|3|||
145422791|NCT04191733|524404216|FG000|Overall Study|Withdrawn due to study closure|13|||
145422792|NCT04191733|524404217|FG001|Overall Study|Withdrawn due to study closure|14|||
145422793|NCT04191733|524404216|FG000|Overall Study|Withdrawal by Subject|2|||
145422794|NCT04191733|524404217|FG001|Overall Study|Withdrawal by Subject|4|||
145422795|NCT04191733|524404216|FG000|Overall Study|Physician Decision|1|||
145422796|NCT04191733|524404217|FG001|Overall Study|Physician Decision|1|||
145422797|NCT04191733|524404216|FG000|Overall Study|Lost to Follow-up|5|||
145422798|NCT04191733|524404217|FG001|Overall Study|Lost to Follow-up|6|||
145422799|NCT04191733|524404216|FG000|Overall Study|Death|0|||
145422800|NCT04191733|524404217|FG001|Overall Study|Death|1|||
145422801|NCT01903733|524404218|FG000|Overall Study|Death|23|||
145422802|NCT01903733|524404219|FG001|Overall Study|Death|54|||
145579057|NCT02517905|524973798|FG000|Overall Study|Withdrawal by Subject|4|||
145579058|NCT02517905|524973799|FG001|Overall Study|Withdrawal by Subject|0|||
145579059|NCT02517905|524973798|FG000|Overall Study|Screen failure|2|||
145579060|NCT02517905|524973799|FG001|Overall Study|Screen failure|2|||
145579061|NCT01755416|524973802|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
145579062|NCT01755416|524973803|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
145579063|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
145422803|NCT01903733|524404220|FG002|Overall Study|Death|30|||
145422804|NCT01903733|524404221|FG003|Overall Study|Death|98|||
145422805|NCT01903733|524404218|FG000|Overall Study|Participant refused further follow-up|35|||
145422806|NCT01903733|524404219|FG001|Overall Study|Participant refused further follow-up|38|||
145422807|NCT01903733|524404220|FG002|Overall Study|Participant refused further follow-up|13|||
145422808|NCT01903733|524404221|FG003|Overall Study|Participant refused further follow-up|9|||
145422809|NCT01903733|524404218|FG000|Overall Study|Lost to Follow-up|18|||
145579064|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
145579065|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
145579066|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Death|1|||
145579067|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Death|0|||
145579068|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Death|0|||
145579069|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
145579070|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
145579071|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
145579072|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
145579073|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
145579074|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
145579075|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
145579076|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
145579077|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
145579078|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
145579079|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
145579080|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
145579081|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
145579082|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
145579083|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
145579084|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
145579085|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
145579086|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
145422810|NCT01903733|524404219|FG001|Overall Study|Lost to Follow-up|19|||
145422811|NCT01903733|524404220|FG002|Overall Study|Lost to Follow-up|6|||
145422812|NCT01903733|524404221|FG003|Overall Study|Lost to Follow-up|9|||
145422813|NCT01903733|524404218|FG000|Overall Study|Other|10|||
145422814|NCT01903733|524404219|FG001|Overall Study|Other|15|||
145422815|NCT01903733|524404220|FG002|Overall Study|Other|12|||
145422816|NCT01903733|524404221|FG003|Overall Study|Other|3|||
145422817|NCT01903733|524404218|FG000|Overall Study|Missing|2|||
145422818|NCT01903733|524404219|FG001|Overall Study|Missing|0|||
145422819|NCT01903733|524404220|FG002|Overall Study|Missing|0|||
145422820|NCT01903733|524404221|FG003|Overall Study|Missing|0|||
145422821|NCT01903733|524404218|FG000|Overall Study|Investigator request|18|||
145422822|NCT01903733|524404219|FG001|Overall Study|Investigator request|0|||
145422823|NCT01903733|524404220|FG002|Overall Study|Investigator request|0|||
145371148|NCT02487771|524209053|FG001|Overall Study|Withdrawal by Subject|5|||
145371149|NCT01871402|524209054|FG000|Overall Study|Lost to Follow-up|1|||
145371150|NCT01871402|524209055|FG001|Overall Study|Lost to Follow-up|0|||
145371151|NCT01871402|524209054|FG000|Overall Study|Withdrawal by Subject|0|||
145371152|NCT01871402|524209055|FG001|Overall Study|Withdrawal by Subject|2|||
145371153|NCT01871402|524209054|FG000|Overall Study|Non-compliance|0|||
145371154|NCT01871402|524209055|FG001|Overall Study|Non-compliance|1|||
145371155|NCT04594941|524209056|FG000|Overall Study|Other|0|||
145371156|NCT04594941|524209057|FG001|Overall Study|Other|3|||
145371157|NCT04594941|524209058|FG002|Overall Study|Other|1|||
145371158|NCT04594941|524209059|FG003|Overall Study|Other|0|||
145371159|NCT01895270|524209062|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
145371160|NCT01895270|524209063|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
145371161|NCT01895270|524209062|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
145371162|NCT01895270|524209063|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
145371163|NCT01895270|524209062|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
145371164|NCT01895270|524209063|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
145371165|NCT01895270|524209062|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
145371166|NCT01895270|524209063|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
145371167|NCT01895270|524209062|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
145371168|NCT01895270|524209063|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
145371169|NCT01895270|524209062|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
145371170|NCT01895270|524209063|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
145371171|NCT01895270|524209062|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
145371172|NCT01895270|524209063|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
145371173|NCT02091375|524209064|FG000|Overall Study|Adverse Event|8|||
145371174|NCT02091375|524209065|FG001|Overall Study|Adverse Event|1|||
145371175|NCT02091375|524209064|FG000|Overall Study|Lost to Follow-up|0|||
145371176|NCT02091375|524209065|FG001|Overall Study|Lost to Follow-up|1|||
145371177|NCT02091375|524209064|FG000|Overall Study|Withdrawal by Subject|0|||
145371178|NCT02091375|524209065|FG001|Overall Study|Withdrawal by Subject|1|||
145371179|NCT02091375|524209064|FG000|Overall Study|Withdrawn by the investigator|1|||
145371180|NCT02091375|524209065|FG001|Overall Study|Withdrawn by the investigator|0|||
145371181|NCT02682823|524209066|FG000|Overall Study|Withdrawal by Subject|0|||
145371182|NCT02682823|524209067|FG001|Overall Study|Withdrawal by Subject|0|||
145371183|NCT02682823|524209068|FG002|Overall Study|Withdrawal by Subject|1|||
145371184|NCT02682823|524209069|FG003|Overall Study|Withdrawal by Subject|0|||
145371185|NCT02682823|524209070|FG004|Overall Study|Withdrawal by Subject|1|||
145371186|NCT02682823|524209066|FG000|Overall Study|Protocol Deviation|0|||
145371187|NCT02682823|524209067|FG001|Overall Study|Protocol Deviation|1|||
145371188|NCT02682823|524209068|FG002|Overall Study|Protocol Deviation|0|||
145422824|NCT01903733|524404221|FG003|Overall Study|Investigator request|0|||
145422825|NCT03878602|524404222|FG000|Overall Study|cord blood donation|7|||
145422826|NCT03878602|524404223|FG001|Overall Study|cord blood donation|1|||
145422827|NCT03878602|524404222|FG000|Overall Study|incomplete data collection|2|||
145422828|NCT03878602|524404223|FG001|Overall Study|incomplete data collection|0|||
145422829|NCT02633527|524404224|FG000|Overall Study|Failed to meet eligibility|0|||
145422830|NCT02633527|524404225|FG001|Overall Study|Failed to meet eligibility|1|||
145422831|NCT02633527|524404226|FG002|Overall Study|Failed to meet eligibility|1|||
145422832|NCT02633527|524404227|FG003|Overall Study|Failed to meet eligibility|0|||
145422833|NCT02633527|524404228|FG004|Overall Study|Failed to meet eligibility|1|||
145422834|NCT02633527|524404224|FG000|Overall Study|Adverse Event|0|||
145422835|NCT02633527|524404225|FG001|Overall Study|Adverse Event|4|||
145422836|NCT02633527|524404226|FG002|Overall Study|Adverse Event|3|||
145422837|NCT02633527|524404227|FG003|Overall Study|Adverse Event|1|||
145422838|NCT02633527|524404228|FG004|Overall Study|Adverse Event|5|||
145422839|NCT02633527|524404224|FG000|Overall Study|Lost to Follow-up|1|||
145422840|NCT02633527|524404225|FG001|Overall Study|Lost to Follow-up|2|||
145422841|NCT02633527|524404226|FG002|Overall Study|Lost to Follow-up|5|||
145422842|NCT02633527|524404227|FG003|Overall Study|Lost to Follow-up|5|||
145422843|NCT02633527|524404228|FG004|Overall Study|Lost to Follow-up|4|||
145422844|NCT02633527|524404224|FG000|Overall Study|Withdrawal by Subject|0|||
145422845|NCT02633527|524404225|FG001|Overall Study|Withdrawal by Subject|3|||
145422846|NCT02633527|524404226|FG002|Overall Study|Withdrawal by Subject|5|||
145422847|NCT02633527|524404227|FG003|Overall Study|Withdrawal by Subject|4|||
145422848|NCT02633527|524404228|FG004|Overall Study|Withdrawal by Subject|4|||
145422849|NCT02633527|524404224|FG000|Overall Study|Protocol Violation|0|||
145422850|NCT02633527|524404225|FG001|Overall Study|Protocol Violation|1|||
145422851|NCT02633527|524404226|FG002|Overall Study|Protocol Violation|1|||
145422852|NCT02633527|524404227|FG003|Overall Study|Protocol Violation|1|||
145422853|NCT02633527|524404228|FG004|Overall Study|Protocol Violation|1|||
145422854|NCT02633527|524404224|FG000|Overall Study|Physician Decision|0|||
145422855|NCT02633527|524404225|FG001|Overall Study|Physician Decision|0|||
145422856|NCT02633527|524404226|FG002|Overall Study|Physician Decision|0|||
145422857|NCT02633527|524404227|FG003|Overall Study|Physician Decision|0|||
145371189|NCT02682823|524209069|FG003|Overall Study|Protocol Deviation|0|||
145579087|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
145579088|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
145579089|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
145579090|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
145579091|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
145579092|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
145579093|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
145579094|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
145579095|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
145579096|NCT03655236|524973804|FG000|Subject Disposition in Part 1 Period|Other|0|||
145579097|NCT03655236|524973805|FG001|Subject Disposition in Part 1 Period|Other|2|||
145579098|NCT03655236|524973806|FG002|Subject Disposition in Part 1 Period|Other|2|||
145579099|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
145579100|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
145371190|NCT02682823|524209070|FG004|Overall Study|Protocol Deviation|0|||
145371191|NCT02682823|524209066|FG000|Overall Study|Adverse Event|0|||
145371192|NCT02682823|524209067|FG001|Overall Study|Adverse Event|0|||
145371193|NCT02682823|524209068|FG002|Overall Study|Adverse Event|0|||
145371194|NCT02682823|524209069|FG003|Overall Study|Adverse Event|1|||
145371195|NCT02682823|524209070|FG004|Overall Study|Adverse Event|0|||
145371196|NCT03781583|524209071|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
145371197|NCT03781583|524209072|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
145371198|NCT03781583|524209073|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
145371199|NCT03781583|524209074|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
145371200|NCT03781583|524209071|FG000|Overall Study|Technology did not work for that person in that environment|1|||
145371201|NCT03781583|524209072|FG001|Overall Study|Technology did not work for that person in that environment|0|||
145371202|NCT03781583|524209073|FG002|Overall Study|Technology did not work for that person in that environment|0|||
145371203|NCT03781583|524209074|FG003|Overall Study|Technology did not work for that person in that environment|0|||
145371204|NCT03781583|524209071|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
145371205|NCT03781583|524209072|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
145371206|NCT03781583|524209073|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
145371207|NCT03781583|524209074|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
145371208|NCT03781583|524209071|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145371209|NCT03781583|524209072|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
145371210|NCT03781583|524209073|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145371211|NCT03781583|524209074|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
145371212|NCT01938430|524209075|FG000|Overall Study|Randomized but Not Treated|0|||
145371213|NCT01938430|524209076|FG001|Overall Study|Randomized but Not Treated|0|||
145371214|NCT01938430|524209077|FG002|Overall Study|Randomized but Not Treated|0|||
145371215|NCT01938430|524209078|FG003|Overall Study|Randomized but Not Treated|0|||
145371216|NCT01938430|524209079|FG004|Overall Study|Randomized but Not Treated|0|||
145371217|NCT01938430|524209080|FG005|Overall Study|Randomized but Not Treated|0|||
145371218|NCT01938430|524209081|FG006|Overall Study|Randomized but Not Treated|0|||
145371219|NCT01938430|524209082|FG007|Overall Study|Randomized but Not Treated|0|||
145371220|NCT01938430|524209083|FG008|Overall Study|Randomized but Not Treated|0|||
145371221|NCT01938430|524209084|FG009|Overall Study|Randomized but Not Treated|0|||
145371222|NCT01938430|524209085|FG010|Overall Study|Randomized but Not Treated|1|||
145371223|NCT01938430|524209086|FG011|Overall Study|Randomized but Not Treated|0|||
145371224|NCT01938430|524209087|FG012|Overall Study|Randomized but Not Treated|0|||
145371225|NCT01938430|524209088|FG013|Overall Study|Randomized but Not Treated|1|||
145371226|NCT01938430|524209075|FG000|Overall Study|Adverse Event|0|||
145371227|NCT01938430|524209076|FG001|Overall Study|Adverse Event|0|||
145371228|NCT01938430|524209077|FG002|Overall Study|Adverse Event|0|||
145371229|NCT01938430|524209078|FG003|Overall Study|Adverse Event|0|||
145371230|NCT01938430|524209079|FG004|Overall Study|Adverse Event|0|||
145371231|NCT01938430|524209080|FG005|Overall Study|Adverse Event|0|||
145371232|NCT01938430|524209081|FG006|Overall Study|Adverse Event|1|||
145371233|NCT01938430|524209082|FG007|Overall Study|Adverse Event|0|||
145371234|NCT01938430|524209083|FG008|Overall Study|Adverse Event|0|||
145371235|NCT01938430|524209084|FG009|Overall Study|Adverse Event|0|||
145371236|NCT01938430|524209085|FG010|Overall Study|Adverse Event|0|||
145371237|NCT01938430|524209086|FG011|Overall Study|Adverse Event|0|||
145371238|NCT01938430|524209087|FG012|Overall Study|Adverse Event|0|||
145371239|NCT01938430|524209088|FG013|Overall Study|Adverse Event|0|||
145371240|NCT01938430|524209075|FG000|Overall Study|Death|1|||
145371241|NCT01938430|524209076|FG001|Overall Study|Death|2|||
145371242|NCT01938430|524209077|FG002|Overall Study|Death|2|||
145422858|NCT02633527|524404228|FG004|Overall Study|Physician Decision|1|||
145422859|NCT02633527|524404224|FG000|Overall Study|Administrative reason|1|||
145422860|NCT02633527|524404225|FG001|Overall Study|Administrative reason|0|||
145422861|NCT02633527|524404226|FG002|Overall Study|Administrative reason|0|||
145422862|NCT02633527|524404227|FG003|Overall Study|Administrative reason|1|||
145422863|NCT02633527|524404228|FG004|Overall Study|Administrative reason|0|||
145422864|NCT02633527|524404224|FG000|Overall Study|Multiple reasons|1|||
145422865|NCT02633527|524404225|FG001|Overall Study|Multiple reasons|0|||
145422866|NCT02633527|524404226|FG002|Overall Study|Multiple reasons|2|||
145422867|NCT02633527|524404227|FG003|Overall Study|Multiple reasons|2|||
145422868|NCT02633527|524404228|FG004|Overall Study|Multiple reasons|1|||
145422869|NCT02191397|524404229|FG000|Overall Study|Adverse Event|28|||
145422870|NCT02191397|524404230|FG001|Overall Study|Adverse Event|17|||
145422871|NCT02191397|524404229|FG000|Overall Study|Lack of Efficacy|10|||
145422872|NCT02191397|524404230|FG001|Overall Study|Lack of Efficacy|5|||
145422873|NCT02191397|524404229|FG000|Overall Study|Protocol Violation|0|||
145422874|NCT02191397|524404230|FG001|Overall Study|Protocol Violation|3|||
145422875|NCT02191397|524404229|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
145422876|NCT02191397|524404230|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
145422877|NCT02191397|524404229|FG000|Overall Study|Lost to Follow-up|10|||
145422878|NCT02191397|524404230|FG001|Overall Study|Lost to Follow-up|11|||
145422879|NCT02191397|524404229|FG000|Overall Study|Physician Decision|8|||
145422880|NCT02191397|524404230|FG001|Overall Study|Physician Decision|3|||
145422881|NCT02191397|524404229|FG000|Overall Study|Withdrawal by Subject|22|||
145422882|NCT02191397|524404230|FG001|Overall Study|Withdrawal by Subject|27|||
145422883|NCT02100644|524404232|FG000|LTG Escalation Phase|Adverse Event|9|||
145422884|NCT02100644|524404233|FG001|LTG Escalation Phase|Adverse Event|0|||
145422885|NCT02100644|524404234|FG002|LTG Escalation Phase|Adverse Event|0|||
145422886|NCT02100644|524404232|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
145422887|NCT02100644|524404233|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
145422888|NCT02100644|524404234|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
145422889|NCT02100644|524404232|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
145422890|NCT02100644|524404233|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
145422891|NCT02100644|524404234|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
145422892|NCT02852005|524404235|FG000|Overall Study|Lost to Follow-up|0|||
145422893|NCT02852005|524404236|FG001|Overall Study|Lost to Follow-up|0|||
145422894|NCT02852005|524404237|FG002|Overall Study|Lost to Follow-up|0|||
145422895|NCT02852005|524404238|FG003|Overall Study|Lost to Follow-up|0|||
145422896|NCT02852005|524404239|FG004|Overall Study|Lost to Follow-up|1|||
145422897|NCT02852005|524404235|FG000|Overall Study|Withdrawal by Subject|1|||
145422898|NCT02852005|524404236|FG001|Overall Study|Withdrawal by Subject|0|||
145422899|NCT02852005|524404237|FG002|Overall Study|Withdrawal by Subject|0|||
145422900|NCT02852005|524404238|FG003|Overall Study|Withdrawal by Subject|0|||
145422901|NCT02852005|524404239|FG004|Overall Study|Withdrawal by Subject|0|||
145422902|NCT00478140|524404242|FG000|Overall Study|Clinical Disease Progression|1|||
145422903|NCT00728182|524404243|FG000|Overall Study|Adverse Event|1|||
145422904|NCT00728182|524404244|FG001|Overall Study|Adverse Event|0|||
145579101|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
145579102|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
145579103|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
145422905|NCT00728182|524404243|FG000|Overall Study|Lost to Follow-up|2|||
145422906|NCT00728182|524404244|FG001|Overall Study|Lost to Follow-up|0|||
145422907|NCT00728182|524404243|FG000|Overall Study|Death|0|||
145422908|NCT00728182|524404244|FG001|Overall Study|Death|2|||
145422909|NCT00728182|524404243|FG000|Overall Study|Protocol Noncompliance|0|||
145422910|NCT00728182|524404244|FG001|Overall Study|Protocol Noncompliance|1|||
145422911|NCT03721107|524404246|FG000|Overall Study|Adverse Event|1|||
145422912|NCT03721107|524404247|FG001|Overall Study|Adverse Event|1|||
145422913|NCT03721107|524404248|FG002|Overall Study|Adverse Event|6|||
145422914|NCT03721107|524404249|FG003|Overall Study|Adverse Event|5|||
145422915|NCT03721107|524404246|FG000|Overall Study|Lost to Follow-up|2|||
145579104|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
145579105|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
145579106|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
145579107|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
145579108|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
145579109|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
145579110|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
145579111|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
145579112|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
145579113|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
145579114|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
145579115|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
145371243|NCT01938430|524209078|FG003|Overall Study|Death|1|||
145371244|NCT01938430|524209079|FG004|Overall Study|Death|0|||
145371245|NCT01938430|524209080|FG005|Overall Study|Death|0|||
145371246|NCT01938430|524209081|FG006|Overall Study|Death|1|||
145371247|NCT01938430|524209082|FG007|Overall Study|Death|1|||
145371248|NCT01938430|524209083|FG008|Overall Study|Death|2|||
145371249|NCT01938430|524209084|FG009|Overall Study|Death|3|||
145371250|NCT01938430|524209085|FG010|Overall Study|Death|0|||
145371251|NCT01938430|524209086|FG011|Overall Study|Death|0|||
145371252|NCT01938430|524209087|FG012|Overall Study|Death|0|||
145371253|NCT01938430|524209088|FG013|Overall Study|Death|0|||
145371254|NCT01938430|524209075|FG000|Overall Study|Investigator's Discretion|0|||
145371255|NCT01938430|524209076|FG001|Overall Study|Investigator's Discretion|0|||
145371256|NCT01938430|524209077|FG002|Overall Study|Investigator's Discretion|1|||
145579116|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
145579117|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
145579118|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
145579119|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
145579120|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
145579121|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
145579122|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
145579123|NCT03655236|524973804|FG000|Subject Disposition in Part 2 Period|Other|1|||
145579124|NCT03655236|524973805|FG001|Subject Disposition in Part 2 Period|Other|0|||
145579125|NCT03655236|524973806|FG002|Subject Disposition in Part 2 Period|Other|0|||
145579126|NCT04258839|524975252|FG000|Overall Study|Adverse Event|2|||
145579127|NCT04258839|524975253|FG001|Overall Study|Adverse Event|4|||
145579128|NCT04258839|524975252|FG000|Overall Study|Lack of Efficacy|0|||
145579129|NCT04258839|524975253|FG001|Overall Study|Lack of Efficacy|2|||
145579130|NCT04258839|524975252|FG000|Overall Study|Lost to Follow-up|2|||
145579131|NCT04258839|524975253|FG001|Overall Study|Lost to Follow-up|0|||
145579132|NCT04258839|524975252|FG000|Overall Study|Withdrawal by Subject|1|||
145579133|NCT04258839|524975253|FG001|Overall Study|Withdrawal by Subject|2|||
145579134|NCT04258839|524975252|FG000|Overall Study|Withdrawal by Caregiver|5|||
145579135|NCT04258839|524975253|FG001|Overall Study|Withdrawal by Caregiver|6|||
145579136|NCT04258839|524975252|FG000|Overall Study|Reason not Specified|0|||
145579137|NCT04258839|524975253|FG001|Overall Study|Reason not Specified|1|||
145579138|NCT00672477|524975258|FG000|Overall Study|Adverse Event|10|||
145579139|NCT00672477|524975259|FG001|Overall Study|Adverse Event|7|||
145579140|NCT00672477|524975258|FG000|Overall Study|Death|7|||
145579141|NCT00672477|524975259|FG001|Overall Study|Death|11|||
145579142|NCT00672477|524975258|FG000|Overall Study|Physician Decision|2|||
145579143|NCT00672477|524975259|FG001|Overall Study|Physician Decision|0|||
145579144|NCT00672477|524975258|FG000|Overall Study|Protocol Violation|1|||
145579145|NCT00672477|524975259|FG001|Overall Study|Protocol Violation|1|||
145579146|NCT00672477|524975258|FG000|Overall Study|Withdrawal by Subject|5|||
145579147|NCT00672477|524975259|FG001|Overall Study|Withdrawal by Subject|3|||
145579148|NCT00672477|524975258|FG000|Overall Study|Lack of Efficacy|1|||
145579149|NCT00672477|524975259|FG001|Overall Study|Lack of Efficacy|1|||
145579150|NCT00672477|524975258|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
145371257|NCT01938430|524209078|FG003|Overall Study|Investigator's Discretion|0|||
145371258|NCT01938430|524209079|FG004|Overall Study|Investigator's Discretion|0|||
145371259|NCT01938430|524209080|FG005|Overall Study|Investigator's Discretion|0|||
145371260|NCT01938430|524209081|FG006|Overall Study|Investigator's Discretion|0|||
145371261|NCT01938430|524209082|FG007|Overall Study|Investigator's Discretion|0|||
145371262|NCT01938430|524209083|FG008|Overall Study|Investigator's Discretion|0|||
145371263|NCT01938430|524209084|FG009|Overall Study|Investigator's Discretion|0|||
145371264|NCT01938430|524209085|FG010|Overall Study|Investigator's Discretion|0|||
145371265|NCT01938430|524209086|FG011|Overall Study|Investigator's Discretion|0|||
145371266|NCT01938430|524209087|FG012|Overall Study|Investigator's Discretion|0|||
145371267|NCT01938430|524209088|FG013|Overall Study|Investigator's Discretion|0|||
145371268|NCT01938430|524209075|FG000|Overall Study|Lack of Efficacy|3|||
145371269|NCT01938430|524209076|FG001|Overall Study|Lack of Efficacy|1|||
145579151|NCT00672477|524975259|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
145579152|NCT02886572|524975260|FG000|Overall Study|Death|8|||
145579153|NCT01933334|524975263|FG000|Overall Study|Adverse Event|5|||
145579154|NCT01933334|524975264|FG001|Overall Study|Adverse Event|1|||
145579155|NCT01933334|524975263|FG000|Overall Study|Withdrawal by Subject|0|||
145579156|NCT01933334|524975264|FG001|Overall Study|Withdrawal by Subject|1|||
145579157|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145371270|NCT01938430|524209077|FG002|Overall Study|Lack of Efficacy|1|||
145371271|NCT01938430|524209078|FG003|Overall Study|Lack of Efficacy|1|||
145371272|NCT01938430|524209079|FG004|Overall Study|Lack of Efficacy|0|||
145371273|NCT01938430|524209080|FG005|Overall Study|Lack of Efficacy|0|||
145371274|NCT01938430|524209081|FG006|Overall Study|Lack of Efficacy|0|||
145371275|NCT01938430|524209082|FG007|Overall Study|Lack of Efficacy|0|||
145371276|NCT01938430|524209083|FG008|Overall Study|Lack of Efficacy|1|||
145579158|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
145579159|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
145579160|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
145371277|NCT01938430|524209084|FG009|Overall Study|Lack of Efficacy|0|||
145371278|NCT01938430|524209085|FG010|Overall Study|Lack of Efficacy|2|||
145371279|NCT01938430|524209086|FG011|Overall Study|Lack of Efficacy|1|||
145371280|NCT01938430|524209087|FG012|Overall Study|Lack of Efficacy|0|||
145371281|NCT01938430|524209088|FG013|Overall Study|Lack of Efficacy|0|||
145371282|NCT01938430|524209075|FG000|Overall Study|Lost to Follow-up|0|||
145371283|NCT01938430|524209076|FG001|Overall Study|Lost to Follow-up|0|||
145371284|NCT01938430|524209077|FG002|Overall Study|Lost to Follow-up|1|||
145371285|NCT01938430|524209078|FG003|Overall Study|Lost to Follow-up|0|||
145371286|NCT01938430|524209079|FG004|Overall Study|Lost to Follow-up|0|||
145371287|NCT01938430|524209080|FG005|Overall Study|Lost to Follow-up|1|||
145371288|NCT01938430|524209081|FG006|Overall Study|Lost to Follow-up|0|||
145371289|NCT01938430|524209082|FG007|Overall Study|Lost to Follow-up|0|||
145371290|NCT01938430|524209083|FG008|Overall Study|Lost to Follow-up|0|||
145371291|NCT01938430|524209084|FG009|Overall Study|Lost to Follow-up|0|||
145371292|NCT01938430|524209085|FG010|Overall Study|Lost to Follow-up|0|||
145371293|NCT01938430|524209086|FG011|Overall Study|Lost to Follow-up|0|||
145371294|NCT01938430|524209087|FG012|Overall Study|Lost to Follow-up|0|||
145371295|NCT01938430|524209088|FG013|Overall Study|Lost to Follow-up|0|||
145371296|NCT01938430|524209075|FG000|Overall Study|Withdrew Consent|0|||
145371297|NCT01938430|524209076|FG001|Overall Study|Withdrew Consent|0|||
145371298|NCT01938430|524209077|FG002|Overall Study|Withdrew Consent|0|||
145371299|NCT01938430|524209078|FG003|Overall Study|Withdrew Consent|0|||
145371300|NCT01938430|524209079|FG004|Overall Study|Withdrew Consent|0|||
145371301|NCT01938430|524209080|FG005|Overall Study|Withdrew Consent|0|||
145579161|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
145579162|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
145371302|NCT01938430|524209081|FG006|Overall Study|Withdrew Consent|0|||
145371303|NCT01938430|524209082|FG007|Overall Study|Withdrew Consent|0|||
145371304|NCT01938430|524209083|FG008|Overall Study|Withdrew Consent|1|||
145371305|NCT01938430|524209084|FG009|Overall Study|Withdrew Consent|0|||
145371306|NCT01938430|524209085|FG010|Overall Study|Withdrew Consent|0|||
145371307|NCT01938430|524209086|FG011|Overall Study|Withdrew Consent|0|||
145371308|NCT01938430|524209087|FG012|Overall Study|Withdrew Consent|0|||
145371309|NCT01938430|524209088|FG013|Overall Study|Withdrew Consent|0|||
145371310|NCT03875482|524209089|FG000|Overall Study|Adverse Event|0|||
145371311|NCT03875482|524209090|FG001|Overall Study|Adverse Event|1|||
145371312|NCT03875482|524209089|FG000|Overall Study|Withdrew consent|5|||
145371313|NCT03875482|524209090|FG001|Overall Study|Withdrew consent|6|||
145371314|NCT03875482|524209089|FG000|Overall Study|Lost to Follow-up|8|||
145371315|NCT03875482|524209090|FG001|Overall Study|Lost to Follow-up|2|||
145371316|NCT03875482|524209089|FG000|Overall Study|Lack of Efficacy|0|||
145371317|NCT03875482|524209090|FG001|Overall Study|Lack of Efficacy|11|||
145371318|NCT02045862|524209091|FG000|Overall Study|Death|0|||
145371319|NCT02045862|524209092|FG001|Overall Study|Death|0|||
145371320|NCT02045862|524209093|FG002|Overall Study|Death|1|||
145371321|NCT02045862|524209091|FG000|Overall Study|Miscellaneous|5|||
145371322|NCT02045862|524209092|FG001|Overall Study|Miscellaneous|0|||
145371323|NCT02045862|524209093|FG002|Overall Study|Miscellaneous|8|||
145371324|NCT02045862|524209091|FG000|Overall Study|Withdrawal by Patient|18|||
145371325|NCT02045862|524209092|FG001|Overall Study|Withdrawal by Patient|27|||
145371326|NCT02045862|524209093|FG002|Overall Study|Withdrawal by Patient|57|||
145371327|NCT02045862|524209091|FG000|Overall Study|Protocol Violation|0|||
145371328|NCT02045862|524209092|FG001|Overall Study|Protocol Violation|0|||
145371329|NCT02045862|524209093|FG002|Overall Study|Protocol Violation|6|||
145371330|NCT02045862|524209091|FG000|Overall Study|Lack of Efficacy|8|||
145371331|NCT02045862|524209092|FG001|Overall Study|Lack of Efficacy|4|||
145371332|NCT02045862|524209093|FG002|Overall Study|Lack of Efficacy|13|||
145371333|NCT02045862|524209091|FG000|Overall Study|Randomized but not Received Study Drug|0|||
145371334|NCT02045862|524209092|FG001|Overall Study|Randomized but not Received Study Drug|2|||
145579163|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
145579164|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
145371335|NCT02045862|524209093|FG002|Overall Study|Randomized but not Received Study Drug|8|||
145371336|NCT02045862|524209091|FG000|Overall Study|Adverse Event|7|||
145371337|NCT02045862|524209092|FG001|Overall Study|Adverse Event|5|||
145371338|NCT02045862|524209093|FG002|Overall Study|Adverse Event|27|||
145371339|NCT02045862|524209091|FG000|Overall Study|Lost to Follow-up|1|||
145371340|NCT02045862|524209092|FG001|Overall Study|Lost to Follow-up|2|||
145371341|NCT02045862|524209093|FG002|Overall Study|Lost to Follow-up|6|||
145371342|NCT00623935|524209094|FG000|Overall Study|Death|1|||
145371343|NCT00623935|524209094|FG000|Overall Study|Patient Declined Transplant|1|||
145371344|NCT04507256|524209095|FG000|Overall Study|Withdrawal by Subject|1|||
145371345|NCT04507256|524209096|FG001|Overall Study|Withdrawal by Subject|0|||
145371346|NCT04507256|524209097|FG002|Overall Study|Withdrawal by Subject|0|||
145371347|NCT04507256|524209098|FG003|Overall Study|Withdrawal by Subject|1|||
145371348|NCT04507256|524209099|FG004|Overall Study|Withdrawal by Subject|0|||
145371349|NCT04507256|524209100|FG005|Overall Study|Withdrawal by Subject|0|||
145422916|NCT03721107|524404247|FG001|Overall Study|Lost to Follow-up|0|||
145579165|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
145579166|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
145371350|NCT00631410|524209113|FG000|Overall Study|Adverse Event|1|||
145371351|NCT00631410|524209114|FG001|Overall Study|Adverse Event|3|||
145371352|NCT00631410|524209113|FG000|Overall Study|Objective Progression or Relapse|4|||
145371353|NCT00631410|524209114|FG001|Overall Study|Objective Progression or Relapse|3|||
145371354|NCT00631410|524209113|FG000|Overall Study|Surgery|1|||
145371355|NCT00631410|524209114|FG001|Overall Study|Surgery|0|||
145371356|NCT00782184|524209115|FG000|Overall Study|Adverse Event|1|||
145371357|NCT00782184|524209116|FG001|Overall Study|Adverse Event|2|||
145371358|NCT00782184|524209115|FG000|Overall Study|Protocol Violation|0|||
145371359|NCT00782184|524209116|FG001|Overall Study|Protocol Violation|1|||
145371360|NCT00782184|524209115|FG000|Overall Study|Withdrawal by Subject|3|||
145371361|NCT00782184|524209116|FG001|Overall Study|Withdrawal by Subject|2|||
145371362|NCT01647516|524209125|FG000|Induction Period (IP)|Physician Decision|2|||
145371363|NCT01647516|524209126|FG001|Induction Period (IP)|Physician Decision|0|||
145371364|NCT01647516|524209127|FG002|Induction Period (IP)|Physician Decision|0|||
145371365|NCT01647516|524209128|FG003|Induction Period (IP)|Physician Decision|0|||
145371366|NCT01647516|524209129|FG004|Induction Period (IP)|Physician Decision|0|||
145371367|NCT01647516|524209130|FG005|Induction Period (IP)|Physician Decision|0|||
145371368|NCT01647516|524209125|FG000|Induction Period (IP)|Adverse Event|1|||
145371369|NCT01647516|524209126|FG001|Induction Period (IP)|Adverse Event|2|||
145371370|NCT01647516|524209127|FG002|Induction Period (IP)|Adverse Event|0|||
145371371|NCT01647516|524209128|FG003|Induction Period (IP)|Adverse Event|0|||
145371372|NCT01647516|524209129|FG004|Induction Period (IP)|Adverse Event|0|||
145371373|NCT01647516|524209130|FG005|Induction Period (IP)|Adverse Event|0|||
145371374|NCT01647516|524209125|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
145371375|NCT01647516|524209126|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
145371376|NCT01647516|524209127|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
145371377|NCT01647516|524209128|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
145371378|NCT01647516|524209129|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
145371379|NCT01647516|524209130|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
145371380|NCT01647516|524209125|FG000|Induction Period (IP)|Participant Choice|0|||
145371381|NCT01647516|524209126|FG001|Induction Period (IP)|Participant Choice|0|||
145371382|NCT01647516|524209127|FG002|Induction Period (IP)|Participant Choice|1|||
145371383|NCT01647516|524209128|FG003|Induction Period (IP)|Participant Choice|0|||
145371384|NCT01647516|524209129|FG004|Induction Period (IP)|Participant Choice|0|||
145371385|NCT01647516|524209130|FG005|Induction Period (IP)|Participant Choice|0|||
145371386|NCT01647516|524209125|FG000|Induction Period (IP)|Lack of Efficacy|1|||
145371387|NCT01647516|524209126|FG001|Induction Period (IP)|Lack of Efficacy|0|||
145371388|NCT01647516|524209127|FG002|Induction Period (IP)|Lack of Efficacy|0|||
145371389|NCT01647516|524209128|FG003|Induction Period (IP)|Lack of Efficacy|0|||
145371390|NCT01647516|524209129|FG004|Induction Period (IP)|Lack of Efficacy|0|||
145371391|NCT01647516|524209130|FG005|Induction Period (IP)|Lack of Efficacy|0|||
145371392|NCT01647516|524209125|FG000|Induction Period (IP)|No study drug received|1|||
145371393|NCT01647516|524209126|FG001|Induction Period (IP)|No study drug received|1|||
145371394|NCT01647516|524209127|FG002|Induction Period (IP)|No study drug received|0|||
145371395|NCT01647516|524209128|FG003|Induction Period (IP)|No study drug received|0|||
145371396|NCT01647516|524209129|FG004|Induction Period (IP)|No study drug received|0|||
145371397|NCT01647516|524209130|FG005|Induction Period (IP)|No study drug received|0|||
145371398|NCT01647516|524209125|FG000|Maintenance Period (MP)|Adverse Event|2|||
145371399|NCT01647516|524209126|FG001|Maintenance Period (MP)|Adverse Event|1|||
145371400|NCT01647516|524209127|FG002|Maintenance Period (MP)|Adverse Event|0|||
145371401|NCT01647516|524209128|FG003|Maintenance Period (MP)|Adverse Event|0|||
145371402|NCT01647516|524209129|FG004|Maintenance Period (MP)|Adverse Event|0|||
145371403|NCT01647516|524209130|FG005|Maintenance Period (MP)|Adverse Event|0|||
145371404|NCT01647516|524209125|FG000|Maintenance Period (MP)|Non-compliance|1|||
145371405|NCT01647516|524209126|FG001|Maintenance Period (MP)|Non-compliance|0|||
145371406|NCT01647516|524209127|FG002|Maintenance Period (MP)|Non-compliance|0|||
145371407|NCT01647516|524209128|FG003|Maintenance Period (MP)|Non-compliance|0|||
145371408|NCT01647516|524209129|FG004|Maintenance Period (MP)|Non-compliance|0|||
145371409|NCT01647516|524209130|FG005|Maintenance Period (MP)|Non-compliance|0|||
145371410|NCT01647516|524209125|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
145371411|NCT01647516|524209126|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
145371412|NCT01647516|524209127|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
145371413|NCT01647516|524209128|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
145371414|NCT01647516|524209129|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
145371415|NCT01647516|524209130|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
145371416|NCT01647516|524209125|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
145579167|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
145371417|NCT01647516|524209126|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
145371418|NCT01647516|524209127|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
145422917|NCT03721107|524404248|FG002|Overall Study|Lost to Follow-up|3|||
145371419|NCT01647516|524209128|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
145371420|NCT01647516|524209129|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
145371421|NCT01647516|524209130|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
145579168|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
145579169|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
145579170|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
145579171|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
145579172|NCT01257204|524975269|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
145371422|NCT01647516|524209125|FG000|Open-Label Period|Adverse Event|0|||
145371423|NCT01647516|524209126|FG001|Open-Label Period|Adverse Event|0|||
145371424|NCT01647516|524209127|FG002|Open-Label Period|Adverse Event|0|||
145371425|NCT01647516|524209128|FG003|Open-Label Period|Adverse Event|5|||
145371426|NCT01647516|524209129|FG004|Open-Label Period|Adverse Event|6|||
145371427|NCT01647516|524209130|FG005|Open-Label Period|Adverse Event|3|||
145371428|NCT01647516|524209125|FG000|Open-Label Period|Pregnancy|0|||
145371429|NCT01647516|524209126|FG001|Open-Label Period|Pregnancy|0|||
145371430|NCT01647516|524209127|FG002|Open-Label Period|Pregnancy|0|||
145371431|NCT01647516|524209128|FG003|Open-Label Period|Pregnancy|0|||
145371432|NCT01647516|524209129|FG004|Open-Label Period|Pregnancy|0|||
145371433|NCT01647516|524209130|FG005|Open-Label Period|Pregnancy|1|||
145371434|NCT01647516|524209125|FG000|Open-Label Period|Non-compliance|0|||
145371435|NCT01647516|524209126|FG001|Open-Label Period|Non-compliance|0|||
145371436|NCT01647516|524209127|FG002|Open-Label Period|Non-compliance|0|||
145371437|NCT01647516|524209128|FG003|Open-Label Period|Non-compliance|1|||
145371438|NCT01647516|524209129|FG004|Open-Label Period|Non-compliance|0|||
145371439|NCT01647516|524209130|FG005|Open-Label Period|Non-compliance|1|||
145371440|NCT01647516|524209125|FG000|Open-Label Period|Physician Decision|0|||
145371441|NCT01647516|524209126|FG001|Open-Label Period|Physician Decision|0|||
145371442|NCT01647516|524209127|FG002|Open-Label Period|Physician Decision|0|||
145371443|NCT01647516|524209128|FG003|Open-Label Period|Physician Decision|1|||
145371444|NCT01647516|524209129|FG004|Open-Label Period|Physician Decision|1|||
145371445|NCT01647516|524209130|FG005|Open-Label Period|Physician Decision|0|||
145371446|NCT01647516|524209125|FG000|Open-Label Period|Withdrawal by Subject|0|||
145371447|NCT01647516|524209126|FG001|Open-Label Period|Withdrawal by Subject|0|||
145371448|NCT01647516|524209127|FG002|Open-Label Period|Withdrawal by Subject|0|||
145371449|NCT01647516|524209128|FG003|Open-Label Period|Withdrawal by Subject|9|||
145371450|NCT01647516|524209129|FG004|Open-Label Period|Withdrawal by Subject|11|||
145371451|NCT01647516|524209130|FG005|Open-Label Period|Withdrawal by Subject|6|||
145371452|NCT01647516|524209125|FG000|Open-Label Period|Lost to Follow-up|0|||
145371453|NCT01647516|524209126|FG001|Open-Label Period|Lost to Follow-up|0|||
145371454|NCT01647516|524209127|FG002|Open-Label Period|Lost to Follow-up|0|||
145371455|NCT01647516|524209128|FG003|Open-Label Period|Lost to Follow-up|1|||
145371456|NCT01647516|524209129|FG004|Open-Label Period|Lost to Follow-up|0|||
145371457|NCT01647516|524209130|FG005|Open-Label Period|Lost to Follow-up|1|||
145371458|NCT01647516|524209125|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145371459|NCT01647516|524209126|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145371460|NCT01647516|524209127|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
145371461|NCT01647516|524209128|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
145371462|NCT01647516|524209129|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
145371463|NCT01647516|524209130|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
145371464|NCT01647516|524209125|FG000|Open-Label Period|Lack of Efficacy|0|||
145371465|NCT01647516|524209126|FG001|Open-Label Period|Lack of Efficacy|0|||
145371466|NCT01647516|524209127|FG002|Open-Label Period|Lack of Efficacy|0|||
145371467|NCT01647516|524209128|FG003|Open-Label Period|Lack of Efficacy|7|||
145371468|NCT01647516|524209129|FG004|Open-Label Period|Lack of Efficacy|9|||
145371469|NCT01647516|524209130|FG005|Open-Label Period|Lack of Efficacy|10|||
145371470|NCT01647516|524209125|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145371471|NCT01647516|524209126|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145371472|NCT01647516|524209127|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
145371473|NCT01647516|524209128|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
145371474|NCT01647516|524209129|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
145371475|NCT01647516|524209130|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
145371476|NCT01647516|524209125|FG000|Open-Label Period|No completion / discontinuation visit|0|||
145371477|NCT01647516|524209126|FG001|Open-Label Period|No completion / discontinuation visit|0|||
145371478|NCT01647516|524209127|FG002|Open-Label Period|No completion / discontinuation visit|0|||
145371479|NCT01647516|524209128|FG003|Open-Label Period|No completion / discontinuation visit|0|||
145371480|NCT01647516|524209129|FG004|Open-Label Period|No completion / discontinuation visit|2|||
145579173|NCT01257204|524975270|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
145371481|NCT01647516|524209130|FG005|Open-Label Period|No completion / discontinuation visit|1|||
145371482|NCT01676896|524209131|FG000|Overall Study|Withdrawal by Subject|12|||
145371483|NCT01676896|524209132|FG001|Overall Study|Withdrawal by Subject|7|||
145371484|NCT01676896|524209133|FG002|Overall Study|Withdrawal by Subject|19|||
145422918|NCT03721107|524404249|FG003|Overall Study|Lost to Follow-up|0|||
145422919|NCT03721107|524404246|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145422920|NCT03721107|524404247|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145422921|NCT03721107|524404248|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
145422922|NCT03721107|524404249|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
145422923|NCT03721107|524404246|FG000|Overall Study|Physician Decision|0|||
145422924|NCT03721107|524404247|FG001|Overall Study|Physician Decision|1|||
145422925|NCT03721107|524404248|FG002|Overall Study|Physician Decision|0|||
145422926|NCT03721107|524404249|FG003|Overall Study|Physician Decision|0|||
145422927|NCT03721107|524404246|FG000|Overall Study|Pregnancy|0|||
145422928|NCT03721107|524404247|FG001|Overall Study|Pregnancy|0|||
145422929|NCT03721107|524404248|FG002|Overall Study|Pregnancy|1|||
145422930|NCT03721107|524404249|FG003|Overall Study|Pregnancy|0|||
145422931|NCT03721107|524404246|FG000|Overall Study|Withdrawal by Subject|1|||
145422932|NCT03721107|524404247|FG001|Overall Study|Withdrawal by Subject|1|||
145422933|NCT03721107|524404248|FG002|Overall Study|Withdrawal by Subject|5|||
145422934|NCT03721107|524404249|FG003|Overall Study|Withdrawal by Subject|5|||
145422935|NCT03721107|524404246|FG000|Overall Study|Other|1|||
145422936|NCT03721107|524404247|FG001|Overall Study|Other|0|||
145422937|NCT03721107|524404248|FG002|Overall Study|Other|0|||
145422938|NCT03721107|524404249|FG003|Overall Study|Other|1|||
145422939|NCT02294019|524404250|FG000|Overall Study|Adverse Event|2|||
145422940|NCT02294019|524404250|FG000|Overall Study|Protocol Violation|68|||
145422941|NCT02294019|524404250|FG000|Overall Study|Lost to Follow-up|31|||
145422942|NCT02294019|524404250|FG000|Overall Study|Other|1|||
145422943|NCT02294019|524404250|FG000|Overall Study|Withdrawal by Subject|1|||
145422944|NCT02554474|524404252|FG000|Overall Study|Protocol Violation|1|||
145422945|NCT02554474|524404253|FG001|Overall Study|Protocol Violation|1|||
145422946|NCT02554474|524404252|FG000|Overall Study|Health issue not related to the study|1|||
145422947|NCT02554474|524404253|FG001|Overall Study|Health issue not related to the study|0|||
145422948|NCT02554474|524404252|FG000|Overall Study|Withdrawal by Subject|1|||
145422949|NCT02554474|524404253|FG001|Overall Study|Withdrawal by Subject|1|||
145422950|NCT03211832|524404254|FG000|Overall Study|No longer with agency|32|||
145422951|NCT03211832|524404255|FG001|Overall Study|No longer with agency|49|||
145422952|NCT03211832|524404256|FG002|Overall Study|No longer with agency|30|||
145422953|NCT03211832|524404254|FG000|Overall Study|Declined survey|3|||
145422954|NCT03211832|524404255|FG001|Overall Study|Declined survey|3|||
145422955|NCT03211832|524404256|FG002|Overall Study|Declined survey|2|||
145422956|NCT03211832|524404254|FG000|Overall Study|Not available during data collection|1|||
145422957|NCT03211832|524404255|FG001|Overall Study|Not available during data collection|0|||
145422958|NCT03211832|524404256|FG002|Overall Study|Not available during data collection|2|||
145422959|NCT01725308|524404259|FG000|Treatment Period I|Did Not Receive Drug|1|||
145422960|NCT01725308|524404260|FG001|Treatment Period I|Did Not Receive Drug|0|||
145422961|NCT01725308|524404261|FG002|Treatment Period I|Did Not Receive Drug|0|||
145422962|NCT01725308|524404259|FG000|Treatment Period I|Adverse Event|5|||
145422963|NCT01725308|524404260|FG001|Treatment Period I|Adverse Event|4|||
145422964|NCT01725308|524404261|FG002|Treatment Period I|Adverse Event|21|||
145422965|NCT01725308|524404259|FG000|Treatment Period I|Insufficient Response|7|||
145422966|NCT01725308|524404260|FG001|Treatment Period I|Insufficient Response|0|||
145422967|NCT01725308|524404261|FG002|Treatment Period I|Insufficient Response|5|||
145422968|NCT01725308|524404259|FG000|Treatment Period I|Worsening of the Target Disease|8|||
145422969|NCT01725308|524404260|FG001|Treatment Period I|Worsening of the Target Disease|0|||
145422970|NCT01725308|524404261|FG002|Treatment Period I|Worsening of the Target Disease|2|||
145371485|NCT01613222|524209136|FG000|Overall Study|Physician Decision|1|||
145371486|NCT01613222|524209136|FG000|Overall Study|Unable to place arterial line|1|||
145371487|NCT01613222|524209136|FG000|Overall Study|Reused disposable sensors|10|||
145371488|NCT01895608|524209137|FG000|Overall Study|change in health status|0|||
145371489|NCT01895608|524209138|FG001|Overall Study|change in health status|1|||
145371490|NCT01895608|524209139|FG002|Overall Study|change in health status|1|||
145371491|NCT01895608|524209140|FG003|Overall Study|change in health status|0|||
145371492|NCT01895608|524209137|FG000|Overall Study|Withdrawal by Subject|0|||
145371493|NCT01895608|524209138|FG001|Overall Study|Withdrawal by Subject|0|||
145371494|NCT01895608|524209139|FG002|Overall Study|Withdrawal by Subject|2|||
145371495|NCT01895608|524209140|FG003|Overall Study|Withdrawal by Subject|0|||
145371496|NCT03505593|524209141|FG000|Overall Study|Withdrawal by Subject|1|||
145371497|NCT03505593|524209141|FG000|Overall Study|Died before procedure|1|||
145371498|NCT03505593|524209141|FG000|Overall Study|Anatomical abnormality|1|||
145371499|NCT03505593|524209141|FG000|Overall Study|Unable to pass through esophagus|1|||
145371500|NCT03505593|524209141|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
145371501|NCT02822573|524209142|FG000|Overall Study|Lost to Follow-up|5|||
145422971|NCT01725308|524404259|FG000|Treatment Period I|Changes in the Episodes|3|||
145422972|NCT01725308|524404260|FG001|Treatment Period I|Changes in the Episodes|0|||
145371502|NCT02822573|524209143|FG001|Overall Study|Lost to Follow-up|3|||
145422973|NCT01725308|524404261|FG002|Treatment Period I|Changes in the Episodes|2|||
145422974|NCT01725308|524404259|FG000|Treatment Period I|Withdrawal of Consent|12|||
145422975|NCT01725308|524404260|FG001|Treatment Period I|Withdrawal of Consent|7|||
145422976|NCT01725308|524404261|FG002|Treatment Period I|Withdrawal of Consent|5|||
145422977|NCT01725308|524404259|FG000|Treatment Period I|Lost to Follow-up|3|||
145422978|NCT01725308|524404260|FG001|Treatment Period I|Lost to Follow-up|2|||
145422979|NCT01725308|524404261|FG002|Treatment Period I|Lost to Follow-up|2|||
145422980|NCT01725308|524404259|FG000|Treatment Period I|Protocol Deviations|3|||
145422981|NCT01725308|524404260|FG001|Treatment Period I|Protocol Deviations|1|||
145422982|NCT01725308|524404261|FG002|Treatment Period I|Protocol Deviations|1|||
145422983|NCT01725308|524404259|FG000|Treatment Period I|Miscellaneous|2|||
145422984|NCT01725308|524404260|FG001|Treatment Period I|Miscellaneous|0|||
145422985|NCT01725308|524404261|FG002|Treatment Period I|Miscellaneous|3|||
145422986|NCT01725308|524404259|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
145422987|NCT01725308|524404260|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
145422988|NCT01725308|524404261|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
145422989|NCT01725308|524404259|FG000|Treatment Period II|Did Not Receive Drug|4|||
145422990|NCT01725308|524404260|FG001|Treatment Period II|Did Not Receive Drug|0|||
145422991|NCT01725308|524404261|FG002|Treatment Period II|Did Not Receive Drug|0|||
145422992|NCT01725308|524404259|FG000|Treatment Period II|Adverse Event|13|||
145422993|NCT01725308|524404260|FG001|Treatment Period II|Adverse Event|8|||
145422994|NCT01725308|524404261|FG002|Treatment Period II|Adverse Event|20|||
145422995|NCT01725308|524404259|FG000|Treatment Period II|Insufficient Response|2|||
145422996|NCT01725308|524404260|FG001|Treatment Period II|Insufficient Response|4|||
145422997|NCT01725308|524404261|FG002|Treatment Period II|Insufficient Response|6|||
145422998|NCT01725308|524404259|FG000|Treatment Period II|Worsening of the Target Disease|1|||
145422999|NCT01725308|524404260|FG001|Treatment Period II|Worsening of the Target Disease|4|||
145423000|NCT01725308|524404261|FG002|Treatment Period II|Worsening of the Target Disease|2|||
145423001|NCT01725308|524404259|FG000|Treatment Period II|Changes in the Episodes|1|||
145423002|NCT01725308|524404260|FG001|Treatment Period II|Changes in the Episodes|0|||
145423003|NCT01725308|524404261|FG002|Treatment Period II|Changes in the Episodes|5|||
145423004|NCT01725308|524404259|FG000|Treatment Period II|Withdrawal of Consent|28|||
145423005|NCT01725308|524404260|FG001|Treatment Period II|Withdrawal of Consent|2|||
145423006|NCT01725308|524404261|FG002|Treatment Period II|Withdrawal of Consent|16|||
145423007|NCT01725308|524404259|FG000|Treatment Period II|Lost to Follow-up|1|||
145423008|NCT01725308|524404260|FG001|Treatment Period II|Lost to Follow-up|5|||
145423009|NCT01725308|524404261|FG002|Treatment Period II|Lost to Follow-up|3|||
145423010|NCT01725308|524404259|FG000|Treatment Period II|Protocol Deviations|0|||
145423011|NCT01725308|524404260|FG001|Treatment Period II|Protocol Deviations|0|||
145423012|NCT01725308|524404261|FG002|Treatment Period II|Protocol Deviations|1|||
145423013|NCT01725308|524404259|FG000|Treatment Period II|Miscellaneous|5|||
145423014|NCT01725308|524404260|FG001|Treatment Period II|Miscellaneous|3|||
145423015|NCT01725308|524404261|FG002|Treatment Period II|Miscellaneous|7|||
145423016|NCT03511209|524404262|FG000|Overall Study|Withdrawal by Subject|2|||
145423017|NCT03511209|524404263|FG001|Overall Study|Withdrawal by Subject|4|||
145423018|NCT03511209|524404262|FG000|Overall Study|Death|1|||
145423019|NCT03511209|524404263|FG001|Overall Study|Death|0|||
145423020|NCT03511209|524404262|FG000|Overall Study|Lost to Follow-up|0|||
145423021|NCT03511209|524404263|FG001|Overall Study|Lost to Follow-up|2|||
145423022|NCT00968968|524404276|FG000|Overall Study|Study closed/terminated|10|||
145423023|NCT00968968|524404277|FG001|Overall Study|Study closed/terminated|10|||
145423024|NCT00968968|524404276|FG000|Overall Study|Protocol defined stopping criteria|3|||
145423025|NCT00968968|524404277|FG001|Overall Study|Protocol defined stopping criteria|1|||
145423026|NCT00968968|524404276|FG000|Overall Study|Withdrawal by Subject|2|||
145423027|NCT00968968|524404277|FG001|Overall Study|Withdrawal by Subject|0|||
145423028|NCT00968968|524404276|FG000|Overall Study|Physician Decision|1|||
145579174|NCT01257204|524975271|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
145579175|NCT01257204|524975269|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
145579176|NCT01257204|524975270|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
145579177|NCT01257204|524975271|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
145579178|NCT01257204|524975269|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
145579179|NCT01257204|524975270|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
145579180|NCT01257204|524975271|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
145579181|NCT01257204|524975269|FG000|Follow-up Period (up to Week 48)|Other|0|||
145579182|NCT01257204|524975270|FG001|Follow-up Period (up to Week 48)|Other|0|||
145423029|NCT00968968|524404277|FG001|Overall Study|Physician Decision|2|||
145423030|NCT00968968|524404276|FG000|Overall Study|Lost to Follow-up|0|||
145423031|NCT00968968|524404277|FG001|Overall Study|Lost to Follow-up|1|||
145423032|NCT00452400|524404280|FG000|Overall Study|Adverse Event|1|||
145423033|NCT00452400|524404281|FG001|Overall Study|Adverse Event|1|||
145423034|NCT00452400|524404282|FG002|Overall Study|Adverse Event|5|||
145579183|NCT01257204|524975271|FG002|Follow-up Period (up to Week 48)|Other|5|||
145579184|NCT02082522|524975274|FG000|Overall Study|Sponsor termination|5|||
145423035|NCT00452400|524404283|FG003|Overall Study|Adverse Event|0|||
145423036|NCT00452400|524404284|FG004|Overall Study|Adverse Event|2|||
145423037|NCT00452400|524404280|FG000|Overall Study|Protocol Violation|0|||
145423038|NCT00452400|524404281|FG001|Overall Study|Protocol Violation|0|||
145423039|NCT00452400|524404282|FG002|Overall Study|Protocol Violation|1|||
145579185|NCT02082522|524975275|FG001|Overall Study|Sponsor termination|3|||
145579186|NCT02082522|524975274|FG000|Overall Study|Withdrawal by Subject|2|||
145579187|NCT02082522|524975275|FG001|Overall Study|Withdrawal by Subject|4|||
145579188|NCT02082522|524975274|FG000|Overall Study|Death|1|||
145579189|NCT02082522|524975275|FG001|Overall Study|Death|0|||
145579190|NCT02082522|524975274|FG000|Overall Study|Lost to Follow-up|1|||
145579191|NCT02082522|524975275|FG001|Overall Study|Lost to Follow-up|0|||
145579192|NCT02082522|524975274|FG000|Overall Study|Physician Decision|3|||
145579193|NCT02082522|524975275|FG001|Overall Study|Physician Decision|1|||
145579194|NCT02082522|524975274|FG000|Overall Study|Disease progression|2|||
145579195|NCT02082522|524975275|FG001|Overall Study|Disease progression|2|||
145371503|NCT02822573|524209142|FG000|Overall Study|Physician Decision|1|||
145371504|NCT02822573|524209143|FG001|Overall Study|Physician Decision|1|||
145371505|NCT02822573|524209142|FG000|Overall Study|Withdrawal by Subject|9|||
145371506|NCT02822573|524209143|FG001|Overall Study|Withdrawal by Subject|5|||
145371507|NCT02822573|524209142|FG000|Overall Study|Protocol Violation|6|||
145371508|NCT02822573|524209143|FG001|Overall Study|Protocol Violation|4|||
145371509|NCT02822573|524209142|FG000|Overall Study|Too sick or ill|2|||
145371510|NCT02822573|524209143|FG001|Overall Study|Too sick or ill|1|||
145371511|NCT02822573|524209142|FG000|Overall Study|Disease Progression|1|||
145371512|NCT02822573|524209143|FG001|Overall Study|Disease Progression|1|||
145371513|NCT02822573|524209142|FG000|Overall Study|No reason given|6|||
145371514|NCT02822573|524209143|FG001|Overall Study|No reason given|4|||
145371515|NCT04143594|524209145|FG000|Overall Study|Withdrew consent|3|||
145371516|NCT04143594|524209146|FG001|Overall Study|Withdrew consent|10|||
145371517|NCT04143594|524209147|FG002|Overall Study|Withdrew consent|3|||
145371518|NCT04143594|524209148|FG003|Overall Study|Withdrew consent|1|||
145371519|NCT04143594|524209145|FG000|Overall Study|Lost to Follow-up|3|||
145371520|NCT04143594|524209146|FG001|Overall Study|Lost to Follow-up|5|||
145371521|NCT04143594|524209147|FG002|Overall Study|Lost to Follow-up|11|||
145371522|NCT04143594|524209148|FG003|Overall Study|Lost to Follow-up|0|||
145371523|NCT04143594|524209145|FG000|Overall Study|Investigator's discretion|2|||
145371524|NCT04143594|524209146|FG001|Overall Study|Investigator's discretion|2|||
145371525|NCT04143594|524209147|FG002|Overall Study|Investigator's discretion|0|||
145371526|NCT04143594|524209148|FG003|Overall Study|Investigator's discretion|0|||
145371527|NCT04143594|524209145|FG000|Overall Study|Randomized but never treated|0|||
145371528|NCT04143594|524209146|FG001|Overall Study|Randomized but never treated|0|||
145371529|NCT04143594|524209147|FG002|Overall Study|Randomized but never treated|0|||
145371530|NCT04143594|524209148|FG003|Overall Study|Randomized but never treated|1|||
145371531|NCT04143594|524209145|FG000|Overall Study|Death|1|||
145371532|NCT04143594|524209146|FG001|Overall Study|Death|0|||
145371533|NCT04143594|524209147|FG002|Overall Study|Death|1|||
145371534|NCT04143594|524209148|FG003|Overall Study|Death|0|||
145371535|NCT04143594|524209145|FG000|Overall Study|Adverse Event|1|||
145371536|NCT04143594|524209146|FG001|Overall Study|Adverse Event|0|||
145371537|NCT04143594|524209147|FG002|Overall Study|Adverse Event|0|||
145371538|NCT04143594|524209148|FG003|Overall Study|Adverse Event|0|||
145371539|NCT04143594|524209145|FG000|Overall Study|Pregnancy|0|||
145371540|NCT04143594|524209146|FG001|Overall Study|Pregnancy|0|||
145371541|NCT04143594|524209147|FG002|Overall Study|Pregnancy|1|||
145371542|NCT04143594|524209148|FG003|Overall Study|Pregnancy|0|||
145371543|NCT04143594|524209145|FG000|Overall Study|Lack of Efficacy|1|||
145371544|NCT04143594|524209146|FG001|Overall Study|Lack of Efficacy|1|||
145371545|NCT04143594|524209147|FG002|Overall Study|Lack of Efficacy|0|||
145371546|NCT04143594|524209148|FG003|Overall Study|Lack of Efficacy|0|||
145371547|NCT02855359|524209151|FG000|Overall Study|Death|2|||
145371548|NCT02855359|524209152|FG001|Overall Study|Death|2|||
145371549|NCT02855359|524209153|FG002|Overall Study|Death|0|||
145371550|NCT02855359|524209154|FG003|Overall Study|Death|0|||
145371551|NCT02855359|524209151|FG000|Overall Study|Study Termination by Sponsor|9|||
145371552|NCT02855359|524209152|FG001|Overall Study|Study Termination by Sponsor|11|||
145371553|NCT02855359|524209153|FG002|Overall Study|Study Termination by Sponsor|0|||
145371554|NCT02855359|524209154|FG003|Overall Study|Study Termination by Sponsor|0|||
145371555|NCT01023256|524209155|FG000|Overall Study|Protocol Violation|2|||
145371556|NCT01023256|524209156|FG001|Overall Study|Protocol Violation|3|||
145371557|NCT01023256|524209157|FG002|Overall Study|Protocol Violation|0|||
145371558|NCT01023256|524209158|FG003|Overall Study|Protocol Violation|0|||
145371559|NCT01023256|524209155|FG000|Overall Study|Randomized but not treated|1|||
145371560|NCT01023256|524209156|FG001|Overall Study|Randomized but not treated|0|||
145371561|NCT01023256|524209157|FG002|Overall Study|Randomized but not treated|1|||
145371562|NCT01023256|524209158|FG003|Overall Study|Randomized but not treated|0|||
145371563|NCT01023256|524209155|FG000|Overall Study|Other|1|||
145371564|NCT01023256|524209156|FG001|Overall Study|Other|0|||
145371565|NCT01023256|524209157|FG002|Overall Study|Other|0|||
145371566|NCT01023256|524209158|FG003|Overall Study|Other|2|||
145579196|NCT02082522|524975274|FG000|Overall Study|Chemotherapy change|1|||
145579197|NCT02082522|524975275|FG001|Overall Study|Chemotherapy change|3|||
145623475|NCT00761774|525133932|FG000|Overall Study|Subject IP non-compliance|1|||
145371567|NCT01023256|524209155|FG000|Overall Study|Adverse Event|0|||
145371568|NCT01023256|524209156|FG001|Overall Study|Adverse Event|0|||
145371569|NCT01023256|524209157|FG002|Overall Study|Adverse Event|0|||
145371570|NCT01023256|524209158|FG003|Overall Study|Adverse Event|1|||
145371571|NCT01023256|524209155|FG000|Overall Study|Withdrawal by Subject|0|||
145371572|NCT01023256|524209156|FG001|Overall Study|Withdrawal by Subject|0|||
145371573|NCT01023256|524209157|FG002|Overall Study|Withdrawal by Subject|0|||
145371574|NCT01023256|524209158|FG003|Overall Study|Withdrawal by Subject|2|||
145371575|NCT03155178|524209159|FG000|Overall Study|Did not meet treatment day baseline|7|||
145371576|NCT03155178|524209160|FG001|Overall Study|Did not meet treatment day baseline|7|||
145371577|NCT03155178|524209161|FG002|Overall Study|Did not meet treatment day baseline|7|||
145371578|NCT03155178|524209162|FG003|Overall Study|Did not meet treatment day baseline|7|||
145371579|NCT00308087|524209163|FG000|Overall Study|Progressive Disease|19|||
145371580|NCT00308087|524209164|FG001|Overall Study|Progressive Disease|21|||
145371581|NCT00308087|524209163|FG000|Overall Study|Study Closure|11|||
145371582|NCT00308087|524209164|FG001|Overall Study|Study Closure|12|||
145371583|NCT00308087|524209163|FG000|Overall Study|Withdrawal by Subject|2|||
145371584|NCT00308087|524209164|FG001|Overall Study|Withdrawal by Subject|1|||
145371585|NCT00308087|524209163|FG000|Overall Study|Other|4|||
145371586|NCT00308087|524209164|FG001|Overall Study|Other|3|||
145371587|NCT01869699|524209166|FG000|Overall Study|Withdrawal by Subject|1|||
145371588|NCT01869699|524209167|FG001|Overall Study|Withdrawal by Subject|0|||
145371589|NCT01475851|524209170|FG000|Overall Study|Protocol defined stopping criteria|1|||
145371590|NCT01475851|524209171|FG001|Overall Study|Protocol defined stopping criteria|0|||
145371591|NCT02447497|524209174|FG000|Overall Study|Did not meet treatment day baseline.|6|||
145371592|NCT02447497|524209175|FG001|Overall Study|Did not meet treatment day baseline.|5|||
145371593|NCT02447497|524209176|FG002|Overall Study|Did not meet treatment day baseline.|2|||
145371594|NCT02447497|524209177|FG003|Overall Study|Did not meet treatment day baseline.|2|||
145371595|NCT02447497|524209174|FG000|Overall Study|Dressing was compromised|0|||
145371596|NCT02447497|524209175|FG001|Overall Study|Dressing was compromised|1|||
145371597|NCT02447497|524209176|FG002|Overall Study|Dressing was compromised|0|||
145371598|NCT02447497|524209177|FG003|Overall Study|Dressing was compromised|0|||
145371599|NCT01322035|524209178|FG000|Overall Study|Lost to Follow-up|8|||
145371600|NCT01322035|524209179|FG001|Overall Study|Lost to Follow-up|3|||
145371601|NCT04569968|524209180|FG000|Overall Study|Lost to Follow-up|2|||
145371602|NCT04569968|524209181|FG001|Overall Study|Lost to Follow-up|5|||
145371603|NCT04569968|524209180|FG000|Overall Study|Story of head and/or neck surgery|2|||
145371604|NCT04569968|524209181|FG001|Overall Study|Story of head and/or neck surgery|2|||
145371605|NCT04569968|524209180|FG000|Overall Study|Time of stroke onset|8|||
145371606|NCT04569968|524209181|FG001|Overall Study|Time of stroke onset|7|||
145371607|NCT04569968|524209180|FG000|Overall Study|Type of strokr|12|||
145371608|NCT04569968|524209181|FG001|Overall Study|Type of strokr|8|||
145371609|NCT04569968|524209180|FG000|Overall Study|Cooperation|8|||
145371610|NCT04569968|524209181|FG001|Overall Study|Cooperation|8|||
145371611|NCT04569968|524209180|FG000|Overall Study|Age interval|17|||
145371612|NCT04569968|524209181|FG001|Overall Study|Age interval|6|||
145371613|NCT04569968|524209180|FG000|Overall Study|Denial of participation to the study|0|||
145371614|NCT04569968|524209181|FG001|Overall Study|Denial of participation to the study|3|||
145371615|NCT04569968|524209180|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
145371616|NCT04569968|524209181|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
145371617|NCT04569968|524209180|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
145371618|NCT04569968|524209181|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
145371619|NCT04569968|524209180|FG000|Overall Study|Quarantine|1|||
145371620|NCT04569968|524209181|FG001|Overall Study|Quarantine|0|||
145371621|NCT04569968|524209180|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
145371622|NCT04569968|524209181|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
145371623|NCT04569968|524209180|FG000|Overall Study|Repetitive stroke|8|||
145371624|NCT04569968|524209181|FG001|Overall Study|Repetitive stroke|0|||
145371625|NCT04569968|524209180|FG000|Overall Study|Insufficient mastication|1|||
145371626|NCT04569968|524209181|FG001|Overall Study|Insufficient mastication|0|||
145371627|NCT04569968|524209180|FG000|Overall Study|Infection|1|||
145371628|NCT04569968|524209181|FG001|Overall Study|Infection|0|||
145371629|NCT00727844|524209182|FG000|Initial Randomization|Physician Decision|2|||
145371630|NCT00727844|524209183|FG001|Initial Randomization|Physician Decision|0|||
145371631|NCT00727844|524209184|FG002|Initial Randomization|Physician Decision|0|||
145371632|NCT00727844|524209185|FG003|Initial Randomization|Physician Decision|0|||
145371633|NCT00574249|524209193|FG000|Overall Study|Adverse Event|6|||
145371634|NCT00574249|524209194|FG001|Overall Study|Adverse Event|18|||
145371635|NCT00574249|524209193|FG000|Overall Study|Lack of Efficacy|5|||
145371636|NCT00574249|524209194|FG001|Overall Study|Lack of Efficacy|3|||
145371637|NCT00574249|524209193|FG000|Overall Study|Lost to Follow-up|4|||
145371638|NCT00574249|524209194|FG001|Overall Study|Lost to Follow-up|3|||
145371639|NCT00574249|524209193|FG000|Overall Study|Protocol Violation|5|||
145371640|NCT00574249|524209194|FG001|Overall Study|Protocol Violation|2|||
145371641|NCT00574249|524209193|FG000|Overall Study|History of carcinoma|1|||
145371642|NCT00574249|524209194|FG001|Overall Study|History of carcinoma|0|||
145371643|NCT00574249|524209193|FG000|Overall Study|Withdrawal by Subject|3|||
145371644|NCT00574249|524209194|FG001|Overall Study|Withdrawal by Subject|0|||
145423040|NCT00452400|524404283|FG003|Overall Study|Protocol Violation|0|||
145423041|NCT00452400|524404284|FG004|Overall Study|Protocol Violation|0|||
145423042|NCT00452400|524404280|FG000|Overall Study|Lost to Follow-up|1|||
145423043|NCT00452400|524404281|FG001|Overall Study|Lost to Follow-up|0|||
145423044|NCT00452400|524404282|FG002|Overall Study|Lost to Follow-up|0|||
145423045|NCT00452400|524404283|FG003|Overall Study|Lost to Follow-up|0|||
145423046|NCT00452400|524404284|FG004|Overall Study|Lost to Follow-up|0|||
145423047|NCT00452400|524404280|FG000|Overall Study|Withdrawal by Subject|1|||
145423048|NCT00452400|524404281|FG001|Overall Study|Withdrawal by Subject|0|||
145423049|NCT00452400|524404282|FG002|Overall Study|Withdrawal by Subject|1|||
145423050|NCT00452400|524404283|FG003|Overall Study|Withdrawal by Subject|0|||
145423051|NCT00452400|524404284|FG004|Overall Study|Withdrawal by Subject|0|||
145423052|NCT00452400|524404280|FG000|Overall Study|Lack of Efficacy|2|||
145423053|NCT00452400|524404281|FG001|Overall Study|Lack of Efficacy|0|||
145423054|NCT00452400|524404282|FG002|Overall Study|Lack of Efficacy|0|||
145423055|NCT00452400|524404283|FG003|Overall Study|Lack of Efficacy|0|||
145423056|NCT00452400|524404284|FG004|Overall Study|Lack of Efficacy|0|||
145423057|NCT00452400|524404280|FG000|Overall Study|Other reasons not listed above|0|||
145423058|NCT00452400|524404281|FG001|Overall Study|Other reasons not listed above|0|||
145423059|NCT00452400|524404282|FG002|Overall Study|Other reasons not listed above|0|||
145423060|NCT00452400|524404283|FG003|Overall Study|Other reasons not listed above|1|||
145423061|NCT00452400|524404284|FG004|Overall Study|Other reasons not listed above|1|||
145423062|NCT02496156|524404286|FG000|Overall Study|Lost to Follow-up|5|||
145423063|NCT02496156|524404287|FG001|Overall Study|Lost to Follow-up|0|||
145423064|NCT02496156|524404286|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
145423065|NCT02496156|524404287|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
145423066|NCT00089583|524404288|FG000|Overall Study|Adverse Event|0|||
145423067|NCT00089583|524404289|FG001|Overall Study|Adverse Event|3|||
145423068|NCT00089583|524404288|FG000|Overall Study|Insufficient Viral Load Response|5|||
145423069|NCT00089583|524404289|FG001|Overall Study|Insufficient Viral Load Response|5|||
145423070|NCT00089583|524404288|FG000|Overall Study|Withdrawal by Subject|0|||
145423071|NCT00089583|524404289|FG001|Overall Study|Withdrawal by Subject|4|||
145423072|NCT00089583|524404288|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
145423073|NCT00089583|524404289|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
145423074|NCT00089583|524404288|FG000|Overall Study|Participant Refused Study Medication|0|||
145423075|NCT00089583|524404289|FG001|Overall Study|Participant Refused Study Medication|2|||
145423076|NCT00089583|524404288|FG000|Overall Study|Non-Compliance|0|||
145423077|NCT00089583|524404289|FG001|Overall Study|Non-Compliance|4|||
145423078|NCT00089583|524404288|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
145423079|NCT00089583|524404289|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
145423080|NCT00089583|524404288|FG000|Overall Study|Participant Management Criteria Met|0|||
145423081|NCT00089583|524404289|FG001|Overall Study|Participant Management Criteria Met|1|||
145423082|NCT00089583|524404288|FG000|Overall Study|Reason Not Provided|0|||
145423083|NCT00089583|524404289|FG001|Overall Study|Reason Not Provided|1|||
145423084|NCT00089583|524404288|FG000|Overall Study|Protocol Violation|0|||
145423085|NCT00089583|524404289|FG001|Overall Study|Protocol Violation|3|||
145423086|NCT00089583|524404288|FG000|Overall Study|Principal Investigator Decision|0|||
145423087|NCT00089583|524404289|FG001|Overall Study|Principal Investigator Decision|10|||
145423088|NCT00089583|524404288|FG000|Overall Study|Start of Disallowed Medication|0|||
145423089|NCT00089583|524404289|FG001|Overall Study|Start of Disallowed Medication|1|||
145423090|NCT00089583|524404288|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
145423091|NCT00089583|524404289|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
145423092|NCT00089583|524404288|FG000|Overall Study|Participant Incarcerated|0|||
145423093|NCT00089583|524404289|FG001|Overall Study|Participant Incarcerated|1|||
145423094|NCT01623154|524404290|FG000|Overall Study|Did not drink Pranactin Citric|4|||
145423095|NCT01703221|524404291|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
145423096|NCT01703221|524404292|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
145423097|NCT01703221|524404293|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145423098|NCT01703221|524404291|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
145423099|NCT01703221|524404292|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
145579198|NCT01863446|524975276|FG000|Overall Study|Withdrawal by Subject|1|||
145423100|NCT01703221|524404293|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
145423101|NCT01703221|524404291|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
145423102|NCT01703221|524404292|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145423103|NCT01703221|524404293|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145423104|NCT01703221|524404291|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
145423105|NCT01703221|524404292|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145423106|NCT01703221|524404293|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145423107|NCT01703221|524404291|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145423108|NCT01703221|524404292|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145423109|NCT01703221|524404293|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
145423110|NCT01703221|524404291|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
145423111|NCT01703221|524404292|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
145579199|NCT01863446|524975277|FG001|Overall Study|Withdrawal by Subject|0|||
145423112|NCT01703221|524404293|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
145423113|NCT01703221|524404291|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
145423114|NCT01703221|524404292|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
145423115|NCT01703221|524404293|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
145423116|NCT01703221|524404291|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
145423117|NCT01703221|524404292|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
145423118|NCT01703221|524404293|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
145423119|NCT05130281|524406464|FG000|Overall Study|Withdrawal by Subject|0|||
145423120|NCT05130281|524406465|FG001|Overall Study|Withdrawal by Subject|0|||
145423121|NCT05130281|524406466|FG002|Overall Study|Withdrawal by Subject|1|||
145423122|NCT03810365|524406468|FG000|Overall Study|Lost to Follow-up|2|||
145423123|NCT03810365|524406469|FG001|Overall Study|Lost to Follow-up|2|||
145423124|NCT03810365|524406468|FG000|Overall Study|Withdrawal by Subject|4|||
145423125|NCT03810365|524406469|FG001|Overall Study|Withdrawal by Subject|5|||
145423126|NCT05333965|524406473|FG000|First Intervention|Adverse Event|0|||
145423127|NCT05333965|524406474|FG001|First Intervention|Adverse Event|1|||
145423128|NCT05333965|524406473|FG000|First Intervention|Withdrawal by Subject|0|||
145423129|NCT05333965|524406474|FG001|First Intervention|Withdrawal by Subject|1|||
145423130|NCT02144337|524406475|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
145423131|NCT02144337|524406476|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
145423132|NCT02144337|524406475|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
145423133|NCT02144337|524406476|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
145423134|NCT02144337|524406475|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
145423135|NCT02144337|524406476|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
145423136|NCT02144337|524406475|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
145423137|NCT02144337|524406476|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
145423138|NCT02144337|524406475|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
145423139|NCT02144337|524406476|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
145423140|NCT03701074|524406477|FG000|Overall Study|Physician Decision|1|||
145423141|NCT03701074|524406478|FG001|Overall Study|Physician Decision|0|||
145423142|NCT01661595|524406479|FG000|Phase 1: Week 0-4|Adverse Event|1|||
145423143|NCT01661595|524406480|FG001|Phase 1: Week 0-4|Adverse Event|0|||
145423144|NCT01661595|524406481|FG002|Phase 1: Week 0-4|Adverse Event|0|||
145423145|NCT01661595|524406482|FG003|Phase 1: Week 0-4|Adverse Event|0|||
145423146|NCT01661595|524406479|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
145423147|NCT01661595|524406480|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
145423148|NCT01661595|524406481|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
145423149|NCT01661595|524406482|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
145423150|NCT01034657|524406483|FG000|Core Phase|Withdrawal by Subject|1|||
145423151|NCT01034657|524406484|FG001|Core Phase|Withdrawal by Subject|0|||
145423152|NCT01034657|524406485|FG002|Core Phase|Withdrawal by Subject|0|||
145423153|NCT01034657|524406483|FG000|Core Phase|Lack of Efficacy|2|||
145423154|NCT01034657|524406484|FG001|Core Phase|Lack of Efficacy|0|||
145423155|NCT01034657|524406485|FG002|Core Phase|Lack of Efficacy|0|||
145423156|NCT01034657|524406483|FG000|Core Phase|Abnormal laboratory value|1|||
145423157|NCT01034657|524406484|FG001|Core Phase|Abnormal laboratory value|0|||
145423158|NCT01034657|524406485|FG002|Core Phase|Abnormal laboratory value|0|||
145423159|NCT01034657|524406483|FG000|Core Phase|Adverse Event|8|||
145423160|NCT01034657|524406484|FG001|Core Phase|Adverse Event|0|||
145423161|NCT01034657|524406485|FG002|Core Phase|Adverse Event|0|||
145423162|NCT01034657|524406483|FG000|Core Phase|Protocol Violation|2|||
145423163|NCT01034657|524406484|FG001|Core Phase|Protocol Violation|0|||
145423164|NCT01034657|524406485|FG002|Core Phase|Protocol Violation|0|||
145423165|NCT01034657|524406483|FG000|Randomized Phase|Withdrawal by Subject|0|||
145423166|NCT01034657|524406484|FG001|Randomized Phase|Withdrawal by Subject|2|||
145423167|NCT01034657|524406485|FG002|Randomized Phase|Withdrawal by Subject|0|||
145423168|NCT01034657|524406483|FG000|Randomized Phase|Lack of Efficacy|5|||
145423169|NCT01034657|524406484|FG001|Randomized Phase|Lack of Efficacy|1|||
145423170|NCT01034657|524406485|FG002|Randomized Phase|Lack of Efficacy|0|||
145423171|NCT01034657|524406483|FG000|Randomized Phase|Abnormal laboratory value|0|||
145423172|NCT01034657|524406484|FG001|Randomized Phase|Abnormal laboratory value|1|||
145423173|NCT01034657|524406485|FG002|Randomized Phase|Abnormal laboratory value|0|||
145423174|NCT01034657|524406483|FG000|Randomized Phase|Adverse Event|0|||
145423175|NCT01034657|524406484|FG001|Randomized Phase|Adverse Event|2|||
145423176|NCT01034657|524406485|FG002|Randomized Phase|Adverse Event|1|||
145423177|NCT00309946|524406486|FG000|Overall Study|Withdrawal by Subject|1|||
145423178|NCT00347269|524406487|FG000|Overall Study|Lost to Follow-up|74|||
145423179|NCT00347269|524406488|FG001|Overall Study|Lost to Follow-up|65|||
145423180|NCT00347269|524406487|FG000|Overall Study|Withdrawal by Subject|18|||
145423181|NCT00347269|524406488|FG001|Overall Study|Withdrawal by Subject|38|||
145423182|NCT00347269|524406487|FG000|Overall Study|Death|2|||
145423183|NCT00347269|524406488|FG001|Overall Study|Death|3|||
145623476|NCT00761774|525133932|FG000|Overall Study|IP stopped by hospital physician|1|||
145423184|NCT03654326|524406489|FG000|Overall Study|Withdrawal by Subject|5|||
145423185|NCT03654326|524406490|FG001|Overall Study|Withdrawal by Subject|3|||
145423186|NCT03654326|524406489|FG000|Overall Study|Physician Decision|0|||
145423187|NCT03654326|524406490|FG001|Overall Study|Physician Decision|1|||
145423188|NCT03654326|524406489|FG000|Overall Study|Unable to adhere to study schedule|0|||
145423189|NCT03654326|524406490|FG001|Overall Study|Unable to adhere to study schedule|1|||
145423190|NCT03654326|524406489|FG000|Overall Study|Lost to Follow-up|1|||
145423191|NCT03654326|524406490|FG001|Overall Study|Lost to Follow-up|1|||
145423192|NCT04893811|524406491|FG000|Vaccination Phase|Death|1|||
145423193|NCT04893811|524406492|FG001|Vaccination Phase|Death|0|||
145423194|NCT04893811|524406491|FG000|Vaccination Phase|Lost to Follow-up|1|||
145423195|NCT04893811|524406492|FG001|Vaccination Phase|Lost to Follow-up|1|||
145423196|NCT04893811|524406491|FG000|Vaccination Phase|Protocol Violation|2|||
145423197|NCT04893811|524406492|FG001|Vaccination Phase|Protocol Violation|0|||
145423198|NCT04893811|524406491|FG000|Vaccination Phase|Withdrawal by Subject|2|||
145423199|NCT04893811|524406492|FG001|Vaccination Phase|Withdrawal by Subject|1|||
145423200|NCT04893811|524406491|FG000|Vaccination Phase|Other|0|||
145423201|NCT04893811|524406492|FG001|Vaccination Phase|Other|1|||
145423202|NCT04893811|524406491|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
145423203|NCT04893811|524406492|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
145423204|NCT04893811|524406491|FG000|Follow-up Phase|Lost to Follow-up|0|||
145423205|NCT04893811|524406492|FG001|Follow-up Phase|Lost to Follow-up|1|||
145423206|NCT00835042|524406493|FG000|First Intervention|Withdrawal by Subject|3|||
145423207|NCT00835042|524406494|FG001|First Intervention|Withdrawal by Subject|0|||
145423208|NCT00835042|524406493|FG000|First Intervention|Adverse Event|1|||
145423209|NCT00835042|524406494|FG001|First Intervention|Adverse Event|2|||
145423210|NCT00835042|524406493|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
145423211|NCT00835042|524406494|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
145423212|NCT02662582|524406495|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
145423213|NCT02662582|524406496|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
145423214|NCT02662582|524406495|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
145423215|NCT02662582|524406496|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
145423216|NCT02662582|524406495|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
145423217|NCT02662582|524406496|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
145423218|NCT02662582|524406495|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145423219|NCT02662582|524406496|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145423220|NCT05451329|524406503|FG000|Overall Study|Adverse Event|1|||
145423221|NCT05451329|524406504|FG001|Overall Study|Adverse Event|1|||
145423222|NCT05451329|524406505|FG002|Overall Study|Adverse Event|0|||
145579200|NCT01863446|524975278|FG002|Overall Study|Withdrawal by Subject|1|||
145579201|NCT01863446|524975279|FG003|Overall Study|Withdrawal by Subject|2|||
145371645|NCT00574249|524209193|FG000|Overall Study|Physician Decision|1|||
145371646|NCT00574249|524209194|FG001|Overall Study|Physician Decision|0|||
145371647|NCT00574249|524209193|FG000|Overall Study|Pregnancy|1|||
145371648|NCT00574249|524209194|FG001|Overall Study|Pregnancy|0|||
145371649|NCT00574249|524209193|FG000|Overall Study|Excluded by company|0|||
145371650|NCT00574249|524209194|FG001|Overall Study|Excluded by company|1|||
145371651|NCT00574249|524209193|FG000|Overall Study|PPD test taken twice|0|||
145371652|NCT00574249|524209194|FG001|Overall Study|PPD test taken twice|1|||
145371653|NCT01680159|524209195|FG000|Screening Period|Not meet criteria for dose-up period|7|||
145371654|NCT01680159|524209195|FG000|Increased Dose Period|Adverse Event|6|||
145371655|NCT01680159|524209195|FG000|Increased Dose Period|Withdrawal by Subject|2|||
145371656|NCT02783729|524209199|FG000|Overall Study|Lack of Efficacy|1|||
145371657|NCT02783729|524209200|FG001|Overall Study|Lack of Efficacy|0|||
145371658|NCT02783729|524209201|FG002|Overall Study|Lack of Efficacy|0|||
145371659|NCT02783729|524209202|FG003|Overall Study|Lack of Efficacy|0|||
145371660|NCT02783729|524209199|FG000|Overall Study|Adverse Event|2|||
145371661|NCT02783729|524209200|FG001|Overall Study|Adverse Event|6|||
145371662|NCT02783729|524209201|FG002|Overall Study|Adverse Event|2|||
145371663|NCT02783729|524209202|FG003|Overall Study|Adverse Event|3|||
145371664|NCT02783729|524209199|FG000|Overall Study|Other|1|||
145371665|NCT02783729|524209200|FG001|Overall Study|Other|6|||
145371666|NCT02783729|524209201|FG002|Overall Study|Other|2|||
145371667|NCT02783729|524209202|FG003|Overall Study|Other|3|||
145371668|NCT02783729|524209199|FG000|Overall Study|Withdrawal by Subject|2|||
145371669|NCT02783729|524209200|FG001|Overall Study|Withdrawal by Subject|3|||
145371670|NCT02783729|524209201|FG002|Overall Study|Withdrawal by Subject|1|||
145371671|NCT02783729|524209202|FG003|Overall Study|Withdrawal by Subject|2|||
145371672|NCT02783729|524209199|FG000|Overall Study|Participant's choice|2|||
145371673|NCT02783729|524209200|FG001|Overall Study|Participant's choice|1|||
145371674|NCT02783729|524209201|FG002|Overall Study|Participant's choice|2|||
145371675|NCT02783729|524209202|FG003|Overall Study|Participant's choice|1|||
145371676|NCT02783729|524209199|FG000|Overall Study|Lost to Follow-up|2|||
145371677|NCT02783729|524209200|FG001|Overall Study|Lost to Follow-up|1|||
145371678|NCT02783729|524209201|FG002|Overall Study|Lost to Follow-up|1|||
145423223|NCT05451329|524406503|FG000|Overall Study|Withdrawal by Subject|1|||
145423224|NCT05451329|524406504|FG001|Overall Study|Withdrawal by Subject|0|||
145371679|NCT02783729|524209202|FG003|Overall Study|Lost to Follow-up|0|||
145371680|NCT04021121|524209205|FG000|Overall Study|Death|3|||
145579202|NCT01863446|524975276|FG000|Overall Study|Physician Decision|0|||
145423225|NCT05451329|524406505|FG002|Overall Study|Withdrawal by Subject|0|||
145423226|NCT05451329|524406503|FG000|Overall Study|Investigational Product Lot exchange|1|||
145423227|NCT05451329|524406504|FG001|Overall Study|Investigational Product Lot exchange|1|||
145423228|NCT05451329|524406505|FG002|Overall Study|Investigational Product Lot exchange|0|||
145423229|NCT02176525|524406508|FG000|Overall Study|Adverse Event|0|||
145423230|NCT02176525|524406509|FG001|Overall Study|Adverse Event|0|||
145423231|NCT02176525|524406510|FG002|Overall Study|Adverse Event|0|||
145423232|NCT02176525|524406511|FG003|Overall Study|Adverse Event|1|||
145423233|NCT02176525|524406512|FG004|Overall Study|Adverse Event|1|||
145423234|NCT02176525|524406513|FG005|Overall Study|Adverse Event|0|||
145423235|NCT02176525|524406514|FG006|Overall Study|Adverse Event|1|||
145423236|NCT02176525|524406515|FG007|Overall Study|Adverse Event|0|||
145423237|NCT02176525|524406508|FG000|Overall Study|not treated|1|||
145423238|NCT02176525|524406509|FG001|Overall Study|not treated|0|||
145423239|NCT02176525|524406510|FG002|Overall Study|not treated|0|||
145423240|NCT02176525|524406511|FG003|Overall Study|not treated|0|||
145423241|NCT02176525|524406512|FG004|Overall Study|not treated|0|||
145423242|NCT02176525|524406513|FG005|Overall Study|not treated|1|||
145423243|NCT02176525|524406514|FG006|Overall Study|not treated|0|||
145423244|NCT02176525|524406515|FG007|Overall Study|not treated|0|||
145423245|NCT04629521|524406518|FG000|Overall Study|Death|1|||
145423246|NCT04629521|524406518|FG000|Overall Study|Lost to Follow-up|3|||
145423247|NCT04629521|524406518|FG000|Overall Study|Subject withdrew consent|3|||
145423248|NCT04629521|524406518|FG000|Overall Study|Enrolled in error|1|||
145423249|NCT01898091|524406521|FG000|Overall Study|Lost to Follow-up|1|||
145423250|NCT01898091|524406522|FG001|Overall Study|Lost to Follow-up|1|||
145423251|NCT01898091|524406521|FG000|Overall Study|Withdrawal by Subject|1|||
145423252|NCT01898091|524406522|FG001|Overall Study|Withdrawal by Subject|5|||
145423253|NCT02369159|524406525|FG000|Overall Study|Adverse Event|0|||
145423254|NCT02369159|524406526|FG001|Overall Study|Adverse Event|1|||
145423255|NCT02369159|524406525|FG000|Overall Study|Lost to Follow-up|1|||
145423256|NCT02369159|524406526|FG001|Overall Study|Lost to Follow-up|1|||
145423257|NCT02369159|524406525|FG000|Overall Study|Withdrawal by Subject|7|||
145423258|NCT02369159|524406526|FG001|Overall Study|Withdrawal by Subject|0|||
145423259|NCT02913326|524406533|FG000|Overall Study|Reason not listed|0|||
145423260|NCT02913326|524406534|FG001|Overall Study|Reason not listed|1|||
145423261|NCT02913326|524406533|FG000|Overall Study|Lost to Follow-up|0|||
145423262|NCT02913326|524406534|FG001|Overall Study|Lost to Follow-up|1|||
145423263|NCT02913326|524406533|FG000|Overall Study|Adverse Event|1|||
145423264|NCT02913326|524406534|FG001|Overall Study|Adverse Event|0|||
145423265|NCT01514422|524406535|FG000|Overall Study|Lost to Follow-up|1|||
145423266|NCT00911157|524406538|FG000|Overall Study|Adverse Event|4|||
145423267|NCT00911157|524406539|FG001|Overall Study|Adverse Event|1|||
145423268|NCT00911157|524406538|FG000|Overall Study|Withdrawal by Subject|1|||
145423269|NCT00911157|524406539|FG001|Overall Study|Withdrawal by Subject|1|||
145423270|NCT00911157|524406538|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
145423271|NCT00911157|524406539|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
145423272|NCT00911157|524406538|FG000|Overall Study|Need to treat for lung cancer|1|||
145423273|NCT00911157|524406539|FG001|Overall Study|Need to treat for lung cancer|0|||
145423274|NCT03769467|524406540|FG000|Overall Study|Adverse Event|1|||
145423275|NCT03769467|524406541|FG001|Overall Study|Adverse Event|1|||
145423276|NCT03769467|524406542|FG002|Overall Study|Adverse Event|0|||
145423277|NCT03769467|524406540|FG000|Overall Study|Death|3|||
145423278|NCT03769467|524406541|FG001|Overall Study|Death|3|||
145423279|NCT03769467|524406542|FG002|Overall Study|Death|0|||
145423280|NCT03769467|524406540|FG000|Overall Study|Study Terminated By Sponsor|2|||
145423281|NCT03769467|524406541|FG001|Overall Study|Study Terminated By Sponsor|1|||
145423282|NCT03769467|524406542|FG002|Overall Study|Study Terminated By Sponsor|0|||
145423283|NCT03769467|524406540|FG000|Overall Study|Withdrawal by Subject|0|||
145423284|NCT03769467|524406541|FG001|Overall Study|Withdrawal by Subject|1|||
145423285|NCT03769467|524406542|FG002|Overall Study|Withdrawal by Subject|0|||
145423286|NCT04565756|524406543|FG000|Overall Study|Withdrawal by Subject|0|||
145423287|NCT04565756|524406544|FG001|Overall Study|Withdrawal by Subject|0|||
145423288|NCT04565756|524406545|FG002|Overall Study|Withdrawal by Subject|0|||
145423289|NCT04565756|524406546|FG003|Overall Study|Withdrawal by Subject|0|||
145423290|NCT04565756|524406547|FG004|Overall Study|Withdrawal by Subject|1|||
145423291|NCT04565756|524406548|FG005|Overall Study|Withdrawal by Subject|0|||
145423292|NCT04565756|524406543|FG000|Overall Study|Protocol Violation|0|||
145423293|NCT04565756|524406544|FG001|Overall Study|Protocol Violation|0|||
145423294|NCT04565756|524406545|FG002|Overall Study|Protocol Violation|0|||
145423295|NCT04565756|524406546|FG003|Overall Study|Protocol Violation|0|||
145423296|NCT04565756|524406547|FG004|Overall Study|Protocol Violation|0|||
145423297|NCT04565756|524406548|FG005|Overall Study|Protocol Violation|1|||
145423298|NCT05259722|524406549|FG000|Overall Study|Adverse Event|2|||
145423299|NCT05259722|524406550|FG001|Overall Study|Adverse Event|24|||
145423300|NCT05259722|524406549|FG000|Overall Study|Lost to Follow-up|5|||
145423301|NCT05259722|524406550|FG001|Overall Study|Lost to Follow-up|1|||
145423302|NCT05259722|524406549|FG000|Overall Study|Lack of Efficacy|8|||
145423303|NCT05259722|524406550|FG001|Overall Study|Lack of Efficacy|26|||
145579203|NCT01863446|524975277|FG001|Overall Study|Physician Decision|0|||
145579204|NCT01863446|524975278|FG002|Overall Study|Physician Decision|1|||
145579205|NCT01863446|524975279|FG003|Overall Study|Physician Decision|0|||
145579206|NCT03603964|524975282|FG000|Overall Study|Death|9|||
145579207|NCT03603964|524975282|FG000|Overall Study|Withdrawal by participant|7|||
145371681|NCT04021121|524209206|FG001|Overall Study|Death|3|||
145371682|NCT04021121|524209207|FG002|Overall Study|Death|5|||
145371683|NCT04021121|524209208|FG003|Overall Study|Death|4|||
145371684|NCT02288091|524209209|FG000|Overall Study|Lost to Follow-up|1|||
145371685|NCT02288091|524209209|FG000|Overall Study|Screen fail|7|||
145371686|NCT04166591|524210954|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145371687|NCT04166591|524210955|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145371688|NCT04166591|524210956|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145371689|NCT04166591|524210957|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145371690|NCT04166591|524210954|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145371691|NCT04166591|524210955|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145371692|NCT04166591|524210956|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145371693|NCT04166591|524210957|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145371694|NCT03030989|524210958|FG000|Overall Study|Fever|2|||
145371695|NCT03030989|524210959|FG001|Overall Study|Fever|2|||
145371696|NCT03030989|524210958|FG000|Overall Study|Rash|2|||
145371697|NCT03030989|524210959|FG001|Overall Study|Rash|1|||
145371698|NCT03030989|524210958|FG000|Overall Study|Fatigue/Overwhelmed|1|||
145371699|NCT03030989|524210959|FG001|Overall Study|Fatigue/Overwhelmed|5|||
145371700|NCT03030989|524210958|FG000|Overall Study|Positive Blood Cultures|2|||
145371701|NCT03030989|524210959|FG001|Overall Study|Positive Blood Cultures|1|||
145371702|NCT03030989|524210958|FG000|Overall Study|Line Removed|0|||
145371703|NCT03030989|524210959|FG001|Overall Study|Line Removed|2|||
145371704|NCT03030989|524210958|FG000|Overall Study|No longer interested|5|||
145371705|NCT03030989|524210959|FG001|Overall Study|No longer interested|3|||
145371706|NCT02730377|524210960|FG000|Overall Study|Other|5|||
145371707|NCT02730377|524210961|FG001|Overall Study|Other|4|||
145371708|NCT02730377|524210960|FG000|Overall Study|Death|1|||
145371709|NCT02730377|524210961|FG001|Overall Study|Death|8|||
145371710|NCT02730377|524210960|FG000|Overall Study|Inadequate glycaemic control|368|||
145371711|NCT02730377|524210961|FG001|Overall Study|Inadequate glycaemic control|473|||
145371712|NCT02730377|524210960|FG000|Overall Study|Adverse Event|79|||
145371713|NCT02730377|524210961|FG001|Overall Study|Adverse Event|41|||
145371714|NCT02730377|524210960|FG000|Overall Study|Protocol Violation|23|||
145371715|NCT02730377|524210961|FG001|Overall Study|Protocol Violation|30|||
145371716|NCT02730377|524210960|FG000|Overall Study|Lack of Efficacy|4|||
145371717|NCT02730377|524210961|FG001|Overall Study|Lack of Efficacy|13|||
145371718|NCT02730377|524210960|FG000|Overall Study|Pregnancy|0|||
145371719|NCT02730377|524210961|FG001|Overall Study|Pregnancy|1|||
145371720|NCT02730377|524210960|FG000|Overall Study|Withdrawal by Subject|45|||
145371721|NCT02730377|524210961|FG001|Overall Study|Withdrawal by Subject|42|||
145371722|NCT02730377|524210960|FG000|Overall Study|Lost to Follow-up|25|||
145371723|NCT02730377|524210961|FG001|Overall Study|Lost to Follow-up|21|||
145371724|NCT02031640|524210962|FG000|Screening Period|Adverse Event|1|||
145371725|NCT02031640|524210963|FG001|Screening Period|Adverse Event|0|||
145371726|NCT02031640|524210964|FG002|Screening Period|Adverse Event|0|||
145371727|NCT02031640|524210965|FG003|Screening Period|Adverse Event|0|||
145371728|NCT02031640|524210966|FG004|Screening Period|Adverse Event|0|||
145371729|NCT02031640|524210967|FG005|Screening Period|Adverse Event|0|||
145371730|NCT02031640|524210962|FG000|Screening Period|Withdrawal by Subject|29|||
145371731|NCT02031640|524210963|FG001|Screening Period|Withdrawal by Subject|0|||
145371732|NCT02031640|524210964|FG002|Screening Period|Withdrawal by Subject|0|||
145371733|NCT02031640|524210965|FG003|Screening Period|Withdrawal by Subject|0|||
145371734|NCT02031640|524210966|FG004|Screening Period|Withdrawal by Subject|0|||
145371735|NCT02031640|524210967|FG005|Screening Period|Withdrawal by Subject|0|||
145371736|NCT02031640|524210962|FG000|Screening Period|Inclusion criteria not met|312|||
145371737|NCT02031640|524210963|FG001|Screening Period|Inclusion criteria not met|0|||
145371738|NCT02031640|524210964|FG002|Screening Period|Inclusion criteria not met|0|||
145371739|NCT02031640|524210965|FG003|Screening Period|Inclusion criteria not met|0|||
145371740|NCT02031640|524210966|FG004|Screening Period|Inclusion criteria not met|0|||
145371741|NCT02031640|524210967|FG005|Screening Period|Inclusion criteria not met|0|||
145371742|NCT02031640|524210962|FG000|Screening Period|Exclusion criteria met|30|||
145371743|NCT02031640|524210963|FG001|Screening Period|Exclusion criteria met|0|||
145371744|NCT02031640|524210964|FG002|Screening Period|Exclusion criteria met|0|||
145371745|NCT02031640|524210965|FG003|Screening Period|Exclusion criteria met|0|||
145371746|NCT02031640|524210966|FG004|Screening Period|Exclusion criteria met|0|||
145371747|NCT02031640|524210967|FG005|Screening Period|Exclusion criteria met|0|||
145371748|NCT02031640|524210962|FG000|Screening Period|Lost to Follow-up|14|||
145371749|NCT02031640|524210963|FG001|Screening Period|Lost to Follow-up|0|||
145579208|NCT03603964|524975282|FG000|Overall Study|Study terminated by Sponsor|19|||
145371750|NCT02031640|524210964|FG002|Screening Period|Lost to Follow-up|0|||
145579209|NCT00684424|524975285|FG000|Overall Study|Adverse Event|1|||
145579210|NCT00684424|524975285|FG000|Overall Study|Lost to Follow-up|2|||
145579211|NCT00684424|524975285|FG000|Overall Study|Other|2|||
145579212|NCT00887341|524975300|FG000|Overall Study|Refused treatment|1|||
145579213|NCT00887341|524975301|FG001|Overall Study|Refused treatment|0|||
145579214|NCT00887341|524975300|FG000|Overall Study|Withdrawal by Subject|1|||
145579215|NCT00887341|524975301|FG001|Overall Study|Withdrawal by Subject|1|||
145579216|NCT00887341|524975300|FG000|Overall Study|Adverse Event|0|||
145579217|NCT00887341|524975301|FG001|Overall Study|Adverse Event|1|||
145579218|NCT00887341|524975300|FG000|Overall Study|Lost to Follow-up|0|||
145579219|NCT00887341|524975301|FG001|Overall Study|Lost to Follow-up|1|||
145579220|NCT01752933|524975304|FG000|Treatment|Disease Progression|3|||
145579221|NCT01752933|524975305|FG001|Treatment|Disease Progression|29|||
145623477|NCT00811187|525133934|FG000|Overall Study|Unable to place device / procedure abort|3|||
145371751|NCT02031640|524210965|FG003|Screening Period|Lost to Follow-up|0|||
145371752|NCT02031640|524210966|FG004|Screening Period|Lost to Follow-up|0|||
145371753|NCT02031640|524210967|FG005|Screening Period|Lost to Follow-up|0|||
145371754|NCT02031640|524210962|FG000|Screening Period|Enrollment closed|26|||
145371755|NCT02031640|524210963|FG001|Screening Period|Enrollment closed|0|||
145371756|NCT02031640|524210964|FG002|Screening Period|Enrollment closed|0|||
145371757|NCT02031640|524210965|FG003|Screening Period|Enrollment closed|0|||
145371758|NCT02031640|524210966|FG004|Screening Period|Enrollment closed|0|||
145371759|NCT02031640|524210967|FG005|Screening Period|Enrollment closed|0|||
145371760|NCT02031640|524210962|FG000|Run-In Period|Adverse Event|4|||
145371761|NCT02031640|524210963|FG001|Run-In Period|Adverse Event|0|||
145371762|NCT02031640|524210964|FG002|Run-In Period|Adverse Event|0|||
145371763|NCT02031640|524210965|FG003|Run-In Period|Adverse Event|0|||
145371764|NCT02031640|524210966|FG004|Run-In Period|Adverse Event|0|||
145371765|NCT02031640|524210967|FG005|Run-In Period|Adverse Event|0|||
145371766|NCT02031640|524210962|FG000|Run-In Period|Withdrawal by Subject|17|||
145371767|NCT02031640|524210963|FG001|Run-In Period|Withdrawal by Subject|0|||
145371768|NCT02031640|524210964|FG002|Run-In Period|Withdrawal by Subject|0|||
145371769|NCT02031640|524210965|FG003|Run-In Period|Withdrawal by Subject|0|||
145371770|NCT02031640|524210966|FG004|Run-In Period|Withdrawal by Subject|0|||
145371771|NCT02031640|524210967|FG005|Run-In Period|Withdrawal by Subject|0|||
145371772|NCT02031640|524210962|FG000|Run-In Period|Inclusion criteria not met|38|||
145371773|NCT02031640|524210963|FG001|Run-In Period|Inclusion criteria not met|0|||
145371774|NCT02031640|524210964|FG002|Run-In Period|Inclusion criteria not met|0|||
145371775|NCT02031640|524210965|FG003|Run-In Period|Inclusion criteria not met|0|||
145371776|NCT02031640|524210966|FG004|Run-In Period|Inclusion criteria not met|0|||
145371777|NCT02031640|524210967|FG005|Run-In Period|Inclusion criteria not met|0|||
145371778|NCT02031640|524210962|FG000|Run-In Period|Exclusion criteria met|8|||
145371779|NCT02031640|524210963|FG001|Run-In Period|Exclusion criteria met|0|||
145371780|NCT02031640|524210964|FG002|Run-In Period|Exclusion criteria met|0|||
145371781|NCT02031640|524210965|FG003|Run-In Period|Exclusion criteria met|0|||
145371782|NCT02031640|524210966|FG004|Run-In Period|Exclusion criteria met|0|||
145371783|NCT02031640|524210967|FG005|Run-In Period|Exclusion criteria met|0|||
145371784|NCT02031640|524210962|FG000|Run-In Period|Randomization criteria not met|85|||
145371785|NCT02031640|524210963|FG001|Run-In Period|Randomization criteria not met|0|||
145371786|NCT02031640|524210964|FG002|Run-In Period|Randomization criteria not met|0|||
145371787|NCT02031640|524210965|FG003|Run-In Period|Randomization criteria not met|0|||
145371788|NCT02031640|524210966|FG004|Run-In Period|Randomization criteria not met|0|||
145371789|NCT02031640|524210967|FG005|Run-In Period|Randomization criteria not met|0|||
145371790|NCT02031640|524210962|FG000|Run-In Period|Various administrative reasons|17|||
145371791|NCT02031640|524210963|FG001|Run-In Period|Various administrative reasons|0|||
145371792|NCT02031640|524210964|FG002|Run-In Period|Various administrative reasons|0|||
145371793|NCT02031640|524210965|FG003|Run-In Period|Various administrative reasons|0|||
145371794|NCT02031640|524210966|FG004|Run-In Period|Various administrative reasons|0|||
145371795|NCT02031640|524210967|FG005|Run-In Period|Various administrative reasons|0|||
145371796|NCT02031640|524210962|FG000|Double-blind Treatment Period|Protocol deviation|0|||
145371797|NCT02031640|524210963|FG001|Double-blind Treatment Period|Protocol deviation|2|||
145371798|NCT02031640|524210964|FG002|Double-blind Treatment Period|Protocol deviation|0|||
145371799|NCT02031640|524210965|FG003|Double-blind Treatment Period|Protocol deviation|1|||
145371800|NCT02031640|524210966|FG004|Double-blind Treatment Period|Protocol deviation|3|||
145371801|NCT02031640|524210967|FG005|Double-blind Treatment Period|Protocol deviation|1|||
145371802|NCT02031640|524210962|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145371803|NCT02031640|524210963|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
145371804|NCT02031640|524210964|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
145371805|NCT02031640|524210965|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
145371806|NCT02031640|524210966|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
145371807|NCT02031640|524210967|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
145371808|NCT02031640|524210962|FG000|Double-blind Treatment Period|Non-compliance|0|||
145371809|NCT02031640|524210963|FG001|Double-blind Treatment Period|Non-compliance|1|||
145371810|NCT02031640|524210964|FG002|Double-blind Treatment Period|Non-compliance|0|||
145371811|NCT02031640|524210965|FG003|Double-blind Treatment Period|Non-compliance|1|||
145423304|NCT05259722|524406549|FG000|Overall Study|Withdrawal by Subject|15|||
145423305|NCT05259722|524406550|FG001|Overall Study|Withdrawal by Subject|33|||
145423306|NCT05259722|524406549|FG000|Overall Study|Various reasons|3|||
145423307|NCT05259722|524406550|FG001|Overall Study|Various reasons|9|||
145423308|NCT05259722|524406549|FG000|Overall Study|Not exposed to IMP|1|||
145423309|NCT05259722|524406550|FG001|Overall Study|Not exposed to IMP|12|||
145423310|NCT05259722|524406549|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
145423311|NCT05259722|524406550|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
145423312|NCT01887600|524406551|FG000|Overall Study|Death|39|||
145423313|NCT01887600|524406552|FG001|Overall Study|Death|16|||
145423314|NCT01887600|524406551|FG000|Overall Study|Lack of Efficacy|3|||
145423315|NCT01887600|524406552|FG001|Overall Study|Lack of Efficacy|26|||
145423316|NCT01887600|524406551|FG000|Overall Study|Lost to Follow-up|5|||
145579222|NCT01752933|524975304|FG000|Treatment|Withdrawal by Subject|0|||
145579223|NCT01752933|524975305|FG001|Treatment|Withdrawal by Subject|5|||
145579224|NCT01752933|524975304|FG000|Treatment|Adverse Event|1|||
145579225|NCT01752933|524975305|FG001|Treatment|Adverse Event|4|||
145579226|NCT01752933|524975304|FG000|Treatment|Physician Decision|0|||
145579227|NCT01752933|524975305|FG001|Treatment|Physician Decision|3|||
145423317|NCT01887600|524406552|FG001|Overall Study|Lost to Follow-up|1|||
145423318|NCT01887600|524406551|FG000|Overall Study|Physician Decision|7|||
145423319|NCT01887600|524406552|FG001|Overall Study|Physician Decision|8|||
145423320|NCT01887600|524406551|FG000|Overall Study|Protocol Deviation|3|||
145423321|NCT01887600|524406552|FG001|Overall Study|Protocol Deviation|0|||
145423322|NCT01887600|524406551|FG000|Overall Study|Withdrawal by Subject|58|||
145423323|NCT01887600|524406552|FG001|Overall Study|Withdrawal by Subject|52|||
145423324|NCT01887600|524406551|FG000|Overall Study|Adverse Event|21|||
145423325|NCT01887600|524406552|FG001|Overall Study|Adverse Event|9|||
145423326|NCT01887600|524406551|FG000|Overall Study|Non-compliance with study drug|3|||
145423327|NCT01887600|524406552|FG001|Overall Study|Non-compliance with study drug|0|||
145423328|NCT01887600|524406551|FG000|Overall Study|Miscellaneous|6|||
145423329|NCT01887600|524406552|FG001|Overall Study|Miscellaneous|2|||
145423330|NCT01887600|524406551|FG000|Overall Study|Progressive Disease|1|||
145423331|NCT01887600|524406552|FG001|Overall Study|Progressive Disease|0|||
145423332|NCT00962650|524406553|FG000|Overall Study|Transgastric DP was not completed|2|||
145423333|NCT03688139|524406554|FG000|Overall Study|Lost to Follow-up|2|||
145423334|NCT03688139|524406555|FG001|Overall Study|Lost to Follow-up|0|||
145423335|NCT03688139|524406554|FG000|Overall Study|Physician Decision|0|||
145423336|NCT03688139|524406555|FG001|Overall Study|Physician Decision|1|||
145423337|NCT03688139|524406554|FG000|Overall Study|Withdrawal by Subject|2|||
145423338|NCT03688139|524406555|FG001|Overall Study|Withdrawal by Subject|3|||
145423339|NCT00231465|524406556|FG000|Overall Study|Completed only one cycle|1|||
145423340|NCT00231465|524406556|FG000|Overall Study|Did not have follow up CT scans|1|||
145423341|NCT00420056|524406557|FG000|Overall Study|Objective progression or relapse|17|||
145423342|NCT03624036|524406558|FG000|Overall Study|Death|2|||
145423343|NCT03624036|524406559|FG001|Overall Study|Death|3|||
145423344|NCT03624036|524406560|FG002|Overall Study|Death|0|||
145423345|NCT03624036|524406561|FG003|Overall Study|Death|1|||
145423346|NCT03624036|524406558|FG000|Overall Study|Withdrawal by Subject|1|||
145423347|NCT03624036|524406559|FG001|Overall Study|Withdrawal by Subject|0|||
145423348|NCT03624036|524406560|FG002|Overall Study|Withdrawal by Subject|1|||
145423349|NCT03624036|524406561|FG003|Overall Study|Withdrawal by Subject|0|||
145423350|NCT03624036|524406558|FG000|Overall Study|Enrolled but Never Treated|1|||
145423351|NCT03624036|524406559|FG001|Overall Study|Enrolled but Never Treated|0|||
145423352|NCT03624036|524406560|FG002|Overall Study|Enrolled but Never Treated|0|||
145423353|NCT03624036|524406561|FG003|Overall Study|Enrolled but Never Treated|0|||
145423354|NCT03624036|524406558|FG000|Overall Study|Reason not Specified|3|||
145423355|NCT03624036|524406559|FG001|Overall Study|Reason not Specified|0|||
145423356|NCT03624036|524406560|FG002|Overall Study|Reason not Specified|2|||
145623478|NCT00811187|525133935|FG001|Overall Study|Unable to place device / procedure abort|3|||
145423357|NCT03624036|524406561|FG003|Overall Study|Reason not Specified|2|||
145423358|NCT01390584|524406571|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
145423359|NCT01390584|524406572|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
145423360|NCT01390584|524406573|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
145423361|NCT00498485|524406574|FG000|Overall Study|Adverse Event|1|||
145423362|NCT00498485|524406575|FG001|Overall Study|Adverse Event|5|||
145423363|NCT03478787|524406576|FG000|Overall Study|Adverse Event|5|||
145423364|NCT03478787|524406577|FG001|Overall Study|Adverse Event|1|||
145423365|NCT03478787|524406576|FG000|Overall Study|Protocol Violation|3|||
145579228|NCT01752933|524975304|FG000|Treatment|Death|0|||
145579229|NCT01752933|524975305|FG001|Treatment|Death|2|||
145579230|NCT01752933|524975304|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
145423366|NCT03478787|524406577|FG001|Overall Study|Protocol Violation|0|||
145423367|NCT03478787|524406576|FG000|Overall Study|Lack of Efficacy|7|||
145423368|NCT03478787|524406577|FG001|Overall Study|Lack of Efficacy|1|||
145423369|NCT03478787|524406576|FG000|Overall Study|Lost to Follow-up|9|||
145579231|NCT01752933|524975305|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
145423370|NCT03478787|524406577|FG001|Overall Study|Lost to Follow-up|5|||
145423371|NCT03478787|524406576|FG000|Overall Study|Withdrawal by Subject|2|||
145423372|NCT03478787|524406577|FG001|Overall Study|Withdrawal by Subject|6|||
145423373|NCT03478787|524406576|FG000|Overall Study|Other, Not Specified|3|||
145423374|NCT03478787|524406577|FG001|Overall Study|Other, Not Specified|0|||
145423375|NCT01712074|524406580|FG000|Placebo Run-in Period|Adverse Event|2|||
145423376|NCT01712074|524406581|FG001|Placebo Run-in Period|Adverse Event|0|||
145423377|NCT01712074|524406582|FG002|Placebo Run-in Period|Adverse Event|0|||
145423378|NCT01712074|524406580|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
145423379|NCT01712074|524406581|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
145423380|NCT01712074|524406582|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
145423381|NCT01712074|524406580|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
145423382|NCT01712074|524406581|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
145423383|NCT01712074|524406582|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
145423384|NCT01712074|524406580|FG000|Placebo Run-in Period|Other|1|||
145579232|NCT01752933|524975304|FG000|Treatment|Patient noncompliant|0|||
145579233|NCT01752933|524975305|FG001|Treatment|Patient noncompliant|1|||
145579234|NCT01752933|524975304|FG000|Treatment|Patient unable to travel to appointments|0|||
145579235|NCT01752933|524975305|FG001|Treatment|Patient unable to travel to appointments|1|||
145579236|NCT01752933|524975304|FG000|Overall Study and Follow-up|Death|4|||
145579237|NCT01752933|524975305|FG001|Overall Study and Follow-up|Death|34|||
145579238|NCT01752933|524975304|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
145423385|NCT01712074|524406581|FG001|Placebo Run-in Period|Other|0|||
145423386|NCT01712074|524406582|FG002|Placebo Run-in Period|Other|0|||
145423387|NCT01712074|524406580|FG000|Placebo Run-in Period|No longer willing to participate|1|||
145423388|NCT01712074|524406581|FG001|Placebo Run-in Period|No longer willing to participate|0|||
145423389|NCT01712074|524406582|FG002|Placebo Run-in Period|No longer willing to participate|0|||
145423390|NCT01712074|524406580|FG000|Double Blind Period|Adverse Event|0|||
145423391|NCT01712074|524406581|FG001|Double Blind Period|Adverse Event|2|||
145423392|NCT01712074|524406582|FG002|Double Blind Period|Adverse Event|1|||
145423393|NCT01712074|524406580|FG000|Double Blind Period|No longer willing to participate|0|||
145423394|NCT01712074|524406581|FG001|Double Blind Period|No longer willing to participate|2|||
145423395|NCT01712074|524406582|FG002|Double Blind Period|No longer willing to participate|4|||
145423396|NCT01712074|524406580|FG000|Double Blind Period|Death|0|||
145423397|NCT01712074|524406581|FG001|Double Blind Period|Death|1|||
145423398|NCT01712074|524406582|FG002|Double Blind Period|Death|0|||
145423399|NCT01712074|524406580|FG000|Double Blind Period|Lost to Follow-up|0|||
145423400|NCT01712074|524406581|FG001|Double Blind Period|Lost to Follow-up|2|||
145423401|NCT01712074|524406582|FG002|Double Blind Period|Lost to Follow-up|1|||
145423402|NCT01712074|524406580|FG000|Double Blind Period|Other|0|||
145423403|NCT01712074|524406581|FG001|Double Blind Period|Other|4|||
145423404|NCT01712074|524406582|FG002|Double Blind Period|Other|1|||
145423405|NCT01712074|524406580|FG000|Double Blind Period|Protocol Violation|0|||
145423406|NCT01712074|524406581|FG001|Double Blind Period|Protocol Violation|0|||
145423407|NCT01712074|524406582|FG002|Double Blind Period|Protocol Violation|1|||
145423408|NCT01712074|524406580|FG000|Double Blind Period|No longer met eligibility criteria|0|||
145423409|NCT01712074|524406581|FG001|Double Blind Period|No longer met eligibility criteria|3|||
145423410|NCT01712074|524406582|FG002|Double Blind Period|No longer met eligibility criteria|0|||
145423411|NCT02268851|524406583|FG000|Overall Study|Death|0|||
145423412|NCT02268851|524406584|FG001|Overall Study|Death|0|||
145423413|NCT02268851|524406585|FG002|Overall Study|Death|0|||
145423414|NCT02268851|524406586|FG003|Overall Study|Death|1|||
145423415|NCT02268851|524406587|FG004|Overall Study|Death|2|||
145423416|NCT02268851|524406588|FG005|Overall Study|Death|1|||
145423417|NCT02268851|524406583|FG000|Overall Study|Adverse Event|0|||
145423418|NCT02268851|524406584|FG001|Overall Study|Adverse Event|0|||
145423419|NCT02268851|524406585|FG002|Overall Study|Adverse Event|0|||
145423420|NCT02268851|524406586|FG003|Overall Study|Adverse Event|0|||
145423421|NCT02268851|524406587|FG004|Overall Study|Adverse Event|2|||
145423422|NCT02268851|524406588|FG005|Overall Study|Adverse Event|2|||
145423423|NCT02268851|524406583|FG000|Overall Study|Withdrawal by Subject|0|||
145423424|NCT02268851|524406584|FG001|Overall Study|Withdrawal by Subject|0|||
145423425|NCT02268851|524406585|FG002|Overall Study|Withdrawal by Subject|0|||
145423426|NCT02268851|524406586|FG003|Overall Study|Withdrawal by Subject|2|||
145423427|NCT02268851|524406587|FG004|Overall Study|Withdrawal by Subject|0|||
145423428|NCT02268851|524406588|FG005|Overall Study|Withdrawal by Subject|1|||
145423429|NCT02268851|524406583|FG000|Overall Study|Progressive Disease|1|||
145423430|NCT02268851|524406584|FG001|Overall Study|Progressive Disease|3|||
145423431|NCT02268851|524406585|FG002|Overall Study|Progressive Disease|0|||
145579239|NCT01752933|524975305|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
145579240|NCT01752933|524975304|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
145579241|NCT01752933|524975305|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
145579242|NCT01752933|524975304|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
145423432|NCT02268851|524406586|FG003|Overall Study|Progressive Disease|0|||
145423433|NCT02268851|524406587|FG004|Overall Study|Progressive Disease|1|||
145423434|NCT02268851|524406588|FG005|Overall Study|Progressive Disease|4|||
145423435|NCT02268851|524406583|FG000|Overall Study|Physician Decision|0|||
145423436|NCT02268851|524406584|FG001|Overall Study|Physician Decision|0|||
145423437|NCT02268851|524406585|FG002|Overall Study|Physician Decision|1|||
145423438|NCT02268851|524406586|FG003|Overall Study|Physician Decision|0|||
145423439|NCT02268851|524406587|FG004|Overall Study|Physician Decision|0|||
145423440|NCT02268851|524406588|FG005|Overall Study|Physician Decision|1|||
145423441|NCT02268851|524406583|FG000|Overall Study|Patient Compliance|0|||
145423442|NCT02268851|524406584|FG001|Overall Study|Patient Compliance|0|||
145423443|NCT02268851|524406585|FG002|Overall Study|Patient Compliance|0|||
145423444|NCT02268851|524406586|FG003|Overall Study|Patient Compliance|0|||
145423445|NCT02268851|524406587|FG004|Overall Study|Patient Compliance|1|||
145423446|NCT02268851|524406588|FG005|Overall Study|Patient Compliance|1|||
145423447|NCT02268851|524406583|FG000|Overall Study|Co-Morbid Condition|0|||
145423448|NCT02268851|524406584|FG001|Overall Study|Co-Morbid Condition|0|||
145423449|NCT02268851|524406585|FG002|Overall Study|Co-Morbid Condition|0|||
145423450|NCT02268851|524406586|FG003|Overall Study|Co-Morbid Condition|0|||
145423451|NCT02268851|524406587|FG004|Overall Study|Co-Morbid Condition|1|||
145423452|NCT02268851|524406588|FG005|Overall Study|Co-Morbid Condition|1|||
145423453|NCT03378635|524406591|FG000|Overall Study|Adverse Event|1|||
145423454|NCT03378635|524406592|FG001|Overall Study|Adverse Event|0|||
145423455|NCT03378635|524406593|FG002|Overall Study|Adverse Event|0|||
145423456|NCT03378635|524406591|FG000|Overall Study|Withdrawal by Subject|1|||
145423457|NCT03378635|524406592|FG001|Overall Study|Withdrawal by Subject|0|||
145423458|NCT03378635|524406593|FG002|Overall Study|Withdrawal by Subject|0|||
145423459|NCT02539394|524406596|FG000|Overall Study|Protocol Violation|1|||
145423460|NCT02539394|524406597|FG001|Overall Study|Protocol Violation|3|||
145423461|NCT02539394|524406596|FG000|Overall Study|Lost to Follow-up|1|||
145423462|NCT02539394|524406597|FG001|Overall Study|Lost to Follow-up|2|||
145423463|NCT02539394|524406596|FG000|Overall Study|Incomplete dataset|6|||
145423464|NCT02539394|524406597|FG001|Overall Study|Incomplete dataset|6|||
145423465|NCT02413346|524406598|FG000|Overall Study|Adverse Event|6|||
145423466|NCT02413346|524406599|FG001|Overall Study|Adverse Event|6|||
145423467|NCT02413346|524406598|FG000|Overall Study|Withdrawal by Subject|30|||
145423468|NCT02413346|524406599|FG001|Overall Study|Withdrawal by Subject|40|||
145423469|NCT02413346|524406598|FG000|Overall Study|Lost to Follow-up|17|||
145423470|NCT02413346|524406599|FG001|Overall Study|Lost to Follow-up|21|||
145423471|NCT02413346|524406598|FG000|Overall Study|Protocol Violation|2|||
145423472|NCT02413346|524406599|FG001|Overall Study|Protocol Violation|0|||
145423473|NCT02413346|524406598|FG000|Overall Study|Other Miscellaneous Reasons|4|||
145423474|NCT02413346|524406599|FG001|Overall Study|Other Miscellaneous Reasons|3|||
145423475|NCT01472835|524406600|FG000|Overall Study|Lost to Follow-up|2|||
145423476|NCT01472835|524406601|FG001|Overall Study|Lost to Follow-up|0|||
145423477|NCT03425188|524406620|FG000|Overall Study|Withdrawal by Subject|1|||
145423478|NCT01835431|524406621|FG000|Overall Study|Adverse Event|1|||
145423479|NCT01835431|524406622|FG001|Overall Study|Adverse Event|0|||
145423480|NCT01835431|524406621|FG000|Overall Study|other|0|||
145423481|NCT01835431|524406622|FG001|Overall Study|other|2|||
145423482|NCT01835431|524406621|FG000|Overall Study|Withdrawal by Subject|6|||
145423483|NCT01835431|524406622|FG001|Overall Study|Withdrawal by Subject|10|||
145423484|NCT01835431|524406621|FG000|Overall Study|Protocol Violation|1|||
145423485|NCT01835431|524406622|FG001|Overall Study|Protocol Violation|0|||
145423486|NCT01316900|524406627|FG000|Overall Study|Adverse Event|10|||
145423487|NCT01316900|524406628|FG001|Overall Study|Adverse Event|10|||
145423488|NCT01316900|524406629|FG002|Overall Study|Adverse Event|15|||
145423489|NCT01316900|524406630|FG003|Overall Study|Adverse Event|9|||
145423490|NCT01316900|524406627|FG000|Overall Study|Lack of Efficacy|17|||
145423491|NCT01316900|524406628|FG001|Overall Study|Lack of Efficacy|9|||
145423492|NCT01316900|524406629|FG002|Overall Study|Lack of Efficacy|5|||
145423493|NCT01316900|524406630|FG003|Overall Study|Lack of Efficacy|7|||
145423494|NCT01316900|524406627|FG000|Overall Study|Protocol Violation|7|||
145579243|NCT01752933|524975305|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
145423495|NCT01316900|524406628|FG001|Overall Study|Protocol Violation|1|||
145423496|NCT01316900|524406629|FG002|Overall Study|Protocol Violation|4|||
145423497|NCT01316900|524406630|FG003|Overall Study|Protocol Violation|0|||
145423498|NCT01316900|524406627|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
145423499|NCT01316900|524406628|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
145423500|NCT01316900|524406629|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
145423501|NCT01316900|524406630|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
145423502|NCT01316900|524406627|FG000|Overall Study|Lost to Follow-up|1|||
145423503|NCT01316900|524406628|FG001|Overall Study|Lost to Follow-up|0|||
145423504|NCT01316900|524406629|FG002|Overall Study|Lost to Follow-up|1|||
145423505|NCT01316900|524406630|FG003|Overall Study|Lost to Follow-up|1|||
145423506|NCT01316900|524406627|FG000|Overall Study|Withdrawal by Subject|7|||
145423507|NCT01316900|524406628|FG001|Overall Study|Withdrawal by Subject|8|||
145423508|NCT01316900|524406629|FG002|Overall Study|Withdrawal by Subject|6|||
145423509|NCT01316900|524406630|FG003|Overall Study|Withdrawal by Subject|9|||
145423510|NCT00562861|524406631|FG000|Overall Study|Adverse Event|1|||
145423511|NCT00562861|524406632|FG001|Overall Study|Adverse Event|1|||
145423512|NCT00562861|524406631|FG000|Overall Study|Lack of Efficacy|5|||
145423513|NCT00562861|524406632|FG001|Overall Study|Lack of Efficacy|5|||
145423514|NCT00562861|524406631|FG000|Overall Study|noncompliance, moved|7|||
145423515|NCT00562861|524406632|FG001|Overall Study|noncompliance, moved|2|||
145423516|NCT00562861|524406631|FG000|Overall Study|Lost to Follow-up|7|||
145423517|NCT00562861|524406632|FG001|Overall Study|Lost to Follow-up|3|||
145423518|NCT01684033|524406633|FG000|Period 1, First 30 Days|Adverse Event|1|||
145423519|NCT01684033|524406634|FG001|Period 1, First 30 Days|Adverse Event|1|||
145423520|NCT01684033|524406633|FG000|Period 1, First 30 Days|Noncompliance|1|||
145423521|NCT01684033|524406634|FG001|Period 1, First 30 Days|Noncompliance|0|||
145423522|NCT01684033|524406633|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
145423523|NCT01684033|524406634|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
145423524|NCT01684033|524406633|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
145423525|NCT01684033|524406634|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
145423526|NCT01684033|524406633|FG000|Period 2, Second 30 Days|Adverse Event|1|||
145423527|NCT01684033|524406634|FG001|Period 2, Second 30 Days|Adverse Event|0|||
145423528|NCT00480025|524406635|FG000|Overall Study|Protocol Violation|12|||
145423529|NCT00480025|524406636|FG001|Overall Study|Protocol Violation|7|||
145423530|NCT00480025|524406635|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
145423531|NCT00480025|524406636|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
145423532|NCT00480025|524406635|FG000|Overall Study|Disease Progression / Recurrence|449|||
145423533|NCT00480025|524406636|FG001|Overall Study|Disease Progression / Recurrence|224|||
145423534|NCT00480025|524406635|FG000|Overall Study|Adverse Event|44|||
145423535|NCT00480025|524406636|FG001|Overall Study|Adverse Event|12|||
145423536|NCT00480025|524406635|FG000|Overall Study|Other|70|||
145423537|NCT00480025|524406636|FG001|Overall Study|Other|29|||
145423538|NCT00480025|524406635|FG000|Overall Study|SAE including intercurrent illness|76|||
145423539|NCT00480025|524406636|FG001|Overall Study|SAE including intercurrent illness|42|||
145423540|NCT03726879|524406638|FG000|Overall Study|Death|11|||
145423541|NCT03726879|524406639|FG001|Overall Study|Death|13|||
145423542|NCT03726879|524406638|FG000|Overall Study|Physician Decision|0|||
145423543|NCT03726879|524406639|FG001|Overall Study|Physician Decision|2|||
145423544|NCT03726879|524406638|FG000|Overall Study|Protocol Violation|0|||
145423545|NCT03726879|524406639|FG001|Overall Study|Protocol Violation|1|||
145423546|NCT03726879|524406638|FG000|Overall Study|Withdrawal by Subject|5|||
145423547|NCT03726879|524406639|FG001|Overall Study|Withdrawal by Subject|6|||
145423548|NCT03726879|524406638|FG000|Overall Study|TSH result is unstable|0|||
145423549|NCT03726879|524406639|FG001|Overall Study|TSH result is unstable|1|||
145423550|NCT03726879|524406638|FG000|Overall Study|Disease relapse|1|||
145423551|NCT03726879|524406639|FG001|Overall Study|Disease relapse|0|||
145423552|NCT03726879|524406638|FG000|Overall Study|Lost to Follow-up|3|||
145423553|NCT03726879|524406639|FG001|Overall Study|Lost to Follow-up|0|||
145423554|NCT02766478|524406641|FG000|Overall Study|Withdrawal by Subject|1|||
145423555|NCT02766478|524406642|FG001|Overall Study|Withdrawal by Subject|1|||
145423556|NCT05626686|524406643|FG000|Overall Study|Protocol Violation|3|||
145423557|NCT05626686|524406643|FG000|Overall Study|Withdrawal by Subject|3|||
145423558|NCT01093573|524406644|FG000|Overall Study|Physician Decision|0|||
145423559|NCT01093573|524406645|FG001|Overall Study|Physician Decision|0|||
145423560|NCT01093573|524406646|FG002|Overall Study|Physician Decision|1|||
145423561|NCT01093573|524406644|FG000|Overall Study|Insurance Denied|0|||
145423562|NCT01093573|524406645|FG001|Overall Study|Insurance Denied|0|||
145423563|NCT01093573|524406646|FG002|Overall Study|Insurance Denied|1|||
145423564|NCT01412983|524406648|FG000|1st Period|Ineligible|0|||
145423565|NCT01412983|524406649|FG001|1st Period|Ineligible|1|||
145423566|NCT01412983|524406648|FG000|1st Period|Positive slit lamp finding|0|||
145423567|NCT01412983|524406649|FG001|1st Period|Positive slit lamp finding|1|||
145423568|NCT01412983|524406648|FG000|1st Period|Unacceptable lens movement|0|||
145423569|NCT01412983|524406649|FG001|1st Period|Unacceptable lens movement|1|||
145423570|NCT01412983|524406648|FG000|1st Period|Inability to maintain wear|0|||
145423571|NCT01412983|524406649|FG001|1st Period|Inability to maintain wear|1|||
145423572|NCT00890097|524406650|FG000|Overall Study|Adverse Event|21|||
145423573|NCT00890097|524406651|FG001|Overall Study|Adverse Event|32|||
145423574|NCT00890097|524406652|FG002|Overall Study|Adverse Event|28|||
145623479|NCT02825043|525133936|FG000|Overall Study|Lost to Follow-up|4|||
145423575|NCT00890097|524406650|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
145423576|NCT00890097|524406651|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
145423577|NCT00890097|524406652|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
145423578|NCT00890097|524406650|FG000|Overall Study|Withdrew Consent|9|||
145423579|NCT00890097|524406651|FG001|Overall Study|Withdrew Consent|6|||
145423580|NCT00890097|524406652|FG002|Overall Study|Withdrew Consent|9|||
145423581|NCT00890097|524406650|FG000|Overall Study|Lost to Follow-up|5|||
145423582|NCT00890097|524406651|FG001|Overall Study|Lost to Follow-up|5|||
145423583|NCT00890097|524406652|FG002|Overall Study|Lost to Follow-up|5|||
145423584|NCT00890097|524406650|FG000|Overall Study|Noncompliance|0|||
145423585|NCT00890097|524406651|FG001|Overall Study|Noncompliance|4|||
145423586|NCT00890097|524406652|FG002|Overall Study|Noncompliance|4|||
145423587|NCT00890097|524406650|FG000|Overall Study|Sponsor Decision|7|||
145423588|NCT00890097|524406651|FG001|Overall Study|Sponsor Decision|11|||
145423589|NCT00890097|524406652|FG002|Overall Study|Sponsor Decision|7|||
145423590|NCT00890097|524406650|FG000|Overall Study|Did not attend final visit|2|||
145423591|NCT00890097|524406651|FG001|Overall Study|Did not attend final visit|3|||
145423592|NCT00890097|524406652|FG002|Overall Study|Did not attend final visit|0|||
145423593|NCT00890097|524406650|FG000|Overall Study|Subject Decision|3|||
145423594|NCT00890097|524406651|FG001|Overall Study|Subject Decision|2|||
145423595|NCT00890097|524406652|FG002|Overall Study|Subject Decision|6|||
145423596|NCT00890097|524406650|FG000|Overall Study|Randomization Error|2|||
145423597|NCT00890097|524406651|FG001|Overall Study|Randomization Error|0|||
145423598|NCT00890097|524406652|FG002|Overall Study|Randomization Error|0|||
145423599|NCT00890097|524406650|FG000|Overall Study|Failed inclusion criteria|3|||
145423600|NCT00890097|524406651|FG001|Overall Study|Failed inclusion criteria|4|||
145423601|NCT00890097|524406652|FG002|Overall Study|Failed inclusion criteria|0|||
145423602|NCT00890097|524406650|FG000|Overall Study|Transportation|0|||
145423603|NCT00890097|524406651|FG001|Overall Study|Transportation|2|||
145423604|NCT00890097|524406652|FG002|Overall Study|Transportation|0|||
145423605|NCT00890097|524406650|FG000|Overall Study|Subject Moved|0|||
145423606|NCT00890097|524406651|FG001|Overall Study|Subject Moved|4|||
145423607|NCT00890097|524406652|FG002|Overall Study|Subject Moved|0|||
145423608|NCT00890097|524406650|FG000|Overall Study|Protocol Deviation|1|||
145423609|NCT00890097|524406651|FG001|Overall Study|Protocol Deviation|1|||
145423610|NCT00890097|524406652|FG002|Overall Study|Protocol Deviation|1|||
145423611|NCT04349098|524406653|FG000|Overall Study|Death|16|||
145423612|NCT04349098|524406654|FG001|Overall Study|Death|8|||
145423613|NCT04349098|524406653|FG000|Overall Study|Lost to Follow-up|11|||
145423614|NCT04349098|524406654|FG001|Overall Study|Lost to Follow-up|8|||
145423615|NCT04349098|524406653|FG000|Overall Study|Withdrawal by Subject|8|||
145423616|NCT04349098|524406654|FG001|Overall Study|Withdrawal by Subject|5|||
145423617|NCT04349098|524406653|FG000|Overall Study|Other|3|||
145423618|NCT04349098|524406654|FG001|Overall Study|Other|5|||
145423619|NCT00289900|524406655|FG000|Overall Study|Adverse Event|28|||
145423620|NCT00289900|524406656|FG001|Overall Study|Adverse Event|40|||
145423621|NCT00289900|524406657|FG002|Overall Study|Adverse Event|13|||
145423622|NCT00289900|524406658|FG003|Overall Study|Adverse Event|19|||
145423623|NCT00289900|524406659|FG004|Overall Study|Adverse Event|20|||
145423624|NCT00289900|524406660|FG005|Overall Study|Adverse Event|33|||
145423625|NCT00289900|524406655|FG000|Overall Study|Lost to Follow-up|7|||
145423626|NCT00289900|524406656|FG001|Overall Study|Lost to Follow-up|7|||
145423627|NCT00289900|524406657|FG002|Overall Study|Lost to Follow-up|8|||
145423628|NCT00289900|524406658|FG003|Overall Study|Lost to Follow-up|8|||
145423629|NCT00289900|524406659|FG004|Overall Study|Lost to Follow-up|4|||
145423630|NCT00289900|524406660|FG005|Overall Study|Lost to Follow-up|8|||
145423631|NCT00289900|524406655|FG000|Overall Study|Participant had flushing|18|||
145423632|NCT00289900|524406656|FG001|Overall Study|Participant had flushing|42|||
145423633|NCT00289900|524406657|FG002|Overall Study|Participant had flushing|1|||
145423634|NCT00289900|524406658|FG003|Overall Study|Participant had flushing|2|||
145423635|NCT00289900|524406659|FG004|Overall Study|Participant had flushing|0|||
145423636|NCT00289900|524406660|FG005|Overall Study|Participant had flushing|4|||
145423637|NCT00289900|524406655|FG000|Overall Study|Other|0|||
145423638|NCT00289900|524406656|FG001|Overall Study|Other|0|||
145423639|NCT00289900|524406657|FG002|Overall Study|Other|0|||
145423640|NCT00289900|524406658|FG003|Overall Study|Other|5|||
145423641|NCT00289900|524406659|FG004|Overall Study|Other|1|||
145423642|NCT00289900|524406660|FG005|Overall Study|Other|0|||
145423643|NCT00289900|524406655|FG000|Overall Study|Participant moved|1|||
145423644|NCT00289900|524406656|FG001|Overall Study|Participant moved|0|||
145423645|NCT00289900|524406657|FG002|Overall Study|Participant moved|0|||
145423646|NCT00289900|524406658|FG003|Overall Study|Participant moved|1|||
145423647|NCT00289900|524406659|FG004|Overall Study|Participant moved|1|||
145423648|NCT00289900|524406660|FG005|Overall Study|Participant moved|1|||
145423649|NCT00289900|524406655|FG000|Overall Study|Withdrawal by Subject|10|||
145423650|NCT00289900|524406656|FG001|Overall Study|Withdrawal by Subject|21|||
145423651|NCT00289900|524406657|FG002|Overall Study|Withdrawal by Subject|8|||
145423652|NCT00289900|524406658|FG003|Overall Study|Withdrawal by Subject|18|||
145423653|NCT00289900|524406659|FG004|Overall Study|Withdrawal by Subject|12|||
145423654|NCT00289900|524406660|FG005|Overall Study|Withdrawal by Subject|11|||
145423655|NCT00289900|524406655|FG000|Overall Study|Protocol Violation|3|||
145423656|NCT00289900|524406656|FG001|Overall Study|Protocol Violation|9|||
145423657|NCT00289900|524406657|FG002|Overall Study|Protocol Violation|2|||
145423658|NCT00289900|524406658|FG003|Overall Study|Protocol Violation|6|||
145423659|NCT00289900|524406659|FG004|Overall Study|Protocol Violation|7|||
145423660|NCT00289900|524406660|FG005|Overall Study|Protocol Violation|4|||
145423661|NCT00289900|524406655|FG000|Overall Study|site terminated|1|||
145423662|NCT00289900|524406656|FG001|Overall Study|site terminated|0|||
145423663|NCT00289900|524406657|FG002|Overall Study|site terminated|1|||
145423664|NCT00289900|524406658|FG003|Overall Study|site terminated|0|||
145423665|NCT00289900|524406659|FG004|Overall Study|site terminated|0|||
145423666|NCT00289900|524406660|FG005|Overall Study|site terminated|0|||
145423667|NCT00289900|524406655|FG000|Overall Study|Not treated|0|||
145423668|NCT00289900|524406656|FG001|Overall Study|Not treated|1|||
145423669|NCT00289900|524406657|FG002|Overall Study|Not treated|0|||
145423670|NCT00289900|524406658|FG003|Overall Study|Not treated|0|||
145423671|NCT00289900|524406659|FG004|Overall Study|Not treated|0|||
145423672|NCT00289900|524406660|FG005|Overall Study|Not treated|0|||
145423673|NCT01152385|524406661|FG000|Overall Study|Withdrawal by Subject|3|||
145423674|NCT01152385|524406662|FG001|Overall Study|Withdrawal by Subject|1|||
145423675|NCT01152385|524406663|FG002|Overall Study|Withdrawal by Subject|1|||
145423676|NCT01152385|524406664|FG003|Overall Study|Withdrawal by Subject|1|||
145423677|NCT01152385|524406661|FG000|Overall Study|Protocol Violation|0|||
145423678|NCT01152385|524406662|FG001|Overall Study|Protocol Violation|0|||
145423679|NCT01152385|524406663|FG002|Overall Study|Protocol Violation|0|||
145423680|NCT01152385|524406664|FG003|Overall Study|Protocol Violation|1|||
145423681|NCT01152385|524406661|FG000|Overall Study|Adverse Event|1|||
145423682|NCT01152385|524406662|FG001|Overall Study|Adverse Event|1|||
145423683|NCT01152385|524406663|FG002|Overall Study|Adverse Event|0|||
145423684|NCT01152385|524406664|FG003|Overall Study|Adverse Event|0|||
145423685|NCT01152385|524406661|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145423686|NCT01152385|524406662|FG001|Overall Study|Study-specific withdrawal criteria|1|||
145423687|NCT01152385|524406663|FG002|Overall Study|Study-specific withdrawal criteria|2|||
145423688|NCT01152385|524406664|FG003|Overall Study|Study-specific withdrawal criteria|0|||
145423689|NCT01152385|524406661|FG000|Overall Study|Other|4|||
145423690|NCT01152385|524406662|FG001|Overall Study|Other|3|||
145423691|NCT01152385|524406663|FG002|Overall Study|Other|2|||
145423692|NCT01152385|524406664|FG003|Overall Study|Other|3|||
145423693|NCT02656173|524406665|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
145423694|NCT02656173|524406666|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
145423695|NCT02656173|524406665|FG000|Overall Study|Adverse Event|7|||
145423696|NCT02656173|524406666|FG001|Overall Study|Adverse Event|5|||
145423697|NCT02656173|524406665|FG000|Overall Study|Withdrawal by Subject|1|||
145423698|NCT02656173|524406666|FG001|Overall Study|Withdrawal by Subject|3|||
145423699|NCT02656173|524406665|FG000|Overall Study|Protocol Violation|0|||
145423700|NCT02656173|524406666|FG001|Overall Study|Protocol Violation|1|||
145423701|NCT02656173|524406665|FG000|Overall Study|Miscellaneous|2|||
145423702|NCT02656173|524406666|FG001|Overall Study|Miscellaneous|0|||
145423703|NCT03449147|524406667|FG000|52-week Treatment Period|Death|0|||
145423704|NCT03449147|524406668|FG001|52-week Treatment Period|Death|1|||
145423705|NCT03449147|524406669|FG002|52-week Treatment Period|Death|0|||
145423706|NCT03449147|524406667|FG000|52-week Treatment Period|Lost to Follow-up|6|||
145423707|NCT03449147|524406668|FG001|52-week Treatment Period|Lost to Follow-up|2|||
145423708|NCT03449147|524406669|FG002|52-week Treatment Period|Lost to Follow-up|5|||
145423709|NCT03449147|524406667|FG000|52-week Treatment Period|Other|0|||
145423710|NCT03449147|524406668|FG001|52-week Treatment Period|Other|1|||
145423711|NCT03449147|524406669|FG002|52-week Treatment Period|Other|2|||
145423712|NCT03449147|524406667|FG000|52-week Treatment Period|Physician Decision|1|||
145423713|NCT03449147|524406668|FG001|52-week Treatment Period|Physician Decision|0|||
145423714|NCT03449147|524406669|FG002|52-week Treatment Period|Physician Decision|3|||
145423715|NCT03449147|524406667|FG000|52-week Treatment Period|Screen Failure|1|||
145423716|NCT03449147|524406668|FG001|52-week Treatment Period|Screen Failure|2|||
145423717|NCT03449147|524406669|FG002|52-week Treatment Period|Screen Failure|0|||
145423718|NCT03449147|524406667|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
145423719|NCT03449147|524406668|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
145423720|NCT03449147|524406669|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
145423721|NCT03449147|524406667|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
145423722|NCT03449147|524406668|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
145423723|NCT03449147|524406669|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
145423724|NCT03449147|524406667|FG000|12-Week Off-Treatment Durability Period|Other|0|||
145423725|NCT03449147|524406668|FG001|12-Week Off-Treatment Durability Period|Other|1|||
145423726|NCT03449147|524406669|FG002|12-Week Off-Treatment Durability Period|Other|0|||
145423727|NCT00992394|524406670|FG000|Overall Study|Lack of Efficacy|6|||
145423728|NCT00992394|524406671|FG001|Overall Study|Lack of Efficacy|3|||
145423729|NCT00992394|524406670|FG000|Overall Study|Adverse Event|4|||
145423730|NCT00992394|524406671|FG001|Overall Study|Adverse Event|5|||
145423731|NCT00992394|524406670|FG000|Overall Study|Withdrawal by Subject|8|||
145423732|NCT00992394|524406671|FG001|Overall Study|Withdrawal by Subject|2|||
145423733|NCT00992394|524406670|FG000|Overall Study|Physician Decision|1|||
145423734|NCT00992394|524406671|FG001|Overall Study|Physician Decision|0|||
145423735|NCT00992394|524406670|FG000|Overall Study|Protocol Violation|2|||
145423736|NCT00992394|524406671|FG001|Overall Study|Protocol Violation|4|||
145423737|NCT00992394|524406670|FG000|Overall Study|Lost to Follow-up|2|||
145423738|NCT00992394|524406671|FG001|Overall Study|Lost to Follow-up|0|||
145423739|NCT00992394|524406670|FG000|Overall Study|Other event|1|||
145423740|NCT00992394|524406671|FG001|Overall Study|Other event|0|||
145579244|NCT01591681|524975306|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
145423741|NCT00974233|524406675|FG000|Induction Chemoimmunotherapy|Death|2|||
145423742|NCT00974233|524406675|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
145423743|NCT00974233|524406675|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
145423744|NCT00974233|524406675|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
145579245|NCT01591681|524975306|FG000|Overall Study|Failed to use system during run-in|1|||
145423745|NCT00974233|524406675|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
145423746|NCT00974233|524406675|FG000|Maintenance Lenalidomide|Adverse Event|8|||
145423747|NCT02113878|524408092|FG000|Overall Study|Adverse Event|1|||
145423748|NCT02113878|524408093|FG001|Overall Study|Adverse Event|0|||
145423749|NCT02113878|524408092|FG000|Overall Study|Withdrawal by Subject|1|||
145423750|NCT02113878|524408093|FG001|Overall Study|Withdrawal by Subject|0|||
145423751|NCT02113878|524408092|FG000|Overall Study|patient non-compliance|1|||
145423752|NCT02113878|524408093|FG001|Overall Study|patient non-compliance|0|||
145423753|NCT00530257|524408094|FG000|Overall Study|Lost to Follow-up|1|||
145423754|NCT05401409|524408097|FG000|Overall Study|Lost to Follow-up|1|||
145423755|NCT05401409|524408098|FG001|Overall Study|Lost to Follow-up|0|||
145423756|NCT06844812|524408099|FG000|Overall Study|Lost to Follow-up|5|||
145423757|NCT06844812|524408099|FG000|Overall Study|stigmatization concerns|2|||
145423758|NCT06844812|524408099|FG000|Overall Study|medication refusal|2|||
145423759|NCT06844812|524408099|FG000|Overall Study|concerns about possible side effects|2|||
145423760|NCT06844812|524408099|FG000|Overall Study|wanting to seek another specialist opinion|2|||
145423761|NCT06844812|524408099|FG000|Overall Study|side effects (dizziness)|1|||
145423762|NCT02410200|524408101|FG000|Overall Study|Adverse Event|2|||
145423763|NCT00203242|524408122|FG000|Overall Study|Lost to Follow-up|1|||
145423764|NCT02715856|524408123|FG000|Overall Study|Software Issues|12|||
145423765|NCT02715856|524408124|FG001|Overall Study|Software Issues|7|||
145423766|NCT02715856|524408123|FG000|Overall Study|Death|6|||
145423767|NCT02715856|524408124|FG001|Overall Study|Death|5|||
145423768|NCT02715856|524408123|FG000|Overall Study|Non- Compliant|0|||
145423769|NCT02715856|524408124|FG001|Overall Study|Non- Compliant|40|||
145423770|NCT01517178|524408125|FG000|Period 1|Adverse Event|1|||
145423771|NCT01517178|524408126|FG001|Period 1|Adverse Event|2|||
145423772|NCT01517178|524408125|FG000|Period 1|Lack of Efficacy|0|||
145423773|NCT01517178|524408126|FG001|Period 1|Lack of Efficacy|1|||
145423774|NCT01517178|524408125|FG000|Period 1|E.g. study termination|3|||
145423775|NCT01517178|524408126|FG001|Period 1|E.g. study termination|1|||
145423776|NCT01517178|524408125|FG000|Period 1|Withdrawal by Subject|0|||
145423777|NCT01517178|524408126|FG001|Period 1|Withdrawal by Subject|1|||
145423778|NCT01517178|524408125|FG000|Period 2|Adverse Event|1|||
145423779|NCT01517178|524408126|FG001|Period 2|Adverse Event|0|||
145423780|NCT01517178|524408125|FG000|Period 2|Withdrawal by Subject|3|||
145423781|NCT01517178|524408126|FG001|Period 2|Withdrawal by Subject|0|||
145423782|NCT01517178|524408125|FG000|Period 2|E.g. study termination|2|||
145423783|NCT01517178|524408126|FG001|Period 2|E.g. study termination|2|||
145423784|NCT00756314|524408140|FG000|Overall Study|Lost to Follow-up|2|||
145423785|NCT00756314|524408141|FG001|Overall Study|Lost to Follow-up|59|||
145423786|NCT02872142|524408143|FG000|Overall Study|Adverse Event|2|||
145423787|NCT02872142|524408143|FG000|Overall Study|Death|1|||
145423788|NCT02872142|524408143|FG000|Overall Study|Participant Decision|3|||
145423789|NCT01903720|524408148|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
145423790|NCT01903720|524408148|FG000|Overall Study|Adverse Event|1|||
145423791|NCT01903720|524408148|FG000|Overall Study|Rescinding of informed consent|2|||
145423792|NCT01903720|524408148|FG000|Overall Study|Lost to Follow-up|2|||
145423793|NCT01903720|524408148|FG000|Overall Study|Treatment with alternative drug|1|||
145423794|NCT03627468|524408151|FG000|Overall Study|Adverse Event|5|||
145423795|NCT03627468|524408152|FG001|Overall Study|Adverse Event|33|||
145423796|NCT03627468|524408151|FG000|Overall Study|Withdrawal by Subject|13|||
145423797|NCT03627468|524408152|FG001|Overall Study|Withdrawal by Subject|23|||
145423798|NCT03627468|524408151|FG000|Overall Study|Physician Decision|1|||
145423799|NCT03627468|524408152|FG001|Overall Study|Physician Decision|0|||
145423800|NCT03627468|524408151|FG000|Overall Study|Protocol Violation|0|||
145423801|NCT03627468|524408152|FG001|Overall Study|Protocol Violation|2|||
145423802|NCT03627468|524408151|FG000|Overall Study|Lost to Follow-up|10|||
145423803|NCT03627468|524408152|FG001|Overall Study|Lost to Follow-up|16|||
145423804|NCT03627468|524408151|FG000|Overall Study|Death|1|||
145423805|NCT03627468|524408152|FG001|Overall Study|Death|0|||
145423806|NCT03627468|524408151|FG000|Overall Study|Pregnancy|1|||
145423807|NCT03627468|524408152|FG001|Overall Study|Pregnancy|1|||
145423808|NCT03627468|524408151|FG000|Overall Study|Lack of Efficacy|0|||
145423809|NCT03627468|524408152|FG001|Overall Study|Lack of Efficacy|2|||
145423810|NCT03627468|524408151|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
145423811|NCT03627468|524408152|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
145423812|NCT05122143|524408153|FG000|Overall Study|Adverse Event|1|||
145423813|NCT05122143|524408154|FG001|Overall Study|Adverse Event|0|||
145423814|NCT05122143|524408155|FG002|Overall Study|Adverse Event|0|||
145423815|NCT05122143|524408156|FG003|Overall Study|Adverse Event|0|||
145423816|NCT05122143|524408157|FG004|Overall Study|Adverse Event|1|||
145423817|NCT05122143|524408158|FG005|Overall Study|Adverse Event|0|||
145423818|NCT05122143|524408153|FG000|Overall Study|Protocol non-compliance|0|||
145423819|NCT05122143|524408154|FG001|Overall Study|Protocol non-compliance|0|||
145423820|NCT05122143|524408155|FG002|Overall Study|Protocol non-compliance|1|||
145423821|NCT05122143|524408156|FG003|Overall Study|Protocol non-compliance|0|||
145423822|NCT05122143|524408157|FG004|Overall Study|Protocol non-compliance|0|||
145423823|NCT05122143|524408158|FG005|Overall Study|Protocol non-compliance|0|||
145423824|NCT05122143|524408153|FG000|Overall Study|Covid contact|0|||
145423825|NCT05122143|524408154|FG001|Overall Study|Covid contact|0|||
145423826|NCT05122143|524408155|FG002|Overall Study|Covid contact|0|||
145423827|NCT05122143|524408156|FG003|Overall Study|Covid contact|0|||
145423828|NCT05122143|524408157|FG004|Overall Study|Covid contact|1|||
145423829|NCT05122143|524408158|FG005|Overall Study|Covid contact|0|||
145423830|NCT00692237|524408159|FG000|Overall Study|Withdrawal by Subject|1|||
145423831|NCT00692237|524408160|FG001|Overall Study|Withdrawal by Subject|3|||
145423832|NCT00692237|524408159|FG000|Overall Study|Adverse Event|0|||
145423833|NCT00692237|524408160|FG001|Overall Study|Adverse Event|1|||
145423834|NCT01347086|524408161|FG000|Overall Study|failed screening visit|0|||
145423835|NCT01347086|524408162|FG001|Overall Study|failed screening visit|0|||
145423836|NCT01347086|524408163|FG002|Overall Study|failed screening visit|1|||
145423837|NCT01347086|524408164|FG003|Overall Study|failed screening visit|0|||
145423838|NCT01347086|524408165|FG004|Overall Study|failed screening visit|0|||
145423839|NCT01347086|524408166|FG005|Overall Study|failed screening visit|0|||
145423840|NCT01347086|524408167|FG006|Overall Study|failed screening visit|1|||
145423841|NCT01347086|524408168|FG007|Overall Study|failed screening visit|1|||
145423842|NCT01347086|524408169|FG008|Overall Study|failed screening visit|0|||
145423843|NCT01347086|524408170|FG009|Overall Study|failed screening visit|1|||
145423844|NCT00395447|524408171|FG000|Overall Study|Death|37|||
145423845|NCT00395447|524408172|FG001|Overall Study|Death|32|||
145423846|NCT00395447|524408171|FG000|Overall Study|Lost to Follow-up|52|||
145423847|NCT00395447|524408172|FG001|Overall Study|Lost to Follow-up|43|||
145423848|NCT00395447|524408171|FG000|Overall Study|Withdrawal by Subject|24|||
145423849|NCT00395447|524408172|FG001|Overall Study|Withdrawal by Subject|19|||
145423850|NCT00395447|524408171|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
145423851|NCT00395447|524408172|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
145423852|NCT02624687|524408174|FG000|Overall Study|Withdrawal by Subject|1|||
145423853|NCT02624687|524408175|FG001|Overall Study|Withdrawal by Subject|1|||
145423854|NCT02624687|524408174|FG000|Overall Study|medical leave from work|0|||
145423855|NCT02624687|524408175|FG001|Overall Study|medical leave from work|1|||
145423856|NCT03111108|524408176|FG000|Overall Study|Death|0|||
145423857|NCT03111108|524408177|FG001|Overall Study|Death|1|||
145423858|NCT03111108|524408176|FG000|Overall Study|Withdrawal by Subject|1|||
145423859|NCT03111108|524408177|FG001|Overall Study|Withdrawal by Subject|0|||
145579246|NCT01649856|524975311|FG000|Overall Study|Withdrawal by Subject|14|||
145423860|NCT01853280|524408178|FG000|Overall Study|Lack of Efficacy|2|||
145423861|NCT01853280|524408179|FG001|Overall Study|Lack of Efficacy|2|||
145423862|NCT01853280|524408178|FG000|Overall Study|Lost to Follow-up|0|||
145423863|NCT01853280|524408179|FG001|Overall Study|Lost to Follow-up|1|||
145423864|NCT01853280|524408178|FG000|Overall Study|Physician Decision|0|||
145423865|NCT01853280|524408179|FG001|Overall Study|Physician Decision|1|||
145423866|NCT01853280|524408178|FG000|Overall Study|Withdrawal by Subject|0|||
145423867|NCT01853280|524408179|FG001|Overall Study|Withdrawal by Subject|1|||
145423868|NCT01853280|524408178|FG000|Overall Study|Ineligible|0|||
145423869|NCT01853280|524408179|FG001|Overall Study|Ineligible|1|||
145423870|NCT00104884|524408180|FG000|Overall Study|Disease progression|4|||
145423871|NCT03032484|524408181|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
145423872|NCT03032484|524408182|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
145423873|NCT03032484|524408181|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
145423874|NCT03032484|524408182|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
145423875|NCT01689649|524408183|FG000|Overall Study|Lack of Efficacy|3|||
145423876|NCT01689649|524408183|FG000|Overall Study|Non-compliance|11|||
145423877|NCT01689649|524408183|FG000|Overall Study|Protocol Violation|3|||
145423878|NCT01689649|524408183|FG000|Overall Study|Lost to Follow-up|5|||
145423879|NCT01725282|524408197|FG000|Overall Study|Adverse Event|1|||
145423880|NCT01725282|524408198|FG001|Overall Study|Adverse Event|3|||
145423881|NCT01725282|524408199|FG002|Overall Study|Adverse Event|6|||
145423882|NCT01725282|524408200|FG003|Overall Study|Adverse Event|4|||
145423883|NCT01725282|524408197|FG000|Overall Study|Exacerbation of Target Disease|1|||
145423884|NCT01725282|524408198|FG001|Overall Study|Exacerbation of Target Disease|0|||
145423885|NCT01725282|524408199|FG002|Overall Study|Exacerbation of Target Disease|0|||
145423886|NCT01725282|524408200|FG003|Overall Study|Exacerbation of Target Disease|1|||
145579247|NCT01649856|524975312|FG001|Overall Study|Withdrawal by Subject|14|||
145423887|NCT01725282|524408197|FG000|Overall Study|Met Exclusion Criteria|0|||
145423888|NCT01725282|524408198|FG001|Overall Study|Met Exclusion Criteria|0|||
145423889|NCT01725282|524408199|FG002|Overall Study|Met Exclusion Criteria|1|||
145423890|NCT01725282|524408200|FG003|Overall Study|Met Exclusion Criteria|0|||
145579248|NCT01649856|524975311|FG000|Overall Study|Protocol Violation|4|||
145579249|NCT01649856|524975312|FG001|Overall Study|Protocol Violation|4|||
145423891|NCT01725282|524408197|FG000|Overall Study|Study Site Withdrawal|0|||
145423892|NCT01725282|524408198|FG001|Overall Study|Study Site Withdrawal|1|||
145423893|NCT01725282|524408199|FG002|Overall Study|Study Site Withdrawal|0|||
145423894|NCT01725282|524408200|FG003|Overall Study|Study Site Withdrawal|0|||
145423895|NCT01725282|524408197|FG000|Overall Study|Withdrawal by Subject|0|||
145423896|NCT01725282|524408198|FG001|Overall Study|Withdrawal by Subject|0|||
145423897|NCT01725282|524408199|FG002|Overall Study|Withdrawal by Subject|1|||
145423898|NCT01725282|524408200|FG003|Overall Study|Withdrawal by Subject|1|||
145423899|NCT01725282|524408197|FG000|Overall Study|Lack of Efficacy|0|||
145423900|NCT01725282|524408198|FG001|Overall Study|Lack of Efficacy|1|||
145423901|NCT01725282|524408199|FG002|Overall Study|Lack of Efficacy|0|||
145423902|NCT01725282|524408200|FG003|Overall Study|Lack of Efficacy|1|||
145423903|NCT04064567|524408201|FG000|Overall Study|Lost to Follow-up|23|||
145423904|NCT04064567|524408202|FG001|Overall Study|Lost to Follow-up|22|||
145423905|NCT04064567|524408201|FG000|Overall Study|Withdrawal by Subject|0|||
145423906|NCT04064567|524408202|FG001|Overall Study|Withdrawal by Subject|1|||
145423907|NCT04064567|524408201|FG000|Overall Study|Reincarcerated|7|||
145423908|NCT04064567|524408202|FG001|Overall Study|Reincarcerated|10|||
145423909|NCT04064567|524408201|FG000|Overall Study|Moved out of U.S.|0|||
145423910|NCT04064567|524408202|FG001|Overall Study|Moved out of U.S.|1|||
145423911|NCT05524948|524408208|FG000|Overall Study|Withdrawal by Subject|1|||
145423912|NCT05524948|524408209|FG001|Overall Study|Withdrawal by Subject|0|||
145423913|NCT05524948|524408208|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
145423914|NCT05524948|524408209|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
145423915|NCT02758626|524408210|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
145423916|NCT02758626|524408211|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
145423917|NCT02758626|524408210|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
145423918|NCT02758626|524408211|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
145423919|NCT02758626|524408210|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
145423920|NCT02758626|524408211|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
145423921|NCT02758626|524408210|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
145423922|NCT02758626|524408211|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
145423923|NCT02739828|524408212|FG000|Overall Study|Adverse Event|1|||
145423924|NCT02739828|524408212|FG000|Overall Study|Lost to Follow-up|4|||
145423925|NCT01682720|524408220|FG000|Overall Study|Randomized but Not Treated|0|||
145423926|NCT01682720|524408221|FG001|Overall Study|Randomized but Not Treated|1|||
145423927|NCT01682720|524408222|FG002|Overall Study|Randomized but Not Treated|1|||
145423928|NCT01682720|524408223|FG003|Overall Study|Randomized but Not Treated|0|||
145423929|NCT01682720|524408220|FG000|Overall Study|Terminated by Sponsor|83|||
145423930|NCT01682720|524408221|FG001|Overall Study|Terminated by Sponsor|0|||
145423931|NCT01682720|524408222|FG002|Overall Study|Terminated by Sponsor|0|||
145423932|NCT01682720|524408223|FG003|Overall Study|Terminated by Sponsor|0|||
145423933|NCT01682720|524408220|FG000|Overall Study|Efficacy Failure|0|||
145423934|NCT01682720|524408221|FG001|Overall Study|Efficacy Failure|3|||
145423935|NCT01682720|524408222|FG002|Overall Study|Efficacy Failure|3|||
145423936|NCT01682720|524408223|FG003|Overall Study|Efficacy Failure|30|||
145423937|NCT01682720|524408220|FG000|Overall Study|Lost to Follow-up|1|||
145423938|NCT01682720|524408221|FG001|Overall Study|Lost to Follow-up|1|||
145423939|NCT01682720|524408222|FG002|Overall Study|Lost to Follow-up|0|||
145423940|NCT01682720|524408223|FG003|Overall Study|Lost to Follow-up|6|||
145423941|NCT01682720|524408220|FG000|Overall Study|Subject Withdrew Consent|0|||
145423942|NCT01682720|524408221|FG001|Overall Study|Subject Withdrew Consent|0|||
145423943|NCT01682720|524408222|FG002|Overall Study|Subject Withdrew Consent|2|||
145423944|NCT01682720|524408223|FG003|Overall Study|Subject Withdrew Consent|2|||
145423945|NCT01682720|524408220|FG000|Overall Study|Adverse Event|1|||
145423946|NCT01682720|524408221|FG001|Overall Study|Adverse Event|0|||
145423947|NCT01682720|524408222|FG002|Overall Study|Adverse Event|1|||
145423948|NCT01682720|524408223|FG003|Overall Study|Adverse Event|1|||
145423949|NCT04204902|524408224|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
145423950|NCT04204902|524408225|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
145423951|NCT01618708|524408226|FG000|Overall Study|Adverse Event|10|||
145423952|NCT01618708|524408227|FG001|Overall Study|Adverse Event|10|||
145423953|NCT01618708|524408226|FG000|Overall Study|Lost to Follow-up|3|||
145423954|NCT01618708|524408227|FG001|Overall Study|Lost to Follow-up|3|||
145423955|NCT01618708|524408226|FG000|Overall Study|Withdrawal by Subject|17|||
145423956|NCT01618708|524408227|FG001|Overall Study|Withdrawal by Subject|22|||
145423957|NCT01618708|524408226|FG000|Overall Study|Lack of Efficacy|8|||
145423958|NCT01618708|524408227|FG001|Overall Study|Lack of Efficacy|8|||
145423959|NCT01618708|524408226|FG000|Overall Study|Technical problems|2|||
145423960|NCT01618708|524408227|FG001|Overall Study|Technical problems|0|||
145423961|NCT01618708|524408226|FG000|Overall Study|Other than specified above|1|||
145423962|NCT01618708|524408227|FG001|Overall Study|Other than specified above|1|||
145423963|NCT01618708|524408226|FG000|Overall Study|Randomized but not treated|3|||
145423964|NCT01618708|524408227|FG001|Overall Study|Randomized but not treated|2|||
145423965|NCT00489476|524408231|FG000|Overall Study|Lost to Follow-up|0|||
145423966|NCT00489476|524408232|FG001|Overall Study|Lost to Follow-up|1|||
145423967|NCT00489476|524408233|FG002|Overall Study|Lost to Follow-up|0|||
145423968|NCT00489476|524408234|FG003|Overall Study|Lost to Follow-up|0|||
145423969|NCT02757963|524408243|FG000|Overall Study|Adverse Event|3|||
145423970|NCT02757963|524408243|FG000|Overall Study|Reached Stopping Criteria|1054|||
145423971|NCT02757963|524408243|FG000|Overall Study|Lost to Follow-up|5|||
145423972|NCT02757963|524408243|FG000|Overall Study|Physician Decision|1|||
145423973|NCT02757963|524408243|FG000|Overall Study|Withdrawal by Subject|34|||
145423974|NCT00655356|524408244|FG000|Overall Study|Withdrawal by Subject|3|||
145423975|NCT00655356|524408245|FG001|Overall Study|Withdrawal by Subject|4|||
145423976|NCT00655356|524408244|FG000|Overall Study|Sponsor Request|10|||
145423977|NCT00655356|524408245|FG001|Overall Study|Sponsor Request|4|||
145423978|NCT00655356|524408244|FG000|Overall Study|Adverse Event|1|||
145423979|NCT00655356|524408245|FG001|Overall Study|Adverse Event|1|||
145423980|NCT00655356|524408244|FG000|Overall Study|Protocol Violation|2|||
145423981|NCT00655356|524408245|FG001|Overall Study|Protocol Violation|1|||
145423982|NCT00655356|524408244|FG000|Overall Study|Other Reason|1|||
145423983|NCT00655356|524408245|FG001|Overall Study|Other Reason|0|||
145423984|NCT01044459|524408246|FG000|Overall Study|Withdrawal by Subject|21|||
145423985|NCT01044459|524408247|FG001|Overall Study|Withdrawal by Subject|28|||
145423986|NCT01044459|524408246|FG000|Overall Study|Terminated by Sponsor|22|||
145423987|NCT01044459|524408247|FG001|Overall Study|Terminated by Sponsor|21|||
145423988|NCT01044459|524408246|FG000|Overall Study|Adverse Event|22|||
145423989|NCT01044459|524408247|FG001|Overall Study|Adverse Event|20|||
145423990|NCT01044459|524408246|FG000|Overall Study|Lack of Efficacy|23|||
145423991|NCT01044459|524408247|FG001|Overall Study|Lack of Efficacy|12|||
145423992|NCT01044459|524408246|FG000|Overall Study|Protocol Violation|11|||
145423993|NCT01044459|524408247|FG001|Overall Study|Protocol Violation|16|||
145423994|NCT01044459|524408246|FG000|Overall Study|Other Reason|7|||
145423995|NCT01044459|524408247|FG001|Overall Study|Other Reason|14|||
145423996|NCT01044459|524408246|FG000|Overall Study|COPD exacerbation|9|||
145423997|NCT01044459|524408247|FG001|Overall Study|COPD exacerbation|8|||
145423998|NCT01044459|524408246|FG000|Overall Study|Lost to Follow-up|18|||
145423999|NCT01044459|524408247|FG001|Overall Study|Lost to Follow-up|12|||
145424000|NCT04105725|524408248|FG000|Primary Intervention|Lost to Follow-up|0|||
145424001|NCT04105725|524408249|FG001|Primary Intervention|Lost to Follow-up|2|||
145424002|NCT04105725|524408248|FG000|Primary Intervention|Withdrawal by Subject|0|||
145424003|NCT04105725|524408249|FG001|Primary Intervention|Withdrawal by Subject|1|||
145424004|NCT05346640|524408250|FG000|Overall Study|Lack of Efficacy|2|||
145424005|NCT05346640|524408250|FG000|Overall Study|Lost to Follow-up|14|||
145424006|NCT05346640|524408250|FG000|Overall Study|Protocol Violation|4|||
145424007|NCT05346640|524408250|FG000|Overall Study|Withdrawal by Subject|2|||
145424008|NCT05346640|524408250|FG000|Overall Study|Physiological Complications|3|||
145424009|NCT05346640|524408250|FG000|Overall Study|Other Reason|3|||
145424010|NCT04634331|524408251|FG000|Overall Study|Withdrawal by Subject|2|||
145424011|NCT04634331|524408252|FG001|Overall Study|Withdrawal by Subject|2|||
145424012|NCT00507507|524408253|FG000|Treatment Period|Lost to Follow-up|0|||
145424013|NCT00507507|524408254|FG001|Treatment Period|Lost to Follow-up|2|||
145424014|NCT00507507|524408253|FG000|Treatment Period|Physician Decision|4|||
145424015|NCT00507507|524408254|FG001|Treatment Period|Physician Decision|1|||
145424016|NCT00507507|524408253|FG000|Treatment Period|Protocol Violation|1|||
145424017|NCT00507507|524408254|FG001|Treatment Period|Protocol Violation|2|||
145424018|NCT00507507|524408253|FG000|Treatment Period|Adverse Event|1|||
145424019|NCT00507507|524408254|FG001|Treatment Period|Adverse Event|1|||
145424020|NCT00507507|524408253|FG000|Treatment Period|Withdrawal by Subject|46|||
145424021|NCT00507507|524408254|FG001|Treatment Period|Withdrawal by Subject|47|||
145424022|NCT00507507|524408253|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
145424023|NCT00507507|524408254|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
145424024|NCT00507507|524408253|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
145424025|NCT00507507|524408254|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
145424026|NCT00507507|524408253|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
145424027|NCT00507507|524408254|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
145424028|NCT02916433|524408255|FG000|Overall Study|Withdrawal by Subject|1|||
145424029|NCT02916433|524408256|FG001|Overall Study|Withdrawal by Subject|0|||
145424030|NCT02916433|524408255|FG000|Overall Study|Physician Decision|1|||
145424031|NCT02916433|524408256|FG001|Overall Study|Physician Decision|0|||
145424032|NCT01694771|524408257|FG000|Overall Study|Adverse Event|18|||
145424033|NCT01694771|524408258|FG001|Overall Study|Adverse Event|16|||
145424034|NCT01694771|524408257|FG000|Overall Study|Lack of Efficacy|1|||
145424035|NCT01694771|524408258|FG001|Overall Study|Lack of Efficacy|0|||
145424036|NCT01694771|524408257|FG000|Overall Study|Non compliance protocol|7|||
145424037|NCT01694771|524408258|FG001|Overall Study|Non compliance protocol|6|||
145424038|NCT01694771|524408257|FG000|Overall Study|Lost to Follow-up|2|||
145424039|NCT01694771|524408258|FG001|Overall Study|Lost to Follow-up|3|||
145424040|NCT01694771|524408257|FG000|Overall Study|Consent withdrawn|7|||
145424041|NCT01694771|524408258|FG001|Overall Study|Consent withdrawn|9|||
145424042|NCT01694771|524408257|FG000|Overall Study|Other reasons|5|||
145424043|NCT01694771|524408258|FG001|Overall Study|Other reasons|6|||
145424044|NCT03927846|524408261|FG000|Overall Study|Lost to Follow-up|10|||
145424045|NCT03927846|524408262|FG001|Overall Study|Lost to Follow-up|11|||
145424046|NCT03878069|524408263|FG000|Overall Study|Death|0|||
145424047|NCT03878069|524408264|FG001|Overall Study|Death|1|||
145424048|NCT03878069|524408265|FG002|Overall Study|Death|0|||
145424049|NCT01251965|524409552|FG000|Overall Study|Participant/physician decision|1|||
145424050|NCT01251965|524409553|FG001|Overall Study|Participant/physician decision|2|||
145424051|NCT01251965|524409554|FG002|Overall Study|Participant/physician decision|0|||
145424052|NCT01251965|524409552|FG000|Overall Study|Death|0|||
145424053|NCT01251965|524409553|FG001|Overall Study|Death|0|||
145424054|NCT01251965|524409554|FG002|Overall Study|Death|11|||
145424055|NCT02371889|524409555|FG000|Overall Study|Adverse medication effect|11|||
145424056|NCT02371889|524409556|FG001|Overall Study|Adverse medication effect|2|||
145424057|NCT02371889|524409555|FG000|Overall Study|Lost to Follow-up|6|||
145424058|NCT02371889|524409556|FG001|Overall Study|Lost to Follow-up|5|||
145424059|NCT02371889|524409555|FG000|Overall Study|Personal time constraints|2|||
145424060|NCT02371889|524409556|FG001|Overall Study|Personal time constraints|4|||
145424061|NCT02371889|524409555|FG000|Overall Study|Lack of Efficacy|0|||
145424062|NCT02371889|524409556|FG001|Overall Study|Lack of Efficacy|2|||
145424063|NCT02371889|524409555|FG000|Overall Study|Relapse|0|||
145424064|NCT02371889|524409556|FG001|Overall Study|Relapse|1|||
145424065|NCT05520333|524409557|FG000|Overall Study|Lost to Follow-up|3|||
145424066|NCT05520333|524409558|FG001|Overall Study|Lost to Follow-up|6|||
145424067|NCT00866775|524409559|FG000|Overall Study|Adverse Event|5|||
145424068|NCT00866775|524409560|FG001|Overall Study|Adverse Event|19|||
145424069|NCT00866775|524409559|FG000|Overall Study|Death|1|||
145424070|NCT00866775|524409560|FG001|Overall Study|Death|0|||
145424071|NCT00866775|524409559|FG000|Overall Study|Lost to Follow-up|0|||
145424072|NCT00866775|524409560|FG001|Overall Study|Lost to Follow-up|4|||
145424073|NCT00866775|524409559|FG000|Overall Study|Physician Decision|0|||
145424074|NCT00866775|524409560|FG001|Overall Study|Physician Decision|3|||
145424075|NCT00866775|524409559|FG000|Overall Study|Protocol Violation|3|||
145424076|NCT00866775|524409560|FG001|Overall Study|Protocol Violation|4|||
145424077|NCT00866775|524409559|FG000|Overall Study|Withdrawal by Subject|4|||
145424078|NCT00866775|524409560|FG001|Overall Study|Withdrawal by Subject|4|||
145424079|NCT00866775|524409559|FG000|Overall Study|met exit criteria|23|||
145424080|NCT00866775|524409560|FG001|Overall Study|met exit criteria|17|||
145424081|NCT00866775|524409559|FG000|Overall Study|discontinued due to communication error|0|||
145424082|NCT00866775|524409560|FG001|Overall Study|discontinued due to communication error|1|||
145424083|NCT01500135|524409561|FG000|Overall Study|Withdrawal of Consent|4|||
145424084|NCT01500135|524409562|FG001|Overall Study|Withdrawal of Consent|0|||
145424085|NCT01500135|524409561|FG000|Overall Study|Lost to Follow-up|6|||
145424086|NCT01500135|524409562|FG001|Overall Study|Lost to Follow-up|4|||
145424087|NCT01500135|524409561|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
145424088|NCT01500135|524409562|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
145424089|NCT01500135|524409561|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
145424090|NCT01500135|524409562|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
145424091|NCT01500135|524409561|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
145424092|NCT01500135|524409562|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
145424093|NCT01500135|524409561|FG000|Overall Study|Participant was a Safety Concern|1|||
145424094|NCT01500135|524409562|FG001|Overall Study|Participant was a Safety Concern|0|||
145424095|NCT01500135|524409561|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
145424096|NCT01500135|524409562|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
145424097|NCT00912509|524409563|FG000|Overall Study|Lost to Follow-up|1|||
145424098|NCT00912509|524409564|FG001|Overall Study|Lost to Follow-up|0|||
145424099|NCT00912509|524409563|FG000|Overall Study|Lack of Efficacy|4|||
145424100|NCT00912509|524409564|FG001|Overall Study|Lack of Efficacy|3|||
145424101|NCT05538728|524409565|FG000|Overall Study|Withdrawal by Subject|1|||
145424102|NCT05538728|524409566|FG001|Overall Study|Withdrawal by Subject|1|||
145424103|NCT01050218|524409567|FG000|Overall Study|Adverse Event|37|||
145424104|NCT01050218|524409567|FG000|Overall Study|Lack of Efficacy|8|||
145424105|NCT01050218|524409567|FG000|Overall Study|Protocol Violation|3|||
145424106|NCT01050218|524409567|FG000|Overall Study|Withdrawal by Subject|18|||
145579250|NCT01649856|524975311|FG000|Overall Study|Treatment Failure|1|||
145579251|NCT01649856|524975312|FG001|Overall Study|Treatment Failure|1|||
145424107|NCT01050218|524409567|FG000|Overall Study|Discontinued by sponsor|18|||
145424108|NCT01050218|524409567|FG000|Overall Study|Compliance|2|||
145424109|NCT01050218|524409567|FG000|Overall Study|Failed to return|7|||
145424110|NCT01050218|524409567|FG000|Overall Study|Serious Adverse Event|1|||
145424111|NCT01050218|524409567|FG000|Overall Study|Family emergency|1|||
145424112|NCT01772693|524409568|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
145579252|NCT01649856|524975311|FG000|Overall Study|Death|69|||
145579253|NCT01649856|524975312|FG001|Overall Study|Death|34|||
145424113|NCT01772693|524409569|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
145424114|NCT01772693|524409568|FG000|Overall Study|Withdrawal by Subject|2|||
145424115|NCT01772693|524409569|FG001|Overall Study|Withdrawal by Subject|0|||
145424116|NCT01772693|524409568|FG000|Overall Study|Alternative Treatment|2|||
145424117|NCT01772693|524409569|FG001|Overall Study|Alternative Treatment|0|||
145424118|NCT00889005|524409572|FG000|Overall Study|Lost to Follow-up|4|||
145424119|NCT00889005|524409573|FG001|Overall Study|Lost to Follow-up|2|||
145424120|NCT00889005|524409572|FG000|Overall Study|Withdrawal by Subject|4|||
145424121|NCT00889005|524409573|FG001|Overall Study|Withdrawal by Subject|0|||
145424122|NCT02605967|524409574|FG000|Overall Study|subject / guardian decision|1|||
145424123|NCT02605967|524409575|FG001|Overall Study|subject / guardian decision|2|||
145424124|NCT02605967|524409574|FG000|Overall Study|Physician Decision|10|||
145424125|NCT02605967|524409575|FG001|Overall Study|Physician Decision|1|||
145424126|NCT02605967|524409574|FG000|Overall Study|Death|4|||
145424127|NCT02605967|524409575|FG001|Overall Study|Death|2|||
145424128|NCT02605967|524409574|FG000|Overall Study|Adverse Event|1|||
145424129|NCT02605967|524409575|FG001|Overall Study|Adverse Event|0|||
145424130|NCT02605967|524409574|FG000|Overall Study|progressive disease|66|||
145424131|NCT02605967|524409575|FG001|Overall Study|progressive disease|35|||
145424132|NCT02244957|524409576|FG000|Overall Study|Lack of Efficacy|1|||
145424133|NCT02244957|524409577|FG001|Overall Study|Lack of Efficacy|0|||
145424134|NCT03760081|524409580|FG000|Overall Study|Miscellaneous|0|||
145424135|NCT03760081|524409581|FG001|Overall Study|Miscellaneous|1|||
145424136|NCT03760081|524409580|FG000|Overall Study|Progressive Disease|5|||
145424137|NCT03760081|524409581|FG001|Overall Study|Progressive Disease|10|||
145424138|NCT03760081|524409580|FG000|Overall Study|Death|1|||
145424139|NCT03760081|524409581|FG001|Overall Study|Death|1|||
145424140|NCT02202577|524409586|FG000|Overall Study|Lost to Follow-up|6|||
145424141|NCT02202577|524409587|FG001|Overall Study|Lost to Follow-up|16|||
145424142|NCT02202577|524409586|FG000|Overall Study|Protocol Violation|7|||
145424143|NCT02202577|524409587|FG001|Overall Study|Protocol Violation|3|||
145424144|NCT01681849|524409592|FG000|Overall Study|Protocol Violation|2|||
145424145|NCT01681849|524409593|FG001|Overall Study|Protocol Violation|0|||
145424146|NCT01681849|524409594|FG002|Overall Study|Protocol Violation|0|||
145424147|NCT01681849|524409592|FG000|Overall Study|Withdrawal by Subject|3|||
145424148|NCT01681849|524409593|FG001|Overall Study|Withdrawal by Subject|5|||
145424149|NCT01681849|524409594|FG002|Overall Study|Withdrawal by Subject|33|||
145424150|NCT01681849|524409592|FG000|Overall Study|Lost to Follow-up|3|||
145424151|NCT01681849|524409593|FG001|Overall Study|Lost to Follow-up|2|||
145424152|NCT01681849|524409594|FG002|Overall Study|Lost to Follow-up|6|||
145424153|NCT04525183|524409597|FG000|Overall Study|Withdrawal by Subject|0|||
145424154|NCT04525183|524409598|FG001|Overall Study|Withdrawal by Subject|0|||
145424155|NCT04525183|524409599|FG002|Overall Study|Withdrawal by Subject|3|||
145424156|NCT04525183|524409597|FG000|Overall Study|Study non-compliance|0|||
145424157|NCT04525183|524409598|FG001|Overall Study|Study non-compliance|0|||
145424158|NCT04525183|524409599|FG002|Overall Study|Study non-compliance|1|||
145424159|NCT04525183|524409597|FG000|Overall Study|Recurrent disease before starting on study|0|||
145424160|NCT04525183|524409598|FG001|Overall Study|Recurrent disease before starting on study|0|||
145424161|NCT04525183|524409599|FG002|Overall Study|Recurrent disease before starting on study|1|||
145424162|NCT01166646|524409600|FG000|Overall Study|Protocol Violation|0|||
145424163|NCT01166646|524409601|FG001|Overall Study|Protocol Violation|1|||
145424164|NCT01166646|524409600|FG000|Overall Study|Adverse Event|1|||
145424165|NCT01166646|524409601|FG001|Overall Study|Adverse Event|0|||
145424166|NCT03777020|524409602|FG000|Overall Study|Withdrawal by Subject|4|||
145424167|NCT03777020|524409603|FG001|Overall Study|Withdrawal by Subject|4|||
145424168|NCT03777020|524409602|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
145424169|NCT03777020|524409603|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
145424170|NCT03460704|524409604|FG000|Overall Study|Withdrawal by Subject|11|||
145424171|NCT03460704|524409605|FG001|Overall Study|Withdrawal by Subject|14|||
145424172|NCT03460704|524409604|FG000|Overall Study|Study terminated by the Sponsor|29|||
145424173|NCT03460704|524409605|FG001|Overall Study|Study terminated by the Sponsor|19|||
145424174|NCT03460704|524409604|FG000|Overall Study|Adverse Event|10|||
145424175|NCT03460704|524409605|FG001|Overall Study|Adverse Event|5|||
145424176|NCT03460704|524409604|FG000|Overall Study|Death|3|||
145424177|NCT03460704|524409605|FG001|Overall Study|Death|2|||
145424178|NCT03460704|524409604|FG000|Overall Study|Non-Compliance with Study Drug|3|||
145424179|NCT03460704|524409605|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145424180|NCT03460704|524409604|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145424181|NCT03460704|524409605|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
145424182|NCT03460704|524409604|FG000|Overall Study|Other|2|||
145424183|NCT03460704|524409605|FG001|Overall Study|Other|1|||
145424184|NCT04126174|524409606|FG000|Overall Study|Lost to Follow-up|3|||
145424185|NCT04126174|524409607|FG001|Overall Study|Lost to Follow-up|3|||
145424186|NCT04439903|524409620|FG000|Overall Study|Withdrawal by Subject|2|||
145424187|NCT04439903|524409620|FG000|Overall Study|Screen Failure|1|||
145424188|NCT02899754|524409621|FG000|Overall Study|Lost to Follow-up|7|||
145424189|NCT02899754|524409622|FG001|Overall Study|Lost to Follow-up|9|||
145424190|NCT04818229|524409623|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
145424191|NCT04818229|524409624|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
145424192|NCT04818229|524409625|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
145424193|NCT04818229|524409623|FG000|Overall Study|Adverse Event|3|||
145424194|NCT04818229|524409624|FG001|Overall Study|Adverse Event|1|||
145424195|NCT04818229|524409625|FG002|Overall Study|Adverse Event|1|||
145424196|NCT04818229|524409623|FG000|Overall Study|Withdrawal by Subject|0|||
145424197|NCT04818229|524409624|FG001|Overall Study|Withdrawal by Subject|0|||
145424198|NCT04818229|524409625|FG002|Overall Study|Withdrawal by Subject|2|||
145424199|NCT04818229|524409623|FG000|Overall Study|Lost to Follow-up|0|||
145424200|NCT04818229|524409624|FG001|Overall Study|Lost to Follow-up|0|||
145424201|NCT04818229|524409625|FG002|Overall Study|Lost to Follow-up|1|||
145424202|NCT03769116|524409632|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
145424203|NCT03769116|524409633|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
145424204|NCT03769116|524409632|FG000|Part 3 - Open Label|Physician Decision|1|||
145424205|NCT03769116|524409633|FG001|Part 3 - Open Label|Physician Decision|0|||
145424206|NCT03769116|524409632|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
145424207|NCT03769116|524409633|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
145424208|NCT02181413|524409636|FG000|Overall Study|Withdrawal by Subject|45|||
145424209|NCT02181413|524409637|FG001|Overall Study|Withdrawal by Subject|61|||
145424210|NCT02181413|524409636|FG000|Overall Study|Reason Not Specified|2|||
145424211|NCT02181413|524409637|FG001|Overall Study|Reason Not Specified|5|||
145424212|NCT02181413|524409636|FG000|Overall Study|Lost to Follow-up|8|||
145424213|NCT02181413|524409637|FG001|Overall Study|Lost to Follow-up|7|||
145424214|NCT04003142|524409639|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
145424215|NCT04003142|524409640|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
145424216|NCT04003142|524409641|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
145424217|NCT04003142|524409642|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
145424218|NCT04003142|524409643|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
145424219|NCT04003142|524409639|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
145424220|NCT04003142|524409640|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
145424221|NCT04003142|524409641|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
145424222|NCT04003142|524409642|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
145424223|NCT04003142|524409643|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
145424224|NCT04003142|524409639|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
145424225|NCT04003142|524409640|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
145424226|NCT04003142|524409641|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145424227|NCT04003142|524409642|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145424228|NCT04003142|524409643|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
145424229|NCT04003142|524409639|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
145424230|NCT04003142|524409640|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
145424231|NCT04003142|524409641|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
145424232|NCT04003142|524409642|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
145424233|NCT04003142|524409643|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
145424234|NCT04003142|524409639|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
145424235|NCT04003142|524409640|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
145424236|NCT04003142|524409641|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
145424237|NCT04003142|524409642|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
145424238|NCT04003142|524409643|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
145424239|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
145424240|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
145424241|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
145424242|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
145424243|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
145424244|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Death|0|||
145424245|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Death|0|||
145424246|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Death|0|||
145424247|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Death|0|||
145424248|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Death|1|||
145424249|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
145424250|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
145424251|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
145424252|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
145424253|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
145424254|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
145424255|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
145424256|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
145424257|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
145424258|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
145424259|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
145424260|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
145424261|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
145579254|NCT01649856|524975311|FG000|Overall Study|Stable or Progressed Disease|5|||
145424262|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
145424263|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
145424264|NCT04003142|524409639|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
145579255|NCT01649856|524975312|FG001|Overall Study|Stable or Progressed Disease|3|||
145424265|NCT04003142|524409640|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
145424266|NCT04003142|524409641|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
145424267|NCT04003142|524409642|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
145424268|NCT04003142|524409643|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
145424269|NCT03382873|524409644|FG000|Overall Study|Lost to Follow-up|9|||
145579256|NCT01649856|524975311|FG000|Overall Study|Lost to Follow-up|20|||
145579257|NCT01649856|524975312|FG001|Overall Study|Lost to Follow-up|16|||
145579258|NCT01649856|524975311|FG000|Overall Study|Lack of Compliance|6|||
145579259|NCT01649856|524975312|FG001|Overall Study|Lack of Compliance|1|||
145579260|NCT01649856|524975311|FG000|Overall Study|Other|20|||
145579261|NCT01649856|524975312|FG001|Overall Study|Other|5|||
145579262|NCT00179647|524975313|FG000|Overall Study|Adverse Event|294|||
145579263|NCT00179647|524975313|FG000|Overall Study|Lack of Efficacy|478|||
145579264|NCT00179647|524975313|FG000|Overall Study|Withdrawal by Subject|83|||
145579265|NCT00179647|524975313|FG000|Overall Study|Lost to Follow-up|4|||
145579266|NCT00179647|524975313|FG000|Overall Study|Death|94|||
145579267|NCT00179647|524975313|FG000|Overall Study|Other|960|||
145371812|NCT02031640|524210966|FG004|Double-blind Treatment Period|Non-compliance|1|||
145371813|NCT02031640|524210967|FG005|Double-blind Treatment Period|Non-compliance|0|||
145424270|NCT03382873|524409645|FG001|Overall Study|Lost to Follow-up|10|||
145424271|NCT03382873|524409644|FG000|Overall Study|Withdrawal by Subject|6|||
145424272|NCT03382873|524409645|FG001|Overall Study|Withdrawal by Subject|11|||
145424273|NCT03382873|524409644|FG000|Overall Study|Visit not completed due to pandemic|16|||
145424274|NCT03382873|524409645|FG001|Overall Study|Visit not completed due to pandemic|41|||
145424275|NCT04755231|524409651|FG000|Overall Study|Lost to Follow-up|5|||
145424276|NCT04755231|524409651|FG000|Overall Study|Withdrawal by Subject|5|||
145424277|NCT04754399|524409652|FG000|Overall Study|Adverse Event|5|||
145424278|NCT04754399|524409652|FG000|Overall Study|Withdrawal by Subject|6|||
145424279|NCT00025233|524409655|FG000|Overall Study|Ineligible: wrong cell type|1|||
145424280|NCT00025233|524409655|FG000|Overall Study|Ineligible: wrong primary|1|||
145424281|NCT00025233|524409655|FG000|Overall Study|Ineligible: improper prior treatment|1|||
145424282|NCT00025233|524409655|FG000|Overall Study|Never treated|1|||
145424283|NCT01720602|524409656|FG000|Overall Study|Adverse Event|3|||
145424284|NCT01720602|524409656|FG000|Overall Study|Progressive disease on therapy|2|||
145579268|NCT00622635|524975314|FG000|Treatment Period 1|Adverse Event|0|||
145579269|NCT00622635|524975315|FG001|Treatment Period 1|Adverse Event|0|||
145579270|NCT00622635|524975316|FG002|Treatment Period 1|Adverse Event|1|||
145371814|NCT02031640|524210962|FG000|Double-blind Treatment Period|Adverse Event|0|||
145371815|NCT02031640|524210963|FG001|Double-blind Treatment Period|Adverse Event|0|||
145371816|NCT02031640|524210964|FG002|Double-blind Treatment Period|Adverse Event|0|||
145371817|NCT02031640|524210965|FG003|Double-blind Treatment Period|Adverse Event|2|||
145371818|NCT02031640|524210966|FG004|Double-blind Treatment Period|Adverse Event|0|||
145371819|NCT02031640|524210967|FG005|Double-blind Treatment Period|Adverse Event|0|||
145371820|NCT02031640|524210962|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145371821|NCT02031640|524210963|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145371822|NCT02031640|524210964|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
145371823|NCT02031640|524210965|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
145371824|NCT02031640|524210966|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
145371825|NCT02031640|524210967|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
145371826|NCT02031640|524210962|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145371827|NCT02031640|524210963|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
145371828|NCT02031640|524210964|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145371829|NCT02031640|524210965|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145371830|NCT02031640|524210966|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
145371831|NCT02031640|524210967|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
145371832|NCT03085238|524210973|FG000|Overall Study|Adverse Event|2|||
145371833|NCT03085238|524210973|FG000|Overall Study|Death|2|||
145371834|NCT05896527|524210974|FG000|Overall Study|Withdrawal by Subject|11|||
145371835|NCT05896527|524210975|FG001|Overall Study|Withdrawal by Subject|10|||
145371836|NCT05896527|524210976|FG002|Overall Study|Withdrawal by Subject|4|||
145371837|NCT05896527|524210977|FG003|Overall Study|Withdrawal by Subject|3|||
145371838|NCT05896527|524210978|FG004|Overall Study|Withdrawal by Subject|2|||
145371839|NCT05896527|524210974|FG000|Overall Study|Lost to Follow-up|0|||
145371840|NCT05896527|524210975|FG001|Overall Study|Lost to Follow-up|2|||
145371841|NCT05896527|524210976|FG002|Overall Study|Lost to Follow-up|2|||
145371842|NCT05896527|524210977|FG003|Overall Study|Lost to Follow-up|2|||
145371843|NCT05896527|524210978|FG004|Overall Study|Lost to Follow-up|1|||
145371844|NCT05896527|524210974|FG000|Overall Study|Significant protocol noncompliance|0|||
145371845|NCT05896527|524210975|FG001|Overall Study|Significant protocol noncompliance|1|||
145371846|NCT05896527|524210976|FG002|Overall Study|Significant protocol noncompliance|0|||
145371847|NCT05896527|524210977|FG003|Overall Study|Significant protocol noncompliance|0|||
145371848|NCT05896527|524210978|FG004|Overall Study|Significant protocol noncompliance|0|||
145424285|NCT00834587|524409662|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
145424286|NCT00834587|524409663|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
145579271|NCT00622635|524975317|FG003|Treatment Period 1|Adverse Event|0|||
145371849|NCT05896527|524210974|FG000|Overall Study|Eligibility criteria not met|1|||
145371850|NCT05896527|524210975|FG001|Overall Study|Eligibility criteria not met|0|||
145371851|NCT05896527|524210976|FG002|Overall Study|Eligibility criteria not met|0|||
145424287|NCT00176254|524409664|FG000|Overall Study|Lost to Follow-up|1|||
145579272|NCT00622635|524975318|FG004|Treatment Period 1|Adverse Event|0|||
145424288|NCT02536339|524409666|FG000|Overall Study|Death|20|||
145424289|NCT02536339|524409666|FG000|Overall Study|Withdrawal by Subject|3|||
145424290|NCT02536339|524409666|FG000|Overall Study|Lost to Follow-up|2|||
145424291|NCT02536339|524409666|FG000|Overall Study|Treatment discontinued|2|||
145424292|NCT02536339|524409666|FG000|Overall Study|Physician Decision|1|||
145424293|NCT02037984|524409668|FG000|Overall Study|Lack of Efficacy|0|||
145424294|NCT02037984|524409669|FG001|Overall Study|Lack of Efficacy|0|||
145424295|NCT02037984|524409670|FG002|Overall Study|Lack of Efficacy|3|||
145424296|NCT02037984|524409671|FG003|Overall Study|Lack of Efficacy|10|||
145424297|NCT02037984|524409672|FG004|Overall Study|Lack of Efficacy|2|||
145424298|NCT02037984|524409673|FG005|Overall Study|Lack of Efficacy|2|||
145424299|NCT02037984|524409674|FG006|Overall Study|Lack of Efficacy|4|||
145424300|NCT02037984|524409675|FG007|Overall Study|Lack of Efficacy|3|||
145424301|NCT02037984|524409668|FG000|Overall Study|Lost to Follow-up|1|||
145579273|NCT00622635|524975319|FG005|Treatment Period 1|Adverse Event|0|||
145579274|NCT00622635|524975314|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145579275|NCT00622635|524975315|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145579276|NCT00622635|524975316|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145579277|NCT00622635|524975317|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145579278|NCT00622635|524975318|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145579279|NCT00622635|524975319|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145579280|NCT00622635|524975314|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
145579281|NCT00622635|524975315|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
145579282|NCT00622635|524975316|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
145579283|NCT00622635|524975317|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
145579284|NCT00622635|524975318|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
145579285|NCT00622635|524975319|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
145579286|NCT00622635|524975314|FG000|Treatment Period 2|Adverse Event|1|||
145579287|NCT00622635|524975315|FG001|Treatment Period 2|Adverse Event|0|||
145579288|NCT00622635|524975316|FG002|Treatment Period 2|Adverse Event|0|||
145579289|NCT00622635|524975317|FG003|Treatment Period 2|Adverse Event|0|||
145579290|NCT00622635|524975318|FG004|Treatment Period 2|Adverse Event|0|||
145579291|NCT00622635|524975319|FG005|Treatment Period 2|Adverse Event|0|||
145579292|NCT00622635|524975314|FG000|Treatment Period 3|Adverse Event|0|||
145579293|NCT00622635|524975315|FG001|Treatment Period 3|Adverse Event|0|||
145579294|NCT00622635|524975316|FG002|Treatment Period 3|Adverse Event|0|||
145579295|NCT00622635|524975317|FG003|Treatment Period 3|Adverse Event|2|||
145579296|NCT00622635|524975318|FG004|Treatment Period 3|Adverse Event|0|||
145579297|NCT00622635|524975319|FG005|Treatment Period 3|Adverse Event|0|||
145579298|NCT00622635|524975314|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145579299|NCT00622635|524975315|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145579300|NCT00622635|524975316|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145424302|NCT02037984|524409669|FG001|Overall Study|Lost to Follow-up|0|||
145424303|NCT02037984|524409670|FG002|Overall Study|Lost to Follow-up|3|||
145424304|NCT02037984|524409671|FG003|Overall Study|Lost to Follow-up|5|||
145424305|NCT02037984|524409672|FG004|Overall Study|Lost to Follow-up|2|||
145424306|NCT02037984|524409673|FG005|Overall Study|Lost to Follow-up|2|||
145424307|NCT02037984|524409674|FG006|Overall Study|Lost to Follow-up|2|||
145424308|NCT02037984|524409675|FG007|Overall Study|Lost to Follow-up|4|||
145424309|NCT02037984|524409668|FG000|Overall Study|Physician Decision|0|||
145424310|NCT02037984|524409669|FG001|Overall Study|Physician Decision|0|||
145424311|NCT02037984|524409670|FG002|Overall Study|Physician Decision|0|||
145424312|NCT02037984|524409671|FG003|Overall Study|Physician Decision|0|||
145424313|NCT02037984|524409672|FG004|Overall Study|Physician Decision|0|||
145424314|NCT02037984|524409673|FG005|Overall Study|Physician Decision|0|||
145424315|NCT02037984|524409674|FG006|Overall Study|Physician Decision|1|||
145424316|NCT02037984|524409675|FG007|Overall Study|Physician Decision|0|||
145424317|NCT02037984|524409668|FG000|Overall Study|Protocol Violation|0|||
145424318|NCT02037984|524409669|FG001|Overall Study|Protocol Violation|0|||
145424319|NCT02037984|524409670|FG002|Overall Study|Protocol Violation|0|||
145424320|NCT02037984|524409671|FG003|Overall Study|Protocol Violation|0|||
145579301|NCT00622635|524975317|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145579302|NCT00622635|524975318|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145579303|NCT00622635|524975319|FG005|Treatment Period 3|Withdrawal by Subject|0|||
145424321|NCT02037984|524409672|FG004|Overall Study|Protocol Violation|0|||
145424322|NCT02037984|524409673|FG005|Overall Study|Protocol Violation|1|||
145424323|NCT02037984|524409674|FG006|Overall Study|Protocol Violation|2|||
145424324|NCT02037984|524409675|FG007|Overall Study|Protocol Violation|0|||
145424325|NCT02037984|524409668|FG000|Overall Study|Technical Problems|0|||
145424326|NCT02037984|524409669|FG001|Overall Study|Technical Problems|0|||
145424327|NCT02037984|524409670|FG002|Overall Study|Technical Problems|3|||
145579304|NCT00835406|524975320|FG000|Period: First Intervention|Adverse Event|0|||
145579305|NCT00835406|524975321|FG001|Period: First Intervention|Adverse Event|1|||
145579306|NCT00835406|524975320|FG000|Period: First Intervention|Withdrawal by Subject|2|||
145579307|NCT00835406|524975321|FG001|Period: First Intervention|Withdrawal by Subject|0|||
145424328|NCT02037984|524409671|FG003|Overall Study|Technical Problems|3|||
145424329|NCT02037984|524409672|FG004|Overall Study|Technical Problems|2|||
145424330|NCT02037984|524409673|FG005|Overall Study|Technical Problems|3|||
145579308|NCT00835406|524975320|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
145579309|NCT00835406|524975321|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
145579310|NCT00281840|524975322|FG000|Overall Study|Adverse Event|12|||
145579311|NCT00281840|524975322|FG000|Overall Study|Physician Decision|6|||
145579312|NCT00281840|524975322|FG000|Overall Study|Withdrawal by Subject|3|||
145579313|NCT00281840|524975322|FG000|Overall Study|Disease Progression|2|||
145579314|NCT00281840|524975322|FG000|Overall Study|exceed maximum delay in treatment|1|||
145579315|NCT00281840|524975322|FG000|Overall Study|Complicating Disease|1|||
145579316|NCT02138214|524975325|FG000|Overall Study|Withdrawal by Subject|0|||
145579317|NCT02138214|524975326|FG001|Overall Study|Withdrawal by Subject|1|||
145579318|NCT02138214|524975327|FG002|Overall Study|Withdrawal by Subject|0|||
145579319|NCT02138214|524975325|FG000|Overall Study|Lost to Follow-up|0|||
145579320|NCT02138214|524975326|FG001|Overall Study|Lost to Follow-up|2|||
145579321|NCT02138214|524975327|FG002|Overall Study|Lost to Follow-up|4|||
145579322|NCT02138214|524975325|FG000|Overall Study|Screen Failure|0|||
145371852|NCT05896527|524210977|FG003|Overall Study|Eligibility criteria not met|0|||
145371853|NCT05896527|524210978|FG004|Overall Study|Eligibility criteria not met|0|||
145371854|NCT05896527|524210974|FG000|Overall Study|Sponsor's decision|0|||
145371855|NCT05896527|524210975|FG001|Overall Study|Sponsor's decision|0|||
145371856|NCT05896527|524210976|FG002|Overall Study|Sponsor's decision|0|||
145371857|NCT05896527|524210977|FG003|Overall Study|Sponsor's decision|1|||
145579323|NCT02138214|524975326|FG001|Overall Study|Screen Failure|1|||
145579324|NCT02138214|524975327|FG002|Overall Study|Screen Failure|0|||
145579325|NCT02185768|524975328|FG000|Overall Study|Patients were not treated|2|||
145579326|NCT03027466|524975333|FG000|Overall Study|Opting out of the app|1869|||
145623480|NCT00329303|525133939|FG000|Overall Study|Lack of Efficacy|1|||
145623481|NCT00329303|525133940|FG001|Overall Study|Lack of Efficacy|0|||
145371858|NCT05896527|524210978|FG004|Overall Study|Sponsor's decision|0|||
145579327|NCT03027466|524975334|FG001|Overall Study|Opting out of the app|1819|||
145579328|NCT03027466|524975335|FG002|Overall Study|Opting out of the app|1743|||
145371859|NCT05896527|524210974|FG000|Overall Study|Investigator's decision|0|||
145371860|NCT05896527|524210975|FG001|Overall Study|Investigator's decision|1|||
145371861|NCT05896527|524210976|FG002|Overall Study|Investigator's decision|0|||
145371862|NCT05896527|524210977|FG003|Overall Study|Investigator's decision|0|||
145371863|NCT05896527|524210978|FG004|Overall Study|Investigator's decision|0|||
145371864|NCT05896527|524210974|FG000|Overall Study|Pregnancy of his partner|0|||
145371865|NCT05896527|524210975|FG001|Overall Study|Pregnancy of his partner|0|||
145371866|NCT05896527|524210976|FG002|Overall Study|Pregnancy of his partner|0|||
145371867|NCT05896527|524210977|FG003|Overall Study|Pregnancy of his partner|1|||
145371868|NCT05896527|524210978|FG004|Overall Study|Pregnancy of his partner|0|||
145371869|NCT01279070|524210979|FG000|Overall Study|Withdrawal by Subject|2|||
145371870|NCT01279070|524210980|FG001|Overall Study|Withdrawal by Subject|3|||
145371871|NCT01279070|524210979|FG000|Overall Study|Acute exacerbation|3|||
145371872|NCT01279070|524210980|FG001|Overall Study|Acute exacerbation|1|||
145371873|NCT01741792|524210981|FG000|Overall Study|Death|6|||
145371874|NCT01741792|524210982|FG001|Overall Study|Death|1|||
145371875|NCT01741792|524210983|FG002|Overall Study|Death|12|||
145371876|NCT02738879|524210984|FG000|Overall Study|Adverse Event|1|||
145371877|NCT02738879|524210985|FG001|Overall Study|Adverse Event|1|||
145371878|NCT02738879|524210984|FG000|Overall Study|Death|0|||
145371879|NCT02738879|524210985|FG001|Overall Study|Death|2|||
145371880|NCT02738879|524210984|FG000|Overall Study|Lost to Follow-up|1|||
145371881|NCT02738879|524210985|FG001|Overall Study|Lost to Follow-up|5|||
145371882|NCT02738879|524210984|FG000|Overall Study|Protocol Violation|1|||
145371883|NCT02738879|524210985|FG001|Overall Study|Protocol Violation|3|||
145371884|NCT02738879|524210984|FG000|Overall Study|Physician Decision|3|||
145371885|NCT02738879|524210985|FG001|Overall Study|Physician Decision|4|||
145371886|NCT02738879|524210984|FG000|Overall Study|Pregnancy|0|||
145371887|NCT02738879|524210985|FG001|Overall Study|Pregnancy|1|||
145371888|NCT02738879|524210984|FG000|Overall Study|Screen Failure|1|||
145371889|NCT02738879|524210985|FG001|Overall Study|Screen Failure|2|||
145371890|NCT02738879|524210984|FG000|Overall Study|Site Discontinued Study Participation|1|||
145371891|NCT02738879|524210985|FG001|Overall Study|Site Discontinued Study Participation|0|||
145371892|NCT02738879|524210984|FG000|Overall Study|Withdrawal by Subject|5|||
145371893|NCT02738879|524210985|FG001|Overall Study|Withdrawal by Subject|7|||
145371894|NCT00890084|524210986|FG000|Overall Study|Adverse Event|16|||
145371895|NCT00890084|524210986|FG000|Overall Study|Lost to Follow-up|126|||
145424331|NCT02037984|524409674|FG006|Overall Study|Technical Problems|4|||
145579329|NCT03027466|524975336|FG003|Overall Study|Opting out of the app|1821|||
145623482|NCT00329303|525133939|FG000|Overall Study|Decision of the sponsor|0|||
145371896|NCT01438294|524210987|FG000|Overall Study|Lost to Follow-up|3|||
145371897|NCT01438294|524210988|FG001|Overall Study|Lost to Follow-up|7|||
145371898|NCT01730534|524210989|FG000|Overall Study|Withdrawal by Subject|97|||
145371899|NCT01730534|524210990|FG001|Overall Study|Withdrawal by Subject|127|||
145371900|NCT01730534|524210989|FG000|Overall Study|Lost to Follow-up|12|||
145371901|NCT01730534|524210990|FG001|Overall Study|Lost to Follow-up|18|||
145371902|NCT02256982|524210991|FG000|Overall Study|Disease Progression|0|||
145371903|NCT02256982|524210992|FG001|Overall Study|Disease Progression|1|||
145579330|NCT02158039|524975337|FG000|Overall Study|Withdrawal by Subject|1|||
145579331|NCT02158039|524975337|FG000|Overall Study|Screen Failure|9|||
145579332|NCT03062891|524975349|FG000|Overall Study|Withdrawal by Subject|2|||
145579333|NCT03062891|524975350|FG001|Overall Study|Withdrawal by Subject|0|||
145579334|NCT03062891|524975349|FG000|Overall Study|Lost to Follow-up|50|||
145579335|NCT03062891|524975350|FG001|Overall Study|Lost to Follow-up|38|||
145579336|NCT01079234|524975353|FG000|Main: Week 0 to 26|Adverse Event|5|||
145579337|NCT01079234|524975354|FG001|Main: Week 0 to 26|Adverse Event|4|||
145579338|NCT01079234|524975355|FG002|Main: Week 0 to 26|Adverse Event|1|||
145579339|NCT01079234|524975356|FG003|Main: Week 0 to 26|Adverse Event|0|||
145579340|NCT01079234|524975353|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
145579341|NCT01079234|524975354|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
145579342|NCT01079234|524975355|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
145579343|NCT01079234|524975356|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
145579344|NCT01079234|524975353|FG000|Main: Week 0 to 26|Protocol Violation|6|||
145579345|NCT01079234|524975354|FG001|Main: Week 0 to 26|Protocol Violation|2|||
145579346|NCT01079234|524975355|FG002|Main: Week 0 to 26|Protocol Violation|4|||
145579347|NCT01079234|524975356|FG003|Main: Week 0 to 26|Protocol Violation|0|||
145579348|NCT01079234|524975353|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
145579349|NCT01079234|524975354|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
145579350|NCT01079234|524975355|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
145579351|NCT01079234|524975356|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
145579352|NCT01079234|524975353|FG000|Main: Week 0 to 26|Unclassified|7|||
145579353|NCT01079234|524975354|FG001|Main: Week 0 to 26|Unclassified|13|||
145579354|NCT01079234|524975355|FG002|Main: Week 0 to 26|Unclassified|4|||
145579355|NCT01079234|524975356|FG003|Main: Week 0 to 26|Unclassified|0|||
145579356|NCT01079234|524975353|FG000|Extension: Week 27 to 52|Adverse Event|0|||
145579357|NCT01079234|524975354|FG001|Extension: Week 27 to 52|Adverse Event|0|||
145579358|NCT01079234|524975355|FG002|Extension: Week 27 to 52|Adverse Event|1|||
145579359|NCT01079234|524975356|FG003|Extension: Week 27 to 52|Adverse Event|0|||
145579360|NCT01079234|524975353|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
145579361|NCT01079234|524975354|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
145579362|NCT01079234|524975355|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
145579363|NCT01079234|524975356|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
145579364|NCT01079234|524975353|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
145579365|NCT01079234|524975354|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
145579366|NCT01079234|524975355|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
145579367|NCT01079234|524975356|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
145579368|NCT01079234|524975353|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
145579369|NCT01079234|524975354|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
145579370|NCT01079234|524975355|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
145579371|NCT01079234|524975356|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
145579372|NCT01079234|524975353|FG000|Extension: Week 27 to 52|Unclassified|0|||
145579373|NCT01079234|524975354|FG001|Extension: Week 27 to 52|Unclassified|0|||
145579374|NCT01079234|524975355|FG002|Extension: Week 27 to 52|Unclassified|4|||
145579375|NCT01079234|524975356|FG003|Extension: Week 27 to 52|Unclassified|7|||
145579376|NCT01334866|524975375|FG000|Overall Study|Withdrawal by Subject|10|||
145579377|NCT01334866|524975375|FG000|Overall Study|Lost to Follow-up|3|||
145424332|NCT02037984|524409675|FG007|Overall Study|Technical Problems|2|||
145424333|NCT02037984|524409668|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145424334|NCT02037984|524409669|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145424335|NCT02037984|524409670|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
145424336|NCT02037984|524409671|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
145424337|NCT02037984|524409672|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
145424338|NCT02037984|524409673|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
145424339|NCT02037984|524409674|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
145424340|NCT02037984|524409675|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
145424341|NCT02037984|524409668|FG000|Overall Study|Withdrawal by Subject|0|||
145424342|NCT02037984|524409669|FG001|Overall Study|Withdrawal by Subject|0|||
145579378|NCT01334866|524975375|FG000|Overall Study|Physician Decision|3|||
145579379|NCT01334866|524975375|FG000|Overall Study|medically necessary prior to procedure|2|||
145579380|NCT01334866|524975375|FG000|Overall Study|medically necessary post-procedure|1|||
145579381|NCT00958880|524975392|FG000|Overall Study|Lost to Follow-up|2|||
145579382|NCT00958880|524975393|FG001|Overall Study|Lost to Follow-up|2|||
145579383|NCT01687166|524975396|FG000|Overall Study|Attempt subject|2|||
145424343|NCT02037984|524409670|FG002|Overall Study|Withdrawal by Subject|0|||
145579384|NCT01687166|524975397|FG001|Overall Study|Attempt subject|3|||
145579385|NCT01687166|524975398|FG002|Overall Study|Attempt subject|2|||
145579386|NCT01687166|524975399|FG003|Overall Study|Attempt subject|0|||
145579387|NCT01687166|524975396|FG000|Overall Study|Did not meet eligibility criteria|4|||
145579388|NCT01687166|524975397|FG001|Overall Study|Did not meet eligibility criteria|6|||
145579389|NCT01687166|524975398|FG002|Overall Study|Did not meet eligibility criteria|1|||
145579390|NCT01687166|524975399|FG003|Overall Study|Did not meet eligibility criteria|1|||
145579391|NCT01687166|524975396|FG000|Overall Study|Adverse Event|2|||
145579392|NCT01687166|524975397|FG001|Overall Study|Adverse Event|1|||
145424344|NCT02037984|524409671|FG003|Overall Study|Withdrawal by Subject|1|||
145424345|NCT02037984|524409672|FG004|Overall Study|Withdrawal by Subject|1|||
145424346|NCT02037984|524409673|FG005|Overall Study|Withdrawal by Subject|3|||
145424347|NCT02037984|524409674|FG006|Overall Study|Withdrawal by Subject|0|||
145424348|NCT02037984|524409675|FG007|Overall Study|Withdrawal by Subject|1|||
145424349|NCT01691092|524409676|FG000|Overall Study|Lost to Follow-up|10|||
145424350|NCT01691092|524409676|FG000|Overall Study|Physician Decision|4|||
145424351|NCT01691092|524409676|FG000|Overall Study|Withdrawal by Subject|3|||
145424352|NCT01691092|524409676|FG000|Overall Study|non-compliance|3|||
145424353|NCT01691092|524409676|FG000|Overall Study|used for different study|2|||
145424354|NCT01691092|524409676|FG000|Overall Study|screen fail|19|||
145424355|NCT00561821|524409679|FG000|Overall Study|Not treated|0|||
145424356|NCT00561821|524409680|FG001|Overall Study|Not treated|0|||
145424357|NCT00561821|524409681|FG002|Overall Study|Not treated|1|||
145424358|NCT00561821|524409682|FG003|Overall Study|Not treated|0|||
145424359|NCT00561821|524409679|FG000|Overall Study|Withdrawal by Subject|0|||
145424360|NCT00561821|524409680|FG001|Overall Study|Withdrawal by Subject|1|||
145424361|NCT00561821|524409681|FG002|Overall Study|Withdrawal by Subject|0|||
145424362|NCT00561821|524409682|FG003|Overall Study|Withdrawal by Subject|2|||
145424363|NCT00561821|524409679|FG000|Overall Study|Reasons not related to trial|2|||
145424364|NCT00561821|524409680|FG001|Overall Study|Reasons not related to trial|1|||
145424365|NCT00561821|524409681|FG002|Overall Study|Reasons not related to trial|0|||
145424366|NCT00561821|524409682|FG003|Overall Study|Reasons not related to trial|0|||
145424367|NCT00561821|524409679|FG000|Overall Study|Other (reason not specified)|1|||
145424368|NCT00561821|524409680|FG001|Overall Study|Other (reason not specified)|1|||
145424369|NCT00561821|524409681|FG002|Overall Study|Other (reason not specified)|0|||
145424370|NCT00561821|524409682|FG003|Overall Study|Other (reason not specified)|0|||
145424371|NCT00561821|524409679|FG000|Overall Study|Adverse Event|2|||
145424372|NCT00561821|524409680|FG001|Overall Study|Adverse Event|3|||
145424373|NCT00561821|524409681|FG002|Overall Study|Adverse Event|1|||
145424374|NCT00561821|524409682|FG003|Overall Study|Adverse Event|1|||
145424375|NCT01657942|524409683|FG000|Overall Study|Alternative Treatment|7|||
145424376|NCT01657942|524409683|FG000|Overall Study|Lost to Follow-up|1|||
145424377|NCT01197300|524411147|FG000|Overall Study|Lost to Follow-up|0|||
145424378|NCT01197300|524411148|FG001|Overall Study|Lost to Follow-up|1|||
145424379|NCT01197300|524411147|FG000|Overall Study|Protocol Violation|0|||
145424380|NCT01197300|524411148|FG001|Overall Study|Protocol Violation|1|||
145424381|NCT04744831|524411149|FG000|Overall Study|Progressive Disease|31|||
145424382|NCT04744831|524411150|FG001|Overall Study|Progressive Disease|27|||
145424383|NCT04744831|524411151|FG002|Overall Study|Progressive Disease|25|||
145424384|NCT04744831|524411149|FG000|Overall Study|Adverse Event|3|||
145424385|NCT04744831|524411150|FG001|Overall Study|Adverse Event|3|||
145424386|NCT04744831|524411151|FG002|Overall Study|Adverse Event|3|||
145424387|NCT04744831|524411149|FG000|Overall Study|Clinical Progression|3|||
145424388|NCT04744831|524411150|FG001|Overall Study|Clinical Progression|2|||
145424389|NCT04744831|524411151|FG002|Overall Study|Clinical Progression|5|||
145424390|NCT04744831|524411149|FG000|Overall Study|Other|0|||
145424391|NCT04744831|524411150|FG001|Overall Study|Other|2|||
145424392|NCT04744831|524411151|FG002|Overall Study|Other|1|||
145424393|NCT04744831|524411149|FG000|Overall Study|Death|0|||
145424394|NCT04744831|524411150|FG001|Overall Study|Death|2|||
145424395|NCT04744831|524411151|FG002|Overall Study|Death|1|||
145424396|NCT00590317|524411156|FG000|Overall Study|Lack of Efficacy|1|||
145424397|NCT00590317|524411157|FG001|Overall Study|Lack of Efficacy|5|||
145424398|NCT03443401|524411164|FG000|Overall Study|Lost to Follow-up|13|||
145424399|NCT03443401|524411164|FG000|Overall Study|Influential outlier|1|||
145424400|NCT02363283|524411165|FG000|Overall Study|Withdrawal by Subject|1|||
145424401|NCT02363283|524411165|FG000|Overall Study|Not eligible due to transaminitis|1|||
145579393|NCT01687166|524975398|FG002|Overall Study|Adverse Event|0|||
145579394|NCT01687166|524975399|FG003|Overall Study|Adverse Event|0|||
145424402|NCT04616196|524411172|FG000|Overall Study|Progressive Disease|3|||
145579395|NCT01687166|524975396|FG000|Overall Study|Physician Decision|3|||
145424403|NCT04616196|524411173|FG001|Overall Study|Progressive Disease|0|||
145579396|NCT01687166|524975397|FG001|Overall Study|Physician Decision|2|||
145424404|NCT04616196|524411174|FG002|Overall Study|Progressive Disease|4|||
145424405|NCT04616196|524411175|FG003|Overall Study|Progressive Disease|1|||
145424406|NCT04616196|524411172|FG000|Overall Study|Death|2|||
145424407|NCT04616196|524411173|FG001|Overall Study|Death|4|||
145424408|NCT04616196|524411174|FG002|Overall Study|Death|1|||
145424409|NCT04616196|524411175|FG003|Overall Study|Death|0|||
145424410|NCT04616196|524411172|FG000|Overall Study|Withdrawal by Subject|0|||
145424411|NCT04616196|524411173|FG001|Overall Study|Withdrawal by Subject|2|||
145424412|NCT04616196|524411174|FG002|Overall Study|Withdrawal by Subject|0|||
145424413|NCT04616196|524411175|FG003|Overall Study|Withdrawal by Subject|0|||
145424414|NCT04616196|524411172|FG000|Overall Study|Lost to Follow-up|1|||
145424415|NCT04616196|524411173|FG001|Overall Study|Lost to Follow-up|0|||
145424416|NCT04616196|524411174|FG002|Overall Study|Lost to Follow-up|0|||
145424417|NCT04616196|524411175|FG003|Overall Study|Lost to Follow-up|0|||
145424418|NCT04616196|524411172|FG000|Overall Study|Sponsor request|2|||
145579397|NCT01687166|524975398|FG002|Overall Study|Physician Decision|1|||
145579398|NCT01687166|524975399|FG003|Overall Study|Physician Decision|0|||
145579399|NCT01687166|524975396|FG000|Overall Study|Withdrawal by Subject|11|||
145579400|NCT01687166|524975397|FG001|Overall Study|Withdrawal by Subject|4|||
145579401|NCT01687166|524975398|FG002|Overall Study|Withdrawal by Subject|3|||
145579402|NCT01687166|524975399|FG003|Overall Study|Withdrawal by Subject|0|||
145579403|NCT01687166|524975396|FG000|Overall Study|Lost to Follow-up|2|||
145579404|NCT01687166|524975397|FG001|Overall Study|Lost to Follow-up|5|||
145579405|NCT01687166|524975398|FG002|Overall Study|Lost to Follow-up|1|||
145579406|NCT01687166|524975399|FG003|Overall Study|Lost to Follow-up|0|||
145623483|NCT00329303|525133940|FG001|Overall Study|Decision of the sponsor|1|||
145371904|NCT03614078|524210993|FG000|Overall Study|Withdrawal by Subject|2|||
145371905|NCT03614078|524210994|FG001|Overall Study|Withdrawal by Subject|2|||
145371906|NCT03614078|524210995|FG002|Overall Study|Withdrawal by Subject|3|||
145371907|NCT03614078|524210993|FG000|Overall Study|Participant Did Not Return for Visit|0|||
145371908|NCT03614078|524210994|FG001|Overall Study|Participant Did Not Return for Visit|1|||
145371909|NCT03614078|524210995|FG002|Overall Study|Participant Did Not Return for Visit|0|||
145371910|NCT03614078|524210993|FG000|Overall Study|High Neutrophils|0|||
145371911|NCT03614078|524210994|FG001|Overall Study|High Neutrophils|0|||
145371912|NCT03614078|524210995|FG002|Overall Study|High Neutrophils|2|||
145371913|NCT03614078|524210993|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
145371914|NCT03614078|524210994|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
145371915|NCT03614078|524210995|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
145371916|NCT03614078|524210993|FG000|Overall Study|Exacerbation of Psoriasis|0|||
145371917|NCT03614078|524210994|FG001|Overall Study|Exacerbation of Psoriasis|1|||
145371918|NCT03614078|524210995|FG002|Overall Study|Exacerbation of Psoriasis|0|||
145371919|NCT03614078|524210993|FG000|Overall Study|Adverse Event|0|||
145371920|NCT03614078|524210994|FG001|Overall Study|Adverse Event|2|||
145371921|NCT03614078|524210995|FG002|Overall Study|Adverse Event|0|||
145371922|NCT03614078|524210993|FG000|Overall Study|Dizziness and Rash|0|||
145371923|NCT03614078|524210994|FG001|Overall Study|Dizziness and Rash|1|||
145371924|NCT03614078|524210995|FG002|Overall Study|Dizziness and Rash|0|||
145371925|NCT04964544|524210998|FG000|Overall Study|Screen failure or other uncategorised|10|||
145371926|NCT04964544|524210998|FG000|Overall Study|Physician Decision|4|||
145371927|NCT04964544|524210998|FG000|Overall Study|Lost to Follow-up|9|||
145371928|NCT04964544|524210998|FG000|Overall Study|Withdrawal by Subject|18|||
145371929|NCT04964544|524210998|FG000|Overall Study|Death|1|||
145371930|NCT02833844|524211004|FG000|Double-Blind Period|Withdrawal by Subject|2|||
145371931|NCT02833844|524211005|FG001|Double-Blind Period|Withdrawal by Subject|3|||
145371932|NCT02833844|524211004|FG000|Double-Blind Period|Protocol Violation|0|||
145371933|NCT02833844|524211005|FG001|Double-Blind Period|Protocol Violation|4|||
145371934|NCT02833844|524211004|FG000|Open-Label Period|Death|0|||
145371935|NCT02833844|524211005|FG001|Open-Label Period|Death|2|||
145371936|NCT02833844|524211004|FG000|Open-Label Period|Lost to Follow-up|1|||
145371937|NCT02833844|524211005|FG001|Open-Label Period|Lost to Follow-up|0|||
145371938|NCT02833844|524211004|FG000|Open-Label Period|Withdrawal by Subject|1|||
145371939|NCT02833844|524211005|FG001|Open-Label Period|Withdrawal by Subject|0|||
145371940|NCT01899742|524211008|FG000|Overall Study|Adverse Event|5|||
145371941|NCT01899742|524211009|FG001|Overall Study|Adverse Event|4|||
145371942|NCT01899742|524211008|FG000|Overall Study|Lack of Efficacy|1|||
145371943|NCT01899742|524211009|FG001|Overall Study|Lack of Efficacy|5|||
145371944|NCT01899742|524211008|FG000|Overall Study|Protocol Violation|2|||
145371945|NCT01899742|524211009|FG001|Overall Study|Protocol Violation|2|||
145371946|NCT01899742|524211008|FG000|Overall Study|Withdrawal by Subject|9|||
145371947|NCT01899742|524211009|FG001|Overall Study|Withdrawal by Subject|5|||
145371948|NCT02662764|524211010|FG000|Overall Study|Adverse Event|6|||
145371949|NCT02662764|524211010|FG000|Overall Study|Lack of Efficacy|8|||
145371950|NCT02662764|524211010|FG000|Overall Study|Protocol Violation|1|||
145371951|NCT02662764|524211010|FG000|Overall Study|Withdrawal by Subject|5|||
145371952|NCT02662764|524211010|FG000|Overall Study|Device failure|4|||
145371953|NCT02662764|524211010|FG000|Overall Study|Patient changed treatment|1|||
145371954|NCT02662764|524211010|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
145371955|NCT01044290|524211011|FG000|Follow-up 1|Death|3|||
145371956|NCT01044290|524211012|FG001|Follow-up 1|Death|3|||
145371957|NCT01044290|524211013|FG002|Follow-up 1|Death|1|||
145371958|NCT01044290|524211011|FG000|Follow-up 1|Withdrawal by Subject|2|||
145371959|NCT01044290|524211012|FG001|Follow-up 1|Withdrawal by Subject|2|||
145371960|NCT01044290|524211013|FG002|Follow-up 1|Withdrawal by Subject|0|||
145371961|NCT01044290|524211011|FG000|Follow-Up 2|Death|0|||
145371962|NCT01044290|524211012|FG001|Follow-Up 2|Death|1|||
145371963|NCT01044290|524211013|FG002|Follow-Up 2|Death|1|||
145371964|NCT01044290|524211011|FG000|Follow-Up 2|Withdrawal by Subject|0|||
145371965|NCT01044290|524211012|FG001|Follow-Up 2|Withdrawal by Subject|1|||
145371966|NCT01044290|524211013|FG002|Follow-Up 2|Withdrawal by Subject|1|||
145371967|NCT04323306|524211015|FG000|Overall Study|Physician Decision|1|||
145371968|NCT04323306|524211016|FG001|Overall Study|Physician Decision|0|||
145371969|NCT04323306|524211017|FG002|Overall Study|Physician Decision|0|||
145371970|NCT04323306|524211018|FG003|Overall Study|Physician Decision|0|||
145371971|NCT04323306|524211019|FG004|Overall Study|Physician Decision|0|||
145579407|NCT01687166|524975396|FG000|Overall Study|Equipment/Device Availability|0|||
145579408|NCT01687166|524975397|FG001|Overall Study|Equipment/Device Availability|1|||
145579409|NCT01687166|524975398|FG002|Overall Study|Equipment/Device Availability|0|||
145579410|NCT01687166|524975399|FG003|Overall Study|Equipment/Device Availability|0|||
145579411|NCT01687166|524975396|FG000|Overall Study|Death|1|||
145579412|NCT01687166|524975397|FG001|Overall Study|Death|1|||
145579413|NCT01687166|524975398|FG002|Overall Study|Death|0|||
145579414|NCT01687166|524975399|FG003|Overall Study|Death|0|||
145579415|NCT01687166|524975396|FG000|Overall Study|Protocol Violation|1|||
145579416|NCT01687166|524975397|FG001|Overall Study|Protocol Violation|1|||
145579417|NCT01687166|524975398|FG002|Overall Study|Protocol Violation|1|||
145579418|NCT01687166|524975399|FG003|Overall Study|Protocol Violation|0|||
145623484|NCT00329303|525133939|FG000|Overall Study|Patient no longer available|1|||
145424419|NCT04616196|524411173|FG001|Overall Study|Sponsor request|1|||
145424420|NCT04616196|524411174|FG002|Overall Study|Sponsor request|1|||
145424421|NCT04616196|524411175|FG003|Overall Study|Sponsor request|2|||
145424422|NCT01394185|524411176|FG000|Overall Study|Withdrawal by Subject|2|||
145424423|NCT01394185|524411177|FG001|Overall Study|Withdrawal by Subject|0|||
145424424|NCT01394185|524411178|FG002|Overall Study|Withdrawal by Subject|0|||
145424425|NCT01394185|524411179|FG003|Overall Study|Withdrawal by Subject|0|||
145424426|NCT01394185|524411180|FG004|Overall Study|Withdrawal by Subject|1|||
145424427|NCT01394185|524411181|FG005|Overall Study|Withdrawal by Subject|0|||
145424428|NCT01394185|524411176|FG000|Overall Study|Change in protocol|3|||
145424429|NCT01394185|524411177|FG001|Overall Study|Change in protocol|0|||
145424430|NCT01394185|524411178|FG002|Overall Study|Change in protocol|0|||
145579419|NCT01687166|524975396|FG000|Overall Study|Subject moved out of state|0|||
145579420|NCT01687166|524975397|FG001|Overall Study|Subject moved out of state|1|||
145579421|NCT01687166|524975398|FG002|Overall Study|Subject moved out of state|0|||
145371972|NCT04323306|524211020|FG005|Overall Study|Physician Decision|0|||
145371973|NCT04323306|524211021|FG006|Overall Study|Physician Decision|0|||
145371974|NCT04323306|524211022|FG007|Overall Study|Physician Decision|0|||
145371975|NCT04323306|524211023|FG008|Overall Study|Physician Decision|0|||
145371976|NCT04323306|524211015|FG000|Overall Study|Withdrawal by Subject|0|||
145371977|NCT04323306|524211016|FG001|Overall Study|Withdrawal by Subject|0|||
145371978|NCT04323306|524211017|FG002|Overall Study|Withdrawal by Subject|0|||
145371979|NCT04323306|524211018|FG003|Overall Study|Withdrawal by Subject|0|||
145371980|NCT04323306|524211019|FG004|Overall Study|Withdrawal by Subject|0|||
145371981|NCT04323306|524211020|FG005|Overall Study|Withdrawal by Subject|1|||
145371982|NCT04323306|524211021|FG006|Overall Study|Withdrawal by Subject|3|||
145371983|NCT04323306|524211022|FG007|Overall Study|Withdrawal by Subject|0|||
145371984|NCT04323306|524211023|FG008|Overall Study|Withdrawal by Subject|1|||
145371985|NCT00089778|524211025|FG000|Overall Study|Protocol Violation|0|||
145371986|NCT00089778|524211026|FG001|Overall Study|Protocol Violation|0|||
145371987|NCT00089778|524211027|FG002|Overall Study|Protocol Violation|1|||
145371988|NCT02677038|524211030|FG000|Overall Study|Physician Decision|1|||
145371989|NCT02677038|524211030|FG000|Overall Study|Withdrawal by Subject|1|||
145371990|NCT01646021|524211031|FG000|Overall Study|Death|77|||
145371991|NCT01646021|524211032|FG001|Overall Study|Death|83|||
145371992|NCT01646021|524211031|FG000|Overall Study|Study Terminated by Sponsor|50|||
145371993|NCT01646021|524211032|FG001|Overall Study|Study Terminated by Sponsor|41|||
145371994|NCT01646021|524211031|FG000|Overall Study|Lost to Follow-up|2|||
145371995|NCT01646021|524211032|FG001|Overall Study|Lost to Follow-up|2|||
145371996|NCT01646021|524211031|FG000|Overall Study|Withdrawal by Subject|10|||
145371997|NCT01646021|524211032|FG001|Overall Study|Withdrawal by Subject|15|||
145371998|NCT04712019|524211033|FG000|Overall Study|Withdrawal by Subject|2|||
145371999|NCT04712019|524211034|FG001|Overall Study|Withdrawal by Subject|2|||
145372000|NCT04712019|524211033|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
145372001|NCT04712019|524211034|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
145372002|NCT01967706|524211049|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
145372003|NCT01967706|524211050|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
145372004|NCT01967706|524211051|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145372005|NCT01967706|524211052|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
145372006|NCT02777970|524211053|FG000|Overall Study|Lost to Follow-up|0|||
145372007|NCT02777970|524211054|FG001|Overall Study|Lost to Follow-up|1|||
145372008|NCT02777970|524211055|FG002|Overall Study|Lost to Follow-up|0|||
145372009|NCT02777970|524211053|FG000|Overall Study|Protocol Violation|1|||
145372010|NCT02777970|524211054|FG001|Overall Study|Protocol Violation|0|||
145372011|NCT02777970|524211055|FG002|Overall Study|Protocol Violation|0|||
145372012|NCT05845567|524211059|FG000|Overall Study|Withdrawal by Subject|1|||
145372013|NCT02347891|524211060|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
145372014|NCT02347891|524211061|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
145372015|NCT02347891|524211060|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
145372016|NCT02347891|524211061|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
145372017|NCT02541669|524211062|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145372018|NCT02541669|524211063|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145372019|NCT02541669|524211064|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
145579422|NCT01687166|524975399|FG003|Overall Study|Subject moved out of state|0|||
145579423|NCT01687166|524975396|FG000|Overall Study|Patient unable to be compliant|1|||
145579424|NCT01687166|524975397|FG001|Overall Study|Patient unable to be compliant|0|||
145579425|NCT01687166|524975398|FG002|Overall Study|Patient unable to be compliant|0|||
145424431|NCT01394185|524411179|FG003|Overall Study|Change in protocol|0|||
145424432|NCT01394185|524411180|FG004|Overall Study|Change in protocol|3|||
145424433|NCT01394185|524411181|FG005|Overall Study|Change in protocol|0|||
145424434|NCT01394185|524411176|FG000|Overall Study|Protocol Violation|1|||
145424435|NCT01394185|524411177|FG001|Overall Study|Protocol Violation|0|||
145424436|NCT01394185|524411178|FG002|Overall Study|Protocol Violation|0|||
145424437|NCT01394185|524411179|FG003|Overall Study|Protocol Violation|1|||
145424438|NCT01394185|524411180|FG004|Overall Study|Protocol Violation|0|||
145424439|NCT01394185|524411181|FG005|Overall Study|Protocol Violation|1|||
145424440|NCT00003907|524411186|FG000|Overall Study|Adverse Event|2|||
145424441|NCT00003907|524411187|FG001|Overall Study|Adverse Event|11|||
145424442|NCT00003907|524411186|FG000|Overall Study|Death|2|||
145424443|NCT00003907|524411187|FG001|Overall Study|Death|0|||
145424444|NCT00003907|524411186|FG000|Overall Study|Withdrawal by Subject|1|||
145424445|NCT00003907|524411187|FG001|Overall Study|Withdrawal by Subject|3|||
145424446|NCT00003907|524411186|FG000|Overall Study|Progressive disease|4|||
145424447|NCT00003907|524411187|FG001|Overall Study|Progressive disease|4|||
145424448|NCT00003907|524411186|FG000|Overall Study|Complicating disease|1|||
145424449|NCT00003907|524411187|FG001|Overall Study|Complicating disease|0|||
145424450|NCT00003907|524411186|FG000|Overall Study|Other|1|||
145424451|NCT00003907|524411187|FG001|Overall Study|Other|3|||
145424452|NCT00003907|524411186|FG000|Overall Study|ineligible or not treated|2|||
145424453|NCT00003907|524411187|FG001|Overall Study|ineligible or not treated|2|||
145424454|NCT00993473|524411188|FG000|Overall Study|Adverse Event|0|||
145424455|NCT00993473|524411189|FG001|Overall Study|Adverse Event|2|||
145424456|NCT00993473|524411188|FG000|Overall Study|Protocol Violation|1|||
145424457|NCT00993473|524411189|FG001|Overall Study|Protocol Violation|2|||
145424458|NCT00993473|524411188|FG000|Overall Study|Lost to Follow-up|1|||
145424459|NCT00993473|524411189|FG001|Overall Study|Lost to Follow-up|0|||
145424460|NCT00993473|524411188|FG000|Overall Study|Withdrawal by Subject|1|||
145424461|NCT00993473|524411189|FG001|Overall Study|Withdrawal by Subject|5|||
145424462|NCT00993473|524411188|FG000|Overall Study|Technical problem with CGM device|0|||
145424463|NCT00993473|524411189|FG001|Overall Study|Technical problem with CGM device|1|||
145424464|NCT00993473|524411188|FG000|Overall Study|Family event|1|||
145424465|NCT00993473|524411189|FG001|Overall Study|Family event|0|||
145424466|NCT03682367|524411195|FG000|Overall Study|Protocol Violation|2|||
145424467|NCT03682367|524411196|FG001|Overall Study|Protocol Violation|1|||
145424468|NCT03682367|524411195|FG000|Overall Study|Closed Study Early|0|||
145424469|NCT03682367|524411196|FG001|Overall Study|Closed Study Early|3|||
145424470|NCT03707821|524411197|FG000|Overall Study|Protocol Violation|0|||
145424471|NCT03707821|524411198|FG001|Overall Study|Protocol Violation|1|||
145424472|NCT03707821|524411197|FG000|Overall Study|Unsatisfactory Visual Response|1|||
145424473|NCT03707821|524411198|FG001|Overall Study|Unsatisfactory Visual Response|0|||
145424474|NCT03707821|524411197|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
145424475|NCT03707821|524411198|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
145424476|NCT00770679|524411201|FG000|Overall Study|Lost to Follow-up|3|||
145424477|NCT00770679|524411201|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
145424478|NCT00129974|524411202|FG000|Overall Study|Other|1|||
145424479|NCT00414609|524411203|FG000|Core Study|Adverse Event|9|||
145424480|NCT00414609|524411204|FG001|Core Study|Adverse Event|11|||
145424481|NCT00414609|524411205|FG002|Core Study|Adverse Event|0|||
145424482|NCT00414609|524411203|FG000|Core Study|Abnormal laboratory values|0|||
145424483|NCT00414609|524411204|FG001|Core Study|Abnormal laboratory values|1|||
145424484|NCT00414609|524411205|FG002|Core Study|Abnormal laboratory values|0|||
145424485|NCT00414609|524411203|FG000|Core Study|Abnormal test procedure results|1|||
145579426|NCT01687166|524975399|FG003|Overall Study|Patient unable to be compliant|0|||
145579427|NCT01687166|524975396|FG000|Overall Study|Physician choice to use different device|1|||
145579428|NCT01687166|524975397|FG001|Overall Study|Physician choice to use different device|2|||
145424486|NCT00414609|524411204|FG001|Core Study|Abnormal test procedure results|1|||
145579429|NCT01687166|524975398|FG002|Overall Study|Physician choice to use different device|4|||
145424487|NCT00414609|524411205|FG002|Core Study|Abnormal test procedure results|0|||
145424488|NCT00414609|524411203|FG000|Core Study|Protocol deviation|0|||
145424489|NCT00414609|524411204|FG001|Core Study|Protocol deviation|1|||
145424490|NCT00414609|524411205|FG002|Core Study|Protocol deviation|0|||
145424491|NCT00414609|524411203|FG000|Core Study|Patient withdrew consent|10|||
145424492|NCT00414609|524411204|FG001|Core Study|Patient withdrew consent|11|||
145424493|NCT00414609|524411205|FG002|Core Study|Patient withdrew consent|0|||
145424494|NCT00414609|524411203|FG000|Core Study|Lost to Follow-up|7|||
145424495|NCT00414609|524411204|FG001|Core Study|Lost to Follow-up|4|||
145424496|NCT00414609|524411205|FG002|Core Study|Lost to Follow-up|0|||
145424497|NCT00414609|524411203|FG000|Core Study|Administrative problems|0|||
145424498|NCT00414609|524411204|FG001|Core Study|Administrative problems|2|||
145424499|NCT00414609|524411205|FG002|Core Study|Administrative problems|0|||
145579430|NCT01687166|524975399|FG003|Overall Study|Physician choice to use different device|0|||
145579431|NCT01687166|524975396|FG000|Overall Study|Insurance|0|||
145579432|NCT01687166|524975397|FG001|Overall Study|Insurance|0|||
145579433|NCT01687166|524975398|FG002|Overall Study|Insurance|1|||
145579434|NCT01687166|524975399|FG003|Overall Study|Insurance|1|||
145579435|NCT02755831|524975400|FG000|Overall Study|Lost to Follow-up|3|||
145579436|NCT02755831|524975401|FG001|Overall Study|Lost to Follow-up|3|||
145579437|NCT01516879|524975402|FG000|Overall Study|Withdrawal by Subject|9|||
145579438|NCT01516879|524975403|FG001|Overall Study|Withdrawal by Subject|11|||
145579439|NCT01516879|524975402|FG000|Overall Study|Death|0|||
145579440|NCT01516879|524975403|FG001|Overall Study|Death|2|||
145579441|NCT01516879|524975402|FG000|Overall Study|Lost to Follow-up|2|||
145579442|NCT01516879|524975403|FG001|Overall Study|Lost to Follow-up|11|||
145579443|NCT01516879|524975402|FG000|Overall Study|Other|5|||
145579444|NCT01516879|524975403|FG001|Overall Study|Other|10|||
145579445|NCT04568122|524975404|FG000|Overall Study|Lost to Follow-up|48|||
145579446|NCT04568122|524975405|FG001|Overall Study|Lost to Follow-up|44|||
145579447|NCT04568122|524975406|FG002|Overall Study|Lost to Follow-up|4|||
145579448|NCT04568122|524975407|FG003|Overall Study|Lost to Follow-up|0|||
145579449|NCT04568122|524975408|FG004|Overall Study|Lost to Follow-up|0|||
145579450|NCT02047604|524975412|FG000|Overall Study|Withdrawal by Subject|0|||
145579451|NCT02047604|524975413|FG001|Overall Study|Withdrawal by Subject|0|||
145579452|NCT02047604|524975414|FG002|Overall Study|Withdrawal by Subject|0|||
145579453|NCT02047604|524975415|FG003|Overall Study|Withdrawal by Subject|0|||
145579454|NCT02047604|524975416|FG004|Overall Study|Withdrawal by Subject|1|||
145579455|NCT02047604|524975417|FG005|Overall Study|Withdrawal by Subject|1|||
145579456|NCT00459134|524975418|FG000|Overall Study|Physician Decision|1|||
145579457|NCT00459134|524975419|FG001|Overall Study|Physician Decision|1|||
145579458|NCT00459134|524975418|FG000|Overall Study|Withdrawal by Subject|8|||
145579459|NCT00459134|524975419|FG001|Overall Study|Withdrawal by Subject|7|||
145579460|NCT00459134|524975418|FG000|Overall Study|Lost to Follow-up|6|||
145579461|NCT00459134|524975419|FG001|Overall Study|Lost to Follow-up|7|||
145579462|NCT00459134|524975418|FG000|Overall Study|Surgery|1|||
145579463|NCT00459134|524975419|FG001|Overall Study|Surgery|2|||
145424500|NCT00414609|524411203|FG000|Core Study|Death|7|||
145424501|NCT00414609|524411204|FG001|Core Study|Death|14|||
145424502|NCT00414609|524411205|FG002|Core Study|Death|0|||
145424503|NCT00414609|524411203|FG000|Extension Study|Adverse Event|0|||
145424504|NCT00414609|524411204|FG001|Extension Study|Adverse Event|0|||
145424505|NCT00414609|524411205|FG002|Extension Study|Adverse Event|14|||
145424506|NCT00414609|524411203|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
145424507|NCT00414609|524411204|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
145424508|NCT00414609|524411205|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
145424509|NCT00414609|524411203|FG000|Extension Study|Withdrawal by Subject|0|||
145424510|NCT00414609|524411204|FG001|Extension Study|Withdrawal by Subject|0|||
145424511|NCT00414609|524411205|FG002|Extension Study|Withdrawal by Subject|13|||
145424512|NCT00414609|524411203|FG000|Extension Study|Lost to Follow-up|0|||
145424513|NCT00414609|524411204|FG001|Extension Study|Lost to Follow-up|0|||
145424514|NCT00414609|524411205|FG002|Extension Study|Lost to Follow-up|10|||
145424515|NCT00414609|524411203|FG000|Extension Study|Administrative problems|0|||
145424516|NCT00414609|524411204|FG001|Extension Study|Administrative problems|0|||
145424517|NCT00414609|524411205|FG002|Extension Study|Administrative problems|1|||
145424518|NCT00414609|524411203|FG000|Extension Study|Death|0|||
145424519|NCT00414609|524411204|FG001|Extension Study|Death|0|||
145424520|NCT00414609|524411205|FG002|Extension Study|Death|17|||
145424521|NCT00266032|524411211|FG000|Treatment|Adverse Event|42|||
145424522|NCT00266032|524411212|FG001|Treatment|Adverse Event|26|||
145424523|NCT00266032|524411213|FG002|Treatment|Adverse Event|10|||
145424524|NCT00266032|524411211|FG000|Treatment|Lost to Follow-up|19|||
145424525|NCT00266032|524411212|FG001|Treatment|Lost to Follow-up|4|||
145424526|NCT00266032|524411213|FG002|Treatment|Lost to Follow-up|2|||
145424527|NCT00266032|524411211|FG000|Treatment|Pregnancy|3|||
145424528|NCT00266032|524411212|FG001|Treatment|Pregnancy|2|||
145579464|NCT00459134|524975418|FG000|Overall Study|Toxicity|4|||
145579465|NCT00459134|524975419|FG001|Overall Study|Toxicity|5|||
145579466|NCT00459134|524975418|FG000|Overall Study|Progression|1|||
145579467|NCT00459134|524975419|FG001|Overall Study|Progression|0|||
145579468|NCT00459134|524975418|FG000|Overall Study|Multiple Reasons|2|||
145579469|NCT00459134|524975419|FG001|Overall Study|Multiple Reasons|3|||
145424529|NCT00266032|524411213|FG002|Treatment|Pregnancy|2|||
145424530|NCT00266032|524411211|FG000|Treatment|Protocol Violation|6|||
145424531|NCT00266032|524411212|FG001|Treatment|Protocol Violation|14|||
145424532|NCT00266032|524411213|FG002|Treatment|Protocol Violation|13|||
145424533|NCT00266032|524411211|FG000|Treatment|Withdrawal by Subject|28|||
145424534|NCT00266032|524411212|FG001|Treatment|Withdrawal by Subject|13|||
145424535|NCT00266032|524411213|FG002|Treatment|Withdrawal by Subject|12|||
145579470|NCT00829621|524975420|FG000|Overall Study|Death|1|||
145424536|NCT00266032|524411211|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
145424537|NCT00266032|524411212|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
145424538|NCT00266032|524411213|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
145579471|NCT00829621|524975421|FG001|Overall Study|Death|0|||
145424539|NCT00266032|524411211|FG000|Open-label Safety Extension|Adverse Event|5|||
145424540|NCT00266032|524411212|FG001|Open-label Safety Extension|Adverse Event|0|||
145424541|NCT00266032|524411213|FG002|Open-label Safety Extension|Adverse Event|4|||
145424542|NCT00266032|524411211|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
145424543|NCT00266032|524411212|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
145424544|NCT00266032|524411213|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
145424545|NCT00266032|524411211|FG000|Open-label Safety Extension|Pregnancy|4|||
145424546|NCT00266032|524411212|FG001|Open-label Safety Extension|Pregnancy|1|||
145424547|NCT00266032|524411213|FG002|Open-label Safety Extension|Pregnancy|2|||
145424548|NCT00266032|524411211|FG000|Open-label Safety Extension|Protocol Violation|1|||
145424549|NCT00266032|524411212|FG001|Open-label Safety Extension|Protocol Violation|3|||
145424550|NCT00266032|524411213|FG002|Open-label Safety Extension|Protocol Violation|2|||
145424551|NCT00266032|524411211|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
145424552|NCT00266032|524411212|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
145424553|NCT00266032|524411213|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
145424554|NCT00266032|524411211|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
145424555|NCT00266032|524411212|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
145424556|NCT00266032|524411213|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
145424557|NCT00124657|524411214|FG000|Overall Study|Toxicity|0|||
145424558|NCT00124657|524411215|FG001|Overall Study|Toxicity|0|||
145424559|NCT00124657|524411216|FG002|Overall Study|Toxicity|1|||
145424560|NCT00124657|524411214|FG000|Overall Study|Non-compliance|1|||
145424561|NCT00124657|524411215|FG001|Overall Study|Non-compliance|0|||
145424562|NCT00124657|524411216|FG002|Overall Study|Non-compliance|4|||
145424563|NCT00124657|524411214|FG000|Overall Study|Progressive disease|14|||
145424564|NCT00124657|524411215|FG001|Overall Study|Progressive disease|5|||
145424565|NCT00124657|524411216|FG002|Overall Study|Progressive disease|27|||
145424566|NCT00124657|524411214|FG000|Overall Study|Intercurrent illness|1|||
145424567|NCT00124657|524411215|FG001|Overall Study|Intercurrent illness|0|||
145424568|NCT00124657|524411216|FG002|Overall Study|Intercurrent illness|0|||
145424569|NCT01475825|524411221|FG000|Overall Study|Adverse Event|41|||
145424570|NCT01475825|524411222|FG001|Overall Study|Adverse Event|15|||
145424571|NCT01475825|524411223|FG002|Overall Study|Adverse Event|27|||
145424572|NCT01475825|524411224|FG003|Overall Study|Adverse Event|11|||
145424573|NCT01475825|524411221|FG000|Overall Study|Death|1|||
145424574|NCT01475825|524411222|FG001|Overall Study|Death|0|||
145424575|NCT01475825|524411223|FG002|Overall Study|Death|1|||
145424576|NCT01475825|524411224|FG003|Overall Study|Death|0|||
145424577|NCT01475825|524411221|FG000|Overall Study|Lack of Efficacy|0|||
145424578|NCT01475825|524411222|FG001|Overall Study|Lack of Efficacy|0|||
145424579|NCT01475825|524411223|FG002|Overall Study|Lack of Efficacy|1|||
145424580|NCT01475825|524411224|FG003|Overall Study|Lack of Efficacy|0|||
145424581|NCT01475825|524411221|FG000|Overall Study|Lost to Follow-up|0|||
145424582|NCT01475825|524411222|FG001|Overall Study|Lost to Follow-up|0|||
145424583|NCT01475825|524411223|FG002|Overall Study|Lost to Follow-up|3|||
145424584|NCT01475825|524411224|FG003|Overall Study|Lost to Follow-up|1|||
145424585|NCT01475825|524411221|FG000|Overall Study|Non-compliance with Study Drug|1|||
145424586|NCT01475825|524411222|FG001|Overall Study|Non-compliance with Study Drug|2|||
145424587|NCT01475825|524411223|FG002|Overall Study|Non-compliance with Study Drug|4|||
145424588|NCT01475825|524411224|FG003|Overall Study|Non-compliance with Study Drug|0|||
145424589|NCT01475825|524411221|FG000|Overall Study|Other: Not available|0|||
145424590|NCT01475825|524411222|FG001|Overall Study|Other: Not available|0|||
145424591|NCT01475825|524411223|FG002|Overall Study|Other: Not available|2|||
145424592|NCT01475825|524411224|FG003|Overall Study|Other: Not available|0|||
145424593|NCT01475825|524411221|FG000|Overall Study|Protocol Violation|1|||
145424594|NCT01475825|524411222|FG001|Overall Study|Protocol Violation|0|||
145424595|NCT01475825|524411223|FG002|Overall Study|Protocol Violation|0|||
145424596|NCT01475825|524411224|FG003|Overall Study|Protocol Violation|0|||
145424597|NCT01475825|524411221|FG000|Overall Study|Physician Decision|0|||
145424598|NCT01475825|524411222|FG001|Overall Study|Physician Decision|1|||
145424599|NCT01475825|524411223|FG002|Overall Study|Physician Decision|0|||
145424600|NCT01475825|524411224|FG003|Overall Study|Physician Decision|0|||
145424601|NCT01475825|524411221|FG000|Overall Study|Withdrawal by Subject|8|||
145424602|NCT01475825|524411222|FG001|Overall Study|Withdrawal by Subject|3|||
145424603|NCT01475825|524411223|FG002|Overall Study|Withdrawal by Subject|11|||
145424604|NCT01475825|524411224|FG003|Overall Study|Withdrawal by Subject|7|||
145424605|NCT01475825|524411221|FG000|Overall Study|Did not enter OLC|15|||
145424606|NCT01475825|524411222|FG001|Overall Study|Did not enter OLC|11|||
145424607|NCT01475825|524411223|FG002|Overall Study|Did not enter OLC|15|||
145424608|NCT01475825|524411224|FG003|Overall Study|Did not enter OLC|11|||
145424609|NCT00160563|524411225|FG000|Overall Study|Adverse Event|1|||
145424610|NCT00160563|524411226|FG001|Overall Study|Adverse Event|1|||
145424611|NCT00160563|524411227|FG002|Overall Study|Adverse Event|1|||
145424612|NCT00160563|524411225|FG000|Overall Study|Lost to Follow-up|1|||
145424613|NCT00160563|524411226|FG001|Overall Study|Lost to Follow-up|1|||
145424614|NCT00160563|524411227|FG002|Overall Study|Lost to Follow-up|2|||
145424615|NCT00160563|524411225|FG000|Overall Study|Protocol Violation|0|||
145424616|NCT00160563|524411226|FG001|Overall Study|Protocol Violation|0|||
145424617|NCT00160563|524411227|FG002|Overall Study|Protocol Violation|3|||
145424618|NCT00160563|524411225|FG000|Overall Study|Withdrawal by Subject|1|||
145424619|NCT00160563|524411226|FG001|Overall Study|Withdrawal by Subject|2|||
145424620|NCT00160563|524411227|FG002|Overall Study|Withdrawal by Subject|3|||
145424621|NCT00160563|524411225|FG000|Overall Study|Other (listed in the study report)|48|||
145424622|NCT00160563|524411226|FG001|Overall Study|Other (listed in the study report)|40|||
145424623|NCT00160563|524411227|FG002|Overall Study|Other (listed in the study report)|81|||
145424624|NCT00160563|524411225|FG000|Overall Study|Missing reason|0|||
145424625|NCT00160563|524411226|FG001|Overall Study|Missing reason|1|||
145424626|NCT00160563|524411227|FG002|Overall Study|Missing reason|0|||
145424627|NCT04157738|524411228|FG000|Overall Study|Moved out of state|0|||
145424628|NCT04157738|524411229|FG001|Overall Study|Moved out of state|2|||
145424629|NCT04157738|524411228|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
145424630|NCT04157738|524411229|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
145424631|NCT03766906|524411234|FG000|Overall Study|Withdrawal by Subject|6|||
145424632|NCT01514357|524411235|FG000|Overall Study|Screen failure|2|||
145424633|NCT01514357|524411236|FG001|Overall Study|Screen failure|0|||
145424634|NCT01514357|524411235|FG000|Overall Study|Withdrawal by Subject|2|||
145424635|NCT01514357|524411236|FG001|Overall Study|Withdrawal by Subject|0|||
145424636|NCT00752219|524411237|FG000|Overall Study|Clinical failure|0|||
145424637|NCT00752219|524411238|FG001|Overall Study|Clinical failure|1|||
145424638|NCT00752219|524411237|FG000|Overall Study|Adverse Event|5|||
145424639|NCT00752219|524411238|FG001|Overall Study|Adverse Event|3|||
145424640|NCT00752219|524411237|FG000|Overall Study|Protocol deviation|1|||
145424641|NCT00752219|524411238|FG001|Overall Study|Protocol deviation|0|||
145424642|NCT00752219|524411237|FG000|Overall Study|Lost to Follow-up|1|||
145424643|NCT00752219|524411238|FG001|Overall Study|Lost to Follow-up|2|||
145424644|NCT00752219|524411237|FG000|Overall Study|Randomized but not treated|1|||
145424645|NCT00752219|524411238|FG001|Overall Study|Randomized but not treated|0|||
145424646|NCT00752219|524411237|FG000|Overall Study|Other|3|||
145424647|NCT00752219|524411238|FG001|Overall Study|Other|0|||
145424648|NCT04691115|524411241|FG000|Overall Study|Withdrawal by Subject|0|||
145424649|NCT04691115|524411242|FG001|Overall Study|Withdrawal by Subject|0|||
145424650|NCT04691115|524411243|FG002|Overall Study|Withdrawal by Subject|0|||
145424651|NCT04691115|524411244|FG003|Overall Study|Withdrawal by Subject|0|||
145424652|NCT04691115|524411245|FG004|Overall Study|Withdrawal by Subject|0|||
145424653|NCT04691115|524411246|FG005|Overall Study|Withdrawal by Subject|1|||
145424654|NCT04691115|524411247|FG006|Overall Study|Withdrawal by Subject|0|||
145424655|NCT04691115|524411248|FG007|Overall Study|Withdrawal by Subject|0|||
145424656|NCT04691115|524411249|FG008|Overall Study|Withdrawal by Subject|0|||
145424657|NCT04691115|524411250|FG009|Overall Study|Withdrawal by Subject|0|||
145424658|NCT04691115|524411251|FG010|Overall Study|Withdrawal by Subject|0|||
145424659|NCT04691115|524411252|FG011|Overall Study|Withdrawal by Subject|0|||
145424660|NCT04691115|524411253|FG012|Overall Study|Withdrawal by Subject|0|||
145424661|NCT04691115|524411254|FG013|Overall Study|Withdrawal by Subject|0|||
145424662|NCT01047540|524411257|FG000|Overall Study|Protocol Violation|1|||
145424663|NCT01047540|524411258|FG001|Overall Study|Protocol Violation|0|||
145424664|NCT01047540|524411259|FG002|Overall Study|Protocol Violation|0|||
145424665|NCT01047540|524411260|FG003|Overall Study|Protocol Violation|0|||
145424666|NCT01047540|524411261|FG004|Overall Study|Protocol Violation|0|||
145424667|NCT01047540|524411257|FG000|Overall Study|Lost to Follow-up|1|||
145424668|NCT01047540|524411258|FG001|Overall Study|Lost to Follow-up|0|||
145424669|NCT01047540|524411259|FG002|Overall Study|Lost to Follow-up|0|||
145424670|NCT01047540|524411260|FG003|Overall Study|Lost to Follow-up|0|||
145424671|NCT01047540|524411261|FG004|Overall Study|Lost to Follow-up|0|||
145424672|NCT01047540|524411257|FG000|Overall Study|Withdrawal by Subject|1|||
145424673|NCT01047540|524411258|FG001|Overall Study|Withdrawal by Subject|0|||
145424674|NCT01047540|524411259|FG002|Overall Study|Withdrawal by Subject|3|||
145424675|NCT01047540|524411260|FG003|Overall Study|Withdrawal by Subject|0|||
145424676|NCT01047540|524411261|FG004|Overall Study|Withdrawal by Subject|1|||
145424677|NCT01047540|524411257|FG000|Overall Study|Pregnancy|1|||
145424678|NCT01047540|524411258|FG001|Overall Study|Pregnancy|0|||
145424679|NCT01047540|524411259|FG002|Overall Study|Pregnancy|0|||
145424680|NCT01047540|524411260|FG003|Overall Study|Pregnancy|0|||
145424681|NCT01047540|524411261|FG004|Overall Study|Pregnancy|0|||
145424682|NCT01047540|524411257|FG000|Overall Study|Adverse Event|1|||
145424683|NCT01047540|524411258|FG001|Overall Study|Adverse Event|0|||
145424684|NCT01047540|524411259|FG002|Overall Study|Adverse Event|0|||
145424685|NCT01047540|524411260|FG003|Overall Study|Adverse Event|0|||
145424686|NCT01047540|524411261|FG004|Overall Study|Adverse Event|0|||
145424687|NCT01437189|524411265|FG000|Overall Study|Adverse Event|3|||
145424688|NCT01437189|524411265|FG000|Overall Study|Lack of Efficacy|4|||
145424689|NCT01437189|524411265|FG000|Overall Study|Withdrawal by Subject|8|||
145424690|NCT04576481|524411272|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
145424691|NCT04576481|524411273|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
145424692|NCT04576481|524411274|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
145579472|NCT00829621|524975420|FG000|Overall Study|Lost to Follow-up|3|||
145424693|NCT04576481|524411275|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
145424694|NCT05261490|524411278|FG000|Overall Study|Other|1|||
145424695|NCT05261490|524411279|FG001|Overall Study|Other|0|||
145424696|NCT05261490|524411280|FG002|Overall Study|Other|0|||
145424697|NCT05261490|524411278|FG000|Overall Study|Study Terminated by Sponsor|1|||
145424698|NCT05261490|524411279|FG001|Overall Study|Study Terminated by Sponsor|1|||
145424699|NCT05261490|524411280|FG002|Overall Study|Study Terminated by Sponsor|4|||
145424700|NCT05261490|524411278|FG000|Overall Study|Death|1|||
145424701|NCT05261490|524411279|FG001|Overall Study|Death|2|||
145424702|NCT05261490|524411280|FG002|Overall Study|Death|0|||
145424703|NCT00456365|524411288|FG000|Overall Study|Lost to Follow-up|1|||
145424704|NCT00456365|524411289|FG001|Overall Study|Lost to Follow-up|3|||
145424705|NCT00456365|524411288|FG000|Overall Study|Withdrawal by Subject|4|||
145424706|NCT00456365|524411289|FG001|Overall Study|Withdrawal by Subject|7|||
145424707|NCT00456365|524411288|FG000|Overall Study|Pregnancy|1|||
145424708|NCT00456365|524411289|FG001|Overall Study|Pregnancy|1|||
145424709|NCT00456365|524411288|FG000|Overall Study|oncologic diagnosis|1|||
145424710|NCT00456365|524411289|FG001|Overall Study|oncologic diagnosis|1|||
145424711|NCT06091956|524411290|FG000|Overall Study|Withdrawal by Subject|1|||
145424712|NCT06091956|524411290|FG000|Overall Study|Complicating Disease|1|||
145424713|NCT03760068|524411296|FG000|Overall Study|Withdrawal by Subject|7|||
145424714|NCT03760068|524411297|FG001|Overall Study|Withdrawal by Subject|8|||
145424715|NCT03760068|524411296|FG000|Overall Study|Adverse Event|1|||
145424716|NCT03760068|524411297|FG001|Overall Study|Adverse Event|2|||
145424717|NCT03760068|524411296|FG000|Overall Study|Administrative Decision by Sponsor|0|||
145424718|NCT03760068|524411297|FG001|Overall Study|Administrative Decision by Sponsor|2|||
145424719|NCT03760068|524411296|FG000|Overall Study|Physician Decision|1|||
145424720|NCT03760068|524411297|FG001|Overall Study|Physician Decision|2|||
145424721|NCT03760068|524411296|FG000|Overall Study|Lost to Follow-up|4|||
145424722|NCT03760068|524411297|FG001|Overall Study|Lost to Follow-up|9|||
145424723|NCT03760068|524411296|FG000|Overall Study|Subject Moved Out of State|1|||
145424724|NCT03760068|524411297|FG001|Overall Study|Subject Moved Out of State|0|||
145424725|NCT01767857|524411302|FG000|Overall Study|Adverse Event|27|||
145424726|NCT01767857|524411303|FG001|Overall Study|Adverse Event|7|||
145424727|NCT01767857|524411302|FG000|Overall Study|Death|28|||
145424728|NCT01767857|524411303|FG001|Overall Study|Death|13|||
145424729|NCT01767857|524411302|FG000|Overall Study|Lack of Efficacy|299|||
145424730|NCT01767857|524411303|FG001|Overall Study|Lack of Efficacy|151|||
145424731|NCT01767857|524411302|FG000|Overall Study|Lost to Follow-up|1|||
145424732|NCT01767857|524411303|FG001|Overall Study|Lost to Follow-up|1|||
145424733|NCT01767857|524411302|FG000|Overall Study|Withdrawal by Subject|38|||
145424734|NCT01767857|524411303|FG001|Overall Study|Withdrawal by Subject|18|||
145424735|NCT01767857|524411302|FG000|Overall Study|Physician Decision|17|||
145424736|NCT01767857|524411303|FG001|Overall Study|Physician Decision|10|||
145424737|NCT01767857|524411302|FG000|Overall Study|Protocol Terminated|1|||
145424738|NCT01767857|524411303|FG001|Overall Study|Protocol Terminated|0|||
145424739|NCT01767857|524411302|FG000|Overall Study|Randomized But Never Treated|19|||
145424740|NCT01767857|524411303|FG001|Overall Study|Randomized But Never Treated|13|||
145424741|NCT01421459|524411304|FG000|Overall Study|Adverse Event|6|||
145424742|NCT01421459|524411305|FG001|Overall Study|Adverse Event|10|||
145424743|NCT01421459|524411304|FG000|Overall Study|Death|1|||
145424744|NCT01421459|524411305|FG001|Overall Study|Death|1|||
145424745|NCT01421459|524411304|FG000|Overall Study|Lack of Efficacy|1|||
145424746|NCT01421459|524411305|FG001|Overall Study|Lack of Efficacy|2|||
145424747|NCT01421459|524411304|FG000|Overall Study|Lost to Follow-up|8|||
145424748|NCT01421459|524411305|FG001|Overall Study|Lost to Follow-up|9|||
145424749|NCT01421459|524411304|FG000|Overall Study|Physician Decision|9|||
145424750|NCT01421459|524411305|FG001|Overall Study|Physician Decision|9|||
145424751|NCT01421459|524411304|FG000|Overall Study|Protocol Violation|8|||
145424752|NCT01421459|524411305|FG001|Overall Study|Protocol Violation|5|||
145424753|NCT01421459|524411304|FG000|Overall Study|Withdrawal by Subject|12|||
145424754|NCT01421459|524411305|FG001|Overall Study|Withdrawal by Subject|16|||
145424755|NCT03289741|524411316|FG000|Overall Study|Adverse Event|1|||
145424756|NCT03289741|524411317|FG001|Overall Study|Adverse Event|1|||
145424757|NCT03289741|524411316|FG000|Overall Study|Physician Decision|2|||
145424758|NCT03289741|524411317|FG001|Overall Study|Physician Decision|2|||
145424759|NCT03289741|524411316|FG000|Overall Study|Withdrawal by Subject|1|||
145424760|NCT03289741|524411317|FG001|Overall Study|Withdrawal by Subject|0|||
145579473|NCT00829621|524975421|FG001|Overall Study|Lost to Follow-up|4|||
145424761|NCT00581100|524412845|FG000|Overall Study|Death|1|||
145424762|NCT00581100|524412846|FG001|Overall Study|Death|0|||
145424763|NCT00581100|524412845|FG000|Overall Study|Adverse Event|2|||
145424764|NCT00581100|524412846|FG001|Overall Study|Adverse Event|1|||
145424765|NCT00581100|524412845|FG000|Overall Study|Withdrawal by Subject|1|||
145424766|NCT00581100|524412846|FG001|Overall Study|Withdrawal by Subject|4|||
145424767|NCT00581100|524412845|FG000|Overall Study|Other|3|||
145424768|NCT00581100|524412846|FG001|Overall Study|Other|0|||
145424769|NCT02904265|524412847|FG000|Overall Study|Physician Decision|1|||
145424770|NCT02904265|524412848|FG001|Overall Study|Physician Decision|2|||
145424771|NCT02579759|524412849|FG000|Overall Study|Protocol Violation|2|||
145424772|NCT02579759|524412850|FG001|Overall Study|Protocol Violation|0|||
145424773|NCT02579759|524412851|FG002|Overall Study|Protocol Violation|0|||
145424774|NCT02579759|524412849|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
145424775|NCT02579759|524412850|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
145424776|NCT02579759|524412851|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
145424777|NCT02579759|524412849|FG000|Overall Study|BfArM hold|13|||
145424778|NCT02579759|524412850|FG001|Overall Study|BfArM hold|12|||
145424779|NCT02579759|524412851|FG002|Overall Study|BfArM hold|12|||
145424780|NCT02579759|524412849|FG000|Overall Study|Sponsor stopped Dose 2|0|||
145424781|NCT02579759|524412850|FG001|Overall Study|Sponsor stopped Dose 2|41|||
145424782|NCT02579759|524412851|FG002|Overall Study|Sponsor stopped Dose 2|0|||
145424783|NCT02579759|524412849|FG000|Overall Study|Non compliance|0|||
145424784|NCT02579759|524412850|FG001|Overall Study|Non compliance|1|||
145424785|NCT02579759|524412851|FG002|Overall Study|Non compliance|0|||
145424786|NCT02579759|524412849|FG000|Overall Study|Pregnancy|0|||
145424787|NCT02579759|524412850|FG001|Overall Study|Pregnancy|1|||
145424788|NCT02579759|524412851|FG002|Overall Study|Pregnancy|0|||
145424789|NCT02579759|524412849|FG000|Overall Study|Inclusion/exclusion criteria|0|||
145424790|NCT02579759|524412850|FG001|Overall Study|Inclusion/exclusion criteria|0|||
145424791|NCT02579759|524412851|FG002|Overall Study|Inclusion/exclusion criteria|1|||
145424792|NCT02579759|524412849|FG000|Overall Study|Adverse Event|4|||
145424793|NCT02579759|524412850|FG001|Overall Study|Adverse Event|3|||
145424794|NCT02579759|524412851|FG002|Overall Study|Adverse Event|1|||
145424795|NCT02579759|524412849|FG000|Overall Study|Withdrawal by Subject|3|||
145424796|NCT02579759|524412850|FG001|Overall Study|Withdrawal by Subject|3|||
145424797|NCT02579759|524412851|FG002|Overall Study|Withdrawal by Subject|5|||
145424798|NCT02579759|524412849|FG000|Overall Study|Lost to Follow-up|2|||
145424799|NCT02579759|524412850|FG001|Overall Study|Lost to Follow-up|2|||
145424800|NCT02579759|524412851|FG002|Overall Study|Lost to Follow-up|2|||
145424801|NCT02336555|524412858|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145424802|NCT02336555|524412859|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145424803|NCT02336555|524412858|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
145424804|NCT02336555|524412859|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
145424805|NCT02336555|524412858|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
145424806|NCT02336555|524412859|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
145424807|NCT00814983|524412865|FG000|Overall Study|Screen failure|1|||
145424808|NCT00814983|524412866|FG001|Overall Study|Screen failure|0|||
145424809|NCT00814983|524412865|FG000|Overall Study|Withdrawal by Subject|1|||
145424810|NCT00814983|524412866|FG001|Overall Study|Withdrawal by Subject|0|||
145424811|NCT00814983|524412865|FG000|Overall Study|Graft failure|1|||
145424812|NCT00814983|524412866|FG001|Overall Study|Graft failure|0|||
145424813|NCT00836901|524412870|FG000|First Intervention|Withdrawal by Subject|1|||
145424814|NCT00836901|524412871|FG001|First Intervention|Withdrawal by Subject|0|||
145424815|NCT00830336|524412872|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
145424816|NCT00830336|524412873|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
145424817|NCT00867334|524412874|FG000|Overall Study|Withdrawal by Subject|0|||
145424818|NCT00867334|524412875|FG001|Overall Study|Withdrawal by Subject|1|||
145424819|NCT00867334|524412874|FG000|Overall Study|Withdrawal by Subject|1|||
145424820|NCT00867334|524412875|FG001|Overall Study|Withdrawal by Subject|0|||
145424821|NCT00867334|524412874|FG000|Overall Study|Withdrawal by Subject|1|||
145424822|NCT00867334|524412875|FG001|Overall Study|Withdrawal by Subject|0|||
145424823|NCT01148771|524412878|FG000|Washout Period|Withdrawal by Subject|0|||
145424824|NCT01148771|524412879|FG001|Washout Period|Withdrawal by Subject|1|||
145424825|NCT01229111|524412884|FG000|Overall Study|Death|1|||
145424826|NCT03464461|524412886|FG000|Overall Study|exclusionary medication given ,|1|||
145424827|NCT03464461|524412887|FG001|Overall Study|exclusionary medication given ,|2|||
145424828|NCT03464461|524412888|FG002|Overall Study|exclusionary medication given ,|0|||
145424829|NCT03464461|524412886|FG000|Overall Study|Physician Decision|0|||
145424830|NCT03464461|524412887|FG001|Overall Study|Physician Decision|1|||
145424831|NCT03464461|524412888|FG002|Overall Study|Physician Decision|0|||
145424832|NCT05463952|524412889|FG000|Treatment|Progressive disease|4|||
145424833|NCT05463952|524412889|FG000|Treatment|Ongoing|2|||
145424834|NCT02096354|524412893|FG000|Overall Study|Physician Decision|4|||
145424835|NCT02096354|524412894|FG001|Overall Study|Physician Decision|5|||
145424836|NCT02096354|524412895|FG002|Overall Study|Physician Decision|0|||
145424837|NCT02096354|524412893|FG000|Overall Study|Withdrawal by Subject|3|||
145424838|NCT02096354|524412894|FG001|Overall Study|Withdrawal by Subject|1|||
145424839|NCT02096354|524412895|FG002|Overall Study|Withdrawal by Subject|0|||
145424840|NCT02096354|524412893|FG000|Overall Study|Adverse Event|7|||
145424841|NCT02096354|524412894|FG001|Overall Study|Adverse Event|4|||
145424842|NCT02096354|524412895|FG002|Overall Study|Adverse Event|0|||
145424843|NCT02096354|524412893|FG000|Overall Study|Ineligible|0|||
145424844|NCT02096354|524412894|FG001|Overall Study|Ineligible|0|||
145424845|NCT02096354|524412895|FG002|Overall Study|Ineligible|11|||
145424846|NCT03579719|524412898|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
145424847|NCT00069953|524412899|FG000|Overall Study|Protocol Violation|2|||
145424848|NCT01646216|524412900|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
145424849|NCT01646216|524412901|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
145424850|NCT01646216|524412900|FG000|Overall Study|Did not complete training|0|||
145424851|NCT01646216|524412901|FG001|Overall Study|Did not complete training|2|||
145424852|NCT01646216|524412900|FG000|Overall Study|Investigator decision|1|||
145424853|NCT01646216|524412901|FG001|Overall Study|Investigator decision|1|||
145424854|NCT00113373|524412904|FG000|Overall Study|Ineligible: wrong primary|1|||
145424855|NCT00113373|524412904|FG000|Overall Study|Ineligible: second primary|1|||
145424856|NCT00113373|524412904|FG000|Overall Study|Never Treated|1|||
145424857|NCT02395627|524412905|FG000|Overall Study|Withdrawal by Subject|0|||
145424858|NCT02395627|524412906|FG001|Overall Study|Withdrawal by Subject|2|||
145424859|NCT02395627|524412907|FG002|Overall Study|Withdrawal by Subject|0|||
145424860|NCT02395627|524412905|FG000|Overall Study|Did not receive pembrolizumab|3|||
145424861|NCT02395627|524412906|FG001|Overall Study|Did not receive pembrolizumab|1|||
145424862|NCT02395627|524412907|FG002|Overall Study|Did not receive pembrolizumab|0|||
145424863|NCT03253627|524412908|FG000|Overall Study|Lost to Follow-up|1|||
145424864|NCT03253627|524412909|FG001|Overall Study|Lost to Follow-up|2|||
145424865|NCT03253627|524412908|FG000|Overall Study|Withdrawal by Subject|0|||
145424866|NCT03253627|524412909|FG001|Overall Study|Withdrawal by Subject|2|||
145424867|NCT03253627|524412908|FG000|Overall Study|Inability to complete MRI|1|||
145424868|NCT03253627|524412909|FG001|Overall Study|Inability to complete MRI|0|||
145424869|NCT03829683|524412910|FG000|Overall Study|Lost to Follow-up|1|||
145424870|NCT03829683|524412911|FG001|Overall Study|Lost to Follow-up|0|||
145424871|NCT03829683|524412910|FG000|Overall Study|Physician Decision|3|||
145424872|NCT03829683|524412911|FG001|Overall Study|Physician Decision|1|||
145424873|NCT03829683|524412910|FG000|Overall Study|Withdrawal by Subject|0|||
145424874|NCT03829683|524412911|FG001|Overall Study|Withdrawal by Subject|1|||
145424875|NCT03829683|524412910|FG000|Overall Study|Discharge from hospital|1|||
145424876|NCT03829683|524412911|FG001|Overall Study|Discharge from hospital|0|||
145424877|NCT03163667|524412912|FG000|Overall Study|Death|15|||
145424878|NCT03163667|524412913|FG001|Overall Study|Death|27|||
145424879|NCT03163667|524412912|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
145424880|NCT03163667|524412913|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
145424881|NCT00979407|524412914|FG000|Overall Study|Withdrawal by Subject|3|||
145424882|NCT00979407|524412915|FG001|Overall Study|Withdrawal by Subject|4|||
145424883|NCT00979407|524412914|FG000|Overall Study|Lost to Follow-up|3|||
145424884|NCT00979407|524412915|FG001|Overall Study|Lost to Follow-up|3|||
145424885|NCT02420314|524412916|FG000|Overall Study|Withdrawal by Subject|1|||
145424886|NCT02420314|524412916|FG000|Overall Study|Protocol Violation|1|||
145424887|NCT05430919|524412917|FG000|Overall Study|Protocol Violation|0|||
145424888|NCT05430919|524412918|FG001|Overall Study|Protocol Violation|0|||
145424889|NCT05430919|524412919|FG002|Overall Study|Protocol Violation|1|||
145424890|NCT05430919|524412920|FG003|Overall Study|Protocol Violation|0|||
145424891|NCT05430919|524412917|FG000|Overall Study|Lost to Follow-up|0|||
145424892|NCT05430919|524412918|FG001|Overall Study|Lost to Follow-up|1|||
145424893|NCT05430919|524412919|FG002|Overall Study|Lost to Follow-up|0|||
145424894|NCT05430919|524412920|FG003|Overall Study|Lost to Follow-up|0|||
145424895|NCT05430919|524412917|FG000|Overall Study|Withdrawal by Subject|3|||
145424896|NCT05430919|524412918|FG001|Overall Study|Withdrawal by Subject|0|||
145424897|NCT05430919|524412919|FG002|Overall Study|Withdrawal by Subject|0|||
145424898|NCT05430919|524412920|FG003|Overall Study|Withdrawal by Subject|1|||
145424899|NCT01335685|524412924|FG000|Overall Study|Study Terminated by Sponsor|2|||
145424900|NCT01335685|524412925|FG001|Overall Study|Study Terminated by Sponsor|1|||
145424901|NCT01335685|524412926|FG002|Overall Study|Study Terminated by Sponsor|1|||
145424902|NCT01335685|524412927|FG003|Overall Study|Study Terminated by Sponsor|10|||
145424903|NCT01335685|524412928|FG004|Overall Study|Study Terminated by Sponsor|0|||
145424904|NCT01335685|524412929|FG005|Overall Study|Study Terminated by Sponsor|4|||
145424905|NCT01335685|524412930|FG006|Overall Study|Study Terminated by Sponsor|2|||
145424906|NCT01335685|524412931|FG007|Overall Study|Study Terminated by Sponsor|3|||
145424907|NCT01335685|524412924|FG000|Overall Study|Withdrawal by Subject|1|||
145579474|NCT00441337|524975422|FG000|Overall Study|Disease Progression|6|||
145579475|NCT00441337|524975423|FG001|Overall Study|Disease Progression|6|||
145424908|NCT01335685|524412925|FG001|Overall Study|Withdrawal by Subject|0|||
145424909|NCT01335685|524412926|FG002|Overall Study|Withdrawal by Subject|0|||
145424910|NCT01335685|524412927|FG003|Overall Study|Withdrawal by Subject|1|||
145424911|NCT01335685|524412928|FG004|Overall Study|Withdrawal by Subject|0|||
145424912|NCT01335685|524412929|FG005|Overall Study|Withdrawal by Subject|0|||
145424913|NCT01335685|524412930|FG006|Overall Study|Withdrawal by Subject|0|||
145424914|NCT01335685|524412931|FG007|Overall Study|Withdrawal by Subject|0|||
145424915|NCT01335685|524412924|FG000|Overall Study|Reason not Specified|0|||
145424916|NCT01335685|524412925|FG001|Overall Study|Reason not Specified|0|||
145424917|NCT01335685|524412926|FG002|Overall Study|Reason not Specified|1|||
145424918|NCT01335685|524412927|FG003|Overall Study|Reason not Specified|0|||
145424919|NCT01335685|524412928|FG004|Overall Study|Reason not Specified|0|||
145424920|NCT01335685|524412929|FG005|Overall Study|Reason not Specified|1|||
145579476|NCT00441337|524975424|FG002|Overall Study|Disease Progression|4|||
145579477|NCT00441337|524975425|FG003|Overall Study|Disease Progression|18|||
145579478|NCT00441337|524975422|FG000|Overall Study|Lost to Follow-up|0|||
145372020|NCT02541669|524211065|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
145372021|NCT02541669|524211066|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
145372022|NCT04739722|524211069|FG000|Overall Study|Lost to Follow-up|5301|||
145372023|NCT04739722|524211069|FG000|Overall Study|Withdrawal by Subject|42|||
145372024|NCT04739722|524211069|FG000|Overall Study|Non Average-risk|1157|||
145372025|NCT00834639|524211070|FG000|Second Intervention|Physician Decision|0|||
145372026|NCT00834639|524211071|FG001|Second Intervention|Physician Decision|2|||
145372027|NCT00725608|524211072|FG000|Overall Study|Lost to Follow-up|60|||
145372028|NCT00725608|524211072|FG000|Overall Study|Adverse Event|14|||
145372029|NCT00725608|524211072|FG000|Overall Study|Individual reasons|86|||
145372030|NCT00725608|524211072|FG000|Overall Study|Other|7|||
145372031|NCT00614120|524211076|FG000|Overall Study|Adverse Event|9|||
145372032|NCT00614120|524211077|FG001|Overall Study|Adverse Event|22|||
145372033|NCT00614120|524211078|FG002|Overall Study|Adverse Event|30|||
145372034|NCT00614120|524211079|FG003|Overall Study|Adverse Event|3|||
145372035|NCT00614120|524211076|FG000|Overall Study|Lack of Efficacy|3|||
145372036|NCT00614120|524211077|FG001|Overall Study|Lack of Efficacy|3|||
145372037|NCT00614120|524211078|FG002|Overall Study|Lack of Efficacy|2|||
145372038|NCT00614120|524211079|FG003|Overall Study|Lack of Efficacy|2|||
145372039|NCT00614120|524211076|FG000|Overall Study|Protocol Violation|2|||
145372040|NCT00614120|524211077|FG001|Overall Study|Protocol Violation|5|||
145372041|NCT00614120|524211078|FG002|Overall Study|Protocol Violation|3|||
145372042|NCT00614120|524211079|FG003|Overall Study|Protocol Violation|1|||
145372043|NCT00614120|524211076|FG000|Overall Study|Withdrawal criteria|1|||
145372044|NCT00614120|524211077|FG001|Overall Study|Withdrawal criteria|0|||
145372045|NCT00614120|524211078|FG002|Overall Study|Withdrawal criteria|0|||
145372046|NCT00614120|524211079|FG003|Overall Study|Withdrawal criteria|0|||
145372047|NCT00614120|524211076|FG000|Overall Study|Withdrawal by Subject|9|||
145372048|NCT00614120|524211077|FG001|Overall Study|Withdrawal by Subject|10|||
145372049|NCT00614120|524211078|FG002|Overall Study|Withdrawal by Subject|16|||
145372050|NCT00614120|524211079|FG003|Overall Study|Withdrawal by Subject|3|||
145372051|NCT00614120|524211076|FG000|Overall Study|Did not meet trial criteria|0|||
145372052|NCT00614120|524211077|FG001|Overall Study|Did not meet trial criteria|1|||
145372053|NCT00614120|524211078|FG002|Overall Study|Did not meet trial criteria|1|||
145372054|NCT00614120|524211079|FG003|Overall Study|Did not meet trial criteria|1|||
145372055|NCT00614120|524211076|FG000|Overall Study|hCG positive (not pregnant)|0|||
145372056|NCT00614120|524211077|FG001|Overall Study|hCG positive (not pregnant)|0|||
145372057|NCT00614120|524211078|FG002|Overall Study|hCG positive (not pregnant)|1|||
145372058|NCT00614120|524211079|FG003|Overall Study|hCG positive (not pregnant)|0|||
145372059|NCT00614120|524211076|FG000|Overall Study|Hypoglycaemia|0|||
145372060|NCT00614120|524211077|FG001|Overall Study|Hypoglycaemia|0|||
145372061|NCT00614120|524211078|FG002|Overall Study|Hypoglycaemia|0|||
145372062|NCT00614120|524211079|FG003|Overall Study|Hypoglycaemia|1|||
145372063|NCT00614120|524211076|FG000|Overall Study|Lack of trial product|3|||
145372064|NCT00614120|524211077|FG001|Overall Study|Lack of trial product|3|||
145372065|NCT00614120|524211078|FG002|Overall Study|Lack of trial product|2|||
145372066|NCT00614120|524211079|FG003|Overall Study|Lack of trial product|0|||
145372067|NCT00614120|524211076|FG000|Overall Study|Late syphilis, latent|1|||
145372068|NCT00614120|524211077|FG001|Overall Study|Late syphilis, latent|0|||
145372069|NCT00614120|524211078|FG002|Overall Study|Late syphilis, latent|0|||
145372070|NCT00614120|524211079|FG003|Overall Study|Late syphilis, latent|0|||
145372071|NCT00614120|524211076|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
145372072|NCT00614120|524211077|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
145372073|NCT00614120|524211078|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
145372074|NCT00614120|524211079|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
145372075|NCT00614120|524211076|FG000|Overall Study|Lost to Follow-up|1|||
145372076|NCT00614120|524211077|FG001|Overall Study|Lost to Follow-up|2|||
145372077|NCT00614120|524211078|FG002|Overall Study|Lost to Follow-up|3|||
145372078|NCT00614120|524211079|FG003|Overall Study|Lost to Follow-up|4|||
145372079|NCT03047720|524211080|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
145372080|NCT03047720|524211081|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
145372081|NCT01154088|524211082|FG000|Overall Study|Lost to Follow-up|4|||
145372082|NCT01154088|524211083|FG001|Overall Study|Lost to Follow-up|6|||
145372083|NCT01154088|524211084|FG002|Overall Study|Lost to Follow-up|7|||
145372084|NCT05129137|524211087|FG000|Second Period|Adverse Event|1|||
145372085|NCT05129137|524211088|FG001|Second Period|Adverse Event|0|||
145372086|NCT05129137|524211089|FG002|Second Period|Adverse Event|0|||
145372087|NCT05129137|524211090|FG003|Second Period|Adverse Event|0|||
145372088|NCT05129137|524211087|FG000|Second Period|Protocol Violation|0|||
145579479|NCT00441337|524975423|FG001|Overall Study|Lost to Follow-up|0|||
145372089|NCT05129137|524211088|FG001|Second Period|Protocol Violation|0|||
145372090|NCT05129137|524211089|FG002|Second Period|Protocol Violation|0|||
145372091|NCT05129137|524211090|FG003|Second Period|Protocol Violation|1|||
145372092|NCT05129137|524211087|FG000|Third Period|Protocol Violation|0|||
145372093|NCT05129137|524211088|FG001|Third Period|Protocol Violation|0|||
145372094|NCT05129137|524211089|FG002|Third Period|Protocol Violation|0|||
145424921|NCT01335685|524412930|FG006|Overall Study|Reason not Specified|0|||
145424922|NCT01335685|524412931|FG007|Overall Study|Reason not Specified|0|||
145424923|NCT00855166|524412932|FG000|Overall Study|Adverse Event|0|||
145424924|NCT00855166|524412933|FG001|Overall Study|Adverse Event|2|||
145424925|NCT00855166|524412932|FG000|Overall Study|Death|0|||
145424926|NCT00855166|524412933|FG001|Overall Study|Death|1|||
145424927|NCT00855166|524412932|FG000|Overall Study|Withdrawal by Subject|1|||
145424928|NCT00855166|524412933|FG001|Overall Study|Withdrawal by Subject|4|||
145424929|NCT00855166|524412932|FG000|Overall Study|Poor/non-compliance|2|||
145424930|NCT00855166|524412933|FG001|Overall Study|Poor/non-compliance|0|||
145424931|NCT00855166|524412932|FG000|Overall Study|Administrative reasons by sponsor|1|||
145424932|NCT00855166|524412933|FG001|Overall Study|Administrative reasons by sponsor|0|||
145424933|NCT00855166|524412932|FG000|Overall Study|Subject no longer meets study criteria|1|||
145424934|NCT00855166|524412933|FG001|Overall Study|Subject no longer meets study criteria|1|||
145424935|NCT00803049|524412934|FG000|Overall Study|Adverse Event|21|||
145424936|NCT00803049|524412935|FG001|Overall Study|Adverse Event|33|||
145424937|NCT00803049|524412936|FG002|Overall Study|Adverse Event|13|||
145424938|NCT00803049|524412937|FG003|Overall Study|Adverse Event|27|||
145424939|NCT00803049|524412934|FG000|Overall Study|Lack of Efficacy|10|||
145424940|NCT00803049|524412935|FG001|Overall Study|Lack of Efficacy|19|||
145424941|NCT00803049|524412936|FG002|Overall Study|Lack of Efficacy|6|||
145424942|NCT00803049|524412937|FG003|Overall Study|Lack of Efficacy|13|||
145372095|NCT05129137|524211090|FG003|Third Period|Protocol Violation|1|||
145372096|NCT05129137|524211087|FG000|Forth Period|Protocol Violation|0|||
145372097|NCT05129137|524211088|FG001|Forth Period|Protocol Violation|1|||
145372098|NCT05129137|524211089|FG002|Forth Period|Protocol Violation|0|||
145372099|NCT05129137|524211090|FG003|Forth Period|Protocol Violation|0|||
145372100|NCT05129137|524211087|FG000|Forth Period|Withdrawal by Subject|0|||
145372101|NCT05129137|524211088|FG001|Forth Period|Withdrawal by Subject|0|||
145372102|NCT05129137|524211089|FG002|Forth Period|Withdrawal by Subject|1|||
145424943|NCT00803049|524412934|FG000|Overall Study|Lost to Follow-up|0|||
145424944|NCT00803049|524412935|FG001|Overall Study|Lost to Follow-up|2|||
145424945|NCT00803049|524412936|FG002|Overall Study|Lost to Follow-up|0|||
145424946|NCT00803049|524412937|FG003|Overall Study|Lost to Follow-up|3|||
145424947|NCT00803049|524412934|FG000|Overall Study|Death|2|||
145424948|NCT00803049|524412935|FG001|Overall Study|Death|1|||
145424949|NCT00803049|524412936|FG002|Overall Study|Death|0|||
145424950|NCT00803049|524412937|FG003|Overall Study|Death|2|||
145424951|NCT00803049|524412934|FG000|Overall Study|Progressive Disease|6|||
145424952|NCT00803049|524412935|FG001|Overall Study|Progressive Disease|10|||
145424953|NCT00803049|524412936|FG002|Overall Study|Progressive Disease|6|||
145424954|NCT00803049|524412937|FG003|Overall Study|Progressive Disease|6|||
145424955|NCT00803049|524412934|FG000|Overall Study|Withdrawal by Subject|19|||
145424956|NCT00803049|524412935|FG001|Overall Study|Withdrawal by Subject|43|||
145424957|NCT00803049|524412936|FG002|Overall Study|Withdrawal by Subject|16|||
145424958|NCT00803049|524412937|FG003|Overall Study|Withdrawal by Subject|44|||
145424959|NCT00803049|524412934|FG000|Overall Study|Protocol Violation|0|||
145424960|NCT00803049|524412935|FG001|Overall Study|Protocol Violation|1|||
145424961|NCT00803049|524412936|FG002|Overall Study|Protocol Violation|1|||
145424962|NCT00803049|524412937|FG003|Overall Study|Protocol Violation|0|||
145424963|NCT00803049|524412934|FG000|Overall Study|Randomized and Not Treated|0|||
145424964|NCT00803049|524412935|FG001|Overall Study|Randomized and Not Treated|0|||
145424965|NCT00803049|524412936|FG002|Overall Study|Randomized and Not Treated|0|||
145424966|NCT00803049|524412937|FG003|Overall Study|Randomized and Not Treated|2|||
145424967|NCT00803049|524412934|FG000|Overall Study|Other than Specified Above|3|||
145424968|NCT00803049|524412935|FG001|Overall Study|Other than Specified Above|9|||
145424969|NCT00803049|524412936|FG002|Overall Study|Other than Specified Above|2|||
145424970|NCT00803049|524412937|FG003|Overall Study|Other than Specified Above|5|||
145424971|NCT01422382|524412938|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
145424972|NCT04082364|524412941|FG000|Overall Study|Death|23|||
145372103|NCT05129137|524211090|FG003|Forth Period|Withdrawal by Subject|0|||
145372104|NCT01084668|524211091|FG000|Overall Study|Lack of Efficacy|5|||
145372105|NCT01084668|524211091|FG000|Overall Study|Withdrawal by Subject|2|||
145424973|NCT04082364|524412942|FG001|Overall Study|Death|1|||
145424974|NCT04082364|524412943|FG002|Overall Study|Death|1|||
145424975|NCT04082364|524412944|FG003|Overall Study|Death|2|||
145424976|NCT04082364|524412945|FG004|Overall Study|Death|1|||
145424977|NCT04082364|524412941|FG000|Overall Study|Lost to Follow-up|1|||
145424978|NCT04082364|524412942|FG001|Overall Study|Lost to Follow-up|0|||
145424979|NCT04082364|524412943|FG002|Overall Study|Lost to Follow-up|0|||
145424980|NCT04082364|524412944|FG003|Overall Study|Lost to Follow-up|0|||
145424981|NCT04082364|524412945|FG004|Overall Study|Lost to Follow-up|1|||
145424982|NCT04082364|524412941|FG000|Overall Study|Physician Decision|1|||
145424983|NCT04082364|524412942|FG001|Overall Study|Physician Decision|1|||
145424984|NCT04082364|524412943|FG002|Overall Study|Physician Decision|0|||
145372106|NCT01084668|524211091|FG000|Overall Study|Pregnancy|1|||
145372107|NCT01084668|524211091|FG000|Overall Study|Non-compliance|1|||
145424985|NCT04082364|524412944|FG003|Overall Study|Physician Decision|2|||
145424986|NCT04082364|524412945|FG004|Overall Study|Physician Decision|1|||
145424987|NCT04082364|524412941|FG000|Overall Study|Withdrawal by Subject|1|||
145424988|NCT04082364|524412942|FG001|Overall Study|Withdrawal by Subject|1|||
145424989|NCT04082364|524412943|FG002|Overall Study|Withdrawal by Subject|0|||
145424990|NCT04082364|524412944|FG003|Overall Study|Withdrawal by Subject|0|||
145424991|NCT04082364|524412945|FG004|Overall Study|Withdrawal by Subject|1|||
145424992|NCT04082364|524412941|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
145424993|NCT04082364|524412942|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
145424994|NCT04082364|524412943|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
145424995|NCT04082364|524412944|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
145424996|NCT04082364|524412945|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
145424997|NCT04082364|524412941|FG000|Overall Study|Disease progression|0|||
145424998|NCT04082364|524412942|FG001|Overall Study|Disease progression|0|||
145424999|NCT04082364|524412943|FG002|Overall Study|Disease progression|0|||
145425000|NCT04082364|524412944|FG003|Overall Study|Disease progression|1|||
145425001|NCT04082364|524412945|FG004|Overall Study|Disease progression|0|||
145425002|NCT03186378|524412946|FG000|Overall Study|Lost to Follow-up|1|||
145425003|NCT03186378|524412947|FG001|Overall Study|Lost to Follow-up|0|||
145425004|NCT02514746|524412948|FG000|Overall Study|Chronically Ill|1|||
145425005|NCT02514746|524412949|FG001|Overall Study|Chronically Ill|2|||
145425006|NCT02514746|524412948|FG000|Overall Study|Physician Decision|4|||
145425007|NCT02514746|524412949|FG001|Overall Study|Physician Decision|2|||
145425008|NCT02514746|524412948|FG000|Overall Study|Withdrawal by Subject|12|||
145425009|NCT02514746|524412949|FG001|Overall Study|Withdrawal by Subject|10|||
145425010|NCT02514746|524412948|FG000|Overall Study|Other|5|||
145425011|NCT02514746|524412949|FG001|Overall Study|Other|1|||
145425012|NCT04042311|524412950|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
145425013|NCT04042311|524412950|FG000|Overall Study|Unable to tolerate|4|||
145425014|NCT04042311|524412950|FG000|Overall Study|Concurrent illness|2|||
145425015|NCT04042311|524412950|FG000|Overall Study|Adverse Event|2|||
145425016|NCT04042311|524412950|FG000|Overall Study|No longer meeting inclusion criteria|2|||
145425017|NCT04042311|524412950|FG000|Overall Study|No reason given|1|||
145425018|NCT04042311|524412950|FG000|Overall Study|Withdrawal by Subject|4|||
145425019|NCT05021224|524412951|FG000|Overall Study|Did not complete all survey items|4|||
145425020|NCT05021224|524412952|FG001|Overall Study|Did not complete all survey items|1|||
145425021|NCT05021224|524412953|FG002|Overall Study|Did not complete all survey items|0|||
145425022|NCT05021224|524412954|FG003|Overall Study|Did not complete all survey items|2|||
145425023|NCT03996395|524412955|FG000|Overall Study|Lost to Follow-up|4|||
145425024|NCT03996395|524412955|FG000|Overall Study|Withdrawal by Subject|1|||
145425025|NCT03996395|524412955|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
145425026|NCT05375929|524412956|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
145425027|NCT05375929|524412957|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145425028|NCT05375929|524412958|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145425029|NCT05375929|524412959|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
145425030|NCT05375929|524412956|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145425031|NCT05375929|524412957|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
145425032|NCT05375929|524412958|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145425033|NCT05375929|524412959|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
145623485|NCT00329303|525133940|FG001|Overall Study|Patient no longer available|0|||
145623486|NCT00329303|525133939|FG000|Overall Study|Patient relocated|0|||
145623487|NCT00329303|525133940|FG001|Overall Study|Patient relocated|1|||
145623488|NCT03582137|525133941|FG000|Overall Study|Adverse Event|1|||
145623489|NCT03582137|525133942|FG001|Overall Study|Adverse Event|0|||
145623490|NCT02303574|525133948|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623491|NCT02303574|525133949|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623492|NCT02303574|525133950|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
145623493|NCT02303574|525133951|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623494|NCT02303574|525133952|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623495|NCT02303574|525133953|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623496|NCT02303574|525133954|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623497|NCT02303574|525133955|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623498|NCT02303574|525133956|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623499|NCT02303574|525133957|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
145623500|NCT02303574|525133948|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623501|NCT02303574|525133949|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623502|NCT02303574|525133950|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623503|NCT02303574|525133951|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623504|NCT02303574|525133952|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623505|NCT02303574|525133953|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623506|NCT02303574|525133954|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623507|NCT02303574|525133955|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
145623508|NCT02303574|525133956|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145623509|NCT02303574|525133957|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
145425034|NCT05375929|524412956|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
145425035|NCT05375929|524412957|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
145425036|NCT05375929|524412958|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
145425037|NCT05375929|524412959|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
145425038|NCT05375929|524412956|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145425039|NCT05375929|524412957|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
145425040|NCT05375929|524412958|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145425041|NCT05375929|524412959|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
145425042|NCT05375929|524412956|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
145425043|NCT05375929|524412957|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145425044|NCT05375929|524412958|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145425045|NCT05375929|524412959|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
145425046|NCT05375929|524412956|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145425047|NCT05375929|524412957|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
145425048|NCT05375929|524412958|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145425049|NCT05375929|524412959|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
145425050|NCT05375929|524412956|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145425051|NCT05375929|524412957|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145425052|NCT05375929|524412958|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
145425053|NCT05375929|524412959|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
145425054|NCT05375929|524412956|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145425055|NCT05375929|524412957|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145425056|NCT05375929|524412958|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
145425057|NCT05375929|524412959|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
145425058|NCT05375929|524412956|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145425059|NCT05375929|524412957|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145425060|NCT05375929|524412958|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
145425061|NCT05375929|524412959|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
145425062|NCT05375929|524412956|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145425063|NCT05375929|524412957|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145425064|NCT05375929|524412958|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
145425065|NCT05375929|524412959|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
145425066|NCT03973489|524412960|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
145425067|NCT03973489|524412961|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425068|NCT03973489|524412962|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425069|NCT03973489|524412963|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425070|NCT03973489|524412964|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
145425071|NCT03973489|524412965|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425072|NCT03973489|524412966|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425073|NCT03973489|524412967|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
145425074|NCT03973489|524412960|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425075|NCT03973489|524412961|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425076|NCT03973489|524412962|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425077|NCT03973489|524412963|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
145425078|NCT03973489|524412964|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
145425079|NCT03973489|524412965|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425080|NCT03973489|524412966|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425081|NCT03973489|524412967|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
145425082|NCT03973489|524412960|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425083|NCT03973489|524412961|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425084|NCT03973489|524412962|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425085|NCT03973489|524412963|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425086|NCT03973489|524412964|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
145425087|NCT03973489|524412965|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425088|NCT03973489|524412966|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
145425089|NCT03973489|524412967|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
145425090|NCT03973489|524412960|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
145425091|NCT03973489|524412961|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425092|NCT03973489|524412962|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425093|NCT03973489|524412963|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
145425094|NCT03973489|524412964|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425095|NCT03973489|524412965|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425096|NCT03973489|524412966|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425097|NCT03973489|524412967|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
145425098|NCT03973489|524412960|FG000|Second Intervention (1 Day)|Adverse Event|0|||
145425099|NCT03973489|524412961|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145425100|NCT03973489|524412962|FG002|Second Intervention (1 Day)|Adverse Event|0|||
145425101|NCT03973489|524412963|FG003|Second Intervention (1 Day)|Adverse Event|1|||
145425102|NCT03973489|524412964|FG004|Second Intervention (1 Day)|Adverse Event|0|||
145425103|NCT03973489|524412965|FG005|Second Intervention (1 Day)|Adverse Event|0|||
145425104|NCT03973489|524412966|FG006|Second Intervention (1 Day)|Adverse Event|0|||
145425105|NCT03973489|524412967|FG007|Second Intervention (1 Day)|Adverse Event|0|||
145425106|NCT03301415|524412968|FG000|Overall Study|Lost to Follow-up|2|||
145425107|NCT03301415|524412968|FG000|Overall Study|Unable to comply with visit schedule|2|||
145425108|NCT03247673|524412969|FG000|Overall Study|Withdrawal by Subject|1|||
145425109|NCT03247673|524412970|FG001|Overall Study|Withdrawal by Subject|0|||
145425110|NCT03247673|524412971|FG002|Overall Study|Withdrawal by Subject|3|||
145425111|NCT03247673|524412969|FG000|Overall Study|Lost to Follow-up|0|||
145425112|NCT03247673|524412970|FG001|Overall Study|Lost to Follow-up|0|||
145425113|NCT03247673|524412971|FG002|Overall Study|Lost to Follow-up|1|||
145425114|NCT02184442|524412972|FG000|Overall Study|Death|61|||
145425115|NCT02184442|524412973|FG001|Overall Study|Death|65|||
145425116|NCT02184442|524412972|FG000|Overall Study|Withdrawal by Subject|3|||
145425117|NCT02184442|524412973|FG001|Overall Study|Withdrawal by Subject|11|||
145425118|NCT04091438|524412974|FG000|Treatment Period 1 (1 Day)|Other|1|||
145425119|NCT04091438|524412975|FG001|Treatment Period 1 (1 Day)|Other|0|||
145425120|NCT04091438|524412974|FG000|Washout Period (1 Day)|Protocol deviation|0|||
145425121|NCT04091438|524412975|FG001|Washout Period (1 Day)|Protocol deviation|1|||
145425122|NCT04091438|524412974|FG000|Washout Period (1 Day)|Other|0|||
145579480|NCT00441337|524975424|FG002|Overall Study|Lost to Follow-up|0|||
145262868|NCT00465894|523808537|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
145262869|NCT00465894|523808538|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
145262870|NCT00495794|523808539|FG000|Overall Study|Pharmacist did not activate patient|522|||
145262871|NCT00495794|523808540|FG001|Overall Study|Pharmacist did not activate patient|0|||
145262872|NCT01636076|523808541|FG000|Overall Study|Terminated by sponsor|1|||
145262873|NCT01636076|523808542|FG001|Overall Study|Terminated by sponsor|1|||
145262874|NCT01636076|523808541|FG000|Overall Study|Lack of Efficacy|0|||
145262875|NCT01636076|523808542|FG001|Overall Study|Lack of Efficacy|1|||
145262876|NCT01636076|523808541|FG000|Overall Study|Lost to Follow-up|1|||
145262877|NCT01636076|523808542|FG001|Overall Study|Lost to Follow-up|0|||
145262878|NCT01636076|523808541|FG000|Overall Study|Physician Decision|1|||
145262879|NCT01636076|523808542|FG001|Overall Study|Physician Decision|1|||
145262880|NCT01636076|523808541|FG000|Overall Study|Non-compliance with study treatment|1|||
145262881|NCT01636076|523808542|FG001|Overall Study|Non-compliance with study treatment|1|||
145262882|NCT01636076|523808541|FG000|Overall Study|Adverse Event|6|||
145262883|NCT01636076|523808542|FG001|Overall Study|Adverse Event|11|||
145262884|NCT01636076|523808541|FG000|Overall Study|Withdrawal by Subject|7|||
145262885|NCT01636076|523808542|FG001|Overall Study|Withdrawal by Subject|10|||
145262886|NCT01159665|523808543|FG000|Overall Study|Withdrawal by Subject|0|||
145262887|NCT01159665|523808544|FG001|Overall Study|Withdrawal by Subject|1|||
145262888|NCT01159665|523808545|FG002|Overall Study|Withdrawal by Subject|0|||
145262889|NCT01159665|523808546|FG003|Overall Study|Withdrawal by Subject|0|||
145262890|NCT01159665|523808547|FG004|Overall Study|Withdrawal by Subject|0|||
145262891|NCT01159665|523808548|FG005|Overall Study|Withdrawal by Subject|0|||
145262892|NCT02173158|523808549|FG000|Efficacy Phase|Adverse Event|1|||
145262893|NCT01190839|523808550|FG000|Overall Study|Adverse Event|32|||
145262894|NCT01190839|523808551|FG001|Overall Study|Adverse Event|41|||
145579481|NCT00441337|524975425|FG003|Overall Study|Lost to Follow-up|1|||
145579482|NCT00441337|524975422|FG000|Overall Study|Sponsor Decision|0|||
145579483|NCT00441337|524975423|FG001|Overall Study|Sponsor Decision|0|||
145579484|NCT00441337|524975424|FG002|Overall Study|Sponsor Decision|1|||
145262895|NCT01190839|523808550|FG000|Overall Study|Protocol Violation|2|||
145262896|NCT01190839|523808551|FG001|Overall Study|Protocol Violation|2|||
145262897|NCT01190839|523808550|FG000|Overall Study|Lost to Follow-up|7|||
145262898|NCT01190839|523808551|FG001|Overall Study|Lost to Follow-up|1|||
145262899|NCT01190839|523808550|FG000|Overall Study|Death|1|||
145262900|NCT01190839|523808551|FG001|Overall Study|Death|0|||
145262901|NCT01190839|523808550|FG000|Overall Study|Trial stopped by Sponsor|71|||
145262902|NCT01190839|523808551|FG001|Overall Study|Trial stopped by Sponsor|68|||
145262903|NCT01190839|523808550|FG000|Overall Study|Undefined|35|||
145262904|NCT01190839|523808551|FG001|Overall Study|Undefined|31|||
145262905|NCT01190839|523808550|FG000|Overall Study|Randomized but not treated|2|||
145262906|NCT01190839|523808551|FG001|Overall Study|Randomized but not treated|4|||
145262907|NCT02058966|523808552|FG000|Open-Label Methamphetamine|Adverse Event|1|||
145262908|NCT02058966|523808552|FG000|First Intervention|Withdrawal by Subject|1|||
145262909|NCT00765726|523808553|FG000|Overall Study|Withdrawal by Subject|1|||
145262910|NCT00765726|523808553|FG000|Overall Study|Discontinuation of study by sponsor|8|||
145262911|NCT02993731|523808554|FG000|Overall Study|Study Termination|101|||
145262912|NCT02993731|523808555|FG001|Overall Study|Study Termination|105|||
145262913|NCT01265511|523808556|FG000|Overall Study|Lack of Efficacy|2|||
145262914|NCT01265511|523808557|FG001|Overall Study|Lack of Efficacy|1|||
145262915|NCT01265511|523808556|FG000|Overall Study|Met stopping rules|0|||
145579485|NCT00441337|524975425|FG003|Overall Study|Sponsor Decision|2|||
145579486|NCT00441337|524975422|FG000|Overall Study|Did not meet inclusion criteria|0|||
145579487|NCT00441337|524975423|FG001|Overall Study|Did not meet inclusion criteria|0|||
145579488|NCT00441337|524975424|FG002|Overall Study|Did not meet inclusion criteria|1|||
145579489|NCT00441337|524975425|FG003|Overall Study|Did not meet inclusion criteria|0|||
145579490|NCT01818336|524977038|FG000|Overall Study|Declined retest visit|0|||
145579491|NCT01818336|524977039|FG001|Overall Study|Declined retest visit|11|||
145579492|NCT01818336|524977038|FG000|Overall Study|Lost to Follow-up|0|||
145579493|NCT01818336|524977039|FG001|Overall Study|Lost to Follow-up|1|||
145579494|NCT03042312|524977042|FG000|Overall Study|Administrative Reason|1|||
145579495|NCT03042312|524977043|FG001|Overall Study|Administrative Reason|1|||
145579496|NCT03042312|524977042|FG000|Overall Study|Adverse Event|0|||
145579497|NCT03042312|524977043|FG001|Overall Study|Adverse Event|1|||
145579498|NCT03042312|524977042|FG000|Overall Study|Lost to Follow-up|1|||
145579499|NCT03042312|524977043|FG001|Overall Study|Lost to Follow-up|3|||
145579500|NCT03042312|524977042|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
145579501|NCT03042312|524977043|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
145579502|NCT03042312|524977042|FG000|Overall Study|Withdrawal by Subject|4|||
145579503|NCT03042312|524977043|FG001|Overall Study|Withdrawal by Subject|5|||
145579504|NCT02805257|524977048|FG000|Overall Study|Lost to Follow-up|7|||
145579505|NCT02805257|524977049|FG001|Overall Study|Lost to Follow-up|6|||
145579506|NCT02805257|524977048|FG000|Overall Study|Death|0|||
145579507|NCT02805257|524977049|FG001|Overall Study|Death|1|||
145579508|NCT01043874|524977051|FG000|Overall Study|Adverse Event|3|||
145579509|NCT01043874|524977051|FG000|Overall Study|Withdrawal by Subject|1|||
145579510|NCT01043874|524977051|FG000|Overall Study|Lack of Efficacy|1|||
145579511|NCT01043874|524977051|FG000|Overall Study|Administrative Problems|1|||
145579512|NCT01627249|524977057|FG000|Overall Study|Death|3|||
145579513|NCT01627249|524977058|FG001|Overall Study|Death|5|||
145579514|NCT01627249|524977059|FG002|Overall Study|Death|3|||
145579515|NCT01627249|524977057|FG000|Overall Study|Withdrawal by Subject|12|||
145579516|NCT01627249|524977058|FG001|Overall Study|Withdrawal by Subject|6|||
145579517|NCT01627249|524977059|FG002|Overall Study|Withdrawal by Subject|9|||
145579518|NCT01627249|524977057|FG000|Overall Study|Missed Visit|1|||
145579519|NCT01627249|524977058|FG001|Overall Study|Missed Visit|1|||
145579520|NCT01627249|524977059|FG002|Overall Study|Missed Visit|0|||
145579521|NCT03266588|524977060|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
145579522|NCT03266588|524977061|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
145579523|NCT03266588|524977062|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
145579524|NCT03266588|524977060|FG000|Observational Period|Withdrawal by Subject|44|||
145579525|NCT03266588|524977061|FG001|Observational Period|Withdrawal by Subject|22|||
145579526|NCT03266588|524977062|FG002|Observational Period|Withdrawal by Subject|13|||
145579527|NCT03266588|524977060|FG000|Observational Period|Non-compliance|18|||
145579528|NCT03266588|524977061|FG001|Observational Period|Non-compliance|12|||
145579529|NCT03266588|524977062|FG002|Observational Period|Non-compliance|10|||
145579530|NCT03266588|524977060|FG000|Observational Period|Lost to Follow-up|8|||
145579531|NCT03266588|524977061|FG001|Observational Period|Lost to Follow-up|12|||
145579532|NCT03266588|524977062|FG002|Observational Period|Lost to Follow-up|4|||
145579533|NCT03266588|524977060|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
145579534|NCT03266588|524977061|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
145579535|NCT03266588|524977062|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
145579536|NCT03266588|524977060|FG000|Observational Period|Protocol Deviation|1|||
145579537|NCT03266588|524977061|FG001|Observational Period|Protocol Deviation|0|||
145579538|NCT03266588|524977062|FG002|Observational Period|Protocol Deviation|0|||
145579539|NCT03266588|524977060|FG000|Observational Period|Other Reasons|3|||
145579540|NCT03266588|524977061|FG001|Observational Period|Other Reasons|0|||
145579541|NCT03266588|524977062|FG002|Observational Period|Other Reasons|1|||
145579542|NCT03266588|524977060|FG000|Long-term Treatment Period|Adverse Event|33|||
145579543|NCT03266588|524977061|FG001|Long-term Treatment Period|Adverse Event|17|||
145579544|NCT03266588|524977062|FG002|Long-term Treatment Period|Adverse Event|8|||
145579545|NCT03266588|524977060|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
145579546|NCT03266588|524977061|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
145579547|NCT03266588|524977062|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
145579548|NCT03266588|524977060|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
145262916|NCT01265511|523808557|FG001|Overall Study|Met stopping rules|2|||
145579549|NCT03266588|524977061|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
145579550|NCT03266588|524977062|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
145579551|NCT03266588|524977060|FG000|Long-term Treatment Period|Non-Compliance|126|||
145623510|NCT00994279|525133962|FG000|Overall Study|Withdrawal by Subject|2|||
145623511|NCT00994279|525133963|FG001|Overall Study|Withdrawal by Subject|2|||
145262917|NCT00323479|523808560|FG000|Overall Study|Adverse Event|2|||
145262918|NCT00323479|523808560|FG000|Overall Study|Withdrawal by Subject|2|||
145579552|NCT03266588|524977061|FG001|Long-term Treatment Period|Non-Compliance|57|||
145579553|NCT03266588|524977062|FG002|Long-term Treatment Period|Non-Compliance|7|||
145579554|NCT03266588|524977060|FG000|Long-term Treatment Period|Pregnancy|11|||
145579555|NCT03266588|524977061|FG001|Long-term Treatment Period|Pregnancy|5|||
145579556|NCT03266588|524977062|FG002|Long-term Treatment Period|Pregnancy|0|||
145579557|NCT03266588|524977060|FG000|Long-term Treatment Period|Protocol Deviation|17|||
145579558|NCT03266588|524977061|FG001|Long-term Treatment Period|Protocol Deviation|10|||
145579559|NCT03266588|524977062|FG002|Long-term Treatment Period|Protocol Deviation|4|||
145579560|NCT03266588|524977060|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
145579561|NCT03266588|524977061|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
145579562|NCT03266588|524977062|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
145579563|NCT03266588|524977060|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
145579564|NCT03266588|524977061|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
145579565|NCT03266588|524977062|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
145579566|NCT03266588|524977060|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
145579567|NCT03266588|524977061|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
145579568|NCT03266588|524977062|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
145579569|NCT03266588|524977060|FG000|Long-term Treatment Period|Other Reasons|5|||
145579570|NCT03266588|524977061|FG001|Long-term Treatment Period|Other Reasons|0|||
145262919|NCT00323479|523808560|FG000|Overall Study|Protocol Violation|3|||
145262920|NCT00323479|523808560|FG000|Overall Study|house moving|1|||
145262921|NCT01362062|523808561|FG000|Overall Study|Adverse Event|1|||
145262922|NCT01362062|523808562|FG001|Overall Study|Adverse Event|0|||
145262923|NCT01362062|523808561|FG000|Overall Study|Lost to Follow-up|11|||
145262924|NCT01362062|523808562|FG001|Overall Study|Lost to Follow-up|0|||
145262925|NCT01362062|523808561|FG000|Overall Study|Withdrawal by Subject|2|||
145262926|NCT01362062|523808562|FG001|Overall Study|Withdrawal by Subject|0|||
145262927|NCT01362062|523808561|FG000|Overall Study|Non-compliant participant|2|||
145579571|NCT03266588|524977062|FG002|Long-term Treatment Period|Other Reasons|0|||
145579572|NCT03266588|524977060|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
145579573|NCT03266588|524977061|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
145579574|NCT03266588|524977062|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
145579575|NCT03087591|524977063|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
145262928|NCT01362062|523808562|FG001|Overall Study|Non-compliant participant|0|||
145262929|NCT01362062|523808561|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
145262930|NCT01362062|523808562|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
145262931|NCT01362062|523808561|FG000|Overall Study|Had significant improvement|9|||
145262932|NCT01362062|523808562|FG001|Overall Study|Had significant improvement|0|||
145262933|NCT02545504|523808565|FG000|Overall Study|Death|174|||
145262934|NCT02545504|523808566|FG001|Overall Study|Death|168|||
145262935|NCT02545504|523808565|FG000|Overall Study|Unknown reason|30|||
145262936|NCT02545504|523808566|FG001|Overall Study|Unknown reason|32|||
145262937|NCT02545504|523808565|FG000|Overall Study|Withdrew consent|9|||
145262938|NCT02545504|523808566|FG001|Overall Study|Withdrew consent|11|||
145262939|NCT02545504|523808565|FG000|Overall Study|Investigator's discretion|3|||
145262940|NCT02545504|523808566|FG001|Overall Study|Investigator's discretion|1|||
145262941|NCT02545504|523808565|FG000|Overall Study|Lost to Follow-up|2|||
145262942|NCT02545504|523808566|FG001|Overall Study|Lost to Follow-up|2|||
145579576|NCT03087591|524977063|FG000|Overall Study|Withdrawal by Subject|1|||
145579577|NCT00982319|524977072|FG000|Overall Study|Surgery date change|1|||
145579578|NCT00982319|524977073|FG001|Overall Study|Surgery date change|0|||
145579579|NCT00982319|524977072|FG000|Overall Study|Preop values out of acceptable range|1|||
145372108|NCT01104246|524211092|FG000|Overall Study|Withdrawal by Subject|1|||
145372109|NCT01104246|524211092|FG000|Overall Study|did not meet inclusion criteria|4|||
145372110|NCT05178641|524211093|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
145372111|NCT05178641|524211094|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
145372112|NCT05178641|524211093|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
145372113|NCT05178641|524211094|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
145372114|NCT01083186|524211096|FG000|Overall Study|Lost to Follow-up|48|||
145372115|NCT01083186|524211096|FG000|Overall Study|Consent Withdrawal|7|||
145372116|NCT01083186|524211096|FG000|Overall Study|Death|3|||
145372117|NCT01083186|524211096|FG000|Overall Study|Adverse Event|3|||
145372118|NCT01083186|524211096|FG000|Overall Study|Lack of Efficacy|2|||
145372119|NCT01083186|524211096|FG000|Overall Study|Hemodialysis Initiation|28|||
145372120|NCT01083186|524211096|FG000|Overall Study|Administrative Reasons|2|||
145372121|NCT01083186|524211096|FG000|Overall Study|Non-compliance to Study Treatment|1|||
145372122|NCT03843632|524211098|FG000|Overall Study|Withdrawal by Subject|1|||
145372123|NCT03843632|524211099|FG001|Overall Study|Withdrawal by Subject|0|||
145372124|NCT03843632|524211100|FG002|Overall Study|Withdrawal by Subject|0|||
145372125|NCT03843632|524211101|FG003|Overall Study|Withdrawal by Subject|0|||
145372126|NCT03403751|524211102|FG000|Overall Study|Death|5|||
145372127|NCT03403751|524211103|FG001|Overall Study|Death|6|||
145372128|NCT03403751|524211102|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
145425123|NCT04091438|524412975|FG001|Washout Period (1 Day)|Other|1|||
145262943|NCT00967343|523808567|FG000|Overall Study|Study termination by sponsor|12|||
145262944|NCT00967343|523808567|FG000|Overall Study|Death|24|||
145262945|NCT00967343|523808567|FG000|Overall Study|Relapse|1|||
145262946|NCT00967343|523808567|FG000|Overall Study|Lost to Follow-up|1|||
145262947|NCT03044730|523808569|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
145262948|NCT03044730|523808569|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
145262949|NCT03044730|523808569|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
145262950|NCT03044730|523808569|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
145262951|NCT03044730|523808569|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
145262952|NCT03044730|523808569|FG000|Cycles 4 and Beyond|Adverse Event|1|||
145262953|NCT03044730|523808569|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
145262954|NCT03044730|523808569|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
145262955|NCT03044730|523808569|FG000|On Follow-up for 2 Years|Death|17|||
145262956|NCT00508820|523808570|FG000|Overall Study|Adverse Event|6|||
145262957|NCT00508820|523808571|FG001|Overall Study|Adverse Event|10|||
145262958|NCT00508820|523808570|FG000|Overall Study|Death|6|||
145262959|NCT00508820|523808571|FG001|Overall Study|Death|8|||
145262960|NCT00508820|523808570|FG000|Overall Study|Lost to Follow-up|1|||
145262961|NCT00508820|523808571|FG001|Overall Study|Lost to Follow-up|1|||
145262962|NCT00508820|523808570|FG000|Overall Study|Physician Decision|8|||
145262963|NCT00508820|523808571|FG001|Overall Study|Physician Decision|2|||
145262964|NCT00508820|523808570|FG000|Overall Study|Pregnancy|0|||
145262965|NCT00508820|523808571|FG001|Overall Study|Pregnancy|2|||
145262966|NCT00508820|523808570|FG000|Overall Study|Protocol Violation|2|||
145262967|NCT00508820|523808571|FG001|Overall Study|Protocol Violation|0|||
145262968|NCT00508820|523808570|FG000|Overall Study|Withdrawal by Subject|10|||
145262969|NCT00508820|523808571|FG001|Overall Study|Withdrawal by Subject|12|||
145262970|NCT00508820|523808570|FG000|Overall Study|Other|11|||
145262971|NCT00508820|523808571|FG001|Overall Study|Other|2|||
145262972|NCT00508820|523808570|FG000|Overall Study|Noncompliance|1|||
145262973|NCT00508820|523808571|FG001|Overall Study|Noncompliance|0|||
145262974|NCT00508820|523808570|FG000|Overall Study|Requirement for alternative therapy|7|||
145262975|NCT00508820|523808571|FG001|Overall Study|Requirement for alternative therapy|15|||
145262976|NCT00508820|523808570|FG000|Overall Study|Protocol-specified Criteria|3|||
145262977|NCT00508820|523808571|FG001|Overall Study|Protocol-specified Criteria|12|||
145262978|NCT01018680|523810061|FG000|Overall Study|Adverse Event|23|||
145262979|NCT01018680|523810062|FG001|Overall Study|Adverse Event|40|||
145262980|NCT01018680|523810061|FG000|Overall Study|Withdrawal by Subject|10|||
145262981|NCT01018680|523810062|FG001|Overall Study|Withdrawal by Subject|10|||
145262982|NCT01018680|523810061|FG000|Overall Study|Protocol Violation|5|||
145262983|NCT01018680|523810062|FG001|Overall Study|Protocol Violation|8|||
145262984|NCT01018680|523810061|FG000|Overall Study|Sponsor Decision|6|||
145262985|NCT01018680|523810062|FG001|Overall Study|Sponsor Decision|7|||
145262986|NCT01018680|523810061|FG000|Overall Study|Lack of Efficacy|8|||
145262987|NCT01018680|523810062|FG001|Overall Study|Lack of Efficacy|2|||
145262988|NCT01018680|523810061|FG000|Overall Study|Lost to Follow-up|5|||
145262989|NCT01018680|523810062|FG001|Overall Study|Lost to Follow-up|3|||
145262990|NCT01018680|523810061|FG000|Overall Study|Entry Criteria Not Met|1|||
145262991|NCT01018680|523810062|FG001|Overall Study|Entry Criteria Not Met|4|||
145262992|NCT01018680|523810061|FG000|Overall Study|Physician Decision|3|||
145262993|NCT01018680|523810062|FG001|Overall Study|Physician Decision|1|||
145262994|NCT02930889|523810063|FG000|Overall Study|Lost to Follow-up|2|||
145262995|NCT02930889|523810063|FG000|Overall Study|Withdrawal by Subject|6|||
145262996|NCT02930889|523810063|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
145262997|NCT04398030|523810064|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
145262998|NCT04398030|523810065|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
145262999|NCT04398030|523810064|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
145263000|NCT04398030|523810065|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
145263001|NCT01674010|523810066|FG000|Open Treatment Phase 1|Adverse Event|10|||
145263002|NCT01674010|523810067|FG001|Open Treatment Phase 1|Adverse Event|0|||
145263003|NCT01674010|523810068|FG002|Open Treatment Phase 1|Adverse Event|0|||
145263004|NCT01674010|523810066|FG000|Open Treatment Phase 1|Death|1|||
145263005|NCT01674010|523810067|FG001|Open Treatment Phase 1|Death|0|||
145263006|NCT01674010|523810068|FG002|Open Treatment Phase 1|Death|0|||
145263007|NCT01674010|523810066|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
145263008|NCT01674010|523810067|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
145263009|NCT01674010|523810068|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
145263010|NCT01674010|523810066|FG000|Open Treatment Phase 1|Physician Decision|9|||
145263011|NCT01674010|523810067|FG001|Open Treatment Phase 1|Physician Decision|0|||
145263012|NCT01674010|523810068|FG002|Open Treatment Phase 1|Physician Decision|0|||
145263013|NCT01674010|523810066|FG000|Open Treatment Phase 1|Protocol Violation|7|||
145263014|NCT01674010|523810067|FG001|Open Treatment Phase 1|Protocol Violation|0|||
145263015|NCT01674010|523810068|FG002|Open Treatment Phase 1|Protocol Violation|0|||
145263016|NCT01674010|523810066|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
145263017|NCT01674010|523810067|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
145263018|NCT01674010|523810068|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
145263019|NCT01674010|523810066|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
145263020|NCT01674010|523810067|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
145623512|NCT00994279|525133962|FG000|Overall Study|Toxicity|1|||
145372129|NCT03403751|524211103|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
145372130|NCT05036668|524211106|FG000|Overall Study|lost to follow Up|0|||
145372131|NCT05036668|524211107|FG001|Overall Study|lost to follow Up|0|||
145372132|NCT05036668|524211108|FG002|Overall Study|lost to follow Up|1|||
145372133|NCT02272842|524211109|FG000|Overall Study|Lost to Follow-up|8|||
145372134|NCT02272842|524211110|FG001|Overall Study|Lost to Follow-up|8|||
145372135|NCT02272842|524211109|FG000|Overall Study|Withdrawal by Subject|8|||
145372136|NCT02272842|524211110|FG001|Overall Study|Withdrawal by Subject|2|||
145372137|NCT02424630|524213103|FG000|Overall Study|No rotator cuff tear|1|||
145372138|NCT02424630|524213104|FG001|Overall Study|No rotator cuff tear|2|||
145372139|NCT02424630|524213103|FG000|Overall Study|Open procedure|0|||
145372140|NCT02424630|524213104|FG001|Overall Study|Open procedure|1|||
145372141|NCT02637895|524213105|FG000|Overall Study|Lost to Follow-up|4|||
145372142|NCT02637895|524213106|FG001|Overall Study|Lost to Follow-up|0|||
145372143|NCT02637895|524213105|FG000|Overall Study|Protocol Violation|0|||
145372144|NCT02637895|524213106|FG001|Overall Study|Protocol Violation|1|||
145372145|NCT02637895|524213105|FG000|Overall Study|Lack of Efficacy|1|||
145372146|NCT02637895|524213106|FG001|Overall Study|Lack of Efficacy|0|||
145372147|NCT02637895|524213105|FG000|Overall Study|Withdrawal by Subject|1|||
145372148|NCT02637895|524213106|FG001|Overall Study|Withdrawal by Subject|1|||
145372149|NCT02637895|524213105|FG000|Overall Study|Abnormal baseline lab|0|||
145372150|NCT02637895|524213106|FG001|Overall Study|Abnormal baseline lab|1|||
145372151|NCT00761280|524213107|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
145372152|NCT00761280|524213108|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
145372153|NCT00761280|524213107|FG000|Randomization to First Dose|Sponsor decision|1|||
145372154|NCT00761280|524213108|FG001|Randomization to First Dose|Sponsor decision|0|||
145372155|NCT00761280|524213107|FG000|Randomization to First Dose|Other|1|||
145372156|NCT00761280|524213108|FG001|Randomization to First Dose|Other|0|||
145372157|NCT00761280|524213107|FG000|First Dose to End of Study|End of trial|5|||
145372158|NCT00761280|524213108|FG001|First Dose to End of Study|End of trial|5|||
145372159|NCT00761280|524213107|FG000|First Dose to End of Study|Progressive disease|5|||
145372160|NCT00761280|524213108|FG001|First Dose to End of Study|Progressive disease|3|||
145372161|NCT00761280|524213107|FG000|First Dose to End of Study|Sponsor decision|1|||
145372162|NCT00761280|524213108|FG001|First Dose to End of Study|Sponsor decision|2|||
145372163|NCT00761280|524213107|FG000|First Dose to End of Study|Death|1|||
145372164|NCT00761280|524213108|FG001|First Dose to End of Study|Death|0|||
145372165|NCT00761280|524213107|FG000|First Dose to End of Study|Lost to Follow-up|0|||
145372166|NCT00761280|524213108|FG001|First Dose to End of Study|Lost to Follow-up|1|||
145372167|NCT01346189|524213112|FG000|Overall Study|Withdrawal by Subject|7|||
145372168|NCT01346189|524213113|FG001|Overall Study|Withdrawal by Subject|5|||
145372169|NCT01346189|524213114|FG002|Overall Study|Withdrawal by Subject|3|||
145372170|NCT01346189|524213115|FG003|Overall Study|Withdrawal by Subject|5|||
145372171|NCT01346189|524213112|FG000|Overall Study|Physician Decision|4|||
145372172|NCT01346189|524213113|FG001|Overall Study|Physician Decision|0|||
145372173|NCT01346189|524213114|FG002|Overall Study|Physician Decision|0|||
145372174|NCT01346189|524213115|FG003|Overall Study|Physician Decision|0|||
145372175|NCT01346189|524213112|FG000|Overall Study|Moved|3|||
145372176|NCT01346189|524213113|FG001|Overall Study|Moved|0|||
145372177|NCT01346189|524213114|FG002|Overall Study|Moved|4|||
145372178|NCT01346189|524213115|FG003|Overall Study|Moved|0|||
145372179|NCT01346189|524213112|FG000|Overall Study|Other|2|||
145372180|NCT01346189|524213113|FG001|Overall Study|Other|4|||
145372181|NCT01346189|524213114|FG002|Overall Study|Other|7|||
145372182|NCT01346189|524213115|FG003|Overall Study|Other|3|||
145372183|NCT01346189|524213112|FG000|Overall Study|Death|0|||
145372184|NCT01346189|524213113|FG001|Overall Study|Death|3|||
145372185|NCT01346189|524213114|FG002|Overall Study|Death|0|||
145372186|NCT01346189|524213115|FG003|Overall Study|Death|0|||
145372187|NCT01346189|524213112|FG000|Overall Study|Non-health system primary care physician|0|||
145372188|NCT01346189|524213113|FG001|Overall Study|Non-health system primary care physician|5|||
145372189|NCT01346189|524213114|FG002|Overall Study|Non-health system primary care physician|0|||
145372190|NCT01346189|524213115|FG003|Overall Study|Non-health system primary care physician|0|||
145372191|NCT01346189|524213112|FG000|Overall Study|Travel|0|||
145372192|NCT01346189|524213113|FG001|Overall Study|Travel|0|||
145372193|NCT01346189|524213114|FG002|Overall Study|Travel|0|||
145372194|NCT01346189|524213115|FG003|Overall Study|Travel|3|||
145372195|NCT00177307|524213120|FG000|Overall Study|Withdrawal by Subject|1|||
145372196|NCT03729570|524213125|FG000|Overall Study|Lost to Follow-up|16|||
145372197|NCT03729570|524213126|FG001|Overall Study|Lost to Follow-up|20|||
145372198|NCT03729570|524213125|FG000|Overall Study|Seroconversion|5|||
145372199|NCT03729570|524213126|FG001|Overall Study|Seroconversion|0|||
145372200|NCT03729570|524213125|FG000|Overall Study|Moved out of the city|1|||
145372201|NCT03729570|524213126|FG001|Overall Study|Moved out of the city|0|||
145372202|NCT03729570|524213125|FG000|Overall Study|Time Conflict|1|||
145372203|NCT03729570|524213126|FG001|Overall Study|Time Conflict|0|||
145372204|NCT03729570|524213125|FG000|Overall Study|Time Commitment|2|||
145372205|NCT03729570|524213126|FG001|Overall Study|Time Commitment|0|||
145263021|NCT01674010|523810068|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
145263022|NCT01674010|523810066|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
145263023|NCT01674010|523810067|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
145263024|NCT01674010|523810068|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
145263025|NCT01674010|523810066|FG000|Randomization Phase 2|Adverse Event|0|||
145263026|NCT01674010|523810067|FG001|Randomization Phase 2|Adverse Event|1|||
145263027|NCT01674010|523810068|FG002|Randomization Phase 2|Adverse Event|1|||
145263028|NCT01674010|523810066|FG000|Randomization Phase 2|Lost to Follow-up|0|||
145263029|NCT01674010|523810067|FG001|Randomization Phase 2|Lost to Follow-up|1|||
145263030|NCT01674010|523810068|FG002|Randomization Phase 2|Lost to Follow-up|2|||
145263031|NCT01674010|523810066|FG000|Randomization Phase 2|Mood episode recurrence|0|||
145263032|NCT01674010|523810067|FG001|Randomization Phase 2|Mood episode recurrence|8|||
145263033|NCT01674010|523810068|FG002|Randomization Phase 2|Mood episode recurrence|2|||
145263034|NCT01674010|523810066|FG000|Randomization Phase 2|Physician Decision|0|||
145263035|NCT01674010|523810067|FG001|Randomization Phase 2|Physician Decision|0|||
145263036|NCT01674010|523810068|FG002|Randomization Phase 2|Physician Decision|2|||
145263037|NCT01674010|523810066|FG000|Randomization Phase 2|Pregnancy|0|||
145263038|NCT01674010|523810067|FG001|Randomization Phase 2|Pregnancy|1|||
145263039|NCT01674010|523810068|FG002|Randomization Phase 2|Pregnancy|1|||
145263040|NCT01674010|523810066|FG000|Randomization Phase 2|Protocol Violation|0|||
145263041|NCT01674010|523810067|FG001|Randomization Phase 2|Protocol Violation|1|||
145263042|NCT01674010|523810068|FG002|Randomization Phase 2|Protocol Violation|1|||
145263043|NCT01674010|523810066|FG000|Randomization Phase 2|Sponsor Decision|0|||
145263044|NCT01674010|523810067|FG001|Randomization Phase 2|Sponsor Decision|42|||
145263045|NCT01674010|523810068|FG002|Randomization Phase 2|Sponsor Decision|45|||
145263046|NCT01674010|523810066|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
145263047|NCT01674010|523810067|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
145263048|NCT01674010|523810068|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
145263049|NCT03159455|523810071|FG000|Overall Study|Adverse Event|0|||
145263050|NCT03159455|523810072|FG001|Overall Study|Adverse Event|0|||
145263051|NCT03159455|523810073|FG002|Overall Study|Adverse Event|0|||
145263052|NCT03159455|523810074|FG003|Overall Study|Adverse Event|0|||
145263053|NCT03159455|523810075|FG004|Overall Study|Adverse Event|0|||
145263054|NCT03159455|523810076|FG005|Overall Study|Adverse Event|1|||
145263055|NCT05056311|523810077|FG000|Overall Study|Lost to Follow-up|14|||
145263056|NCT05056311|523810077|FG000|Overall Study|Withdrawal by Subject|1|||
145263057|NCT05056311|523810077|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
145263058|NCT02713490|523810081|FG000|Overall Study|Withdrawal by Subject|2|||
145263059|NCT02713490|523810082|FG001|Overall Study|Withdrawal by Subject|1|||
145263060|NCT02713490|523810081|FG000|Overall Study|Did not receive study drug|1|||
145263061|NCT02713490|523810082|FG001|Overall Study|Did not receive study drug|0|||
145263062|NCT02713490|523810081|FG000|Overall Study|Met exclusion criteria|0|||
145263063|NCT02713490|523810082|FG001|Overall Study|Met exclusion criteria|1|||
145263064|NCT03799198|523810083|FG000|Overall Study|Lost to Follow-up|4|||
145263065|NCT03799198|523810084|FG001|Overall Study|Lost to Follow-up|8|||
145263066|NCT03799198|523810083|FG000|Overall Study|Death|0|||
145263067|NCT03799198|523810084|FG001|Overall Study|Death|1|||
145263068|NCT00960869|523810085|FG000|Overall Study|Adverse Event|17|||
145263069|NCT00960869|523810086|FG001|Overall Study|Adverse Event|26|||
145263070|NCT00960869|523810085|FG000|Overall Study|Withdrawal by Subject|16|||
145263071|NCT00960869|523810086|FG001|Overall Study|Withdrawal by Subject|14|||
145263072|NCT00960869|523810085|FG000|Overall Study|Lost to Follow-up|1|||
145263073|NCT00960869|523810086|FG001|Overall Study|Lost to Follow-up|4|||
145263074|NCT00960869|523810085|FG000|Overall Study|Misc|19|||
145263075|NCT00960869|523810086|FG001|Overall Study|Misc|18|||
145579580|NCT00982319|524977073|FG001|Overall Study|Preop values out of acceptable range|1|||
145579581|NCT00982319|524977072|FG000|Overall Study|Pregnancy|0|||
145263076|NCT01714726|523810087|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
145263077|NCT01714726|523810088|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
145263078|NCT01714726|523810089|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
145263079|NCT01714726|523810090|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
145579582|NCT00982319|524977073|FG001|Overall Study|Pregnancy|1|||
145579583|NCT03614793|524977075|FG000|Overall Study|Lost to Follow-up|1|||
145579584|NCT03614793|524977076|FG001|Overall Study|Lost to Follow-up|2|||
145579585|NCT03614793|524977075|FG000|Overall Study|Lack of Efficacy|0|||
145579586|NCT03614793|524977076|FG001|Overall Study|Lack of Efficacy|5|||
145579587|NCT03614793|524977075|FG000|Overall Study|Withdrawal by Subject|0|||
145263080|NCT01714726|523810087|FG000|Double-Blinded Induction Period|Adverse Event|0|||
145263081|NCT01714726|523810088|FG001|Double-Blinded Induction Period|Adverse Event|1|||
145263082|NCT01714726|523810089|FG002|Double-Blinded Induction Period|Adverse Event|0|||
145263083|NCT01714726|523810090|FG003|Double-Blinded Induction Period|Adverse Event|0|||
145263084|NCT01714726|523810087|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
145263085|NCT01714726|523810088|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
145372206|NCT03729570|524213125|FG000|Overall Study|Bad Experience|0|||
145579588|NCT03614793|524977076|FG001|Overall Study|Withdrawal by Subject|1|||
145263086|NCT01714726|523810089|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
145263087|NCT01714726|523810090|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
145263088|NCT01714726|523810087|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
145263089|NCT01714726|523810088|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
145263090|NCT01714726|523810089|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
145263091|NCT01714726|523810090|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
145263092|NCT01714726|523810087|FG000|Open-Label Period|Other|0|||
145263093|NCT01714726|523810088|FG001|Open-Label Period|Other|0|||
145263094|NCT01714726|523810089|FG002|Open-Label Period|Other|1|||
145263095|NCT01714726|523810090|FG003|Open-Label Period|Other|3|||
145263096|NCT01714726|523810087|FG000|Open-Label Period|Adverse Event|0|||
145263097|NCT01714726|523810088|FG001|Open-Label Period|Adverse Event|0|||
145263098|NCT01714726|523810089|FG002|Open-Label Period|Adverse Event|1|||
145263099|NCT01714726|523810090|FG003|Open-Label Period|Adverse Event|0|||
145263100|NCT01714726|523810087|FG000|Open-Label Period|Withdrawal by Subject|0|||
145263101|NCT01714726|523810088|FG001|Open-Label Period|Withdrawal by Subject|0|||
145263102|NCT01714726|523810089|FG002|Open-Label Period|Withdrawal by Subject|9|||
145263103|NCT01714726|523810090|FG003|Open-Label Period|Withdrawal by Subject|19|||
145263104|NCT01714726|523810087|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
145263105|NCT01714726|523810088|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
145263106|NCT01714726|523810089|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
145263107|NCT01714726|523810090|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
145263108|NCT01714726|523810087|FG000|Open-Label Period|Lost to Follow-up|0|||
145263109|NCT01714726|523810088|FG001|Open-Label Period|Lost to Follow-up|0|||
145263110|NCT01714726|523810089|FG002|Open-Label Period|Lost to Follow-up|3|||
145263111|NCT01714726|523810090|FG003|Open-Label Period|Lost to Follow-up|4|||
145263112|NCT02501642|523810091|FG000|Overall Study|Lost to Follow-up|7|||
145263113|NCT02501642|523810092|FG001|Overall Study|Lost to Follow-up|11|||
145263114|NCT00548340|523810095|FG000|Overall Study|Protocol Violation|2|||
145263115|NCT00548340|523810096|FG001|Overall Study|Protocol Violation|3|||
145263116|NCT00548340|523810097|FG002|Overall Study|Protocol Violation|3|||
145263117|NCT00548340|523810095|FG000|Overall Study|Adverse Event|2|||
145263118|NCT00548340|523810096|FG001|Overall Study|Adverse Event|2|||
145263119|NCT00548340|523810097|FG002|Overall Study|Adverse Event|2|||
145263120|NCT00548340|523810095|FG000|Overall Study|Lost to Follow-up|1|||
145263121|NCT00548340|523810096|FG001|Overall Study|Lost to Follow-up|1|||
145263122|NCT00548340|523810097|FG002|Overall Study|Lost to Follow-up|0|||
145263123|NCT00548340|523810095|FG000|Overall Study|Withdrawal by Subject|2|||
145263124|NCT00548340|523810096|FG001|Overall Study|Withdrawal by Subject|4|||
145263125|NCT00548340|523810097|FG002|Overall Study|Withdrawal by Subject|3|||
145263126|NCT00548340|523810095|FG000|Overall Study|Other|1|||
145263127|NCT00548340|523810096|FG001|Overall Study|Other|1|||
145263128|NCT00548340|523810097|FG002|Overall Study|Other|1|||
145263129|NCT01846442|523810098|FG000|Overall Study|Adverse Event|2|||
145263130|NCT01846442|523810099|FG001|Overall Study|Adverse Event|4|||
145263131|NCT01846442|523810100|FG002|Overall Study|Adverse Event|2|||
145263132|NCT01846442|523810101|FG003|Overall Study|Adverse Event|1|||
145263133|NCT01846442|523810098|FG000|Overall Study|Lost to Follow-up|0|||
145263134|NCT01846442|523810099|FG001|Overall Study|Lost to Follow-up|0|||
145263135|NCT01846442|523810100|FG002|Overall Study|Lost to Follow-up|1|||
145263136|NCT01846442|523810101|FG003|Overall Study|Lost to Follow-up|0|||
145263137|NCT01846442|523810098|FG000|Overall Study|Withdrawal by Subject|3|||
145263138|NCT01846442|523810099|FG001|Overall Study|Withdrawal by Subject|2|||
145263139|NCT01846442|523810100|FG002|Overall Study|Withdrawal by Subject|0|||
145263140|NCT01846442|523810101|FG003|Overall Study|Withdrawal by Subject|1|||
145263141|NCT01846442|523810098|FG000|Overall Study|Left the city/Lost medication|1|||
145263142|NCT01846442|523810099|FG001|Overall Study|Left the city/Lost medication|0|||
145263143|NCT01846442|523810100|FG002|Overall Study|Left the city/Lost medication|1|||
145263144|NCT01846442|523810101|FG003|Overall Study|Left the city/Lost medication|1|||
145263145|NCT02600559|523810108|FG000|Overall Study|Withdrawal by Subject|3|||
145263146|NCT02600559|523810108|FG000|Overall Study|Lost to Follow-up|20|||
145263147|NCT01153971|523810111|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
145263148|NCT01153971|523810111|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
145263149|NCT01153971|523810111|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
145263150|NCT01153971|523810111|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
145263151|NCT01153971|523810111|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
145263152|NCT01153971|523810111|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
145263153|NCT01153971|523810111|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
145263154|NCT03628781|523810112|FG000|Overall Study|Lost to Follow-up|16|||
145263155|NCT03628781|523810113|FG001|Overall Study|Lost to Follow-up|8|||
145263156|NCT03628781|523810112|FG000|Overall Study|Withdrawal by Subject|16|||
145263157|NCT03628781|523810113|FG001|Overall Study|Withdrawal by Subject|1|||
145263158|NCT00379639|523810114|FG000|Overall Study|Disease Progression|3|||
145263159|NCT00379639|523810115|FG001|Overall Study|Disease Progression|3|||
145263160|NCT00379639|523810116|FG002|Overall Study|Disease Progression|3|||
145263161|NCT00379639|523810117|FG003|Overall Study|Disease Progression|4|||
145579589|NCT03614793|524977075|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
145579590|NCT03614793|524977076|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
145579591|NCT02496884|524977077|FG000|Overall Study|Counted twice as enrolled|2|||
145579592|NCT02496884|524977078|FG001|Overall Study|Counted twice as enrolled|0|||
145579593|NCT02496884|524977079|FG002|Overall Study|Counted twice as enrolled|0|||
145579594|NCT02496884|524977080|FG003|Overall Study|Counted twice as enrolled|0|||
145579595|NCT02496884|524977077|FG000|Overall Study|Withdrawal by Subject|0|||
145579596|NCT02496884|524977078|FG001|Overall Study|Withdrawal by Subject|3|||
145579597|NCT02496884|524977079|FG002|Overall Study|Withdrawal by Subject|0|||
145579598|NCT02496884|524977080|FG003|Overall Study|Withdrawal by Subject|0|||
145579599|NCT00097591|524977081|FG000|Overall Study|Withdrawal of consent|342|||
145579600|NCT00097591|524977082|FG001|Overall Study|Withdrawal of consent|323|||
145579601|NCT00097591|524977081|FG000|Overall Study|Less than 6 months on study drug|9|||
145579602|NCT00097591|524977082|FG001|Overall Study|Less than 6 months on study drug|7|||
145579603|NCT00097591|524977081|FG000|Overall Study|Unable to attend termination visit|53|||
145579604|NCT00097591|524977082|FG001|Overall Study|Unable to attend termination visit|51|||
145579605|NCT00097591|524977081|FG000|Overall Study|Lost to follow up|6|||
145579606|NCT00097591|524977082|FG001|Overall Study|Lost to follow up|10|||
145579607|NCT00097591|524977081|FG000|Overall Study|Other|0|||
145579608|NCT00097591|524977082|FG001|Overall Study|Other|3|||
145579609|NCT01168999|524977087|FG000|Overall Study|Lost to Follow-up|2|||
145263162|NCT00379639|523810118|FG004|Overall Study|Disease Progression|4|||
145263163|NCT00379639|523810114|FG000|Overall Study|Physician Decision|0|||
145263164|NCT00379639|523810115|FG001|Overall Study|Physician Decision|2|||
145263165|NCT00379639|523810116|FG002|Overall Study|Physician Decision|1|||
145263166|NCT00379639|523810117|FG003|Overall Study|Physician Decision|1|||
145263167|NCT00379639|523810118|FG004|Overall Study|Physician Decision|0|||
145263168|NCT00379639|523810114|FG000|Overall Study|Symptomatic Deterioration|0|||
145263169|NCT00379639|523810115|FG001|Overall Study|Symptomatic Deterioration|0|||
145263170|NCT00379639|523810116|FG002|Overall Study|Symptomatic Deterioration|1|||
145263171|NCT00379639|523810117|FG003|Overall Study|Symptomatic Deterioration|0|||
145263172|NCT00379639|523810118|FG004|Overall Study|Symptomatic Deterioration|1|||
145263173|NCT00379639|523810114|FG000|Overall Study|Adverse Event|0|||
145263174|NCT00379639|523810115|FG001|Overall Study|Adverse Event|0|||
145263175|NCT00379639|523810116|FG002|Overall Study|Adverse Event|1|||
145263176|NCT00379639|523810117|FG003|Overall Study|Adverse Event|0|||
145263177|NCT00379639|523810118|FG004|Overall Study|Adverse Event|1|||
145263178|NCT00379639|523810114|FG000|Overall Study|Lost to Follow-up|0|||
145263179|NCT00379639|523810115|FG001|Overall Study|Lost to Follow-up|0|||
145263180|NCT00379639|523810116|FG002|Overall Study|Lost to Follow-up|0|||
145263181|NCT00379639|523810117|FG003|Overall Study|Lost to Follow-up|1|||
145263182|NCT00379639|523810118|FG004|Overall Study|Lost to Follow-up|0|||
145263183|NCT00379639|523810114|FG000|Overall Study|Other|0|||
145263184|NCT00379639|523810115|FG001|Overall Study|Other|0|||
145263185|NCT00379639|523810116|FG002|Overall Study|Other|3|||
145263186|NCT00379639|523810117|FG003|Overall Study|Other|0|||
145263187|NCT00379639|523810118|FG004|Overall Study|Other|0|||
145263188|NCT03053102|523810121|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
145263189|NCT03053102|523810121|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
145263190|NCT01798056|523810122|FG000|Overall Study|Serious Adverse Event|13|||
145263191|NCT01798056|523810123|FG001|Overall Study|Serious Adverse Event|12|||
145263192|NCT01798056|523810122|FG000|Overall Study|Withdrawal by Subject|12|||
145263193|NCT01798056|523810123|FG001|Overall Study|Withdrawal by Subject|9|||
145263194|NCT01798056|523810122|FG000|Overall Study|Migrated/moved from study area|1|||
145263195|NCT01798056|523810123|FG001|Overall Study|Migrated/moved from study area|1|||
145263196|NCT01798056|523810122|FG000|Overall Study|Lost to Follow-up|1|||
145263197|NCT01798056|523810123|FG001|Overall Study|Lost to Follow-up|1|||
145263198|NCT01798056|523810122|FG000|Overall Study|Other|0|||
145579610|NCT01168999|524977088|FG001|Overall Study|Lost to Follow-up|1|||
145579611|NCT01168999|524977089|FG002|Overall Study|Lost to Follow-up|0|||
145579612|NCT01168999|524977090|FG003|Overall Study|Lost to Follow-up|0|||
145579613|NCT04317586|524977091|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
145579614|NCT04317586|524977091|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
145579615|NCT01276327|524977092|FG000|Overall Study|Adverse Event|1|||
145263199|NCT01798056|523810123|FG001|Overall Study|Other|2|||
145263200|NCT01238861|523810126|FG000|Overall Study|Lost to Follow-up|4|||
145263201|NCT01238861|523810127|FG001|Overall Study|Lost to Follow-up|2|||
145263202|NCT01238861|523810128|FG002|Overall Study|Lost to Follow-up|3|||
145263203|NCT01238861|523810129|FG003|Overall Study|Lost to Follow-up|1|||
145263204|NCT01238861|523810130|FG004|Overall Study|Lost to Follow-up|1|||
145263205|NCT01238861|523810131|FG005|Overall Study|Lost to Follow-up|2|||
145263206|NCT01238861|523810126|FG000|Overall Study|Unplanned surgery|1|||
145263207|NCT01238861|523810127|FG001|Overall Study|Unplanned surgery|0|||
145579616|NCT01276327|524977093|FG001|Overall Study|Adverse Event|3|||
145579617|NCT01276327|524977092|FG000|Overall Study|Withdrawal by Subject|1|||
145263208|NCT01238861|523810128|FG002|Overall Study|Unplanned surgery|0|||
145263209|NCT01238861|523810129|FG003|Overall Study|Unplanned surgery|0|||
145263210|NCT01238861|523810130|FG004|Overall Study|Unplanned surgery|0|||
145263211|NCT01238861|523810131|FG005|Overall Study|Unplanned surgery|0|||
145263212|NCT01238861|523810126|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
145263213|NCT01238861|523810127|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
145263214|NCT01238861|523810128|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
145263215|NCT01238861|523810129|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
145263216|NCT01238861|523810130|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
145263217|NCT01238861|523810131|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
145263218|NCT01238861|523810126|FG000|Overall Study|Incorrect enrollment/randomization|0|||
145263219|NCT01238861|523810127|FG001|Overall Study|Incorrect enrollment/randomization|0|||
145263220|NCT01238861|523810128|FG002|Overall Study|Incorrect enrollment/randomization|1|||
145263221|NCT01238861|523810129|FG003|Overall Study|Incorrect enrollment/randomization|0|||
145263222|NCT01238861|523810130|FG004|Overall Study|Incorrect enrollment/randomization|1|||
145263223|NCT01238861|523810131|FG005|Overall Study|Incorrect enrollment/randomization|0|||
145263224|NCT01238861|523810126|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
145263225|NCT01238861|523810127|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
145263226|NCT01238861|523810128|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
145263227|NCT01238861|523810129|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
145263228|NCT01238861|523810130|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
145263229|NCT01238861|523810131|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
145263230|NCT01238861|523810126|FG000|Overall Study|Subject moved out of state/area|0|||
145263231|NCT01238861|523810127|FG001|Overall Study|Subject moved out of state/area|0|||
145263232|NCT01238861|523810128|FG002|Overall Study|Subject moved out of state/area|1|||
145263233|NCT01238861|523810129|FG003|Overall Study|Subject moved out of state/area|1|||
145263234|NCT01238861|523810130|FG004|Overall Study|Subject moved out of state/area|0|||
145263235|NCT01238861|523810131|FG005|Overall Study|Subject moved out of state/area|0|||
145263236|NCT01238861|523810126|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
145263237|NCT01238861|523810127|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
145263238|NCT01238861|523810128|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
145263239|NCT01238861|523810129|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
145263240|NCT01238861|523810130|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
145263241|NCT01238861|523810131|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
145263242|NCT01238861|523810126|FG000|Overall Study|Personal problems|0|||
145263243|NCT01238861|523810127|FG001|Overall Study|Personal problems|0|||
145263244|NCT01238861|523810128|FG002|Overall Study|Personal problems|0|||
145263245|NCT01238861|523810129|FG003|Overall Study|Personal problems|1|||
145263246|NCT01238861|523810130|FG004|Overall Study|Personal problems|0|||
145263247|NCT01238861|523810131|FG005|Overall Study|Personal problems|0|||
145263248|NCT01238861|523810126|FG000|Overall Study|Unable to continue visits|0|||
145263249|NCT01238861|523810127|FG001|Overall Study|Unable to continue visits|0|||
145263250|NCT01238861|523810128|FG002|Overall Study|Unable to continue visits|0|||
145263251|NCT01238861|523810129|FG003|Overall Study|Unable to continue visits|1|||
145263252|NCT01238861|523810130|FG004|Overall Study|Unable to continue visits|0|||
145263253|NCT01238861|523810131|FG005|Overall Study|Unable to continue visits|1|||
145263254|NCT01238861|523810126|FG000|Overall Study|Serious adverse event|0|||
145263255|NCT01238861|523810127|FG001|Overall Study|Serious adverse event|0|||
145263256|NCT01238861|523810128|FG002|Overall Study|Serious adverse event|0|||
145263257|NCT01238861|523810129|FG003|Overall Study|Serious adverse event|0|||
145263258|NCT01238861|523810130|FG004|Overall Study|Serious adverse event|0|||
145263259|NCT01238861|523810131|FG005|Overall Study|Serious adverse event|1|||
145263260|NCT01238861|523810126|FG000|Overall Study|Lack of compliance|0|||
145263261|NCT01238861|523810127|FG001|Overall Study|Lack of compliance|0|||
145263262|NCT01238861|523810128|FG002|Overall Study|Lack of compliance|0|||
145263263|NCT01238861|523810129|FG003|Overall Study|Lack of compliance|0|||
145263264|NCT01238861|523810130|FG004|Overall Study|Lack of compliance|0|||
145263265|NCT01238861|523810131|FG005|Overall Study|Lack of compliance|1|||
145263266|NCT01238861|523810126|FG000|Overall Study|Adverse Event|0|||
145263267|NCT01238861|523810127|FG001|Overall Study|Adverse Event|1|||
145263268|NCT01238861|523810128|FG002|Overall Study|Adverse Event|0|||
145263269|NCT01238861|523810129|FG003|Overall Study|Adverse Event|0|||
145263270|NCT01238861|523810130|FG004|Overall Study|Adverse Event|0|||
145263271|NCT01238861|523810131|FG005|Overall Study|Adverse Event|0|||
145263272|NCT01238861|523810126|FG000|Overall Study|Withdrawal by Subject|6|||
145263273|NCT01238861|523810127|FG001|Overall Study|Withdrawal by Subject|5|||
145263274|NCT01238861|523810128|FG002|Overall Study|Withdrawal by Subject|4|||
145263275|NCT01238861|523810129|FG003|Overall Study|Withdrawal by Subject|8|||
145263276|NCT01238861|523810130|FG004|Overall Study|Withdrawal by Subject|10|||
145263277|NCT01238861|523810131|FG005|Overall Study|Withdrawal by Subject|9|||
145263278|NCT01269346|523810132|FG000|Treatment Phase|Disease progression|3|||
145263279|NCT01269346|523810132|FG000|Treatment Phase|Adverse Event|3|||
145263280|NCT01269346|523810132|FG000|Treatment Phase|Withdrawal by Subject|1|||
145263281|NCT01269346|523810132|FG000|Treatment Phase|Other|2|||
145263282|NCT01269346|523810132|FG000|Extension Phase|Adverse Event|6|||
145263283|NCT01269346|523810132|FG000|Extension Phase|Withdrawal by Subject|4|||
145263284|NCT01269346|523810132|FG000|Extension Phase|Disease progression|22|||
145263285|NCT01269346|523810132|FG000|Extension Phase|Physician decision or participant choice|9|||
145263286|NCT01269346|523810132|FG000|Extension Phase|Clinical progression|1|||
145263287|NCT01269346|523810132|FG000|Extension Phase|Started a prohibited con med|1|||
145263288|NCT00247416|523810133|FG000|Overall Study|3 patients were found to be ineligible|1|||
145263289|NCT00247416|523810134|FG001|Overall Study|3 patients were found to be ineligible|2|||
145263290|NCT04963231|523810136|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
145263291|NCT04963231|523810137|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
145263292|NCT04963231|523810138|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
145263293|NCT04963231|523810136|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
145263294|NCT04963231|523810137|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
145263295|NCT04963231|523810138|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
145263296|NCT04963231|523810136|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
145263297|NCT04963231|523810137|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
145263298|NCT04963231|523810138|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
145263299|NCT04963231|523810136|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
145263300|NCT04963231|523810137|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
145263301|NCT04963231|523810138|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
145263302|NCT04963231|523810136|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
145263303|NCT04963231|523810137|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
145263304|NCT04963231|523810138|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
145263305|NCT04963231|523810136|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
145263306|NCT04963231|523810137|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
145263307|NCT04963231|523810138|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
145263308|NCT04963231|523810136|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
145263309|NCT04963231|523810137|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
145263310|NCT04963231|523810138|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
145263311|NCT01928758|523810144|FG000|Overall Study|Lost to Follow-up|14|||
145263312|NCT01928758|523810145|FG001|Overall Study|Lost to Follow-up|9|||
145263313|NCT01928758|523810144|FG000|Overall Study|Withdrawal by Subject|5|||
145263314|NCT01928758|523810145|FG001|Overall Study|Withdrawal by Subject|2|||
145263315|NCT01928758|523810144|FG000|Overall Study|Adverse Event|3|||
145263316|NCT01928758|523810145|FG001|Overall Study|Adverse Event|5|||
145263317|NCT01928758|523810144|FG000|Overall Study|Protocol Violation|3|||
145263318|NCT01928758|523810145|FG001|Overall Study|Protocol Violation|4|||
145263319|NCT02718131|523810146|FG000|Overall Study|Withdrawal by Subject|1|||
145263320|NCT02718131|523810147|FG001|Overall Study|Withdrawal by Subject|0|||
145263321|NCT02718131|523810146|FG000|Overall Study|Adverse Event|1|||
145263322|NCT02718131|523810147|FG001|Overall Study|Adverse Event|0|||
145263323|NCT02718131|523810146|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
145263324|NCT02718131|523810147|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
145263325|NCT01097057|523810148|FG000|Overall Study|Physician Decision|3|||
145263326|NCT03198559|523810149|FG000|Overall Study|Adverse Event|2|||
145263327|NCT03737812|523810150|FG000|Overall Study|Withdrawal by Subject|1|||
145263328|NCT03737812|523810151|FG001|Overall Study|Withdrawal by Subject|2|||
145263329|NCT03737812|523810152|FG002|Overall Study|Withdrawal by Subject|1|||
145263330|NCT03737812|523810150|FG000|Overall Study|Sponsor Discontinued the Study|4|||
145263331|NCT03737812|523810151|FG001|Overall Study|Sponsor Discontinued the Study|3|||
145263332|NCT03737812|523810152|FG002|Overall Study|Sponsor Discontinued the Study|2|||
145263333|NCT03737812|523810150|FG000|Overall Study|Adverse Event|0|||
145263334|NCT03737812|523810151|FG001|Overall Study|Adverse Event|1|||
145263335|NCT03737812|523810152|FG002|Overall Study|Adverse Event|0|||
145263336|NCT03737812|523810150|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
145263337|NCT03737812|523810151|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
145263338|NCT03737812|523810152|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
145263339|NCT02624713|523810153|FG000|Overall Study|Lost to Follow-up|14|||
145263340|NCT02624713|523810154|FG001|Overall Study|Lost to Follow-up|0|||
145263341|NCT01911546|523810158|FG000|Overall Study|Lost to Follow-up|1|||
145263342|NCT01911546|523810158|FG000|Overall Study|Everolimus was discontinued|5|||
145263343|NCT01474291|523810161|FG000|Overall Study|Not Evaluable for Efficacy|26|||
145263344|NCT01474291|523810161|FG000|Overall Study|Lack of Treatment Efficacy|88|||
145579618|NCT01276327|524977093|FG001|Overall Study|Withdrawal by Subject|0|||
145579619|NCT00807092|524977094|FG000|Overall Study|Adverse Event|0|||
145579620|NCT00807092|524977095|FG001|Overall Study|Adverse Event|1|||
145263345|NCT01474291|523810161|FG000|Overall Study|Adverse Event|53|||
145263346|NCT01474291|523810161|FG000|Overall Study|Lost to Follow-up|29|||
145263347|NCT01474291|523810161|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
145263348|NCT01474291|523810161|FG000|Overall Study|No Reason Reported|10|||
145579621|NCT00807092|524977094|FG000|Overall Study|Protocol Violation|0|||
145579622|NCT00807092|524977095|FG001|Overall Study|Protocol Violation|2|||
145579623|NCT00807092|524977094|FG000|Overall Study|Withdrawal by Subject|1|||
145579624|NCT00807092|524977095|FG001|Overall Study|Withdrawal by Subject|0|||
145579625|NCT00807092|524977094|FG000|Overall Study|CGMS data collection failed|0|||
145579626|NCT00807092|524977095|FG001|Overall Study|CGMS data collection failed|1|||
145579627|NCT01794949|524977096|FG000|Overall Study|Lost to Follow-up|1|||
145579628|NCT01794949|524977097|FG001|Overall Study|Lost to Follow-up|0|||
145579629|NCT03003676|524977098|FG000|Overall Study|Lack of Efficacy|5|||
145579630|NCT03003676|524977099|FG001|Overall Study|Lack of Efficacy|7|||
145579631|NCT03003676|524977098|FG000|Overall Study|Withdrawal by Subject|0|||
145579632|NCT03003676|524977099|FG001|Overall Study|Withdrawal by Subject|1|||
145579633|NCT03003676|524977098|FG000|Overall Study|Hepatitis B infection|1|||
145579634|NCT03003676|524977099|FG001|Overall Study|Hepatitis B infection|0|||
145579635|NCT03766646|524977100|FG000|Overall Study|Withdrawal by Subject|1|||
145579636|NCT03766646|524977101|FG001|Overall Study|Withdrawal by Subject|0|||
145579637|NCT03766646|524977100|FG000|Overall Study|Protocol Violation|0|||
145579638|NCT03766646|524977101|FG001|Overall Study|Protocol Violation|3|||
145579639|NCT01931839|524977111|FG000|Overall Study|Death|0|||
145579640|NCT01931839|524977112|FG001|Overall Study|Death|1|||
145579641|NCT01931839|524977113|FG002|Overall Study|Death|2|||
145579642|NCT01931839|524977114|FG003|Overall Study|Death|0|||
145579643|NCT01931839|524977115|FG004|Overall Study|Death|0|||
145579644|NCT01931839|524977116|FG005|Overall Study|Death|0|||
145579645|NCT01931839|524977117|FG006|Overall Study|Death|0|||
145579646|NCT01931839|524977111|FG000|Overall Study|Physician Decision|1|||
145579647|NCT01931839|524977112|FG001|Overall Study|Physician Decision|0|||
145579648|NCT01931839|524977113|FG002|Overall Study|Physician Decision|1|||
145579649|NCT01931839|524977114|FG003|Overall Study|Physician Decision|0|||
145579650|NCT01931839|524977115|FG004|Overall Study|Physician Decision|0|||
145579651|NCT01931839|524977116|FG005|Overall Study|Physician Decision|0|||
145579652|NCT01931839|524977117|FG006|Overall Study|Physician Decision|1|||
145579653|NCT01931839|524977111|FG000|Overall Study|Withdrawal of consent|0|||
145579654|NCT01931839|524977112|FG001|Overall Study|Withdrawal of consent|0|||
145579655|NCT01931839|524977113|FG002|Overall Study|Withdrawal of consent|0|||
145579656|NCT01931839|524977114|FG003|Overall Study|Withdrawal of consent|0|||
145579657|NCT01931839|524977115|FG004|Overall Study|Withdrawal of consent|1|||
145579658|NCT01931839|524977116|FG005|Overall Study|Withdrawal of consent|0|||
145579659|NCT01931839|524977117|FG006|Overall Study|Withdrawal of consent|0|||
145579660|NCT01931839|524977111|FG000|Overall Study|Adverse Event|9|||
145579661|NCT01931839|524977112|FG001|Overall Study|Adverse Event|4|||
145579662|NCT01931839|524977113|FG002|Overall Study|Adverse Event|1|||
145579663|NCT01931839|524977114|FG003|Overall Study|Adverse Event|3|||
145579664|NCT01931839|524977115|FG004|Overall Study|Adverse Event|0|||
145579665|NCT01931839|524977116|FG005|Overall Study|Adverse Event|0|||
145579666|NCT01931839|524977117|FG006|Overall Study|Adverse Event|1|||
145579667|NCT01931839|524977111|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
145579668|NCT01931839|524977112|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
145579669|NCT01931839|524977113|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
145579670|NCT01931839|524977114|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
145579671|NCT01931839|524977115|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
145579672|NCT01931839|524977116|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
145579673|NCT01931839|524977117|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
145579674|NCT01931839|524977111|FG000|Overall Study|Other non-compliance|15|||
145579675|NCT01931839|524977112|FG001|Overall Study|Other non-compliance|9|||
145579676|NCT01931839|524977113|FG002|Overall Study|Other non-compliance|12|||
145579677|NCT01931839|524977114|FG003|Overall Study|Other non-compliance|3|||
145579678|NCT01931839|524977115|FG004|Overall Study|Other non-compliance|0|||
145579679|NCT01931839|524977116|FG005|Overall Study|Other non-compliance|3|||
145263349|NCT01474291|523810161|FG000|Overall Study|Death|2|||
145263350|NCT02213666|523810162|FG000|Overall Study|Withdrawal by Subject|1|||
145263351|NCT01399619|523810163|FG000|Overall Study|Adverse Event|10|||
145263352|NCT01399619|523810164|FG001|Overall Study|Adverse Event|0|||
145579680|NCT01931839|524977117|FG006|Overall Study|Other non-compliance|0|||
145579681|NCT01931839|524977111|FG000|Overall Study|Lost to Follow-up|1|||
145579682|NCT01931839|524977112|FG001|Overall Study|Lost to Follow-up|2|||
145579683|NCT01931839|524977113|FG002|Overall Study|Lost to Follow-up|4|||
145579684|NCT01931839|524977114|FG003|Overall Study|Lost to Follow-up|5|||
145579685|NCT01931839|524977115|FG004|Overall Study|Lost to Follow-up|0|||
145579686|NCT01931839|524977116|FG005|Overall Study|Lost to Follow-up|0|||
145579687|NCT01931839|524977117|FG006|Overall Study|Lost to Follow-up|0|||
145579688|NCT01931839|524977111|FG000|Overall Study|Other|4|||
145579689|NCT01931839|524977112|FG001|Overall Study|Other|2|||
145579690|NCT01931839|524977113|FG002|Overall Study|Other|6|||
145579691|NCT01931839|524977114|FG003|Overall Study|Other|0|||
145579692|NCT01931839|524977115|FG004|Overall Study|Other|0|||
145263353|NCT01399619|523810165|FG002|Overall Study|Adverse Event|4|||
145579693|NCT01931839|524977116|FG005|Overall Study|Other|0|||
145579694|NCT01931839|524977117|FG006|Overall Study|Other|0|||
145579695|NCT03224468|524977123|FG000|Overall Study|Did not obtain MM card|53|||
145579696|NCT03224468|524977124|FG001|Overall Study|Did not obtain MM card|0|||
145263354|NCT01399619|523810166|FG003|Overall Study|Adverse Event|10|||
145579697|NCT03224468|524977123|FG000|Overall Study|Lost to Follow-up|4|||
145623513|NCT00994279|525133963|FG001|Overall Study|Toxicity|0|||
145623514|NCT00994279|525133962|FG000|Overall Study|Multiple reasons|1|||
145372207|NCT03729570|524213126|FG001|Overall Study|Bad Experience|1|||
145372208|NCT03729570|524213125|FG000|Overall Study|No reason provided|2|||
145372209|NCT03729570|524213126|FG001|Overall Study|No reason provided|1|||
145372210|NCT03729570|524213125|FG000|Overall Study|Family Conflict|0|||
145372211|NCT03729570|524213126|FG001|Overall Study|Family Conflict|1|||
145372212|NCT03729570|524213125|FG000|Overall Study|Did not want to continue taking medications|0|||
145372213|NCT03729570|524213126|FG001|Overall Study|Did not want to continue taking medications|1|||
145372214|NCT03729570|524213125|FG000|Overall Study|Found another PrEP provider|1|||
145372215|NCT03729570|524213126|FG001|Overall Study|Found another PrEP provider|0|||
145372216|NCT03729570|524213125|FG000|Overall Study|Did not enjoy being in the control group|0|||
145372217|NCT03729570|524213126|FG001|Overall Study|Did not enjoy being in the control group|1|||
145372218|NCT01867294|524213129|FG000|Overall Study|Withdrawal by Subject|1|||
145372219|NCT01867294|524213130|FG001|Overall Study|Withdrawal by Subject|1|||
145372220|NCT01867294|524213131|FG002|Overall Study|Withdrawal by Subject|0|||
145372221|NCT01867294|524213132|FG003|Overall Study|Withdrawal by Subject|0|||
145372222|NCT00278148|524213133|FG000|Phase II - Expansion Phase|Disease progression|0|||
145372223|NCT00278148|524213134|FG001|Phase II - Expansion Phase|Disease progression|0|||
145372224|NCT00278148|524213135|FG002|Phase II - Expansion Phase|Disease progression|4|||
145372225|NCT00278148|524213133|FG000|Phase II - Expansion Phase|Adverse Event|0|||
145372226|NCT00278148|524213134|FG001|Phase II - Expansion Phase|Adverse Event|0|||
145372227|NCT00278148|524213135|FG002|Phase II - Expansion Phase|Adverse Event|2|||
145372228|NCT02083185|524213137|FG000|Overall Study|Lost to Follow-up|0|||
145372229|NCT02083185|524213138|FG001|Overall Study|Lost to Follow-up|3|||
145372230|NCT02083185|524213139|FG002|Overall Study|Lost to Follow-up|0|||
145372231|NCT02083185|524213137|FG000|Overall Study|Withdrawal by Subject|9|||
145372232|NCT02083185|524213138|FG001|Overall Study|Withdrawal by Subject|15|||
145372233|NCT02083185|524213139|FG002|Overall Study|Withdrawal by Subject|1|||
145372234|NCT02083185|524213137|FG000|Overall Study|Death|2|||
145372235|NCT02083185|524213138|FG001|Overall Study|Death|2|||
145372236|NCT02083185|524213139|FG002|Overall Study|Death|1|||
145372237|NCT02083185|524213137|FG000|Overall Study|Reason not Specified|9|||
145372238|NCT02083185|524213138|FG001|Overall Study|Reason not Specified|6|||
145372239|NCT02083185|524213139|FG002|Overall Study|Reason not Specified|5|||
145372240|NCT02083185|524213137|FG000|Overall Study|Study Terminated by Sponsor|0|||
145372241|NCT02083185|524213138|FG001|Overall Study|Study Terminated by Sponsor|1|||
145372242|NCT02083185|524213139|FG002|Overall Study|Study Terminated by Sponsor|0|||
145372243|NCT02083185|524213137|FG000|Overall Study|Did not Receive Study Drug|0|||
145372244|NCT02083185|524213138|FG001|Overall Study|Did not Receive Study Drug|2|||
145372245|NCT02083185|524213139|FG002|Overall Study|Did not Receive Study Drug|0|||
145372246|NCT03419598|524213140|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
145372247|NCT01740128|524213141|FG000|Overall Study|Pregnancy|0|||
145372248|NCT01740128|524213142|FG001|Overall Study|Pregnancy|1|||
145372249|NCT01740128|524213141|FG000|Overall Study|Protocol Violation|1|||
145372250|NCT01740128|524213142|FG001|Overall Study|Protocol Violation|2|||
145372251|NCT01740128|524213141|FG000|Overall Study|Lost to Follow-up|2|||
145372252|NCT01740128|524213142|FG001|Overall Study|Lost to Follow-up|2|||
145372253|NCT01740128|524213141|FG000|Overall Study|Withdrawal by Subject|1|||
145372254|NCT01740128|524213142|FG001|Overall Study|Withdrawal by Subject|0|||
145372255|NCT01740128|524213141|FG000|Overall Study|Insufficient protocol compliance|2|||
145372256|NCT01740128|524213142|FG001|Overall Study|Insufficient protocol compliance|2|||
145372257|NCT02474589|524213143|FG000|Overall Study|Adverse Event|6|||
145372258|NCT02474589|524213144|FG001|Overall Study|Adverse Event|2|||
145372259|NCT02474589|524213143|FG000|Overall Study|Lost to Follow-up|6|||
145372260|NCT02474589|524213144|FG001|Overall Study|Lost to Follow-up|1|||
145372261|NCT02474589|524213143|FG000|Overall Study|Protocol Violation|4|||
145372262|NCT02474589|524213144|FG001|Overall Study|Protocol Violation|1|||
145372263|NCT02474589|524213143|FG000|Overall Study|Withdrawal by Subject|4|||
145372264|NCT02474589|524213144|FG001|Overall Study|Withdrawal by Subject|0|||
145372265|NCT02474589|524213143|FG000|Overall Study|Inability to complete study procedures|5|||
145372266|NCT02474589|524213144|FG001|Overall Study|Inability to complete study procedures|1|||
145372267|NCT02658734|524213147|FG000|Overall Study|Adverse Event|2|||
145372268|NCT02658734|524213147|FG000|Overall Study|Death|4|||
145372269|NCT02658734|524213147|FG000|Overall Study|Lost to Follow-up|7|||
145372270|NCT02658734|524213147|FG000|Overall Study|Withdrawal of Consent|16|||
145372271|NCT02658734|524213147|FG000|Overall Study|Disease Progression|28|||
145623515|NCT00994279|525133963|FG001|Overall Study|Multiple reasons|3|||
145623516|NCT00859014|525133964|FG000|Overall Study|Death|4|||
145372272|NCT01546168|524213150|FG000|Overall Study|Lost to Follow-up|1|||
145372273|NCT01546168|524213151|FG001|Overall Study|Lost to Follow-up|0|||
145372274|NCT01546168|524213150|FG000|Overall Study|Withdrawal by Subject|1|||
145372275|NCT01546168|524213151|FG001|Overall Study|Withdrawal by Subject|0|||
145372276|NCT01546168|524213150|FG000|Overall Study|ineligible after signing consent|2|||
145372277|NCT01546168|524213151|FG001|Overall Study|ineligible after signing consent|0|||
145372278|NCT00423189|524213154|FG000|Overall Study|Death|0|||
145579698|NCT03224468|524977124|FG001|Overall Study|Lost to Follow-up|11|||
145579699|NCT03224468|524977123|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
145579700|NCT03224468|524977124|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
145579701|NCT01978119|524977125|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
145579702|NCT01978119|524977126|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
145579703|NCT01978119|524977125|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
145579704|NCT01978119|524977126|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
145263355|NCT01399619|523810163|FG000|Overall Study|Lack of Efficacy|9|||
145263356|NCT01399619|523810164|FG001|Overall Study|Lack of Efficacy|0|||
145263357|NCT01399619|523810165|FG002|Overall Study|Lack of Efficacy|5|||
145263358|NCT01399619|523810166|FG003|Overall Study|Lack of Efficacy|0|||
145263359|NCT01399619|523810163|FG000|Overall Study|Withdrawal by Subject|6|||
145263360|NCT01399619|523810164|FG001|Overall Study|Withdrawal by Subject|0|||
145263361|NCT01399619|523810165|FG002|Overall Study|Withdrawal by Subject|3|||
145263362|NCT01399619|523810166|FG003|Overall Study|Withdrawal by Subject|4|||
145263363|NCT01399619|523810163|FG000|Overall Study|Protocol Violation|0|||
145263364|NCT01399619|523810164|FG001|Overall Study|Protocol Violation|0|||
145263365|NCT01399619|523810165|FG002|Overall Study|Protocol Violation|0|||
145579705|NCT01978119|524977125|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145579706|NCT01978119|524977126|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
145263366|NCT01399619|523810166|FG003|Overall Study|Protocol Violation|1|||
145263367|NCT01399619|523810163|FG000|Overall Study|Not treated|0|||
145263368|NCT01399619|523810164|FG001|Overall Study|Not treated|0|||
145263369|NCT01399619|523810165|FG002|Overall Study|Not treated|0|||
145263370|NCT01399619|523810166|FG003|Overall Study|Not treated|2|||
145263371|NCT00229931|523810189|FG000|Overall Study|Death|1|||
145263372|NCT00229931|523810190|FG001|Overall Study|Death|0|||
145263373|NCT00229931|523810189|FG000|Overall Study|Lost to Follow-up|3|||
145263374|NCT00229931|523810190|FG001|Overall Study|Lost to Follow-up|2|||
145263375|NCT00475657|523810191|FG000|Overall Study|Death|1|||
145263376|NCT00475657|523810191|FG000|Overall Study|Sponsor's Decision|3|||
145263377|NCT02992743|523810192|FG000|Overall Study|Withdrawal by Subject|1|||
145263378|NCT02992743|523810193|FG001|Overall Study|Withdrawal by Subject|1|||
145263379|NCT02992743|523810192|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
145263380|NCT02992743|523810193|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
145263381|NCT02992743|523810192|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
145263382|NCT02992743|523810193|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
145263383|NCT02992743|523810192|FG000|Overall Study|No measurable disease|1|||
145263384|NCT02992743|523810193|FG001|Overall Study|No measurable disease|0|||
145263385|NCT02992743|523810192|FG000|Overall Study|Lost to Follow-up|0|||
145263386|NCT02992743|523810193|FG001|Overall Study|Lost to Follow-up|1|||
145263387|NCT00998166|523810196|FG000|Overall Study|Early Study Termination|8|||
145263388|NCT04585906|523810209|FG000|Overall Study|Lost to Follow-up|8|||
145263389|NCT04585906|523810210|FG001|Overall Study|Lost to Follow-up|5|||
145263390|NCT00198107|523812034|FG000|Double-Blind Period|Adverse Event|1|||
145263391|NCT00198107|523812035|FG001|Double-Blind Period|Adverse Event|1|||
145263392|NCT00198107|523812036|FG002|Double-Blind Period|Adverse Event|0|||
145263393|NCT00198107|523812034|FG000|Double-Blind Period|Lack of Efficacy|2|||
145263394|NCT00198107|523812035|FG001|Double-Blind Period|Lack of Efficacy|0|||
145263395|NCT00198107|523812036|FG002|Double-Blind Period|Lack of Efficacy|0|||
145263396|NCT00198107|523812034|FG000|Double-Blind Period|Lost to Follow-up|2|||
145263397|NCT00198107|523812035|FG001|Double-Blind Period|Lost to Follow-up|1|||
145263398|NCT00198107|523812036|FG002|Double-Blind Period|Lost to Follow-up|0|||
145263399|NCT00198107|523812034|FG000|Double-Blind Period|Physician Decision|1|||
145263400|NCT00198107|523812035|FG001|Double-Blind Period|Physician Decision|0|||
145263401|NCT00198107|523812036|FG002|Double-Blind Period|Physician Decision|0|||
145263402|NCT00198107|523812034|FG000|Double-Blind Period|Withdrawal by Subject|0|||
145263403|NCT00198107|523812035|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145263404|NCT00198107|523812036|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145263405|NCT00198107|523812034|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
145263406|NCT00198107|523812035|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
145263407|NCT00198107|523812036|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
145579707|NCT00812812|524977127|FG000|Overall Study|Adverse Event|2|||
145579708|NCT00812812|524977128|FG001|Overall Study|Adverse Event|1|||
145263408|NCT02513732|523812037|FG000|Overall Study|Lost to Follow-up|11|||
145263409|NCT02513732|523812037|FG000|Overall Study|Death|9|||
145263410|NCT02513732|523812037|FG000|Overall Study|Changing hospital|2|||
145263411|NCT00934661|523812038|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
145263412|NCT00934661|523812039|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
145263413|NCT00474994|523812048|FG000|Overall Study|Patient Not treated|1|||
145263414|NCT00474994|523812048|FG000|Overall Study|Patient evaluable for toxicity only|3|||
145263415|NCT00474994|523812048|FG000|Overall Study|Patient found to be ineligible|1|||
145263416|NCT00278473|523812049|FG000|Overall Study|drop out|4|||
145263417|NCT00278473|523812050|FG001|Overall Study|drop out|3|||
145263418|NCT00761761|523812054|FG000|Overall Study|Lost to Follow-up|3|||
145263419|NCT00761761|523812055|FG001|Overall Study|Lost to Follow-up|1|||
145263420|NCT00761761|523812054|FG000|Overall Study|Withdrawal by Subject|3|||
145263421|NCT00761761|523812055|FG001|Overall Study|Withdrawal by Subject|0|||
145263422|NCT03472586|523812062|FG000|Overall Study|Physician Decision|6|||
145263423|NCT03472586|523812062|FG000|Overall Study|Death|6|||
145263424|NCT03472586|523812062|FG000|Overall Study|Adverse Event|1|||
145263425|NCT02706327|523812064|FG000|Overall Study|Lost to Follow-up|1|||
145263426|NCT02706327|523812065|FG001|Overall Study|Lost to Follow-up|1|||
145263427|NCT02706327|523812066|FG002|Overall Study|Lost to Follow-up|2|||
145263428|NCT02652793|523812069|FG000|Overall Study|Adverse Event|1|||
145263429|NCT02652793|523812069|FG000|Overall Study|Lost to Follow-up|2|||
145263430|NCT02652793|523812069|FG000|Overall Study|Withdrawal by Subject|1|||
145263431|NCT03868410|523812072|FG000|Overall Study|Physician Decision|0|||
145263432|NCT03868410|523812073|FG001|Overall Study|Physician Decision|1|||
145263433|NCT01059175|523812074|FG000|Overall Study|Death|17|||
145263434|NCT01059175|523812075|FG001|Overall Study|Death|17|||
145263435|NCT01059175|523812074|FG000|Overall Study|Adverse Event|4|||
145263436|NCT01059175|523812075|FG001|Overall Study|Adverse Event|2|||
145263437|NCT01059175|523812074|FG000|Overall Study|Lost to Follow-up|0|||
145263438|NCT01059175|523812075|FG001|Overall Study|Lost to Follow-up|1|||
145263439|NCT02957149|523812076|FG000|Overall Study|Withdrawal by Subject|5|||
145263440|NCT06045026|523812077|FG000|Overall Study|Lost to Follow-up|60|||
145263441|NCT06045026|523812077|FG000|Overall Study|Adverse Event|12|||
145263442|NCT06045026|523812077|FG000|Overall Study|Withdrawal by Subject|3|||
145263443|NCT06045026|523812077|FG000|Overall Study|Enrollment closed|1|||
145263444|NCT04511533|523812078|FG000|Treatment|Other|2|||
145263445|NCT04511533|523812078|FG000|Treatment|Withdrawal by Subject|11|||
145263446|NCT04511533|523812078|FG000|Treatment|Death|5|||
145263447|NCT04511533|523812078|FG000|Treatment|Physician Decision|1|||
145263448|NCT04511533|523812078|FG000|Treatment|Progressive Disease|61|||
145263449|NCT04511533|523812078|FG000|Follow-Up|Other|7|||
145263450|NCT04511533|523812078|FG000|Follow-Up|Withdrawal by Subject|5|||
145263451|NCT04511533|523812078|FG000|Follow-Up|Lost to Follow-up|2|||
145263452|NCT04511533|523812078|FG000|Follow-Up|Death|4|||
145263453|NCT01224171|523812079|FG000|Overall Study|Adverse Event|8|||
145263454|NCT01224171|523812080|FG001|Overall Study|Adverse Event|4|||
145263455|NCT01224171|523812079|FG000|Overall Study|Protocol Violation|0|||
145263456|NCT01224171|523812080|FG001|Overall Study|Protocol Violation|1|||
145263457|NCT01224171|523812079|FG000|Overall Study|Lack of Efficacy|5|||
145263458|NCT01224171|523812080|FG001|Overall Study|Lack of Efficacy|1|||
145263459|NCT01224171|523812079|FG000|Overall Study|Withdrawal of Consent|2|||
145263460|NCT01224171|523812080|FG001|Overall Study|Withdrawal of Consent|4|||
145263461|NCT01224171|523812079|FG000|Overall Study|Lost to Follow-up|0|||
145263462|NCT01224171|523812080|FG001|Overall Study|Lost to Follow-up|3|||
145263463|NCT03471507|523812086|FG000|Overall Study|Lost to Follow-up|1|||
145263464|NCT03471507|523812087|FG001|Overall Study|Lost to Follow-up|3|||
145263465|NCT03471507|523812086|FG000|Overall Study|Physician Decision|0|||
145263466|NCT03471507|523812087|FG001|Overall Study|Physician Decision|1|||
145263467|NCT03471507|523812086|FG000|Overall Study|Withdrawal by Subject|2|||
145263468|NCT03471507|523812087|FG001|Overall Study|Withdrawal by Subject|1|||
145263469|NCT00750061|523812089|FG000|Overall Study|Adverse Event|2|||
145263470|NCT00750061|523812090|FG001|Overall Study|Adverse Event|0|||
145263471|NCT00750061|523812089|FG000|Overall Study|Withdrawal by Subject|0|||
145263472|NCT00750061|523812090|FG001|Overall Study|Withdrawal by Subject|1|||
145263473|NCT00750061|523812089|FG000|Overall Study|Physician Decision|0|||
145263474|NCT00750061|523812090|FG001|Overall Study|Physician Decision|1|||
145263475|NCT02708524|523812091|FG000|Overall Study|Adverse Event|0|||
145263476|NCT02708524|523812092|FG001|Overall Study|Adverse Event|1|||
145263477|NCT02708524|523812093|FG002|Overall Study|Adverse Event|0|||
145263478|NCT02708524|523812094|FG003|Overall Study|Adverse Event|0|||
145263479|NCT02708524|523812091|FG000|Overall Study|Lens Discomfort|1|||
145263480|NCT02708524|523812092|FG001|Overall Study|Lens Discomfort|0|||
145263481|NCT02708524|523812093|FG002|Overall Study|Lens Discomfort|1|||
145579709|NCT00812812|524977127|FG000|Overall Study|Lack of Efficacy|1|||
145263482|NCT02708524|523812094|FG003|Overall Study|Lens Discomfort|0|||
145263483|NCT02708524|523812091|FG000|Overall Study|Lost to Follow-up|1|||
145263484|NCT02708524|523812092|FG001|Overall Study|Lost to Follow-up|1|||
145263485|NCT02708524|523812093|FG002|Overall Study|Lost to Follow-up|1|||
145263486|NCT02708524|523812094|FG003|Overall Study|Lost to Follow-up|0|||
145263487|NCT02708524|523812091|FG000|Overall Study|Protocol Violation|0|||
145263488|NCT02708524|523812092|FG001|Overall Study|Protocol Violation|1|||
145263489|NCT02708524|523812093|FG002|Overall Study|Protocol Violation|0|||
145263490|NCT02708524|523812094|FG003|Overall Study|Protocol Violation|0|||
145263491|NCT02708524|523812091|FG000|Overall Study|Withdrawal by Subject|1|||
145263492|NCT02708524|523812092|FG001|Overall Study|Withdrawal by Subject|1|||
145263493|NCT02708524|523812093|FG002|Overall Study|Withdrawal by Subject|0|||
145263494|NCT02708524|523812094|FG003|Overall Study|Withdrawal by Subject|0|||
145263495|NCT02708524|523812091|FG000|Overall Study|Dispensed incorrect study lens|0|||
145263496|NCT02708524|523812092|FG001|Overall Study|Dispensed incorrect study lens|1|||
145263497|NCT02708524|523812093|FG002|Overall Study|Dispensed incorrect study lens|1|||
145263498|NCT02708524|523812094|FG003|Overall Study|Dispensed incorrect study lens|0|||
145263499|NCT02708524|523812091|FG000|Overall Study|Did not wear lens at final visit|0|||
145263500|NCT02708524|523812092|FG001|Overall Study|Did not wear lens at final visit|1|||
145263501|NCT02708524|523812093|FG002|Overall Study|Did not wear lens at final visit|0|||
145263502|NCT02708524|523812094|FG003|Overall Study|Did not wear lens at final visit|0|||
145263503|NCT02708524|523812091|FG000|Overall Study|Subject lost study lens|1|||
145263504|NCT02708524|523812092|FG001|Overall Study|Subject lost study lens|0|||
145263505|NCT02708524|523812093|FG002|Overall Study|Subject lost study lens|0|||
145263506|NCT02708524|523812094|FG003|Overall Study|Subject lost study lens|0|||
145263507|NCT00381680|523812095|FG000|Overall Study|Adverse Event|9|||
145263508|NCT00381680|523812096|FG001|Overall Study|Adverse Event|3|||
145263509|NCT00381680|523812095|FG000|Overall Study|Death|10|||
145263510|NCT00381680|523812096|FG001|Overall Study|Death|7|||
145263511|NCT00381680|523812095|FG000|Overall Study|Lost to Follow-up|3|||
145263512|NCT00381680|523812096|FG001|Overall Study|Lost to Follow-up|2|||
145263513|NCT00381680|523812095|FG000|Overall Study|Physician Decision|25|||
145263514|NCT00381680|523812096|FG001|Overall Study|Physician Decision|6|||
145263515|NCT00381680|523812095|FG000|Overall Study|Withdrawal by Subject|3|||
145263516|NCT00381680|523812096|FG001|Overall Study|Withdrawal by Subject|1|||
145263517|NCT00381680|523812095|FG000|Overall Study|Entry onto another COG Trial|1|||
145263518|NCT00381680|523812096|FG001|Overall Study|Entry onto another COG Trial|2|||
145263519|NCT00381680|523812095|FG000|Overall Study|Alternative Therapy|11|||
145263520|NCT00381680|523812096|FG001|Overall Study|Alternative Therapy|5|||
145263521|NCT00381680|523812095|FG000|Overall Study|Secondary Malignancy|3|||
145263522|NCT00381680|523812096|FG001|Overall Study|Secondary Malignancy|0|||
145263523|NCT00381680|523812095|FG000|Overall Study|Delay initiation|1|||
145263524|NCT00381680|523812096|FG001|Overall Study|Delay initiation|0|||
145263525|NCT00381680|523812095|FG000|Overall Study|Stem Cell Transplant|26|||
145263526|NCT00381680|523812096|FG001|Overall Study|Stem Cell Transplant|10|||
145263527|NCT00381680|523812095|FG000|Overall Study|Relapse|18|||
145263528|NCT00381680|523812096|FG001|Overall Study|Relapse|9|||
145263529|NCT00381680|523812095|FG000|Overall Study|Induction Failure|4|||
145263530|NCT00381680|523812096|FG001|Overall Study|Induction Failure|1|||
145263531|NCT00381680|523812095|FG000|Overall Study|Progression|1|||
145263532|NCT00381680|523812096|FG001|Overall Study|Progression|1|||
145263533|NCT00381680|523812095|FG000|Overall Study|Other not otherwise specified|7|||
145263534|NCT00381680|523812096|FG001|Overall Study|Other not otherwise specified|2|||
145263535|NCT00381680|523812095|FG000|Overall Study|Ineligible|3|||
145263536|NCT00381680|523812096|FG001|Overall Study|Ineligible|1|||
145263537|NCT00361504|523812099|FG000|Overall Study|Withdrawal by Subject|94|||
145263538|NCT00361504|523812100|FG001|Overall Study|Withdrawal by Subject|31|||
145263539|NCT00361504|523812099|FG000|Overall Study|Lost to Follow-up|40|||
145263540|NCT00361504|523812100|FG001|Overall Study|Lost to Follow-up|7|||
145263541|NCT00361504|523812099|FG000|Overall Study|Adverse Event|203|||
145263542|NCT00361504|523812100|FG001|Overall Study|Adverse Event|82|||
145263543|NCT00361504|523812099|FG000|Overall Study|Lack of Efficacy|72|||
145263544|NCT00361504|523812100|FG001|Overall Study|Lack of Efficacy|7|||
145263545|NCT00361504|523812099|FG000|Overall Study|Resolution of Pain|2|||
145263546|NCT00361504|523812100|FG001|Overall Study|Resolution of Pain|0|||
145263547|NCT00361504|523812099|FG000|Overall Study|Study medication non compliant|42|||
145263548|NCT00361504|523812100|FG001|Overall Study|Study medication non compliant|15|||
145263549|NCT00361504|523812099|FG000|Overall Study|All other|28|||
145263550|NCT00361504|523812100|FG001|Overall Study|All other|3|||
145263551|NCT01374516|523812106|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
145263552|NCT01374516|523812107|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
145263553|NCT01374516|523812106|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
145263554|NCT01374516|523812107|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
145263555|NCT01374516|523812106|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
145263556|NCT01374516|523812107|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
145263557|NCT01374516|523812106|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
145263558|NCT01374516|523812107|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
145263559|NCT01374516|523812106|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
145263560|NCT01374516|523812107|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
145263561|NCT01374516|523812106|FG000|Surveillance Expansion Period|Protocol Violation|386|||
145579710|NCT00812812|524977128|FG001|Overall Study|Lack of Efficacy|0|||
145263562|NCT01374516|523812107|FG001|Surveillance Expansion Period|Protocol Violation|217|||
145263563|NCT01374516|523812106|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
145263564|NCT01374516|523812107|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
145263565|NCT01374516|523812106|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
145263566|NCT01374516|523812107|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
145263567|NCT01374516|523812106|FG000|Surveillance Expansion Period|Serious adverse event|20|||
145263568|NCT01374516|523812107|FG001|Surveillance Expansion Period|Serious adverse event|5|||
145263569|NCT00450814|523812109|FG000|Overall Study|Failed to complete the initial therapy|0|||
145263570|NCT00450814|523812110|FG001|Overall Study|Failed to complete the initial therapy|0|||
145263571|NCT00450814|523812111|FG002|Overall Study|Failed to complete the initial therapy|0|||
145372279|NCT00423189|524213155|FG001|Overall Study|Death|1|||
145579711|NCT00812812|524977127|FG000|Overall Study|Lost to Follow-up|0|||
145579712|NCT00812812|524977128|FG001|Overall Study|Lost to Follow-up|1|||
145579713|NCT00812812|524977127|FG000|Overall Study|Withdrawal by Subject|0|||
145579714|NCT00812812|524977128|FG001|Overall Study|Withdrawal by Subject|2|||
145579715|NCT03095417|524977129|FG000|Overall Study|missed|1|||
145579716|NCT03095417|524977130|FG001|Overall Study|missed|2|||
145579717|NCT03095417|524977131|FG002|Overall Study|missed|0|||
145579718|NCT03095417|524977132|FG003|Overall Study|missed|1|||
145579719|NCT03095417|524977129|FG000|Overall Study|Lost to Follow-up|2|||
145372280|NCT00423189|524213156|FG002|Overall Study|Death|0|||
145372281|NCT01258075|524213163|FG000|Overall Study|Adverse Event|8|||
145372282|NCT01258075|524213164|FG001|Overall Study|Adverse Event|3|||
145372283|NCT01258075|524213163|FG000|Overall Study|Lost to Follow-up|11|||
145372284|NCT01258075|524213164|FG001|Overall Study|Lost to Follow-up|6|||
145372285|NCT01258075|524213163|FG000|Overall Study|Withdrawal by Subject|10|||
145372286|NCT01258075|524213164|FG001|Overall Study|Withdrawal by Subject|7|||
145372287|NCT01258075|524213163|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
145372288|NCT01258075|524213164|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
145372289|NCT01258075|524213163|FG000|Overall Study|Other|12|||
145372290|NCT01258075|524213164|FG001|Overall Study|Other|5|||
145372291|NCT00070018|524213165|FG000|Overall Study|Adverse Event|2|||
145372292|NCT00070018|524213165|FG000|Overall Study|Lack of Efficacy|1|||
145372293|NCT00070018|524213165|FG000|Overall Study|Withdrawal by Subject|1|||
145372294|NCT02939716|524213166|FG000|Overall Study|scanner failure|0|||
145372295|NCT02939716|524213167|FG001|Overall Study|scanner failure|0|||
145372296|NCT02939716|524213168|FG002|Overall Study|scanner failure|0|||
145372297|NCT02939716|524213169|FG003|Overall Study|scanner failure|1|||
145372298|NCT02939716|524213170|FG004|Overall Study|scanner failure|1|||
145372299|NCT02939716|524213171|FG005|Overall Study|scanner failure|1|||
145372300|NCT00985959|524213174|FG000|Overall Study|Adverse Event|0|||
145372301|NCT00985959|524213175|FG001|Overall Study|Adverse Event|0|||
145372302|NCT00985959|524213176|FG002|Overall Study|Adverse Event|19|||
145372303|NCT00985959|524213174|FG000|Overall Study|Withdrawal by Subject|0|||
145372304|NCT00985959|524213175|FG001|Overall Study|Withdrawal by Subject|0|||
145372305|NCT00985959|524213176|FG002|Overall Study|Withdrawal by Subject|8|||
145372306|NCT00985959|524213174|FG000|Overall Study|Progressive disease|1|||
145372307|NCT00985959|524213175|FG001|Overall Study|Progressive disease|2|||
145372308|NCT00985959|524213176|FG002|Overall Study|Progressive disease|8|||
145372309|NCT00985959|524213174|FG000|Overall Study|Unrecovered toxicity|0|||
145372310|NCT00985959|524213175|FG001|Overall Study|Unrecovered toxicity|0|||
145372311|NCT00985959|524213176|FG002|Overall Study|Unrecovered toxicity|7|||
145372312|NCT00985959|524213174|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
145372313|NCT00985959|524213175|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
145372314|NCT00985959|524213176|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
145372315|NCT00985959|524213174|FG000|Overall Study|Complete response observed over 2 cycles|0|||
145372316|NCT00985959|524213175|FG001|Overall Study|Complete response observed over 2 cycles|1|||
145372317|NCT00985959|524213176|FG002|Overall Study|Complete response observed over 2 cycles|4|||
145372318|NCT00985959|524213174|FG000|Overall Study|Other|0|||
145372319|NCT00985959|524213175|FG001|Overall Study|Other|0|||
145372320|NCT00985959|524213176|FG002|Overall Study|Other|11|||
145372321|NCT03197870|524213184|FG000|Overall Study|Adverse Event|9|||
145372322|NCT03197870|524213185|FG001|Overall Study|Adverse Event|4|||
145372323|NCT03197870|524213186|FG002|Overall Study|Adverse Event|6|||
145372324|NCT03197870|524213184|FG000|Overall Study|Withdrawal by Subject|2|||
145372325|NCT03197870|524213185|FG001|Overall Study|Withdrawal by Subject|3|||
145372326|NCT03197870|524213186|FG002|Overall Study|Withdrawal by Subject|0|||
145372327|NCT03197870|524213184|FG000|Overall Study|Lost to Follow-up|2|||
145372328|NCT03197870|524213185|FG001|Overall Study|Lost to Follow-up|2|||
145372329|NCT03197870|524213186|FG002|Overall Study|Lost to Follow-up|0|||
145372330|NCT03197870|524213184|FG000|Overall Study|data not available|1|||
145372331|NCT03197870|524213185|FG001|Overall Study|data not available|1|||
145372332|NCT03197870|524213186|FG002|Overall Study|data not available|0|||
145372333|NCT01618019|524213187|FG000|Overall Study|Withdrawal by Subject|14|||
145579720|NCT03095417|524977130|FG001|Overall Study|Lost to Follow-up|2|||
145579721|NCT03095417|524977131|FG002|Overall Study|Lost to Follow-up|1|||
145579722|NCT03095417|524977132|FG003|Overall Study|Lost to Follow-up|0|||
145372334|NCT01618019|524213188|FG001|Overall Study|Withdrawal by Subject|14|||
145372335|NCT01542034|524213189|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
145372336|NCT01542034|524213190|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
145372337|NCT01542034|524213189|FG000|Overall Study|Administrative decision|0|||
145372338|NCT01542034|524213190|FG001|Overall Study|Administrative decision|3|||
145372339|NCT01542034|524213189|FG000|Overall Study|Subject Noncompliance|1|||
145372340|NCT01542034|524213190|FG001|Overall Study|Subject Noncompliance|0|||
145372341|NCT01542034|524213189|FG000|Overall Study|Adverse Event|2|||
145372342|NCT01542034|524213190|FG001|Overall Study|Adverse Event|2|||
145372343|NCT01542034|524213189|FG000|Overall Study|Lost to Follow-up|7|||
145372344|NCT01542034|524213190|FG001|Overall Study|Lost to Follow-up|6|||
145579723|NCT03095417|524977129|FG000|Overall Study|refusal|0|||
145579724|NCT03095417|524977130|FG001|Overall Study|refusal|1|||
145263572|NCT00450814|523812112|FG003|Overall Study|Failed to complete the initial therapy|1|||
145263573|NCT00450814|523812113|FG004|Overall Study|Failed to complete the initial therapy|1|||
145263574|NCT00450814|523812114|FG005|Overall Study|Failed to complete the initial therapy|1|||
145263575|NCT00450814|523812115|FG006|Overall Study|Failed to complete the initial therapy|0|||
145263576|NCT00450814|523812116|FG007|Overall Study|Failed to complete the initial therapy|0|||
145263577|NCT00450814|523812117|FG008|Overall Study|Failed to complete the initial therapy|0|||
145263578|NCT00450814|523812118|FG009|Overall Study|Failed to complete the initial therapy|0|||
145263579|NCT00450814|523812119|FG010|Overall Study|Failed to complete the initial therapy|0|||
145263580|NCT00450814|523812109|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
145263581|NCT00450814|523812110|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
145263582|NCT00450814|523812111|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
145263583|NCT00450814|523812112|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
145263584|NCT00450814|523812113|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
145263585|NCT00450814|523812114|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
145263586|NCT00450814|523812115|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
145263587|NCT00450814|523812116|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
145263588|NCT00450814|523812117|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
145263589|NCT00450814|523812118|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
145263590|NCT00450814|523812119|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
145263591|NCT04145531|523812120|FG000|Part A|Adverse Event|2|||
145263592|NCT04145531|523812121|FG001|Part A|Adverse Event|12|||
145263593|NCT04145531|523812122|FG002|Part A|Adverse Event|6|||
145263594|NCT04145531|523812123|FG003|Part A|Adverse Event|0|||
145263595|NCT04145531|523812120|FG000|Part A|Death|1|||
145263596|NCT04145531|523812121|FG001|Part A|Death|2|||
145263597|NCT04145531|523812122|FG002|Part A|Death|0|||
145263598|NCT04145531|523812123|FG003|Part A|Death|0|||
145263599|NCT04145531|523812120|FG000|Part A|Physician Decision|2|||
145263600|NCT04145531|523812121|FG001|Part A|Physician Decision|5|||
145263601|NCT04145531|523812122|FG002|Part A|Physician Decision|2|||
145263602|NCT04145531|523812123|FG003|Part A|Physician Decision|0|||
145263603|NCT04145531|523812120|FG000|Part A|Progressive disease|0|||
145263604|NCT04145531|523812121|FG001|Part A|Progressive disease|2|||
145263605|NCT04145531|523812122|FG002|Part A|Progressive disease|1|||
145263606|NCT04145531|523812123|FG003|Part A|Progressive disease|0|||
145263607|NCT04145531|523812120|FG000|Part A|Protocol deviation|0|||
145263608|NCT04145531|523812121|FG001|Part A|Protocol deviation|0|||
145263609|NCT04145531|523812122|FG002|Part A|Protocol deviation|1|||
145263610|NCT04145531|523812123|FG003|Part A|Protocol deviation|0|||
145263611|NCT04145531|523812120|FG000|Part A|Withdrawal by parent or guardian|1|||
145263612|NCT04145531|523812121|FG001|Part A|Withdrawal by parent or guardian|0|||
145263613|NCT04145531|523812122|FG002|Part A|Withdrawal by parent or guardian|0|||
145263614|NCT04145531|523812123|FG003|Part A|Withdrawal by parent or guardian|0|||
145263615|NCT04145531|523812120|FG000|Part A|Withdrawal by participant|0|||
145263616|NCT04145531|523812121|FG001|Part A|Withdrawal by participant|0|||
145263617|NCT04145531|523812122|FG002|Part A|Withdrawal by participant|1|||
145263618|NCT04145531|523812123|FG003|Part A|Withdrawal by participant|0|||
145263619|NCT04145531|523812120|FG000|Part A|Other|0|||
145263620|NCT04145531|523812121|FG001|Part A|Other|0|||
145263621|NCT04145531|523812122|FG002|Part A|Other|1|||
145263622|NCT04145531|523812123|FG003|Part A|Other|0|||
145263623|NCT04145531|523812120|FG000|Part B|Adverse Event|0|||
145263624|NCT04145531|523812121|FG001|Part B|Adverse Event|0|||
145263625|NCT04145531|523812122|FG002|Part B|Adverse Event|0|||
145579725|NCT03095417|524977131|FG002|Overall Study|refusal|0|||
145579726|NCT03095417|524977132|FG003|Overall Study|refusal|1|||
145263626|NCT04145531|523812123|FG003|Part B|Adverse Event|21|||
145263627|NCT04145531|523812120|FG000|Part B|Physician Decision|0|||
145263628|NCT04145531|523812121|FG001|Part B|Physician Decision|0|||
145263629|NCT04145531|523812122|FG002|Part B|Physician Decision|0|||
145263630|NCT04145531|523812123|FG003|Part B|Physician Decision|7|||
145579727|NCT03095417|524977129|FG000|Overall Study|Withdrawal by Subject|8|||
145579728|NCT03095417|524977130|FG001|Overall Study|Withdrawal by Subject|2|||
145263631|NCT04145531|523812120|FG000|Part B|Progressive disease|0|||
145263632|NCT04145531|523812121|FG001|Part B|Progressive disease|0|||
145263633|NCT04145531|523812122|FG002|Part B|Progressive disease|0|||
145263634|NCT04145531|523812123|FG003|Part B|Progressive disease|1|||
145263635|NCT04145531|523812120|FG000|Part B|Recurrent disease|0|||
145263636|NCT04145531|523812121|FG001|Part B|Recurrent disease|0|||
145263637|NCT04145531|523812122|FG002|Part B|Recurrent disease|0|||
145263638|NCT04145531|523812123|FG003|Part B|Recurrent disease|1|||
145263639|NCT04145531|523812120|FG000|Part B|Withdrawal by parent or guardian|0|||
145263640|NCT04145531|523812121|FG001|Part B|Withdrawal by parent or guardian|0|||
145263641|NCT04145531|523812122|FG002|Part B|Withdrawal by parent or guardian|0|||
145263642|NCT04145531|523812123|FG003|Part B|Withdrawal by parent or guardian|3|||
145263643|NCT04145531|523812120|FG000|Part B|Withdrawal by participant|0|||
145263644|NCT04145531|523812121|FG001|Part B|Withdrawal by participant|0|||
145579729|NCT03095417|524977131|FG002|Overall Study|Withdrawal by Subject|5|||
145579730|NCT03095417|524977132|FG003|Overall Study|Withdrawal by Subject|4|||
145579731|NCT03095417|524977129|FG000|Overall Study|Physician Decision|1|||
145579732|NCT03095417|524977130|FG001|Overall Study|Physician Decision|2|||
145579733|NCT03095417|524977131|FG002|Overall Study|Physician Decision|2|||
145579734|NCT03095417|524977132|FG003|Overall Study|Physician Decision|2|||
145579735|NCT03095417|524977129|FG000|Overall Study|Death|1|||
145579736|NCT03095417|524977130|FG001|Overall Study|Death|2|||
145579737|NCT03095417|524977131|FG002|Overall Study|Death|1|||
145579738|NCT03095417|524977132|FG003|Overall Study|Death|3|||
145623517|NCT00859014|525133964|FG000|Overall Study|Lost to Follow-up|1|||
145623518|NCT00162942|525133965|FG000|Overall Study|Adverse Event|10|||
145623519|NCT00162942|525133966|FG001|Overall Study|Adverse Event|6|||
145623520|NCT00162942|525133965|FG000|Overall Study|Death|1|||
145623521|NCT00162942|525133966|FG001|Overall Study|Death|0|||
145623522|NCT00162942|525133965|FG000|Overall Study|Withdrawal by Subject|3|||
145623523|NCT00162942|525133966|FG001|Overall Study|Withdrawal by Subject|6|||
145623524|NCT00162942|525133965|FG000|Overall Study|Physician Decision|1|||
145623525|NCT00162942|525133966|FG001|Overall Study|Physician Decision|0|||
145623526|NCT00162942|525133965|FG000|Overall Study|Enter Open-Label Study|76|||
145623527|NCT00162942|525133966|FG001|Overall Study|Enter Open-Label Study|35|||
145623528|NCT00162942|525133965|FG000|Overall Study|Alternate Therapy|6|||
145623529|NCT00162942|525133966|FG001|Overall Study|Alternate Therapy|2|||
145623530|NCT00162942|525133965|FG000|Overall Study|Lack of Efficacy|1|||
145623531|NCT00162942|525133966|FG001|Overall Study|Lack of Efficacy|0|||
145623532|NCT00162942|525133965|FG000|Overall Study|Flare During Active Treatment|7|||
145623533|NCT00162942|525133966|FG001|Overall Study|Flare During Active Treatment|3|||
145623534|NCT00162942|525133965|FG000|Overall Study|2 or more consecutive treatments missed|1|||
145623535|NCT00162942|525133966|FG001|Overall Study|2 or more consecutive treatments missed|0|||
145623536|NCT01163149|525133970|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
145623537|NCT01163149|525133971|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145623538|NCT01163149|525133972|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
145623539|NCT01163149|525133970|FG000|Extension Treatment Period|Adverse Event|0|||
145623540|NCT01163149|525133971|FG001|Extension Treatment Period|Adverse Event|1|||
145623541|NCT01163149|525133972|FG002|Extension Treatment Period|Adverse Event|0|||
145623542|NCT01163149|525133970|FG000|Extension Treatment Period|Noncompliance|0|||
145623543|NCT01163149|525133971|FG001|Extension Treatment Period|Noncompliance|0|||
145623544|NCT01163149|525133972|FG002|Extension Treatment Period|Noncompliance|1|||
145623545|NCT01192295|525133973|FG000|Overall Study|Adverse Event|3|||
145623546|NCT01192295|525133974|FG001|Overall Study|Adverse Event|7|||
145623547|NCT01192295|525133973|FG000|Overall Study|Withdrawal by Subject|3|||
145623548|NCT01192295|525133974|FG001|Overall Study|Withdrawal by Subject|4|||
145623549|NCT01192295|525133973|FG000|Overall Study|Lost to Follow-up|0|||
145623550|NCT01192295|525133974|FG001|Overall Study|Lost to Follow-up|1|||
145623551|NCT01192295|525133973|FG000|Overall Study|Lack of Efficacy|0|||
145623552|NCT01192295|525133974|FG001|Overall Study|Lack of Efficacy|5|||
145623553|NCT01192295|525133973|FG000|Overall Study|Administrative|4|||
145623554|NCT01192295|525133974|FG001|Overall Study|Administrative|6|||
145623555|NCT00630539|525133975|FG000|Overall Study|Adverse Event|1|||
145623556|NCT00630539|525133976|FG001|Overall Study|Adverse Event|3|||
145623557|NCT00630539|525133977|FG002|Overall Study|Adverse Event|1|||
145623558|NCT00630539|525133978|FG003|Overall Study|Adverse Event|2|||
145623559|NCT00630539|525133975|FG000|Overall Study|Withdrawal by Subject|0|||
145623560|NCT00630539|525133976|FG001|Overall Study|Withdrawal by Subject|1|||
145623561|NCT00630539|525133977|FG002|Overall Study|Withdrawal by Subject|0|||
145623562|NCT00630539|525133978|FG003|Overall Study|Withdrawal by Subject|1|||
145623563|NCT01700530|525133979|FG000|Overall Study|Withdrawal by Subject|0|||
145623564|NCT01700530|525133980|FG001|Overall Study|Withdrawal by Subject|3|||
145623565|NCT01700530|525133981|FG002|Overall Study|Withdrawal by Subject|1|||
145623566|NCT02806336|525133994|FG000|Overall Study|Physician Decision|1|||
145623567|NCT02806336|525133995|FG001|Overall Study|Physician Decision|0|||
145623568|NCT02806336|525133994|FG000|Overall Study|Withdrawal by Subject|2|||
145623569|NCT02806336|525133995|FG001|Overall Study|Withdrawal by Subject|4|||
145623570|NCT02806336|525133994|FG000|Overall Study|COVID-19 research shut down|3|||
145623571|NCT02806336|525133995|FG001|Overall Study|COVID-19 research shut down|4|||
145623572|NCT02806336|525133994|FG000|Overall Study|Lack of Efficacy|0|||
145623573|NCT02806336|525133995|FG001|Overall Study|Lack of Efficacy|1|||
145623574|NCT04159896|525133996|FG000|Overall Study|Lack of Efficacy|7|||
145263645|NCT04145531|523812122|FG002|Part B|Withdrawal by participant|0|||
145579739|NCT02571452|524977133|FG000|Overall Study Treatment|Protocol Violation|0|||
145623575|NCT04159896|525133996|FG000|Overall Study|Withdrawal by Subject|1|||
145623576|NCT04159896|525133996|FG000|Overall Study|Adverse Event|1|||
145623577|NCT04159896|525133996|FG000|Overall Study|A transient ischaemic attack|1|||
145263646|NCT04145531|523812123|FG003|Part B|Withdrawal by participant|1|||
145263647|NCT04145531|523812120|FG000|Part B|Other|0|||
145579740|NCT02571452|524977134|FG001|Overall Study Treatment|Protocol Violation|1|||
145623578|NCT05705167|525133997|FG000|Overall Study|Randomised but not Treated|0|||
145623579|NCT05705167|525133998|FG001|Overall Study|Randomised but not Treated|2|||
145623580|NCT05705167|525133999|FG002|Overall Study|Randomised but not Treated|0|||
145263648|NCT04145531|523812121|FG001|Part B|Other|0|||
145263649|NCT04145531|523812122|FG002|Part B|Other|0|||
145263650|NCT04145531|523812123|FG003|Part B|Other|1|||
145263651|NCT04988035|523812124|FG000|Overall Study|Death|19|||
145263652|NCT04988035|523812125|FG001|Overall Study|Death|13|||
145263653|NCT04988035|523812124|FG000|Overall Study|Lost to Follow-up|12|||
145263654|NCT04988035|523812125|FG001|Overall Study|Lost to Follow-up|6|||
145263655|NCT04988035|523812124|FG000|Overall Study|Protocol Violation|0|||
145263656|NCT04988035|523812125|FG001|Overall Study|Protocol Violation|1|||
145263657|NCT04988035|523812124|FG000|Overall Study|Withdrawal by Subject|2|||
145263658|NCT04988035|523812125|FG001|Overall Study|Withdrawal by Subject|4|||
145263659|NCT04988035|523812124|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
145263660|NCT04988035|523812125|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
145263661|NCT03602976|523812126|FG000|Overall Study|Withdrawal by Subject|1|||
145263662|NCT03732534|523812127|FG000|Overall Study|Study terminated by Sponsor|6|||
145263663|NCT02190604|523812128|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263664|NCT02190604|523812129|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263665|NCT02190604|523812130|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263666|NCT02190604|523812131|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263667|NCT02190604|523812132|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263668|NCT02190604|523812133|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263669|NCT02190604|523812134|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263670|NCT02190604|523812135|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263671|NCT02190604|523812136|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263672|NCT02190604|523812137|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263673|NCT02190604|523812138|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263674|NCT02190604|523812139|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263675|NCT02190604|523812140|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263676|NCT02190604|523812141|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263677|NCT02190604|523812142|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
145263678|NCT02190604|523812143|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263679|NCT02190604|523812144|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263680|NCT02190604|523812145|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263681|NCT02190604|523812146|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
145263682|NCT02190604|523812128|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263683|NCT02190604|523812129|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263684|NCT02190604|523812130|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263685|NCT02190604|523812131|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263686|NCT02190604|523812132|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263687|NCT02190604|523812133|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263688|NCT02190604|523812134|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263689|NCT02190604|523812135|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263690|NCT02190604|523812136|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263691|NCT02190604|523812137|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263692|NCT02190604|523812138|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263693|NCT02190604|523812139|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263694|NCT02190604|523812140|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263695|NCT02190604|523812141|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
145263696|NCT02190604|523812142|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263697|NCT02190604|523812143|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263698|NCT02190604|523812144|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263699|NCT02190604|523812145|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263700|NCT02190604|523812146|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
145263701|NCT02797951|523812147|FG000|Overall Study|Adverse Event|4|||
145263702|NCT02797951|523812147|FG000|Overall Study|Death|1|||
145263703|NCT02797951|523812147|FG000|Overall Study|Lack of Efficacy|19|||
145263704|NCT02797951|523812147|FG000|Overall Study|Lost to Follow-up|4|||
145263705|NCT02797951|523812147|FG000|Overall Study|Physician Decision|6|||
145263706|NCT02797951|523812147|FG000|Overall Study|Withdrawal by Subject|15|||
145263707|NCT03735849|523812148|FG000|Overall Study|Lost to Follow-up|1|||
145263708|NCT03735849|523812149|FG001|Overall Study|Lost to Follow-up|0|||
145263709|NCT03735849|523812150|FG002|Overall Study|Lost to Follow-up|0|||
145263710|NCT03735849|523812148|FG000|Overall Study|Participant unable to adhere to visit|1|||
145263711|NCT03735849|523812149|FG001|Overall Study|Participant unable to adhere to visit|0|||
145263712|NCT03735849|523812150|FG002|Overall Study|Participant unable to adhere to visit|0|||
145263713|NCT03735849|523812148|FG000|Overall Study|Not Randomized|0|||
145263714|NCT03735849|523812149|FG001|Overall Study|Not Randomized|0|||
145263715|NCT03735849|523812150|FG002|Overall Study|Not Randomized|4|||
145263716|NCT04626947|523812153|FG000|Overall Study|Study terminated|14|||
145263717|NCT00265109|523812158|FG000|Overall Study|Withdrawal by Subject|5|||
145263718|NCT00265109|523812158|FG000|Overall Study|Adverse Event|1|||
145263719|NCT03556202|523812161|FG000|Extension Treatment Period|Adverse Event|18|||
145579741|NCT02571452|524977133|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
145579742|NCT02571452|524977134|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
145579743|NCT02571452|524977133|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
145579744|NCT02571452|524977134|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
145579745|NCT01877421|524977135|FG000|Phase 2|Lost to Follow-up|0|||
145579746|NCT01877421|524977136|FG001|Phase 2|Lost to Follow-up|0|||
145579747|NCT01877421|524977137|FG002|Phase 2|Lost to Follow-up|0|||
145579748|NCT01877421|524977138|FG003|Phase 2|Lost to Follow-up|0|||
145579749|NCT01877421|524977139|FG004|Phase 2|Lost to Follow-up|0|||
145579750|NCT01877421|524977140|FG005|Phase 2|Lost to Follow-up|0|||
145579751|NCT01877421|524977141|FG006|Phase 2|Lost to Follow-up|1|||
145579752|NCT01877421|524977142|FG007|Phase 2|Lost to Follow-up|0|||
145579753|NCT01877421|524977143|FG008|Phase 2|Lost to Follow-up|0|||
145579754|NCT01877421|524977144|FG009|Phase 2|Lost to Follow-up|0|||
145579755|NCT01877421|524977145|FG010|Phase 2|Lost to Follow-up|0|||
145579756|NCT01877421|524977146|FG011|Phase 2|Lost to Follow-up|0|||
145579757|NCT01877421|524977147|FG012|Phase 2|Lost to Follow-up|0|||
145579758|NCT01877421|524977148|FG013|Phase 2|Lost to Follow-up|0|||
145579759|NCT01877421|524977149|FG014|Phase 2|Lost to Follow-up|0|||
145579760|NCT01877421|524977150|FG015|Phase 2|Lost to Follow-up|0|||
145579761|NCT01877421|524977151|FG016|Phase 2|Lost to Follow-up|0|||
145579762|NCT01877421|524977152|FG017|Phase 2|Lost to Follow-up|0|||
145579763|NCT01877421|524977135|FG000|Phase 2|Withdrawal by Subject|0|||
145579764|NCT01877421|524977136|FG001|Phase 2|Withdrawal by Subject|0|||
145579765|NCT01877421|524977137|FG002|Phase 2|Withdrawal by Subject|0|||
145579766|NCT01877421|524977138|FG003|Phase 2|Withdrawal by Subject|0|||
145579767|NCT01877421|524977139|FG004|Phase 2|Withdrawal by Subject|0|||
145579768|NCT01877421|524977140|FG005|Phase 2|Withdrawal by Subject|0|||
145579769|NCT01877421|524977141|FG006|Phase 2|Withdrawal by Subject|0|||
145579770|NCT01877421|524977142|FG007|Phase 2|Withdrawal by Subject|0|||
145579771|NCT01877421|524977143|FG008|Phase 2|Withdrawal by Subject|1|||
145579772|NCT01877421|524977144|FG009|Phase 2|Withdrawal by Subject|0|||
145579773|NCT01877421|524977145|FG010|Phase 2|Withdrawal by Subject|1|||
145579774|NCT01877421|524977146|FG011|Phase 2|Withdrawal by Subject|0|||
145579775|NCT01877421|524977147|FG012|Phase 2|Withdrawal by Subject|1|||
145579776|NCT01877421|524977148|FG013|Phase 2|Withdrawal by Subject|0|||
145579777|NCT01877421|524977149|FG014|Phase 2|Withdrawal by Subject|0|||
145579778|NCT01877421|524977150|FG015|Phase 2|Withdrawal by Subject|1|||
145579779|NCT01877421|524977151|FG016|Phase 2|Withdrawal by Subject|0|||
145579780|NCT01877421|524977152|FG017|Phase 2|Withdrawal by Subject|0|||
145579781|NCT01877421|524977135|FG000|Phase 2|Protocol Violation|0|||
145579782|NCT01877421|524977136|FG001|Phase 2|Protocol Violation|0|||
145579783|NCT01877421|524977137|FG002|Phase 2|Protocol Violation|0|||
145579784|NCT01877421|524977138|FG003|Phase 2|Protocol Violation|0|||
145579785|NCT01877421|524977139|FG004|Phase 2|Protocol Violation|0|||
145579786|NCT01877421|524977140|FG005|Phase 2|Protocol Violation|0|||
145579787|NCT01877421|524977141|FG006|Phase 2|Protocol Violation|0|||
145579788|NCT01877421|524977142|FG007|Phase 2|Protocol Violation|0|||
145579789|NCT01877421|524977143|FG008|Phase 2|Protocol Violation|0|||
145579790|NCT01877421|524977144|FG009|Phase 2|Protocol Violation|0|||
145579791|NCT01877421|524977145|FG010|Phase 2|Protocol Violation|1|||
145579792|NCT01877421|524977146|FG011|Phase 2|Protocol Violation|0|||
145579793|NCT01877421|524977147|FG012|Phase 2|Protocol Violation|0|||
145579794|NCT01877421|524977148|FG013|Phase 2|Protocol Violation|0|||
145579795|NCT01877421|524977149|FG014|Phase 2|Protocol Violation|0|||
145579796|NCT01877421|524977150|FG015|Phase 2|Protocol Violation|0|||
145579797|NCT01877421|524977151|FG016|Phase 2|Protocol Violation|0|||
145579798|NCT01877421|524977152|FG017|Phase 2|Protocol Violation|0|||
145579799|NCT00908960|524977155|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
145579800|NCT00908960|524977156|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
145579801|NCT00908960|524977157|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
145579802|NCT01158924|524977159|FG000|Overall Study|Withdrawal by Subject|1|||
145579803|NCT01158924|524977160|FG001|Overall Study|Withdrawal by Subject|2|||
145579804|NCT01158924|524977159|FG000|Overall Study|Lost to Follow-up|0|||
145372345|NCT01508130|524213194|FG000|Overall Study|Adverse Event|81|||
145579805|NCT01158924|524977160|FG001|Overall Study|Lost to Follow-up|1|||
145579806|NCT03795922|524977161|FG000|Overall Study|Adverse Event|2|||
145579807|NCT03795922|524977162|FG001|Overall Study|Adverse Event|1|||
145579808|NCT03795922|524977161|FG000|Overall Study|Withdrawal by Subject|5|||
145579809|NCT03795922|524977162|FG001|Overall Study|Withdrawal by Subject|13|||
145372346|NCT01508130|524213195|FG001|Overall Study|Adverse Event|28|||
145579810|NCT03795922|524977161|FG000|Overall Study|Lost to Follow-up|2|||
145579811|NCT03795922|524977162|FG001|Overall Study|Lost to Follow-up|3|||
145579812|NCT03795922|524977161|FG000|Overall Study|Pregnancy|0|||
145579813|NCT03795922|524977162|FG001|Overall Study|Pregnancy|1|||
145579814|NCT03795922|524977161|FG000|Overall Study|Physician Decision|1|||
145579815|NCT03795922|524977162|FG001|Overall Study|Physician Decision|2|||
145579816|NCT03795922|524977161|FG000|Overall Study|Protocol Violation|0|||
145372347|NCT01508130|524213194|FG000|Overall Study|Death|3|||
145579817|NCT03795922|524977162|FG001|Overall Study|Protocol Violation|1|||
145579818|NCT03795922|524977161|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
145579819|NCT03795922|524977162|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
145579820|NCT01416805|524977177|FG000|Overall Study|Lost to Follow-up|4|||
145579821|NCT01416805|524977178|FG001|Overall Study|Lost to Follow-up|4|||
145579822|NCT03056690|524977179|FG000|Overall Study|Adverse Event|3|||
145579823|NCT03056690|524977180|FG001|Overall Study|Adverse Event|2|||
145579824|NCT03056690|524977179|FG000|Overall Study|Lack of Efficacy|1|||
145579825|NCT03056690|524977180|FG001|Overall Study|Lack of Efficacy|2|||
145579826|NCT03056690|524977179|FG000|Overall Study|Lost to Follow-up|3|||
145579827|NCT03056690|524977180|FG001|Overall Study|Lost to Follow-up|2|||
145579828|NCT03056690|524977179|FG000|Overall Study|Protocol Violation|2|||
145579829|NCT03056690|524977180|FG001|Overall Study|Protocol Violation|2|||
145579830|NCT03056690|524977179|FG000|Overall Study|Withdrawal by Subject|3|||
145579831|NCT03056690|524977180|FG001|Overall Study|Withdrawal by Subject|6|||
145579832|NCT03056690|524977179|FG000|Overall Study|Non-compliance with Study Drug|1|||
145579833|NCT03056690|524977180|FG001|Overall Study|Non-compliance with Study Drug|0|||
145579834|NCT03056690|524977179|FG000|Overall Study|Miscellaneous|1|||
145579835|NCT03056690|524977180|FG001|Overall Study|Miscellaneous|2|||
145263720|NCT03556202|523812162|FG001|Extension Treatment Period|Adverse Event|14|||
145263721|NCT03556202|523812163|FG002|Extension Treatment Period|Adverse Event|9|||
145263722|NCT03556202|523812161|FG000|Extension Treatment Period|Death|2|||
145263723|NCT03556202|523812162|FG001|Extension Treatment Period|Death|6|||
145263724|NCT03556202|523812163|FG002|Extension Treatment Period|Death|0|||
145263725|NCT03556202|523812161|FG000|Extension Treatment Period|Lack of Efficacy|5|||
145263726|NCT03556202|523812162|FG001|Extension Treatment Period|Lack of Efficacy|12|||
145263727|NCT03556202|523812163|FG002|Extension Treatment Period|Lack of Efficacy|18|||
145263728|NCT03556202|523812161|FG000|Extension Treatment Period|Lost to Follow-up|9|||
145263729|NCT03556202|523812162|FG001|Extension Treatment Period|Lost to Follow-up|20|||
145263730|NCT03556202|523812163|FG002|Extension Treatment Period|Lost to Follow-up|2|||
145263731|NCT03556202|523812161|FG000|Extension Treatment Period|Pregnancy|2|||
145263732|NCT03556202|523812162|FG001|Extension Treatment Period|Pregnancy|4|||
145263733|NCT03556202|523812163|FG002|Extension Treatment Period|Pregnancy|3|||
145263734|NCT03556202|523812161|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
145263735|NCT03556202|523812162|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
145263736|NCT03556202|523812163|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
145263737|NCT03556202|523812161|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
145263738|NCT03556202|523812162|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
145263739|NCT03556202|523812163|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
145263740|NCT03556202|523812161|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
145263741|NCT03556202|523812162|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
145263742|NCT03556202|523812163|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
145263743|NCT03556202|523812161|FG000|Extension Treatment Period|Physician Decision|0|||
145263744|NCT03556202|523812162|FG001|Extension Treatment Period|Physician Decision|8|||
145263745|NCT03556202|523812163|FG002|Extension Treatment Period|Physician Decision|2|||
145263746|NCT03556202|523812161|FG000|Extension Treatment Period|Protocol Violation|0|||
145263747|NCT03556202|523812162|FG001|Extension Treatment Period|Protocol Violation|1|||
145263748|NCT03556202|523812163|FG002|Extension Treatment Period|Protocol Violation|1|||
145263749|NCT03556202|523812161|FG000|Extension Treatment Period|Sponsor Decision|0|||
145263750|NCT03556202|523812162|FG001|Extension Treatment Period|Sponsor Decision|1|||
145263751|NCT03556202|523812163|FG002|Extension Treatment Period|Sponsor Decision|0|||
145263752|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
145263753|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
145263754|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
145263755|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Death|1|||
145263756|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Death|0|||
145263757|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Death|0|||
145263758|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
145263759|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
145263760|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
145263761|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
145263762|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
145579836|NCT01723904|524977183|FG000|Overall Study|Noncompliant|3|||
145579837|NCT01723904|524977183|FG000|Overall Study|Adverse Event|5|||
145579838|NCT01723904|524977183|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
145579839|NCT02127307|524977190|FG000|Overall Study|Protocol Violation|36|||
145579840|NCT02127307|524977190|FG000|Overall Study|Lost to Follow-up|2|||
145263763|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
145263764|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
145263765|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
145263766|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
145263767|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
145263768|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
145263769|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
145579841|NCT02127307|524977190|FG000|Overall Study|Death|101|||
145579842|NCT02127307|524977190|FG000|Overall Study|Other than specified above|169|||
145579843|NCT00235989|524977192|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
145579844|NCT00235989|524977193|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
145579845|NCT00235989|524977194|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
145579846|NCT00235989|524977195|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
145579847|NCT00235989|524977196|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
145579848|NCT00235989|524977197|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
145579849|NCT00235989|524977192|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
145579850|NCT00235989|524977193|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
145579851|NCT00235989|524977194|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
145579852|NCT00235989|524977195|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
145579853|NCT00235989|524977196|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
145579854|NCT00235989|524977197|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
145579855|NCT00235989|524977192|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
145579856|NCT00235989|524977193|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
145579857|NCT00235989|524977194|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
145579858|NCT00235989|524977195|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
145579859|NCT00235989|524977196|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
145372348|NCT01508130|524213195|FG001|Overall Study|Death|1|||
145372349|NCT01508130|524213194|FG000|Overall Study|Protocol Violation|2|||
145372350|NCT01508130|524213195|FG001|Overall Study|Protocol Violation|0|||
145372351|NCT01508130|524213194|FG000|Overall Study|Lost to Follow-up|25|||
145372352|NCT01508130|524213195|FG001|Overall Study|Lost to Follow-up|2|||
145372353|NCT01508130|524213194|FG000|Overall Study|Withdrawal by Subject|3|||
145372354|NCT01508130|524213195|FG001|Overall Study|Withdrawal by Subject|3|||
145372355|NCT01508130|524213194|FG000|Overall Study|Subject's substantial non-compliance|25|||
145372356|NCT01508130|524213195|FG001|Overall Study|Subject's substantial non-compliance|9|||
145372357|NCT01508130|524213194|FG000|Overall Study|Insufficient therapeutic response|74|||
145372358|NCT01508130|524213195|FG001|Overall Study|Insufficient therapeutic response|23|||
145372359|NCT01508130|524213194|FG000|Overall Study|Administrative|14|||
145372360|NCT01508130|524213195|FG001|Overall Study|Administrative|3|||
145372361|NCT00978250|524213197|FG000|Overall Study|Late determination of ineligibility|0|||
145372362|NCT00978250|524213198|FG001|Overall Study|Late determination of ineligibility|1|||
145372363|NCT00978250|524213199|FG002|Overall Study|Late determination of ineligibility|0|||
145372364|NCT00978250|524213200|FG003|Overall Study|Late determination of ineligibility|1|||
145372365|NCT00387010|524213202|FG000|Dose Titration Period|Adverse Event|12|||
145372366|NCT00387010|524213202|FG000|Dose Titration Period|Lack of Efficacy|5|||
145372367|NCT00387010|524213202|FG000|Dose Titration Period|Withdrawal by Subject|3|||
145372368|NCT00387010|524213202|FG000|Dose Titration Period|Protocol Violation|1|||
145372369|NCT00387010|524213202|FG000|Dose Titration Period|Lost to Follow-up|2|||
145372370|NCT00387010|524213202|FG000|Dose Titration Period|Noncompliance with study medication|8|||
145372371|NCT00387010|524213202|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
145372372|NCT00387010|524213202|FG000|Treatment Period|Adverse Event|4|||
145372373|NCT00387010|524213202|FG000|Treatment Period|Withdrawal by Subject|1|||
145372374|NCT00387010|524213202|FG000|Treatment Period|Noncompliance with study medication|2|||
145372375|NCT00387010|524213202|FG000|Treatment Period|Noncompliance with study procedures|3|||
145372376|NCT00387010|524213202|FG000|Treatment Period|Participant reported study drug stolen|1|||
145372377|NCT00520481|524213203|FG000|Overall Study|Adverse Event|4|||
145372378|NCT00520481|524213204|FG001|Overall Study|Adverse Event|1|||
145372379|NCT00520481|524213203|FG000|Overall Study|Withdrawal by Subject|3|||
145372380|NCT00520481|524213204|FG001|Overall Study|Withdrawal by Subject|0|||
145372381|NCT00381043|524213214|FG000|Overall Study|Lost to Follow-up|8|||
145372382|NCT00381043|524213215|FG001|Overall Study|Lost to Follow-up|6|||
145372383|NCT00381043|524213214|FG000|Overall Study|Withdrawal by Subject|3|||
145372384|NCT00381043|524213215|FG001|Overall Study|Withdrawal by Subject|1|||
145372385|NCT00381043|524213214|FG000|Overall Study|wanted more care|0|||
145372386|NCT00381043|524213215|FG001|Overall Study|wanted more care|1|||
145372387|NCT00381043|524213214|FG000|Overall Study|incarcerated|1|||
145372388|NCT00381043|524213215|FG001|Overall Study|incarcerated|0|||
145372389|NCT00471718|524213216|FG000|Overall Study|Adverse Event|3|||
145372390|NCT00471718|524213216|FG000|Overall Study|other complicating disease|1|||
145372391|NCT00471718|524213216|FG000|Overall Study|disease progression|22|||
145372392|NCT00471718|524213216|FG000|Overall Study|Withdrawal by Subject|1|||
145372393|NCT01446237|524213217|FG000|Overall Study|Adverse Event|1|||
145372394|NCT01446237|524213217|FG000|Overall Study|Lost to Follow-up|2|||
145372395|NCT01446237|524213217|FG000|Overall Study|Withdrawal by Subject|7|||
145372396|NCT01931956|524213218|FG000|Overall Study|Death|42|||
145372397|NCT01931956|524213219|FG001|Overall Study|Death|7|||
145372398|NCT01931956|524213220|FG002|Overall Study|Death|379|||
145372399|NCT01931956|524213221|FG003|Overall Study|Death|96|||
145372400|NCT01931956|524213218|FG000|Overall Study|Withdrawal by Subject|5|||
145372401|NCT01931956|524213219|FG001|Overall Study|Withdrawal by Subject|0|||
145372402|NCT01931956|524213220|FG002|Overall Study|Withdrawal by Subject|70|||
145372403|NCT01931956|524213221|FG003|Overall Study|Withdrawal by Subject|30|||
145579860|NCT00235989|524977197|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
145579861|NCT00235989|524977192|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
145579862|NCT00235989|524977193|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
145579863|NCT00235989|524977194|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
145579864|NCT00235989|524977195|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
145579865|NCT00235989|524977196|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
145579866|NCT00235989|524977197|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
145579867|NCT00235989|524977192|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
145579868|NCT00235989|524977193|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
145579869|NCT00235989|524977194|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
145579870|NCT00235989|524977195|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
145579871|NCT00235989|524977196|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
145579872|NCT00235989|524977197|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
145579873|NCT01971346|524977198|FG000|Overall Study|Protocol Violation|3|||
145579874|NCT01971346|524977198|FG000|Overall Study|Lost to Follow-up|2|||
145579875|NCT01971346|524977198|FG000|Overall Study|Withdrawal by Subject|2|||
145579876|NCT01971346|524977198|FG000|Overall Study|Physician Decision|1|||
145579877|NCT04187196|524977199|FG000|Overall Study|Screen Failure|2|||
145579878|NCT04187196|524977200|FG001|Overall Study|Screen Failure|0|||
145579879|NCT00298831|524977201|FG000|Overall Study|Adverse Event|1|||
145579880|NCT00298831|524977201|FG000|Overall Study|Lost to Follow-up|3|||
145579881|NCT00298831|524977201|FG000|Overall Study|Withdrawal by Subject|1|||
145579882|NCT00298831|524977201|FG000|Overall Study|Participants did not receive treatment|27|||
145579883|NCT00183872|524977202|FG000|Overall Study|Death|3|||
145579884|NCT00183872|524977202|FG000|Overall Study|Adverse Event|9|||
145579885|NCT00183872|524977202|FG000|Overall Study|Withdrawal by Subject|2|||
145579886|NCT00183872|524977202|FG000|Overall Study|Drug delayed more than 28 days|2|||
145579887|NCT02052466|524977203|FG000|Overall Study|Withdrawal by Subject|1|||
145579888|NCT02052466|524977203|FG000|Overall Study|Acromial fracture|1|||
145579889|NCT00595582|524977205|FG000|Overall Study|Pilot study that PI terminated|2|||
145579890|NCT00595582|524977205|FG000|Overall Study|Lost to Follow-up|1|||
145579891|NCT00595582|524977205|FG000|Overall Study|Adverse Event|2|||
145579892|NCT00595582|524977205|FG000|Overall Study|Physician Decision|5|||
145579893|NCT02797262|524977206|FG000|Overall Study|Withdrawal by Subject|5|||
145579894|NCT02797262|524977207|FG001|Overall Study|Withdrawal by Subject|1|||
145579895|NCT02797262|524977206|FG000|Overall Study|Lost to Follow-up|10|||
145579896|NCT02797262|524977207|FG001|Overall Study|Lost to Follow-up|7|||
145579897|NCT02797262|524977206|FG000|Overall Study|Death|1|||
145579898|NCT02797262|524977207|FG001|Overall Study|Death|2|||
145579899|NCT02797262|524977206|FG000|Overall Study|Adverse Event|1|||
145579900|NCT02797262|524977207|FG001|Overall Study|Adverse Event|0|||
145579901|NCT02797262|524977206|FG000|Overall Study|COVID-19|2|||
145579902|NCT02797262|524977207|FG001|Overall Study|COVID-19|1|||
145579903|NCT02797262|524977206|FG000|Overall Study|Out-of-country|1|||
145579904|NCT02797262|524977207|FG001|Overall Study|Out-of-country|0|||
145579905|NCT01600586|524977208|FG000|Overall Study|Physician Decision|3|||
145579906|NCT01600586|524977209|FG001|Overall Study|Physician Decision|3|||
145579907|NCT01978184|524977212|FG000|Overall Study|Progressive disease|5|||
145263770|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
145263771|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
145263772|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
145263773|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
145263774|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
145263775|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
145263776|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
145263777|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
145263778|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
145579908|NCT01978184|524977213|FG001|Overall Study|Progressive disease|5|||
145579909|NCT01978184|524977212|FG000|Overall Study|Other than PDA|2|||
145579910|NCT01978184|524977213|FG001|Overall Study|Other than PDA|2|||
145579911|NCT01978184|524977212|FG000|Overall Study|Physician Decision|0|||
145579912|NCT01978184|524977213|FG001|Overall Study|Physician Decision|3|||
145579913|NCT01978184|524977212|FG000|Overall Study|Noncompliance|1|||
145579914|NCT01978184|524977213|FG001|Overall Study|Noncompliance|2|||
145579915|NCT01978184|524977212|FG000|Overall Study|Death|1|||
145579916|NCT01978184|524977213|FG001|Overall Study|Death|0|||
145263779|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
145579917|NCT01978184|524977212|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
145579918|NCT01978184|524977213|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
145263780|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
145579919|NCT00965848|524977220|FG000|Overall Study|Protocol Violation|3|||
145579920|NCT00965848|524977221|FG001|Overall Study|Protocol Violation|0|||
145579921|NCT00965848|524977222|FG002|Overall Study|Protocol Violation|1|||
145579922|NCT00965848|524977220|FG000|Overall Study|Death|11|||
145579923|NCT00965848|524977221|FG001|Overall Study|Death|1|||
145579924|NCT00965848|524977222|FG002|Overall Study|Death|5|||
145579925|NCT00965848|524977220|FG000|Overall Study|Lost to Follow-up|0|||
145579926|NCT00965848|524977221|FG001|Overall Study|Lost to Follow-up|0|||
145579927|NCT00965848|524977222|FG002|Overall Study|Lost to Follow-up|1|||
145579928|NCT00965848|524977220|FG000|Overall Study|Withdrawal by Subject|1|||
145579929|NCT00965848|524977221|FG001|Overall Study|Withdrawal by Subject|0|||
145579930|NCT00965848|524977222|FG002|Overall Study|Withdrawal by Subject|0|||
145579931|NCT00965848|524977220|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
145579932|NCT00965848|524977221|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
145579933|NCT00965848|524977222|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
145579934|NCT00965848|524977220|FG000|Overall Study|Not Clinically Evaluable|7|||
145372404|NCT01931956|524213218|FG000|Overall Study|Lost to Follow-up|2|||
145372405|NCT01931956|524213219|FG001|Overall Study|Lost to Follow-up|0|||
145372406|NCT01931956|524213220|FG002|Overall Study|Lost to Follow-up|11|||
145372407|NCT01931956|524213221|FG003|Overall Study|Lost to Follow-up|7|||
145372408|NCT01931956|524213218|FG000|Overall Study|Expected|2|||
145372409|NCT01931956|524213219|FG001|Overall Study|Expected|0|||
145372410|NCT01931956|524213220|FG002|Overall Study|Expected|6|||
145372411|NCT01931956|524213221|FG003|Overall Study|Expected|0|||
145372412|NCT01931956|524213218|FG000|Overall Study|Not due|0|||
145372413|NCT01931956|524213219|FG001|Overall Study|Not due|0|||
145372414|NCT01931956|524213220|FG002|Overall Study|Not due|21|||
145372415|NCT01931956|524213221|FG003|Overall Study|Not due|0|||
145372416|NCT02847494|524213222|FG000|Overall Study|Lost to Follow-up|8|||
145372417|NCT02847494|524213223|FG001|Overall Study|Lost to Follow-up|5|||
145372418|NCT02294175|524213224|FG000|Overall Study|Withdrawal by Subject|1|||
145372419|NCT02294175|524213225|FG001|Overall Study|Withdrawal by Subject|2|||
145372420|NCT02294175|524213224|FG000|Overall Study|pt taking excluded medication|3|||
145372421|NCT02294175|524213225|FG001|Overall Study|pt taking excluded medication|1|||
145372422|NCT02294175|524213224|FG000|Overall Study|Protocol Violation|1|||
145372423|NCT02294175|524213225|FG001|Overall Study|Protocol Violation|0|||
145372424|NCT02294175|524213224|FG000|Overall Study|Lost to Follow-up|0|||
145372425|NCT02294175|524213225|FG001|Overall Study|Lost to Follow-up|1|||
145372426|NCT02294175|524213224|FG000|Overall Study|wound healed|0|||
145372427|NCT02294175|524213225|FG001|Overall Study|wound healed|2|||
145372428|NCT01901653|524213228|FG000|Overall Study|Death|2|||
145372429|NCT01901653|524213229|FG001|Overall Study|Death|1|||
145372430|NCT01901653|524213230|FG002|Overall Study|Death|8|||
145372431|NCT01901653|524213231|FG003|Overall Study|Death|3|||
145372432|NCT01901653|524213232|FG004|Overall Study|Death|2|||
145372433|NCT01901653|524213233|FG005|Overall Study|Death|2|||
145372434|NCT01901653|524213234|FG006|Overall Study|Death|6|||
145372435|NCT01901653|524213235|FG007|Overall Study|Death|9|||
145372436|NCT01901653|524213236|FG008|Overall Study|Death|1|||
145372437|NCT01901653|524213237|FG009|Overall Study|Death|16|||
145372438|NCT01901653|524213238|FG010|Overall Study|Death|2|||
145372439|NCT01901653|524213239|FG011|Overall Study|Death|15|||
145372440|NCT01901653|524213240|FG012|Overall Study|Death|4|||
145372441|NCT01901653|524213228|FG000|Overall Study|Lost to Follow-up|1|||
145372442|NCT01901653|524213229|FG001|Overall Study|Lost to Follow-up|0|||
145372443|NCT01901653|524213230|FG002|Overall Study|Lost to Follow-up|2|||
145372444|NCT01901653|524213231|FG003|Overall Study|Lost to Follow-up|0|||
145372445|NCT01901653|524213232|FG004|Overall Study|Lost to Follow-up|0|||
145372446|NCT01901653|524213233|FG005|Overall Study|Lost to Follow-up|1|||
145372447|NCT01901653|524213234|FG006|Overall Study|Lost to Follow-up|0|||
145372448|NCT01901653|524213235|FG007|Overall Study|Lost to Follow-up|1|||
145372449|NCT01901653|524213236|FG008|Overall Study|Lost to Follow-up|0|||
145372450|NCT01901653|524213237|FG009|Overall Study|Lost to Follow-up|0|||
145372451|NCT01901653|524213238|FG010|Overall Study|Lost to Follow-up|0|||
145372452|NCT01901653|524213239|FG011|Overall Study|Lost to Follow-up|0|||
145372453|NCT01901653|524213240|FG012|Overall Study|Lost to Follow-up|0|||
145372454|NCT01901653|524213228|FG000|Overall Study|Withdrawal by Subject|0|||
145372455|NCT01901653|524213229|FG001|Overall Study|Withdrawal by Subject|0|||
145372456|NCT01901653|524213230|FG002|Overall Study|Withdrawal by Subject|0|||
145372457|NCT01901653|524213231|FG003|Overall Study|Withdrawal by Subject|0|||
145372458|NCT01901653|524213232|FG004|Overall Study|Withdrawal by Subject|0|||
145372459|NCT01901653|524213233|FG005|Overall Study|Withdrawal by Subject|0|||
145372460|NCT01901653|524213234|FG006|Overall Study|Withdrawal by Subject|1|||
145372461|NCT01901653|524213235|FG007|Overall Study|Withdrawal by Subject|0|||
145372462|NCT01901653|524213236|FG008|Overall Study|Withdrawal by Subject|0|||
145372463|NCT01901653|524213237|FG009|Overall Study|Withdrawal by Subject|0|||
145372464|NCT01901653|524213238|FG010|Overall Study|Withdrawal by Subject|0|||
145372465|NCT01901653|524213239|FG011|Overall Study|Withdrawal by Subject|0|||
145372466|NCT01901653|524213240|FG012|Overall Study|Withdrawal by Subject|0|||
145372467|NCT01901653|524213228|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
145372468|NCT01901653|524213229|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
145372469|NCT01901653|524213230|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
145372470|NCT01901653|524213231|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
145579935|NCT00965848|524977221|FG001|Overall Study|Not Clinically Evaluable|1|||
145579936|NCT00965848|524977222|FG002|Overall Study|Not Clinically Evaluable|1|||
145579937|NCT00965848|524977220|FG000|Overall Study|Other|5|||
145579938|NCT00965848|524977221|FG001|Overall Study|Other|0|||
145579939|NCT00965848|524977222|FG002|Overall Study|Other|1|||
145579940|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
145579941|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
145579942|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
145579943|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
145579944|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
145579945|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
145579946|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
145579947|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
145579948|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
145579949|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
145579950|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
145579951|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
145579952|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
145579953|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
145372471|NCT01901653|524213232|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
145372472|NCT01901653|524213233|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
145372473|NCT01901653|524213234|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
145372474|NCT01901653|524213235|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
145372475|NCT01901653|524213236|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
145372476|NCT01901653|524213237|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
145372477|NCT01901653|524213238|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
145372478|NCT01901653|524213239|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
145372479|NCT01901653|524213240|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
145372480|NCT02841280|524213241|FG000|Overall Study|Adverse Event|2|||
145372481|NCT02841280|524213242|FG001|Overall Study|Adverse Event|1|||
145372482|NCT02841280|524213241|FG000|Overall Study|Death|1|||
145372483|NCT02841280|524213242|FG001|Overall Study|Death|0|||
145372484|NCT02841280|524213241|FG000|Overall Study|Lost to Follow-up|2|||
145372485|NCT02841280|524213242|FG001|Overall Study|Lost to Follow-up|2|||
145372486|NCT02841280|524213241|FG000|Overall Study|Withdrawal by Subject|7|||
145372487|NCT02841280|524213242|FG001|Overall Study|Withdrawal by Subject|3|||
145372488|NCT02841280|524213241|FG000|Overall Study|Stop Point: BP above threshold|2|||
145372489|NCT02841280|524213242|FG001|Overall Study|Stop Point: BP above threshold|0|||
145372490|NCT04553471|524213243|FG000|Overall Study|Did not start treatment on protocol|3|||
145372491|NCT04553471|524213243|FG000|Overall Study|Death|1|||
145372492|NCT01340027|524213245|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
145372493|NCT01340027|524213246|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
145372494|NCT01340027|524213247|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
145372495|NCT01340027|524213248|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
145372496|NCT01340027|524213249|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
145372497|NCT01340027|524213250|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
145372498|NCT01340027|524213251|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
145372499|NCT01340027|524213252|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
145372500|NCT01340027|524213253|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
145372501|NCT01340027|524213254|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
145372502|NCT01340027|524213255|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
145372503|NCT01340027|524213256|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
145372504|NCT01340027|524213245|FG000|Overall Study|Adverse Event|0|||
145372505|NCT01340027|524213246|FG001|Overall Study|Adverse Event|1|||
145372506|NCT01340027|524213247|FG002|Overall Study|Adverse Event|2|||
145372507|NCT01340027|524213248|FG003|Overall Study|Adverse Event|0|||
145372508|NCT01340027|524213249|FG004|Overall Study|Adverse Event|1|||
145372509|NCT01340027|524213250|FG005|Overall Study|Adverse Event|2|||
145372510|NCT01340027|524213251|FG006|Overall Study|Adverse Event|2|||
145372511|NCT01340027|524213252|FG007|Overall Study|Adverse Event|1|||
145372512|NCT01340027|524213253|FG008|Overall Study|Adverse Event|4|||
145372513|NCT01340027|524213254|FG009|Overall Study|Adverse Event|1|||
145372514|NCT01340027|524213255|FG010|Overall Study|Adverse Event|1|||
145372515|NCT01340027|524213256|FG011|Overall Study|Adverse Event|3|||
145372516|NCT01340027|524213245|FG000|Overall Study|Lack of Efficacy|0|||
145372517|NCT01340027|524213246|FG001|Overall Study|Lack of Efficacy|0|||
145372518|NCT01340027|524213247|FG002|Overall Study|Lack of Efficacy|0|||
145372519|NCT01340027|524213248|FG003|Overall Study|Lack of Efficacy|0|||
145372520|NCT01340027|524213249|FG004|Overall Study|Lack of Efficacy|0|||
145579954|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
145372521|NCT01340027|524213250|FG005|Overall Study|Lack of Efficacy|0|||
145372522|NCT01340027|524213251|FG006|Overall Study|Lack of Efficacy|1|||
145372523|NCT01340027|524213252|FG007|Overall Study|Lack of Efficacy|1|||
145579955|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
145579956|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
145579957|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
145372524|NCT01340027|524213253|FG008|Overall Study|Lack of Efficacy|1|||
145372525|NCT01340027|524213254|FG009|Overall Study|Lack of Efficacy|0|||
145372526|NCT01340027|524213255|FG010|Overall Study|Lack of Efficacy|0|||
145372527|NCT01340027|524213256|FG011|Overall Study|Lack of Efficacy|0|||
145372528|NCT01340027|524213245|FG000|Overall Study|Lost to Follow-up|0|||
145372529|NCT01340027|524213246|FG001|Overall Study|Lost to Follow-up|1|||
145372530|NCT01340027|524213247|FG002|Overall Study|Lost to Follow-up|0|||
145372531|NCT01340027|524213248|FG003|Overall Study|Lost to Follow-up|0|||
145372532|NCT01340027|524213249|FG004|Overall Study|Lost to Follow-up|0|||
145372533|NCT01340027|524213250|FG005|Overall Study|Lost to Follow-up|0|||
145372534|NCT01340027|524213251|FG006|Overall Study|Lost to Follow-up|1|||
145372535|NCT01340027|524213252|FG007|Overall Study|Lost to Follow-up|0|||
145372536|NCT01340027|524213253|FG008|Overall Study|Lost to Follow-up|0|||
145372537|NCT01340027|524213254|FG009|Overall Study|Lost to Follow-up|1|||
145372538|NCT01340027|524213255|FG010|Overall Study|Lost to Follow-up|0|||
145372539|NCT01340027|524213256|FG011|Overall Study|Lost to Follow-up|0|||
145372540|NCT01340027|524213245|FG000|Overall Study|Protocol Violation|1|||
145372541|NCT01340027|524213246|FG001|Overall Study|Protocol Violation|2|||
145372542|NCT01340027|524213247|FG002|Overall Study|Protocol Violation|0|||
145372543|NCT01340027|524213248|FG003|Overall Study|Protocol Violation|0|||
145372544|NCT01340027|524213249|FG004|Overall Study|Protocol Violation|6|||
145372545|NCT01340027|524213250|FG005|Overall Study|Protocol Violation|0|||
145372546|NCT01340027|524213251|FG006|Overall Study|Protocol Violation|0|||
145372547|NCT01340027|524213252|FG007|Overall Study|Protocol Violation|1|||
145372548|NCT01340027|524213253|FG008|Overall Study|Protocol Violation|2|||
145372549|NCT01340027|524213254|FG009|Overall Study|Protocol Violation|2|||
145372550|NCT01340027|524213255|FG010|Overall Study|Protocol Violation|0|||
145372551|NCT01340027|524213256|FG011|Overall Study|Protocol Violation|0|||
145263781|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
145263782|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
145263783|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
145263784|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
145263785|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
145263786|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
145263787|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
145263788|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
145263789|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
145263790|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
145263791|NCT03556202|523812161|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
145263792|NCT03556202|523812162|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
145263793|NCT03556202|523812163|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
145263794|NCT04604015|523812172|FG000|Overall Study|Incomplete Data Collection|33|||
145263795|NCT03289676|523812175|FG000|Overall Study|Withdrawal by Subject|2|||
145263796|NCT03289676|523812176|FG001|Overall Study|Withdrawal by Subject|0|||
145263797|NCT03289676|523812175|FG000|Overall Study|Protocol Violation|2|||
145263798|NCT03289676|523812176|FG001|Overall Study|Protocol Violation|0|||
145263799|NCT03289676|523812175|FG000|Overall Study|Lost to Follow-up|0|||
145263800|NCT03289676|523812176|FG001|Overall Study|Lost to Follow-up|1|||
145263801|NCT02576652|523812177|FG000|Overall Study|Withdrawal by Subject|2|||
145263802|NCT04557189|523812186|FG000|Overall Study|Adverse Event|0|||
145263803|NCT04557189|523812187|FG001|Overall Study|Adverse Event|1|||
145263804|NCT04557189|523812186|FG000|Overall Study|Lost to Follow-up|1|||
145263805|NCT04557189|523812187|FG001|Overall Study|Lost to Follow-up|1|||
145263806|NCT04557189|523812186|FG000|Overall Study|Withdrawal by Subject|2|||
145263807|NCT04557189|523812187|FG001|Overall Study|Withdrawal by Subject|1|||
145263808|NCT04557189|523812186|FG000|Overall Study|Reason not Specified|3|||
145263809|NCT04557189|523812187|FG001|Overall Study|Reason not Specified|6|||
145263810|NCT01087944|523812203|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
145263811|NCT01087944|523812204|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
145263812|NCT01087944|523812203|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
145263813|NCT01087944|523812204|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
145263814|NCT00540228|523812205|FG000|Overall Study|Adverse Event|2|||
145263815|NCT00540228|523812206|FG001|Overall Study|Adverse Event|0|||
145263816|NCT00540228|523812207|FG002|Overall Study|Adverse Event|0|||
145263817|NCT00540228|523812208|FG003|Overall Study|Adverse Event|0|||
145372552|NCT01340027|524213245|FG000|Overall Study|Withdrawal by Subject|4|||
145372553|NCT01340027|524213246|FG001|Overall Study|Withdrawal by Subject|3|||
145263818|NCT00540228|523812209|FG004|Overall Study|Adverse Event|0|||
145263819|NCT00540228|523812205|FG000|Overall Study|Lost to Follow-up|1|||
145263820|NCT00540228|523812206|FG001|Overall Study|Lost to Follow-up|1|||
145263821|NCT00540228|523812207|FG002|Overall Study|Lost to Follow-up|0|||
145263822|NCT00540228|523812208|FG003|Overall Study|Lost to Follow-up|0|||
145263823|NCT00540228|523812209|FG004|Overall Study|Lost to Follow-up|0|||
145372554|NCT01340027|524213247|FG002|Overall Study|Withdrawal by Subject|1|||
145372555|NCT01340027|524213248|FG003|Overall Study|Withdrawal by Subject|3|||
145579958|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
145579959|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
145579960|NCT00813761|524977223|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
145579961|NCT00813761|524977224|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
145579962|NCT00813761|524977225|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
145579963|NCT00813761|524977226|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
145263824|NCT02451137|523812210|FG000|Overall Study|Randomized but not treated|19|||
145263825|NCT02451137|523812211|FG001|Overall Study|Randomized but not treated|27|||
145263826|NCT02451137|523812210|FG000|Overall Study|Adverse Event|43|||
145263827|NCT02451137|523812211|FG001|Overall Study|Adverse Event|42|||
145263828|NCT02451137|523812210|FG000|Overall Study|Lack of Efficacy|4|||
145263829|NCT02451137|523812211|FG001|Overall Study|Lack of Efficacy|9|||
145263830|NCT02451137|523812210|FG000|Overall Study|Participant decision:discontinue insulin|41|||
145579964|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
145579965|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
145579966|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
145579967|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
145579968|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
145579969|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
145579970|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
145579971|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
145579972|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
145579973|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
145579974|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
145579975|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
145372556|NCT01340027|524213249|FG004|Overall Study|Withdrawal by Subject|3|||
145372557|NCT01340027|524213250|FG005|Overall Study|Withdrawal by Subject|2|||
145372558|NCT01340027|524213251|FG006|Overall Study|Withdrawal by Subject|3|||
145372559|NCT01340027|524213252|FG007|Overall Study|Withdrawal by Subject|4|||
145372560|NCT01340027|524213253|FG008|Overall Study|Withdrawal by Subject|1|||
145372561|NCT01340027|524213254|FG009|Overall Study|Withdrawal by Subject|2|||
145372562|NCT01340027|524213255|FG010|Overall Study|Withdrawal by Subject|0|||
145372563|NCT01340027|524213256|FG011|Overall Study|Withdrawal by Subject|1|||
145372564|NCT01340027|524213245|FG000|Overall Study|Miscellaneous|0|||
145372565|NCT01340027|524213246|FG001|Overall Study|Miscellaneous|0|||
145372566|NCT01340027|524213247|FG002|Overall Study|Miscellaneous|0|||
145372567|NCT01340027|524213248|FG003|Overall Study|Miscellaneous|1|||
145372568|NCT01340027|524213249|FG004|Overall Study|Miscellaneous|0|||
145372569|NCT01340027|524213250|FG005|Overall Study|Miscellaneous|0|||
145372570|NCT01340027|524213251|FG006|Overall Study|Miscellaneous|0|||
145372571|NCT01340027|524213252|FG007|Overall Study|Miscellaneous|0|||
145372572|NCT01340027|524213253|FG008|Overall Study|Miscellaneous|0|||
145372573|NCT01340027|524213254|FG009|Overall Study|Miscellaneous|0|||
145372574|NCT01340027|524213255|FG010|Overall Study|Miscellaneous|1|||
145372575|NCT01340027|524213256|FG011|Overall Study|Miscellaneous|0|||
145372576|NCT00833482|524213257|FG000|Days 11-20|Adverse Event|0|||
145372577|NCT00833482|524213258|FG001|Days 11-20|Adverse Event|2|||
145372578|NCT00833482|524213259|FG002|Days 11-20|Adverse Event|0|||
145372579|NCT00833482|524213260|FG003|Days 11-20|Adverse Event|0|||
145372580|NCT00833482|524213261|FG004|Days 11-20|Adverse Event|0|||
145372581|NCT00833482|524213262|FG005|Days 11-20|Adverse Event|0|||
145372582|NCT00833482|524213257|FG000|Days 11-20|Withdrawal by Subject|0|||
145372583|NCT00833482|524213258|FG001|Days 11-20|Withdrawal by Subject|1|||
145372584|NCT00833482|524213259|FG002|Days 11-20|Withdrawal by Subject|0|||
145372585|NCT00833482|524213260|FG003|Days 11-20|Withdrawal by Subject|0|||
145372586|NCT00833482|524213261|FG004|Days 11-20|Withdrawal by Subject|0|||
145372587|NCT00833482|524213262|FG005|Days 11-20|Withdrawal by Subject|0|||
145372588|NCT00833482|524213257|FG000|Days 21-30|Adverse Event|0|||
145372589|NCT00833482|524213258|FG001|Days 21-30|Adverse Event|0|||
145372590|NCT00833482|524213259|FG002|Days 21-30|Adverse Event|1|||
145372591|NCT00833482|524213260|FG003|Days 21-30|Adverse Event|0|||
145372592|NCT00833482|524213261|FG004|Days 21-30|Adverse Event|0|||
145372593|NCT00833482|524213262|FG005|Days 21-30|Adverse Event|0|||
145372594|NCT00833482|524213257|FG000|Days 21-30|Withdrawal by Subject|0|||
145372595|NCT00833482|524213258|FG001|Days 21-30|Withdrawal by Subject|0|||
145372596|NCT00833482|524213259|FG002|Days 21-30|Withdrawal by Subject|0|||
145372597|NCT00833482|524213260|FG003|Days 21-30|Withdrawal by Subject|0|||
145372598|NCT00833482|524213261|FG004|Days 21-30|Withdrawal by Subject|1|||
145579976|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
145579977|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
145372599|NCT00833482|524213262|FG005|Days 21-30|Withdrawal by Subject|0|||
145372600|NCT02496091|524213263|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145372601|NCT01970475|524213267|FG000|Overall Study|Withdrawal by Subject|11|||
145263831|NCT02451137|523812211|FG001|Overall Study|Participant decision:discontinue insulin|43|||
145372602|NCT01970475|524213268|FG001|Overall Study|Withdrawal by Subject|6|||
145372603|NCT01970475|524213267|FG000|Overall Study|Adverse Event|7|||
145372604|NCT01970475|524213268|FG001|Overall Study|Adverse Event|3|||
145579978|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
145263832|NCT02451137|523812210|FG000|Overall Study|Hypoglycemia|2|||
145263833|NCT02451137|523812211|FG001|Overall Study|Hypoglycemia|1|||
145263834|NCT02451137|523812210|FG000|Overall Study|Investigator's decision|23|||
145263835|NCT02451137|523812211|FG001|Overall Study|Investigator's decision|19|||
145263836|NCT02451137|523812210|FG000|Overall Study|Lost to Follow-up|53|||
145263837|NCT02451137|523812211|FG001|Overall Study|Lost to Follow-up|61|||
145263838|NCT02451137|523812210|FG000|Overall Study|Physician Decision|6|||
145263839|NCT02451137|523812211|FG001|Overall Study|Physician Decision|5|||
145263840|NCT02451137|523812210|FG000|Overall Study|Sponsor decision|13|||
145263841|NCT02451137|523812211|FG001|Overall Study|Sponsor decision|25|||
145263842|NCT02451137|523812210|FG000|Overall Study|Withdrawal by Subject|40|||
145263843|NCT02451137|523812211|FG001|Overall Study|Withdrawal by Subject|63|||
145263844|NCT02451137|523812210|FG000|Overall Study|Other than specified above|2|||
145263845|NCT02451137|523812211|FG001|Overall Study|Other than specified above|3|||
145263846|NCT01977573|523812212|FG000|Overall Study|Adverse Event|7|||
145263847|NCT01977573|523812213|FG001|Overall Study|Adverse Event|0|||
145263848|NCT01977573|523812214|FG002|Overall Study|Adverse Event|2|||
145263849|NCT01977573|523812215|FG003|Overall Study|Adverse Event|1|||
145263850|NCT01977573|523812212|FG000|Overall Study|Lost to Follow-up|1|||
145263851|NCT01977573|523812213|FG001|Overall Study|Lost to Follow-up|0|||
145263852|NCT01977573|523812214|FG002|Overall Study|Lost to Follow-up|0|||
145263853|NCT01977573|523812215|FG003|Overall Study|Lost to Follow-up|1|||
145263854|NCT01977573|523812212|FG000|Overall Study|Physician Decision|1|||
145263855|NCT01977573|523812213|FG001|Overall Study|Physician Decision|0|||
145263856|NCT01977573|523812214|FG002|Overall Study|Physician Decision|0|||
145263857|NCT01977573|523812215|FG003|Overall Study|Physician Decision|0|||
145263858|NCT01977573|523812212|FG000|Overall Study|Protocol Violation|3|||
145263859|NCT01977573|523812213|FG001|Overall Study|Protocol Violation|1|||
145263860|NCT01977573|523812214|FG002|Overall Study|Protocol Violation|0|||
145263861|NCT01977573|523812215|FG003|Overall Study|Protocol Violation|0|||
145263862|NCT01977573|523812212|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
145263863|NCT01977573|523812213|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
145263864|NCT01977573|523812214|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
145263865|NCT01977573|523812215|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
145263866|NCT01977573|523812212|FG000|Overall Study|Withdrawal by Subject|6|||
145263867|NCT01977573|523812213|FG001|Overall Study|Withdrawal by Subject|1|||
145263868|NCT01977573|523812214|FG002|Overall Study|Withdrawal by Subject|1|||
145263869|NCT01977573|523812215|FG003|Overall Study|Withdrawal by Subject|1|||
145263870|NCT03996694|523813491|FG000|First Washout (7 Days)|positive urine drug screen|0|||
145263871|NCT03996694|523813492|FG001|First Washout (7 Days)|positive urine drug screen|0|||
145263872|NCT03996694|523813493|FG002|First Washout (7 Days)|positive urine drug screen|1|||
145263873|NCT03996694|523813494|FG003|First Washout (7 Days)|positive urine drug screen|0|||
145263874|NCT03996694|523813495|FG004|First Washout (7 Days)|positive urine drug screen|0|||
145263875|NCT03996694|523813496|FG005|First Washout (7 Days)|positive urine drug screen|0|||
145263876|NCT03996694|523813491|FG000|First Washout (7 Days)|Adverse Event|0|||
145263877|NCT03996694|523813492|FG001|First Washout (7 Days)|Adverse Event|1|||
145263878|NCT03996694|523813493|FG002|First Washout (7 Days)|Adverse Event|0|||
145263879|NCT03996694|523813494|FG003|First Washout (7 Days)|Adverse Event|0|||
145263880|NCT03996694|523813495|FG004|First Washout (7 Days)|Adverse Event|0|||
145263881|NCT03996694|523813496|FG005|First Washout (7 Days)|Adverse Event|0|||
145263882|NCT03996694|523813491|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
145263883|NCT03996694|523813492|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
145263884|NCT03996694|523813493|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
145263885|NCT03996694|523813494|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
145263886|NCT03996694|523813495|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
145263887|NCT03996694|523813496|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
145263888|NCT03996694|523813491|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
145263889|NCT03996694|523813492|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
145263890|NCT03996694|523813493|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
145263891|NCT03996694|523813494|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
145579979|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
145263892|NCT03996694|523813495|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
145263893|NCT03996694|523813496|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
145579980|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
145579981|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
145263894|NCT00656669|523813503|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
145263895|NCT00656669|523813503|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
145263896|NCT00656669|523813503|FG000|AC (Cycles 6-9)|Adverse Event|1|||
145263897|NCT00656669|523813503|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
145263898|NCT02777554|523813506|FG000|Overall Study|Adverse Event|4|||
145263899|NCT02777554|523813507|FG001|Overall Study|Adverse Event|4|||
145263900|NCT02777554|523813508|FG002|Overall Study|Adverse Event|0|||
145263901|NCT02777554|523813509|FG003|Overall Study|Adverse Event|1|||
145263902|NCT02777554|523813510|FG004|Overall Study|Adverse Event|0|||
145263903|NCT02777554|523813511|FG005|Overall Study|Adverse Event|0|||
145263904|NCT02777554|523813506|FG000|Overall Study|Withdrawal by Subject|3|||
145263905|NCT02777554|523813507|FG001|Overall Study|Withdrawal by Subject|1|||
145579982|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
145579983|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
145579984|NCT00813761|524977223|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
145579985|NCT00813761|524977224|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
145579986|NCT00813761|524977225|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
145579987|NCT00813761|524977226|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
145579988|NCT00983814|524977228|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
145579989|NCT00983814|524977229|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
145579990|NCT00983814|524977230|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
145579991|NCT00983814|524977228|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
145579992|NCT00983814|524977229|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
145579993|NCT00983814|524977230|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
145579994|NCT00983814|524977228|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
145623581|NCT05705167|525134000|FG003|Overall Study|Randomised but not Treated|7|||
145623582|NCT05705167|525134001|FG004|Overall Study|Randomised but not Treated|0|||
145623583|NCT05705167|525134002|FG005|Overall Study|Randomised but not Treated|0|||
145623584|NCT05705167|525134003|FG006|Overall Study|Randomised but not Treated|0|||
145623585|NCT05705167|525133997|FG000|Overall Study|Death|0|||
145623586|NCT05705167|525133998|FG001|Overall Study|Death|0|||
145623587|NCT05705167|525133999|FG002|Overall Study|Death|3|||
145623588|NCT05705167|525134000|FG003|Overall Study|Death|0|||
145623589|NCT05705167|525134001|FG004|Overall Study|Death|1|||
145623590|NCT05705167|525134002|FG005|Overall Study|Death|1|||
145623591|NCT05705167|525134003|FG006|Overall Study|Death|1|||
145623592|NCT05705167|525133997|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
145623593|NCT05705167|525133998|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
145623594|NCT05705167|525133999|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
145623595|NCT05705167|525134000|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
145623596|NCT05705167|525134001|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
145623597|NCT05705167|525134002|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
145623598|NCT05705167|525134003|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
145623599|NCT04529538|525134004|FG000|Overall Study|Lost to Follow-up|3|||
145623600|NCT04529538|525134005|FG001|Overall Study|Lost to Follow-up|2|||
145263906|NCT02777554|523813508|FG002|Overall Study|Withdrawal by Subject|1|||
145263907|NCT02777554|523813509|FG003|Overall Study|Withdrawal by Subject|0|||
145263908|NCT02777554|523813510|FG004|Overall Study|Withdrawal by Subject|0|||
145263909|NCT02777554|523813511|FG005|Overall Study|Withdrawal by Subject|0|||
145263910|NCT02777554|523813506|FG000|Overall Study|Discharged early due to hurricane|22|||
145263911|NCT02777554|523813507|FG001|Overall Study|Discharged early due to hurricane|20|||
145263912|NCT02777554|523813508|FG002|Overall Study|Discharged early due to hurricane|0|||
145263913|NCT02777554|523813509|FG003|Overall Study|Discharged early due to hurricane|0|||
145263914|NCT02777554|523813510|FG004|Overall Study|Discharged early due to hurricane|0|||
145263915|NCT02777554|523813511|FG005|Overall Study|Discharged early due to hurricane|0|||
145263916|NCT02777554|523813506|FG000|Overall Study|Other - Miscellaneous|1|||
145263917|NCT02777554|523813507|FG001|Overall Study|Other - Miscellaneous|0|||
145263918|NCT02777554|523813508|FG002|Overall Study|Other - Miscellaneous|0|||
145263919|NCT02777554|523813509|FG003|Overall Study|Other - Miscellaneous|0|||
145263920|NCT02777554|523813510|FG004|Overall Study|Other - Miscellaneous|0|||
145263921|NCT02777554|523813511|FG005|Overall Study|Other - Miscellaneous|0|||
145263922|NCT00066573|523813512|FG000|Overall Study|Did not received protocol treatment|28|||
145263923|NCT00066573|523813513|FG001|Overall Study|Did not received protocol treatment|28|||
145263924|NCT02147132|523813514|FG000|Overall Study|Lost to Follow-up|1|||
145263925|NCT02147132|523813515|FG001|Overall Study|Lost to Follow-up|0|||
145263926|NCT02147132|523813516|FG002|Overall Study|Lost to Follow-up|0|||
145263927|NCT02147132|523813517|FG003|Overall Study|Lost to Follow-up|0|||
145263928|NCT01013207|523813518|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
145263929|NCT01541644|523813523|FG000|Overall Study|Withdrawal by Subject|3|||
145263930|NCT01458535|523813526|FG000|Overall Study|Other|0|||
145263931|NCT01458535|523813527|FG001|Overall Study|Other|0|||
145579995|NCT00983814|524977229|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
145579996|NCT00983814|524977230|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
145579997|NCT00983814|524977228|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
145579998|NCT00983814|524977229|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
145579999|NCT00983814|524977230|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
145580000|NCT00983814|524977228|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
145580001|NCT00983814|524977229|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
145623601|NCT04529538|525134006|FG002|Overall Study|Lost to Follow-up|1|||
145623602|NCT04529538|525134007|FG003|Overall Study|Lost to Follow-up|0|||
145263932|NCT01458535|523813528|FG002|Overall Study|Other|0|||
145623603|NCT04529538|525134008|FG004|Overall Study|Lost to Follow-up|1|||
145263933|NCT01458535|523813529|FG003|Overall Study|Other|0|||
145263934|NCT01458535|523813530|FG004|Overall Study|Other|1|||
145623604|NCT04529538|525134009|FG005|Overall Study|Lost to Follow-up|1|||
145263935|NCT01458535|523813531|FG005|Overall Study|Other|1|||
145263936|NCT01458535|523813526|FG000|Overall Study|Withdrawal by Subject|0|||
145263937|NCT01458535|523813527|FG001|Overall Study|Withdrawal by Subject|0|||
145263938|NCT01458535|523813528|FG002|Overall Study|Withdrawal by Subject|2|||
145263939|NCT01458535|523813529|FG003|Overall Study|Withdrawal by Subject|0|||
145263940|NCT01458535|523813530|FG004|Overall Study|Withdrawal by Subject|1|||
145263941|NCT01458535|523813531|FG005|Overall Study|Withdrawal by Subject|1|||
145263942|NCT01458535|523813526|FG000|Overall Study|Lost to Follow-up|0|||
145263943|NCT01458535|523813527|FG001|Overall Study|Lost to Follow-up|2|||
145263944|NCT01458535|523813528|FG002|Overall Study|Lost to Follow-up|0|||
145263945|NCT01458535|523813529|FG003|Overall Study|Lost to Follow-up|3|||
145263946|NCT01458535|523813530|FG004|Overall Study|Lost to Follow-up|2|||
145263947|NCT01458535|523813531|FG005|Overall Study|Lost to Follow-up|2|||
145263948|NCT01458535|523813526|FG000|Overall Study|Adverse Event|0|||
145263949|NCT01458535|523813527|FG001|Overall Study|Adverse Event|0|||
145263950|NCT01458535|523813528|FG002|Overall Study|Adverse Event|0|||
145263951|NCT01458535|523813529|FG003|Overall Study|Adverse Event|1|||
145263952|NCT01458535|523813530|FG004|Overall Study|Adverse Event|0|||
145263953|NCT01458535|523813531|FG005|Overall Study|Adverse Event|0|||
145263954|NCT02842736|523813532|FG000|Overall Study|Lost to Follow-up|13|||
145263955|NCT02842736|523813532|FG000|Overall Study|Intervention for menstrual bleeding|17|||
145263956|NCT02842736|523813532|FG000|Overall Study|Withdrawal by Subject|4|||
145263957|NCT02842736|523813532|FG000|Overall Study|Pregnancy|3|||
145263958|NCT02842736|523813532|FG000|Overall Study|Hysterectomy for fibroids|2|||
145263959|NCT02842736|523813532|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
145263960|NCT02842736|523813532|FG000|Overall Study|IUD: Mirena|1|||
145263961|NCT02660489|523813536|FG000|Overall Study|Lost to Follow-up|1|||
145263962|NCT02660489|523813537|FG001|Overall Study|Lost to Follow-up|1|||
145263963|NCT02660489|523813536|FG000|Overall Study|Adverse Event|1|||
145263964|NCT02660489|523813537|FG001|Overall Study|Adverse Event|3|||
145263965|NCT02660489|523813536|FG000|Overall Study|no rhinovirus infection|4|||
145263966|NCT02660489|523813537|FG001|Overall Study|no rhinovirus infection|4|||
145263967|NCT03417245|523813538|FG000|Overall Study|Adverse Event|1|||
145263968|NCT03417245|523813539|FG001|Overall Study|Adverse Event|0|||
145263969|NCT03417245|523813538|FG000|Overall Study|Protocol Violation|1|||
145263970|NCT03417245|523813539|FG001|Overall Study|Protocol Violation|0|||
145263971|NCT03417245|523813538|FG000|Overall Study|Withdrawal by Subject|1|||
145263972|NCT03417245|523813539|FG001|Overall Study|Withdrawal by Subject|1|||
145263973|NCT00761735|523813544|FG000|Overall Study|Lost to Follow-up|6|||
145263974|NCT00761735|523813544|FG000|Overall Study|Withdrawal by Subject|6|||
145263975|NCT00761735|523813544|FG000|Overall Study|Non-compliance with protocol|1|||
145263976|NCT00761735|523813544|FG000|Overall Study|Administrative|1|||
145263977|NCT03290131|523813545|FG000|Overall Study|Adverse Event|22|||
145263978|NCT03290131|523813546|FG001|Overall Study|Adverse Event|57|||
145263979|NCT03290131|523813547|FG002|Overall Study|Adverse Event|11|||
145263980|NCT03290131|523813545|FG000|Overall Study|Withdrawal by Subject|18|||
145263981|NCT03290131|523813546|FG001|Overall Study|Withdrawal by Subject|13|||
145263982|NCT03290131|523813547|FG002|Overall Study|Withdrawal by Subject|8|||
145263983|NCT03290131|523813545|FG000|Overall Study|MS Relapse|2|||
145263984|NCT03290131|523813546|FG001|Overall Study|MS Relapse|1|||
145263985|NCT03290131|523813547|FG002|Overall Study|MS Relapse|0|||
145263986|NCT03290131|523813545|FG000|Overall Study|Unknown reason|0|||
145263987|NCT03290131|523813546|FG001|Overall Study|Unknown reason|1|||
145263988|NCT03290131|523813547|FG002|Overall Study|Unknown reason|0|||
145263989|NCT00933543|523813549|FG000|Overall Study|Adverse Event|2|||
145263990|NCT00933543|523813550|FG001|Overall Study|Adverse Event|1|||
145263991|NCT00933543|523813549|FG000|Overall Study|Lost to Follow-up|0|||
145263992|NCT00933543|523813550|FG001|Overall Study|Lost to Follow-up|1|||
145263993|NCT00933543|523813549|FG000|Overall Study|Withdrawal by Subject|0|||
145263994|NCT00933543|523813550|FG001|Overall Study|Withdrawal by Subject|1|||
145263995|NCT00933543|523813549|FG000|Overall Study|Lack of Efficacy|0|||
145263996|NCT00933543|523813550|FG001|Overall Study|Lack of Efficacy|3|||
145263997|NCT00933543|523813549|FG000|Overall Study|Other|1|||
145263998|NCT00933543|523813550|FG001|Overall Study|Other|1|||
145263999|NCT04629534|523813553|FG000|Overall Study|Physician Decision|1|||
145264000|NCT04629534|523813554|FG001|Overall Study|Physician Decision|0|||
145264001|NCT04629534|523813553|FG000|Overall Study|Protocol Violation|0|||
145264002|NCT04629534|523813554|FG001|Overall Study|Protocol Violation|2|||
145264003|NCT01049360|523813557|FG000|Period 1|Adverse Event|0|||
145264004|NCT01049360|523813558|FG001|Period 1|Adverse Event|1|||
145264005|NCT01049360|523813559|FG002|Period 1|Adverse Event|0|||
145264006|NCT01049360|523813560|FG003|Period 1|Adverse Event|1|||
145264007|NCT01049360|523813561|FG004|Period 1|Adverse Event|0|||
145264008|NCT01049360|523813562|FG005|Period 1|Adverse Event|0|||
145264009|NCT01049360|523813563|FG006|Period 1|Adverse Event|0|||
145264010|NCT01049360|523813564|FG007|Period 1|Adverse Event|1|||
145264011|NCT01049360|523813565|FG008|Period 1|Adverse Event|0|||
145264012|NCT01049360|523813566|FG009|Period 1|Adverse Event|0|||
145264013|NCT01049360|523813567|FG010|Period 1|Adverse Event|0|||
145264014|NCT01049360|523813568|FG011|Period 1|Adverse Event|0|||
145264015|NCT01049360|523813569|FG012|Period 1|Adverse Event|1|||
145580002|NCT00983814|524977230|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
145580003|NCT01994395|524977236|FG000|Overall Study|Withdrawal by Subject|1|||
145580004|NCT01994395|524977237|FG001|Overall Study|Withdrawal by Subject|2|||
145580005|NCT03136068|524979143|FG000|Overall Study|Lost to Follow-up|1|||
145580006|NCT03136068|524979144|FG001|Overall Study|Lost to Follow-up|1|||
145580007|NCT03136068|524979143|FG000|Overall Study|Protocol Violation|1|||
145580008|NCT03136068|524979144|FG001|Overall Study|Protocol Violation|0|||
145580009|NCT01337089|524979145|FG000|Overall Study|Adverse Event|237|||
145580010|NCT01337089|524979145|FG000|Overall Study|Withdrawal by Subject|129|||
145580011|NCT01337089|524979145|FG000|Overall Study|Withdrawal by Investigator|33|||
145580012|NCT01337089|524979145|FG000|Overall Study|Met Withdrawal Criteria|3|||
145580013|NCT01337089|524979145|FG000|Overall Study|Lost to Follow-up|2|||
145580014|NCT01040871|524979146|FG000|Overall Study|Adverse Event|6|||
145580015|NCT01040871|524979147|FG001|Overall Study|Adverse Event|2|||
145580016|NCT01040871|524979146|FG000|Overall Study|Withdrawal by Subject|2|||
145580017|NCT01040871|524979147|FG001|Overall Study|Withdrawal by Subject|0|||
145580018|NCT01040871|524979146|FG000|Overall Study|Death|1|||
145580019|NCT01040871|524979147|FG001|Overall Study|Death|3|||
145580020|NCT01040871|524979146|FG000|Overall Study|Lack of Efficacy|1|||
145372605|NCT01970475|524213267|FG000|Overall Study|Lost to Follow-up|2|||
145372606|NCT01970475|524213268|FG001|Overall Study|Lost to Follow-up|2|||
145372607|NCT01970475|524213267|FG000|Overall Study|Protocol Violation|1|||
145372608|NCT01970475|524213268|FG001|Overall Study|Protocol Violation|0|||
145264016|NCT01049360|523813570|FG013|Period 1|Adverse Event|1|||
145264017|NCT01049360|523813571|FG014|Period 1|Adverse Event|0|||
145264018|NCT01049360|523813572|FG015|Period 1|Adverse Event|0|||
145264019|NCT01049360|523813573|FG016|Period 1|Adverse Event|1|||
145264020|NCT01049360|523813574|FG017|Period 1|Adverse Event|0|||
145264021|NCT01049360|523813575|FG018|Period 1|Adverse Event|1|||
145264022|NCT01049360|523813576|FG019|Period 1|Adverse Event|0|||
145264023|NCT01049360|523813557|FG000|Period 1|Did not meet inc/exc criteria|0|||
145264024|NCT01049360|523813558|FG001|Period 1|Did not meet inc/exc criteria|0|||
145264025|NCT01049360|523813559|FG002|Period 1|Did not meet inc/exc criteria|0|||
145264026|NCT01049360|523813560|FG003|Period 1|Did not meet inc/exc criteria|0|||
145264027|NCT01049360|523813561|FG004|Period 1|Did not meet inc/exc criteria|0|||
145264028|NCT01049360|523813562|FG005|Period 1|Did not meet inc/exc criteria|0|||
145264029|NCT01049360|523813563|FG006|Period 1|Did not meet inc/exc criteria|0|||
145264030|NCT01049360|523813564|FG007|Period 1|Did not meet inc/exc criteria|1|||
145264031|NCT01049360|523813565|FG008|Period 1|Did not meet inc/exc criteria|1|||
145264032|NCT01049360|523813566|FG009|Period 1|Did not meet inc/exc criteria|0|||
145264033|NCT01049360|523813567|FG010|Period 1|Did not meet inc/exc criteria|0|||
145264034|NCT01049360|523813568|FG011|Period 1|Did not meet inc/exc criteria|0|||
145264035|NCT01049360|523813569|FG012|Period 1|Did not meet inc/exc criteria|0|||
145264036|NCT01049360|523813570|FG013|Period 1|Did not meet inc/exc criteria|0|||
145264037|NCT01049360|523813571|FG014|Period 1|Did not meet inc/exc criteria|0|||
145264038|NCT01049360|523813572|FG015|Period 1|Did not meet inc/exc criteria|0|||
145264039|NCT01049360|523813573|FG016|Period 1|Did not meet inc/exc criteria|0|||
145264040|NCT01049360|523813574|FG017|Period 1|Did not meet inc/exc criteria|0|||
145264041|NCT01049360|523813575|FG018|Period 1|Did not meet inc/exc criteria|0|||
145264042|NCT01049360|523813576|FG019|Period 1|Did not meet inc/exc criteria|0|||
145372609|NCT04338269|524215020|FG000|Overall Study|Death|86|||
145372610|NCT04338269|524215021|FG001|Overall Study|Death|89|||
145372611|NCT04338269|524215020|FG000|Overall Study|Lost to Follow-up|1|||
145372612|NCT04338269|524215021|FG001|Overall Study|Lost to Follow-up|2|||
145372613|NCT04338269|524215020|FG000|Overall Study|Physician Decision|1|||
145372614|NCT04338269|524215021|FG001|Overall Study|Physician Decision|0|||
145372615|NCT04338269|524215020|FG000|Overall Study|Withdrawal by Subject|14|||
145372616|NCT04338269|524215021|FG001|Overall Study|Withdrawal by Subject|11|||
145372617|NCT03339726|524215022|FG000|Overall Study|Withdrawal by Subject|1|||
145372618|NCT03339726|524215023|FG001|Overall Study|Withdrawal by Subject|0|||
145372619|NCT03339726|524215024|FG002|Overall Study|Withdrawal by Subject|0|||
145372620|NCT03339726|524215022|FG000|Overall Study|Lost to Follow-up|0|||
145372621|NCT03339726|524215023|FG001|Overall Study|Lost to Follow-up|1|||
145372622|NCT03339726|524215024|FG002|Overall Study|Lost to Follow-up|0|||
145264043|NCT01049360|523813557|FG000|Period 1|Withdrawal by Subject|0|||
145264044|NCT01049360|523813558|FG001|Period 1|Withdrawal by Subject|0|||
145264045|NCT01049360|523813559|FG002|Period 1|Withdrawal by Subject|0|||
145264046|NCT01049360|523813560|FG003|Period 1|Withdrawal by Subject|0|||
145580021|NCT01040871|524979147|FG001|Overall Study|Lack of Efficacy|1|||
145580022|NCT01040871|524979146|FG000|Overall Study|drug supply issue|1|||
145580023|NCT01040871|524979147|FG001|Overall Study|drug supply issue|0|||
145580024|NCT01040871|524979146|FG000|Overall Study|Randomized and Not Treated|2|||
145580025|NCT01040871|524979147|FG001|Overall Study|Randomized and Not Treated|1|||
145372623|NCT03960021|524215030|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
145372624|NCT02203851|524215031|FG000|Overall Study|Lost to Follow-up|4|||
145623605|NCT04529538|525134010|FG006|Overall Study|Lost to Follow-up|2|||
145264047|NCT01049360|523813561|FG004|Period 1|Withdrawal by Subject|0|||
145264048|NCT01049360|523813562|FG005|Period 1|Withdrawal by Subject|0|||
145264049|NCT01049360|523813563|FG006|Period 1|Withdrawal by Subject|0|||
145372625|NCT02203851|524215031|FG000|Overall Study|Withdrawal by Subject|6|||
145372626|NCT02203851|524215031|FG000|Overall Study|Other|1|||
145372627|NCT04161079|524215032|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
145372628|NCT02515994|524215033|FG000|Overall Study|Protocol Violation|3|||
145372629|NCT02515994|524215034|FG001|Overall Study|Protocol Violation|5|||
145372630|NCT02515994|524215033|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
145372631|NCT02515994|524215034|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
145372632|NCT02515994|524215033|FG000|Overall Study|Adverse Event|3|||
145372633|NCT02515994|524215034|FG001|Overall Study|Adverse Event|1|||
145372634|NCT02515994|524215033|FG000|Overall Study|Withdrawal by Subject|2|||
145372635|NCT02515994|524215034|FG001|Overall Study|Withdrawal by Subject|0|||
145372636|NCT03391232|524215035|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
145372637|NCT03391232|524215036|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
145372638|NCT03391232|524215035|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
145372639|NCT03391232|524215036|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
145372640|NCT02091960|524215037|FG000|Overall Study|Death|7|||
145372641|NCT02091960|524215037|FG000|Overall Study|Withdrawal by Subject|1|||
145372642|NCT02091960|524215037|FG000|Overall Study|Miscellaneous Reasons|37|||
145372643|NCT01995175|524215039|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
145372644|NCT01995175|524215039|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
145372645|NCT01995175|524215039|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
145372646|NCT01995175|524215039|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
145372647|NCT01995175|524215039|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
145372648|NCT01995175|524215039|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
145372649|NCT01995175|524215039|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
145372650|NCT01995175|524215039|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
145372651|NCT01995175|524215039|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
145372652|NCT00984061|524215040|FG000|Clarithromycin Alone|Protocol Violation|1|||
145372653|NCT02691013|524215041|FG000|Overall Study|Withdrawal by Subject|3|||
145372654|NCT02691013|524215042|FG001|Overall Study|Withdrawal by Subject|0|||
145372655|NCT02111785|524215045|FG000|Overall Study|Death|0|||
145372656|NCT02111785|524215046|FG001|Overall Study|Death|1|||
145372657|NCT02111785|524215047|FG002|Overall Study|Death|0|||
145372658|NCT02111785|524215048|FG003|Overall Study|Death|0|||
145372659|NCT00759785|524215057|FG000|Overall Study|Participant sample not evaluable|11|||
145372660|NCT00759785|524215058|FG001|Overall Study|Participant sample not evaluable|2|||
145372661|NCT00759785|524215057|FG000|Overall Study|Participant sample lost|0|||
145372662|NCT00759785|524215058|FG001|Overall Study|Participant sample lost|1|||
145372663|NCT00759785|524215057|FG000|Overall Study|Protocol Violation|1|||
145372664|NCT00759785|524215058|FG001|Overall Study|Protocol Violation|0|||
145372665|NCT00759785|524215057|FG000|Overall Study|Physician Decision|0|||
145372666|NCT00759785|524215058|FG001|Overall Study|Physician Decision|1|||
145372667|NCT00759785|524215057|FG000|Overall Study|Withdrawal by Subject|0|||
145372668|NCT00759785|524215058|FG001|Overall Study|Withdrawal by Subject|1|||
145372669|NCT04521621|524215062|FG000|Overall Study|Death|17|||
145372670|NCT04521621|524215063|FG001|Overall Study|Death|8|||
145372671|NCT04521621|524215064|FG002|Overall Study|Death|8|||
145372672|NCT04521621|524215065|FG003|Overall Study|Death|5|||
145372673|NCT04521621|524215066|FG004|Overall Study|Death|2|||
145372674|NCT04521621|524215067|FG005|Overall Study|Death|7|||
145372675|NCT04521621|524215068|FG006|Overall Study|Death|0|||
145372676|NCT04521621|524215069|FG007|Overall Study|Death|0|||
145372677|NCT04521621|524215062|FG000|Overall Study|Study Terminated by Sponsor|4|||
145372678|NCT04521621|524215063|FG001|Overall Study|Study Terminated by Sponsor|6|||
145372679|NCT04521621|524215064|FG002|Overall Study|Study Terminated by Sponsor|8|||
145372680|NCT04521621|524215065|FG003|Overall Study|Study Terminated by Sponsor|0|||
145372681|NCT04521621|524215066|FG004|Overall Study|Study Terminated by Sponsor|1|||
145372682|NCT04521621|524215067|FG005|Overall Study|Study Terminated by Sponsor|7|||
145372683|NCT04521621|524215068|FG006|Overall Study|Study Terminated by Sponsor|0|||
145372684|NCT04521621|524215069|FG007|Overall Study|Study Terminated by Sponsor|0|||
145372685|NCT04521621|524215062|FG000|Overall Study|Withdrawal by Subject|0|||
145372686|NCT04521621|524215063|FG001|Overall Study|Withdrawal by Subject|0|||
145580026|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
145580027|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
145580028|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
145580029|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
145372687|NCT04521621|524215064|FG002|Overall Study|Withdrawal by Subject|1|||
145372688|NCT04521621|524215065|FG003|Overall Study|Withdrawal by Subject|1|||
145372689|NCT04521621|524215066|FG004|Overall Study|Withdrawal by Subject|0|||
145372690|NCT04521621|524215067|FG005|Overall Study|Withdrawal by Subject|0|||
145372691|NCT04521621|524215068|FG006|Overall Study|Withdrawal by Subject|0|||
145372692|NCT04521621|524215069|FG007|Overall Study|Withdrawal by Subject|0|||
145580030|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Death|235|||
145580031|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Death|167|||
145580032|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Death|1|||
145580033|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Death|0|||
145580034|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
145580035|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
145580036|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
145580037|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
145372693|NCT04521621|524215062|FG000|Overall Study|Allocated in error without study intervention|1|||
145372694|NCT04521621|524215063|FG001|Overall Study|Allocated in error without study intervention|0|||
145372695|NCT04521621|524215064|FG002|Overall Study|Allocated in error without study intervention|0|||
145372696|NCT04521621|524215065|FG003|Overall Study|Allocated in error without study intervention|0|||
145372697|NCT04521621|524215066|FG004|Overall Study|Allocated in error without study intervention|0|||
145372698|NCT04521621|524215067|FG005|Overall Study|Allocated in error without study intervention|0|||
145372699|NCT04521621|524215068|FG006|Overall Study|Allocated in error without study intervention|0|||
145372700|NCT04521621|524215069|FG007|Overall Study|Allocated in error without study intervention|0|||
145372701|NCT03671564|524215070|FG000|Overall Study|Progressive Disease|3|||
145372702|NCT03671564|524215071|FG001|Overall Study|Progressive Disease|5|||
145372703|NCT03671564|524215072|FG002|Overall Study|Progressive Disease|3|||
145372704|NCT03671564|524215070|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
145372705|NCT03671564|524215071|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
145372706|NCT03671564|524215072|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
145372707|NCT03671564|524215070|FG000|Overall Study|Withdrawal by Subject|1|||
145372708|NCT03671564|524215071|FG001|Overall Study|Withdrawal by Subject|1|||
145372709|NCT03671564|524215072|FG002|Overall Study|Withdrawal by Subject|0|||
145372710|NCT01968707|524215078|FG000|Overall Study|Did not meet treatment day baseline|49|||
145372711|NCT01968707|524215079|FG001|Overall Study|Did not meet treatment day baseline|12|||
145372712|NCT01968707|524215080|FG002|Overall Study|Did not meet treatment day baseline|41|||
145372713|NCT01968707|524215081|FG003|Overall Study|Did not meet treatment day baseline|44|||
145372714|NCT01968707|524215082|FG004|Overall Study|Did not meet treatment day baseline|36|||
145372715|NCT01968707|524215083|FG005|Overall Study|Did not meet treatment day baseline|11|||
145372716|NCT01968707|524215084|FG006|Overall Study|Did not meet treatment day baseline|34|||
145372717|NCT01968707|524215085|FG007|Overall Study|Did not meet treatment day baseline|35|||
145372718|NCT00108485|524215093|FG000|Overall Study|Withdrawal by Subject|3|||
145372719|NCT00108485|524215094|FG001|Overall Study|Withdrawal by Subject|0|||
145372720|NCT00108485|524215093|FG000|Overall Study|Lost to Follow-up|0|||
145372721|NCT00108485|524215094|FG001|Overall Study|Lost to Follow-up|2|||
145372722|NCT00380081|524215100|FG000|Overall Study|Withdrawal by Subject|0|||
145372723|NCT00380081|524215101|FG001|Overall Study|Withdrawal by Subject|0|||
145372724|NCT00380081|524215102|FG002|Overall Study|Withdrawal by Subject|0|||
145372725|NCT00380081|524215103|FG003|Overall Study|Withdrawal by Subject|0|||
145372726|NCT00380081|524215104|FG004|Overall Study|Withdrawal by Subject|1|||
145372727|NCT00380081|524215105|FG005|Overall Study|Withdrawal by Subject|0|||
145372728|NCT00380081|524215100|FG000|Overall Study|Family Emergency|0|||
145372729|NCT00380081|524215101|FG001|Overall Study|Family Emergency|0|||
145372730|NCT00380081|524215102|FG002|Overall Study|Family Emergency|0|||
145372731|NCT00380081|524215103|FG003|Overall Study|Family Emergency|0|||
145372732|NCT00380081|524215104|FG004|Overall Study|Family Emergency|0|||
145372733|NCT00380081|524215105|FG005|Overall Study|Family Emergency|1|||
145372734|NCT02231879|524215106|FG000|Overall Study|Adverse Event|2|||
145372735|NCT02231879|524215107|FG001|Overall Study|Adverse Event|1|||
145372736|NCT02231879|524215106|FG000|Overall Study|Lack of Efficacy|0|||
145372737|NCT02231879|524215107|FG001|Overall Study|Lack of Efficacy|1|||
145372738|NCT00189306|524215108|FG000|Treatment Period|Withdrawal by Subject|2|||
145372739|NCT00189306|524215108|FG000|Treatment Period|Adverse Event|2|||
145372740|NCT00189306|524215108|FG000|Treatment Period|Protocol Violation|1|||
145372741|NCT00189306|524215108|FG000|Posttreatment Period|Death|1|||
145372742|NCT00189306|524215108|FG000|Posttreatment Period|Withdrawal by Subject|2|||
145372743|NCT00189306|524215108|FG000|Posttreatment Period|Noncompliance|1|||
145372744|NCT00189306|524215108|FG000|Posttreatment Period|Target lesion excised|1|||
145372745|NCT00189306|524215108|FG000|Posttreatment Period|Protocol Violation|1|||
145372746|NCT00189306|524215108|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
145372747|NCT00189306|524215108|FG000|Posttreatment Period|Local skin reaction/sign|1|||
145372748|NCT00189306|524215108|FG000|Long-Term Follow-up|Adverse Event|2|||
145372749|NCT00189306|524215108|FG000|Long-Term Follow-up|Death|4|||
145372750|NCT00189306|524215108|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
145372751|NCT00189306|524215108|FG000|Long-Term Follow-up|Intercurrent disease|2|||
145372752|NCT00189306|524215108|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
145372753|NCT00189306|524215108|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
145580038|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
145372754|NCT00459706|524215109|FG000|Overall Study|Adverse Event|19|||
145372755|NCT00459706|524215110|FG001|Overall Study|Adverse Event|13|||
145372756|NCT00459706|524215109|FG000|Overall Study|Withdrawal by Subject|1|||
145580039|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
145372757|NCT00459706|524215110|FG001|Overall Study|Withdrawal by Subject|6|||
145264050|NCT01049360|523813564|FG007|Period 1|Withdrawal by Subject|0|||
145264051|NCT01049360|523813565|FG008|Period 1|Withdrawal by Subject|1|||
145264052|NCT01049360|523813566|FG009|Period 1|Withdrawal by Subject|0|||
145264053|NCT01049360|523813567|FG010|Period 1|Withdrawal by Subject|1|||
145264054|NCT01049360|523813568|FG011|Period 1|Withdrawal by Subject|0|||
145264055|NCT01049360|523813569|FG012|Period 1|Withdrawal by Subject|1|||
145264056|NCT01049360|523813570|FG013|Period 1|Withdrawal by Subject|0|||
145264057|NCT01049360|523813571|FG014|Period 1|Withdrawal by Subject|0|||
145264058|NCT01049360|523813572|FG015|Period 1|Withdrawal by Subject|0|||
145264059|NCT01049360|523813573|FG016|Period 1|Withdrawal by Subject|0|||
145264060|NCT01049360|523813574|FG017|Period 1|Withdrawal by Subject|0|||
145264061|NCT01049360|523813575|FG018|Period 1|Withdrawal by Subject|0|||
145264062|NCT01049360|523813576|FG019|Period 1|Withdrawal by Subject|0|||
145264063|NCT01049360|523813557|FG000|Period 2|Protocol Violation|0|||
145580040|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
145264064|NCT01049360|523813558|FG001|Period 2|Protocol Violation|0|||
145264065|NCT01049360|523813559|FG002|Period 2|Protocol Violation|0|||
145264066|NCT01049360|523813560|FG003|Period 2|Protocol Violation|1|||
145264067|NCT01049360|523813561|FG004|Period 2|Protocol Violation|0|||
145264068|NCT01049360|523813562|FG005|Period 2|Protocol Violation|0|||
145264069|NCT01049360|523813563|FG006|Period 2|Protocol Violation|0|||
145264070|NCT01049360|523813564|FG007|Period 2|Protocol Violation|0|||
145264071|NCT01049360|523813565|FG008|Period 2|Protocol Violation|0|||
145264072|NCT01049360|523813566|FG009|Period 2|Protocol Violation|0|||
145264073|NCT01049360|523813567|FG010|Period 2|Protocol Violation|0|||
145264074|NCT01049360|523813568|FG011|Period 2|Protocol Violation|0|||
145264075|NCT01049360|523813569|FG012|Period 2|Protocol Violation|0|||
145264076|NCT01049360|523813570|FG013|Period 2|Protocol Violation|0|||
145264077|NCT01049360|523813571|FG014|Period 2|Protocol Violation|1|||
145580041|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
145580042|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Other|1|||
145580043|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Other|2|||
145580044|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Other|0|||
145580045|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Other|0|||
145580046|NCT00673049|524979149|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
145580047|NCT00673049|524979150|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
145580048|NCT00673049|524979151|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
145580049|NCT00673049|524979152|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
145580050|NCT00673049|524979149|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
145580051|NCT00673049|524979150|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
145580052|NCT00673049|524979151|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
145580053|NCT00673049|524979152|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
145580054|NCT00673049|524979149|FG000|After Progression on Erlotinib|Death|0|||
145580055|NCT00673049|524979150|FG001|After Progression on Erlotinib|Death|0|||
145580056|NCT00673049|524979151|FG002|After Progression on Erlotinib|Death|0|||
145580057|NCT00673049|524979152|FG003|After Progression on Erlotinib|Death|71|||
145580058|NCT00673049|524979149|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
145580059|NCT00673049|524979150|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
145580060|NCT00673049|524979151|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
145580061|NCT00673049|524979152|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
145580062|NCT00673049|524979149|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
145580063|NCT00673049|524979150|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
145580064|NCT00673049|524979151|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
145580065|NCT00673049|524979152|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
145580066|NCT00673049|524979149|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
145580067|NCT00673049|524979150|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
145264078|NCT01049360|523813572|FG015|Period 2|Protocol Violation|1|||
145264079|NCT01049360|523813573|FG016|Period 2|Protocol Violation|0|||
145264080|NCT01049360|523813574|FG017|Period 2|Protocol Violation|0|||
145264081|NCT01049360|523813575|FG018|Period 2|Protocol Violation|0|||
145580068|NCT00673049|524979151|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
145623606|NCT04529538|525134011|FG007|Overall Study|Lost to Follow-up|0|||
145623607|NCT04529538|525134004|FG000|Overall Study|Not eligible at enrollment|0|||
145623608|NCT04529538|525134005|FG001|Overall Study|Not eligible at enrollment|1|||
145623609|NCT04529538|525134006|FG002|Overall Study|Not eligible at enrollment|2|||
145264082|NCT01049360|523813576|FG019|Period 2|Protocol Violation|0|||
145264083|NCT01049360|523813557|FG000|Period 2|Adverse Event|0|||
145264084|NCT01049360|523813558|FG001|Period 2|Adverse Event|1|||
145264085|NCT01049360|523813559|FG002|Period 2|Adverse Event|0|||
145264086|NCT01049360|523813560|FG003|Period 2|Adverse Event|0|||
145264087|NCT01049360|523813561|FG004|Period 2|Adverse Event|0|||
145264088|NCT01049360|523813562|FG005|Period 2|Adverse Event|0|||
145264089|NCT01049360|523813563|FG006|Period 2|Adverse Event|0|||
145264090|NCT01049360|523813564|FG007|Period 2|Adverse Event|0|||
145264091|NCT01049360|523813565|FG008|Period 2|Adverse Event|1|||
145264092|NCT01049360|523813566|FG009|Period 2|Adverse Event|0|||
145264093|NCT01049360|523813567|FG010|Period 2|Adverse Event|0|||
145264094|NCT01049360|523813568|FG011|Period 2|Adverse Event|0|||
145264095|NCT01049360|523813569|FG012|Period 2|Adverse Event|0|||
145264096|NCT01049360|523813570|FG013|Period 2|Adverse Event|0|||
145264097|NCT01049360|523813571|FG014|Period 2|Adverse Event|0|||
145264098|NCT01049360|523813572|FG015|Period 2|Adverse Event|0|||
145264099|NCT01049360|523813573|FG016|Period 2|Adverse Event|0|||
145264100|NCT01049360|523813574|FG017|Period 2|Adverse Event|0|||
145264101|NCT01049360|523813575|FG018|Period 2|Adverse Event|0|||
145264102|NCT01049360|523813576|FG019|Period 2|Adverse Event|1|||
145264103|NCT01049360|523813557|FG000|Period 2|Withdrawal by Subject|0|||
145264104|NCT01049360|523813558|FG001|Period 2|Withdrawal by Subject|0|||
145264105|NCT01049360|523813559|FG002|Period 2|Withdrawal by Subject|0|||
145264106|NCT01049360|523813560|FG003|Period 2|Withdrawal by Subject|1|||
145264107|NCT01049360|523813561|FG004|Period 2|Withdrawal by Subject|0|||
145264108|NCT01049360|523813562|FG005|Period 2|Withdrawal by Subject|0|||
145264109|NCT01049360|523813563|FG006|Period 2|Withdrawal by Subject|0|||
145264110|NCT01049360|523813564|FG007|Period 2|Withdrawal by Subject|0|||
145264111|NCT01049360|523813565|FG008|Period 2|Withdrawal by Subject|0|||
145264112|NCT01049360|523813566|FG009|Period 2|Withdrawal by Subject|0|||
145264113|NCT01049360|523813567|FG010|Period 2|Withdrawal by Subject|0|||
145264114|NCT01049360|523813568|FG011|Period 2|Withdrawal by Subject|0|||
145264115|NCT01049360|523813569|FG012|Period 2|Withdrawal by Subject|0|||
145264116|NCT01049360|523813570|FG013|Period 2|Withdrawal by Subject|0|||
145264117|NCT01049360|523813571|FG014|Period 2|Withdrawal by Subject|1|||
145264118|NCT01049360|523813572|FG015|Period 2|Withdrawal by Subject|0|||
145264119|NCT01049360|523813573|FG016|Period 2|Withdrawal by Subject|0|||
145264120|NCT01049360|523813574|FG017|Period 2|Withdrawal by Subject|0|||
145264121|NCT01049360|523813575|FG018|Period 2|Withdrawal by Subject|0|||
145264122|NCT01049360|523813576|FG019|Period 2|Withdrawal by Subject|1|||
145264123|NCT01049360|523813557|FG000|Period 2|Lack of Efficacy|0|||
145264124|NCT01049360|523813558|FG001|Period 2|Lack of Efficacy|0|||
145264125|NCT01049360|523813559|FG002|Period 2|Lack of Efficacy|0|||
145264126|NCT01049360|523813560|FG003|Period 2|Lack of Efficacy|0|||
145264127|NCT01049360|523813561|FG004|Period 2|Lack of Efficacy|0|||
145264128|NCT01049360|523813562|FG005|Period 2|Lack of Efficacy|1|||
145264129|NCT01049360|523813563|FG006|Period 2|Lack of Efficacy|0|||
145264130|NCT01049360|523813564|FG007|Period 2|Lack of Efficacy|0|||
145264131|NCT01049360|523813565|FG008|Period 2|Lack of Efficacy|0|||
145264132|NCT01049360|523813566|FG009|Period 2|Lack of Efficacy|0|||
145264133|NCT01049360|523813567|FG010|Period 2|Lack of Efficacy|0|||
145264134|NCT01049360|523813568|FG011|Period 2|Lack of Efficacy|0|||
145264135|NCT01049360|523813569|FG012|Period 2|Lack of Efficacy|0|||
145264136|NCT01049360|523813570|FG013|Period 2|Lack of Efficacy|0|||
145264137|NCT01049360|523813571|FG014|Period 2|Lack of Efficacy|0|||
145264138|NCT01049360|523813572|FG015|Period 2|Lack of Efficacy|0|||
145264139|NCT01049360|523813573|FG016|Period 2|Lack of Efficacy|0|||
145264140|NCT01049360|523813574|FG017|Period 2|Lack of Efficacy|0|||
145264141|NCT01049360|523813575|FG018|Period 2|Lack of Efficacy|0|||
145264142|NCT01049360|523813576|FG019|Period 2|Lack of Efficacy|0|||
145264143|NCT01049360|523813557|FG000|Period 4|Protocol Violation|0|||
145264144|NCT01049360|523813558|FG001|Period 4|Protocol Violation|0|||
145264145|NCT01049360|523813559|FG002|Period 4|Protocol Violation|0|||
145264146|NCT01049360|523813560|FG003|Period 4|Protocol Violation|0|||
145264147|NCT01049360|523813561|FG004|Period 4|Protocol Violation|0|||
145264148|NCT01049360|523813562|FG005|Period 4|Protocol Violation|0|||
145264149|NCT01049360|523813563|FG006|Period 4|Protocol Violation|0|||
145264150|NCT01049360|523813564|FG007|Period 4|Protocol Violation|0|||
145264151|NCT01049360|523813565|FG008|Period 4|Protocol Violation|0|||
145264152|NCT01049360|523813566|FG009|Period 4|Protocol Violation|0|||
145264153|NCT01049360|523813567|FG010|Period 4|Protocol Violation|0|||
145264154|NCT01049360|523813568|FG011|Period 4|Protocol Violation|0|||
145264155|NCT01049360|523813569|FG012|Period 4|Protocol Violation|0|||
145264156|NCT01049360|523813570|FG013|Period 4|Protocol Violation|0|||
145264157|NCT01049360|523813571|FG014|Period 4|Protocol Violation|0|||
145264158|NCT01049360|523813572|FG015|Period 4|Protocol Violation|0|||
145264159|NCT01049360|523813573|FG016|Period 4|Protocol Violation|0|||
145264160|NCT01049360|523813574|FG017|Period 4|Protocol Violation|1|||
145264161|NCT01049360|523813575|FG018|Period 4|Protocol Violation|0|||
145264162|NCT01049360|523813576|FG019|Period 4|Protocol Violation|0|||
145264163|NCT01049360|523813557|FG000|Period 4|Withdrawal by Subject|0|||
145264164|NCT01049360|523813558|FG001|Period 4|Withdrawal by Subject|0|||
145264165|NCT01049360|523813559|FG002|Period 4|Withdrawal by Subject|0|||
145264166|NCT01049360|523813560|FG003|Period 4|Withdrawal by Subject|1|||
145264167|NCT01049360|523813561|FG004|Period 4|Withdrawal by Subject|0|||
145264168|NCT01049360|523813562|FG005|Period 4|Withdrawal by Subject|0|||
145264169|NCT01049360|523813563|FG006|Period 4|Withdrawal by Subject|0|||
145264170|NCT01049360|523813564|FG007|Period 4|Withdrawal by Subject|0|||
145264171|NCT01049360|523813565|FG008|Period 4|Withdrawal by Subject|0|||
145264172|NCT01049360|523813566|FG009|Period 4|Withdrawal by Subject|0|||
145264173|NCT01049360|523813567|FG010|Period 4|Withdrawal by Subject|0|||
145264174|NCT01049360|523813568|FG011|Period 4|Withdrawal by Subject|0|||
145264175|NCT01049360|523813569|FG012|Period 4|Withdrawal by Subject|0|||
145580069|NCT00673049|524979152|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
145580070|NCT02044510|524979153|FG000|Overall Study|Adverse Event|1|||
145580071|NCT02044510|524979154|FG001|Overall Study|Adverse Event|2|||
145580072|NCT01175824|524979155|FG000|Overall Study|Adverse Event|2|||
145580073|NCT01175824|524979156|FG001|Overall Study|Adverse Event|1|||
145580074|NCT01175824|524979155|FG000|Overall Study|Lack of Efficacy|2|||
145580075|NCT01175824|524979156|FG001|Overall Study|Lack of Efficacy|0|||
145580076|NCT01175824|524979155|FG000|Overall Study|Lost to Follow-up|0|||
145580077|NCT01175824|524979156|FG001|Overall Study|Lost to Follow-up|1|||
145580078|NCT01175824|524979155|FG000|Overall Study|Physician Decision|0|||
145580079|NCT01175824|524979156|FG001|Overall Study|Physician Decision|4|||
145580080|NCT01175824|524979155|FG000|Overall Study|Protocol Violation|2|||
145580081|NCT01175824|524979156|FG001|Overall Study|Protocol Violation|5|||
145580082|NCT01175824|524979155|FG000|Overall Study|Withdrawal by Subject|3|||
145580083|NCT01175824|524979156|FG001|Overall Study|Withdrawal by Subject|7|||
145580084|NCT01175824|524979155|FG000|Overall Study|Sponsor Decision|1|||
145580085|NCT01175824|524979156|FG001|Overall Study|Sponsor Decision|0|||
145580086|NCT01175824|524979155|FG000|Overall Study|Entry Criteria Not Met|6|||
145580087|NCT01175824|524979156|FG001|Overall Study|Entry Criteria Not Met|4|||
145580088|NCT03455855|524979157|FG000|Overall Study|Lost to Follow-up|4|||
145580089|NCT03455855|524979158|FG001|Overall Study|Lost to Follow-up|2|||
145580090|NCT02979535|524979159|FG000|Overall Study|Non compliance with the protocol|78|||
145580091|NCT02979535|524979160|FG001|Overall Study|Non compliance with the protocol|82|||
145580092|NCT02979535|524979159|FG000|Overall Study|Consent withdrawn by participant|11|||
145580093|NCT02979535|524979160|FG001|Overall Study|Consent withdrawn by participant|18|||
145580094|NCT02979535|524979159|FG000|Overall Study|Lost to Follow-up|6|||
145580095|NCT02979535|524979160|FG001|Overall Study|Lost to Follow-up|1|||
145580096|NCT04820673|524979161|FG000|Overall Study|Adverse Event|6|||
145580097|NCT04820673|524979161|FG000|Overall Study|Due to Lack of Effectiveness|1|||
145580098|NCT04820673|524979161|FG000|Overall Study|Pregnancy|1|||
145264176|NCT01049360|523813570|FG013|Period 4|Withdrawal by Subject|0|||
145264177|NCT01049360|523813571|FG014|Period 4|Withdrawal by Subject|0|||
145580099|NCT04820673|524979161|FG000|Overall Study|Voluntary Withdrawal|20|||
145580100|NCT04820673|524979161|FG000|Overall Study|Lost to Follow-up|10|||
145580101|NCT00587587|524979162|FG000|Overall Study|Lost to Follow-up|6|||
145580102|NCT00587587|524979163|FG001|Overall Study|Lost to Follow-up|1|||
145580103|NCT00767000|524979169|FG000|54-week Study|Adverse Event|4|||
145580104|NCT00767000|524979170|FG001|54-week Study|Adverse Event|6|||
145580105|NCT00767000|524979171|FG002|54-week Study|Adverse Event|6|||
145580106|NCT00767000|524979172|FG003|54-week Study|Adverse Event|8|||
145580107|NCT00767000|524979173|FG004|54-week Study|Adverse Event|4|||
145580108|NCT00767000|524979169|FG000|54-week Study|Creaninine/creatinine clearance|2|||
145580109|NCT00767000|524979170|FG001|54-week Study|Creaninine/creatinine clearance|1|||
145580110|NCT00767000|524979171|FG002|54-week Study|Creaninine/creatinine clearance|2|||
145580111|NCT00767000|524979172|FG003|54-week Study|Creaninine/creatinine clearance|2|||
145580112|NCT00767000|524979173|FG004|54-week Study|Creaninine/creatinine clearance|4|||
145580113|NCT00767000|524979169|FG000|54-week Study|Hyperglycemia|0|||
145580114|NCT00767000|524979170|FG001|54-week Study|Hyperglycemia|0|||
145580115|NCT00767000|524979171|FG002|54-week Study|Hyperglycemia|1|||
145580116|NCT00767000|524979172|FG003|54-week Study|Hyperglycemia|0|||
145580117|NCT00767000|524979173|FG004|54-week Study|Hyperglycemia|1|||
145580118|NCT00767000|524979169|FG000|54-week Study|Hypoglycemia|0|||
145580119|NCT00767000|524979170|FG001|54-week Study|Hypoglycemia|1|||
145580120|NCT00767000|524979171|FG002|54-week Study|Hypoglycemia|0|||
145580121|NCT00767000|524979172|FG003|54-week Study|Hypoglycemia|0|||
145264178|NCT01049360|523813572|FG015|Period 4|Withdrawal by Subject|0|||
145264179|NCT01049360|523813573|FG016|Period 4|Withdrawal by Subject|0|||
145264180|NCT01049360|523813574|FG017|Period 4|Withdrawal by Subject|0|||
145264181|NCT01049360|523813575|FG018|Period 4|Withdrawal by Subject|0|||
145264182|NCT01049360|523813576|FG019|Period 4|Withdrawal by Subject|0|||
145264183|NCT00429026|523813577|FG000|Overall Study|Inevaluable for response.|40|||
145264184|NCT01012765|523813578|FG000|Treatment Period 1|Adverse Event|1|||
145264185|NCT01012765|523813579|FG001|Treatment Period 1|Adverse Event|0|||
145580122|NCT00767000|524979173|FG004|54-week Study|Hypoglycemia|0|||
145264186|NCT01012765|523813580|FG002|Treatment Period 1|Adverse Event|1|||
145264187|NCT01012765|523813581|FG003|Treatment Period 1|Adverse Event|0|||
145264188|NCT01012765|523813582|FG004|Treatment Period 1|Adverse Event|0|||
145264189|NCT01012765|523813583|FG005|Treatment Period 1|Adverse Event|0|||
145264190|NCT01012765|523813578|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145580123|NCT00767000|524979169|FG000|54-week Study|Interruption of study medication|0|||
145580124|NCT00767000|524979170|FG001|54-week Study|Interruption of study medication|0|||
145580125|NCT00767000|524979171|FG002|54-week Study|Interruption of study medication|1|||
145580126|NCT00767000|524979172|FG003|54-week Study|Interruption of study medication|0|||
145580127|NCT00767000|524979173|FG004|54-week Study|Interruption of study medication|0|||
145580128|NCT00767000|524979169|FG000|54-week Study|Lack of Efficacy|2|||
145580129|NCT00767000|524979170|FG001|54-week Study|Lack of Efficacy|0|||
145580130|NCT00767000|524979171|FG002|54-week Study|Lack of Efficacy|1|||
145580131|NCT00767000|524979172|FG003|54-week Study|Lack of Efficacy|0|||
145580132|NCT00767000|524979173|FG004|54-week Study|Lack of Efficacy|5|||
145580133|NCT00767000|524979169|FG000|54-week Study|Lost to Follow-up|4|||
145580134|NCT00767000|524979170|FG001|54-week Study|Lost to Follow-up|0|||
145580135|NCT00767000|524979171|FG002|54-week Study|Lost to Follow-up|1|||
145580136|NCT00767000|524979172|FG003|54-week Study|Lost to Follow-up|4|||
145580137|NCT00767000|524979173|FG004|54-week Study|Lost to Follow-up|2|||
145580138|NCT00767000|524979169|FG000|54-week Study|Physician Decision|4|||
145580139|NCT00767000|524979170|FG001|54-week Study|Physician Decision|0|||
145580140|NCT00767000|524979171|FG002|54-week Study|Physician Decision|1|||
145580141|NCT00767000|524979172|FG003|54-week Study|Physician Decision|1|||
145580142|NCT00767000|524979173|FG004|54-week Study|Physician Decision|1|||
145580143|NCT00767000|524979169|FG000|54-week Study|Progressive disease|0|||
145580144|NCT00767000|524979170|FG001|54-week Study|Progressive disease|0|||
145580145|NCT00767000|524979171|FG002|54-week Study|Progressive disease|1|||
145580146|NCT00767000|524979172|FG003|54-week Study|Progressive disease|0|||
145580147|NCT00767000|524979173|FG004|54-week Study|Progressive disease|0|||
145580148|NCT00767000|524979169|FG000|54-week Study|Protocol Violation|0|||
145580149|NCT00767000|524979170|FG001|54-week Study|Protocol Violation|0|||
145580150|NCT00767000|524979171|FG002|54-week Study|Protocol Violation|1|||
145580151|NCT00767000|524979172|FG003|54-week Study|Protocol Violation|2|||
145580152|NCT00767000|524979173|FG004|54-week Study|Protocol Violation|0|||
145580153|NCT00767000|524979169|FG000|54-week Study|Withdrawal by Subject|2|||
145580154|NCT00767000|524979170|FG001|54-week Study|Withdrawal by Subject|3|||
145580155|NCT00767000|524979171|FG002|54-week Study|Withdrawal by Subject|5|||
145580156|NCT00767000|524979172|FG003|54-week Study|Withdrawal by Subject|11|||
145580157|NCT00767000|524979173|FG004|54-week Study|Withdrawal by Subject|13|||
145580158|NCT00767000|524979169|FG000|54-week Study|Study terminated by sponsor|90|||
145580159|NCT00767000|524979170|FG001|54-week Study|Study terminated by sponsor|102|||
145580160|NCT00767000|524979171|FG002|54-week Study|Study terminated by sponsor|89|||
145580161|NCT00767000|524979172|FG003|54-week Study|Study terminated by sponsor|196|||
145580162|NCT00767000|524979173|FG004|54-week Study|Study terminated by sponsor|194|||
145580163|NCT00767000|524979169|FG000|54-week Study|Reason not reported|0|||
145580164|NCT00767000|524979170|FG001|54-week Study|Reason not reported|0|||
145580165|NCT00767000|524979171|FG002|54-week Study|Reason not reported|0|||
145580166|NCT00767000|524979172|FG003|54-week Study|Reason not reported|1|||
145580167|NCT00767000|524979173|FG004|54-week Study|Reason not reported|0|||
145580168|NCT00767000|524979169|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
145580169|NCT00767000|524979170|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
145580170|NCT00767000|524979171|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
145580171|NCT00767000|524979172|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
145580172|NCT00767000|524979173|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
145580173|NCT02039505|524979175|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
145580174|NCT02039505|524979176|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
145580175|NCT02039505|524979177|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
145580176|NCT02039505|524979178|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
145580177|NCT02039505|524979179|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
145580178|NCT02039505|524979180|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
145264191|NCT01012765|523813579|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145264192|NCT01012765|523813580|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145264193|NCT01012765|523813581|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145264194|NCT01012765|523813582|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145264195|NCT01012765|523813583|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145264196|NCT01012765|523813578|FG000|Treatment Period 1|Administrative problems|0|||
145264197|NCT01012765|523813579|FG001|Treatment Period 1|Administrative problems|0|||
145264198|NCT01012765|523813580|FG002|Treatment Period 1|Administrative problems|1|||
145264199|NCT01012765|523813581|FG003|Treatment Period 1|Administrative problems|1|||
145264200|NCT01012765|523813582|FG004|Treatment Period 1|Administrative problems|1|||
145580179|NCT02039505|524979181|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
145580180|NCT02039505|524979175|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
145264201|NCT01012765|523813583|FG005|Treatment Period 1|Administrative problems|0|||
145264202|NCT01012765|523813578|FG000|Treatment Period 1|Protocol Violation|0|||
145264203|NCT01012765|523813579|FG001|Treatment Period 1|Protocol Violation|0|||
145264204|NCT01012765|523813580|FG002|Treatment Period 1|Protocol Violation|0|||
145580181|NCT02039505|524979176|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
145580182|NCT02039505|524979177|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
145580183|NCT02039505|524979178|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
145580184|NCT02039505|524979179|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
145580185|NCT02039505|524979180|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
145580186|NCT02039505|524979181|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
145580187|NCT02039505|524979175|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
145264205|NCT01012765|523813581|FG003|Treatment Period 1|Protocol Violation|2|||
145264206|NCT01012765|523813582|FG004|Treatment Period 1|Protocol Violation|1|||
145264207|NCT01012765|523813583|FG005|Treatment Period 1|Protocol Violation|0|||
145264208|NCT01012765|523813578|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
145264209|NCT01012765|523813579|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
145264210|NCT01012765|523813580|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
145264211|NCT01012765|523813581|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
145264212|NCT01012765|523813582|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
145264213|NCT01012765|523813583|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
145264214|NCT01012765|523813578|FG000|Treatment Period 2|Withdrawal by Subject|1|||
145264215|NCT01012765|523813579|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145264216|NCT01012765|523813580|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145264217|NCT01012765|523813581|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145264218|NCT01012765|523813582|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145264219|NCT01012765|523813583|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145264220|NCT01012765|523813578|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
145264221|NCT01012765|523813579|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
145264222|NCT01012765|523813580|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
145264223|NCT01012765|523813581|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
145264224|NCT01012765|523813582|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
145264225|NCT01012765|523813583|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
145264226|NCT01012765|523813578|FG000|Treatment Period 2|Adverse Event|0|||
145264227|NCT01012765|523813579|FG001|Treatment Period 2|Adverse Event|1|||
145264228|NCT01012765|523813580|FG002|Treatment Period 2|Adverse Event|1|||
145264229|NCT01012765|523813581|FG003|Treatment Period 2|Adverse Event|0|||
145264230|NCT01012765|523813582|FG004|Treatment Period 2|Adverse Event|0|||
145264231|NCT01012765|523813583|FG005|Treatment Period 2|Adverse Event|0|||
145264232|NCT01012765|523813578|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
145264233|NCT01012765|523813579|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
145264234|NCT01012765|523813580|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
145264235|NCT01012765|523813581|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
145264236|NCT01012765|523813582|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
145264237|NCT01012765|523813583|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
145264238|NCT00499694|523813592|FG000|Overall Study|Patient never received treatment.|1|||
145264239|NCT03457701|523813593|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
145264240|NCT03457701|523813594|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
145264241|NCT03457701|523813593|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
145264242|NCT03457701|523813594|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
145264243|NCT02370173|523813599|FG000|Overall Study|Protocol Violation|1|||
145264244|NCT02370173|523813600|FG001|Overall Study|Protocol Violation|1|||
145264245|NCT02370173|523813599|FG000|Overall Study|Withdrawal by Subject|2|||
145264246|NCT02370173|523813600|FG001|Overall Study|Withdrawal by Subject|2|||
145264247|NCT04034225|523813601|FG000|Overall Study|Death|3|||
145264248|NCT04034225|523813601|FG000|Overall Study|Withdrawal by Subject|2|||
145264249|NCT04034225|523813601|FG000|Overall Study|Study termination by Sponsor|18|||
145264250|NCT04034225|523813601|FG000|Overall Study|Physician Decision|1|||
145264251|NCT04034225|523813601|FG000|Overall Study|Lack of Efficacy|1|||
145264252|NCT00307736|523813605|FG000|Overall Study|Adverse Event|0|||
145264253|NCT00307736|523813606|FG001|Overall Study|Adverse Event|0|||
145264254|NCT00307736|523813607|FG002|Overall Study|Adverse Event|1|||
145264255|NCT00307736|523813608|FG003|Overall Study|Adverse Event|3|||
145264256|NCT00307736|523813605|FG000|Overall Study|Withdrawal by Subject|0|||
145264257|NCT00307736|523813606|FG001|Overall Study|Withdrawal by Subject|0|||
145264258|NCT00307736|523813607|FG002|Overall Study|Withdrawal by Subject|2|||
145264259|NCT00307736|523813608|FG003|Overall Study|Withdrawal by Subject|0|||
145264260|NCT01365182|523813610|FG000|Overall Study|Withdrawal by Subject|10|||
145264261|NCT01365182|523813611|FG001|Overall Study|Withdrawal by Subject|13|||
145264262|NCT01365182|523813612|FG002|Overall Study|Withdrawal by Subject|12|||
145264263|NCT00736840|523813613|FG000|Overall Study|Lost to Follow-up|13|||
145264264|NCT01411917|523813614|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
145264265|NCT01411917|523813615|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
145264266|NCT01728194|523813620|FG000|Overall Study|Lost to Follow-up|4|||
145580188|NCT02039505|524979176|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145580189|NCT02039505|524979177|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145264267|NCT01728194|523813621|FG001|Overall Study|Lost to Follow-up|3|||
145264268|NCT01728194|523813620|FG000|Overall Study|Physician Decision|4|||
145264269|NCT01728194|523813621|FG001|Overall Study|Physician Decision|0|||
145264270|NCT01728194|523813620|FG000|Overall Study|Withdrawal by Subject|7|||
145264271|NCT01728194|523813621|FG001|Overall Study|Withdrawal by Subject|3|||
145264272|NCT01728194|523813620|FG000|Overall Study|Perceived Medication Side Effects|4|||
145264273|NCT01728194|523813621|FG001|Overall Study|Perceived Medication Side Effects|0|||
145264274|NCT01728194|523813620|FG000|Overall Study|Family Member Request|1|||
145264275|NCT01728194|523813621|FG001|Overall Study|Family Member Request|0|||
145580190|NCT02039505|524979178|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145580191|NCT02039505|524979179|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145580192|NCT02039505|524979180|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145580193|NCT02039505|524979181|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
145580194|NCT02039505|524979175|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
145580195|NCT02039505|524979176|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
145580196|NCT02039505|524979177|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
145580197|NCT02039505|524979178|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
145580198|NCT02039505|524979179|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
145580199|NCT02039505|524979180|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
145580200|NCT02039505|524979181|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
145580201|NCT02039505|524979175|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
145580202|NCT02039505|524979176|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
145580203|NCT02039505|524979177|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
145580204|NCT02039505|524979178|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
145580205|NCT02039505|524979179|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
145580206|NCT02039505|524979180|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
145580207|NCT02039505|524979181|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
145580208|NCT02039505|524979175|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
145580209|NCT02039505|524979176|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
145580210|NCT02039505|524979177|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
145580211|NCT02039505|524979178|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
145580212|NCT02039505|524979179|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
145580213|NCT02039505|524979180|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
145580214|NCT02039505|524979181|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
145580215|NCT02039505|524979175|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580216|NCT02039505|524979176|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580217|NCT02039505|524979177|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580218|NCT02039505|524979178|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
145580219|NCT02039505|524979179|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580220|NCT02039505|524979180|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580221|NCT02039505|524979181|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
145580222|NCT02039505|524979175|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580223|NCT02039505|524979176|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580224|NCT02039505|524979177|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580225|NCT02039505|524979178|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580226|NCT02039505|524979179|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580227|NCT02039505|524979180|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
145580228|NCT02039505|524979181|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
145580229|NCT02039505|524979175|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580230|NCT02039505|524979176|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580231|NCT02039505|524979177|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580232|NCT02039505|524979178|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580233|NCT02039505|524979179|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580234|NCT02039505|524979180|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
145580235|NCT02039505|524979181|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
145580236|NCT02039505|524979175|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580237|NCT02039505|524979176|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580238|NCT02039505|524979177|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580239|NCT02039505|524979178|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580240|NCT02039505|524979179|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580241|NCT02039505|524979180|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
145580242|NCT02039505|524979181|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
145580243|NCT02039505|524979175|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580244|NCT02039505|524979176|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580245|NCT02039505|524979177|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580246|NCT02039505|524979178|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580247|NCT02039505|524979179|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580248|NCT02039505|524979180|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
145580249|NCT02039505|524979181|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
145580250|NCT00633984|524979182|FG000|Overall Study|Lost to Follow-up|0|||
145580251|NCT00633984|524979183|FG001|Overall Study|Lost to Follow-up|6|||
145580252|NCT00633984|524979182|FG000|Overall Study|Withdrawal by Subject|8|||
145580253|NCT00633984|524979183|FG001|Overall Study|Withdrawal by Subject|7|||
145580254|NCT00633984|524979182|FG000|Overall Study|Hospitalized|1|||
145372758|NCT00459706|524215109|FG000|Overall Study|Physician Decision|2|||
145372759|NCT00459706|524215110|FG001|Overall Study|Physician Decision|0|||
145372760|NCT00459706|524215109|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
145372761|NCT00459706|524215110|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145372762|NCT00459706|524215109|FG000|Overall Study|Protocol Violation|2|||
145372763|NCT00459706|524215110|FG001|Overall Study|Protocol Violation|1|||
145372764|NCT00459706|524215109|FG000|Overall Study|Failed to Return|1|||
145580255|NCT00633984|524979183|FG001|Overall Study|Hospitalized|0|||
145580256|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
145580257|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
145580258|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
145580259|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580260|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580261|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580262|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580263|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580264|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
145580265|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
145580266|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
145580267|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
145580268|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580269|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580270|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580271|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580272|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580273|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
145580274|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580275|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
145580276|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
145580277|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580278|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580279|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580280|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580281|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580282|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
145580283|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
145580284|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
145580285|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
145580286|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580287|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580288|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580289|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580290|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580291|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
145580292|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580293|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
145580294|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580295|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580296|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580297|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580298|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580299|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580300|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
145580301|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
145580302|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580303|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580304|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580305|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580306|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580307|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580308|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580309|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
145580310|NCT01172938|524979185|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580311|NCT01172938|524979186|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
145580312|NCT01172938|524979187|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
145580313|NCT01172938|524979188|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580314|NCT01172938|524979189|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580315|NCT01172938|524979190|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580316|NCT01172938|524979191|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580317|NCT01172938|524979192|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580318|NCT01172938|524979193|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
145580319|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
145580320|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
145580321|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
145580322|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
145580323|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
145580324|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
145580325|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
145580326|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
145580327|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
145580328|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
145580329|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
145580330|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
145580331|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
145264276|NCT02309372|523813624|FG000|Overall Study|Lost to Follow-up|3|||
145264277|NCT02309372|523813625|FG001|Overall Study|Lost to Follow-up|2|||
145264278|NCT00242658|523813627|FG000|Overall Study|Lost to Follow-up|22|||
145580332|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
145580333|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
145580334|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
145580335|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
145372765|NCT00459706|524215110|FG001|Overall Study|Failed to Return|0|||
145264279|NCT00242658|523813628|FG001|Overall Study|Lost to Follow-up|19|||
145264280|NCT02811640|523813630|FG000|Overall Study|Technology malfunction|2|||
145264281|NCT00553319|523813634|FG000|Overall Study|Lost to Follow-up|10|||
145264282|NCT00553319|523813635|FG001|Overall Study|Lost to Follow-up|9|||
145264283|NCT00553319|523813636|FG002|Overall Study|Lost to Follow-up|5|||
145264284|NCT00553319|523813634|FG000|Overall Study|wanted treatment elsewhere|2|||
145264285|NCT00553319|523813635|FG001|Overall Study|wanted treatment elsewhere|1|||
145264286|NCT00553319|523813636|FG002|Overall Study|wanted treatment elsewhere|1|||
145264287|NCT00553319|523813634|FG000|Overall Study|non-compliance|0|||
145264288|NCT00553319|523813635|FG001|Overall Study|non-compliance|0|||
145264289|NCT00553319|523813636|FG002|Overall Study|non-compliance|2|||
145264290|NCT00553319|523813634|FG000|Overall Study|incarceration|1|||
145264291|NCT00553319|523813635|FG001|Overall Study|incarceration|0|||
145264292|NCT00553319|523813636|FG002|Overall Study|incarceration|0|||
145264293|NCT00553319|523813634|FG000|Overall Study|moved|1|||
145264294|NCT00553319|523813635|FG001|Overall Study|moved|0|||
145264295|NCT00553319|523813636|FG002|Overall Study|moved|1|||
145264296|NCT01731600|523813642|FG000|Overall Study|Adverse Event|2|||
145264297|NCT01731600|523813643|FG001|Overall Study|Adverse Event|0|||
145264298|NCT01731600|523813642|FG000|Overall Study|Withdrawal criteria|1|||
145264299|NCT01731600|523813643|FG001|Overall Study|Withdrawal criteria|0|||
145264300|NCT01731600|523813642|FG000|Overall Study|Other reasons|3|||
145264301|NCT01731600|523813643|FG001|Overall Study|Other reasons|0|||
145264302|NCT03575975|523813644|FG000|Overall Study|Lost to Follow-up|1|||
145264303|NCT03575975|523813645|FG001|Overall Study|Lost to Follow-up|0|||
145264304|NCT03575975|523813646|FG002|Overall Study|Lost to Follow-up|0|||
145264305|NCT00129220|523813648|FG000|Study Period II|Adverse Event|9|||
145264306|NCT00129220|523813649|FG001|Study Period II|Adverse Event|5|||
145264307|NCT00129220|523813650|FG002|Study Period II|Adverse Event|7|||
145264308|NCT00129220|523813648|FG000|Study Period II|Lack of Efficacy|15|||
145264309|NCT00129220|523813649|FG001|Study Period II|Lack of Efficacy|1|||
145264310|NCT00129220|523813650|FG002|Study Period II|Lack of Efficacy|28|||
145264311|NCT00129220|523813648|FG000|Study Period II|Entry Criteria Not Met|2|||
145264312|NCT00129220|523813649|FG001|Study Period II|Entry Criteria Not Met|0|||
145264313|NCT00129220|523813650|FG002|Study Period II|Entry Criteria Not Met|2|||
145264314|NCT00129220|523813648|FG000|Study Period II|Protocol Violation|4|||
145264315|NCT00129220|523813649|FG001|Study Period II|Protocol Violation|2|||
145264316|NCT00129220|523813650|FG002|Study Period II|Protocol Violation|1|||
145264317|NCT00129220|523813648|FG000|Study Period II|Physician Decision|0|||
145264318|NCT00129220|523813649|FG001|Study Period II|Physician Decision|1|||
145264319|NCT00129220|523813650|FG002|Study Period II|Physician Decision|0|||
145264320|NCT00129220|523813648|FG000|Study Period II|Withdrawal by Subject|1|||
145264321|NCT00129220|523813649|FG001|Study Period II|Withdrawal by Subject|3|||
145264322|NCT00129220|523813650|FG002|Study Period II|Withdrawal by Subject|4|||
145264323|NCT00129220|523813648|FG000|Study Period II|Reason Not Specified|2|||
145264324|NCT00129220|523813649|FG001|Study Period II|Reason Not Specified|0|||
145264325|NCT00129220|523813650|FG002|Study Period II|Reason Not Specified|5|||
145264326|NCT00129220|523813648|FG000|Study Period III|Adverse Event|1|||
145264327|NCT00129220|523813649|FG001|Study Period III|Adverse Event|0|||
145264328|NCT00129220|523813650|FG002|Study Period III|Adverse Event|3|||
145264329|NCT00129220|523813648|FG000|Study Period III|Protocol Violation|1|||
145264330|NCT00129220|523813649|FG001|Study Period III|Protocol Violation|1|||
145264331|NCT00129220|523813650|FG002|Study Period III|Protocol Violation|2|||
145264332|NCT00129220|523813648|FG000|Study Period III|Withdrawal by Subject|1|||
145264333|NCT00129220|523813649|FG001|Study Period III|Withdrawal by Subject|0|||
145264334|NCT00129220|523813650|FG002|Study Period III|Withdrawal by Subject|3|||
145264335|NCT00129220|523813648|FG000|Study Period III|Sponsor Decision|1|||
145264336|NCT00129220|523813649|FG001|Study Period III|Sponsor Decision|0|||
145264337|NCT00129220|523813650|FG002|Study Period III|Sponsor Decision|0|||
145264338|NCT00129220|523813648|FG000|Study Period III|Reason Not Specified|9|||
145264339|NCT00129220|523813649|FG001|Study Period III|Reason Not Specified|0|||
145264340|NCT00129220|523813650|FG002|Study Period III|Reason Not Specified|2|||
145264341|NCT01883362|523813652|FG000|Treatment|Adverse Event|1|||
145264342|NCT01883362|523813653|FG001|Treatment|Adverse Event|8|||
145264343|NCT01883362|523813652|FG000|Treatment|Withdrawal by Subject|6|||
145264344|NCT01883362|523813653|FG001|Treatment|Withdrawal by Subject|2|||
145264345|NCT01883362|523813652|FG000|Treatment|Administrative problems|4|||
145264346|NCT01883362|523813653|FG001|Treatment|Administrative problems|1|||
145264347|NCT01883362|523813652|FG000|Treatment|Relapse|4|||
145264348|NCT01883362|523813653|FG001|Treatment|Relapse|2|||
145264349|NCT01883362|523813652|FG000|Treatment|Randomized, not treated|1|||
145264350|NCT01883362|523813653|FG001|Treatment|Randomized, not treated|1|||
145264351|NCT01883362|523813652|FG000|Post Treatment Follow-up|Protocol Violation|0|||
145264352|NCT01883362|523813653|FG001|Post Treatment Follow-up|Protocol Violation|1|||
145264353|NCT01883362|523813652|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
145264354|NCT01883362|523813653|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
145264355|NCT01883362|523813652|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
145264356|NCT01883362|523813653|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
145264357|NCT01883362|523813652|FG000|Post Treatment Follow-up|Administrative problems|2|||
145264358|NCT01883362|523813653|FG001|Post Treatment Follow-up|Administrative problems|0|||
145264359|NCT01883362|523813652|FG000|Post Treatment Follow-up|Death|8|||
145264360|NCT01883362|523813653|FG001|Post Treatment Follow-up|Death|4|||
145264361|NCT01883362|523813652|FG000|Post Treatment Follow-up|Relapse|1|||
145264362|NCT01883362|523813653|FG001|Post Treatment Follow-up|Relapse|2|||
145264363|NCT01230489|523813655|FG000|Overall Study|Death|2|||
145264364|NCT01230489|523813655|FG000|Overall Study|Adverse Event|2|||
145264365|NCT01230489|523813655|FG000|Overall Study|Treatment modality changed|1|||
145264366|NCT02064231|523815519|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
145264367|NCT02064231|523815520|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
145264368|NCT02064231|523815521|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
145264369|NCT02064231|523815522|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
145264370|NCT02064231|523815519|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
145264371|NCT02064231|523815520|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
145264372|NCT02064231|523815521|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
145264373|NCT02064231|523815522|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
145264374|NCT02064231|523815519|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
145264375|NCT02064231|523815520|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
145264376|NCT02064231|523815521|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
145264377|NCT02064231|523815522|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
145264378|NCT02064231|523815519|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
145264379|NCT02064231|523815520|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
145264380|NCT02064231|523815521|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
145264381|NCT02064231|523815522|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
145264382|NCT04854421|523815524|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
145264383|NCT04854421|523815525|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
145264384|NCT02322866|523815526|FG000|Overall Study|Adverse Event|6|||
145264385|NCT02322866|523815527|FG001|Overall Study|Adverse Event|11|||
145264386|NCT02322866|523815526|FG000|Overall Study|Withdrawal of Consent|16|||
145264387|NCT02322866|523815527|FG001|Overall Study|Withdrawal of Consent|25|||
145264388|NCT02322866|523815526|FG000|Overall Study|Lost to Follow-up|36|||
145264389|NCT02322866|523815527|FG001|Overall Study|Lost to Follow-up|39|||
145264390|NCT02322866|523815526|FG000|Overall Study|Protocol Violation|1|||
145264391|NCT02322866|523815527|FG001|Overall Study|Protocol Violation|0|||
145264392|NCT02322866|523815526|FG000|Overall Study|Noncompliance with Treatment|3|||
145264393|NCT02322866|523815527|FG001|Overall Study|Noncompliance with Treatment|4|||
145264394|NCT02322866|523815526|FG000|Overall Study|Lack of Efficacy|3|||
145264395|NCT02322866|523815527|FG001|Overall Study|Lack of Efficacy|1|||
145264396|NCT02322866|523815526|FG000|Overall Study|Other Miscellaneous Reasons|6|||
145264397|NCT02322866|523815527|FG001|Overall Study|Other Miscellaneous Reasons|6|||
145264398|NCT00718809|523815528|FG000|Overall Study|Disease progression|9|||
145264399|NCT00718809|523815529|FG001|Overall Study|Disease progression|7|||
145264400|NCT00718809|523815528|FG000|Overall Study|Adverse Event|1|||
145264401|NCT00718809|523815529|FG001|Overall Study|Adverse Event|1|||
145264402|NCT00718809|523815528|FG000|Overall Study|Withdrawal by Subject|0|||
145264403|NCT00718809|523815529|FG001|Overall Study|Withdrawal by Subject|1|||
145264404|NCT00718809|523815528|FG000|Overall Study|Lost to Follow-up|1|||
145264405|NCT00718809|523815529|FG001|Overall Study|Lost to Follow-up|0|||
145264406|NCT00718809|523815528|FG000|Overall Study|Noncompliance|1|||
145264407|NCT00718809|523815529|FG001|Overall Study|Noncompliance|0|||
145264408|NCT00463385|523815530|FG000|Overall Study|Other|4|||
145264409|NCT00463385|523815531|FG001|Overall Study|Other|3|||
145264410|NCT00463385|523815532|FG002|Overall Study|Other|6|||
145264411|NCT00463385|523815533|FG003|Overall Study|Other|4|||
145264412|NCT00463385|523815530|FG000|Overall Study|Adverse Event|5|||
145264413|NCT00463385|523815531|FG001|Overall Study|Adverse Event|8|||
145264414|NCT00463385|523815532|FG002|Overall Study|Adverse Event|4|||
145264415|NCT00463385|523815533|FG003|Overall Study|Adverse Event|2|||
145264416|NCT00463385|523815530|FG000|Overall Study|Lack of Efficacy|6|||
145264417|NCT00463385|523815531|FG001|Overall Study|Lack of Efficacy|6|||
145264418|NCT00463385|523815532|FG002|Overall Study|Lack of Efficacy|7|||
145264419|NCT00463385|523815533|FG003|Overall Study|Lack of Efficacy|9|||
145264420|NCT00463385|523815530|FG000|Overall Study|Withdrawal by Subject|3|||
145264421|NCT00463385|523815531|FG001|Overall Study|Withdrawal by Subject|3|||
145264422|NCT00463385|523815532|FG002|Overall Study|Withdrawal by Subject|3|||
145264423|NCT00463385|523815533|FG003|Overall Study|Withdrawal by Subject|4|||
145264424|NCT00463385|523815530|FG000|Overall Study|Lost to Follow-up|0|||
145264425|NCT00463385|523815531|FG001|Overall Study|Lost to Follow-up|0|||
145264426|NCT00463385|523815532|FG002|Overall Study|Lost to Follow-up|0|||
145264427|NCT00463385|523815533|FG003|Overall Study|Lost to Follow-up|1|||
145264428|NCT00463385|523815530|FG000|Overall Study|Death|2|||
145264429|NCT00463385|523815531|FG001|Overall Study|Death|1|||
145264430|NCT00463385|523815532|FG002|Overall Study|Death|2|||
145264431|NCT00463385|523815533|FG003|Overall Study|Death|0|||
145264432|NCT00463385|523815530|FG000|Overall Study|Missing|2|||
145580336|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
145580337|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145372766|NCT00459706|524215109|FG000|Overall Study|Other|0|||
145372767|NCT00459706|524215110|FG001|Overall Study|Other|1|||
145372768|NCT02017912|524215111|FG000|Overall Study|Withdrawal by Subject|2|||
145372769|NCT02017912|524215112|FG001|Overall Study|Withdrawal by Subject|1|||
145372770|NCT02017912|524215111|FG000|Overall Study|miscellaneous|1|||
145372771|NCT02017912|524215112|FG001|Overall Study|miscellaneous|1|||
145372772|NCT03640481|524215113|FG000|Overall Study|Death|14|||
145372773|NCT03640481|524215114|FG001|Overall Study|Death|14|||
145372774|NCT03640481|524215115|FG002|Overall Study|Death|0|||
145372775|NCT03640481|524215116|FG003|Overall Study|Death|0|||
145372776|NCT03640481|524215113|FG000|Overall Study|Lost to Follow-up|2|||
145372777|NCT03640481|524215114|FG001|Overall Study|Lost to Follow-up|0|||
145372778|NCT03640481|524215115|FG002|Overall Study|Lost to Follow-up|0|||
145372779|NCT03640481|524215116|FG003|Overall Study|Lost to Follow-up|0|||
145372780|NCT03640481|524215113|FG000|Overall Study|Site terminated by sponsor|1|||
145372781|NCT03640481|524215114|FG001|Overall Study|Site terminated by sponsor|3|||
145372782|NCT03640481|524215115|FG002|Overall Study|Site terminated by sponsor|0|||
145372783|NCT03640481|524215116|FG003|Overall Study|Site terminated by sponsor|0|||
145372784|NCT03640481|524215113|FG000|Overall Study|Study terminated by sponsor|29|||
145372785|NCT03640481|524215114|FG001|Overall Study|Study terminated by sponsor|42|||
145372786|NCT03640481|524215115|FG002|Overall Study|Study terminated by sponsor|1|||
145580338|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580339|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
145580340|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580341|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580342|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580343|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145264433|NCT00463385|523815531|FG001|Overall Study|Missing|0|||
145372787|NCT03640481|524215116|FG003|Overall Study|Study terminated by sponsor|0|||
145372788|NCT03640481|524215113|FG000|Overall Study|Withdrawal by Subject|5|||
145372789|NCT03640481|524215114|FG001|Overall Study|Withdrawal by Subject|4|||
145372790|NCT03640481|524215115|FG002|Overall Study|Withdrawal by Subject|0|||
145372791|NCT03640481|524215116|FG003|Overall Study|Withdrawal by Subject|1|||
145264434|NCT00463385|523815532|FG002|Overall Study|Missing|0|||
145264435|NCT00463385|523815533|FG003|Overall Study|Missing|2|||
145264436|NCT00463385|523815530|FG000|Overall Study|1 participant received commercial drug|0|||
145264437|NCT00463385|523815531|FG001|Overall Study|1 participant received commercial drug|1|||
145264438|NCT00463385|523815532|FG002|Overall Study|1 participant received commercial drug|0|||
145264439|NCT00463385|523815533|FG003|Overall Study|1 participant received commercial drug|0|||
145264440|NCT00798161|523815534|FG000|Overall Study|Adverse Event|3|||
145372792|NCT03640481|524215113|FG000|Overall Study|Other|26|||
145264441|NCT00798161|523815535|FG001|Overall Study|Adverse Event|4|||
145264442|NCT00798161|523815536|FG002|Overall Study|Adverse Event|6|||
145264443|NCT00798161|523815537|FG003|Overall Study|Adverse Event|6|||
145264444|NCT00798161|523815538|FG004|Overall Study|Adverse Event|5|||
145264445|NCT00798161|523815539|FG005|Overall Study|Adverse Event|2|||
145264446|NCT00798161|523815540|FG006|Overall Study|Adverse Event|4|||
145264447|NCT00798161|523815534|FG000|Overall Study|Protocol Violation|2|||
145264448|NCT00798161|523815535|FG001|Overall Study|Protocol Violation|1|||
145264449|NCT00798161|523815536|FG002|Overall Study|Protocol Violation|3|||
145264450|NCT00798161|523815537|FG003|Overall Study|Protocol Violation|3|||
145264451|NCT00798161|523815538|FG004|Overall Study|Protocol Violation|3|||
145264452|NCT00798161|523815539|FG005|Overall Study|Protocol Violation|2|||
145264453|NCT00798161|523815540|FG006|Overall Study|Protocol Violation|0|||
145264454|NCT00798161|523815534|FG000|Overall Study|Lost to Follow-up|1|||
145264455|NCT00798161|523815535|FG001|Overall Study|Lost to Follow-up|3|||
145264456|NCT00798161|523815536|FG002|Overall Study|Lost to Follow-up|4|||
145264457|NCT00798161|523815537|FG003|Overall Study|Lost to Follow-up|3|||
145264458|NCT00798161|523815538|FG004|Overall Study|Lost to Follow-up|4|||
145264459|NCT00798161|523815539|FG005|Overall Study|Lost to Follow-up|0|||
145264460|NCT00798161|523815540|FG006|Overall Study|Lost to Follow-up|0|||
145264461|NCT00798161|523815534|FG000|Overall Study|Withdrawal by Subject|5|||
145264462|NCT00798161|523815535|FG001|Overall Study|Withdrawal by Subject|4|||
145264463|NCT00798161|523815536|FG002|Overall Study|Withdrawal by Subject|5|||
145264464|NCT00798161|523815537|FG003|Overall Study|Withdrawal by Subject|4|||
145264465|NCT00798161|523815538|FG004|Overall Study|Withdrawal by Subject|2|||
145264466|NCT00798161|523815539|FG005|Overall Study|Withdrawal by Subject|3|||
145264467|NCT00798161|523815540|FG006|Overall Study|Withdrawal by Subject|1|||
145264468|NCT00798161|523815534|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
145264469|NCT00798161|523815535|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
145264470|NCT00798161|523815536|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
145264471|NCT00798161|523815537|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
145264472|NCT00798161|523815538|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
145264473|NCT00798161|523815539|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
145264474|NCT00798161|523815540|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
145580344|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580345|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
145580346|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
145580347|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
145580348|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
145580349|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
145580350|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
145580351|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
145580352|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
145580353|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
145580354|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
145580355|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145580356|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
145580357|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
145580358|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
145580359|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145580360|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145580361|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145580362|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145264475|NCT00344968|523815541|FG000|Overall Study|Adverse Event|5|||
145264476|NCT00344968|523815542|FG001|Overall Study|Adverse Event|4|||
145264477|NCT00344968|523815543|FG002|Overall Study|Adverse Event|15|||
145264478|NCT00344968|523815541|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
145264479|NCT00344968|523815542|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145264480|NCT00344968|523815543|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145264481|NCT00344968|523815541|FG000|Overall Study|Protocol Violation|2|||
145580363|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
145580364|NCT01172938|524979185|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
145580365|NCT01172938|524979186|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
145264482|NCT00344968|523815542|FG001|Overall Study|Protocol Violation|2|||
145264483|NCT00344968|523815543|FG002|Overall Study|Protocol Violation|5|||
145264484|NCT00344968|523815541|FG000|Overall Study|Withdrawal by Subject|14|||
145264485|NCT00344968|523815542|FG001|Overall Study|Withdrawal by Subject|31|||
145264486|NCT00344968|523815543|FG002|Overall Study|Withdrawal by Subject|27|||
145264487|NCT00344968|523815541|FG000|Overall Study|Lost to Follow-up|24|||
145264488|NCT00344968|523815542|FG001|Overall Study|Lost to Follow-up|37|||
145264489|NCT00344968|523815543|FG002|Overall Study|Lost to Follow-up|37|||
145264490|NCT00344968|523815541|FG000|Overall Study|Death|11|||
145264491|NCT00344968|523815542|FG001|Overall Study|Death|27|||
145264492|NCT00344968|523815543|FG002|Overall Study|Death|31|||
145264493|NCT00344968|523815541|FG000|Overall Study|Other|0|||
145264494|NCT00344968|523815542|FG001|Overall Study|Other|1|||
145264495|NCT00344968|523815543|FG002|Overall Study|Other|0|||
145264496|NCT03735680|523815544|FG000|Overall Study|Withdrawal by Subject|0|||
145264497|NCT03735680|523815545|FG001|Overall Study|Withdrawal by Subject|1|||
145264498|NCT03735680|523815546|FG002|Overall Study|Withdrawal by Subject|0|||
145264499|NCT03735680|523815547|FG003|Overall Study|Withdrawal by Subject|0|||
145264500|NCT03735680|523815548|FG004|Overall Study|Withdrawal by Subject|0|||
145264501|NCT03735680|523815549|FG005|Overall Study|Withdrawal by Subject|1|||
145264502|NCT03735680|523815544|FG000|Overall Study|Patient unable or unwilling to continue|0|||
145264503|NCT03735680|523815545|FG001|Overall Study|Patient unable or unwilling to continue|0|||
145264504|NCT03735680|523815546|FG002|Overall Study|Patient unable or unwilling to continue|1|||
145264505|NCT03735680|523815547|FG003|Overall Study|Patient unable or unwilling to continue|0|||
145264506|NCT03735680|523815548|FG004|Overall Study|Patient unable or unwilling to continue|0|||
145264507|NCT03735680|523815549|FG005|Overall Study|Patient unable or unwilling to continue|0|||
145264508|NCT00503035|523815562|FG000|Overall Study|Lost to Follow-up|2|||
145264509|NCT00503035|523815562|FG000|Overall Study|Physician Decision|3|||
145264510|NCT00503035|523815562|FG000|Overall Study|Ineligible|15|||
145264511|NCT04001790|523815563|FG000|Overall Study|Withdrawal by Subject|1|||
145264512|NCT04001790|523815564|FG001|Overall Study|Withdrawal by Subject|2|||
145264513|NCT05028816|523815565|FG000|Overall Study|Lost to Follow-up|5|||
145264514|NCT05028816|523815566|FG001|Overall Study|Lost to Follow-up|3|||
145264515|NCT05028816|523815565|FG000|Overall Study|Withdrawal by Subject|4|||
145264516|NCT05028816|523815566|FG001|Overall Study|Withdrawal by Subject|1|||
145264517|NCT05028816|523815565|FG000|Overall Study|Physician Decision|1|||
145264518|NCT05028816|523815566|FG001|Overall Study|Physician Decision|0|||
145264519|NCT05064436|523815567|FG000|Overall Study|Other Reasons|1|||
145264520|NCT05064436|523815568|FG001|Overall Study|Other Reasons|0|||
145264521|NCT01711736|523815569|FG000|Overall Study|Lost to Follow-up|4|||
145264522|NCT01711736|523815570|FG001|Overall Study|Lost to Follow-up|1|||
145264523|NCT01711736|523815569|FG000|Overall Study|Withdrawal by Subject|6|||
145264524|NCT01711736|523815570|FG001|Overall Study|Withdrawal by Subject|6|||
145264525|NCT01711736|523815569|FG000|Overall Study|Migrated/moved from study area|2|||
145264526|NCT01711736|523815570|FG001|Overall Study|Migrated/moved from study area|1|||
145264527|NCT01342445|523815571|FG000|Overall Study|Experienced side effects|0|||
145264528|NCT01342445|523815572|FG001|Overall Study|Experienced side effects|2|||
145264529|NCT05450198|523815577|FG000|Overall Study|Withdrawal by Subject|1|||
145264530|NCT05450198|523815578|FG001|Overall Study|Withdrawal by Subject|1|||
145264531|NCT05450198|523815579|FG002|Overall Study|Withdrawal by Subject|2|||
145264532|NCT05450198|523815580|FG003|Overall Study|Withdrawal by Subject|0|||
145264533|NCT05450198|523815577|FG000|Overall Study|Lost to Follow-up|1|||
145264534|NCT05450198|523815578|FG001|Overall Study|Lost to Follow-up|0|||
145264535|NCT05450198|523815579|FG002|Overall Study|Lost to Follow-up|2|||
145264536|NCT05450198|523815580|FG003|Overall Study|Lost to Follow-up|1|||
145264537|NCT01319422|523815581|FG000|Overall Study|Withdrawal by Subject|1|||
145264538|NCT01319422|523815582|FG001|Overall Study|Withdrawal by Subject|0|||
145264539|NCT00401726|523815589|FG000|Overall Study|Adverse Event|34|||
145264540|NCT00401726|523815590|FG001|Overall Study|Adverse Event|45|||
145264541|NCT00401726|523815589|FG000|Overall Study|Death|0|||
145264542|NCT00401726|523815590|FG001|Overall Study|Death|3|||
145264543|NCT00401726|523815589|FG000|Overall Study|Sponsor Request|0|||
145264544|NCT00401726|523815590|FG001|Overall Study|Sponsor Request|1|||
145264545|NCT00401726|523815589|FG000|Overall Study|Physician Decision|3|||
145264546|NCT00401726|523815590|FG001|Overall Study|Physician Decision|6|||
145264547|NCT00401726|523815589|FG000|Overall Study|Lost to Follow-up|23|||
145264548|NCT00401726|523815590|FG001|Overall Study|Lost to Follow-up|20|||
145264549|NCT00401726|523815589|FG000|Overall Study|Protocol Violation|6|||
145264550|NCT00401726|523815590|FG001|Overall Study|Protocol Violation|3|||
145264551|NCT00401726|523815589|FG000|Overall Study|Withdrawal by Subject|18|||
145264552|NCT00401726|523815590|FG001|Overall Study|Withdrawal by Subject|24|||
145580366|NCT01172938|524979187|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
145580367|NCT01172938|524979188|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
145264553|NCT00401726|523815589|FG000|Overall Study|Lack of Efficacy|4|||
145264554|NCT00401726|523815590|FG001|Overall Study|Lack of Efficacy|6|||
145264555|NCT00401726|523815589|FG000|Overall Study|Protocol Deviation|9|||
145264556|NCT00401726|523815590|FG001|Overall Study|Protocol Deviation|4|||
145264557|NCT02067728|523815591|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
145264558|NCT02067728|523815592|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
145264559|NCT02067728|523815591|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
145264560|NCT02067728|523815592|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
145264561|NCT02067728|523815591|FG000|6 Month Measurements|Unable to attend|114|||
145264562|NCT02067728|523815592|FG001|6 Month Measurements|Unable to attend|97|||
145264563|NCT03532048|523815594|FG000|Overall Study|Lost to Follow-up|12|||
145264564|NCT03532048|523815595|FG001|Overall Study|Lost to Follow-up|17|||
145264565|NCT03532048|523815594|FG000|Overall Study|Withdrawal by Subject|7|||
145264566|NCT03532048|523815595|FG001|Overall Study|Withdrawal by Subject|0|||
145264567|NCT04837807|523815596|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
145264568|NCT04837807|523815597|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
145264569|NCT00308555|523815598|FG000|Overall Study|Withdrawal by Subject|1|||
145264570|NCT00308555|523815599|FG001|Overall Study|Withdrawal by Subject|0|||
145264571|NCT00308555|523815598|FG000|Overall Study|Physician Decision|2|||
145264572|NCT00308555|523815599|FG001|Overall Study|Physician Decision|0|||
145264573|NCT00814502|523815600|FG000|Overall Study|Adverse Event|1|||
145264574|NCT00814502|523815601|FG001|Overall Study|Adverse Event|0|||
145264575|NCT00814502|523815600|FG000|Overall Study|Withdrawal by Subject|0|||
145264576|NCT00814502|523815601|FG001|Overall Study|Withdrawal by Subject|2|||
145264577|NCT01901393|523815602|FG000|Overall Study|Adverse Event|1|||
145580368|NCT01172938|524979189|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
145372793|NCT03640481|524215114|FG001|Overall Study|Other|12|||
145372794|NCT03640481|524215115|FG002|Overall Study|Other|1|||
145372795|NCT03640481|524215116|FG003|Overall Study|Other|0|||
145372796|NCT03640481|524215113|FG000|Overall Study|Randomized, but not treated|1|||
145372797|NCT03640481|524215114|FG001|Overall Study|Randomized, but not treated|3|||
145372798|NCT03640481|524215115|FG002|Overall Study|Randomized, but not treated|0|||
145372799|NCT03640481|524215116|FG003|Overall Study|Randomized, but not treated|0|||
145372800|NCT00535847|524215117|FG000|Overall Study|Adverse Event|5|||
145372801|NCT00535847|524215118|FG001|Overall Study|Adverse Event|3|||
145372802|NCT00535847|524215119|FG002|Overall Study|Adverse Event|2|||
145372803|NCT00535847|524215117|FG000|Overall Study|Non compliance|1|||
145372804|NCT00535847|524215118|FG001|Overall Study|Non compliance|1|||
145372805|NCT00535847|524215119|FG002|Overall Study|Non compliance|0|||
145372806|NCT00535847|524215117|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
145372807|NCT00535847|524215118|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
145372808|NCT00535847|524215119|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
145372809|NCT05007041|524215120|FG000|Overall Study|Missing Diary Entries|0|||
145372810|NCT05007041|524215121|FG001|Overall Study|Missing Diary Entries|1|||
145372811|NCT02850016|524215122|FG000|Overall Study|Withdrawal by Subject|1|||
145372812|NCT02850016|524215123|FG001|Overall Study|Withdrawal by Subject|2|||
145372813|NCT00976209|524215125|FG000|Treatment Period 1|Protocol Violation|1|||
145372814|NCT00976209|524215126|FG001|Treatment Period 1|Protocol Violation|0|||
145372815|NCT00976209|524215125|FG000|Treatment Period 1|Lost to Follow-up|2|||
145372816|NCT00976209|524215126|FG001|Treatment Period 1|Lost to Follow-up|0|||
145372817|NCT00976209|524215125|FG000|Treatment Period 1|Other|0|||
145372818|NCT00976209|524215126|FG001|Treatment Period 1|Other|1|||
145372819|NCT00976209|524215125|FG000|Wash-out Period|Adverse Event|1|||
145372820|NCT00976209|524215126|FG001|Wash-out Period|Adverse Event|2|||
145372821|NCT00976209|524215125|FG000|Wash-out Period|Lost to Follow-up|1|||
145372822|NCT00976209|524215126|FG001|Wash-out Period|Lost to Follow-up|0|||
145372823|NCT00976209|524215125|FG000|Wash-out Period|Protocol Violation|1|||
145372824|NCT00976209|524215126|FG001|Wash-out Period|Protocol Violation|0|||
145372825|NCT00976209|524215125|FG000|Wash-out Period|Other|1|||
145372826|NCT00976209|524215126|FG001|Wash-out Period|Other|0|||
145372827|NCT00976209|524215125|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145372828|NCT00976209|524215126|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145372829|NCT00976209|524215125|FG000|Treatment Period 2|Lost to Follow-up|0|||
145372830|NCT00976209|524215126|FG001|Treatment Period 2|Lost to Follow-up|1|||
145372831|NCT01252563|524215127|FG000|Overall Study|Contract Deviation|41|||
145372832|NCT01252563|524215127|FG000|Overall Study|Centralized Registration Deviation|30|||
145372833|NCT01252563|524215127|FG000|Overall Study|Lost to Follow-up|161|||
145372834|NCT01252563|524215127|FG000|Overall Study|No visit after first day of treatment|194|||
145372835|NCT01252563|524215127|FG000|Overall Study|No drug administration|6|||
145372836|NCT02951533|524215131|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
145372837|NCT02951533|524215132|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
145372838|NCT02951533|524215133|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
145372839|NCT02951533|524215131|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
145372840|NCT02951533|524215132|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
145372841|NCT02951533|524215133|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
145372842|NCT02951533|524215131|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
145372843|NCT02951533|524215132|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
145372844|NCT02951533|524215133|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
145372845|NCT02951533|524215131|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
145372846|NCT02951533|524215132|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
145372847|NCT02951533|524215133|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
145372848|NCT02951533|524215131|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
145372849|NCT02951533|524215132|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
145580369|NCT01172938|524979190|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
145264578|NCT01901393|523815603|FG001|Overall Study|Adverse Event|0|||
145264579|NCT04113746|523815608|FG000|Overall Study|Lost to Follow-up|4|||
145264580|NCT04113746|523815609|FG001|Overall Study|Lost to Follow-up|4|||
145264581|NCT03125382|523815610|FG000|Randomization|screening failure|1|||
145264582|NCT03125382|523815611|FG001|Randomization|screening failure|4|||
145264583|NCT03125382|523815612|FG002|Randomization|screening failure|2|||
145264584|NCT03125382|523815613|FG003|Randomization|screening failure|0|||
145264585|NCT03125382|523815610|FG000|Follow-up|Death|1|||
145264586|NCT03125382|523815611|FG001|Follow-up|Death|2|||
145264587|NCT03125382|523815612|FG002|Follow-up|Death|1|||
145264588|NCT03125382|523815613|FG003|Follow-up|Death|2|||
145264589|NCT03125382|523815610|FG000|Follow-up|Lost to Follow-up|1|||
145264590|NCT03125382|523815611|FG001|Follow-up|Lost to Follow-up|4|||
145264591|NCT03125382|523815612|FG002|Follow-up|Lost to Follow-up|3|||
145264592|NCT03125382|523815613|FG003|Follow-up|Lost to Follow-up|1|||
145264593|NCT01050998|523815615|FG000|Overall Study|Adverse Event|1|||
145264594|NCT01050998|523815616|FG001|Overall Study|Adverse Event|0|||
145264595|NCT01050998|523815617|FG002|Overall Study|Adverse Event|1|||
145264596|NCT01050998|523815618|FG003|Overall Study|Adverse Event|0|||
145264597|NCT01050998|523815619|FG004|Overall Study|Adverse Event|2|||
145264598|NCT01050998|523815615|FG000|Overall Study|Withdrawal by Subject|0|||
145264599|NCT01050998|523815616|FG001|Overall Study|Withdrawal by Subject|0|||
145264600|NCT01050998|523815617|FG002|Overall Study|Withdrawal by Subject|0|||
145264601|NCT01050998|523815618|FG003|Overall Study|Withdrawal by Subject|1|||
145264602|NCT01050998|523815619|FG004|Overall Study|Withdrawal by Subject|3|||
145264603|NCT01050998|523815615|FG000|Overall Study|Other|3|||
145264604|NCT01050998|523815616|FG001|Overall Study|Other|2|||
145264605|NCT01050998|523815617|FG002|Overall Study|Other|1|||
145264606|NCT01050998|523815618|FG003|Overall Study|Other|1|||
145264607|NCT01050998|523815619|FG004|Overall Study|Other|5|||
145264608|NCT01050998|523815615|FG000|Overall Study|Data integrity issues|0|||
145264609|NCT01050998|523815616|FG001|Overall Study|Data integrity issues|0|||
145264610|NCT01050998|523815617|FG002|Overall Study|Data integrity issues|1|||
145264611|NCT01050998|523815618|FG003|Overall Study|Data integrity issues|1|||
145264612|NCT01050998|523815619|FG004|Overall Study|Data integrity issues|4|||
145264613|NCT04246593|523815626|FG000|Overall Study|Withdrawal by Subject|14|||
145264614|NCT04246593|523815627|FG001|Overall Study|Withdrawal by Subject|13|||
145264615|NCT04246593|523815626|FG000|Overall Study|Lost to Follow-up|124|||
145264616|NCT04246593|523815627|FG001|Overall Study|Lost to Follow-up|71|||
145264617|NCT04246593|523815626|FG000|Overall Study|Moved out of area/became ineligible|3|||
145264618|NCT04246593|523815627|FG001|Overall Study|Moved out of area/became ineligible|1|||
145264619|NCT04246593|523815626|FG000|Overall Study|Reason unknown|4|||
145264620|NCT04246593|523815627|FG001|Overall Study|Reason unknown|2|||
145264621|NCT01326312|523815632|FG000|Overall Study|Adverse Event|11|||
145264622|NCT01326312|523815633|FG001|Overall Study|Adverse Event|11|||
145264623|NCT01326312|523815634|FG002|Overall Study|Adverse Event|1|||
145264624|NCT01326312|523815632|FG000|Overall Study|Withdrawal by Subject|1|||
145264625|NCT01326312|523815633|FG001|Overall Study|Withdrawal by Subject|2|||
145264626|NCT01326312|523815634|FG002|Overall Study|Withdrawal by Subject|1|||
145264627|NCT01326312|523815632|FG000|Overall Study|Protocol Violation|0|||
145264628|NCT01326312|523815633|FG001|Overall Study|Protocol Violation|1|||
145264629|NCT01326312|523815634|FG002|Overall Study|Protocol Violation|0|||
145264630|NCT01326312|523815632|FG000|Overall Study|Lack of Efficacy|13|||
145264631|NCT01326312|523815633|FG001|Overall Study|Lack of Efficacy|7|||
145264632|NCT01326312|523815634|FG002|Overall Study|Lack of Efficacy|1|||
145264633|NCT01326312|523815632|FG000|Overall Study|Death|1|||
145264634|NCT01326312|523815633|FG001|Overall Study|Death|0|||
145264635|NCT01326312|523815634|FG002|Overall Study|Death|1|||
145264636|NCT01326312|523815632|FG000|Overall Study|progressive disease|0|||
145264637|NCT01326312|523815633|FG001|Overall Study|progressive disease|1|||
145264638|NCT01326312|523815634|FG002|Overall Study|progressive disease|1|||
145264639|NCT01326312|523815632|FG000|Overall Study|Study terminated by Sponsor|8|||
145580370|NCT01172938|524979191|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
145580371|NCT01172938|524979192|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
145580372|NCT01172938|524979193|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
145580373|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
145264640|NCT01326312|523815633|FG001|Overall Study|Study terminated by Sponsor|32|||
145264641|NCT01326312|523815634|FG002|Overall Study|Study terminated by Sponsor|46|||
145264642|NCT01326312|523815632|FG000|Overall Study|Treatment arm terminated|19|||
145264643|NCT01326312|523815633|FG001|Overall Study|Treatment arm terminated|0|||
145264644|NCT01326312|523815634|FG002|Overall Study|Treatment arm terminated|0|||
145264645|NCT01326312|523815632|FG000|Overall Study|QTc > 500|0|||
145264646|NCT01326312|523815633|FG001|Overall Study|QTc > 500|1|||
145264647|NCT01326312|523815634|FG002|Overall Study|QTc > 500|0|||
145264648|NCT00234533|523815641|FG000|Overall Study|Withdrawal by Subject|6|||
145264649|NCT00234533|523815641|FG000|Overall Study|Adverse Event|2|||
145264650|NCT00234533|523815641|FG000|Overall Study|Enrolled but not treated|3|||
145264651|NCT04338685|523815642|FG000|Overall Study|Death|3|||
145264652|NCT04338685|523815643|FG001|Overall Study|Death|4|||
145264653|NCT04338685|523815644|FG002|Overall Study|Death|2|||
145264654|NCT04338685|523815645|FG003|Overall Study|Death|4|||
145264655|NCT04338685|523815646|FG004|Overall Study|Death|4|||
145264656|NCT04338685|523815647|FG005|Overall Study|Death|8|||
145264657|NCT04338685|523815648|FG006|Overall Study|Death|1|||
145264658|NCT04338685|523815649|FG007|Overall Study|Death|0|||
145264659|NCT04338685|523815650|FG008|Overall Study|Death|0|||
145264660|NCT04338685|523815642|FG000|Overall Study|Study terminated by Sponsor|0|||
145580374|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
145580375|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
145580376|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
145580377|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
145580378|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
145580379|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
145580380|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
145580381|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
145580382|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145580383|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
145580384|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
145580385|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145580386|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145580387|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145580388|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145580389|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
145623610|NCT04529538|525134007|FG003|Overall Study|Not eligible at enrollment|1|||
145623611|NCT04529538|525134008|FG004|Overall Study|Not eligible at enrollment|0|||
145264661|NCT04338685|523815643|FG001|Overall Study|Study terminated by Sponsor|0|||
145264662|NCT04338685|523815644|FG002|Overall Study|Study terminated by Sponsor|1|||
145264663|NCT04338685|523815645|FG003|Overall Study|Study terminated by Sponsor|4|||
145264664|NCT04338685|523815646|FG004|Overall Study|Study terminated by Sponsor|0|||
145264665|NCT04338685|523815647|FG005|Overall Study|Study terminated by Sponsor|5|||
145264666|NCT04338685|523815648|FG006|Overall Study|Study terminated by Sponsor|2|||
145264667|NCT04338685|523815649|FG007|Overall Study|Study terminated by Sponsor|4|||
145264668|NCT04338685|523815650|FG008|Overall Study|Study terminated by Sponsor|1|||
145264669|NCT04338685|523815642|FG000|Overall Study|Withdrawal by Subject|1|||
145264670|NCT04338685|523815643|FG001|Overall Study|Withdrawal by Subject|2|||
145264671|NCT04338685|523815644|FG002|Overall Study|Withdrawal by Subject|0|||
145264672|NCT04338685|523815645|FG003|Overall Study|Withdrawal by Subject|2|||
145264673|NCT04338685|523815646|FG004|Overall Study|Withdrawal by Subject|0|||
145264674|NCT04338685|523815647|FG005|Overall Study|Withdrawal by Subject|5|||
145264675|NCT04338685|523815648|FG006|Overall Study|Withdrawal by Subject|1|||
145264676|NCT04338685|523815649|FG007|Overall Study|Withdrawal by Subject|1|||
145264677|NCT04338685|523815650|FG008|Overall Study|Withdrawal by Subject|0|||
145264678|NCT02967055|523815651|FG000|Overall Study|Excluded|40|||
145264679|NCT02967055|523815651|FG000|Overall Study|Screen fail|3|||
145264680|NCT02967055|523815651|FG000|Overall Study|Lost to Follow-up|2|||
145264681|NCT02967055|523815651|FG000|Overall Study|Stopped due to side effects|3|||
145264682|NCT02967055|523815651|FG000|Overall Study|Stopped due to drug cost|1|||
145264683|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
145264684|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
145264685|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
145264686|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
145264687|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
145264688|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
145264689|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
145264690|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
145264691|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
145264692|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
145264693|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
145264694|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
145264695|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
145264696|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
145264697|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
145264698|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
145264699|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
145264700|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
145264701|NCT00570492|523815652|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
145264702|NCT00570492|523815653|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
145264703|NCT00570492|523815654|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
145264704|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145264705|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
145264706|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
145264707|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
145264708|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
145264709|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
145264710|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
145264711|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
145264712|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
145264713|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
145264714|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
145264715|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
145264716|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
145264717|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
145264718|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
145264719|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
145264720|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
145264721|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
145264722|NCT00570492|523815652|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
145264723|NCT00570492|523815653|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
145264724|NCT00570492|523815654|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
145264725|NCT00976989|523815655|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
145264726|NCT00976989|523815656|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
145264727|NCT00976989|523815657|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
145264728|NCT00976989|523815655|FG000|Overall Study|Death|5|||
145264729|NCT00976989|523815656|FG001|Overall Study|Death|7|||
145264730|NCT00976989|523815657|FG002|Overall Study|Death|10|||
145264731|NCT00976989|523815655|FG000|Overall Study|Refused Treatment|4|||
145264732|NCT00976989|523815656|FG001|Overall Study|Refused Treatment|3|||
145264733|NCT00976989|523815657|FG002|Overall Study|Refused Treatment|5|||
145264734|NCT00976989|523815655|FG000|Overall Study|Failure to Return|2|||
145264735|NCT00976989|523815656|FG001|Overall Study|Failure to Return|1|||
145264736|NCT00976989|523815657|FG002|Overall Study|Failure to Return|0|||
145264737|NCT00976989|523815655|FG000|Overall Study|Recurrence of Disease|0|||
145264738|NCT00976989|523815656|FG001|Overall Study|Recurrence of Disease|1|||
145264739|NCT00976989|523815657|FG002|Overall Study|Recurrence of Disease|0|||
145264740|NCT00976989|523815655|FG000|Overall Study|Other|1|||
145264741|NCT00976989|523815656|FG001|Overall Study|Other|0|||
145264742|NCT00976989|523815657|FG002|Overall Study|Other|1|||
145264743|NCT00908375|523815658|FG000|Overall Study|Withdrawal by Subject|2|||
145264744|NCT00908375|523815659|FG001|Overall Study|Withdrawal by Subject|4|||
145264745|NCT00908375|523815658|FG000|Overall Study|Lost to Follow-up|8|||
145264746|NCT00908375|523815659|FG001|Overall Study|Lost to Follow-up|6|||
145264747|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Adverse Event|6|||
145264748|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Adverse Event|6|||
145264749|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Death|14|||
145264750|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Death|11|||
145264751|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
145264752|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
145264753|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
145264754|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
145264755|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
145264756|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
145264757|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Disease Progression|1|||
145264758|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Disease Progression|0|||
145264759|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
145264760|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
145264761|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
145264762|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
145264763|NCT04419558|523815660|FG000|DB Period (48 Weeks)|Participant Decision|4|||
145264764|NCT04419558|523815661|FG001|DB Period (48 Weeks)|Participant Decision|3|||
145580390|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
145264765|NCT04419558|523815660|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
145264766|NCT04419558|523815661|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
145264767|NCT04419558|523815660|FG000|OLE Period (48 Weeks)|Death|4|||
145264768|NCT04419558|523815661|FG001|OLE Period (48 Weeks)|Death|6|||
145264769|NCT04419558|523815660|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
145264770|NCT04419558|523815661|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
145264771|NCT04419558|523815660|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
145264772|NCT04419558|523815661|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
145580391|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145580392|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145264773|NCT00903357|523815662|FG000|First Intervention|Withdrawal by Subject|5|||
145264774|NCT00903357|523815663|FG001|First Intervention|Withdrawal by Subject|3|||
145264775|NCT00903357|523815662|FG000|First Intervention|Flu|0|||
145264776|NCT00903357|523815663|FG001|First Intervention|Flu|1|||
145264777|NCT00903357|523815662|FG000|Wash Out Period of 2 Weeks|Flu|0|||
145264778|NCT00903357|523815663|FG001|Wash Out Period of 2 Weeks|Flu|1|||
145264779|NCT00903357|523815662|FG000|Second Intervention|Lost to Follow-up|1|||
145264780|NCT00903357|523815663|FG001|Second Intervention|Lost to Follow-up|0|||
145264781|NCT00678652|523815666|FG000|Overall Study|Protocol Violation|2|||
145264782|NCT00678652|523815667|FG001|Overall Study|Protocol Violation|0|||
145264783|NCT00678652|523815668|FG002|Overall Study|Protocol Violation|0|||
145264784|NCT00678652|523815669|FG003|Overall Study|Protocol Violation|0|||
145264785|NCT00678652|523815666|FG000|Overall Study|Pregnancy|0|||
145264786|NCT00678652|523815667|FG001|Overall Study|Pregnancy|0|||
145264787|NCT00678652|523815668|FG002|Overall Study|Pregnancy|1|||
145264788|NCT00678652|523815669|FG003|Overall Study|Pregnancy|0|||
145264789|NCT00678652|523815666|FG000|Overall Study|Relocation|1|||
145264790|NCT00678652|523815667|FG001|Overall Study|Relocation|0|||
145264791|NCT00678652|523815668|FG002|Overall Study|Relocation|0|||
145264792|NCT00678652|523815669|FG003|Overall Study|Relocation|0|||
145264793|NCT03958045|523815672|FG000|Overall Study|Withdrawal by Subject|1|||
145264794|NCT00674440|523815673|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
145264795|NCT00674440|523815673|FG000|Overall Study|did not have surgery, so unevaluable|7|||
145264796|NCT00674440|523815673|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
145264797|NCT03329404|523815674|FG000|Overall Study|The study was suspended.|1|||
145264798|NCT03329404|523815675|FG001|Overall Study|The study was suspended.|4|||
145264799|NCT04095039|523815676|FG000|Overall Study|Withdrawal by Subject|2|||
145264800|NCT04095039|523815677|FG001|Overall Study|Withdrawal by Subject|16|||
145264801|NCT04095039|523815676|FG000|Overall Study|Transplanted|21|||
145264802|NCT04095039|523815677|FG001|Overall Study|Transplanted|24|||
145264803|NCT04095039|523815676|FG000|Overall Study|Transferred to Non-study Facility|47|||
145264804|NCT04095039|523815677|FG001|Overall Study|Transferred to Non-study Facility|44|||
145264805|NCT04095039|523815676|FG000|Overall Study|Withdrawal from internvention target|0|||
145264806|NCT04095039|523815677|FG001|Overall Study|Withdrawal from internvention target|2|||
145264807|NCT04095039|523815676|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
145264808|NCT04095039|523815677|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
145264809|NCT04095039|523815676|FG000|Overall Study|Cacliphylaxis|0|||
145264810|NCT04095039|523815677|FG001|Overall Study|Cacliphylaxis|1|||
145264811|NCT04095039|523815676|FG000|Overall Study|Pregnancy|1|||
145264812|NCT04095039|523815677|FG001|Overall Study|Pregnancy|0|||
145264813|NCT01326481|523815680|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
145264814|NCT02441517|523815688|FG000|Overall Study|Lost to Follow-up|1|||
145264815|NCT02441517|523815688|FG000|Overall Study|Withdrawal by Subject|2|||
145264816|NCT02441517|523815688|FG000|Overall Study|Study Terminated by Sponsor|1|||
145264817|NCT01393444|523815689|FG000|Overall Study|Withdrawal by Subject|1|||
145264818|NCT01393444|523815689|FG000|Overall Study|Determined ineligible during screening.|2|||
145264819|NCT03039699|523815690|FG000|Overall Study|Incorrect inclusion|5|||
145264820|NCT03039699|523815691|FG001|Overall Study|Incorrect inclusion|4|||
145264821|NCT03039699|523815690|FG000|Overall Study|Lack of data to assess study endpoint|5|||
145264822|NCT03039699|523815691|FG001|Overall Study|Lack of data to assess study endpoint|3|||
145264823|NCT03039699|523815690|FG000|Overall Study|Bacterial infection|12|||
145264824|NCT03039699|523815691|FG001|Overall Study|Bacterial infection|28|||
145264825|NCT00761462|523817703|FG000|Treatment|Subjects never received study medication|23|||
145264826|NCT00761462|523817704|FG001|Treatment|Subjects never received study medication|12|||
145264827|NCT00761462|523817703|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
145264828|NCT00761462|523817704|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
145264829|NCT00761462|523817703|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
145264830|NCT00761462|523817704|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
145264831|NCT00761462|523817703|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
145264832|NCT00761462|523817704|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
145264833|NCT02383966|523817705|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
145264834|NCT02383966|523817706|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
145264835|NCT02383966|523817705|FG000|Overall Study|Randomized, but not treated|1|||
145264836|NCT02383966|523817706|FG001|Overall Study|Randomized, but not treated|3|||
145264837|NCT02163759|523817707|FG000|Overall Study|Withdrawal by Subject|1|||
145264838|NCT02163759|523817708|FG001|Overall Study|Withdrawal by Subject|5|||
145264839|NCT02163759|523817709|FG002|Overall Study|Withdrawal by Subject|1|||
145264840|NCT02163759|523817707|FG000|Overall Study|Adverse Event|0|||
145264841|NCT02163759|523817708|FG001|Overall Study|Adverse Event|0|||
145264842|NCT02163759|523817709|FG002|Overall Study|Adverse Event|1|||
145264843|NCT02163759|523817707|FG000|Overall Study|Death|0|||
145264844|NCT02163759|523817708|FG001|Overall Study|Death|0|||
145264845|NCT02163759|523817709|FG002|Overall Study|Death|1|||
145264846|NCT03575806|523817716|FG000|Overall Study|Withdrawal by Subject|0|||
145264847|NCT03575806|523817717|FG001|Overall Study|Withdrawal by Subject|2|||
145623612|NCT04529538|525134009|FG005|Overall Study|Not eligible at enrollment|0|||
145372850|NCT02951533|524215133|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
145372851|NCT02951533|524215131|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
145372852|NCT02951533|524215132|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
145372853|NCT02951533|524215133|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
145372854|NCT02951533|524215131|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
145372855|NCT02951533|524215132|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
145372856|NCT02951533|524215133|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
145372857|NCT02951533|524215131|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
145372858|NCT02951533|524215132|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
145372859|NCT02951533|524215133|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
145372860|NCT02951533|524215131|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
145372861|NCT02951533|524215132|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
145372862|NCT02951533|524215133|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
145372863|NCT02951533|524215131|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
145372864|NCT02951533|524215132|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
145372865|NCT02951533|524215133|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
145372866|NCT02951533|524215131|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
145372867|NCT02951533|524215132|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
145372868|NCT02951533|524215133|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
145372869|NCT02029989|524215134|FG000|Overall Study|Withdrawal by Subject|1|||
145372870|NCT02029989|524215135|FG001|Overall Study|Withdrawal by Subject|0|||
145372871|NCT02029989|524215134|FG000|Overall Study|Withdrawal: Fear of needles|1|||
145372872|NCT02029989|524215135|FG001|Overall Study|Withdrawal: Fear of needles|0|||
145372873|NCT02029989|524215134|FG000|Overall Study|Change of location|2|||
145372874|NCT02029989|524215135|FG001|Overall Study|Change of location|3|||
145372875|NCT02029989|524215134|FG000|Overall Study|Physician Decision|2|||
145372876|NCT02029989|524215135|FG001|Overall Study|Physician Decision|0|||
145372877|NCT02029989|524215134|FG000|Overall Study|Lost to Follow-up|9|||
145372878|NCT02029989|524215135|FG001|Overall Study|Lost to Follow-up|7|||
145372879|NCT02029989|524215134|FG000|Overall Study|Death|0|||
145372880|NCT02029989|524215135|FG001|Overall Study|Death|1|||
145372881|NCT02029989|524215134|FG000|Overall Study|Protocol Violation|1|||
145372882|NCT02029989|524215135|FG001|Overall Study|Protocol Violation|0|||
145372883|NCT02727777|524215142|FG000|Overall Study|Screen Failure|2|||
145372884|NCT02727777|524215143|FG001|Overall Study|Screen Failure|0|||
145372885|NCT02727777|524215144|FG002|Overall Study|Screen Failure|0|||
145372886|NCT02727777|524215142|FG000|Overall Study|Progressive disease|2|||
145372887|NCT02727777|524215143|FG001|Overall Study|Progressive disease|0|||
145372888|NCT02727777|524215144|FG002|Overall Study|Progressive disease|0|||
145372889|NCT01738503|524215145|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
145372890|NCT01738503|524215146|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372891|NCT01738503|524215147|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372892|NCT01738503|524215148|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372893|NCT01738503|524215149|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372894|NCT01738503|524215150|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372895|NCT01738503|524215151|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
145372896|NCT01738503|524215145|FG000|Treatment Period|Adverse Event|0|||
145372897|NCT01738503|524215146|FG001|Treatment Period|Adverse Event|1|||
145372898|NCT01738503|524215147|FG002|Treatment Period|Adverse Event|0|||
145372899|NCT01738503|524215148|FG003|Treatment Period|Adverse Event|1|||
145372900|NCT01738503|524215149|FG004|Treatment Period|Adverse Event|2|||
145372901|NCT01738503|524215150|FG005|Treatment Period|Adverse Event|2|||
145372902|NCT01738503|524215151|FG006|Treatment Period|Adverse Event|2|||
145372903|NCT01738503|524215145|FG000|Treatment Period|Lost to Follow-up|0|||
145372904|NCT01738503|524215146|FG001|Treatment Period|Lost to Follow-up|0|||
145372905|NCT01738503|524215147|FG002|Treatment Period|Lost to Follow-up|3|||
145372906|NCT01738503|524215148|FG003|Treatment Period|Lost to Follow-up|4|||
145372907|NCT01738503|524215149|FG004|Treatment Period|Lost to Follow-up|1|||
145372908|NCT01738503|524215150|FG005|Treatment Period|Lost to Follow-up|1|||
145372909|NCT01738503|524215151|FG006|Treatment Period|Lost to Follow-up|5|||
145372910|NCT01738503|524215145|FG000|Treatment Period|Withdrawal by Subject|0|||
145372911|NCT01738503|524215146|FG001|Treatment Period|Withdrawal by Subject|1|||
145372912|NCT01738503|524215147|FG002|Treatment Period|Withdrawal by Subject|0|||
145372913|NCT01738503|524215148|FG003|Treatment Period|Withdrawal by Subject|1|||
145372914|NCT01738503|524215149|FG004|Treatment Period|Withdrawal by Subject|1|||
145372915|NCT01738503|524215150|FG005|Treatment Period|Withdrawal by Subject|1|||
145372916|NCT01738503|524215151|FG006|Treatment Period|Withdrawal by Subject|1|||
145372917|NCT01738503|524215145|FG000|Treatment Period|Protocol Violation|0|||
145372918|NCT01738503|524215146|FG001|Treatment Period|Protocol Violation|3|||
145372919|NCT01738503|524215147|FG002|Treatment Period|Protocol Violation|1|||
145372920|NCT01738503|524215148|FG003|Treatment Period|Protocol Violation|0|||
145372921|NCT01738503|524215149|FG004|Treatment Period|Protocol Violation|4|||
145372922|NCT01738503|524215150|FG005|Treatment Period|Protocol Violation|2|||
145372923|NCT01738503|524215151|FG006|Treatment Period|Protocol Violation|0|||
145264848|NCT03575806|523817716|FG000|Overall Study|Protocol Violation|0|||
145264849|NCT03575806|523817717|FG001|Overall Study|Protocol Violation|2|||
145264850|NCT00219349|523817718|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
145264851|NCT00219349|523817718|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
145264852|NCT00219349|523817718|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
145264853|NCT00219349|523817718|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
145264854|NCT00270205|523817720|FG000|Overall Study|Lost to Follow-up|1|||
145264855|NCT00270205|523817721|FG001|Overall Study|Lost to Follow-up|0|||
145264856|NCT00270205|523817722|FG002|Overall Study|Lost to Follow-up|0|||
145264857|NCT00270205|523817723|FG003|Overall Study|Lost to Follow-up|1|||
145264858|NCT00869362|523817727|FG000|Overall Study|Death|0|||
145264859|NCT00869362|523817728|FG001|Overall Study|Death|2|||
145264860|NCT00869362|523817727|FG000|Overall Study|Lost to Follow-up|1|||
145264861|NCT00869362|523817728|FG001|Overall Study|Lost to Follow-up|3|||
145264862|NCT02646566|523817729|FG000|Overall Study|Lost to Follow-up|5|||
145264863|NCT02646566|523817730|FG001|Overall Study|Lost to Follow-up|4|||
145264864|NCT02646566|523817731|FG002|Overall Study|Lost to Follow-up|5|||
145264865|NCT02646566|523817729|FG000|Overall Study|Treatment failure|1|||
145264866|NCT02646566|523817730|FG001|Overall Study|Treatment failure|0|||
145264867|NCT02646566|523817731|FG002|Overall Study|Treatment failure|0|||
145264868|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Adverse Event|4|||
145264869|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Adverse Event|3|||
145264870|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Adverse Event|0|||
145264871|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Adverse Event|0|||
145264872|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Death|24|||
145264873|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Death|9|||
145264874|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Death|0|||
145264875|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Death|0|||
145264876|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
145264877|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
145264878|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
145264879|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
145264880|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Physician Decision|4|||
145264881|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Physician Decision|1|||
145264882|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Physician Decision|0|||
145264883|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Physician Decision|0|||
145264884|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Progressive disease|1|||
145264885|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Progressive disease|0|||
145264886|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Progressive disease|0|||
145264887|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Progressive disease|0|||
145264888|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
145264889|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
145264890|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
145580393|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
145580394|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145580395|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145264891|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
145264892|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
145264893|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
145264894|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
145264895|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
145264896|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
145264897|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
145264898|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
145264899|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
145264900|NCT04579666|523817739|FG000|RTP (Up to Week 52)|Other|2|||
145264901|NCT04579666|523817740|FG001|RTP (Up to Week 52)|Other|0|||
145264902|NCT04579666|523817741|FG002|RTP (Up to Week 52)|Other|0|||
145264903|NCT04579666|523817742|FG003|RTP (Up to Week 52)|Other|0|||
145264904|NCT04579666|523817739|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
145264905|NCT04579666|523817740|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
145580396|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145580397|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145580398|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145264906|NCT04579666|523817741|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
145264907|NCT04579666|523817742|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
145264908|NCT04579666|523817739|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
145264909|NCT04579666|523817740|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
145264910|NCT04579666|523817741|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
145264911|NCT04579666|523817742|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
145264912|NCT04579666|523817739|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
145264913|NCT04579666|523817740|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
145264914|NCT04579666|523817741|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
145264915|NCT04579666|523817742|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
145623613|NCT04529538|525134010|FG006|Overall Study|Not eligible at enrollment|0|||
145623614|NCT04529538|525134011|FG007|Overall Study|Not eligible at enrollment|1|||
145623615|NCT04529538|525134004|FG000|Overall Study|Withdrawal by Subject|0|||
145623616|NCT04529538|525134005|FG001|Overall Study|Withdrawal by Subject|1|||
145623617|NCT04529538|525134006|FG002|Overall Study|Withdrawal by Subject|1|||
145623618|NCT04529538|525134007|FG003|Overall Study|Withdrawal by Subject|2|||
145623619|NCT04529538|525134008|FG004|Overall Study|Withdrawal by Subject|0|||
145623620|NCT04529538|525134009|FG005|Overall Study|Withdrawal by Subject|2|||
145623621|NCT04529538|525134010|FG006|Overall Study|Withdrawal by Subject|3|||
145623622|NCT04529538|525134011|FG007|Overall Study|Withdrawal by Subject|0|||
145623623|NCT04529538|525134004|FG000|Overall Study|Other|0|||
145623624|NCT04529538|525134005|FG001|Overall Study|Other|1|||
145623625|NCT04529538|525134006|FG002|Overall Study|Other|0|||
145623626|NCT04529538|525134007|FG003|Overall Study|Other|0|||
145623627|NCT04529538|525134008|FG004|Overall Study|Other|0|||
145623628|NCT04529538|525134009|FG005|Overall Study|Other|0|||
145623629|NCT04529538|525134010|FG006|Overall Study|Other|0|||
145580399|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
145580400|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
145580401|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
145580402|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
145580403|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
145580404|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
145580405|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
145580406|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
145580407|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
145580408|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
145580409|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580410|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580411|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
145580412|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580413|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580414|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580415|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580416|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580417|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
145580418|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145264916|NCT04579666|523817739|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
145264917|NCT04579666|523817740|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
145264918|NCT04579666|523817741|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
145264919|NCT04579666|523817742|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
145264920|NCT04579666|523817739|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
145264921|NCT04579666|523817740|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
145264922|NCT04579666|523817741|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
145264923|NCT04579666|523817742|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
145264924|NCT01982942|523817743|FG000|Overall Study|Adverse Event|10|||
145264925|NCT01982942|523817744|FG001|Overall Study|Adverse Event|5|||
145264926|NCT01982942|523817743|FG000|Overall Study|Lost to Follow-up|4|||
145264927|NCT01982942|523817744|FG001|Overall Study|Lost to Follow-up|3|||
145264928|NCT01982942|523817743|FG000|Overall Study|Multiple sclerosis progression|3|||
145580419|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
145580420|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
145580421|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145580422|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145580423|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145580424|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145580425|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
145580426|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
145580427|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145623630|NCT04529538|525134011|FG007|Overall Study|Other|0|||
145623631|NCT04529538|525134004|FG000|Overall Study|Adverse Event|0|||
145623632|NCT04529538|525134005|FG001|Overall Study|Adverse Event|0|||
145580428|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
145623633|NCT04529538|525134006|FG002|Overall Study|Adverse Event|0|||
145623634|NCT04529538|525134007|FG003|Overall Study|Adverse Event|1|||
145623635|NCT04529538|525134008|FG004|Overall Study|Adverse Event|0|||
145264929|NCT01982942|523817744|FG001|Overall Study|Multiple sclerosis progression|2|||
145264930|NCT01982942|523817743|FG000|Overall Study|Wanted to try therapy not permitted|1|||
145264931|NCT01982942|523817744|FG001|Overall Study|Wanted to try therapy not permitted|0|||
145264932|NCT01982942|523817743|FG000|Overall Study|Subject declined future visits|0|||
145623636|NCT04529538|525134009|FG005|Overall Study|Adverse Event|0|||
145623637|NCT04529538|525134010|FG006|Overall Study|Adverse Event|0|||
145580429|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145580430|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145580431|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145580432|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145580433|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145580434|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
145264933|NCT01982942|523817744|FG001|Overall Study|Subject declined future visits|1|||
145264934|NCT01982942|523817743|FG000|Overall Study|Left geographical area|2|||
145264935|NCT01982942|523817744|FG001|Overall Study|Left geographical area|0|||
145264936|NCT01982942|523817743|FG000|Overall Study|Too many pills|1|||
145264937|NCT01982942|523817744|FG001|Overall Study|Too many pills|0|||
145264938|NCT01982942|523817743|FG000|Overall Study|MS Relapse|0|||
145264939|NCT01982942|523817744|FG001|Overall Study|MS Relapse|1|||
145264940|NCT01982942|523817743|FG000|Overall Study|Chose to join a stem cell trial|0|||
145264941|NCT01982942|523817744|FG001|Overall Study|Chose to join a stem cell trial|1|||
145264942|NCT01982942|523817743|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
145264943|NCT01982942|523817744|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
145264944|NCT04576702|523817745|FG000|Overall Study|Death|1|||
145264945|NCT04576702|523817746|FG001|Overall Study|Death|0|||
145264946|NCT04576702|523817747|FG002|Overall Study|Death|0|||
145264947|NCT04576702|523817748|FG003|Overall Study|Death|0|||
145264948|NCT04576702|523817745|FG000|Overall Study|Withdrawal by Subject|0|||
145264949|NCT04576702|523817746|FG001|Overall Study|Withdrawal by Subject|2|||
145264950|NCT04576702|523817747|FG002|Overall Study|Withdrawal by Subject|1|||
145264951|NCT04576702|523817748|FG003|Overall Study|Withdrawal by Subject|0|||
145264952|NCT04576702|523817745|FG000|Overall Study|Lost to Follow-up|3|||
145264953|NCT04576702|523817746|FG001|Overall Study|Lost to Follow-up|3|||
145264954|NCT04576702|523817747|FG002|Overall Study|Lost to Follow-up|3|||
145264955|NCT04576702|523817748|FG003|Overall Study|Lost to Follow-up|4|||
145264956|NCT00465101|523817749|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
145264957|NCT00465101|523817749|FG000|Overall Study|Change in health precluded follow up|4|||
145264958|NCT00465101|523817749|FG000|Overall Study|Did not meet study criteria|4|||
145264959|NCT00465101|523817749|FG000|Overall Study|Lost to Follow-up|5|||
145264960|NCT00465101|523817749|FG000|Overall Study|Other|6|||
145264961|NCT00465101|523817749|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
145264962|NCT00465101|523817749|FG000|Overall Study|Patient postponed procedure|1|||
145264963|NCT00465101|523817749|FG000|Overall Study|Site closed due to IRB expiration|1|||
145264964|NCT00465101|523817749|FG000|Overall Study|Unable to obtain IRB approval|1|||
145264965|NCT00465101|523817749|FG000|Overall Study|Death|3|||
145264966|NCT00465101|523817749|FG000|Overall Study|Withdrawal by Subject|25|||
145264967|NCT00465101|523817749|FG000|Overall Study|Physician Decision|1|||
145264968|NCT00465101|523817749|FG000|Overall Study|Withdrew consent prior to procedure|3|||
145264969|NCT03099096|523817750|FG000|Overall Study|Adverse Event|1|||
145264970|NCT03099096|523817750|FG000|Overall Study|Physician Decision|1|||
145264971|NCT02985996|523817752|FG000|Overall Study|Withdrawal by Subject|0|||
145264972|NCT02985996|523817753|FG001|Overall Study|Withdrawal by Subject|0|||
145264973|NCT02985996|523817754|FG002|Overall Study|Withdrawal by Subject|1|||
145264974|NCT02985996|523817755|FG003|Overall Study|Withdrawal by Subject|0|||
145264975|NCT02985996|523817756|FG004|Overall Study|Withdrawal by Subject|0|||
145264976|NCT02985996|523817752|FG000|Overall Study|Protocol Violation|0|||
145264977|NCT02985996|523817753|FG001|Overall Study|Protocol Violation|1|||
145264978|NCT02985996|523817754|FG002|Overall Study|Protocol Violation|0|||
145264979|NCT02985996|523817755|FG003|Overall Study|Protocol Violation|0|||
145264980|NCT02985996|523817756|FG004|Overall Study|Protocol Violation|0|||
145264981|NCT01484691|523817757|FG000|Overall Study|Withdrawal by Subject|1|||
145264982|NCT01484691|523817758|FG001|Overall Study|Withdrawal by Subject|1|||
145264983|NCT01484691|523817759|FG002|Overall Study|Withdrawal by Subject|1|||
145264984|NCT01484691|523817757|FG000|Overall Study|Physician Decision|0|||
145580435|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
145580436|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145264985|NCT01484691|523817758|FG001|Overall Study|Physician Decision|2|||
145264986|NCT01484691|523817759|FG002|Overall Study|Physician Decision|1|||
145264987|NCT04668157|523817762|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
145264988|NCT04668157|523817763|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
145264989|NCT04668157|523817762|FG000|Treatment Period (52 Weeks)|Other|0|||
145264990|NCT04668157|523817763|FG001|Treatment Period (52 Weeks)|Other|2|||
145264991|NCT05664672|523817769|FG000|Overall Study|Adverse Event|0|||
145264992|NCT05664672|523817770|FG001|Overall Study|Adverse Event|0|||
145264993|NCT05664672|523817771|FG002|Overall Study|Adverse Event|0|||
145264994|NCT05664672|523817772|FG003|Overall Study|Adverse Event|0|||
145264995|NCT05664672|523817773|FG004|Overall Study|Adverse Event|0|||
145264996|NCT05664672|523817774|FG005|Overall Study|Adverse Event|1|||
145264997|NCT05664672|523817769|FG000|Overall Study|Withdrawal by Subject|0|||
145264998|NCT05664672|523817770|FG001|Overall Study|Withdrawal by Subject|1|||
145264999|NCT05664672|523817771|FG002|Overall Study|Withdrawal by Subject|3|||
145265000|NCT05664672|523817772|FG003|Overall Study|Withdrawal by Subject|0|||
145580437|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
145580438|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580439|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580440|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580441|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580442|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580443|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580444|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
145580445|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580446|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580447|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580448|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580449|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580450|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580451|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580452|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
145580453|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
145580454|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
145580455|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
145580456|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
145580457|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
145372924|NCT01738503|524215145|FG000|Treatment Period|Other|0|||
145372925|NCT01738503|524215146|FG001|Treatment Period|Other|0|||
145372926|NCT01738503|524215147|FG002|Treatment Period|Other|1|||
145265001|NCT05664672|523817773|FG004|Overall Study|Withdrawal by Subject|5|||
145265002|NCT05664672|523817774|FG005|Overall Study|Withdrawal by Subject|6|||
145265003|NCT05664672|523817769|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
145265004|NCT05664672|523817770|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145265005|NCT05664672|523817771|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145265006|NCT05664672|523817772|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
145265007|NCT05664672|523817773|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
145265008|NCT05664672|523817774|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
145265009|NCT05664672|523817769|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
145265010|NCT05664672|523817770|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
145265011|NCT05664672|523817771|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
145265012|NCT05664672|523817772|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
145265013|NCT05664672|523817773|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
145265014|NCT05664672|523817774|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
145265015|NCT04768881|523817777|FG000|Overall Study|Completed Study Follow-up|0|||
145265016|NCT04768881|523817778|FG001|Overall Study|Completed Study Follow-up|2|||
145265017|NCT04768881|523817777|FG000|Overall Study|Death|3|||
145265018|NCT04768881|523817778|FG001|Overall Study|Death|2|||
145265019|NCT04768881|523817777|FG000|Overall Study|Study Terminated by Sponsor|2|||
145265020|NCT04768881|523817778|FG001|Overall Study|Study Terminated by Sponsor|2|||
145265021|NCT04768881|523817777|FG000|Overall Study|Withdrawal by Subject|2|||
145265022|NCT04768881|523817778|FG001|Overall Study|Withdrawal by Subject|0|||
145265023|NCT04768881|523817777|FG000|Overall Study|Other|2|||
145265024|NCT04768881|523817778|FG001|Overall Study|Other|0|||
145265025|NCT04236986|523817779|FG000|Overall Study|Withdrawal by Subject|3|||
145265026|NCT04236986|523817780|FG001|Overall Study|Withdrawal by Subject|1|||
145265027|NCT01990339|523817790|FG000|Overall Study|Data Not Available|49|||
145265028|NCT01990339|523817790|FG000|Overall Study|Voluntary Withdrawal|1402|||
145265029|NCT01990339|523817790|FG000|Overall Study|Lost to Follow-up|861|||
145265030|NCT01038609|523817791|FG000|Overall Study|Adverse Event|0|||
145265031|NCT01038609|523817792|FG001|Overall Study|Adverse Event|0|||
145265032|NCT01038609|523817793|FG002|Overall Study|Adverse Event|1|||
145265033|NCT01038609|523817794|FG003|Overall Study|Adverse Event|0|||
145265034|NCT01038609|523817795|FG004|Overall Study|Adverse Event|0|||
145265035|NCT01038609|523817791|FG000|Overall Study|Dosing Error|0|||
145265036|NCT01038609|523817792|FG001|Overall Study|Dosing Error|0|||
145265037|NCT01038609|523817793|FG002|Overall Study|Dosing Error|0|||
145265038|NCT01038609|523817794|FG003|Overall Study|Dosing Error|1|||
145265039|NCT01038609|523817795|FG004|Overall Study|Dosing Error|1|||
145265040|NCT01038609|523817791|FG000|Overall Study|Death in the Family|1|||
145265041|NCT01038609|523817792|FG001|Overall Study|Death in the Family|0|||
145265042|NCT01038609|523817793|FG002|Overall Study|Death in the Family|0|||
145265043|NCT01038609|523817794|FG003|Overall Study|Death in the Family|0|||
145265044|NCT01038609|523817795|FG004|Overall Study|Death in the Family|0|||
145265045|NCT01038609|523817791|FG000|Overall Study|Refusal of Blood Draws|0|||
145265046|NCT01038609|523817792|FG001|Overall Study|Refusal of Blood Draws|1|||
145265047|NCT01038609|523817793|FG002|Overall Study|Refusal of Blood Draws|0|||
145265048|NCT01038609|523817794|FG003|Overall Study|Refusal of Blood Draws|0|||
145265049|NCT01038609|523817795|FG004|Overall Study|Refusal of Blood Draws|0|||
145265050|NCT01590810|523817796|FG000|Overall Study|Physician Decision|0|||
145265051|NCT01590810|523817797|FG001|Overall Study|Physician Decision|1|||
145265052|NCT01590810|523817798|FG002|Overall Study|Physician Decision|1|||
145265053|NCT01590810|523817799|FG003|Overall Study|Physician Decision|0|||
145265054|NCT01590810|523817800|FG004|Overall Study|Physician Decision|0|||
145265055|NCT01314261|523817801|FG000|Overall Study|Adverse Event|1|||
145265056|NCT01314261|523817802|FG001|Overall Study|Adverse Event|0|||
145265057|NCT01314261|523817803|FG002|Overall Study|Adverse Event|0|||
145265058|NCT01314261|523817804|FG003|Overall Study|Adverse Event|0|||
145265059|NCT01314261|523817801|FG000|Overall Study|Withdrawal by Subject|0|||
145265060|NCT01314261|523817802|FG001|Overall Study|Withdrawal by Subject|3|||
145265061|NCT01314261|523817803|FG002|Overall Study|Withdrawal by Subject|1|||
145265062|NCT01314261|523817804|FG003|Overall Study|Withdrawal by Subject|0|||
145265063|NCT01314261|523817801|FG000|Overall Study|Lost to Follow-up|1|||
145265064|NCT01314261|523817802|FG001|Overall Study|Lost to Follow-up|0|||
145265065|NCT01314261|523817803|FG002|Overall Study|Lost to Follow-up|2|||
145265066|NCT01314261|523817804|FG003|Overall Study|Lost to Follow-up|2|||
145265067|NCT01314261|523817801|FG000|Overall Study|Virologic Failure|0|||
145265068|NCT01314261|523817802|FG001|Overall Study|Virologic Failure|1|||
145265069|NCT01314261|523817803|FG002|Overall Study|Virologic Failure|0|||
145265070|NCT01314261|523817804|FG003|Overall Study|Virologic Failure|1|||
145265071|NCT02129192|523817805|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
145265072|NCT02129192|523817806|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
145265073|NCT01231620|523817807|FG000|Overall Study|Physician Decision|3|||
145265074|NCT01231620|523817808|FG001|Overall Study|Physician Decision|5|||
145265075|NCT01231620|523817809|FG002|Overall Study|Physician Decision|10|||
145265076|NCT01231620|523817807|FG000|Overall Study|Death|12|||
145265077|NCT01231620|523817808|FG001|Overall Study|Death|14|||
145265078|NCT01231620|523817809|FG002|Overall Study|Death|11|||
145265079|NCT01231620|523817807|FG000|Overall Study|Adverse Event|2|||
145265080|NCT01231620|523817808|FG001|Overall Study|Adverse Event|2|||
145265081|NCT01231620|523817809|FG002|Overall Study|Adverse Event|1|||
145265082|NCT01231620|523817807|FG000|Overall Study|Withdrawal by Subject|6|||
145265083|NCT01231620|523817808|FG001|Overall Study|Withdrawal by Subject|6|||
145265084|NCT01231620|523817809|FG002|Overall Study|Withdrawal by Subject|8|||
145265085|NCT01231620|523817807|FG000|Overall Study|Lost to Follow-up|3|||
145265086|NCT01231620|523817808|FG001|Overall Study|Lost to Follow-up|4|||
145265087|NCT01231620|523817809|FG002|Overall Study|Lost to Follow-up|9|||
145265088|NCT02400281|523817811|FG000|Overall Study|Adverse Event|0|||
145265089|NCT02400281|523817812|FG001|Overall Study|Adverse Event|0|||
145265090|NCT02400281|523817813|FG002|Overall Study|Adverse Event|1|||
145265091|NCT02400281|523817814|FG003|Overall Study|Adverse Event|0|||
145265092|NCT02400281|523817815|FG004|Overall Study|Adverse Event|1|||
145265093|NCT02400281|523817816|FG005|Overall Study|Adverse Event|0|||
145265094|NCT02400281|523817811|FG000|Overall Study|Physician Decision|0|||
145265095|NCT02400281|523817812|FG001|Overall Study|Physician Decision|0|||
145265096|NCT02400281|523817813|FG002|Overall Study|Physician Decision|1|||
145265097|NCT02400281|523817814|FG003|Overall Study|Physician Decision|0|||
145265098|NCT02400281|523817815|FG004|Overall Study|Physician Decision|0|||
145265099|NCT02400281|523817816|FG005|Overall Study|Physician Decision|0|||
145265100|NCT04524507|523817817|FG000|Overall Study|Lost to Follow-up|2|||
145265101|NCT04524507|523817818|FG001|Overall Study|Lost to Follow-up|4|||
145265102|NCT04524507|523817817|FG000|Overall Study|Withdrawal by Subject|2|||
145265103|NCT04524507|523817818|FG001|Overall Study|Withdrawal by Subject|9|||
145265104|NCT04524507|523817817|FG000|Overall Study|Death|2|||
145265105|NCT04524507|523817818|FG001|Overall Study|Death|10|||
145265106|NCT00412360|523817819|FG000|Overall Study|Lost to Follow-up|0|||
145265107|NCT00412360|523817820|FG001|Overall Study|Lost to Follow-up|1|||
145265108|NCT00412360|523817819|FG000|Overall Study|Not Transplanted|1|||
145265109|NCT00412360|523817820|FG001|Overall Study|Not Transplanted|2|||
145265110|NCT03655951|523817824|FG000|Overall Study|Lost to Follow-up|39|||
145580458|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
145580459|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
145580460|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
145265111|NCT03655951|523817825|FG001|Overall Study|Lost to Follow-up|20|||
145265112|NCT03655951|523817824|FG000|Overall Study|Withdrawal by Subject|0|||
145265113|NCT03655951|523817825|FG001|Overall Study|Withdrawal by Subject|1|||
145265114|NCT01078974|523817828|FG000|Overall Study|Adverse Event|3|||
145265115|NCT02569996|523817830|FG000|Overall Study|Adverse Event|6|||
145265116|NCT02569996|523817830|FG000|Overall Study|Physician Decision|3|||
145265117|NCT02569996|523817830|FG000|Overall Study|Progression of the disease|18|||
145265118|NCT02569996|523817830|FG000|Overall Study|New anti-lymphoma treatment|1|||
145265119|NCT02569996|523817830|FG000|Overall Study|Non-compliance|9|||
145265120|NCT02569996|523817830|FG000|Overall Study|Withdrawal by Subject|5|||
145265121|NCT02569996|523817830|FG000|Overall Study|Lost to Follow-up|5|||
145265122|NCT02569996|523817830|FG000|Overall Study|Complete remission|7|||
145265123|NCT02569996|523817830|FG000|Overall Study|Unknown reason|1|||
145265124|NCT01383317|523817831|FG000|Overall Study|Lost to Follow-up|2|||
145580461|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
145580462|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
145580463|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
145372927|NCT01738503|524215148|FG003|Treatment Period|Other|0|||
145372928|NCT01738503|524215149|FG004|Treatment Period|Other|0|||
145372929|NCT01738503|524215150|FG005|Treatment Period|Other|0|||
145372930|NCT01738503|524215151|FG006|Treatment Period|Other|0|||
145372931|NCT01738503|524215145|FG000|PET Imaging Sub-study|Adverse Event|0|||
145372932|NCT01738503|524215146|FG001|PET Imaging Sub-study|Adverse Event|0|||
145372933|NCT01738503|524215147|FG002|PET Imaging Sub-study|Adverse Event|0|||
145372934|NCT01738503|524215148|FG003|PET Imaging Sub-study|Adverse Event|0|||
145372935|NCT01738503|524215149|FG004|PET Imaging Sub-study|Adverse Event|0|||
145372936|NCT01738503|524215150|FG005|PET Imaging Sub-study|Adverse Event|1|||
145372937|NCT01738503|524215151|FG006|PET Imaging Sub-study|Adverse Event|0|||
145372938|NCT01738503|524215145|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145372939|NCT01738503|524215146|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145372940|NCT01738503|524215147|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145372941|NCT01738503|524215148|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145372942|NCT01738503|524215149|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
145372943|NCT01738503|524215150|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
145372944|NCT01738503|524215151|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
145372945|NCT04696354|524215152|FG000|Overall Study|Study termination|6|||
145372946|NCT04696354|524215153|FG001|Overall Study|Study termination|6|||
145372947|NCT03005327|524215154|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145372948|NCT03005327|524215155|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145372949|NCT03005327|524215156|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
145372950|NCT03005327|524215157|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
145372951|NCT03005327|524215154|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145372952|NCT03005327|524215155|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145372953|NCT03005327|524215156|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145372954|NCT03005327|524215157|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145372955|NCT04687072|524215158|FG000|Overall Study|Adverse Event|2|||
145372956|NCT04687072|524215159|FG001|Overall Study|Adverse Event|0|||
145372957|NCT04687072|524215158|FG000|Overall Study|Death|1|||
145372958|NCT04687072|524215159|FG001|Overall Study|Death|0|||
145372959|NCT04687072|524215158|FG000|Overall Study|Lack of Efficacy|2|||
145372960|NCT04687072|524215159|FG001|Overall Study|Lack of Efficacy|1|||
145372961|NCT04687072|524215158|FG000|Overall Study|Physician Decision|1|||
145372962|NCT04687072|524215159|FG001|Overall Study|Physician Decision|0|||
145372963|NCT04687072|524215158|FG000|Overall Study|Pregnancy|1|||
145372964|NCT04687072|524215159|FG001|Overall Study|Pregnancy|0|||
145372965|NCT04687072|524215158|FG000|Overall Study|Requires Prohibited Medication|2|||
145372966|NCT04687072|524215159|FG001|Overall Study|Requires Prohibited Medication|0|||
145372967|NCT04687072|524215158|FG000|Overall Study|Withdrawal of Consent|11|||
145372968|NCT04687072|524215159|FG001|Overall Study|Withdrawal of Consent|6|||
145372969|NCT04687072|524215158|FG000|Overall Study|Miscellaneous|4|||
145372970|NCT04687072|524215159|FG001|Overall Study|Miscellaneous|1|||
145372971|NCT02600845|524215164|FG000|Overall Study|Reason Not Specified|3|||
145372972|NCT02600845|524215164|FG000|Overall Study|Non-compliance with Study Procedures|10|||
145372973|NCT02600845|524215164|FG000|Overall Study|Consent Withdrawal|5|||
145372974|NCT00965341|524215165|FG000|Overall Study|Withdrew consent|1|||
145372975|NCT00965341|524215166|FG001|Overall Study|Withdrew consent|5|||
145372976|NCT00965341|524215165|FG000|Overall Study|Lost to Follow-up|1|||
145372977|NCT00965341|524215166|FG001|Overall Study|Lost to Follow-up|0|||
145372978|NCT00965341|524215165|FG000|Overall Study|Transportation issues|4|||
145372979|NCT00965341|524215166|FG001|Overall Study|Transportation issues|3|||
145372980|NCT03055494|524217110|FG000|Overall Study|Lost to Follow-up|6|||
145372981|NCT03055494|524217111|FG001|Overall Study|Lost to Follow-up|0|||
145372982|NCT03055494|524217110|FG000|Overall Study|Physician Decision|2|||
145372983|NCT03055494|524217111|FG001|Overall Study|Physician Decision|0|||
145372984|NCT03055494|524217110|FG000|Overall Study|Withdrawal by Subject|1|||
145372985|NCT03055494|524217111|FG001|Overall Study|Withdrawal by Subject|0|||
145372986|NCT03055494|524217110|FG000|Overall Study|Adverse Event|0|||
145372987|NCT03055494|524217111|FG001|Overall Study|Adverse Event|1|||
145372988|NCT03055494|524217110|FG000|Overall Study|Non-compliance with study treatment|1|||
145372989|NCT03055494|524217111|FG001|Overall Study|Non-compliance with study treatment|0|||
145372990|NCT03197467|524217114|FG000|Overall Study|Withdrawal by Subject|1|||
145372991|NCT03666533|524217116|FG000|Overall Study|Lost to Follow-up|2|||
145372992|NCT03666533|524217117|FG001|Overall Study|Lost to Follow-up|2|||
145372993|NCT02017717|524217118|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145372994|NCT02017717|524217119|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145623638|NCT04529538|525134011|FG007|Overall Study|Adverse Event|0|||
145372995|NCT02017717|524217120|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145372996|NCT02017717|524217121|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145372997|NCT02017717|524217122|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145372998|NCT02017717|524217123|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145372999|NCT02017717|524217124|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145373000|NCT02017717|524217125|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
145373001|NCT02017717|524217126|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
145373002|NCT02017717|524217118|FG000|Before Treatment Period|Participant request to stop therapy|0|||
145373003|NCT02017717|524217119|FG001|Before Treatment Period|Participant request to stop therapy|0|||
145373004|NCT02017717|524217120|FG002|Before Treatment Period|Participant request to stop therapy|0|||
145373005|NCT02017717|524217121|FG003|Before Treatment Period|Participant request to stop therapy|0|||
145373006|NCT02017717|524217122|FG004|Before Treatment Period|Participant request to stop therapy|0|||
145373007|NCT02017717|524217123|FG005|Before Treatment Period|Participant request to stop therapy|0|||
145373008|NCT02017717|524217124|FG006|Before Treatment Period|Participant request to stop therapy|0|||
145373009|NCT02017717|524217125|FG007|Before Treatment Period|Participant request to stop therapy|0|||
145373010|NCT02017717|524217126|FG008|Before Treatment Period|Participant request to stop therapy|5|||
145373011|NCT02017717|524217118|FG000|Before Treatment Period|Participant withdrew consent|0|||
145373012|NCT02017717|524217119|FG001|Before Treatment Period|Participant withdrew consent|0|||
145373013|NCT02017717|524217120|FG002|Before Treatment Period|Participant withdrew consent|0|||
145373014|NCT02017717|524217121|FG003|Before Treatment Period|Participant withdrew consent|0|||
145373015|NCT02017717|524217122|FG004|Before Treatment Period|Participant withdrew consent|0|||
145373016|NCT02017717|524217123|FG005|Before Treatment Period|Participant withdrew consent|0|||
145373017|NCT02017717|524217124|FG006|Before Treatment Period|Participant withdrew consent|2|||
145373018|NCT02017717|524217125|FG007|Before Treatment Period|Participant withdrew consent|0|||
145373019|NCT02017717|524217126|FG008|Before Treatment Period|Participant withdrew consent|11|||
145373020|NCT02017717|524217118|FG000|Before Treatment Period|Lost to Follow-up|0|||
145373021|NCT02017717|524217119|FG001|Before Treatment Period|Lost to Follow-up|0|||
145373022|NCT02017717|524217120|FG002|Before Treatment Period|Lost to Follow-up|0|||
145373023|NCT02017717|524217121|FG003|Before Treatment Period|Lost to Follow-up|0|||
145373024|NCT02017717|524217122|FG004|Before Treatment Period|Lost to Follow-up|0|||
145373025|NCT02017717|524217123|FG005|Before Treatment Period|Lost to Follow-up|0|||
145373026|NCT02017717|524217124|FG006|Before Treatment Period|Lost to Follow-up|0|||
145373027|NCT02017717|524217125|FG007|Before Treatment Period|Lost to Follow-up|0|||
145373028|NCT02017717|524217126|FG008|Before Treatment Period|Lost to Follow-up|1|||
145373029|NCT02017717|524217118|FG000|Before Treatment Period|Participant no longer met criteria|0|||
145373030|NCT02017717|524217119|FG001|Before Treatment Period|Participant no longer met criteria|0|||
145373031|NCT02017717|524217120|FG002|Before Treatment Period|Participant no longer met criteria|0|||
145373032|NCT02017717|524217121|FG003|Before Treatment Period|Participant no longer met criteria|0|||
145373033|NCT02017717|524217122|FG004|Before Treatment Period|Participant no longer met criteria|0|||
145373034|NCT02017717|524217123|FG005|Before Treatment Period|Participant no longer met criteria|1|||
145373035|NCT02017717|524217124|FG006|Before Treatment Period|Participant no longer met criteria|0|||
145373036|NCT02017717|524217125|FG007|Before Treatment Period|Participant no longer met criteria|1|||
145373037|NCT02017717|524217126|FG008|Before Treatment Period|Participant no longer met criteria|2|||
145373038|NCT02017717|524217118|FG000|Before Treatment Period|other reason|0|||
145373039|NCT02017717|524217119|FG001|Before Treatment Period|other reason|0|||
145373040|NCT02017717|524217120|FG002|Before Treatment Period|other reason|0|||
145373041|NCT02017717|524217121|FG003|Before Treatment Period|other reason|0|||
145373042|NCT02017717|524217122|FG004|Before Treatment Period|other reason|0|||
145373043|NCT02017717|524217123|FG005|Before Treatment Period|other reason|0|||
145373044|NCT02017717|524217124|FG006|Before Treatment Period|other reason|0|||
145373045|NCT02017717|524217125|FG007|Before Treatment Period|other reason|0|||
145373046|NCT02017717|524217126|FG008|Before Treatment Period|other reason|1|||
145373047|NCT02017717|524217118|FG000|Treatment Period|Disease progression|7|||
145373048|NCT02017717|524217119|FG001|Treatment Period|Disease progression|9|||
145373049|NCT02017717|524217120|FG002|Treatment Period|Disease progression|12|||
145373050|NCT02017717|524217121|FG003|Treatment Period|Disease progression|20|||
145373051|NCT02017717|524217122|FG004|Treatment Period|Disease progression|26|||
145373052|NCT02017717|524217123|FG005|Treatment Period|Disease progression|16|||
145373053|NCT02017717|524217124|FG006|Treatment Period|Disease progression|22|||
145373054|NCT02017717|524217125|FG007|Treatment Period|Disease progression|165|||
145373055|NCT02017717|524217126|FG008|Treatment Period|Disease progression|135|||
145373056|NCT02017717|524217118|FG000|Treatment Period|Study drug toxicity|3|||
145373057|NCT02017717|524217119|FG001|Treatment Period|Study drug toxicity|0|||
145373058|NCT02017717|524217120|FG002|Treatment Period|Study drug toxicity|1|||
145373059|NCT02017717|524217121|FG003|Treatment Period|Study drug toxicity|4|||
145373060|NCT02017717|524217122|FG004|Treatment Period|Study drug toxicity|4|||
145373061|NCT02017717|524217123|FG005|Treatment Period|Study drug toxicity|5|||
145373062|NCT02017717|524217124|FG006|Treatment Period|Study drug toxicity|3|||
145373063|NCT02017717|524217125|FG007|Treatment Period|Study drug toxicity|7|||
145373064|NCT02017717|524217126|FG008|Treatment Period|Study drug toxicity|11|||
145373065|NCT02017717|524217118|FG000|Treatment Period|Death|0|||
145265125|NCT01383317|523817832|FG001|Overall Study|Lost to Follow-up|1|||
145265126|NCT01383317|523817831|FG000|Overall Study|Death|1|||
145265127|NCT01383317|523817832|FG001|Overall Study|Death|0|||
145265128|NCT01383317|523817831|FG000|Overall Study|Adverse Event|0|||
145265129|NCT01383317|523817832|FG001|Overall Study|Adverse Event|1|||
145580464|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
145580465|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
145580466|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
145580467|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
145580468|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
145580469|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
145580470|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
145580471|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
145580472|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580473|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580474|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580475|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580476|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580477|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580478|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580479|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
145580480|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
145580481|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580482|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
145580483|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580484|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580485|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580486|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580487|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580488|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145580489|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
145265130|NCT01349816|523817833|FG000|Overall Study|Withdrawal by Subject|4|||
145265131|NCT01349816|523817833|FG000|Overall Study|Physician Decision|1|||
145265132|NCT01349816|523817833|FG000|Overall Study|Adverse Event|14|||
145265133|NCT01349816|523817833|FG000|Overall Study|Lost to Follow-up|2|||
145265134|NCT01349816|523817833|FG000|Overall Study|Protocol Violation|1|||
145265135|NCT01349816|523817833|FG000|Overall Study|Protocol-specified criteria|8|||
145265136|NCT02911285|523817835|FG000|Overall Study|Lost to Follow-up|8|||
145265137|NCT02911285|523817836|FG001|Overall Study|Lost to Follow-up|5|||
145265138|NCT02911285|523817835|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
145265139|NCT02911285|523817836|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
145265140|NCT01397409|523817837|FG000|Stage 2|Adverse Event|0|||
145265141|NCT01397409|523817838|FG001|Stage 2|Adverse Event|0|||
145265142|NCT01397409|523817839|FG002|Stage 2|Adverse Event|0|||
145265143|NCT01397409|523817840|FG003|Stage 2|Adverse Event|0|||
145265144|NCT01397409|523817841|FG004|Stage 2|Adverse Event|6|||
145265145|NCT01397409|523817842|FG005|Stage 2|Adverse Event|3|||
145265146|NCT01397409|523817843|FG006|Stage 2|Adverse Event|0|||
145265147|NCT01397409|523817844|FG007|Stage 2|Adverse Event|0|||
145265148|NCT01397409|523817845|FG008|Stage 2|Adverse Event|0|||
145265149|NCT01397409|523817846|FG009|Stage 2|Adverse Event|0|||
145265150|NCT01397409|523817837|FG000|Stage 2|Personal Reasons|0|||
145265151|NCT01397409|523817838|FG001|Stage 2|Personal Reasons|0|||
145265152|NCT01397409|523817839|FG002|Stage 2|Personal Reasons|0|||
145265153|NCT01397409|523817840|FG003|Stage 2|Personal Reasons|0|||
145265154|NCT01397409|523817841|FG004|Stage 2|Personal Reasons|1|||
145265155|NCT01397409|523817842|FG005|Stage 2|Personal Reasons|0|||
145265156|NCT01397409|523817843|FG006|Stage 2|Personal Reasons|0|||
145265157|NCT01397409|523817844|FG007|Stage 2|Personal Reasons|0|||
145265158|NCT01397409|523817845|FG008|Stage 2|Personal Reasons|0|||
145265159|NCT01397409|523817846|FG009|Stage 2|Personal Reasons|0|||
145265160|NCT01397409|523817837|FG000|Stage 2|Other Miscellaneous Reasons|0|||
145265161|NCT01397409|523817838|FG001|Stage 2|Other Miscellaneous Reasons|0|||
145580490|NCT01172938|524979185|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580491|NCT01172938|524979186|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580492|NCT01172938|524979187|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
145580493|NCT01172938|524979188|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145265162|NCT01397409|523817839|FG002|Stage 2|Other Miscellaneous Reasons|0|||
145265163|NCT01397409|523817840|FG003|Stage 2|Other Miscellaneous Reasons|0|||
145265164|NCT01397409|523817841|FG004|Stage 2|Other Miscellaneous Reasons|1|||
145265165|NCT01397409|523817842|FG005|Stage 2|Other Miscellaneous Reasons|1|||
145265166|NCT01397409|523817843|FG006|Stage 2|Other Miscellaneous Reasons|0|||
145265167|NCT01397409|523817844|FG007|Stage 2|Other Miscellaneous Reasons|0|||
145265168|NCT01397409|523817845|FG008|Stage 2|Other Miscellaneous Reasons|0|||
145580494|NCT01172938|524979189|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580495|NCT01172938|524979190|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580496|NCT01172938|524979191|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580497|NCT01172938|524979192|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580498|NCT01172938|524979193|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
145580499|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580500|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
145580501|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
145580502|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580503|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580504|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580505|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580506|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
145580507|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
145580508|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
145580509|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
145580510|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
145580511|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
145580512|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
145580513|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
145580514|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
145580515|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
145580516|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
145580517|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
145580518|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
145580519|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
145580520|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
145580521|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
145580522|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
145580523|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
145580524|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
145580525|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
145580526|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580527|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580528|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
145580529|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580530|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580531|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580532|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580533|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
145580534|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
145580535|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580536|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580537|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580538|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580539|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580540|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580541|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145580542|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
145580543|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
145623639|NCT04529538|525134004|FG000|Overall Study|Protocol Deviation|0|||
145623640|NCT04529538|525134005|FG001|Overall Study|Protocol Deviation|0|||
145265169|NCT01397409|523817846|FG009|Stage 2|Other Miscellaneous Reasons|0|||
145265170|NCT01397409|523817837|FG000|Stage 3|Adverse Event|0|||
145265171|NCT01397409|523817838|FG001|Stage 3|Adverse Event|0|||
145265172|NCT01397409|523817839|FG002|Stage 3|Adverse Event|0|||
145265173|NCT01397409|523817840|FG003|Stage 3|Adverse Event|0|||
145265174|NCT01397409|523817841|FG004|Stage 3|Adverse Event|0|||
145265175|NCT01397409|523817842|FG005|Stage 3|Adverse Event|0|||
145265176|NCT01397409|523817843|FG006|Stage 3|Adverse Event|0|||
145265177|NCT01397409|523817844|FG007|Stage 3|Adverse Event|1|||
145265178|NCT01397409|523817845|FG008|Stage 3|Adverse Event|0|||
145265179|NCT01397409|523817846|FG009|Stage 3|Adverse Event|0|||
145265180|NCT01397409|523817837|FG000|Stage 3|Other Miscellaneous Reasons|0|||
145265181|NCT01397409|523817838|FG001|Stage 3|Other Miscellaneous Reasons|0|||
145623641|NCT04529538|525134006|FG002|Overall Study|Protocol Deviation|0|||
145623642|NCT04529538|525134007|FG003|Overall Study|Protocol Deviation|1|||
145265182|NCT01397409|523817839|FG002|Stage 3|Other Miscellaneous Reasons|0|||
145265183|NCT01397409|523817840|FG003|Stage 3|Other Miscellaneous Reasons|0|||
145265184|NCT01397409|523817841|FG004|Stage 3|Other Miscellaneous Reasons|0|||
145265185|NCT01397409|523817842|FG005|Stage 3|Other Miscellaneous Reasons|0|||
145265186|NCT01397409|523817843|FG006|Stage 3|Other Miscellaneous Reasons|0|||
145265187|NCT01397409|523817844|FG007|Stage 3|Other Miscellaneous Reasons|1|||
145265188|NCT01397409|523817845|FG008|Stage 3|Other Miscellaneous Reasons|0|||
145265189|NCT01397409|523817846|FG009|Stage 3|Other Miscellaneous Reasons|0|||
145265190|NCT00422227|523817847|FG000|Overall Study|Adverse Event|3|||
145265191|NCT00422227|523817848|FG001|Overall Study|Adverse Event|8|||
145265192|NCT00422227|523817847|FG000|Overall Study|Lost to Follow-up|1|||
145265193|NCT00422227|523817848|FG001|Overall Study|Lost to Follow-up|3|||
145265194|NCT00422227|523817847|FG000|Overall Study|Withdrawal by Subject|0|||
145265195|NCT00422227|523817848|FG001|Overall Study|Withdrawal by Subject|4|||
145265196|NCT01207427|523817849|FG000|Double-blind Treatment Period|Adverse Event|0|||
145265197|NCT01207427|523817850|FG001|Double-blind Treatment Period|Adverse Event|1|||
145265198|NCT01207427|523817851|FG002|Double-blind Treatment Period|Adverse Event|0|||
145265199|NCT01207427|523817849|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145265200|NCT01207427|523817850|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145265201|NCT01207427|523817851|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
145265202|NCT01207427|523817849|FG000|Double-blind Treatment Period|Protocol Violation|2|||
145265203|NCT01207427|523817850|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145265204|NCT01207427|523817851|FG002|Double-blind Treatment Period|Protocol Violation|1|||
145265205|NCT01207427|523817849|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145265206|NCT01207427|523817850|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145265207|NCT01207427|523817851|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145265208|NCT03418727|523817852|FG000|Overall Study|Adverse Event|1|||
145265209|NCT03418727|523817853|FG001|Overall Study|Adverse Event|2|||
145265210|NCT03418727|523817854|FG002|Overall Study|Adverse Event|0|||
145265211|NCT03418727|523817852|FG000|Overall Study|Withdrawal by Subject|0|||
145265212|NCT03418727|523817853|FG001|Overall Study|Withdrawal by Subject|0|||
145265213|NCT03418727|523817854|FG002|Overall Study|Withdrawal by Subject|2|||
145265214|NCT00686894|523817856|FG000|Overall Study|Relapse|2|||
145265215|NCT00686894|523817856|FG000|Overall Study|Protocol Violation|4|||
145265216|NCT01791543|523817857|FG000|Overall Study|Lost to Follow-up|1|||
145265217|NCT01791543|523817857|FG000|Overall Study|Adverse Event|1|||
145265218|NCT01790633|523817862|FG000|Overall Study|Protocol Violation|1|||
145265219|NCT01790633|523817863|FG001|Overall Study|Protocol Violation|2|||
145265220|NCT01790633|523817862|FG000|Overall Study|Did not have serology performed|47|||
145265221|NCT01790633|523817863|FG001|Overall Study|Did not have serology performed|0|||
145265222|NCT01790633|523817862|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
145265223|NCT01790633|523817863|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
145265224|NCT01302366|523819230|FG000|Overall Study|patient choice or noncompliance|5|||
145265225|NCT00467051|523819231|FG000|Overall Study|Adverse Event|2|||
145265226|NCT01740297|523819232|FG000|Overall Study|Withdrawal by Subject|4|||
145265227|NCT01740297|523819233|FG001|Overall Study|Withdrawal by Subject|16|||
145265228|NCT01740297|523819234|FG002|Overall Study|Withdrawal by Subject|17|||
145265229|NCT01740297|523819232|FG000|Overall Study|Death|8|||
145265230|NCT01740297|523819233|FG001|Overall Study|Death|46|||
145265231|NCT01740297|523819234|FG002|Overall Study|Death|40|||
145265232|NCT01740297|523819232|FG000|Overall Study|Lost to Follow-up|1|||
145265233|NCT01740297|523819233|FG001|Overall Study|Lost to Follow-up|2|||
145265234|NCT01740297|523819234|FG002|Overall Study|Lost to Follow-up|4|||
145265235|NCT02985541|523819238|FG000|Overall Study|Withdrawal by Subject|33|||
145265236|NCT02985541|523819238|FG000|Overall Study|Lost to Follow-up|26|||
145265237|NCT02985541|523819238|FG000|Overall Study|Adverse Event|27|||
145265238|NCT02985541|523819238|FG000|Overall Study|Physician Decision|2|||
145265239|NCT02985541|523819238|FG000|Overall Study|Pregnancy|2|||
145265240|NCT02985541|523819238|FG000|Overall Study|Wish for pregnancy|44|||
145265241|NCT02985541|523819238|FG000|Overall Study|Other reason|5|||
145265242|NCT02985541|523819238|FG000|Overall Study|Not valid for analysis|2|||
145265243|NCT01479777|523819245|FG000|Overall Study|Physician Decision|2|||
145580544|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145580545|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145580546|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
145265244|NCT00451191|523819249|FG000|Overall Study|withdrawal or received alternate tx|15|||
145265245|NCT00451191|523819250|FG001|Overall Study|withdrawal or received alternate tx|11|||
145265246|NCT01241591|523819258|FG000|Overall Study|Lack of Efficacy|5|||
145265247|NCT01241591|523819259|FG001|Overall Study|Lack of Efficacy|2|||
145265248|NCT01241591|523819260|FG002|Overall Study|Lack of Efficacy|2|||
145265249|NCT01241591|523819261|FG003|Overall Study|Lack of Efficacy|3|||
145265250|NCT01241591|523819258|FG000|Overall Study|Protocol Violation|5|||
145265251|NCT01241591|523819259|FG001|Overall Study|Protocol Violation|2|||
145265252|NCT01241591|523819260|FG002|Overall Study|Protocol Violation|3|||
145265253|NCT01241591|523819261|FG003|Overall Study|Protocol Violation|0|||
145265254|NCT01241591|523819258|FG000|Overall Study|Lost to Follow-up|1|||
145265255|NCT01241591|523819259|FG001|Overall Study|Lost to Follow-up|2|||
145265256|NCT01241591|523819260|FG002|Overall Study|Lost to Follow-up|2|||
145265257|NCT01241591|523819261|FG003|Overall Study|Lost to Follow-up|2|||
145265258|NCT01241591|523819258|FG000|Overall Study|Screen Failure|3|||
145265259|NCT01241591|523819259|FG001|Overall Study|Screen Failure|2|||
145265260|NCT01241591|523819260|FG002|Overall Study|Screen Failure|1|||
145265261|NCT01241591|523819261|FG003|Overall Study|Screen Failure|0|||
145265262|NCT01241591|523819258|FG000|Overall Study|Withdrawal by Subject|6|||
145265263|NCT01241591|523819259|FG001|Overall Study|Withdrawal by Subject|4|||
145265264|NCT01241591|523819260|FG002|Overall Study|Withdrawal by Subject|2|||
145265265|NCT01241591|523819261|FG003|Overall Study|Withdrawal by Subject|2|||
145265266|NCT01241591|523819258|FG000|Overall Study|Other|0|||
145265267|NCT01241591|523819259|FG001|Overall Study|Other|1|||
145265268|NCT01241591|523819260|FG002|Overall Study|Other|0|||
145265269|NCT01241591|523819261|FG003|Overall Study|Other|1|||
145265270|NCT01241591|523819258|FG000|Overall Study|Adverse Event|3|||
145265271|NCT01241591|523819259|FG001|Overall Study|Adverse Event|11|||
145265272|NCT01241591|523819260|FG002|Overall Study|Adverse Event|12|||
145265273|NCT01241591|523819261|FG003|Overall Study|Adverse Event|4|||
145265274|NCT01945034|523819262|FG000|Overall Study|Medication Error|0|||
145265275|NCT01945034|523819263|FG001|Overall Study|Medication Error|1|||
145265276|NCT01945034|523819264|FG002|Overall Study|Medication Error|0|||
145265277|NCT01945034|523819262|FG000|Overall Study|Withdrawal by Subject|0|||
145265278|NCT01945034|523819263|FG001|Overall Study|Withdrawal by Subject|3|||
145265279|NCT01945034|523819264|FG002|Overall Study|Withdrawal by Subject|1|||
145265280|NCT01945034|523819262|FG000|Overall Study|Other|0|||
145265281|NCT01945034|523819263|FG001|Overall Study|Other|1|||
145265282|NCT01945034|523819264|FG002|Overall Study|Other|3|||
145265283|NCT01945034|523819262|FG000|Overall Study|Lost to Follow-up|0|||
145425124|NCT02691494|524412980|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
145425125|NCT02691494|524412981|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
145425126|NCT02691494|524412982|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
145425127|NCT02691494|524412980|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145425128|NCT02691494|524412981|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145425129|NCT02691494|524412982|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
145425130|NCT02691494|524412980|FG000|Post-Treatment Follow-Up Period|Other|2|||
145425131|NCT02691494|524412981|FG001|Post-Treatment Follow-Up Period|Other|1|||
145425132|NCT02691494|524412982|FG002|Post-Treatment Follow-Up Period|Other|1|||
145425133|NCT02691494|524412980|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
145425134|NCT02691494|524412981|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
145425135|NCT02691494|524412982|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
145425136|NCT02691494|524412980|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
145425137|NCT02691494|524412981|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
145425138|NCT02691494|524412982|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
145425139|NCT03379870|524413888|FG000|Overall Study|Lost to Follow-up|1|||
145425140|NCT03379870|524413889|FG001|Overall Study|Lost to Follow-up|0|||
145425141|NCT03379870|524413888|FG000|Overall Study|Protocol Violation|1|||
145425142|NCT03379870|524413889|FG001|Overall Study|Protocol Violation|1|||
145425143|NCT02471144|524413890|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
145425144|NCT02471144|524413891|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
145425145|NCT02471144|524413892|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
145425146|NCT02471144|524413893|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
145425147|NCT02471144|524413894|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
145425148|NCT02471144|524413895|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
145425149|NCT02471144|524413896|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
145425150|NCT02471144|524413897|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
145425151|NCT02471144|524413898|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
145425152|NCT02471144|524413899|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
145425153|NCT02471144|524413900|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
145425154|NCT02471144|524413890|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425155|NCT02471144|524413891|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425156|NCT02471144|524413892|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425157|NCT02471144|524413893|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
145580547|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145580548|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145580549|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145425158|NCT02471144|524413894|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425159|NCT02471144|524413895|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425160|NCT02471144|524413896|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425161|NCT02471144|524413897|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425162|NCT02471144|524413898|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425163|NCT02471144|524413899|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425164|NCT02471144|524413900|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
145425165|NCT02471144|524413890|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425166|NCT02471144|524413891|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145580550|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
145580551|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
145580552|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
145580553|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580554|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580555|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
145580556|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580557|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580558|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580559|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580560|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580561|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
145580562|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580563|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
145580564|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580565|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580566|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145623643|NCT04529538|525134008|FG004|Overall Study|Protocol Deviation|0|||
145425167|NCT02471144|524413892|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
145425168|NCT02471144|524413893|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425169|NCT02471144|524413894|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425170|NCT02471144|524413895|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425171|NCT02471144|524413896|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425172|NCT02471144|524413897|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425173|NCT02471144|524413898|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425174|NCT02471144|524413899|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425175|NCT02471144|524413900|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
145425176|NCT02471144|524413890|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
145425177|NCT02471144|524413891|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
145425178|NCT02471144|524413892|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425179|NCT02471144|524413893|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425180|NCT02471144|524413894|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425181|NCT02471144|524413895|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425182|NCT02471144|524413896|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425183|NCT02471144|524413897|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425184|NCT02471144|524413898|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425185|NCT02471144|524413899|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425186|NCT02471144|524413900|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
145425187|NCT02471144|524413890|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425188|NCT02471144|524413891|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425189|NCT02471144|524413892|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425190|NCT02471144|524413893|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425191|NCT02471144|524413894|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145425192|NCT02471144|524413895|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425193|NCT02471144|524413896|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145425194|NCT02471144|524413897|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425195|NCT02471144|524413898|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
145425196|NCT02471144|524413899|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425197|NCT02471144|524413900|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
145425198|NCT02471144|524413890|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425199|NCT02471144|524413891|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425200|NCT02471144|524413892|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425201|NCT02471144|524413893|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425202|NCT02471144|524413894|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425203|NCT02471144|524413895|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
145425204|NCT02471144|524413896|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425205|NCT02471144|524413897|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425206|NCT02471144|524413898|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
145425207|NCT02471144|524413899|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425208|NCT02471144|524413900|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
145425209|NCT02471144|524413890|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425210|NCT02471144|524413891|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425211|NCT02471144|524413892|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425212|NCT02471144|524413893|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425213|NCT02471144|524413894|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425214|NCT02471144|524413895|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425215|NCT02471144|524413896|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425216|NCT02471144|524413897|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425217|NCT02471144|524413898|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
145425218|NCT02471144|524413899|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425219|NCT02471144|524413900|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
145425220|NCT02471144|524413890|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425221|NCT02471144|524413891|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425222|NCT02471144|524413892|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425223|NCT02471144|524413893|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425224|NCT02471144|524413894|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425225|NCT02471144|524413895|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145623644|NCT04529538|525134009|FG005|Overall Study|Protocol Deviation|0|||
145623645|NCT04529538|525134010|FG006|Overall Study|Protocol Deviation|0|||
145425226|NCT02471144|524413896|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425227|NCT02471144|524413897|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
145425228|NCT02471144|524413898|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
145425229|NCT02471144|524413899|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425230|NCT02471144|524413900|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
145425231|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425232|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425233|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425234|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425235|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425236|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425237|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425238|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425239|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
145425240|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
145425241|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
145425242|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425243|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425244|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425245|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425246|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425247|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425248|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425249|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425250|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425251|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
145425252|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
145425253|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425254|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425255|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425256|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425257|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425258|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425259|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425260|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425261|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425262|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
145425263|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
145425264|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425265|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425266|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425267|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425268|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425269|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425270|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425271|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425272|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
145425273|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
145425274|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
145425275|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425276|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425277|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145580567|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580568|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580569|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
145580570|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
145580571|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145580572|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
145580573|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
145580574|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145580575|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145623646|NCT04529538|525134011|FG007|Overall Study|Protocol Deviation|0|||
145623647|NCT04529538|525134004|FG000|Overall Study|Physician Decision|0|||
145623648|NCT04529538|525134005|FG001|Overall Study|Physician Decision|0|||
145623649|NCT04529538|525134006|FG002|Overall Study|Physician Decision|0|||
145623650|NCT04529538|525134007|FG003|Overall Study|Physician Decision|0|||
145623651|NCT04529538|525134008|FG004|Overall Study|Physician Decision|0|||
145623652|NCT04529538|525134009|FG005|Overall Study|Physician Decision|1|||
145623653|NCT04529538|525134010|FG006|Overall Study|Physician Decision|0|||
145623654|NCT04529538|525134011|FG007|Overall Study|Physician Decision|1|||
145623655|NCT02223182|525134012|FG000|Double-Blind Period|Adverse Event|0|||
145623656|NCT02223182|525134013|FG001|Double-Blind Period|Adverse Event|2|||
145623657|NCT02223182|525134014|FG002|Double-Blind Period|Adverse Event|1|||
145623658|NCT02223182|525134015|FG003|Double-Blind Period|Adverse Event|0|||
145623659|NCT02223182|525134012|FG000|Double-Blind Period|Withdrawal by Subject|1|||
145623660|NCT02223182|525134013|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145623661|NCT02223182|525134014|FG002|Double-Blind Period|Withdrawal by Subject|1|||
145623662|NCT02223182|525134015|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145623663|NCT02223182|525134012|FG000|Double-Blind Period|Lost to Follow-up|0|||
145623664|NCT02223182|525134013|FG001|Double-Blind Period|Lost to Follow-up|1|||
145623665|NCT02223182|525134014|FG002|Double-Blind Period|Lost to Follow-up|0|||
145623666|NCT02223182|525134015|FG003|Double-Blind Period|Lost to Follow-up|0|||
145623667|NCT02223182|525134012|FG000|Double-Blind Period|Non Compliance|0|||
145623668|NCT02223182|525134013|FG001|Double-Blind Period|Non Compliance|0|||
145623669|NCT02223182|525134014|FG002|Double-Blind Period|Non Compliance|0|||
145623670|NCT02223182|525134015|FG003|Double-Blind Period|Non Compliance|1|||
145623671|NCT02223182|525134012|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
145623672|NCT02223182|525134013|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
145623673|NCT02223182|525134014|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
145623674|NCT02223182|525134015|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
145623675|NCT02223182|525134012|FG000|Open-Label 500 Period|Adverse Event|1|||
145623676|NCT02223182|525134013|FG001|Open-Label 500 Period|Adverse Event|0|||
145623677|NCT02223182|525134014|FG002|Open-Label 500 Period|Adverse Event|2|||
145623678|NCT02223182|525134015|FG003|Open-Label 500 Period|Adverse Event|1|||
145623679|NCT02223182|525134012|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
145623680|NCT02223182|525134013|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
145623681|NCT02223182|525134014|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
145623682|NCT02223182|525134015|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
145623683|NCT02223182|525134012|FG000|Open-Label 500 Period|Physician Decision|0|||
145623684|NCT02223182|525134013|FG001|Open-Label 500 Period|Physician Decision|0|||
145623685|NCT02223182|525134014|FG002|Open-Label 500 Period|Physician Decision|0|||
145623686|NCT02223182|525134015|FG003|Open-Label 500 Period|Physician Decision|1|||
145623687|NCT02223182|525134012|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
145623688|NCT02223182|525134013|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
145623689|NCT02223182|525134014|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
145623690|NCT02223182|525134015|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
145623691|NCT02223182|525134012|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
145623692|NCT02223182|525134013|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
145623693|NCT02223182|525134014|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
145623694|NCT02223182|525134015|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
145623695|NCT02223182|525134012|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
145373066|NCT02017717|524217119|FG001|Treatment Period|Death|0|||
145623696|NCT02223182|525134013|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
145623697|NCT02223182|525134014|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
145623698|NCT02223182|525134015|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
145623699|NCT02223182|525134012|FG000|Open-Label 300 Period|Non Compliance|0|||
145623700|NCT02223182|525134013|FG001|Open-Label 300 Period|Non Compliance|2|||
145623701|NCT02223182|525134014|FG002|Open-Label 300 Period|Non Compliance|1|||
145623702|NCT02223182|525134015|FG003|Open-Label 300 Period|Non Compliance|0|||
145373067|NCT02017717|524217120|FG002|Treatment Period|Death|1|||
145373068|NCT02017717|524217121|FG003|Treatment Period|Death|0|||
145623703|NCT02099539|525134020|FG000|Overall Study|Progressive Disease|3|||
145623704|NCT02099539|525134021|FG001|Overall Study|Progressive Disease|2|||
145373069|NCT02017717|524217122|FG004|Treatment Period|Death|0|||
145580576|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145580577|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145580578|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
145580579|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
145580580|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580581|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580582|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
145580583|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580584|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580585|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580586|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580587|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145425278|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425279|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425280|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425281|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425282|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425283|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425284|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
145425285|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
145425286|NCT02471144|524413890|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425287|NCT02471144|524413891|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425288|NCT02471144|524413892|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425289|NCT02471144|524413893|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425290|NCT02471144|524413894|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425291|NCT02471144|524413895|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425292|NCT02471144|524413896|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425293|NCT02471144|524413897|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425294|NCT02471144|524413898|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
145425295|NCT02471144|524413899|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
145425296|NCT02471144|524413900|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
145425297|NCT04129398|524413907|FG000|Overall Study|Physician Decision|2|||
145425298|NCT03058952|524413908|FG000|Overall Study|Adverse Event|1|||
145425299|NCT03058952|524413909|FG001|Overall Study|Adverse Event|0|||
145425300|NCT03058952|524413908|FG000|Overall Study|Lost to Follow-up|15|||
145425301|NCT03058952|524413909|FG001|Overall Study|Lost to Follow-up|15|||
145425302|NCT03058952|524413908|FG000|Overall Study|Withdrawal by Subject|7|||
145425303|NCT03058952|524413909|FG001|Overall Study|Withdrawal by Subject|11|||
145425304|NCT04280783|524413910|FG000|Overall Study|Family issues unrelated to the study.|1|||
145425305|NCT04280783|524413911|FG001|Overall Study|Family issues unrelated to the study.|0|||
145425306|NCT04280783|524413910|FG000|Overall Study|Withdrawal by Subject|0|||
145425307|NCT04280783|524413911|FG001|Overall Study|Withdrawal by Subject|1|||
145425308|NCT04110145|524413912|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145425309|NCT04110145|524413913|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145425310|NCT04110145|524413914|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145425311|NCT04110145|524413915|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
145425312|NCT04110145|524413916|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
145425313|NCT00980044|524413917|FG000|Overall Study|Withdrawal by Subject|5|||
145425314|NCT00980044|524413918|FG001|Overall Study|Withdrawal by Subject|7|||
145425315|NCT00980044|524413919|FG002|Overall Study|Withdrawal by Subject|3|||
145425316|NCT00980044|524413917|FG000|Overall Study|Protocol Violation|0|||
145425317|NCT00980044|524413918|FG001|Overall Study|Protocol Violation|0|||
145425318|NCT00980044|524413919|FG002|Overall Study|Protocol Violation|2|||
145425319|NCT00185614|524413920|FG000|Inter-treatment Period|Physician Decision|1|||
145425320|NCT00185614|524413920|FG000|Inter-treatment Period|Relapse|2|||
145425321|NCT00185614|524413920|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
145425322|NCT01904279|524413930|FG000|Overall Study|Lack of Efficacy|2|||
145425323|NCT01904279|524413931|FG001|Overall Study|Lack of Efficacy|3|||
145425324|NCT01904279|524413930|FG000|Overall Study|Withdrawal by Subject|1|||
145425325|NCT01904279|524413931|FG001|Overall Study|Withdrawal by Subject|0|||
145425326|NCT03257657|524413939|FG000|Overall Study|Lost to Follow-up|0|||
145425327|NCT03257657|524413940|FG001|Overall Study|Lost to Follow-up|3|||
145425328|NCT03257657|524413939|FG000|Overall Study|Withdrawn|0|||
145425329|NCT03257657|524413940|FG001|Overall Study|Withdrawn|1|||
145425330|NCT03257657|524413939|FG000|Overall Study|Noted not eligible right after enrolled|0|||
145425331|NCT03257657|524413940|FG001|Overall Study|Noted not eligible right after enrolled|1|||
145425332|NCT02801578|524413941|FG000|Overall Study|Adverse Event|2|||
145425333|NCT00137449|524413942|FG000|Overall Study|Disease Progression|8|||
145425334|NCT00137449|524413943|FG001|Overall Study|Disease Progression|13|||
145425335|NCT00137449|524413942|FG000|Overall Study|Death|4|||
145425336|NCT00137449|524413943|FG001|Overall Study|Death|3|||
145425337|NCT00137449|524413942|FG000|Overall Study|Adverse Event|3|||
145425338|NCT00137449|524413943|FG001|Overall Study|Adverse Event|1|||
145425339|NCT00137449|524413942|FG000|Overall Study|Withdrawal by Subject|1|||
145425340|NCT00137449|524413943|FG001|Overall Study|Withdrawal by Subject|1|||
145425341|NCT01356940|524413951|FG000|First Intervention (28 Days)|Adverse Event|1|||
145425342|NCT01356940|524413952|FG001|First Intervention (28 Days)|Adverse Event|0|||
145425343|NCT01356940|524413951|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
145425344|NCT01356940|524413952|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
145425345|NCT00668642|524413953|FG000|First Off-cycle|Cancer progression|1|||
145425346|NCT00668642|524413954|FG001|First Off-cycle|Cancer progression|0|||
145425347|NCT00668642|524413953|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
145425348|NCT00668642|524413954|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
145425349|NCT03412591|524413955|FG000|Overall Study|Withdrawal by Subject|1|||
145425350|NCT03412591|524413956|FG001|Overall Study|Withdrawal by Subject|8|||
145425351|NCT03412591|524413955|FG000|Overall Study|Adverse Event|0|||
145425352|NCT03412591|524413956|FG001|Overall Study|Adverse Event|1|||
145425353|NCT02272985|524413957|FG000|Overall Study|Withdrawal by Subject|1|||
145425354|NCT02272985|524413957|FG000|Overall Study|hip fracture|1|||
145425355|NCT02272985|524413957|FG000|Overall Study|kidney transplantation|1|||
145425356|NCT02263547|524413962|FG000|Overall Study|Adverse Event|1|||
145425357|NCT02263547|524413962|FG000|Overall Study|Lost to Follow-up|2|||
145425358|NCT00505687|524413965|FG000|Overall Study|Important protocol violation|2|||
145425359|NCT00505687|524413965|FG000|Overall Study|Lack of Efficacy|15|||
145425360|NCT00505687|524413965|FG000|Overall Study|Adverse Event|48|||
145425361|NCT00505687|524413965|FG000|Overall Study|Subject withdrew consent|15|||
145425362|NCT00505687|524413965|FG000|Overall Study|Lost to Follow-up|1|||
145425363|NCT00505687|524413965|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
145425364|NCT00505687|524413965|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
145425365|NCT00505687|524413965|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
145425366|NCT00505687|524413965|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
145425367|NCT00505687|524413965|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
145425368|NCT00505687|524413965|FG000|Overall Study|Other: Disease Progression|1|||
145425369|NCT00505687|524413965|FG000|Overall Study|Other: As Per Sponsor|8|||
145425370|NCT01935947|524413966|FG000|Overall Study|Adverse Event|0|||
145425371|NCT01935947|524413967|FG001|Overall Study|Adverse Event|2|||
145425372|NCT01935947|524413968|FG002|Overall Study|Adverse Event|0|||
145425373|NCT01935947|524413966|FG000|Overall Study|Diease Progression|2|||
145425374|NCT01935947|524413967|FG001|Overall Study|Diease Progression|2|||
145425375|NCT01935947|524413968|FG002|Overall Study|Diease Progression|2|||
145425376|NCT01935947|524413966|FG000|Overall Study|Death|1|||
145425377|NCT01935947|524413967|FG001|Overall Study|Death|0|||
145425378|NCT01935947|524413968|FG002|Overall Study|Death|0|||
145425379|NCT00425555|524413971|FG000|Overall Study|Withdrawal by Subject|11|||
145425380|NCT00425555|524413972|FG001|Overall Study|Withdrawal by Subject|8|||
145425381|NCT00425555|524413971|FG000|Overall Study|Lost to Follow-up|0|||
145425382|NCT00425555|524413972|FG001|Overall Study|Lost to Follow-up|1|||
145425383|NCT00425555|524413971|FG000|Overall Study|Administrative problems|3|||
145425384|NCT00425555|524413972|FG001|Overall Study|Administrative problems|0|||
145425385|NCT00425555|524413971|FG000|Overall Study|Death|1|||
145425386|NCT00425555|524413972|FG001|Overall Study|Death|2|||
145425387|NCT00425555|524413971|FG000|Overall Study|New cancer therapy|2|||
145425388|NCT00425555|524413972|FG001|Overall Study|New cancer therapy|1|||
145425389|NCT00425555|524413971|FG000|Overall Study|Disease progression|36|||
145425390|NCT00425555|524413972|FG001|Overall Study|Disease progression|33|||
145425391|NCT00425555|524413971|FG000|Overall Study|Adverse Event|25|||
145425392|NCT00425555|524413972|FG001|Overall Study|Adverse Event|15|||
145425393|NCT00425555|524413971|FG000|Overall Study|Protocol Violation|1|||
145425394|NCT00425555|524413972|FG001|Overall Study|Protocol Violation|0|||
145425395|NCT04102514|524413973|FG000|Overall Study|Death|3|||
145425396|NCT04102514|524413974|FG001|Overall Study|Death|0|||
145425397|NCT04102514|524413975|FG002|Overall Study|Death|0|||
145425398|NCT04102514|524413976|FG003|Overall Study|Death|0|||
145425399|NCT04102514|524413973|FG000|Overall Study|Lost to Follow-up|0|||
145580588|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
145580589|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145425400|NCT04102514|524413974|FG001|Overall Study|Lost to Follow-up|0|||
145425401|NCT04102514|524413975|FG002|Overall Study|Lost to Follow-up|3|||
145425402|NCT04102514|524413976|FG003|Overall Study|Lost to Follow-up|0|||
145425403|NCT04102514|524413973|FG000|Overall Study|Physician Decision|0|||
145425404|NCT04102514|524413974|FG001|Overall Study|Physician Decision|0|||
145425405|NCT04102514|524413975|FG002|Overall Study|Physician Decision|1|||
145425406|NCT04102514|524413976|FG003|Overall Study|Physician Decision|0|||
145425407|NCT04102514|524413973|FG000|Overall Study|Withdrawal by Subject|7|||
145425408|NCT04102514|524413974|FG001|Overall Study|Withdrawal by Subject|13|||
145425409|NCT04102514|524413975|FG002|Overall Study|Withdrawal by Subject|7|||
145425410|NCT04102514|524413976|FG003|Overall Study|Withdrawal by Subject|14|||
145373070|NCT02017717|524217123|FG005|Treatment Period|Death|2|||
145373071|NCT02017717|524217124|FG006|Treatment Period|Death|0|||
145373072|NCT02017717|524217125|FG007|Treatment Period|Death|0|||
145373073|NCT02017717|524217126|FG008|Treatment Period|Death|0|||
145373074|NCT02017717|524217118|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
145373075|NCT02017717|524217119|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
145373076|NCT02017717|524217120|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
145373077|NCT02017717|524217121|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
145373078|NCT02017717|524217122|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
145373079|NCT02017717|524217123|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
145373080|NCT02017717|524217124|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
145373081|NCT02017717|524217125|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
145373082|NCT02017717|524217126|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
145373083|NCT02017717|524217118|FG000|Treatment Period|Participant request to stop therapy|0|||
145373084|NCT02017717|524217119|FG001|Treatment Period|Participant request to stop therapy|0|||
145373085|NCT02017717|524217120|FG002|Treatment Period|Participant request to stop therapy|3|||
145373086|NCT02017717|524217121|FG003|Treatment Period|Participant request to stop therapy|6|||
145373087|NCT02017717|524217122|FG004|Treatment Period|Participant request to stop therapy|0|||
145373088|NCT02017717|524217123|FG005|Treatment Period|Participant request to stop therapy|2|||
145373089|NCT02017717|524217124|FG006|Treatment Period|Participant request to stop therapy|1|||
145373090|NCT02017717|524217125|FG007|Treatment Period|Participant request to stop therapy|4|||
145373091|NCT02017717|524217126|FG008|Treatment Period|Participant request to stop therapy|7|||
145373092|NCT02017717|524217118|FG000|Treatment Period|Participant withdrew consent|0|||
145373093|NCT02017717|524217119|FG001|Treatment Period|Participant withdrew consent|0|||
145373094|NCT02017717|524217120|FG002|Treatment Period|Participant withdrew consent|1|||
145373095|NCT02017717|524217121|FG003|Treatment Period|Participant withdrew consent|0|||
145373096|NCT02017717|524217122|FG004|Treatment Period|Participant withdrew consent|0|||
145373097|NCT02017717|524217123|FG005|Treatment Period|Participant withdrew consent|2|||
145373098|NCT02017717|524217124|FG006|Treatment Period|Participant withdrew consent|0|||
145373099|NCT02017717|524217125|FG007|Treatment Period|Participant withdrew consent|1|||
145373100|NCT02017717|524217126|FG008|Treatment Period|Participant withdrew consent|4|||
145373101|NCT02017717|524217118|FG000|Treatment Period|Participant no longer met criteria|0|||
145373102|NCT02017717|524217119|FG001|Treatment Period|Participant no longer met criteria|0|||
145373103|NCT02017717|524217120|FG002|Treatment Period|Participant no longer met criteria|0|||
145373104|NCT02017717|524217121|FG003|Treatment Period|Participant no longer met criteria|0|||
145373105|NCT02017717|524217122|FG004|Treatment Period|Participant no longer met criteria|0|||
145373106|NCT02017717|524217123|FG005|Treatment Period|Participant no longer met criteria|0|||
145373107|NCT02017717|524217124|FG006|Treatment Period|Participant no longer met criteria|0|||
145373108|NCT02017717|524217125|FG007|Treatment Period|Participant no longer met criteria|0|||
145373109|NCT02017717|524217126|FG008|Treatment Period|Participant no longer met criteria|1|||
145373110|NCT02017717|524217118|FG000|Treatment Period|Other reasons|0|||
145373111|NCT02017717|524217119|FG001|Treatment Period|Other reasons|0|||
145373112|NCT02017717|524217120|FG002|Treatment Period|Other reasons|0|||
145373113|NCT02017717|524217121|FG003|Treatment Period|Other reasons|1|||
145373114|NCT02017717|524217122|FG004|Treatment Period|Other reasons|0|||
145373115|NCT02017717|524217123|FG005|Treatment Period|Other reasons|1|||
145373116|NCT02017717|524217124|FG006|Treatment Period|Other reasons|1|||
145373117|NCT02017717|524217125|FG007|Treatment Period|Other reasons|1|||
145373118|NCT02017717|524217126|FG008|Treatment Period|Other reasons|1|||
145373119|NCT02017717|524217118|FG000|Treatment Period|Maximum clinical benefit|0|||
145373120|NCT02017717|524217119|FG001|Treatment Period|Maximum clinical benefit|0|||
145373121|NCT02017717|524217120|FG002|Treatment Period|Maximum clinical benefit|0|||
145373122|NCT02017717|524217121|FG003|Treatment Period|Maximum clinical benefit|0|||
145373123|NCT02017717|524217122|FG004|Treatment Period|Maximum clinical benefit|0|||
145373124|NCT02017717|524217123|FG005|Treatment Period|Maximum clinical benefit|0|||
145373125|NCT02017717|524217124|FG006|Treatment Period|Maximum clinical benefit|0|||
145373126|NCT02017717|524217125|FG007|Treatment Period|Maximum clinical benefit|0|||
145373127|NCT02017717|524217126|FG008|Treatment Period|Maximum clinical benefit|1|||
145373128|NCT02017717|524217118|FG000|Treatment Period|Not reported|0|||
145373129|NCT02017717|524217119|FG001|Treatment Period|Not reported|1|||
145373130|NCT02017717|524217120|FG002|Treatment Period|Not reported|0|||
145373131|NCT02017717|524217121|FG003|Treatment Period|Not reported|0|||
145373132|NCT02017717|524217122|FG004|Treatment Period|Not reported|0|||
145373133|NCT02017717|524217123|FG005|Treatment Period|Not reported|0|||
145373134|NCT02017717|524217124|FG006|Treatment Period|Not reported|0|||
145373135|NCT02017717|524217125|FG007|Treatment Period|Not reported|0|||
145373136|NCT02017717|524217126|FG008|Treatment Period|Not reported|0|||
145373137|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
145373138|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
145373139|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
145373140|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
145373141|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
145425411|NCT04102514|524413973|FG000|Overall Study|Moved to longterm care facility|6|||
145425412|NCT04102514|524413974|FG001|Overall Study|Moved to longterm care facility|0|||
145425413|NCT04102514|524413975|FG002|Overall Study|Moved to longterm care facility|4|||
145425414|NCT04102514|524413976|FG003|Overall Study|Moved to longterm care facility|0|||
145425415|NCT03268499|524413977|FG000|Overall Study|Withdrawal by Subject|2|||
145425416|NCT03268499|524413978|FG001|Overall Study|Withdrawal by Subject|1|||
145425417|NCT03533491|524413983|FG000|Overall Study|Lost to Follow-up|2|||
145425418|NCT05071027|524413991|FG000|Overall Study|Lost to Follow-up|1|||
145425419|NCT05071027|524413992|FG001|Overall Study|Lost to Follow-up|4|||
145425420|NCT00595075|524413998|FG000|Overall Study|Withdrawal by Subject|1|||
145425421|NCT00595075|524413999|FG001|Overall Study|Withdrawal by Subject|0|||
145425422|NCT03249558|524414001|FG000|Overall Study|Lost to Follow-up|2|||
145425423|NCT03249558|524414002|FG001|Overall Study|Lost to Follow-up|1|||
145425424|NCT03249558|524414003|FG002|Overall Study|Lost to Follow-up|4|||
145425425|NCT03249558|524414001|FG000|Overall Study|Physician Decision|1|||
145425426|NCT03249558|524414002|FG001|Overall Study|Physician Decision|0|||
145425427|NCT03249558|524414003|FG002|Overall Study|Physician Decision|0|||
145425428|NCT03249558|524414001|FG000|Overall Study|Withdrawal by Subject|6|||
145425429|NCT03249558|524414002|FG001|Overall Study|Withdrawal by Subject|5|||
145425430|NCT03249558|524414003|FG002|Overall Study|Withdrawal by Subject|7|||
145425431|NCT03249558|524414001|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
145425432|NCT03249558|524414002|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
145425433|NCT03249558|524414003|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
145425434|NCT03249558|524414001|FG000|Overall Study|Protocol Violation|1|||
145425435|NCT03249558|524414002|FG001|Overall Study|Protocol Violation|1|||
145425436|NCT03249558|524414003|FG002|Overall Study|Protocol Violation|2|||
145425437|NCT00908141|524414004|FG000|Overall Study|Withdrawal by Subject|0|||
145425438|NCT00908141|524414005|FG001|Overall Study|Withdrawal by Subject|1|||
145425439|NCT02657356|524415732|FG000|Overall Study|Death|1|||
145425440|NCT02657356|524415733|FG001|Overall Study|Death|0|||
145425441|NCT02657356|524415732|FG000|Overall Study|Withdrawal by Subject|5|||
145425442|NCT02657356|524415733|FG001|Overall Study|Withdrawal by Subject|6|||
145425443|NCT02657356|524415732|FG000|Overall Study|Terminated by Sponsor|8|||
145425444|NCT02657356|524415733|FG001|Overall Study|Terminated by Sponsor|5|||
145425445|NCT02657356|524415732|FG000|Overall Study|Rolled over to EAP study|6|||
145425446|NCT02657356|524415733|FG001|Overall Study|Rolled over to EAP study|4|||
145425447|NCT05654181|524415734|FG000|Overall Study|Adverse Event|1|||
145425448|NCT05654181|524415735|FG001|Overall Study|Adverse Event|0|||
145425449|NCT05654181|524415736|FG002|Overall Study|Adverse Event|0|||
145425450|NCT05654181|524415737|FG003|Overall Study|Adverse Event|0|||
145425451|NCT05654181|524415738|FG004|Overall Study|Adverse Event|0|||
145425452|NCT05654181|524415739|FG005|Overall Study|Adverse Event|0|||
145425453|NCT05654181|524415740|FG006|Overall Study|Adverse Event|0|||
145425454|NCT05654181|524415741|FG007|Overall Study|Adverse Event|1|||
145425455|NCT05654181|524415742|FG008|Overall Study|Adverse Event|0|||
145425456|NCT05654181|524415743|FG009|Overall Study|Adverse Event|0|||
145425457|NCT05654181|524415734|FG000|Overall Study|Withdrawal by Subject|0|||
145425458|NCT05654181|524415735|FG001|Overall Study|Withdrawal by Subject|0|||
145425459|NCT05654181|524415736|FG002|Overall Study|Withdrawal by Subject|0|||
145425460|NCT05654181|524415737|FG003|Overall Study|Withdrawal by Subject|0|||
145425461|NCT05654181|524415738|FG004|Overall Study|Withdrawal by Subject|0|||
145425462|NCT05654181|524415739|FG005|Overall Study|Withdrawal by Subject|0|||
145425463|NCT05654181|524415740|FG006|Overall Study|Withdrawal by Subject|0|||
145425464|NCT05654181|524415741|FG007|Overall Study|Withdrawal by Subject|1|||
145425465|NCT05654181|524415742|FG008|Overall Study|Withdrawal by Subject|0|||
145425466|NCT05654181|524415743|FG009|Overall Study|Withdrawal by Subject|0|||
145425467|NCT05654181|524415734|FG000|Overall Study|Other|0|||
145425468|NCT05654181|524415735|FG001|Overall Study|Other|0|||
145425469|NCT05654181|524415736|FG002|Overall Study|Other|0|||
145425470|NCT05654181|524415737|FG003|Overall Study|Other|0|||
145425471|NCT05654181|524415738|FG004|Overall Study|Other|1|||
145425472|NCT05654181|524415739|FG005|Overall Study|Other|1|||
145425473|NCT05654181|524415740|FG006|Overall Study|Other|0|||
145425474|NCT05654181|524415741|FG007|Overall Study|Other|0|||
145425475|NCT05654181|524415742|FG008|Overall Study|Other|0|||
145425476|NCT05654181|524415743|FG009|Overall Study|Other|0|||
145425477|NCT04101331|524415744|FG000|Overall Study|Adverse Event|9|||
145425478|NCT04101331|524415744|FG000|Overall Study|Disease progression|82|||
145425479|NCT04101331|524415744|FG000|Overall Study|Withdrawal by Subject|1|||
145425480|NCT04101331|524415744|FG000|Overall Study|Investigator decision|6|||
145425481|NCT04101331|524415744|FG000|Overall Study|Death|6|||
145425482|NCT04101331|524415744|FG000|Overall Study|Allogenic transplant|1|||
145425483|NCT02254291|524415745|FG000|Overall Study|Withdrawal by Subject|0|||
145425484|NCT02254291|524415746|FG001|Overall Study|Withdrawal by Subject|3|||
145425485|NCT02254291|524415747|FG002|Overall Study|Withdrawal by Subject|1|||
145425486|NCT02254291|524415745|FG000|Overall Study|Missing follow-up information|0|||
145425487|NCT02254291|524415746|FG001|Overall Study|Missing follow-up information|0|||
145425488|NCT02254291|524415747|FG002|Overall Study|Missing follow-up information|1|||
145425489|NCT00833703|524415754|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
145425490|NCT00833703|524415755|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
145425491|NCT01557569|524415758|FG000|Overall Study|Adverse Event|2|||
145425492|NCT01557569|524415759|FG001|Overall Study|Adverse Event|0|||
145425493|NCT01557569|524415758|FG000|Overall Study|high blood pressure|0|||
145425494|NCT01557569|524415759|FG001|Overall Study|high blood pressure|1|||
145425495|NCT01557569|524415758|FG000|Overall Study|Withdrawal by Subject|3|||
145425496|NCT01557569|524415759|FG001|Overall Study|Withdrawal by Subject|5|||
145425497|NCT01557569|524415758|FG000|Overall Study|noncompliance with rules of residential|0|||
145425498|NCT01557569|524415759|FG001|Overall Study|noncompliance with rules of residential|1|||
145425499|NCT00267488|524415760|FG000|Overall Study|Sponsor Terminated Study|9|||
145425500|NCT00267488|524415760|FG000|Overall Study|Protocol Violation|1|||
145425501|NCT00267488|524415760|FG000|Overall Study|Other (Disease Progression)|1|||
145425502|NCT02254460|524415761|FG000|Overall Study|Adverse Event|1|||
145425503|NCT02254460|524415762|FG001|Overall Study|Adverse Event|0|||
145425504|NCT01149460|524415767|FG000|Overall Study|Withdrawal by Subject|0|||
145425505|NCT01149460|524415768|FG001|Overall Study|Withdrawal by Subject|2|||
145425506|NCT02489279|524415769|FG000|Overall Study|Lost to Follow-up|12|||
145425507|NCT02489279|524415770|FG001|Overall Study|Lost to Follow-up|10|||
145425508|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
145425509|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
145425510|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
145425511|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
145425512|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
145425513|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
145425514|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
145425515|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
145425516|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
145425517|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
145425518|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
145425519|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
145425520|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
145425521|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
145425522|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
145425523|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
145425524|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
145425525|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
145425526|NCT01432444|524415771|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
145425527|NCT01432444|524415772|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
145425528|NCT01432444|524415773|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
145425529|NCT01432444|524415771|FG000|Treatment Phase|Lost to Follow-up|0|||
145425530|NCT01432444|524415772|FG001|Treatment Phase|Lost to Follow-up|33|||
145425531|NCT01432444|524415773|FG002|Treatment Phase|Lost to Follow-up|0|||
145425532|NCT01432444|524415771|FG000|Treatment Phase|Adverse Event|0|||
145425533|NCT01432444|524415772|FG001|Treatment Phase|Adverse Event|37|||
145425534|NCT01432444|524415773|FG002|Treatment Phase|Adverse Event|0|||
145425535|NCT01432444|524415771|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
145425536|NCT01432444|524415772|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
145425537|NCT01432444|524415773|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
145425538|NCT01432444|524415771|FG000|Treatment Phase|Physician Decision|0|||
145425539|NCT01432444|524415772|FG001|Treatment Phase|Physician Decision|5|||
145425540|NCT01432444|524415773|FG002|Treatment Phase|Physician Decision|0|||
145425541|NCT01432444|524415771|FG000|Treatment Phase|Withdrawal by Subject|0|||
145425542|NCT01432444|524415772|FG001|Treatment Phase|Withdrawal by Subject|41|||
145425543|NCT01432444|524415773|FG002|Treatment Phase|Withdrawal by Subject|0|||
145425544|NCT01432444|524415771|FG000|Treatment Phase|Protocol Deviation|0|||
145425545|NCT01432444|524415772|FG001|Treatment Phase|Protocol Deviation|3|||
145425546|NCT01432444|524415773|FG002|Treatment Phase|Protocol Deviation|0|||
145425547|NCT01432444|524415771|FG000|Treatment Phase|Lack of Efficacy|0|||
145425548|NCT01432444|524415772|FG001|Treatment Phase|Lack of Efficacy|10|||
145425549|NCT01432444|524415773|FG002|Treatment Phase|Lack of Efficacy|0|||
145425550|NCT01432444|524415771|FG000|Extension Phase|Lost to Follow-up|0|||
145425551|NCT01432444|524415772|FG001|Extension Phase|Lost to Follow-up|0|||
145425552|NCT01432444|524415773|FG002|Extension Phase|Lost to Follow-up|17|||
145425553|NCT01432444|524415771|FG000|Extension Phase|Adverse Event|0|||
145425554|NCT01432444|524415772|FG001|Extension Phase|Adverse Event|0|||
145425555|NCT01432444|524415773|FG002|Extension Phase|Adverse Event|10|||
145425556|NCT01432444|524415771|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
145425557|NCT01432444|524415772|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
145425558|NCT01432444|524415773|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
145425559|NCT01432444|524415771|FG000|Extension Phase|Met Withdrawal Criteria|0|||
145425560|NCT01432444|524415772|FG001|Extension Phase|Met Withdrawal Criteria|0|||
145425561|NCT01432444|524415773|FG002|Extension Phase|Met Withdrawal Criteria|144|||
145425562|NCT01432444|524415771|FG000|Extension Phase|Physician Decision|0|||
145425563|NCT01432444|524415772|FG001|Extension Phase|Physician Decision|0|||
145425564|NCT01432444|524415773|FG002|Extension Phase|Physician Decision|1|||
145425565|NCT01432444|524415771|FG000|Extension Phase|Withdrawal by Subject|0|||
145425566|NCT01432444|524415772|FG001|Extension Phase|Withdrawal by Subject|0|||
145425567|NCT01432444|524415773|FG002|Extension Phase|Withdrawal by Subject|13|||
145425568|NCT00666263|524415776|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
145425569|NCT00666263|524415777|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
145425570|NCT00666263|524415776|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
145425571|NCT00666263|524415777|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
145425572|NCT00666263|524415776|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
145425573|NCT00666263|524415777|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
145425574|NCT03802916|524415779|FG000|Overall Study|Adverse Event|0|||
145425575|NCT03802916|524415780|FG001|Overall Study|Adverse Event|1|||
145425576|NCT03802916|524415779|FG000|Overall Study|Withdrawal by Subject|0|||
145425577|NCT03802916|524415780|FG001|Overall Study|Withdrawal by Subject|1|||
145425578|NCT01817777|524415781|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
145425579|NCT01817777|524415782|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
145425580|NCT01817777|524415783|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
145425581|NCT01817777|524415781|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
145425582|NCT01817777|524415782|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
145425583|NCT01817777|524415783|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
145425584|NCT01817777|524415781|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
145425585|NCT01817777|524415782|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
145425586|NCT01817777|524415783|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
145425587|NCT01817777|524415781|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
145425588|NCT01817777|524415782|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
145425589|NCT01817777|524415783|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
145425590|NCT01817777|524415781|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
145425591|NCT01817777|524415782|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
145425592|NCT01817777|524415783|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
145425593|NCT00619918|524415784|FG000|Overall Study|Withdrawal by Subject|4|||
145425594|NCT00619918|524415785|FG001|Overall Study|Withdrawal by Subject|3|||
145425595|NCT00619918|524415784|FG000|Overall Study|Physician Decision|2|||
145425596|NCT00619918|524415785|FG001|Overall Study|Physician Decision|4|||
145425597|NCT00619918|524415784|FG000|Overall Study|Transfer to outside facility|3|||
145425598|NCT00619918|524415785|FG001|Overall Study|Transfer to outside facility|3|||
145425599|NCT00619918|524415784|FG000|Overall Study|Left before receiving first dose|7|||
145425600|NCT00619918|524415785|FG001|Overall Study|Left before receiving first dose|6|||
145425601|NCT00619918|524415784|FG000|Overall Study|ICU admission|4|||
145425602|NCT00619918|524415785|FG001|Overall Study|ICU admission|6|||
145425603|NCT04661839|524415788|FG000|Overall Study|Not Treated|0|||
145425604|NCT04661839|524415789|FG001|Overall Study|Not Treated|0|||
145425605|NCT04661839|524415790|FG002|Overall Study|Not Treated|1|||
145425606|NCT04661839|524415791|FG003|Overall Study|Not Treated|0|||
145425607|NCT04661839|524415788|FG000|Overall Study|Lost to Follow-up|1|||
145425608|NCT04661839|524415789|FG001|Overall Study|Lost to Follow-up|0|||
145425609|NCT04661839|524415790|FG002|Overall Study|Lost to Follow-up|0|||
145425610|NCT04661839|524415791|FG003|Overall Study|Lost to Follow-up|1|||
145425611|NCT01946880|524415792|FG000|Overall Study|Lost to Follow-up|1|||
145425612|NCT01946880|524415793|FG001|Overall Study|Lost to Follow-up|0|||
145425613|NCT01946880|524415792|FG000|Overall Study|Physician Decision|1|||
145425614|NCT01946880|524415793|FG001|Overall Study|Physician Decision|1|||
145425615|NCT01946880|524415792|FG000|Overall Study|Withdrawal by Subject|3|||
145425616|NCT01946880|524415793|FG001|Overall Study|Withdrawal by Subject|2|||
145425617|NCT01946880|524415792|FG000|Overall Study|Met Primary Endpoint|1|||
145425618|NCT01946880|524415793|FG001|Overall Study|Met Primary Endpoint|0|||
145425619|NCT01946880|524415792|FG000|Overall Study|Personal and Family Issues|1|||
145425620|NCT01946880|524415793|FG001|Overall Study|Personal and Family Issues|0|||
145425621|NCT02951819|524415797|FG000|Overall Study|Death|9|||
145425622|NCT02951819|524415798|FG001|Overall Study|Death|7|||
145425623|NCT02951819|524415797|FG000|Overall Study|Withdrawal by Subject|3|||
145425624|NCT02951819|524415798|FG001|Overall Study|Withdrawal by Subject|0|||
145425625|NCT02951819|524415797|FG000|Overall Study|Adverse Event|1|||
145425626|NCT02951819|524415798|FG001|Overall Study|Adverse Event|0|||
145425627|NCT02951819|524415797|FG000|Overall Study|Lack of Efficacy|4|||
145425628|NCT02951819|524415798|FG001|Overall Study|Lack of Efficacy|0|||
145425629|NCT02951819|524415797|FG000|Overall Study|Lost to Follow-up|1|||
145425630|NCT02951819|524415798|FG001|Overall Study|Lost to Follow-up|0|||
145425631|NCT02951819|524415797|FG000|Overall Study|Progressive Disease|1|||
145425632|NCT02951819|524415798|FG001|Overall Study|Progressive Disease|0|||
145425633|NCT02951819|524415797|FG000|Overall Study|Other|9|||
145425634|NCT02951819|524415798|FG001|Overall Study|Other|0|||
145425635|NCT03715829|524415799|FG000|Dose Ranging Period|Adverse Event|2|||
145425636|NCT03715829|524415800|FG001|Dose Ranging Period|Adverse Event|4|||
145425637|NCT03715829|524415801|FG002|Dose Ranging Period|Adverse Event|5|||
145425638|NCT03715829|524415802|FG003|Dose Ranging Period|Adverse Event|2|||
145425639|NCT03715829|524415803|FG004|Dose Ranging Period|Adverse Event|3|||
145425640|NCT03715829|524415804|FG005|Dose Ranging Period|Adverse Event|3|||
145425641|NCT03715829|524415805|FG006|Dose Ranging Period|Adverse Event|0|||
145425642|NCT03715829|524415806|FG007|Dose Ranging Period|Adverse Event|0|||
145425643|NCT03715829|524415807|FG008|Dose Ranging Period|Adverse Event|0|||
145425644|NCT03715829|524415808|FG009|Dose Ranging Period|Adverse Event|0|||
145425645|NCT03715829|524415809|FG010|Dose Ranging Period|Adverse Event|0|||
145425646|NCT03715829|524415799|FG000|Dose Ranging Period|Lack of Efficacy|0|||
145425647|NCT03715829|524415800|FG001|Dose Ranging Period|Lack of Efficacy|1|||
145425648|NCT03715829|524415801|FG002|Dose Ranging Period|Lack of Efficacy|0|||
145425649|NCT03715829|524415802|FG003|Dose Ranging Period|Lack of Efficacy|1|||
145425650|NCT03715829|524415803|FG004|Dose Ranging Period|Lack of Efficacy|0|||
145425651|NCT03715829|524415804|FG005|Dose Ranging Period|Lack of Efficacy|0|||
145425652|NCT03715829|524415805|FG006|Dose Ranging Period|Lack of Efficacy|0|||
145425653|NCT03715829|524415806|FG007|Dose Ranging Period|Lack of Efficacy|0|||
145425654|NCT03715829|524415807|FG008|Dose Ranging Period|Lack of Efficacy|0|||
145425655|NCT03715829|524415808|FG009|Dose Ranging Period|Lack of Efficacy|0|||
145425656|NCT03715829|524415809|FG010|Dose Ranging Period|Lack of Efficacy|0|||
145425657|NCT03715829|524415799|FG000|Dose Ranging Period|Lost to Follow-up|2|||
145425658|NCT03715829|524415800|FG001|Dose Ranging Period|Lost to Follow-up|0|||
145425659|NCT03715829|524415801|FG002|Dose Ranging Period|Lost to Follow-up|1|||
145425660|NCT03715829|524415802|FG003|Dose Ranging Period|Lost to Follow-up|1|||
145425661|NCT03715829|524415803|FG004|Dose Ranging Period|Lost to Follow-up|1|||
145425662|NCT03715829|524415804|FG005|Dose Ranging Period|Lost to Follow-up|2|||
145425663|NCT03715829|524415805|FG006|Dose Ranging Period|Lost to Follow-up|0|||
145425664|NCT03715829|524415806|FG007|Dose Ranging Period|Lost to Follow-up|0|||
145425665|NCT03715829|524415807|FG008|Dose Ranging Period|Lost to Follow-up|0|||
145425666|NCT03715829|524415808|FG009|Dose Ranging Period|Lost to Follow-up|0|||
145425667|NCT03715829|524415809|FG010|Dose Ranging Period|Lost to Follow-up|0|||
145425668|NCT03715829|524415799|FG000|Dose Ranging Period|Protocol Violation|0|||
145425669|NCT03715829|524415800|FG001|Dose Ranging Period|Protocol Violation|0|||
145425670|NCT03715829|524415801|FG002|Dose Ranging Period|Protocol Violation|0|||
145425671|NCT03715829|524415802|FG003|Dose Ranging Period|Protocol Violation|1|||
145425672|NCT03715829|524415803|FG004|Dose Ranging Period|Protocol Violation|0|||
145425673|NCT03715829|524415804|FG005|Dose Ranging Period|Protocol Violation|0|||
145425674|NCT03715829|524415805|FG006|Dose Ranging Period|Protocol Violation|0|||
145425675|NCT03715829|524415806|FG007|Dose Ranging Period|Protocol Violation|0|||
145425676|NCT03715829|524415807|FG008|Dose Ranging Period|Protocol Violation|0|||
145425677|NCT03715829|524415808|FG009|Dose Ranging Period|Protocol Violation|0|||
145425678|NCT03715829|524415809|FG010|Dose Ranging Period|Protocol Violation|0|||
145425679|NCT03715829|524415799|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
145425680|NCT03715829|524415800|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
145425681|NCT03715829|524415801|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
145425682|NCT03715829|524415802|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
145425683|NCT03715829|524415803|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
145425684|NCT03715829|524415804|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
145425685|NCT03715829|524415805|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
145425686|NCT03715829|524415806|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
145425687|NCT03715829|524415807|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
145425688|NCT03715829|524415808|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
145425689|NCT03715829|524415809|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
145425690|NCT03715829|524415799|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425691|NCT03715829|524415800|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425692|NCT03715829|524415801|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
145623705|NCT02099539|525134022|FG002|Overall Study|Progressive Disease|2|||
145425693|NCT03715829|524415802|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425694|NCT03715829|524415803|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425695|NCT03715829|524415804|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425696|NCT03715829|524415805|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425697|NCT03715829|524415806|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425698|NCT03715829|524415807|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425699|NCT03715829|524415808|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425700|NCT03715829|524415809|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
145425701|NCT03715829|524415799|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425702|NCT03715829|524415800|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425703|NCT03715829|524415801|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
145425704|NCT03715829|524415802|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425705|NCT03715829|524415803|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
145425706|NCT03715829|524415804|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425707|NCT03715829|524415805|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425708|NCT03715829|524415806|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425709|NCT03715829|524415807|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425710|NCT03715829|524415808|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425711|NCT03715829|524415809|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
145425712|NCT03715829|524415799|FG000|Dose Ranging Period|Other|0|||
145425713|NCT03715829|524415800|FG001|Dose Ranging Period|Other|0|||
145425714|NCT03715829|524415801|FG002|Dose Ranging Period|Other|2|||
145425715|NCT03715829|524415802|FG003|Dose Ranging Period|Other|0|||
145425716|NCT03715829|524415803|FG004|Dose Ranging Period|Other|0|||
145425717|NCT03715829|524415804|FG005|Dose Ranging Period|Other|3|||
145425718|NCT03715829|524415805|FG006|Dose Ranging Period|Other|0|||
145425719|NCT03715829|524415806|FG007|Dose Ranging Period|Other|0|||
145425720|NCT03715829|524415807|FG008|Dose Ranging Period|Other|0|||
145425721|NCT03715829|524415808|FG009|Dose Ranging Period|Other|0|||
145425722|NCT03715829|524415809|FG010|Dose Ranging Period|Other|0|||
145425723|NCT03715829|524415799|FG000|Extension Period|Adverse Event|0|||
145425724|NCT03715829|524415800|FG001|Extension Period|Adverse Event|0|||
145425725|NCT03715829|524415801|FG002|Extension Period|Adverse Event|0|||
145425726|NCT03715829|524415802|FG003|Extension Period|Adverse Event|0|||
145425727|NCT03715829|524415803|FG004|Extension Period|Adverse Event|0|||
145425728|NCT03715829|524415804|FG005|Extension Period|Adverse Event|0|||
145425729|NCT03715829|524415805|FG006|Extension Period|Adverse Event|3|||
145425730|NCT03715829|524415806|FG007|Extension Period|Adverse Event|1|||
145425731|NCT03715829|524415807|FG008|Extension Period|Adverse Event|6|||
145425732|NCT03715829|524415808|FG009|Extension Period|Adverse Event|0|||
145425733|NCT03715829|524415809|FG010|Extension Period|Adverse Event|0|||
145425734|NCT03715829|524415799|FG000|Extension Period|Lack of Efficacy|0|||
145425735|NCT03715829|524415800|FG001|Extension Period|Lack of Efficacy|0|||
145425736|NCT03715829|524415801|FG002|Extension Period|Lack of Efficacy|0|||
145425737|NCT03715829|524415802|FG003|Extension Period|Lack of Efficacy|0|||
145425738|NCT03715829|524415803|FG004|Extension Period|Lack of Efficacy|0|||
145425739|NCT03715829|524415804|FG005|Extension Period|Lack of Efficacy|0|||
145425740|NCT03715829|524415805|FG006|Extension Period|Lack of Efficacy|1|||
145425741|NCT03715829|524415806|FG007|Extension Period|Lack of Efficacy|9|||
145425742|NCT03715829|524415807|FG008|Extension Period|Lack of Efficacy|2|||
145425743|NCT03715829|524415808|FG009|Extension Period|Lack of Efficacy|0|||
145425744|NCT03715829|524415809|FG010|Extension Period|Lack of Efficacy|0|||
145425745|NCT03715829|524415799|FG000|Extension Period|Lost to Follow-up|0|||
145425746|NCT03715829|524415800|FG001|Extension Period|Lost to Follow-up|0|||
145425747|NCT03715829|524415801|FG002|Extension Period|Lost to Follow-up|0|||
145425748|NCT03715829|524415802|FG003|Extension Period|Lost to Follow-up|0|||
145425749|NCT03715829|524415803|FG004|Extension Period|Lost to Follow-up|0|||
145425750|NCT03715829|524415804|FG005|Extension Period|Lost to Follow-up|0|||
145425751|NCT03715829|524415805|FG006|Extension Period|Lost to Follow-up|0|||
145425752|NCT03715829|524415806|FG007|Extension Period|Lost to Follow-up|0|||
145425753|NCT03715829|524415807|FG008|Extension Period|Lost to Follow-up|2|||
145425754|NCT03715829|524415808|FG009|Extension Period|Lost to Follow-up|0|||
145425755|NCT03715829|524415809|FG010|Extension Period|Lost to Follow-up|0|||
145425756|NCT03715829|524415799|FG000|Extension Period|Protocol Violation|0|||
145425757|NCT03715829|524415800|FG001|Extension Period|Protocol Violation|0|||
145425758|NCT03715829|524415801|FG002|Extension Period|Protocol Violation|0|||
145425759|NCT03715829|524415802|FG003|Extension Period|Protocol Violation|0|||
145425760|NCT03715829|524415803|FG004|Extension Period|Protocol Violation|0|||
145425761|NCT03715829|524415804|FG005|Extension Period|Protocol Violation|0|||
145425762|NCT03715829|524415805|FG006|Extension Period|Protocol Violation|0|||
145425763|NCT03715829|524415806|FG007|Extension Period|Protocol Violation|0|||
145425764|NCT03715829|524415807|FG008|Extension Period|Protocol Violation|1|||
145425765|NCT03715829|524415808|FG009|Extension Period|Protocol Violation|0|||
145425766|NCT03715829|524415809|FG010|Extension Period|Protocol Violation|0|||
145425767|NCT03715829|524415799|FG000|Extension Period|Withdrawal by Subject|0|||
145425768|NCT03715829|524415800|FG001|Extension Period|Withdrawal by Subject|0|||
145265284|NCT01945034|523819263|FG001|Overall Study|Lost to Follow-up|0|||
145425769|NCT03715829|524415801|FG002|Extension Period|Withdrawal by Subject|0|||
145425770|NCT03715829|524415802|FG003|Extension Period|Withdrawal by Subject|0|||
145425771|NCT03715829|524415803|FG004|Extension Period|Withdrawal by Subject|0|||
145425772|NCT03715829|524415804|FG005|Extension Period|Withdrawal by Subject|0|||
145425773|NCT03715829|524415805|FG006|Extension Period|Withdrawal by Subject|3|||
145425774|NCT03715829|524415806|FG007|Extension Period|Withdrawal by Subject|3|||
145425775|NCT03715829|524415807|FG008|Extension Period|Withdrawal by Subject|12|||
145425776|NCT03715829|524415808|FG009|Extension Period|Withdrawal by Subject|3|||
145425777|NCT03715829|524415809|FG010|Extension Period|Withdrawal by Subject|0|||
145425778|NCT03715829|524415799|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425779|NCT03715829|524415800|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425780|NCT03715829|524415801|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425781|NCT03715829|524415802|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425782|NCT03715829|524415803|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425783|NCT03715829|524415804|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425784|NCT03715829|524415805|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425785|NCT03715829|524415806|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
145425786|NCT03715829|524415807|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
145425787|NCT03715829|524415808|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425788|NCT03715829|524415809|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
145425789|NCT03715829|524415799|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425790|NCT03715829|524415800|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425791|NCT03715829|524415801|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425792|NCT03715829|524415802|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425793|NCT03715829|524415803|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425794|NCT03715829|524415804|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425795|NCT03715829|524415805|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425796|NCT03715829|524415806|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425797|NCT03715829|524415807|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
145425798|NCT03715829|524415808|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425799|NCT03715829|524415809|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
145425800|NCT03715829|524415799|FG000|Extension Period|Other|0|||
145425801|NCT03715829|524415800|FG001|Extension Period|Other|0|||
145425802|NCT03715829|524415801|FG002|Extension Period|Other|0|||
145425803|NCT03715829|524415802|FG003|Extension Period|Other|0|||
145425804|NCT03715829|524415803|FG004|Extension Period|Other|0|||
145425805|NCT03715829|524415804|FG005|Extension Period|Other|0|||
145425806|NCT03715829|524415805|FG006|Extension Period|Other|1|||
145425807|NCT03715829|524415806|FG007|Extension Period|Other|2|||
145425808|NCT03715829|524415807|FG008|Extension Period|Other|4|||
145425809|NCT03715829|524415808|FG009|Extension Period|Other|0|||
145425810|NCT03715829|524415809|FG010|Extension Period|Other|0|||
145425811|NCT03647137|524415810|FG000|Overall Study|Scan Limitation|2|||
145425812|NCT03647137|524415811|FG001|Overall Study|Scan Limitation|1|||
145425813|NCT03647137|524415812|FG002|Overall Study|Scan Limitation|1|||
145425814|NCT03647137|524415813|FG003|Overall Study|Scan Limitation|2|||
145425815|NCT01443026|524415814|FG000|Overall Study|Physician Decision|1|||
145425816|NCT01443026|524415815|FG001|Overall Study|Physician Decision|0|||
145425817|NCT01443026|524415814|FG000|Overall Study|Death|0|||
145425818|NCT01443026|524415815|FG001|Overall Study|Death|1|||
145425819|NCT01443026|524415814|FG000|Overall Study|Withdrawal by Subject|0|||
145580590|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580591|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
145580592|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580593|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145425820|NCT01443026|524415815|FG001|Overall Study|Withdrawal by Subject|3|||
145425821|NCT01443026|524415814|FG000|Overall Study|Lost to Follow-up|2|||
145425822|NCT01443026|524415815|FG001|Overall Study|Lost to Follow-up|1|||
145425823|NCT00581919|524415816|FG000|Overall Study|Adverse Event|8|||
145425824|NCT00581919|524415816|FG000|Overall Study|Death|1|||
145425825|NCT00581919|524415816|FG000|Overall Study|Disease Progression|10|||
145425826|NCT00581919|524415816|FG000|Overall Study|Physician Decision|1|||
145425827|NCT00581919|524415816|FG000|Overall Study|Other Complicating Disease|1|||
145425828|NCT00581919|524415816|FG000|Overall Study|Started Non-Protocol Therapy|2|||
145425829|NCT00581919|524415816|FG000|Overall Study|Withdrawal by Subject|1|||
145580594|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580595|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580596|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580597|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
145580598|NCT01172938|524979185|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580599|NCT01172938|524979186|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580600|NCT01172938|524979187|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580601|NCT01172938|524979188|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580602|NCT01172938|524979189|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580603|NCT01172938|524979190|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580604|NCT01172938|524979191|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580605|NCT01172938|524979192|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
145580606|NCT01172938|524979193|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
145580607|NCT00003498|524979194|FG000|Overall Study|Not evaluable.|4|||
145580608|NCT02956629|524979195|FG000|Overall Study|Adverse Event|0|||
145580609|NCT02956629|524979196|FG001|Overall Study|Adverse Event|0|||
145580610|NCT02956629|524979197|FG002|Overall Study|Adverse Event|1|||
145580611|NCT02956629|524979198|FG003|Overall Study|Adverse Event|0|||
145425830|NCT02034565|524415817|FG000|Overall Study|Adverse Event|1|||
145425831|NCT02034565|524415818|FG001|Overall Study|Adverse Event|0|||
145425832|NCT01813357|524415825|FG000|Overall Study|Lost to Follow-up|5|||
145425833|NCT01813357|524415826|FG001|Overall Study|Lost to Follow-up|6|||
145425834|NCT03773562|524415827|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
145425835|NCT03773562|524415827|FG000|Overall Study|Lost to Follow-up|10|||
145425836|NCT03773562|524415827|FG000|Overall Study|Withdrawal by Subject|1|||
145425837|NCT01272219|524415828|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
145425838|NCT01272219|524415829|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
145425839|NCT01272219|524415830|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
145425840|NCT01272219|524415831|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
145425841|NCT01272219|524415832|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
145425842|NCT01272219|524415833|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
145425843|NCT01272219|524415828|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
145425844|NCT01272219|524415829|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
145425845|NCT01272219|524415830|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
145425846|NCT01272219|524415831|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
145425847|NCT01272219|524415832|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
145425848|NCT01272219|524415833|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
145425849|NCT01272219|524415828|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
145425850|NCT01272219|524415829|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
145425851|NCT01272219|524415830|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
145425852|NCT01272219|524415831|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
145425853|NCT01272219|524415832|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
145425854|NCT01272219|524415833|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
145425855|NCT01272219|524415828|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
145425856|NCT01272219|524415829|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
145425857|NCT01272219|524415830|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
145425858|NCT01272219|524415831|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
145425859|NCT01272219|524415832|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
145425860|NCT01272219|524415833|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
145425861|NCT01272219|524415828|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
145425862|NCT01272219|524415829|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
145425863|NCT01272219|524415830|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
145425864|NCT01272219|524415831|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
145425865|NCT01272219|524415832|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
145425866|NCT01272219|524415833|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
145425867|NCT01272219|524415828|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145425868|NCT01272219|524415829|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
145425869|NCT01272219|524415830|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
145425870|NCT01272219|524415831|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
145425871|NCT01272219|524415832|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145425872|NCT01272219|524415833|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
145425873|NCT01272219|524415828|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145425874|NCT01272219|524415829|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145425875|NCT01272219|524415830|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145425876|NCT01272219|524415831|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
145425877|NCT01272219|524415832|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145425878|NCT01272219|524415833|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
145425879|NCT01272219|524415828|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145425880|NCT01272219|524415829|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
145425881|NCT01272219|524415830|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145425882|NCT01272219|524415831|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
145425883|NCT01272219|524415832|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145425884|NCT01272219|524415833|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
145425885|NCT01272219|524415828|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145425886|NCT01272219|524415829|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
145425887|NCT01272219|524415830|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
145425888|NCT01272219|524415831|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
145425889|NCT01272219|524415832|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145425890|NCT01272219|524415833|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
145425891|NCT01272219|524415828|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145425892|NCT01272219|524415829|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
145425893|NCT01272219|524415830|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
145425894|NCT01272219|524415831|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
145425895|NCT01272219|524415832|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145425896|NCT01272219|524415833|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
145580612|NCT02956629|524979199|FG004|Overall Study|Adverse Event|0|||
145580613|NCT02956629|524979200|FG005|Overall Study|Adverse Event|0|||
145580614|NCT02956629|524979195|FG000|Overall Study|Lost to Follow-up|2|||
145425897|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
145425898|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
145425899|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
145425900|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
145425901|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
145425902|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
145425903|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145425904|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145425905|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145425906|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
145425907|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
145425908|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
145425909|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145425910|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145425911|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145425912|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
145425913|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
145425914|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
145425915|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145425916|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145425917|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145425918|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
145425919|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
145425920|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
145425921|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
145425922|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
145425923|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
145425924|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
145425925|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
145425926|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
145425927|NCT01272219|524415828|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
145425928|NCT01272219|524415829|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
145425929|NCT01272219|524415830|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
145425930|NCT01272219|524415831|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
145425931|NCT01272219|524415832|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
145425932|NCT01272219|524415833|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
145425933|NCT03131479|524415834|FG000|Overall Study|Adverse Event|0|||
145425934|NCT03131479|524415835|FG001|Overall Study|Adverse Event|0|||
145425935|NCT03131479|524415836|FG002|Overall Study|Adverse Event|1|||
145425936|NCT03131479|524415837|FG003|Overall Study|Adverse Event|1|||
145425937|NCT03131479|524415838|FG004|Overall Study|Adverse Event|0|||
145425938|NCT03131479|524415834|FG000|Overall Study|Subject/Guardian Decision|0|||
145425939|NCT03131479|524415835|FG001|Overall Study|Subject/Guardian Decision|0|||
145425940|NCT03131479|524415836|FG002|Overall Study|Subject/Guardian Decision|0|||
145425941|NCT03131479|524415837|FG003|Overall Study|Subject/Guardian Decision|1|||
145425942|NCT03131479|524415838|FG004|Overall Study|Subject/Guardian Decision|0|||
145425943|NCT01491919|524415839|FG000|Overall Study|Insufficient PK sampling|1|||
145425944|NCT01491919|524415840|FG001|Overall Study|Insufficient PK sampling|2|||
145425945|NCT01491919|524415841|FG002|Overall Study|Insufficient PK sampling|1|||
145425946|NCT04003389|524415842|FG000|Overall Study|Adverse Event|27|||
145425947|NCT04003389|524415843|FG001|Overall Study|Adverse Event|34|||
145425948|NCT04003389|524415844|FG002|Overall Study|Adverse Event|28|||
145425949|NCT04003389|524415842|FG000|Overall Study|Lost to Follow-up|39|||
145425950|NCT04003389|524415843|FG001|Overall Study|Lost to Follow-up|30|||
145425951|NCT04003389|524415844|FG002|Overall Study|Lost to Follow-up|33|||
145425952|NCT04003389|524415842|FG000|Overall Study|Protocol Violation|1|||
145425953|NCT04003389|524415843|FG001|Overall Study|Protocol Violation|6|||
145425954|NCT04003389|524415844|FG002|Overall Study|Protocol Violation|5|||
145425955|NCT04003389|524415842|FG000|Overall Study|Withdrawal by Subject|119|||
145425956|NCT04003389|524415843|FG001|Overall Study|Withdrawal by Subject|79|||
145425957|NCT04003389|524415844|FG002|Overall Study|Withdrawal by Subject|85|||
145425958|NCT04003389|524415842|FG000|Overall Study|Miscellaneous|14|||
145425959|NCT04003389|524415843|FG001|Overall Study|Miscellaneous|11|||
145425960|NCT04003389|524415844|FG002|Overall Study|Miscellaneous|14|||
145425961|NCT04003389|524415842|FG000|Overall Study|Participant did not receive study drug|1|||
145425962|NCT04003389|524415843|FG001|Overall Study|Participant did not receive study drug|0|||
145425963|NCT04003389|524415844|FG002|Overall Study|Participant did not receive study drug|0|||
145425964|NCT04806373|524415850|FG000|Overall Study|Withdrawal by Subject|1|||
145425965|NCT04806373|524415851|FG001|Overall Study|Withdrawal by Subject|1|||
145425966|NCT05810597|524415852|FG000|Period 1|Adverse Event|2|||
145425967|NCT05810597|524415853|FG001|Period 1|Adverse Event|0|||
145425968|NCT05810597|524415852|FG000|Period 1|Physician Decision|1|||
145425969|NCT05810597|524415853|FG001|Period 1|Physician Decision|0|||
145425970|NCT02061085|524415858|FG000|Overall Study|Adverse Event|8|||
145425971|NCT04903093|524415859|FG000|Overall Study|Withdrawal by Subject|0|||
145425972|NCT04903093|524415860|FG001|Overall Study|Withdrawal by Subject|0|||
145623706|NCT02099539|525134023|FG003|Overall Study|Progressive Disease|1|||
145623707|NCT02099539|525134024|FG004|Overall Study|Progressive Disease|4|||
145623708|NCT02099539|525134025|FG005|Overall Study|Progressive Disease|2|||
145425973|NCT04903093|524415861|FG002|Overall Study|Withdrawal by Subject|0|||
145425974|NCT04903093|524415862|FG003|Overall Study|Withdrawal by Subject|1|||
145425975|NCT04903093|524415863|FG004|Overall Study|Withdrawal by Subject|0|||
145425976|NCT04903093|524415864|FG005|Overall Study|Withdrawal by Subject|0|||
145425977|NCT03204812|524415874|FG000|Overall Study|Adverse Event|3|||
145425978|NCT02412436|524415875|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
145425979|NCT02412436|524415875|FG000|Overall Study|Lost to Follow-up|6|||
145425980|NCT02412436|524415875|FG000|Overall Study|Unable to get to clinic|3|||
145425981|NCT02412436|524415875|FG000|Overall Study|Death|1|||
145425982|NCT02412436|524415875|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
145425983|NCT00392288|524415876|FG000|Overall Study|Adverse Event|17|||
145425984|NCT00392288|524415877|FG001|Overall Study|Adverse Event|7|||
145425985|NCT00392288|524415878|FG002|Overall Study|Adverse Event|8|||
145425986|NCT00392288|524415876|FG000|Overall Study|Lack of Efficacy|8|||
145425987|NCT00392288|524415877|FG001|Overall Study|Lack of Efficacy|5|||
145425988|NCT00392288|524415878|FG002|Overall Study|Lack of Efficacy|3|||
145425989|NCT00392288|524415876|FG000|Overall Study|Protocol Violation|1|||
145425990|NCT00392288|524415877|FG001|Overall Study|Protocol Violation|3|||
145425991|NCT00392288|524415878|FG002|Overall Study|Protocol Violation|1|||
145425992|NCT00392288|524415876|FG000|Overall Study|Lost to Follow-up|1|||
145425993|NCT00392288|524415877|FG001|Overall Study|Lost to Follow-up|1|||
145425994|NCT00392288|524415878|FG002|Overall Study|Lost to Follow-up|1|||
145425995|NCT00392288|524415876|FG000|Overall Study|Withdrawal by Subject|1|||
145425996|NCT00392288|524415877|FG001|Overall Study|Withdrawal by Subject|0|||
145425997|NCT00392288|524415878|FG002|Overall Study|Withdrawal by Subject|2|||
145425998|NCT00392288|524415876|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
145425999|NCT00392288|524415877|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
145426000|NCT00392288|524415878|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
145426001|NCT00392288|524415876|FG000|Overall Study|Other|3|||
145426002|NCT00392288|524415877|FG001|Overall Study|Other|4|||
145426003|NCT00392288|524415878|FG002|Overall Study|Other|1|||
145426004|NCT02544763|524415879|FG000|Overall Study|Adverse Event|8|||
145426005|NCT02544763|524415880|FG001|Overall Study|Adverse Event|8|||
145426006|NCT02544763|524415881|FG002|Overall Study|Adverse Event|0|||
145426007|NCT02544763|524415879|FG000|Overall Study|Withdrawn by parent/guardian|1|||
145426008|NCT02544763|524415880|FG001|Overall Study|Withdrawn by parent/guardian|1|||
145426009|NCT02544763|524415881|FG002|Overall Study|Withdrawn by parent/guardian|1|||
145426010|NCT02544763|524415879|FG000|Overall Study|Met withdrawal criteria|0|||
145426011|NCT02544763|524415880|FG001|Overall Study|Met withdrawal criteria|2|||
145426012|NCT02544763|524415881|FG002|Overall Study|Met withdrawal criteria|0|||
145426013|NCT02544763|524415879|FG000|Overall Study|Physician Decision|0|||
145426014|NCT02544763|524415880|FG001|Overall Study|Physician Decision|1|||
145426015|NCT02544763|524415881|FG002|Overall Study|Physician Decision|0|||
145426016|NCT02544763|524415879|FG000|Overall Study|Difficulties taking IMP|1|||
145426017|NCT02544763|524415880|FG001|Overall Study|Difficulties taking IMP|0|||
145426018|NCT02544763|524415881|FG002|Overall Study|Difficulties taking IMP|0|||
145426019|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
145426020|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145426021|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145426022|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145426023|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
145426024|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
145426025|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145426026|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145426027|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145426028|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
145426029|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
145426030|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145426031|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145426032|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145426033|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
145426034|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
145426035|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145426036|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145426037|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145426038|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
145426039|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
145623709|NCT02099539|525134026|FG006|Overall Study|Progressive Disease|0|||
145623710|NCT02099539|525134020|FG000|Overall Study|Adverse Event|0|||
145426040|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145426041|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145426042|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145426043|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
145426044|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
145426045|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145426046|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145426047|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145426048|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
145426049|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
145426050|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145426051|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145426052|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145426053|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
145426054|NCT01111552|524415882|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
145426055|NCT01111552|524415883|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145426056|NCT01111552|524415884|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145426057|NCT01111552|524415885|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145426058|NCT01111552|524415886|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
145426059|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145426060|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145426061|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145426062|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
145426063|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
145426064|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
145426065|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145426066|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
145426067|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
145426068|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
145426069|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145426070|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
145426071|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145426072|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145426073|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
145426074|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145426075|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
145426076|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145426077|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145426078|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
145426079|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145426080|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
145426081|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145426082|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145426083|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
145426084|NCT01111552|524415882|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145426085|NCT01111552|524415883|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145426086|NCT01111552|524415884|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
145426087|NCT01111552|524415885|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145426088|NCT01111552|524415886|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
145426089|NCT01027351|524415888|FG000|Overall Study|Withdrawal by Subject|1|||
145426090|NCT01027351|524415889|FG001|Overall Study|Withdrawal by Subject|0|||
145426091|NCT01027351|524415890|FG002|Overall Study|Withdrawal by Subject|1|||
145426092|NCT01027351|524415891|FG003|Overall Study|Withdrawal by Subject|0|||
145426093|NCT01027351|524415892|FG004|Overall Study|Withdrawal by Subject|3|||
145426094|NCT01027351|524415893|FG005|Overall Study|Withdrawal by Subject|5|||
145426095|NCT01027351|524415888|FG000|Overall Study|Lost to Follow-up|1|||
145426096|NCT01027351|524415889|FG001|Overall Study|Lost to Follow-up|1|||
145426097|NCT01027351|524415890|FG002|Overall Study|Lost to Follow-up|0|||
145426098|NCT01027351|524415891|FG003|Overall Study|Lost to Follow-up|1|||
145426099|NCT01027351|524415892|FG004|Overall Study|Lost to Follow-up|6|||
145426100|NCT01027351|524415893|FG005|Overall Study|Lost to Follow-up|0|||
145426101|NCT01027351|524415888|FG000|Overall Study|Inappropriate enrollment|0|||
145426102|NCT01027351|524415889|FG001|Overall Study|Inappropriate enrollment|0|||
145426103|NCT01027351|524415890|FG002|Overall Study|Inappropriate enrollment|0|||
145426104|NCT01027351|524415891|FG003|Overall Study|Inappropriate enrollment|0|||
145580615|NCT02956629|524979196|FG001|Overall Study|Lost to Follow-up|5|||
145580616|NCT02956629|524979197|FG002|Overall Study|Lost to Follow-up|3|||
145580617|NCT02956629|524979198|FG003|Overall Study|Lost to Follow-up|1|||
145580618|NCT02956629|524979199|FG004|Overall Study|Lost to Follow-up|0|||
145580619|NCT02956629|524979200|FG005|Overall Study|Lost to Follow-up|1|||
145580620|NCT02956629|524979195|FG000|Overall Study|Withdrawal by Subject|3|||
145580621|NCT02956629|524979196|FG001|Overall Study|Withdrawal by Subject|1|||
145426105|NCT01027351|524415892|FG004|Overall Study|Inappropriate enrollment|1|||
145426106|NCT01027351|524415893|FG005|Overall Study|Inappropriate enrollment|0|||
145426107|NCT01027351|524415888|FG000|Overall Study|Protocol Violation|1|||
145426108|NCT01027351|524415889|FG001|Overall Study|Protocol Violation|0|||
145426109|NCT01027351|524415890|FG002|Overall Study|Protocol Violation|0|||
145426110|NCT01027351|524415891|FG003|Overall Study|Protocol Violation|1|||
145426111|NCT01027351|524415892|FG004|Overall Study|Protocol Violation|1|||
145426112|NCT01027351|524415893|FG005|Overall Study|Protocol Violation|0|||
145426113|NCT04650893|524415894|FG000|Overall Study|Lost to Follow-up|11|||
145426114|NCT04650893|524415895|FG001|Overall Study|Lost to Follow-up|10|||
145426115|NCT04650893|524415896|FG002|Overall Study|Lost to Follow-up|11|||
145426116|NCT04090749|524415899|FG000|Open Label Pilot|Lost to Follow-up|1|||
145426117|NCT04090749|524415900|FG001|Open Label Pilot|Lost to Follow-up|0|||
145426118|NCT04090749|524415901|FG002|Open Label Pilot|Lost to Follow-up|0|||
145426119|NCT04090749|524415899|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
145426120|NCT04090749|524415900|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
145426121|NCT04090749|524415901|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
145426122|NCT04090749|524415899|FG000|Pilot Trial|Lost to Follow-up|0|||
145426123|NCT04090749|524415900|FG001|Pilot Trial|Lost to Follow-up|1|||
145426124|NCT04090749|524415901|FG002|Pilot Trial|Lost to Follow-up|1|||
145426125|NCT02528305|524415902|FG000|Overall Study|Withdrawal by Subject|1|||
145426126|NCT02528305|524415902|FG000|Overall Study|Adverse Event|1|||
145426127|NCT02528305|524415902|FG000|Overall Study|Physician Decision|1|||
145426128|NCT01444781|524417377|FG000|Overall Study|Lost to Follow-up|0|||
145426129|NCT01444781|524417378|FG001|Overall Study|Lost to Follow-up|3|||
145426130|NCT01444781|524417379|FG002|Overall Study|Lost to Follow-up|1|||
145426131|NCT01444781|524417377|FG000|Overall Study|Withdrawal by Subject|3|||
145426132|NCT01444781|524417378|FG001|Overall Study|Withdrawal by Subject|1|||
145426133|NCT01444781|524417379|FG002|Overall Study|Withdrawal by Subject|2|||
145426134|NCT03283241|524417380|FG000|Overall Study|Adverse Event|4|||
145426135|NCT03283241|524417381|FG001|Overall Study|Adverse Event|1|||
145426136|NCT03283241|524417380|FG000|Overall Study|Withdrawal by Subject|0|||
145426137|NCT03283241|524417381|FG001|Overall Study|Withdrawal by Subject|1|||
145426138|NCT03283241|524417380|FG000|Overall Study|Subject relocated to Finland|0|||
145426139|NCT03283241|524417381|FG001|Overall Study|Subject relocated to Finland|1|||
145426140|NCT02439957|524417382|FG000|Overall Study|Study Terminated|3|||
145426141|NCT02439957|524417383|FG001|Overall Study|Study Terminated|3|||
145426142|NCT00586157|524417384|FG000|First Intervention|Worsening behavior|1|||
145426143|NCT00586157|524417385|FG001|First Intervention|Worsening behavior|0|||
145426144|NCT00586157|524417384|FG000|Second Intervention|Withdrawal by Subject|1|||
145426145|NCT00586157|524417385|FG001|Second Intervention|Withdrawal by Subject|0|||
145426146|NCT00586157|524417384|FG000|Second Intervention|Worsening behavior|1|||
145426147|NCT00586157|524417385|FG001|Second Intervention|Worsening behavior|0|||
145426148|NCT00586157|524417384|FG000|Second Intervention|Adverse Event|0|||
145426149|NCT00586157|524417385|FG001|Second Intervention|Adverse Event|1|||
145426150|NCT02014467|524417386|FG000|Overall Study|Adverse Event|4|||
145426151|NCT02014467|524417387|FG001|Overall Study|Adverse Event|0|||
145426152|NCT02014467|524417386|FG000|Overall Study|Protocol Violation|3|||
145426153|NCT02014467|524417387|FG001|Overall Study|Protocol Violation|0|||
145426154|NCT02014467|524417386|FG000|Overall Study|Physician Decision|2|||
145426155|NCT02014467|524417387|FG001|Overall Study|Physician Decision|3|||
145426156|NCT02014467|524417386|FG000|Overall Study|Withdrawal by Subject|16|||
145426157|NCT02014467|524417387|FG001|Overall Study|Withdrawal by Subject|4|||
145426158|NCT01230060|524417388|FG000|Overall Study|Withdrawal by Subject|1|||
145426159|NCT00480532|524417391|FG000|Overall Study|Withdrawal by Subject|2|||
145426160|NCT00480532|524417392|FG001|Overall Study|Withdrawal by Subject|4|||
145426161|NCT00480532|524417393|FG002|Overall Study|Withdrawal by Subject|3|||
145426162|NCT00480532|524417394|FG003|Overall Study|Withdrawal by Subject|1|||
145426163|NCT00480532|524417391|FG000|Overall Study|Protocol Violation|0|||
145426164|NCT00480532|524417392|FG001|Overall Study|Protocol Violation|0|||
145426165|NCT00480532|524417393|FG002|Overall Study|Protocol Violation|1|||
145426166|NCT00480532|524417394|FG003|Overall Study|Protocol Violation|0|||
145580622|NCT02956629|524979197|FG002|Overall Study|Withdrawal by Subject|0|||
145580623|NCT02956629|524979198|FG003|Overall Study|Withdrawal by Subject|0|||
145580624|NCT02956629|524979199|FG004|Overall Study|Withdrawal by Subject|0|||
145426167|NCT00831389|524417395|FG000|Overall Study|Withdrawal by Subject|0|||
145426168|NCT00831389|524417396|FG001|Overall Study|Withdrawal by Subject|1|||
145426169|NCT00278161|524417398|FG000|Overall Study|Death|11|||
145426170|NCT00443456|524417399|FG000|Overall Study|Adverse Event|16|||
145426171|NCT00443456|524417399|FG000|Overall Study|Move|1|||
145426172|NCT00443456|524417399|FG000|Overall Study|Withdrawal by Subject|1|||
145426173|NCT03242434|524417400|FG000|Overall Study|Death|0|||
145580625|NCT02956629|524979200|FG005|Overall Study|Withdrawal by Subject|0|||
145580626|NCT05282004|524979208|FG000|Overall Study|Adverse Event|2|||
145580627|NCT04808609|524979209|FG000|Overall Study|Lost to Follow-up|0|||
145580628|NCT04808609|524979210|FG001|Overall Study|Lost to Follow-up|2|||
145580629|NCT04808609|524979209|FG000|Overall Study|Administrative Withdrawal|0|||
145580630|NCT04808609|524979210|FG001|Overall Study|Administrative Withdrawal|1|||
145426174|NCT03242434|524417401|FG001|Overall Study|Death|2|||
145426175|NCT02157610|524417402|FG000|Overall Study|Death|4|||
145426176|NCT02157610|524417403|FG001|Overall Study|Death|4|||
145426177|NCT01592747|524417404|FG000|Overall Study|Loss of Therapeutic Response|107|||
145426178|NCT01592747|524417405|FG001|Overall Study|Loss of Therapeutic Response|108|||
145426179|NCT01592747|524417406|FG002|Overall Study|Loss of Therapeutic Response|100|||
145426180|NCT01592747|524417404|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
145426181|NCT01592747|524417405|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
145426182|NCT01592747|524417406|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
145426183|NCT01592747|524417404|FG000|Overall Study|Adverse Event|1|||
145426184|NCT01592747|524417405|FG001|Overall Study|Adverse Event|0|||
145426185|NCT01592747|524417406|FG002|Overall Study|Adverse Event|0|||
145426186|NCT01592747|524417404|FG000|Overall Study|Protocol Violation|4|||
145426187|NCT01592747|524417405|FG001|Overall Study|Protocol Violation|0|||
145426188|NCT01592747|524417406|FG002|Overall Study|Protocol Violation|4|||
145426189|NCT01592747|524417404|FG000|Overall Study|Lack of Efficacy|0|||
145426190|NCT01592747|524417405|FG001|Overall Study|Lack of Efficacy|1|||
145426191|NCT01592747|524417406|FG002|Overall Study|Lack of Efficacy|0|||
145426192|NCT01592747|524417404|FG000|Overall Study|Withdrawal by Subject|2|||
145426193|NCT01592747|524417405|FG001|Overall Study|Withdrawal by Subject|0|||
145426194|NCT01592747|524417406|FG002|Overall Study|Withdrawal by Subject|2|||
145426195|NCT01592747|524417404|FG000|Overall Study|Lost to Follow-up|1|||
145426196|NCT01592747|524417405|FG001|Overall Study|Lost to Follow-up|0|||
145426197|NCT01592747|524417406|FG002|Overall Study|Lost to Follow-up|1|||
145426198|NCT01592747|524417404|FG000|Overall Study|Other Reasons|1|||
145426199|NCT01592747|524417405|FG001|Overall Study|Other Reasons|1|||
145426200|NCT01592747|524417406|FG002|Overall Study|Other Reasons|0|||
145426201|NCT02367885|524417407|FG000|Overall Study|Lost to Follow-up|1|||
145426202|NCT02367885|524417408|FG001|Overall Study|Lost to Follow-up|0|||
145426203|NCT02367885|524417409|FG002|Overall Study|Lost to Follow-up|0|||
145426204|NCT02367885|524417407|FG000|Overall Study|Withdrawal by Subject|1|||
145426205|NCT02367885|524417408|FG001|Overall Study|Withdrawal by Subject|0|||
145426206|NCT02367885|524417409|FG002|Overall Study|Withdrawal by Subject|0|||
145426207|NCT01602484|524417410|FG000|Overall Study|Airway issues unrelated to study|0|||
145426208|NCT01602484|524417411|FG001|Overall Study|Airway issues unrelated to study|1|||
145426209|NCT01378195|524417412|FG000|Overall Study|Lost to Follow-up|29|||
145426210|NCT01378195|524417413|FG001|Overall Study|Lost to Follow-up|18|||
145426211|NCT03427619|524417414|FG000|Overall Study|Physician Decision|3|||
145426212|NCT03427619|524417414|FG000|Overall Study|Withdrawal by Subject|4|||
145426213|NCT03427619|524417414|FG000|Overall Study|Lost to Follow-up|5|||
145426214|NCT03427619|524417414|FG000|Overall Study|Administrative|4|||
145426215|NCT03427619|524417414|FG000|Overall Study|Other|2|||
145426216|NCT03427619|524417414|FG000|Overall Study|Unknown or Missing Completion Status|48|||
145426217|NCT05763381|524417420|FG000|Overall Study|Lost to Follow-up|2|||
145426218|NCT05763381|524417421|FG001|Overall Study|Lost to Follow-up|3|||
145426219|NCT05763381|524417420|FG000|Overall Study|Withdrawal by Subject|1|||
145426220|NCT05763381|524417421|FG001|Overall Study|Withdrawal by Subject|2|||
145426221|NCT03787615|524417425|FG000|Overall Study|Withdrawal by Subject|2|||
145426222|NCT03787615|524417425|FG000|Overall Study|Lost to Follow-up|2|||
145426223|NCT02697448|524417427|FG000|Overall Study|Protocol Violation|2|||
145426224|NCT02697448|524417428|FG001|Overall Study|Protocol Violation|4|||
145426225|NCT02697448|524417427|FG000|Overall Study|Clinical concerns during ablation|1|||
145426226|NCT02697448|524417428|FG001|Overall Study|Clinical concerns during ablation|1|||
145580631|NCT01993719|524979211|FG000|First Drug Administration|Not treated|1|||
145580632|NCT01993719|524979212|FG001|First Drug Administration|Not treated|0|||
145580633|NCT01993719|524979213|FG002|First Drug Administration|Not treated|0|||
145580634|NCT01993719|524979214|FG003|First Drug Administration|Not treated|0|||
145580635|NCT01993719|524979215|FG004|First Drug Administration|Not treated|0|||
145580636|NCT04067141|524979222|FG000|First Intervention|Withdrawal by Subject|0|||
145580637|NCT04067141|524979223|FG001|First Intervention|Withdrawal by Subject|1|||
145580638|NCT04067141|524979222|FG000|Second Intervention|Adverse Event|0|||
145426227|NCT02697448|524417427|FG000|Overall Study|No data collected|2|||
145426228|NCT02697448|524417428|FG001|Overall Study|No data collected|0|||
145426229|NCT05418426|524417430|FG000|Overall Study|Adverse Event|0|||
145426230|NCT05418426|524417431|FG001|Overall Study|Adverse Event|1|||
145580639|NCT04067141|524979223|FG001|Second Intervention|Adverse Event|2|||
145580640|NCT03295201|524979224|FG000|Overall Study|Lost to Follow-up|1|||
145426231|NCT05418426|524417432|FG002|Overall Study|Adverse Event|0|||
145426232|NCT05418426|524417430|FG000|Overall Study|Withdrawal by Subject|0|||
145580641|NCT03295201|524979225|FG001|Overall Study|Lost to Follow-up|1|||
145580642|NCT03295201|524979224|FG000|Overall Study|Hospital admission|0|||
145580643|NCT03295201|524979225|FG001|Overall Study|Hospital admission|1|||
145373142|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
145373143|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
145373144|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
145373145|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
145373146|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
145373147|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
145373148|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
145373149|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
145373150|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
145373151|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
145373152|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
145373153|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
145373154|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
145373155|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
145373156|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
145373157|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
145373158|NCT04488419|524217127|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
145373159|NCT04488419|524217128|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
145373160|NCT04488419|524217129|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
145373161|NCT04488419|524217127|FG000|Primary Analysis Population|Adverse Event|6|||
145373162|NCT04488419|524217128|FG001|Primary Analysis Population|Adverse Event|9|||
145373163|NCT04488419|524217129|FG002|Primary Analysis Population|Adverse Event|0|||
145373164|NCT04488419|524217127|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
145373165|NCT04488419|524217128|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
145373166|NCT04488419|524217129|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
145373167|NCT04488419|524217127|FG000|Primary Analysis Population|Protocol Violation|1|||
145373168|NCT04488419|524217128|FG001|Primary Analysis Population|Protocol Violation|1|||
145373169|NCT04488419|524217129|FG002|Primary Analysis Population|Protocol Violation|0|||
145373170|NCT04488419|524217127|FG000|Primary Analysis Population|Undetermined|7|||
145373171|NCT04488419|524217128|FG001|Primary Analysis Population|Undetermined|3|||
145373172|NCT04488419|524217129|FG002|Primary Analysis Population|Undetermined|0|||
145373173|NCT04488419|524217127|FG000|Primary Analysis Population|>1 Reason|2|||
145373174|NCT04488419|524217128|FG001|Primary Analysis Population|>1 Reason|4|||
145373175|NCT04488419|524217129|FG002|Primary Analysis Population|>1 Reason|0|||
145373176|NCT04045132|524217132|FG000|Overall Study|Lost to Follow-up|3|||
145373177|NCT04045132|524217133|FG001|Overall Study|Lost to Follow-up|6|||
145373178|NCT01632150|524217136|FG000|Overall Study|Disease progression|27|||
145373179|NCT01632150|524217136|FG000|Overall Study|Study drug toxicity|1|||
145373180|NCT01632150|524217136|FG000|Overall Study|Unrelated adverse event|7|||
145373181|NCT01632150|524217136|FG000|Overall Study|Withdrawal by Subject|2|||
145373182|NCT01632150|524217136|FG000|Overall Study|Patient underwent autologous transplant|1|||
145373183|NCT01632150|524217136|FG000|Overall Study|Moved to compassionate program|2|||
145373184|NCT02879994|524217139|FG000|Overall Study|off treatment early|7|||
145373185|NCT02879994|524217139|FG000|Overall Study|Adverse Event|2|||
145373186|NCT02879994|524217139|FG000|Overall Study|Death|2|||
145373187|NCT02143791|524217140|FG000|Enrolled|Withdrawal by Subject|4|||
145373188|NCT02143791|524217140|FG000|Trial Stimulation|Lack of Efficacy|21|||
145373189|NCT02143791|524217140|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
145373190|NCT02143791|524217140|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
145373191|NCT02143791|524217140|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
145373192|NCT02143791|524217140|FG000|Any Programming (3-6 Months)|Missing Data|1|||
145373193|NCT02143791|524217140|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
145373194|NCT04327661|524217147|FG000|Overall Study|Withdrawal by Subject|1|||
145373195|NCT04327661|524217148|FG001|Overall Study|Withdrawal by Subject|0|||
145373196|NCT04327661|524217149|FG002|Overall Study|Withdrawal by Subject|0|||
145373197|NCT01877551|524217154|FG000|Overall Study|Physician Decision|0|||
145373198|NCT01877551|524217155|FG001|Overall Study|Physician Decision|1|||
145373199|NCT01282164|524217159|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
145373200|NCT01282164|524217160|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
145373201|NCT01185509|524217163|FG000|Overall Study|Progression/Relapse|9|||
145373202|NCT01185509|524217164|FG001|Overall Study|Progression/Relapse|15|||
145373203|NCT01185509|524217163|FG000|Overall Study|Physician Decision|2|||
145373204|NCT01185509|524217164|FG001|Overall Study|Physician Decision|2|||
145373205|NCT01185509|524217163|FG000|Overall Study|Withdrawal by Subject|0|||
145373206|NCT01185509|524217164|FG001|Overall Study|Withdrawal by Subject|1|||
145373207|NCT01185509|524217163|FG000|Overall Study|Death|0|||
145373208|NCT01185509|524217164|FG001|Overall Study|Death|1|||
145373209|NCT01185509|524217163|FG000|Overall Study|Intercurrent Illness|0|||
145373210|NCT01185509|524217164|FG001|Overall Study|Intercurrent Illness|1|||
145373211|NCT02062944|524217173|FG000|Overall Study|Lost to Follow-up|1|||
145373212|NCT02062944|524217173|FG000|Overall Study|New hemotological disorder identified|1|||
145373213|NCT02062944|524217173|FG000|Overall Study|Uncontrolled Hypertension|1|||
145580644|NCT00572572|524979226|FG000|Overall Study|Withdrawal by Subject|3|||
145580645|NCT00572572|524979227|FG001|Overall Study|Withdrawal by Subject|6|||
145580646|NCT00889421|524979228|FG000|Overall Study|Lack of Efficacy|3|||
145580647|NCT01958918|524979229|FG000|Overall Study|Death|1|||
145580648|NCT01958918|524979230|FG001|Overall Study|Death|3|||
145580649|NCT01958918|524979229|FG000|Overall Study|Lost to Follow-up|4|||
145580650|NCT01958918|524979230|FG001|Overall Study|Lost to Follow-up|7|||
145580651|NCT01958918|524979229|FG000|Overall Study|Withdrawal by Subject|13|||
145580652|NCT01958918|524979230|FG001|Overall Study|Withdrawal by Subject|8|||
145580653|NCT01958918|524979229|FG000|Overall Study|Lack of Efficacy|13|||
145580654|NCT01958918|524979230|FG001|Overall Study|Lack of Efficacy|10|||
145580655|NCT01958918|524979229|FG000|Overall Study|Adverse Event|12|||
145580656|NCT01958918|524979230|FG001|Overall Study|Adverse Event|12|||
145580657|NCT01958918|524979229|FG000|Overall Study|administrative problems|0|||
145580658|NCT01958918|524979230|FG001|Overall Study|administrative problems|2|||
145580659|NCT02114892|524979234|FG000|Overall Study|Lost to Follow-up|1|||
145580660|NCT02114892|524979235|FG001|Overall Study|Lost to Follow-up|2|||
145580661|NCT00659269|524979239|FG000|Overall Study|Physician Decision|1|||
145580662|NCT00659269|524979240|FG001|Overall Study|Physician Decision|1|||
145580663|NCT00718042|524979242|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
145580664|NCT00718042|524979243|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
145580665|NCT00718042|524979244|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
145580666|NCT00718042|524979245|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
145580667|NCT00718042|524979246|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
145580668|NCT00718042|524979247|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
145580669|NCT00718042|524979242|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
145580670|NCT00718042|524979243|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
145580671|NCT00718042|524979244|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
145580672|NCT00718042|524979245|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
145580673|NCT00718042|524979246|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
145580674|NCT00718042|524979247|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
145580675|NCT00718042|524979242|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
145580676|NCT00718042|524979243|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
145580677|NCT00718042|524979244|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
145580678|NCT00718042|524979245|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
145580679|NCT00718042|524979246|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
145580680|NCT00718042|524979247|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
145580681|NCT00718042|524979242|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
145580682|NCT00718042|524979243|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
145580683|NCT00718042|524979244|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
145580684|NCT00718042|524979245|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
145580685|NCT00718042|524979246|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
145580686|NCT00718042|524979247|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
145580687|NCT00718042|524979242|FG000|Donor Follow-up|Lost to Follow-up|13|||
145580688|NCT00718042|524979243|FG001|Donor Follow-up|Lost to Follow-up|0|||
145580689|NCT00718042|524979244|FG002|Donor Follow-up|Lost to Follow-up|0|||
145580690|NCT00718042|524979245|FG003|Donor Follow-up|Lost to Follow-up|0|||
145580691|NCT00718042|524979246|FG004|Donor Follow-up|Lost to Follow-up|19|||
145580692|NCT00718042|524979247|FG005|Donor Follow-up|Lost to Follow-up|0|||
145580693|NCT04327934|524979248|FG000|Overall Study|Did not qualify|7|||
145580694|NCT04327934|524979249|FG001|Overall Study|Did not qualify|4|||
145580695|NCT04327934|524979248|FG000|Overall Study|Physician Decision|0|||
145580696|NCT04327934|524979249|FG001|Overall Study|Physician Decision|1|||
145580697|NCT02610140|524979256|FG000|Randomization and Treatment Period|Radiological progression|23|||
145580698|NCT02610140|524979257|FG001|Randomization and Treatment Period|Radiological progression|15|||
145580699|NCT02610140|524979256|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
145580700|NCT02610140|524979257|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
145580701|NCT02610140|524979256|FG000|Randomization and Treatment Period|Protocol Violation|1|||
145580702|NCT02610140|524979257|FG001|Randomization and Treatment Period|Protocol Violation|0|||
145580703|NCT02610140|524979256|FG000|Randomization and Treatment Period|Physician Decision|0|||
145580704|NCT02610140|524979257|FG001|Randomization and Treatment Period|Physician Decision|1|||
145580705|NCT02610140|524979256|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
145580706|NCT02610140|524979257|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
145580707|NCT02610140|524979256|FG000|Randomization and Treatment Period|Death|7|||
145623711|NCT02099539|525134021|FG001|Overall Study|Adverse Event|0|||
145373214|NCT02062944|524217173|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
145373215|NCT02122770|524217174|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
145373216|NCT02122770|524217175|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145373217|NCT02122770|524217176|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
145580708|NCT02610140|524979257|FG001|Randomization and Treatment Period|Death|1|||
145580709|NCT02610140|524979256|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
145580710|NCT02610140|524979257|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
145426233|NCT05418426|524417431|FG001|Overall Study|Withdrawal by Subject|1|||
145426234|NCT05418426|524417432|FG002|Overall Study|Withdrawal by Subject|0|||
145426235|NCT05418426|524417430|FG000|Overall Study|Protocol Violation|0|||
145426236|NCT05418426|524417431|FG001|Overall Study|Protocol Violation|0|||
145426237|NCT05418426|524417432|FG002|Overall Study|Protocol Violation|1|||
145426238|NCT01674062|524417433|FG000|Overall Study|Insufficient Therapeutic Response|56|||
145426239|NCT01674062|524417434|FG001|Overall Study|Insufficient Therapeutic Response|26|||
145426240|NCT01674062|524417433|FG000|Overall Study|Other|8|||
145426241|NCT01674062|524417434|FG001|Overall Study|Other|1|||
145426242|NCT01674062|524417433|FG000|Overall Study|Adverse Event|1|||
145426243|NCT01674062|524417434|FG001|Overall Study|Adverse Event|1|||
145426244|NCT01674062|524417433|FG000|Overall Study|Death|0|||
145426245|NCT01674062|524417434|FG001|Overall Study|Death|1|||
145426246|NCT01674062|524417433|FG000|Overall Study|Programming Error|1|||
145426247|NCT01674062|524417434|FG001|Overall Study|Programming Error|0|||
145426248|NCT04620668|524417435|FG000|Overall Study|Withdrawal by Subject|2|||
145580711|NCT02610140|524979256|FG000|Randomization and Treatment Period|Adverse Event|44|||
145580712|NCT02610140|524979257|FG001|Randomization and Treatment Period|Adverse Event|13|||
145580713|NCT02610140|524979256|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
145426249|NCT04620668|524417436|FG001|Overall Study|Withdrawal by Subject|0|||
145426250|NCT04620668|524417435|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
145426251|NCT04620668|524417436|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
145426252|NCT04620668|524417435|FG000|Overall Study|Removed before analysis: missing data|2|||
145426253|NCT04620668|524417436|FG001|Overall Study|Removed before analysis: missing data|0|||
145426254|NCT04620668|524417435|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
145426255|NCT04620668|524417436|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
145426256|NCT04620668|524417435|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
145426257|NCT04620668|524417436|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
145426258|NCT02655601|524417437|FG000|Overall Study|Adverse Event|0|||
145426259|NCT02655601|524417438|FG001|Overall Study|Adverse Event|0|||
145426260|NCT02655601|524417439|FG002|Overall Study|Adverse Event|0|||
145426261|NCT02655601|524417440|FG003|Overall Study|Adverse Event|1|||
145426262|NCT02655601|524417441|FG004|Overall Study|Adverse Event|1|||
145426263|NCT02655601|524417442|FG005|Overall Study|Adverse Event|0|||
145426264|NCT02655601|524417437|FG000|Overall Study|Physician Decision|0|||
145426265|NCT02655601|524417438|FG001|Overall Study|Physician Decision|0|||
145426266|NCT02655601|524417439|FG002|Overall Study|Physician Decision|0|||
145426267|NCT02655601|524417440|FG003|Overall Study|Physician Decision|0|||
145426268|NCT02655601|524417441|FG004|Overall Study|Physician Decision|1|||
145426269|NCT02655601|524417442|FG005|Overall Study|Physician Decision|1|||
145426270|NCT02655601|524417437|FG000|Overall Study|Withdrawal by Subject|0|||
145426271|NCT02655601|524417438|FG001|Overall Study|Withdrawal by Subject|0|||
145426272|NCT02655601|524417439|FG002|Overall Study|Withdrawal by Subject|0|||
145426273|NCT02655601|524417440|FG003|Overall Study|Withdrawal by Subject|0|||
145426274|NCT02655601|524417441|FG004|Overall Study|Withdrawal by Subject|4|||
145426275|NCT02655601|524417442|FG005|Overall Study|Withdrawal by Subject|8|||
145426276|NCT02655601|524417437|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
145426277|NCT02655601|524417438|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145426278|NCT02655601|524417439|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145426279|NCT02655601|524417440|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145426280|NCT02655601|524417441|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145426281|NCT02655601|524417442|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
145426282|NCT00829868|524417443|FG000|Washout|Physician Decision|1|||
145426283|NCT00829868|524417444|FG001|Washout|Physician Decision|0|||
145426284|NCT01969409|524417445|FG000|Overall Study|Death|2|||
145426285|NCT01969409|524417446|FG001|Overall Study|Death|2|||
145426286|NCT01969409|524417445|FG000|Overall Study|Transplant|1|||
145426287|NCT01969409|524417446|FG001|Overall Study|Transplant|1|||
145426288|NCT01969409|524417445|FG000|Overall Study|Withdrawal by Subject|0|||
145580714|NCT02610140|524979257|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
145580715|NCT02610140|524979256|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
145580716|NCT02610140|524979257|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
145426289|NCT01969409|524417446|FG001|Overall Study|Withdrawal by Subject|1|||
145426290|NCT02799043|524417447|FG000|Overall Study|Adverse Event|0|||
145426291|NCT02799043|524417448|FG001|Overall Study|Adverse Event|1|||
145426292|NCT02799043|524417447|FG000|Overall Study|Death|1|||
145580717|NCT02610140|524979256|FG000|Randomization and Treatment Period|Not treated|3|||
145580718|NCT02610140|524979257|FG001|Randomization and Treatment Period|Not treated|10|||
145426293|NCT02799043|524417448|FG001|Overall Study|Death|1|||
145426294|NCT02799043|524417447|FG000|Overall Study|Lost to Follow-up|3|||
145426295|NCT02799043|524417448|FG001|Overall Study|Lost to Follow-up|6|||
145426296|NCT02799043|524417447|FG000|Overall Study|Withdrawal by Subject|4|||
145426297|NCT02799043|524417448|FG001|Overall Study|Withdrawal by Subject|4|||
145426298|NCT02799043|524417447|FG000|Overall Study|Moved to different country|0|||
145426299|NCT02799043|524417448|FG001|Overall Study|Moved to different country|1|||
145426300|NCT02799043|524417447|FG000|Overall Study|Trial Screen Failure|1|||
145426301|NCT02799043|524417448|FG001|Overall Study|Trial Screen Failure|0|||
145426302|NCT02799043|524417447|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
145426303|NCT02799043|524417448|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
145426304|NCT01554904|524417449|FG000|Overall Study|Withdrawal by Subject|3|||
145426305|NCT01554904|524417449|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
145426306|NCT01051661|524417452|FG000|Overall Study|Adverse Event|1|||
145426307|NCT01051661|524417453|FG001|Overall Study|Adverse Event|1|||
145426308|NCT01051661|524417454|FG002|Overall Study|Adverse Event|1|||
145426309|NCT01051661|524417455|FG003|Overall Study|Adverse Event|1|||
145426310|NCT01051661|524417456|FG004|Overall Study|Adverse Event|0|||
145426311|NCT01051661|524417457|FG005|Overall Study|Adverse Event|0|||
145426312|NCT01051661|524417452|FG000|Overall Study|Lost to Follow-up|13|||
145426313|NCT01051661|524417453|FG001|Overall Study|Lost to Follow-up|22|||
145426314|NCT01051661|524417454|FG002|Overall Study|Lost to Follow-up|15|||
145426315|NCT01051661|524417455|FG003|Overall Study|Lost to Follow-up|17|||
145426316|NCT01051661|524417456|FG004|Overall Study|Lost to Follow-up|10|||
145426317|NCT01051661|524417457|FG005|Overall Study|Lost to Follow-up|24|||
145426318|NCT01051661|524417452|FG000|Overall Study|Migrated/moved from study area|1|||
145426319|NCT01051661|524417453|FG001|Overall Study|Migrated/moved from study area|6|||
145426320|NCT01051661|524417454|FG002|Overall Study|Migrated/moved from study area|6|||
145426321|NCT01051661|524417455|FG003|Overall Study|Migrated/moved from study area|8|||
145426322|NCT01051661|524417456|FG004|Overall Study|Migrated/moved from study area|7|||
145426323|NCT01051661|524417457|FG005|Overall Study|Migrated/moved from study area|3|||
145580719|NCT02610140|524979256|FG000|Safety Follow-up|Other|0|||
145580720|NCT02610140|524979257|FG001|Safety Follow-up|Other|2|||
145580721|NCT02610140|524979256|FG000|Safety Follow-up|Lost to Follow-up|1|||
145580722|NCT02610140|524979257|FG001|Safety Follow-up|Lost to Follow-up|0|||
145580723|NCT02610140|524979256|FG000|Safety Follow-up|No follow-up|5|||
145580724|NCT02610140|524979257|FG001|Safety Follow-up|No follow-up|3|||
145580725|NCT02610140|524979256|FG000|Safety Follow-up|Death|12|||
145580726|NCT02610140|524979257|FG001|Safety Follow-up|Death|2|||
145580727|NCT02610140|524979256|FG000|Safety Follow-up|Deterioration of general conditions|15|||
145580728|NCT02610140|524979257|FG001|Safety Follow-up|Deterioration of general conditions|5|||
145580729|NCT02610140|524979256|FG000|Safety Follow-up|Withdrawal by Subject|12|||
145580730|NCT02610140|524979257|FG001|Safety Follow-up|Withdrawal by Subject|12|||
145580731|NCT02610140|524979256|FG000|Active Follow-up|Progressive disease - radiological|30|||
145580732|NCT02610140|524979257|FG001|Active Follow-up|Progressive disease - radiological|22|||
145580733|NCT02610140|524979256|FG000|Active Follow-up|Death|8|||
145580734|NCT02610140|524979257|FG001|Active Follow-up|Death|1|||
145580735|NCT02610140|524979256|FG000|Active Follow-up|Withdrawal by Subject|4|||
145580736|NCT02610140|524979257|FG001|Active Follow-up|Withdrawal by Subject|0|||
145580737|NCT02610140|524979256|FG000|Active Follow-up|Progressive disease - clinical|1|||
145580738|NCT02610140|524979257|FG001|Active Follow-up|Progressive disease - clinical|2|||
145580739|NCT02610140|524979256|FG000|Active Follow-up|Deterioration of general conditions|1|||
145580740|NCT02610140|524979257|FG001|Active Follow-up|Deterioration of general conditions|0|||
145580741|NCT02610140|524979256|FG000|Active Follow-up|Ongoing but not completed|4|||
145580742|NCT02610140|524979257|FG001|Active Follow-up|Ongoing but not completed|1|||
145580743|NCT02610140|524979256|FG000|Long-term Follow-up|Death|86|||
145580744|NCT02610140|524979257|FG001|Long-term Follow-up|Death|44|||
145580745|NCT02610140|524979256|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
145580746|NCT02610140|524979257|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
145580747|NCT02610140|524979256|FG000|Long-term Follow-up|Lost to Follow-up|1|||
145580748|NCT02610140|524979257|FG001|Long-term Follow-up|Lost to Follow-up|2|||
145580749|NCT02610140|524979256|FG000|Long-term Follow-up|Ongoing but not completed|30|||
145580750|NCT02610140|524979257|FG001|Long-term Follow-up|Ongoing but not completed|17|||
145580751|NCT02617589|524979258|FG000|Randomization|Request to Discontinue Study Treatment|1|||
145580752|NCT02617589|524979259|FG001|Randomization|Request to Discontinue Study Treatment|3|||
145580753|NCT02617589|524979258|FG000|Randomization|Participant Withdrew Consent|1|||
145580754|NCT02617589|524979259|FG001|Randomization|Participant Withdrew Consent|2|||
145580755|NCT02617589|524979258|FG000|Treatment|Other Reasons|3|||
145580756|NCT02617589|524979259|FG001|Treatment|Other Reasons|3|||
145580757|NCT02617589|524979258|FG000|Treatment|Poor/Non Compliance|1|||
145580758|NCT02617589|524979259|FG001|Treatment|Poor/Non Compliance|1|||
145580759|NCT02617589|524979258|FG000|Treatment|Maximum Clinical Benefit|0|||
145580760|NCT02617589|524979259|FG001|Treatment|Maximum Clinical Benefit|2|||
145580761|NCT02617589|524979258|FG000|Treatment|Participant Withdrew Consent|2|||
145623712|NCT02099539|525134022|FG002|Overall Study|Adverse Event|1|||
145426324|NCT01051661|524417452|FG000|Overall Study|Refused blood sampling|0|||
145426325|NCT01051661|524417453|FG001|Overall Study|Refused blood sampling|0|||
145426326|NCT01051661|524417454|FG002|Overall Study|Refused blood sampling|0|||
145426327|NCT01051661|524417455|FG003|Overall Study|Refused blood sampling|0|||
145426328|NCT01051661|524417456|FG004|Overall Study|Refused blood sampling|0|||
145580762|NCT02617589|524979259|FG001|Treatment|Participant Withdrew Consent|6|||
145580763|NCT02617589|524979258|FG000|Treatment|Participant Request to Discontinue|12|||
145580764|NCT02617589|524979259|FG001|Treatment|Participant Request to Discontinue|21|||
145580765|NCT02617589|524979258|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
145580766|NCT02617589|524979259|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
145580767|NCT02617589|524979258|FG000|Treatment|Death|1|||
145373218|NCT02122770|524217177|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
145373219|NCT02122770|524217178|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145373220|NCT02122770|524217179|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
145373221|NCT02122770|524217174|FG000|Part A: Drug-drug Interaction 2|Other|0|||
145373222|NCT02122770|524217175|FG001|Part A: Drug-drug Interaction 2|Other|0|||
145373223|NCT02122770|524217176|FG002|Part A: Drug-drug Interaction 2|Other|1|||
145373224|NCT02122770|524217177|FG003|Part A: Drug-drug Interaction 2|Other|0|||
145373225|NCT02122770|524217178|FG004|Part A: Drug-drug Interaction 2|Other|0|||
145373226|NCT02122770|524217179|FG005|Part A: Drug-drug Interaction 2|Other|0|||
145373227|NCT02122770|524217174|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145373228|NCT02122770|524217175|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
145373229|NCT02122770|524217176|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145373230|NCT02122770|524217177|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145373231|NCT02122770|524217178|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145373232|NCT02122770|524217179|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
145373233|NCT02122770|524217174|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
145373234|NCT02122770|524217175|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
145373235|NCT02122770|524217176|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
145373236|NCT02122770|524217177|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
145373237|NCT02122770|524217178|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
145373238|NCT02122770|524217179|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
145373239|NCT02122770|524217174|FG000|Part B: Standard of Care|Adverse Event|0|||
145373240|NCT02122770|524217175|FG001|Part B: Standard of Care|Adverse Event|0|||
145373241|NCT02122770|524217176|FG002|Part B: Standard of Care|Adverse Event|0|||
145373242|NCT02122770|524217177|FG003|Part B: Standard of Care|Adverse Event|0|||
145373243|NCT02122770|524217178|FG004|Part B: Standard of Care|Adverse Event|4|||
145373244|NCT02122770|524217179|FG005|Part B: Standard of Care|Adverse Event|1|||
145373245|NCT02122770|524217174|FG000|Part B: Standard of Care|Other|0|||
145373246|NCT02122770|524217175|FG001|Part B: Standard of Care|Other|0|||
145373247|NCT02122770|524217176|FG002|Part B: Standard of Care|Other|0|||
145373248|NCT02122770|524217177|FG003|Part B: Standard of Care|Other|0|||
145373249|NCT02122770|524217178|FG004|Part B: Standard of Care|Other|0|||
145373250|NCT02122770|524217179|FG005|Part B: Standard of Care|Other|2|||
145373251|NCT02122770|524217174|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
145373252|NCT02122770|524217175|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
145373253|NCT02122770|524217176|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
145373254|NCT02122770|524217177|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
145373255|NCT02122770|524217178|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
145373256|NCT02122770|524217179|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
145373257|NCT02122770|524217174|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
145373258|NCT02122770|524217175|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
145373259|NCT02122770|524217176|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
145373260|NCT02122770|524217177|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
145373261|NCT02122770|524217178|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
145373262|NCT02122770|524217179|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
145373263|NCT02122770|524217174|FG000|Part B: Standard of Care|Progressive Disease|0|||
145373264|NCT02122770|524217175|FG001|Part B: Standard of Care|Progressive Disease|0|||
145373265|NCT02122770|524217176|FG002|Part B: Standard of Care|Progressive Disease|0|||
145373266|NCT02122770|524217177|FG003|Part B: Standard of Care|Progressive Disease|0|||
145373267|NCT02122770|524217178|FG004|Part B: Standard of Care|Progressive Disease|10|||
145373268|NCT02122770|524217179|FG005|Part B: Standard of Care|Progressive Disease|8|||
145373269|NCT01041976|524217180|FG000|Overall Study|Withdrawal by Subject|3|||
145373270|NCT01041976|524217181|FG001|Overall Study|Withdrawal by Subject|0|||
145373271|NCT01041976|524217180|FG000|Overall Study|Incarceration|2|||
145373272|NCT01041976|524217181|FG001|Overall Study|Incarceration|0|||
145373273|NCT01041976|524217180|FG000|Overall Study|Death|0|||
145373274|NCT01041976|524217181|FG001|Overall Study|Death|4|||
145373275|NCT02370667|524217182|FG000|Overall Study|Lost to Follow-up|0|||
145373276|NCT02370667|524217183|FG001|Overall Study|Lost to Follow-up|1|||
145373277|NCT02370667|524217184|FG002|Overall Study|Lost to Follow-up|0|||
145373278|NCT02612610|524217185|FG000|Overall Study|Withdrawal by Subject|1|||
145373279|NCT02612610|524217186|FG001|Overall Study|Withdrawal by Subject|1|||
145373280|NCT02612610|524217187|FG002|Overall Study|Withdrawal by Subject|0|||
145373281|NCT02612610|524217188|FG003|Overall Study|Withdrawal by Subject|2|||
145373282|NCT02612610|524217185|FG000|Overall Study|Adverse Event|2|||
145373283|NCT02612610|524217186|FG001|Overall Study|Adverse Event|2|||
145580768|NCT02617589|524979259|FG001|Treatment|Death|1|||
145580769|NCT02617589|524979258|FG000|Treatment|Study Drug Toxicity|27|||
145580770|NCT02617589|524979259|FG001|Treatment|Study Drug Toxicity|20|||
145580771|NCT02617589|524979258|FG000|Treatment|Disease Progression|216|||
145580772|NCT02617589|524979259|FG001|Treatment|Disease Progression|136|||
145580773|NCT01975389|524979260|FG000|Overall Study|Adverse Event|10|||
145580774|NCT01975389|524979261|FG001|Overall Study|Adverse Event|6|||
145580775|NCT01975389|524979260|FG000|Overall Study|Death|61|||
145580776|NCT01975389|524979261|FG001|Overall Study|Death|54|||
145580777|NCT01975389|524979260|FG000|Overall Study|Lost to Follow-up|81|||
145580778|NCT01975389|524979261|FG001|Overall Study|Lost to Follow-up|86|||
145580779|NCT01975389|524979260|FG000|Overall Study|Withdrawal by Subject|90|||
145580780|NCT01975389|524979261|FG001|Overall Study|Withdrawal by Subject|76|||
145580781|NCT01975389|524979260|FG000|Overall Study|Other|6|||
145580782|NCT01975389|524979261|FG001|Overall Study|Other|9|||
145580783|NCT01975389|524979260|FG000|Overall Study|Randomized, not treated|4|||
145580784|NCT01975389|524979261|FG001|Overall Study|Randomized, not treated|5|||
145580785|NCT01312961|524979262|FG000|Overall Study|Adverse Event|3|||
145580786|NCT01312961|524979263|FG001|Overall Study|Adverse Event|3|||
145580787|NCT01312961|524979262|FG000|Overall Study|Lack of Efficacy|11|||
145580788|NCT01312961|524979263|FG001|Overall Study|Lack of Efficacy|1|||
145580789|NCT01312961|524979262|FG000|Overall Study|Poor compliance to protocol|1|||
145580790|NCT01312961|524979263|FG001|Overall Study|Poor compliance to protocol|0|||
145580791|NCT01312961|524979262|FG000|Overall Study|Other than specified above|2|||
145580792|NCT01312961|524979263|FG001|Overall Study|Other than specified above|3|||
145580793|NCT02460198|524979266|FG000|Overall Study|Adverse Event|1|||
145580794|NCT02460198|524979267|FG001|Overall Study|Adverse Event|3|||
145580795|NCT02460198|524979266|FG000|Overall Study|Death|36|||
145580796|NCT02460198|524979267|FG001|Overall Study|Death|28|||
145580797|NCT02460198|524979266|FG000|Overall Study|Lost to Follow-up|1|||
145580798|NCT02460198|524979267|FG001|Overall Study|Lost to Follow-up|1|||
145580799|NCT02460198|524979266|FG000|Overall Study|Transferred to Extension Study|15|||
145580800|NCT02460198|524979267|FG001|Overall Study|Transferred to Extension Study|15|||
145580801|NCT02460198|524979266|FG000|Overall Study|Withdrawal by Subject|2|||
145580802|NCT02460198|524979267|FG001|Overall Study|Withdrawal by Subject|4|||
145580803|NCT02460198|524979266|FG000|Overall Study|Site Terminated By Sponsor|0|||
145580804|NCT02460198|524979267|FG001|Overall Study|Site Terminated By Sponsor|1|||
145580805|NCT02460198|524979266|FG000|Overall Study|Did Not Continue on Extension Study|6|||
145580806|NCT02460198|524979267|FG001|Overall Study|Did Not Continue on Extension Study|11|||
145580807|NCT00931307|524979268|FG000|Overall Study|Lack of Efficacy|12|||
145580808|NCT00931307|524979268|FG000|Overall Study|Biomicroscopy|1|||
145580809|NCT00691210|524979269|FG000|Overall Study|Progression of Disease|0|||
145580810|NCT00691210|524979270|FG001|Overall Study|Progression of Disease|0|||
145580811|NCT00691210|524979271|FG002|Overall Study|Progression of Disease|0|||
145580812|NCT00691210|524979272|FG003|Overall Study|Progression of Disease|2|||
145580813|NCT00691210|524979273|FG004|Overall Study|Progression of Disease|0|||
145580814|NCT00691210|524979274|FG005|Overall Study|Progression of Disease|0|||
145580815|NCT00691210|524979275|FG006|Overall Study|Progression of Disease|0|||
145580816|NCT00691210|524979276|FG007|Overall Study|Progression of Disease|0|||
145580817|NCT00691210|524979269|FG000|Overall Study|Lack of Efficacy|0|||
145580818|NCT00691210|524979270|FG001|Overall Study|Lack of Efficacy|0|||
145580819|NCT00691210|524979271|FG002|Overall Study|Lack of Efficacy|0|||
145580820|NCT00691210|524979272|FG003|Overall Study|Lack of Efficacy|1|||
145580821|NCT00691210|524979273|FG004|Overall Study|Lack of Efficacy|0|||
145580822|NCT00691210|524979274|FG005|Overall Study|Lack of Efficacy|1|||
145580823|NCT00691210|524979275|FG006|Overall Study|Lack of Efficacy|0|||
145580824|NCT00691210|524979276|FG007|Overall Study|Lack of Efficacy|0|||
145580825|NCT01208233|524979277|FG000|Overall Study|Adverse Event|0|||
145580826|NCT01208233|524979278|FG001|Overall Study|Adverse Event|1|||
145580827|NCT01208233|524979279|FG002|Overall Study|Adverse Event|2|||
145580828|NCT01208233|524979280|FG003|Overall Study|Adverse Event|0|||
145623713|NCT02099539|525134023|FG003|Overall Study|Adverse Event|1|||
145373284|NCT02612610|524217187|FG002|Overall Study|Adverse Event|3|||
145373285|NCT02612610|524217188|FG003|Overall Study|Adverse Event|10|||
145373286|NCT02612610|524217185|FG000|Overall Study|Lost to Follow-up|0|||
145580829|NCT01208233|524979281|FG004|Overall Study|Adverse Event|3|||
145580830|NCT01208233|524979282|FG005|Overall Study|Adverse Event|5|||
145580831|NCT01208233|524979277|FG000|Overall Study|Death|0|||
145580832|NCT01208233|524979278|FG001|Overall Study|Death|0|||
145580833|NCT01208233|524979279|FG002|Overall Study|Death|0|||
145580834|NCT01208233|524979280|FG003|Overall Study|Death|0|||
145580835|NCT01208233|524979281|FG004|Overall Study|Death|3|||
145580836|NCT01208233|524979282|FG005|Overall Study|Death|5|||
145580837|NCT01208233|524979277|FG000|Overall Study|Did not meet entrance criteria|2|||
145580838|NCT01208233|524979278|FG001|Overall Study|Did not meet entrance criteria|1|||
145580839|NCT01208233|524979279|FG002|Overall Study|Did not meet entrance criteria|1|||
145580840|NCT01208233|524979280|FG003|Overall Study|Did not meet entrance criteria|0|||
145580841|NCT01208233|524979281|FG004|Overall Study|Did not meet entrance criteria|1|||
145580842|NCT01208233|524979282|FG005|Overall Study|Did not meet entrance criteria|0|||
145580843|NCT01208233|524979277|FG000|Overall Study|Medication error without adverse event|0|||
145373287|NCT02612610|524217186|FG001|Overall Study|Lost to Follow-up|1|||
145373288|NCT02612610|524217187|FG002|Overall Study|Lost to Follow-up|0|||
145373289|NCT02612610|524217188|FG003|Overall Study|Lost to Follow-up|0|||
145373290|NCT02612610|524217185|FG000|Overall Study|Protocol Violation|0|||
145373291|NCT02612610|524217186|FG001|Overall Study|Protocol Violation|1|||
145373292|NCT02612610|524217187|FG002|Overall Study|Protocol Violation|1|||
145373293|NCT02612610|524217188|FG003|Overall Study|Protocol Violation|0|||
145373294|NCT02612610|524217185|FG000|Overall Study|Lack of Efficacy|1|||
145373295|NCT02612610|524217186|FG001|Overall Study|Lack of Efficacy|2|||
145373296|NCT02612610|524217187|FG002|Overall Study|Lack of Efficacy|0|||
145373297|NCT02612610|524217188|FG003|Overall Study|Lack of Efficacy|1|||
145426329|NCT01051661|524417457|FG005|Overall Study|Refused blood sampling|1|||
145426330|NCT01051661|524417452|FG000|Overall Study|Data not reliable|1|||
145426331|NCT01051661|524417453|FG001|Overall Study|Data not reliable|0|||
145426332|NCT01051661|524417454|FG002|Overall Study|Data not reliable|0|||
145426333|NCT01051661|524417455|FG003|Overall Study|Data not reliable|0|||
145426334|NCT01051661|524417456|FG004|Overall Study|Data not reliable|0|||
145426335|NCT01051661|524417457|FG005|Overall Study|Data not reliable|1|||
145426336|NCT01051661|524417452|FG000|Overall Study|Unable to attend visit(s)|2|||
145426337|NCT01051661|524417453|FG001|Overall Study|Unable to attend visit(s)|4|||
145426338|NCT01051661|524417454|FG002|Overall Study|Unable to attend visit(s)|2|||
145426339|NCT01051661|524417455|FG003|Overall Study|Unable to attend visit(s)|1|||
145426340|NCT01051661|524417456|FG004|Overall Study|Unable to attend visit(s)|3|||
145426341|NCT01051661|524417457|FG005|Overall Study|Unable to attend visit(s)|2|||
145426342|NCT01051661|524417452|FG000|Overall Study|Consent not received from both parents|0|||
145426343|NCT01051661|524417453|FG001|Overall Study|Consent not received from both parents|0|||
145426344|NCT01051661|524417454|FG002|Overall Study|Consent not received from both parents|0|||
145426345|NCT01051661|524417455|FG003|Overall Study|Consent not received from both parents|0|||
145426346|NCT01051661|524417456|FG004|Overall Study|Consent not received from both parents|0|||
145426347|NCT01051661|524417457|FG005|Overall Study|Consent not received from both parents|1|||
145426348|NCT01051661|524417452|FG000|Overall Study|Failure to comply with protocol|0|||
145426349|NCT01051661|524417453|FG001|Overall Study|Failure to comply with protocol|0|||
145426350|NCT01051661|524417454|FG002|Overall Study|Failure to comply with protocol|2|||
145426351|NCT01051661|524417455|FG003|Overall Study|Failure to comply with protocol|0|||
145426352|NCT01051661|524417456|FG004|Overall Study|Failure to comply with protocol|0|||
145426353|NCT01051661|524417457|FG005|Overall Study|Failure to comply with protocol|0|||
145426354|NCT01051661|524417452|FG000|Overall Study|Subject lost legal representation|0|||
145426355|NCT01051661|524417453|FG001|Overall Study|Subject lost legal representation|0|||
145426356|NCT01051661|524417454|FG002|Overall Study|Subject lost legal representation|0|||
145426357|NCT01051661|524417455|FG003|Overall Study|Subject lost legal representation|0|||
145426358|NCT01051661|524417456|FG004|Overall Study|Subject lost legal representation|1|||
145426359|NCT01051661|524417457|FG005|Overall Study|Subject lost legal representation|0|||
145426360|NCT01051661|524417452|FG000|Overall Study|Protocol Violation|0|||
145426361|NCT01051661|524417453|FG001|Overall Study|Protocol Violation|0|||
145426362|NCT01051661|524417454|FG002|Overall Study|Protocol Violation|0|||
145426363|NCT01051661|524417455|FG003|Overall Study|Protocol Violation|1|||
145426364|NCT01051661|524417456|FG004|Overall Study|Protocol Violation|2|||
145426365|NCT01051661|524417457|FG005|Overall Study|Protocol Violation|1|||
145580844|NCT01208233|524979278|FG001|Overall Study|Medication error without adverse event|0|||
145580845|NCT01208233|524979279|FG002|Overall Study|Medication error without adverse event|0|||
145580846|NCT01208233|524979280|FG003|Overall Study|Medication error without adverse event|0|||
145580847|NCT01208233|524979281|FG004|Overall Study|Medication error without adverse event|0|||
145580848|NCT01208233|524979282|FG005|Overall Study|Medication error without adverse event|1|||
145580849|NCT01208233|524979277|FG000|Overall Study|Study terminated by sponsor|0|||
145580850|NCT01208233|524979278|FG001|Overall Study|Study terminated by sponsor|0|||
145580851|NCT01208233|524979279|FG002|Overall Study|Study terminated by sponsor|0|||
145580852|NCT01208233|524979280|FG003|Overall Study|Study terminated by sponsor|0|||
145580853|NCT01208233|524979281|FG004|Overall Study|Study terminated by sponsor|10|||
145580854|NCT01208233|524979282|FG005|Overall Study|Study terminated by sponsor|7|||
145580855|NCT01208233|524979277|FG000|Overall Study|Protocol Violation|0|||
145580856|NCT01208233|524979278|FG001|Overall Study|Protocol Violation|0|||
145580857|NCT01208233|524979279|FG002|Overall Study|Protocol Violation|0|||
145580858|NCT01208233|524979280|FG003|Overall Study|Protocol Violation|0|||
145623714|NCT02099539|525134024|FG004|Overall Study|Adverse Event|0|||
145373298|NCT02612610|524217185|FG000|Overall Study|Physician Decision|0|||
145373299|NCT02612610|524217186|FG001|Overall Study|Physician Decision|1|||
145373300|NCT02612610|524217187|FG002|Overall Study|Physician Decision|0|||
145373301|NCT02612610|524217188|FG003|Overall Study|Physician Decision|0|||
145426366|NCT01051661|524417452|FG000|Overall Study|Withdrawal by Subject|16|||
145426367|NCT01051661|524417453|FG001|Overall Study|Withdrawal by Subject|30|||
145426368|NCT01051661|524417454|FG002|Overall Study|Withdrawal by Subject|13|||
145426369|NCT01051661|524417455|FG003|Overall Study|Withdrawal by Subject|28|||
145426370|NCT01051661|524417456|FG004|Overall Study|Withdrawal by Subject|12|||
145580859|NCT01208233|524979281|FG004|Overall Study|Protocol Violation|3|||
145580860|NCT01208233|524979282|FG005|Overall Study|Protocol Violation|0|||
145426371|NCT01051661|524417457|FG005|Overall Study|Withdrawal by Subject|34|||
145426372|NCT01916226|524417458|FG000|Overall Study|Adverse Event|1|||
145426373|NCT01916226|524417459|FG001|Overall Study|Adverse Event|0|||
145426374|NCT01916226|524417460|FG002|Overall Study|Adverse Event|1|||
145426375|NCT01916226|524417461|FG003|Overall Study|Adverse Event|1|||
145426376|NCT01916226|524417458|FG000|Overall Study|Lack of Efficacy|0|||
145426377|NCT01916226|524417459|FG001|Overall Study|Lack of Efficacy|0|||
145426378|NCT01916226|524417460|FG002|Overall Study|Lack of Efficacy|2|||
145426379|NCT01916226|524417461|FG003|Overall Study|Lack of Efficacy|1|||
145426380|NCT01916226|524417458|FG000|Overall Study|Protocol Violation|0|||
145426381|NCT01916226|524417459|FG001|Overall Study|Protocol Violation|1|||
145426382|NCT01916226|524417460|FG002|Overall Study|Protocol Violation|0|||
145426383|NCT01916226|524417461|FG003|Overall Study|Protocol Violation|1|||
145426384|NCT01916226|524417458|FG000|Overall Study|Physician Decision|0|||
145426385|NCT01916226|524417459|FG001|Overall Study|Physician Decision|0|||
145426386|NCT01916226|524417460|FG002|Overall Study|Physician Decision|0|||
145426387|NCT01916226|524417461|FG003|Overall Study|Physician Decision|1|||
145426388|NCT00680914|524417464|FG000|Overall Study|Consent withdrawal|6|||
145426389|NCT00680914|524417465|FG001|Overall Study|Consent withdrawal|3|||
145426390|NCT00680914|524417464|FG000|Overall Study|Lost to Follow-up|4|||
145426391|NCT00680914|524417465|FG001|Overall Study|Lost to Follow-up|0|||
145426392|NCT00680914|524417464|FG000|Overall Study|serious adverse event (SAE)|0|||
145426393|NCT00680914|524417465|FG001|Overall Study|serious adverse event (SAE)|1|||
145426394|NCT01848457|524417466|FG000|Overall Study|Death|1|||
145426395|NCT01848457|524417467|FG001|Overall Study|Death|0|||
145426396|NCT01848457|524417468|FG002|Overall Study|Death|0|||
145426397|NCT01848457|524417469|FG003|Overall Study|Death|0|||
145426398|NCT00421408|524417470|FG000|Overall Study|Lost to Follow-up|30|||
145426399|NCT00421408|524417471|FG001|Overall Study|Lost to Follow-up|20|||
145426400|NCT00421408|524417470|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
145426401|NCT00421408|524417471|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
145426402|NCT00787800|524417475|FG000|Overall Study|Withdrawal by Subject|3|||
145426403|NCT00787800|524417476|FG001|Overall Study|Withdrawal by Subject|5|||
145426404|NCT00787800|524417475|FG000|Overall Study|Death|0|||
145426405|NCT00787800|524417476|FG001|Overall Study|Death|2|||
145426406|NCT04309500|524417479|FG000|Overall Study|Lost to Follow-up|1|||
145426407|NCT04309500|524417480|FG001|Overall Study|Lost to Follow-up|0|||
145426408|NCT04309500|524417481|FG002|Overall Study|Lost to Follow-up|0|||
145426409|NCT04309500|524417482|FG003|Overall Study|Lost to Follow-up|0|||
145426410|NCT00773461|524417484|FG000|Overall Study|Adverse Event|1|||
145426411|NCT00773461|524417485|FG001|Overall Study|Adverse Event|3|||
145426412|NCT00773461|524417484|FG000|Overall Study|Withdrawal by Subject|4|||
145426413|NCT00773461|524417485|FG001|Overall Study|Withdrawal by Subject|1|||
145426414|NCT00913835|524417486|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
145426415|NCT00913835|524417487|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
145426416|NCT00913835|524417486|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
145426417|NCT00913835|524417487|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
145426418|NCT00913835|524417486|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
145426419|NCT00913835|524417487|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
145426420|NCT00913835|524417486|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
145426421|NCT00913835|524417487|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
145426422|NCT00913835|524417486|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
145426423|NCT00913835|524417487|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
145426424|NCT00637156|524417490|FG000|Overall Study|Withdrawal by Subject|0|||
145426425|NCT00637156|524417491|FG001|Overall Study|Withdrawal by Subject|7|||
145426426|NCT00637156|524417490|FG000|Overall Study|Death|0|||
145426427|NCT00637156|524417491|FG001|Overall Study|Death|1|||
145426428|NCT00637156|524417490|FG000|Overall Study|Lost to Follow-up|10|||
145426429|NCT00637156|524417491|FG001|Overall Study|Lost to Follow-up|16|||
145426430|NCT00461812|524417492|FG000|Overall Study|study terminated|10|||
145426431|NCT01308788|524417493|FG000|2-year Treatment|medication change by treating physician|4|||
145426432|NCT01308788|524417494|FG001|2-year Treatment|medication change by treating physician|11|||
145426433|NCT00322218|524417495|FG000|Overall Study|Death|3|||
145426434|NCT00322218|524417496|FG001|Overall Study|Death|6|||
145426435|NCT03193437|524417503|FG000|Overall Study|Adverse Event|4|||
145426436|NCT03193437|524417503|FG000|Overall Study|Withdrawal by Subject|2|||
145426437|NCT03193437|524417503|FG000|Overall Study|Disease Progression|2|||
145426438|NCT02414841|524417506|FG000|Overall Study|Withdrawal by Subject|7|||
145426439|NCT02414841|524417507|FG001|Overall Study|Withdrawal by Subject|5|||
145426440|NCT02414841|524417506|FG000|Overall Study|Lost to Follow-up|13|||
145426441|NCT02414841|524417507|FG001|Overall Study|Lost to Follow-up|6|||
145426442|NCT02414841|524417506|FG000|Overall Study|Death|17|||
145426443|NCT02414841|524417507|FG001|Overall Study|Death|14|||
145426444|NCT02414841|524417506|FG000|Overall Study|Received a Kidney Transplant|13|||
145426445|NCT02414841|524417507|FG001|Overall Study|Received a Kidney Transplant|4|||
145426446|NCT02414841|524417506|FG000|Overall Study|Randomized But Not Treated|6|||
145426447|NCT02414841|524417507|FG001|Overall Study|Randomized But Not Treated|4|||
145426448|NCT03941093|524417517|FG000|Overall Study|Protocol Violation|0|||
145623715|NCT02099539|525134025|FG005|Overall Study|Adverse Event|0|||
145373302|NCT02612610|524217185|FG000|Overall Study|Noncompliance|1|||
145373303|NCT02612610|524217186|FG001|Overall Study|Noncompliance|0|||
145373304|NCT02612610|524217187|FG002|Overall Study|Noncompliance|0|||
145373305|NCT02612610|524217188|FG003|Overall Study|Noncompliance|0|||
145373306|NCT02612610|524217185|FG000|Overall Study|Cough Improvement|0|||
145373307|NCT02612610|524217186|FG001|Overall Study|Cough Improvement|0|||
145373308|NCT02612610|524217187|FG002|Overall Study|Cough Improvement|1|||
145373309|NCT02612610|524217188|FG003|Overall Study|Cough Improvement|0|||
145373310|NCT00176644|524217189|FG000|Overall Study|Withdrawal by Subject|1|||
145373311|NCT01801280|524217190|FG000|Period 1|Withdrawal by Subject|0|||
145373312|NCT01801280|524217191|FG001|Period 1|Withdrawal by Subject|1|||
145373313|NCT01801280|524217192|FG002|Period 1|Withdrawal by Subject|0|||
145373314|NCT01801280|524217193|FG003|Period 1|Withdrawal by Subject|0|||
145373315|NCT01801280|524217190|FG000|Period 2|Withdrawal by Subject|1|||
145373316|NCT01801280|524217191|FG001|Period 2|Withdrawal by Subject|0|||
145373317|NCT01801280|524217192|FG002|Period 2|Withdrawal by Subject|0|||
145373318|NCT01801280|524217193|FG003|Period 2|Withdrawal by Subject|0|||
145373319|NCT01801280|524217190|FG000|Period 4|Protocol Violation|0|||
145373320|NCT01801280|524217191|FG001|Period 4|Protocol Violation|0|||
145373321|NCT01801280|524217192|FG002|Period 4|Protocol Violation|1|||
145373322|NCT01801280|524217193|FG003|Period 4|Protocol Violation|0|||
145373323|NCT01866657|524217199|FG000|Overall Study|Surgery canceled|2|||
145373324|NCT01866657|524217200|FG001|Overall Study|Surgery canceled|0|||
145373325|NCT03973918|524217203|FG000|Overall Study|Adverse Event|0|||
145373326|NCT03973918|524217204|FG001|Overall Study|Adverse Event|0|||
145373327|NCT03973918|524217205|FG002|Overall Study|Adverse Event|0|||
145373328|NCT03973918|524217206|FG003|Overall Study|Adverse Event|1|||
145373329|NCT03973918|524217203|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145373330|NCT03973918|524217204|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
145373331|NCT03973918|524217205|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145373332|NCT03973918|524217206|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
145373333|NCT04351373|524217207|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
145373334|NCT02880865|524217215|FG000|Overall Study|Adverse Event|1|||
145373335|NCT02880865|524217216|FG001|Overall Study|Adverse Event|0|||
145373336|NCT02880865|524217215|FG000|Overall Study|Withdrawal by Subject|0|||
145373337|NCT02880865|524217216|FG001|Overall Study|Withdrawal by Subject|2|||
145373338|NCT02880865|524217215|FG000|Overall Study|Physician Decision|0|||
145373339|NCT02880865|524217216|FG001|Overall Study|Physician Decision|1|||
145373340|NCT03045276|524217217|FG000|Intervention Phase|Withdrawal by Subject|7|||
145373341|NCT03045276|524217218|FG001|Intervention Phase|Withdrawal by Subject|2|||
145373342|NCT03045276|524217219|FG002|Intervention Phase|Withdrawal by Subject|3|||
145373343|NCT03045276|524217220|FG003|Intervention Phase|Withdrawal by Subject|7|||
145373344|NCT03045276|524217217|FG000|Intervention Phase|Developed exclusionary criteria|3|||
145373345|NCT03045276|524217218|FG001|Intervention Phase|Developed exclusionary criteria|3|||
145373346|NCT03045276|524217219|FG002|Intervention Phase|Developed exclusionary criteria|0|||
145373347|NCT03045276|524217220|FG003|Intervention Phase|Developed exclusionary criteria|0|||
145373348|NCT03045276|524217217|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
145373349|NCT03045276|524217218|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
145373350|NCT03045276|524217219|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
145373351|NCT03045276|524217220|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
145373352|NCT03045276|524217217|FG000|Follow-Up Phase|Lost to Follow-up|0|||
145373353|NCT03045276|524217218|FG001|Follow-Up Phase|Lost to Follow-up|1|||
145373354|NCT03045276|524217219|FG002|Follow-Up Phase|Lost to Follow-up|0|||
145373355|NCT03045276|524217220|FG003|Follow-Up Phase|Lost to Follow-up|1|||
145373356|NCT03045276|524217217|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
145373357|NCT03045276|524217218|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
145373358|NCT03045276|524217219|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
145373359|NCT03045276|524217220|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
145373360|NCT01744184|524217224|FG000|Overall Study|Adverse Event|1|||
145373361|NCT01744184|524217225|FG001|Overall Study|Adverse Event|0|||
145373362|NCT01744184|524217224|FG000|Overall Study|Withdrawal by Subject|0|||
145373363|NCT01744184|524217225|FG001|Overall Study|Withdrawal by Subject|1|||
145373364|NCT02091986|524217229|FG000|Overall Study|7 rand in error 1 patient decision|2|||
145373365|NCT02091986|524217230|FG001|Overall Study|7 rand in error 1 patient decision|3|||
145373366|NCT02091986|524217231|FG002|Overall Study|7 rand in error 1 patient decision|3|||
145373367|NCT02091986|524217229|FG000|Overall Study|Lost to Follow-up|1|||
145373368|NCT02091986|524217230|FG001|Overall Study|Lost to Follow-up|0|||
145373369|NCT02091986|524217231|FG002|Overall Study|Lost to Follow-up|0|||
145373370|NCT02091986|524217229|FG000|Overall Study|Withdrawal by Subject|4|||
145373371|NCT02091986|524217230|FG001|Overall Study|Withdrawal by Subject|8|||
145373372|NCT02091986|524217231|FG002|Overall Study|Withdrawal by Subject|3|||
145373373|NCT02091986|524217229|FG000|Overall Study|Adverse Event|0|||
145373374|NCT02091986|524217230|FG001|Overall Study|Adverse Event|0|||
145373375|NCT02091986|524217231|FG002|Overall Study|Adverse Event|2|||
145373376|NCT02537431|524217235|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
145373377|NCT00794040|524217236|FG000|Overall Study|Withdrawal by Subject|3|||
145373378|NCT00794040|524217237|FG001|Overall Study|Withdrawal by Subject|4|||
145373379|NCT00794040|524217236|FG000|Overall Study|Physician Decision|0|||
145373380|NCT00794040|524217237|FG001|Overall Study|Physician Decision|1|||
145373381|NCT02419612|524217238|FG000|Short-term Treatment Period|Adverse Event|1|||
145373382|NCT02419612|524217239|FG001|Short-term Treatment Period|Adverse Event|1|||
145373383|NCT02419612|524217238|FG000|Short-term Treatment Period|Death|0|||
145373384|NCT02419612|524217239|FG001|Short-term Treatment Period|Death|2|||
145373385|NCT02419612|524217238|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
145373386|NCT02419612|524217239|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
145373387|NCT02419612|524217238|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
145373388|NCT02419612|524217239|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
145373389|NCT02419612|524217238|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
145373390|NCT02419612|524217239|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
145373391|NCT02419612|524217238|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
145373392|NCT02419612|524217239|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
145373393|NCT02419612|524217238|FG000|Short-term Treatment Period|Worsening of liver function|0|||
145373394|NCT02419612|524217239|FG001|Short-term Treatment Period|Worsening of liver function|1|||
145373395|NCT02419612|524217238|FG000|Short-term Treatment Period|Subject moved out of state|0|||
145373396|NCT02419612|524217239|FG001|Short-term Treatment Period|Subject moved out of state|1|||
145373397|NCT02419612|524217238|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
145373398|NCT02419612|524217239|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
145373399|NCT02419612|524217238|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
145373400|NCT02419612|524217239|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
145373401|NCT02419612|524217238|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
145373402|NCT02419612|524217239|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
145373403|NCT02419612|524217238|FG000|Long-term Treatment Period|Death|0|||
145373404|NCT02419612|524217239|FG001|Long-term Treatment Period|Death|1|||
145373405|NCT02419612|524217238|FG000|Long-term Treatment Period|Adverse Event|0|||
145373406|NCT02419612|524217239|FG001|Long-term Treatment Period|Adverse Event|5|||
145373407|NCT02419612|524217238|FG000|Long-term Treatment Period|Other|4|||
145373408|NCT02419612|524217239|FG001|Long-term Treatment Period|Other|4|||
145373409|NCT02419612|524217238|FG000|Long-term Treatment Period|Subject Decision|2|||
145373410|NCT02419612|524217239|FG001|Long-term Treatment Period|Subject Decision|4|||
145373411|NCT02419612|524217238|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
145373412|NCT02419612|524217239|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
145373413|NCT01095978|524217240|FG000|Overall Study|Did not take Klacid SR|2|||
145373414|NCT01095978|524217240|FG000|Overall Study|Adverse Event|1|||
145373415|NCT00960986|524217248|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
145373416|NCT00960986|524217249|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
145373417|NCT00960986|524217250|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
145373418|NCT00960986|524217251|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
145373419|NCT00960986|524217248|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
145373420|NCT00960986|524217249|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
145373421|NCT00960986|524217250|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
145373422|NCT00960986|524217251|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
145373423|NCT00960986|524217248|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
145373424|NCT00960986|524217249|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
145373425|NCT00960986|524217250|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
145373426|NCT00960986|524217251|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
145373427|NCT00960986|524217248|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145373428|NCT00960986|524217249|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
145373429|NCT00960986|524217250|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145373430|NCT00960986|524217251|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
145373431|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
145373432|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
145373433|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
145373434|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
145373435|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Death|0|||
145373436|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Death|0|||
145373437|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Death|1|||
145373438|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Death|0|||
145373439|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145373440|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145373441|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
145373442|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
145373443|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
145373444|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
145426449|NCT03941093|524417518|FG001|Overall Study|Protocol Violation|1|||
145426450|NCT03941093|524417517|FG000|Overall Study|Withdrawal by Subject|9|||
145426451|NCT03941093|524417518|FG001|Overall Study|Withdrawal by Subject|6|||
145426452|NCT03768336|524419388|FG000|Overall Study|Lost to Follow-up|3|||
145426453|NCT03768336|524419389|FG001|Overall Study|Lost to Follow-up|2|||
145426454|NCT03768336|524419388|FG000|Overall Study|Became Ineligible|2|||
145426455|NCT03768336|524419389|FG001|Overall Study|Became Ineligible|0|||
145426456|NCT03768336|524419388|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
145426457|NCT03768336|524419389|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
145426458|NCT03768336|524419388|FG000|Overall Study|Missed final survey (post-treatment|0|||
145426459|NCT03768336|524419389|FG001|Overall Study|Missed final survey (post-treatment|1|||
145426460|NCT06790303|524419390|FG000|Overall Study|Study Terminated by sponsor|4|||
145426461|NCT06790303|524419390|FG000|Overall Study|Death|4|||
145426462|NCT00500331|524419393|FG000|Overall Study|Adverse Event|0|||
145426463|NCT00500331|524419394|FG001|Overall Study|Adverse Event|2|||
145426464|NCT00500331|524419395|FG002|Overall Study|Adverse Event|0|||
145426465|NCT00500331|524419396|FG003|Overall Study|Adverse Event|1|||
145426466|NCT00500331|524419397|FG004|Overall Study|Adverse Event|2|||
145426467|NCT00500331|524419398|FG005|Overall Study|Adverse Event|2|||
145426468|NCT00500331|524419399|FG006|Overall Study|Adverse Event|0|||
145426469|NCT00500331|524419393|FG000|Overall Study|Lost to Follow-up|1|||
145426470|NCT00500331|524419394|FG001|Overall Study|Lost to Follow-up|1|||
145426471|NCT00500331|524419395|FG002|Overall Study|Lost to Follow-up|1|||
145426472|NCT00500331|524419396|FG003|Overall Study|Lost to Follow-up|2|||
145426473|NCT00500331|524419397|FG004|Overall Study|Lost to Follow-up|1|||
145426474|NCT00500331|524419398|FG005|Overall Study|Lost to Follow-up|0|||
145426475|NCT00500331|524419399|FG006|Overall Study|Lost to Follow-up|0|||
145426476|NCT00500331|524419393|FG000|Overall Study|Protocol Violation|3|||
145426477|NCT00500331|524419394|FG001|Overall Study|Protocol Violation|1|||
145426478|NCT00500331|524419395|FG002|Overall Study|Protocol Violation|1|||
145426479|NCT00500331|524419396|FG003|Overall Study|Protocol Violation|0|||
145426480|NCT00500331|524419397|FG004|Overall Study|Protocol Violation|1|||
145426481|NCT00500331|524419398|FG005|Overall Study|Protocol Violation|1|||
145426482|NCT00500331|524419399|FG006|Overall Study|Protocol Violation|1|||
145426483|NCT00500331|524419393|FG000|Overall Study|Withdrawal by Subject|4|||
145426484|NCT00500331|524419394|FG001|Overall Study|Withdrawal by Subject|0|||
145426485|NCT00500331|524419395|FG002|Overall Study|Withdrawal by Subject|1|||
145426486|NCT00500331|524419396|FG003|Overall Study|Withdrawal by Subject|5|||
145426487|NCT00500331|524419397|FG004|Overall Study|Withdrawal by Subject|0|||
145426488|NCT00500331|524419398|FG005|Overall Study|Withdrawal by Subject|1|||
145426489|NCT00500331|524419399|FG006|Overall Study|Withdrawal by Subject|1|||
145426490|NCT00500331|524419393|FG000|Overall Study|Lack of Efficacy|3|||
145426491|NCT00500331|524419394|FG001|Overall Study|Lack of Efficacy|1|||
145426492|NCT00500331|524419395|FG002|Overall Study|Lack of Efficacy|0|||
145426493|NCT00500331|524419396|FG003|Overall Study|Lack of Efficacy|0|||
145426494|NCT00500331|524419397|FG004|Overall Study|Lack of Efficacy|0|||
145426495|NCT00500331|524419398|FG005|Overall Study|Lack of Efficacy|0|||
145426496|NCT00500331|524419399|FG006|Overall Study|Lack of Efficacy|0|||
145426497|NCT00500331|524419393|FG000|Overall Study|Liver function test abnormality|0|||
145426498|NCT00500331|524419394|FG001|Overall Study|Liver function test abnormality|0|||
145426499|NCT00500331|524419395|FG002|Overall Study|Liver function test abnormality|1|||
145426500|NCT00500331|524419396|FG003|Overall Study|Liver function test abnormality|0|||
145426501|NCT00500331|524419397|FG004|Overall Study|Liver function test abnormality|0|||
145426502|NCT00500331|524419398|FG005|Overall Study|Liver function test abnormality|0|||
145426503|NCT00500331|524419399|FG006|Overall Study|Liver function test abnormality|0|||
145426504|NCT00500331|524419393|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
145426505|NCT00500331|524419394|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
145426506|NCT00500331|524419395|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
145426507|NCT00500331|524419396|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
145580861|NCT01208233|524979277|FG000|Overall Study|Other|2|||
145580862|NCT01208233|524979278|FG001|Overall Study|Other|1|||
145580863|NCT01208233|524979279|FG002|Overall Study|Other|0|||
145580864|NCT01208233|524979280|FG003|Overall Study|Other|0|||
145580865|NCT01208233|524979281|FG004|Overall Study|Other|0|||
145580866|NCT01208233|524979282|FG005|Overall Study|Other|1|||
145580867|NCT01208233|524979277|FG000|Overall Study|Withdrawal by Subject|1|||
145580868|NCT01208233|524979278|FG001|Overall Study|Withdrawal by Subject|0|||
145426508|NCT00500331|524419397|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
145580869|NCT01208233|524979279|FG002|Overall Study|Withdrawal by Subject|1|||
145426509|NCT00500331|524419398|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
145426510|NCT00500331|524419399|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
145426511|NCT00500331|524419393|FG000|Overall Study|Didn't return for continuation of study|1|||
145426512|NCT00500331|524419394|FG001|Overall Study|Didn't return for continuation of study|0|||
145426513|NCT00500331|524419395|FG002|Overall Study|Didn't return for continuation of study|0|||
145426514|NCT00500331|524419396|FG003|Overall Study|Didn't return for continuation of study|0|||
145580870|NCT01208233|524979280|FG003|Overall Study|Withdrawal by Subject|1|||
145580871|NCT01208233|524979281|FG004|Overall Study|Withdrawal by Subject|4|||
145426515|NCT00500331|524419397|FG004|Overall Study|Didn't return for continuation of study|0|||
145426516|NCT00500331|524419398|FG005|Overall Study|Didn't return for continuation of study|0|||
145426517|NCT00500331|524419399|FG006|Overall Study|Didn't return for continuation of study|0|||
145426518|NCT00500331|524419393|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
145426519|NCT00500331|524419394|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426520|NCT00500331|524419395|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426521|NCT00500331|524419396|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426522|NCT00500331|524419397|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426523|NCT00500331|524419398|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426524|NCT00500331|524419399|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
145426525|NCT00500331|524419393|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
145426526|NCT00500331|524419394|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
145426527|NCT00500331|524419395|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
145426528|NCT00500331|524419396|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
145426529|NCT00500331|524419397|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
145426530|NCT00500331|524419398|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
145426531|NCT00500331|524419399|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
145426532|NCT00500331|524419393|FG000|Overall Study|Participant was randomized by mistake|1|||
145426533|NCT00500331|524419394|FG001|Overall Study|Participant was randomized by mistake|0|||
145426534|NCT00500331|524419395|FG002|Overall Study|Participant was randomized by mistake|0|||
145426535|NCT00500331|524419396|FG003|Overall Study|Participant was randomized by mistake|0|||
145426536|NCT00500331|524419397|FG004|Overall Study|Participant was randomized by mistake|0|||
145426537|NCT00500331|524419398|FG005|Overall Study|Participant was randomized by mistake|0|||
145426538|NCT00500331|524419399|FG006|Overall Study|Participant was randomized by mistake|0|||
145426539|NCT00500331|524419393|FG000|Overall Study|Diabetologist nurse in the study|0|||
145426540|NCT00500331|524419394|FG001|Overall Study|Diabetologist nurse in the study|0|||
145426541|NCT00500331|524419395|FG002|Overall Study|Diabetologist nurse in the study|1|||
145426542|NCT00500331|524419396|FG003|Overall Study|Diabetologist nurse in the study|0|||
145426543|NCT00500331|524419397|FG004|Overall Study|Diabetologist nurse in the study|0|||
145426544|NCT00500331|524419398|FG005|Overall Study|Diabetologist nurse in the study|0|||
145426545|NCT00500331|524419399|FG006|Overall Study|Diabetologist nurse in the study|0|||
145580872|NCT01208233|524979282|FG005|Overall Study|Withdrawal by Subject|2|||
145580873|NCT01181895|524979283|FG000|Overall Study|Adverse Event|3|||
145426546|NCT00500331|524419393|FG000|Overall Study|State ban of biological samples export|0|||
145426547|NCT00500331|524419394|FG001|Overall Study|State ban of biological samples export|0|||
145426548|NCT00500331|524419395|FG002|Overall Study|State ban of biological samples export|0|||
145426549|NCT00500331|524419396|FG003|Overall Study|State ban of biological samples export|1|||
145426550|NCT00500331|524419397|FG004|Overall Study|State ban of biological samples export|0|||
145426551|NCT00500331|524419398|FG005|Overall Study|State ban of biological samples export|0|||
145426552|NCT00500331|524419399|FG006|Overall Study|State ban of biological samples export|0|||
145426553|NCT00500331|524419393|FG000|Overall Study|Protocol violated|0|||
145426554|NCT00500331|524419394|FG001|Overall Study|Protocol violated|0|||
145426555|NCT00500331|524419395|FG002|Overall Study|Protocol violated|0|||
145426556|NCT00500331|524419396|FG003|Overall Study|Protocol violated|1|||
145426557|NCT00500331|524419397|FG004|Overall Study|Protocol violated|0|||
145426558|NCT00500331|524419398|FG005|Overall Study|Protocol violated|0|||
145426559|NCT00500331|524419399|FG006|Overall Study|Protocol violated|0|||
145426560|NCT03345550|524419400|FG000|Overall Study|Withdrawal by Subject|1|||
145426561|NCT03345550|524419401|FG001|Overall Study|Withdrawal by Subject|0|||
145426562|NCT03345550|524419400|FG000|Overall Study|Lost to Follow-up|4|||
145426563|NCT03345550|524419401|FG001|Overall Study|Lost to Follow-up|5|||
145426564|NCT03033784|524419405|FG000|Overall Study|Anxiety related to MRI scanner|0|||
145426565|NCT03033784|524419406|FG001|Overall Study|Anxiety related to MRI scanner|1|||
145426566|NCT03033784|524419407|FG002|Overall Study|Anxiety related to MRI scanner|0|||
145426567|NCT03033784|524419408|FG003|Overall Study|Anxiety related to MRI scanner|0|||
145426568|NCT03033784|524419409|FG004|Overall Study|Anxiety related to MRI scanner|0|||
145426569|NCT03033784|524419410|FG005|Overall Study|Anxiety related to MRI scanner|0|||
145426570|NCT03033784|524419411|FG006|Overall Study|Anxiety related to MRI scanner|0|||
145426571|NCT03033784|524419412|FG007|Overall Study|Anxiety related to MRI scanner|0|||
145426572|NCT03033784|524419413|FG008|Overall Study|Anxiety related to MRI scanner|0|||
145426573|NCT03033784|524419414|FG009|Overall Study|Anxiety related to MRI scanner|0|||
145426574|NCT03033784|524419415|FG010|Overall Study|Anxiety related to MRI scanner|0|||
145426575|NCT03033784|524419416|FG011|Overall Study|Anxiety related to MRI scanner|0|||
145426576|NCT03033784|524419417|FG012|Overall Study|Anxiety related to MRI scanner|0|||
145580874|NCT01181895|524979284|FG001|Overall Study|Adverse Event|1|||
145426577|NCT03033784|524419405|FG000|Overall Study|Withdrawal by Subject|0|||
145426578|NCT03033784|524419406|FG001|Overall Study|Withdrawal by Subject|0|||
145426579|NCT03033784|524419407|FG002|Overall Study|Withdrawal by Subject|0|||
145426580|NCT03033784|524419408|FG003|Overall Study|Withdrawal by Subject|0|||
145426581|NCT03033784|524419409|FG004|Overall Study|Withdrawal by Subject|0|||
145373445|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
145373446|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
145373447|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145373448|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145373449|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
145373450|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
145373451|NCT00960986|524217248|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
145373452|NCT00960986|524217249|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
145373453|NCT00960986|524217250|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
145373454|NCT00960986|524217251|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
145373455|NCT04413552|524217252|FG000|Overall Study|Adverse Event|0|||
145373456|NCT04413552|524217253|FG001|Overall Study|Adverse Event|0|||
145373457|NCT04413552|524217254|FG002|Overall Study|Adverse Event|0|||
145373458|NCT04413552|524217255|FG003|Overall Study|Adverse Event|0|||
145373459|NCT04413552|524217256|FG004|Overall Study|Adverse Event|0|||
145373460|NCT04413552|524217257|FG005|Overall Study|Adverse Event|0|||
145373461|NCT04413552|524217258|FG006|Overall Study|Adverse Event|1|||
145373462|NCT04413552|524217259|FG007|Overall Study|Adverse Event|0|||
145373463|NCT04413552|524217260|FG008|Overall Study|Adverse Event|0|||
145373464|NCT04413552|524217261|FG009|Overall Study|Adverse Event|0|||
145373465|NCT01794793|524217263|FG000|Treatment Period|Withdrawal by Subject|24|||
145373466|NCT01794793|524217263|FG000|Treatment Period|Lack of Efficacy|22|||
145373467|NCT01794793|524217263|FG000|Treatment Period|Adverse Event|17|||
145373468|NCT01794793|524217263|FG000|Treatment Period|Physician Decision|14|||
145373469|NCT01794793|524217263|FG000|Treatment Period|Lost to Follow-up|7|||
145373470|NCT01794793|524217263|FG000|Treatment Period|Death|6|||
145373471|NCT01794793|524217263|FG000|Treatment Period|Protocol Violation|5|||
145373472|NCT01794793|524217263|FG000|Treatment Period|administrative problem|3|||
145373473|NCT01794793|524217263|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
145373474|NCT01794793|524217263|FG000|Post-treatment Follow-up|Adverse Event|8|||
145373475|NCT01794793|524217263|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
145373476|NCT01794793|524217263|FG000|Post-treatment Follow-up|administrative problem|5|||
145373477|NCT01794793|524217263|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
145373478|NCT01794793|524217263|FG000|Post-treatment Follow-up|Protocol Violation|3|||
145373479|NCT02234596|524217264|FG000|Overall Study|Participant not treated|2|||
145373480|NCT04852679|524217265|FG000|Main Intervention Period|Withdrawal by Subject|3|||
145373481|NCT04852679|524217265|FG000|Main Intervention Period|Adverse Event|1|||
145373482|NCT04852679|524217265|FG000|Main Intervention Period|Progressive Disease|16|||
145373483|NCT04852679|524217265|FG000|Main Intervention Period|Refused study visit|1|||
145373484|NCT04852679|524217265|FG000|Independent Injection Period|Missed study visit|1|||
145373485|NCT01944670|524219059|FG000|Overall Study|Lost to Follow-up|2|||
145373486|NCT03408444|524219060|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
145373487|NCT03408444|524219061|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145373488|NCT03408444|524219062|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145373489|NCT03408444|524219063|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
145373490|NCT03408444|524219060|FG000|Overall Study|Lens Discomfort|0|||
145373491|NCT03408444|524219061|FG001|Overall Study|Lens Discomfort|1|||
145373492|NCT03408444|524219062|FG002|Overall Study|Lens Discomfort|0|||
145373493|NCT03408444|524219063|FG003|Overall Study|Lens Discomfort|0|||
145373494|NCT03408444|524219060|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
145373495|NCT03408444|524219061|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
145373496|NCT03408444|524219062|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
145373497|NCT03408444|524219063|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
145373498|NCT03408444|524219060|FG000|Overall Study|Withdrawal by Subject|0|||
145373499|NCT03408444|524219061|FG001|Overall Study|Withdrawal by Subject|2|||
145373500|NCT03408444|524219062|FG002|Overall Study|Withdrawal by Subject|3|||
145373501|NCT03408444|524219063|FG003|Overall Study|Withdrawal by Subject|0|||
145373502|NCT03408444|524219060|FG000|Overall Study|Lost to Follow-up|0|||
145373503|NCT03408444|524219061|FG001|Overall Study|Lost to Follow-up|0|||
145373504|NCT03408444|524219062|FG002|Overall Study|Lost to Follow-up|1|||
145373505|NCT03408444|524219063|FG003|Overall Study|Lost to Follow-up|0|||
145373506|NCT03408444|524219060|FG000|Overall Study|Adverse Event|0|||
145373507|NCT03408444|524219061|FG001|Overall Study|Adverse Event|0|||
145373508|NCT03408444|524219062|FG002|Overall Study|Adverse Event|0|||
145373509|NCT03408444|524219063|FG003|Overall Study|Adverse Event|1|||
145373510|NCT03408444|524219060|FG000|Overall Study|Lens Handling Difficulties|0|||
145373511|NCT03408444|524219061|FG001|Overall Study|Lens Handling Difficulties|0|||
145373512|NCT03408444|524219062|FG002|Overall Study|Lens Handling Difficulties|1|||
145426582|NCT03033784|524419410|FG005|Overall Study|Withdrawal by Subject|0|||
145373513|NCT03408444|524219063|FG003|Overall Study|Lens Handling Difficulties|0|||
145373514|NCT03408444|524219060|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145373515|NCT03408444|524219061|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145373516|NCT03408444|524219062|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
145426583|NCT03033784|524419411|FG006|Overall Study|Withdrawal by Subject|0|||
145426584|NCT03033784|524419412|FG007|Overall Study|Withdrawal by Subject|0|||
145426585|NCT03033784|524419413|FG008|Overall Study|Withdrawal by Subject|0|||
145426586|NCT03033784|524419414|FG009|Overall Study|Withdrawal by Subject|0|||
145426587|NCT03033784|524419415|FG010|Overall Study|Withdrawal by Subject|0|||
145426588|NCT03033784|524419416|FG011|Overall Study|Withdrawal by Subject|0|||
145426589|NCT03033784|524419417|FG012|Overall Study|Withdrawal by Subject|2|||
145426590|NCT03332056|524419418|FG000|Overall Study|Incomplete questionnaires|8|||
145426591|NCT03332056|524419419|FG001|Overall Study|Incomplete questionnaires|9|||
145426592|NCT03332056|524419418|FG000|Overall Study|Passed stone prior to surgery date|1|||
145426593|NCT03332056|524419419|FG001|Overall Study|Passed stone prior to surgery date|0|||
145426594|NCT03332056|524419418|FG000|Overall Study|Did not require a ureteral stent|0|||
145426595|NCT03332056|524419419|FG001|Overall Study|Did not require a ureteral stent|1|||
145426596|NCT02374255|524419420|FG000|Overall Study|Withdrawal by Subject|2|||
145426597|NCT02374255|524419421|FG001|Overall Study|Withdrawal by Subject|0|||
145426598|NCT02374255|524419422|FG002|Overall Study|Withdrawal by Subject|0|||
145426599|NCT02374255|524419423|FG003|Overall Study|Withdrawal by Subject|0|||
145426600|NCT02093520|524419424|FG000|Overall Study|Not treated|6|||
145426601|NCT02093520|524419425|FG001|Overall Study|Not treated|22|||
145426602|NCT03014089|524419426|FG000|Overall Study|Withdrawal by Subject|0|||
145426603|NCT03014089|524419427|FG001|Overall Study|Withdrawal by Subject|1|||
145426604|NCT03014089|524419428|FG002|Overall Study|Withdrawal by Subject|1|||
145426605|NCT03014089|524419429|FG003|Overall Study|Withdrawal by Subject|1|||
145426606|NCT03014089|524419426|FG000|Overall Study|Lost to Follow-up|1|||
145426607|NCT03014089|524419427|FG001|Overall Study|Lost to Follow-up|0|||
145426608|NCT03014089|524419428|FG002|Overall Study|Lost to Follow-up|0|||
145426609|NCT03014089|524419429|FG003|Overall Study|Lost to Follow-up|0|||
145426610|NCT03014089|524419426|FG000|Overall Study|Adverse Event|1|||
145426611|NCT03014089|524419427|FG001|Overall Study|Adverse Event|0|||
145426612|NCT03014089|524419428|FG002|Overall Study|Adverse Event|1|||
145426613|NCT03014089|524419429|FG003|Overall Study|Adverse Event|0|||
145426614|NCT00851084|524419430|FG000|Overall Study|Randomized but not treated|1|||
145426615|NCT00851084|524419431|FG001|Overall Study|Randomized but not treated|0|||
145426616|NCT00851084|524419430|FG000|Overall Study|Adverse Event|26|||
145426617|NCT00851084|524419431|FG001|Overall Study|Adverse Event|36|||
145426618|NCT00851084|524419430|FG000|Overall Study|Disease progression|52|||
145426619|NCT00851084|524419431|FG001|Overall Study|Disease progression|47|||
145426620|NCT00851084|524419430|FG000|Overall Study|Poor compliance to protocol|1|||
145426621|NCT00851084|524419431|FG001|Overall Study|Poor compliance to protocol|1|||
145426622|NCT00851084|524419430|FG000|Overall Study|Physician Decision|13|||
145426623|NCT00851084|524419431|FG001|Overall Study|Physician Decision|14|||
145426624|NCT00851084|524419430|FG000|Overall Study|Consent withdrawn|0|||
145426625|NCT00851084|524419431|FG001|Overall Study|Consent withdrawn|2|||
145426626|NCT00851084|524419430|FG000|Overall Study|Withdrawal by Subject|11|||
145426627|NCT00851084|524419431|FG001|Overall Study|Withdrawal by Subject|12|||
145426628|NCT00851084|524419430|FG000|Overall Study|Metastatic surgery|6|||
145426629|NCT00851084|524419431|FG001|Overall Study|Metastatic surgery|6|||
145426630|NCT00851084|524419430|FG000|Overall Study|Other|7|||
145426631|NCT00851084|524419431|FG001|Overall Study|Other|1|||
145426632|NCT00321932|524419432|FG000|Overall Study|Death|3|||
145426633|NCT00321932|524419433|FG001|Overall Study|Death|6|||
145426634|NCT00321932|524419432|FG000|Overall Study|Withdrawal by Subject|3|||
145426635|NCT00321932|524419433|FG001|Overall Study|Withdrawal by Subject|6|||
145426636|NCT00321932|524419432|FG000|Overall Study|Early relapse|2|||
145426637|NCT00321932|524419433|FG001|Overall Study|Early relapse|8|||
145426638|NCT00321932|524419432|FG000|Overall Study|Missing data|2|||
145426639|NCT00321932|524419433|FG001|Overall Study|Missing data|1|||
145426640|NCT00734032|524419434|FG000|Overall Study|Adverse Event|0|||
145426641|NCT00734032|524419435|FG001|Overall Study|Adverse Event|1|||
145426642|NCT00734032|524419436|FG002|Overall Study|Adverse Event|0|||
145426643|NCT00734032|524419437|FG003|Overall Study|Adverse Event|0|||
145426644|NCT02301897|524419442|FG000|Treatment Course 1|Non-Compliance|0|||
145426645|NCT02301897|524419443|FG001|Treatment Course 1|Non-Compliance|0|||
145426646|NCT02301897|524419444|FG002|Treatment Course 1|Non-Compliance|1|||
145426647|NCT02301897|524419442|FG000|Treatment Course 1|Adverse Event|1|||
145426648|NCT02301897|524419443|FG001|Treatment Course 1|Adverse Event|1|||
145426649|NCT02301897|524419444|FG002|Treatment Course 1|Adverse Event|0|||
145426650|NCT02301897|524419442|FG000|Treatment Course 1|Lost to Follow-up|1|||
145426651|NCT02301897|524419443|FG001|Treatment Course 1|Lost to Follow-up|2|||
145426652|NCT02301897|524419444|FG002|Treatment Course 1|Lost to Follow-up|1|||
145426653|NCT02301897|524419442|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
145426654|NCT02301897|524419443|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
145426655|NCT02301897|524419444|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
145426656|NCT02301897|524419442|FG000|Treatment Course 1|Withdrawal by Subject|0|||
145426657|NCT02301897|524419443|FG001|Treatment Course 1|Withdrawal by Subject|0|||
145426658|NCT02301897|524419444|FG002|Treatment Course 1|Withdrawal by Subject|2|||
145426659|NCT02301897|524419442|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
145426660|NCT02301897|524419443|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
145373517|NCT03408444|524219063|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
145373518|NCT04984681|524219064|FG000|Overall Study|Lost to Follow-up|3|||
145373519|NCT04984681|524219065|FG001|Overall Study|Lost to Follow-up|1|||
145373520|NCT01214252|524219066|FG000|Overall Study|Not eligible per protocol|82|||
145373521|NCT04777201|524219070|FG000|Main Study|Withdrawal by Subject|19|||
145373522|NCT04777201|524219071|FG001|Main Study|Withdrawal by Subject|27|||
145373523|NCT04777201|524219072|FG002|Main Study|Withdrawal by Subject|0|||
145373524|NCT04777201|524219070|FG000|Main Study|Death|13|||
145373525|NCT04777201|524219071|FG001|Main Study|Death|27|||
145373526|NCT04777201|524219072|FG002|Main Study|Death|0|||
145373527|NCT04777201|524219070|FG000|Main Study|Subject missed the safety follow-up visit|9|||
145373528|NCT04777201|524219071|FG001|Main Study|Subject missed the safety follow-up visit|10|||
145373529|NCT04777201|524219072|FG002|Main Study|Subject missed the safety follow-up visit|0|||
145373530|NCT04777201|524219070|FG000|Main Study|Physician Decision|8|||
145373531|NCT04777201|524219071|FG001|Main Study|Physician Decision|10|||
145373532|NCT04777201|524219072|FG002|Main Study|Physician Decision|0|||
145373533|NCT04777201|524219070|FG000|Main Study|Adverse Event|8|||
145373534|NCT04777201|524219071|FG001|Main Study|Adverse Event|8|||
145373535|NCT04777201|524219072|FG002|Main Study|Adverse Event|0|||
145373536|NCT04777201|524219070|FG000|Main Study|Lost to Follow-up|9|||
145373537|NCT04777201|524219071|FG001|Main Study|Lost to Follow-up|4|||
145373538|NCT04777201|524219072|FG002|Main Study|Lost to Follow-up|0|||
145373539|NCT04777201|524219070|FG000|Main Study|Reason not specified|3|||
145373540|NCT04777201|524219071|FG001|Main Study|Reason not specified|3|||
145373541|NCT04777201|524219072|FG002|Main Study|Reason not specified|0|||
145373542|NCT04777201|524219070|FG000|Main Study|Lack of Efficacy|1|||
145373543|NCT04777201|524219071|FG001|Main Study|Lack of Efficacy|1|||
145373544|NCT04777201|524219072|FG002|Main Study|Lack of Efficacy|0|||
145373545|NCT04777201|524219070|FG000|Main Study|Protocol Violation|1|||
145373546|NCT04777201|524219071|FG001|Main Study|Protocol Violation|0|||
145373547|NCT04777201|524219072|FG002|Main Study|Protocol Violation|0|||
145373548|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
145373549|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
145373550|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
145373551|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
145373552|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
145373553|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
145373554|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
145373555|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
145373556|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
145373557|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
145373558|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
145373559|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
145373560|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
145373561|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
145373562|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
145373563|NCT04777201|524219070|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
145373564|NCT04777201|524219071|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
145373565|NCT04777201|524219072|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
145373566|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Adverse Event|6|||
145373567|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Adverse Event|14|||
145373568|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Death|3|||
145373569|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Death|1|||
145373570|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
145373571|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
145373572|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
145373573|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
145373574|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
145373575|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
145373576|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
145373577|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
145373578|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
145373579|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
145373580|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Physician Decision|2|||
145373581|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Physician Decision|4|||
145373582|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Pregnancy|2|||
145373583|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Pregnancy|1|||
145373584|NCT02275780|524219073|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
145373585|NCT02275780|524219074|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
145373586|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
145373587|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
145373588|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
145373589|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
145580875|NCT01181895|524979285|FG002|Overall Study|Adverse Event|1|||
145580876|NCT01181895|524979283|FG000|Overall Study|Lack of Efficacy|8|||
145580877|NCT01181895|524979284|FG001|Overall Study|Lack of Efficacy|9|||
145580878|NCT01181895|524979285|FG002|Overall Study|Lack of Efficacy|9|||
145580879|NCT01181895|524979283|FG000|Overall Study|Protocol Violation|2|||
145580880|NCT01181895|524979284|FG001|Overall Study|Protocol Violation|1|||
145580881|NCT01181895|524979285|FG002|Overall Study|Protocol Violation|0|||
145580882|NCT01181895|524979283|FG000|Overall Study|Lost to Follow-up|0|||
145373590|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
145373591|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
145373592|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
145373593|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
145373594|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
145373595|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
145373596|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
145373597|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
145373598|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
145373599|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
145373600|NCT02275780|524219073|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
145373601|NCT02275780|524219074|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
145373602|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
145373603|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
145373604|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
145373605|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
145373606|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
145373607|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
145373608|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
145373609|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
145373610|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
145373611|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
145373612|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
145373613|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
145373614|NCT02275780|524219073|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
145373615|NCT02275780|524219074|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
145373616|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
145373617|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
145373618|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
145373619|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
145373620|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
145373621|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
145373622|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
145373623|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
145373624|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
145373625|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
145373626|NCT02275780|524219073|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
145373627|NCT02275780|524219074|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
145373628|NCT01054300|524219077|FG000|Period 1|Adverse Event|1|||
145373629|NCT01054300|524219078|FG001|Period 1|Adverse Event|0|||
145373630|NCT01054300|524219079|FG002|Period 1|Adverse Event|0|||
145373631|NCT01054300|524219080|FG003|Period 1|Adverse Event|0|||
145373632|NCT01054300|524219077|FG000|Period 2|Withdrawal by Subject|0|||
145373633|NCT01054300|524219078|FG001|Period 2|Withdrawal by Subject|0|||
145373634|NCT01054300|524219079|FG002|Period 2|Withdrawal by Subject|1|||
145373635|NCT01054300|524219080|FG003|Period 2|Withdrawal by Subject|0|||
145373636|NCT00738881|524219084|FG000|Overall Study|Withdrawal by Subject|0|||
145373637|NCT00738881|524219085|FG001|Overall Study|Withdrawal by Subject|2|||
145373638|NCT00348790|524219086|FG000|Completed Treatment|Withdrawal by Subject|4|||
145373639|NCT00348790|524219086|FG000|Completed Treatment|Disease progression|14|||
145373640|NCT00348790|524219086|FG000|Completed Treatment|Adverse Event|4|||
145373641|NCT00348790|524219086|FG000|Completed Treatment|Required surgery|2|||
145373642|NCT00348790|524219086|FG000|Completed Treatment|Unable to travel to study site|1|||
145373643|NCT04186806|524219087|FG000|Period 1: 7 Days|Adverse Event|1|||
145373644|NCT04186806|524219088|FG001|Period 1: 7 Days|Adverse Event|0|||
145373645|NCT03409107|524219089|FG000|Overall Study|Withdrawal by Subject|4|||
145580883|NCT01181895|524979284|FG001|Overall Study|Lost to Follow-up|1|||
145580884|NCT01181895|524979285|FG002|Overall Study|Lost to Follow-up|2|||
145580885|NCT01181895|524979283|FG000|Overall Study|Investigator Discretion|1|||
145623716|NCT02099539|525134026|FG006|Overall Study|Adverse Event|0|||
145373646|NCT03409107|524219090|FG001|Overall Study|Withdrawal by Subject|2|||
145580886|NCT01181895|524979284|FG001|Overall Study|Investigator Discretion|2|||
145580887|NCT01181895|524979285|FG002|Overall Study|Investigator Discretion|1|||
145580888|NCT01181895|524979283|FG000|Overall Study|Withdrawal by Subject|3|||
145580889|NCT01181895|524979284|FG001|Overall Study|Withdrawal by Subject|0|||
145580890|NCT01181895|524979285|FG002|Overall Study|Withdrawal by Subject|5|||
145580891|NCT00555438|524979288|FG000|10 Days Post-operative|Death|4|||
145580892|NCT00555438|524979288|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
145580893|NCT05789875|524979291|FG000|Overall Study|Lost to Follow-up|6|||
145580894|NCT02447991|524979292|FG000|Overall Study|Withdrawn by subject - no data|0|||
145580895|NCT02447991|524979293|FG001|Overall Study|Withdrawn by subject - no data|2|||
145580896|NCT02447991|524979292|FG000|Overall Study|Withdrawn by Subject - with data|4|||
145580897|NCT02447991|524979293|FG001|Overall Study|Withdrawn by Subject - with data|4|||
145580898|NCT02447991|524979292|FG000|Overall Study|Lost to Follow-up - no data|3|||
145580899|NCT02447991|524979293|FG001|Overall Study|Lost to Follow-up - no data|6|||
145580900|NCT02447991|524979292|FG000|Overall Study|Lost to follow-up - with data|0|||
145580901|NCT02447991|524979293|FG001|Overall Study|Lost to follow-up - with data|3|||
145580902|NCT02447991|524979292|FG000|Overall Study|End of study - no treatment results|3|||
145580903|NCT02447991|524979293|FG001|Overall Study|End of study - no treatment results|6|||
145580904|NCT02447991|524979292|FG000|Overall Study|End of study - partial treatment results|0|||
145580905|NCT02447991|524979293|FG001|Overall Study|End of study - partial treatment results|9|||
145580906|NCT02770391|524979296|FG000|Overall Study|Lost to Follow-up|2|||
145580907|NCT02770391|524979296|FG000|Overall Study|Withdrawal by Subject|1|||
145580908|NCT02770391|524979296|FG000|Overall Study|Surgery delayed unevaluable|2|||
145580909|NCT02770391|524979296|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
145580910|NCT03333486|524979299|FG000|Overall Study|Withdrawal by Subject|1|||
145580911|NCT03333486|524979299|FG000|Overall Study|Lost to Follow-up|1|||
145580912|NCT03246529|524979308|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
145580913|NCT03246529|524979309|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
145580914|NCT03246529|524979310|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
145580915|NCT03246529|524979308|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
145580916|NCT03246529|524979309|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
145580917|NCT03246529|524979310|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
145580918|NCT03246529|524979308|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
145580919|NCT03246529|524979309|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
145580920|NCT03246529|524979310|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
145580921|NCT03246529|524979308|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
145580922|NCT03246529|524979309|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
145580923|NCT03246529|524979310|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
145580924|NCT03246529|524979308|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
145580925|NCT03246529|524979309|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
145580926|NCT03246529|524979310|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
145580927|NCT03246529|524979308|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
145580928|NCT03246529|524979309|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
145580929|NCT03246529|524979310|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
145580930|NCT03246529|524979308|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
145580931|NCT03246529|524979309|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
145580932|NCT03246529|524979310|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
145580933|NCT03246529|524979308|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
145580934|NCT03246529|524979309|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
145580935|NCT03246529|524979310|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
145580936|NCT03246529|524979308|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
145580937|NCT03246529|524979309|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
145580938|NCT03246529|524979310|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
145580939|NCT06748040|524979317|FG000|Overall Study|Death|3|||
145580940|NCT06748040|524979318|FG001|Overall Study|Death|4|||
145580941|NCT06748040|524979317|FG000|Overall Study|Lost to Follow-up|134|||
145580942|NCT06748040|524979318|FG001|Overall Study|Lost to Follow-up|132|||
145580943|NCT06748040|524979317|FG000|Overall Study|Withdrawal by Subject|3|||
145580944|NCT06748040|524979318|FG001|Overall Study|Withdrawal by Subject|5|||
145580945|NCT04419493|524980775|FG000|Wash-out After Period 1|Adverse Event|1|||
145580946|NCT04419493|524980776|FG001|Wash-out After Period 1|Adverse Event|2|||
145580947|NCT04419493|524980777|FG002|Wash-out After Period 1|Adverse Event|1|||
145580948|NCT04419493|524980778|FG003|Wash-out After Period 1|Adverse Event|0|||
145580949|NCT00524134|524980779|FG000|Overall Study|Withdrawal by Subject|1|||
145580950|NCT00524134|524980779|FG000|Overall Study|Physician Decision|1|||
145373647|NCT03409107|524219089|FG000|Overall Study|Physician Decision|1|||
145580951|NCT01782131|524980780|FG000|Overall Study|Death|93|||
145580952|NCT01782131|524980781|FG001|Overall Study|Death|96|||
145580953|NCT01782131|524980780|FG000|Overall Study|Lost to Follow-up|1|||
145580954|NCT01782131|524980781|FG001|Overall Study|Lost to Follow-up|3|||
145426661|NCT02301897|524419444|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
145426662|NCT02301897|524419442|FG000|Treatment Course 2|Lost to Follow-up|0|||
145426663|NCT02301897|524419443|FG001|Treatment Course 2|Lost to Follow-up|2|||
145426664|NCT02301897|524419444|FG002|Treatment Course 2|Lost to Follow-up|0|||
145426665|NCT02301897|524419442|FG000|Treatment Course 2|Pregnancy|0|||
145426666|NCT02301897|524419443|FG001|Treatment Course 2|Pregnancy|1|||
145426667|NCT02301897|524419444|FG002|Treatment Course 2|Pregnancy|1|||
145426668|NCT02301897|524419442|FG000|Treatment Course 2|Withdrawal by Subject|0|||
145426669|NCT02301897|524419443|FG001|Treatment Course 2|Withdrawal by Subject|2|||
145426670|NCT02301897|524419444|FG002|Treatment Course 2|Withdrawal by Subject|0|||
145426671|NCT02301897|524419442|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
145426672|NCT02301897|524419443|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
145426673|NCT02301897|524419444|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
145426674|NCT00337168|524419445|FG000|Overall Study|Death|5|||
145426675|NCT00337168|524419445|FG000|Overall Study|Not protocol specified|2|||
145426676|NCT00337168|524419445|FG000|Overall Study|Did not start therapy|1|||
145426677|NCT01225952|524419446|FG000|Overall Study|Lost to Follow-up|1|||
145426678|NCT01225952|524419447|FG001|Overall Study|Lost to Follow-up|0|||
145426679|NCT01225952|524419448|FG002|Overall Study|Lost to Follow-up|0|||
145426680|NCT01225952|524419446|FG000|Overall Study|Study Eye Explanted|0|||
145426681|NCT01225952|524419447|FG001|Overall Study|Study Eye Explanted|0|||
145426682|NCT01225952|524419448|FG002|Overall Study|Study Eye Explanted|1|||
145426683|NCT01225952|524419446|FG000|Overall Study|Withdrawal by Subject|4|||
145426684|NCT01225952|524419447|FG001|Overall Study|Withdrawal by Subject|4|||
145426685|NCT01225952|524419448|FG002|Overall Study|Withdrawal by Subject|5|||
145426686|NCT01225952|524419446|FG000|Overall Study|Surgical complications|1|||
145426687|NCT01225952|524419447|FG001|Overall Study|Surgical complications|0|||
145426688|NCT01225952|524419448|FG002|Overall Study|Surgical complications|0|||
145426689|NCT01217892|524419452|FG000|Overall Study|Adverse Event|1|||
145426690|NCT01217892|524419453|FG001|Overall Study|Adverse Event|1|||
145426691|NCT01217892|524419454|FG002|Overall Study|Adverse Event|1|||
145426692|NCT01217892|524419455|FG003|Overall Study|Adverse Event|0|||
145426693|NCT01217892|524419452|FG000|Overall Study|Withdrawal by Subject|0|||
145426694|NCT01217892|524419453|FG001|Overall Study|Withdrawal by Subject|2|||
145426695|NCT01217892|524419454|FG002|Overall Study|Withdrawal by Subject|1|||
145426696|NCT01217892|524419455|FG003|Overall Study|Withdrawal by Subject|0|||
145426697|NCT01217892|524419452|FG000|Overall Study|Lab value|1|||
145426698|NCT01217892|524419453|FG001|Overall Study|Lab value|0|||
145426699|NCT01217892|524419454|FG002|Overall Study|Lab value|1|||
145426700|NCT01217892|524419455|FG003|Overall Study|Lab value|0|||
145426701|NCT01217892|524419452|FG000|Overall Study|Subject no longer meets study criteria|5|||
145426702|NCT01217892|524419453|FG001|Overall Study|Subject no longer meets study criteria|2|||
145426703|NCT01217892|524419454|FG002|Overall Study|Subject no longer meets study criteria|4|||
145426704|NCT01217892|524419455|FG003|Overall Study|Subject no longer meets study criteria|8|||
145426705|NCT01217892|524419452|FG000|Overall Study|Incorrect enrollment|0|||
145426706|NCT01217892|524419453|FG001|Overall Study|Incorrect enrollment|1|||
145426707|NCT01217892|524419454|FG002|Overall Study|Incorrect enrollment|1|||
145426708|NCT01217892|524419455|FG003|Overall Study|Incorrect enrollment|0|||
145426709|NCT01217892|524419452|FG000|Overall Study|Poor/Non-Compliance|0|||
145426710|NCT01217892|524419453|FG001|Overall Study|Poor/Non-Compliance|0|||
145426711|NCT01217892|524419454|FG002|Overall Study|Poor/Non-Compliance|1|||
145426712|NCT01217892|524419455|FG003|Overall Study|Poor/Non-Compliance|0|||
145426713|NCT01052779|524419456|FG000|Overall Study|Adverse Event|1|||
145426714|NCT01052779|524419457|FG001|Overall Study|Adverse Event|4|||
145426715|NCT01052779|524419456|FG000|Overall Study|Withdrawal by Subject|1|||
145426716|NCT01052779|524419457|FG001|Overall Study|Withdrawal by Subject|2|||
145426717|NCT01052779|524419456|FG000|Overall Study|Other-Protocol Violation|1|||
145426718|NCT01052779|524419457|FG001|Overall Study|Other-Protocol Violation|1|||
145426719|NCT01052779|524419456|FG000|Overall Study|Other-Surgery|0|||
145426720|NCT01052779|524419457|FG001|Overall Study|Other-Surgery|2|||
145426721|NCT01052779|524419456|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
145426722|NCT01052779|524419457|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
145426723|NCT03663582|524419458|FG000|Overall Study|Physician Decision|1|||
145426724|NCT02853136|524419459|FG000|Wash-out|Adverse Event|0|||
145426725|NCT02853136|524419460|FG001|Wash-out|Adverse Event|0|||
145426726|NCT02853136|524419461|FG002|Wash-out|Adverse Event|0|||
145580955|NCT01782131|524980780|FG000|Overall Study|Withdrawal by Subject|10|||
145580956|NCT01782131|524980781|FG001|Overall Study|Withdrawal by Subject|10|||
145580957|NCT01782131|524980780|FG000|Overall Study|Randomized but not treated|5|||
145580958|NCT01782131|524980781|FG001|Overall Study|Randomized but not treated|5|||
145580959|NCT01782131|524980780|FG000|Overall Study|Reason not provided|0|||
145426727|NCT02853136|524419462|FG003|Wash-out|Adverse Event|1|||
145426728|NCT00841815|524419463|FG000|Washout|Withdrawal by Subject|0|||
145426729|NCT00841815|524419464|FG001|Washout|Withdrawal by Subject|1|||
145426730|NCT03729609|524419465|FG000|Overall Study|Protocol Violation|1|||
145426731|NCT03412929|524419470|FG000|Overall Study|Protocol Violation|3|||
145426732|NCT00605189|524419471|FG000|Overall Study|Adverse Event|1|||
145426733|NCT00605189|524419472|FG001|Overall Study|Adverse Event|0|||
145426734|NCT00605189|524419473|FG002|Overall Study|Adverse Event|0|||
145426735|NCT00605189|524419471|FG000|Overall Study|Other|2|||
145426736|NCT00605189|524419472|FG001|Overall Study|Other|2|||
145426737|NCT00605189|524419473|FG002|Overall Study|Other|0|||
145426738|NCT03685149|524419474|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
145426739|NCT03685149|524419475|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
145426740|NCT03685149|524419474|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145426741|NCT03685149|524419475|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145426742|NCT03685149|524419474|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
145426743|NCT03685149|524419475|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
145426744|NCT01922895|524419477|FG000|Overall Study|Death|0|||
145426745|NCT01922895|524419478|FG001|Overall Study|Death|1|||
145426746|NCT01922895|524419477|FG000|Overall Study|Withdrawal by Subject|1|||
145426747|NCT01922895|524419478|FG001|Overall Study|Withdrawal by Subject|2|||
145426748|NCT01922895|524419477|FG000|Overall Study|Lost to Follow-up|5|||
145426749|NCT01922895|524419478|FG001|Overall Study|Lost to Follow-up|11|||
145426750|NCT05142306|524419481|FG000|Overall Study|Withdrawal by Subject|0|||
145426751|NCT05142306|524419482|FG001|Overall Study|Withdrawal by Subject|0|||
145426752|NCT05142306|524419483|FG002|Overall Study|Withdrawal by Subject|1|||
145426753|NCT04079920|524419484|FG000|Overall Study|Adverse event, not related to study drug|2|||
145426754|NCT04079920|524419484|FG000|Overall Study|Adverse event related to study drug|10|||
145426755|NCT04079920|524419484|FG000|Overall Study|Death|2|||
145426756|NCT04079920|524419484|FG000|Overall Study|Lost to Follow-up|22|||
145426757|NCT04079920|524419484|FG000|Overall Study|Physician Decision|1|||
145426758|NCT04079920|524419484|FG000|Overall Study|Withdrawal by Subject|11|||
145426759|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
145426760|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
145426761|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
145426762|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
145426763|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
145426764|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
145426765|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
145426766|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
145426767|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
145426768|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
145426769|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145426770|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145426771|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
145426772|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
145426773|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
145426774|NCT05014919|524419487|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
145426775|NCT05014919|524419488|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
145426776|NCT05014919|524419489|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
145426777|NCT05014919|524419487|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
145426778|NCT05014919|524419488|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
145426779|NCT05014919|524419489|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
145426780|NCT05014919|524419487|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
145426781|NCT05014919|524419488|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
145426782|NCT05014919|524419489|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
145426783|NCT05305651|524419490|FG000|Overall Study|Death|1|||
145426784|NCT05305651|524419490|FG000|Overall Study|Withdrawal by Subject|4|||
145426785|NCT05305651|524419490|FG000|Overall Study|Lost to Follow-up|4|||
145426786|NCT00522379|524419491|FG000|Overall Study|Adverse Event|12|||
145426787|NCT00522379|524419492|FG001|Overall Study|Adverse Event|15|||
145426788|NCT00522379|524419493|FG002|Overall Study|Adverse Event|12|||
145426789|NCT00522379|524419494|FG003|Overall Study|Adverse Event|5|||
145426790|NCT00522379|524419495|FG004|Overall Study|Adverse Event|17|||
145426791|NCT00522379|524419491|FG000|Overall Study|Lack of Efficacy|3|||
145426792|NCT00522379|524419492|FG001|Overall Study|Lack of Efficacy|0|||
145426793|NCT00522379|524419493|FG002|Overall Study|Lack of Efficacy|2|||
145426794|NCT00522379|524419494|FG003|Overall Study|Lack of Efficacy|2|||
145623717|NCT02099539|525134020|FG000|Overall Study|Physician Decision|0|||
145623718|NCT02099539|525134021|FG001|Overall Study|Physician Decision|0|||
145623719|NCT02099539|525134022|FG002|Overall Study|Physician Decision|0|||
145623720|NCT02099539|525134023|FG003|Overall Study|Physician Decision|0|||
145426795|NCT00522379|524419495|FG004|Overall Study|Lack of Efficacy|7|||
145426796|NCT00522379|524419491|FG000|Overall Study|Withdrawal by Subject|2|||
145426797|NCT00522379|524419492|FG001|Overall Study|Withdrawal by Subject|3|||
145426798|NCT00522379|524419493|FG002|Overall Study|Withdrawal by Subject|1|||
145426799|NCT00522379|524419494|FG003|Overall Study|Withdrawal by Subject|2|||
145426800|NCT00522379|524419495|FG004|Overall Study|Withdrawal by Subject|0|||
145623721|NCT02099539|525134024|FG004|Overall Study|Physician Decision|0|||
145623722|NCT02099539|525134025|FG005|Overall Study|Physician Decision|1|||
145623723|NCT02099539|525134026|FG006|Overall Study|Physician Decision|0|||
145580960|NCT01782131|524980781|FG001|Overall Study|Reason not provided|1|||
145580961|NCT00796718|524980782|FG000|Overall Study|Adverse Event|2|||
145580962|NCT00796718|524980782|FG000|Overall Study|Exclusion Criteria|1|||
145580963|NCT00796718|524980782|FG000|Overall Study|Lost to Follow-up|5|||
145580964|NCT00796718|524980782|FG000|Overall Study|Withdrawal by Informed Consent|1|||
145580965|NCT02627677|524980784|FG000|Overall Study|Adverse event (not progressive disease)|1|||
145580966|NCT02627677|524980785|FG001|Overall Study|Adverse event (not progressive disease)|4|||
145580967|NCT02627677|524980786|FG002|Overall Study|Adverse event (not progressive disease)|1|||
145580968|NCT02627677|524980784|FG000|Overall Study|Progressive disease|1|||
145580969|NCT02627677|524980785|FG001|Overall Study|Progressive disease|3|||
145580970|NCT02627677|524980786|FG002|Overall Study|Progressive disease|0|||
145580971|NCT02627677|524980784|FG000|Overall Study|Lack of Efficacy|1|||
145580972|NCT02627677|524980785|FG001|Overall Study|Lack of Efficacy|2|||
145580973|NCT02627677|524980786|FG002|Overall Study|Lack of Efficacy|0|||
145580974|NCT02627677|524980784|FG000|Overall Study|Lost to Follow-up|0|||
145580975|NCT02627677|524980785|FG001|Overall Study|Lost to Follow-up|0|||
145580976|NCT02627677|524980786|FG002|Overall Study|Lost to Follow-up|1|||
145580977|NCT02627677|524980784|FG000|Overall Study|Pregnancy|0|||
145580978|NCT02627677|524980785|FG001|Overall Study|Pregnancy|1|||
145580979|NCT02627677|524980786|FG002|Overall Study|Pregnancy|0|||
145580980|NCT02627677|524980784|FG000|Overall Study|Study Terminated by Sponsor|5|||
145580981|NCT02627677|524980785|FG001|Overall Study|Study Terminated by Sponsor|10|||
145580982|NCT02627677|524980786|FG002|Overall Study|Study Terminated by Sponsor|6|||
145580983|NCT02627677|524980784|FG000|Overall Study|Physician Decision|0|||
145580984|NCT02627677|524980785|FG001|Overall Study|Physician Decision|0|||
145580985|NCT02627677|524980786|FG002|Overall Study|Physician Decision|2|||
145580986|NCT02627677|524980784|FG000|Overall Study|Withdrawal by Subject|2|||
145623724|NCT03473756|525134028|FG000|Overall Study|Withdrawal by Subject|1|||
145623725|NCT03473756|525134029|FG001|Overall Study|Withdrawal by Subject|4|||
145580987|NCT02627677|524980785|FG001|Overall Study|Withdrawal by Subject|1|||
145580988|NCT02627677|524980786|FG002|Overall Study|Withdrawal by Subject|1|||
145580989|NCT02627677|524980784|FG000|Overall Study|Reason not Specified|0|||
145580990|NCT02627677|524980785|FG001|Overall Study|Reason not Specified|0|||
145580991|NCT02627677|524980786|FG002|Overall Study|Reason not Specified|1|||
145580992|NCT02627677|524980784|FG000|Overall Study|Randomized but not Treated|1|||
145580993|NCT02627677|524980785|FG001|Overall Study|Randomized but not Treated|0|||
145580994|NCT02627677|524980786|FG002|Overall Study|Randomized but not Treated|0|||
145580995|NCT00317772|524980787|FG000|Overall Study|Adverse Event|0|||
145580996|NCT00317772|524980788|FG001|Overall Study|Adverse Event|0|||
145580997|NCT00317772|524980789|FG002|Overall Study|Adverse Event|0|||
145580998|NCT00317772|524980790|FG003|Overall Study|Adverse Event|2|||
145580999|NCT00317772|524980787|FG000|Overall Study|Disease Progression|2|||
145581000|NCT00317772|524980788|FG001|Overall Study|Disease Progression|2|||
145581001|NCT00317772|524980789|FG002|Overall Study|Disease Progression|1|||
145581002|NCT00317772|524980790|FG003|Overall Study|Disease Progression|7|||
145581003|NCT01073618|524980791|FG000|Overall Study|Death|208|||
145581004|NCT01073618|524980791|FG000|Overall Study|Adverse Event|19|||
145581005|NCT01073618|524980791|FG000|Overall Study|Other|80|||
145581006|NCT02696850|524980792|FG000|Overall Study|Withdrawal by Subject|3|||
145581007|NCT02696850|524980793|FG001|Overall Study|Withdrawal by Subject|3|||
145581008|NCT02696850|524980792|FG000|Overall Study|Lost to Follow-up|8|||
145581009|NCT02696850|524980793|FG001|Overall Study|Lost to Follow-up|5|||
145581010|NCT02621606|524980796|FG000|Overall Study|Withdrawal by Subject|0|||
145581011|NCT02621606|524980797|FG001|Overall Study|Withdrawal by Subject|1|||
145581012|NCT02621606|524980798|FG002|Overall Study|Withdrawal by Subject|0|||
145581013|NCT00009737|524980802|FG000|Overall Study|Adverse Event|112|||
145581014|NCT00009737|524980803|FG001|Overall Study|Adverse Event|75|||
145581015|NCT00009737|524980802|FG000|Overall Study|Death|4|||
145581016|NCT00009737|524980803|FG001|Overall Study|Death|6|||
145581017|NCT00009737|524980802|FG000|Overall Study|Lack of Efficacy|17|||
145623726|NCT03473756|525134028|FG000|Overall Study|Adverse Event|6|||
145373648|NCT03409107|524219090|FG001|Overall Study|Physician Decision|0|||
145373649|NCT03409107|524219089|FG000|Overall Study|Lost to Follow-up|7|||
145373650|NCT03409107|524219090|FG001|Overall Study|Lost to Follow-up|2|||
145581018|NCT00009737|524980803|FG001|Overall Study|Lack of Efficacy|15|||
145581019|NCT00009737|524980802|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
145581020|NCT00009737|524980803|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
145581021|NCT00009737|524980802|FG000|Overall Study|Other Protocol Violation|1|||
145581022|NCT00009737|524980803|FG001|Overall Study|Other Protocol Violation|0|||
145581023|NCT00009737|524980802|FG000|Overall Study|Refused Treatment|15|||
145581024|NCT00009737|524980803|FG001|Overall Study|Refused Treatment|16|||
145581025|NCT00009737|524980802|FG000|Overall Study|Lost to Follow-up|1|||
145581026|NCT00009737|524980803|FG001|Overall Study|Lost to Follow-up|1|||
145581027|NCT00009737|524980802|FG000|Overall Study|Administrative/Other Reasons|7|||
145581028|NCT00009737|524980803|FG001|Overall Study|Administrative/Other Reasons|1|||
145581029|NCT01163682|524980804|FG000|Overall Study|Lost to Follow-up|6|||
145581030|NCT01163682|524980805|FG001|Overall Study|Lost to Follow-up|9|||
145623727|NCT03473756|525134029|FG001|Overall Study|Adverse Event|7|||
145426801|NCT00522379|524419491|FG000|Overall Study|Protocol Violation|1|||
145426802|NCT00522379|524419492|FG001|Overall Study|Protocol Violation|1|||
145426803|NCT00522379|524419493|FG002|Overall Study|Protocol Violation|2|||
145426804|NCT00522379|524419494|FG003|Overall Study|Protocol Violation|0|||
145426805|NCT00522379|524419495|FG004|Overall Study|Protocol Violation|0|||
145426806|NCT00522379|524419491|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
145426807|NCT00522379|524419492|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
145426808|NCT00522379|524419493|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
145426809|NCT00522379|524419494|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
145426810|NCT00522379|524419495|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
145426811|NCT00522379|524419491|FG000|Overall Study|Lost to Follow-up|1|||
145426812|NCT00522379|524419492|FG001|Overall Study|Lost to Follow-up|0|||
145426813|NCT00522379|524419493|FG002|Overall Study|Lost to Follow-up|4|||
145426814|NCT00522379|524419494|FG003|Overall Study|Lost to Follow-up|2|||
145426815|NCT00522379|524419495|FG004|Overall Study|Lost to Follow-up|2|||
145426816|NCT00522379|524419491|FG000|Overall Study|Randomization error|0|||
145426817|NCT00522379|524419492|FG001|Overall Study|Randomization error|0|||
145426818|NCT00522379|524419493|FG002|Overall Study|Randomization error|0|||
145426819|NCT00522379|524419494|FG003|Overall Study|Randomization error|0|||
145426820|NCT00522379|524419495|FG004|Overall Study|Randomization error|1|||
145426821|NCT00522379|524419491|FG000|Overall Study|Dispensing error|1|||
145426822|NCT00522379|524419492|FG001|Overall Study|Dispensing error|0|||
145426823|NCT00522379|524419493|FG002|Overall Study|Dispensing error|0|||
145426824|NCT00522379|524419494|FG003|Overall Study|Dispensing error|1|||
145426825|NCT00522379|524419495|FG004|Overall Study|Dispensing error|0|||
145426826|NCT00522379|524419491|FG000|Overall Study|Subject Moved|1|||
145426827|NCT00522379|524419492|FG001|Overall Study|Subject Moved|1|||
145426828|NCT00522379|524419493|FG002|Overall Study|Subject Moved|0|||
145581031|NCT04713748|524980806|FG000|Overall Study|Not enough kits allocated|35|||
145581032|NCT02461589|524980807|FG000|Overall Study|Withdrawal by Subject|5|||
145581033|NCT02461589|524980808|FG001|Overall Study|Withdrawal by Subject|1|||
145581034|NCT02461589|524980809|FG002|Overall Study|Withdrawal by Subject|3|||
145581035|NCT02461589|524980810|FG003|Overall Study|Withdrawal by Subject|2|||
145581036|NCT02461589|524980811|FG004|Overall Study|Withdrawal by Subject|1|||
145581037|NCT02461589|524980812|FG005|Overall Study|Withdrawal by Subject|2|||
145581038|NCT02461589|524980813|FG006|Overall Study|Withdrawal by Subject|1|||
145581039|NCT02461589|524980814|FG007|Overall Study|Withdrawal by Subject|3|||
145581040|NCT02461589|524980815|FG008|Overall Study|Withdrawal by Subject|3|||
145581041|NCT02461589|524980816|FG009|Overall Study|Withdrawal by Subject|1|||
145581042|NCT02461589|524980807|FG000|Overall Study|Lost to Follow-up|0|||
145581043|NCT02461589|524980808|FG001|Overall Study|Lost to Follow-up|0|||
145581044|NCT02461589|524980809|FG002|Overall Study|Lost to Follow-up|2|||
145581045|NCT02461589|524980810|FG003|Overall Study|Lost to Follow-up|3|||
145581046|NCT02461589|524980811|FG004|Overall Study|Lost to Follow-up|1|||
145426829|NCT00522379|524419494|FG003|Overall Study|Subject Moved|0|||
145426830|NCT00522379|524419495|FG004|Overall Study|Subject Moved|0|||
145426831|NCT00522379|524419491|FG000|Overall Study|Sponsor Request|0|||
145426832|NCT00522379|524419492|FG001|Overall Study|Sponsor Request|1|||
145426833|NCT00522379|524419493|FG002|Overall Study|Sponsor Request|0|||
145426834|NCT00522379|524419494|FG003|Overall Study|Sponsor Request|0|||
145426835|NCT00522379|524419495|FG004|Overall Study|Sponsor Request|0|||
145426836|NCT00522379|524419491|FG000|Overall Study|Family Problem|0|||
145426837|NCT00522379|524419492|FG001|Overall Study|Family Problem|0|||
145426838|NCT00522379|524419493|FG002|Overall Study|Family Problem|1|||
145426839|NCT00522379|524419494|FG003|Overall Study|Family Problem|0|||
145426840|NCT00522379|524419495|FG004|Overall Study|Family Problem|0|||
145426841|NCT00522379|524419491|FG000|Overall Study|Site Closed|0|||
145426842|NCT00522379|524419492|FG001|Overall Study|Site Closed|0|||
145426843|NCT00522379|524419493|FG002|Overall Study|Site Closed|0|||
145426844|NCT00522379|524419494|FG003|Overall Study|Site Closed|1|||
145426845|NCT00522379|524419495|FG004|Overall Study|Site Closed|0|||
145426846|NCT00522379|524419491|FG000|Overall Study|Subject Withdrawal|0|||
145426847|NCT00522379|524419492|FG001|Overall Study|Subject Withdrawal|0|||
145426848|NCT00522379|524419493|FG002|Overall Study|Subject Withdrawal|0|||
145426849|NCT00522379|524419494|FG003|Overall Study|Subject Withdrawal|1|||
145426850|NCT00522379|524419495|FG004|Overall Study|Subject Withdrawal|0|||
145581047|NCT02461589|524980812|FG005|Overall Study|Lost to Follow-up|1|||
145581048|NCT02461589|524980813|FG006|Overall Study|Lost to Follow-up|3|||
145581049|NCT02461589|524980814|FG007|Overall Study|Lost to Follow-up|1|||
145581050|NCT02461589|524980815|FG008|Overall Study|Lost to Follow-up|3|||
145426851|NCT00967499|524419496|FG000|Overall Study|Adverse Event|0|||
145426852|NCT00967499|524419497|FG001|Overall Study|Adverse Event|1|||
145426853|NCT00967499|524419496|FG000|Overall Study|Protocol Violation|1|||
145426854|NCT00967499|524419497|FG001|Overall Study|Protocol Violation|0|||
145426855|NCT00967499|524419496|FG000|Overall Study|Sponsor Decision|1|||
145426856|NCT00967499|524419497|FG001|Overall Study|Sponsor Decision|0|||
145426857|NCT00967499|524419496|FG000|Overall Study|Randomized but not treated|63|||
145426858|NCT00967499|524419497|FG001|Overall Study|Randomized but not treated|59|||
145581051|NCT02461589|524980816|FG009|Overall Study|Lost to Follow-up|1|||
145581052|NCT02461589|524980807|FG000|Overall Study|Death|0|||
145426859|NCT02298946|524419501|FG000|Overall Study|Did not receive treatment|2|||
145426860|NCT02298946|524419502|FG001|Overall Study|Did not receive treatment|0|||
145426861|NCT02298946|524419501|FG000|Overall Study|Unevaluable|2|||
145426862|NCT02298946|524419502|FG001|Overall Study|Unevaluable|1|||
145426863|NCT00050011|524419503|FG000|Overall Study|Adverse Event|41|||
145426864|NCT00050011|524419504|FG001|Overall Study|Adverse Event|46|||
145426865|NCT00050011|524419503|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145426866|NCT00050011|524419504|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145426867|NCT00050011|524419503|FG000|Overall Study|Abnormal test procedure results|0|||
145426868|NCT00050011|524419504|FG001|Overall Study|Abnormal test procedure results|1|||
145426869|NCT00050011|524419503|FG000|Overall Study|Lack of Efficacy|16|||
145426870|NCT00050011|524419504|FG001|Overall Study|Lack of Efficacy|21|||
145426871|NCT00050011|524419503|FG000|Overall Study|Participant condition no longer required|1|||
145426872|NCT00050011|524419504|FG001|Overall Study|Participant condition no longer required|0|||
145426873|NCT00050011|524419503|FG000|Overall Study|Protocol Violation|4|||
145426874|NCT00050011|524419504|FG001|Overall Study|Protocol Violation|10|||
145426875|NCT00050011|524419503|FG000|Overall Study|Withdrawal by Subject|34|||
145426876|NCT00050011|524419504|FG001|Overall Study|Withdrawal by Subject|26|||
145426877|NCT00050011|524419503|FG000|Overall Study|Lost to Follow-up|7|||
145426878|NCT00050011|524419504|FG001|Overall Study|Lost to Follow-up|9|||
145426879|NCT00050011|524419503|FG000|Overall Study|Administrative problems|10|||
145426880|NCT00050011|524419504|FG001|Overall Study|Administrative problems|6|||
145426881|NCT00050011|524419503|FG000|Overall Study|Death|7|||
145426882|NCT00050011|524419504|FG001|Overall Study|Death|4|||
145426883|NCT00050011|524419503|FG000|Overall Study|Unknown - Reason is missing|0|||
145426884|NCT00050011|524419504|FG001|Overall Study|Unknown - Reason is missing|2|||
145426885|NCT05535972|524419505|FG000|Overall Study|Withdrawal by Subject|31|||
145426886|NCT05535972|524419505|FG000|Overall Study|Lost to Follow-up|5|||
145426887|NCT05535972|524419505|FG000|Overall Study|Adverse Event|6|||
145426888|NCT05535972|524419505|FG000|Overall Study|Protocol Deviation|2|||
145426889|NCT04197583|524419508|FG000|Overall Study|Study Stent Replacement|34|||
145426890|NCT04197583|524419509|FG001|Overall Study|Study Stent Replacement|8|||
145426891|NCT04197583|524419508|FG000|Overall Study|Lost to Follow-up|14|||
145426892|NCT04197583|524419509|FG001|Overall Study|Lost to Follow-up|3|||
145426893|NCT04197583|524419508|FG000|Overall Study|Death|3|||
145426894|NCT04197583|524419509|FG001|Overall Study|Death|0|||
145426895|NCT04197583|524419508|FG000|Overall Study|Physician Decision|1|||
145426896|NCT04197583|524419509|FG001|Overall Study|Physician Decision|0|||
145426897|NCT04197583|524419508|FG000|Overall Study|Withdrawal by Subject|1|||
145426898|NCT04197583|524419509|FG001|Overall Study|Withdrawal by Subject|1|||
145426899|NCT04197583|524419508|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
145426900|NCT04197583|524419509|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
145426901|NCT04197583|524419508|FG000|Overall Study|Screen Failure|0|||
145426902|NCT04197583|524419509|FG001|Overall Study|Screen Failure|20|||
145426903|NCT04629196|524419510|FG000|Overall Study|Subject discontinued study drug|1|||
145426904|NCT04629196|524419511|FG001|Overall Study|Subject discontinued study drug|0|||
145426905|NCT04629196|524419510|FG000|Overall Study|Subject study drug dosing increased|1|||
145426906|NCT04629196|524419511|FG001|Overall Study|Subject study drug dosing increased|1|||
145426907|NCT04629196|524419510|FG000|Overall Study|Withdrawal by Subject|1|||
145426908|NCT04629196|524419511|FG001|Overall Study|Withdrawal by Subject|2|||
145426909|NCT01450631|524419515|FG000|Overall Study|Lost to Follow-up|2|||
145426910|NCT01450631|524419516|FG001|Overall Study|Lost to Follow-up|4|||
145426911|NCT01450631|524419515|FG000|Overall Study|Withdrawal by Subject|1|||
145426912|NCT01450631|524419516|FG001|Overall Study|Withdrawal by Subject|0|||
145426913|NCT00323622|524419519|FG000|Overall Study|Other|30|||
145426914|NCT00323622|524419520|FG001|Overall Study|Other|91|||
145426915|NCT00323622|524419521|FG002|Overall Study|Other|4|||
145426916|NCT00323622|524419522|FG003|Overall Study|Other|12|||
145426917|NCT00323622|524419523|FG004|Overall Study|Other|32|||
145426918|NCT00323622|524419524|FG005|Overall Study|Other|74|||
145426919|NCT00323622|524419525|FG006|Overall Study|Other|5|||
145426920|NCT00323622|524419526|FG007|Overall Study|Other|13|||
145581053|NCT02461589|524980808|FG001|Overall Study|Death|0|||
145581054|NCT02461589|524980809|FG002|Overall Study|Death|0|||
145426921|NCT00323622|524419519|FG000|Overall Study|Death|1|||
145426922|NCT00323622|524419520|FG001|Overall Study|Death|1|||
145426923|NCT00323622|524419521|FG002|Overall Study|Death|0|||
145426924|NCT00323622|524419522|FG003|Overall Study|Death|0|||
145426925|NCT00323622|524419523|FG004|Overall Study|Death|7|||
145426926|NCT00323622|524419524|FG005|Overall Study|Death|0|||
145426927|NCT00323622|524419525|FG006|Overall Study|Death|0|||
145426928|NCT00323622|524419526|FG007|Overall Study|Death|2|||
145426929|NCT00835354|524419527|FG000|First Intervention|Adverse Event|0|||
145426930|NCT00835354|524419528|FG001|First Intervention|Adverse Event|1|||
145426931|NCT02613507|524419533|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
145426932|NCT02613507|524419534|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
145581055|NCT02461589|524980810|FG003|Overall Study|Death|0|||
145426933|NCT02613507|524419533|FG000|Pre-Treamtent|Participant withdrew consent|0|||
145581056|NCT02461589|524980811|FG004|Overall Study|Death|0|||
145581057|NCT02461589|524980812|FG005|Overall Study|Death|0|||
145581058|NCT02461589|524980813|FG006|Overall Study|Death|0|||
145581059|NCT02461589|524980814|FG007|Overall Study|Death|1|||
145581060|NCT02461589|524980815|FG008|Overall Study|Death|0|||
145581061|NCT02461589|524980816|FG009|Overall Study|Death|0|||
145581062|NCT02461589|524980807|FG000|Overall Study|Unclassified|0|||
145581063|NCT02461589|524980808|FG001|Overall Study|Unclassified|0|||
145581064|NCT02461589|524980809|FG002|Overall Study|Unclassified|0|||
145581065|NCT02461589|524980810|FG003|Overall Study|Unclassified|0|||
145581066|NCT02461589|524980811|FG004|Overall Study|Unclassified|0|||
145581067|NCT02461589|524980812|FG005|Overall Study|Unclassified|0|||
145581068|NCT02461589|524980813|FG006|Overall Study|Unclassified|1|||
145581069|NCT02461589|524980814|FG007|Overall Study|Unclassified|0|||
145581070|NCT02461589|524980815|FG008|Overall Study|Unclassified|0|||
145581071|NCT02461589|524980816|FG009|Overall Study|Unclassified|2|||
145581072|NCT02461589|524980807|FG000|Overall Study|Missing follow-up information|1|||
145581073|NCT02461589|524980808|FG001|Overall Study|Missing follow-up information|1|||
145581074|NCT02461589|524980809|FG002|Overall Study|Missing follow-up information|0|||
145581075|NCT02461589|524980810|FG003|Overall Study|Missing follow-up information|0|||
145581076|NCT02461589|524980811|FG004|Overall Study|Missing follow-up information|0|||
145581077|NCT02461589|524980812|FG005|Overall Study|Missing follow-up information|0|||
145581078|NCT02461589|524980813|FG006|Overall Study|Missing follow-up information|1|||
145581079|NCT02461589|524980814|FG007|Overall Study|Missing follow-up information|0|||
145581080|NCT02461589|524980815|FG008|Overall Study|Missing follow-up information|0|||
145581081|NCT02461589|524980816|FG009|Overall Study|Missing follow-up information|0|||
145581082|NCT02461589|524980807|FG000|Overall Study|Withdrawal from trial before exposure|0|||
145581083|NCT02461589|524980808|FG001|Overall Study|Withdrawal from trial before exposure|0|||
145581084|NCT02461589|524980809|FG002|Overall Study|Withdrawal from trial before exposure|0|||
145581085|NCT02461589|524980810|FG003|Overall Study|Withdrawal from trial before exposure|0|||
145581086|NCT02461589|524980811|FG004|Overall Study|Withdrawal from trial before exposure|0|||
145581087|NCT02461589|524980812|FG005|Overall Study|Withdrawal from trial before exposure|0|||
145581088|NCT02461589|524980813|FG006|Overall Study|Withdrawal from trial before exposure|0|||
145581089|NCT02461589|524980814|FG007|Overall Study|Withdrawal from trial before exposure|0|||
145581090|NCT02461589|524980815|FG008|Overall Study|Withdrawal from trial before exposure|0|||
145581091|NCT02461589|524980816|FG009|Overall Study|Withdrawal from trial before exposure|1|||
145581092|NCT01557946|524980817|FG000|Overall Study|Adverse Event|3|||
145581093|NCT01557946|524980818|FG001|Overall Study|Adverse Event|0|||
145581094|NCT00406029|524980819|FG000|Overall Study|Adverse Event|12|||
145581095|NCT00406029|524980820|FG001|Overall Study|Adverse Event|2|||
145581096|NCT00406029|524980821|FG002|Overall Study|Adverse Event|5|||
145581097|NCT00406029|524980822|FG003|Overall Study|Adverse Event|10|||
145581098|NCT00406029|524980823|FG004|Overall Study|Adverse Event|7|||
145581099|NCT00406029|524980819|FG000|Overall Study|Withdrawal by Subject|3|||
145581100|NCT00406029|524980820|FG001|Overall Study|Withdrawal by Subject|4|||
145581101|NCT00406029|524980821|FG002|Overall Study|Withdrawal by Subject|2|||
145581102|NCT00406029|524980822|FG003|Overall Study|Withdrawal by Subject|2|||
145581103|NCT00406029|524980823|FG004|Overall Study|Withdrawal by Subject|0|||
145581104|NCT00406029|524980819|FG000|Overall Study|Protocol Violation|1|||
145581105|NCT00406029|524980820|FG001|Overall Study|Protocol Violation|2|||
145581106|NCT00406029|524980821|FG002|Overall Study|Protocol Violation|0|||
145581107|NCT00406029|524980822|FG003|Overall Study|Protocol Violation|2|||
145581108|NCT00406029|524980823|FG004|Overall Study|Protocol Violation|0|||
145581109|NCT00406029|524980819|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
145581110|NCT00406029|524980820|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
145581111|NCT00406029|524980821|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
145581112|NCT00406029|524980822|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
145581113|NCT00406029|524980823|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
145581114|NCT00406029|524980819|FG000|Overall Study|Randomized in Error|0|||
145581115|NCT00406029|524980820|FG001|Overall Study|Randomized in Error|0|||
145581116|NCT00406029|524980821|FG002|Overall Study|Randomized in Error|2|||
145581117|NCT00406029|524980822|FG003|Overall Study|Randomized in Error|3|||
145581118|NCT00406029|524980823|FG004|Overall Study|Randomized in Error|1|||
145581119|NCT01038921|524980824|FG000|Overall Study|Withdrawal by Subject|1|||
145581120|NCT01038921|524980825|FG001|Overall Study|Withdrawal by Subject|0|||
145581121|NCT01038921|524980824|FG000|Overall Study|Physician Decision|1|||
145581122|NCT01038921|524980825|FG001|Overall Study|Physician Decision|0|||
145581123|NCT01831089|524980826|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
145581124|NCT01831089|524980827|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
145581125|NCT01831089|524980828|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
145581126|NCT01831089|524980829|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
145581127|NCT01831089|524980830|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
145581128|NCT01831089|524980831|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
145581129|NCT01831089|524980826|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
145581130|NCT01831089|524980827|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
145265285|NCT01945034|523819264|FG002|Overall Study|Lost to Follow-up|2|||
145426934|NCT02613507|524419534|FG001|Pre-Treamtent|Participant withdrew consent|4|||
145426935|NCT02613507|524419533|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
145426936|NCT02613507|524419534|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
145426937|NCT02613507|524419533|FG000|Treatment|Not reported|3|||
145426938|NCT02613507|524419534|FG001|Treatment|Not reported|0|||
145426939|NCT02613507|524419533|FG000|Treatment|Other reasons|8|||
145426940|NCT02613507|524419534|FG001|Treatment|Other reasons|0|||
145426941|NCT02613507|524419533|FG000|Treatment|Participant no longer meets criteria|3|||
145426942|NCT02613507|524419534|FG001|Treatment|Participant no longer meets criteria|0|||
145426943|NCT02613507|524419533|FG000|Treatment|Maximum clinical benefit|5|||
145426944|NCT02613507|524419534|FG001|Treatment|Maximum clinical benefit|10|||
145426945|NCT02613507|524419533|FG000|Treatment|Lost to Follow-up|1|||
145426946|NCT02613507|524419534|FG001|Treatment|Lost to Follow-up|0|||
145426947|NCT02613507|524419533|FG000|Treatment|Participant withdrew consent|0|||
145426948|NCT02613507|524419534|FG001|Treatment|Participant withdrew consent|2|||
145426949|NCT02613507|524419533|FG000|Treatment|Participant request to discontinue study treatment|13|||
145426950|NCT02613507|524419534|FG001|Treatment|Participant request to discontinue study treatment|17|||
145426951|NCT02613507|524419533|FG000|Treatment|Adverse event unrelated to study drug|20|||
145426952|NCT02613507|524419534|FG001|Treatment|Adverse event unrelated to study drug|3|||
145426953|NCT02613507|524419533|FG000|Treatment|Death|2|||
145426954|NCT02613507|524419534|FG001|Treatment|Death|0|||
145426955|NCT02613507|524419533|FG000|Treatment|Study drug toxicity|19|||
145426956|NCT02613507|524419534|FG001|Treatment|Study drug toxicity|14|||
145426957|NCT02613507|524419533|FG000|Treatment|Disease progression|263|||
145426958|NCT02613507|524419534|FG001|Treatment|Disease progression|110|||
145426959|NCT03648372|524419545|FG000|Overall Study|Withdrawal by Subject|2|||
145426960|NCT03648372|524419546|FG001|Overall Study|Withdrawal by Subject|0|||
145426961|NCT03648372|524419547|FG002|Overall Study|Withdrawal by Subject|0|||
145426962|NCT03648372|524419548|FG003|Overall Study|Withdrawal by Subject|0|||
145426963|NCT03648372|524419549|FG004|Overall Study|Withdrawal by Subject|0|||
145426964|NCT03648372|524419550|FG005|Overall Study|Withdrawal by Subject|1|||
145581131|NCT01831089|524980828|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
145581132|NCT01831089|524980829|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
145581133|NCT01831089|524980830|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
145581134|NCT01831089|524980831|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
145581135|NCT01831089|524980826|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
145581136|NCT01831089|524980827|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
145581137|NCT01831089|524980828|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
145581138|NCT01831089|524980829|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
145581139|NCT01831089|524980830|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
145581140|NCT01831089|524980831|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
145581141|NCT01831089|524980826|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
145581142|NCT01831089|524980827|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
145581143|NCT01831089|524980828|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
145581144|NCT01831089|524980829|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
145581145|NCT01831089|524980830|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
145426965|NCT03648372|524419551|FG006|Overall Study|Withdrawal by Subject|2|||
145426966|NCT03648372|524419552|FG007|Overall Study|Withdrawal by Subject|0|||
145426967|NCT03648372|524419553|FG008|Overall Study|Withdrawal by Subject|0|||
145426968|NCT03648372|524419554|FG009|Overall Study|Withdrawal by Subject|0|||
145426969|NCT03648372|524419555|FG010|Overall Study|Withdrawal by Subject|2|||
145426970|NCT03648372|524419556|FG011|Overall Study|Withdrawal by Subject|0|||
145426971|NCT03648372|524419557|FG012|Overall Study|Withdrawal by Subject|2|||
145426972|NCT03648372|524419558|FG013|Overall Study|Withdrawal by Subject|0|||
145426973|NCT03648372|524419559|FG014|Overall Study|Withdrawal by Subject|0|||
145426974|NCT03648372|524419560|FG015|Overall Study|Withdrawal by Subject|0|||
145426975|NCT03648372|524419561|FG016|Overall Study|Withdrawal by Subject|1|||
145426976|NCT03648372|524419562|FG017|Overall Study|Withdrawal by Subject|0|||
145426977|NCT03648372|524419563|FG018|Overall Study|Withdrawal by Subject|0|||
145426978|NCT03648372|524419564|FG019|Overall Study|Withdrawal by Subject|0|||
145426979|NCT03648372|524419565|FG020|Overall Study|Withdrawal by Subject|0|||
145426980|NCT03648372|524419545|FG000|Overall Study|Progressive Disease|2|||
145426981|NCT03648372|524419546|FG001|Overall Study|Progressive Disease|3|||
145426982|NCT03648372|524419547|FG002|Overall Study|Progressive Disease|4|||
145581146|NCT01831089|524980831|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
145426983|NCT03648372|524419548|FG003|Overall Study|Progressive Disease|3|||
145426984|NCT03648372|524419549|FG004|Overall Study|Progressive Disease|2|||
145426985|NCT03648372|524419550|FG005|Overall Study|Progressive Disease|2|||
145426986|NCT03648372|524419551|FG006|Overall Study|Progressive Disease|3|||
145426987|NCT03648372|524419552|FG007|Overall Study|Progressive Disease|3|||
145426988|NCT03648372|524419553|FG008|Overall Study|Progressive Disease|5|||
145426989|NCT03648372|524419554|FG009|Overall Study|Progressive Disease|5|||
145426990|NCT03648372|524419555|FG010|Overall Study|Progressive Disease|2|||
145426991|NCT03648372|524419556|FG011|Overall Study|Progressive Disease|3|||
145581147|NCT01831089|524980826|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
145426992|NCT03648372|524419557|FG012|Overall Study|Progressive Disease|3|||
145426993|NCT03648372|524419558|FG013|Overall Study|Progressive Disease|3|||
145426994|NCT03648372|524419559|FG014|Overall Study|Progressive Disease|6|||
145426995|NCT03648372|524419560|FG015|Overall Study|Progressive Disease|0|||
145426996|NCT03648372|524419561|FG016|Overall Study|Progressive Disease|0|||
145426997|NCT03648372|524419562|FG017|Overall Study|Progressive Disease|0|||
145426998|NCT03648372|524419563|FG018|Overall Study|Progressive Disease|0|||
145426999|NCT03648372|524419564|FG019|Overall Study|Progressive Disease|0|||
145427000|NCT03648372|524419565|FG020|Overall Study|Progressive Disease|0|||
145427001|NCT03648372|524419545|FG000|Overall Study|Other|0|||
145427002|NCT03648372|524419546|FG001|Overall Study|Other|0|||
145427003|NCT03648372|524419547|FG002|Overall Study|Other|0|||
145427004|NCT03648372|524419548|FG003|Overall Study|Other|0|||
145427005|NCT03648372|524419549|FG004|Overall Study|Other|1|||
145427006|NCT03648372|524419550|FG005|Overall Study|Other|0|||
145427007|NCT03648372|524419551|FG006|Overall Study|Other|0|||
145427008|NCT03648372|524419552|FG007|Overall Study|Other|0|||
145427009|NCT03648372|524419553|FG008|Overall Study|Other|0|||
145427010|NCT03648372|524419554|FG009|Overall Study|Other|0|||
145427011|NCT03648372|524419555|FG010|Overall Study|Other|1|||
145427012|NCT03648372|524419556|FG011|Overall Study|Other|2|||
145427013|NCT03648372|524419557|FG012|Overall Study|Other|1|||
145427014|NCT03648372|524419558|FG013|Overall Study|Other|3|||
145427015|NCT03648372|524419559|FG014|Overall Study|Other|0|||
145427016|NCT03648372|524419560|FG015|Overall Study|Other|5|||
145427017|NCT03648372|524419561|FG016|Overall Study|Other|1|||
145427018|NCT03648372|524419562|FG017|Overall Study|Other|5|||
145427019|NCT03648372|524419563|FG018|Overall Study|Other|0|||
145427020|NCT03648372|524419564|FG019|Overall Study|Other|1|||
145427021|NCT03648372|524419565|FG020|Overall Study|Other|0|||
145427022|NCT03648372|524419545|FG000|Overall Study|Lost to Follow-up|0|||
145427023|NCT03648372|524419546|FG001|Overall Study|Lost to Follow-up|0|||
145427024|NCT03648372|524419547|FG002|Overall Study|Lost to Follow-up|0|||
145427025|NCT03648372|524419548|FG003|Overall Study|Lost to Follow-up|0|||
145427026|NCT03648372|524419549|FG004|Overall Study|Lost to Follow-up|0|||
145427027|NCT03648372|524419550|FG005|Overall Study|Lost to Follow-up|0|||
145427028|NCT03648372|524419551|FG006|Overall Study|Lost to Follow-up|0|||
145427029|NCT03648372|524419552|FG007|Overall Study|Lost to Follow-up|0|||
145427030|NCT03648372|524419553|FG008|Overall Study|Lost to Follow-up|0|||
145427031|NCT03648372|524419554|FG009|Overall Study|Lost to Follow-up|0|||
145427032|NCT03648372|524419555|FG010|Overall Study|Lost to Follow-up|0|||
145427033|NCT03648372|524419556|FG011|Overall Study|Lost to Follow-up|0|||
145427034|NCT03648372|524419557|FG012|Overall Study|Lost to Follow-up|0|||
145427035|NCT03648372|524419558|FG013|Overall Study|Lost to Follow-up|1|||
145427036|NCT03648372|524419559|FG014|Overall Study|Lost to Follow-up|0|||
145427037|NCT03648372|524419560|FG015|Overall Study|Lost to Follow-up|1|||
145427038|NCT03648372|524419561|FG016|Overall Study|Lost to Follow-up|0|||
145427039|NCT03648372|524419562|FG017|Overall Study|Lost to Follow-up|1|||
145427040|NCT03648372|524419563|FG018|Overall Study|Lost to Follow-up|0|||
145427041|NCT03648372|524419564|FG019|Overall Study|Lost to Follow-up|0|||
145427042|NCT03648372|524419565|FG020|Overall Study|Lost to Follow-up|0|||
145427043|NCT03648372|524419545|FG000|Overall Study|Start of a New Systemic Treatment|0|||
145427044|NCT03648372|524419546|FG001|Overall Study|Start of a New Systemic Treatment|0|||
145427045|NCT03648372|524419547|FG002|Overall Study|Start of a New Systemic Treatment|0|||
145427046|NCT03648372|524419548|FG003|Overall Study|Start of a New Systemic Treatment|0|||
145427047|NCT03648372|524419549|FG004|Overall Study|Start of a New Systemic Treatment|0|||
145427048|NCT03648372|524419550|FG005|Overall Study|Start of a New Systemic Treatment|0|||
145427049|NCT03648372|524419551|FG006|Overall Study|Start of a New Systemic Treatment|0|||
145427050|NCT03648372|524419552|FG007|Overall Study|Start of a New Systemic Treatment|2|||
145581148|NCT01831089|524980827|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
145581149|NCT01831089|524980828|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
145581150|NCT01831089|524980829|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
145427051|NCT03648372|524419553|FG008|Overall Study|Start of a New Systemic Treatment|0|||
145427052|NCT03648372|524419554|FG009|Overall Study|Start of a New Systemic Treatment|0|||
145427053|NCT03648372|524419555|FG010|Overall Study|Start of a New Systemic Treatment|1|||
145427054|NCT03648372|524419556|FG011|Overall Study|Start of a New Systemic Treatment|0|||
145427055|NCT03648372|524419557|FG012|Overall Study|Start of a New Systemic Treatment|0|||
145427056|NCT03648372|524419558|FG013|Overall Study|Start of a New Systemic Treatment|0|||
145427057|NCT03648372|524419559|FG014|Overall Study|Start of a New Systemic Treatment|0|||
145427058|NCT03648372|524419560|FG015|Overall Study|Start of a New Systemic Treatment|0|||
145427059|NCT03648372|524419561|FG016|Overall Study|Start of a New Systemic Treatment|0|||
145427060|NCT03648372|524419562|FG017|Overall Study|Start of a New Systemic Treatment|0|||
145427061|NCT03648372|524419563|FG018|Overall Study|Start of a New Systemic Treatment|0|||
145427062|NCT03648372|524419564|FG019|Overall Study|Start of a New Systemic Treatment|0|||
145427063|NCT03648372|524419565|FG020|Overall Study|Start of a New Systemic Treatment|0|||
145427064|NCT03514134|524420942|FG000|Overall Study|Lost to Follow-up|0|||
145427065|NCT03514134|524420943|FG001|Overall Study|Lost to Follow-up|1|||
145427066|NCT00003645|524420944|FG000|Overall Study|Death|4|||
145427067|NCT00003645|524420945|FG001|Overall Study|Death|1|||
145427068|NCT00003645|524420944|FG000|Overall Study|Lost to Follow-up|7|||
145427069|NCT00003645|524420945|FG001|Overall Study|Lost to Follow-up|8|||
145427070|NCT00003645|524420944|FG000|Overall Study|Withdrawal by Subject|1|||
145427071|NCT00003645|524420945|FG001|Overall Study|Withdrawal by Subject|3|||
145427072|NCT03360344|524420946|FG000|Overall Study|Withdrawal by Subject|0|||
145427073|NCT03360344|524420947|FG001|Overall Study|Withdrawal by Subject|1|||
145427074|NCT03360344|524420948|FG002|Overall Study|Withdrawal by Subject|1|||
145427075|NCT00959049|524420953|FG000|Overall Study|Adverse Event|1|||
145427076|NCT00959049|524420954|FG001|Overall Study|Adverse Event|0|||
145427077|NCT00959049|524420955|FG002|Overall Study|Adverse Event|0|||
145427078|NCT00959049|524420956|FG003|Overall Study|Adverse Event|0|||
145427079|NCT00959049|524420957|FG004|Overall Study|Adverse Event|0|||
145427080|NCT00959049|524420958|FG005|Overall Study|Adverse Event|0|||
145427081|NCT00959049|524420953|FG000|Overall Study|Lost to Follow-up|17|||
145427082|NCT00959049|524420954|FG001|Overall Study|Lost to Follow-up|5|||
145427083|NCT00959049|524420955|FG002|Overall Study|Lost to Follow-up|1|||
145427084|NCT00959049|524420956|FG003|Overall Study|Lost to Follow-up|10|||
145427085|NCT00959049|524420957|FG004|Overall Study|Lost to Follow-up|9|||
145427086|NCT00959049|524420958|FG005|Overall Study|Lost to Follow-up|1|||
145427087|NCT00959049|524420953|FG000|Overall Study|Contraindicated medication|0|||
145427088|NCT00959049|524420954|FG001|Overall Study|Contraindicated medication|0|||
145427089|NCT00959049|524420955|FG002|Overall Study|Contraindicated medication|0|||
145427090|NCT00959049|524420956|FG003|Overall Study|Contraindicated medication|1|||
145427091|NCT00959049|524420957|FG004|Overall Study|Contraindicated medication|0|||
145427092|NCT00959049|524420958|FG005|Overall Study|Contraindicated medication|0|||
145427093|NCT00959049|524420953|FG000|Overall Study|Withdrawal by Subject|0|||
145427094|NCT00959049|524420954|FG001|Overall Study|Withdrawal by Subject|2|||
145427095|NCT00959049|524420955|FG002|Overall Study|Withdrawal by Subject|0|||
145427096|NCT00959049|524420956|FG003|Overall Study|Withdrawal by Subject|0|||
145427097|NCT00959049|524420957|FG004|Overall Study|Withdrawal by Subject|0|||
145427098|NCT00959049|524420958|FG005|Overall Study|Withdrawal by Subject|0|||
145427099|NCT01892189|524420961|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
145427100|NCT01892189|524420962|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
145427101|NCT01892189|524420963|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
145427102|NCT01892189|524420964|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
145427103|NCT01892189|524420965|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
145427104|NCT01892189|524420966|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
145427105|NCT01892189|524420967|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
145427106|NCT01892189|524420968|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
145427107|NCT01892189|524420969|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
145427108|NCT01892189|524420961|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145427109|NCT01892189|524420962|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145427110|NCT01892189|524420963|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
145427111|NCT01892189|524420964|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145427112|NCT01892189|524420965|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145427113|NCT01892189|524420966|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145427114|NCT01892189|524420967|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145427115|NCT01892189|524420968|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145427116|NCT01892189|524420969|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145427117|NCT01892189|524420961|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427118|NCT01892189|524420962|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427119|NCT01892189|524420963|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427120|NCT01892189|524420964|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427121|NCT01892189|524420965|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427122|NCT01892189|524420966|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
145427123|NCT01892189|524420967|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427124|NCT01892189|524420968|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427125|NCT01892189|524420969|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
145427126|NCT00095576|524420970|FG000|Overall Study|Adverse Event|5|||
145427127|NCT00095576|524420971|FG001|Overall Study|Adverse Event|3|||
145427128|NCT00095576|524420970|FG000|Overall Study|Lost to Follow-up|233|||
145427129|NCT00095576|524420971|FG001|Overall Study|Lost to Follow-up|229|||
145427130|NCT00095576|524420970|FG000|Overall Study|Protocol Violation|1|||
145427131|NCT00095576|524420971|FG001|Overall Study|Protocol Violation|0|||
145427132|NCT00095576|524420970|FG000|Overall Study|Withdrawal by Subject|34|||
145427133|NCT00095576|524420971|FG001|Overall Study|Withdrawal by Subject|47|||
145427134|NCT00095576|524420970|FG000|Overall Study|Option to switch to a rollover study|1097|||
145427135|NCT00095576|524420971|FG001|Overall Study|Option to switch to a rollover study|1099|||
145427136|NCT00095576|524420970|FG000|Overall Study|Site terminated|75|||
145427137|NCT00095576|524420971|FG001|Overall Study|Site terminated|67|||
145427138|NCT00095576|524420970|FG000|Overall Study|Subject moved|30|||
145427139|NCT00095576|524420971|FG001|Overall Study|Subject moved|36|||
145427140|NCT01344356|524420972|FG000|Overall Study|Physician Decision|0|||
145427141|NCT01344356|524420973|FG001|Overall Study|Physician Decision|3|||
145427142|NCT01344356|524420972|FG000|Overall Study|Lost to Follow-up|0|||
145581151|NCT01831089|524980830|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
145581152|NCT01831089|524980831|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
145581153|NCT01831089|524980826|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
145581154|NCT01831089|524980827|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
145581155|NCT01831089|524980828|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
145581156|NCT01831089|524980829|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
145581157|NCT01831089|524980830|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
145373651|NCT03409107|524219089|FG000|Overall Study|Adverse Event|5|||
145373652|NCT03409107|524219090|FG001|Overall Study|Adverse Event|3|||
145373653|NCT00916344|524219091|FG000|Overall Study|Death|2|||
145373654|NCT00916344|524219091|FG000|Overall Study|ICD upgrade|1|||
145373655|NCT00916344|524219091|FG000|Overall Study|Drop-out|5|||
145373656|NCT03687372|524219096|FG000|Overall Study|Lost to Follow-up|12|||
145373657|NCT03687372|524219097|FG001|Overall Study|Lost to Follow-up|21|||
145373658|NCT03687372|524219096|FG000|Overall Study|Withdrawal by Subject|4|||
145373659|NCT03687372|524219097|FG001|Overall Study|Withdrawal by Subject|17|||
145373660|NCT03687372|524219096|FG000|Overall Study|Investigator Decision|1|||
145373661|NCT03687372|524219097|FG001|Overall Study|Investigator Decision|1|||
145373662|NCT03602391|524219100|FG000|Overall Study|COVID-19|7|||
145373663|NCT03602391|524219101|FG001|Overall Study|COVID-19|6|||
145373664|NCT00705718|524219112|FG000|Overall Study|Death|6|||
145373665|NCT00705718|524219113|FG001|Overall Study|Death|6|||
145373666|NCT00705718|524219112|FG000|Overall Study|Not due for Visit|0|||
145373667|NCT00705718|524219113|FG001|Overall Study|Not due for Visit|12|||
145373668|NCT00705718|524219112|FG000|Overall Study|Follow up not done|1|||
145373669|NCT00705718|524219113|FG001|Overall Study|Follow up not done|4|||
145373670|NCT02954653|524219114|FG000|Overall Study|Death|3|||
145373671|NCT02954653|524219115|FG001|Overall Study|Death|1|||
145373672|NCT02954653|524219116|FG002|Overall Study|Death|0|||
145373673|NCT02954653|524219117|FG003|Overall Study|Death|0|||
145373674|NCT02954653|524219118|FG004|Overall Study|Death|0|||
145373675|NCT02954653|524219119|FG005|Overall Study|Death|0|||
145373676|NCT02954653|524219120|FG006|Overall Study|Death|0|||
145373677|NCT02954653|524219121|FG007|Overall Study|Death|0|||
145373678|NCT02954653|524219122|FG008|Overall Study|Death|0|||
145373679|NCT02954653|524219114|FG000|Overall Study|Randomized but did not receive treatment|1|||
145373680|NCT02954653|524219115|FG001|Overall Study|Randomized but did not receive treatment|0|||
145373681|NCT02954653|524219116|FG002|Overall Study|Randomized but did not receive treatment|0|||
145373682|NCT02954653|524219117|FG003|Overall Study|Randomized but did not receive treatment|0|||
145373683|NCT02954653|524219118|FG004|Overall Study|Randomized but did not receive treatment|0|||
145373684|NCT02954653|524219119|FG005|Overall Study|Randomized but did not receive treatment|0|||
145373685|NCT02954653|524219120|FG006|Overall Study|Randomized but did not receive treatment|0|||
145373686|NCT02954653|524219121|FG007|Overall Study|Randomized but did not receive treatment|0|||
145373687|NCT02954653|524219122|FG008|Overall Study|Randomized but did not receive treatment|0|||
145373688|NCT02954653|524219114|FG000|Overall Study|Started another anti-cancer therapy|0|||
145373689|NCT02954653|524219115|FG001|Overall Study|Started another anti-cancer therapy|1|||
145373690|NCT02954653|524219116|FG002|Overall Study|Started another anti-cancer therapy|0|||
145373691|NCT02954653|524219117|FG003|Overall Study|Started another anti-cancer therapy|0|||
145373692|NCT02954653|524219118|FG004|Overall Study|Started another anti-cancer therapy|0|||
145373693|NCT02954653|524219119|FG005|Overall Study|Started another anti-cancer therapy|0|||
145373694|NCT02954653|524219120|FG006|Overall Study|Started another anti-cancer therapy|0|||
145373695|NCT02954653|524219121|FG007|Overall Study|Started another anti-cancer therapy|0|||
145373696|NCT02954653|524219122|FG008|Overall Study|Started another anti-cancer therapy|0|||
145373697|NCT02954653|524219114|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
145373698|NCT02954653|524219115|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
145373699|NCT02954653|524219116|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
145373700|NCT02954653|524219117|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
145373701|NCT02954653|524219118|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
145373702|NCT02954653|524219119|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
145373703|NCT02954653|524219120|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
145373704|NCT02954653|524219121|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
145373705|NCT02954653|524219122|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
145373706|NCT03054064|524219123|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
145373707|NCT03054064|524219123|FG000|Overall Study|Investigator Decision|2|||
145373708|NCT03054064|524219123|FG000|Overall Study|Bladder Issue|1|||
145581158|NCT01831089|524980831|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
145373709|NCT03054064|524219123|FG000|Overall Study|High Blood Pressure|1|||
145373710|NCT03054064|524219123|FG000|Overall Study|Change in Status|1|||
145373711|NCT01459718|524219126|FG000|Overall Study|Physician Decision|1|||
145373712|NCT01459718|524219126|FG000|Overall Study|Lost to Follow-up|1|||
145373713|NCT01459718|524219126|FG000|Overall Study|Adverse Event|1|||
145373714|NCT00581542|524219127|FG000|Overall Study|they met an exclusion criteria|2|||
145373715|NCT00581542|524219128|FG001|Overall Study|they met an exclusion criteria|2|||
145373716|NCT00581542|524219127|FG000|Overall Study|Lost to Follow-up|9|||
145581159|NCT01831089|524980826|FG000|Cohort III: Dose Level 3|Global end of study|0|||
145373717|NCT00581542|524219128|FG001|Overall Study|Lost to Follow-up|21|||
145373718|NCT01546571|524219129|FG000|Overall Study|Adverse Event|1|||
145373719|NCT01546571|524219130|FG001|Overall Study|Adverse Event|0|||
145373720|NCT01546571|524219131|FG002|Overall Study|Adverse Event|0|||
145373721|NCT01546571|524219132|FG003|Overall Study|Adverse Event|1|||
145373722|NCT01546571|524219133|FG004|Overall Study|Adverse Event|0|||
145373723|NCT01546571|524219129|FG000|Overall Study|assigned placebo in Part A|0|||
145373724|NCT01546571|524219130|FG001|Overall Study|assigned placebo in Part A|0|||
145373725|NCT01546571|524219131|FG002|Overall Study|assigned placebo in Part A|22|||
145373726|NCT01546571|524219132|FG003|Overall Study|assigned placebo in Part A|0|||
145373727|NCT01546571|524219133|FG004|Overall Study|assigned placebo in Part A|0|||
145373728|NCT01546571|524219129|FG000|Overall Study|Death|0|||
145373729|NCT01546571|524219130|FG001|Overall Study|Death|1|||
145373730|NCT01546571|524219131|FG002|Overall Study|Death|0|||
145373731|NCT01546571|524219132|FG003|Overall Study|Death|0|||
145373732|NCT01546571|524219133|FG004|Overall Study|Death|0|||
145373733|NCT01546571|524219129|FG000|Overall Study|Lost to Follow-up|0|||
145373734|NCT01546571|524219130|FG001|Overall Study|Lost to Follow-up|0|||
145373735|NCT01546571|524219131|FG002|Overall Study|Lost to Follow-up|2|||
145373736|NCT01546571|524219132|FG003|Overall Study|Lost to Follow-up|2|||
145373737|NCT01546571|524219133|FG004|Overall Study|Lost to Follow-up|3|||
145373738|NCT01546571|524219129|FG000|Overall Study|Pregnancy|0|||
145373739|NCT01546571|524219130|FG001|Overall Study|Pregnancy|0|||
145373740|NCT01546571|524219131|FG002|Overall Study|Pregnancy|0|||
145373741|NCT01546571|524219132|FG003|Overall Study|Pregnancy|1|||
145373742|NCT01546571|524219133|FG004|Overall Study|Pregnancy|0|||
145373743|NCT01546571|524219129|FG000|Overall Study|Disease Progression|20|||
145373744|NCT01546571|524219130|FG001|Overall Study|Disease Progression|18|||
145373745|NCT01546571|524219131|FG002|Overall Study|Disease Progression|15|||
145373746|NCT01546571|524219132|FG003|Overall Study|Disease Progression|73|||
145373747|NCT01546571|524219133|FG004|Overall Study|Disease Progression|37|||
145373748|NCT01546571|524219129|FG000|Overall Study|Withdrawal by Subject|1|||
145373749|NCT01546571|524219130|FG001|Overall Study|Withdrawal by Subject|2|||
145373750|NCT01546571|524219131|FG002|Overall Study|Withdrawal by Subject|4|||
145373751|NCT01546571|524219132|FG003|Overall Study|Withdrawal by Subject|9|||
145373752|NCT01546571|524219133|FG004|Overall Study|Withdrawal by Subject|2|||
145373753|NCT01546571|524219129|FG000|Overall Study|Intercurrent Illness|1|||
145373754|NCT01546571|524219130|FG001|Overall Study|Intercurrent Illness|2|||
145373755|NCT01546571|524219131|FG002|Overall Study|Intercurrent Illness|0|||
145373756|NCT01546571|524219132|FG003|Overall Study|Intercurrent Illness|0|||
145373757|NCT01546571|524219133|FG004|Overall Study|Intercurrent Illness|0|||
145373758|NCT01546571|524219129|FG000|Overall Study|Other Cancers|0|||
145373759|NCT01546571|524219130|FG001|Overall Study|Other Cancers|0|||
145373760|NCT01546571|524219131|FG002|Overall Study|Other Cancers|0|||
145373761|NCT01546571|524219132|FG003|Overall Study|Other Cancers|3|||
145373762|NCT01546571|524219133|FG004|Overall Study|Other Cancers|1|||
145373763|NCT01546571|524219129|FG000|Overall Study|Other|0|||
145373764|NCT01546571|524219130|FG001|Overall Study|Other|0|||
145373765|NCT01546571|524219131|FG002|Overall Study|Other|3|||
145373766|NCT01546571|524219132|FG003|Overall Study|Other|0|||
145373767|NCT01546571|524219133|FG004|Overall Study|Other|0|||
145373768|NCT01880086|524219136|FG000|Overall Study|Lost to Follow-up|1|||
145373769|NCT01880086|524219137|FG001|Overall Study|Lost to Follow-up|1|||
145373770|NCT05174949|524219143|FG000|Overall Study|Physician Decision|1|||
145373771|NCT05174949|524219144|FG001|Overall Study|Physician Decision|2|||
145373772|NCT05174949|524219145|FG002|Overall Study|Physician Decision|0|||
145373773|NCT05174949|524219146|FG003|Overall Study|Physician Decision|1|||
145373774|NCT05174949|524219147|FG004|Overall Study|Physician Decision|0|||
145373775|NCT05174949|524219148|FG005|Overall Study|Physician Decision|0|||
145373776|NCT05174949|524219143|FG000|Overall Study|Withdrawal by Subject|0|||
145373777|NCT05174949|524219144|FG001|Overall Study|Withdrawal by Subject|1|||
145373778|NCT05174949|524219145|FG002|Overall Study|Withdrawal by Subject|0|||
145373779|NCT05174949|524219146|FG003|Overall Study|Withdrawal by Subject|0|||
145373780|NCT05174949|524219147|FG004|Overall Study|Withdrawal by Subject|0|||
145373781|NCT05174949|524219148|FG005|Overall Study|Withdrawal by Subject|0|||
145373782|NCT05174949|524219143|FG000|Overall Study|Lost to Follow-up|0|||
145373783|NCT05174949|524219144|FG001|Overall Study|Lost to Follow-up|0|||
145373784|NCT05174949|524219145|FG002|Overall Study|Lost to Follow-up|0|||
145373785|NCT05174949|524219146|FG003|Overall Study|Lost to Follow-up|1|||
145373786|NCT05174949|524219147|FG004|Overall Study|Lost to Follow-up|0|||
145373787|NCT05174949|524219148|FG005|Overall Study|Lost to Follow-up|0|||
145373788|NCT01123941|524219151|FG000|Overall Study|Lost to Follow-up|2|||
145373789|NCT01123941|524219152|FG001|Overall Study|Lost to Follow-up|1|||
145373790|NCT05083923|524219160|FG000|Overall Study|Adverse Event|2|||
145373791|NCT05083923|524219161|FG001|Overall Study|Adverse Event|0|||
145373792|NCT05083923|524219160|FG000|Overall Study|Lack of Efficacy|1|||
145373793|NCT05083923|524219161|FG001|Overall Study|Lack of Efficacy|3|||
145373794|NCT05083923|524219160|FG000|Overall Study|Withdrawal by Subject|2|||
145373795|NCT05083923|524219161|FG001|Overall Study|Withdrawal by Subject|6|||
145373796|NCT05083923|524219160|FG000|Overall Study|Reason Not Specified|0|||
145623728|NCT03473756|525134028|FG000|Overall Study|Lack of Efficacy|3|||
145623729|NCT03473756|525134029|FG001|Overall Study|Lack of Efficacy|10|||
145623730|NCT03473756|525134028|FG000|Overall Study|Physician Decision|0|||
145623731|NCT03473756|525134029|FG001|Overall Study|Physician Decision|2|||
145623732|NCT03473756|525134028|FG000|Overall Study|End of study treatment|0|||
145623733|NCT03473756|525134029|FG001|Overall Study|End of study treatment|2|||
145623734|NCT03473756|525134028|FG000|Overall Study|Lost to Follow-up|0|||
145623735|NCT03473756|525134029|FG001|Overall Study|Lost to Follow-up|1|||
145623736|NCT03714022|525134030|FG000|Overall Study|Adverse Event|1|||
145623737|NCT03714022|525134031|FG001|Overall Study|Adverse Event|0|||
145623738|NCT03714022|525134030|FG000|Overall Study|Consent withdrawal|0|||
145623739|NCT03714022|525134031|FG001|Overall Study|Consent withdrawal|1|||
145623740|NCT03714022|525134030|FG000|Overall Study|Lost to Follow-up|3|||
145623741|NCT03714022|525134031|FG001|Overall Study|Lost to Follow-up|2|||
145623742|NCT01007552|525134032|FG000|Overall Study|Withdrawal by Subject|1|||
145623743|NCT01106976|525135557|FG000|Overall Study|Lost to Follow-up|8|||
145623744|NCT04170023|525135562|FG000|LTE Period|Withdrawal by Subject|1|||
145623745|NCT04170023|525135563|FG001|LTE Period|Withdrawal by Subject|0|||
145623746|NCT04170023|525135564|FG002|LTE Period|Withdrawal by Subject|0|||
145623747|NCT04170023|525135562|FG000|LTE Period|Study Termination|11|||
145623748|NCT04170023|525135563|FG001|LTE Period|Study Termination|11|||
145623749|NCT04170023|525135564|FG002|LTE Period|Study Termination|5|||
145623750|NCT03836664|525135567|FG000|Overall Study|Didn't complete forms and lost drug|3|||
145623751|NCT03836664|525135568|FG001|Overall Study|Didn't complete forms and lost drug|3|||
145623752|NCT03566680|525135569|FG000|Overall Study|Pregnancy|1|||
145623753|NCT03566680|525135569|FG000|Overall Study|Lost to Follow-up|13|||
145623754|NCT03566680|525135569|FG000|Overall Study|Withdrawal by Subject|3|||
145623755|NCT02724020|525135570|FG000|Overall Study|Death|16|||
145623756|NCT02724020|525135571|FG001|Overall Study|Death|18|||
145623757|NCT02724020|525135572|FG002|Overall Study|Death|19|||
145623758|NCT02724020|525135570|FG000|Overall Study|Lost to Follow-up|0|||
145623759|NCT02724020|525135571|FG001|Overall Study|Lost to Follow-up|3|||
145623760|NCT02724020|525135572|FG002|Overall Study|Lost to Follow-up|0|||
145623761|NCT02724020|525135570|FG000|Overall Study|Site Terminated by Sponsor|15|||
145623762|NCT02724020|525135571|FG001|Overall Study|Site Terminated by Sponsor|8|||
145623763|NCT02724020|525135572|FG002|Overall Study|Site Terminated by Sponsor|8|||
145623764|NCT02724020|525135570|FG000|Overall Study|Withdrawal by Subject|1|||
145623765|NCT02724020|525135571|FG001|Overall Study|Withdrawal by Subject|3|||
145427143|NCT01344356|524420973|FG001|Overall Study|Lost to Follow-up|6|||
145427144|NCT00856557|524420974|FG000|Overall Study|No patients with contextual flags|12|||
145623766|NCT02724020|525135572|FG002|Overall Study|Withdrawal by Subject|5|||
145623767|NCT04337489|525135573|FG000|Overall Study|Withdrawal by Subject|1|||
145623768|NCT04537949|525135577|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
145623769|NCT04537949|525135578|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
145623770|NCT04537949|525135579|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
145623771|NCT04537949|525135580|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
145373797|NCT05083923|524219161|FG001|Overall Study|Reason Not Specified|1|||
145373798|NCT03099694|524219164|FG000|Overall Study|Withdrawal by Subject|11|||
145373799|NCT03099694|524219165|FG001|Overall Study|Withdrawal by Subject|13|||
145373800|NCT03099694|524219164|FG000|Overall Study|Lost to Follow-up|9|||
145373801|NCT03099694|524219165|FG001|Overall Study|Lost to Follow-up|5|||
145373802|NCT02291601|524219166|FG000|Abdomen|Did not qualify|333|||
145373803|NCT02291601|524219167|FG001|Abdomen|Did not qualify|54|||
145373804|NCT02291601|524219168|FG002|Abdomen|Did not qualify|339|||
145373805|NCT02291601|524219166|FG000|Groin|Did not qualify|183|||
145373806|NCT02291601|524219167|FG001|Groin|Did not qualify|30|||
145373807|NCT02291601|524219168|FG002|Groin|Did not qualify|177|||
145373808|NCT03379753|524219169|FG000|Overall Study|Withdrawal by Subject|2|||
145373809|NCT03379753|524219170|FG001|Overall Study|Withdrawal by Subject|1|||
145373810|NCT03379753|524219169|FG000|Overall Study|not having correct procedure|1|||
145373811|NCT03379753|524219170|FG001|Overall Study|not having correct procedure|2|||
145373812|NCT03379753|524219169|FG000|Overall Study|No primary outcome|12|||
145373813|NCT03379753|524219170|FG001|Overall Study|No primary outcome|22|||
145373814|NCT04017832|524219184|FG000|Overall Study|Withdrawal by Subject|13|||
145373815|NCT04017832|524219185|FG001|Overall Study|Withdrawal by Subject|12|||
145373816|NCT04017832|524219186|FG002|Overall Study|Withdrawal by Subject|21|||
145373817|NCT04017832|524219187|FG003|Overall Study|Withdrawal by Subject|7|||
145373818|NCT04017832|524219184|FG000|Overall Study|Lost to Follow-up|0|||
145373819|NCT04017832|524219185|FG001|Overall Study|Lost to Follow-up|3|||
145373820|NCT04017832|524219186|FG002|Overall Study|Lost to Follow-up|3|||
145373821|NCT04017832|524219187|FG003|Overall Study|Lost to Follow-up|1|||
145373822|NCT04017832|524219184|FG000|Overall Study|Physician Decision|1|||
145427145|NCT00856557|524420975|FG001|Overall Study|No patients with contextual flags|16|||
145623772|NCT04537949|525135581|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
145623773|NCT04537949|525135582|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
145623774|NCT04537949|525135583|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
145623775|NCT04537949|525135584|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
145581160|NCT01831089|524980827|FG001|Cohort III: Dose Level 3|Global end of study|0|||
145581161|NCT01831089|524980828|FG002|Cohort III: Dose Level 3|Global end of study|1|||
145581162|NCT01831089|524980829|FG003|Cohort III: Dose Level 3|Global end of study|0|||
145581163|NCT01831089|524980830|FG004|Cohort III: Dose Level 3|Global end of study|0|||
145581164|NCT01831089|524980831|FG005|Cohort III: Dose Level 3|Global end of study|0|||
145581165|NCT01831089|524980826|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
145581166|NCT01831089|524980827|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
145581167|NCT01831089|524980828|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
145581168|NCT01831089|524980829|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
145581169|NCT01831089|524980830|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
145581170|NCT01831089|524980831|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
145581171|NCT01831089|524980826|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
145581172|NCT01831089|524980827|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
145581173|NCT01831089|524980828|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
145581174|NCT01831089|524980829|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
145581175|NCT01831089|524980830|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
145581176|NCT01831089|524980831|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
145581177|NCT01831089|524980826|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
145581178|NCT01831089|524980827|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
145581179|NCT01831089|524980828|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
145581180|NCT01831089|524980829|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
145581181|NCT01831089|524980830|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
145581182|NCT01831089|524980831|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
145581183|NCT01831089|524980826|FG000|Cohort V: Dose Level 5|Death|0|||
145581184|NCT01831089|524980827|FG001|Cohort V: Dose Level 5|Death|0|||
145581185|NCT01831089|524980828|FG002|Cohort V: Dose Level 5|Death|0|||
145581186|NCT01831089|524980829|FG003|Cohort V: Dose Level 5|Death|0|||
145581187|NCT01831089|524980830|FG004|Cohort V: Dose Level 5|Death|1|||
145581188|NCT01831089|524980831|FG005|Cohort V: Dose Level 5|Death|0|||
145581189|NCT01831089|524980826|FG000|Cohort V: Dose Level 5|Global end of study|0|||
145581190|NCT01831089|524980827|FG001|Cohort V: Dose Level 5|Global end of study|0|||
145581191|NCT01831089|524980828|FG002|Cohort V: Dose Level 5|Global end of study|0|||
145581192|NCT01831089|524980829|FG003|Cohort V: Dose Level 5|Global end of study|0|||
145427146|NCT03673176|524420976|FG000|Overall Study|Death prior to intervention|1|||
145427147|NCT03673176|524420976|FG000|Overall Study|Death following intervention|3|||
145427148|NCT03673176|524420976|FG000|Overall Study|Withdrawal by Subject|1|||
145427149|NCT02378480|524420977|FG000|Overall Study|Physician Decision|1|||
145427150|NCT02378480|524420978|FG001|Overall Study|Physician Decision|1|||
145427151|NCT02378480|524420977|FG000|Overall Study|Death|1|||
145427152|NCT02378480|524420978|FG001|Overall Study|Death|2|||
145427153|NCT02378480|524420977|FG000|Overall Study|Randomized, but Not Treated|6|||
145427154|NCT02378480|524420978|FG001|Overall Study|Randomized, but Not Treated|4|||
145427155|NCT02378480|524420977|FG000|Overall Study|Adverse Event|0|||
145427156|NCT02378480|524420978|FG001|Overall Study|Adverse Event|1|||
145427157|NCT02378480|524420977|FG000|Overall Study|Missed EOT/PTE Visit|1|||
145427158|NCT02378480|524420978|FG001|Overall Study|Missed EOT/PTE Visit|2|||
145427159|NCT02378480|524420977|FG000|Overall Study|Withdrawal by Subject|9|||
145427160|NCT02378480|524420978|FG001|Overall Study|Withdrawal by Subject|4|||
145427161|NCT02378480|524420977|FG000|Overall Study|Lost to Follow-up|10|||
145427162|NCT02378480|524420978|FG001|Overall Study|Lost to Follow-up|18|||
145427163|NCT04507763|524420980|FG000|Overall Study|Participants did not meet entrance criteria|201|||
145427164|NCT01905540|524420981|FG000|Period 3|Other|1|||
145427165|NCT01905540|524420982|FG001|Period 3|Other|0|||
145427166|NCT01905540|524420983|FG002|Period 3|Other|1|||
145427167|NCT01905540|524420984|FG003|Period 3|Other|1|||
145427168|NCT03847519|524420985|FG000|Overall Study|Death|5|||
145427169|NCT03847519|524420986|FG001|Overall Study|Death|8|||
145427170|NCT03847519|524420987|FG002|Overall Study|Death|1|||
145427171|NCT03847519|524420985|FG000|Overall Study|Lost to Follow-up|1|||
145427172|NCT03847519|524420986|FG001|Overall Study|Lost to Follow-up|2|||
145427173|NCT03847519|524420987|FG002|Overall Study|Lost to Follow-up|0|||
145427174|NCT03847519|524420985|FG000|Overall Study|Study Terminated by Sponsor|0|||
145427175|NCT03847519|524420986|FG001|Overall Study|Study Terminated by Sponsor|3|||
145427176|NCT03847519|524420987|FG002|Overall Study|Study Terminated by Sponsor|2|||
145427177|NCT02609503|524420992|FG000|Overall Study|Adverse Event|1|||
145427178|NCT02609503|524420992|FG000|Overall Study|Death|1|||
145427179|NCT02609503|524420992|FG000|Overall Study|Withdrawal by Subject|1|||
145427180|NCT02609503|524420992|FG000|Overall Study|Disease progression|1|||
145427181|NCT02457065|524420998|FG000|Overall Study|Lost to Follow-up|9|||
145427182|NCT02457065|524420999|FG001|Overall Study|Lost to Follow-up|11|||
145427183|NCT04642079|524421002|FG000|Overall Study|Lost to Follow-up|2|||
145427184|NCT04642079|524421003|FG001|Overall Study|Lost to Follow-up|5|||
145427185|NCT04642079|524421004|FG002|Overall Study|Lost to Follow-up|2|||
145581193|NCT01831089|524980830|FG004|Cohort V: Dose Level 5|Global end of study|2|||
145581194|NCT01831089|524980831|FG005|Cohort V: Dose Level 5|Global end of study|0|||
145581195|NCT01831089|524980826|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
145427186|NCT04642079|524421005|FG003|Overall Study|Lost to Follow-up|0|||
145427187|NCT04642079|524421002|FG000|Overall Study|Withdrawal by Subject|0|||
145427188|NCT04642079|524421003|FG001|Overall Study|Withdrawal by Subject|4|||
145427189|NCT04642079|524421004|FG002|Overall Study|Withdrawal by Subject|1|||
145427190|NCT04642079|524421005|FG003|Overall Study|Withdrawal by Subject|2|||
145427191|NCT04642079|524421002|FG000|Overall Study|Other|0|||
145427192|NCT04642079|524421003|FG001|Overall Study|Other|0|||
145427193|NCT04642079|524421004|FG002|Overall Study|Other|0|||
145427194|NCT04642079|524421005|FG003|Overall Study|Other|1|||
145427195|NCT04642079|524421002|FG000|Overall Study|No longer met eligibility criteria|1|||
145427196|NCT04642079|524421003|FG001|Overall Study|No longer met eligibility criteria|0|||
145427197|NCT04642079|524421004|FG002|Overall Study|No longer met eligibility criteria|1|||
145427198|NCT04642079|524421005|FG003|Overall Study|No longer met eligibility criteria|1|||
145427199|NCT02796651|524421007|FG000|Overall Study|Adverse Event|6|||
145427200|NCT02796651|524421007|FG000|Overall Study|Lost to Follow-up|1|||
145427201|NCT02796651|524421007|FG000|Overall Study|Withdrawal by Subject|4|||
145427202|NCT02796651|524421007|FG000|Overall Study|Protocol Violation|4|||
145427203|NCT02796651|524421007|FG000|Overall Study|Lack of Efficacy|1|||
145427204|NCT02796651|524421007|FG000|Overall Study|Other|10|||
145427205|NCT05360784|524421008|FG000|Overall Study|Discontinued|25|||
145427206|NCT05360784|524421009|FG001|Overall Study|Discontinued|11|||
145427207|NCT02251041|524421013|FG000|Overall Study|Did not receive intervention|15|||
145427208|NCT02251041|524421014|FG001|Overall Study|Did not receive intervention|4|||
145427209|NCT04918771|524421015|FG000|Overall Study|Withdrawal by Subject|4|||
145427210|NCT04918771|524421016|FG001|Overall Study|Withdrawal by Subject|5|||
145427211|NCT04918771|524421015|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
145427212|NCT04918771|524421016|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
145427213|NCT02971163|524421017|FG000|Overall Study|Lost to Follow-up|4|||
145427214|NCT02971163|524421018|FG001|Overall Study|Lost to Follow-up|2|||
145427215|NCT02940223|524421027|FG000|Overall Study|Failed Requirement|2|||
145427216|NCT02940223|524421028|FG001|Overall Study|Failed Requirement|0|||
145427217|NCT00526799|524421029|FG000|Overall Study|Withdrawal by Subject|1|||
145427218|NCT00526799|524421030|FG001|Overall Study|Withdrawal by Subject|0|||
145427219|NCT00526799|524421029|FG000|Overall Study|Intercurrent Complicating Disease|0|||
145427220|NCT00526799|524421030|FG001|Overall Study|Intercurrent Complicating Disease|1|||
145427221|NCT02871219|524421042|FG000|Overall Study|Adverse Event|15|||
145427222|NCT02871219|524421042|FG000|Overall Study|Death|3|||
145427223|NCT02871219|524421042|FG000|Overall Study|Progression|3|||
145427224|NCT02871219|524421042|FG000|Overall Study|Infections|7|||
145427225|NCT02871219|524421042|FG000|Overall Study|Infusion Related|4|||
145427226|NCT04134936|524421043|FG000|Overall Study|Adverse Event|3|||
145427227|NCT04134936|524421044|FG001|Overall Study|Adverse Event|2|||
145427228|NCT04134936|524421043|FG000|Overall Study|Withdrawal by Subject|2|||
145427229|NCT04134936|524421044|FG001|Overall Study|Withdrawal by Subject|3|||
145427230|NCT04134936|524421043|FG000|Overall Study|Physician Decision|0|||
145427231|NCT04134936|524421044|FG001|Overall Study|Physician Decision|1|||
145427232|NCT04134936|524421043|FG000|Overall Study|Progressive disease, joined another trial|1|||
145427233|NCT04134936|524421044|FG001|Overall Study|Progressive disease, joined another trial|0|||
145427234|NCT04134936|524421043|FG000|Overall Study|Progressive disease|1|||
145427235|NCT04134936|524421044|FG001|Overall Study|Progressive disease|0|||
145427236|NCT03518060|524421045|FG000|Overall Study|Death|1|||
145427237|NCT03518060|524421045|FG000|Overall Study|Poor adherence|1|||
145427238|NCT03518060|524421045|FG000|Overall Study|Withdrawal of informed consent|2|||
145427239|NCT03518060|524421045|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
145427240|NCT03518060|524421045|FG000|Overall Study|Physician Decision|7|||
145427241|NCT03518060|524421045|FG000|Overall Study|Adverse drug reactions|23|||
145581196|NCT01831089|524980827|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
145581197|NCT01831089|524980828|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
145581198|NCT01831089|524980829|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
145581199|NCT01831089|524980830|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
145581200|NCT01831089|524980831|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
145581201|NCT01831089|524980826|FG000|Cohort B: Arm B|Progressive disease|0|||
145427242|NCT03518060|524421045|FG000|Overall Study|Withdrawal by Subject|25|||
145427243|NCT03518060|524421045|FG000|Overall Study|Lost to Follow-up|13|||
145427244|NCT02097225|524421047|FG000|Dose Level 4|Adverse Event|0|||
145581202|NCT01831089|524980827|FG001|Cohort B: Arm B|Progressive disease|0|||
145581203|NCT01831089|524980828|FG002|Cohort B: Arm B|Progressive disease|0|||
145581204|NCT01831089|524980829|FG003|Cohort B: Arm B|Progressive disease|0|||
145427245|NCT02097225|524421048|FG001|Dose Level 4|Adverse Event|0|||
145427246|NCT02097225|524421049|FG002|Dose Level 4|Adverse Event|0|||
145427247|NCT02097225|524421050|FG003|Dose Level 4|Adverse Event|0|||
145427248|NCT02097225|524421051|FG004|Dose Level 4|Adverse Event|1|||
145427249|NCT01852214|524421053|FG000|Period 1|Adverse Event|1|||
145581205|NCT01831089|524980830|FG004|Cohort B: Arm B|Progressive disease|0|||
145427250|NCT01852214|524421054|FG001|Period 1|Adverse Event|2|||
145427251|NCT01852214|524421053|FG000|Period 1|Withdrawal by Subject|0|||
145427252|NCT01852214|524421054|FG001|Period 1|Withdrawal by Subject|1|||
145427253|NCT01852214|524421053|FG000|Washout Period|Withdrawal by Subject|0|||
145427254|NCT01852214|524421054|FG001|Washout Period|Withdrawal by Subject|1|||
145427255|NCT02679274|524421055|FG000|Overall Study|Withdrawal by Subject|1|||
145427256|NCT02679274|524421056|FG001|Overall Study|Withdrawal by Subject|0|||
145427257|NCT04976855|524421057|FG000|Part I|Withdrawal by Subject|0|||
145427258|NCT04976855|524421058|FG001|Part I|Withdrawal by Subject|1|||
145427259|NCT04976855|524421059|FG002|Part I|Withdrawal by Subject|0|||
145427260|NCT04976855|524421060|FG003|Part I|Withdrawal by Subject|0|||
145427261|NCT04976855|524421061|FG004|Part I|Withdrawal by Subject|0|||
145427262|NCT04976855|524421062|FG005|Part I|Withdrawal by Subject|0|||
145427263|NCT04976855|524421063|FG006|Part I|Withdrawal by Subject|0|||
145427264|NCT04976855|524421057|FG000|Part II|Adverse Event|0|||
145427265|NCT04976855|524421058|FG001|Part II|Adverse Event|0|||
145427266|NCT04976855|524421059|FG002|Part II|Adverse Event|0|||
145427267|NCT04976855|524421060|FG003|Part II|Adverse Event|1|||
145427268|NCT04976855|524421061|FG004|Part II|Adverse Event|0|||
145427269|NCT04976855|524421062|FG005|Part II|Adverse Event|0|||
145427270|NCT04976855|524421063|FG006|Part II|Adverse Event|0|||
145427271|NCT04976855|524421057|FG000|Part II|Withdrawal by Subject|0|||
145427272|NCT04976855|524421058|FG001|Part II|Withdrawal by Subject|0|||
145427273|NCT04976855|524421059|FG002|Part II|Withdrawal by Subject|0|||
145427274|NCT04976855|524421060|FG003|Part II|Withdrawal by Subject|0|||
145427275|NCT04976855|524421061|FG004|Part II|Withdrawal by Subject|1|||
145427276|NCT04976855|524421062|FG005|Part II|Withdrawal by Subject|0|||
145427277|NCT04976855|524421063|FG006|Part II|Withdrawal by Subject|0|||
145427278|NCT04976855|524421057|FG000|Part II|Lost to Follow-up|0|||
145427279|NCT04976855|524421058|FG001|Part II|Lost to Follow-up|0|||
145427280|NCT04976855|524421059|FG002|Part II|Lost to Follow-up|0|||
145427281|NCT04976855|524421060|FG003|Part II|Lost to Follow-up|0|||
145427282|NCT04976855|524421061|FG004|Part II|Lost to Follow-up|0|||
145427283|NCT04976855|524421062|FG005|Part II|Lost to Follow-up|1|||
145427284|NCT04976855|524421063|FG006|Part II|Lost to Follow-up|0|||
145427285|NCT05487378|524421064|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
145427286|NCT05487378|524421065|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
145427287|NCT05487378|524421064|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
145427288|NCT05487378|524421065|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
145427289|NCT01385995|524421073|FG000|Period 1, 2 Months|Physician Decision|1|||
145427290|NCT01385995|524421074|FG001|Period 1, 2 Months|Physician Decision|0|||
145427291|NCT00112385|524421075|FG000|Overall Study|Lost to Follow-up|1|||
145427292|NCT00112385|524421076|FG001|Overall Study|Lost to Follow-up|0|||
145427293|NCT00112385|524421075|FG000|Overall Study|Withdrawal by Subject|0|||
145427294|NCT00112385|524421076|FG001|Overall Study|Withdrawal by Subject|1|||
145427295|NCT00835172|524421092|FG000|Washout|Protocol Violation|0|||
145427296|NCT00835172|524421093|FG001|Washout|Protocol Violation|1|||
145427297|NCT04191135|524421101|FG000|Induction Treatment|Not Treated|2|||
145427298|NCT04191135|524421102|FG001|Induction Treatment|Not Treated|0|||
145427299|NCT04191135|524421103|FG002|Induction Treatment|Not Treated|0|||
145427300|NCT04191135|524421101|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
145427301|NCT04191135|524421102|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
145427302|NCT04191135|524421103|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
145581206|NCT01831089|524980831|FG005|Cohort B: Arm B|Progressive disease|8|||
145427303|NCT04191135|524421101|FG000|Induction Treatment|Adverse Event|25|||
145427304|NCT04191135|524421102|FG001|Induction Treatment|Adverse Event|0|||
145427305|NCT04191135|524421103|FG002|Induction Treatment|Adverse Event|0|||
145427306|NCT04191135|524421101|FG000|Induction Treatment|Clinical Progression|8|||
145427307|NCT04191135|524421102|FG001|Induction Treatment|Clinical Progression|0|||
145427308|NCT04191135|524421103|FG002|Induction Treatment|Clinical Progression|0|||
145427309|NCT04191135|524421101|FG000|Induction Treatment|Excluded Medication|1|||
145427310|NCT04191135|524421102|FG001|Induction Treatment|Excluded Medication|0|||
145427311|NCT04191135|524421103|FG002|Induction Treatment|Excluded Medication|0|||
145581207|NCT01831089|524980826|FG000|Cohort B: Arm B|Physician Decision|0|||
145581208|NCT01831089|524980827|FG001|Cohort B: Arm B|Physician Decision|0|||
145581209|NCT01831089|524980828|FG002|Cohort B: Arm B|Physician Decision|0|||
145581210|NCT01831089|524980829|FG003|Cohort B: Arm B|Physician Decision|0|||
145581211|NCT01831089|524980830|FG004|Cohort B: Arm B|Physician Decision|0|||
145581212|NCT01831089|524980831|FG005|Cohort B: Arm B|Physician Decision|2|||
145581213|NCT01831089|524980826|FG000|Cohort B: Arm B|Never treated|0|||
145427312|NCT04191135|524421101|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
145427313|NCT04191135|524421102|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
145427314|NCT04191135|524421103|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
145427315|NCT04191135|524421101|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
145427316|NCT04191135|524421102|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
145427317|NCT04191135|524421103|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
145427318|NCT04191135|524421101|FG000|Induction Treatment|Physician Decision|2|||
145427319|NCT04191135|524421102|FG001|Induction Treatment|Physician Decision|0|||
145581214|NCT01831089|524980827|FG001|Cohort B: Arm B|Never treated|0|||
145581215|NCT01831089|524980828|FG002|Cohort B: Arm B|Never treated|0|||
145427320|NCT04191135|524421103|FG002|Induction Treatment|Physician Decision|0|||
145427321|NCT04191135|524421101|FG000|Induction Treatment|Progressive Disease|135|||
145427322|NCT04191135|524421102|FG001|Induction Treatment|Progressive Disease|0|||
145427323|NCT04191135|524421103|FG002|Induction Treatment|Progressive Disease|0|||
145427324|NCT04191135|524421101|FG000|Induction Treatment|Protocol Violation|10|||
145427325|NCT04191135|524421102|FG001|Induction Treatment|Protocol Violation|0|||
145427326|NCT04191135|524421103|FG002|Induction Treatment|Protocol Violation|0|||
145427327|NCT04191135|524421101|FG000|Induction Treatment|Withdrawal by Subject|4|||
145427328|NCT04191135|524421102|FG001|Induction Treatment|Withdrawal by Subject|0|||
145427329|NCT04191135|524421103|FG002|Induction Treatment|Withdrawal by Subject|0|||
145427330|NCT04191135|524421101|FG000|Randomized Treatment|Death|0|||
145427331|NCT04191135|524421102|FG001|Randomized Treatment|Death|50|||
145427332|NCT04191135|524421103|FG002|Randomized Treatment|Death|54|||
145427333|NCT04191135|524421101|FG000|Randomized Treatment|Lost to Follow-up|0|||
145427334|NCT04191135|524421102|FG001|Randomized Treatment|Lost to Follow-up|0|||
145427335|NCT04191135|524421103|FG002|Randomized Treatment|Lost to Follow-up|1|||
145427336|NCT04191135|524421101|FG000|Randomized Treatment|Withdrawal by Subject|0|||
145427337|NCT04191135|524421102|FG001|Randomized Treatment|Withdrawal by Subject|2|||
145427338|NCT04191135|524421103|FG002|Randomized Treatment|Withdrawal by Subject|0|||
145427339|NCT04191135|524421101|FG000|Randomized Treatment|Ongoing in Trial|0|||
145427340|NCT04191135|524421102|FG001|Randomized Treatment|Ongoing in Trial|83|||
145427341|NCT04191135|524421103|FG002|Randomized Treatment|Ongoing in Trial|81|||
145427342|NCT01373281|524422499|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
145427343|NCT01373281|524422500|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
145427344|NCT01373281|524422499|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
145427345|NCT01373281|524422500|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
145427346|NCT01373281|524422499|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
145427347|NCT01373281|524422500|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
145427348|NCT01373281|524422499|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
145427349|NCT01373281|524422500|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
145427350|NCT01373281|524422499|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
145427351|NCT01373281|524422500|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
145427352|NCT01373281|524422499|FG000|Surveillance Expansion Period|Protocol Violation|9|||
145427353|NCT01373281|524422500|FG001|Surveillance Expansion Period|Protocol Violation|1|||
145427354|NCT01373281|524422499|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
145427355|NCT01373281|524422500|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
145427356|NCT01373281|524422499|FG000|Surveillance Expansion Period|Serious adverse event|3|||
145427357|NCT01373281|524422500|FG001|Surveillance Expansion Period|Serious adverse event|4|||
145427358|NCT00488293|524422513|FG000|Overall Study|Lost to Follow-up|28|||
145427359|NCT00488293|524422514|FG001|Overall Study|Lost to Follow-up|25|||
145427360|NCT00488293|524422513|FG000|Overall Study|Withdrawal by Subject|5|||
145427361|NCT00488293|524422514|FG001|Overall Study|Withdrawal by Subject|3|||
145427362|NCT00488293|524422513|FG000|Overall Study|Death|2|||
145427363|NCT00488293|524422514|FG001|Overall Study|Death|1|||
145427364|NCT00488293|524422513|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
145427365|NCT00488293|524422514|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
145427366|NCT00939185|524422515|FG000|Overall Study|Adverse Event|3|||
145427367|NCT00939185|524422515|FG000|Overall Study|Lack of Efficacy|1|||
145427368|NCT00939185|524422515|FG000|Overall Study|Lost to Follow-up|6|||
145427369|NCT00939185|524422515|FG000|Overall Study|Other|3|||
145427370|NCT00939185|524422515|FG000|Overall Study|Withdrawal by Subject|2|||
145427371|NCT00939185|524422515|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
145427372|NCT00363298|524422516|FG000|First Study Week|Lack of Efficacy|6|||
145427373|NCT00363298|524422517|FG001|First Study Week|Lack of Efficacy|5|||
145427374|NCT00363298|524422516|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
145427375|NCT00363298|524422517|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
145427376|NCT00133705|524422523|FG000|Overall Study|Withdrawal by Subject|2|||
145427377|NCT00133705|524422524|FG001|Overall Study|Withdrawal by Subject|3|||
145427378|NCT03468998|524422525|FG000|Overall Study|Withdrawal by Subject|1|||
145427379|NCT03468998|524422526|FG001|Overall Study|Withdrawal by Subject|1|||
145427380|NCT03468998|524422527|FG002|Overall Study|Withdrawal by Subject|0|||
145427381|NCT03468998|524422528|FG003|Overall Study|Withdrawal by Subject|4|||
145427382|NCT03468998|524422529|FG004|Overall Study|Withdrawal by Subject|1|||
145427383|NCT03468998|524422530|FG005|Overall Study|Withdrawal by Subject|0|||
145427384|NCT00836706|524422533|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
145427385|NCT00836706|524422534|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
145427386|NCT01992757|524422537|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
145427387|NCT03440411|524422538|FG000|Overall Study|Adverse Event|0|||
145427388|NCT03440411|524422539|FG001|Overall Study|Adverse Event|0|||
145427389|NCT03440411|524422540|FG002|Overall Study|Adverse Event|1|||
145427390|NCT03440411|524422541|FG003|Overall Study|Adverse Event|0|||
145427391|NCT03440411|524422538|FG000|Overall Study|PD|2|||
145581216|NCT01831089|524980829|FG003|Cohort B: Arm B|Never treated|0|||
145581217|NCT01831089|524980830|FG004|Cohort B: Arm B|Never treated|0|||
145427392|NCT03440411|524422539|FG001|Overall Study|PD|1|||
145427393|NCT03440411|524422540|FG002|Overall Study|PD|1|||
145427394|NCT03440411|524422541|FG003|Overall Study|PD|1|||
145427395|NCT03440411|524422538|FG000|Overall Study|Withdrawal by Subject|1|||
145427396|NCT03440411|524422539|FG001|Overall Study|Withdrawal by Subject|0|||
145427397|NCT03440411|524422540|FG002|Overall Study|Withdrawal by Subject|0|||
145427398|NCT03440411|524422541|FG003|Overall Study|Withdrawal by Subject|0|||
145427399|NCT03440411|524422538|FG000|Overall Study|Closed study by sponsor|0|||
145427400|NCT03440411|524422539|FG001|Overall Study|Closed study by sponsor|0|||
145427401|NCT03440411|524422540|FG002|Overall Study|Closed study by sponsor|0|||
145427402|NCT03440411|524422541|FG003|Overall Study|Closed study by sponsor|1|||
145427403|NCT00688740|524422542|FG000|Overall Study|Adverse Event|45|||
145581218|NCT01831089|524980831|FG005|Cohort B: Arm B|Never treated|2|||
145427404|NCT00688740|524422543|FG001|Overall Study|Adverse Event|8|||
145427405|NCT00688740|524422542|FG000|Overall Study|Death|2|||
145427406|NCT00688740|524422543|FG001|Overall Study|Death|2|||
145427407|NCT00688740|524422542|FG000|Overall Study|Lost to Follow-up|0|||
145427408|NCT00688740|524422543|FG001|Overall Study|Lost to Follow-up|1|||
145427409|NCT00688740|524422542|FG000|Overall Study|Consent Withdrawn|17|||
145427410|NCT00688740|524422543|FG001|Overall Study|Consent Withdrawn|17|||
145427411|NCT00688740|524422542|FG000|Overall Study|Breast Cancer Relapse|1|||
145427412|NCT00688740|524422543|FG001|Overall Study|Breast Cancer Relapse|4|||
145427413|NCT00688740|524422542|FG000|Overall Study|Violation of Inclusion Criteria|1|||
145427414|NCT00688740|524422543|FG001|Overall Study|Violation of Inclusion Criteria|3|||
145427415|NCT00567502|524422544|FG000|Overall Study|Lost to Follow-up|91|||
145427416|NCT00567502|524422545|FG001|Overall Study|Lost to Follow-up|14|||
145427417|NCT00567502|524422546|FG002|Overall Study|Lost to Follow-up|351|||
145427418|NCT00567502|524422547|FG003|Overall Study|Lost to Follow-up|2|||
145427419|NCT00567502|524422544|FG000|Overall Study|Death|65|||
145427420|NCT00567502|524422545|FG001|Overall Study|Death|16|||
145427421|NCT00567502|524422546|FG002|Overall Study|Death|360|||
145427422|NCT00567502|524422547|FG003|Overall Study|Death|5|||
145427423|NCT00567502|524422544|FG000|Overall Study|Other|64|||
145427424|NCT00567502|524422545|FG001|Overall Study|Other|2|||
145427425|NCT00567502|524422546|FG002|Overall Study|Other|134|||
145427426|NCT00567502|524422547|FG003|Overall Study|Other|6|||
145427427|NCT00567502|524422544|FG000|Overall Study|Participant request|12|||
145427428|NCT00567502|524422545|FG001|Overall Study|Participant request|1|||
145427429|NCT00567502|524422546|FG002|Overall Study|Participant request|33|||
145427430|NCT00567502|524422547|FG003|Overall Study|Participant request|1|||
145427431|NCT00567502|524422544|FG000|Overall Study|Sponsor request|9|||
145427432|NCT00567502|524422545|FG001|Overall Study|Sponsor request|0|||
145427433|NCT00567502|524422546|FG002|Overall Study|Sponsor request|30|||
145427434|NCT00567502|524422547|FG003|Overall Study|Sponsor request|1|||
145427435|NCT00567502|524422544|FG000|Overall Study|Never Initiated Treatment|0|||
145427436|NCT00567502|524422545|FG001|Overall Study|Never Initiated Treatment|0|||
145427437|NCT00567502|524422546|FG002|Overall Study|Never Initiated Treatment|0|||
145427438|NCT00567502|524422547|FG003|Overall Study|Never Initiated Treatment|72|||
145427439|NCT01285102|524422548|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
145427440|NCT00557440|524422558|FG000|Treatment Period 1|Adverse Event|0|||
145427441|NCT00557440|524422559|FG001|Treatment Period 1|Adverse Event|0|||
145427442|NCT00557440|524422560|FG002|Treatment Period 1|Adverse Event|1|||
145427443|NCT03524157|524422561|FG000|Overall Study|cytology not readable|0|||
145427444|NCT03524157|524422562|FG001|Overall Study|cytology not readable|0|||
145427445|NCT03524157|524422563|FG002|Overall Study|cytology not readable|1|||
145427446|NCT02743962|524422564|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
145427447|NCT02743962|524422565|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
145427448|NCT00725985|524422566|FG000|ITP- Treatment Disposition|Adverse Event|20|||
145427449|NCT00725985|524422567|FG001|ITP- Treatment Disposition|Adverse Event|10|||
145427450|NCT00725985|524422568|FG002|ITP- Treatment Disposition|Adverse Event|5|||
145581219|NCT01831089|524980826|FG000|Cohort B: Arm B|Adverse Event|0|||
145581220|NCT01831089|524980827|FG001|Cohort B: Arm B|Adverse Event|0|||
145581221|NCT01831089|524980828|FG002|Cohort B: Arm B|Adverse Event|0|||
145581222|NCT01831089|524980829|FG003|Cohort B: Arm B|Adverse Event|0|||
145581223|NCT01831089|524980830|FG004|Cohort B: Arm B|Adverse Event|0|||
145427451|NCT00725985|524422569|FG003|ITP- Treatment Disposition|Adverse Event|0|||
145427452|NCT00725985|524422570|FG004|ITP- Treatment Disposition|Adverse Event|0|||
145427453|NCT00725985|524422571|FG005|ITP- Treatment Disposition|Adverse Event|0|||
145581224|NCT01831089|524980831|FG005|Cohort B: Arm B|Adverse Event|1|||
145427454|NCT00725985|524422572|FG006|ITP- Treatment Disposition|Adverse Event|0|||
145427455|NCT00725985|524422573|FG007|ITP- Treatment Disposition|Adverse Event|0|||
145427456|NCT00725985|524422574|FG008|ITP- Treatment Disposition|Adverse Event|0|||
145427457|NCT00725985|524422575|FG009|ITP- Treatment Disposition|Adverse Event|0|||
145427458|NCT00725985|524422576|FG010|ITP- Treatment Disposition|Adverse Event|0|||
145427459|NCT00725985|524422577|FG011|ITP- Treatment Disposition|Adverse Event|0|||
145427460|NCT00725985|524422566|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427461|NCT00725985|524422567|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427462|NCT00725985|524422568|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
145427463|NCT00725985|524422569|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427464|NCT00725985|524422570|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427465|NCT00725985|524422571|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427466|NCT00725985|524422572|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427467|NCT00725985|524422573|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427468|NCT00725985|524422574|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427469|NCT00725985|524422575|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427470|NCT00725985|524422576|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427471|NCT00725985|524422577|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
145427472|NCT00725985|524422566|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
145427473|NCT00725985|524422567|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
145427474|NCT00725985|524422568|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
145427475|NCT00725985|524422569|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
145427476|NCT00725985|524422570|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
145427477|NCT00725985|524422571|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
145427478|NCT00725985|524422572|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
145427479|NCT00725985|524422573|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
145427480|NCT00725985|524422574|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
145427481|NCT00725985|524422575|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
145427482|NCT00725985|524422576|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
145427483|NCT00725985|524422577|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
145427484|NCT00725985|524422566|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
145427485|NCT00725985|524422567|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
145427486|NCT00725985|524422568|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
145427487|NCT00725985|524422569|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
145427488|NCT00725985|524422570|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
145427489|NCT00725985|524422571|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
145427490|NCT00725985|524422572|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
145427491|NCT00725985|524422573|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
145427492|NCT00725985|524422574|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
145427493|NCT00725985|524422575|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
145427494|NCT00725985|524422576|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
145427495|NCT00725985|524422577|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
145427496|NCT00725985|524422566|FG000|ITP- Treatment Disposition|Other|50|||
145427497|NCT00725985|524422567|FG001|ITP- Treatment Disposition|Other|38|||
145427498|NCT00725985|524422568|FG002|ITP- Treatment Disposition|Other|24|||
145427499|NCT00725985|524422569|FG003|ITP- Treatment Disposition|Other|0|||
145427500|NCT00725985|524422570|FG004|ITP- Treatment Disposition|Other|0|||
145427501|NCT00725985|524422571|FG005|ITP- Treatment Disposition|Other|0|||
145427502|NCT00725985|524422572|FG006|ITP- Treatment Disposition|Other|0|||
145427503|NCT00725985|524422573|FG007|ITP- Treatment Disposition|Other|0|||
145427504|NCT00725985|524422574|FG008|ITP- Treatment Disposition|Other|0|||
145427505|NCT00725985|524422575|FG009|ITP- Treatment Disposition|Other|0|||
145427506|NCT00725985|524422576|FG010|ITP- Treatment Disposition|Other|0|||
145427507|NCT00725985|524422577|FG011|ITP- Treatment Disposition|Other|0|||
145427508|NCT00725985|524422566|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427509|NCT00725985|524422567|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427510|NCT00725985|524422568|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427511|NCT00725985|524422569|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
145427512|NCT00725985|524422570|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
145427513|NCT00725985|524422571|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
145427514|NCT00725985|524422572|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427515|NCT00725985|524422573|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427516|NCT00725985|524422574|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427517|NCT00725985|524422575|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427518|NCT00725985|524422576|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427519|NCT00725985|524422577|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
145427520|NCT00725985|524422566|FG000|OLMP (Up to 96 Weeks)|Death|0|||
145427521|NCT00725985|524422567|FG001|OLMP (Up to 96 Weeks)|Death|0|||
145427522|NCT00725985|524422568|FG002|OLMP (Up to 96 Weeks)|Death|0|||
145427523|NCT00725985|524422569|FG003|OLMP (Up to 96 Weeks)|Death|0|||
145427524|NCT00725985|524422570|FG004|OLMP (Up to 96 Weeks)|Death|1|||
145427525|NCT00725985|524422571|FG005|OLMP (Up to 96 Weeks)|Death|0|||
145427526|NCT00725985|524422572|FG006|OLMP (Up to 96 Weeks)|Death|0|||
145427527|NCT00725985|524422573|FG007|OLMP (Up to 96 Weeks)|Death|0|||
145427528|NCT00725985|524422574|FG008|OLMP (Up to 96 Weeks)|Death|0|||
145427529|NCT00725985|524422575|FG009|OLMP (Up to 96 Weeks)|Death|0|||
145427530|NCT00725985|524422576|FG010|OLMP (Up to 96 Weeks)|Death|0|||
145427531|NCT00725985|524422577|FG011|OLMP (Up to 96 Weeks)|Death|0|||
145427532|NCT00725985|524422566|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427533|NCT00725985|524422567|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427534|NCT00725985|524422568|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427535|NCT00725985|524422569|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
145427536|NCT00725985|524422570|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427537|NCT00725985|524422571|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427538|NCT00725985|524422572|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427539|NCT00725985|524422573|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427540|NCT00725985|524422574|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427541|NCT00725985|524422575|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427542|NCT00725985|524422576|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427543|NCT00725985|524422577|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
145427544|NCT00725985|524422566|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427545|NCT00725985|524422567|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427546|NCT00725985|524422568|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427547|NCT00725985|524422569|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427548|NCT00725985|524422570|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427549|NCT00725985|524422571|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
145427550|NCT00725985|524422572|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427551|NCT00725985|524422573|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427552|NCT00725985|524422574|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427553|NCT00725985|524422575|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427554|NCT00725985|524422576|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427555|NCT00725985|524422577|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
145427556|NCT00725985|524422566|FG000|OLMP (Up to 96 Weeks)|Other|0|||
145427557|NCT00725985|524422567|FG001|OLMP (Up to 96 Weeks)|Other|0|||
145427558|NCT00725985|524422568|FG002|OLMP (Up to 96 Weeks)|Other|0|||
145427559|NCT00725985|524422569|FG003|OLMP (Up to 96 Weeks)|Other|15|||
145427560|NCT00725985|524422570|FG004|OLMP (Up to 96 Weeks)|Other|20|||
145427561|NCT00725985|524422571|FG005|OLMP (Up to 96 Weeks)|Other|44|||
145427562|NCT00725985|524422572|FG006|OLMP (Up to 96 Weeks)|Other|0|||
145427563|NCT00725985|524422573|FG007|OLMP (Up to 96 Weeks)|Other|0|||
145427564|NCT00725985|524422574|FG008|OLMP (Up to 96 Weeks)|Other|0|||
145427565|NCT00725985|524422575|FG009|OLMP (Up to 96 Weeks)|Other|0|||
145427566|NCT00725985|524422576|FG010|OLMP (Up to 96 Weeks)|Other|0|||
145427567|NCT00725985|524422577|FG011|OLMP (Up to 96 Weeks)|Other|0|||
145427568|NCT00725985|524422566|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427569|NCT00725985|524422567|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427570|NCT00725985|524422568|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427571|NCT00725985|524422569|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427572|NCT00725985|524422570|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427573|NCT00725985|524422571|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427574|NCT00725985|524422572|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427575|NCT00725985|524422573|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
145427576|NCT00725985|524422574|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427577|NCT00725985|524422575|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427578|NCT00725985|524422576|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427579|NCT00725985|524422577|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
145427580|NCT00725985|524422566|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427581|NCT00725985|524422567|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427582|NCT00725985|524422568|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427583|NCT00725985|524422569|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427584|NCT00725985|524422570|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427585|NCT00725985|524422571|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427586|NCT00725985|524422572|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427587|NCT00725985|524422573|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427588|NCT00725985|524422574|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
145427589|NCT00725985|524422575|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427590|NCT00725985|524422576|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427591|NCT00725985|524422577|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
145427592|NCT00725985|524422566|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427593|NCT00725985|524422567|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427594|NCT00725985|524422568|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427595|NCT00725985|524422569|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427596|NCT00725985|524422570|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427597|NCT00725985|524422571|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427598|NCT00725985|524422572|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
145427599|NCT00725985|524422573|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
145427600|NCT00725985|524422574|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
145427601|NCT00725985|524422575|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427602|NCT00725985|524422576|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427603|NCT00725985|524422577|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
145427604|NCT00725985|524422566|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427605|NCT00725985|524422567|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427606|NCT00725985|524422568|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427607|NCT00725985|524422569|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427608|NCT00725985|524422570|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145581225|NCT01831089|524980826|FG000|Cohort B: Arm B|Global end of study|0|||
145581226|NCT01831089|524980827|FG001|Cohort B: Arm B|Global end of study|0|||
145581227|NCT01831089|524980828|FG002|Cohort B: Arm B|Global end of study|0|||
145373823|NCT04017832|524219185|FG001|Overall Study|Physician Decision|1|||
145373824|NCT04017832|524219186|FG002|Overall Study|Physician Decision|1|||
145373825|NCT04017832|524219187|FG003|Overall Study|Physician Decision|1|||
145373826|NCT04017832|524219184|FG000|Overall Study|Death|2|||
145373827|NCT04017832|524219185|FG001|Overall Study|Death|2|||
145373828|NCT04017832|524219186|FG002|Overall Study|Death|1|||
145373829|NCT04017832|524219187|FG003|Overall Study|Death|0|||
145373830|NCT01419080|524219190|FG000|Overall Study|Withdrawal by Subject|75|||
145373831|NCT01419080|524219190|FG000|Overall Study|Death|30|||
145373832|NCT01419080|524219190|FG000|Overall Study|Lost to Follow-up|23|||
145373833|NCT01419080|524219190|FG000|Overall Study|Too Ill|3|||
145373834|NCT02375555|524219202|FG000|Induction Period|Adverse Event|7|||
145373835|NCT02375555|524219202|FG000|Induction Period|Withdrawal by Subject|2|||
145373836|NCT02375555|524219202|FG000|Induction Period|Other|1|||
145373837|NCT02375555|524219202|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
145373838|NCT02375555|524219202|FG000|Maintenance Period|Adverse Event|2|||
145373839|NCT02375555|524219202|FG000|Maintenance Period|Withdrawal by Subject|4|||
145373840|NCT02375555|524219202|FG000|Maintenance Period|Death|1|||
145373841|NCT02375555|524219202|FG000|Maintenance Period|Disease Progression|5|||
145373842|NCT02375555|524219202|FG000|Maintenance Period|Patient Non-compliance|1|||
145373843|NCT02375555|524219202|FG000|Maintenance Period|Still on maintenance|16|||
145373844|NCT02548351|524219213|FG000|Overall Study|Withdrawal by Subject|149|||
145373845|NCT02548351|524219214|FG001|Overall Study|Withdrawal by Subject|154|||
145373846|NCT02548351|524219215|FG002|Overall Study|Withdrawal by Subject|152|||
145373847|NCT02548351|524219213|FG000|Overall Study|Death|11|||
145373848|NCT02548351|524219214|FG001|Overall Study|Death|15|||
145373849|NCT02548351|524219215|FG002|Overall Study|Death|12|||
145373850|NCT02548351|524219213|FG000|Overall Study|Adverse Event|22|||
145373851|NCT02548351|524219214|FG001|Overall Study|Adverse Event|56|||
145373852|NCT02548351|524219215|FG002|Overall Study|Adverse Event|36|||
145373853|NCT02548351|524219213|FG000|Overall Study|Study Terminated by Sponsor|549|||
145373854|NCT02548351|524219214|FG001|Overall Study|Study Terminated by Sponsor|509|||
145373855|NCT02548351|524219215|FG002|Overall Study|Study Terminated by Sponsor|528|||
145373856|NCT02548351|524219213|FG000|Overall Study|Site Closure|14|||
145373857|NCT02548351|524219214|FG001|Overall Study|Site Closure|5|||
145373858|NCT02548351|524219215|FG002|Overall Study|Site Closure|7|||
145373859|NCT02548351|524219213|FG000|Overall Study|Non-compliance with Study Drug|4|||
145373860|NCT02548351|524219214|FG001|Overall Study|Non-compliance with Study Drug|2|||
145373861|NCT02548351|524219215|FG002|Overall Study|Non-compliance with Study Drug|0|||
145373862|NCT02548351|524219213|FG000|Overall Study|Protocol Violation|2|||
145373863|NCT02548351|524219214|FG001|Overall Study|Protocol Violation|1|||
145373864|NCT02548351|524219215|FG002|Overall Study|Protocol Violation|2|||
145373865|NCT02548351|524219213|FG000|Overall Study|Physician Decision|11|||
145373866|NCT02548351|524219214|FG001|Overall Study|Physician Decision|18|||
145373867|NCT02548351|524219215|FG002|Overall Study|Physician Decision|11|||
145373868|NCT02548351|524219213|FG000|Overall Study|Lost to Follow-up|43|||
145373869|NCT02548351|524219214|FG001|Overall Study|Lost to Follow-up|50|||
145373870|NCT02548351|524219215|FG002|Overall Study|Lost to Follow-up|57|||
145373871|NCT02548351|524219213|FG000|Overall Study|Other|19|||
145373872|NCT02548351|524219214|FG001|Overall Study|Other|16|||
145373873|NCT02548351|524219215|FG002|Overall Study|Other|20|||
145373874|NCT02548351|524219213|FG000|Overall Study|Missing|1|||
145373875|NCT02548351|524219214|FG001|Overall Study|Missing|1|||
145373876|NCT02548351|524219215|FG002|Overall Study|Missing|0|||
145373877|NCT00125242|524219217|FG000|Overall Study|did not qualify|7|||
145373878|NCT00125242|524219218|FG001|Overall Study|did not qualify|2|||
145373879|NCT01664949|524219221|FG000|Overall Study|Adverse Event|11|||
145373880|NCT01664949|524219222|FG001|Overall Study|Adverse Event|12|||
145373881|NCT01664949|524219221|FG000|Overall Study|Lack of Efficacy|1|||
145373882|NCT01664949|524219222|FG001|Overall Study|Lack of Efficacy|1|||
145373883|NCT01664949|524219221|FG000|Overall Study|Lost to Follow-up|1|||
145373884|NCT01664949|524219222|FG001|Overall Study|Lost to Follow-up|2|||
145373885|NCT01664949|524219221|FG000|Overall Study|Personal Reasons|3|||
145373886|NCT01664949|524219222|FG001|Overall Study|Personal Reasons|4|||
145373887|NCT01664949|524219221|FG000|Overall Study|Protocol Violation|5|||
145373888|NCT01664949|524219222|FG001|Overall Study|Protocol Violation|5|||
145373889|NCT01664949|524219221|FG000|Overall Study|Other Miscellaneous Reasons|3|||
145373890|NCT01664949|524219222|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145373891|NCT01263782|524219224|FG000|Overall Study|Death|0|||
145373892|NCT01263782|524219225|FG001|Overall Study|Death|0|||
145373893|NCT01263782|524219226|FG002|Overall Study|Death|1|||
145373894|NCT01263782|524219227|FG003|Overall Study|Death|0|||
145373895|NCT01263782|524219224|FG000|Overall Study|Progressive disease|0|||
145373896|NCT01263782|524219225|FG001|Overall Study|Progressive disease|0|||
145373897|NCT01263782|524219226|FG002|Overall Study|Progressive disease|0|||
145373898|NCT01263782|524219227|FG003|Overall Study|Progressive disease|1|||
145373899|NCT01263782|524219224|FG000|Overall Study|Too early|0|||
145373900|NCT01263782|524219225|FG001|Overall Study|Too early|0|||
145427609|NCT00725985|524422571|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427610|NCT00725985|524422572|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427611|NCT00725985|524422573|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427612|NCT00725985|524422574|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
145427613|NCT00725985|524422575|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
145427614|NCT00725985|524422576|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
145427615|NCT00725985|524422577|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
145427616|NCT03931330|524422579|FG000|Overall Study|Physician Decision|1|||
145427617|NCT01381679|524422584|FG000|Overall Study|Adverse Event|3|||
145427618|NCT01381679|524422584|FG000|Overall Study|Lost to Follow-up|885|||
145427619|NCT04023487|524422585|FG000|Overall Study|Lost to Follow-up|5|||
145427620|NCT04023487|524422586|FG001|Overall Study|Lost to Follow-up|4|||
145427621|NCT04023487|524422585|FG000|Overall Study|Pregnancy|1|||
145427622|NCT04023487|524422586|FG001|Overall Study|Pregnancy|2|||
145427623|NCT04023487|524422585|FG000|Overall Study|Withdrawal by Subject|4|||
145427624|NCT04023487|524422586|FG001|Overall Study|Withdrawal by Subject|5|||
145427625|NCT04023487|524422585|FG000|Overall Study|Partially completed testing|8|||
145427626|NCT04023487|524422586|FG001|Overall Study|Partially completed testing|4|||
145427627|NCT05473715|524422589|FG000|Overall Study|Trial terminate|2|||
145427628|NCT05473715|524422590|FG001|Overall Study|Trial terminate|1|||
145427629|NCT02592863|524422592|FG000|Overall Study|Withdrawal by Subject|2|||
145427630|NCT02592863|524422593|FG001|Overall Study|Withdrawal by Subject|2|||
145427631|NCT02592863|524422592|FG000|Overall Study|Lost to Follow-up|1|||
145427632|NCT02592863|524422593|FG001|Overall Study|Lost to Follow-up|1|||
145427633|NCT02743221|524422594|FG000|Overall Study|Progressive disease|29|||
145427634|NCT02743221|524422595|FG001|Overall Study|Progressive disease|38|||
145427635|NCT02743221|524422594|FG000|Overall Study|Adverse Event|17|||
145427636|NCT02743221|524422595|FG001|Overall Study|Adverse Event|14|||
145427637|NCT02743221|524422594|FG000|Overall Study|non medical reason|8|||
145427638|NCT02743221|524422595|FG001|Overall Study|non medical reason|2|||
145427639|NCT02743221|524422594|FG000|Overall Study|Physician Decision|2|||
145427640|NCT02743221|524422595|FG001|Overall Study|Physician Decision|5|||
145427641|NCT02743221|524422594|FG000|Overall Study|Patient not eligible, not treated|0|||
145427642|NCT02743221|524422595|FG001|Overall Study|Patient not eligible, not treated|1|||
145427643|NCT03528902|524422598|FG000|Overall Study|Adverse Event|1|||
145427644|NCT03528902|524422599|FG001|Overall Study|Adverse Event|0|||
145427645|NCT03411044|524422600|FG000|Overall Study|Death|30|||
145427646|NCT03411044|524422600|FG000|Overall Study|Withdrawal by Subject|48|||
145427647|NCT03411044|524422600|FG000|Overall Study|Lost to Follow-up|78|||
145427648|NCT03411044|524422600|FG000|Overall Study|Adverse Event|30|||
145427649|NCT03411044|524422600|FG000|Overall Study|Missing status|4|||
145427650|NCT00023595|524422607|FG000|5 Year Follow up|Lost to Follow-up|2|||
145427651|NCT00023595|524422608|FG001|5 Year Follow up|Lost to Follow-up|2|||
145427652|NCT00023595|524422609|FG002|5 Year Follow up|Lost to Follow-up|1|||
145427653|NCT00023595|524422610|FG003|5 Year Follow up|Lost to Follow-up|7|||
145427654|NCT00023595|524422611|FG004|5 Year Follow up|Lost to Follow-up|3|||
145427655|NCT00023595|524422607|FG000|10 Year Follow up|Lost to Follow-up|12|||
145427656|NCT00023595|524422608|FG001|10 Year Follow up|Lost to Follow-up|10|||
145427657|NCT00023595|524422609|FG002|10 Year Follow up|Lost to Follow-up|3|||
145427658|NCT00023595|524422610|FG003|10 Year Follow up|Lost to Follow-up|0|||
145427659|NCT00023595|524422611|FG004|10 Year Follow up|Lost to Follow-up|0|||
145427660|NCT05889468|524422612|FG000|Overall Study|Lost to Follow-up|9|||
145427661|NCT05889468|524422613|FG001|Overall Study|Lost to Follow-up|2|||
145427662|NCT05889468|524422612|FG000|Overall Study|Withdrawal by Subject|2|||
145427663|NCT05889468|524422613|FG001|Overall Study|Withdrawal by Subject|2|||
145427664|NCT03900650|524422618|FG000|Overall Study|Withdrawal by Subject|1|||
145427665|NCT03900650|524422619|FG001|Overall Study|Withdrawal by Subject|1|||
145427666|NCT03900650|524422620|FG002|Overall Study|Withdrawal by Subject|0|||
145427667|NCT03900650|524422621|FG003|Overall Study|Withdrawal by Subject|0|||
145427668|NCT03900650|524422618|FG000|Overall Study|Withdrawn by staff|1|||
145427669|NCT03900650|524422619|FG001|Overall Study|Withdrawn by staff|0|||
145581228|NCT01831089|524980829|FG003|Cohort B: Arm B|Global end of study|0|||
145427670|NCT03900650|524422620|FG002|Overall Study|Withdrawn by staff|0|||
145427671|NCT03900650|524422621|FG003|Overall Study|Withdrawn by staff|0|||
145427672|NCT02014376|524422624|FG000|Overall Study|Adverse Event|1|||
145581229|NCT01831089|524980830|FG004|Cohort B: Arm B|Global end of study|0|||
145427673|NCT02014376|524422625|FG001|Overall Study|Adverse Event|1|||
145581230|NCT01831089|524980831|FG005|Cohort B: Arm B|Global end of study|1|||
145581231|NCT02013765|524980832|FG000|Overall Study|Trial was terminated by sponsor|1|||
145581232|NCT02443298|524980837|FG000|Overall Study|Adverse Event|3|||
145427674|NCT02014376|524422626|FG002|Overall Study|Adverse Event|0|||
145427675|NCT02014376|524422624|FG000|Overall Study|Lost to Follow-up|2|||
145427676|NCT02014376|524422625|FG001|Overall Study|Lost to Follow-up|0|||
145427677|NCT02014376|524422626|FG002|Overall Study|Lost to Follow-up|0|||
145427678|NCT00721110|524422631|FG000|Overall Study|Ultram use|1|||
145427679|NCT00721110|524422632|FG001|Overall Study|Ultram use|0|||
145427680|NCT00721110|524422633|FG002|Overall Study|Ultram use|0|||
145427681|NCT00721110|524422634|FG003|Overall Study|Ultram use|0|||
145581233|NCT02443298|524980838|FG001|Overall Study|Adverse Event|3|||
145581234|NCT02443298|524980837|FG000|Overall Study|Withdrawal by Subject|1|||
145581235|NCT02443298|524980838|FG001|Overall Study|Withdrawal by Subject|2|||
145581236|NCT02822794|524980842|FG000|Overall Study|Withdrew Consent|1|||
145581237|NCT02822794|524980843|FG001|Overall Study|Withdrew Consent|0|||
145581238|NCT05101252|524980846|FG000|Overall Study|Unsatisfactory Test Article|1|||
145581239|NCT05101252|524980847|FG001|Overall Study|Unsatisfactory Test Article|0|||
145581240|NCT05101252|524980846|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145581241|NCT05101252|524980847|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
145581242|NCT05101252|524980846|FG000|Overall Study|Withdrew Consent during study|0|||
145581243|NCT05101252|524980847|FG001|Overall Study|Withdrew Consent during study|1|||
145581244|NCT05101252|524980846|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
145581245|NCT05101252|524980847|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
145581246|NCT03732248|524980848|FG000|Overall Study|Withdrawal by Subject|1|||
145373901|NCT01263782|524219226|FG002|Overall Study|Too early|1|||
145373902|NCT01263782|524219227|FG003|Overall Study|Too early|0|||
145373903|NCT01263782|524219224|FG000|Overall Study|Inevaluable|0|||
145373904|NCT01263782|524219225|FG001|Overall Study|Inevaluable|0|||
145373905|NCT01263782|524219226|FG002|Overall Study|Inevaluable|1|||
145373906|NCT01263782|524219227|FG003|Overall Study|Inevaluable|0|||
145373907|NCT00915876|524219228|FG000|Overall Study|Adverse Event|0|||
145373908|NCT00915876|524219229|FG001|Overall Study|Adverse Event|1|||
145373909|NCT04545567|524219231|FG000|Overall Study|tested positive for SARS-co-V2|1|||
145373910|NCT04545567|524219232|FG001|Overall Study|tested positive for SARS-co-V2|1|||
145373911|NCT04545567|524219231|FG000|Overall Study|Withdrawal by Subject|0|||
145373912|NCT04545567|524219232|FG001|Overall Study|Withdrawal by Subject|1|||
145373913|NCT03626363|524219236|FG000|Overall Study|Protocol Violation|4|||
145373914|NCT03626363|524219237|FG001|Overall Study|Protocol Violation|0|||
145373915|NCT03626363|524219236|FG000|Overall Study|Lost to Follow-up|5|||
145373916|NCT03626363|524219237|FG001|Overall Study|Lost to Follow-up|7|||
145373917|NCT00533702|524219238|FG000|Overall Study|Withdrawal by Subject|3|||
145373918|NCT00533702|524219239|FG001|Overall Study|Withdrawal by Subject|1|||
145373919|NCT00533702|524219238|FG000|Overall Study|Found ineligible after randomization|2|||
145373920|NCT00533702|524219239|FG001|Overall Study|Found ineligible after randomization|1|||
145373921|NCT01984892|524219240|FG000|Overall Study|Progressive disease|7|||
145373922|NCT04464720|524219241|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
145373923|NCT01294696|524219250|FG000|Overall Study|Screening failures|7|||
145373924|NCT01294696|524219250|FG000|Overall Study|Protocol Violation|8|||
145373925|NCT01294696|524219250|FG000|Overall Study|Missing BPI Response|7|||
145373926|NCT01294696|524219250|FG000|Overall Study|Site closure|52|||
145373927|NCT02417961|524221148|FG000|Overall Study|Adverse Event|1|||
145373928|NCT02417961|524221148|FG000|Overall Study|Lost to Follow-up|1|||
145373929|NCT02417961|524221148|FG000|Overall Study|Withdrawal by Subject|2|||
145373930|NCT05079750|524221149|FG000|Overall Study|Lost to Follow-up|0|||
145373931|NCT05079750|524221150|FG001|Overall Study|Lost to Follow-up|0|||
145373932|NCT05079750|524221151|FG002|Overall Study|Lost to Follow-up|1|||
145373933|NCT05091346|524221152|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
145373934|NCT05091346|524221153|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
145373935|NCT05091346|524221154|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
145373936|NCT05091346|524221155|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
145373937|NCT05091346|524221156|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
145373938|NCT05091346|524221152|FG000|Overall Study|Death|6|||
145373939|NCT05091346|524221153|FG001|Overall Study|Death|5|||
145373940|NCT05091346|524221154|FG002|Overall Study|Death|8|||
145373941|NCT05091346|524221155|FG003|Overall Study|Death|16|||
145373942|NCT05091346|524221156|FG004|Overall Study|Death|26|||
145373943|NCT05091346|524221152|FG000|Overall Study|Lost to Follow-up|0|||
145373944|NCT05091346|524221153|FG001|Overall Study|Lost to Follow-up|0|||
145373945|NCT05091346|524221154|FG002|Overall Study|Lost to Follow-up|0|||
145373946|NCT05091346|524221155|FG003|Overall Study|Lost to Follow-up|1|||
145373947|NCT05091346|524221156|FG004|Overall Study|Lost to Follow-up|0|||
145373948|NCT05091346|524221152|FG000|Overall Study|Withdrawal by Subject|0|||
145373949|NCT05091346|524221153|FG001|Overall Study|Withdrawal by Subject|1|||
145373950|NCT05091346|524221154|FG002|Overall Study|Withdrawal by Subject|2|||
145373951|NCT05091346|524221155|FG003|Overall Study|Withdrawal by Subject|2|||
145373952|NCT05091346|524221156|FG004|Overall Study|Withdrawal by Subject|1|||
145373953|NCT00197002|524221157|FG000|Overall Study|Adverse Event|0|||
145373954|NCT00197002|524221158|FG001|Overall Study|Adverse Event|1|||
145373955|NCT00197002|524221159|FG002|Overall Study|Adverse Event|0|||
145373956|NCT00197002|524221157|FG000|Overall Study|Protocol Violation|1|||
145373957|NCT00197002|524221158|FG001|Overall Study|Protocol Violation|0|||
145373958|NCT00197002|524221159|FG002|Overall Study|Protocol Violation|2|||
145373959|NCT00197002|524221157|FG000|Overall Study|Withdrawal by Subject|9|||
145373960|NCT00197002|524221158|FG001|Overall Study|Withdrawal by Subject|5|||
145581247|NCT03732248|524980849|FG001|Overall Study|Withdrawal by Subject|0|||
145581248|NCT02266381|524980850|FG000|Overall Study|Physician Decision|3|||
145581249|NCT02266381|524980851|FG001|Overall Study|Physician Decision|5|||
145427682|NCT00721110|524422631|FG000|Overall Study|vertical incision|0|||
145427683|NCT00721110|524422632|FG001|Overall Study|vertical incision|0|||
145427684|NCT00721110|524422633|FG002|Overall Study|vertical incision|1|||
145427685|NCT00721110|524422634|FG003|Overall Study|vertical incision|0|||
145427686|NCT02226653|524422641|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
145427687|NCT02226653|524422642|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
145427688|NCT02226653|524422641|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
145427689|NCT02226653|524422642|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
145427690|NCT00209131|524422650|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
145427691|NCT00209131|524422651|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
145427692|NCT03034044|524422652|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
145427693|NCT00791648|524424102|FG000|Overall Study|Physician Decision|0|||
145427694|NCT00791648|524424103|FG001|Overall Study|Physician Decision|1|||
145427695|NCT00791648|524424102|FG000|Overall Study|Withdrawal by Subject|0|||
145427696|NCT00791648|524424103|FG001|Overall Study|Withdrawal by Subject|1|||
145427697|NCT00462826|524424104|FG000|Overall Study|Ineligible - second primary|1|||
145427698|NCT00462826|524424104|FG000|Overall Study|Ineligible - wrong cell type|1|||
145427699|NCT00462826|524424104|FG000|Overall Study|Ineligible - wrong primary|2|||
145427700|NCT00462826|524424104|FG000|Overall Study|Never treated|1|||
145427701|NCT01397253|524424105|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
145427702|NCT01397253|524424106|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
145427703|NCT03502681|524424107|FG000|Overall Study|Adverse Event|1|||
145427704|NCT03502681|524424108|FG001|Overall Study|Adverse Event|1|||
145427705|NCT03502681|524424107|FG000|Overall Study|Disease Progression|2|||
145427706|NCT03502681|524424108|FG001|Overall Study|Disease Progression|1|||
145427707|NCT03436732|524424109|FG000|Overall Study|Not treated-enrolled in different study|1|||
145427708|NCT03436732|524424110|FG001|Overall Study|Not treated-enrolled in different study|0|||
145427709|NCT03436732|524424109|FG000|Overall Study|Off study after cycle 1|1|||
145427710|NCT03436732|524424110|FG001|Overall Study|Off study after cycle 1|0|||
145427711|NCT03436732|524424109|FG000|Overall Study|Adverse Event|2|||
145427712|NCT03436732|524424110|FG001|Overall Study|Adverse Event|0|||
145427713|NCT03436732|524424109|FG000|Overall Study|Death|0|||
145427714|NCT03436732|524424110|FG001|Overall Study|Death|1|||
145427715|NCT03552029|524424114|FG000|Overall Study|Death|3|||
145427716|NCT03552029|524424115|FG001|Overall Study|Death|0|||
145427717|NCT03552029|524424114|FG000|Overall Study|Adverse Event|1|||
145427718|NCT03552029|524424115|FG001|Overall Study|Adverse Event|0|||
145427719|NCT03552029|524424114|FG000|Overall Study|Lack of Efficacy|0|||
145427720|NCT03552029|524424115|FG001|Overall Study|Lack of Efficacy|2|||
145427721|NCT03552029|524424114|FG000|Overall Study|Physician Decision|0|||
145427722|NCT03552029|524424115|FG001|Overall Study|Physician Decision|1|||
145427723|NCT03552029|524424114|FG000|Overall Study|Study terminated by Sponsor|0|||
145427724|NCT03552029|524424115|FG001|Overall Study|Study terminated by Sponsor|1|||
145427725|NCT03552029|524424114|FG000|Overall Study|Other|0|||
145427726|NCT03552029|524424115|FG001|Overall Study|Other|2|||
145427727|NCT02989857|524424116|FG000|Randomization Phase|Not Treated|3|||
145427728|NCT02989857|524424117|FG001|Randomization Phase|Not Treated|2|||
145427729|NCT02989857|524424118|FG002|Randomization Phase|Not Treated|0|||
145427730|NCT00633126|524424121|FG000|Overall Study|Did not receive full dose|1|||
145427731|NCT03243084|524424131|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
145427732|NCT03243084|524424132|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
145427733|NCT03322566|524424133|FG000|Overall Study|Death|34|||
145427734|NCT03322566|524424134|FG001|Overall Study|Death|35|||
145427735|NCT03322566|524424135|FG002|Overall Study|Death|23|||
145427736|NCT03322566|524424133|FG000|Overall Study|Physician Decision|6|||
145427737|NCT03322566|524424134|FG001|Overall Study|Physician Decision|7|||
145427738|NCT03322566|524424135|FG002|Overall Study|Physician Decision|2|||
145427739|NCT03322566|524424133|FG000|Overall Study|Withdrawal by Subject|4|||
145427740|NCT03322566|524424134|FG001|Overall Study|Withdrawal by Subject|3|||
145427741|NCT03322566|524424135|FG002|Overall Study|Withdrawal by Subject|6|||
145427742|NCT03322566|524424133|FG000|Overall Study|Lost to Follow-up|0|||
145427743|NCT03322566|524424134|FG001|Overall Study|Lost to Follow-up|0|||
145373961|NCT00197002|524221159|FG002|Overall Study|Withdrawal by Subject|7|||
145427744|NCT03322566|524424135|FG002|Overall Study|Lost to Follow-up|1|||
145427745|NCT03322566|524424133|FG000|Overall Study|Study terminated by sponsor|1|||
145373962|NCT00197002|524221157|FG000|Overall Study|Migrated/moved from study area|3|||
145373963|NCT00197002|524221158|FG001|Overall Study|Migrated/moved from study area|5|||
145373964|NCT00197002|524221159|FG002|Overall Study|Migrated/moved from study area|1|||
145373965|NCT00197002|524221157|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
145373966|NCT00197002|524221158|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
145373967|NCT00197002|524221159|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
145373968|NCT00197002|524221157|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
145373969|NCT00197002|524221158|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
145427746|NCT03322566|524424134|FG001|Overall Study|Study terminated by sponsor|0|||
145427747|NCT03322566|524424135|FG002|Overall Study|Study terminated by sponsor|1|||
145427748|NCT00863304|524424138|FG000|Overall Study|Adverse Event|10|||
145427749|NCT00863304|524424139|FG001|Overall Study|Adverse Event|4|||
145427750|NCT00863304|524424140|FG002|Overall Study|Adverse Event|14|||
145427751|NCT00863304|524424141|FG003|Overall Study|Adverse Event|16|||
145427752|NCT00863304|524424138|FG000|Overall Study|Lost to Follow-up|1|||
145427753|NCT00863304|524424139|FG001|Overall Study|Lost to Follow-up|5|||
145427754|NCT00863304|524424140|FG002|Overall Study|Lost to Follow-up|4|||
145427755|NCT00863304|524424141|FG003|Overall Study|Lost to Follow-up|2|||
145427756|NCT00863304|524424138|FG000|Overall Study|Lack of Efficacy|57|||
145427757|NCT00863304|524424139|FG001|Overall Study|Lack of Efficacy|26|||
145427758|NCT00863304|524424140|FG002|Overall Study|Lack of Efficacy|30|||
145427759|NCT00863304|524424141|FG003|Overall Study|Lack of Efficacy|28|||
145427760|NCT00863304|524424138|FG000|Overall Study|Withdrawal by Subject|19|||
145427761|NCT00863304|524424139|FG001|Overall Study|Withdrawal by Subject|14|||
145427762|NCT00863304|524424140|FG002|Overall Study|Withdrawal by Subject|20|||
145427763|NCT00863304|524424141|FG003|Overall Study|Withdrawal by Subject|18|||
145427764|NCT00863304|524424138|FG000|Overall Study|Other|1|||
145427765|NCT00863304|524424139|FG001|Overall Study|Other|0|||
145427766|NCT00863304|524424140|FG002|Overall Study|Other|0|||
145427767|NCT00863304|524424141|FG003|Overall Study|Other|1|||
145427768|NCT00863304|524424138|FG000|Overall Study|Protocol Violation|2|||
145427769|NCT00863304|524424139|FG001|Overall Study|Protocol Violation|6|||
145427770|NCT00863304|524424140|FG002|Overall Study|Protocol Violation|2|||
145427771|NCT00863304|524424141|FG003|Overall Study|Protocol Violation|0|||
145427772|NCT00863304|524424138|FG000|Overall Study|Randomized, but not Treated|3|||
145427773|NCT00863304|524424139|FG001|Overall Study|Randomized, but not Treated|1|||
145427774|NCT00863304|524424140|FG002|Overall Study|Randomized, but not Treated|4|||
145427775|NCT00863304|524424141|FG003|Overall Study|Randomized, but not Treated|1|||
145427776|NCT00863304|524424138|FG000|Overall Study|Entered extension study|101|||
145427777|NCT00863304|524424139|FG001|Overall Study|Entered extension study|129|||
145427778|NCT00863304|524424140|FG002|Overall Study|Entered extension study|113|||
145427779|NCT00863304|524424141|FG003|Overall Study|Entered extension study|125|||
145427780|NCT02327169|524424142|FG000|Overall Study|Progressive Disease|1|||
145427781|NCT02327169|524424143|FG001|Overall Study|Progressive Disease|3|||
145427782|NCT02327169|524424144|FG002|Overall Study|Progressive Disease|4|||
145427783|NCT02327169|524424145|FG003|Overall Study|Progressive Disease|3|||
145427784|NCT02327169|524424146|FG004|Overall Study|Progressive Disease|4|||
145427785|NCT02327169|524424147|FG005|Overall Study|Progressive Disease|3|||
145427786|NCT02327169|524424148|FG006|Overall Study|Progressive Disease|3|||
145427787|NCT02327169|524424149|FG007|Overall Study|Progressive Disease|3|||
145427788|NCT02327169|524424150|FG008|Overall Study|Progressive Disease|4|||
145427789|NCT02327169|524424151|FG009|Overall Study|Progressive Disease|4|||
145427790|NCT02327169|524424152|FG010|Overall Study|Progressive Disease|4|||
145427791|NCT02327169|524424153|FG011|Overall Study|Progressive Disease|3|||
145427792|NCT02327169|524424154|FG012|Overall Study|Progressive Disease|1|||
145427793|NCT02327169|524424155|FG013|Overall Study|Progressive Disease|3|||
145427794|NCT02327169|524424156|FG014|Overall Study|Progressive Disease|3|||
145427795|NCT02327169|524424142|FG000|Overall Study|Adverse Event|2|||
145427796|NCT02327169|524424143|FG001|Overall Study|Adverse Event|0|||
145427797|NCT02327169|524424144|FG002|Overall Study|Adverse Event|1|||
145427798|NCT02327169|524424145|FG003|Overall Study|Adverse Event|0|||
145427799|NCT02327169|524424146|FG004|Overall Study|Adverse Event|1|||
145427800|NCT02327169|524424147|FG005|Overall Study|Adverse Event|0|||
145427801|NCT02327169|524424148|FG006|Overall Study|Adverse Event|0|||
145427802|NCT02327169|524424149|FG007|Overall Study|Adverse Event|0|||
145427803|NCT02327169|524424150|FG008|Overall Study|Adverse Event|0|||
145427804|NCT02327169|524424151|FG009|Overall Study|Adverse Event|2|||
145427805|NCT02327169|524424152|FG010|Overall Study|Adverse Event|0|||
145427806|NCT02327169|524424153|FG011|Overall Study|Adverse Event|3|||
145427807|NCT02327169|524424154|FG012|Overall Study|Adverse Event|0|||
145427808|NCT02327169|524424155|FG013|Overall Study|Adverse Event|2|||
145427809|NCT02327169|524424156|FG014|Overall Study|Adverse Event|1|||
145427810|NCT02327169|524424142|FG000|Overall Study|Symptomatic Deterioration|0|||
145427811|NCT02327169|524424143|FG001|Overall Study|Symptomatic Deterioration|0|||
145427812|NCT02327169|524424144|FG002|Overall Study|Symptomatic Deterioration|1|||
145427813|NCT02327169|524424145|FG003|Overall Study|Symptomatic Deterioration|0|||
145427814|NCT02327169|524424146|FG004|Overall Study|Symptomatic Deterioration|1|||
145427815|NCT02327169|524424147|FG005|Overall Study|Symptomatic Deterioration|1|||
145427816|NCT02327169|524424148|FG006|Overall Study|Symptomatic Deterioration|0|||
145427817|NCT02327169|524424149|FG007|Overall Study|Symptomatic Deterioration|0|||
145427818|NCT02327169|524424150|FG008|Overall Study|Symptomatic Deterioration|2|||
145623776|NCT04537949|525135577|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
145427819|NCT02327169|524424151|FG009|Overall Study|Symptomatic Deterioration|1|||
145427820|NCT02327169|524424152|FG010|Overall Study|Symptomatic Deterioration|0|||
145427821|NCT02327169|524424153|FG011|Overall Study|Symptomatic Deterioration|0|||
145427822|NCT02327169|524424154|FG012|Overall Study|Symptomatic Deterioration|0|||
145427823|NCT02327169|524424155|FG013|Overall Study|Symptomatic Deterioration|2|||
145427824|NCT02327169|524424156|FG014|Overall Study|Symptomatic Deterioration|1|||
145427825|NCT02327169|524424142|FG000|Overall Study|Reason Not Specified|0|||
145427826|NCT02327169|524424143|FG001|Overall Study|Reason Not Specified|0|||
145581250|NCT02266381|524980852|FG002|Overall Study|Physician Decision|4|||
145581251|NCT00733824|524980853|FG000|Phase I|Withdrawal by Subject|1|||
145581252|NCT00733824|524980854|FG001|Phase I|Withdrawal by Subject|0|||
145581253|NCT00733824|524980855|FG002|Phase I|Withdrawal by Subject|0|||
145581254|NCT00733824|524980856|FG003|Phase I|Withdrawal by Subject|0|||
145581255|NCT00733824|524980857|FG004|Phase I|Withdrawal by Subject|0|||
145581256|NCT01243944|524980859|FG000|Overall Study|Adverse Event|15|||
145581257|NCT01243944|524980860|FG001|Overall Study|Adverse Event|13|||
145581258|NCT01243944|524980859|FG000|Overall Study|Lost to Follow-up|2|||
145581259|NCT01243944|524980860|FG001|Overall Study|Lost to Follow-up|1|||
145373970|NCT00197002|524221159|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
145373971|NCT00197002|524221157|FG000|Overall Study|Others|3|||
145373972|NCT00197002|524221158|FG001|Overall Study|Others|1|||
145373973|NCT00197002|524221159|FG002|Overall Study|Others|1|||
145373974|NCT03569293|524221160|FG000|Overall Study|Adverse Event|4|||
145373975|NCT03569293|524221161|FG001|Overall Study|Adverse Event|1|||
145373976|NCT03569293|524221162|FG002|Overall Study|Adverse Event|5|||
145373977|NCT03569293|524221163|FG003|Overall Study|Adverse Event|1|||
145373978|NCT03569293|524221164|FG004|Overall Study|Adverse Event|0|||
145373979|NCT03569293|524221165|FG005|Overall Study|Adverse Event|0|||
145373980|NCT03569293|524221160|FG000|Overall Study|Withdrawal by Subject|16|||
145373981|NCT03569293|524221161|FG001|Overall Study|Withdrawal by Subject|2|||
145373982|NCT03569293|524221162|FG002|Overall Study|Withdrawal by Subject|4|||
145373983|NCT03569293|524221163|FG003|Overall Study|Withdrawal by Subject|1|||
145373984|NCT03569293|524221164|FG004|Overall Study|Withdrawal by Subject|0|||
145373985|NCT03569293|524221165|FG005|Overall Study|Withdrawal by Subject|0|||
145373986|NCT03569293|524221160|FG000|Overall Study|Lost to Follow-up|1|||
145373987|NCT03569293|524221161|FG001|Overall Study|Lost to Follow-up|3|||
145373988|NCT03569293|524221162|FG002|Overall Study|Lost to Follow-up|1|||
145373989|NCT03569293|524221163|FG003|Overall Study|Lost to Follow-up|1|||
145373990|NCT03569293|524221164|FG004|Overall Study|Lost to Follow-up|0|||
145373991|NCT03569293|524221165|FG005|Overall Study|Lost to Follow-up|0|||
145373992|NCT03569293|524221160|FG000|Overall Study|Other|8|||
145373993|NCT03569293|524221161|FG001|Overall Study|Other|2|||
145373994|NCT03569293|524221162|FG002|Overall Study|Other|1|||
145373995|NCT03569293|524221163|FG003|Overall Study|Other|1|||
145373996|NCT03569293|524221164|FG004|Overall Study|Other|0|||
145373997|NCT03569293|524221165|FG005|Overall Study|Other|0|||
145373998|NCT03569293|524221160|FG000|Overall Study|Ongoing at Time of Analysis|8|||
145373999|NCT03569293|524221161|FG001|Overall Study|Ongoing at Time of Analysis|1|||
145374000|NCT03569293|524221162|FG002|Overall Study|Ongoing at Time of Analysis|3|||
145374001|NCT03569293|524221163|FG003|Overall Study|Ongoing at Time of Analysis|0|||
145374002|NCT03569293|524221164|FG004|Overall Study|Ongoing at Time of Analysis|0|||
145374003|NCT03569293|524221165|FG005|Overall Study|Ongoing at Time of Analysis|0|||
145374004|NCT05072106|524221176|FG000|Overall Study|Progressive disease|3|||
145374005|NCT05072106|524221177|FG001|Overall Study|Progressive disease|3|||
145374006|NCT05072106|524221176|FG000|Overall Study|Compassionate use|3|||
145374007|NCT05072106|524221177|FG001|Overall Study|Compassionate use|1|||
145374008|NCT05072106|524221176|FG000|Overall Study|Withdrawal by Subject|1|||
145374009|NCT05072106|524221177|FG001|Overall Study|Withdrawal by Subject|0|||
145374010|NCT03839459|524221178|FG000|Overall Study|Withdrawal by Subject|2|||
145374011|NCT03839459|524221178|FG000|Overall Study|progression of disease|3|||
145374012|NCT04240886|524221189|FG000|Treatment Phase|Death|4|||
145374013|NCT04240886|524221189|FG000|Treatment Phase|Discontinuation by Subject|1|||
145374014|NCT04240886|524221189|FG000|Treatment Phase|Adverse Event|5|||
145374015|NCT04240886|524221189|FG000|Follow-up Phase|Withdrawal by Subject|1|||
145374016|NCT04240886|524221189|FG000|Follow-up Phase|Discontinuation by Subject|1|||
145374017|NCT04240886|524221189|FG000|Follow-up Phase|Death|2|||
145374018|NCT02276053|524221192|FG000|Overall Study|Death|2|||
145374019|NCT02276053|524221192|FG000|Overall Study|Adverse Event|5|||
145374020|NCT02276053|524221192|FG000|Overall Study|Lack of Efficacy|2|||
145374021|NCT02276053|524221192|FG000|Overall Study|Withdrawal by Subject|1|||
145374022|NCT02276053|524221192|FG000|Overall Study|Patient does not meet selection criteria|3|||
145374023|NCT02276053|524221192|FG000|Overall Study|Patient needs to increase baseline AED|1|||
145374024|NCT01632904|524221193|FG000|Overall Study|Adverse Event|4|||
145374025|NCT01632904|524221194|FG001|Overall Study|Adverse Event|1|||
145374026|NCT01632904|524221193|FG000|Overall Study|Physician Decision|0|||
145374027|NCT01632904|524221194|FG001|Overall Study|Physician Decision|1|||
145374028|NCT01632904|524221193|FG000|Overall Study|Subject decision|3|||
145374029|NCT01632904|524221194|FG001|Overall Study|Subject decision|2|||
145581260|NCT01243944|524980859|FG000|Overall Study|Physician Decision|2|||
145581261|NCT01243944|524980860|FG001|Overall Study|Physician Decision|7|||
145374030|NCT01632904|524221193|FG000|Overall Study|Disease Progression|0|||
145374031|NCT01632904|524221194|FG001|Overall Study|Disease Progression|1|||
145374032|NCT01632904|524221193|FG000|Overall Study|Reason for discontinuation not available|0|||
145374033|NCT01632904|524221194|FG001|Overall Study|Reason for discontinuation not available|1|||
145374034|NCT04743804|524221195|FG000|Overall Study|Other|1|||
145374035|NCT04743804|524221196|FG001|Overall Study|Other|0|||
145581262|NCT01243944|524980859|FG000|Overall Study|Disease progression|12|||
145581263|NCT01243944|524980860|FG001|Overall Study|Disease progression|11|||
145581264|NCT01243944|524980859|FG000|Overall Study|Protocol deviation|1|||
145581265|NCT01243944|524980860|FG001|Overall Study|Protocol deviation|1|||
145581266|NCT01243944|524980859|FG000|Overall Study|Participant decision|10|||
145581267|NCT01243944|524980860|FG001|Overall Study|Participant decision|15|||
145581268|NCT01243944|524980859|FG000|Overall Study|Death|2|||
145581269|NCT01243944|524980860|FG001|Overall Study|Death|3|||
145581270|NCT01243944|524980859|FG000|Overall Study|Non-compliance with study treatment|1|||
145581271|NCT01243944|524980860|FG001|Overall Study|Non-compliance with study treatment|0|||
145581272|NCT01731171|524980871|FG000|Overall Study|Withdrawal by Subject|4|||
145581273|NCT01731171|524980872|FG001|Overall Study|Withdrawal by Subject|1|||
145581274|NCT01731171|524980871|FG000|Overall Study|Lost to Follow-up|3|||
145581275|NCT01731171|524980872|FG001|Overall Study|Lost to Follow-up|2|||
145581276|NCT01731171|524980871|FG000|Overall Study|Moved out of Area|0|||
145581277|NCT01731171|524980872|FG001|Overall Study|Moved out of Area|2|||
145581278|NCT01731171|524980871|FG000|Overall Study|Terminated for Lack of Adherence|0|||
145581279|NCT01731171|524980872|FG001|Overall Study|Terminated for Lack of Adherence|1|||
145581280|NCT01731171|524980871|FG000|Overall Study|Terminated for Safety Reasons|0|||
145581281|NCT01731171|524980872|FG001|Overall Study|Terminated for Safety Reasons|1|||
145581282|NCT01410110|524980873|FG000|Overall Study|Withdrawal by Subject|4|||
145581283|NCT01410110|524980874|FG001|Overall Study|Withdrawal by Subject|2|||
145581284|NCT03653429|524980875|FG000|Overall Study|Physician Decision|4|||
145581285|NCT03653429|524980876|FG001|Overall Study|Physician Decision|10|||
145581286|NCT00403546|524980877|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
145581287|NCT00403546|524980878|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
145581288|NCT00403546|524980879|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
145581289|NCT00403546|524980877|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
145581290|NCT00403546|524980878|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
145581291|NCT00403546|524980879|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
145581292|NCT00403546|524980877|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
145581293|NCT00403546|524980878|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
145581294|NCT00403546|524980879|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
145581295|NCT00403546|524980877|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
145581296|NCT00403546|524980878|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
145581297|NCT00403546|524980879|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
145581298|NCT00403546|524980877|FG000|Screening Phase|Screening Failure|22|||
145581299|NCT00403546|524980878|FG001|Screening Phase|Screening Failure|0|||
145581300|NCT00403546|524980879|FG002|Screening Phase|Screening Failure|0|||
145581301|NCT00403546|524980877|FG000|Screening Phase|Adverse Event|1|||
145581302|NCT00403546|524980878|FG001|Screening Phase|Adverse Event|0|||
145581303|NCT00403546|524980879|FG002|Screening Phase|Adverse Event|0|||
145581304|NCT00403546|524980877|FG000|Screening Phase|Terminated Prior to Randomization|5|||
145581305|NCT00403546|524980878|FG001|Screening Phase|Terminated Prior to Randomization|0|||
145581306|NCT00403546|524980879|FG002|Screening Phase|Terminated Prior to Randomization|0|||
145374036|NCT04743804|524221195|FG000|Overall Study|Withdrawal by Subject|0|||
145374037|NCT04743804|524221196|FG001|Overall Study|Withdrawal by Subject|1|||
145374038|NCT04743804|524221195|FG000|Overall Study|Study Terminated by Sponsor|1|||
145374039|NCT04743804|524221196|FG001|Overall Study|Study Terminated by Sponsor|4|||
145374040|NCT04743804|524221195|FG000|Overall Study|Physician Decision|0|||
145374041|NCT04743804|524221196|FG001|Overall Study|Physician Decision|1|||
145374042|NCT04743804|524221195|FG000|Overall Study|Death|3|||
145374043|NCT04743804|524221196|FG001|Overall Study|Death|0|||
145374044|NCT04542499|524221207|FG000|Overall Study|Adverse Event|23|||
145374045|NCT04542499|524221208|FG001|Overall Study|Adverse Event|43|||
145374046|NCT04542499|524221207|FG000|Overall Study|Lack of Efficacy|5|||
145374047|NCT04542499|524221208|FG001|Overall Study|Lack of Efficacy|2|||
145374048|NCT04542499|524221207|FG000|Overall Study|Lost to Follow-up|3|||
145374049|NCT04542499|524221208|FG001|Overall Study|Lost to Follow-up|4|||
145374050|NCT04542499|524221207|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
145374051|NCT04542499|524221208|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
145374052|NCT04542499|524221207|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
145374053|NCT04542499|524221208|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
145374054|NCT04542499|524221207|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145374055|NCT04542499|524221208|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145374056|NCT04542499|524221207|FG000|Overall Study|Physician Decision|0|||
145374057|NCT04542499|524221208|FG001|Overall Study|Physician Decision|1|||
145374058|NCT04542499|524221207|FG000|Overall Study|Site Terminated by Sponsor|3|||
145374059|NCT04542499|524221208|FG001|Overall Study|Site Terminated by Sponsor|5|||
145374060|NCT04542499|524221207|FG000|Overall Study|Withdrawal by Subject|12|||
145374061|NCT04542499|524221208|FG001|Overall Study|Withdrawal by Subject|33|||
145581307|NCT00403546|524980877|FG000|Randomized Trial|Early Terminations|0|||
145374062|NCT04542499|524221207|FG000|Overall Study|Other|2|||
145374063|NCT04542499|524221208|FG001|Overall Study|Other|2|||
145581308|NCT00403546|524980878|FG001|Randomized Trial|Early Terminations|17|||
145581309|NCT00403546|524980879|FG002|Randomized Trial|Early Terminations|16|||
145427827|NCT02327169|524424144|FG002|Overall Study|Reason Not Specified|1|||
145427828|NCT02327169|524424145|FG003|Overall Study|Reason Not Specified|0|||
145581310|NCT02604589|524980885|FG000|Overall Study|catheter dislodgement|0|||
145581311|NCT02604589|524980886|FG001|Overall Study|catheter dislodgement|0|||
145581312|NCT02604589|524980887|FG002|Overall Study|catheter dislodgement|1|||
145581313|NCT00793910|524980888|FG000|Overall Study|discarded study pills|0|||
145581314|NCT00793910|524980889|FG001|Overall Study|discarded study pills|1|||
145581315|NCT00793910|524980888|FG000|Overall Study|did not pick up medications|1|||
145581316|NCT00793910|524980889|FG001|Overall Study|did not pick up medications|1|||
145581317|NCT00793910|524980888|FG000|Overall Study|ineligible based on entry criteria|2|||
145581318|NCT00793910|524980889|FG001|Overall Study|ineligible based on entry criteria|3|||
145581319|NCT00793910|524980888|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
145581320|NCT00793910|524980889|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
145581321|NCT00793910|524980888|FG000|Overall Study|Withdrawal by Subject|0|||
145581322|NCT00793910|524980889|FG001|Overall Study|Withdrawal by Subject|1|||
145581323|NCT01700946|524980890|FG000|Overall Study|Lost to Follow-up|1|||
145581324|NCT01700946|524980891|FG001|Overall Study|Lost to Follow-up|0|||
145581325|NCT01700946|524980890|FG000|Overall Study|Physician Decision|7|||
145581326|NCT01700946|524980891|FG001|Overall Study|Physician Decision|12|||
145581327|NCT01700946|524980890|FG000|Overall Study|Withdrawal by Subject|0|||
145581328|NCT01700946|524980891|FG001|Overall Study|Withdrawal by Subject|2|||
145581329|NCT01700946|524980890|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
145581330|NCT01700946|524980891|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
145581331|NCT01700946|524980890|FG000|Overall Study|Relapse|2|||
145581332|NCT01700946|524980891|FG001|Overall Study|Relapse|1|||
145581333|NCT01700946|524980890|FG000|Overall Study|Unacceptable toxicity|1|||
145581334|NCT01700946|524980891|FG001|Overall Study|Unacceptable toxicity|0|||
145581335|NCT02799082|524980899|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
145581336|NCT02799082|524980900|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
145581337|NCT02799082|524980899|FG000|Overall Study|Protocol Violation|0|||
145581338|NCT02799082|524980900|FG001|Overall Study|Protocol Violation|1|||
145581339|NCT04496258|524980901|FG000|Overall Study|Withdrawal by Subject|2|||
145581340|NCT04496258|524980902|FG001|Overall Study|Withdrawal by Subject|1|||
145581341|NCT00861341|524980905|FG000|Overall Study|Withdrawal by Subject|2|||
145581342|NCT04382612|524980914|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
145581343|NCT01328002|524980915|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
145581344|NCT01328002|524980916|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
145581345|NCT01328002|524980915|FG000|Open-Label Period|Adverse Event|8|||
145581346|NCT01328002|524980916|FG001|Open-Label Period|Adverse Event|0|||
145581347|NCT01328002|524980915|FG000|Open-Label Period|Lack of Efficacy|3|||
145581348|NCT01328002|524980916|FG001|Open-Label Period|Lack of Efficacy|0|||
145581349|NCT01328002|524980915|FG000|Open-Label Period|Protocol Violation|2|||
145581350|NCT01328002|524980916|FG001|Open-Label Period|Protocol Violation|0|||
145427829|NCT02327169|524424146|FG004|Overall Study|Reason Not Specified|0|||
145427830|NCT02327169|524424147|FG005|Overall Study|Reason Not Specified|0|||
145427831|NCT02327169|524424148|FG006|Overall Study|Reason Not Specified|0|||
145427832|NCT02327169|524424149|FG007|Overall Study|Reason Not Specified|0|||
145427833|NCT02327169|524424150|FG008|Overall Study|Reason Not Specified|0|||
145427834|NCT02327169|524424151|FG009|Overall Study|Reason Not Specified|1|||
145427835|NCT02327169|524424152|FG010|Overall Study|Reason Not Specified|2|||
145427836|NCT02327169|524424153|FG011|Overall Study|Reason Not Specified|1|||
145427837|NCT02327169|524424154|FG012|Overall Study|Reason Not Specified|0|||
145427838|NCT02327169|524424155|FG013|Overall Study|Reason Not Specified|0|||
145427839|NCT02327169|524424156|FG014|Overall Study|Reason Not Specified|2|||
145427840|NCT02327169|524424142|FG000|Overall Study|Withdrawal by Subject|1|||
145427841|NCT02327169|524424143|FG001|Overall Study|Withdrawal by Subject|0|||
145427842|NCT02327169|524424144|FG002|Overall Study|Withdrawal by Subject|0|||
145581351|NCT01328002|524980915|FG000|Open-Label Period|Withdrawal by Subject|9|||
145581352|NCT01328002|524980916|FG001|Open-Label Period|Withdrawal by Subject|0|||
145581353|NCT01328002|524980915|FG000|Open-Label Period|Lost to Follow-up|6|||
145427843|NCT02327169|524424145|FG003|Overall Study|Withdrawal by Subject|0|||
145427844|NCT02327169|524424146|FG004|Overall Study|Withdrawal by Subject|1|||
145427845|NCT02327169|524424147|FG005|Overall Study|Withdrawal by Subject|0|||
145427846|NCT02327169|524424148|FG006|Overall Study|Withdrawal by Subject|0|||
145427847|NCT02327169|524424149|FG007|Overall Study|Withdrawal by Subject|1|||
145581354|NCT01328002|524980916|FG001|Open-Label Period|Lost to Follow-up|0|||
145581355|NCT01328002|524980915|FG000|Open-Label Period|Other Reason|2|||
145581356|NCT01328002|524980916|FG001|Open-Label Period|Other Reason|0|||
145427848|NCT02327169|524424150|FG008|Overall Study|Withdrawal by Subject|0|||
145581357|NCT01328002|524980915|FG000|Double-Blind Period|Adverse Event|1|||
145427849|NCT02327169|524424151|FG009|Overall Study|Withdrawal by Subject|0|||
145427850|NCT02327169|524424152|FG010|Overall Study|Withdrawal by Subject|0|||
145427851|NCT02327169|524424153|FG011|Overall Study|Withdrawal by Subject|0|||
145427852|NCT02327169|524424154|FG012|Overall Study|Withdrawal by Subject|0|||
145374064|NCT04035434|524221212|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374065|NCT04035434|524221213|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374066|NCT04035434|524221214|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374067|NCT04035434|524221215|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
145374068|NCT04035434|524221216|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374069|NCT04035434|524221217|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374070|NCT04035434|524221218|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374071|NCT04035434|524221219|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374072|NCT04035434|524221220|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374073|NCT04035434|524221221|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374074|NCT04035434|524221222|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374075|NCT04035434|524221223|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374076|NCT04035434|524221224|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374077|NCT04035434|524221212|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145374078|NCT04035434|524221213|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145374079|NCT04035434|524221214|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
145374080|NCT04035434|524221215|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145374081|NCT04035434|524221216|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
145374082|NCT04035434|524221217|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145374083|NCT04035434|524221218|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
145374084|NCT04035434|524221219|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145374085|NCT04035434|524221220|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145374086|NCT04035434|524221221|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
145374087|NCT04035434|524221222|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
145374088|NCT04035434|524221223|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
145374089|NCT04035434|524221224|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
145374090|NCT04035434|524221212|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374091|NCT04035434|524221213|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145374092|NCT04035434|524221214|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145374093|NCT04035434|524221215|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374094|NCT04035434|524221216|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145374095|NCT04035434|524221217|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145374096|NCT04035434|524221218|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374097|NCT04035434|524221219|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374098|NCT04035434|524221220|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145374099|NCT04035434|524221221|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
145374100|NCT04035434|524221222|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374101|NCT04035434|524221223|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
145374102|NCT04035434|524221224|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
145374103|NCT04035434|524221212|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374104|NCT04035434|524221213|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374105|NCT04035434|524221214|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374106|NCT04035434|524221215|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
145374107|NCT04035434|524221216|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374108|NCT04035434|524221217|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374109|NCT04035434|524221218|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374110|NCT04035434|524221219|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374111|NCT04035434|524221220|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374112|NCT04035434|524221221|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374113|NCT04035434|524221222|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374114|NCT04035434|524221223|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374115|NCT04035434|524221224|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
145374116|NCT04035434|524221212|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374117|NCT04035434|524221213|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374118|NCT04035434|524221214|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374119|NCT04035434|524221215|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374120|NCT04035434|524221216|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374121|NCT04035434|524221217|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
145374122|NCT04035434|524221218|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
145374123|NCT04035434|524221219|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374124|NCT04035434|524221220|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374125|NCT04035434|524221221|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374126|NCT04035434|524221222|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374127|NCT04035434|524221223|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145374128|NCT04035434|524221224|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
145623777|NCT04537949|525135578|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
145623778|NCT04537949|525135579|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
145623779|NCT04537949|525135580|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
145623780|NCT04537949|525135581|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
145623781|NCT04537949|525135582|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
145623782|NCT04537949|525135583|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
145623783|NCT04537949|525135584|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
145623784|NCT04537949|525135577|FG000|Follow-up Phase|Lost to Follow-up|0|||
145623785|NCT04537949|525135578|FG001|Follow-up Phase|Lost to Follow-up|3|||
145623786|NCT04537949|525135579|FG002|Follow-up Phase|Lost to Follow-up|0|||
145623787|NCT04537949|525135580|FG003|Follow-up Phase|Lost to Follow-up|0|||
145623788|NCT04537949|525135581|FG004|Follow-up Phase|Lost to Follow-up|0|||
145623789|NCT04537949|525135582|FG005|Follow-up Phase|Lost to Follow-up|0|||
145623790|NCT04537949|525135583|FG006|Follow-up Phase|Lost to Follow-up|0|||
145623791|NCT04537949|525135584|FG007|Follow-up Phase|Lost to Follow-up|0|||
145623792|NCT04537949|525135577|FG000|Follow-up Phase|personal reasons|0|||
145623793|NCT04537949|525135578|FG001|Follow-up Phase|personal reasons|0|||
145623794|NCT04537949|525135579|FG002|Follow-up Phase|personal reasons|0|||
145623795|NCT04537949|525135580|FG003|Follow-up Phase|personal reasons|1|||
145623796|NCT04537949|525135581|FG004|Follow-up Phase|personal reasons|1|||
145623797|NCT04537949|525135582|FG005|Follow-up Phase|personal reasons|0|||
145623798|NCT04537949|525135583|FG006|Follow-up Phase|personal reasons|0|||
145623799|NCT04537949|525135584|FG007|Follow-up Phase|personal reasons|0|||
145623800|NCT04537949|525135577|FG000|Follow-up Phase|Withdrawal by Subject|0|||
145623801|NCT04537949|525135578|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145623802|NCT04537949|525135579|FG002|Follow-up Phase|Withdrawal by Subject|0|||
145623803|NCT04537949|525135580|FG003|Follow-up Phase|Withdrawal by Subject|0|||
145623804|NCT04537949|525135581|FG004|Follow-up Phase|Withdrawal by Subject|1|||
145374129|NCT04035434|524221212|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374130|NCT04035434|524221213|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374131|NCT04035434|524221214|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374132|NCT04035434|524221215|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145581358|NCT01328002|524980916|FG001|Double-Blind Period|Adverse Event|0|||
145581359|NCT01328002|524980915|FG000|Double-Blind Period|Lack of Efficacy|1|||
145581360|NCT01328002|524980916|FG001|Double-Blind Period|Lack of Efficacy|0|||
145581361|NCT03149328|524980917|FG000|Overall Study|Withdrawal by Subject|30|||
145581362|NCT03149328|524980918|FG001|Overall Study|Withdrawal by Subject|26|||
145581363|NCT03149328|524980917|FG000|Overall Study|Changed Dialysis Modality|18|||
145581364|NCT03149328|524980918|FG001|Overall Study|Changed Dialysis Modality|1|||
145581365|NCT03149328|524980917|FG000|Overall Study|Transplant|9|||
145581366|NCT03149328|524980918|FG001|Overall Study|Transplant|1|||
145581367|NCT03149328|524980917|FG000|Overall Study|Lost to Follow-up|25|||
145581368|NCT03149328|524980918|FG001|Overall Study|Lost to Follow-up|16|||
145581369|NCT03149328|524980917|FG000|Overall Study|Left Study Site|1|||
145581370|NCT03149328|524980918|FG001|Overall Study|Left Study Site|2|||
145581371|NCT03149328|524980917|FG000|Overall Study|Language Barrier|1|||
145581372|NCT03149328|524980918|FG001|Overall Study|Language Barrier|0|||
145581373|NCT00766415|524980922|FG000|Overall Study|Withdrawal by Subject|0|||
145581374|NCT00766415|524980923|FG001|Overall Study|Withdrawal by Subject|1|||
145581375|NCT00061048|524980924|FG000|Overall Study|Adverse Event|2|||
145581376|NCT00061048|524980924|FG000|Overall Study|disease progression|20|||
145581377|NCT01114516|524980925|FG000|Overall Study|Lost to Follow-up|2|||
145581378|NCT01114516|524980926|FG001|Overall Study|Lost to Follow-up|1|||
145581379|NCT02758236|524980928|FG000|Overall Study|Investigator discretion|43|||
145581380|NCT00023452|524980929|FG000|Overall Study|Ineligible for Study|163|||
145581381|NCT00023452|524980930|FG001|Overall Study|Ineligible for Study|159|||
145581382|NCT00023452|524980929|FG000|Overall Study|Out of Window|129|||
145581383|NCT00023452|524980930|FG001|Overall Study|Out of Window|69|||
145581384|NCT00023452|524980929|FG000|Overall Study|Death|2|||
145581385|NCT00023452|524980930|FG001|Overall Study|Death|0|||
145581386|NCT00023452|524980929|FG000|Overall Study|Withdrawal by Subject|66|||
145581387|NCT00023452|524980930|FG001|Overall Study|Withdrawal by Subject|54|||
145581388|NCT00023452|524980929|FG000|Overall Study|Adverse Event|139|||
145581389|NCT00023452|524980930|FG001|Overall Study|Adverse Event|196|||
145581390|NCT00023452|524980929|FG000|Overall Study|Lost to Follow-up|293|||
145581391|NCT00023452|524980930|FG001|Overall Study|Lost to Follow-up|60|||
145581392|NCT00023452|524980929|FG000|Overall Study|Physician Decision|49|||
145581393|NCT00023452|524980930|FG001|Overall Study|Physician Decision|21|||
145581394|NCT00023452|524980929|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
145581395|NCT00023452|524980930|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
145623805|NCT04537949|525135582|FG005|Follow-up Phase|Withdrawal by Subject|0|||
145623806|NCT04537949|525135583|FG006|Follow-up Phase|Withdrawal by Subject|0|||
145581396|NCT00023452|524980929|FG000|Overall Study|Pregnant|53|||
145581397|NCT00023452|524980930|FG001|Overall Study|Pregnant|20|||
145581398|NCT00023452|524980929|FG000|Overall Study|Other|204|||
145581399|NCT00023452|524980930|FG001|Overall Study|Other|69|||
145581400|NCT01940705|524980932|FG000|Overall Study|Lost to Follow-up|1|||
145581401|NCT01940705|524980933|FG001|Overall Study|Lost to Follow-up|3|||
145581402|NCT01940705|524980934|FG002|Overall Study|Lost to Follow-up|2|||
145581403|NCT01940705|524980935|FG003|Overall Study|Lost to Follow-up|2|||
145581404|NCT01940705|524980932|FG000|Overall Study|Withdrawal by Subject|2|||
145581405|NCT01940705|524980933|FG001|Overall Study|Withdrawal by Subject|2|||
145581406|NCT01940705|524980934|FG002|Overall Study|Withdrawal by Subject|3|||
145581407|NCT01940705|524980935|FG003|Overall Study|Withdrawal by Subject|2|||
145581408|NCT01940705|524980932|FG000|Overall Study|Intervention not given|0|||
145581409|NCT01940705|524980933|FG001|Overall Study|Intervention not given|3|||
145581410|NCT01940705|524980934|FG002|Overall Study|Intervention not given|3|||
145581411|NCT01940705|524980935|FG003|Overall Study|Intervention not given|0|||
145581412|NCT01940705|524980932|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
145581413|NCT01940705|524980933|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
145581414|NCT01940705|524980934|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
145581415|NCT01940705|524980935|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
145581416|NCT00432380|524983117|FG000|Overall Study|Migrated/moved from study area|3|||
145581417|NCT00432380|524983118|FG001|Overall Study|Migrated/moved from study area|4|||
145581418|NCT00432380|524983119|FG002|Overall Study|Migrated/moved from study area|1|||
145581419|NCT00432380|524983117|FG000|Overall Study|Adverse Event|1|||
145581420|NCT00432380|524983118|FG001|Overall Study|Adverse Event|0|||
145581421|NCT00432380|524983119|FG002|Overall Study|Adverse Event|0|||
145581422|NCT01071395|524983120|FG000|Overall Study|Withdrawal by Subject|2|||
145581423|NCT01071395|524983121|FG001|Overall Study|Withdrawal by Subject|1|||
145581424|NCT01071395|524983120|FG000|Overall Study|Adverse Event|3|||
145581425|NCT01071395|524983121|FG001|Overall Study|Adverse Event|1|||
145581426|NCT02032901|524983122|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
145581427|NCT02032901|524983123|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
145581428|NCT02032901|524983122|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
145581429|NCT02032901|524983123|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
145581430|NCT01722331|524983124|FG000|Part 1|Adverse Event|5|||
145581431|NCT01722331|524983125|FG001|Part 1|Adverse Event|0|||
145581432|NCT01722331|524983126|FG002|Part 1|Adverse Event|0|||
145581433|NCT01722331|524983127|FG003|Part 1|Adverse Event|0|||
145581434|NCT01722331|524983128|FG004|Part 1|Adverse Event|0|||
145581435|NCT01722331|524983129|FG005|Part 1|Adverse Event|0|||
145581436|NCT01722331|524983130|FG006|Part 1|Adverse Event|0|||
145581437|NCT01722331|524983124|FG000|Part 1|Lack of Efficacy|0|||
145581438|NCT01722331|524983125|FG001|Part 1|Lack of Efficacy|0|||
145581439|NCT01722331|524983126|FG002|Part 1|Lack of Efficacy|1|||
145581440|NCT01722331|524983127|FG003|Part 1|Lack of Efficacy|0|||
145581441|NCT01722331|524983128|FG004|Part 1|Lack of Efficacy|2|||
145581442|NCT01722331|524983129|FG005|Part 1|Lack of Efficacy|0|||
145581443|NCT01722331|524983130|FG006|Part 1|Lack of Efficacy|0|||
145581444|NCT01722331|524983124|FG000|Part 1|Lost to Follow-up|1|||
145581445|NCT01722331|524983125|FG001|Part 1|Lost to Follow-up|0|||
145581446|NCT01722331|524983126|FG002|Part 1|Lost to Follow-up|2|||
145581447|NCT01722331|524983127|FG003|Part 1|Lost to Follow-up|0|||
145581448|NCT01722331|524983128|FG004|Part 1|Lost to Follow-up|1|||
145581449|NCT01722331|524983129|FG005|Part 1|Lost to Follow-up|0|||
145581450|NCT01722331|524983130|FG006|Part 1|Lost to Follow-up|0|||
145581451|NCT01722331|524983124|FG000|Part 1|Physician Decision|0|||
145581452|NCT01722331|524983125|FG001|Part 1|Physician Decision|0|||
145581453|NCT01722331|524983126|FG002|Part 1|Physician Decision|3|||
145581454|NCT01722331|524983127|FG003|Part 1|Physician Decision|0|||
145581455|NCT01722331|524983128|FG004|Part 1|Physician Decision|1|||
145581456|NCT01722331|524983129|FG005|Part 1|Physician Decision|0|||
145581457|NCT01722331|524983130|FG006|Part 1|Physician Decision|0|||
145581458|NCT01722331|524983124|FG000|Part 1|Pregnancy|1|||
145581459|NCT01722331|524983125|FG001|Part 1|Pregnancy|0|||
145581460|NCT01722331|524983126|FG002|Part 1|Pregnancy|0|||
145581461|NCT01722331|524983127|FG003|Part 1|Pregnancy|0|||
145581462|NCT01722331|524983128|FG004|Part 1|Pregnancy|0|||
145581463|NCT01722331|524983129|FG005|Part 1|Pregnancy|0|||
145581464|NCT01722331|524983130|FG006|Part 1|Pregnancy|0|||
145581465|NCT01722331|524983124|FG000|Part 1|Progressive Disease|0|||
145581466|NCT01722331|524983125|FG001|Part 1|Progressive Disease|0|||
145581467|NCT01722331|524983126|FG002|Part 1|Progressive Disease|0|||
145581468|NCT01722331|524983127|FG003|Part 1|Progressive Disease|0|||
145581469|NCT01722331|524983128|FG004|Part 1|Progressive Disease|1|||
145581470|NCT01722331|524983129|FG005|Part 1|Progressive Disease|0|||
145581471|NCT01722331|524983130|FG006|Part 1|Progressive Disease|0|||
145581472|NCT01722331|524983124|FG000|Part 1|Protocol Violation|1|||
145581473|NCT01722331|524983125|FG001|Part 1|Protocol Violation|0|||
145581474|NCT01722331|524983126|FG002|Part 1|Protocol Violation|0|||
145581475|NCT01722331|524983127|FG003|Part 1|Protocol Violation|0|||
145581476|NCT01722331|524983128|FG004|Part 1|Protocol Violation|1|||
145581477|NCT01722331|524983129|FG005|Part 1|Protocol Violation|0|||
145581478|NCT01722331|524983130|FG006|Part 1|Protocol Violation|0|||
145581479|NCT01722331|524983124|FG000|Part 1|Withdrawal by Subject|2|||
145581480|NCT01722331|524983125|FG001|Part 1|Withdrawal by Subject|0|||
145581481|NCT01722331|524983126|FG002|Part 1|Withdrawal by Subject|3|||
145581482|NCT01722331|524983127|FG003|Part 1|Withdrawal by Subject|0|||
145581483|NCT01722331|524983128|FG004|Part 1|Withdrawal by Subject|3|||
145581484|NCT01722331|524983129|FG005|Part 1|Withdrawal by Subject|0|||
145581485|NCT01722331|524983130|FG006|Part 1|Withdrawal by Subject|0|||
145581486|NCT01722331|524983124|FG000|Part 2|Adverse Event|3|||
145581487|NCT01722331|524983125|FG001|Part 2|Adverse Event|0|||
145581488|NCT01722331|524983126|FG002|Part 2|Adverse Event|0|||
145581489|NCT01722331|524983127|FG003|Part 2|Adverse Event|0|||
145581490|NCT01722331|524983128|FG004|Part 2|Adverse Event|0|||
145581491|NCT01722331|524983129|FG005|Part 2|Adverse Event|1|||
145581492|NCT01722331|524983130|FG006|Part 2|Adverse Event|0|||
145581493|NCT01722331|524983124|FG000|Part 2|Lack of Efficacy|3|||
145581494|NCT01722331|524983125|FG001|Part 2|Lack of Efficacy|0|||
145581495|NCT01722331|524983126|FG002|Part 2|Lack of Efficacy|11|||
145581496|NCT01722331|524983127|FG003|Part 2|Lack of Efficacy|0|||
145581497|NCT01722331|524983128|FG004|Part 2|Lack of Efficacy|0|||
145581498|NCT01722331|524983129|FG005|Part 2|Lack of Efficacy|3|||
145581499|NCT01722331|524983130|FG006|Part 2|Lack of Efficacy|3|||
145581500|NCT01722331|524983124|FG000|Part 2|Lost to Follow-up|0|||
145581501|NCT01722331|524983125|FG001|Part 2|Lost to Follow-up|0|||
145581502|NCT01722331|524983126|FG002|Part 2|Lost to Follow-up|3|||
145581503|NCT01722331|524983127|FG003|Part 2|Lost to Follow-up|0|||
145581504|NCT01722331|524983128|FG004|Part 2|Lost to Follow-up|0|||
145581505|NCT01722331|524983129|FG005|Part 2|Lost to Follow-up|1|||
145581506|NCT01722331|524983130|FG006|Part 2|Lost to Follow-up|1|||
145581507|NCT01722331|524983124|FG000|Part 2|Non-Compliance with Study Drug|1|||
145581508|NCT01722331|524983125|FG001|Part 2|Non-Compliance with Study Drug|0|||
145581509|NCT01722331|524983126|FG002|Part 2|Non-Compliance with Study Drug|1|||
145581510|NCT01722331|524983127|FG003|Part 2|Non-Compliance with Study Drug|0|||
145581511|NCT01722331|524983128|FG004|Part 2|Non-Compliance with Study Drug|0|||
145581512|NCT01722331|524983129|FG005|Part 2|Non-Compliance with Study Drug|0|||
145581513|NCT01722331|524983130|FG006|Part 2|Non-Compliance with Study Drug|0|||
145581514|NCT01722331|524983124|FG000|Part 2|Physician Decision|0|||
145581515|NCT01722331|524983125|FG001|Part 2|Physician Decision|0|||
145581516|NCT01722331|524983126|FG002|Part 2|Physician Decision|2|||
145581517|NCT01722331|524983127|FG003|Part 2|Physician Decision|0|||
145581518|NCT01722331|524983128|FG004|Part 2|Physician Decision|0|||
145581519|NCT01722331|524983129|FG005|Part 2|Physician Decision|0|||
145581520|NCT01722331|524983130|FG006|Part 2|Physician Decision|0|||
145581521|NCT01722331|524983124|FG000|Part 2|Pregnancy|0|||
145581522|NCT01722331|524983125|FG001|Part 2|Pregnancy|0|||
145581523|NCT01722331|524983126|FG002|Part 2|Pregnancy|0|||
145581524|NCT01722331|524983127|FG003|Part 2|Pregnancy|0|||
145581525|NCT01722331|524983128|FG004|Part 2|Pregnancy|0|||
145581526|NCT01722331|524983129|FG005|Part 2|Pregnancy|1|||
145581527|NCT01722331|524983130|FG006|Part 2|Pregnancy|0|||
145581528|NCT01722331|524983124|FG000|Part 2|Progressive Disease|0|||
145581529|NCT01722331|524983125|FG001|Part 2|Progressive Disease|0|||
145581530|NCT01722331|524983126|FG002|Part 2|Progressive Disease|1|||
145581531|NCT01722331|524983127|FG003|Part 2|Progressive Disease|0|||
145581532|NCT01722331|524983128|FG004|Part 2|Progressive Disease|0|||
145581533|NCT01722331|524983129|FG005|Part 2|Progressive Disease|0|||
145581534|NCT01722331|524983130|FG006|Part 2|Progressive Disease|0|||
145581535|NCT01722331|524983124|FG000|Part 2|Protocol Violation|1|||
145581536|NCT01722331|524983125|FG001|Part 2|Protocol Violation|0|||
145581537|NCT01722331|524983126|FG002|Part 2|Protocol Violation|0|||
145581538|NCT01722331|524983127|FG003|Part 2|Protocol Violation|0|||
145581539|NCT01722331|524983128|FG004|Part 2|Protocol Violation|0|||
145581540|NCT01722331|524983129|FG005|Part 2|Protocol Violation|0|||
145581541|NCT01722331|524983130|FG006|Part 2|Protocol Violation|0|||
145581542|NCT01722331|524983124|FG000|Part 2|Withdrawal by Subject|5|||
145581543|NCT01722331|524983125|FG001|Part 2|Withdrawal by Subject|0|||
145581544|NCT01722331|524983126|FG002|Part 2|Withdrawal by Subject|3|||
145581545|NCT01722331|524983127|FG003|Part 2|Withdrawal by Subject|0|||
145581546|NCT01722331|524983128|FG004|Part 2|Withdrawal by Subject|0|||
145581547|NCT01722331|524983129|FG005|Part 2|Withdrawal by Subject|2|||
145581548|NCT01722331|524983130|FG006|Part 2|Withdrawal by Subject|2|||
145581549|NCT01722331|524983124|FG000|Part 2|Other Protocol Specified Criteria|6|||
145581550|NCT01722331|524983125|FG001|Part 2|Other Protocol Specified Criteria|0|||
145581551|NCT01722331|524983126|FG002|Part 2|Other Protocol Specified Criteria|10|||
145581552|NCT01722331|524983127|FG003|Part 2|Other Protocol Specified Criteria|0|||
145581553|NCT01722331|524983128|FG004|Part 2|Other Protocol Specified Criteria|0|||
145581554|NCT01722331|524983129|FG005|Part 2|Other Protocol Specified Criteria|2|||
145581555|NCT01722331|524983130|FG006|Part 2|Other Protocol Specified Criteria|1|||
145581556|NCT01722331|524983124|FG000|Part 3|Adverse Event|2|||
145581557|NCT01722331|524983125|FG001|Part 3|Adverse Event|2|||
145581558|NCT01722331|524983126|FG002|Part 3|Adverse Event|0|||
145581559|NCT01722331|524983127|FG003|Part 3|Adverse Event|1|||
145581560|NCT01722331|524983128|FG004|Part 3|Adverse Event|0|||
145581561|NCT01722331|524983129|FG005|Part 3|Adverse Event|0|||
145581562|NCT01722331|524983130|FG006|Part 3|Adverse Event|0|||
145581563|NCT01722331|524983124|FG000|Part 3|Death|1|||
145581564|NCT01722331|524983125|FG001|Part 3|Death|0|||
145581565|NCT01722331|524983126|FG002|Part 3|Death|0|||
145581566|NCT01722331|524983127|FG003|Part 3|Death|0|||
145581567|NCT01722331|524983128|FG004|Part 3|Death|0|||
145581568|NCT01722331|524983129|FG005|Part 3|Death|0|||
145427853|NCT02327169|524424155|FG013|Overall Study|Withdrawal by Subject|0|||
145427854|NCT02327169|524424156|FG014|Overall Study|Withdrawal by Subject|3|||
145427855|NCT02327169|524424142|FG000|Overall Study|Lost to Follow-up|0|||
145427856|NCT02327169|524424143|FG001|Overall Study|Lost to Follow-up|0|||
145427857|NCT02327169|524424144|FG002|Overall Study|Lost to Follow-up|0|||
145427858|NCT02327169|524424145|FG003|Overall Study|Lost to Follow-up|0|||
145427859|NCT02327169|524424146|FG004|Overall Study|Lost to Follow-up|1|||
145427860|NCT02327169|524424147|FG005|Overall Study|Lost to Follow-up|0|||
145427861|NCT02327169|524424148|FG006|Overall Study|Lost to Follow-up|0|||
145427862|NCT02327169|524424149|FG007|Overall Study|Lost to Follow-up|0|||
145427863|NCT02327169|524424150|FG008|Overall Study|Lost to Follow-up|0|||
145427864|NCT02327169|524424151|FG009|Overall Study|Lost to Follow-up|0|||
145427865|NCT02327169|524424152|FG010|Overall Study|Lost to Follow-up|0|||
145427866|NCT02327169|524424153|FG011|Overall Study|Lost to Follow-up|0|||
145427867|NCT02327169|524424154|FG012|Overall Study|Lost to Follow-up|0|||
145427868|NCT02327169|524424155|FG013|Overall Study|Lost to Follow-up|0|||
145427869|NCT02327169|524424156|FG014|Overall Study|Lost to Follow-up|0|||
145427870|NCT03766399|524424157|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427871|NCT03766399|524424158|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427872|NCT03766399|524424159|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427873|NCT03766399|524424160|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427874|NCT03766399|524424161|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427875|NCT03766399|524424162|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427876|NCT03766399|524424163|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427877|NCT03766399|524424164|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427878|NCT03766399|524424165|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427879|NCT03766399|524424166|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427880|NCT03766399|524424167|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427881|NCT03766399|524424168|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427882|NCT03766399|524424169|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427883|NCT03766399|524424170|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
145427884|NCT03766399|524424171|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427885|NCT03766399|524424172|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427886|NCT03766399|524424173|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427887|NCT03766399|524424174|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
145427888|NCT05030766|524424175|FG000|Phase 1 Participants|Lost to Follow-up|12|||
145427889|NCT05030766|524424176|FG001|Phase 1 Participants|Lost to Follow-up|22|||
145427890|NCT05030766|524424177|FG002|Phase 1 Participants|Lost to Follow-up|0|||
145427891|NCT05030766|524424178|FG003|Phase 1 Participants|Lost to Follow-up|0|||
145427892|NCT05030766|524424175|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
145427893|NCT05030766|524424176|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
145427894|NCT05030766|524424177|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
145427895|NCT05030766|524424178|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
145427896|NCT05030766|524424175|FG000|Phase 2 Participants|Lost to Follow-up|0|||
145427897|NCT05030766|524424176|FG001|Phase 2 Participants|Lost to Follow-up|0|||
145427898|NCT05030766|524424177|FG002|Phase 2 Participants|Lost to Follow-up|6|||
145427899|NCT05030766|524424178|FG003|Phase 2 Participants|Lost to Follow-up|2|||
145427900|NCT00645658|524424179|FG000|Overall Study|Withdrawal by Subject|1|||
145427901|NCT00645658|524424180|FG001|Overall Study|Withdrawal by Subject|0|||
145427902|NCT00645658|524424179|FG000|Overall Study|Did not complete all assesments|0|||
145427903|NCT00645658|524424180|FG001|Overall Study|Did not complete all assesments|2|||
145427904|NCT01309230|524424183|FG000|Overall Study|Withdrawal by Subject|0|||
145427905|NCT01309230|524424184|FG001|Overall Study|Withdrawal by Subject|2|||
145427906|NCT01309230|524424183|FG000|Overall Study|Observation arm closed|0|||
145427907|NCT01309230|524424184|FG001|Overall Study|Observation arm closed|2|||
145427908|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
145427909|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145427910|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145427911|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145427912|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145427913|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145581569|NCT01722331|524983130|FG006|Part 3|Death|0|||
145581570|NCT01722331|524983124|FG000|Part 3|Lack of Efficacy|1|||
145581571|NCT01722331|524983125|FG001|Part 3|Lack of Efficacy|0|||
145581572|NCT01722331|524983126|FG002|Part 3|Lack of Efficacy|0|||
145427914|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
145427915|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
145427916|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
145427917|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
145427918|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
145581573|NCT01722331|524983127|FG003|Part 3|Lack of Efficacy|0|||
145581574|NCT01722331|524983128|FG004|Part 3|Lack of Efficacy|0|||
145427919|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
145427920|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
145427921|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
145427922|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
145427923|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
145427924|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
145427925|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
145427926|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
145427927|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
145427928|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
145427929|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
145427930|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
145427931|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
145427932|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
145427933|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
145427934|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
145427935|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
145427936|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
145427937|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
145427938|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
145427939|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
145427940|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
145427941|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
145427942|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
145427943|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
145427944|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
145427945|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
145427946|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
145427947|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
145427948|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
145427949|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
145427950|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
145427951|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427952|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427953|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427954|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427955|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427956|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
145427957|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427958|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
145427959|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427960|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427961|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427962|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427963|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
145427964|NCT01362790|524424187|FG000|Pilot Phase & Phase 2|Death on study|0|||
145427965|NCT01362790|524424188|FG001|Pilot Phase & Phase 2|Death on study|0|||
145427966|NCT01362790|524424189|FG002|Pilot Phase & Phase 2|Death on study|0|||
145427967|NCT01362790|524424190|FG003|Pilot Phase & Phase 2|Death on study|1|||
145427968|NCT01362790|524424191|FG004|Pilot Phase & Phase 2|Death on study|0|||
145427969|NCT01362790|524424192|FG005|Pilot Phase & Phase 2|Death on study|0|||
145427970|NCT01362790|524424193|FG006|Pilot Phase & Phase 2|Death on study|0|||
145427971|NCT01362790|524424187|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
145427972|NCT01362790|524424188|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
145427973|NCT01362790|524424189|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
145427974|NCT01362790|524424190|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
145427975|NCT01362790|524424191|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
145427976|NCT01362790|524424192|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
145427977|NCT01362790|524424193|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
145427978|NCT01362790|524424187|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145427979|NCT01362790|524424188|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145427980|NCT01362790|524424189|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145427981|NCT01362790|524424190|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145427982|NCT01362790|524424191|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
145581575|NCT01722331|524983129|FG005|Part 3|Lack of Efficacy|0|||
145581576|NCT01722331|524983130|FG006|Part 3|Lack of Efficacy|0|||
145581577|NCT01722331|524983124|FG000|Part 3|Lost to Follow-up|3|||
145581578|NCT01722331|524983125|FG001|Part 3|Lost to Follow-up|4|||
145427983|NCT01362790|524424192|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145581579|NCT01722331|524983126|FG002|Part 3|Lost to Follow-up|0|||
145581580|NCT01722331|524983127|FG003|Part 3|Lost to Follow-up|0|||
145581581|NCT01722331|524983128|FG004|Part 3|Lost to Follow-up|0|||
145427984|NCT01362790|524424193|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
145427985|NCT01362790|524424187|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
145427986|NCT01362790|524424188|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
145427987|NCT01362790|524424189|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
145427988|NCT01362790|524424190|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
145427989|NCT01362790|524424191|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
145427990|NCT01362790|524424192|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
145427991|NCT01362790|524424193|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
145427992|NCT00759395|524424195|FG000|Overall Study|Adverse Event|1|||
145427993|NCT00759395|524424196|FG001|Overall Study|Adverse Event|0|||
145427994|NCT00759395|524424195|FG000|Overall Study|Withdrawal by Subject|1|||
145427995|NCT00759395|524424196|FG001|Overall Study|Withdrawal by Subject|0|||
145427996|NCT00759395|524424195|FG000|Overall Study|Lack of Efficacy|0|||
145427997|NCT00759395|524424196|FG001|Overall Study|Lack of Efficacy|2|||
145427998|NCT00437073|524424197|FG000|Overall Study|Sponsor Terminated Study|1|||
145427999|NCT00437073|524424198|FG001|Overall Study|Sponsor Terminated Study|0|||
145428000|NCT00437073|524424197|FG000|Overall Study|Physician Decision|0|||
145428001|NCT00437073|524424198|FG001|Overall Study|Physician Decision|1|||
145428002|NCT03485157|524424199|FG000|Double Blind Phase|Lost to Follow-up|4|||
145428003|NCT03485157|524424200|FG001|Double Blind Phase|Lost to Follow-up|4|||
145428004|NCT03485157|524424199|FG000|Double Blind Phase|Adverse Event|2|||
145428005|NCT03485157|524424200|FG001|Double Blind Phase|Adverse Event|1|||
145428006|NCT03485157|524424199|FG000|Double Blind Phase|Withdrawal by Subject|6|||
145428007|NCT03485157|524424200|FG001|Double Blind Phase|Withdrawal by Subject|9|||
145428008|NCT03485157|524424199|FG000|Double Blind Phase|Removal by PI|3|||
145428009|NCT03485157|524424200|FG001|Double Blind Phase|Removal by PI|7|||
145428010|NCT03485157|524424199|FG000|Open Label Phase|Lost to Follow-up|1|||
145428011|NCT03485157|524424200|FG001|Open Label Phase|Lost to Follow-up|2|||
145428012|NCT03485157|524424199|FG000|Open Label Phase|Adverse Event|0|||
145428013|NCT03485157|524424200|FG001|Open Label Phase|Adverse Event|1|||
145428014|NCT03485157|524424199|FG000|Open Label Phase|Withdrawal by Subject|1|||
145428015|NCT03485157|524424200|FG001|Open Label Phase|Withdrawal by Subject|2|||
145428016|NCT03485157|524424199|FG000|Open Label Phase|Removal by PI|2|||
145428017|NCT03485157|524424200|FG001|Open Label Phase|Removal by PI|0|||
145428018|NCT04875533|524424201|FG000|Overall Study|Adverse Event|6|||
145428019|NCT04875533|524424202|FG001|Overall Study|Adverse Event|4|||
145428020|NCT04875533|524424201|FG000|Overall Study|Protocol Violation|4|||
145428021|NCT04875533|524424202|FG001|Overall Study|Protocol Violation|0|||
145428022|NCT04875533|524424201|FG000|Overall Study|Withdrawal by Subject|8|||
145428023|NCT04875533|524424202|FG001|Overall Study|Withdrawal by Subject|5|||
145428024|NCT04875533|524424201|FG000|Overall Study|No longer meets eligibility criteria|1|||
145428025|NCT04875533|524424202|FG001|Overall Study|No longer meets eligibility criteria|0|||
145428026|NCT04875533|524424201|FG000|Overall Study|Other|0|||
145428027|NCT04875533|524424202|FG001|Overall Study|Other|2|||
145428028|NCT02011542|524424204|FG000|Overall Study|Physician Decision|1|||
145428029|NCT01299961|524424205|FG000|Overall Study|Adverse Event|3|||
145428030|NCT01299961|524424205|FG000|Overall Study|Lack of Efficacy|2|||
145428031|NCT01299961|524424205|FG000|Overall Study|Lost to Follow-up|1|||
145428032|NCT00663260|524424206|FG000|Overall Study|Lack of Efficacy|2|||
145428033|NCT00663260|524424207|FG001|Overall Study|Lack of Efficacy|0|||
145428034|NCT00663260|524424208|FG002|Overall Study|Lack of Efficacy|0|||
145428035|NCT00663260|524424206|FG000|Overall Study|Adverse Event|12|||
145428036|NCT00663260|524424207|FG001|Overall Study|Adverse Event|7|||
145428037|NCT00663260|524424208|FG002|Overall Study|Adverse Event|6|||
145428038|NCT00663260|524424206|FG000|Overall Study|Withdrawal by Subject|3|||
145428039|NCT00663260|524424207|FG001|Overall Study|Withdrawal by Subject|1|||
145428040|NCT00663260|524424208|FG002|Overall Study|Withdrawal by Subject|6|||
145428041|NCT00663260|524424206|FG000|Overall Study|Death|1|||
145428042|NCT00663260|524424207|FG001|Overall Study|Death|0|||
145428043|NCT00663260|524424208|FG002|Overall Study|Death|1|||
145428044|NCT00663260|524424206|FG000|Overall Study|Lost to Follow-up|0|||
145428045|NCT00663260|524424207|FG001|Overall Study|Lost to Follow-up|1|||
145428046|NCT00663260|524424208|FG002|Overall Study|Lost to Follow-up|0|||
145428047|NCT00663260|524424206|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
145428048|NCT00663260|524424207|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
145428049|NCT00663260|524424208|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
145428050|NCT02607722|524424209|FG000|Overall Study|No data reliability|1|||
145623807|NCT04537949|525135584|FG007|Follow-up Phase|Withdrawal by Subject|0|||
145428051|NCT02607722|524424209|FG000|Overall Study|no patient visit|18|||
145428052|NCT02607722|524424209|FG000|Overall Study|missing info in CRF|13|||
145428053|NCT02607722|524424209|FG000|Overall Study|Withdrawal by Subject|616|||
145428054|NCT02607722|524424209|FG000|Overall Study|Lost to Follow-up|312|||
145428055|NCT02607722|524424209|FG000|Overall Study|Improved|22|||
145428056|NCT02607722|524424209|FG000|Overall Study|Lack of Efficacy|316|||
145428057|NCT02607722|524424209|FG000|Overall Study|Adverse Event|2553|||
145428058|NCT02607722|524424209|FG000|Overall Study|Not treated|1|||
145428059|NCT02607722|524424209|FG000|Overall Study|No CRF collected|138|||
145428060|NCT02607722|524424209|FG000|Overall Study|without CRF|4225|||
145428061|NCT02607722|524424209|FG000|Overall Study|Physician Decision|367|||
145428062|NCT02135133|524424210|FG000|Overall Study|Adverse Event|10|||
145428063|NCT02135133|524424210|FG000|Overall Study|regulatory mandate|5|||
145581582|NCT01722331|524983129|FG005|Part 3|Lost to Follow-up|1|||
145581583|NCT01722331|524983130|FG006|Part 3|Lost to Follow-up|0|||
145581584|NCT01722331|524983124|FG000|Part 3|Non-Compliance with Study Drug|0|||
145581585|NCT01722331|524983125|FG001|Part 3|Non-Compliance with Study Drug|1|||
145581586|NCT01722331|524983126|FG002|Part 3|Non-Compliance with Study Drug|0|||
145581587|NCT01722331|524983127|FG003|Part 3|Non-Compliance with Study Drug|0|||
145581588|NCT01722331|524983128|FG004|Part 3|Non-Compliance with Study Drug|0|||
145581589|NCT01722331|524983129|FG005|Part 3|Non-Compliance with Study Drug|0|||
145581590|NCT01722331|524983130|FG006|Part 3|Non-Compliance with Study Drug|0|||
145581591|NCT01722331|524983124|FG000|Part 3|Physician Decision|1|||
145581592|NCT01722331|524983125|FG001|Part 3|Physician Decision|1|||
145581593|NCT01722331|524983126|FG002|Part 3|Physician Decision|0|||
145581594|NCT01722331|524983127|FG003|Part 3|Physician Decision|0|||
145581595|NCT01722331|524983128|FG004|Part 3|Physician Decision|0|||
145581596|NCT01722331|524983129|FG005|Part 3|Physician Decision|0|||
145581597|NCT01722331|524983130|FG006|Part 3|Physician Decision|1|||
145581598|NCT01722331|524983124|FG000|Part 3|Protocol Violation|2|||
145581599|NCT01722331|524983125|FG001|Part 3|Protocol Violation|1|||
145581600|NCT01722331|524983126|FG002|Part 3|Protocol Violation|0|||
145581601|NCT01722331|524983127|FG003|Part 3|Protocol Violation|0|||
145581602|NCT01722331|524983128|FG004|Part 3|Protocol Violation|0|||
145581603|NCT01722331|524983129|FG005|Part 3|Protocol Violation|0|||
145581604|NCT01722331|524983130|FG006|Part 3|Protocol Violation|0|||
145581605|NCT01722331|524983124|FG000|Part 3|Withdrawal by Subject|4|||
145581606|NCT01722331|524983125|FG001|Part 3|Withdrawal by Subject|7|||
145581607|NCT01722331|524983126|FG002|Part 3|Withdrawal by Subject|0|||
145581608|NCT01722331|524983127|FG003|Part 3|Withdrawal by Subject|0|||
145581609|NCT01722331|524983128|FG004|Part 3|Withdrawal by Subject|0|||
145581610|NCT01722331|524983129|FG005|Part 3|Withdrawal by Subject|2|||
145581611|NCT01722331|524983130|FG006|Part 3|Withdrawal by Subject|1|||
145581612|NCT01722331|524983124|FG000|Part 3|Other Protocol Specified Criteria|1|||
145581613|NCT01722331|524983125|FG001|Part 3|Other Protocol Specified Criteria|1|||
145581614|NCT01722331|524983126|FG002|Part 3|Other Protocol Specified Criteria|0|||
145581615|NCT01722331|524983127|FG003|Part 3|Other Protocol Specified Criteria|0|||
145581616|NCT01722331|524983128|FG004|Part 3|Other Protocol Specified Criteria|0|||
145581617|NCT01722331|524983129|FG005|Part 3|Other Protocol Specified Criteria|0|||
145581618|NCT01722331|524983130|FG006|Part 3|Other Protocol Specified Criteria|0|||
145581619|NCT01343082|524983133|FG000|The run-in Period|Not meeting criteria|3|||
145581620|NCT01343082|524983134|FG001|The run-in Period|Not meeting criteria|4|||
145581621|NCT01343082|524983135|FG002|The run-in Period|Not meeting criteria|5|||
145581622|NCT01343082|524983133|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
145581623|NCT01343082|524983134|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
145581624|NCT01343082|524983135|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
145581625|NCT01343082|524983133|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
145581626|NCT01343082|524983134|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
145581627|NCT01343082|524983135|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
145581628|NCT01343082|524983133|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
145581629|NCT01343082|524983134|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
145581630|NCT01343082|524983135|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
145581631|NCT01343082|524983133|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
145581632|NCT01343082|524983134|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
145581633|NCT01343082|524983135|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
145581634|NCT01154166|524983136|FG000|Overall Study|Adverse Event|14|||
145581635|NCT01154166|524983137|FG001|Overall Study|Adverse Event|9|||
145581636|NCT01154166|524983136|FG000|Overall Study|Lost to Follow-up|1|||
145581637|NCT01154166|524983137|FG001|Overall Study|Lost to Follow-up|1|||
145581638|NCT01154166|524983136|FG000|Overall Study|Protocol Violation|4|||
145581639|NCT01154166|524983137|FG001|Overall Study|Protocol Violation|1|||
145581640|NCT01154166|524983136|FG000|Overall Study|Withdrawal by Subject|10|||
145265286|NCT01945034|523819262|FG000|Overall Study|Protocol Violation|1|||
145428064|NCT05081843|524424211|FG000|Overall Study|Lost to Follow-up|135|||
145581641|NCT01154166|524983137|FG001|Overall Study|Withdrawal by Subject|1|||
145581642|NCT01154166|524983136|FG000|Overall Study|Lack of Efficacy|3|||
145581643|NCT01154166|524983137|FG001|Overall Study|Lack of Efficacy|0|||
145581644|NCT01154166|524983136|FG000|Overall Study|Disease Progression|1|||
145581645|NCT01154166|524983137|FG001|Overall Study|Disease Progression|0|||
145581646|NCT01154166|524983136|FG000|Overall Study|Poor Compliance|1|||
145581647|NCT01154166|524983137|FG001|Overall Study|Poor Compliance|0|||
145428065|NCT05081843|524424212|FG001|Overall Study|Lost to Follow-up|145|||
145581648|NCT04265755|524983138|FG000|Overall Study|Withdrawal by Subject|39|||
145581649|NCT04265755|524983138|FG000|Overall Study|Decision by sponsor|2|||
145581650|NCT04265755|524983138|FG000|Overall Study|Lost to Follow-up|11|||
145581651|NCT04265755|524983138|FG000|Overall Study|Death|1|||
145581652|NCT01375049|524983139|FG000|Overall Study|Adverse Event|2|||
145623808|NCT01113463|525135588|FG000|Overall Study|Physician Decision|5|||
145623809|NCT02412761|525135590|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145623810|NCT02412761|525135591|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145374133|NCT04035434|524221216|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374134|NCT04035434|524221217|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374135|NCT04035434|524221218|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
145374136|NCT04035434|524221219|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374137|NCT04035434|524221220|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374138|NCT04035434|524221221|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374139|NCT04035434|524221222|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374140|NCT04035434|524221223|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374141|NCT04035434|524221224|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
145374142|NCT04035434|524221212|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374143|NCT04035434|524221213|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374144|NCT04035434|524221214|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374145|NCT04035434|524221215|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374146|NCT04035434|524221216|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374147|NCT04035434|524221217|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
145374148|NCT04035434|524221218|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
145374149|NCT04035434|524221219|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374150|NCT04035434|524221220|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374151|NCT04035434|524221221|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374152|NCT04035434|524221222|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374153|NCT04035434|524221223|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374154|NCT04035434|524221224|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
145374155|NCT04488497|524221225|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
145374156|NCT04488497|524221226|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
145374157|NCT04488497|524221225|FG000|Intervention|Physician Decision|2|||
145374158|NCT04488497|524221226|FG001|Intervention|Physician Decision|1|||
145374159|NCT04488497|524221225|FG000|Intervention|Withdrawal by Subject|5|||
145374160|NCT04488497|524221226|FG001|Intervention|Withdrawal by Subject|6|||
145374161|NCT04488497|524221225|FG000|Intervention|Lost to Follow-up|2|||
145374162|NCT04488497|524221226|FG001|Intervention|Lost to Follow-up|0|||
145374163|NCT04488497|524221225|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
145374164|NCT04488497|524221226|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
145374165|NCT04488497|524221225|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
145374166|NCT04488497|524221226|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
145374167|NCT01668966|524221234|FG000|Overall Study|Withdrawal by Subject|1|||
145374168|NCT01668966|524221234|FG000|Overall Study|Death|1|||
145374169|NCT01668966|524221234|FG000|Overall Study|Not treated|2|||
145374170|NCT04063657|524221237|FG000|Overall Study|Lost to Follow-up|1|||
145374171|NCT04063657|524221238|FG001|Overall Study|Lost to Follow-up|0|||
145374172|NCT01473394|524221241|FG000|Overall Study|Adverse Event|13|||
145374173|NCT01473394|524221242|FG001|Overall Study|Adverse Event|16|||
145374174|NCT01473394|524221241|FG000|Overall Study|Insufficient Therapeutic Response|4|||
145374175|NCT01473394|524221242|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145374176|NCT01473394|524221241|FG000|Overall Study|Protocol Violation|7|||
145374177|NCT01473394|524221242|FG001|Overall Study|Protocol Violation|5|||
145374178|NCT01473394|524221241|FG000|Overall Study|Withdrew Consent|12|||
145374179|NCT01473394|524221242|FG001|Overall Study|Withdrew Consent|10|||
145374180|NCT01473394|524221241|FG000|Overall Study|Lost to Follow-up|9|||
145374181|NCT01473394|524221242|FG001|Overall Study|Lost to Follow-up|11|||
145374182|NCT00552032|524221243|FG000|Overall Study|Withdrawal by Subject|2|||
145374183|NCT00552032|524221244|FG001|Overall Study|Withdrawal by Subject|2|||
145374184|NCT00552032|524221243|FG000|Overall Study|Protocol Violation|7|||
145374185|NCT00552032|524221244|FG001|Overall Study|Protocol Violation|12|||
145374186|NCT00552032|524221243|FG000|Overall Study|Lost to Follow-up|8|||
145374187|NCT00552032|524221244|FG001|Overall Study|Lost to Follow-up|5|||
145374188|NCT04430738|524221245|FG000|Phase 1: Dose Escalation|Death|1|||
145374189|NCT04430738|524221246|FG001|Phase 1: Dose Escalation|Death|4|||
145374190|NCT04430738|524221247|FG002|Phase 1: Dose Escalation|Death|4|||
145374191|NCT04430738|524221248|FG003|Phase 1: Dose Escalation|Death|1|||
145374192|NCT04430738|524221249|FG004|Phase 1: Dose Escalation|Death|6|||
145428066|NCT02402647|524424213|FG000|Overall Study|Lost to Follow-up|13|||
145428067|NCT02402647|524424214|FG001|Overall Study|Lost to Follow-up|7|||
145374193|NCT04430738|524221250|FG005|Phase 1: Dose Escalation|Death|0|||
145374194|NCT04430738|524221245|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
145374195|NCT04430738|524221246|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145374196|NCT04430738|524221247|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
145428068|NCT02402647|524424213|FG000|Overall Study|Protocol Violation|1|||
145428069|NCT02402647|524424214|FG001|Overall Study|Protocol Violation|1|||
145428070|NCT02402647|524424213|FG000|Overall Study|scheduled and timed out|2|||
145428071|NCT02402647|524424214|FG001|Overall Study|scheduled and timed out|1|||
145428072|NCT02402647|524424213|FG000|Overall Study|medical illness|2|||
145428073|NCT02402647|524424214|FG001|Overall Study|medical illness|4|||
145428074|NCT02402647|524424213|FG000|Overall Study|Moved|2|||
145428075|NCT02402647|524424214|FG001|Overall Study|Moved|0|||
145428076|NCT02402647|524424213|FG000|Overall Study|loved one illness|1|||
145428077|NCT02402647|524424214|FG001|Overall Study|loved one illness|0|||
145428078|NCT02402647|524424213|FG000|Overall Study|deceased preexisting condition|2|||
145428079|NCT02402647|524424214|FG001|Overall Study|deceased preexisting condition|0|||
145428080|NCT02402647|524424213|FG000|Overall Study|Other|2|||
145428081|NCT02402647|524424214|FG001|Overall Study|Other|1|||
145428082|NCT01969058|524424216|FG000|Overall Study|Withdrawal by Subject|2|||
145428083|NCT01969058|524424217|FG001|Overall Study|Withdrawal by Subject|0|||
145428084|NCT01969058|524424216|FG000|Overall Study|Adverse Event|1|||
145428085|NCT01969058|524424217|FG001|Overall Study|Adverse Event|0|||
145428086|NCT00964678|524424230|FG000|Overall Study|Physician Decision|4|||
145428087|NCT03359395|524424231|FG000|First Intervention A / B|Withdrawal by Subject|1|||
145428088|NCT03359395|524424232|FG001|First Intervention A / B|Withdrawal by Subject|0|||
145428089|NCT03359395|524424231|FG000|First Intervention A / B|Lost to Follow-up|2|||
145428090|NCT03359395|524424232|FG001|First Intervention A / B|Lost to Follow-up|3|||
145428091|NCT03359395|524424231|FG000|Second Intervention B/A|Exclusion criteria|0|||
145428092|NCT03359395|524424232|FG001|Second Intervention B/A|Exclusion criteria|1|||
145428093|NCT03359395|524424231|FG000|Second Intervention B/A|Lost to Follow-up|3|||
145428094|NCT03359395|524424232|FG001|Second Intervention B/A|Lost to Follow-up|2|||
145428095|NCT03977155|524425663|FG000|Overall Study|Adverse Event|3|||
145428096|NCT03977155|524425664|FG001|Overall Study|Adverse Event|0|||
145428097|NCT03977155|524425665|FG002|Overall Study|Adverse Event|0|||
145428098|NCT03977155|524425663|FG000|Overall Study|Lost to Follow-up|0|||
145428099|NCT03977155|524425664|FG001|Overall Study|Lost to Follow-up|1|||
145428100|NCT03977155|524425665|FG002|Overall Study|Lost to Follow-up|0|||
145428101|NCT03977155|524425663|FG000|Overall Study|Withdrawal by Subject|1|||
145428102|NCT03977155|524425664|FG001|Overall Study|Withdrawal by Subject|1|||
145428103|NCT03977155|524425665|FG002|Overall Study|Withdrawal by Subject|2|||
145428104|NCT03977155|524425663|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
145428105|NCT03977155|524425664|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
145428106|NCT03977155|524425665|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
145428107|NCT00936936|524425666|FG000|Overall Study|Adverse Event|7|||
145428108|NCT00936936|524425667|FG001|Overall Study|Adverse Event|1|||
145428109|NCT00936936|524425666|FG000|Overall Study|Disease Progression|2|||
145428110|NCT00936936|524425667|FG001|Overall Study|Disease Progression|2|||
145428111|NCT00936936|524425666|FG000|Overall Study|Unrelated|3|||
145428112|NCT00936936|524425667|FG001|Overall Study|Unrelated|1|||
145428113|NCT02278003|524425668|FG000|Overall Study|Withdrawal by Subject|11|||
145428114|NCT02278003|524425669|FG001|Overall Study|Withdrawal by Subject|0|||
145428115|NCT02278003|524425668|FG000|Overall Study|Not Treated|1|||
145428116|NCT02278003|524425669|FG001|Overall Study|Not Treated|0|||
145428117|NCT02278003|524425668|FG000|Overall Study|Recognition task improperly completed|7|||
145428118|NCT02278003|524425669|FG001|Overall Study|Recognition task improperly completed|0|||
145428119|NCT02296476|524425670|FG000|Overall Study|Disease Progression|6|||
145428120|NCT02296476|524425671|FG001|Overall Study|Disease Progression|4|||
145428121|NCT02296476|524425672|FG002|Overall Study|Disease Progression|2|||
145428122|NCT03440385|524425674|FG000|Overall Study|Other Reason|4|||
145428123|NCT03440385|524425675|FG001|Overall Study|Other Reason|1|||
145428124|NCT03440385|524425674|FG000|Overall Study|Site Closed|1|||
145428125|NCT03440385|524425675|FG001|Overall Study|Site Closed|0|||
145428126|NCT03440385|524425674|FG000|Overall Study|Lost to Follow-up|2|||
145428127|NCT03440385|524425675|FG001|Overall Study|Lost to Follow-up|0|||
145428128|NCT03440385|524425674|FG000|Overall Study|Withdrawal by Subject|12|||
145428129|NCT03440385|524425675|FG001|Overall Study|Withdrawal by Subject|6|||
145428130|NCT03440385|524425674|FG000|Overall Study|Lack of Efficacy|9|||
145428131|NCT03440385|524425675|FG001|Overall Study|Lack of Efficacy|2|||
145428132|NCT03440385|524425674|FG000|Overall Study|Adverse Event|15|||
145428133|NCT03440385|524425675|FG001|Overall Study|Adverse Event|11|||
145428134|NCT00730327|524425677|FG000|Overall Study|Lost to Follow-up|14|||
145428135|NCT00730327|524425678|FG001|Overall Study|Lost to Follow-up|16|||
145428136|NCT00730327|524425677|FG000|Overall Study|Adverse Event|8|||
145428137|NCT00730327|524425678|FG001|Overall Study|Adverse Event|1|||
145428138|NCT00730327|524425677|FG000|Overall Study|Withdrawal by Subject|3|||
145428139|NCT00730327|524425678|FG001|Overall Study|Withdrawal by Subject|13|||
145428140|NCT00730327|524425677|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
145428141|NCT00730327|524425678|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
145428142|NCT02332928|524425684|FG000|Overall Study|Withdrawal by Subject|0|||
145428143|NCT02332928|524425685|FG001|Overall Study|Withdrawal by Subject|2|||
145428144|NCT02332928|524425684|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
145428145|NCT02332928|524425685|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
145581653|NCT01375049|524983139|FG000|Overall Study|Lost to Follow-up|1|||
145581654|NCT01375049|524983139|FG000|Overall Study|Withdrawal by Subject|2|||
145581655|NCT01375049|524983139|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
145581656|NCT01575561|524983140|FG000|Overall Study|Adverse Event|9|||
145581657|NCT01575561|524983140|FG000|Overall Study|Lack of Efficacy|8|||
145581658|NCT01575561|524983140|FG000|Overall Study|Lost to Follow-up|6|||
145581659|NCT01575561|524983140|FG000|Overall Study|Protocol Violation|4|||
145581660|NCT01575561|524983140|FG000|Overall Study|Withdrawal by Subject|11|||
145581661|NCT01575561|524983140|FG000|Overall Study|administration|1|||
145581662|NCT02554773|524983141|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
145581663|NCT02554773|524983142|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
145581664|NCT02554773|524983141|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
145581665|NCT02554773|524983142|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
145581666|NCT02554773|524983141|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
145581667|NCT02554773|524983142|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
145581668|NCT02554773|524983141|FG000|Original Dose Regimen (SAS 1)|Death|1|||
145581669|NCT02554773|524983142|FG001|Original Dose Regimen (SAS 1)|Death|0|||
145581670|NCT02554773|524983141|FG000|Original Dose Regimen (SAS 1)|Other|4|||
145581671|NCT02554773|524983142|FG001|Original Dose Regimen (SAS 1)|Other|0|||
145581672|NCT02554773|524983141|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
145581673|NCT02554773|524983142|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
145581674|NCT02554773|524983141|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
145581675|NCT02554773|524983142|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
145581676|NCT02554773|524983141|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
145581677|NCT02554773|524983142|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
145581678|NCT02554773|524983141|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
145581679|NCT02554773|524983142|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
145581680|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
145581681|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
145581682|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
145581683|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Death|1|||
145581684|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
145581685|NCT02840877|524983143|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
145581686|NCT02840877|524983143|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
145581687|NCT02840877|524983143|FG000|12 Weeks to 6 Months|Treatment failure|1|||
145581688|NCT02840877|524983143|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
145581689|NCT02840877|524983143|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
145581690|NCT02840877|524983143|FG000|12 Weeks to 6 Months|Death|1|||
145581691|NCT02840877|524983143|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
145581692|NCT02840877|524983143|FG000|6 Months to 18 Months|Treatment failure|7|||
145581693|NCT02840877|524983143|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
145581694|NCT02840877|524983143|FG000|6 Months to 18 Months|Moved/transferred out|6|||
145581695|NCT02840877|524983143|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
145581696|NCT02840877|524983143|FG000|6 Months to 18 Months|Death|4|||
145581697|NCT02840877|524983143|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
145581698|NCT02840877|524983143|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
145581699|NCT02840877|524983143|FG000|6 Months to 18 Months|Still in study.|14|||
145581700|NCT02530619|524983153|FG000|Registered for Study|Withdrawal by Subject|2|||
145581701|NCT02530619|524983153|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
145581702|NCT02530619|524983153|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
145581703|NCT02530619|524983153|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
145581704|NCT02530619|524983153|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
145581705|NCT02530619|524983153|FG000|Follow-up Period (6 Months)|Death|4|||
145581706|NCT02530619|524983153|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
145581707|NCT02530619|524983153|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
145581708|NCT01854554|524983166|FG000|Overall Study|Denial of Insurance Coverage|12|||
145581709|NCT01854554|524983167|FG001|Overall Study|Denial of Insurance Coverage|0|||
145581710|NCT01854554|524983166|FG000|Overall Study|Decided to get treatment locally|1|||
145581711|NCT01854554|524983167|FG001|Overall Study|Decided to get treatment locally|5|||
145581712|NCT01854554|524983166|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
145581713|NCT01854554|524983167|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
145581714|NCT01854554|524983166|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
145581715|NCT01854554|524983167|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
145581716|NCT01854554|524983166|FG000|Overall Study|Progression|0|||
145581717|NCT01854554|524983167|FG001|Overall Study|Progression|1|||
145581718|NCT01854554|524983166|FG000|Overall Study|Lost to Follow-up|0|||
145581719|NCT01854554|524983167|FG001|Overall Study|Lost to Follow-up|1|||
145623811|NCT02412761|525135592|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145623812|NCT02412761|525135593|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145428146|NCT04484857|524425691|FG000|Overall Study|Adverse Event|2|||
145428147|NCT04484857|524425691|FG000|Overall Study|Death|10|||
145428148|NCT04484857|524425691|FG000|Overall Study|Withdrawal by Subject|3|||
145428149|NCT04484857|524425691|FG000|Overall Study|Transferred/Relocation|5|||
145428150|NCT04484857|524425691|FG000|Overall Study|Kidney Transplant|7|||
145428151|NCT04484857|524425691|FG000|Overall Study|Other than specified|4|||
145428152|NCT04484857|524425691|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
145428153|NCT02095106|524425699|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
145428154|NCT02095106|524425700|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
145428155|NCT01182350|524425701|FG000|Overall Study|Adverse Event|5|||
145428156|NCT01182350|524425702|FG001|Overall Study|Adverse Event|0|||
145428157|NCT01182350|524425703|FG002|Overall Study|Adverse Event|0|||
145428158|NCT01182350|524425704|FG003|Overall Study|Adverse Event|0|||
145428159|NCT01182350|524425705|FG004|Overall Study|Adverse Event|0|||
145428160|NCT01182350|524425701|FG000|Overall Study|Disease Progression|15|||
145428161|NCT01182350|524425702|FG001|Overall Study|Disease Progression|12|||
145428162|NCT01182350|524425703|FG002|Overall Study|Disease Progression|0|||
145428163|NCT01182350|524425704|FG003|Overall Study|Disease Progression|1|||
145428164|NCT01182350|524425705|FG004|Overall Study|Disease Progression|0|||
145428165|NCT01182350|524425701|FG000|Overall Study|Death|0|||
145428166|NCT01182350|524425702|FG001|Overall Study|Death|1|||
145428167|NCT01182350|524425703|FG002|Overall Study|Death|1|||
145428168|NCT01182350|524425704|FG003|Overall Study|Death|0|||
145428169|NCT01182350|524425705|FG004|Overall Study|Death|0|||
145428170|NCT01182350|524425701|FG000|Overall Study|Withdrawal by Subject|3|||
145428171|NCT01182350|524425702|FG001|Overall Study|Withdrawal by Subject|1|||
145428172|NCT01182350|524425703|FG002|Overall Study|Withdrawal by Subject|0|||
145428173|NCT01182350|524425704|FG003|Overall Study|Withdrawal by Subject|1|||
145428174|NCT01182350|524425705|FG004|Overall Study|Withdrawal by Subject|0|||
145428175|NCT01182350|524425701|FG000|Overall Study|Alternative Therapy|2|||
145428176|NCT01182350|524425702|FG001|Overall Study|Alternative Therapy|0|||
145428177|NCT01182350|524425703|FG002|Overall Study|Alternative Therapy|1|||
145428178|NCT01182350|524425704|FG003|Overall Study|Alternative Therapy|0|||
145428179|NCT01182350|524425705|FG004|Overall Study|Alternative Therapy|0|||
145428180|NCT01182350|524425701|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
145428181|NCT01182350|524425702|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
145428182|NCT01182350|524425703|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
145428183|NCT01182350|524425704|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
145428184|NCT01182350|524425705|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
145428185|NCT01182350|524425701|FG000|Overall Study|Unevaluable for Biopsy|0|||
145428186|NCT01182350|524425702|FG001|Overall Study|Unevaluable for Biopsy|0|||
145428187|NCT01182350|524425703|FG002|Overall Study|Unevaluable for Biopsy|0|||
145428188|NCT01182350|524425704|FG003|Overall Study|Unevaluable for Biopsy|0|||
145428189|NCT01182350|524425705|FG004|Overall Study|Unevaluable for Biopsy|3|||
145428190|NCT02919618|524425708|FG000|Overall Study|Death|1|||
145428191|NCT04770285|524425710|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
145428192|NCT04770285|524425711|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
145428193|NCT04770285|524425710|FG000|Overall Study|Lack of Efficacy|0|||
145428194|NCT04770285|524425711|FG001|Overall Study|Lack of Efficacy|1|||
145428195|NCT04770285|524425710|FG000|Overall Study|Lost to Follow-up|11|||
145428196|NCT04770285|524425711|FG001|Overall Study|Lost to Follow-up|8|||
145428197|NCT04770285|524425710|FG000|Overall Study|Protocol Deviation|6|||
145428198|NCT04770285|524425711|FG001|Overall Study|Protocol Deviation|6|||
145428199|NCT04770285|524425710|FG000|Overall Study|Technical Problem|0|||
145428200|NCT04770285|524425711|FG001|Overall Study|Technical Problem|1|||
145428201|NCT04770285|524425710|FG000|Overall Study|Withdrawal by Subject|9|||
145428202|NCT04770285|524425711|FG001|Overall Study|Withdrawal by Subject|8|||
145428203|NCT04770285|524425710|FG000|Overall Study|Reason Not Specified|0|||
145428204|NCT04770285|524425711|FG001|Overall Study|Reason Not Specified|1|||
145428205|NCT03895372|524425714|FG000|Investigational Treatment Period|Adverse Event|1|||
145428206|NCT03895372|524425715|FG001|Investigational Treatment Period|Adverse Event|0|||
145428207|NCT03895372|524425716|FG002|Investigational Treatment Period|Adverse Event|0|||
145623813|NCT02412761|525135594|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145428208|NCT03895372|524425717|FG003|Investigational Treatment Period|Adverse Event|0|||
145428209|NCT03895372|524425718|FG004|Investigational Treatment Period|Adverse Event|0|||
145428210|NCT03895372|524425719|FG005|Investigational Treatment Period|Adverse Event|0|||
145428211|NCT03895372|524425720|FG006|Investigational Treatment Period|Adverse Event|4|||
145428212|NCT03895372|524425721|FG007|Investigational Treatment Period|Adverse Event|3|||
145428213|NCT03895372|524425714|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
145428214|NCT03895372|524425715|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
145428215|NCT03895372|524425716|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
145428216|NCT03895372|524425717|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
145428217|NCT03895372|524425718|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
145428218|NCT03895372|524425719|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
145428219|NCT03895372|524425720|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
145428220|NCT03895372|524425721|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
145581720|NCT02819726|524983168|FG000|Part A (All Participants)|Lost to Follow-up|0|||
145581721|NCT02819726|524983169|FG001|Part A (All Participants)|Lost to Follow-up|1|||
145581722|NCT02819726|524983170|FG002|Part A (All Participants)|Lost to Follow-up|0|||
145581723|NCT02819726|524983171|FG003|Part A (All Participants)|Lost to Follow-up|0|||
145581724|NCT02819726|524983168|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
145581725|NCT02819726|524983169|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
145581726|NCT02819726|524983170|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
145581727|NCT02819726|524983171|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
145581728|NCT02819726|524983168|FG000|Part A (All Participants)|Protocol non-compliance|3|||
145581729|NCT02819726|524983169|FG001|Part A (All Participants)|Protocol non-compliance|4|||
145581730|NCT02819726|524983170|FG002|Part A (All Participants)|Protocol non-compliance|5|||
145581731|NCT02819726|524983171|FG003|Part A (All Participants)|Protocol non-compliance|0|||
145581732|NCT02819726|524983168|FG000|Part B (All Participants)|Lost to Follow-up|1|||
145581733|NCT02819726|524983169|FG001|Part B (All Participants)|Lost to Follow-up|1|||
145581734|NCT02819726|524983170|FG002|Part B (All Participants)|Lost to Follow-up|2|||
145581735|NCT02819726|524983171|FG003|Part B (All Participants)|Lost to Follow-up|2|||
145581736|NCT02819726|524983168|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
145581737|NCT02819726|524983169|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
145581738|NCT02819726|524983170|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
145581739|NCT02819726|524983171|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
145581740|NCT02819726|524983168|FG000|Part B (All Participants)|Protocol non-compliance|0|||
145581741|NCT02819726|524983169|FG001|Part B (All Participants)|Protocol non-compliance|0|||
145581742|NCT02819726|524983170|FG002|Part B (All Participants)|Protocol non-compliance|1|||
145581743|NCT02819726|524983171|FG003|Part B (All Participants)|Protocol non-compliance|0|||
145428221|NCT03895372|524425714|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
145428222|NCT03895372|524425715|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
145428223|NCT03895372|524425716|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
145428224|NCT03895372|524425717|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
145428225|NCT03895372|524425718|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
145428226|NCT03895372|524425719|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
145428227|NCT03895372|524425720|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
145428228|NCT03895372|524425721|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
145428229|NCT03895372|524425714|FG000|Investigational Treatment Period|Other|0|||
145428230|NCT03895372|524425715|FG001|Investigational Treatment Period|Other|0|||
145428231|NCT03895372|524425716|FG002|Investigational Treatment Period|Other|0|||
145428232|NCT03895372|524425717|FG003|Investigational Treatment Period|Other|0|||
145428233|NCT03895372|524425718|FG004|Investigational Treatment Period|Other|0|||
145428234|NCT03895372|524425719|FG005|Investigational Treatment Period|Other|1|||
145428235|NCT03895372|524425720|FG006|Investigational Treatment Period|Other|0|||
145428236|NCT03895372|524425721|FG007|Investigational Treatment Period|Other|2|||
145428237|NCT03895372|524425714|FG000|Investigational Treatment Period|Protocol Violation|0|||
145428238|NCT03895372|524425715|FG001|Investigational Treatment Period|Protocol Violation|0|||
145428239|NCT03895372|524425716|FG002|Investigational Treatment Period|Protocol Violation|0|||
145428240|NCT03895372|524425717|FG003|Investigational Treatment Period|Protocol Violation|1|||
145428241|NCT03895372|524425718|FG004|Investigational Treatment Period|Protocol Violation|0|||
145428242|NCT03895372|524425719|FG005|Investigational Treatment Period|Protocol Violation|0|||
145428243|NCT03895372|524425720|FG006|Investigational Treatment Period|Protocol Violation|0|||
145428244|NCT03895372|524425721|FG007|Investigational Treatment Period|Protocol Violation|0|||
145428245|NCT03895372|524425714|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
145428246|NCT03895372|524425715|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
145428247|NCT03895372|524425716|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
145428248|NCT03895372|524425717|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
145428249|NCT03895372|524425718|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
145428250|NCT03895372|524425719|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
145428251|NCT03895372|524425720|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
145428252|NCT03895372|524425721|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
145428253|NCT03895372|524425714|FG000|Extension Treatment Period|Adverse Event|0|||
145428254|NCT03895372|524425715|FG001|Extension Treatment Period|Adverse Event|1|||
145428255|NCT03895372|524425716|FG002|Extension Treatment Period|Adverse Event|0|||
145428256|NCT03895372|524425717|FG003|Extension Treatment Period|Adverse Event|1|||
145428257|NCT03895372|524425718|FG004|Extension Treatment Period|Adverse Event|0|||
145428258|NCT03895372|524425719|FG005|Extension Treatment Period|Adverse Event|0|||
145428259|NCT03895372|524425720|FG006|Extension Treatment Period|Adverse Event|3|||
145428260|NCT03895372|524425721|FG007|Extension Treatment Period|Adverse Event|3|||
145428261|NCT03895372|524425714|FG000|Extension Treatment Period|Other|1|||
145428262|NCT03895372|524425715|FG001|Extension Treatment Period|Other|3|||
145428263|NCT03895372|524425716|FG002|Extension Treatment Period|Other|0|||
145428264|NCT03895372|524425717|FG003|Extension Treatment Period|Other|0|||
145428265|NCT03895372|524425718|FG004|Extension Treatment Period|Other|1|||
145581744|NCT00359762|524983172|FG000|Period II|Adverse Event|17|||
145623814|NCT02412761|525135595|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145374197|NCT04430738|524221248|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145374198|NCT04430738|524221249|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
145374199|NCT04430738|524221250|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
145374200|NCT04430738|524221245|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145374201|NCT04430738|524221246|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
145374202|NCT04430738|524221247|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145374203|NCT04430738|524221248|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
145374204|NCT04430738|524221249|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145374205|NCT04430738|524221250|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
145374206|NCT04430738|524221245|FG000|Phase 1: Dose Escalation|Other|1|||
145374207|NCT04430738|524221246|FG001|Phase 1: Dose Escalation|Other|0|||
145374208|NCT04430738|524221247|FG002|Phase 1: Dose Escalation|Other|0|||
145374209|NCT04430738|524221248|FG003|Phase 1: Dose Escalation|Other|0|||
145374210|NCT04430738|524221249|FG004|Phase 1: Dose Escalation|Other|0|||
145374211|NCT04430738|524221250|FG005|Phase 1: Dose Escalation|Other|0|||
145374212|NCT04430738|524221245|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145374213|NCT04430738|524221246|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145374214|NCT04430738|524221247|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145374215|NCT04430738|524221248|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145374216|NCT04430738|524221249|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
145374217|NCT04430738|524221250|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
145374218|NCT04430738|524221245|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145374219|NCT04430738|524221246|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145374220|NCT04430738|524221247|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145374221|NCT04430738|524221248|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145374222|NCT04430738|524221249|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
145374223|NCT04430738|524221250|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
145374224|NCT00878969|524221258|FG000|Overall Study|Physician Decision|5|||
145374225|NCT00878969|524221259|FG001|Overall Study|Physician Decision|3|||
145374226|NCT00878969|524221260|FG002|Overall Study|Physician Decision|2|||
145374227|NCT00878969|524221258|FG000|Overall Study|Withdrawal by Subject|1|||
145374228|NCT00878969|524221259|FG001|Overall Study|Withdrawal by Subject|6|||
145374229|NCT00878969|524221260|FG002|Overall Study|Withdrawal by Subject|3|||
145374230|NCT00878969|524221258|FG000|Overall Study|kidney transplant|2|||
145374231|NCT00878969|524221259|FG001|Overall Study|kidney transplant|3|||
145374232|NCT00878969|524221260|FG002|Overall Study|kidney transplant|2|||
145374233|NCT00878969|524221258|FG000|Overall Study|Adverse Event|3|||
145374234|NCT00878969|524221259|FG001|Overall Study|Adverse Event|1|||
145374235|NCT00878969|524221260|FG002|Overall Study|Adverse Event|2|||
145374236|NCT00878969|524221258|FG000|Overall Study|Lost to Follow-up|2|||
145374237|NCT00878969|524221259|FG001|Overall Study|Lost to Follow-up|1|||
145374238|NCT00878969|524221260|FG002|Overall Study|Lost to Follow-up|0|||
145374239|NCT00878969|524221258|FG000|Overall Study|Protocol Violation|2|||
145374240|NCT00878969|524221259|FG001|Overall Study|Protocol Violation|0|||
145374241|NCT00878969|524221260|FG002|Overall Study|Protocol Violation|0|||
145374242|NCT00878969|524221258|FG000|Overall Study|Death|0|||
145374243|NCT00878969|524221259|FG001|Overall Study|Death|0|||
145374244|NCT00878969|524221260|FG002|Overall Study|Death|2|||
145374245|NCT00878969|524221258|FG000|Overall Study|Pregnancy|0|||
145374246|NCT00878969|524221259|FG001|Overall Study|Pregnancy|1|||
145374247|NCT00878969|524221260|FG002|Overall Study|Pregnancy|0|||
145374248|NCT00655733|524221261|FG000|Overall Study|Lost to Follow-up|2|||
145374249|NCT00655733|524221262|FG001|Overall Study|Lost to Follow-up|2|||
145374250|NCT00655733|524221261|FG000|Overall Study|Adverse Event|2|||
145374251|NCT00655733|524221262|FG001|Overall Study|Adverse Event|2|||
145374252|NCT00655733|524221261|FG000|Overall Study|Withdrawal by Subject|3|||
145374253|NCT00655733|524221262|FG001|Overall Study|Withdrawal by Subject|3|||
145374254|NCT00655733|524221261|FG000|Overall Study|Physician Decision|0|||
145374255|NCT00655733|524221262|FG001|Overall Study|Physician Decision|1|||
145374256|NCT02035748|524221263|FG000|Overall Study|Adverse Event|5|||
145374257|NCT02035748|524221263|FG000|Overall Study|Death|3|||
145374258|NCT02035748|524221263|FG000|Overall Study|Lost to Follow-up|2|||
145374259|NCT02035748|524221263|FG000|Overall Study|Physician Decision|3|||
145374260|NCT02035748|524221263|FG000|Overall Study|Withdrawal by Subject|6|||
145374261|NCT02035748|524221263|FG000|Overall Study|Progressive Disease|1|||
145374262|NCT01088243|524221265|FG000|Overall Study|Adverse Event|1|||
145374263|NCT01088243|524221266|FG001|Overall Study|Adverse Event|0|||
145374264|NCT00597506|524221267|FG000|Overall Study|Subject is being followed for survival|1|||
145374265|NCT03199612|524221270|FG000|Overall Study|Adverse Event|1|||
145374266|NCT03199612|524221271|FG001|Overall Study|Adverse Event|0|||
145374267|NCT02543892|524221276|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
145374268|NCT02543892|524221277|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
145374269|NCT02543892|524221278|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
145623815|NCT01657682|525135596|FG000|Overall Study|Lost to Follow-up|1|||
145623816|NCT01657682|525135597|FG001|Overall Study|Lost to Follow-up|0|||
145623817|NCT01657682|525135598|FG002|Overall Study|Lost to Follow-up|0|||
145623818|NCT01657682|525135596|FG000|Overall Study|Withdrawal by Subject|0|||
145374270|NCT02543892|524221279|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
145374271|NCT02543892|524221280|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
145374272|NCT02543892|524221281|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
145374273|NCT02543892|524221282|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
145374274|NCT02543892|524221283|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
145374275|NCT02543892|524221276|FG000|Received Vaccination 2|Physician Decision|0|||
145374276|NCT02543892|524221277|FG001|Received Vaccination 2|Physician Decision|0|||
145374277|NCT02543892|524221278|FG002|Received Vaccination 2|Physician Decision|0|||
145374278|NCT02543892|524221279|FG003|Received Vaccination 2|Physician Decision|0|||
145374279|NCT02543892|524221280|FG004|Received Vaccination 2|Physician Decision|0|||
145374280|NCT02543892|524221281|FG005|Received Vaccination 2|Physician Decision|1|||
145374281|NCT02543892|524221282|FG006|Received Vaccination 2|Physician Decision|0|||
145374282|NCT02543892|524221283|FG007|Received Vaccination 2|Physician Decision|0|||
145374283|NCT02543892|524221276|FG000|Received Vaccination 2|Adverse Event|0|||
145374284|NCT02543892|524221277|FG001|Received Vaccination 2|Adverse Event|1|||
145374285|NCT02543892|524221278|FG002|Received Vaccination 2|Adverse Event|0|||
145374286|NCT02543892|524221279|FG003|Received Vaccination 2|Adverse Event|0|||
145374287|NCT02543892|524221280|FG004|Received Vaccination 2|Adverse Event|0|||
145374288|NCT02543892|524221281|FG005|Received Vaccination 2|Adverse Event|0|||
145374289|NCT02543892|524221282|FG006|Received Vaccination 2|Adverse Event|0|||
145374290|NCT02543892|524221283|FG007|Received Vaccination 2|Adverse Event|0|||
145374291|NCT02543892|524221276|FG000|Had Immunology Data|Withdrawal by Subject|0|||
145374292|NCT02543892|524221277|FG001|Had Immunology Data|Withdrawal by Subject|0|||
145374293|NCT02543892|524221278|FG002|Had Immunology Data|Withdrawal by Subject|0|||
145374294|NCT02543892|524221279|FG003|Had Immunology Data|Withdrawal by Subject|0|||
145374295|NCT02543892|524221280|FG004|Had Immunology Data|Withdrawal by Subject|0|||
145374296|NCT02543892|524221281|FG005|Had Immunology Data|Withdrawal by Subject|0|||
145374297|NCT02543892|524221282|FG006|Had Immunology Data|Withdrawal by Subject|1|||
145374298|NCT02543892|524221283|FG007|Had Immunology Data|Withdrawal by Subject|0|||
145374299|NCT00081731|524221284|FG000|Overall Study|scientific integrity issue|8|||
145374300|NCT00081731|524221285|FG001|Overall Study|scientific integrity issue|8|||
145374301|NCT00785213|524221286|FG000|Quinine Sulfate Alone|Adverse Event|4|||
145374302|NCT00785213|524221286|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
145374303|NCT01500213|524221287|FG000|Overall Study|Adverse Event|35|||
145374304|NCT01500213|524221288|FG001|Overall Study|Adverse Event|35|||
145374305|NCT01500213|524221287|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
145374306|NCT01500213|524221288|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
145374307|NCT01500213|524221287|FG000|Overall Study|Withdrawal by Subject|28|||
145374308|NCT01500213|524221288|FG001|Overall Study|Withdrawal by Subject|37|||
145374309|NCT01500213|524221287|FG000|Overall Study|Death|7|||
145374310|NCT01500213|524221288|FG001|Overall Study|Death|3|||
145374311|NCT01500213|524221287|FG000|Overall Study|Disease Progression|13|||
145374312|NCT01500213|524221288|FG001|Overall Study|Disease Progression|21|||
145374313|NCT01500213|524221287|FG000|Overall Study|Protocol Violation|19|||
145374314|NCT01500213|524221288|FG001|Overall Study|Protocol Violation|19|||
145374315|NCT01500213|524221287|FG000|Overall Study|Physician Decision|12|||
145374316|NCT01500213|524221288|FG001|Overall Study|Physician Decision|10|||
145374317|NCT01500213|524221287|FG000|Overall Study|Lack of Efficacy|9|||
145374318|NCT01500213|524221288|FG001|Overall Study|Lack of Efficacy|7|||
145374319|NCT01500213|524221287|FG000|Overall Study|Lost to Follow-up|3|||
145374320|NCT01500213|524221288|FG001|Overall Study|Lost to Follow-up|6|||
145374321|NCT01500213|524221287|FG000|Overall Study|Other Reasons|7|||
145374322|NCT01500213|524221288|FG001|Overall Study|Other Reasons|5|||
145374323|NCT02386345|524221289|FG000|Overall Study|Not treated|14|||
145374324|NCT02386345|524221289|FG000|Overall Study|Lost to Follow-up|1|||
145374325|NCT02386345|524221289|FG000|Overall Study|Adverse Event|5|||
145374326|NCT02386345|524221289|FG000|Overall Study|Repeat Procedure|10|||
145374327|NCT02386345|524221289|FG000|Overall Study|Did not complete 12-month follow-up|72|||
145374328|NCT01537068|524221292|FG000|Overall Study|Lost to Follow-up|2|||
145374329|NCT01537068|524221293|FG001|Overall Study|Lost to Follow-up|1|||
145374330|NCT01537068|524221292|FG000|Overall Study|Adverse Event|0|||
145374331|NCT01537068|524221293|FG001|Overall Study|Adverse Event|1|||
145374332|NCT01537068|524221292|FG000|Overall Study|Withdrawal by Subject|1|||
145374333|NCT01537068|524221293|FG001|Overall Study|Withdrawal by Subject|1|||
145374334|NCT01537068|524221292|FG000|Overall Study|Lack of Efficacy|1|||
145374335|NCT01537068|524221293|FG001|Overall Study|Lack of Efficacy|0|||
145374336|NCT06011161|524221294|FG000|Overall Study|Withdrawal by Subject|2|||
145374337|NCT06011161|524221294|FG000|Overall Study|Lost to Follow-up|5|||
145374338|NCT00430352|524221295|FG000|Overall Study|Disease progression|58|||
145374339|NCT00430352|524221295|FG000|Overall Study|Withdrawal by Subject|11|||
145374340|NCT00430352|524221295|FG000|Overall Study|Adverse Event|16|||
145374341|NCT00430352|524221295|FG000|Overall Study|Death|5|||
145374342|NCT00430352|524221295|FG000|Overall Study|Other|48|||
145428266|NCT03895372|524425719|FG005|Extension Treatment Period|Other|0|||
145428267|NCT03895372|524425720|FG006|Extension Treatment Period|Other|0|||
145428268|NCT03895372|524425721|FG007|Extension Treatment Period|Other|2|||
145428269|NCT03895372|524425714|FG000|Extension Treatment Period|Pregnancy|0|||
145428270|NCT03895372|524425715|FG001|Extension Treatment Period|Pregnancy|0|||
145428271|NCT03895372|524425716|FG002|Extension Treatment Period|Pregnancy|0|||
145428272|NCT03895372|524425717|FG003|Extension Treatment Period|Pregnancy|0|||
145428273|NCT03895372|524425718|FG004|Extension Treatment Period|Pregnancy|1|||
145428274|NCT03895372|524425719|FG005|Extension Treatment Period|Pregnancy|0|||
145428275|NCT03895372|524425720|FG006|Extension Treatment Period|Pregnancy|0|||
145428276|NCT03895372|524425721|FG007|Extension Treatment Period|Pregnancy|0|||
145428277|NCT03895372|524425714|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
145428278|NCT03895372|524425715|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
145428279|NCT03895372|524425716|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
145428280|NCT03895372|524425717|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
145428281|NCT03895372|524425718|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
145428282|NCT03895372|524425719|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
145428283|NCT03895372|524425720|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
145428284|NCT03895372|524425721|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
145428285|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
145428286|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
145428287|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
145428288|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
145428289|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
145428290|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
145428291|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
145428292|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
145428293|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
145428294|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
145428295|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
145428296|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
145428297|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
145428298|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
145428299|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
145428300|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
145428301|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
145428302|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
145428303|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
145428304|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
145428305|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
145428306|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
145428307|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
145428308|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
145428309|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
145428310|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
145428311|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
145428312|NCT03093415|524425722|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
145428313|NCT03093415|524425723|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
145428314|NCT03093415|524425724|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
145428315|NCT03093415|524425722|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
145428316|NCT03093415|524425723|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
145428317|NCT03093415|524425724|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
145428318|NCT03559530|524425725|FG000|Overall Study|non-location of medical records|44|||
145428319|NCT03559530|524425726|FG001|Overall Study|non-location of medical records|0|||
145428320|NCT03559530|524425725|FG000|Overall Study|culture results not considered for treat|29|||
145428321|NCT03559530|524425726|FG001|Overall Study|culture results not considered for treat|0|||
145428322|NCT03559530|524425725|FG000|Overall Study|duplicate cases|8|||
145428323|NCT03559530|524425726|FG001|Overall Study|duplicate cases|0|||
145428324|NCT03559530|524425725|FG000|Overall Study|other species of Acinetobacte|7|||
145428325|NCT03559530|524425726|FG001|Overall Study|other species of Acinetobacte|0|||
145428326|NCT03559530|524425725|FG000|Overall Study|contamination / colonization|3|||
145428327|NCT03559530|524425726|FG001|Overall Study|contamination / colonization|0|||
145428328|NCT01646827|524425727|FG000|Overall Study|Lost to Follow-up|0|||
145428329|NCT01646827|524425728|FG001|Overall Study|Lost to Follow-up|3|||
145265287|NCT01945034|523819263|FG001|Overall Study|Protocol Violation|0|||
145428330|NCT01646827|524425727|FG000|Overall Study|Physician Decision|1|||
145428331|NCT01646827|524425728|FG001|Overall Study|Physician Decision|2|||
145428332|NCT01646827|524425727|FG000|Overall Study|Withdrawal by Subject|1|||
145428333|NCT01646827|524425728|FG001|Overall Study|Withdrawal by Subject|0|||
145428334|NCT01472185|524425733|FG000|Overall Study|Randomized but Not Treated|0|||
145428335|NCT01472185|524425734|FG001|Overall Study|Randomized but Not Treated|1|||
145428336|NCT01472185|524425733|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
145428337|NCT01472185|524425734|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
145428338|NCT01472185|524425733|FG000|Overall Study|Hyperglycemia|5|||
145428339|NCT01472185|524425734|FG001|Overall Study|Hyperglycemia|2|||
145428340|NCT01472185|524425733|FG000|Overall Study|Investigator's Discretion|3|||
145428341|NCT01472185|524425734|FG001|Overall Study|Investigator's Discretion|1|||
145428342|NCT01472185|524425733|FG000|Overall Study|Lost to Follow-up|4|||
145428343|NCT01472185|524425734|FG001|Overall Study|Lost to Follow-up|1|||
145428344|NCT01472185|524425733|FG000|Overall Study|Protocol Violation|5|||
145428345|NCT01472185|524425734|FG001|Overall Study|Protocol Violation|1|||
145623819|NCT01657682|525135597|FG001|Overall Study|Withdrawal by Subject|1|||
145623820|NCT01657682|525135598|FG002|Overall Study|Withdrawal by Subject|1|||
145623821|NCT01657682|525135596|FG000|Overall Study|Adverse Event|0|||
145623822|NCT01657682|525135597|FG001|Overall Study|Adverse Event|1|||
145623823|NCT01657682|525135598|FG002|Overall Study|Adverse Event|0|||
145623824|NCT00562965|525135599|FG000|Overall Study|Withdrawal by Subject|0|||
145623825|NCT00562965|525135600|FG001|Overall Study|Withdrawal by Subject|1|||
145623826|NCT00562965|525135599|FG000|Overall Study|Death|2|||
145623827|NCT00562965|525135600|FG001|Overall Study|Death|4|||
145623828|NCT00562965|525135599|FG000|Overall Study|Lost to Follow-up|1|||
145623829|NCT00562965|525135600|FG001|Overall Study|Lost to Follow-up|0|||
145623830|NCT00562965|525135599|FG000|Overall Study|Other|0|||
145623831|NCT00562965|525135600|FG001|Overall Study|Other|1|||
145623832|NCT01719861|525135603|FG000|Cycle 1|Death|4|||
145623833|NCT01719861|525135603|FG000|Cycle 2|Death|1|||
145623834|NCT00958009|525135604|FG000|Overall Study|Adverse Event|1|||
145623835|NCT00958009|525135604|FG000|Overall Study|Subject found device difficult to use|1|||
145623836|NCT00087490|525135607|FG000|Overall Study|Death|6|||
145623837|NCT00087490|525135608|FG001|Overall Study|Death|4|||
145623838|NCT00087490|525135607|FG000|Overall Study|Adverse Event|3|||
145623839|NCT00087490|525135608|FG001|Overall Study|Adverse Event|8|||
145623840|NCT00087490|525135607|FG000|Overall Study|Lack of Efficacy|0|||
145623841|NCT00087490|525135608|FG001|Overall Study|Lack of Efficacy|2|||
145623842|NCT00087490|525135607|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
145623843|NCT00087490|525135608|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
145623844|NCT00087490|525135607|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
145623845|NCT00087490|525135608|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
145374343|NCT00347919|524221301|FG000|Overall Study|Lost to Follow-up|11|||
145374344|NCT00347919|524221302|FG001|Overall Study|Lost to Follow-up|13|||
145374345|NCT00347919|524221303|FG002|Overall Study|Lost to Follow-up|0|||
145374346|NCT00347919|524221301|FG000|Overall Study|Withdrawal by Subject|6|||
145374347|NCT00347919|524221302|FG001|Overall Study|Withdrawal by Subject|8|||
145374348|NCT00347919|524221303|FG002|Overall Study|Withdrawal by Subject|0|||
145374349|NCT00347919|524221301|FG000|Overall Study|Physician Decision|1|||
145374350|NCT00347919|524221302|FG001|Overall Study|Physician Decision|1|||
145374351|NCT00347919|524221303|FG002|Overall Study|Physician Decision|0|||
145374352|NCT00347919|524221301|FG000|Overall Study|Sponsor terminated study|15|||
145374353|NCT00347919|524221302|FG001|Overall Study|Sponsor terminated study|10|||
145374354|NCT00347919|524221303|FG002|Overall Study|Sponsor terminated study|16|||
145374355|NCT00347919|524221301|FG000|Overall Study|Death|35|||
145374356|NCT00347919|524221302|FG001|Overall Study|Death|42|||
145374357|NCT00347919|524221303|FG002|Overall Study|Death|19|||
145374358|NCT00347919|524221301|FG000|Overall Study|Par. Started Other Treatment|1|||
145374359|NCT00347919|524221302|FG001|Overall Study|Par. Started Other Treatment|1|||
145374360|NCT00347919|524221303|FG002|Overall Study|Par. Started Other Treatment|1|||
145374361|NCT00347919|524221301|FG000|Overall Study|Missing|2|||
145374362|NCT00347919|524221302|FG001|Overall Study|Missing|1|||
145374363|NCT00347919|524221303|FG002|Overall Study|Missing|2|||
145374364|NCT01597375|524221304|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
145374365|NCT01597375|524221305|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
145374366|NCT01597375|524221304|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
145374367|NCT01597375|524221305|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
145374368|NCT01597375|524221304|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
145374369|NCT01597375|524221305|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
145374370|NCT01597375|524221304|FG000|Washout (2 Weeks)|Adverse Event|1|||
145374371|NCT01597375|524221305|FG001|Washout (2 Weeks)|Adverse Event|0|||
145374372|NCT01597375|524221304|FG000|Second Intervention|Failed to react at both Aspirin|1|||
145428346|NCT01472185|524425733|FG000|Overall Study|Subject Noncompliance|8|||
145428347|NCT01472185|524425734|FG001|Overall Study|Subject Noncompliance|15|||
145428348|NCT01472185|524425733|FG000|Overall Study|Subject Withdrew Consent|6|||
145428349|NCT01472185|524425734|FG001|Overall Study|Subject Withdrew Consent|3|||
145428350|NCT00427700|524425735|FG000|Overall Study|Lost to Follow-up|2|||
145428351|NCT00427700|524425736|FG001|Overall Study|Lost to Follow-up|5|||
145428352|NCT00427700|524425735|FG000|Overall Study|no induction of menses|1|||
145428353|NCT00427700|524425736|FG001|Overall Study|no induction of menses|4|||
145428354|NCT00427700|524425735|FG000|Overall Study|Pregnancy|0|||
145428355|NCT00427700|524425736|FG001|Overall Study|Pregnancy|2|||
145428356|NCT00815633|524425737|FG000|Overall Study|study terminated|1|||
145428357|NCT03038087|524425738|FG000|Overall Study|lost data|1|||
145428358|NCT00635050|524425743|FG000|Overall Study|Withdrawal by Subject|1|||
145428359|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
145428360|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
145428361|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
145428362|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
145428363|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
145428364|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
145428365|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
145428366|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
145428367|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
145581745|NCT00359762|524983173|FG001|Period II|Adverse Event|0|||
145581746|NCT00359762|524983174|FG002|Period II|Adverse Event|0|||
145581747|NCT00359762|524983175|FG003|Period II|Adverse Event|0|||
145581748|NCT00359762|524983176|FG004|Period II|Adverse Event|49|||
145581749|NCT00359762|524983172|FG000|Period II|Protocol Violation|18|||
145581750|NCT00359762|524983173|FG001|Period II|Protocol Violation|0|||
145581751|NCT00359762|524983174|FG002|Period II|Protocol Violation|0|||
145581752|NCT00359762|524983175|FG003|Period II|Protocol Violation|0|||
145581753|NCT00359762|524983176|FG004|Period II|Protocol Violation|11|||
145581754|NCT00359762|524983172|FG000|Period II|Physician Decision|17|||
145581755|NCT00359762|524983173|FG001|Period II|Physician Decision|0|||
145581756|NCT00359762|524983174|FG002|Period II|Physician Decision|0|||
145581757|NCT00359762|524983175|FG003|Period II|Physician Decision|0|||
145581758|NCT00359762|524983176|FG004|Period II|Physician Decision|23|||
145581759|NCT00359762|524983172|FG000|Period II|Death|2|||
145581760|NCT00359762|524983173|FG001|Period II|Death|0|||
145581761|NCT00359762|524983174|FG002|Period II|Death|0|||
145581762|NCT00359762|524983175|FG003|Period II|Death|0|||
145581763|NCT00359762|524983176|FG004|Period II|Death|4|||
145581764|NCT00359762|524983172|FG000|Period II|Lack of Efficacy|11|||
145581765|NCT00359762|524983173|FG001|Period II|Lack of Efficacy|0|||
145581766|NCT00359762|524983174|FG002|Period II|Lack of Efficacy|0|||
145581767|NCT00359762|524983175|FG003|Period II|Lack of Efficacy|0|||
145581768|NCT00359762|524983176|FG004|Period II|Lack of Efficacy|8|||
145581769|NCT00359762|524983172|FG000|Period II|Lost to follow up|5|||
145581770|NCT00359762|524983173|FG001|Period II|Lost to follow up|0|||
145581771|NCT00359762|524983174|FG002|Period II|Lost to follow up|0|||
145581772|NCT00359762|524983175|FG003|Period II|Lost to follow up|0|||
145581773|NCT00359762|524983176|FG004|Period II|Lost to follow up|5|||
145581774|NCT00359762|524983172|FG000|Period II|Entry Criteria Not Met|8|||
145581775|NCT00359762|524983173|FG001|Period II|Entry Criteria Not Met|0|||
145581776|NCT00359762|524983174|FG002|Period II|Entry Criteria Not Met|0|||
145581777|NCT00359762|524983175|FG003|Period II|Entry Criteria Not Met|0|||
145581778|NCT00359762|524983176|FG004|Period II|Entry Criteria Not Met|4|||
145581779|NCT00359762|524983172|FG000|Period II|Subject Decision|50|||
145581780|NCT00359762|524983173|FG001|Period II|Subject Decision|0|||
145581781|NCT00359762|524983174|FG002|Period II|Subject Decision|0|||
145581782|NCT00359762|524983175|FG003|Period II|Subject Decision|0|||
145581783|NCT00359762|524983176|FG004|Period II|Subject Decision|70|||
145581784|NCT00359762|524983172|FG000|Period III|Protocol Violation|0|||
145581785|NCT00359762|524983173|FG001|Period III|Protocol Violation|5|||
145428368|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
145581786|NCT00359762|524983174|FG002|Period III|Protocol Violation|3|||
145581787|NCT00359762|524983175|FG003|Period III|Protocol Violation|8|||
145581788|NCT00359762|524983176|FG004|Period III|Protocol Violation|0|||
145581789|NCT00359762|524983172|FG000|Period III|Adverse Event|0|||
145581790|NCT00359762|524983173|FG001|Period III|Adverse Event|3|||
145581791|NCT00359762|524983174|FG002|Period III|Adverse Event|4|||
145581792|NCT00359762|524983175|FG003|Period III|Adverse Event|10|||
145581793|NCT00359762|524983176|FG004|Period III|Adverse Event|0|||
145581794|NCT00359762|524983172|FG000|Period III|Physician Decision|0|||
145581795|NCT00359762|524983173|FG001|Period III|Physician Decision|5|||
145581796|NCT00359762|524983174|FG002|Period III|Physician Decision|9|||
145428369|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
145428370|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
145428371|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
145581797|NCT00359762|524983175|FG003|Period III|Physician Decision|15|||
145581798|NCT00359762|524983176|FG004|Period III|Physician Decision|0|||
145581799|NCT00359762|524983172|FG000|Period III|Lack of Efficacy|0|||
145581800|NCT00359762|524983173|FG001|Period III|Lack of Efficacy|7|||
145581801|NCT00359762|524983174|FG002|Period III|Lack of Efficacy|5|||
145581802|NCT00359762|524983175|FG003|Period III|Lack of Efficacy|9|||
145581803|NCT00359762|524983176|FG004|Period III|Lack of Efficacy|0|||
145623846|NCT00087490|525135607|FG000|Overall Study|Randomized but not treated|7|||
145623847|NCT00087490|525135608|FG001|Overall Study|Randomized but not treated|18|||
145623848|NCT03379233|525135612|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
145428372|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
145428373|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
145428374|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
145428375|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
145428376|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
145428377|NCT00086515|524425748|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
145428378|NCT00086515|524425749|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
145428379|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
145428380|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
145428381|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
145428382|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
145428383|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
145428384|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
145428385|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
145428386|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
145428387|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
145428388|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
145428389|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
145428390|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
145428391|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
145428392|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
145428393|NCT00086515|524425748|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
145428394|NCT00086515|524425749|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
145428395|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
145428396|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
145428397|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
145428398|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
145428399|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
145428400|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
145428401|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
145428402|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
145428403|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
145428404|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
145428405|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
145428406|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
145428407|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
145428408|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
145428409|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
145428410|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
145428411|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
145428412|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
145428413|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
145428414|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
145428415|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
145428416|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
145428417|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
145428418|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
145428419|NCT00086515|524425748|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
145428420|NCT00086515|524425749|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
145428421|NCT01435356|524425750|FG000|Overall Study|Adverse Event|2|||
145428422|NCT01435356|524425751|FG001|Overall Study|Adverse Event|0|||
145428423|NCT01435356|524425750|FG000|Overall Study|Disease progression/recurrence|17|||
145428424|NCT01435356|524425751|FG001|Overall Study|Disease progression/recurrence|10|||
145428425|NCT01435356|524425750|FG000|Overall Study|Protocol Violation|0|||
145428426|NCT01435356|524425751|FG001|Overall Study|Protocol Violation|1|||
145428427|NCT01435356|524425750|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
145428428|NCT01435356|524425751|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
145428429|NCT01435356|524425750|FG000|Overall Study|Withdrawal by Subject|1|||
145428430|NCT01435356|524425751|FG001|Overall Study|Withdrawal by Subject|1|||
145428431|NCT01435356|524425750|FG000|Overall Study|Facial palsy|1|||
145428432|NCT01435356|524425751|FG001|Overall Study|Facial palsy|0|||
145428433|NCT01435356|524425750|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
145428434|NCT01435356|524425751|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
145428435|NCT01435356|524425750|FG000|Overall Study|Physician Decision|1|||
145428436|NCT01435356|524425751|FG001|Overall Study|Physician Decision|0|||
145265288|NCT01945034|523819264|FG002|Overall Study|Protocol Violation|1|||
145428437|NCT01435356|524425750|FG000|Overall Study|Patient decision|3|||
145428438|NCT01435356|524425751|FG001|Overall Study|Patient decision|0|||
145428439|NCT01435356|524425750|FG000|Overall Study|Patient moved to another city|1|||
145428440|NCT01435356|524425751|FG001|Overall Study|Patient moved to another city|1|||
145428441|NCT05205616|524425752|FG000|Overall Study|Lost to Follow-up|4|||
145428442|NCT05205616|524425753|FG001|Overall Study|Lost to Follow-up|4|||
145428443|NCT01849276|524425758|FG000|Followed for Survival for 5 Years|Death|1|||
145428444|NCT01849276|524425758|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
145428445|NCT00539500|524425759|FG000|Overall Study|Disease Progression|1|||
145428446|NCT00539500|524425759|FG000|Overall Study|Lost to Follow-up|2|||
145428447|NCT02657343|524425760|FG000|Overall Study|Death|0|||
145428448|NCT02657343|524425761|FG001|Overall Study|Death|2|||
145428449|NCT02657343|524425762|FG002|Overall Study|Death|0|||
145428450|NCT02657343|524425763|FG003|Overall Study|Death|0|||
145428451|NCT02657343|524425764|FG004|Overall Study|Death|0|||
145428452|NCT02657343|524425765|FG005|Overall Study|Death|0|||
145428453|NCT02657343|524425760|FG000|Overall Study|Patient went to hospice|1|||
145428454|NCT02657343|524425761|FG001|Overall Study|Patient went to hospice|0|||
145428455|NCT02657343|524425762|FG002|Overall Study|Patient went to hospice|0|||
145428456|NCT02657343|524425763|FG003|Overall Study|Patient went to hospice|0|||
145428457|NCT02657343|524425764|FG004|Overall Study|Patient went to hospice|0|||
145428458|NCT02657343|524425765|FG005|Overall Study|Patient went to hospice|0|||
145428459|NCT02657343|524425760|FG000|Overall Study|Withdrawal by Subject|0|||
145428460|NCT02657343|524425761|FG001|Overall Study|Withdrawal by Subject|0|||
145428461|NCT02657343|524425762|FG002|Overall Study|Withdrawal by Subject|0|||
145428462|NCT02657343|524425763|FG003|Overall Study|Withdrawal by Subject|0|||
145428463|NCT02657343|524425764|FG004|Overall Study|Withdrawal by Subject|1|||
145428464|NCT02657343|524425765|FG005|Overall Study|Withdrawal by Subject|0|||
145428465|NCT02904096|524425766|FG000|Overall Study|Adverse Event|1|||
145428466|NCT02904096|524425767|FG001|Overall Study|Adverse Event|0|||
145428467|NCT02904096|524425766|FG000|Overall Study|Withdrawal by Subject|4|||
145428468|NCT02904096|524425767|FG001|Overall Study|Withdrawal by Subject|3|||
145428469|NCT02904096|524425766|FG000|Overall Study|Lost to Follow-up|10|||
145428470|NCT02904096|524425767|FG001|Overall Study|Lost to Follow-up|17|||
145428471|NCT02904096|524425766|FG000|Overall Study|Non-compliant|3|||
145428472|NCT02904096|524425767|FG001|Overall Study|Non-compliant|1|||
145428473|NCT02904096|524425766|FG000|Overall Study|Sponsor instructed|1|||
145428474|NCT02904096|524425767|FG001|Overall Study|Sponsor instructed|0|||
145428475|NCT01979185|524425772|FG000|Period 2|Other|0|||
145428476|NCT01979185|524425773|FG001|Period 2|Other|1|||
145428477|NCT00980798|524425774|FG000|Overall Study|Adverse Event|7|||
145428478|NCT00980798|524425775|FG001|Overall Study|Adverse Event|36|||
145428479|NCT00980798|524425774|FG000|Overall Study|Lack of Efficacy|16|||
145428480|NCT00980798|524425775|FG001|Overall Study|Lack of Efficacy|5|||
145428481|NCT00980798|524425774|FG000|Overall Study|Lost to Follow-up|0|||
145428482|NCT00980798|524425775|FG001|Overall Study|Lost to Follow-up|1|||
145428483|NCT00980798|524425774|FG000|Overall Study|Physician Decision|2|||
145428484|NCT00980798|524425775|FG001|Overall Study|Physician Decision|1|||
145428485|NCT00980798|524425774|FG000|Overall Study|Withdrawal by Subject|8|||
145428486|NCT00980798|524425775|FG001|Overall Study|Withdrawal by Subject|11|||
145428487|NCT00980798|524425774|FG000|Overall Study|Other|0|||
145428488|NCT00980798|524425775|FG001|Overall Study|Other|1|||
145428489|NCT03238196|524425776|FG000|Overall Study|Adverse Event|3|||
145428490|NCT03238196|524425777|FG001|Overall Study|Adverse Event|0|||
145428491|NCT03238196|524425778|FG002|Overall Study|Adverse Event|2|||
145428492|NCT03238196|524425779|FG003|Overall Study|Adverse Event|2|||
145428493|NCT03238196|524425776|FG000|Overall Study|Withdrawal by Subject|4|||
145428494|NCT03238196|524425777|FG001|Overall Study|Withdrawal by Subject|1|||
145428495|NCT03238196|524425778|FG002|Overall Study|Withdrawal by Subject|1|||
145428496|NCT03238196|524425779|FG003|Overall Study|Withdrawal by Subject|0|||
145581804|NCT00359762|524983172|FG000|Period III|Lost to follow up|0|||
145581805|NCT00359762|524983173|FG001|Period III|Lost to follow up|1|||
145581806|NCT00359762|524983174|FG002|Period III|Lost to follow up|1|||
145581807|NCT00359762|524983175|FG003|Period III|Lost to follow up|2|||
145581808|NCT00359762|524983176|FG004|Period III|Lost to follow up|0|||
145581809|NCT00359762|524983172|FG000|Period III|Entry Criteria Not Met|0|||
145581810|NCT00359762|524983173|FG001|Period III|Entry Criteria Not Met|1|||
145581811|NCT00359762|524983174|FG002|Period III|Entry Criteria Not Met|0|||
145581812|NCT00359762|524983175|FG003|Period III|Entry Criteria Not Met|1|||
145581813|NCT00359762|524983176|FG004|Period III|Entry Criteria Not Met|0|||
145581814|NCT00359762|524983172|FG000|Period III|Subject Decision|0|||
145581815|NCT00359762|524983173|FG001|Period III|Subject Decision|7|||
145581816|NCT00359762|524983174|FG002|Period III|Subject Decision|8|||
145581817|NCT00359762|524983175|FG003|Period III|Subject Decision|20|||
145581818|NCT00359762|524983176|FG004|Period III|Subject Decision|0|||
145581819|NCT01033747|524983180|FG000|Overall Study|Adverse Event|9|||
145581820|NCT01033747|524983181|FG001|Overall Study|Adverse Event|4|||
145428497|NCT03238196|524425776|FG000|Overall Study|Disease progression|14|||
145581821|NCT01033747|524983180|FG000|Overall Study|Abnormal Laboratory Value|1|||
145581822|NCT01033747|524983181|FG001|Overall Study|Abnormal Laboratory Value|0|||
145428498|NCT03238196|524425777|FG001|Overall Study|Disease progression|2|||
145428499|NCT03238196|524425778|FG002|Overall Study|Disease progression|3|||
145428500|NCT03238196|524425779|FG003|Overall Study|Disease progression|2|||
145428501|NCT03238196|524425776|FG000|Overall Study|Still on treatment|1|||
145428502|NCT03238196|524425777|FG001|Overall Study|Still on treatment|0|||
145428503|NCT03238196|524425778|FG002|Overall Study|Still on treatment|0|||
145428504|NCT03238196|524425779|FG003|Overall Study|Still on treatment|0|||
145428505|NCT00847730|524425780|FG000|Overall Study|Multiple interruptions in therapy|8|||
145428506|NCT03211416|524425790|FG000|Overall Study|Adverse Event|7|||
145428507|NCT03211416|524425790|FG000|Overall Study|Lack of Efficacy|2|||
145428508|NCT03211416|524425790|FG000|Overall Study|Physician Decision|1|||
145428509|NCT03709472|524425794|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
145428510|NCT03709472|524425795|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
145428511|NCT03709472|524425794|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
145428512|NCT03709472|524425795|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
145428513|NCT03559556|524425796|FG000|Overall Study|Withdrawal by Subject|1|||
145428514|NCT02496000|524425802|FG000|Overall Study|Withdrawal by Subject|1|||
145428515|NCT02496000|524425803|FG001|Overall Study|Withdrawal by Subject|2|||
145428516|NCT02496000|524425804|FG002|Overall Study|Withdrawal by Subject|0|||
145428517|NCT02496000|524425802|FG000|Overall Study|Lost to Follow-up|1|||
145428518|NCT02496000|524425803|FG001|Overall Study|Lost to Follow-up|0|||
145428519|NCT02496000|524425804|FG002|Overall Study|Lost to Follow-up|1|||
145428520|NCT02496000|524425802|FG000|Overall Study|Protocol Violation|0|||
145428521|NCT02496000|524425803|FG001|Overall Study|Protocol Violation|0|||
145428522|NCT02496000|524425804|FG002|Overall Study|Protocol Violation|1|||
145428523|NCT02496000|524425802|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
145428524|NCT02496000|524425803|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
145428525|NCT02496000|524425804|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
145428526|NCT02496000|524425802|FG000|Overall Study|undetermined|0|||
145428527|NCT02496000|524425803|FG001|Overall Study|undetermined|1|||
145428528|NCT02496000|524425804|FG002|Overall Study|undetermined|0|||
145428529|NCT02255656|524425805|FG000|Overall Study|Adverse Event|11|||
145428530|NCT02255656|524425805|FG000|Overall Study|Poor compliance to protocol|3|||
145428531|NCT02255656|524425805|FG000|Overall Study|Lost to Follow-up|30|||
145428532|NCT02255656|524425805|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
145428533|NCT02255656|524425805|FG000|Overall Study|Other|126|||
145428534|NCT01877278|524425806|FG000|Overall Study|Lost to Follow-up|3|||
145428535|NCT01877278|524425807|FG001|Overall Study|Lost to Follow-up|3|||
145428536|NCT04727151|524425808|FG000|Overall Study|Death|0|||
145428537|NCT04727151|524425809|FG001|Overall Study|Death|0|||
145428538|NCT04727151|524425810|FG002|Overall Study|Death|0|||
145428539|NCT04727151|524425811|FG003|Overall Study|Death|0|||
145428540|NCT04727151|524425812|FG004|Overall Study|Death|3|||
145428541|NCT04727151|524425808|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145428542|NCT04727151|524425809|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145428543|NCT04727151|524425810|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145428544|NCT04727151|524425811|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
145428545|NCT04727151|524425812|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
145581823|NCT01033747|524983180|FG000|Overall Study|Abnormal test procedure|0|||
145581824|NCT01033747|524983181|FG001|Overall Study|Abnormal test procedure|1|||
145581825|NCT01033747|524983180|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
145581826|NCT01033747|524983181|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145581827|NCT01033747|524983180|FG000|Overall Study|Protocol Violation|1|||
145581828|NCT01033747|524983181|FG001|Overall Study|Protocol Violation|0|||
145581829|NCT01033747|524983180|FG000|Overall Study|Withdrawal by Subject|9|||
145581830|NCT01033747|524983181|FG001|Overall Study|Withdrawal by Subject|6|||
145581831|NCT01033747|524983180|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
145581832|NCT01033747|524983181|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
145581833|NCT01033747|524983180|FG000|Overall Study|Stopped at end of Extension 1|2|||
145581834|NCT01033747|524983181|FG001|Overall Study|Stopped at end of Extension 1|0|||
145581835|NCT02613481|524983182|FG000|Overall Study|Lost to Follow-up|7|||
145581836|NCT02613481|524983182|FG000|Overall Study|Withdrawal by Subject|2|||
145581837|NCT00803023|524983183|FG000|Overall Study|Adverse Event|5|||
145428546|NCT03510715|524425813|FG000|Overall Study|Adverse Event|1|||
145428547|NCT03510715|524425814|FG001|Overall Study|Adverse Event|0|||
145428548|NCT02038036|524425817|FG000|Core Study|Adverse Event|7|||
145581838|NCT00803023|524983184|FG001|Overall Study|Adverse Event|4|||
145581839|NCT00803023|524983185|FG002|Overall Study|Adverse Event|8|||
145581840|NCT00803023|524983186|FG003|Overall Study|Adverse Event|6|||
145428549|NCT02038036|524425818|FG001|Core Study|Adverse Event|7|||
145428550|NCT02038036|524425817|FG000|Core Study|Death|1|||
145428551|NCT02038036|524425818|FG001|Core Study|Death|1|||
145428552|NCT02038036|524425817|FG000|Core Study|Disease progression|2|||
145428553|NCT02038036|524425818|FG001|Core Study|Disease progression|2|||
145428554|NCT02038036|524425817|FG000|Core Study|Lost to Follow-up|0|||
145428555|NCT02038036|524425818|FG001|Core Study|Lost to Follow-up|1|||
145428556|NCT02038036|524425817|FG000|Core Study|Physician Decision|2|||
145428557|NCT02038036|524425818|FG001|Core Study|Physician Decision|1|||
145428558|NCT02038036|524425817|FG000|Core Study|Subject/guardian decision|0|||
145428559|NCT02038036|524425818|FG001|Core Study|Subject/guardian decision|1|||
145428560|NCT02038036|524425817|FG000|Core Study|Withdrawal by Subject|3|||
145428561|NCT02038036|524425818|FG001|Core Study|Withdrawal by Subject|1|||
145428562|NCT02038036|524425817|FG000|Crossover Period|Withdrawal by Subject|0|||
145428563|NCT02038036|524425818|FG001|Crossover Period|Withdrawal by Subject|3|||
145428564|NCT02038036|524425817|FG000|Crossover Period|Adverse Event|0|||
145428565|NCT02038036|524425818|FG001|Crossover Period|Adverse Event|9|||
145428566|NCT02038036|524425817|FG000|Crossover Period|Death|0|||
145428567|NCT02038036|524425818|FG001|Crossover Period|Death|2|||
145428568|NCT02038036|524425817|FG000|Crossover Period|Disease progression|0|||
145428569|NCT02038036|524425818|FG001|Crossover Period|Disease progression|3|||
145428570|NCT02038036|524425817|FG000|Crossover Period|Lost to Follow-up|0|||
145428571|NCT02038036|524425818|FG001|Crossover Period|Lost to Follow-up|1|||
145428572|NCT02038036|524425817|FG000|Crossover Period|Physician Decision|0|||
145428573|NCT02038036|524425818|FG001|Crossover Period|Physician Decision|2|||
145428574|NCT03164356|524425820|FG000|Overall Study|Lost to Follow-up|1|||
145428575|NCT03164356|524425821|FG001|Overall Study|Lost to Follow-up|1|||
145428576|NCT03164356|524425822|FG002|Overall Study|Lost to Follow-up|2|||
145428577|NCT03164356|524425823|FG003|Overall Study|Lost to Follow-up|1|||
145428578|NCT03164356|524425820|FG000|Overall Study|Physician Decision|0|||
145428579|NCT03164356|524425821|FG001|Overall Study|Physician Decision|0|||
145428580|NCT03164356|524425822|FG002|Overall Study|Physician Decision|3|||
145428581|NCT03164356|524425823|FG003|Overall Study|Physician Decision|0|||
145428582|NCT03164356|524425820|FG000|Overall Study|Protocol Violation|2|||
145428583|NCT03164356|524425821|FG001|Overall Study|Protocol Violation|1|||
145428584|NCT03164356|524425822|FG002|Overall Study|Protocol Violation|0|||
145428585|NCT03164356|524425823|FG003|Overall Study|Protocol Violation|0|||
145428586|NCT03164356|524425820|FG000|Overall Study|Withdrawal by Subject|1|||
145428587|NCT03164356|524425821|FG001|Overall Study|Withdrawal by Subject|0|||
145428588|NCT03164356|524425822|FG002|Overall Study|Withdrawal by Subject|0|||
145428589|NCT03164356|524425823|FG003|Overall Study|Withdrawal by Subject|0|||
145428590|NCT03164356|524425820|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
145428591|NCT03164356|524425821|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
145428592|NCT03164356|524425822|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
145428593|NCT03164356|524425823|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
145428594|NCT03164356|524425820|FG000|Overall Study|Subject Incarcerated|0|||
145428595|NCT03164356|524425821|FG001|Overall Study|Subject Incarcerated|1|||
145428596|NCT03164356|524425822|FG002|Overall Study|Subject Incarcerated|0|||
145428597|NCT03164356|524425823|FG003|Overall Study|Subject Incarcerated|0|||
145428598|NCT03164356|524425820|FG000|Overall Study|Prosthetist unable to participate|0|||
145428599|NCT03164356|524425821|FG001|Overall Study|Prosthetist unable to participate|2|||
145428600|NCT03164356|524425822|FG002|Overall Study|Prosthetist unable to participate|1|||
145428601|NCT03164356|524425823|FG003|Overall Study|Prosthetist unable to participate|0|||
145428602|NCT02520154|524425828|FG000|Overall Study|Death|1|||
145428603|NCT02520154|524425828|FG000|Overall Study|Withdrawal by Subject|2|||
145428604|NCT02520154|524425828|FG000|Overall Study|Physician Decision|2|||
145428605|NCT04976777|524427843|FG000|Overall Study|COVID-19 Infection|1|||
145428606|NCT04976777|524427844|FG001|Overall Study|COVID-19 Infection|0|||
145428607|NCT00442702|524427845|FG000|Titration Period|Adverse Event|2|||
145428608|NCT00442702|524427846|FG001|Titration Period|Adverse Event|0|||
145428609|NCT00442702|524427845|FG000|Titration Period|Death|3|||
145428610|NCT00442702|524427846|FG001|Titration Period|Death|2|||
145428611|NCT00442702|524427845|FG000|Titration Period|Insufficient Therapeutic Response|1|||
145428612|NCT00442702|524427846|FG001|Titration Period|Insufficient Therapeutic Response|0|||
145428613|NCT00442702|524427845|FG000|Titration Period|Refused Treatment|4|||
145428614|NCT00442702|524427846|FG001|Titration Period|Refused Treatment|1|||
145428615|NCT00442702|524427845|FG000|Titration Period|Failure to return|1|||
145428616|NCT00442702|524427846|FG001|Titration Period|Failure to return|0|||
145581841|NCT00803023|524983183|FG000|Overall Study|Withdrawal by Subject|0|||
145581842|NCT00803023|524983184|FG001|Overall Study|Withdrawal by Subject|2|||
145428617|NCT00442702|524427845|FG000|Titration Period|Hospitalized in another hospital|1|||
145428618|NCT00442702|524427846|FG001|Titration Period|Hospitalized in another hospital|0|||
145428619|NCT00442702|524427845|FG000|Evaluation Period|Adverse Event|1|||
145428620|NCT00442702|524427846|FG001|Evaluation Period|Adverse Event|0|||
145428621|NCT00442702|524427845|FG000|Evaluation Period|Death|1|||
145428622|NCT00442702|524427846|FG001|Evaluation Period|Death|1|||
145428623|NCT00442702|524427845|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
145428624|NCT00442702|524427846|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
145428625|NCT00442702|524427845|FG000|Evaluation Period|Refused treatment|1|||
145428626|NCT00442702|524427846|FG001|Evaluation Period|Refused treatment|1|||
145428627|NCT00442702|524427845|FG000|Evaluation Period|Renal transplant|0|||
145428628|NCT00442702|524427846|FG001|Evaluation Period|Renal transplant|1|||
145623849|NCT03379233|525135613|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
145623850|NCT00965484|525135614|FG000|Overall Study|Protocol Violation|1|||
145623851|NCT00965484|525135614|FG000|Overall Study|Withdrawal by Subject|1|||
145623852|NCT00848211|525135615|FG000|Overall Study|Protocol Violation|0|||
145623853|NCT00848211|525135616|FG001|Overall Study|Protocol Violation|1|||
145623854|NCT00848211|525135617|FG002|Overall Study|Protocol Violation|1|||
145623855|NCT00848211|525135618|FG003|Overall Study|Protocol Violation|0|||
145623856|NCT00848211|525135615|FG000|Overall Study|Adverse Event|0|||
145623857|NCT00848211|525135616|FG001|Overall Study|Adverse Event|0|||
145623858|NCT00848211|525135617|FG002|Overall Study|Adverse Event|0|||
145623859|NCT00848211|525135618|FG003|Overall Study|Adverse Event|0|||
145623860|NCT02531438|525135619|FG000|Overall Study|Adverse Event|7|||
145623861|NCT02531438|525135620|FG001|Overall Study|Adverse Event|9|||
145623862|NCT02531438|525135619|FG000|Overall Study|Lost to Follow-up|0|||
145623863|NCT02531438|525135620|FG001|Overall Study|Lost to Follow-up|3|||
145623864|NCT02531438|525135619|FG000|Overall Study|Withdrawal by Subject|7|||
145623865|NCT02531438|525135620|FG001|Overall Study|Withdrawal by Subject|8|||
145623866|NCT02531438|525135619|FG000|Overall Study|Physician Decision|0|||
145623867|NCT02531438|525135620|FG001|Overall Study|Physician Decision|1|||
145623868|NCT02531438|525135619|FG000|Overall Study|Death|6|||
145623869|NCT02531438|525135620|FG001|Overall Study|Death|3|||
145623870|NCT02531438|525135619|FG000|Overall Study|Randomized, but Not Treated|4|||
145623871|NCT02531438|525135620|FG001|Overall Study|Randomized, but Not Treated|0|||
145623872|NCT02531438|525135619|FG000|Overall Study|Missed EOT/PTE Visit|5|||
145623873|NCT02531438|525135620|FG001|Overall Study|Missed EOT/PTE Visit|2|||
145623874|NCT02531438|525135619|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
145623875|NCT02531438|525135620|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
145623876|NCT01124617|525135621|FG000|Overall Study|Adverse Event|5|||
145623877|NCT01124617|525135622|FG001|Overall Study|Adverse Event|2|||
145623878|NCT01124617|525135621|FG000|Overall Study|Lack of Efficacy|2|||
145623879|NCT01124617|525135622|FG001|Overall Study|Lack of Efficacy|1|||
145623880|NCT01124617|525135621|FG000|Overall Study|Protocol Violation|1|||
145623881|NCT01124617|525135622|FG001|Overall Study|Protocol Violation|1|||
145623882|NCT01124617|525135621|FG000|Overall Study|Withdrawal by Subject|9|||
145623883|NCT01124617|525135622|FG001|Overall Study|Withdrawal by Subject|1|||
145623884|NCT01124617|525135621|FG000|Overall Study|Other|2|||
145623885|NCT01124617|525135622|FG001|Overall Study|Other|1|||
145623886|NCT00945477|525135623|FG000|Overall Study|Adverse Event|3|||
145623887|NCT00945477|525135623|FG000|Overall Study|Lack of Efficacy|2|||
145623888|NCT00945477|525135623|FG000|Overall Study|Withdrawal by Subject|1|||
145623889|NCT01813422|525135624|FG000|Overall Study|Withdrawal by Subject|14|||
145623890|NCT01813422|525135625|FG001|Overall Study|Withdrawal by Subject|8|||
145623891|NCT01813422|525135624|FG000|Overall Study|Death|2|||
145623892|NCT01813422|525135625|FG001|Overall Study|Death|3|||
145623893|NCT01813422|525135624|FG000|Overall Study|Sponsor Decision|2|||
145623894|NCT01813422|525135625|FG001|Overall Study|Sponsor Decision|1|||
145623895|NCT01813422|525135624|FG000|Overall Study|Lost to Follow-up|2|||
145623896|NCT01813422|525135625|FG001|Overall Study|Lost to Follow-up|4|||
145623897|NCT01653743|525135626|FG000|Overall Study|Withdrawal by Subject|1|||
145623898|NCT01653743|525135627|FG001|Overall Study|Withdrawal by Subject|0|||
145623899|NCT01653743|525135626|FG000|Overall Study|Investigator discretion|3|||
145623900|NCT01653743|525135627|FG001|Overall Study|Investigator discretion|0|||
145623901|NCT03704298|525135631|FG000|Overall Study|Death|3|||
145623902|NCT03704298|525135632|FG001|Overall Study|Death|1|||
145623903|NCT03704298|525135633|FG002|Overall Study|Death|1|||
145623904|NCT03704298|525135634|FG003|Overall Study|Death|0|||
145623905|NCT03704298|525135631|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
145623906|NCT03704298|525135632|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
145623907|NCT03704298|525135633|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
145623908|NCT03704298|525135634|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
145623909|NCT03704298|525135631|FG000|Overall Study|Withdrawal by Subject|1|||
145623910|NCT03704298|525135632|FG001|Overall Study|Withdrawal by Subject|0|||
145623911|NCT03704298|525135633|FG002|Overall Study|Withdrawal by Subject|0|||
145623912|NCT03704298|525135634|FG003|Overall Study|Withdrawal by Subject|0|||
145623913|NCT03704298|525135631|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
145623914|NCT03704298|525135632|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
145623915|NCT03704298|525135633|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
145623916|NCT03704298|525135634|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
145623917|NCT04796935|525135635|FG000|Overall Study|Withdrawal by Subject|0|||
145623918|NCT04796935|525135636|FG001|Overall Study|Withdrawal by Subject|1|||
145623919|NCT04796935|525135635|FG000|Overall Study|Physician Decision|0|||
145623920|NCT04796935|525135636|FG001|Overall Study|Physician Decision|1|||
145623921|NCT04796935|525135635|FG000|Overall Study|Device not available|1|||
145623922|NCT04796935|525135636|FG001|Overall Study|Device not available|0|||
145623923|NCT04796935|525135635|FG000|Overall Study|Trained provider not available|1|||
145623924|NCT04796935|525135636|FG001|Overall Study|Trained provider not available|0|||
145428629|NCT00442702|524427845|FG000|Evaluation Period|Failure to return|1|||
145428630|NCT00442702|524427846|FG001|Evaluation Period|Failure to return|0|||
145428631|NCT00442702|524427845|FG000|Evaluation Period|Site closure|0|||
145428632|NCT00442702|524427846|FG001|Evaluation Period|Site closure|1|||
145428633|NCT04123704|524427857|FG000|Overall Study|Disease progression|2|||
145428634|NCT01425814|524427863|FG000|Period 1|Stability criteria not fulfilled|0|||
145428635|NCT01425814|524427864|FG001|Period 1|Stability criteria not fulfilled|1|||
145428636|NCT01425814|524427865|FG002|Period 1|Stability criteria not fulfilled|0|||
145428637|NCT01425814|524427866|FG003|Period 1|Stability criteria not fulfilled|0|||
145428638|NCT01425814|524427867|FG004|Period 1|Stability criteria not fulfilled|0|||
145428639|NCT01425814|524427868|FG005|Period 1|Stability criteria not fulfilled|0|||
145428640|NCT01425814|524427863|FG000|Period 2|Stability criteria not fulfilled|0|||
145428641|NCT01425814|524427864|FG001|Period 2|Stability criteria not fulfilled|1|||
145428642|NCT01425814|524427865|FG002|Period 2|Stability criteria not fulfilled|0|||
145428643|NCT01425814|524427866|FG003|Period 2|Stability criteria not fulfilled|0|||
145428644|NCT01425814|524427867|FG004|Period 2|Stability criteria not fulfilled|0|||
145428645|NCT01425814|524427868|FG005|Period 2|Stability criteria not fulfilled|0|||
145428646|NCT01425814|524427863|FG000|Period 3|Adverse Event|0|||
145428647|NCT01425814|524427864|FG001|Period 3|Adverse Event|0|||
145428648|NCT01425814|524427865|FG002|Period 3|Adverse Event|0|||
145428649|NCT01425814|524427866|FG003|Period 3|Adverse Event|0|||
145428650|NCT01425814|524427867|FG004|Period 3|Adverse Event|0|||
145428651|NCT01425814|524427868|FG005|Period 3|Adverse Event|1|||
145428652|NCT01425814|524427863|FG000|Period 4|Adverse Event|1|||
145428653|NCT01425814|524427864|FG001|Period 4|Adverse Event|0|||
145428654|NCT01425814|524427865|FG002|Period 4|Adverse Event|1|||
145428655|NCT01425814|524427866|FG003|Period 4|Adverse Event|0|||
145428656|NCT01425814|524427867|FG004|Period 4|Adverse Event|0|||
145428657|NCT01425814|524427868|FG005|Period 4|Adverse Event|0|||
145428658|NCT01425814|524427863|FG000|Period 5|Stability criteria not fulfilled|0|||
145428659|NCT01425814|524427864|FG001|Period 5|Stability criteria not fulfilled|0|||
145428660|NCT01425814|524427865|FG002|Period 5|Stability criteria not fulfilled|1|||
145428661|NCT01425814|524427866|FG003|Period 5|Stability criteria not fulfilled|0|||
145428662|NCT01425814|524427867|FG004|Period 5|Stability criteria not fulfilled|0|||
145428663|NCT01425814|524427868|FG005|Period 5|Stability criteria not fulfilled|1|||
145428664|NCT02546323|524427870|FG000|Overall Study|Withdrawal by Subject|36|||
145428665|NCT02546323|524427871|FG001|Overall Study|Withdrawal by Subject|33|||
145428666|NCT02546323|524427870|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
145428667|NCT02546323|524427871|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
145428668|NCT02546323|524427870|FG000|Overall Study|Adverse Event|17|||
145428669|NCT02546323|524427871|FG001|Overall Study|Adverse Event|11|||
145428670|NCT02546323|524427870|FG000|Overall Study|Patient Specific Reasons|1|||
145428671|NCT02546323|524427871|FG001|Overall Study|Patient Specific Reasons|2|||
145428672|NCT02546323|524427870|FG000|Overall Study|Lost to Follow-up|2|||
145428673|NCT02546323|524427871|FG001|Overall Study|Lost to Follow-up|3|||
145428674|NCT02546323|524427870|FG000|Overall Study|Non-compliance with Study Drug|2|||
145428675|NCT02546323|524427871|FG001|Overall Study|Non-compliance with Study Drug|2|||
145428676|NCT02546323|524427870|FG000|Overall Study|Met Withdrawal Criteria|2|||
145428677|NCT02546323|524427871|FG001|Overall Study|Met Withdrawal Criteria|14|||
145428678|NCT04476784|524427872|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
145428679|NCT04476784|524427873|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
145428680|NCT00478257|524427874|FG000|Overall Study|Withdrawal by Subject|8|||
145428681|NCT00478257|524427875|FG001|Overall Study|Withdrawal by Subject|3|||
145428682|NCT01055028|524427877|FG000|Screening|Screen Failure|1|||
145428683|NCT01055028|524427878|FG001|Screening|Screen Failure|1|||
145428684|NCT01055028|524427877|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
145428685|NCT01055028|524427878|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
145428686|NCT01055028|524427877|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
145428687|NCT01055028|524427878|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
145428688|NCT01055028|524427877|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
145428689|NCT01055028|524427878|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
145428690|NCT03605693|524427879|FG000|Overall Study|Lost to Follow-up|4|||
145428691|NCT03605693|524427880|FG001|Overall Study|Lost to Follow-up|0|||
145428692|NCT03605693|524427879|FG000|Overall Study|Physician Decision|1|||
145428693|NCT03605693|524427880|FG001|Overall Study|Physician Decision|0|||
145428694|NCT01605097|524427883|FG000|Overall Study|Protocol Violation|1|||
145428695|NCT02038647|524427884|FG000|Overall Study|Progressive Disease|50|||
145428696|NCT02038647|524427885|FG001|Overall Study|Progressive Disease|59|||
145428697|NCT02038647|524427884|FG000|Overall Study|Adverse Event|18|||
145428698|NCT02038647|524427885|FG001|Overall Study|Adverse Event|10|||
145623925|NCT00410384|525135637|FG000|Overall Study|Withdrawal by Subject|28|||
145428699|NCT02038647|524427884|FG000|Overall Study|Symptomatic Deterioration|7|||
145428700|NCT02038647|524427885|FG001|Overall Study|Symptomatic Deterioration|7|||
145428701|NCT02038647|524427884|FG000|Overall Study|Withdrawal by Subject|5|||
145428702|NCT02038647|524427885|FG001|Overall Study|Withdrawal by Subject|2|||
145428703|NCT02038647|524427884|FG000|Overall Study|Not Reported|0|||
145428704|NCT02038647|524427885|FG001|Overall Study|Not Reported|1|||
145428705|NCT02038647|524427884|FG000|Overall Study|Ongoing at Datacut|9|||
145428706|NCT02038647|524427885|FG001|Overall Study|Ongoing at Datacut|10|||
145428707|NCT03078868|524427886|FG000|Overall Study|Physician Decision|3|||
145428708|NCT03038620|524427887|FG000|Overall Study|Lost to Follow-up|18|||
145428709|NCT03038620|524427888|FG001|Overall Study|Lost to Follow-up|23|||
145428710|NCT03038620|524427887|FG000|Overall Study|Withdrawal by Subject|0|||
145428711|NCT03038620|524427888|FG001|Overall Study|Withdrawal by Subject|15|||
145428712|NCT03038620|524427887|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
145428713|NCT03038620|524427888|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
145428714|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Adverse Event|3|||
145428715|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Adverse Event|0|||
145428716|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Adverse Event|0|||
145428717|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
145428718|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
145428719|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
145428720|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
145428721|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
145428722|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
145428723|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
145428724|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
145428725|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
145428726|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
145428727|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
145428728|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
145428729|NCT04380142|524427889|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
145428730|NCT04380142|524427890|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
145428731|NCT04380142|524427891|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
145428732|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145428733|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145428734|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Adverse Event|14|||
145428735|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
145428736|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
145428737|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
145428738|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145428739|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
145428740|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
145428741|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
145428742|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
145428743|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
145428744|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
145428745|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
145428746|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
145428747|NCT04380142|524427889|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
145428748|NCT04380142|524427890|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
145428749|NCT04380142|524427891|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
145428750|NCT02106832|524427898|FG000|Overall Study|Adverse Event|1|||
145428751|NCT02106832|524427899|FG001|Overall Study|Adverse Event|2|||
145428752|NCT02106832|524427900|FG002|Overall Study|Adverse Event|3|||
145428753|NCT02106832|524427901|FG003|Overall Study|Adverse Event|0|||
145428754|NCT02106832|524427898|FG000|Overall Study|Death|4|||
145428755|NCT02106832|524427899|FG001|Overall Study|Death|4|||
145428756|NCT02106832|524427900|FG002|Overall Study|Death|1|||
145428757|NCT02106832|524427901|FG003|Overall Study|Death|4|||
145428758|NCT02106832|524427898|FG000|Overall Study|Deterioration of general conditions|0|||
145428759|NCT02106832|524427899|FG001|Overall Study|Deterioration of general conditions|0|||
145428760|NCT02106832|524427900|FG002|Overall Study|Deterioration of general conditions|1|||
145428761|NCT02106832|524427901|FG003|Overall Study|Deterioration of general conditions|0|||
145428762|NCT02106832|524427898|FG000|Overall Study|Lost to Follow-up|0|||
145428763|NCT02106832|524427899|FG001|Overall Study|Lost to Follow-up|1|||
145428764|NCT02106832|524427900|FG002|Overall Study|Lost to Follow-up|1|||
145428765|NCT02106832|524427901|FG003|Overall Study|Lost to Follow-up|3|||
145428766|NCT02106832|524427898|FG000|Overall Study|Physician Decision|1|||
145428767|NCT02106832|524427899|FG001|Overall Study|Physician Decision|0|||
145428768|NCT02106832|524427900|FG002|Overall Study|Physician Decision|0|||
145581843|NCT00803023|524983185|FG002|Overall Study|Withdrawal by Subject|0|||
145428769|NCT02106832|524427901|FG003|Overall Study|Physician Decision|0|||
145581844|NCT00803023|524983186|FG003|Overall Study|Withdrawal by Subject|0|||
145581845|NCT00803023|524983183|FG000|Overall Study|Lost to Follow-up|0|||
145428770|NCT02106832|524427898|FG000|Overall Study|Protocol Violation|0|||
145428771|NCT02106832|524427899|FG001|Overall Study|Protocol Violation|0|||
145428772|NCT02106832|524427900|FG002|Overall Study|Protocol Violation|0|||
145428773|NCT02106832|524427901|FG003|Overall Study|Protocol Violation|1|||
145581846|NCT00803023|524983184|FG001|Overall Study|Lost to Follow-up|1|||
145428774|NCT02106832|524427898|FG000|Overall Study|Withdrawal by Subject|17|||
145428775|NCT02106832|524427899|FG001|Overall Study|Withdrawal by Subject|17|||
145428776|NCT02106832|524427900|FG002|Overall Study|Withdrawal by Subject|10|||
145428777|NCT02106832|524427901|FG003|Overall Study|Withdrawal by Subject|7|||
145428778|NCT02106832|524427898|FG000|Overall Study|Technical problems|0|||
145428779|NCT02106832|524427899|FG001|Overall Study|Technical problems|1|||
145428780|NCT02106832|524427900|FG002|Overall Study|Technical problems|0|||
145428781|NCT02106832|524427901|FG003|Overall Study|Technical problems|0|||
145428782|NCT01968980|524427916|FG000|Overall Study|Death|0|||
145428783|NCT01968980|524427917|FG001|Overall Study|Death|1|||
145428784|NCT01968980|524427916|FG000|Overall Study|Adverse Event|1|||
145428785|NCT01968980|524427917|FG001|Overall Study|Adverse Event|3|||
145428786|NCT01968980|524427916|FG000|Overall Study|Does not meet entry criteria|1|||
145428787|NCT01968980|524427917|FG001|Overall Study|Does not meet entry criteria|3|||
145428788|NCT01968980|524427916|FG000|Overall Study|Withdrawal by Subject|13|||
145428789|NCT01968980|524427917|FG001|Overall Study|Withdrawal by Subject|5|||
145428790|NCT01968980|524427916|FG000|Overall Study|Other unspecified|1|||
145428791|NCT01968980|524427917|FG001|Overall Study|Other unspecified|2|||
145428792|NCT00265122|524427918|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145428793|NCT00265122|524427919|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145428794|NCT00265122|524427920|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
145428795|NCT00265122|524427921|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
145428796|NCT00265122|524427922|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
145428797|NCT00265122|524427923|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
145428798|NCT00265122|524427918|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
145428799|NCT00265122|524427919|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145428800|NCT00265122|524427920|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145428801|NCT00265122|524427921|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
145428802|NCT00265122|524427922|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145428803|NCT00265122|524427923|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
145428804|NCT00265122|524427918|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145428805|NCT00265122|524427919|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
145428806|NCT00265122|524427920|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
145428807|NCT00265122|524427921|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
145428808|NCT00265122|524427922|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145428809|NCT00265122|524427923|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
145428810|NCT00265122|524427918|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
145428811|NCT00265122|524427919|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
145428812|NCT00265122|524427920|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
145428813|NCT00265122|524427921|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
145428814|NCT00265122|524427922|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
145428815|NCT00265122|524427923|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
145428816|NCT00265122|524427918|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
145428817|NCT00265122|524427919|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
145428818|NCT00265122|524427920|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
145428819|NCT00265122|524427921|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
145428820|NCT00265122|524427922|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
145428821|NCT00265122|524427923|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
145428822|NCT00265122|524427918|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
145428823|NCT00265122|524427919|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145428824|NCT00265122|524427920|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
145428825|NCT00265122|524427921|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
145428826|NCT00265122|524427922|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145428827|NCT00265122|524427923|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
145428828|NCT04716894|524427924|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
145428829|NCT04716894|524427924|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
145428830|NCT00982280|524427944|FG000|Observation Period|Not eligible to be dosed|19|||
145428831|NCT00982280|524427944|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
145428832|NCT00982280|524427944|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
145428833|NCT00982280|524427944|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
145428834|NCT00982280|524427944|FG000|Maintenance Period|Adverse Event|1|||
145581847|NCT00803023|524983185|FG002|Overall Study|Lost to Follow-up|2|||
145581848|NCT00803023|524983186|FG003|Overall Study|Lost to Follow-up|1|||
145581849|NCT00803023|524983183|FG000|Overall Study|Lack of Efficacy|0|||
145581850|NCT00803023|524983184|FG001|Overall Study|Lack of Efficacy|1|||
145428835|NCT01506726|524427950|FG000|Overall Study|Adverse Event|1|||
145428836|NCT01506726|524427951|FG001|Overall Study|Adverse Event|2|||
145428837|NCT02231580|524427952|FG000|Overall Study|Adverse Event|5|||
145428838|NCT02231580|524427953|FG001|Overall Study|Adverse Event|0|||
145581851|NCT00803023|524983185|FG002|Overall Study|Lack of Efficacy|1|||
145581852|NCT00803023|524983186|FG003|Overall Study|Lack of Efficacy|1|||
145581853|NCT02647658|524983187|FG000|Overall Study|Consent refusal|15|||
145581854|NCT02647658|524983188|FG001|Overall Study|Consent refusal|24|||
145581855|NCT01542528|524983189|FG000|Overall Study|Lost to Follow-up|2|||
145581856|NCT01542528|524983190|FG001|Overall Study|Lost to Follow-up|1|||
145374373|NCT01597375|524221305|FG001|Second Intervention|Failed to react at both Aspirin|1|||
145374374|NCT04713592|524221310|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145374375|NCT04713592|524221311|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
145374376|NCT04713592|524221312|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145374377|NCT04713592|524221313|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
145374378|NCT04713592|524221310|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
145581857|NCT01542528|524983189|FG000|Overall Study|Physician Decision|1|||
145581858|NCT01542528|524983190|FG001|Overall Study|Physician Decision|0|||
145374379|NCT04713592|524221311|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
145374380|NCT04713592|524221312|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
145374381|NCT04713592|524221313|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
145374382|NCT04713592|524221310|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
145374383|NCT04713592|524221311|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
145374384|NCT04713592|524221312|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
145374385|NCT04713592|524221313|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
145374386|NCT04713592|524221310|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145374387|NCT04713592|524221311|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
145374388|NCT04713592|524221312|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
145374389|NCT04713592|524221313|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
145374390|NCT04713592|524221310|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
145374391|NCT04713592|524221311|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
145374392|NCT04713592|524221312|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
145374393|NCT04713592|524221313|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
145374394|NCT04713592|524221310|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145374395|NCT04713592|524221311|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
145374396|NCT04713592|524221312|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145374397|NCT04713592|524221313|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
145374398|NCT04713592|524221310|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
145374399|NCT04713592|524221311|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
145374400|NCT04713592|524221312|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
145374401|NCT04713592|524221313|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
145374402|NCT02225366|524221314|FG000|Overall Study|Lack of Efficacy|1|||
145374403|NCT02225366|524221315|FG001|Overall Study|Lack of Efficacy|0|||
145374404|NCT01190267|524221318|FG000|Overall Study|Adverse Event|10|||
145374405|NCT01190267|524221319|FG001|Overall Study|Adverse Event|0|||
145374406|NCT01190267|524221318|FG000|Overall Study|Treatment Failure|8|||
145374407|NCT01190267|524221319|FG001|Overall Study|Treatment Failure|2|||
145374408|NCT01190267|524221318|FG000|Overall Study|Lost to Follow-up|2|||
145374409|NCT01190267|524221319|FG001|Overall Study|Lost to Follow-up|0|||
145374410|NCT01190267|524221318|FG000|Overall Study|Withdrawal by Subject|13|||
145374411|NCT01190267|524221319|FG001|Overall Study|Withdrawal by Subject|1|||
145374412|NCT01190267|524221318|FG000|Overall Study|Protocol Violation|8|||
145374413|NCT01190267|524221319|FG001|Overall Study|Protocol Violation|1|||
145374414|NCT01382225|524221322|FG000|Overall Study|Adverse Event|3|||
145374415|NCT01382225|524221323|FG001|Overall Study|Adverse Event|2|||
145374416|NCT01382225|524221322|FG000|Overall Study|Protocol Violation|2|||
145374417|NCT01382225|524221323|FG001|Overall Study|Protocol Violation|1|||
145374418|NCT01382225|524221322|FG000|Overall Study|Subject Withdrew Consent|5|||
145374419|NCT01382225|524221323|FG001|Overall Study|Subject Withdrew Consent|2|||
145374420|NCT01382225|524221322|FG000|Overall Study|Other|4|||
145374421|NCT01382225|524221323|FG001|Overall Study|Other|2|||
145374422|NCT05376241|524223282|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
145374423|NCT05376241|524223282|FG000|Overall Study|103 did not complete the survey|103|||
145374424|NCT05376241|524223282|FG000|Overall Study|17 failed 2 attention check questions|17|||
145374425|NCT03036098|524223283|FG000|Pre-Treatment|Other Reasons|1|||
145374426|NCT03036098|524223284|FG001|Pre-Treatment|Other Reasons|2|||
145374427|NCT03036098|524223285|FG002|Pre-Treatment|Other Reasons|0|||
145374428|NCT03036098|524223286|FG003|Pre-Treatment|Other Reasons|5|||
145374429|NCT03036098|524223283|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
145374430|NCT03036098|524223284|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
145374431|NCT03036098|524223285|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
145374432|NCT03036098|524223286|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
145581859|NCT01542528|524983189|FG000|Overall Study|Withdrawal by Subject|9|||
145581860|NCT01542528|524983190|FG001|Overall Study|Withdrawal by Subject|6|||
145374433|NCT03036098|524223283|FG000|Pre-Treatment|Withdrawal by Subject|1|||
145374434|NCT03036098|524223284|FG001|Pre-Treatment|Withdrawal by Subject|14|||
145581861|NCT04382326|524983197|FG000|Overall Study|Adverse Event, not serious|1|||
145374435|NCT03036098|524223285|FG002|Pre-Treatment|Withdrawal by Subject|0|||
145374436|NCT03036098|524223286|FG003|Pre-Treatment|Withdrawal by Subject|5|||
145374437|NCT03036098|524223283|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
145374438|NCT03036098|524223284|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
145374439|NCT03036098|524223285|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
145374440|NCT03036098|524223286|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
145374441|NCT03036098|524223283|FG000|Treatment|Disease Progression|130|||
145374442|NCT03036098|524223284|FG001|Treatment|Disease Progression|77|||
145374443|NCT03036098|524223285|FG002|Treatment|Disease Progression|168|||
145374444|NCT03036098|524223286|FG003|Treatment|Disease Progression|50|||
145374445|NCT03036098|524223283|FG000|Treatment|Study Drug Toxicity|95|||
145374446|NCT03036098|524223284|FG001|Treatment|Study Drug Toxicity|45|||
145374447|NCT03036098|524223285|FG002|Treatment|Study Drug Toxicity|26|||
145374448|NCT03036098|524223286|FG003|Treatment|Study Drug Toxicity|22|||
145374449|NCT03036098|524223283|FG000|Treatment|Death|9|||
145374450|NCT03036098|524223284|FG001|Treatment|Death|3|||
145374451|NCT03036098|524223285|FG002|Treatment|Death|1|||
145374452|NCT03036098|524223286|FG003|Treatment|Death|2|||
145374453|NCT03036098|524223283|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
145374454|NCT03036098|524223284|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
145374455|NCT03036098|524223285|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
145374456|NCT03036098|524223286|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
145374457|NCT03036098|524223283|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
145374458|NCT03036098|524223284|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
145374459|NCT03036098|524223285|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
145374460|NCT03036098|524223286|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
145374461|NCT03036098|524223283|FG000|Treatment|Withdrawal by Subject|2|||
145374462|NCT03036098|524223284|FG001|Treatment|Withdrawal by Subject|9|||
145374463|NCT03036098|524223285|FG002|Treatment|Withdrawal by Subject|2|||
145374464|NCT03036098|524223286|FG003|Treatment|Withdrawal by Subject|4|||
145374465|NCT03036098|524223283|FG000|Treatment|Maximum Clinical Benefit|6|||
145374466|NCT03036098|524223284|FG001|Treatment|Maximum Clinical Benefit|1|||
145374467|NCT03036098|524223285|FG002|Treatment|Maximum Clinical Benefit|6|||
145374468|NCT03036098|524223286|FG003|Treatment|Maximum Clinical Benefit|10|||
145374469|NCT03036098|524223283|FG000|Treatment|Poor/Non Compliance|1|||
145374470|NCT03036098|524223284|FG001|Treatment|Poor/Non Compliance|2|||
145374471|NCT03036098|524223285|FG002|Treatment|Poor/Non Compliance|0|||
145374472|NCT03036098|524223286|FG003|Treatment|Poor/Non Compliance|1|||
145374473|NCT03036098|524223283|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
145374474|NCT03036098|524223284|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
145374475|NCT03036098|524223285|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
145374476|NCT03036098|524223286|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
145374477|NCT03036098|524223283|FG000|Treatment|Administrative Reason by Sponsor|1|||
145374478|NCT03036098|524223284|FG001|Treatment|Administrative Reason by Sponsor|0|||
145374479|NCT03036098|524223285|FG002|Treatment|Administrative Reason by Sponsor|2|||
145374480|NCT03036098|524223286|FG003|Treatment|Administrative Reason by Sponsor|1|||
145581862|NCT04382326|524983198|FG001|Overall Study|Adverse Event, not serious|2|||
145581863|NCT04382326|524983197|FG000|Overall Study|Other|1|||
145581864|NCT04382326|524983198|FG001|Overall Study|Other|0|||
145581865|NCT04382326|524983197|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
145581866|NCT04382326|524983198|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
145581867|NCT04382326|524983197|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
145581868|NCT04382326|524983198|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
145581869|NCT04382326|524983197|FG000|Overall Study|Protocol Violation|29|||
145581870|NCT04382326|524983198|FG001|Overall Study|Protocol Violation|23|||
145581871|NCT04382326|524983197|FG000|Overall Study|Physician Decision|0|||
145581872|NCT04382326|524983198|FG001|Overall Study|Physician Decision|1|||
145581873|NCT04382326|524983197|FG000|Overall Study|Lost to Follow-up|48|||
145581874|NCT04382326|524983198|FG001|Overall Study|Lost to Follow-up|63|||
145581875|NCT04382326|524983197|FG000|Overall Study|Adverse Event, non-fatal|1|||
145581876|NCT04382326|524983198|FG001|Overall Study|Adverse Event, non-fatal|1|||
145581877|NCT01762761|524983199|FG000|Overall Study|Adverse Event|15|||
145581878|NCT01762761|524983200|FG001|Overall Study|Adverse Event|17|||
145581879|NCT01762761|524983199|FG000|Overall Study|Lack of Efficacy|9|||
145581880|NCT01762761|524983200|FG001|Overall Study|Lack of Efficacy|25|||
145581881|NCT01762761|524983199|FG000|Overall Study|Protocol Violation|1|||
145581882|NCT01762761|524983200|FG001|Overall Study|Protocol Violation|1|||
145581883|NCT01762761|524983199|FG000|Overall Study|Study closed/terminated|0|||
145581884|NCT01762761|524983200|FG001|Overall Study|Study closed/terminated|2|||
145581885|NCT01762761|524983199|FG000|Overall Study|Lost to Follow-up|3|||
145581886|NCT01762761|524983200|FG001|Overall Study|Lost to Follow-up|6|||
145374481|NCT03036098|524223283|FG000|Treatment|Other Reasons|31|||
145374482|NCT03036098|524223284|FG001|Treatment|Other Reasons|5|||
145374483|NCT03036098|524223285|FG002|Treatment|Other Reasons|21|||
145581887|NCT01762761|524983199|FG000|Overall Study|Physician Decision|4|||
145581888|NCT01762761|524983200|FG001|Overall Study|Physician Decision|6|||
145428839|NCT04724837|524427954|FG000|Overall Study|Other|4|||
145428840|NCT04724837|524427955|FG001|Overall Study|Other|16|||
145428841|NCT04724837|524427956|FG002|Overall Study|Other|0|||
145428842|NCT04724837|524427954|FG000|Overall Study|Withdrawal by Subject|2|||
145428843|NCT04724837|524427955|FG001|Overall Study|Withdrawal by Subject|9|||
145428844|NCT04724837|524427956|FG002|Overall Study|Withdrawal by Subject|9|||
145428845|NCT04724837|524427954|FG000|Overall Study|Adverse Event|2|||
145428846|NCT04724837|524427955|FG001|Overall Study|Adverse Event|7|||
145428847|NCT04724837|524427956|FG002|Overall Study|Adverse Event|4|||
145428848|NCT04724837|524427954|FG000|Overall Study|Lost to Follow-up|0|||
145428849|NCT04724837|524427955|FG001|Overall Study|Lost to Follow-up|1|||
145428850|NCT04724837|524427956|FG002|Overall Study|Lost to Follow-up|3|||
145428851|NCT04724837|524427954|FG000|Overall Study|Physician Decision|1|||
145428852|NCT04724837|524427955|FG001|Overall Study|Physician Decision|2|||
145428853|NCT04724837|524427956|FG002|Overall Study|Physician Decision|0|||
145428854|NCT04724837|524427954|FG000|Overall Study|Death|0|||
145428855|NCT04724837|524427955|FG001|Overall Study|Death|0|||
145428856|NCT04724837|524427956|FG002|Overall Study|Death|1|||
145428857|NCT04724837|524427954|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
145428858|NCT04724837|524427955|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
145428859|NCT04724837|524427956|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
145428860|NCT04724837|524427954|FG000|Overall Study|Study Terminated by Sponsor|0|||
145428861|NCT04724837|524427955|FG001|Overall Study|Study Terminated by Sponsor|1|||
145428862|NCT04724837|524427956|FG002|Overall Study|Study Terminated by Sponsor|0|||
145428863|NCT03620981|524427957|FG000|Overall Study|Adverse Event|14|||
145428864|NCT03620981|524427958|FG001|Overall Study|Adverse Event|38|||
145428865|NCT03620981|524427959|FG002|Overall Study|Adverse Event|25|||
145428866|NCT03620981|524427957|FG000|Overall Study|Lack of Efficacy|2|||
145428867|NCT03620981|524427958|FG001|Overall Study|Lack of Efficacy|1|||
145428868|NCT03620981|524427959|FG002|Overall Study|Lack of Efficacy|1|||
145428869|NCT03620981|524427957|FG000|Overall Study|Physician Decision|7|||
145428870|NCT03620981|524427958|FG001|Overall Study|Physician Decision|4|||
145428871|NCT03620981|524427959|FG002|Overall Study|Physician Decision|4|||
145428872|NCT03620981|524427957|FG000|Overall Study|Protocol Violation|1|||
145428873|NCT03620981|524427958|FG001|Overall Study|Protocol Violation|2|||
145428874|NCT03620981|524427959|FG002|Overall Study|Protocol Violation|1|||
145428875|NCT03620981|524427957|FG000|Overall Study|Withdrawal by Legal Representative|2|||
145428876|NCT03620981|524427958|FG001|Overall Study|Withdrawal by Legal Representative|1|||
145428877|NCT03620981|524427959|FG002|Overall Study|Withdrawal by Legal Representative|1|||
145428878|NCT03620981|524427957|FG000|Overall Study|Withdrawal by Care Giver|2|||
145428879|NCT03620981|524427958|FG001|Overall Study|Withdrawal by Care Giver|0|||
145428880|NCT03620981|524427959|FG002|Overall Study|Withdrawal by Care Giver|1|||
145428881|NCT03620981|524427957|FG000|Overall Study|Non-compliance with Study Drug|1|||
145428882|NCT03620981|524427958|FG001|Overall Study|Non-compliance with Study Drug|1|||
145428883|NCT03620981|524427959|FG002|Overall Study|Non-compliance with Study Drug|0|||
145428884|NCT04347538|524427960|FG000|Overall Study|Lost to Follow-up|4|||
145428885|NCT04347538|524427961|FG001|Overall Study|Lost to Follow-up|5|||
145428886|NCT04347538|524427962|FG002|Overall Study|Lost to Follow-up|7|||
145428887|NCT02259231|524427963|FG000|Overall Study|Adverse Event|1|||
145428888|NCT02259231|524427964|FG001|Overall Study|Adverse Event|1|||
145428889|NCT02259231|524427965|FG002|Overall Study|Adverse Event|2|||
145428890|NCT02259231|524427966|FG003|Overall Study|Adverse Event|0|||
145428891|NCT02259231|524427967|FG004|Overall Study|Adverse Event|0|||
145428892|NCT02259231|524427968|FG005|Overall Study|Adverse Event|0|||
145428893|NCT02259231|524427969|FG006|Overall Study|Adverse Event|0|||
145428894|NCT02259231|524427963|FG000|Overall Study|Progressive Disease|4|||
145428895|NCT02259231|524427964|FG001|Overall Study|Progressive Disease|5|||
145428896|NCT02259231|524427965|FG002|Overall Study|Progressive Disease|4|||
145428897|NCT02259231|524427966|FG003|Overall Study|Progressive Disease|5|||
145428898|NCT02259231|524427967|FG004|Overall Study|Progressive Disease|4|||
145428899|NCT02259231|524427968|FG005|Overall Study|Progressive Disease|5|||
145428900|NCT02259231|524427969|FG006|Overall Study|Progressive Disease|4|||
145428901|NCT02259231|524427963|FG000|Overall Study|Sponsor termination of study|1|||
145428902|NCT02259231|524427964|FG001|Overall Study|Sponsor termination of study|0|||
145428903|NCT02259231|524427965|FG002|Overall Study|Sponsor termination of study|0|||
145428904|NCT02259231|524427966|FG003|Overall Study|Sponsor termination of study|1|||
145428905|NCT02259231|524427967|FG004|Overall Study|Sponsor termination of study|2|||
145428906|NCT02259231|524427968|FG005|Overall Study|Sponsor termination of study|1|||
145428907|NCT02259231|524427969|FG006|Overall Study|Sponsor termination of study|1|||
145428908|NCT04938427|524427970|FG000|Overall Study|Adverse Event|5|||
145428909|NCT04938427|524427971|FG001|Overall Study|Adverse Event|19|||
145428910|NCT04938427|524427970|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145428911|NCT04938427|524427971|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145428912|NCT04938427|524427970|FG000|Overall Study|Withdrawal by Subject|1|||
145428913|NCT04938427|524427971|FG001|Overall Study|Withdrawal by Subject|0|||
145428914|NCT04938427|524427970|FG000|Overall Study|Reason Not Specified|2|||
145623926|NCT00410384|525135638|FG001|Overall Study|Withdrawal by Subject|17|||
145428915|NCT04938427|524427971|FG001|Overall Study|Reason Not Specified|1|||
145428916|NCT03633058|524427980|FG000|Overall Study|Adverse Event|0|||
145428917|NCT03633058|524427981|FG001|Overall Study|Adverse Event|0|||
145428918|NCT03633058|524427982|FG002|Overall Study|Adverse Event|1|||
145428919|NCT03633058|524427983|FG003|Overall Study|Adverse Event|0|||
145428920|NCT03312543|524427986|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
145428921|NCT03312543|524427987|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
145428922|NCT03312543|524427986|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
145428923|NCT03312543|524427987|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
145428924|NCT03312543|524427986|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
145428925|NCT03312543|524427987|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
145581889|NCT01762761|524983199|FG000|Overall Study|Withdrawal by Subject|7|||
145581890|NCT01762761|524983200|FG001|Overall Study|Withdrawal by Subject|8|||
145581891|NCT01709227|524983206|FG000|Overall Study|Physician Decision|1|||
145581892|NCT01709227|524983207|FG001|Overall Study|Physician Decision|0|||
145581893|NCT01709227|524983206|FG000|Overall Study|Pleural Peritoneal communication|0|||
145581894|NCT01709227|524983207|FG001|Overall Study|Pleural Peritoneal communication|9|||
145581895|NCT04479618|524983211|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
145581896|NCT04479618|524983212|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
145581897|NCT04479618|524983213|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
145581898|NCT04479618|524983211|FG000|Overall Study|Lack of Efficacy|1|||
145581899|NCT04479618|524983212|FG001|Overall Study|Lack of Efficacy|0|||
145581900|NCT04479618|524983213|FG002|Overall Study|Lack of Efficacy|0|||
145581901|NCT04479618|524983211|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
145581902|NCT04479618|524983212|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
145581903|NCT04479618|524983213|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
145581904|NCT04479618|524983211|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
145581905|NCT04479618|524983212|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
145581906|NCT04479618|524983213|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
145581907|NCT04479618|524983211|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
145581908|NCT04479618|524983212|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
145581909|NCT04479618|524983213|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
145581910|NCT04479618|524983211|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
145581911|NCT04479618|524983212|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
145581912|NCT04479618|524983213|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
145581913|NCT01047683|524983216|FG000|Overall Study|Adverse Event|3|||
145581914|NCT01047683|524983217|FG001|Overall Study|Adverse Event|1|||
145581915|NCT01047683|524983218|FG002|Overall Study|Adverse Event|0|||
145581916|NCT01047683|524983216|FG000|Overall Study|Withdrew Consent|1|||
145581917|NCT01047683|524983217|FG001|Overall Study|Withdrew Consent|4|||
145581918|NCT01047683|524983218|FG002|Overall Study|Withdrew Consent|2|||
145581919|NCT01047683|524983216|FG000|Overall Study|Lost to Follow-up|0|||
145581920|NCT01047683|524983217|FG001|Overall Study|Lost to Follow-up|1|||
145581921|NCT01047683|524983218|FG002|Overall Study|Lost to Follow-up|0|||
145581922|NCT01047683|524983216|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
145581923|NCT01047683|524983217|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
145581924|NCT01047683|524983218|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
145581925|NCT00833924|524983231|FG000|Overall Study|Death|21|||
145581926|NCT00833924|524983231|FG000|Overall Study|Conversion|2|||
145581927|NCT00833924|524983231|FG000|Overall Study|Lost to Follow-up|2|||
145581928|NCT00833924|524983231|FG000|Overall Study|Withdrawal by Subject|13|||
145581929|NCT00833924|524983231|FG000|Overall Study|In study follow-up|71|||
145581930|NCT01485861|524983232|FG000|Phase Ib|Death|1|||
145581931|NCT01485861|524983233|FG001|Phase Ib|Death|0|||
145428926|NCT03312543|524427986|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
145428927|NCT03312543|524427987|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
145428928|NCT03312543|524427986|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
145428929|NCT03312543|524427987|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
145428930|NCT03312543|524427986|FG000|Regression (Week 12 to Week 24)|Death|0|||
145428931|NCT03312543|524427987|FG001|Regression (Week 12 to Week 24)|Death|1|||
145428932|NCT04507269|524427988|FG000|Overall Study|Withdrawal by Subject|1|||
145428933|NCT04507269|524427989|FG001|Overall Study|Withdrawal by Subject|1|||
145581932|NCT01485861|524983234|FG002|Phase Ib|Death|0|||
145581933|NCT01485861|524983235|FG003|Phase Ib|Death|0|||
145581934|NCT01485861|524983236|FG004|Phase Ib|Death|0|||
145428934|NCT04507269|524427990|FG002|Overall Study|Withdrawal by Subject|0|||
145428935|NCT04507269|524427991|FG003|Overall Study|Withdrawal by Subject|0|||
145581935|NCT01485861|524983237|FG005|Phase Ib|Death|0|||
145581936|NCT01485861|524983232|FG000|Phase Ib|Physician Decision|1|||
145581937|NCT01485861|524983233|FG001|Phase Ib|Physician Decision|1|||
145581938|NCT01485861|524983234|FG002|Phase Ib|Physician Decision|0|||
145581939|NCT01485861|524983235|FG003|Phase Ib|Physician Decision|0|||
145581940|NCT01485861|524983236|FG004|Phase Ib|Physician Decision|0|||
145581941|NCT01485861|524983237|FG005|Phase Ib|Physician Decision|0|||
145581942|NCT01485861|524983232|FG000|Phase Ib|Adverse Event|0|||
145581943|NCT01485861|524983233|FG001|Phase Ib|Adverse Event|4|||
145581944|NCT01485861|524983234|FG002|Phase Ib|Adverse Event|0|||
145581945|NCT01485861|524983235|FG003|Phase Ib|Adverse Event|0|||
145581946|NCT01485861|524983236|FG004|Phase Ib|Adverse Event|0|||
145581947|NCT01485861|524983237|FG005|Phase Ib|Adverse Event|0|||
145581948|NCT01485861|524983232|FG000|Phase Ib|Progression of disease|5|||
145581949|NCT01485861|524983233|FG001|Phase Ib|Progression of disease|0|||
145581950|NCT01485861|524983234|FG002|Phase Ib|Progression of disease|0|||
145581951|NCT01485861|524983235|FG003|Phase Ib|Progression of disease|0|||
145581952|NCT01485861|524983236|FG004|Phase Ib|Progression of disease|0|||
145581953|NCT01485861|524983237|FG005|Phase Ib|Progression of disease|0|||
145581954|NCT01485861|524983232|FG000|Phase Ib|Other|3|||
145581955|NCT01485861|524983233|FG001|Phase Ib|Other|0|||
145581956|NCT01485861|524983234|FG002|Phase Ib|Other|0|||
145581957|NCT01485861|524983235|FG003|Phase Ib|Other|0|||
145581958|NCT01485861|524983236|FG004|Phase Ib|Other|0|||
145581959|NCT01485861|524983237|FG005|Phase Ib|Other|0|||
145581960|NCT01485861|524983232|FG000|Phase Ib|Withdrawal by Subject|4|||
145581961|NCT01485861|524983233|FG001|Phase Ib|Withdrawal by Subject|1|||
145581962|NCT01485861|524983234|FG002|Phase Ib|Withdrawal by Subject|0|||
145581963|NCT01485861|524983235|FG003|Phase Ib|Withdrawal by Subject|0|||
145581964|NCT01485861|524983236|FG004|Phase Ib|Withdrawal by Subject|0|||
145428936|NCT04507269|524427992|FG004|Overall Study|Withdrawal by Subject|0|||
145428937|NCT04507269|524427993|FG005|Overall Study|Withdrawal by Subject|0|||
145428938|NCT04507269|524427988|FG000|Overall Study|Lost to Follow-up|0|||
145428939|NCT04507269|524427989|FG001|Overall Study|Lost to Follow-up|0|||
145428940|NCT04507269|524427990|FG002|Overall Study|Lost to Follow-up|0|||
145428941|NCT04507269|524427991|FG003|Overall Study|Lost to Follow-up|0|||
145428942|NCT04507269|524427992|FG004|Overall Study|Lost to Follow-up|1|||
145428943|NCT04507269|524427993|FG005|Overall Study|Lost to Follow-up|0|||
145428944|NCT05852340|524427994|FG000|Period 5|Not completing the meal|0|||
145428945|NCT05852340|524427995|FG001|Period 5|Not completing the meal|1|||
145428946|NCT05852340|524427996|FG002|Period 5|Not completing the meal|0|||
145428947|NCT05852340|524427997|FG003|Period 5|Not completing the meal|0|||
145428948|NCT05852340|524427994|FG000|Period 5|Adverse Event|0|||
145428949|NCT05852340|524427995|FG001|Period 5|Adverse Event|0|||
145428950|NCT05852340|524427996|FG002|Period 5|Adverse Event|0|||
145428951|NCT05852340|524427997|FG003|Period 5|Adverse Event|1|||
145428952|NCT01722669|524428000|FG000|Overall Study|Withdrawal by Subject|0|||
145428953|NCT01722669|524428001|FG001|Overall Study|Withdrawal by Subject|0|||
145428954|NCT01722669|524428002|FG002|Overall Study|Withdrawal by Subject|0|||
145428955|NCT01722669|524428003|FG003|Overall Study|Withdrawal by Subject|0|||
145428956|NCT01722669|524428004|FG004|Overall Study|Withdrawal by Subject|0|||
145428957|NCT01722669|524428005|FG005|Overall Study|Withdrawal by Subject|2|||
145428958|NCT04116489|524428006|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
145428959|NCT04116489|524428006|FG000|Overall Study|Withdrawal by Subject|1|||
145428960|NCT03781570|524428007|FG000|Overall Study|Technical Issues (equipment failure)|31|||
145428961|NCT03781570|524428007|FG000|Overall Study|Withdrawal by Subject|7|||
145428962|NCT03781570|524428007|FG000|Overall Study|Physical Constraints|11|||
145428963|NCT01107496|524428008|FG000|Overall Study|Adverse Event|1|||
145428964|NCT01107496|524428009|FG001|Overall Study|Adverse Event|0|||
145428965|NCT01107496|524428008|FG000|Overall Study|Lack of Efficacy|1|||
145428966|NCT01107496|524428009|FG001|Overall Study|Lack of Efficacy|0|||
145428967|NCT01107496|524428008|FG000|Overall Study|Protocol Violation|0|||
145428968|NCT01107496|524428009|FG001|Overall Study|Protocol Violation|1|||
145428969|NCT01107496|524428008|FG000|Overall Study|Lost to Follow-up|0|||
145428970|NCT01107496|524428009|FG001|Overall Study|Lost to Follow-up|1|||
145428971|NCT01346592|524428010|FG000|Overall Study|Lost to Follow-up|62|||
145428972|NCT01346592|524428011|FG001|Overall Study|Lost to Follow-up|29|||
145428973|NCT01346592|524428012|FG002|Overall Study|Lost to Follow-up|29|||
145428974|NCT01346592|524428010|FG000|Overall Study|Protocol Violation|2|||
145428975|NCT01346592|524428011|FG001|Overall Study|Protocol Violation|1|||
145581965|NCT01485861|524983237|FG005|Phase Ib|Withdrawal by Subject|0|||
145581966|NCT01485861|524983232|FG000|Phase II|Death|0|||
145581967|NCT01485861|524983233|FG001|Phase II|Death|0|||
145581968|NCT01485861|524983234|FG002|Phase II|Death|67|||
145581969|NCT01485861|524983235|FG003|Phase II|Death|71|||
145581970|NCT01485861|524983236|FG004|Phase II|Death|68|||
145581971|NCT01485861|524983237|FG005|Phase II|Death|0|||
145428976|NCT01346592|524428012|FG002|Overall Study|Protocol Violation|0|||
145428977|NCT01346592|524428010|FG000|Overall Study|Death|1|||
145428978|NCT01346592|524428011|FG001|Overall Study|Death|3|||
145428979|NCT01346592|524428012|FG002|Overall Study|Death|4|||
145581972|NCT01485861|524983232|FG000|Phase II|Progression of Disease|0|||
145581973|NCT01485861|524983233|FG001|Phase II|Progression of Disease|0|||
145581974|NCT01485861|524983234|FG002|Phase II|Progression of Disease|1|||
145581975|NCT01485861|524983235|FG003|Phase II|Progression of Disease|0|||
145428980|NCT01346592|524428010|FG000|Overall Study|Adverse Event|0|||
145428981|NCT01346592|524428011|FG001|Overall Study|Adverse Event|1|||
145428982|NCT01346592|524428012|FG002|Overall Study|Adverse Event|0|||
145428983|NCT01346592|524428010|FG000|Overall Study|Withdrawal by Subject|77|||
145428984|NCT01346592|524428011|FG001|Overall Study|Withdrawal by Subject|51|||
145428985|NCT01346592|524428012|FG002|Overall Study|Withdrawal by Subject|38|||
145428986|NCT01346592|524428010|FG000|Overall Study|Inappropriate enrollment|3|||
145428987|NCT01346592|524428011|FG001|Overall Study|Inappropriate enrollment|1|||
145428988|NCT01346592|524428012|FG002|Overall Study|Inappropriate enrollment|1|||
145428989|NCT01346592|524428010|FG000|Overall Study|Administrative reason|1|||
145428990|NCT01346592|524428011|FG001|Overall Study|Administrative reason|0|||
145428991|NCT01346592|524428012|FG002|Overall Study|Administrative reason|0|||
145428992|NCT01346592|524428010|FG000|Overall Study|Unable to Classify|7|||
145428993|NCT01346592|524428011|FG001|Overall Study|Unable to Classify|3|||
145428994|NCT01346592|524428012|FG002|Overall Study|Unable to Classify|6|||
145428995|NCT05318287|524428014|FG000|Overall Study|Lost to Follow-up|8|||
145428996|NCT04144517|524428017|FG000|Overall Study|Physician Decision|0|||
145428997|NCT04144517|524428018|FG001|Overall Study|Physician Decision|1|||
145428998|NCT04144517|524428017|FG000|Overall Study|Other|2|||
145428999|NCT04144517|524428018|FG001|Overall Study|Other|2|||
145429000|NCT04144517|524428017|FG000|Overall Study|Death|6|||
145429001|NCT04144517|524428018|FG001|Overall Study|Death|3|||
145429002|NCT02757768|524428022|FG000|Overall Study|Randomized Never Received Study Drug|3|||
145429003|NCT02757768|524428023|FG001|Overall Study|Randomized Never Received Study Drug|4|||
145429004|NCT02757768|524428022|FG000|Overall Study|Adverse Event|5|||
145429005|NCT02757768|524428023|FG001|Overall Study|Adverse Event|3|||
145429006|NCT02757768|524428022|FG000|Overall Study|Lack of Efficacy|2|||
145429007|NCT02757768|524428023|FG001|Overall Study|Lack of Efficacy|1|||
145429008|NCT02757768|524428022|FG000|Overall Study|Lost to Follow-up|1|||
145429009|NCT02757768|524428023|FG001|Overall Study|Lost to Follow-up|0|||
145429010|NCT02757768|524428022|FG000|Overall Study|Protocol Deviation|2|||
145429011|NCT02757768|524428023|FG001|Overall Study|Protocol Deviation|9|||
145429012|NCT02757768|524428022|FG000|Overall Study|Withdrawal by Subject|16|||
145429013|NCT02757768|524428023|FG001|Overall Study|Withdrawal by Subject|9|||
145429014|NCT02757768|524428022|FG000|Overall Study|Miscellaneous|4|||
145429015|NCT02757768|524428023|FG001|Overall Study|Miscellaneous|2|||
145429016|NCT02495883|524428030|FG000|Overall Study|Excessive head motion|1|||
145429017|NCT02495883|524428031|FG001|Overall Study|Excessive head motion|0|||
145429018|NCT03557502|524428032|FG000|Protocol 2|Withdrawal by Subject|1|||
145429019|NCT03557502|524428033|FG001|Protocol 2|Withdrawal by Subject|1|||
145429020|NCT03557502|524428032|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
145429021|NCT03557502|524428033|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
145429022|NCT05943990|524428039|FG000|Overall Study|Study Terminated by Sponsor|0|||
145429023|NCT05943990|524428040|FG001|Overall Study|Study Terminated by Sponsor|0|||
145429024|NCT05943990|524428041|FG002|Overall Study|Study Terminated by Sponsor|1|||
145429025|NCT02552225|524429641|FG000|Overall Study|Withdrawal by Subject|1|||
145429026|NCT02552225|524429642|FG001|Overall Study|Withdrawal by Subject|0|||
145429027|NCT03122184|524429643|FG000|Overall Study|Lost to Follow-up|4|||
145429028|NCT03122184|524429644|FG001|Overall Study|Lost to Follow-up|6|||
145429029|NCT03122184|524429643|FG000|Overall Study|Withdrawal by Subject|3|||
145429030|NCT03122184|524429644|FG001|Overall Study|Withdrawal by Subject|0|||
145429031|NCT03122184|524429643|FG000|Overall Study|Terminated due to cognitive problem|1|||
145429032|NCT03122184|524429644|FG001|Overall Study|Terminated due to cognitive problem|0|||
145429033|NCT01168596|524429645|FG000|Overall Study|Withdrawal by Subject|3|||
145429034|NCT01168596|524429646|FG001|Overall Study|Withdrawal by Subject|1|||
145429035|NCT02297516|524429649|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
145429036|NCT02297516|524429650|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
145429037|NCT02297516|524429649|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
145429038|NCT02297516|524429650|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
145429039|NCT02297516|524429649|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
145429040|NCT02297516|524429650|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
145581976|NCT01485861|524983236|FG004|Phase II|Progression of Disease|0|||
145581977|NCT01485861|524983237|FG005|Phase II|Progression of Disease|0|||
145581978|NCT01485861|524983232|FG000|Phase II|Other|0|||
145429041|NCT00710593|524429651|FG000|Overall Study|Incarceration|1|||
145429042|NCT00710593|524429652|FG001|Overall Study|Incarceration|0|||
145429043|NCT00710593|524429651|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
145429044|NCT00710593|524429652|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
145429045|NCT00710593|524429651|FG000|Overall Study|Lost to Follow-up|3|||
145429046|NCT00710593|524429652|FG001|Overall Study|Lost to Follow-up|1|||
145429047|NCT00710593|524429651|FG000|Overall Study|Moved out of area|1|||
145429048|NCT00710593|524429652|FG001|Overall Study|Moved out of area|0|||
145429049|NCT00710593|524429651|FG000|Overall Study|Failure to adhere or complete study eval|1|||
145429050|NCT00710593|524429652|FG001|Overall Study|Failure to adhere or complete study eval|1|||
145429051|NCT00710593|524429651|FG000|Overall Study|Protocol Violation|1|||
145581979|NCT01485861|524983233|FG001|Phase II|Other|0|||
145581980|NCT01485861|524983234|FG002|Phase II|Other|0|||
145429052|NCT00710593|524429652|FG001|Overall Study|Protocol Violation|1|||
145429053|NCT00710593|524429651|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
145429054|NCT00710593|524429652|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
145429055|NCT04490278|524429653|FG000|Overall Study|Lost to Follow-up|6|||
145429056|NCT00366457|524429656|FG000|Overall Study|never began study therapy|2|||
145429057|NCT02829996|524429657|FG000|Overall Study|Withdrawal by Subject|1|||
145429058|NCT02829996|524429658|FG001|Overall Study|Withdrawal by Subject|0|||
145429059|NCT02829996|524429659|FG002|Overall Study|Withdrawal by Subject|0|||
145429060|NCT02829996|524429660|FG003|Overall Study|Withdrawal by Subject|0|||
145429061|NCT02829996|524429661|FG004|Overall Study|Withdrawal by Subject|0|||
145429062|NCT00189423|524429662|FG000|Overall Study|Death|746|||
145429063|NCT00189423|524429663|FG001|Overall Study|Death|747|||
145429064|NCT00189423|524429662|FG000|Overall Study|Withdrawal by Subject|9|||
145429065|NCT00189423|524429663|FG001|Overall Study|Withdrawal by Subject|9|||
145429066|NCT00189423|524429662|FG000|Overall Study|Lost to Follow-up|10|||
145429067|NCT00189423|524429663|FG001|Overall Study|Lost to Follow-up|10|||
145429068|NCT01497197|524429664|FG000|Overall Study|Lost to Follow-up|1|||
145429069|NCT01497197|524429665|FG001|Overall Study|Lost to Follow-up|0|||
145429070|NCT01497197|524429664|FG000|Overall Study|Protocol Violation|0|||
145429071|NCT01497197|524429665|FG001|Overall Study|Protocol Violation|2|||
145429072|NCT01497197|524429664|FG000|Overall Study|Withdrawal by Subject|2|||
145429073|NCT01497197|524429665|FG001|Overall Study|Withdrawal by Subject|1|||
145429074|NCT01497197|524429664|FG000|Overall Study|Excessive/lack of response to treatment|1|||
145429075|NCT01497197|524429665|FG001|Overall Study|Excessive/lack of response to treatment|0|||
145429076|NCT01497197|524429664|FG000|Overall Study|Risk of OHSS|1|||
145429077|NCT01497197|524429665|FG001|Overall Study|Risk of OHSS|0|||
145429078|NCT01497197|524429664|FG000|Overall Study|No oocytes retrieved|3|||
145429079|NCT01497197|524429665|FG001|Overall Study|No oocytes retrieved|2|||
145429080|NCT01497197|524429664|FG000|Overall Study|No fertilisation|6|||
145429081|NCT01497197|524429665|FG001|Overall Study|No fertilisation|5|||
145429082|NCT01497197|524429664|FG000|Overall Study|Intention to freeze all embryos|0|||
145429083|NCT01497197|524429665|FG001|Overall Study|Intention to freeze all embryos|1|||
145429084|NCT01497197|524429664|FG000|Overall Study|All embryos discarded|0|||
145429085|NCT01497197|524429665|FG001|Overall Study|All embryos discarded|3|||
145429086|NCT01497197|524429664|FG000|Overall Study|Other|3|||
145429087|NCT01497197|524429665|FG001|Overall Study|Other|1|||
145429088|NCT00565747|524429670|FG000|Overall Study|No embryo transfer|67|||
145429089|NCT00565747|524429671|FG001|Overall Study|No embryo transfer|73|||
145429090|NCT00183248|524429672|FG000|Overall Study|Lost to Follow-up|0|||
145429091|NCT00183248|524429673|FG001|Overall Study|Lost to Follow-up|1|||
145429092|NCT00183248|524429672|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
145429093|NCT00183248|524429673|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
145429094|NCT04734210|524429676|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
145429095|NCT04734210|524429677|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
145429096|NCT04734210|524429678|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
145429097|NCT04734210|524429676|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
145429098|NCT04734210|524429677|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
145429099|NCT04734210|524429678|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
145429100|NCT04734210|524429676|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
145429101|NCT04734210|524429677|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
145429102|NCT04734210|524429678|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
145429103|NCT04734210|524429676|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
145429104|NCT04734210|524429677|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
145429105|NCT04734210|524429678|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
145429106|NCT02684461|524429679|FG000|Overall Study|Adverse Event|1|||
145429107|NCT02684461|524429680|FG001|Overall Study|Adverse Event|0|||
145429108|NCT02684461|524429681|FG002|Overall Study|Adverse Event|0|||
145429109|NCT02684461|524429679|FG000|Overall Study|Lack of Efficacy|1|||
145429110|NCT02684461|524429680|FG001|Overall Study|Lack of Efficacy|2|||
145429111|NCT02684461|524429681|FG002|Overall Study|Lack of Efficacy|0|||
145429112|NCT02390076|524429682|FG000|Overall Study|Lost to Follow-up|2|||
145429113|NCT02390076|524429683|FG001|Overall Study|Lost to Follow-up|1|||
145429114|NCT02390076|524429684|FG002|Overall Study|Lost to Follow-up|4|||
145429115|NCT01206517|524429687|FG000|Overall Study|Withdrawal by Subject|0|||
145581981|NCT01485861|524983235|FG003|Phase II|Other|1|||
145581982|NCT01485861|524983236|FG004|Phase II|Other|0|||
145581983|NCT01485861|524983237|FG005|Phase II|Other|0|||
145429116|NCT01206517|524429688|FG001|Overall Study|Withdrawal by Subject|0|||
145429117|NCT01206517|524429689|FG002|Overall Study|Withdrawal by Subject|2|||
145581984|NCT01485861|524983232|FG000|Phase II|Withdrawal by Subject|0|||
145581985|NCT01485861|524983233|FG001|Phase II|Withdrawal by Subject|0|||
145429118|NCT01206517|524429690|FG003|Overall Study|Withdrawal by Subject|0|||
145429119|NCT01206517|524429691|FG004|Overall Study|Withdrawal by Subject|1|||
145429120|NCT01206517|524429692|FG005|Overall Study|Withdrawal by Subject|0|||
145429121|NCT03493958|524429693|FG000|Overall Study|Withdrawal by Subject|6|||
145429122|NCT03493958|524429693|FG000|Overall Study|Lost to Follow-up|7|||
145429123|NCT03493958|524429693|FG000|Overall Study|Did not complete all required study procedures|2|||
145429124|NCT01029535|524429694|FG000|Overall Study|Lost to Follow-up|24|||
145429125|NCT01029535|524429694|FG000|Overall Study|Protocol Violation|2|||
145429126|NCT01029535|524429694|FG000|Overall Study|Participant Withdrew Consent|2|||
145429127|NCT01029535|524429694|FG000|Overall Study|Adverse Event|1|||
145429128|NCT01029535|524429694|FG000|Overall Study|Use of Another Treatment|1|||
145429129|NCT01029535|524429694|FG000|Overall Study|Death|1|||
145429130|NCT01358734|524429695|FG000|Overall Study|Adverse Event|4|||
145429131|NCT01358734|524429696|FG001|Overall Study|Adverse Event|7|||
145429132|NCT01358734|524429697|FG002|Overall Study|Adverse Event|3|||
145429133|NCT01358734|524429695|FG000|Overall Study|Lack of Efficacy|0|||
145429134|NCT01358734|524429696|FG001|Overall Study|Lack of Efficacy|1|||
145429135|NCT01358734|524429697|FG002|Overall Study|Lack of Efficacy|3|||
145429136|NCT01358734|524429695|FG000|Overall Study|Withdrawal by Subject|1|||
145429137|NCT01358734|524429696|FG001|Overall Study|Withdrawal by Subject|6|||
145429138|NCT01358734|524429697|FG002|Overall Study|Withdrawal by Subject|3|||
145429139|NCT01358734|524429695|FG000|Overall Study|Death|3|||
145429140|NCT01358734|524429696|FG001|Overall Study|Death|7|||
145429141|NCT01358734|524429697|FG002|Overall Study|Death|2|||
145429142|NCT01358734|524429695|FG000|Overall Study|Progressive Disease|5|||
145429143|NCT01358734|524429696|FG001|Overall Study|Progressive Disease|13|||
145429144|NCT01358734|524429697|FG002|Overall Study|Progressive Disease|16|||
145429145|NCT01358734|524429695|FG000|Overall Study|Non-compliance with study drug|0|||
145429146|NCT01358734|524429696|FG001|Overall Study|Non-compliance with study drug|0|||
145429147|NCT01358734|524429697|FG002|Overall Study|Non-compliance with study drug|1|||
145429148|NCT01358734|524429695|FG000|Overall Study|Other|2|||
145429149|NCT01358734|524429696|FG001|Overall Study|Other|5|||
145429150|NCT01358734|524429697|FG002|Overall Study|Other|4|||
145429151|NCT01358734|524429695|FG000|Overall Study|Protocol Violation|0|||
145429152|NCT01358734|524429696|FG001|Overall Study|Protocol Violation|0|||
145429153|NCT01358734|524429697|FG002|Overall Study|Protocol Violation|2|||
145429154|NCT00553254|524429704|FG000|Overall Study|Death|3|||
145429155|NCT00553254|524429705|FG001|Overall Study|Death|6|||
145429156|NCT00553254|524429706|FG002|Overall Study|Death|25|||
145429157|NCT00553254|524429704|FG000|Overall Study|Lost to Follow-up|0|||
145429158|NCT00553254|524429705|FG001|Overall Study|Lost to Follow-up|0|||
145429159|NCT00553254|524429706|FG002|Overall Study|Lost to Follow-up|2|||
145429160|NCT00553254|524429704|FG000|Overall Study|Withdrawal by Subject|2|||
145429161|NCT00553254|524429705|FG001|Overall Study|Withdrawal by Subject|0|||
145429162|NCT00553254|524429706|FG002|Overall Study|Withdrawal by Subject|2|||
145429163|NCT00553254|524429704|FG000|Overall Study|Study terminated by Sponsor|0|||
145429164|NCT00553254|524429705|FG001|Overall Study|Study terminated by Sponsor|0|||
145429165|NCT00553254|524429706|FG002|Overall Study|Study terminated by Sponsor|1|||
145429166|NCT00553254|524429704|FG000|Overall Study|Other|1|||
145429167|NCT00553254|524429705|FG001|Overall Study|Other|0|||
145429168|NCT00553254|524429706|FG002|Overall Study|Other|13|||
145429169|NCT02314923|524429709|FG000|Overall Study|Death|0|||
145429170|NCT02314923|524429710|FG001|Overall Study|Death|0|||
145429171|NCT02314923|524429711|FG002|Overall Study|Death|0|||
145429172|NCT02314923|524429712|FG003|Overall Study|Death|1|||
145429173|NCT02314923|524429713|FG004|Overall Study|Death|0|||
145429174|NCT02314923|524429714|FG005|Overall Study|Death|0|||
145429175|NCT02314923|524429715|FG006|Overall Study|Death|0|||
145429176|NCT02314923|524429716|FG007|Overall Study|Death|0|||
145429177|NCT02314923|524429717|FG008|Overall Study|Death|0|||
145374484|NCT03036098|524223286|FG003|Treatment|Other Reasons|8|||
145374485|NCT03036098|524223283|FG000|Treatment|Ongoing Treatment|0|||
145374486|NCT03036098|524223284|FG001|Treatment|Ongoing Treatment|0|||
145374487|NCT03036098|524223285|FG002|Treatment|Ongoing Treatment|23|||
145374488|NCT03036098|524223286|FG003|Treatment|Ongoing Treatment|0|||
145374489|NCT02059434|524223287|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
145374490|NCT02059434|524223288|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
145374491|NCT02059434|524223289|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
145374492|NCT02059434|524223290|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
145374493|NCT02059434|524223291|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
145374494|NCT02059434|524223292|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
145374495|NCT02059434|524223293|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
145429178|NCT02314923|524429718|FG009|Overall Study|Death|0|||
145429179|NCT02314923|524429709|FG000|Overall Study|Lost to Follow-up|2|||
145429180|NCT02314923|524429710|FG001|Overall Study|Lost to Follow-up|3|||
145429181|NCT02314923|524429711|FG002|Overall Study|Lost to Follow-up|1|||
145429182|NCT02314923|524429712|FG003|Overall Study|Lost to Follow-up|0|||
145429183|NCT02314923|524429713|FG004|Overall Study|Lost to Follow-up|0|||
145429184|NCT02314923|524429714|FG005|Overall Study|Lost to Follow-up|0|||
145429185|NCT02314923|524429715|FG006|Overall Study|Lost to Follow-up|3|||
145429186|NCT02314923|524429716|FG007|Overall Study|Lost to Follow-up|4|||
145429187|NCT02314923|524429717|FG008|Overall Study|Lost to Follow-up|2|||
145429188|NCT02314923|524429718|FG009|Overall Study|Lost to Follow-up|0|||
145429189|NCT02314923|524429709|FG000|Overall Study|Withdrawal by Subject|0|||
145429190|NCT02314923|524429710|FG001|Overall Study|Withdrawal by Subject|0|||
145429191|NCT02314923|524429711|FG002|Overall Study|Withdrawal by Subject|1|||
145429192|NCT02314923|524429712|FG003|Overall Study|Withdrawal by Subject|0|||
145429193|NCT02314923|524429713|FG004|Overall Study|Withdrawal by Subject|1|||
145429194|NCT02314923|524429714|FG005|Overall Study|Withdrawal by Subject|0|||
145429195|NCT02314923|524429715|FG006|Overall Study|Withdrawal by Subject|1|||
145429196|NCT02314923|524429716|FG007|Overall Study|Withdrawal by Subject|0|||
145429197|NCT02314923|524429717|FG008|Overall Study|Withdrawal by Subject|0|||
145429198|NCT02314923|524429718|FG009|Overall Study|Withdrawal by Subject|0|||
145429199|NCT02314923|524429709|FG000|Overall Study|Physician Decision|0|||
145429200|NCT02314923|524429710|FG001|Overall Study|Physician Decision|1|||
145429201|NCT02314923|524429711|FG002|Overall Study|Physician Decision|0|||
145429202|NCT02314923|524429712|FG003|Overall Study|Physician Decision|0|||
145429203|NCT02314923|524429713|FG004|Overall Study|Physician Decision|0|||
145429204|NCT02314923|524429714|FG005|Overall Study|Physician Decision|0|||
145429205|NCT02314923|524429715|FG006|Overall Study|Physician Decision|0|||
145429206|NCT02314923|524429716|FG007|Overall Study|Physician Decision|0|||
145429207|NCT02314923|524429717|FG008|Overall Study|Physician Decision|0|||
145429208|NCT02314923|524429718|FG009|Overall Study|Physician Decision|0|||
145429209|NCT02314923|524429709|FG000|Overall Study|Participant unavailable|0|||
145429210|NCT02314923|524429710|FG001|Overall Study|Participant unavailable|0|||
145429211|NCT02314923|524429711|FG002|Overall Study|Participant unavailable|0|||
145429212|NCT02314923|524429712|FG003|Overall Study|Participant unavailable|0|||
145429213|NCT02314923|524429713|FG004|Overall Study|Participant unavailable|0|||
145429214|NCT02314923|524429714|FG005|Overall Study|Participant unavailable|1|||
145429215|NCT02314923|524429715|FG006|Overall Study|Participant unavailable|0|||
145429216|NCT02314923|524429716|FG007|Overall Study|Participant unavailable|0|||
145429217|NCT02314923|524429717|FG008|Overall Study|Participant unavailable|0|||
145429218|NCT02314923|524429718|FG009|Overall Study|Participant unavailable|0|||
145429219|NCT02314923|524429709|FG000|Overall Study|Screen failure|0|||
145429220|NCT02314923|524429710|FG001|Overall Study|Screen failure|0|||
145429221|NCT02314923|524429711|FG002|Overall Study|Screen failure|0|||
145429222|NCT02314923|524429712|FG003|Overall Study|Screen failure|0|||
145429223|NCT02314923|524429713|FG004|Overall Study|Screen failure|0|||
145429224|NCT02314923|524429714|FG005|Overall Study|Screen failure|0|||
145429225|NCT02314923|524429715|FG006|Overall Study|Screen failure|1|||
145429226|NCT02314923|524429716|FG007|Overall Study|Screen failure|0|||
145429227|NCT02314923|524429717|FG008|Overall Study|Screen failure|0|||
145429228|NCT02314923|524429718|FG009|Overall Study|Screen failure|0|||
145429229|NCT02314923|524429709|FG000|Overall Study|Participant relocation|1|||
145429230|NCT02314923|524429710|FG001|Overall Study|Participant relocation|0|||
145429231|NCT02314923|524429711|FG002|Overall Study|Participant relocation|0|||
145429232|NCT02314923|524429712|FG003|Overall Study|Participant relocation|0|||
145429233|NCT02314923|524429713|FG004|Overall Study|Participant relocation|0|||
145429234|NCT02314923|524429714|FG005|Overall Study|Participant relocation|0|||
145429235|NCT02314923|524429715|FG006|Overall Study|Participant relocation|0|||
145429236|NCT02314923|524429716|FG007|Overall Study|Participant relocation|1|||
145429237|NCT02314923|524429717|FG008|Overall Study|Participant relocation|0|||
145429238|NCT02314923|524429718|FG009|Overall Study|Participant relocation|0|||
145429239|NCT06582732|524429719|FG000|Initial Study Period|Adverse Event|0|||
145429240|NCT06582732|524429720|FG001|Initial Study Period|Adverse Event|0|||
145429241|NCT06582732|524429721|FG002|Initial Study Period|Adverse Event|0|||
145429242|NCT06582732|524429722|FG003|Initial Study Period|Adverse Event|2|||
145429243|NCT06582732|524429723|FG004|Initial Study Period|Adverse Event|0|||
145429244|NCT06582732|524429724|FG005|Initial Study Period|Adverse Event|0|||
145429245|NCT06582732|524429725|FG006|Initial Study Period|Adverse Event|0|||
145429246|NCT06582732|524429719|FG000|Initial Study Period|Death|1|||
145429247|NCT06582732|524429720|FG001|Initial Study Period|Death|0|||
145429248|NCT06582732|524429721|FG002|Initial Study Period|Death|0|||
145429249|NCT06582732|524429722|FG003|Initial Study Period|Death|0|||
145429250|NCT06582732|524429723|FG004|Initial Study Period|Death|1|||
145429251|NCT06582732|524429724|FG005|Initial Study Period|Death|0|||
145429252|NCT06582732|524429725|FG006|Initial Study Period|Death|0|||
145429253|NCT06582732|524429719|FG000|Initial Study Period|Lost to Follow-up|0|||
145429254|NCT06582732|524429720|FG001|Initial Study Period|Lost to Follow-up|0|||
145429255|NCT06582732|524429721|FG002|Initial Study Period|Lost to Follow-up|2|||
145429256|NCT06582732|524429722|FG003|Initial Study Period|Lost to Follow-up|0|||
145429257|NCT06582732|524429723|FG004|Initial Study Period|Lost to Follow-up|0|||
145429258|NCT06582732|524429724|FG005|Initial Study Period|Lost to Follow-up|0|||
145429259|NCT06582732|524429725|FG006|Initial Study Period|Lost to Follow-up|0|||
145429260|NCT06582732|524429719|FG000|Initial Study Period|Withdrawal by Subject|0|||
145429261|NCT06582732|524429720|FG001|Initial Study Period|Withdrawal by Subject|1|||
145429262|NCT06582732|524429721|FG002|Initial Study Period|Withdrawal by Subject|0|||
145429263|NCT06582732|524429722|FG003|Initial Study Period|Withdrawal by Subject|1|||
145429264|NCT06582732|524429723|FG004|Initial Study Period|Withdrawal by Subject|3|||
145429265|NCT06582732|524429724|FG005|Initial Study Period|Withdrawal by Subject|1|||
145429266|NCT06582732|524429725|FG006|Initial Study Period|Withdrawal by Subject|2|||
145429267|NCT06582732|524429719|FG000|Initial Study Period|Moved Away|0|||
145429268|NCT06582732|524429720|FG001|Initial Study Period|Moved Away|0|||
145429269|NCT06582732|524429721|FG002|Initial Study Period|Moved Away|0|||
145429270|NCT06582732|524429722|FG003|Initial Study Period|Moved Away|0|||
145429271|NCT06582732|524429723|FG004|Initial Study Period|Moved Away|1|||
145429272|NCT06582732|524429724|FG005|Initial Study Period|Moved Away|0|||
145429273|NCT06582732|524429725|FG006|Initial Study Period|Moved Away|0|||
145429274|NCT05134649|524429728|FG000|Overall Study|Lost to Follow-up|12|||
145429275|NCT05134649|524429728|FG000|Overall Study|Withdrawal by Subject|14|||
145429276|NCT05134649|524429728|FG000|Overall Study|Pregnancy|1|||
145429277|NCT05134649|524429728|FG000|Overall Study|Other, not specified|3|||
145429278|NCT03232567|524429729|FG000|Overall Study|Withdrawal by Subject|0|||
145429279|NCT03232567|524429730|FG001|Overall Study|Withdrawal by Subject|1|||
145429280|NCT03232567|524429731|FG002|Overall Study|Withdrawal by Subject|0|||
145429281|NCT03232567|524429732|FG003|Overall Study|Withdrawal by Subject|0|||
145429282|NCT01153516|524429733|FG000|Overall Study|Both subjects refused surgery|2|||
145429283|NCT01153516|524429734|FG001|Overall Study|Both subjects refused surgery|0|||
145429284|NCT05837481|524429735|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
145429285|NCT05837481|524429736|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
145429286|NCT04581395|524429737|FG000|Overall Study|Protocol Violation|4|||
145429287|NCT04581395|524429738|FG001|Overall Study|Protocol Violation|3|||
145429288|NCT04581395|524429739|FG002|Overall Study|Protocol Violation|2|||
145429289|NCT04581395|524429737|FG000|Overall Study|Physician Decision|0|||
145429290|NCT04581395|524429738|FG001|Overall Study|Physician Decision|1|||
145429291|NCT04581395|524429739|FG002|Overall Study|Physician Decision|0|||
145429292|NCT04562090|524429747|FG000|Overall Study|Withdrawal by Subject|3|||
145429293|NCT04562090|524429748|FG001|Overall Study|Withdrawal by Subject|4|||
145429294|NCT04562090|524429747|FG000|Overall Study|Protocol Violation|2|||
145429295|NCT04562090|524429748|FG001|Overall Study|Protocol Violation|0|||
145429296|NCT04562090|524429747|FG000|Overall Study|Lack of Efficacy|0|||
145429297|NCT04562090|524429748|FG001|Overall Study|Lack of Efficacy|1|||
145429298|NCT04562090|524429747|FG000|Overall Study|Adverse Event|1|||
145429299|NCT04562090|524429748|FG001|Overall Study|Adverse Event|4|||
145429300|NCT04562090|524429747|FG000|Overall Study|Miscellaneous|0|||
145429301|NCT04562090|524429748|FG001|Overall Study|Miscellaneous|3|||
145429302|NCT00071032|524429750|FG000|Overall Study|Lost to Follow-up|1|||
145429303|NCT00071032|524429751|FG001|Overall Study|Lost to Follow-up|1|||
145429304|NCT00071032|524429750|FG000|Overall Study|Withdrawal by Subject|8|||
145429305|NCT00071032|524429751|FG001|Overall Study|Withdrawal by Subject|6|||
145429306|NCT00071032|524429750|FG000|Overall Study|Missing Primary Outcome|0|||
145429307|NCT00071032|524429751|FG001|Overall Study|Missing Primary Outcome|1|||
145429308|NCT05852470|524429752|FG000|Overall Study|Withdrawal by Subject|0|||
145429309|NCT05852470|524429753|FG001|Overall Study|Withdrawal by Subject|1|||
145429310|NCT06071104|524429754|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
145429311|NCT01903863|524429755|FG000|Overall Study|Physician Decision|2|||
145429312|NCT01903863|524429756|FG001|Overall Study|Physician Decision|0|||
145429313|NCT02420717|524429759|FG000|Overall Study|Did not receive all study medication|2|||
145429314|NCT02420717|524429760|FG001|Overall Study|Did not receive all study medication|0|||
145429315|NCT02420717|524429761|FG002|Overall Study|Did not receive all study medication|0|||
145429316|NCT03636022|524429762|FG000|Overall Study|Withdrawal by Subject|1|||
145429317|NCT03636022|524429763|FG001|Overall Study|Withdrawal by Subject|3|||
145429318|NCT01972659|524429773|FG000|Overall Study|Protocol Violation|2|||
145429319|NCT01972659|524429774|FG001|Overall Study|Protocol Violation|2|||
145581986|NCT01485861|524983234|FG002|Phase II|Withdrawal by Subject|6|||
145581987|NCT01485861|524983235|FG003|Phase II|Withdrawal by Subject|3|||
145581988|NCT01485861|524983236|FG004|Phase II|Withdrawal by Subject|4|||
145581989|NCT01485861|524983237|FG005|Phase II|Withdrawal by Subject|0|||
145429320|NCT01972659|524429773|FG000|Overall Study|problems realted to acceleromyograph|2|||
145429321|NCT01972659|524429774|FG001|Overall Study|problems realted to acceleromyograph|1|||
145429322|NCT02457793|524429777|FG000|Overall Study|Reason not specified|0|||
145429323|NCT02457793|524429778|FG001|Overall Study|Reason not specified|0|||
145429324|NCT02457793|524429779|FG002|Overall Study|Reason not specified|0|||
145429325|NCT02457793|524429780|FG003|Overall Study|Reason not specified|1|||
145429326|NCT02457793|524429781|FG004|Overall Study|Reason not specified|1|||
145429327|NCT02457793|524429782|FG005|Overall Study|Reason not specified|1|||
145429328|NCT02457793|524429777|FG000|Overall Study|Withdrawal by Subject|0|||
145429329|NCT02457793|524429778|FG001|Overall Study|Withdrawal by Subject|4|||
145429330|NCT02457793|524429779|FG002|Overall Study|Withdrawal by Subject|2|||
145429331|NCT02457793|524429780|FG003|Overall Study|Withdrawal by Subject|2|||
145429332|NCT02457793|524429781|FG004|Overall Study|Withdrawal by Subject|2|||
145429333|NCT02457793|524429782|FG005|Overall Study|Withdrawal by Subject|2|||
145429334|NCT02457793|524429777|FG000|Overall Study|Adverse Event|0|||
145429335|NCT02457793|524429778|FG001|Overall Study|Adverse Event|0|||
145429336|NCT02457793|524429779|FG002|Overall Study|Adverse Event|0|||
145429337|NCT02457793|524429780|FG003|Overall Study|Adverse Event|1|||
145429338|NCT02457793|524429781|FG004|Overall Study|Adverse Event|0|||
145429339|NCT02457793|524429782|FG005|Overall Study|Adverse Event|0|||
145429340|NCT02457793|524429777|FG000|Overall Study|Physician Decision|1|||
145429341|NCT02457793|524429778|FG001|Overall Study|Physician Decision|0|||
145429342|NCT02457793|524429779|FG002|Overall Study|Physician Decision|1|||
145429343|NCT02457793|524429780|FG003|Overall Study|Physician Decision|1|||
145429344|NCT02457793|524429781|FG004|Overall Study|Physician Decision|1|||
145429345|NCT02457793|524429782|FG005|Overall Study|Physician Decision|3|||
145429346|NCT03814044|524429787|FG000|Overall Study|Protocol deviation|1|||
145429347|NCT00835367|524429799|FG000|Washout|Adverse Event|2|||
145429348|NCT00835367|524429800|FG001|Washout|Adverse Event|0|||
145429349|NCT00835367|524429799|FG000|Washout|Withdrawal by Subject|1|||
145429350|NCT00835367|524429800|FG001|Washout|Withdrawal by Subject|0|||
145429351|NCT00835367|524429799|FG000|Second Intervention|Adverse Event|1|||
145429352|NCT00835367|524429800|FG001|Second Intervention|Adverse Event|1|||
145429353|NCT05929326|524429801|FG000|Overall Study|unqualified sample|2|||
145429354|NCT05929326|524429802|FG001|Overall Study|unqualified sample|3|||
145429355|NCT05929326|524429803|FG002|Overall Study|unqualified sample|7|||
145429356|NCT04890509|524429804|FG000|Overall Study|Death|4|||
145429357|NCT04890509|524429805|FG001|Overall Study|Death|4|||
145429358|NCT04569084|524429808|FG000|Overall Study|Adverse Event|10|||
145429359|NCT04569084|524429809|FG001|Overall Study|Adverse Event|14|||
145429360|NCT04569084|524429808|FG000|Overall Study|Death|2|||
145429361|NCT04569084|524429809|FG001|Overall Study|Death|3|||
145429362|NCT04569084|524429808|FG000|Overall Study|Lost to Follow-up|1|||
145429363|NCT04569084|524429809|FG001|Overall Study|Lost to Follow-up|1|||
145429364|NCT04569084|524429808|FG000|Overall Study|Physician Decision|3|||
145429365|NCT04569084|524429809|FG001|Overall Study|Physician Decision|3|||
145429366|NCT04569084|524429808|FG000|Overall Study|Protocol Violation|2|||
145429367|NCT04569084|524429809|FG001|Overall Study|Protocol Violation|1|||
145429368|NCT04569084|524429808|FG000|Overall Study|Withdrawal by Subject|20|||
145429369|NCT04569084|524429809|FG001|Overall Study|Withdrawal by Subject|21|||
145429370|NCT04569084|524429808|FG000|Overall Study|Study terminated by sponsor|26|||
145429371|NCT04569084|524429809|FG001|Overall Study|Study terminated by sponsor|23|||
145429372|NCT04569084|524429808|FG000|Overall Study|Other|3|||
145429373|NCT04569084|524429809|FG001|Overall Study|Other|5|||
145429374|NCT03759379|524431794|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
145429375|NCT03759379|524431795|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
145429376|NCT03759379|524431794|FG000|Treatment Period|Death|2|||
145429377|NCT03759379|524431795|FG001|Treatment Period|Death|3|||
145429378|NCT03759379|524431794|FG000|Treatment Period|Lost to Follow-up|1|||
145429379|NCT03759379|524431795|FG001|Treatment Period|Lost to Follow-up|0|||
145429380|NCT03759379|524431794|FG000|Treatment Period|Physician Decision|0|||
145429381|NCT03759379|524431795|FG001|Treatment Period|Physician Decision|1|||
145429382|NCT02333799|524431796|FG000|Treatment Period|Withdrawal by Subject|1|||
145429383|NCT02333799|524431796|FG000|Treatment Period|Death|6|||
145429384|NCT02333799|524431796|FG000|6 Month Follow Up Period|Physician Decision|1|||
145429385|NCT02333799|524431796|FG000|6 Month Follow Up Period|Death|1|||
145429386|NCT02333799|524431796|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
145429387|NCT02333799|524431796|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
145429388|NCT05484895|524431797|FG000|Overall Study|Lost to Follow-up|63|||
145429389|NCT05484895|524431798|FG001|Overall Study|Lost to Follow-up|64|||
145429390|NCT00876447|524431799|FG000|Overall Study|Other miscellaneous reasons|3|||
145581990|NCT01485861|524983232|FG000|Phase II|Lost to Follow-up|0|||
145429391|NCT00876447|524431800|FG001|Overall Study|Other miscellaneous reasons|8|||
145429392|NCT00876447|524431799|FG000|Overall Study|Site closure|19|||
145429393|NCT00876447|524431800|FG001|Overall Study|Site closure|14|||
145429394|NCT00876447|524431799|FG000|Overall Study|Protocol Violation|9|||
145429395|NCT00876447|524431800|FG001|Overall Study|Protocol Violation|3|||
145429396|NCT00876447|524431799|FG000|Overall Study|Personal reasons|30|||
145429397|NCT00876447|524431800|FG001|Overall Study|Personal reasons|28|||
145581991|NCT01485861|524983233|FG001|Phase II|Lost to Follow-up|0|||
145581992|NCT01485861|524983234|FG002|Phase II|Lost to Follow-up|2|||
145581993|NCT01485861|524983235|FG003|Phase II|Lost to Follow-up|3|||
145429398|NCT00876447|524431799|FG000|Overall Study|Lost to Follow-up|6|||
145429399|NCT00876447|524431800|FG001|Overall Study|Lost to Follow-up|15|||
145429400|NCT00876447|524431799|FG000|Overall Study|Pregnancy|4|||
145429401|NCT00876447|524431800|FG001|Overall Study|Pregnancy|2|||
145429402|NCT00876447|524431799|FG000|Overall Study|Lack of Efficacy|5|||
145429403|NCT00876447|524431800|FG001|Overall Study|Lack of Efficacy|3|||
145429404|NCT00876447|524431799|FG000|Overall Study|Adverse Event|4|||
145429405|NCT00876447|524431800|FG001|Overall Study|Adverse Event|8|||
145429406|NCT04507204|524431806|FG000|Overall Study|Adverse Event|8|||
145429407|NCT04507204|524431807|FG001|Overall Study|Adverse Event|13|||
145429408|NCT04507204|524431806|FG000|Overall Study|Death|0|||
145429409|NCT04507204|524431807|FG001|Overall Study|Death|1|||
145429410|NCT04507204|524431806|FG000|Overall Study|Lost to Follow-up|15|||
145429411|NCT04507204|524431807|FG001|Overall Study|Lost to Follow-up|14|||
145429412|NCT04507204|524431806|FG000|Overall Study|Poor Compliance with Protocol|2|||
145429413|NCT04507204|524431807|FG001|Overall Study|Poor Compliance with Protocol|4|||
145429414|NCT04507204|524431806|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
145429415|NCT04507204|524431807|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
145429416|NCT04507204|524431806|FG000|Overall Study|Withdrawal of Patient Consent|21|||
145429417|NCT04507204|524431807|FG001|Overall Study|Withdrawal of Patient Consent|13|||
145429418|NCT01822925|524431812|FG000|Overall Study|Adverse Event|1|||
145429419|NCT01822925|524431813|FG001|Overall Study|Adverse Event|1|||
145429420|NCT01822925|524431814|FG002|Overall Study|Adverse Event|1|||
145429421|NCT01822925|524431815|FG003|Overall Study|Adverse Event|1|||
145429422|NCT01822925|524431812|FG000|Overall Study|Lost to Follow-up|0|||
145429423|NCT01822925|524431813|FG001|Overall Study|Lost to Follow-up|1|||
145429424|NCT01822925|524431814|FG002|Overall Study|Lost to Follow-up|0|||
145429425|NCT01822925|524431815|FG003|Overall Study|Lost to Follow-up|0|||
145429426|NCT01822925|524431812|FG000|Overall Study|Protocol Violation|1|||
145429427|NCT01822925|524431813|FG001|Overall Study|Protocol Violation|0|||
145429428|NCT01822925|524431814|FG002|Overall Study|Protocol Violation|0|||
145429429|NCT01822925|524431815|FG003|Overall Study|Protocol Violation|1|||
145429430|NCT01822925|524431812|FG000|Overall Study|Withdrawal by Subject|2|||
145429431|NCT01822925|524431813|FG001|Overall Study|Withdrawal by Subject|0|||
145429432|NCT01822925|524431814|FG002|Overall Study|Withdrawal by Subject|2|||
145429433|NCT01822925|524431815|FG003|Overall Study|Withdrawal by Subject|2|||
145429434|NCT01822925|524431812|FG000|Overall Study|Taking prohibited medication|2|||
145429435|NCT01822925|524431813|FG001|Overall Study|Taking prohibited medication|0|||
145429436|NCT01822925|524431814|FG002|Overall Study|Taking prohibited medication|0|||
145429437|NCT01822925|524431815|FG003|Overall Study|Taking prohibited medication|1|||
145429438|NCT00904371|524431819|FG000|Overall Study|Adverse Event|2|||
145429439|NCT00904371|524431819|FG000|Overall Study|Lost to Follow-up|4|||
145429440|NCT00904371|524431819|FG000|Overall Study|Discontinued at target blood pressure|2|||
145429441|NCT00904371|524431819|FG000|Overall Study|Continued with Tritace|1|||
145429442|NCT02300233|524431831|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
145429443|NCT02300233|524431832|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
145429444|NCT02300233|524431833|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
145429445|NCT02300233|524431831|FG000|Overall Study|Withdrawal by Subject|1|||
145429446|NCT02300233|524431832|FG001|Overall Study|Withdrawal by Subject|0|||
145429447|NCT02300233|524431833|FG002|Overall Study|Withdrawal by Subject|3|||
145429448|NCT02300233|524431831|FG000|Overall Study|Investigator Judgement|0|||
145429449|NCT02300233|524431832|FG001|Overall Study|Investigator Judgement|0|||
145429450|NCT02300233|524431833|FG002|Overall Study|Investigator Judgement|1|||
145429451|NCT02300233|524431831|FG000|Overall Study|Reason Not Specified|0|||
145429452|NCT02300233|524431832|FG001|Overall Study|Reason Not Specified|0|||
145429453|NCT02300233|524431833|FG002|Overall Study|Reason Not Specified|5|||
145429454|NCT03331354|524431834|FG000|Overall Study|Withdrawal by Subject|1|||
145429455|NCT03331354|524431835|FG001|Overall Study|Withdrawal by Subject|3|||
145429456|NCT03331354|524431834|FG000|Overall Study|Lost to Follow-up|3|||
145429457|NCT03331354|524431835|FG001|Overall Study|Lost to Follow-up|3|||
145429458|NCT03331354|524431834|FG000|Overall Study|Found employment before initiated active intervention|0|||
145429459|NCT03331354|524431835|FG001|Overall Study|Found employment before initiated active intervention|4|||
145429460|NCT00928668|524431836|FG000|Overall Study|Adverse Event|1|||
145429461|NCT00928668|524431837|FG001|Overall Study|Adverse Event|0|||
145429462|NCT00928668|524431838|FG002|Overall Study|Adverse Event|0|||
145429463|NCT00928668|524431839|FG003|Overall Study|Adverse Event|0|||
145429464|NCT00928668|524431840|FG004|Overall Study|Adverse Event|0|||
145429465|NCT00928668|524431836|FG000|Overall Study|Protocol Violation|0|||
145429466|NCT00928668|524431837|FG001|Overall Study|Protocol Violation|0|||
145429467|NCT00928668|524431838|FG002|Overall Study|Protocol Violation|0|||
145429468|NCT00928668|524431839|FG003|Overall Study|Protocol Violation|0|||
145429469|NCT00928668|524431840|FG004|Overall Study|Protocol Violation|1|||
145429470|NCT00928668|524431836|FG000|Overall Study|Withdrawal by Subject|0|||
145429471|NCT00928668|524431837|FG001|Overall Study|Withdrawal by Subject|1|||
145429472|NCT00928668|524431838|FG002|Overall Study|Withdrawal by Subject|1|||
145429473|NCT00928668|524431839|FG003|Overall Study|Withdrawal by Subject|0|||
145429474|NCT00928668|524431840|FG004|Overall Study|Withdrawal by Subject|0|||
145429475|NCT00928668|524431836|FG000|Overall Study|Other reasons not listed above|0|||
145429476|NCT00928668|524431837|FG001|Overall Study|Other reasons not listed above|0|||
145429477|NCT00928668|524431838|FG002|Overall Study|Other reasons not listed above|0|||
145429478|NCT00928668|524431839|FG003|Overall Study|Other reasons not listed above|1|||
145429479|NCT00928668|524431840|FG004|Overall Study|Other reasons not listed above|0|||
145429480|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429481|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
145429482|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145581994|NCT01485861|524983236|FG004|Phase II|Lost to Follow-up|5|||
145429483|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
145429484|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
145429485|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
145429486|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
145429487|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429488|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429489|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429490|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429491|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429492|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429493|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429494|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429495|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
145429496|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
145429497|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
145429498|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
145429499|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
145429500|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
145429501|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
145429502|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
145429503|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
145429504|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
145429505|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
145429506|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
145429507|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
145429508|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
145429509|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
145429510|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
145429511|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
145429512|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
145429513|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
145429514|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429515|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429516|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429517|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429518|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429519|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429520|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429521|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429522|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429523|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429524|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429525|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429526|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429527|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
145429528|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
145429529|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429530|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
145429531|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145429532|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145429533|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145429534|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
145429535|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429536|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429537|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429538|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429539|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429540|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429541|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429542|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429543|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145429544|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429545|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429546|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429547|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
145429548|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429549|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145581995|NCT01485861|524983237|FG005|Phase II|Lost to Follow-up|0|||
145581996|NCT01485861|524983232|FG000|Phase II|Study Ended|0|||
145581997|NCT01485861|524983233|FG001|Phase II|Study Ended|0|||
145581998|NCT01485861|524983234|FG002|Phase II|Study Ended|7|||
145581999|NCT01485861|524983235|FG003|Phase II|Study Ended|8|||
145582000|NCT01485861|524983236|FG004|Phase II|Study Ended|6|||
145582001|NCT01485861|524983237|FG005|Phase II|Study Ended|0|||
145582002|NCT01485861|524983232|FG000|Safety Phase|Death|0|||
145582003|NCT01485861|524983233|FG001|Safety Phase|Death|0|||
145582004|NCT01485861|524983234|FG002|Safety Phase|Death|0|||
145582005|NCT01485861|524983235|FG003|Safety Phase|Death|0|||
145582006|NCT01485861|524983236|FG004|Safety Phase|Death|0|||
145582007|NCT01485861|524983237|FG005|Safety Phase|Death|2|||
145582008|NCT01485861|524983232|FG000|Safety Phase|Adverse Event|0|||
145582009|NCT01485861|524983233|FG001|Safety Phase|Adverse Event|0|||
145582010|NCT01485861|524983234|FG002|Safety Phase|Adverse Event|0|||
145582011|NCT01485861|524983235|FG003|Safety Phase|Adverse Event|0|||
145582012|NCT01485861|524983236|FG004|Safety Phase|Adverse Event|0|||
145582013|NCT01485861|524983237|FG005|Safety Phase|Adverse Event|1|||
145582014|NCT01485861|524983232|FG000|Safety Phase|Other|0|||
145582015|NCT01485861|524983233|FG001|Safety Phase|Other|0|||
145582016|NCT01485861|524983234|FG002|Safety Phase|Other|0|||
145582017|NCT01485861|524983235|FG003|Safety Phase|Other|0|||
145582018|NCT01485861|524983236|FG004|Safety Phase|Other|0|||
145582019|NCT01485861|524983237|FG005|Safety Phase|Other|5|||
145582020|NCT01485861|524983232|FG000|Safety Phase|Progression of Disease|0|||
145582021|NCT01485861|524983233|FG001|Safety Phase|Progression of Disease|0|||
145582022|NCT01485861|524983234|FG002|Safety Phase|Progression of Disease|0|||
145582023|NCT01485861|524983235|FG003|Safety Phase|Progression of Disease|0|||
145582024|NCT01485861|524983236|FG004|Safety Phase|Progression of Disease|0|||
145582025|NCT01485861|524983237|FG005|Safety Phase|Progression of Disease|9|||
145582026|NCT01485861|524983232|FG000|Safety Phase|Withdrawal by Subject|0|||
145582027|NCT01485861|524983233|FG001|Safety Phase|Withdrawal by Subject|0|||
145582028|NCT01485861|524983234|FG002|Safety Phase|Withdrawal by Subject|0|||
145582029|NCT01485861|524983235|FG003|Safety Phase|Withdrawal by Subject|0|||
145582030|NCT01485861|524983236|FG004|Safety Phase|Withdrawal by Subject|0|||
145582031|NCT01485861|524983237|FG005|Safety Phase|Withdrawal by Subject|6|||
145582032|NCT01485861|524983232|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
145582033|NCT01485861|524983233|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
145582034|NCT01485861|524983234|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
145582035|NCT01485861|524983235|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
145582036|NCT01485861|524983236|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
145582037|NCT01485861|524983237|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
145582038|NCT01260922|524983238|FG000|First Intervention|Withdrawal by Subject|0|||
145582039|NCT01260922|524983239|FG001|First Intervention|Withdrawal by Subject|1|||
145582040|NCT01260922|524983238|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
145582041|NCT01260922|524983239|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
145582042|NCT01260922|524983238|FG000|Second Intervention|Emesis|0|||
145582043|NCT01260922|524983239|FG001|Second Intervention|Emesis|2|||
145582044|NCT05061446|524983242|FG000|Overall Study|Adverse Event|2|||
145582045|NCT05061446|524983243|FG001|Overall Study|Adverse Event|0|||
145582046|NCT05061446|524983244|FG002|Overall Study|Adverse Event|0|||
145582047|NCT05061446|524983242|FG000|Overall Study|Participant no longer available due to personal reason|0|||
145582048|NCT05061446|524983243|FG001|Overall Study|Participant no longer available due to personal reason|1|||
145429550|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
145429551|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429552|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429553|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429554|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429555|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429556|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429557|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429558|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429559|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
145429560|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429561|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145582049|NCT05061446|524983244|FG002|Overall Study|Participant no longer available due to personal reason|0|||
145582050|NCT05857527|524983247|FG000|Overall Study|Withdrawal by Subject|0|||
145582051|NCT05857527|524983248|FG001|Overall Study|Withdrawal by Subject|1|||
145582052|NCT02543346|524983249|FG000|Second Priming Visit|Withdrawal by Subject|0|||
145582053|NCT02543346|524983250|FG001|Second Priming Visit|Withdrawal by Subject|2|||
145582054|NCT02543346|524983251|FG002|Second Priming Visit|Withdrawal by Subject|2|||
145582055|NCT02543346|524983252|FG003|Second Priming Visit|Withdrawal by Subject|2|||
145582056|NCT02543346|524983249|FG000|Second Priming Visit|Adverse Event|1|||
145429562|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
145429563|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429564|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429565|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429566|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429567|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429568|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429569|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429570|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429571|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429572|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429573|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429574|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429575|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
145429576|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145429577|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145429578|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145429579|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429580|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429581|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429582|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429583|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429584|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429585|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429586|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429587|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429588|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429589|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429590|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429591|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145429592|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
145429593|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
145429594|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
145429595|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
145429596|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
145429597|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
145429598|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
145429599|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
145429600|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
145429601|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
145429602|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
145429603|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
145429604|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
145429605|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
145429606|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
145429607|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
145429608|NCT02958865|524431842|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429609|NCT02958865|524431843|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429610|NCT02958865|524431844|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429611|NCT02958865|524431845|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429612|NCT02958865|524431846|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
145429613|NCT02958865|524431847|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429614|NCT02958865|524431848|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429615|NCT02958865|524431849|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429616|NCT02958865|524431850|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429617|NCT02958865|524431851|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429618|NCT02958865|524431852|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429619|NCT02958865|524431853|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429620|NCT02958865|524431854|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429621|NCT02958865|524431855|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429622|NCT02958865|524431856|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429623|NCT02958865|524431857|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145429624|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429625|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429626|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429627|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429628|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429629|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429630|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429631|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145429632|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145429633|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
145429634|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
145429635|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145429636|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
145429637|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145429638|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
145429639|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
145429640|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429641|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429642|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429643|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429644|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429645|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429646|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429647|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429648|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
145429649|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
145429650|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429651|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
145429652|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429653|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
145429654|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
145429655|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
145429656|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429657|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429658|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429659|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429660|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429661|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429662|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429663|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429664|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429665|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
145429666|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429667|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429668|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429669|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429670|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
145429671|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
145429672|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429673|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429674|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429675|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429676|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429677|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429678|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429679|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429680|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429681|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429682|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
145429683|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
145429684|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
145429685|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
145429686|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
145429687|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
145429688|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
145429689|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
145429690|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
145429691|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
145429692|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
145429693|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
145429694|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
145429695|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
145429696|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
145429697|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
145429698|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
145429699|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
145429700|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
145429701|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
145429702|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
145429703|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
145429704|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429705|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429706|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429707|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429708|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429709|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429710|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429711|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429712|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429713|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429714|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429715|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429716|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429717|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
145429718|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429719|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
145429720|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429721|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429722|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429723|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429724|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429725|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429726|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429727|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429728|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429729|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429730|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429731|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429732|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429733|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
145429734|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429735|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
145429736|NCT02958865|524431842|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429737|NCT02958865|524431843|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429738|NCT02958865|524431844|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429739|NCT02958865|524431845|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429740|NCT02958865|524431846|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429741|NCT02958865|524431847|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429742|NCT02958865|524431848|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429743|NCT02958865|524431849|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429744|NCT02958865|524431850|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429745|NCT02958865|524431851|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
145429746|NCT02958865|524431852|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429747|NCT02958865|524431853|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429748|NCT02958865|524431854|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429749|NCT02958865|524431855|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429750|NCT02958865|524431856|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429751|NCT02958865|524431857|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
145429752|NCT01767987|524431858|FG000|Overall Study|Physician Decision|4|||
145429753|NCT01767987|524431859|FG001|Overall Study|Physician Decision|1|||
145429754|NCT01983111|524431864|FG000|Overall Study|Withdrawal by Subject|8|||
145429755|NCT01983111|524431865|FG001|Overall Study|Withdrawal by Subject|6|||
145429756|NCT01983111|524431864|FG000|Overall Study|Adverse Event|4|||
145429757|NCT01983111|524431865|FG001|Overall Study|Adverse Event|0|||
145429758|NCT01983111|524431864|FG000|Overall Study|Protocol Violation|0|||
145429759|NCT01983111|524431865|FG001|Overall Study|Protocol Violation|1|||
145429760|NCT00855335|524431866|FG000|Overall Study|Lost to Follow-up|0|||
145429761|NCT00855335|524431867|FG001|Overall Study|Lost to Follow-up|0|||
145429762|NCT00855335|524431868|FG002|Overall Study|Lost to Follow-up|3|||
145429763|NCT00855335|524431869|FG003|Overall Study|Lost to Follow-up|1|||
145429764|NCT00855335|524431870|FG004|Overall Study|Lost to Follow-up|0|||
145429765|NCT00855335|524431866|FG000|Overall Study|Withdrawal by Subject|0|||
145429766|NCT00855335|524431867|FG001|Overall Study|Withdrawal by Subject|0|||
145429767|NCT00855335|524431868|FG002|Overall Study|Withdrawal by Subject|0|||
145429768|NCT00855335|524431869|FG003|Overall Study|Withdrawal by Subject|1|||
145429769|NCT00855335|524431870|FG004|Overall Study|Withdrawal by Subject|0|||
145429770|NCT00855335|524431866|FG000|Overall Study|Adverse Event|2|||
145429771|NCT00855335|524431867|FG001|Overall Study|Adverse Event|0|||
145429772|NCT00855335|524431868|FG002|Overall Study|Adverse Event|0|||
145429773|NCT00855335|524431869|FG003|Overall Study|Adverse Event|0|||
145429774|NCT00855335|524431870|FG004|Overall Study|Adverse Event|0|||
145429775|NCT00855335|524431866|FG000|Overall Study|Physician Decision|1|||
145429776|NCT00855335|524431867|FG001|Overall Study|Physician Decision|1|||
145429777|NCT00855335|524431868|FG002|Overall Study|Physician Decision|0|||
145429778|NCT00855335|524431869|FG003|Overall Study|Physician Decision|0|||
145429779|NCT00855335|524431870|FG004|Overall Study|Physician Decision|0|||
145429780|NCT00855335|524431866|FG000|Overall Study|Other|2|||
145429781|NCT00855335|524431867|FG001|Overall Study|Other|1|||
145429782|NCT00855335|524431868|FG002|Overall Study|Other|2|||
145429783|NCT00855335|524431869|FG003|Overall Study|Other|5|||
145429784|NCT00855335|524431870|FG004|Overall Study|Other|1|||
145429785|NCT02526290|524431871|FG000|Overall Study|Adverse Event|3|||
145429786|NCT02526290|524431871|FG000|Overall Study|Withdrawal by Subject|4|||
145429787|NCT02526290|524431871|FG000|Overall Study|Physician Decision|1|||
145429788|NCT02082977|524431872|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
145429789|NCT02082977|524431873|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
145429790|NCT02082977|524431874|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
145429791|NCT02082977|524431875|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
145429792|NCT02082977|524431876|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
145429793|NCT02082977|524431877|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
145429794|NCT02082977|524431878|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
145429795|NCT02082977|524431879|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
145429796|NCT02082977|524431880|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
145429797|NCT02082977|524431881|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
145429798|NCT02082977|524431872|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429799|NCT02082977|524431873|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429800|NCT02082977|524431874|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429801|NCT02082977|524431875|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429802|NCT02082977|524431876|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429803|NCT02082977|524431877|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429804|NCT02082977|524431878|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429805|NCT02082977|524431879|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
145429806|NCT02082977|524431880|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429807|NCT02082977|524431881|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
145429808|NCT02082977|524431872|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429809|NCT02082977|524431873|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429810|NCT02082977|524431874|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429811|NCT02082977|524431875|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429812|NCT02082977|524431876|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429813|NCT02082977|524431877|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
145429814|NCT02082977|524431878|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429815|NCT02082977|524431879|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429816|NCT02082977|524431880|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429817|NCT02082977|524431881|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
145429818|NCT02082977|524431872|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145429819|NCT02082977|524431873|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145429820|NCT02082977|524431874|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145429821|NCT02082977|524431875|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145429822|NCT02082977|524431876|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145429823|NCT02082977|524431877|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145429824|NCT02082977|524431878|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
145429825|NCT02082977|524431879|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
145429826|NCT02082977|524431880|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
145429827|NCT02082977|524431881|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
145429828|NCT02082977|524431872|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429829|NCT02082977|524431873|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429830|NCT02082977|524431874|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429831|NCT02082977|524431875|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429832|NCT02082977|524431876|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429833|NCT02082977|524431877|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429834|NCT02082977|524431878|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429835|NCT02082977|524431879|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
145429836|NCT02082977|524431880|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429837|NCT02082977|524431881|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
145429838|NCT00049543|524431885|FG000|Overall Study|still on treatment|2|||
145429839|NCT00049543|524431886|FG001|Overall Study|still on treatment|9|||
145429840|NCT00105066|524431887|FG000|Overall Study|Adverse Event|2|||
145429841|NCT00105066|524431888|FG001|Overall Study|Adverse Event|5|||
145429842|NCT00787150|524431889|FG000|Overall Study|Adverse Event|4|||
145429843|NCT00787150|524431890|FG001|Overall Study|Adverse Event|4|||
145429844|NCT00787150|524431891|FG002|Overall Study|Adverse Event|4|||
145429845|NCT00787150|524431889|FG000|Overall Study|Physician Decision|1|||
145582057|NCT02543346|524983250|FG001|Second Priming Visit|Adverse Event|0|||
145429846|NCT00787150|524431890|FG001|Overall Study|Physician Decision|2|||
145429847|NCT00787150|524431891|FG002|Overall Study|Physician Decision|1|||
145429848|NCT00787150|524431889|FG000|Overall Study|Withdrawal by Subject|2|||
145429849|NCT00787150|524431890|FG001|Overall Study|Withdrawal by Subject|1|||
145429850|NCT00787150|524431891|FG002|Overall Study|Withdrawal by Subject|0|||
145429851|NCT00787150|524431889|FG000|Overall Study|Dosing incorrect study durg|2|||
145429852|NCT00787150|524431890|FG001|Overall Study|Dosing incorrect study durg|0|||
145429853|NCT00787150|524431891|FG002|Overall Study|Dosing incorrect study durg|0|||
145429854|NCT04079738|524431898|FG000|Study Treatment|Death|1|||
145429855|NCT04079738|524431899|FG001|Study Treatment|Death|0|||
145429856|NCT04079738|524431900|FG002|Study Treatment|Death|0|||
145429857|NCT04079738|524431901|FG003|Study Treatment|Death|0|||
145429858|NCT04079738|524431898|FG000|Study Treatment|Adverse Event|2|||
145429859|NCT04079738|524431899|FG001|Study Treatment|Adverse Event|0|||
145429860|NCT04079738|524431900|FG002|Study Treatment|Adverse Event|0|||
145429861|NCT04079738|524431901|FG003|Study Treatment|Adverse Event|0|||
145429862|NCT04079738|524431898|FG000|Study Treatment|withdrawal before treatment|1|||
145429863|NCT04079738|524431899|FG001|Study Treatment|withdrawal before treatment|0|||
145429864|NCT04079738|524431900|FG002|Study Treatment|withdrawal before treatment|0|||
145429865|NCT04079738|524431901|FG003|Study Treatment|withdrawal before treatment|0|||
145429866|NCT04079738|524431898|FG000|Study Treatment|symptomatic deterioration|2|||
145429867|NCT04079738|524431899|FG001|Study Treatment|symptomatic deterioration|0|||
145429868|NCT04079738|524431900|FG002|Study Treatment|symptomatic deterioration|0|||
145429869|NCT04079738|524431901|FG003|Study Treatment|symptomatic deterioration|0|||
145429870|NCT04079738|524431898|FG000|Study Treatment|Disease Progression|1|||
145429871|NCT04079738|524431899|FG001|Study Treatment|Disease Progression|0|||
145429872|NCT04079738|524431900|FG002|Study Treatment|Disease Progression|0|||
145429873|NCT04079738|524431901|FG003|Study Treatment|Disease Progression|0|||
145429874|NCT04079738|524431898|FG000|Study Treatment|withdrawal after treatment|1|||
145429875|NCT04079738|524431899|FG001|Study Treatment|withdrawal after treatment|0|||
145429876|NCT04079738|524431900|FG002|Study Treatment|withdrawal after treatment|0|||
145429877|NCT04079738|524431901|FG003|Study Treatment|withdrawal after treatment|0|||
145429878|NCT04079738|524431898|FG000|Follow up|Withdrawal by Subject|3|||
145429879|NCT04079738|524431899|FG001|Follow up|Withdrawal by Subject|0|||
145429880|NCT04079738|524431900|FG002|Follow up|Withdrawal by Subject|0|||
145429881|NCT04079738|524431901|FG003|Follow up|Withdrawal by Subject|0|||
145429882|NCT04079738|524431898|FG000|Follow up|Death|5|||
145429883|NCT04079738|524431899|FG001|Follow up|Death|0|||
145429884|NCT04079738|524431900|FG002|Follow up|Death|0|||
145429885|NCT04079738|524431901|FG003|Follow up|Death|0|||
145429886|NCT03448393|524431904|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429887|NCT03448393|524431905|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429888|NCT03448393|524431906|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
145429889|NCT03448393|524431907|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429890|NCT03448393|524431908|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429891|NCT03448393|524431909|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429892|NCT03448393|524431910|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145429893|NCT03448393|524431911|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
145582058|NCT02543346|524983251|FG002|Second Priming Visit|Adverse Event|0|||
145582059|NCT02543346|524983252|FG003|Second Priming Visit|Adverse Event|0|||
145582060|NCT01748994|524983253|FG000|Overall Study|Lost to Follow-up|8|||
145582061|NCT01748994|524983254|FG001|Overall Study|Lost to Follow-up|6|||
145582062|NCT02141516|524983255|FG000|Overall Study|Adverse Event|0|||
145582063|NCT02141516|524983256|FG001|Overall Study|Adverse Event|1|||
145582064|NCT02141516|524983257|FG002|Overall Study|Adverse Event|0|||
145582065|NCT02141516|524983255|FG000|Overall Study|Lost to Follow-up|0|||
145582066|NCT02141516|524983256|FG001|Overall Study|Lost to Follow-up|1|||
145582067|NCT02141516|524983257|FG002|Overall Study|Lost to Follow-up|0|||
145582068|NCT02141516|524983255|FG000|Overall Study|Other|0|||
145582069|NCT02141516|524983256|FG001|Overall Study|Other|3|||
145429894|NCT03448393|524431912|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
145429895|NCT03448393|524431904|FG000|Dose Expansion|Not treated - screen failure|0|||
145429896|NCT03448393|524431905|FG001|Dose Expansion|Not treated - screen failure|0|||
145429897|NCT03448393|524431906|FG002|Dose Expansion|Not treated - screen failure|0|||
145582070|NCT02141516|524983257|FG002|Overall Study|Other|0|||
145582071|NCT03251924|524983258|FG000|Overall Study|Disease Progression|6|||
145429898|NCT03448393|524431907|FG003|Dose Expansion|Not treated - screen failure|0|||
145429899|NCT03448393|524431908|FG004|Dose Expansion|Not treated - screen failure|0|||
145429900|NCT03448393|524431909|FG005|Dose Expansion|Not treated - screen failure|0|||
145429901|NCT03448393|524431910|FG006|Dose Expansion|Not treated - screen failure|0|||
145429902|NCT03448393|524431911|FG007|Dose Expansion|Not treated - screen failure|0|||
145429903|NCT03448393|524431912|FG008|Dose Expansion|Not treated - screen failure|7|||
145429904|NCT01587196|524431913|FG000|Overall Study|Lost to Follow-up|50|||
145429905|NCT01587196|524431913|FG000|Overall Study|Withdrawal by Subject|4|||
145429906|NCT00642759|524431914|FG000|Overall Study|Protocol Violation|1|||
145429907|NCT00643279|524431919|FG000|Overall Study|Death|13|||
145429908|NCT00643279|524431920|FG001|Overall Study|Death|11|||
145429909|NCT00643279|524431919|FG000|Overall Study|Withdrawal by Subject|3|||
145429910|NCT00643279|524431920|FG001|Overall Study|Withdrawal by Subject|0|||
145429911|NCT00643279|524431919|FG000|Overall Study|Lost to Follow-up|0|||
145429912|NCT00643279|524431920|FG001|Overall Study|Lost to Follow-up|1|||
145429913|NCT00643279|524431919|FG000|Overall Study|Physician Decision|0|||
145429914|NCT00643279|524431920|FG001|Overall Study|Physician Decision|1|||
145429915|NCT03612570|524431921|FG000|Overall Study|Lost to Follow-up|1|||
145429916|NCT05185453|524431924|FG000|Overall Study|Lost to Follow-up|13|||
145429917|NCT05185453|524431925|FG001|Overall Study|Lost to Follow-up|3|||
145429918|NCT03537508|524431926|FG000|Overall Study|Adverse Event|2|||
145429919|NCT03537508|524431927|FG001|Overall Study|Adverse Event|1|||
145429920|NCT03537508|524431926|FG000|Overall Study|Protocol Violation|65|||
145429921|NCT03537508|524431927|FG001|Overall Study|Protocol Violation|48|||
145429922|NCT03537508|524431926|FG000|Overall Study|Lost to Follow-up|86|||
145429923|NCT03537508|524431927|FG001|Overall Study|Lost to Follow-up|60|||
145429924|NCT03537508|524431926|FG000|Overall Study|Withdrawal by parent/guardian|263|||
145429925|NCT03537508|524431927|FG001|Overall Study|Withdrawal by parent/guardian|149|||
145429926|NCT03274466|524431948|FG000|Overall Study|Withdrawal by Subject|7|||
145429927|NCT03274466|524431949|FG001|Overall Study|Withdrawal by Subject|3|||
145429928|NCT03274466|524431948|FG000|Overall Study|Protocol Specified Withdrawal|5|||
145429929|NCT03274466|524431949|FG001|Overall Study|Protocol Specified Withdrawal|11|||
145429930|NCT03274466|524431948|FG000|Overall Study|Lost to Follow-up|5|||
145429931|NCT03274466|524431949|FG001|Overall Study|Lost to Follow-up|7|||
145429932|NCT03274466|524431948|FG000|Overall Study|Subject Non-compliance|0|||
145429933|NCT03274466|524431949|FG001|Overall Study|Subject Non-compliance|1|||
145429934|NCT03274466|524431948|FG000|Overall Study|Adverse Event|3|||
145429935|NCT03274466|524431949|FG001|Overall Study|Adverse Event|3|||
145429936|NCT03274466|524431948|FG000|Overall Study|Physician Decision|0|||
145429937|NCT03274466|524431949|FG001|Overall Study|Physician Decision|1|||
145429938|NCT03274466|524431948|FG000|Overall Study|Protocol Violation|3|||
145429939|NCT03274466|524431949|FG001|Overall Study|Protocol Violation|3|||
145429940|NCT06022107|524431953|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
145429941|NCT06022107|524431953|FG000|Overall Study|Dropped out of study for higher level of care|1|||
145429942|NCT06022107|524431953|FG000|Overall Study|Lost to Follow-up|2|||
145429943|NCT04795531|524433986|FG000|Overall Study|Withdrawal by Subject|4|||
145429944|NCT04795531|524433987|FG001|Overall Study|Withdrawal by Subject|4|||
145429945|NCT04795531|524433986|FG000|Overall Study|Lost to Follow-up|0|||
145429946|NCT04795531|524433987|FG001|Overall Study|Lost to Follow-up|1|||
145429947|NCT04795531|524433986|FG000|Overall Study|Physician Decision|0|||
145429948|NCT04795531|524433987|FG001|Overall Study|Physician Decision|2|||
145429949|NCT04795531|524433986|FG000|Overall Study|Death|2|||
145429950|NCT04795531|524433987|FG001|Overall Study|Death|1|||
145429951|NCT04887831|524433988|FG000|Overall Study|Death|26|||
145429952|NCT04887831|524433989|FG001|Overall Study|Death|26|||
145429953|NCT04887831|524433988|FG000|Overall Study|Lost to Follow-up|0|||
145429954|NCT04887831|524433989|FG001|Overall Study|Lost to Follow-up|1|||
145429955|NCT04887831|524433988|FG000|Overall Study|Withdrawal by Subject|2|||
145429956|NCT04887831|524433989|FG001|Overall Study|Withdrawal by Subject|1|||
145429957|NCT04887831|524433988|FG000|Overall Study|Study Terminated by Sponsor|18|||
145429958|NCT04887831|524433989|FG001|Overall Study|Study Terminated by Sponsor|17|||
145429959|NCT04887831|524433988|FG000|Overall Study|Other|1|||
145429960|NCT04887831|524433989|FG001|Overall Study|Other|0|||
145429961|NCT03396445|524433990|FG000|Treatment Period|Death|2|||
145429962|NCT03396445|524433991|FG001|Treatment Period|Death|2|||
145429963|NCT03396445|524433992|FG002|Treatment Period|Death|1|||
145429964|NCT03396445|524433993|FG003|Treatment Period|Death|1|||
145429965|NCT03396445|524433994|FG004|Treatment Period|Death|3|||
145429966|NCT03396445|524433995|FG005|Treatment Period|Death|2|||
145429967|NCT03396445|524433996|FG006|Treatment Period|Death|5|||
145429968|NCT03396445|524433997|FG007|Treatment Period|Death|3|||
145429969|NCT03396445|524433998|FG008|Treatment Period|Death|3|||
145429970|NCT03396445|524433999|FG009|Treatment Period|Death|3|||
145429971|NCT03396445|524434000|FG010|Treatment Period|Death|7|||
145429972|NCT03396445|524434001|FG011|Treatment Period|Death|12|||
145429973|NCT03396445|524434002|FG012|Treatment Period|Death|28|||
145429974|NCT03396445|524434003|FG013|Treatment Period|Death|14|||
145429975|NCT03396445|524434004|FG014|Treatment Period|Death|10|||
145429976|NCT03396445|524434005|FG015|Treatment Period|Death|8|||
145429977|NCT03396445|524434006|FG016|Treatment Period|Death|18|||
145429978|NCT03396445|524434007|FG017|Treatment Period|Death|0|||
145429979|NCT03396445|524434008|FG018|Treatment Period|Death|0|||
145623927|NCT00410384|525135639|FG002|Overall Study|Withdrawal by Subject|20|||
145429980|NCT03396445|524434009|FG019|Treatment Period|Death|0|||
145429981|NCT03396445|524434010|FG020|Treatment Period|Death|0|||
145429982|NCT03396445|524434011|FG021|Treatment Period|Death|0|||
145429983|NCT03396445|524434012|FG022|Treatment Period|Death|0|||
145429984|NCT03396445|524434013|FG023|Treatment Period|Death|0|||
145429985|NCT03396445|524434014|FG024|Treatment Period|Death|0|||
145429986|NCT03396445|524434015|FG025|Treatment Period|Death|0|||
145429987|NCT03396445|524433990|FG000|Treatment Period|Lost to Follow-up|0|||
145429988|NCT03396445|524433991|FG001|Treatment Period|Lost to Follow-up|0|||
145429989|NCT03396445|524433992|FG002|Treatment Period|Lost to Follow-up|0|||
145429990|NCT03396445|524433993|FG003|Treatment Period|Lost to Follow-up|0|||
145429991|NCT03396445|524433994|FG004|Treatment Period|Lost to Follow-up|0|||
145429992|NCT03396445|524433995|FG005|Treatment Period|Lost to Follow-up|0|||
145429993|NCT03396445|524433996|FG006|Treatment Period|Lost to Follow-up|0|||
145429994|NCT03396445|524433997|FG007|Treatment Period|Lost to Follow-up|0|||
145429995|NCT03396445|524433998|FG008|Treatment Period|Lost to Follow-up|0|||
145429996|NCT03396445|524433999|FG009|Treatment Period|Lost to Follow-up|0|||
145429997|NCT03396445|524434000|FG010|Treatment Period|Lost to Follow-up|0|||
145429998|NCT03396445|524434001|FG011|Treatment Period|Lost to Follow-up|0|||
145429999|NCT03396445|524434002|FG012|Treatment Period|Lost to Follow-up|1|||
145430000|NCT03396445|524434003|FG013|Treatment Period|Lost to Follow-up|0|||
145430001|NCT03396445|524434004|FG014|Treatment Period|Lost to Follow-up|1|||
145430002|NCT03396445|524434005|FG015|Treatment Period|Lost to Follow-up|0|||
145430003|NCT03396445|524434006|FG016|Treatment Period|Lost to Follow-up|0|||
145430004|NCT03396445|524434007|FG017|Treatment Period|Lost to Follow-up|0|||
145430005|NCT03396445|524434008|FG018|Treatment Period|Lost to Follow-up|0|||
145430006|NCT03396445|524434009|FG019|Treatment Period|Lost to Follow-up|0|||
145430007|NCT03396445|524434010|FG020|Treatment Period|Lost to Follow-up|0|||
145430008|NCT03396445|524434011|FG021|Treatment Period|Lost to Follow-up|0|||
145430009|NCT03396445|524434012|FG022|Treatment Period|Lost to Follow-up|0|||
145430010|NCT03396445|524434013|FG023|Treatment Period|Lost to Follow-up|0|||
145430011|NCT03396445|524434014|FG024|Treatment Period|Lost to Follow-up|0|||
145430012|NCT03396445|524434015|FG025|Treatment Period|Lost to Follow-up|0|||
145430013|NCT03396445|524433990|FG000|Treatment Period|Physician Decision|0|||
145430014|NCT03396445|524433991|FG001|Treatment Period|Physician Decision|0|||
145430015|NCT03396445|524433992|FG002|Treatment Period|Physician Decision|0|||
145430016|NCT03396445|524433993|FG003|Treatment Period|Physician Decision|0|||
145430017|NCT03396445|524433994|FG004|Treatment Period|Physician Decision|1|||
145430018|NCT03396445|524433995|FG005|Treatment Period|Physician Decision|0|||
145430019|NCT03396445|524433996|FG006|Treatment Period|Physician Decision|0|||
145430020|NCT03396445|524433997|FG007|Treatment Period|Physician Decision|0|||
145430021|NCT03396445|524433998|FG008|Treatment Period|Physician Decision|0|||
145430022|NCT03396445|524433999|FG009|Treatment Period|Physician Decision|1|||
145430023|NCT03396445|524434000|FG010|Treatment Period|Physician Decision|0|||
145430024|NCT03396445|524434001|FG011|Treatment Period|Physician Decision|0|||
145430025|NCT03396445|524434002|FG012|Treatment Period|Physician Decision|0|||
145430026|NCT03396445|524434003|FG013|Treatment Period|Physician Decision|0|||
145430027|NCT03396445|524434004|FG014|Treatment Period|Physician Decision|0|||
145430028|NCT03396445|524434005|FG015|Treatment Period|Physician Decision|0|||
145430029|NCT03396445|524434006|FG016|Treatment Period|Physician Decision|0|||
145430030|NCT03396445|524434007|FG017|Treatment Period|Physician Decision|0|||
145430031|NCT03396445|524434008|FG018|Treatment Period|Physician Decision|0|||
145430032|NCT03396445|524434009|FG019|Treatment Period|Physician Decision|0|||
145430033|NCT03396445|524434010|FG020|Treatment Period|Physician Decision|0|||
145430034|NCT03396445|524434011|FG021|Treatment Period|Physician Decision|0|||
145430035|NCT03396445|524434012|FG022|Treatment Period|Physician Decision|0|||
145430036|NCT03396445|524434013|FG023|Treatment Period|Physician Decision|0|||
145430037|NCT03396445|524434014|FG024|Treatment Period|Physician Decision|0|||
145430038|NCT03396445|524434015|FG025|Treatment Period|Physician Decision|0|||
145430039|NCT03396445|524433990|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430040|NCT03396445|524433991|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430041|NCT03396445|524433992|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430042|NCT03396445|524433993|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430043|NCT03396445|524433994|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430044|NCT03396445|524433995|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430045|NCT03396445|524433996|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430046|NCT03396445|524433997|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430047|NCT03396445|524433998|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430048|NCT03396445|524433999|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430049|NCT03396445|524434000|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145623928|NCT00410384|525135637|FG000|Overall Study|Adverse Event|23|||
145374496|NCT02059434|524223294|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
145374497|NCT02059434|524223295|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
145374498|NCT02059434|524223287|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
145374499|NCT02059434|524223288|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
145374500|NCT02059434|524223289|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
145374501|NCT02059434|524223290|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
145374502|NCT02059434|524223291|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
145374503|NCT02059434|524223292|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
145374504|NCT02059434|524223293|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
145374505|NCT02059434|524223294|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
145374506|NCT02059434|524223295|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
145374507|NCT02059434|524223287|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
145374508|NCT02059434|524223288|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
145374509|NCT02059434|524223289|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
145374510|NCT02059434|524223290|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
145374511|NCT02059434|524223291|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
145374512|NCT02059434|524223292|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
145374513|NCT02059434|524223293|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
145374514|NCT02059434|524223294|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
145374515|NCT02059434|524223295|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
145374516|NCT02059434|524223287|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
145374517|NCT02059434|524223288|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
145374518|NCT02059434|524223289|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
145374519|NCT02059434|524223290|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
145374520|NCT02059434|524223291|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
145374521|NCT02059434|524223292|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
145374522|NCT02059434|524223293|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
145374523|NCT02059434|524223294|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
145374524|NCT02059434|524223295|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
145374525|NCT02059434|524223287|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374526|NCT02059434|524223288|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374527|NCT02059434|524223289|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374528|NCT02059434|524223290|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374529|NCT02059434|524223291|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374530|NCT02059434|524223292|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374531|NCT02059434|524223293|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374532|NCT02059434|524223294|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
145374533|NCT02059434|524223295|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
145374534|NCT03201874|524223300|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
145374535|NCT03201874|524223301|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
145374536|NCT03201874|524223300|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
145374537|NCT03201874|524223301|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
145374538|NCT02907593|524223302|FG000|Overall Study|Withdrawal by Subject|0|||
145374539|NCT02907593|524223303|FG001|Overall Study|Withdrawal by Subject|0|||
145374540|NCT02907593|524223304|FG002|Overall Study|Withdrawal by Subject|1|||
145374541|NCT02907593|524223305|FG003|Overall Study|Withdrawal by Subject|0|||
145374542|NCT02659514|524223320|FG000|Overall Study|Adverse Event|3|||
145374543|NCT02659514|524223321|FG001|Overall Study|Adverse Event|12|||
145374544|NCT02659514|524223320|FG000|Overall Study|Disease Progression|23|||
145374545|NCT02659514|524223321|FG001|Overall Study|Disease Progression|13|||
145374546|NCT02659514|524223320|FG000|Overall Study|Withdrawal by Subject|0|||
145374547|NCT02659514|524223321|FG001|Overall Study|Withdrawal by Subject|4|||
145374548|NCT02659514|524223320|FG000|Overall Study|Lost to Follow-up|0|||
145374549|NCT02659514|524223321|FG001|Overall Study|Lost to Follow-up|1|||
145374550|NCT02659514|524223320|FG000|Overall Study|Death|6|||
145374551|NCT02659514|524223321|FG001|Overall Study|Death|1|||
145374552|NCT02659514|524223320|FG000|Overall Study|Reason Unspecified|0|||
145374553|NCT02659514|524223321|FG001|Overall Study|Reason Unspecified|3|||
145374554|NCT04495816|524223324|FG000|Overall Study|Lost to Follow-up|10|||
145374555|NCT04495816|524223325|FG001|Overall Study|Lost to Follow-up|4|||
145374556|NCT04495816|524223324|FG000|Overall Study|Withdrawal by Subject|3|||
145374557|NCT04495816|524223325|FG001|Overall Study|Withdrawal by Subject|5|||
145374558|NCT03536949|524223326|FG000|Overall Study|Adverse Event|4|||
145374559|NCT03536949|524223327|FG001|Overall Study|Adverse Event|0|||
145374560|NCT03536949|524223326|FG000|Overall Study|Lost to Follow-up|2|||
145374561|NCT03536949|524223327|FG001|Overall Study|Lost to Follow-up|1|||
145582072|NCT03251924|524983259|FG001|Overall Study|Disease Progression|6|||
145582073|NCT03251924|524983260|FG002|Overall Study|Disease Progression|7|||
145374562|NCT03536949|524223326|FG000|Overall Study|Withdrawal by Subject|6|||
145582074|NCT03251924|524983261|FG003|Overall Study|Disease Progression|8|||
145582075|NCT03251924|524983262|FG004|Overall Study|Disease Progression|8|||
145374563|NCT03536949|524223327|FG001|Overall Study|Withdrawal by Subject|0|||
145374564|NCT03536949|524223326|FG000|Overall Study|Non-compliance|2|||
145374565|NCT03536949|524223327|FG001|Overall Study|Non-compliance|1|||
145374566|NCT06137703|524223329|FG000|Overall Study|Other|0|||
145374567|NCT06137703|524223330|FG001|Overall Study|Other|1|||
145374568|NCT06137703|524223331|FG002|Overall Study|Other|0|||
145374569|NCT06137703|524223332|FG003|Overall Study|Other|0|||
145374570|NCT06137703|524223329|FG000|Overall Study|Adverse Event|0|||
145374571|NCT06137703|524223330|FG001|Overall Study|Adverse Event|0|||
145374572|NCT06137703|524223331|FG002|Overall Study|Adverse Event|1|||
145374573|NCT06137703|524223332|FG003|Overall Study|Adverse Event|0|||
145374574|NCT04329091|524223333|FG000|Overall Study|Physician Decision|5|||
145374575|NCT00741091|524223336|FG000|Overall Study|Death|13|||
145374576|NCT00741091|524223336|FG000|Overall Study|Lost to Follow-up|16|||
145374577|NCT00741091|524223336|FG000|Overall Study|Withdrawal by Subject|6|||
145374578|NCT00741091|524223336|FG000|Overall Study|Missed Visit|22|||
145374579|NCT01801358|524223337|FG000|Overall Study|Adverse Event|0|||
145374580|NCT01801358|524223338|FG001|Overall Study|Adverse Event|2|||
145374581|NCT01801358|524223339|FG002|Overall Study|Adverse Event|1|||
145374582|NCT01801358|524223340|FG003|Overall Study|Adverse Event|0|||
145374583|NCT01801358|524223341|FG004|Overall Study|Adverse Event|0|||
145374584|NCT01801358|524223342|FG005|Overall Study|Adverse Event|1|||
145374585|NCT01801358|524223337|FG000|Overall Study|Physician Decision|0|||
145374586|NCT01801358|524223338|FG001|Overall Study|Physician Decision|0|||
145374587|NCT01801358|524223339|FG002|Overall Study|Physician Decision|1|||
145374588|NCT01801358|524223340|FG003|Overall Study|Physician Decision|0|||
145374589|NCT01801358|524223341|FG004|Overall Study|Physician Decision|0|||
145374590|NCT01801358|524223342|FG005|Overall Study|Physician Decision|0|||
145374591|NCT01801358|524223337|FG000|Overall Study|Progressive Disease|6|||
145374592|NCT01801358|524223338|FG001|Overall Study|Progressive Disease|4|||
145374593|NCT01801358|524223339|FG002|Overall Study|Progressive Disease|4|||
145374594|NCT01801358|524223340|FG003|Overall Study|Progressive Disease|5|||
145374595|NCT01801358|524223341|FG004|Overall Study|Progressive Disease|6|||
145374596|NCT01801358|524223342|FG005|Overall Study|Progressive Disease|5|||
145374597|NCT01801358|524223337|FG000|Overall Study|Withdrawal by Subject|0|||
145374598|NCT01801358|524223338|FG001|Overall Study|Withdrawal by Subject|0|||
145374599|NCT01801358|524223339|FG002|Overall Study|Withdrawal by Subject|0|||
145374600|NCT01801358|524223340|FG003|Overall Study|Withdrawal by Subject|1|||
145374601|NCT01801358|524223341|FG004|Overall Study|Withdrawal by Subject|0|||
145374602|NCT01801358|524223342|FG005|Overall Study|Withdrawal by Subject|2|||
145374603|NCT03787303|524223343|FG000|Overall Study|Death|1|||
145374604|NCT03787303|524223343|FG000|Overall Study|Premature Termination of Study|1|||
145374605|NCT01527487|524223344|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
145374606|NCT01527487|524223345|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
145374607|NCT01527487|524223344|FG000|Overall Study|Disease Progression|4|||
145374608|NCT01527487|524223345|FG001|Overall Study|Disease Progression|1|||
145374609|NCT01527487|524223344|FG000|Overall Study|Adverse Event|1|||
145374610|NCT01527487|524223345|FG001|Overall Study|Adverse Event|1|||
145374611|NCT01527487|524223344|FG000|Overall Study|Death|0|||
145374612|NCT01527487|524223345|FG001|Overall Study|Death|1|||
145374613|NCT01210495|524223348|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
145374614|NCT01210495|524223349|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
145374615|NCT01210495|524223350|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
145374616|NCT01210495|524223351|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
145374617|NCT01210495|524223348|FG000|Overall Study|Death|14|||
145374618|NCT01210495|524223349|FG001|Overall Study|Death|7|||
145374619|NCT01210495|524223350|FG002|Overall Study|Death|112|||
145374620|NCT01210495|524223351|FG003|Overall Study|Death|54|||
145374621|NCT01210495|524223348|FG000|Overall Study|Study Terminated by Sponsor|0|||
145374622|NCT01210495|524223349|FG001|Overall Study|Study Terminated by Sponsor|0|||
145374623|NCT01210495|524223350|FG002|Overall Study|Study Terminated by Sponsor|4|||
145374624|NCT01210495|524223351|FG003|Overall Study|Study Terminated by Sponsor|11|||
145374625|NCT01210495|524223348|FG000|Overall Study|Lost to Follow-up|0|||
145374626|NCT01210495|524223349|FG001|Overall Study|Lost to Follow-up|0|||
145374627|NCT01210495|524223350|FG002|Overall Study|Lost to Follow-up|1|||
145374628|NCT01210495|524223351|FG003|Overall Study|Lost to Follow-up|1|||
145374629|NCT01210495|524223348|FG000|Overall Study|Other unspecified|0|||
145374630|NCT01210495|524223349|FG001|Overall Study|Other unspecified|0|||
145374631|NCT01210495|524223350|FG002|Overall Study|Other unspecified|6|||
145374632|NCT01210495|524223351|FG003|Overall Study|Other unspecified|0|||
145374633|NCT01384019|524223352|FG000|Overall Study|Withdrawal by Subject|3|||
145374634|NCT01384019|524223353|FG001|Overall Study|Withdrawal by Subject|0|||
145374635|NCT01384019|524223352|FG000|Overall Study|Death|1|||
145374636|NCT01384019|524223353|FG001|Overall Study|Death|0|||
145623929|NCT00410384|525135638|FG001|Overall Study|Adverse Event|18|||
145623930|NCT00410384|525135639|FG002|Overall Study|Adverse Event|23|||
145374637|NCT01384019|524223352|FG000|Overall Study|MRI refusal|6|||
145374638|NCT01384019|524223353|FG001|Overall Study|MRI refusal|6|||
145374639|NCT00767039|524223356|FG000|Overall Study|Death|5|||
145374640|NCT00767039|524223357|FG001|Overall Study|Death|2|||
145582076|NCT03251924|524983263|FG005|Overall Study|Disease Progression|7|||
145582077|NCT03251924|524983264|FG006|Overall Study|Disease Progression|6|||
145374641|NCT01826370|524223358|FG000|Overall Study|Protocol Violation|6|||
145374642|NCT01826370|524223358|FG000|Overall Study|Lost to Follow-up|12|||
145374643|NCT01826370|524223358|FG000|Overall Study|Other reason not defined above|2|||
145374644|NCT04416737|524223360|FG000|Week 1 (First Injection)|Physician Decision|0|||
145374645|NCT04416737|524223361|FG001|Week 1 (First Injection)|Physician Decision|1|||
145374646|NCT01472757|524223367|FG000|Overall Study|Withdrawal by Subject|1|||
145374647|NCT01472757|524223368|FG001|Overall Study|Withdrawal by Subject|2|||
145374648|NCT01472757|524223369|FG002|Overall Study|Withdrawal by Subject|2|||
145374649|NCT01472757|524223370|FG003|Overall Study|Withdrawal by Subject|0|||
145374650|NCT01472757|524223367|FG000|Overall Study|Asthma exacerbation|4|||
145374651|NCT01472757|524223368|FG001|Overall Study|Asthma exacerbation|1|||
145374652|NCT01472757|524223369|FG002|Overall Study|Asthma exacerbation|2|||
145374653|NCT01472757|524223370|FG003|Overall Study|Asthma exacerbation|1|||
145374654|NCT01472757|524223367|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
145374655|NCT01472757|524223368|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
145374656|NCT01472757|524223369|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
145374657|NCT01472757|524223370|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
145374658|NCT01472757|524223367|FG000|Overall Study|Protocol Violation|3|||
145374659|NCT01472757|524223368|FG001|Overall Study|Protocol Violation|2|||
145374660|NCT01472757|524223369|FG002|Overall Study|Protocol Violation|4|||
145374661|NCT01472757|524223370|FG003|Overall Study|Protocol Violation|4|||
145374662|NCT01472757|524223367|FG000|Overall Study|Other reasons|1|||
145374663|NCT01472757|524223368|FG001|Overall Study|Other reasons|0|||
145374664|NCT01472757|524223369|FG002|Overall Study|Other reasons|2|||
145374665|NCT01472757|524223370|FG003|Overall Study|Other reasons|2|||
145374666|NCT04489381|524223375|FG000|Overall Study|Lost to Follow-up|2|||
145374667|NCT04489381|524223376|FG001|Overall Study|Lost to Follow-up|3|||
145374668|NCT04489381|524223375|FG000|Overall Study|Withdrawal by Subject|1|||
145374669|NCT04489381|524223376|FG001|Overall Study|Withdrawal by Subject|0|||
145374670|NCT00526331|524223379|FG000|Overall Study|Sponsor Termination|55|||
145374671|NCT01259375|524223380|FG000|Overall Study|Adverse Event|1|||
145374672|NCT00478699|524223385|FG000|Overall Study|Inclusion Error|1|||
145374673|NCT00478699|524223386|FG001|Overall Study|Inclusion Error|7|||
145374674|NCT00478699|524223385|FG000|Overall Study|Not receive study treatment|6|||
145374675|NCT00478699|524223386|FG001|Overall Study|Not receive study treatment|30|||
145374676|NCT01043705|524223389|FG000|Overall Study|Death|28|||
145374677|NCT01043705|524223390|FG001|Overall Study|Death|60|||
145374678|NCT01043705|524223391|FG002|Overall Study|Death|26|||
145374679|NCT01043705|524223389|FG000|Overall Study|Lost to Follow-up|27|||
145374680|NCT01043705|524223390|FG001|Overall Study|Lost to Follow-up|12|||
145374681|NCT01043705|524223391|FG002|Overall Study|Lost to Follow-up|0|||
145374682|NCT01043705|524223389|FG000|Overall Study|Multiple Reasons|4|||
145374683|NCT01043705|524223390|FG001|Overall Study|Multiple Reasons|7|||
145374684|NCT01043705|524223391|FG002|Overall Study|Multiple Reasons|0|||
145374685|NCT01043705|524223389|FG000|Overall Study|Protocol Violation|2|||
145374686|NCT01043705|524223390|FG001|Overall Study|Protocol Violation|1|||
145374687|NCT01043705|524223391|FG002|Overall Study|Protocol Violation|0|||
145374688|NCT01043705|524223389|FG000|Overall Study|Withdrawal by Subject|8|||
145374689|NCT01043705|524223390|FG001|Overall Study|Withdrawal by Subject|6|||
145374690|NCT01043705|524223391|FG002|Overall Study|Withdrawal by Subject|0|||
145374691|NCT01043705|524223389|FG000|Overall Study|Site Closure|8|||
145374692|NCT01043705|524223390|FG001|Overall Study|Site Closure|0|||
145374693|NCT01043705|524223391|FG002|Overall Study|Site Closure|0|||
145374694|NCT01043705|524223389|FG000|Overall Study|Subsequent Procedure|9|||
145374695|NCT01043705|524223390|FG001|Overall Study|Subsequent Procedure|24|||
145374696|NCT01043705|524223391|FG002|Overall Study|Subsequent Procedure|29|||
145374697|NCT01043705|524223389|FG000|Overall Study|Adverse Event|0|||
145374698|NCT01043705|524223390|FG001|Overall Study|Adverse Event|2|||
145374699|NCT01043705|524223391|FG002|Overall Study|Adverse Event|0|||
145374700|NCT01043705|524223389|FG000|Overall Study|Screen Fail|21|||
145374701|NCT01043705|524223390|FG001|Overall Study|Screen Fail|0|||
145374702|NCT01043705|524223391|FG002|Overall Study|Screen Fail|0|||
145374703|NCT01043705|524223389|FG000|Overall Study|Other|0|||
145374704|NCT01043705|524223390|FG001|Overall Study|Other|19|||
145582078|NCT03251924|524983265|FG007|Overall Study|Disease Progression|10|||
145374705|NCT01043705|524223391|FG002|Overall Study|Other|25|||
145374706|NCT02003963|524223393|FG000|Overall Study|Lost to Follow-up|2|||
145374707|NCT02003963|524223394|FG001|Overall Study|Lost to Follow-up|1|||
145374708|NCT00656851|524223400|FG000|Overall Study|Withdrawal by Subject|0|||
145374709|NCT00656851|524223401|FG001|Overall Study|Withdrawal by Subject|4|||
145374710|NCT04050124|524223402|FG000|Overall Study|Death|1|||
145374711|NCT04050124|524223403|FG001|Overall Study|Death|0|||
145374712|NCT04601103|524223404|FG000|Overall Study|Needed crown & cleaning|0|||
145374713|NCT04601103|524223405|FG001|Overall Study|Needed crown & cleaning|0|||
145374714|NCT04601103|524223406|FG002|Overall Study|Needed crown & cleaning|1|||
145582079|NCT03251924|524983266|FG008|Overall Study|Disease Progression|6|||
145374715|NCT04601103|524223404|FG000|Overall Study|study was terminated|18|||
145374716|NCT04601103|524223405|FG001|Overall Study|study was terminated|18|||
145374717|NCT04601103|524223406|FG002|Overall Study|study was terminated|16|||
145374718|NCT04442269|524223410|FG000|Overall Study|Adverse Event|1|||
145374719|NCT04442269|524223411|FG001|Overall Study|Adverse Event|0|||
145374720|NCT04442269|524223410|FG000|Overall Study|Death|0|||
145374721|NCT04442269|524223411|FG001|Overall Study|Death|1|||
145374722|NCT04442269|524223410|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
145374723|NCT04442269|524223411|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
145374724|NCT04442269|524223410|FG000|Overall Study|Lost to Follow-up|1|||
145374725|NCT04442269|524223411|FG001|Overall Study|Lost to Follow-up|0|||
145374726|NCT04442269|524223410|FG000|Overall Study|Withdrawal by Subject|3|||
145374727|NCT04442269|524223411|FG001|Overall Study|Withdrawal by Subject|2|||
145374728|NCT04442269|524223410|FG000|Overall Study|Protocol Deviation|0|||
145374729|NCT04442269|524223411|FG001|Overall Study|Protocol Deviation|1|||
145374730|NCT04442269|524223410|FG000|Overall Study|Travel Limitations|1|||
145374731|NCT04442269|524223411|FG001|Overall Study|Travel Limitations|1|||
145374732|NCT03802565|524223415|FG000|Overall Study|Adverse Event|0|||
145374733|NCT03802565|524223416|FG001|Overall Study|Adverse Event|1|||
145374734|NCT03802565|524223417|FG002|Overall Study|Adverse Event|2|||
145374735|NCT03802565|524223418|FG003|Overall Study|Adverse Event|1|||
145374736|NCT03802565|524223419|FG004|Overall Study|Adverse Event|1|||
145374737|NCT03802565|524223415|FG000|Overall Study|Withdrawal by Subject|2|||
145374738|NCT03802565|524223416|FG001|Overall Study|Withdrawal by Subject|2|||
145374739|NCT03802565|524223417|FG002|Overall Study|Withdrawal by Subject|2|||
145374740|NCT03802565|524223418|FG003|Overall Study|Withdrawal by Subject|0|||
145374741|NCT03802565|524223419|FG004|Overall Study|Withdrawal by Subject|1|||
145374742|NCT03802565|524223415|FG000|Overall Study|Protocol Violation|2|||
145374743|NCT03802565|524223416|FG001|Overall Study|Protocol Violation|1|||
145374744|NCT03802565|524223417|FG002|Overall Study|Protocol Violation|4|||
145374745|NCT03802565|524223418|FG003|Overall Study|Protocol Violation|5|||
145374746|NCT03802565|524223419|FG004|Overall Study|Protocol Violation|1|||
145374747|NCT03802565|524223415|FG000|Overall Study|Lost to Follow-up|0|||
145374748|NCT03802565|524223416|FG001|Overall Study|Lost to Follow-up|0|||
145374749|NCT03802565|524223417|FG002|Overall Study|Lost to Follow-up|1|||
145374750|NCT03802565|524223418|FG003|Overall Study|Lost to Follow-up|0|||
145374751|NCT03802565|524223419|FG004|Overall Study|Lost to Follow-up|0|||
145374752|NCT03802565|524223415|FG000|Overall Study|Subjects Related to Each Other|1|||
145374753|NCT03802565|524223416|FG001|Overall Study|Subjects Related to Each Other|0|||
145374754|NCT03802565|524223417|FG002|Overall Study|Subjects Related to Each Other|0|||
145374755|NCT03802565|524223418|FG003|Overall Study|Subjects Related to Each Other|2|||
145374756|NCT03802565|524223419|FG004|Overall Study|Subjects Related to Each Other|1|||
145374757|NCT03802565|524223415|FG000|Overall Study|Elevated Enzymes|0|||
145374758|NCT03802565|524223416|FG001|Overall Study|Elevated Enzymes|0|||
145374759|NCT03802565|524223417|FG002|Overall Study|Elevated Enzymes|0|||
145374760|NCT03802565|524223418|FG003|Overall Study|Elevated Enzymes|0|||
145374761|NCT03802565|524223419|FG004|Overall Study|Elevated Enzymes|2|||
145374762|NCT03932331|524223423|FG000|Overall Study|Death|0|||
145374763|NCT03932331|524223424|FG001|Overall Study|Death|7|||
145374764|NCT03932331|524223425|FG002|Overall Study|Death|2|||
145374765|NCT03932331|524223423|FG000|Overall Study|Withdrawal by Subject|0|||
145374766|NCT03932331|524223424|FG001|Overall Study|Withdrawal by Subject|3|||
145374767|NCT03932331|524223425|FG002|Overall Study|Withdrawal by Subject|0|||
145374768|NCT03932331|524223423|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
145374769|NCT03932331|524223424|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
145374770|NCT03932331|524223425|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
145374771|NCT03932331|524223423|FG000|Overall Study|Progressive disease|3|||
145374772|NCT03932331|524223424|FG001|Overall Study|Progressive disease|0|||
145374773|NCT03932331|524223425|FG002|Overall Study|Progressive disease|0|||
145374774|NCT03932331|524223423|FG000|Overall Study|Lung infection|1|||
145374775|NCT03932331|524223424|FG001|Overall Study|Lung infection|0|||
145374776|NCT03932331|524223425|FG002|Overall Study|Lung infection|0|||
145374777|NCT03932331|524223423|FG000|Overall Study|Other|0|||
145374778|NCT03932331|524223424|FG001|Overall Study|Other|0|||
145374779|NCT03932331|524223425|FG002|Overall Study|Other|58|||
145374780|NCT02484651|524223426|FG000|Overall Study|Patients' data files were corrupted.|1|||
145374781|NCT02484651|524223427|FG001|Overall Study|Patients' data files were corrupted.|1|||
145374782|NCT02484651|524223426|FG000|Overall Study|BIS monitoring failed.|1|||
145582080|NCT03251924|524983258|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
145374783|NCT02484651|524223427|FG001|Overall Study|BIS monitoring failed.|1|||
145374784|NCT02484651|524223426|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
145374785|NCT02484651|524223427|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
145374786|NCT05238025|524223428|FG000|Overall Study|Adverse Event|2|||
145374787|NCT05238025|524223429|FG001|Overall Study|Adverse Event|2|||
145374788|NCT05238025|524223428|FG000|Overall Study|Lost to Follow-up|334|||
145374789|NCT05238025|524223429|FG001|Overall Study|Lost to Follow-up|339|||
145374790|NCT05238025|524223428|FG000|Overall Study|Withdrawal by Subject|203|||
145582081|NCT03251924|524983259|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
145374791|NCT05238025|524223429|FG001|Overall Study|Withdrawal by Subject|222|||
145374792|NCT05238025|524223428|FG000|Overall Study|Physician Decision|20|||
145374793|NCT05238025|524223429|FG001|Overall Study|Physician Decision|8|||
145374794|NCT05238025|524223428|FG000|Overall Study|Protocol Violation|6|||
145374795|NCT05238025|524223429|FG001|Overall Study|Protocol Violation|2|||
145374796|NCT05238025|524223428|FG000|Overall Study|Death|38|||
145374797|NCT05238025|524223429|FG001|Overall Study|Death|32|||
145374798|NCT05238025|524223428|FG000|Overall Study|Study terminated by Sponsor|6358|||
145374799|NCT05238025|524223429|FG001|Overall Study|Study terminated by Sponsor|6358|||
145374800|NCT05238025|524223428|FG000|Overall Study|Other Reason|669|||
145374801|NCT05238025|524223429|FG001|Overall Study|Other Reason|690|||
145374802|NCT03814720|524223432|FG000|Overall Study|Lost to Follow-up|0|||
145374803|NCT03814720|524223433|FG001|Overall Study|Lost to Follow-up|1|||
145374804|NCT03814720|524223434|FG002|Overall Study|Lost to Follow-up|0|||
145374805|NCT03814720|524223435|FG003|Overall Study|Lost to Follow-up|0|||
145374806|NCT03814720|524223436|FG004|Overall Study|Lost to Follow-up|0|||
145374807|NCT02135107|524223443|FG000|Treatment Period|Withdrawal by Subject|11|||
145374808|NCT02135107|524223444|FG001|Treatment Period|Withdrawal by Subject|0|||
145374809|NCT02135107|524223445|FG002|Treatment Period|Withdrawal by Subject|0|||
145374810|NCT02135107|524223446|FG003|Treatment Period|Withdrawal by Subject|0|||
145374811|NCT02135107|524223443|FG000|Treatment Period|Adverse Event|5|||
145374812|NCT02135107|524223444|FG001|Treatment Period|Adverse Event|2|||
145374813|NCT02135107|524223445|FG002|Treatment Period|Adverse Event|0|||
145374814|NCT02135107|524223446|FG003|Treatment Period|Adverse Event|0|||
145374815|NCT02135107|524223443|FG000|Treatment Period|Pregnancy|1|||
145374816|NCT02135107|524223444|FG001|Treatment Period|Pregnancy|0|||
145374817|NCT02135107|524223445|FG002|Treatment Period|Pregnancy|0|||
145374818|NCT02135107|524223446|FG003|Treatment Period|Pregnancy|0|||
145374819|NCT02135107|524223443|FG000|Treatment Period|Other|115|||
145374820|NCT02135107|524223444|FG001|Treatment Period|Other|24|||
145374821|NCT02135107|524223445|FG002|Treatment Period|Other|0|||
145374822|NCT02135107|524223446|FG003|Treatment Period|Other|0|||
145374823|NCT02135107|524223443|FG000|Maintenance Therapy Period|Adverse Event|0|||
145374824|NCT02135107|524223444|FG001|Maintenance Therapy Period|Adverse Event|0|||
145374825|NCT02135107|524223445|FG002|Maintenance Therapy Period|Adverse Event|3|||
145374826|NCT02135107|524223446|FG003|Maintenance Therapy Period|Adverse Event|7|||
145374827|NCT02135107|524223443|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
145374828|NCT02135107|524223444|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
145374829|NCT02135107|524223445|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
145374830|NCT02135107|524223446|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
145374831|NCT02135107|524223443|FG000|Maintenance Therapy Period|Pregnancy|0|||
145374832|NCT02135107|524223444|FG001|Maintenance Therapy Period|Pregnancy|0|||
145374833|NCT02135107|524223445|FG002|Maintenance Therapy Period|Pregnancy|0|||
145374834|NCT02135107|524223446|FG003|Maintenance Therapy Period|Pregnancy|1|||
145374835|NCT02135107|524223443|FG000|Maintenance Therapy Period|Other|0|||
145374836|NCT02135107|524223444|FG001|Maintenance Therapy Period|Other|0|||
145374837|NCT02135107|524223445|FG002|Maintenance Therapy Period|Other|7|||
145374838|NCT02135107|524223446|FG003|Maintenance Therapy Period|Other|8|||
145374839|NCT02278120|524223448|FG000|Treatment Period|Progressive disease|234|||
145374840|NCT02278120|524223449|FG001|Treatment Period|Progressive disease|260|||
145374841|NCT02278120|524223448|FG000|Treatment Period|Subject/guardian decision|23|||
145374842|NCT02278120|524223449|FG001|Treatment Period|Subject/guardian decision|20|||
145374843|NCT02278120|524223448|FG000|Treatment Period|Adverse Event|16|||
145374844|NCT02278120|524223449|FG001|Treatment Period|Adverse Event|14|||
145374845|NCT02278120|524223448|FG000|Treatment Period|Physician Decision|14|||
145374846|NCT02278120|524223449|FG001|Treatment Period|Physician Decision|27|||
145374847|NCT02278120|524223448|FG000|Treatment Period|Death|3|||
145374848|NCT02278120|524223449|FG001|Treatment Period|Death|3|||
145374849|NCT02278120|524223448|FG000|Treatment Period|Lost to Follow-up|2|||
145374850|NCT02278120|524223449|FG001|Treatment Period|Lost to Follow-up|0|||
145374851|NCT02278120|524223448|FG000|Treatment Period|Protocol deviation|0|||
145374852|NCT02278120|524223449|FG001|Treatment Period|Protocol deviation|2|||
145374853|NCT02278120|524223448|FG000|Treatment Period|Study terminated as per protocol|43|||
145374854|NCT02278120|524223449|FG001|Treatment Period|Study terminated as per protocol|11|||
145374855|NCT02278120|524223448|FG000|Post-treatment Efficacy Follow-up|Death|0|||
145374856|NCT02278120|524223449|FG001|Post-treatment Efficacy Follow-up|Death|1|||
145374857|NCT02278120|524223448|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
145374858|NCT02278120|524223449|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145374859|NCT02278120|524223448|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
145374860|NCT02278120|524223449|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
145374861|NCT02278120|524223448|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
145374862|NCT02278120|524223449|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
145374863|NCT02278120|524223448|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145374864|NCT02278120|524223449|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145374865|NCT03197324|524223450|FG000|Overall Study|Adverse Event|0|||
145374866|NCT03197324|524223451|FG001|Overall Study|Adverse Event|1|||
145374867|NCT00102531|524223452|FG000|Overall Study|Adverse Event|0|||
145374868|NCT00102531|524223453|FG001|Overall Study|Adverse Event|1|||
145374869|NCT00102531|524223452|FG000|Overall Study|Disease Progression|5|||
145374870|NCT00102531|524223453|FG001|Overall Study|Disease Progression|9|||
145374871|NCT00102531|524223452|FG000|Overall Study|Physician Decision|0|||
145374872|NCT00102531|524223453|FG001|Overall Study|Physician Decision|1|||
145582082|NCT03251924|524983260|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
145582083|NCT03251924|524983261|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
145582084|NCT03251924|524983262|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
145374873|NCT01077739|524223455|FG000|Overall Study|Premature withdrawal|1|||
145374874|NCT01077739|524223456|FG001|Overall Study|Premature withdrawal|3|||
145374875|NCT01077739|524223455|FG000|Overall Study|Withdrawal by Subject|1|||
145374876|NCT01077739|524223456|FG001|Overall Study|Withdrawal by Subject|0|||
145374877|NCT01077739|524223455|FG000|Overall Study|Death|0|||
145374878|NCT01077739|524223456|FG001|Overall Study|Death|3|||
145374879|NCT01077739|524223455|FG000|Overall Study|Unacceptable toxicity|1|||
145374880|NCT01077739|524223456|FG001|Overall Study|Unacceptable toxicity|2|||
145374881|NCT01077739|524223455|FG000|Overall Study|Other|2|||
145374882|NCT01077739|524223456|FG001|Overall Study|Other|2|||
145374883|NCT00877071|524223457|FG000|Overall Study|disease progression|2|||
145374884|NCT05723328|524223458|FG000|Overall Study|Investigator's Decision|5|||
145374885|NCT05723328|524223459|FG001|Overall Study|Investigator's Decision|2|||
145374886|NCT00954512|524223461|FG000|Overall Study|Withdrawal by Subject|0|||
145374887|NCT00954512|524223462|FG001|Overall Study|Withdrawal by Subject|0|||
145374888|NCT00954512|524223463|FG002|Overall Study|Withdrawal by Subject|0|||
145374889|NCT00954512|524223464|FG003|Overall Study|Withdrawal by Subject|0|||
145374890|NCT00954512|524223465|FG004|Overall Study|Withdrawal by Subject|0|||
145374891|NCT00954512|524223466|FG005|Overall Study|Withdrawal by Subject|1|||
145374892|NCT00954512|524223461|FG000|Overall Study|Adverse Event|0|||
145374893|NCT00954512|524223462|FG001|Overall Study|Adverse Event|0|||
145374894|NCT00954512|524223463|FG002|Overall Study|Adverse Event|0|||
145374895|NCT00954512|524223464|FG003|Overall Study|Adverse Event|0|||
145374896|NCT00954512|524223465|FG004|Overall Study|Adverse Event|1|||
145374897|NCT00954512|524223466|FG005|Overall Study|Adverse Event|2|||
145374898|NCT00954512|524223461|FG000|Overall Study|Physician Decision|0|||
145374899|NCT00954512|524223462|FG001|Overall Study|Physician Decision|1|||
145374900|NCT00954512|524223463|FG002|Overall Study|Physician Decision|0|||
145374901|NCT00954512|524223464|FG003|Overall Study|Physician Decision|1|||
145374902|NCT00954512|524223465|FG004|Overall Study|Physician Decision|0|||
145374903|NCT00954512|524223466|FG005|Overall Study|Physician Decision|0|||
145374904|NCT00954512|524223461|FG000|Overall Study|Symptomatic Deterioration|0|||
145374905|NCT00954512|524223462|FG001|Overall Study|Symptomatic Deterioration|1|||
145374906|NCT00954512|524223463|FG002|Overall Study|Symptomatic Deterioration|0|||
145374907|NCT00954512|524223464|FG003|Overall Study|Symptomatic Deterioration|0|||
145374908|NCT00954512|524223465|FG004|Overall Study|Symptomatic Deterioration|2|||
145374909|NCT00954512|524223466|FG005|Overall Study|Symptomatic Deterioration|0|||
145374910|NCT00954512|524223461|FG000|Overall Study|Progression of Disease|2|||
145374911|NCT00954512|524223462|FG001|Overall Study|Progression of Disease|1|||
145374912|NCT00954512|524223463|FG002|Overall Study|Progression of Disease|0|||
145374913|NCT00954512|524223464|FG003|Overall Study|Progression of Disease|1|||
145374914|NCT00954512|524223465|FG004|Overall Study|Progression of Disease|1|||
145374915|NCT00954512|524223466|FG005|Overall Study|Progression of Disease|1|||
145374916|NCT03495154|524223467|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
145374917|NCT03495154|524223467|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
145374918|NCT03495154|524223467|FG000|Overall Study|Screen Failures During Surgery|6|||
145374919|NCT03495154|524223467|FG000|Overall Study|Death|2|||
145374920|NCT03495154|524223467|FG000|Overall Study|Lost to Follow-up|16|||
145374921|NCT03495154|524223467|FG000|Overall Study|Withdrawal by Subject|2|||
145374922|NCT03495154|524223467|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
145374923|NCT05685732|524223468|FG000|Overall Study|Withdrawal by Subject|2|||
145374924|NCT05685732|524223469|FG001|Overall Study|Withdrawal by Subject|0|||
145374925|NCT05685732|524223470|FG002|Overall Study|Withdrawal by Subject|2|||
145374926|NCT05685732|524223471|FG003|Overall Study|Withdrawal by Subject|3|||
145374927|NCT05685732|524223468|FG000|Overall Study|Protocol Violation|1|||
145374928|NCT05685732|524223469|FG001|Overall Study|Protocol Violation|2|||
145374929|NCT05685732|524223470|FG002|Overall Study|Protocol Violation|4|||
145374930|NCT05685732|524223471|FG003|Overall Study|Protocol Violation|1|||
145374931|NCT05685732|524223468|FG000|Overall Study|Lost to Follow-up|5|||
145374932|NCT05685732|524223469|FG001|Overall Study|Lost to Follow-up|1|||
145374933|NCT05685732|524223470|FG002|Overall Study|Lost to Follow-up|3|||
145374934|NCT05685732|524223471|FG003|Overall Study|Lost to Follow-up|1|||
145374935|NCT05685732|524223468|FG000|Overall Study|Adverse Event|2|||
145374936|NCT05685732|524223469|FG001|Overall Study|Adverse Event|1|||
145374937|NCT05685732|524223470|FG002|Overall Study|Adverse Event|0|||
145374938|NCT05685732|524223471|FG003|Overall Study|Adverse Event|0|||
145374939|NCT05685732|524223468|FG000|Overall Study|Physician Decision|1|||
145374940|NCT05685732|524223469|FG001|Overall Study|Physician Decision|0|||
145374941|NCT05685732|524223470|FG002|Overall Study|Physician Decision|0|||
145374942|NCT05685732|524223471|FG003|Overall Study|Physician Decision|0|||
145374943|NCT02640404|524223472|FG000|Overall Study|Protocol Violation|1|||
145374944|NCT02640404|524223473|FG001|Overall Study|Protocol Violation|0|||
145374945|NCT02640404|524223472|FG000|Overall Study|Withdrawal by Subject|1|||
145374946|NCT02640404|524223473|FG001|Overall Study|Withdrawal by Subject|0|||
145374947|NCT04908202|524223475|FG000|Pre-Treatment Period|OTHER REASONS|3|||
145374948|NCT04908202|524223476|FG001|Pre-Treatment Period|OTHER REASONS|1|||
145374949|NCT04908202|524223477|FG002|Pre-Treatment Period|OTHER REASONS|0|||
145374950|NCT04908202|524223478|FG003|Pre-Treatment Period|OTHER REASONS|0|||
145374951|NCT04908202|524223475|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
145374952|NCT04908202|524223476|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145374953|NCT04908202|524223477|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145374954|NCT04908202|524223478|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145374955|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
145374956|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
145374957|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145374958|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145374959|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
145374960|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
145374961|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
145374962|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
145374963|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
145374964|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
145374965|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145374966|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145374967|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
145374968|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
145374969|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145374970|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145374971|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145374972|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
145374973|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145374974|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
145374975|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145374976|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145374977|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145374978|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145374979|NCT04908202|524223475|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
145374980|NCT04908202|524223476|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
145374981|NCT04908202|524223477|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
145374982|NCT04908202|524223478|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
145374983|NCT04908202|524223475|FG000|Active Treatment Period|OTHER REASONS|0|||
145374984|NCT04908202|524223476|FG001|Active Treatment Period|OTHER REASONS|0|||
145374985|NCT04908202|524223477|FG002|Active Treatment Period|OTHER REASONS|1|||
145374986|NCT04908202|524223478|FG003|Active Treatment Period|OTHER REASONS|3|||
145430050|NCT03396445|524434001|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430051|NCT03396445|524434002|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
145430052|NCT03396445|524434003|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430053|NCT03396445|524434004|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
145430054|NCT03396445|524434005|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430055|NCT03396445|524434006|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430056|NCT03396445|524434007|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430057|NCT03396445|524434008|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430058|NCT03396445|524434009|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430059|NCT03396445|524434010|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145623931|NCT00410384|525135637|FG000|Overall Study|Lack of Efficacy|20|||
145374987|NCT04908202|524223475|FG000|Active Treatment Period|Lack of Efficacy|0|||
145374988|NCT04908202|524223476|FG001|Active Treatment Period|Lack of Efficacy|0|||
145374989|NCT04908202|524223477|FG002|Active Treatment Period|Lack of Efficacy|4|||
145374990|NCT04908202|524223478|FG003|Active Treatment Period|Lack of Efficacy|5|||
145374991|NCT04908202|524223475|FG000|Active Treatment Period|Adverse Event|0|||
145374992|NCT04908202|524223476|FG001|Active Treatment Period|Adverse Event|0|||
145374993|NCT04908202|524223477|FG002|Active Treatment Period|Adverse Event|5|||
145374994|NCT04908202|524223478|FG003|Active Treatment Period|Adverse Event|8|||
145374995|NCT04908202|524223475|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145374996|NCT04908202|524223476|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
145374997|NCT04908202|524223477|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
145374998|NCT04908202|524223478|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
145374999|NCT04908202|524223475|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145375000|NCT04908202|524223476|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
145375001|NCT04908202|524223477|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
145375002|NCT04908202|524223478|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
145375003|NCT04908202|524223475|FG000|Active Treatment Period|Lost to Follow-up|0|||
145375004|NCT04908202|524223476|FG001|Active Treatment Period|Lost to Follow-up|0|||
145375005|NCT04908202|524223477|FG002|Active Treatment Period|Lost to Follow-up|2|||
145375006|NCT04908202|524223478|FG003|Active Treatment Period|Lost to Follow-up|2|||
145375007|NCT04908202|524223475|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145375008|NCT04908202|524223476|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145375009|NCT04908202|524223477|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
145375010|NCT04908202|524223478|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
145375011|NCT04908202|524223475|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145375012|NCT04908202|524223476|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
145375013|NCT04908202|524223477|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145375014|NCT04908202|524223478|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
145375015|NCT04908202|524223475|FG000|Active Treatment Period|ONGOING Treatment|0|||
145430060|NCT03396445|524434011|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430061|NCT03396445|524434012|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430062|NCT03396445|524434013|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430063|NCT03396445|524434014|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430064|NCT03396445|524434015|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
145430065|NCT03396445|524433990|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
145430066|NCT03396445|524433991|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
145430067|NCT03396445|524433992|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
145430068|NCT03396445|524433993|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
145430069|NCT03396445|524433994|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
145430070|NCT03396445|524433995|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430071|NCT03396445|524433996|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
145430072|NCT03396445|524433997|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430073|NCT03396445|524433998|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430074|NCT03396445|524433999|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430075|NCT03396445|524434000|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430076|NCT03396445|524434001|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430077|NCT03396445|524434002|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430078|NCT03396445|524434003|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430079|NCT03396445|524434004|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430080|NCT03396445|524434005|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430081|NCT03396445|524434006|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430082|NCT03396445|524434007|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430083|NCT03396445|524434008|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430084|NCT03396445|524434009|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430085|NCT03396445|524434010|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430086|NCT03396445|524434011|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430087|NCT03396445|524434012|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430088|NCT03396445|524434013|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430089|NCT03396445|524434014|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430090|NCT03396445|524434015|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
145430091|NCT03396445|524433990|FG000|Treatment Period|Withdrawal by Subject|0|||
145430092|NCT03396445|524433991|FG001|Treatment Period|Withdrawal by Subject|0|||
145430093|NCT03396445|524433992|FG002|Treatment Period|Withdrawal by Subject|0|||
145623932|NCT00410384|525135638|FG001|Overall Study|Lack of Efficacy|12|||
145375016|NCT04908202|524223476|FG001|Active Treatment Period|ONGOING Treatment|0|||
145375017|NCT04908202|524223477|FG002|Active Treatment Period|ONGOING Treatment|117|||
145430094|NCT03396445|524433993|FG003|Treatment Period|Withdrawal by Subject|0|||
145430095|NCT03396445|524433994|FG004|Treatment Period|Withdrawal by Subject|0|||
145430096|NCT03396445|524433995|FG005|Treatment Period|Withdrawal by Subject|0|||
145430097|NCT03396445|524433996|FG006|Treatment Period|Withdrawal by Subject|0|||
145430098|NCT03396445|524433997|FG007|Treatment Period|Withdrawal by Subject|0|||
145430099|NCT03396445|524433998|FG008|Treatment Period|Withdrawal by Subject|0|||
145430100|NCT03396445|524433999|FG009|Treatment Period|Withdrawal by Subject|0|||
145430101|NCT03396445|524434000|FG010|Treatment Period|Withdrawal by Subject|0|||
145430102|NCT03396445|524434001|FG011|Treatment Period|Withdrawal by Subject|0|||
145430103|NCT03396445|524434002|FG012|Treatment Period|Withdrawal by Subject|0|||
145430104|NCT03396445|524434003|FG013|Treatment Period|Withdrawal by Subject|0|||
145430105|NCT03396445|524434004|FG014|Treatment Period|Withdrawal by Subject|1|||
145430106|NCT03396445|524434005|FG015|Treatment Period|Withdrawal by Subject|0|||
145430107|NCT03396445|524434006|FG016|Treatment Period|Withdrawal by Subject|1|||
145430108|NCT03396445|524434007|FG017|Treatment Period|Withdrawal by Subject|0|||
145430109|NCT03396445|524434008|FG018|Treatment Period|Withdrawal by Subject|0|||
145430110|NCT03396445|524434009|FG019|Treatment Period|Withdrawal by Subject|0|||
145430111|NCT03396445|524434010|FG020|Treatment Period|Withdrawal by Subject|0|||
145430112|NCT03396445|524434011|FG021|Treatment Period|Withdrawal by Subject|0|||
145430113|NCT03396445|524434012|FG022|Treatment Period|Withdrawal by Subject|0|||
145430114|NCT03396445|524434013|FG023|Treatment Period|Withdrawal by Subject|0|||
145430115|NCT03396445|524434014|FG024|Treatment Period|Withdrawal by Subject|0|||
145430116|NCT03396445|524434015|FG025|Treatment Period|Withdrawal by Subject|0|||
145430117|NCT03396445|524433990|FG000|Switch-over Period|Death|0|||
145430118|NCT03396445|524433991|FG001|Switch-over Period|Death|0|||
145430119|NCT03396445|524433992|FG002|Switch-over Period|Death|0|||
145430120|NCT03396445|524433993|FG003|Switch-over Period|Death|0|||
145430121|NCT03396445|524433994|FG004|Switch-over Period|Death|0|||
145430122|NCT03396445|524433995|FG005|Switch-over Period|Death|0|||
145430123|NCT03396445|524433996|FG006|Switch-over Period|Death|0|||
145430124|NCT03396445|524433997|FG007|Switch-over Period|Death|0|||
145430125|NCT03396445|524433998|FG008|Switch-over Period|Death|0|||
145430126|NCT03396445|524433999|FG009|Switch-over Period|Death|0|||
145430127|NCT03396445|524434000|FG010|Switch-over Period|Death|0|||
145430128|NCT03396445|524434001|FG011|Switch-over Period|Death|0|||
145430129|NCT03396445|524434002|FG012|Switch-over Period|Death|0|||
145430130|NCT03396445|524434003|FG013|Switch-over Period|Death|0|||
145430131|NCT03396445|524434004|FG014|Switch-over Period|Death|0|||
145430132|NCT03396445|524434005|FG015|Switch-over Period|Death|0|||
145430133|NCT03396445|524434006|FG016|Switch-over Period|Death|0|||
145430134|NCT03396445|524434007|FG017|Switch-over Period|Death|0|||
145430135|NCT03396445|524434008|FG018|Switch-over Period|Death|1|||
145430136|NCT03396445|524434009|FG019|Switch-over Period|Death|2|||
145430137|NCT03396445|524434010|FG020|Switch-over Period|Death|2|||
145430138|NCT03396445|524434011|FG021|Switch-over Period|Death|1|||
145430139|NCT03396445|524434012|FG022|Switch-over Period|Death|2|||
145430140|NCT03396445|524434013|FG023|Switch-over Period|Death|0|||
145430141|NCT03396445|524434014|FG024|Switch-over Period|Death|1|||
145430142|NCT03396445|524434015|FG025|Switch-over Period|Death|6|||
145430143|NCT03396445|524433990|FG000|Switch-over Period|Lost to Follow-up|0|||
145430144|NCT03396445|524433991|FG001|Switch-over Period|Lost to Follow-up|0|||
145430145|NCT03396445|524433992|FG002|Switch-over Period|Lost to Follow-up|0|||
145430146|NCT03396445|524433993|FG003|Switch-over Period|Lost to Follow-up|0|||
145430147|NCT03396445|524433994|FG004|Switch-over Period|Lost to Follow-up|0|||
145430148|NCT03396445|524433995|FG005|Switch-over Period|Lost to Follow-up|0|||
145430149|NCT03396445|524433996|FG006|Switch-over Period|Lost to Follow-up|0|||
145430150|NCT03396445|524433997|FG007|Switch-over Period|Lost to Follow-up|0|||
145430151|NCT03396445|524433998|FG008|Switch-over Period|Lost to Follow-up|0|||
145430152|NCT03396445|524433999|FG009|Switch-over Period|Lost to Follow-up|0|||
145430153|NCT03396445|524434000|FG010|Switch-over Period|Lost to Follow-up|0|||
145430154|NCT03396445|524434001|FG011|Switch-over Period|Lost to Follow-up|0|||
145582085|NCT03251924|524983263|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
145582086|NCT03251924|524983264|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
145582087|NCT03251924|524983265|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
145582088|NCT03251924|524983266|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
145582089|NCT03251924|524983258|FG000|Overall Study|Death|0|||
145582090|NCT03251924|524983259|FG001|Overall Study|Death|1|||
145582091|NCT03251924|524983260|FG002|Overall Study|Death|0|||
145582092|NCT03251924|524983261|FG003|Overall Study|Death|1|||
145582093|NCT03251924|524983262|FG004|Overall Study|Death|1|||
145582094|NCT03251924|524983263|FG005|Overall Study|Death|1|||
145582095|NCT03251924|524983264|FG006|Overall Study|Death|0|||
145430155|NCT03396445|524434002|FG012|Switch-over Period|Lost to Follow-up|0|||
145430156|NCT03396445|524434003|FG013|Switch-over Period|Lost to Follow-up|0|||
145430157|NCT03396445|524434004|FG014|Switch-over Period|Lost to Follow-up|0|||
145430158|NCT03396445|524434005|FG015|Switch-over Period|Lost to Follow-up|0|||
145430159|NCT03396445|524434006|FG016|Switch-over Period|Lost to Follow-up|0|||
145430160|NCT03396445|524434007|FG017|Switch-over Period|Lost to Follow-up|0|||
145430161|NCT03396445|524434008|FG018|Switch-over Period|Lost to Follow-up|0|||
145582096|NCT03251924|524983265|FG007|Overall Study|Death|0|||
145430162|NCT03396445|524434009|FG019|Switch-over Period|Lost to Follow-up|0|||
145430163|NCT03396445|524434010|FG020|Switch-over Period|Lost to Follow-up|0|||
145430164|NCT03396445|524434011|FG021|Switch-over Period|Lost to Follow-up|0|||
145430165|NCT03396445|524434012|FG022|Switch-over Period|Lost to Follow-up|0|||
145430166|NCT03396445|524434013|FG023|Switch-over Period|Lost to Follow-up|1|||
145430167|NCT03396445|524434014|FG024|Switch-over Period|Lost to Follow-up|0|||
145430168|NCT03396445|524434015|FG025|Switch-over Period|Lost to Follow-up|0|||
145430169|NCT02538614|524434019|FG000|Overall Study|Progressive Disease|2|||
145430170|NCT04622592|524434020|FG000|Overall Study|Death|0|||
145430171|NCT04622592|524434021|FG001|Overall Study|Death|0|||
145430172|NCT04622592|524434022|FG002|Overall Study|Death|1|||
145430173|NCT04622592|524434023|FG003|Overall Study|Death|0|||
145430174|NCT04622592|524434024|FG004|Overall Study|Death|0|||
145430175|NCT04622592|524434025|FG005|Overall Study|Death|0|||
145430176|NCT04622592|524434026|FG006|Overall Study|Death|0|||
145430177|NCT04622592|524434027|FG007|Overall Study|Death|1|||
145430178|NCT04622592|524434020|FG000|Overall Study|Lost to Follow-up|0|||
145430179|NCT04622592|524434021|FG001|Overall Study|Lost to Follow-up|0|||
145430180|NCT04622592|524434022|FG002|Overall Study|Lost to Follow-up|0|||
145430181|NCT04622592|524434023|FG003|Overall Study|Lost to Follow-up|3|||
145430182|NCT04622592|524434024|FG004|Overall Study|Lost to Follow-up|1|||
145430183|NCT04622592|524434025|FG005|Overall Study|Lost to Follow-up|0|||
145430184|NCT04622592|524434026|FG006|Overall Study|Lost to Follow-up|2|||
145430185|NCT04622592|524434027|FG007|Overall Study|Lost to Follow-up|2|||
145430186|NCT04622592|524434020|FG000|Overall Study|Physician Decision|0|||
145430187|NCT04622592|524434021|FG001|Overall Study|Physician Decision|0|||
145430188|NCT04622592|524434022|FG002|Overall Study|Physician Decision|0|||
145430189|NCT04622592|524434023|FG003|Overall Study|Physician Decision|0|||
145430190|NCT04622592|524434024|FG004|Overall Study|Physician Decision|1|||
145430191|NCT04622592|524434025|FG005|Overall Study|Physician Decision|0|||
145430192|NCT04622592|524434026|FG006|Overall Study|Physician Decision|0|||
145430193|NCT04622592|524434027|FG007|Overall Study|Physician Decision|0|||
145430194|NCT04622592|524434020|FG000|Overall Study|Withdrawal by Subject|1|||
145430195|NCT04622592|524434021|FG001|Overall Study|Withdrawal by Subject|0|||
145430196|NCT04622592|524434022|FG002|Overall Study|Withdrawal by Subject|2|||
145430197|NCT04622592|524434023|FG003|Overall Study|Withdrawal by Subject|0|||
145430198|NCT04622592|524434024|FG004|Overall Study|Withdrawal by Subject|0|||
145430199|NCT04622592|524434025|FG005|Overall Study|Withdrawal by Subject|0|||
145430200|NCT04622592|524434026|FG006|Overall Study|Withdrawal by Subject|1|||
145430201|NCT04622592|524434027|FG007|Overall Study|Withdrawal by Subject|4|||
145430202|NCT04622592|524434020|FG000|Overall Study|Other than specified above|0|||
145375018|NCT04908202|524223478|FG003|Active Treatment Period|ONGOING Treatment|114|||
145375019|NCT05397171|524223479|FG000|Overall Study|Death|2|||
145375020|NCT05397171|524223480|FG001|Overall Study|Death|3|||
145375021|NCT05397171|524223481|FG002|Overall Study|Death|3|||
145375022|NCT05397171|524223479|FG000|Overall Study|Study Terminated By Sponsor|1|||
145375023|NCT05397171|524223480|FG001|Overall Study|Study Terminated By Sponsor|2|||
145375024|NCT05397171|524223481|FG002|Overall Study|Study Terminated By Sponsor|3|||
145375025|NCT05397171|524223479|FG000|Overall Study|Withdrawal by Subject|0|||
145375026|NCT05397171|524223480|FG001|Overall Study|Withdrawal by Subject|1|||
145375027|NCT05397171|524223481|FG002|Overall Study|Withdrawal by Subject|1|||
145375028|NCT02100670|524223482|FG000|Overall Study|Adverse Event|10|||
145375029|NCT02100670|524223483|FG001|Overall Study|Adverse Event|3|||
145375030|NCT02100670|524223484|FG002|Overall Study|Adverse Event|3|||
145375031|NCT02100670|524223485|FG003|Overall Study|Adverse Event|0|||
145375032|NCT02100670|524223482|FG000|Overall Study|Lost to Follow-up|1|||
145375033|NCT02100670|524223483|FG001|Overall Study|Lost to Follow-up|0|||
145375034|NCT02100670|524223484|FG002|Overall Study|Lost to Follow-up|0|||
145375035|NCT02100670|524223485|FG003|Overall Study|Lost to Follow-up|0|||
145430203|NCT04622592|524434021|FG001|Overall Study|Other than specified above|0|||
145430204|NCT04622592|524434022|FG002|Overall Study|Other than specified above|1|||
145430205|NCT04622592|524434023|FG003|Overall Study|Other than specified above|0|||
145430206|NCT04622592|524434024|FG004|Overall Study|Other than specified above|0|||
145430207|NCT04622592|524434025|FG005|Overall Study|Other than specified above|0|||
145430208|NCT04622592|524434026|FG006|Overall Study|Other than specified above|0|||
145375036|NCT02100670|524223482|FG000|Overall Study|Protocol Violation|0|||
145430209|NCT04622592|524434027|FG007|Overall Study|Other than specified above|0|||
145430210|NCT03580044|524434033|FG000|Overall Study|Death|2|||
145430211|NCT03580044|524434034|FG001|Overall Study|Death|1|||
145430212|NCT03580044|524434033|FG000|Overall Study|Withdrawal by Subject|1|||
145623933|NCT00410384|525135639|FG002|Overall Study|Lack of Efficacy|17|||
145375037|NCT02100670|524223483|FG001|Overall Study|Protocol Violation|1|||
145375038|NCT02100670|524223484|FG002|Overall Study|Protocol Violation|0|||
145375039|NCT02100670|524223485|FG003|Overall Study|Protocol Violation|1|||
145375040|NCT02100670|524223482|FG000|Overall Study|Withdrawal of Consent|0|||
145375041|NCT02100670|524223483|FG001|Overall Study|Withdrawal of Consent|1|||
145430213|NCT03580044|524434034|FG001|Overall Study|Withdrawal by Subject|1|||
145430214|NCT01664624|524434035|FG000|Overall Study|Adverse Event|0|||
145430215|NCT01664624|524434036|FG001|Overall Study|Adverse Event|1|||
145623934|NCT00410384|525135637|FG000|Overall Study|Lack of Compliance|2|||
145623935|NCT00410384|525135638|FG001|Overall Study|Lack of Compliance|2|||
145623936|NCT00410384|525135639|FG002|Overall Study|Lack of Compliance|2|||
145623937|NCT00410384|525135637|FG000|Overall Study|Lost to Follow-up|4|||
145623938|NCT00410384|525135638|FG001|Overall Study|Lost to Follow-up|6|||
145623939|NCT00410384|525135639|FG002|Overall Study|Lost to Follow-up|6|||
145623940|NCT00410384|525135637|FG000|Overall Study|Protocol Violation|6|||
145623941|NCT00410384|525135638|FG001|Overall Study|Protocol Violation|6|||
145623942|NCT00410384|525135639|FG002|Overall Study|Protocol Violation|6|||
145623943|NCT00410384|525135637|FG000|Overall Study|Physician Decision|3|||
145623944|NCT00410384|525135638|FG001|Overall Study|Physician Decision|3|||
145623945|NCT00410384|525135639|FG002|Overall Study|Physician Decision|4|||
145623946|NCT00410384|525135637|FG000|Overall Study|Other|3|||
145623947|NCT00410384|525135638|FG001|Overall Study|Other|8|||
145623948|NCT00410384|525135639|FG002|Overall Study|Other|4|||
145623949|NCT01253200|525135640|FG000|Overall Study|Death|1|||
145623950|NCT01253200|525135641|FG001|Overall Study|Death|0|||
145623951|NCT01253200|525135642|FG002|Overall Study|Death|0|||
145623952|NCT01253200|525135643|FG003|Overall Study|Death|0|||
145623953|NCT01253200|525135644|FG004|Overall Study|Death|0|||
145623954|NCT01253200|525135640|FG000|Overall Study|Lost to Follow-up|1|||
145623955|NCT01253200|525135641|FG001|Overall Study|Lost to Follow-up|1|||
145623956|NCT01253200|525135642|FG002|Overall Study|Lost to Follow-up|0|||
145623957|NCT01253200|525135643|FG003|Overall Study|Lost to Follow-up|0|||
145623958|NCT01253200|525135644|FG004|Overall Study|Lost to Follow-up|0|||
145375042|NCT02100670|524223484|FG002|Overall Study|Withdrawal of Consent|1|||
145375043|NCT02100670|524223485|FG003|Overall Study|Withdrawal of Consent|0|||
145375044|NCT02100670|524223482|FG000|Overall Study|No swelling no pain|1|||
145375045|NCT02100670|524223483|FG001|Overall Study|No swelling no pain|0|||
145375046|NCT02100670|524223484|FG002|Overall Study|No swelling no pain|0|||
145375047|NCT02100670|524223485|FG003|Overall Study|No swelling no pain|0|||
145375048|NCT02100670|524223482|FG000|Overall Study|Poor Efficacy|0|||
145375049|NCT02100670|524223483|FG001|Overall Study|Poor Efficacy|1|||
145375050|NCT02100670|524223484|FG002|Overall Study|Poor Efficacy|0|||
145375051|NCT02100670|524223485|FG003|Overall Study|Poor Efficacy|0|||
145375052|NCT02100670|524223482|FG000|Overall Study|Physician Decision|0|||
145375053|NCT02100670|524223483|FG001|Overall Study|Physician Decision|1|||
145375054|NCT02100670|524223484|FG002|Overall Study|Physician Decision|0|||
145375055|NCT02100670|524223485|FG003|Overall Study|Physician Decision|0|||
145375056|NCT02100670|524223482|FG000|Overall Study|Withdrawal by Subject|1|||
145375057|NCT02100670|524223483|FG001|Overall Study|Withdrawal by Subject|0|||
145375058|NCT02100670|524223484|FG002|Overall Study|Withdrawal by Subject|0|||
145375059|NCT02100670|524223485|FG003|Overall Study|Withdrawal by Subject|0|||
145375060|NCT01390428|524225180|FG000|Overall Study|Elective Surgery|0|||
145375061|NCT01390428|524225181|FG001|Overall Study|Elective Surgery|0|||
145375062|NCT01390428|524225182|FG002|Overall Study|Elective Surgery|0|||
145375063|NCT01390428|524225183|FG003|Overall Study|Elective Surgery|0|||
145375064|NCT01390428|524225184|FG004|Overall Study|Elective Surgery|1|||
145375065|NCT01390428|524225185|FG005|Overall Study|Elective Surgery|0|||
145375066|NCT01390428|524225180|FG000|Overall Study|Withdrawal by Subject|0|||
145375067|NCT01390428|524225181|FG001|Overall Study|Withdrawal by Subject|0|||
145375068|NCT01390428|524225182|FG002|Overall Study|Withdrawal by Subject|1|||
145375069|NCT01390428|524225183|FG003|Overall Study|Withdrawal by Subject|0|||
145375070|NCT01390428|524225184|FG004|Overall Study|Withdrawal by Subject|0|||
145375071|NCT01390428|524225185|FG005|Overall Study|Withdrawal by Subject|0|||
145375072|NCT05897827|524225188|FG000|Overall Study|Lost to Follow-up|33|||
145375073|NCT05897827|524225189|FG001|Overall Study|Lost to Follow-up|14|||
145375074|NCT05897827|524225188|FG000|Overall Study|Withdrawal by Subject|1|||
145375075|NCT05897827|524225189|FG001|Overall Study|Withdrawal by Subject|1|||
145375076|NCT01004406|524225190|FG000|Overall Study|Withdrawal by Subject|2|||
145375077|NCT01004406|524225191|FG001|Overall Study|Withdrawal by Subject|0|||
145375078|NCT01004406|524225190|FG000|Overall Study|Lost to Follow-up|1|||
145375079|NCT01004406|524225191|FG001|Overall Study|Lost to Follow-up|0|||
145375080|NCT01752634|524225192|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145375081|NCT01752634|524225193|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145375082|NCT01752634|524225194|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
145375083|NCT01752634|524225195|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
145375084|NCT01752634|524225196|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
145375085|NCT01752634|524225197|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
145375086|NCT01752634|524225192|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145375087|NCT01752634|524225193|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
145375088|NCT01752634|524225194|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145430216|NCT01664624|524434037|FG002|Overall Study|Adverse Event|0|||
145623959|NCT01253200|525135640|FG000|Overall Study|Withdrawal by Subject|2|||
145375089|NCT01752634|524225195|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145623960|NCT01253200|525135641|FG001|Overall Study|Withdrawal by Subject|0|||
145623961|NCT01253200|525135642|FG002|Overall Study|Withdrawal by Subject|0|||
145623962|NCT01253200|525135643|FG003|Overall Study|Withdrawal by Subject|0|||
145375090|NCT01752634|524225196|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145375091|NCT01752634|524225197|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
145375092|NCT01752634|524225192|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
145375093|NCT01752634|524225193|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
145375094|NCT01752634|524225194|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145375095|NCT01752634|524225195|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145375096|NCT01752634|524225196|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
145375097|NCT01752634|524225197|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
145375098|NCT01752634|524225192|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
145375099|NCT01752634|524225193|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145375100|NCT01752634|524225194|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
145375101|NCT01752634|524225195|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145375102|NCT01752634|524225196|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
145375103|NCT01752634|524225197|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
145375104|NCT01752634|524225192|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
145375105|NCT01752634|524225193|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
145375106|NCT01752634|524225194|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
145375107|NCT01752634|524225195|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
145375108|NCT01752634|524225196|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
145375109|NCT01752634|524225197|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
145375110|NCT01752634|524225192|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
145375111|NCT01752634|524225193|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
145375112|NCT01752634|524225194|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
145375113|NCT01752634|524225195|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
145375114|NCT01752634|524225196|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
145375115|NCT01752634|524225197|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
145375116|NCT01752634|524225192|FG000|Week 24 to Week 260|Physician Decision|1|||
145375117|NCT01752634|524225193|FG001|Week 24 to Week 260|Physician Decision|2|||
145375118|NCT01752634|524225194|FG002|Week 24 to Week 260|Physician Decision|4|||
145375119|NCT01752634|524225195|FG003|Week 24 to Week 260|Physician Decision|2|||
145375120|NCT01752634|524225196|FG004|Week 24 to Week 260|Physician Decision|1|||
145375121|NCT01752634|524225197|FG005|Week 24 to Week 260|Physician Decision|0|||
145375122|NCT01752634|524225192|FG000|Week 24 to Week 260|Death|0|||
145375123|NCT01752634|524225193|FG001|Week 24 to Week 260|Death|1|||
145375124|NCT01752634|524225194|FG002|Week 24 to Week 260|Death|0|||
145430217|NCT01664624|524434038|FG003|Overall Study|Adverse Event|0|||
145430218|NCT01517984|524434044|FG000|Overall Study|Lost to Follow-up|0|||
145430219|NCT01517984|524434045|FG001|Overall Study|Lost to Follow-up|1|||
145430220|NCT01517984|524434046|FG002|Overall Study|Lost to Follow-up|0|||
145430221|NCT01517984|524434047|FG003|Overall Study|Lost to Follow-up|0|||
145430222|NCT01517984|524434044|FG000|Overall Study|Withdrawal by Subject|1|||
145430223|NCT01517984|524434045|FG001|Overall Study|Withdrawal by Subject|8|||
145430224|NCT01517984|524434046|FG002|Overall Study|Withdrawal by Subject|4|||
145430225|NCT01517984|524434047|FG003|Overall Study|Withdrawal by Subject|1|||
145430226|NCT01517984|524434044|FG000|Overall Study|Screen Failure|4|||
145430227|NCT01517984|524434045|FG001|Overall Study|Screen Failure|0|||
145430228|NCT01517984|524434046|FG002|Overall Study|Screen Failure|0|||
145430229|NCT01517984|524434047|FG003|Overall Study|Screen Failure|0|||
145582097|NCT03251924|524983266|FG008|Overall Study|Death|0|||
145582098|NCT03251924|524983258|FG000|Overall Study|Study Drug Toxicity|0|||
145582099|NCT03251924|524983259|FG001|Overall Study|Study Drug Toxicity|0|||
145582100|NCT03251924|524983260|FG002|Overall Study|Study Drug Toxicity|0|||
145582101|NCT03251924|524983261|FG003|Overall Study|Study Drug Toxicity|1|||
145582102|NCT03251924|524983262|FG004|Overall Study|Study Drug Toxicity|0|||
145582103|NCT03251924|524983263|FG005|Overall Study|Study Drug Toxicity|0|||
145582104|NCT03251924|524983264|FG006|Overall Study|Study Drug Toxicity|0|||
145582105|NCT03251924|524983265|FG007|Overall Study|Study Drug Toxicity|0|||
145582106|NCT03251924|524983266|FG008|Overall Study|Study Drug Toxicity|1|||
145582107|NCT03251924|524983258|FG000|Overall Study|Other Reasons|0|||
145582108|NCT03251924|524983259|FG001|Overall Study|Other Reasons|0|||
145582109|NCT03251924|524983260|FG002|Overall Study|Other Reasons|0|||
145582110|NCT03251924|524983261|FG003|Overall Study|Other Reasons|0|||
145582111|NCT03251924|524983262|FG004|Overall Study|Other Reasons|0|||
145582112|NCT03251924|524983263|FG005|Overall Study|Other Reasons|0|||
145582113|NCT03251924|524983264|FG006|Overall Study|Other Reasons|0|||
145375125|NCT01752634|524225195|FG003|Week 24 to Week 260|Death|0|||
145430230|NCT01517984|524434044|FG000|Overall Study|Ineligible for randomization|0|||
145375126|NCT01752634|524225196|FG004|Week 24 to Week 260|Death|0|||
145375127|NCT01752634|524225197|FG005|Week 24 to Week 260|Death|0|||
145375128|NCT01752634|524225192|FG000|Week 24 to Week 260|Pregnancy|0|||
145430231|NCT01517984|524434045|FG001|Overall Study|Ineligible for randomization|14|||
145582114|NCT03251924|524983265|FG007|Overall Study|Other Reasons|0|||
145375129|NCT01752634|524225193|FG001|Week 24 to Week 260|Pregnancy|0|||
145375130|NCT01752634|524225194|FG002|Week 24 to Week 260|Pregnancy|1|||
145430232|NCT01517984|524434046|FG002|Overall Study|Ineligible for randomization|0|||
145582115|NCT03251924|524983266|FG008|Overall Study|Other Reasons|1|||
145430233|NCT01517984|524434047|FG003|Overall Study|Ineligible for randomization|0|||
145623963|NCT01253200|525135644|FG004|Overall Study|Withdrawal by Subject|0|||
145623964|NCT01253200|525135640|FG000|Overall Study|Protocol Violation|1|||
145430234|NCT04903288|524434049|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
145430235|NCT04903288|524434049|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
145430236|NCT04903288|524434049|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
145430237|NCT04903288|524434049|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
145430238|NCT00573768|524434050|FG000|Overall Study|Adverse Event|1|||
145430239|NCT00573768|524434051|FG001|Overall Study|Adverse Event|1|||
145375131|NCT01752634|524225195|FG003|Week 24 to Week 260|Pregnancy|0|||
145375132|NCT01752634|524225196|FG004|Week 24 to Week 260|Pregnancy|0|||
145375133|NCT01752634|524225197|FG005|Week 24 to Week 260|Pregnancy|0|||
145375134|NCT01752634|524225192|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
145375135|NCT01752634|524225193|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
145375136|NCT01752634|524225194|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
145375137|NCT01752634|524225195|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
145375138|NCT01752634|524225196|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
145375139|NCT01752634|524225197|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
145375140|NCT01752634|524225192|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
145430240|NCT00573768|524434052|FG002|Overall Study|Adverse Event|2|||
145430241|NCT00573768|524434050|FG000|Overall Study|Protocol Violation|1|||
145430242|NCT00573768|524434051|FG001|Overall Study|Protocol Violation|0|||
145430243|NCT00573768|524434052|FG002|Overall Study|Protocol Violation|1|||
145375141|NCT01752634|524225193|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
145375142|NCT01752634|524225194|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
145582116|NCT03251924|524983258|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145582117|NCT03251924|524983259|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145582118|NCT03251924|524983260|FG002|Overall Study|Participant request to discontinue study treatment|0|||
145582119|NCT03251924|524983261|FG003|Overall Study|Participant request to discontinue study treatment|0|||
145582120|NCT03251924|524983262|FG004|Overall Study|Participant request to discontinue study treatment|0|||
145582121|NCT03251924|524983263|FG005|Overall Study|Participant request to discontinue study treatment|0|||
145582122|NCT03251924|524983264|FG006|Overall Study|Participant request to discontinue study treatment|0|||
145582123|NCT03251924|524983265|FG007|Overall Study|Participant request to discontinue study treatment|1|||
145582124|NCT03251924|524983266|FG008|Overall Study|Participant request to discontinue study treatment|0|||
145582125|NCT00153101|524983267|FG000|Overall Study|Lost to Follow-up|14|||
145582126|NCT00153101|524983268|FG001|Overall Study|Lost to Follow-up|14|||
145582127|NCT00153101|524983269|FG002|Overall Study|Lost to Follow-up|12|||
145582128|NCT00153101|524983270|FG003|Overall Study|Lost to Follow-up|5|||
145582129|NCT00153101|524983271|FG004|Overall Study|Lost to Follow-up|5|||
145582130|NCT00153101|524983267|FG000|Overall Study|Withdrawal by Subject|3|||
145582131|NCT00153101|524983268|FG001|Overall Study|Withdrawal by Subject|4|||
145582132|NCT00153101|524983269|FG002|Overall Study|Withdrawal by Subject|3|||
145582133|NCT00153101|524983270|FG003|Overall Study|Withdrawal by Subject|3|||
145582134|NCT00153101|524983271|FG004|Overall Study|Withdrawal by Subject|5|||
145582135|NCT03169153|524983272|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
145582136|NCT03169153|524983273|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
145582137|NCT03169153|524983272|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
145582138|NCT03169153|524983273|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
145582139|NCT03169153|524983272|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
145582140|NCT03169153|524983273|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
145582141|NCT03169153|524983272|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
145582142|NCT03169153|524983273|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
145582143|NCT03299192|524983274|FG000|Overall Study|Fell before classes started|1|||
145582144|NCT03299192|524983275|FG001|Overall Study|Fell before classes started|0|||
145375143|NCT01752634|524225195|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
145375144|NCT01752634|524225196|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
145430244|NCT00573768|524434050|FG000|Overall Study|Withdrawal by Subject|0|||
145430245|NCT00573768|524434051|FG001|Overall Study|Withdrawal by Subject|1|||
145430246|NCT00573768|524434052|FG002|Overall Study|Withdrawal by Subject|0|||
145582145|NCT03299192|524983276|FG002|Overall Study|Fell before classes started|0|||
145582146|NCT03299192|524983274|FG000|Overall Study|Other|0|||
145582147|NCT03299192|524983275|FG001|Overall Study|Other|2|||
145582148|NCT03299192|524983276|FG002|Overall Study|Other|1|||
145623965|NCT01253200|525135641|FG001|Overall Study|Protocol Violation|4|||
145623966|NCT01253200|525135642|FG002|Overall Study|Protocol Violation|0|||
145375145|NCT01752634|524225197|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
145430247|NCT00573768|524434050|FG000|Overall Study|Lost to Follow-up|0|||
145430248|NCT00573768|524434051|FG001|Overall Study|Lost to Follow-up|0|||
145582149|NCT00983580|524983278|FG000|Overall Study|Cancel Prior to treatment|1|||
145582150|NCT00983580|524983279|FG001|Overall Study|Cancel Prior to treatment|3|||
145582151|NCT00983580|524983278|FG000|Overall Study|Protocol Violation|1|||
145430249|NCT00573768|524434052|FG002|Overall Study|Lost to Follow-up|1|||
145582152|NCT00983580|524983279|FG001|Overall Study|Protocol Violation|1|||
145375146|NCT01752634|524225192|FG000|Week 24 to Week 260|Adverse Event|4|||
145375147|NCT01752634|524225193|FG001|Week 24 to Week 260|Adverse Event|8|||
145375148|NCT01752634|524225194|FG002|Week 24 to Week 260|Adverse Event|8|||
145375149|NCT01752634|524225195|FG003|Week 24 to Week 260|Adverse Event|4|||
145375150|NCT01752634|524225196|FG004|Week 24 to Week 260|Adverse Event|2|||
145375151|NCT01752634|524225197|FG005|Week 24 to Week 260|Adverse Event|0|||
145375152|NCT05562934|524225201|FG000|Overall Study|Adverse Event|0|||
145375153|NCT05562934|524225202|FG001|Overall Study|Adverse Event|2|||
145375154|NCT05562934|524225203|FG002|Overall Study|Adverse Event|0|||
145375155|NCT05562934|524225204|FG003|Overall Study|Adverse Event|0|||
145375156|NCT05562934|524225205|FG004|Overall Study|Adverse Event|2|||
145375157|NCT05562934|524225201|FG000|Overall Study|Lost to Follow-up|0|||
145375158|NCT05562934|524225202|FG001|Overall Study|Lost to Follow-up|0|||
145375159|NCT05562934|524225203|FG002|Overall Study|Lost to Follow-up|0|||
145375160|NCT05562934|524225204|FG003|Overall Study|Lost to Follow-up|0|||
145430250|NCT00583219|524434057|FG000|Phase 2|Withdrawal by Subject|1|||
145430251|NCT04617860|524434058|FG000|Overall Study|Adverse Event|0|||
145430252|NCT04617860|524434059|FG001|Overall Study|Adverse Event|2|||
145430253|NCT04617860|524434060|FG002|Overall Study|Adverse Event|2|||
145430254|NCT04617860|524434058|FG000|Overall Study|Withdrawal by Subject|0|||
145430255|NCT04617860|524434059|FG001|Overall Study|Withdrawal by Subject|0|||
145430256|NCT04617860|524434060|FG002|Overall Study|Withdrawal by Subject|2|||
145430257|NCT04617860|524434058|FG000|Overall Study|Physician Decision|0|||
145430258|NCT04617860|524434059|FG001|Overall Study|Physician Decision|1|||
145430259|NCT04617860|524434060|FG002|Overall Study|Physician Decision|0|||
145430260|NCT04617860|524434058|FG000|Overall Study|Sponsor Decision|0|||
145430261|NCT04617860|524434059|FG001|Overall Study|Sponsor Decision|3|||
145430262|NCT04617860|524434060|FG002|Overall Study|Sponsor Decision|1|||
145430263|NCT04617860|524434058|FG000|Overall Study|Termination of Study by Sponsor|8|||
145430264|NCT04617860|524434059|FG001|Overall Study|Termination of Study by Sponsor|4|||
145430265|NCT04617860|524434060|FG002|Overall Study|Termination of Study by Sponsor|13|||
145430266|NCT02507934|524434061|FG000|Overall Study|Lost to Follow-up|2|||
145430267|NCT02507934|524434062|FG001|Overall Study|Lost to Follow-up|0|||
145623967|NCT01253200|525135643|FG003|Overall Study|Protocol Violation|0|||
145623968|NCT01253200|525135644|FG004|Overall Study|Protocol Violation|5|||
145623969|NCT01253200|525135640|FG000|Overall Study|intents|10|||
145623970|NCT01253200|525135641|FG001|Overall Study|intents|10|||
145623971|NCT01253200|525135642|FG002|Overall Study|intents|1|||
145623972|NCT01253200|525135643|FG003|Overall Study|intents|3|||
145623973|NCT01253200|525135644|FG004|Overall Study|intents|0|||
145623974|NCT01253200|525135640|FG000|Overall Study|Attempts|6|||
145623975|NCT01253200|525135641|FG001|Overall Study|Attempts|4|||
145623976|NCT01253200|525135642|FG002|Overall Study|Attempts|1|||
145623977|NCT01253200|525135643|FG003|Overall Study|Attempts|2|||
145623978|NCT01253200|525135644|FG004|Overall Study|Attempts|0|||
145623979|NCT02049437|525135645|FG000|Period 1|Adverse Event|1|||
145623980|NCT02049437|525135646|FG001|Period 1|Adverse Event|1|||
145623981|NCT02049437|525135645|FG000|Period 1|Adverse Event|1|||
145623982|NCT02049437|525135646|FG001|Period 1|Adverse Event|0|||
145623983|NCT00783718|525135647|FG000|Induction Phase|Adverse Event|4|||
145623984|NCT00783718|525135648|FG001|Induction Phase|Adverse Event|0|||
145623985|NCT00783718|525135649|FG002|Induction Phase|Adverse Event|7|||
145623986|NCT00783718|525135650|FG003|Induction Phase|Adverse Event|0|||
145623987|NCT00783718|525135651|FG004|Induction Phase|Adverse Event|0|||
145623988|NCT00783718|525135652|FG005|Induction Phase|Adverse Event|0|||
145623989|NCT00783718|525135653|FG006|Induction Phase|Adverse Event|0|||
145623990|NCT00783718|525135647|FG000|Induction Phase|Protocol Violation|1|||
145623991|NCT00783718|525135648|FG001|Induction Phase|Protocol Violation|1|||
145623992|NCT00783718|525135649|FG002|Induction Phase|Protocol Violation|6|||
145623993|NCT00783718|525135650|FG003|Induction Phase|Protocol Violation|0|||
145623994|NCT00783718|525135651|FG004|Induction Phase|Protocol Violation|0|||
145623995|NCT00783718|525135652|FG005|Induction Phase|Protocol Violation|0|||
145623996|NCT00783718|525135653|FG006|Induction Phase|Protocol Violation|0|||
145623997|NCT00783718|525135647|FG000|Induction Phase|Lack of Efficacy|5|||
145623998|NCT00783718|525135648|FG001|Induction Phase|Lack of Efficacy|2|||
145623999|NCT00783718|525135649|FG002|Induction Phase|Lack of Efficacy|14|||
145624000|NCT00783718|525135650|FG003|Induction Phase|Lack of Efficacy|0|||
145375161|NCT05562934|524225205|FG004|Overall Study|Lost to Follow-up|1|||
145375162|NCT05562934|524225201|FG000|Overall Study|Protocol Violation|0|||
145430268|NCT02507934|524434061|FG000|Overall Study|Withdrawal by Subject|2|||
145430269|NCT02507934|524434062|FG001|Overall Study|Withdrawal by Subject|0|||
145430270|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145375163|NCT05562934|524225202|FG001|Overall Study|Protocol Violation|0|||
145375164|NCT05562934|524225203|FG002|Overall Study|Protocol Violation|0|||
145375165|NCT05562934|524225204|FG003|Overall Study|Protocol Violation|1|||
145375166|NCT05562934|524225205|FG004|Overall Study|Protocol Violation|1|||
145430271|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
145624001|NCT00783718|525135651|FG004|Induction Phase|Lack of Efficacy|0|||
145624002|NCT00783718|525135652|FG005|Induction Phase|Lack of Efficacy|0|||
145624003|NCT00783718|525135653|FG006|Induction Phase|Lack of Efficacy|0|||
145430272|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145430273|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
145430274|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
145430275|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
145430276|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
145430277|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
145430278|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
145430279|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
145430280|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
145430281|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
145430282|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145430283|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145430284|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145430285|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145430286|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
145375167|NCT05562934|524225201|FG000|Overall Study|Withdrawal by Subject|0|||
145375168|NCT05562934|524225202|FG001|Overall Study|Withdrawal by Subject|0|||
145430287|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
145430288|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
145430289|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
145430290|NCT02836249|524434063|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
145430291|NCT02836249|524434064|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145430292|NCT02836249|524434065|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145430293|NCT02836249|524434066|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
145582153|NCT00983580|524983278|FG000|Overall Study|Ineligible|3|||
145375169|NCT05562934|524225203|FG002|Overall Study|Withdrawal by Subject|1|||
145375170|NCT05562934|524225204|FG003|Overall Study|Withdrawal by Subject|1|||
145375171|NCT05562934|524225205|FG004|Overall Study|Withdrawal by Subject|0|||
145375172|NCT05128773|524225208|FG000|Overall Study|Sponsor decision to terminate study|3|||
145375173|NCT04982575|524225209|FG000|Overall Study|Withdrawal by Subject|2|||
145375174|NCT04982575|524225210|FG001|Overall Study|Withdrawal by Subject|0|||
145375175|NCT04982575|524225211|FG002|Overall Study|Withdrawal by Subject|2|||
145375176|NCT04322539|524225216|FG000|Overall Study|Adverse Event|2|||
145375177|NCT04322539|524225217|FG001|Overall Study|Adverse Event|0|||
145375178|NCT04322539|524225216|FG000|Overall Study|Death|411|||
145375179|NCT04322539|524225217|FG001|Overall Study|Death|203|||
145375180|NCT04322539|524225216|FG000|Overall Study|Lost to Follow-up|3|||
145375181|NCT04322539|524225217|FG001|Overall Study|Lost to Follow-up|1|||
145375182|NCT04322539|524225216|FG000|Overall Study|Withdrawal of consent|14|||
145375183|NCT04322539|524225217|FG001|Overall Study|Withdrawal of consent|8|||
145375184|NCT04322539|524225216|FG000|Overall Study|Radiological Disease Progression|6|||
145375185|NCT04322539|524225217|FG001|Overall Study|Radiological Disease Progression|0|||
145375186|NCT04322539|524225216|FG000|Overall Study|Sponsor Decision|19|||
145375187|NCT04322539|524225217|FG001|Overall Study|Sponsor Decision|14|||
145582154|NCT00983580|524983279|FG001|Overall Study|Ineligible|0|||
145582155|NCT01652716|524983280|FG000|Overall Study|Loss of glucose control|1|||
145582156|NCT01652716|524983281|FG001|Overall Study|Loss of glucose control|0|||
145582157|NCT01652716|524983280|FG000|Overall Study|Administrative|0|||
145582158|NCT01652716|524983281|FG001|Overall Study|Administrative|2|||
145582159|NCT01652716|524983280|FG000|Overall Study|Investigator decision|1|||
145582160|NCT01652716|524983281|FG001|Overall Study|Investigator decision|4|||
145582161|NCT01652716|524983280|FG000|Overall Study|Lost to Follow-up|12|||
145582162|NCT01652716|524983281|FG001|Overall Study|Lost to Follow-up|11|||
145582163|NCT01652716|524983280|FG000|Overall Study|Protocol Violation|2|||
145582164|NCT01652716|524983281|FG001|Overall Study|Protocol Violation|1|||
145582165|NCT01652716|524983280|FG000|Overall Study|Adverse Event|7|||
145582166|NCT01652716|524983281|FG001|Overall Study|Adverse Event|10|||
145582167|NCT01652716|524983280|FG000|Overall Study|Withdrawal by Subject|33|||
145582168|NCT01652716|524983281|FG001|Overall Study|Withdrawal by Subject|18|||
145582169|NCT01337297|524983283|FG000|Overall Study|They entered to single anodal tDCS|4|||
145582170|NCT01337297|524983284|FG001|Overall Study|They entered to single anodal tDCS|3|||
145582171|NCT01337297|524983283|FG000|Overall Study|Lost to Follow-up|1|||
145375188|NCT04322539|524225216|FG000|Overall Study|Other|6|||
145375189|NCT04322539|524225217|FG001|Overall Study|Other|4|||
145375190|NCT03617861|524225218|FG000|Second Intervention (1 Day)|Adverse Event|0|||
145430294|NCT02836249|524434063|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145430295|NCT02836249|524434064|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
145582172|NCT01337297|524983284|FG001|Overall Study|Lost to Follow-up|3|||
145582173|NCT02778204|524983285|FG000|Overall Study|Adverse Event|1|||
145582174|NCT02778204|524983286|FG001|Overall Study|Adverse Event|0|||
145582175|NCT02778204|524983287|FG002|Overall Study|Adverse Event|0|||
145375191|NCT03617861|524225219|FG001|Second Intervention (1 Day)|Adverse Event|0|||
145375192|NCT03617861|524225220|FG002|Second Intervention (1 Day)|Adverse Event|1|||
145375193|NCT03617861|524225221|FG003|Second Intervention (1 Day)|Adverse Event|0|||
145430296|NCT02836249|524434065|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
145430297|NCT02836249|524434066|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
145430298|NCT02836249|524434063|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145430299|NCT02836249|524434064|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
145430300|NCT02836249|524434065|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
145430301|NCT02836249|524434066|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
145430302|NCT02836249|524434063|FG000|Open-Label TAF Treatment Phase|Death|0|||
145430303|NCT02836249|524434064|FG001|Open-Label TAF Treatment Phase|Death|0|||
145430304|NCT02836249|524434065|FG002|Open-Label TAF Treatment Phase|Death|1|||
145430305|NCT02836249|524434066|FG003|Open-Label TAF Treatment Phase|Death|0|||
145430306|NCT02836249|524434063|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145430307|NCT02836249|524434064|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145430308|NCT02836249|524434065|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
145430309|NCT02836249|524434066|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
145430310|NCT02836249|524434063|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
145430311|NCT02836249|524434064|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
145430312|NCT02836249|524434065|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
145430313|NCT02836249|524434066|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
145430314|NCT04752566|524434067|FG000|Overall Study|Protocol Violation|0|||
145430315|NCT04752566|524434068|FG001|Overall Study|Protocol Violation|1|||
145430316|NCT04752566|524434067|FG000|Overall Study|Death|1|||
145430317|NCT04752566|524434068|FG001|Overall Study|Death|0|||
145430318|NCT04752566|524434067|FG000|Overall Study|Adverse Event|1|||
145430319|NCT04752566|524434068|FG001|Overall Study|Adverse Event|0|||
145430320|NCT04752566|524434067|FG000|Overall Study|Withdrawal by Subject|2|||
145430321|NCT04752566|524434068|FG001|Overall Study|Withdrawal by Subject|0|||
145430322|NCT04752566|524434067|FG000|Overall Study|Physician Decision|1|||
145430323|NCT04752566|524434068|FG001|Overall Study|Physician Decision|1|||
145430324|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
145430325|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
145430326|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
145430327|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
145430328|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145430329|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
145430330|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145430331|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
145430332|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
145430333|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
145430334|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
145430335|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
145430336|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
145430337|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
145430338|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
145430339|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
145430340|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
145430341|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
145430342|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
145430343|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
145430344|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
145430345|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
145430346|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
145430347|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
145430348|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
145430349|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
145430350|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
145430351|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
145430352|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
145430353|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
145430354|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
145430355|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
145430356|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
145430357|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
145430358|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
145624004|NCT00783718|525135647|FG000|Induction Phase|Withdrawal by Subject|3|||
145624005|NCT00783718|525135648|FG001|Induction Phase|Withdrawal by Subject|4|||
145430359|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
145430360|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
145430361|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
145624006|NCT00783718|525135649|FG002|Induction Phase|Withdrawal by Subject|8|||
145430362|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
145430363|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
145430364|NCT04392154|524434069|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145430365|NCT04392154|524434070|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
145430366|NCT04392154|524434071|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145430367|NCT04392154|524434072|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
145582176|NCT02778204|524983288|FG003|Overall Study|Adverse Event|0|||
145582177|NCT02778204|524983285|FG000|Overall Study|Withdrawal by Subject|0|||
145430368|NCT04392154|524434069|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145430369|NCT04392154|524434070|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145430370|NCT04392154|524434071|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
145430371|NCT04392154|524434072|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
145430372|NCT04392154|524434069|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145430373|NCT04392154|524434070|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145430374|NCT04392154|524434071|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
145430375|NCT04392154|524434072|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
145430376|NCT04392154|524434069|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145430377|NCT04392154|524434070|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145430378|NCT04392154|524434071|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
145430379|NCT04392154|524434072|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
145430380|NCT01559935|524434073|FG000|Car Phase|Toxicity|4|||
145430381|NCT01559935|524434073|FG000|Car Phase|Death|1|||
145430382|NCT01559935|524434073|FG000|Car Phase|Lack of Efficacy|2|||
145430383|NCT01559935|524434073|FG000|Car Phase|Lost to Follow-up|1|||
145430384|NCT01559935|524434073|FG000|Car Phase|Physician Decision|1|||
145430385|NCT01559935|524434073|FG000|Car Phase|Withdrawal by Subject|2|||
145430386|NCT01559935|524434073|FG000|Car Phase|Per protocol|1|||
145430387|NCT01559935|524434073|FG000|Car Phase|Insurance|1|||
145430388|NCT01559935|524434073|FG000|Car Phase|non-compliance|1|||
145430389|NCT01559935|524434073|FG000|BiRD Phase|Toxicity|1|||
145430390|NCT01559935|524434073|FG000|BiRD Phase|Lack of Efficacy|1|||
145430391|NCT01559935|524434073|FG000|BiRD Phase|Withdrawal by Subject|2|||
145430392|NCT01559935|524434073|FG000|Maintenance Phase|Remains on study|28|||
145430393|NCT01559935|524434073|FG000|Maintenance Phase|Toxicity|1|||
145430394|NCT01559935|524434073|FG000|Maintenance Phase|Lack of Efficacy|18|||
145430395|NCT01559935|524434073|FG000|Maintenance Phase|Withdrawal by Subject|5|||
145430396|NCT01559935|524434073|FG000|Maintenance Phase|Non-compliance|2|||
145430397|NCT02661815|524434074|FG000|Overall Study|Withdrawal by Subject|1|||
145430398|NCT02661815|524434075|FG001|Overall Study|Withdrawal by Subject|0|||
145430399|NCT02661815|524434076|FG002|Overall Study|Withdrawal by Subject|0|||
145430400|NCT02661815|524434077|FG003|Overall Study|Withdrawal by Subject|0|||
145430401|NCT00654355|524434084|FG000|Overall Study|Lost to Follow-up|2|||
145375194|NCT01702532|524225222|FG000|Overall Study|Adverse Event|0|||
145375195|NCT01702532|524225223|FG001|Overall Study|Adverse Event|1|||
145375196|NCT00623597|524225224|FG000|Overall Study|Failed to return|1|||
145375197|NCT00623597|524225225|FG001|Overall Study|Failed to return|0|||
145375198|NCT02339155|524225228|FG000|Overall Study|Adverse Event|0|||
145375199|NCT02339155|524225229|FG001|Overall Study|Adverse Event|6|||
145375200|NCT02339155|524225228|FG000|Overall Study|Death|1|||
145375201|NCT02339155|524225229|FG001|Overall Study|Death|1|||
145375202|NCT02339155|524225228|FG000|Overall Study|Lost to Follow-up|8|||
145375203|NCT02339155|524225229|FG001|Overall Study|Lost to Follow-up|9|||
145375204|NCT02339155|524225228|FG000|Overall Study|Physician Decision|2|||
145375205|NCT02339155|524225229|FG001|Overall Study|Physician Decision|1|||
145375206|NCT02339155|524225228|FG000|Overall Study|Withdrawal by Subject|4|||
145375207|NCT02339155|524225229|FG001|Overall Study|Withdrawal by Subject|4|||
145375208|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Adverse Event|0|||
145375209|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Adverse Event|1|||
145430402|NCT00654355|524434085|FG001|Overall Study|Lost to Follow-up|2|||
145430403|NCT05805150|524434090|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
145430404|NCT05805150|524434091|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
145430405|NCT02284893|524434092|FG000|26 Week (Short Term)|Adverse Event|1|||
145430406|NCT02284893|524434093|FG001|26 Week (Short Term)|Adverse Event|9|||
145430407|NCT02284893|524434092|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
145430408|NCT02284893|524434093|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
145430409|NCT02284893|524434092|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
145430410|NCT02284893|524434093|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
145430411|NCT02284893|524434092|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
145375210|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Adverse Event|0|||
145375211|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Adverse Event|0|||
145375212|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Adverse Event|0|||
145375213|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Adverse Event|0|||
145430412|NCT02284893|524434093|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
145375214|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Death|0|||
145375215|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Death|0|||
145375216|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Death|1|||
145375217|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Death|0|||
145375218|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Death|0|||
145375219|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Death|0|||
145375220|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
145375221|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
145375222|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
145375223|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
145375224|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
145375225|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
145375226|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145375227|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145375228|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
145375229|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145375230|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145375231|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
145375232|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145375233|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145375234|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145375235|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
145375236|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145375237|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
145375238|NCT03226678|524225232|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
145375239|NCT03226678|524225233|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
145375240|NCT03226678|524225234|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145375241|NCT03226678|524225235|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145375242|NCT03226678|524225236|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145375243|NCT03226678|524225237|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
145375244|NCT03226678|524225232|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145375245|NCT03226678|524225233|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145375246|NCT03226678|524225234|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145375247|NCT03226678|524225235|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
145375248|NCT03226678|524225236|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
145375249|NCT03226678|524225237|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
145375250|NCT03226678|524225232|FG000|Part B (Long-Term Extension Phase)|Death|0|||
145375251|NCT03226678|524225233|FG001|Part B (Long-Term Extension Phase)|Death|0|||
145375252|NCT03226678|524225234|FG002|Part B (Long-Term Extension Phase)|Death|0|||
145375253|NCT03226678|524225235|FG003|Part B (Long-Term Extension Phase)|Death|0|||
145375254|NCT03226678|524225236|FG004|Part B (Long-Term Extension Phase)|Death|0|||
145375255|NCT03226678|524225237|FG005|Part B (Long-Term Extension Phase)|Death|1|||
145375256|NCT03226678|524225232|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145375257|NCT03226678|524225233|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145375258|NCT03226678|524225234|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145375259|NCT03226678|524225235|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145375260|NCT03226678|524225236|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
145375261|NCT03226678|524225237|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
145375262|NCT03226678|524225232|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145375263|NCT03226678|524225233|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145375264|NCT03226678|524225234|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145375265|NCT03226678|524225235|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
145375266|NCT03226678|524225236|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
145375267|NCT03226678|524225237|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
145375268|NCT03226678|524225232|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145375269|NCT03226678|524225233|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145375270|NCT03226678|524225234|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145375271|NCT03226678|524225235|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145375272|NCT03226678|524225236|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
145375273|NCT03226678|524225237|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
145375274|NCT03427268|524225240|FG000|Overall Study|Progressive disease|25|||
145375275|NCT03427268|524225240|FG000|Overall Study|Never treated|2|||
145375276|NCT03427268|524225240|FG000|Overall Study|Compassionate use|1|||
145375277|NCT03427268|524225240|FG000|Overall Study|Withdrawal by Subject|1|||
145375278|NCT03427268|524225240|FG000|Overall Study|Adverse Event|3|||
145375279|NCT00345878|524225244|FG000|Overall Study|Adverse Event|1|||
145375280|NCT00345878|524225245|FG001|Overall Study|Adverse Event|0|||
145375281|NCT00345878|524225244|FG000|Overall Study|Lost to Follow-up|2|||
145375282|NCT00345878|524225245|FG001|Overall Study|Lost to Follow-up|1|||
145375283|NCT00345878|524225244|FG000|Overall Study|Other|1|||
145375284|NCT00345878|524225245|FG001|Overall Study|Other|0|||
145375285|NCT01643798|524225246|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
145375286|NCT01643798|524225247|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
145375287|NCT01349322|524225249|FG000|Overall Study|Protocol Violation|45|||
145375288|NCT01349322|524225250|FG001|Overall Study|Protocol Violation|47|||
145375289|NCT01097421|524225252|FG000|Overall Study|Adverse Event|8|||
145375290|NCT01097421|524225252|FG000|Overall Study|Protocol Violation|2|||
145375291|NCT01097421|524225252|FG000|Overall Study|Lost to Follow-up|1|||
145375292|NCT01097421|524225252|FG000|Overall Study|Withdrawal by Subject|3|||
145375293|NCT01120249|524225255|FG000|Overall Study|No protocol treatment received|21|||
145375294|NCT01120249|524225256|FG001|Overall Study|No protocol treatment received|15|||
145375295|NCT01120249|524225255|FG000|Overall Study|Disease recurrence|107|||
145375296|NCT01120249|524225256|FG001|Overall Study|Disease recurrence|57|||
145375297|NCT01120249|524225255|FG000|Overall Study|Death|1|||
145375298|NCT01120249|524225256|FG001|Overall Study|Death|0|||
145375299|NCT01120249|524225255|FG000|Overall Study|Adverse Event|40|||
145375300|NCT01120249|524225256|FG001|Overall Study|Adverse Event|276|||
145375301|NCT01120249|524225255|FG000|Overall Study|Participant refusal|34|||
145375302|NCT01120249|524225256|FG001|Overall Study|Participant refusal|42|||
145375303|NCT01120249|524225255|FG000|Overall Study|Other reasons, not protocol specified|29|||
145375304|NCT01120249|524225256|FG001|Overall Study|Other reasons, not protocol specified|22|||
145375305|NCT01482962|524225257|FG000|Overall Study|Progressive Disease|65|||
145375306|NCT01482962|524225258|FG001|Overall Study|Progressive Disease|53|||
145375307|NCT01482962|524225257|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
145375308|NCT01482962|524225258|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
145375309|NCT01482962|524225257|FG000|Overall Study|Adverse Event|18|||
145375310|NCT01482962|524225258|FG001|Overall Study|Adverse Event|22|||
145375311|NCT01482962|524225257|FG000|Overall Study|Withdrawal by Participant|8|||
145375312|NCT01482962|524225258|FG001|Overall Study|Withdrawal by Participant|13|||
145375313|NCT01482962|524225257|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
145375314|NCT01482962|524225258|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
145375315|NCT01482962|524225257|FG000|Overall Study|Other Reason|1|||
145375316|NCT01482962|524225258|FG001|Overall Study|Other Reason|5|||
145375317|NCT01482962|524225257|FG000|Overall Study|Study Terminated by Sponsor|5|||
145375318|NCT01482962|524225258|FG001|Overall Study|Study Terminated by Sponsor|2|||
145375319|NCT01482962|524225257|FG000|Overall Study|Did not Receive Study Drug|1|||
145375320|NCT01482962|524225258|FG001|Overall Study|Did not Receive Study Drug|6|||
145375321|NCT02407457|524225259|FG000|1 Month|Death|3|||
145375322|NCT02407457|524225260|FG001|1 Month|Death|0|||
145375323|NCT02407457|524225259|FG000|1 Month|Lost to Follow-up|1|||
145375324|NCT02407457|524225260|FG001|1 Month|Lost to Follow-up|1|||
145375325|NCT02407457|524225259|FG000|1 Month|missed visit|2|||
145375326|NCT02407457|524225260|FG001|1 Month|missed visit|5|||
145375327|NCT02407457|524225259|FG000|6-Month|Death|2|||
145375328|NCT02407457|524225260|FG001|6-Month|Death|8|||
145375329|NCT02407457|524225259|FG000|6-Month|Lost to Follow-up|2|||
145375330|NCT02407457|524225260|FG001|6-Month|Lost to Follow-up|2|||
145375331|NCT02407457|524225259|FG000|6-Month|missed visit|16|||
145375332|NCT02407457|524225260|FG001|6-Month|missed visit|14|||
145375333|NCT02407457|524225259|FG000|6-Month|Open Repair|0|||
145375334|NCT02407457|524225260|FG001|6-Month|Open Repair|1|||
145375335|NCT02407457|524225259|FG000|1 Year|Death|6|||
145375336|NCT02407457|524225260|FG001|1 Year|Death|11|||
145375337|NCT02407457|524225259|FG000|1 Year|Lost to Follow-up|3|||
145375338|NCT02407457|524225260|FG001|1 Year|Lost to Follow-up|2|||
145375339|NCT02407457|524225259|FG000|1 Year|Missed Visit|24|||
145375340|NCT02407457|524225260|FG001|1 Year|Missed Visit|14|||
145375341|NCT02407457|524225259|FG000|1 Year|Open Repair|0|||
145375342|NCT02407457|524225260|FG001|1 Year|Open Repair|1|||
145375343|NCT02407457|524225259|FG000|2-year|Death|14|||
145582178|NCT02778204|524983286|FG001|Overall Study|Withdrawal by Subject|0|||
145375344|NCT02407457|524225260|FG001|2-year|Death|8|||
145375345|NCT02407457|524225259|FG000|2-year|Lost to Follow-up|7|||
145375346|NCT02407457|524225260|FG001|2-year|Lost to Follow-up|10|||
145375347|NCT02407457|524225259|FG000|2-year|Missed Visit|13|||
145375348|NCT02407457|524225260|FG001|2-year|Missed Visit|15|||
145375349|NCT02407457|524225259|FG000|2-year|Open Repair|0|||
145375350|NCT02407457|524225260|FG001|2-year|Open Repair|2|||
145375351|NCT02407457|524225259|FG000|3-year|Death|11|||
145375352|NCT02407457|524225260|FG001|3-year|Death|10|||
145375353|NCT02407457|524225259|FG000|3-year|Lost to Follow-up|9|||
145375354|NCT02407457|524225260|FG001|3-year|Lost to Follow-up|10|||
145582179|NCT02778204|524983287|FG002|Overall Study|Withdrawal by Subject|1|||
145375355|NCT02407457|524225259|FG000|3-year|Missed Visit|19|||
145375356|NCT02407457|524225260|FG001|3-year|Missed Visit|16|||
145375357|NCT02407457|524225259|FG000|4-year|Death|18|||
145375358|NCT02407457|524225260|FG001|4-year|Death|10|||
145375359|NCT02407457|524225259|FG000|4-year|Lost to Follow-up|10|||
145375360|NCT02407457|524225260|FG001|4-year|Lost to Follow-up|12|||
145375361|NCT02407457|524225259|FG000|4-year|Missed Visit|18|||
145375362|NCT02407457|524225260|FG001|4-year|Missed Visit|16|||
145375363|NCT02407457|524225259|FG000|5-year|Death|10|||
145375364|NCT02407457|524225260|FG001|5-year|Death|3|||
145375365|NCT02407457|524225259|FG000|5-year|Lost to Follow-up|22|||
145375366|NCT02407457|524225260|FG001|5-year|Lost to Follow-up|13|||
145375367|NCT02407457|524225259|FG000|5-year|Missed Visit|9|||
145375368|NCT02407457|524225260|FG001|5-year|Missed Visit|1|||
145375369|NCT03332628|524225263|FG000|Overall Study|Physician Decision|2|||
145375370|NCT02505334|524225266|FG000|Main Treatment Period|Adverse Event|3|||
145375371|NCT02505334|524225267|FG001|Main Treatment Period|Adverse Event|3|||
145375372|NCT02505334|524225266|FG000|Main Treatment Period|Lack of Efficacy|7|||
145375373|NCT02505334|524225267|FG001|Main Treatment Period|Lack of Efficacy|17|||
145375374|NCT02505334|524225266|FG000|Main Treatment Period|Protocol Violation|0|||
145375375|NCT02505334|524225267|FG001|Main Treatment Period|Protocol Violation|1|||
145375376|NCT02505334|524225266|FG000|Main Treatment Period|Withdrawal by Subject|1|||
145375377|NCT02505334|524225267|FG001|Main Treatment Period|Withdrawal by Subject|8|||
145375378|NCT02505334|524225266|FG000|Main Treatment Period|Unclassified|4|||
145375379|NCT02505334|524225267|FG001|Main Treatment Period|Unclassified|10|||
145375380|NCT02505334|524225266|FG000|Extension Treatment Period|Adverse Event|5|||
145375381|NCT02505334|524225267|FG001|Extension Treatment Period|Adverse Event|0|||
145375382|NCT02505334|524225266|FG000|Extension Treatment Period|Lack of Efficacy|4|||
145375383|NCT02505334|524225267|FG001|Extension Treatment Period|Lack of Efficacy|0|||
145375384|NCT02505334|524225266|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
145375385|NCT02505334|524225267|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145375386|NCT02505334|524225266|FG000|Extension Treatment Period|Unclassified|3|||
145375387|NCT02505334|524225267|FG001|Extension Treatment Period|Unclassified|0|||
145375388|NCT01629823|524225271|FG000|Trial Period|Missed visit|11|||
145375389|NCT01629823|524225272|FG001|Trial Period|Missed visit|9|||
145375390|NCT01629823|524225273|FG002|Trial Period|Missed visit|8|||
145375391|NCT01629823|524225271|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145375392|NCT01629823|524225272|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145375393|NCT01629823|524225273|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
145375394|NCT01629823|524225271|FG000|Trial Period|Pregnancy|1|||
145375395|NCT01629823|524225272|FG001|Trial Period|Pregnancy|0|||
145375396|NCT01629823|524225273|FG002|Trial Period|Pregnancy|0|||
145375397|NCT01629823|524225271|FG000|Trial Period|Adverse Event|0|||
145375398|NCT01629823|524225272|FG001|Trial Period|Adverse Event|1|||
145375399|NCT01629823|524225273|FG002|Trial Period|Adverse Event|0|||
145375400|NCT01629823|524225271|FG000|Trial Period|Out-of-window visit|0|||
145375401|NCT01629823|524225272|FG001|Trial Period|Out-of-window visit|2|||
145375402|NCT01629823|524225273|FG002|Trial Period|Out-of-window visit|0|||
145375403|NCT01629823|524225271|FG000|Trial Period|Failed to hold medication|0|||
145375404|NCT01629823|524225272|FG001|Trial Period|Failed to hold medication|0|||
145375405|NCT01629823|524225273|FG002|Trial Period|Failed to hold medication|1|||
145375406|NCT01629823|524225271|FG000|Washout Period|Safety|2|||
145375407|NCT01629823|524225272|FG001|Washout Period|Safety|5|||
145375408|NCT01629823|524225273|FG002|Washout Period|Safety|0|||
145375409|NCT01629823|524225271|FG000|Washout Period|Pregnancy|1|||
145375410|NCT01629823|524225272|FG001|Washout Period|Pregnancy|0|||
145375411|NCT01629823|524225273|FG002|Washout Period|Pregnancy|0|||
145375412|NCT01629823|524225271|FG000|Washout Period|Protocol Violation|0|||
145375413|NCT01629823|524225272|FG001|Washout Period|Protocol Violation|1|||
145375414|NCT01629823|524225273|FG002|Washout Period|Protocol Violation|0|||
145375415|NCT00525902|524225274|FG000|Overall Study|Lack of Efficacy|1|||
145375416|NCT02258542|524225275|FG000|Overall Study|eg. not made to the visit|7|||
145375417|NCT02258542|524225276|FG001|Overall Study|eg. not made to the visit|4|||
145375418|NCT02258542|524225277|FG002|Overall Study|eg. not made to the visit|0|||
145375419|NCT02258542|524225278|FG003|Overall Study|eg. not made to the visit|1|||
145375420|NCT02258542|524225275|FG000|Overall Study|study specific discount. criteria|1|||
145375421|NCT02258542|524225276|FG001|Overall Study|study specific discount. criteria|1|||
145375422|NCT02258542|524225277|FG002|Overall Study|study specific discount. criteria|0|||
145375423|NCT02258542|524225278|FG003|Overall Study|study specific discount. criteria|0|||
145375424|NCT02258542|524225275|FG000|Overall Study|Withdrawal by Subject|20|||
145375425|NCT02258542|524225276|FG001|Overall Study|Withdrawal by Subject|20|||
145375426|NCT02258542|524225277|FG002|Overall Study|Withdrawal by Subject|7|||
145375427|NCT02258542|524225278|FG003|Overall Study|Withdrawal by Subject|1|||
145375428|NCT02258542|524225275|FG000|Overall Study|Lost to Follow-up|5|||
145375429|NCT02258542|524225276|FG001|Overall Study|Lost to Follow-up|12|||
145375430|NCT02258542|524225277|FG002|Overall Study|Lost to Follow-up|1|||
145375431|NCT02258542|524225278|FG003|Overall Study|Lost to Follow-up|2|||
145375432|NCT02258542|524225275|FG000|Overall Study|Death|5|||
145375433|NCT02258542|524225276|FG001|Overall Study|Death|4|||
145375434|NCT02258542|524225277|FG002|Overall Study|Death|0|||
145375435|NCT02258542|524225278|FG003|Overall Study|Death|1|||
145375436|NCT02258542|524225275|FG000|Overall Study|Adverse Event|3|||
145375437|NCT02258542|524225276|FG001|Overall Study|Adverse Event|4|||
145375438|NCT02258542|524225277|FG002|Overall Study|Adverse Event|0|||
145375439|NCT02258542|524225278|FG003|Overall Study|Adverse Event|0|||
145375440|NCT02258542|524225275|FG000|Overall Study|Protocol Violation|1|||
145375441|NCT02258542|524225276|FG001|Overall Study|Protocol Violation|2|||
145375442|NCT02258542|524225277|FG002|Overall Study|Protocol Violation|0|||
145430413|NCT02284893|524434092|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
145375443|NCT02258542|524225278|FG003|Overall Study|Protocol Violation|0|||
145375444|NCT02258542|524225275|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145375445|NCT02258542|524225276|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
145375446|NCT02258542|524225277|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145375447|NCT02258542|524225278|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
145375448|NCT00628095|524225282|FG000|Overall Study|Adverse Event|5|||
145375449|NCT00628095|524225283|FG001|Overall Study|Adverse Event|3|||
145375450|NCT00628095|524225282|FG000|Overall Study|Lack of Efficacy|0|||
145375451|NCT00628095|524225283|FG001|Overall Study|Lack of Efficacy|3|||
145375452|NCT00628095|524225282|FG000|Overall Study|Withdrawal by Subject|2|||
145375453|NCT00628095|524225283|FG001|Overall Study|Withdrawal by Subject|0|||
145375454|NCT00628095|524225282|FG000|Overall Study|Other|0|||
145375455|NCT00628095|524225283|FG001|Overall Study|Other|1|||
145375456|NCT03235115|524225284|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145375457|NCT03235115|524225285|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145375458|NCT03235115|524225286|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145375459|NCT03235115|524225287|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145375460|NCT03235115|524225288|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
145375461|NCT03235115|524225289|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
145375462|NCT05020366|524225292|FG000|Overall Study|Lost to Follow-up|2|||
145375463|NCT05020366|524225293|FG001|Overall Study|Lost to Follow-up|0|||
145375464|NCT05020366|524225292|FG000|Overall Study|Withdrawal by Subject|2|||
145375465|NCT05020366|524225293|FG001|Overall Study|Withdrawal by Subject|0|||
145375466|NCT04326439|524225295|FG000|Overall Study|Withdrawal by Subject|1|||
145375467|NCT04326439|524225296|FG001|Overall Study|Withdrawal by Subject|0|||
145375468|NCT04326439|524225295|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
145375469|NCT04326439|524225296|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
145375470|NCT04326439|524225295|FG000|Overall Study|Relapse after Induction 2|0|||
145375471|NCT04326439|524225296|FG001|Overall Study|Relapse after Induction 2|1|||
145375472|NCT04326439|524225295|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
145375473|NCT04326439|524225296|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
145375474|NCT01032239|524225297|FG000|Overall Study|Lost to Follow-up|3|||
145375475|NCT01032239|524225298|FG001|Overall Study|Lost to Follow-up|2|||
145375476|NCT01032239|524225297|FG000|Overall Study|Withdrawal by Subject|2|||
145375477|NCT01032239|524225298|FG001|Overall Study|Withdrawal by Subject|3|||
145375478|NCT01032239|524225297|FG000|Overall Study|Death|1|||
145375479|NCT01032239|524225298|FG001|Overall Study|Death|0|||
145375480|NCT01032239|524225297|FG000|Overall Study|Protocol Violation|1|||
145375481|NCT01032239|524225298|FG001|Overall Study|Protocol Violation|0|||
145375482|NCT03782298|524225299|FG000|Overall Study|Protocol Deviation|4|||
145375483|NCT01797081|524225300|FG000|Overall Study|Adverse Event|1|||
145375484|NCT01797081|524225301|FG001|Overall Study|Adverse Event|0|||
145375485|NCT01797081|524225302|FG002|Overall Study|Adverse Event|1|||
145375486|NCT01797081|524225303|FG003|Overall Study|Adverse Event|0|||
145375487|NCT01797081|524225300|FG000|Overall Study|Pregnancy|1|||
145375488|NCT01797081|524225301|FG001|Overall Study|Pregnancy|0|||
145375489|NCT01797081|524225302|FG002|Overall Study|Pregnancy|0|||
145375490|NCT01797081|524225303|FG003|Overall Study|Pregnancy|0|||
145375491|NCT01797081|524225300|FG000|Overall Study|Personal Reasons|12|||
145375492|NCT01797081|524225301|FG001|Overall Study|Personal Reasons|4|||
145375493|NCT01797081|524225302|FG002|Overall Study|Personal Reasons|4|||
145375494|NCT01797081|524225303|FG003|Overall Study|Personal Reasons|8|||
145430414|NCT02284893|524434093|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
145430415|NCT02284893|524434092|FG000|26 Week (Short Term)|Other|1|||
145430416|NCT02284893|524434093|FG001|26 Week (Short Term)|Other|1|||
145430417|NCT02284893|524434092|FG000|52 Week (Long Term)|Adverse Event|3|||
145430418|NCT02284893|524434093|FG001|52 Week (Long Term)|Adverse Event|1|||
145624007|NCT00783718|525135650|FG003|Induction Phase|Withdrawal by Subject|0|||
145375495|NCT01797081|524225300|FG000|Overall Study|Protocol Violation|0|||
145375496|NCT01797081|524225301|FG001|Overall Study|Protocol Violation|0|||
145375497|NCT01797081|524225302|FG002|Overall Study|Protocol Violation|0|||
145375498|NCT01797081|524225303|FG003|Overall Study|Protocol Violation|1|||
145375499|NCT05513703|524225307|FG000|Overall Study|Death|4|||
145375500|NCT05513703|524225307|FG000|Overall Study|Study terminated by sponsor|5|||
145375501|NCT01793688|524225311|FG000|Overall Study|Protocol Violation|2|||
145375502|NCT04972968|524225312|FG000|Overall Study|Adverse Event|3|||
145375503|NCT04972968|524225313|FG001|Overall Study|Adverse Event|1|||
145375504|NCT04972968|524225314|FG002|Overall Study|Adverse Event|1|||
145375505|NCT04972968|524225315|FG003|Overall Study|Adverse Event|7|||
145430419|NCT02284893|524434092|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
145624008|NCT00783718|525135651|FG004|Induction Phase|Withdrawal by Subject|0|||
145375506|NCT04972968|524225312|FG000|Overall Study|Lack of Efficacy|2|||
145375507|NCT04972968|524225313|FG001|Overall Study|Lack of Efficacy|1|||
145375508|NCT04972968|524225314|FG002|Overall Study|Lack of Efficacy|0|||
145375509|NCT04972968|524225315|FG003|Overall Study|Lack of Efficacy|0|||
145375510|NCT04972968|524225312|FG000|Overall Study|Withdrawal by Subject|7|||
145375511|NCT04972968|524225313|FG001|Overall Study|Withdrawal by Subject|4|||
145430420|NCT02284893|524434093|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
145430421|NCT02284893|524434092|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
145430422|NCT02284893|524434093|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
145430423|NCT02284893|524434092|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
145430424|NCT02284893|524434093|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
145430425|NCT02284893|524434092|FG000|52 Week (Long Term)|Non-Compliance|2|||
145430426|NCT02284893|524434093|FG001|52 Week (Long Term)|Non-Compliance|3|||
145430427|NCT02757430|524434096|FG000|Overall Study|Physician Decision|6|||
145430428|NCT02757430|524434096|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
145430429|NCT02757430|524434096|FG000|Overall Study|No informed consent|1|||
145430430|NCT02757430|524434096|FG000|Overall Study|No procedure performed|2|||
145430431|NCT02706392|524434108|FG000|Overall Study|Death|1|||
145430432|NCT02706392|524434109|FG001|Overall Study|Death|0|||
145430433|NCT02706392|524434110|FG002|Overall Study|Death|2|||
145430434|NCT02706392|524434111|FG003|Overall Study|Death|2|||
145430435|NCT02706392|524434112|FG004|Overall Study|Death|5|||
145430436|NCT02706392|524434113|FG005|Overall Study|Death|2|||
145430437|NCT01467466|524434117|FG000|Overall Study|Withdrawal by Subject|15|||
145430438|NCT01467466|524434118|FG001|Overall Study|Withdrawal by Subject|18|||
145430439|NCT01467466|524434119|FG002|Overall Study|Withdrawal by Subject|13|||
145430440|NCT01467466|524434120|FG003|Overall Study|Withdrawal by Subject|11|||
145430441|NCT01467466|524434117|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
145430442|NCT01467466|524434118|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
145430443|NCT01467466|524434119|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
145430444|NCT01467466|524434120|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
145430445|NCT01467466|524434117|FG000|Overall Study|Procedure Cancelled|46|||
145430446|NCT01467466|524434118|FG001|Overall Study|Procedure Cancelled|45|||
145430447|NCT01467466|524434119|FG002|Overall Study|Procedure Cancelled|25|||
145430448|NCT01467466|524434120|FG003|Overall Study|Procedure Cancelled|29|||
145430449|NCT01467466|524434117|FG000|Overall Study|No Endpoint Blood Draw|38|||
145430450|NCT01467466|524434118|FG001|Overall Study|No Endpoint Blood Draw|32|||
145430451|NCT01467466|524434119|FG002|Overall Study|No Endpoint Blood Draw|51|||
145430452|NCT01467466|524434120|FG003|Overall Study|No Endpoint Blood Draw|43|||
145430453|NCT00210132|524434123|FG000|Overall Study|Protocol Violation|1|||
145430454|NCT00210132|524434124|FG001|Overall Study|Protocol Violation|4|||
145430455|NCT02711202|524434125|FG000|Overall Study|Adverse Event|3|||
145430456|NCT02711202|524434126|FG001|Overall Study|Adverse Event|0|||
145430457|NCT02711202|524434125|FG000|Overall Study|graft loss|1|||
145430458|NCT02711202|524434126|FG001|Overall Study|graft loss|0|||
145430459|NCT01889251|524434127|FG000|Overall Study|Adverse Event|1|||
145430460|NCT01889251|524434128|FG001|Overall Study|Adverse Event|0|||
145430461|NCT01344226|524434131|FG000|Overall Study|Protocol Violation|2|||
145430462|NCT01344226|524434131|FG000|Overall Study|Withdrawal by Subject|3|||
145430463|NCT01344226|524434131|FG000|Overall Study|Lack of Efficacy|3|||
145430464|NCT03330847|524434132|FG000|Overall Study|Patients ongoing study|62|||
145430465|NCT03330847|524434133|FG001|Overall Study|Patients ongoing study|65|||
145430466|NCT03330847|524434134|FG002|Overall Study|Patients ongoing study|15|||
145430467|NCT05211596|524434137|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
145430468|NCT05211596|524434137|FG000|Baseline to 6 Months|Death|1|||
145430469|NCT05211596|524434137|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
145430470|NCT05211596|524434137|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
145430471|NCT05715827|524434138|FG000|Overall Study|Physician Decision|0|||
145430472|NCT05715827|524434139|FG001|Overall Study|Physician Decision|1|||
145430473|NCT05715827|524434138|FG000|Overall Study|console communication error|0|||
145430474|NCT05715827|524434139|FG001|Overall Study|console communication error|1|||
145430475|NCT04846868|524434140|FG000|Overall Study|Adverse Event|12|||
145430476|NCT04846868|524434141|FG001|Overall Study|Adverse Event|11|||
145430477|NCT04846868|524434140|FG000|Overall Study|Protocol deviation|6|||
145430478|NCT04846868|524434141|FG001|Overall Study|Protocol deviation|2|||
145430479|NCT04846868|524434140|FG000|Overall Study|Perceived lack of efficacy|3|||
145430480|NCT04846868|524434141|FG001|Overall Study|Perceived lack of efficacy|2|||
145430481|NCT04846868|524434140|FG000|Overall Study|Change of residence|2|||
145430482|NCT04846868|524434141|FG001|Overall Study|Change of residence|3|||
145624009|NCT00783718|525135652|FG005|Induction Phase|Withdrawal by Subject|0|||
145430483|NCT04846868|524434140|FG000|Overall Study|Burden of study procedures|1|||
145430484|NCT04846868|524434141|FG001|Overall Study|Burden of study procedures|1|||
145430485|NCT04846868|524434140|FG000|Overall Study|No reason available|2|||
145430486|NCT04846868|524434141|FG001|Overall Study|No reason available|5|||
145430487|NCT04846868|524434140|FG000|Overall Study|Other reason listed|20|||
145430488|NCT04846868|524434141|FG001|Overall Study|Other reason listed|10|||
145430489|NCT04846868|524434140|FG000|Overall Study|Not treated|0|||
145430490|NCT04846868|524434141|FG001|Overall Study|Not treated|1|||
145430491|NCT04116853|524434142|FG000|Overall Study|Adverse Event|1|||
145430492|NCT04116853|524434143|FG001|Overall Study|Adverse Event|3|||
145430493|NCT04116853|524434142|FG000|Overall Study|Lost to Follow-up|2|||
145430494|NCT04116853|524434143|FG001|Overall Study|Lost to Follow-up|0|||
145430495|NCT04116853|524434142|FG000|Overall Study|Incarceration|0|||
145430496|NCT04116853|524434143|FG001|Overall Study|Incarceration|1|||
145430497|NCT04116853|524434142|FG000|Overall Study|Pregnancy|1|||
145430498|NCT04116853|524434143|FG001|Overall Study|Pregnancy|1|||
145430499|NCT04116853|524434142|FG000|Overall Study|Began Other Weight Loss program|4|||
145430500|NCT04116853|524434143|FG001|Overall Study|Began Other Weight Loss program|8|||
145430501|NCT04116853|524434142|FG000|Overall Study|Began Anti-Obesity Medication|3|||
145430502|NCT04116853|524434143|FG001|Overall Study|Began Anti-Obesity Medication|3|||
145430503|NCT04116853|524434142|FG000|Overall Study|Protocol Violation|0|||
145430504|NCT04116853|524434143|FG001|Overall Study|Protocol Violation|1|||
145430505|NCT00618787|524434144|FG000|Overall Study|Adverse Event|0|||
145430506|NCT00618787|524434145|FG001|Overall Study|Adverse Event|1|||
145430507|NCT00618787|524434144|FG000|Overall Study|Withdrawal by Subject|2|||
145430508|NCT00618787|524434145|FG001|Overall Study|Withdrawal by Subject|1|||
145430509|NCT00618787|524434144|FG000|Overall Study|Lost to Follow-up|1|||
145430510|NCT00618787|524434145|FG001|Overall Study|Lost to Follow-up|0|||
145430511|NCT01107886|524434146|FG000|Overall Study|Lost to Follow-up|15|||
145430512|NCT01107886|524434147|FG001|Overall Study|Lost to Follow-up|13|||
145430513|NCT01107886|524434146|FG000|Overall Study|Withdrawal by Subject|180|||
145430514|NCT01107886|524434147|FG001|Overall Study|Withdrawal by Subject|196|||
145430515|NCT01107886|524434146|FG000|Overall Study|Administrative withdrawal of consent|7|||
145430516|NCT01107886|524434147|FG001|Overall Study|Administrative withdrawal of consent|5|||
145430517|NCT01994876|524434148|FG000|Test Period 1|Withdrawal by Subject|0|||
145430518|NCT01994876|524434149|FG001|Test Period 1|Withdrawal by Subject|1|||
145430519|NCT01994876|524434148|FG000|Test Period 1|Adverse Event|0|||
145430520|NCT01994876|524434149|FG001|Test Period 1|Adverse Event|1|||
145430521|NCT01994876|524434148|FG000|Test Period 2|Adverse Event|1|||
145430522|NCT01994876|524434149|FG001|Test Period 2|Adverse Event|0|||
145430523|NCT01994876|524434148|FG000|Test Period 2|Protocol Violation|0|||
145430524|NCT01994876|524434149|FG001|Test Period 2|Protocol Violation|1|||
145430525|NCT05819398|524434150|FG000|Overall Study|Withdrawal by Subject|11|||
145430526|NCT05819398|524434151|FG001|Overall Study|Withdrawal by Subject|7|||
145430527|NCT05819398|524434152|FG002|Overall Study|Withdrawal by Subject|6|||
145430528|NCT05819398|524434153|FG003|Overall Study|Withdrawal by Subject|6|||
145430529|NCT05819398|524434150|FG000|Overall Study|Lost to Follow-up|0|||
145430530|NCT05819398|524434151|FG001|Overall Study|Lost to Follow-up|2|||
145430531|NCT05819398|524434152|FG002|Overall Study|Lost to Follow-up|0|||
145430532|NCT05819398|524434153|FG003|Overall Study|Lost to Follow-up|1|||
145430533|NCT05819398|524434150|FG000|Overall Study|Adverse Event|1|||
145430534|NCT05819398|524434151|FG001|Overall Study|Adverse Event|3|||
145430535|NCT05819398|524434152|FG002|Overall Study|Adverse Event|4|||
145430536|NCT05819398|524434153|FG003|Overall Study|Adverse Event|5|||
145430537|NCT05819398|524434150|FG000|Overall Study|Other than listed|0|||
145430538|NCT05819398|524434151|FG001|Overall Study|Other than listed|2|||
145430539|NCT05819398|524434152|FG002|Overall Study|Other than listed|2|||
145430540|NCT05819398|524434153|FG003|Overall Study|Other than listed|0|||
145430541|NCT05819398|524434150|FG000|Overall Study|Lack of Efficacy|0|||
145430542|NCT05819398|524434151|FG001|Overall Study|Lack of Efficacy|1|||
145430543|NCT05819398|524434152|FG002|Overall Study|Lack of Efficacy|0|||
145430544|NCT05819398|524434153|FG003|Overall Study|Lack of Efficacy|0|||
145430545|NCT05819398|524434150|FG000|Overall Study|Study terminated by sponsor|20|||
145430546|NCT05819398|524434151|FG001|Overall Study|Study terminated by sponsor|18|||
145430547|NCT05819398|524434152|FG002|Overall Study|Study terminated by sponsor|20|||
145430548|NCT05819398|524434153|FG003|Overall Study|Study terminated by sponsor|22|||
145430549|NCT01649869|524434154|FG000|Overall Study|Family member illness|1|||
145430550|NCT01649869|524434155|FG001|Overall Study|Family member illness|0|||
145430551|NCT01649869|524434154|FG000|Overall Study|Required treatment outside protocol|1|||
145430552|NCT01649869|524434155|FG001|Overall Study|Required treatment outside protocol|0|||
145430553|NCT01649869|524434154|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
145430554|NCT01649869|524434155|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
145430555|NCT02776735|524434156|FG000|Overall Study|Adverse Event|0|||
145430556|NCT02776735|524434157|FG001|Overall Study|Adverse Event|0|||
145430557|NCT02776735|524434158|FG002|Overall Study|Adverse Event|0|||
145430558|NCT02776735|524434159|FG003|Overall Study|Adverse Event|1|||
145430559|NCT02776735|524434160|FG004|Overall Study|Adverse Event|0|||
145430560|NCT02776735|524434161|FG005|Overall Study|Adverse Event|1|||
145430561|NCT02776735|524434156|FG000|Overall Study|Lost to Follow-up|0|||
145430562|NCT02776735|524434157|FG001|Overall Study|Lost to Follow-up|0|||
145430563|NCT02776735|524434158|FG002|Overall Study|Lost to Follow-up|0|||
145430564|NCT02776735|524434159|FG003|Overall Study|Lost to Follow-up|1|||
145430565|NCT02776735|524434160|FG004|Overall Study|Lost to Follow-up|0|||
145430566|NCT02776735|524434161|FG005|Overall Study|Lost to Follow-up|0|||
145430567|NCT02776735|524434156|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145430568|NCT02776735|524434157|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145430569|NCT02776735|524434158|FG002|Overall Study|Withdrawal by parent/guardian|2|||
145430570|NCT02776735|524434159|FG003|Overall Study|Withdrawal by parent/guardian|2|||
145430571|NCT02776735|524434160|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145430572|NCT02776735|524434161|FG005|Overall Study|Withdrawal by parent/guardian|0|||
145430573|NCT02776735|524434156|FG000|Overall Study|Withdrawal by Subject|1|||
145375512|NCT04972968|524225314|FG002|Overall Study|Withdrawal by Subject|3|||
145375513|NCT04972968|524225315|FG003|Overall Study|Withdrawal by Subject|2|||
145375514|NCT04972968|524225312|FG000|Overall Study|Study Terminated by Sponsor|25|||
145375515|NCT04972968|524225313|FG001|Overall Study|Study Terminated by Sponsor|28|||
145375516|NCT04972968|524225314|FG002|Overall Study|Study Terminated by Sponsor|32|||
145375517|NCT04972968|524225315|FG003|Overall Study|Study Terminated by Sponsor|27|||
145375518|NCT04972968|524225312|FG000|Overall Study|Other|1|||
145375519|NCT04972968|524225313|FG001|Overall Study|Other|0|||
145375520|NCT04972968|524225314|FG002|Overall Study|Other|1|||
145375521|NCT04972968|524225315|FG003|Overall Study|Other|1|||
145375522|NCT01698879|524225316|FG000|Overall Study|Withdrawal by Subject|1|||
145375523|NCT01698879|524225317|FG001|Overall Study|Withdrawal by Subject|0|||
145375524|NCT01698879|524225318|FG002|Overall Study|Withdrawal by Subject|0|||
145375525|NCT03649178|524225319|FG000|Overall Study|Adverse Event|1|||
145375526|NCT03649178|524225320|FG001|Overall Study|Adverse Event|2|||
145375527|NCT03649178|524225319|FG000|Overall Study|Withdrawal by Subject|0|||
145375528|NCT03649178|524225320|FG001|Overall Study|Withdrawal by Subject|2|||
145375529|NCT03649178|524225319|FG000|Overall Study|COVID regulation required halt in protocol|1|||
145375530|NCT03649178|524225320|FG001|Overall Study|COVID regulation required halt in protocol|0|||
145375531|NCT03003494|524225322|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
145375532|NCT01317797|524225328|FG000|Overall Study|Other|0|||
145375533|NCT01317797|524225329|FG001|Overall Study|Other|1|||
145375534|NCT01317797|524225330|FG002|Overall Study|Other|0|||
145375535|NCT01317797|524225328|FG000|Overall Study|Withdrawal of Patient|0|||
145375536|NCT01317797|524225329|FG001|Overall Study|Withdrawal of Patient|0|||
145375537|NCT01317797|524225330|FG002|Overall Study|Withdrawal of Patient|1|||
145375538|NCT04697056|524226704|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
145375539|NCT04697056|524226705|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
145375540|NCT05741346|524226706|FG000|Overall Study|Withdrawn due to termination of study|28|||
145375541|NCT05906836|524226715|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
145375542|NCT05906836|524226715|FG000|Overall Study|Lost to Follow-up|1|||
145375543|NCT01451164|524226716|FG000|Overall Study|Adverse Event|19|||
145375544|NCT01451164|524226717|FG001|Overall Study|Adverse Event|12|||
145375545|NCT01451164|524226718|FG002|Overall Study|Adverse Event|18|||
145375546|NCT01451164|524226719|FG003|Overall Study|Adverse Event|21|||
145375547|NCT01451164|524226716|FG000|Overall Study|Withdrawal Criteria|1|||
145375548|NCT01451164|524226717|FG001|Overall Study|Withdrawal Criteria|1|||
145375549|NCT01451164|524226718|FG002|Overall Study|Withdrawal Criteria|1|||
145375550|NCT01451164|524226719|FG003|Overall Study|Withdrawal Criteria|1|||
145375551|NCT01451164|524226716|FG000|Overall Study|Physician Decision|2|||
145375552|NCT01451164|524226717|FG001|Overall Study|Physician Decision|0|||
145375553|NCT01451164|524226718|FG002|Overall Study|Physician Decision|1|||
145375554|NCT01451164|524226719|FG003|Overall Study|Physician Decision|0|||
145375555|NCT01451164|524226716|FG000|Overall Study|Withdrawal by Subject|14|||
145375556|NCT01451164|524226717|FG001|Overall Study|Withdrawal by Subject|11|||
145375557|NCT01451164|524226718|FG002|Overall Study|Withdrawal by Subject|16|||
145375558|NCT01451164|524226719|FG003|Overall Study|Withdrawal by Subject|17|||
145375559|NCT01451164|524226716|FG000|Overall Study|Protocol Violation|0|||
145375560|NCT01451164|524226717|FG001|Overall Study|Protocol Violation|1|||
145375561|NCT01451164|524226718|FG002|Overall Study|Protocol Violation|0|||
145375562|NCT01451164|524226719|FG003|Overall Study|Protocol Violation|0|||
145375563|NCT01451164|524226716|FG000|Overall Study|Lack of Efficacy|7|||
145375564|NCT01451164|524226717|FG001|Overall Study|Lack of Efficacy|9|||
145375565|NCT01451164|524226718|FG002|Overall Study|Lack of Efficacy|9|||
145375566|NCT01451164|524226719|FG003|Overall Study|Lack of Efficacy|7|||
145375567|NCT01846221|524226720|FG000|Overall Study|Catheter Failure|2|||
145375568|NCT01846221|524226721|FG001|Overall Study|Catheter Failure|0|||
145375569|NCT01846221|524226720|FG000|Overall Study|Age Exclusion|1|||
145375570|NCT01846221|524226721|FG001|Overall Study|Age Exclusion|0|||
145375571|NCT04599933|524226722|FG000|Overall Study|Adverse Event|4|||
145375572|NCT04599933|524226723|FG001|Overall Study|Adverse Event|1|||
145375573|NCT04599933|524226722|FG000|Overall Study|Withdrawal by Subject|4|||
145375574|NCT04599933|524226723|FG001|Overall Study|Withdrawal by Subject|2|||
145375575|NCT04599933|524226722|FG000|Overall Study|Lost to Follow-up|0|||
145375576|NCT04599933|524226723|FG001|Overall Study|Lost to Follow-up|1|||
145375577|NCT04599933|524226722|FG000|Overall Study|Physician Decision|0|||
145375578|NCT04599933|524226723|FG001|Overall Study|Physician Decision|1|||
145375579|NCT04599933|524226722|FG000|Overall Study|Screen Failure|1|||
145375580|NCT04599933|524226723|FG001|Overall Study|Screen Failure|2|||
145375581|NCT02963558|524226724|FG000|Overall Study|Withdrawn by investigator|1|||
145375582|NCT02963558|524226725|FG001|Overall Study|Withdrawn by investigator|0|||
145375583|NCT02963558|524226724|FG000|Overall Study|Withdrawal by Subject|0|||
145375584|NCT02963558|524226725|FG001|Overall Study|Withdrawal by Subject|1|||
145375585|NCT02045732|524226730|FG000|Overall Study|At the discretion of the investigator|1|||
145375586|NCT02045732|524226731|FG001|Overall Study|At the discretion of the investigator|1|||
145375587|NCT02560623|524226732|FG000|Overall Study|Unable to swallow sponge|0|||
145375588|NCT02560623|524226733|FG001|Overall Study|Unable to swallow sponge|1|||
145375589|NCT02560623|524226734|FG002|Overall Study|Unable to swallow sponge|0|||
145375590|NCT02560623|524226735|FG003|Overall Study|Unable to swallow sponge|0|||
145375591|NCT02560623|524226732|FG000|Overall Study|Intervention prior to sponge administration|0|||
145375592|NCT02560623|524226733|FG001|Overall Study|Intervention prior to sponge administration|1|||
145375593|NCT02560623|524226734|FG002|Overall Study|Intervention prior to sponge administration|0|||
145375594|NCT02560623|524226735|FG003|Overall Study|Intervention prior to sponge administration|0|||
145375595|NCT05014815|524226738|FG000|Overall Study|Death|63|||
145375596|NCT05014815|524226739|FG001|Overall Study|Death|70|||
145375597|NCT05014815|524226738|FG000|Overall Study|Withdrawal by Subject|10|||
145375598|NCT05014815|524226739|FG001|Overall Study|Withdrawal by Subject|10|||
145375599|NCT05014815|524226738|FG000|Overall Study|Lost to Follow-up|4|||
145375600|NCT05014815|524226739|FG001|Overall Study|Lost to Follow-up|2|||
145375601|NCT05014815|524226738|FG000|Overall Study|Physician Decision|2|||
145375602|NCT05014815|524226739|FG001|Overall Study|Physician Decision|4|||
145375603|NCT06303167|524226744|FG000|Overall Study|Ineligible|1|||
145375604|NCT06303167|524226744|FG000|Overall Study|Never start protocol therapy|2|||
145375605|NCT06303167|524226744|FG000|Overall Study|Disease progression|16|||
145375606|NCT04076059|524226747|FG000|Double Blind Phase|Progressive disease|22|||
145375607|NCT04076059|524226748|FG001|Double Blind Phase|Progressive disease|26|||
145430574|NCT02776735|524434157|FG001|Overall Study|Withdrawal by Subject|0|||
145430575|NCT02776735|524434158|FG002|Overall Study|Withdrawal by Subject|0|||
145430576|NCT02776735|524434159|FG003|Overall Study|Withdrawal by Subject|0|||
145430577|NCT02776735|524434160|FG004|Overall Study|Withdrawal by Subject|0|||
145430578|NCT02776735|524434161|FG005|Overall Study|Withdrawal by Subject|1|||
145430579|NCT02776735|524434156|FG000|Overall Study|Other|0|||
145430580|NCT02776735|524434157|FG001|Overall Study|Other|0|||
145430581|NCT02776735|524434158|FG002|Overall Study|Other|3|||
145430582|NCT02776735|524434159|FG003|Overall Study|Other|0|||
145430583|NCT02776735|524434160|FG004|Overall Study|Other|0|||
145430584|NCT02776735|524434161|FG005|Overall Study|Other|0|||
145430585|NCT05847686|524435881|FG000|Overall Study|Withdrawal by Subject|3|||
145430586|NCT03716830|524435882|FG000|Overall Study|Withdrawal by Subject|2|||
145430587|NCT03716830|524435883|FG001|Overall Study|Withdrawal by Subject|2|||
145430588|NCT03716830|524435884|FG002|Overall Study|Withdrawal by Subject|6|||
145430589|NCT03716830|524435885|FG003|Overall Study|Withdrawal by Subject|5|||
145430590|NCT03716830|524435882|FG000|Overall Study|Adverse Event|1|||
145430591|NCT03716830|524435883|FG001|Overall Study|Adverse Event|2|||
145375608|NCT04076059|524226749|FG002|Double Blind Phase|Progressive disease|0|||
145375609|NCT04076059|524226747|FG000|Double Blind Phase|Withdrawal by Subject|4|||
145375610|NCT04076059|524226748|FG001|Double Blind Phase|Withdrawal by Subject|11|||
145375611|NCT04076059|524226749|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145375612|NCT04076059|524226747|FG000|Double Blind Phase|Death|1|||
145375613|NCT04076059|524226748|FG001|Double Blind Phase|Death|1|||
145375614|NCT04076059|524226749|FG002|Double Blind Phase|Death|0|||
145375615|NCT04076059|524226747|FG000|Double Blind Phase|Lost to Follow-up|1|||
145375616|NCT04076059|524226748|FG001|Double Blind Phase|Lost to Follow-up|0|||
145375617|NCT04076059|524226749|FG002|Double Blind Phase|Lost to Follow-up|0|||
145375618|NCT04076059|524226747|FG000|Double Blind Phase|Adverse Event|5|||
145375619|NCT04076059|524226748|FG001|Double Blind Phase|Adverse Event|1|||
145375620|NCT04076059|524226749|FG002|Double Blind Phase|Adverse Event|0|||
145375621|NCT04076059|524226747|FG000|Double Blind Phase|Ongoing Participants|82|||
145375622|NCT04076059|524226748|FG001|Double Blind Phase|Ongoing Participants|18|||
145375623|NCT04076059|524226749|FG002|Double Blind Phase|Ongoing Participants|0|||
145375624|NCT04076059|524226747|FG000|Double Blind Phase|Miscellaneous|3|||
145375625|NCT04076059|524226748|FG001|Double Blind Phase|Miscellaneous|1|||
145375626|NCT04076059|524226749|FG002|Double Blind Phase|Miscellaneous|0|||
145375627|NCT04076059|524226747|FG000|Double Blind Phase|Protocol Deviation|1|||
145375628|NCT04076059|524226748|FG001|Double Blind Phase|Protocol Deviation|1|||
145375629|NCT04076059|524226749|FG002|Double Blind Phase|Protocol Deviation|0|||
145375630|NCT04076059|524226747|FG000|Double Blind Phase|Did not take study drug|1|||
145375631|NCT04076059|524226748|FG001|Double Blind Phase|Did not take study drug|1|||
145375632|NCT04076059|524226749|FG002|Double Blind Phase|Did not take study drug|0|||
145375633|NCT04076059|524226747|FG000|Open Label Phase|Progressive disease|0|||
145375634|NCT04076059|524226748|FG001|Open Label Phase|Progressive disease|0|||
145375635|NCT04076059|524226749|FG002|Open Label Phase|Progressive disease|7|||
145375636|NCT04076059|524226747|FG000|Open Label Phase|Withdrawal by Subject|0|||
145375637|NCT04076059|524226748|FG001|Open Label Phase|Withdrawal by Subject|0|||
145375638|NCT04076059|524226749|FG002|Open Label Phase|Withdrawal by Subject|3|||
145375639|NCT04076059|524226747|FG000|Open Label Phase|Death|0|||
145375640|NCT04076059|524226748|FG001|Open Label Phase|Death|0|||
145375641|NCT04076059|524226749|FG002|Open Label Phase|Death|2|||
145375642|NCT04076059|524226747|FG000|Open Label Phase|Ongoing Participants|0|||
145375643|NCT04076059|524226748|FG001|Open Label Phase|Ongoing Participants|0|||
145375644|NCT04076059|524226749|FG002|Open Label Phase|Ongoing Participants|11|||
145430592|NCT03716830|524435884|FG002|Overall Study|Adverse Event|0|||
145430593|NCT03716830|524435885|FG003|Overall Study|Adverse Event|1|||
145430594|NCT03716830|524435882|FG000|Overall Study|Lost to Follow-up|1|||
145430595|NCT03716830|524435883|FG001|Overall Study|Lost to Follow-up|1|||
145375645|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Death|117|||
145375646|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Death|197|||
145375647|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
145375648|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
145375649|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
145375650|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
145375651|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
145375652|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
145375653|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
145375654|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
145375655|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
145375656|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
145375657|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
145375658|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
145375659|NCT02677896|524226750|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
145375660|NCT02677896|524226751|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
145375661|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
145375662|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
145375663|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
145375664|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
145375665|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
145375666|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
145375667|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
145375668|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
145375669|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
145375670|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
145375671|NCT02677896|524226750|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
145375672|NCT02677896|524226751|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
145375673|NCT03385304|524226755|FG000|Overall Study|Death|19|||
145375674|NCT03385304|524226756|FG001|Overall Study|Death|7|||
145375675|NCT03385304|524226755|FG000|Overall Study|Lost to Follow-up|17|||
145375676|NCT03385304|524226756|FG001|Overall Study|Lost to Follow-up|14|||
145375677|NCT03385304|524226755|FG000|Overall Study|Withdrawal by Subject|3|||
145375678|NCT03385304|524226756|FG001|Overall Study|Withdrawal by Subject|2|||
145375679|NCT03385304|524226755|FG000|Overall Study|Incarceration|2|||
145375680|NCT03385304|524226756|FG001|Overall Study|Incarceration|3|||
145375681|NCT01701193|524226757|FG000|Overall Study|Withdrawal by Subject|2|||
145375682|NCT01701193|524226758|FG001|Overall Study|Withdrawal by Subject|2|||
145375683|NCT01701193|524226759|FG002|Overall Study|Withdrawal by Subject|1|||
145375684|NCT01701193|524226760|FG003|Overall Study|Withdrawal by Subject|2|||
145375685|NCT01701193|524226757|FG000|Overall Study|Adverse Event|1|||
145375686|NCT01701193|524226758|FG001|Overall Study|Adverse Event|0|||
145375687|NCT01701193|524226759|FG002|Overall Study|Adverse Event|0|||
145375688|NCT01701193|524226760|FG003|Overall Study|Adverse Event|0|||
145375689|NCT03181503|524226767|FG000|Overall Study|Adverse Event|2|||
145375690|NCT03181503|524226768|FG001|Overall Study|Adverse Event|2|||
145375691|NCT03181503|524226767|FG000|Overall Study|Protocol Violation|1|||
145375692|NCT03181503|524226768|FG001|Overall Study|Protocol Violation|0|||
145375693|NCT03181503|524226767|FG000|Overall Study|Withdrawal by Subject|3|||
145375694|NCT03181503|524226768|FG001|Overall Study|Withdrawal by Subject|0|||
145375695|NCT03181503|524226767|FG000|Overall Study|Lost to Follow-up|1|||
145375696|NCT03181503|524226768|FG001|Overall Study|Lost to Follow-up|1|||
145375697|NCT01892085|524226771|FG000|Overall Study|Death|4|||
145375698|NCT01892085|524226772|FG001|Overall Study|Death|1|||
145375699|NCT01892085|524226773|FG002|Overall Study|Death|3|||
145375700|NCT01892085|524226771|FG000|Overall Study|Withdrawal by Subject|2|||
145375701|NCT01892085|524226772|FG001|Overall Study|Withdrawal by Subject|0|||
145375702|NCT01892085|524226773|FG002|Overall Study|Withdrawal by Subject|2|||
145375703|NCT01549041|524226774|FG000|Overall Study|Lack of Efficacy|2|||
145375704|NCT01549041|524226775|FG001|Overall Study|Lack of Efficacy|4|||
145375705|NCT01549041|524226774|FG000|Overall Study|Adverse Event|0|||
145375706|NCT01549041|524226775|FG001|Overall Study|Adverse Event|4|||
145375707|NCT01199822|524226780|FG000|Overall Study|Investigator discontinued therapy|0|||
145375708|NCT01199822|524226781|FG001|Overall Study|Investigator discontinued therapy|1|||
145375709|NCT01199822|524226782|FG002|Overall Study|Investigator discontinued therapy|0|||
145375710|NCT00480493|524226783|FG000|Overall Study|moved|2|||
145375711|NCT00480493|524226784|FG001|Overall Study|moved|7|||
145430596|NCT03716830|524435884|FG002|Overall Study|Lost to Follow-up|0|||
145430597|NCT03716830|524435885|FG003|Overall Study|Lost to Follow-up|0|||
145375712|NCT04027075|524226785|FG000|Overall Study|Lost to Follow-up|41|||
145375713|NCT04027075|524226786|FG001|Overall Study|Lost to Follow-up|22|||
145375714|NCT02844907|524226787|FG000|With Dexamethasone|No IV access|1|||
145430598|NCT03309202|524435888|FG000|Overall Study|Lost to Follow-up|1|||
145375715|NCT00550862|524226788|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
145375716|NCT00550862|524226789|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
145375717|NCT00550862|524226790|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
145375718|NCT00550862|524226791|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
145375719|NCT00550862|524226792|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
145375720|NCT00550862|524226788|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
145375721|NCT00550862|524226789|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145375722|NCT00550862|524226790|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
145375723|NCT00550862|524226791|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145375724|NCT00550862|524226792|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
145375725|NCT00550862|524226788|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145375726|NCT00550862|524226789|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145375727|NCT00550862|524226790|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
145375728|NCT00550862|524226791|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145375729|NCT00550862|524226792|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
145375730|NCT00550862|524226788|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145375731|NCT00550862|524226789|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145375732|NCT00550862|524226790|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
145375733|NCT00550862|524226791|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145375734|NCT00550862|524226792|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
145375735|NCT00550862|524226788|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145375736|NCT00550862|524226789|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
145375737|NCT00550862|524226790|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145375738|NCT00550862|524226791|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145375739|NCT00550862|524226792|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
145375740|NCT00550862|524226788|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145375741|NCT00550862|524226789|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145375742|NCT00550862|524226790|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145375743|NCT00550862|524226791|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
145375744|NCT00550862|524226792|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
145430599|NCT03309202|524435889|FG001|Overall Study|Lost to Follow-up|0|||
145430600|NCT03309202|524435890|FG002|Overall Study|Lost to Follow-up|0|||
145430601|NCT03309202|524435891|FG003|Overall Study|Lost to Follow-up|0|||
145430602|NCT01209767|524435892|FG000|Overall Study|Withdrawal by Subject|1|||
145430603|NCT01209767|524435892|FG000|Overall Study|Lost to Follow-up|3|||
145430604|NCT01702298|524435893|FG000|Overall Study|Withdrawal by Subject|1|||
145430605|NCT03898180|524435897|FG000|Overall Study|Death|178|||
145430606|NCT03898180|524435898|FG001|Overall Study|Death|173|||
145430607|NCT03898180|524435897|FG000|Overall Study|Physician Decision|1|||
145430608|NCT03898180|524435898|FG001|Overall Study|Physician Decision|0|||
145430609|NCT03898180|524435897|FG000|Overall Study|Sponsor Decision|3|||
145430610|NCT03898180|524435898|FG001|Overall Study|Sponsor Decision|0|||
145430611|NCT03898180|524435897|FG000|Overall Study|Lost to Follow-up|1|||
145430612|NCT03898180|524435898|FG001|Overall Study|Lost to Follow-up|0|||
145430613|NCT03898180|524435897|FG000|Overall Study|Withdrawal by Subject|5|||
145430614|NCT03898180|524435898|FG001|Overall Study|Withdrawal by Subject|4|||
145430615|NCT03502200|524435906|FG000|Overall Study|Adverse Event|1|||
145430616|NCT03502200|524435907|FG001|Overall Study|Adverse Event|0|||
145430617|NCT03502200|524435906|FG000|Overall Study|Lost to Follow-up|36|||
145430618|NCT03502200|524435907|FG001|Overall Study|Lost to Follow-up|38|||
145430619|NCT03502200|524435906|FG000|Overall Study|Study Team Decision|1|||
145430620|NCT03502200|524435907|FG001|Overall Study|Study Team Decision|1|||
145430621|NCT03502200|524435906|FG000|Overall Study|Withdrawal by Subject|5|||
145430622|NCT03502200|524435907|FG001|Overall Study|Withdrawal by Subject|7|||
145430623|NCT03502200|524435906|FG000|Overall Study|Death|0|||
145430624|NCT03502200|524435907|FG001|Overall Study|Death|2|||
145430625|NCT04138056|524435913|FG000|Primary Study|Lost to Follow-up|3|||
145430626|NCT04138056|524435914|FG001|Primary Study|Lost to Follow-up|4|||
145430627|NCT04138056|524435915|FG002|Primary Study|Lost to Follow-up|1|||
145430628|NCT04138056|524435916|FG003|Primary Study|Lost to Follow-up|1|||
145430629|NCT04138056|524435917|FG004|Primary Study|Lost to Follow-up|4|||
145430630|NCT04138056|524435913|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
145624010|NCT00783718|525135653|FG006|Induction Phase|Withdrawal by Subject|0|||
145430631|NCT04138056|524435914|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
145430632|NCT04138056|524435915|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
145430633|NCT04138056|524435916|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
145430634|NCT04138056|524435917|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
145375745|NCT00550862|524226788|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145375746|NCT00550862|524226789|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145375747|NCT00550862|524226790|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145375748|NCT00550862|524226791|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
145430635|NCT04138056|524435913|FG000|Extension Study|Lost to Follow-up|1|||
145430636|NCT04138056|524435914|FG001|Extension Study|Lost to Follow-up|2|||
145375749|NCT00550862|524226792|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
145375750|NCT00550862|524226788|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145375751|NCT00550862|524226789|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145375752|NCT00550862|524226790|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145375753|NCT00550862|524226791|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
145375754|NCT00550862|524226792|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
145375755|NCT00550862|524226788|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
145375756|NCT00550862|524226789|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
145375757|NCT00550862|524226790|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
145375758|NCT00550862|524226791|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
145375759|NCT00550862|524226792|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
145430637|NCT04138056|524435915|FG002|Extension Study|Lost to Follow-up|1|||
145430638|NCT04138056|524435916|FG003|Extension Study|Lost to Follow-up|0|||
145430639|NCT04138056|524435917|FG004|Extension Study|Lost to Follow-up|1|||
145430640|NCT01276106|524435924|FG000|Overall Study|Adverse Event|3|||
145430641|NCT01276106|524435925|FG001|Overall Study|Adverse Event|3|||
145430642|NCT01276106|524435926|FG002|Overall Study|Adverse Event|11|||
145430643|NCT01276106|524435927|FG003|Overall Study|Adverse Event|3|||
145430644|NCT01276106|524435924|FG000|Overall Study|Withdrawal by Subject|6|||
145430645|NCT01276106|524435925|FG001|Overall Study|Withdrawal by Subject|3|||
145430646|NCT01276106|524435926|FG002|Overall Study|Withdrawal by Subject|1|||
145375760|NCT00550862|524226788|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145375761|NCT00550862|524226789|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145375762|NCT00550862|524226790|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145375763|NCT00550862|524226791|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
145375764|NCT00550862|524226792|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
145375765|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
145375766|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
145375767|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
145375768|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
145375769|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
145430647|NCT01276106|524435927|FG003|Overall Study|Withdrawal by Subject|6|||
145430648|NCT01276106|524435924|FG000|Overall Study|Lack of Efficacy|0|||
145430649|NCT01276106|524435925|FG001|Overall Study|Lack of Efficacy|1|||
145430650|NCT01276106|524435926|FG002|Overall Study|Lack of Efficacy|0|||
145430651|NCT01276106|524435927|FG003|Overall Study|Lack of Efficacy|1|||
145430652|NCT01276106|524435924|FG000|Overall Study|Lost to Follow-up|2|||
145430653|NCT01276106|524435925|FG001|Overall Study|Lost to Follow-up|1|||
145430654|NCT01276106|524435926|FG002|Overall Study|Lost to Follow-up|1|||
145430655|NCT01276106|524435927|FG003|Overall Study|Lost to Follow-up|0|||
145430656|NCT01276106|524435924|FG000|Overall Study|Physician Decision|0|||
145430657|NCT01276106|524435925|FG001|Overall Study|Physician Decision|0|||
145430658|NCT01276106|524435926|FG002|Overall Study|Physician Decision|1|||
145430659|NCT01276106|524435927|FG003|Overall Study|Physician Decision|1|||
145430660|NCT01276106|524435924|FG000|Overall Study|Protocol Violation|1|||
145375770|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
145375771|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
145375772|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
145375773|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
145375774|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
145375775|NCT00455520|524226793|FG000|Open Label Tapentadol Extended Release|All other|33|||
145375776|NCT00455520|524226794|FG001|Open Label Tapentadol Extended Release|All other|0|||
145375777|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
145375778|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
145375779|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
145375780|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
145430661|NCT01276106|524435925|FG001|Overall Study|Protocol Violation|1|||
145430662|NCT01276106|524435926|FG002|Overall Study|Protocol Violation|0|||
145582180|NCT02778204|524983288|FG003|Overall Study|Withdrawal by Subject|2|||
145430663|NCT01276106|524435927|FG003|Overall Study|Protocol Violation|2|||
145430664|NCT01276106|524435924|FG000|Overall Study|Insufficient therapeutic effects|0|||
145430665|NCT01276106|524435925|FG001|Overall Study|Insufficient therapeutic effects|0|||
145430666|NCT01276106|524435926|FG002|Overall Study|Insufficient therapeutic effects|2|||
145582181|NCT02778204|524983285|FG000|Overall Study|Lost to Follow-up|1|||
145582182|NCT02778204|524983286|FG001|Overall Study|Lost to Follow-up|0|||
145375781|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
145375782|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
145375783|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
145375784|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
145375785|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
145375786|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
145375787|NCT00455520|524226793|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
145375788|NCT00455520|524226794|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
145375789|NCT00986986|524226797|FG000|Overall Study|Lost to Follow-up|0|||
145375790|NCT00986986|524226798|FG001|Overall Study|Lost to Follow-up|1|||
145375791|NCT00955968|524226803|FG000|Overall Study|Death|2|||
145375792|NCT00955968|524226804|FG001|Overall Study|Death|4|||
145375793|NCT00955968|524226803|FG000|Overall Study|Withdrawal by Subject|35|||
145375794|NCT00955968|524226804|FG001|Overall Study|Withdrawal by Subject|31|||
145375795|NCT00955968|524226803|FG000|Overall Study|Lost to Follow-up|45|||
145375796|NCT00955968|524226804|FG001|Overall Study|Lost to Follow-up|39|||
145375797|NCT00955968|524226803|FG000|Overall Study|Site closed|55|||
145375798|NCT00955968|524226804|FG001|Overall Study|Site closed|52|||
145375799|NCT01785849|524226805|FG000|Overall Study|Death|7|||
145375800|NCT01785849|524226806|FG001|Overall Study|Death|9|||
145375801|NCT01785849|524226805|FG000|Overall Study|Protocol Specified Criteria|29|||
145375802|NCT01785849|524226806|FG001|Overall Study|Protocol Specified Criteria|1|||
145375803|NCT01785849|524226805|FG000|Overall Study|Withdrawal by Subject|15|||
145375804|NCT01785849|524226806|FG001|Overall Study|Withdrawal by Subject|12|||
145375805|NCT01785849|524226805|FG000|Overall Study|Sponsor Decision|0|||
145375806|NCT01785849|524226806|FG001|Overall Study|Sponsor Decision|1|||
145375807|NCT01785849|524226805|FG000|Overall Study|Lost to Follow-up|10|||
145375808|NCT01785849|524226806|FG001|Overall Study|Lost to Follow-up|11|||
145375809|NCT01940900|524226807|FG000|Overall Study|Physician Decision|4|||
145375810|NCT01940900|524226808|FG001|Overall Study|Physician Decision|0|||
145375811|NCT01940900|524226807|FG000|Overall Study|Adverse Event|10|||
145375812|NCT01940900|524226808|FG001|Overall Study|Adverse Event|15|||
145375813|NCT01940900|524226807|FG000|Overall Study|Withdrawal by Subject|11|||
145375814|NCT01940900|524226808|FG001|Overall Study|Withdrawal by Subject|15|||
145375815|NCT01940900|524226807|FG000|Overall Study|Lost to Follow-up|1|||
145375816|NCT01940900|524226808|FG001|Overall Study|Lost to Follow-up|0|||
145375817|NCT01940900|524226807|FG000|Overall Study|Sponsor Decision|1|||
145375818|NCT01940900|524226808|FG001|Overall Study|Sponsor Decision|0|||
145375819|NCT01940900|524226807|FG000|Overall Study|subject non-compliance|1|||
145375820|NCT01940900|524226808|FG001|Overall Study|subject non-compliance|1|||
145375821|NCT01940900|524226807|FG000|Overall Study|other|1|||
145375822|NCT01940900|524226808|FG001|Overall Study|other|0|||
145375823|NCT00742508|524226811|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
145375824|NCT00742508|524226812|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
145375825|NCT00742508|524226811|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
145375826|NCT00742508|524226812|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
145375827|NCT00742508|524226811|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
145375828|NCT00742508|524226812|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
145375829|NCT00742508|524226811|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
145375830|NCT00742508|524226812|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
145375831|NCT00742508|524226811|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
145375832|NCT00742508|524226812|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
145375833|NCT02431806|524226813|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
145375834|NCT02431806|524226814|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
145375835|NCT02431806|524226815|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
145375836|NCT02431806|524226816|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
145375837|NCT02431806|524226813|FG000|Double-blind Treatment Period|Adverse Event|4|||
145375838|NCT02431806|524226814|FG001|Double-blind Treatment Period|Adverse Event|7|||
145375839|NCT02431806|524226815|FG002|Double-blind Treatment Period|Adverse Event|11|||
145375840|NCT02431806|524226816|FG003|Double-blind Treatment Period|Adverse Event|7|||
145375841|NCT02431806|524226813|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
145375842|NCT02431806|524226814|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145375843|NCT02431806|524226815|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
145375844|NCT02431806|524226816|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
145375845|NCT02431806|524226813|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
145375846|NCT02431806|524226814|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
145375847|NCT02431806|524226815|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
145375848|NCT02431806|524226816|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
145375849|NCT02431806|524226813|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
145375850|NCT02431806|524226814|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
145375851|NCT02431806|524226815|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
145375852|NCT02431806|524226816|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
145375853|NCT02431806|524226813|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
145375854|NCT02431806|524226814|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
145375855|NCT02431806|524226815|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
145375856|NCT02431806|524226816|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
145375857|NCT02431806|524226813|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
145375858|NCT02431806|524226814|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
145375859|NCT02431806|524226815|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
145375860|NCT02431806|524226816|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
145375861|NCT04450407|524226819|FG000|Overall Study|Withdrawal by Subject|10|||
145375862|NCT04450407|524226820|FG001|Overall Study|Withdrawal by Subject|1|||
145375863|NCT04450407|524226821|FG002|Overall Study|Withdrawal by Subject|4|||
145375864|NCT04450407|524226819|FG000|Overall Study|Adverse Event|0|||
145375865|NCT04450407|524226820|FG001|Overall Study|Adverse Event|0|||
145375866|NCT04450407|524226821|FG002|Overall Study|Adverse Event|1|||
145375867|NCT04450407|524226819|FG000|Overall Study|Lost to Follow-up|1|||
145375868|NCT04450407|524226820|FG001|Overall Study|Lost to Follow-up|0|||
145375869|NCT04450407|524226821|FG002|Overall Study|Lost to Follow-up|0|||
145375870|NCT04450407|524226819|FG000|Overall Study|Physician Decision|0|||
145375871|NCT04450407|524226820|FG001|Overall Study|Physician Decision|0|||
145375872|NCT04450407|524226821|FG002|Overall Study|Physician Decision|1|||
145375873|NCT04450407|524226819|FG000|Overall Study|Pregnancy|1|||
145375874|NCT04450407|524226820|FG001|Overall Study|Pregnancy|0|||
145375875|NCT04450407|524226821|FG002|Overall Study|Pregnancy|0|||
145375876|NCT04450407|524226819|FG000|Overall Study|Protocol Violation|2|||
145375877|NCT04450407|524226820|FG001|Overall Study|Protocol Violation|0|||
145375878|NCT04450407|524226821|FG002|Overall Study|Protocol Violation|0|||
145375879|NCT04450407|524226819|FG000|Overall Study|Investigational site terminated by sponsor|3|||
145375880|NCT04450407|524226820|FG001|Overall Study|Investigational site terminated by sponsor|0|||
145375881|NCT04450407|524226821|FG002|Overall Study|Investigational site terminated by sponsor|2|||
145375882|NCT00474045|524226822|FG000|Overall Study|Adverse Event|18|||
145375883|NCT00474045|524226823|FG001|Overall Study|Adverse Event|8|||
145375884|NCT00474045|524226822|FG000|Overall Study|Unclassified|1|||
145375885|NCT00474045|524226823|FG001|Overall Study|Unclassified|3|||
145375886|NCT00474045|524226822|FG000|Overall Study|Lack of Efficacy|0|||
145375887|NCT00474045|524226823|FG001|Overall Study|Lack of Efficacy|9|||
145375888|NCT00474045|524226822|FG000|Overall Study|Lost to Follow-up|1|||
145375889|NCT00474045|524226823|FG001|Overall Study|Lost to Follow-up|1|||
145375890|NCT00474045|524226822|FG000|Overall Study|Protocol Violation|10|||
145375891|NCT00474045|524226823|FG001|Overall Study|Protocol Violation|12|||
145375892|NCT00474045|524226822|FG000|Overall Study|Withdrawal by Subject|16|||
145375893|NCT00474045|524226823|FG001|Overall Study|Withdrawal by Subject|18|||
145375894|NCT00474045|524226822|FG000|Overall Study|Withdrawal criteria|60|||
145375895|NCT00474045|524226823|FG001|Overall Study|Withdrawal criteria|50|||
145375896|NCT02009397|524226824|FG000|Overall Study|Protocol Violation|6|||
145375897|NCT02009397|524226824|FG000|Overall Study|Death|8|||
145375898|NCT02009397|524226824|FG000|Overall Study|Lost to Follow-up|6|||
145375899|NCT01645891|524226830|FG000|Overall Study|Adverse Event|6|||
145375900|NCT01645891|524226831|FG001|Overall Study|Adverse Event|10|||
145375901|NCT01645891|524226830|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
145375902|NCT01645891|524226831|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
145375903|NCT01645891|524226830|FG000|Overall Study|Withdrawal by Subject|3|||
145375904|NCT01645891|524226831|FG001|Overall Study|Withdrawal by Subject|3|||
145375905|NCT01645891|524226830|FG000|Overall Study|Protocol Violation|4|||
145375906|NCT01645891|524226831|FG001|Overall Study|Protocol Violation|0|||
145375907|NCT01645891|524226830|FG000|Overall Study|Lost to Follow-up|4|||
145375908|NCT01645891|524226831|FG001|Overall Study|Lost to Follow-up|1|||
145375909|NCT01645891|524226830|FG000|Overall Study|Death|0|||
145375910|NCT01645891|524226831|FG001|Overall Study|Death|2|||
145375911|NCT01173055|524226834|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
145375912|NCT01173055|524226835|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
145375913|NCT01173055|524226834|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
145375914|NCT01173055|524226835|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
145375915|NCT04814368|524226836|FG000|Overall Study|Study Terminated by Sponsor|0|||
145375916|NCT04814368|524226837|FG001|Overall Study|Study Terminated by Sponsor|3|||
145375917|NCT04814368|524226838|FG002|Overall Study|Study Terminated by Sponsor|0|||
145375918|NCT04814368|524226839|FG003|Overall Study|Study Terminated by Sponsor|2|||
145375919|NCT04814368|524226836|FG000|Overall Study|Subject Decision|1|||
145375920|NCT04814368|524226837|FG001|Overall Study|Subject Decision|2|||
145375921|NCT04814368|524226838|FG002|Overall Study|Subject Decision|0|||
145375922|NCT04814368|524226839|FG003|Overall Study|Subject Decision|0|||
145375923|NCT02928770|524227970|FG000|Overall Study|Withdrawal by Subject|2|||
145375924|NCT04250714|524227975|FG000|Overall Study|Treatment - withdrawal by subject|14|||
145375925|NCT04250714|524227975|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
145375926|NCT04250714|524227975|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
145375927|NCT04250714|524227975|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
145375928|NCT04250714|524227975|FG000|Overall Study|Treatment - Death|1|||
145375929|NCT04250714|524227975|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
145375930|NCT04250714|524227975|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
145375931|NCT04250714|524227975|FG000|Overall Study|Attempt|2|||
145375932|NCT04250714|524227975|FG000|Overall Study|Intent|7|||
145375933|NCT04392167|524227982|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
145375934|NCT00473824|524227983|FG000|Overall Study|Virologic Breakthrough|1|||
145375935|NCT00473824|524227984|FG001|Overall Study|Virologic Breakthrough|0|||
145375936|NCT00473824|524227983|FG000|Overall Study|Adverse Event|1|||
145375937|NCT00473824|524227984|FG001|Overall Study|Adverse Event|0|||
145375938|NCT00473824|524227983|FG000|Overall Study|Death|1|||
145375939|NCT00473824|524227984|FG001|Overall Study|Death|0|||
145375940|NCT00473824|524227983|FG000|Overall Study|Lost to Follow-up|1|||
145375941|NCT00473824|524227984|FG001|Overall Study|Lost to Follow-up|0|||
145375942|NCT00473824|524227983|FG000|Overall Study|Withdrawal by physician|1|||
145375943|NCT00473824|524227984|FG001|Overall Study|Withdrawal by physician|0|||
145375944|NCT04247880|524227985|FG000|Overall Study|Lost to Follow-up|24|||
145375945|NCT04247880|524227986|FG001|Overall Study|Lost to Follow-up|17|||
145375946|NCT04247880|524227985|FG000|Overall Study|Withdrawal by Subject|3|||
145375947|NCT04247880|524227986|FG001|Overall Study|Withdrawal by Subject|0|||
145375948|NCT02720744|524227988|FG000|Overall Study|Protocol Violation|0|||
145375949|NCT02720744|524227989|FG001|Overall Study|Protocol Violation|2|||
145375950|NCT02720744|524227988|FG000|Overall Study|Pregnancy|2|||
145375951|NCT02720744|524227989|FG001|Overall Study|Pregnancy|0|||
145375952|NCT02720744|524227988|FG000|Overall Study|Lack of Efficacy|2|||
145375953|NCT02720744|524227989|FG001|Overall Study|Lack of Efficacy|8|||
145375954|NCT02720744|524227988|FG000|Overall Study|Adverse Event|21|||
145375955|NCT02720744|524227989|FG001|Overall Study|Adverse Event|3|||
145375956|NCT02720744|524227988|FG000|Overall Study|Withdrawal by Subject|11|||
145375957|NCT02720744|524227989|FG001|Overall Study|Withdrawal by Subject|11|||
145375958|NCT02720744|524227988|FG000|Overall Study|Lost to follow up|2|||
145375959|NCT02720744|524227989|FG001|Overall Study|Lost to follow up|0|||
145375960|NCT02720744|524227988|FG000|Overall Study|Non Compliance with Investigational Product|0|||
145375961|NCT02720744|524227989|FG001|Overall Study|Non Compliance with Investigational Product|1|||
145375962|NCT02720744|524227988|FG000|Overall Study|Excluded Concomitant Medication|0|||
145375963|NCT02720744|524227989|FG001|Overall Study|Excluded Concomitant Medication|1|||
145375964|NCT02052596|524227998|FG000|Active Phase|Adverse Event|3|||
145375965|NCT02052596|524227999|FG001|Active Phase|Adverse Event|2|||
145375966|NCT02052596|524227998|FG000|Active Phase|Lost to Follow-up|8|||
145375967|NCT02052596|524227999|FG001|Active Phase|Lost to Follow-up|11|||
145375968|NCT02052596|524227998|FG000|Active Phase|Protocol Violation|1|||
145375969|NCT02052596|524227999|FG001|Active Phase|Protocol Violation|2|||
145375970|NCT02052596|524227998|FG000|Active Phase|Withdrawal by Subject|3|||
145375971|NCT02052596|524227999|FG001|Active Phase|Withdrawal by Subject|4|||
145375972|NCT02052596|524227998|FG000|Active Phase|Enrolled in error|1|||
145375973|NCT02052596|524227999|FG001|Active Phase|Enrolled in error|0|||
145375974|NCT02052596|524227998|FG000|Active Phase|Lost due to Crohn's disease|0|||
145375975|NCT02052596|524227999|FG001|Active Phase|Lost due to Crohn's disease|1|||
145375976|NCT02052596|524227998|FG000|Safety Phase|Adverse Event|6|||
145375977|NCT02052596|524227999|FG001|Safety Phase|Adverse Event|3|||
145375978|NCT02052596|524227998|FG000|Safety Phase|Lost to Follow-up|11|||
145375979|NCT02052596|524227999|FG001|Safety Phase|Lost to Follow-up|18|||
145375980|NCT02052596|524227998|FG000|Safety Phase|Protocol Violation|1|||
145375981|NCT02052596|524227999|FG001|Safety Phase|Protocol Violation|2|||
145375982|NCT02052596|524227998|FG000|Safety Phase|Withdrawal by Subject|8|||
145375983|NCT02052596|524227999|FG001|Safety Phase|Withdrawal by Subject|11|||
145375984|NCT02052596|524227998|FG000|Safety Phase|Enrolled in error|1|||
145375985|NCT02052596|524227999|FG001|Safety Phase|Enrolled in error|0|||
145375986|NCT02052596|524227998|FG000|Safety Phase|Lost due to Crohn's disease|0|||
145375987|NCT02052596|524227999|FG001|Safety Phase|Lost due to Crohn's disease|1|||
145375988|NCT00558896|524228000|FG000|Overall Study|Adverse Event|1|||
145375989|NCT00558896|524228001|FG001|Overall Study|Adverse Event|1|||
145375990|NCT00558896|524228002|FG002|Overall Study|Adverse Event|1|||
145375991|NCT00558896|524228003|FG003|Overall Study|Adverse Event|3|||
145375992|NCT00558896|524228004|FG004|Overall Study|Adverse Event|4|||
145375993|NCT00558896|524228005|FG005|Overall Study|Adverse Event|10|||
145375994|NCT00558896|524228006|FG006|Overall Study|Adverse Event|3|||
145375995|NCT00558896|524228000|FG000|Overall Study|Death|3|||
145375996|NCT00558896|524228001|FG001|Overall Study|Death|0|||
145375997|NCT00558896|524228002|FG002|Overall Study|Death|2|||
145375998|NCT00558896|524228003|FG003|Overall Study|Death|3|||
145375999|NCT00558896|524228004|FG004|Overall Study|Death|2|||
145376000|NCT00558896|524228005|FG005|Overall Study|Death|2|||
145376001|NCT00558896|524228006|FG006|Overall Study|Death|6|||
145376002|NCT00558896|524228000|FG000|Overall Study|Withdrawal by Subject|2|||
145376003|NCT00558896|524228001|FG001|Overall Study|Withdrawal by Subject|1|||
145376004|NCT00558896|524228002|FG002|Overall Study|Withdrawal by Subject|1|||
145376005|NCT00558896|524228003|FG003|Overall Study|Withdrawal by Subject|1|||
145376006|NCT00558896|524228004|FG004|Overall Study|Withdrawal by Subject|1|||
145376007|NCT00558896|524228005|FG005|Overall Study|Withdrawal by Subject|5|||
145376008|NCT00558896|524228006|FG006|Overall Study|Withdrawal by Subject|5|||
145376009|NCT00558896|524228000|FG000|Overall Study|Alternative Treatment|2|||
145376010|NCT00558896|524228001|FG001|Overall Study|Alternative Treatment|2|||
145376011|NCT00558896|524228002|FG002|Overall Study|Alternative Treatment|0|||
145376012|NCT00558896|524228003|FG003|Overall Study|Alternative Treatment|2|||
145376013|NCT00558896|524228004|FG004|Overall Study|Alternative Treatment|6|||
145376014|NCT00558896|524228005|FG005|Overall Study|Alternative Treatment|7|||
145376015|NCT00558896|524228006|FG006|Overall Study|Alternative Treatment|1|||
145376016|NCT00558896|524228000|FG000|Overall Study|Physician discretion|3|||
145376017|NCT00558896|524228001|FG001|Overall Study|Physician discretion|2|||
145376018|NCT00558896|524228002|FG002|Overall Study|Physician discretion|1|||
145376019|NCT00558896|524228003|FG003|Overall Study|Physician discretion|2|||
145376020|NCT00558896|524228004|FG004|Overall Study|Physician discretion|1|||
145376021|NCT00558896|524228005|FG005|Overall Study|Physician discretion|3|||
145376022|NCT00558896|524228006|FG006|Overall Study|Physician discretion|3|||
145376023|NCT00558896|524228000|FG000|Overall Study|Continues on treatment|10|||
145376024|NCT00558896|524228001|FG001|Overall Study|Continues on treatment|1|||
145376025|NCT00558896|524228002|FG002|Overall Study|Continues on treatment|0|||
145376026|NCT00558896|524228003|FG003|Overall Study|Continues on treatment|1|||
145376027|NCT00558896|524228004|FG004|Overall Study|Continues on treatment|9|||
145376028|NCT00558896|524228005|FG005|Overall Study|Continues on treatment|25|||
145376029|NCT00558896|524228006|FG006|Overall Study|Continues on treatment|6|||
145376030|NCT00250458|524228010|FG000|Overall Study|Lost to Follow-up|4|||
145376031|NCT00250458|524228011|FG001|Overall Study|Lost to Follow-up|2|||
145376032|NCT00250458|524228010|FG000|Overall Study|Protocol Violation|0|||
145376033|NCT00250458|524228011|FG001|Overall Study|Protocol Violation|1|||
145376034|NCT00250458|524228010|FG000|Overall Study|Withdrawal by Subject|4|||
145376035|NCT00250458|524228011|FG001|Overall Study|Withdrawal by Subject|2|||
145376036|NCT00250458|524228010|FG000|Overall Study|Lack of Migraine Attack|20|||
145376037|NCT00250458|524228011|FG001|Overall Study|Lack of Migraine Attack|9|||
145376038|NCT00250458|524228010|FG000|Overall Study|Qualifying migraine but did not treat|3|||
145376039|NCT00250458|524228011|FG001|Overall Study|Qualifying migraine but did not treat|3|||
145376040|NCT00250458|524228010|FG000|Overall Study|Other|1|||
145376041|NCT00250458|524228011|FG001|Overall Study|Other|0|||
145376042|NCT00723190|524228015|FG000|Overall Study|Withdrawal by Subject|45|||
145376043|NCT00723190|524228015|FG000|Overall Study|Lost to Follow-up|37|||
145376044|NCT00723190|524228015|FG000|Overall Study|Adverse Event|18|||
145376045|NCT00723190|524228015|FG000|Overall Study|Lack of Efficacy|16|||
145376046|NCT00723190|524228015|FG000|Overall Study|Protocol Violation|15|||
145376047|NCT00723190|524228015|FG000|Overall Study|Other-Premature Discontinuation|9|||
145376048|NCT00723190|524228015|FG000|Overall Study|Other-Not included in safety population|2|||
145376049|NCT00454818|524228016|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
145376050|NCT00454818|524228017|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145376051|NCT00454818|524228018|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145376052|NCT00454818|524228019|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145376053|NCT00454818|524228020|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
145376054|NCT00454818|524228016|FG000|Phase I: Open-label Dose-escalation|Death|0|||
145376055|NCT00454818|524228017|FG001|Phase I: Open-label Dose-escalation|Death|1|||
145376056|NCT00454818|524228018|FG002|Phase I: Open-label Dose-escalation|Death|0|||
145376057|NCT00454818|524228019|FG003|Phase I: Open-label Dose-escalation|Death|0|||
145376058|NCT00454818|524228020|FG004|Phase I: Open-label Dose-escalation|Death|0|||
145376059|NCT00454818|524228016|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145376060|NCT00454818|524228017|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145376061|NCT00454818|524228018|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
145376062|NCT00454818|524228019|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
145376063|NCT00454818|524228020|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
145376064|NCT00454818|524228016|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145376065|NCT00454818|524228017|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
145376066|NCT00454818|524228018|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145376067|NCT00454818|524228019|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
145376068|NCT00454818|524228020|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
145376069|NCT00454818|524228016|FG000|Phase 2: Randomized Double-blind|Death|0|||
145376070|NCT00454818|524228017|FG001|Phase 2: Randomized Double-blind|Death|1|||
145376071|NCT00454818|524228018|FG002|Phase 2: Randomized Double-blind|Death|0|||
145376072|NCT00454818|524228019|FG003|Phase 2: Randomized Double-blind|Death|0|||
145376073|NCT00454818|524228020|FG004|Phase 2: Randomized Double-blind|Death|1|||
145376074|NCT00454818|524228016|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145376075|NCT00454818|524228017|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145376076|NCT00454818|524228018|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
145376077|NCT00454818|524228019|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
145582183|NCT02778204|524983287|FG002|Overall Study|Lost to Follow-up|2|||
145376078|NCT00454818|524228020|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
145376079|NCT00454818|524228016|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145376080|NCT00454818|524228017|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145376081|NCT00454818|524228018|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
145376082|NCT00454818|524228019|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
145376083|NCT00454818|524228020|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
145376084|NCT03448939|524228023|FG000|Overall Study|Adverse Event|5|||
145376085|NCT03448939|524228024|FG001|Overall Study|Adverse Event|1|||
145376086|NCT03448939|524228023|FG000|Overall Study|Lost to Follow-up|6|||
145376087|NCT03448939|524228024|FG001|Overall Study|Lost to Follow-up|6|||
145376088|NCT03448939|524228023|FG000|Overall Study|Pregnancy|1|||
145376089|NCT03448939|524228024|FG001|Overall Study|Pregnancy|1|||
145376090|NCT03448939|524228023|FG000|Overall Study|Withdrawal by Subject|9|||
145376091|NCT03448939|524228024|FG001|Overall Study|Withdrawal by Subject|3|||
145376092|NCT03488225|524228025|FG000|Overall Study|Off Protocol Therapy|2|||
145376093|NCT03488225|524228025|FG000|Overall Study|Stem Cell Transplant|2|||
145376094|NCT01472965|524228026|FG000|Overall Study|Withdrawal by Subject|1|||
145376095|NCT01472965|524228027|FG001|Overall Study|Withdrawal by Subject|0|||
145376096|NCT04631107|524228030|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
145376097|NCT04631107|524228030|FG000|Second Intervention (1 Night)|Adverse Event|1|||
145376098|NCT04631107|524228030|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
145376099|NCT04631107|524228030|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
145376100|NCT00096993|524228034|FG000|Overall Study|Death|1|||
145376101|NCT00096993|524228035|FG001|Overall Study|Death|0|||
145376102|NCT00096993|524228034|FG000|Overall Study|Disease progression|56|||
145376103|NCT00096993|524228035|FG001|Overall Study|Disease progression|53|||
145376104|NCT00096993|524228034|FG000|Overall Study|Adverse Event|2|||
145376105|NCT00096993|524228035|FG001|Overall Study|Adverse Event|8|||
145376106|NCT00096993|524228034|FG000|Overall Study|Subject's decision|3|||
145376107|NCT00096993|524228035|FG001|Overall Study|Subject's decision|1|||
145376108|NCT00096993|524228034|FG000|Overall Study|Physician Decision|2|||
145376109|NCT00096993|524228035|FG001|Overall Study|Physician Decision|1|||
145376110|NCT00096993|524228034|FG000|Overall Study|Non-compliance|0|||
145376111|NCT00096993|524228035|FG001|Overall Study|Non-compliance|1|||
145376112|NCT00096993|524228034|FG000|Overall Study|Other unspecified|1|||
145376113|NCT00096993|524228035|FG001|Overall Study|Other unspecified|1|||
145376114|NCT05020899|524228036|FG000|8 Week Follow-up|Lost to Follow-up|3|||
145376115|NCT05020899|524228037|FG001|8 Week Follow-up|Lost to Follow-up|6|||
145376116|NCT05020899|524228036|FG000|12 Week Follow-up|Lost to Follow-up|1|||
145376117|NCT05020899|524228037|FG001|12 Week Follow-up|Lost to Follow-up|0|||
145376118|NCT05020899|524228036|FG000|12 Week Follow-up|Death|0|||
145376119|NCT05020899|524228037|FG001|12 Week Follow-up|Death|1|||
145376120|NCT01068626|524228040|FG000|Overall Study|Adverse Event|3|||
145376121|NCT01068626|524228041|FG001|Overall Study|Adverse Event|0|||
145376122|NCT01068626|524228040|FG000|Overall Study|Withdrawal by Subject|0|||
145376123|NCT01068626|524228041|FG001|Overall Study|Withdrawal by Subject|2|||
145376124|NCT00808639|524228043|FG000|Overall Study|Disease progression before surgery.|1|||
145376125|NCT00191282|524228044|FG000|Overall Study|Adverse Event|5|||
145376126|NCT00191282|524228045|FG001|Overall Study|Adverse Event|6|||
145376127|NCT00191282|524228044|FG000|Overall Study|Death|51|||
145376128|NCT00191282|524228045|FG001|Overall Study|Death|51|||
145376129|NCT00191282|524228044|FG000|Overall Study|Lack of Efficacy|11|||
145376130|NCT00191282|524228045|FG001|Overall Study|Lack of Efficacy|6|||
145376131|NCT00191282|524228044|FG000|Overall Study|Noncompliance|14|||
145376132|NCT00191282|524228045|FG001|Overall Study|Noncompliance|17|||
145376133|NCT00191282|524228044|FG000|Overall Study|Patient moved|11|||
145376134|NCT00191282|524228045|FG001|Overall Study|Patient moved|14|||
145376135|NCT00191282|524228044|FG000|Overall Study|Withdrawal by Subject|59|||
145376136|NCT00191282|524228045|FG001|Overall Study|Withdrawal by Subject|44|||
145376137|NCT00191282|524228044|FG000|Overall Study|Physician Decision|18|||
145376138|NCT00191282|524228045|FG001|Overall Study|Physician Decision|15|||
145376139|NCT00191282|524228044|FG000|Overall Study|Protocol entry criteria not met|14|||
145376140|NCT00191282|524228045|FG001|Overall Study|Protocol entry criteria not met|9|||
145376141|NCT00191282|524228044|FG000|Overall Study|Protocol Violation|9|||
145376142|NCT00191282|524228045|FG001|Overall Study|Protocol Violation|12|||
145376143|NCT00191282|524228044|FG000|Overall Study|Severity of outcome|2|||
145376144|NCT00191282|524228045|FG001|Overall Study|Severity of outcome|5|||
145376145|NCT00191282|524228044|FG000|Overall Study|Sponsor's decision|2|||
145376146|NCT00191282|524228045|FG001|Overall Study|Sponsor's decision|2|||
145376147|NCT00191282|524228044|FG000|Overall Study|Lost to Follow-up|24|||
145376148|NCT00191282|524228045|FG001|Overall Study|Lost to Follow-up|31|||
145376149|NCT04756154|524228048|FG000|Overall Study|Did not meet treatment day baseline|30|||
145376150|NCT04756154|524228049|FG001|Overall Study|Did not meet treatment day baseline|28|||
145376151|NCT04756154|524228050|FG002|Overall Study|Did not meet treatment day baseline|7|||
145376152|NCT04756154|524228048|FG000|Overall Study|Did not return for final sample collection|1|||
145376153|NCT04756154|524228049|FG001|Overall Study|Did not return for final sample collection|1|||
145376154|NCT04756154|524228050|FG002|Overall Study|Did not return for final sample collection|0|||
145376155|NCT03589976|524228051|FG000|Overall Study|Death|5|||
145430667|NCT01276106|524435927|FG003|Overall Study|Insufficient therapeutic effects|0|||
145430668|NCT01242514|524435930|FG000|Overall Study|e.g., project closure|1042|||
145430669|NCT01242514|524435931|FG001|Overall Study|e.g., project closure|305|||
145430670|NCT01242514|524435932|FG002|Overall Study|e.g., project closure|171|||
145430671|NCT01242514|524435930|FG000|Overall Study|Subject decision|33|||
145624011|NCT00783718|525135647|FG000|Induction Phase|Lost to Follow-up|1|||
145430672|NCT01242514|524435931|FG001|Overall Study|Subject decision|8|||
145430673|NCT01242514|524435932|FG002|Overall Study|Subject decision|2|||
145430674|NCT01242514|524435930|FG000|Overall Study|Severe non-compliance to protocol|5|||
145430675|NCT01242514|524435931|FG001|Overall Study|Severe non-compliance to protocol|2|||
145430676|NCT01242514|524435932|FG002|Overall Study|Severe non-compliance to protocol|1|||
145430677|NCT01242514|524435930|FG000|Overall Study|Lack of therapeutic response|99|||
145430678|NCT01242514|524435931|FG001|Overall Study|Lack of therapeutic response|16|||
145430679|NCT01242514|524435932|FG002|Overall Study|Lack of therapeutic response|10|||
145430680|NCT01242514|524435930|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
145430681|NCT01242514|524435931|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
145430682|NCT01242514|524435932|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
145430683|NCT01242514|524435930|FG000|Overall Study|Lost to Follow-up|14|||
145430684|NCT01242514|524435931|FG001|Overall Study|Lost to Follow-up|5|||
145624012|NCT00783718|525135648|FG001|Induction Phase|Lost to Follow-up|0|||
145624013|NCT00783718|525135649|FG002|Induction Phase|Lost to Follow-up|1|||
145624014|NCT00783718|525135650|FG003|Induction Phase|Lost to Follow-up|0|||
145624015|NCT00783718|525135651|FG004|Induction Phase|Lost to Follow-up|0|||
145624016|NCT00783718|525135652|FG005|Induction Phase|Lost to Follow-up|0|||
145624017|NCT00783718|525135653|FG006|Induction Phase|Lost to Follow-up|0|||
145376156|NCT03589976|524228052|FG001|Overall Study|Death|1|||
145376157|NCT03589976|524228051|FG000|Overall Study|Adverse Event|5|||
145376158|NCT03589976|524228052|FG001|Overall Study|Adverse Event|1|||
145376159|NCT03589976|524228051|FG000|Overall Study|Withdrawal by Subject|4|||
145376160|NCT03589976|524228052|FG001|Overall Study|Withdrawal by Subject|1|||
145376161|NCT03589976|524228051|FG000|Overall Study|Lost to Follow-up|1|||
145376162|NCT03589976|524228052|FG001|Overall Study|Lost to Follow-up|0|||
145376163|NCT03589976|524228051|FG000|Overall Study|Other|4|||
145376164|NCT03589976|524228052|FG001|Overall Study|Other|3|||
145376165|NCT02089334|524228053|FG000|Overall Study|Withdrawal by Subject|0|||
145376166|NCT02089334|524228054|FG001|Overall Study|Withdrawal by Subject|0|||
145376167|NCT02089334|524228055|FG002|Overall Study|Withdrawal by Subject|0|||
145376168|NCT02089334|524228056|FG003|Overall Study|Withdrawal by Subject|2|||
145376169|NCT02089334|524228053|FG000|Overall Study|Adverse Event|0|||
145376170|NCT02089334|524228054|FG001|Overall Study|Adverse Event|0|||
145376171|NCT02089334|524228055|FG002|Overall Study|Adverse Event|0|||
145376172|NCT02089334|524228056|FG003|Overall Study|Adverse Event|2|||
145376173|NCT02089334|524228053|FG000|Overall Study|Progressive disease|0|||
145376174|NCT02089334|524228054|FG001|Overall Study|Progressive disease|0|||
145376175|NCT02089334|524228055|FG002|Overall Study|Progressive disease|0|||
145376176|NCT02089334|524228056|FG003|Overall Study|Progressive disease|2|||
145376177|NCT02089334|524228053|FG000|Overall Study|Physician Decision|0|||
145376178|NCT02089334|524228054|FG001|Overall Study|Physician Decision|0|||
145376179|NCT02089334|524228055|FG002|Overall Study|Physician Decision|1|||
145376180|NCT02089334|524228056|FG003|Overall Study|Physician Decision|1|||
145376181|NCT04778059|524228057|FG000|Overall Study|Death|2|||
145376182|NCT04778059|524228058|FG001|Overall Study|Death|2|||
145376183|NCT04778059|524228059|FG002|Overall Study|Death|1|||
145376184|NCT04778059|524228060|FG003|Overall Study|Death|1|||
145376185|NCT04778059|524228061|FG004|Overall Study|Death|1|||
145376186|NCT04778059|524228057|FG000|Overall Study|Lost to Follow-up|0|||
145376187|NCT04778059|524228058|FG001|Overall Study|Lost to Follow-up|0|||
145376188|NCT04778059|524228059|FG002|Overall Study|Lost to Follow-up|0|||
145376189|NCT04778059|524228060|FG003|Overall Study|Lost to Follow-up|0|||
145624018|NCT00783718|525135647|FG000|Maintenance Phase|Adverse Event|12|||
145376190|NCT04778059|524228061|FG004|Overall Study|Lost to Follow-up|1|||
145376191|NCT04778059|524228057|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
145376192|NCT04778059|524228058|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
145376193|NCT04778059|524228059|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
145376194|NCT04778059|524228060|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
145376195|NCT04778059|524228061|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
145376196|NCT02832375|524228062|FG000|Overall Study|Lost to Follow-up|1|||
145376197|NCT02832375|524228063|FG001|Overall Study|Lost to Follow-up|0|||
145376198|NCT02832375|524228062|FG000|Overall Study|Withdrawal of Consent|1|||
145430685|NCT01242514|524435932|FG002|Overall Study|Lost to Follow-up|4|||
145430686|NCT01242514|524435930|FG000|Overall Study|Adverse Event|129|||
145624019|NCT00783718|525135648|FG001|Maintenance Phase|Adverse Event|0|||
145376199|NCT02832375|524228063|FG001|Overall Study|Withdrawal of Consent|0|||
145376200|NCT00514904|524228069|FG000|Overall Study|Withdrawal by Subject|3|||
145430687|NCT01242514|524435931|FG001|Overall Study|Adverse Event|18|||
145430688|NCT01242514|524435932|FG002|Overall Study|Adverse Event|19|||
145430689|NCT00862940|524435934|FG000|Overall Study|Adverse Event|15|||
145624020|NCT00783718|525135649|FG002|Maintenance Phase|Adverse Event|0|||
145624021|NCT00783718|525135650|FG003|Maintenance Phase|Adverse Event|15|||
145376201|NCT00514904|524228070|FG001|Overall Study|Withdrawal by Subject|2|||
145376202|NCT00514904|524228069|FG000|Overall Study|Lost to Follow-up|21|||
145376203|NCT00514904|524228070|FG001|Overall Study|Lost to Follow-up|3|||
145376204|NCT03430895|524228071|FG000|Overall Study|Not Treated|2|||
145376205|NCT04216589|524228074|FG000|Overall Study|Withdrawal by Subject|2|||
145376206|NCT04216589|524228074|FG000|Overall Study|Protocol Violation|1|||
145376207|NCT04216589|524228074|FG000|Overall Study|Incarceration|1|||
145376208|NCT03721835|524228075|FG000|Overall Study|Participant not able to return|1|||
145376209|NCT03721835|524228075|FG000|Overall Study|Lost to Follow-up|1|||
145376210|NCT03721835|524228075|FG000|Overall Study|Revision of the components of the study device|2|||
145376211|NCT03721835|524228075|FG000|Overall Study|Sponsor terminated study|6|||
145376212|NCT03721835|524228075|FG000|Overall Study|Death|1|||
145376213|NCT03721835|524228075|FG000|Overall Study|Sponsor decision|1|||
145376214|NCT01306045|524228080|FG000|Met General Eligibility Criteria|Screen failures|193|||
145376215|NCT01306045|524228081|FG001|Met General Eligibility Criteria|Screen failures|11|||
145376216|NCT01306045|524228082|FG002|Met General Eligibility Criteria|Screen failures|8|||
145376217|NCT03976323|524228091|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
145376218|NCT03976323|524228092|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145376219|NCT03976323|524228093|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
145376220|NCT03976323|524228091|FG000|Induction Phase|Death|80|||
145376221|NCT03976323|524228092|FG001|Induction Phase|Death|0|||
145376222|NCT03976323|524228093|FG002|Induction Phase|Death|0|||
145376223|NCT03976323|524228091|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
145376224|NCT03976323|524228092|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
145376225|NCT03976323|524228093|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
145376226|NCT03976323|524228091|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145376227|NCT03976323|524228092|FG001|Maintenance Phase|Withdrawal by Subject|9|||
145376228|NCT03976323|524228093|FG002|Maintenance Phase|Withdrawal by Subject|3|||
145376229|NCT03976323|524228091|FG000|Maintenance Phase|Physician Decision|0|||
145376230|NCT03976323|524228092|FG001|Maintenance Phase|Physician Decision|0|||
145376231|NCT03976323|524228093|FG002|Maintenance Phase|Physician Decision|1|||
145376232|NCT03976323|524228091|FG000|Maintenance Phase|Death|0|||
145376233|NCT03976323|524228092|FG001|Maintenance Phase|Death|228|||
145376234|NCT03976323|524228093|FG002|Maintenance Phase|Death|234|||
145376235|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
145376236|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
145376237|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
145376238|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
145376239|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
145376240|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
145376241|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
145376242|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
145376243|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
145376244|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
145376245|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
145376246|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
145376247|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
145376248|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
145376249|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
145376250|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
145376251|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
145376252|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
145376253|NCT02294461|524228094|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
145376254|NCT02294461|524228095|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
145376255|NCT02294461|524228096|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
145376256|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
145376257|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
145376258|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
145376259|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
145376260|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
145376261|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
145376262|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
145376263|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
145430690|NCT00862940|524435935|FG001|Overall Study|Adverse Event|12|||
145430691|NCT00862940|524435934|FG000|Overall Study|Lack of Efficacy|1|||
145430692|NCT00862940|524435935|FG001|Overall Study|Lack of Efficacy|3|||
145624022|NCT00783718|525135651|FG004|Maintenance Phase|Adverse Event|7|||
145582184|NCT02778204|524983288|FG003|Overall Study|Lost to Follow-up|1|||
145376264|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
145376265|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
145376266|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
145376267|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
145376268|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
145376269|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
145376270|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
145376271|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
145376272|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
145376273|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
145376274|NCT02294461|524228094|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
145376275|NCT02294461|524228095|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
145376276|NCT02294461|524228096|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
145376277|NCT04676412|524229649|FG000|Overall Study|Death|28|||
145376278|NCT04676412|524229650|FG001|Overall Study|Death|31|||
145376279|NCT04676412|524229649|FG000|Overall Study|Lost to Follow-up|1|||
145376280|NCT04676412|524229650|FG001|Overall Study|Lost to Follow-up|2|||
145376281|NCT04676412|524229649|FG000|Overall Study|Sponsor Decision|20|||
145376282|NCT04676412|524229650|FG001|Overall Study|Sponsor Decision|23|||
145376283|NCT04676412|524229649|FG000|Overall Study|Withdrawal by Subject|0|||
145376284|NCT04676412|524229650|FG001|Overall Study|Withdrawal by Subject|2|||
145376285|NCT04550832|524229651|FG000|Overall Study|Adverse Event|0|||
145376286|NCT04550832|524229652|FG001|Overall Study|Adverse Event|0|||
145376287|NCT04550832|524229653|FG002|Overall Study|Adverse Event|2|||
145376288|NCT04550832|524229654|FG003|Overall Study|Adverse Event|0|||
145376289|NCT04550832|524229655|FG004|Overall Study|Adverse Event|1|||
145376290|NCT04823130|524229656|FG000|Overall Study|Withdrawal by Subject|2|||
145376291|NCT04823130|524229657|FG001|Overall Study|Withdrawal by Subject|3|||
145376292|NCT04823130|524229656|FG000|Overall Study|Failure to meet inclusion criteria|6|||
145376293|NCT04823130|524229657|FG001|Overall Study|Failure to meet inclusion criteria|4|||
145376294|NCT04823130|524229656|FG000|Overall Study|Other-unspecified|1|||
145376295|NCT04823130|524229657|FG001|Overall Study|Other-unspecified|0|||
145376296|NCT03315455|524229659|FG000|Overall Study|Ongoing in the Study|13|||
145376297|NCT03315455|524229660|FG001|Overall Study|Ongoing in the Study|24|||
145376298|NCT03315455|524229661|FG002|Overall Study|Ongoing in the Study|17|||
145376299|NCT03315455|524229662|FG003|Overall Study|Ongoing in the Study|15|||
145376300|NCT03315455|524229659|FG000|Overall Study|Withdrawal by Subject|0|||
145376301|NCT03315455|524229660|FG001|Overall Study|Withdrawal by Subject|1|||
145376302|NCT03315455|524229661|FG002|Overall Study|Withdrawal by Subject|0|||
145376303|NCT03315455|524229662|FG003|Overall Study|Withdrawal by Subject|0|||
145376304|NCT04439357|524229663|FG000|Overall Study|Disease Progression|4|||
145376305|NCT01458951|524229671|FG000|Overall Study|Other|1|||
145376306|NCT01458951|524229672|FG001|Overall Study|Other|0|||
145376307|NCT01458951|524229673|FG002|Overall Study|Other|0|||
145376308|NCT01458951|524229671|FG000|Overall Study|Protocol Violation|5|||
145376309|NCT01458951|524229672|FG001|Overall Study|Protocol Violation|1|||
145376310|NCT01458951|524229673|FG002|Overall Study|Protocol Violation|0|||
145376311|NCT01458951|524229671|FG000|Overall Study|Withdrawal by Subject|2|||
145376312|NCT01458951|524229672|FG001|Overall Study|Withdrawal by Subject|0|||
145376313|NCT01458951|524229673|FG002|Overall Study|Withdrawal by Subject|2|||
145376314|NCT01458951|524229671|FG000|Overall Study|Adverse Event|7|||
145376315|NCT01458951|524229672|FG001|Overall Study|Adverse Event|0|||
145376316|NCT01458951|524229673|FG002|Overall Study|Adverse Event|2|||
145376317|NCT01458951|524229671|FG000|Overall Study|Insufficient Clinical Response|17|||
145376318|NCT01458951|524229672|FG001|Overall Study|Insufficient Clinical Response|0|||
145376319|NCT01458951|524229673|FG002|Overall Study|Insufficient Clinical Response|11|||
145376320|NCT01573767|524229678|FG000|Overall Study|Adverse Event|0|||
145376321|NCT01573767|524229679|FG001|Overall Study|Adverse Event|1|||
145376322|NCT01573767|524229680|FG002|Overall Study|Adverse Event|0|||
145376323|NCT01573767|524229681|FG003|Overall Study|Adverse Event|1|||
145376324|NCT01573767|524229678|FG000|Overall Study|Lack of Efficacy|18|||
145376325|NCT01573767|524229679|FG001|Overall Study|Lack of Efficacy|15|||
145376326|NCT01573767|524229680|FG002|Overall Study|Lack of Efficacy|12|||
145376327|NCT01573767|524229681|FG003|Overall Study|Lack of Efficacy|17|||
145376328|NCT01573767|524229678|FG000|Overall Study|Protocol Violation|3|||
145376329|NCT01573767|524229679|FG001|Overall Study|Protocol Violation|1|||
145376330|NCT01573767|524229680|FG002|Overall Study|Protocol Violation|1|||
145376331|NCT01573767|524229681|FG003|Overall Study|Protocol Violation|3|||
145430693|NCT00862940|524435934|FG000|Overall Study|Protocol Violation|2|||
145376332|NCT01573767|524229678|FG000|Overall Study|Lost to Follow-up|0|||
145376333|NCT01573767|524229679|FG001|Overall Study|Lost to Follow-up|1|||
145376334|NCT01573767|524229680|FG002|Overall Study|Lost to Follow-up|1|||
145376335|NCT01573767|524229681|FG003|Overall Study|Lost to Follow-up|1|||
145376336|NCT01573767|524229678|FG000|Overall Study|Physician Decision|1|||
145582185|NCT02778204|524983285|FG000|Overall Study|Protocol Violation|0|||
145582186|NCT02778204|524983286|FG001|Overall Study|Protocol Violation|0|||
145376337|NCT01573767|524229679|FG001|Overall Study|Physician Decision|2|||
145376338|NCT01573767|524229680|FG002|Overall Study|Physician Decision|0|||
145376339|NCT01573767|524229681|FG003|Overall Study|Physician Decision|2|||
145376340|NCT01573767|524229678|FG000|Overall Study|Withdrawal by Subject|0|||
145376341|NCT01573767|524229679|FG001|Overall Study|Withdrawal by Subject|1|||
145376342|NCT01573767|524229680|FG002|Overall Study|Withdrawal by Subject|0|||
145376343|NCT01573767|524229681|FG003|Overall Study|Withdrawal by Subject|0|||
145376344|NCT01371877|524229684|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
145376345|NCT01371877|524229685|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
145376346|NCT05932225|524229686|FG000|Overall Study|Lost to Follow-up|0|||
145376347|NCT05932225|524229687|FG001|Overall Study|Lost to Follow-up|1|||
145376348|NCT05932225|524229688|FG002|Overall Study|Lost to Follow-up|0|||
145376349|NCT05932225|524229686|FG000|Overall Study|Withdrawal by Subject|1|||
145376350|NCT05932225|524229687|FG001|Overall Study|Withdrawal by Subject|0|||
145376351|NCT05932225|524229688|FG002|Overall Study|Withdrawal by Subject|0|||
145376352|NCT05932225|524229686|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
145376353|NCT05932225|524229687|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
145376354|NCT05932225|524229688|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
145376355|NCT03117881|524229689|FG000|Baseline|Withdrawal by Subject|21|||
145376356|NCT03117881|524229690|FG001|Baseline|Withdrawal by Subject|10|||
145376357|NCT03117881|524229691|FG002|Baseline|Withdrawal by Subject|0|||
145376358|NCT03117881|524229689|FG000|Baseline|Lost to Follow-up|22|||
145376359|NCT03117881|524229690|FG001|Baseline|Lost to Follow-up|25|||
145376360|NCT03117881|524229691|FG002|Baseline|Lost to Follow-up|0|||
145376361|NCT03117881|524229689|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
145376362|NCT03117881|524229690|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
145376363|NCT03117881|524229691|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
145376364|NCT03117881|524229689|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
145376365|NCT03117881|524229690|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
145376366|NCT03117881|524229691|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
145376367|NCT03117881|524229689|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
145376368|NCT03117881|524229690|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
145376369|NCT03117881|524229691|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
145376370|NCT03117881|524229689|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
145376371|NCT03117881|524229690|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
145376372|NCT03117881|524229691|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
145376373|NCT03117881|524229689|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
145376374|NCT03117881|524229690|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
145376375|NCT03117881|524229691|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
145376376|NCT03117881|524229689|FG000|6-Month Follow-Up|Did not complete test|53|||
145376377|NCT03117881|524229690|FG001|6-Month Follow-Up|Did not complete test|25|||
145376378|NCT03117881|524229691|FG002|6-Month Follow-Up|Did not complete test|7|||
145376379|NCT03117881|524229689|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
145376380|NCT03117881|524229690|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
145376381|NCT03117881|524229691|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
145376382|NCT03117881|524229689|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
145376383|NCT03117881|524229690|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
145376384|NCT03117881|524229691|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
145376385|NCT03117881|524229689|FG000|12-Month Follow-Up|Did not complete test|40|||
145376386|NCT03117881|524229690|FG001|12-Month Follow-Up|Did not complete test|0|||
145376387|NCT03117881|524229691|FG002|12-Month Follow-Up|Did not complete test|0|||
145376388|NCT00308750|524229694|FG000|Overall Study|Adverse Event|9|||
145376389|NCT00308750|524229695|FG001|Overall Study|Adverse Event|9|||
145376390|NCT00308750|524229696|FG002|Overall Study|Adverse Event|13|||
145376391|NCT00308750|524229694|FG000|Overall Study|Withdrawal by Subject|6|||
145376392|NCT00308750|524229695|FG001|Overall Study|Withdrawal by Subject|2|||
145376393|NCT00308750|524229696|FG002|Overall Study|Withdrawal by Subject|3|||
145376394|NCT00308750|524229694|FG000|Overall Study|Physician Decision|3|||
145376395|NCT00308750|524229695|FG001|Overall Study|Physician Decision|4|||
145376396|NCT00308750|524229696|FG002|Overall Study|Physician Decision|3|||
145376397|NCT00308750|524229694|FG000|Overall Study|Sponsor Decision|1|||
145582187|NCT02778204|524983287|FG002|Overall Study|Protocol Violation|1|||
145582188|NCT02778204|524983288|FG003|Overall Study|Protocol Violation|0|||
145582189|NCT02778204|524983285|FG000|Overall Study|Eligibility Violation|0|||
145582190|NCT02778204|524983286|FG001|Overall Study|Eligibility Violation|0|||
145376398|NCT00308750|524229695|FG001|Overall Study|Sponsor Decision|0|||
145376399|NCT00308750|524229696|FG002|Overall Study|Sponsor Decision|0|||
145376400|NCT00308750|524229694|FG000|Overall Study|Disease Progression|47|||
145376401|NCT00308750|524229695|FG001|Overall Study|Disease Progression|24|||
145376402|NCT00308750|524229696|FG002|Overall Study|Disease Progression|28|||
145376403|NCT00308750|524229694|FG000|Overall Study|Unrelated Complication|3|||
145376404|NCT00308750|524229695|FG001|Overall Study|Unrelated Complication|0|||
145376405|NCT00308750|524229696|FG002|Overall Study|Unrelated Complication|1|||
145582191|NCT02778204|524983287|FG002|Overall Study|Eligibility Violation|0|||
145582192|NCT02778204|524983288|FG003|Overall Study|Eligibility Violation|1|||
145376406|NCT00308750|524229694|FG000|Overall Study|Death|1|||
145376407|NCT00308750|524229695|FG001|Overall Study|Death|0|||
145376408|NCT00308750|524229696|FG002|Overall Study|Death|1|||
145376409|NCT00308750|524229694|FG000|Overall Study|Protocol Violation|1|||
145376410|NCT00308750|524229695|FG001|Overall Study|Protocol Violation|0|||
145376411|NCT00308750|524229696|FG002|Overall Study|Protocol Violation|0|||
145376412|NCT00308750|524229694|FG000|Overall Study|New Primary Disease Identified|1|||
145376413|NCT00308750|524229695|FG001|Overall Study|New Primary Disease Identified|1|||
145376414|NCT00308750|524229696|FG002|Overall Study|New Primary Disease Identified|0|||
145376415|NCT01358578|524229697|FG000|Induction Period|Adverse Event|2|||
145376416|NCT01358578|524229698|FG001|Induction Period|Adverse Event|4|||
145376417|NCT01358578|524229699|FG002|Induction Period|Adverse Event|2|||
145376418|NCT01358578|524229700|FG003|Induction Period|Adverse Event|6|||
145376419|NCT01358578|524229701|FG004|Induction Period|Adverse Event|0|||
145376420|NCT01358578|524229702|FG005|Induction Period|Adverse Event|0|||
145376421|NCT01358578|524229697|FG000|Induction Period|Lack of Efficacy|0|||
145376422|NCT01358578|524229698|FG001|Induction Period|Lack of Efficacy|0|||
145376423|NCT01358578|524229699|FG002|Induction Period|Lack of Efficacy|9|||
145376424|NCT01358578|524229700|FG003|Induction Period|Lack of Efficacy|1|||
145376425|NCT01358578|524229701|FG004|Induction Period|Lack of Efficacy|0|||
145376426|NCT01358578|524229702|FG005|Induction Period|Lack of Efficacy|0|||
145376427|NCT01358578|524229697|FG000|Induction Period|Lost to Follow-up|0|||
145376428|NCT01358578|524229698|FG001|Induction Period|Lost to Follow-up|0|||
145376429|NCT01358578|524229699|FG002|Induction Period|Lost to Follow-up|1|||
145376430|NCT01358578|524229700|FG003|Induction Period|Lost to Follow-up|4|||
145376431|NCT01358578|524229701|FG004|Induction Period|Lost to Follow-up|0|||
145376432|NCT01358578|524229702|FG005|Induction Period|Lost to Follow-up|0|||
145430694|NCT00862940|524435935|FG001|Overall Study|Protocol Violation|5|||
145430695|NCT00862940|524435934|FG000|Overall Study|Withdrawal by Subject|4|||
145376433|NCT01358578|524229697|FG000|Induction Period|Physician Decision|2|||
145430696|NCT00862940|524435935|FG001|Overall Study|Withdrawal by Subject|6|||
145430697|NCT00862940|524435934|FG000|Overall Study|Non-compliance|4|||
145430698|NCT00862940|524435935|FG001|Overall Study|Non-compliance|0|||
145430699|NCT00862940|524435934|FG000|Overall Study|Lost to Follow-up|0|||
145430700|NCT00862940|524435935|FG001|Overall Study|Lost to Follow-up|1|||
145430701|NCT00862940|524435934|FG000|Overall Study|Administrative or other reason(s)|4|||
145430702|NCT00862940|524435935|FG001|Overall Study|Administrative or other reason(s)|3|||
145430703|NCT03261505|524435936|FG000|Overall Study|Withdrawal by Subject|2|||
145430704|NCT03261505|524435937|FG001|Overall Study|Withdrawal by Subject|3|||
145430705|NCT03261505|524435938|FG002|Overall Study|Withdrawal by Subject|4|||
145430706|NCT03261505|524435939|FG003|Overall Study|Withdrawal by Subject|3|||
145430707|NCT03261505|524435936|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145430708|NCT03261505|524435937|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145430709|NCT03261505|524435938|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
145430710|NCT03261505|524435939|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
145430711|NCT03261505|524435936|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145430712|NCT03261505|524435937|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145430713|NCT03261505|524435938|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
145430714|NCT03261505|524435939|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
145582193|NCT01916304|524983289|FG000|Overall Study|Screening failure|17|||
145582194|NCT04666441|524983290|FG000|Overall Study|Lost to Follow-up|1|||
145582195|NCT04666441|524983291|FG001|Overall Study|Lost to Follow-up|4|||
145376434|NCT01358578|524229698|FG001|Induction Period|Physician Decision|1|||
145376435|NCT01358578|524229699|FG002|Induction Period|Physician Decision|2|||
145376436|NCT01358578|524229700|FG003|Induction Period|Physician Decision|0|||
145376437|NCT01358578|524229701|FG004|Induction Period|Physician Decision|0|||
145376438|NCT01358578|524229702|FG005|Induction Period|Physician Decision|0|||
145376439|NCT01358578|524229697|FG000|Induction Period|Protocol Deviation|3|||
145582196|NCT04666441|524983292|FG002|Overall Study|Lost to Follow-up|1|||
145582197|NCT04666441|524983293|FG003|Overall Study|Lost to Follow-up|3|||
145582198|NCT04666441|524983294|FG004|Overall Study|Lost to Follow-up|0|||
145582199|NCT04666441|524983295|FG005|Overall Study|Lost to Follow-up|2|||
145582200|NCT04666441|524983296|FG006|Overall Study|Lost to Follow-up|2|||
145376440|NCT01358578|524229698|FG001|Induction Period|Protocol Deviation|5|||
145376441|NCT01358578|524229699|FG002|Induction Period|Protocol Deviation|0|||
145376442|NCT01358578|524229700|FG003|Induction Period|Protocol Deviation|3|||
145582201|NCT04666441|524983297|FG007|Overall Study|Lost to Follow-up|2|||
145582202|NCT04666441|524983290|FG000|Overall Study|Subject Decision|1|||
145582203|NCT04666441|524983291|FG001|Overall Study|Subject Decision|1|||
145376443|NCT01358578|524229701|FG004|Induction Period|Protocol Deviation|0|||
145376444|NCT01358578|524229702|FG005|Induction Period|Protocol Deviation|0|||
145376445|NCT01358578|524229697|FG000|Induction Period|technical problems|0|||
145376446|NCT01358578|524229698|FG001|Induction Period|technical problems|0|||
145376447|NCT01358578|524229699|FG002|Induction Period|technical problems|1|||
145376448|NCT01358578|524229700|FG003|Induction Period|technical problems|1|||
145376449|NCT01358578|524229701|FG004|Induction Period|technical problems|0|||
145376450|NCT01358578|524229702|FG005|Induction Period|technical problems|0|||
145376451|NCT01358578|524229697|FG000|Induction Period|Withdrawal by Subject|5|||
145376452|NCT01358578|524229698|FG001|Induction Period|Withdrawal by Subject|5|||
145376453|NCT01358578|524229699|FG002|Induction Period|Withdrawal by Subject|10|||
145376454|NCT01358578|524229700|FG003|Induction Period|Withdrawal by Subject|6|||
145376455|NCT01358578|524229701|FG004|Induction Period|Withdrawal by Subject|0|||
145376456|NCT01358578|524229702|FG005|Induction Period|Withdrawal by Subject|0|||
145376457|NCT01358578|524229697|FG000|Maintenance Period|Adverse Event|2|||
145376458|NCT01358578|524229698|FG001|Maintenance Period|Adverse Event|7|||
145376459|NCT01358578|524229699|FG002|Maintenance Period|Adverse Event|0|||
145376460|NCT01358578|524229700|FG003|Maintenance Period|Adverse Event|6|||
145376461|NCT01358578|524229701|FG004|Maintenance Period|Adverse Event|4|||
145376462|NCT01358578|524229702|FG005|Maintenance Period|Adverse Event|3|||
145376463|NCT01358578|524229697|FG000|Maintenance Period|Lack of Efficacy|10|||
145376464|NCT01358578|524229698|FG001|Maintenance Period|Lack of Efficacy|2|||
145376465|NCT01358578|524229699|FG002|Maintenance Period|Lack of Efficacy|0|||
145376466|NCT01358578|524229700|FG003|Maintenance Period|Lack of Efficacy|11|||
145376467|NCT01358578|524229701|FG004|Maintenance Period|Lack of Efficacy|3|||
145376468|NCT01358578|524229702|FG005|Maintenance Period|Lack of Efficacy|0|||
145376469|NCT01358578|524229697|FG000|Maintenance Period|Lost to Follow-up|4|||
145376470|NCT01358578|524229698|FG001|Maintenance Period|Lost to Follow-up|0|||
145376471|NCT01358578|524229699|FG002|Maintenance Period|Lost to Follow-up|0|||
145376472|NCT01358578|524229700|FG003|Maintenance Period|Lost to Follow-up|5|||
145376473|NCT01358578|524229701|FG004|Maintenance Period|Lost to Follow-up|1|||
145376474|NCT01358578|524229702|FG005|Maintenance Period|Lost to Follow-up|1|||
145376475|NCT01358578|524229697|FG000|Maintenance Period|Non-compliance with study treatment|3|||
145376476|NCT01358578|524229698|FG001|Maintenance Period|Non-compliance with study treatment|1|||
145376477|NCT01358578|524229699|FG002|Maintenance Period|Non-compliance with study treatment|0|||
145376478|NCT01358578|524229700|FG003|Maintenance Period|Non-compliance with study treatment|2|||
145376479|NCT01358578|524229701|FG004|Maintenance Period|Non-compliance with study treatment|1|||
145376480|NCT01358578|524229702|FG005|Maintenance Period|Non-compliance with study treatment|2|||
145376481|NCT01358578|524229697|FG000|Maintenance Period|Physician Decision|0|||
145376482|NCT01358578|524229698|FG001|Maintenance Period|Physician Decision|1|||
145376483|NCT01358578|524229699|FG002|Maintenance Period|Physician Decision|0|||
145376484|NCT01358578|524229700|FG003|Maintenance Period|Physician Decision|1|||
145376485|NCT01358578|524229701|FG004|Maintenance Period|Physician Decision|0|||
145376486|NCT01358578|524229702|FG005|Maintenance Period|Physician Decision|0|||
145376487|NCT01358578|524229697|FG000|Maintenance Period|Pregnancy|1|||
145376488|NCT01358578|524229698|FG001|Maintenance Period|Pregnancy|0|||
145376489|NCT01358578|524229699|FG002|Maintenance Period|Pregnancy|0|||
145376490|NCT01358578|524229700|FG003|Maintenance Period|Pregnancy|0|||
145376491|NCT01358578|524229701|FG004|Maintenance Period|Pregnancy|0|||
145376492|NCT01358578|524229702|FG005|Maintenance Period|Pregnancy|0|||
145376493|NCT01358578|524229697|FG000|Maintenance Period|Protocol deviation|7|||
145376494|NCT01358578|524229698|FG001|Maintenance Period|Protocol deviation|4|||
145376495|NCT01358578|524229699|FG002|Maintenance Period|Protocol deviation|0|||
145376496|NCT01358578|524229700|FG003|Maintenance Period|Protocol deviation|2|||
145376497|NCT01358578|524229701|FG004|Maintenance Period|Protocol deviation|2|||
145376498|NCT01358578|524229702|FG005|Maintenance Period|Protocol deviation|2|||
145376499|NCT01358578|524229697|FG000|Maintenance Period|Withdrawal by Subject|12|||
145376500|NCT01358578|524229698|FG001|Maintenance Period|Withdrawal by Subject|7|||
145376501|NCT01358578|524229699|FG002|Maintenance Period|Withdrawal by Subject|2|||
145376502|NCT01358578|524229700|FG003|Maintenance Period|Withdrawal by Subject|15|||
145376503|NCT01358578|524229701|FG004|Maintenance Period|Withdrawal by Subject|6|||
145376504|NCT01358578|524229702|FG005|Maintenance Period|Withdrawal by Subject|3|||
145376505|NCT01358578|524229697|FG000|Follow-up Period|Adverse Event|1|||
145376506|NCT01358578|524229698|FG001|Follow-up Period|Adverse Event|1|||
145376507|NCT01358578|524229699|FG002|Follow-up Period|Adverse Event|0|||
145376508|NCT01358578|524229700|FG003|Follow-up Period|Adverse Event|0|||
145376509|NCT01358578|524229701|FG004|Follow-up Period|Adverse Event|0|||
145376510|NCT01358578|524229702|FG005|Follow-up Period|Adverse Event|0|||
145376511|NCT01358578|524229697|FG000|Follow-up Period|Lack of Efficacy|3|||
145376512|NCT01358578|524229698|FG001|Follow-up Period|Lack of Efficacy|0|||
145376513|NCT01358578|524229699|FG002|Follow-up Period|Lack of Efficacy|4|||
145376514|NCT01358578|524229700|FG003|Follow-up Period|Lack of Efficacy|1|||
145376515|NCT01358578|524229701|FG004|Follow-up Period|Lack of Efficacy|0|||
145376516|NCT01358578|524229702|FG005|Follow-up Period|Lack of Efficacy|0|||
145376517|NCT01358578|524229697|FG000|Follow-up Period|Lost to Follow-up|0|||
145376518|NCT01358578|524229698|FG001|Follow-up Period|Lost to Follow-up|1|||
145376519|NCT01358578|524229699|FG002|Follow-up Period|Lost to Follow-up|0|||
145376520|NCT01358578|524229700|FG003|Follow-up Period|Lost to Follow-up|4|||
145376521|NCT01358578|524229701|FG004|Follow-up Period|Lost to Follow-up|0|||
145376522|NCT01358578|524229702|FG005|Follow-up Period|Lost to Follow-up|0|||
145582204|NCT04666441|524983292|FG002|Overall Study|Subject Decision|3|||
145376523|NCT01358578|524229697|FG000|Follow-up Period|non- compliance with study treatment|1|||
145376524|NCT01358578|524229698|FG001|Follow-up Period|non- compliance with study treatment|0|||
145376525|NCT01358578|524229699|FG002|Follow-up Period|non- compliance with study treatment|0|||
145376526|NCT01358578|524229700|FG003|Follow-up Period|non- compliance with study treatment|0|||
145376527|NCT01358578|524229701|FG004|Follow-up Period|non- compliance with study treatment|0|||
145376528|NCT01358578|524229702|FG005|Follow-up Period|non- compliance with study treatment|0|||
145376529|NCT01358578|524229697|FG000|Follow-up Period|Pregnancy|1|||
145376530|NCT01358578|524229698|FG001|Follow-up Period|Pregnancy|0|||
145376531|NCT01358578|524229699|FG002|Follow-up Period|Pregnancy|0|||
145376532|NCT01358578|524229700|FG003|Follow-up Period|Pregnancy|0|||
145376533|NCT01358578|524229701|FG004|Follow-up Period|Pregnancy|0|||
145376534|NCT01358578|524229702|FG005|Follow-up Period|Pregnancy|0|||
145376535|NCT01358578|524229697|FG000|Follow-up Period|Withdrawal by Subject|3|||
145376536|NCT01358578|524229698|FG001|Follow-up Period|Withdrawal by Subject|3|||
145376537|NCT01358578|524229699|FG002|Follow-up Period|Withdrawal by Subject|1|||
145376538|NCT01358578|524229700|FG003|Follow-up Period|Withdrawal by Subject|12|||
145376539|NCT01358578|524229701|FG004|Follow-up Period|Withdrawal by Subject|0|||
145376540|NCT01358578|524229702|FG005|Follow-up Period|Withdrawal by Subject|0|||
145376541|NCT01358578|524229697|FG000|Follow-up Period|Physician Decision|1|||
145376542|NCT01358578|524229698|FG001|Follow-up Period|Physician Decision|1|||
145376543|NCT01358578|524229699|FG002|Follow-up Period|Physician Decision|0|||
145376544|NCT01358578|524229700|FG003|Follow-up Period|Physician Decision|2|||
145376545|NCT01358578|524229701|FG004|Follow-up Period|Physician Decision|0|||
145376546|NCT01358578|524229702|FG005|Follow-up Period|Physician Decision|0|||
145376547|NCT03605849|524229703|FG000|Overall Study|Adverse Event|20|||
145376548|NCT03605849|524229704|FG001|Overall Study|Adverse Event|21|||
145376549|NCT03605849|524229705|FG002|Overall Study|Adverse Event|29|||
145376550|NCT03605849|524229706|FG003|Overall Study|Adverse Event|11|||
145376551|NCT03605849|524229703|FG000|Overall Study|Lack of Efficacy|4|||
145376552|NCT03605849|524229704|FG001|Overall Study|Lack of Efficacy|7|||
145376553|NCT03605849|524229705|FG002|Overall Study|Lack of Efficacy|9|||
145376554|NCT03605849|524229706|FG003|Overall Study|Lack of Efficacy|2|||
145376555|NCT03605849|524229703|FG000|Overall Study|Lost to Follow-up|8|||
145376556|NCT03605849|524229704|FG001|Overall Study|Lost to Follow-up|8|||
145376557|NCT03605849|524229705|FG002|Overall Study|Lost to Follow-up|14|||
145376558|NCT03605849|524229706|FG003|Overall Study|Lost to Follow-up|11|||
145376559|NCT03605849|524229703|FG000|Overall Study|Non-compliance With IMP|6|||
145376560|NCT03605849|524229704|FG001|Overall Study|Non-compliance With IMP|5|||
145376561|NCT03605849|524229705|FG002|Overall Study|Non-compliance With IMP|2|||
145376562|NCT03605849|524229706|FG003|Overall Study|Non-compliance With IMP|1|||
145376563|NCT03605849|524229703|FG000|Overall Study|Protocol Deviation|1|||
145376564|NCT03605849|524229704|FG001|Overall Study|Protocol Deviation|2|||
145376565|NCT03605849|524229705|FG002|Overall Study|Protocol Deviation|1|||
145376566|NCT03605849|524229706|FG003|Overall Study|Protocol Deviation|3|||
145376567|NCT03605849|524229703|FG000|Overall Study|Withdrawal by Subject|33|||
145376568|NCT03605849|524229704|FG001|Overall Study|Withdrawal by Subject|28|||
145376569|NCT03605849|524229705|FG002|Overall Study|Withdrawal by Subject|30|||
145376570|NCT03605849|524229706|FG003|Overall Study|Withdrawal by Subject|28|||
145376571|NCT03605849|524229703|FG000|Overall Study|Site Terminated by Sponsor|0|||
145376572|NCT03605849|524229704|FG001|Overall Study|Site Terminated by Sponsor|0|||
145376573|NCT03605849|524229705|FG002|Overall Study|Site Terminated by Sponsor|0|||
145376574|NCT03605849|524229706|FG003|Overall Study|Site Terminated by Sponsor|1|||
145376575|NCT03605849|524229703|FG000|Overall Study|Physician Decision|2|||
145376576|NCT03605849|524229704|FG001|Overall Study|Physician Decision|1|||
145376577|NCT03605849|524229705|FG002|Overall Study|Physician Decision|2|||
145376578|NCT03605849|524229706|FG003|Overall Study|Physician Decision|1|||
145376579|NCT03605849|524229703|FG000|Overall Study|Enrolled, but not Treated|2|||
145376580|NCT03605849|524229704|FG001|Overall Study|Enrolled, but not Treated|2|||
145376581|NCT03605849|524229705|FG002|Overall Study|Enrolled, but not Treated|3|||
145376582|NCT03605849|524229706|FG003|Overall Study|Enrolled, but not Treated|2|||
145376583|NCT03605849|524229703|FG000|Overall Study|Other (COVID-19 Related)|0|||
145376584|NCT03605849|524229704|FG001|Overall Study|Other (COVID-19 Related)|1|||
145376585|NCT03605849|524229705|FG002|Overall Study|Other (COVID-19 Related)|1|||
145376586|NCT03605849|524229706|FG003|Overall Study|Other (COVID-19 Related)|0|||
145376587|NCT03605849|524229703|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
145376588|NCT03605849|524229704|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
145376589|NCT03605849|524229705|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
145376590|NCT03605849|524229706|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
145376591|NCT02304380|524229707|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145376592|NCT02304380|524229708|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145376593|NCT02304380|524229709|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145376594|NCT02304380|524229710|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
145376595|NCT02304380|524229711|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145376596|NCT02304380|524229712|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
145582205|NCT04666441|524983293|FG003|Overall Study|Subject Decision|1|||
145376597|NCT01027897|524229713|FG000|Overall Study|Protocol Violation|1|||
145376598|NCT01027897|524229713|FG000|Overall Study|Withdrawal by Subject|1|||
145376599|NCT00328094|524229714|FG000|Overall Study|Physician Decision|3|||
145376600|NCT00328094|524229715|FG001|Overall Study|Physician Decision|3|||
145376601|NCT01911780|524229716|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
145376602|NCT01911780|524229717|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
145376603|NCT01911780|524229716|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
145376604|NCT01911780|524229717|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
145376605|NCT01911780|524229716|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
145376606|NCT01911780|524229717|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
145376607|NCT01911780|524229716|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
145376608|NCT01911780|524229717|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
145376609|NCT01911780|524229716|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
145376610|NCT01911780|524229717|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
145376611|NCT01911780|524229716|FG000|Extension Period (52 Weeks)|Personal reason|1|||
145376612|NCT01911780|524229717|FG001|Extension Period (52 Weeks)|Personal reason|1|||
145376613|NCT02667626|524229718|FG000|Overall Study|Withdrawal by Subject|0|||
145376614|NCT02667626|524229719|FG001|Overall Study|Withdrawal by Subject|1|||
145376615|NCT00985426|524229723|FG000|Overall Study|Adverse Event|0|||
145376616|NCT00985426|524229724|FG001|Overall Study|Adverse Event|1|||
145430715|NCT03261505|524435936|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
145430716|NCT03261505|524435937|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145430717|NCT03261505|524435938|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145430718|NCT03261505|524435939|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
145430719|NCT00879398|524435940|FG000|Overall Study|Visit Stop|399|||
145430720|NCT00879398|524435940|FG000|Overall Study|Lack of Efficacy|64|||
145430721|NCT00879398|524435940|FG000|Overall Study|Adverse Event|41|||
145430722|NCT00879398|524435940|FG000|Overall Study|Other Reasons|171|||
145430723|NCT03773484|524435943|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
145430724|NCT05552859|524435950|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
145430725|NCT05552859|524435951|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
145430726|NCT04251533|524435952|FG000|Overall Study|Progressive disease|33|||
145430727|NCT04251533|524435953|FG001|Overall Study|Progressive disease|29|||
145430728|NCT04251533|524435954|FG002|Overall Study|Progressive disease|22|||
145430729|NCT04251533|524435952|FG000|Overall Study|Death|5|||
145430730|NCT04251533|524435953|FG001|Overall Study|Death|1|||
145430731|NCT04251533|524435954|FG002|Overall Study|Death|3|||
145430732|NCT04251533|524435952|FG000|Overall Study|Physician Decision|3|||
145376617|NCT00985426|524229723|FG000|Overall Study|Subject Non-Compliance|3|||
145376618|NCT00985426|524229724|FG001|Overall Study|Subject Non-Compliance|3|||
145376619|NCT00985426|524229723|FG000|Overall Study|Withdrawal by Subject|12|||
145376620|NCT00985426|524229724|FG001|Overall Study|Withdrawal by Subject|16|||
145376621|NCT00985426|524229723|FG000|Overall Study|Lost to Follow-up|8|||
145376622|NCT00985426|524229724|FG001|Overall Study|Lost to Follow-up|10|||
145376623|NCT00985426|524229723|FG000|Overall Study|Death|7|||
145376624|NCT00985426|524229724|FG001|Overall Study|Death|3|||
145376625|NCT00985426|524229723|FG000|Overall Study|Protocol Violation|2|||
145376626|NCT00985426|524229724|FG001|Overall Study|Protocol Violation|0|||
145376627|NCT00985426|524229723|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
145376628|NCT00985426|524229724|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
145430733|NCT04251533|524435953|FG001|Overall Study|Physician Decision|2|||
145430734|NCT04251533|524435954|FG002|Overall Study|Physician Decision|4|||
145430735|NCT04251533|524435952|FG000|Overall Study|Participant decision|1|||
145430736|NCT04251533|524435953|FG001|Overall Study|Participant decision|3|||
145430737|NCT04251533|524435954|FG002|Overall Study|Participant decision|1|||
145430738|NCT04251533|524435952|FG000|Overall Study|Adverse Event|2|||
145430739|NCT04251533|524435953|FG001|Overall Study|Adverse Event|1|||
145430740|NCT04251533|524435954|FG002|Overall Study|Adverse Event|1|||
145430741|NCT00432965|524435957|FG000|Overall Study|Lost to Follow-up|22|||
145430742|NCT00432965|524435958|FG001|Overall Study|Lost to Follow-up|19|||
145430743|NCT00432965|524435957|FG000|Overall Study|Withdrawal by Subject|13|||
145376629|NCT01661933|524229725|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
145376630|NCT01661933|524229725|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
145376631|NCT01935128|524229728|FG000|Overall Study|Death|1|||
145430744|NCT00432965|524435958|FG001|Overall Study|Withdrawal by Subject|13|||
145430745|NCT00432965|524435957|FG000|Overall Study|Physician Decision|14|||
145430746|NCT00432965|524435958|FG001|Overall Study|Physician Decision|13|||
145430747|NCT00432965|524435957|FG000|Overall Study|Lack of Efficacy|8|||
145430748|NCT00432965|524435958|FG001|Overall Study|Lack of Efficacy|13|||
145430749|NCT00432965|524435957|FG000|Overall Study|Non-compliance|7|||
145430750|NCT00432965|524435958|FG001|Overall Study|Non-compliance|0|||
145376632|NCT01935128|524229728|FG000|Overall Study|Adverse Event|6|||
145376633|NCT00204477|524229735|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
145430751|NCT00432965|524435957|FG000|Overall Study|Adverse Event|22|||
145376634|NCT00204477|524229736|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
145376635|NCT00204477|524229735|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
145376636|NCT00204477|524229736|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
145376637|NCT00150800|524229737|FG000|Overall Study|Adverse Event|89|||
145376638|NCT00150800|524229737|FG000|Overall Study|Death|18|||
145376639|NCT00150800|524229737|FG000|Overall Study|Lack of Efficacy|166|||
145376640|NCT00150800|524229737|FG000|Overall Study|Lost to Follow-up|58|||
145376641|NCT00150800|524229737|FG000|Overall Study|Subject's choice|90|||
145376642|NCT00150800|524229737|FG000|Overall Study|No compliance|18|||
145376643|NCT00150800|524229737|FG000|Overall Study|IP misshandling|1|||
145376644|NCT00150800|524229737|FG000|Overall Study|Site closure|24|||
145376645|NCT00150800|524229737|FG000|Overall Study|Protocol non-adherence|2|||
145376646|NCT00150800|524229737|FG000|Overall Study|Nobody to accompany patient|1|||
145376647|NCT00150800|524229737|FG000|Overall Study|Distance too long for patient|1|||
145376648|NCT00150800|524229737|FG000|Overall Study|Neurosurgery|2|||
145376649|NCT00150800|524229737|FG000|Overall Study|BRV monotherapy|1|||
145376650|NCT00150800|524229737|FG000|Overall Study|Visit refusal|3|||
145376651|NCT00150800|524229737|FG000|Overall Study|Sponsor's request|2|||
145376652|NCT00150800|524229737|FG000|Overall Study|Generalized Epilepsy|1|||
145376653|NCT00150800|524229737|FG000|Overall Study|Moved from area/country|8|||
145376654|NCT00150800|524229737|FG000|Overall Study|PI retiring|2|||
145376655|NCT00150800|524229737|FG000|Overall Study|PI leaving site|2|||
145376656|NCT00150800|524229737|FG000|Overall Study|Patient insurance|1|||
145376657|NCT00150800|524229737|FG000|Overall Study|Surgical intervention|4|||
145376658|NCT00150800|524229737|FG000|Overall Study|Pregnancy planned|1|||
145376659|NCT00150800|524229737|FG000|Overall Study|PI discontinuation request|1|||
145376660|NCT03619902|524229738|FG000|Overall Study|Termination of Study by Investigator|1|||
145376661|NCT03619902|524229738|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
145376662|NCT01966068|524229741|FG000|Overall Study|Withdrawal by Subject|57|||
145376663|NCT01966068|524229741|FG000|Overall Study|Lost to Follow-up|81|||
145376664|NCT01790828|524229743|FG000|Overall Study|Other|34|||
145376665|NCT00710684|524229748|FG000|Overall Study|Adverse Event|11|||
145376666|NCT00710684|524229749|FG001|Overall Study|Adverse Event|19|||
145376667|NCT00710684|524229750|FG002|Overall Study|Adverse Event|16|||
145376668|NCT00710684|524229748|FG000|Overall Study|Lack of Efficacy|4|||
145376669|NCT00710684|524229749|FG001|Overall Study|Lack of Efficacy|3|||
145376670|NCT00710684|524229750|FG002|Overall Study|Lack of Efficacy|5|||
145376671|NCT00710684|524229748|FG000|Overall Study|Protocol Violation|5|||
145376672|NCT00710684|524229749|FG001|Overall Study|Protocol Violation|5|||
145376673|NCT00710684|524229750|FG002|Overall Study|Protocol Violation|5|||
145376674|NCT00710684|524229748|FG000|Overall Study|Lost to Follow-up|4|||
145376675|NCT00710684|524229749|FG001|Overall Study|Lost to Follow-up|6|||
145376676|NCT00710684|524229750|FG002|Overall Study|Lost to Follow-up|7|||
145376677|NCT00710684|524229748|FG000|Overall Study|Physician Decision|0|||
145376678|NCT00710684|524229749|FG001|Overall Study|Physician Decision|2|||
145376679|NCT00710684|524229750|FG002|Overall Study|Physician Decision|4|||
145376680|NCT00710684|524229748|FG000|Overall Study|Withdrawal by Subject|24|||
145376681|NCT00710684|524229749|FG001|Overall Study|Withdrawal by Subject|18|||
145376682|NCT00710684|524229750|FG002|Overall Study|Withdrawal by Subject|11|||
145376683|NCT00710684|524229748|FG000|Overall Study|Missing|1|||
145376684|NCT00710684|524229749|FG001|Overall Study|Missing|0|||
145376685|NCT00710684|524229750|FG002|Overall Study|Missing|0|||
145376686|NCT00710684|524229748|FG000|Overall Study|Did not continue after week 24|25|||
145376687|NCT00710684|524229749|FG001|Overall Study|Did not continue after week 24|21|||
145376688|NCT00710684|524229750|FG002|Overall Study|Did not continue after week 24|16|||
145376689|NCT03026530|524229755|FG000|Overall Study|Lost to Follow-up|19|||
145376690|NCT03026530|524229756|FG001|Overall Study|Lost to Follow-up|24|||
145376691|NCT03026530|524229755|FG000|Overall Study|Protocol Violation|2|||
145376692|NCT03026530|524229756|FG001|Overall Study|Protocol Violation|5|||
145376693|NCT03301740|524229757|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
145376694|NCT03301740|524229758|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
145376695|NCT03301740|524229757|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
145376696|NCT03301740|524229758|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
145376697|NCT01037127|524229760|FG000|Overall Study|Lost to Follow-up|2|||
145376698|NCT01037127|524229761|FG001|Overall Study|Lost to Follow-up|4|||
145376699|NCT01037127|524229760|FG000|Overall Study|Physician Decision|1|||
145376700|NCT01037127|524229761|FG001|Overall Study|Physician Decision|0|||
145376701|NCT01037127|524229760|FG000|Overall Study|Study Closed Terminated|2|||
145376702|NCT01037127|524229761|FG001|Overall Study|Study Closed Terminated|17|||
145376703|NCT02637713|524229765|FG000|Overall Study|Screen Failure|2|||
145376704|NCT02847182|524229766|FG000|Overall Study|Withdrawal by Subject|0|||
145376705|NCT02847182|524229767|FG001|Overall Study|Withdrawal by Subject|1|||
145376706|NCT04325698|524229769|FG000|Overall Study|Study Terminated By Sponsor|1|||
145376707|NCT04325698|524229770|FG001|Overall Study|Study Terminated By Sponsor|1|||
145376708|NCT04325698|524229769|FG000|Overall Study|Withdrawal by Subject|0|||
145376709|NCT04325698|524229770|FG001|Overall Study|Withdrawal by Subject|2|||
145376710|NCT04253782|524229771|FG000|Overall Study|Death|2|||
145376711|NCT04253782|524229772|FG001|Overall Study|Death|0|||
145376712|NCT00778102|524229773|FG000|Overall Study|Adverse Event|8|||
145376713|NCT00778102|524229774|FG001|Overall Study|Adverse Event|5|||
145376714|NCT00778102|524229773|FG000|Overall Study|Death|1|||
145376715|NCT00778102|524229774|FG001|Overall Study|Death|1|||
145376716|NCT00778102|524229773|FG000|Overall Study|Lost to Follow-up|1|||
145376717|NCT00778102|524229774|FG001|Overall Study|Lost to Follow-up|0|||
145376718|NCT00778102|524229773|FG000|Overall Study|Violation of Selection Criteria|1|||
145376719|NCT00778102|524229774|FG001|Overall Study|Violation of Selection Criteria|1|||
145376720|NCT00778102|524229773|FG000|Overall Study|Protocol Violation|0|||
145376721|NCT00778102|524229774|FG001|Overall Study|Protocol Violation|1|||
145376722|NCT00778102|524229773|FG000|Overall Study|Refused Treatment|2|||
145376723|NCT00778102|524229774|FG001|Overall Study|Refused Treatment|3|||
145376724|NCT00778102|524229773|FG000|Overall Study|Withdrawal by Subject|1|||
145376725|NCT00778102|524229774|FG001|Overall Study|Withdrawal by Subject|1|||
145376726|NCT00778102|524229773|FG000|Overall Study|Administrative Reason|7|||
145376727|NCT00778102|524229774|FG001|Overall Study|Administrative Reason|10|||
145376728|NCT01328548|524229775|FG000|Overall Study|Death|3|||
145376729|NCT01328548|524229776|FG001|Overall Study|Death|0|||
145376730|NCT01328548|524229775|FG000|Overall Study|Protocol Violation|1|||
145376731|NCT01328548|524229776|FG001|Overall Study|Protocol Violation|0|||
145376732|NCT04506905|524229779|FG000|Overall Study|Lost to Follow-up|1|||
145376733|NCT04506905|524229780|FG001|Overall Study|Lost to Follow-up|0|||
145376734|NCT04506905|524229781|FG002|Overall Study|Lost to Follow-up|0|||
145376735|NCT04506905|524229782|FG003|Overall Study|Lost to Follow-up|1|||
145376736|NCT04506905|524229783|FG004|Overall Study|Lost to Follow-up|0|||
145376737|NCT04506905|524229784|FG005|Overall Study|Lost to Follow-up|0|||
145376738|NCT04506905|524229785|FG006|Overall Study|Lost to Follow-up|0|||
145376739|NCT04506905|524229786|FG007|Overall Study|Lost to Follow-up|0|||
145376740|NCT04506905|524229787|FG008|Overall Study|Lost to Follow-up|0|||
145376741|NCT04506905|524229779|FG000|Overall Study|Withdrawal by Subject|0|||
145376742|NCT04506905|524229780|FG001|Overall Study|Withdrawal by Subject|0|||
145376743|NCT04506905|524229781|FG002|Overall Study|Withdrawal by Subject|0|||
145376744|NCT04506905|524229782|FG003|Overall Study|Withdrawal by Subject|2|||
145376745|NCT04506905|524229783|FG004|Overall Study|Withdrawal by Subject|0|||
145376746|NCT04506905|524229784|FG005|Overall Study|Withdrawal by Subject|0|||
145376747|NCT04506905|524229785|FG006|Overall Study|Withdrawal by Subject|0|||
145376748|NCT04506905|524229786|FG007|Overall Study|Withdrawal by Subject|0|||
145376749|NCT04506905|524229787|FG008|Overall Study|Withdrawal by Subject|0|||
145376750|NCT02000882|524231559|FG000|Overall Study|Adverse Event|3|||
145376751|NCT02000882|524231559|FG000|Overall Study|Physician Decision|2|||
145376752|NCT02000882|524231559|FG000|Overall Study|Withdrawal by Subject|1|||
145376753|NCT00549601|524231560|FG000|Randomized|Protocol Violation|0|||
145376754|NCT00549601|524231561|FG001|Randomized|Protocol Violation|0|||
145376755|NCT00549601|524231562|FG002|Randomized|Protocol Violation|1|||
145376756|NCT00549601|524231560|FG000|Randomized|Withdrawal by Subject|0|||
145376757|NCT00549601|524231561|FG001|Randomized|Withdrawal by Subject|1|||
145376758|NCT00549601|524231562|FG002|Randomized|Withdrawal by Subject|1|||
145376759|NCT00549601|524231560|FG000|Received Study Drug|Adverse Event|2|||
145376760|NCT00549601|524231561|FG001|Received Study Drug|Adverse Event|5|||
145376761|NCT00549601|524231562|FG002|Received Study Drug|Adverse Event|1|||
145376762|NCT00549601|524231560|FG000|Received Study Drug|Death|0|||
145376763|NCT00549601|524231561|FG001|Received Study Drug|Death|1|||
145376764|NCT00549601|524231562|FG002|Received Study Drug|Death|0|||
145376765|NCT00549601|524231560|FG000|Received Study Drug|Lost to Follow-up|0|||
145376766|NCT00549601|524231561|FG001|Received Study Drug|Lost to Follow-up|1|||
145376767|NCT00549601|524231562|FG002|Received Study Drug|Lost to Follow-up|1|||
145376768|NCT00549601|524231560|FG000|Received Study Drug|Protocol Violation|3|||
145376769|NCT00549601|524231561|FG001|Received Study Drug|Protocol Violation|4|||
145376770|NCT00549601|524231562|FG002|Received Study Drug|Protocol Violation|1|||
145376771|NCT00549601|524231560|FG000|Received Study Drug|Withdrawal by Subject|2|||
145376772|NCT00549601|524231561|FG001|Received Study Drug|Withdrawal by Subject|0|||
145376773|NCT00549601|524231562|FG002|Received Study Drug|Withdrawal by Subject|1|||
145376774|NCT00224406|524231566|FG000|Overall Study|Re-transplant|0|||
145376775|NCT00224406|524231567|FG001|Overall Study|Re-transplant|2|||
145376776|NCT00224406|524231566|FG000|Overall Study|Death|0|||
145430752|NCT00432965|524435958|FG001|Overall Study|Adverse Event|19|||
145376777|NCT00224406|524231567|FG001|Overall Study|Death|1|||
145376778|NCT00224406|524231566|FG000|Overall Study|Transplant cancelled|0|||
145376779|NCT00224406|524231567|FG001|Overall Study|Transplant cancelled|4|||
145376780|NCT00224406|524231566|FG000|Overall Study|Drug not delivered|2|||
145376781|NCT00224406|524231567|FG001|Overall Study|Drug not delivered|0|||
145376782|NCT00224406|524231566|FG000|Overall Study|Other|4|||
145376783|NCT00224406|524231567|FG001|Overall Study|Other|0|||
145376784|NCT00224406|524231566|FG000|Overall Study|Transplant cancelled|3|||
145376785|NCT00224406|524231567|FG001|Overall Study|Transplant cancelled|0|||
145376786|NCT01556997|524231568|FG000|Overall Study|Adverse Event|10|||
145376787|NCT01556997|524231569|FG001|Overall Study|Adverse Event|12|||
145376788|NCT01556997|524231570|FG002|Overall Study|Adverse Event|12|||
145376789|NCT01556997|524231568|FG000|Overall Study|Lost to Follow-up|6|||
145430753|NCT00432965|524435957|FG000|Overall Study|Death|3|||
145582206|NCT04666441|524983294|FG004|Overall Study|Subject Decision|0|||
145582207|NCT04666441|524983295|FG005|Overall Study|Subject Decision|1|||
145582208|NCT04666441|524983296|FG006|Overall Study|Subject Decision|3|||
145582209|NCT04666441|524983297|FG007|Overall Study|Subject Decision|2|||
145582210|NCT01306617|524983298|FG000|Overall Study|Adverse Event|1|||
145582211|NCT01306617|524983299|FG001|Overall Study|Adverse Event|0|||
145582212|NCT01306617|524983300|FG002|Overall Study|Adverse Event|0|||
145582213|NCT01306617|524983298|FG000|Overall Study|Virologic Failure|0|||
145582214|NCT01306617|524983299|FG001|Overall Study|Virologic Failure|0|||
145582215|NCT01306617|524983300|FG002|Overall Study|Virologic Failure|5|||
145582216|NCT01306617|524983298|FG000|Overall Study|Non-compliance|0|||
145582217|NCT01306617|524983299|FG001|Overall Study|Non-compliance|1|||
145582218|NCT01306617|524983300|FG002|Overall Study|Non-compliance|0|||
145582219|NCT03779841|524983308|FG000|Randomized Population|Did Not Receive Treatment|3|||
145582220|NCT03779841|524983309|FG001|Randomized Population|Did Not Receive Treatment|1|||
145582221|NCT03779841|524983310|FG002|Randomized Population|Did Not Receive Treatment|0|||
145582222|NCT03779841|524983308|FG000|Treated (Safety) Population|Adverse Event|1|||
145582223|NCT03779841|524983309|FG001|Treated (Safety) Population|Adverse Event|1|||
145582224|NCT03779841|524983310|FG002|Treated (Safety) Population|Adverse Event|0|||
145582225|NCT03779841|524983308|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
145582226|NCT03779841|524983309|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
145582227|NCT03779841|524983310|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
145582228|NCT03779841|524983308|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
145582229|NCT03779841|524983309|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
145582230|NCT03779841|524983310|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
145582231|NCT03779841|524983308|FG000|Treated (Safety) Population|Death|1|||
145582232|NCT03779841|524983309|FG001|Treated (Safety) Population|Death|0|||
145582233|NCT03779841|524983310|FG002|Treated (Safety) Population|Death|2|||
145582234|NCT01632579|524983311|FG000|Washout Period|Adverse Event|1|||
145582235|NCT01632579|524983312|FG001|Washout Period|Adverse Event|0|||
145582236|NCT01632579|524983313|FG002|Washout Period|Adverse Event|0|||
145582237|NCT01632579|524983314|FG003|Washout Period|Adverse Event|0|||
145582238|NCT01632579|524983315|FG004|Washout Period|Adverse Event|0|||
145582239|NCT01632579|524983316|FG005|Washout Period|Adverse Event|0|||
145582240|NCT01632579|524983317|FG006|Washout Period|Adverse Event|0|||
145582241|NCT01632579|524983318|FG007|Washout Period|Adverse Event|0|||
145582242|NCT01632579|524983319|FG008|Washout Period|Adverse Event|0|||
145582243|NCT01632579|524983311|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
145582244|NCT01632579|524983312|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
145582245|NCT01632579|524983313|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
145582246|NCT01632579|524983314|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
145582247|NCT01632579|524983315|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
145582248|NCT01632579|524983316|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
145582249|NCT01632579|524983317|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
145582250|NCT01632579|524983318|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
145582251|NCT01632579|524983319|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
145582252|NCT00818441|524983320|FG000|Overall Study|Death|69|||
145582253|NCT00818441|524983321|FG001|Overall Study|Death|26|||
145582254|NCT00818441|524983320|FG000|Overall Study|Other|5|||
145582255|NCT00818441|524983321|FG001|Overall Study|Other|0|||
145582256|NCT00818441|524983320|FG000|Overall Study|Lost to Follow-up|2|||
145582257|NCT00818441|524983321|FG001|Overall Study|Lost to Follow-up|1|||
145582258|NCT00818441|524983320|FG000|Overall Study|Withdrawal by Subject|2|||
145582259|NCT00818441|524983321|FG001|Overall Study|Withdrawal by Subject|0|||
145582260|NCT00818441|524983320|FG000|Overall Study|Adverse Event|0|||
145582261|NCT00818441|524983321|FG001|Overall Study|Adverse Event|1|||
145582262|NCT00818441|524983320|FG000|Overall Study|Study terminated by sponsor|11|||
145582263|NCT00818441|524983321|FG001|Overall Study|Study terminated by sponsor|2|||
145582264|NCT00898677|524983322|FG000|Overall Study|Adverse Event|0|||
145582265|NCT00898677|524983323|FG001|Overall Study|Adverse Event|0|||
145582266|NCT00898677|524983324|FG002|Overall Study|Adverse Event|1|||
145582267|NCT00898677|524983325|FG003|Overall Study|Adverse Event|0|||
145582268|NCT00898677|524983322|FG000|Overall Study|Lost to Follow-up|0|||
145430754|NCT00432965|524435958|FG001|Overall Study|Death|4|||
145582269|NCT00898677|524983323|FG001|Overall Study|Lost to Follow-up|0|||
145582270|NCT00898677|524983324|FG002|Overall Study|Lost to Follow-up|2|||
145582271|NCT00898677|524983325|FG003|Overall Study|Lost to Follow-up|0|||
145582272|NCT00898677|524983322|FG000|Overall Study|Protocol Violation|1|||
145582273|NCT00898677|524983323|FG001|Overall Study|Protocol Violation|1|||
145582274|NCT00898677|524983324|FG002|Overall Study|Protocol Violation|2|||
145582275|NCT00898677|524983325|FG003|Overall Study|Protocol Violation|0|||
145624023|NCT00783718|525135652|FG005|Maintenance Phase|Adverse Event|6|||
145582276|NCT00898677|524983322|FG000|Overall Study|Withdrawal by Subject|0|||
145582277|NCT00898677|524983323|FG001|Overall Study|Withdrawal by Subject|0|||
145582278|NCT00898677|524983324|FG002|Overall Study|Withdrawal by Subject|0|||
145582279|NCT00898677|524983325|FG003|Overall Study|Withdrawal by Subject|1|||
145582280|NCT00898677|524983322|FG000|Overall Study|Not Treated: Adverse Event|0|||
145582281|NCT00898677|524983323|FG001|Overall Study|Not Treated: Adverse Event|2|||
145376790|NCT01556997|524231569|FG001|Overall Study|Lost to Follow-up|6|||
145430755|NCT00432965|524435957|FG000|Overall Study|Exclusionary Methods|1|||
145430756|NCT00432965|524435958|FG001|Overall Study|Exclusionary Methods|2|||
145430757|NCT00432965|524435957|FG000|Overall Study|Incomplete Data|4|||
145430758|NCT00432965|524435958|FG001|Overall Study|Incomplete Data|3|||
145376791|NCT01556997|524231570|FG002|Overall Study|Lost to Follow-up|4|||
145376792|NCT01556997|524231568|FG000|Overall Study|Physician Decision|1|||
145376793|NCT01556997|524231569|FG001|Overall Study|Physician Decision|1|||
145376794|NCT01556997|524231570|FG002|Overall Study|Physician Decision|1|||
145376795|NCT01556997|524231568|FG000|Overall Study|Withdrawal by Subject|7|||
145376796|NCT01556997|524231569|FG001|Overall Study|Withdrawal by Subject|6|||
145376797|NCT01556997|524231570|FG002|Overall Study|Withdrawal by Subject|8|||
145376798|NCT01556997|524231568|FG000|Overall Study|Other|2|||
145376799|NCT01556997|524231569|FG001|Overall Study|Other|3|||
145376800|NCT01556997|524231570|FG002|Overall Study|Other|7|||
145376801|NCT01250171|524231574|FG000|Overall Study|Administrative reasons|1|||
145376802|NCT01250171|524231575|FG001|Overall Study|Administrative reasons|0|||
145376803|NCT01250171|524231576|FG002|Overall Study|Administrative reasons|0|||
145376804|NCT02949908|524231577|FG000|Overall Study|Study termination|2|||
145376805|NCT02607280|524231580|FG000|Overall Study|Adverse Event|4|||
145376806|NCT02607280|524231581|FG001|Overall Study|Adverse Event|0|||
145376807|NCT02607280|524231580|FG000|Overall Study|Decrease in CrCl <15|0|||
145376808|NCT02607280|524231581|FG001|Overall Study|Decrease in CrCl <15|1|||
145376809|NCT00590538|524231582|FG000|Overall Study|Study terminated before completed|2|||
145376810|NCT02309723|524231583|FG000|Overall Study|Withdrawal by Subject|24|||
145376811|NCT02309723|524231584|FG001|Overall Study|Withdrawal by Subject|23|||
145376812|NCT02309723|524231585|FG002|Overall Study|Withdrawal by Subject|24|||
145376813|NCT01125813|524231586|FG000|Overall Study|Death|1|||
145376814|NCT01125813|524231586|FG000|Overall Study|Withdrawal by Subject|1|||
145376815|NCT01125813|524231586|FG000|Overall Study|Screen Failures|4|||
145376816|NCT02539134|524231587|FG000|Overall Study|Lost to Follow-up|1|||
145376817|NCT02539134|524231588|FG001|Overall Study|Lost to Follow-up|0|||
145376818|NCT02539134|524231589|FG002|Overall Study|Lost to Follow-up|0|||
145376819|NCT02539134|524231590|FG003|Overall Study|Lost to Follow-up|0|||
145376820|NCT02539134|524231591|FG004|Overall Study|Lost to Follow-up|0|||
145376821|NCT02539134|524231592|FG005|Overall Study|Lost to Follow-up|0|||
145376822|NCT01143064|524231593|FG000|Overall Study|Death|109|||
145376823|NCT01143064|524231594|FG001|Overall Study|Death|91|||
145376824|NCT01143064|524231593|FG000|Overall Study|Adverse Event|0|||
145376825|NCT01143064|524231594|FG001|Overall Study|Adverse Event|1|||
145376826|NCT01143064|524231593|FG000|Overall Study|Withdrawal by Subject|7|||
145376827|NCT01143064|524231594|FG001|Overall Study|Withdrawal by Subject|5|||
145376828|NCT01143064|524231593|FG000|Overall Study|Lost to Follow-up|17|||
145376829|NCT01143064|524231594|FG001|Overall Study|Lost to Follow-up|14|||
145376830|NCT01143064|524231593|FG000|Overall Study|Physician Decision|0|||
145376831|NCT01143064|524231594|FG001|Overall Study|Physician Decision|4|||
145376832|NCT02453282|524231595|FG000|Overall Study|Death|275|||
145376833|NCT02453282|524231596|FG001|Overall Study|Death|277|||
145376834|NCT02453282|524231597|FG002|Overall Study|Death|296|||
145376835|NCT02453282|524231595|FG000|Overall Study|Lost to Follow-up|1|||
145376836|NCT02453282|524231596|FG001|Overall Study|Lost to Follow-up|0|||
145376837|NCT02453282|524231597|FG002|Overall Study|Lost to Follow-up|2|||
145376838|NCT02453282|524231595|FG000|Overall Study|Withdrawal by Subject|12|||
145376839|NCT02453282|524231596|FG001|Overall Study|Withdrawal by Subject|10|||
145376840|NCT02453282|524231597|FG002|Overall Study|Withdrawal by Subject|11|||
145376841|NCT02453282|524231595|FG000|Overall Study|Participants ongoing at data cut-off|85|||
145376842|NCT02453282|524231596|FG001|Overall Study|Participants ongoing at data cut-off|84|||
145582282|NCT00898677|524983324|FG002|Overall Study|Not Treated: Adverse Event|1|||
145376843|NCT02453282|524231597|FG002|Overall Study|Participants ongoing at data cut-off|62|||
145376844|NCT02453282|524231595|FG000|Overall Study|Other|1|||
145376845|NCT02453282|524231596|FG001|Overall Study|Other|1|||
145430759|NCT02302222|524435963|FG000|Overall Study|Physician Decision|0|||
145430760|NCT02302222|524435964|FG001|Overall Study|Physician Decision|4|||
145430761|NCT02302222|524435963|FG000|Overall Study|Lost to Follow-up|1|||
145430762|NCT02302222|524435964|FG001|Overall Study|Lost to Follow-up|0|||
145430763|NCT02302222|524435963|FG000|Overall Study|Treatment discontinued before day 5|0|||
145430764|NCT02302222|524435964|FG001|Overall Study|Treatment discontinued before day 5|1|||
145430765|NCT02302222|524435963|FG000|Overall Study|Withdrawn prior to any treatment|0|||
145430766|NCT02302222|524435964|FG001|Overall Study|Withdrawn prior to any treatment|1|||
145430767|NCT03193801|524435965|FG000|Overall Study|Physician Decision|2|||
145430768|NCT03193801|524435965|FG000|Overall Study|Withdrawal by Subject|1|||
145582283|NCT00898677|524983325|FG003|Overall Study|Not Treated: Adverse Event|0|||
145376846|NCT02453282|524231597|FG002|Overall Study|Other|1|||
145376847|NCT02327013|524231598|FG000|Overall Study|Adverse Event|4|||
145376848|NCT02327013|524231599|FG001|Overall Study|Adverse Event|4|||
145376849|NCT02327013|524231600|FG002|Overall Study|Adverse Event|3|||
145376850|NCT02327013|524231601|FG003|Overall Study|Adverse Event|0|||
145376851|NCT02327013|524231602|FG004|Overall Study|Adverse Event|1|||
145376852|NCT02327013|524231598|FG000|Overall Study|Lack of Efficacy|2|||
145430769|NCT03138564|524435966|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
145430770|NCT03138564|524435967|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
145430771|NCT03138564|524435966|FG000|Overall Study|Lost to Follow-up|16|||
145430772|NCT03138564|524435967|FG001|Overall Study|Lost to Follow-up|2|||
145430773|NCT03138564|524435966|FG000|Overall Study|Withdrawal by Subject|48|||
145430774|NCT03138564|524435967|FG001|Overall Study|Withdrawal by Subject|4|||
145430775|NCT03138564|524435966|FG000|Overall Study|No longer met eligibility criteria|2|||
145430776|NCT03138564|524435967|FG001|Overall Study|No longer met eligibility criteria|0|||
145430777|NCT03138564|524435966|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
145430778|NCT03138564|524435967|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
145430779|NCT03138564|524435966|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
145430780|NCT03138564|524435967|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
145430781|NCT03138564|524435966|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
145430782|NCT03138564|524435967|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
145430783|NCT03138564|524435966|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
145430784|NCT03138564|524435967|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
145430785|NCT03909971|524435969|FG000|Overall Study|Participant transition to rollover study|26|||
145430786|NCT03909971|524435970|FG001|Overall Study|Participant transition to rollover study|9|||
145430787|NCT03909971|524435969|FG000|Overall Study|Global Deterioration of Health Status|2|||
145430788|NCT03909971|524435970|FG001|Overall Study|Global Deterioration of Health Status|2|||
145430789|NCT03909971|524435969|FG000|Overall Study|Progressive Disease|28|||
145430790|NCT03909971|524435970|FG001|Overall Study|Progressive Disease|21|||
145430791|NCT03909971|524435969|FG000|Overall Study|Death|6|||
145430792|NCT03909971|524435970|FG001|Overall Study|Death|6|||
145430793|NCT03909971|524435969|FG000|Overall Study|Adverse Event|1|||
145430794|NCT03909971|524435970|FG001|Overall Study|Adverse Event|2|||
145430795|NCT03909971|524435969|FG000|Overall Study|Withdrawal by Subject|2|||
145430796|NCT03909971|524435970|FG001|Overall Study|Withdrawal by Subject|1|||
145430797|NCT03909971|524435969|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
145430798|NCT03909971|524435970|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
145430799|NCT03909971|524435969|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
145430800|NCT03909971|524435970|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
145430801|NCT05177354|524435971|FG000|Implant to 30-day Visit|Physician Decision|1|||
145430802|NCT05177354|524435971|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
145430803|NCT05177354|524435971|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
145430804|NCT05177354|524435971|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
145430805|NCT03734536|524435972|FG000|Overall Study|Withdrew Consent|1|||
145430806|NCT03734536|524435973|FG001|Overall Study|Withdrew Consent|5|||
145430807|NCT03734536|524435972|FG000|Overall Study|Lost to Follow-up|10|||
145430808|NCT03734536|524435973|FG001|Overall Study|Lost to Follow-up|7|||
145430809|NCT06028464|524435977|FG000|Washout|Positive drug test.|1|||
145430810|NCT03189719|524435978|FG000|Overall Study|Death|325|||
145430811|NCT03189719|524435979|FG001|Overall Study|Death|361|||
145430812|NCT03189719|524435978|FG000|Overall Study|Physician Decision|1|||
145430813|NCT03189719|524435979|FG001|Overall Study|Physician Decision|0|||
145430814|NCT03189719|524435978|FG000|Overall Study|Sponsor Decision|40|||
145430815|NCT03189719|524435979|FG001|Overall Study|Sponsor Decision|12|||
145430816|NCT03189719|524435978|FG000|Overall Study|Withdrawal by Subject|7|||
145624024|NCT00783718|525135653|FG006|Maintenance Phase|Adverse Event|16|||
145376853|NCT02327013|524231599|FG001|Overall Study|Lack of Efficacy|0|||
145376854|NCT02327013|524231600|FG002|Overall Study|Lack of Efficacy|5|||
145376855|NCT02327013|524231601|FG003|Overall Study|Lack of Efficacy|0|||
145376856|NCT02327013|524231602|FG004|Overall Study|Lack of Efficacy|1|||
145376857|NCT02327013|524231598|FG000|Overall Study|Non-compliance with IMP|1|||
145376858|NCT02327013|524231599|FG001|Overall Study|Non-compliance with IMP|2|||
145376859|NCT02327013|524231600|FG002|Overall Study|Non-compliance with IMP|7|||
145376860|NCT02327013|524231601|FG003|Overall Study|Non-compliance with IMP|0|||
145376861|NCT02327013|524231602|FG004|Overall Study|Non-compliance with IMP|0|||
145376862|NCT02327013|524231598|FG000|Overall Study|Withdrawal of Consent|1|||
145376863|NCT02327013|524231599|FG001|Overall Study|Withdrawal of Consent|0|||
145376864|NCT02327013|524231600|FG002|Overall Study|Withdrawal of Consent|3|||
145376865|NCT02327013|524231601|FG003|Overall Study|Withdrawal of Consent|0|||
145376866|NCT02327013|524231602|FG004|Overall Study|Withdrawal of Consent|0|||
145376867|NCT02327013|524231598|FG000|Overall Study|Lost to Follow-up|2|||
145376868|NCT02327013|524231599|FG001|Overall Study|Lost to Follow-up|4|||
145376869|NCT02327013|524231600|FG002|Overall Study|Lost to Follow-up|5|||
145376870|NCT02327013|524231601|FG003|Overall Study|Lost to Follow-up|0|||
145376871|NCT02327013|524231602|FG004|Overall Study|Lost to Follow-up|0|||
145376872|NCT02327013|524231598|FG000|Overall Study|Administrative or other reason(s)|1|||
145376873|NCT02327013|524231599|FG001|Overall Study|Administrative or other reason(s)|5|||
145376874|NCT02327013|524231600|FG002|Overall Study|Administrative or other reason(s)|11|||
145624025|NCT00783718|525135647|FG000|Maintenance Phase|Protocol Violation|1|||
145624026|NCT00783718|525135648|FG001|Maintenance Phase|Protocol Violation|0|||
145624027|NCT00783718|525135649|FG002|Maintenance Phase|Protocol Violation|0|||
145624028|NCT00783718|525135650|FG003|Maintenance Phase|Protocol Violation|0|||
145624029|NCT00783718|525135651|FG004|Maintenance Phase|Protocol Violation|0|||
145624030|NCT00783718|525135652|FG005|Maintenance Phase|Protocol Violation|0|||
145624031|NCT00783718|525135653|FG006|Maintenance Phase|Protocol Violation|2|||
145624032|NCT00783718|525135647|FG000|Maintenance Phase|Lack of Efficacy|83|||
145624033|NCT00783718|525135648|FG001|Maintenance Phase|Lack of Efficacy|0|||
145624034|NCT00783718|525135649|FG002|Maintenance Phase|Lack of Efficacy|0|||
145624035|NCT00783718|525135650|FG003|Maintenance Phase|Lack of Efficacy|61|||
145624036|NCT00783718|525135651|FG004|Maintenance Phase|Lack of Efficacy|31|||
145624037|NCT00783718|525135652|FG005|Maintenance Phase|Lack of Efficacy|33|||
145624038|NCT00783718|525135653|FG006|Maintenance Phase|Lack of Efficacy|155|||
145624039|NCT00783718|525135647|FG000|Maintenance Phase|Withdrawal by Subject|6|||
145624040|NCT00783718|525135648|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145624041|NCT00783718|525135649|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145624042|NCT00783718|525135650|FG003|Maintenance Phase|Withdrawal by Subject|2|||
145624043|NCT00783718|525135651|FG004|Maintenance Phase|Withdrawal by Subject|5|||
145624044|NCT00783718|525135652|FG005|Maintenance Phase|Withdrawal by Subject|2|||
145624045|NCT00783718|525135653|FG006|Maintenance Phase|Withdrawal by Subject|20|||
145624046|NCT00783718|525135647|FG000|Maintenance Phase|Lost to Follow-up|3|||
145624047|NCT00783718|525135648|FG001|Maintenance Phase|Lost to Follow-up|0|||
145624048|NCT00783718|525135649|FG002|Maintenance Phase|Lost to Follow-up|0|||
145624049|NCT00783718|525135650|FG003|Maintenance Phase|Lost to Follow-up|0|||
145624050|NCT00783718|525135651|FG004|Maintenance Phase|Lost to Follow-up|2|||
145624051|NCT00783718|525135652|FG005|Maintenance Phase|Lost to Follow-up|0|||
145624052|NCT00783718|525135653|FG006|Maintenance Phase|Lost to Follow-up|2|||
145624053|NCT01605136|525135656|FG000|Study Period|Withdrawal by Subject|2|||
145624054|NCT01605136|525135657|FG001|Study Period|Withdrawal by Subject|0|||
145624055|NCT01605136|525135656|FG000|Study Period|Physician Decision|1|||
145624056|NCT01605136|525135657|FG001|Study Period|Physician Decision|1|||
145624057|NCT01605136|525135656|FG000|Study Period|Lost to Follow-up|0|||
145624058|NCT01605136|525135657|FG001|Study Period|Lost to Follow-up|2|||
145624059|NCT01605136|525135656|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
145624060|NCT01605136|525135657|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
145624061|NCT01072929|525135658|FG000|Overall Study|Adverse Event|8|||
145624062|NCT01072929|525135659|FG001|Overall Study|Adverse Event|11|||
145624063|NCT01072929|525135660|FG002|Overall Study|Adverse Event|2|||
145624064|NCT01072929|525135658|FG000|Overall Study|Lack of Efficacy|7|||
145624065|NCT01072929|525135659|FG001|Overall Study|Lack of Efficacy|4|||
145624066|NCT01072929|525135660|FG002|Overall Study|Lack of Efficacy|0|||
145624067|NCT01072929|525135658|FG000|Overall Study|Withdrawal by Subject|7|||
145624068|NCT01072929|525135659|FG001|Overall Study|Withdrawal by Subject|15|||
145624069|NCT01072929|525135660|FG002|Overall Study|Withdrawal by Subject|3|||
145624070|NCT01072929|525135658|FG000|Overall Study|Protocol Violation|13|||
145624071|NCT01072929|525135659|FG001|Overall Study|Protocol Violation|11|||
145430817|NCT03189719|524435979|FG001|Overall Study|Withdrawal by Subject|3|||
145582284|NCT00898677|524983322|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
145582285|NCT00898677|524983323|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
145582286|NCT00898677|524983324|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
145582287|NCT00898677|524983325|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
145582288|NCT00898677|524983322|FG000|Overall Study|Not Treated: Pregnancy|0|||
145582289|NCT00898677|524983323|FG001|Overall Study|Not Treated: Pregnancy|0|||
145582290|NCT00898677|524983324|FG002|Overall Study|Not Treated: Pregnancy|1|||
145582291|NCT00898677|524983325|FG003|Overall Study|Not Treated: Pregnancy|0|||
145582292|NCT00898677|524983322|FG000|Overall Study|Not Treated: Protocol Violation|2|||
145582293|NCT00898677|524983323|FG001|Overall Study|Not Treated: Protocol Violation|0|||
145582294|NCT00898677|524983324|FG002|Overall Study|Not Treated: Protocol Violation|2|||
145582295|NCT00898677|524983325|FG003|Overall Study|Not Treated: Protocol Violation|0|||
145582296|NCT00898677|524983322|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
145582297|NCT00898677|524983323|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
145582298|NCT00898677|524983324|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
145582299|NCT00898677|524983325|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
145582300|NCT00898677|524983322|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
145624072|NCT01072929|525135660|FG002|Overall Study|Protocol Violation|2|||
145624073|NCT01072929|525135658|FG000|Overall Study|Lost to Follow-up|8|||
145624074|NCT01072929|525135659|FG001|Overall Study|Lost to Follow-up|4|||
145624075|NCT01072929|525135660|FG002|Overall Study|Lost to Follow-up|1|||
145624076|NCT01072929|525135658|FG000|Overall Study|Noncompliance with study medication|0|||
145624077|NCT01072929|525135659|FG001|Overall Study|Noncompliance with study medication|3|||
145430818|NCT02769481|524435980|FG000|Overall Study|Protocol Violation|1|||
145582301|NCT00898677|524983323|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
145624078|NCT01072929|525135660|FG002|Overall Study|Noncompliance with study medication|0|||
145624079|NCT01072929|525135658|FG000|Overall Study|Noncompliance with study procedures|1|||
145624080|NCT01072929|525135659|FG001|Overall Study|Noncompliance with study procedures|0|||
145430819|NCT02769481|524435981|FG001|Overall Study|Protocol Violation|0|||
145430820|NCT02769481|524435980|FG000|Overall Study|Adverse Event|3|||
145430821|NCT02769481|524435981|FG001|Overall Study|Adverse Event|6|||
145430822|NCT02769481|524435980|FG000|Overall Study|Entry Criteria Not Met|1|||
145430823|NCT02769481|524435981|FG001|Overall Study|Entry Criteria Not Met|2|||
145430824|NCT02769481|524435980|FG000|Overall Study|Withdrawal by Subject|14|||
145430825|NCT02769481|524435981|FG001|Overall Study|Withdrawal by Subject|16|||
145430826|NCT02769481|524435980|FG000|Overall Study|Lost to Follow-up|9|||
145430827|NCT02769481|524435981|FG001|Overall Study|Lost to Follow-up|9|||
145430828|NCT02769481|524435980|FG000|Overall Study|Physician Decision|0|||
145430829|NCT02769481|524435981|FG001|Overall Study|Physician Decision|1|||
145430830|NCT02769481|524435980|FG000|Overall Study|Terminated by Sponsor|1|||
145430831|NCT02769481|524435981|FG001|Overall Study|Terminated by Sponsor|0|||
145430832|NCT02769481|524435980|FG000|Overall Study|Death|0|||
145430833|NCT02769481|524435981|FG001|Overall Study|Death|1|||
145430834|NCT02769481|524435980|FG000|Overall Study|Undefined|4|||
145430835|NCT02769481|524435981|FG001|Overall Study|Undefined|1|||
145430836|NCT05212168|524435982|FG000|Overall Study|Lost to Follow-up|0|||
145430837|NCT05212168|524435983|FG001|Overall Study|Lost to Follow-up|3|||
145430838|NCT05212168|524435982|FG000|Overall Study|Study terminated by sponsor|30|||
145430839|NCT05212168|524435983|FG001|Overall Study|Study terminated by sponsor|27|||
145430840|NCT05212168|524435982|FG000|Overall Study|Other|4|||
145430841|NCT05212168|524435983|FG001|Overall Study|Other|7|||
145430842|NCT01346176|524435985|FG000|Recruited|Protocol Violation|1|||
145430843|NCT01346176|524435986|FG001|Recruited|Protocol Violation|0|||
145430844|NCT01346176|524435987|FG002|Recruited|Protocol Violation|0|||
145430845|NCT01346176|524435985|FG000|Completed Advance Directive|Death|3|||
145430846|NCT01346176|524435986|FG001|Completed Advance Directive|Death|2|||
145430847|NCT01346176|524435987|FG002|Completed Advance Directive|Death|2|||
145430848|NCT01346176|524435985|FG000|Completed Advance Directive|Became Ineligible|3|||
145430849|NCT01346176|524435986|FG001|Completed Advance Directive|Became Ineligible|0|||
145430850|NCT01346176|524435987|FG002|Completed Advance Directive|Became Ineligible|1|||
145430851|NCT01346176|524435985|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
145430852|NCT01346176|524435986|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
145430853|NCT01346176|524435987|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
145430854|NCT01346176|524435985|FG000|Completed Satisfaction Survey|Death|3|||
145430855|NCT01346176|524435986|FG001|Completed Satisfaction Survey|Death|0|||
145430856|NCT01346176|524435987|FG002|Completed Satisfaction Survey|Death|2|||
145430857|NCT01346176|524435985|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
145430858|NCT01346176|524435986|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
145430859|NCT01346176|524435987|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
145430860|NCT04522973|524435988|FG000|Overall Study|Lost to Follow-up|4|||
145430861|NCT04522973|524435988|FG000|Overall Study|Could not adhere to study schedule|1|||
145430862|NCT05489328|524437637|FG000|Overall Study|Lost to Follow-up|0|||
145430863|NCT05489328|524437638|FG001|Overall Study|Lost to Follow-up|0|||
145430864|NCT05489328|524437639|FG002|Overall Study|Lost to Follow-up|1|||
145430865|NCT05489328|524437640|FG003|Overall Study|Lost to Follow-up|0|||
145430866|NCT05489328|524437641|FG004|Overall Study|Lost to Follow-up|2|||
145430867|NCT05489328|524437642|FG005|Overall Study|Lost to Follow-up|0|||
145430868|NCT05489328|524437643|FG006|Overall Study|Lost to Follow-up|0|||
145430869|NCT05489328|524437644|FG007|Overall Study|Lost to Follow-up|1|||
145430870|NCT05489328|524437645|FG008|Overall Study|Lost to Follow-up|0|||
145376875|NCT02327013|524231601|FG003|Overall Study|Administrative or other reason(s)|1|||
145376876|NCT02327013|524231602|FG004|Overall Study|Administrative or other reason(s)|1|||
145376877|NCT02327013|524231598|FG000|Overall Study|Protocol Violation|0|||
145376878|NCT02327013|524231599|FG001|Overall Study|Protocol Violation|0|||
145376879|NCT02327013|524231600|FG002|Overall Study|Protocol Violation|3|||
145376880|NCT02327013|524231601|FG003|Overall Study|Protocol Violation|0|||
145376881|NCT02327013|524231602|FG004|Overall Study|Protocol Violation|1|||
145430871|NCT05489328|524437637|FG000|Overall Study|Withdrawal by Subject|0|||
145430872|NCT05489328|524437638|FG001|Overall Study|Withdrawal by Subject|0|||
145430873|NCT05489328|524437639|FG002|Overall Study|Withdrawal by Subject|0|||
145430874|NCT05489328|524437640|FG003|Overall Study|Withdrawal by Subject|0|||
145430875|NCT05489328|524437641|FG004|Overall Study|Withdrawal by Subject|0|||
145430876|NCT05489328|524437642|FG005|Overall Study|Withdrawal by Subject|0|||
145430877|NCT05489328|524437643|FG006|Overall Study|Withdrawal by Subject|1|||
145430878|NCT05489328|524437644|FG007|Overall Study|Withdrawal by Subject|1|||
145430879|NCT05489328|524437645|FG008|Overall Study|Withdrawal by Subject|0|||
145430880|NCT05489328|524437637|FG000|Overall Study|Other|0|||
145376882|NCT02327013|524231598|FG000|Overall Study|Withdrawal before treatment|2|||
145376883|NCT02327013|524231599|FG001|Overall Study|Withdrawal before treatment|1|||
145376884|NCT02327013|524231600|FG002|Overall Study|Withdrawal before treatment|5|||
145376885|NCT02327013|524231601|FG003|Overall Study|Withdrawal before treatment|0|||
145430881|NCT05489328|524437638|FG001|Overall Study|Other|0|||
145430882|NCT05489328|524437639|FG002|Overall Study|Other|0|||
145430883|NCT05489328|524437640|FG003|Overall Study|Other|0|||
145430884|NCT05489328|524437641|FG004|Overall Study|Other|0|||
145430885|NCT05489328|524437642|FG005|Overall Study|Other|0|||
145430886|NCT05489328|524437643|FG006|Overall Study|Other|0|||
145430887|NCT05489328|524437644|FG007|Overall Study|Other|1|||
145430888|NCT05489328|524437645|FG008|Overall Study|Other|1|||
145430889|NCT01083602|524437646|FG000|Overall Study|Adverse Event|11|||
145430890|NCT01083602|524437646|FG000|Overall Study|New Cancer Therapy|2|||
145430891|NCT01083602|524437646|FG000|Overall Study|Death|1|||
145430892|NCT01083602|524437646|FG000|Overall Study|Withdrawal by Subject|5|||
145430893|NCT01083602|524437646|FG000|Overall Study|Lack of Efficacy|36|||
145430894|NCT01657370|524437647|FG000|Overall Study|Withdrawal by Subject|0|||
145430895|NCT01657370|524437648|FG001|Overall Study|Withdrawal by Subject|0|||
145430896|NCT01657370|524437649|FG002|Overall Study|Withdrawal by Subject|1|||
145430897|NCT01657370|524437650|FG003|Overall Study|Withdrawal by Subject|0|||
145430898|NCT01657370|524437651|FG004|Overall Study|Withdrawal by Subject|0|||
145430899|NCT01657370|524437652|FG005|Overall Study|Withdrawal by Subject|1|||
145430900|NCT01657370|524437647|FG000|Overall Study|Physician Decision|2|||
145430901|NCT01657370|524437648|FG001|Overall Study|Physician Decision|3|||
145430902|NCT01657370|524437649|FG002|Overall Study|Physician Decision|1|||
145430903|NCT01657370|524437650|FG003|Overall Study|Physician Decision|2|||
145430904|NCT01657370|524437651|FG004|Overall Study|Physician Decision|5|||
145430905|NCT01657370|524437652|FG005|Overall Study|Physician Decision|0|||
145430906|NCT01657370|524437647|FG000|Overall Study|Lack of Qualifying Event|1|||
145430907|NCT01657370|524437648|FG001|Overall Study|Lack of Qualifying Event|0|||
145430908|NCT01657370|524437649|FG002|Overall Study|Lack of Qualifying Event|3|||
145430909|NCT01657370|524437650|FG003|Overall Study|Lack of Qualifying Event|2|||
145430910|NCT01657370|524437651|FG004|Overall Study|Lack of Qualifying Event|1|||
145430911|NCT01657370|524437652|FG005|Overall Study|Lack of Qualifying Event|2|||
145430912|NCT01657370|524437647|FG000|Overall Study|Adverse Event|0|||
145430913|NCT01657370|524437648|FG001|Overall Study|Adverse Event|0|||
145430914|NCT01657370|524437649|FG002|Overall Study|Adverse Event|0|||
145430915|NCT01657370|524437650|FG003|Overall Study|Adverse Event|0|||
145430916|NCT01657370|524437651|FG004|Overall Study|Adverse Event|1|||
145430917|NCT01657370|524437652|FG005|Overall Study|Adverse Event|0|||
145430918|NCT01657370|524437647|FG000|Overall Study|Protocol Violation|1|||
145430919|NCT01657370|524437648|FG001|Overall Study|Protocol Violation|1|||
145430920|NCT01657370|524437649|FG002|Overall Study|Protocol Violation|1|||
145430921|NCT01657370|524437650|FG003|Overall Study|Protocol Violation|1|||
145430922|NCT01657370|524437651|FG004|Overall Study|Protocol Violation|0|||
145430923|NCT01657370|524437652|FG005|Overall Study|Protocol Violation|0|||
145430924|NCT01657370|524437647|FG000|Overall Study|Lost to Follow-up|2|||
145430925|NCT01657370|524437648|FG001|Overall Study|Lost to Follow-up|0|||
145430926|NCT01657370|524437649|FG002|Overall Study|Lost to Follow-up|1|||
145430927|NCT01657370|524437650|FG003|Overall Study|Lost to Follow-up|0|||
145430928|NCT01657370|524437651|FG004|Overall Study|Lost to Follow-up|0|||
145430929|NCT01657370|524437652|FG005|Overall Study|Lost to Follow-up|1|||
145430930|NCT03021486|524437653|FG000|Overall Study|Withdrawal by Subject|1|||
145430931|NCT03021486|524437654|FG001|Overall Study|Withdrawal by Subject|1|||
145430932|NCT03021486|524437655|FG002|Overall Study|Withdrawal by Subject|3|||
145430933|NCT03021486|524437653|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
145430934|NCT03021486|524437654|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
145430935|NCT03021486|524437655|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
145430936|NCT04043286|524437656|FG000|Overall Study|Withdrawal by Subject|2|||
145430937|NCT04043286|524437657|FG001|Overall Study|Withdrawal by Subject|2|||
145430938|NCT03698279|524437658|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145430939|NCT03698279|524437659|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145430940|NCT03698279|524437660|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145430941|NCT03698279|524437661|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145430942|NCT03698279|524437662|FG004|Overall Study|Withdrawal by parent/guardian|0|||
145430943|NCT03698279|524437663|FG005|Overall Study|Withdrawal by parent/guardian|0|||
145430944|NCT03698279|524437658|FG000|Overall Study|Protocol deviation|1|||
145430945|NCT03698279|524437659|FG001|Overall Study|Protocol deviation|0|||
145430946|NCT03698279|524437660|FG002|Overall Study|Protocol deviation|1|||
145430947|NCT03698279|524437661|FG003|Overall Study|Protocol deviation|0|||
145430948|NCT03698279|524437662|FG004|Overall Study|Protocol deviation|0|||
145430949|NCT03698279|524437663|FG005|Overall Study|Protocol deviation|0|||
145430950|NCT03698279|524437658|FG000|Overall Study|Withdrawal by Subject|0|||
145430951|NCT03698279|524437659|FG001|Overall Study|Withdrawal by Subject|0|||
145430952|NCT03698279|524437660|FG002|Overall Study|Withdrawal by Subject|1|||
145430953|NCT03698279|524437661|FG003|Overall Study|Withdrawal by Subject|0|||
145430954|NCT03698279|524437662|FG004|Overall Study|Withdrawal by Subject|0|||
145430955|NCT03698279|524437663|FG005|Overall Study|Withdrawal by Subject|0|||
145430956|NCT03698279|524437658|FG000|Overall Study|Lost to Follow-up|3|||
145430957|NCT03698279|524437659|FG001|Overall Study|Lost to Follow-up|1|||
145430958|NCT03698279|524437660|FG002|Overall Study|Lost to Follow-up|4|||
145430959|NCT03698279|524437661|FG003|Overall Study|Lost to Follow-up|5|||
145430960|NCT03698279|524437662|FG004|Overall Study|Lost to Follow-up|0|||
145430961|NCT03698279|524437663|FG005|Overall Study|Lost to Follow-up|0|||
145430962|NCT00415636|524437664|FG000|Overall Study|Symptomatic deterioration|1|||
145430963|NCT00415636|524437665|FG001|Overall Study|Symptomatic deterioration|0|||
145430964|NCT00415636|524437666|FG002|Overall Study|Symptomatic deterioration|1|||
145430965|NCT00415636|524437667|FG003|Overall Study|Symptomatic deterioration|2|||
145430966|NCT00415636|524437668|FG004|Overall Study|Symptomatic deterioration|0|||
145430967|NCT00415636|524437669|FG005|Overall Study|Symptomatic deterioration|1|||
145430968|NCT00415636|524437664|FG000|Overall Study|Adverse Event|0|||
145430969|NCT00415636|524437665|FG001|Overall Study|Adverse Event|0|||
145430970|NCT00415636|524437666|FG002|Overall Study|Adverse Event|0|||
145430971|NCT00415636|524437667|FG003|Overall Study|Adverse Event|1|||
145430972|NCT00415636|524437668|FG004|Overall Study|Adverse Event|1|||
145430973|NCT00415636|524437669|FG005|Overall Study|Adverse Event|0|||
145430974|NCT00415636|524437664|FG000|Overall Study|Withdrawal by Subject|0|||
145430975|NCT00415636|524437665|FG001|Overall Study|Withdrawal by Subject|0|||
145430976|NCT00415636|524437666|FG002|Overall Study|Withdrawal by Subject|0|||
145430977|NCT00415636|524437667|FG003|Overall Study|Withdrawal by Subject|0|||
145430978|NCT00415636|524437668|FG004|Overall Study|Withdrawal by Subject|1|||
145430979|NCT00415636|524437669|FG005|Overall Study|Withdrawal by Subject|0|||
145430980|NCT00415636|524437664|FG000|Overall Study|Disease progression|0|||
145430981|NCT00415636|524437665|FG001|Overall Study|Disease progression|0|||
145430982|NCT00415636|524437666|FG002|Overall Study|Disease progression|0|||
145430983|NCT00415636|524437667|FG003|Overall Study|Disease progression|3|||
145430984|NCT00415636|524437668|FG004|Overall Study|Disease progression|0|||
145430985|NCT00415636|524437669|FG005|Overall Study|Disease progression|1|||
145430986|NCT01263119|524437670|FG000|Period 1|Protocol Violation|2|||
145430987|NCT01263119|524437670|FG000|Period 2|Adverse Event|2|||
145430988|NCT02138825|524437671|FG000|Main Study Treatment|Adverse Event|11|||
145430989|NCT02138825|524437672|FG001|Main Study Treatment|Adverse Event|3|||
145430990|NCT02138825|524437671|FG000|Main Study Treatment|Death|1|||
145430991|NCT02138825|524437672|FG001|Main Study Treatment|Death|2|||
145430992|NCT02138825|524437671|FG000|Main Study Treatment|Protocol Violation|2|||
145430993|NCT02138825|524437672|FG001|Main Study Treatment|Protocol Violation|2|||
145430994|NCT02138825|524437671|FG000|Main Study Treatment|Sponsor decision|12|||
145430995|NCT02138825|524437672|FG001|Main Study Treatment|Sponsor decision|18|||
145430996|NCT02138825|524437671|FG000|Main Study Treatment|Study terminated by sponsor|10|||
145430997|NCT02138825|524437672|FG001|Main Study Treatment|Study terminated by sponsor|9|||
145430998|NCT02138825|524437671|FG000|Main Study Treatment|Withdrawal by Subject|3|||
145430999|NCT02138825|524437672|FG001|Main Study Treatment|Withdrawal by Subject|1|||
145431000|NCT02138825|524437671|FG000|Main Study Treatment|Medical decision|1|||
145431001|NCT02138825|524437672|FG001|Main Study Treatment|Medical decision|0|||
145431002|NCT02138825|524437671|FG000|Long-term Extension|Study termination by sponsor|32|||
145431003|NCT02138825|524437672|FG001|Long-term Extension|Study termination by sponsor|38|||
145431004|NCT02138825|524437671|FG000|Safety Follow-up|Adverse Event|4|||
145431005|NCT02138825|524437672|FG001|Safety Follow-up|Adverse Event|3|||
145431006|NCT02138825|524437671|FG000|Safety Follow-up|Death|11|||
145431007|NCT02138825|524437672|FG001|Safety Follow-up|Death|5|||
145431008|NCT02138825|524437671|FG000|Safety Follow-up|Withdrawal by Subject|5|||
145431009|NCT02138825|524437672|FG001|Safety Follow-up|Withdrawal by Subject|3|||
145431010|NCT02138825|524437671|FG000|Safety Follow-up|clinic worsening|1|||
145431011|NCT02138825|524437672|FG001|Safety Follow-up|clinic worsening|0|||
145431012|NCT02138825|524437671|FG000|Safety Follow-up|withdrawal by PI|1|||
145431013|NCT02138825|524437672|FG001|Safety Follow-up|withdrawal by PI|0|||
145431014|NCT02138825|524437671|FG000|Safety Follow-up|logistical difficulties|0|||
145431015|NCT02138825|524437672|FG001|Safety Follow-up|logistical difficulties|1|||
145431016|NCT02138825|524437671|FG000|Safety Follow-up|progressive disease|0|||
145431017|NCT02138825|524437672|FG001|Safety Follow-up|progressive disease|2|||
145431018|NCT02138825|524437671|FG000|Safety Follow-up|too unwell to attend the visit|0|||
145431019|NCT02138825|524437672|FG001|Safety Follow-up|too unwell to attend the visit|1|||
145431020|NCT02138825|524437671|FG000|Safety Follow-up|treatment unblinded|0|||
145431021|NCT02138825|524437672|FG001|Safety Follow-up|treatment unblinded|1|||
145431022|NCT02138825|524437671|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
145431023|NCT02138825|524437672|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
145431024|NCT05201807|524437675|FG000|Overall Study|Adverse Event|1|||
145431025|NCT05201807|524437675|FG000|Overall Study|COVID-19 Related|1|||
145431026|NCT02367456|524437681|FG000|Overall Study|Death|8|||
145431027|NCT02367456|524437682|FG001|Overall Study|Death|24|||
145431028|NCT02367456|524437683|FG002|Overall Study|Death|17|||
145431029|NCT02367456|524437681|FG000|Overall Study|Lost to Follow-up|1|||
145431030|NCT02367456|524437682|FG001|Overall Study|Lost to Follow-up|3|||
145431031|NCT02367456|524437683|FG002|Overall Study|Lost to Follow-up|1|||
145431032|NCT02367456|524437681|FG000|Overall Study|Other reason|3|||
145431033|NCT02367456|524437682|FG001|Overall Study|Other reason|3|||
145431034|NCT02367456|524437683|FG002|Overall Study|Other reason|9|||
145431035|NCT02367456|524437681|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
145431036|NCT02367456|524437682|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
145431037|NCT02367456|524437683|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
145431038|NCT02862574|524437684|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145431039|NCT02862574|524437685|FG001|Double-Blind Treatment Period|Adverse Event|1|||
145431040|NCT02862574|524437686|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145431041|NCT02862574|524437684|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
145431042|NCT02862574|524437685|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
145431043|NCT02862574|524437686|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
145431044|NCT02862574|524437684|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
145431045|NCT02862574|524437685|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
145431046|NCT02862574|524437686|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
145431047|NCT04573972|524437687|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
145431048|NCT04573972|524437688|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
145431049|NCT00976456|524437689|FG000|Overall Study|Adverse Event|17|||
145431050|NCT00976456|524437690|FG001|Overall Study|Adverse Event|22|||
145431051|NCT00976456|524437689|FG000|Overall Study|Death|7|||
145431052|NCT00976456|524437690|FG001|Overall Study|Death|9|||
145431053|NCT00976456|524437689|FG000|Overall Study|Lack of Efficacy|5|||
145431054|NCT00976456|524437690|FG001|Overall Study|Lack of Efficacy|2|||
145431055|NCT00976456|524437689|FG000|Overall Study|Withdrawal by Subject|3|||
145431056|NCT00976456|524437690|FG001|Overall Study|Withdrawal by Subject|1|||
145431057|NCT00976456|524437689|FG000|Overall Study|screening failure, unknown|11|||
145431058|NCT00976456|524437690|FG001|Overall Study|screening failure, unknown|4|||
145431059|NCT02037529|524437691|FG000|Overall Study|Withdrawal by Subject|1|||
145431060|NCT02037529|524437692|FG001|Overall Study|Withdrawal by Subject|3|||
145431061|NCT02037529|524437691|FG000|Overall Study|Adverse Event|0|||
145431062|NCT02037529|524437692|FG001|Overall Study|Adverse Event|1|||
145431063|NCT00833690|524437696|FG000|Overall Study|Withdrawal by Subject|1|||
145431064|NCT00833690|524437697|FG001|Overall Study|Withdrawal by Subject|0|||
145431065|NCT00833690|524437698|FG002|Overall Study|Withdrawal by Subject|0|||
145431066|NCT00833690|524437696|FG000|Overall Study|Discontinued study drug|3|||
145431067|NCT00833690|524437697|FG001|Overall Study|Discontinued study drug|2|||
145431068|NCT00833690|524437698|FG002|Overall Study|Discontinued study drug|0|||
145431069|NCT04562116|524437704|FG000|Overall Study|Lost to Follow-up|1|||
145431070|NCT04562116|524437704|FG000|Overall Study|Withdrawal by Subject|3|||
145431071|NCT01143402|524437711|FG000|Overall Study|Rapid clinical decline|1|||
145431072|NCT01143402|524437712|FG001|Overall Study|Rapid clinical decline|1|||
145431073|NCT01143402|524437713|FG002|Overall Study|Rapid clinical decline|0|||
145431074|NCT01143402|524437711|FG000|Overall Study|Not Treated|0|||
145431075|NCT01143402|524437712|FG001|Overall Study|Not Treated|0|||
145431076|NCT01143402|524437713|FG002|Overall Study|Not Treated|1|||
145431077|NCT04462471|524437714|FG000|Overall Study|Adverse Event|0|||
145431078|NCT04462471|524437715|FG001|Overall Study|Adverse Event|1|||
145431079|NCT04462471|524437716|FG002|Overall Study|Adverse Event|0|||
145431080|NCT04462471|524437717|FG003|Overall Study|Adverse Event|0|||
145431081|NCT04462471|524437714|FG000|Overall Study|Disease progression|1|||
145431082|NCT04462471|524437715|FG001|Overall Study|Disease progression|0|||
145431083|NCT04462471|524437716|FG002|Overall Study|Disease progression|0|||
145431084|NCT04462471|524437717|FG003|Overall Study|Disease progression|0|||
145431085|NCT00397540|524437718|FG000|Overall Study|short follow-up duration < 12 months|1|||
145431086|NCT00397540|524437719|FG001|Overall Study|short follow-up duration < 12 months|0|||
145431087|NCT01215851|524437723|FG000|Treatment Period|Adverse Event|1|||
145431088|NCT01215851|524437724|FG001|Treatment Period|Adverse Event|1|||
145431089|NCT01215851|524437725|FG002|Treatment Period|Adverse Event|1|||
145431090|NCT01215851|524437726|FG003|Treatment Period|Adverse Event|3|||
145431091|NCT01215851|524437727|FG004|Treatment Period|Adverse Event|0|||
145431092|NCT01215851|524437728|FG005|Treatment Period|Adverse Event|1|||
145431093|NCT01215851|524437723|FG000|Follow up Period|Lost to Follow-up|0|||
145431094|NCT01215851|524437724|FG001|Follow up Period|Lost to Follow-up|0|||
145431095|NCT01215851|524437725|FG002|Follow up Period|Lost to Follow-up|0|||
145431096|NCT01215851|524437726|FG003|Follow up Period|Lost to Follow-up|0|||
145431097|NCT01215851|524437727|FG004|Follow up Period|Lost to Follow-up|0|||
145431098|NCT01215851|524437728|FG005|Follow up Period|Lost to Follow-up|1|||
145431099|NCT03510273|524437731|FG000|Overall Study|Withdrawal by Subject|2|||
145431100|NCT03510273|524437731|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
145431101|NCT03510273|524437731|FG000|Overall Study|Moved away from study area|4|||
145431102|NCT02589938|524437732|FG000|Overall Study|Withdrawal by Subject|11|||
145431103|NCT02589938|524437733|FG001|Overall Study|Withdrawal by Subject|5|||
145431104|NCT02589938|524437734|FG002|Overall Study|Withdrawal by Subject|6|||
145431105|NCT02589938|524437732|FG000|Overall Study|Lost to Follow-up|3|||
145431106|NCT02589938|524437733|FG001|Overall Study|Lost to Follow-up|3|||
145431107|NCT02589938|524437734|FG002|Overall Study|Lost to Follow-up|3|||
145431108|NCT02589938|524437732|FG000|Overall Study|Death|1|||
145431109|NCT02589938|524437733|FG001|Overall Study|Death|0|||
145431110|NCT02589938|524437734|FG002|Overall Study|Death|1|||
145431111|NCT02589938|524437732|FG000|Overall Study|Protocol Violation|6|||
145431112|NCT02589938|524437733|FG001|Overall Study|Protocol Violation|2|||
145431113|NCT02589938|524437734|FG002|Overall Study|Protocol Violation|3|||
145431114|NCT02589938|524437732|FG000|Overall Study|Physician Decision|1|||
145431115|NCT02589938|524437733|FG001|Overall Study|Physician Decision|0|||
145431116|NCT02589938|524437734|FG002|Overall Study|Physician Decision|0|||
145431117|NCT02589938|524437732|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
145431118|NCT02589938|524437733|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
145431119|NCT02589938|524437734|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
145431120|NCT01121757|524437736|FG000|First Drug|Death|1|||
145431121|NCT01121757|524437737|FG001|First Drug|Death|0|||
145431122|NCT01121757|524437736|FG000|First Drug|Disease Progression|0|||
145431123|NCT01121757|524437737|FG001|First Drug|Disease Progression|2|||
145431124|NCT01121757|524437736|FG000|Combination|Physician Decision|0|||
145431125|NCT01121757|524437737|FG001|Combination|Physician Decision|1|||
145431126|NCT01121757|524437736|FG000|Combination|Disease Progression|2|||
145431127|NCT01121757|524437737|FG001|Combination|Disease Progression|0|||
145431128|NCT01380080|524437750|FG000|Overall Study|Death|36|||
145431129|NCT01380080|524437751|FG001|Overall Study|Death|44|||
145431130|NCT01380080|524437750|FG000|Overall Study|Site is closing|28|||
145431131|NCT01380080|524437751|FG001|Overall Study|Site is closing|31|||
145431132|NCT01380080|524437750|FG000|Overall Study|Not able to get to clinic|7|||
145431133|NCT01380080|524437751|FG001|Overall Study|Not able to get to clinic|1|||
145431134|NCT01380080|524437750|FG000|Overall Study|Not willing to adhere to requirements|6|||
145431135|NCT01380080|524437751|FG001|Overall Study|Not willing to adhere to requirements|2|||
145431136|NCT01380080|524437750|FG000|Overall Study|Withdrawal by Subject|5|||
145431137|NCT01380080|524437751|FG001|Overall Study|Withdrawal by Subject|2|||
145431138|NCT01380080|524437750|FG000|Overall Study|Lost to Follow-up|3|||
145431139|NCT01380080|524437751|FG001|Overall Study|Lost to Follow-up|3|||
145431140|NCT05901636|524437752|FG000|Overall Study|Lost to Follow-up|0|||
145431141|NCT05901636|524437753|FG001|Overall Study|Lost to Follow-up|1|||
145431142|NCT05901636|524437754|FG002|Overall Study|Lost to Follow-up|0|||
145431143|NCT05901636|524437755|FG003|Overall Study|Lost to Follow-up|1|||
145431144|NCT05901636|524437756|FG004|Overall Study|Lost to Follow-up|1|||
145431145|NCT05901636|524437757|FG005|Overall Study|Lost to Follow-up|3|||
145431146|NCT05901636|524437758|FG006|Overall Study|Lost to Follow-up|1|||
145431147|NCT05901636|524437752|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
145431148|NCT05901636|524437753|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
145431149|NCT05901636|524437754|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
145431150|NCT05901636|524437755|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
145431151|NCT05901636|524437756|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
145431152|NCT05901636|524437757|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
145431153|NCT05901636|524437758|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
145431154|NCT05901636|524437752|FG000|Overall Study|Withdrawal by Subject|1|||
145431155|NCT05901636|524437753|FG001|Overall Study|Withdrawal by Subject|1|||
145431156|NCT05901636|524437754|FG002|Overall Study|Withdrawal by Subject|0|||
145431157|NCT05901636|524437755|FG003|Overall Study|Withdrawal by Subject|0|||
145431158|NCT05901636|524437756|FG004|Overall Study|Withdrawal by Subject|1|||
145431159|NCT05901636|524437757|FG005|Overall Study|Withdrawal by Subject|1|||
145431160|NCT05901636|524437758|FG006|Overall Study|Withdrawal by Subject|0|||
145431161|NCT05901636|524437752|FG000|Overall Study|Other|0|||
145431162|NCT05901636|524437753|FG001|Overall Study|Other|0|||
145431163|NCT05901636|524437754|FG002|Overall Study|Other|1|||
145431164|NCT05901636|524437755|FG003|Overall Study|Other|1|||
145431165|NCT05901636|524437756|FG004|Overall Study|Other|0|||
145431166|NCT05901636|524437757|FG005|Overall Study|Other|0|||
145431167|NCT05901636|524437758|FG006|Overall Study|Other|0|||
145431168|NCT02303821|524437759|FG000|Overall Study|Withdrawal by Subject|0|||
145431169|NCT02303821|524437760|FG001|Overall Study|Withdrawal by Subject|0|||
145431170|NCT02303821|524437761|FG002|Overall Study|Withdrawal by Subject|0|||
145431171|NCT02303821|524437762|FG003|Overall Study|Withdrawal by Subject|0|||
145431172|NCT02303821|524437763|FG004|Overall Study|Withdrawal by Subject|0|||
145431173|NCT02303821|524437764|FG005|Overall Study|Withdrawal by Subject|0|||
145431174|NCT02303821|524437765|FG006|Overall Study|Withdrawal by Subject|0|||
145431175|NCT02303821|524437766|FG007|Overall Study|Withdrawal by Subject|2|||
145431176|NCT02303821|524437759|FG000|Overall Study|Death|0|||
145582302|NCT00898677|524983324|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
145582303|NCT00898677|524983325|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
145431177|NCT02303821|524437760|FG001|Overall Study|Death|2|||
145431178|NCT02303821|524437761|FG002|Overall Study|Death|0|||
145431179|NCT02303821|524437762|FG003|Overall Study|Death|0|||
145431180|NCT02303821|524437763|FG004|Overall Study|Death|0|||
145431181|NCT02303821|524437764|FG005|Overall Study|Death|3|||
145431182|NCT02303821|524437765|FG006|Overall Study|Death|41|||
145431183|NCT02303821|524437766|FG007|Overall Study|Death|29|||
145431184|NCT02303821|524437759|FG000|Overall Study|Lost to Follow-up|0|||
145431185|NCT02303821|524437760|FG001|Overall Study|Lost to Follow-up|0|||
145431186|NCT02303821|524437761|FG002|Overall Study|Lost to Follow-up|0|||
145431187|NCT02303821|524437762|FG003|Overall Study|Lost to Follow-up|0|||
145431188|NCT02303821|524437763|FG004|Overall Study|Lost to Follow-up|0|||
145431189|NCT02303821|524437764|FG005|Overall Study|Lost to Follow-up|0|||
145431190|NCT02303821|524437765|FG006|Overall Study|Lost to Follow-up|1|||
145431191|NCT02303821|524437766|FG007|Overall Study|Lost to Follow-up|0|||
145431192|NCT02303821|524437759|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431193|NCT02303821|524437760|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431194|NCT02303821|524437761|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431195|NCT02303821|524437762|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431196|NCT02303821|524437763|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431197|NCT02303821|524437764|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431198|NCT02303821|524437765|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
145431199|NCT02303821|524437766|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
145431200|NCT02303821|524437759|FG000|Overall Study|Decision by sponsor|0|||
145431201|NCT02303821|524437760|FG001|Overall Study|Decision by sponsor|0|||
145431202|NCT02303821|524437761|FG002|Overall Study|Decision by sponsor|0|||
145431203|NCT02303821|524437762|FG003|Overall Study|Decision by sponsor|0|||
145431204|NCT02303821|524437763|FG004|Overall Study|Decision by sponsor|0|||
145431205|NCT02303821|524437764|FG005|Overall Study|Decision by sponsor|1|||
145431206|NCT02303821|524437765|FG006|Overall Study|Decision by sponsor|0|||
145431207|NCT02303821|524437766|FG007|Overall Study|Decision by sponsor|0|||
145431208|NCT02303821|524437759|FG000|Overall Study|Protocol-specified criteria|0|||
145431209|NCT02303821|524437760|FG001|Overall Study|Protocol-specified criteria|1|||
145431210|NCT02303821|524437761|FG002|Overall Study|Protocol-specified criteria|0|||
145431211|NCT02303821|524437762|FG003|Overall Study|Protocol-specified criteria|0|||
145431212|NCT02303821|524437763|FG004|Overall Study|Protocol-specified criteria|0|||
145431213|NCT02303821|524437764|FG005|Overall Study|Protocol-specified criteria|1|||
145431214|NCT02303821|524437765|FG006|Overall Study|Protocol-specified criteria|0|||
145431215|NCT02303821|524437766|FG007|Overall Study|Protocol-specified criteria|0|||
145431216|NCT04583618|524437772|FG000|Overall Study|Adverse Event|0|||
145431217|NCT04583618|524437773|FG001|Overall Study|Adverse Event|0|||
145431218|NCT04583618|524437774|FG002|Overall Study|Adverse Event|1|||
145431219|NCT04583618|524437775|FG003|Overall Study|Adverse Event|0|||
145431220|NCT04583618|524437776|FG004|Overall Study|Adverse Event|0|||
145431221|NCT04583618|524437772|FG000|Overall Study|Protocol deviation|1|||
145431222|NCT04583618|524437773|FG001|Overall Study|Protocol deviation|1|||
145431223|NCT04583618|524437774|FG002|Overall Study|Protocol deviation|1|||
145431224|NCT04583618|524437775|FG003|Overall Study|Protocol deviation|0|||
145431225|NCT04583618|524437776|FG004|Overall Study|Protocol deviation|0|||
145431226|NCT04583618|524437772|FG000|Overall Study|Withdrawal by Subject|2|||
145431227|NCT04583618|524437773|FG001|Overall Study|Withdrawal by Subject|1|||
145431228|NCT04583618|524437774|FG002|Overall Study|Withdrawal by Subject|3|||
145431229|NCT04583618|524437775|FG003|Overall Study|Withdrawal by Subject|1|||
145431230|NCT04583618|524437776|FG004|Overall Study|Withdrawal by Subject|1|||
145431231|NCT04583618|524437772|FG000|Overall Study|Lost to Follow-up|0|||
145431232|NCT04583618|524437773|FG001|Overall Study|Lost to Follow-up|1|||
145431233|NCT04583618|524437774|FG002|Overall Study|Lost to Follow-up|3|||
145431234|NCT04583618|524437775|FG003|Overall Study|Lost to Follow-up|1|||
145431235|NCT04583618|524437776|FG004|Overall Study|Lost to Follow-up|1|||
145431236|NCT06272383|524437789|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
145431237|NCT06272383|524437790|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
145431238|NCT04398706|524437791|FG000|Overall Study|Adverse Event|0|||
145431239|NCT04398706|524437792|FG001|Overall Study|Adverse Event|0|||
145431240|NCT04398706|524437793|FG002|Overall Study|Adverse Event|0|||
145431241|NCT04398706|524437794|FG003|Overall Study|Adverse Event|0|||
145431242|NCT04398706|524437795|FG004|Overall Study|Adverse Event|0|||
145431243|NCT04398706|524437796|FG005|Overall Study|Adverse Event|1|||
145431244|NCT04398706|524437797|FG006|Overall Study|Adverse Event|1|||
145431245|NCT04398706|524437798|FG007|Overall Study|Adverse Event|0|||
145431246|NCT04398706|524437791|FG000|Overall Study|Lost to Follow-up|0|||
145431247|NCT04398706|524437792|FG001|Overall Study|Lost to Follow-up|1|||
145431248|NCT04398706|524437793|FG002|Overall Study|Lost to Follow-up|2|||
145431249|NCT04398706|524437794|FG003|Overall Study|Lost to Follow-up|1|||
145431250|NCT04398706|524437795|FG004|Overall Study|Lost to Follow-up|6|||
145431251|NCT04398706|524437796|FG005|Overall Study|Lost to Follow-up|3|||
145431252|NCT04398706|524437797|FG006|Overall Study|Lost to Follow-up|8|||
145431253|NCT04398706|524437798|FG007|Overall Study|Lost to Follow-up|2|||
145431254|NCT04398706|524437791|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145431255|NCT04398706|524437792|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145431256|NCT04398706|524437793|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145431257|NCT04398706|524437794|FG003|Overall Study|Withdrawal by parent/guardian|2|||
145431258|NCT04398706|524437795|FG004|Overall Study|Withdrawal by parent/guardian|19|||
145431259|NCT04398706|524437796|FG005|Overall Study|Withdrawal by parent/guardian|23|||
145431260|NCT04398706|524437797|FG006|Overall Study|Withdrawal by parent/guardian|13|||
145431261|NCT04398706|524437798|FG007|Overall Study|Withdrawal by parent/guardian|11|||
145431262|NCT04398706|524437791|FG000|Overall Study|Protocol deviation|0|||
145431263|NCT04398706|524437792|FG001|Overall Study|Protocol deviation|1|||
145431264|NCT04398706|524437793|FG002|Overall Study|Protocol deviation|0|||
145431265|NCT04398706|524437794|FG003|Overall Study|Protocol deviation|0|||
145624081|NCT01072929|525135660|FG002|Overall Study|Noncompliance with study procedures|1|||
145624082|NCT01072929|525135658|FG000|Overall Study|Other|0|||
145624083|NCT01072929|525135659|FG001|Overall Study|Other|3|||
145376886|NCT02327013|524231602|FG004|Overall Study|Withdrawal before treatment|0|||
145376887|NCT02380859|524231605|FG000|Overall Study|Withdrawal by Subject|2|||
145376888|NCT02380859|524231606|FG001|Overall Study|Withdrawal by Subject|0|||
145376889|NCT01565668|524231607|FG000|Overall Study|Death|2|||
145376890|NCT01565668|524231608|FG001|Overall Study|Death|1|||
145376891|NCT01565668|524231607|FG000|Overall Study|Lack of Efficacy|4|||
145376892|NCT01565668|524231608|FG001|Overall Study|Lack of Efficacy|2|||
145376893|NCT01565668|524231607|FG000|Overall Study|Participant went on Hospice Care|1|||
145376894|NCT01565668|524231608|FG001|Overall Study|Participant went on Hospice Care|0|||
145376895|NCT01565668|524231607|FG000|Overall Study|Adverse Event|6|||
145376896|NCT01565668|524231608|FG001|Overall Study|Adverse Event|1|||
145376897|NCT01565668|524231607|FG000|Overall Study|Randomized, but never received drug|0|||
145376898|NCT01565668|524231608|FG001|Overall Study|Randomized, but never received drug|2|||
145376899|NCT01565668|524231607|FG000|Overall Study|Progressive disease|13|||
145376900|NCT01565668|524231608|FG001|Overall Study|Progressive disease|14|||
145376901|NCT01565668|524231607|FG000|Overall Study|Withdrawal by Subject|1|||
145376902|NCT01565668|524231608|FG001|Overall Study|Withdrawal by Subject|3|||
145376903|NCT01565668|524231607|FG000|Overall Study|HSCT Transplant|11|||
145376904|NCT01565668|524231608|FG001|Overall Study|HSCT Transplant|15|||
145376905|NCT04258254|524231609|FG000|Overall Study|Withdrawal by Subject|0|||
145376906|NCT04258254|524231610|FG001|Overall Study|Withdrawal by Subject|1|||
145376907|NCT04258254|524231611|FG002|Overall Study|Withdrawal by Subject|0|||
145376908|NCT02255552|524231612|FG000|Overall Study|Participants enrolled into another study|0|||
145376909|NCT02255552|524231613|FG001|Overall Study|Participants enrolled into another study|11|||
145376910|NCT02255552|524231612|FG000|Overall Study|Withdrawal by Subject|1|||
145376911|NCT02255552|524231613|FG001|Overall Study|Withdrawal by Subject|4|||
145376912|NCT01447446|524231614|FG000|Overall Study|Death|6|||
145376913|NCT01447446|524231615|FG001|Overall Study|Death|3|||
145376914|NCT01447446|524231616|FG002|Overall Study|Death|2|||
145376915|NCT01447446|524231617|FG003|Overall Study|Death|1|||
145376916|NCT01447446|524231618|FG004|Overall Study|Death|7|||
145376917|NCT01447446|524231619|FG005|Overall Study|Death|0|||
145376918|NCT01447446|524231614|FG000|Overall Study|Adverse Event|3|||
145376919|NCT01447446|524231615|FG001|Overall Study|Adverse Event|0|||
145376920|NCT01447446|524231616|FG002|Overall Study|Adverse Event|1|||
145376921|NCT01447446|524231617|FG003|Overall Study|Adverse Event|0|||
145376922|NCT01447446|524231618|FG004|Overall Study|Adverse Event|2|||
145376923|NCT01447446|524231619|FG005|Overall Study|Adverse Event|0|||
145376924|NCT01447446|524231614|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
145376925|NCT01447446|524231615|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
145376926|NCT01447446|524231616|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
145376927|NCT01447446|524231617|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
145376928|NCT01447446|524231618|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
145376929|NCT01447446|524231619|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
145376930|NCT01447446|524231614|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
145376931|NCT01447446|524231615|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
145376932|NCT01447446|524231616|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
145376933|NCT01447446|524231617|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
145376934|NCT01447446|524231618|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
145376935|NCT01447446|524231619|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
145376936|NCT01447446|524231614|FG000|Overall Study|Administrative/Other|34|||
145376937|NCT01447446|524231615|FG001|Overall Study|Administrative/Other|9|||
145376938|NCT01447446|524231616|FG002|Overall Study|Administrative/Other|10|||
145376939|NCT01447446|524231617|FG003|Overall Study|Administrative/Other|2|||
145376940|NCT01447446|524231618|FG004|Overall Study|Administrative/Other|33|||
145376941|NCT01447446|524231619|FG005|Overall Study|Administrative/Other|4|||
145376942|NCT01447446|524231614|FG000|Overall Study|SVR12 Assessment|13|||
145376943|NCT01447446|524231615|FG001|Overall Study|SVR12 Assessment|1|||
145376944|NCT01447446|524231616|FG002|Overall Study|SVR12 Assessment|2|||
145376945|NCT01447446|524231617|FG003|Overall Study|SVR12 Assessment|1|||
145376946|NCT01447446|524231618|FG004|Overall Study|SVR12 Assessment|5|||
145376947|NCT01447446|524231619|FG005|Overall Study|SVR12 Assessment|5|||
145376948|NCT01447446|524231614|FG000|Overall Study|New Treatment Started|8|||
145376949|NCT01447446|524231615|FG001|Overall Study|New Treatment Started|2|||
145376950|NCT01447446|524231616|FG002|Overall Study|New Treatment Started|1|||
145376951|NCT01447446|524231617|FG003|Overall Study|New Treatment Started|0|||
145376952|NCT01447446|524231618|FG004|Overall Study|New Treatment Started|2|||
145376953|NCT01447446|524231619|FG005|Overall Study|New Treatment Started|0|||
145376954|NCT01447446|524231614|FG000|Overall Study|Reason not Specified|1|||
145376955|NCT01447446|524231615|FG001|Overall Study|Reason not Specified|1|||
145376956|NCT01447446|524231616|FG002|Overall Study|Reason not Specified|1|||
145376957|NCT01447446|524231617|FG003|Overall Study|Reason not Specified|1|||
145624084|NCT01072929|525135660|FG002|Overall Study|Other|0|||
145431266|NCT04398706|524437795|FG004|Overall Study|Protocol deviation|6|||
145431267|NCT04398706|524437796|FG005|Overall Study|Protocol deviation|4|||
145431268|NCT04398706|524437797|FG006|Overall Study|Protocol deviation|6|||
145431269|NCT04398706|524437798|FG007|Overall Study|Protocol deviation|3|||
145431270|NCT01323192|524439284|FG000|Overall Study|Adverse Event|6|||
145431271|NCT01323192|524439285|FG001|Overall Study|Adverse Event|1|||
145431272|NCT01323192|524439284|FG000|Overall Study|Withdrawal by Subject|3|||
145431273|NCT01323192|524439285|FG001|Overall Study|Withdrawal by Subject|1|||
145431274|NCT01323192|524439284|FG000|Overall Study|Noncompliance with study medication|0|||
145431275|NCT01323192|524439285|FG001|Overall Study|Noncompliance with study medication|3|||
145431276|NCT01323192|524439284|FG000|Overall Study|Nonmedical reasons|0|||
145431277|NCT01323192|524439285|FG001|Overall Study|Nonmedical reasons|1|||
145431278|NCT02276040|524439291|FG000|Overall Study|Physician Decision|15|||
145431279|NCT02835690|524439292|FG000|Overall Study|Death|12|||
145431280|NCT02835690|524439293|FG001|Overall Study|Death|11|||
145431281|NCT02835690|524439294|FG002|Overall Study|Death|13|||
145431282|NCT02835690|524439292|FG000|Overall Study|Transferred to Extension Study|2|||
145431283|NCT02835690|524439293|FG001|Overall Study|Transferred to Extension Study|2|||
145431284|NCT02835690|524439294|FG002|Overall Study|Transferred to Extension Study|1|||
145431285|NCT02835690|524439292|FG000|Overall Study|Did Not Continue on Extension Study|0|||
145431286|NCT02835690|524439293|FG001|Overall Study|Did Not Continue on Extension Study|0|||
145431287|NCT02835690|524439294|FG002|Overall Study|Did Not Continue on Extension Study|1|||
145431288|NCT02835690|524439292|FG000|Overall Study|Not Treated|0|||
145431289|NCT02835690|524439293|FG001|Overall Study|Not Treated|2|||
145431290|NCT02835690|524439294|FG002|Overall Study|Not Treated|0|||
145431291|NCT03674281|524439295|FG000|Overall Study|screen failure|2|||
145431292|NCT03674281|524439296|FG001|Overall Study|screen failure|0|||
145431293|NCT03674281|524439297|FG002|Overall Study|screen failure|0|||
145431294|NCT03674281|524439295|FG000|Overall Study|Withdrawal by Subject|1|||
145431295|NCT03674281|524439296|FG001|Overall Study|Withdrawal by Subject|3|||
145431296|NCT03674281|524439297|FG002|Overall Study|Withdrawal by Subject|3|||
145431297|NCT00582907|524439298|FG000|1st Course|Withdrawal by Subject|1|||
145431298|NCT00582907|524439299|FG001|1st Course|Withdrawal by Subject|0|||
145431299|NCT00582907|524439300|FG002|1st Course|Withdrawal by Subject|0|||
145431300|NCT00582907|524439301|FG003|1st Course|Withdrawal by Subject|0|||
145431301|NCT00582907|524439298|FG000|1st Course|Lost to Follow-up|0|||
145431302|NCT00582907|524439299|FG001|1st Course|Lost to Follow-up|0|||
145431303|NCT00582907|524439300|FG002|1st Course|Lost to Follow-up|0|||
145431304|NCT00582907|524439301|FG003|1st Course|Lost to Follow-up|1|||
145431305|NCT00582907|524439298|FG000|2nd Course|Lack of Efficacy|1|||
145431306|NCT00582907|524439299|FG001|2nd Course|Lack of Efficacy|0|||
145431307|NCT00582907|524439300|FG002|2nd Course|Lack of Efficacy|0|||
145431308|NCT00582907|524439301|FG003|2nd Course|Lack of Efficacy|0|||
145431309|NCT01441960|524439302|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
145431310|NCT01441960|524439303|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
145431311|NCT01441960|524439302|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
145431312|NCT01441960|524439303|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
145431313|NCT01441960|524439302|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
145431314|NCT01441960|524439303|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
145431315|NCT00069641|524439309|FG000|Overall Study|Death|1|||
145431316|NCT00069641|524439310|FG001|Overall Study|Death|0|||
145431317|NCT00069641|524439311|FG002|Overall Study|Death|1|||
145431318|NCT03186638|524439312|FG000|Overall Study|Withdrawal by Subject|4|||
145431319|NCT03186638|524439313|FG001|Overall Study|Withdrawal by Subject|4|||
145431320|NCT03186638|524439312|FG000|Overall Study|Withdrawn due to medical problem|3|||
145431321|NCT03186638|524439313|FG001|Overall Study|Withdrawn due to medical problem|2|||
145431322|NCT03186638|524439312|FG000|Overall Study|Lost to Follow-up|1|||
145431323|NCT03186638|524439313|FG001|Overall Study|Lost to Follow-up|0|||
145431324|NCT02239926|524439314|FG000|Overall Study|Withdrawal by Subject|0|||
145431325|NCT02239926|524439315|FG001|Overall Study|Withdrawal by Subject|1|||
145431326|NCT05067335|524439320|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
145431327|NCT05067335|524439321|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
145431328|NCT05067335|524439322|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
145431329|NCT05067335|524439323|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
145431330|NCT05067335|524439320|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
145431331|NCT05067335|524439321|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
145431332|NCT05067335|524439322|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
145431333|NCT05067335|524439323|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
145431334|NCT05067335|524439320|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
145431335|NCT05067335|524439321|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
145431336|NCT05067335|524439322|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
145431337|NCT05067335|524439323|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
145431338|NCT05067335|524439320|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
145431339|NCT05067335|524439321|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145624085|NCT01027871|525135661|FG000|Overall Study|Physician Decision|1|||
145624086|NCT01027871|525135662|FG001|Overall Study|Physician Decision|5|||
145624087|NCT01027871|525135663|FG002|Overall Study|Physician Decision|0|||
145624088|NCT01027871|525135661|FG000|Overall Study|Protocol Violation|0|||
145624089|NCT01027871|525135662|FG001|Overall Study|Protocol Violation|2|||
145624090|NCT01027871|525135663|FG002|Overall Study|Protocol Violation|2|||
145376958|NCT01447446|524231618|FG004|Overall Study|Reason not Specified|1|||
145376959|NCT01447446|524231619|FG005|Overall Study|Reason not Specified|0|||
145376960|NCT03747302|524231622|FG000|Overall Study|Withdrawal by Subject|1|||
145376961|NCT03747302|524231623|FG001|Overall Study|Withdrawal by Subject|2|||
145376962|NCT01032070|524231626|FG000|Overall Study|Disease progression|13|||
145376963|NCT01032070|524231627|FG001|Overall Study|Disease progression|8|||
145376964|NCT01032070|524231626|FG000|Overall Study|Medical or ethical reasons|0|||
145376965|NCT01032070|524231627|FG001|Overall Study|Medical or ethical reasons|2|||
145376966|NCT01032070|524231626|FG000|Overall Study|Withdrawal by Subject|0|||
145376967|NCT01032070|524231627|FG001|Overall Study|Withdrawal by Subject|2|||
145376968|NCT02772276|524231628|FG000|Overall Study|Lost to Follow-up|0|||
145376969|NCT02772276|524231629|FG001|Overall Study|Lost to Follow-up|0|||
145376970|NCT02772276|524231630|FG002|Overall Study|Lost to Follow-up|0|||
145376971|NCT02772276|524231631|FG003|Overall Study|Lost to Follow-up|0|||
145376972|NCT02772276|524231632|FG004|Overall Study|Lost to Follow-up|0|||
145376973|NCT02772276|524231633|FG005|Overall Study|Lost to Follow-up|0|||
145376974|NCT02772276|524231634|FG006|Overall Study|Lost to Follow-up|1|||
145376975|NCT02772276|524231635|FG007|Overall Study|Lost to Follow-up|0|||
145376976|NCT02772276|524231636|FG008|Overall Study|Lost to Follow-up|0|||
145376977|NCT02772276|524231637|FG009|Overall Study|Lost to Follow-up|0|||
145376978|NCT02772276|524231638|FG010|Overall Study|Lost to Follow-up|0|||
145376979|NCT02772276|524231639|FG011|Overall Study|Lost to Follow-up|0|||
145376980|NCT02772276|524231640|FG012|Overall Study|Lost to Follow-up|0|||
145376981|NCT02772276|524231628|FG000|Overall Study|Withdrew consent|0|||
145376982|NCT02772276|524231629|FG001|Overall Study|Withdrew consent|0|||
145376983|NCT02772276|524231630|FG002|Overall Study|Withdrew consent|0|||
145376984|NCT02772276|524231631|FG003|Overall Study|Withdrew consent|0|||
145376985|NCT02772276|524231632|FG004|Overall Study|Withdrew consent|0|||
145376986|NCT02772276|524231633|FG005|Overall Study|Withdrew consent|0|||
145376987|NCT02772276|524231634|FG006|Overall Study|Withdrew consent|0|||
145376988|NCT02772276|524231635|FG007|Overall Study|Withdrew consent|1|||
145376989|NCT02772276|524231636|FG008|Overall Study|Withdrew consent|0|||
145376990|NCT02772276|524231637|FG009|Overall Study|Withdrew consent|0|||
145376991|NCT02772276|524231638|FG010|Overall Study|Withdrew consent|0|||
145376992|NCT02772276|524231639|FG011|Overall Study|Withdrew consent|0|||
145376993|NCT02772276|524231640|FG012|Overall Study|Withdrew consent|0|||
145376994|NCT00738062|524231641|FG000|Open Label Treatment|Lack of Efficacy|5|||
145376995|NCT00738062|524231642|FG001|Open Label Treatment|Lack of Efficacy|0|||
145376996|NCT00738062|524231643|FG002|Open Label Treatment|Lack of Efficacy|0|||
145376997|NCT00738062|524231641|FG000|Open Label Treatment|Adverse Event|11|||
145376998|NCT00738062|524231642|FG001|Open Label Treatment|Adverse Event|0|||
145376999|NCT00738062|524231643|FG002|Open Label Treatment|Adverse Event|0|||
145377000|NCT00738062|524231641|FG000|Open Label Treatment|Protocol Violation|2|||
145377001|NCT00738062|524231642|FG001|Open Label Treatment|Protocol Violation|0|||
145377002|NCT00738062|524231643|FG002|Open Label Treatment|Protocol Violation|0|||
145377003|NCT00738062|524231641|FG000|Open Label Treatment|Withdrawal by Subject|9|||
145377004|NCT00738062|524231642|FG001|Open Label Treatment|Withdrawal by Subject|0|||
145377005|NCT00738062|524231643|FG002|Open Label Treatment|Withdrawal by Subject|0|||
145377006|NCT00738062|524231641|FG000|Open Label Treatment|Investigator Decision|1|||
145377007|NCT00738062|524231642|FG001|Open Label Treatment|Investigator Decision|0|||
145377008|NCT00738062|524231643|FG002|Open Label Treatment|Investigator Decision|0|||
145377009|NCT00738062|524231641|FG000|Open-Label Extension|Adverse Event|5|||
145377010|NCT00738062|524231642|FG001|Open-Label Extension|Adverse Event|0|||
145377011|NCT00738062|524231643|FG002|Open-Label Extension|Adverse Event|0|||
145377012|NCT00738062|524231641|FG000|Open-Label Extension|Physician Decision|1|||
145377013|NCT00738062|524231642|FG001|Open-Label Extension|Physician Decision|0|||
145377014|NCT00738062|524231643|FG002|Open-Label Extension|Physician Decision|0|||
145377015|NCT00738062|524231641|FG000|Open-Label Extension|Lack of Efficacy|2|||
145377016|NCT00738062|524231642|FG001|Open-Label Extension|Lack of Efficacy|0|||
145377017|NCT00738062|524231643|FG002|Open-Label Extension|Lack of Efficacy|0|||
145377018|NCT00738062|524231641|FG000|Open-Label Extension|Withdrawal by Subject|6|||
145377019|NCT00738062|524231642|FG001|Open-Label Extension|Withdrawal by Subject|0|||
145377020|NCT00738062|524231643|FG002|Open-Label Extension|Withdrawal by Subject|0|||
145377021|NCT00738062|524231641|FG000|Open-Label Extension|Protocol Violation|1|||
145377022|NCT00738062|524231642|FG001|Open-Label Extension|Protocol Violation|0|||
145377023|NCT00738062|524231643|FG002|Open-Label Extension|Protocol Violation|0|||
145377024|NCT00738062|524231641|FG000|Open-Label Extension|Study Terminated|2|||
145377025|NCT00738062|524231642|FG001|Open-Label Extension|Study Terminated|0|||
145377026|NCT00738062|524231643|FG002|Open-Label Extension|Study Terminated|0|||
145377027|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
145624091|NCT01027871|525135661|FG000|Overall Study|Withdrawal by Subject|1|||
145431340|NCT05067335|524439322|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145431341|NCT05067335|524439323|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
145431342|NCT05067335|524439320|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145431343|NCT05067335|524439321|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
145431344|NCT05067335|524439322|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145431345|NCT05067335|524439323|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
145431346|NCT05067335|524439320|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
145431347|NCT05067335|524439321|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
145431348|NCT05067335|524439322|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
145431349|NCT05067335|524439323|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
145431350|NCT05067335|524439320|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145431351|NCT05067335|524439321|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145431352|NCT05067335|524439322|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
145431353|NCT05067335|524439323|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
145431354|NCT05067335|524439320|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145431355|NCT05067335|524439321|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145431356|NCT05067335|524439322|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
145431357|NCT05067335|524439323|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
145431358|NCT05067335|524439320|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145431359|NCT05067335|524439321|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145431360|NCT05067335|524439322|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
145431361|NCT05067335|524439323|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
145431362|NCT05067335|524439320|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145431363|NCT05067335|524439321|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145431364|NCT05067335|524439322|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
145431365|NCT05067335|524439323|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
145431366|NCT02234362|524439324|FG000|Overall Study|Not eligible after first screening visit|17|||
145431367|NCT02234362|524439324|FG000|Overall Study|Lost to Follow-up|6|||
145431368|NCT02234362|524439324|FG000|Overall Study|Withdrawal by Subject|3|||
145431369|NCT00261833|524439332|FG000|Overall Study|Death|1|||
145431370|NCT00261833|524439333|FG001|Overall Study|Death|3|||
145431371|NCT00261833|524439332|FG000|Overall Study|Adverse Event|1|||
145431372|NCT00261833|524439333|FG001|Overall Study|Adverse Event|4|||
145431373|NCT00261833|524439332|FG000|Overall Study|Withdrawal by Subject|5|||
145431374|NCT00261833|524439333|FG001|Overall Study|Withdrawal by Subject|7|||
145431375|NCT00261833|524439332|FG000|Overall Study|Protocol Violation|0|||
145431376|NCT00261833|524439333|FG001|Overall Study|Protocol Violation|1|||
145431377|NCT00261833|524439332|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
145431378|NCT00261833|524439333|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
145431379|NCT00261833|524439332|FG000|Overall Study|Lung transplantation|1|||
145431380|NCT00261833|524439333|FG001|Overall Study|Lung transplantation|1|||
145431381|NCT00261833|524439332|FG000|Overall Study|Missing reason|1|||
145431382|NCT00261833|524439333|FG001|Overall Study|Missing reason|0|||
145431383|NCT00261833|524439332|FG000|Overall Study|Not interested in being participant|0|||
145431384|NCT00261833|524439333|FG001|Overall Study|Not interested in being participant|1|||
145431385|NCT00402987|524439336|FG000|Overall Study|Lack of Efficacy|0|||
145431386|NCT00402987|524439337|FG001|Overall Study|Lack of Efficacy|0|||
145431387|NCT00402987|524439338|FG002|Overall Study|Lack of Efficacy|1|||
145377028|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
145377029|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
145377030|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
145377031|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Death|1|||
145377032|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Death|1|||
145377033|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
145377034|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
145377035|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
145377036|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
145377037|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
145377038|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
145377039|NCT00033657|524231644|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
145377040|NCT00033657|524231645|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
145377041|NCT00033657|524231644|FG000|Surgical Resection|not complete resection|0|||
145377042|NCT00033657|524231645|FG001|Surgical Resection|not complete resection|3|||
145377043|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
145377044|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
145377045|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
145377046|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
145377047|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|Death|2|||
145377048|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|Death|1|||
145377049|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
145377050|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
145377051|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
145377052|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
145377053|NCT00033657|524231644|FG000|Adjuvant Chemotherapy|Other|0|||
145377054|NCT00033657|524231645|FG001|Adjuvant Chemotherapy|Other|2|||
145377055|NCT02248974|524231646|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
145377056|NCT02248974|524231647|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
145377057|NCT02248974|524231646|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
145377058|NCT02248974|524231647|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
145377059|NCT02248974|524231646|FG000|1-Day Follow-Up|Enrolled in another study|1|||
145377060|NCT02248974|524231647|FG001|1-Day Follow-Up|Enrolled in another study|0|||
145377061|NCT02248974|524231646|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
145377062|NCT02248974|524231647|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
145377063|NCT02248974|524231646|FG000|1-Week Follow-Up|Enrolled in another study|1|||
145377064|NCT02248974|524231647|FG001|1-Week Follow-Up|Enrolled in another study|1|||
145377065|NCT02248974|524231646|FG000|1-Week Follow-Up|Transferred to another facility|1|||
145377066|NCT02248974|524231647|FG001|1-Week Follow-Up|Transferred to another facility|0|||
145377067|NCT02248974|524231646|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
145377068|NCT02248974|524231647|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
145377069|NCT02248974|524231646|FG000|1-Week Follow-Up|Death|1|||
145377070|NCT02248974|524231647|FG001|1-Week Follow-Up|Death|1|||
145377071|NCT02248974|524231646|FG000|1-Week Follow-Up|Excluded because of age|0|||
145377072|NCT02248974|524231647|FG001|1-Week Follow-Up|Excluded because of age|1|||
145377073|NCT02248974|524231646|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
145377074|NCT02248974|524231647|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
145377075|NCT02248974|524231646|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
145377076|NCT02248974|524231647|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
145377077|NCT02248974|524231646|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
145377078|NCT02248974|524231647|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
145377079|NCT02248974|524231646|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
145377080|NCT02248974|524231647|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
145377081|NCT02248974|524231646|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
145377082|NCT02248974|524231647|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
145377083|NCT02332239|524231648|FG000|Overall Study|Lost to Follow-up|4|||
145377084|NCT02332239|524231649|FG001|Overall Study|Lost to Follow-up|6|||
145377085|NCT00894790|524231650|FG000|Overall Study|Protocol Violation|0|||
145377086|NCT00894790|524231651|FG001|Overall Study|Protocol Violation|1|||
145377087|NCT00894790|524231650|FG000|Overall Study|Lost to Follow-up|0|||
145377088|NCT00894790|524231651|FG001|Overall Study|Lost to Follow-up|1|||
145377089|NCT00894790|524231650|FG000|Overall Study|Did not meet entrance criteria|1|||
145377090|NCT00894790|524231651|FG001|Overall Study|Did not meet entrance criteria|0|||
145377091|NCT04093492|524231652|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
145377092|NCT04093492|524231653|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
145377093|NCT04093492|524231654|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
145377094|NCT04093492|524231655|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
145377095|NCT04093492|524231652|FG000|25 Weeks Gestational Age (GA)|No response|5|||
145377096|NCT04093492|524231653|FG001|25 Weeks Gestational Age (GA)|No response|5|||
145377097|NCT04093492|524231654|FG002|25 Weeks Gestational Age (GA)|No response|5|||
145377098|NCT04093492|524231655|FG003|25 Weeks Gestational Age (GA)|No response|2|||
145377099|NCT04093492|524231652|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145377100|NCT04093492|524231653|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145377101|NCT04093492|524231654|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
145377102|NCT04093492|524231655|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
145377103|NCT04093492|524231652|FG000|30 Weeks GA|Delivered before assessment|1|||
145377104|NCT04093492|524231653|FG001|30 Weeks GA|Delivered before assessment|2|||
145377105|NCT04093492|524231654|FG002|30 Weeks GA|Delivered before assessment|0|||
145377106|NCT04093492|524231655|FG003|30 Weeks GA|Delivered before assessment|0|||
145377107|NCT04093492|524231652|FG000|30 Weeks GA|No response|7|||
145377108|NCT04093492|524231653|FG001|30 Weeks GA|No response|5|||
145377109|NCT04093492|524231654|FG002|30 Weeks GA|No response|5|||
145377110|NCT04093492|524231655|FG003|30 Weeks GA|No response|2|||
145377111|NCT04093492|524231652|FG000|30 Weeks GA|Lost to Follow-up|0|||
145377112|NCT04093492|524231653|FG001|30 Weeks GA|Lost to Follow-up|1|||
145377113|NCT04093492|524231654|FG002|30 Weeks GA|Lost to Follow-up|0|||
145377114|NCT04093492|524231655|FG003|30 Weeks GA|Lost to Follow-up|0|||
145377115|NCT04093492|524231652|FG000|34 Weeks GA|Delivered before assessment|6|||
145377116|NCT04093492|524231653|FG001|34 Weeks GA|Delivered before assessment|3|||
145377117|NCT04093492|524231654|FG002|34 Weeks GA|Delivered before assessment|0|||
145377118|NCT04093492|524231655|FG003|34 Weeks GA|Delivered before assessment|0|||
145377119|NCT04093492|524231652|FG000|34 Weeks GA|No response|0|||
145377120|NCT04093492|524231653|FG001|34 Weeks GA|No response|7|||
145377121|NCT04093492|524231654|FG002|34 Weeks GA|No response|5|||
145377122|NCT04093492|524231655|FG003|34 Weeks GA|No response|3|||
145377123|NCT04093492|524231652|FG000|34 Weeks GA|Lost to Follow-up|0|||
145377124|NCT04093492|524231653|FG001|34 Weeks GA|Lost to Follow-up|1|||
145377125|NCT04093492|524231654|FG002|34 Weeks GA|Lost to Follow-up|0|||
145377126|NCT04093492|524231655|FG003|34 Weeks GA|Lost to Follow-up|0|||
145377127|NCT00006305|524231661|FG000|Overall Study|Withdrawal by Subject|17|||
145377128|NCT00006305|524231662|FG001|Overall Study|Withdrawal by Subject|10|||
145377129|NCT00006305|524231663|FG002|Overall Study|Withdrawal by Subject|15|||
145377130|NCT00006305|524231664|FG003|Overall Study|Withdrawal by Subject|14|||
145377131|NCT00662558|524231665|FG000|Overall Study|Adverse Event|21|||
145377132|NCT00662558|524231666|FG001|Overall Study|Adverse Event|59|||
145377133|NCT00662558|524231665|FG000|Overall Study|Lack of Efficacy|4|||
145377134|NCT00662558|524231666|FG001|Overall Study|Lack of Efficacy|7|||
145377135|NCT00662558|524231665|FG000|Overall Study|Lost to Follow-up|13|||
145377136|NCT00662558|524231666|FG001|Overall Study|Lost to Follow-up|10|||
145377137|NCT00662558|524231665|FG000|Overall Study|Other|9|||
145377138|NCT00662558|524231666|FG001|Overall Study|Other|14|||
145377139|NCT00662558|524231665|FG000|Overall Study|Withdrawal by Subject|7|||
145377140|NCT00662558|524231666|FG001|Overall Study|Withdrawal by Subject|12|||
145377141|NCT00662558|524231665|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
145377142|NCT00662558|524231666|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
145377143|NCT00783224|524231669|FG000|Overall Study|Adverse Event|0|||
145377144|NCT00783224|524231670|FG001|Overall Study|Adverse Event|0|||
145377145|NCT00783224|524231671|FG002|Overall Study|Adverse Event|1|||
145377146|NCT00783224|524231672|FG003|Overall Study|Adverse Event|0|||
145377147|NCT00783224|524231669|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
145377148|NCT00783224|524231670|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
145377149|NCT00783224|524231671|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
145377150|NCT00783224|524231672|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
145377151|NCT00783224|524231669|FG000|Overall Study|Inappropriate as a study subject|0|||
145377152|NCT00783224|524231670|FG001|Overall Study|Inappropriate as a study subject|0|||
145377153|NCT00783224|524231671|FG002|Overall Study|Inappropriate as a study subject|0|||
145377154|NCT00783224|524231672|FG003|Overall Study|Inappropriate as a study subject|1|||
145377155|NCT01711619|524231673|FG000|Overall Study|Early study termination|10|||
145377156|NCT01711619|524231674|FG001|Overall Study|Early study termination|14|||
145377157|NCT01711619|524231673|FG000|Overall Study|Withdrawal by Subject|3|||
145377158|NCT01711619|524231674|FG001|Overall Study|Withdrawal by Subject|7|||
145377159|NCT01711619|524231673|FG000|Overall Study|Protocol Violation|2|||
145377160|NCT01711619|524231674|FG001|Overall Study|Protocol Violation|3|||
145377161|NCT01711619|524231673|FG000|Overall Study|Adverse Event|2|||
145377162|NCT01711619|524231674|FG001|Overall Study|Adverse Event|0|||
145377163|NCT01711619|524231673|FG000|Overall Study|Lost to Follow-up|1|||
145377164|NCT01711619|524231674|FG001|Overall Study|Lost to Follow-up|0|||
145377165|NCT00503997|524231682|FG000|Overall Study|disease progression|1|||
145377166|NCT00503997|524231682|FG000|Overall Study|Adverse Event|5|||
145377167|NCT00503997|524231682|FG000|Overall Study|Death|1|||
145377168|NCT00503997|524231682|FG000|Overall Study|Withdrawal by Subject|1|||
145377169|NCT01935700|524231685|FG000|Overall Study|Withdrawal by Subject|1|||
145377170|NCT01935700|524231686|FG001|Overall Study|Withdrawal by Subject|0|||
145377171|NCT01935700|524231685|FG000|Overall Study|Physician Decision|4|||
145377172|NCT01935700|524231686|FG001|Overall Study|Physician Decision|0|||
145377173|NCT01440569|524231690|FG000|Main Study|Enrolled but not treated|1|||
145377174|NCT01440569|524231691|FG001|Main Study|Enrolled but not treated|0|||
145377175|NCT01440569|524231690|FG000|Main Study|Adverse Event|9|||
145377176|NCT01440569|524231691|FG001|Main Study|Adverse Event|0|||
145377177|NCT01440569|524231690|FG000|Main Study|Pregnancy|1|||
145377178|NCT01440569|524231691|FG001|Main Study|Pregnancy|0|||
145377179|NCT01440569|524231690|FG000|Main Study|Investigator's Discretion|1|||
145377180|NCT01440569|524231691|FG001|Main Study|Investigator's Discretion|1|||
145377181|NCT01440569|524231690|FG000|Main Study|Withdrew Consent|7|||
145377182|NCT01440569|524231691|FG001|Main Study|Withdrew Consent|1|||
145377183|NCT01440569|524231690|FG000|Main Study|Lost to Follow-up|13|||
145377184|NCT01440569|524231691|FG001|Main Study|Lost to Follow-up|2|||
145377185|NCT01440569|524231690|FG000|Main Study|Subject Non-Compliance|3|||
145377186|NCT01440569|524231691|FG001|Main Study|Subject Non-Compliance|0|||
145377187|NCT01440569|524231690|FG000|Main Study|Protocol Violation|1|||
145377188|NCT01440569|524231691|FG001|Main Study|Protocol Violation|0|||
145377189|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Adverse Event|3|||
145377190|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Adverse Event|0|||
145377191|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Pregnancy|1|||
145377192|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Pregnancy|0|||
145377193|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
145377194|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
145377195|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
145377196|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
145377197|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
145377198|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
145377199|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
145377200|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
145377201|NCT01440569|524231690|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
145377202|NCT01440569|524231691|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
145377203|NCT00435487|524231696|FG000|Overall Study|Death|3|||
145377204|NCT00435487|524231697|FG001|Overall Study|Death|4|||
145377205|NCT00435487|524231696|FG000|Overall Study|Adverse Event|0|||
145377206|NCT00435487|524231697|FG001|Overall Study|Adverse Event|3|||
145377207|NCT00435487|524231696|FG000|Overall Study|Lost to Follow-up|2|||
145377208|NCT00435487|524231697|FG001|Overall Study|Lost to Follow-up|2|||
145377209|NCT00435487|524231696|FG000|Overall Study|Other|5|||
145377210|NCT00435487|524231697|FG001|Overall Study|Other|2|||
145377211|NCT00435487|524231696|FG000|Overall Study|Withdrawal by Subject|2|||
145377212|NCT00435487|524231697|FG001|Overall Study|Withdrawal by Subject|1|||
145377213|NCT00435487|524231696|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
145377214|NCT00435487|524231697|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
145377215|NCT00435487|524231696|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
145377216|NCT00435487|524231697|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
145377217|NCT00835679|524231701|FG000|Overall Study|Withdrawal by Subject|1|||
145377218|NCT00835679|524231702|FG001|Overall Study|Withdrawal by Subject|0|||
145377219|NCT00835679|524231703|FG002|Overall Study|Withdrawal by Subject|0|||
145377220|NCT00835679|524231704|FG003|Overall Study|Withdrawal by Subject|0|||
145377221|NCT00483704|524231707|FG000|Randomization|Withdrawal by Subject|19|||
145377222|NCT00483704|524231708|FG001|Randomization|Withdrawal by Subject|28|||
145377223|NCT00483704|524231709|FG002|Randomization|Withdrawal by Subject|18|||
145377224|NCT00483704|524231707|FG000|Randomization|Protocol Violation|14|||
145377225|NCT00483704|524231708|FG001|Randomization|Protocol Violation|25|||
145377226|NCT00483704|524231709|FG002|Randomization|Protocol Violation|22|||
145377227|NCT00483704|524231707|FG000|Randomization|Lost to Follow-up|14|||
145377228|NCT00483704|524231708|FG001|Randomization|Lost to Follow-up|14|||
145377229|NCT00483704|524231709|FG002|Randomization|Lost to Follow-up|19|||
145377230|NCT00483704|524231707|FG000|Randomization|Pregnancy|1|||
145377231|NCT00483704|524231708|FG001|Randomization|Pregnancy|0|||
145377232|NCT00483704|524231709|FG002|Randomization|Pregnancy|0|||
145377233|NCT00483704|524231707|FG000|Randomization|Physician Decision|2|||
145377234|NCT00483704|524231708|FG001|Randomization|Physician Decision|4|||
145377235|NCT00483704|524231709|FG002|Randomization|Physician Decision|0|||
145377236|NCT00483704|524231707|FG000|Randomization|Progressive disease|0|||
145377237|NCT00483704|524231708|FG001|Randomization|Progressive disease|0|||
145377238|NCT00483704|524231709|FG002|Randomization|Progressive disease|1|||
145377239|NCT00483704|524231707|FG000|Randomization|Lack of qualifying migraines|21|||
145377240|NCT00483704|524231708|FG001|Randomization|Lack of qualifying migraines|25|||
145377241|NCT00483704|524231709|FG002|Randomization|Lack of qualifying migraines|31|||
145377242|NCT00483704|524231707|FG000|Treatment|Lack of qualifying migraines|101|||
145377243|NCT00483704|524231708|FG001|Treatment|Lack of qualifying migraines|99|||
145377244|NCT00483704|524231709|FG002|Treatment|Lack of qualifying migraines|116|||
145377245|NCT00483704|524231707|FG000|Treatment|Adverse Event|3|||
145377246|NCT00483704|524231708|FG001|Treatment|Adverse Event|5|||
145377247|NCT00483704|524231709|FG002|Treatment|Adverse Event|4|||
145377248|NCT00483704|524231707|FG000|Treatment|Withdrawal by Subject|16|||
145377249|NCT00483704|524231708|FG001|Treatment|Withdrawal by Subject|12|||
145377250|NCT00483704|524231709|FG002|Treatment|Withdrawal by Subject|21|||
145377251|NCT00483704|524231707|FG000|Treatment|Protocol Violation|6|||
145377252|NCT00483704|524231708|FG001|Treatment|Protocol Violation|3|||
145377253|NCT00483704|524231709|FG002|Treatment|Protocol Violation|5|||
145377254|NCT00483704|524231707|FG000|Treatment|Lost to Follow-up|2|||
145377255|NCT00483704|524231708|FG001|Treatment|Lost to Follow-up|7|||
145377256|NCT00483704|524231709|FG002|Treatment|Lost to Follow-up|5|||
145377257|NCT00483704|524231707|FG000|Treatment|Lack of Efficacy|1|||
145377258|NCT00483704|524231708|FG001|Treatment|Lack of Efficacy|1|||
145377259|NCT00483704|524231709|FG002|Treatment|Lack of Efficacy|1|||
145377260|NCT00483704|524231707|FG000|Treatment|Pregnancy|0|||
145377261|NCT00483704|524231708|FG001|Treatment|Pregnancy|1|||
145377262|NCT00483704|524231709|FG002|Treatment|Pregnancy|0|||
145377263|NCT00483704|524231707|FG000|Treatment|Physician Decision|0|||
145377264|NCT00483704|524231708|FG001|Treatment|Physician Decision|1|||
145377265|NCT00483704|524231709|FG002|Treatment|Physician Decision|4|||
145377266|NCT00084318|524231712|FG000|Overall Study|Withdrawal by Subject|5|||
145377267|NCT00084318|524231713|FG001|Overall Study|Withdrawal by Subject|2|||
145377268|NCT00084318|524231712|FG000|Overall Study|Protocol Violation|15|||
145377269|NCT00084318|524231713|FG001|Overall Study|Protocol Violation|11|||
145377270|NCT00084318|524231712|FG000|Overall Study|No protocol treatment|2|||
145377271|NCT00084318|524231713|FG001|Overall Study|No protocol treatment|0|||
145377272|NCT00138073|524231715|FG000|Overall Study|lack of resources|55|||
145377273|NCT02345889|524231719|FG000|Overall Study|Inadequate Bowel Prep|17|||
145377274|NCT02345889|524231720|FG001|Overall Study|Inadequate Bowel Prep|16|||
145377275|NCT02345889|524231721|FG002|Overall Study|Inadequate Bowel Prep|18|||
145431388|NCT00402987|524439339|FG003|Overall Study|Lack of Efficacy|0|||
145431389|NCT02434081|524439340|FG000|Overall Study|Death (never started treatment)|2|||
145431390|NCT02434081|524439340|FG000|Overall Study|Death|2|||
145431391|NCT02434081|524439340|FG000|Overall Study|Progression|20|||
145431392|NCT02434081|524439340|FG000|Overall Study|Adverse Event|20|||
145431393|NCT02434081|524439340|FG000|Overall Study|Physician Decision|2|||
145431394|NCT02434081|524439340|FG000|Overall Study|Withdrawal by Subject|1|||
145431395|NCT02434081|524439340|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
145431396|NCT01668004|524439341|FG000|Overall Study|Adverse Event|7|||
145431397|NCT01668004|524439341|FG000|Overall Study|Withdrawal by Subject|2|||
145431398|NCT01668004|524439341|FG000|Overall Study|Lost to Follow-up|5|||
145431399|NCT01668004|524439341|FG000|Overall Study|Lack of Efficacy|9|||
145431400|NCT01668004|524439341|FG000|Overall Study|Non-compliance with treatment|2|||
145431401|NCT00419744|524439342|FG000|Overall Study|Adverse Event|39|||
145431402|NCT00419744|524439343|FG001|Overall Study|Adverse Event|40|||
145431403|NCT00419744|524439344|FG002|Overall Study|Adverse Event|50|||
145431404|NCT00419744|524439342|FG000|Overall Study|Withdrawal by Subject|45|||
145431405|NCT00419744|524439343|FG001|Overall Study|Withdrawal by Subject|49|||
145431406|NCT00419744|524439344|FG002|Overall Study|Withdrawal by Subject|52|||
145431407|NCT00419744|524439342|FG000|Overall Study|Lost to Follow-up|8|||
145431408|NCT00419744|524439343|FG001|Overall Study|Lost to Follow-up|10|||
145431409|NCT00419744|524439344|FG002|Overall Study|Lost to Follow-up|6|||
145431410|NCT00419744|524439342|FG000|Overall Study|Protocol Violation|4|||
145431411|NCT00419744|524439343|FG001|Overall Study|Protocol Violation|7|||
145431412|NCT00419744|524439344|FG002|Overall Study|Protocol Violation|8|||
145431413|NCT00419744|524439342|FG000|Overall Study|Randomized in error|9|||
145431414|NCT00419744|524439343|FG001|Overall Study|Randomized in error|6|||
145431415|NCT00419744|524439344|FG002|Overall Study|Randomized in error|7|||
145431416|NCT00419744|524439342|FG000|Overall Study|Moving out of state|2|||
145431417|NCT00419744|524439343|FG001|Overall Study|Moving out of state|0|||
145431418|NCT00419744|524439344|FG002|Overall Study|Moving out of state|1|||
145431419|NCT00419744|524439342|FG000|Overall Study|Physician Decision|10|||
145431420|NCT00419744|524439343|FG001|Overall Study|Physician Decision|5|||
145431421|NCT00419744|524439344|FG002|Overall Study|Physician Decision|6|||
145431422|NCT00419744|524439342|FG000|Overall Study|Spirometry mouthpiece issues|0|||
145431423|NCT00419744|524439343|FG001|Overall Study|Spirometry mouthpiece issues|1|||
145431424|NCT00419744|524439344|FG002|Overall Study|Spirometry mouthpiece issues|2|||
145431425|NCT00419744|524439342|FG000|Overall Study|Incorrect medication kit dispensed|0|||
145431426|NCT00419744|524439343|FG001|Overall Study|Incorrect medication kit dispensed|0|||
145431427|NCT00419744|524439344|FG002|Overall Study|Incorrect medication kit dispensed|1|||
145431428|NCT01500317|524439351|FG000|Overall Study|Withdrawal by Subject|3|||
145431429|NCT01500317|524439352|FG001|Overall Study|Withdrawal by Subject|2|||
145431430|NCT01500317|524439353|FG002|Overall Study|Withdrawal by Subject|0|||
145431431|NCT02090764|524439354|FG000|Overall Study|Adverse Event|1|||
145431432|NCT02090764|524439355|FG001|Overall Study|Adverse Event|3|||
145431433|NCT02090764|524439354|FG000|Overall Study|Lack of Efficacy|0|||
145431434|NCT02090764|524439355|FG001|Overall Study|Lack of Efficacy|13|||
145431435|NCT02090764|524439354|FG000|Overall Study|Withdrawal by Subject|2|||
145431436|NCT02090764|524439355|FG001|Overall Study|Withdrawal by Subject|1|||
145431437|NCT02090764|524439354|FG000|Overall Study|Intercurrent illness and other|1|||
145431438|NCT02090764|524439355|FG001|Overall Study|Intercurrent illness and other|1|||
145431439|NCT02090764|524439354|FG000|Overall Study|Lost to Follow-up|2|||
145431440|NCT02090764|524439355|FG001|Overall Study|Lost to Follow-up|2|||
145431441|NCT02131766|524439356|FG000|Overall Study|Withdrawal by Subject|4|||
145431442|NCT00718315|524439358|FG000|Overall Study|Adverse Event|1|||
145431443|NCT00718315|524439359|FG001|Overall Study|Adverse Event|2|||
145431444|NCT00718315|524439360|FG002|Overall Study|Adverse Event|3|||
145431445|NCT00718315|524439358|FG000|Overall Study|Death|6|||
145431446|NCT00718315|524439359|FG001|Overall Study|Death|6|||
145431447|NCT00718315|524439360|FG002|Overall Study|Death|5|||
145431448|NCT00718315|524439358|FG000|Overall Study|Lost to Follow-up|2|||
145431449|NCT00718315|524439359|FG001|Overall Study|Lost to Follow-up|3|||
145431450|NCT00718315|524439360|FG002|Overall Study|Lost to Follow-up|4|||
145431451|NCT00718315|524439358|FG000|Overall Study|Protocol Violation|5|||
145431452|NCT00718315|524439359|FG001|Overall Study|Protocol Violation|5|||
145431453|NCT00718315|524439360|FG002|Overall Study|Protocol Violation|3|||
145431454|NCT00718315|524439358|FG000|Overall Study|Erlotinib dose decreased|4|||
145431455|NCT00718315|524439359|FG001|Overall Study|Erlotinib dose decreased|3|||
145431456|NCT00718315|524439360|FG002|Overall Study|Erlotinib dose decreased|1|||
145431457|NCT00718315|524439358|FG000|Overall Study|Use of Minocyclin|1|||
145431458|NCT00718315|524439359|FG001|Overall Study|Use of Minocyclin|1|||
145431459|NCT00718315|524439360|FG002|Overall Study|Use of Minocyclin|1|||
145431460|NCT00718315|524439358|FG000|Overall Study|Disease progression|0|||
145431461|NCT00718315|524439359|FG001|Overall Study|Disease progression|1|||
145431462|NCT00718315|524439360|FG002|Overall Study|Disease progression|1|||
145431463|NCT00718315|524439358|FG000|Overall Study|Other|0|||
145431464|NCT00718315|524439359|FG001|Overall Study|Other|0|||
145431465|NCT00718315|524439360|FG002|Overall Study|Other|1|||
145431466|NCT00718315|524439358|FG000|Overall Study|Use of ATB and Corticoids|0|||
145431467|NCT00718315|524439359|FG001|Overall Study|Use of ATB and Corticoids|1|||
145431468|NCT00718315|524439360|FG002|Overall Study|Use of ATB and Corticoids|2|||
145431469|NCT00806585|524439362|FG000|Overall Study|Study terminated by Sponsor|0|||
145431470|NCT00806585|524439363|FG001|Overall Study|Study terminated by Sponsor|0|||
145431471|NCT00806585|524439364|FG002|Overall Study|Study terminated by Sponsor|1|||
145431472|NCT00806585|524439365|FG003|Overall Study|Study terminated by Sponsor|2|||
145431473|NCT00806585|524439366|FG004|Overall Study|Study terminated by Sponsor|0|||
145431474|NCT00806585|524439362|FG000|Overall Study|Protocol Violation|3|||
145431475|NCT00806585|524439363|FG001|Overall Study|Protocol Violation|1|||
145431476|NCT00806585|524439364|FG002|Overall Study|Protocol Violation|2|||
145431477|NCT00806585|524439365|FG003|Overall Study|Protocol Violation|0|||
145431478|NCT00806585|524439366|FG004|Overall Study|Protocol Violation|0|||
145431479|NCT00806585|524439362|FG000|Overall Study|Physician Decision|0|||
145431480|NCT00806585|524439363|FG001|Overall Study|Physician Decision|2|||
145431481|NCT00806585|524439364|FG002|Overall Study|Physician Decision|3|||
145431482|NCT00806585|524439365|FG003|Overall Study|Physician Decision|0|||
145431483|NCT00806585|524439366|FG004|Overall Study|Physician Decision|1|||
145431484|NCT00806585|524439362|FG000|Overall Study|Lost to Follow-up|2|||
145431485|NCT00806585|524439363|FG001|Overall Study|Lost to Follow-up|1|||
145431486|NCT00806585|524439364|FG002|Overall Study|Lost to Follow-up|2|||
145431487|NCT00806585|524439365|FG003|Overall Study|Lost to Follow-up|2|||
145431488|NCT00806585|524439366|FG004|Overall Study|Lost to Follow-up|5|||
145431489|NCT00806585|524439362|FG000|Overall Study|Lack of Efficacy|1|||
145431490|NCT00806585|524439363|FG001|Overall Study|Lack of Efficacy|0|||
145431491|NCT00806585|524439364|FG002|Overall Study|Lack of Efficacy|0|||
145431492|NCT00806585|524439365|FG003|Overall Study|Lack of Efficacy|0|||
145431493|NCT00806585|524439366|FG004|Overall Study|Lack of Efficacy|0|||
145431494|NCT00806585|524439362|FG000|Overall Study|Adverse Event|1|||
145431495|NCT00806585|524439363|FG001|Overall Study|Adverse Event|5|||
145431496|NCT00806585|524439364|FG002|Overall Study|Adverse Event|3|||
145431497|NCT00806585|524439365|FG003|Overall Study|Adverse Event|4|||
145431498|NCT00806585|524439366|FG004|Overall Study|Adverse Event|2|||
145431499|NCT00806585|524439362|FG000|Overall Study|Withdrawal by Subject|10|||
145431500|NCT00806585|524439363|FG001|Overall Study|Withdrawal by Subject|8|||
145431501|NCT00806585|524439364|FG002|Overall Study|Withdrawal by Subject|9|||
145431502|NCT00806585|524439365|FG003|Overall Study|Withdrawal by Subject|3|||
145431503|NCT00806585|524439366|FG004|Overall Study|Withdrawal by Subject|11|||
145431504|NCT00806585|524439362|FG000|Overall Study|Completion status unknown|15|||
145431505|NCT00806585|524439363|FG001|Overall Study|Completion status unknown|14|||
145431506|NCT00806585|524439364|FG002|Overall Study|Completion status unknown|12|||
145431507|NCT00806585|524439365|FG003|Overall Study|Completion status unknown|4|||
145431508|NCT00806585|524439366|FG004|Overall Study|Completion status unknown|12|||
145431509|NCT00673920|524439374|FG000|Baseline up to Week 48|Withdrew consent|1|||
145431510|NCT00673920|524439375|FG001|Baseline up to Week 48|Withdrew consent|0|||
145431511|NCT00673920|524439376|FG002|Baseline up to Week 48|Withdrew consent|2|||
145431512|NCT00673920|524439377|FG003|Baseline up to Week 48|Withdrew consent|0|||
145431513|NCT00673920|524439378|FG004|Baseline up to Week 48|Withdrew consent|0|||
145431514|NCT00673920|524439379|FG005|Baseline up to Week 48|Withdrew consent|0|||
145431515|NCT00673920|524439380|FG006|Baseline up to Week 48|Withdrew consent|0|||
145431516|NCT00673920|524439381|FG007|Baseline up to Week 48|Withdrew consent|0|||
145431517|NCT00673920|524439374|FG000|Baseline up to Week 48|Refused treatment|1|||
145431518|NCT00673920|524439375|FG001|Baseline up to Week 48|Refused treatment|0|||
145431519|NCT00673920|524439376|FG002|Baseline up to Week 48|Refused treatment|0|||
145431520|NCT00673920|524439377|FG003|Baseline up to Week 48|Refused treatment|0|||
145431521|NCT00673920|524439378|FG004|Baseline up to Week 48|Refused treatment|0|||
145431522|NCT00673920|524439379|FG005|Baseline up to Week 48|Refused treatment|0|||
145431523|NCT00673920|524439380|FG006|Baseline up to Week 48|Refused treatment|0|||
145431524|NCT00673920|524439381|FG007|Baseline up to Week 48|Refused treatment|0|||
145431525|NCT00673920|524439374|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
145431526|NCT00673920|524439375|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
145431527|NCT00673920|524439376|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431528|NCT00673920|524439377|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431529|NCT00673920|524439378|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431530|NCT00673920|524439379|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431531|NCT00673920|524439380|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431532|NCT00673920|524439381|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
145431533|NCT00673920|524439374|FG000|Baseline up to Week 48|Protocol Violation|0|||
145431534|NCT00673920|524439375|FG001|Baseline up to Week 48|Protocol Violation|0|||
145431535|NCT00673920|524439376|FG002|Baseline up to Week 48|Protocol Violation|1|||
145431536|NCT00673920|524439377|FG003|Baseline up to Week 48|Protocol Violation|0|||
145431537|NCT00673920|524439378|FG004|Baseline up to Week 48|Protocol Violation|0|||
145431538|NCT00673920|524439379|FG005|Baseline up to Week 48|Protocol Violation|0|||
145431539|NCT00673920|524439380|FG006|Baseline up to Week 48|Protocol Violation|0|||
145431540|NCT00673920|524439381|FG007|Baseline up to Week 48|Protocol Violation|0|||
145431541|NCT00673920|524439374|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431542|NCT00673920|524439375|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431543|NCT00673920|524439376|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
145431544|NCT00673920|524439377|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431545|NCT00673920|524439378|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431546|NCT00673920|524439379|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431547|NCT00673920|524439380|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431548|NCT00673920|524439381|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
145431549|NCT00673920|524439374|FG000|Baseline up to Week 48|Administrative/Other|0|||
145431550|NCT00673920|524439375|FG001|Baseline up to Week 48|Administrative/Other|1|||
145431551|NCT00673920|524439376|FG002|Baseline up to Week 48|Administrative/Other|2|||
145431552|NCT00673920|524439377|FG003|Baseline up to Week 48|Administrative/Other|0|||
145431553|NCT00673920|524439378|FG004|Baseline up to Week 48|Administrative/Other|0|||
145431554|NCT00673920|524439379|FG005|Baseline up to Week 48|Administrative/Other|0|||
145431555|NCT00673920|524439380|FG006|Baseline up to Week 48|Administrative/Other|0|||
145431556|NCT00673920|524439381|FG007|Baseline up to Week 48|Administrative/Other|0|||
145431557|NCT00673920|524439374|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431558|NCT00673920|524439375|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
145431559|NCT00673920|524439376|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
145431560|NCT00673920|524439377|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431561|NCT00673920|524439378|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431562|NCT00673920|524439379|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431563|NCT00673920|524439380|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431564|NCT00673920|524439381|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
145431565|NCT00673920|524439374|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431566|NCT00673920|524439375|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431567|NCT00673920|524439376|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431568|NCT00673920|524439377|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431569|NCT00673920|524439378|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431570|NCT00673920|524439379|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431571|NCT00673920|524439380|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
145431572|NCT00673920|524439381|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
145431573|NCT00673920|524439374|FG000|Week 24 to Week 48|Failure to return|0|||
145431574|NCT00673920|524439375|FG001|Week 24 to Week 48|Failure to return|0|||
145431575|NCT00673920|524439376|FG002|Week 24 to Week 48|Failure to return|0|||
145431576|NCT00673920|524439377|FG003|Week 24 to Week 48|Failure to return|0|||
145431577|NCT00673920|524439378|FG004|Week 24 to Week 48|Failure to return|0|||
145431578|NCT00673920|524439379|FG005|Week 24 to Week 48|Failure to return|1|||
145431579|NCT00673920|524439380|FG006|Week 24 to Week 48|Failure to return|0|||
145431580|NCT00673920|524439381|FG007|Week 24 to Week 48|Failure to return|0|||
145431581|NCT00673920|524439374|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431582|NCT00673920|524439375|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431583|NCT00673920|524439376|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431584|NCT00673920|524439377|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431585|NCT00673920|524439378|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431586|NCT00673920|524439379|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
145431587|NCT00673920|524439380|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431588|NCT00673920|524439381|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
145431589|NCT00673920|524439374|FG000|Week 24 to Week 48|Death|0|||
145431590|NCT00673920|524439375|FG001|Week 24 to Week 48|Death|0|||
145431591|NCT00673920|524439376|FG002|Week 24 to Week 48|Death|0|||
145431592|NCT00673920|524439377|FG003|Week 24 to Week 48|Death|0|||
145431593|NCT00673920|524439378|FG004|Week 24 to Week 48|Death|0|||
145431594|NCT00673920|524439379|FG005|Week 24 to Week 48|Death|1|||
145431595|NCT00673920|524439380|FG006|Week 24 to Week 48|Death|0|||
145431596|NCT00673920|524439381|FG007|Week 24 to Week 48|Death|0|||
145431597|NCT00673920|524439374|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
145431598|NCT00673920|524439375|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
145624092|NCT01027871|525135662|FG001|Overall Study|Withdrawal by Subject|2|||
145624093|NCT01027871|525135663|FG002|Overall Study|Withdrawal by Subject|2|||
145624094|NCT01027871|525135661|FG000|Overall Study|Adverse Event|0|||
145431599|NCT00673920|524439376|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
145431600|NCT00673920|524439377|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
145431601|NCT00673920|524439378|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
145431602|NCT00673920|524439379|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
145431603|NCT00673920|524439380|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
145431604|NCT00673920|524439381|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
145431605|NCT04856527|524439382|FG000|Overall Study|Unable to complete experimental task|2|||
145431606|NCT04856527|524439383|FG001|Overall Study|Unable to complete experimental task|0|||
145431607|NCT01463527|524439386|FG000|Overall Study|Protocol Violation|1|||
145431608|NCT01463527|524439387|FG001|Overall Study|Protocol Violation|1|||
145624095|NCT01027871|525135662|FG001|Overall Study|Adverse Event|2|||
145582304|NCT00898677|524983322|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
145582305|NCT00898677|524983323|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
145582306|NCT00898677|524983324|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
145582307|NCT00898677|524983325|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
145582308|NCT00898677|524983322|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
145377276|NCT02345889|524231722|FG003|Overall Study|Inadequate Bowel Prep|14|||
145377277|NCT02345889|524231719|FG000|Overall Study|Polyposis identified during procedure|1|||
145377278|NCT02345889|524231720|FG001|Overall Study|Polyposis identified during procedure|1|||
145377279|NCT02345889|524231721|FG002|Overall Study|Polyposis identified during procedure|0|||
145377280|NCT02345889|524231722|FG003|Overall Study|Polyposis identified during procedure|1|||
145377281|NCT02345889|524231719|FG000|Overall Study|Recognized ineligible post-randomization|1|||
145377282|NCT02345889|524231720|FG001|Overall Study|Recognized ineligible post-randomization|0|||
145377283|NCT02345889|524231721|FG002|Overall Study|Recognized ineligible post-randomization|2|||
145377284|NCT02345889|524231722|FG003|Overall Study|Recognized ineligible post-randomization|1|||
145377285|NCT02345889|524231719|FG000|Overall Study|Ulcerative Colitis identified|1|||
145377286|NCT02345889|524231720|FG001|Overall Study|Ulcerative Colitis identified|0|||
145377287|NCT02345889|524231721|FG002|Overall Study|Ulcerative Colitis identified|0|||
145377288|NCT02345889|524231722|FG003|Overall Study|Ulcerative Colitis identified|0|||
145377289|NCT02345889|524231719|FG000|Overall Study|Cecum not intubated|1|||
145377290|NCT02345889|524231720|FG001|Overall Study|Cecum not intubated|0|||
145377291|NCT02345889|524231721|FG002|Overall Study|Cecum not intubated|0|||
145377292|NCT02345889|524231722|FG003|Overall Study|Cecum not intubated|0|||
145377293|NCT00962091|524231723|FG000|Overall Study|Withdrawal by Subject|1|||
145377294|NCT00962091|524231724|FG001|Overall Study|Withdrawal by Subject|2|||
145377295|NCT00962091|524231725|FG002|Overall Study|Withdrawal by Subject|1|||
145377296|NCT00962091|524231726|FG003|Overall Study|Withdrawal by Subject|1|||
145377297|NCT00962091|524231727|FG004|Overall Study|Withdrawal by Subject|0|||
145377298|NCT00962091|524231728|FG005|Overall Study|Withdrawal by Subject|1|||
145377299|NCT00962091|524231729|FG006|Overall Study|Withdrawal by Subject|0|||
145377300|NCT00962091|524231723|FG000|Overall Study|Adverse Event|0|||
145377301|NCT00962091|524231724|FG001|Overall Study|Adverse Event|0|||
145377302|NCT00962091|524231725|FG002|Overall Study|Adverse Event|0|||
145377303|NCT00962091|524231726|FG003|Overall Study|Adverse Event|0|||
145377304|NCT00962091|524231727|FG004|Overall Study|Adverse Event|0|||
145377305|NCT00962091|524231728|FG005|Overall Study|Adverse Event|0|||
145377306|NCT00962091|524231729|FG006|Overall Study|Adverse Event|1|||
145377307|NCT03521817|524231730|FG000|Overall Study|Protocol Violation|0|||
145377308|NCT03521817|524231731|FG001|Overall Study|Protocol Violation|1|||
145377309|NCT00908596|524233500|FG000|Overall Study|Other reasons|46|||
145377310|NCT00908596|524233501|FG001|Overall Study|Other reasons|6|||
145377311|NCT00908596|524233502|FG002|Overall Study|Other reasons|2|||
145377312|NCT00908596|524233503|FG003|Overall Study|Other reasons|0|||
145377313|NCT00908596|524233500|FG000|Overall Study|Lost to Follow-up|0|||
145377314|NCT00908596|524233501|FG001|Overall Study|Lost to Follow-up|1|||
145377315|NCT00908596|524233502|FG002|Overall Study|Lost to Follow-up|12|||
145377316|NCT00908596|524233503|FG003|Overall Study|Lost to Follow-up|4|||
145377317|NCT00908596|524233500|FG000|Overall Study|Death|0|||
145377318|NCT00908596|524233501|FG001|Overall Study|Death|5|||
145377319|NCT00908596|524233502|FG002|Overall Study|Death|57|||
145377320|NCT00908596|524233503|FG003|Overall Study|Death|32|||
145377321|NCT00908596|524233500|FG000|Overall Study|Protocol Violation|1|||
145377322|NCT00908596|524233501|FG001|Overall Study|Protocol Violation|0|||
145377323|NCT00908596|524233502|FG002|Overall Study|Protocol Violation|0|||
145377324|NCT00908596|524233503|FG003|Overall Study|Protocol Violation|0|||
145377325|NCT00908596|524233500|FG000|Overall Study|Withdrawal by Subject|0|||
145377326|NCT00908596|524233501|FG001|Overall Study|Withdrawal by Subject|1|||
145377327|NCT00908596|524233502|FG002|Overall Study|Withdrawal by Subject|3|||
145377328|NCT00908596|524233503|FG003|Overall Study|Withdrawal by Subject|1|||
145377329|NCT02609724|524233508|FG000|Overall Study|Death|2|||
145377330|NCT02609724|524233509|FG001|Overall Study|Death|0|||
145377331|NCT02609724|524233510|FG002|Overall Study|Death|1|||
145377332|NCT02609724|524233508|FG000|Overall Study|Withdrawal by Subject|1|||
145377333|NCT02609724|524233509|FG001|Overall Study|Withdrawal by Subject|2|||
145377334|NCT02609724|524233510|FG002|Overall Study|Withdrawal by Subject|3|||
145377335|NCT02609724|524233508|FG000|Overall Study|Illness|2|||
145377336|NCT02609724|524233509|FG001|Overall Study|Illness|1|||
145377337|NCT02609724|524233510|FG002|Overall Study|Illness|0|||
145377338|NCT03077659|524233511|FG000|Overall Study|Withdrawal by Subject|0|||
145377339|NCT03077659|524233512|FG001|Overall Study|Withdrawal by Subject|0|||
145377340|NCT03077659|524233513|FG002|Overall Study|Withdrawal by Subject|1|||
145377341|NCT00087126|524233517|FG000|Overall Study|Ineligible - second primary|1|||
145377342|NCT00087126|524233517|FG000|Overall Study|Never treated|1|||
145582309|NCT00898677|524983323|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
145582310|NCT00898677|524983324|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
145377343|NCT01162122|524233518|FG000|Overall Study|Withdrawal by Subject|52|||
145377344|NCT01162122|524233519|FG001|Overall Study|Withdrawal by Subject|43|||
145377345|NCT01162122|524233518|FG000|Overall Study|Lost to Follow-up|73|||
145624096|NCT01027871|525135663|FG002|Overall Study|Adverse Event|2|||
145624097|NCT01027871|525135661|FG000|Overall Study|Sponsor Decision|0|||
145624098|NCT01027871|525135662|FG001|Overall Study|Sponsor Decision|2|||
145624099|NCT01027871|525135663|FG002|Overall Study|Sponsor Decision|0|||
145624100|NCT01027871|525135661|FG000|Overall Study|Discontinued Prior to Treatment|0|||
145624101|NCT01027871|525135662|FG001|Overall Study|Discontinued Prior to Treatment|0|||
145624102|NCT01027871|525135663|FG002|Overall Study|Discontinued Prior to Treatment|1|||
145624103|NCT04833855|525135664|FG000|Overall Study|Decision by sponsor|0|||
145624104|NCT04833855|525135665|FG001|Overall Study|Decision by sponsor|1|||
145624105|NCT04833855|525135666|FG002|Overall Study|Decision by sponsor|0|||
145624106|NCT04833855|525135667|FG003|Overall Study|Decision by sponsor|0|||
145624107|NCT04833855|525135664|FG000|Overall Study|Withdrawal by Subject|4|||
145624108|NCT04833855|525135665|FG001|Overall Study|Withdrawal by Subject|1|||
145624109|NCT04833855|525135666|FG002|Overall Study|Withdrawal by Subject|3|||
145624110|NCT04833855|525135667|FG003|Overall Study|Withdrawal by Subject|1|||
145624111|NCT04833855|525135664|FG000|Overall Study|Lost to Follow-up|1|||
145624112|NCT04833855|525135665|FG001|Overall Study|Lost to Follow-up|0|||
145624113|NCT04833855|525135666|FG002|Overall Study|Lost to Follow-up|2|||
145624114|NCT04833855|525135667|FG003|Overall Study|Lost to Follow-up|2|||
145624115|NCT04833855|525135664|FG000|Overall Study|Protocol specified criteria|0|||
145624116|NCT04833855|525135665|FG001|Overall Study|Protocol specified criteria|0|||
145624117|NCT04833855|525135666|FG002|Overall Study|Protocol specified criteria|2|||
145624118|NCT04833855|525135667|FG003|Overall Study|Protocol specified criteria|1|||
145624119|NCT03782727|525135668|FG000|Overall Study|Lost to Follow-up|32|||
145624120|NCT04824131|525135671|FG000|CAB LA Oral Phase|Adverse Event|1|||
145624121|NCT04824131|525135671|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
145624122|NCT04824131|525135671|FG000|Step 3|Withdrawal by Subject|2|||
145624123|NCT03686384|525135673|FG000|Overall Study|Lack of Efficacy|4|||
145624124|NCT03686384|525135674|FG001|Overall Study|Lack of Efficacy|13|||
145624125|NCT03686384|525135673|FG000|Overall Study|Lost to Follow-up|3|||
145624126|NCT03686384|525135674|FG001|Overall Study|Lost to Follow-up|0|||
145624127|NCT03686384|525135673|FG000|Overall Study|Physician Decision|0|||
145624128|NCT03686384|525135674|FG001|Overall Study|Physician Decision|1|||
145624129|NCT03686384|525135673|FG000|Overall Study|Took prohibited medication|0|||
145624130|NCT03686384|525135674|FG001|Overall Study|Took prohibited medication|1|||
145624131|NCT04640571|525135675|FG000|Overall Study|Withdrawal by Subject|0|||
145624132|NCT04640571|525135676|FG001|Overall Study|Withdrawal by Subject|0|||
145624133|NCT04640571|525135677|FG002|Overall Study|Withdrawal by Subject|0|||
145624134|NCT04640571|525135678|FG003|Overall Study|Withdrawal by Subject|0|||
145582311|NCT00898677|524983325|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
145582312|NCT00898677|524983322|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
145582313|NCT00898677|524983323|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
145582314|NCT00898677|524983324|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
145582315|NCT00898677|524983325|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
145582316|NCT00898677|524983322|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
145582317|NCT00898677|524983323|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
145582318|NCT00898677|524983324|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
145582319|NCT00898677|524983325|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
145582320|NCT00898677|524983322|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
145582321|NCT00898677|524983323|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
145624135|NCT04640571|525135679|FG004|Overall Study|Withdrawal by Subject|0|||
145624136|NCT04640571|525135680|FG005|Overall Study|Withdrawal by Subject|2|||
145624137|NCT03008122|525135682|FG000|Overall Study|Physician Decision|3|||
145624138|NCT03008122|525135683|FG001|Overall Study|Physician Decision|2|||
145624139|NCT03008122|525135684|FG002|Overall Study|Physician Decision|0|||
145624140|NCT03008122|525135682|FG000|Overall Study|Withdrawal by Subject|1|||
145624141|NCT03008122|525135683|FG001|Overall Study|Withdrawal by Subject|3|||
145624142|NCT03008122|525135684|FG002|Overall Study|Withdrawal by Subject|0|||
145624143|NCT03008122|525135682|FG000|Overall Study|Lost to Follow-up|4|||
145624144|NCT03008122|525135683|FG001|Overall Study|Lost to Follow-up|8|||
145624145|NCT03008122|525135684|FG002|Overall Study|Lost to Follow-up|3|||
145624146|NCT03008122|525135682|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
145624147|NCT03008122|525135683|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
145624148|NCT03008122|525135684|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
145624149|NCT03008122|525135682|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
145624150|NCT03008122|525135683|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
145624151|NCT03008122|525135684|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
145624152|NCT03008122|525135682|FG000|Overall Study|Death|0|||
145624153|NCT03008122|525135683|FG001|Overall Study|Death|0|||
145624154|NCT03008122|525135684|FG002|Overall Study|Death|1|||
145624155|NCT02338609|525135687|FG000|Overall Study|Physician Decision|1|||
145624156|NCT02338609|525135687|FG000|Overall Study|Death|1|||
145624157|NCT04736056|525135689|FG000|Overall Study|Death|0|||
145582322|NCT00898677|524983324|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
145624158|NCT04736056|525135690|FG001|Overall Study|Death|0|||
145624159|NCT04736056|525135691|FG002|Overall Study|Death|0|||
145377346|NCT01162122|524233519|FG001|Overall Study|Lost to Follow-up|91|||
145377347|NCT01162122|524233518|FG000|Overall Study|Adverse Event|3|||
145377348|NCT01162122|524233519|FG001|Overall Study|Adverse Event|2|||
145377349|NCT01162122|524233518|FG000|Overall Study|Death|51|||
145377350|NCT01162122|524233519|FG001|Overall Study|Death|46|||
145377351|NCT01162122|524233518|FG000|Overall Study|Protocol Violation|2|||
145377352|NCT01162122|524233519|FG001|Overall Study|Protocol Violation|2|||
145377353|NCT01162122|524233518|FG000|Overall Study|Inappropriate enrollment|5|||
145377354|NCT01162122|524233519|FG001|Overall Study|Inappropriate enrollment|4|||
145377355|NCT01162122|524233518|FG000|Overall Study|Administrative reason|1|||
145377356|NCT01162122|524233519|FG001|Overall Study|Administrative reason|1|||
145377357|NCT01162122|524233518|FG000|Overall Study|Unable to classify|3|||
145377358|NCT01162122|524233519|FG001|Overall Study|Unable to classify|7|||
145377359|NCT01162122|524233518|FG000|Overall Study|Missing primary reason|1|||
145377360|NCT01162122|524233519|FG001|Overall Study|Missing primary reason|0|||
145377361|NCT00926536|524233530|FG000|Overall Study|Physician Decision|1|||
145377362|NCT00926536|524233531|FG001|Overall Study|Physician Decision|2|||
145377363|NCT05087966|524233532|FG000|Overall Study|Lost to Follow-up|1|||
145377364|NCT05087966|524233532|FG000|Overall Study|Withdrawal by Subject|5|||
145377365|NCT01267201|524233533|FG000|First Intervention Period|Withdrawal by Subject|1|||
145377366|NCT01267201|524233534|FG001|First Intervention Period|Withdrawal by Subject|0|||
145377367|NCT01267201|524233535|FG002|First Intervention Period|Withdrawal by Subject|0|||
145377368|NCT01267201|524233536|FG003|First Intervention Period|Withdrawal by Subject|0|||
145377369|NCT01267201|524233537|FG004|First Intervention Period|Withdrawal by Subject|0|||
145377370|NCT01267201|524233538|FG005|First Intervention Period|Withdrawal by Subject|0|||
145377371|NCT01267201|524233533|FG000|Second Intervention Period|Withdrawal by Subject|0|||
145377372|NCT01267201|524233534|FG001|Second Intervention Period|Withdrawal by Subject|1|||
145377373|NCT01267201|524233535|FG002|Second Intervention Period|Withdrawal by Subject|0|||
145377374|NCT01267201|524233536|FG003|Second Intervention Period|Withdrawal by Subject|0|||
145377375|NCT01267201|524233537|FG004|Second Intervention Period|Withdrawal by Subject|0|||
145377376|NCT01267201|524233538|FG005|Second Intervention Period|Withdrawal by Subject|0|||
145377377|NCT02124759|524233539|FG000|Overall Study|Withdrawal by Subject|3|||
145377378|NCT02124759|524233540|FG001|Overall Study|Withdrawal by Subject|1|||
145377379|NCT02124759|524233541|FG002|Overall Study|Withdrawal by Subject|1|||
145377380|NCT02124759|524233539|FG000|Overall Study|Screen Fail|2|||
145377381|NCT02124759|524233540|FG001|Overall Study|Screen Fail|2|||
145377382|NCT02124759|524233541|FG002|Overall Study|Screen Fail|3|||
145377383|NCT03689543|524233544|FG000|Overall Study|Adverse Event|0|||
145431609|NCT01463527|524439386|FG000|Overall Study|Crying >20% of sedation|5|||
145431610|NCT01463527|524439387|FG001|Overall Study|Crying >20% of sedation|6|||
145431611|NCT01493414|524439390|FG000|Overall Study|Adverse Event|405|||
145431612|NCT01493414|524439390|FG000|Overall Study|Disease progression|204|||
145431613|NCT01493414|524439390|FG000|Overall Study|Death|101|||
145431614|NCT01493414|524439390|FG000|Overall Study|Physician Decision|93|||
145431615|NCT01493414|524439390|FG000|Overall Study|Withdrawal by Subject|79|||
145431616|NCT01493414|524439390|FG000|Overall Study|Protocol deviation|27|||
145431617|NCT01493414|524439390|FG000|Overall Study|Administrative problems|25|||
145431618|NCT01493414|524439390|FG000|Overall Study|Lost to Follow-up|16|||
145431619|NCT02303262|524439393|FG000|Overall Study|Withdrawal by Subject|2|||
145431620|NCT01728246|524439394|FG000|Overall Study|Participant needed rescue medication|1|||
145431621|NCT01728246|524439395|FG001|Overall Study|Participant needed rescue medication|5|||
145431622|NCT01728246|524439394|FG000|Overall Study|Protocol Violation|1|||
145431623|NCT01728246|524439395|FG001|Overall Study|Protocol Violation|0|||
145431624|NCT01728246|524439394|FG000|Overall Study|Withdrawal by Subject|2|||
145431625|NCT01728246|524439395|FG001|Overall Study|Withdrawal by Subject|3|||
145431626|NCT01728246|524439394|FG000|Overall Study|Lost to Follow-up|23|||
145431627|NCT01728246|524439395|FG001|Overall Study|Lost to Follow-up|22|||
145431628|NCT01728246|524439394|FG000|Overall Study|Lack of Efficacy|1|||
145431629|NCT01728246|524439395|FG001|Overall Study|Lack of Efficacy|1|||
145431630|NCT01728246|524439394|FG000|Overall Study|Adverse Event|8|||
145431631|NCT01728246|524439395|FG001|Overall Study|Adverse Event|5|||
145431632|NCT03097289|524439396|FG000|Overall Study|Adverse Event|1|||
145431633|NCT03097289|524439396|FG000|Overall Study|Equipment failure|2|||
145431634|NCT03097289|524439396|FG000|Overall Study|Collected platelet product unusable|3|||
145431635|NCT00619866|524439400|FG000|Weeks 1 - 12|Adverse Event|0|||
145582323|NCT00898677|524983325|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
145431636|NCT00619866|524439401|FG001|Weeks 1 - 12|Adverse Event|1|||
145431637|NCT00619866|524439402|FG002|Weeks 1 - 12|Adverse Event|2|||
145431638|NCT00619866|524439403|FG003|Weeks 1 - 12|Adverse Event|0|||
145582324|NCT00836875|524983328|FG000|Overall Study|Death|3|||
145582325|NCT00836875|524983329|FG001|Overall Study|Death|2|||
145431639|NCT00619866|524439404|FG004|Weeks 1 - 12|Adverse Event|0|||
145624160|NCT04736056|525135692|FG003|Overall Study|Death|1|||
145377384|NCT03689543|524233545|FG001|Overall Study|Adverse Event|0|||
145377385|NCT03689543|524233546|FG002|Overall Study|Adverse Event|1|||
145377386|NCT00932451|524233547|FG000|Overall Study|Withdrawal by Subject|69|||
145431640|NCT00619866|524439400|FG000|Weeks 1 - 12|Non-compliance|0|||
145582326|NCT00836875|524983328|FG000|Overall Study|Withdrawal by Subject|0|||
145624161|NCT04736056|525135689|FG000|Overall Study|Lost to Follow-up|1|||
145624162|NCT04736056|525135690|FG001|Overall Study|Lost to Follow-up|0|||
145624163|NCT04736056|525135691|FG002|Overall Study|Lost to Follow-up|1|||
145624164|NCT04736056|525135692|FG003|Overall Study|Lost to Follow-up|1|||
145624165|NCT04736056|525135689|FG000|Overall Study|Withdrawal by Subject|2|||
145624166|NCT04736056|525135690|FG001|Overall Study|Withdrawal by Subject|0|||
145624167|NCT04736056|525135691|FG002|Overall Study|Withdrawal by Subject|0|||
145624168|NCT04736056|525135692|FG003|Overall Study|Withdrawal by Subject|0|||
145624169|NCT04736056|525135689|FG000|Overall Study|Physician Decision|1|||
145624170|NCT04736056|525135690|FG001|Overall Study|Physician Decision|0|||
145624171|NCT04736056|525135691|FG002|Overall Study|Physician Decision|1|||
145624172|NCT04736056|525135692|FG003|Overall Study|Physician Decision|0|||
145624173|NCT02148718|525135693|FG000|Overall Study|Protocol Violation|26|||
145624174|NCT02148718|525135693|FG000|Overall Study|Discontinued Study Prematurely|5|||
145624175|NCT00231179|525137596|FG000|Overall Study|Lost to Follow-up|21|||
145624176|NCT00231179|525137597|FG001|Overall Study|Lost to Follow-up|21|||
145624177|NCT00231179|525137596|FG000|Overall Study|Withdrawal by Subject|3|||
145624178|NCT00231179|525137597|FG001|Overall Study|Withdrawal by Subject|3|||
145624179|NCT02206685|525137598|FG000|Overall Study|Surgery cancelled/changed|2|||
145624180|NCT02206685|525137599|FG001|Overall Study|Surgery cancelled/changed|3|||
145624181|NCT02206685|525137598|FG000|Overall Study|Withdrawal by Subject|1|||
145624182|NCT02206685|525137599|FG001|Overall Study|Withdrawal by Subject|2|||
145624183|NCT02206685|525137598|FG000|Overall Study|Protocol Violation|2|||
145624184|NCT02206685|525137599|FG001|Overall Study|Protocol Violation|2|||
145624185|NCT01345292|525137600|FG000|Overall Study|Withdrawal by Subject|2|||
145624186|NCT01345292|525137601|FG001|Overall Study|Withdrawal by Subject|0|||
145624187|NCT01345292|525137602|FG002|Overall Study|Withdrawal by Subject|1|||
145624188|NCT05406791|525137606|FG000|Overall Study|Lost to Follow-up|13|||
145624189|NCT05406791|525137607|FG001|Overall Study|Lost to Follow-up|10|||
145624190|NCT00515086|525137608|FG000|Overall Study|Adverse Event|1|||
145624191|NCT00515086|525137609|FG001|Overall Study|Adverse Event|1|||
145624192|NCT00515086|525137610|FG002|Overall Study|Adverse Event|2|||
145624193|NCT00515086|525137611|FG003|Overall Study|Adverse Event|3|||
145624194|NCT00515086|525137608|FG000|Overall Study|Administrative|1|||
145624195|NCT00515086|525137609|FG001|Overall Study|Administrative|1|||
145624196|NCT00515086|525137610|FG002|Overall Study|Administrative|0|||
145624197|NCT00515086|525137611|FG003|Overall Study|Administrative|0|||
145624198|NCT00515086|525137608|FG000|Overall Study|Withdrawal by Subject|1|||
145624199|NCT00515086|525137609|FG001|Overall Study|Withdrawal by Subject|0|||
145624200|NCT00515086|525137610|FG002|Overall Study|Withdrawal by Subject|0|||
145624201|NCT00515086|525137611|FG003|Overall Study|Withdrawal by Subject|1|||
145624202|NCT00515086|525137608|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
145624203|NCT00515086|525137609|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145624204|NCT00515086|525137610|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
145624205|NCT00515086|525137611|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
145624206|NCT00515086|525137608|FG000|Overall Study|Lost to Follow-up|1|||
145624207|NCT00515086|525137609|FG001|Overall Study|Lost to Follow-up|0|||
145624208|NCT00515086|525137610|FG002|Overall Study|Lost to Follow-up|0|||
145624209|NCT00515086|525137611|FG003|Overall Study|Lost to Follow-up|0|||
145624210|NCT00515086|525137608|FG000|Overall Study|Study drug no longer required|0|||
145624211|NCT00515086|525137609|FG001|Overall Study|Study drug no longer required|1|||
145624212|NCT00515086|525137610|FG002|Overall Study|Study drug no longer required|0|||
145624213|NCT00515086|525137611|FG003|Overall Study|Study drug no longer required|0|||
145624214|NCT00515086|525137608|FG000|Overall Study|Death|2|||
145624215|NCT00515086|525137609|FG001|Overall Study|Death|0|||
145624216|NCT00515086|525137610|FG002|Overall Study|Death|0|||
145624217|NCT00515086|525137611|FG003|Overall Study|Death|0|||
145624218|NCT02373813|525137612|FG000|Run-In Period|Other, Not Specified|5|||
145624219|NCT02373813|525137613|FG001|Run-In Period|Other, Not Specified|0|||
145624220|NCT02373813|525137614|FG002|Run-In Period|Other, Not Specified|0|||
145624221|NCT02373813|525137615|FG003|Run-In Period|Other, Not Specified|0|||
145624222|NCT02373813|525137612|FG000|Run-In Period|Withdrawal by Subject|16|||
145624223|NCT02373813|525137613|FG001|Run-In Period|Withdrawal by Subject|0|||
145624224|NCT02373813|525137614|FG002|Run-In Period|Withdrawal by Subject|0|||
145624225|NCT02373813|525137615|FG003|Run-In Period|Withdrawal by Subject|0|||
145624226|NCT02373813|525137612|FG000|Run-In Period|Decision by Sponsor|11|||
145624227|NCT02373813|525137613|FG001|Run-In Period|Decision by Sponsor|0|||
145624228|NCT02373813|525137614|FG002|Run-In Period|Decision by Sponsor|0|||
145624229|NCT02373813|525137615|FG003|Run-In Period|Decision by Sponsor|0|||
145624230|NCT02373813|525137612|FG000|Run-In Period|Protocol Violation|75|||
145624231|NCT02373813|525137613|FG001|Run-In Period|Protocol Violation|0|||
145624232|NCT02373813|525137614|FG002|Run-In Period|Protocol Violation|0|||
145624233|NCT02373813|525137615|FG003|Run-In Period|Protocol Violation|0|||
145624234|NCT02373813|525137612|FG000|Run-In Period|Lost to Follow-up|2|||
145624235|NCT02373813|525137613|FG001|Run-In Period|Lost to Follow-up|0|||
145624236|NCT02373813|525137614|FG002|Run-In Period|Lost to Follow-up|0|||
145624237|NCT02373813|525137615|FG003|Run-In Period|Lost to Follow-up|0|||
145624238|NCT02373813|525137612|FG000|Run-In Period|Adverse Event|3|||
145431641|NCT00619866|524439401|FG001|Weeks 1 - 12|Non-compliance|0|||
145431642|NCT00619866|524439402|FG002|Weeks 1 - 12|Non-compliance|1|||
145431643|NCT00619866|524439403|FG003|Weeks 1 - 12|Non-compliance|0|||
145582327|NCT00836875|524983329|FG001|Overall Study|Withdrawal by Subject|1|||
145582328|NCT03422003|524984940|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
145377387|NCT00932451|524233547|FG000|Overall Study|Lost to Follow-up|22|||
145377388|NCT00932451|524233547|FG000|Overall Study|Death|726|||
145377389|NCT00932451|524233547|FG000|Overall Study|Other reasons|5|||
145377390|NCT01634659|524233565|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
145377391|NCT01634659|524233566|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
145377392|NCT01634659|524233565|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
145377393|NCT01634659|524233566|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
145377394|NCT03627416|524233567|FG000|Overall Study|Adverse Event|0|||
145377395|NCT03627416|524233568|FG001|Overall Study|Adverse Event|1|||
145377396|NCT01294371|524233569|FG000|Overall Study|Adverse Event|1|||
145377397|NCT01294371|524233569|FG000|Overall Study|Withdrawal by Subject|12|||
145377398|NCT01294371|524233569|FG000|Overall Study|Lost to Follow-up|6|||
145377399|NCT01294371|524233569|FG000|Overall Study|Administrative Reason|1|||
145377400|NCT01294371|524233569|FG000|Overall Study|Other|14|||
145377401|NCT02968433|524233570|FG000|Overall Study|Withdrawal by Subject|1|||
145377402|NCT05619536|524233571|FG000|Overall Study|Withdrawal by Subject|0|||
145377403|NCT05619536|524233572|FG001|Overall Study|Withdrawal by Subject|1|||
145377404|NCT05619536|524233573|FG002|Overall Study|Withdrawal by Subject|0|||
145377405|NCT05619536|524233574|FG003|Overall Study|Withdrawal by Subject|1|||
145377406|NCT05619536|524233571|FG000|Overall Study|Lost to Follow-up|0|||
145377407|NCT05619536|524233572|FG001|Overall Study|Lost to Follow-up|1|||
145377408|NCT05619536|524233573|FG002|Overall Study|Lost to Follow-up|1|||
145377409|NCT05619536|524233574|FG003|Overall Study|Lost to Follow-up|0|||
145377410|NCT00875433|524233575|FG000|Overall Study|Progressive disease|41|||
145377411|NCT00875433|524233575|FG000|Overall Study|Other Adverse Event|14|||
145377412|NCT00875433|524233575|FG000|Overall Study|Withdrawal by Subject|2|||
145377413|NCT00875433|524233575|FG000|Overall Study|Other|3|||
145377414|NCT04272606|524233576|FG000|Overall Study|Protocol Violation|1|||
145377415|NCT04272606|524233577|FG001|Overall Study|Protocol Violation|1|||
145377416|NCT04272606|524233576|FG000|Overall Study|Physician Decision|0|||
145377417|NCT04272606|524233577|FG001|Overall Study|Physician Decision|1|||
145377418|NCT00725101|524233578|FG000|Overall Study|Death|3|||
145377419|NCT00725101|524233578|FG000|Overall Study|Lost to Follow-up|353|||
145377420|NCT00725101|524233578|FG000|Overall Study|Protocol Violation|1|||
145377421|NCT00725101|524233578|FG000|Overall Study|Withdrawal by Subject|127|||
145377422|NCT00725101|524233578|FG000|Overall Study|not specified/no reason given|11|||
145377423|NCT00622336|524233579|FG000|Treatment Phase|Progression of Disease|181|||
145377424|NCT00622336|524233579|FG000|Treatment Phase|Adverse Event|46|||
145377425|NCT00622336|524233579|FG000|Treatment Phase|Other|40|||
145377426|NCT00622336|524233579|FG000|Treatment Phase|Death|14|||
145377427|NCT00622336|524233579|FG000|Treatment Phase|Lack of therapeutic effect|13|||
145377428|NCT00622336|524233579|FG000|Treatment Phase|Withdrawal by Subject|13|||
145377429|NCT00622336|524233579|FG000|Treatment Phase|Lost to Follow-up|2|||
145377430|NCT00622336|524233579|FG000|Extension Phase|Adverse Event|2|||
145377431|NCT00622336|524233579|FG000|Extension Phase|Progressive Disease|6|||
145377432|NCT00622336|524233579|FG000|Extension Phase|Lack of therapeutic effect|2|||
145377433|NCT00622336|524233579|FG000|Extension Phase|Withdrawal by Subject|1|||
145377434|NCT00622336|524233579|FG000|Extension Phase|Lost to Follow-up|1|||
145377435|NCT00622336|524233579|FG000|Extension Phase|Other|9|||
145377436|NCT02923245|524233580|FG000|Overall Study|ultrasound order was cancelled|2|||
145377437|NCT02923245|524233581|FG001|Overall Study|ultrasound order was cancelled|1|||
145377438|NCT03912428|524233582|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145377439|NCT03912428|524233583|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
145377440|NCT03912428|524233584|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145377441|NCT03912428|524233585|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
145377442|NCT03912428|524233582|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
145377443|NCT03912428|524233583|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
145377444|NCT03912428|524233584|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
145377445|NCT03912428|524233585|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
145377446|NCT03912428|524233582|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145377447|NCT03912428|524233583|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145624239|NCT02373813|525137613|FG001|Run-In Period|Adverse Event|0|||
145377448|NCT03912428|524233584|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
145377449|NCT03912428|524233585|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
145377450|NCT03233204|524233586|FG000|Overall Study|Adverse Event|1|||
145377451|NCT03233204|524233586|FG000|Overall Study|Death|1|||
145377452|NCT03233204|524233586|FG000|Overall Study|Withdrawal by Subject|1|||
145377453|NCT03233204|524233586|FG000|Overall Study|Progressive Disease|3|||
145377454|NCT02520427|524233588|FG000|Overall Study|Decision by sponsor|0|||
145377455|NCT02520427|524233589|FG001|Overall Study|Decision by sponsor|0|||
145377456|NCT02520427|524233590|FG002|Overall Study|Decision by sponsor|0|||
145431644|NCT00619866|524439404|FG004|Weeks 1 - 12|Non-compliance|0|||
145431645|NCT00619866|524439400|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
145582329|NCT03422003|524984941|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
145582330|NCT03422003|524984940|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
145582331|NCT03422003|524984941|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
145582332|NCT01404312|524984942|FG000|Overall Study|Death|21|||
145582333|NCT01404312|524984943|FG001|Overall Study|Death|27|||
145582334|NCT01404312|524984942|FG000|Overall Study|Withdrawal by Subject|15|||
145582335|NCT01404312|524984943|FG001|Overall Study|Withdrawal by Subject|18|||
145582336|NCT01404312|524984942|FG000|Overall Study|Participant Unable to get to clinic|93|||
145582337|NCT01404312|524984943|FG001|Overall Study|Participant Unable to get to clinic|103|||
145582338|NCT01404312|524984942|FG000|Overall Study|Lost to Follow-up|115|||
145582339|NCT01404312|524984943|FG001|Overall Study|Lost to Follow-up|111|||
145582340|NCT01404312|524984942|FG000|Overall Study|Site closed|22|||
145582341|NCT01404312|524984943|FG001|Overall Study|Site closed|21|||
145582342|NCT01404312|524984942|FG000|Overall Study|Participant not willing to adhere to req|31|||
145582343|NCT01404312|524984943|FG001|Overall Study|Participant not willing to adhere to req|29|||
145582344|NCT01404312|524984942|FG000|Overall Study|Severe debilitation, unable to continue|1|||
145582345|NCT01404312|524984943|FG001|Overall Study|Severe debilitation, unable to continue|2|||
145582346|NCT03794089|524984946|FG000|Overall Study|Lost to Follow-up|4|||
145582347|NCT03794089|524984947|FG001|Overall Study|Lost to Follow-up|1|||
145582348|NCT03794089|524984946|FG000|Overall Study|Withdrawal by Subject|2|||
145582349|NCT03794089|524984947|FG001|Overall Study|Withdrawal by Subject|0|||
145582350|NCT03985423|524984948|FG000|Overall Study|Adverse Event|1|||
145582351|NCT03985423|524984948|FG000|Overall Study|Death|2|||
145582352|NCT03985423|524984948|FG000|Overall Study|Physician Decision|1|||
145582353|NCT03985423|524984948|FG000|Overall Study|Withdrawal by Subject|2|||
145582354|NCT03985423|524984948|FG000|Overall Study|Lack of insurance and citizenship|1|||
145582355|NCT01045447|524984959|FG000|Overall Study|Adverse Event|0|||
145582356|NCT01045447|524984960|FG001|Overall Study|Adverse Event|1|||
145582357|NCT01045447|524984959|FG000|Overall Study|Lack of Efficacy|3|||
145582358|NCT01045447|524984960|FG001|Overall Study|Lack of Efficacy|1|||
145582359|NCT01045447|524984959|FG000|Overall Study|Protocol Violation|6|||
145582360|NCT01045447|524984960|FG001|Overall Study|Protocol Violation|3|||
145582361|NCT01045447|524984959|FG000|Overall Study|Withdrawal Criteria|10|||
145582362|NCT01045447|524984960|FG001|Overall Study|Withdrawal Criteria|10|||
145582363|NCT01045447|524984959|FG000|Overall Study|Unclassified|17|||
145582364|NCT01045447|524984960|FG001|Overall Study|Unclassified|13|||
145582365|NCT00129987|524984961|FG000|1st Educational Session|Withdrawal by Subject|141|||
145582366|NCT00129987|524984962|FG001|1st Educational Session|Withdrawal by Subject|109|||
145582367|NCT00129987|524984961|FG000|1 Year|Withdrawal by Subject|32|||
145582368|NCT00129987|524984962|FG001|1 Year|Withdrawal by Subject|21|||
145582369|NCT00116805|524984963|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
145582370|NCT00116805|524984964|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
145582371|NCT00116805|524984963|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
145582372|NCT00116805|524984964|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
145582373|NCT00116805|524984963|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
145582374|NCT00116805|524984964|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
145582375|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
145582376|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
145582377|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
145582378|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
145582379|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
145582380|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
145582381|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
145582382|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
145582383|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
145582384|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
145582385|NCT00116805|524984963|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
145582386|NCT00116805|524984964|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
145582387|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
145582388|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
145582389|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
145431646|NCT00619866|524439401|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
145582390|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
145582391|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
145582392|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
145582393|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
145582394|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
145582395|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
145431647|NCT00619866|524439402|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
145431648|NCT00619866|524439403|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
145431649|NCT00619866|524439404|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
145431650|NCT00619866|524439400|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
145431651|NCT00619866|524439401|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
145431652|NCT00619866|524439402|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
145431653|NCT00619866|524439403|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
145431654|NCT00619866|524439404|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
145431655|NCT00619866|524439400|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
145431656|NCT00619866|524439401|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
145431657|NCT00619866|524439402|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
145431658|NCT00619866|524439403|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
145431659|NCT00619866|524439404|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
145624240|NCT02373813|525137614|FG002|Run-In Period|Adverse Event|0|||
145377457|NCT02520427|524233591|FG003|Overall Study|Decision by sponsor|0|||
145377458|NCT02520427|524233592|FG004|Overall Study|Decision by sponsor|0|||
145377459|NCT02520427|524233593|FG005|Overall Study|Decision by sponsor|0|||
145377460|NCT02520427|524233594|FG006|Overall Study|Decision by sponsor|0|||
145377461|NCT02520427|524233595|FG007|Overall Study|Decision by sponsor|0|||
145377462|NCT02520427|524233596|FG008|Overall Study|Decision by sponsor|1|||
145377463|NCT02520427|524233597|FG009|Overall Study|Decision by sponsor|1|||
145377464|NCT02520427|524233598|FG010|Overall Study|Decision by sponsor|0|||
145377465|NCT02520427|524233599|FG011|Overall Study|Decision by sponsor|0|||
145377466|NCT02520427|524233600|FG012|Overall Study|Decision by sponsor|0|||
145377467|NCT02520427|524233601|FG013|Overall Study|Decision by sponsor|0|||
145377468|NCT02520427|524233602|FG014|Overall Study|Decision by sponsor|0|||
145377469|NCT02520427|524233603|FG015|Overall Study|Decision by sponsor|0|||
145377470|NCT02520427|524233604|FG016|Overall Study|Decision by sponsor|0|||
145377471|NCT02520427|524233605|FG017|Overall Study|Decision by sponsor|0|||
145377472|NCT02520427|524233606|FG018|Overall Study|Decision by sponsor|0|||
145377473|NCT02520427|524233607|FG019|Overall Study|Decision by sponsor|0|||
145377474|NCT02520427|524233608|FG020|Overall Study|Decision by sponsor|0|||
145377475|NCT02520427|524233609|FG021|Overall Study|Decision by sponsor|0|||
145377476|NCT02520427|524233610|FG022|Overall Study|Decision by sponsor|0|||
145377477|NCT02520427|524233611|FG023|Overall Study|Decision by sponsor|0|||
145377478|NCT02520427|524233612|FG024|Overall Study|Decision by sponsor|0|||
145377479|NCT02520427|524233613|FG025|Overall Study|Decision by sponsor|0|||
145377480|NCT02520427|524233588|FG000|Overall Study|Withdrawal by Subject|0|||
145377481|NCT02520427|524233589|FG001|Overall Study|Withdrawal by Subject|0|||
145377482|NCT02520427|524233590|FG002|Overall Study|Withdrawal by Subject|1|||
145377483|NCT02520427|524233591|FG003|Overall Study|Withdrawal by Subject|0|||
145377484|NCT02520427|524233592|FG004|Overall Study|Withdrawal by Subject|0|||
145377485|NCT02520427|524233593|FG005|Overall Study|Withdrawal by Subject|0|||
145377486|NCT02520427|524233594|FG006|Overall Study|Withdrawal by Subject|0|||
145377487|NCT02520427|524233595|FG007|Overall Study|Withdrawal by Subject|0|||
145377488|NCT02520427|524233596|FG008|Overall Study|Withdrawal by Subject|0|||
145377489|NCT02520427|524233597|FG009|Overall Study|Withdrawal by Subject|0|||
145377490|NCT02520427|524233598|FG010|Overall Study|Withdrawal by Subject|0|||
145377491|NCT02520427|524233599|FG011|Overall Study|Withdrawal by Subject|0|||
145377492|NCT02520427|524233600|FG012|Overall Study|Withdrawal by Subject|1|||
145377493|NCT02520427|524233601|FG013|Overall Study|Withdrawal by Subject|1|||
145377494|NCT02520427|524233602|FG014|Overall Study|Withdrawal by Subject|1|||
145377495|NCT02520427|524233603|FG015|Overall Study|Withdrawal by Subject|0|||
145377496|NCT02520427|524233604|FG016|Overall Study|Withdrawal by Subject|1|||
145377497|NCT02520427|524233605|FG017|Overall Study|Withdrawal by Subject|0|||
145377498|NCT02520427|524233606|FG018|Overall Study|Withdrawal by Subject|0|||
145377499|NCT02520427|524233607|FG019|Overall Study|Withdrawal by Subject|3|||
145377500|NCT02520427|524233608|FG020|Overall Study|Withdrawal by Subject|2|||
145377501|NCT02520427|524233609|FG021|Overall Study|Withdrawal by Subject|0|||
145377502|NCT02520427|524233610|FG022|Overall Study|Withdrawal by Subject|0|||
145377503|NCT02520427|524233611|FG023|Overall Study|Withdrawal by Subject|0|||
145377504|NCT02520427|524233612|FG024|Overall Study|Withdrawal by Subject|0|||
145377505|NCT02520427|524233613|FG025|Overall Study|Withdrawal by Subject|0|||
145377506|NCT02520427|524233588|FG000|Overall Study|Death|1|||
145377507|NCT02520427|524233589|FG001|Overall Study|Death|0|||
145377508|NCT02520427|524233590|FG002|Overall Study|Death|0|||
145377509|NCT02520427|524233591|FG003|Overall Study|Death|0|||
145377510|NCT02520427|524233592|FG004|Overall Study|Death|0|||
145431660|NCT00619866|524439400|FG000|Weeks 1 - 12|Sponsor Decision|0|||
145624241|NCT02373813|525137615|FG003|Run-In Period|Adverse Event|0|||
145377511|NCT02520427|524233593|FG005|Overall Study|Death|0|||
145377512|NCT02520427|524233594|FG006|Overall Study|Death|0|||
145377513|NCT02520427|524233595|FG007|Overall Study|Death|0|||
145377514|NCT02520427|524233596|FG008|Overall Study|Death|0|||
145377515|NCT02520427|524233597|FG009|Overall Study|Death|0|||
145377516|NCT02520427|524233598|FG010|Overall Study|Death|0|||
145377517|NCT02520427|524233599|FG011|Overall Study|Death|0|||
145377518|NCT02520427|524233600|FG012|Overall Study|Death|0|||
145377519|NCT02520427|524233601|FG013|Overall Study|Death|0|||
145377520|NCT02520427|524233602|FG014|Overall Study|Death|0|||
145431661|NCT00619866|524439401|FG001|Weeks 1 - 12|Sponsor Decision|1|||
145431662|NCT00619866|524439402|FG002|Weeks 1 - 12|Sponsor Decision|0|||
145431663|NCT00619866|524439403|FG003|Weeks 1 - 12|Sponsor Decision|0|||
145431664|NCT00619866|524439404|FG004|Weeks 1 - 12|Sponsor Decision|0|||
145431665|NCT00619866|524439400|FG000|Weeks 13 - 24|Adverse Event|0|||
145431666|NCT00619866|524439401|FG001|Weeks 13 - 24|Adverse Event|0|||
145431667|NCT00619866|524439402|FG002|Weeks 13 - 24|Adverse Event|2|||
145431668|NCT00619866|524439403|FG003|Weeks 13 - 24|Adverse Event|1|||
145431669|NCT00619866|524439404|FG004|Weeks 13 - 24|Adverse Event|0|||
145431670|NCT00619866|524439400|FG000|Weeks 13 - 24|Protocol Deviation|0|||
145431671|NCT00619866|524439401|FG001|Weeks 13 - 24|Protocol Deviation|0|||
145431672|NCT00619866|524439402|FG002|Weeks 13 - 24|Protocol Deviation|0|||
145431673|NCT00619866|524439403|FG003|Weeks 13 - 24|Protocol Deviation|1|||
145431674|NCT00619866|524439404|FG004|Weeks 13 - 24|Protocol Deviation|0|||
145431675|NCT00619866|524439400|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
145431676|NCT00619866|524439401|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
145431677|NCT00619866|524439402|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
145431678|NCT00619866|524439403|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
145431679|NCT00619866|524439404|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
145431680|NCT00619866|524439400|FG000|Weeks 13 - 24|Non-compliance|0|||
145431681|NCT00619866|524439401|FG001|Weeks 13 - 24|Non-compliance|1|||
145431682|NCT00619866|524439402|FG002|Weeks 13 - 24|Non-compliance|1|||
145431683|NCT00619866|524439403|FG003|Weeks 13 - 24|Non-compliance|0|||
145431684|NCT00619866|524439404|FG004|Weeks 13 - 24|Non-compliance|0|||
145431685|NCT00619866|524439400|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
145431686|NCT00619866|524439401|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
145431687|NCT00619866|524439402|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
145431688|NCT00619866|524439403|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
145431689|NCT00619866|524439404|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
145431690|NCT01656161|524439405|FG000|Overall Study|Death|3|||
145431691|NCT01656161|524439405|FG000|Overall Study|Adverse Event|2|||
145431692|NCT01656161|524439405|FG000|Overall Study|Protocol Violation|1|||
145431693|NCT01656161|524439405|FG000|Overall Study|Withdrawal by Subject|1|||
145431694|NCT00776230|524439406|FG000|Overall Study|Lost to Follow-up|2|||
145431695|NCT00776230|524439407|FG001|Overall Study|Lost to Follow-up|1|||
145431696|NCT00776230|524439408|FG002|Overall Study|Lost to Follow-up|5|||
145431697|NCT00776230|524439406|FG000|Overall Study|Not vaccinated at Day 0|1|||
145431698|NCT00776230|524439407|FG001|Overall Study|Not vaccinated at Day 0|0|||
145431699|NCT00776230|524439408|FG002|Overall Study|Not vaccinated at Day 0|0|||
145431700|NCT00776230|524439406|FG000|Overall Study|Withdrawal by Subject|0|||
145431701|NCT00776230|524439407|FG001|Overall Study|Withdrawal by Subject|1|||
145431702|NCT00776230|524439408|FG002|Overall Study|Withdrawal by Subject|0|||
145431703|NCT00776230|524439406|FG000|Overall Study|Subject missed Visit 4|0|||
145431704|NCT00776230|524439407|FG001|Overall Study|Subject missed Visit 4|1|||
145431705|NCT00776230|524439408|FG002|Overall Study|Subject missed Visit 4|0|||
145431706|NCT00485173|524439409|FG000|Overall Study|Death|4|||
145431707|NCT00485173|524439410|FG001|Overall Study|Death|3|||
145431708|NCT00485173|524439409|FG000|Overall Study|Lost to Follow-up|32|||
145431709|NCT00485173|524439410|FG001|Overall Study|Lost to Follow-up|61|||
145431710|NCT00829244|524439411|FG000|Overall Study|Adverse Event|1|||
145431711|NCT00829244|524439412|FG001|Overall Study|Adverse Event|3|||
145431712|NCT00829244|524439411|FG000|Overall Study|Protocol Violation|1|||
145431713|NCT00829244|524439412|FG001|Overall Study|Protocol Violation|0|||
145431714|NCT00829244|524439411|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
145431715|NCT00829244|524439412|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
145431716|NCT00829244|524439411|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
145431717|NCT00829244|524439412|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
145431718|NCT00829244|524439411|FG000|Overall Study|No fertilization|2|||
145431719|NCT00829244|524439412|FG001|Overall Study|No fertilization|2|||
145431720|NCT00829244|524439411|FG000|Overall Study|All embryos discarded|0|||
145431721|NCT00829244|524439412|FG001|Overall Study|All embryos discarded|3|||
145431722|NCT00829244|524439411|FG000|Overall Study|No embryo cleavage|0|||
145431723|NCT00829244|524439412|FG001|Overall Study|No embryo cleavage|2|||
145431724|NCT04222673|524439413|FG000|Overall Study|Lost to Follow-up|5|||
145582396|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
145582397|NCT00116805|524984963|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
145431725|NCT03213509|524439417|FG000|Overall Study|Did not consent for verbal autopsy|4|||
145431726|NCT03213509|524439418|FG001|Overall Study|Did not consent for verbal autopsy|5|||
145431727|NCT02297412|524439419|FG000|Overall Study|Canceled|1|||
145431728|NCT02297412|524439420|FG001|Overall Study|Canceled|1|||
145431729|NCT03110562|524439421|FG000|Initial Treatment Period|Disease Progression|1|||
145431730|NCT03110562|524439422|FG001|Initial Treatment Period|Disease Progression|1|||
145431731|NCT03110562|524439423|FG002|Initial Treatment Period|Disease Progression|0|||
145431732|NCT03110562|524439424|FG003|Initial Treatment Period|Disease Progression|0|||
145431733|NCT03110562|524439421|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
145431734|NCT03110562|524439422|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
145431735|NCT03110562|524439423|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
145431736|NCT03110562|524439424|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
145431737|NCT03110562|524439421|FG000|Initial Treatment Period|Adverse Event|1|||
145431738|NCT03110562|524439422|FG001|Initial Treatment Period|Adverse Event|0|||
145431739|NCT03110562|524439423|FG002|Initial Treatment Period|Adverse Event|0|||
145431740|NCT03110562|524439424|FG003|Initial Treatment Period|Adverse Event|0|||
145431741|NCT03110562|524439421|FG000|Initial Treatment Period|Death|74|||
145431742|NCT03110562|524439422|FG001|Initial Treatment Period|Death|82|||
145431743|NCT03110562|524439423|FG002|Initial Treatment Period|Death|0|||
145431744|NCT03110562|524439424|FG003|Initial Treatment Period|Death|0|||
145431745|NCT03110562|524439421|FG000|Initial Treatment Period|Lost to Follow-up|13|||
145431746|NCT03110562|524439422|FG001|Initial Treatment Period|Lost to Follow-up|8|||
145431747|NCT03110562|524439423|FG002|Initial Treatment Period|Lost to Follow-up|0|||
145431748|NCT03110562|524439424|FG003|Initial Treatment Period|Lost to Follow-up|0|||
145431749|NCT03110562|524439421|FG000|Initial Treatment Period|Protocol Deviation|1|||
145431750|NCT03110562|524439422|FG001|Initial Treatment Period|Protocol Deviation|0|||
145431751|NCT03110562|524439423|FG002|Initial Treatment Period|Protocol Deviation|0|||
145431752|NCT03110562|524439424|FG003|Initial Treatment Period|Protocol Deviation|0|||
145431753|NCT03110562|524439421|FG000|Initial Treatment Period|Physician Decision|2|||
145431754|NCT03110562|524439422|FG001|Initial Treatment Period|Physician Decision|1|||
145431755|NCT03110562|524439423|FG002|Initial Treatment Period|Physician Decision|0|||
145431756|NCT03110562|524439424|FG003|Initial Treatment Period|Physician Decision|0|||
145431757|NCT03110562|524439421|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
145431758|NCT03110562|524439422|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
145431759|NCT03110562|524439423|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
145431760|NCT03110562|524439424|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
145431761|NCT03110562|524439421|FG000|Initial Treatment Period|Other|5|||
145431762|NCT03110562|524439422|FG001|Initial Treatment Period|Other|4|||
145431763|NCT03110562|524439423|FG002|Initial Treatment Period|Other|0|||
145431764|NCT03110562|524439424|FG003|Initial Treatment Period|Other|0|||
145431765|NCT03110562|524439421|FG000|Initial Treatment Period|Randomized but never treated|0|||
145431766|NCT03110562|524439422|FG001|Initial Treatment Period|Randomized but never treated|3|||
145431767|NCT03110562|524439423|FG002|Initial Treatment Period|Randomized but never treated|0|||
145431768|NCT03110562|524439424|FG003|Initial Treatment Period|Randomized but never treated|0|||
145431769|NCT03110562|524439421|FG000|Crossover Period|Disease Progression|0|||
145431770|NCT03110562|524439422|FG001|Crossover Period|Disease Progression|0|||
145431771|NCT03110562|524439423|FG002|Crossover Period|Disease Progression|1|||
145431772|NCT03110562|524439424|FG003|Crossover Period|Disease Progression|0|||
145582398|NCT00116805|524984964|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
145582399|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
145582400|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
145582401|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
145582402|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
145582403|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
145582404|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
145582405|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
145582406|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
145582407|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
145582408|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
145582409|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
145582410|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
145582411|NCT00116805|524984963|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
145582412|NCT00116805|524984964|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
145582413|NCT00116805|524984963|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
145582414|NCT00116805|524984964|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
145582415|NCT00116805|524984963|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
145582416|NCT00116805|524984964|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
145582417|NCT00116805|524984963|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
145582418|NCT00116805|524984964|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
145582419|NCT00116805|524984963|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
145582420|NCT00116805|524984964|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
145582421|NCT00116805|524984963|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
145582422|NCT00116805|524984964|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
145582423|NCT00116805|524984963|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
145582424|NCT00116805|524984964|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
145582425|NCT00116805|524984963|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
145582426|NCT00116805|524984964|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
145582427|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
145582428|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
145624242|NCT02373813|525137612|FG000|Run-In Period|Noncompliance|1|||
145431773|NCT03110562|524439421|FG000|Crossover Period|Withdrawal by Subject|0|||
145431774|NCT03110562|524439422|FG001|Crossover Period|Withdrawal by Subject|0|||
145431775|NCT03110562|524439423|FG002|Crossover Period|Withdrawal by Subject|8|||
145431776|NCT03110562|524439424|FG003|Crossover Period|Withdrawal by Subject|6|||
145431777|NCT03110562|524439421|FG000|Crossover Period|Death|0|||
145431778|NCT03110562|524439422|FG001|Crossover Period|Death|0|||
145431779|NCT03110562|524439423|FG002|Crossover Period|Death|37|||
145431780|NCT03110562|524439424|FG003|Crossover Period|Death|3|||
145431781|NCT03110562|524439421|FG000|Crossover Period|Lost to Follow-up|0|||
145431782|NCT03110562|524439422|FG001|Crossover Period|Lost to Follow-up|0|||
145431783|NCT03110562|524439423|FG002|Crossover Period|Lost to Follow-up|0|||
145431784|NCT03110562|524439424|FG003|Crossover Period|Lost to Follow-up|1|||
145431785|NCT03110562|524439421|FG000|Crossover Period|Other|0|||
145431786|NCT03110562|524439422|FG001|Crossover Period|Other|0|||
145431787|NCT03110562|524439423|FG002|Crossover Period|Other|1|||
145431788|NCT03110562|524439424|FG003|Crossover Period|Other|1|||
145431789|NCT03110562|524439421|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
145431790|NCT03110562|524439422|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
145431791|NCT03110562|524439423|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
145431792|NCT03110562|524439424|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
145431793|NCT03012880|524439428|FG000|Overall Study|Withdrawal by Subject|1|||
145431794|NCT03012880|524439429|FG001|Overall Study|Withdrawal by Subject|0|||
145431795|NCT03012880|524439428|FG000|Overall Study|Ineligible|1|||
145431796|NCT03012880|524439429|FG001|Overall Study|Ineligible|0|||
145431797|NCT01355627|524439430|FG000|Overall Study|Request By the Patient to Discontinue|5|||
145431798|NCT01355627|524439431|FG001|Overall Study|Request By the Patient to Discontinue|7|||
145431799|NCT01355627|524439430|FG000|Overall Study|Lost to Follow-up|8|||
145431800|NCT01355627|524439431|FG001|Overall Study|Lost to Follow-up|7|||
145431801|NCT01355627|524439430|FG000|Overall Study|Fatal Adverse Event|19|||
145431802|NCT01355627|524439431|FG001|Overall Study|Fatal Adverse Event|23|||
145431803|NCT01355627|524439430|FG000|Overall Study|Other|1|||
145431804|NCT01355627|524439431|FG001|Overall Study|Other|1|||
145431805|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
145431806|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
145431807|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
145431808|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
145431809|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
145431810|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
145431811|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
145431812|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
145431813|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
145431814|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
145431815|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
145431816|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
145431817|NCT04532749|524439432|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
145431818|NCT04532749|524439433|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
145431819|NCT04532749|524439432|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
145431820|NCT04532749|524439433|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
145431821|NCT04532749|524439432|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
145431822|NCT04532749|524439433|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
145431823|NCT04532749|524439432|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
145431824|NCT04532749|524439433|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
145431825|NCT01897493|524440762|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
145431826|NCT04388826|524440763|FG000|Overall Study|Lost to Follow-up|3|||
145431827|NCT04388826|524440764|FG001|Overall Study|Lost to Follow-up|2|||
145431828|NCT04388826|524440763|FG000|Overall Study|Adverse Event|1|||
145431829|NCT04388826|524440764|FG001|Overall Study|Adverse Event|0|||
145431830|NCT03983421|524440766|FG000|Overall Study|Lost to Follow-up|1|||
145431831|NCT03386773|524440767|FG000|Overall Study|Lost to Follow-up|24|||
145431832|NCT03386773|524440768|FG001|Overall Study|Lost to Follow-up|33|||
145431833|NCT03386773|524440767|FG000|Overall Study|Withdrawal by Subject|3|||
145431834|NCT03386773|524440768|FG001|Overall Study|Withdrawal by Subject|2|||
145431835|NCT03639610|524440769|FG000|Overall Study|Adverse Event|7|||
145431836|NCT03639610|524440770|FG001|Overall Study|Adverse Event|1|||
145431837|NCT03639610|524440771|FG002|Overall Study|Adverse Event|0|||
145431838|NCT03639610|524440769|FG000|Overall Study|Physician Decision|3|||
145431839|NCT03639610|524440770|FG001|Overall Study|Physician Decision|1|||
145582429|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
145431840|NCT03639610|524440771|FG002|Overall Study|Physician Decision|0|||
145431841|NCT03639610|524440769|FG000|Overall Study|Disease progression|8|||
145431842|NCT03639610|524440770|FG001|Overall Study|Disease progression|5|||
145431843|NCT03639610|524440771|FG002|Overall Study|Disease progression|3|||
145431844|NCT03639610|524440769|FG000|Overall Study|Study terminated by sponsor|2|||
145431845|NCT03639610|524440770|FG001|Overall Study|Study terminated by sponsor|1|||
145624243|NCT02373813|525137613|FG001|Run-In Period|Noncompliance|0|||
145624244|NCT02373813|525137614|FG002|Run-In Period|Noncompliance|0|||
145624245|NCT02373813|525137615|FG003|Run-In Period|Noncompliance|0|||
145624246|NCT02373813|525137612|FG000|Run-In Period|Ineligibility Determined|3|||
145624247|NCT02373813|525137613|FG001|Run-In Period|Ineligibility Determined|0|||
145624248|NCT02373813|525137614|FG002|Run-In Period|Ineligibility Determined|0|||
145624249|NCT02373813|525137615|FG003|Run-In Period|Ineligibility Determined|0|||
145624250|NCT02373813|525137612|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
145624251|NCT02373813|525137613|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
145624252|NCT02373813|525137614|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
145624253|NCT02373813|525137615|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
145624254|NCT02373813|525137612|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145624255|NCT02373813|525137613|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
145624256|NCT02373813|525137614|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
145624257|NCT02373813|525137615|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
145624258|NCT02373813|525137612|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145624259|NCT02373813|525137613|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
145624260|NCT02373813|525137614|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
145624261|NCT02373813|525137615|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
145624262|NCT02373813|525137612|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145624263|NCT02373813|525137613|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
145624264|NCT02373813|525137614|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
145624265|NCT02373813|525137615|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
145624266|NCT01764386|525137623|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
145624267|NCT01764386|525137624|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
145624268|NCT01764386|525137623|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
145624269|NCT01764386|525137624|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
145624270|NCT01764386|525137623|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
145624271|NCT01764386|525137624|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
145624272|NCT01764386|525137623|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
145624273|NCT01764386|525137624|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
145624274|NCT01764386|525137623|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
145624275|NCT01764386|525137624|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
145624276|NCT01764386|525137623|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
145624277|NCT01764386|525137624|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
145624278|NCT01764386|525137623|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
145624279|NCT01764386|525137624|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
145624280|NCT01764386|525137623|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
145624281|NCT01764386|525137624|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
145624282|NCT02271594|525137625|FG000|Overall Study|Study closed; recruiting failure|19|||
145624283|NCT02271594|525137626|FG001|Overall Study|Study closed; recruiting failure|12|||
145624284|NCT00495469|525137627|FG000|Overall Study|Adverse Event|0|||
145624285|NCT00495469|525137628|FG001|Overall Study|Adverse Event|1|||
145624286|NCT00495469|525137629|FG002|Overall Study|Adverse Event|3|||
145624287|NCT00495469|525137630|FG003|Overall Study|Adverse Event|0|||
145624288|NCT00495469|525137631|FG004|Overall Study|Adverse Event|1|||
145624289|NCT00495469|525137632|FG005|Overall Study|Adverse Event|1|||
145624290|NCT00495469|525137633|FG006|Overall Study|Adverse Event|1|||
145624291|NCT00495469|525137627|FG000|Overall Study|Lost to Follow-up|1|||
145624292|NCT00495469|525137628|FG001|Overall Study|Lost to Follow-up|1|||
145624293|NCT00495469|525137629|FG002|Overall Study|Lost to Follow-up|3|||
145624294|NCT00495469|525137630|FG003|Overall Study|Lost to Follow-up|1|||
145624295|NCT00495469|525137631|FG004|Overall Study|Lost to Follow-up|0|||
145624296|NCT00495469|525137632|FG005|Overall Study|Lost to Follow-up|0|||
145624297|NCT00495469|525137633|FG006|Overall Study|Lost to Follow-up|0|||
145624298|NCT00495469|525137627|FG000|Overall Study|Protocol Violation|0|||
145624299|NCT00495469|525137628|FG001|Overall Study|Protocol Violation|0|||
145624300|NCT00495469|525137629|FG002|Overall Study|Protocol Violation|0|||
145624301|NCT00495469|525137630|FG003|Overall Study|Protocol Violation|0|||
145431846|NCT03639610|524440771|FG002|Overall Study|Study terminated by sponsor|1|||
145431847|NCT03639610|524440769|FG000|Overall Study|Patient request to stop treatment|1|||
145431848|NCT03639610|524440770|FG001|Overall Study|Patient request to stop treatment|2|||
145431849|NCT03639610|524440771|FG002|Overall Study|Patient request to stop treatment|0|||
145431850|NCT02410772|524440773|FG000|Overall Study|Death|3|||
145624302|NCT00495469|525137631|FG004|Overall Study|Protocol Violation|1|||
145624303|NCT00495469|525137632|FG005|Overall Study|Protocol Violation|2|||
145624304|NCT00495469|525137633|FG006|Overall Study|Protocol Violation|0|||
145624305|NCT00495469|525137627|FG000|Overall Study|Withdrawal by Subject|5|||
145431851|NCT02410772|524440774|FG001|Overall Study|Death|4|||
145431852|NCT02410772|524440775|FG002|Overall Study|Death|8|||
145624306|NCT00495469|525137628|FG001|Overall Study|Withdrawal by Subject|3|||
145431853|NCT02410772|524440773|FG000|Overall Study|Lost to Follow-up|31|||
145377521|NCT02520427|524233603|FG015|Overall Study|Death|0|||
145377522|NCT02520427|524233604|FG016|Overall Study|Death|2|||
145377523|NCT02520427|524233605|FG017|Overall Study|Death|1|||
145377524|NCT02520427|524233606|FG018|Overall Study|Death|3|||
145377525|NCT02520427|524233607|FG019|Overall Study|Death|2|||
145377526|NCT02520427|524233608|FG020|Overall Study|Death|0|||
145377527|NCT02520427|524233609|FG021|Overall Study|Death|0|||
145377528|NCT02520427|524233610|FG022|Overall Study|Death|1|||
145377529|NCT02520427|524233611|FG023|Overall Study|Death|0|||
145377530|NCT02520427|524233612|FG024|Overall Study|Death|1|||
145377531|NCT02520427|524233613|FG025|Overall Study|Death|0|||
145377532|NCT00793624|524233614|FG000|Overall Study|Adverse Event|18|||
145377533|NCT00793624|524233615|FG001|Overall Study|Adverse Event|16|||
145377534|NCT00793624|524233616|FG002|Overall Study|Adverse Event|15|||
145377535|NCT00793624|524233617|FG003|Overall Study|Adverse Event|20|||
145377536|NCT00793624|524233614|FG000|Overall Study|Lost to Follow-up|2|||
145377537|NCT00793624|524233615|FG001|Overall Study|Lost to Follow-up|2|||
145377538|NCT00793624|524233616|FG002|Overall Study|Lost to Follow-up|4|||
145377539|NCT00793624|524233617|FG003|Overall Study|Lost to Follow-up|0|||
145377540|NCT00793624|524233614|FG000|Overall Study|Withdrawal by Subject|20|||
145377541|NCT00793624|524233615|FG001|Overall Study|Withdrawal by Subject|9|||
145377542|NCT00793624|524233616|FG002|Overall Study|Withdrawal by Subject|11|||
145377543|NCT00793624|524233617|FG003|Overall Study|Withdrawal by Subject|14|||
145377544|NCT00793624|524233614|FG000|Overall Study|Lack of Efficacy|9|||
145377545|NCT00793624|524233615|FG001|Overall Study|Lack of Efficacy|2|||
145377546|NCT00793624|524233616|FG002|Overall Study|Lack of Efficacy|1|||
145377547|NCT00793624|524233617|FG003|Overall Study|Lack of Efficacy|3|||
145377548|NCT00793624|524233614|FG000|Overall Study|Non compliance with protocol|2|||
145377549|NCT00793624|524233615|FG001|Overall Study|Non compliance with protocol|3|||
145377550|NCT00793624|524233616|FG002|Overall Study|Non compliance with protocol|2|||
145377551|NCT00793624|524233617|FG003|Overall Study|Non compliance with protocol|3|||
145377552|NCT00793624|524233614|FG000|Overall Study|Other reason not described above|6|||
145377553|NCT00793624|524233615|FG001|Overall Study|Other reason not described above|4|||
145377554|NCT00793624|524233616|FG002|Overall Study|Other reason not described above|6|||
145377555|NCT00793624|524233617|FG003|Overall Study|Other reason not described above|3|||
145377556|NCT02326298|524233620|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377557|NCT02326298|524233621|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377558|NCT02326298|524233622|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
145377559|NCT02326298|524233623|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377560|NCT02326298|524233624|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377561|NCT02326298|524233625|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377562|NCT02326298|524233626|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377563|NCT02326298|524233627|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377564|NCT02326298|524233628|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377565|NCT02326298|524233629|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377566|NCT02326298|524233630|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377567|NCT02326298|524233631|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377568|NCT02326298|524233632|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377569|NCT02326298|524233633|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
145377570|NCT02326298|524233620|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
145377571|NCT02326298|524233621|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377572|NCT02326298|524233622|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377573|NCT02326298|524233623|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377574|NCT02326298|524233624|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377575|NCT02326298|524233625|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377576|NCT02326298|524233626|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377577|NCT02326298|524233627|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377578|NCT02326298|524233628|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377579|NCT02326298|524233629|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377580|NCT02326298|524233630|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377581|NCT02326298|524233631|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377582|NCT02326298|524233632|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377583|NCT02326298|524233633|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
145377584|NCT02326298|524233620|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
145377585|NCT02326298|524233621|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
145377586|NCT02326298|524233622|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377587|NCT02326298|524233623|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377588|NCT02326298|524233624|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377589|NCT02326298|524233625|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377590|NCT02326298|524233626|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377591|NCT02326298|524233627|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377592|NCT02326298|524233628|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145431854|NCT02410772|524440774|FG001|Overall Study|Lost to Follow-up|23|||
145431855|NCT02410772|524440775|FG002|Overall Study|Lost to Follow-up|22|||
145431856|NCT02410772|524440773|FG000|Overall Study|Pregnancy|8|||
145431857|NCT02410772|524440774|FG001|Overall Study|Pregnancy|4|||
145431858|NCT02410772|524440775|FG002|Overall Study|Pregnancy|5|||
145431859|NCT02410772|524440773|FG000|Overall Study|Protocol Violation|8|||
145431860|NCT02410772|524440774|FG001|Overall Study|Protocol Violation|8|||
145431861|NCT02410772|524440775|FG002|Overall Study|Protocol Violation|4|||
145431862|NCT02410772|524440773|FG000|Overall Study|Baseline Drug Resistance|49|||
145431863|NCT02410772|524440774|FG001|Overall Study|Baseline Drug Resistance|40|||
145431864|NCT02410772|524440775|FG002|Overall Study|Baseline Drug Resistance|51|||
145431865|NCT02410772|524440773|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
145431866|NCT02410772|524440774|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
145431867|NCT02410772|524440775|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
145431868|NCT02410772|524440773|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
145431869|NCT02410772|524440774|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
145431870|NCT02410772|524440775|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
145431871|NCT01645176|524440778|FG000|Overall Study|Lack of Efficacy|4|||
145431872|NCT01645176|524440778|FG000|Overall Study|did not complete final MRI|1|||
145431873|NCT05878067|524440779|FG000|Overall Study|Lost to Follow-up|2|||
145431874|NCT00949533|524440782|FG000|Overall Study|Lost to Follow-up|0|||
145431875|NCT00949533|524440783|FG001|Overall Study|Lost to Follow-up|1|||
145431876|NCT00560417|524440786|FG000|Overall Study|Adverse Event|3|||
145431877|NCT00560417|524440787|FG001|Overall Study|Adverse Event|2|||
145431878|NCT00560417|524440786|FG000|Overall Study|Entry Criteria Not Met|1|||
145431879|NCT00560417|524440787|FG001|Overall Study|Entry Criteria Not Met|0|||
145431880|NCT00560417|524440786|FG000|Overall Study|Lost to Follow-up|0|||
145431881|NCT00560417|524440787|FG001|Overall Study|Lost to Follow-up|1|||
145431882|NCT00560417|524440786|FG000|Overall Study|Physician Decision|2|||
145431883|NCT00560417|524440787|FG001|Overall Study|Physician Decision|6|||
145431884|NCT00560417|524440786|FG000|Overall Study|Protocol Violation|6|||
145431885|NCT00560417|524440787|FG001|Overall Study|Protocol Violation|5|||
145431886|NCT00560417|524440786|FG000|Overall Study|Sponsor Decision|2|||
145431887|NCT00560417|524440787|FG001|Overall Study|Sponsor Decision|0|||
145431888|NCT00560417|524440786|FG000|Overall Study|Withdrawal by Subject|3|||
145431889|NCT00560417|524440787|FG001|Overall Study|Withdrawal by Subject|3|||
145431890|NCT00557193|524440790|FG000|Induction|Adverse Event|2|||
145431891|NCT00557193|524440791|FG001|Induction|Adverse Event|0|||
145431892|NCT00557193|524440792|FG002|Induction|Adverse Event|0|||
145431893|NCT00557193|524440793|FG003|Induction|Adverse Event|0|||
145431894|NCT00557193|524440794|FG004|Induction|Adverse Event|0|||
145431895|NCT00557193|524440795|FG005|Induction|Adverse Event|0|||
145431896|NCT00557193|524440790|FG000|Induction|Death|6|||
145431897|NCT00557193|524440791|FG001|Induction|Death|0|||
145431898|NCT00557193|524440792|FG002|Induction|Death|0|||
145431899|NCT00557193|524440793|FG003|Induction|Death|0|||
145431900|NCT00557193|524440794|FG004|Induction|Death|0|||
145431901|NCT00557193|524440795|FG005|Induction|Death|0|||
145431902|NCT00557193|524440790|FG000|Induction|Physician Decision|3|||
145431903|NCT00557193|524440791|FG001|Induction|Physician Decision|0|||
145431904|NCT00557193|524440792|FG002|Induction|Physician Decision|0|||
145431905|NCT00557193|524440793|FG003|Induction|Physician Decision|0|||
145431906|NCT00557193|524440794|FG004|Induction|Physician Decision|0|||
145431907|NCT00557193|524440795|FG005|Induction|Physician Decision|0|||
145431908|NCT00557193|524440790|FG000|Induction|Withdrawal by Subject|1|||
145431909|NCT00557193|524440791|FG001|Induction|Withdrawal by Subject|0|||
145431910|NCT00557193|524440792|FG002|Induction|Withdrawal by Subject|0|||
145431911|NCT00557193|524440793|FG003|Induction|Withdrawal by Subject|0|||
145431912|NCT00557193|524440794|FG004|Induction|Withdrawal by Subject|0|||
145431913|NCT00557193|524440795|FG005|Induction|Withdrawal by Subject|0|||
145431914|NCT00557193|524440790|FG000|Induction|Refusal of Further Protocol Therapy|2|||
145431915|NCT00557193|524440791|FG001|Induction|Refusal of Further Protocol Therapy|0|||
145431916|NCT00557193|524440792|FG002|Induction|Refusal of Further Protocol Therapy|0|||
145431917|NCT00557193|524440793|FG003|Induction|Refusal of Further Protocol Therapy|0|||
145431918|NCT00557193|524440794|FG004|Induction|Refusal of Further Protocol Therapy|0|||
145431919|NCT00557193|524440795|FG005|Induction|Refusal of Further Protocol Therapy|0|||
145431920|NCT00557193|524440790|FG000|Induction|Ineligible|8|||
145431921|NCT00557193|524440791|FG001|Induction|Ineligible|0|||
145431922|NCT00557193|524440792|FG002|Induction|Ineligible|0|||
145431923|NCT00557193|524440793|FG003|Induction|Ineligible|0|||
145431924|NCT00557193|524440794|FG004|Induction|Ineligible|0|||
145431925|NCT00557193|524440795|FG005|Induction|Ineligible|0|||
145431926|NCT00557193|524440790|FG000|Induction|Inevaluable for post Induction|2|||
145431927|NCT00557193|524440791|FG001|Induction|Inevaluable for post Induction|0|||
145431928|NCT00557193|524440792|FG002|Induction|Inevaluable for post Induction|0|||
145431929|NCT00557193|524440793|FG003|Induction|Inevaluable for post Induction|0|||
145431930|NCT00557193|524440794|FG004|Induction|Inevaluable for post Induction|0|||
145431931|NCT00557193|524440795|FG005|Induction|Inevaluable for post Induction|0|||
145431932|NCT00557193|524440790|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
145431933|NCT00557193|524440791|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145431934|NCT00557193|524440792|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145431935|NCT00557193|524440793|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145431936|NCT00557193|524440794|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145431937|NCT00557193|524440795|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
145431938|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145431939|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
145431940|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
145431941|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
145431942|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
145431943|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
145431944|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
145431945|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
145431946|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
145431947|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
145431948|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
145431949|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
145431950|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
145431951|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
145431952|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
145431953|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
145431954|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
145431955|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
145431956|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
145431957|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
145431958|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
145431959|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
145431960|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
145431961|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
145431962|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
145431963|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
145431964|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
145431965|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
145431966|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
145431967|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
145431968|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145431969|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145431970|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
145431971|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145431972|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145431973|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
145431974|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145431975|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145431976|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
145431977|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145431978|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145431979|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
145431980|NCT00557193|524440790|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145431981|NCT00557193|524440791|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145431982|NCT00557193|524440792|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
145431983|NCT00557193|524440793|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145431984|NCT00557193|524440794|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
145431985|NCT00557193|524440795|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
145431986|NCT00622726|524440796|FG000|March, 2008 to August, 2010|Death|5|||
145431987|NCT00622726|524440797|FG001|March, 2008 to August, 2010|Death|2|||
145431988|NCT00622726|524440796|FG000|August, 2010 to April, 2013|Death|1|||
145431989|NCT00622726|524440797|FG001|August, 2010 to April, 2013|Death|5|||
145431990|NCT01948427|524440798|FG000|Overall Study|Serious Adverse Event|3|||
145431991|NCT01948427|524440799|FG001|Overall Study|Serious Adverse Event|0|||
145431992|NCT01948427|524440800|FG002|Overall Study|Serious Adverse Event|0|||
145624307|NCT00495469|525137629|FG002|Overall Study|Withdrawal by Subject|1|||
145431993|NCT01948427|524440801|FG003|Overall Study|Serious Adverse Event|0|||
145624308|NCT00495469|525137630|FG003|Overall Study|Withdrawal by Subject|3|||
145624309|NCT00495469|525137631|FG004|Overall Study|Withdrawal by Subject|3|||
145431994|NCT01948427|524440802|FG004|Overall Study|Serious Adverse Event|1|||
145431995|NCT01948427|524440798|FG000|Overall Study|Investigator Request|0|||
145431996|NCT01948427|524440799|FG001|Overall Study|Investigator Request|8|||
145431997|NCT01948427|524440800|FG002|Overall Study|Investigator Request|0|||
145431998|NCT01948427|524440801|FG003|Overall Study|Investigator Request|0|||
145431999|NCT01948427|524440802|FG004|Overall Study|Investigator Request|6|||
145432000|NCT01948427|524440798|FG000|Overall Study|Lost to Follow-up|1|||
145432001|NCT01948427|524440799|FG001|Overall Study|Lost to Follow-up|0|||
145432002|NCT01948427|524440800|FG002|Overall Study|Lost to Follow-up|0|||
145432003|NCT01948427|524440801|FG003|Overall Study|Lost to Follow-up|0|||
145432004|NCT01948427|524440802|FG004|Overall Study|Lost to Follow-up|4|||
145432005|NCT01948427|524440798|FG000|Overall Study|Withdrawal by Subject|2|||
145432006|NCT01948427|524440799|FG001|Overall Study|Withdrawal by Subject|0|||
145432007|NCT01948427|524440800|FG002|Overall Study|Withdrawal by Subject|0|||
145432008|NCT01948427|524440801|FG003|Overall Study|Withdrawal by Subject|0|||
145432009|NCT01948427|524440802|FG004|Overall Study|Withdrawal by Subject|1|||
145432010|NCT01948427|524440798|FG000|Overall Study|Other, Not Specified|1|||
145432011|NCT01948427|524440799|FG001|Overall Study|Other, Not Specified|9|||
145432012|NCT01948427|524440800|FG002|Overall Study|Other, Not Specified|0|||
145432013|NCT01948427|524440801|FG003|Overall Study|Other, Not Specified|0|||
145432014|NCT01948427|524440802|FG004|Overall Study|Other, Not Specified|2|||
145432015|NCT00754572|524440803|FG000|Overall Study|Adverse Event|19|||
145432016|NCT00754572|524440803|FG000|Overall Study|Other|39|||
145582430|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
145582431|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
145582432|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
145582433|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
145582434|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
145582435|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
145582436|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
145582437|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
145582438|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
145582439|NCT00116805|524984963|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
145582440|NCT00116805|524984964|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
145582441|NCT00116805|524984963|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
145582442|NCT00116805|524984964|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
145582443|NCT00116805|524984963|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
145582444|NCT00116805|524984964|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
145582445|NCT00116805|524984963|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
145582446|NCT00116805|524984964|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
145582447|NCT00116805|524984963|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
145582448|NCT00116805|524984964|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
145582449|NCT00116805|524984963|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
145582450|NCT00116805|524984964|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
145582451|NCT00116805|524984963|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
145582452|NCT00116805|524984964|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
145582453|NCT00116805|524984963|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
145582454|NCT00116805|524984964|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
145582455|NCT00116805|524984963|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
145582456|NCT00116805|524984964|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
145582457|NCT00116805|524984963|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
145582458|NCT00116805|524984964|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
145582459|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
145582460|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
145582461|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
145582462|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
145582463|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Adverse Event|5|||
145582464|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Adverse Event|3|||
145582465|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Adverse Event|4|||
145582466|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Adverse Event|10|||
145582467|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
145582468|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
145582469|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
145582470|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
145582471|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
145432017|NCT00754572|524440803|FG000|Overall Study|Protocol Violation|3|||
145432018|NCT00754572|524440803|FG000|Overall Study|Withdrawal by Subject|3|||
145432019|NCT00754572|524440803|FG000|Overall Study|Lack of Efficacy|2|||
145432020|NCT00754572|524440803|FG000|Overall Study|Death|1|||
145432021|NCT00754572|524440803|FG000|Overall Study|Administrative Reason|3|||
145432022|NCT00754572|524440803|FG000|Overall Study|Lost to Follow-up|1|||
145432023|NCT01170663|524440804|FG000|Overall Study|Lost to Follow-up|3|||
145432024|NCT01170663|524440805|FG001|Overall Study|Lost to Follow-up|9|||
145432025|NCT01170663|524440804|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
145432026|NCT01170663|524440805|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
145432027|NCT02006927|524440808|FG000|Overall Study|Adverse Event|2|||
145432028|NCT02006927|524440808|FG000|Overall Study|Withdrawal by Subject|1|||
145432029|NCT02735200|524440809|FG000|Overall Study|Lost to Follow-up|0|||
145432030|NCT02735200|524440810|FG001|Overall Study|Lost to Follow-up|5|||
145432031|NCT02735200|524440809|FG000|Overall Study|Withdrawal by Subject|8|||
145432032|NCT02735200|524440810|FG001|Overall Study|Withdrawal by Subject|0|||
145432033|NCT02746809|524440811|FG000|Enrollment|Inclusion Exclusion not met|9|||
145432034|NCT02746809|524440811|FG000|Enrollment|Withdrawal by Subject|1|||
145432035|NCT02746809|524440811|FG000|Enrollment|Expected Enrollment Met|2|||
145432036|NCT02746809|524440811|FG000|Procedure|Death|1|||
145432037|NCT02746809|524440811|FG000|1-Month|Death|5|||
145432038|NCT02746809|524440811|FG000|6-Month|Death|2|||
145432039|NCT02746809|524440811|FG000|6-Month|Withdrawal by Subject|1|||
145432040|NCT02746809|524440811|FG000|12-Month|Death|3|||
145432041|NCT02746809|524440811|FG000|12-Month|Withdrawal by Subject|2|||
145432042|NCT02746809|524440811|FG000|24-Month|Death|1|||
145432043|NCT02746809|524440811|FG000|24-Month|Withdrawal by Subject|1|||
145432044|NCT02746809|524440811|FG000|36-Month|Death|8|||
145432045|NCT02746809|524440811|FG000|36-Month|Withdrawal by Subject|1|||
145432046|NCT02746809|524440811|FG000|48-Month|Death|7|||
145432047|NCT02746809|524440811|FG000|48-Month|Withdrawal by Subject|1|||
145432048|NCT02746809|524440811|FG000|60-Month|Death|1|||
145432049|NCT02746809|524440811|FG000|60-Month|Lost to Follow-up|2|||
145432050|NCT01164007|524440812|FG000|Overall Study|Adverse Event|5|||
145432051|NCT01164007|524440812|FG000|Overall Study|Progression of Disease|30|||
145432052|NCT01164007|524440812|FG000|Overall Study|Protocol Violation|1|||
145432053|NCT01164007|524440812|FG000|Overall Study|Withdrawal by Subject|1|||
145432054|NCT01164007|524440812|FG000|Overall Study|Medical Decision|3|||
145432055|NCT00894387|524440815|FG000|Overall Study|Adverse Event|44|||
145432056|NCT00894387|524440816|FG001|Overall Study|Adverse Event|45|||
145432057|NCT00894387|524440815|FG000|Overall Study|Abnormal Laboratory values|2|||
145582472|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
145582473|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
145582474|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
145582475|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Pregnancy|5|||
145582476|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Pregnancy|0|||
145582477|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Pregnancy|3|||
145582478|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Pregnancy|2|||
145624310|NCT00495469|525137632|FG005|Overall Study|Withdrawal by Subject|2|||
145624311|NCT00495469|525137633|FG006|Overall Study|Withdrawal by Subject|3|||
145432058|NCT00894387|524440816|FG001|Overall Study|Abnormal Laboratory values|2|||
145582479|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Non-compliance|1|||
145582480|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Non-compliance|4|||
145582481|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Non-compliance|0|||
145624312|NCT00495469|525137627|FG000|Overall Study|Lack of Efficacy|0|||
145377593|NCT02326298|524233629|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377594|NCT02326298|524233630|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377595|NCT02326298|524233631|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377596|NCT02326298|524233632|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377597|NCT02326298|524233633|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
145377598|NCT02326298|524233620|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
145377599|NCT02326298|524233621|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
145377600|NCT02326298|524233622|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377601|NCT02326298|524233623|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377602|NCT02326298|524233624|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377603|NCT02326298|524233625|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377604|NCT02326298|524233626|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145432059|NCT00894387|524440815|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145432060|NCT00894387|524440816|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145432061|NCT00894387|524440815|FG000|Overall Study|Lost to Follow-up|3|||
145432062|NCT00894387|524440816|FG001|Overall Study|Lost to Follow-up|5|||
145432063|NCT00894387|524440815|FG000|Overall Study|Administrative problems|2|||
145432064|NCT00894387|524440816|FG001|Overall Study|Administrative problems|2|||
145432065|NCT00894387|524440815|FG000|Overall Study|Death|77|||
145432066|NCT00894387|524440816|FG001|Overall Study|Death|76|||
145432067|NCT00894387|524440815|FG000|Overall Study|Protocol Deviation|4|||
145432068|NCT00894387|524440816|FG001|Overall Study|Protocol Deviation|0|||
145432069|NCT00894387|524440815|FG000|Overall Study|Patient's request|25|||
145432070|NCT00894387|524440816|FG001|Overall Study|Patient's request|30|||
145432071|NCT00894387|524440815|FG000|Overall Study|Other (Missing)|5|||
145432072|NCT00894387|524440816|FG001|Overall Study|Other (Missing)|3|||
145432073|NCT00894387|524440815|FG000|Overall Study|Mis-randomized|13|||
145432074|NCT00894387|524440816|FG001|Overall Study|Mis-randomized|9|||
145432075|NCT00894387|524440815|FG000|Overall Study|GCP non-compliance|0|||
145432076|NCT00894387|524440816|FG001|Overall Study|GCP non-compliance|2|||
145432077|NCT01977222|524440817|FG000|Overall Study|Withdrawal by Subject|1|||
145432078|NCT04165824|524440818|FG000|Overall Study|Adverse Event|23|||
145432079|NCT04165824|524440818|FG000|Overall Study|Physician Decision|1|||
145432080|NCT04165824|524440818|FG000|Overall Study|Withdrawal by Subject|17|||
145432081|NCT04165824|524440818|FG000|Overall Study|Other|5|||
145432082|NCT04403919|524440819|FG000|Overall Study|Lost to Follow-up|0|||
145432083|NCT04403919|524440820|FG001|Overall Study|Lost to Follow-up|0|||
145432084|NCT04403919|524440821|FG002|Overall Study|Lost to Follow-up|0|||
145432085|NCT04403919|524440822|FG003|Overall Study|Lost to Follow-up|1|||
145432086|NCT03746015|524440823|FG000|Overall Study|Withdrawal of Consent|1|||
145432087|NCT03746015|524440824|FG001|Overall Study|Withdrawal of Consent|0|||
145432088|NCT03746015|524440825|FG002|Overall Study|Withdrawal of Consent|0|||
145432089|NCT05448950|524440826|FG000|Overall Study|Death|2|||
145432090|NCT05448950|524440826|FG000|Overall Study|Withdrawal by Subject|1|||
145432091|NCT05448950|524440826|FG000|Overall Study|AVG abandoned|4|||
145432092|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Adverse Event|6|||
145432093|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Adverse Event|15|||
145432094|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Adverse Event|0|||
145432095|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Death|0|||
145432096|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Death|2|||
145432097|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Death|0|||
145432098|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
145432099|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
145432100|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
145432101|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
145432102|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
145432103|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
145432104|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Physician Decision|1|||
145432105|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Physician Decision|1|||
145432106|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Physician Decision|0|||
145432107|NCT02921256|524440827|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
145432108|NCT02921256|524440828|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
145432109|NCT02921256|524440829|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
145432110|NCT02921256|524440827|FG000|Arm Ib v Arm III|Adverse Event|9|||
145432111|NCT02921256|524440828|FG001|Arm Ib v Arm III|Adverse Event|0|||
145432112|NCT02921256|524440829|FG002|Arm Ib v Arm III|Adverse Event|4|||
145432113|NCT02921256|524440827|FG000|Arm Ib v Arm III|Death|1|||
145432114|NCT02921256|524440828|FG001|Arm Ib v Arm III|Death|0|||
145432115|NCT02921256|524440829|FG002|Arm Ib v Arm III|Death|1|||
145432116|NCT02921256|524440827|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
145432117|NCT02921256|524440828|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
145432118|NCT02921256|524440829|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
145432119|NCT02921256|524440827|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
145432120|NCT02921256|524440828|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
145432121|NCT02921256|524440829|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
145432122|NCT02921256|524440827|FG000|Arm Ib v Arm III|Physician Decision|4|||
145432123|NCT02921256|524440828|FG001|Arm Ib v Arm III|Physician Decision|0|||
145432124|NCT02921256|524440829|FG002|Arm Ib v Arm III|Physician Decision|1|||
145432125|NCT02921256|524440827|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
145432126|NCT02921256|524440828|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
145432127|NCT02921256|524440829|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
145432128|NCT01038323|524440831|FG000|Overall Study|Withdrawal by Subject|3|||
145432129|NCT01038323|524440832|FG001|Overall Study|Withdrawal by Subject|2|||
145432130|NCT01038323|524440833|FG002|Overall Study|Withdrawal by Subject|4|||
145432131|NCT01959932|524440834|FG000|Overall Study|Withdrawal by Subject|1|||
145432132|NCT01959932|524440835|FG001|Overall Study|Withdrawal by Subject|0|||
145432133|NCT01959932|524440836|FG002|Overall Study|Withdrawal by Subject|0|||
145432134|NCT00016354|524440843|FG000|Overall Study|Lack of Efficacy|0|||
145432135|NCT00016354|524440844|FG001|Overall Study|Lack of Efficacy|0|||
145432136|NCT00016354|524440845|FG002|Overall Study|Lack of Efficacy|0|||
145432137|NCT00016354|524440846|FG003|Overall Study|Lack of Efficacy|0|||
145432138|NCT00016354|524440847|FG004|Overall Study|Lack of Efficacy|0|||
145432139|NCT00016354|524440848|FG005|Overall Study|Lack of Efficacy|0|||
145432140|NCT00016354|524440849|FG006|Overall Study|Lack of Efficacy|0|||
145432141|NCT00016354|524440850|FG007|Overall Study|Lack of Efficacy|1|||
145432142|NCT04756531|524440855|FG000|Overall Study|Adverse Event|0|||
145432143|NCT04756531|524440856|FG001|Overall Study|Adverse Event|0|||
145432144|NCT04756531|524440857|FG002|Overall Study|Adverse Event|0|||
145432145|NCT04756531|524440858|FG003|Overall Study|Adverse Event|0|||
145432146|NCT04756531|524440859|FG004|Overall Study|Adverse Event|1|||
145432147|NCT04756531|524440860|FG005|Overall Study|Adverse Event|0|||
145432148|NCT04756531|524440861|FG006|Overall Study|Adverse Event|0|||
145432149|NCT04756531|524440862|FG007|Overall Study|Adverse Event|0|||
145432150|NCT04756531|524440863|FG008|Overall Study|Adverse Event|0|||
145432151|NCT04756531|524440864|FG009|Overall Study|Adverse Event|0|||
145582482|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Non-compliance|3|||
145377605|NCT02326298|524233627|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377606|NCT02326298|524233628|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377607|NCT02326298|524233629|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377608|NCT02326298|524233630|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377609|NCT02326298|524233631|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377610|NCT02326298|524233632|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377611|NCT02326298|524233633|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
145377612|NCT02326298|524233620|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377613|NCT02326298|524233621|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377614|NCT02326298|524233622|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
145377615|NCT02326298|524233623|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377616|NCT02326298|524233624|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377617|NCT02326298|524233625|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377618|NCT02326298|524233626|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377619|NCT02326298|524233627|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377620|NCT02326298|524233628|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377621|NCT02326298|524233629|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377622|NCT02326298|524233630|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377623|NCT02326298|524233631|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377624|NCT02326298|524233632|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377625|NCT02326298|524233633|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
145377626|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377627|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377628|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377629|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377630|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377631|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145377632|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
145377633|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145377634|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145377635|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
145377636|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377637|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145432152|NCT04756531|524440865|FG010|Overall Study|Adverse Event|0|||
145432153|NCT04756531|524440866|FG011|Overall Study|Adverse Event|0|||
145432154|NCT04756531|524440867|FG012|Overall Study|Adverse Event|0|||
145432155|NCT04756531|524440868|FG013|Overall Study|Adverse Event|0|||
145432156|NCT04756531|524440869|FG014|Overall Study|Adverse Event|0|||
145432157|NCT04756531|524440870|FG015|Overall Study|Adverse Event|0|||
145432158|NCT04756531|524440871|FG016|Overall Study|Adverse Event|0|||
145432159|NCT04756531|524440872|FG017|Overall Study|Adverse Event|0|||
145432160|NCT04756531|524440855|FG000|Overall Study|Withdrawal by Subject|0|||
145432161|NCT04756531|524440856|FG001|Overall Study|Withdrawal by Subject|0|||
145432162|NCT04756531|524440857|FG002|Overall Study|Withdrawal by Subject|0|||
145432163|NCT04756531|524440858|FG003|Overall Study|Withdrawal by Subject|0|||
145432164|NCT04756531|524440859|FG004|Overall Study|Withdrawal by Subject|0|||
145432165|NCT04756531|524440860|FG005|Overall Study|Withdrawal by Subject|0|||
145432166|NCT04756531|524440861|FG006|Overall Study|Withdrawal by Subject|1|||
145432167|NCT04756531|524440862|FG007|Overall Study|Withdrawal by Subject|0|||
145432168|NCT04756531|524440863|FG008|Overall Study|Withdrawal by Subject|0|||
145432169|NCT04756531|524440864|FG009|Overall Study|Withdrawal by Subject|0|||
145432170|NCT04756531|524440865|FG010|Overall Study|Withdrawal by Subject|0|||
145432171|NCT04756531|524440866|FG011|Overall Study|Withdrawal by Subject|0|||
145432172|NCT04756531|524440867|FG012|Overall Study|Withdrawal by Subject|0|||
145432173|NCT04756531|524440868|FG013|Overall Study|Withdrawal by Subject|0|||
145432174|NCT04756531|524440869|FG014|Overall Study|Withdrawal by Subject|0|||
145432175|NCT04756531|524440870|FG015|Overall Study|Withdrawal by Subject|0|||
145432176|NCT04756531|524440871|FG016|Overall Study|Withdrawal by Subject|0|||
145432177|NCT04756531|524440872|FG017|Overall Study|Withdrawal by Subject|0|||
145582483|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Other|0|||
145582484|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Other|3|||
145432178|NCT05643495|524440873|FG000|Overall Study|Adverse Event|0|||
145432179|NCT05643495|524440874|FG001|Overall Study|Adverse Event|1|||
145432180|NCT05643495|524440873|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145432181|NCT05643495|524440874|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
145582485|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Other|3|||
145432182|NCT02257528|524440875|FG000|Overall Study|Never received study treatment|1|||
145432183|NCT04237584|524440879|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
145432184|NCT04237584|524440880|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
145432185|NCT04237584|524440881|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
145432186|NCT04237584|524440882|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
145432187|NCT04237584|524440879|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145432188|NCT04237584|524440880|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145432189|NCT04237584|524440881|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
145432190|NCT04237584|524440882|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
145432191|NCT04237584|524440879|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145432192|NCT04237584|524440880|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145432193|NCT04237584|524440881|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
145432194|NCT04237584|524440882|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
145432195|NCT04237584|524440879|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
145432196|NCT04237584|524440880|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
145582486|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Other|1|||
145582487|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
145582488|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
145582489|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
145582490|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
145582491|NCT01760954|524984965|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
145582492|NCT01760954|524984966|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
145582493|NCT01760954|524984967|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
145582494|NCT01760954|524984968|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
145582495|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
145582496|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
145582497|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
145582498|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
145582499|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
145582500|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
145582501|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
145582502|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
145582503|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
145582504|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
145582505|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
145582506|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
145582507|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
145582508|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
145582509|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
145582510|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
145582511|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
145582512|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
145582513|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
145582514|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
145582515|NCT01760954|524984965|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
145582516|NCT01760954|524984966|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
145582517|NCT01760954|524984967|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
145582518|NCT01760954|524984968|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
145582519|NCT01159938|524984969|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
145582520|NCT01159938|524984970|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
145582521|NCT01159938|524984971|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
145582522|NCT01159938|524984972|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
145582523|NCT01159938|524984973|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
145582524|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Adverse Event|5|||
145582525|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Adverse Event|8|||
145582526|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Adverse Event|4|||
145582527|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Adverse Event|8|||
145582528|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
145582529|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
145582530|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
145582531|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
145582532|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
145582533|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
145582534|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
145432197|NCT04237584|524440881|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
145432198|NCT04237584|524440882|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
145432199|NCT04237584|524440879|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145432200|NCT04237584|524440880|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145432201|NCT04237584|524440881|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
145432202|NCT04237584|524440882|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
145432203|NCT05239221|524440883|FG000|Overall Study|Adverse Event|0|||
145432204|NCT05239221|524440884|FG001|Overall Study|Adverse Event|0|||
145432205|NCT05239221|524440885|FG002|Overall Study|Adverse Event|0|||
145432206|NCT05239221|524440886|FG003|Overall Study|Adverse Event|0|||
145432207|NCT05239221|524440887|FG004|Overall Study|Adverse Event|0|||
145432208|NCT05239221|524440888|FG005|Overall Study|Adverse Event|0|||
145432209|NCT05239221|524440889|FG006|Overall Study|Adverse Event|1|||
145432210|NCT05239221|524440890|FG007|Overall Study|Adverse Event|0|||
145432211|NCT05239221|524440891|FG008|Overall Study|Adverse Event|0|||
145432212|NCT05239221|524440892|FG009|Overall Study|Adverse Event|0|||
145432213|NCT05239221|524440893|FG010|Overall Study|Adverse Event|1|||
145432214|NCT05239221|524440894|FG011|Overall Study|Adverse Event|1|||
145432215|NCT05239221|524440895|FG012|Overall Study|Adverse Event|0|||
145432216|NCT05239221|524440896|FG013|Overall Study|Adverse Event|0|||
145432217|NCT05239221|524440897|FG014|Overall Study|Adverse Event|0|||
145432218|NCT05239221|524440898|FG015|Overall Study|Adverse Event|0|||
145432219|NCT05239221|524440883|FG000|Overall Study|Withdrawal by Subject|0|||
145432220|NCT05239221|524440884|FG001|Overall Study|Withdrawal by Subject|0|||
145432221|NCT05239221|524440885|FG002|Overall Study|Withdrawal by Subject|0|||
145432222|NCT05239221|524440886|FG003|Overall Study|Withdrawal by Subject|0|||
145432223|NCT05239221|524440887|FG004|Overall Study|Withdrawal by Subject|0|||
145432224|NCT05239221|524440888|FG005|Overall Study|Withdrawal by Subject|0|||
145432225|NCT05239221|524440889|FG006|Overall Study|Withdrawal by Subject|0|||
145432226|NCT05239221|524440890|FG007|Overall Study|Withdrawal by Subject|0|||
145432227|NCT05239221|524440891|FG008|Overall Study|Withdrawal by Subject|0|||
145432228|NCT05239221|524440892|FG009|Overall Study|Withdrawal by Subject|0|||
145432229|NCT05239221|524440893|FG010|Overall Study|Withdrawal by Subject|1|||
145432230|NCT05239221|524440894|FG011|Overall Study|Withdrawal by Subject|0|||
145432231|NCT05239221|524440895|FG012|Overall Study|Withdrawal by Subject|0|||
145377638|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377639|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
145377640|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377641|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377642|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377643|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377644|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377645|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
145377646|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
145582535|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
145582536|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Physician Decision|1|||
145582537|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Physician Decision|0|||
145582538|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Physician Decision|0|||
145582539|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Physician Decision|0|||
145582540|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
145582541|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
145582542|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
145582543|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
145582544|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Pregnancy|0|||
145582545|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Pregnancy|1|||
145582546|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Pregnancy|0|||
145582547|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Pregnancy|0|||
145377647|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377648|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
145377649|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377650|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377651|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377652|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145377653|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
145432232|NCT05239221|524440896|FG013|Overall Study|Withdrawal by Subject|0|||
145432233|NCT05239221|524440897|FG014|Overall Study|Withdrawal by Subject|0|||
145582548|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
145582549|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
145582550|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
145377654|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377655|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377656|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377657|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377658|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377659|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
145377660|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377661|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377662|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377663|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377664|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377665|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377666|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377667|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
145377668|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377669|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377670|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377671|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377672|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377673|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377674|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
145377675|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377676|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377677|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377678|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377679|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377680|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145377681|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
145432234|NCT05239221|524440898|FG015|Overall Study|Withdrawal by Subject|1|||
145432235|NCT02581930|524440899|FG000|Overall Study|Withdrawal by Subject|1|||
145432236|NCT02581930|524440899|FG000|Overall Study|patient declined further treatment|1|||
145432237|NCT01400412|524440900|FG000|Overall Study|Lost to Follow-up|4|||
145432238|NCT01400412|524440901|FG001|Overall Study|Lost to Follow-up|7|||
145432239|NCT01400412|524440900|FG000|Overall Study|Withdrawal by Subject|3|||
145432240|NCT01400412|524440901|FG001|Overall Study|Withdrawal by Subject|4|||
145432241|NCT01400412|524440900|FG000|Overall Study|Unable to complete|3|||
145432242|NCT01400412|524440901|FG001|Overall Study|Unable to complete|3|||
145432243|NCT01400412|524440900|FG000|Overall Study|Never started study treatment|0|||
145432244|NCT01400412|524440901|FG001|Overall Study|Never started study treatment|3|||
145432245|NCT04696146|524442630|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
145432246|NCT04696146|524442631|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
145432247|NCT04696146|524442630|FG000|Overall Study|Off hours issue with product|1|||
145432248|NCT04696146|524442631|FG001|Overall Study|Off hours issue with product|0|||
145432249|NCT01334918|524442634|FG000|Overall Study|Did not receive study drug|6|||
145432250|NCT01334918|524442635|FG001|Overall Study|Did not receive study drug|0|||
145432251|NCT01334918|524442634|FG000|Overall Study|Adverse Event|2|||
145432252|NCT01334918|524442635|FG001|Overall Study|Adverse Event|0|||
145432253|NCT01334918|524442634|FG000|Overall Study|Withdrawal by Subject|0|||
145432254|NCT01334918|524442635|FG001|Overall Study|Withdrawal by Subject|1|||
145432255|NCT00529633|524442636|FG000|Overall Study|Withdrawal by Subject|1|||
145432256|NCT00529633|524442637|FG001|Overall Study|Withdrawal by Subject|1|||
145432257|NCT00805389|524442642|FG000|Overall Study|Adverse Event|0|||
145432258|NCT00805389|524442643|FG001|Overall Study|Adverse Event|0|||
145432259|NCT00805389|524442644|FG002|Overall Study|Adverse Event|1|||
145432260|NCT00805389|524442645|FG003|Overall Study|Adverse Event|2|||
145432261|NCT00805389|524442646|FG004|Overall Study|Adverse Event|0|||
145432262|NCT00805389|524442642|FG000|Overall Study|Lost to Follow-up|4|||
145432263|NCT00805389|524442643|FG001|Overall Study|Lost to Follow-up|3|||
145432264|NCT00805389|524442644|FG002|Overall Study|Lost to Follow-up|6|||
145432265|NCT00805389|524442645|FG003|Overall Study|Lost to Follow-up|10|||
145432266|NCT00805389|524442646|FG004|Overall Study|Lost to Follow-up|9|||
145432267|NCT00805389|524442642|FG000|Overall Study|Protocol Violation|0|||
145432268|NCT00805389|524442643|FG001|Overall Study|Protocol Violation|0|||
145432269|NCT00805389|524442644|FG002|Overall Study|Protocol Violation|1|||
145432270|NCT00805389|524442645|FG003|Overall Study|Protocol Violation|0|||
145432271|NCT00805389|524442646|FG004|Overall Study|Protocol Violation|0|||
145432272|NCT00805389|524442642|FG000|Overall Study|Withdrawal by Subject|3|||
145432273|NCT00805389|524442643|FG001|Overall Study|Withdrawal by Subject|2|||
145432274|NCT00805389|524442644|FG002|Overall Study|Withdrawal by Subject|4|||
145432275|NCT00805389|524442645|FG003|Overall Study|Withdrawal by Subject|5|||
145432276|NCT00805389|524442646|FG004|Overall Study|Withdrawal by Subject|4|||
145432277|NCT01276704|524442647|FG000|Overall Study|Lost to Follow-up|2|||
145432278|NCT01276704|524442648|FG001|Overall Study|Lost to Follow-up|3|||
145432279|NCT01276704|524442647|FG000|Overall Study|Non-compliant|2|||
145432280|NCT01276704|524442648|FG001|Overall Study|Non-compliant|2|||
145432281|NCT01276704|524442647|FG000|Overall Study|Withdrawal by Subject|7|||
145432282|NCT01276704|524442648|FG001|Overall Study|Withdrawal by Subject|1|||
145432283|NCT01276704|524442647|FG000|Overall Study|Physician Decision|3|||
145432284|NCT01276704|524442648|FG001|Overall Study|Physician Decision|5|||
145432285|NCT01359956|524442649|FG000|Overall Study|Death|58|||
145432286|NCT01359956|524442650|FG001|Overall Study|Death|60|||
145432287|NCT01359956|524442651|FG002|Overall Study|Death|66|||
145432288|NCT01359956|524442652|FG003|Overall Study|Death|57|||
145432289|NCT01359956|524442649|FG000|Overall Study|Lost to Follow-up|3|||
145432290|NCT01359956|524442650|FG001|Overall Study|Lost to Follow-up|4|||
145432291|NCT01359956|524442651|FG002|Overall Study|Lost to Follow-up|1|||
145432292|NCT01359956|524442652|FG003|Overall Study|Lost to Follow-up|1|||
145432293|NCT01784029|524442653|FG000|Overall Study|Lost to Follow-up|19|||
145432294|NCT01784029|524442654|FG001|Overall Study|Lost to Follow-up|20|||
145432295|NCT01784029|524442655|FG002|Overall Study|Lost to Follow-up|22|||
145432296|NCT00370292|524442656|FG000|Overall Study|Disease Progression|4|||
145432297|NCT00370292|524442656|FG000|Overall Study|Adverse Event|7|||
145432298|NCT00370292|524442656|FG000|Overall Study|Physician Decision|2|||
145432299|NCT00276419|524442657|FG000|First Intervention|Adverse Event|1|||
145432300|NCT00276419|524442658|FG001|First Intervention|Adverse Event|0|||
145432301|NCT00276419|524442657|FG000|First Intervention|Withdrawal by Subject|0|||
145432302|NCT00276419|524442658|FG001|First Intervention|Withdrawal by Subject|2|||
145432303|NCT02704208|524442659|FG000|Overall Study|Lost to Follow-up|42|||
145432304|NCT02704208|524442660|FG001|Overall Study|Lost to Follow-up|37|||
145432305|NCT03801525|524442661|FG000|Overall Study|Adverse Event|17|||
145432306|NCT03801525|524442662|FG001|Overall Study|Adverse Event|1|||
145432307|NCT03801525|524442663|FG002|Overall Study|Adverse Event|0|||
145432308|NCT03801525|524442661|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
145432309|NCT03801525|524442662|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
145432310|NCT03801525|524442663|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
145432311|NCT03801525|524442661|FG000|Overall Study|Death|29|||
145432312|NCT03801525|524442662|FG001|Overall Study|Death|1|||
145432313|NCT03801525|524442663|FG002|Overall Study|Death|4|||
145432314|NCT03801525|524442661|FG000|Overall Study|Disease Progression|6|||
145432315|NCT03801525|524442662|FG001|Overall Study|Disease Progression|0|||
145377682|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377683|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377684|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377685|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377686|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377687|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377688|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377689|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
145377690|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377691|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377692|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377693|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377694|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377695|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
145377696|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377697|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377698|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377699|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377700|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377701|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377702|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
145377703|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
145377704|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377705|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377706|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377707|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377708|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145432316|NCT03801525|524442663|FG002|Overall Study|Disease Progression|1|||
145432317|NCT03801525|524442661|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
145432318|NCT03801525|524442662|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
145432319|NCT03801525|524442663|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
145377709|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
145377710|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377711|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377712|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377713|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377714|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377715|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377716|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377717|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
145377718|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377719|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377720|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377721|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377722|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377723|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
145377724|NCT02326298|524233620|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377725|NCT02326298|524233621|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377726|NCT02326298|524233622|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377727|NCT02326298|524233623|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377728|NCT02326298|524233624|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377729|NCT02326298|524233625|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
145377730|NCT02326298|524233626|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377731|NCT02326298|524233627|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377732|NCT02326298|524233628|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377733|NCT02326298|524233629|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377734|NCT02326298|524233630|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377735|NCT02326298|524233631|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377736|NCT02326298|524233632|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377737|NCT02326298|524233633|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
145377738|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
145377739|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
145377740|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
145377741|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
145377742|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
145377743|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
145377744|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
145377745|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
145377746|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
145377747|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
145377748|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
145377749|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
145377750|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
145377751|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
145377752|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377753|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377754|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377755|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377756|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377757|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377758|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377759|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377760|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377761|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377762|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377763|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
145377764|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
145377765|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
145377766|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377767|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377768|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377769|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377770|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145582551|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
145582552|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Death|0|||
145377771|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377772|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377773|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377774|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377775|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377776|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377777|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145377778|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
145377779|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
145377780|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377781|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377782|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377783|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377784|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377785|NCT02326298|524233625|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377786|NCT02326298|524233626|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377787|NCT02326298|524233627|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377788|NCT02326298|524233628|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377789|NCT02326298|524233629|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377790|NCT02326298|524233630|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377791|NCT02326298|524233631|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377792|NCT02326298|524233632|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
145377793|NCT02326298|524233633|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
145377794|NCT02326298|524233620|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377795|NCT02326298|524233621|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377796|NCT02326298|524233622|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377797|NCT02326298|524233623|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145377798|NCT02326298|524233624|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
145432320|NCT03801525|524442661|FG000|Overall Study|Investigator Decision|18|||
145432321|NCT03801525|524442662|FG001|Overall Study|Investigator Decision|1|||
145432322|NCT03801525|524442663|FG002|Overall Study|Investigator Decision|0|||
145432323|NCT03801525|524442661|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
145432324|NCT03801525|524442662|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
145432325|NCT03801525|524442663|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
145432326|NCT03801525|524442661|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
145432327|NCT03801525|524442662|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
145432328|NCT03801525|524442663|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
145432329|NCT03801525|524442661|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
145432330|NCT03801525|524442662|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
145432331|NCT03801525|524442663|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
145432332|NCT03801525|524442661|FG000|Overall Study|Withdrawal of Subject Consent|38|||
145432333|NCT03801525|524442662|FG001|Overall Study|Withdrawal of Subject Consent|2|||
145432334|NCT03801525|524442663|FG002|Overall Study|Withdrawal of Subject Consent|1|||
145432335|NCT03801525|524442661|FG000|Overall Study|Reason not Specified|4|||
145432336|NCT03801525|524442662|FG001|Overall Study|Reason not Specified|0|||
145432337|NCT03801525|524442663|FG002|Overall Study|Reason not Specified|4|||
145432338|NCT03545672|524442666|FG000|Overall Study|Uncertain diagnosis|2|||
145432339|NCT03545672|524442667|FG001|Overall Study|Uncertain diagnosis|1|||
145432340|NCT03545672|524442666|FG000|Overall Study|Protocol Violation|2|||
145432341|NCT03545672|524442667|FG001|Overall Study|Protocol Violation|2|||
145432342|NCT01628913|524442668|FG000|Overall Study|Adverse Event|12|||
145432343|NCT01628913|524442669|FG001|Overall Study|Adverse Event|5|||
145432344|NCT01628913|524442668|FG000|Overall Study|Disease Progression|11|||
145432345|NCT01628913|524442669|FG001|Overall Study|Disease Progression|14|||
145432346|NCT01628913|524442668|FG000|Overall Study|Protocol Violation|1|||
145432347|NCT01628913|524442669|FG001|Overall Study|Protocol Violation|0|||
145432348|NCT01628913|524442668|FG000|Overall Study|Death|1|||
145432349|NCT01628913|524442669|FG001|Overall Study|Death|0|||
145432350|NCT01628913|524442668|FG000|Overall Study|study terminated by Sponsor|4|||
145432351|NCT01628913|524442669|FG001|Overall Study|study terminated by Sponsor|9|||
145432352|NCT01628913|524442668|FG000|Overall Study|Withdrawal by Subject|1|||
145432353|NCT01628913|524442669|FG001|Overall Study|Withdrawal by Subject|0|||
145432354|NCT01628913|524442668|FG000|Overall Study|Physician Decision|1|||
145432355|NCT01628913|524442669|FG001|Overall Study|Physician Decision|3|||
145432356|NCT04047446|524442671|FG000|Overall Study|Physician Decision|1|||
145432357|NCT04047446|524442672|FG001|Overall Study|Physician Decision|0|||
145432358|NCT00329420|524442673|FG000|Re-induction Phase|Lack of Efficacy|0|||
145432359|NCT00329420|524442674|FG001|Re-induction Phase|Lack of Efficacy|1|||
145432360|NCT00329420|524442675|FG002|Re-induction Phase|Lack of Efficacy|0|||
145624313|NCT00495469|525137628|FG001|Overall Study|Lack of Efficacy|0|||
145624314|NCT00495469|525137629|FG002|Overall Study|Lack of Efficacy|0|||
145624315|NCT00495469|525137630|FG003|Overall Study|Lack of Efficacy|0|||
145432361|NCT00329420|524442673|FG000|Re-induction Phase|Withdrawal of Consent|0|||
145432362|NCT00329420|524442674|FG001|Re-induction Phase|Withdrawal of Consent|0|||
145432363|NCT00329420|524442675|FG002|Re-induction Phase|Withdrawal of Consent|1|||
145432364|NCT00329420|524442673|FG000|Re-induction Phase|Did not respond to re-induction|6|||
145432365|NCT00329420|524442674|FG001|Re-induction Phase|Did not respond to re-induction|5|||
145432366|NCT00329420|524442675|FG002|Re-induction Phase|Did not respond to re-induction|7|||
145432367|NCT00329420|524442673|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
145432368|NCT00329420|524442674|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
145432369|NCT00329420|524442675|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
145432370|NCT00329420|524442673|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
145432371|NCT00329420|524442674|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
145432372|NCT00329420|524442675|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
145432373|NCT00329420|524442673|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
145432374|NCT00329420|524442674|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
145432375|NCT00329420|524442675|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
145432376|NCT00892008|524442678|FG000|Overall Study|Death|5|||
145432377|NCT00892008|524442678|FG000|Overall Study|Lack of Efficacy|3|||
145432378|NCT00892008|524442678|FG000|Overall Study|Lost to Follow-up|142|||
145432379|NCT00892008|524442678|FG000|Overall Study|Other|378|||
145432380|NCT00892008|524442678|FG000|Overall Study|Adverse Event|37|||
145432381|NCT02724839|524442679|FG000|Overall Study|Withdrawal by Subject|1|||
145432382|NCT02724839|524442680|FG001|Overall Study|Withdrawal by Subject|1|||
145432383|NCT02724839|524442681|FG002|Overall Study|Withdrawal by Subject|0|||
145432384|NCT02724839|524442679|FG000|Overall Study|Lost to Follow-up|0|||
145432385|NCT02724839|524442680|FG001|Overall Study|Lost to Follow-up|3|||
145432386|NCT02724839|524442681|FG002|Overall Study|Lost to Follow-up|2|||
145432387|NCT02724839|524442679|FG000|Overall Study|Physician Decision|0|||
145432388|NCT02724839|524442680|FG001|Overall Study|Physician Decision|0|||
145432389|NCT02724839|524442681|FG002|Overall Study|Physician Decision|3|||
145432390|NCT01198587|524442683|FG000|Overall Study|Lost to Follow-up|8|||
145432391|NCT01198587|524442684|FG001|Overall Study|Lost to Follow-up|0|||
145432392|NCT01198587|524442685|FG002|Overall Study|Lost to Follow-up|9|||
145432393|NCT01198587|524442686|FG003|Overall Study|Lost to Follow-up|0|||
145432394|NCT01493089|524442687|FG000|Overall Study|Protocol Violation|2|||
145432395|NCT01493089|524442688|FG001|Overall Study|Protocol Violation|2|||
145432396|NCT01493089|524442687|FG000|Overall Study|Withdrawal by Subject|1|||
145432397|NCT01493089|524442688|FG001|Overall Study|Withdrawal by Subject|0|||
145432398|NCT01493089|524442687|FG000|Overall Study|Physician Decision|0|||
145432399|NCT01493089|524442688|FG001|Overall Study|Physician Decision|1|||
145432400|NCT01959529|524442689|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
145432401|NCT01959529|524442690|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
145432402|NCT01959529|524442689|FG000|Overall Study|Lost to Follow-up|4|||
145432403|NCT01959529|524442690|FG001|Overall Study|Lost to Follow-up|1|||
145432404|NCT01959529|524442689|FG000|Overall Study|Other|70|||
145432405|NCT01959529|524442690|FG001|Overall Study|Other|68|||
145432406|NCT01959529|524442689|FG000|Overall Study|Hypoglycaemia|1|||
145432407|NCT01959529|524442690|FG001|Overall Study|Hypoglycaemia|1|||
145432408|NCT01959529|524442689|FG000|Overall Study|Lack of glycaemic control|1|||
145432409|NCT01959529|524442690|FG001|Overall Study|Lack of glycaemic control|1|||
145432410|NCT01870869|524442691|FG000|Overall Study|Implanted with nonstudy device|1|||
145432411|NCT01870869|524442692|FG001|Overall Study|Implanted with nonstudy device|3|||
145432412|NCT01870869|524442693|FG002|Overall Study|Implanted with nonstudy device|14|||
145432413|NCT01870869|524442694|FG003|Overall Study|Implanted with nonstudy device|4|||
145582553|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Death|1|||
145582554|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Death|0|||
145582555|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Death|0|||
145582556|NCT00071487|524984979|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
145582557|NCT00071487|524984980|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
145582558|NCT00071487|524984981|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
145582559|NCT00071487|524984982|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
145624316|NCT00495469|525137631|FG004|Overall Study|Lack of Efficacy|0|||
145624317|NCT00495469|525137632|FG005|Overall Study|Lack of Efficacy|0|||
145432414|NCT01870869|524442691|FG000|Overall Study|Death|0|||
145582560|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
145624318|NCT00495469|525137633|FG006|Overall Study|Lack of Efficacy|1|||
145432415|NCT01870869|524442692|FG001|Overall Study|Death|0|||
145432416|NCT01870869|524442693|FG002|Overall Study|Death|7|||
145432417|NCT01870869|524442694|FG003|Overall Study|Death|1|||
145432418|NCT01870869|524442691|FG000|Overall Study|Subject choice|6|||
145624319|NCT00495469|525137627|FG000|Overall Study|Liver function test abnormality|0|||
145624320|NCT00495469|525137628|FG001|Overall Study|Liver function test abnormality|1|||
145432419|NCT01870869|524442692|FG001|Overall Study|Subject choice|2|||
145432420|NCT01870869|524442693|FG002|Overall Study|Subject choice|22|||
145432421|NCT01870869|524442694|FG003|Overall Study|Subject choice|8|||
145432422|NCT01870869|524442691|FG000|Overall Study|Lost to Follow-up|10|||
145432423|NCT01870869|524442692|FG001|Overall Study|Lost to Follow-up|2|||
145432424|NCT01870869|524442693|FG002|Overall Study|Lost to Follow-up|25|||
145432425|NCT01870869|524442694|FG003|Overall Study|Lost to Follow-up|3|||
145432426|NCT01870869|524442691|FG000|Overall Study|Reason not Specified|1|||
145432427|NCT01870869|524442692|FG001|Overall Study|Reason not Specified|2|||
145432428|NCT01870869|524442693|FG002|Overall Study|Reason not Specified|20|||
145432429|NCT01870869|524442694|FG003|Overall Study|Reason not Specified|4|||
145432430|NCT01870869|524442691|FG000|Overall Study|Not evaluable|10|||
145432431|NCT01870869|524442692|FG001|Overall Study|Not evaluable|5|||
145432432|NCT01870869|524442693|FG002|Overall Study|Not evaluable|42|||
145432433|NCT01870869|524442694|FG003|Overall Study|Not evaluable|10|||
145432434|NCT02448381|524442696|FG000|Overall Study|Adverse Event|2|||
145432435|NCT02448381|524442697|FG001|Overall Study|Adverse Event|0|||
145432436|NCT02448381|524442696|FG000|Overall Study|Lost to Follow-up|16|||
145432437|NCT02448381|524442697|FG001|Overall Study|Lost to Follow-up|9|||
145432438|NCT02448381|524442696|FG000|Overall Study|Physician Decision|1|||
145432439|NCT02448381|524442697|FG001|Overall Study|Physician Decision|1|||
145432440|NCT02448381|524442696|FG000|Overall Study|Pregnancy|1|||
145432441|NCT02448381|524442697|FG001|Overall Study|Pregnancy|0|||
145432442|NCT02448381|524442696|FG000|Overall Study|Withdrawal by Subject|13|||
145432443|NCT02448381|524442697|FG001|Overall Study|Withdrawal by Subject|9|||
145432444|NCT02448381|524442696|FG000|Overall Study|Noncompliance with Study Procedures|2|||
145432445|NCT02448381|524442697|FG001|Overall Study|Noncompliance with Study Procedures|0|||
145432446|NCT00335829|524442700|FG000|Overall Study|Withdrawal by Subject|1|||
145432447|NCT00335829|524442700|FG000|Overall Study|Lost to Follow-up|1|||
145432448|NCT00335829|524442700|FG000|Overall Study|Adverse Event|1|||
145432449|NCT00854360|524442701|FG000|Overall Study|Adverse Event|0|||
145432450|NCT00854360|524442702|FG001|Overall Study|Adverse Event|1|||
145432451|NCT00854360|524442703|FG002|Overall Study|Adverse Event|2|||
145432452|NCT00854360|524442704|FG003|Overall Study|Adverse Event|6|||
145432453|NCT00854360|524442701|FG000|Overall Study|Withdrawal by Subject|0|||
145432454|NCT00854360|524442702|FG001|Overall Study|Withdrawal by Subject|0|||
145432455|NCT00854360|524442703|FG002|Overall Study|Withdrawal by Subject|0|||
145432456|NCT00854360|524442704|FG003|Overall Study|Withdrawal by Subject|1|||
145432457|NCT00854360|524442701|FG000|Overall Study|Pregnancy|0|||
145432458|NCT00854360|524442702|FG001|Overall Study|Pregnancy|1|||
145432459|NCT00854360|524442703|FG002|Overall Study|Pregnancy|0|||
145432460|NCT00854360|524442704|FG003|Overall Study|Pregnancy|0|||
145432461|NCT00854360|524442701|FG000|Overall Study|Lack of Efficacy|2|||
145432462|NCT00854360|524442702|FG001|Overall Study|Lack of Efficacy|1|||
145432463|NCT00854360|524442703|FG002|Overall Study|Lack of Efficacy|0|||
145432464|NCT00854360|524442704|FG003|Overall Study|Lack of Efficacy|0|||
145432465|NCT00854360|524442701|FG000|Overall Study|Other|0|||
145432466|NCT00854360|524442702|FG001|Overall Study|Other|0|||
145432467|NCT00854360|524442703|FG002|Overall Study|Other|0|||
145432468|NCT00854360|524442704|FG003|Overall Study|Other|3|||
145432469|NCT00744861|524442710|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
145432470|NCT00744861|524442711|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
145432471|NCT00744861|524442712|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
145432472|NCT00744861|524442713|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
145432473|NCT00744861|524442710|FG000|Feasibility Stage 1|Pregnancy|0|||
145432474|NCT00744861|524442711|FG001|Feasibility Stage 1|Pregnancy|1|||
145432475|NCT00744861|524442712|FG002|Feasibility Stage 1|Pregnancy|0|||
145432476|NCT00744861|524442713|FG003|Feasibility Stage 1|Pregnancy|0|||
145432477|NCT00744861|524442710|FG000|Pivotal Stage 2|Adverse Event|0|||
145432478|NCT00744861|524442711|FG001|Pivotal Stage 2|Adverse Event|0|||
145432479|NCT00744861|524442712|FG002|Pivotal Stage 2|Adverse Event|6|||
145432480|NCT00744861|524442713|FG003|Pivotal Stage 2|Adverse Event|11|||
145432481|NCT00744861|524442710|FG000|Pivotal Stage 2|Death|0|||
145582561|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
145582562|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
145582563|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
145582564|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145582565|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145432482|NCT00744861|524442711|FG001|Pivotal Stage 2|Death|0|||
145582566|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
145432483|NCT00744861|524442712|FG002|Pivotal Stage 2|Death|0|||
145432484|NCT00744861|524442713|FG003|Pivotal Stage 2|Death|1|||
145432485|NCT00744861|524442710|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
145432486|NCT00744861|524442711|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
145432487|NCT00744861|524442712|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
145432488|NCT00744861|524442713|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
145432489|NCT00744861|524442710|FG000|Pivotal Stage 2|Physician Decision|0|||
145432490|NCT00744861|524442711|FG001|Pivotal Stage 2|Physician Decision|0|||
145432491|NCT00744861|524442712|FG002|Pivotal Stage 2|Physician Decision|3|||
145432492|NCT00744861|524442713|FG003|Pivotal Stage 2|Physician Decision|1|||
145432493|NCT00744861|524442710|FG000|Pivotal Stage 2|Protocol Violation|0|||
145624321|NCT00495469|525137629|FG002|Overall Study|Liver function test abnormality|0|||
145624322|NCT00495469|525137630|FG003|Overall Study|Liver function test abnormality|0|||
145624323|NCT00495469|525137631|FG004|Overall Study|Liver function test abnormality|0|||
145624324|NCT00495469|525137632|FG005|Overall Study|Liver function test abnormality|0|||
145624325|NCT00495469|525137633|FG006|Overall Study|Liver function test abnormality|0|||
145624326|NCT00495469|525137627|FG000|Overall Study|ST depression at randomisation in ECG|0|||
145624327|NCT00495469|525137628|FG001|Overall Study|ST depression at randomisation in ECG|1|||
145624328|NCT00495469|525137629|FG002|Overall Study|ST depression at randomisation in ECG|0|||
145624329|NCT00495469|525137630|FG003|Overall Study|ST depression at randomisation in ECG|0|||
145624330|NCT00495469|525137631|FG004|Overall Study|ST depression at randomisation in ECG|0|||
145624331|NCT00495469|525137632|FG005|Overall Study|ST depression at randomisation in ECG|0|||
145624332|NCT00495469|525137633|FG006|Overall Study|ST depression at randomisation in ECG|0|||
145624333|NCT04454567|525137634|FG000|Overall Study|Study Terminated by Sponsor|1|||
145624334|NCT04454567|525137635|FG001|Overall Study|Study Terminated by Sponsor|1|||
145624335|NCT01123161|525137637|FG000|Overall Study|Lost to Follow-up|1|||
145624336|NCT01123161|525137638|FG001|Overall Study|Lost to Follow-up|0|||
145624337|NCT01123161|525137637|FG000|Overall Study|Withdrawal by Subject|1|||
145624338|NCT01123161|525137638|FG001|Overall Study|Withdrawal by Subject|0|||
145624339|NCT00367237|525137640|FG000|Overall Study|Adverse Event|7|||
145624340|NCT00367237|525137641|FG001|Overall Study|Adverse Event|2|||
145624341|NCT00367237|525137640|FG000|Overall Study|Lost to Follow-up|1|||
145624342|NCT00367237|525137641|FG001|Overall Study|Lost to Follow-up|0|||
145624343|NCT00367237|525137640|FG000|Overall Study|Withdrawal by Subject|0|||
145624344|NCT00367237|525137641|FG001|Overall Study|Withdrawal by Subject|4|||
145624345|NCT00367237|525137640|FG000|Overall Study|Protocol Violation|2|||
145624346|NCT00367237|525137641|FG001|Overall Study|Protocol Violation|5|||
145624347|NCT01175707|525137642|FG000|Overall Study|Adverse Event|4|||
145624348|NCT01175707|525137643|FG001|Overall Study|Adverse Event|6|||
145624349|NCT03239210|525137648|FG000|Overall Study|Lost to Follow-up|2|||
145624350|NCT03239210|525137649|FG001|Overall Study|Lost to Follow-up|2|||
145624351|NCT03239210|525137648|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
145624352|NCT03239210|525137649|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
145624353|NCT03239210|525137648|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
145624354|NCT03239210|525137649|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
145624355|NCT00051311|525137654|FG000|Overall Study|Starting new study|0|||
145624356|NCT00051311|525137655|FG001|Overall Study|Starting new study|1|||
145624357|NCT00051311|525137654|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
145624358|NCT00051311|525137655|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
145624359|NCT00051311|525137654|FG000|Overall Study|Death of recipient|8|||
145624360|NCT00051311|525137655|FG001|Overall Study|Death of recipient|8|||
145624361|NCT00051311|525137654|FG000|Overall Study|Recipient taken off study|4|||
145624362|NCT00051311|525137655|FG001|Overall Study|Recipient taken off study|4|||
145624363|NCT01427907|525137656|FG000|Overall Study|Withdrawal by Subject|3|||
145624364|NCT01427907|525137657|FG001|Overall Study|Withdrawal by Subject|4|||
145624365|NCT00335153|525137658|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
145624366|NCT00335153|525137658|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
145624367|NCT00335153|525137658|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
145624368|NCT00335153|525137658|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
145624369|NCT00335153|525137658|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
145582567|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
145582568|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145582569|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145582570|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
145582571|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
145582572|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
145582573|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
145582574|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
145582575|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
145582576|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145432494|NCT00744861|524442711|FG001|Pivotal Stage 2|Protocol Violation|0|||
145432495|NCT00744861|524442712|FG002|Pivotal Stage 2|Protocol Violation|0|||
145432496|NCT00744861|524442713|FG003|Pivotal Stage 2|Protocol Violation|1|||
145432497|NCT00744861|524442710|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
145432498|NCT00744861|524442711|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
145432499|NCT00744861|524442712|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
145582577|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145582578|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
145582579|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
145582580|NCT00071487|524984979|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
145624370|NCT00335153|525137658|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
145432500|NCT00744861|524442713|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
145582581|NCT00071487|524984980|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
145582582|NCT00071487|524984981|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
145582583|NCT00071487|524984982|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
145582584|NCT02318329|524984985|FG000|Overall Study|Progressive Disease|2|||
145582585|NCT02318329|524984986|FG001|Overall Study|Progressive Disease|3|||
145582586|NCT02318329|524984987|FG002|Overall Study|Progressive Disease|2|||
145582587|NCT02318329|524984988|FG003|Overall Study|Progressive Disease|3|||
145582588|NCT02318329|524984989|FG004|Overall Study|Progressive Disease|3|||
145582589|NCT02318329|524984990|FG005|Overall Study|Progressive Disease|3|||
145582590|NCT02318329|524984991|FG006|Overall Study|Progressive Disease|1|||
145582591|NCT02318329|524984992|FG007|Overall Study|Progressive Disease|1|||
145582592|NCT02318329|524984993|FG008|Overall Study|Progressive Disease|5|||
145582593|NCT02318329|524984994|FG009|Overall Study|Progressive Disease|39|||
145582594|NCT02318329|524984985|FG000|Overall Study|Death|0|||
145582595|NCT02318329|524984986|FG001|Overall Study|Death|0|||
145582596|NCT02318329|524984987|FG002|Overall Study|Death|0|||
145582597|NCT02318329|524984988|FG003|Overall Study|Death|0|||
145582598|NCT02318329|524984989|FG004|Overall Study|Death|0|||
145582599|NCT02318329|524984990|FG005|Overall Study|Death|0|||
145582600|NCT02318329|524984991|FG006|Overall Study|Death|0|||
145582601|NCT02318329|524984992|FG007|Overall Study|Death|0|||
145582602|NCT02318329|524984993|FG008|Overall Study|Death|0|||
145582603|NCT02318329|524984994|FG009|Overall Study|Death|5|||
145582604|NCT02318329|524984985|FG000|Overall Study|Lost to Follow-up|0|||
145432501|NCT00744861|524442710|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
145432502|NCT00744861|524442711|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
145432503|NCT00744861|524442712|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
145432504|NCT00744861|524442713|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
145432505|NCT02493764|524442714|FG000|Overall Study|Adverse Event|2|||
145432506|NCT02493764|524442715|FG001|Overall Study|Adverse Event|2|||
145432507|NCT02493764|524442714|FG000|Overall Study|Death|44|||
145432508|NCT02493764|524442715|FG001|Overall Study|Death|58|||
145432509|NCT02493764|524442714|FG000|Overall Study|Lost to Follow-up|2|||
145432510|NCT02493764|524442715|FG001|Overall Study|Lost to Follow-up|1|||
145432511|NCT02493764|524442714|FG000|Overall Study|Protocol Violation|6|||
145432512|NCT02493764|524442715|FG001|Overall Study|Protocol Violation|7|||
145432513|NCT02493764|524442714|FG000|Overall Study|Physician Decision|1|||
145432514|NCT02493764|524442715|FG001|Overall Study|Physician Decision|1|||
145432515|NCT02493764|524442714|FG000|Overall Study|Participant moved|17|||
145432516|NCT02493764|524442715|FG001|Overall Study|Participant moved|5|||
145432517|NCT02493764|524442714|FG000|Overall Study|Withdrawal parent/guardian|0|||
145432518|NCT02493764|524442715|FG001|Overall Study|Withdrawal parent/guardian|1|||
145432519|NCT02493764|524442714|FG000|Overall Study|Withdrawal by Subject|11|||
145432520|NCT02493764|524442715|FG001|Overall Study|Withdrawal by Subject|7|||
145432521|NCT01561976|524442716|FG000|Period 1|Adverse Event|0|||
145432522|NCT01561976|524442717|FG001|Period 1|Adverse Event|0|||
145432523|NCT01561976|524442718|FG002|Period 1|Adverse Event|1|||
145432524|NCT01561976|524442719|FG003|Period 1|Adverse Event|0|||
145432525|NCT01561976|524442720|FG004|Period 1|Adverse Event|0|||
145432526|NCT01561976|524442721|FG005|Period 1|Adverse Event|0|||
145432527|NCT01561976|524442716|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
145432528|NCT01561976|524442717|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
145432529|NCT01561976|524442718|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
145432530|NCT01561976|524442719|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
145432531|NCT01561976|524442720|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
145432532|NCT01561976|524442721|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
145432533|NCT01561976|524442716|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145432534|NCT01561976|524442717|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145432535|NCT01561976|524442718|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145432536|NCT01561976|524442719|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145432537|NCT01561976|524442720|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
145432538|NCT01561976|524442721|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
145432539|NCT01561976|524442716|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
145432540|NCT01561976|524442717|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
145432541|NCT01561976|524442718|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
145582605|NCT02318329|524984986|FG001|Overall Study|Lost to Follow-up|0|||
145582606|NCT02318329|524984987|FG002|Overall Study|Lost to Follow-up|0|||
145582607|NCT02318329|524984988|FG003|Overall Study|Lost to Follow-up|0|||
145432542|NCT01561976|524442719|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
145432543|NCT01561976|524442720|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
145432544|NCT01561976|524442721|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
145432545|NCT01612676|524442724|FG000|Overall Study|Adverse Event|2|||
145432546|NCT01612676|524442725|FG001|Overall Study|Adverse Event|3|||
145432547|NCT01612676|524442726|FG002|Overall Study|Adverse Event|1|||
145432548|NCT01612676|524442727|FG003|Overall Study|Adverse Event|3|||
145432549|NCT01612676|524442724|FG000|Overall Study|Protocol Violation|0|||
145582608|NCT02318329|524984989|FG004|Overall Study|Lost to Follow-up|0|||
145582609|NCT02318329|524984990|FG005|Overall Study|Lost to Follow-up|0|||
145582610|NCT02318329|524984991|FG006|Overall Study|Lost to Follow-up|0|||
145432550|NCT01612676|524442725|FG001|Overall Study|Protocol Violation|1|||
145432551|NCT01612676|524442726|FG002|Overall Study|Protocol Violation|0|||
145432552|NCT01612676|524442727|FG003|Overall Study|Protocol Violation|0|||
145432553|NCT04846231|524442734|FG000|Overall Study|Lost to Follow-up|1|||
145432554|NCT04846231|524442735|FG001|Overall Study|Lost to Follow-up|0|||
145432555|NCT04846231|524442736|FG002|Overall Study|Lost to Follow-up|0|||
145432556|NCT04846231|524442737|FG003|Overall Study|Lost to Follow-up|0|||
145432557|NCT04846231|524442738|FG004|Overall Study|Lost to Follow-up|0|||
145432558|NCT04846231|524442739|FG005|Overall Study|Lost to Follow-up|0|||
145432559|NCT04846231|524442740|FG006|Overall Study|Lost to Follow-up|0|||
145432560|NCT04846231|524442741|FG007|Overall Study|Lost to Follow-up|1|||
145432561|NCT04846231|524442734|FG000|Overall Study|Withdrawal by Subject|0|||
145432562|NCT04846231|524442735|FG001|Overall Study|Withdrawal by Subject|1|||
145432563|NCT04846231|524442736|FG002|Overall Study|Withdrawal by Subject|2|||
145432564|NCT04846231|524442737|FG003|Overall Study|Withdrawal by Subject|1|||
145432565|NCT04846231|524442738|FG004|Overall Study|Withdrawal by Subject|0|||
145432566|NCT04846231|524442739|FG005|Overall Study|Withdrawal by Subject|0|||
145432567|NCT04846231|524442740|FG006|Overall Study|Withdrawal by Subject|0|||
145432568|NCT04846231|524442741|FG007|Overall Study|Withdrawal by Subject|0|||
145432569|NCT04846231|524442734|FG000|Overall Study|Protocol Violation|0|||
145432570|NCT04846231|524442735|FG001|Overall Study|Protocol Violation|1|||
145432571|NCT04846231|524442736|FG002|Overall Study|Protocol Violation|0|||
145432572|NCT04846231|524442737|FG003|Overall Study|Protocol Violation|0|||
145432573|NCT04846231|524442738|FG004|Overall Study|Protocol Violation|0|||
145432574|NCT04846231|524442739|FG005|Overall Study|Protocol Violation|0|||
145432575|NCT04846231|524442740|FG006|Overall Study|Protocol Violation|0|||
145432576|NCT04846231|524442741|FG007|Overall Study|Protocol Violation|0|||
145432577|NCT04846231|524442734|FG000|Overall Study|Adverse Event|0|||
145432578|NCT04846231|524442735|FG001|Overall Study|Adverse Event|0|||
145432579|NCT04846231|524442736|FG002|Overall Study|Adverse Event|0|||
145432580|NCT04846231|524442737|FG003|Overall Study|Adverse Event|0|||
145432581|NCT04846231|524442738|FG004|Overall Study|Adverse Event|0|||
145432582|NCT04846231|524442739|FG005|Overall Study|Adverse Event|0|||
145432583|NCT04846231|524442740|FG006|Overall Study|Adverse Event|1|||
145432584|NCT04846231|524442741|FG007|Overall Study|Adverse Event|1|||
145432585|NCT02980107|524442742|FG000|Overall Study|Withdrawal by Subject|51|||
145432586|NCT02980107|524442743|FG001|Overall Study|Withdrawal by Subject|62|||
145432587|NCT04064905|524442746|FG000|Overall Study|Lost to Follow-up|0|||
145432588|NCT04064905|524442747|FG001|Overall Study|Lost to Follow-up|3|||
145432589|NCT04064905|524442748|FG002|Overall Study|Lost to Follow-up|1|||
145432590|NCT04064905|524442749|FG003|Overall Study|Lost to Follow-up|4|||
145432591|NCT04064905|524442750|FG004|Overall Study|Lost to Follow-up|2|||
145432592|NCT00789555|524442754|FG000|Overall Study|Protocol Amendment|78|||
145432593|NCT00789555|524442755|FG001|Overall Study|Protocol Amendment|76|||
145432594|NCT00789555|524442756|FG002|Overall Study|Protocol Amendment|80|||
145432595|NCT00789555|524442754|FG000|Overall Study|Adverse Event|17|||
145432596|NCT00789555|524442755|FG001|Overall Study|Adverse Event|7|||
145432597|NCT00789555|524442756|FG002|Overall Study|Adverse Event|10|||
145432598|NCT00789555|524442754|FG000|Overall Study|Lost to Follow-up|9|||
145432599|NCT00789555|524442755|FG001|Overall Study|Lost to Follow-up|10|||
145432600|NCT00789555|524442756|FG002|Overall Study|Lost to Follow-up|18|||
145432601|NCT00789555|524442754|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
145432602|NCT00789555|524442755|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
145432603|NCT00789555|524442756|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
145432604|NCT00789555|524442754|FG000|Overall Study|Treatment failure|11|||
145432605|NCT00789555|524442755|FG001|Overall Study|Treatment failure|8|||
145432606|NCT00789555|524442756|FG002|Overall Study|Treatment failure|12|||
145432607|NCT00789555|524442754|FG000|Overall Study|Protocol Violation|6|||
145432608|NCT00789555|524442755|FG001|Overall Study|Protocol Violation|9|||
145432609|NCT00789555|524442756|FG002|Overall Study|Protocol Violation|13|||
145582611|NCT02318329|524984992|FG007|Overall Study|Lost to Follow-up|0|||
145582612|NCT02318329|524984993|FG008|Overall Study|Lost to Follow-up|0|||
145582613|NCT02318329|524984994|FG009|Overall Study|Lost to Follow-up|1|||
145582614|NCT02318329|524984985|FG000|Overall Study|Withdrawal by Subject|0|||
145432610|NCT00698841|524442757|FG000|Overall Study|Withdrawal by Subject|2|||
145432611|NCT00698841|524442757|FG000|Overall Study|Adverse Event|3|||
145432612|NCT00698841|524442757|FG000|Overall Study|Disease progression|7|||
145432613|NCT00698841|524442757|FG000|Overall Study|Failure to meet eligibility criteria|2|||
145432614|NCT00698841|524442757|FG000|Overall Study|Study drug toxicity|2|||
145432615|NCT00698841|524442757|FG000|Overall Study|Other|2|||
145432616|NCT00404248|524442758|FG000|Overall Study|pts declining status|0|||
145432617|NCT00404248|524442759|FG001|Overall Study|pts declining status|1|||
145432618|NCT00404248|524442760|FG002|Overall Study|pts declining status|0|||
145432619|NCT00404248|524442761|FG003|Overall Study|pts declining status|0|||
145432620|NCT00404248|524442762|FG004|Overall Study|pts declining status|0|||
145432621|NCT00404248|524442763|FG005|Overall Study|pts declining status|0|||
145432622|NCT00404248|524442764|FG006|Overall Study|pts declining status|0|||
145432623|NCT00404248|524442765|FG007|Overall Study|pts declining status|0|||
145582615|NCT02318329|524984986|FG001|Overall Study|Withdrawal by Subject|0|||
145582616|NCT02318329|524984987|FG002|Overall Study|Withdrawal by Subject|0|||
145582617|NCT02318329|524984988|FG003|Overall Study|Withdrawal by Subject|0|||
145582618|NCT02318329|524984989|FG004|Overall Study|Withdrawal by Subject|0|||
145582619|NCT02318329|524984990|FG005|Overall Study|Withdrawal by Subject|0|||
145582620|NCT02318329|524984991|FG006|Overall Study|Withdrawal by Subject|0|||
145582621|NCT02318329|524984992|FG007|Overall Study|Withdrawal by Subject|0|||
145582622|NCT02318329|524984993|FG008|Overall Study|Withdrawal by Subject|0|||
145582623|NCT02318329|524984994|FG009|Overall Study|Withdrawal by Subject|6|||
145582624|NCT02318329|524984985|FG000|Overall Study|Other|1|||
145582625|NCT02318329|524984986|FG001|Overall Study|Other|1|||
145582626|NCT02318329|524984987|FG002|Overall Study|Other|1|||
145582627|NCT02318329|524984988|FG003|Overall Study|Other|0|||
145582628|NCT02318329|524984989|FG004|Overall Study|Other|0|||
145582629|NCT02318329|524984990|FG005|Overall Study|Other|0|||
145582630|NCT02318329|524984991|FG006|Overall Study|Other|0|||
145582631|NCT02318329|524984992|FG007|Overall Study|Other|0|||
145582632|NCT02318329|524984993|FG008|Overall Study|Other|1|||
145582633|NCT02318329|524984994|FG009|Overall Study|Other|1|||
145582634|NCT00581945|524984997|FG000|Overall Study|Adverse Event|4|||
145582635|NCT00581945|524984998|FG001|Overall Study|Adverse Event|4|||
145582636|NCT00581945|524984997|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145582637|NCT00581945|524984998|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145582638|NCT00581945|524984997|FG000|Overall Study|Withdrawal by Subject|2|||
145582639|NCT00581945|524984998|FG001|Overall Study|Withdrawal by Subject|6|||
145582640|NCT00581945|524984997|FG000|Overall Study|Death|1|||
145582641|NCT00581945|524984998|FG001|Overall Study|Death|0|||
145582642|NCT01075321|524985005|FG000|Overall Study|Withdrawal by Subject|0|||
145582643|NCT01075321|524985006|FG001|Overall Study|Withdrawal by Subject|0|||
145582644|NCT01075321|524985007|FG002|Overall Study|Withdrawal by Subject|1|||
145582645|NCT01075321|524985008|FG003|Overall Study|Withdrawal by Subject|1|||
145582646|NCT01075321|524985005|FG000|Overall Study|Protocol Violation|0|||
145582647|NCT01075321|524985006|FG001|Overall Study|Protocol Violation|0|||
145582648|NCT01075321|524985007|FG002|Overall Study|Protocol Violation|1|||
145582649|NCT01075321|524985008|FG003|Overall Study|Protocol Violation|0|||
145582650|NCT01075321|524985005|FG000|Overall Study|Treatment Incomplete due to progression|1|||
145582651|NCT01075321|524985006|FG001|Overall Study|Treatment Incomplete due to progression|0|||
145582652|NCT01075321|524985007|FG002|Overall Study|Treatment Incomplete due to progression|0|||
145582653|NCT01075321|524985008|FG003|Overall Study|Treatment Incomplete due to progression|0|||
145582654|NCT01075321|524985005|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
145582655|NCT01075321|524985006|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
145582656|NCT01075321|524985007|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
145582657|NCT01075321|524985008|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
145582658|NCT00982020|524985009|FG000|Overall Study|Adverse Event|19|||
145582659|NCT00982020|524985010|FG001|Overall Study|Adverse Event|15|||
145582660|NCT00982020|524985009|FG000|Overall Study|Withdrawal by Subject|11|||
145582661|NCT00982020|524985010|FG001|Overall Study|Withdrawal by Subject|14|||
145582662|NCT00982020|524985009|FG000|Overall Study|Lost to Follow-up|5|||
145582663|NCT00982020|524985010|FG001|Overall Study|Lost to Follow-up|11|||
145582664|NCT00982020|524985009|FG000|Overall Study|Lack of Efficacy|10|||
145582665|NCT00982020|524985010|FG001|Overall Study|Lack of Efficacy|4|||
145582666|NCT00982020|524985009|FG000|Overall Study|Parent/Caregiver Decision|5|||
145582667|NCT00982020|524985010|FG001|Overall Study|Parent/Caregiver Decision|5|||
145582668|NCT00982020|524985009|FG000|Overall Study|Treatment Non-compliance|3|||
145582669|NCT00982020|524985010|FG001|Overall Study|Treatment Non-compliance|6|||
145582670|NCT00982020|524985009|FG000|Overall Study|Physician Decision|2|||
145582671|NCT00982020|524985010|FG001|Overall Study|Physician Decision|5|||
145582672|NCT00982020|524985009|FG000|Overall Study|Entry Criteria Not Met|2|||
145582673|NCT00982020|524985010|FG001|Overall Study|Entry Criteria Not Met|1|||
145582674|NCT00982020|524985009|FG000|Overall Study|Protocol Violation|0|||
145432624|NCT00404248|524442766|FG008|Overall Study|pts declining status|0|||
145432625|NCT04646005|524442767|FG000|Overall Study|Adverse Event|1|||
145432626|NCT04646005|524442767|FG000|Overall Study|Progressive Disease|71|||
145432627|NCT04646005|524442767|FG000|Overall Study|Death|20|||
145432628|NCT04646005|524442767|FG000|Overall Study|Withdrawal by Subject|12|||
145432629|NCT04646005|524442767|FG000|Overall Study|Sponsor Request|9|||
145432630|NCT05788991|524442768|FG000|Overall Study|Not treated with study medication|1|||
145432631|NCT05788991|524442769|FG001|Overall Study|Not treated with study medication|3|||
145432632|NCT05788991|524442768|FG000|Overall Study|Withdrawal by Subject|1|||
145432633|NCT05788991|524442769|FG001|Overall Study|Withdrawal by Subject|0|||
145432634|NCT05788991|524442768|FG000|Overall Study|Lack of Efficacy|0|||
145432635|NCT05788991|524442769|FG001|Overall Study|Lack of Efficacy|1|||
145432636|NCT05788991|524442768|FG000|Overall Study|Protocol Violation|1|||
145582675|NCT00982020|524985010|FG001|Overall Study|Protocol Violation|2|||
145582676|NCT00982020|524985009|FG000|Overall Study|Clinical Relapse|0|||
145582677|NCT00982020|524985010|FG001|Overall Study|Clinical Relapse|1|||
145582678|NCT00003457|524985013|FG000|Overall Study|Not evaluable|9|||
145582679|NCT00466193|524985014|FG000|Overall Study|Adverse Event|0|||
145582680|NCT00466193|524985015|FG001|Overall Study|Adverse Event|1|||
145432637|NCT05788991|524442769|FG001|Overall Study|Protocol Violation|2|||
145432638|NCT04464473|524442770|FG000|Overall Study|New piercing could not be removed for scanning|0|||
145432639|NCT04464473|524442771|FG001|Overall Study|New piercing could not be removed for scanning|0|||
145582681|NCT00466193|524985014|FG000|Overall Study|Lost to Follow-up|2|||
145582682|NCT00466193|524985015|FG001|Overall Study|Lost to Follow-up|4|||
145582683|NCT00466193|524985014|FG000|Overall Study|Physician Decision|1|||
145582684|NCT00466193|524985015|FG001|Overall Study|Physician Decision|0|||
145582685|NCT00466193|524985014|FG000|Overall Study|Protocol Violation|1|||
145582686|NCT00466193|524985015|FG001|Overall Study|Protocol Violation|1|||
145582687|NCT00466193|524985014|FG000|Overall Study|Withdrawal by Subject|7|||
145582688|NCT00466193|524985015|FG001|Overall Study|Withdrawal by Subject|2|||
145582689|NCT00466193|524985014|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
145582690|NCT00466193|524985015|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
145582691|NCT02246998|524985016|FG000|Overall Study|Adverse Event|0|||
145582692|NCT02246998|524985017|FG001|Overall Study|Adverse Event|1|||
145582693|NCT02246998|524985018|FG002|Overall Study|Adverse Event|1|||
145582694|NCT02246998|524985019|FG003|Overall Study|Adverse Event|0|||
145582695|NCT02246998|524985016|FG000|Overall Study|Lost to Follow-up|1|||
145582696|NCT02246998|524985017|FG001|Overall Study|Lost to Follow-up|0|||
145582697|NCT02246998|524985018|FG002|Overall Study|Lost to Follow-up|0|||
145582698|NCT02246998|524985019|FG003|Overall Study|Lost to Follow-up|1|||
145582699|NCT02246998|524985016|FG000|Overall Study|Randomized but Never Dosed|1|||
145582700|NCT02246998|524985017|FG001|Overall Study|Randomized but Never Dosed|2|||
145582701|NCT02246998|524985018|FG002|Overall Study|Randomized but Never Dosed|2|||
145582702|NCT02246998|524985019|FG003|Overall Study|Randomized but Never Dosed|1|||
145582703|NCT00353704|524985032|FG000|Overall Study|Protocol Violation|3|||
145582704|NCT00353704|524985033|FG001|Overall Study|Protocol Violation|1|||
145582705|NCT02473614|524985034|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
145582706|NCT02473614|524985035|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
145582707|NCT02525133|524985036|FG000|Overall Study|Adverse Event|0|||
145582708|NCT02525133|524985037|FG001|Overall Study|Adverse Event|1|||
145582709|NCT02525133|524985036|FG000|Overall Study|Death|0|||
145582710|NCT02525133|524985037|FG001|Overall Study|Death|1|||
145582711|NCT02525133|524985036|FG000|Overall Study|did not meet randomization criteria|1|||
145582712|NCT02525133|524985037|FG001|Overall Study|did not meet randomization criteria|0|||
145582713|NCT02525133|524985036|FG000|Overall Study|Lost to Follow-up|5|||
145582714|NCT02525133|524985037|FG001|Overall Study|Lost to Follow-up|1|||
145582715|NCT02525133|524985036|FG000|Overall Study|randomized not enrolled|3|||
145582716|NCT02525133|524985037|FG001|Overall Study|randomized not enrolled|0|||
145582717|NCT02525133|524985036|FG000|Overall Study|Withdrawal by Subject|1|||
145582718|NCT02525133|524985037|FG001|Overall Study|Withdrawal by Subject|0|||
145582719|NCT01075074|524985038|FG000|Overall Study|Surgeon changed to open incisional case|1|||
145582720|NCT01075074|524985039|FG001|Overall Study|Surgeon changed to open incisional case|2|||
145582721|NCT01075074|524985040|FG002|Overall Study|Surgeon changed to open incisional case|2|||
145582722|NCT01181921|524985042|FG000|Overall Study|Lost to Follow-up|1|||
145582723|NCT03669081|524985043|FG000|Overall Study|Data could not be validated|1|||
145582724|NCT03669081|524985044|FG001|Overall Study|Data could not be validated|1|||
145582725|NCT00389324|524985045|FG000|Run-In Phase|Adverse Event|1|||
145582726|NCT00389324|524985045|FG000|Run-In Phase|Lost to Follow-up|1|||
145582727|NCT00389324|524985045|FG000|Run-In Phase|Withdrawal by Subject|1|||
145582728|NCT00389324|524985045|FG000|Subcutaneous Phase|Adverse Event|2|||
145582729|NCT00389324|524985045|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
145582730|NCT00389324|524985045|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
145582731|NCT00389324|524985045|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
145582732|NCT02519504|524985046|FG000|Overall Study|Protocol Violation|6|||
145582733|NCT02519504|524985047|FG001|Overall Study|Protocol Violation|5|||
145582734|NCT02519504|524985046|FG000|Overall Study|Ineligible for direct testing|12|||
145582735|NCT02519504|524985047|FG001|Overall Study|Ineligible for direct testing|12|||
145582736|NCT02519504|524985046|FG000|Overall Study|Did not participate in direct testing|95|||
145582737|NCT02519504|524985047|FG001|Overall Study|Did not participate in direct testing|86|||
145582738|NCT01925183|524985050|FG000|Overall Study|Adverse Event|1|||
145582739|NCT01925183|524985051|FG001|Overall Study|Adverse Event|0|||
145582740|NCT00534352|524985054|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
145582741|NCT00534352|524985054|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
145582742|NCT00534352|524985054|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
145582743|NCT00534352|524985054|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
145582744|NCT00534352|524985054|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
145582745|NCT00534352|524985054|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
145582746|NCT00360334|524985055|FG000|Overall Study|Adverse Event|7|||
145582747|NCT00360334|524985056|FG001|Overall Study|Adverse Event|4|||
145582748|NCT00360334|524985055|FG000|Overall Study|Protocol Violation|1|||
145582749|NCT00360334|524985056|FG001|Overall Study|Protocol Violation|1|||
145582750|NCT00360334|524985055|FG000|Overall Study|Physician Decision|2|||
145582751|NCT00360334|524985056|FG001|Overall Study|Physician Decision|3|||
145582752|NCT00360334|524985055|FG000|Overall Study|Lack of Efficacy|0|||
145582753|NCT00360334|524985056|FG001|Overall Study|Lack of Efficacy|1|||
145582754|NCT00360334|524985055|FG000|Overall Study|Entry criterion not met|1|||
145582755|NCT00360334|524985056|FG001|Overall Study|Entry criterion not met|2|||
145432640|NCT04464473|524442772|FG002|Overall Study|New piercing could not be removed for scanning|0|||
145432641|NCT04464473|524442773|FG003|Overall Study|New piercing could not be removed for scanning|1|||
145432642|NCT04464473|524442774|FG004|Overall Study|New piercing could not be removed for scanning|0|||
145432643|NCT04464473|524442775|FG005|Overall Study|New piercing could not be removed for scanning|0|||
145432644|NCT04464473|524442770|FG000|Overall Study|Adverse Event|0|||
145432645|NCT04464473|524442771|FG001|Overall Study|Adverse Event|0|||
145432646|NCT04464473|524442772|FG002|Overall Study|Adverse Event|0|||
145432647|NCT04464473|524442773|FG003|Overall Study|Adverse Event|1|||
145432648|NCT04464473|524442774|FG004|Overall Study|Adverse Event|0|||
145432649|NCT04464473|524442775|FG005|Overall Study|Adverse Event|0|||
145432650|NCT04464473|524442770|FG000|Overall Study|Lost to Follow-up|0|||
145432651|NCT04464473|524442771|FG001|Overall Study|Lost to Follow-up|0|||
145432652|NCT04464473|524442772|FG002|Overall Study|Lost to Follow-up|0|||
145432653|NCT04464473|524442773|FG003|Overall Study|Lost to Follow-up|1|||
145432654|NCT04464473|524442774|FG004|Overall Study|Lost to Follow-up|0|||
145432655|NCT04464473|524442775|FG005|Overall Study|Lost to Follow-up|0|||
145432656|NCT03802396|524442776|FG000|Overall Study|Withdrawal by Subject|2|||
145432657|NCT03802396|524442777|FG001|Overall Study|Withdrawal by Subject|0|||
145432658|NCT03802396|524442776|FG000|Overall Study|Surgery Cancelled|1|||
145432659|NCT03802396|524442777|FG001|Overall Study|Surgery Cancelled|0|||
145432660|NCT01576783|524444026|FG000|Overall Study|Change in Medical Care|1|||
145432661|NCT01576783|524444027|FG001|Overall Study|Change in Medical Care|0|||
145432662|NCT01576783|524444026|FG000|Overall Study|Lost to Follow-up|14|||
145432663|NCT01576783|524444027|FG001|Overall Study|Lost to Follow-up|16|||
145432664|NCT01576783|524444026|FG000|Overall Study|Withdrawal by Subject|5|||
145432665|NCT01576783|524444027|FG001|Overall Study|Withdrawal by Subject|1|||
145432666|NCT02777086|524444029|FG000|Overall Study|Lost to Follow-up|96|||
145432667|NCT02777086|524444030|FG001|Overall Study|Lost to Follow-up|99|||
145432668|NCT01133665|524444031|FG000|Overall Study|Physician Decision|2|||
145432669|NCT01819272|524444032|FG000|Overall Study|Adverse Event|1|||
145432670|NCT01819272|524444033|FG001|Overall Study|Adverse Event|0|||
145432671|NCT01819272|524444034|FG002|Overall Study|Adverse Event|0|||
145432672|NCT01819272|524444035|FG003|Overall Study|Adverse Event|2|||
145432673|NCT01819272|524444036|FG004|Overall Study|Adverse Event|0|||
145432674|NCT01819272|524444037|FG005|Overall Study|Adverse Event|0|||
145432675|NCT01819272|524444032|FG000|Overall Study|Lost to Follow-up|3|||
145432676|NCT01819272|524444033|FG001|Overall Study|Lost to Follow-up|0|||
145432677|NCT01819272|524444034|FG002|Overall Study|Lost to Follow-up|1|||
145432678|NCT01819272|524444035|FG003|Overall Study|Lost to Follow-up|0|||
145432679|NCT01819272|524444036|FG004|Overall Study|Lost to Follow-up|0|||
145432680|NCT01819272|524444037|FG005|Overall Study|Lost to Follow-up|3|||
145432681|NCT01819272|524444032|FG000|Overall Study|Protocol Violation|0|||
145432682|NCT01819272|524444033|FG001|Overall Study|Protocol Violation|0|||
145432683|NCT01819272|524444034|FG002|Overall Study|Protocol Violation|0|||
145432684|NCT01819272|524444035|FG003|Overall Study|Protocol Violation|1|||
145432685|NCT01819272|524444036|FG004|Overall Study|Protocol Violation|2|||
145432686|NCT01819272|524444037|FG005|Overall Study|Protocol Violation|3|||
145432687|NCT01819272|524444032|FG000|Overall Study|Physician Decision|0|||
145432688|NCT01819272|524444033|FG001|Overall Study|Physician Decision|1|||
145432689|NCT01819272|524444034|FG002|Overall Study|Physician Decision|0|||
145432690|NCT01819272|524444035|FG003|Overall Study|Physician Decision|0|||
145432691|NCT01819272|524444036|FG004|Overall Study|Physician Decision|0|||
145432692|NCT01819272|524444037|FG005|Overall Study|Physician Decision|0|||
145432693|NCT01819272|524444032|FG000|Overall Study|Withdrawal of Consent|0|||
145432694|NCT01819272|524444033|FG001|Overall Study|Withdrawal of Consent|1|||
145432695|NCT01819272|524444034|FG002|Overall Study|Withdrawal of Consent|2|||
145432696|NCT01819272|524444035|FG003|Overall Study|Withdrawal of Consent|1|||
145432697|NCT01819272|524444036|FG004|Overall Study|Withdrawal of Consent|0|||
145582756|NCT00360334|524985055|FG000|Overall Study|Subject decision|8|||
145432698|NCT01819272|524444037|FG005|Overall Study|Withdrawal of Consent|1|||
145432699|NCT01819272|524444032|FG000|Overall Study|Loss of Glucose Control|2|||
145432700|NCT01819272|524444033|FG001|Overall Study|Loss of Glucose Control|1|||
145432701|NCT01819272|524444034|FG002|Overall Study|Loss of Glucose Control|0|||
145432702|NCT01819272|524444035|FG003|Overall Study|Loss of Glucose Control|1|||
145432703|NCT01819272|524444036|FG004|Overall Study|Loss of Glucose Control|2|||
145432704|NCT01819272|524444037|FG005|Overall Study|Loss of Glucose Control|0|||
145432705|NCT00560508|524444038|FG000|12 Week Double-blind Period|Adverse Event|3|||
145432706|NCT00560508|524444039|FG001|12 Week Double-blind Period|Adverse Event|2|||
145432707|NCT00560508|524444038|FG000|12 Week Double-blind Period|Protocol Violation|1|||
145432708|NCT00560508|524444039|FG001|12 Week Double-blind Period|Protocol Violation|0|||
145582757|NCT00360334|524985056|FG001|Overall Study|Subject decision|2|||
145582758|NCT01898793|524985057|FG000|Overall Study|Death|2|||
145582759|NCT01898793|524985058|FG001|Overall Study|Death|1|||
145582760|NCT01898793|524985059|FG002|Overall Study|Death|4|||
145582761|NCT01898793|524985060|FG003|Overall Study|Death|0|||
145582762|NCT01898793|524985061|FG004|Overall Study|Death|0|||
145582763|NCT01898793|524985062|FG005|Overall Study|Death|0|||
145582764|NCT01898793|524985063|FG006|Overall Study|Death|0|||
145582765|NCT02199691|524985064|FG000|Overall Study|Protocol Violation|3|||
145582766|NCT02199691|524985065|FG001|Overall Study|Protocol Violation|3|||
145582767|NCT02199691|524985066|FG002|Overall Study|Protocol Violation|6|||
145582768|NCT02199691|524985067|FG003|Overall Study|Protocol Violation|7|||
145582769|NCT02199691|524985064|FG000|Overall Study|Withdrawal by Subject|5|||
145582770|NCT02199691|524985065|FG001|Overall Study|Withdrawal by Subject|3|||
145582771|NCT02199691|524985066|FG002|Overall Study|Withdrawal by Subject|12|||
145582772|NCT02199691|524985067|FG003|Overall Study|Withdrawal by Subject|13|||
145582773|NCT02199691|524985064|FG000|Overall Study|Lost to Follow-up|2|||
145582774|NCT02199691|524985065|FG001|Overall Study|Lost to Follow-up|1|||
145582775|NCT02199691|524985066|FG002|Overall Study|Lost to Follow-up|9|||
145582776|NCT02199691|524985067|FG003|Overall Study|Lost to Follow-up|10|||
145582777|NCT00774995|524985068|FG000|Overall Study|Protocol Violation|0|||
145582778|NCT00774995|524985069|FG001|Overall Study|Protocol Violation|0|||
145582779|NCT00774995|524985070|FG002|Overall Study|Protocol Violation|1|||
145582780|NCT00774995|524985071|FG003|Overall Study|Protocol Violation|0|||
145582781|NCT01209624|524985077|FG000|Overall Study|Death|2|||
145582782|NCT01209624|524985077|FG000|Overall Study|Adverse Event|13|||
145582783|NCT01209624|524985077|FG000|Overall Study|Lack of Efficacy|17|||
145582784|NCT01209624|524985077|FG000|Overall Study|Lost to Follow-up|290|||
145582785|NCT01209624|524985077|FG000|Overall Study|Other|4|||
145582786|NCT03403634|524985082|FG000|Overall Study|Disease progression|3|||
145582787|NCT03403634|524985082|FG000|Overall Study|Did not meet eligibility criteria|4|||
145582788|NCT03964454|524985083|FG000|Overall Study|Lost to Follow-up|13|||
145582789|NCT03964454|524985084|FG001|Overall Study|Lost to Follow-up|7|||
145582790|NCT03964454|524985083|FG000|Overall Study|Withdrawal by Subject|4|||
145582791|NCT03964454|524985084|FG001|Overall Study|Withdrawal by Subject|11|||
145582792|NCT01539291|524987338|FG000|Study GS-US-312-0116|Adverse Event|9|||
145582793|NCT01539291|524987339|FG001|Study GS-US-312-0116|Adverse Event|0|||
145582794|NCT01539291|524987340|FG002|Study GS-US-312-0116|Adverse Event|0|||
145582795|NCT01539291|524987341|FG003|Study GS-US-312-0116|Adverse Event|0|||
145582796|NCT01539291|524987338|FG000|Study GS-US-312-0116|Physician Decision|1|||
145582797|NCT01539291|524987339|FG001|Study GS-US-312-0116|Physician Decision|0|||
145582798|NCT01539291|524987340|FG002|Study GS-US-312-0116|Physician Decision|0|||
145582799|NCT01539291|524987341|FG003|Study GS-US-312-0116|Physician Decision|0|||
145582800|NCT01539291|524987338|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
145582801|NCT01539291|524987339|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
145582802|NCT01539291|524987340|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
145582803|NCT01539291|524987341|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
145582804|NCT01539291|524987338|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
145582805|NCT01539291|524987339|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
145582806|NCT01539291|524987340|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
145582807|NCT01539291|524987341|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
145582808|NCT01539291|524987338|FG000|Study GS-US-312-0116|Other|1|||
145582809|NCT01539291|524987339|FG001|Study GS-US-312-0116|Other|0|||
145582810|NCT01539291|524987340|FG002|Study GS-US-312-0116|Other|0|||
145582811|NCT01539291|524987341|FG003|Study GS-US-312-0116|Other|0|||
145582812|NCT01539291|524987338|FG000|Study GS-US-312-0117|Adverse Event|22|||
145582813|NCT01539291|524987339|FG001|Study GS-US-312-0117|Adverse Event|1|||
145582814|NCT01539291|524987340|FG002|Study GS-US-312-0117|Adverse Event|9|||
145582815|NCT01539291|524987341|FG003|Study GS-US-312-0117|Adverse Event|12|||
145582816|NCT01539291|524987338|FG000|Study GS-US-312-0117|Physician Decision|9|||
145582817|NCT01539291|524987339|FG001|Study GS-US-312-0117|Physician Decision|0|||
145582818|NCT01539291|524987340|FG002|Study GS-US-312-0117|Physician Decision|6|||
145582819|NCT01539291|524987341|FG003|Study GS-US-312-0117|Physician Decision|4|||
145582820|NCT01539291|524987338|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
145582821|NCT01539291|524987339|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
145582822|NCT01539291|524987340|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
145624371|NCT00335153|525137658|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
145624372|NCT00335153|525137658|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
145582823|NCT01539291|524987341|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
145582824|NCT01539291|524987338|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
145582825|NCT01539291|524987339|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
145582826|NCT01539291|524987340|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
145582827|NCT01539291|524987341|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
145582828|NCT01539291|524987338|FG000|Study GS-US-312-0117|Other|2|||
145582829|NCT01539291|524987339|FG001|Study GS-US-312-0117|Other|1|||
145582830|NCT01539291|524987340|FG002|Study GS-US-312-0117|Other|1|||
145582831|NCT01539291|524987341|FG003|Study GS-US-312-0117|Other|1|||
145582832|NCT04450264|524987342|FG000|Overall Study|Incomplete survey|13|||
145582833|NCT04450264|524987343|FG001|Overall Study|Incomplete survey|19|||
145624373|NCT00335153|525137658|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
145624374|NCT00335153|525137658|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
145624375|NCT01818700|525137659|FG000|Overall Study|Adverse Event|67|||
145432709|NCT00560508|524444038|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
145432710|NCT00560508|524444039|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
145432711|NCT00560508|524444038|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
145432712|NCT00560508|524444039|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
145432713|NCT00560508|524444038|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
145432714|NCT00560508|524444039|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
145432715|NCT00560508|524444038|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
145432716|NCT00560508|524444039|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
145432717|NCT00560508|524444038|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
145432718|NCT00560508|524444039|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
145432719|NCT01146613|524444040|FG000|Overall Study|Lost to Follow-up|3|||
145432720|NCT01146613|524444041|FG001|Overall Study|Lost to Follow-up|8|||
145432721|NCT01146613|524444040|FG000|Overall Study|Lack of Efficacy|0|||
145432722|NCT01146613|524444041|FG001|Overall Study|Lack of Efficacy|1|||
145432723|NCT01146613|524444040|FG000|Overall Study|Death|1|||
145432724|NCT01146613|524444041|FG001|Overall Study|Death|0|||
145432725|NCT01146613|524444040|FG000|Overall Study|Physician Decision|1|||
145432726|NCT01146613|524444041|FG001|Overall Study|Physician Decision|0|||
145432727|NCT01146613|524444040|FG000|Overall Study|Withdrawal by Subject|0|||
145432728|NCT01146613|524444041|FG001|Overall Study|Withdrawal by Subject|3|||
145432729|NCT01146613|524444040|FG000|Overall Study|schedule conflict|1|||
145432730|NCT01146613|524444041|FG001|Overall Study|schedule conflict|0|||
145432731|NCT01146613|524444040|FG000|Overall Study|Outpatient detox|1|||
145432732|NCT01146613|524444041|FG001|Overall Study|Outpatient detox|0|||
145432733|NCT02164864|524444042|FG000|Overall Study|Trial disease worsening|7|||
145432734|NCT02164864|524444043|FG001|Overall Study|Trial disease worsening|5|||
145432735|NCT02164864|524444044|FG002|Overall Study|Trial disease worsening|1|||
145432736|NCT02164864|524444042|FG000|Overall Study|Other pre-existing disease worsening|6|||
145432737|NCT02164864|524444043|FG001|Overall Study|Other pre-existing disease worsening|4|||
145432738|NCT02164864|524444044|FG002|Overall Study|Other pre-existing disease worsening|9|||
145432739|NCT02164864|524444042|FG000|Overall Study|Other Adverse Event (AE)|52|||
145432740|NCT02164864|524444043|FG001|Overall Study|Other Adverse Event (AE)|32|||
145432741|NCT02164864|524444044|FG002|Overall Study|Other Adverse Event (AE)|49|||
145432742|NCT02164864|524444042|FG000|Overall Study|Protocol Violation|2|||
145432743|NCT02164864|524444043|FG001|Overall Study|Protocol Violation|4|||
145432744|NCT02164864|524444044|FG002|Overall Study|Protocol Violation|1|||
145432745|NCT02164864|524444042|FG000|Overall Study|Lost to Follow-up|4|||
145432746|NCT02164864|524444043|FG001|Overall Study|Lost to Follow-up|3|||
145432747|NCT02164864|524444044|FG002|Overall Study|Lost to Follow-up|2|||
145432748|NCT02164864|524444042|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
145432749|NCT02164864|524444043|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
145432750|NCT02164864|524444044|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
145432751|NCT02164864|524444042|FG000|Overall Study|Other than stated|3|||
145432752|NCT02164864|524444043|FG001|Overall Study|Other than stated|4|||
145432753|NCT02164864|524444044|FG002|Overall Study|Other than stated|14|||
145432754|NCT00652834|524444045|FG000|Overall Study|Withdrawal by Subject|3|||
145432755|NCT00652834|524444045|FG000|Overall Study|Lost to Follow-up|2|||
145432756|NCT00320606|524444046|FG000|Overall Study|Adverse Event|1|||
145432757|NCT00320606|524444046|FG000|Overall Study|Protocol Violation|1|||
145432758|NCT00320606|524444046|FG000|Overall Study|Withdrawal by Subject|1|||
145432759|NCT03984825|524444047|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
145432760|NCT03984825|524444047|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
145432761|NCT03984825|524444047|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
145432762|NCT02569853|524444048|FG000|Overall Study|Adverse Event|2|||
145432763|NCT02569853|524444049|FG001|Overall Study|Adverse Event|0|||
145432764|NCT02569853|524444048|FG000|Overall Study|Withdrawal by Subject|3|||
145432765|NCT02569853|524444049|FG001|Overall Study|Withdrawal by Subject|2|||
145432766|NCT02569853|524444048|FG000|Overall Study|Lost to Follow-up|3|||
145432767|NCT02569853|524444049|FG001|Overall Study|Lost to Follow-up|3|||
145624376|NCT01818700|525137659|FG000|Overall Study|Lack of Efficacy|2|||
145432768|NCT02569853|524444048|FG000|Overall Study|Protocol Violation|1|||
145432769|NCT02569853|524444049|FG001|Overall Study|Protocol Violation|1|||
145432770|NCT02569853|524444048|FG000|Overall Study|Did not experience migraine attack|10|||
145432771|NCT02569853|524444049|FG001|Overall Study|Did not experience migraine attack|7|||
145432772|NCT02569853|524444048|FG000|Overall Study|Physician Decision|1|||
145432773|NCT02569853|524444049|FG001|Overall Study|Physician Decision|1|||
145432774|NCT02271880|524444053|FG000|Overall Study|Premature discontinuation of study|3|||
145432775|NCT02271880|524444054|FG001|Overall Study|Premature discontinuation of study|4|||
145432776|NCT00474903|524444055|FG000|Overall Study|Protocol Violation|1|||
145432777|NCT00474903|524444056|FG001|Overall Study|Protocol Violation|5|||
145432778|NCT00474903|524444057|FG002|Overall Study|Protocol Violation|2|||
145624377|NCT01818700|525137659|FG000|Overall Study|Lost to Follow-up|5|||
145432779|NCT00399529|524444058|FG000|Overall Study|Off Study Prior to Treatment|2|||
145432780|NCT00742625|524444062|FG000|Remission Induction|Progression|6|||
145432781|NCT00742625|524444062|FG000|Remission Induction|Failed induction|8|||
145432782|NCT00742625|524444062|FG000|Remission Induction|Adverse Event|3|||
145432783|NCT00742625|524444062|FG000|Remission Induction|Death|10|||
145432784|NCT00742625|524444062|FG000|Remission Induction|Refusal|5|||
145432785|NCT00742625|524444062|FG000|Remission Induction|Non protocol treatment|17|||
145432786|NCT00742625|524444062|FG000|Remission Induction|Other, not specified|5|||
145432787|NCT00742625|524444062|FG000|Consolidation|Progression|5|||
145432788|NCT00742625|524444062|FG000|Consolidation|Adverse Event|1|||
145432789|NCT00742625|524444062|FG000|Consolidation|Death|1|||
145432790|NCT00742625|524444062|FG000|Consolidation|Refused|1|||
145432791|NCT00742625|524444062|FG000|Consolidation|Non protocol therapy|13|||
145432792|NCT02519842|524444063|FG000|Base Study: Cycle 1|Screening Failure|1|||
145432793|NCT02519842|524444064|FG001|Base Study: Cycle 1|Screening Failure|1|||
145432794|NCT02519842|524444065|FG002|Base Study: Cycle 1|Screening Failure|0|||
145432795|NCT02519842|524444063|FG000|Base Study: Cycle 1|Adverse Event|1|||
145432796|NCT02519842|524444064|FG001|Base Study: Cycle 1|Adverse Event|0|||
145432797|NCT02519842|524444065|FG002|Base Study: Cycle 1|Adverse Event|0|||
145432798|NCT02519842|524444063|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
145432799|NCT02519842|524444064|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
145432800|NCT02519842|524444065|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
145432801|NCT02519842|524444063|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
145432802|NCT02519842|524444064|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
145432803|NCT02519842|524444065|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
145432804|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
145432805|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
145432806|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
145432807|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
145432808|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
145432809|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
145432810|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145432811|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
145432812|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
145432813|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
145432814|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
145432815|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
145432816|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Death|0|||
145432817|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Death|0|||
145432818|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Death|1|||
145432819|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
145432820|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
145432821|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
145432822|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
145432823|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
145432824|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
145432825|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
145432826|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
145432827|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
145432828|NCT02519842|524444063|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
145432829|NCT02519842|524444064|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
145432830|NCT02519842|524444065|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
145432831|NCT01816295|524444066|FG000|Double Blind Phase|Adverse Event|11|||
145432832|NCT01816295|524444067|FG001|Double Blind Phase|Adverse Event|8|||
145432833|NCT01816295|524444066|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
145432834|NCT01816295|524444067|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
145432835|NCT01816295|524444066|FG000|Double Blind Phase|Lost to Follow-up|3|||
145432836|NCT01816295|524444067|FG001|Double Blind Phase|Lost to Follow-up|5|||
145432837|NCT01816295|524444066|FG000|Double Blind Phase|Physician Decision|2|||
145432838|NCT01816295|524444067|FG001|Double Blind Phase|Physician Decision|2|||
145432839|NCT01816295|524444066|FG000|Double Blind Phase|Protocol Violation|17|||
145432840|NCT01816295|524444067|FG001|Double Blind Phase|Protocol Violation|11|||
145432841|NCT01816295|524444066|FG000|Double Blind Phase|Sponsor Decision|8|||
145432842|NCT01816295|524444067|FG001|Double Blind Phase|Sponsor Decision|8|||
145432843|NCT01816295|524444066|FG000|Double Blind Phase|Withdrawal by Subject|22|||
145432844|NCT01816295|524444067|FG001|Double Blind Phase|Withdrawal by Subject|20|||
145432845|NCT01816295|524444066|FG000|OLE Phase|Adverse Event|17|||
145432846|NCT01816295|524444067|FG001|OLE Phase|Adverse Event|15|||
145432847|NCT01816295|524444066|FG000|OLE Phase|Death|1|||
145582834|NCT03320070|524987346|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
145582835|NCT03320070|524987347|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
145582836|NCT03320070|524987346|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
145582837|NCT03320070|524987347|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
145582838|NCT03320070|524987346|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
145582839|NCT03320070|524987347|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
145582840|NCT03320070|524987346|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
145582841|NCT03320070|524987347|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
145582842|NCT03320070|524987346|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
145582843|NCT03320070|524987347|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
145582844|NCT03320070|524987346|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
145432848|NCT01816295|524444067|FG001|OLE Phase|Death|0|||
145432849|NCT01816295|524444066|FG000|OLE Phase|Entry Criteria Not Met|3|||
145432850|NCT01816295|524444067|FG001|OLE Phase|Entry Criteria Not Met|5|||
145432851|NCT01816295|524444066|FG000|OLE Phase|Lost to Follow-up|5|||
145432852|NCT01816295|524444067|FG001|OLE Phase|Lost to Follow-up|5|||
145432853|NCT01816295|524444066|FG000|OLE Phase|Physician Decision|3|||
145432854|NCT01816295|524444067|FG001|OLE Phase|Physician Decision|1|||
145432855|NCT01816295|524444066|FG000|OLE Phase|Protocol Violation|4|||
145432856|NCT01816295|524444067|FG001|OLE Phase|Protocol Violation|4|||
145432857|NCT01816295|524444066|FG000|OLE Phase|Sponsor Decision|7|||
145432858|NCT01816295|524444067|FG001|OLE Phase|Sponsor Decision|9|||
145432859|NCT01816295|524444066|FG000|OLE Phase|Withdrawal by Subject|10|||
145432860|NCT01816295|524444067|FG001|OLE Phase|Withdrawal by Subject|10|||
145432861|NCT01816295|524444066|FG000|OLE Phase|Lack of Efficacy|3|||
145432862|NCT01816295|524444067|FG001|OLE Phase|Lack of Efficacy|7|||
145432863|NCT01156844|524444070|FG000|Overall Study|Adverse Event|0|||
145432864|NCT01156844|524444071|FG001|Overall Study|Adverse Event|0|||
145432865|NCT01156844|524444072|FG002|Overall Study|Adverse Event|1|||
145432866|NCT01156844|524444073|FG003|Overall Study|Adverse Event|1|||
145432867|NCT01156844|524444070|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145432868|NCT01156844|524444071|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145432869|NCT01156844|524444072|FG002|Overall Study|Abnormal test procedure result(s)|2|||
145432870|NCT01156844|524444073|FG003|Overall Study|Abnormal test procedure result(s)|2|||
145432871|NCT01156844|524444070|FG000|Overall Study|Withdrawal by Subject|0|||
145432872|NCT01156844|524444071|FG001|Overall Study|Withdrawal by Subject|0|||
145432873|NCT01156844|524444072|FG002|Overall Study|Withdrawal by Subject|2|||
145432874|NCT01156844|524444073|FG003|Overall Study|Withdrawal by Subject|2|||
145432875|NCT01156844|524444070|FG000|Overall Study|Lost to Follow-up|0|||
145432876|NCT01156844|524444071|FG001|Overall Study|Lost to Follow-up|0|||
145432877|NCT01156844|524444072|FG002|Overall Study|Lost to Follow-up|1|||
145432878|NCT01156844|524444073|FG003|Overall Study|Lost to Follow-up|0|||
145432879|NCT01156844|524444070|FG000|Overall Study|Administrative problems|0|||
145432880|NCT01156844|524444071|FG001|Overall Study|Administrative problems|1|||
145432881|NCT01156844|524444072|FG002|Overall Study|Administrative problems|0|||
145432882|NCT01156844|524444073|FG003|Overall Study|Administrative problems|1|||
145432883|NCT01156844|524444070|FG000|Overall Study|Protocol deviation|2|||
145432884|NCT01156844|524444071|FG001|Overall Study|Protocol deviation|0|||
145432885|NCT01156844|524444072|FG002|Overall Study|Protocol deviation|0|||
145432886|NCT01156844|524444073|FG003|Overall Study|Protocol deviation|0|||
145432887|NCT04067011|524444074|FG000|Overall Study|Not Treated|8|||
145432888|NCT04067011|524444075|FG001|Overall Study|Not Treated|7|||
145432889|NCT04067011|524444076|FG002|Overall Study|Not Treated|5|||
145432890|NCT04067011|524444074|FG000|Overall Study|Adverse Event|2|||
145432891|NCT04067011|524444075|FG001|Overall Study|Adverse Event|1|||
145432892|NCT04067011|524444076|FG002|Overall Study|Adverse Event|0|||
145432893|NCT04067011|524444074|FG000|Overall Study|Withdrawal by Subject|6|||
145432894|NCT04067011|524444075|FG001|Overall Study|Withdrawal by Subject|2|||
145432895|NCT04067011|524444076|FG002|Overall Study|Withdrawal by Subject|1|||
145432896|NCT04067011|524444074|FG000|Overall Study|Lost to Follow-up|0|||
145432897|NCT04067011|524444075|FG001|Overall Study|Lost to Follow-up|0|||
145432898|NCT04067011|524444076|FG002|Overall Study|Lost to Follow-up|1|||
145432899|NCT04067011|524444074|FG000|Overall Study|Physician Decision|1|||
145432900|NCT04067011|524444075|FG001|Overall Study|Physician Decision|1|||
145432901|NCT04067011|524444076|FG002|Overall Study|Physician Decision|0|||
145432902|NCT04067011|524444074|FG000|Overall Study|Other Reasons|2|||
145432903|NCT04067011|524444075|FG001|Overall Study|Other Reasons|0|||
145432904|NCT04067011|524444076|FG002|Overall Study|Other Reasons|1|||
145432905|NCT04067011|524444074|FG000|Overall Study|Missing|0|||
145432906|NCT04067011|524444075|FG001|Overall Study|Missing|2|||
145432907|NCT04067011|524444076|FG002|Overall Study|Missing|0|||
145432908|NCT05209386|524444077|FG000|Overall Study|Withdrawal by Subject|8|||
145624378|NCT01818700|525137659|FG000|Overall Study|Withdrawal by Subject|27|||
145624379|NCT01818700|525137659|FG000|Overall Study|Protocol Violation|2|||
145432909|NCT05209386|524444077|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
145432910|NCT05200845|524444079|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
145432911|NCT05200845|524444080|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
145624380|NCT01818700|525137659|FG000|Overall Study|Other|1|||
145432912|NCT05200845|524444081|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
145432913|NCT05200845|524444082|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
145582845|NCT03320070|524987347|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
145582846|NCT02416791|524987350|FG000|6 Months|Lost to Follow-up|0|||
145432914|NCT05200845|524444079|FG000|Overall Study|Withdrawal by Subject|0|||
145432915|NCT05200845|524444080|FG001|Overall Study|Withdrawal by Subject|1|||
145432916|NCT05200845|524444081|FG002|Overall Study|Withdrawal by Subject|1|||
145432917|NCT05200845|524444082|FG003|Overall Study|Withdrawal by Subject|0|||
145432918|NCT02412670|524444085|FG000|Overall Study|Adverse Event|4|||
145432919|NCT02412670|524444086|FG001|Overall Study|Adverse Event|1|||
145432920|NCT02412670|524444085|FG000|Overall Study|Physician Decision|1|||
145432921|NCT02412670|524444086|FG001|Overall Study|Physician Decision|0|||
145432922|NCT02412670|524444085|FG000|Overall Study|Withdrawal by Subject|1|||
145432923|NCT02412670|524444086|FG001|Overall Study|Withdrawal by Subject|0|||
145432924|NCT02412670|524444085|FG000|Overall Study|Ineligible|1|||
145432925|NCT02412670|524444086|FG001|Overall Study|Ineligible|0|||
145432926|NCT01567722|524444088|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
145432927|NCT01567722|524444089|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
145432928|NCT01567722|524444090|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
145432929|NCT01567722|524444088|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
145432930|NCT01567722|524444089|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
145432931|NCT01567722|524444090|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
145432932|NCT01567722|524444088|FG000|Overall Study|Protocol closure by the OCG|2|||
145432933|NCT01567722|524444089|FG001|Overall Study|Protocol closure by the OCG|0|||
145432934|NCT01567722|524444090|FG002|Overall Study|Protocol closure by the OCG|0|||
145432935|NCT01567722|524444088|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
145432936|NCT01567722|524444089|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
145432937|NCT01567722|524444090|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
145432938|NCT02170064|524444093|FG000|Overall Study|Withdrawal by Subject|5|||
145432939|NCT02170064|524444094|FG001|Overall Study|Withdrawal by Subject|1|||
145432940|NCT02170064|524444095|FG002|Overall Study|Withdrawal by Subject|1|||
145432941|NCT02170064|524444093|FG000|Overall Study|Physician Decision|1|||
145432942|NCT02170064|524444094|FG001|Overall Study|Physician Decision|1|||
145432943|NCT02170064|524444095|FG002|Overall Study|Physician Decision|0|||
145432944|NCT03323164|524444096|FG000|Overall Study|Poor quality imaging/scans|2|||
145432945|NCT03323164|524444097|FG001|Overall Study|Poor quality imaging/scans|2|||
145432946|NCT04211363|524444098|FG000|Overall Study|Adverse Event|5|||
145432947|NCT04211363|524444099|FG001|Overall Study|Adverse Event|2|||
145432948|NCT04211363|524444098|FG000|Overall Study|Physician Decision|0|||
145432949|NCT04211363|524444099|FG001|Overall Study|Physician Decision|1|||
145432950|NCT04211363|524444098|FG000|Overall Study|Protocol Violation|1|||
145432951|NCT04211363|524444099|FG001|Overall Study|Protocol Violation|0|||
145432952|NCT04211363|524444098|FG000|Overall Study|Pregnancy|1|||
145432953|NCT04211363|524444099|FG001|Overall Study|Pregnancy|0|||
145432954|NCT04211363|524444098|FG000|Overall Study|Lost to Follow-up|12|||
145432955|NCT04211363|524444099|FG001|Overall Study|Lost to Follow-up|4|||
145432956|NCT04211363|524444098|FG000|Overall Study|Withdrawal by Subject|11|||
145432957|NCT04211363|524444099|FG001|Overall Study|Withdrawal by Subject|11|||
145432958|NCT04211363|524444098|FG000|Overall Study|Other|1|||
145432959|NCT04211363|524444099|FG001|Overall Study|Other|2|||
145432960|NCT03961308|524444104|FG000|Overall Study|Withdrawal by Subject|1|||
145432961|NCT03961308|524444105|FG001|Overall Study|Withdrawal by Subject|0|||
145432962|NCT03961308|524444104|FG000|Overall Study|Other|1|||
145432963|NCT03961308|524444105|FG001|Overall Study|Other|0|||
145432964|NCT03961308|524444104|FG000|Overall Study|Lost to Follow-up|0|||
145432965|NCT03961308|524444105|FG001|Overall Study|Lost to Follow-up|1|||
145432966|NCT03961308|524444104|FG000|Overall Study|Adverse Event|0|||
145432967|NCT03961308|524444105|FG001|Overall Study|Adverse Event|1|||
145432968|NCT00659425|524444108|FG000|Overall Study|Disease progression|1|||
145432969|NCT00659425|524444109|FG001|Overall Study|Disease progression|0|||
145432970|NCT00659425|524444110|FG002|Overall Study|Disease progression|0|||
145582847|NCT02416791|524987351|FG001|6 Months|Lost to Follow-up|0|||
145582848|NCT02416791|524987352|FG002|6 Months|Lost to Follow-up|1|||
145582849|NCT01054729|524987353|FG000|Overall Study|Randomized but Not Treated|0|||
145582850|NCT01054729|524987354|FG001|Overall Study|Randomized but Not Treated|1|||
145582851|NCT01054729|524987355|FG002|Overall Study|Randomized but Not Treated|0|||
145582852|NCT01054729|524987356|FG003|Overall Study|Randomized but Not Treated|0|||
145432971|NCT00659425|524444111|FG003|Overall Study|Disease progression|1|||
145432972|NCT00659425|524444112|FG004|Overall Study|Disease progression|0|||
145432973|NCT00659425|524444113|FG005|Overall Study|Disease progression|2|||
145432974|NCT00659425|524444114|FG006|Overall Study|Disease progression|4|||
145582853|NCT01054729|524987353|FG000|Overall Study|Adverse Event|1|||
145432975|NCT00659425|524444115|FG007|Overall Study|Disease progression|3|||
145432976|NCT00659425|524444116|FG008|Overall Study|Disease progression|5|||
145432977|NCT00659425|524444117|FG009|Overall Study|Disease progression|3|||
145432978|NCT00659425|524444108|FG000|Overall Study|Death|0|||
145432979|NCT00659425|524444109|FG001|Overall Study|Death|0|||
145432980|NCT00659425|524444110|FG002|Overall Study|Death|0|||
145432981|NCT00659425|524444111|FG003|Overall Study|Death|1|||
145432982|NCT00659425|524444112|FG004|Overall Study|Death|0|||
145432983|NCT00659425|524444113|FG005|Overall Study|Death|0|||
145432984|NCT00659425|524444114|FG006|Overall Study|Death|1|||
145432985|NCT00659425|524444115|FG007|Overall Study|Death|0|||
145432986|NCT00659425|524444116|FG008|Overall Study|Death|0|||
145432987|NCT00659425|524444117|FG009|Overall Study|Death|0|||
145432988|NCT00659425|524444108|FG000|Overall Study|Adverse Event|0|||
145432989|NCT00659425|524444109|FG001|Overall Study|Adverse Event|0|||
145432990|NCT00659425|524444110|FG002|Overall Study|Adverse Event|0|||
145432991|NCT00659425|524444111|FG003|Overall Study|Adverse Event|0|||
145432992|NCT00659425|524444112|FG004|Overall Study|Adverse Event|0|||
145432993|NCT00659425|524444113|FG005|Overall Study|Adverse Event|1|||
145432994|NCT00659425|524444114|FG006|Overall Study|Adverse Event|0|||
145432995|NCT00659425|524444115|FG007|Overall Study|Adverse Event|3|||
145432996|NCT00659425|524444116|FG008|Overall Study|Adverse Event|1|||
145432997|NCT00659425|524444117|FG009|Overall Study|Adverse Event|4|||
145432998|NCT00659425|524444108|FG000|Overall Study|Investigator Discretion|0|||
145432999|NCT00659425|524444109|FG001|Overall Study|Investigator Discretion|0|||
145433000|NCT00659425|524444110|FG002|Overall Study|Investigator Discretion|0|||
145433001|NCT00659425|524444111|FG003|Overall Study|Investigator Discretion|0|||
145433002|NCT00659425|524444112|FG004|Overall Study|Investigator Discretion|0|||
145433003|NCT00659425|524444113|FG005|Overall Study|Investigator Discretion|1|||
145433004|NCT00659425|524444114|FG006|Overall Study|Investigator Discretion|0|||
145433005|NCT00659425|524444115|FG007|Overall Study|Investigator Discretion|3|||
145433006|NCT00659425|524444116|FG008|Overall Study|Investigator Discretion|0|||
145433007|NCT00659425|524444117|FG009|Overall Study|Investigator Discretion|0|||
145433008|NCT00659425|524444108|FG000|Overall Study|Other|0|||
145433009|NCT00659425|524444109|FG001|Overall Study|Other|1|||
145433010|NCT00659425|524444110|FG002|Overall Study|Other|1|||
145433011|NCT00659425|524444111|FG003|Overall Study|Other|2|||
145433012|NCT00659425|524444112|FG004|Overall Study|Other|4|||
145433013|NCT00659425|524444113|FG005|Overall Study|Other|0|||
145433014|NCT00659425|524444114|FG006|Overall Study|Other|3|||
145433015|NCT00659425|524444115|FG007|Overall Study|Other|2|||
145433016|NCT00659425|524444116|FG008|Overall Study|Other|0|||
145433017|NCT00659425|524444117|FG009|Overall Study|Other|6|||
145433018|NCT03358030|524444118|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
145433019|NCT03358030|524444119|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
145433020|NCT03358030|524444120|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
145433021|NCT03358030|524444121|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
145433022|NCT03358030|524444118|FG000|Overall Study|Ineligibility|0|||
145433023|NCT03358030|524444119|FG001|Overall Study|Ineligibility|0|||
145433024|NCT03358030|524444120|FG002|Overall Study|Ineligibility|0|||
145433025|NCT03358030|524444121|FG003|Overall Study|Ineligibility|2|||
145433026|NCT03358030|524444118|FG000|Overall Study|Voluntary Withdrawal|1|||
145433027|NCT03358030|524444119|FG001|Overall Study|Voluntary Withdrawal|1|||
145433028|NCT03358030|524444120|FG002|Overall Study|Voluntary Withdrawal|3|||
145433029|NCT03358030|524444121|FG003|Overall Study|Voluntary Withdrawal|1|||
145433030|NCT03358030|524444118|FG000|Overall Study|Other|0|||
145433031|NCT03358030|524444119|FG001|Overall Study|Other|0|||
145433032|NCT03358030|524444120|FG002|Overall Study|Other|1|||
145433033|NCT03358030|524444121|FG003|Overall Study|Other|0|||
145433034|NCT03342560|524444122|FG000|Overall Study|Lost to Follow-up|2|||
145433035|NCT02604511|524444123|FG000|Overall Study|Adverse Event|3|||
145433036|NCT02604511|524444123|FG000|Overall Study|Disease Progression|4|||
145433037|NCT02604511|524444123|FG000|Overall Study|Withdrawal by Subject|3|||
145433038|NCT02604511|524444123|FG000|Overall Study|Participant ineligible|1|||
145433039|NCT02604511|524444123|FG000|Overall Study|Intercurrent illness|1|||
145433040|NCT03770286|524444124|FG000|Overall Study|Lost to Follow-up|6|||
145433041|NCT03770286|524444125|FG001|Overall Study|Lost to Follow-up|4|||
145433042|NCT03770286|524444126|FG002|Overall Study|Lost to Follow-up|3|||
145433043|NCT03770286|524444124|FG000|Overall Study|Protocol Violation|1|||
145433044|NCT03770286|524444125|FG001|Overall Study|Protocol Violation|0|||
145433045|NCT03770286|524444126|FG002|Overall Study|Protocol Violation|2|||
145433046|NCT01729039|524444129|FG000|Overall Study|disqualified|2|||
145433047|NCT01729039|524444130|FG001|Overall Study|disqualified|5|||
145433048|NCT01729039|524444129|FG000|Overall Study|Withdrawal by Subject|8|||
145433049|NCT01729039|524444130|FG001|Overall Study|Withdrawal by Subject|7|||
145433050|NCT02114177|524445935|FG000|Overall Study|Lost to Follow-up|1|||
145433051|NCT02114177|524445936|FG001|Overall Study|Lost to Follow-up|2|||
145433052|NCT02114177|524445935|FG000|Overall Study|Withdrawal by Subject|6|||
145433053|NCT02114177|524445936|FG001|Overall Study|Withdrawal by Subject|1|||
145433054|NCT02114177|524445935|FG000|Overall Study|Other|2|||
145433055|NCT02114177|524445936|FG001|Overall Study|Other|1|||
145433056|NCT01770743|524445939|FG000|Overall Study|Adverse Event|1|||
145433057|NCT01770743|524445940|FG001|Overall Study|Adverse Event|0|||
145433058|NCT01770743|524445941|FG002|Overall Study|Adverse Event|0|||
145433059|NCT01770743|524445942|FG003|Overall Study|Adverse Event|0|||
145624381|NCT01417000|525137666|FG000|Overall Study|Death|59|||
145433060|NCT01770743|524445943|FG004|Overall Study|Adverse Event|0|||
145433061|NCT01770743|524445939|FG000|Overall Study|Withdrawal by Subject|0|||
145433062|NCT01770743|524445940|FG001|Overall Study|Withdrawal by Subject|0|||
145433063|NCT01770743|524445941|FG002|Overall Study|Withdrawal by Subject|1|||
145433064|NCT01770743|524445942|FG003|Overall Study|Withdrawal by Subject|1|||
145433065|NCT01770743|524445943|FG004|Overall Study|Withdrawal by Subject|1|||
145433066|NCT01770743|524445939|FG000|Overall Study|Lost to Follow-up|0|||
145433067|NCT01770743|524445940|FG001|Overall Study|Lost to Follow-up|2|||
145433068|NCT01770743|524445941|FG002|Overall Study|Lost to Follow-up|0|||
145433069|NCT01770743|524445942|FG003|Overall Study|Lost to Follow-up|0|||
145433070|NCT01770743|524445943|FG004|Overall Study|Lost to Follow-up|1|||
145433071|NCT01770743|524445939|FG000|Overall Study|Sponsor Terminated Subject|1|||
145433072|NCT01770743|524445940|FG001|Overall Study|Sponsor Terminated Subject|0|||
145433073|NCT01770743|524445941|FG002|Overall Study|Sponsor Terminated Subject|0|||
145433074|NCT01770743|524445942|FG003|Overall Study|Sponsor Terminated Subject|1|||
145433075|NCT01770743|524445943|FG004|Overall Study|Sponsor Terminated Subject|0|||
145433076|NCT01770743|524445939|FG000|Overall Study|Moving Out of State|0|||
145433077|NCT01770743|524445940|FG001|Overall Study|Moving Out of State|1|||
145433078|NCT01770743|524445941|FG002|Overall Study|Moving Out of State|0|||
145433079|NCT01770743|524445942|FG003|Overall Study|Moving Out of State|0|||
145433080|NCT01770743|524445943|FG004|Overall Study|Moving Out of State|0|||
145433081|NCT01585025|524445944|FG000|Overall Study|Withdrawal by Subject|0|||
145433082|NCT01585025|524445945|FG001|Overall Study|Withdrawal by Subject|3|||
145433083|NCT01585025|524445946|FG002|Overall Study|Withdrawal by Subject|4|||
145433084|NCT01732536|524445947|FG000|Overall Study|Withdrawal by Subject|1|||
145433085|NCT01732536|524445948|FG001|Overall Study|Withdrawal by Subject|1|||
145433086|NCT05111145|524445951|FG000|Overall Study|Commercial drug is available for participant|76|||
145433087|NCT05111145|524445951|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
145433088|NCT02336815|524445954|FG000|Overall Study|Disease Progression|45|||
145433089|NCT02336815|524445955|FG001|Overall Study|Disease Progression|70|||
145433090|NCT02336815|524445954|FG000|Overall Study|Adverse Event|18|||
145433091|NCT02336815|524445955|FG001|Overall Study|Adverse Event|39|||
145433092|NCT02336815|524445954|FG000|Overall Study|Physician Decision|11|||
145433093|NCT02336815|524445955|FG001|Overall Study|Physician Decision|4|||
145433094|NCT02336815|524445954|FG000|Overall Study|Withdrawal by Subject|3|||
145433095|NCT02336815|524445955|FG001|Overall Study|Withdrawal by Subject|2|||
145433096|NCT02336815|524445954|FG000|Overall Study|Lost to Follow-up|1|||
145433097|NCT02336815|524445955|FG001|Overall Study|Lost to Follow-up|3|||
145433098|NCT02336815|524445954|FG000|Overall Study|Other|1|||
145433099|NCT02336815|524445955|FG001|Overall Study|Other|5|||
145433100|NCT00952705|524445956|FG000|Overall Study|Lost to Follow-up|24|||
145433101|NCT00952705|524445957|FG001|Overall Study|Lost to Follow-up|8|||
145433102|NCT00952705|524445958|FG002|Overall Study|Lost to Follow-up|9|||
145433103|NCT00952705|524445956|FG000|Overall Study|Withdrawal by Subject|2|||
145433104|NCT00952705|524445957|FG001|Overall Study|Withdrawal by Subject|1|||
145433105|NCT00952705|524445958|FG002|Overall Study|Withdrawal by Subject|1|||
145433106|NCT00952705|524445956|FG000|Overall Study|Death|2|||
145433107|NCT00952705|524445957|FG001|Overall Study|Death|0|||
145433108|NCT00952705|524445958|FG002|Overall Study|Death|0|||
145433109|NCT00952705|524445956|FG000|Overall Study|Incarcerated post dose|5|||
145433110|NCT00952705|524445957|FG001|Overall Study|Incarcerated post dose|0|||
145433111|NCT00952705|524445958|FG002|Overall Study|Incarcerated post dose|0|||
145433112|NCT00952705|524445956|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
145433113|NCT00952705|524445957|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
145433114|NCT00952705|524445958|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
145433115|NCT03728933|524445959|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145433116|NCT03728933|524445960|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145433117|NCT03728933|524445961|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145433118|NCT03728933|524445959|FG000|Overall Study|Withdrawal by Subject|0|||
145433119|NCT03728933|524445960|FG001|Overall Study|Withdrawal by Subject|0|||
145433120|NCT03728933|524445961|FG002|Overall Study|Withdrawal by Subject|1|||
145433121|NCT03728933|524445959|FG000|Overall Study|Lost to Follow-up|0|||
145433122|NCT03728933|524445960|FG001|Overall Study|Lost to Follow-up|1|||
145433123|NCT03728933|524445961|FG002|Overall Study|Lost to Follow-up|0|||
145433124|NCT03728933|524445959|FG000|Overall Study|Adverse Event|1|||
145433125|NCT03728933|524445960|FG001|Overall Study|Adverse Event|0|||
145433126|NCT03728933|524445961|FG002|Overall Study|Adverse Event|0|||
145433127|NCT02986074|524445962|FG000|First Trial Period|Adverse Event|1|||
145433128|NCT02986074|524445963|FG001|First Trial Period|Adverse Event|0|||
145433129|NCT02986074|524445964|FG002|First Trial Period|Adverse Event|0|||
145433130|NCT02986074|524445965|FG003|First Trial Period|Adverse Event|0|||
145433131|NCT02986074|524445962|FG000|Follow up Period|system explant|0|||
145433132|NCT02986074|524445963|FG001|Follow up Period|system explant|0|||
145433133|NCT02986074|524445964|FG002|Follow up Period|system explant|1|||
145433134|NCT02986074|524445965|FG003|Follow up Period|system explant|2|||
145433135|NCT02986074|524445962|FG000|Follow up Period|Physician Decision|0|||
145433136|NCT02986074|524445963|FG001|Follow up Period|Physician Decision|0|||
145433137|NCT02986074|524445964|FG002|Follow up Period|Physician Decision|0|||
145433138|NCT02986074|524445965|FG003|Follow up Period|Physician Decision|1|||
145433139|NCT02415556|524445966|FG000|Overall Study|Adverse Event|3|||
145433140|NCT02415556|524445967|FG001|Overall Study|Adverse Event|4|||
145433141|NCT02415556|524445968|FG002|Overall Study|Adverse Event|2|||
145433142|NCT02415556|524445969|FG003|Overall Study|Adverse Event|4|||
145433143|NCT02415556|524445966|FG000|Overall Study|Lost to Follow-up|4|||
145433144|NCT02415556|524445967|FG001|Overall Study|Lost to Follow-up|5|||
145433145|NCT02415556|524445968|FG002|Overall Study|Lost to Follow-up|4|||
145433146|NCT02415556|524445969|FG003|Overall Study|Lost to Follow-up|1|||
145433147|NCT02415556|524445966|FG000|Overall Study|Withdrawal by Subject|13|||
145433148|NCT02415556|524445967|FG001|Overall Study|Withdrawal by Subject|4|||
145433149|NCT02415556|524445968|FG002|Overall Study|Withdrawal by Subject|14|||
145433150|NCT02415556|524445969|FG003|Overall Study|Withdrawal by Subject|12|||
145433151|NCT02415556|524445966|FG000|Overall Study|Physician Decision|1|||
145433152|NCT02415556|524445967|FG001|Overall Study|Physician Decision|3|||
145433153|NCT02415556|524445968|FG002|Overall Study|Physician Decision|1|||
145433154|NCT02415556|524445969|FG003|Overall Study|Physician Decision|2|||
145433155|NCT02415556|524445966|FG000|Overall Study|Censored - study completion|4|||
145433156|NCT02415556|524445967|FG001|Overall Study|Censored - study completion|5|||
145433157|NCT02415556|524445968|FG002|Overall Study|Censored - study completion|1|||
145433158|NCT02415556|524445969|FG003|Overall Study|Censored - study completion|0|||
145433159|NCT02415556|524445966|FG000|Overall Study|Family-related issues|0|||
145433160|NCT02415556|524445967|FG001|Overall Study|Family-related issues|0|||
145433161|NCT02415556|524445968|FG002|Overall Study|Family-related issues|0|||
145433162|NCT02415556|524445969|FG003|Overall Study|Family-related issues|1|||
145433163|NCT00399035|524445972|FG000|Overall Study|Death|289|||
145433164|NCT00399035|524445973|FG001|Overall Study|Death|141|||
145433165|NCT00399035|524445974|FG002|Overall Study|Death|234|||
145433166|NCT00399035|524445972|FG000|Overall Study|Lost to Follow-up|2|||
145433167|NCT00399035|524445973|FG001|Overall Study|Lost to Follow-up|1|||
145433168|NCT00399035|524445974|FG002|Overall Study|Lost to Follow-up|5|||
145433169|NCT00399035|524445972|FG000|Overall Study|Withdrawal by Subject|19|||
145433170|NCT00399035|524445973|FG001|Overall Study|Withdrawal by Subject|15|||
145433171|NCT00399035|524445974|FG002|Overall Study|Withdrawal by Subject|12|||
145433172|NCT00399035|524445972|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
145433173|NCT00399035|524445973|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
145433174|NCT00399035|524445974|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
145433175|NCT00399035|524445972|FG000|Overall Study|Severe non-compliance with protocol|2|||
145433176|NCT00399035|524445973|FG001|Overall Study|Severe non-compliance with protocol|1|||
145433177|NCT00399035|524445974|FG002|Overall Study|Severe non-compliance with protocol|0|||
145433178|NCT02949011|524445977|FG000|Overall Study|Adverse Event|6|||
145433179|NCT02949011|524445978|FG001|Overall Study|Adverse Event|7|||
145433180|NCT02949011|524445979|FG002|Overall Study|Adverse Event|3|||
145433181|NCT02949011|524445977|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145433182|NCT02949011|524445978|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
145433183|NCT02949011|524445979|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
145433184|NCT02949011|524445977|FG000|Overall Study|Protocol Deviation|5|||
145433185|NCT02949011|524445978|FG001|Overall Study|Protocol Deviation|3|||
145433186|NCT02949011|524445979|FG002|Overall Study|Protocol Deviation|3|||
145433187|NCT02949011|524445977|FG000|Overall Study|Lack of Efficacy|0|||
145433188|NCT02949011|524445978|FG001|Overall Study|Lack of Efficacy|2|||
145433189|NCT02949011|524445979|FG002|Overall Study|Lack of Efficacy|0|||
145433190|NCT02949011|524445977|FG000|Overall Study|Withdrawal by Subject|13|||
145433191|NCT02949011|524445978|FG001|Overall Study|Withdrawal by Subject|13|||
145433192|NCT02949011|524445979|FG002|Overall Study|Withdrawal by Subject|21|||
145433193|NCT02949011|524445977|FG000|Overall Study|Lost to Follow-up|7|||
145433194|NCT02949011|524445978|FG001|Overall Study|Lost to Follow-up|5|||
145433195|NCT02949011|524445979|FG002|Overall Study|Lost to Follow-up|5|||
145433196|NCT02949011|524445977|FG000|Overall Study|Death|0|||
145433197|NCT02949011|524445978|FG001|Overall Study|Death|0|||
145433198|NCT02949011|524445979|FG002|Overall Study|Death|1|||
145433199|NCT02949011|524445977|FG000|Overall Study|Miscellaneous|2|||
145433200|NCT02949011|524445978|FG001|Overall Study|Miscellaneous|4|||
145433201|NCT02949011|524445979|FG002|Overall Study|Miscellaneous|6|||
145433202|NCT01213082|524445983|FG000|Overall Study|Lost to Follow-up|6|||
145433203|NCT01213082|524445984|FG001|Overall Study|Lost to Follow-up|7|||
145433204|NCT01213082|524445985|FG002|Overall Study|Lost to Follow-up|4|||
145624382|NCT01417000|525137667|FG001|Overall Study|Death|28|||
145624383|NCT01417000|525137666|FG000|Overall Study|Lost to Follow-up|1|||
145433205|NCT01213082|524445983|FG000|Overall Study|Physician Decision|0|||
145433206|NCT01213082|524445984|FG001|Overall Study|Physician Decision|0|||
145433207|NCT01213082|524445985|FG002|Overall Study|Physician Decision|1|||
145433208|NCT01627691|524445986|FG000|Overall Study|Death|11|||
145433209|NCT01627691|524445986|FG000|Overall Study|Lost to Follow-up|3|||
145433210|NCT01627691|524445986|FG000|Overall Study|Withdrawal by Subject|1|||
145433211|NCT01627691|524445986|FG000|Overall Study|Missed the visit|3|||
145433212|NCT02115321|524445987|FG000|Overall Study|Death|1|||
145624384|NCT01417000|525137667|FG001|Overall Study|Lost to Follow-up|0|||
145582854|NCT01054729|524987354|FG001|Overall Study|Adverse Event|1|||
145582855|NCT01054729|524987355|FG002|Overall Study|Adverse Event|2|||
145582856|NCT01054729|524987356|FG003|Overall Study|Adverse Event|1|||
145582857|NCT01054729|524987353|FG000|Overall Study|Withdrawal by Subject|1|||
145582858|NCT01054729|524987354|FG001|Overall Study|Withdrawal by Subject|0|||
145582859|NCT01054729|524987355|FG002|Overall Study|Withdrawal by Subject|1|||
145582860|NCT01054729|524987356|FG003|Overall Study|Withdrawal by Subject|0|||
145582861|NCT01054729|524987353|FG000|Overall Study|Lost to Follow-up|0|||
145582862|NCT01054729|524987354|FG001|Overall Study|Lost to Follow-up|1|||
145582863|NCT01054729|524987355|FG002|Overall Study|Lost to Follow-up|0|||
145582864|NCT01054729|524987356|FG003|Overall Study|Lost to Follow-up|0|||
145582865|NCT01054729|524987353|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
145582866|NCT01054729|524987354|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
145582867|NCT01054729|524987355|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
145582868|NCT01054729|524987356|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
145582869|NCT01054729|524987353|FG000|Overall Study|Non-responder|1|||
145582870|NCT01054729|524987354|FG001|Overall Study|Non-responder|0|||
145582871|NCT01054729|524987355|FG002|Overall Study|Non-responder|1|||
145582872|NCT01054729|524987356|FG003|Overall Study|Non-responder|1|||
145582873|NCT01054729|524987353|FG000|Overall Study|PEG/RBV Non-responder|1|||
145582874|NCT01054729|524987354|FG001|Overall Study|PEG/RBV Non-responder|0|||
145582875|NCT01054729|524987355|FG002|Overall Study|PEG/RBV Non-responder|1|||
145582876|NCT01054729|524987356|FG003|Overall Study|PEG/RBV Non-responder|0|||
145582877|NCT01054729|524987353|FG000|Overall Study|Personal/Obligations|0|||
145582878|NCT01054729|524987354|FG001|Overall Study|Personal/Obligations|1|||
145582879|NCT01054729|524987355|FG002|Overall Study|Personal/Obligations|0|||
145582880|NCT01054729|524987356|FG003|Overall Study|Personal/Obligations|0|||
145582881|NCT01054729|524987353|FG000|Overall Study|Subject moved|0|||
145582882|NCT01054729|524987354|FG001|Overall Study|Subject moved|0|||
145582883|NCT01054729|524987355|FG002|Overall Study|Subject moved|1|||
145582884|NCT01054729|524987356|FG003|Overall Study|Subject moved|0|||
145582885|NCT01054729|524987353|FG000|Overall Study|Lack of Efficacy|0|||
145582886|NCT01054729|524987354|FG001|Overall Study|Lack of Efficacy|0|||
145582887|NCT01054729|524987355|FG002|Overall Study|Lack of Efficacy|0|||
145582888|NCT01054729|524987356|FG003|Overall Study|Lack of Efficacy|1|||
145582889|NCT00562159|524987357|FG000|Overall Study|Adverse Event|11|||
145582890|NCT00562159|524987358|FG001|Overall Study|Adverse Event|8|||
145582891|NCT00562159|524987357|FG000|Overall Study|Lost to Follow-up|5|||
145582892|NCT00562159|524987358|FG001|Overall Study|Lost to Follow-up|4|||
145582893|NCT00562159|524987357|FG000|Overall Study|Withdrawal by Subject|9|||
145582894|NCT00562159|524987358|FG001|Overall Study|Withdrawal by Subject|8|||
145582895|NCT00562159|524987357|FG000|Overall Study|Protocol Violation|12|||
145582896|NCT00562159|524987358|FG001|Overall Study|Protocol Violation|12|||
145582897|NCT00562159|524987357|FG000|Overall Study|Did not meet protocol eligibility|1|||
145582898|NCT00562159|524987358|FG001|Overall Study|Did not meet protocol eligibility|1|||
145582899|NCT01992536|524987362|FG000|Overall Study|Administrative Reason|0|||
145582900|NCT01992536|524987363|FG001|Overall Study|Administrative Reason|0|||
145582901|NCT01992536|524987364|FG002|Overall Study|Administrative Reason|0|||
145582902|NCT01992536|524987365|FG003|Overall Study|Administrative Reason|0|||
145582903|NCT01992536|524987366|FG004|Overall Study|Administrative Reason|0|||
145582904|NCT01992536|524987367|FG005|Overall Study|Administrative Reason|0|||
145582905|NCT01992536|524987368|FG006|Overall Study|Administrative Reason|7|||
145582906|NCT01992536|524987369|FG007|Overall Study|Administrative Reason|0|||
145582907|NCT01992536|524987370|FG008|Overall Study|Administrative Reason|0|||
145582908|NCT01992536|524987371|FG009|Overall Study|Administrative Reason|0|||
145582909|NCT01992536|524987362|FG000|Overall Study|Lost to Follow-up|4|||
145582910|NCT01992536|524987363|FG001|Overall Study|Lost to Follow-up|2|||
145582911|NCT01992536|524987364|FG002|Overall Study|Lost to Follow-up|1|||
145582912|NCT01992536|524987365|FG003|Overall Study|Lost to Follow-up|0|||
145582913|NCT01992536|524987366|FG004|Overall Study|Lost to Follow-up|0|||
145582914|NCT01992536|524987367|FG005|Overall Study|Lost to Follow-up|1|||
145582915|NCT01992536|524987368|FG006|Overall Study|Lost to Follow-up|0|||
145582916|NCT01992536|524987369|FG007|Overall Study|Lost to Follow-up|0|||
145582917|NCT01992536|524987370|FG008|Overall Study|Lost to Follow-up|1|||
145582918|NCT01992536|524987371|FG009|Overall Study|Lost to Follow-up|1|||
145582919|NCT01992536|524987362|FG000|Overall Study|Withdrawal by Subject|0|||
145582920|NCT01992536|524987363|FG001|Overall Study|Withdrawal by Subject|1|||
145582921|NCT01992536|524987364|FG002|Overall Study|Withdrawal by Subject|0|||
145582922|NCT01992536|524987365|FG003|Overall Study|Withdrawal by Subject|2|||
145582923|NCT01992536|524987366|FG004|Overall Study|Withdrawal by Subject|0|||
145582924|NCT01992536|524987367|FG005|Overall Study|Withdrawal by Subject|0|||
145582925|NCT01992536|524987368|FG006|Overall Study|Withdrawal by Subject|0|||
145582926|NCT01992536|524987369|FG007|Overall Study|Withdrawal by Subject|0|||
145582927|NCT01992536|524987370|FG008|Overall Study|Withdrawal by Subject|0|||
145582928|NCT01992536|524987371|FG009|Overall Study|Withdrawal by Subject|0|||
145582929|NCT02317575|524987372|FG000|Period 1|Difficulty with venous cannulation|0|||
145582930|NCT02317575|524987373|FG001|Period 1|Difficulty with venous cannulation|1|||
145433213|NCT02115321|524445988|FG001|Overall Study|Death|0|||
145433214|NCT01908140|524445990|FG000|Overall Study|Other or Progressive Disease|5|||
145433215|NCT01908140|524445991|FG001|Overall Study|Other or Progressive Disease|12|||
145433216|NCT01908140|524445990|FG000|Overall Study|Lack of Efficacy|7|||
145433217|NCT01908140|524445991|FG001|Overall Study|Lack of Efficacy|5|||
145433218|NCT01908140|524445990|FG000|Overall Study|Withdrawal by Subject|23|||
145433219|NCT01908140|524445991|FG001|Overall Study|Withdrawal by Subject|24|||
145433220|NCT01908140|524445990|FG000|Overall Study|Lost to Follow-up|1|||
145433221|NCT01908140|524445991|FG001|Overall Study|Lost to Follow-up|6|||
145433222|NCT01908140|524445990|FG000|Overall Study|Protocol Violation|8|||
145433223|NCT01908140|524445991|FG001|Overall Study|Protocol Violation|9|||
145433224|NCT01908140|524445990|FG000|Overall Study|Adverse Event|22|||
145433225|NCT01908140|524445991|FG001|Overall Study|Adverse Event|23|||
145433226|NCT03218917|524445992|FG000|Overall Study|Adverse Event|3|||
145433227|NCT03218917|524445993|FG001|Overall Study|Adverse Event|3|||
145433228|NCT03218917|524445994|FG002|Overall Study|Adverse Event|2|||
145433229|NCT03218917|524445992|FG000|Overall Study|Subject withdrew consent|2|||
145433230|NCT03218917|524445993|FG001|Overall Study|Subject withdrew consent|4|||
145433231|NCT03218917|524445994|FG002|Overall Study|Subject withdrew consent|10|||
145433232|NCT03218917|524445992|FG000|Overall Study|Physician Decision|0|||
145433233|NCT03218917|524445993|FG001|Overall Study|Physician Decision|1|||
145433234|NCT03218917|524445994|FG002|Overall Study|Physician Decision|1|||
145433235|NCT03218917|524445992|FG000|Overall Study|Lost to Follow-up|1|||
145433236|NCT03218917|524445993|FG001|Overall Study|Lost to Follow-up|0|||
145433237|NCT03218917|524445994|FG002|Overall Study|Lost to Follow-up|0|||
145433238|NCT03218917|524445992|FG000|Overall Study|Reason Missing|0|||
145433239|NCT03218917|524445993|FG001|Overall Study|Reason Missing|2|||
145433240|NCT03218917|524445994|FG002|Overall Study|Reason Missing|0|||
145433241|NCT03218917|524445992|FG000|Overall Study|Death|0|||
145433242|NCT03218917|524445993|FG001|Overall Study|Death|1|||
145433243|NCT03218917|524445994|FG002|Overall Study|Death|0|||
145433244|NCT03218917|524445992|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145433245|NCT03218917|524445993|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145433246|NCT03218917|524445994|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145433247|NCT01307449|524445995|FG000|Overall Study|Adverse Event|1|||
145433248|NCT01307449|524445996|FG001|Overall Study|Adverse Event|0|||
145433249|NCT01307449|524445997|FG002|Overall Study|Adverse Event|0|||
145433250|NCT01307449|524445998|FG003|Overall Study|Adverse Event|0|||
145433251|NCT02639390|524445999|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
145433252|NCT02639390|524446000|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
145582931|NCT02317575|524987374|FG002|Period 1|Difficulty with venous cannulation|0|||
145582932|NCT02317575|524987375|FG003|Period 1|Difficulty with venous cannulation|0|||
145582933|NCT02317575|524987376|FG004|Period 1|Difficulty with venous cannulation|0|||
145582934|NCT02317575|524987372|FG000|Period 1|Withdrawal by Subject|1|||
145582935|NCT02317575|524987373|FG001|Period 1|Withdrawal by Subject|0|||
145582936|NCT02317575|524987374|FG002|Period 1|Withdrawal by Subject|0|||
145582937|NCT02317575|524987375|FG003|Period 1|Withdrawal by Subject|0|||
145582938|NCT02317575|524987376|FG004|Period 1|Withdrawal by Subject|0|||
145582939|NCT04831736|524987379|FG000|Overall Study|Withdrawal by Subject|0|||
145582940|NCT04831736|524987380|FG001|Overall Study|Withdrawal by Subject|1|||
145582941|NCT03551938|524987381|FG000|3-Month Follow Up|Lost to Follow-up|39|||
145582942|NCT03551938|524987382|FG001|3-Month Follow Up|Lost to Follow-up|38|||
145582943|NCT03551938|524987381|FG000|6-Month Follow Up|Lost to Follow-up|46|||
145582944|NCT03551938|524987382|FG001|6-Month Follow Up|Lost to Follow-up|42|||
145582945|NCT03551938|524987381|FG000|9-Month Follow Up|Lost to Follow-up|44|||
145582946|NCT03551938|524987382|FG001|9-Month Follow Up|Lost to Follow-up|43|||
145582947|NCT02159482|524987383|FG000|Overall Study|Withdrawal by Subject|2|||
145582948|NCT02159482|524987383|FG000|Overall Study|Physician Decision|3|||
145582949|NCT00504829|524987388|FG000|Overall Study|Protocol Violation|6|||
145582950|NCT00504829|524987389|FG001|Overall Study|Protocol Violation|4|||
145582951|NCT00504829|524987390|FG002|Overall Study|Protocol Violation|10|||
145582952|NCT03465540|524987391|FG000|Overall Study|Withdrawal by Subject|0|||
145433253|NCT00698828|524446003|FG000|Overall Study|Adverse Event|3|||
145433254|NCT00698828|524446004|FG001|Overall Study|Adverse Event|4|||
145433255|NCT00698828|524446005|FG002|Overall Study|Adverse Event|4|||
145433256|NCT00698828|524446003|FG000|Overall Study|Death|0|||
145433257|NCT00698828|524446004|FG001|Overall Study|Death|0|||
145433258|NCT00698828|524446005|FG002|Overall Study|Death|1|||
145433259|NCT00698828|524446003|FG000|Overall Study|Exacerbation of COPD|1|||
145433260|NCT00698828|524446004|FG001|Overall Study|Exacerbation of COPD|3|||
145433261|NCT00698828|524446005|FG002|Overall Study|Exacerbation of COPD|0|||
145433262|NCT00698828|524446003|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
145433263|NCT00698828|524446004|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
145433264|NCT00698828|524446005|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
145582953|NCT03465540|524987392|FG001|Overall Study|Withdrawal by Subject|0|||
145582954|NCT03465540|524987393|FG002|Overall Study|Withdrawal by Subject|1|||
145582955|NCT03465540|524987394|FG003|Overall Study|Withdrawal by Subject|1|||
145582956|NCT03465540|524987395|FG004|Overall Study|Withdrawal by Subject|1|||
145624385|NCT01417000|525137666|FG000|Overall Study|Study Terminated by Sponsor|1|||
145624386|NCT01417000|525137667|FG001|Overall Study|Study Terminated by Sponsor|1|||
145624387|NCT00558753|525137673|FG000|Overall Study|Lost to Follow-up|5|||
145624388|NCT00558753|525137674|FG001|Overall Study|Lost to Follow-up|7|||
145624389|NCT01414166|525137678|FG000|Overall Study|Adverse Event|10|||
145624390|NCT01414166|525137679|FG001|Overall Study|Adverse Event|2|||
145624391|NCT01414166|525137678|FG000|Overall Study|Lost to Follow-up|4|||
145624392|NCT01414166|525137679|FG001|Overall Study|Lost to Follow-up|1|||
145624393|NCT01414166|525137678|FG000|Overall Study|Non-compliance with study drug|2|||
145624394|NCT01414166|525137679|FG001|Overall Study|Non-compliance with study drug|0|||
145624395|NCT01414166|525137678|FG000|Overall Study|Physician Decision|2|||
145624396|NCT01414166|525137679|FG001|Overall Study|Physician Decision|0|||
145624397|NCT01414166|525137678|FG000|Overall Study|Protocol Violation|2|||
145433265|NCT00698828|524446003|FG000|Overall Study|Investigator/Sponsor decision|1|||
145433266|NCT00698828|524446004|FG001|Overall Study|Investigator/Sponsor decision|0|||
145433267|NCT00698828|524446005|FG002|Overall Study|Investigator/Sponsor decision|2|||
145582957|NCT03465540|524987396|FG005|Overall Study|Withdrawal by Subject|0|||
145582958|NCT03465540|524987391|FG000|Overall Study|Lost to Follow-up|0|||
145582959|NCT03465540|524987392|FG001|Overall Study|Lost to Follow-up|1|||
145582960|NCT03465540|524987393|FG002|Overall Study|Lost to Follow-up|0|||
145582961|NCT03465540|524987394|FG003|Overall Study|Lost to Follow-up|0|||
145582962|NCT03465540|524987395|FG004|Overall Study|Lost to Follow-up|1|||
145582963|NCT03465540|524987396|FG005|Overall Study|Lost to Follow-up|0|||
145582964|NCT03465540|524987391|FG000|Overall Study|Death|1|||
145582965|NCT03465540|524987392|FG001|Overall Study|Death|1|||
145582966|NCT03465540|524987393|FG002|Overall Study|Death|0|||
145582967|NCT03465540|524987394|FG003|Overall Study|Death|2|||
145582968|NCT03465540|524987395|FG004|Overall Study|Death|0|||
145582969|NCT03465540|524987396|FG005|Overall Study|Death|2|||
145582970|NCT03465540|524987391|FG000|Overall Study|Protocol specified criteria|0|||
145582971|NCT03465540|524987392|FG001|Overall Study|Protocol specified criteria|2|||
145582972|NCT03465540|524987393|FG002|Overall Study|Protocol specified criteria|2|||
145582973|NCT03465540|524987394|FG003|Overall Study|Protocol specified criteria|0|||
145582974|NCT03465540|524987395|FG004|Overall Study|Protocol specified criteria|2|||
145582975|NCT03465540|524987396|FG005|Overall Study|Protocol specified criteria|0|||
145582976|NCT04443218|524987397|FG000|Overall Study|Exited study for other reasons|9|||
145582977|NCT04443218|524987397|FG000|Overall Study|Withdrawal by Subject|1|||
145582978|NCT04443218|524987397|FG000|Overall Study|Lost to Follow-up|4|||
145582979|NCT04443218|524987397|FG000|Overall Study|Death|19|||
145582980|NCT02660944|524987406|FG000|Overall Study|Adverse Event|3|||
145582981|NCT02660944|524987407|FG001|Overall Study|Adverse Event|4|||
145582982|NCT02660944|524987406|FG000|Overall Study|Physician Decision|3|||
145582983|NCT02660944|524987407|FG001|Overall Study|Physician Decision|1|||
145582984|NCT02660944|524987406|FG000|Overall Study|Withdrawal by Subject|5|||
145582985|NCT02660944|524987407|FG001|Overall Study|Withdrawal by Subject|3|||
145582986|NCT02660944|524987406|FG000|Overall Study|Lost to Follow-up|4|||
145582987|NCT02660944|524987407|FG001|Overall Study|Lost to Follow-up|1|||
145582988|NCT02660944|524987406|FG000|Overall Study|Subject schedule|0|||
145582989|NCT02660944|524987407|FG001|Overall Study|Subject schedule|1|||
145582990|NCT02660944|524987406|FG000|Overall Study|Exclusion criteria met|2|||
145582991|NCT02660944|524987407|FG001|Overall Study|Exclusion criteria met|0|||
145582992|NCT02843568|524987408|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
145582993|NCT02843568|524987409|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
145582994|NCT02843568|524987408|FG000|Overall Study|Death|3|||
145582995|NCT02843568|524987409|FG001|Overall Study|Death|3|||
145582996|NCT02843568|524987408|FG000|Overall Study|Withdrawal by Subject|1|||
145582997|NCT02843568|524987409|FG001|Overall Study|Withdrawal by Subject|1|||
145582998|NCT02843568|524987408|FG000|Overall Study|Lost to Follow-up|2|||
145582999|NCT02843568|524987409|FG001|Overall Study|Lost to Follow-up|0|||
145624398|NCT01414166|525137679|FG001|Overall Study|Protocol Violation|0|||
145624399|NCT01414166|525137678|FG000|Overall Study|Study terminated by Sponsor|68|||
145624400|NCT01414166|525137679|FG001|Overall Study|Study terminated by Sponsor|75|||
145624401|NCT01414166|525137678|FG000|Overall Study|Withdrawal by Subject|3|||
145624402|NCT01414166|525137679|FG001|Overall Study|Withdrawal by Subject|5|||
145433268|NCT00698828|524446003|FG000|Overall Study|Lost to Follow-up|1|||
145433269|NCT00698828|524446004|FG001|Overall Study|Lost to Follow-up|1|||
145433270|NCT00698828|524446005|FG002|Overall Study|Lost to Follow-up|0|||
145433271|NCT00698828|524446003|FG000|Overall Study|Withdrew consent|0|||
145583000|NCT03586999|524987410|FG000|Overall Study|Lack of Efficacy|2|||
145583001|NCT04096560|524987411|FG000|Overall Study|Reason not Specified|1|||
145583002|NCT04096560|524987412|FG001|Overall Study|Reason not Specified|0|||
145583003|NCT04096560|524987413|FG002|Overall Study|Reason not Specified|0|||
145583004|NCT04096560|524987414|FG003|Overall Study|Reason not Specified|0|||
145583005|NCT04096560|524987415|FG004|Overall Study|Reason not Specified|1|||
145583006|NCT04096560|524987416|FG005|Overall Study|Reason not Specified|1|||
145583007|NCT04096560|524987417|FG006|Overall Study|Reason not Specified|1|||
145583008|NCT04096560|524987418|FG007|Overall Study|Reason not Specified|0|||
145624403|NCT03682536|525137680|FG000|Randomization|Withdrawal by Subject|0|||
145433272|NCT00698828|524446004|FG001|Overall Study|Withdrew consent|7|||
145433273|NCT00698828|524446005|FG002|Overall Study|Withdrew consent|4|||
145433274|NCT00698828|524446003|FG000|Overall Study|Withdrew consent (not treated)|2|||
145433275|NCT00698828|524446004|FG001|Overall Study|Withdrew consent (not treated)|0|||
145433276|NCT00698828|524446005|FG002|Overall Study|Withdrew consent (not treated)|0|||
145433277|NCT02013609|524446006|FG000|Overall Study|Withdrawal by Subject|9|||
145433278|NCT02013609|524446006|FG000|Overall Study|Lost to Follow-up|3|||
145433279|NCT02013609|524446006|FG000|Overall Study|Adverse Event|3|||
145433280|NCT02013609|524446006|FG000|Overall Study|Met Withdrawal Criteria|3|||
145433281|NCT01119287|524446007|FG000|Overall Study|Patient Decision, not related to AE|0|||
145433282|NCT01119287|524446008|FG001|Overall Study|Patient Decision, not related to AE|0|||
145433283|NCT01119287|524446009|FG002|Overall Study|Patient Decision, not related to AE|2|||
145433284|NCT01119287|524446010|FG003|Overall Study|Patient Decision, not related to AE|2|||
145433285|NCT01119287|524446011|FG004|Overall Study|Patient Decision, not related to AE|1|||
145433286|NCT01119287|524446012|FG005|Overall Study|Patient Decision, not related to AE|0|||
145433287|NCT01076010|524446013|FG000|Overall Study|Death|15|||
145433288|NCT01076010|524446014|FG001|Overall Study|Death|1|||
145433289|NCT01076010|524446015|FG002|Overall Study|Death|0|||
145433290|NCT01076010|524446013|FG000|Overall Study|Adverse Event|7|||
145433291|NCT01076010|524446014|FG001|Overall Study|Adverse Event|2|||
145433292|NCT01076010|524446015|FG002|Overall Study|Adverse Event|0|||
145433293|NCT01076010|524446013|FG000|Overall Study|Progressive disease|90|||
145433294|NCT01076010|524446014|FG001|Overall Study|Progressive disease|30|||
145433295|NCT01076010|524446015|FG002|Overall Study|Progressive disease|1|||
145433296|NCT01076010|524446013|FG000|Overall Study|Lack of Efficacy|4|||
145433297|NCT01076010|524446014|FG001|Overall Study|Lack of Efficacy|0|||
145433298|NCT01076010|524446015|FG002|Overall Study|Lack of Efficacy|0|||
145433299|NCT01076010|524446013|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
145433300|NCT01076010|524446014|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
145433301|NCT01076010|524446015|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
145433302|NCT01076010|524446013|FG000|Overall Study|Significant Surgical Procedure|0|||
145433303|NCT01076010|524446014|FG001|Overall Study|Significant Surgical Procedure|1|||
145433304|NCT01076010|524446015|FG002|Overall Study|Significant Surgical Procedure|0|||
145433305|NCT01076010|524446013|FG000|Overall Study|Protocol Violation|0|||
145433306|NCT01076010|524446014|FG001|Overall Study|Protocol Violation|1|||
145433307|NCT01076010|524446015|FG002|Overall Study|Protocol Violation|0|||
145433308|NCT01076010|524446013|FG000|Overall Study|Noncompliance|1|||
145433309|NCT01076010|524446014|FG001|Overall Study|Noncompliance|1|||
145433310|NCT01076010|524446015|FG002|Overall Study|Noncompliance|0|||
145433311|NCT01076010|524446013|FG000|Overall Study|Withdrawal by Subject|3|||
145433312|NCT01076010|524446014|FG001|Overall Study|Withdrawal by Subject|0|||
145433313|NCT01076010|524446015|FG002|Overall Study|Withdrawal by Subject|1|||
145433314|NCT01076010|524446013|FG000|Overall Study|Other|5|||
145433315|NCT01076010|524446014|FG001|Overall Study|Other|2|||
145433316|NCT01076010|524446015|FG002|Overall Study|Other|0|||
145433317|NCT00945659|524446017|FG000|Overall Study|Lost to Follow-up|7|||
145433318|NCT00945659|524446018|FG001|Overall Study|Lost to Follow-up|20|||
145433319|NCT00945659|524446019|FG002|Overall Study|Lost to Follow-up|17|||
145433320|NCT00565409|524446020|FG000|Period 1 Open Label|Adverse Event|17|||
145433321|NCT00565409|524446021|FG001|Period 1 Open Label|Adverse Event|0|||
145433322|NCT00565409|524446022|FG002|Period 1 Open Label|Adverse Event|0|||
145433323|NCT00565409|524446023|FG003|Period 1 Open Label|Adverse Event|0|||
145433324|NCT00565409|524446020|FG000|Period 1 Open Label|Death|2|||
145433325|NCT00565409|524446021|FG001|Period 1 Open Label|Death|0|||
145433326|NCT00565409|524446022|FG002|Period 1 Open Label|Death|0|||
145433327|NCT00565409|524446023|FG003|Period 1 Open Label|Death|0|||
145433328|NCT00565409|524446020|FG000|Period 1 Open Label|Lost to Follow-up|1|||
145433329|NCT00565409|524446021|FG001|Period 1 Open Label|Lost to Follow-up|0|||
145433330|NCT00565409|524446022|FG002|Period 1 Open Label|Lost to Follow-up|0|||
145433331|NCT00565409|524446023|FG003|Period 1 Open Label|Lost to Follow-up|0|||
145433332|NCT00565409|524446020|FG000|Period 1 Open Label|Other|21|||
145433333|NCT00565409|524446021|FG001|Period 1 Open Label|Other|0|||
145433334|NCT00565409|524446022|FG002|Period 1 Open Label|Other|0|||
145433335|NCT00565409|524446023|FG003|Period 1 Open Label|Other|0|||
145433336|NCT00565409|524446020|FG000|Period 1 Open Label|Protocol Violation|14|||
145433337|NCT00565409|524446021|FG001|Period 1 Open Label|Protocol Violation|0|||
145433338|NCT00565409|524446022|FG002|Period 1 Open Label|Protocol Violation|0|||
145433339|NCT00565409|524446023|FG003|Period 1 Open Label|Protocol Violation|0|||
145433340|NCT00565409|524446020|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
145433341|NCT00565409|524446021|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145433342|NCT00565409|524446022|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145433343|NCT00565409|524446023|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
145433344|NCT00565409|524446020|FG000|Period 1 Open Label|no conclusion of participation record|1|||
145433345|NCT00565409|524446021|FG001|Period 1 Open Label|no conclusion of participation record|0|||
145433346|NCT00565409|524446022|FG002|Period 1 Open Label|no conclusion of participation record|0|||
145433347|NCT00565409|524446023|FG003|Period 1 Open Label|no conclusion of participation record|0|||
145433348|NCT00565409|524446020|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
145433349|NCT00565409|524446021|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
145433350|NCT00565409|524446022|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
145433351|NCT00565409|524446023|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
145433352|NCT00565409|524446020|FG000|Period 2 Double-Blind|Adverse Event|0|||
145433353|NCT00565409|524446021|FG001|Period 2 Double-Blind|Adverse Event|7|||
145433354|NCT00565409|524446022|FG002|Period 2 Double-Blind|Adverse Event|4|||
145433355|NCT00565409|524446023|FG003|Period 2 Double-Blind|Adverse Event|5|||
145433356|NCT00565409|524446020|FG000|Period 2 Double-Blind|Death|0|||
145433357|NCT00565409|524446021|FG001|Period 2 Double-Blind|Death|2|||
145433358|NCT00565409|524446022|FG002|Period 2 Double-Blind|Death|0|||
145433359|NCT00565409|524446023|FG003|Period 2 Double-Blind|Death|0|||
145433360|NCT00565409|524446020|FG000|Period 2 Double-Blind|Protocol Violation|0|||
145433361|NCT00565409|524446021|FG001|Period 2 Double-Blind|Protocol Violation|4|||
145433362|NCT00565409|524446022|FG002|Period 2 Double-Blind|Protocol Violation|6|||
145433363|NCT00565409|524446023|FG003|Period 2 Double-Blind|Protocol Violation|2|||
145433364|NCT00565409|524446020|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
145433365|NCT00565409|524446021|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
145433366|NCT00565409|524446022|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
145433367|NCT00565409|524446023|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
145433368|NCT00565409|524446020|FG000|Period 2 Double-Blind|Other|0|||
145433369|NCT00565409|524446021|FG001|Period 2 Double-Blind|Other|4|||
145433370|NCT00565409|524446022|FG002|Period 2 Double-Blind|Other|5|||
145433371|NCT00565409|524446023|FG003|Period 2 Double-Blind|Other|9|||
145433372|NCT00565409|524446020|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
145433373|NCT00565409|524446021|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
145433374|NCT00565409|524446022|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
145433375|NCT00565409|524446023|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
145433376|NCT02257684|524446028|FG000|Overall Study|Adverse Event|2|||
145433377|NCT02257684|524446028|FG000|Overall Study|Lack of Efficacy|1|||
145433378|NCT02257684|524446028|FG000|Overall Study|Sponsor's Decision|1|||
145433379|NCT01448616|524446029|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
145433380|NCT01448616|524446030|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145433381|NCT01448616|524446031|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145433382|NCT01448616|524446032|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
145433383|NCT01448616|524446029|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
145433384|NCT01448616|524446030|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145433385|NCT01448616|524446031|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145433386|NCT01448616|524446032|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
145433387|NCT01448616|524446029|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
145433388|NCT01448616|524446030|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
145433389|NCT01448616|524446031|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
145433390|NCT01448616|524446032|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
145433391|NCT01448616|524446029|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
145433392|NCT01448616|524446030|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
145433393|NCT01448616|524446031|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
145433394|NCT01448616|524446032|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
145433395|NCT01448616|524446029|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
145433396|NCT01448616|524446030|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
145433397|NCT01448616|524446031|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
145433398|NCT01448616|524446032|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
145433399|NCT02943473|524446033|FG000|Overall Study|enrolled but not dosed|1|||
145433400|NCT02943473|524446033|FG000|Overall Study|screen failure|1|||
145433401|NCT02943473|524446033|FG000|Overall Study|Physician Decision|4|||
145433402|NCT00431964|524446040|FG000|Overall Study|Adverse Event|1|||
145624404|NCT03682536|525137681|FG001|Randomization|Withdrawal by Subject|2|||
145433403|NCT00431964|524446041|FG001|Overall Study|Adverse Event|0|||
145433404|NCT00431964|524446040|FG000|Overall Study|Lost to Follow-up|1|||
145433405|NCT00431964|524446041|FG001|Overall Study|Lost to Follow-up|2|||
145433406|NCT00431964|524446040|FG000|Overall Study|Physician Decision|2|||
145433407|NCT00431964|524446041|FG001|Overall Study|Physician Decision|2|||
145433408|NCT00431964|524446040|FG000|Overall Study|Withdrawal by Subject|2|||
145433409|NCT00431964|524446041|FG001|Overall Study|Withdrawal by Subject|1|||
145433410|NCT00431964|524446040|FG000|Overall Study|Parental Consent Withdrawn|0|||
145433411|NCT00431964|524446041|FG001|Overall Study|Parental Consent Withdrawn|2|||
145433412|NCT00431964|524446040|FG000|Overall Study|Due to Unstable Health|0|||
145433413|NCT00431964|524446041|FG001|Overall Study|Due to Unstable Health|1|||
145433414|NCT00654732|524446042|FG000|Overall Study|Adverse Event|4|||
145433415|NCT00654732|524446043|FG001|Overall Study|Adverse Event|6|||
145433416|NCT01734902|524446048|FG000|Overall Study|Other than listed|0|||
145433417|NCT01734902|524446049|FG001|Overall Study|Other than listed|2|||
145433418|NCT00060944|524446052|FG000|Overall Study|Adverse Event|12|||
145433419|NCT00060944|524446053|FG001|Overall Study|Adverse Event|10|||
145433420|NCT00060944|524446052|FG000|Overall Study|Death|2|||
145433421|NCT00060944|524446053|FG001|Overall Study|Death|3|||
145433422|NCT00060944|524446052|FG000|Overall Study|Withdrawal by Subject|18|||
145433423|NCT00060944|524446053|FG001|Overall Study|Withdrawal by Subject|5|||
145433424|NCT00060944|524446052|FG000|Overall Study|Disease Progression|93|||
145433425|NCT00060944|524446053|FG001|Overall Study|Disease Progression|94|||
145433426|NCT00060944|524446052|FG000|Overall Study|Lost to Follow-up|1|||
145433427|NCT00060944|524446053|FG001|Overall Study|Lost to Follow-up|0|||
145433428|NCT00060944|524446052|FG000|Overall Study|Subject Ineligible To Continue|2|||
145433429|NCT00060944|524446053|FG001|Overall Study|Subject Ineligible To Continue|1|||
145433430|NCT00060944|524446052|FG000|Overall Study|Treatment Switch|0|||
145433431|NCT00060944|524446053|FG001|Overall Study|Treatment Switch|13|||
145433432|NCT00060944|524446052|FG000|Overall Study|Other|2|||
145433433|NCT00060944|524446053|FG001|Overall Study|Other|4|||
145433434|NCT00060944|524446052|FG000|Overall Study|randomized but not treated|6|||
145433435|NCT00060944|524446053|FG001|Overall Study|randomized but not treated|4|||
145433436|NCT02536664|524446058|FG000|Overall Study|Inadequate completion of documentation|2|||
145433437|NCT02536664|524446059|FG001|Overall Study|Inadequate completion of documentation|4|||
145433438|NCT02536664|524446058|FG000|Overall Study|Progression|13|||
145433439|NCT02536664|524446059|FG001|Overall Study|Progression|18|||
145433440|NCT02536664|524446058|FG000|Overall Study|Death due to lymphoma|2|||
145433441|NCT02536664|524446059|FG001|Overall Study|Death due to lymphoma|1|||
145433442|NCT02536664|524446058|FG000|Overall Study|Death due to other reason|3|||
145433443|NCT02536664|524446059|FG001|Overall Study|Death due to other reason|2|||
145433444|NCT02536664|524446058|FG000|Overall Study|Intolerability|8|||
145433445|NCT02536664|524446059|FG001|Overall Study|Intolerability|6|||
145433446|NCT02536664|524446058|FG000|Overall Study|Withdrawal by Subject|8|||
145433447|NCT02536664|524446059|FG001|Overall Study|Withdrawal by Subject|5|||
145433448|NCT02536664|524446058|FG000|Overall Study|Other|18|||
145433449|NCT02536664|524446059|FG001|Overall Study|Other|24|||
145433450|NCT02536664|524446058|FG000|Overall Study|Missing|53|||
145433451|NCT02536664|524446059|FG001|Overall Study|Missing|20|||
145433452|NCT03383666|524446060|FG000|Overall Study|Withdrawal by Subject|2|||
145433453|NCT03383666|524446060|FG000|Overall Study|Lost to Follow-up|2|||
145433454|NCT02359903|524446061|FG000|Overall Study|Adverse Event|0|||
145433455|NCT02359903|524446062|FG001|Overall Study|Adverse Event|2|||
145433456|NCT03507127|524446070|FG000|Overall Study|Withdrawal by Subject|1|||
145433457|NCT03507127|524446071|FG001|Overall Study|Withdrawal by Subject|0|||
145433458|NCT03507127|524446070|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
145433459|NCT03507127|524446071|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
145433460|NCT00746811|524446076|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
145433461|NCT00746811|524446077|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
145433462|NCT02505425|524446081|FG000|Overall Study|Lost to Follow-up|41|||
145433463|NCT02505425|524446082|FG001|Overall Study|Lost to Follow-up|61|||
145433464|NCT02505425|524446083|FG002|Overall Study|Lost to Follow-up|31|||
145433465|NCT02505425|524446084|FG003|Overall Study|Lost to Follow-up|19|||
145433466|NCT02505425|524446081|FG000|Overall Study|Withdrawal by Subject|39|||
145433467|NCT02505425|524446082|FG001|Overall Study|Withdrawal by Subject|9|||
145433468|NCT02505425|524446083|FG002|Overall Study|Withdrawal by Subject|19|||
145433469|NCT02505425|524446084|FG003|Overall Study|Withdrawal by Subject|7|||
145433470|NCT02505425|524446081|FG000|Overall Study|Death|8|||
145433471|NCT02505425|524446082|FG001|Overall Study|Death|12|||
145433472|NCT02505425|524446083|FG002|Overall Study|Death|0|||
145433473|NCT02505425|524446084|FG003|Overall Study|Death|0|||
145433474|NCT02031302|524446085|FG000|Overall Study|Death|115|||
145433475|NCT02031302|524446086|FG001|Overall Study|Death|0|||
145433476|NCT02031302|524446085|FG000|Overall Study|Not treated with study valve system|18|||
145433477|NCT02031302|524446086|FG001|Overall Study|Not treated with study valve system|0|||
145433478|NCT02031302|524446085|FG000|Overall Study|Missed Follow Up|27|||
145433479|NCT02031302|524446086|FG001|Overall Study|Missed Follow Up|0|||
145433480|NCT02031302|524446085|FG000|Overall Study|Lost to Follow-up|4|||
145433481|NCT02031302|524446086|FG001|Overall Study|Lost to Follow-up|0|||
145433482|NCT02293551|524446093|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
145433483|NCT02293551|524446094|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
145433484|NCT02293551|524446095|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
145433485|NCT02293551|524446096|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
145433486|NCT02293551|524446097|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
145583009|NCT04096560|524987411|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145433487|NCT02293551|524446098|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
145583010|NCT04096560|524987412|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145433488|NCT02293551|524446093|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
145433489|NCT02293551|524446094|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
145433490|NCT02293551|524446095|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
145583011|NCT04096560|524987413|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145433491|NCT02293551|524446096|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
145433492|NCT02293551|524446097|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
145624405|NCT03682536|525137680|FG000|Treatment|Other Reasons|8|||
145624406|NCT03682536|525137681|FG001|Treatment|Other Reasons|7|||
145624407|NCT03682536|525137680|FG000|Treatment|Physician Decision|5|||
145624408|NCT03682536|525137681|FG001|Treatment|Physician Decision|5|||
145624409|NCT03682536|525137680|FG000|Treatment|Protocol Violation|1|||
145624410|NCT03682536|525137681|FG001|Treatment|Protocol Violation|0|||
145624411|NCT03682536|525137680|FG000|Treatment|Study Terminated by Sponsor|1|||
145624412|NCT03682536|525137681|FG001|Treatment|Study Terminated by Sponsor|2|||
145624413|NCT03682536|525137680|FG000|Treatment|Lost to Follow-up|0|||
145624414|NCT03682536|525137681|FG001|Treatment|Lost to Follow-up|1|||
145624415|NCT03682536|525137680|FG000|Treatment|Withdrawal by Subject|16|||
145624416|NCT03682536|525137681|FG001|Treatment|Withdrawal by Subject|18|||
145624417|NCT03682536|525137680|FG000|Treatment|Lack of Efficacy|41|||
145624418|NCT03682536|525137681|FG001|Treatment|Lack of Efficacy|68|||
145624419|NCT03682536|525137680|FG000|Treatment|Disease Progression|9|||
145433493|NCT02293551|524446098|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
145624420|NCT03682536|525137681|FG001|Treatment|Disease Progression|7|||
145624421|NCT03682536|525137680|FG000|Treatment|Adverse Event|9|||
145624422|NCT03682536|525137681|FG001|Treatment|Adverse Event|5|||
145624423|NCT03682536|525137680|FG000|Treatment|Death|14|||
145624424|NCT03682536|525137681|FG001|Treatment|Death|13|||
145624425|NCT05489224|525137682|FG000|Treatment Period I|Withdrawal by Subject|6|||
145624426|NCT05489224|525137683|FG001|Treatment Period I|Withdrawal by Subject|5|||
145624427|NCT05489224|525137684|FG002|Treatment Period I|Withdrawal by Subject|0|||
145624428|NCT05489224|525137682|FG000|Treatment Period I|Adverse Event|3|||
145624429|NCT05489224|525137683|FG001|Treatment Period I|Adverse Event|11|||
145624430|NCT05489224|525137684|FG002|Treatment Period I|Adverse Event|0|||
145624431|NCT05489224|525137682|FG000|Treatment Period I|Lost to Follow-up|0|||
145624432|NCT05489224|525137683|FG001|Treatment Period I|Lost to Follow-up|1|||
145624433|NCT05489224|525137684|FG002|Treatment Period I|Lost to Follow-up|0|||
145624434|NCT05489224|525137682|FG000|Treatment Period I|Physician Decision|0|||
145624435|NCT05489224|525137683|FG001|Treatment Period I|Physician Decision|1|||
145624436|NCT05489224|525137684|FG002|Treatment Period I|Physician Decision|0|||
145624437|NCT05489224|525137682|FG000|Treatment Period II up to Week 32|Ongoing|222|||
145624438|NCT05489224|525137683|FG001|Treatment Period II up to Week 32|Ongoing|107|||
145624439|NCT05489224|525137684|FG002|Treatment Period II up to Week 32|Ongoing|107|||
145624440|NCT05489224|525137682|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
145624441|NCT05489224|525137683|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
145624442|NCT05489224|525137684|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
145624443|NCT05489224|525137682|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
145624444|NCT05489224|525137683|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
145624445|NCT05489224|525137684|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
145624446|NCT04887285|525137685|FG000|Overall Study|Lost to Follow-up|0|||
145624447|NCT04887285|525137686|FG001|Overall Study|Lost to Follow-up|2|||
145624448|NCT04887285|525137687|FG002|Overall Study|Lost to Follow-up|3|||
145624449|NCT02820051|525137688|FG000|Overall Study|Lost to Follow-up|7|||
145624450|NCT02820051|525137689|FG001|Overall Study|Lost to Follow-up|4|||
145624451|NCT01222247|525137694|FG000|Overall Study|Lost to Follow-up|2|||
145624452|NCT01222247|525137695|FG001|Overall Study|Lost to Follow-up|2|||
145624453|NCT03289455|525137696|FG000|Overall Study|Death|1|||
145624454|NCT03289455|525137697|FG001|Overall Study|Death|0|||
145624455|NCT03289455|525137698|FG002|Overall Study|Death|0|||
145624456|NCT03289455|525137696|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
145624457|NCT03289455|525137697|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
145624458|NCT03289455|525137698|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
145624459|NCT03289455|525137696|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
145624460|NCT03289455|525137697|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
145624461|NCT03289455|525137698|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
145624462|NCT03289455|525137696|FG000|Overall Study|Progressive disease|3|||
145624463|NCT03289455|525137697|FG001|Overall Study|Progressive disease|4|||
145624464|NCT03289455|525137698|FG002|Overall Study|Progressive disease|5|||
145624465|NCT00333788|525137699|FG000|Overall Study|Adverse Event|44|||
145624466|NCT00333788|525137699|FG000|Overall Study|Lack of Efficacy|80|||
145433494|NCT02293551|524446093|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
145433495|NCT02293551|524446094|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
145433496|NCT02293551|524446095|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
145433497|NCT02293551|524446096|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
145433498|NCT02293551|524446097|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
145433499|NCT02293551|524446098|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
145624467|NCT00333788|525137699|FG000|Overall Study|Lost to Follow-up|2|||
145624468|NCT00333788|525137699|FG000|Overall Study|Withdrawal by Subject|24|||
145433500|NCT02936323|524446099|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433501|NCT02936323|524446100|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145433502|NCT02936323|524446101|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433503|NCT02936323|524446102|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145433504|NCT02936323|524446103|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145433505|NCT02936323|524446104|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
145433506|NCT02936323|524446105|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433507|NCT02936323|524446106|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433508|NCT02936323|524446107|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433509|NCT02936323|524446108|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
145433510|NCT02936323|524446099|FG000|Phase 1 Dose Escalation|Death|2|||
145433511|NCT02936323|524446100|FG001|Phase 1 Dose Escalation|Death|1|||
145433512|NCT02936323|524446101|FG002|Phase 1 Dose Escalation|Death|3|||
145433513|NCT02936323|524446102|FG003|Phase 1 Dose Escalation|Death|1|||
145583012|NCT04096560|524987414|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145583013|NCT04096560|524987415|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145583014|NCT04096560|524987416|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
145583015|NCT04096560|524987417|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
145583016|NCT04096560|524987418|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
145583017|NCT04096560|524987411|FG000|Overall Study|Study Terminated by Sponsor|0|||
145433514|NCT02936323|524446103|FG004|Phase 1 Dose Escalation|Death|2|||
145433515|NCT02936323|524446104|FG005|Phase 1 Dose Escalation|Death|3|||
145433516|NCT02936323|524446105|FG006|Phase 1 Dose Escalation|Death|3|||
145433517|NCT02936323|524446106|FG007|Phase 1 Dose Escalation|Death|0|||
145433518|NCT02936323|524446107|FG008|Phase 1 Dose Escalation|Death|0|||
145433519|NCT02936323|524446108|FG009|Phase 1 Dose Escalation|Death|0|||
145433520|NCT02936323|524446099|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433521|NCT02936323|524446100|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433522|NCT02936323|524446101|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433523|NCT02936323|524446102|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433524|NCT02936323|524446103|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433525|NCT02936323|524446104|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
145433526|NCT02936323|524446105|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433527|NCT02936323|524446106|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433528|NCT02936323|524446107|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433529|NCT02936323|524446108|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
145433530|NCT02936323|524446099|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433531|NCT02936323|524446100|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433532|NCT02936323|524446101|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433533|NCT02936323|524446102|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433534|NCT02936323|524446103|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433535|NCT02936323|524446104|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433536|NCT02936323|524446105|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
145433537|NCT02936323|524446106|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
145433538|NCT02936323|524446107|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
145433539|NCT02936323|524446108|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
145433540|NCT02936323|524446099|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
145433541|NCT02936323|524446100|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
145433542|NCT02936323|524446101|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
145433543|NCT02936323|524446102|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
145433544|NCT02936323|524446103|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
145433545|NCT02936323|524446104|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
145433546|NCT02936323|524446105|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
145433547|NCT02936323|524446106|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
145583018|NCT04096560|524987412|FG001|Overall Study|Study Terminated by Sponsor|0|||
145583019|NCT04096560|524987413|FG002|Overall Study|Study Terminated by Sponsor|0|||
145583020|NCT04096560|524987414|FG003|Overall Study|Study Terminated by Sponsor|5|||
145583021|NCT04096560|524987415|FG004|Overall Study|Study Terminated by Sponsor|6|||
145583022|NCT04096560|524987416|FG005|Overall Study|Study Terminated by Sponsor|4|||
145583023|NCT04096560|524987417|FG006|Overall Study|Study Terminated by Sponsor|6|||
145583024|NCT04096560|524987418|FG007|Overall Study|Study Terminated by Sponsor|1|||
145583025|NCT04096560|524987411|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145583026|NCT04096560|524987412|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145583027|NCT04096560|524987413|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145583028|NCT04096560|524987414|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145433548|NCT02936323|524446107|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
145433549|NCT02936323|524446108|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
145433550|NCT02936323|524446099|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433551|NCT02936323|524446100|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145583029|NCT04096560|524987415|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145624469|NCT00333788|525137699|FG000|Overall Study|Other: Non-compliance|2|||
145624470|NCT00333788|525137699|FG000|Overall Study|Other: Moved|2|||
145433552|NCT02936323|524446101|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433553|NCT02936323|524446102|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433554|NCT02936323|524446103|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433555|NCT02936323|524446104|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433556|NCT02936323|524446105|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433557|NCT02936323|524446106|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
145433558|NCT02936323|524446107|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
145433559|NCT02936323|524446108|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
145433560|NCT02936323|524446099|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433561|NCT02936323|524446100|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433562|NCT02936323|524446101|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433563|NCT02936323|524446102|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433564|NCT02936323|524446103|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433565|NCT02936323|524446104|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433566|NCT02936323|524446105|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433567|NCT02936323|524446106|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433568|NCT02936323|524446107|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
145433569|NCT02936323|524446108|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
145433570|NCT02936323|524446099|FG000|Phase 2a Dose Expansion|Death|0|||
145433571|NCT02936323|524446100|FG001|Phase 2a Dose Expansion|Death|0|||
145433572|NCT02936323|524446101|FG002|Phase 2a Dose Expansion|Death|0|||
145433573|NCT02936323|524446102|FG003|Phase 2a Dose Expansion|Death|0|||
145433574|NCT02936323|524446103|FG004|Phase 2a Dose Expansion|Death|0|||
145433575|NCT02936323|524446104|FG005|Phase 2a Dose Expansion|Death|0|||
145433576|NCT02936323|524446105|FG006|Phase 2a Dose Expansion|Death|0|||
145433577|NCT02936323|524446106|FG007|Phase 2a Dose Expansion|Death|4|||
145433578|NCT02936323|524446107|FG008|Phase 2a Dose Expansion|Death|8|||
145433579|NCT02936323|524446108|FG009|Phase 2a Dose Expansion|Death|10|||
145433580|NCT02781558|524446109|FG000|Overall Study|Lost to Follow-up|2|||
145433581|NCT02781558|524446110|FG001|Overall Study|Lost to Follow-up|2|||
145433582|NCT02781558|524446109|FG000|Overall Study|Adverse Event|1|||
145433583|NCT02781558|524446110|FG001|Overall Study|Adverse Event|0|||
145433584|NCT01542788|524446111|FG000|Overall Study|Randomized but Not Treated|2|||
145433585|NCT01542788|524446112|FG001|Overall Study|Randomized but Not Treated|0|||
145433586|NCT01542788|524446111|FG000|Overall Study|Lack of Efficacy|41|||
145433587|NCT01542788|524446112|FG001|Overall Study|Lack of Efficacy|71|||
145433588|NCT01542788|524446111|FG000|Overall Study|Lost to Follow-up|5|||
145433589|NCT01542788|524446112|FG001|Overall Study|Lost to Follow-up|0|||
145433590|NCT01542788|524446111|FG000|Overall Study|Death|3|||
145433591|NCT01542788|524446112|FG001|Overall Study|Death|0|||
145433592|NCT01542788|524446111|FG000|Overall Study|Protocol Violation|2|||
145433593|NCT01542788|524446112|FG001|Overall Study|Protocol Violation|0|||
145433594|NCT01542788|524446111|FG000|Overall Study|Physician Decision|1|||
145433595|NCT01542788|524446112|FG001|Overall Study|Physician Decision|0|||
145433596|NCT01542788|524446111|FG000|Overall Study|Withdrawal by Subject|1|||
145433597|NCT01542788|524446112|FG001|Overall Study|Withdrawal by Subject|0|||
145433598|NCT04712669|524446117|FG000|Double Blind Phase|Adverse Event|4|||
145433599|NCT04712669|524446118|FG001|Double Blind Phase|Adverse Event|4|||
145433600|NCT04712669|524446119|FG002|Double Blind Phase|Adverse Event|3|||
145433601|NCT04712669|524446120|FG003|Double Blind Phase|Adverse Event|0|||
145433602|NCT04712669|524446121|FG004|Double Blind Phase|Adverse Event|0|||
145433603|NCT04712669|524446122|FG005|Double Blind Phase|Adverse Event|0|||
145433604|NCT04712669|524446123|FG006|Double Blind Phase|Adverse Event|0|||
145433605|NCT04712669|524446124|FG007|Double Blind Phase|Adverse Event|0|||
145433606|NCT04712669|524446117|FG000|Double Blind Phase|Physician Decision|1|||
145433607|NCT04712669|524446118|FG001|Double Blind Phase|Physician Decision|0|||
145433608|NCT04712669|524446119|FG002|Double Blind Phase|Physician Decision|0|||
145433609|NCT04712669|524446120|FG003|Double Blind Phase|Physician Decision|0|||
145433610|NCT04712669|524446121|FG004|Double Blind Phase|Physician Decision|0|||
145433611|NCT04712669|524446122|FG005|Double Blind Phase|Physician Decision|0|||
145433612|NCT04712669|524446123|FG006|Double Blind Phase|Physician Decision|0|||
145433613|NCT04712669|524446124|FG007|Double Blind Phase|Physician Decision|0|||
145583030|NCT04096560|524987416|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145583031|NCT04096560|524987417|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
145583032|NCT04096560|524987418|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
145583033|NCT01343407|524987422|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
145433614|NCT04712669|524446117|FG000|Double Blind Phase|Withdrawal by Subject|3|||
145433615|NCT04712669|524446118|FG001|Double Blind Phase|Withdrawal by Subject|6|||
145433616|NCT04712669|524446119|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145433617|NCT04712669|524446120|FG003|Double Blind Phase|Withdrawal by Subject|0|||
145433618|NCT04712669|524446121|FG004|Double Blind Phase|Withdrawal by Subject|0|||
145583034|NCT01343407|524987423|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
145433619|NCT04712669|524446122|FG005|Double Blind Phase|Withdrawal by Subject|0|||
145433620|NCT04712669|524446123|FG006|Double Blind Phase|Withdrawal by Subject|0|||
145433621|NCT04712669|524446124|FG007|Double Blind Phase|Withdrawal by Subject|0|||
145433622|NCT04712669|524446117|FG000|Double Blind Phase|Termination by Sponsor|0|||
145433623|NCT04712669|524446118|FG001|Double Blind Phase|Termination by Sponsor|0|||
145433624|NCT04712669|524446119|FG002|Double Blind Phase|Termination by Sponsor|1|||
145433625|NCT04712669|524446120|FG003|Double Blind Phase|Termination by Sponsor|0|||
145433626|NCT04712669|524446121|FG004|Double Blind Phase|Termination by Sponsor|0|||
145433627|NCT04712669|524446122|FG005|Double Blind Phase|Termination by Sponsor|0|||
145433628|NCT04712669|524446123|FG006|Double Blind Phase|Termination by Sponsor|0|||
145433629|NCT04712669|524446124|FG007|Double Blind Phase|Termination by Sponsor|0|||
145433630|NCT04712669|524446117|FG000|Open Label Phase|Adverse Event|0|||
145433631|NCT04712669|524446118|FG001|Open Label Phase|Adverse Event|0|||
145433632|NCT04712669|524446119|FG002|Open Label Phase|Adverse Event|0|||
145433633|NCT04712669|524446120|FG003|Open Label Phase|Adverse Event|1|||
145433634|NCT04712669|524446121|FG004|Open Label Phase|Adverse Event|1|||
145433635|NCT04712669|524446122|FG005|Open Label Phase|Adverse Event|3|||
145433636|NCT04712669|524446123|FG006|Open Label Phase|Adverse Event|1|||
145433637|NCT04712669|524446124|FG007|Open Label Phase|Adverse Event|2|||
145433638|NCT04712669|524446117|FG000|Open Label Phase|Death|0|||
145433639|NCT04712669|524446118|FG001|Open Label Phase|Death|0|||
145433640|NCT04712669|524446119|FG002|Open Label Phase|Death|0|||
145433641|NCT04712669|524446120|FG003|Open Label Phase|Death|1|||
145433642|NCT04712669|524446121|FG004|Open Label Phase|Death|0|||
145433643|NCT04712669|524446122|FG005|Open Label Phase|Death|0|||
145433644|NCT04712669|524446123|FG006|Open Label Phase|Death|0|||
145433645|NCT04712669|524446124|FG007|Open Label Phase|Death|0|||
145433646|NCT04712669|524446117|FG000|Open Label Phase|Lack of Efficacy|0|||
145433647|NCT04712669|524446118|FG001|Open Label Phase|Lack of Efficacy|0|||
145433648|NCT04712669|524446119|FG002|Open Label Phase|Lack of Efficacy|0|||
145433649|NCT04712669|524446120|FG003|Open Label Phase|Lack of Efficacy|0|||
145433650|NCT04712669|524446121|FG004|Open Label Phase|Lack of Efficacy|1|||
145433651|NCT04712669|524446122|FG005|Open Label Phase|Lack of Efficacy|0|||
145433652|NCT04712669|524446123|FG006|Open Label Phase|Lack of Efficacy|0|||
145433653|NCT04712669|524446124|FG007|Open Label Phase|Lack of Efficacy|0|||
145433654|NCT04712669|524446117|FG000|Open Label Phase|Lost to Follow-up|0|||
145433655|NCT04712669|524446118|FG001|Open Label Phase|Lost to Follow-up|0|||
145433656|NCT04712669|524446119|FG002|Open Label Phase|Lost to Follow-up|0|||
145433657|NCT04712669|524446120|FG003|Open Label Phase|Lost to Follow-up|0|||
145433658|NCT04712669|524446121|FG004|Open Label Phase|Lost to Follow-up|0|||
145433659|NCT04712669|524446122|FG005|Open Label Phase|Lost to Follow-up|0|||
145433660|NCT04712669|524446123|FG006|Open Label Phase|Lost to Follow-up|1|||
145433661|NCT04712669|524446124|FG007|Open Label Phase|Lost to Follow-up|1|||
145433662|NCT04712669|524446117|FG000|Open Label Phase|Physician Decision|0|||
145433663|NCT04712669|524446118|FG001|Open Label Phase|Physician Decision|0|||
145433664|NCT04712669|524446119|FG002|Open Label Phase|Physician Decision|0|||
145433665|NCT04712669|524446120|FG003|Open Label Phase|Physician Decision|1|||
145433666|NCT04712669|524446121|FG004|Open Label Phase|Physician Decision|0|||
145433667|NCT04712669|524446122|FG005|Open Label Phase|Physician Decision|0|||
145433668|NCT04712669|524446123|FG006|Open Label Phase|Physician Decision|0|||
145433669|NCT04712669|524446124|FG007|Open Label Phase|Physician Decision|0|||
145433670|NCT04712669|524446117|FG000|Open Label Phase|Withdrawal by Subject|0|||
145433671|NCT04712669|524446118|FG001|Open Label Phase|Withdrawal by Subject|0|||
145433672|NCT04712669|524446119|FG002|Open Label Phase|Withdrawal by Subject|0|||
145433673|NCT04712669|524446120|FG003|Open Label Phase|Withdrawal by Subject|1|||
145433674|NCT04712669|524446121|FG004|Open Label Phase|Withdrawal by Subject|5|||
145433675|NCT04712669|524446122|FG005|Open Label Phase|Withdrawal by Subject|5|||
145433676|NCT04712669|524446123|FG006|Open Label Phase|Withdrawal by Subject|0|||
145433677|NCT04712669|524446124|FG007|Open Label Phase|Withdrawal by Subject|4|||
145433678|NCT04712669|524446117|FG000|Open Label Phase|Termination by Sponsor|0|||
145433679|NCT04712669|524446118|FG001|Open Label Phase|Termination by Sponsor|0|||
145433680|NCT04712669|524446119|FG002|Open Label Phase|Termination by Sponsor|0|||
145433681|NCT04712669|524446120|FG003|Open Label Phase|Termination by Sponsor|11|||
145433682|NCT04712669|524446121|FG004|Open Label Phase|Termination by Sponsor|9|||
145433683|NCT04712669|524446122|FG005|Open Label Phase|Termination by Sponsor|14|||
145433684|NCT04712669|524446123|FG006|Open Label Phase|Termination by Sponsor|0|||
145433685|NCT04712669|524446124|FG007|Open Label Phase|Termination by Sponsor|14|||
145433686|NCT04577404|524446125|FG000|Overall Study|Adverse Event|31|||
145433687|NCT04577404|524446125|FG000|Overall Study|Death|1|||
145433688|NCT04577404|524446125|FG000|Overall Study|Lack of Efficacy|3|||
145433689|NCT04577404|524446125|FG000|Overall Study|Physician Decision|7|||
145433690|NCT04577404|524446125|FG000|Overall Study|Withdrawal by Subject|21|||
145433691|NCT04577404|524446125|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
145433692|NCT03586973|524446135|FG000|Overall Study|Death|15|||
145433693|NCT03586973|524446136|FG001|Overall Study|Death|8|||
145433694|NCT03586973|524446135|FG000|Overall Study|Site Terminated by Sponsor|3|||
145433695|NCT03586973|524446136|FG001|Overall Study|Site Terminated by Sponsor|6|||
145433696|NCT03586973|524446135|FG000|Overall Study|Withdrawal by Subject|1|||
145433697|NCT03586973|524446136|FG001|Overall Study|Withdrawal by Subject|0|||
145433698|NCT03586973|524446135|FG000|Overall Study|Lost to Follow-up|1|||
145433699|NCT03586973|524446136|FG001|Overall Study|Lost to Follow-up|0|||
145433700|NCT02661672|524446140|FG000|Overall Study|Lost to Follow-up|1|||
145583035|NCT01343407|524987424|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
145583036|NCT01343407|524987425|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
145583037|NCT01343407|524987426|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
145583038|NCT01343407|524987427|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
145583039|NCT01343407|524987422|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
145583040|NCT01343407|524987423|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
145583041|NCT01343407|524987424|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
145583042|NCT01343407|524987425|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
145583043|NCT01343407|524987426|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
145583044|NCT01343407|524987427|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
145583045|NCT04079933|524987435|FG000|Overall Study|Withdrawal by Subject|3|||
145583046|NCT04079933|524987436|FG001|Overall Study|Withdrawal by Subject|4|||
145583047|NCT04079933|524987435|FG000|Overall Study|Lost to Follow-up|0|||
145583048|NCT04079933|524987436|FG001|Overall Study|Lost to Follow-up|1|||
145583049|NCT01986829|524987441|FG000|Overall Study|Death|1|||
145583050|NCT04788147|524987442|FG000|Overall Study|Screen Failure|3|||
145583051|NCT04788147|524987443|FG001|Overall Study|Screen Failure|10|||
145433701|NCT02661672|524446140|FG000|Overall Study|Death|4|||
145433702|NCT00269113|524447781|FG000|Overall Study|Adverse Event|14|||
145433703|NCT00269113|524447782|FG001|Overall Study|Adverse Event|7|||
145433704|NCT00269113|524447781|FG000|Overall Study|Lack of Efficacy|35|||
145433705|NCT00269113|524447782|FG001|Overall Study|Lack of Efficacy|18|||
145433706|NCT00269113|524447781|FG000|Overall Study|Early Improvement|2|||
145433707|NCT00269113|524447782|FG001|Overall Study|Early Improvement|0|||
145433708|NCT00269113|524447781|FG000|Overall Study|Withdrawal by Subject|0|||
145433709|NCT00269113|524447782|FG001|Overall Study|Withdrawal by Subject|2|||
145433710|NCT00269113|524447781|FG000|Overall Study|Death|6|||
145433711|NCT00269113|524447782|FG001|Overall Study|Death|2|||
145433712|NCT00269113|524447781|FG000|Overall Study|Lost to Follow-up|2|||
145433713|NCT00269113|524447782|FG001|Overall Study|Lost to Follow-up|1|||
145433714|NCT00269113|524447781|FG000|Overall Study|Protocol Violation|15|||
145433715|NCT00269113|524447782|FG001|Overall Study|Protocol Violation|5|||
145433716|NCT00269113|524447781|FG000|Overall Study|Other|0|||
145433717|NCT00269113|524447782|FG001|Overall Study|Other|2|||
145433718|NCT00503984|524447783|FG000|Overall Study|Protocol Violation|0|||
145433719|NCT00503984|524447784|FG001|Overall Study|Protocol Violation|1|||
145433720|NCT00503984|524447785|FG002|Overall Study|Protocol Violation|0|||
145433721|NCT00503984|524447786|FG003|Overall Study|Protocol Violation|0|||
145433722|NCT00503984|524447787|FG004|Overall Study|Protocol Violation|0|||
145433723|NCT00503984|524447788|FG005|Overall Study|Protocol Violation|0|||
145433724|NCT00503984|524447783|FG000|Overall Study|Adverse Event|0|||
145433725|NCT00503984|524447784|FG001|Overall Study|Adverse Event|1|||
145433726|NCT00503984|524447785|FG002|Overall Study|Adverse Event|0|||
145433727|NCT00503984|524447786|FG003|Overall Study|Adverse Event|0|||
145433728|NCT00503984|524447787|FG004|Overall Study|Adverse Event|0|||
145433729|NCT00503984|524447788|FG005|Overall Study|Adverse Event|0|||
145433730|NCT00503984|524447783|FG000|Overall Study|Death|0|||
145433731|NCT00503984|524447784|FG001|Overall Study|Death|0|||
145433732|NCT00503984|524447785|FG002|Overall Study|Death|0|||
145433733|NCT00503984|524447786|FG003|Overall Study|Death|0|||
145433734|NCT00503984|524447787|FG004|Overall Study|Death|1|||
145433735|NCT00503984|524447788|FG005|Overall Study|Death|0|||
145433736|NCT02122380|524447791|FG000|First Intervention (30 Days)|Adverse Event|1|||
145433737|NCT02122380|524447792|FG001|First Intervention (30 Days)|Adverse Event|0|||
145433738|NCT02122380|524447791|FG000|First Intervention (30 Days)|Physician Decision|0|||
145433739|NCT02122380|524447792|FG001|First Intervention (30 Days)|Physician Decision|1|||
145433740|NCT02122380|524447791|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
145433741|NCT02122380|524447792|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
145433742|NCT02122380|524447791|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
145433743|NCT02122380|524447792|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
145433744|NCT02122380|524447791|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
145433745|NCT02122380|524447792|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
145433746|NCT00140140|524447794|FG000|Overall Study|Unacceptable toxicity|1|||
145433747|NCT00140140|524447795|FG001|Overall Study|Unacceptable toxicity|1|||
145433748|NCT00140140|524447796|FG002|Overall Study|Unacceptable toxicity|2|||
145433749|NCT00140140|524447794|FG000|Overall Study|Physician Decision|1|||
145433750|NCT00140140|524447795|FG001|Overall Study|Physician Decision|1|||
145433751|NCT00140140|524447796|FG002|Overall Study|Physician Decision|0|||
145433752|NCT03376516|524447797|FG000|Overall Study|Not treated|1|||
145433753|NCT03376516|524447797|FG000|Overall Study|Consent withdrawn|1|||
145433754|NCT01581684|524447798|FG000|Overall Study|Other reason not defined|0|||
145433755|NCT01581684|524447799|FG001|Overall Study|Other reason not defined|0|||
145433756|NCT01581684|524447800|FG002|Overall Study|Other reason not defined|0|||
145433757|NCT01581684|524447801|FG003|Overall Study|Other reason not defined|0|||
145433758|NCT01581684|524447802|FG004|Overall Study|Other reason not defined|0|||
145433759|NCT01581684|524447803|FG005|Overall Study|Other reason not defined|0|||
145433760|NCT01581684|524447804|FG006|Overall Study|Other reason not defined|0|||
145433761|NCT01581684|524447805|FG007|Overall Study|Other reason not defined|0|||
145433762|NCT01581684|524447806|FG008|Overall Study|Other reason not defined|1|||
145433763|NCT01581684|524447807|FG009|Overall Study|Other reason not defined|0|||
145433764|NCT00598650|524447808|FG000|Overall Study|Withdrawal by Subject|3|||
145433765|NCT00598650|524447808|FG000|Overall Study|Adverse Event|18|||
145433766|NCT00598650|524447808|FG000|Overall Study|No treatment for 3 weeks|1|||
145433767|NCT00598650|524447808|FG000|Overall Study|Not eligible|1|||
145433768|NCT00598650|524447808|FG000|Overall Study|Prohibited Concomitant Medication|2|||
145433769|NCT00598650|524447808|FG000|Overall Study|Physician Decision|2|||
145433770|NCT01128569|524447809|FG000|Washout Period 1|Adverse Event|0|||
145433771|NCT01128569|524447810|FG001|Washout Period 1|Adverse Event|0|||
145433772|NCT01128569|524447811|FG002|Washout Period 1|Adverse Event|1|||
145433773|NCT01128569|524447812|FG003|Washout Period 1|Adverse Event|0|||
145433774|NCT01128569|524447813|FG004|Washout Period 1|Adverse Event|0|||
145433775|NCT01128569|524447814|FG005|Washout Period 1|Adverse Event|0|||
145433776|NCT01128569|524447809|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145433777|NCT01128569|524447810|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145433778|NCT01128569|524447811|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145433779|NCT01128569|524447812|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145433780|NCT01128569|524447813|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145433781|NCT01128569|524447814|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145433782|NCT03338400|524447815|FG000|Overall Study|Lost to Follow-up|1|||
145433783|NCT03338400|524447816|FG001|Overall Study|Lost to Follow-up|2|||
145433784|NCT01865487|524447820|FG000|Overall Study|Lost to Follow-up|0|||
145433785|NCT01865487|524447821|FG001|Overall Study|Lost to Follow-up|0|||
145433786|NCT01865487|524447822|FG002|Overall Study|Lost to Follow-up|0|||
145433787|NCT01865487|524447823|FG003|Overall Study|Lost to Follow-up|1|||
145433788|NCT01865487|524447824|FG004|Overall Study|Lost to Follow-up|0|||
145433789|NCT01865487|524447825|FG005|Overall Study|Lost to Follow-up|0|||
145433790|NCT01865487|524447826|FG006|Overall Study|Lost to Follow-up|1|||
145433791|NCT01865487|524447827|FG007|Overall Study|Lost to Follow-up|0|||
145433792|NCT01865487|524447828|FG008|Overall Study|Lost to Follow-up|0|||
145433793|NCT01865487|524447829|FG009|Overall Study|Lost to Follow-up|0|||
145433794|NCT01865487|524447820|FG000|Overall Study|Withdrawal by Subject|0|||
145433795|NCT01865487|524447821|FG001|Overall Study|Withdrawal by Subject|0|||
145433796|NCT01865487|524447822|FG002|Overall Study|Withdrawal by Subject|0|||
145433797|NCT01865487|524447823|FG003|Overall Study|Withdrawal by Subject|0|||
145433798|NCT01865487|524447824|FG004|Overall Study|Withdrawal by Subject|1|||
145433799|NCT01865487|524447825|FG005|Overall Study|Withdrawal by Subject|0|||
145433800|NCT01865487|524447826|FG006|Overall Study|Withdrawal by Subject|0|||
145433801|NCT01865487|524447827|FG007|Overall Study|Withdrawal by Subject|0|||
145433802|NCT01865487|524447828|FG008|Overall Study|Withdrawal by Subject|0|||
145433803|NCT01865487|524447829|FG009|Overall Study|Withdrawal by Subject|0|||
145433804|NCT01531998|524447834|FG000|Overall Study|Withdrawal by Subject|3|||
145433805|NCT00107276|524447840|FG000|Overall Study|Progression|46|||
145433806|NCT00107276|524447840|FG000|Overall Study|Adverse Event|6|||
145433807|NCT00107276|524447840|FG000|Overall Study|M.D. decision|2|||
145433808|NCT00107276|524447840|FG000|Overall Study|Patient refusal|1|||
145433809|NCT00107276|524447840|FG000|Overall Study|Death|1|||
145433810|NCT00107276|524447840|FG000|Overall Study|Ineligible|16|||
145433811|NCT03179761|524447841|FG000|Overall Study|Death|2|||
145433812|NCT03179761|524447842|FG001|Overall Study|Death|5|||
145433813|NCT03179761|524447841|FG000|Overall Study|Lost to Follow-up|2|||
145433814|NCT03179761|524447842|FG001|Overall Study|Lost to Follow-up|2|||
145433815|NCT03179761|524447841|FG000|Overall Study|Protocol Violation|1|||
145433816|NCT03179761|524447842|FG001|Overall Study|Protocol Violation|0|||
145433817|NCT03179761|524447841|FG000|Overall Study|Withdrawal by Subject|1|||
145433818|NCT03179761|524447842|FG001|Overall Study|Withdrawal by Subject|4|||
145624471|NCT00333788|525137699|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
145624472|NCT00333788|525137699|FG000|Overall Study|Other: Investigator decision|1|||
145624473|NCT00333788|525137699|FG000|Overall Study|Other: Quality of life concern|1|||
145624474|NCT00333788|525137699|FG000|Overall Study|Other: Sponsor decision|1|||
145624475|NCT00333788|525137699|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
145624476|NCT00333788|525137699|FG000|Overall Study|Other: Medical monitor decision|1|||
145624477|NCT00333788|525137699|FG000|Overall Study|Other: Physician decision|1|||
145624478|NCT00333788|525137699|FG000|Overall Study|Other: Signed consent for another study|1|||
145624479|NCT02956967|525137703|FG000|Overall Study|Adverse Event|3|||
145624480|NCT02956967|525137703|FG000|Overall Study|Reason non-related to neutropenia|10|||
145624481|NCT02956967|525137703|FG000|Overall Study|Lost to Follow-up|5|||
145624482|NCT02956967|525137703|FG000|Overall Study|Missing|1|||
145433819|NCT03179761|524447841|FG000|Overall Study|Investigator Request|0|||
145433820|NCT03179761|524447842|FG001|Overall Study|Investigator Request|2|||
145433821|NCT04661033|524447843|FG000|Overall Study|Adverse Event|0|||
145433822|NCT04661033|524447844|FG001|Overall Study|Adverse Event|0|||
145433823|NCT04661033|524447845|FG002|Overall Study|Adverse Event|1|||
145433824|NCT04661033|524447846|FG003|Overall Study|Adverse Event|0|||
145433825|NCT04661033|524447843|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
145624483|NCT02956967|525137703|FG000|Overall Study|Termination of Nivestim administration|29|||
145624484|NCT02322775|525137704|FG000|Overall Study|Adverse Event|1|||
145624485|NCT02322775|525137705|FG001|Overall Study|Adverse Event|0|||
145624486|NCT02322775|525137704|FG000|Overall Study|Lost to Follow-up|0|||
145624487|NCT02322775|525137705|FG001|Overall Study|Lost to Follow-up|1|||
145624488|NCT02322775|525137704|FG000|Overall Study|Protocol Violation|1|||
145624489|NCT02322775|525137705|FG001|Overall Study|Protocol Violation|0|||
145624490|NCT02322775|525137704|FG000|Overall Study|Withdrawal by Subject|3|||
145624491|NCT02322775|525137705|FG001|Overall Study|Withdrawal by Subject|4|||
145624492|NCT02322775|525137704|FG000|Overall Study|Not willing to perform all FU visits|0|||
145624493|NCT02322775|525137705|FG001|Overall Study|Not willing to perform all FU visits|1|||
145624494|NCT04482855|525137706|FG000|Overall Study|Lost to Follow-up|1|||
145624495|NCT04482855|525137707|FG001|Overall Study|Lost to Follow-up|0|||
145624496|NCT04482855|525137706|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
145624497|NCT04482855|525137707|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
145433826|NCT04661033|524447844|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145433827|NCT04661033|524447845|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145433828|NCT04661033|524447846|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
145433829|NCT04661033|524447843|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
145433830|NCT04661033|524447844|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
145433831|NCT04661033|524447845|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
145433832|NCT04661033|524447846|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
145433833|NCT04661033|524447843|FG000|Overall Study|Early discontinuation as per PI|1|||
145433834|NCT04661033|524447844|FG001|Overall Study|Early discontinuation as per PI|0|||
145433835|NCT04661033|524447845|FG002|Overall Study|Early discontinuation as per PI|0|||
145433836|NCT04661033|524447846|FG003|Overall Study|Early discontinuation as per PI|0|||
145433837|NCT03440008|524447849|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
145433838|NCT03440008|524447850|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
145433839|NCT03440008|524447849|FG000|Overall Study|Withdrawal by Subject|1|||
145433840|NCT03440008|524447850|FG001|Overall Study|Withdrawal by Subject|0|||
145433841|NCT03498716|524447858|FG000|Overall Study|Withdrawal by Subject|88|||
145433842|NCT03498716|524447859|FG001|Overall Study|Withdrawal by Subject|73|||
145433843|NCT03498716|524447858|FG000|Overall Study|Study Terminated By Sponsor|933|||
145433844|NCT03498716|524447859|FG001|Overall Study|Study Terminated By Sponsor|927|||
145433845|NCT03498716|524447858|FG000|Overall Study|Lost to Follow-up|15|||
145433846|NCT03498716|524447859|FG001|Overall Study|Lost to Follow-up|26|||
145433847|NCT03498716|524447858|FG000|Overall Study|Disease Relapse|0|||
145433848|NCT03498716|524447859|FG001|Overall Study|Disease Relapse|1|||
145433849|NCT03498716|524447858|FG000|Overall Study|Death|58|||
145433850|NCT03498716|524447859|FG001|Overall Study|Death|72|||
145433851|NCT03498716|524447858|FG000|Overall Study|Physician Decision|4|||
145433852|NCT03498716|524447859|FG001|Overall Study|Physician Decision|2|||
145433853|NCT02284191|524447860|FG000|Overall Study|Withdrawal by Subject|1|||
145433854|NCT02284191|524447861|FG001|Overall Study|Withdrawal by Subject|3|||
145433855|NCT02284191|524447860|FG000|Overall Study|Lost to Follow-up|1|||
145433856|NCT02284191|524447861|FG001|Overall Study|Lost to Follow-up|0|||
145433857|NCT01570387|524447865|FG000|Overall Study|Adverse Event|1|||
145433858|NCT01570387|524447866|FG001|Overall Study|Adverse Event|0|||
145433859|NCT01570387|524447867|FG002|Overall Study|Adverse Event|0|||
145433860|NCT01570387|524447868|FG003|Overall Study|Adverse Event|0|||
145433861|NCT01570387|524447865|FG000|Overall Study|Death|0|||
145433862|NCT01570387|524447866|FG001|Overall Study|Death|0|||
145433863|NCT01570387|524447867|FG002|Overall Study|Death|0|||
145433864|NCT01570387|524447868|FG003|Overall Study|Death|1|||
145433865|NCT01570387|524447865|FG000|Overall Study|Withdrawal by Subject|0|||
145433866|NCT01570387|524447866|FG001|Overall Study|Withdrawal by Subject|0|||
145433867|NCT01570387|524447867|FG002|Overall Study|Withdrawal by Subject|0|||
145433868|NCT01570387|524447868|FG003|Overall Study|Withdrawal by Subject|1|||
145433869|NCT03139448|524447869|FG000|Overall Study|Lack of Efficacy|6|||
145433870|NCT03139448|524447870|FG001|Overall Study|Lack of Efficacy|7|||
145433871|NCT03139448|524447869|FG000|Overall Study|Location of procedure changed|2|||
145433872|NCT03139448|524447870|FG001|Overall Study|Location of procedure changed|8|||
145433873|NCT03139448|524447869|FG000|Overall Study|Withdrawal by Subject|3|||
145433874|NCT03139448|524447870|FG001|Overall Study|Withdrawal by Subject|6|||
145433875|NCT03139448|524447869|FG000|Overall Study|Screen fail|1|||
145433876|NCT03139448|524447870|FG001|Overall Study|Screen fail|3|||
145433877|NCT03139448|524447869|FG000|Overall Study|Physician Decision|0|||
145433878|NCT03139448|524447870|FG001|Overall Study|Physician Decision|2|||
145433879|NCT00760552|524447871|FG000|Overall Study|Death|2|||
145433880|NCT00760552|524447872|FG001|Overall Study|Death|0|||
145433881|NCT00760552|524447871|FG000|Overall Study|Lost to Follow-up|11|||
145433882|NCT00760552|524447872|FG001|Overall Study|Lost to Follow-up|10|||
145433883|NCT01823289|524447881|FG000|Overall Study|Lost to Follow-up|5|||
145433884|NCT01823289|524447881|FG000|Overall Study|Adverse Event|5|||
145433885|NCT01823289|524447881|FG000|Overall Study|Lack of Efficacy|1|||
145433886|NCT01823289|524447881|FG000|Overall Study|Physician Decision|9|||
145433887|NCT01823289|524447881|FG000|Overall Study|Administered contraindicated medicine|1|||
145433888|NCT01823289|524447881|FG000|Overall Study|Transaminase increased more than 3 times|1|||
145433889|NCT01823289|524447881|FG000|Overall Study|Drug affected efficacy and safety|1|||
145433890|NCT01823289|524447881|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
145433891|NCT01736917|524447882|FG000|Overall Study|Adverse Event|1|||
145433892|NCT01736917|524447882|FG000|Overall Study|Protocol Violation|10|||
145433893|NCT01911260|524447883|FG000|Supplementation Period|transference or evasion of school|7|||
145433894|NCT01911260|524447884|FG001|Supplementation Period|transference or evasion of school|9|||
145433895|NCT01911260|524447885|FG002|Supplementation Period|transference or evasion of school|7|||
145433896|NCT01911260|524447886|FG003|Supplementation Period|transference or evasion of school|6|||
145433897|NCT01911260|524447883|FG000|Supplementation Period|Adverse Event|2|||
145433898|NCT01911260|524447884|FG001|Supplementation Period|Adverse Event|0|||
145433899|NCT01911260|524447885|FG002|Supplementation Period|Adverse Event|1|||
145433900|NCT01911260|524447886|FG003|Supplementation Period|Adverse Event|0|||
145433901|NCT01911260|524447883|FG000|Supplementation Period|refused to receive supplement|1|||
145433902|NCT01911260|524447884|FG001|Supplementation Period|refused to receive supplement|0|||
145433903|NCT01911260|524447885|FG002|Supplementation Period|refused to receive supplement|1|||
145433904|NCT01911260|524447886|FG003|Supplementation Period|refused to receive supplement|0|||
145433905|NCT01911260|524447883|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
145433906|NCT01911260|524447884|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
145433907|NCT01911260|524447885|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
145433908|NCT01911260|524447886|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
145433909|NCT01911260|524447883|FG000|Follow-up Period|transference or evasion of school|13|||
145433910|NCT01911260|524447884|FG001|Follow-up Period|transference or evasion of school|20|||
145433911|NCT01911260|524447885|FG002|Follow-up Period|transference or evasion of school|15|||
145433912|NCT01911260|524447886|FG003|Follow-up Period|transference or evasion of school|12|||
145433913|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
145433914|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
145433915|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
145433916|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Death|0|||
145433917|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Death|0|||
145433918|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Death|1|||
145433919|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
145433920|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
145433921|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
145433922|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
145433923|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
145433924|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
145433925|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
145433926|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
145433927|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
145433928|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Graft loss|0|||
145433929|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Graft loss|0|||
145433930|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Graft loss|7|||
145433931|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
145433932|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
145433933|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
145433934|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
145433935|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
145433936|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
145433937|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
145433938|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
145433939|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
145433940|NCT00956293|524447889|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
145433941|NCT00956293|524447890|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
145433942|NCT00956293|524447891|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
145433943|NCT00956293|524447889|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
145433944|NCT00956293|524447890|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
145433945|NCT00956293|524447891|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
145433946|NCT00956293|524447889|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
145433947|NCT00956293|524447890|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
145433948|NCT00956293|524447891|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
145433949|NCT00956293|524447889|FG000|Main Period (Randomization)|Adverse Event|0|||
145433950|NCT00956293|524447890|FG001|Main Period (Randomization)|Adverse Event|15|||
145433951|NCT00956293|524447891|FG002|Main Period (Randomization)|Adverse Event|0|||
145433952|NCT00956293|524447889|FG000|Follow-up Period|Follow-up period was terminated.|20|||
145433953|NCT00956293|524447890|FG001|Follow-up Period|Follow-up period was terminated.|32|||
145583052|NCT04788147|524987442|FG000|Overall Study|Incomplete RMRS image session|2|||
145583053|NCT04788147|524987443|FG001|Overall Study|Incomplete RMRS image session|0|||
145583054|NCT00781326|524987446|FG000|Phase I|Adverse Event|1|||
145583055|NCT00781326|524987446|FG000|Phase I|Withdrawal by Subject|1|||
145583056|NCT00781326|524987446|FG000|Phase I|Physician Decision|2|||
145583057|NCT02401672|524987449|FG000|Overall Study|Withdrawal by Subject|1|||
145583058|NCT02401672|524987450|FG001|Overall Study|Withdrawal by Subject|3|||
145583059|NCT04796610|524987451|FG000|Overall Study|Withdrawal by Subject|1|||
145583060|NCT04796610|524987452|FG001|Overall Study|Withdrawal by Subject|0|||
145583061|NCT04796610|524987453|FG002|Overall Study|Withdrawal by Subject|0|||
145583062|NCT04796610|524987454|FG003|Overall Study|Withdrawal by Subject|0|||
145583063|NCT04796610|524987451|FG000|Overall Study|Lost to Follow-up|2|||
145583064|NCT04796610|524987452|FG001|Overall Study|Lost to Follow-up|0|||
145583065|NCT04796610|524987453|FG002|Overall Study|Lost to Follow-up|1|||
145583066|NCT04796610|524987454|FG003|Overall Study|Lost to Follow-up|1|||
145433954|NCT00956293|524447891|FG002|Follow-up Period|Follow-up period was terminated.|0|||
145433955|NCT01240863|524447894|FG000|Open-label Titration Period|Adverse Event|47|||
145433956|NCT01240863|524447895|FG001|Open-label Titration Period|Adverse Event|0|||
145433957|NCT01240863|524447896|FG002|Open-label Titration Period|Adverse Event|0|||
145433958|NCT01240863|524447894|FG000|Open-label Titration Period|Lack of Efficacy|19|||
145433959|NCT01240863|524447895|FG001|Open-label Titration Period|Lack of Efficacy|0|||
145433960|NCT01240863|524447896|FG002|Open-label Titration Period|Lack of Efficacy|0|||
145433961|NCT01240863|524447894|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
145433962|NCT01240863|524447895|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
145433963|NCT01240863|524447896|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
145433964|NCT01240863|524447894|FG000|Open-label Titration Period|Protocol Violation|7|||
145433965|NCT01240863|524447895|FG001|Open-label Titration Period|Protocol Violation|0|||
145433966|NCT01240863|524447896|FG002|Open-label Titration Period|Protocol Violation|0|||
145433967|NCT01240863|524447894|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
145433968|NCT01240863|524447895|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
145433969|NCT01240863|524447896|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
145433970|NCT01240863|524447894|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
145433971|NCT01240863|524447895|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
145433972|NCT01240863|524447896|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
145433973|NCT01240863|524447894|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
145433974|NCT01240863|524447895|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
145433975|NCT01240863|524447896|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
145433976|NCT01240863|524447894|FG000|Open-label Titration Period|Other|7|||
145433977|NCT01240863|524447895|FG001|Open-label Titration Period|Other|0|||
145433978|NCT01240863|524447896|FG002|Open-label Titration Period|Other|0|||
145433979|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
145433980|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
145433981|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
145433982|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
145433983|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
145433984|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
145433985|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
145433986|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
145433987|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
145433988|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
145433989|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
145433990|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
145433991|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
145433992|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
145433993|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
145433994|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
145433995|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
145433996|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
145433997|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
145433998|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
145433999|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
145434000|NCT01240863|524447894|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
145434001|NCT01240863|524447895|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
145434002|NCT01240863|524447896|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
145583067|NCT01459796|524987455|FG000|Overall Study|Non compliance with protocol|2|||
145583068|NCT01459796|524987456|FG001|Overall Study|Non compliance with protocol|4|||
145583069|NCT01459796|524987455|FG000|Overall Study|Adverse Event|5|||
145434003|NCT05899829|524447897|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
145434004|NCT05899829|524447898|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
145434005|NCT05899829|524447897|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
145434006|NCT05899829|524447898|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
145434007|NCT00636181|524447901|FG000|Overall Study|Withdrawal by Subject|8|||
145434008|NCT00636181|524447902|FG001|Overall Study|Withdrawal by Subject|6|||
145434009|NCT00636181|524447903|FG002|Overall Study|Withdrawal by Subject|10|||
145434010|NCT04549454|524447906|FG000|T1 to T2|Lost to Follow-up|22|||
145434011|NCT04549454|524447907|FG001|T1 to T2|Lost to Follow-up|26|||
145434012|NCT04549454|524447906|FG000|T1 to T3|Lost to Follow-up|31|||
145434013|NCT04549454|524447907|FG001|T1 to T3|Lost to Follow-up|36|||
145434014|NCT00867035|524447913|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
145434015|NCT00867035|524447914|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
145434016|NCT00867035|524447913|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
145434017|NCT00867035|524447914|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
145434018|NCT02993263|524447920|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
145434019|NCT00545779|524447925|FG000|Overall Study|Violation of selection criteria at entry|8|||
145434020|NCT00545779|524447925|FG000|Overall Study|Other protocol violation|1|||
145434021|NCT00545779|524447925|FG000|Overall Study|Did not cooperate|7|||
145434022|NCT00545779|524447925|FG000|Overall Study|Withdrawal by Subject|20|||
145434023|NCT00545779|524447925|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
145434024|NCT00545779|524447925|FG000|Overall Study|Failure to return|3|||
145434025|NCT01405196|524447926|FG000|Overall Study|Study Terminated by Sponsor|0|||
145434026|NCT01405196|524447927|FG001|Overall Study|Study Terminated by Sponsor|0|||
145434027|NCT01405196|524447928|FG002|Overall Study|Study Terminated by Sponsor|9|||
145434028|NCT01405196|524447929|FG003|Overall Study|Study Terminated by Sponsor|0|||
145434029|NCT01405196|524447926|FG000|Overall Study|Other|2|||
145434030|NCT01405196|524447927|FG001|Overall Study|Other|2|||
145434031|NCT01405196|524447928|FG002|Overall Study|Other|5|||
145434032|NCT01405196|524447929|FG003|Overall Study|Other|0|||
145434033|NCT01405196|524447926|FG000|Overall Study|Withdrawal by Subject|4|||
145434034|NCT01405196|524447927|FG001|Overall Study|Withdrawal by Subject|6|||
145434035|NCT01405196|524447928|FG002|Overall Study|Withdrawal by Subject|3|||
145434036|NCT01405196|524447929|FG003|Overall Study|Withdrawal by Subject|6|||
145434037|NCT01405196|524447926|FG000|Overall Study|Adverse Event|2|||
145434038|NCT01405196|524447927|FG001|Overall Study|Adverse Event|2|||
145434039|NCT01405196|524447928|FG002|Overall Study|Adverse Event|0|||
145434040|NCT01405196|524447929|FG003|Overall Study|Adverse Event|2|||
145434041|NCT01405196|524447926|FG000|Overall Study|Death|1|||
145434042|NCT01405196|524447927|FG001|Overall Study|Death|0|||
145434043|NCT01405196|524447928|FG002|Overall Study|Death|3|||
145434044|NCT01405196|524447929|FG003|Overall Study|Death|0|||
145434045|NCT01405196|524447926|FG000|Overall Study|Lost to Follow-up|2|||
145434046|NCT01405196|524447927|FG001|Overall Study|Lost to Follow-up|2|||
145434047|NCT01405196|524447928|FG002|Overall Study|Lost to Follow-up|3|||
145434048|NCT01405196|524447929|FG003|Overall Study|Lost to Follow-up|1|||
145434049|NCT00542178|524447930|FG000|Overall Study|did not complete year 4 follow-up|75|||
145434050|NCT00542178|524447931|FG001|Overall Study|did not complete year 4 follow-up|80|||
145434051|NCT00542178|524447932|FG002|Overall Study|did not complete year 4 follow-up|74|||
145434052|NCT00542178|524447933|FG003|Overall Study|did not complete year 4 follow-up|62|||
145434053|NCT00542178|524447934|FG004|Overall Study|did not complete year 4 follow-up|64|||
145434054|NCT00542178|524447935|FG005|Overall Study|did not complete year 4 follow-up|89|||
145434055|NCT00542178|524447936|FG006|Overall Study|did not complete year 4 follow-up|87|||
145434056|NCT00542178|524447937|FG007|Overall Study|did not complete year 4 follow-up|85|||
145434057|NCT02611037|524447938|FG000|Overall Study|Withdrawal prior to treatment|2|||
145434058|NCT02611037|524447939|FG001|Overall Study|Withdrawal prior to treatment|0|||
145434059|NCT05270863|524447940|FG000|Visit 2 First Intervention|Randomization error|0|||
145434060|NCT05270863|524447941|FG001|Visit 2 First Intervention|Randomization error|0|||
145434061|NCT05270863|524447942|FG002|Visit 2 First Intervention|Randomization error|0|||
145434062|NCT05270863|524447943|FG003|Visit 2 First Intervention|Randomization error|1|||
145434063|NCT05270863|524447944|FG004|Visit 2 First Intervention|Randomization error|0|||
145434064|NCT05270863|524447945|FG005|Visit 2 First Intervention|Randomization error|0|||
145434065|NCT05270863|524447940|FG000|First Washout|Withdrawal by Subject|0|||
145434066|NCT05270863|524447941|FG001|First Washout|Withdrawal by Subject|0|||
145434067|NCT05270863|524447942|FG002|First Washout|Withdrawal by Subject|0|||
145434068|NCT05270863|524447943|FG003|First Washout|Withdrawal by Subject|0|||
145434069|NCT05270863|524447944|FG004|First Washout|Withdrawal by Subject|1|||
145434070|NCT05270863|524447945|FG005|First Washout|Withdrawal by Subject|1|||
145434071|NCT05270863|524447940|FG000|First Washout|Lost to Follow-up|0|||
145434072|NCT05270863|524447941|FG001|First Washout|Lost to Follow-up|0|||
145434073|NCT05270863|524447942|FG002|First Washout|Lost to Follow-up|0|||
145434074|NCT05270863|524447943|FG003|First Washout|Lost to Follow-up|0|||
145434075|NCT05270863|524447944|FG004|First Washout|Lost to Follow-up|0|||
145434076|NCT05270863|524447945|FG005|First Washout|Lost to Follow-up|1|||
145434077|NCT05270863|524447940|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
145583070|NCT01459796|524987456|FG001|Overall Study|Adverse Event|5|||
145583071|NCT01459796|524987455|FG000|Overall Study|Withdrawal by Subject|6|||
145583072|NCT01459796|524987456|FG001|Overall Study|Withdrawal by Subject|3|||
145583073|NCT01459796|524987455|FG000|Overall Study|Lost to Follow-up|5|||
145583074|NCT01459796|524987456|FG001|Overall Study|Lost to Follow-up|4|||
145583075|NCT01459796|524987455|FG000|Overall Study|Reason unspecified|1|||
145583076|NCT01459796|524987456|FG001|Overall Study|Reason unspecified|2|||
145583077|NCT01459796|524987455|FG000|Overall Study|Decision by the sponsor|75|||
145583078|NCT01459796|524987456|FG001|Overall Study|Decision by the sponsor|108|||
145583079|NCT00701051|524987457|FG000|Screening|Failed Screening|40|||
145583080|NCT00701051|524987458|FG001|Screening|Failed Screening|0|||
145583081|NCT00701051|524987459|FG002|Screening|Failed Screening|0|||
145583082|NCT00701051|524987457|FG000|Screening|Time conflicts|19|||
145583083|NCT00701051|524987458|FG001|Screening|Time conflicts|0|||
145583084|NCT00701051|524987459|FG002|Screening|Time conflicts|0|||
145583085|NCT00701051|524987457|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
145583086|NCT00701051|524987458|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
145583087|NCT00701051|524987459|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
145583088|NCT02059148|524987460|FG000|Treatment 1|Protocol Violation|0|||
145583089|NCT02059148|524987461|FG001|Treatment 1|Protocol Violation|0|||
145583090|NCT02059148|524987462|FG002|Treatment 1|Protocol Violation|0|||
145583091|NCT02059148|524987463|FG003|Treatment 1|Protocol Violation|0|||
145583092|NCT02059148|524987464|FG004|Treatment 1|Protocol Violation|0|||
145583093|NCT02059148|524987465|FG005|Treatment 1|Protocol Violation|1|||
145583094|NCT03231371|524987467|FG000|Overall Study|Withdrawal by Subject|1|||
145583095|NCT03231371|524987467|FG000|Overall Study|chose or were ineligible to have MRI|12|||
145583096|NCT03634579|524987470|FG000|Overall Study|study termination|9|||
145583097|NCT01525082|524987471|FG000|Overall Study|Death|1|||
145583098|NCT03321981|524987472|FG000|Overall Study|Progressive Disease (PD)|15|||
145583099|NCT03321981|524987473|FG001|Overall Study|Progressive Disease (PD)|30|||
145583100|NCT03321981|524987474|FG002|Overall Study|Progressive Disease (PD)|47|||
145583101|NCT03321981|524987472|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
145583102|NCT03321981|524987473|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
145583103|NCT03321981|524987474|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
145583104|NCT03321981|524987472|FG000|Overall Study|Adverse Event|0|||
145583105|NCT03321981|524987473|FG001|Overall Study|Adverse Event|0|||
145583106|NCT03321981|524987474|FG002|Overall Study|Adverse Event|2|||
145583107|NCT03321981|524987472|FG000|Overall Study|symptomatic deterioration|0|||
145583108|NCT03321981|524987473|FG001|Overall Study|symptomatic deterioration|1|||
145583109|NCT03321981|524987474|FG002|Overall Study|symptomatic deterioration|1|||
145583110|NCT03321981|524987472|FG000|Overall Study|Lack of compliance|0|||
145583111|NCT03321981|524987473|FG001|Overall Study|Lack of compliance|1|||
145583112|NCT03321981|524987474|FG002|Overall Study|Lack of compliance|0|||
145583113|NCT03321981|524987472|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
145583114|NCT03321981|524987473|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
145583115|NCT03321981|524987474|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
145583116|NCT03321981|524987472|FG000|Overall Study|Death|0|||
145583117|NCT03321981|524987473|FG001|Overall Study|Death|1|||
145583118|NCT03321981|524987474|FG002|Overall Study|Death|0|||
145583119|NCT03321981|524987472|FG000|Overall Study|Subject withdrawal of investigational product|0|||
145583120|NCT03321981|524987473|FG001|Overall Study|Subject withdrawal of investigational product|1|||
145583121|NCT03321981|524987474|FG002|Overall Study|Subject withdrawal of investigational product|0|||
145583122|NCT03321981|524987472|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
145583123|NCT03321981|524987473|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
145583124|NCT03321981|524987474|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
145583125|NCT03321981|524987472|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
145583126|NCT03321981|524987473|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
145583127|NCT03321981|524987474|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
145583128|NCT04111497|524987477|FG000|Overall Study|relapse of primary disease|1|||
145583129|NCT04111497|524987477|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
145583130|NCT03880578|524987478|FG000|Overall Study|Withdrawal by Subject|0|||
145583131|NCT03880578|524987479|FG001|Overall Study|Withdrawal by Subject|3|||
145583132|NCT03880578|524987480|FG002|Overall Study|Withdrawal by Subject|1|||
145583133|NCT03880578|524987478|FG000|Overall Study|Death|0|||
145583134|NCT03880578|524987479|FG001|Overall Study|Death|1|||
145583135|NCT03880578|524987480|FG002|Overall Study|Death|0|||
145583136|NCT03105362|524987481|FG000|Overall Study|Withdrawal by Subject|1|||
145583137|NCT03105362|524987481|FG000|Overall Study|Lost to Follow-up|1|||
145583138|NCT01440946|524987482|FG000|Overall Study|Lost to Follow-up|1|||
145583139|NCT01440946|524987483|FG001|Overall Study|Lost to Follow-up|1|||
145583140|NCT01440946|524987482|FG000|Overall Study|Physician Decision|1|||
145583141|NCT01440946|524987483|FG001|Overall Study|Physician Decision|0|||
145583142|NCT01603875|524987487|FG000|Overall Study|Preexisting rabies antibody|3|||
145583143|NCT01603875|524987488|FG001|Overall Study|Preexisting rabies antibody|4|||
145583144|NCT01603875|524987489|FG002|Overall Study|Preexisting rabies antibody|3|||
145583145|NCT01603875|524987487|FG000|Overall Study|Lost to Follow-up|4|||
145583146|NCT01603875|524987488|FG001|Overall Study|Lost to Follow-up|3|||
145583147|NCT01603875|524987489|FG002|Overall Study|Lost to Follow-up|6|||
145583148|NCT01603875|524987487|FG000|Overall Study|Protocol Violation|0|||
145583149|NCT01603875|524987488|FG001|Overall Study|Protocol Violation|1|||
145583150|NCT01603875|524987489|FG002|Overall Study|Protocol Violation|0|||
145583151|NCT04122443|524987494|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
145583152|NCT04122443|524987495|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
145583153|NCT04122443|524987496|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
145583154|NCT04122443|524987494|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
145583155|NCT04122443|524987495|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
145583156|NCT04122443|524987496|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
145583157|NCT01072201|524987497|FG000|Overall Study|Lost to Follow-up|0|||
145583158|NCT01072201|524987498|FG001|Overall Study|Lost to Follow-up|1|||
145583159|NCT01578551|524987500|FG000|Overall Study|Adverse Event|1|||
145583160|NCT01578551|524987501|FG001|Overall Study|Adverse Event|0|||
145583161|NCT04028388|524987502|FG000|Overall Study|Evaluations missing|3|||
145583162|NCT04028388|524987503|FG001|Overall Study|Evaluations missing|6|||
145583163|NCT04028388|524987502|FG000|Overall Study|Not started|2|||
145583164|NCT04028388|524987503|FG001|Overall Study|Not started|0|||
145583165|NCT05204134|524987504|FG000|Overall Study|Withdrawal by Subject|3|||
145583166|NCT05204134|524987504|FG000|Overall Study|Physician Decision|1|||
145583167|NCT01312467|524987513|FG000|Overall Study|Adverse Event|4|||
145583168|NCT01312467|524987513|FG000|Overall Study|Lost to Follow-up|1|||
145583169|NCT01312467|524987513|FG000|Overall Study|Withdrawal by Subject|2|||
145583170|NCT01312467|524987513|FG000|Overall Study|Deported to country of origin|1|||
145583171|NCT01312467|524987513|FG000|Overall Study|Another medical condition|1|||
145583172|NCT01312467|524987513|FG000|Overall Study|Ineligible|4|||
145583173|NCT02752048|524987514|FG000|Overall Study|Withdrawal by Subject|0|||
145583174|NCT02752048|524987515|FG001|Overall Study|Withdrawal by Subject|0|||
145583175|NCT02752048|524987516|FG002|Overall Study|Withdrawal by Subject|3|||
145583176|NCT00132769|524987517|FG000|Overall Study|Withdrawal by Subject|1|||
145583177|NCT00132769|524987518|FG001|Overall Study|Withdrawal by Subject|3|||
145583178|NCT00132769|524987517|FG000|Overall Study|Lack of Efficacy|7|||
145583179|NCT00132769|524987518|FG001|Overall Study|Lack of Efficacy|6|||
145583180|NCT00132769|524987517|FG000|Overall Study|Adverse Event|2|||
145583181|NCT00132769|524987518|FG001|Overall Study|Adverse Event|1|||
145583182|NCT00132769|524987517|FG000|Overall Study|Protocol Violation|1|||
145583183|NCT00132769|524987518|FG001|Overall Study|Protocol Violation|1|||
145583184|NCT01431508|524987519|FG000|Overall Study|Lack of Efficacy|1|||
145583185|NCT01431508|524987519|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
145583186|NCT00129259|524987520|FG000|Overall Study|Lost to Follow-up|1|||
145583187|NCT00129259|524987521|FG001|Overall Study|Lost to Follow-up|1|||
145583188|NCT00129259|524987520|FG000|Overall Study|Withdrawal by Subject|2|||
145583189|NCT00129259|524987521|FG001|Overall Study|Withdrawal by Subject|1|||
145583190|NCT00129259|524987520|FG000|Overall Study|Only available minimal phone assessments|0|||
145583191|NCT00129259|524987521|FG001|Overall Study|Only available minimal phone assessments|1|||
145583192|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583193|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583194|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583195|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583196|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
145583197|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583198|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583199|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
145583200|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
145583201|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583202|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
145583203|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
145583204|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583205|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583206|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583207|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
145583208|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
145583209|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
145583210|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
145583211|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
145434078|NCT05270863|524447941|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
145434079|NCT05270863|524447942|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
145434080|NCT05270863|524447943|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
145434081|NCT05270863|524447944|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
145434082|NCT05270863|524447945|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
145434083|NCT05270863|524447940|FG000|Second Washout|Withdrawal by Subject|1|||
145434084|NCT05270863|524447941|FG001|Second Washout|Withdrawal by Subject|1|||
145434085|NCT05270863|524447942|FG002|Second Washout|Withdrawal by Subject|0|||
145434086|NCT05270863|524447943|FG003|Second Washout|Withdrawal by Subject|0|||
145434087|NCT05270863|524447944|FG004|Second Washout|Withdrawal by Subject|0|||
145434088|NCT05270863|524447945|FG005|Second Washout|Withdrawal by Subject|0|||
145434089|NCT05270863|524447940|FG000|Second Washout|Lost to Follow-up|0|||
145434090|NCT05270863|524447941|FG001|Second Washout|Lost to Follow-up|0|||
145434091|NCT05270863|524447942|FG002|Second Washout|Lost to Follow-up|0|||
145434092|NCT05270863|524447943|FG003|Second Washout|Lost to Follow-up|1|||
145434093|NCT05270863|524447944|FG004|Second Washout|Lost to Follow-up|0|||
145434094|NCT05270863|524447945|FG005|Second Washout|Lost to Follow-up|0|||
145434095|NCT02561962|524447946|FG000|Overall Study|Withdrawal by Subject|1|||
145434096|NCT02561962|524447947|FG001|Overall Study|Withdrawal by Subject|0|||
145434097|NCT02561962|524447948|FG002|Overall Study|Withdrawal by Subject|0|||
145434098|NCT02561962|524447949|FG003|Overall Study|Withdrawal by Subject|0|||
145434099|NCT02561962|524447950|FG004|Overall Study|Withdrawal by Subject|1|||
145434100|NCT02561962|524447951|FG005|Overall Study|Withdrawal by Subject|1|||
145434101|NCT02561962|524447952|FG006|Overall Study|Withdrawal by Subject|2|||
145434102|NCT02561962|524447953|FG007|Overall Study|Withdrawal by Subject|1|||
145434103|NCT02561962|524447954|FG008|Overall Study|Withdrawal by Subject|0|||
145434104|NCT02561962|524447946|FG000|Overall Study|Decision by sponsor|0|||
145434105|NCT02561962|524447947|FG001|Overall Study|Decision by sponsor|0|||
145434106|NCT02561962|524447948|FG002|Overall Study|Decision by sponsor|0|||
145434107|NCT02561962|524447949|FG003|Overall Study|Decision by sponsor|0|||
145434108|NCT02561962|524447950|FG004|Overall Study|Decision by sponsor|1|||
145434109|NCT02561962|524447951|FG005|Overall Study|Decision by sponsor|1|||
145434110|NCT02561962|524447952|FG006|Overall Study|Decision by sponsor|0|||
145434111|NCT02561962|524447953|FG007|Overall Study|Decision by sponsor|3|||
145434112|NCT02561962|524447954|FG008|Overall Study|Decision by sponsor|0|||
145434113|NCT02561962|524447946|FG000|Overall Study|Lost to Follow-up|0|||
145434114|NCT02561962|524447947|FG001|Overall Study|Lost to Follow-up|0|||
145434115|NCT02561962|524447948|FG002|Overall Study|Lost to Follow-up|0|||
145434116|NCT02561962|524447949|FG003|Overall Study|Lost to Follow-up|0|||
145434117|NCT02561962|524447950|FG004|Overall Study|Lost to Follow-up|0|||
145434118|NCT02561962|524447951|FG005|Overall Study|Lost to Follow-up|1|||
145434119|NCT02561962|524447952|FG006|Overall Study|Lost to Follow-up|0|||
145583212|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
145583213|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
145434120|NCT02561962|524447953|FG007|Overall Study|Lost to Follow-up|0|||
145434121|NCT02561962|524447954|FG008|Overall Study|Lost to Follow-up|0|||
145434122|NCT01150357|524447955|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
145434123|NCT01150357|524447956|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
145434124|NCT01150357|524447957|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
145434125|NCT01150357|524447955|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
145434126|NCT01150357|524447956|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
145434127|NCT01150357|524447957|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
145434128|NCT01150357|524447955|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
145434129|NCT01150357|524447956|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
145434130|NCT01150357|524447957|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
145434131|NCT01150357|524447955|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
145434132|NCT01150357|524447956|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
145434133|NCT01150357|524447957|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
145434134|NCT01150357|524447955|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
145434135|NCT01150357|524447956|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
145434136|NCT01150357|524447957|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
145434137|NCT01150357|524447955|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
145434138|NCT01150357|524447956|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
145434139|NCT01150357|524447957|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
145434140|NCT01150357|524447955|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
145434141|NCT01150357|524447956|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
145434142|NCT01150357|524447957|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
145434143|NCT00639457|524449553|FG000|Overall Study|Withdrawal by Subject|2|||
145434144|NCT00639457|524449554|FG001|Overall Study|Withdrawal by Subject|3|||
145434145|NCT03235050|524449555|FG000|Overall Study|Adverse Event|0|||
145434146|NCT03235050|524449556|FG001|Overall Study|Adverse Event|0|||
145434147|NCT03235050|524449557|FG002|Overall Study|Adverse Event|1|||
145434148|NCT03235050|524449558|FG003|Overall Study|Adverse Event|4|||
145624498|NCT04482855|525137706|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
145624499|NCT04482855|525137707|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
145624500|NCT00764868|525137708|FG000|Overall Study|Adverse Event|18|||
145624501|NCT00764868|525137708|FG000|Overall Study|Withdrawal by Subject|31|||
145624502|NCT00764868|525137708|FG000|Overall Study|Non-compliance|16|||
145624503|NCT00764868|525137708|FG000|Overall Study|Lost to Follow-up|25|||
145624504|NCT00764868|525137708|FG000|Overall Study|Lack of Efficacy|5|||
145624505|NCT00764868|525137708|FG000|Overall Study|Subject moved|7|||
145624506|NCT00764868|525137708|FG000|Overall Study|Pregnancy|3|||
145624507|NCT00764868|525137708|FG000|Overall Study|Prohibited medication|1|||
145624508|NCT00764868|525137708|FG000|Overall Study|Out of town|1|||
145624509|NCT00764868|525137708|FG000|Overall Study|Misuse and compliance of study drug|1|||
145624510|NCT00764868|525137708|FG000|Overall Study|Subject sent to boarding school|1|||
145624511|NCT00764868|525137708|FG000|Overall Study|Met an exclusion criteria|1|||
145624512|NCT00764868|525137708|FG000|Overall Study|Positive drug screen|2|||
145624513|NCT00764868|525137708|FG000|Overall Study|Sponsor requested withdrawal|1|||
145624514|NCT00819234|525137717|FG000|Overall Study|Withdrawal by Subject|8|||
145624515|NCT00819234|525137718|FG001|Overall Study|Withdrawal by Subject|13|||
145624516|NCT00819234|525137719|FG002|Overall Study|Withdrawal by Subject|6|||
145624517|NCT00819234|525137720|FG003|Overall Study|Withdrawal by Subject|3|||
145624518|NCT00819234|525137721|FG004|Overall Study|Withdrawal by Subject|0|||
145624519|NCT00819234|525137722|FG005|Overall Study|Withdrawal by Subject|4|||
145624520|NCT00819234|525137723|FG006|Overall Study|Withdrawal by Subject|4|||
145624521|NCT00819234|525137724|FG007|Overall Study|Withdrawal by Subject|8|||
145624522|NCT00819234|525137725|FG008|Overall Study|Withdrawal by Subject|5|||
145624523|NCT00819234|525137726|FG009|Overall Study|Withdrawal by Subject|3|||
145624524|NCT00819234|525137717|FG000|Overall Study|Adverse Event|0|||
145624525|NCT00819234|525137718|FG001|Overall Study|Adverse Event|0|||
145624526|NCT00819234|525137719|FG002|Overall Study|Adverse Event|1|||
145624527|NCT00819234|525137720|FG003|Overall Study|Adverse Event|0|||
145624528|NCT00819234|525137721|FG004|Overall Study|Adverse Event|0|||
145624529|NCT00819234|525137722|FG005|Overall Study|Adverse Event|2|||
145624530|NCT00819234|525137723|FG006|Overall Study|Adverse Event|0|||
145624531|NCT00819234|525137724|FG007|Overall Study|Adverse Event|0|||
145624532|NCT00819234|525137725|FG008|Overall Study|Adverse Event|0|||
145624533|NCT00819234|525137726|FG009|Overall Study|Adverse Event|0|||
145624534|NCT00819234|525137717|FG000|Overall Study|Physician Decision|0|||
145624535|NCT00819234|525137718|FG001|Overall Study|Physician Decision|0|||
145624536|NCT00819234|525137719|FG002|Overall Study|Physician Decision|0|||
145624537|NCT00819234|525137720|FG003|Overall Study|Physician Decision|1|||
145624538|NCT00819234|525137721|FG004|Overall Study|Physician Decision|0|||
145624539|NCT00819234|525137722|FG005|Overall Study|Physician Decision|0|||
145624540|NCT00819234|525137723|FG006|Overall Study|Physician Decision|0|||
145624541|NCT00819234|525137724|FG007|Overall Study|Physician Decision|0|||
145624542|NCT00819234|525137725|FG008|Overall Study|Physician Decision|0|||
145624543|NCT00819234|525137726|FG009|Overall Study|Physician Decision|2|||
145624544|NCT00819234|525137717|FG000|Overall Study|Protocol Violation|0|||
145624545|NCT00819234|525137718|FG001|Overall Study|Protocol Violation|0|||
145624546|NCT00819234|525137719|FG002|Overall Study|Protocol Violation|1|||
145624547|NCT00819234|525137720|FG003|Overall Study|Protocol Violation|0|||
145624548|NCT00819234|525137721|FG004|Overall Study|Protocol Violation|0|||
145624549|NCT00819234|525137722|FG005|Overall Study|Protocol Violation|0|||
145624550|NCT00819234|525137723|FG006|Overall Study|Protocol Violation|0|||
145624551|NCT00819234|525137724|FG007|Overall Study|Protocol Violation|0|||
145624552|NCT00819234|525137725|FG008|Overall Study|Protocol Violation|0|||
145624553|NCT00819234|525137726|FG009|Overall Study|Protocol Violation|0|||
145624554|NCT00819234|525137717|FG000|Overall Study|Lost to Follow-up|2|||
145624555|NCT00819234|525137718|FG001|Overall Study|Lost to Follow-up|2|||
145624556|NCT00819234|525137719|FG002|Overall Study|Lost to Follow-up|0|||
145624557|NCT00819234|525137720|FG003|Overall Study|Lost to Follow-up|2|||
145624558|NCT00819234|525137721|FG004|Overall Study|Lost to Follow-up|1|||
145624559|NCT00819234|525137722|FG005|Overall Study|Lost to Follow-up|1|||
145624560|NCT00819234|525137723|FG006|Overall Study|Lost to Follow-up|1|||
145624561|NCT00819234|525137724|FG007|Overall Study|Lost to Follow-up|1|||
145624562|NCT00819234|525137725|FG008|Overall Study|Lost to Follow-up|1|||
145624563|NCT00819234|525137726|FG009|Overall Study|Lost to Follow-up|2|||
145624564|NCT04438785|525137727|FG000|Overall Study|change of weight, give up intervention|2|||
145624565|NCT04438785|525137728|FG001|Overall Study|change of weight, give up intervention|10|||
145624566|NCT04011033|525137729|FG000|Overall Study|Physician Decision|2|||
145624567|NCT04011033|525137730|FG001|Overall Study|Physician Decision|3|||
145624568|NCT04011033|525137729|FG000|Overall Study|Withdrawal by Subject|1|||
145624569|NCT04011033|525137730|FG001|Overall Study|Withdrawal by Subject|0|||
145624570|NCT01823341|525137731|FG000|Overall Study|Failed run-in|7|||
145624571|NCT01823341|525137731|FG000|Overall Study|Withdrawal by Subject|7|||
145624572|NCT01823341|525137731|FG000|Overall Study|Adverse Event|1|||
145624573|NCT02027935|525137732|FG000|Overall Study|Death|1|||
145624574|NCT02027935|525137732|FG000|Overall Study|Lack of Efficacy|5|||
145624575|NCT02027935|525137732|FG000|Overall Study|Study Closure|1|||
145624576|NCT00689104|525137733|FG000|Overall Study|Eligibility criterion not met|5|||
145624577|NCT00689104|525137734|FG001|Overall Study|Eligibility criterion not met|8|||
145624578|NCT00689104|525137735|FG002|Overall Study|Eligibility criterion not met|0|||
145624579|NCT00689104|525137736|FG003|Overall Study|Eligibility criterion not met|4|||
145624580|NCT00689104|525137733|FG000|Overall Study|Adverse Event|13|||
145624581|NCT00689104|525137734|FG001|Overall Study|Adverse Event|25|||
145624582|NCT00689104|525137735|FG002|Overall Study|Adverse Event|16|||
145624583|NCT00689104|525137736|FG003|Overall Study|Adverse Event|24|||
145624584|NCT00689104|525137733|FG000|Overall Study|Lack of Efficacy|5|||
145624585|NCT00689104|525137734|FG001|Overall Study|Lack of Efficacy|6|||
145624586|NCT00689104|525137735|FG002|Overall Study|Lack of Efficacy|2|||
145624587|NCT00689104|525137736|FG003|Overall Study|Lack of Efficacy|3|||
145624588|NCT00689104|525137733|FG000|Overall Study|Withdrawal by Subject|12|||
145624589|NCT00689104|525137734|FG001|Overall Study|Withdrawal by Subject|11|||
145624590|NCT00689104|525137735|FG002|Overall Study|Withdrawal by Subject|18|||
145624591|NCT00689104|525137736|FG003|Overall Study|Withdrawal by Subject|11|||
145624592|NCT00689104|525137733|FG000|Overall Study|Lost to Follow-up|4|||
145624593|NCT00689104|525137734|FG001|Overall Study|Lost to Follow-up|3|||
145624594|NCT00689104|525137735|FG002|Overall Study|Lost to Follow-up|2|||
145624595|NCT00689104|525137736|FG003|Overall Study|Lost to Follow-up|5|||
145624596|NCT00689104|525137733|FG000|Overall Study|Protocol Violation|2|||
145624597|NCT00689104|525137734|FG001|Overall Study|Protocol Violation|3|||
145624598|NCT00689104|525137735|FG002|Overall Study|Protocol Violation|5|||
145624599|NCT00689104|525137736|FG003|Overall Study|Protocol Violation|3|||
145624600|NCT00689104|525137733|FG000|Overall Study|Randomized but never received study drug|2|||
145624601|NCT00689104|525137734|FG001|Overall Study|Randomized but never received study drug|1|||
145624602|NCT00689104|525137735|FG002|Overall Study|Randomized but never received study drug|1|||
145624603|NCT00689104|525137736|FG003|Overall Study|Randomized but never received study drug|0|||
145583214|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
145583215|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
145583216|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
145583217|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
145583218|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
145583219|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
145583220|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
145583221|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
145583222|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
145583223|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
145583224|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583225|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583226|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583227|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583228|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583229|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
145583230|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
145583231|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583232|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583233|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
145583234|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
145583235|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
145583236|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583237|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583238|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583239|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
145583240|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583241|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583242|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145624604|NCT00689104|525137733|FG000|Overall Study|Physician Decision|1|||
145624605|NCT00689104|525137734|FG001|Overall Study|Physician Decision|0|||
145624606|NCT00689104|525137735|FG002|Overall Study|Physician Decision|0|||
145624607|NCT00689104|525137736|FG003|Overall Study|Physician Decision|0|||
145624608|NCT00689104|525137733|FG000|Overall Study|Non-compliance with study procedures|0|||
145583243|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583244|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583245|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
145583246|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583247|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583248|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145624609|NCT00689104|525137734|FG001|Overall Study|Non-compliance with study procedures|0|||
145624610|NCT00689104|525137735|FG002|Overall Study|Non-compliance with study procedures|1|||
145624611|NCT00689104|525137736|FG003|Overall Study|Non-compliance with study procedures|0|||
145624612|NCT04873817|525137737|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
145624613|NCT04873817|525137737|FG000|Overall Study|Lost to Follow-up|4|||
145624614|NCT04873817|525137737|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
145624615|NCT04873817|525137737|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
145624616|NCT04873817|525137737|FG000|Overall Study|Other Reasons|3|||
145624617|NCT00924560|525137741|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
145624618|NCT00924560|525137742|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
145624619|NCT00924560|525137743|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
145624620|NCT00924560|525137741|FG000|Overall Study|Non Compliance with the Protocol|20|||
145624621|NCT00924560|525137742|FG001|Overall Study|Non Compliance with the Protocol|15|||
145624622|NCT00924560|525137743|FG002|Overall Study|Non Compliance with the Protocol|4|||
145624623|NCT00924560|525137741|FG000|Overall Study|Physician Decision|2|||
145624624|NCT00924560|525137742|FG001|Overall Study|Physician Decision|3|||
145624625|NCT00924560|525137743|FG002|Overall Study|Physician Decision|4|||
145624626|NCT00924560|525137741|FG000|Overall Study|Withdrawal by Subject|50|||
145624627|NCT00924560|525137742|FG001|Overall Study|Withdrawal by Subject|44|||
145624628|NCT00924560|525137743|FG002|Overall Study|Withdrawal by Subject|18|||
145624629|NCT00924560|525137741|FG000|Overall Study|Adverse Event|39|||
145624630|NCT00924560|525137742|FG001|Overall Study|Adverse Event|33|||
145624631|NCT00924560|525137743|FG002|Overall Study|Adverse Event|0|||
145624632|NCT00924560|525137741|FG000|Overall Study|Pregnancy|5|||
145624633|NCT00924560|525137742|FG001|Overall Study|Pregnancy|7|||
145434149|NCT03235050|524449559|FG004|Overall Study|Adverse Event|1|||
145434150|NCT03235050|524449555|FG000|Overall Study|Death|0|||
145434151|NCT03235050|524449556|FG001|Overall Study|Death|0|||
145434152|NCT03235050|524449557|FG002|Overall Study|Death|0|||
145434153|NCT03235050|524449558|FG003|Overall Study|Death|2|||
145434154|NCT03235050|524449559|FG004|Overall Study|Death|1|||
145434155|NCT03235050|524449555|FG000|Overall Study|Lost to Follow-up|1|||
145434156|NCT03235050|524449556|FG001|Overall Study|Lost to Follow-up|2|||
145434157|NCT03235050|524449557|FG002|Overall Study|Lost to Follow-up|1|||
145434158|NCT03235050|524449558|FG003|Overall Study|Lost to Follow-up|2|||
145434159|NCT03235050|524449559|FG004|Overall Study|Lost to Follow-up|0|||
145434160|NCT03235050|524449555|FG000|Overall Study|Withdrawal by Subject|3|||
145624634|NCT00924560|525137743|FG002|Overall Study|Pregnancy|1|||
145624635|NCT00924560|525137741|FG000|Overall Study|Lost to Follow-up|78|||
145624636|NCT00924560|525137742|FG001|Overall Study|Lost to Follow-up|94|||
145624637|NCT00924560|525137743|FG002|Overall Study|Lost to Follow-up|45|||
145434161|NCT03235050|524449556|FG001|Overall Study|Withdrawal by Subject|2|||
145624638|NCT00924560|525137741|FG000|Overall Study|Miscellaneous Reasons|13|||
145624639|NCT00924560|525137742|FG001|Overall Study|Miscellaneous Reasons|10|||
145624640|NCT00924560|525137743|FG002|Overall Study|Miscellaneous Reasons|10|||
145624641|NCT00663962|525137746|FG000|Overall Study|somnolence|1|||
145624642|NCT00663962|525137747|FG001|Overall Study|somnolence|0|||
145624643|NCT00604786|525137748|FG000|Overall Study|Lost to Follow-up|2|||
145624644|NCT00604786|525137749|FG001|Overall Study|Lost to Follow-up|0|||
145624645|NCT00665561|525137754|FG000|Overall Study|Death recorded on subject summary pages|75|||
145624646|NCT00665561|525137755|FG001|Overall Study|Death recorded on subject summary pages|75|||
145624647|NCT00665561|525137754|FG000|Overall Study|Does not meet entrance criteria|19|||
145624648|NCT00665561|525137755|FG001|Overall Study|Does not meet entrance criteria|21|||
145624649|NCT00665561|525137754|FG000|Overall Study|Lost to Follow-up|203|||
145624650|NCT00665561|525137755|FG001|Overall Study|Lost to Follow-up|264|||
145624651|NCT00665561|525137754|FG000|Overall Study|Withdrawal by Subject|74|||
145624652|NCT00665561|525137755|FG001|Overall Study|Withdrawal by Subject|65|||
145624653|NCT00665561|525137754|FG000|Overall Study|Other|123|||
145624654|NCT00665561|525137755|FG001|Overall Study|Other|108|||
145624655|NCT00665561|525137754|FG000|Overall Study|Site closed|8|||
145624656|NCT00665561|525137755|FG001|Overall Study|Site closed|0|||
145624657|NCT00665561|525137754|FG000|Overall Study|Withdrawn due to pregnancy|0|||
145624658|NCT00665561|525137755|FG001|Overall Study|Withdrawn due to pregnancy|1|||
145624659|NCT02337361|525137756|FG000|3-month Follow-up|Lost to Follow-up|19|||
145624660|NCT02337361|525137757|FG001|3-month Follow-up|Lost to Follow-up|14|||
145624661|NCT02337361|525137756|FG000|6-month Follow-up|Lost to Follow-up|2|||
145624662|NCT02337361|525137757|FG001|6-month Follow-up|Lost to Follow-up|4|||
145434162|NCT03235050|524449557|FG002|Overall Study|Withdrawal by Subject|2|||
145434163|NCT03235050|524449558|FG003|Overall Study|Withdrawal by Subject|5|||
145624663|NCT01101542|525137758|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
145624664|NCT01101542|525137758|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
145624665|NCT01101542|525137758|FG000|Year 4 Surveillance Period|Other|287|||
145624666|NCT01101542|525137758|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
145434164|NCT03235050|524449559|FG004|Overall Study|Withdrawal by Subject|7|||
145434165|NCT03235050|524449555|FG000|Overall Study|Other reasons|0|||
145434166|NCT03235050|524449556|FG001|Overall Study|Other reasons|1|||
145434167|NCT03235050|524449557|FG002|Overall Study|Other reasons|0|||
145434168|NCT03235050|524449558|FG003|Overall Study|Other reasons|1|||
145434169|NCT03235050|524449559|FG004|Overall Study|Other reasons|2|||
145434170|NCT00492557|524449560|FG000|Overall Study|Subject request|12|||
145434171|NCT00492557|524449561|FG001|Overall Study|Subject request|11|||
145434172|NCT00492557|524449560|FG000|Overall Study|Protocol Violation|7|||
145624667|NCT01101542|525137758|FG000|Year 5 Surveillance Period|Pregnancy|1|||
145624668|NCT01101542|525137758|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
145624669|NCT01101542|525137758|FG000|Year 6 Surveillance Period|Pregnancy|1|||
145624670|NCT01101542|525137758|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
145624671|NCT00701311|525137759|FG000|Overall Study|Lack of Efficacy|3|||
145624672|NCT00701311|525137759|FG000|Overall Study|Adverse Event|3|||
145624673|NCT00701311|525137759|FG000|Overall Study|Withdrawal by Subject|2|||
145624674|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Adverse Event|5|||
145624675|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Adverse Event|13|||
145624676|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Adverse Event|0|||
145624677|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
145624678|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
145624679|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
145624680|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
145624681|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
145624682|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
145624683|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
145624684|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
145624685|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
145624686|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
145624687|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
145624688|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
145434173|NCT00492557|524449561|FG001|Overall Study|Protocol Violation|8|||
145434174|NCT00492557|524449560|FG000|Overall Study|Other|2|||
145434175|NCT00492557|524449561|FG001|Overall Study|Other|2|||
145434176|NCT00492557|524449560|FG000|Overall Study|Death|1|||
145434177|NCT00492557|524449561|FG001|Overall Study|Death|1|||
145434178|NCT00492557|524449560|FG000|Overall Study|Adverse Event|1|||
145434179|NCT00492557|524449561|FG001|Overall Study|Adverse Event|0|||
145434180|NCT00492557|524449560|FG000|Overall Study|Failed to return|1|||
145434181|NCT00492557|524449561|FG001|Overall Study|Failed to return|0|||
145434182|NCT00492557|524449560|FG000|Overall Study|Lost to Follow-up|0|||
145434183|NCT00492557|524449561|FG001|Overall Study|Lost to Follow-up|1|||
145434184|NCT03423121|524449565|FG000|Overall Study|Lost to Follow-up|2|||
145434185|NCT03423121|524449566|FG001|Overall Study|Lost to Follow-up|6|||
145434186|NCT03423121|524449565|FG000|Overall Study|Adverse Event|1|||
145583249|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583250|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583251|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
145434187|NCT03423121|524449566|FG001|Overall Study|Adverse Event|0|||
145434188|NCT01192126|524449567|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
145434189|NCT01192126|524449568|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
145434190|NCT01192126|524449567|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
145434191|NCT01192126|524449568|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
145434192|NCT01354223|524449569|FG000|Overall Study|Withdrawal by Subject|3|||
145434193|NCT01354223|524449570|FG001|Overall Study|Withdrawal by Subject|1|||
145583252|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583253|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583254|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583255|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
145583256|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583257|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583258|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583259|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583260|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145434194|NCT04102007|524449571|FG000|Overall Study|Adverse Event|4|||
145434195|NCT04102007|524449571|FG000|Overall Study|Lost to Follow-up|3|||
145434196|NCT04102007|524449571|FG000|Overall Study|Withdrawal by Subject|12|||
145434197|NCT04102007|524449571|FG000|Overall Study|Eligibility Violation|5|||
145434198|NCT04102007|524449571|FG000|Overall Study|Lack of Efficacy|6|||
145434199|NCT04102007|524449571|FG000|Overall Study|Protocol Deviation|5|||
145434200|NCT04102007|524449571|FG000|Overall Study|Protocol Compliance|1|||
145434201|NCT04102007|524449571|FG000|Overall Study|Withdrew Treatment|2|||
145434202|NCT04102007|524449571|FG000|Overall Study|Pregnancy|1|||
145434203|NCT05173974|524449572|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
145434204|NCT05173974|524449573|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
145434205|NCT05173974|524449574|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
145434206|NCT05173974|524449575|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
145434207|NCT05173974|524449572|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
145434208|NCT05173974|524449573|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
145434209|NCT05173974|524449574|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
145434210|NCT05173974|524449575|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
145434211|NCT03289143|524449576|FG000|Overall Study|Caregiver Unavailability|1|||
145434212|NCT03289143|524449577|FG001|Overall Study|Caregiver Unavailability|1|||
145434213|NCT03289143|524449578|FG002|Overall Study|Caregiver Unavailability|0|||
145434214|NCT03289143|524449579|FG003|Overall Study|Caregiver Unavailability|0|||
145434215|NCT03289143|524449576|FG000|Overall Study|Research Department Closure|0|||
145434216|NCT03289143|524449577|FG001|Overall Study|Research Department Closure|0|||
145434217|NCT03289143|524449578|FG002|Overall Study|Research Department Closure|1|||
145434218|NCT03289143|524449579|FG003|Overall Study|Research Department Closure|0|||
145434219|NCT03289143|524449576|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
145434220|NCT03289143|524449577|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
145434221|NCT03289143|524449578|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
145434222|NCT03289143|524449579|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
145434223|NCT03289143|524449576|FG000|Overall Study|Medical Monitor Decision|1|||
145434224|NCT03289143|524449577|FG001|Overall Study|Medical Monitor Decision|0|||
145434225|NCT03289143|524449578|FG002|Overall Study|Medical Monitor Decision|0|||
145434226|NCT03289143|524449579|FG003|Overall Study|Medical Monitor Decision|0|||
145434227|NCT03289143|524449576|FG000|Overall Study|Participant Non-Compliance|0|||
145434228|NCT03289143|524449577|FG001|Overall Study|Participant Non-Compliance|0|||
145434229|NCT03289143|524449578|FG002|Overall Study|Participant Non-Compliance|1|||
145434230|NCT03289143|524449579|FG003|Overall Study|Participant Non-Compliance|0|||
145434231|NCT03289143|524449576|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
145434232|NCT03289143|524449577|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
145434233|NCT03289143|524449578|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
145434234|NCT03289143|524449579|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
145434235|NCT03289143|524449576|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
145434236|NCT03289143|524449577|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
145434237|NCT03289143|524449578|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
145434238|NCT03289143|524449579|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
145434239|NCT03289143|524449576|FG000|Overall Study|Caregiver Passed Away|1|||
145434240|NCT03289143|524449577|FG001|Overall Study|Caregiver Passed Away|0|||
145434241|NCT03289143|524449578|FG002|Overall Study|Caregiver Passed Away|0|||
145434242|NCT03289143|524449579|FG003|Overall Study|Caregiver Passed Away|0|||
145434243|NCT03289143|524449576|FG000|Overall Study|Physician Decision|0|||
145434244|NCT03289143|524449577|FG001|Overall Study|Physician Decision|2|||
145434245|NCT03289143|524449578|FG002|Overall Study|Physician Decision|2|||
145434246|NCT03289143|524449579|FG003|Overall Study|Physician Decision|2|||
145434247|NCT03289143|524449576|FG000|Overall Study|Protocol Deviation|2|||
145434248|NCT03289143|524449577|FG001|Overall Study|Protocol Deviation|1|||
145434249|NCT03289143|524449578|FG002|Overall Study|Protocol Deviation|3|||
145434250|NCT03289143|524449579|FG003|Overall Study|Protocol Deviation|1|||
145434251|NCT03289143|524449576|FG000|Overall Study|Study Terminated By Sponsor|101|||
145434252|NCT03289143|524449577|FG001|Overall Study|Study Terminated By Sponsor|75|||
145434253|NCT03289143|524449578|FG002|Overall Study|Study Terminated By Sponsor|100|||
145434254|NCT03289143|524449579|FG003|Overall Study|Study Terminated By Sponsor|69|||
145434255|NCT03289143|524449576|FG000|Overall Study|Withdrawal by Subject|14|||
145434256|NCT03289143|524449577|FG001|Overall Study|Withdrawal by Subject|6|||
145434257|NCT03289143|524449578|FG002|Overall Study|Withdrawal by Subject|14|||
145434258|NCT03289143|524449579|FG003|Overall Study|Withdrawal by Subject|12|||
145434259|NCT03289143|524449576|FG000|Overall Study|Adverse Event|10|||
145434260|NCT03289143|524449577|FG001|Overall Study|Adverse Event|7|||
145434261|NCT03289143|524449578|FG002|Overall Study|Adverse Event|6|||
145434262|NCT03289143|524449579|FG003|Overall Study|Adverse Event|5|||
145434263|NCT03289143|524449576|FG000|Overall Study|Death|2|||
145434264|NCT03289143|524449577|FG001|Overall Study|Death|0|||
145434265|NCT03289143|524449578|FG002|Overall Study|Death|2|||
145583261|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
145583262|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583263|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145434266|NCT03289143|524449579|FG003|Overall Study|Death|1|||
145434267|NCT03289143|524449576|FG000|Overall Study|Lost to Follow-up|2|||
145434268|NCT03289143|524449577|FG001|Overall Study|Lost to Follow-up|1|||
145434269|NCT03289143|524449578|FG002|Overall Study|Lost to Follow-up|1|||
145434270|NCT03289143|524449579|FG003|Overall Study|Lost to Follow-up|0|||
145434271|NCT03289143|524449576|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
145434272|NCT03289143|524449577|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
145434273|NCT03289143|524449578|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
145434274|NCT03289143|524449579|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
145434275|NCT03289143|524449576|FG000|Overall Study|Withdrawal by Caregiver|0|||
145434276|NCT03289143|524449577|FG001|Overall Study|Withdrawal by Caregiver|1|||
145434277|NCT03289143|524449578|FG002|Overall Study|Withdrawal by Caregiver|0|||
145434278|NCT03289143|524449579|FG003|Overall Study|Withdrawal by Caregiver|0|||
145434279|NCT03289143|524449576|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
145434280|NCT03289143|524449577|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
145434281|NCT03289143|524449578|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
145434282|NCT03289143|524449579|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
145434283|NCT03289143|524449576|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
145434284|NCT03289143|524449577|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
145434285|NCT03289143|524449578|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
145434286|NCT03289143|524449579|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
145434287|NCT00730756|524449580|FG000|Overall Study|Adverse Event|2|||
145265289|NCT02389621|523819267|FG000|Treatment Period|Withdrawal by Subject|1|||
145265290|NCT02389621|523819268|FG001|Treatment Period|Withdrawal by Subject|1|||
145265291|NCT02389621|523819267|FG000|Posttreatment Period|Adverse Event|3|||
145265292|NCT02389621|523819268|FG001|Posttreatment Period|Adverse Event|1|||
145265293|NCT02389621|523819267|FG000|Posttreatment Period|Withdrawal by Subject|3|||
145265294|NCT02389621|523819268|FG001|Posttreatment Period|Withdrawal by Subject|2|||
145265295|NCT02389621|523819267|FG000|Posttreatment Period|Lost to Follow-up|1|||
145265296|NCT02389621|523819268|FG001|Posttreatment Period|Lost to Follow-up|1|||
145434288|NCT00730756|524449581|FG001|Overall Study|Adverse Event|0|||
145434289|NCT00730756|524449580|FG000|Overall Study|Lack of Efficacy|1|||
145434290|NCT00730756|524449581|FG001|Overall Study|Lack of Efficacy|1|||
145434291|NCT00730756|524449580|FG000|Overall Study|Protocol Deviation|1|||
145434292|NCT00730756|524449581|FG001|Overall Study|Protocol Deviation|2|||
145434293|NCT00730756|524449580|FG000|Overall Study|Lost to Follow-up|0|||
145434294|NCT00730756|524449581|FG001|Overall Study|Lost to Follow-up|1|||
145434295|NCT00730756|524449580|FG000|Overall Study|Withdrew Consent|0|||
145434296|NCT00730756|524449581|FG001|Overall Study|Withdrew Consent|1|||
145434297|NCT00948688|524449582|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
145434298|NCT00948688|524449583|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
145434299|NCT00948688|524449582|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
145434300|NCT00948688|524449583|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
145434301|NCT00948688|524449582|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
145434302|NCT00948688|524449583|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
145434303|NCT01977898|524449584|FG000|Overall Study|Non functioning catheter|1|||
145434304|NCT01977898|524449585|FG001|Overall Study|Non functioning catheter|1|||
145434305|NCT01049373|524449591|FG000|Overall Study|Protocol Violation|9|||
145434306|NCT01049373|524449592|FG001|Overall Study|Protocol Violation|9|||
145434307|NCT01049373|524449591|FG000|Overall Study|Withdrawal by Subject|8|||
145434308|NCT01049373|524449592|FG001|Overall Study|Withdrawal by Subject|5|||
145434309|NCT01049373|524449591|FG000|Overall Study|Adverse Event|3|||
145434310|NCT01049373|524449592|FG001|Overall Study|Adverse Event|3|||
145434311|NCT01049373|524449591|FG000|Overall Study|Lost to Follow-up|9|||
145434312|NCT01049373|524449592|FG001|Overall Study|Lost to Follow-up|4|||
145434313|NCT01049373|524449591|FG000|Overall Study|no evaluable study values|9|||
145434314|NCT01049373|524449592|FG001|Overall Study|no evaluable study values|21|||
145434315|NCT01049373|524449591|FG000|Overall Study|Other|1|||
145434316|NCT01049373|524449592|FG001|Overall Study|Other|1|||
145434317|NCT01049373|524449591|FG000|Overall Study|Non-cooperation|0|||
145434318|NCT01049373|524449592|FG001|Overall Study|Non-cooperation|1|||
145434319|NCT01693367|524449593|FG000|Overall Study|Withdrawal by Subject|1|||
145434320|NCT01693367|524449594|FG001|Overall Study|Withdrawal by Subject|1|||
145434321|NCT01693367|524449593|FG000|Overall Study|Physician Decision|0|||
145434322|NCT01693367|524449594|FG001|Overall Study|Physician Decision|1|||
145434323|NCT03610048|524449595|FG000|Overall Study|Study terminated by sponsor|84|||
145434324|NCT03610048|524449595|FG000|Overall Study|Adverse Event|32|||
145434325|NCT03610048|524449595|FG000|Overall Study|Withdrawal by Subject|31|||
145434326|NCT03610048|524449595|FG000|Overall Study|Lost to Follow-up|8|||
145434327|NCT03610048|524449595|FG000|Overall Study|Other|4|||
145434328|NCT03610048|524449595|FG000|Overall Study|Physician Decision|1|||
145434329|NCT03610048|524449595|FG000|Overall Study|Pregnancy|1|||
145434330|NCT01155050|524449596|FG000|Overall Study|Lost to Follow-up|15|||
145434331|NCT01155050|524449597|FG001|Overall Study|Lost to Follow-up|20|||
145434332|NCT01155050|524449598|FG002|Overall Study|Lost to Follow-up|19|||
145434333|NCT01155050|524449599|FG003|Overall Study|Lost to Follow-up|22|||
145434334|NCT02136914|524449600|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
145434335|NCT02136914|524449601|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
145434336|NCT02136914|524449600|FG000|Overall Study|Withdrawal by Subject|3|||
145434337|NCT02136914|524449601|FG001|Overall Study|Withdrawal by Subject|10|||
145434338|NCT02136914|524449600|FG000|Overall Study|Subject Unwilling to Proceed|7|||
145434339|NCT02136914|524449601|FG001|Overall Study|Subject Unwilling to Proceed|2|||
145434340|NCT02136914|524449600|FG000|Overall Study|Lost to Follow-up|1|||
145434341|NCT02136914|524449601|FG001|Overall Study|Lost to Follow-up|1|||
145583264|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583265|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583266|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583267|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583268|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583269|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583270|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583271|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
145583272|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583273|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583274|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583275|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583276|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583277|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583278|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583279|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583280|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
145583281|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583282|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583283|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583284|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583285|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583286|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583287|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
145583288|NCT01609556|524987525|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
145583289|NCT01609556|524987526|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583290|NCT01609556|524987527|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583291|NCT01609556|524987528|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583292|NCT01609556|524987529|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583293|NCT01609556|524987530|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
145583294|NCT01609556|524987531|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583295|NCT01609556|524987532|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583296|NCT01609556|524987533|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583297|NCT01609556|524987534|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583298|NCT01609556|524987535|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
145583299|NCT01609556|524987536|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583300|NCT01609556|524987537|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583301|NCT01609556|524987538|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583302|NCT01609556|524987539|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583303|NCT01609556|524987540|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
145583304|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583305|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583306|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583307|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583308|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583309|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583310|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583311|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583312|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583313|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583314|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583315|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
145583316|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
145583317|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
145583318|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
145583319|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
145583320|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583321|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583322|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583323|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583324|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583325|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583326|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583327|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583328|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583329|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145434342|NCT02136914|524449600|FG000|Overall Study|Did Not Receive Study Drug|2|||
145434343|NCT02136914|524449601|FG001|Overall Study|Did Not Receive Study Drug|0|||
145434344|NCT02136914|524449600|FG000|Overall Study|Lack of Efficacy|1|||
145434345|NCT02136914|524449601|FG001|Overall Study|Lack of Efficacy|0|||
145434346|NCT02136914|524449600|FG000|Overall Study|Death|0|||
145434347|NCT02136914|524449601|FG001|Overall Study|Death|1|||
145434348|NCT00329030|524449604|FG000|Overall Study|Withdrawal by Subject|1|||
145434349|NCT00329030|524449605|FG001|Overall Study|Withdrawal by Subject|3|||
145434350|NCT00329030|524449604|FG000|Overall Study|Progressive Disease|6|||
145434351|NCT00329030|524449605|FG001|Overall Study|Progressive Disease|2|||
145434352|NCT00329030|524449604|FG000|Overall Study|Ineligible Pathology|1|||
145434353|NCT00329030|524449605|FG001|Overall Study|Ineligible Pathology|1|||
145434354|NCT00325143|524449606|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
145434355|NCT00325143|524449606|FG000|Overall Study|Migrated/moved from study area|1|||
145434356|NCT00325143|524449606|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
145434357|NCT00325143|524449606|FG000|Overall Study|Withdrawal by Subject|8|||
145434358|NCT02286895|524449607|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
145434359|NCT02286895|524449608|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
145434360|NCT02286895|524449607|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
145434361|NCT02286895|524449608|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
145434362|NCT02286895|524449607|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
145434363|NCT02286895|524449608|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
145434364|NCT03036852|524449609|FG000|Overall Study|Death|2|||
145434365|NCT03036852|524449609|FG000|Overall Study|Lack of Efficacy|2|||
145434366|NCT03036852|524449609|FG000|Overall Study|Adverse Event|1|||
145434367|NCT03036852|524449609|FG000|Overall Study|Lost to Follow-up|1|||
145434368|NCT02441218|524449616|FG000|Overall Study|Death|503|||
145434369|NCT02441218|524449617|FG001|Overall Study|Death|553|||
145434370|NCT02441218|524449616|FG000|Overall Study|Withdrawal by Subject|73|||
145434371|NCT02441218|524449617|FG001|Overall Study|Withdrawal by Subject|58|||
145434372|NCT02441218|524449616|FG000|Overall Study|Lost to Follow-up|2|||
145434373|NCT02441218|524449617|FG001|Overall Study|Lost to Follow-up|1|||
145434374|NCT01541371|524449618|FG000|Overall Study|Withdrawal by Subject|14|||
145434375|NCT01541371|524449618|FG000|Overall Study|Lost to Follow-up|21|||
145434376|NCT01541371|524449618|FG000|Overall Study|Adverse Event|15|||
145434377|NCT01541371|524449618|FG000|Overall Study|Lack of Efficacy|12|||
145434378|NCT01541371|524449618|FG000|Overall Study|Protocol Violation|6|||
145434379|NCT01541371|524449618|FG000|Overall Study|Study medication non-compliance|3|||
145434380|NCT01541371|524449618|FG000|Overall Study|Other|6|||
145434381|NCT00163189|524449621|FG000|Overall Study|Other|6|||
145434382|NCT00163189|524449621|FG000|Overall Study|Lost to Follow-up|1|||
145434383|NCT00163189|524449621|FG000|Overall Study|Protocol Violation|2|||
145434384|NCT00163189|524449621|FG000|Overall Study|Death|3|||
145434385|NCT00163189|524449621|FG000|Overall Study|Adverse Event|6|||
145434386|NCT00163189|524449621|FG000|Overall Study|Lack of Efficacy|7|||
145434387|NCT00163189|524449621|FG000|Overall Study|Study terminated by sponsor|11|||
145434388|NCT00163189|524449621|FG000|Overall Study|Withdrawal by Subject|11|||
145434389|NCT00163189|524449621|FG000|Overall Study|Did not meet continuation criterion|16|||
145434390|NCT02154061|524449622|FG000|Overall Study|Pregnancy|1|||
145434391|NCT02154061|524449623|FG001|Overall Study|Pregnancy|0|||
145434392|NCT02154061|524449622|FG000|Overall Study|enrolled but not vaccinated|1|||
145434393|NCT02154061|524449623|FG001|Overall Study|enrolled but not vaccinated|0|||
145434394|NCT03435380|524449624|FG000|Overall Study|Death|1|||
145583330|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583331|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
145583332|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
145583333|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
145583334|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
145583335|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
145583336|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583337|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583338|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583339|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145434395|NCT03435380|524449625|FG001|Overall Study|Death|2|||
145434396|NCT03435380|524449626|FG002|Overall Study|Death|1|||
145434397|NCT03435380|524449624|FG000|Overall Study|Lost to Follow-up|12|||
145583340|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145434398|NCT03435380|524449625|FG001|Overall Study|Lost to Follow-up|8|||
145434399|NCT03435380|524449626|FG002|Overall Study|Lost to Follow-up|6|||
145583341|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583342|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145434400|NCT03435380|524449624|FG000|Overall Study|Physician Decision|1|||
145434401|NCT03435380|524449625|FG001|Overall Study|Physician Decision|0|||
145434402|NCT03435380|524449626|FG002|Overall Study|Physician Decision|0|||
145434403|NCT03435380|524449624|FG000|Overall Study|Withdrawal by Subject|0|||
145434404|NCT03435380|524449625|FG001|Overall Study|Withdrawal by Subject|1|||
145583343|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583344|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583345|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583346|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583347|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
145583348|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
145583349|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
145583350|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
145583351|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
145583352|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583353|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583354|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583355|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583356|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583357|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583358|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583359|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583360|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583361|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583362|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583363|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583364|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
145583365|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145434405|NCT03435380|524449626|FG002|Overall Study|Withdrawal by Subject|1|||
145434406|NCT03435380|524449624|FG000|Overall Study|Ineligible|0|||
145434407|NCT03435380|524449625|FG001|Overall Study|Ineligible|1|||
145434408|NCT03435380|524449626|FG002|Overall Study|Ineligible|1|||
145434409|NCT01936831|524449627|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434410|NCT01936831|524449628|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434411|NCT01936831|524449629|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434412|NCT01936831|524449630|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434413|NCT01936831|524449631|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434414|NCT01936831|524449632|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
145434415|NCT01936831|524449633|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434416|NCT01936831|524449634|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434417|NCT01936831|524449635|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
145434418|NCT02431325|524449636|FG000|Overall Study|Adverse Event|3|||
145434419|NCT02431325|524449637|FG001|Overall Study|Adverse Event|0|||
145434420|NCT02431325|524449636|FG000|Overall Study|Lost to Follow-up|0|||
145583366|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583367|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
145583368|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583369|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583370|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583371|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583372|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583373|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583374|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583375|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583376|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583377|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583378|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583379|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
145583380|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
145583381|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
145583382|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
145583383|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
145583384|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583385|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145434421|NCT02431325|524449637|FG001|Overall Study|Lost to Follow-up|1|||
145434422|NCT02431325|524449636|FG000|Overall Study|Withdrawal by Subject|1|||
145434423|NCT02431325|524449637|FG001|Overall Study|Withdrawal by Subject|2|||
145434424|NCT02431325|524449636|FG000|Overall Study|Declined to take study medication|1|||
145434425|NCT02431325|524449637|FG001|Overall Study|Declined to take study medication|0|||
145434426|NCT02431325|524449636|FG000|Overall Study|Withdrew before starting study medication|1|||
145434427|NCT02431325|524449637|FG001|Overall Study|Withdrew before starting study medication|0|||
145624689|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
145624690|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
145624691|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
145624692|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Physician Decision|2|||
145624693|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Physician Decision|3|||
145624694|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Physician Decision|0|||
145624695|NCT01449929|525137760|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
145624696|NCT01449929|525137761|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
145624697|NCT01449929|525137762|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
145624698|NCT01449929|525137760|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
145624699|NCT01449929|525137761|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
145624700|NCT01449929|525137762|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
145624701|NCT01449929|525137760|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
145624702|NCT01449929|525137761|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
145624703|NCT01449929|525137762|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
145624704|NCT01449929|525137760|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
145624705|NCT01449929|525137761|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
145624706|NCT01449929|525137762|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
145624707|NCT03015740|525137763|FG000|Overall Study|Adverse Event|1|||
145624708|NCT03015740|525137764|FG001|Overall Study|Adverse Event|0|||
145624709|NCT03015740|525137765|FG002|Overall Study|Adverse Event|0|||
145624710|NCT03015740|525137763|FG000|Overall Study|Death|3|||
145624711|NCT03015740|525137764|FG001|Overall Study|Death|5|||
145624712|NCT03015740|525137765|FG002|Overall Study|Death|0|||
145624713|NCT03015740|525137763|FG000|Overall Study|Withdrawal by Subject|2|||
145624714|NCT03015740|525137764|FG001|Overall Study|Withdrawal by Subject|0|||
145624715|NCT03015740|525137765|FG002|Overall Study|Withdrawal by Subject|0|||
145624716|NCT03253653|525137770|FG000|Overall Study|Withdrawal by Subject|4|||
145624717|NCT03253653|525137771|FG001|Overall Study|Withdrawal by Subject|1|||
145624718|NCT03253653|525137770|FG000|Overall Study|Protocol Violation|0|||
145624719|NCT03253653|525137771|FG001|Overall Study|Protocol Violation|5|||
145624720|NCT02624778|525139666|FG000|Overall Study|Lost to Follow-up|0|||
145624721|NCT02624778|525139667|FG001|Overall Study|Lost to Follow-up|0|||
145624722|NCT02624778|525139668|FG002|Overall Study|Lost to Follow-up|1|||
145624723|NCT02624778|525139669|FG003|Overall Study|Lost to Follow-up|0|||
145624724|NCT02624778|525139670|FG004|Overall Study|Lost to Follow-up|0|||
145624725|NCT02624778|525139671|FG005|Overall Study|Lost to Follow-up|0|||
145624726|NCT02624778|525139672|FG006|Overall Study|Lost to Follow-up|0|||
145624727|NCT02624778|525139673|FG007|Overall Study|Lost to Follow-up|0|||
145624728|NCT02624778|525139674|FG008|Overall Study|Lost to Follow-up|0|||
145624729|NCT02624778|525139666|FG000|Overall Study|Withdrawal by Subject|0|||
145624730|NCT02624778|525139667|FG001|Overall Study|Withdrawal by Subject|1|||
145624731|NCT02624778|525139668|FG002|Overall Study|Withdrawal by Subject|0|||
145624732|NCT02624778|525139669|FG003|Overall Study|Withdrawal by Subject|0|||
145624733|NCT02624778|525139670|FG004|Overall Study|Withdrawal by Subject|0|||
145624734|NCT02624778|525139671|FG005|Overall Study|Withdrawal by Subject|1|||
145624735|NCT02624778|525139672|FG006|Overall Study|Withdrawal by Subject|1|||
145624736|NCT02624778|525139673|FG007|Overall Study|Withdrawal by Subject|1|||
145624737|NCT02624778|525139674|FG008|Overall Study|Withdrawal by Subject|1|||
145624738|NCT02624778|525139666|FG000|Overall Study|Adverse Event|0|||
145624739|NCT02624778|525139667|FG001|Overall Study|Adverse Event|0|||
145624740|NCT02624778|525139668|FG002|Overall Study|Adverse Event|0|||
145624741|NCT02624778|525139669|FG003|Overall Study|Adverse Event|0|||
145624742|NCT02624778|525139670|FG004|Overall Study|Adverse Event|0|||
145624743|NCT02624778|525139671|FG005|Overall Study|Adverse Event|0|||
145624744|NCT02624778|525139672|FG006|Overall Study|Adverse Event|0|||
145624745|NCT02624778|525139673|FG007|Overall Study|Adverse Event|0|||
145624746|NCT02624778|525139674|FG008|Overall Study|Adverse Event|2|||
145624747|NCT02624778|525139666|FG000|Overall Study|Death|0|||
145624748|NCT02624778|525139667|FG001|Overall Study|Death|0|||
145624749|NCT02624778|525139668|FG002|Overall Study|Death|0|||
145624750|NCT02624778|525139669|FG003|Overall Study|Death|0|||
145624751|NCT02624778|525139670|FG004|Overall Study|Death|0|||
145624752|NCT02624778|525139671|FG005|Overall Study|Death|0|||
145624753|NCT02624778|525139672|FG006|Overall Study|Death|1|||
145624754|NCT02624778|525139673|FG007|Overall Study|Death|0|||
145624755|NCT02624778|525139674|FG008|Overall Study|Death|0|||
145624756|NCT02624778|525139666|FG000|Overall Study|Physician Decision|0|||
145624757|NCT02624778|525139667|FG001|Overall Study|Physician Decision|0|||
145624758|NCT02624778|525139668|FG002|Overall Study|Physician Decision|0|||
145624759|NCT02624778|525139669|FG003|Overall Study|Physician Decision|0|||
145624760|NCT02624778|525139670|FG004|Overall Study|Physician Decision|0|||
145624761|NCT02624778|525139671|FG005|Overall Study|Physician Decision|0|||
145624762|NCT02624778|525139672|FG006|Overall Study|Physician Decision|0|||
145624763|NCT02624778|525139673|FG007|Overall Study|Physician Decision|3|||
145624764|NCT02624778|525139674|FG008|Overall Study|Physician Decision|3|||
145624765|NCT04610684|525139675|FG000|Study Treatment|Withdrawal by Subject|1|||
145434428|NCT02431325|524449636|FG000|Overall Study|Placebo shortage|2|||
145434429|NCT02431325|524449637|FG001|Overall Study|Placebo shortage|0|||
145434430|NCT01534481|524449641|FG000|Overall Study|Lost to Follow-up|29|||
145434431|NCT01534481|524449642|FG001|Overall Study|Lost to Follow-up|24|||
145434432|NCT01534481|524449641|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
145434433|NCT01534481|524449642|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
145434434|NCT01130337|524449643|FG000|Overall Study|Withdrawal by Subject|3|||
145434435|NCT01130337|524449643|FG000|Overall Study|Principal investigator decision|1|||
145434436|NCT01130337|524449643|FG000|Overall Study|Death|1|||
145434437|NCT01130337|524449643|FG000|Overall Study|Disease progression|1|||
145434438|NCT01130337|524449643|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
145434439|NCT01130337|524449643|FG000|Overall Study|Surgical resection (R2)|1|||
145434440|NCT05525910|524449644|FG000|Period 4|Per sponsor due to study timelines|0|||
145434441|NCT05525910|524449645|FG001|Period 4|Per sponsor due to study timelines|0|||
145434442|NCT05525910|524449646|FG002|Period 4|Per sponsor due to study timelines|1|||
145434443|NCT05525910|524449647|FG003|Period 4|Per sponsor due to study timelines|1|||
145434444|NCT05525910|524449648|FG004|Period 4|Per sponsor due to study timelines|1|||
145434445|NCT03886493|524449650|FG000|Overall Study|Adverse Event|1|||
145434446|NCT00181844|524449651|FG000|Signed Consent|Withdrawal by Subject|5|||
145434447|NCT00181844|524449651|FG000|Signed Consent|Did not meet entrance criteria|7|||
145434448|NCT00181844|524449651|FG000|Exposed to Study Medication|Adverse Event|10|||
145434449|NCT00181844|524449651|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
145434450|NCT00181844|524449651|FG000|Exposed to Study Medication|Non-compliance|2|||
145434451|NCT00181844|524449651|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
145434452|NCT00181844|524449651|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
145434453|NCT01987557|524449661|FG000|Overall Study|Protocol Violation|1|||
145434454|NCT01987557|524449662|FG001|Overall Study|Protocol Violation|0|||
145434455|NCT01987557|524449663|FG002|Overall Study|Protocol Violation|1|||
145434456|NCT01987557|524449661|FG000|Overall Study|Withdrawal by Subject|2|||
145434457|NCT01987557|524449662|FG001|Overall Study|Withdrawal by Subject|1|||
145434458|NCT01987557|524449663|FG002|Overall Study|Withdrawal by Subject|2|||
145434459|NCT01987557|524449661|FG000|Overall Study|Adverse Event|0|||
145434460|NCT01987557|524449662|FG001|Overall Study|Adverse Event|2|||
145434461|NCT01987557|524449663|FG002|Overall Study|Adverse Event|0|||
145434462|NCT01880957|524449664|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
145434463|NCT01880957|524449665|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
145434464|NCT01880957|524449664|FG000|Overall Study|Lost to Follow-up|11|||
145434465|NCT01880957|524449665|FG001|Overall Study|Lost to Follow-up|0|||
145434466|NCT01880957|524449664|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
145434467|NCT01880957|524449665|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
145434468|NCT01854528|524449666|FG000|Overall Study|Adverse Event|0|||
145434469|NCT01854528|524449667|FG001|Overall Study|Adverse Event|4|||
145434470|NCT01854528|524449666|FG000|Overall Study|Withdrawal by Subject|0|||
145434471|NCT01854528|524449667|FG001|Overall Study|Withdrawal by Subject|2|||
145434472|NCT01854528|524449666|FG000|Overall Study|Virologic Failure|0|||
145434473|NCT01854528|524449667|FG001|Overall Study|Virologic Failure|9|||
145434474|NCT02951780|524449668|FG000|Period 1|Adverse Event|0|||
145434475|NCT02951780|524449669|FG001|Period 1|Adverse Event|0|||
145434476|NCT02951780|524449670|FG002|Period 1|Adverse Event|0|||
145434477|NCT02951780|524449671|FG003|Period 1|Adverse Event|1|||
145434478|NCT02951780|524449672|FG004|Period 1|Adverse Event|0|||
145434479|NCT02951780|524449673|FG005|Period 1|Adverse Event|0|||
145434480|NCT02951780|524449674|FG006|Period 1|Adverse Event|0|||
145434481|NCT02951780|524449675|FG007|Period 1|Adverse Event|0|||
145583386|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583387|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583388|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583389|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583390|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583391|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583392|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583393|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583394|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145434482|NCT02951780|524449676|FG008|Period 1|Adverse Event|0|||
145434483|NCT02951780|524449668|FG000|Period 1|Scheduling Conflicts|0|||
145434484|NCT02951780|524449669|FG001|Period 1|Scheduling Conflicts|0|||
145434485|NCT02951780|524449670|FG002|Period 1|Scheduling Conflicts|0|||
145434486|NCT02951780|524449671|FG003|Period 1|Scheduling Conflicts|0|||
145434487|NCT02951780|524449672|FG004|Period 1|Scheduling Conflicts|0|||
145434488|NCT02951780|524449673|FG005|Period 1|Scheduling Conflicts|0|||
145434489|NCT02951780|524449674|FG006|Period 1|Scheduling Conflicts|0|||
145434490|NCT02951780|524449675|FG007|Period 1|Scheduling Conflicts|1|||
145434491|NCT02951780|524449676|FG008|Period 1|Scheduling Conflicts|0|||
145434492|NCT02951780|524449668|FG000|Period 2|Scheduling Conflicts|0|||
145434493|NCT02951780|524449669|FG001|Period 2|Scheduling Conflicts|0|||
145434494|NCT02951780|524449670|FG002|Period 2|Scheduling Conflicts|0|||
145434495|NCT02951780|524449671|FG003|Period 2|Scheduling Conflicts|0|||
145434496|NCT02951780|524449672|FG004|Period 2|Scheduling Conflicts|0|||
145434497|NCT02951780|524449673|FG005|Period 2|Scheduling Conflicts|0|||
145434498|NCT02951780|524449674|FG006|Period 2|Scheduling Conflicts|0|||
145434499|NCT02951780|524449675|FG007|Period 2|Scheduling Conflicts|1|||
145434500|NCT02951780|524449676|FG008|Period 2|Scheduling Conflicts|0|||
145434501|NCT02289469|524449679|FG000|Overall Study|Unable to match a control|6|||
145434502|NCT02289469|524449680|FG001|Overall Study|Unable to match a control|0|||
145434503|NCT03508050|524449681|FG000|Overall Study|Pleural adhesions|1|||
145434504|NCT03508050|524449682|FG001|Overall Study|Pleural adhesions|0|||
145434505|NCT03508050|524449681|FG000|Overall Study|Mucus plug|1|||
145434506|NCT03508050|524449682|FG001|Overall Study|Mucus plug|0|||
145434507|NCT03508050|524449681|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
145434508|NCT03508050|524449682|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
145434509|NCT03508050|524449681|FG000|Overall Study|Sustained desaturation|0|||
145434510|NCT03508050|524449682|FG001|Overall Study|Sustained desaturation|1|||
145434511|NCT01082614|524449683|FG000|Overall Study|Adverse Event|1|||
145434512|NCT01082614|524449684|FG001|Overall Study|Adverse Event|4|||
145434513|NCT01082614|524449683|FG000|Overall Study|Equipment Malfunction|0|||
145434514|NCT01082614|524449684|FG001|Overall Study|Equipment Malfunction|1|||
145434515|NCT01082614|524449683|FG000|Overall Study|Physician Decision|2|||
145434516|NCT01082614|524449684|FG001|Overall Study|Physician Decision|0|||
145434517|NCT03710889|524449685|FG000|Overall Study|Adverse Event|2|||
145434518|NCT03710889|524449685|FG000|Overall Study|Protocol Deviation|1|||
145434519|NCT04881760|524449686|FG000|Overall Study|Adverse Event|0|||
145434520|NCT04881760|524449687|FG001|Overall Study|Adverse Event|1|||
145434521|NCT04881760|524449688|FG002|Overall Study|Adverse Event|1|||
145434522|NCT04881760|524449689|FG003|Overall Study|Adverse Event|0|||
145434523|NCT04881760|524449690|FG004|Overall Study|Adverse Event|1|||
145434524|NCT04881760|524449691|FG005|Overall Study|Adverse Event|1|||
145434525|NCT04881760|524449692|FG006|Overall Study|Adverse Event|2|||
145434526|NCT04881760|524449686|FG000|Overall Study|Death|0|||
145434527|NCT04881760|524449687|FG001|Overall Study|Death|0|||
145434528|NCT04881760|524449688|FG002|Overall Study|Death|0|||
145434529|NCT04881760|524449689|FG003|Overall Study|Death|1|||
145434530|NCT04881760|524449690|FG004|Overall Study|Death|0|||
145434531|NCT04881760|524449691|FG005|Overall Study|Death|0|||
145434532|NCT04881760|524449692|FG006|Overall Study|Death|0|||
145434533|NCT04881760|524449686|FG000|Overall Study|Lost to Follow-up|5|||
145434534|NCT04881760|524449687|FG001|Overall Study|Lost to Follow-up|7|||
145434535|NCT04881760|524449688|FG002|Overall Study|Lost to Follow-up|5|||
145434536|NCT04881760|524449689|FG003|Overall Study|Lost to Follow-up|1|||
145434537|NCT04881760|524449690|FG004|Overall Study|Lost to Follow-up|2|||
145434538|NCT04881760|524449691|FG005|Overall Study|Lost to Follow-up|4|||
145434539|NCT04881760|524449692|FG006|Overall Study|Lost to Follow-up|4|||
145434540|NCT04881760|524449686|FG000|Overall Study|Withdrawal by Subject|13|||
145434541|NCT04881760|524449687|FG001|Overall Study|Withdrawal by Subject|1|||
145434542|NCT04881760|524449688|FG002|Overall Study|Withdrawal by Subject|1|||
145434543|NCT04881760|524449689|FG003|Overall Study|Withdrawal by Subject|4|||
145434544|NCT04881760|524449690|FG004|Overall Study|Withdrawal by Subject|2|||
145434545|NCT04881760|524449691|FG005|Overall Study|Withdrawal by Subject|1|||
145434546|NCT04881760|524449692|FG006|Overall Study|Withdrawal by Subject|2|||
145434547|NCT04881760|524449686|FG000|Overall Study|Randomized but Never Treated|0|||
145434548|NCT04881760|524449687|FG001|Overall Study|Randomized but Never Treated|0|||
145434549|NCT04881760|524449688|FG002|Overall Study|Randomized but Never Treated|0|||
145434550|NCT04881760|524449689|FG003|Overall Study|Randomized but Never Treated|1|||
145434551|NCT04881760|524449690|FG004|Overall Study|Randomized but Never Treated|0|||
145434552|NCT04881760|524449691|FG005|Overall Study|Randomized but Never Treated|0|||
145434553|NCT04881760|524449692|FG006|Overall Study|Randomized but Never Treated|0|||
145434554|NCT04881760|524449686|FG000|Overall Study|Inadvertent Enrollment|2|||
145434555|NCT04881760|524449687|FG001|Overall Study|Inadvertent Enrollment|0|||
145434556|NCT04881760|524449688|FG002|Overall Study|Inadvertent Enrollment|0|||
145434557|NCT04881760|524449689|FG003|Overall Study|Inadvertent Enrollment|0|||
145434558|NCT04881760|524449690|FG004|Overall Study|Inadvertent Enrollment|0|||
145434559|NCT04881760|524449691|FG005|Overall Study|Inadvertent Enrollment|0|||
145434560|NCT04881760|524449692|FG006|Overall Study|Inadvertent Enrollment|0|||
145434561|NCT04881760|524449686|FG000|Overall Study|Site Closure|0|||
145434562|NCT04881760|524449687|FG001|Overall Study|Site Closure|0|||
145434563|NCT04881760|524449688|FG002|Overall Study|Site Closure|0|||
145434564|NCT04881760|524449689|FG003|Overall Study|Site Closure|1|||
145434565|NCT04881760|524449690|FG004|Overall Study|Site Closure|0|||
145434566|NCT04881760|524449691|FG005|Overall Study|Site Closure|0|||
145434567|NCT04881760|524449692|FG006|Overall Study|Site Closure|0|||
145434568|NCT02081586|524449693|FG000|Overall Study|Lost to Follow-up|0|||
145434569|NCT02081586|524449694|FG001|Overall Study|Lost to Follow-up|1|||
145434570|NCT02081586|524449695|FG002|Overall Study|Lost to Follow-up|0|||
145434571|NCT02081586|524449696|FG003|Overall Study|Lost to Follow-up|1|||
145434572|NCT02081586|524449693|FG000|Overall Study|Head injury not related to study|0|||
145434573|NCT02081586|524449694|FG001|Overall Study|Head injury not related to study|0|||
145434574|NCT02081586|524449695|FG002|Overall Study|Head injury not related to study|1|||
145434575|NCT02081586|524449696|FG003|Overall Study|Head injury not related to study|0|||
145434576|NCT01816984|524449699|FG000|Overall Study|declining health status|1|||
145434577|NCT05076045|524449702|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
145434578|NCT05076045|524449703|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
145434579|NCT04704193|524449710|FG000|Overall Study|Withdrawal by Subject|1|||
145434580|NCT00829998|524449713|FG000|Washout|Adverse Event|0|||
145434581|NCT00829998|524449714|FG001|Washout|Adverse Event|1|||
145434582|NCT02735421|524451342|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
145434583|NCT02735421|524451342|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
145434584|NCT02735421|524451342|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
145434585|NCT02735421|524451342|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
145434586|NCT02735421|524451342|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
145434587|NCT02735421|524451342|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
145434588|NCT02735421|524451342|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
145434589|NCT03549338|524451343|FG000|Overall Study|Progressive Disease|1|||
145434590|NCT03549338|524451344|FG001|Overall Study|Progressive Disease|0|||
145434591|NCT03549338|524451345|FG002|Overall Study|Progressive Disease|0|||
145434592|NCT03549338|524451343|FG000|Overall Study|Clinical Progression|0|||
145434593|NCT03549338|524451344|FG001|Overall Study|Clinical Progression|1|||
145434594|NCT03549338|524451345|FG002|Overall Study|Clinical Progression|0|||
145434595|NCT01492426|524451346|FG000|Treatment|Death|0|||
145434596|NCT01492426|524451347|FG001|Treatment|Death|1|||
145434597|NCT01492426|524451346|FG000|Treatment|Other|1|||
145434598|NCT01492426|524451347|FG001|Treatment|Other|0|||
145434599|NCT01492426|524451346|FG000|Treatment|Adverse Event|25|||
145434600|NCT01492426|524451347|FG001|Treatment|Adverse Event|25|||
145434601|NCT01492426|524451346|FG000|Treatment|Lack of Efficacy|38|||
145434602|NCT01492426|524451347|FG001|Treatment|Lack of Efficacy|5|||
145434603|NCT01492426|524451346|FG000|Treatment|Participant withdrew consent|1|||
145434604|NCT01492426|524451347|FG001|Treatment|Participant withdrew consent|2|||
145434605|NCT01492426|524451346|FG000|Treatment|Poor compliance/noncompliance|1|||
145434606|NCT01492426|524451347|FG001|Treatment|Poor compliance/noncompliance|0|||
145434607|NCT01492426|524451346|FG000|Treatment|Subject requested discontinue study drug|7|||
145434608|NCT01492426|524451347|FG001|Treatment|Subject requested discontinue study drug|3|||
145434609|NCT01492426|524451346|FG000|Treatment|Lost to Follow-up|9|||
145434610|NCT01492426|524451347|FG001|Treatment|Lost to Follow-up|4|||
145434611|NCT01492426|524451346|FG000|Treatment|Participant does not meet study criteria|1|||
145434612|NCT01492426|524451347|FG001|Treatment|Participant does not meet study criteria|0|||
145434613|NCT01492426|524451346|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
145434614|NCT01492426|524451347|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
145434615|NCT01492426|524451346|FG000|Follow-Up|Death|1|||
145434616|NCT01492426|524451347|FG001|Follow-Up|Death|0|||
145434617|NCT01492426|524451346|FG000|Follow-Up|Other|4|||
145434618|NCT01492426|524451347|FG001|Follow-Up|Other|2|||
145434619|NCT01492426|524451346|FG000|Follow-Up|Participant Withdrew Consent|6|||
145434620|NCT01492426|524451347|FG001|Follow-Up|Participant Withdrew Consent|1|||
145434621|NCT01492426|524451346|FG000|Follow-Up|Lost to Follow-up|12|||
145434622|NCT01492426|524451347|FG001|Follow-Up|Lost to Follow-up|6|||
145434623|NCT02026011|524451350|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
145434624|NCT02026011|524451351|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
145434625|NCT02026011|524451350|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
145434626|NCT02026011|524451351|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
145434627|NCT02026011|524451350|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
145434628|NCT02026011|524451351|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
145434629|NCT02026011|524451350|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
145434630|NCT02026011|524451351|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
145434631|NCT00939107|524451352|FG000|Overall Study|Lost to Follow-up|14|||
145434632|NCT00939107|524451353|FG001|Overall Study|Lost to Follow-up|12|||
145434633|NCT05010070|524451354|FG000|Overall Study|Lost to Follow-up|1|||
145434634|NCT05010070|524451354|FG000|Overall Study|Withdrawal by Subject|1|||
145434635|NCT00652743|524451355|FG000|Months 12-18|Lost to Follow-up|1|||
145434636|NCT00652743|524451356|FG001|Months 12-18|Lost to Follow-up|2|||
145434637|NCT00652743|524451357|FG002|Months 12-18|Lost to Follow-up|7|||
145434638|NCT00652743|524451355|FG000|Months 24-30|Other|5|||
145434639|NCT00652743|524451356|FG001|Months 24-30|Other|1|||
145434640|NCT00652743|524451357|FG002|Months 24-30|Other|11|||
145434641|NCT00652743|524451355|FG000|Months 36-42|Serious Adverse Events|0|||
145434642|NCT00652743|524451356|FG001|Months 36-42|Serious Adverse Events|1|||
145434643|NCT00652743|524451357|FG002|Months 36-42|Serious Adverse Events|1|||
145434644|NCT00652743|524451355|FG000|Months 36-42|Withdrawal by Subject|1|||
145434645|NCT00652743|524451356|FG001|Months 36-42|Withdrawal by Subject|1|||
145434646|NCT00652743|524451357|FG002|Months 36-42|Withdrawal by Subject|0|||
145434647|NCT00652743|524451355|FG000|Months 36-42|Lost to Follow-up|0|||
145434648|NCT00652743|524451356|FG001|Months 36-42|Lost to Follow-up|1|||
145434649|NCT00652743|524451357|FG002|Months 36-42|Lost to Follow-up|0|||
145624766|NCT04610684|525139675|FG000|Study Treatment|Disease Progression|2|||
145624767|NCT04610684|525139675|FG000|Follow up|Death|2|||
145624768|NCT04610684|525139675|FG000|Follow up|Withdrawal by Subject|1|||
145624769|NCT02153788|525139676|FG000|Overall Study|Physician Decision|2|||
145624770|NCT02153788|525139677|FG001|Overall Study|Physician Decision|1|||
145624771|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
145624772|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
145624773|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
145624774|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
145624775|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
145624776|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
145624777|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
145624778|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
145624779|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
145624780|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
145624781|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
145624782|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
145624783|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
145624784|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
145624785|NCT04672460|525139678|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
145624786|NCT04672460|525139679|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
145624787|NCT04672460|525139678|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
145624788|NCT04672460|525139679|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
145624789|NCT04672460|525139678|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
145624790|NCT04672460|525139679|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
145624791|NCT04672460|525139678|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
145624792|NCT04672460|525139679|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
145624793|NCT04672460|525139678|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
145624794|NCT04672460|525139679|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
145624795|NCT04672460|525139678|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
145624796|NCT04672460|525139679|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
145624797|NCT04672460|525139678|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
145624798|NCT04672460|525139679|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
145624799|NCT04672460|525139678|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
145624800|NCT04672460|525139679|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
145624801|NCT04672460|525139678|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
145624802|NCT04672460|525139679|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
145624803|NCT04672460|525139678|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
145624804|NCT04672460|525139679|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
145624805|NCT01876043|525139682|FG000|Overall Study|Death|1|||
145624806|NCT01876043|525139682|FG000|Overall Study|Withdrawal by Subject|1|||
145624807|NCT00079937|525139683|FG000|Overall Study|Adverse Event|2|||
145624808|NCT00079937|525139684|FG001|Overall Study|Adverse Event|1|||
145624809|NCT00079937|525139683|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145624810|NCT00079937|525139684|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145624811|NCT00079937|525139683|FG000|Overall Study|Subject no longer requires study drug|3|||
145624812|NCT00079937|525139684|FG001|Overall Study|Subject no longer requires study drug|0|||
145624813|NCT00079937|525139683|FG000|Overall Study|Protocol Violation|8|||
145624814|NCT00079937|525139684|FG001|Overall Study|Protocol Violation|6|||
145434650|NCT00652743|524451355|FG000|Months 36-42|Migrated/moved from study area|1|||
145434651|NCT00652743|524451356|FG001|Months 36-42|Migrated/moved from study area|0|||
145434652|NCT00652743|524451357|FG002|Months 36-42|Migrated/moved from study area|0|||
145434653|NCT00652743|524451355|FG000|Months 36-42|Other|4|||
145434654|NCT00652743|524451356|FG001|Months 36-42|Other|2|||
145434655|NCT00652743|524451357|FG002|Months 36-42|Other|8|||
145434656|NCT01246960|524451362|FG000|Overall Study|Lost to Follow-up|3|||
145434657|NCT01246960|524451363|FG001|Overall Study|Lost to Follow-up|1|||
145434658|NCT01246960|524451362|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
145434659|NCT01246960|524451363|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
145434660|NCT00105534|524451367|FG000|Overall Study|Adverse Event|2|||
145434661|NCT00105534|524451368|FG001|Overall Study|Adverse Event|5|||
145434662|NCT00105534|524451367|FG000|Overall Study|Protocol Violation|1|||
145434663|NCT00105534|524451368|FG001|Overall Study|Protocol Violation|4|||
145434664|NCT00105534|524451367|FG000|Overall Study|Withdrawal by Subject|6|||
145624815|NCT00079937|525139683|FG000|Overall Study|Withdrawal by Subject|21|||
145624816|NCT00079937|525139684|FG001|Overall Study|Withdrawal by Subject|7|||
145624817|NCT00079937|525139683|FG000|Overall Study|Lost to Follow-up|12|||
145624818|NCT00079937|525139684|FG001|Overall Study|Lost to Follow-up|5|||
145624819|NCT00079937|525139683|FG000|Overall Study|Administrative problems|22|||
145434665|NCT00105534|524451368|FG001|Overall Study|Withdrawal by Subject|6|||
145434666|NCT00105534|524451367|FG000|Overall Study|Lost to Follow-up|5|||
145434667|NCT00105534|524451368|FG001|Overall Study|Lost to Follow-up|1|||
145434668|NCT00105534|524451367|FG000|Overall Study|Lack of Efficacy|7|||
145434669|NCT00105534|524451368|FG001|Overall Study|Lack of Efficacy|15|||
145434670|NCT00105534|524451367|FG000|Overall Study|Treatment unmasked|1|||
145434671|NCT00105534|524451368|FG001|Overall Study|Treatment unmasked|0|||
145434672|NCT00105534|524451367|FG000|Overall Study|Other Reason|0|||
145434673|NCT00105534|524451368|FG001|Overall Study|Other Reason|2|||
145434674|NCT01621178|524451369|FG000|Overall Study|Adverse Event|5|||
145434675|NCT01621178|524451370|FG001|Overall Study|Adverse Event|2|||
145434676|NCT01621178|524451371|FG002|Overall Study|Adverse Event|8|||
145434677|NCT01621178|524451369|FG000|Overall Study|Death|6|||
145434678|NCT01621178|524451370|FG001|Overall Study|Death|7|||
145434679|NCT01621178|524451371|FG002|Overall Study|Death|2|||
145434680|NCT01621178|524451369|FG000|Overall Study|Lost to Follow-up|1|||
145434681|NCT01621178|524451370|FG001|Overall Study|Lost to Follow-up|2|||
145434682|NCT01621178|524451371|FG002|Overall Study|Lost to Follow-up|1|||
145434683|NCT01621178|524451369|FG000|Overall Study|Withdrawal by Subject|14|||
145434684|NCT01621178|524451370|FG001|Overall Study|Withdrawal by Subject|17|||
145434685|NCT01621178|524451371|FG002|Overall Study|Withdrawal by Subject|18|||
145434686|NCT01621178|524451369|FG000|Overall Study|Physician Decision|5|||
145434687|NCT01621178|524451370|FG001|Overall Study|Physician Decision|2|||
145434688|NCT01621178|524451371|FG002|Overall Study|Physician Decision|7|||
145434689|NCT02935192|524451372|FG000|Overall Study|Withdrawal by Subject|8|||
145434690|NCT02935192|524451373|FG001|Overall Study|Withdrawal by Subject|4|||
145434691|NCT02465931|524451374|FG000|Overall Study|Lost to Follow-up|9|||
145434692|NCT02465931|524451375|FG001|Overall Study|Lost to Follow-up|11|||
145434693|NCT02465931|524451374|FG000|Overall Study|Protocol Violation|1|||
145434694|NCT02465931|524451375|FG001|Overall Study|Protocol Violation|0|||
145434695|NCT02465931|524451374|FG000|Overall Study|Withdrawal by Subject|1|||
145434696|NCT02465931|524451375|FG001|Overall Study|Withdrawal by Subject|0|||
145434697|NCT02896257|524451377|FG000|Providers|Without eligible patients|21|||
145434698|NCT02896257|524451378|FG001|Providers|Without eligible patients|28|||
145434699|NCT02896257|524451377|FG000|Patients|PFT entry criteria not met|43|||
145434700|NCT02896257|524451378|FG001|Patients|PFT entry criteria not met|50|||
145434701|NCT02896257|524451377|FG000|Patients|No capacity to review|8|||
145434702|NCT02896257|524451378|FG001|Patients|No capacity to review|11|||
145434703|NCT02896257|524451377|FG000|Patients|Appointment rescheduled/cancelled|5|||
145434704|NCT02896257|524451378|FG001|Patients|Appointment rescheduled/cancelled|7|||
145434705|NCT02896257|524451377|FG000|Patients|PCP not assigned a clinic|4|||
145434706|NCT02896257|524451378|FG001|Patients|PCP not assigned a clinic|0|||
145434707|NCT02896257|524451377|FG000|Patients|No history of COPD|0|||
145434708|NCT02896257|524451378|FG001|Patients|No history of COPD|1|||
145434709|NCT02896257|524451377|FG000|Patients|Deceased between review and index date|0|||
145583395|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583396|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583397|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583398|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
145583399|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
145583400|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583401|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583402|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583403|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583404|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583405|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583406|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583407|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583408|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583409|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583410|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583411|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
145434710|NCT02896257|524451378|FG001|Patients|Deceased between review and index date|1|||
145434711|NCT02896257|524451377|FG000|Patients|No ICS Rx upon review|1|||
145434712|NCT02896257|524451378|FG001|Patients|No ICS Rx upon review|1|||
145434713|NCT02896257|524451377|FG000|Patients|Protocol Violation|2|||
145583412|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
145583413|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
145434714|NCT02896257|524451378|FG001|Patients|Protocol Violation|1|||
145434715|NCT02896257|524451377|FG000|Patients|Hospice care|0|||
145434716|NCT02896257|524451378|FG001|Patients|Hospice care|1|||
145434717|NCT04778592|524451380|FG000|Overall Study|Adverse Event|1|||
145434718|NCT04778592|524451381|FG001|Overall Study|Adverse Event|2|||
145434719|NCT04778592|524451380|FG000|Overall Study|Withdrawal by Subject|1|||
145434720|NCT04778592|524451381|FG001|Overall Study|Withdrawal by Subject|2|||
145434721|NCT03423602|524451382|FG000|Overall Study|Death|1|||
145434722|NCT03423602|524451382|FG000|Overall Study|Lost to Follow-up|6|||
145434723|NCT03423602|524451382|FG000|Overall Study|Protocol Violation|1|||
145434724|NCT03423602|524451382|FG000|Overall Study|Withdrawal by Subject|4|||
145434725|NCT01126190|524451388|FG000|Double-Blind Phase|Death|0|||
145434726|NCT01126190|524451389|FG001|Double-Blind Phase|Death|1|||
145434727|NCT01126190|524451390|FG002|Double-Blind Phase|Death|0|||
145434728|NCT01126190|524451388|FG000|Double-Blind Phase|Adverse Event|1|||
145434729|NCT01126190|524451389|FG001|Double-Blind Phase|Adverse Event|2|||
145434730|NCT01126190|524451390|FG002|Double-Blind Phase|Adverse Event|0|||
145434731|NCT01126190|524451388|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
145434732|NCT01126190|524451389|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
145434733|NCT01126190|524451390|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145434734|NCT01126190|524451388|FG000|Double-Blind Phase|Request of Investigator|1|||
145434735|NCT01126190|524451389|FG001|Double-Blind Phase|Request of Investigator|0|||
145434736|NCT01126190|524451390|FG002|Double-Blind Phase|Request of Investigator|0|||
145434737|NCT01126190|524451388|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
145434738|NCT01126190|524451389|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
145434739|NCT01126190|524451390|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
145434740|NCT01126190|524451388|FG000|Double-Blind Phase|Non-compliance|1|||
145434741|NCT01126190|524451389|FG001|Double-Blind Phase|Non-compliance|0|||
145434742|NCT01126190|524451390|FG002|Double-Blind Phase|Non-compliance|0|||
145434743|NCT01126190|524451388|FG000|Double-Blind Phase|Lost to Follow-up|1|||
145434744|NCT01126190|524451389|FG001|Double-Blind Phase|Lost to Follow-up|3|||
145434745|NCT01126190|524451390|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145434746|NCT01126190|524451388|FG000|Open-Label Phase|Death|0|||
145434747|NCT01126190|524451389|FG001|Open-Label Phase|Death|0|||
145434748|NCT01126190|524451390|FG002|Open-Label Phase|Death|1|||
145434749|NCT01126190|524451388|FG000|Open-Label Phase|Adverse Event|0|||
145434750|NCT01126190|524451389|FG001|Open-Label Phase|Adverse Event|0|||
145434751|NCT01126190|524451390|FG002|Open-Label Phase|Adverse Event|4|||
145434752|NCT01126190|524451388|FG000|Open-Label Phase|Withdrawal by Subject|0|||
145434753|NCT01126190|524451389|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145434754|NCT01126190|524451390|FG002|Open-Label Phase|Withdrawal by Subject|6|||
145434755|NCT00524121|524451391|FG000|Overall Study|Disease progression|6|||
145434756|NCT00524121|524451391|FG000|Overall Study|Adverse Event|4|||
145434757|NCT00524121|524451391|FG000|Overall Study|Patient refused|2|||
145434758|NCT00524121|524451391|FG000|Overall Study|Other|1|||
145434759|NCT00524121|524451391|FG000|Overall Study|Death|1|||
145434760|NCT00524121|524451391|FG000|Overall Study|Not treated (became ineligible)|4|||
145434761|NCT00524121|524451391|FG000|Overall Study|Not treated (changed mind)|1|||
145434762|NCT01840943|524451392|FG000|Overall Study|Withdrawal by Subject|5|||
145434763|NCT01840943|524451393|FG001|Overall Study|Withdrawal by Subject|6|||
145434764|NCT01840943|524451392|FG000|Overall Study|Physician Decision|4|||
145434765|NCT01840943|524451393|FG001|Overall Study|Physician Decision|2|||
145434766|NCT01840943|524451392|FG000|Overall Study|Lost to Follow-up|4|||
145434767|NCT01840943|524451393|FG001|Overall Study|Lost to Follow-up|4|||
145434768|NCT01114737|524451394|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
145434769|NCT01114737|524451395|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
145434770|NCT01114737|524451394|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
145434771|NCT01114737|524451395|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
145434772|NCT01114737|524451394|FG000|Randomized Treatment Period|Pregnancy|1|||
145434773|NCT01114737|524451395|FG001|Randomized Treatment Period|Pregnancy|0|||
145434774|NCT01114737|524451394|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
145434775|NCT01114737|524451395|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
145434776|NCT01114737|524451394|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
145434777|NCT01114737|524451395|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
145434778|NCT01114737|524451394|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
145434779|NCT01114737|524451395|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
145434780|NCT01446874|524451398|FG000|Overall Study|Not eligible|1|||
145624820|NCT00079937|525139684|FG001|Overall Study|Administrative problems|11|||
145624821|NCT02949271|525139685|FG000|Overall Study|Lack of Efficacy|5|||
145624822|NCT02949271|525139686|FG001|Overall Study|Lack of Efficacy|4|||
145624823|NCT02949271|525139685|FG000|Overall Study|Lost to Follow-up|3|||
145434781|NCT01446874|524451399|FG001|Overall Study|Not eligible|0|||
145434782|NCT01446874|524451400|FG002|Overall Study|Not eligible|0|||
145434783|NCT01446874|524451398|FG000|Overall Study|No surgery/No qualifying surgery|1|||
145434784|NCT01446874|524451399|FG001|Overall Study|No surgery/No qualifying surgery|0|||
145434785|NCT01446874|524451400|FG002|Overall Study|No surgery/No qualifying surgery|12|||
145434786|NCT01446874|524451398|FG000|Overall Study|Non-compliance|0|||
145434787|NCT01446874|524451399|FG001|Overall Study|Non-compliance|4|||
145434788|NCT01446874|524451400|FG002|Overall Study|Non-compliance|0|||
145434789|NCT01446874|524451398|FG000|Overall Study|Antibiotics for pre-op infection|0|||
145434790|NCT01446874|524451399|FG001|Overall Study|Antibiotics for pre-op infection|0|||
145434791|NCT01446874|524451400|FG002|Overall Study|Antibiotics for pre-op infection|2|||
145434792|NCT01446874|524451398|FG000|Overall Study|Withdrawal by Subject|0|||
145434793|NCT01446874|524451399|FG001|Overall Study|Withdrawal by Subject|0|||
145434794|NCT01446874|524451400|FG002|Overall Study|Withdrawal by Subject|4|||
145624824|NCT02949271|525139686|FG001|Overall Study|Lost to Follow-up|6|||
145434795|NCT01135992|524451401|FG000|Overall Study|Adverse Event|1|||
145624825|NCT02949271|525139685|FG000|Overall Study|Physician Decision|5|||
145624826|NCT02949271|525139686|FG001|Overall Study|Physician Decision|5|||
145624827|NCT02949271|525139685|FG000|Overall Study|Protocol Violation|6|||
145624828|NCT02949271|525139686|FG001|Overall Study|Protocol Violation|3|||
145624829|NCT02949271|525139685|FG000|Overall Study|Withdrawal by Subject|1|||
145624830|NCT02949271|525139686|FG001|Overall Study|Withdrawal by Subject|0|||
145624831|NCT02949271|525139685|FG000|Overall Study|Delivered prior to intervention|7|||
145624832|NCT02949271|525139686|FG001|Overall Study|Delivered prior to intervention|9|||
145624833|NCT02949271|525139685|FG000|Overall Study|Outside the window for cervical dilation|2|||
145624834|NCT02949271|525139686|FG001|Overall Study|Outside the window for cervical dilation|3|||
145624835|NCT05458102|525139689|FG000|Overall Study|Withdrew consent|2|||
145624836|NCT05458102|525139690|FG001|Overall Study|Withdrew consent|0|||
145624837|NCT05458102|525139689|FG000|Overall Study|Adverse Event|1|||
145624838|NCT05458102|525139690|FG001|Overall Study|Adverse Event|0|||
145624839|NCT05458102|525139689|FG000|Overall Study|Enrolled but never treated|1|||
145624840|NCT05458102|525139690|FG001|Overall Study|Enrolled but never treated|0|||
145624841|NCT05458102|525139689|FG000|Overall Study|Protocol Violation|1|||
145624842|NCT05458102|525139690|FG001|Overall Study|Protocol Violation|0|||
145624843|NCT00852475|525139693|FG000|Overall Study|Lost to Follow-up|3|||
145624844|NCT00852475|525139694|FG001|Overall Study|Lost to Follow-up|4|||
145624845|NCT04531540|525139699|FG000|Overall Study|Adverse Event|1|||
145624846|NCT04531540|525139699|FG000|Overall Study|Protocol Violation|3|||
145624847|NCT04531540|525139699|FG000|Overall Study|Withdrawal by Subject|4|||
145624848|NCT04531540|525139699|FG000|Overall Study|Found to be Ineligible|1|||
145624849|NCT00926393|525139700|FG000|Overall Study|Withdrawal by Subject|1|||
145624850|NCT00926393|525139701|FG001|Overall Study|Withdrawal by Subject|2|||
145624851|NCT00926393|525139700|FG000|Overall Study|Adverse Event|1|||
145624852|NCT00926393|525139701|FG001|Overall Study|Adverse Event|1|||
145624853|NCT01403987|525139703|FG000|Overall Study|Residents forgot their secret PIN|18|||
145624854|NCT01403987|525139704|FG001|Overall Study|Residents forgot their secret PIN|17|||
145624855|NCT01403987|525139705|FG002|Overall Study|Residents forgot their secret PIN|18|||
145624856|NCT00180674|525139707|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
145624857|NCT00180674|525139707|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
145624858|NCT00278564|525139709|FG000|Overall Study|Lack of Efficacy|4|||
145624859|NCT01094743|525139710|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
145624860|NCT02851511|525139711|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
145624861|NCT02851511|525139712|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
145624862|NCT02851511|525139713|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
145624863|NCT02851511|525139714|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
145624864|NCT02851511|525139711|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
145624865|NCT02851511|525139712|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
145624866|NCT02851511|525139713|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
145624867|NCT02851511|525139714|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
145624868|NCT02851511|525139711|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
145624869|NCT02851511|525139712|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
145434796|NCT01135992|524451401|FG000|Overall Study|Lack of Efficacy|1|||
145434797|NCT01135992|524451401|FG000|Overall Study|Protocol Violation|2|||
145434798|NCT01135992|524451401|FG000|Overall Study|Withdrawal criteria|10|||
145434799|NCT01135992|524451401|FG000|Overall Study|Unclassified|7|||
145434800|NCT02660229|524451403|FG000|Overall Study|Adverse Event|2|||
145434801|NCT02660229|524451404|FG001|Overall Study|Adverse Event|0|||
145434802|NCT02660229|524451403|FG000|Overall Study|Withdrawal by Subject|0|||
145434803|NCT02660229|524451404|FG001|Overall Study|Withdrawal by Subject|1|||
145434804|NCT01466491|524451405|FG000|Overall Study|Protocol Violation|0|||
145434805|NCT01466491|524451406|FG001|Overall Study|Protocol Violation|3|||
145434806|NCT01466491|524451407|FG002|Overall Study|Protocol Violation|2|||
145434807|NCT01466491|524451408|FG003|Overall Study|Protocol Violation|0|||
145624870|NCT02851511|525139713|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
145624871|NCT02851511|525139714|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
145624872|NCT02851511|525139711|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
145434808|NCT01466491|524451405|FG000|Overall Study|Missing Data|0|||
145624873|NCT02851511|525139712|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
145624874|NCT02851511|525139713|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
145434809|NCT01466491|524451406|FG001|Overall Study|Missing Data|0|||
145434810|NCT01466491|524451407|FG002|Overall Study|Missing Data|1|||
145434811|NCT01466491|524451408|FG003|Overall Study|Missing Data|0|||
145624875|NCT02851511|525139714|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
145624876|NCT02851511|525139711|FG000|Phase I|Physician Decision|0|||
145624877|NCT02851511|525139712|FG001|Phase I|Physician Decision|0|||
145624878|NCT02851511|525139713|FG002|Phase I|Physician Decision|0|||
145624879|NCT02851511|525139714|FG003|Phase I|Physician Decision|1|||
145434812|NCT02852967|524451409|FG000|Overall Study|Adverse Event|3|||
145434813|NCT02852967|524451410|FG001|Overall Study|Adverse Event|1|||
145434814|NCT02852967|524451411|FG002|Overall Study|Adverse Event|0|||
145434815|NCT02852967|524451412|FG003|Overall Study|Adverse Event|1|||
145434816|NCT02852967|524451413|FG004|Overall Study|Adverse Event|0|||
145434817|NCT02852967|524451409|FG000|Overall Study|Death|1|||
145434818|NCT02852967|524451410|FG001|Overall Study|Death|0|||
145434819|NCT02852967|524451411|FG002|Overall Study|Death|0|||
145434820|NCT02852967|524451412|FG003|Overall Study|Death|0|||
145434821|NCT02852967|524451413|FG004|Overall Study|Death|0|||
145434822|NCT02852967|524451409|FG000|Overall Study|Lost to Follow-up|1|||
145434823|NCT02852967|524451410|FG001|Overall Study|Lost to Follow-up|2|||
145434824|NCT02852967|524451411|FG002|Overall Study|Lost to Follow-up|3|||
145434825|NCT02852967|524451412|FG003|Overall Study|Lost to Follow-up|4|||
145434826|NCT02852967|524451413|FG004|Overall Study|Lost to Follow-up|4|||
145434827|NCT02852967|524451409|FG000|Overall Study|Withdrawal by Subject|6|||
145434828|NCT02852967|524451410|FG001|Overall Study|Withdrawal by Subject|12|||
145434829|NCT02852967|524451411|FG002|Overall Study|Withdrawal by Subject|7|||
145434830|NCT02852967|524451412|FG003|Overall Study|Withdrawal by Subject|10|||
145434831|NCT02852967|524451413|FG004|Overall Study|Withdrawal by Subject|10|||
145434832|NCT02852967|524451409|FG000|Overall Study|SAE|0|||
145434833|NCT02852967|524451410|FG001|Overall Study|SAE|0|||
145434834|NCT02852967|524451411|FG002|Overall Study|SAE|0|||
145434835|NCT02852967|524451412|FG003|Overall Study|SAE|3|||
145434836|NCT02852967|524451413|FG004|Overall Study|SAE|0|||
145434837|NCT02852967|524451409|FG000|Overall Study|Elevated Liver Enzymes|2|||
145434838|NCT02852967|524451410|FG001|Overall Study|Elevated Liver Enzymes|0|||
145434839|NCT02852967|524451411|FG002|Overall Study|Elevated Liver Enzymes|0|||
145434840|NCT02852967|524451412|FG003|Overall Study|Elevated Liver Enzymes|2|||
145434841|NCT02852967|524451413|FG004|Overall Study|Elevated Liver Enzymes|2|||
145434842|NCT02852967|524451409|FG000|Overall Study|Physician Decision|0|||
145434843|NCT02852967|524451410|FG001|Overall Study|Physician Decision|0|||
145434844|NCT02852967|524451411|FG002|Overall Study|Physician Decision|0|||
145434845|NCT02852967|524451412|FG003|Overall Study|Physician Decision|1|||
145434846|NCT02852967|524451413|FG004|Overall Study|Physician Decision|0|||
145434847|NCT02852967|524451409|FG000|Overall Study|Lack of Efficacy|0|||
145434848|NCT02852967|524451410|FG001|Overall Study|Lack of Efficacy|1|||
145434849|NCT02852967|524451411|FG002|Overall Study|Lack of Efficacy|0|||
145434850|NCT02852967|524451412|FG003|Overall Study|Lack of Efficacy|0|||
145434851|NCT02852967|524451413|FG004|Overall Study|Lack of Efficacy|0|||
145434852|NCT02852967|524451409|FG000|Overall Study|Non-compliance|0|||
145434853|NCT02852967|524451410|FG001|Overall Study|Non-compliance|0|||
145434854|NCT02852967|524451411|FG002|Overall Study|Non-compliance|1|||
145434855|NCT02852967|524451412|FG003|Overall Study|Non-compliance|1|||
145434856|NCT02852967|524451413|FG004|Overall Study|Non-compliance|0|||
145434857|NCT02852967|524451409|FG000|Overall Study|Dispensing Drug Violation|0|||
145434858|NCT02852967|524451410|FG001|Overall Study|Dispensing Drug Violation|0|||
145434859|NCT02852967|524451411|FG002|Overall Study|Dispensing Drug Violation|1|||
145434860|NCT02852967|524451412|FG003|Overall Study|Dispensing Drug Violation|0|||
145434861|NCT02852967|524451413|FG004|Overall Study|Dispensing Drug Violation|0|||
145434862|NCT02852967|524451409|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
145434863|NCT02852967|524451410|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
145434864|NCT02852967|524451411|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
145434865|NCT02852967|524451412|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
145434866|NCT02852967|524451413|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
145434867|NCT03046446|524451414|FG000|Overall Study|Lack of Efficacy|7|||
145434868|NCT03046446|524451414|FG000|Overall Study|Adverse Event|6|||
145434869|NCT03046446|524451414|FG000|Overall Study|Lost to Follow-up|3|||
145434870|NCT03046446|524451414|FG000|Overall Study|Withdrawal by Subject|14|||
145434871|NCT03046446|524451414|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
145434872|NCT03046446|524451414|FG000|Overall Study|Disease Progression (see caveats)|25|||
145434873|NCT03046446|524451414|FG000|Overall Study|Non OA related knee surgery|1|||
145434874|NCT02808897|524451415|FG000|Overall Study|Lost to Follow-up|9|||
145434875|NCT02808897|524451416|FG001|Overall Study|Lost to Follow-up|11|||
145434876|NCT01496287|524451417|FG000|Overall Study|Lost to Follow-up|1|||
145434877|NCT01496287|524451417|FG000|Overall Study|Incomplete anesthesia|5|||
145434878|NCT03012334|524451418|FG000|Period 1|Withdrawal by Subject|0|||
145434879|NCT03012334|524451419|FG001|Period 1|Withdrawal by Subject|0|||
145434880|NCT03012334|524451420|FG002|Period 1|Withdrawal by Subject|0|||
145434881|NCT03012334|524451421|FG003|Period 1|Withdrawal by Subject|0|||
145434882|NCT03012334|524451422|FG004|Period 1|Withdrawal by Subject|0|||
145434883|NCT03012334|524451423|FG005|Period 1|Withdrawal by Subject|0|||
145434884|NCT03012334|524451424|FG006|Period 1|Withdrawal by Subject|0|||
145434885|NCT03012334|524451425|FG007|Period 1|Withdrawal by Subject|0|||
145434886|NCT03012334|524451426|FG008|Period 1|Withdrawal by Subject|0|||
145434887|NCT03012334|524451427|FG009|Period 1|Withdrawal by Subject|1|||
145434888|NCT03012334|524451418|FG000|Period 2|Withdrawal by Subject|0|||
145434889|NCT03012334|524451419|FG001|Period 2|Withdrawal by Subject|1|||
145434890|NCT03012334|524451420|FG002|Period 2|Withdrawal by Subject|0|||
145434891|NCT03012334|524451421|FG003|Period 2|Withdrawal by Subject|0|||
145434892|NCT03012334|524451422|FG004|Period 2|Withdrawal by Subject|0|||
145434893|NCT03012334|524451423|FG005|Period 2|Withdrawal by Subject|0|||
145434894|NCT03012334|524451424|FG006|Period 2|Withdrawal by Subject|0|||
145434895|NCT03012334|524451425|FG007|Period 2|Withdrawal by Subject|0|||
145434896|NCT03012334|524451426|FG008|Period 2|Withdrawal by Subject|0|||
145434897|NCT03012334|524451427|FG009|Period 2|Withdrawal by Subject|0|||
145434898|NCT03012334|524451418|FG000|Period 2|Protocol Violation|0|||
145434899|NCT03012334|524451419|FG001|Period 2|Protocol Violation|0|||
145434900|NCT03012334|524451420|FG002|Period 2|Protocol Violation|1|||
145434901|NCT03012334|524451421|FG003|Period 2|Protocol Violation|0|||
145434902|NCT03012334|524451422|FG004|Period 2|Protocol Violation|0|||
145434903|NCT03012334|524451423|FG005|Period 2|Protocol Violation|0|||
145434904|NCT03012334|524451424|FG006|Period 2|Protocol Violation|0|||
145434905|NCT03012334|524451425|FG007|Period 2|Protocol Violation|1|||
145434906|NCT03012334|524451426|FG008|Period 2|Protocol Violation|0|||
145434907|NCT03012334|524451427|FG009|Period 2|Protocol Violation|0|||
145434908|NCT03012334|524451418|FG000|Period 4|Non-Compliance|0|||
145434909|NCT03012334|524451419|FG001|Period 4|Non-Compliance|0|||
145434910|NCT03012334|524451420|FG002|Period 4|Non-Compliance|0|||
145434911|NCT03012334|524451421|FG003|Period 4|Non-Compliance|0|||
145434912|NCT03012334|524451422|FG004|Period 4|Non-Compliance|0|||
145434913|NCT03012334|524451423|FG005|Period 4|Non-Compliance|0|||
145434914|NCT03012334|524451424|FG006|Period 4|Non-Compliance|1|||
145434915|NCT03012334|524451425|FG007|Period 4|Non-Compliance|0|||
145434916|NCT03012334|524451426|FG008|Period 4|Non-Compliance|0|||
145434917|NCT03012334|524451427|FG009|Period 4|Non-Compliance|0|||
145434918|NCT03012334|524451418|FG000|Period 4|Adverse Event|0|||
145434919|NCT03012334|524451419|FG001|Period 4|Adverse Event|0|||
145434920|NCT03012334|524451420|FG002|Period 4|Adverse Event|0|||
145434921|NCT03012334|524451421|FG003|Period 4|Adverse Event|0|||
145434922|NCT03012334|524451422|FG004|Period 4|Adverse Event|0|||
145434923|NCT03012334|524451423|FG005|Period 4|Adverse Event|0|||
145434924|NCT03012334|524451424|FG006|Period 4|Adverse Event|0|||
145434925|NCT03012334|524451425|FG007|Period 4|Adverse Event|0|||
145434926|NCT03012334|524451426|FG008|Period 4|Adverse Event|1|||
145434927|NCT03012334|524451427|FG009|Period 4|Adverse Event|0|||
145434928|NCT01823107|524451428|FG000|Overall Study|Withdrawal by Subject|1|||
145434929|NCT00256126|524451429|FG000|Overall Study|Adverse Event|1|||
145434930|NCT00256126|524451430|FG001|Overall Study|Adverse Event|0|||
145434931|NCT00256126|524451429|FG000|Overall Study|Other|1|||
145434932|NCT00256126|524451430|FG001|Overall Study|Other|2|||
145434933|NCT00800735|524451431|FG000|Overall Study|Administrative/Other|2|||
145434934|NCT00800735|524451431|FG000|Overall Study|Insufficient Therapeutic Response|2|||
145434935|NCT00800735|524451431|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
145434936|NCT00800735|524451431|FG000|Overall Study|Withdrew Consent|3|||
145434937|NCT02133573|524451437|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
145434938|NCT02133573|524451438|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
145434939|NCT02133573|524451437|FG000|Overall Study|Child Deaths|3|||
145434940|NCT02133573|524451438|FG001|Overall Study|Child Deaths|5|||
145434941|NCT02133573|524451437|FG000|Overall Study|Child Declined Follow Ups|2|||
145434942|NCT02133573|524451438|FG001|Overall Study|Child Declined Follow Ups|1|||
145434943|NCT02133573|524451437|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
145434944|NCT02133573|524451438|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
145434945|NCT00454116|524451440|FG000|Overall Study|Adverse Event|5|||
145434946|NCT00454116|524451441|FG001|Overall Study|Adverse Event|11|||
145434947|NCT00454116|524451442|FG002|Overall Study|Adverse Event|9|||
145434948|NCT00454116|524451440|FG000|Overall Study|Condition under investigation worsened|17|||
145434949|NCT00454116|524451441|FG001|Overall Study|Condition under investigation worsened|13|||
145434950|NCT00454116|524451442|FG002|Overall Study|Condition under investigation worsened|18|||
145434951|NCT00454116|524451440|FG000|Overall Study|Withdrawal by Subject|3|||
145434952|NCT00454116|524451441|FG001|Overall Study|Withdrawal by Subject|3|||
145434953|NCT00454116|524451442|FG002|Overall Study|Withdrawal by Subject|1|||
145434954|NCT00454116|524451440|FG000|Overall Study|Other|2|||
145434955|NCT00454116|524451441|FG001|Overall Study|Other|2|||
145434956|NCT00454116|524451442|FG002|Overall Study|Other|0|||
145434957|NCT01917318|524451445|FG000|First Treatment|Withdrawal by Subject|0|||
145624880|NCT02851511|525139711|FG000|Phase I|Withdrawal by Subject|2|||
145434958|NCT01917318|524451446|FG001|First Treatment|Withdrawal by Subject|1|||
145434959|NCT01008618|524451447|FG000|Period 1 (Titration Period)|Physician Decision|2|||
145434960|NCT01008618|524451448|FG001|Period 1 (Titration Period)|Physician Decision|0|||
145434961|NCT01008618|524451449|FG002|Period 1 (Titration Period)|Physician Decision|0|||
145434962|NCT01008618|524451447|FG000|Period 1 (Titration Period)|Adverse Event|33|||
145434963|NCT01008618|524451448|FG001|Period 1 (Titration Period)|Adverse Event|0|||
145434964|NCT01008618|524451449|FG002|Period 1 (Titration Period)|Adverse Event|0|||
145434965|NCT01008618|524451447|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
145434966|NCT01008618|524451448|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
145434967|NCT01008618|524451449|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
145434968|NCT01008618|524451447|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
145434969|NCT01008618|524451448|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
145434970|NCT01008618|524451449|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
145624881|NCT02851511|525139712|FG001|Phase I|Withdrawal by Subject|1|||
145583414|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
145583415|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
145583416|NCT01609556|524987525|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583417|NCT01609556|524987526|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583418|NCT01609556|524987527|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583419|NCT01609556|524987528|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583420|NCT01609556|524987529|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583421|NCT01609556|524987530|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583422|NCT01609556|524987531|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583423|NCT01609556|524987532|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583424|NCT01609556|524987533|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583425|NCT01609556|524987534|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583426|NCT01609556|524987535|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583427|NCT01609556|524987536|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583428|NCT01609556|524987537|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
145583429|NCT01609556|524987538|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583430|NCT01609556|524987539|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583431|NCT01609556|524987540|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
145583432|NCT04452344|524987541|FG000|Overall Study|Withdrawal by Subject|3|||
145583433|NCT04452344|524987542|FG001|Overall Study|Withdrawal by Subject|6|||
145583434|NCT04452344|524987541|FG000|Overall Study|Adverse Event|1|||
145583435|NCT04452344|524987542|FG001|Overall Study|Adverse Event|2|||
145583436|NCT04452344|524987541|FG000|Overall Study|Lost to Follow-up|2|||
145583437|NCT04452344|524987542|FG001|Overall Study|Lost to Follow-up|2|||
145583438|NCT04452344|524987541|FG000|Overall Study|No Post-Op Visit|6|||
145583439|NCT04452344|524987542|FG001|Overall Study|No Post-Op Visit|7|||
145583440|NCT02788175|524987546|FG000|Overall Study|Protocol Violation|3|||
145583441|NCT02788175|524987546|FG000|Overall Study|Withdrawal by Subject|4|||
145583442|NCT02788175|524987546|FG000|Overall Study|Ineligible prior to study agent|6|||
145583443|NCT00162136|524987547|FG000|Overall Study|Adverse Event|1|||
145583444|NCT00162136|524987547|FG000|Overall Study|Death|1|||
145583445|NCT00162136|524987547|FG000|Overall Study|Disease Progression/Relapse|23|||
145583446|NCT00162136|524987547|FG000|Overall Study|Investigator Request|5|||
145583447|NCT00162136|524987547|FG000|Overall Study|Study Drug Toxicity|4|||
145583448|NCT00162136|524987547|FG000|Overall Study|Withdrawal by Subject|1|||
145583449|NCT01968434|524987552|FG000|Overall Study|Lost to Follow-up|3|||
145583450|NCT01968434|524987553|FG001|Overall Study|Lost to Follow-up|6|||
145583451|NCT00428610|524987556|FG000|Overall Study|Death Due to Adverse Event|3|||
145583452|NCT00428610|524987557|FG001|Overall Study|Death Due to Adverse Event|0|||
145583453|NCT00428610|524987558|FG002|Overall Study|Death Due to Adverse Event|5|||
145583454|NCT00428610|524987556|FG000|Overall Study|Death Due to Progressive Disease|0|||
145583455|NCT00428610|524987557|FG001|Overall Study|Death Due to Progressive Disease|0|||
145583456|NCT00428610|524987558|FG002|Overall Study|Death Due to Progressive Disease|2|||
145583457|NCT00428610|524987556|FG000|Overall Study|Adverse Event|2|||
145583458|NCT00428610|524987557|FG001|Overall Study|Adverse Event|3|||
145583459|NCT00428610|524987558|FG002|Overall Study|Adverse Event|2|||
145583460|NCT00428610|524987556|FG000|Overall Study|Investigator Decision|2|||
145583461|NCT00428610|524987557|FG001|Overall Study|Investigator Decision|1|||
145583462|NCT00428610|524987558|FG002|Overall Study|Investigator Decision|1|||
145583463|NCT00428610|524987556|FG000|Overall Study|Progressive Disease|42|||
145583464|NCT00428610|524987557|FG001|Overall Study|Progressive Disease|14|||
145583465|NCT00428610|524987558|FG002|Overall Study|Progressive Disease|22|||
145583466|NCT00428610|524987556|FG000|Overall Study|Withdrawal by Subject|4|||
145583467|NCT00428610|524987557|FG001|Overall Study|Withdrawal by Subject|0|||
145583468|NCT00428610|524987558|FG002|Overall Study|Withdrawal by Subject|0|||
145583469|NCT00262834|524989337|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
145583470|NCT00262834|524989338|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
145583471|NCT02352493|524989345|FG000|Overall Study|Pregnancy|0|||
145583472|NCT02352493|524989346|FG001|Overall Study|Pregnancy|0|||
145583473|NCT02352493|524989347|FG002|Overall Study|Pregnancy|0|||
145583474|NCT02352493|524989348|FG003|Overall Study|Pregnancy|0|||
145583475|NCT02352493|524989349|FG004|Overall Study|Pregnancy|0|||
145583476|NCT02352493|524989350|FG005|Overall Study|Pregnancy|0|||
145583477|NCT02352493|524989351|FG006|Overall Study|Pregnancy|1|||
145583478|NCT02352493|524989352|FG007|Overall Study|Pregnancy|0|||
145583479|NCT02352493|524989353|FG008|Overall Study|Pregnancy|1|||
145583480|NCT02352493|524989354|FG009|Overall Study|Pregnancy|0|||
145583481|NCT02352493|524989355|FG010|Overall Study|Pregnancy|0|||
145583482|NCT02352493|524989356|FG011|Overall Study|Pregnancy|0|||
145583483|NCT02352493|524989357|FG012|Overall Study|Pregnancy|0|||
145583484|NCT02352493|524989358|FG013|Overall Study|Pregnancy|0|||
145583485|NCT02352493|524989359|FG014|Overall Study|Pregnancy|0|||
145583486|NCT02352493|524989360|FG015|Overall Study|Pregnancy|0|||
145583487|NCT02352493|524989361|FG016|Overall Study|Pregnancy|0|||
145583488|NCT02352493|524989362|FG017|Overall Study|Pregnancy|0|||
145583489|NCT02352493|524989345|FG000|Overall Study|Withdrawal by Subject|0|||
145624882|NCT02851511|525139713|FG002|Phase I|Withdrawal by Subject|0|||
145434971|NCT01008618|524451447|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
145434972|NCT01008618|524451448|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
145434973|NCT01008618|524451449|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
145434974|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
145434975|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
145434976|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
145434977|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
145434978|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
145434979|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
145434980|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
145434981|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
145434982|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
145434983|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
145434984|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
145434985|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
145434986|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
145434987|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
145434988|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
145434989|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
145434990|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
145434991|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
145434992|NCT01008618|524451447|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
145434993|NCT01008618|524451448|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
145434994|NCT01008618|524451449|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
145434995|NCT02927795|524451450|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
145434996|NCT02927795|524451450|FG000|Overall Study|Not Treated|4|||
145434997|NCT02581891|524451451|FG000|Overall Study|Adverse Event|4|||
145434998|NCT02581891|524451452|FG001|Overall Study|Adverse Event|6|||
145434999|NCT02581891|524451451|FG000|Overall Study|Death|3|||
145435000|NCT02581891|524451452|FG001|Overall Study|Death|4|||
145435001|NCT02581891|524451451|FG000|Overall Study|Lost to Follow-up|1|||
145435002|NCT02581891|524451452|FG001|Overall Study|Lost to Follow-up|2|||
145435003|NCT02581891|524451451|FG000|Overall Study|Physician Decision|0|||
145435004|NCT02581891|524451452|FG001|Overall Study|Physician Decision|1|||
145435005|NCT02581891|524451451|FG000|Overall Study|Withdrawal by Subject|4|||
145435006|NCT02581891|524451452|FG001|Overall Study|Withdrawal by Subject|5|||
145435007|NCT02581891|524451451|FG000|Overall Study|Other Reasons|3|||
145435008|NCT02581891|524451452|FG001|Overall Study|Other Reasons|1|||
145435009|NCT02581891|524451451|FG000|Overall Study|Discontinued during followup|1|||
145435010|NCT02581891|524451452|FG001|Overall Study|Discontinued during followup|0|||
145435011|NCT01832727|524451456|FG000|Overall Study|Adverse Event|4|||
145435012|NCT01832727|524451457|FG001|Overall Study|Adverse Event|6|||
145435013|NCT01832727|524451458|FG002|Overall Study|Adverse Event|1|||
145435014|NCT01832727|524451459|FG003|Overall Study|Adverse Event|0|||
145435015|NCT01832727|524451460|FG004|Overall Study|Adverse Event|1|||
145435016|NCT01832727|524451461|FG005|Overall Study|Adverse Event|1|||
145435017|NCT01832727|524451462|FG006|Overall Study|Adverse Event|2|||
145435018|NCT01832727|524451463|FG007|Overall Study|Adverse Event|1|||
145435019|NCT01832727|524451464|FG008|Overall Study|Adverse Event|9|||
145435020|NCT01832727|524451456|FG000|Overall Study|Disease progression|3|||
145435021|NCT01832727|524451457|FG001|Overall Study|Disease progression|0|||
145435022|NCT01832727|524451458|FG002|Overall Study|Disease progression|2|||
145435023|NCT01832727|524451459|FG003|Overall Study|Disease progression|1|||
145435024|NCT01832727|524451460|FG004|Overall Study|Disease progression|3|||
145435025|NCT01832727|524451461|FG005|Overall Study|Disease progression|3|||
145435026|NCT01832727|524451462|FG006|Overall Study|Disease progression|6|||
145435027|NCT01832727|524451463|FG007|Overall Study|Disease progression|2|||
145435028|NCT01832727|524451464|FG008|Overall Study|Disease progression|7|||
145435029|NCT01832727|524451456|FG000|Overall Study|Lost to Follow-up|0|||
145435030|NCT01832727|524451457|FG001|Overall Study|Lost to Follow-up|0|||
145435031|NCT01832727|524451458|FG002|Overall Study|Lost to Follow-up|0|||
145435032|NCT01832727|524451459|FG003|Overall Study|Lost to Follow-up|1|||
145435033|NCT01832727|524451460|FG004|Overall Study|Lost to Follow-up|0|||
145435034|NCT01832727|524451461|FG005|Overall Study|Lost to Follow-up|0|||
145435035|NCT01832727|524451462|FG006|Overall Study|Lost to Follow-up|0|||
145435036|NCT01832727|524451463|FG007|Overall Study|Lost to Follow-up|0|||
145435037|NCT01832727|524451464|FG008|Overall Study|Lost to Follow-up|0|||
145435038|NCT01832727|524451456|FG000|Overall Study|Physician Decision|1|||
145435039|NCT01832727|524451457|FG001|Overall Study|Physician Decision|0|||
145435040|NCT01832727|524451458|FG002|Overall Study|Physician Decision|0|||
145435041|NCT01832727|524451459|FG003|Overall Study|Physician Decision|1|||
145435042|NCT01832727|524451460|FG004|Overall Study|Physician Decision|0|||
145435043|NCT01832727|524451461|FG005|Overall Study|Physician Decision|1|||
145435044|NCT01832727|524451462|FG006|Overall Study|Physician Decision|0|||
145435045|NCT01832727|524451463|FG007|Overall Study|Physician Decision|0|||
145435046|NCT01832727|524451464|FG008|Overall Study|Physician Decision|0|||
145435047|NCT01832727|524451456|FG000|Overall Study|Withdrawal by Subject|1|||
145435048|NCT01832727|524451457|FG001|Overall Study|Withdrawal by Subject|1|||
145435049|NCT01832727|524451458|FG002|Overall Study|Withdrawal by Subject|0|||
145435050|NCT01832727|524451459|FG003|Overall Study|Withdrawal by Subject|1|||
145435051|NCT01832727|524451460|FG004|Overall Study|Withdrawal by Subject|0|||
145435052|NCT01832727|524451461|FG005|Overall Study|Withdrawal by Subject|1|||
145435053|NCT01832727|524451462|FG006|Overall Study|Withdrawal by Subject|0|||
145435054|NCT01832727|524451463|FG007|Overall Study|Withdrawal by Subject|2|||
145435055|NCT01832727|524451464|FG008|Overall Study|Withdrawal by Subject|1|||
145435056|NCT01832727|524451456|FG000|Overall Study|Study terminated by sponsor|0|||
145435057|NCT01832727|524451457|FG001|Overall Study|Study terminated by sponsor|0|||
145435058|NCT01832727|524451458|FG002|Overall Study|Study terminated by sponsor|0|||
145435059|NCT01832727|524451459|FG003|Overall Study|Study terminated by sponsor|0|||
145435060|NCT01832727|524451460|FG004|Overall Study|Study terminated by sponsor|0|||
145435061|NCT01832727|524451461|FG005|Overall Study|Study terminated by sponsor|0|||
145435062|NCT01832727|524451462|FG006|Overall Study|Study terminated by sponsor|0|||
145435063|NCT01832727|524451463|FG007|Overall Study|Study terminated by sponsor|1|||
145435064|NCT01832727|524451464|FG008|Overall Study|Study terminated by sponsor|1|||
145435065|NCT03434834|524451465|FG000|Overall Study|unable to swallow OCT probe|16|||
145435066|NCT01812057|524451473|FG000|Overall Study|Protocol Violation|1|||
145435067|NCT01812057|524451474|FG001|Overall Study|Protocol Violation|0|||
145435068|NCT01812057|524451473|FG000|Overall Study|Physician Decision|1|||
145435069|NCT01812057|524451474|FG001|Overall Study|Physician Decision|0|||
145435070|NCT01657305|524451478|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
145435071|NCT01657305|524451478|FG000|Overall Study|Withdrawal by Subject|4|||
145435072|NCT01657305|524451478|FG000|Overall Study|Adverse Event|1|||
145435073|NCT01657305|524451478|FG000|Overall Study|Lost to Follow-up|1|||
145435074|NCT01657305|524451478|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
145435075|NCT01133847|524451479|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
145435076|NCT01133847|524451480|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
145435077|NCT01133847|524451481|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
145435078|NCT01133847|524451479|FG000|Follow-Up Phase|Lost to Follow-up|1|||
145435079|NCT01133847|524451480|FG001|Follow-Up Phase|Lost to Follow-up|3|||
145435080|NCT01133847|524451481|FG002|Follow-Up Phase|Lost to Follow-up|7|||
145435081|NCT02961244|524451484|FG000|Overall Study|Protocol Violation|0|||
145435082|NCT02961244|524451485|FG001|Overall Study|Protocol Violation|1|||
145435083|NCT02961244|524451484|FG000|Overall Study|Withdrawal by Subject|1|||
145435084|NCT02961244|524451485|FG001|Overall Study|Withdrawal by Subject|2|||
145435085|NCT02961244|524451484|FG000|Overall Study|Surgery plan change after study approval|0|||
145435086|NCT02961244|524451485|FG001|Overall Study|Surgery plan change after study approval|2|||
145435087|NCT02961244|524451484|FG000|Overall Study|Lost to Follow-up|0|||
145435088|NCT02961244|524451485|FG001|Overall Study|Lost to Follow-up|2|||
145435089|NCT02961244|524451484|FG000|Overall Study|İnadequate data|0|||
145435090|NCT02961244|524451485|FG001|Overall Study|İnadequate data|2|||
145435091|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
145435092|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
145583490|NCT02352493|524989346|FG001|Overall Study|Withdrawal by Subject|0|||
145583491|NCT02352493|524989347|FG002|Overall Study|Withdrawal by Subject|0|||
145583492|NCT02352493|524989348|FG003|Overall Study|Withdrawal by Subject|0|||
145583493|NCT02352493|524989349|FG004|Overall Study|Withdrawal by Subject|0|||
145583494|NCT02352493|524989350|FG005|Overall Study|Withdrawal by Subject|0|||
145583495|NCT02352493|524989351|FG006|Overall Study|Withdrawal by Subject|0|||
145583496|NCT02352493|524989352|FG007|Overall Study|Withdrawal by Subject|0|||
145583497|NCT02352493|524989353|FG008|Overall Study|Withdrawal by Subject|1|||
145583498|NCT02352493|524989354|FG009|Overall Study|Withdrawal by Subject|0|||
145583499|NCT02352493|524989355|FG010|Overall Study|Withdrawal by Subject|0|||
145583500|NCT02352493|524989356|FG011|Overall Study|Withdrawal by Subject|0|||
145583501|NCT02352493|524989357|FG012|Overall Study|Withdrawal by Subject|0|||
145583502|NCT02352493|524989358|FG013|Overall Study|Withdrawal by Subject|0|||
145435093|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
145435094|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
145435095|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
145435096|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
145583503|NCT02352493|524989359|FG014|Overall Study|Withdrawal by Subject|1|||
145583504|NCT02352493|524989360|FG015|Overall Study|Withdrawal by Subject|0|||
145583505|NCT02352493|524989361|FG016|Overall Study|Withdrawal by Subject|0|||
145583506|NCT02352493|524989362|FG017|Overall Study|Withdrawal by Subject|0|||
145435097|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
145435098|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
145435099|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
145435100|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
145435101|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
145435102|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
145435103|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
145435104|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
145435105|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
145435106|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
145435107|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
145435108|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
145435109|NCT03789292|524451486|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
145435110|NCT03789292|524451487|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
145435111|NCT03789292|524451488|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
145435112|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
145435113|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
145435114|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
145435115|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
145435116|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
145435117|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
145435118|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
145435119|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
145435120|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
145435121|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
145435122|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
145435123|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
145435124|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
145435125|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
145435126|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
145435127|NCT03789292|524451486|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
145435128|NCT03789292|524451487|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
145435129|NCT03789292|524451488|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
145435130|NCT00967616|524451489|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
145435131|NCT00967616|524451490|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
145435132|NCT00967616|524451489|FG000|Overall Study|Death|0|||
145435133|NCT00967616|524451490|FG001|Overall Study|Death|3|||
145435134|NCT00967616|524451489|FG000|Overall Study|Withdrawal by Subject|8|||
145435135|NCT00967616|524451490|FG001|Overall Study|Withdrawal by Subject|4|||
145435136|NCT00967616|524451489|FG000|Overall Study|Progressive Disease|31|||
145435137|NCT00967616|524451490|FG001|Overall Study|Progressive Disease|18|||
145435138|NCT00967616|524451489|FG000|Overall Study|Other|8|||
145435139|NCT00967616|524451490|FG001|Overall Study|Other|8|||
145435140|NCT00967616|524451489|FG000|Overall Study|Protocol Violation|1|||
145435141|NCT00967616|524451490|FG001|Overall Study|Protocol Violation|0|||
145435142|NCT01696643|524451491|FG000|Overall Study|Adverse Event|15|||
145435143|NCT01696643|524451492|FG001|Overall Study|Adverse Event|7|||
145435144|NCT01696643|524451491|FG000|Overall Study|Death|1|||
145435145|NCT01696643|524451492|FG001|Overall Study|Death|2|||
145435146|NCT01696643|524451491|FG000|Overall Study|Lack of Efficacy|3|||
145435147|NCT01696643|524451492|FG001|Overall Study|Lack of Efficacy|0|||
145435148|NCT01696643|524451491|FG000|Overall Study|Lost to Follow-up|67|||
145435149|NCT01696643|524451492|FG001|Overall Study|Lost to Follow-up|67|||
145435150|NCT01696643|524451491|FG000|Overall Study|Physician Decision|3|||
145435151|NCT01696643|524451492|FG001|Overall Study|Physician Decision|2|||
145435152|NCT01696643|524451491|FG000|Overall Study|Pregnancy|0|||
145435153|NCT01696643|524451492|FG001|Overall Study|Pregnancy|1|||
145435154|NCT01696643|524451491|FG000|Overall Study|Protocol Violation|7|||
145435155|NCT01696643|524451492|FG001|Overall Study|Protocol Violation|7|||
145435156|NCT01696643|524451491|FG000|Overall Study|Study Terminated by Sponsor|286|||
145435157|NCT01696643|524451492|FG001|Overall Study|Study Terminated by Sponsor|294|||
145435158|NCT01696643|524451491|FG000|Overall Study|Withdrawal by Subject|142|||
145435159|NCT01696643|524451492|FG001|Overall Study|Withdrawal by Subject|149|||
145435160|NCT01696643|524451491|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
145435161|NCT01696643|524451492|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
145435162|NCT01696643|524451491|FG000|Overall Study|Site Error|2|||
145435163|NCT01696643|524451492|FG001|Overall Study|Site Error|1|||
145435164|NCT01696643|524451491|FG000|Overall Study|Participant Incarcerated|0|||
145435165|NCT01696643|524451492|FG001|Overall Study|Participant Incarcerated|1|||
145435166|NCT01696643|524451491|FG000|Overall Study|Medical Monitor Decision|0|||
145435167|NCT01696643|524451492|FG001|Overall Study|Medical Monitor Decision|2|||
145435168|NCT01696643|524451491|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
145435169|NCT01696643|524451492|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
145435170|NCT00518180|524451493|FG000|Overall Study|Withdrawal by Subject|29|||
145435171|NCT00518180|524451494|FG001|Overall Study|Withdrawal by Subject|30|||
145435172|NCT00518180|524451495|FG002|Overall Study|Withdrawal by Subject|42|||
145435173|NCT00518180|524451493|FG000|Overall Study|Lost to Follow-up|30|||
145435174|NCT00518180|524451494|FG001|Overall Study|Lost to Follow-up|28|||
145435175|NCT00518180|524451495|FG002|Overall Study|Lost to Follow-up|34|||
145435176|NCT00518180|524451493|FG000|Overall Study|Administrative reason|0|||
145435177|NCT00518180|524451494|FG001|Overall Study|Administrative reason|2|||
145435178|NCT00518180|524451495|FG002|Overall Study|Administrative reason|2|||
145435179|NCT00518180|524451493|FG000|Overall Study|Protocol Violation|5|||
145435180|NCT00518180|524451494|FG001|Overall Study|Protocol Violation|7|||
145435181|NCT00518180|524451495|FG002|Overall Study|Protocol Violation|4|||
145435182|NCT00518180|524451493|FG000|Overall Study|Unable to classify|0|||
145435183|NCT00518180|524451494|FG001|Overall Study|Unable to classify|2|||
145435184|NCT00518180|524451495|FG002|Overall Study|Unable to classify|0|||
145435185|NCT00518180|524451493|FG000|Overall Study|Adverse Event|1|||
145435186|NCT00518180|524451494|FG001|Overall Study|Adverse Event|0|||
145435187|NCT00518180|524451495|FG002|Overall Study|Adverse Event|0|||
145435188|NCT00508482|524451496|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
145435189|NCT00508482|524451497|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
145435190|NCT00508482|524451498|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
145435191|NCT00508482|524451496|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
145435192|NCT00508482|524451497|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
145435193|NCT00508482|524451498|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
145435194|NCT00508482|524451496|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
145435195|NCT00508482|524451497|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
145435196|NCT00508482|524451498|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
145435197|NCT01538199|524451503|FG000|Overall Study|Lost to Follow-up|1|||
145435198|NCT01538199|524451504|FG001|Overall Study|Lost to Follow-up|2|||
145435199|NCT01538199|524451505|FG002|Overall Study|Lost to Follow-up|1|||
145435200|NCT01538199|524451506|FG003|Overall Study|Lost to Follow-up|0|||
145435201|NCT01538199|524451503|FG000|Overall Study|participant did not have time|1|||
145435202|NCT01538199|524451504|FG001|Overall Study|participant did not have time|0|||
145435203|NCT01538199|524451505|FG002|Overall Study|participant did not have time|0|||
145435204|NCT01538199|524451506|FG003|Overall Study|participant did not have time|2|||
145435205|NCT01538199|524451503|FG000|Overall Study|Lack of Efficacy|0|||
145435206|NCT01538199|524451504|FG001|Overall Study|Lack of Efficacy|1|||
145435207|NCT01538199|524451505|FG002|Overall Study|Lack of Efficacy|0|||
145435208|NCT01538199|524451506|FG003|Overall Study|Lack of Efficacy|0|||
145435209|NCT00322049|524452825|FG000|Overall Study|Moved out of area|0|||
145435210|NCT00322049|524452826|FG001|Overall Study|Moved out of area|0|||
145435211|NCT00322049|524452827|FG002|Overall Study|Moved out of area|0|||
145435212|NCT00322049|524452828|FG003|Overall Study|Moved out of area|1|||
145435213|NCT00322049|524452825|FG000|Overall Study|Infected with Dengue during study|0|||
145435214|NCT00322049|524452826|FG001|Overall Study|Infected with Dengue during study|1|||
145435215|NCT00322049|524452827|FG002|Overall Study|Infected with Dengue during study|0|||
145435216|NCT00322049|524452828|FG003|Overall Study|Infected with Dengue during study|0|||
145435217|NCT01173679|524452829|FG000|Overall Study|Death|1|||
145435218|NCT00755807|524452832|FG000|Acute Phase|Adverse Event|16|||
145435219|NCT00755807|524452833|FG001|Acute Phase|Adverse Event|5|||
145435220|NCT00755807|524452832|FG000|Acute Phase|Protocol Violation|1|||
145435221|NCT00755807|524452833|FG001|Acute Phase|Protocol Violation|3|||
145435222|NCT00755807|524452832|FG000|Acute Phase|Withdrawal by Subject|1|||
145435223|NCT00755807|524452833|FG001|Acute Phase|Withdrawal by Subject|2|||
145435224|NCT00755807|524452832|FG000|Acute Phase|Lack of Efficacy|0|||
145435225|NCT00755807|524452833|FG001|Acute Phase|Lack of Efficacy|1|||
145435226|NCT00755807|524452832|FG000|Acute Phase|Physician Decision|0|||
145435227|NCT00755807|524452833|FG001|Acute Phase|Physician Decision|1|||
145435228|NCT00755807|524452832|FG000|Open-label Extension Phase|Adverse Event|7|||
145435229|NCT00755807|524452833|FG001|Open-label Extension Phase|Adverse Event|7|||
145435230|NCT00755807|524452832|FG000|Open-label Extension Phase|Protocol Violation|5|||
145435231|NCT00755807|524452833|FG001|Open-label Extension Phase|Protocol Violation|2|||
145435232|NCT00755807|524452832|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
145435233|NCT00755807|524452833|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
145435234|NCT00755807|524452832|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
145435235|NCT00755807|524452833|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
145435236|NCT00755807|524452832|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
145435237|NCT00755807|524452833|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
145435238|NCT00755807|524452832|FG000|Open-label Extension Phase|Sponsor Decision|0|||
145435239|NCT00755807|524452833|FG001|Open-label Extension Phase|Sponsor Decision|1|||
145435240|NCT00529243|524452835|FG000|Overall Study|Adverse Event|1|||
145435241|NCT00529243|524452835|FG000|Overall Study|Death|1|||
145435242|NCT00529243|524452835|FG000|Overall Study|Relocated|1|||
145435243|NCT02921789|524452838|FG000|Overall Study|Adverse Event|0|||
145435244|NCT02921789|524452839|FG001|Overall Study|Adverse Event|1|||
145435245|NCT02921789|524452838|FG000|Overall Study|Lost to Follow-up|1|||
145435246|NCT02921789|524452839|FG001|Overall Study|Lost to Follow-up|0|||
145435247|NCT02921789|524452838|FG000|Overall Study|Protocol Deviation|2|||
145435248|NCT02921789|524452839|FG001|Overall Study|Protocol Deviation|0|||
145435249|NCT02921789|524452838|FG000|Overall Study|Withdrawal by Subject|2|||
145435250|NCT02921789|524452839|FG001|Overall Study|Withdrawal by Subject|1|||
145435251|NCT02921789|524452838|FG000|Overall Study|Miscellaneous|3|||
145435252|NCT02921789|524452839|FG001|Overall Study|Miscellaneous|2|||
145435253|NCT04099277|524452840|FG000|Overall Study|Physician Decision|1|||
145435254|NCT04099277|524452840|FG000|Overall Study|Withdrawal by Subject|1|||
145435255|NCT00305877|524452841|FG000|Overall Study|Lack of Efficacy|6|||
145435256|NCT00305877|524452842|FG001|Overall Study|Lack of Efficacy|9|||
145435257|NCT00305877|524452841|FG000|Overall Study|Adverse Event|9|||
145435258|NCT00305877|524452842|FG001|Overall Study|Adverse Event|14|||
145435259|NCT00305877|524452841|FG000|Overall Study|Death|0|||
145435260|NCT00305877|524452842|FG001|Overall Study|Death|1|||
145435261|NCT00305877|524452841|FG000|Overall Study|Withdrawal by Subject|4|||
145435262|NCT00305877|524452842|FG001|Overall Study|Withdrawal by Subject|2|||
145435263|NCT00305877|524452841|FG000|Overall Study|Physician Decision|1|||
145435264|NCT00305877|524452842|FG001|Overall Study|Physician Decision|1|||
145435265|NCT00305877|524452841|FG000|Overall Study|Never start treatment|2|||
145435266|NCT00305877|524452842|FG001|Overall Study|Never start treatment|5|||
145435267|NCT00305877|524452841|FG000|Overall Study|Ineligible|2|||
145435268|NCT00305877|524452842|FG001|Overall Study|Ineligible|1|||
145435269|NCT00305877|524452841|FG000|Overall Study|Transportation issue with daily RT|0|||
145435270|NCT00305877|524452842|FG001|Overall Study|Transportation issue with daily RT|1|||
145435271|NCT02580877|524452843|FG000|Overall Study|Withdrawal by Subject|1|||
145435272|NCT02580877|524452844|FG001|Overall Study|Withdrawal by Subject|3|||
145435273|NCT02580877|524452843|FG000|Overall Study|Adverse Event|0|||
145435274|NCT02580877|524452844|FG001|Overall Study|Adverse Event|1|||
145435275|NCT02727322|524452845|FG000|Overall Study|Withdrawal by Subject|1|||
145435276|NCT02727322|524452846|FG001|Overall Study|Withdrawal by Subject|1|||
145435277|NCT02727322|524452845|FG000|Overall Study|Protocol Violation|1|||
145435278|NCT02727322|524452846|FG001|Overall Study|Protocol Violation|0|||
145435279|NCT02903823|524452847|FG000|Overall Study|Physician Decision|5|||
145435280|NCT02903823|524452847|FG000|Overall Study|Could not advance catheter|1|||
145435281|NCT02903823|524452847|FG000|Overall Study|Catheter dislodgement|1|||
145435282|NCT00355030|524452854|FG000|Study Period 1 Treatment|Adverse Event|1|||
145435283|NCT00355030|524452855|FG001|Study Period 1 Treatment|Adverse Event|1|||
145435284|NCT00355030|524452854|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
145435285|NCT00355030|524452855|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
145435286|NCT00355030|524452854|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
145435287|NCT00355030|524452855|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
145435288|NCT00355030|524452854|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
145435289|NCT00355030|524452855|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
145435290|NCT00355030|524452854|FG000|Study Period 1 Treatment|Physician Decision|0|||
145435291|NCT00355030|524452855|FG001|Study Period 1 Treatment|Physician Decision|1|||
145435292|NCT00355030|524452854|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
145435293|NCT00355030|524452855|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
145435294|NCT00355030|524452854|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
145435295|NCT00355030|524452855|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
145435296|NCT00355030|524452854|FG000|Study Period 1 Treatment|Other|2|||
145435297|NCT00355030|524452855|FG001|Study Period 1 Treatment|Other|6|||
145435298|NCT00355030|524452854|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
145435299|NCT00355030|524452855|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
145435300|NCT00355030|524452854|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
145435301|NCT00355030|524452855|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
145435302|NCT01123148|524452856|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
145435303|NCT01123148|524452856|FG000|Overall Study|Didn't meet milestone criteria|1|||
145435304|NCT00339040|524452857|FG000|Stage I|Not able to attend clinic|1|||
145435305|NCT00339040|524452858|FG001|Stage I|Not able to attend clinic|0|||
145435306|NCT00339040|524452857|FG000|Stage I|Protocol Violation|1|||
145435307|NCT00339040|524452858|FG001|Stage I|Protocol Violation|1|||
145435308|NCT00339040|524452857|FG000|Stage II|Lost to Follow-up|3|||
145435309|NCT00339040|524452858|FG001|Stage II|Lost to Follow-up|0|||
145435310|NCT00339040|524452857|FG000|Stage II|Withdrawal by Subject|1|||
145435311|NCT00339040|524452858|FG001|Stage II|Withdrawal by Subject|2|||
145435312|NCT00339040|524452857|FG000|Stage II|Protocol Violation|3|||
145435313|NCT00339040|524452858|FG001|Stage II|Protocol Violation|0|||
145435314|NCT00339040|524452857|FG000|Stage II|Not able to attend clinic|1|||
145583507|NCT02352493|524989345|FG000|Overall Study|Lost to Follow-up|0|||
145583508|NCT02352493|524989346|FG001|Overall Study|Lost to Follow-up|0|||
145435315|NCT00339040|524452858|FG001|Stage II|Not able to attend clinic|0|||
145435316|NCT00339040|524452857|FG000|Stage II|Site closing|2|||
145435317|NCT00339040|524452858|FG001|Stage II|Site closing|0|||
145435318|NCT00690794|524452859|FG000|Overall Study|Adverse Event|12|||
145435319|NCT00690794|524452860|FG001|Overall Study|Adverse Event|10|||
145435320|NCT00690794|524452859|FG000|Overall Study|Lost to Follow-up|1|||
145435321|NCT00690794|524452860|FG001|Overall Study|Lost to Follow-up|4|||
145435322|NCT00690794|524452859|FG000|Overall Study|Withdrawal by Subject|0|||
145435323|NCT00690794|524452860|FG001|Overall Study|Withdrawal by Subject|9|||
145435324|NCT00690794|524452859|FG000|Overall Study|Protocol Violation|6|||
145435325|NCT00690794|524452860|FG001|Overall Study|Protocol Violation|7|||
145435326|NCT00690794|524452859|FG000|Overall Study|Noncompliance|1|||
145435327|NCT00690794|524452860|FG001|Overall Study|Noncompliance|2|||
145435328|NCT00690794|524452859|FG000|Overall Study|Other not specified|1|||
145435329|NCT00690794|524452860|FG001|Overall Study|Other not specified|3|||
145435330|NCT02808429|524452863|FG000|Overall Study|Lost to Follow-up|1|||
145435331|NCT02808429|524452864|FG001|Overall Study|Lost to Follow-up|0|||
145435332|NCT02808429|524452865|FG002|Overall Study|Lost to Follow-up|0|||
145435333|NCT02808429|524452863|FG000|Overall Study|Protocol Violation|0|||
145435334|NCT02808429|524452864|FG001|Overall Study|Protocol Violation|1|||
145435335|NCT02808429|524452865|FG002|Overall Study|Protocol Violation|0|||
145435336|NCT02808429|524452863|FG000|Overall Study|Premature study termination by sponsor|2|||
145435337|NCT02808429|524452864|FG001|Overall Study|Premature study termination by sponsor|0|||
145435338|NCT02808429|524452865|FG002|Overall Study|Premature study termination by sponsor|1|||
145435339|NCT02808429|524452863|FG000|Overall Study|Relocation|0|||
145435340|NCT02808429|524452864|FG001|Overall Study|Relocation|0|||
145435341|NCT02808429|524452865|FG002|Overall Study|Relocation|1|||
145435342|NCT01788943|524452866|FG000|Overall Study|Withdrawal by Subject|1|||
145435343|NCT01788943|524452867|FG001|Overall Study|Withdrawal by Subject|0|||
145435344|NCT04436744|524452879|FG000|Overall Study|Adverse Event|1|||
145435345|NCT04436744|524452880|FG001|Overall Study|Adverse Event|1|||
145435346|NCT04436744|524452879|FG000|Overall Study|Death|1|||
145435347|NCT04436744|524452880|FG001|Overall Study|Death|0|||
145435348|NCT04436744|524452879|FG000|Overall Study|Lost to Follow-up|0|||
145435349|NCT04436744|524452880|FG001|Overall Study|Lost to Follow-up|2|||
145435350|NCT04436744|524452879|FG000|Overall Study|Physician Decision|0|||
145435351|NCT04436744|524452880|FG001|Overall Study|Physician Decision|1|||
145435352|NCT04436744|524452879|FG000|Overall Study|Progressive Disease|0|||
145435353|NCT04436744|524452880|FG001|Overall Study|Progressive Disease|4|||
145435354|NCT04436744|524452879|FG000|Overall Study|Protocol Deviation|1|||
145435355|NCT04436744|524452880|FG001|Overall Study|Protocol Deviation|1|||
145435356|NCT04436744|524452879|FG000|Overall Study|Withdrawal by Subject|1|||
145435357|NCT04436744|524452880|FG001|Overall Study|Withdrawal by Subject|2|||
145435358|NCT01378117|524452881|FG000|Overall Study|withdrawal|2|||
145435359|NCT01378117|524452882|FG001|Overall Study|withdrawal|1|||
145435360|NCT01378117|524452883|FG002|Overall Study|withdrawal|2|||
145435361|NCT01378117|524452881|FG000|Overall Study|discharged before med given|2|||
145435362|NCT01378117|524452882|FG001|Overall Study|discharged before med given|0|||
145435363|NCT01378117|524452883|FG002|Overall Study|discharged before med given|1|||
145435364|NCT00575666|524452886|FG000|Overall Study|Withdrawal by Subject|3|||
145435365|NCT00575666|524452887|FG001|Overall Study|Withdrawal by Subject|2|||
145435366|NCT00575666|524452886|FG000|Overall Study|Physician Decision|1|||
145435367|NCT00575666|524452887|FG001|Overall Study|Physician Decision|1|||
145435368|NCT01374425|524452888|FG000|Overall Study|Radiographic Disease Progression|86|||
145435369|NCT01374425|524452889|FG001|Overall Study|Radiographic Disease Progression|81|||
145435370|NCT01374425|524452888|FG000|Overall Study|Clinical Disease Progression|9|||
145435371|NCT01374425|524452889|FG001|Overall Study|Clinical Disease Progression|6|||
145435372|NCT01374425|524452888|FG000|Overall Study|Adverse Event|29|||
145435373|NCT01374425|524452889|FG001|Overall Study|Adverse Event|18|||
145435374|NCT01374425|524452888|FG000|Overall Study|Death (Progression of Disease)|1|||
145435375|NCT01374425|524452889|FG001|Overall Study|Death (Progression of Disease)|0|||
145435376|NCT01374425|524452888|FG000|Overall Study|Death (Adverse Event)|2|||
145435377|NCT01374425|524452889|FG001|Overall Study|Death (Adverse Event)|4|||
145435378|NCT01374425|524452888|FG000|Overall Study|Withdrawal by Subject|6|||
145435379|NCT01374425|524452889|FG001|Overall Study|Withdrawal by Subject|7|||
145435380|NCT01374425|524452888|FG000|Overall Study|Refused Treatment|10|||
145435381|NCT01374425|524452889|FG001|Overall Study|Refused Treatment|24|||
145435382|NCT01374425|524452888|FG000|Overall Study|Protocol Violation|2|||
145435383|NCT01374425|524452889|FG001|Overall Study|Protocol Violation|3|||
145435384|NCT01374425|524452888|FG000|Overall Study|Sponsor Decision|0|||
145435385|NCT01374425|524452889|FG001|Overall Study|Sponsor Decision|1|||
145435386|NCT01374425|524452888|FG000|Overall Study|Lost to Follow-up|2|||
145435387|NCT01374425|524452889|FG001|Overall Study|Lost to Follow-up|1|||
145435388|NCT01374425|524452888|FG000|Overall Study|Other|41|||
145435389|NCT01374425|524452889|FG001|Overall Study|Other|43|||
145435390|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
145435391|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
145435392|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
145435393|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
145435394|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
145435395|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
145435396|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
145583509|NCT02352493|524989347|FG002|Overall Study|Lost to Follow-up|0|||
145583510|NCT02352493|524989348|FG003|Overall Study|Lost to Follow-up|0|||
145435397|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
145435398|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
145435399|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
145435400|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
145435401|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
145435402|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
145435403|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
145435404|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
145435405|NCT00546481|524452890|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
145435406|NCT00546481|524452891|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
145435407|NCT00546481|524452892|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
145435408|NCT00546481|524452890|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
145435409|NCT00546481|524452891|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
145435410|NCT00546481|524452892|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
145435411|NCT00546481|524452890|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
145435412|NCT00546481|524452891|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
145435413|NCT00546481|524452892|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
145435414|NCT00546481|524452890|FG000|Maintenance Phase (CERA)|Other Reason|0|||
145435415|NCT00546481|524452891|FG001|Maintenance Phase (CERA)|Other Reason|0|||
145435416|NCT00546481|524452892|FG002|Maintenance Phase (CERA)|Other Reason|1|||
145435417|NCT02761642|524452897|FG000|Overall Study|Did not Receive Study Treatment|3|||
145435418|NCT02761642|524452897|FG000|Overall Study|Adverse Event|13|||
145435419|NCT02761642|524452897|FG000|Overall Study|Withdrawal by Subject|2|||
145435420|NCT02761642|524452897|FG000|Overall Study|Non-compliant|7|||
145435421|NCT02761642|524452897|FG000|Overall Study|Death|3|||
145435422|NCT02761642|524452897|FG000|Overall Study|Lack of Efficacy|20|||
145435423|NCT02761642|524452897|FG000|Overall Study|Physician Decision|1|||
145435424|NCT02761642|524452897|FG000|Overall Study|Reason Unspecified|21|||
145435425|NCT00950651|524452898|FG000|Overall Study|Adverse Event|17|||
145435426|NCT00950651|524452899|FG001|Overall Study|Adverse Event|20|||
145435427|NCT00950651|524452898|FG000|Overall Study|Death|1|||
145435428|NCT00950651|524452899|FG001|Overall Study|Death|0|||
145435429|NCT00950651|524452898|FG000|Overall Study|Lack of Efficacy|2|||
145435430|NCT00950651|524452899|FG001|Overall Study|Lack of Efficacy|2|||
145435431|NCT00950651|524452898|FG000|Overall Study|Protocol Violation|3|||
145435432|NCT00950651|524452899|FG001|Overall Study|Protocol Violation|4|||
145435433|NCT00950651|524452898|FG000|Overall Study|Withdrawal by Subject|8|||
145435434|NCT00950651|524452899|FG001|Overall Study|Withdrawal by Subject|9|||
145435435|NCT03783780|524452902|FG000|Overall Study|Withdrawn prior to completion|1|||
145435436|NCT02850978|524452907|FG000|Overall Study|Uncollectable CRF|27|||
145435437|NCT02850978|524452907|FG000|Overall Study|No visit since the first visit|35|||
145435438|NCT02850978|524452907|FG000|Overall Study|Adverse Event|81|||
145435439|NCT02850978|524452907|FG000|Overall Study|Lack of Efficacy|40|||
145435440|NCT02850978|524452907|FG000|Overall Study|Improvement in condition|34|||
145435441|NCT02850978|524452907|FG000|Overall Study|Lost to Follow-up|121|||
145435442|NCT02850978|524452907|FG000|Overall Study|Reason not listed|88|||
145435443|NCT00421148|524452908|FG000|Overall Study|Lost to Follow-up|0|||
145435444|NCT00421148|524452909|FG001|Overall Study|Lost to Follow-up|0|||
145435445|NCT00421148|524452910|FG002|Overall Study|Lost to Follow-up|0|||
145435446|NCT00421148|524452911|FG003|Overall Study|Lost to Follow-up|0|||
145435447|NCT00421148|524452912|FG004|Overall Study|Lost to Follow-up|0|||
145435448|NCT00421148|524452913|FG005|Overall Study|Lost to Follow-up|0|||
145435449|NCT00421148|524452914|FG006|Overall Study|Lost to Follow-up|0|||
145435450|NCT00421148|524452915|FG007|Overall Study|Lost to Follow-up|0|||
145435451|NCT00421148|524452916|FG008|Overall Study|Lost to Follow-up|0|||
145435452|NCT00421148|524452917|FG009|Overall Study|Lost to Follow-up|0|||
145435453|NCT00421148|524452918|FG010|Overall Study|Lost to Follow-up|0|||
145435454|NCT00421148|524452919|FG011|Overall Study|Lost to Follow-up|0|||
145435455|NCT00421148|524452920|FG012|Overall Study|Lost to Follow-up|0|||
145583511|NCT02352493|524989349|FG004|Overall Study|Lost to Follow-up|0|||
145583512|NCT02352493|524989350|FG005|Overall Study|Lost to Follow-up|0|||
145583513|NCT02352493|524989351|FG006|Overall Study|Lost to Follow-up|0|||
145583514|NCT02352493|524989352|FG007|Overall Study|Lost to Follow-up|0|||
145435456|NCT00421148|524452921|FG013|Overall Study|Lost to Follow-up|0|||
145435457|NCT00421148|524452922|FG014|Overall Study|Lost to Follow-up|0|||
145435458|NCT00421148|524452923|FG015|Overall Study|Lost to Follow-up|0|||
145435459|NCT00421148|524452924|FG016|Overall Study|Lost to Follow-up|0|||
145435460|NCT00421148|524452925|FG017|Overall Study|Lost to Follow-up|1|||
145435461|NCT00421148|524452926|FG018|Overall Study|Lost to Follow-up|0|||
145435462|NCT00421148|524452927|FG019|Overall Study|Lost to Follow-up|0|||
145435463|NCT00421148|524452908|FG000|Overall Study|Withdrawal by Subject|0|||
145435464|NCT00421148|524452909|FG001|Overall Study|Withdrawal by Subject|0|||
145435465|NCT00421148|524452910|FG002|Overall Study|Withdrawal by Subject|0|||
145435466|NCT00421148|524452911|FG003|Overall Study|Withdrawal by Subject|0|||
145583515|NCT02352493|524989353|FG008|Overall Study|Lost to Follow-up|0|||
145435467|NCT00421148|524452912|FG004|Overall Study|Withdrawal by Subject|0|||
145583516|NCT02352493|524989354|FG009|Overall Study|Lost to Follow-up|1|||
145583517|NCT02352493|524989355|FG010|Overall Study|Lost to Follow-up|0|||
145435468|NCT00421148|524452913|FG005|Overall Study|Withdrawal by Subject|0|||
145435469|NCT00421148|524452914|FG006|Overall Study|Withdrawal by Subject|0|||
145435470|NCT00421148|524452915|FG007|Overall Study|Withdrawal by Subject|0|||
145435471|NCT00421148|524452916|FG008|Overall Study|Withdrawal by Subject|0|||
145435472|NCT00421148|524452917|FG009|Overall Study|Withdrawal by Subject|0|||
145435473|NCT00421148|524452918|FG010|Overall Study|Withdrawal by Subject|0|||
145435474|NCT00421148|524452919|FG011|Overall Study|Withdrawal by Subject|0|||
145435475|NCT00421148|524452920|FG012|Overall Study|Withdrawal by Subject|0|||
145435476|NCT00421148|524452921|FG013|Overall Study|Withdrawal by Subject|0|||
145435477|NCT00421148|524452922|FG014|Overall Study|Withdrawal by Subject|0|||
145435478|NCT00421148|524452923|FG015|Overall Study|Withdrawal by Subject|0|||
145435479|NCT00421148|524452924|FG016|Overall Study|Withdrawal by Subject|0|||
145435480|NCT00421148|524452925|FG017|Overall Study|Withdrawal by Subject|1|||
145435481|NCT00421148|524452926|FG018|Overall Study|Withdrawal by Subject|0|||
145435482|NCT00421148|524452927|FG019|Overall Study|Withdrawal by Subject|0|||
145435483|NCT00421148|524452908|FG000|Overall Study|Protocol Violation|0|||
145435484|NCT00421148|524452909|FG001|Overall Study|Protocol Violation|0|||
145435485|NCT00421148|524452910|FG002|Overall Study|Protocol Violation|0|||
145435486|NCT00421148|524452911|FG003|Overall Study|Protocol Violation|0|||
145435487|NCT00421148|524452912|FG004|Overall Study|Protocol Violation|0|||
145435488|NCT00421148|524452913|FG005|Overall Study|Protocol Violation|1|||
145435489|NCT00421148|524452914|FG006|Overall Study|Protocol Violation|0|||
145435490|NCT00421148|524452915|FG007|Overall Study|Protocol Violation|0|||
145435491|NCT00421148|524452916|FG008|Overall Study|Protocol Violation|0|||
145435492|NCT00421148|524452917|FG009|Overall Study|Protocol Violation|0|||
145435493|NCT00421148|524452918|FG010|Overall Study|Protocol Violation|0|||
145435494|NCT00421148|524452919|FG011|Overall Study|Protocol Violation|0|||
145435495|NCT00421148|524452920|FG012|Overall Study|Protocol Violation|0|||
145435496|NCT00421148|524452921|FG013|Overall Study|Protocol Violation|0|||
145435497|NCT00421148|524452922|FG014|Overall Study|Protocol Violation|0|||
145435498|NCT00421148|524452923|FG015|Overall Study|Protocol Violation|0|||
145435499|NCT00421148|524452924|FG016|Overall Study|Protocol Violation|0|||
145435500|NCT00421148|524452925|FG017|Overall Study|Protocol Violation|0|||
145435501|NCT00421148|524452926|FG018|Overall Study|Protocol Violation|1|||
145435502|NCT00421148|524452927|FG019|Overall Study|Protocol Violation|0|||
145435503|NCT00570713|524452928|FG000|Overall Study|Adverse Event|16|||
145435504|NCT00570713|524452929|FG001|Overall Study|Adverse Event|9|||
145435505|NCT00570713|524452928|FG000|Overall Study|Death|7|||
145435506|NCT00570713|524452929|FG001|Overall Study|Death|7|||
145435507|NCT00570713|524452928|FG000|Overall Study|Lack of Efficacy|40|||
145435508|NCT00570713|524452929|FG001|Overall Study|Lack of Efficacy|49|||
145435509|NCT00570713|524452928|FG000|Overall Study|Physician Decision|2|||
145435510|NCT00570713|524452929|FG001|Overall Study|Physician Decision|2|||
145435511|NCT00570713|524452928|FG000|Overall Study|Withdrawal by Subject|3|||
145435512|NCT00570713|524452929|FG001|Overall Study|Withdrawal by Subject|3|||
145435513|NCT00570713|524452928|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
145435514|NCT00570713|524452929|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
145435515|NCT01822665|524452932|FG000|Overall Study|Adverse Event|3|||
145435516|NCT01822665|524452932|FG000|Overall Study|Other Reason|5|||
145435517|NCT04540367|524452933|FG000|Overall Study|Withdrawal by Subject|0|||
145435518|NCT04540367|524452934|FG001|Overall Study|Withdrawal by Subject|0|||
145435519|NCT04540367|524452935|FG002|Overall Study|Withdrawal by Subject|0|||
145435520|NCT04540367|524452936|FG003|Overall Study|Withdrawal by Subject|2|||
145435521|NCT04540367|524452933|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
145435522|NCT04540367|524452934|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
145435523|NCT04540367|524452935|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
145435524|NCT04540367|524452936|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
145435525|NCT04540367|524452933|FG000|Overall Study|Adverse Event|0|||
145435526|NCT04540367|524452934|FG001|Overall Study|Adverse Event|0|||
145583518|NCT02352493|524989356|FG011|Overall Study|Lost to Follow-up|0|||
145583519|NCT02352493|524989357|FG012|Overall Study|Lost to Follow-up|1|||
145435527|NCT04540367|524452935|FG002|Overall Study|Adverse Event|1|||
145435528|NCT04540367|524452936|FG003|Overall Study|Adverse Event|1|||
145435529|NCT00907621|524452940|FG000|Overall Study|Lost to Follow-up|6|||
145435530|NCT00907621|524452941|FG001|Overall Study|Lost to Follow-up|3|||
145435531|NCT00907621|524452940|FG000|Overall Study|intercurrent febrile illness|1|||
145435532|NCT00907621|524452941|FG001|Overall Study|intercurrent febrile illness|1|||
145435533|NCT00902330|524452946|FG000|Overall Study|Too overwhelmed by treatment|2|||
145435534|NCT00902330|524452947|FG001|Overall Study|Too overwhelmed by treatment|5|||
145435535|NCT00902330|524452946|FG000|Overall Study|Adverse Event|1|||
145435536|NCT00902330|524452947|FG001|Overall Study|Adverse Event|0|||
145435537|NCT00902330|524452946|FG000|Overall Study|No post baseline data|1|||
145435538|NCT00902330|524452947|FG001|Overall Study|No post baseline data|0|||
145435539|NCT02121509|524452948|FG000|Washout Period (35 Days)|Adverse Event|1|||
145435540|NCT02121509|524452949|FG001|Washout Period (35 Days)|Adverse Event|1|||
145435541|NCT02121509|524452950|FG002|Washout Period (35 Days)|Adverse Event|0|||
145435542|NCT02121509|524452951|FG003|Washout Period (35 Days)|Adverse Event|0|||
145435543|NCT02121509|524452948|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
145435544|NCT02121509|524452949|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
145435545|NCT02121509|524452950|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
145435546|NCT02121509|524452951|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
145435547|NCT02121509|524452948|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
145435548|NCT02121509|524452949|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
145435549|NCT02121509|524452950|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
145435550|NCT02121509|524452951|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
145435551|NCT03402841|524452957|FG000|Overall Study|Withdrawal by Subject|3|||
145435552|NCT03402841|524452957|FG000|Overall Study|Lost to Follow-up|2|||
145435553|NCT03402841|524452957|FG000|Overall Study|Death|146|||
145435554|NCT03984188|524452960|FG000|Overall Study|Death|2|||
145435555|NCT03984188|524452961|FG001|Overall Study|Death|4|||
145435556|NCT03984188|524452960|FG000|Overall Study|Physician Decision|0|||
145435557|NCT03984188|524452961|FG001|Overall Study|Physician Decision|2|||
145435558|NCT03984188|524452960|FG000|Overall Study|Lost to Follow-up|3|||
145435559|NCT03984188|524452961|FG001|Overall Study|Lost to Follow-up|2|||
145435560|NCT03984188|524452960|FG000|Overall Study|Withdrawal by Subject|6|||
145435561|NCT03984188|524452961|FG001|Overall Study|Withdrawal by Subject|0|||
145435562|NCT03384875|524452962|FG000|Overall Study|Death|1|||
145435563|NCT03384875|524452963|FG001|Overall Study|Death|1|||
145435564|NCT03384875|524452964|FG002|Overall Study|Death|0|||
145435565|NCT03384875|524452962|FG000|Overall Study|Reason not provided|1|||
145435566|NCT03384875|524452963|FG001|Overall Study|Reason not provided|0|||
145435567|NCT03384875|524452964|FG002|Overall Study|Reason not provided|0|||
145435568|NCT01978145|524455104|FG000|Treatment Period 1|Adverse Event|1|||
145435569|NCT01978145|524455105|FG001|Treatment Period 1|Adverse Event|9|||
145435570|NCT01978145|524455104|FG000|Treatment Period 1|Physician Decision|1|||
145435571|NCT01978145|524455105|FG001|Treatment Period 1|Physician Decision|0|||
145435572|NCT01978145|524455104|FG000|Treatment Period 1|Withdrawal by Subject|5|||
145435573|NCT01978145|524455105|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145435574|NCT01978145|524455104|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
145435575|NCT01978145|524455105|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
145435576|NCT01978145|524455104|FG000|Washout Period 1|Adverse Event|0|||
145435577|NCT01978145|524455105|FG001|Washout Period 1|Adverse Event|1|||
145435578|NCT01978145|524455104|FG000|Washout Period 1|Withdrawal by Subject|1|||
145435579|NCT01978145|524455105|FG001|Washout Period 1|Withdrawal by Subject|1|||
145435580|NCT01978145|524455104|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
145435581|NCT01978145|524455105|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
145435582|NCT01978145|524455104|FG000|Treatment Period 2|Adverse Event|3|||
145435583|NCT01978145|524455105|FG001|Treatment Period 2|Adverse Event|3|||
145435584|NCT01978145|524455104|FG000|Treatment Period 2|Protocol Violation|0|||
145435585|NCT01978145|524455105|FG001|Treatment Period 2|Protocol Violation|1|||
145435586|NCT01978145|524455104|FG000|Treatment Period 2|Lost to Follow-up|1|||
145435587|NCT01978145|524455105|FG001|Treatment Period 2|Lost to Follow-up|1|||
145435588|NCT01978145|524455104|FG000|Treatment Period 2|Withdrawal by Subject|7|||
145435589|NCT01978145|524455105|FG001|Treatment Period 2|Withdrawal by Subject|4|||
145435590|NCT01978145|524455104|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
145435591|NCT01978145|524455105|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
145435592|NCT01250054|524455106|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
145435593|NCT01250054|524455107|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
145435594|NCT01047007|524455115|FG000|Overall Study|Adverse Event|0|||
145435595|NCT01047007|524455116|FG001|Overall Study|Adverse Event|2|||
145435596|NCT01047007|524455117|FG002|Overall Study|Adverse Event|1|||
145583520|NCT02352493|524989358|FG013|Overall Study|Lost to Follow-up|2|||
145435597|NCT01047007|524455118|FG003|Overall Study|Adverse Event|0|||
145435598|NCT01047007|524455115|FG000|Overall Study|Progressive Disease|2|||
145435599|NCT01047007|524455116|FG001|Overall Study|Progressive Disease|4|||
145435600|NCT01047007|524455117|FG002|Overall Study|Progressive Disease|1|||
145435601|NCT01047007|524455118|FG003|Overall Study|Progressive Disease|0|||
145435602|NCT03759600|524455119|FG000|Overall Study|Adverse Event|2|||
145583521|NCT02352493|524989359|FG014|Overall Study|Lost to Follow-up|0|||
145583522|NCT02352493|524989360|FG015|Overall Study|Lost to Follow-up|0|||
145583523|NCT02352493|524989361|FG016|Overall Study|Lost to Follow-up|0|||
145583524|NCT02352493|524989362|FG017|Overall Study|Lost to Follow-up|0|||
145435603|NCT03759600|524455119|FG000|Overall Study|Progressive Disease|15|||
145435604|NCT03759600|524455119|FG000|Overall Study|Site Terminated by Sponsor|3|||
145435605|NCT03257358|524455120|FG000|Overall Study|Adverse Event|25|||
145435606|NCT03257358|524455121|FG001|Overall Study|Adverse Event|12|||
145435607|NCT03257358|524455120|FG000|Overall Study|Lack of Efficacy|1|||
145435608|NCT03257358|524455121|FG001|Overall Study|Lack of Efficacy|1|||
145435609|NCT03257358|524455120|FG000|Overall Study|Lost to Follow-up|12|||
145435610|NCT03257358|524455121|FG001|Overall Study|Lost to Follow-up|4|||
145583525|NCT02162810|524989363|FG000|Overall Study|Protocol Violation|1|||
145583526|NCT02162810|524989364|FG001|Overall Study|Protocol Violation|0|||
145583527|NCT02162810|524989363|FG000|Overall Study|patients did not report compliance|4|||
145583528|NCT02162810|524989364|FG001|Overall Study|patients did not report compliance|1|||
145583529|NCT02546544|524989369|FG000|Overall Study|Disease Progression|14|||
145583530|NCT02546544|524989369|FG000|Overall Study|Adverse Event|1|||
145583531|NCT02546544|524989369|FG000|Overall Study|Withdrawal by Subject|1|||
145583532|NCT01921348|524989370|FG000|Overall Study|Withdrawal by Subject|1|||
145583533|NCT01921348|524989371|FG001|Overall Study|Withdrawal by Subject|0|||
145583534|NCT01921348|524989370|FG000|Overall Study|Lost to Follow-up|0|||
145583535|NCT01921348|524989371|FG001|Overall Study|Lost to Follow-up|2|||
145583536|NCT01465334|524989372|FG000|Overall Study|Disease Progression|1|||
145583537|NCT01465334|524989373|FG001|Overall Study|Disease Progression|0|||
145583538|NCT01465334|524989372|FG000|Overall Study|Adverse Event|1|||
145583539|NCT01465334|524989373|FG001|Overall Study|Adverse Event|0|||
145583540|NCT01465334|524989372|FG000|Overall Study|Richter's transformation|0|||
145583541|NCT01465334|524989373|FG001|Overall Study|Richter's transformation|3|||
145583542|NCT01465334|524989372|FG000|Overall Study|Refractory Disease|0|||
145583543|NCT01465334|524989373|FG001|Overall Study|Refractory Disease|3|||
145583544|NCT02548962|524989374|FG000|Overall Study|Withdrawal by Subject|1|||
145583545|NCT02548962|524989375|FG001|Overall Study|Withdrawal by Subject|0|||
145583546|NCT01114646|524989379|FG000|Overall Study|Withdrawal by Subject|3|||
145583547|NCT01114646|524989380|FG001|Overall Study|Withdrawal by Subject|2|||
145583548|NCT01046110|524989381|FG000|Overall Study|Adverse Event|9|||
145583549|NCT01046110|524989382|FG001|Overall Study|Adverse Event|2|||
145583550|NCT01046110|524989381|FG000|Overall Study|Lack of Efficacy|0|||
145583551|NCT01046110|524989382|FG001|Overall Study|Lack of Efficacy|1|||
145583552|NCT01046110|524989381|FG000|Overall Study|Protocol Violation|7|||
145583553|NCT01046110|524989382|FG001|Overall Study|Protocol Violation|12|||
145583554|NCT01046110|524989381|FG000|Overall Study|Withdrawal Criteria|3|||
145583555|NCT01046110|524989382|FG001|Overall Study|Withdrawal Criteria|5|||
145583556|NCT01046110|524989381|FG000|Overall Study|Unclassified|36|||
145583557|NCT01046110|524989382|FG001|Overall Study|Unclassified|35|||
145583558|NCT01233817|524989383|FG000|Overall Study|Lost to Follow-up|1|||
145583559|NCT01233817|524989383|FG000|Overall Study|Withdrawal by Subject|2|||
145583560|NCT01202773|524989386|FG000|Overall Study|Adverse Event|4|||
145583561|NCT01202773|524989387|FG001|Overall Study|Adverse Event|5|||
145583562|NCT01202773|524989388|FG002|Overall Study|Adverse Event|5|||
145583563|NCT01202773|524989386|FG000|Overall Study|Lack of Efficacy|5|||
145583564|NCT01202773|524989387|FG001|Overall Study|Lack of Efficacy|4|||
145583565|NCT01202773|524989388|FG002|Overall Study|Lack of Efficacy|9|||
145583566|NCT01202773|524989386|FG000|Overall Study|Entry Criteria Not Met|2|||
145583567|NCT01202773|524989387|FG001|Overall Study|Entry Criteria Not Met|0|||
145583568|NCT01202773|524989388|FG002|Overall Study|Entry Criteria Not Met|1|||
145583569|NCT01202773|524989386|FG000|Overall Study|Lost to Follow-up|1|||
145583570|NCT01202773|524989387|FG001|Overall Study|Lost to Follow-up|2|||
145583571|NCT01202773|524989388|FG002|Overall Study|Lost to Follow-up|2|||
145583572|NCT01202773|524989386|FG000|Overall Study|Withdrawal by Subject|13|||
145583573|NCT01202773|524989387|FG001|Overall Study|Withdrawal by Subject|6|||
145583574|NCT01202773|524989388|FG002|Overall Study|Withdrawal by Subject|5|||
145583575|NCT01202773|524989386|FG000|Overall Study|Physician Decision|2|||
145583576|NCT01202773|524989387|FG001|Overall Study|Physician Decision|0|||
145583577|NCT01202773|524989388|FG002|Overall Study|Physician Decision|0|||
145583578|NCT01202773|524989386|FG000|Overall Study|Protocol Violation|11|||
145583579|NCT01202773|524989387|FG001|Overall Study|Protocol Violation|6|||
145583580|NCT01202773|524989388|FG002|Overall Study|Protocol Violation|10|||
145583581|NCT01202773|524989386|FG000|Overall Study|Sponsor Decision|19|||
145583582|NCT01202773|524989387|FG001|Overall Study|Sponsor Decision|20|||
145583583|NCT01202773|524989388|FG002|Overall Study|Sponsor Decision|23|||
145583584|NCT00575588|524989389|FG000|Overall Study|Adverse Event|11|||
145583585|NCT00575588|524989390|FG001|Overall Study|Adverse Event|13|||
145583586|NCT00575588|524989389|FG000|Overall Study|Withdrawal by Subject|27|||
145583587|NCT00575588|524989390|FG001|Overall Study|Withdrawal by Subject|31|||
145435611|NCT03257358|524455120|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
145435612|NCT03257358|524455121|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
145435613|NCT03257358|524455120|FG000|Overall Study|Physician Decision|2|||
145583588|NCT00575588|524989389|FG000|Overall Study|Lost to Follow-up|1|||
145583589|NCT00575588|524989390|FG001|Overall Study|Lost to Follow-up|3|||
145583590|NCT00575588|524989389|FG000|Overall Study|Death|4|||
145583591|NCT00575588|524989390|FG001|Overall Study|Death|2|||
145435614|NCT03257358|524455121|FG001|Overall Study|Physician Decision|2|||
145435615|NCT03257358|524455120|FG000|Overall Study|Protocol Violation|5|||
145583592|NCT00575588|524989389|FG000|Overall Study|Incorrect enrollment|8|||
145583593|NCT00575588|524989390|FG001|Overall Study|Incorrect enrollment|4|||
145583594|NCT00575588|524989389|FG000|Overall Study|Study specific discontinuation criteria|203|||
145583595|NCT00575588|524989390|FG001|Overall Study|Study specific discontinuation criteria|218|||
145583596|NCT00575588|524989389|FG000|Overall Study|Severe non-compliance to protocol|5|||
145583597|NCT00575588|524989390|FG001|Overall Study|Severe non-compliance to protocol|7|||
145583598|NCT00575588|524989389|FG000|Overall Study|Safety reasons|2|||
145624883|NCT02851511|525139714|FG003|Phase I|Withdrawal by Subject|3|||
145624884|NCT02851511|525139711|FG000|Phase II|Physician Decision|18|||
145624885|NCT02851511|525139712|FG001|Phase II|Physician Decision|16|||
145624886|NCT02851511|525139713|FG002|Phase II|Physician Decision|0|||
145624887|NCT02851511|525139714|FG003|Phase II|Physician Decision|0|||
145624888|NCT02851511|525139711|FG000|Phase II|Withdrawal by Subject|18|||
145624889|NCT02851511|525139712|FG001|Phase II|Withdrawal by Subject|16|||
145624890|NCT02851511|525139713|FG002|Phase II|Withdrawal by Subject|0|||
145624891|NCT02851511|525139714|FG003|Phase II|Withdrawal by Subject|0|||
145624892|NCT02851511|525139711|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
145624893|NCT02851511|525139712|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
145624894|NCT02851511|525139713|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
145624895|NCT02851511|525139714|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
145624896|NCT02851511|525139711|FG000|Phase II|Lost to Follow-up|0|||
145624897|NCT02851511|525139712|FG001|Phase II|Lost to Follow-up|1|||
145624898|NCT02851511|525139713|FG002|Phase II|Lost to Follow-up|0|||
145624899|NCT02851511|525139714|FG003|Phase II|Lost to Follow-up|0|||
145624900|NCT03606460|525139715|FG000|Overall Study|Lost to Follow-up|1|||
145624901|NCT03606460|525139716|FG001|Overall Study|Lost to Follow-up|8|||
145624902|NCT00003377|525139717|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
145624903|NCT00003377|525139718|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
145624904|NCT00003377|525139719|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
145624905|NCT00003377|525139720|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
145624906|NCT00003377|525139721|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
145624907|NCT00003377|525139717|FG000|Period II|Ureteral stent complications|0|||
145624908|NCT00003377|525139718|FG001|Period II|Ureteral stent complications|0|||
145624909|NCT00003377|525139719|FG002|Period II|Ureteral stent complications|0|||
145624910|NCT00003377|525139720|FG003|Period II|Ureteral stent complications|0|||
145624911|NCT00003377|525139721|FG004|Period II|Ureteral stent complications|1|||
145624912|NCT04541186|525139723|FG000|Main Study|Adverse Event|0|||
145624913|NCT04541186|525139724|FG001|Main Study|Adverse Event|0|||
145624914|NCT04541186|525139725|FG002|Main Study|Adverse Event|4|||
145624915|NCT04541186|525139726|FG003|Main Study|Adverse Event|0|||
145435616|NCT03257358|524455121|FG001|Overall Study|Protocol Violation|3|||
145435617|NCT03257358|524455120|FG000|Overall Study|Technical problems|4|||
145435618|NCT03257358|524455121|FG001|Overall Study|Technical problems|1|||
145435619|NCT03257358|524455120|FG000|Overall Study|Withdrawal by Subject|8|||
145435620|NCT03257358|524455121|FG001|Overall Study|Withdrawal by Subject|3|||
145435621|NCT03257358|524455120|FG000|Overall Study|Withdrawal of informed consent|9|||
145435622|NCT03257358|524455121|FG001|Overall Study|Withdrawal of informed consent|5|||
145435623|NCT03257358|524455120|FG000|Overall Study|New therapy for study indication|1|||
145435624|NCT03257358|524455121|FG001|Overall Study|New therapy for study indication|0|||
145435625|NCT03257358|524455120|FG000|Overall Study|No longer requires treatment|0|||
145435626|NCT03257358|524455121|FG001|Overall Study|No longer requires treatment|1|||
145435627|NCT01248793|524455122|FG000|Overall Study|Lost to Follow-up|0|||
145435628|NCT01248793|524455123|FG001|Overall Study|Lost to Follow-up|1|||
145435629|NCT01248793|524455122|FG000|Overall Study|Adverse Event|1|||
145435630|NCT01248793|524455123|FG001|Overall Study|Adverse Event|1|||
145435631|NCT01248793|524455122|FG000|Overall Study|Protocol Violation|0|||
145435632|NCT01248793|524455123|FG001|Overall Study|Protocol Violation|1|||
145435633|NCT01248793|524455122|FG000|Overall Study|Withdrawal by Subject|3|||
145435634|NCT01248793|524455123|FG001|Overall Study|Withdrawal by Subject|3|||
145435635|NCT01747915|524455124|FG000|Overall Study|Other|1|||
145435636|NCT01747915|524455125|FG001|Overall Study|Other|1|||
145435637|NCT01747915|524455126|FG002|Overall Study|Other|1|||
145435638|NCT01747915|524455124|FG000|Overall Study|Adverse Event|8|||
145435639|NCT01747915|524455125|FG001|Overall Study|Adverse Event|5|||
145435640|NCT01747915|524455126|FG002|Overall Study|Adverse Event|2|||
145435641|NCT01747915|524455124|FG000|Overall Study|Death|0|||
145435642|NCT01747915|524455125|FG001|Overall Study|Death|0|||
145435643|NCT01747915|524455126|FG002|Overall Study|Death|1|||
145435644|NCT01747915|524455124|FG000|Overall Study|Lack of Efficacy|0|||
145435645|NCT01747915|524455125|FG001|Overall Study|Lack of Efficacy|1|||
145435646|NCT01747915|524455126|FG002|Overall Study|Lack of Efficacy|0|||
145435647|NCT01747915|524455124|FG000|Overall Study|Lost to Follow-up|1|||
145435648|NCT01747915|524455125|FG001|Overall Study|Lost to Follow-up|0|||
145435649|NCT01747915|524455126|FG002|Overall Study|Lost to Follow-up|0|||
145435650|NCT01747915|524455124|FG000|Overall Study|Withdrawal by Subject|4|||
145435651|NCT01747915|524455125|FG001|Overall Study|Withdrawal by Subject|4|||
145435652|NCT01747915|524455126|FG002|Overall Study|Withdrawal by Subject|1|||
145435653|NCT01747915|524455124|FG000|Overall Study|Protocol Violation|1|||
145435654|NCT01747915|524455125|FG001|Overall Study|Protocol Violation|0|||
145435655|NCT01747915|524455126|FG002|Overall Study|Protocol Violation|0|||
145435656|NCT01747915|524455124|FG000|Overall Study|Pregnancy|0|||
145624916|NCT04541186|525139727|FG004|Main Study|Adverse Event|0|||
145624917|NCT04541186|525139723|FG000|Main Study|Investigator Decision|0|||
145624918|NCT04541186|525139724|FG001|Main Study|Investigator Decision|0|||
145624919|NCT04541186|525139725|FG002|Main Study|Investigator Decision|1|||
145624920|NCT04541186|525139726|FG003|Main Study|Investigator Decision|1|||
145435657|NCT01747915|524455125|FG001|Overall Study|Pregnancy|0|||
145435658|NCT01747915|524455126|FG002|Overall Study|Pregnancy|1|||
145435659|NCT01073293|524455129|FG000|Overall Study|Lost to Follow-up|0|||
145435660|NCT01073293|524455130|FG001|Overall Study|Lost to Follow-up|1|||
145435661|NCT01073293|524455129|FG000|Overall Study|Withdrawal by Subject|5|||
145435662|NCT01073293|524455130|FG001|Overall Study|Withdrawal by Subject|10|||
145435663|NCT00305448|524455131|FG000|Overall Study|Protocol Violation|0|||
145435664|NCT00305448|524455132|FG001|Overall Study|Protocol Violation|1|||
145435665|NCT00305448|524455133|FG002|Overall Study|Protocol Violation|0|||
145435666|NCT00305448|524455131|FG000|Overall Study|Withdrawal by Subject|2|||
145435667|NCT00305448|524455132|FG001|Overall Study|Withdrawal by Subject|0|||
145435668|NCT00305448|524455133|FG002|Overall Study|Withdrawal by Subject|1|||
145435669|NCT00305448|524455131|FG000|Overall Study|Adverse Event|1|||
145435670|NCT00305448|524455132|FG001|Overall Study|Adverse Event|0|||
145435671|NCT00305448|524455133|FG002|Overall Study|Adverse Event|1|||
145435672|NCT00305448|524455131|FG000|Overall Study|Disease Progression|27|||
145435673|NCT00305448|524455132|FG001|Overall Study|Disease Progression|31|||
145435674|NCT00305448|524455133|FG002|Overall Study|Disease Progression|28|||
145435675|NCT00305448|524455131|FG000|Overall Study|Subjective Disease Progression|1|||
145435676|NCT00305448|524455132|FG001|Overall Study|Subjective Disease Progression|2|||
145435677|NCT00305448|524455133|FG002|Overall Study|Subjective Disease Progression|2|||
145435678|NCT00305448|524455131|FG000|Overall Study|Tumor Marker Elevation|0|||
145435679|NCT00305448|524455132|FG001|Overall Study|Tumor Marker Elevation|0|||
145435680|NCT00305448|524455133|FG002|Overall Study|Tumor Marker Elevation|1|||
145435681|NCT00506142|524455140|FG000|Overall Study|Adverse Event|8|||
145435682|NCT00506142|524455141|FG001|Overall Study|Adverse Event|7|||
145435683|NCT00506142|524455140|FG000|Overall Study|Lack of Efficacy|21|||
145435684|NCT00506142|524455141|FG001|Overall Study|Lack of Efficacy|7|||
145435685|NCT00506142|524455140|FG000|Overall Study|Withdrawal by Subject|4|||
145435686|NCT00506142|524455141|FG001|Overall Study|Withdrawal by Subject|5|||
145435687|NCT00506142|524455140|FG000|Overall Study|Physician Decision|1|||
145435688|NCT00506142|524455141|FG001|Overall Study|Physician Decision|0|||
145435689|NCT00506142|524455140|FG000|Overall Study|New health condition|1|||
145435690|NCT00506142|524455141|FG001|Overall Study|New health condition|0|||
145435691|NCT03500211|524455144|FG000|Overall Study|Withdrawal by Subject|1|||
145435692|NCT03500211|524455145|FG001|Overall Study|Withdrawal by Subject|1|||
145435693|NCT04460183|524455146|FG000|Overall Study|Lost to Follow-up|3|||
145435694|NCT04460183|524455147|FG001|Overall Study|Lost to Follow-up|1|||
145435695|NCT04460183|524455146|FG000|Overall Study|Withdrawal by Subject|1|||
145435696|NCT04460183|524455147|FG001|Overall Study|Withdrawal by Subject|0|||
145435697|NCT00487981|524455148|FG000|Overall Study|Hypothyroidism diagnosis|1|||
145435698|NCT03848416|524455150|FG000|Overall Study|Withdrawal by Subject|1|||
145435699|NCT03848416|524455151|FG001|Overall Study|Withdrawal by Subject|0|||
145435700|NCT03848416|524455152|FG002|Overall Study|Withdrawal by Subject|0|||
145435701|NCT03848416|524455150|FG000|Overall Study|Death|0|||
145435702|NCT03848416|524455151|FG001|Overall Study|Death|0|||
145435703|NCT03848416|524455152|FG002|Overall Study|Death|1|||
145435704|NCT00856609|524455156|FG000|Overall Study|Adverse Event|1|||
145435705|NCT00856609|524455157|FG001|Overall Study|Adverse Event|0|||
145435706|NCT00783432|524455158|FG000|Overall Study|Adverse Event|22|||
145435707|NCT00783432|524455159|FG001|Overall Study|Adverse Event|17|||
145435708|NCT00783432|524455158|FG000|Overall Study|Lack of Efficacy|20|||
145435709|NCT00783432|524455159|FG001|Overall Study|Lack of Efficacy|21|||
145435710|NCT00783432|524455158|FG000|Overall Study|Lost to Follow-up|11|||
145435711|NCT00783432|524455159|FG001|Overall Study|Lost to Follow-up|6|||
145435712|NCT00783432|524455158|FG000|Overall Study|Withdrawal by Subject|23|||
145435713|NCT00783432|524455159|FG001|Overall Study|Withdrawal by Subject|20|||
145435714|NCT00783432|524455158|FG000|Overall Study|subject moved|3|||
145435715|NCT00783432|524455159|FG001|Overall Study|subject moved|5|||
145435716|NCT00783432|524455158|FG000|Overall Study|Protocol Violation|6|||
145435717|NCT00783432|524455159|FG001|Overall Study|Protocol Violation|9|||
145435718|NCT01436110|524455160|FG000|Overall Study|Lack of Efficacy|23|||
145435719|NCT01436110|524455161|FG001|Overall Study|Lack of Efficacy|14|||
145435720|NCT01436110|524455162|FG002|Overall Study|Lack of Efficacy|9|||
145435721|NCT01436110|524455160|FG000|Overall Study|Withdrawal by Subject|6|||
145435722|NCT01436110|524455161|FG001|Overall Study|Withdrawal by Subject|8|||
145435723|NCT01436110|524455162|FG002|Overall Study|Withdrawal by Subject|4|||
145435724|NCT01436110|524455160|FG000|Overall Study|Adverse Event|2|||
145435725|NCT01436110|524455161|FG001|Overall Study|Adverse Event|1|||
145435726|NCT01436110|524455162|FG002|Overall Study|Adverse Event|2|||
145435727|NCT01436110|524455160|FG000|Overall Study|Physician Decision|3|||
145435728|NCT01436110|524455161|FG001|Overall Study|Physician Decision|1|||
145435729|NCT01436110|524455162|FG002|Overall Study|Physician Decision|1|||
145435730|NCT01436110|524455160|FG000|Overall Study|Lost to Follow-up|1|||
145435731|NCT01436110|524455161|FG001|Overall Study|Lost to Follow-up|1|||
145435732|NCT01436110|524455162|FG002|Overall Study|Lost to Follow-up|3|||
145435733|NCT01436110|524455160|FG000|Overall Study|Protocol Violation|3|||
145435734|NCT01436110|524455161|FG001|Overall Study|Protocol Violation|1|||
145435735|NCT01436110|524455162|FG002|Overall Study|Protocol Violation|1|||
145435736|NCT01436110|524455160|FG000|Overall Study|Did Not Receive Trial Medication|1|||
145435737|NCT01436110|524455161|FG001|Overall Study|Did Not Receive Trial Medication|0|||
145435738|NCT01436110|524455162|FG002|Overall Study|Did Not Receive Trial Medication|3|||
145435739|NCT03273907|524455163|FG000|Overall Study|Death|1|||
145435740|NCT03273907|524455163|FG000|Overall Study|Lost to Follow-up|4|||
145435741|NCT03273907|524455163|FG000|Overall Study|Withdrawal by Subject|2|||
145435742|NCT03273907|524455163|FG000|Overall Study|COVID 19|2|||
145435743|NCT01088503|524455164|FG000|Overall Study|Withdrawal by Subject|118|||
145435744|NCT01088503|524455165|FG001|Overall Study|Withdrawal by Subject|327|||
145435745|NCT01088503|524455166|FG002|Overall Study|Withdrawal by Subject|10|||
145435746|NCT01088503|524455164|FG000|Overall Study|Death|64|||
145435747|NCT01088503|524455165|FG001|Overall Study|Death|358|||
145435748|NCT01088503|524455166|FG002|Overall Study|Death|7|||
145435749|NCT00110214|524455167|FG000|Overall Study|Never started treatment|21|||
145435750|NCT00110214|524455168|FG001|Overall Study|Never started treatment|20|||
145435751|NCT00110214|524455167|FG000|Overall Study|Disease progression or death|260|||
145435752|NCT00110214|524455168|FG001|Overall Study|Disease progression or death|151|||
145435753|NCT00110214|524455167|FG000|Overall Study|Adverse Event|115|||
145435754|NCT00110214|524455168|FG001|Overall Study|Adverse Event|192|||
145435755|NCT00110214|524455167|FG000|Overall Study|Refused further treatment|52|||
145435756|NCT00110214|524455168|FG001|Overall Study|Refused further treatment|65|||
145435757|NCT00110214|524455167|FG000|Overall Study|Other (not specified)|61|||
145435758|NCT00110214|524455168|FG001|Overall Study|Other (not specified)|75|||
145435759|NCT01847092|524455169|FG000|Overall Study|Adverse Event|12|||
145435760|NCT01847092|524455170|FG001|Overall Study|Adverse Event|3|||
145435761|NCT01847092|524455169|FG000|Overall Study|Withdrawal by Subject|5|||
145435762|NCT01847092|524455170|FG001|Overall Study|Withdrawal by Subject|5|||
145435763|NCT01847092|524455169|FG000|Overall Study|Protocol Specified|8|||
145435764|NCT01847092|524455170|FG001|Overall Study|Protocol Specified|0|||
145435765|NCT01847092|524455169|FG000|Overall Study|Physician Decision|1|||
145435766|NCT01847092|524455170|FG001|Overall Study|Physician Decision|1|||
145435767|NCT01847092|524455169|FG000|Overall Study|Protocol Violation|0|||
145435768|NCT01847092|524455170|FG001|Overall Study|Protocol Violation|2|||
145435769|NCT03604497|524455172|FG000|Overall Study|Protocol Violation|52|||
145435770|NCT00811954|524455173|FG000|Overall Study|Death|10|||
145435771|NCT00811954|524455174|FG001|Overall Study|Death|6|||
145435772|NCT00811954|524455175|FG002|Overall Study|Death|13|||
145435773|NCT00811954|524455173|FG000|Overall Study|Lost to Follow-up|29|||
145435774|NCT00811954|524455174|FG001|Overall Study|Lost to Follow-up|23|||
145435775|NCT00811954|524455175|FG002|Overall Study|Lost to Follow-up|34|||
145435776|NCT00811954|524455173|FG000|Overall Study|Not able to get to clinic|28|||
145435777|NCT00811954|524455174|FG001|Overall Study|Not able to get to clinic|35|||
145435778|NCT00811954|524455175|FG002|Overall Study|Not able to get to clinic|30|||
145435779|NCT00811954|524455173|FG000|Overall Study|Not willing to adhere to requirements|12|||
145435780|NCT00811954|524455174|FG001|Overall Study|Not willing to adhere to requirements|2|||
145435781|NCT00811954|524455175|FG002|Overall Study|Not willing to adhere to requirements|16|||
145435782|NCT00811954|524455173|FG000|Overall Study|Withdraw consent prior study completion|4|||
145435783|NCT00811954|524455174|FG001|Overall Study|Withdraw consent prior study completion|6|||
145435784|NCT00811954|524455175|FG002|Overall Study|Withdraw consent prior study completion|5|||
145435785|NCT00811954|524455173|FG000|Overall Study|Site Closure|4|||
145435786|NCT00811954|524455174|FG001|Overall Study|Site Closure|0|||
145435787|NCT00811954|524455175|FG002|Overall Study|Site Closure|1|||
145435788|NCT00811954|524455173|FG000|Overall Study|Severe Debilitation|2|||
145435789|NCT00811954|524455174|FG001|Overall Study|Severe Debilitation|0|||
145435790|NCT00811954|524455175|FG002|Overall Study|Severe Debilitation|1|||
145435791|NCT00811954|524455173|FG000|Overall Study|Complete Protocol: No follow-up|0|||
145435792|NCT00811954|524455174|FG001|Overall Study|Complete Protocol: No follow-up|0|||
145435793|NCT00811954|524455175|FG002|Overall Study|Complete Protocol: No follow-up|1|||
145435794|NCT01016067|524455176|FG000|Overall Study|Lost to Follow-up|1|||
145435795|NCT01016067|524455177|FG001|Overall Study|Lost to Follow-up|2|||
145435796|NCT01016067|524455176|FG000|Overall Study|Physician Decision|1|||
145435797|NCT01016067|524455177|FG001|Overall Study|Physician Decision|1|||
145435798|NCT01016067|524455176|FG000|Overall Study|Withdrew due to Relocation|0|||
145435799|NCT01016067|524455177|FG001|Overall Study|Withdrew due to Relocation|1|||
145624921|NCT04541186|525139727|FG004|Main Study|Investigator Decision|0|||
145435800|NCT00186628|524455179|FG000|Overall Study|Death|2|||
145435801|NCT00186628|524455179|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
145435802|NCT04828707|524455182|FG000|Overall Study|Lost to Follow-up|3|||
145435803|NCT04828707|524455183|FG001|Overall Study|Lost to Follow-up|2|||
145435804|NCT04828707|524455182|FG000|Overall Study|Withdrawal by Subject|2|||
145435805|NCT04828707|524455183|FG001|Overall Study|Withdrawal by Subject|1|||
145435806|NCT00501644|524455186|FG000|Overall Study|Adverse Event|4|||
145435807|NCT00501644|524455186|FG000|Overall Study|Withdrawal by Subject|1|||
145435808|NCT02394561|524455187|FG000|CORE Phase|Adverse Event|7|||
145435809|NCT02394561|524455188|FG001|CORE Phase|Adverse Event|9|||
145624922|NCT04541186|525139723|FG000|Main Study|Withdrawal by Subject|1|||
145435810|NCT02394561|524455187|FG000|CORE Phase|Death|0|||
145624923|NCT04541186|525139724|FG001|Main Study|Withdrawal by Subject|1|||
145435811|NCT02394561|524455188|FG001|CORE Phase|Death|1|||
145435812|NCT02394561|524455187|FG000|CORE Phase|Pregnancy|1|||
145435813|NCT02394561|524455188|FG001|CORE Phase|Pregnancy|0|||
145435814|NCT02394561|524455187|FG000|CORE Phase|Lost to Follow-up|1|||
145435815|NCT02394561|524455188|FG001|CORE Phase|Lost to Follow-up|0|||
145435816|NCT02394561|524455187|FG000|CORE Phase|Physician Decision|1|||
145435817|NCT02394561|524455188|FG001|CORE Phase|Physician Decision|1|||
145435818|NCT02394561|524455187|FG000|CORE Phase|Withdrawal by Subject|2|||
145435819|NCT02394561|524455188|FG001|CORE Phase|Withdrawal by Subject|2|||
145435820|NCT02394561|524455187|FG000|CORE Phase|Lack of Efficacy|1|||
145435821|NCT02394561|524455188|FG001|CORE Phase|Lack of Efficacy|6|||
145435822|NCT02394561|524455187|FG000|Extension Phase|Adverse Event|6|||
145435823|NCT02394561|524455188|FG001|Extension Phase|Adverse Event|1|||
145435824|NCT02394561|524455187|FG000|Extension Phase|Death|0|||
145435825|NCT02394561|524455188|FG001|Extension Phase|Death|1|||
145435826|NCT02394561|524455187|FG000|Extension Phase|Protocol Violation|1|||
145435827|NCT02394561|524455188|FG001|Extension Phase|Protocol Violation|0|||
145435828|NCT02394561|524455187|FG000|Extension Phase|Lost to Follow-up|1|||
145435829|NCT02394561|524455188|FG001|Extension Phase|Lost to Follow-up|0|||
145435830|NCT02394561|524455187|FG000|Extension Phase|Physician Decision|0|||
145435831|NCT02394561|524455188|FG001|Extension Phase|Physician Decision|2|||
145435832|NCT02394561|524455187|FG000|Extension Phase|Withdrawal by Subject|0|||
145435833|NCT02394561|524455188|FG001|Extension Phase|Withdrawal by Subject|5|||
145435834|NCT02394561|524455187|FG000|Extension Phase|Lack of Efficacy|3|||
145435835|NCT02394561|524455188|FG001|Extension Phase|Lack of Efficacy|3|||
145435836|NCT02553629|524455189|FG000|Overall Study|Logistic reasons|3|||
145435837|NCT02553629|524455190|FG001|Overall Study|Logistic reasons|6|||
145435838|NCT00696878|524455193|FG000|Overall Study|Adverse Event|8|||
145435839|NCT00696878|524455193|FG000|Overall Study|Withdrawal by Subject|87|||
145435840|NCT00696878|524455193|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
145435841|NCT00696878|524455193|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
145435842|NCT00696878|524455193|FG000|Overall Study|Trial stopped|32|||
145435843|NCT00696878|524455193|FG000|Overall Study|Other reason (not specified)|55|||
145435844|NCT02259114|524455198|FG000|Overall Study|Progressive Disease|14|||
145435845|NCT02259114|524455199|FG001|Overall Study|Progressive Disease|2|||
145435846|NCT02259114|524455200|FG002|Overall Study|Progressive Disease|10|||
145435847|NCT02259114|524455201|FG003|Overall Study|Progressive Disease|2|||
145435848|NCT02259114|524455202|FG004|Overall Study|Progressive Disease|5|||
145435849|NCT02259114|524455198|FG000|Overall Study|Adverse Event|2|||
145435850|NCT02259114|524455199|FG001|Overall Study|Adverse Event|1|||
145435851|NCT02259114|524455200|FG002|Overall Study|Adverse Event|0|||
145435852|NCT02259114|524455201|FG003|Overall Study|Adverse Event|0|||
145435853|NCT02259114|524455202|FG004|Overall Study|Adverse Event|1|||
145435854|NCT02259114|524455198|FG000|Overall Study|Death|3|||
145435855|NCT02259114|524455199|FG001|Overall Study|Death|0|||
145435856|NCT02259114|524455200|FG002|Overall Study|Death|1|||
145435857|NCT02259114|524455201|FG003|Overall Study|Death|0|||
145435858|NCT02259114|524455202|FG004|Overall Study|Death|0|||
145435859|NCT02259114|524455198|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
145435860|NCT02259114|524455199|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
145435861|NCT02259114|524455200|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
145435862|NCT02259114|524455201|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
145435863|NCT02259114|524455202|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
145435864|NCT02259114|524455198|FG000|Overall Study|Withdrawal by Subject|0|||
145435865|NCT02259114|524455199|FG001|Overall Study|Withdrawal by Subject|0|||
145435866|NCT02259114|524455200|FG002|Overall Study|Withdrawal by Subject|1|||
145435867|NCT02259114|524455201|FG003|Overall Study|Withdrawal by Subject|1|||
145435868|NCT02259114|524455202|FG004|Overall Study|Withdrawal by Subject|0|||
145435869|NCT02259114|524455198|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
145435870|NCT02259114|524455199|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
145435871|NCT02259114|524455200|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
145435872|NCT02259114|524455201|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
145435873|NCT02259114|524455202|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
145435874|NCT02259114|524455198|FG000|Overall Study|Not Treated|1|||
145583599|NCT00575588|524989390|FG001|Overall Study|Safety reasons|1|||
145583600|NCT00575588|524989389|FG000|Overall Study|Elevated triglyceride|1|||
145583601|NCT00575588|524989390|FG001|Overall Study|Elevated triglyceride|0|||
145583602|NCT00575588|524989389|FG000|Overall Study|Patient moved|1|||
145583603|NCT00575588|524989390|FG001|Overall Study|Patient moved|3|||
145435875|NCT02259114|524455199|FG001|Overall Study|Not Treated|0|||
145435876|NCT02259114|524455200|FG002|Overall Study|Not Treated|0|||
145435877|NCT02259114|524455201|FG003|Overall Study|Not Treated|0|||
145435878|NCT02259114|524455202|FG004|Overall Study|Not Treated|0|||
145435879|NCT03937479|524455203|FG000|Overall Study|Adverse Event|2|||
145435880|NCT03937479|524455204|FG001|Overall Study|Adverse Event|3|||
145435881|NCT03937479|524455205|FG002|Overall Study|Adverse Event|0|||
145435882|NCT03937479|524455206|FG003|Overall Study|Adverse Event|0|||
145435883|NCT03937479|524455207|FG004|Overall Study|Adverse Event|1|||
145435884|NCT03937479|524455203|FG000|Overall Study|Withdrawal by Subject|3|||
145435885|NCT03937479|524455204|FG001|Overall Study|Withdrawal by Subject|5|||
145435886|NCT03937479|524455205|FG002|Overall Study|Withdrawal by Subject|2|||
145435887|NCT03937479|524455206|FG003|Overall Study|Withdrawal by Subject|2|||
145435888|NCT03937479|524455207|FG004|Overall Study|Withdrawal by Subject|1|||
145435889|NCT03937479|524455203|FG000|Overall Study|Protocol Violation|5|||
145435890|NCT03937479|524455204|FG001|Overall Study|Protocol Violation|6|||
145435891|NCT03937479|524455205|FG002|Overall Study|Protocol Violation|4|||
145435892|NCT03937479|524455206|FG003|Overall Study|Protocol Violation|3|||
145435893|NCT03937479|524455207|FG004|Overall Study|Protocol Violation|2|||
145435894|NCT03937479|524455203|FG000|Overall Study|Lost to Follow-up|0|||
145435895|NCT03937479|524455204|FG001|Overall Study|Lost to Follow-up|1|||
145435896|NCT03937479|524455205|FG002|Overall Study|Lost to Follow-up|0|||
145435897|NCT03937479|524455206|FG003|Overall Study|Lost to Follow-up|1|||
145435898|NCT03937479|524455207|FG004|Overall Study|Lost to Follow-up|0|||
145435899|NCT03937479|524455203|FG000|Overall Study|Physician Decision|0|||
145435900|NCT03937479|524455204|FG001|Overall Study|Physician Decision|0|||
145435901|NCT03937479|524455205|FG002|Overall Study|Physician Decision|1|||
145435902|NCT03937479|524455206|FG003|Overall Study|Physician Decision|0|||
145435903|NCT03937479|524455207|FG004|Overall Study|Physician Decision|1|||
145435904|NCT00940602|524455211|FG000|Overall Study|Administrative problems|1|||
145435905|NCT00940602|524455212|FG001|Overall Study|Administrative problems|1|||
145435906|NCT00940602|524455211|FG000|Overall Study|Patient/guardian decision|13|||
145435907|NCT00940602|524455212|FG001|Overall Study|Patient/guardian decision|28|||
145435908|NCT00940602|524455211|FG000|Overall Study|Physician Decision|8|||
145435909|NCT00940602|524455212|FG001|Overall Study|Physician Decision|5|||
145435910|NCT00940602|524455211|FG000|Overall Study|Pregnancy|1|||
145435911|NCT00940602|524455212|FG001|Overall Study|Pregnancy|0|||
145435912|NCT00940602|524455211|FG000|Overall Study|Protocol Deviation (untreated)|1|||
145435913|NCT00940602|524455212|FG001|Overall Study|Protocol Deviation (untreated)|0|||
145435914|NCT00940602|524455211|FG000|Overall Study|Disease progression|8|||
145435915|NCT00940602|524455212|FG001|Overall Study|Disease progression|2|||
145435916|NCT00940602|524455211|FG000|Overall Study|Death|38|||
145435917|NCT00940602|524455212|FG001|Overall Study|Death|19|||
145435918|NCT00940602|524455211|FG000|Overall Study|Lost to Follow-up|3|||
145435919|NCT00940602|524455212|FG001|Overall Study|Lost to Follow-up|1|||
145435920|NCT00940602|524455211|FG000|Overall Study|Patient withdrew consent|26|||
145435921|NCT00940602|524455212|FG001|Overall Study|Patient withdrew consent|13|||
145435922|NCT00940602|524455211|FG000|Overall Study|Adverse Event|7|||
145435923|NCT00940602|524455212|FG001|Overall Study|Adverse Event|2|||
145435924|NCT00940602|524455211|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
145435925|NCT00940602|524455212|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
145435926|NCT03768427|524455213|FG000|Overall Study|Death|0|||
145435927|NCT03768427|524455214|FG001|Overall Study|Death|0|||
145435928|NCT03768427|524455215|FG002|Overall Study|Death|1|||
145435929|NCT03768427|524455216|FG003|Overall Study|Death|0|||
145435930|NCT03768427|524455213|FG000|Overall Study|Lost to Follow-up|2|||
145435931|NCT03768427|524455214|FG001|Overall Study|Lost to Follow-up|0|||
145435932|NCT03768427|524455215|FG002|Overall Study|Lost to Follow-up|0|||
145435933|NCT03768427|524455216|FG003|Overall Study|Lost to Follow-up|0|||
145435934|NCT03768427|524455213|FG000|Overall Study|Physician Decision|3|||
145435935|NCT03768427|524455214|FG001|Overall Study|Physician Decision|2|||
145435936|NCT03768427|524455215|FG002|Overall Study|Physician Decision|4|||
145435937|NCT03768427|524455216|FG003|Overall Study|Physician Decision|4|||
145435938|NCT03768427|524455213|FG000|Overall Study|Withdrawal by Subject|7|||
145435939|NCT03768427|524455214|FG001|Overall Study|Withdrawal by Subject|2|||
145435940|NCT03768427|524455215|FG002|Overall Study|Withdrawal by Subject|6|||
145435941|NCT03768427|524455216|FG003|Overall Study|Withdrawal by Subject|7|||
145435942|NCT01644643|524455219|FG000|Overall Study|Death|1|||
145435943|NCT01644643|524455220|FG001|Overall Study|Death|0|||
145435944|NCT01644643|524455221|FG002|Overall Study|Death|3|||
145435945|NCT01644643|524455222|FG003|Overall Study|Death|3|||
145435946|NCT01644643|524455219|FG000|Overall Study|Lost to Follow-up|0|||
145435947|NCT01644643|524455220|FG001|Overall Study|Lost to Follow-up|0|||
145435948|NCT01644643|524455221|FG002|Overall Study|Lost to Follow-up|0|||
145435949|NCT01644643|524455222|FG003|Overall Study|Lost to Follow-up|4|||
145435950|NCT01644643|524455219|FG000|Overall Study|Withdrawal by Subject|1|||
145435951|NCT01644643|524455220|FG001|Overall Study|Withdrawal by Subject|0|||
145435952|NCT01644643|524455221|FG002|Overall Study|Withdrawal by Subject|2|||
145435953|NCT01644643|524455222|FG003|Overall Study|Withdrawal by Subject|1|||
145435954|NCT01644643|524455219|FG000|Overall Study|Other Eligibility criteria|0|||
145435955|NCT01644643|524455220|FG001|Overall Study|Other Eligibility criteria|0|||
145435956|NCT01644643|524455221|FG002|Overall Study|Other Eligibility criteria|0|||
145435957|NCT01644643|524455222|FG003|Overall Study|Other Eligibility criteria|2|||
145435958|NCT02756403|524455223|FG000|Overall Study|Unable to swallow medication|0|||
145435959|NCT02756403|524455224|FG001|Overall Study|Unable to swallow medication|1|||
145435960|NCT02756403|524455225|FG002|Overall Study|Unable to swallow medication|1|||
145435961|NCT02756403|524455226|FG003|Overall Study|Unable to swallow medication|1|||
145435962|NCT02756403|524455223|FG000|Overall Study|Did not complete Procedure|0|||
145435963|NCT02756403|524455224|FG001|Overall Study|Did not complete Procedure|1|||
145435964|NCT02756403|524455225|FG002|Overall Study|Did not complete Procedure|0|||
145435965|NCT02756403|524455226|FG003|Overall Study|Did not complete Procedure|0|||
145435966|NCT02756403|524455223|FG000|Overall Study|Changed Mind About Procedure|0|||
145435967|NCT02756403|524455224|FG001|Overall Study|Changed Mind About Procedure|0|||
145435968|NCT02756403|524455225|FG002|Overall Study|Changed Mind About Procedure|1|||
145435969|NCT02756403|524455226|FG003|Overall Study|Changed Mind About Procedure|0|||
145435970|NCT02756403|524455223|FG000|Overall Study|Protocol Violation|0|||
145435971|NCT02756403|524455224|FG001|Overall Study|Protocol Violation|1|||
145435972|NCT02756403|524455225|FG002|Overall Study|Protocol Violation|0|||
145435973|NCT02756403|524455226|FG003|Overall Study|Protocol Violation|1|||
145435974|NCT00776789|524455229|FG000|Overall Study|Consent refusal|2|||
145435975|NCT00776789|524455230|FG001|Overall Study|Consent refusal|2|||
145435976|NCT00776789|524455229|FG000|Overall Study|Poor quality video|1|||
145435977|NCT00776789|524455230|FG001|Overall Study|Poor quality video|1|||
145435978|NCT02765399|524455235|FG000|Overall Study|Nausea|1|||
145435979|NCT02765399|524455236|FG001|Overall Study|Nausea|0|||
145435980|NCT00120627|524455241|FG000|Overall Study|Withdrawal by Subject|5|||
145435981|NCT00120627|524455242|FG001|Overall Study|Withdrawal by Subject|5|||
145435982|NCT04016714|524455243|FG000|Overall Study|Death|1|||
145435983|NCT04016714|524455244|FG001|Overall Study|Death|0|||
145435984|NCT04016714|524455243|FG000|Overall Study|Lost to Follow-up|3|||
145435985|NCT04016714|524455244|FG001|Overall Study|Lost to Follow-up|1|||
145435986|NCT04016714|524455243|FG000|Overall Study|Physician Decision|3|||
145435987|NCT04016714|524455244|FG001|Overall Study|Physician Decision|3|||
145435988|NCT04016714|524455243|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
145435989|NCT04016714|524455244|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
145435990|NCT01677988|524455249|FG000|Overall Study|Lack of Efficacy|2|||
145435991|NCT00271544|524455253|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
145435992|NCT00271544|524455253|FG000|Overall Study|Model 4196 lead not attempted|9|||
145435993|NCT00271544|524455253|FG000|Overall Study|Implant not attempted|4|||
145435994|NCT00165789|524455254|FG000|Overall Study|Adverse Event|0|||
145435995|NCT00165789|524455255|FG001|Overall Study|Adverse Event|3|||
145435996|NCT00165789|524455256|FG002|Overall Study|Adverse Event|0|||
145435997|NCT00165789|524455257|FG003|Overall Study|Adverse Event|12|||
145435998|NCT00165789|524455254|FG000|Overall Study|Withdrawal by Subject|0|||
145435999|NCT00165789|524455255|FG001|Overall Study|Withdrawal by Subject|1|||
145436000|NCT00165789|524455256|FG002|Overall Study|Withdrawal by Subject|1|||
145436001|NCT00165789|524455257|FG003|Overall Study|Withdrawal by Subject|2|||
145436002|NCT01816048|524455258|FG000|Overall Study|Adverse Event|1|||
145436003|NCT01816048|524455258|FG000|Overall Study|Death|1|||
145624924|NCT04541186|525139725|FG002|Main Study|Withdrawal by Subject|0|||
145624925|NCT04541186|525139726|FG003|Main Study|Withdrawal by Subject|0|||
145624926|NCT04541186|525139727|FG004|Main Study|Withdrawal by Subject|0|||
145624927|NCT04541186|525139723|FG000|Main Study|COVID-19-related Dose Interruption|0|||
145624928|NCT04541186|525139724|FG001|Main Study|COVID-19-related Dose Interruption|0|||
145624929|NCT04541186|525139725|FG002|Main Study|COVID-19-related Dose Interruption|0|||
145624930|NCT04541186|525139726|FG003|Main Study|COVID-19-related Dose Interruption|0|||
145624931|NCT04541186|525139727|FG004|Main Study|COVID-19-related Dose Interruption|1|||
145624932|NCT04541186|525139723|FG000|Main Study|Randomized in Error Not Treated|0|||
145624933|NCT04541186|525139724|FG001|Main Study|Randomized in Error Not Treated|0|||
145624934|NCT04541186|525139725|FG002|Main Study|Randomized in Error Not Treated|1|||
145624935|NCT04541186|525139726|FG003|Main Study|Randomized in Error Not Treated|0|||
145624936|NCT04541186|525139727|FG004|Main Study|Randomized in Error Not Treated|0|||
145624937|NCT04541186|525139723|FG000|Fibrate Expansion Study|Other than Specified|0|||
145624938|NCT04541186|525139724|FG001|Fibrate Expansion Study|Other than Specified|0|||
145624939|NCT04541186|525139725|FG002|Fibrate Expansion Study|Other than Specified|0|||
145624940|NCT04541186|525139726|FG003|Fibrate Expansion Study|Other than Specified|0|||
145436004|NCT01816048|524455258|FG000|Overall Study|Withdrawal by Subject|1|||
145624941|NCT04541186|525139727|FG004|Fibrate Expansion Study|Other than Specified|1|||
145624942|NCT02256969|525139728|FG000|Overall Study|Screenfailed or withdrew|2|||
145624943|NCT02256969|525139729|FG001|Overall Study|Screenfailed or withdrew|1|||
145624944|NCT02256969|525139730|FG002|Overall Study|Screenfailed or withdrew|1|||
145624945|NCT00303303|525139736|FG000|Overall Study|Withdrawal by Subject|0|||
145624946|NCT00303303|525139737|FG001|Overall Study|Withdrawal by Subject|0|||
145624947|NCT00303303|525139738|FG002|Overall Study|Withdrawal by Subject|1|||
145624948|NCT03085017|525139739|FG000|Overall Study|Death|0|||
145624949|NCT03085017|525139740|FG001|Overall Study|Death|3|||
145436005|NCT01816048|524455258|FG000|Overall Study|Disease Progression|3|||
145436006|NCT04290624|524455259|FG000|Overall Study|Adverse Event|1|||
145436007|NCT04290624|524455260|FG001|Overall Study|Adverse Event|0|||
145436008|NCT01847443|524455261|FG000|Study Period 1|Withdrawal by Subject|0|||
145436009|NCT01847443|524455262|FG001|Study Period 1|Withdrawal by Subject|1|||
145436010|NCT01847443|524455263|FG002|Study Period 1|Withdrawal by Subject|0|||
145436011|NCT01847443|524455264|FG003|Study Period 1|Withdrawal by Subject|0|||
145624950|NCT00058058|525139742|FG000|Overall Study|Withdrawal by Subject|4|||
145436012|NCT01847443|524455261|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
145436013|NCT01847443|524455262|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
145436014|NCT01847443|524455263|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
145436015|NCT01847443|524455264|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
145436016|NCT01847443|524455261|FG000|Washout Period Before Study Period 2|Other reason|1|||
145436017|NCT01847443|524455262|FG001|Washout Period Before Study Period 2|Other reason|0|||
145436018|NCT01847443|524455263|FG002|Washout Period Before Study Period 2|Other reason|0|||
145436019|NCT01847443|524455264|FG003|Washout Period Before Study Period 2|Other reason|0|||
145436020|NCT01847443|524455261|FG000|Washout Period Before Study Period 3|Other reason|1|||
145436021|NCT01847443|524455262|FG001|Washout Period Before Study Period 3|Other reason|0|||
145436022|NCT01847443|524455263|FG002|Washout Period Before Study Period 3|Other reason|0|||
145436023|NCT01847443|524455264|FG003|Washout Period Before Study Period 3|Other reason|0|||
145436024|NCT01847443|524455261|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
145436025|NCT01847443|524455262|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
145436026|NCT01847443|524455263|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
145436027|NCT01847443|524455264|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
145436028|NCT01847443|524455261|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
145436029|NCT01847443|524455262|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
145436030|NCT01847443|524455263|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
145436031|NCT01847443|524455264|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
145436032|NCT03571971|524455265|FG000|Overall Study|Lost to Follow-up|2|||
145436033|NCT03571971|524455266|FG001|Overall Study|Lost to Follow-up|2|||
145436034|NCT03571971|524455265|FG000|Overall Study|Protocol Violation|2|||
145436035|NCT03571971|524455266|FG001|Overall Study|Protocol Violation|3|||
145436036|NCT03571971|524455265|FG000|Overall Study|Withdrawal by Subject|2|||
145436037|NCT03571971|524455266|FG001|Overall Study|Withdrawal by Subject|0|||
145436038|NCT03571971|524455265|FG000|Overall Study|Incomplete primary outcome data|2|||
145436039|NCT03571971|524455266|FG001|Overall Study|Incomplete primary outcome data|0|||
145436040|NCT04067492|524455267|FG000|Overall Study|Lost to Follow-up|0|||
145436041|NCT04067492|524455268|FG001|Overall Study|Lost to Follow-up|0|||
145436042|NCT04067492|524455269|FG002|Overall Study|Lost to Follow-up|0|||
145436043|NCT04067492|524455270|FG003|Overall Study|Lost to Follow-up|0|||
145436044|NCT04067492|524455271|FG004|Overall Study|Lost to Follow-up|0|||
145436045|NCT04067492|524455272|FG005|Overall Study|Lost to Follow-up|1|||
145436046|NCT04067492|524455267|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
145436047|NCT04067492|524455268|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
145436048|NCT04067492|524455269|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
145436049|NCT04067492|524455270|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
145436050|NCT04067492|524455271|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
145436051|NCT04067492|524455272|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
145436052|NCT04067492|524455267|FG000|Overall Study|COVID-19 epidemiological situation|0|||
145436053|NCT04067492|524455268|FG001|Overall Study|COVID-19 epidemiological situation|0|||
145436054|NCT04067492|524455269|FG002|Overall Study|COVID-19 epidemiological situation|0|||
145436055|NCT04067492|524455270|FG003|Overall Study|COVID-19 epidemiological situation|1|||
145436056|NCT04067492|524455271|FG004|Overall Study|COVID-19 epidemiological situation|0|||
145436057|NCT04067492|524455272|FG005|Overall Study|COVID-19 epidemiological situation|0|||
145436058|NCT03950856|524455280|FG000|Overall Study|Death|1|||
145436059|NCT03950856|524455281|FG001|Overall Study|Death|2|||
145436060|NCT03950856|524455282|FG002|Overall Study|Death|0|||
145436061|NCT03950856|524455283|FG003|Overall Study|Death|0|||
145436062|NCT03950856|524455280|FG000|Overall Study|Lost to Follow-up|5|||
145436063|NCT03950856|524455281|FG001|Overall Study|Lost to Follow-up|6|||
145436064|NCT03950856|524455282|FG002|Overall Study|Lost to Follow-up|8|||
145436065|NCT03950856|524455283|FG003|Overall Study|Lost to Follow-up|2|||
145436066|NCT03950856|524455280|FG000|Overall Study|Protocol Violation|2|||
145436067|NCT03950856|524455281|FG001|Overall Study|Protocol Violation|0|||
145436068|NCT03950856|524455282|FG002|Overall Study|Protocol Violation|0|||
145436069|NCT03950856|524455283|FG003|Overall Study|Protocol Violation|1|||
145436070|NCT03950856|524455280|FG000|Overall Study|Withdrawal by Subject|4|||
145436071|NCT03950856|524455281|FG001|Overall Study|Withdrawal by Subject|1|||
145436072|NCT03950856|524455282|FG002|Overall Study|Withdrawal by Subject|3|||
145436073|NCT03950856|524455283|FG003|Overall Study|Withdrawal by Subject|1|||
145436074|NCT03950856|524455280|FG000|Overall Study|Unable to phone|7|||
145436075|NCT03950856|524455281|FG001|Overall Study|Unable to phone|6|||
145436076|NCT03950856|524455282|FG002|Overall Study|Unable to phone|7|||
145436077|NCT03950856|524455283|FG003|Overall Study|Unable to phone|2|||
145436078|NCT00656370|524455284|FG000|Overall Study|Screen Failures|7|||
145436079|NCT00656370|524455284|FG000|Overall Study|Alternates|3|||
145436080|NCT03391882|524455285|FG000|Study Overall|Adverse Event|3|||
145436081|NCT03391882|524455286|FG001|Study Overall|Adverse Event|6|||
145436082|NCT03391882|524455287|FG002|Study Overall|Adverse Event|1|||
145624951|NCT00058058|525139742|FG000|Overall Study|Ineligible|20|||
145624952|NCT00058058|525139742|FG000|Overall Study|Claustrophobic|5|||
145436083|NCT03391882|524455288|FG003|Study Overall|Adverse Event|1|||
145436084|NCT03391882|524455289|FG004|Study Overall|Adverse Event|3|||
145436085|NCT03391882|524455290|FG005|Study Overall|Adverse Event|1|||
145436086|NCT03391882|524455285|FG000|Study Overall|Lack of Efficacy|13|||
145436087|NCT03391882|524455286|FG001|Study Overall|Lack of Efficacy|9|||
145436088|NCT03391882|524455287|FG002|Study Overall|Lack of Efficacy|0|||
145436089|NCT03391882|524455288|FG003|Study Overall|Lack of Efficacy|0|||
145436090|NCT03391882|524455289|FG004|Study Overall|Lack of Efficacy|0|||
145436091|NCT03391882|524455290|FG005|Study Overall|Lack of Efficacy|0|||
145436092|NCT03391882|524455285|FG000|Study Overall|Withdrawal by Subject|3|||
145436093|NCT03391882|524455286|FG001|Study Overall|Withdrawal by Subject|3|||
145436094|NCT03391882|524455287|FG002|Study Overall|Withdrawal by Subject|2|||
145436095|NCT03391882|524455288|FG003|Study Overall|Withdrawal by Subject|2|||
145436096|NCT03391882|524455289|FG004|Study Overall|Withdrawal by Subject|1|||
145436097|NCT03391882|524455290|FG005|Study Overall|Withdrawal by Subject|3|||
145436098|NCT03391882|524455285|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
145436099|NCT03391882|524455286|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
145436100|NCT03391882|524455287|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
145436101|NCT03391882|524455288|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
145436102|NCT03391882|524455289|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
145436103|NCT03391882|524455290|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
145436104|NCT03391882|524455285|FG000|Study Overall|Protocol Violation|1|||
145436105|NCT03391882|524455286|FG001|Study Overall|Protocol Violation|0|||
145436106|NCT03391882|524455287|FG002|Study Overall|Protocol Violation|0|||
145436107|NCT03391882|524455288|FG003|Study Overall|Protocol Violation|0|||
145436108|NCT03391882|524455289|FG004|Study Overall|Protocol Violation|0|||
145436109|NCT03391882|524455290|FG005|Study Overall|Protocol Violation|0|||
145436110|NCT03391882|524455285|FG000|Part A - Titration Phase|Adverse Event|3|||
145436111|NCT03391882|524455286|FG001|Part A - Titration Phase|Adverse Event|6|||
145436112|NCT03391882|524455287|FG002|Part A - Titration Phase|Adverse Event|0|||
145436113|NCT03391882|524455288|FG003|Part A - Titration Phase|Adverse Event|0|||
145436114|NCT03391882|524455289|FG004|Part A - Titration Phase|Adverse Event|0|||
145436115|NCT03391882|524455290|FG005|Part A - Titration Phase|Adverse Event|0|||
145436116|NCT03391882|524455285|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
145436117|NCT03391882|524455286|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
145436118|NCT03391882|524455287|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
145436119|NCT03391882|524455288|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
145436120|NCT03391882|524455289|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
145436121|NCT03391882|524455290|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
145436122|NCT03391882|524455285|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
145436123|NCT03391882|524455286|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
145436124|NCT03391882|524455287|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
145436125|NCT03391882|524455288|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
145436126|NCT03391882|524455289|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
145436127|NCT03391882|524455290|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
145436128|NCT03391882|524455285|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
145436129|NCT03391882|524455286|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
145436130|NCT03391882|524455287|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
145436131|NCT03391882|524455288|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
145436132|NCT03391882|524455289|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
145436133|NCT03391882|524455290|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
145436134|NCT03391882|524455285|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
145436135|NCT03391882|524455286|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
145436136|NCT03391882|524455287|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
145436137|NCT03391882|524455288|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
145436138|NCT03391882|524455289|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
145436139|NCT03391882|524455290|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
145436140|NCT03391882|524455285|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
145436141|NCT03391882|524455286|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
145436142|NCT03391882|524455287|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
145436143|NCT03391882|524455288|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
145436144|NCT03391882|524455289|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
145436145|NCT03391882|524455290|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
145436146|NCT03391882|524455285|FG000|Part B - Treatment Phase|Adverse Event|0|||
145436147|NCT03391882|524455286|FG001|Part B - Treatment Phase|Adverse Event|0|||
145436148|NCT03391882|524455287|FG002|Part B - Treatment Phase|Adverse Event|1|||
145436149|NCT03391882|524455288|FG003|Part B - Treatment Phase|Adverse Event|1|||
145436150|NCT03391882|524455289|FG004|Part B - Treatment Phase|Adverse Event|3|||
145436151|NCT03391882|524455290|FG005|Part B - Treatment Phase|Adverse Event|1|||
145436152|NCT03391882|524455285|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
145436153|NCT03391882|524455286|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
145436154|NCT03391882|524455287|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
145436155|NCT03391882|524455288|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
145436156|NCT03391882|524455289|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
145624953|NCT00058058|525139742|FG000|Overall Study|technical issues|6|||
145624954|NCT00058058|525139742|FG000|Overall Study|Poor positioning, illness,pain|3|||
145624955|NCT02374957|525139746|FG000|Overall Study|Patient did not complete forms correctly|1|||
145624956|NCT02374957|525139747|FG001|Overall Study|Patient did not complete forms correctly|0|||
145624957|NCT00748969|525139748|FG000|Overall Study|Withdrawal by Subject|1|||
145624958|NCT00748969|525139749|FG001|Overall Study|Withdrawal by Subject|0|||
145624959|NCT00748969|525139748|FG000|Overall Study|Withdrawal by Subject|0|||
145624960|NCT00748969|525139749|FG001|Overall Study|Withdrawal by Subject|1|||
145624961|NCT00972543|525139750|FG000|Overall Study|Adverse Event|1|||
145624962|NCT00972543|525139751|FG001|Overall Study|Adverse Event|0|||
145624963|NCT00972543|525139750|FG000|Overall Study|Early study termination by sponsor|4|||
145624964|NCT00972543|525139751|FG001|Overall Study|Early study termination by sponsor|1|||
145624965|NCT03255941|525139752|FG000|Overall Study|Not eligible or refused injection|37|||
145624966|NCT03255941|525139753|FG001|Overall Study|Not eligible or refused injection|44|||
145624967|NCT03255941|525139754|FG002|Overall Study|Not eligible or refused injection|5|||
145624968|NCT03255941|525139755|FG003|Overall Study|Not eligible or refused injection|6|||
145624969|NCT03255941|525139752|FG000|Overall Study|Did not complete exit interview|1|||
145624970|NCT03255941|525139753|FG001|Overall Study|Did not complete exit interview|2|||
145624971|NCT03255941|525139754|FG002|Overall Study|Did not complete exit interview|0|||
145624972|NCT03255941|525139755|FG003|Overall Study|Did not complete exit interview|0|||
145624973|NCT01004263|525139756|FG000|Overall Study|Adverse Event|15|||
145624974|NCT01004263|525139756|FG000|Overall Study|Withdrawal by Subject|58|||
145624975|NCT01004263|525139756|FG000|Overall Study|Protocol Violation|10|||
145624976|NCT01004263|525139756|FG000|Overall Study|Lost to Follow-up|64|||
145624977|NCT01004263|525139756|FG000|Overall Study|Lack of Efficacy|13|||
145624978|NCT01004263|525139756|FG000|Overall Study|Pregnancy|2|||
145624979|NCT01004263|525139756|FG000|Overall Study|Physician Decision|15|||
145624980|NCT01004263|525139756|FG000|Overall Study|Lack of Qualifying Event|2|||
145624981|NCT02478359|525139757|FG000|Overall Study|Disenrolled from health plan|106|||
145624982|NCT02478359|525139758|FG001|Overall Study|Disenrolled from health plan|65|||
145624983|NCT00372528|525139759|FG000|Overall Study|Lack of Efficacy|1|||
145624984|NCT00372528|525139759|FG000|Overall Study|Adverse Event|1|||
145624985|NCT00372528|525139759|FG000|Overall Study|Study Terminated by Sponsor|18|||
145624986|NCT00372528|525139759|FG000|Overall Study|Other|1|||
145624987|NCT05124899|525139760|FG000|Overall Study|Lost to Follow-up|3|||
145624988|NCT03432533|525139761|FG000|Overall Study|Lost to Follow-up|1|||
145624989|NCT03432533|525139762|FG001|Overall Study|Lost to Follow-up|2|||
145624990|NCT03432533|525139761|FG000|Overall Study|Withdrawal by Subject|14|||
145624991|NCT03432533|525139762|FG001|Overall Study|Withdrawal by Subject|9|||
145624992|NCT00797225|525139765|FG000|Weeks 1 to 12|Adverse Event|0|||
145624993|NCT00797225|525139766|FG001|Weeks 1 to 12|Adverse Event|0|||
145624994|NCT00797225|525139767|FG002|Weeks 1 to 12|Adverse Event|1|||
145624995|NCT00797225|525139768|FG003|Weeks 1 to 12|Adverse Event|0|||
145624996|NCT00797225|525139769|FG004|Weeks 1 to 12|Adverse Event|0|||
145624997|NCT00797225|525139770|FG005|Weeks 1 to 12|Adverse Event|0|||
145624998|NCT00797225|525139771|FG006|Weeks 1 to 12|Adverse Event|0|||
145624999|NCT00797225|525139772|FG007|Weeks 1 to 12|Adverse Event|0|||
145625000|NCT00797225|525139765|FG000|Weeks 1 to 12|Non-compliance|0|||
145625001|NCT00797225|525139766|FG001|Weeks 1 to 12|Non-compliance|1|||
145625002|NCT00797225|525139767|FG002|Weeks 1 to 12|Non-compliance|0|||
145436157|NCT03391882|524455290|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
145436158|NCT00543985|524455291|FG000|Overall Study|Withdrawal by Subject|4|||
145436159|NCT01280968|524455292|FG000|Overall Study|Lost to Follow-up|8|||
145436160|NCT01280968|524455293|FG001|Overall Study|Lost to Follow-up|2|||
145436161|NCT01280968|524455292|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
145436162|NCT01280968|524455293|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
145436163|NCT01280968|524455292|FG000|Overall Study|Commuting Problems|2|||
145436164|NCT01280968|524455293|FG001|Overall Study|Commuting Problems|0|||
145436165|NCT01280968|524455292|FG000|Overall Study|Anxiety|2|||
145436166|NCT01280968|524455293|FG001|Overall Study|Anxiety|0|||
145436167|NCT01280968|524455292|FG000|Overall Study|Adverse Event|1|||
145436168|NCT01280968|524455293|FG001|Overall Study|Adverse Event|0|||
145436169|NCT01280968|524455292|FG000|Overall Study|Scheduling Conflicts|1|||
145625003|NCT00797225|525139768|FG003|Weeks 1 to 12|Non-compliance|0|||
145625004|NCT00797225|525139769|FG004|Weeks 1 to 12|Non-compliance|0|||
145625005|NCT00797225|525139770|FG005|Weeks 1 to 12|Non-compliance|0|||
145625006|NCT00797225|525139771|FG006|Weeks 1 to 12|Non-compliance|0|||
145625007|NCT00797225|525139772|FG007|Weeks 1 to 12|Non-compliance|0|||
145625008|NCT00797225|525139765|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
145625009|NCT00797225|525139766|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
145625010|NCT00797225|525139767|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
145625011|NCT00797225|525139768|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
145625012|NCT00797225|525139769|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
145625013|NCT00797225|525139770|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
145625014|NCT00797225|525139771|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
145625015|NCT00797225|525139772|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
145625016|NCT00797225|525139765|FG000|Weeks 1 to 12|Sponsor Decision|1|||
145625017|NCT00797225|525139766|FG001|Weeks 1 to 12|Sponsor Decision|0|||
145625018|NCT00797225|525139767|FG002|Weeks 1 to 12|Sponsor Decision|0|||
145436170|NCT01280968|524455293|FG001|Overall Study|Scheduling Conflicts|1|||
145436171|NCT01280968|524455292|FG000|Overall Study|Pre-existing Neurological Condition|1|||
145436172|NCT01280968|524455293|FG001|Overall Study|Pre-existing Neurological Condition|0|||
145436173|NCT01280968|524455292|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
145436174|NCT01280968|524455293|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
145436175|NCT00038948|524455294|FG000|Overall Study|Adverse Event|131|||
145436176|NCT00038948|524455295|FG001|Overall Study|Adverse Event|43|||
145436177|NCT00038948|524455294|FG000|Overall Study|Lost to Follow-up|4|||
145436178|NCT00038948|524455295|FG001|Overall Study|Lost to Follow-up|4|||
145436179|NCT00038948|524455294|FG000|Overall Study|Nonmedical event|5|||
145436180|NCT00038948|524455295|FG001|Overall Study|Nonmedical event|7|||
145436181|NCT00038948|524455294|FG000|Overall Study|Withdrawal by Subject|23|||
145436182|NCT00038948|524455295|FG001|Overall Study|Withdrawal by Subject|10|||
145436183|NCT00038948|524455294|FG000|Overall Study|Protocol Violation|3|||
145436184|NCT00038948|524455295|FG001|Overall Study|Protocol Violation|7|||
145436185|NCT00038948|524455294|FG000|Overall Study|Lack of Efficacy|3|||
145436186|NCT00038948|524455295|FG001|Overall Study|Lack of Efficacy|6|||
145436187|NCT02670473|524455296|FG000|Overall Study|Withdrawal by Subject|1|||
145436188|NCT01404234|524455297|FG000|Overall Study|Withdrawal by Subject|2|||
145436189|NCT01214837|524455298|FG000|Overall Study|Death|0|||
145436190|NCT01214837|524455299|FG001|Overall Study|Death|0|||
145436191|NCT01214837|524455300|FG002|Overall Study|Death|1|||
145436192|NCT01214837|524455298|FG000|Overall Study|Adverse Event|1|||
145436193|NCT01214837|524455299|FG001|Overall Study|Adverse Event|2|||
145436194|NCT01214837|524455300|FG002|Overall Study|Adverse Event|1|||
145436195|NCT01214837|524455298|FG000|Overall Study|Withdrawal by Subject|27|||
145436196|NCT01214837|524455299|FG001|Overall Study|Withdrawal by Subject|36|||
145436197|NCT01214837|524455300|FG002|Overall Study|Withdrawal by Subject|28|||
145436198|NCT01214837|524455298|FG000|Overall Study|Lost to Follow-up|20|||
145436199|NCT01214837|524455299|FG001|Overall Study|Lost to Follow-up|15|||
145436200|NCT01214837|524455300|FG002|Overall Study|Lost to Follow-up|21|||
145436201|NCT01214837|524455298|FG000|Overall Study|Inappropriate Enrolment|0|||
145436202|NCT01214837|524455299|FG001|Overall Study|Inappropriate Enrolment|1|||
145436203|NCT01214837|524455300|FG002|Overall Study|Inappropriate Enrolment|2|||
145436204|NCT01214837|524455298|FG000|Overall Study|Administrative Reason|2|||
145436205|NCT01214837|524455299|FG001|Overall Study|Administrative Reason|6|||
145436206|NCT01214837|524455300|FG002|Overall Study|Administrative Reason|4|||
145436207|NCT01214837|524455298|FG000|Overall Study|Protocol Violation|3|||
145436208|NCT01214837|524455299|FG001|Overall Study|Protocol Violation|1|||
145436209|NCT01214837|524455300|FG002|Overall Study|Protocol Violation|5|||
145436210|NCT01214837|524455298|FG000|Overall Study|Unable to Classify|1|||
145436211|NCT01214837|524455299|FG001|Overall Study|Unable to Classify|3|||
145436212|NCT01214837|524455300|FG002|Overall Study|Unable to Classify|0|||
145489784|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
145489785|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
145489786|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
145489787|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
145489788|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
145489789|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
145489790|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
145489791|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
145489792|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
145489793|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
145489794|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
145489795|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
145489796|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
145625019|NCT00797225|525139768|FG003|Weeks 1 to 12|Sponsor Decision|0|||
145625020|NCT00797225|525139769|FG004|Weeks 1 to 12|Sponsor Decision|0|||
145625021|NCT00797225|525139770|FG005|Weeks 1 to 12|Sponsor Decision|0|||
145489797|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
145489798|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
145489799|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
145489800|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
145489801|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
145489802|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
145489803|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
145489804|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
145625022|NCT00797225|525139771|FG006|Weeks 1 to 12|Sponsor Decision|0|||
145625023|NCT00797225|525139772|FG007|Weeks 1 to 12|Sponsor Decision|0|||
145625024|NCT00797225|525139765|FG000|Weeks 13 to 24|Non-compliance|0|||
145625025|NCT00797225|525139766|FG001|Weeks 13 to 24|Non-compliance|2|||
145625026|NCT00797225|525139767|FG002|Weeks 13 to 24|Non-compliance|0|||
145436213|NCT00272792|524456850|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
145436214|NCT00272792|524456851|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
145436215|NCT00272792|524456850|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
145436216|NCT00272792|524456851|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
145436217|NCT00272792|524456850|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
145436218|NCT00272792|524456851|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
145436219|NCT00272792|524456850|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
145436220|NCT00272792|524456851|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
145436221|NCT02332187|524456861|FG000|Overall Study|Withdrawal by Subject|2|||
145436222|NCT02332187|524456862|FG001|Overall Study|Withdrawal by Subject|2|||
145436223|NCT02332187|524456861|FG000|Overall Study|Adverse Event|0|||
145436224|NCT02332187|524456862|FG001|Overall Study|Adverse Event|1|||
145436225|NCT02391311|524456863|FG000|Overall Study|Lost to Follow-up|2|||
145436226|NCT02391311|524456864|FG001|Overall Study|Lost to Follow-up|1|||
145436227|NCT02391311|524456863|FG000|Overall Study|deemed ineligible after baseline|1|||
145436228|NCT02391311|524456864|FG001|Overall Study|deemed ineligible after baseline|1|||
145436229|NCT03183063|524456865|FG000|Overall Study|Withdrawal by Subject|2|||
145436230|NCT03183063|524456866|FG001|Overall Study|Withdrawal by Subject|0|||
145436231|NCT03183063|524456867|FG002|Overall Study|Withdrawal by Subject|0|||
145436232|NCT03183063|524456865|FG000|Overall Study|Physician Decision|3|||
145436233|NCT03183063|524456866|FG001|Overall Study|Physician Decision|4|||
145436234|NCT03183063|524456867|FG002|Overall Study|Physician Decision|4|||
145436235|NCT00688467|524456868|FG000|Treatment Period 1|Adverse Event|2|||
145436236|NCT00688467|524456869|FG001|Treatment Period 1|Adverse Event|1|||
145436237|NCT00688467|524456868|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
145436238|NCT00688467|524456869|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
145436239|NCT00688467|524456868|FG000|Treatment Period 2|Protocol Violation|0|||
145436240|NCT00688467|524456869|FG001|Treatment Period 2|Protocol Violation|1|||
145436241|NCT00688467|524456868|FG000|Treatment Period 2|Adverse Event|0|||
145436242|NCT00688467|524456869|FG001|Treatment Period 2|Adverse Event|1|||
145436243|NCT00077974|524456874|FG000|Overall Study|Adverse Event|22|||
145436244|NCT00077974|524456874|FG000|Overall Study|Protocol Violation|1|||
145436245|NCT00077974|524456874|FG000|Overall Study|Withdrawal by Subject|3|||
145436246|NCT00077974|524456874|FG000|Overall Study|Lack of Efficacy|76|||
145436247|NCT00077974|524456874|FG000|Overall Study|Decision of Sponsor|2|||
145436248|NCT01343888|524456875|FG000|Overall Study|Adverse Event|12|||
145436249|NCT01343888|524456876|FG001|Overall Study|Adverse Event|22|||
145436250|NCT01343888|524456877|FG002|Overall Study|Adverse Event|5|||
145436251|NCT01343888|524456875|FG000|Overall Study|Lack of Efficacy|9|||
145436252|NCT01343888|524456876|FG001|Overall Study|Lack of Efficacy|9|||
145436253|NCT01343888|524456877|FG002|Overall Study|Lack of Efficacy|13|||
145436254|NCT01343888|524456875|FG000|Overall Study|Lost to Follow-up|0|||
145436255|NCT01343888|524456876|FG001|Overall Study|Lost to Follow-up|2|||
145436256|NCT01343888|524456877|FG002|Overall Study|Lost to Follow-up|1|||
145436257|NCT01343888|524456875|FG000|Overall Study|Protocol Violation|0|||
145436258|NCT01343888|524456876|FG001|Overall Study|Protocol Violation|2|||
145436259|NCT01343888|524456877|FG002|Overall Study|Protocol Violation|0|||
145436260|NCT01343888|524456875|FG000|Overall Study|Withdrawal by Subject|4|||
145436261|NCT01343888|524456876|FG001|Overall Study|Withdrawal by Subject|4|||
145436262|NCT01343888|524456877|FG002|Overall Study|Withdrawal by Subject|2|||
145436263|NCT01343888|524456875|FG000|Overall Study|other than stated above|0|||
145436264|NCT01343888|524456876|FG001|Overall Study|other than stated above|0|||
145436265|NCT01343888|524456877|FG002|Overall Study|other than stated above|1|||
145436266|NCT04108273|524456883|FG000|Overall Study|COVID Pandemic|1|||
145436267|NCT04108273|524456884|FG001|Overall Study|COVID Pandemic|0|||
145436268|NCT01331681|524456892|FG000|Overall Study|Adverse Event|10|||
145436269|NCT01331681|524456893|FG001|Overall Study|Adverse Event|13|||
145625027|NCT00797225|525139768|FG003|Weeks 13 to 24|Non-compliance|0|||
145625028|NCT00797225|525139769|FG004|Weeks 13 to 24|Non-compliance|0|||
145625029|NCT00797225|525139770|FG005|Weeks 13 to 24|Non-compliance|0|||
145436270|NCT01331681|524456894|FG002|Overall Study|Adverse Event|10|||
145625030|NCT00797225|525139771|FG006|Weeks 13 to 24|Non-compliance|0|||
145625031|NCT00797225|525139772|FG007|Weeks 13 to 24|Non-compliance|0|||
145625032|NCT00797225|525139765|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
145625033|NCT00797225|525139766|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
145625034|NCT00797225|525139767|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
145625035|NCT00797225|525139768|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
145436271|NCT01331681|524456892|FG000|Overall Study|Death|6|||
145436272|NCT01331681|524456893|FG001|Overall Study|Death|6|||
145436273|NCT01331681|524456894|FG002|Overall Study|Death|2|||
145436274|NCT01331681|524456892|FG000|Overall Study|Lack of Efficacy|0|||
145436275|NCT01331681|524456893|FG001|Overall Study|Lack of Efficacy|1|||
145436276|NCT01331681|524456894|FG002|Overall Study|Lack of Efficacy|0|||
145436277|NCT01331681|524456892|FG000|Overall Study|Withdrawal by Subject|12|||
145436278|NCT01331681|524456893|FG001|Overall Study|Withdrawal by Subject|8|||
145436279|NCT01331681|524456894|FG002|Overall Study|Withdrawal by Subject|15|||
145625036|NCT00797225|525139769|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
145436280|NCT01331681|524456892|FG000|Overall Study|Protocol Violation|1|||
145436281|NCT01331681|524456893|FG001|Overall Study|Protocol Violation|1|||
145436282|NCT01331681|524456894|FG002|Overall Study|Protocol Violation|0|||
145436283|NCT01331681|524456892|FG000|Overall Study|Lost to Follow-up|2|||
145436284|NCT01331681|524456893|FG001|Overall Study|Lost to Follow-up|4|||
145436285|NCT01331681|524456894|FG002|Overall Study|Lost to Follow-up|1|||
145436286|NCT01331681|524456892|FG000|Overall Study|Physician Decision|2|||
145436287|NCT01331681|524456893|FG001|Overall Study|Physician Decision|0|||
145436288|NCT01331681|524456894|FG002|Overall Study|Physician Decision|4|||
145436289|NCT01331681|524456892|FG000|Overall Study|Therapeutic procedure required|1|||
145436290|NCT01331681|524456893|FG001|Overall Study|Therapeutic procedure required|0|||
145436291|NCT01331681|524456894|FG002|Overall Study|Therapeutic procedure required|0|||
145436292|NCT01331681|524456892|FG000|Overall Study|Sponsor decision|1|||
145436293|NCT01331681|524456893|FG001|Overall Study|Sponsor decision|1|||
145436294|NCT01331681|524456894|FG002|Overall Study|Sponsor decision|0|||
145436295|NCT01331681|524456892|FG000|Overall Study|Switching to other therapy|0|||
145436296|NCT01331681|524456893|FG001|Overall Study|Switching to other therapy|0|||
145436297|NCT01331681|524456894|FG002|Overall Study|Switching to other therapy|1|||
145436298|NCT01331681|524456892|FG000|Overall Study|Not Received Study Treatment|0|||
145436299|NCT01331681|524456893|FG001|Overall Study|Not Received Study Treatment|0|||
145436300|NCT01331681|524456894|FG002|Overall Study|Not Received Study Treatment|2|||
145436301|NCT00658541|524456899|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
145436302|NCT00658541|524456900|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145436303|NCT00658541|524456899|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
145436304|NCT00658541|524456900|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
145436305|NCT01063348|524456901|FG000|Overall Study|Lost to Follow-up|3|||
145436306|NCT01063348|524456902|FG001|Overall Study|Lost to Follow-up|10|||
145436307|NCT00269087|524456903|FG000|Overall Study|Adverse Event|20|||
145436308|NCT00269087|524456903|FG000|Overall Study|Withdrawal by Subject|1|||
145436309|NCT00269087|524456903|FG000|Overall Study|Exacerbation of COPD|13|||
145436310|NCT01188967|524456904|FG000|Overall Study|Withdrawal by Subject|1|||
145436311|NCT01188967|524456905|FG001|Overall Study|Withdrawal by Subject|1|||
145436312|NCT01188967|524456904|FG000|Overall Study|Physician Decision|1|||
145436313|NCT01188967|524456905|FG001|Overall Study|Physician Decision|1|||
145436314|NCT01188967|524456904|FG000|Overall Study|Lost to Follow-up|3|||
145436315|NCT01188967|524456905|FG001|Overall Study|Lost to Follow-up|2|||
145436316|NCT00523978|524456906|FG000|Overall Study|Withdrawal by Subject|3|||
145436317|NCT00523978|524456907|FG001|Overall Study|Withdrawal by Subject|7|||
145436318|NCT00523978|524456906|FG000|Overall Study|Screen Failures|5|||
145436319|NCT00523978|524456907|FG001|Overall Study|Screen Failures|1|||
145436320|NCT00523978|524456906|FG000|Overall Study|Death|1|||
145436321|NCT00523978|524456907|FG001|Overall Study|Death|0|||
145436322|NCT04577781|524456910|FG000|Overall Study|Adverse Event|2|||
145436323|NCT04577781|524456911|FG001|Overall Study|Adverse Event|2|||
145436324|NCT04577781|524456910|FG000|Overall Study|Physician Decision|1|||
145436325|NCT04577781|524456911|FG001|Overall Study|Physician Decision|0|||
145436326|NCT04103450|524456913|FG000|Overall Study|Adverse Event|4|||
145436327|NCT04103450|524456914|FG001|Overall Study|Adverse Event|2|||
145436328|NCT04103450|524456913|FG000|Overall Study|Lack of Efficacy|3|||
145436329|NCT04103450|524456914|FG001|Overall Study|Lack of Efficacy|0|||
145436330|NCT04103450|524456913|FG000|Overall Study|Withdrawal by Subject|5|||
145436331|NCT04103450|524456914|FG001|Overall Study|Withdrawal by Subject|3|||
145436332|NCT04103450|524456913|FG000|Overall Study|Lost to Follow-up|1|||
145436333|NCT04103450|524456914|FG001|Overall Study|Lost to Follow-up|2|||
145436334|NCT04103450|524456913|FG000|Overall Study|Physician Decision|1|||
145436335|NCT04103450|524456914|FG001|Overall Study|Physician Decision|2|||
145436336|NCT04103450|524456913|FG000|Overall Study|Protocol Violation|1|||
145436337|NCT04103450|524456914|FG001|Overall Study|Protocol Violation|0|||
145436338|NCT04103450|524456913|FG000|Overall Study|Other|1|||
145436339|NCT04103450|524456914|FG001|Overall Study|Other|1|||
145436340|NCT02712788|524456917|FG000|Overall Study|Physician Decision|1|||
145436341|NCT02712788|524456918|FG001|Overall Study|Physician Decision|0|||
145436342|NCT02712788|524456917|FG000|Overall Study|Protocol Violation|1|||
145436343|NCT02712788|524456918|FG001|Overall Study|Protocol Violation|0|||
145436344|NCT01463033|524456919|FG000|Overall Study|Lost to Follow-up|4|||
145436345|NCT01463033|524456920|FG001|Overall Study|Lost to Follow-up|4|||
145436346|NCT01463033|524456919|FG000|Overall Study|Death|3|||
145436347|NCT01463033|524456920|FG001|Overall Study|Death|2|||
145436348|NCT01368614|524456921|FG000|Screening Period|Screen Failure|58|||
145436349|NCT01368614|524456922|FG001|Screening Period|Screen Failure|0|||
145436350|NCT01368614|524456923|FG002|Screening Period|Screen Failure|0|||
145436351|NCT01368614|524456924|FG003|Screening Period|Screen Failure|0|||
145436352|NCT01368614|524456921|FG000|Study Period|Withdrawal by Subject|0|||
145436353|NCT01368614|524456922|FG001|Study Period|Withdrawal by Subject|1|||
145436354|NCT01368614|524456923|FG002|Study Period|Withdrawal by Subject|1|||
145436355|NCT01368614|524456924|FG003|Study Period|Withdrawal by Subject|3|||
145436356|NCT01368614|524456921|FG000|Study Period|Lost to Follow-up|0|||
145436357|NCT01368614|524456922|FG001|Study Period|Lost to Follow-up|0|||
145436358|NCT01368614|524456923|FG002|Study Period|Lost to Follow-up|1|||
145625037|NCT00797225|525139770|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
145625038|NCT00797225|525139771|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
145625039|NCT00797225|525139772|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
145625040|NCT00797225|525139765|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
145625041|NCT00797225|525139766|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
145625042|NCT00797225|525139767|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
145625043|NCT00797225|525139768|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
145625044|NCT00797225|525139769|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
145625045|NCT00797225|525139770|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
145625046|NCT00797225|525139771|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
145625047|NCT00797225|525139772|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
145625048|NCT00797225|525139765|FG000|Weeks 13 to 24|Adverse Event|0|||
145625049|NCT00797225|525139766|FG001|Weeks 13 to 24|Adverse Event|1|||
145625050|NCT00797225|525139767|FG002|Weeks 13 to 24|Adverse Event|0|||
145625051|NCT00797225|525139768|FG003|Weeks 13 to 24|Adverse Event|0|||
145625052|NCT00797225|525139769|FG004|Weeks 13 to 24|Adverse Event|0|||
145625053|NCT00797225|525139770|FG005|Weeks 13 to 24|Adverse Event|0|||
145625054|NCT00797225|525139771|FG006|Weeks 13 to 24|Adverse Event|1|||
145625055|NCT00797225|525139772|FG007|Weeks 13 to 24|Adverse Event|0|||
145625056|NCT00797225|525139765|FG000|Weeks 13 to 24|Sponsor Decision|0|||
145625057|NCT00797225|525139766|FG001|Weeks 13 to 24|Sponsor Decision|0|||
145625058|NCT00797225|525139767|FG002|Weeks 13 to 24|Sponsor Decision|0|||
145625059|NCT00797225|525139768|FG003|Weeks 13 to 24|Sponsor Decision|0|||
145625060|NCT00797225|525139769|FG004|Weeks 13 to 24|Sponsor Decision|0|||
145625061|NCT00797225|525139770|FG005|Weeks 13 to 24|Sponsor Decision|0|||
145625062|NCT00797225|525139771|FG006|Weeks 13 to 24|Sponsor Decision|1|||
145625063|NCT00797225|525139772|FG007|Weeks 13 to 24|Sponsor Decision|0|||
145625064|NCT00578227|525139773|FG000|Overall Study|Lost to Follow-up|0|||
145625065|NCT00578227|525139774|FG001|Overall Study|Lost to Follow-up|1|||
145625066|NCT00578227|525139775|FG002|Overall Study|Lost to Follow-up|1|||
145625067|NCT00578227|525139773|FG000|Overall Study|Withdrawal by Subject|5|||
145625068|NCT00578227|525139774|FG001|Overall Study|Withdrawal by Subject|1|||
145625069|NCT00578227|525139775|FG002|Overall Study|Withdrawal by Subject|3|||
145625070|NCT02929108|525139781|FG000|Overall Study|Hospice patient death|100|||
145625071|NCT02929108|525139782|FG001|Overall Study|Hospice patient death|64|||
145625072|NCT02929108|525139783|FG002|Overall Study|Hospice patient death|28|||
145625073|NCT02929108|525139784|FG003|Overall Study|Hospice patient death|46|||
145625074|NCT02929108|525139785|FG004|Overall Study|Hospice patient death|55|||
145625075|NCT02929108|525139786|FG005|Overall Study|Hospice patient death|28|||
145625076|NCT02929108|525139787|FG006|Overall Study|Hospice patient death|78|||
145625077|NCT00052962|525139788|FG000|Overall Study|Not evaluable|0|||
145625078|NCT00052962|525139789|FG001|Overall Study|Not evaluable|2|||
145625079|NCT00052962|525139788|FG000|Overall Study|Not randomized/not evaluable|1|||
145625080|NCT00052962|525139789|FG001|Overall Study|Not randomized/not evaluable|0|||
145625081|NCT02084082|525139791|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
145625082|NCT02084082|525139792|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
145625083|NCT02084082|525139793|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
145625084|NCT02084082|525139794|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
145625085|NCT02084082|525139791|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145625086|NCT02084082|525139792|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145625087|NCT02084082|525139793|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
145625088|NCT02084082|525139794|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
145625089|NCT05174065|525139818|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
145625090|NCT05174065|525139819|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
145625091|NCT05174065|525139820|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
145625092|NCT05174065|525139818|FG000|Placebo-controlled Period|Other|0|||
145436359|NCT01368614|524456924|FG003|Study Period|Lost to Follow-up|0|||
145436360|NCT00244621|524456925|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145625093|NCT05174065|525139819|FG001|Placebo-controlled Period|Other|1|||
145625094|NCT05174065|525139820|FG002|Placebo-controlled Period|Other|0|||
145625095|NCT05174065|525139818|FG000|Placebo-controlled Period|Adverse Event|1|||
145625096|NCT05174065|525139819|FG001|Placebo-controlled Period|Adverse Event|1|||
145625097|NCT05174065|525139820|FG002|Placebo-controlled Period|Adverse Event|0|||
145625098|NCT05174065|525139818|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
145625099|NCT05174065|525139819|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
145625100|NCT05174065|525139820|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
145625101|NCT05174065|525139818|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
145625102|NCT05174065|525139819|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
145625103|NCT05174065|525139820|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
145625104|NCT05174065|525139818|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
145625105|NCT05174065|525139819|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
145625106|NCT05174065|525139820|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
145625107|NCT01641861|525139821|FG000|Overall Study|Lost to Follow-up|21|||
145625108|NCT01641861|525139822|FG001|Overall Study|Lost to Follow-up|16|||
145625109|NCT01641861|525139821|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
145625110|NCT01641861|525139822|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
145436361|NCT00244621|524456926|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145436362|NCT00244621|524456927|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
145436363|NCT00244621|524456925|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145436364|NCT00244621|524456926|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145436365|NCT00244621|524456927|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145436366|NCT00244621|524456925|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145436367|NCT00244621|524456926|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
145436368|NCT00244621|524456927|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
145436369|NCT00244621|524456925|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
145436370|NCT00244621|524456926|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
145436371|NCT00244621|524456927|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
145436372|NCT00244621|524456925|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145436373|NCT00244621|524456926|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
145436374|NCT00244621|524456927|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
145436375|NCT00244621|524456925|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
145436376|NCT00244621|524456926|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145436377|NCT00244621|524456927|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
145436378|NCT00244621|524456925|FG000|Open-label Treatment Period|Adverse Event|0|||
145436379|NCT00244621|524456926|FG001|Open-label Treatment Period|Adverse Event|0|||
145436380|NCT00244621|524456927|FG002|Open-label Treatment Period|Adverse Event|1|||
145436381|NCT00244621|524456925|FG000|Open-label Treatment Period|Moved abroad|0|||
145436382|NCT00244621|524456926|FG001|Open-label Treatment Period|Moved abroad|0|||
145436383|NCT00244621|524456927|FG002|Open-label Treatment Period|Moved abroad|1|||
145436384|NCT01847755|524456931|FG000|Overall Study|Adverse Event|2|||
145436385|NCT01847755|524456931|FG000|Overall Study|Withdrawal by Subject|2|||
145436386|NCT01847755|524456931|FG000|Overall Study|Physician Decision|1|||
145436387|NCT01193101|524456932|FG000|Overall Study|Adverse Event|0|||
145436388|NCT01193101|524456933|FG001|Overall Study|Adverse Event|1|||
145436389|NCT01193101|524456934|FG002|Overall Study|Adverse Event|1|||
145436390|NCT01193101|524456935|FG003|Overall Study|Adverse Event|3|||
145436391|NCT01193101|524456932|FG000|Overall Study|Lack of Efficacy|3|||
145436392|NCT01193101|524456933|FG001|Overall Study|Lack of Efficacy|1|||
145436393|NCT01193101|524456934|FG002|Overall Study|Lack of Efficacy|0|||
145436394|NCT01193101|524456935|FG003|Overall Study|Lack of Efficacy|8|||
145436395|NCT01193101|524456932|FG000|Overall Study|Withdrawal by Subject|2|||
145436396|NCT01193101|524456933|FG001|Overall Study|Withdrawal by Subject|4|||
145436397|NCT01193101|524456934|FG002|Overall Study|Withdrawal by Subject|1|||
145436398|NCT01193101|524456935|FG003|Overall Study|Withdrawal by Subject|1|||
145436399|NCT01193101|524456932|FG000|Overall Study|Administrative problems|0|||
145436400|NCT01193101|524456933|FG001|Overall Study|Administrative problems|0|||
145436401|NCT01193101|524456934|FG002|Overall Study|Administrative problems|1|||
145436402|NCT01193101|524456935|FG003|Overall Study|Administrative problems|0|||
145436403|NCT01193101|524456932|FG000|Overall Study|Abnormal test procedure results|0|||
145436404|NCT01193101|524456933|FG001|Overall Study|Abnormal test procedure results|1|||
145436405|NCT01193101|524456934|FG002|Overall Study|Abnormal test procedure results|0|||
145436406|NCT01193101|524456935|FG003|Overall Study|Abnormal test procedure results|0|||
145436407|NCT02347085|524456936|FG000|Overall Study|Adverse Event|2|||
145436408|NCT02347085|524456936|FG000|Overall Study|Lack of Efficacy|1|||
145436409|NCT02347085|524456936|FG000|Overall Study|Withdrawal by Subject|4|||
145436410|NCT02347085|524456936|FG000|Overall Study|Lost to Follow-up|1|||
145436411|NCT02347085|524456936|FG000|Overall Study|Protocol Criteria|2|||
145436412|NCT01904721|524456938|FG000|Overall Study|Other Reasons|0|||
145436413|NCT01904721|524456939|FG001|Overall Study|Other Reasons|0|||
145436414|NCT01904721|524456940|FG002|Overall Study|Other Reasons|1|||
145436415|NCT01904721|524456941|FG003|Overall Study|Other Reasons|1|||
145436416|NCT01904721|524456942|FG004|Overall Study|Other Reasons|2|||
145436417|NCT01904721|524456943|FG005|Overall Study|Other Reasons|2|||
145436418|NCT01904721|524456944|FG006|Overall Study|Other Reasons|2|||
145436419|NCT01904721|524456938|FG000|Overall Study|Personal Reasons|0|||
145436420|NCT01904721|524456939|FG001|Overall Study|Personal Reasons|0|||
145436421|NCT01904721|524456940|FG002|Overall Study|Personal Reasons|0|||
145436422|NCT01904721|524456941|FG003|Overall Study|Personal Reasons|0|||
145436423|NCT01904721|524456942|FG004|Overall Study|Personal Reasons|2|||
145436424|NCT01904721|524456943|FG005|Overall Study|Personal Reasons|3|||
145436425|NCT01904721|524456944|FG006|Overall Study|Personal Reasons|3|||
145436426|NCT01904721|524456938|FG000|Overall Study|Lost to Follow-up|0|||
145436427|NCT01904721|524456939|FG001|Overall Study|Lost to Follow-up|0|||
145436428|NCT01904721|524456940|FG002|Overall Study|Lost to Follow-up|0|||
145436429|NCT01904721|524456941|FG003|Overall Study|Lost to Follow-up|0|||
145436430|NCT01904721|524456942|FG004|Overall Study|Lost to Follow-up|1|||
145436431|NCT01904721|524456943|FG005|Overall Study|Lost to Follow-up|3|||
145436432|NCT01904721|524456944|FG006|Overall Study|Lost to Follow-up|1|||
145436433|NCT01904721|524456938|FG000|Overall Study|Lack of Efficacy|0|||
145583604|NCT00575588|524989389|FG000|Overall Study|Impossible to determine HbA1c|0|||
145436434|NCT01904721|524456939|FG001|Overall Study|Lack of Efficacy|0|||
145436435|NCT01904721|524456940|FG002|Overall Study|Lack of Efficacy|0|||
145436436|NCT01904721|524456941|FG003|Overall Study|Lack of Efficacy|0|||
145436437|NCT01904721|524456942|FG004|Overall Study|Lack of Efficacy|0|||
145436438|NCT01904721|524456943|FG005|Overall Study|Lack of Efficacy|0|||
145436439|NCT01904721|524456944|FG006|Overall Study|Lack of Efficacy|1|||
145436440|NCT01904721|524456938|FG000|Overall Study|Adverse Event|0|||
145436441|NCT01904721|524456939|FG001|Overall Study|Adverse Event|0|||
145436442|NCT01904721|524456940|FG002|Overall Study|Adverse Event|0|||
145436443|NCT01904721|524456941|FG003|Overall Study|Adverse Event|0|||
145436444|NCT01904721|524456942|FG004|Overall Study|Adverse Event|3|||
145436445|NCT01904721|524456943|FG005|Overall Study|Adverse Event|1|||
145436446|NCT01904721|524456944|FG006|Overall Study|Adverse Event|0|||
145436447|NCT01957865|524456945|FG000|Overall Study|Found HIV negative|0|||
145436448|NCT01957865|524456946|FG001|Overall Study|Found HIV negative|0|||
145436449|NCT01957865|524456947|FG002|Overall Study|Found HIV negative|1|||
145436450|NCT01957865|524456945|FG000|Overall Study|Lost to Follow-up|0|||
145436451|NCT01957865|524456946|FG001|Overall Study|Lost to Follow-up|2|||
145436452|NCT01957865|524456947|FG002|Overall Study|Lost to Follow-up|2|||
145436453|NCT01077063|524456951|FG000|Overall Study|Adverse Event|3|||
145436454|NCT01077063|524456952|FG001|Overall Study|Adverse Event|0|||
145436455|NCT01077063|524456951|FG000|Overall Study|Death|1|||
145436456|NCT01077063|524456952|FG001|Overall Study|Death|1|||
145436457|NCT01077063|524456951|FG000|Overall Study|Withdrawal by Subject|0|||
145436458|NCT01077063|524456952|FG001|Overall Study|Withdrawal by Subject|2|||
145436459|NCT02750930|524456953|FG000|Overall Study|Study closed/terminated|8|||
145436460|NCT00553631|524456954|FG000|Overall Study|Withdrawal by Subject|0|||
145436461|NCT00553631|524456955|FG001|Overall Study|Withdrawal by Subject|1|||
145436462|NCT00553631|524456954|FG000|Overall Study|Lost to Follow-up|1|||
145436463|NCT00553631|524456955|FG001|Overall Study|Lost to Follow-up|0|||
145436464|NCT00527618|524456956|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
145436465|NCT00527618|524456957|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
145436466|NCT00527618|524456956|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
145436467|NCT00527618|524456957|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
145436468|NCT00527618|524456956|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
145436469|NCT00527618|524456957|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
145436470|NCT00527618|524456956|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
145436471|NCT00527618|524456957|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
145436472|NCT00527618|524456956|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
145436473|NCT00527618|524456957|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
145436474|NCT00527618|524456956|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
145436475|NCT00527618|524456957|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
145436476|NCT01490918|524456958|FG000|Overall Study|Lost to Follow-up|2|||
145436477|NCT01490918|524456959|FG001|Overall Study|Lost to Follow-up|1|||
145436478|NCT01490918|524456960|FG002|Overall Study|Lost to Follow-up|0|||
145436479|NCT01490918|524456958|FG000|Overall Study|Withdrawal by Subject|7|||
145436480|NCT01490918|524456959|FG001|Overall Study|Withdrawal by Subject|8|||
145436481|NCT01490918|524456960|FG002|Overall Study|Withdrawal by Subject|3|||
145436482|NCT01490918|524456958|FG000|Overall Study|Adverse Event|0|||
145436483|NCT01490918|524456959|FG001|Overall Study|Adverse Event|0|||
145436484|NCT01490918|524456960|FG002|Overall Study|Adverse Event|1|||
145436485|NCT01490918|524456958|FG000|Overall Study|other cause|4|||
145436486|NCT01490918|524456959|FG001|Overall Study|other cause|5|||
145436487|NCT01490918|524456960|FG002|Overall Study|other cause|8|||
145436488|NCT00648037|524456963|FG000|Overall Study|Not Treated|1|||
145436489|NCT00648037|524456963|FG000|Overall Study|Withdrawal by Subject|1|||
145436490|NCT00648037|524456963|FG000|Overall Study|Adverse Event|11|||
145436491|NCT00648037|524456963|FG000|Overall Study|Relapse|2|||
145436492|NCT00648037|524456963|FG000|Overall Study|Other|1|||
145436493|NCT02967679|524456964|FG000|Overall Study|Adverse Event|1|||
145436494|NCT00114127|524456966|FG000|Overall Study|Adverse Event|2|||
145436495|NCT00114127|524456967|FG001|Overall Study|Adverse Event|1|||
145436496|NCT00114127|524456966|FG000|Overall Study|Lost to Follow-up|1|||
145436497|NCT00114127|524456967|FG001|Overall Study|Lost to Follow-up|0|||
145436498|NCT00114127|524456966|FG000|Overall Study|Withdrawal by Subject|1|||
145436499|NCT00114127|524456967|FG001|Overall Study|Withdrawal by Subject|3|||
145436500|NCT03188263|524456968|FG000|Overall Study|Withdrawal by Subject|3|||
145436501|NCT03188263|524456969|FG001|Overall Study|Withdrawal by Subject|0|||
145436502|NCT03188263|524456968|FG000|Overall Study|Physician Decision|1|||
145436503|NCT03188263|524456969|FG001|Overall Study|Physician Decision|0|||
145436504|NCT00881894|524456970|FG000|Overall Study|Consent withdrawn|0|||
145436505|NCT00881894|524456971|FG001|Overall Study|Consent withdrawn|1|||
145436506|NCT00881894|524456970|FG000|Overall Study|Other reasons for premature termination|1|||
145436507|NCT00881894|524456971|FG001|Overall Study|Other reasons for premature termination|2|||
145436508|NCT00469833|524456972|FG000|Overall Study|No IV access|2|||
145436509|NCT01253369|524456973|FG000|Overall Study|Adverse Event|4|||
145436510|NCT01253369|524456973|FG000|Overall Study|Withdrawal by Subject|2|||
145436511|NCT01253369|524456973|FG000|Overall Study|Death|1|||
145436512|NCT01253369|524456973|FG000|Overall Study|Progressive disease|23|||
145436513|NCT01253369|524456973|FG000|Overall Study|Not Evaluable|3|||
145436514|NCT01284959|524456975|FG000|Overall Study|Withdrawal by Subject|1|||
145436515|NCT01284959|524456976|FG001|Overall Study|Withdrawal by Subject|0|||
145436516|NCT01284959|524456977|FG002|Overall Study|Withdrawal by Subject|0|||
145436517|NCT01284959|524456975|FG000|Overall Study|Adverse Event|0|||
145436518|NCT01284959|524456976|FG001|Overall Study|Adverse Event|0|||
145436519|NCT01284959|524456977|FG002|Overall Study|Adverse Event|1|||
145436520|NCT00363311|524456978|FG000|Overall Study|Adverse Event|6|||
145436521|NCT00363311|524456979|FG001|Overall Study|Adverse Event|4|||
145436522|NCT00363311|524456978|FG000|Overall Study|Lost to Follow-up|3|||
145436523|NCT00363311|524456979|FG001|Overall Study|Lost to Follow-up|0|||
145436524|NCT00363311|524456978|FG000|Overall Study|Protocol Violation|1|||
145436525|NCT00363311|524456979|FG001|Overall Study|Protocol Violation|2|||
145436526|NCT00363311|524456978|FG000|Overall Study|Withdrawal by Subject|12|||
145436527|NCT00363311|524456979|FG001|Overall Study|Withdrawal by Subject|6|||
145436528|NCT00363311|524456978|FG000|Overall Study|Physician Decision|1|||
145436529|NCT00363311|524456979|FG001|Overall Study|Physician Decision|1|||
145436530|NCT00363311|524456978|FG000|Overall Study|Sponsor Terminated Study|2|||
145436531|NCT00363311|524456979|FG001|Overall Study|Sponsor Terminated Study|2|||
145436532|NCT00363311|524456978|FG000|Overall Study|Disease Progression|46|||
145436533|NCT00363311|524456979|FG001|Overall Study|Disease Progression|26|||
145436534|NCT00363311|524456978|FG000|Overall Study|Non-Compliance|1|||
145436535|NCT00363311|524456979|FG001|Overall Study|Non-Compliance|1|||
145436536|NCT00363311|524456978|FG000|Overall Study|Participant Refused Biopsy|1|||
145436537|NCT00363311|524456979|FG001|Overall Study|Participant Refused Biopsy|0|||
145436538|NCT00363311|524456978|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
145436539|NCT00363311|524456979|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
145436540|NCT00363311|524456978|FG000|Overall Study|Participant Opted for Treatment|1|||
145436541|NCT00363311|524456979|FG001|Overall Study|Participant Opted for Treatment|0|||
145436542|NCT00363311|524456978|FG000|Overall Study|Participant Moved to Another Country|1|||
145436543|NCT00363311|524456979|FG001|Overall Study|Participant Moved to Another Country|0|||
145436544|NCT00363311|524456978|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
145436545|NCT00363311|524456979|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
145436546|NCT00363311|524456978|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
145436547|NCT00363311|524456979|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
145436548|NCT00363311|524456978|FG000|Overall Study|Participant Moved to Louisiana|0|||
145436549|NCT00363311|524456979|FG001|Overall Study|Participant Moved to Louisiana|1|||
145436550|NCT02103062|524456984|FG000|Overall Study|Adverse Event|1|||
145436551|NCT02103062|524456985|FG001|Overall Study|Adverse Event|2|||
145436552|NCT02103062|524456984|FG000|Overall Study|Progressive Disease|17|||
145436553|NCT02103062|524456985|FG001|Overall Study|Progressive Disease|20|||
145436554|NCT02103062|524456984|FG000|Overall Study|Death|0|||
145436555|NCT02103062|524456985|FG001|Overall Study|Death|1|||
145436556|NCT01182298|524456986|FG000|Overall Study|Lack of Efficacy|4|||
145436557|NCT01182298|524456986|FG000|Overall Study|Withdrawal by Subject|2|||
145436558|NCT00959907|524456990|FG000|Overall Study|Protocol Violation|0|||
145436559|NCT00959907|524456991|FG001|Overall Study|Protocol Violation|1|||
145436560|NCT00959907|524456990|FG000|Overall Study|Adverse Event|1|||
145436561|NCT00959907|524456991|FG001|Overall Study|Adverse Event|0|||
145436562|NCT00959907|524456990|FG000|Overall Study|Withdrawal by Subject|2|||
145436563|NCT00959907|524456991|FG001|Overall Study|Withdrawal by Subject|0|||
145436564|NCT03958331|524456992|FG000|Overall Study|Withdrawal by Subject|3|||
145436565|NCT03958331|524456993|FG001|Overall Study|Withdrawal by Subject|1|||
145436566|NCT03958331|524456994|FG002|Overall Study|Withdrawal by Subject|5|||
145436567|NCT03958331|524456992|FG000|Overall Study|Weaned from medicine|2|||
145436568|NCT03958331|524456993|FG001|Overall Study|Weaned from medicine|0|||
145436569|NCT03958331|524456994|FG002|Overall Study|Weaned from medicine|0|||
145436570|NCT03958331|524456992|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
145436571|NCT03958331|524456993|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
145436572|NCT03958331|524456994|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
145436573|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
145436574|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
145436575|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
145436576|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
145436577|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
145436578|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
145436579|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
145436580|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
145436581|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
145436582|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
145436583|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
145436584|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
145436585|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
145436586|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
145436587|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
145436588|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
145436589|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
145436590|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
145436591|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
145436592|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
145436593|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
145436594|NCT04021290|524457004|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
145436595|NCT04021290|524457005|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
145436596|NCT04021290|524457006|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
145436597|NCT04021290|524457004|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
145436598|NCT04021290|524457005|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
145436599|NCT04021290|524457006|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
145436600|NCT04021290|524457004|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
145436601|NCT04021290|524457005|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
145436602|NCT04021290|524457006|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
145436603|NCT04021290|524457004|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
145436604|NCT04021290|524457005|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
145436605|NCT04021290|524457006|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
145436606|NCT04021290|524457004|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
145436607|NCT04021290|524457005|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
145436608|NCT04021290|524457006|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
145436609|NCT01174563|524457007|FG000|Overall Study|Progressive Disease|45|||
145436610|NCT01174563|524457007|FG000|Overall Study|Death|5|||
145436611|NCT01174563|524457007|FG000|Overall Study|Investigator's Discretion|5|||
145436612|NCT01174563|524457007|FG000|Overall Study|Participant Withdrew Consent|3|||
145436613|NCT01174563|524457007|FG000|Overall Study|Rash Adverse Event|1|||
145436614|NCT01174563|524457007|FG000|Overall Study|Sponsor's decision|1|||
145436615|NCT02015039|524457011|FG000|Overall Study|Not eligible|0|||
145436616|NCT02015039|524457012|FG001|Overall Study|Not eligible|1|||
145436617|NCT01088906|524457016|FG000|Overall Study|Inclusion error|1|||
145436618|NCT01088906|524457016|FG000|Overall Study|Did not receive study treatment|3|||
145436619|NCT01088906|524457016|FG000|Overall Study|Missing data|1|||
145436620|NCT03247829|524458679|FG000|Overall Study|Death|3|||
145436621|NCT03247829|524458680|FG001|Overall Study|Death|4|||
145436622|NCT03247829|524458679|FG000|Overall Study|Enter Hospice Care|1|||
145436623|NCT03247829|524458680|FG001|Overall Study|Enter Hospice Care|0|||
145436624|NCT03247829|524458679|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
145436625|NCT03247829|524458680|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
145436626|NCT03247829|524458679|FG000|Overall Study|LVAD Explant|1|||
145436627|NCT03247829|524458680|FG001|Overall Study|LVAD Explant|1|||
145436628|NCT03247829|524458679|FG000|Overall Study|Transplant|1|||
145436629|NCT03247829|524458680|FG001|Overall Study|Transplant|1|||
145436630|NCT00427011|524458681|FG000|Overall Study|Adverse Event|10|||
145436631|NCT00427011|524458681|FG000|Overall Study|Withdrawal by Subject|1|||
145436632|NCT00427011|524458681|FG000|Overall Study|Lack of Efficacy|2|||
145436633|NCT00427011|524458681|FG000|Overall Study|Other|12|||
145436634|NCT00288015|524458682|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
145436635|NCT00288015|524458682|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
145436636|NCT00288015|524458682|FG000|First Response Assessment|Withdrawal by Subject|1|||
145436637|NCT00288015|524458682|FG000|First Response Assessment|Death|1|||
145436638|NCT00288015|524458682|FG000|First Response Assessment|Physician Decision|2|||
145436639|NCT00288015|524458682|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
145436640|NCT00288015|524458682|FG000|Follow up for Survival x 2 Years|Death|13|||
145436641|NCT00288015|524458682|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
145436642|NCT00288015|524458682|FG000|Follow up for Survival x 2 Years|Other|9|||
145436643|NCT00443703|524458683|FG000|Overall Study|Never Treated|3|||
145436644|NCT00443703|524458684|FG001|Overall Study|Never Treated|1|||
145436645|NCT00443703|524458683|FG000|Overall Study|Adverse Event|7|||
145436646|NCT00443703|524458684|FG001|Overall Study|Adverse Event|3|||
145436647|NCT00443703|524458683|FG000|Overall Study|Lack of Efficacy|3|||
145436648|NCT00443703|524458684|FG001|Overall Study|Lack of Efficacy|1|||
145436649|NCT00443703|524458683|FG000|Overall Study|Lost to Follow-up|0|||
145436650|NCT00443703|524458684|FG001|Overall Study|Lost to Follow-up|4|||
145625111|NCT01641861|525139821|FG000|Overall Study|Died due to drowning|0|||
145436651|NCT00443703|524458683|FG000|Overall Study|Physician Decision|4|||
145436652|NCT00443703|524458684|FG001|Overall Study|Physician Decision|2|||
145436653|NCT00443703|524458683|FG000|Overall Study|Protocol Violation|1|||
145436654|NCT00443703|524458684|FG001|Overall Study|Protocol Violation|1|||
145436655|NCT00443703|524458683|FG000|Overall Study|Withdrawal by Subject|9|||
145436656|NCT00443703|524458684|FG001|Overall Study|Withdrawal by Subject|6|||
145436657|NCT00443703|524458683|FG000|Overall Study|Progressive Disease|1|||
145436658|NCT00443703|524458684|FG001|Overall Study|Progressive Disease|0|||
145436659|NCT01669902|524458689|FG000|Overall Study|Adverse Event|11|||
145436660|NCT01669902|524458689|FG000|Overall Study|Lack of Efficacy|10|||
145436661|NCT01669902|524458689|FG000|Overall Study|Other|8|||
145436662|NCT00457392|524458690|FG000|Overall Study|Objective Progression or Relapse|229|||
145436663|NCT00457392|524458691|FG001|Overall Study|Objective Progression or Relapse|296|||
145436664|NCT00457392|524458690|FG000|Overall Study|Death|106|||
145436665|NCT00457392|524458691|FG001|Overall Study|Death|106|||
145436666|NCT00457392|524458690|FG000|Overall Study|Adverse Event|84|||
145436667|NCT00457392|524458691|FG001|Overall Study|Adverse Event|41|||
145436668|NCT00457392|524458690|FG000|Overall Study|Global Deterioration of Health Status|22|||
145436669|NCT00457392|524458691|FG001|Overall Study|Global Deterioration of Health Status|8|||
145436670|NCT00457392|524458690|FG000|Overall Study|Withdrawal by Subject|14|||
145436671|NCT00457392|524458691|FG001|Overall Study|Withdrawal by Subject|8|||
145436672|NCT00457392|524458690|FG000|Overall Study|Lost to Follow-up|6|||
145436673|NCT00457392|524458691|FG001|Overall Study|Lost to Follow-up|7|||
145436674|NCT00457392|524458690|FG000|Overall Study|Protocol Violation|4|||
145436675|NCT00457392|524458691|FG001|Overall Study|Protocol Violation|3|||
145436676|NCT00457392|524458690|FG000|Overall Study|Other|7|||
145436677|NCT00457392|524458691|FG001|Overall Study|Other|4|||
145436678|NCT00457392|524458690|FG000|Overall Study|Study Terminated by Sponsor|1|||
145436679|NCT00457392|524458691|FG001|Overall Study|Study Terminated by Sponsor|4|||
145436680|NCT00457392|524458690|FG000|Overall Study|Randomized, Not Treated|7|||
145436681|NCT00457392|524458691|FG001|Overall Study|Randomized, Not Treated|3|||
145436682|NCT00980148|524458692|FG000|Overall Study|Discharged from facility|89|||
145436683|NCT00980148|524458693|FG001|Overall Study|Discharged from facility|96|||
145436684|NCT00980148|524458692|FG000|Overall Study|Received other antichlamydia treatment|20|||
145436685|NCT00980148|524458693|FG001|Overall Study|Received other antichlamydia treatment|14|||
145436686|NCT00980148|524458692|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
145436687|NCT00980148|524458693|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
145436688|NCT00980148|524458692|FG000|Overall Study|Various other reasons|8|||
145436689|NCT00980148|524458693|FG001|Overall Study|Various other reasons|9|||
145436690|NCT01462929|524458694|FG000|Overall Study|Adverse Event|3|||
145436691|NCT01462929|524458695|FG001|Overall Study|Adverse Event|3|||
145436692|NCT01462929|524458696|FG002|Overall Study|Adverse Event|4|||
145436693|NCT01462929|524458694|FG000|Overall Study|Withdrawal by Subject|2|||
145436694|NCT01462929|524458695|FG001|Overall Study|Withdrawal by Subject|1|||
145436695|NCT01462929|524458696|FG002|Overall Study|Withdrawal by Subject|0|||
145436696|NCT01462929|524458694|FG000|Overall Study|Lack of Efficacy|0|||
145436697|NCT01462929|524458695|FG001|Overall Study|Lack of Efficacy|0|||
145436698|NCT01462929|524458696|FG002|Overall Study|Lack of Efficacy|1|||
145436699|NCT01309204|524458701|FG000|Overall Study|Adverse Event|48|||
145436700|NCT01309204|524458702|FG001|Overall Study|Adverse Event|58|||
145436701|NCT01309204|524458701|FG000|Overall Study|Lost to Follow-up|2|||
145436702|NCT01309204|524458702|FG001|Overall Study|Lost to Follow-up|2|||
145436703|NCT01309204|524458701|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
145436704|NCT01309204|524458702|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
145436705|NCT01309204|524458701|FG000|Overall Study|Inadequate control of IOP|4|||
145436706|NCT01309204|524458702|FG001|Overall Study|Inadequate control of IOP|4|||
145436707|NCT01309204|524458701|FG000|Overall Study|Other|4|||
145436708|NCT01309204|524458702|FG001|Overall Study|Other|1|||
145436709|NCT00925002|524458703|FG000|Overall Study|Other|1|||
145436710|NCT00925002|524458704|FG001|Overall Study|Other|4|||
145436711|NCT00925002|524458705|FG002|Overall Study|Other|0|||
145436712|NCT00925002|524458703|FG000|Overall Study|Death|1|||
145436713|NCT00925002|524458704|FG001|Overall Study|Death|1|||
145436714|NCT00925002|524458705|FG002|Overall Study|Death|5|||
145436715|NCT00925002|524458703|FG000|Overall Study|Adverse Event|3|||
145436716|NCT00925002|524458704|FG001|Overall Study|Adverse Event|1|||
145436717|NCT00925002|524458705|FG002|Overall Study|Adverse Event|2|||
145436718|NCT00925002|524458703|FG000|Overall Study|Participant withdrew consent|1|||
145436719|NCT00925002|524458704|FG001|Overall Study|Participant withdrew consent|3|||
145436720|NCT00925002|524458705|FG002|Overall Study|Participant withdrew consent|3|||
145436721|NCT00002766|524458706|FG000|Overall Study|Withdrawal by Subject|0|||
145436722|NCT00002766|524458707|FG001|Overall Study|Withdrawal by Subject|1|||
145436723|NCT00002766|524458706|FG000|Overall Study|Patient Not Treated|1|||
145436724|NCT00002766|524458707|FG001|Overall Study|Patient Not Treated|2|||
145436725|NCT00002766|524458706|FG000|Overall Study|Adverse Event|1|||
145436726|NCT00002766|524458707|FG001|Overall Study|Adverse Event|1|||
145436727|NCT00002766|524458706|FG000|Overall Study|Protocol Violation|1|||
145436728|NCT00002766|524458707|FG001|Overall Study|Protocol Violation|0|||
145436729|NCT00328172|524458710|FG000|Overall Study|Adverse Event|3|||
145436730|NCT00328172|524458711|FG001|Overall Study|Adverse Event|2|||
145436731|NCT00328172|524458712|FG002|Overall Study|Adverse Event|1|||
145436732|NCT00328172|524458713|FG003|Overall Study|Adverse Event|2|||
145436733|NCT00328172|524458714|FG004|Overall Study|Adverse Event|1|||
145436734|NCT00328172|524458710|FG000|Overall Study|Protocol Violation|0|||
145436735|NCT00328172|524458711|FG001|Overall Study|Protocol Violation|1|||
145436736|NCT00328172|524458712|FG002|Overall Study|Protocol Violation|1|||
145625112|NCT01641861|525139822|FG001|Overall Study|Died due to drowning|1|||
145625113|NCT00814489|525139823|FG000|Overall Study|Other|2|||
145625114|NCT00814489|525139824|FG001|Overall Study|Other|0|||
145625115|NCT00814489|525139825|FG002|Overall Study|Other|1|||
145625116|NCT01515319|525139851|FG000|Overall Study|Withdrawal by Subject|0|||
145625117|NCT01515319|525139852|FG001|Overall Study|Withdrawal by Subject|0|||
145625118|NCT01515319|525139853|FG002|Overall Study|Withdrawal by Subject|0|||
145625119|NCT01515319|525139854|FG003|Overall Study|Withdrawal by Subject|0|||
145625120|NCT01515319|525139855|FG004|Overall Study|Withdrawal by Subject|0|||
145625121|NCT01515319|525139856|FG005|Overall Study|Withdrawal by Subject|0|||
145625122|NCT01515319|525139857|FG006|Overall Study|Withdrawal by Subject|1|||
145625123|NCT01515319|525139858|FG007|Overall Study|Withdrawal by Subject|0|||
145625124|NCT01515319|525139859|FG008|Overall Study|Withdrawal by Subject|0|||
145625125|NCT01515319|525139860|FG009|Overall Study|Withdrawal by Subject|0|||
145583605|NCT00575588|524989390|FG001|Overall Study|Impossible to determine HbA1c|1|||
145583606|NCT01430130|524989391|FG000|Overall Study|Lost to Follow-up|1|||
145583607|NCT01430130|524989391|FG000|Overall Study|Infection on Control Side of Incision|1|||
145583608|NCT03525834|524989392|FG000|Overall Study|Progressive disease|1|||
145583609|NCT02828111|524989396|FG000|Overall Study|Withdrawal by Subject|0|||
145583610|NCT02828111|524989397|FG001|Overall Study|Withdrawal by Subject|0|||
145583611|NCT02828111|524989398|FG002|Overall Study|Withdrawal by Subject|2|||
145583612|NCT02828111|524989399|FG003|Overall Study|Withdrawal by Subject|0|||
145583613|NCT02828111|524989400|FG004|Overall Study|Withdrawal by Subject|0|||
145583614|NCT02828111|524989396|FG000|Overall Study|Lost to Follow-up|0|||
145583615|NCT02828111|524989397|FG001|Overall Study|Lost to Follow-up|0|||
145625126|NCT01515319|525139851|FG000|Overall Study|Adverse Event|0|||
145625127|NCT01515319|525139852|FG001|Overall Study|Adverse Event|0|||
145625128|NCT01515319|525139853|FG002|Overall Study|Adverse Event|0|||
145625129|NCT01515319|525139854|FG003|Overall Study|Adverse Event|0|||
145625130|NCT01515319|525139855|FG004|Overall Study|Adverse Event|0|||
145625131|NCT01515319|525139856|FG005|Overall Study|Adverse Event|0|||
145625132|NCT01515319|525139857|FG006|Overall Study|Adverse Event|0|||
145625133|NCT01515319|525139858|FG007|Overall Study|Adverse Event|0|||
145625134|NCT01515319|525139859|FG008|Overall Study|Adverse Event|3|||
145625135|NCT01515319|525139860|FG009|Overall Study|Adverse Event|0|||
145625136|NCT01515319|525139851|FG000|Overall Study|Protocol Violation|0|||
145625137|NCT01515319|525139852|FG001|Overall Study|Protocol Violation|0|||
145583616|NCT02828111|524989398|FG002|Overall Study|Lost to Follow-up|0|||
145583617|NCT02828111|524989399|FG003|Overall Study|Lost to Follow-up|1|||
145583618|NCT02828111|524989400|FG004|Overall Study|Lost to Follow-up|1|||
145583619|NCT00614939|524989403|FG000|Overall Study|Withdrawal by Subject|10|||
145583620|NCT00614939|524989404|FG001|Overall Study|Withdrawal by Subject|17|||
145583621|NCT00614939|524989403|FG000|Overall Study|Study specific discontinuation criteris|13|||
145583622|NCT00614939|524989404|FG001|Overall Study|Study specific discontinuation criteris|16|||
145583623|NCT00614939|524989403|FG000|Overall Study|Adverse Event|2|||
145583624|NCT00614939|524989404|FG001|Overall Study|Adverse Event|5|||
145583625|NCT00614939|524989403|FG000|Overall Study|Incorrect enrollment|1|||
145583626|NCT00614939|524989404|FG001|Overall Study|Incorrect enrollment|2|||
145583627|NCT00614939|524989403|FG000|Overall Study|Death|4|||
145583628|NCT00614939|524989404|FG001|Overall Study|Death|3|||
145583629|NCT00614939|524989403|FG000|Overall Study|Poor/non-compliance|4|||
145583630|NCT00614939|524989404|FG001|Overall Study|Poor/non-compliance|0|||
145583631|NCT00614939|524989403|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
145625138|NCT01515319|525139853|FG002|Overall Study|Protocol Violation|0|||
145436737|NCT00328172|524458713|FG003|Overall Study|Protocol Violation|0|||
145436738|NCT00328172|524458714|FG004|Overall Study|Protocol Violation|0|||
145436739|NCT00328172|524458710|FG000|Overall Study|Lost to Follow-up|1|||
145436740|NCT00328172|524458711|FG001|Overall Study|Lost to Follow-up|1|||
145436741|NCT00328172|524458712|FG002|Overall Study|Lost to Follow-up|2|||
145436742|NCT00328172|524458713|FG003|Overall Study|Lost to Follow-up|1|||
145436743|NCT00328172|524458714|FG004|Overall Study|Lost to Follow-up|1|||
145436744|NCT00328172|524458710|FG000|Overall Study|Withdrawal by Subject|1|||
145436745|NCT00328172|524458711|FG001|Overall Study|Withdrawal by Subject|1|||
145436746|NCT00328172|524458712|FG002|Overall Study|Withdrawal by Subject|1|||
145436747|NCT00328172|524458713|FG003|Overall Study|Withdrawal by Subject|6|||
145436748|NCT00328172|524458714|FG004|Overall Study|Withdrawal by Subject|0|||
145583632|NCT00614939|524989404|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
145583633|NCT00840970|524989405|FG000|Overall Study|Adverse Event|0|||
145583634|NCT00840970|524989406|FG001|Overall Study|Adverse Event|0|||
145583635|NCT00840970|524989407|FG002|Overall Study|Adverse Event|1|||
145583636|NCT01751568|524989412|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
145583637|NCT01751568|524989413|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
145625139|NCT01515319|525139854|FG003|Overall Study|Protocol Violation|0|||
145625140|NCT01515319|525139855|FG004|Overall Study|Protocol Violation|0|||
145436749|NCT00328172|524458710|FG000|Overall Study|Lack of Efficacy|14|||
145625141|NCT01515319|525139856|FG005|Overall Study|Protocol Violation|0|||
145625142|NCT01515319|525139857|FG006|Overall Study|Protocol Violation|0|||
145436750|NCT00328172|524458711|FG001|Overall Study|Lack of Efficacy|9|||
145436751|NCT00328172|524458712|FG002|Overall Study|Lack of Efficacy|4|||
145436752|NCT00328172|524458713|FG003|Overall Study|Lack of Efficacy|4|||
145436753|NCT00328172|524458714|FG004|Overall Study|Lack of Efficacy|3|||
145436754|NCT00328172|524458710|FG000|Overall Study|Other reason (not specified)|3|||
145436755|NCT00328172|524458711|FG001|Overall Study|Other reason (not specified)|0|||
145436756|NCT00328172|524458712|FG002|Overall Study|Other reason (not specified)|1|||
145436757|NCT00328172|524458713|FG003|Overall Study|Other reason (not specified)|0|||
145436758|NCT00328172|524458714|FG004|Overall Study|Other reason (not specified)|0|||
145436759|NCT00558636|524458715|FG000|Treatment|Adverse Event|9|||
145436760|NCT00558636|524458716|FG001|Treatment|Adverse Event|2|||
145436761|NCT00558636|524458715|FG000|Treatment|Withdrawal by Subject|2|||
145436762|NCT00558636|524458716|FG001|Treatment|Withdrawal by Subject|0|||
145436763|NCT00558636|524458715|FG000|Treatment|Premature termination of the study|35|||
145436764|NCT00558636|524458716|FG001|Treatment|Premature termination of the study|37|||
145436765|NCT00558636|524458715|FG000|Treatment|Disease progression|1|||
145436766|NCT00558636|524458716|FG001|Treatment|Disease progression|5|||
145436767|NCT00558636|524458715|FG000|Follow-up|Premature termination of the study|12|||
145436768|NCT00558636|524458716|FG001|Follow-up|Premature termination of the study|7|||
145436769|NCT01990742|524458717|FG000|Overall Study|Withdrawal by facility|407|||
145436770|NCT01990742|524458718|FG001|Overall Study|Withdrawal by facility|1083|||
145436771|NCT01990742|524458717|FG000|Overall Study|Facility closed|0|||
145436772|NCT01990742|524458718|FG001|Overall Study|Facility closed|270|||
145436773|NCT03443687|524458719|FG000|Overall Study|Lost to Follow-up|3|||
145436774|NCT03443687|524458720|FG001|Overall Study|Lost to Follow-up|5|||
145436775|NCT03443687|524458719|FG000|Overall Study|Withdrawal by Subject|1|||
145436776|NCT03443687|524458720|FG001|Overall Study|Withdrawal by Subject|0|||
145436777|NCT03443687|524458719|FG000|Overall Study|Discontinued intervention|1|||
145436778|NCT03443687|524458720|FG001|Overall Study|Discontinued intervention|1|||
145436779|NCT02329743|524458728|FG000|Overall Study|Adverse Event|1|||
145436780|NCT02329743|524458729|FG001|Overall Study|Adverse Event|1|||
145436781|NCT02329743|524458730|FG002|Overall Study|Adverse Event|3|||
145436782|NCT02329743|524458728|FG000|Overall Study|Lost to Follow-up|1|||
145436783|NCT02329743|524458729|FG001|Overall Study|Lost to Follow-up|0|||
145436784|NCT02329743|524458730|FG002|Overall Study|Lost to Follow-up|1|||
145436785|NCT02329743|524458728|FG000|Overall Study|Withdrawal by Subject|4|||
145436786|NCT02329743|524458729|FG001|Overall Study|Withdrawal by Subject|4|||
145436787|NCT02329743|524458730|FG002|Overall Study|Withdrawal by Subject|1|||
145436788|NCT02329743|524458728|FG000|Overall Study|Other|0|||
145436789|NCT02329743|524458729|FG001|Overall Study|Other|2|||
145436790|NCT02329743|524458730|FG002|Overall Study|Other|3|||
145436791|NCT05518461|524458739|FG000|Overall Study|Lost to Follow-up|25|||
145436792|NCT03326063|524458741|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
145436793|NCT03326063|524458742|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
145436794|NCT01876381|524458743|FG000|Overall Study|Lack of Efficacy|5|||
145436795|NCT01876381|524458743|FG000|Overall Study|Physician Decision|1|||
145436796|NCT01876381|524458743|FG000|Overall Study|Withdrawal by Subject|1|||
145436797|NCT00332696|524458744|FG000|Overall Study|Death|24|||
145436798|NCT00332696|524458745|FG001|Overall Study|Death|14|||
145436799|NCT00332696|524458744|FG000|Overall Study|Insufficient therapeutic effect|4|||
145436800|NCT00332696|524458745|FG001|Overall Study|Insufficient therapeutic effect|11|||
145436801|NCT00332696|524458744|FG000|Overall Study|Adverse Event|1|||
145436802|NCT00332696|524458745|FG001|Overall Study|Adverse Event|2|||
145436803|NCT00332696|524458744|FG000|Overall Study|Condition does not justify treatment|0|||
145436804|NCT00332696|524458745|FG001|Overall Study|Condition does not justify treatment|2|||
145436805|NCT00332696|524458744|FG000|Overall Study|Lost to Follow-up|0|||
145436806|NCT00332696|524458745|FG001|Overall Study|Lost to Follow-up|1|||
145583638|NCT01751568|524989414|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
145583639|NCT02504866|524989415|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
145583640|NCT02504866|524989416|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
145583641|NCT02504866|524989417|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
145583642|NCT01775137|524989418|FG000|Overall Study|Death|1|||
145583643|NCT01775137|524989418|FG000|Overall Study|Protocol deviation|2|||
145583644|NCT01775137|524989418|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145436807|NCT00332696|524458744|FG000|Overall Study|Withdrawal by Subject|1|||
145436808|NCT00332696|524458745|FG001|Overall Study|Withdrawal by Subject|0|||
145436809|NCT00382174|524458746|FG000|Overall Study|Lost to Follow-up|1|||
145436810|NCT00382174|524458747|FG001|Overall Study|Lost to Follow-up|4|||
145583645|NCT01775137|524989418|FG000|Overall Study|Adverse Event|1|||
145583646|NCT01775137|524989418|FG000|Overall Study|Withdrawal by participants|5|||
145625143|NCT01515319|525139858|FG007|Overall Study|Protocol Violation|0|||
145436811|NCT00382174|524458748|FG002|Overall Study|Lost to Follow-up|5|||
145583647|NCT02673697|524989421|FG000|Overall Study|Adverse Event|2|||
145625144|NCT01515319|525139859|FG008|Overall Study|Protocol Violation|2|||
145436812|NCT00382174|524458746|FG000|Overall Study|Adverse Event|1|||
145436813|NCT00382174|524458747|FG001|Overall Study|Adverse Event|4|||
145436814|NCT00382174|524458748|FG002|Overall Study|Adverse Event|5|||
145436815|NCT00382174|524458746|FG000|Overall Study|Withdrawal by Subject|1|||
145436816|NCT00382174|524458747|FG001|Overall Study|Withdrawal by Subject|4|||
145436817|NCT00382174|524458748|FG002|Overall Study|Withdrawal by Subject|5|||
145436818|NCT00382174|524458746|FG000|Overall Study|Non compliance|1|||
145436819|NCT00382174|524458747|FG001|Overall Study|Non compliance|0|||
145436820|NCT00382174|524458748|FG002|Overall Study|Non compliance|1|||
145436821|NCT00382174|524458746|FG000|Overall Study|Physician Decision|0|||
145436822|NCT00382174|524458747|FG001|Overall Study|Physician Decision|2|||
145436823|NCT00382174|524458748|FG002|Overall Study|Physician Decision|2|||
145436824|NCT00382174|524458746|FG000|Overall Study|Failed to meet criteria|0|||
145436825|NCT00382174|524458747|FG001|Overall Study|Failed to meet criteria|1|||
145436826|NCT00382174|524458748|FG002|Overall Study|Failed to meet criteria|1|||
145436827|NCT00382174|524458746|FG000|Overall Study|Wounds merged|0|||
145436828|NCT00382174|524458747|FG001|Overall Study|Wounds merged|2|||
145436829|NCT00382174|524458748|FG002|Overall Study|Wounds merged|2|||
145436830|NCT00461708|524458749|FG000|Overall Study|Adverse Event|17|||
145436831|NCT00461708|524458750|FG001|Overall Study|Adverse Event|7|||
145436832|NCT00461708|524458749|FG000|Overall Study|Lack of Efficacy|68|||
145436833|NCT00461708|524458750|FG001|Overall Study|Lack of Efficacy|20|||
145436834|NCT00461708|524458749|FG000|Overall Study|Physician Decision|10|||
145436835|NCT00461708|524458750|FG001|Overall Study|Physician Decision|4|||
145436836|NCT00461708|524458749|FG000|Overall Study|Withdrawal by Subject|8|||
145436837|NCT00461708|524458750|FG001|Overall Study|Withdrawal by Subject|2|||
145436838|NCT00461708|524458749|FG000|Overall Study|Other|4|||
145436839|NCT00461708|524458750|FG001|Overall Study|Other|4|||
145436840|NCT00461708|524458749|FG000|Overall Study|Death|8|||
145436841|NCT00461708|524458750|FG001|Overall Study|Death|1|||
145436842|NCT02750514|524458751|FG000|Track 1|Disease progression|20|||
145436843|NCT02750514|524458752|FG001|Track 1|Disease progression|1|||
145436844|NCT02750514|524458753|FG002|Track 1|Disease progression|0|||
145436845|NCT02750514|524458754|FG003|Track 1|Disease progression|1|||
145436846|NCT02750514|524458755|FG004|Track 1|Disease progression|0|||
145436847|NCT02750514|524458751|FG000|Track 1|Adverse event unrelated to study drug|1|||
145436848|NCT02750514|524458752|FG001|Track 1|Adverse event unrelated to study drug|0|||
145436849|NCT02750514|524458753|FG002|Track 1|Adverse event unrelated to study drug|0|||
145436850|NCT02750514|524458754|FG003|Track 1|Adverse event unrelated to study drug|0|||
145436851|NCT02750514|524458755|FG004|Track 1|Adverse event unrelated to study drug|0|||
145436852|NCT02750514|524458751|FG000|Track 1|Study drug toxicity|4|||
145436853|NCT02750514|524458752|FG001|Track 1|Study drug toxicity|1|||
145436854|NCT02750514|524458753|FG002|Track 1|Study drug toxicity|0|||
145436855|NCT02750514|524458754|FG003|Track 1|Study drug toxicity|1|||
145436856|NCT02750514|524458755|FG004|Track 1|Study drug toxicity|0|||
145436857|NCT02750514|524458751|FG000|Track 1|Participant request to discontinue|1|||
145436858|NCT02750514|524458752|FG001|Track 1|Participant request to discontinue|0|||
145436859|NCT02750514|524458753|FG002|Track 1|Participant request to discontinue|0|||
145436860|NCT02750514|524458754|FG003|Track 1|Participant request to discontinue|0|||
145436861|NCT02750514|524458755|FG004|Track 1|Participant request to discontinue|0|||
145436862|NCT02750514|524458751|FG000|Track 1|Other reasons|1|||
145436863|NCT02750514|524458752|FG001|Track 1|Other reasons|0|||
145436864|NCT02750514|524458753|FG002|Track 1|Other reasons|0|||
145436865|NCT02750514|524458754|FG003|Track 1|Other reasons|0|||
145436866|NCT02750514|524458755|FG004|Track 1|Other reasons|0|||
145436867|NCT02750514|524458751|FG000|Track 2|Disease progression|4|||
145436868|NCT02750514|524458752|FG001|Track 2|Disease progression|5|||
145436869|NCT02750514|524458753|FG002|Track 2|Disease progression|2|||
145436870|NCT02750514|524458754|FG003|Track 2|Disease progression|5|||
145436871|NCT02750514|524458755|FG004|Track 2|Disease progression|0|||
145436872|NCT02750514|524458751|FG000|Track 2|Adverse event unrelated to study drug|1|||
145436873|NCT02750514|524458752|FG001|Track 2|Adverse event unrelated to study drug|0|||
145436874|NCT02750514|524458753|FG002|Track 2|Adverse event unrelated to study drug|0|||
145436875|NCT02750514|524458754|FG003|Track 2|Adverse event unrelated to study drug|0|||
145436876|NCT02750514|524458755|FG004|Track 2|Adverse event unrelated to study drug|0|||
145436877|NCT02750514|524458751|FG000|Track 2|Study drug toxicity|1|||
145436878|NCT02750514|524458752|FG001|Track 2|Study drug toxicity|2|||
145436879|NCT02750514|524458753|FG002|Track 2|Study drug toxicity|0|||
145436880|NCT02750514|524458754|FG003|Track 2|Study drug toxicity|2|||
145436881|NCT02750514|524458755|FG004|Track 2|Study drug toxicity|0|||
145436882|NCT02750514|524458751|FG000|Track 2|Participant withdrew consent|0|||
145436883|NCT02750514|524458752|FG001|Track 2|Participant withdrew consent|1|||
145436884|NCT02750514|524458753|FG002|Track 2|Participant withdrew consent|0|||
145436885|NCT02750514|524458754|FG003|Track 2|Participant withdrew consent|0|||
145436886|NCT02750514|524458755|FG004|Track 2|Participant withdrew consent|0|||
145436887|NCT02750514|524458751|FG000|Track 3|Disease progression|0|||
145436888|NCT02750514|524458752|FG001|Track 3|Disease progression|24|||
145436889|NCT02750514|524458753|FG002|Track 3|Disease progression|13|||
145436890|NCT02750514|524458754|FG003|Track 3|Disease progression|14|||
145436891|NCT02750514|524458755|FG004|Track 3|Disease progression|0|||
145436892|NCT02750514|524458751|FG000|Track 3|Adverse event unrelated to study drug|0|||
145436893|NCT02750514|524458752|FG001|Track 3|Adverse event unrelated to study drug|1|||
145436894|NCT02750514|524458753|FG002|Track 3|Adverse event unrelated to study drug|1|||
145436895|NCT02750514|524458754|FG003|Track 3|Adverse event unrelated to study drug|1|||
145436896|NCT02750514|524458755|FG004|Track 3|Adverse event unrelated to study drug|0|||
145436897|NCT02750514|524458751|FG000|Track 3|Study drug toxicity|0|||
145436898|NCT02750514|524458752|FG001|Track 3|Study drug toxicity|3|||
145436899|NCT02750514|524458753|FG002|Track 3|Study drug toxicity|0|||
145436900|NCT02750514|524458754|FG003|Track 3|Study drug toxicity|1|||
145436901|NCT02750514|524458755|FG004|Track 3|Study drug toxicity|0|||
145436902|NCT02750514|524458751|FG000|Track 3|Participant request to discontinue|0|||
145436903|NCT02750514|524458752|FG001|Track 3|Participant request to discontinue|2|||
145436904|NCT02750514|524458753|FG002|Track 3|Participant request to discontinue|0|||
145436905|NCT02750514|524458754|FG003|Track 3|Participant request to discontinue|0|||
145436906|NCT02750514|524458755|FG004|Track 3|Participant request to discontinue|0|||
145436907|NCT02750514|524458751|FG000|Track 3|Participant withdrew consent|0|||
145436908|NCT02750514|524458752|FG001|Track 3|Participant withdrew consent|3|||
145436909|NCT02750514|524458753|FG002|Track 3|Participant withdrew consent|1|||
145436910|NCT02750514|524458754|FG003|Track 3|Participant withdrew consent|0|||
145436911|NCT02750514|524458755|FG004|Track 3|Participant withdrew consent|0|||
145436912|NCT02750514|524458751|FG000|Track 3|Other reasons|0|||
145436913|NCT02750514|524458752|FG001|Track 3|Other reasons|3|||
145436914|NCT02750514|524458753|FG002|Track 3|Other reasons|0|||
145436915|NCT02750514|524458754|FG003|Track 3|Other reasons|0|||
145436916|NCT02750514|524458755|FG004|Track 3|Other reasons|0|||
145436917|NCT02750514|524458751|FG000|Track 4|Study drug toxicity|0|||
145436918|NCT02750514|524458752|FG001|Track 4|Study drug toxicity|6|||
145436919|NCT02750514|524458753|FG002|Track 4|Study drug toxicity|0|||
145436920|NCT02750514|524458754|FG003|Track 4|Study drug toxicity|5|||
145436921|NCT02750514|524458755|FG004|Track 4|Study drug toxicity|0|||
145436922|NCT02750514|524458751|FG000|Track 4|Participant request to discontinue|0|||
145436923|NCT02750514|524458752|FG001|Track 4|Participant request to discontinue|1|||
145436924|NCT02750514|524458753|FG002|Track 4|Participant request to discontinue|0|||
145436925|NCT02750514|524458754|FG003|Track 4|Participant request to discontinue|1|||
145436926|NCT02750514|524458755|FG004|Track 4|Participant request to discontinue|0|||
145436927|NCT02750514|524458751|FG000|Track 4|Participant withdrew consent|0|||
145436928|NCT02750514|524458752|FG001|Track 4|Participant withdrew consent|1|||
145436929|NCT02750514|524458753|FG002|Track 4|Participant withdrew consent|0|||
145436930|NCT02750514|524458754|FG003|Track 4|Participant withdrew consent|0|||
145436931|NCT02750514|524458755|FG004|Track 4|Participant withdrew consent|0|||
145436932|NCT02750514|524458751|FG000|Track 4|Other reasons|0|||
145436933|NCT02750514|524458752|FG001|Track 4|Other reasons|5|||
145436934|NCT02750514|524458753|FG002|Track 4|Other reasons|0|||
145436935|NCT02750514|524458754|FG003|Track 4|Other reasons|3|||
145436936|NCT02750514|524458755|FG004|Track 4|Other reasons|0|||
145436937|NCT02750514|524458751|FG000|Track 4|Disease progression|0|||
145436938|NCT02750514|524458752|FG001|Track 4|Disease progression|33|||
145436939|NCT02750514|524458753|FG002|Track 4|Disease progression|0|||
145436940|NCT02750514|524458754|FG003|Track 4|Disease progression|32|||
145436941|NCT02750514|524458755|FG004|Track 4|Disease progression|0|||
145436942|NCT02750514|524458751|FG000|Track 4|Adverse event unrelated to study drug|0|||
145436943|NCT02750514|524458752|FG001|Track 4|Adverse event unrelated to study drug|5|||
145436944|NCT02750514|524458753|FG002|Track 4|Adverse event unrelated to study drug|0|||
145436945|NCT02750514|524458754|FG003|Track 4|Adverse event unrelated to study drug|0|||
145436946|NCT02750514|524458755|FG004|Track 4|Adverse event unrelated to study drug|0|||
145436947|NCT02750514|524458751|FG000|Track 4|Death|0|||
145436948|NCT02750514|524458752|FG001|Track 4|Death|0|||
145436949|NCT02750514|524458753|FG002|Track 4|Death|0|||
145436950|NCT02750514|524458754|FG003|Track 4|Death|1|||
145583648|NCT02673697|524989422|FG001|Overall Study|Adverse Event|0|||
145583649|NCT02673697|524989421|FG000|Overall Study|Death|32|||
145583650|NCT02673697|524989422|FG001|Overall Study|Death|24|||
145583651|NCT02673697|524989421|FG000|Overall Study|Lost to Follow-up|5|||
145583652|NCT02673697|524989422|FG001|Overall Study|Lost to Follow-up|2|||
145583653|NCT02673697|524989421|FG000|Overall Study|Physician Decision|2|||
145583654|NCT02673697|524989422|FG001|Overall Study|Physician Decision|1|||
145583655|NCT02673697|524989421|FG000|Overall Study|Withdrawal by Subject|10|||
145583656|NCT02673697|524989422|FG001|Overall Study|Withdrawal by Subject|7|||
145583657|NCT02673697|524989421|FG000|Overall Study|Change subj medical status|1|||
145436951|NCT02750514|524458755|FG004|Track 4|Death|0|||
145436952|NCT02750514|524458751|FG000|Track 5|Disease progression|0|||
145436953|NCT02750514|524458752|FG001|Track 5|Disease progression|0|||
145436954|NCT02750514|524458753|FG002|Track 5|Disease progression|0|||
145436955|NCT02750514|524458754|FG003|Track 5|Disease progression|0|||
145436956|NCT02750514|524458755|FG004|Track 5|Disease progression|34|||
145436957|NCT02750514|524458751|FG000|Track 5|Adverse event unrelated to study drug|0|||
145436958|NCT02750514|524458752|FG001|Track 5|Adverse event unrelated to study drug|0|||
145436959|NCT02750514|524458753|FG002|Track 5|Adverse event unrelated to study drug|0|||
145583658|NCT02673697|524989422|FG001|Overall Study|Change subj medical status|2|||
145436960|NCT02750514|524458754|FG003|Track 5|Adverse event unrelated to study drug|0|||
145436961|NCT02750514|524458755|FG004|Track 5|Adverse event unrelated to study drug|2|||
145436962|NCT02750514|524458751|FG000|Track 5|Study drug toxicity|0|||
145436963|NCT02750514|524458752|FG001|Track 5|Study drug toxicity|0|||
145436964|NCT02750514|524458753|FG002|Track 5|Study drug toxicity|0|||
145436965|NCT02750514|524458754|FG003|Track 5|Study drug toxicity|0|||
145436966|NCT02750514|524458755|FG004|Track 5|Study drug toxicity|2|||
145436967|NCT02750514|524458751|FG000|Track 5|Participant request to discontinue|0|||
145436968|NCT02750514|524458752|FG001|Track 5|Participant request to discontinue|0|||
145436969|NCT02750514|524458753|FG002|Track 5|Participant request to discontinue|0|||
145436970|NCT02750514|524458754|FG003|Track 5|Participant request to discontinue|0|||
145436971|NCT02750514|524458755|FG004|Track 5|Participant request to discontinue|3|||
145436972|NCT02750514|524458751|FG000|Track 5|Other reasons|0|||
145436973|NCT02750514|524458752|FG001|Track 5|Other reasons|0|||
145436974|NCT02750514|524458753|FG002|Track 5|Other reasons|0|||
145436975|NCT02750514|524458754|FG003|Track 5|Other reasons|0|||
145436976|NCT02750514|524458755|FG004|Track 5|Other reasons|2|||
145436977|NCT01464879|524458756|FG000|Overall Study|Physician Decision|1|||
145436978|NCT01464879|524458756|FG000|Overall Study|Non-compliance|1|||
145436979|NCT02230189|524458757|FG000|Overall Study|Withdrawal by Subject|3|||
145436980|NCT02230189|524458758|FG001|Overall Study|Withdrawal by Subject|0|||
145583659|NCT02673697|524989421|FG000|Overall Study|Explant|10|||
145583660|NCT02673697|524989422|FG001|Overall Study|Explant|5|||
145583661|NCT02673697|524989421|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
145583662|NCT02673697|524989422|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
145583663|NCT00437489|524989423|FG000|Overall Study|Study terminated by sponsor|23|||
145436981|NCT02230189|524458759|FG002|Overall Study|Withdrawal by Subject|1|||
145436982|NCT02230189|524458757|FG000|Overall Study|Lost to Follow-up|1|||
145436983|NCT02230189|524458758|FG001|Overall Study|Lost to Follow-up|0|||
145436984|NCT02230189|524458759|FG002|Overall Study|Lost to Follow-up|0|||
145436985|NCT02230189|524458757|FG000|Overall Study|Physician Decision|1|||
145436986|NCT02230189|524458758|FG001|Overall Study|Physician Decision|0|||
145436987|NCT02230189|524458759|FG002|Overall Study|Physician Decision|0|||
145436988|NCT02271529|524458765|FG000|Overall Study|Withdrawal by Subject|1|||
145436989|NCT00811720|524458766|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
145436990|NCT00811720|524458767|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
145436991|NCT00811720|524458766|FG000|All Treated Patients|Adverse Event|20|||
145436992|NCT00811720|524458767|FG001|All Treated Patients|Adverse Event|62|||
145436993|NCT00811720|524458766|FG000|All Treated Patients|Lack of Efficacy|22|||
145436994|NCT00811720|524458767|FG001|All Treated Patients|Lack of Efficacy|18|||
145436995|NCT00811720|524458766|FG000|All Treated Patients|Non-compliance|0|||
145436996|NCT00811720|524458767|FG001|All Treated Patients|Non-compliance|14|||
145436997|NCT00811720|524458766|FG000|All Treated Patients|Protocol Violation|9|||
145436998|NCT00811720|524458767|FG001|All Treated Patients|Protocol Violation|16|||
145436999|NCT00811720|524458766|FG000|All Treated Patients|Withdrawal by Subject|28|||
145437000|NCT00811720|524458767|FG001|All Treated Patients|Withdrawal by Subject|34|||
145437001|NCT00811720|524458766|FG000|All Treated Patients|Lost to Follow-up|10|||
145437002|NCT00811720|524458767|FG001|All Treated Patients|Lost to Follow-up|16|||
145437003|NCT00811720|524458766|FG000|All Treated Patients|Other Reason|7|||
145437004|NCT00811720|524458767|FG001|All Treated Patients|Other Reason|4|||
145437005|NCT00800982|524458769|FG000|Overall Study|Lost to Follow-up|1|||
145437006|NCT00800982|524458770|FG001|Overall Study|Lost to Follow-up|2|||
145437007|NCT00800982|524458769|FG000|Overall Study|Withdrawal by Subject|0|||
145437008|NCT00800982|524458770|FG001|Overall Study|Withdrawal by Subject|1|||
145437009|NCT00800982|524458769|FG000|Overall Study|Patient moved out of state|1|||
145437010|NCT00800982|524458770|FG001|Overall Study|Patient moved out of state|0|||
145437011|NCT01824290|524458771|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
145437012|NCT01824290|524458772|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
145437013|NCT01824290|524458773|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
145437014|NCT01824290|524458774|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
145437015|NCT01824290|524458771|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
145437016|NCT01824290|524458772|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
145437017|NCT01824290|524458773|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
145437018|NCT01824290|524458774|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
145437019|NCT01824290|524458771|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
145437020|NCT01824290|524458772|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
145437021|NCT01824290|524458773|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
145437022|NCT01824290|524458774|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
145437023|NCT01824290|524458771|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
145437024|NCT01824290|524458772|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
145437025|NCT01824290|524458773|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
145437026|NCT01824290|524458774|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
145437027|NCT01824290|524458771|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
145437028|NCT01824290|524458772|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
145437029|NCT01824290|524458773|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
145437030|NCT01824290|524458774|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
145437031|NCT01824290|524458771|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
145437032|NCT01824290|524458772|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
145437033|NCT01824290|524458773|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
145437034|NCT01824290|524458774|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
145437035|NCT00699413|524458776|FG000|Overall Study|Withdrawal by Subject|0|||
145437036|NCT00699413|524458777|FG001|Overall Study|Withdrawal by Subject|2|||
145437037|NCT00699413|524458776|FG000|Overall Study|Study terminated by sponsor|4|||
145437038|NCT00699413|524458777|FG001|Overall Study|Study terminated by sponsor|2|||
145437039|NCT02779777|524458778|FG000|Overall Study|Disease Progression|1|||
145437040|NCT02779777|524458779|FG001|Overall Study|Disease Progression|0|||
145437041|NCT02779777|524458780|FG002|Overall Study|Disease Progression|0|||
145437042|NCT02779777|524458778|FG000|Overall Study|Adverse Event|3|||
145437043|NCT02779777|524458779|FG001|Overall Study|Adverse Event|1|||
145437044|NCT02779777|524458780|FG002|Overall Study|Adverse Event|0|||
145437045|NCT02779777|524458778|FG000|Overall Study|Physician Decision|9|||
145437046|NCT02779777|524458779|FG001|Overall Study|Physician Decision|0|||
145437047|NCT02779777|524458780|FG002|Overall Study|Physician Decision|1|||
145437048|NCT02779777|524458778|FG000|Overall Study|Withdrawal by Subject|1|||
145437049|NCT02779777|524458779|FG001|Overall Study|Withdrawal by Subject|0|||
145437050|NCT02779777|524458780|FG002|Overall Study|Withdrawal by Subject|0|||
145437051|NCT03289533|524458781|FG000|Overall Study|Death|12|||
145437052|NCT03289533|524458781|FG000|Overall Study|Terminated from study by sponsor|10|||
145437053|NCT00539240|524458782|FG000|Overall Study|Withdrawal by Subject|0|||
145437054|NCT00539240|524458783|FG001|Overall Study|Withdrawal by Subject|2|||
145437055|NCT00539240|524458784|FG002|Overall Study|Withdrawal by Subject|0|||
145437056|NCT00539240|524458782|FG000|Overall Study|Protocol Violation|1|||
145437057|NCT00539240|524458783|FG001|Overall Study|Protocol Violation|1|||
145437058|NCT00539240|524458784|FG002|Overall Study|Protocol Violation|4|||
145437059|NCT00539240|524458782|FG000|Overall Study|Lost to Follow-up|2|||
145437060|NCT00539240|524458783|FG001|Overall Study|Lost to Follow-up|3|||
145437061|NCT00539240|524458784|FG002|Overall Study|Lost to Follow-up|1|||
145437062|NCT00539240|524458782|FG000|Overall Study|Adverse Event|3|||
145437063|NCT00539240|524458783|FG001|Overall Study|Adverse Event|1|||
145437064|NCT00539240|524458784|FG002|Overall Study|Adverse Event|10|||
145437065|NCT01055613|524458785|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
145437066|NCT01055613|524458786|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145437067|NCT01055613|524458785|FG000|Overall Study|Unacceptable lens fit|1|||
145437068|NCT01055613|524458786|FG001|Overall Study|Unacceptable lens fit|0|||
145437069|NCT01055613|524458785|FG000|Overall Study|Discomfort|2|||
145437070|NCT01055613|524458786|FG001|Overall Study|Discomfort|1|||
145437071|NCT01055613|524458785|FG000|Overall Study|Lost to Follow-up|1|||
145437072|NCT01055613|524458786|FG001|Overall Study|Lost to Follow-up|1|||
145437073|NCT01055613|524458785|FG000|Overall Study|Protocol Violation|1|||
145437074|NCT01055613|524458786|FG001|Overall Study|Protocol Violation|1|||
145437075|NCT01055613|524458785|FG000|Overall Study|Subject Disinterest|1|||
145437076|NCT01055613|524458786|FG001|Overall Study|Subject Disinterest|1|||
145437077|NCT01595529|524458787|FG000|Overall Study|Adverse Event|2|||
145437078|NCT01595529|524458788|FG001|Overall Study|Adverse Event|0|||
145437079|NCT01595529|524458787|FG000|Overall Study|Subject Non-Compliant|2|||
145437080|NCT01595529|524458788|FG001|Overall Study|Subject Non-Compliant|0|||
145437081|NCT01595529|524458787|FG000|Overall Study|Lost to Follow-up|8|||
145437082|NCT01595529|524458788|FG001|Overall Study|Lost to Follow-up|14|||
145437083|NCT01595529|524458787|FG000|Overall Study|Protocol Violation|1|||
145437084|NCT01595529|524458788|FG001|Overall Study|Protocol Violation|2|||
145437085|NCT01595529|524458787|FG000|Overall Study|Physician Decision|1|||
145437086|NCT01595529|524458788|FG001|Overall Study|Physician Decision|0|||
145437087|NCT01595529|524458787|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
145437088|NCT01595529|524458788|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
145437089|NCT01595529|524458787|FG000|Overall Study|Administrative Decision|1|||
145437090|NCT01595529|524458788|FG001|Overall Study|Administrative Decision|0|||
145437091|NCT01595529|524458787|FG000|Overall Study|Entry Failure/Screening Failure|6|||
145437092|NCT01595529|524458788|FG001|Overall Study|Entry Failure/Screening Failure|1|||
145437093|NCT02629861|524458791|FG000|Overall Study|Adverse Event|7|||
145437094|NCT02629861|524458792|FG001|Overall Study|Adverse Event|5|||
145437095|NCT02629861|524458793|FG002|Overall Study|Adverse Event|4|||
145437096|NCT02629861|524458791|FG000|Overall Study|Withdrawal by Subject|5|||
145437097|NCT02629861|524458792|FG001|Overall Study|Withdrawal by Subject|8|||
145437098|NCT02629861|524458793|FG002|Overall Study|Withdrawal by Subject|13|||
145437099|NCT02629861|524458791|FG000|Overall Study|Protocol Violation|2|||
145437100|NCT02629861|524458792|FG001|Overall Study|Protocol Violation|3|||
145437101|NCT02629861|524458793|FG002|Overall Study|Protocol Violation|7|||
145437102|NCT02629861|524458791|FG000|Overall Study|Lost to Follow-up|12|||
145583664|NCT00437489|524989424|FG001|Overall Study|Study terminated by sponsor|21|||
145583665|NCT00437489|524989423|FG000|Overall Study|Lost to Follow-up|0|||
145583666|NCT00437489|524989424|FG001|Overall Study|Lost to Follow-up|1|||
145625145|NCT01515319|525139860|FG009|Overall Study|Protocol Violation|0|||
145437103|NCT02629861|524458792|FG001|Overall Study|Lost to Follow-up|9|||
145437104|NCT02629861|524458793|FG002|Overall Study|Lost to Follow-up|4|||
145437105|NCT02629861|524458791|FG000|Overall Study|Other|1|||
145437106|NCT02629861|524458792|FG001|Overall Study|Other|1|||
145437107|NCT02629861|524458793|FG002|Overall Study|Other|0|||
145437108|NCT02629861|524458791|FG000|Overall Study|Pregnancy|2|||
145437109|NCT02629861|524458792|FG001|Overall Study|Pregnancy|1|||
145437110|NCT02629861|524458793|FG002|Overall Study|Pregnancy|0|||
145437111|NCT00730886|524458794|FG000|Overall Study|Lost to Follow-up|1|||
145437112|NCT00730886|524458795|FG001|Overall Study|Lost to Follow-up|0|||
145437113|NCT00730886|524458794|FG000|Overall Study|Physician Decision|1|||
145437114|NCT00730886|524458795|FG001|Overall Study|Physician Decision|0|||
145437115|NCT01991483|524458796|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
145437116|NCT01991483|524458797|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
145437117|NCT01991483|524458798|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
145437118|NCT01991483|524458799|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
145437119|NCT01991483|524458796|FG000|Dose Level 600 mg|Physician Decision|0|||
145437120|NCT01991483|524458797|FG001|Dose Level 600 mg|Physician Decision|0|||
145437121|NCT01991483|524458798|FG002|Dose Level 600 mg|Physician Decision|1|||
145437122|NCT01991483|524458799|FG003|Dose Level 600 mg|Physician Decision|0|||
145437123|NCT01991483|524458796|FG000|Dose Level 1000 mg|Protocol Violation|0|||
145437124|NCT01991483|524458797|FG001|Dose Level 1000 mg|Protocol Violation|0|||
145437125|NCT01991483|524458798|FG002|Dose Level 1000 mg|Protocol Violation|0|||
145437126|NCT01991483|524458799|FG003|Dose Level 1000 mg|Protocol Violation|1|||
145437127|NCT02030821|524458802|FG000|Overall Study|Physician Decision|2|||
145437128|NCT02030821|524458803|FG001|Overall Study|Physician Decision|2|||
145437129|NCT02030821|524458804|FG002|Overall Study|Physician Decision|5|||
145437130|NCT02030821|524458805|FG003|Overall Study|Physician Decision|2|||
145437131|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
145437132|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
145437133|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
145437134|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
145437135|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
145437136|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
145437137|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
145437138|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
145437139|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
145437140|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
145437141|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
145437142|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
145437143|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
145437144|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
145437145|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
145437146|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
145437147|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
145437148|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
145437149|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
145437150|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
145437151|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
145437152|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
145437153|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
145437154|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
145437155|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
145437156|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
145437157|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
145437158|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
145437159|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
145437160|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
145437161|NCT00716274|524458807|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
145437162|NCT00716274|524458808|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
145437163|NCT00716274|524458809|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
145437164|NCT00716274|524458810|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
145437165|NCT00716274|524458811|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
145437166|NCT00716274|524458812|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
145437167|NCT00716274|524458807|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
145437168|NCT00716274|524458808|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
145437169|NCT00716274|524458809|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
145437170|NCT00716274|524458810|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
145437171|NCT00716274|524458811|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
145437172|NCT00716274|524458812|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
145437173|NCT00716274|524458807|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
145437174|NCT00716274|524458808|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
145437175|NCT00716274|524458809|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
145437176|NCT00716274|524458810|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
145437177|NCT00716274|524458811|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
145437178|NCT00716274|524458812|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
145437179|NCT00716274|524458807|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
145437180|NCT00716274|524458808|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
145437181|NCT00716274|524458809|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
145437182|NCT00716274|524458810|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
145437183|NCT00716274|524458811|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
145437184|NCT00716274|524458812|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
145437185|NCT00716274|524458807|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
145437186|NCT00716274|524458808|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
145437187|NCT00716274|524458809|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
145437188|NCT00716274|524458810|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
145437189|NCT00716274|524458811|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
145437190|NCT00716274|524458812|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
145437191|NCT00444106|524458822|FG000|Overall Study|Lost to Follow-up|2|||
145437192|NCT00444106|524458823|FG001|Overall Study|Lost to Follow-up|1|||
145437193|NCT00444106|524458824|FG002|Overall Study|Lost to Follow-up|0|||
145437194|NCT00444106|524458822|FG000|Overall Study|Abnormal Test Procedure Results|0|||
145437195|NCT00444106|524458823|FG001|Overall Study|Abnormal Test Procedure Results|0|||
145437196|NCT00444106|524458824|FG002|Overall Study|Abnormal Test Procedure Results|1|||
145437197|NCT01634152|524458825|FG000|Overall Study|Adverse Event|2|||
145437198|NCT01634152|524458826|FG001|Overall Study|Adverse Event|0|||
145437199|NCT01634152|524458827|FG002|Overall Study|Adverse Event|2|||
145437200|NCT01634152|524458825|FG000|Overall Study|Consent withdrawn not due to AE|1|||
145437201|NCT01634152|524458826|FG001|Overall Study|Consent withdrawn not due to AE|0|||
145437202|NCT01634152|524458827|FG002|Overall Study|Consent withdrawn not due to AE|1|||
145437203|NCT01634152|524458825|FG000|Overall Study|Not treated|0|||
145437204|NCT01634152|524458826|FG001|Overall Study|Not treated|1|||
145437205|NCT01634152|524458827|FG002|Overall Study|Not treated|0|||
145437206|NCT01634152|524458825|FG000|Overall Study|Other reason not defined above|1|||
145437207|NCT01634152|524458826|FG001|Overall Study|Other reason not defined above|0|||
145437208|NCT01634152|524458827|FG002|Overall Study|Other reason not defined above|1|||
145437209|NCT01152437|524458828|FG000|Overall Study|Other Adverse Event|8|||
145437210|NCT01152437|524458829|FG001|Overall Study|Other Adverse Event|1|||
145437211|NCT01152437|524458830|FG002|Overall Study|Other Adverse Event|7|||
145437212|NCT01152437|524458828|FG000|Overall Study|Not treated|0|||
145437213|NCT01152437|524458829|FG001|Overall Study|Not treated|1|||
145437214|NCT01152437|524458830|FG002|Overall Study|Not treated|2|||
145437215|NCT01152437|524458828|FG000|Overall Study|Progressive disease|27|||
145437216|NCT01152437|524458829|FG001|Overall Study|Progressive disease|13|||
145437217|NCT01152437|524458830|FG002|Overall Study|Progressive disease|32|||
145437218|NCT01152437|524458828|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
145437219|NCT01152437|524458829|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
145437220|NCT01152437|524458830|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
145437221|NCT00279214|524458832|FG000|Overall Study|Physician Decision|3|||
145437222|NCT00279214|524458833|FG001|Overall Study|Physician Decision|2|||
145437223|NCT01897532|524458835|FG000|Discontinuation From Treatment|Not Treated|7|||
145437224|NCT01897532|524458836|FG001|Discontinuation From Treatment|Not Treated|5|||
145437225|NCT01897532|524458835|FG000|Discontinuation From Treatment|Other reason than specified|196|||
145437226|NCT01897532|524458836|FG001|Discontinuation From Treatment|Other reason than specified|176|||
145437227|NCT01897532|524458835|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
145437228|NCT01897532|524458836|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
145437229|NCT01897532|524458835|FG000|Discontinuation From Treatment|Non compliance|24|||
145437230|NCT01897532|524458836|FG001|Discontinuation From Treatment|Non compliance|15|||
145437231|NCT01897532|524458835|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
145437232|NCT01897532|524458836|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
145437233|NCT01897532|524458835|FG000|Discontinuation From Trial|Not Treated|7|||
145437234|NCT01897532|524458836|FG001|Discontinuation From Trial|Not Treated|5|||
145437235|NCT01897532|524458835|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
145437236|NCT01897532|524458836|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
145437237|NCT00953706|524458839|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
145437238|NCT00953706|524458840|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
145437239|NCT00953706|524458841|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
145437240|NCT00953706|524458842|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
145437241|NCT00953706|524458839|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
145437242|NCT00953706|524458840|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
145437243|NCT00953706|524458841|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
145437244|NCT00953706|524458842|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
145437245|NCT00953706|524458839|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
145437246|NCT00953706|524458840|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
145437247|NCT00953706|524458841|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
145437248|NCT00953706|524458842|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
145437249|NCT00953706|524458839|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
145437250|NCT00953706|524458840|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
145437251|NCT00953706|524458841|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
145437252|NCT00953706|524458842|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
145437253|NCT00953706|524458839|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
145437254|NCT00953706|524458840|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
145437255|NCT00953706|524458841|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
145437256|NCT00953706|524458842|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
145437257|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
145437258|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
145437259|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
145437260|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
145437261|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
145437262|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
145437263|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
145437264|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
145437265|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
145437266|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
145437267|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
145437268|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
145437269|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
145437270|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
145437271|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
145437272|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
145437273|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
145437274|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
145437275|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
145437276|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
145437277|NCT00953706|524458839|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
145437278|NCT00953706|524458840|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
145437279|NCT00953706|524458841|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
145437280|NCT00953706|524458842|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
145437281|NCT00457626|524458843|FG000|Overall Study|Adverse Event|3|||
145437282|NCT00457626|524458843|FG000|Overall Study|Administrative Problems|2|||
145437283|NCT00457626|524458843|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
145437284|NCT01783444|524460513|FG000|Treatment Phase|Adverse Event|9|||
145437285|NCT01783444|524460514|FG001|Treatment Phase|Adverse Event|20|||
145437286|NCT01783444|524460515|FG002|Treatment Phase|Adverse Event|19|||
145437287|NCT01783444|524460513|FG000|Treatment Phase|Disease Progression|76|||
145437288|NCT01783444|524460514|FG001|Treatment Phase|Disease Progression|66|||
145437289|NCT01783444|524460515|FG002|Treatment Phase|Disease Progression|64|||
145437290|NCT01783444|524460513|FG000|Treatment Phase|Death|2|||
145437291|NCT01783444|524460514|FG001|Treatment Phase|Death|2|||
145437292|NCT01783444|524460515|FG002|Treatment Phase|Death|2|||
145437293|NCT01783444|524460513|FG000|Treatment Phase|Protocol Violation|1|||
145437294|NCT01783444|524460514|FG001|Treatment Phase|Protocol Violation|1|||
145437295|NCT01783444|524460515|FG002|Treatment Phase|Protocol Violation|2|||
145437296|NCT01783444|524460513|FG000|Treatment Phase|Withdrawal by Subject|6|||
145437297|NCT01783444|524460514|FG001|Treatment Phase|Withdrawal by Subject|8|||
145437298|NCT01783444|524460515|FG002|Treatment Phase|Withdrawal by Subject|9|||
145437299|NCT01783444|524460513|FG000|Treatment Phase|Administrative problems|2|||
145437300|NCT01783444|524460514|FG001|Treatment Phase|Administrative problems|0|||
145437301|NCT01783444|524460515|FG002|Treatment Phase|Administrative problems|1|||
145437302|NCT01783444|524460513|FG000|Treatment Phase|Physician Decision|8|||
145583667|NCT03321019|524989433|FG000|Overall Study|Withdrawal by Subject|0|||
145583668|NCT03321019|524989434|FG001|Overall Study|Withdrawal by Subject|6|||
145583669|NCT03321019|524989433|FG000|Overall Study|Lost to Follow-up|0|||
145583670|NCT03321019|524989434|FG001|Overall Study|Lost to Follow-up|22|||
145437303|NCT01783444|524460514|FG001|Treatment Phase|Physician Decision|6|||
145437304|NCT01783444|524460515|FG002|Treatment Phase|Physician Decision|5|||
145437305|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
145583671|NCT04934670|524989435|FG000|Overall Study|Death|4|||
145583672|NCT04934670|524989436|FG001|Overall Study|Death|0|||
145583673|NCT04934670|524989435|FG000|Overall Study|Lost to Follow-up|1|||
145437306|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
145437307|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
145437308|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
145437309|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
145437310|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
145437311|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
145437312|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
145437313|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
145437314|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
145437315|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
145437316|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
145437317|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
145437318|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
145437319|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
145437320|NCT01783444|524460513|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
145437321|NCT01783444|524460514|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
145437322|NCT01783444|524460515|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
145437323|NCT00552071|524460516|FG000|Overall Study|Adverse Event|1|||
145437324|NCT00552071|524460517|FG001|Overall Study|Adverse Event|0|||
145437325|NCT00552071|524460516|FG000|Overall Study|Lack of Efficacy|1|||
145437326|NCT00552071|524460517|FG001|Overall Study|Lack of Efficacy|0|||
145437327|NCT00552071|524460516|FG000|Overall Study|Physician Decision|1|||
145437328|NCT00552071|524460517|FG001|Overall Study|Physician Decision|0|||
145437329|NCT00552071|524460516|FG000|Overall Study|Pregnancy|1|||
145437330|NCT00552071|524460517|FG001|Overall Study|Pregnancy|0|||
145437331|NCT00552071|524460516|FG000|Overall Study|Death|0|||
145437332|NCT00552071|524460517|FG001|Overall Study|Death|1|||
145437333|NCT00552071|524460516|FG000|Overall Study|Withdrawal by Subject|0|||
145437334|NCT00552071|524460517|FG001|Overall Study|Withdrawal by Subject|1|||
145437335|NCT00937495|524460522|FG000|Overall Study|Protocol Violation|2|||
145437336|NCT00441272|524460523|FG000|Overall Study|Study terminated prior to enrollment|25|||
145437337|NCT00441272|524460524|FG001|Overall Study|Study terminated prior to enrollment|25|||
145437338|NCT01856322|524460525|FG000|Overall Study|off study due to lack of accrual|0|||
145437339|NCT01856322|524460526|FG001|Overall Study|off study due to lack of accrual|0|||
145437340|NCT01856322|524460527|FG002|Overall Study|off study due to lack of accrual|3|||
145437341|NCT00954447|524460528|FG000|Overall Study|Adverse Event|33|||
145437342|NCT00954447|524460529|FG001|Overall Study|Adverse Event|25|||
145437343|NCT00954447|524460528|FG000|Overall Study|Lack of Efficacy|17|||
145437344|NCT00954447|524460529|FG001|Overall Study|Lack of Efficacy|3|||
145437345|NCT00954447|524460528|FG000|Overall Study|Protocol Violation|5|||
145437346|NCT00954447|524460529|FG001|Overall Study|Protocol Violation|7|||
145437347|NCT00954447|524460528|FG000|Overall Study|Lost to Follow-up|8|||
145437348|NCT00954447|524460529|FG001|Overall Study|Lost to Follow-up|14|||
145437349|NCT00954447|524460528|FG000|Overall Study|Withdrawal by Subject|26|||
145437350|NCT00954447|524460529|FG001|Overall Study|Withdrawal by Subject|21|||
145437351|NCT00954447|524460528|FG000|Overall Study|Other|21|||
145437352|NCT00954447|524460529|FG001|Overall Study|Other|18|||
145437353|NCT04592341|524460530|FG000|Overall Study|Physician Decision|5|||
145437354|NCT04592341|524460530|FG000|Overall Study|Study Terminated by Sponsor|5|||
145437355|NCT04592341|524460530|FG000|Overall Study|Withdrawal by Subject|53|||
145437356|NCT04592341|524460530|FG000|Overall Study|Lost to Follow-up|3|||
145437357|NCT04592341|524460530|FG000|Overall Study|Death|1|||
145437358|NCT04592341|524460530|FG000|Overall Study|Adverse Event|5|||
145437359|NCT04592341|524460530|FG000|Overall Study|other|4|||
145437360|NCT00692003|524460531|FG000|Overall Study|Sponsor Decision|5|||
145437361|NCT00692003|524460532|FG001|Overall Study|Sponsor Decision|1|||
145437362|NCT01535287|524460535|FG000|Overall Study|drug not prepared in time|5|||
145437363|NCT01535287|524460536|FG001|Overall Study|drug not prepared in time|6|||
145437364|NCT00517699|524460537|FG000|Overall Study|Withdrawal by Subject|1|||
145437365|NCT00517699|524460537|FG000|Overall Study|Lack of Efficacy|1|||
145437366|NCT00517699|524460537|FG000|Overall Study|Administrative error|1|||
145437367|NCT00517699|524460537|FG000|Overall Study|Study terminated by Sponsor|2|||
145437368|NCT00887159|524460545|FG000|Overall Study|Disease progression|6|||
145437369|NCT00887159|524460546|FG001|Overall Study|Disease progression|39|||
145583674|NCT04934670|524989436|FG001|Overall Study|Lost to Follow-up|4|||
145583675|NCT03067441|524989439|FG000|Overall Study|Withdrawal by Subject|16|||
145583676|NCT03067441|524989440|FG001|Overall Study|Withdrawal by Subject|34|||
145437370|NCT00887159|524460547|FG002|Overall Study|Disease progression|33|||
145437371|NCT00887159|524460545|FG000|Overall Study|Adverse Event|3|||
145437372|NCT00887159|524460546|FG001|Overall Study|Adverse Event|4|||
145437373|NCT00887159|524460547|FG002|Overall Study|Adverse Event|17|||
145437374|NCT00887159|524460545|FG000|Overall Study|Death|2|||
145583677|NCT03067441|524989439|FG000|Overall Study|Lost to Follow-up|7|||
145583678|NCT03067441|524989440|FG001|Overall Study|Lost to Follow-up|5|||
145437375|NCT00887159|524460546|FG001|Overall Study|Death|2|||
145437376|NCT00887159|524460547|FG002|Overall Study|Death|0|||
145437377|NCT00887159|524460545|FG000|Overall Study|Withdrawal by Subject|4|||
145437378|NCT00887159|524460546|FG001|Overall Study|Withdrawal by Subject|4|||
145437379|NCT00887159|524460547|FG002|Overall Study|Withdrawal by Subject|2|||
145437380|NCT00887159|524460545|FG000|Overall Study|Alternative therapy|2|||
145437381|NCT00887159|524460546|FG001|Overall Study|Alternative therapy|0|||
145437382|NCT00887159|524460547|FG002|Overall Study|Alternative therapy|0|||
145437383|NCT00887159|524460545|FG000|Overall Study|Physician Decision|1|||
145437384|NCT00887159|524460546|FG001|Overall Study|Physician Decision|1|||
145437385|NCT00887159|524460547|FG002|Overall Study|Physician Decision|0|||
145437386|NCT00887159|524460545|FG000|Overall Study|Sympomatic deterioration|1|||
145437387|NCT00887159|524460546|FG001|Overall Study|Sympomatic deterioration|0|||
145437388|NCT00887159|524460547|FG002|Overall Study|Sympomatic deterioration|0|||
145437389|NCT00887159|524460545|FG000|Overall Study|Treatment delayed|1|||
145437390|NCT00887159|524460546|FG001|Overall Study|Treatment delayed|1|||
145437391|NCT00887159|524460547|FG002|Overall Study|Treatment delayed|0|||
145437392|NCT00887159|524460545|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
145437393|NCT00887159|524460546|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
145437394|NCT00887159|524460547|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
145437395|NCT00887159|524460545|FG000|Overall Study|Received more tx instead of observation|1|||
145437396|NCT00887159|524460546|FG001|Overall Study|Received more tx instead of observation|0|||
145437397|NCT00887159|524460547|FG002|Overall Study|Received more tx instead of observation|0|||
145437398|NCT00887159|524460545|FG000|Overall Study|Ineligible|5|||
145437399|NCT00887159|524460546|FG001|Overall Study|Ineligible|1|||
145437400|NCT00887159|524460547|FG002|Overall Study|Ineligible|0|||
145437401|NCT00887159|524460545|FG000|Overall Study|Never started assigned therapy|3|||
145437402|NCT00887159|524460546|FG001|Overall Study|Never started assigned therapy|3|||
145437403|NCT00887159|524460547|FG002|Overall Study|Never started assigned therapy|4|||
145437404|NCT06164691|524460552|FG000|Overall Study|Withdrawal by Subject|2|||
145437405|NCT06164691|524460553|FG001|Overall Study|Withdrawal by Subject|0|||
145437406|NCT06164691|524460554|FG002|Overall Study|Withdrawal by Subject|0|||
145437407|NCT00812955|524460555|FG000|Overall Study|Adverse Event|7|||
145437408|NCT00812955|524460556|FG001|Overall Study|Adverse Event|6|||
145437409|NCT00812955|524460557|FG002|Overall Study|Adverse Event|3|||
145437410|NCT00812955|524460558|FG003|Overall Study|Adverse Event|4|||
145437411|NCT00812955|524460555|FG000|Overall Study|Lost to Follow-up|2|||
145437412|NCT00812955|524460556|FG001|Overall Study|Lost to Follow-up|1|||
145437413|NCT00812955|524460557|FG002|Overall Study|Lost to Follow-up|1|||
145437414|NCT00812955|524460558|FG003|Overall Study|Lost to Follow-up|2|||
145437415|NCT00812955|524460555|FG000|Overall Study|Withdrawal by Subject|1|||
145437416|NCT00812955|524460556|FG001|Overall Study|Withdrawal by Subject|0|||
145437417|NCT00812955|524460557|FG002|Overall Study|Withdrawal by Subject|1|||
145437418|NCT00812955|524460558|FG003|Overall Study|Withdrawal by Subject|2|||
145437419|NCT00812955|524460555|FG000|Overall Study|randomized in error|0|||
145437420|NCT00812955|524460556|FG001|Overall Study|randomized in error|0|||
145437421|NCT00812955|524460557|FG002|Overall Study|randomized in error|1|||
145437422|NCT00812955|524460558|FG003|Overall Study|randomized in error|0|||
145437423|NCT01815424|524460560|FG000|Week 0 to 16|Adverse Event|1|||
145437424|NCT01815424|524460561|FG001|Week 0 to 16|Adverse Event|3|||
145437425|NCT01815424|524460562|FG002|Week 0 to 16|Adverse Event|3|||
145437426|NCT01815424|524460563|FG003|Week 0 to 16|Adverse Event|0|||
145437427|NCT01815424|524460564|FG004|Week 0 to 16|Adverse Event|0|||
145437428|NCT01815424|524460560|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
145437429|NCT01815424|524460561|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
145437430|NCT01815424|524460562|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
145437431|NCT01815424|524460563|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
145583679|NCT03067441|524989439|FG000|Overall Study|Adverse Event|7|||
145583680|NCT03067441|524989440|FG001|Overall Study|Adverse Event|14|||
145583681|NCT03067441|524989439|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
145583682|NCT03067441|524989440|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
145583683|NCT03067441|524989439|FG000|Overall Study|Physician Decision|1|||
145583684|NCT03067441|524989440|FG001|Overall Study|Physician Decision|3|||
145437432|NCT01815424|524460564|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
145437433|NCT01815424|524460560|FG000|Week 0 to 16|Lost to Follow-up|0|||
145437434|NCT01815424|524460561|FG001|Week 0 to 16|Lost to Follow-up|1|||
145437435|NCT01815424|524460562|FG002|Week 0 to 16|Lost to Follow-up|0|||
145437436|NCT01815424|524460563|FG003|Week 0 to 16|Lost to Follow-up|0|||
145437437|NCT01815424|524460564|FG004|Week 0 to 16|Lost to Follow-up|0|||
145583685|NCT03067441|524989439|FG000|Overall Study|Other|1|||
145437438|NCT01815424|524460560|FG000|Week 0 to 16|Withdrawal by Subject|0|||
145437439|NCT01815424|524460561|FG001|Week 0 to 16|Withdrawal by Subject|0|||
145437440|NCT01815424|524460562|FG002|Week 0 to 16|Withdrawal by Subject|1|||
145437441|NCT01815424|524460563|FG003|Week 0 to 16|Withdrawal by Subject|0|||
145437442|NCT01815424|524460564|FG004|Week 0 to 16|Withdrawal by Subject|0|||
145583686|NCT03067441|524989440|FG001|Overall Study|Other|1|||
145583687|NCT01592708|524989441|FG000|Overall Study|Protocol Violation|3|||
145437443|NCT01815424|524460560|FG000|Week 0 to 16|Other|1|||
145437444|NCT01815424|524460561|FG001|Week 0 to 16|Other|0|||
145437445|NCT01815424|524460562|FG002|Week 0 to 16|Other|3|||
145437446|NCT01815424|524460563|FG003|Week 0 to 16|Other|0|||
145437447|NCT01815424|524460564|FG004|Week 0 to 16|Other|0|||
145437448|NCT01815424|524460560|FG000|Week 0 to 16|Protocol Violation|1|||
145437449|NCT01815424|524460561|FG001|Week 0 to 16|Protocol Violation|0|||
145437450|NCT01815424|524460562|FG002|Week 0 to 16|Protocol Violation|0|||
145437451|NCT01815424|524460563|FG003|Week 0 to 16|Protocol Violation|0|||
145437452|NCT01815424|524460564|FG004|Week 0 to 16|Protocol Violation|0|||
145437453|NCT01815424|524460560|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
145437454|NCT01815424|524460561|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
145437455|NCT01815424|524460562|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
145437456|NCT01815424|524460563|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
145437457|NCT01815424|524460564|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
145437458|NCT01815424|524460560|FG000|Week 16 to 52|Other|0|||
145437459|NCT01815424|524460561|FG001|Week 16 to 52|Other|1|||
145437460|NCT01815424|524460562|FG002|Week 16 to 52|Other|0|||
145437461|NCT01815424|524460563|FG003|Week 16 to 52|Other|0|||
145437462|NCT01815424|524460564|FG004|Week 16 to 52|Other|0|||
145437463|NCT01815424|524460560|FG000|Week 16 to 52|Adverse Event|0|||
145437464|NCT01815424|524460561|FG001|Week 16 to 52|Adverse Event|0|||
145437465|NCT01815424|524460562|FG002|Week 16 to 52|Adverse Event|0|||
145437466|NCT01815424|524460563|FG003|Week 16 to 52|Adverse Event|0|||
145437467|NCT01815424|524460564|FG004|Week 16 to 52|Adverse Event|1|||
145437468|NCT01815424|524460560|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
145437469|NCT01815424|524460561|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
145437470|NCT01815424|524460562|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
145437471|NCT01815424|524460563|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
145437472|NCT01815424|524460564|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
145437473|NCT01815424|524460560|FG000|Week 16 to 52|Lost to Follow-up|0|||
145437474|NCT01815424|524460561|FG001|Week 16 to 52|Lost to Follow-up|2|||
145437475|NCT01815424|524460562|FG002|Week 16 to 52|Lost to Follow-up|0|||
145437476|NCT01815424|524460563|FG003|Week 16 to 52|Lost to Follow-up|2|||
145437477|NCT01815424|524460564|FG004|Week 16 to 52|Lost to Follow-up|1|||
145437478|NCT01815424|524460560|FG000|Week 16 to 52|Withdrawal by Subject|1|||
145437479|NCT01815424|524460561|FG001|Week 16 to 52|Withdrawal by Subject|2|||
145437480|NCT01815424|524460562|FG002|Week 16 to 52|Withdrawal by Subject|0|||
145437481|NCT01815424|524460563|FG003|Week 16 to 52|Withdrawal by Subject|0|||
145437482|NCT01815424|524460564|FG004|Week 16 to 52|Withdrawal by Subject|0|||
145437483|NCT04723355|524460565|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
145437484|NCT04723355|524460565|FG000|Overall Study|Errors in the informed consent form|2|||
145437485|NCT03374358|524460566|FG000|Overall Study|Withdrawal by Subject|0|||
145437486|NCT03374358|524460567|FG001|Overall Study|Withdrawal by Subject|2|||
145437487|NCT01127633|524460568|FG000|Overall Study|Adverse Event|74|||
145437488|NCT01127633|524460569|FG001|Overall Study|Adverse Event|73|||
145437489|NCT01127633|524460568|FG000|Overall Study|Death|40|||
145437490|NCT01127633|524460569|FG001|Overall Study|Death|43|||
145437491|NCT01127633|524460568|FG000|Overall Study|Lost to Follow-up|4|||
145437492|NCT01127633|524460569|FG001|Overall Study|Lost to Follow-up|0|||
145437493|NCT01127633|524460568|FG000|Overall Study|Parent/Caregiver Decision|246|||
145437494|NCT01127633|524460569|FG001|Overall Study|Parent/Caregiver Decision|228|||
145437495|NCT01127633|524460568|FG000|Overall Study|Physician Decision|60|||
145437496|NCT01127633|524460569|FG001|Overall Study|Physician Decision|45|||
145437497|NCT01127633|524460568|FG000|Overall Study|Withdrawal by Subject|57|||
145437498|NCT01127633|524460569|FG001|Overall Study|Withdrawal by Subject|72|||
145437499|NCT01127633|524460568|FG000|Overall Study|Sponsor Decision|163|||
145437500|NCT01127633|524460569|FG001|Overall Study|Sponsor Decision|195|||
145437501|NCT01127633|524460568|FG000|Overall Study|Protocol Violation|8|||
145437502|NCT01127633|524460569|FG001|Overall Study|Protocol Violation|16|||
145437503|NCT01127633|524460568|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
145437504|NCT01127633|524460569|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
145437505|NCT01127633|524460568|FG000|Overall Study|Not treated|1|||
145437506|NCT01127633|524460569|FG001|Overall Study|Not treated|0|||
145437507|NCT02805790|524460573|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
145437508|NCT02805790|524460574|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
145437509|NCT00825994|524460577|FG000|Overall Study|Withdrawal by Subject|2|||
145437510|NCT00825994|524460577|FG000|Overall Study|Lost to Follow-up|1|||
145437511|NCT00825994|524460577|FG000|Overall Study|Protocol Violation|1|||
145437512|NCT00825994|524460577|FG000|Overall Study|Placebo Responder at V2|1|||
145437513|NCT00616642|524460580|FG000|Overall Study|Withdrawal by Subject|0|||
145437514|NCT00616642|524460581|FG001|Overall Study|Withdrawal by Subject|1|||
145437515|NCT01673646|524460587|FG000|Overall Study|Adverse Event|2|||
145437516|NCT01673646|524460588|FG001|Overall Study|Adverse Event|1|||
145437517|NCT01673646|524460589|FG002|Overall Study|Adverse Event|1|||
145437518|NCT01673646|524460587|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145437519|NCT01673646|524460588|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145437520|NCT01673646|524460589|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145437521|NCT01673646|524460587|FG000|Overall Study|Condition no longer requires study drug|0|||
145437522|NCT01673646|524460588|FG001|Overall Study|Condition no longer requires study drug|1|||
145437523|NCT01673646|524460589|FG002|Overall Study|Condition no longer requires study drug|0|||
145437524|NCT01673646|524460587|FG000|Overall Study|Withdrawal by Subject|0|||
145437525|NCT01673646|524460588|FG001|Overall Study|Withdrawal by Subject|2|||
145437526|NCT01673646|524460589|FG002|Overall Study|Withdrawal by Subject|2|||
145437527|NCT01673646|524460587|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
145437528|NCT01673646|524460588|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
145437529|NCT01673646|524460589|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
145437530|NCT01881009|524460590|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
145437531|NCT01881009|524460591|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
145437532|NCT01194245|524460592|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
145437533|NCT01194245|524460593|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
145437534|NCT01194245|524460594|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
145437535|NCT01194245|524460595|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
145437536|NCT01194245|524460596|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
145437537|NCT01194245|524460592|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
145437538|NCT01194245|524460593|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
145437539|NCT01194245|524460594|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
145437540|NCT01194245|524460595|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
145437541|NCT01194245|524460596|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
145437542|NCT01194245|524460592|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
145437543|NCT01194245|524460593|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
145437544|NCT01194245|524460594|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
145437545|NCT01194245|524460595|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
145437546|NCT01194245|524460596|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
145437547|NCT01194245|524460592|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
145437548|NCT01194245|524460593|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
145437549|NCT01194245|524460594|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
145437550|NCT01194245|524460595|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
145437551|NCT01194245|524460596|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
145437552|NCT01194245|524460592|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145437553|NCT01194245|524460593|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145437554|NCT01194245|524460594|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145437555|NCT01194245|524460595|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145437556|NCT01194245|524460596|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
145437557|NCT01194245|524460592|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145437558|NCT01194245|524460593|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145437559|NCT01194245|524460594|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
145437560|NCT01194245|524460595|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
145437561|NCT01194245|524460596|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
145437562|NCT02216526|524460600|FG000|Overall Study|Adverse Event|1|||
145437563|NCT02216526|524460601|FG001|Overall Study|Adverse Event|1|||
145437564|NCT02216526|524460602|FG002|Overall Study|Adverse Event|0|||
145437565|NCT02216526|524460600|FG000|Overall Study|Death|0|||
145437566|NCT02216526|524460601|FG001|Overall Study|Death|1|||
145437567|NCT02216526|524460602|FG002|Overall Study|Death|3|||
145437568|NCT02216526|524460600|FG000|Overall Study|Protocol Violation|2|||
145437569|NCT02216526|524460601|FG001|Overall Study|Protocol Violation|0|||
145437570|NCT02216526|524460602|FG002|Overall Study|Protocol Violation|2|||
145437571|NCT02216526|524460600|FG000|Overall Study|Hospitalization|2|||
145437572|NCT02216526|524460601|FG001|Overall Study|Hospitalization|1|||
145437573|NCT02216526|524460602|FG002|Overall Study|Hospitalization|3|||
145437574|NCT01882465|524460603|FG000|Period 1|Lens Discomfort|0|||
145437575|NCT01882465|524460604|FG001|Period 1|Lens Discomfort|0|||
145437576|NCT01882465|524460605|FG002|Period 1|Lens Discomfort|0|||
145437577|NCT01882465|524460606|FG003|Period 1|Lens Discomfort|1|||
145437578|NCT01882465|524460607|FG004|Period 1|Lens Discomfort|0|||
145437579|NCT01882465|524460608|FG005|Period 1|Lens Discomfort|0|||
145437580|NCT01882465|524460609|FG006|Period 1|Lens Discomfort|0|||
145437581|NCT01882465|524460603|FG000|Period 1|Withdrawal by Subject|0|||
145437582|NCT01882465|524460604|FG001|Period 1|Withdrawal by Subject|0|||
145437583|NCT01882465|524460605|FG002|Period 1|Withdrawal by Subject|0|||
145437584|NCT01882465|524460606|FG003|Period 1|Withdrawal by Subject|0|||
145437585|NCT01882465|524460607|FG004|Period 1|Withdrawal by Subject|0|||
145437586|NCT01882465|524460608|FG005|Period 1|Withdrawal by Subject|0|||
145437587|NCT01882465|524460609|FG006|Period 1|Withdrawal by Subject|1|||
145437588|NCT01882465|524460603|FG000|Period 2|Protocol Violation|0|||
145437589|NCT01882465|524460604|FG001|Period 2|Protocol Violation|0|||
145437590|NCT01882465|524460605|FG002|Period 2|Protocol Violation|0|||
145437591|NCT01882465|524460606|FG003|Period 2|Protocol Violation|0|||
145437592|NCT01882465|524460607|FG004|Period 2|Protocol Violation|1|||
145437593|NCT01882465|524460608|FG005|Period 2|Protocol Violation|0|||
145437594|NCT01882465|524460609|FG006|Period 2|Protocol Violation|0|||
145437595|NCT03824392|524460610|FG000|Overall Study|Adverse Event|1|||
145437596|NCT03824392|524460611|FG001|Overall Study|Adverse Event|0|||
145437597|NCT03824392|524460612|FG002|Overall Study|Adverse Event|0|||
145437598|NCT03824392|524460613|FG003|Overall Study|Adverse Event|0|||
145437599|NCT03824392|524460610|FG000|Overall Study|Investigator Decision|0|||
145437600|NCT03824392|524460611|FG001|Overall Study|Investigator Decision|1|||
145437601|NCT03824392|524460612|FG002|Overall Study|Investigator Decision|0|||
145437602|NCT03824392|524460613|FG003|Overall Study|Investigator Decision|0|||
145437603|NCT03824392|524460610|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
145437604|NCT03824392|524460611|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
145437605|NCT03824392|524460612|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
145437606|NCT03824392|524460613|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
145437607|NCT03894891|524460616|FG000|Overall Study|Withdrawal by Subject|1|||
145437608|NCT03894891|524460616|FG000|Overall Study|Completed protocol treatment per protocol|5|||
145437609|NCT00251693|524460623|FG000|Overall Study|Adverse Event|17|||
145437610|NCT00251693|524460624|FG001|Overall Study|Adverse Event|9|||
145437611|NCT00251693|524460625|FG002|Overall Study|Adverse Event|9|||
145437612|NCT00251693|524460623|FG000|Overall Study|Protocol Violation|2|||
145437613|NCT00251693|524460624|FG001|Overall Study|Protocol Violation|0|||
145437614|NCT00251693|524460625|FG002|Overall Study|Protocol Violation|2|||
145437615|NCT00251693|524460623|FG000|Overall Study|Lost to Follow-up|12|||
145437616|NCT00251693|524460624|FG001|Overall Study|Lost to Follow-up|7|||
145437617|NCT00251693|524460625|FG002|Overall Study|Lost to Follow-up|8|||
145437618|NCT00251693|524460623|FG000|Overall Study|Withdrawal by Subject|11|||
145437619|NCT00251693|524460624|FG001|Overall Study|Withdrawal by Subject|17|||
145437620|NCT00251693|524460625|FG002|Overall Study|Withdrawal by Subject|14|||
145437621|NCT00251693|524460623|FG000|Overall Study|Lack of Efficacy|0|||
145437622|NCT00251693|524460624|FG001|Overall Study|Lack of Efficacy|1|||
145437623|NCT00251693|524460625|FG002|Overall Study|Lack of Efficacy|0|||
145437624|NCT00251693|524460623|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
145437625|NCT00251693|524460624|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
145437626|NCT00251693|524460625|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
145437627|NCT00251693|524460623|FG000|Overall Study|Noncompliant|0|||
145437628|NCT00251693|524460624|FG001|Overall Study|Noncompliant|0|||
145437629|NCT00251693|524460625|FG002|Overall Study|Noncompliant|2|||
145437630|NCT00251693|524460623|FG000|Overall Study|Possible Barrett's esophagus|3|||
145437631|NCT00251693|524460624|FG001|Overall Study|Possible Barrett's esophagus|5|||
145437632|NCT00251693|524460625|FG002|Overall Study|Possible Barrett's esophagus|2|||
145437633|NCT00251693|524460623|FG000|Overall Study|Subject request/subject unavailable|1|||
145437634|NCT00251693|524460624|FG001|Overall Study|Subject request/subject unavailable|2|||
145437635|NCT00251693|524460625|FG002|Overall Study|Subject request/subject unavailable|0|||
145437636|NCT00251693|524460623|FG000|Overall Study|Abnormal laboratory findings|0|||
145437637|NCT00251693|524460624|FG001|Overall Study|Abnormal laboratory findings|0|||
145437638|NCT00251693|524460625|FG002|Overall Study|Abnormal laboratory findings|1|||
145437639|NCT01030822|524460626|FG000|Overall Study|Moved/migrated from study area|6|||
145437640|NCT01030822|524460627|FG001|Overall Study|Moved/migrated from study area|7|||
145437641|NCT01030822|524460628|FG002|Overall Study|Moved/migrated from study area|3|||
145437642|NCT01030822|524460626|FG000|Overall Study|Withdrawal by Subject|16|||
145437643|NCT01030822|524460627|FG001|Overall Study|Withdrawal by Subject|13|||
145437644|NCT01030822|524460628|FG002|Overall Study|Withdrawal by Subject|16|||
145437645|NCT01030822|524460626|FG000|Overall Study|Lost to Follow-up|9|||
145437646|NCT01030822|524460627|FG001|Overall Study|Lost to Follow-up|4|||
145437647|NCT01030822|524460628|FG002|Overall Study|Lost to Follow-up|7|||
145437648|NCT00401843|524460629|FG000|Overall Study|Achieved Complete Response|1|||
145437649|NCT00401843|524460630|FG001|Overall Study|Achieved Complete Response|5|||
145437650|NCT00401843|524460631|FG002|Overall Study|Achieved Complete Response|11|||
145437651|NCT00401843|524460629|FG000|Overall Study|Adverse Event|7|||
145583688|NCT01592708|524989442|FG001|Overall Study|Protocol Violation|0|||
145437652|NCT00401843|524460630|FG001|Overall Study|Adverse Event|26|||
145437653|NCT00401843|524460631|FG002|Overall Study|Adverse Event|27|||
145437654|NCT00401843|524460629|FG000|Overall Study|Death|0|||
145437655|NCT00401843|524460630|FG001|Overall Study|Death|8|||
145437656|NCT00401843|524460631|FG002|Overall Study|Death|10|||
145437657|NCT00401843|524460629|FG000|Overall Study|Disease progression|10|||
145437658|NCT00401843|524460630|FG001|Overall Study|Disease progression|60|||
145437659|NCT00401843|524460631|FG002|Overall Study|Disease progression|49|||
145437660|NCT00401843|524460629|FG000|Overall Study|End of Study|1|||
145437661|NCT00401843|524460630|FG001|Overall Study|End of Study|1|||
145437662|NCT00401843|524460631|FG002|Overall Study|End of Study|2|||
145437663|NCT00401843|524460629|FG000|Overall Study|Lost to Follow-up|0|||
145437664|NCT00401843|524460630|FG001|Overall Study|Lost to Follow-up|0|||
145437665|NCT00401843|524460631|FG002|Overall Study|Lost to Follow-up|2|||
145437666|NCT00401843|524460629|FG000|Overall Study|Other Unspecified|0|||
145437667|NCT00401843|524460630|FG001|Overall Study|Other Unspecified|3|||
145437668|NCT00401843|524460631|FG002|Overall Study|Other Unspecified|5|||
145437669|NCT00401843|524460629|FG000|Overall Study|Physician Decision|0|||
145437670|NCT00401843|524460630|FG001|Overall Study|Physician Decision|16|||
145437671|NCT00401843|524460631|FG002|Overall Study|Physician Decision|10|||
145437672|NCT00401843|524460629|FG000|Overall Study|Protocol Violation|0|||
145437673|NCT00401843|524460630|FG001|Overall Study|Protocol Violation|0|||
145437674|NCT00401843|524460631|FG002|Overall Study|Protocol Violation|1|||
145437675|NCT00401843|524460629|FG000|Overall Study|Withdrawal by Subject|1|||
145437676|NCT00401843|524460630|FG001|Overall Study|Withdrawal by Subject|5|||
145437677|NCT00401843|524460631|FG002|Overall Study|Withdrawal by Subject|5|||
145437678|NCT00401843|524460629|FG000|Overall Study|Withdrawal of consent to study agent|1|||
145437679|NCT00401843|524460630|FG001|Overall Study|Withdrawal of consent to study agent|15|||
145437680|NCT00401843|524460631|FG002|Overall Study|Withdrawal of consent to study agent|17|||
145437681|NCT00401843|524460629|FG000|Overall Study|Randomized but not Treated|0|||
145437682|NCT00401843|524460630|FG001|Overall Study|Randomized but not Treated|2|||
145437683|NCT00401843|524460631|FG002|Overall Study|Randomized but not Treated|3|||
145437684|NCT00401843|524460629|FG000|Overall Study|Received incorrect treatment|0|||
145437685|NCT00401843|524460630|FG001|Overall Study|Received incorrect treatment|3|||
145437686|NCT00401843|524460631|FG002|Overall Study|Received incorrect treatment|0|||
145437687|NCT01932788|524460644|FG000|Overall Study|Protocol Violation|18|||
145437688|NCT01932788|524460645|FG001|Overall Study|Protocol Violation|0|||
145437689|NCT01932788|524460644|FG000|Overall Study|Lost to Follow-up|18|||
145437690|NCT01932788|524460645|FG001|Overall Study|Lost to Follow-up|46|||
145437691|NCT01932788|524460644|FG000|Overall Study|Lack of Efficacy|2|||
145437692|NCT01932788|524460645|FG001|Overall Study|Lack of Efficacy|0|||
145437693|NCT01932788|524460644|FG000|Overall Study|Withdrawal by Subject|0|||
145437694|NCT01932788|524460645|FG001|Overall Study|Withdrawal by Subject|5|||
145437695|NCT01171677|524460646|FG000|Overall Study|Withdrawal by Subject|0|||
145437696|NCT01171677|524460647|FG001|Overall Study|Withdrawal by Subject|3|||
145437697|NCT01171677|524460646|FG000|Overall Study|Adverse Event|1|||
145437698|NCT01171677|524460647|FG001|Overall Study|Adverse Event|0|||
145437699|NCT01171677|524460646|FG000|Overall Study|completed <70% IntenSati classes|5|||
145437700|NCT01171677|524460647|FG001|Overall Study|completed <70% IntenSati classes|0|||
145437701|NCT04422431|524460652|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
145437702|NCT04422431|524460652|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
145437703|NCT04422431|524460652|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
145437704|NCT04422431|524460652|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
145437705|NCT04422431|524460652|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
145437706|NCT04422431|524460652|FG000|Extension Period (48 Weeks)|Other than specified|2|||
145437707|NCT01085214|524460655|FG000|Overall Study|Alternate treatment required|1|||
145437708|NCT01900665|524460656|FG000|Placebo Controlled Period|Death|9|||
145437709|NCT01900665|524460657|FG001|Placebo Controlled Period|Death|16|||
145437710|NCT01900665|524460656|FG000|Placebo Controlled Period|Adverse Event|48|||
145437711|NCT01900665|524460657|FG001|Placebo Controlled Period|Adverse Event|39|||
145437712|NCT01900665|524460656|FG000|Placebo Controlled Period|Protocol Violation|1|||
145437713|NCT01900665|524460657|FG001|Placebo Controlled Period|Protocol Violation|7|||
145437714|NCT01900665|524460656|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
145437715|NCT01900665|524460657|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
145437716|NCT01900665|524460656|FG000|Placebo Controlled Period|Physician Decision|11|||
145437717|NCT01900665|524460657|FG001|Placebo Controlled Period|Physician Decision|7|||
145437718|NCT01900665|524460656|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
145437719|NCT01900665|524460657|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
145437720|NCT01900665|524460656|FG000|Placebo Controlled Period|Caregiver Decision|33|||
145437721|NCT01900665|524460657|FG001|Placebo Controlled Period|Caregiver Decision|41|||
145437722|NCT01900665|524460656|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
145437723|NCT01900665|524460657|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
145437724|NCT01900665|524460656|FG000|Open Label Period|Adverse Event|16|||
145437725|NCT01900665|524460657|FG001|Open Label Period|Adverse Event|20|||
145437726|NCT01900665|524460656|FG000|Open Label Period|Death|5|||
145437727|NCT01900665|524460657|FG001|Open Label Period|Death|6|||
145437728|NCT01900665|524460656|FG000|Open Label Period|Lost to Follow-up|1|||
145437729|NCT01900665|524460657|FG001|Open Label Period|Lost to Follow-up|1|||
145437730|NCT01900665|524460656|FG000|Open Label Period|Parent/Caregiver Decision|33|||
145437731|NCT01900665|524460657|FG001|Open Label Period|Parent/Caregiver Decision|34|||
145437732|NCT01900665|524460656|FG000|Open Label Period|Physician Decision|4|||
145437733|NCT01900665|524460657|FG001|Open Label Period|Physician Decision|4|||
145437734|NCT01900665|524460656|FG000|Open Label Period|Protocol Violation|0|||
145437735|NCT01900665|524460657|FG001|Open Label Period|Protocol Violation|1|||
145437736|NCT01900665|524460656|FG000|Open Label Period|Sponsor Decision|802|||
145437737|NCT01900665|524460657|FG001|Open Label Period|Sponsor Decision|765|||
145437738|NCT01900665|524460656|FG000|Open Label Period|Withdrawal by Subject|20|||
145437739|NCT01900665|524460657|FG001|Open Label Period|Withdrawal by Subject|28|||
145437740|NCT02317627|524460659|FG000|Overall Study|Withdrawal by Subject|0|||
145437741|NCT02317627|524460660|FG001|Overall Study|Withdrawal by Subject|1|||
145437742|NCT02317627|524460661|FG002|Overall Study|Withdrawal by Subject|1|||
145437743|NCT02317627|524460659|FG000|Overall Study|Lost to Follow-up|2|||
145437744|NCT02317627|524460660|FG001|Overall Study|Lost to Follow-up|0|||
145437745|NCT02317627|524460661|FG002|Overall Study|Lost to Follow-up|0|||
145437746|NCT02317627|524460659|FG000|Overall Study|Stopped by Investigator|0|||
145437747|NCT02317627|524460660|FG001|Overall Study|Stopped by Investigator|1|||
145437748|NCT02317627|524460661|FG002|Overall Study|Stopped by Investigator|0|||
145437749|NCT02317627|524460659|FG000|Overall Study|Adverse Event|0|||
145437750|NCT02317627|524460660|FG001|Overall Study|Adverse Event|2|||
145437751|NCT02317627|524460661|FG002|Overall Study|Adverse Event|3|||
145437752|NCT02317627|524460659|FG000|Overall Study|Non-compliance with study drug|0|||
145437753|NCT02317627|524460660|FG001|Overall Study|Non-compliance with study drug|1|||
145437754|NCT02317627|524460661|FG002|Overall Study|Non-compliance with study drug|0|||
145437755|NCT04749914|524460662|FG000|Period 1|Adverse Event|1|||
145437756|NCT04749914|524460663|FG001|Period 1|Adverse Event|0|||
145437757|NCT04749914|524460664|FG002|Period 1|Adverse Event|0|||
145437758|NCT04749914|524460665|FG003|Period 1|Adverse Event|0|||
145437759|NCT04749914|524460662|FG000|Period 1|Withdrawal by Subject|1|||
145437760|NCT04749914|524460663|FG001|Period 1|Withdrawal by Subject|0|||
145437761|NCT04749914|524460664|FG002|Period 1|Withdrawal by Subject|1|||
145437762|NCT04749914|524460665|FG003|Period 1|Withdrawal by Subject|0|||
145437763|NCT04046939|524460666|FG000|Primary Assessment Period|Adverse Event|1|||
145437764|NCT04046939|524460667|FG001|Primary Assessment Period|Adverse Event|0|||
145437765|NCT04046939|524460668|FG002|Primary Assessment Period|Adverse Event|0|||
145437766|NCT04046939|524460669|FG003|Primary Assessment Period|Adverse Event|0|||
145437767|NCT04046939|524460666|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
145437768|NCT04046939|524460667|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
145437769|NCT04046939|524460668|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
145437770|NCT04046939|524460669|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
145437771|NCT04046939|524460666|FG000|Primary Assessment Period|Physician Decision|0|||
145437772|NCT04046939|524460667|FG001|Primary Assessment Period|Physician Decision|0|||
145437773|NCT04046939|524460668|FG002|Primary Assessment Period|Physician Decision|1|||
145437774|NCT04046939|524460669|FG003|Primary Assessment Period|Physician Decision|0|||
145437775|NCT04046939|524460666|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
145437776|NCT04046939|524460667|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
145437777|NCT04046939|524460668|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
145437778|NCT04046939|524460669|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
145437779|NCT00403130|524460670|FG000|2 Years From Start of Treatment|Not Eligible|3|||
145437780|NCT00403130|524460670|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
145437781|NCT00403130|524460670|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
145437782|NCT00403130|524460670|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
145437783|NCT00806260|524460671|FG000|Period 1 (1 Day)|Adverse Event|0|||
145437784|NCT00806260|524460672|FG001|Period 1 (1 Day)|Adverse Event|0|||
145437785|NCT00806260|524460673|FG002|Period 1 (1 Day)|Adverse Event|0|||
145437786|NCT00806260|524460674|FG003|Period 1 (1 Day)|Adverse Event|0|||
145437787|NCT00806260|524460675|FG004|Period 1 (1 Day)|Adverse Event|3|||
145437788|NCT00806260|524460676|FG005|Period 1 (1 Day)|Adverse Event|0|||
145437789|NCT00806260|524460671|FG000|Period 2|Adverse Event|0|||
145437790|NCT00806260|524460672|FG001|Period 2|Adverse Event|0|||
145437791|NCT00806260|524460673|FG002|Period 2|Adverse Event|0|||
145437792|NCT00806260|524460674|FG003|Period 2|Adverse Event|1|||
145437793|NCT00806260|524460675|FG004|Period 2|Adverse Event|0|||
145437794|NCT00806260|524460676|FG005|Period 2|Adverse Event|0|||
145437795|NCT00806260|524460671|FG000|Period 2|Protocol Violation|1|||
145437796|NCT00806260|524460672|FG001|Period 2|Protocol Violation|0|||
145437797|NCT00806260|524460673|FG002|Period 2|Protocol Violation|1|||
145437798|NCT00806260|524460674|FG003|Period 2|Protocol Violation|0|||
145583689|NCT02328326|524989447|FG000|Overall Study|Withdrawal by Subject|10|||
145583690|NCT02328326|524989448|FG001|Overall Study|Withdrawal by Subject|3|||
145583691|NCT02328326|524989447|FG000|Overall Study|Death|2|||
145583692|NCT02328326|524989448|FG001|Overall Study|Death|1|||
145583693|NCT02328326|524989447|FG000|Overall Study|Lost to Follow-up|10|||
145583694|NCT02328326|524989448|FG001|Overall Study|Lost to Follow-up|4|||
145583695|NCT02056301|524989449|FG000|Overall Study|Protocol Violation|1|||
145437799|NCT00806260|524460675|FG004|Period 2|Protocol Violation|0|||
145437800|NCT00806260|524460676|FG005|Period 2|Protocol Violation|0|||
145437801|NCT00806260|524460671|FG000|Period 2|Need to take concomitant medication|1|||
145437802|NCT00806260|524460672|FG001|Period 2|Need to take concomitant medication|0|||
145437803|NCT00806260|524460673|FG002|Period 2|Need to take concomitant medication|0|||
145437804|NCT00806260|524460674|FG003|Period 2|Need to take concomitant medication|0|||
145583696|NCT02056301|524989450|FG001|Overall Study|Protocol Violation|2|||
145583697|NCT02056301|524989449|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
145437805|NCT00806260|524460675|FG004|Period 2|Need to take concomitant medication|0|||
145437806|NCT00806260|524460676|FG005|Period 2|Need to take concomitant medication|0|||
145437807|NCT00806260|524460671|FG000|Period 2|sponsor request|0|||
145437808|NCT00806260|524460672|FG001|Period 2|sponsor request|0|||
145437809|NCT00806260|524460673|FG002|Period 2|sponsor request|1|||
145583698|NCT02056301|524989450|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
145583699|NCT02056301|524989449|FG000|Overall Study|Withdrawal by Subject|0|||
145583700|NCT02056301|524989450|FG001|Overall Study|Withdrawal by Subject|1|||
145583701|NCT02056301|524989449|FG000|Overall Study|Issues with epidural|0|||
145583702|NCT02056301|524989450|FG001|Overall Study|Issues with epidural|3|||
145583703|NCT02209324|524989455|FG000|Overall Study|Adverse Event|2|||
145583704|NCT02209324|524989455|FG000|Overall Study|Lack of Efficacy|1|||
145583705|NCT02209324|524989455|FG000|Overall Study|Lost to Follow-up|1|||
145583706|NCT02209324|524989455|FG000|Overall Study|Physician Decision|3|||
145583707|NCT02209324|524989455|FG000|Overall Study|Protocol Violation|14|||
145583708|NCT02209324|524989455|FG000|Overall Study|Withdrawal by Subject|8|||
145583709|NCT02209324|524989455|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
145583710|NCT02209324|524989455|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
145583711|NCT02209324|524989455|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
145583712|NCT03433456|524989456|FG000|Overall Study|Death|1|||
145583713|NCT03433456|524989457|FG001|Overall Study|Death|1|||
145583714|NCT03433456|524989456|FG000|Overall Study|Lost to Follow-up|14|||
145583715|NCT03433456|524989457|FG001|Overall Study|Lost to Follow-up|11|||
145583716|NCT03433456|524989456|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
145583717|NCT03433456|524989457|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
145583718|NCT01198600|524989465|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
145583719|NCT01198600|524989466|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
145583720|NCT01198600|524989467|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
145583721|NCT01198600|524989468|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
145583722|NCT01198600|524989465|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
145583723|NCT01198600|524989466|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
145583724|NCT01198600|524989467|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
145583725|NCT01198600|524989468|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
145583726|NCT01198600|524989465|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
145583727|NCT01198600|524989466|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
145583728|NCT01198600|524989467|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
145583729|NCT01198600|524989468|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
145583730|NCT01198600|524989465|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
145583731|NCT01198600|524989466|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
145583732|NCT01198600|524989467|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
145583733|NCT01198600|524989468|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
145583734|NCT01198600|524989465|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
145583735|NCT01198600|524989466|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
145583736|NCT01198600|524989467|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
145583737|NCT01198600|524989468|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
145583738|NCT01198600|524989465|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
145583739|NCT01198600|524989466|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
145583740|NCT01198600|524989467|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
145583741|NCT01198600|524989468|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
145583742|NCT01198600|524989465|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
145583743|NCT01198600|524989466|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
145583744|NCT01198600|524989467|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
145583745|NCT01198600|524989468|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
145583746|NCT01785602|524989469|FG000|Overall Study|Withdrawal by Subject|2|||
145583747|NCT01785602|524989470|FG001|Overall Study|Withdrawal by Subject|0|||
145583748|NCT01785602|524989469|FG000|Overall Study|Lost to Follow-up|1|||
145583749|NCT01785602|524989470|FG001|Overall Study|Lost to Follow-up|1|||
145583750|NCT01785602|524989469|FG000|Overall Study|Adverse Event|3|||
145583751|NCT01785602|524989470|FG001|Overall Study|Adverse Event|5|||
145583752|NCT01785602|524989469|FG000|Overall Study|Administrative problems|7|||
145583753|NCT01785602|524989470|FG001|Overall Study|Administrative problems|3|||
145583754|NCT04177108|524989472|FG000|Overall Study|Withdrawal by Subject|4|||
145583755|NCT04177108|524989473|FG001|Overall Study|Withdrawal by Subject|8|||
145583756|NCT04177108|524989474|FG002|Overall Study|Withdrawal by Subject|9|||
145583757|NCT04177108|524989475|FG003|Overall Study|Withdrawal by Subject|11|||
145583758|NCT04177108|524989476|FG004|Overall Study|Withdrawal by Subject|13|||
145583759|NCT04177108|524989472|FG000|Overall Study|Physician Decision|23|||
145583760|NCT04177108|524989473|FG001|Overall Study|Physician Decision|15|||
145583761|NCT04177108|524989474|FG002|Overall Study|Physician Decision|18|||
145583762|NCT04177108|524989475|FG003|Overall Study|Physician Decision|29|||
145583763|NCT04177108|524989476|FG004|Overall Study|Physician Decision|23|||
145583764|NCT04177108|524989472|FG000|Overall Study|Reason Not Specified|0|||
145583765|NCT04177108|524989473|FG001|Overall Study|Reason Not Specified|1|||
145583766|NCT04177108|524989474|FG002|Overall Study|Reason Not Specified|0|||
145583767|NCT04177108|524989475|FG003|Overall Study|Reason Not Specified|0|||
145583768|NCT04177108|524989476|FG004|Overall Study|Reason Not Specified|2|||
145583769|NCT04177108|524989472|FG000|Overall Study|Lost to Follow-up|0|||
145583770|NCT04177108|524989473|FG001|Overall Study|Lost to Follow-up|0|||
145583771|NCT04177108|524989474|FG002|Overall Study|Lost to Follow-up|1|||
145583772|NCT04177108|524989475|FG003|Overall Study|Lost to Follow-up|1|||
145583773|NCT04177108|524989476|FG004|Overall Study|Lost to Follow-up|1|||
145583774|NCT04177108|524989472|FG000|Overall Study|Death|16|||
145583775|NCT04177108|524989473|FG001|Overall Study|Death|19|||
145583776|NCT04177108|524989474|FG002|Overall Study|Death|13|||
145583777|NCT04177108|524989475|FG003|Overall Study|Death|17|||
145583778|NCT04177108|524989476|FG004|Overall Study|Death|18|||
145583779|NCT02041429|524989479|FG000|Overall Study|Progressive Disease|2|||
145583780|NCT02041429|524989480|FG001|Overall Study|Progressive Disease|2|||
145583781|NCT02041429|524989481|FG002|Overall Study|Progressive Disease|3|||
145583782|NCT02041429|524989482|FG003|Overall Study|Progressive Disease|2|||
145583783|NCT02041429|524989479|FG000|Overall Study|Toxicity|0|||
145583784|NCT02041429|524989480|FG001|Overall Study|Toxicity|1|||
145583785|NCT02041429|524989481|FG002|Overall Study|Toxicity|4|||
145583786|NCT02041429|524989482|FG003|Overall Study|Toxicity|2|||
145583787|NCT02041429|524989479|FG000|Overall Study|Withdrawal by Subject|0|||
145583788|NCT02041429|524989480|FG001|Overall Study|Withdrawal by Subject|1|||
145583789|NCT02041429|524989481|FG002|Overall Study|Withdrawal by Subject|0|||
145583790|NCT02041429|524989482|FG003|Overall Study|Withdrawal by Subject|0|||
145583791|NCT02041429|524989479|FG000|Overall Study|On Maintenance Therapy|1|||
145583792|NCT02041429|524989480|FG001|Overall Study|On Maintenance Therapy|0|||
145583793|NCT02041429|524989481|FG002|Overall Study|On Maintenance Therapy|0|||
145583794|NCT02041429|524989482|FG003|Overall Study|On Maintenance Therapy|2|||
145583795|NCT01427712|524989483|FG000|Overall Study|Transfer to a different hospital|2|||
145583796|NCT01427712|524989483|FG000|Overall Study|Lost to Follow-up|1|||
145583797|NCT01427712|524989483|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
145583798|NCT01427712|524989483|FG000|Overall Study|Failure to visit|1|||
145583799|NCT00784043|524989484|FG000|Overall Study|Withdrawal by Subject|8|||
145583800|NCT00784043|524989485|FG001|Overall Study|Withdrawal by Subject|5|||
145583801|NCT00784043|524989484|FG000|Overall Study|Protocol Terminated|23|||
145583802|NCT00784043|524989485|FG001|Overall Study|Protocol Terminated|1|||
145583803|NCT01143259|524989486|FG000|Overall Study|Withdrawal by Subject|3|||
145583804|NCT01143259|524989487|FG001|Overall Study|Withdrawal by Subject|2|||
145583805|NCT01143259|524989486|FG000|Overall Study|Protocol Violation|13|||
145583806|NCT01143259|524989487|FG001|Overall Study|Protocol Violation|9|||
145583807|NCT01143259|524989486|FG000|Overall Study|Screen Failure|7|||
145583808|NCT01143259|524989487|FG001|Overall Study|Screen Failure|9|||
145583809|NCT00099983|524989488|FG000|Overall Study|Lost to Follow-up|2|||
145583810|NCT00099983|524989489|FG001|Overall Study|Lost to Follow-up|3|||
145583811|NCT00099983|524989488|FG000|Overall Study|Missing Source Documents|14|||
145583812|NCT00099983|524989489|FG001|Overall Study|Missing Source Documents|15|||
145583813|NCT00099983|524989488|FG000|Overall Study|Withdrawal by Subject|3|||
145583814|NCT00099983|524989489|FG001|Overall Study|Withdrawal by Subject|2|||
145583815|NCT00099983|524989488|FG000|Overall Study|Adverse Event|1|||
145583816|NCT00099983|524989489|FG001|Overall Study|Adverse Event|1|||
145583817|NCT00099983|524989488|FG000|Overall Study|Lack of Efficacy|0|||
145583818|NCT00099983|524989489|FG001|Overall Study|Lack of Efficacy|1|||
145583819|NCT00099983|524989488|FG000|Overall Study|Unable to return for appointments|1|||
145583820|NCT00099983|524989489|FG001|Overall Study|Unable to return for appointments|1|||
145583821|NCT00099983|524989488|FG000|Overall Study|Moved|1|||
145583822|NCT00099983|524989489|FG001|Overall Study|Moved|0|||
145583823|NCT00099983|524989488|FG000|Overall Study|Other psychiatric problem|1|||
145583824|NCT00099983|524989489|FG001|Overall Study|Other psychiatric problem|0|||
145583825|NCT00099983|524989488|FG000|Overall Study|Incarcerated|0|||
145583826|NCT00099983|524989489|FG001|Overall Study|Incarcerated|1|||
145583827|NCT00099983|524989488|FG000|Overall Study|Intolerant of burden of visits|0|||
145583828|NCT00099983|524989489|FG001|Overall Study|Intolerant of burden of visits|1|||
145583829|NCT00099983|524989488|FG000|Overall Study|Other issue|1|||
145583830|NCT00099983|524989489|FG001|Overall Study|Other issue|0|||
145437810|NCT00806260|524460674|FG003|Period 2|sponsor request|1|||
145437811|NCT00806260|524460675|FG004|Period 2|sponsor request|0|||
145583831|NCT02641080|524989490|FG000|Overall Study|Physician Decision|2|||
145583832|NCT02641080|524989491|FG001|Overall Study|Physician Decision|0|||
145583833|NCT02641080|524989490|FG000|Overall Study|Withdrawal by Subject|0|||
145583834|NCT02641080|524989491|FG001|Overall Study|Withdrawal by Subject|1|||
145583835|NCT02641080|524989490|FG000|Overall Study|Rehab Center denied use of pumps|0|||
145437812|NCT00806260|524460676|FG005|Period 2|sponsor request|0|||
145583836|NCT02641080|524989491|FG001|Overall Study|Rehab Center denied use of pumps|3|||
145583837|NCT02641080|524989490|FG000|Overall Study|Lost to Follow-up|0|||
145583838|NCT02641080|524989491|FG001|Overall Study|Lost to Follow-up|3|||
145583839|NCT00803634|524989492|FG000|Overall Study|Withdrew Consent|1|||
145583840|NCT00803634|524989493|FG001|Overall Study|Withdrew Consent|0|||
145437813|NCT00806260|524460671|FG000|Period 3|Protocol Violation|0|||
145583841|NCT00803634|524989492|FG000|Overall Study|Lost to Follow-up|2|||
145583842|NCT00803634|524989493|FG001|Overall Study|Lost to Follow-up|3|||
145583843|NCT00803634|524989492|FG000|Overall Study|Death|3|||
145583844|NCT00803634|524989493|FG001|Overall Study|Death|2|||
145583845|NCT04307186|524989496|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
145583846|NCT04307186|524989496|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
145583847|NCT04307186|524989496|FG000|Washout 3-14 Days|Progressive disease|1|||
145583848|NCT04307186|524989496|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
145583849|NCT04307186|524989496|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
145583850|NCT03835533|524989500|FG000|Overall Study|Death|5|||
145583851|NCT03835533|524989501|FG001|Overall Study|Death|10|||
145583852|NCT03835533|524989502|FG002|Overall Study|Death|9|||
145583853|NCT03835533|524989500|FG000|Overall Study|Withdrawal by Subject|2|||
145583854|NCT03835533|524989501|FG001|Overall Study|Withdrawal by Subject|2|||
145583855|NCT03835533|524989502|FG002|Overall Study|Withdrawal by Subject|2|||
145583856|NCT03835533|524989500|FG000|Overall Study|Lost to Follow-up|1|||
145583857|NCT03835533|524989501|FG001|Overall Study|Lost to Follow-up|0|||
145583858|NCT03835533|524989502|FG002|Overall Study|Lost to Follow-up|0|||
145583859|NCT03930745|524989503|FG000|Overall Study|Lost to Follow-up|10|||
145583860|NCT03930745|524989504|FG001|Overall Study|Lost to Follow-up|5|||
145583861|NCT03930745|524989503|FG000|Overall Study|Withdrawal by Subject|1|||
145583862|NCT03930745|524989504|FG001|Overall Study|Withdrawal by Subject|2|||
145583863|NCT03930745|524989503|FG000|Overall Study|Protocol Violation|2|||
145583864|NCT03930745|524989504|FG001|Overall Study|Protocol Violation|2|||
145583865|NCT03930745|524989503|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
145583866|NCT03930745|524989504|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
145583867|NCT03930745|524989503|FG000|Overall Study|Adverse Event|0|||
145583868|NCT03930745|524989504|FG001|Overall Study|Adverse Event|1|||
145583869|NCT03930745|524989503|FG000|Overall Study|Pregnancy|0|||
145583870|NCT03930745|524989504|FG001|Overall Study|Pregnancy|1|||
145583871|NCT04095858|524989507|FG000|Overall Study|Death|1|||
145583872|NCT04095858|524989508|FG001|Overall Study|Death|0|||
145583873|NCT04095858|524989507|FG000|Overall Study|Study terminated by Sponsor|2|||
145583874|NCT04095858|524989508|FG001|Overall Study|Study terminated by Sponsor|4|||
145583875|NCT01344460|524989509|FG000|Overall Study|Withdrawal by Subject|1|||
145583876|NCT01344460|524989509|FG000|Overall Study|Lost to Follow-up|2|||
145583877|NCT03285477|524989510|FG000|Treatment and Response Assessment Period|Death|1|||
145583878|NCT03285477|524989511|FG001|Treatment and Response Assessment Period|Death|0|||
145583879|NCT03285477|524989510|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
145583880|NCT03285477|524989511|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
145583881|NCT03285477|524989510|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
145583882|NCT03285477|524989511|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
145583883|NCT03285477|524989510|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
145583884|NCT03285477|524989511|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
145583885|NCT03285477|524989510|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
145583886|NCT03285477|524989511|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
145583887|NCT03483623|524989512|FG000|Overall Study|43 complete sets achieved|1|||
145583888|NCT00852397|524989515|FG000|Overall Study|Adverse Event|4|||
145583889|NCT00852397|524989516|FG001|Overall Study|Adverse Event|6|||
145583890|NCT00852397|524989517|FG002|Overall Study|Adverse Event|4|||
145583891|NCT00852397|524989515|FG000|Overall Study|Death|0|||
145583892|NCT00852397|524989516|FG001|Overall Study|Death|0|||
145583893|NCT00852397|524989517|FG002|Overall Study|Death|1|||
145583894|NCT00852397|524989515|FG000|Overall Study|Withdrawal by Subject|4|||
145583895|NCT00852397|524989516|FG001|Overall Study|Withdrawal by Subject|1|||
145437814|NCT00806260|524460672|FG001|Period 3|Protocol Violation|1|||
145437815|NCT00806260|524460673|FG002|Period 3|Protocol Violation|1|||
145437816|NCT00806260|524460674|FG003|Period 3|Protocol Violation|0|||
145437817|NCT00806260|524460675|FG004|Period 3|Protocol Violation|0|||
145437818|NCT00806260|524460676|FG005|Period 3|Protocol Violation|0|||
145437819|NCT00806260|524460671|FG000|Period 3|Pregnancy|1|||
145437820|NCT00806260|524460672|FG001|Period 3|Pregnancy|0|||
145437821|NCT00806260|524460673|FG002|Period 3|Pregnancy|0|||
145437822|NCT00806260|524460674|FG003|Period 3|Pregnancy|0|||
145583896|NCT00852397|524989517|FG002|Overall Study|Withdrawal by Subject|2|||
145583897|NCT00852397|524989515|FG000|Overall Study|Study terminated by sponsor|2|||
145583898|NCT00852397|524989516|FG001|Overall Study|Study terminated by sponsor|1|||
145583899|NCT00852397|524989517|FG002|Overall Study|Study terminated by sponsor|6|||
145583900|NCT00852397|524989515|FG000|Overall Study|Difficulty in study site visit|1|||
145583901|NCT00852397|524989516|FG001|Overall Study|Difficulty in study site visit|0|||
145583902|NCT00852397|524989517|FG002|Overall Study|Difficulty in study site visit|0|||
145583903|NCT00852397|524989515|FG000|Overall Study|Protocol Violation|0|||
145583904|NCT00852397|524989516|FG001|Overall Study|Protocol Violation|0|||
145583905|NCT00852397|524989517|FG002|Overall Study|Protocol Violation|1|||
145437823|NCT00806260|524460675|FG004|Period 3|Pregnancy|0|||
145437824|NCT00806260|524460676|FG005|Period 3|Pregnancy|0|||
145437825|NCT00237042|524460677|FG000|Treatment|Became ineligible post-randomization|0|||
145583906|NCT02239510|524991861|FG000|Overall Study|Lost to Follow-up|2|||
145583907|NCT02239510|524991862|FG001|Overall Study|Lost to Follow-up|1|||
145437826|NCT00237042|524460678|FG001|Treatment|Became ineligible post-randomization|1|||
145437827|NCT00237042|524460679|FG002|Treatment|Became ineligible post-randomization|16|||
145437828|NCT00237042|524460677|FG000|Treatment|Moved out of state|1|||
145437829|NCT00237042|524460678|FG001|Treatment|Moved out of state|1|||
145437830|NCT00237042|524460679|FG002|Treatment|Moved out of state|1|||
145437831|NCT00237042|524460677|FG000|Treatment|Completed no treatment|5|||
145437832|NCT00237042|524460678|FG001|Treatment|Completed no treatment|5|||
145437833|NCT00237042|524460679|FG002|Treatment|Completed no treatment|21|||
145437834|NCT00237042|524460677|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
145437835|NCT00237042|524460678|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
145437836|NCT00237042|524460679|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
145437837|NCT00237042|524460677|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
145437838|NCT00237042|524460678|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
145437839|NCT00237042|524460679|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
145437840|NCT01074931|524460684|FG000|Overall Study|Economic reasons|1|||
145437841|NCT01074931|524460684|FG000|Overall Study|Death|5|||
145437842|NCT03132467|524460685|FG000|Overall Study|Adverse Event|2|||
145437843|NCT03132467|524460685|FG000|Overall Study|Withdrawal by Subject|2|||
145437844|NCT05414175|524460686|FG000|Overall Study|Withdrawal by Subject|1|||
145437845|NCT05414175|524460686|FG000|Overall Study|Other Reasons|1|||
145437846|NCT05223673|524460687|FG000|Overall Study|Protocol Violation|1|||
145437847|NCT05223673|524460687|FG000|Overall Study|Study termination|6|||
145437848|NCT00027560|524460688|FG000|Overall Study|Withdrawal by Subject|1|||
145437849|NCT03559270|524460690|FG000|Overall Study|Adverse Event|6|||
145437850|NCT03559270|524460691|FG001|Overall Study|Adverse Event|5|||
145437851|NCT03559270|524460692|FG002|Overall Study|Adverse Event|3|||
145437852|NCT03559270|524460693|FG003|Overall Study|Adverse Event|0|||
145437853|NCT03559270|524460690|FG000|Overall Study|Lack of Efficacy|34|||
145437854|NCT03559270|524460691|FG001|Overall Study|Lack of Efficacy|52|||
145437855|NCT03559270|524460692|FG002|Overall Study|Lack of Efficacy|37|||
145583908|NCT00074282|524991865|FG000|Step 1|Adverse Event|32|||
145583909|NCT00074282|524991866|FG001|Step 1|Adverse Event|0|||
145583910|NCT00074282|524991867|FG002|Step 1|Adverse Event|0|||
145583911|NCT00074282|524991865|FG000|Step 1|Death|6|||
145583912|NCT00074282|524991866|FG001|Step 1|Death|0|||
145583913|NCT00074282|524991867|FG002|Step 1|Death|0|||
145583914|NCT00074282|524991865|FG000|Step 1|Withdrawal by Subject|7|||
145583915|NCT00074282|524991866|FG001|Step 1|Withdrawal by Subject|0|||
145583916|NCT00074282|524991867|FG002|Step 1|Withdrawal by Subject|0|||
145583917|NCT00074282|524991865|FG000|Step 1|Disease progression|2|||
145583918|NCT00074282|524991866|FG001|Step 1|Disease progression|0|||
145583919|NCT00074282|524991867|FG002|Step 1|Disease progression|0|||
145583920|NCT00074282|524991865|FG000|Step 1|Alternative therapy|2|||
145583921|NCT00074282|524991866|FG001|Step 1|Alternative therapy|0|||
145583922|NCT00074282|524991867|FG002|Step 1|Alternative therapy|0|||
145583923|NCT00074282|524991865|FG000|Step 1|Other complicating disease|2|||
145583924|NCT00074282|524991866|FG001|Step 1|Other complicating disease|0|||
145583925|NCT00074282|524991867|FG002|Step 1|Other complicating disease|0|||
145583926|NCT00074282|524991865|FG000|Step 1|Physician Decision|1|||
145583927|NCT00074282|524991866|FG001|Step 1|Physician Decision|0|||
145583928|NCT00074282|524991867|FG002|Step 1|Physician Decision|0|||
145583929|NCT00074282|524991865|FG000|Step 1|Ineligible|4|||
145583930|NCT00074282|524991866|FG001|Step 1|Ineligible|0|||
145583931|NCT00074282|524991867|FG002|Step 1|Ineligible|0|||
145583932|NCT00074282|524991865|FG000|Step 1|Never started treatment|2|||
145583933|NCT00074282|524991866|FG001|Step 1|Never started treatment|0|||
145583934|NCT00074282|524991867|FG002|Step 1|Never started treatment|0|||
145583935|NCT00074282|524991865|FG000|Step 2|Adverse Event|0|||
145583936|NCT00074282|524991866|FG001|Step 2|Adverse Event|2|||
145583937|NCT00074282|524991867|FG002|Step 2|Adverse Event|12|||
145583938|NCT00074282|524991865|FG000|Step 2|Disease progression|0|||
145583939|NCT00074282|524991866|FG001|Step 2|Disease progression|0|||
145583940|NCT00074282|524991867|FG002|Step 2|Disease progression|5|||
145583941|NCT00074282|524991865|FG000|Step 2|Death|0|||
145583942|NCT00074282|524991866|FG001|Step 2|Death|0|||
145583943|NCT00074282|524991867|FG002|Step 2|Death|3|||
145583944|NCT00074282|524991865|FG000|Step 2|Withdrawal by Subject|0|||
145583945|NCT00074282|524991866|FG001|Step 2|Withdrawal by Subject|0|||
145583946|NCT00074282|524991867|FG002|Step 2|Withdrawal by Subject|2|||
145583947|NCT00074282|524991865|FG000|Step 2|Physician Decision|0|||
145583948|NCT00074282|524991866|FG001|Step 2|Physician Decision|0|||
145583949|NCT00074282|524991867|FG002|Step 2|Physician Decision|1|||
145583950|NCT00074282|524991865|FG000|Step 2|Ineligible|0|||
145583951|NCT00074282|524991866|FG001|Step 2|Ineligible|0|||
145437856|NCT03559270|524460693|FG003|Overall Study|Lack of Efficacy|2|||
145437857|NCT03559270|524460690|FG000|Overall Study|Death|0|||
145437858|NCT03559270|524460691|FG001|Overall Study|Death|2|||
145437859|NCT03559270|524460692|FG002|Overall Study|Death|0|||
145437860|NCT03559270|524460693|FG003|Overall Study|Death|0|||
145437861|NCT03559270|524460690|FG000|Overall Study|Lost to Follow-up|16|||
145437862|NCT03559270|524460691|FG001|Overall Study|Lost to Follow-up|4|||
145583952|NCT00074282|524991867|FG002|Step 2|Ineligible|1|||
145583953|NCT00464542|524991868|FG000|Pre-treatment|Withdrawal by Subject|2|||
145583954|NCT03859323|524991870|FG000|Overall Study|Lost to Follow-up|0|||
145583955|NCT03859323|524991871|FG001|Overall Study|Lost to Follow-up|0|||
145437863|NCT03559270|524460692|FG002|Overall Study|Lost to Follow-up|12|||
145437864|NCT03559270|524460693|FG003|Overall Study|Lost to Follow-up|3|||
145437865|NCT03559270|524460690|FG000|Overall Study|Sponsor Decision|38|||
145437866|NCT03559270|524460691|FG001|Overall Study|Sponsor Decision|31|||
145437867|NCT03559270|524460692|FG002|Overall Study|Sponsor Decision|35|||
145437868|NCT03559270|524460693|FG003|Overall Study|Sponsor Decision|18|||
145437869|NCT03559270|524460690|FG000|Overall Study|Withdrawal by Subject|19|||
145437870|NCT03559270|524460691|FG001|Overall Study|Withdrawal by Subject|21|||
145437871|NCT03559270|524460692|FG002|Overall Study|Withdrawal by Subject|18|||
145437872|NCT03559270|524460693|FG003|Overall Study|Withdrawal by Subject|7|||
145437873|NCT03559270|524460690|FG000|Overall Study|Physician Decision|3|||
145437874|NCT03559270|524460691|FG001|Overall Study|Physician Decision|2|||
145437875|NCT03559270|524460692|FG002|Overall Study|Physician Decision|1|||
145437876|NCT03559270|524460693|FG003|Overall Study|Physician Decision|0|||
145437877|NCT03559270|524460690|FG000|Overall Study|Pregnancy|0|||
145437878|NCT03559270|524460691|FG001|Overall Study|Pregnancy|1|||
145437879|NCT03559270|524460692|FG002|Overall Study|Pregnancy|0|||
145437880|NCT03559270|524460693|FG003|Overall Study|Pregnancy|0|||
145437881|NCT03559270|524460690|FG000|Overall Study|Protocol Violation|1|||
145437882|NCT03559270|524460691|FG001|Overall Study|Protocol Violation|0|||
145437883|NCT03559270|524460692|FG002|Overall Study|Protocol Violation|2|||
145583956|NCT03859323|524991872|FG002|Overall Study|Lost to Follow-up|0|||
145583957|NCT03859323|524991873|FG003|Overall Study|Lost to Follow-up|0|||
145583958|NCT03859323|524991874|FG004|Overall Study|Lost to Follow-up|0|||
145583959|NCT03859323|524991875|FG005|Overall Study|Lost to Follow-up|0|||
145583960|NCT03859323|524991876|FG006|Overall Study|Lost to Follow-up|1|||
145583961|NCT03859323|524991877|FG007|Overall Study|Lost to Follow-up|0|||
145583962|NCT03859323|524991878|FG008|Overall Study|Lost to Follow-up|0|||
145583963|NCT03859323|524991879|FG009|Overall Study|Lost to Follow-up|0|||
145583964|NCT03859323|524991880|FG010|Overall Study|Lost to Follow-up|0|||
145583965|NCT03859323|524991881|FG011|Overall Study|Lost to Follow-up|0|||
145583966|NCT03859323|524991882|FG012|Overall Study|Lost to Follow-up|0|||
145583967|NCT03859323|524991870|FG000|Overall Study|Withdrawal by Subject|0|||
145583968|NCT03859323|524991871|FG001|Overall Study|Withdrawal by Subject|0|||
145583969|NCT03859323|524991872|FG002|Overall Study|Withdrawal by Subject|1|||
145583970|NCT03859323|524991873|FG003|Overall Study|Withdrawal by Subject|0|||
145583971|NCT03859323|524991874|FG004|Overall Study|Withdrawal by Subject|0|||
145583972|NCT03859323|524991875|FG005|Overall Study|Withdrawal by Subject|1|||
145583973|NCT03859323|524991876|FG006|Overall Study|Withdrawal by Subject|0|||
145583974|NCT03859323|524991877|FG007|Overall Study|Withdrawal by Subject|0|||
145583975|NCT03859323|524991878|FG008|Overall Study|Withdrawal by Subject|0|||
145583976|NCT03859323|524991879|FG009|Overall Study|Withdrawal by Subject|1|||
145583977|NCT03859323|524991880|FG010|Overall Study|Withdrawal by Subject|1|||
145583978|NCT03859323|524991881|FG011|Overall Study|Withdrawal by Subject|2|||
145583979|NCT03859323|524991882|FG012|Overall Study|Withdrawal by Subject|1|||
145583980|NCT03859323|524991870|FG000|Overall Study|Pregnancy|0|||
145583981|NCT03859323|524991871|FG001|Overall Study|Pregnancy|0|||
145583982|NCT03859323|524991872|FG002|Overall Study|Pregnancy|0|||
145583983|NCT03859323|524991873|FG003|Overall Study|Pregnancy|0|||
145583984|NCT03859323|524991874|FG004|Overall Study|Pregnancy|0|||
145583985|NCT03859323|524991875|FG005|Overall Study|Pregnancy|0|||
145583986|NCT03859323|524991876|FG006|Overall Study|Pregnancy|0|||
145583987|NCT03859323|524991877|FG007|Overall Study|Pregnancy|0|||
145583988|NCT03859323|524991878|FG008|Overall Study|Pregnancy|0|||
145583989|NCT03859323|524991879|FG009|Overall Study|Pregnancy|1|||
145583990|NCT03859323|524991880|FG010|Overall Study|Pregnancy|0|||
145583991|NCT03859323|524991881|FG011|Overall Study|Pregnancy|0|||
145583992|NCT03859323|524991882|FG012|Overall Study|Pregnancy|0|||
145583993|NCT01682460|524991883|FG000|Overall Study|Withdrawal by Subject|2|||
145583994|NCT01682460|524991883|FG000|Overall Study|Did not meet inclusion criteria|2|||
145583995|NCT02055352|524991887|FG000|Overall Study|Adverse Event|0|||
145583996|NCT02055352|524991888|FG001|Overall Study|Adverse Event|1|||
145583997|NCT02055352|524991887|FG000|Overall Study|Non-eligible|0|||
145583998|NCT02055352|524991888|FG001|Overall Study|Non-eligible|1|||
145583999|NCT02055352|524991887|FG000|Overall Study|Poor compliance|1|||
145437884|NCT03559270|524460693|FG003|Overall Study|Protocol Violation|0|||
145584000|NCT02055352|524991888|FG001|Overall Study|Poor compliance|1|||
145437885|NCT04472650|524462518|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
145584001|NCT02055352|524991887|FG000|Overall Study|Death|1|||
145584002|NCT02055352|524991888|FG001|Overall Study|Death|2|||
145584003|NCT02055352|524991887|FG000|Overall Study|Patient decision|1|||
145584004|NCT02055352|524991888|FG001|Overall Study|Patient decision|1|||
145584005|NCT02055352|524991887|FG000|Overall Study|Use of prohibited treatment|0|||
145584006|NCT02055352|524991888|FG001|Overall Study|Use of prohibited treatment|3|||
145437886|NCT04472650|524462519|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
145437887|NCT02549989|524462522|FG000|Overall Study|Adverse Event|4|||
145584007|NCT02055352|524991887|FG000|Overall Study|AE, study drug would be detrimental|1|||
145584008|NCT02055352|524991888|FG001|Overall Study|AE, study drug would be detrimental|3|||
145584009|NCT02055352|524991887|FG000|Overall Study|Withdrawal of informed consent|1|||
145584010|NCT02055352|524991888|FG001|Overall Study|Withdrawal of informed consent|0|||
145437888|NCT02549989|524462522|FG000|Overall Study|Death|1|||
145437889|NCT02549989|524462522|FG000|Overall Study|Lack of Efficacy|19|||
145437890|NCT02549989|524462522|FG000|Overall Study|Withdrawal by Subject|3|||
145437891|NCT01333722|524462526|FG000|Overall Study|Lack of Efficacy|0|||
145437892|NCT01333722|524462527|FG001|Overall Study|Lack of Efficacy|2|||
145437893|NCT01333722|524462526|FG000|Overall Study|Withdrawal by Subject|0|||
145437894|NCT01333722|524462527|FG001|Overall Study|Withdrawal by Subject|1|||
145437895|NCT00784368|524462530|FG000|Overall Study|Physician Decision|0|||
145437896|NCT00784368|524462531|FG001|Overall Study|Physician Decision|0|||
145437897|NCT00784368|524462532|FG002|Overall Study|Physician Decision|6|||
145437898|NCT00784368|524462530|FG000|Overall Study|Lack of Efficacy|2|||
145437899|NCT00784368|524462531|FG001|Overall Study|Lack of Efficacy|0|||
145437900|NCT00784368|524462532|FG002|Overall Study|Lack of Efficacy|1|||
145437901|NCT00784368|524462530|FG000|Overall Study|Adverse Event|6|||
145437902|NCT00784368|524462531|FG001|Overall Study|Adverse Event|9|||
145437903|NCT00784368|524462532|FG002|Overall Study|Adverse Event|2|||
145437904|NCT00784368|524462530|FG000|Overall Study|Diagnosis of fever|0|||
145437905|NCT00784368|524462531|FG001|Overall Study|Diagnosis of fever|0|||
145437906|NCT00784368|524462532|FG002|Overall Study|Diagnosis of fever|1|||
145437907|NCT00784368|524462530|FG000|Overall Study|Worsening of complications|0|||
145437908|NCT00784368|524462531|FG001|Overall Study|Worsening of complications|0|||
145437909|NCT00784368|524462532|FG002|Overall Study|Worsening of complications|1|||
145437910|NCT00784368|524462530|FG000|Overall Study|Worsening of symptoms|0|||
145437911|NCT00784368|524462531|FG001|Overall Study|Worsening of symptoms|1|||
145437912|NCT00784368|524462532|FG002|Overall Study|Worsening of symptoms|0|||
145437913|NCT00784368|524462530|FG000|Overall Study|Withdrawal of informed consent|0|||
145437914|NCT00784368|524462531|FG001|Overall Study|Withdrawal of informed consent|1|||
145437915|NCT00784368|524462532|FG002|Overall Study|Withdrawal of informed consent|0|||
145437916|NCT04776161|524462536|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
145437917|NCT04776161|524462537|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
145437918|NCT04776161|524462538|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
145437919|NCT04776161|524462536|FG000|Overall Study|Withdrawal by Subject|1|||
145437920|NCT04776161|524462537|FG001|Overall Study|Withdrawal by Subject|0|||
145437921|NCT04776161|524462538|FG002|Overall Study|Withdrawal by Subject|1|||
145437922|NCT04776161|524462536|FG000|Overall Study|Adverse Event|0|||
145437923|NCT04776161|524462537|FG001|Overall Study|Adverse Event|1|||
145437924|NCT04776161|524462538|FG002|Overall Study|Adverse Event|1|||
145437925|NCT00342628|524462539|FG000|Overall Study|Withdrawal by Subject|19|||
145437926|NCT00342628|524462540|FG001|Overall Study|Withdrawal by Subject|19|||
145437927|NCT00342628|524462541|FG002|Overall Study|Withdrawal by Subject|18|||
145437928|NCT00342628|524462539|FG000|Overall Study|Death|1|||
145437929|NCT00342628|524462540|FG001|Overall Study|Death|1|||
145437930|NCT00342628|524462541|FG002|Overall Study|Death|0|||
145437931|NCT00342628|524462539|FG000|Overall Study|moved residence|0|||
145437932|NCT00342628|524462540|FG001|Overall Study|moved residence|1|||
145437933|NCT00342628|524462541|FG002|Overall Study|moved residence|1|||
145437934|NCT01944020|524462542|FG000|Overall Study|Withdrawal by Subject|5|||
145437935|NCT01944020|524462543|FG001|Overall Study|Withdrawal by Subject|0|||
145437936|NCT00938912|524462544|FG000|Overall Study|Withdrawal by Subject|28|||
145437937|NCT00938912|524462544|FG000|Overall Study|Lost to Follow-up|4|||
145437938|NCT00938912|524462544|FG000|Overall Study|Lack of Efficacy|43|||
145437939|NCT00938912|524462544|FG000|Overall Study|Adverse event, non-fatal|24|||
145437940|NCT00938912|524462544|FG000|Overall Study|Adverse event, fatal|1|||
145437941|NCT00938912|524462544|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
145437942|NCT00938912|524462544|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
145437943|NCT00938912|524462544|FG000|Overall Study|Participant needed prohibit medication|1|||
145437944|NCT00938912|524462544|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
145437945|NCT00938912|524462544|FG000|Overall Study|Did not meet Eligibility criteria|1|||
145437946|NCT00938912|524462544|FG000|Overall Study|Participant relocated not related to AE|1|||
145437947|NCT00938912|524462544|FG000|Overall Study|Participant moved to another city|1|||
145437948|NCT00938912|524462544|FG000|Overall Study|Participant experienced break through seizures|1|||
145437949|NCT00938912|524462544|FG000|Overall Study|No longer wished to participate in the study|1|||
145437950|NCT00938912|524462544|FG000|Overall Study|Protocol Deviation|2|||
145437951|NCT03341637|524462545|FG000|Overall Study|Lost to Follow-up|1|||
145437952|NCT03341637|524462546|FG001|Overall Study|Lost to Follow-up|0|||
145437953|NCT03341637|524462545|FG000|Overall Study|Withdrawal by Subject|3|||
145437954|NCT03341637|524462546|FG001|Overall Study|Withdrawal by Subject|3|||
145437955|NCT03341637|524462545|FG000|Overall Study|Reason not Specified|1|||
145437956|NCT03341637|524462546|FG001|Overall Study|Reason not Specified|1|||
145437957|NCT00803738|524462547|FG000|Overall Study|Adverse Event|3|||
145437958|NCT00803738|524462548|FG001|Overall Study|Adverse Event|5|||
145437959|NCT00803738|524462547|FG000|Overall Study|Lost to Follow-up|4|||
145584011|NCT02055352|524991887|FG000|Overall Study|Reason unknown|1|||
145437960|NCT00803738|524462548|FG001|Overall Study|Lost to Follow-up|4|||
145584012|NCT02055352|524991888|FG001|Overall Study|Reason unknown|5|||
145584013|NCT05349617|524991891|FG000|Overall Study|Death|1|||
145437961|NCT00803738|524462547|FG000|Overall Study|Protocol Violation|18|||
145437962|NCT00803738|524462548|FG001|Overall Study|Protocol Violation|10|||
145437963|NCT00803738|524462547|FG000|Overall Study|Withdrawal by Subject|1|||
145437964|NCT00803738|524462548|FG001|Overall Study|Withdrawal by Subject|4|||
145437965|NCT00803738|524462547|FG000|Overall Study|Lack of Efficacy|10|||
145437966|NCT00803738|524462548|FG001|Overall Study|Lack of Efficacy|16|||
145437967|NCT00803738|524462547|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
145437968|NCT00803738|524462548|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
145437969|NCT00803738|524462547|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
145437970|NCT00803738|524462548|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
145437971|NCT02897115|524462553|FG000|Overall Study|Early termination of study by sponsor|11|||
145437972|NCT02897115|524462554|FG001|Overall Study|Early termination of study by sponsor|8|||
145437973|NCT00856323|524462556|FG000|Overall Study|Withdrawal by Subject|2|||
145437974|NCT01639469|524462561|FG000|Overall Study|Death|4|||
145437975|NCT01639469|524462562|FG001|Overall Study|Death|2|||
145437976|NCT01639469|524462561|FG000|Overall Study|Lost to Follow-up|1|||
145437977|NCT01639469|524462562|FG001|Overall Study|Lost to Follow-up|1|||
145437978|NCT01119443|524462563|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
145437979|NCT01119443|524462564|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
145437980|NCT00420381|524462565|FG000|Overall Study|Protocol Violation|1|||
145437981|NCT01428219|524462566|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
145437982|NCT02071771|524462567|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
145437983|NCT02071771|524462568|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
145437984|NCT02071771|524462567|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
145437985|NCT02071771|524462568|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
145437986|NCT02078752|524462569|FG000|Overall Study|Death|0|||
145437987|NCT02078752|524462570|FG001|Overall Study|Death|3|||
145437988|NCT02078752|524462571|FG002|Overall Study|Death|0|||
145437989|NCT02078752|524462572|FG003|Overall Study|Death|0|||
145437990|NCT02078752|524462573|FG004|Overall Study|Death|0|||
145437991|NCT02078752|524462574|FG005|Overall Study|Death|1|||
145437992|NCT02078752|524462575|FG006|Overall Study|Death|0|||
145437993|NCT02078752|524462576|FG007|Overall Study|Death|1|||
145437994|NCT02078752|524462577|FG008|Overall Study|Death|0|||
145437995|NCT02078752|524462578|FG009|Overall Study|Death|4|||
145437996|NCT02078752|524462569|FG000|Overall Study|Lost to Follow-up|1|||
145437997|NCT02078752|524462570|FG001|Overall Study|Lost to Follow-up|0|||
145437998|NCT02078752|524462571|FG002|Overall Study|Lost to Follow-up|0|||
145437999|NCT02078752|524462572|FG003|Overall Study|Lost to Follow-up|1|||
145438000|NCT02078752|524462573|FG004|Overall Study|Lost to Follow-up|0|||
145438001|NCT02078752|524462574|FG005|Overall Study|Lost to Follow-up|0|||
145438002|NCT02078752|524462575|FG006|Overall Study|Lost to Follow-up|0|||
145438003|NCT02078752|524462576|FG007|Overall Study|Lost to Follow-up|0|||
145438004|NCT02078752|524462577|FG008|Overall Study|Lost to Follow-up|0|||
145438005|NCT02078752|524462578|FG009|Overall Study|Lost to Follow-up|0|||
145438006|NCT02078752|524462569|FG000|Overall Study|Withdrawal by Subject|1|||
145438007|NCT02078752|524462570|FG001|Overall Study|Withdrawal by Subject|1|||
145438008|NCT02078752|524462571|FG002|Overall Study|Withdrawal by Subject|1|||
145438009|NCT02078752|524462572|FG003|Overall Study|Withdrawal by Subject|1|||
145438010|NCT02078752|524462573|FG004|Overall Study|Withdrawal by Subject|0|||
145438011|NCT02078752|524462574|FG005|Overall Study|Withdrawal by Subject|3|||
145438012|NCT02078752|524462575|FG006|Overall Study|Withdrawal by Subject|2|||
145438013|NCT02078752|524462576|FG007|Overall Study|Withdrawal by Subject|1|||
145438014|NCT02078752|524462577|FG008|Overall Study|Withdrawal by Subject|0|||
145438015|NCT02078752|524462578|FG009|Overall Study|Withdrawal by Subject|1|||
145438016|NCT02078752|524462569|FG000|Overall Study|Other|0|||
145438017|NCT02078752|524462570|FG001|Overall Study|Other|3|||
145438018|NCT02078752|524462571|FG002|Overall Study|Other|0|||
145438019|NCT02078752|524462572|FG003|Overall Study|Other|0|||
145438020|NCT02078752|524462573|FG004|Overall Study|Other|1|||
145438021|NCT02078752|524462574|FG005|Overall Study|Other|0|||
145438022|NCT02078752|524462575|FG006|Overall Study|Other|0|||
145438023|NCT02078752|524462576|FG007|Overall Study|Other|1|||
145438024|NCT02078752|524462577|FG008|Overall Study|Other|0|||
145438025|NCT02078752|524462578|FG009|Overall Study|Other|0|||
145438026|NCT02078752|524462569|FG000|Overall Study|Study terminated by sponsor|0|||
145438027|NCT02078752|524462570|FG001|Overall Study|Study terminated by sponsor|0|||
145438028|NCT02078752|524462571|FG002|Overall Study|Study terminated by sponsor|0|||
145438029|NCT02078752|524462572|FG003|Overall Study|Study terminated by sponsor|0|||
145438030|NCT02078752|524462573|FG004|Overall Study|Study terminated by sponsor|0|||
145438031|NCT02078752|524462574|FG005|Overall Study|Study terminated by sponsor|0|||
145438032|NCT02078752|524462575|FG006|Overall Study|Study terminated by sponsor|0|||
145438033|NCT02078752|524462576|FG007|Overall Study|Study terminated by sponsor|0|||
145584014|NCT05349617|524991892|FG001|Overall Study|Death|1|||
145584015|NCT05349617|524991891|FG000|Overall Study|Lost to Follow-up|3|||
145438034|NCT02078752|524462577|FG008|Overall Study|Study terminated by sponsor|0|||
145438035|NCT02078752|524462578|FG009|Overall Study|Study terminated by sponsor|5|||
145584016|NCT05349617|524991892|FG001|Overall Study|Lost to Follow-up|8|||
145584017|NCT05349617|524991891|FG000|Overall Study|Withdrawal by Subject|2|||
145438036|NCT00775268|524462590|FG000|Baseline|Drug not synthesize dose|1|||
145438037|NCT00775268|524462591|FG001|Baseline|Drug not synthesize dose|0|||
145438038|NCT00775268|524462590|FG000|Baseline|Not treated-ineligible per CT|0|||
145438039|NCT00775268|524462591|FG001|Baseline|Not treated-ineligible per CT|1|||
145438040|NCT00775268|524462590|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
145438041|NCT00775268|524462591|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
145438042|NCT00775268|524462590|FG000|After Completion|Participant missed scan appointment|1|||
145438043|NCT00775268|524462591|FG001|After Completion|Participant missed scan appointment|0|||
145438044|NCT02383862|524462594|FG000|3 Month Follow up|Lost to Follow-up|23|||
145438045|NCT02383862|524462595|FG001|3 Month Follow up|Lost to Follow-up|21|||
145438046|NCT01833494|524462596|FG000|Overall Study|Adverse Event|24|||
145438047|NCT01833494|524462596|FG000|Overall Study|Physician Decision|6|||
145438048|NCT01833494|524462596|FG000|Overall Study|Withdrawal by Subject|6|||
145438049|NCT01833494|524462596|FG000|Overall Study|Decrease in serum phosphorus|4|||
145438050|NCT01833494|524462596|FG000|Overall Study|Decrease in serum calcium|4|||
145438051|NCT01833494|524462596|FG000|Overall Study|Increase in serum ferritin|1|||
145438052|NCT01694433|524462601|FG000|Overall Study|Adverse Event|7|||
145438053|NCT01694433|524462602|FG001|Overall Study|Adverse Event|0|||
145438054|NCT01694433|524462601|FG000|Overall Study|Physician Decision|1|||
145438055|NCT01694433|524462602|FG001|Overall Study|Physician Decision|0|||
145438056|NCT01694433|524462601|FG000|Overall Study|Withdrawal by Subject|3|||
145438057|NCT01694433|524462602|FG001|Overall Study|Withdrawal by Subject|4|||
145438058|NCT00374595|524462605|FG000|Overall Study|Death|23|||
145438059|NCT00374595|524462605|FG000|Overall Study|Withdrawal by Subject|39|||
145438060|NCT00374595|524462605|FG000|Overall Study|Lost to Follow-up|3|||
145438061|NCT00374595|524462605|FG000|Overall Study|too much time commitment|1|||
145438062|NCT00374595|524462605|FG000|Overall Study|transfer care to other clinical site|1|||
145438063|NCT00374595|524462605|FG000|Overall Study|relocation|3|||
145438064|NCT03745768|524462606|FG000|Overall Study|discontinued study|2|||
145438065|NCT03745768|524462607|FG001|Overall Study|discontinued study|0|||
145438066|NCT00443118|524462608|FG000|Overall Study|unknown primary outcome|3|||
145438067|NCT00443118|524462609|FG001|Overall Study|unknown primary outcome|1|||
145438068|NCT00443118|524462610|FG002|Overall Study|unknown primary outcome|0|||
145438069|NCT00443118|524462608|FG000|Overall Study|Withdrawal by Subject|1|||
145438070|NCT00443118|524462609|FG001|Overall Study|Withdrawal by Subject|0|||
145438071|NCT00443118|524462610|FG002|Overall Study|Withdrawal by Subject|0|||
145438072|NCT04232943|524462611|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
145438073|NCT04232943|524462612|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
145438074|NCT04232943|524462613|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
145438075|NCT04232943|524462611|FG000|Overall Study|Withdrawal by Subject|1|||
145438076|NCT04232943|524462612|FG001|Overall Study|Withdrawal by Subject|1|||
145438077|NCT04232943|524462613|FG002|Overall Study|Withdrawal by Subject|0|||
145438078|NCT01664247|524462619|FG000|Overall Study|Adverse Event|5|||
145438079|NCT01664247|524462620|FG001|Overall Study|Adverse Event|3|||
145438080|NCT01664247|524462619|FG000|Overall Study|Protocol Violation|3|||
145438081|NCT01664247|524462620|FG001|Overall Study|Protocol Violation|5|||
145438082|NCT01664247|524462619|FG000|Overall Study|Withdrawal Criteria|1|||
145438083|NCT01664247|524462620|FG001|Overall Study|Withdrawal Criteria|4|||
145438084|NCT01664247|524462619|FG000|Overall Study|Unclassified|5|||
145438085|NCT01664247|524462620|FG001|Overall Study|Unclassified|29|||
145438086|NCT01023217|524462621|FG000|Overall Study|Withdrawal by Subject|1|||
145438087|NCT01023217|524462622|FG001|Overall Study|Withdrawal by Subject|0|||
145438088|NCT01106157|524462623|FG000|Overall Study|Withdrawal by Subject|1|||
145438089|NCT01106157|524462624|FG001|Overall Study|Withdrawal by Subject|0|||
145438090|NCT02298868|524462625|FG000|Overall Study|Adverse Event|1|||
145438091|NCT02298868|524462625|FG000|Overall Study|Death|1|||
145438092|NCT02298868|524462625|FG000|Overall Study|Patient underwent transplant|1|||
145438093|NCT01000506|524462626|FG000|Overall Study|Adverse Event|6|||
145438094|NCT01000506|524462627|FG001|Overall Study|Adverse Event|5|||
145438095|NCT01000506|524462628|FG002|Overall Study|Adverse Event|8|||
145438096|NCT01000506|524462629|FG003|Overall Study|Adverse Event|9|||
145438097|NCT01000506|524462626|FG000|Overall Study|Lack of Efficacy|8|||
145438098|NCT01000506|524462627|FG001|Overall Study|Lack of Efficacy|6|||
145438099|NCT01000506|524462628|FG002|Overall Study|Lack of Efficacy|4|||
145438100|NCT01000506|524462629|FG003|Overall Study|Lack of Efficacy|4|||
145438101|NCT01000506|524462626|FG000|Overall Study|Protocol Violation|1|||
145438102|NCT01000506|524462627|FG001|Overall Study|Protocol Violation|1|||
145438103|NCT01000506|524462628|FG002|Overall Study|Protocol Violation|0|||
145438104|NCT01000506|524462629|FG003|Overall Study|Protocol Violation|0|||
145438105|NCT01000506|524462626|FG000|Overall Study|Lost to Follow-up|1|||
145438106|NCT01000506|524462627|FG001|Overall Study|Lost to Follow-up|1|||
145438107|NCT01000506|524462628|FG002|Overall Study|Lost to Follow-up|4|||
145438108|NCT01000506|524462629|FG003|Overall Study|Lost to Follow-up|0|||
145438109|NCT01000506|524462626|FG000|Overall Study|Physician Decision|1|||
145438110|NCT01000506|524462627|FG001|Overall Study|Physician Decision|3|||
145438111|NCT01000506|524462628|FG002|Overall Study|Physician Decision|3|||
145438112|NCT01000506|524462629|FG003|Overall Study|Physician Decision|3|||
145438113|NCT01000506|524462626|FG000|Overall Study|Withdrawal by Subject|11|||
145438114|NCT01000506|524462627|FG001|Overall Study|Withdrawal by Subject|8|||
145438115|NCT01000506|524462628|FG002|Overall Study|Withdrawal by Subject|2|||
145438116|NCT01000506|524462629|FG003|Overall Study|Withdrawal by Subject|7|||
145438117|NCT03064074|524462630|FG000|Overall Study|Physician Decision|0|||
145438118|NCT03064074|524462631|FG001|Overall Study|Physician Decision|0|||
145438119|NCT03064074|524462632|FG002|Overall Study|Physician Decision|0|||
145438120|NCT03064074|524462633|FG003|Overall Study|Physician Decision|1|||
145438121|NCT03962855|524462636|FG000|Overall Study|Death|0|||
145438122|NCT03962855|524462637|FG001|Overall Study|Death|1|||
145438123|NCT03962855|524462636|FG000|Overall Study|Lost to Follow-up|0|||
145438124|NCT03962855|524462637|FG001|Overall Study|Lost to Follow-up|1|||
145438125|NCT03962855|524462636|FG000|Overall Study|Adverse Event|0|||
145438126|NCT03962855|524462637|FG001|Overall Study|Adverse Event|1|||
145438127|NCT03962855|524462636|FG000|Overall Study|Physician Decision|0|||
145438128|NCT03962855|524462637|FG001|Overall Study|Physician Decision|2|||
145438129|NCT00532844|524462639|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
145438130|NCT00532844|524462640|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
145438131|NCT00532844|524462639|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
145438132|NCT00532844|524462640|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
145438133|NCT00532844|524462639|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
145438134|NCT00532844|524462640|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
145438135|NCT00532844|524462639|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
145438136|NCT00532844|524462640|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
145438137|NCT00532844|524462639|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
145438138|NCT00532844|524462640|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
145438139|NCT04389866|524462645|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
145438140|NCT04389866|524462646|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
145438141|NCT04940130|524462651|FG000|Overall Study|Travel|1|||
145438142|NCT04940130|524462652|FG001|Overall Study|Travel|0|||
145438143|NCT04940130|524462653|FG002|Overall Study|Travel|2|||
145438144|NCT04940130|524462651|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
145438145|NCT04940130|524462652|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
145438146|NCT04940130|524462653|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
145438147|NCT04940130|524462651|FG000|Overall Study|Adverse Event|0|||
145438148|NCT04940130|524462652|FG001|Overall Study|Adverse Event|0|||
145438149|NCT04940130|524462653|FG002|Overall Study|Adverse Event|2|||
145438150|NCT04940130|524462651|FG000|Overall Study|Disease progression/treatment failure|0|||
145438151|NCT04940130|524462652|FG001|Overall Study|Disease progression/treatment failure|0|||
145438152|NCT04940130|524462653|FG002|Overall Study|Disease progression/treatment failure|1|||
145438153|NCT04940130|524462651|FG000|Overall Study|Participant refusal|0|||
145438154|NCT04940130|524462652|FG001|Overall Study|Participant refusal|0|||
145438155|NCT04940130|524462653|FG002|Overall Study|Participant refusal|1|||
145438156|NCT02240121|524462654|FG000|Overall Study|Protocol Violation|1|||
145438157|NCT02240121|524462655|FG001|Overall Study|Protocol Violation|2|||
145438158|NCT02240121|524462654|FG000|Overall Study|Physician Decision|0|||
145438159|NCT02240121|524462655|FG001|Overall Study|Physician Decision|1|||
145438160|NCT02240121|524462654|FG000|Overall Study|Change in protocol interpretation|1|||
145438161|NCT02240121|524462655|FG001|Overall Study|Change in protocol interpretation|0|||
145438162|NCT02240121|524462654|FG000|Overall Study|Lack of Efficacy|2|||
145438163|NCT02240121|524462655|FG001|Overall Study|Lack of Efficacy|3|||
145438164|NCT02240121|524462654|FG000|Overall Study|Site closed|1|||
145438165|NCT02240121|524462655|FG001|Overall Study|Site closed|1|||
145438166|NCT02240121|524462654|FG000|Overall Study|Pregnancy|1|||
145438167|NCT02240121|524462655|FG001|Overall Study|Pregnancy|0|||
145438168|NCT02240121|524462654|FG000|Overall Study|Adverse Event|2|||
145438169|NCT02240121|524462655|FG001|Overall Study|Adverse Event|4|||
145438170|NCT02240121|524462654|FG000|Overall Study|Withdrawal by Subject|6|||
145438171|NCT02240121|524462655|FG001|Overall Study|Withdrawal by Subject|2|||
145438172|NCT02240121|524462654|FG000|Overall Study|Lost to Follow-up|3|||
145438173|NCT02240121|524462655|FG001|Overall Study|Lost to Follow-up|4|||
145438174|NCT02240121|524462654|FG000|Overall Study|Other than specified|1|||
145438175|NCT02240121|524462655|FG001|Overall Study|Other than specified|3|||
145438176|NCT00833027|524462657|FG000|Overall Study|Adverse Event|33|||
145438177|NCT00833027|524462657|FG000|Overall Study|Death|1|||
145438178|NCT00833027|524462657|FG000|Overall Study|Lack of Efficacy|12|||
145438179|NCT00833027|524462657|FG000|Overall Study|Lost to Follow-up|24|||
145584018|NCT05349617|524991892|FG001|Overall Study|Withdrawal by Subject|10|||
145438180|NCT00833027|524462657|FG000|Overall Study|Protocol Violation|115|||
145438181|NCT00833027|524462657|FG000|Overall Study|Withdrawal by Subject|16|||
145438182|NCT00833027|524462657|FG000|Overall Study|Missing|10|||
145438183|NCT03069716|524462660|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
145438184|NCT03069716|524462661|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
145438185|NCT03069716|524462662|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
145438186|NCT03069716|524462660|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
145438187|NCT03069716|524462661|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
145438188|NCT03069716|524462662|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
145438189|NCT03069716|524462660|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
145438190|NCT03069716|524462661|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
145438191|NCT03069716|524462662|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
145438192|NCT03069716|524462660|FG000|Randomized Treatment|Withdrawal by Subject|0|||
145438193|NCT03069716|524462661|FG001|Randomized Treatment|Withdrawal by Subject|2|||
145438194|NCT03069716|524462662|FG002|Randomized Treatment|Withdrawal by Subject|0|||
145438195|NCT03092479|524462663|FG000|Overall Study|Lost to Follow-up|3|||
145438196|NCT03092479|524462664|FG001|Overall Study|Lost to Follow-up|2|||
145438197|NCT03092479|524462663|FG000|Overall Study|Withdrawal by Subject|4|||
145438198|NCT03092479|524462664|FG001|Overall Study|Withdrawal by Subject|0|||
145438199|NCT03913130|524462667|FG000|Overall Study|Sponsor Decision|1|||
145438200|NCT05653700|524462668|FG000|Overall Study|Non Responders|9|||
145438201|NCT05653700|524462669|FG001|Overall Study|Non Responders|0|||
145438202|NCT01985022|524462685|FG000|Overall Study|Lost to Follow-up|0|||
145438203|NCT01985022|524462686|FG001|Overall Study|Lost to Follow-up|1|||
145438204|NCT01985022|524462685|FG000|Overall Study|Protocol Violation|0|||
145438205|NCT01985022|524462686|FG001|Overall Study|Protocol Violation|1|||
145438206|NCT01985022|524462685|FG000|Overall Study|Withdrawal by Subject|4|||
145438207|NCT01985022|524462686|FG001|Overall Study|Withdrawal by Subject|1|||
145438208|NCT04790279|524464206|FG000|Overall Study|Did not meet medication start criteria|27|||
145438209|NCT04790279|524464207|FG001|Overall Study|Did not meet medication start criteria|15|||
145438210|NCT04790279|524464206|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
145438211|NCT04790279|524464207|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
145438212|NCT04790279|524464206|FG000|Overall Study|Protocol Violation|8|||
145438213|NCT04790279|524464207|FG001|Overall Study|Protocol Violation|3|||
145438214|NCT04790279|524464206|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
145438215|NCT04790279|524464207|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
145438216|NCT00678288|524464219|FG000|Overall Study|Adverse Event|0|||
145438217|NCT00678288|524464220|FG001|Overall Study|Adverse Event|2|||
145438218|NCT00678288|524464219|FG000|Overall Study|Withdrawal by Subject|1|||
145438219|NCT00678288|524464220|FG001|Overall Study|Withdrawal by Subject|1|||
145438220|NCT00678288|524464219|FG000|Overall Study|Study terminated by the sponsor|2|||
145438221|NCT00678288|524464220|FG001|Overall Study|Study terminated by the sponsor|0|||
145438222|NCT00678288|524464219|FG000|Overall Study|Not compliant with study medication|0|||
145438223|NCT00678288|524464220|FG001|Overall Study|Not compliant with study medication|1|||
145438224|NCT00678288|524464219|FG000|Overall Study|Switch to commercial drug|0|||
145438225|NCT00678288|524464220|FG001|Overall Study|Switch to commercial drug|1|||
145438226|NCT00678288|524464219|FG000|Overall Study|Reason not reported|1|||
145438227|NCT00678288|524464220|FG001|Overall Study|Reason not reported|0|||
145438228|NCT00678288|524464219|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
145438229|NCT00678288|524464220|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
145438230|NCT02628444|524464223|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
145438231|NCT02628444|524464224|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438232|NCT02628444|524464225|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438233|NCT02628444|524464226|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438234|NCT02628444|524464227|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438235|NCT02628444|524464228|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438236|NCT02628444|524464229|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438237|NCT02628444|524464230|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145438238|NCT02628444|524464231|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
145584019|NCT03811912|524991895|FG000|Overall Study|Withdrew Consent|4|||
145584020|NCT03811912|524991896|FG001|Overall Study|Withdrew Consent|2|||
145584021|NCT04401579|524991897|FG000|Overall Study|Death|23|||
145584022|NCT04401579|524991898|FG001|Overall Study|Death|36|||
145584023|NCT04401579|524991897|FG000|Overall Study|Lost to Follow-up|40|||
145584024|NCT04401579|524991898|FG001|Overall Study|Lost to Follow-up|41|||
145584025|NCT04401579|524991897|FG000|Overall Study|Withdrawal by Subject|8|||
145584026|NCT04401579|524991898|FG001|Overall Study|Withdrawal by Subject|16|||
145584027|NCT04401579|524991897|FG000|Overall Study|Physician Decision|1|||
145584028|NCT04401579|524991898|FG001|Overall Study|Physician Decision|2|||
145584029|NCT04401579|524991897|FG000|Overall Study|Became ineligible after enrollment|1|||
145584030|NCT04401579|524991898|FG001|Overall Study|Became ineligible after enrollment|1|||
145584031|NCT04401579|524991897|FG000|Overall Study|Enrolled but treatment not administered|7|||
145584032|NCT04401579|524991898|FG001|Overall Study|Enrolled but treatment not administered|9|||
145584033|NCT04401579|524991897|FG000|Overall Study|Adverse Event|2|||
145584034|NCT04401579|524991898|FG001|Overall Study|Adverse Event|1|||
145584035|NCT04401579|524991897|FG000|Overall Study|Scheduling error|1|||
145584036|NCT04401579|524991898|FG001|Overall Study|Scheduling error|2|||
145584037|NCT04401579|524991897|FG000|Overall Study|Transferred to another hospital|1|||
145438239|NCT02628444|524464223|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438240|NCT02628444|524464224|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
145438241|NCT02628444|524464225|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
145438242|NCT02628444|524464226|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438243|NCT02628444|524464227|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438244|NCT02628444|524464228|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438245|NCT02628444|524464229|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438246|NCT02628444|524464230|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438247|NCT02628444|524464231|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
145438248|NCT02628444|524464223|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
145438249|NCT02628444|524464224|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
145438250|NCT02628444|524464225|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
145438251|NCT02628444|524464226|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438252|NCT02628444|524464227|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438253|NCT02628444|524464228|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438254|NCT02628444|524464229|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438255|NCT02628444|524464230|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438256|NCT02628444|524464231|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438257|NCT02628444|524464223|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
145438258|NCT02628444|524464224|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
145438259|NCT02628444|524464225|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
145438260|NCT02628444|524464226|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438261|NCT02628444|524464227|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438262|NCT02628444|524464228|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438263|NCT02628444|524464229|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438264|NCT02628444|524464230|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438265|NCT02628444|524464231|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
145438266|NCT02628444|524464223|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
145438267|NCT02628444|524464224|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
145438268|NCT02628444|524464225|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
145438269|NCT02628444|524464226|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438270|NCT02628444|524464227|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438271|NCT02628444|524464228|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438272|NCT02628444|524464229|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438273|NCT02628444|524464230|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438274|NCT02628444|524464231|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
145438275|NCT02628444|524464223|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438276|NCT02628444|524464224|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438277|NCT02628444|524464225|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438278|NCT02628444|524464226|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
145438279|NCT02628444|524464227|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438280|NCT02628444|524464228|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438281|NCT02628444|524464229|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438282|NCT02628444|524464230|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438283|NCT02628444|524464231|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
145438284|NCT02628444|524464223|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
145438285|NCT02628444|524464224|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
145438286|NCT02628444|524464225|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
145438287|NCT02628444|524464226|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
145438288|NCT02628444|524464227|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
145438289|NCT02628444|524464228|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
145438290|NCT02628444|524464229|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
145438291|NCT02628444|524464230|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
145438292|NCT02628444|524464231|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
145438293|NCT02628444|524464223|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438294|NCT02628444|524464224|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438295|NCT02628444|524464225|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
145438296|NCT02628444|524464226|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
145438297|NCT02628444|524464227|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
145438298|NCT02628444|524464228|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
145438299|NCT02628444|524464229|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
145438300|NCT02628444|524464230|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
145438301|NCT02628444|524464231|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
145438302|NCT02628444|524464223|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438303|NCT02628444|524464224|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438304|NCT02628444|524464225|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438305|NCT02628444|524464226|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438306|NCT02628444|524464227|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
145438307|NCT02628444|524464228|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438308|NCT02628444|524464229|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
145438309|NCT02628444|524464230|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
145438310|NCT02628444|524464231|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
145438311|NCT02628444|524464223|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
145438312|NCT02628444|524464224|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
145438313|NCT02628444|524464225|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
145438314|NCT02628444|524464226|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
145438315|NCT02628444|524464227|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
145438316|NCT02628444|524464228|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
145438317|NCT02628444|524464229|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
145438318|NCT02628444|524464230|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
145438319|NCT02628444|524464231|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
145438320|NCT02079909|524464232|FG000|Overall Study|Adverse Event|23|||
145438321|NCT02079909|524464233|FG001|Overall Study|Adverse Event|23|||
145438322|NCT02079909|524464234|FG002|Overall Study|Adverse Event|7|||
145438323|NCT02079909|524464232|FG000|Overall Study|Withdrawal by Subject|9|||
145438324|NCT02079909|524464233|FG001|Overall Study|Withdrawal by Subject|17|||
145438325|NCT02079909|524464234|FG002|Overall Study|Withdrawal by Subject|4|||
145438326|NCT02079909|524464232|FG000|Overall Study|Lost to Follow-up|2|||
145438327|NCT02079909|524464233|FG001|Overall Study|Lost to Follow-up|3|||
145438328|NCT02079909|524464234|FG002|Overall Study|Lost to Follow-up|1|||
145438329|NCT02079909|524464232|FG000|Overall Study|Death|2|||
145438330|NCT02079909|524464233|FG001|Overall Study|Death|2|||
145438331|NCT02079909|524464234|FG002|Overall Study|Death|0|||
145438332|NCT02079909|524464232|FG000|Overall Study|Lack of Efficacy|0|||
145438333|NCT02079909|524464233|FG001|Overall Study|Lack of Efficacy|0|||
145438334|NCT02079909|524464234|FG002|Overall Study|Lack of Efficacy|1|||
145438335|NCT02079909|524464232|FG000|Overall Study|Protocol Violation|0|||
145438336|NCT02079909|524464233|FG001|Overall Study|Protocol Violation|1|||
145438337|NCT02079909|524464234|FG002|Overall Study|Protocol Violation|1|||
145438338|NCT02079909|524464232|FG000|Overall Study|Physician Decision|0|||
145438339|NCT02079909|524464233|FG001|Overall Study|Physician Decision|1|||
145438340|NCT02079909|524464234|FG002|Overall Study|Physician Decision|1|||
145438341|NCT02079909|524464232|FG000|Overall Study|Relocation etc.|2|||
145438342|NCT02079909|524464233|FG001|Overall Study|Relocation etc.|2|||
145438343|NCT02079909|524464234|FG002|Overall Study|Relocation etc.|3|||
145438344|NCT00720356|524464237|FG000|Registration to Study|Determined to have methylated MGMT|67|||
145438345|NCT00720356|524464237|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
145438346|NCT00720356|524464237|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
145438347|NCT00720356|524464237|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
145438348|NCT00720356|524464237|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
145438349|NCT00720356|524464237|FG000|Follow up Until Death|Withdrawal by Subject|1|||
145438350|NCT00720356|524464237|FG000|Follow up Until Death|Alive at last data collection|4|||
145438351|NCT02237001|524464240|FG000|Overall Study|Lost to Follow-up|2|||
145438352|NCT02237001|524464240|FG000|Overall Study|Withdrawal by Subject|1|||
145438353|NCT02237001|524464240|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
145438354|NCT02237001|524464240|FG000|Overall Study|Re-operation|4|||
145438355|NCT02237001|524464240|FG000|Overall Study|Incarceration|1|||
145438356|NCT01713582|524464241|FG000|Overall Study|Disease progression|3|||
145438357|NCT01713582|524464242|FG001|Overall Study|Disease progression|3|||
145438358|NCT01713582|524464243|FG002|Overall Study|Disease progression|3|||
145438359|NCT01713582|524464244|FG003|Overall Study|Disease progression|2|||
145438360|NCT01713582|524464245|FG004|Overall Study|Disease progression|3|||
145438361|NCT01713582|524464246|FG005|Overall Study|Disease progression|3|||
145438362|NCT01713582|524464247|FG006|Overall Study|Disease progression|3|||
145438363|NCT01713582|524464248|FG007|Overall Study|Disease progression|3|||
145438364|NCT01713582|524464249|FG008|Overall Study|Disease progression|3|||
145438365|NCT01713582|524464250|FG009|Overall Study|Disease progression|11|||
145438366|NCT01713582|524464251|FG010|Overall Study|Disease progression|10|||
145438367|NCT01713582|524464252|FG011|Overall Study|Disease progression|5|||
145584038|NCT04401579|524991898|FG001|Overall Study|Transferred to another hospital|2|||
145584039|NCT00489970|524991899|FG000|Persistence Year 9|Lost to Follow-up|2|||
145438368|NCT01713582|524464253|FG012|Overall Study|Disease progression|3|||
145438369|NCT01713582|524464254|FG013|Overall Study|Disease progression|3|||
145584040|NCT00489970|524991900|FG001|Persistence Year 9|Lost to Follow-up|2|||
145584041|NCT00489970|524991901|FG002|Persistence Year 9|Lost to Follow-up|3|||
145584042|NCT00489970|524991899|FG000|Persistence Year 9|Other|1|||
145584043|NCT00489970|524991900|FG001|Persistence Year 9|Other|0|||
145584044|NCT00489970|524991901|FG002|Persistence Year 9|Other|2|||
145438370|NCT01713582|524464255|FG014|Overall Study|Disease progression|6|||
145438371|NCT01713582|524464256|FG015|Overall Study|Disease progression|6|||
145438372|NCT01713582|524464257|FG016|Overall Study|Disease progression|5|||
145438373|NCT01713582|524464258|FG017|Overall Study|Disease progression|2|||
145438374|NCT01713582|524464259|FG018|Overall Study|Disease progression|3|||
145438375|NCT01713582|524464260|FG019|Overall Study|Disease progression|5|||
145438376|NCT01713582|524464261|FG020|Overall Study|Disease progression|15|||
145438377|NCT01713582|524464241|FG000|Overall Study|Death|0|||
145438378|NCT01713582|524464242|FG001|Overall Study|Death|0|||
145438379|NCT01713582|524464243|FG002|Overall Study|Death|0|||
145438380|NCT01713582|524464244|FG003|Overall Study|Death|1|||
145438381|NCT01713582|524464245|FG004|Overall Study|Death|1|||
145438382|NCT01713582|524464246|FG005|Overall Study|Death|3|||
145438383|NCT01713582|524464247|FG006|Overall Study|Death|3|||
145438384|NCT01713582|524464248|FG007|Overall Study|Death|2|||
145438385|NCT01713582|524464249|FG008|Overall Study|Death|3|||
145438386|NCT01713582|524464250|FG009|Overall Study|Death|4|||
145438387|NCT01713582|524464251|FG010|Overall Study|Death|3|||
145438388|NCT01713582|524464252|FG011|Overall Study|Death|0|||
145438389|NCT01713582|524464253|FG012|Overall Study|Death|0|||
145438390|NCT01713582|524464254|FG013|Overall Study|Death|0|||
145438391|NCT01713582|524464255|FG014|Overall Study|Death|0|||
145438392|NCT01713582|524464256|FG015|Overall Study|Death|0|||
145438393|NCT01713582|524464257|FG016|Overall Study|Death|0|||
145438394|NCT01713582|524464258|FG017|Overall Study|Death|0|||
145438395|NCT01713582|524464259|FG018|Overall Study|Death|0|||
145438396|NCT01713582|524464260|FG019|Overall Study|Death|0|||
145438397|NCT01713582|524464261|FG020|Overall Study|Death|0|||
145438398|NCT01713582|524464241|FG000|Overall Study|Adverse event-related|0|||
145438399|NCT01713582|524464242|FG001|Overall Study|Adverse event-related|0|||
145438400|NCT01713582|524464243|FG002|Overall Study|Adverse event-related|0|||
145438401|NCT01713582|524464244|FG003|Overall Study|Adverse event-related|0|||
145438402|NCT01713582|524464245|FG004|Overall Study|Adverse event-related|0|||
145438403|NCT01713582|524464246|FG005|Overall Study|Adverse event-related|0|||
145438404|NCT01713582|524464247|FG006|Overall Study|Adverse event-related|0|||
145438405|NCT01713582|524464248|FG007|Overall Study|Adverse event-related|0|||
145438406|NCT01713582|524464249|FG008|Overall Study|Adverse event-related|0|||
145438407|NCT01713582|524464250|FG009|Overall Study|Adverse event-related|1|||
145438408|NCT01713582|524464251|FG010|Overall Study|Adverse event-related|1|||
145438409|NCT01713582|524464252|FG011|Overall Study|Adverse event-related|0|||
145438410|NCT01713582|524464253|FG012|Overall Study|Adverse event-related|0|||
145438411|NCT01713582|524464254|FG013|Overall Study|Adverse event-related|0|||
145438412|NCT01713582|524464255|FG014|Overall Study|Adverse event-related|0|||
145438413|NCT01713582|524464256|FG015|Overall Study|Adverse event-related|0|||
145438414|NCT01713582|524464257|FG016|Overall Study|Adverse event-related|0|||
145438415|NCT01713582|524464258|FG017|Overall Study|Adverse event-related|0|||
145438416|NCT01713582|524464259|FG018|Overall Study|Adverse event-related|1|||
145438417|NCT01713582|524464260|FG019|Overall Study|Adverse event-related|0|||
145438418|NCT01713582|524464261|FG020|Overall Study|Adverse event-related|0|||
145438419|NCT01713582|524464241|FG000|Overall Study|Adverse event-unrelated|0|||
145438420|NCT01713582|524464242|FG001|Overall Study|Adverse event-unrelated|0|||
145438421|NCT01713582|524464243|FG002|Overall Study|Adverse event-unrelated|0|||
145438422|NCT01713582|524464244|FG003|Overall Study|Adverse event-unrelated|0|||
145438423|NCT01713582|524464245|FG004|Overall Study|Adverse event-unrelated|0|||
145438424|NCT01713582|524464246|FG005|Overall Study|Adverse event-unrelated|1|||
145438425|NCT01713582|524464247|FG006|Overall Study|Adverse event-unrelated|1|||
145438426|NCT01713582|524464248|FG007|Overall Study|Adverse event-unrelated|1|||
145438427|NCT01713582|524464249|FG008|Overall Study|Adverse event-unrelated|0|||
145438428|NCT01713582|524464250|FG009|Overall Study|Adverse event-unrelated|0|||
145438429|NCT01713582|524464251|FG010|Overall Study|Adverse event-unrelated|0|||
145438430|NCT01713582|524464252|FG011|Overall Study|Adverse event-unrelated|0|||
145438431|NCT01713582|524464253|FG012|Overall Study|Adverse event-unrelated|0|||
145438432|NCT01713582|524464254|FG013|Overall Study|Adverse event-unrelated|1|||
145438433|NCT01713582|524464255|FG014|Overall Study|Adverse event-unrelated|1|||
145438434|NCT01713582|524464256|FG015|Overall Study|Adverse event-unrelated|0|||
145438435|NCT01713582|524464257|FG016|Overall Study|Adverse event-unrelated|0|||
145584045|NCT01438411|524991902|FG000|Overall Study|Adverse Event|8|||
145438436|NCT01713582|524464258|FG017|Overall Study|Adverse event-unrelated|0|||
145438437|NCT01713582|524464259|FG018|Overall Study|Adverse event-unrelated|0|||
145438438|NCT01713582|524464260|FG019|Overall Study|Adverse event-unrelated|0|||
145438439|NCT01713582|524464261|FG020|Overall Study|Adverse event-unrelated|0|||
145438440|NCT01713582|524464241|FG000|Overall Study|Withdrawal of consent|0|||
145438441|NCT01713582|524464242|FG001|Overall Study|Withdrawal of consent|0|||
145584046|NCT01438411|524991902|FG000|Overall Study|Lost to Follow-up|1|||
145584047|NCT01438411|524991902|FG000|Overall Study|Lack of Efficacy|1|||
145584048|NCT01438411|524991902|FG000|Overall Study|Withdrawal by Subject|3|||
145584049|NCT01863680|524991903|FG000|Overall Study|Adverse Event|17|||
145584050|NCT01863680|524991903|FG000|Overall Study|Risk of OHSS|17|||
145584051|NCT01863680|524991903|FG000|Overall Study|Spontaneous pregnancy|2|||
145584052|NCT01863680|524991903|FG000|Overall Study|Withdrawal by Subject|1|||
145584053|NCT01863680|524991903|FG000|Overall Study|Did not undergo IVF/ET|14|||
145584054|NCT01863680|524991903|FG000|Overall Study|Other|6|||
145584055|NCT00618514|524991904|FG000|Overall Study|Lost to Follow-up|11|||
145584056|NCT00618514|524991905|FG001|Overall Study|Lost to Follow-up|12|||
145584057|NCT00618514|524991906|FG002|Overall Study|Lost to Follow-up|4|||
145584058|NCT00566228|524991911|FG000|Overall Study|Withdrawal by Subject|1|||
145584059|NCT00566228|524991912|FG001|Overall Study|Withdrawal by Subject|0|||
145584060|NCT00566228|524991911|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
145584061|NCT00566228|524991912|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
145584062|NCT00566228|524991911|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
145584063|NCT00566228|524991912|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
145584064|NCT00566228|524991911|FG000|Overall Study|progressed before infusion could occur|0|||
145584065|NCT00566228|524991912|FG001|Overall Study|progressed before infusion could occur|1|||
145584066|NCT02707055|524991915|FG000|Phase 1|Withdrawal by Subject|1|||
145584067|NCT02707055|524991916|FG001|Phase 1|Withdrawal by Subject|2|||
145584068|NCT02707055|524991915|FG000|Phase 1|Physician Decision|0|||
145584069|NCT02707055|524991916|FG001|Phase 1|Physician Decision|1|||
145584070|NCT02707055|524991915|FG000|Phase 2|Adverse Event|1|||
145584071|NCT02707055|524991916|FG001|Phase 2|Adverse Event|2|||
145584072|NCT00902304|524991917|FG000|Overall Study|Adverse Event|4|||
145584073|NCT00902304|524991918|FG001|Overall Study|Adverse Event|10|||
145584074|NCT00902304|524991919|FG002|Overall Study|Adverse Event|25|||
145584075|NCT00902304|524991917|FG000|Overall Study|Investigator discretion|3|||
145584076|NCT00902304|524991918|FG001|Overall Study|Investigator discretion|5|||
145584077|NCT00902304|524991919|FG002|Overall Study|Investigator discretion|13|||
145584078|NCT00902304|524991917|FG000|Overall Study|Lost to Follow-up|7|||
145584079|NCT00902304|524991918|FG001|Overall Study|Lost to Follow-up|7|||
145584080|NCT00902304|524991919|FG002|Overall Study|Lost to Follow-up|7|||
145584081|NCT00902304|524991917|FG000|Overall Study|Protocol Violation|9|||
145584082|NCT00902304|524991918|FG001|Overall Study|Protocol Violation|18|||
145584083|NCT00902304|524991919|FG002|Overall Study|Protocol Violation|20|||
145584084|NCT00902304|524991917|FG000|Overall Study|Withdrawal by Subject|32|||
145584085|NCT00902304|524991918|FG001|Overall Study|Withdrawal by Subject|22|||
145584086|NCT00902304|524991919|FG002|Overall Study|Withdrawal by Subject|43|||
145584087|NCT00902304|524991917|FG000|Overall Study|includes pregnancy|3|||
145584088|NCT00902304|524991918|FG001|Overall Study|includes pregnancy|9|||
145584089|NCT00902304|524991919|FG002|Overall Study|includes pregnancy|2|||
145584090|NCT05706506|524991920|FG000|Overall Study|Adverse Event|1|||
145584091|NCT05706506|524991920|FG000|Overall Study|Withdrawal by Subject|4|||
145584092|NCT05706506|524991920|FG000|Overall Study|Lost to Follow-up|2|||
145584093|NCT05706506|524991920|FG000|Overall Study|Inadvertent Enrolment|12|||
145584094|NCT05706506|524991920|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
145584095|NCT05706506|524991920|FG000|Overall Study|Participant Moved Out of State|1|||
145584096|NCT02646423|524991921|FG000|Overall Study|Adverse Event|5|||
145584097|NCT02646423|524991922|FG001|Overall Study|Adverse Event|7|||
145584098|NCT02646423|524991921|FG000|Overall Study|Ineligible|2|||
145584099|NCT02646423|524991922|FG001|Overall Study|Ineligible|1|||
145584100|NCT00844194|524991926|FG000|Overall Study|Adverse Event|17|||
145584101|NCT00844194|524991927|FG001|Overall Study|Adverse Event|5|||
145584102|NCT00844194|524991926|FG000|Overall Study|Protocol Violation|1|||
145584103|NCT00844194|524991927|FG001|Overall Study|Protocol Violation|1|||
145584104|NCT00844194|524991926|FG000|Overall Study|Lost to Follow-up|1|||
145584105|NCT00844194|524991927|FG001|Overall Study|Lost to Follow-up|1|||
145584106|NCT00844194|524991926|FG000|Overall Study|Withdrawal by Subject|2|||
145584107|NCT00844194|524991927|FG001|Overall Study|Withdrawal by Subject|1|||
145584108|NCT00844194|524991926|FG000|Overall Study|Lack of Efficacy|3|||
145584109|NCT00844194|524991927|FG001|Overall Study|Lack of Efficacy|0|||
145584110|NCT00844194|524991926|FG000|Overall Study|Other reason (not specified)|1|||
145584111|NCT00844194|524991927|FG001|Overall Study|Other reason (not specified)|0|||
145584112|NCT02223390|524991928|FG000|Overall Study|Lost to Follow-up|9|||
145584113|NCT02223390|524991929|FG001|Overall Study|Lost to Follow-up|4|||
145584114|NCT00795600|524991931|FG000|Overall Study|Adverse Event|1|||
145584115|NCT00795600|524991932|FG001|Overall Study|Adverse Event|1|||
145584116|NCT00795600|524991931|FG000|Overall Study|Protocol Violation|1|||
145584117|NCT00795600|524991932|FG001|Overall Study|Protocol Violation|2|||
145584118|NCT00795600|524991931|FG000|Overall Study|Withdrawal by Subject|1|||
145584119|NCT00795600|524991932|FG001|Overall Study|Withdrawal by Subject|0|||
145584120|NCT00795600|524991931|FG000|Overall Study|Unclassified|1|||
145584121|NCT00795600|524991932|FG001|Overall Study|Unclassified|1|||
145584122|NCT03936244|524991936|FG000|Overall Study|Lost to Follow-up|5|||
145584123|NCT03936244|524991937|FG001|Overall Study|Lost to Follow-up|1|||
145584124|NCT03936244|524991936|FG000|Overall Study|Physician Decision|7|||
145438442|NCT01713582|524464243|FG002|Overall Study|Withdrawal of consent|1|||
145438443|NCT01713582|524464244|FG003|Overall Study|Withdrawal of consent|0|||
145438444|NCT01713582|524464245|FG004|Overall Study|Withdrawal of consent|0|||
145438445|NCT01713582|524464246|FG005|Overall Study|Withdrawal of consent|1|||
145438446|NCT01713582|524464247|FG006|Overall Study|Withdrawal of consent|0|||
145438447|NCT01713582|524464248|FG007|Overall Study|Withdrawal of consent|0|||
145438448|NCT01713582|524464249|FG008|Overall Study|Withdrawal of consent|0|||
145438449|NCT01713582|524464250|FG009|Overall Study|Withdrawal of consent|1|||
145438450|NCT01713582|524464251|FG010|Overall Study|Withdrawal of consent|0|||
145438451|NCT01713582|524464252|FG011|Overall Study|Withdrawal of consent|0|||
145438452|NCT01713582|524464253|FG012|Overall Study|Withdrawal of consent|0|||
145438453|NCT01713582|524464254|FG013|Overall Study|Withdrawal of consent|0|||
145438454|NCT01713582|524464255|FG014|Overall Study|Withdrawal of consent|0|||
145438455|NCT01713582|524464256|FG015|Overall Study|Withdrawal of consent|0|||
145438456|NCT01713582|524464257|FG016|Overall Study|Withdrawal of consent|0|||
145438457|NCT01713582|524464258|FG017|Overall Study|Withdrawal of consent|0|||
145438458|NCT01713582|524464259|FG018|Overall Study|Withdrawal of consent|1|||
145438459|NCT01713582|524464260|FG019|Overall Study|Withdrawal of consent|0|||
145438460|NCT01713582|524464261|FG020|Overall Study|Withdrawal of consent|0|||
145438461|NCT01713582|524464241|FG000|Overall Study|Lack of Efficacy|0|||
145438462|NCT01713582|524464242|FG001|Overall Study|Lack of Efficacy|0|||
145438463|NCT01713582|524464243|FG002|Overall Study|Lack of Efficacy|0|||
145438464|NCT01713582|524464244|FG003|Overall Study|Lack of Efficacy|0|||
145438465|NCT01713582|524464245|FG004|Overall Study|Lack of Efficacy|0|||
145438466|NCT01713582|524464246|FG005|Overall Study|Lack of Efficacy|0|||
145438467|NCT01713582|524464247|FG006|Overall Study|Lack of Efficacy|0|||
145438468|NCT01713582|524464248|FG007|Overall Study|Lack of Efficacy|0|||
145438469|NCT01713582|524464249|FG008|Overall Study|Lack of Efficacy|0|||
145438470|NCT01713582|524464250|FG009|Overall Study|Lack of Efficacy|1|||
145438471|NCT01713582|524464251|FG010|Overall Study|Lack of Efficacy|2|||
145438472|NCT01713582|524464252|FG011|Overall Study|Lack of Efficacy|0|||
145438473|NCT01713582|524464253|FG012|Overall Study|Lack of Efficacy|0|||
145438474|NCT01713582|524464254|FG013|Overall Study|Lack of Efficacy|0|||
145438475|NCT01713582|524464255|FG014|Overall Study|Lack of Efficacy|0|||
145438476|NCT01713582|524464256|FG015|Overall Study|Lack of Efficacy|0|||
145438477|NCT01713582|524464257|FG016|Overall Study|Lack of Efficacy|0|||
145438478|NCT01713582|524464258|FG017|Overall Study|Lack of Efficacy|0|||
145438479|NCT01713582|524464259|FG018|Overall Study|Lack of Efficacy|0|||
145438480|NCT01713582|524464260|FG019|Overall Study|Lack of Efficacy|0|||
145438481|NCT01713582|524464261|FG020|Overall Study|Lack of Efficacy|0|||
145438482|NCT01713582|524464241|FG000|Overall Study|Withdrawal by Subject|0|||
145438483|NCT01713582|524464242|FG001|Overall Study|Withdrawal by Subject|0|||
145438484|NCT01713582|524464243|FG002|Overall Study|Withdrawal by Subject|0|||
145438485|NCT01713582|524464244|FG003|Overall Study|Withdrawal by Subject|0|||
145438486|NCT01713582|524464245|FG004|Overall Study|Withdrawal by Subject|0|||
145438487|NCT01713582|524464246|FG005|Overall Study|Withdrawal by Subject|0|||
145438488|NCT01713582|524464247|FG006|Overall Study|Withdrawal by Subject|0|||
145438489|NCT01713582|524464248|FG007|Overall Study|Withdrawal by Subject|0|||
145438490|NCT01713582|524464249|FG008|Overall Study|Withdrawal by Subject|0|||
145438491|NCT01713582|524464250|FG009|Overall Study|Withdrawal by Subject|0|||
145438492|NCT01713582|524464251|FG010|Overall Study|Withdrawal by Subject|0|||
145584125|NCT03936244|524991937|FG001|Overall Study|Physician Decision|3|||
145584126|NCT01248884|524991942|FG000|Overall Study|Withdrawal by Subject|1|||
145584127|NCT01248884|524991943|FG001|Overall Study|Withdrawal by Subject|3|||
145584128|NCT01248884|524991944|FG002|Overall Study|Withdrawal by Subject|1|||
145584129|NCT01248884|524991942|FG000|Overall Study|Adverse Event|1|||
145584130|NCT01248884|524991943|FG001|Overall Study|Adverse Event|0|||
145584131|NCT01248884|524991944|FG002|Overall Study|Adverse Event|0|||
145584132|NCT02511431|524991945|FG000|Treatment|Lost to Follow-up|0|||
145584133|NCT02511431|524991946|FG001|Treatment|Lost to Follow-up|0|||
145584134|NCT02511431|524991947|FG002|Treatment|Lost to Follow-up|1|||
145584135|NCT02511431|524991948|FG003|Treatment|Lost to Follow-up|0|||
145584136|NCT02511431|524991949|FG004|Treatment|Lost to Follow-up|0|||
145584137|NCT02511431|524991950|FG005|Treatment|Lost to Follow-up|1|||
145625146|NCT01575860|525141995|FG000|Overall Study|Withdrawal by Subject|1|||
145438493|NCT01713582|524464252|FG011|Overall Study|Withdrawal by Subject|0|||
145438494|NCT01713582|524464253|FG012|Overall Study|Withdrawal by Subject|0|||
145438495|NCT01713582|524464254|FG013|Overall Study|Withdrawal by Subject|0|||
145438496|NCT01713582|524464255|FG014|Overall Study|Withdrawal by Subject|0|||
145438497|NCT01713582|524464256|FG015|Overall Study|Withdrawal by Subject|0|||
145438498|NCT01713582|524464257|FG016|Overall Study|Withdrawal by Subject|0|||
145438499|NCT01713582|524464258|FG017|Overall Study|Withdrawal by Subject|1|||
145438500|NCT01713582|524464259|FG018|Overall Study|Withdrawal by Subject|0|||
145438501|NCT01713582|524464260|FG019|Overall Study|Withdrawal by Subject|0|||
145584138|NCT01854827|524991951|FG000|Overall Study|Death|1|||
145584139|NCT00736996|524991952|FG000|Overall Study|Lost to Follow-up|1|||
145584140|NCT00736996|524991953|FG001|Overall Study|Lost to Follow-up|9|||
145584141|NCT00736996|524991954|FG002|Overall Study|Lost to Follow-up|2|||
145438502|NCT01713582|524464261|FG020|Overall Study|Withdrawal by Subject|0|||
145438503|NCT01713582|524464241|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
145438504|NCT01713582|524464242|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
145438505|NCT01713582|524464243|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
145438506|NCT01713582|524464244|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
145438507|NCT01713582|524464245|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
145438508|NCT01713582|524464246|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
145438509|NCT01713582|524464247|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
145438510|NCT01713582|524464248|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
145438511|NCT01713582|524464249|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
145438512|NCT01713582|524464250|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
145438513|NCT01713582|524464251|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
145438514|NCT01713582|524464252|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
145438515|NCT01713582|524464253|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
145438516|NCT01713582|524464254|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
145438517|NCT01713582|524464255|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
145438518|NCT01713582|524464256|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
145438519|NCT01713582|524464257|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
145438520|NCT01713582|524464258|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
145438521|NCT01713582|524464259|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
145438522|NCT01713582|524464260|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
145438523|NCT01713582|524464261|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
145438524|NCT01713582|524464241|FG000|Overall Study|Disease progression and adverse event|0|||
145438525|NCT01713582|524464242|FG001|Overall Study|Disease progression and adverse event|0|||
145438526|NCT01713582|524464243|FG002|Overall Study|Disease progression and adverse event|0|||
145438527|NCT01713582|524464244|FG003|Overall Study|Disease progression and adverse event|0|||
145438528|NCT01713582|524464245|FG004|Overall Study|Disease progression and adverse event|0|||
145438529|NCT01713582|524464246|FG005|Overall Study|Disease progression and adverse event|0|||
145438530|NCT01713582|524464247|FG006|Overall Study|Disease progression and adverse event|0|||
145438531|NCT01713582|524464248|FG007|Overall Study|Disease progression and adverse event|0|||
145438532|NCT01713582|524464249|FG008|Overall Study|Disease progression and adverse event|0|||
145438533|NCT01713582|524464250|FG009|Overall Study|Disease progression and adverse event|0|||
145438534|NCT01713582|524464251|FG010|Overall Study|Disease progression and adverse event|0|||
145438535|NCT01713582|524464252|FG011|Overall Study|Disease progression and adverse event|0|||
145438536|NCT01713582|524464253|FG012|Overall Study|Disease progression and adverse event|0|||
145438537|NCT01713582|524464254|FG013|Overall Study|Disease progression and adverse event|0|||
145438538|NCT01713582|524464255|FG014|Overall Study|Disease progression and adverse event|0|||
145438539|NCT01713582|524464256|FG015|Overall Study|Disease progression and adverse event|0|||
145438540|NCT01713582|524464257|FG016|Overall Study|Disease progression and adverse event|1|||
145438541|NCT01713582|524464258|FG017|Overall Study|Disease progression and adverse event|0|||
145438542|NCT01713582|524464259|FG018|Overall Study|Disease progression and adverse event|0|||
145438543|NCT01713582|524464260|FG019|Overall Study|Disease progression and adverse event|0|||
145438544|NCT01713582|524464261|FG020|Overall Study|Disease progression and adverse event|0|||
145438545|NCT03427814|524464264|FG000|Overall Study|Withdrawal by Subject|4|||
145438546|NCT03427814|524464265|FG001|Overall Study|Withdrawal by Subject|4|||
145438547|NCT03427814|524464264|FG000|Overall Study|Lost to Follow-up|0|||
145438548|NCT03427814|524464265|FG001|Overall Study|Lost to Follow-up|2|||
145438549|NCT03427814|524464264|FG000|Overall Study|Death|42|||
145438550|NCT03427814|524464265|FG001|Overall Study|Death|31|||
145438551|NCT03427814|524464264|FG000|Overall Study|Sponsor's Decision|1|||
145438552|NCT03427814|524464265|FG001|Overall Study|Sponsor's Decision|0|||
145438553|NCT03427814|524464264|FG000|Overall Study|Investigator's Decision|1|||
145438554|NCT03427814|524464265|FG001|Overall Study|Investigator's Decision|2|||
145438555|NCT03427814|524464264|FG000|Overall Study|Disease progression|1|||
145438556|NCT03427814|524464265|FG001|Overall Study|Disease progression|0|||
145438557|NCT03427814|524464264|FG000|Overall Study|Treatment Completed|0|||
145438558|NCT03427814|524464265|FG001|Overall Study|Treatment Completed|1|||
145438559|NCT03427814|524464264|FG000|Overall Study|Sponsor's Decision to End study|21|||
145438560|NCT03427814|524464265|FG001|Overall Study|Sponsor's Decision to End study|25|||
145438561|NCT03427814|524464264|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
145438562|NCT03427814|524464265|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
145438563|NCT03846427|524464266|FG000|Overall Study|Death|13|||
145438564|NCT03846427|524464266|FG000|Overall Study|Withdrawal by Subject|3|||
145438565|NCT03846427|524464266|FG000|Overall Study|Physician Decision|1|||
145438566|NCT01334554|524464267|FG000|Overall Study|Adverse Event|4|||
145438567|NCT01334554|524464268|FG001|Overall Study|Adverse Event|2|||
145584142|NCT00462384|524991955|FG000|Overall Study|Adverse Event|2|||
145438568|NCT02393859|524464270|FG000|Overall Study|Decision by Sponsor|2|||
145438569|NCT02393859|524464271|FG001|Overall Study|Decision by Sponsor|4|||
145438570|NCT02393859|524464270|FG000|Overall Study|Withdrawal by Subject|11|||
145438571|NCT02393859|524464271|FG001|Overall Study|Withdrawal by Subject|6|||
145438572|NCT02393859|524464270|FG000|Overall Study|Death|27|||
145438573|NCT02393859|524464271|FG001|Overall Study|Death|10|||
145438574|NCT02393859|524464270|FG000|Overall Study|Lost to Follow-up|1|||
145438575|NCT02393859|524464271|FG001|Overall Study|Lost to Follow-up|1|||
145438576|NCT01979614|524464272|FG000|Overall Study|Adverse Event|1|||
145438577|NCT01979614|524464273|FG001|Overall Study|Adverse Event|1|||
145438578|NCT00661830|524464274|FG000|Overall Study|Death|37|||
145438579|NCT00661830|524464275|FG001|Overall Study|Death|33|||
145438580|NCT00661830|524464274|FG000|Overall Study|Lost to Follow-up|1|||
145438581|NCT00661830|524464275|FG001|Overall Study|Lost to Follow-up|3|||
145438582|NCT00661830|524464274|FG000|Overall Study|Withdrawal by Subject|1|||
145438583|NCT00661830|524464275|FG001|Overall Study|Withdrawal by Subject|1|||
145438584|NCT00661830|524464274|FG000|Overall Study|Other reason|1|||
145438585|NCT00661830|524464275|FG001|Overall Study|Other reason|5|||
145438586|NCT00488514|524464276|FG000|Overall Study|Adverse Event|41|||
145438587|NCT00488514|524464276|FG000|Overall Study|Lost to Follow-up|44|||
145438588|NCT00488514|524464276|FG000|Overall Study|Protocol Violation|32|||
145438589|NCT00488514|524464276|FG000|Overall Study|Withdrawal by Subject|106|||
145438590|NCT00488514|524464276|FG000|Overall Study|Lack of Efficacy|28|||
145438591|NCT00488514|524464276|FG000|Overall Study|Did not meet criteria for treatment|30|||
145438592|NCT00488514|524464276|FG000|Overall Study|Postive drug screen|1|||
145438593|NCT00488514|524464276|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
145438594|NCT00488514|524464276|FG000|Overall Study|Investigator decision|1|||
145438595|NCT00488514|524464276|FG000|Overall Study|Participant had too few migraines|5|||
145438596|NCT00488514|524464276|FG000|Overall Study|Increase in number of migraines|2|||
145438597|NCT00488514|524464276|FG000|Overall Study|Increased use of concomitant medication|1|||
145438598|NCT04971967|524464281|FG000|Overall Study|Lost to Follow-up|6|||
145438599|NCT04971967|524464282|FG001|Overall Study|Lost to Follow-up|7|||
145438600|NCT01475721|524464285|FG000|Overall Study|Death|3|||
145438601|NCT01475721|524464286|FG001|Overall Study|Death|6|||
145438602|NCT01475721|524464285|FG000|Overall Study|Withdrawal by Subject|8|||
145438603|NCT01475721|524464286|FG001|Overall Study|Withdrawal by Subject|8|||
145438604|NCT01048242|524464287|FG000|Overall Study|See study flow chart|4|||
145438605|NCT01048242|524464288|FG001|Overall Study|See study flow chart|2|||
145438606|NCT02364037|524464289|FG000|Overall Study|Withdrawal by Subject|7|||
145438607|NCT02364037|524464290|FG001|Overall Study|Withdrawal by Subject|4|||
145438608|NCT02364037|524464289|FG000|Overall Study|Lost to Follow-up|37|||
145438609|NCT02364037|524464290|FG001|Overall Study|Lost to Follow-up|49|||
145438610|NCT01772550|524464291|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
145438611|NCT01772550|524464292|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
145438612|NCT01772550|524464293|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
145438613|NCT01772550|524464291|FG000|Overall Study|Adverse Event|0|||
145438614|NCT01772550|524464292|FG001|Overall Study|Adverse Event|0|||
145438615|NCT01772550|524464293|FG002|Overall Study|Adverse Event|1|||
145438616|NCT00559104|524464294|FG000|Overall Study|Lack of Efficacy|9|||
145438617|NCT00559104|524464295|FG001|Overall Study|Lack of Efficacy|0|||
145438618|NCT00387088|524464296|FG000|Overall Study|Adverse Event|143|||
145438619|NCT00387088|524464297|FG001|Overall Study|Adverse Event|156|||
145438620|NCT00387088|524464296|FG000|Overall Study|Protocol Violation|47|||
145438621|NCT00387088|524464297|FG001|Overall Study|Protocol Violation|35|||
145438622|NCT00387088|524464296|FG000|Overall Study|Withdrawal by Subject|20|||
145438623|NCT00387088|524464297|FG001|Overall Study|Withdrawal by Subject|35|||
145438624|NCT00387088|524464296|FG000|Overall Study|Lack of Efficacy|28|||
145438625|NCT00387088|524464297|FG001|Overall Study|Lack of Efficacy|67|||
145438626|NCT00387088|524464296|FG000|Overall Study|Lost to Follow-up|22|||
145438627|NCT00387088|524464297|FG001|Overall Study|Lost to Follow-up|28|||
145438628|NCT00387088|524464296|FG000|Overall Study|Other|58|||
145438629|NCT00387088|524464297|FG001|Overall Study|Other|52|||
145438630|NCT03432494|524464302|FG000|Overall Study|Death|1|||
145438631|NCT03432494|524464302|FG000|Overall Study|Noncompliance|1|||
145438632|NCT00856635|524464303|FG000|Overall Study|Lost to Follow-up|2|||
145438633|NCT00856635|524464304|FG001|Overall Study|Lost to Follow-up|5|||
145438634|NCT00856635|524464303|FG000|Overall Study|Pregnancy|1|||
145438635|NCT00856635|524464304|FG001|Overall Study|Pregnancy|0|||
145438636|NCT00856635|524464303|FG000|Overall Study|Withdrawal by Subject|3|||
145438637|NCT00856635|524464304|FG001|Overall Study|Withdrawal by Subject|1|||
145438638|NCT00856635|524464303|FG000|Overall Study|Serious Adverse Event|1|||
145438639|NCT00856635|524464304|FG001|Overall Study|Serious Adverse Event|0|||
145438640|NCT00856635|524464303|FG000|Overall Study|Other|1|||
145438641|NCT00856635|524464304|FG001|Overall Study|Other|0|||
145438642|NCT00856635|524464303|FG000|Overall Study|Discontinued at Randomization|2|||
145438643|NCT00856635|524464304|FG001|Overall Study|Discontinued at Randomization|2|||
145438644|NCT01244035|524464305|FG000|Part 1: Period 1|Adverse Event|0|||
145438645|NCT01244035|524464306|FG001|Part 1: Period 1|Adverse Event|0|||
145438646|NCT01244035|524464307|FG002|Part 1: Period 1|Adverse Event|0|||
145438647|NCT01244035|524464308|FG003|Part 1: Period 1|Adverse Event|0|||
145438648|NCT01244035|524464309|FG004|Part 1: Period 1|Adverse Event|0|||
145438649|NCT01244035|524464310|FG005|Part 1: Period 1|Adverse Event|1|||
145438650|NCT01244035|524464305|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
145438651|NCT01244035|524464306|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
145438652|NCT01244035|524464307|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
145438653|NCT01244035|524464308|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
145438654|NCT01244035|524464309|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
145438655|NCT01244035|524464310|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
145438656|NCT01244035|524464305|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
145438657|NCT01244035|524464306|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
145438658|NCT01244035|524464307|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
145438659|NCT01244035|524464308|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
145438660|NCT01244035|524464309|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
145438661|NCT01244035|524464310|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
145438662|NCT01244035|524464305|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
145438663|NCT01244035|524464306|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
145438664|NCT01244035|524464307|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
145438665|NCT01244035|524464308|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
145438666|NCT01244035|524464309|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
145438667|NCT01244035|524464310|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
145438668|NCT01244035|524464305|FG000|Part 1: Period 3|Adverse Event|0|||
145438669|NCT01244035|524464306|FG001|Part 1: Period 3|Adverse Event|0|||
145438670|NCT01244035|524464307|FG002|Part 1: Period 3|Adverse Event|0|||
145438671|NCT01244035|524464308|FG003|Part 1: Period 3|Adverse Event|0|||
145438672|NCT01244035|524464309|FG004|Part 1: Period 3|Adverse Event|0|||
145438673|NCT01244035|524464310|FG005|Part 1: Period 3|Adverse Event|1|||
145438674|NCT01244035|524464305|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
145438675|NCT01244035|524464306|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
145438676|NCT01244035|524464307|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
145438677|NCT01244035|524464308|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
145438678|NCT01244035|524464309|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
145438679|NCT01244035|524464310|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
145438680|NCT01244035|524464305|FG000|Part 1: Period 3|Protocol Deviation|0|||
145438681|NCT01244035|524464306|FG001|Part 1: Period 3|Protocol Deviation|1|||
145438682|NCT01244035|524464307|FG002|Part 1: Period 3|Protocol Deviation|0|||
145438683|NCT01244035|524464308|FG003|Part 1: Period 3|Protocol Deviation|0|||
145438684|NCT01244035|524464309|FG004|Part 1: Period 3|Protocol Deviation|0|||
145438685|NCT01244035|524464310|FG005|Part 1: Period 3|Protocol Deviation|0|||
145438686|NCT00347932|524464311|FG000|Overall Study|Adverse Event|4|||
145438687|NCT00347932|524464312|FG001|Overall Study|Adverse Event|5|||
145438688|NCT00347932|524464311|FG000|Overall Study|Lack of Efficacy|3|||
145438689|NCT00347932|524464312|FG001|Overall Study|Lack of Efficacy|14|||
145438690|NCT00347932|524464311|FG000|Overall Study|Lost to Follow-up|10|||
145438691|NCT00347932|524464312|FG001|Overall Study|Lost to Follow-up|9|||
145438692|NCT00347932|524464311|FG000|Overall Study|Withdrawal by Subject|10|||
145438693|NCT00347932|524464312|FG001|Overall Study|Withdrawal by Subject|16|||
145438694|NCT00347932|524464311|FG000|Overall Study|Did not meet inclusion criteria|4|||
145438695|NCT00347932|524464312|FG001|Overall Study|Did not meet inclusion criteria|8|||
145438696|NCT04512001|524464313|FG000|Week 0 to Week 24|Adverse Event|14|||
145438697|NCT04512001|524464314|FG001|Week 0 to Week 24|Adverse Event|10|||
145438698|NCT04512001|524464315|FG002|Week 0 to Week 24|Adverse Event|0|||
145438699|NCT04512001|524464316|FG003|Week 0 to Week 24|Adverse Event|0|||
145438700|NCT04512001|524464317|FG004|Week 0 to Week 24|Adverse Event|0|||
145438701|NCT04512001|524464313|FG000|Week 0 to Week 24|Death|0|||
145438702|NCT04512001|524464314|FG001|Week 0 to Week 24|Death|2|||
145438703|NCT04512001|524464315|FG002|Week 0 to Week 24|Death|0|||
145438704|NCT04512001|524464316|FG003|Week 0 to Week 24|Death|0|||
145438705|NCT04512001|524464317|FG004|Week 0 to Week 24|Death|0|||
145438706|NCT04512001|524464313|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
145438707|NCT04512001|524464314|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
145438708|NCT04512001|524464315|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
145438709|NCT04512001|524464316|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
145438710|NCT04512001|524464317|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
145438711|NCT04512001|524464313|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
145438712|NCT04512001|524464314|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
145438713|NCT04512001|524464315|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
145438714|NCT04512001|524464316|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
145438715|NCT04512001|524464317|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
145438716|NCT04512001|524464313|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
145438717|NCT04512001|524464314|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
145438718|NCT04512001|524464315|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
145438719|NCT04512001|524464316|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
145438720|NCT04512001|524464317|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
145438721|NCT04512001|524464313|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
145438722|NCT04512001|524464314|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
145438723|NCT04512001|524464315|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
145438724|NCT04512001|524464316|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
145438725|NCT04512001|524464317|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
145438726|NCT04512001|524464313|FG000|Week 24 to Week 63|Adverse Event|0|||
145438727|NCT04512001|524464314|FG001|Week 24 to Week 63|Adverse Event|0|||
145438728|NCT04512001|524464315|FG002|Week 24 to Week 63|Adverse Event|13|||
145438729|NCT04512001|524464316|FG003|Week 24 to Week 63|Adverse Event|8|||
145438730|NCT04512001|524464317|FG004|Week 24 to Week 63|Adverse Event|6|||
145438731|NCT04512001|524464313|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
145438732|NCT04512001|524464314|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
145438733|NCT04512001|524464315|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
145438734|NCT04512001|524464316|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
145438735|NCT04512001|524464317|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
145438736|NCT04512001|524464313|FG000|Week 24 to Week 63|Death|0|||
145438737|NCT04512001|524464314|FG001|Week 24 to Week 63|Death|0|||
145438738|NCT04512001|524464315|FG002|Week 24 to Week 63|Death|0|||
145438739|NCT04512001|524464316|FG003|Week 24 to Week 63|Death|1|||
145438740|NCT04512001|524464317|FG004|Week 24 to Week 63|Death|1|||
145438741|NCT04512001|524464313|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
145438742|NCT04512001|524464314|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
145438743|NCT04512001|524464315|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
145438744|NCT04512001|524464316|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
145438745|NCT04512001|524464317|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
145438746|NCT04512001|524464313|FG000|Week 24 to Week 63|Miscellaneous|0|||
145438747|NCT04512001|524464314|FG001|Week 24 to Week 63|Miscellaneous|0|||
145438748|NCT04512001|524464315|FG002|Week 24 to Week 63|Miscellaneous|3|||
145438749|NCT04512001|524464316|FG003|Week 24 to Week 63|Miscellaneous|2|||
145438750|NCT04512001|524464317|FG004|Week 24 to Week 63|Miscellaneous|1|||
145438751|NCT02776683|524464318|FG000|Pre-switch Period|Protocol Violation|1|||
145438752|NCT02776683|524464319|FG001|Pre-switch Period|Protocol Violation|0|||
145438753|NCT02776683|524464318|FG000|Pre-switch Period|Adverse Event|21|||
145438754|NCT02776683|524464319|FG001|Pre-switch Period|Adverse Event|0|||
145438755|NCT02776683|524464318|FG000|Pre-switch Period|Withdrawal by Subject|9|||
145438756|NCT02776683|524464319|FG001|Pre-switch Period|Withdrawal by Subject|0|||
145438757|NCT02776683|524464318|FG000|Pre-switch Period|Physician Decision|7|||
145438758|NCT02776683|524464319|FG001|Pre-switch Period|Physician Decision|0|||
145625147|NCT01575860|525141995|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
145625148|NCT00582790|525142005|FG000|Overall Study|Rapid progression of disease|1|||
145625149|NCT03681691|525142006|FG000|Overall Study|COVID|1|||
145625150|NCT03681691|525142007|FG001|Overall Study|COVID|0|||
145625151|NCT03681691|525142006|FG000|Overall Study|prolonged bleeding|1|||
145625152|NCT03681691|525142007|FG001|Overall Study|prolonged bleeding|0|||
145625153|NCT03681691|525142006|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
145625154|NCT03681691|525142007|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
145625155|NCT02334306|525142008|FG000|Double-blind Period|Adverse Event|0|||
145625156|NCT02334306|525142009|FG001|Double-blind Period|Adverse Event|1|||
145625157|NCT02334306|525142008|FG000|Double-blind Period|Withdrawal by Subject|1|||
145625158|NCT02334306|525142009|FG001|Double-blind Period|Withdrawal by Subject|1|||
145625159|NCT03302156|525142010|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
145625160|NCT03302156|525142011|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
145625161|NCT03302156|525142012|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
145625162|NCT02390557|525142013|FG000|Wave 2|Survey non-respondent|72|||
145625163|NCT02390557|525142014|FG001|Wave 2|Survey non-respondent|41|||
145625164|NCT02390557|525142015|FG002|Wave 2|Survey non-respondent|23|||
145625165|NCT03278028|525142018|FG000|Overall Study|Lost to Follow-up|1|||
145625166|NCT03278028|525142019|FG001|Overall Study|Lost to Follow-up|0|||
145625167|NCT03278028|525142018|FG000|Overall Study|Withdrawal by Subject|3|||
145625168|NCT03278028|525142019|FG001|Overall Study|Withdrawal by Subject|1|||
145625169|NCT03278028|525142018|FG000|Overall Study|Pregnancy|0|||
145625170|NCT03278028|525142019|FG001|Overall Study|Pregnancy|1|||
145625171|NCT00463151|525142020|FG000|Overall Study|Adverse Event|0|||
145625172|NCT00463151|525142021|FG001|Overall Study|Adverse Event|0|||
145625173|NCT00463151|525142022|FG002|Overall Study|Adverse Event|1|||
145625174|NCT00463151|525142023|FG003|Overall Study|Adverse Event|0|||
145438759|NCT02776683|524464318|FG000|Pre-switch Period|Progressive disease|39|||
145438760|NCT02776683|524464319|FG001|Pre-switch Period|Progressive disease|0|||
145438761|NCT02776683|524464318|FG000|Pre-switch Period|Other than listed|3|||
145625175|NCT00463151|525142020|FG000|Overall Study|Lack of Efficacy|2|||
145625176|NCT00463151|525142021|FG001|Overall Study|Lack of Efficacy|5|||
145625177|NCT00463151|525142022|FG002|Overall Study|Lack of Efficacy|2|||
145625178|NCT00463151|525142023|FG003|Overall Study|Lack of Efficacy|5|||
145625179|NCT00463151|525142020|FG000|Overall Study|Protocol Violation|0|||
145625180|NCT00463151|525142021|FG001|Overall Study|Protocol Violation|0|||
145625181|NCT00463151|525142022|FG002|Overall Study|Protocol Violation|0|||
145625182|NCT00463151|525142023|FG003|Overall Study|Protocol Violation|1|||
145625183|NCT00463151|525142020|FG000|Overall Study|Withdrawal by Subject|0|||
145438762|NCT02776683|524464319|FG001|Pre-switch Period|Other than listed|0|||
145438763|NCT02776683|524464318|FG000|Post-switch Period|Adverse Event|0|||
145625184|NCT00463151|525142021|FG001|Overall Study|Withdrawal by Subject|0|||
145438764|NCT02776683|524464319|FG001|Post-switch Period|Adverse Event|3|||
145438765|NCT02776683|524464318|FG000|Post-switch Period|Withdrawal by Subject|0|||
145438766|NCT02776683|524464319|FG001|Post-switch Period|Withdrawal by Subject|2|||
145438767|NCT02776683|524464318|FG000|Post-switch Period|Physician Decision|0|||
145438768|NCT02776683|524464319|FG001|Post-switch Period|Physician Decision|3|||
145438769|NCT02776683|524464318|FG000|Post-switch Period|Progressive disease|0|||
145438770|NCT02776683|524464319|FG001|Post-switch Period|Progressive disease|20|||
145438771|NCT02776683|524464318|FG000|Post-switch Period|Other than listed|0|||
145438772|NCT02776683|524464319|FG001|Post-switch Period|Other than listed|15|||
145438773|NCT00400517|524464321|FG000|Overall Study|Withdrawal by Subject|1|||
145438774|NCT00400517|524464321|FG000|Overall Study|Physician Decision|1|||
145438775|NCT02141672|524464325|FG000|Overall Study|Adverse Event|0|||
145438776|NCT02141672|524464326|FG001|Overall Study|Adverse Event|1|||
145584143|NCT00462384|524991955|FG000|Overall Study|Death|2|||
145584144|NCT00462384|524991955|FG000|Overall Study|Withdrawal by Subject|1|||
145584145|NCT00462384|524991955|FG000|Overall Study|Other|4|||
145584146|NCT02667912|524991956|FG000|Overall Study|Death|3|||
145584147|NCT02667912|524991957|FG001|Overall Study|Death|1|||
145584148|NCT02667912|524991956|FG000|Overall Study|Withdrawal by Subject|1|||
145584149|NCT02667912|524991957|FG001|Overall Study|Withdrawal by Subject|2|||
145584150|NCT02667912|524991956|FG000|Overall Study|Withdrawal by Subject|1|||
145584151|NCT02667912|524991957|FG001|Overall Study|Withdrawal by Subject|0|||
145584152|NCT00797667|524991958|FG000|Overall Study|Lack of Efficacy|0|||
145584153|NCT00797667|524991959|FG001|Overall Study|Lack of Efficacy|1|||
145584154|NCT00797667|524991960|FG002|Overall Study|Lack of Efficacy|0|||
145584155|NCT00797667|524991958|FG000|Overall Study|Lost to Follow-up|8|||
145584156|NCT00797667|524991959|FG001|Overall Study|Lost to Follow-up|12|||
145584157|NCT00797667|524991960|FG002|Overall Study|Lost to Follow-up|2|||
145584158|NCT00797667|524991958|FG000|Overall Study|Physician Decision|3|||
145584159|NCT00797667|524991959|FG001|Overall Study|Physician Decision|1|||
145584160|NCT00797667|524991960|FG002|Overall Study|Physician Decision|0|||
145584161|NCT00797667|524991958|FG000|Overall Study|Pregnancy|2|||
145584162|NCT00797667|524991959|FG001|Overall Study|Pregnancy|0|||
145584163|NCT00797667|524991960|FG002|Overall Study|Pregnancy|0|||
145584164|NCT00797667|524991958|FG000|Overall Study|Protocol Violation|2|||
145584165|NCT00797667|524991959|FG001|Overall Study|Protocol Violation|7|||
145584166|NCT00797667|524991960|FG002|Overall Study|Protocol Violation|0|||
145584167|NCT00797667|524991958|FG000|Overall Study|Study Terminated by Sponsor|217|||
145584168|NCT00797667|524991959|FG001|Overall Study|Study Terminated by Sponsor|216|||
145584169|NCT00797667|524991960|FG002|Overall Study|Study Terminated by Sponsor|115|||
145584170|NCT00797667|524991958|FG000|Overall Study|Withdrawal by Subject|9|||
145584171|NCT00797667|524991959|FG001|Overall Study|Withdrawal by Subject|14|||
145584172|NCT00797667|524991960|FG002|Overall Study|Withdrawal by Subject|2|||
145584173|NCT00797667|524991958|FG000|Overall Study|Adverse Event|19|||
145584174|NCT00797667|524991959|FG001|Overall Study|Adverse Event|8|||
145584175|NCT00797667|524991960|FG002|Overall Study|Adverse Event|8|||
145584176|NCT01229436|524991961|FG000|Overall Study|Withdrawal by Subject|2|||
145584177|NCT01229436|524991961|FG000|Overall Study|Lost to Follow-up|3|||
145584178|NCT00096941|524991962|FG000|Overall Study|disease progression|3|||
145584179|NCT00022516|524991963|FG000|Overall Study|Adverse Event|0|||
145584180|NCT00022516|524991964|FG001|Overall Study|Adverse Event|59|||
145584181|NCT00022516|524991963|FG000|Overall Study|Lack of Efficacy|0|||
145584182|NCT00022516|524991964|FG001|Overall Study|Lack of Efficacy|27|||
145584183|NCT00022516|524991963|FG000|Overall Study|Physician Decision|0|||
145584184|NCT00022516|524991964|FG001|Overall Study|Physician Decision|1|||
145584185|NCT00022516|524991963|FG000|Overall Study|Protocol Violation|1|||
145584186|NCT00022516|524991964|FG001|Overall Study|Protocol Violation|3|||
145584187|NCT00022516|524991963|FG000|Overall Study|Withdrawal by Subject|2|||
145584188|NCT00022516|524991964|FG001|Overall Study|Withdrawal by Subject|113|||
145584189|NCT00022516|524991963|FG000|Overall Study|Incomplete documentation|0|||
145584190|NCT00022516|524991964|FG001|Overall Study|Incomplete documentation|27|||
145584191|NCT01767116|524991971|FG000|Overall Study|Lost to Follow-up|2|||
145584192|NCT01767116|524991972|FG001|Overall Study|Lost to Follow-up|2|||
145584193|NCT00439777|524991973|FG000|Treatment Period|Death|29|||
145584194|NCT00439777|524991974|FG001|Treatment Period|Death|21|||
145584195|NCT00439777|524991973|FG000|Treatment Period|Study terminated by sponsor|125|||
145584196|NCT00439777|524991974|FG001|Treatment Period|Study terminated by sponsor|132|||
145438777|NCT02141672|524464327|FG002|Overall Study|Adverse Event|0|||
145438778|NCT02141672|524464325|FG000|Overall Study|Death|10|||
145584197|NCT00439777|524991973|FG000|Treatment Period|Site closed by investigator|0|||
145584198|NCT00439777|524991974|FG001|Treatment Period|Site closed by investigator|1|||
145438779|NCT02141672|524464326|FG001|Overall Study|Death|2|||
145438780|NCT02141672|524464327|FG002|Overall Study|Death|1|||
145438781|NCT02141672|524464325|FG000|Overall Study|Lack of Efficacy|0|||
145584199|NCT00439777|524991973|FG000|Treatment Period|Did not take study treatment|7|||
145584200|NCT00439777|524991974|FG001|Treatment Period|Did not take study treatment|8|||
145584201|NCT00439777|524991973|FG000|Treatment Period|Adverse Event|111|||
145584202|NCT00439777|524991974|FG001|Treatment Period|Adverse Event|92|||
145584203|NCT00439777|524991973|FG000|Treatment Period|Protocol Violation|23|||
145625185|NCT00463151|525142022|FG002|Overall Study|Withdrawal by Subject|0|||
145625186|NCT00463151|525142023|FG003|Overall Study|Withdrawal by Subject|1|||
145625187|NCT05349084|525142024|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
145625188|NCT00293462|525142025|FG000|Overall Study|Withdrawal by Subject|4|||
145625189|NCT00293462|525142026|FG001|Overall Study|Withdrawal by Subject|3|||
145625190|NCT00293462|525142027|FG002|Overall Study|Withdrawal by Subject|8|||
145625191|NCT00293462|525142025|FG000|Overall Study|Death|1|||
145625192|NCT00293462|525142026|FG001|Overall Study|Death|0|||
145625193|NCT00293462|525142027|FG002|Overall Study|Death|0|||
145625194|NCT00293462|525142025|FG000|Overall Study|Lost to Follow-up|0|||
145625195|NCT00293462|525142026|FG001|Overall Study|Lost to Follow-up|1|||
145625196|NCT00293462|525142027|FG002|Overall Study|Lost to Follow-up|0|||
145625197|NCT00293462|525142025|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
145625198|NCT00293462|525142026|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
145625199|NCT00293462|525142027|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
145625200|NCT00293462|525142025|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
145625201|NCT00293462|525142026|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
145625202|NCT00293462|525142027|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
145625203|NCT00293462|525142025|FG000|Overall Study|Refuse Radiation Treatment|1|||
145625204|NCT00293462|525142026|FG001|Overall Study|Refuse Radiation Treatment|0|||
145625205|NCT00293462|525142027|FG002|Overall Study|Refuse Radiation Treatment|0|||
145625206|NCT00293462|525142025|FG000|Overall Study|No Show|0|||
145625207|NCT00293462|525142026|FG001|Overall Study|No Show|0|||
145625208|NCT00293462|525142027|FG002|Overall Study|No Show|1|||
145625209|NCT00293462|525142025|FG000|Overall Study|Went back to his home country|0|||
145625210|NCT00293462|525142026|FG001|Overall Study|Went back to his home country|0|||
145625211|NCT00293462|525142027|FG002|Overall Study|Went back to his home country|1|||
145625212|NCT00293462|525142025|FG000|Overall Study|Blood clot after chemotherapy|0|||
145625213|NCT00293462|525142026|FG001|Overall Study|Blood clot after chemotherapy|0|||
145625214|NCT00293462|525142027|FG002|Overall Study|Blood clot after chemotherapy|1|||
145625215|NCT00293462|525142025|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
145625216|NCT00293462|525142026|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
145625217|NCT00293462|525142027|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
145625218|NCT00293462|525142025|FG000|Overall Study|Possible Tracheostomy leakage|0|||
145625219|NCT00293462|525142026|FG001|Overall Study|Possible Tracheostomy leakage|1|||
145625220|NCT00293462|525142027|FG002|Overall Study|Possible Tracheostomy leakage|0|||
145625221|NCT00293462|525142025|FG000|Overall Study|Low radiation dose in oral cavity|0|||
145625222|NCT00293462|525142026|FG001|Overall Study|Low radiation dose in oral cavity|1|||
145625223|NCT00293462|525142027|FG002|Overall Study|Low radiation dose in oral cavity|0|||
145625224|NCT00293462|525142025|FG000|Overall Study|Physician Decision|0|||
145625225|NCT00293462|525142026|FG001|Overall Study|Physician Decision|1|||
145625226|NCT00293462|525142027|FG002|Overall Study|Physician Decision|0|||
145625227|NCT00688688|525142028|FG000|Overall Study|Eligibility criterion not met|7|||
145625228|NCT00688688|525142029|FG001|Overall Study|Eligibility criterion not met|7|||
145625229|NCT00688688|525142030|FG002|Overall Study|Eligibility criterion not met|10|||
145625230|NCT00688688|525142028|FG000|Overall Study|Adverse Event|52|||
145625231|NCT00688688|525142029|FG001|Overall Study|Adverse Event|51|||
145625232|NCT00688688|525142030|FG002|Overall Study|Adverse Event|50|||
145438782|NCT02141672|524464326|FG001|Overall Study|Lack of Efficacy|0|||
145438783|NCT02141672|524464327|FG002|Overall Study|Lack of Efficacy|2|||
145438784|NCT02141672|524464325|FG000|Overall Study|Lost to Follow-up|1|||
145438785|NCT02141672|524464326|FG001|Overall Study|Lost to Follow-up|1|||
145438786|NCT02141672|524464327|FG002|Overall Study|Lost to Follow-up|3|||
145438787|NCT02141672|524464325|FG000|Overall Study|Physician Decision|1|||
145438788|NCT02141672|524464326|FG001|Overall Study|Physician Decision|2|||
145438789|NCT02141672|524464327|FG002|Overall Study|Physician Decision|5|||
145625233|NCT00688688|525142028|FG000|Overall Study|Lack of Efficacy|34|||
145625234|NCT00688688|525142029|FG001|Overall Study|Lack of Efficacy|25|||
145625235|NCT00688688|525142030|FG002|Overall Study|Lack of Efficacy|45|||
145625236|NCT00688688|525142028|FG000|Overall Study|Withdrawal by Subject|66|||
145625237|NCT00688688|525142029|FG001|Overall Study|Withdrawal by Subject|75|||
145625238|NCT00688688|525142030|FG002|Overall Study|Withdrawal by Subject|65|||
145625239|NCT00688688|525142028|FG000|Overall Study|Lost to Follow-up|14|||
145625240|NCT00688688|525142029|FG001|Overall Study|Lost to Follow-up|7|||
145625241|NCT00688688|525142030|FG002|Overall Study|Lost to Follow-up|7|||
145625242|NCT00688688|525142028|FG000|Overall Study|Protocol Violation|6|||
145625243|NCT00688688|525142029|FG001|Overall Study|Protocol Violation|9|||
145625244|NCT00688688|525142030|FG002|Overall Study|Protocol Violation|11|||
145625245|NCT00688688|525142028|FG000|Overall Study|Randomized but never received study drug|1|||
145625246|NCT00688688|525142029|FG001|Overall Study|Randomized but never received study drug|0|||
145625247|NCT00688688|525142030|FG002|Overall Study|Randomized but never received study drug|0|||
145625248|NCT00688688|525142028|FG000|Overall Study|Non-compliance with study procedures|5|||
145438790|NCT02141672|524464325|FG000|Overall Study|Protocol Violation|0|||
145438791|NCT02141672|524464326|FG001|Overall Study|Protocol Violation|0|||
145438792|NCT02141672|524464327|FG002|Overall Study|Protocol Violation|1|||
145438793|NCT02141672|524464325|FG000|Overall Study|Withdrawal by Subject|3|||
145438794|NCT02141672|524464326|FG001|Overall Study|Withdrawal by Subject|2|||
145438795|NCT02141672|524464327|FG002|Overall Study|Withdrawal by Subject|5|||
145438796|NCT02141672|524464325|FG000|Overall Study|refused to follow-up|1|||
145438797|NCT02141672|524464326|FG001|Overall Study|refused to follow-up|0|||
145438798|NCT02141672|524464327|FG002|Overall Study|refused to follow-up|1|||
145438799|NCT01118780|524464328|FG000|Overall Study|Adverse Event|15|||
145438800|NCT01118780|524464329|FG001|Overall Study|Adverse Event|15|||
145438801|NCT01118780|524464328|FG000|Overall Study|Death|1|||
145438802|NCT01118780|524464329|FG001|Overall Study|Death|0|||
145438803|NCT01118780|524464328|FG000|Overall Study|Lack of Efficacy|2|||
145438804|NCT01118780|524464329|FG001|Overall Study|Lack of Efficacy|6|||
145438805|NCT01118780|524464328|FG000|Overall Study|Physician Decision|2|||
145438806|NCT01118780|524464329|FG001|Overall Study|Physician Decision|0|||
145438807|NCT01118780|524464328|FG000|Overall Study|Protocol Violation|3|||
145438808|NCT01118780|524464329|FG001|Overall Study|Protocol Violation|6|||
145438809|NCT01118780|524464328|FG000|Overall Study|Withdrawal by Subject|13|||
145438810|NCT01118780|524464329|FG001|Overall Study|Withdrawal by Subject|8|||
145438811|NCT02457247|524464332|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
145438812|NCT02457247|524464333|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
145438813|NCT02457247|524464334|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
145438814|NCT02457247|524464335|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
145438815|NCT02457247|524464332|FG000|Period 1|Significant Protocol Deviation|1|||
145438816|NCT02457247|524464333|FG001|Period 1|Significant Protocol Deviation|1|||
145438817|NCT02457247|524464334|FG002|Period 1|Significant Protocol Deviation|0|||
145438818|NCT02457247|524464335|FG003|Period 1|Significant Protocol Deviation|0|||
145438819|NCT02457247|524464332|FG000|Period 1|Voluntary Withdrawal|1|||
145438820|NCT02457247|524464333|FG001|Period 1|Voluntary Withdrawal|0|||
145438821|NCT02457247|524464334|FG002|Period 1|Voluntary Withdrawal|0|||
145438822|NCT02457247|524464335|FG003|Period 1|Voluntary Withdrawal|0|||
145438823|NCT02457247|524464332|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
145438824|NCT02457247|524464333|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
145438825|NCT02457247|524464334|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
145438826|NCT02457247|524464335|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
145438827|NCT02457247|524464332|FG000|Period 2|Significant Protocol Deviation|1|||
145438828|NCT02457247|524464333|FG001|Period 2|Significant Protocol Deviation|0|||
145438829|NCT02457247|524464334|FG002|Period 2|Significant Protocol Deviation|0|||
145438830|NCT02457247|524464335|FG003|Period 2|Significant Protocol Deviation|0|||
145438831|NCT02457247|524464332|FG000|Period 2|Lost to Follow-up|0|||
145438832|NCT02457247|524464333|FG001|Period 2|Lost to Follow-up|1|||
145438833|NCT02457247|524464334|FG002|Period 2|Lost to Follow-up|0|||
145438834|NCT02457247|524464335|FG003|Period 2|Lost to Follow-up|0|||
145438835|NCT02457247|524464332|FG000|Period 2|Voluntary Withdrawal|1|||
145438836|NCT02457247|524464333|FG001|Period 2|Voluntary Withdrawal|1|||
145438837|NCT02457247|524464334|FG002|Period 2|Voluntary Withdrawal|0|||
145438838|NCT02457247|524464335|FG003|Period 2|Voluntary Withdrawal|0|||
145438839|NCT02954887|524464336|FG000|Overall Study|Withdrawal by Subject|3|||
145438840|NCT02954887|524464336|FG000|Overall Study|Lack of Efficacy|3|||
145438841|NCT02954887|524464336|FG000|Overall Study|Other|1|||
145438842|NCT04571060|524464337|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
145438843|NCT04571060|524464338|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
145438844|NCT04571060|524464337|FG000|Overall Study|Never treated migraine|47|||
145438845|NCT04571060|524464338|FG001|Overall Study|Never treated migraine|36|||
145438846|NCT04571060|524464337|FG000|Overall Study|Protocol Violation|4|||
145438847|NCT04571060|524464338|FG001|Overall Study|Protocol Violation|2|||
145438848|NCT04571060|524464337|FG000|Overall Study|Withdrawal by Subject|6|||
145438849|NCT04571060|524464338|FG001|Overall Study|Withdrawal by Subject|2|||
145438850|NCT04571060|524464337|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
145438851|NCT04571060|524464338|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
145438852|NCT01508910|524464341|FG000|Treatment|Death|2|||
145438853|NCT01508910|524464342|FG001|Treatment|Death|3|||
145438854|NCT01508910|524464343|FG002|Treatment|Death|2|||
145438855|NCT01508910|524464344|FG003|Treatment|Death|0|||
145584204|NCT00439777|524991974|FG001|Treatment Period|Protocol Violation|30|||
145438856|NCT01508910|524464341|FG000|Treatment|Lost to Follow-up|0|||
145438857|NCT01508910|524464342|FG001|Treatment|Lost to Follow-up|0|||
145438858|NCT01508910|524464343|FG002|Treatment|Lost to Follow-up|2|||
145438859|NCT01508910|524464344|FG003|Treatment|Lost to Follow-up|1|||
145438860|NCT01508910|524464341|FG000|Treatment|Withdrawal by Subject|0|||
145438861|NCT01508910|524464342|FG001|Treatment|Withdrawal by Subject|1|||
145438862|NCT01508910|524464343|FG002|Treatment|Withdrawal by Subject|6|||
145438863|NCT01508910|524464344|FG003|Treatment|Withdrawal by Subject|1|||
145438864|NCT01508910|524464341|FG000|Treatment|Sponsor Decision|0|||
145438865|NCT01508910|524464342|FG001|Treatment|Sponsor Decision|0|||
145438866|NCT01508910|524464343|FG002|Treatment|Sponsor Decision|0|||
145438867|NCT01508910|524464344|FG003|Treatment|Sponsor Decision|1|||
145438868|NCT04819113|524464346|FG000|Overall Study|Withdrawal by parent/guardian|3|||
145584205|NCT00439777|524991973|FG000|Treatment Period|Withdrawal by Subject|66|||
145438869|NCT04819113|524464346|FG000|Overall Study|Lost to Follow-up|1|||
145438870|NCT04819113|524464346|FG000|Overall Study|Withdrawn before vaccination|2|||
145438871|NCT01342094|524464349|FG000|Overall Study|Adverse Event|5|||
145438872|NCT01342094|524464350|FG001|Overall Study|Adverse Event|0|||
145438873|NCT01342094|524464349|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
145438874|NCT01342094|524464350|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
145438875|NCT01342094|524464349|FG000|Overall Study|Withdrawal by Subject|0|||
145438876|NCT01342094|524464350|FG001|Overall Study|Withdrawal by Subject|2|||
145438877|NCT02806414|524464351|FG000|Overall Study|Lost to Follow-up|2|||
145438878|NCT02573948|524464360|FG000|Longitudinal Cohort|Death|9|||
145438879|NCT02573948|524464360|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
145438880|NCT02573948|524464360|FG000|Longitudinal Cohort|Incarcerated|25|||
145438881|NCT01673126|524464361|FG000|Overall Study|change of diagnosis|4|||
145438882|NCT01673126|524464362|FG001|Overall Study|change of diagnosis|3|||
145438883|NCT01913327|524464367|FG000|Overall Study|Withdrawal by Subject|0|||
145438884|NCT01913327|524464368|FG001|Overall Study|Withdrawal by Subject|1|||
145438885|NCT00628446|524465860|FG000|Overall Study|Lost to Follow-up|3|||
145438886|NCT00628446|524465860|FG000|Overall Study|Withdrawal by Subject|1|||
145438887|NCT00628446|524465860|FG000|Overall Study|Protocol Violation|3|||
145438888|NCT00756275|524465861|FG000|Overall Study|Lost to Follow-up|25|||
145438889|NCT00756275|524465862|FG001|Overall Study|Lost to Follow-up|21|||
145438890|NCT00756275|524465861|FG000|Overall Study|Withdrawal by Subject|4|||
145438891|NCT00756275|524465862|FG001|Overall Study|Withdrawal by Subject|7|||
145438892|NCT00551031|524465863|FG000|Overall Study|Adverse Event|0|||
145438893|NCT00551031|524465864|FG001|Overall Study|Adverse Event|1|||
145438894|NCT00551031|524465865|FG002|Overall Study|Adverse Event|0|||
145438895|NCT00551031|524465866|FG003|Overall Study|Adverse Event|0|||
145438896|NCT00551031|524465867|FG004|Overall Study|Adverse Event|0|||
145438897|NCT00551031|524465863|FG000|Overall Study|Protocol Violation|1|||
145438898|NCT00551031|524465864|FG001|Overall Study|Protocol Violation|1|||
145438899|NCT00551031|524465865|FG002|Overall Study|Protocol Violation|0|||
145438900|NCT00551031|524465866|FG003|Overall Study|Protocol Violation|0|||
145438901|NCT00551031|524465867|FG004|Overall Study|Protocol Violation|0|||
145438902|NCT00551031|524465863|FG000|Overall Study|Lost to Follow-up|0|||
145438903|NCT00551031|524465864|FG001|Overall Study|Lost to Follow-up|1|||
145438904|NCT00551031|524465865|FG002|Overall Study|Lost to Follow-up|0|||
145438905|NCT00551031|524465866|FG003|Overall Study|Lost to Follow-up|1|||
145438906|NCT00551031|524465867|FG004|Overall Study|Lost to Follow-up|1|||
145438907|NCT00551031|524465863|FG000|Overall Study|Withdrawal by Subject|0|||
145438908|NCT00551031|524465864|FG001|Overall Study|Withdrawal by Subject|4|||
145438909|NCT00551031|524465865|FG002|Overall Study|Withdrawal by Subject|1|||
145438910|NCT00551031|524465866|FG003|Overall Study|Withdrawal by Subject|2|||
145438911|NCT00551031|524465867|FG004|Overall Study|Withdrawal by Subject|0|||
145438912|NCT00551031|524465863|FG000|Overall Study|Serious Adverse Event|0|||
145438913|NCT00551031|524465864|FG001|Overall Study|Serious Adverse Event|2|||
145438914|NCT00551031|524465865|FG002|Overall Study|Serious Adverse Event|1|||
145438915|NCT00551031|524465866|FG003|Overall Study|Serious Adverse Event|0|||
145438916|NCT00551031|524465867|FG004|Overall Study|Serious Adverse Event|0|||
145438917|NCT00551031|524465863|FG000|Overall Study|Did not receive vaccine|1|||
145438918|NCT00551031|524465864|FG001|Overall Study|Did not receive vaccine|2|||
145438919|NCT00551031|524465865|FG002|Overall Study|Did not receive vaccine|0|||
145438920|NCT00551031|524465866|FG003|Overall Study|Did not receive vaccine|0|||
145438921|NCT00551031|524465867|FG004|Overall Study|Did not receive vaccine|0|||
145438922|NCT00682929|524465872|FG000|Overall Study|Adverse Event|4|||
145438923|NCT00682929|524465873|FG001|Overall Study|Adverse Event|1|||
145438924|NCT00682929|524465874|FG002|Overall Study|Adverse Event|1|||
145438925|NCT00682929|524465872|FG000|Overall Study|Withdrawal by Subject|1|||
145438926|NCT00682929|524465873|FG001|Overall Study|Withdrawal by Subject|2|||
145438927|NCT00682929|524465874|FG002|Overall Study|Withdrawal by Subject|1|||
145438928|NCT00682929|524465872|FG000|Overall Study|dosing compliance < 80%|0|||
145438929|NCT00682929|524465873|FG001|Overall Study|dosing compliance < 80%|2|||
145438930|NCT00682929|524465874|FG002|Overall Study|dosing compliance < 80%|0|||
145438931|NCT00682929|524465872|FG000|Overall Study|lag in DEA renewal|1|||
145438932|NCT00682929|524465873|FG001|Overall Study|lag in DEA renewal|0|||
145438933|NCT00682929|524465874|FG002|Overall Study|lag in DEA renewal|0|||
145438934|NCT00456755|524465879|FG000|Overall Study|Lost to Follow-up|2|||
145438935|NCT00456755|524465880|FG001|Overall Study|Lost to Follow-up|1|||
145584206|NCT00439777|524991974|FG001|Treatment Period|Withdrawal by Subject|118|||
145438936|NCT04072835|524465885|FG000|Overall Study|Overall trial ended|603|||
145438937|NCT04072835|524465885|FG000|Overall Study|Ablation|97|||
145438938|NCT04072835|524465885|FG000|Overall Study|Withdrawal of consent|66|||
145438939|NCT04072835|524465885|FG000|Overall Study|Physician Decision|50|||
145438940|NCT04072835|524465885|FG000|Overall Study|Lost to Follow-up|39|||
145438941|NCT04072835|524465885|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
145438942|NCT04072835|524465885|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
145438943|NCT04072835|524465885|FG000|Overall Study|Adverse Event|25|||
145625249|NCT00688688|525142029|FG001|Overall Study|Non-compliance with study procedures|3|||
145625250|NCT00688688|525142030|FG002|Overall Study|Non-compliance with study procedures|4|||
145625251|NCT00688688|525142028|FG000|Overall Study|Taking exclusionary medications|1|||
145625252|NCT00688688|525142029|FG001|Overall Study|Taking exclusionary medications|0|||
145625253|NCT00688688|525142030|FG002|Overall Study|Taking exclusionary medications|0|||
145625254|NCT00688688|525142028|FG000|Overall Study|Site closure|0|||
145625255|NCT00688688|525142029|FG001|Overall Study|Site closure|1|||
145625256|NCT00688688|525142030|FG002|Overall Study|Site closure|0|||
145438944|NCT04072835|524465885|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
145438945|NCT04072835|524465885|FG000|Overall Study|Death|11|||
145438946|NCT04072835|524465885|FG000|Overall Study|Participant felt the drug did not work|8|||
145438947|NCT04072835|524465885|FG000|Overall Study|Participant tolerability|5|||
145438948|NCT04072835|524465885|FG000|Overall Study|Missing|5|||
145438949|NCT04072835|524465885|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
145438950|NCT04072835|524465885|FG000|Overall Study|Pregnancy|3|||
145438951|NCT00399568|524465886|FG000|Overall Study|Adverse Event|1|||
145438952|NCT00399568|524465887|FG001|Overall Study|Adverse Event|2|||
145438953|NCT00399568|524465886|FG000|Overall Study|Withdrawal by Subject|7|||
145438954|NCT00399568|524465887|FG001|Overall Study|Withdrawal by Subject|3|||
145438955|NCT00399568|524465886|FG000|Overall Study|Protocol non-compliance|2|||
145438956|NCT00399568|524465887|FG001|Overall Study|Protocol non-compliance|2|||
145438957|NCT00399568|524465886|FG000|Overall Study|Lost to Follow-up|2|||
145438958|NCT00399568|524465887|FG001|Overall Study|Lost to Follow-up|2|||
145438959|NCT00841776|524465890|FG000|Overall Study|Lack of Efficacy|0|||
145438960|NCT00841776|524465891|FG001|Overall Study|Lack of Efficacy|1|||
145438961|NCT00841776|524465890|FG000|Overall Study|Lost to Follow-up|2|||
145438962|NCT00841776|524465891|FG001|Overall Study|Lost to Follow-up|1|||
145584207|NCT00439777|524991973|FG000|Treatment Period|Lack of Efficacy|1|||
145584208|NCT00439777|524991974|FG001|Treatment Period|Lack of Efficacy|4|||
145584209|NCT00439777|524991973|FG000|Treatment Period|Lost to Follow-up|8|||
145584210|NCT00439777|524991974|FG001|Treatment Period|Lost to Follow-up|10|||
145584211|NCT00439777|524991973|FG000|Treatment Period|Protocol driven decision point|1|||
145584212|NCT00439777|524991974|FG001|Treatment Period|Protocol driven decision point|3|||
145584213|NCT00439777|524991973|FG000|Treatment Period|Physician Decision|7|||
145584214|NCT00439777|524991974|FG001|Treatment Period|Physician Decision|18|||
145584215|NCT00439777|524991973|FG000|Treatment Period|Clinical endpoint reached|26|||
145584216|NCT00439777|524991974|FG001|Treatment Period|Clinical endpoint reached|13|||
145584217|NCT00439777|524991973|FG000|Treatment Period|Technical problems|3|||
145584218|NCT00439777|524991974|FG001|Treatment Period|Technical problems|1|||
145584219|NCT00439777|524991973|FG000|Treatment Period|Participant convenience|12|||
145584220|NCT00439777|524991974|FG001|Treatment Period|Participant convenience|8|||
145584221|NCT00439777|524991973|FG000|Observational Period|Protocol Violation|0|||
145584222|NCT00439777|524991974|FG001|Observational Period|Protocol Violation|2|||
145584223|NCT00439777|524991973|FG000|Observational Period|Withdrawal by Subject|9|||
145584224|NCT00439777|524991974|FG001|Observational Period|Withdrawal by Subject|5|||
145584225|NCT00439777|524991973|FG000|Observational Period|Lost to Follow-up|1|||
145584226|NCT00439777|524991974|FG001|Observational Period|Lost to Follow-up|11|||
145584227|NCT00439777|524991973|FG000|Observational Period|Death|27|||
145584228|NCT00439777|524991974|FG001|Observational Period|Death|20|||
145584229|NCT00439777|524991973|FG000|Observational Period|Study terminated by sponsor|3|||
145584230|NCT00439777|524991974|FG001|Observational Period|Study terminated by sponsor|1|||
145584231|NCT00439777|524991973|FG000|Observational Period|Protocol driven decision point|0|||
145584232|NCT00439777|524991974|FG001|Observational Period|Protocol driven decision point|1|||
145584233|NCT00439777|524991973|FG000|Observational Period|Lack of Efficacy|1|||
145584234|NCT00439777|524991974|FG001|Observational Period|Lack of Efficacy|0|||
145584235|NCT00439777|524991973|FG000|Observational Period|Technical problems|0|||
145584236|NCT00439777|524991974|FG001|Observational Period|Technical problems|1|||
145584237|NCT00661492|524991975|FG000|Overall Study|Adverse Event|16|||
145584238|NCT00661492|524991976|FG001|Overall Study|Adverse Event|13|||
145584239|NCT00661492|524991975|FG000|Overall Study|Disease Progression|44|||
145584240|NCT00661492|524991976|FG001|Overall Study|Disease Progression|14|||
145584241|NCT00661492|524991975|FG000|Overall Study|Patient Request|6|||
145584242|NCT00661492|524991976|FG001|Overall Study|Patient Request|1|||
145584243|NCT00661492|524991975|FG000|Overall Study|Investigator Request|1|||
145584244|NCT00661492|524991976|FG001|Overall Study|Investigator Request|0|||
145584245|NCT00661492|524991975|FG000|Overall Study|Lost to Follow-up|0|||
145584246|NCT00661492|524991976|FG001|Overall Study|Lost to Follow-up|1|||
145584247|NCT00661492|524991975|FG000|Overall Study|Other|1|||
145584248|NCT00661492|524991976|FG001|Overall Study|Other|0|||
145584249|NCT01024387|524991977|FG000|Overall Study|Radiographic Progression|29|||
145584250|NCT01024387|524991977|FG000|Overall Study|Symptomatic Progression|10|||
145438963|NCT00841776|524465890|FG000|Overall Study|Withdrawal by Subject|0|||
145438964|NCT00841776|524465891|FG001|Overall Study|Withdrawal by Subject|1|||
145438965|NCT02477527|524465892|FG000|Overall Study|Lost to Follow-up|2|||
145438966|NCT02477527|524465892|FG000|Overall Study|Withdrawal by Subject|1|||
145438967|NCT02477527|524465892|FG000|Overall Study|Screen Failure|3|||
145438968|NCT04567524|524465893|FG000|Overall Study|Adverse Event|1|||
145438969|NCT04567524|524465894|FG001|Overall Study|Adverse Event|1|||
145438970|NCT04567524|524465895|FG002|Overall Study|Adverse Event|0|||
145438971|NCT04567524|524465896|FG003|Overall Study|Adverse Event|0|||
145438972|NCT04567524|524465893|FG000|Overall Study|Withdrawal by Subject|2|||
145438973|NCT04567524|524465894|FG001|Overall Study|Withdrawal by Subject|0|||
145438974|NCT04567524|524465895|FG002|Overall Study|Withdrawal by Subject|0|||
145438975|NCT04567524|524465896|FG003|Overall Study|Withdrawal by Subject|1|||
145438976|NCT01147393|524465899|FG000|Dose Level 1|Dose limiting Toxicity|2|||
145438977|NCT01147393|524465899|FG000|Dose Level -1|Dose Limited Toxicity|1|||
145438978|NCT00592631|524465902|FG000|Overall Study|Lost to Follow-up|0|||
145438979|NCT00592631|524465903|FG001|Overall Study|Lost to Follow-up|2|||
145438980|NCT03688919|524465904|FG000|Overall Study|Lost to Follow-up|2|||
145438981|NCT03688919|524465905|FG001|Overall Study|Lost to Follow-up|1|||
145438982|NCT03688919|524465904|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
145438983|NCT03688919|524465905|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
145438984|NCT03389308|524465908|FG000|Overall Study|Withdrawal by Subject|5|||
145438985|NCT03389308|524465908|FG000|Overall Study|Lost to Follow-up|3|||
145438986|NCT03389308|524465908|FG000|Overall Study|Adverse Event|2|||
145438987|NCT03389308|524465908|FG000|Overall Study|Sponsor Request|2|||
145438988|NCT03198767|524465912|FG000|Overall Study|Protocol Violation|0|||
145438989|NCT03198767|524465913|FG001|Overall Study|Protocol Violation|0|||
145438990|NCT03198767|524465914|FG002|Overall Study|Protocol Violation|0|||
145438991|NCT03198767|524465915|FG003|Overall Study|Protocol Violation|6|||
145438992|NCT03198767|524465916|FG004|Overall Study|Protocol Violation|0|||
145438993|NCT03198767|524465917|FG005|Overall Study|Protocol Violation|0|||
145438994|NCT03198767|524465918|FG006|Overall Study|Protocol Violation|0|||
145438995|NCT00570323|524465919|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
145438996|NCT00570323|524465920|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
145438997|NCT00570323|524465919|FG000|Started Treatment After Randomization|Protocol Violation|1|||
145438998|NCT00570323|524465920|FG001|Started Treatment After Randomization|Protocol Violation|0|||
145438999|NCT00570323|524465919|FG000|Started Treatment After Randomization|Physician Decision|1|||
145439000|NCT00570323|524465920|FG001|Started Treatment After Randomization|Physician Decision|0|||
145439001|NCT00570323|524465919|FG000|Complete Study After Start|Lost to Follow-up|0|||
145439002|NCT00570323|524465920|FG001|Complete Study After Start|Lost to Follow-up|1|||
145439003|NCT00570323|524465919|FG000|Complete Study After Start|Withdrawal by Subject|2|||
145439004|NCT00570323|524465920|FG001|Complete Study After Start|Withdrawal by Subject|0|||
145439005|NCT00570323|524465919|FG000|Complete Study After Start|Physician Decision|1|||
145439006|NCT00570323|524465920|FG001|Complete Study After Start|Physician Decision|0|||
145439007|NCT02639247|524465923|FG000|Overall Study|Lost to Follow-up|2|||
145439008|NCT02639247|524465924|FG001|Overall Study|Lost to Follow-up|1|||
145439009|NCT02639247|524465923|FG000|Overall Study|Death|2|||
145439010|NCT02639247|524465924|FG001|Overall Study|Death|0|||
145439011|NCT02639247|524465923|FG000|Overall Study|Withdrew Consent|0|||
145439012|NCT02639247|524465924|FG001|Overall Study|Withdrew Consent|1|||
145439013|NCT02639247|524465923|FG000|Overall Study|Protocol Violation|1|||
145439014|NCT02639247|524465924|FG001|Overall Study|Protocol Violation|0|||
145439015|NCT02651116|524465926|FG000|Overall Study|Adverse Event|0|||
145439016|NCT02651116|524465927|FG001|Overall Study|Adverse Event|1|||
145439017|NCT02651116|524465926|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
145439018|NCT02651116|524465927|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
145439019|NCT00041470|524465935|FG000|Overall Study|Loss of Funding|38|||
145439020|NCT00739310|524465936|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
145439021|NCT00739310|524465936|FG000|Overall Study|Withdrawal by Subject|1|||
145439022|NCT00739310|524465936|FG000|Overall Study|Lost to Follow-up|2|||
145439023|NCT01459666|524465937|FG000|Overall Study|PI left institution|5|||
145439024|NCT01459666|524465938|FG001|Overall Study|PI left institution|4|||
145584251|NCT01024387|524991977|FG000|Overall Study|Physician Decision|5|||
145584252|NCT01024387|524991977|FG000|Overall Study|Withdrawal by Subject|5|||
145584253|NCT01024387|524991977|FG000|Overall Study|Death|2|||
145584254|NCT01024387|524991977|FG000|Overall Study|Prolonged Treatment Delay|1|||
145439025|NCT01061385|524465939|FG000|Overall Study|Lost to Follow-up|1|||
145584255|NCT01024387|524991977|FG000|Overall Study|Adverse Event|3|||
145584256|NCT01024387|524991977|FG000|Overall Study|Other|5|||
145439026|NCT01061385|524465940|FG001|Overall Study|Lost to Follow-up|0|||
145439027|NCT01061385|524465939|FG000|Overall Study|subject decision not related to AE|0|||
145439028|NCT01061385|524465940|FG001|Overall Study|subject decision not related to AE|1|||
145439029|NCT02803203|524465941|FG000|Overall Study|Adverse Event|4|||
145439030|NCT02803203|524465941|FG000|Overall Study|Death|4|||
145584257|NCT03855189|524991978|FG000|Overall Study|Adverse Event|5|||
145439031|NCT02803203|524465941|FG000|Overall Study|Progressive disease|29|||
145439032|NCT02803203|524465941|FG000|Overall Study|Withdrawal by Subject|8|||
145439033|NCT02803203|524465941|FG000|Overall Study|Complete resection of target disease|2|||
145439034|NCT02803203|524465941|FG000|Overall Study|Switched to commercial Osi|1|||
145584258|NCT03855189|524991979|FG001|Overall Study|Adverse Event|2|||
145625257|NCT00688688|525142028|FG000|Overall Study|Violation of exclusion criterion|0|||
145625258|NCT00688688|525142029|FG001|Overall Study|Violation of exclusion criterion|1|||
145625259|NCT00688688|525142030|FG002|Overall Study|Violation of exclusion criterion|0|||
145439035|NCT02803203|524465941|FG000|Overall Study|Participant moved away|1|||
145439036|NCT00533429|524465942|FG000|Overall Study|Adverse Event|3|||
145439037|NCT00533429|524465943|FG001|Overall Study|Adverse Event|1|||
145439038|NCT00533429|524465942|FG000|Overall Study|Death|1|||
145439039|NCT00533429|524465943|FG001|Overall Study|Death|0|||
145439040|NCT00533429|524465942|FG000|Overall Study|Withdrawal by Subject|2|||
145439041|NCT00533429|524465943|FG001|Overall Study|Withdrawal by Subject|0|||
145439042|NCT00533429|524465942|FG000|Overall Study|Progressive Disease|12|||
145439043|NCT00533429|524465943|FG001|Overall Study|Progressive Disease|13|||
145625260|NCT03283553|525142034|FG000|Patient Participant Flow|Death|5|||
145625261|NCT03283553|525142035|FG001|Patient Participant Flow|Death|10|||
145625262|NCT03283553|525142034|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
145439044|NCT00533429|524465942|FG000|Overall Study|Symptomatic deterioration|1|||
145439045|NCT00533429|524465943|FG001|Overall Study|Symptomatic deterioration|2|||
145439046|NCT02655887|524465950|FG000|Overall Study|Lost to Follow-up|3|||
145439047|NCT02655887|524465950|FG000|Overall Study|Death|4|||
145439048|NCT02655887|524465950|FG000|Overall Study|Withdrawal by Subject|3|||
145439049|NCT02655887|524465950|FG000|Overall Study|Missed 12-month follow-up visit|4|||
145439050|NCT03637491|524465951|FG000|Overall Study|Death|9|||
145439051|NCT03637491|524465952|FG001|Overall Study|Death|9|||
145439052|NCT03637491|524465953|FG002|Overall Study|Death|5|||
145439053|NCT03637491|524465954|FG003|Overall Study|Death|3|||
145625263|NCT03283553|525142035|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
145625264|NCT03283553|525142034|FG000|Patient Participant Flow|Lost to Follow-up|1|||
145625265|NCT03283553|525142035|FG001|Patient Participant Flow|Lost to Follow-up|1|||
145625266|NCT03283553|525142034|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
145625267|NCT03283553|525142035|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
145625268|NCT03283553|525142034|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
145625269|NCT03283553|525142035|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
145625270|NCT03283553|525142034|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
145625271|NCT03283553|525142035|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
145625272|NCT03686683|525142036|FG000|Overall Study|Withdrawal by Subject|52|||
145625273|NCT03686683|525142037|FG001|Overall Study|Withdrawal by Subject|32|||
145625274|NCT03686683|525142036|FG000|Overall Study|Lost to Follow-up|23|||
145625275|NCT03686683|525142037|FG001|Overall Study|Lost to Follow-up|19|||
145625276|NCT03686683|525142036|FG000|Overall Study|Adverse Event|1|||
145625277|NCT03686683|525142037|FG001|Overall Study|Adverse Event|0|||
145625278|NCT03686683|525142036|FG000|Overall Study|Death|10|||
145625279|NCT03686683|525142037|FG001|Overall Study|Death|5|||
145625280|NCT03686683|525142036|FG000|Overall Study|Progressive Disease|1|||
145625281|NCT03686683|525142037|FG001|Overall Study|Progressive Disease|1|||
145625282|NCT03686683|525142036|FG000|Overall Study|Noncompliance|1|||
145625283|NCT03686683|525142037|FG001|Overall Study|Noncompliance|0|||
145625284|NCT03686683|525142036|FG000|Overall Study|Physician Decision|1|||
145625285|NCT03686683|525142037|FG001|Overall Study|Physician Decision|1|||
145625286|NCT03686683|525142036|FG000|Overall Study|Screen fail post-randomization|1|||
145625287|NCT03686683|525142037|FG001|Overall Study|Screen fail post-randomization|0|||
145625288|NCT03686683|525142036|FG000|Overall Study|Protocol Violation|3|||
145625289|NCT03686683|525142037|FG001|Overall Study|Protocol Violation|0|||
145625290|NCT03686683|525142036|FG000|Overall Study|No data available|1|||
145625291|NCT03686683|525142037|FG001|Overall Study|No data available|0|||
145625292|NCT00372060|525142038|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
145625293|NCT00372060|525142039|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
145439054|NCT03637491|524465951|FG000|Overall Study|Lost to Follow-up|0|||
145439055|NCT03637491|524465952|FG001|Overall Study|Lost to Follow-up|1|||
145439056|NCT03637491|524465953|FG002|Overall Study|Lost to Follow-up|0|||
145439057|NCT03637491|524465954|FG003|Overall Study|Lost to Follow-up|1|||
145439058|NCT03637491|524465951|FG000|Overall Study|Study Terminated By Sponsor|0|||
145439059|NCT03637491|524465952|FG001|Overall Study|Study Terminated By Sponsor|2|||
145439060|NCT03637491|524465953|FG002|Overall Study|Study Terminated By Sponsor|1|||
145439061|NCT03637491|524465954|FG003|Overall Study|Study Terminated By Sponsor|0|||
145439062|NCT03637491|524465951|FG000|Overall Study|Withdrawal by Subject|1|||
145439063|NCT03637491|524465952|FG001|Overall Study|Withdrawal by Subject|0|||
145439064|NCT03637491|524465953|FG002|Overall Study|Withdrawal by Subject|1|||
145625294|NCT00372060|525142038|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
145625295|NCT00372060|525142039|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
145625296|NCT00372060|525142038|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
145625297|NCT00372060|525142039|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
145625298|NCT00372060|525142038|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
145439065|NCT03637491|524465954|FG003|Overall Study|Withdrawal by Subject|2|||
145439066|NCT02185534|524465957|FG000|First Period|Withdrawal by Subject|0|||
145439067|NCT02185534|524465958|FG001|First Period|Withdrawal by Subject|0|||
145439068|NCT02185534|524465959|FG002|First Period|Withdrawal by Subject|0|||
145439069|NCT02185534|524465960|FG003|First Period|Withdrawal by Subject|1|||
145439070|NCT02185534|524465961|FG004|First Period|Withdrawal by Subject|0|||
145439071|NCT02185534|524465962|FG005|First Period|Withdrawal by Subject|0|||
145439072|NCT02185534|524465957|FG000|First Washout Period|Withdrawal by Subject|1|||
145439073|NCT02185534|524465958|FG001|First Washout Period|Withdrawal by Subject|0|||
145439074|NCT02185534|524465959|FG002|First Washout Period|Withdrawal by Subject|0|||
145439075|NCT02185534|524465960|FG003|First Washout Period|Withdrawal by Subject|0|||
145439076|NCT02185534|524465961|FG004|First Washout Period|Withdrawal by Subject|1|||
145439077|NCT02185534|524465962|FG005|First Washout Period|Withdrawal by Subject|0|||
145439078|NCT02185534|524465957|FG000|First Washout Period|Protocol Violation|0|||
145439079|NCT02185534|524465958|FG001|First Washout Period|Protocol Violation|0|||
145439080|NCT02185534|524465959|FG002|First Washout Period|Protocol Violation|0|||
145439081|NCT02185534|524465960|FG003|First Washout Period|Protocol Violation|0|||
145439082|NCT02185534|524465961|FG004|First Washout Period|Protocol Violation|0|||
145439083|NCT02185534|524465962|FG005|First Washout Period|Protocol Violation|1|||
145439084|NCT00600067|524465977|FG000|Overall Study|Adverse Event|0|||
145439085|NCT00600067|524465978|FG001|Overall Study|Adverse Event|1|||
145439086|NCT00600067|524465977|FG000|Overall Study|Lost to Follow-up|2|||
145439087|NCT00600067|524465978|FG001|Overall Study|Lost to Follow-up|3|||
145439088|NCT00600067|524465977|FG000|Overall Study|protocol non-compliance|0|||
145439089|NCT00600067|524465978|FG001|Overall Study|protocol non-compliance|3|||
145439090|NCT00600067|524465977|FG000|Overall Study|Lack of Efficacy|1|||
145439091|NCT00600067|524465978|FG001|Overall Study|Lack of Efficacy|0|||
145439092|NCT01220401|524465987|FG000|Overall Study|Withdrawal by Subject|2|||
145439093|NCT01220401|524465987|FG000|Overall Study|Protocol Violation|1|||
145439094|NCT04179305|524465991|FG000|Overall Study|Death|1|||
145439095|NCT04179305|524465992|FG001|Overall Study|Death|1|||
145439096|NCT04179305|524465993|FG002|Overall Study|Death|0|||
145439097|NCT04179305|524465994|FG003|Overall Study|Death|0|||
145439098|NCT04179305|524465991|FG000|Overall Study|Lost to Follow-up|1|||
145439099|NCT04179305|524465992|FG001|Overall Study|Lost to Follow-up|1|||
145439100|NCT04179305|524465993|FG002|Overall Study|Lost to Follow-up|0|||
145439101|NCT04179305|524465994|FG003|Overall Study|Lost to Follow-up|0|||
145439102|NCT04179305|524465991|FG000|Overall Study|Withdrawal by Subject|0|||
145439103|NCT04179305|524465992|FG001|Overall Study|Withdrawal by Subject|1|||
145439104|NCT04179305|524465993|FG002|Overall Study|Withdrawal by Subject|0|||
145439105|NCT04179305|524465994|FG003|Overall Study|Withdrawal by Subject|0|||
145439106|NCT04179305|524465991|FG000|Overall Study|Did not have scan|1|||
145439107|NCT04179305|524465992|FG001|Overall Study|Did not have scan|0|||
145439108|NCT04179305|524465993|FG002|Overall Study|Did not have scan|0|||
145439109|NCT04179305|524465994|FG003|Overall Study|Did not have scan|0|||
145439110|NCT04179305|524465991|FG000|Overall Study|In hospice care|3|||
145439111|NCT04179305|524465992|FG001|Overall Study|In hospice care|0|||
145439112|NCT04179305|524465993|FG002|Overall Study|In hospice care|0|||
145439113|NCT04179305|524465994|FG003|Overall Study|In hospice care|0|||
145439114|NCT03192137|524465997|FG000|Overall Study|Adverse Event|10|||
145439115|NCT03192137|524465998|FG001|Overall Study|Adverse Event|11|||
145439116|NCT03192137|524465997|FG000|Overall Study|Physician Decision|1|||
145439117|NCT03192137|524465998|FG001|Overall Study|Physician Decision|0|||
145439118|NCT03192137|524465997|FG000|Overall Study|Lack of Efficacy|20|||
145439119|NCT03192137|524465998|FG001|Overall Study|Lack of Efficacy|37|||
145439120|NCT03192137|524465997|FG000|Overall Study|Withdrawal by Subject|3|||
145439121|NCT03192137|524465998|FG001|Overall Study|Withdrawal by Subject|3|||
145584259|NCT03855189|524991980|FG002|Overall Study|Adverse Event|4|||
145584260|NCT03855189|524991978|FG000|Overall Study|Treatment Failure|1|||
145584261|NCT03855189|524991979|FG001|Overall Study|Treatment Failure|1|||
145584262|NCT03855189|524991980|FG002|Overall Study|Treatment Failure|2|||
145584263|NCT03855189|524991978|FG000|Overall Study|Noncompliance with Protocol|0|||
145439122|NCT03192137|524465997|FG000|Overall Study|Protocol Violation|4|||
145439123|NCT03192137|524465998|FG001|Overall Study|Protocol Violation|3|||
145439124|NCT03192137|524465997|FG000|Overall Study|Surgery Cancelled|4|||
145439125|NCT03192137|524465998|FG001|Overall Study|Surgery Cancelled|1|||
145439126|NCT03192137|524465997|FG000|Overall Study|Other - Various Administrative Reasons|8|||
145439127|NCT03192137|524465998|FG001|Overall Study|Other - Various Administrative Reasons|3|||
145439128|NCT02737501|524466001|FG000|Randomized Phase|Died|41|||
145439129|NCT02737501|524466002|FG001|Randomized Phase|Died|29|||
145439130|NCT02737501|524466003|FG002|Randomized Phase|Died|0|||
145439131|NCT02737501|524466001|FG000|Randomized Phase|Withdrawal by Subject|16|||
145439132|NCT02737501|524466002|FG001|Randomized Phase|Withdrawal by Subject|6|||
145439133|NCT02737501|524466003|FG002|Randomized Phase|Withdrawal by Subject|0|||
145439134|NCT02737501|524466001|FG000|Randomized Phase|Lost to Follow-up|0|||
145439135|NCT02737501|524466002|FG001|Randomized Phase|Lost to Follow-up|1|||
145584264|NCT03855189|524991979|FG001|Overall Study|Noncompliance with Protocol|1|||
145584265|NCT03855189|524991980|FG002|Overall Study|Noncompliance with Protocol|0|||
145439136|NCT02737501|524466003|FG002|Randomized Phase|Lost to Follow-up|0|||
145439137|NCT02737501|524466001|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
145584266|NCT03855189|524991978|FG000|Overall Study|Did Not Return|4|||
145584267|NCT03855189|524991979|FG001|Overall Study|Did Not Return|3|||
145584268|NCT03855189|524991980|FG002|Overall Study|Did Not Return|0|||
145584269|NCT00586105|524991981|FG000|Overall Study|Adverse Event|4|||
145584270|NCT00586105|524991981|FG000|Overall Study|Death|2|||
145584271|NCT00586105|524991981|FG000|Overall Study|Protocol Violation|1|||
145584272|NCT00586105|524991981|FG000|Overall Study|Withdrawal by Subject|3|||
145584273|NCT00586105|524991981|FG000|Overall Study|Disease progression|19|||
145584274|NCT00586105|524991981|FG000|Overall Study|Switched to commercial drug|9|||
145584275|NCT00586105|524991981|FG000|Overall Study|Reason not reported|1|||
145584276|NCT03238001|524991984|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
145584277|NCT03238001|524991984|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
145584278|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
145584279|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
145584280|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
145584281|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
145584282|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
145584283|NCT03238001|524991984|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
145584284|NCT03791398|524991988|FG000|Overall Study|Progression of Disease Under Study|2|||
145584285|NCT03791398|524991989|FG001|Overall Study|Progression of Disease Under Study|0|||
145584286|NCT03791398|524991990|FG002|Overall Study|Progression of Disease Under Study|0|||
145584287|NCT02207829|524991993|FG000|Overall Study|Adverse Event|10|||
145584288|NCT02207829|524991994|FG001|Overall Study|Adverse Event|9|||
145584289|NCT02207829|524991993|FG000|Overall Study|Lack of Efficacy|7|||
145584290|NCT02207829|524991994|FG001|Overall Study|Lack of Efficacy|5|||
145584291|NCT02207829|524991993|FG000|Overall Study|Lost to Follow-up|2|||
145584292|NCT02207829|524991994|FG001|Overall Study|Lost to Follow-up|2|||
145584293|NCT02207829|524991993|FG000|Overall Study|Protocol deviation|5|||
145584294|NCT02207829|524991994|FG001|Overall Study|Protocol deviation|4|||
145584295|NCT02207829|524991993|FG000|Overall Study|Withdrew consent|18|||
145584296|NCT02207829|524991994|FG001|Overall Study|Withdrew consent|14|||
145584297|NCT00766376|524991995|FG000|Overall Study|Withdrawal by Subject|27|||
145584298|NCT00101101|524991996|FG000|Overall Study|never received vaccine|20|||
145584299|NCT01418209|524991997|FG000|Overall Study|Withdrawal by Subject|1|||
145584300|NCT01418209|524991998|FG001|Overall Study|Withdrawal by Subject|0|||
145584301|NCT01418209|524991999|FG002|Overall Study|Withdrawal by Subject|1|||
145584302|NCT01418209|524991997|FG000|Overall Study|Did not provide hot flash diary data|1|||
145584303|NCT01418209|524991998|FG001|Overall Study|Did not provide hot flash diary data|3|||
145584304|NCT01418209|524991999|FG002|Overall Study|Did not provide hot flash diary data|3|||
145584305|NCT01800903|524992000|FG000|Second Test Period|unable to catheterise|1|||
145584306|NCT01800903|524992001|FG001|Second Test Period|unable to catheterise|0|||
145584307|NCT01800903|524992002|FG002|Second Test Period|unable to catheterise|0|||
145584308|NCT01800903|524992003|FG003|Second Test Period|unable to catheterise|0|||
145584309|NCT01800903|524992004|FG004|Second Test Period|unable to catheterise|0|||
145584310|NCT01800903|524992005|FG005|Second Test Period|unable to catheterise|0|||
145584311|NCT00080223|524992008|FG000|Overall Study|Adverse Event|23|||
145584312|NCT00080223|524992008|FG000|Overall Study|Death|21|||
145584313|NCT00080223|524992008|FG000|Overall Study|Withdrawal by Subject|13|||
145584314|NCT00080223|524992008|FG000|Overall Study|Lung Transplantation|9|||
145584315|NCT00080223|524992008|FG000|Overall Study|Non-compliance With Study Treatment|7|||
145584316|NCT00080223|524992008|FG000|Overall Study|Participant unwilling to continue|2|||
145584317|NCT00080223|524992008|FG000|Overall Study|Physician Decision|1|||
145584318|NCT03099382|524992015|FG000|Overall Study|Protocol Violation|2|||
145584319|NCT03099382|524992016|FG001|Overall Study|Protocol Violation|3|||
145584320|NCT01802411|524992017|FG000|Overall Study|Death|2|||
145584321|NCT01802411|524992018|FG001|Overall Study|Death|1|||
145584322|NCT01802411|524992017|FG000|Overall Study|Adverse Event|2|||
145584323|NCT01802411|524992018|FG001|Overall Study|Adverse Event|7|||
145584324|NCT01802411|524992017|FG000|Overall Study|Lack of Efficacy|8|||
145584325|NCT01802411|524992018|FG001|Overall Study|Lack of Efficacy|10|||
145584326|NCT01802411|524992017|FG000|Overall Study|Withdrawal by Subject|0|||
145584327|NCT01802411|524992018|FG001|Overall Study|Withdrawal by Subject|2|||
145584328|NCT01802411|524992017|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
145439138|NCT02737501|524466002|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
145584329|NCT01802411|524992018|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
145439139|NCT02737501|524466003|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
145439140|NCT02737501|524466001|FG000|Randomized Phase|Reason not Specified|1|||
145584330|NCT01802411|524992017|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
145584331|NCT01802411|524992018|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
145584332|NCT01802411|524992017|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
145584333|NCT01802411|524992018|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
145584334|NCT00560833|524992031|FG000|Overall Study|Adverse Event|16|||
145584335|NCT00560833|524992032|FG001|Overall Study|Adverse Event|10|||
145584336|NCT00560833|524992033|FG002|Overall Study|Adverse Event|25|||
145584337|NCT00560833|524992034|FG003|Overall Study|Adverse Event|23|||
145439141|NCT02737501|524466002|FG001|Randomized Phase|Reason not Specified|1|||
145584338|NCT00560833|524992035|FG004|Overall Study|Adverse Event|35|||
145584339|NCT00560833|524992031|FG000|Overall Study|Lost to Follow-up|0|||
145584340|NCT00560833|524992032|FG001|Overall Study|Lost to Follow-up|0|||
145584341|NCT00560833|524992033|FG002|Overall Study|Lost to Follow-up|1|||
145584342|NCT00560833|524992034|FG003|Overall Study|Lost to Follow-up|0|||
145584343|NCT00560833|524992035|FG004|Overall Study|Lost to Follow-up|0|||
145584344|NCT00560833|524992031|FG000|Overall Study|Lack of Efficacy|22|||
145584345|NCT00560833|524992032|FG001|Overall Study|Lack of Efficacy|9|||
145584346|NCT00560833|524992033|FG002|Overall Study|Lack of Efficacy|6|||
145584347|NCT00560833|524992034|FG003|Overall Study|Lack of Efficacy|4|||
145584348|NCT00560833|524992035|FG004|Overall Study|Lack of Efficacy|4|||
145584349|NCT00560833|524992031|FG000|Overall Study|Participant uncooperative|5|||
145584350|NCT00560833|524992032|FG001|Overall Study|Participant uncooperative|5|||
145584351|NCT00560833|524992033|FG002|Overall Study|Participant uncooperative|4|||
145584352|NCT00560833|524992034|FG003|Overall Study|Participant uncooperative|4|||
145584353|NCT00560833|524992035|FG004|Overall Study|Participant uncooperative|2|||
145584354|NCT00560833|524992031|FG000|Overall Study|Other|1|||
145584355|NCT00560833|524992032|FG001|Overall Study|Other|1|||
145584356|NCT00560833|524992033|FG002|Overall Study|Other|3|||
145584357|NCT00560833|524992034|FG003|Overall Study|Other|0|||
145584358|NCT00560833|524992035|FG004|Overall Study|Other|0|||
145584359|NCT00560833|524992031|FG000|Overall Study|Never received drug|0|||
145584360|NCT00560833|524992032|FG001|Overall Study|Never received drug|1|||
145584361|NCT00560833|524992033|FG002|Overall Study|Never received drug|0|||
145584362|NCT00560833|524992034|FG003|Overall Study|Never received drug|0|||
145584363|NCT00560833|524992035|FG004|Overall Study|Never received drug|1|||
145584364|NCT01059617|524992036|FG000|Overall Study|Other|7|||
145584365|NCT01059617|524992037|FG001|Overall Study|Other|1|||
145584366|NCT01059617|524992038|FG002|Overall Study|Other|8|||
145584367|NCT01059617|524992039|FG003|Overall Study|Other|6|||
145584368|NCT03864614|524992043|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
145584369|NCT03864614|524992044|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
145584370|NCT03864614|524992045|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
145584371|NCT03864614|524992046|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
145584372|NCT03864614|524992043|FG000|Overall Study|Withdrawal by Subject|72|||
145584373|NCT03864614|524992044|FG001|Overall Study|Withdrawal by Subject|100|||
145584374|NCT03864614|524992045|FG002|Overall Study|Withdrawal by Subject|1|||
145584375|NCT03864614|524992046|FG003|Overall Study|Withdrawal by Subject|21|||
145584376|NCT03864614|524992043|FG000|Overall Study|Lost to Follow-up|45|||
145584377|NCT03864614|524992044|FG001|Overall Study|Lost to Follow-up|54|||
145584378|NCT03864614|524992045|FG002|Overall Study|Lost to Follow-up|0|||
145584379|NCT03864614|524992046|FG003|Overall Study|Lost to Follow-up|9|||
145584380|NCT03864614|524992043|FG000|Overall Study|Adverse Event|42|||
145584381|NCT03864614|524992044|FG001|Overall Study|Adverse Event|30|||
145584382|NCT03864614|524992045|FG002|Overall Study|Adverse Event|1|||
145584383|NCT03864614|524992046|FG003|Overall Study|Adverse Event|9|||
145584384|NCT03864614|524992043|FG000|Overall Study|Protocol Deviation|6|||
145584385|NCT03864614|524992044|FG001|Overall Study|Protocol Deviation|26|||
145584386|NCT03864614|524992045|FG002|Overall Study|Protocol Deviation|0|||
145584387|NCT03864614|524992046|FG003|Overall Study|Protocol Deviation|1|||
145584388|NCT03864614|524992043|FG000|Overall Study|Physician Decision|7|||
145584389|NCT03864614|524992044|FG001|Overall Study|Physician Decision|10|||
145584390|NCT03864614|524992045|FG002|Overall Study|Physician Decision|1|||
145584391|NCT03864614|524992046|FG003|Overall Study|Physician Decision|5|||
145584392|NCT03864614|524992043|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
145584393|NCT03864614|524992044|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
145584394|NCT03864614|524992045|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
145584395|NCT03864614|524992046|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
145584396|NCT03864614|524992043|FG000|Overall Study|Sponsor Decision|1|||
145584397|NCT03864614|524992044|FG001|Overall Study|Sponsor Decision|2|||
145584398|NCT03864614|524992045|FG002|Overall Study|Sponsor Decision|0|||
145584399|NCT03864614|524992046|FG003|Overall Study|Sponsor Decision|0|||
145584400|NCT03864614|524992043|FG000|Overall Study|Pregnancy|0|||
145584401|NCT03864614|524992044|FG001|Overall Study|Pregnancy|1|||
145584402|NCT03864614|524992045|FG002|Overall Study|Pregnancy|0|||
145584403|NCT03864614|524992046|FG003|Overall Study|Pregnancy|0|||
145584404|NCT03864614|524992043|FG000|Overall Study|Other|7|||
145584405|NCT03864614|524992044|FG001|Overall Study|Other|9|||
145584406|NCT03864614|524992045|FG002|Overall Study|Other|1|||
145584407|NCT03864614|524992046|FG003|Overall Study|Other|4|||
145584408|NCT03864614|524992043|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
145584409|NCT03864614|524992044|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
145584410|NCT03864614|524992045|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
145584411|NCT03864614|524992046|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
145584412|NCT04837482|524993528|FG000|Period 2|Withdrawal by Subject|0|||
145584413|NCT04837482|524993529|FG001|Period 2|Withdrawal by Subject|1|||
145584414|NCT00086346|524993533|FG000|Randomization|Did not receive test article|4|||
145584415|NCT00086346|524993534|FG001|Randomization|Did not receive test article|4|||
145625299|NCT00372060|525142039|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
145625300|NCT00372060|525142038|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
145625301|NCT00372060|525142039|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
145625302|NCT00372060|525142038|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
145625303|NCT00372060|525142039|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
145439142|NCT02737501|524466003|FG002|Randomized Phase|Reason not Specified|0|||
145439143|NCT02737501|524466001|FG000|Randomized Phase|Never Treated|1|||
145439144|NCT02737501|524466002|FG001|Randomized Phase|Never Treated|1|||
145439145|NCT02737501|524466003|FG002|Randomized Phase|Never Treated|0|||
145439146|NCT02737501|524466001|FG000|Crossover Phase|Died|0|||
145439147|NCT02737501|524466002|FG001|Crossover Phase|Died|0|||
145439148|NCT02737501|524466003|FG002|Crossover Phase|Died|22|||
145439149|NCT02737501|524466001|FG000|Crossover Phase|Withdrew Consent|0|||
145439150|NCT02737501|524466002|FG001|Crossover Phase|Withdrew Consent|0|||
145439151|NCT02737501|524466003|FG002|Crossover Phase|Withdrew Consent|9|||
145439152|NCT02737501|524466001|FG000|Crossover Phase|Physician Decision|0|||
145439153|NCT02737501|524466002|FG001|Crossover Phase|Physician Decision|0|||
145439154|NCT02737501|524466003|FG002|Crossover Phase|Physician Decision|1|||
145439155|NCT02737501|524466001|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
145439156|NCT02737501|524466002|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
145439157|NCT02737501|524466003|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
145439158|NCT01261975|524466004|FG000|Overall Study|Surgical complication|1|||
145439159|NCT01070979|524466007|FG000|Overall Study|Adverse Event|2|||
145439160|NCT01070979|524466008|FG001|Overall Study|Adverse Event|3|||
145439161|NCT01070979|524466009|FG002|Overall Study|Adverse Event|3|||
145439162|NCT01070979|524466007|FG000|Overall Study|Lost to Follow-up|2|||
145439163|NCT01070979|524466008|FG001|Overall Study|Lost to Follow-up|1|||
145439164|NCT01070979|524466009|FG002|Overall Study|Lost to Follow-up|1|||
145439165|NCT01070979|524466007|FG000|Overall Study|Protocol Violation|0|||
145439166|NCT01070979|524466008|FG001|Overall Study|Protocol Violation|2|||
145439167|NCT01070979|524466009|FG002|Overall Study|Protocol Violation|6|||
145439168|NCT01070979|524466007|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
145439169|NCT01070979|524466008|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
145439170|NCT01070979|524466009|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
145439171|NCT01070979|524466007|FG000|Overall Study|Withdrawal by Subject|3|||
145439172|NCT01070979|524466008|FG001|Overall Study|Withdrawal by Subject|1|||
145439173|NCT01070979|524466009|FG002|Overall Study|Withdrawal by Subject|1|||
145439174|NCT01070979|524466007|FG000|Overall Study|No study drug taken|0|||
145439175|NCT01070979|524466008|FG001|Overall Study|No study drug taken|1|||
145439176|NCT01070979|524466009|FG002|Overall Study|No study drug taken|0|||
145439177|NCT00142792|524466010|FG000|Overall Study|Death|0|||
145439178|NCT00142792|524466011|FG001|Overall Study|Death|0|||
145439179|NCT00142792|524466012|FG002|Overall Study|Death|1|||
145439180|NCT00142792|524466010|FG000|Overall Study|Withdrawal by Subject|3|||
145439181|NCT00142792|524466011|FG001|Overall Study|Withdrawal by Subject|2|||
145439182|NCT00142792|524466012|FG002|Overall Study|Withdrawal by Subject|3|||
145439183|NCT00142792|524466010|FG000|Overall Study|Lost to Follow-up|8|||
145439184|NCT00142792|524466011|FG001|Overall Study|Lost to Follow-up|11|||
145439185|NCT00142792|524466012|FG002|Overall Study|Lost to Follow-up|7|||
145439186|NCT00142792|524466010|FG000|Overall Study|No category|1|||
145439187|NCT00142792|524466011|FG001|Overall Study|No category|2|||
145625304|NCT01579578|525142051|FG000|Overall Study|Death|4|||
145625305|NCT01579578|525142052|FG001|Overall Study|Death|1|||
145625306|NCT01579578|525142051|FG000|Overall Study|Lost to Follow-up|1|||
145625307|NCT01579578|525142052|FG001|Overall Study|Lost to Follow-up|1|||
145625308|NCT01579578|525142051|FG000|Overall Study|Withdrawal by Subject|2|||
145439188|NCT00142792|524466012|FG002|Overall Study|No category|1|||
145439189|NCT00437268|524466013|FG000|Overall Study|Adverse Event|1|||
145439190|NCT00437268|524466014|FG001|Overall Study|Adverse Event|1|||
145439191|NCT00437268|524466013|FG000|Overall Study|Withdrawal by Subject|2|||
145439192|NCT00437268|524466014|FG001|Overall Study|Withdrawal by Subject|2|||
145439193|NCT00437268|524466013|FG000|Overall Study|Progressive disease|9|||
145439194|NCT00437268|524466014|FG001|Overall Study|Progressive disease|9|||
145625309|NCT01579578|525142052|FG001|Overall Study|Withdrawal by Subject|1|||
145625310|NCT01579578|525142051|FG000|Overall Study|Eligibility criteria|3|||
145625311|NCT01579578|525142052|FG001|Overall Study|Eligibility criteria|9|||
145625312|NCT01579578|525142051|FG000|Overall Study|Ongoing|3|||
145625313|NCT01579578|525142052|FG001|Overall Study|Ongoing|0|||
145625314|NCT01770860|525142053|FG000|Overall Study|Withdrawal by Subject|4|||
145439195|NCT00437268|524466013|FG000|Overall Study|Physician Decision|1|||
145439196|NCT00437268|524466014|FG001|Overall Study|Physician Decision|0|||
145625315|NCT01770860|525142053|FG000|Overall Study|Lost to Follow-up|1|||
145439197|NCT00437268|524466013|FG000|Overall Study|Death|0|||
145439198|NCT00437268|524466014|FG001|Overall Study|Death|1|||
145439199|NCT00444925|524466019|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
145439200|NCT00444925|524466020|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
145439201|NCT00444925|524466021|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
145439202|NCT00444925|524466019|FG000|Double-blind Treatment Period|Death|2|||
145439203|NCT00444925|524466020|FG001|Double-blind Treatment Period|Death|0|||
145439204|NCT00444925|524466021|FG002|Double-blind Treatment Period|Death|0|||
145439205|NCT00444925|524466019|FG000|Double-blind Treatment Period|Adverse Event|6|||
145439206|NCT00444925|524466020|FG001|Double-blind Treatment Period|Adverse Event|28|||
145439207|NCT00444925|524466021|FG002|Double-blind Treatment Period|Adverse Event|44|||
145439208|NCT00444925|524466019|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
145439209|NCT00444925|524466020|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
145439210|NCT00444925|524466021|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
145439211|NCT00444925|524466019|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
145439212|NCT00444925|524466020|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
145439213|NCT00444925|524466021|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
145439214|NCT00444925|524466019|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
145439215|NCT00444925|524466020|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
145439216|NCT00444925|524466021|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
145439217|NCT00444925|524466019|FG000|Double-blind Treatment Period|Other|7|||
145439218|NCT00444925|524466020|FG001|Double-blind Treatment Period|Other|7|||
145439219|NCT00444925|524466021|FG002|Double-blind Treatment Period|Other|12|||
145439220|NCT00810277|524468343|FG000|Overall Study|Adverse Event|1|||
145439221|NCT00532129|524468344|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
145439222|NCT00532129|524468344|FG000|Treatment Period|Physician Decision|15|||
145439223|NCT00532129|524468344|FG000|Treatment Period|Disease progression|3|||
145439224|NCT00532129|524468344|FG000|Treatment Period|Protocol Violation|1|||
145439225|NCT00532129|524468344|FG000|Treatment Period|Other|5|||
145439226|NCT00532129|524468344|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
145439227|NCT00532129|524468344|FG000|Follow-up Period|Disease progression|57|||
145439228|NCT00532129|524468344|FG000|Follow-up Period|Lost to Follow-up|1|||
145439229|NCT00532129|524468344|FG000|Follow-up Period|Other|6|||
145439230|NCT04551898|524468345|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
145439231|NCT04551898|524468346|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
145439232|NCT04551898|524468347|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
145439233|NCT04551898|524468348|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
145439234|NCT04551898|524468345|FG000|Overall Study|Withdrawal by Subject|5|||
145439235|NCT04551898|524468346|FG001|Overall Study|Withdrawal by Subject|1|||
145439236|NCT04551898|524468347|FG002|Overall Study|Withdrawal by Subject|2|||
145439237|NCT04551898|524468348|FG003|Overall Study|Withdrawal by Subject|2|||
145439238|NCT04551898|524468345|FG000|Overall Study|Lost to Follow-up|2|||
145439239|NCT04551898|524468346|FG001|Overall Study|Lost to Follow-up|1|||
145439240|NCT04551898|524468347|FG002|Overall Study|Lost to Follow-up|2|||
145439241|NCT04551898|524468348|FG003|Overall Study|Lost to Follow-up|2|||
145439242|NCT04551898|524468345|FG000|Overall Study|Death|1|||
145439243|NCT04551898|524468346|FG001|Overall Study|Death|0|||
145439244|NCT04551898|524468347|FG002|Overall Study|Death|0|||
145439245|NCT04551898|524468348|FG003|Overall Study|Death|0|||
145439246|NCT04551898|524468345|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
145439247|NCT04551898|524468346|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
145439248|NCT04551898|524468347|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
145439249|NCT04551898|524468348|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
145439250|NCT01336712|524468351|FG000|Overall Study|Death|2|||
145439251|NCT01336712|524468351|FG000|Overall Study|Lack of Efficacy|1|||
145439252|NCT04263766|524468358|FG000|Overall Study|Withdrawal by Subject|6|||
145439253|NCT04263766|524468359|FG001|Overall Study|Withdrawal by Subject|4|||
145439254|NCT04263766|524468358|FG000|Overall Study|Lack of Efficacy|1|||
145439255|NCT04263766|524468359|FG001|Overall Study|Lack of Efficacy|3|||
145439256|NCT01891396|524468361|FG000|Overall Study|Withdrawal by Subject|4|||
145439257|NCT01891396|524468362|FG001|Overall Study|Withdrawal by Subject|4|||
145439258|NCT01891396|524468363|FG002|Overall Study|Withdrawal by Subject|3|||
145439259|NCT01891396|524468361|FG000|Overall Study|Lost to Follow-up|0|||
145439260|NCT01891396|524468362|FG001|Overall Study|Lost to Follow-up|1|||
145439261|NCT01891396|524468363|FG002|Overall Study|Lost to Follow-up|0|||
145439262|NCT03462758|524468364|FG000|Overall Study|Chose no or other method of contraception|20|||
145439263|NCT03462758|524468365|FG001|Overall Study|Chose no or other method of contraception|23|||
145439264|NCT03462758|524468364|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
145439265|NCT03462758|524468365|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
145439266|NCT03462758|524468364|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
145439267|NCT03462758|524468365|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
145439268|NCT03462758|524468364|FG000|Overall Study|Medical contraindication|2|||
145439269|NCT03462758|524468365|FG001|Overall Study|Medical contraindication|2|||
145439270|NCT03462758|524468364|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
145439271|NCT03462758|524468365|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
145439272|NCT02820844|524468366|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
145439273|NCT02820844|524468367|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
145439274|NCT02820844|524468368|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
145439275|NCT02820844|524468369|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
145439276|NCT02820844|524468370|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
145439277|NCT02820844|524468371|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
145439278|NCT02820844|524468366|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
145439279|NCT02820844|524468367|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
145439280|NCT02820844|524468368|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
145439281|NCT02820844|524468369|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
145439282|NCT02820844|524468370|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
145439283|NCT02820844|524468371|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
145439284|NCT02820844|524468366|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
145439285|NCT02820844|524468367|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
145439286|NCT02820844|524468368|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
145439287|NCT02820844|524468369|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
145439288|NCT02820844|524468370|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
145439289|NCT02820844|524468371|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
145439290|NCT02820844|524468366|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
145439291|NCT02820844|524468367|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
145439292|NCT02820844|524468368|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
145439293|NCT02820844|524468369|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
145439294|NCT02820844|524468370|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
145439295|NCT02820844|524468371|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
145439296|NCT02820844|524468366|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
145439297|NCT02820844|524468367|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
145439298|NCT02820844|524468368|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
145439299|NCT02820844|524468369|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
145439300|NCT02820844|524468370|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
145439301|NCT02820844|524468371|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
145439302|NCT02820844|524468366|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
145439303|NCT02820844|524468367|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
145439304|NCT02820844|524468368|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
145439305|NCT02820844|524468369|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
145439306|NCT02820844|524468370|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
145439307|NCT02820844|524468371|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
145439308|NCT02820844|524468366|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
145439309|NCT02820844|524468367|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
145439310|NCT02820844|524468368|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
145439311|NCT02820844|524468369|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
145439312|NCT02820844|524468370|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
145439313|NCT02820844|524468371|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
145439314|NCT02820844|524468366|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439315|NCT02820844|524468367|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439316|NCT02820844|524468368|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
145439317|NCT02820844|524468369|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
145439318|NCT02820844|524468370|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439319|NCT02820844|524468371|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439320|NCT02820844|524468366|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
145439321|NCT02820844|524468367|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
145439322|NCT02820844|524468368|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
145439323|NCT02820844|524468369|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
145439324|NCT02820844|524468370|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
145439325|NCT02820844|524468371|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
145439326|NCT02820844|524468366|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439327|NCT02820844|524468367|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439328|NCT02820844|524468368|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439329|NCT02820844|524468369|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439330|NCT02820844|524468370|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
145439331|NCT02820844|524468371|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
145439332|NCT02266147|524468373|FG000|PART 1: Dose Escalation|Physician Decision|0|||
145439333|NCT02266147|524468374|FG001|PART 1: Dose Escalation|Physician Decision|0|||
145439334|NCT02266147|524468375|FG002|PART 1: Dose Escalation|Physician Decision|1|||
145439335|NCT02266147|524468376|FG003|PART 1: Dose Escalation|Physician Decision|0|||
145584416|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Adverse Event|94|||
145439336|NCT02266147|524468373|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
145439337|NCT02266147|524468374|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
145439338|NCT02266147|524468375|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
145439339|NCT02266147|524468376|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
145439340|NCT02266147|524468373|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
145439341|NCT02266147|524468374|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
145439342|NCT02266147|524468375|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
145439343|NCT02266147|524468376|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
145439344|NCT02266147|524468373|FG000|PART 1: Dose Escalation|Other|1|||
145439345|NCT02266147|524468374|FG001|PART 1: Dose Escalation|Other|1|||
145439346|NCT02266147|524468375|FG002|PART 1: Dose Escalation|Other|0|||
145439347|NCT02266147|524468376|FG003|PART 1: Dose Escalation|Other|0|||
145439348|NCT02266147|524468373|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
145439349|NCT02266147|524468374|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
145439350|NCT02266147|524468375|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
145439351|NCT02266147|524468376|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
145439352|NCT02266147|524468373|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
145439353|NCT02266147|524468374|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
145439354|NCT02266147|524468375|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
145439355|NCT02266147|524468376|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
145439356|NCT00573391|524468377|FG000|Overall Study|study stopped|2|||
145439357|NCT00573391|524468378|FG001|Overall Study|study stopped|2|||
145439358|NCT00573391|524468377|FG000|Overall Study|Death|1|||
145439359|NCT00573391|524468378|FG001|Overall Study|Death|0|||
145439360|NCT00413660|524468381|FG000|Up To Week 12|Adverse Event|1|||
145439361|NCT00413660|524468382|FG001|Up To Week 12|Adverse Event|3|||
145439362|NCT00413660|524468383|FG002|Up To Week 12|Adverse Event|1|||
145439363|NCT00413660|524468384|FG003|Up To Week 12|Adverse Event|4|||
145439364|NCT00413660|524468385|FG004|Up To Week 12|Adverse Event|6|||
145439365|NCT00413660|524468386|FG005|Up To Week 12|Adverse Event|4|||
145439366|NCT00413660|524468387|FG006|Up To Week 12|Adverse Event|1|||
145439367|NCT00413660|524468388|FG007|Up To Week 12|Adverse Event|0|||
145439368|NCT00413660|524468389|FG008|Up To Week 12|Adverse Event|0|||
145439369|NCT00413660|524468390|FG009|Up To Week 12|Adverse Event|0|||
145439370|NCT00413660|524468391|FG010|Up To Week 12|Adverse Event|0|||
145439371|NCT00413660|524468381|FG000|Up To Week 12|Lack of Efficacy|2|||
145439372|NCT00413660|524468382|FG001|Up To Week 12|Lack of Efficacy|0|||
145439373|NCT00413660|524468383|FG002|Up To Week 12|Lack of Efficacy|0|||
145439374|NCT00413660|524468384|FG003|Up To Week 12|Lack of Efficacy|0|||
145439375|NCT00413660|524468385|FG004|Up To Week 12|Lack of Efficacy|0|||
145439376|NCT00413660|524468386|FG005|Up To Week 12|Lack of Efficacy|0|||
145439377|NCT00413660|524468387|FG006|Up To Week 12|Lack of Efficacy|5|||
145439378|NCT00413660|524468388|FG007|Up To Week 12|Lack of Efficacy|0|||
145439379|NCT00413660|524468389|FG008|Up To Week 12|Lack of Efficacy|0|||
145439380|NCT00413660|524468390|FG009|Up To Week 12|Lack of Efficacy|0|||
145439381|NCT00413660|524468391|FG010|Up To Week 12|Lack of Efficacy|0|||
145439382|NCT00413660|524468381|FG000|Up To Week 12|Lost to Follow-up|0|||
145439383|NCT00413660|524468382|FG001|Up To Week 12|Lost to Follow-up|1|||
145439384|NCT00413660|524468383|FG002|Up To Week 12|Lost to Follow-up|0|||
145439385|NCT00413660|524468384|FG003|Up To Week 12|Lost to Follow-up|0|||
145439386|NCT00413660|524468385|FG004|Up To Week 12|Lost to Follow-up|1|||
145439387|NCT00413660|524468386|FG005|Up To Week 12|Lost to Follow-up|0|||
145439388|NCT00413660|524468387|FG006|Up To Week 12|Lost to Follow-up|0|||
145439389|NCT00413660|524468388|FG007|Up To Week 12|Lost to Follow-up|0|||
145439390|NCT00413660|524468389|FG008|Up To Week 12|Lost to Follow-up|0|||
145439391|NCT00413660|524468390|FG009|Up To Week 12|Lost to Follow-up|0|||
145439392|NCT00413660|524468391|FG010|Up To Week 12|Lost to Follow-up|0|||
145439393|NCT00413660|524468381|FG000|Up To Week 12|Withdrawal by Subject|0|||
145439394|NCT00413660|524468382|FG001|Up To Week 12|Withdrawal by Subject|2|||
145439395|NCT00413660|524468383|FG002|Up To Week 12|Withdrawal by Subject|0|||
145439396|NCT00413660|524468384|FG003|Up To Week 12|Withdrawal by Subject|2|||
145439397|NCT00413660|524468385|FG004|Up To Week 12|Withdrawal by Subject|0|||
145439398|NCT00413660|524468386|FG005|Up To Week 12|Withdrawal by Subject|2|||
145439399|NCT00413660|524468387|FG006|Up To Week 12|Withdrawal by Subject|2|||
145439400|NCT00413660|524468388|FG007|Up To Week 12|Withdrawal by Subject|0|||
145439401|NCT00413660|524468389|FG008|Up To Week 12|Withdrawal by Subject|0|||
145439402|NCT00413660|524468390|FG009|Up To Week 12|Withdrawal by Subject|0|||
145439403|NCT00413660|524468391|FG010|Up To Week 12|Withdrawal by Subject|0|||
145439404|NCT00413660|524468381|FG000|Up To Week 12|Randomized, Not Treated|1|||
145439405|NCT00413660|524468382|FG001|Up To Week 12|Randomized, Not Treated|0|||
145439406|NCT00413660|524468383|FG002|Up To Week 12|Randomized, Not Treated|0|||
145439407|NCT00413660|524468384|FG003|Up To Week 12|Randomized, Not Treated|1|||
145439408|NCT00413660|524468385|FG004|Up To Week 12|Randomized, Not Treated|0|||
145439409|NCT00413660|524468386|FG005|Up To Week 12|Randomized, Not Treated|0|||
145439410|NCT00413660|524468387|FG006|Up To Week 12|Randomized, Not Treated|0|||
145439411|NCT00413660|524468388|FG007|Up To Week 12|Randomized, Not Treated|0|||
145439412|NCT00413660|524468389|FG008|Up To Week 12|Randomized, Not Treated|0|||
145439413|NCT00413660|524468390|FG009|Up To Week 12|Randomized, Not Treated|0|||
145439414|NCT00413660|524468391|FG010|Up To Week 12|Randomized, Not Treated|0|||
145584417|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Adverse Event|11|||
145584418|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
145584419|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
145584420|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
145584421|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
145584422|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
145584423|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
145584424|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
145584425|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
145584426|NCT00086346|524993533|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
145584427|NCT00086346|524993534|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
145584428|NCT03727750|524993535|FG000|Overall Study|Death|45|||
145584429|NCT03727750|524993535|FG000|Overall Study|Withdrawal by Subject|2|||
145584430|NCT03727750|524993535|FG000|Overall Study|Lost to Follow-up|1|||
145584431|NCT03727750|524993535|FG000|Overall Study|Other|1|||
145584432|NCT01303627|524993536|FG000|Overall Study|the failure while performing URS|0|||
145584433|NCT01303627|524993537|FG001|Overall Study|the failure while performing URS|1|||
145584434|NCT00321919|524993540|FG000|Overall Study|Adverse Event|17|||
145584435|NCT00321919|524993541|FG001|Overall Study|Adverse Event|10|||
145584436|NCT00321919|524993540|FG000|Overall Study|Death|21|||
145584437|NCT00321919|524993541|FG001|Overall Study|Death|17|||
145584438|NCT00321919|524993540|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145584439|NCT00321919|524993541|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145584440|NCT00321919|524993540|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
145584441|NCT00321919|524993541|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145584442|NCT00321919|524993540|FG000|Overall Study|Refused Treatment|23|||
145584443|NCT00321919|524993541|FG001|Overall Study|Refused Treatment|14|||
145584444|NCT00321919|524993540|FG000|Overall Study|Other Protocol Violation|2|||
145584445|NCT00321919|524993541|FG001|Overall Study|Other Protocol Violation|3|||
145584446|NCT00321919|524993540|FG000|Overall Study|Failure to Return|3|||
145584447|NCT00321919|524993541|FG001|Overall Study|Failure to Return|1|||
145584448|NCT00321919|524993540|FG000|Overall Study|Other withdrawal reason|7|||
145584449|NCT00321919|524993541|FG001|Overall Study|Other withdrawal reason|6|||
145584450|NCT01227889|524993542|FG000|Randomized Phase (RP)|Adverse Event|13|||
145584451|NCT01227889|524993543|FG001|Randomized Phase (RP)|Adverse Event|0|||
145584452|NCT01227889|524993542|FG000|Randomized Phase (RP)|Physician Decision|13|||
145584453|NCT01227889|524993543|FG001|Randomized Phase (RP)|Physician Decision|5|||
145584454|NCT01227889|524993542|FG000|Randomized Phase (RP)|Progressive Disease|135|||
145584455|NCT01227889|524993543|FG001|Randomized Phase (RP)|Progressive Disease|52|||
145584456|NCT01227889|524993542|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
145584457|NCT01227889|524993543|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
145584458|NCT01227889|524993542|FG000|Randomized Phase (RP)|Missing|1|||
145584459|NCT01227889|524993543|FG001|Randomized Phase (RP)|Missing|3|||
145584460|NCT01227889|524993542|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
145584461|NCT01227889|524993543|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
145584462|NCT01227889|524993542|FG000|Crossover Phase|Adverse Event|0|||
145584463|NCT01227889|524993543|FG001|Crossover Phase|Adverse Event|1|||
145584464|NCT01227889|524993542|FG000|Crossover Phase|Physician Decision|0|||
145584465|NCT01227889|524993543|FG001|Crossover Phase|Physician Decision|3|||
145584466|NCT01227889|524993542|FG000|Crossover Phase|Progressive Disease|0|||
145584467|NCT01227889|524993543|FG001|Crossover Phase|Progressive Disease|31|||
145584468|NCT01227889|524993542|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
145584469|NCT01227889|524993543|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
145584470|NCT01227889|524993542|FG000|Crossover Phase|Withdrawal by Subject|0|||
145584471|NCT01227889|524993543|FG001|Crossover Phase|Withdrawal by Subject|1|||
145584472|NCT04121962|524993546|FG000|Overall Study|Lost to Follow-up|42|||
145584473|NCT04121962|524993547|FG001|Overall Study|Lost to Follow-up|39|||
145584474|NCT01175382|524993548|FG000|Overall Study|Lost to Follow-up|4|||
145584475|NCT01175382|524993549|FG001|Overall Study|Lost to Follow-up|3|||
145439415|NCT00413660|524468381|FG000|Up To Week 12|Other|3|||
145439416|NCT00413660|524468382|FG001|Up To Week 12|Other|1|||
145584476|NCT01175382|524993550|FG002|Overall Study|Lost to Follow-up|1|||
145584477|NCT01175382|524993548|FG000|Overall Study|Physician Decision|0|||
145584478|NCT01175382|524993549|FG001|Overall Study|Physician Decision|1|||
145584479|NCT01175382|524993550|FG002|Overall Study|Physician Decision|0|||
145584480|NCT01175382|524993548|FG000|Overall Study|Withdrawal by Subject|0|||
145584481|NCT01175382|524993549|FG001|Overall Study|Withdrawal by Subject|0|||
145584482|NCT01175382|524993550|FG002|Overall Study|Withdrawal by Subject|1|||
145584483|NCT01175382|524993548|FG000|Overall Study|No longer having problem|1|||
145584484|NCT01175382|524993549|FG001|Overall Study|No longer having problem|0|||
145584485|NCT01175382|524993550|FG002|Overall Study|No longer having problem|1|||
145584486|NCT01175382|524993548|FG000|Overall Study|Unable/unwilling to attend visits|3|||
145584487|NCT01175382|524993549|FG001|Overall Study|Unable/unwilling to attend visits|1|||
145439417|NCT00413660|524468383|FG002|Up To Week 12|Other|6|||
145439418|NCT00413660|524468384|FG003|Up To Week 12|Other|1|||
145439419|NCT00413660|524468385|FG004|Up To Week 12|Other|2|||
145439420|NCT00413660|524468386|FG005|Up To Week 12|Other|4|||
145439421|NCT00413660|524468387|FG006|Up To Week 12|Other|3|||
145439422|NCT00413660|524468388|FG007|Up To Week 12|Other|0|||
145584488|NCT01175382|524993550|FG002|Overall Study|Unable/unwilling to attend visits|2|||
145439423|NCT00413660|524468389|FG008|Up To Week 12|Other|0|||
145439424|NCT00413660|524468390|FG009|Up To Week 12|Other|0|||
145439425|NCT00413660|524468391|FG010|Up To Week 12|Other|0|||
145439426|NCT00413660|524468381|FG000|Post Week 12|Adverse Event|2|||
145439427|NCT00413660|524468382|FG001|Post Week 12|Adverse Event|0|||
145439428|NCT00413660|524468383|FG002|Post Week 12|Adverse Event|2|||
145439429|NCT00413660|524468384|FG003|Post Week 12|Adverse Event|1|||
145439430|NCT00413660|524468385|FG004|Post Week 12|Adverse Event|4|||
145439431|NCT00413660|524468386|FG005|Post Week 12|Adverse Event|2|||
145439432|NCT00413660|524468387|FG006|Post Week 12|Adverse Event|2|||
145439433|NCT00413660|524468388|FG007|Post Week 12|Adverse Event|0|||
145439434|NCT00413660|524468389|FG008|Post Week 12|Adverse Event|0|||
145439435|NCT00413660|524468390|FG009|Post Week 12|Adverse Event|0|||
145439436|NCT00413660|524468391|FG010|Post Week 12|Adverse Event|0|||
145439437|NCT00413660|524468381|FG000|Post Week 12|Lack of Efficacy|0|||
145439438|NCT00413660|524468382|FG001|Post Week 12|Lack of Efficacy|0|||
145439439|NCT00413660|524468383|FG002|Post Week 12|Lack of Efficacy|1|||
145439440|NCT00413660|524468384|FG003|Post Week 12|Lack of Efficacy|0|||
145439441|NCT00413660|524468385|FG004|Post Week 12|Lack of Efficacy|0|||
145439442|NCT00413660|524468386|FG005|Post Week 12|Lack of Efficacy|0|||
145439443|NCT00413660|524468387|FG006|Post Week 12|Lack of Efficacy|0|||
145439444|NCT00413660|524468388|FG007|Post Week 12|Lack of Efficacy|0|||
145439445|NCT00413660|524468389|FG008|Post Week 12|Lack of Efficacy|0|||
145439446|NCT00413660|524468390|FG009|Post Week 12|Lack of Efficacy|1|||
145439447|NCT00413660|524468391|FG010|Post Week 12|Lack of Efficacy|0|||
145439448|NCT00413660|524468381|FG000|Post Week 12|Lost to Follow-up|0|||
145439449|NCT00413660|524468382|FG001|Post Week 12|Lost to Follow-up|1|||
145439450|NCT00413660|524468383|FG002|Post Week 12|Lost to Follow-up|1|||
145439451|NCT00413660|524468384|FG003|Post Week 12|Lost to Follow-up|0|||
145439452|NCT00413660|524468385|FG004|Post Week 12|Lost to Follow-up|0|||
145439453|NCT00413660|524468386|FG005|Post Week 12|Lost to Follow-up|0|||
145439454|NCT00413660|524468387|FG006|Post Week 12|Lost to Follow-up|0|||
145439455|NCT00413660|524468388|FG007|Post Week 12|Lost to Follow-up|0|||
145439456|NCT00413660|524468389|FG008|Post Week 12|Lost to Follow-up|0|||
145439457|NCT00413660|524468390|FG009|Post Week 12|Lost to Follow-up|0|||
145439458|NCT00413660|524468391|FG010|Post Week 12|Lost to Follow-up|0|||
145584489|NCT01175382|524993548|FG000|Overall Study|Unwilling to follow protocol|0|||
145584490|NCT01175382|524993549|FG001|Overall Study|Unwilling to follow protocol|1|||
145439459|NCT00413660|524468381|FG000|Post Week 12|Withdrawal by Subject|0|||
145439460|NCT00413660|524468382|FG001|Post Week 12|Withdrawal by Subject|1|||
145439461|NCT00413660|524468383|FG002|Post Week 12|Withdrawal by Subject|1|||
145439462|NCT00413660|524468384|FG003|Post Week 12|Withdrawal by Subject|0|||
145439463|NCT00413660|524468385|FG004|Post Week 12|Withdrawal by Subject|1|||
145439464|NCT00413660|524468386|FG005|Post Week 12|Withdrawal by Subject|0|||
145439465|NCT00413660|524468387|FG006|Post Week 12|Withdrawal by Subject|0|||
145439466|NCT00413660|524468388|FG007|Post Week 12|Withdrawal by Subject|0|||
145439467|NCT00413660|524468389|FG008|Post Week 12|Withdrawal by Subject|0|||
145439468|NCT00413660|524468390|FG009|Post Week 12|Withdrawal by Subject|0|||
145439469|NCT00413660|524468391|FG010|Post Week 12|Withdrawal by Subject|1|||
145439470|NCT00413660|524468381|FG000|Post Week 12|Other|1|||
145439471|NCT00413660|524468382|FG001|Post Week 12|Other|2|||
145439472|NCT00413660|524468383|FG002|Post Week 12|Other|3|||
145439473|NCT00413660|524468384|FG003|Post Week 12|Other|0|||
145584491|NCT01175382|524993550|FG002|Overall Study|Unwilling to follow protocol|0|||
145584492|NCT01175382|524993548|FG000|Overall Study|Unable to tolerate study meds|0|||
145584493|NCT01175382|524993549|FG001|Overall Study|Unable to tolerate study meds|1|||
145439474|NCT00413660|524468385|FG004|Post Week 12|Other|1|||
145439475|NCT00413660|524468386|FG005|Post Week 12|Other|1|||
145439476|NCT00413660|524468387|FG006|Post Week 12|Other|1|||
145439477|NCT00413660|524468388|FG007|Post Week 12|Other|0|||
145439478|NCT00413660|524468389|FG008|Post Week 12|Other|0|||
145439479|NCT00413660|524468390|FG009|Post Week 12|Other|0|||
145439480|NCT00413660|524468391|FG010|Post Week 12|Other|0|||
145439481|NCT03896477|524468392|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
145439482|NCT03896477|524468393|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
145439483|NCT03896477|524468394|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
145439484|NCT03896477|524468392|FG000|Overall Study|Parent Requested Withdrawal|8|||
145439485|NCT03896477|524468393|FG001|Overall Study|Parent Requested Withdrawal|12|||
145439486|NCT03896477|524468394|FG002|Overall Study|Parent Requested Withdrawal|9|||
145439487|NCT03896477|524468392|FG000|Overall Study|Adverse Event|0|||
145439488|NCT03896477|524468393|FG001|Overall Study|Adverse Event|0|||
145584494|NCT01175382|524993550|FG002|Overall Study|Unable to tolerate study meds|1|||
145584495|NCT00774787|524993551|FG000|Overall Study|Lost to Follow-up|1|||
145625316|NCT01770860|525142053|FG000|Overall Study|Administrative decision made by the PI|1|||
145625317|NCT01528709|525142054|FG000|Overall Study|Death|2|||
145625318|NCT01528709|525142055|FG001|Overall Study|Death|0|||
145625319|NCT01528709|525142054|FG000|Overall Study|Withdrawal by Subject|10|||
145625320|NCT01528709|525142055|FG001|Overall Study|Withdrawal by Subject|15|||
145625321|NCT01528709|525142054|FG000|Overall Study|allergy|1|||
145625322|NCT01528709|525142055|FG001|Overall Study|allergy|0|||
145625323|NCT01237678|525142056|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
145625324|NCT01237678|525142057|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
145625325|NCT01237678|525142058|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
145625326|NCT01237678|525142056|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
145625327|NCT01237678|525142057|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
145625328|NCT01237678|525142058|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
145625329|NCT01237678|525142056|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
145625330|NCT01237678|525142057|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
145625331|NCT01237678|525142058|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
145625332|NCT01237678|525142056|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
145625333|NCT01237678|525142057|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
145625334|NCT01237678|525142058|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
145625335|NCT01237678|525142056|FG000|Phase II|Adverse Event|0|||
145625336|NCT01237678|525142057|FG001|Phase II|Adverse Event|39|||
145625337|NCT01237678|525142058|FG002|Phase II|Adverse Event|9|||
145625338|NCT01237678|525142056|FG000|Phase II|Death|0|||
145625339|NCT01237678|525142057|FG001|Phase II|Death|0|||
145625340|NCT01237678|525142058|FG002|Phase II|Death|2|||
145625341|NCT01237678|525142056|FG000|Phase II|Lack of Efficacy|0|||
145625342|NCT01237678|525142057|FG001|Phase II|Lack of Efficacy|25|||
145625343|NCT01237678|525142058|FG002|Phase II|Lack of Efficacy|3|||
145625344|NCT01237678|525142056|FG000|Phase II|Withdrawal by Subject|0|||
145625345|NCT01237678|525142057|FG001|Phase II|Withdrawal by Subject|1|||
145625346|NCT01237678|525142058|FG002|Phase II|Withdrawal by Subject|5|||
145625347|NCT01237678|525142056|FG000|Phase II|Completed Cycles 4-6|0|||
145625348|NCT01237678|525142057|FG001|Phase II|Completed Cycles 4-6|11|||
145625349|NCT01237678|525142058|FG002|Phase II|Completed Cycles 4-6|21|||
145625350|NCT01237678|525142056|FG000|Phase II|Sponsor Decision/Study Closed|0|||
145625351|NCT01237678|525142057|FG001|Phase II|Sponsor Decision/Study Closed|18|||
145625352|NCT01237678|525142058|FG002|Phase II|Sponsor Decision/Study Closed|7|||
145625353|NCT01237678|525142056|FG000|Phase II|Randomized but were not treated|0|||
145625354|NCT01237678|525142057|FG001|Phase II|Randomized but were not treated|4|||
145625355|NCT01237678|525142058|FG002|Phase II|Randomized but were not treated|3|||
145625356|NCT01648283|525142065|FG000|Overall Study|Withdrawal by Subject|14|||
145625357|NCT01511250|525142067|FG000|Overall Study|Withdrawal of Consent|1|||
145625358|NCT01511250|525142068|FG001|Overall Study|Withdrawal of Consent|0|||
145625359|NCT01511250|525142069|FG002|Overall Study|Withdrawal of Consent|0|||
145625360|NCT01511250|525142070|FG003|Overall Study|Withdrawal of Consent|0|||
145625361|NCT01511250|525142071|FG004|Overall Study|Withdrawal of Consent|0|||
145625362|NCT01511250|525142072|FG005|Overall Study|Withdrawal of Consent|0|||
145625363|NCT01511250|525142073|FG006|Overall Study|Withdrawal of Consent|0|||
145625364|NCT01511250|525142074|FG007|Overall Study|Withdrawal of Consent|1|||
145625365|NCT01511250|525142075|FG008|Overall Study|Withdrawal of Consent|1|||
145625366|NCT01511250|525142076|FG009|Overall Study|Withdrawal of Consent|0|||
145625367|NCT01511250|525142067|FG000|Overall Study|Sponsor/Investigator Decision|1|||
145625368|NCT01511250|525142068|FG001|Overall Study|Sponsor/Investigator Decision|0|||
145625369|NCT01511250|525142069|FG002|Overall Study|Sponsor/Investigator Decision|0|||
145625370|NCT01511250|525142070|FG003|Overall Study|Sponsor/Investigator Decision|0|||
145625371|NCT01511250|525142071|FG004|Overall Study|Sponsor/Investigator Decision|0|||
145625372|NCT01511250|525142072|FG005|Overall Study|Sponsor/Investigator Decision|0|||
145625373|NCT01511250|525142073|FG006|Overall Study|Sponsor/Investigator Decision|0|||
145625374|NCT01511250|525142074|FG007|Overall Study|Sponsor/Investigator Decision|0|||
145625375|NCT01511250|525142075|FG008|Overall Study|Sponsor/Investigator Decision|0|||
145625376|NCT01511250|525142076|FG009|Overall Study|Sponsor/Investigator Decision|0|||
145625377|NCT01511250|525142067|FG000|Overall Study|Lost to Follow-up|7|||
145625378|NCT01511250|525142068|FG001|Overall Study|Lost to Follow-up|3|||
145625379|NCT01511250|525142069|FG002|Overall Study|Lost to Follow-up|3|||
145625380|NCT01511250|525142070|FG003|Overall Study|Lost to Follow-up|3|||
145625381|NCT01511250|525142071|FG004|Overall Study|Lost to Follow-up|0|||
145625382|NCT01511250|525142072|FG005|Overall Study|Lost to Follow-up|0|||
145625383|NCT01511250|525142073|FG006|Overall Study|Lost to Follow-up|2|||
145625384|NCT01511250|525142074|FG007|Overall Study|Lost to Follow-up|3|||
145625385|NCT01511250|525142075|FG008|Overall Study|Lost to Follow-up|13|||
145625386|NCT01511250|525142076|FG009|Overall Study|Lost to Follow-up|5|||
145625387|NCT01511250|525142067|FG000|Overall Study|Protocol Violation|0|||
145625388|NCT01511250|525142068|FG001|Overall Study|Protocol Violation|2|||
145625389|NCT01511250|525142069|FG002|Overall Study|Protocol Violation|1|||
145625390|NCT01511250|525142070|FG003|Overall Study|Protocol Violation|0|||
145625391|NCT01511250|525142071|FG004|Overall Study|Protocol Violation|0|||
145439489|NCT03896477|524468394|FG002|Overall Study|Adverse Event|1|||
145439490|NCT03896477|524468392|FG000|Overall Study|Death|1|||
145439491|NCT03896477|524468393|FG001|Overall Study|Death|0|||
145439492|NCT03896477|524468394|FG002|Overall Study|Death|0|||
145439493|NCT03896477|524468392|FG000|Overall Study|Other|5|||
145439494|NCT03896477|524468393|FG001|Overall Study|Other|6|||
145439495|NCT03896477|524468394|FG002|Overall Study|Other|7|||
145439496|NCT03896477|524468392|FG000|Overall Study|Lost to Follow-up|2|||
145439497|NCT03896477|524468393|FG001|Overall Study|Lost to Follow-up|1|||
145439498|NCT03896477|524468394|FG002|Overall Study|Lost to Follow-up|1|||
145439499|NCT01791517|524468395|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
145439500|NCT01791517|524468396|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
145439501|NCT01791517|524468397|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
145439502|NCT01791517|524468398|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
145439503|NCT01791517|524468399|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
145439504|NCT01791517|524468400|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
145439505|NCT01791517|524468401|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
145439506|NCT01791517|524468402|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
145439507|NCT01791517|524468403|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
145439508|NCT01791517|524468404|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
145439509|NCT01791517|524468405|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
145439510|NCT01791517|524468406|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
145439511|NCT01791517|524468395|FG000|Phase I: Period 1|Adverse Event|0|||
145439512|NCT01791517|524468396|FG001|Phase I: Period 1|Adverse Event|0|||
145439513|NCT01791517|524468397|FG002|Phase I: Period 1|Adverse Event|1|||
145439514|NCT01791517|524468398|FG003|Phase I: Period 1|Adverse Event|1|||
145439515|NCT01791517|524468399|FG004|Phase I: Period 1|Adverse Event|0|||
145439516|NCT01791517|524468400|FG005|Phase I: Period 1|Adverse Event|0|||
145439517|NCT01791517|524468401|FG006|Phase I: Period 1|Adverse Event|0|||
145439518|NCT01791517|524468402|FG007|Phase I: Period 1|Adverse Event|0|||
145439519|NCT01791517|524468403|FG008|Phase I: Period 1|Adverse Event|0|||
145439520|NCT01791517|524468404|FG009|Phase I: Period 1|Adverse Event|0|||
145439521|NCT01791517|524468405|FG010|Phase I: Period 1|Adverse Event|0|||
145439522|NCT01791517|524468406|FG011|Phase I: Period 1|Adverse Event|0|||
145439523|NCT01791517|524468395|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
145439524|NCT01791517|524468396|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439525|NCT01791517|524468397|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145584496|NCT02019719|524993552|FG000|Overall Study|Adverse Event|1|||
145439526|NCT01791517|524468398|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439527|NCT01791517|524468399|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439528|NCT01791517|524468400|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439529|NCT01791517|524468401|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439530|NCT01791517|524468402|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439531|NCT01791517|524468403|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439532|NCT01791517|524468404|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439533|NCT01791517|524468405|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439534|NCT01791517|524468406|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
145439535|NCT01791517|524468395|FG000|Phase I: Period 1|Protocol Violation|0|||
145439536|NCT01791517|524468396|FG001|Phase I: Period 1|Protocol Violation|1|||
145439537|NCT01791517|524468397|FG002|Phase I: Period 1|Protocol Violation|0|||
145439538|NCT01791517|524468398|FG003|Phase I: Period 1|Protocol Violation|0|||
145439539|NCT01791517|524468399|FG004|Phase I: Period 1|Protocol Violation|0|||
145439540|NCT01791517|524468400|FG005|Phase I: Period 1|Protocol Violation|0|||
145439541|NCT01791517|524468401|FG006|Phase I: Period 1|Protocol Violation|0|||
145439542|NCT01791517|524468402|FG007|Phase I: Period 1|Protocol Violation|0|||
145439543|NCT01791517|524468403|FG008|Phase I: Period 1|Protocol Violation|0|||
145439544|NCT01791517|524468404|FG009|Phase I: Period 1|Protocol Violation|0|||
145439545|NCT01791517|524468405|FG010|Phase I: Period 1|Protocol Violation|0|||
145439546|NCT01791517|524468406|FG011|Phase I: Period 1|Protocol Violation|0|||
145439547|NCT01791517|524468395|FG000|Phase I: Period 1|Lost to Follow-up|0|||
145439548|NCT01791517|524468396|FG001|Phase I: Period 1|Lost to Follow-up|0|||
145584497|NCT02019719|524993553|FG001|Overall Study|Adverse Event|0|||
145584498|NCT02019719|524993554|FG002|Overall Study|Adverse Event|0|||
145584499|NCT02019719|524993555|FG003|Overall Study|Adverse Event|1|||
145584500|NCT02019719|524993556|FG004|Overall Study|Adverse Event|1|||
145584501|NCT02019719|524993552|FG000|Overall Study|Protocol Violation|1|||
145584502|NCT02019719|524993553|FG001|Overall Study|Protocol Violation|1|||
145439549|NCT01791517|524468397|FG002|Phase I: Period 1|Lost to Follow-up|0|||
145439550|NCT01791517|524468398|FG003|Phase I: Period 1|Lost to Follow-up|1|||
145439551|NCT01791517|524468399|FG004|Phase I: Period 1|Lost to Follow-up|0|||
145439552|NCT01791517|524468400|FG005|Phase I: Period 1|Lost to Follow-up|0|||
145439553|NCT01791517|524468401|FG006|Phase I: Period 1|Lost to Follow-up|1|||
145439554|NCT01791517|524468402|FG007|Phase I: Period 1|Lost to Follow-up|0|||
145439555|NCT01791517|524468403|FG008|Phase I: Period 1|Lost to Follow-up|1|||
145439556|NCT01791517|524468404|FG009|Phase I: Period 1|Lost to Follow-up|1|||
145439557|NCT01791517|524468405|FG010|Phase I: Period 1|Lost to Follow-up|0|||
145584503|NCT02019719|524993554|FG002|Overall Study|Protocol Violation|0|||
145439558|NCT01791517|524468406|FG011|Phase I: Period 1|Lost to Follow-up|0|||
145439559|NCT01791517|524468395|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439560|NCT01791517|524468396|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439561|NCT01791517|524468397|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439562|NCT01791517|524468398|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439563|NCT01791517|524468399|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439564|NCT01791517|524468400|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439565|NCT01791517|524468401|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439566|NCT01791517|524468402|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439567|NCT01791517|524468403|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439568|NCT01791517|524468404|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439569|NCT01791517|524468405|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
145439570|NCT01791517|524468406|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
145439571|NCT01791517|524468395|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
145439572|NCT01791517|524468396|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439573|NCT01791517|524468397|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439574|NCT01791517|524468398|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439575|NCT01791517|524468399|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439576|NCT01791517|524468400|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439577|NCT01791517|524468401|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439578|NCT01791517|524468402|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439579|NCT01791517|524468403|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145584504|NCT02019719|524993555|FG003|Overall Study|Protocol Violation|0|||
145584505|NCT02019719|524993556|FG004|Overall Study|Protocol Violation|0|||
145584506|NCT02019719|524993552|FG000|Overall Study|Protocol defined stopping criteria|2|||
145584507|NCT02019719|524993553|FG001|Overall Study|Protocol defined stopping criteria|0|||
145584508|NCT02019719|524993554|FG002|Overall Study|Protocol defined stopping criteria|0|||
145584509|NCT02019719|524993555|FG003|Overall Study|Protocol defined stopping criteria|1|||
145584510|NCT02019719|524993556|FG004|Overall Study|Protocol defined stopping criteria|1|||
145584511|NCT02019719|524993552|FG000|Overall Study|Physician Decision|2|||
145584512|NCT02019719|524993553|FG001|Overall Study|Physician Decision|0|||
145584513|NCT02019719|524993554|FG002|Overall Study|Physician Decision|0|||
145584514|NCT02019719|524993555|FG003|Overall Study|Physician Decision|0|||
145584515|NCT02019719|524993556|FG004|Overall Study|Physician Decision|0|||
145584516|NCT01055639|524993560|FG000|Overall Study|Adverse Event|0|||
145584517|NCT01055639|524993561|FG001|Overall Study|Adverse Event|1|||
145584518|NCT01055639|524993560|FG000|Overall Study|Lack of Efficacy|0|||
145584519|NCT01055639|524993561|FG001|Overall Study|Lack of Efficacy|1|||
145584520|NCT01055639|524993560|FG000|Overall Study|Lost to Follow-up|8|||
145584521|NCT01055639|524993561|FG001|Overall Study|Lost to Follow-up|11|||
145584522|NCT01055639|524993560|FG000|Overall Study|Protocol Violation|5|||
145584523|NCT01055639|524993561|FG001|Overall Study|Protocol Violation|5|||
145584524|NCT01055639|524993560|FG000|Overall Study|Withdrawal by Subject|8|||
145584525|NCT01055639|524993561|FG001|Overall Study|Withdrawal by Subject|11|||
145584526|NCT00765245|524993562|FG000|Overall Study|disease progression|3|||
145584527|NCT00765245|524993563|FG001|Overall Study|disease progression|2|||
145584528|NCT00765245|524993562|FG000|Overall Study|Withdrawal by Subject|3|||
145584529|NCT00765245|524993563|FG001|Overall Study|Withdrawal by Subject|0|||
145584530|NCT00765245|524993562|FG000|Overall Study|Adverse Event|5|||
145584531|NCT00765245|524993563|FG001|Overall Study|Adverse Event|0|||
145584532|NCT00765245|524993562|FG000|Overall Study|Physician Decision|1|||
145584533|NCT00765245|524993563|FG001|Overall Study|Physician Decision|0|||
145584534|NCT00765245|524993562|FG000|Overall Study|Death|1|||
145584535|NCT00765245|524993563|FG001|Overall Study|Death|0|||
145584536|NCT01197950|524993567|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
145584537|NCT01197950|524993568|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
145584538|NCT01197950|524993569|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
145584539|NCT01659021|524993570|FG000|Main Study|Adverse Event|2|||
145584540|NCT01659021|524993571|FG001|Main Study|Adverse Event|3|||
145584541|NCT01659021|524993570|FG000|Main Study|Lost to Follow-up|1|||
145584542|NCT01659021|524993571|FG001|Main Study|Lost to Follow-up|0|||
145584543|NCT01659021|524993570|FG000|Main Study|Unknown Reasons|2|||
145584544|NCT01659021|524993571|FG001|Main Study|Unknown Reasons|1|||
145584545|NCT01659021|524993570|FG000|Main Study|Physician Decision|34|||
145584546|NCT01659021|524993571|FG001|Main Study|Physician Decision|16|||
145584547|NCT01659021|524993570|FG000|Main Study|Withdrawal by Subject|19|||
145584548|NCT01659021|524993571|FG001|Main Study|Withdrawal by Subject|16|||
145584549|NCT01659021|524993570|FG000|Main Study|Study Terminated by Sponsor|16|||
145584550|NCT01659021|524993571|FG001|Main Study|Study Terminated by Sponsor|1|||
145584551|NCT01659021|524993570|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
145584552|NCT01659021|524993571|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
145439580|NCT01791517|524468404|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439581|NCT01791517|524468405|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439582|NCT01791517|524468406|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
145439583|NCT01791517|524468395|FG000|Phase I: Period 2|Protocol Violation|0|||
145439584|NCT01791517|524468396|FG001|Phase I: Period 2|Protocol Violation|0|||
145439585|NCT01791517|524468397|FG002|Phase I: Period 2|Protocol Violation|0|||
145439586|NCT01791517|524468398|FG003|Phase I: Period 2|Protocol Violation|1|||
145439587|NCT01791517|524468399|FG004|Phase I: Period 2|Protocol Violation|0|||
145439588|NCT01791517|524468400|FG005|Phase I: Period 2|Protocol Violation|0|||
145439589|NCT01791517|524468401|FG006|Phase I: Period 2|Protocol Violation|0|||
145439590|NCT01791517|524468402|FG007|Phase I: Period 2|Protocol Violation|0|||
145439591|NCT01791517|524468403|FG008|Phase I: Period 2|Protocol Violation|0|||
145439592|NCT01791517|524468404|FG009|Phase I: Period 2|Protocol Violation|0|||
145439593|NCT01791517|524468405|FG010|Phase I: Period 2|Protocol Violation|0|||
145439594|NCT01791517|524468406|FG011|Phase I: Period 2|Protocol Violation|0|||
145439595|NCT01791517|524468395|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
145439596|NCT01791517|524468396|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
145439597|NCT01791517|524468397|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
145439598|NCT01791517|524468398|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
145439599|NCT01791517|524468399|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
145439600|NCT01791517|524468400|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
145439601|NCT01791517|524468401|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
145439602|NCT01791517|524468402|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
145439603|NCT01791517|524468403|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
145439604|NCT01791517|524468404|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
145439605|NCT01791517|524468405|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
145439606|NCT01791517|524468406|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
145439607|NCT01791517|524468395|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439608|NCT01791517|524468396|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439609|NCT01791517|524468397|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439610|NCT01791517|524468398|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439611|NCT01791517|524468399|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439612|NCT01791517|524468400|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439613|NCT01791517|524468401|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439614|NCT01791517|524468402|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439615|NCT01791517|524468403|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439616|NCT01791517|524468404|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439617|NCT01791517|524468405|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
145439618|NCT01791517|524468406|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
145439619|NCT01791517|524468395|FG000|Phase I: Period 2|Lens Discomfort|0|||
145439620|NCT01791517|524468396|FG001|Phase I: Period 2|Lens Discomfort|0|||
145439621|NCT01791517|524468397|FG002|Phase I: Period 2|Lens Discomfort|0|||
145439622|NCT01791517|524468398|FG003|Phase I: Period 2|Lens Discomfort|0|||
145439623|NCT01791517|524468399|FG004|Phase I: Period 2|Lens Discomfort|0|||
145439624|NCT01791517|524468400|FG005|Phase I: Period 2|Lens Discomfort|1|||
145439625|NCT01791517|524468401|FG006|Phase I: Period 2|Lens Discomfort|0|||
145439626|NCT01791517|524468402|FG007|Phase I: Period 2|Lens Discomfort|0|||
145439627|NCT01791517|524468403|FG008|Phase I: Period 2|Lens Discomfort|0|||
145439628|NCT01791517|524468404|FG009|Phase I: Period 2|Lens Discomfort|0|||
145439629|NCT01791517|524468405|FG010|Phase I: Period 2|Lens Discomfort|0|||
145439630|NCT01791517|524468406|FG011|Phase I: Period 2|Lens Discomfort|0|||
145439631|NCT01791517|524468395|FG000|Phase I: Period 2|Lost to Follow-up|0|||
145439632|NCT01791517|524468396|FG001|Phase I: Period 2|Lost to Follow-up|3|||
145439633|NCT01791517|524468397|FG002|Phase I: Period 2|Lost to Follow-up|2|||
145439634|NCT01791517|524468398|FG003|Phase I: Period 2|Lost to Follow-up|0|||
145439635|NCT01791517|524468399|FG004|Phase I: Period 2|Lost to Follow-up|0|||
145439636|NCT01791517|524468400|FG005|Phase I: Period 2|Lost to Follow-up|0|||
145439637|NCT01791517|524468401|FG006|Phase I: Period 2|Lost to Follow-up|0|||
145439638|NCT01791517|524468402|FG007|Phase I: Period 2|Lost to Follow-up|0|||
145439639|NCT01791517|524468403|FG008|Phase I: Period 2|Lost to Follow-up|0|||
145439640|NCT01791517|524468404|FG009|Phase I: Period 2|Lost to Follow-up|0|||
145439641|NCT01791517|524468405|FG010|Phase I: Period 2|Lost to Follow-up|0|||
145439642|NCT01791517|524468406|FG011|Phase I: Period 2|Lost to Follow-up|0|||
145439643|NCT01791517|524468395|FG000|Phase I: Period 3|Lens Discomfort|0|||
145439644|NCT01791517|524468396|FG001|Phase I: Period 3|Lens Discomfort|0|||
145439645|NCT01791517|524468397|FG002|Phase I: Period 3|Lens Discomfort|0|||
145439646|NCT01791517|524468398|FG003|Phase I: Period 3|Lens Discomfort|0|||
145439647|NCT01791517|524468399|FG004|Phase I: Period 3|Lens Discomfort|0|||
145439648|NCT01791517|524468400|FG005|Phase I: Period 3|Lens Discomfort|0|||
145439649|NCT01791517|524468401|FG006|Phase I: Period 3|Lens Discomfort|0|||
145439650|NCT01791517|524468402|FG007|Phase I: Period 3|Lens Discomfort|0|||
145439651|NCT01791517|524468403|FG008|Phase I: Period 3|Lens Discomfort|0|||
145439652|NCT01791517|524468404|FG009|Phase I: Period 3|Lens Discomfort|0|||
145439653|NCT01791517|524468405|FG010|Phase I: Period 3|Lens Discomfort|0|||
145439654|NCT01791517|524468406|FG011|Phase I: Period 3|Lens Discomfort|1|||
145439655|NCT01791517|524468395|FG000|Phase I: Period 3|Lost to Follow-up|0|||
145439656|NCT01791517|524468396|FG001|Phase I: Period 3|Lost to Follow-up|1|||
145439657|NCT01791517|524468397|FG002|Phase I: Period 3|Lost to Follow-up|0|||
145439658|NCT01791517|524468398|FG003|Phase I: Period 3|Lost to Follow-up|0|||
145439659|NCT01791517|524468399|FG004|Phase I: Period 3|Lost to Follow-up|1|||
145439660|NCT01791517|524468400|FG005|Phase I: Period 3|Lost to Follow-up|0|||
145439661|NCT01791517|524468401|FG006|Phase I: Period 3|Lost to Follow-up|0|||
145439662|NCT01791517|524468402|FG007|Phase I: Period 3|Lost to Follow-up|0|||
145439663|NCT01791517|524468403|FG008|Phase I: Period 3|Lost to Follow-up|0|||
145439664|NCT01791517|524468404|FG009|Phase I: Period 3|Lost to Follow-up|0|||
145439665|NCT01791517|524468405|FG010|Phase I: Period 3|Lost to Follow-up|0|||
145439666|NCT01791517|524468406|FG011|Phase I: Period 3|Lost to Follow-up|0|||
145439667|NCT01791517|524468395|FG000|Phase I: Period 3|Adverse Event|0|||
145439668|NCT01791517|524468396|FG001|Phase I: Period 3|Adverse Event|0|||
145439669|NCT01791517|524468397|FG002|Phase I: Period 3|Adverse Event|0|||
145439670|NCT01791517|524468398|FG003|Phase I: Period 3|Adverse Event|1|||
145439671|NCT01791517|524468399|FG004|Phase I: Period 3|Adverse Event|0|||
145439672|NCT01791517|524468400|FG005|Phase I: Period 3|Adverse Event|0|||
145439673|NCT01791517|524468401|FG006|Phase I: Period 3|Adverse Event|0|||
145439674|NCT01791517|524468402|FG007|Phase I: Period 3|Adverse Event|0|||
145439675|NCT01791517|524468403|FG008|Phase I: Period 3|Adverse Event|0|||
145439676|NCT01791517|524468404|FG009|Phase I: Period 3|Adverse Event|0|||
145439677|NCT01791517|524468405|FG010|Phase I: Period 3|Adverse Event|0|||
145439678|NCT01791517|524468406|FG011|Phase I: Period 3|Adverse Event|0|||
145439679|NCT01791517|524468395|FG000|Phase II|Lost to Follow-up|1|||
145439680|NCT01791517|524468396|FG001|Phase II|Lost to Follow-up|0|||
145439681|NCT01791517|524468397|FG002|Phase II|Lost to Follow-up|1|||
145439682|NCT01791517|524468398|FG003|Phase II|Lost to Follow-up|0|||
145439683|NCT01791517|524468399|FG004|Phase II|Lost to Follow-up|1|||
145439684|NCT01791517|524468400|FG005|Phase II|Lost to Follow-up|2|||
145439685|NCT01791517|524468401|FG006|Phase II|Lost to Follow-up|0|||
145439686|NCT01791517|524468402|FG007|Phase II|Lost to Follow-up|1|||
145439687|NCT01791517|524468403|FG008|Phase II|Lost to Follow-up|1|||
145439688|NCT01791517|524468404|FG009|Phase II|Lost to Follow-up|1|||
145439689|NCT01791517|524468405|FG010|Phase II|Lost to Follow-up|0|||
145439690|NCT01791517|524468406|FG011|Phase II|Lost to Follow-up|0|||
145439691|NCT01791517|524468395|FG000|Phase II|Withdrawal by Subject|1|||
145439692|NCT01791517|524468396|FG001|Phase II|Withdrawal by Subject|0|||
145439693|NCT01791517|524468397|FG002|Phase II|Withdrawal by Subject|0|||
145439694|NCT01791517|524468398|FG003|Phase II|Withdrawal by Subject|0|||
145439695|NCT01791517|524468399|FG004|Phase II|Withdrawal by Subject|0|||
145439696|NCT01791517|524468400|FG005|Phase II|Withdrawal by Subject|2|||
145439697|NCT01791517|524468401|FG006|Phase II|Withdrawal by Subject|0|||
145439698|NCT01791517|524468402|FG007|Phase II|Withdrawal by Subject|1|||
145439699|NCT01791517|524468403|FG008|Phase II|Withdrawal by Subject|0|||
145439700|NCT01791517|524468404|FG009|Phase II|Withdrawal by Subject|0|||
145439701|NCT01791517|524468405|FG010|Phase II|Withdrawal by Subject|1|||
145439702|NCT01791517|524468406|FG011|Phase II|Withdrawal by Subject|0|||
145439703|NCT01791517|524468395|FG000|Phase II|Lack of Efficacy|0|||
145439704|NCT01791517|524468396|FG001|Phase II|Lack of Efficacy|0|||
145439705|NCT01791517|524468397|FG002|Phase II|Lack of Efficacy|0|||
145439706|NCT01791517|524468398|FG003|Phase II|Lack of Efficacy|0|||
145439707|NCT01791517|524468399|FG004|Phase II|Lack of Efficacy|1|||
145439708|NCT01791517|524468400|FG005|Phase II|Lack of Efficacy|0|||
145439709|NCT01791517|524468401|FG006|Phase II|Lack of Efficacy|0|||
145439710|NCT01791517|524468402|FG007|Phase II|Lack of Efficacy|0|||
145439711|NCT01791517|524468403|FG008|Phase II|Lack of Efficacy|0|||
145439712|NCT01791517|524468404|FG009|Phase II|Lack of Efficacy|0|||
145439713|NCT01791517|524468405|FG010|Phase II|Lack of Efficacy|0|||
145439714|NCT01791517|524468406|FG011|Phase II|Lack of Efficacy|0|||
145439715|NCT01791517|524468395|FG000|Phase II|Adverse Event|0|||
145439716|NCT01791517|524468396|FG001|Phase II|Adverse Event|0|||
145439717|NCT01791517|524468397|FG002|Phase II|Adverse Event|0|||
145439718|NCT01791517|524468398|FG003|Phase II|Adverse Event|0|||
145439719|NCT01791517|524468399|FG004|Phase II|Adverse Event|0|||
145584553|NCT01659021|524993570|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
145584554|NCT01659021|524993571|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
145584555|NCT02079805|524993572|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145584556|NCT02079805|524993573|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
145439720|NCT01791517|524468400|FG005|Phase II|Adverse Event|0|||
145439721|NCT01791517|524468401|FG006|Phase II|Adverse Event|2|||
145439722|NCT01791517|524468402|FG007|Phase II|Adverse Event|1|||
145439723|NCT01791517|524468403|FG008|Phase II|Adverse Event|0|||
145439724|NCT01791517|524468404|FG009|Phase II|Adverse Event|1|||
145439725|NCT01791517|524468405|FG010|Phase II|Adverse Event|0|||
145439726|NCT01791517|524468406|FG011|Phase II|Adverse Event|0|||
145439727|NCT01791517|524468395|FG000|Phase II|Lens Handling Difficulties|0|||
145439728|NCT01791517|524468396|FG001|Phase II|Lens Handling Difficulties|0|||
145439729|NCT01791517|524468397|FG002|Phase II|Lens Handling Difficulties|0|||
145584557|NCT02079805|524993572|FG000|Overall Study|Voluntary Withdrawal|0|||
145439730|NCT01791517|524468398|FG003|Phase II|Lens Handling Difficulties|0|||
145439731|NCT01791517|524468399|FG004|Phase II|Lens Handling Difficulties|0|||
145439732|NCT01791517|524468400|FG005|Phase II|Lens Handling Difficulties|0|||
145439733|NCT01791517|524468401|FG006|Phase II|Lens Handling Difficulties|0|||
145439734|NCT01791517|524468402|FG007|Phase II|Lens Handling Difficulties|0|||
145439735|NCT01791517|524468403|FG008|Phase II|Lens Handling Difficulties|1|||
145439736|NCT01791517|524468404|FG009|Phase II|Lens Handling Difficulties|0|||
145439737|NCT01791517|524468405|FG010|Phase II|Lens Handling Difficulties|0|||
145439738|NCT01791517|524468406|FG011|Phase II|Lens Handling Difficulties|0|||
145439739|NCT01791517|524468395|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
145439740|NCT01791517|524468396|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
145439741|NCT01791517|524468397|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
145439742|NCT01791517|524468398|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
145439743|NCT01791517|524468399|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
145439744|NCT01791517|524468400|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
145439745|NCT01791517|524468401|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
145439746|NCT01791517|524468402|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
145439747|NCT01791517|524468403|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
145439748|NCT01791517|524468404|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
145439749|NCT01791517|524468405|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
145439750|NCT01791517|524468406|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
145439751|NCT01791517|524468395|FG000|Phase II|Pre-Existing Ocular Issue|0|||
145439752|NCT01791517|524468396|FG001|Phase II|Pre-Existing Ocular Issue|0|||
145439753|NCT01791517|524468397|FG002|Phase II|Pre-Existing Ocular Issue|0|||
145439754|NCT01791517|524468398|FG003|Phase II|Pre-Existing Ocular Issue|0|||
145439755|NCT01791517|524468399|FG004|Phase II|Pre-Existing Ocular Issue|0|||
145439756|NCT01791517|524468400|FG005|Phase II|Pre-Existing Ocular Issue|0|||
145439757|NCT01791517|524468401|FG006|Phase II|Pre-Existing Ocular Issue|0|||
145439758|NCT01791517|524468402|FG007|Phase II|Pre-Existing Ocular Issue|0|||
145439759|NCT01791517|524468403|FG008|Phase II|Pre-Existing Ocular Issue|0|||
145439760|NCT01791517|524468404|FG009|Phase II|Pre-Existing Ocular Issue|0|||
145439761|NCT01791517|524468405|FG010|Phase II|Pre-Existing Ocular Issue|0|||
145439762|NCT01791517|524468406|FG011|Phase II|Pre-Existing Ocular Issue|1|||
145439763|NCT00589797|524468407|FG000|Overall Study|Death|1|||
145439764|NCT00589797|524468408|FG001|Overall Study|Death|0|||
145439765|NCT00589797|524468407|FG000|Overall Study|Lost to Follow-up|12|||
145439766|NCT00589797|524468408|FG001|Overall Study|Lost to Follow-up|9|||
145439767|NCT00589797|524468407|FG000|Overall Study|Physician Decision|8|||
145439768|NCT00589797|524468408|FG001|Overall Study|Physician Decision|3|||
145439769|NCT00589797|524468407|FG000|Overall Study|Withdrawal by Subject|6|||
145439770|NCT00589797|524468408|FG001|Overall Study|Withdrawal by Subject|5|||
145439771|NCT00589797|524468407|FG000|Overall Study|Non-Randomized Training Subjects|46|||
145439772|NCT00589797|524468408|FG001|Overall Study|Non-Randomized Training Subjects|6|||
145439773|NCT03230318|524468413|FG000|Overall Study|Radiographic disease progression|72|||
145439774|NCT03230318|524468414|FG001|Overall Study|Radiographic disease progression|19|||
145439775|NCT03230318|524468413|FG000|Overall Study|Clinical progression|17|||
145439776|NCT03230318|524468414|FG001|Overall Study|Clinical progression|7|||
145439777|NCT03230318|524468413|FG000|Overall Study|Adverse Event|5|||
145439778|NCT03230318|524468414|FG001|Overall Study|Adverse Event|3|||
145439779|NCT03230318|524468413|FG000|Overall Study|Physician Decision|2|||
145439780|NCT03230318|524468414|FG001|Overall Study|Physician Decision|3|||
145439781|NCT03230318|524468413|FG000|Overall Study|Death|3|||
145439782|NCT03230318|524468414|FG001|Overall Study|Death|2|||
145439783|NCT03230318|524468413|FG000|Overall Study|Lost to Follow-up|1|||
145439784|NCT03230318|524468414|FG001|Overall Study|Lost to Follow-up|0|||
145439785|NCT03230318|524468413|FG000|Overall Study|Withdrawal by Subject|1|||
145439786|NCT03230318|524468414|FG001|Overall Study|Withdrawal by Subject|3|||
145439787|NCT03230318|524468413|FG000|Overall Study|Other|3|||
145439788|NCT03230318|524468414|FG001|Overall Study|Other|7|||
145439789|NCT04011735|524468415|FG000|Overall Study|Withdrawal by Subject|1|||
145439790|NCT04011735|524468416|FG001|Overall Study|Withdrawal by Subject|0|||
145439791|NCT04011735|524468417|FG002|Overall Study|Withdrawal by Subject|1|||
145439792|NCT04011735|524468415|FG000|Overall Study|Met exclusion criteria after study entry|0|||
145439793|NCT04011735|524468416|FG001|Overall Study|Met exclusion criteria after study entry|1|||
145439794|NCT04011735|524468417|FG002|Overall Study|Met exclusion criteria after study entry|0|||
145439795|NCT01492088|524468424|FG000|Overall Study|Withdrawal by Patient|0|||
145439796|NCT01492088|524468425|FG001|Overall Study|Withdrawal by Patient|2|||
145439797|NCT01492088|524468426|FG002|Overall Study|Withdrawal by Patient|0|||
145439798|NCT01492088|524468424|FG000|Overall Study|Death|1|||
145584558|NCT02079805|524993573|FG001|Overall Study|Voluntary Withdrawal|1|||
145584559|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
145584560|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
145584561|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
145584562|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
145584563|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
145584564|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
145584565|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
145584566|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
145584567|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
145584568|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
145584569|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
145439799|NCT01492088|524468425|FG001|Overall Study|Death|6|||
145625392|NCT01511250|525142072|FG005|Overall Study|Protocol Violation|0|||
145625393|NCT01511250|525142073|FG006|Overall Study|Protocol Violation|0|||
145625394|NCT01511250|525142074|FG007|Overall Study|Protocol Violation|0|||
145625395|NCT01511250|525142075|FG008|Overall Study|Protocol Violation|0|||
145625396|NCT01511250|525142076|FG009|Overall Study|Protocol Violation|0|||
145625397|NCT01763047|525142077|FG000|Period 1|Test Article Not Available|4|||
145625398|NCT01763047|525142078|FG001|Period 1|Test Article Not Available|1|||
145625399|NCT01763047|525142077|FG000|Period 1|Protocol Violation|4|||
145625400|NCT01763047|525142078|FG001|Period 1|Protocol Violation|4|||
145625401|NCT01763047|525142077|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
145625402|NCT01763047|525142078|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
145625403|NCT01763047|525142077|FG000|Period 1|Adverse Event|0|||
145625404|NCT01763047|525142078|FG001|Period 1|Adverse Event|1|||
145625405|NCT01763047|525142077|FG000|Period 1|Unsatisfactory Visual Response|0|||
145625406|NCT01763047|525142078|FG001|Period 1|Unsatisfactory Visual Response|3|||
145625407|NCT01763047|525142077|FG000|Period 1|Lens Power Not Available|0|||
145625408|NCT01763047|525142078|FG001|Period 1|Lens Power Not Available|1|||
145625409|NCT01763047|525142077|FG000|Period 1|Study Site office Closed|0|||
145625410|NCT01763047|525142078|FG001|Period 1|Study Site office Closed|1|||
145625411|NCT01763047|525142077|FG000|Period 2|Lens Discomfort|1|||
145625412|NCT01763047|525142078|FG001|Period 2|Lens Discomfort|0|||
145625413|NCT01763047|525142077|FG000|Period 2|No longer meets Eligibility Criteria|1|||
145625414|NCT01763047|525142078|FG001|Period 2|No longer meets Eligibility Criteria|0|||
145625415|NCT01763047|525142077|FG000|Period 2|Study Site office Closed|1|||
145625416|NCT01763047|525142078|FG001|Period 2|Study Site office Closed|1|||
145625417|NCT01763047|525142077|FG000|Period 2|Unsatisfactory Visual Response|1|||
145625418|NCT01763047|525142078|FG001|Period 2|Unsatisfactory Visual Response|1|||
145625419|NCT01763047|525142077|FG000|Period 2|Protocol Violation|0|||
145625420|NCT01763047|525142078|FG001|Period 2|Protocol Violation|2|||
145625421|NCT01763047|525142077|FG000|Period 2|Unsatisfactory lens Fitting|0|||
145625422|NCT01763047|525142078|FG001|Period 2|Unsatisfactory lens Fitting|1|||
145625423|NCT00916006|525142081|FG000|Overall Study|Adverse Event|1|||
145625424|NCT00916006|525142082|FG001|Overall Study|Adverse Event|1|||
145625425|NCT00916006|525142081|FG000|Overall Study|Withdrawal by Subject|2|||
145625426|NCT00916006|525142082|FG001|Overall Study|Withdrawal by Subject|5|||
145625427|NCT00916006|525142081|FG000|Overall Study|Protocol Violation|0|||
145625428|NCT00916006|525142082|FG001|Overall Study|Protocol Violation|1|||
145625429|NCT01008748|525142087|FG000|Overall Study|Lost to Follow-up|80|||
145625430|NCT01008748|525142087|FG000|Overall Study|Other|1|||
145625431|NCT00832780|525142092|FG000|Overall Study|Death|16|||
145625432|NCT00832780|525142092|FG000|Overall Study|Lost to Follow-up|4|||
145625433|NCT00832780|525142092|FG000|Overall Study|no reason given|2|||
145625434|NCT00832780|525142092|FG000|Overall Study|other complicating condition|2|||
145625435|NCT00832780|525142092|FG000|Overall Study|Physician Decision|1|||
145625436|NCT01767909|525142097|FG000|Overall Study|Withdrawal by Subject|4|||
145625437|NCT01767909|525142098|FG001|Overall Study|Withdrawal by Subject|7|||
145625438|NCT01767909|525142097|FG000|Overall Study|Adverse Event|3|||
145625439|NCT01767909|525142098|FG001|Overall Study|Adverse Event|1|||
145625440|NCT01767909|525142097|FG000|Overall Study|Withdrawal by Study Partner|3|||
145625441|NCT01767909|525142098|FG001|Overall Study|Withdrawal by Study Partner|1|||
145439800|NCT01492088|524468426|FG002|Overall Study|Death|2|||
145439801|NCT01492088|524468424|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
145439802|NCT01492088|524468425|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
145439803|NCT01492088|524468426|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
145439804|NCT01492088|524468424|FG000|Overall Study|Alive at Last Follow-up|0|||
145439805|NCT01492088|524468425|FG001|Overall Study|Alive at Last Follow-up|6|||
145439806|NCT01492088|524468426|FG002|Overall Study|Alive at Last Follow-up|11|||
145439807|NCT02379052|524468427|FG000|Overall Study|Protocol Violation|0|||
145439808|NCT02379052|524468428|FG001|Overall Study|Protocol Violation|1|||
145439809|NCT02379052|524468427|FG000|Overall Study|Adverse Event|0|||
145625442|NCT01767909|525142097|FG000|Overall Study|Non-Compliance|2|||
145625443|NCT01767909|525142098|FG001|Overall Study|Non-Compliance|0|||
145439810|NCT02379052|524468428|FG001|Overall Study|Adverse Event|1|||
145625444|NCT01767909|525142097|FG000|Overall Study|Perceived Lack of Efficacy|1|||
145625445|NCT01767909|525142098|FG001|Overall Study|Perceived Lack of Efficacy|0|||
145625446|NCT01767909|525142097|FG000|Overall Study|Investigator Recommendation|0|||
145625447|NCT01767909|525142098|FG001|Overall Study|Investigator Recommendation|1|||
145625448|NCT01767909|525142097|FG000|Overall Study|Lost to Follow-up|0|||
145625449|NCT01767909|525142098|FG001|Overall Study|Lost to Follow-up|1|||
145625450|NCT01767909|525142097|FG000|Overall Study|LP uncessessful|0|||
145625451|NCT01767909|525142098|FG001|Overall Study|LP uncessessful|1|||
145625452|NCT01723774|525142099|FG000|Neoadjuvant|Ki67 > 10%|4|||
145625453|NCT01723774|525142100|FG001|Neoadjuvant|Ki67 > 10%|0|||
145625454|NCT01723774|525142101|FG002|Neoadjuvant|Ki67 > 10%|10|||
145625455|NCT01723774|525142102|FG003|Neoadjuvant|Ki67 > 10%|0|||
145625456|NCT01723774|525142099|FG000|Neoadjuvant|Withdrawal by Subject|3|||
145439811|NCT02379052|524468427|FG000|Overall Study|Physician Decision|1|||
145439812|NCT02379052|524468428|FG001|Overall Study|Physician Decision|1|||
145439813|NCT02379052|524468427|FG000|Overall Study|Withdrawal by Subject|2|||
145439814|NCT02379052|524468428|FG001|Overall Study|Withdrawal by Subject|0|||
145439815|NCT02379052|524468427|FG000|Overall Study|Lost to Follow-up|2|||
145439816|NCT02379052|524468428|FG001|Overall Study|Lost to Follow-up|1|||
145439817|NCT02379052|524468427|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
145439818|NCT02379052|524468428|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
145439819|NCT02379052|524468427|FG000|Overall Study|Subject was Incarcerated|0|||
145439820|NCT02379052|524468428|FG001|Overall Study|Subject was Incarcerated|1|||
145439821|NCT00127855|524468429|FG000|Primary Vaccination Course|Adverse Event|0|||
145439822|NCT00127855|524468430|FG001|Primary Vaccination Course|Adverse Event|0|||
145439823|NCT00127855|524468431|FG002|Primary Vaccination Course|Adverse Event|1|||
145439824|NCT00127855|524468432|FG003|Primary Vaccination Course|Adverse Event|0|||
145439825|NCT00127855|524468433|FG004|Primary Vaccination Course|Adverse Event|0|||
145439826|NCT00127855|524468429|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
145439827|NCT00127855|524468430|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
145439828|NCT00127855|524468431|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
145439829|NCT00127855|524468432|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
145439830|NCT00127855|524468433|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
145439831|NCT00127855|524468429|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
145439832|NCT00127855|524468430|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
145439833|NCT00127855|524468431|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
145439834|NCT00127855|524468432|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
145439835|NCT00127855|524468433|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
145439836|NCT00127855|524468429|FG000|Primary Vaccination Course|Other|0|||
145439837|NCT00127855|524468430|FG001|Primary Vaccination Course|Other|0|||
145439838|NCT00127855|524468431|FG002|Primary Vaccination Course|Other|0|||
145439839|NCT00127855|524468432|FG003|Primary Vaccination Course|Other|0|||
145439840|NCT00127855|524468433|FG004|Primary Vaccination Course|Other|1|||
145439841|NCT02343302|524468434|FG000|Overall Study|Physician Decision|1|||
145439842|NCT02343302|524468435|FG001|Overall Study|Physician Decision|1|||
145439843|NCT01887717|524468436|FG000|Overall Study|Withdrawal by Subject|1|||
145439844|NCT01887717|524468437|FG001|Overall Study|Withdrawal by Subject|7|||
145439845|NCT01887717|524468436|FG000|Overall Study|Physician Decision|0|||
145439846|NCT01887717|524468437|FG001|Overall Study|Physician Decision|2|||
145439847|NCT01887717|524468436|FG000|Overall Study|Administrative reasons|5|||
145439848|NCT01887717|524468437|FG001|Overall Study|Administrative reasons|2|||
145439849|NCT00920556|524468438|FG000|Overall Study|Adverse Event|16|||
145439850|NCT00920556|524468438|FG000|Overall Study|Physician Decision|7|||
145439851|NCT00920556|524468438|FG000|Overall Study|Withdrawal by Subject|1|||
145439852|NCT01299389|524468439|FG000|Double-blind|Adverse Event|45|||
145439853|NCT01299389|524468440|FG001|Double-blind|Adverse Event|27|||
145439854|NCT01299389|524468441|FG002|Double-blind|Adverse Event|0|||
145439855|NCT01299389|524468442|FG003|Double-blind|Adverse Event|0|||
145439856|NCT01299389|524468439|FG000|Double-blind|Lack of Efficacy|45|||
145439857|NCT01299389|524468440|FG001|Double-blind|Lack of Efficacy|21|||
145439858|NCT01299389|524468441|FG002|Double-blind|Lack of Efficacy|0|||
145439859|NCT01299389|524468442|FG003|Double-blind|Lack of Efficacy|0|||
145439860|NCT01299389|524468439|FG000|Double-blind|Lost to Follow-up|2|||
145439861|NCT01299389|524468440|FG001|Double-blind|Lost to Follow-up|1|||
145439862|NCT01299389|524468441|FG002|Double-blind|Lost to Follow-up|0|||
145439863|NCT01299389|524468442|FG003|Double-blind|Lost to Follow-up|0|||
145439864|NCT01299389|524468439|FG000|Double-blind|Withdrawal by Subject|16|||
145439865|NCT01299389|524468440|FG001|Double-blind|Withdrawal by Subject|13|||
145439866|NCT01299389|524468441|FG002|Double-blind|Withdrawal by Subject|0|||
145439867|NCT01299389|524468442|FG003|Double-blind|Withdrawal by Subject|0|||
145439868|NCT01299389|524468439|FG000|Double-blind|Other|1|||
145439869|NCT01299389|524468440|FG001|Double-blind|Other|1|||
145439870|NCT01299389|524468441|FG002|Double-blind|Other|0|||
145439871|NCT01299389|524468442|FG003|Double-blind|Other|0|||
145584570|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
145439872|NCT01299389|524468439|FG000|Double-blind|"fail to meet study population criteria"|0|||
145439873|NCT01299389|524468440|FG001|Double-blind|"fail to meet study population criteria"|1|||
145439874|NCT01299389|524468441|FG002|Double-blind|"fail to meet study population criteria"|0|||
145584571|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
145439875|NCT01299389|524468442|FG003|Double-blind|"fail to meet study population criteria"|0|||
145439876|NCT01299389|524468439|FG000|Post-observational|Other|0|||
145439877|NCT01299389|524468440|FG001|Post-observational|Other|0|||
145439878|NCT01299389|524468441|FG002|Post-observational|Other|12|||
145439879|NCT01299389|524468442|FG003|Post-observational|Other|6|||
145439880|NCT04245709|524468443|FG000|Overall Study|Adverse Event|13|||
145439881|NCT04245709|524468443|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
145439882|NCT00889707|524468445|FG000|Overall Study|Adverse Event|1|||
145439883|NCT00889707|524468446|FG001|Overall Study|Adverse Event|0|||
145439884|NCT00889707|524468445|FG000|Overall Study|Withdrawal by Subject|4|||
145439885|NCT00889707|524468446|FG001|Overall Study|Withdrawal by Subject|3|||
145439886|NCT00889707|524468445|FG000|Overall Study|Lost to Follow-up|0|||
145439887|NCT00889707|524468446|FG001|Overall Study|Lost to Follow-up|2|||
145439888|NCT00889707|524468445|FG000|Overall Study|Lack of Efficacy|2|||
145439889|NCT00889707|524468446|FG001|Overall Study|Lack of Efficacy|5|||
145439890|NCT02948582|524468447|FG000|Washout Period 1|Adverse Event|0|||
145439891|NCT02948582|524468448|FG001|Washout Period 1|Adverse Event|2|||
145439892|NCT02948582|524468449|FG002|Washout Period 1|Adverse Event|0|||
145439893|NCT02948582|524468450|FG003|Washout Period 1|Adverse Event|0|||
145439894|NCT02948582|524468451|FG004|Washout Period 1|Adverse Event|0|||
145439895|NCT02948582|524468452|FG005|Washout Period 1|Adverse Event|0|||
145439896|NCT02948582|524468447|FG000|Washout Period 1|Protocol Violation|0|||
145439897|NCT02948582|524468448|FG001|Washout Period 1|Protocol Violation|0|||
145439898|NCT02948582|524468449|FG002|Washout Period 1|Protocol Violation|0|||
145439899|NCT02948582|524468450|FG003|Washout Period 1|Protocol Violation|0|||
145439900|NCT02948582|524468451|FG004|Washout Period 1|Protocol Violation|0|||
145439901|NCT02948582|524468452|FG005|Washout Period 1|Protocol Violation|1|||
145439902|NCT02948582|524468447|FG000|Washout Period 2|Adverse Event|0|||
145439903|NCT02948582|524468448|FG001|Washout Period 2|Adverse Event|1|||
145439904|NCT02948582|524468449|FG002|Washout Period 2|Adverse Event|0|||
145439905|NCT02948582|524468450|FG003|Washout Period 2|Adverse Event|0|||
145439906|NCT02948582|524468451|FG004|Washout Period 2|Adverse Event|0|||
145439907|NCT02948582|524468452|FG005|Washout Period 2|Adverse Event|0|||
145439908|NCT02948582|524468447|FG000|Washout Period 2|personal reasons|0|||
145439909|NCT02948582|524468448|FG001|Washout Period 2|personal reasons|0|||
145439910|NCT02948582|524468449|FG002|Washout Period 2|personal reasons|0|||
145439911|NCT02948582|524468450|FG003|Washout Period 2|personal reasons|1|||
145439912|NCT02948582|524468451|FG004|Washout Period 2|personal reasons|0|||
145439913|NCT02948582|524468452|FG005|Washout Period 2|personal reasons|0|||
145439914|NCT02948582|524468447|FG000|Washout Period 4|Adverse Event|1|||
145439915|NCT02948582|524468448|FG001|Washout Period 4|Adverse Event|0|||
145439916|NCT02948582|524468449|FG002|Washout Period 4|Adverse Event|1|||
145439917|NCT02948582|524468450|FG003|Washout Period 4|Adverse Event|0|||
145439918|NCT02948582|524468451|FG004|Washout Period 4|Adverse Event|0|||
145439919|NCT02948582|524468452|FG005|Washout Period 4|Adverse Event|0|||
145439920|NCT02041299|524468453|FG000|Overall Study|Adverse Event|9|||
145439921|NCT02041299|524468454|FG001|Overall Study|Adverse Event|3|||
145439922|NCT02041299|524468453|FG000|Overall Study|Lost to Follow-up|4|||
145439923|NCT02041299|524468454|FG001|Overall Study|Lost to Follow-up|1|||
145439924|NCT02041299|524468453|FG000|Overall Study|Physician Decision|1|||
145439925|NCT02041299|524468454|FG001|Overall Study|Physician Decision|1|||
145439926|NCT02041299|524468453|FG000|Overall Study|Withdrawal by Subject|13|||
145439927|NCT02041299|524468454|FG001|Overall Study|Withdrawal by Subject|7|||
145439928|NCT02041299|524468453|FG000|Overall Study|Protocol Violation|11|||
145439929|NCT02041299|524468454|FG001|Overall Study|Protocol Violation|4|||
145439930|NCT02041299|524468453|FG000|Overall Study|Termination of the study|7|||
145439931|NCT02041299|524468454|FG001|Overall Study|Termination of the study|3|||
145439932|NCT02041299|524468453|FG000|Overall Study|Required bone marrow transplant|0|||
145439933|NCT02041299|524468454|FG001|Overall Study|Required bone marrow transplant|1|||
145439934|NCT02041299|524468453|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
145439935|NCT02041299|524468454|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
145439936|NCT02389465|524468455|FG000|Overall Study|Lost to Follow-up|1|||
145439937|NCT02389465|524468456|FG001|Overall Study|Lost to Follow-up|3|||
145439938|NCT02389465|524468457|FG002|Overall Study|Lost to Follow-up|3|||
145439939|NCT02389465|524468458|FG003|Overall Study|Lost to Follow-up|0|||
145439940|NCT02389465|524468455|FG000|Overall Study|Physician Decision|0|||
145439941|NCT02389465|524468456|FG001|Overall Study|Physician Decision|0|||
145439942|NCT02389465|524468457|FG002|Overall Study|Physician Decision|0|||
145439943|NCT02389465|524468458|FG003|Overall Study|Physician Decision|1|||
145439944|NCT02389465|524468455|FG000|Overall Study|Withdrawal by Subject|0|||
145439945|NCT02389465|524468456|FG001|Overall Study|Withdrawal by Subject|1|||
145439946|NCT02389465|524468457|FG002|Overall Study|Withdrawal by Subject|2|||
145439947|NCT02389465|524468458|FG003|Overall Study|Withdrawal by Subject|2|||
145439948|NCT04419467|524468459|FG000|Overall Study|Not treated with IP|0|||
145439949|NCT04419467|524468460|FG001|Overall Study|Not treated with IP|0|||
145439950|NCT04419467|524468461|FG002|Overall Study|Not treated with IP|2|||
145439951|NCT04419467|524468459|FG000|Overall Study|Adverse Event|0|||
145439952|NCT04419467|524468460|FG001|Overall Study|Adverse Event|2|||
145439953|NCT04419467|524468461|FG002|Overall Study|Adverse Event|0|||
145439954|NCT04419467|524468459|FG000|Overall Study|Death|1|||
145439955|NCT04419467|524468460|FG001|Overall Study|Death|0|||
145439956|NCT04419467|524468461|FG002|Overall Study|Death|0|||
145439957|NCT04419467|524468459|FG000|Overall Study|Lost to Follow-up|0|||
145439958|NCT04419467|524468460|FG001|Overall Study|Lost to Follow-up|1|||
145439959|NCT04419467|524468461|FG002|Overall Study|Lost to Follow-up|2|||
145439960|NCT04419467|524468459|FG000|Overall Study|Withdrawal by Subject|0|||
145439961|NCT04419467|524468460|FG001|Overall Study|Withdrawal by Subject|0|||
145439962|NCT04419467|524468461|FG002|Overall Study|Withdrawal by Subject|4|||
145439963|NCT04419467|524468459|FG000|Overall Study|Pandemic related|0|||
145439964|NCT04419467|524468460|FG001|Overall Study|Pandemic related|0|||
145439965|NCT04419467|524468461|FG002|Overall Study|Pandemic related|1|||
145625457|NCT01723774|525142100|FG001|Neoadjuvant|Withdrawal by Subject|1|||
145625458|NCT01723774|525142101|FG002|Neoadjuvant|Withdrawal by Subject|0|||
145625459|NCT01723774|525142102|FG003|Neoadjuvant|Withdrawal by Subject|0|||
145625460|NCT01723774|525142099|FG000|Neoadjuvant|Disease progression|0|||
145439966|NCT04419467|524468459|FG000|Overall Study|Reason not known|1|||
145584572|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
145584573|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
145584574|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
145584575|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
145584576|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
145584577|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
145584578|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
145584579|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
145584580|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
145584581|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
145584582|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
145584583|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
145584584|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
145584585|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
145584586|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
145584587|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
145584588|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
145584589|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
145584590|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
145584591|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
145584592|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
145584593|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
145584594|NCT00383435|524993574|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
145584595|NCT00383435|524993575|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
145584596|NCT00383435|524993576|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
145584597|NCT00383435|524993577|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
145584598|NCT00383435|524993578|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
145584599|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
145584600|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
145584601|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
145584602|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
145584603|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
145584604|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
145584605|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
145584606|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
145584607|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
145584608|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
145584609|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
145584610|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
145584611|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
145584612|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
145584613|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
145584614|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
145584615|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
145584616|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
145584617|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
145584618|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
145584619|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145584620|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
145584621|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
145584622|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
145584623|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
145584624|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
145584625|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
145625461|NCT01723774|525142100|FG001|Neoadjuvant|Disease progression|1|||
145625462|NCT01723774|525142101|FG002|Neoadjuvant|Disease progression|1|||
145439967|NCT04419467|524468460|FG001|Overall Study|Reason not known|0|||
145439968|NCT04419467|524468461|FG002|Overall Study|Reason not known|0|||
145439969|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
145439970|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145439971|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
145439972|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
145439973|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
145439974|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
145439975|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
145439976|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
145584626|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
145584627|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
145584628|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
145584629|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
145584630|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
145584631|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
145584632|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
145584633|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
145584634|NCT00383435|524993574|FG000|26-Week Treatment Safety Extension|Administrative|1|||
145584635|NCT00383435|524993575|FG001|26-Week Treatment Safety Extension|Administrative|1|||
145584636|NCT00383435|524993576|FG002|26-Week Treatment Safety Extension|Administrative|0|||
145584637|NCT00383435|524993577|FG003|26-Week Treatment Safety Extension|Administrative|1|||
145584638|NCT00383435|524993578|FG004|26-Week Treatment Safety Extension|Administrative|0|||
145584639|NCT02347761|524993579|FG000|All Collected|Death|1|||
145584640|NCT02347761|524993580|FG001|All Collected|Death|0|||
145584641|NCT02347761|524993581|FG002|All Collected|Death|0|||
145584642|NCT02347761|524993579|FG000|All Collected|Lost to Follow-up|3|||
145584643|NCT02347761|524993580|FG001|All Collected|Lost to Follow-up|2|||
145584644|NCT02347761|524993581|FG002|All Collected|Lost to Follow-up|3|||
145584645|NCT02347761|524993579|FG000|All Collected|Withdrawal by Subject|11|||
145584646|NCT02347761|524993580|FG001|All Collected|Withdrawal by Subject|11|||
145584647|NCT02347761|524993581|FG002|All Collected|Withdrawal by Subject|22|||
145584648|NCT02347761|524993579|FG000|All Collected|invetigator disretion|2|||
145584649|NCT02347761|524993580|FG001|All Collected|invetigator disretion|0|||
145584650|NCT02347761|524993581|FG002|All Collected|invetigator disretion|0|||
145584651|NCT02347761|524993579|FG000|All Collected|instillation site pain|0|||
145584652|NCT02347761|524993580|FG001|All Collected|instillation site pain|0|||
145584653|NCT02347761|524993581|FG002|All Collected|instillation site pain|1|||
145584654|NCT02347761|524993579|FG000|All Collected|exacerbation of COPD|0|||
145584655|NCT02347761|524993580|FG001|All Collected|exacerbation of COPD|0|||
145584656|NCT02347761|524993581|FG002|All Collected|exacerbation of COPD|1|||
145584657|NCT02347761|524993579|FG000|All Collected|moved/travel|0|||
145584658|NCT02347761|524993580|FG001|All Collected|moved/travel|1|||
145584659|NCT02347761|524993581|FG002|All Collected|moved/travel|0|||
145584660|NCT02347761|524993579|FG000|On Study Treatment|Lack of Efficacy|2|||
145584661|NCT02347761|524993580|FG001|On Study Treatment|Lack of Efficacy|3|||
145584662|NCT02347761|524993581|FG002|On Study Treatment|Lack of Efficacy|4|||
145584663|NCT02347761|524993579|FG000|On Study Treatment|non-compliance with study medication|0|||
145584664|NCT02347761|524993580|FG001|On Study Treatment|non-compliance with study medication|0|||
145584665|NCT02347761|524993581|FG002|On Study Treatment|non-compliance with study medication|2|||
145584666|NCT02347761|524993579|FG000|On Study Treatment|Withdrawal by Subject|7|||
145584667|NCT02347761|524993580|FG001|On Study Treatment|Withdrawal by Subject|3|||
145584668|NCT02347761|524993581|FG002|On Study Treatment|Withdrawal by Subject|5|||
145584669|NCT02347761|524993579|FG000|On Study Treatment|move/travel|2|||
145584670|NCT02347761|524993580|FG001|On Study Treatment|move/travel|6|||
145584671|NCT02347761|524993581|FG002|On Study Treatment|move/travel|5|||
145584672|NCT02347761|524993579|FG000|On Study Treatment|dissastisfaction with device|2|||
145584673|NCT02347761|524993580|FG001|On Study Treatment|dissastisfaction with device|1|||
145584674|NCT02347761|524993581|FG002|On Study Treatment|dissastisfaction with device|4|||
145584675|NCT02347761|524993579|FG000|On Study Treatment|Lost to Follow-up|2|||
145584676|NCT02347761|524993580|FG001|On Study Treatment|Lost to Follow-up|1|||
145584677|NCT02347761|524993581|FG002|On Study Treatment|Lost to Follow-up|1|||
145584678|NCT02347761|524993579|FG000|On Study Treatment|investigator discretion|2|||
145625463|NCT01723774|525142102|FG003|Neoadjuvant|Disease progression|0|||
145584679|NCT02347761|524993580|FG001|On Study Treatment|investigator discretion|0|||
145625464|NCT01723774|525142099|FG000|Neoadjuvant|Adverse Event|0|||
145584680|NCT02347761|524993581|FG002|On Study Treatment|investigator discretion|0|||
145584681|NCT02347761|524993579|FG000|On Study Treatment|durg not working|0|||
145584682|NCT02347761|524993580|FG001|On Study Treatment|durg not working|1|||
145625465|NCT01723774|525142100|FG001|Neoadjuvant|Adverse Event|1|||
145584683|NCT02347761|524993581|FG002|On Study Treatment|durg not working|1|||
145584684|NCT02347761|524993579|FG000|On Study Treatment|Adverse Event|10|||
145584685|NCT02347761|524993580|FG001|On Study Treatment|Adverse Event|8|||
145584686|NCT02347761|524993581|FG002|On Study Treatment|Adverse Event|20|||
145584687|NCT01131312|524993582|FG000|Overall Study|Lost to Follow-up|425|||
145584688|NCT01131312|524993583|FG001|Overall Study|Lost to Follow-up|229|||
145439977|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
145439978|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
145439979|NCT01925768|524468462|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
145439980|NCT01925768|524468463|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
145439981|NCT01925768|524468462|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
145439982|NCT01925768|524468463|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
145439983|NCT01925768|524468462|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
145439984|NCT01925768|524468463|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
145439985|NCT01925768|524468462|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
145439986|NCT01925768|524468463|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
145439987|NCT01925768|524468462|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
145439988|NCT01925768|524468463|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
145439989|NCT01925768|524468462|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
145439990|NCT01925768|524468463|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
145439991|NCT00003631|524468465|FG000|Overall Study|Patient not treated|1|||
145439992|NCT00003631|524468466|FG001|Overall Study|Patient not treated|0|||
145439993|NCT00003631|524468467|FG002|Overall Study|Patient not treated|1|||
145439994|NCT00003631|524468465|FG000|Overall Study|Protocol Violation|1|||
145439995|NCT00003631|524468466|FG001|Overall Study|Protocol Violation|0|||
145439996|NCT00003631|524468467|FG002|Overall Study|Protocol Violation|0|||
145439997|NCT00003631|524468465|FG000|Overall Study|Adverse Event|1|||
145439998|NCT00003631|524468466|FG001|Overall Study|Adverse Event|1|||
145439999|NCT00003631|524468467|FG002|Overall Study|Adverse Event|5|||
145440000|NCT00003631|524468465|FG000|Overall Study|Death|0|||
145440001|NCT00003631|524468466|FG001|Overall Study|Death|0|||
145440002|NCT00003631|524468467|FG002|Overall Study|Death|1|||
145440003|NCT00003631|524468465|FG000|Overall Study|Evaluable for toxicity only|0|||
145440004|NCT00003631|524468466|FG001|Overall Study|Evaluable for toxicity only|0|||
145440005|NCT00003631|524468467|FG002|Overall Study|Evaluable for toxicity only|2|||
145440006|NCT00087698|524468477|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
145440007|NCT00087698|524468477|FG000|Overall Study|Death from Other Causes|3|||
145440008|NCT00087698|524468477|FG000|Overall Study|Adverse Event|4|||
145440009|NCT00087698|524468477|FG000|Overall Study|Withdrawal by Subject|4|||
145440010|NCT00087698|524468477|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
145440011|NCT00087698|524468477|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
145440012|NCT00087698|524468477|FG000|Overall Study|Clinical Relapse|1|||
145440013|NCT00087698|524468477|FG000|Overall Study|Death from Study Disease|2|||
145440014|NCT00087698|524468477|FG000|Overall Study|Death from Study Drug Toxicity|2|||
145440015|NCT00087698|524468477|FG000|Overall Study|Protocol Violation|1|||
145440016|NCT01853462|524468478|FG000|Overall Study|Withdrawal by Subject|1|||
145440017|NCT01853462|524468479|FG001|Overall Study|Withdrawal by Subject|1|||
145440018|NCT03943290|524468483|FG000|Overall Study|Sponsor Terminated Study|6|||
145440019|NCT03943290|524468484|FG001|Overall Study|Sponsor Terminated Study|1|||
145440020|NCT03943290|524468485|FG002|Overall Study|Sponsor Terminated Study|11|||
145440021|NCT03943290|524468486|FG003|Overall Study|Sponsor Terminated Study|6|||
145440022|NCT03943290|524468487|FG004|Overall Study|Sponsor Terminated Study|7|||
145440023|NCT03943290|524468488|FG005|Overall Study|Sponsor Terminated Study|6|||
145440024|NCT03943290|524468489|FG006|Overall Study|Sponsor Terminated Study|6|||
145440025|NCT03943290|524468490|FG007|Overall Study|Sponsor Terminated Study|7|||
145440026|NCT03943290|524468491|FG008|Overall Study|Sponsor Terminated Study|8|||
145440027|NCT03943290|524468483|FG000|Overall Study|Lost to Follow-up|1|||
145440028|NCT03943290|524468484|FG001|Overall Study|Lost to Follow-up|0|||
145440029|NCT03943290|524468485|FG002|Overall Study|Lost to Follow-up|1|||
145440030|NCT03943290|524468486|FG003|Overall Study|Lost to Follow-up|0|||
145440031|NCT03943290|524468487|FG004|Overall Study|Lost to Follow-up|0|||
145440032|NCT03943290|524468488|FG005|Overall Study|Lost to Follow-up|0|||
145440033|NCT03943290|524468489|FG006|Overall Study|Lost to Follow-up|0|||
145440034|NCT03943290|524468490|FG007|Overall Study|Lost to Follow-up|1|||
145440035|NCT03943290|524468491|FG008|Overall Study|Lost to Follow-up|0|||
145440036|NCT03943290|524468483|FG000|Overall Study|Withdrawal by Subject|0|||
145440037|NCT03943290|524468484|FG001|Overall Study|Withdrawal by Subject|0|||
145440038|NCT03943290|524468485|FG002|Overall Study|Withdrawal by Subject|1|||
145440039|NCT03943290|524468486|FG003|Overall Study|Withdrawal by Subject|0|||
145440040|NCT03943290|524468487|FG004|Overall Study|Withdrawal by Subject|0|||
145440041|NCT03943290|524468488|FG005|Overall Study|Withdrawal by Subject|0|||
145440042|NCT03943290|524468489|FG006|Overall Study|Withdrawal by Subject|0|||
145440043|NCT03943290|524468490|FG007|Overall Study|Withdrawal by Subject|0|||
145440044|NCT03943290|524468491|FG008|Overall Study|Withdrawal by Subject|0|||
145440045|NCT04068922|524468495|FG000|Overall Study|Lost to Follow-up|5|||
145440046|NCT04068922|524468495|FG000|Overall Study|Withdrawal by Subject|7|||
145440047|NCT04068922|524468495|FG000|Overall Study|Adverse Event|1|||
145440048|NCT03542266|524468496|FG000|Treatment Phase|Withdrawal by Subject|1|||
145440049|NCT03542266|524468496|FG000|Treatment Phase|Adverse Event|1|||
145440050|NCT03542266|524468496|FG000|Treatment Phase|PD|1|||
145625466|NCT01723774|525142101|FG002|Neoadjuvant|Adverse Event|2|||
145625467|NCT01723774|525142102|FG003|Neoadjuvant|Adverse Event|0|||
145440051|NCT00625586|524468497|FG000|Overall Study|Adverse Event|1|||
145440052|NCT00625586|524468497|FG000|Overall Study|Progressive disease|1|||
145440053|NCT00657267|524468510|FG000|Overall Study|Progressive disease|45|||
145440054|NCT00657267|524468510|FG000|Overall Study|Adverse Event|9|||
145440055|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Death|2|||
145440056|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
145440057|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
145440058|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Physician Decision|1|||
145440059|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
145440060|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
145440061|NCT00786422|524468511|FG000|Rivaroxaban Treatment|Adverse Event|2|||
145440062|NCT00786422|524468511|FG000|Follow-up Period|Death|1|||
145440063|NCT00786422|524468511|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
145440064|NCT03484429|524468512|FG000|Overall Study|Withdrawal by Subject|1|||
145440065|NCT03484429|524468513|FG001|Overall Study|Withdrawal by Subject|0|||
145440066|NCT03484429|524468512|FG000|Overall Study|Adverse Event|2|||
145440067|NCT03484429|524468513|FG001|Overall Study|Adverse Event|0|||
145440068|NCT04466384|524468514|FG000|First Phase|Protocol Violation|1|||
145440069|NCT04466384|524468515|FG001|First Phase|Protocol Violation|0|||
145440070|NCT04466384|524468514|FG000|First Phase|Missing data|1|||
145440071|NCT04466384|524468515|FG001|First Phase|Missing data|0|||
145440072|NCT04466384|524468514|FG000|Cross Over Phase|Physician Decision|1|||
145440073|NCT04466384|524468515|FG001|Cross Over Phase|Physician Decision|0|||
145440074|NCT04466384|524468514|FG000|Cross Over Phase|Withdrawal by Subject|0|||
145440075|NCT04466384|524468515|FG001|Cross Over Phase|Withdrawal by Subject|1|||
145440076|NCT02268383|524468516|FG000|Overall Study|Death|12|||
145440077|NCT02268383|524468516|FG000|Overall Study|Lost to Follow-up|2|||
145440078|NCT02268383|524468516|FG000|Overall Study|Withdrawal by Subject|9|||
145440079|NCT02268383|524468516|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
145440080|NCT02268383|524468516|FG000|Overall Study|Protocol deviation|3|||
145440081|NCT02268383|524468516|FG000|Overall Study|Sponsor decision|22|||
145440082|NCT02268383|524468516|FG000|Overall Study|Not reported|12|||
145440083|NCT04162470|524468517|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
145440084|NCT02964273|524469723|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
145440085|NCT02964273|524469724|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
145440086|NCT02964273|524469725|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
145440087|NCT02964273|524469726|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
145440088|NCT02964273|524469723|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
145440089|NCT02964273|524469724|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
145440090|NCT02964273|524469725|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
145440091|NCT02964273|524469726|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
145440092|NCT02964273|524469723|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
145440093|NCT02964273|524469724|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
145440094|NCT02964273|524469725|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
145440095|NCT02964273|524469726|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
145440096|NCT02964273|524469723|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
145440097|NCT02964273|524469724|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
145440098|NCT02964273|524469725|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
145440099|NCT02964273|524469726|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
145440100|NCT02964273|524469723|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
145440101|NCT02964273|524469724|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
145440102|NCT02964273|524469725|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
145440103|NCT02964273|524469726|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
145440104|NCT02964273|524469723|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
145440105|NCT02964273|524469724|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
145440106|NCT02964273|524469725|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
145440107|NCT02964273|524469726|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
145440108|NCT04245449|524469728|FG000|Overall Study|COVID shutdown|7|||
145440109|NCT03073525|524469729|FG000|Overall Study|Withdrawal by Subject|0|||
145440110|NCT03073525|524469730|FG001|Overall Study|Withdrawal by Subject|0|||
145440111|NCT03073525|524469731|FG002|Overall Study|Withdrawal by Subject|3|||
145440112|NCT01976299|524469732|FG000|Overall Study|Withdrawal by Subject|3|||
145440113|NCT01976299|524469733|FG001|Overall Study|Withdrawal by Subject|1|||
145440114|NCT01976299|524469732|FG000|Overall Study|Death|4|||
145440115|NCT01976299|524469733|FG001|Overall Study|Death|2|||
145440116|NCT01976299|524469732|FG000|Overall Study|Lost to Follow-up|7|||
145440117|NCT01976299|524469733|FG001|Overall Study|Lost to Follow-up|1|||
145440118|NCT01976299|524469732|FG000|Overall Study|See clarification above in comments|9|||
145440119|NCT01976299|524469733|FG001|Overall Study|See clarification above in comments|2|||
145625468|NCT01723774|525142099|FG000|Neoadjuvant|High estradiol|0|||
145625469|NCT01723774|525142100|FG001|Neoadjuvant|High estradiol|1|||
145625470|NCT01723774|525142101|FG002|Neoadjuvant|High estradiol|0|||
145625471|NCT01723774|525142102|FG003|Neoadjuvant|High estradiol|0|||
145625472|NCT04956692|525142105|FG000|Overall Study|Death|115|||
145625473|NCT04956692|525142106|FG001|Overall Study|Death|47|||
145625474|NCT04956692|525142105|FG000|Overall Study|Lost to Follow-up|0|||
145625475|NCT04956692|525142106|FG001|Overall Study|Lost to Follow-up|1|||
145625476|NCT04956692|525142105|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145625477|NCT04956692|525142106|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145625478|NCT04956692|525142105|FG000|Overall Study|Withdrawal by Subject|5|||
145625479|NCT04956692|525142106|FG001|Overall Study|Withdrawal by Subject|2|||
145625480|NCT04956692|525142105|FG000|Overall Study|Ongoing in Study|236|||
145625481|NCT04956692|525142106|FG001|Overall Study|Ongoing in Study|123|||
145625482|NCT04639947|525142107|FG000|Overall Study|Screen fail|1|||
145625483|NCT02696785|525142112|FG000|Blinded Treatment Period|Adverse Event|0|||
145625484|NCT02696785|525142113|FG001|Blinded Treatment Period|Adverse Event|1|||
145625485|NCT02696785|525142114|FG002|Blinded Treatment Period|Adverse Event|3|||
145625486|NCT02696785|525142115|FG003|Blinded Treatment Period|Adverse Event|0|||
145625487|NCT02696785|525142112|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
145625488|NCT02696785|525142113|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
145625489|NCT02696785|525142114|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
145625490|NCT02696785|525142115|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
145625491|NCT02696785|525142112|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
145625492|NCT02696785|525142113|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
145625493|NCT02696785|525142114|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
145625494|NCT02696785|525142115|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
145625495|NCT02696785|525142112|FG000|Blinded Treatment Period|Screen Failure|1|||
145625496|NCT02696785|525142113|FG001|Blinded Treatment Period|Screen Failure|0|||
145625497|NCT02696785|525142114|FG002|Blinded Treatment Period|Screen Failure|0|||
145625498|NCT02696785|525142115|FG003|Blinded Treatment Period|Screen Failure|0|||
145625499|NCT02696785|525142112|FG000|Washout Period|Withdrawal by Subject|0|||
145625500|NCT02696785|525142113|FG001|Washout Period|Withdrawal by Subject|1|||
145625501|NCT02696785|525142114|FG002|Washout Period|Withdrawal by Subject|0|||
145625502|NCT02696785|525142115|FG003|Washout Period|Withdrawal by Subject|0|||
145625503|NCT02696785|525142112|FG000|Washout Period|Lack of Efficacy|0|||
145625504|NCT02696785|525142113|FG001|Washout Period|Lack of Efficacy|1|||
145625505|NCT02696785|525142114|FG002|Washout Period|Lack of Efficacy|0|||
145625506|NCT02696785|525142115|FG003|Washout Period|Lack of Efficacy|0|||
145625507|NCT02696785|525142112|FG000|Extended Treatment Period|Adverse Event|2|||
145625508|NCT02696785|525142113|FG001|Extended Treatment Period|Adverse Event|3|||
145625509|NCT02696785|525142114|FG002|Extended Treatment Period|Adverse Event|2|||
145625510|NCT02696785|525142115|FG003|Extended Treatment Period|Adverse Event|1|||
145625511|NCT02696785|525142112|FG000|Extended Treatment Period|Lack of Efficacy|0|||
145625512|NCT02696785|525142113|FG001|Extended Treatment Period|Lack of Efficacy|1|||
145625513|NCT02696785|525142114|FG002|Extended Treatment Period|Lack of Efficacy|0|||
145625514|NCT02696785|525142115|FG003|Extended Treatment Period|Lack of Efficacy|0|||
145625515|NCT02696785|525142112|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
145625516|NCT02696785|525142113|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
145625517|NCT02696785|525142114|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
145625518|NCT02696785|525142115|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
145625519|NCT02696785|525142112|FG000|Follow-up Period|Adverse Event|0|||
145625520|NCT02696785|525142113|FG001|Follow-up Period|Adverse Event|0|||
145625521|NCT02696785|525142114|FG002|Follow-up Period|Adverse Event|8|||
145625522|NCT02696785|525142115|FG003|Follow-up Period|Adverse Event|2|||
145625523|NCT02696785|525142112|FG000|Follow-up Period|Lost to Follow-up|0|||
145625524|NCT02696785|525142113|FG001|Follow-up Period|Lost to Follow-up|0|||
145625525|NCT02696785|525142114|FG002|Follow-up Period|Lost to Follow-up|0|||
145625526|NCT02696785|525142115|FG003|Follow-up Period|Lost to Follow-up|1|||
145625527|NCT02696785|525142112|FG000|Follow-up Period|Lack of Efficacy|0|||
145625528|NCT02696785|525142113|FG001|Follow-up Period|Lack of Efficacy|0|||
145625529|NCT02696785|525142114|FG002|Follow-up Period|Lack of Efficacy|0|||
145625530|NCT02696785|525142115|FG003|Follow-up Period|Lack of Efficacy|1|||
145625531|NCT02696785|525142112|FG000|Follow-up Period|Withdrawal by Subject|1|||
145625532|NCT02696785|525142113|FG001|Follow-up Period|Withdrawal by Subject|0|||
145625533|NCT02696785|525142114|FG002|Follow-up Period|Withdrawal by Subject|5|||
145625534|NCT02696785|525142115|FG003|Follow-up Period|Withdrawal by Subject|4|||
145625535|NCT04863898|525142119|FG000|Overall Study|Away from study clinic during intervention training period|2|||
145625536|NCT04863898|525142119|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
145625537|NCT04863898|525142119|FG000|Overall Study|Lost to Follow-up|3|||
145625538|NCT04863898|525142119|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
145625539|NCT04863898|525142119|FG000|Overall Study|No longer employed at clinic|3|||
145625540|NCT03285711|525142120|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
145625541|NCT03285711|525142121|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
145625542|NCT03285711|525142122|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
145625543|NCT03285711|525142123|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
145625544|NCT03285711|525142120|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
145625545|NCT03285711|525142121|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
145625546|NCT03285711|525142122|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
145625547|NCT03285711|525142123|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
145625548|NCT03285711|525142120|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
145625549|NCT03285711|525142121|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
145625550|NCT03285711|525142122|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
145625551|NCT03285711|525142123|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
145625552|NCT03285711|525142120|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
145625553|NCT03285711|525142121|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
145625554|NCT03285711|525142122|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
145625555|NCT03285711|525142123|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
145625556|NCT02431533|525142124|FG000|Overall Study|Withdrawal by Subject|1|||
145625557|NCT02431533|525142125|FG001|Overall Study|Withdrawal by Subject|3|||
145625558|NCT02431533|525142124|FG000|Overall Study|Developed Exclusionary criteria|1|||
145625559|NCT02431533|525142125|FG001|Overall Study|Developed Exclusionary criteria|0|||
145625560|NCT00235495|525142126|FG000|Overall Study|Death|52|||
145625561|NCT00235495|525142127|FG001|Overall Study|Death|42|||
145625562|NCT00235495|525142126|FG000|Overall Study|Withdrawal by Subject|5|||
145625563|NCT00235495|525142127|FG001|Overall Study|Withdrawal by Subject|3|||
145625564|NCT00235495|525142126|FG000|Overall Study|Lost to Follow-up|11|||
145625565|NCT00235495|525142127|FG001|Overall Study|Lost to Follow-up|13|||
145625566|NCT00235495|525142126|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
145625567|NCT00235495|525142127|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
145625568|NCT02234310|525142128|FG000|Overall Study|Physician Decision|1|||
145625569|NCT02234310|525142128|FG000|Overall Study|Adverse Event|1|||
145625570|NCT02234310|525142128|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
145625571|NCT02234310|525142128|FG000|Overall Study|Withdrawal by Subject|2|||
145625572|NCT03251378|525142129|FG000|Overall Study|Death|3|||
145625573|NCT03251378|525142130|FG001|Overall Study|Death|2|||
145625574|NCT03251378|525142131|FG002|Overall Study|Death|3|||
145625575|NCT03251378|525142132|FG003|Overall Study|Death|30|||
145625576|NCT03251378|525142133|FG004|Overall Study|Death|24|||
145625577|NCT03251378|525142134|FG005|Overall Study|Death|12|||
145625578|NCT03251378|525142135|FG006|Overall Study|Death|12|||
145625579|NCT03251378|525142129|FG000|Overall Study|Lost to Follow-up|0|||
145625580|NCT03251378|525142130|FG001|Overall Study|Lost to Follow-up|0|||
145625581|NCT03251378|525142131|FG002|Overall Study|Lost to Follow-up|1|||
145625582|NCT03251378|525142132|FG003|Overall Study|Lost to Follow-up|3|||
145625583|NCT03251378|525142133|FG004|Overall Study|Lost to Follow-up|0|||
145625584|NCT03251378|525142134|FG005|Overall Study|Lost to Follow-up|0|||
145625585|NCT03251378|525142135|FG006|Overall Study|Lost to Follow-up|0|||
145625586|NCT03251378|525142129|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
145625587|NCT03251378|525142130|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
145625588|NCT03251378|525142131|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
145625589|NCT03251378|525142132|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
145625590|NCT03251378|525142133|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
145625591|NCT03251378|525142134|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
145625592|NCT03251378|525142135|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
145625593|NCT03251378|525142129|FG000|Overall Study|Progressive disease|2|||
145625594|NCT03251378|525142130|FG001|Overall Study|Progressive disease|0|||
145440120|NCT01645735|524469736|FG000|Overall Study|Physician Decision|2|||
145440121|NCT01645735|524469737|FG001|Overall Study|Physician Decision|0|||
145440122|NCT01645735|524469736|FG000|Overall Study|Withdrawal by Subject|1|||
145440123|NCT01645735|524469737|FG001|Overall Study|Withdrawal by Subject|0|||
145440124|NCT01645735|524469736|FG000|Overall Study|Protocol Violation|1|||
145440125|NCT01645735|524469737|FG001|Overall Study|Protocol Violation|0|||
145440126|NCT01645735|524469736|FG000|Overall Study|Adverse Event|0|||
145440127|NCT01645735|524469737|FG001|Overall Study|Adverse Event|1|||
145440128|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
145440129|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
145440130|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
145440131|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
145440132|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
145440133|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
145440134|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
145440135|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
145440136|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
145440137|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
145440138|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
145440139|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
145440140|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
145440141|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
145440142|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
145440143|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
145440144|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
145440145|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
145440146|NCT02831855|524469744|FG000|Open Label Phase (24 Weeks)|Other|4|||
145440147|NCT02831855|524469745|FG001|Open Label Phase (24 Weeks)|Other|0|||
145440148|NCT02831855|524469746|FG002|Open Label Phase (24 Weeks)|Other|0|||
145440149|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
145440150|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
145440151|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
145440152|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Death|0|||
145440153|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Death|0|||
145440154|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Death|2|||
145440155|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
145440156|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
145440157|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
145440158|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
145440159|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
145440160|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
145440161|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
145440162|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
145440163|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
145440164|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Other|0|||
145440165|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Other|2|||
145440166|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Other|5|||
145440167|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
145440168|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
145440169|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
145440170|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
145440171|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
145440172|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
145440173|NCT02831855|524469744|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
145440174|NCT02831855|524469745|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
145440175|NCT02831855|524469746|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
145440176|NCT02236572|524469748|FG000|Overall Study|Withdrawal by Subject|1|||
145440177|NCT02236572|524469748|FG000|Overall Study|Protocol Violation|1|||
145440178|NCT02236572|524469748|FG000|Overall Study|Lost to Follow-up|1|||
145440179|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
145440180|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
145440181|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
145440182|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
145440183|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
145440184|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
145440185|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
145440186|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
145440187|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
145440188|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
145440189|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
145440190|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
145440191|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
145440192|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
145440193|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
145440194|NCT01057693|524469749|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
145440195|NCT01057693|524469750|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
145440196|NCT01057693|524469751|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
145440197|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
145440198|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
145440199|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
145440200|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
145440201|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
145440202|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
145440203|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
145440204|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
145440205|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
145440206|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
145440207|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
145440208|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
145440209|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
145440210|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
145440211|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
145440212|NCT01057693|524469749|FG000|Between Single-Blind and Double-Blind|Other|6|||
145440213|NCT01057693|524469750|FG001|Between Single-Blind and Double-Blind|Other|0|||
145440214|NCT01057693|524469751|FG002|Between Single-Blind and Double-Blind|Other|0|||
145440215|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
145440216|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
145440217|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
145440218|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
145440219|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
145440220|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
145440221|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
145440222|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
145440223|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
145440224|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
145440225|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
145440226|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
145440227|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
145440228|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
145440229|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
145440230|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
145440231|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
145440232|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
145440233|NCT01057693|524469749|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
145440234|NCT01057693|524469750|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
145440235|NCT01057693|524469751|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
145440236|NCT02413996|524469752|FG000|Overall Study|not comfortable with the intervention|9|||
145440237|NCT02413996|524469753|FG001|Overall Study|not comfortable with the intervention|2|||
145440238|NCT01881789|524469757|FG000|Overall Study|Withdrawal by Subject|0|||
145440239|NCT01881789|524469758|FG001|Overall Study|Withdrawal by Subject|2|||
145440240|NCT01881789|524469759|FG002|Overall Study|Withdrawal by Subject|1|||
145440241|NCT01881789|524469760|FG003|Overall Study|Withdrawal by Subject|0|||
145440242|NCT01881789|524469761|FG004|Overall Study|Withdrawal by Subject|1|||
145440243|NCT01881789|524469762|FG005|Overall Study|Withdrawal by Subject|1|||
145440244|NCT01881789|524469757|FG000|Overall Study|Study Terminated by Sponsor|0|||
145440245|NCT01881789|524469758|FG001|Overall Study|Study Terminated by Sponsor|0|||
145440246|NCT01881789|524469759|FG002|Overall Study|Study Terminated by Sponsor|0|||
145440247|NCT01881789|524469760|FG003|Overall Study|Study Terminated by Sponsor|0|||
145440248|NCT01881789|524469761|FG004|Overall Study|Study Terminated by Sponsor|0|||
145440249|NCT01881789|524469762|FG005|Overall Study|Study Terminated by Sponsor|1|||
145440250|NCT01881789|524469757|FG000|Overall Study|Other|3|||
145440251|NCT01881789|524469758|FG001|Overall Study|Other|5|||
145440252|NCT01881789|524469759|FG002|Overall Study|Other|2|||
145440253|NCT01881789|524469760|FG003|Overall Study|Other|3|||
145440254|NCT01881789|524469761|FG004|Overall Study|Other|1|||
145440255|NCT01881789|524469762|FG005|Overall Study|Other|1|||
145440256|NCT02834819|524469765|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
145440257|NCT02834819|524469766|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
145440258|NCT03465722|524469769|FG000|Overall Study|Withdrawal by Subject|21|||
145440259|NCT03465722|524469770|FG001|Overall Study|Withdrawal by Subject|14|||
145440260|NCT03465722|524469769|FG000|Overall Study|Death|89|||
145440261|NCT03465722|524469770|FG001|Overall Study|Death|87|||
145440262|NCT03465722|524469769|FG000|Overall Study|Lost to Follow-up|5|||
145440263|NCT03465722|524469770|FG001|Overall Study|Lost to Follow-up|3|||
145440264|NCT03465722|524469769|FG000|Overall Study|Administrative/Other|33|||
145440265|NCT03465722|524469770|FG001|Overall Study|Administrative/Other|32|||
145440266|NCT03465722|524469769|FG000|Overall Study|Not treated|1|||
145440267|NCT03465722|524469770|FG001|Overall Study|Not treated|2|||
145440268|NCT03465722|524469769|FG000|Overall Study|Sponsor decision|91|||
145440269|NCT03465722|524469770|FG001|Overall Study|Sponsor decision|98|||
145440270|NCT01635998|524469774|FG000|Overall Study|Death|1|||
145440271|NCT01635998|524469775|FG001|Overall Study|Death|1|||
145440272|NCT01635998|524469774|FG000|Overall Study|Lost to Follow-up|2|||
145440273|NCT01635998|524469775|FG001|Overall Study|Lost to Follow-up|1|||
145440274|NCT01635998|524469774|FG000|Overall Study|Withdrawal by Subject|1|||
145440275|NCT01635998|524469775|FG001|Overall Study|Withdrawal by Subject|5|||
145440276|NCT00846846|524469776|FG000|Overall Study|Death|56|||
145440277|NCT00846846|524469776|FG000|Overall Study|Withdrawal by Subject|19|||
145440278|NCT04339413|524469777|FG000|Overall Study|Reason Not Specified|2|||
145440279|NCT04339413|524469778|FG001|Overall Study|Reason Not Specified|7|||
145440280|NCT04339413|524469777|FG000|Overall Study|Study Terminated by Sponsor|30|||
145625595|NCT03251378|525142131|FG002|Overall Study|Progressive disease|0|||
145625596|NCT03251378|525142132|FG003|Overall Study|Progressive disease|1|||
145625597|NCT03251378|525142133|FG004|Overall Study|Progressive disease|0|||
145625598|NCT03251378|525142134|FG005|Overall Study|Progressive disease|0|||
145625599|NCT03251378|525142135|FG006|Overall Study|Progressive disease|0|||
145625600|NCT03251378|525142129|FG000|Overall Study|Physician Decision|0|||
145625601|NCT03251378|525142130|FG001|Overall Study|Physician Decision|2|||
145625602|NCT03251378|525142131|FG002|Overall Study|Physician Decision|0|||
145625603|NCT03251378|525142132|FG003|Overall Study|Physician Decision|0|||
145625604|NCT03251378|525142133|FG004|Overall Study|Physician Decision|0|||
145625605|NCT03251378|525142134|FG005|Overall Study|Physician Decision|0|||
145625606|NCT03251378|525142135|FG006|Overall Study|Physician Decision|0|||
145625607|NCT03251378|525142129|FG000|Overall Study|Other|2|||
145625608|NCT03251378|525142130|FG001|Overall Study|Other|3|||
145625609|NCT03251378|525142131|FG002|Overall Study|Other|2|||
145625610|NCT03251378|525142132|FG003|Overall Study|Other|0|||
145625611|NCT03251378|525142133|FG004|Overall Study|Other|1|||
145625612|NCT03251378|525142134|FG005|Overall Study|Other|1|||
145625613|NCT03251378|525142135|FG006|Overall Study|Other|1|||
145625614|NCT03251378|525142129|FG000|Overall Study|Other|0|||
145625615|NCT03251378|525142130|FG001|Overall Study|Other|0|||
145625616|NCT03251378|525142131|FG002|Overall Study|Other|0|||
145625617|NCT03251378|525142132|FG003|Overall Study|Other|4|||
145625618|NCT03251378|525142133|FG004|Overall Study|Other|13|||
145625619|NCT03251378|525142134|FG005|Overall Study|Other|0|||
145625620|NCT03251378|525142135|FG006|Overall Study|Other|0|||
145625621|NCT04739423|525142138|FG000|Overall Study|Protocol Violation|0|||
145625622|NCT04739423|525142139|FG001|Overall Study|Protocol Violation|1|||
145625623|NCT04739423|525142140|FG002|Overall Study|Protocol Violation|0|||
145625624|NCT04739423|525142141|FG003|Overall Study|Protocol Violation|0|||
145625625|NCT04739423|525142142|FG004|Overall Study|Protocol Violation|0|||
145625626|NCT04739423|525142143|FG005|Overall Study|Protocol Violation|0|||
145625627|NCT04739423|525142138|FG000|Overall Study|Adverse Event|0|||
145625628|NCT04739423|525142139|FG001|Overall Study|Adverse Event|0|||
145625629|NCT04739423|525142140|FG002|Overall Study|Adverse Event|1|||
145625630|NCT04739423|525142141|FG003|Overall Study|Adverse Event|0|||
145625631|NCT04739423|525142142|FG004|Overall Study|Adverse Event|1|||
145625632|NCT04739423|525142143|FG005|Overall Study|Adverse Event|0|||
145625633|NCT04739423|525142138|FG000|Overall Study|Withdrawal by Subject|0|||
145625634|NCT04739423|525142139|FG001|Overall Study|Withdrawal by Subject|0|||
145625635|NCT04739423|525142140|FG002|Overall Study|Withdrawal by Subject|0|||
145625636|NCT04739423|525142141|FG003|Overall Study|Withdrawal by Subject|0|||
145440281|NCT04339413|524469778|FG001|Overall Study|Study Terminated by Sponsor|33|||
145440282|NCT04339413|524469777|FG000|Overall Study|Progressive Disease|9|||
145440283|NCT04339413|524469778|FG001|Overall Study|Progressive Disease|6|||
145440284|NCT04339413|524469777|FG000|Overall Study|Withdrawal by Subject|9|||
145440285|NCT04339413|524469778|FG001|Overall Study|Withdrawal by Subject|10|||
145440286|NCT04339413|524469777|FG000|Overall Study|Physician Decision|3|||
145440287|NCT04339413|524469778|FG001|Overall Study|Physician Decision|1|||
145440288|NCT04339413|524469777|FG000|Overall Study|Death|2|||
145440289|NCT04339413|524469778|FG001|Overall Study|Death|0|||
145440290|NCT04339413|524469777|FG000|Overall Study|Adverse Event|3|||
145440291|NCT04339413|524469778|FG001|Overall Study|Adverse Event|0|||
145440292|NCT00442416|524469781|FG000|Overall Study|Adverse Event|4|||
145440293|NCT00442416|524469782|FG001|Overall Study|Adverse Event|1|||
145440294|NCT00442416|524469781|FG000|Overall Study|Death|1|||
145440295|NCT00442416|524469782|FG001|Overall Study|Death|0|||
145440296|NCT00442416|524469781|FG000|Overall Study|Lack of Efficacy|2|||
145625637|NCT04739423|525142142|FG004|Overall Study|Withdrawal by Subject|0|||
145625638|NCT04739423|525142143|FG005|Overall Study|Withdrawal by Subject|1|||
145440297|NCT00442416|524469782|FG001|Overall Study|Lack of Efficacy|0|||
145440298|NCT00442416|524469781|FG000|Overall Study|Protocol Violation|2|||
145440299|NCT00442416|524469782|FG001|Overall Study|Protocol Violation|3|||
145625639|NCT03005288|525142149|FG000|Overall Study|Withdrawal by Subject|7|||
145625640|NCT03005288|525142150|FG001|Overall Study|Withdrawal by Subject|5|||
145625641|NCT03005288|525142149|FG000|Overall Study|Lost to Follow-up|0|||
145625642|NCT03005288|525142150|FG001|Overall Study|Lost to Follow-up|1|||
145625643|NCT03005288|525142149|FG000|Overall Study|Adverse Event|5|||
145625644|NCT03005288|525142150|FG001|Overall Study|Adverse Event|0|||
145625645|NCT03005288|525142149|FG000|Overall Study|Protocol deviation|0|||
145625646|NCT03005288|525142150|FG001|Overall Study|Protocol deviation|1|||
145625647|NCT03005288|525142149|FG000|Overall Study|Physician Decision|0|||
145440300|NCT00442416|524469781|FG000|Overall Study|Withdrew consent|1|||
145625648|NCT03005288|525142150|FG001|Overall Study|Physician Decision|1|||
145625649|NCT03590743|525142152|FG000|Overall Study|Withdrawal by Subject|0|||
145625650|NCT03590743|525142153|FG001|Overall Study|Withdrawal by Subject|1|||
145625651|NCT01221181|525142161|FG000|Overall Study|Lost to Follow-up|1|||
145625652|NCT00429793|525142162|FG000|Overall Study|Improper pre-protocol treatment|3|||
145440301|NCT00442416|524469782|FG001|Overall Study|Withdrew consent|2|||
145625653|NCT00429793|525142162|FG000|Overall Study|Required test not done|1|||
145625654|NCT00429793|525142162|FG000|Overall Study|Never treated|1|||
145440302|NCT00442416|524469781|FG000|Overall Study|Administrative/Other|27|||
145440303|NCT00442416|524469782|FG001|Overall Study|Administrative/Other|33|||
145440304|NCT00955474|524469785|FG000|Overall Study|Physician Decision|7|||
145440305|NCT00955474|524469786|FG001|Overall Study|Physician Decision|5|||
145440306|NCT00003869|524469787|FG000|Overall Study|Adverse Event|14|||
145440307|NCT00003869|524469788|FG001|Overall Study|Adverse Event|3|||
145440308|NCT00003869|524469787|FG000|Overall Study|Withdrawal by Subject|21|||
145440309|NCT00003869|524469788|FG001|Overall Study|Withdrawal by Subject|3|||
145440310|NCT00003869|524469787|FG000|Overall Study|Death|1|||
145440311|NCT00003869|524469788|FG001|Overall Study|Death|2|||
145440312|NCT00003869|524469787|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
145440313|NCT00003869|524469788|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
145440314|NCT01964378|524469789|FG000|Overall Study|Disc. due to death before first dosing|0|||
145440315|NCT01964378|524469790|FG001|Overall Study|Disc. due to death before first dosing|1|||
145440316|NCT01964378|524469789|FG000|Overall Study|Disc. due to AE before first dosing|1|||
145440317|NCT01964378|524469790|FG001|Overall Study|Disc. due to AE before first dosing|0|||
145440318|NCT01964378|524469789|FG000|Overall Study|Death|3|||
145440319|NCT01964378|524469790|FG001|Overall Study|Death|2|||
145440320|NCT01964378|524469789|FG000|Overall Study|Adverse Event|12|||
145440321|NCT01964378|524469790|FG001|Overall Study|Adverse Event|5|||
145440322|NCT01964378|524469789|FG000|Overall Study|Lack of Efficacy|0|||
145440323|NCT01964378|524469790|FG001|Overall Study|Lack of Efficacy|1|||
145440324|NCT01964378|524469789|FG000|Overall Study|Protocol Violation|0|||
145440325|NCT01964378|524469790|FG001|Overall Study|Protocol Violation|1|||
145440326|NCT01964378|524469789|FG000|Overall Study|Lost to Follow-up|0|||
145440327|NCT01964378|524469790|FG001|Overall Study|Lost to Follow-up|1|||
145440328|NCT01964378|524469789|FG000|Overall Study|Withdrawal by Subject|7|||
145440329|NCT01964378|524469790|FG001|Overall Study|Withdrawal by Subject|5|||
145440330|NCT01964378|524469789|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
145440331|NCT01964378|524469790|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
145440332|NCT01964378|524469789|FG000|Overall Study|Other|1|||
145440333|NCT01964378|524469790|FG001|Overall Study|Other|2|||
145440334|NCT00326599|524469791|FG000|Overall Study|Withdrawal by Subject|1|||
145440335|NCT00326599|524469792|FG001|Overall Study|Withdrawal by Subject|0|||
145440336|NCT00326599|524469793|FG002|Overall Study|Withdrawal by Subject|5|||
145440337|NCT00326599|524469794|FG003|Overall Study|Withdrawal by Subject|2|||
145440338|NCT00326599|524469791|FG000|Overall Study|Adverse Event|1|||
145440339|NCT00326599|524469792|FG001|Overall Study|Adverse Event|0|||
145440340|NCT00326599|524469793|FG002|Overall Study|Adverse Event|32|||
145440341|NCT00326599|524469794|FG003|Overall Study|Adverse Event|3|||
145440342|NCT00326599|524469791|FG000|Overall Study|Disease Progression|3|||
145440343|NCT00326599|524469792|FG001|Overall Study|Disease Progression|1|||
145440344|NCT00326599|524469793|FG002|Overall Study|Disease Progression|13|||
145440345|NCT00326599|524469794|FG003|Overall Study|Disease Progression|11|||
145440346|NCT00326599|524469791|FG000|Overall Study|Alternate Treatment|1|||
145440347|NCT00326599|524469792|FG001|Overall Study|Alternate Treatment|0|||
145440348|NCT00326599|524469793|FG002|Overall Study|Alternate Treatment|0|||
145440349|NCT00326599|524469794|FG003|Overall Study|Alternate Treatment|0|||
145440350|NCT00326599|524469791|FG000|Overall Study|Death|0|||
145440351|NCT00326599|524469792|FG001|Overall Study|Death|0|||
145440352|NCT00326599|524469793|FG002|Overall Study|Death|1|||
145440353|NCT00326599|524469794|FG003|Overall Study|Death|2|||
145440354|NCT00326599|524469791|FG000|Overall Study|Other Unspecified Reason|0|||
145440355|NCT00326599|524469792|FG001|Overall Study|Other Unspecified Reason|0|||
145440356|NCT00326599|524469793|FG002|Overall Study|Other Unspecified Reason|2|||
145440357|NCT00326599|524469794|FG003|Overall Study|Other Unspecified Reason|1|||
145440358|NCT03386435|524469795|FG000|Overall Study|Protocol Violation|5|||
145440359|NCT03386435|524469796|FG001|Overall Study|Protocol Violation|7|||
145440360|NCT01162473|524469802|FG000|Overall Study|Adverse Event|2|||
145584689|NCT01131312|524993584|FG002|Overall Study|Lost to Follow-up|351|||
145440361|NCT01162473|524469803|FG001|Overall Study|Adverse Event|1|||
145440362|NCT01162473|524469802|FG000|Overall Study|Withdrawal by Subject|0|||
145440363|NCT01162473|524469803|FG001|Overall Study|Withdrawal by Subject|4|||
145440364|NCT02382991|524469807|FG000|Overall Study|Adverse Event|1|||
145440365|NCT02382991|524469808|FG001|Overall Study|Adverse Event|2|||
145440366|NCT02382991|524469807|FG000|Overall Study|Lost to Follow-up|1|||
145440367|NCT02382991|524469808|FG001|Overall Study|Lost to Follow-up|0|||
145440368|NCT02382991|524469807|FG000|Overall Study|Withdrawal by Subject|0|||
145440369|NCT02382991|524469808|FG001|Overall Study|Withdrawal by Subject|1|||
145440370|NCT03382912|524469810|FG000|Overall Study|Physician Decision|0|||
145440371|NCT03382912|524469811|FG001|Overall Study|Physician Decision|1|||
145440372|NCT03382912|524469810|FG000|Overall Study|Sponsor Decision|6|||
145440373|NCT03382912|524469811|FG001|Overall Study|Sponsor Decision|6|||
145440374|NCT03382912|524469810|FG000|Overall Study|Withdrawal by Subject|0|||
145440375|NCT03382912|524469811|FG001|Overall Study|Withdrawal by Subject|5|||
145440376|NCT04570384|524469812|FG000|Overall Study|Adverse Event|2|||
145440377|NCT04570384|524469813|FG001|Overall Study|Adverse Event|1|||
145440378|NCT04570384|524469812|FG000|Overall Study|Death|2|||
145440379|NCT04570384|524469813|FG001|Overall Study|Death|5|||
145440380|NCT04570384|524469812|FG000|Overall Study|Lost to Follow-up|1|||
145440381|NCT04570384|524469813|FG001|Overall Study|Lost to Follow-up|0|||
145440382|NCT04570384|524469812|FG000|Overall Study|Other|1|||
145440383|NCT04570384|524469813|FG001|Overall Study|Other|0|||
145440384|NCT04570384|524469812|FG000|Overall Study|Protocol Violation|0|||
145440385|NCT04570384|524469813|FG001|Overall Study|Protocol Violation|1|||
145440386|NCT04570384|524469812|FG000|Overall Study|Sponsor Decision|1|||
145440387|NCT04570384|524469813|FG001|Overall Study|Sponsor Decision|0|||
145440388|NCT04570384|524469812|FG000|Overall Study|Withdrawal by Subject|4|||
145440389|NCT04570384|524469813|FG001|Overall Study|Withdrawal by Subject|2|||
145440390|NCT03265145|524469814|FG000|Overall Study|Protocol Violation|2|||
145440391|NCT03265145|524469815|FG001|Overall Study|Protocol Violation|0|||
145440392|NCT03265145|524469814|FG000|Overall Study|Adverse Event|1|||
145440393|NCT03265145|524469815|FG001|Overall Study|Adverse Event|0|||
145440394|NCT03265145|524469814|FG000|Overall Study|Withdrawal by Subject|23|||
145440395|NCT03265145|524469815|FG001|Overall Study|Withdrawal by Subject|19|||
145440396|NCT03265145|524469814|FG000|Overall Study|Death|12|||
145440397|NCT03265145|524469815|FG001|Overall Study|Death|12|||
145440398|NCT03265145|524469814|FG000|Overall Study|Lost to Follow-up|13|||
145440399|NCT03265145|524469815|FG001|Overall Study|Lost to Follow-up|9|||
145440400|NCT03265145|524469814|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
145440401|NCT03265145|524469815|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
145440402|NCT03265145|524469814|FG000|Overall Study|Switched back to previous medication|1|||
145440403|NCT03265145|524469815|FG001|Overall Study|Switched back to previous medication|0|||
145440404|NCT03265145|524469814|FG000|Overall Study|Did not want to take medication|1|||
145440405|NCT03265145|524469815|FG001|Overall Study|Did not want to take medication|0|||
145440406|NCT03265145|524469814|FG000|Overall Study|Subject could not afford medication|0|||
145440407|NCT03265145|524469815|FG001|Overall Study|Subject could not afford medication|1|||
145440408|NCT03265145|524469814|FG000|Overall Study|Site closed|2|||
145440409|NCT03265145|524469815|FG001|Overall Study|Site closed|3|||
145440410|NCT03265145|524469814|FG000|Overall Study|Incorrectly randomized|16|||
145440411|NCT03265145|524469815|FG001|Overall Study|Incorrectly randomized|6|||
145440412|NCT03265145|524469814|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
145440413|NCT03265145|524469815|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
145440414|NCT03265145|524469814|FG000|Overall Study|Physician Decision|0|||
145440415|NCT03265145|524469815|FG001|Overall Study|Physician Decision|3|||
145440416|NCT03265145|524469814|FG000|Overall Study|Subject transferred to another facility|0|||
145440417|NCT03265145|524469815|FG001|Overall Study|Subject transferred to another facility|1|||
145440418|NCT05005273|524469816|FG000|Overall Study|Study Terminated|1|||
145440419|NCT05005273|524469817|FG001|Overall Study|Study Terminated|0|||
145440420|NCT04409834|524469818|FG000|Overall Study|Death|55|||
145440421|NCT04409834|524469819|FG001|Overall Study|Death|62|||
145440422|NCT02112656|524469820|FG000|Overall Study|Death|78|||
145440423|NCT02112656|524469821|FG001|Overall Study|Death|82|||
145440424|NCT02112656|524469820|FG000|Overall Study|Withdrawal by Subject|9|||
145440425|NCT02112656|524469821|FG001|Overall Study|Withdrawal by Subject|11|||
145440426|NCT02112656|524469820|FG000|Overall Study|Lost to Follow-up|2|||
145440427|NCT02112656|524469821|FG001|Overall Study|Lost to Follow-up|4|||
145440428|NCT02112656|524469820|FG000|Overall Study|Noncompliance|1|||
145440429|NCT02112656|524469821|FG001|Overall Study|Noncompliance|2|||
145440430|NCT04749745|524469822|FG000|Overall Study|Withdrawal by Subject|1|||
145440431|NCT04749745|524469823|FG001|Overall Study|Withdrawal by Subject|0|||
145440432|NCT01365455|524469828|FG000|Induction Period|Adverse Event|5|||
145440433|NCT01365455|524469829|FG001|Induction Period|Adverse Event|3|||
145440434|NCT01365455|524469830|FG002|Induction Period|Adverse Event|4|||
145440435|NCT01365455|524469831|FG003|Induction Period|Adverse Event|0|||
145440436|NCT01365455|524469832|FG004|Induction Period|Adverse Event|0|||
145440437|NCT01365455|524469828|FG000|Induction Period|Lack of Efficacy|1|||
145440438|NCT01365455|524469829|FG001|Induction Period|Lack of Efficacy|1|||
145440439|NCT01365455|524469830|FG002|Induction Period|Lack of Efficacy|0|||
145440440|NCT01365455|524469831|FG003|Induction Period|Lack of Efficacy|0|||
145440441|NCT01365455|524469832|FG004|Induction Period|Lack of Efficacy|0|||
145440442|NCT01365455|524469828|FG000|Induction Period|Pregnancy|0|||
145440443|NCT01365455|524469829|FG001|Induction Period|Pregnancy|1|||
145440444|NCT01365455|524469830|FG002|Induction Period|Pregnancy|0|||
145440445|NCT01365455|524469831|FG003|Induction Period|Pregnancy|0|||
145440446|NCT01365455|524469832|FG004|Induction Period|Pregnancy|0|||
145440447|NCT01365455|524469828|FG000|Induction Period|Protocol deviation|0|||
145440448|NCT01365455|524469829|FG001|Induction Period|Protocol deviation|1|||
145584690|NCT02682264|524993585|FG000|Overall Study|Withdrawal by Subject|56|||
145440449|NCT01365455|524469830|FG002|Induction Period|Protocol deviation|1|||
145440450|NCT01365455|524469831|FG003|Induction Period|Protocol deviation|0|||
145440451|NCT01365455|524469832|FG004|Induction Period|Protocol deviation|0|||
145440452|NCT01365455|524469828|FG000|Induction Period|Subject/guardian decision|9|||
145440453|NCT01365455|524469829|FG001|Induction Period|Subject/guardian decision|1|||
145440454|NCT01365455|524469830|FG002|Induction Period|Subject/guardian decision|8|||
145625655|NCT00429793|525142162|FG000|Overall Study|Non-measurable|1|||
145440455|NCT01365455|524469831|FG003|Induction Period|Subject/guardian decision|0|||
145440456|NCT01365455|524469832|FG004|Induction Period|Subject/guardian decision|0|||
145440457|NCT01365455|524469828|FG000|Induction Period|Lost to Follow-up|0|||
145440458|NCT01365455|524469829|FG001|Induction Period|Lost to Follow-up|0|||
145440459|NCT01365455|524469830|FG002|Induction Period|Lost to Follow-up|3|||
145440460|NCT01365455|524469831|FG003|Induction Period|Lost to Follow-up|0|||
145440461|NCT01365455|524469832|FG004|Induction Period|Lost to Follow-up|0|||
145440462|NCT01365455|524469828|FG000|Maintenance Period|Adverse Event|12|||
145440463|NCT01365455|524469829|FG001|Maintenance Period|Adverse Event|5|||
145440464|NCT01365455|524469830|FG002|Maintenance Period|Adverse Event|1|||
145440465|NCT01365455|524469831|FG003|Maintenance Period|Adverse Event|2|||
145440466|NCT01365455|524469832|FG004|Maintenance Period|Adverse Event|4|||
145440467|NCT01365455|524469828|FG000|Maintenance Period|Lack of Efficacy|10|||
145440468|NCT01365455|524469829|FG001|Maintenance Period|Lack of Efficacy|2|||
145440469|NCT01365455|524469830|FG002|Maintenance Period|Lack of Efficacy|0|||
145440470|NCT01365455|524469831|FG003|Maintenance Period|Lack of Efficacy|2|||
145440471|NCT01365455|524469832|FG004|Maintenance Period|Lack of Efficacy|2|||
145440472|NCT01365455|524469828|FG000|Maintenance Period|Lost to Follow-up|2|||
145440473|NCT01365455|524469829|FG001|Maintenance Period|Lost to Follow-up|4|||
145440474|NCT01365455|524469830|FG002|Maintenance Period|Lost to Follow-up|0|||
145440475|NCT01365455|524469831|FG003|Maintenance Period|Lost to Follow-up|0|||
145440476|NCT01365455|524469832|FG004|Maintenance Period|Lost to Follow-up|3|||
145440477|NCT01365455|524469828|FG000|Maintenance Period|Non-compliance with study treatment|0|||
145440478|NCT01365455|524469829|FG001|Maintenance Period|Non-compliance with study treatment|0|||
145440479|NCT01365455|524469830|FG002|Maintenance Period|Non-compliance with study treatment|0|||
145440480|NCT01365455|524469831|FG003|Maintenance Period|Non-compliance with study treatment|1|||
145440481|NCT01365455|524469832|FG004|Maintenance Period|Non-compliance with study treatment|0|||
145440482|NCT01365455|524469828|FG000|Maintenance Period|Physician Decision|0|||
145440483|NCT01365455|524469829|FG001|Maintenance Period|Physician Decision|1|||
145440484|NCT01365455|524469830|FG002|Maintenance Period|Physician Decision|0|||
145440485|NCT01365455|524469831|FG003|Maintenance Period|Physician Decision|0|||
145440486|NCT01365455|524469832|FG004|Maintenance Period|Physician Decision|1|||
145440487|NCT01365455|524469828|FG000|Maintenance Period|Pregnancy|0|||
145440488|NCT01365455|524469829|FG001|Maintenance Period|Pregnancy|4|||
145440489|NCT01365455|524469830|FG002|Maintenance Period|Pregnancy|0|||
145440490|NCT01365455|524469831|FG003|Maintenance Period|Pregnancy|0|||
145440491|NCT01365455|524469832|FG004|Maintenance Period|Pregnancy|2|||
145440492|NCT01365455|524469828|FG000|Maintenance Period|Protocol deviation|1|||
145440493|NCT01365455|524469829|FG001|Maintenance Period|Protocol deviation|1|||
145440494|NCT01365455|524469830|FG002|Maintenance Period|Protocol deviation|0|||
145440495|NCT01365455|524469831|FG003|Maintenance Period|Protocol deviation|0|||
145440496|NCT01365455|524469832|FG004|Maintenance Period|Protocol deviation|0|||
145440497|NCT01365455|524469828|FG000|Maintenance Period|Subject/guardian decision|4|||
145440498|NCT01365455|524469829|FG001|Maintenance Period|Subject/guardian decision|6|||
145440499|NCT01365455|524469830|FG002|Maintenance Period|Subject/guardian decision|2|||
145440500|NCT01365455|524469831|FG003|Maintenance Period|Subject/guardian decision|4|||
145440501|NCT01365455|524469832|FG004|Maintenance Period|Subject/guardian decision|1|||
145440502|NCT03965403|524469833|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
145440503|NCT03718325|524471363|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
145440504|NCT03718325|524471364|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
145440505|NCT03718325|524471365|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
145440506|NCT03718325|524471363|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
145440507|NCT03718325|524471364|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
145440508|NCT03718325|524471365|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
145440509|NCT03145064|524471366|FG000|Overall Study|Death|24|||
145440510|NCT03145064|524471366|FG000|Overall Study|Lost to Follow-up|3|||
145440511|NCT03145064|524471366|FG000|Overall Study|Withdrawal by Subject|6|||
145440512|NCT03145064|524471366|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
145440513|NCT03145064|524471366|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
145440514|NCT01396187|524471367|FG000|Overall Study|Adverse Event|0|||
145440515|NCT01396187|524471368|FG001|Overall Study|Adverse Event|1|||
145440516|NCT01396187|524471369|FG002|Overall Study|Adverse Event|0|||
145440517|NCT01396187|524471370|FG003|Overall Study|Adverse Event|0|||
145440518|NCT01396187|524471371|FG004|Overall Study|Adverse Event|0|||
145440519|NCT01396187|524471367|FG000|Overall Study|Withdrawal by Subject|0|||
145440520|NCT01396187|524471368|FG001|Overall Study|Withdrawal by Subject|1|||
145440521|NCT01396187|524471369|FG002|Overall Study|Withdrawal by Subject|1|||
145440522|NCT01396187|524471370|FG003|Overall Study|Withdrawal by Subject|0|||
145440523|NCT01396187|524471371|FG004|Overall Study|Withdrawal by Subject|0|||
145584691|NCT02682264|524993586|FG001|Overall Study|Withdrawal by Subject|45|||
145584692|NCT02682264|524993585|FG000|Overall Study|Lost to Follow-up|49|||
145440524|NCT01396187|524471367|FG000|Overall Study|Other|1|||
145440525|NCT01396187|524471368|FG001|Overall Study|Other|1|||
145440526|NCT01396187|524471369|FG002|Overall Study|Other|0|||
145440527|NCT01396187|524471370|FG003|Overall Study|Other|0|||
145440528|NCT01396187|524471371|FG004|Overall Study|Other|1|||
145440529|NCT01898286|524471372|FG000|Overall Study|Withdrawal by Subject|1|||
145440530|NCT01898286|524471372|FG000|Overall Study|Protocol Violation|1|||
145440531|NCT01898286|524471372|FG000|Overall Study|Lost to Follow-up|1|||
145440532|NCT02257242|524471373|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
145440533|NCT02257242|524471374|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440534|NCT02257242|524471375|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440535|NCT02257242|524471376|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440536|NCT02257242|524471377|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440537|NCT02257242|524471378|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440538|NCT02257242|524471379|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440539|NCT02257242|524471380|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440540|NCT02257242|524471381|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
145440541|NCT01453036|524471382|FG000|Overall Study|Lost to Follow-up|26|||
145440542|NCT01453036|524471383|FG001|Overall Study|Lost to Follow-up|115|||
145440543|NCT01453036|524471384|FG002|Overall Study|Lost to Follow-up|31|||
145440544|NCT03692403|524471385|FG000|Overall Study|Withdrawal by Subject|1|||
145440545|NCT03692403|524471386|FG001|Overall Study|Withdrawal by Subject|0|||
145440546|NCT03692403|524471387|FG002|Overall Study|Withdrawal by Subject|1|||
145440547|NCT03692403|524471388|FG003|Overall Study|Withdrawal by Subject|0|||
145440548|NCT03692403|524471385|FG000|Overall Study|Adverse Event|0|||
145440549|NCT03692403|524471386|FG001|Overall Study|Adverse Event|0|||
145440550|NCT03692403|524471387|FG002|Overall Study|Adverse Event|0|||
145440551|NCT03692403|524471388|FG003|Overall Study|Adverse Event|1|||
145440552|NCT03692403|524471385|FG000|Overall Study|Pregnancy|0|||
145440553|NCT03692403|524471386|FG001|Overall Study|Pregnancy|1|||
145440554|NCT03692403|524471387|FG002|Overall Study|Pregnancy|0|||
145440555|NCT03692403|524471388|FG003|Overall Study|Pregnancy|0|||
145440556|NCT03692403|524471385|FG000|Overall Study|Other|0|||
145440557|NCT03692403|524471386|FG001|Overall Study|Other|0|||
145440558|NCT03692403|524471387|FG002|Overall Study|Other|1|||
145440559|NCT03692403|524471388|FG003|Overall Study|Other|0|||
145440560|NCT02848092|524471390|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
145440561|NCT02848092|524471391|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
145440562|NCT02848092|524471390|FG000|1-month Post-training Follow-up|Adverse Event|2|||
145440563|NCT02848092|524471391|FG001|1-month Post-training Follow-up|Adverse Event|1|||
145440564|NCT02848092|524471390|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
145440565|NCT02848092|524471391|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
145440566|NCT02848092|524471390|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
145440567|NCT02848092|524471391|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
145440568|NCT02848092|524471390|FG000|1-month Post-training Follow-up|fatigue|0|||
145440569|NCT02848092|524471391|FG001|1-month Post-training Follow-up|fatigue|1|||
145440570|NCT02848092|524471390|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
145440571|NCT02848092|524471391|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
145440572|NCT02848092|524471390|FG000|6-month Post-training Follow-up|Adverse Event|1|||
145440573|NCT02848092|524471391|FG001|6-month Post-training Follow-up|Adverse Event|1|||
145440574|NCT02848092|524471390|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
145440575|NCT02848092|524471391|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
145440576|NCT02848092|524471390|FG000|6-month Post-training Follow-up|frustrated with task|1|||
145440577|NCT02848092|524471391|FG001|6-month Post-training Follow-up|frustrated with task|0|||
145440578|NCT02848092|524471390|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
145440579|NCT02848092|524471391|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
145440580|NCT02848092|524471390|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
145584693|NCT02682264|524993586|FG001|Overall Study|Lost to Follow-up|41|||
145584694|NCT02682264|524993585|FG000|Overall Study|Lack of Efficacy|14|||
145584695|NCT02682264|524993586|FG001|Overall Study|Lack of Efficacy|16|||
145584696|NCT02682264|524993585|FG000|Overall Study|Withdrawal by Parent|6|||
145440581|NCT02848092|524471391|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
145440582|NCT01349673|524471396|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
145440583|NCT01349673|524471396|FG000|Overall Study|No Longer Qualified For Study|1|||
145440584|NCT01349673|524471396|FG000|Overall Study|Site Closure|10|||
145440585|NCT01349673|524471396|FG000|Overall Study|Withdrawal by Subject|21|||
145440586|NCT01349673|524471396|FG000|Overall Study|Lost to Follow-up|6|||
145440587|NCT01349673|524471396|FG000|Overall Study|Adverse Event|17|||
145584697|NCT02682264|524993586|FG001|Overall Study|Withdrawal by Parent|7|||
145584698|NCT02682264|524993585|FG000|Overall Study|Adverse Event|9|||
145584699|NCT02682264|524993586|FG001|Overall Study|Adverse Event|0|||
145584700|NCT02682264|524993585|FG000|Overall Study|Noncompliance with study drug|1|||
145584701|NCT02682264|524993586|FG001|Overall Study|Noncompliance with study drug|4|||
145584702|NCT02682264|524993585|FG000|Overall Study|Pregnancy|1|||
145440588|NCT01349673|524471396|FG000|Overall Study|Study Terminated By Sponsor|50|||
145440589|NCT01349673|524471396|FG000|Overall Study|Lack of Efficacy|8|||
145440590|NCT01665911|524471397|FG000|Overall Study|Protocol Violation|4|||
145440591|NCT01665911|524471397|FG000|Overall Study|Withdrawal by Subject|1|||
145440592|NCT01665911|524471397|FG000|Overall Study|Adverse Event|1|||
145440593|NCT01724216|524471404|FG000|Overall Study|Scan was not completed|1|||
145440594|NCT00564733|524471405|FG000|Overall Study|Withdrawal by Subject|4|||
145440595|NCT00564733|524471405|FG000|Overall Study|Ineligible|5|||
145440596|NCT01484496|524471408|FG000|Period 1|Protocol Violation|3|||
145440597|NCT01484496|524471409|FG001|Period 1|Protocol Violation|4|||
145440598|NCT01484496|524471410|FG002|Period 1|Protocol Violation|0|||
145440599|NCT01484496|524471411|FG003|Period 1|Protocol Violation|0|||
145440600|NCT01484496|524471408|FG000|Period 1|Physician Decision|5|||
145440601|NCT01484496|524471409|FG001|Period 1|Physician Decision|1|||
145440602|NCT01484496|524471410|FG002|Period 1|Physician Decision|0|||
145440603|NCT01484496|524471411|FG003|Period 1|Physician Decision|0|||
145440604|NCT01484496|524471408|FG000|Period 1|Lack of Efficacy|10|||
145440605|NCT01484496|524471409|FG001|Period 1|Lack of Efficacy|15|||
145440606|NCT01484496|524471410|FG002|Period 1|Lack of Efficacy|0|||
145440607|NCT01484496|524471411|FG003|Period 1|Lack of Efficacy|0|||
145440608|NCT01484496|524471408|FG000|Period 1|Adverse Event|25|||
145440609|NCT01484496|524471409|FG001|Period 1|Adverse Event|40|||
145440610|NCT01484496|524471410|FG002|Period 1|Adverse Event|0|||
145440611|NCT01484496|524471411|FG003|Period 1|Adverse Event|0|||
145440612|NCT01484496|524471408|FG000|Period 1|Withdrawal by Subject|15|||
145440613|NCT01484496|524471409|FG001|Period 1|Withdrawal by Subject|12|||
145440614|NCT01484496|524471410|FG002|Period 1|Withdrawal by Subject|0|||
145440615|NCT01484496|524471411|FG003|Period 1|Withdrawal by Subject|0|||
145440616|NCT01484496|524471408|FG000|Period 1|Lost to Follow-up|2|||
145440617|NCT01484496|524471409|FG001|Period 1|Lost to Follow-up|6|||
145440618|NCT01484496|524471410|FG002|Period 1|Lost to Follow-up|0|||
145440619|NCT01484496|524471411|FG003|Period 1|Lost to Follow-up|0|||
145440620|NCT01484496|524471408|FG000|Period 1|Positive Pregnancy|1|||
145440621|NCT01484496|524471409|FG001|Period 1|Positive Pregnancy|6|||
145440622|NCT01484496|524471410|FG002|Period 1|Positive Pregnancy|0|||
145440623|NCT01484496|524471411|FG003|Period 1|Positive Pregnancy|0|||
145440624|NCT01484496|524471408|FG000|Period 1|Treatment Failure|3|||
145440625|NCT01484496|524471409|FG001|Period 1|Treatment Failure|6|||
145440626|NCT01484496|524471410|FG002|Period 1|Treatment Failure|0|||
145440627|NCT01484496|524471411|FG003|Period 1|Treatment Failure|0|||
145440628|NCT01484496|524471408|FG000|Period 1|Lack of Compliance|2|||
145440629|NCT01484496|524471409|FG001|Period 1|Lack of Compliance|1|||
145440630|NCT01484496|524471410|FG002|Period 1|Lack of Compliance|0|||
145440631|NCT01484496|524471411|FG003|Period 1|Lack of Compliance|0|||
145440632|NCT01484496|524471408|FG000|Period 1|Unable to Visit Site|0|||
145440633|NCT01484496|524471409|FG001|Period 1|Unable to Visit Site|2|||
145440634|NCT01484496|524471410|FG002|Period 1|Unable to Visit Site|0|||
145440635|NCT01484496|524471411|FG003|Period 1|Unable to Visit Site|0|||
145440636|NCT01484496|524471408|FG000|Period 2|Lack of Efficacy|0|||
145440637|NCT01484496|524471409|FG001|Period 2|Lack of Efficacy|0|||
145440638|NCT01484496|524471410|FG002|Period 2|Lack of Efficacy|1|||
145440639|NCT01484496|524471411|FG003|Period 2|Lack of Efficacy|3|||
145440640|NCT01484496|524471408|FG000|Period 2|Adverse Event|0|||
145440641|NCT01484496|524471409|FG001|Period 2|Adverse Event|0|||
145440642|NCT01484496|524471410|FG002|Period 2|Adverse Event|5|||
145440643|NCT01484496|524471411|FG003|Period 2|Adverse Event|13|||
145440644|NCT01484496|524471408|FG000|Period 2|Other|0|||
145440645|NCT01484496|524471409|FG001|Period 2|Other|0|||
145440646|NCT01484496|524471410|FG002|Period 2|Other|9|||
145584703|NCT02682264|524993586|FG001|Overall Study|Pregnancy|2|||
145440647|NCT01484496|524471411|FG003|Period 2|Other|6|||
145440648|NCT00506779|524471412|FG000|Overall Study|Withdrawal by Subject|1|||
145440649|NCT00506779|524471413|FG001|Overall Study|Withdrawal by Subject|0|||
145440650|NCT00506779|524471414|FG002|Overall Study|Withdrawal by Subject|1|||
145440651|NCT00506779|524471415|FG003|Overall Study|Withdrawal by Subject|0|||
145584704|NCT02682264|524993585|FG000|Overall Study|Recovery|1|||
145440652|NCT00506779|524471412|FG000|Overall Study|Adverse Event|0|||
145440653|NCT00506779|524471413|FG001|Overall Study|Adverse Event|1|||
145440654|NCT00506779|524471414|FG002|Overall Study|Adverse Event|1|||
145440655|NCT00506779|524471415|FG003|Overall Study|Adverse Event|1|||
145440656|NCT01456130|524471417|FG000|Overall Study|Adverse Event|4|||
145440657|NCT01456130|524471417|FG000|Overall Study|Voluntary Withdrawal|1|||
145440658|NCT01456130|524471417|FG000|Overall Study|Lack of Efficacy|4|||
145440659|NCT01456130|524471417|FG000|Overall Study|Other|1|||
145440660|NCT04908683|524471418|FG000|Overall Study|Failure to meet continuation criteria|34|||
145584705|NCT02682264|524993586|FG001|Overall Study|Recovery|2|||
145584706|NCT02682264|524993585|FG000|Overall Study|Progressive Disease|1|||
145625656|NCT01394991|525142163|FG000|Overall Study|Adverse Event|0|||
145625657|NCT01394991|525142164|FG001|Overall Study|Adverse Event|4|||
145625658|NCT01394991|525142163|FG000|Overall Study|Lack of Efficacy|5|||
145625659|NCT01394991|525142164|FG001|Overall Study|Lack of Efficacy|7|||
145625660|NCT01394991|525142163|FG000|Overall Study|Lost to Follow-up|6|||
145625661|NCT01394991|525142164|FG001|Overall Study|Lost to Follow-up|8|||
145625662|NCT01394991|525142163|FG000|Overall Study|Physician Decision|1|||
145625663|NCT01394991|525142164|FG001|Overall Study|Physician Decision|3|||
145625664|NCT01394991|525142163|FG000|Overall Study|Protocol Violation|1|||
145625665|NCT01394991|525142164|FG001|Overall Study|Protocol Violation|1|||
145625666|NCT01394991|525142163|FG000|Overall Study|Withdrawal by Subject|20|||
145625667|NCT01394991|525142164|FG001|Overall Study|Withdrawal by Subject|17|||
145625668|NCT01394991|525142163|FG000|Overall Study|Chemotherapy Termination|10|||
145625669|NCT01394991|525142164|FG001|Overall Study|Chemotherapy Termination|15|||
145625670|NCT01394991|525142163|FG000|Overall Study|Disease Progression|7|||
145625671|NCT01394991|525142164|FG001|Overall Study|Disease Progression|7|||
145625672|NCT01394991|525142163|FG000|Overall Study|Prematurely Termination of Trial|9|||
145625673|NCT01394991|525142164|FG001|Overall Study|Prematurely Termination of Trial|10|||
145625674|NCT03073005|525142165|FG000|Overall Study|Death|6|||
145625675|NCT03073005|525142166|FG001|Overall Study|Death|0|||
145625676|NCT03073005|525142167|FG002|Overall Study|Death|7|||
145625677|NCT03073005|525142168|FG003|Overall Study|Death|0|||
145625678|NCT03073005|525142165|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
145625679|NCT03073005|525142166|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
145625680|NCT03073005|525142167|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
145625681|NCT03073005|525142168|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
145625682|NCT03073005|525142165|FG000|Overall Study|Lost to Follow-up|2|||
145625683|NCT03073005|525142166|FG001|Overall Study|Lost to Follow-up|2|||
145625684|NCT03073005|525142167|FG002|Overall Study|Lost to Follow-up|1|||
145625685|NCT03073005|525142168|FG003|Overall Study|Lost to Follow-up|2|||
145625686|NCT03073005|525142165|FG000|Overall Study|Withdrawal by Subject|0|||
145625687|NCT03073005|525142166|FG001|Overall Study|Withdrawal by Subject|4|||
145625688|NCT03073005|525142167|FG002|Overall Study|Withdrawal by Subject|4|||
145625689|NCT03073005|525142168|FG003|Overall Study|Withdrawal by Subject|4|||
145625690|NCT01734811|525142169|FG000|Overall Study|Lost to Follow-up|2|||
145625691|NCT01734811|525142170|FG001|Overall Study|Lost to Follow-up|3|||
145625692|NCT01734811|525142169|FG000|Overall Study|Withdrawal by Subject|2|||
145625693|NCT01734811|525142170|FG001|Overall Study|Withdrawal by Subject|0|||
145625694|NCT02427646|525142171|FG000|Overall Study|Lack of Efficacy|2|||
145625695|NCT02427646|525142172|FG001|Overall Study|Lack of Efficacy|3|||
145625696|NCT02427646|525142171|FG000|Overall Study|Physician Decision|1|||
145625697|NCT02427646|525142172|FG001|Overall Study|Physician Decision|4|||
145625698|NCT02427646|525142171|FG000|Overall Study|Protocol Violation|3|||
145625699|NCT02427646|525142172|FG001|Overall Study|Protocol Violation|3|||
145625700|NCT02427646|525142171|FG000|Overall Study|Bothersome hand weakness|2|||
145625701|NCT02427646|525142172|FG001|Overall Study|Bothersome hand weakness|4|||
145625702|NCT03824236|525142173|FG000|Overall Study|Lost to Follow-up|0|||
145625703|NCT03824236|525142174|FG001|Overall Study|Lost to Follow-up|0|||
145625704|NCT03824236|525142175|FG002|Overall Study|Lost to Follow-up|1|||
145625705|NCT01290094|525142176|FG000|Overall Study|Withdrawal by Subject|1|||
145440661|NCT04908683|524471419|FG001|Overall Study|Failure to meet continuation criteria|22|||
145440662|NCT04908683|524471418|FG000|Overall Study|Initiated prohibited medication|3|||
145440663|NCT04908683|524471419|FG001|Overall Study|Initiated prohibited medication|0|||
145440664|NCT04908683|524471418|FG000|Overall Study|Randomized by mistake|1|||
145440665|NCT04908683|524471419|FG001|Overall Study|Randomized by mistake|0|||
145440666|NCT04908683|524471418|FG000|Overall Study|Lost to Follow-up|679|||
145625706|NCT01290094|525142176|FG000|Overall Study|Lost to Follow-up|5|||
145625707|NCT01712685|525142181|FG000|Overall Study|pt declined to participate before trmt|1|||
145440667|NCT04908683|524471419|FG001|Overall Study|Lost to Follow-up|341|||
145440668|NCT04908683|524471418|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
145440669|NCT04908683|524471419|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
145440670|NCT04908683|524471418|FG000|Overall Study|Physician Decision|44|||
145625708|NCT01871285|525142182|FG000|First Intervention (1 Day)|Adverse Event|1|||
145625709|NCT01871285|525142183|FG001|First Intervention (1 Day)|Adverse Event|0|||
145625710|NCT01871285|525142184|FG002|First Intervention (1 Day)|Adverse Event|0|||
145625711|NCT01871285|525142185|FG003|First Intervention (1 Day)|Adverse Event|0|||
145625712|NCT01871285|525142182|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
145625713|NCT01871285|525142183|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
145625714|NCT01871285|525142184|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
145625715|NCT01871285|525142185|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
145625716|NCT04091672|525144068|FG000|Overall Study|Death|6|||
145625717|NCT04091672|525144069|FG001|Overall Study|Death|6|||
145625718|NCT04091672|525144068|FG000|Overall Study|Lost to Follow-up|7|||
145625719|NCT04091672|525144069|FG001|Overall Study|Lost to Follow-up|7|||
145625720|NCT04091672|525144068|FG000|Overall Study|Withdrawal by Subject|3|||
145625721|NCT04091672|525144069|FG001|Overall Study|Withdrawal by Subject|3|||
145625722|NCT04091672|525144068|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
145584707|NCT02682264|524993586|FG001|Overall Study|Progressive Disease|0|||
145584708|NCT02682264|524993585|FG000|Overall Study|Technical Problems|0|||
145584709|NCT02682264|524993586|FG001|Overall Study|Technical Problems|1|||
145584710|NCT02682264|524993585|FG000|Overall Study|Moved abroad and unable to continue|0|||
145584711|NCT02682264|524993586|FG001|Overall Study|Moved abroad and unable to continue|3|||
145584712|NCT02682264|524993585|FG000|Overall Study|Stopped test article application|0|||
145584713|NCT02682264|524993586|FG001|Overall Study|Stopped test article application|1|||
145584714|NCT03447769|524993588|FG000|Overall Study|Progressive disease|138|||
145584715|NCT03447769|524993589|FG001|Overall Study|Progressive disease|148|||
145584716|NCT03447769|524993588|FG000|Overall Study|Study terminated by Sponsor|60|||
145584717|NCT03447769|524993589|FG001|Overall Study|Study terminated by Sponsor|44|||
145584718|NCT03447769|524993588|FG000|Overall Study|Adverse Event|34|||
145584719|NCT03447769|524993589|FG001|Overall Study|Adverse Event|31|||
145584720|NCT03447769|524993588|FG000|Overall Study|Patient decision|27|||
145584721|NCT03447769|524993589|FG001|Overall Study|Patient decision|27|||
145584722|NCT03447769|524993588|FG000|Overall Study|Protocol deviation|4|||
145584723|NCT03447769|524993589|FG001|Overall Study|Protocol deviation|6|||
145584724|NCT03447769|524993588|FG000|Overall Study|Death|2|||
145584725|NCT03447769|524993589|FG001|Overall Study|Death|7|||
145440671|NCT04908683|524471419|FG001|Overall Study|Physician Decision|35|||
145440672|NCT04908683|524471418|FG000|Overall Study|Technical problems|12|||
145440673|NCT04908683|524471419|FG001|Overall Study|Technical problems|9|||
145440674|NCT04908683|524471418|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
145440675|NCT04908683|524471419|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
145440676|NCT04908683|524471418|FG000|Overall Study|Protocol Violation|2|||
145440677|NCT04908683|524471419|FG001|Overall Study|Protocol Violation|0|||
145440678|NCT04908683|524471418|FG000|Overall Study|Withdrawal by Subject|1188|||
145440679|NCT04908683|524471419|FG001|Overall Study|Withdrawal by Subject|570|||
145440680|NCT04908683|524471418|FG000|Overall Study|Site Closure by Sponsor|6|||
145440681|NCT04908683|524471419|FG001|Overall Study|Site Closure by Sponsor|3|||
145440682|NCT04908683|524471418|FG000|Overall Study|Adverse Event|21|||
145440683|NCT04908683|524471419|FG001|Overall Study|Adverse Event|11|||
145440684|NCT04908683|524471418|FG000|Overall Study|Death|101|||
145440685|NCT04908683|524471419|FG001|Overall Study|Death|61|||
145440686|NCT04908683|524471418|FG000|Overall Study|Sponsor's decision|14398|||
145440687|NCT04908683|524471419|FG001|Overall Study|Sponsor's decision|7205|||
145440688|NCT04908683|524471418|FG000|Overall Study|Other|92|||
145440689|NCT04908683|524471419|FG001|Overall Study|Other|50|||
145440690|NCT04908683|524471418|FG000|Overall Study|Randomized not vaccinated|108|||
145440691|NCT04908683|524471419|FG001|Overall Study|Randomized not vaccinated|52|||
145440692|NCT02688192|524471420|FG000|Overall Study|Lost to Follow-up|11|||
145440693|NCT02688192|524471421|FG001|Overall Study|Lost to Follow-up|5|||
145440694|NCT02688192|524471420|FG000|Overall Study|Physician Decision|1|||
145440695|NCT02688192|524471421|FG001|Overall Study|Physician Decision|0|||
145440696|NCT00075764|524471422|FG000|Overall Study|Adverse Event|5|||
145440697|NCT00075764|524471423|FG001|Overall Study|Adverse Event|12|||
145440698|NCT00075764|524471422|FG000|Overall Study|Death|4|||
145440699|NCT00075764|524471423|FG001|Overall Study|Death|8|||
145440700|NCT00075764|524471422|FG000|Overall Study|Withdrawal by Subject|28|||
145440701|NCT00075764|524471423|FG001|Overall Study|Withdrawal by Subject|18|||
145440702|NCT00075764|524471422|FG000|Overall Study|Progression|269|||
145440703|NCT00075764|524471423|FG001|Overall Study|Progression|274|||
145440704|NCT00075764|524471422|FG000|Overall Study|Still on treatment|8|||
145440705|NCT00075764|524471423|FG001|Overall Study|Still on treatment|15|||
145440706|NCT00075764|524471422|FG000|Overall Study|Delinquent|4|||
145440707|NCT00075764|524471423|FG001|Overall Study|Delinquent|2|||
145440708|NCT00075764|524471422|FG000|Overall Study|Not protocol specified|27|||
145440709|NCT00075764|524471423|FG001|Overall Study|Not protocol specified|19|||
145440710|NCT00075764|524471422|FG000|Overall Study|Under review|0|||
145440711|NCT00075764|524471423|FG001|Overall Study|Under review|1|||
145440712|NCT02817594|524471427|FG000|Overall Study|Withdrawal by Subject|1|||
145440713|NCT02817594|524471427|FG000|Overall Study|Other|1|||
145440714|NCT02817594|524471427|FG000|Overall Study|Did Not Receive Treatment|1|||
145440715|NCT02010593|524471428|FG000|Overall Study|Lost to Follow-up|1|||
145584726|NCT03447769|524993588|FG000|Overall Study|Technical problems|1|||
145584727|NCT03447769|524993589|FG001|Overall Study|Technical problems|0|||
145440716|NCT02010593|524471429|FG001|Overall Study|Lost to Follow-up|0|||
145440717|NCT02010593|524471428|FG000|Overall Study|Physician Decision|1|||
145440718|NCT02010593|524471429|FG001|Overall Study|Physician Decision|0|||
145440719|NCT02010593|524471428|FG000|Overall Study|Unable to adhere to visit schedule|0|||
145440720|NCT02010593|524471429|FG001|Overall Study|Unable to adhere to visit schedule|2|||
145440721|NCT01773967|524471430|FG000|Overall Study|Lost to Follow-up|15|||
145440722|NCT01773967|524471431|FG001|Overall Study|Lost to Follow-up|13|||
145440723|NCT01135459|524471432|FG000|Overall Study|Adverse Event|8|||
145440724|NCT01135459|524471433|FG001|Overall Study|Adverse Event|10|||
145584728|NCT03447769|524993588|FG000|Overall Study|Lost to Follow-up|0|||
145584729|NCT03447769|524993589|FG001|Overall Study|Lost to Follow-up|1|||
145584730|NCT03447769|524993588|FG000|Overall Study|Physician Decision|13|||
145584731|NCT03447769|524993589|FG001|Overall Study|Physician Decision|5|||
145584732|NCT03879798|524993591|FG000|Overall Study|Adverse Event|0|||
145440725|NCT01135459|524471432|FG000|Overall Study|Lack of Efficacy|3|||
145440726|NCT01135459|524471433|FG001|Overall Study|Lack of Efficacy|1|||
145440727|NCT01135459|524471432|FG000|Overall Study|Withdrawal by Subject|2|||
145440728|NCT01135459|524471433|FG001|Overall Study|Withdrawal by Subject|3|||
145440729|NCT01135459|524471432|FG000|Overall Study|Protocol Violation|5|||
145440730|NCT01135459|524471433|FG001|Overall Study|Protocol Violation|3|||
145440731|NCT01135459|524471432|FG000|Overall Study|Lost to Follow-up|2|||
145440732|NCT01135459|524471433|FG001|Overall Study|Lost to Follow-up|1|||
145440733|NCT01135459|524471432|FG000|Overall Study|Non-compliance to study procedures|0|||
145440734|NCT01135459|524471433|FG001|Overall Study|Non-compliance to study procedures|1|||
145440735|NCT01135459|524471432|FG000|Overall Study|Other than specified|1|||
145440736|NCT01135459|524471433|FG001|Overall Study|Other than specified|1|||
145440737|NCT00709319|524471434|FG000|Overall Study|Death|4|||
145440738|NCT00709319|524471434|FG000|Overall Study|Withdrawal by Subject|2|||
145440739|NCT00090779|524471438|FG000|Step 1|Withdrawal by Subject|4|||
145440740|NCT00090779|524471439|FG001|Step 1|Withdrawal by Subject|2|||
145440741|NCT00090779|524471438|FG000|Step 1|Lost to Follow-up|3|||
145440742|NCT00090779|524471439|FG001|Step 1|Lost to Follow-up|2|||
145440743|NCT00090779|524471438|FG000|Step 1|Death|0|||
145440744|NCT00090779|524471439|FG001|Step 1|Death|2|||
145440745|NCT00090779|524471438|FG000|Step 1|Physician Decision|1|||
145440746|NCT00090779|524471439|FG001|Step 1|Physician Decision|0|||
145440747|NCT00090779|524471438|FG000|Step 1|Pregnancy|1|||
145440748|NCT00090779|524471439|FG001|Step 1|Pregnancy|0|||
145440749|NCT00090779|524471438|FG000|Step 1|Non-compliance to study requirements|0|||
145440750|NCT00090779|524471439|FG001|Step 1|Non-compliance to study requirements|1|||
145440751|NCT00090779|524471438|FG000|Step 1|Subject relocated|2|||
145440752|NCT00090779|524471439|FG001|Step 1|Subject relocated|8|||
145440753|NCT00090779|524471438|FG000|Step 2|Off study per study closure|6|||
145440754|NCT00090779|524471439|FG001|Step 2|Off study per study closure|16|||
145440755|NCT00090779|524471438|FG000|Step 2|Subject relocated|0|||
145440756|NCT00090779|524471439|FG001|Step 2|Subject relocated|1|||
145440757|NCT00090779|524471438|FG000|Step 2|Non-compliance to study requirements|0|||
145440758|NCT00090779|524471439|FG001|Step 2|Non-compliance to study requirements|1|||
145440759|NCT00090779|524471438|FG000|Step 3|Initiation of ART and off extended study|3|||
145440760|NCT00090779|524471439|FG001|Step 3|Initiation of ART and off extended study|2|||
145440761|NCT00090779|524471438|FG000|Step 3|Off extended study due to study closure|4|||
145440762|NCT00090779|524471439|FG001|Step 3|Off extended study due to study closure|3|||
145440763|NCT04860869|524471446|FG000|Overall Study|Withdrawal by Subject|1|||
145440764|NCT04860869|524471447|FG001|Overall Study|Withdrawal by Subject|0|||
145440765|NCT00590967|524471448|FG000|Overall Study|Withdrawal by Subject|1|||
145440766|NCT00590967|524471449|FG001|Overall Study|Withdrawal by Subject|1|||
145440767|NCT00590967|524471448|FG000|Overall Study|Ineligible|1|||
145440768|NCT00590967|524471449|FG001|Overall Study|Ineligible|0|||
145440769|NCT00590967|524471448|FG000|Overall Study|Poor performance status|0|||
145440770|NCT00590967|524471449|FG001|Overall Study|Poor performance status|1|||
145440771|NCT00590967|524471448|FG000|Overall Study|Non-compliant|0|||
145440772|NCT00590967|524471449|FG001|Overall Study|Non-compliant|2|||
145440773|NCT00590967|524471448|FG000|Overall Study|Did not sign consent form|0|||
145440774|NCT00590967|524471449|FG001|Overall Study|Did not sign consent form|1|||
145440775|NCT00590967|524471448|FG000|Overall Study|Did not receive chemo per protocol|1|||
145440776|NCT00590967|524471449|FG001|Overall Study|Did not receive chemo per protocol|0|||
145440777|NCT01151020|524471450|FG000|Overall Study|Death|25|||
145440778|NCT01151020|524471450|FG000|Overall Study|Conversion to open repair|1|||
145440779|NCT01151020|524471450|FG000|Overall Study|Lost to Follow-up|4|||
145440780|NCT01151020|524471450|FG000|Overall Study|Withdrawal by Subject|22|||
145440781|NCT01151020|524471450|FG000|Overall Study|Patients did not receive the device|2|||
145440782|NCT03606486|524471451|FG000|Overall Study|Unable to collect sample|5|||
145440783|NCT01737762|524471458|FG000|Overall Study|Adverse Event|2|||
145440784|NCT01737762|524471459|FG001|Overall Study|Adverse Event|2|||
145440785|NCT01737762|524471458|FG000|Overall Study|Lost to Follow-up|1|||
145440786|NCT01737762|524471459|FG001|Overall Study|Lost to Follow-up|0|||
145440787|NCT01737762|524471458|FG000|Overall Study|Withdrawal by Subject|2|||
145440788|NCT01737762|524471459|FG001|Overall Study|Withdrawal by Subject|2|||
145440789|NCT01737762|524471458|FG000|Overall Study|Progressive disease|1|||
145584733|NCT03879798|524993592|FG001|Overall Study|Adverse Event|0|||
145584734|NCT03879798|524993593|FG002|Overall Study|Adverse Event|0|||
145584735|NCT03879798|524993594|FG003|Overall Study|Adverse Event|0|||
145440790|NCT01737762|524471459|FG001|Overall Study|Progressive disease|2|||
145440791|NCT01737762|524471458|FG000|Overall Study|Physician Decision|1|||
145440792|NCT01737762|524471459|FG001|Overall Study|Physician Decision|1|||
145440793|NCT01737762|524471458|FG000|Overall Study|Moved from area|2|||
145440794|NCT01737762|524471459|FG001|Overall Study|Moved from area|1|||
145440795|NCT01737762|524471458|FG000|Overall Study|Trial termination|11|||
145440796|NCT01737762|524471459|FG001|Overall Study|Trial termination|9|||
145440797|NCT02148263|524471460|FG000|Overall Study|Withdrawal by Subject|3|||
145440798|NCT02148263|524471461|FG001|Overall Study|Withdrawal by Subject|2|||
145584736|NCT03879798|524993595|FG004|Overall Study|Adverse Event|0|||
145584737|NCT03879798|524993596|FG005|Overall Study|Adverse Event|1|||
145440799|NCT00503425|524471462|FG000|Overall Study|Participant files lost|6|||
145440800|NCT00503425|524471462|FG000|Overall Study|Adverse Event|5|||
145440801|NCT00503425|524471462|FG000|Overall Study|Lack of Efficacy|25|||
145440802|NCT00503425|524471462|FG000|Overall Study|Withdrawal by Subject|8|||
145440803|NCT00503425|524471462|FG000|Overall Study|Lost to Follow-up|3|||
145440804|NCT00503425|524471462|FG000|Overall Study|Death|3|||
145440805|NCT00503425|524471462|FG000|Overall Study|Missing Data/Unknown|4|||
145440806|NCT03364231|524471463|FG000|Overall Study|Adverse Event|1|||
145440807|NCT03364231|524471464|FG001|Overall Study|Adverse Event|4|||
145440808|NCT03364231|524471463|FG000|Overall Study|Death|1|||
145440809|NCT03364231|524471464|FG001|Overall Study|Death|0|||
145440810|NCT03364231|524471463|FG000|Overall Study|Investigator Decision|2|||
145440811|NCT03364231|524471464|FG001|Overall Study|Investigator Decision|2|||
145440812|NCT03364231|524471463|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
145440813|NCT03364231|524471464|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
145440814|NCT03364231|524471463|FG000|Overall Study|Withdrawal of Subject Consent|1|||
145440815|NCT03364231|524471464|FG001|Overall Study|Withdrawal of Subject Consent|0|||
145440816|NCT03364231|524471463|FG000|Overall Study|Reason Not Specified|1|||
145440817|NCT03364231|524471464|FG001|Overall Study|Reason Not Specified|0|||
145440818|NCT03364231|524471463|FG000|Overall Study|Disease Progression|0|||
145440819|NCT03364231|524471464|FG001|Overall Study|Disease Progression|6|||
145440820|NCT02503085|524471465|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
145440821|NCT02503085|524471466|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
145440822|NCT02503085|524471467|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
145440823|NCT02503085|524471468|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
145440824|NCT02012218|524471469|FG000|Overall Study|Withdrawal by Subject|1|||
145440825|NCT02012218|524471470|FG001|Overall Study|Withdrawal by Subject|0|||
145440826|NCT02012218|524471471|FG002|Overall Study|Withdrawal by Subject|1|||
145440827|NCT02012218|524471472|FG003|Overall Study|Withdrawal by Subject|1|||
145440828|NCT02012218|524471473|FG004|Overall Study|Withdrawal by Subject|1|||
145440829|NCT02012218|524471469|FG000|Overall Study|Adverse Event|1|||
145440830|NCT02012218|524471470|FG001|Overall Study|Adverse Event|0|||
145440831|NCT02012218|524471471|FG002|Overall Study|Adverse Event|0|||
145440832|NCT02012218|524471472|FG003|Overall Study|Adverse Event|1|||
145440833|NCT02012218|524471473|FG004|Overall Study|Adverse Event|0|||
145440834|NCT02012218|524471469|FG000|Overall Study|Lost to Follow-up|0|||
145440835|NCT02012218|524471470|FG001|Overall Study|Lost to Follow-up|1|||
145440836|NCT02012218|524471471|FG002|Overall Study|Lost to Follow-up|1|||
145440837|NCT02012218|524471472|FG003|Overall Study|Lost to Follow-up|0|||
145440838|NCT02012218|524471473|FG004|Overall Study|Lost to Follow-up|0|||
145440839|NCT02012218|524471469|FG000|Overall Study|Protocol Specified|1|||
145440840|NCT02012218|524471470|FG001|Overall Study|Protocol Specified|0|||
145440841|NCT02012218|524471471|FG002|Overall Study|Protocol Specified|0|||
145440842|NCT02012218|524471472|FG003|Overall Study|Protocol Specified|0|||
145440843|NCT02012218|524471473|FG004|Overall Study|Protocol Specified|0|||
145440844|NCT02012218|524471469|FG000|Overall Study|Protocol Deviation|1|||
145440845|NCT02012218|524471470|FG001|Overall Study|Protocol Deviation|0|||
145440846|NCT02012218|524471471|FG002|Overall Study|Protocol Deviation|0|||
145440847|NCT02012218|524471472|FG003|Overall Study|Protocol Deviation|0|||
145440848|NCT02012218|524471473|FG004|Overall Study|Protocol Deviation|0|||
145440849|NCT04872569|524471474|FG000|Overall Study|Withdrawal by Subject|2|||
145440850|NCT04417257|524471477|FG000|Pilot Phase 2|Adverse Event|2|||
145440851|NCT04417257|524471478|FG001|Pilot Phase 2|Adverse Event|0|||
145440852|NCT04417257|524471477|FG000|Pilot Phase 2|Death|14|||
145440853|NCT04417257|524471478|FG001|Pilot Phase 2|Death|11|||
145440854|NCT04417257|524471477|FG000|Pilot Phase 2|Lost to Follow-up|3|||
145440855|NCT04417257|524471478|FG001|Pilot Phase 2|Lost to Follow-up|5|||
145440856|NCT04417257|524471477|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
145440857|NCT04417257|524471478|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
145440858|NCT04417257|524471477|FG000|Pilot Phase 2|Hepatic impairment|1|||
145440859|NCT04417257|524471478|FG001|Pilot Phase 2|Hepatic impairment|0|||
145440860|NCT04417257|524471477|FG000|Pilot Phase 2|Unblinding|1|||
145440861|NCT04417257|524471478|FG001|Pilot Phase 2|Unblinding|0|||
145440862|NCT04417257|524471477|FG000|Pilot Phase 2|All other|0|||
145440863|NCT04417257|524471478|FG001|Pilot Phase 2|All other|2|||
145440864|NCT04417257|524471477|FG000|Phase 3 Extension|Death|3|||
145440865|NCT04417257|524471478|FG001|Phase 3 Extension|Death|1|||
145440866|NCT04417257|524471477|FG000|Phase 3 Extension|Lost to Follow-up|4|||
145440867|NCT04417257|524471478|FG001|Phase 3 Extension|Lost to Follow-up|2|||
145440868|NCT04417257|524471477|FG000|Phase 3 Extension|Patient withdrawal|2|||
145440869|NCT04417257|524471478|FG001|Phase 3 Extension|Patient withdrawal|2|||
145440870|NCT04417257|524471477|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
145440871|NCT04417257|524471478|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
145440872|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
145440873|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
145440874|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
145440875|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
145584738|NCT03879798|524993591|FG000|Overall Study|Lack of Efficacy|0|||
145440876|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
145440877|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
145440878|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
145440879|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
145440880|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
145440881|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
145440882|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
145440883|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
145440884|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
145440885|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
145440886|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
145440887|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
145440888|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
145440889|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
145584739|NCT03879798|524993592|FG001|Overall Study|Lack of Efficacy|0|||
145584740|NCT03879798|524993593|FG002|Overall Study|Lack of Efficacy|0|||
145584741|NCT03879798|524993594|FG003|Overall Study|Lack of Efficacy|0|||
145584742|NCT03879798|524993595|FG004|Overall Study|Lack of Efficacy|0|||
145584743|NCT03879798|524993596|FG005|Overall Study|Lack of Efficacy|1|||
145584744|NCT03879798|524993591|FG000|Overall Study|Withdrawal by Subject|0|||
145584745|NCT03879798|524993592|FG001|Overall Study|Withdrawal by Subject|0|||
145584746|NCT03879798|524993593|FG002|Overall Study|Withdrawal by Subject|0|||
145584747|NCT03879798|524993594|FG003|Overall Study|Withdrawal by Subject|0|||
145584748|NCT03879798|524993595|FG004|Overall Study|Withdrawal by Subject|0|||
145584749|NCT03879798|524993596|FG005|Overall Study|Withdrawal by Subject|1|||
145584750|NCT01255358|524993597|FG000|Overall Study|Adverse Event|2|||
145584751|NCT01255358|524993597|FG000|Overall Study|Protocol Violation|2|||
145584752|NCT03950739|524993598|FG000|Treatment Phase|Adverse Event|2|||
145584753|NCT03950739|524993598|FG000|Optional Extension Phase|Death|1|||
145584754|NCT03950739|524993598|FG000|Optional Extension Phase|Progressive Disease|5|||
145584755|NCT03950739|524993598|FG000|Optional Extension Phase|Adverse Event|7|||
145584756|NCT03950739|524993598|FG000|Optional Extension Phase|Lost to Follow-up|2|||
145584757|NCT03950739|524993598|FG000|Optional Extension Phase|Site Closure|2|||
145584758|NCT03950739|524993598|FG000|Optional Extension Phase|Pregnancy|1|||
145584759|NCT03783923|524993610|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
145584760|NCT03783923|524993611|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
145584761|NCT03783923|524993610|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
145584762|NCT03783923|524993611|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
145584763|NCT03783923|524993610|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
145584764|NCT03783923|524993611|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
145584765|NCT03783923|524993610|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
145584766|NCT03783923|524993611|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
145584767|NCT03783923|524993610|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
145584768|NCT03783923|524993611|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
145584769|NCT00817089|524993612|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
145584770|NCT00817089|524993613|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
145584771|NCT00817089|524993614|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
145584772|NCT00817089|524993615|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
145584773|NCT00817089|524993612|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
145584774|NCT00817089|524993613|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
145584775|NCT00817089|524993614|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
145584776|NCT00817089|524993615|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
145584777|NCT00856583|524993619|FG000|Overall Study|Lack of Efficacy|389|||
145584778|NCT00856583|524993620|FG001|Overall Study|Lack of Efficacy|377|||
145584779|NCT00856583|524993619|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
145584780|NCT00856583|524993620|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
145584781|NCT00856583|524993619|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
145584782|NCT00856583|524993620|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
145440890|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
145440891|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
145440892|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
145440893|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
145584783|NCT00856583|524993619|FG000|Overall Study|Non-compliance|305|||
145584784|NCT00856583|524993620|FG001|Overall Study|Non-compliance|262|||
145584785|NCT00856583|524993619|FG000|Overall Study|Withdrawal by Subject|1092|||
145584786|NCT00856583|524993620|FG001|Overall Study|Withdrawal by Subject|919|||
145584787|NCT00856583|524993619|FG000|Overall Study|Physician Decision|59|||
145584788|NCT00856583|524993620|FG001|Overall Study|Physician Decision|82|||
145440894|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
145584789|NCT00856583|524993619|FG000|Overall Study|Pregnancy|14|||
145584790|NCT00856583|524993620|FG001|Overall Study|Pregnancy|5|||
145584791|NCT00856583|524993619|FG000|Overall Study|Other|92|||
145584792|NCT00856583|524993620|FG001|Overall Study|Other|104|||
145440895|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
145440896|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
145440897|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
145440898|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
145440899|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
145440900|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
145440901|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
145440902|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
145440903|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
145440904|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
145440905|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
145440906|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
145440907|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
145440908|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
145440909|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
145440910|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
145440911|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
145440912|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
145440913|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
145440914|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
145440915|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
145440916|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
145440917|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
145440918|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
145440919|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
145440920|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
145440921|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
145440922|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
145440923|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
145440924|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
145440925|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
145440926|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
145440927|NCT04951622|524471479|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
145440928|NCT04951622|524471480|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
145440929|NCT04951622|524471481|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
145440930|NCT04951622|524471482|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
145440931|NCT04951622|524471483|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
145440932|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
145440933|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
145440934|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
145440935|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
145440936|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
145440937|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
145440938|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
145440939|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
145440940|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
145440941|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
145440942|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
145440943|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
145440944|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
145440945|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
145440946|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
145440947|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
145440948|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
145440949|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
145440950|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
145440951|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
145440952|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
145440953|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
145440954|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
145440955|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
145440956|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
145440957|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
145440958|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
145440959|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
145440960|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
145440961|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
145440962|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
145440963|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
145440964|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
145440965|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
145440966|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
145440967|NCT04951622|524471479|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
145440968|NCT04951622|524471480|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
145440969|NCT04951622|524471481|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
145440970|NCT04951622|524471482|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
145440971|NCT04951622|524471483|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
145440972|NCT00943761|524471485|FG000|Overall Study|Lost to Follow-up|2|||
145440973|NCT00943761|524471486|FG001|Overall Study|Lost to Follow-up|0|||
145440974|NCT00943761|524471485|FG000|Overall Study|Withdrawal by Subject|2|||
145440975|NCT00943761|524471486|FG001|Overall Study|Withdrawal by Subject|1|||
145440976|NCT02708680|524471487|FG000|Overall Study|Withdrawal by Subject|4|||
145440977|NCT02708680|524471488|FG001|Overall Study|Withdrawal by Subject|12|||
145440978|NCT02708680|524471489|FG002|Overall Study|Withdrawal by Subject|12|||
145440979|NCT02708680|524471487|FG000|Overall Study|Death|4|||
145440980|NCT02708680|524471488|FG001|Overall Study|Death|19|||
145440981|NCT02708680|524471489|FG002|Overall Study|Death|21|||
145440982|NCT02708680|524471487|FG000|Overall Study|Lost to Follow-up|0|||
145440983|NCT02708680|524471488|FG001|Overall Study|Lost to Follow-up|3|||
145440984|NCT02708680|524471489|FG002|Overall Study|Lost to Follow-up|3|||
145440985|NCT02708680|524471487|FG000|Overall Study|Study Terminated By Sponsor|0|||
145440986|NCT02708680|524471488|FG001|Overall Study|Study Terminated By Sponsor|5|||
145440987|NCT02708680|524471489|FG002|Overall Study|Study Terminated By Sponsor|4|||
145440988|NCT02708680|524471487|FG000|Overall Study|Other than Specified|0|||
145440989|NCT02708680|524471488|FG001|Overall Study|Other than Specified|0|||
145440990|NCT02708680|524471489|FG002|Overall Study|Other than Specified|1|||
145440991|NCT02708680|524471487|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
145440992|NCT02708680|524471488|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
145440993|NCT02708680|524471489|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
145440994|NCT01342926|524471490|FG000|Overall Study|Adverse Event|5|||
145440995|NCT01342926|524471491|FG001|Overall Study|Adverse Event|8|||
145440996|NCT01342926|524471492|FG002|Overall Study|Adverse Event|10|||
145440997|NCT01342926|524471493|FG003|Overall Study|Adverse Event|7|||
145440998|NCT01342926|524471490|FG000|Overall Study|Lost to Follow-up|0|||
145440999|NCT01342926|524471491|FG001|Overall Study|Lost to Follow-up|1|||
145441000|NCT01342926|524471492|FG002|Overall Study|Lost to Follow-up|1|||
145441001|NCT01342926|524471493|FG003|Overall Study|Lost to Follow-up|0|||
145441002|NCT01342926|524471490|FG000|Overall Study|Investigator Discretion|2|||
145441003|NCT01342926|524471491|FG001|Overall Study|Investigator Discretion|2|||
145441004|NCT01342926|524471492|FG002|Overall Study|Investigator Discretion|0|||
145441005|NCT01342926|524471493|FG003|Overall Study|Investigator Discretion|0|||
145441006|NCT01342926|524471490|FG000|Overall Study|Withdrawal by Subject|2|||
145441007|NCT01342926|524471491|FG001|Overall Study|Withdrawal by Subject|4|||
145441008|NCT01342926|524471492|FG002|Overall Study|Withdrawal by Subject|3|||
145441009|NCT01342926|524471493|FG003|Overall Study|Withdrawal by Subject|5|||
145441010|NCT00326001|524471496|FG000|Overall Study|Adverse Event|4|||
145441011|NCT00326001|524471497|FG001|Overall Study|Adverse Event|5|||
145441012|NCT00326001|524471496|FG000|Overall Study|Physician Decision|3|||
145441013|NCT00326001|524471497|FG001|Overall Study|Physician Decision|3|||
145441014|NCT03941483|524471500|FG000|Overall Study|Miscellaneous|2|||
145441015|NCT03941483|524471501|FG001|Overall Study|Miscellaneous|3|||
145441016|NCT03941483|524471502|FG002|Overall Study|Miscellaneous|0|||
145441017|NCT03941483|524471500|FG000|Overall Study|Study Terminated by Sponsor|1|||
145441018|NCT03941483|524471501|FG001|Overall Study|Study Terminated by Sponsor|0|||
145441019|NCT03941483|524471502|FG002|Overall Study|Study Terminated by Sponsor|0|||
145441020|NCT03941483|524471500|FG000|Overall Study|Withdrawal by Subject|1|||
145441021|NCT03941483|524471501|FG001|Overall Study|Withdrawal by Subject|4|||
145441022|NCT03941483|524471502|FG002|Overall Study|Withdrawal by Subject|1|||
145441023|NCT03941483|524471500|FG000|Overall Study|Lost to Follow-up|2|||
145441024|NCT03941483|524471501|FG001|Overall Study|Lost to Follow-up|1|||
145441025|NCT03941483|524471502|FG002|Overall Study|Lost to Follow-up|8|||
145441026|NCT03941483|524471500|FG000|Overall Study|Death|3|||
145441027|NCT03941483|524471501|FG001|Overall Study|Death|2|||
145441028|NCT03941483|524471502|FG002|Overall Study|Death|6|||
145441029|NCT03154476|524471503|FG000|Overall Study|Lost to Follow-up|4|||
145441030|NCT03154476|524471504|FG001|Overall Study|Lost to Follow-up|4|||
145441031|NCT03816176|524471505|FG000|Overall Study|Miscellaneous|5|||
145441032|NCT03816176|524471505|FG000|Overall Study|Lack of Efficacy|4|||
145441033|NCT03816176|524471505|FG000|Overall Study|Adverse Event|3|||
145441034|NCT04267926|524473059|FG000|Overall Study|abnormal labs. No longer eligible|0|||
145441035|NCT04267926|524473060|FG001|Overall Study|abnormal labs. No longer eligible|0|||
145441036|NCT04267926|524473061|FG002|Overall Study|abnormal labs. No longer eligible|1|||
145441037|NCT04267926|524473059|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
145441038|NCT04267926|524473060|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
145441039|NCT04267926|524473061|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
145441040|NCT02489318|524473064|FG000|Randomized|Withdrawal by Subject|0|||
145441041|NCT02489318|524473065|FG001|Randomized|Withdrawal by Subject|1|||
145441042|NCT02489318|524473064|FG000|Treated|Adverse Event|19|||
145441043|NCT02489318|524473065|FG001|Treated|Adverse Event|62|||
145441044|NCT02489318|524473064|FG000|Treated|Death|13|||
145441045|NCT02489318|524473065|FG001|Treated|Death|11|||
145441046|NCT02489318|524473064|FG000|Treated|Physician Decision|4|||
145441047|NCT02489318|524473065|FG001|Treated|Physician Decision|6|||
145441048|NCT02489318|524473064|FG000|Treated|Protocol Violation|1|||
145441049|NCT02489318|524473065|FG001|Treated|Protocol Violation|2|||
145441050|NCT02489318|524473064|FG000|Treated|Withdrawal by Subject|37|||
145441051|NCT02489318|524473065|FG001|Treated|Withdrawal by Subject|36|||
145441052|NCT02489318|524473064|FG000|Treated|Other: Progressive Disease|245|||
145441053|NCT02489318|524473065|FG001|Treated|Other: Progressive Disease|138|||
145441054|NCT02489318|524473064|FG000|Treated|Other|0|||
145441055|NCT02489318|524473065|FG001|Treated|Other|2|||
145441056|NCT02489318|524473064|FG000|Treated|Ongoing|0|||
145441057|NCT02489318|524473065|FG001|Treated|Ongoing|267|||
145441058|NCT01306643|524473066|FG000|Overall Study|Adverse Event|5|||
145441059|NCT01306643|524473066|FG000|Overall Study|Disease Progression|7|||
145441060|NCT01306643|524473066|FG000|Overall Study|Other: Change in Eligibility Status|1|||
145441061|NCT02479880|524473069|FG000|Overall Study|Study Terminated by Sponsor|13|||
145441062|NCT02479880|524473070|FG001|Overall Study|Study Terminated by Sponsor|12|||
145441063|NCT02479880|524473069|FG000|Overall Study|Pregnancy|0|||
145441064|NCT02479880|524473070|FG001|Overall Study|Pregnancy|1|||
145441065|NCT00355368|524473071|FG000|Overall Study|Protocol Violation|8|||
145441066|NCT00355368|524473072|FG001|Overall Study|Protocol Violation|7|||
145441067|NCT00355368|524473071|FG000|Overall Study|cardiac arrest prior to intubation|2|||
145441068|NCT00355368|524473072|FG001|Overall Study|cardiac arrest prior to intubation|2|||
145441069|NCT03801928|524473073|FG000|Overall Study|Adverse Event|1|||
145441070|NCT03801928|524473074|FG001|Overall Study|Adverse Event|0|||
145441071|NCT03801928|524473075|FG002|Overall Study|Adverse Event|1|||
145441072|NCT03801928|524473076|FG003|Overall Study|Adverse Event|2|||
145441073|NCT03801928|524473077|FG004|Overall Study|Adverse Event|0|||
145441074|NCT03801928|524473078|FG005|Overall Study|Adverse Event|2|||
145441075|NCT03801928|524473073|FG000|Overall Study|Lack of Efficacy|0|||
145441076|NCT03801928|524473074|FG001|Overall Study|Lack of Efficacy|0|||
145441077|NCT03801928|524473075|FG002|Overall Study|Lack of Efficacy|1|||
145441078|NCT03801928|524473076|FG003|Overall Study|Lack of Efficacy|0|||
145441079|NCT03801928|524473077|FG004|Overall Study|Lack of Efficacy|0|||
145441080|NCT03801928|524473078|FG005|Overall Study|Lack of Efficacy|0|||
145441081|NCT03801928|524473073|FG000|Overall Study|Lost to Follow-up|5|||
145441082|NCT03801928|524473074|FG001|Overall Study|Lost to Follow-up|1|||
145441083|NCT03801928|524473075|FG002|Overall Study|Lost to Follow-up|1|||
145584793|NCT00856583|524993619|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
145584794|NCT00856583|524993620|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
145584795|NCT01944046|524993621|FG000|Randomized to DB|Adverse Event|5|||
145584796|NCT01944046|524993622|FG001|Randomized to DB|Adverse Event|2|||
145584797|NCT01944046|524993621|FG000|Randomized to DB|Clinical Worsening|3|||
145584798|NCT01944046|524993622|FG001|Randomized to DB|Clinical Worsening|2|||
145441084|NCT03801928|524473076|FG003|Overall Study|Lost to Follow-up|4|||
145441085|NCT03801928|524473077|FG004|Overall Study|Lost to Follow-up|4|||
145441086|NCT03801928|524473078|FG005|Overall Study|Lost to Follow-up|2|||
145441087|NCT03801928|524473073|FG000|Overall Study|Withdrawal by Subject|0|||
145441088|NCT03801928|524473074|FG001|Overall Study|Withdrawal by Subject|0|||
145441089|NCT03801928|524473075|FG002|Overall Study|Withdrawal by Subject|2|||
145441090|NCT03801928|524473076|FG003|Overall Study|Withdrawal by Subject|1|||
145441091|NCT03801928|524473077|FG004|Overall Study|Withdrawal by Subject|0|||
145441092|NCT03801928|524473078|FG005|Overall Study|Withdrawal by Subject|0|||
145441093|NCT03801928|524473073|FG000|Overall Study|Other|0|||
145441094|NCT03801928|524473074|FG001|Overall Study|Other|2|||
145441095|NCT03801928|524473075|FG002|Overall Study|Other|0|||
145441096|NCT03801928|524473076|FG003|Overall Study|Other|1|||
145441097|NCT03801928|524473077|FG004|Overall Study|Other|0|||
145584799|NCT01944046|524993621|FG000|Randomized to DB|Lost to Follow-up|3|||
145441098|NCT03801928|524473078|FG005|Overall Study|Other|1|||
145441099|NCT02370368|524473081|FG000|Overall Study|Adverse Event|1|||
145441100|NCT02370368|524473082|FG001|Overall Study|Adverse Event|2|||
145441101|NCT02370368|524473081|FG000|Overall Study|Withdrawal by Subject|5|||
145441102|NCT02370368|524473082|FG001|Overall Study|Withdrawal by Subject|4|||
145441103|NCT03369665|524473083|FG000|Overall Study|Adverse Event|3|||
145441104|NCT03369665|524473083|FG000|Overall Study|Lost to Follow-up|7|||
145441105|NCT03369665|524473083|FG000|Overall Study|Withdrawal by Subject|15|||
145441106|NCT03369665|524473083|FG000|Overall Study|Progression Disease|2|||
145441107|NCT03369665|524473083|FG000|Overall Study|Not classified|3|||
145441108|NCT05197049|524473084|FG000|Overall Study|Death|0|||
145441109|NCT05197049|524473085|FG001|Overall Study|Death|1|||
145441110|NCT05197049|524473086|FG002|Overall Study|Death|0|||
145441111|NCT05197049|524473084|FG000|Overall Study|Lost to Follow-up|3|||
145441112|NCT05197049|524473085|FG001|Overall Study|Lost to Follow-up|1|||
145441113|NCT05197049|524473086|FG002|Overall Study|Lost to Follow-up|0|||
145441114|NCT05197049|524473084|FG000|Overall Study|Withdrawal by Subject|15|||
145441115|NCT05197049|524473085|FG001|Overall Study|Withdrawal by Subject|3|||
145441116|NCT05197049|524473086|FG002|Overall Study|Withdrawal by Subject|1|||
145441117|NCT05197049|524473084|FG000|Overall Study|GCP non-compliance|1|||
145441118|NCT05197049|524473085|FG001|Overall Study|GCP non-compliance|2|||
145441119|NCT05197049|524473086|FG002|Overall Study|GCP non-compliance|0|||
145441120|NCT00579553|524473087|FG000|Overall Study|Lost to Follow-up|16|||
145441121|NCT00579553|524473088|FG001|Overall Study|Lost to Follow-up|13|||
145441122|NCT03748641|524473089|FG000|Overall Study|Ongoing|155|||
145441123|NCT03748641|524473090|FG001|Overall Study|Ongoing|148|||
145441124|NCT03748641|524473091|FG002|Overall Study|Ongoing|66|||
145441125|NCT03748641|524473092|FG003|Overall Study|Ongoing|79|||
145441126|NCT03748641|524473093|FG004|Overall Study|Ongoing|84|||
145441127|NCT03748641|524473089|FG000|Overall Study|Death|54|||
145441128|NCT03748641|524473090|FG001|Overall Study|Death|59|||
145441129|NCT03748641|524473091|FG002|Overall Study|Death|51|||
145441130|NCT03748641|524473092|FG003|Overall Study|Death|42|||
145441131|NCT03748641|524473093|FG004|Overall Study|Death|9|||
145441132|NCT03748641|524473089|FG000|Overall Study|Lost to Follow-up|0|||
145441133|NCT03748641|524473090|FG001|Overall Study|Lost to Follow-up|2|||
145441134|NCT03748641|524473091|FG002|Overall Study|Lost to Follow-up|1|||
145441135|NCT03748641|524473092|FG003|Overall Study|Lost to Follow-up|0|||
145441136|NCT03748641|524473093|FG004|Overall Study|Lost to Follow-up|0|||
145441137|NCT03748641|524473089|FG000|Overall Study|Withdrawal by Subject|3|||
145441138|NCT03748641|524473090|FG001|Overall Study|Withdrawal by Subject|2|||
145441139|NCT03748641|524473091|FG002|Overall Study|Withdrawal by Subject|5|||
145441140|NCT03748641|524473092|FG003|Overall Study|Withdrawal by Subject|3|||
145441141|NCT03748641|524473093|FG004|Overall Study|Withdrawal by Subject|2|||
145441142|NCT04834726|524473094|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
145441143|NCT04834726|524473095|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
145441144|NCT04834726|524473096|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
145441145|NCT04834726|524473097|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
145441146|NCT04834726|524473098|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
145441147|NCT04834726|524473099|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
145441148|NCT04834726|524473100|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
145441149|NCT04834726|524473101|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
145441150|NCT04834726|524473102|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
145441151|NCT01144416|524473117|FG000|Intervention Period|Adverse Event|5|||
145441152|NCT01144416|524473118|FG001|Intervention Period|Adverse Event|6|||
145441153|NCT01144416|524473117|FG000|Intervention Period|Insufficient ovarian response|11|||
145441154|NCT01144416|524473118|FG001|Intervention Period|Insufficient ovarian response|17|||
145441155|NCT01144416|524473117|FG000|Intervention Period|Risk of OHSS|0|||
145441156|NCT01144416|524473118|FG001|Intervention Period|Risk of OHSS|1|||
145441157|NCT01144416|524473117|FG000|Intervention Period|Too high ovarian response|4|||
145441158|NCT01144416|524473118|FG001|Intervention Period|Too high ovarian response|2|||
145441159|NCT01144416|524473117|FG000|Intervention Period|No/too few/bad oocytes|7|||
145441160|NCT01144416|524473118|FG001|Intervention Period|No/too few/bad oocytes|5|||
145441161|NCT01144416|524473117|FG000|Intervention Period|No or abnormal fertilization|25|||
145441162|NCT01144416|524473118|FG001|Intervention Period|No or abnormal fertilization|10|||
145441163|NCT01144416|524473117|FG000|Intervention Period|No/too few/bad quality embryos|3|||
145441164|NCT01144416|524473118|FG001|Intervention Period|No/too few/bad quality embryos|3|||
145441165|NCT01144416|524473117|FG000|Intervention Period|Other|7|||
145441166|NCT01144416|524473118|FG001|Intervention Period|Other|5|||
145441167|NCT00124072|524473119|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
145441168|NCT00124072|524473120|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
145441169|NCT00124072|524473121|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
145441170|NCT00124072|524473122|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
145441171|NCT00124072|524473119|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
145441172|NCT00124072|524473120|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
145441173|NCT00124072|524473121|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
145441174|NCT00124072|524473122|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
145441175|NCT00124072|524473119|FG000|Overall Study|Death|499|||
145441176|NCT00124072|524473120|FG001|Overall Study|Death|484|||
145441177|NCT00124072|524473121|FG002|Overall Study|Death|471|||
145441178|NCT00124072|524473122|FG003|Overall Study|Death|480|||
145441179|NCT02534883|524473123|FG000|Overall Study|Early Termination|8|||
145441180|NCT02534883|524473124|FG001|Overall Study|Early Termination|3|||
145441181|NCT03328832|524473125|FG000|Overall Study|Lost to Follow-up|0|||
145441182|NCT03328832|524473126|FG001|Overall Study|Lost to Follow-up|1|||
145441183|NCT00714948|524473135|FG000|Overall Study|Adverse Event|2|||
145441184|NCT03390504|524473140|FG000|Overall Study|Lost to Follow-up|2|||
145441185|NCT03390504|524473141|FG001|Overall Study|Lost to Follow-up|4|||
145441186|NCT03390504|524473142|FG002|Overall Study|Lost to Follow-up|0|||
145441187|NCT03390504|524473143|FG003|Overall Study|Lost to Follow-up|1|||
145441188|NCT03390504|524473140|FG000|Overall Study|Withdrawal by Subject|3|||
145441189|NCT03390504|524473141|FG001|Overall Study|Withdrawal by Subject|15|||
145441190|NCT03390504|524473142|FG002|Overall Study|Withdrawal by Subject|5|||
145441191|NCT03390504|524473143|FG003|Overall Study|Withdrawal by Subject|2|||
145441192|NCT03390504|524473140|FG000|Overall Study|Other|1|||
145441193|NCT03390504|524473141|FG001|Overall Study|Other|2|||
145441194|NCT03390504|524473142|FG002|Overall Study|Other|2|||
145441195|NCT03390504|524473143|FG003|Overall Study|Other|6|||
145441196|NCT00980538|524473144|FG000|Overall Study|Lost to Follow-up|20|||
145441197|NCT00980538|524473144|FG000|Overall Study|Sponsor's Decision|4|||
145441198|NCT00980538|524473144|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
145441199|NCT00980538|524473144|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
145441200|NCT00980538|524473144|FG000|Overall Study|Switch to Commercially Available Medication|25|||
145441201|NCT00980538|524473144|FG000|Overall Study|Participant Non-Compliant|9|||
145441202|NCT00980538|524473144|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
145441203|NCT00980538|524473144|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
145441204|NCT00980538|524473144|FG000|Overall Study|Other|60|||
145441205|NCT00980538|524473144|FG000|Overall Study|Other|1|||
145441206|NCT01544348|524473145|FG000|Overall Study|Lost to Follow-up|1|||
145441207|NCT01544348|524473146|FG001|Overall Study|Lost to Follow-up|0|||
145441208|NCT01544348|524473147|FG002|Overall Study|Lost to Follow-up|0|||
145441209|NCT01544348|524473148|FG003|Overall Study|Lost to Follow-up|0|||
145441210|NCT01544348|524473149|FG004|Overall Study|Lost to Follow-up|0|||
145441211|NCT01544348|524473150|FG005|Overall Study|Lost to Follow-up|0|||
145441212|NCT01544348|524473151|FG006|Overall Study|Lost to Follow-up|1|||
145441213|NCT01544348|524473152|FG007|Overall Study|Lost to Follow-up|0|||
145441214|NCT01544348|524473145|FG000|Overall Study|Withdrawal by Subject|1|||
145441215|NCT01544348|524473146|FG001|Overall Study|Withdrawal by Subject|0|||
145441216|NCT01544348|524473147|FG002|Overall Study|Withdrawal by Subject|0|||
145441217|NCT01544348|524473148|FG003|Overall Study|Withdrawal by Subject|0|||
145441218|NCT01544348|524473149|FG004|Overall Study|Withdrawal by Subject|1|||
145441219|NCT01544348|524473150|FG005|Overall Study|Withdrawal by Subject|2|||
145441220|NCT01544348|524473151|FG006|Overall Study|Withdrawal by Subject|1|||
145441221|NCT01544348|524473152|FG007|Overall Study|Withdrawal by Subject|0|||
145441222|NCT01544348|524473145|FG000|Overall Study|Physician Decision|0|||
145441223|NCT01544348|524473146|FG001|Overall Study|Physician Decision|0|||
145441224|NCT01544348|524473147|FG002|Overall Study|Physician Decision|0|||
145441225|NCT01544348|524473148|FG003|Overall Study|Physician Decision|0|||
145441226|NCT01544348|524473149|FG004|Overall Study|Physician Decision|0|||
145441227|NCT01544348|524473150|FG005|Overall Study|Physician Decision|1|||
145441228|NCT01544348|524473151|FG006|Overall Study|Physician Decision|0|||
145441229|NCT01544348|524473152|FG007|Overall Study|Physician Decision|0|||
145441230|NCT01445847|524473153|FG000|Overall Study|Protocol Violation|13|||
145441231|NCT01445847|524473154|FG001|Overall Study|Protocol Violation|14|||
145441232|NCT01445847|524473153|FG000|Overall Study|Missed Data|1|||
145441233|NCT01445847|524473154|FG001|Overall Study|Missed Data|0|||
145441234|NCT00707993|524473155|FG000|Overall Study|Adverse Event|16|||
145441235|NCT00707993|524473156|FG001|Overall Study|Adverse Event|20|||
145441236|NCT00707993|524473155|FG000|Overall Study|Protocol Violation|4|||
145441237|NCT00707993|524473156|FG001|Overall Study|Protocol Violation|7|||
145441238|NCT00707993|524473155|FG000|Overall Study|Lost to Follow-up|0|||
145441239|NCT00707993|524473156|FG001|Overall Study|Lost to Follow-up|4|||
145441240|NCT00707993|524473155|FG000|Overall Study|Withdrawal by Subject|12|||
145441241|NCT00707993|524473156|FG001|Overall Study|Withdrawal by Subject|16|||
145441242|NCT00707993|524473155|FG000|Overall Study|Hyperglycemic Rescue|55|||
145441243|NCT00707993|524473156|FG001|Overall Study|Hyperglycemic Rescue|47|||
145441244|NCT00707993|524473155|FG000|Overall Study|Other|2|||
145441245|NCT00707993|524473156|FG001|Overall Study|Other|0|||
145441246|NCT03654274|524473160|FG000|Overall Study|Adverse Event|19|||
145441247|NCT03654274|524473161|FG001|Overall Study|Adverse Event|23|||
145441248|NCT03654274|524473162|FG002|Overall Study|Adverse Event|24|||
145441249|NCT03654274|524473160|FG000|Overall Study|Protocol Deviation|0|||
145441250|NCT03654274|524473161|FG001|Overall Study|Protocol Deviation|2|||
145441251|NCT03654274|524473162|FG002|Overall Study|Protocol Deviation|0|||
145441252|NCT03654274|524473160|FG000|Overall Study|Lost to Follow-up|8|||
145441253|NCT03654274|524473161|FG001|Overall Study|Lost to Follow-up|6|||
145441254|NCT03654274|524473162|FG002|Overall Study|Lost to Follow-up|5|||
145441255|NCT03654274|524473160|FG000|Overall Study|Withdrawal by Subject|46|||
145441256|NCT03654274|524473161|FG001|Overall Study|Withdrawal by Subject|25|||
145441257|NCT03654274|524473162|FG002|Overall Study|Withdrawal by Subject|33|||
145441258|NCT03654274|524473160|FG000|Overall Study|Lack of Efficacy|4|||
145441259|NCT03654274|524473161|FG001|Overall Study|Lack of Efficacy|5|||
145441260|NCT03654274|524473162|FG002|Overall Study|Lack of Efficacy|7|||
145441261|NCT03654274|524473160|FG000|Overall Study|Pregnancy|2|||
145441262|NCT03654274|524473161|FG001|Overall Study|Pregnancy|2|||
145441263|NCT03654274|524473162|FG002|Overall Study|Pregnancy|1|||
145441264|NCT03654274|524473160|FG000|Overall Study|Other|27|||
145441265|NCT03654274|524473161|FG001|Overall Study|Other|29|||
145441266|NCT03654274|524473162|FG002|Overall Study|Other|32|||
145441267|NCT03654274|524473160|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
145441268|NCT03654274|524473161|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
145441269|NCT03654274|524473162|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
145441270|NCT01102491|524473165|FG000|Overall Study|Protocol Violation|11|||
145441271|NCT01102491|524473166|FG001|Overall Study|Protocol Violation|12|||
145441272|NCT01265992|524473167|FG000|Overall Study|Lost to Follow-up|1|||
145441273|NCT01265992|524473167|FG000|Overall Study|Withdrawal by Subject|1|||
145441274|NCT01265992|524473167|FG000|Overall Study|Adverse Event|1|||
145441275|NCT01265992|524473167|FG000|Overall Study|Administrative reasons|2|||
145441276|NCT01265992|524473167|FG000|Overall Study|Stopped treatment|3|||
145441277|NCT01265992|524473167|FG000|Overall Study|Did not receive treatment|1|||
145441278|NCT01837680|524473168|FG000|Overall Study|Lost to Follow-up|2|||
145441279|NCT01837680|524473169|FG001|Overall Study|Lost to Follow-up|2|||
145441280|NCT01837680|524473168|FG000|Overall Study|lack of insurance|0|||
145441281|NCT01837680|524473169|FG001|Overall Study|lack of insurance|2|||
145441282|NCT01837680|524473168|FG000|Overall Study|allergic reaction|6|||
145441283|NCT01837680|524473169|FG001|Overall Study|allergic reaction|0|||
145441284|NCT01837680|524473168|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
145441285|NCT01837680|524473169|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
145441286|NCT03008070|524473170|FG000|Overall Study|Adverse Event|3|||
145441287|NCT03008070|524473171|FG001|Overall Study|Adverse Event|3|||
145441288|NCT03008070|524473172|FG002|Overall Study|Adverse Event|3|||
145441289|NCT03008070|524473170|FG000|Overall Study|Lost to Follow-up|1|||
145441290|NCT03008070|524473171|FG001|Overall Study|Lost to Follow-up|1|||
145441291|NCT03008070|524473172|FG002|Overall Study|Lost to Follow-up|0|||
145441292|NCT03008070|524473170|FG000|Overall Study|Non compliance|0|||
145441293|NCT03008070|524473171|FG001|Overall Study|Non compliance|1|||
145441294|NCT03008070|524473172|FG002|Overall Study|Non compliance|1|||
145441295|NCT03008070|524473170|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
145441296|NCT03008070|524473171|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
145441297|NCT03008070|524473172|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
145441298|NCT03008070|524473170|FG000|Overall Study|Withdrawal by Subject|2|||
145441299|NCT03008070|524473171|FG001|Overall Study|Withdrawal by Subject|0|||
145441300|NCT03008070|524473172|FG002|Overall Study|Withdrawal by Subject|1|||
145441301|NCT03008070|524473170|FG000|Overall Study|Use of prohibited drug|0|||
145441302|NCT03008070|524473171|FG001|Overall Study|Use of prohibited drug|0|||
145441303|NCT03008070|524473172|FG002|Overall Study|Use of prohibited drug|2|||
145441304|NCT03960684|524473176|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
145441305|NCT02151786|524473177|FG000|Overall Study|Unavailability of Case Report Form|26|||
145441306|NCT02151786|524473177|FG000|Overall Study|Outside the Contract Period|1|||
145441307|NCT02151786|524473177|FG000|Overall Study|Randomized, not Treated|1|||
145441308|NCT02151786|524473177|FG000|Overall Study|Unavailability of Information|8|||
145441309|NCT03533660|524473178|FG000|Overall Study|Withdrawal by Subject|2|||
145441310|NCT03533660|524473179|FG001|Overall Study|Withdrawal by Subject|2|||
145441311|NCT03533660|524473178|FG000|Overall Study|Death|2|||
145441312|NCT03533660|524473179|FG001|Overall Study|Death|4|||
145441313|NCT03533660|524473178|FG000|Overall Study|Adverse Event|0|||
145441314|NCT03533660|524473179|FG001|Overall Study|Adverse Event|2|||
145441315|NCT03761056|524473183|FG000|Overall Study|Death|8|||
145441316|NCT03761056|524473183|FG000|Overall Study|Enrolled but never treated|2|||
145441317|NCT03761056|524473183|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
145441318|NCT03761056|524473183|FG000|Overall Study|Investigator decision|1|||
145441319|NCT00996658|524473184|FG000|Overall Study|Adverse Event|2|||
145441320|NCT00996658|524473185|FG001|Overall Study|Adverse Event|5|||
145441321|NCT00996658|524473184|FG000|Overall Study|Protocol Violation|0|||
145441322|NCT00996658|524473185|FG001|Overall Study|Protocol Violation|1|||
145441323|NCT00996658|524473184|FG000|Overall Study|Lost to Follow-up|2|||
145441324|NCT00996658|524473185|FG001|Overall Study|Lost to Follow-up|5|||
145441325|NCT00996658|524473184|FG000|Overall Study|Non-compliance issues|3|||
145441326|NCT00996658|524473185|FG001|Overall Study|Non-compliance issues|3|||
145441327|NCT00996658|524473184|FG000|Overall Study|Other|9|||
145441328|NCT00996658|524473185|FG001|Overall Study|Other|7|||
145441329|NCT02685826|524473187|FG000|Overall Study|Adverse Event|2|||
145441330|NCT02685826|524473188|FG001|Overall Study|Adverse Event|0|||
145441331|NCT02685826|524473189|FG002|Overall Study|Adverse Event|1|||
145441332|NCT02685826|524473187|FG000|Overall Study|Progressive Disease|2|||
145441333|NCT02685826|524473188|FG001|Overall Study|Progressive Disease|1|||
145625723|NCT04091672|525144069|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
145625724|NCT05296629|525144070|FG000|Overall Study|Withdrawal by Subject|3|||
145441334|NCT02685826|524473189|FG002|Overall Study|Progressive Disease|0|||
145441335|NCT02685826|524473187|FG000|Overall Study|Withdrawal by Subject|2|||
145441336|NCT02685826|524473188|FG001|Overall Study|Withdrawal by Subject|0|||
145441337|NCT02685826|524473189|FG002|Overall Study|Withdrawal by Subject|0|||
145441338|NCT02685826|524473187|FG000|Overall Study|Full Clinical Hold by FDA|19|||
145441339|NCT02685826|524473188|FG001|Overall Study|Full Clinical Hold by FDA|9|||
145441340|NCT02685826|524473189|FG002|Overall Study|Full Clinical Hold by FDA|20|||
145441341|NCT01444430|524473190|FG000|Overall Study|Withdrawal by Subject|53|||
145441342|NCT01444430|524473191|FG001|Overall Study|Withdrawal by Subject|72|||
145441343|NCT01444430|524473190|FG000|Overall Study|Death|6|||
145441344|NCT01444430|524473191|FG001|Overall Study|Death|8|||
145441345|NCT01444430|524473190|FG000|Overall Study|Lost to Follow-up|2|||
145441346|NCT01444430|524473191|FG001|Overall Study|Lost to Follow-up|0|||
145441347|NCT01444430|524473190|FG000|Overall Study|CRF termination module not completed.|0|||
145441348|NCT01444430|524473191|FG001|Overall Study|CRF termination module not completed.|1|||
145441349|NCT02842086|524473196|FG000|Overall Study|Randomized but Never Treated|6|||
145441350|NCT02842086|524473197|FG001|Overall Study|Randomized but Never Treated|6|||
145441351|NCT02842086|524473196|FG000|Overall Study|Still in Double-Blind Phase|7|||
145441352|NCT02842086|524473197|FG001|Overall Study|Still in Double-Blind Phase|3|||
145441353|NCT02842086|524473196|FG000|Overall Study|Adverse Event|18|||
145441354|NCT02842086|524473197|FG001|Overall Study|Adverse Event|20|||
145441355|NCT02842086|524473196|FG000|Overall Study|Death|3|||
145441356|NCT02842086|524473197|FG001|Overall Study|Death|3|||
145441357|NCT02842086|524473196|FG000|Overall Study|Investigator's Discretion|9|||
145441358|NCT02842086|524473197|FG001|Overall Study|Investigator's Discretion|13|||
145441359|NCT02842086|524473196|FG000|Overall Study|Non-Compliance with Study Drug|9|||
145441360|NCT02842086|524473197|FG001|Overall Study|Non-Compliance with Study Drug|8|||
145441361|NCT02842086|524473196|FG000|Overall Study|Protocol Violation|8|||
145441362|NCT02842086|524473197|FG001|Overall Study|Protocol Violation|4|||
145441363|NCT02842086|524473196|FG000|Overall Study|Withdrew Consent|205|||
145441364|NCT02842086|524473197|FG001|Overall Study|Withdrew Consent|194|||
145441365|NCT02842086|524473196|FG000|Overall Study|Lost to Follow-up|274|||
145441366|NCT02842086|524473197|FG001|Overall Study|Lost to Follow-up|236|||
145441367|NCT02842086|524473196|FG000|Overall Study|HIV-1 Infection|5|||
145441368|NCT02842086|524473197|FG001|Overall Study|HIV-1 Infection|6|||
145441369|NCT03451851|524473198|FG000|PCP: Week 0 -16|Adverse Event|1|||
145441370|NCT03451851|524473199|FG001|PCP: Week 0 -16|Adverse Event|0|||
145441371|NCT03451851|524473200|FG002|PCP: Week 0 -16|Adverse Event|0|||
145441372|NCT03451851|524473201|FG003|PCP: Week 0 -16|Adverse Event|0|||
145441373|NCT03451851|524473202|FG004|PCP: Week 0 -16|Adverse Event|0|||
145441374|NCT03451851|524473203|FG005|PCP: Week 0 -16|Adverse Event|0|||
145441375|NCT03451851|524473204|FG006|PCP: Week 0 -16|Adverse Event|1|||
145441376|NCT03451851|524473205|FG007|PCP: Week 0 -16|Adverse Event|0|||
145441377|NCT03451851|524473198|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441378|NCT03451851|524473199|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441379|NCT03451851|524473200|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
145441380|NCT03451851|524473201|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441381|NCT03451851|524473202|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441382|NCT03451851|524473203|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441383|NCT03451851|524473204|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441384|NCT03451851|524473205|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
145441385|NCT03451851|524473198|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441386|NCT03451851|524473199|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441387|NCT03451851|524473200|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
145441388|NCT03451851|524473201|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441389|NCT03451851|524473202|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441390|NCT03451851|524473203|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441391|NCT03451851|524473204|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441392|NCT03451851|524473205|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
145441393|NCT03451851|524473198|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145441394|NCT03451851|524473199|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145441395|NCT03451851|524473200|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145441396|NCT03451851|524473201|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145625725|NCT05296629|525144071|FG001|Overall Study|Withdrawal by Subject|10|||
145625726|NCT05296629|525144072|FG002|Overall Study|Withdrawal by Subject|4|||
145625727|NCT05296629|525144070|FG000|Overall Study|Lost to Follow-up|2|||
145441397|NCT03451851|524473202|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
145441398|NCT03451851|524473203|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
145441399|NCT03451851|524473204|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145625728|NCT05296629|525144071|FG001|Overall Study|Lost to Follow-up|7|||
145441400|NCT03451851|524473205|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
145625729|NCT05296629|525144072|FG002|Overall Study|Lost to Follow-up|1|||
145441401|NCT03451851|524473198|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441402|NCT03451851|524473199|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441403|NCT03451851|524473200|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441404|NCT03451851|524473201|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441405|NCT03451851|524473202|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
145441406|NCT03451851|524473203|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441407|NCT03451851|524473204|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441408|NCT03451851|524473205|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
145441409|NCT03451851|524473198|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441410|NCT03451851|524473199|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441411|NCT03451851|524473200|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441412|NCT03451851|524473201|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441413|NCT03451851|524473202|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
145441414|NCT03451851|524473203|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441415|NCT03451851|524473204|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441416|NCT03451851|524473205|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
145441417|NCT03581292|524473206|FG000|Overall Study|Physician Decision|9|||
145441418|NCT03581292|524473207|FG001|Overall Study|Physician Decision|5|||
145441419|NCT03581292|524473206|FG000|Overall Study|Withdrawal by Subject|3|||
145441420|NCT03581292|524473207|FG001|Overall Study|Withdrawal by Subject|0|||
145441421|NCT03581292|524473206|FG000|Overall Study|Withdrawal before Therapy Start|1|||
145441422|NCT03581292|524473207|FG001|Overall Study|Withdrawal before Therapy Start|0|||
145441423|NCT07214935|524473208|FG000|Overall Study|Adverse Event|1|||
145441424|NCT07214935|524473209|FG001|Overall Study|Adverse Event|1|||
145441425|NCT07214935|524473210|FG002|Overall Study|Adverse Event|1|||
145441426|NCT07214935|524473211|FG003|Overall Study|Adverse Event|0|||
145441427|NCT07214935|524473208|FG000|Overall Study|Lost to Follow-up|0|||
145441428|NCT07214935|524473209|FG001|Overall Study|Lost to Follow-up|1|||
145441429|NCT07214935|524473210|FG002|Overall Study|Lost to Follow-up|0|||
145441430|NCT07214935|524473211|FG003|Overall Study|Lost to Follow-up|0|||
145441431|NCT07214935|524473208|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
145441432|NCT07214935|524473209|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
145441433|NCT07214935|524473210|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
145441434|NCT07214935|524473211|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
145441435|NCT07214935|524473208|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
145441436|NCT07214935|524473209|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
145441437|NCT07214935|524473210|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
145441438|NCT07214935|524473211|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
145441439|NCT00972023|524474533|FG000|Overall Study|Withdrawal by Subject|1|||
145441440|NCT02595879|524474534|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
145441441|NCT02595879|524474535|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
145441442|NCT01650831|524474536|FG000|Overall Study|Screen failure|1|||
145441443|NCT02522429|524474537|FG000|Overall Study|Lost to Follow-up|8|||
145441444|NCT02522429|524474537|FG000|Overall Study|Adverse Event|2|||
145441445|NCT02522429|524474537|FG000|Overall Study|Death|1|||
145441446|NCT02522429|524474537|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
145441447|NCT05554146|524474538|FG000|Overall Study|Adverse Event|0|||
145441448|NCT05554146|524474539|FG001|Overall Study|Adverse Event|1|||
145441449|NCT05554146|524474540|FG002|Overall Study|Adverse Event|0|||
145441450|NCT05554146|524474541|FG003|Overall Study|Adverse Event|0|||
145441451|NCT05554146|524474538|FG000|Overall Study|Protocol Violation|0|||
145441452|NCT05554146|524474539|FG001|Overall Study|Protocol Violation|1|||
145441453|NCT05554146|524474540|FG002|Overall Study|Protocol Violation|0|||
145441454|NCT05554146|524474541|FG003|Overall Study|Protocol Violation|0|||
145441455|NCT05554146|524474538|FG000|Overall Study|No longer interested in participating|0|||
145441456|NCT05554146|524474539|FG001|Overall Study|No longer interested in participating|0|||
145441457|NCT05554146|524474540|FG002|Overall Study|No longer interested in participating|1|||
145441458|NCT05554146|524474541|FG003|Overall Study|No longer interested in participating|0|||
145441459|NCT05554146|524474538|FG000|Overall Study|Lost to Follow-up|1|||
145441460|NCT05554146|524474539|FG001|Overall Study|Lost to Follow-up|0|||
145441461|NCT05554146|524474540|FG002|Overall Study|Lost to Follow-up|0|||
145441462|NCT05554146|524474541|FG003|Overall Study|Lost to Follow-up|0|||
145441463|NCT02763059|524474548|FG000|Overall Study|Lost to Follow-up|4|||
145441464|NCT02763059|524474549|FG001|Overall Study|Lost to Follow-up|1|||
145441465|NCT02763059|524474550|FG002|Overall Study|Lost to Follow-up|6|||
145441466|NCT02763059|524474548|FG000|Overall Study|Withdrawal by Subject|1|||
145441467|NCT02763059|524474549|FG001|Overall Study|Withdrawal by Subject|0|||
145441468|NCT02763059|524474550|FG002|Overall Study|Withdrawal by Subject|3|||
145441469|NCT00175916|524474551|FG000|Overall Study|Death|19|||
145441470|NCT00175916|524474551|FG000|Overall Study|Adverse Event|81|||
145441471|NCT00175916|524474551|FG000|Overall Study|Lack of Efficacy|354|||
145441472|NCT00175916|524474551|FG000|Overall Study|Lost to Follow-up|17|||
145441473|NCT00175916|524474551|FG000|Overall Study|Subject Choice|98|||
145441474|NCT00175916|524474551|FG000|Overall Study|Lack of compliance|8|||
145441475|NCT00175916|524474551|FG000|Overall Study|Patient cannot record seizures|1|||
145441476|NCT00175916|524474551|FG000|Overall Study|Sponsor decision|17|||
145441477|NCT00175916|524474551|FG000|Overall Study|Vigabatrin intake|1|||
145441478|NCT00175916|524474551|FG000|Overall Study|Suicidal behaviour|1|||
145441479|NCT00175916|524474551|FG000|Overall Study|Withdrawal by Subject|1|||
145441480|NCT00175916|524474551|FG000|Overall Study|Seizure - free|4|||
145441481|NCT00175916|524474551|FG000|Overall Study|Administrative reason|1|||
145441482|NCT00175916|524474551|FG000|Overall Study|Pregnancy|1|||
145441483|NCT00175916|524474551|FG000|Overall Study|Patient's request|2|||
145441484|NCT00175916|524474551|FG000|Overall Study|Treating physiciant's choice|1|||
145441485|NCT00175916|524474551|FG000|Overall Study|Moved overseas|1|||
145441486|NCT00175916|524474551|FG000|Overall Study|Loss of job and economic burden|1|||
145441487|NCT00175916|524474551|FG000|Overall Study|Site was closed|9|||
145441488|NCT00175916|524474551|FG000|Overall Study|Patient went to prison|1|||
145441489|NCT04024436|524474552|FG000|Overall Study|Death|10|||
145441490|NCT04024436|524474553|FG001|Overall Study|Death|14|||
145441491|NCT04024436|524474554|FG002|Overall Study|Death|2|||
145441492|NCT04024436|524474555|FG003|Overall Study|Death|7|||
145441493|NCT04024436|524474552|FG000|Overall Study|Loss to follow up|1|||
145441494|NCT04024436|524474553|FG001|Overall Study|Loss to follow up|0|||
145441495|NCT04024436|524474554|FG002|Overall Study|Loss to follow up|0|||
145441496|NCT04024436|524474555|FG003|Overall Study|Loss to follow up|1|||
145441497|NCT04024436|524474552|FG000|Overall Study|Withdrawal of consent|2|||
145441498|NCT04024436|524474553|FG001|Overall Study|Withdrawal of consent|0|||
145441499|NCT04024436|524474554|FG002|Overall Study|Withdrawal of consent|0|||
145441500|NCT04024436|524474555|FG003|Overall Study|Withdrawal of consent|1|||
145441501|NCT04024436|524474552|FG000|Overall Study|Study termination by sponsor|4|||
145441502|NCT04024436|524474553|FG001|Overall Study|Study termination by sponsor|6|||
145441503|NCT04024436|524474554|FG002|Overall Study|Study termination by sponsor|2|||
145441504|NCT04024436|524474555|FG003|Overall Study|Study termination by sponsor|11|||
145441505|NCT04024436|524474552|FG000|Overall Study|Reason Not Specified|0|||
145441506|NCT04024436|524474553|FG001|Overall Study|Reason Not Specified|1|||
145441507|NCT04024436|524474554|FG002|Overall Study|Reason Not Specified|0|||
145441508|NCT04024436|524474555|FG003|Overall Study|Reason Not Specified|2|||
145441509|NCT00540592|524474556|FG000|Overall Study|Adverse Event|0|||
145441510|NCT00540592|524474557|FG001|Overall Study|Adverse Event|1|||
145441511|NCT00540592|524474558|FG002|Overall Study|Adverse Event|0|||
145441512|NCT00540592|524474559|FG003|Overall Study|Adverse Event|0|||
145441513|NCT00540592|524474560|FG004|Overall Study|Adverse Event|1|||
145441514|NCT00540592|524474561|FG005|Overall Study|Adverse Event|0|||
145441515|NCT00540592|524474562|FG006|Overall Study|Adverse Event|0|||
145441516|NCT00540592|524474563|FG007|Overall Study|Adverse Event|1|||
145441517|NCT00540592|524474564|FG008|Overall Study|Adverse Event|1|||
145441518|NCT00540592|524474565|FG009|Overall Study|Adverse Event|2|||
145441519|NCT00540592|524474556|FG000|Overall Study|Lost to Follow-up|2|||
145441520|NCT00540592|524474557|FG001|Overall Study|Lost to Follow-up|0|||
145441521|NCT00540592|524474558|FG002|Overall Study|Lost to Follow-up|0|||
145441522|NCT00540592|524474559|FG003|Overall Study|Lost to Follow-up|0|||
145441523|NCT00540592|524474560|FG004|Overall Study|Lost to Follow-up|0|||
145441524|NCT00540592|524474561|FG005|Overall Study|Lost to Follow-up|0|||
145441525|NCT00540592|524474562|FG006|Overall Study|Lost to Follow-up|0|||
145441526|NCT00540592|524474563|FG007|Overall Study|Lost to Follow-up|0|||
145441527|NCT00540592|524474564|FG008|Overall Study|Lost to Follow-up|0|||
145441528|NCT00540592|524474565|FG009|Overall Study|Lost to Follow-up|0|||
145441529|NCT00540592|524474556|FG000|Overall Study|Withdrawal by Subject|0|||
145441530|NCT00540592|524474557|FG001|Overall Study|Withdrawal by Subject|0|||
145441531|NCT00540592|524474558|FG002|Overall Study|Withdrawal by Subject|1|||
145441532|NCT00540592|524474559|FG003|Overall Study|Withdrawal by Subject|1|||
145441533|NCT00540592|524474560|FG004|Overall Study|Withdrawal by Subject|0|||
145441534|NCT00540592|524474561|FG005|Overall Study|Withdrawal by Subject|0|||
145441535|NCT00540592|524474562|FG006|Overall Study|Withdrawal by Subject|0|||
145441536|NCT00540592|524474563|FG007|Overall Study|Withdrawal by Subject|0|||
145441537|NCT00540592|524474564|FG008|Overall Study|Withdrawal by Subject|0|||
145441538|NCT00540592|524474565|FG009|Overall Study|Withdrawal by Subject|0|||
145441539|NCT03901963|524474569|FG000|Overall Study|Lost to Follow-up|1|||
145441540|NCT03901963|524474570|FG001|Overall Study|Lost to Follow-up|1|||
145441541|NCT03901963|524474569|FG000|Overall Study|Physician Decision|1|||
145441542|NCT03901963|524474570|FG001|Overall Study|Physician Decision|2|||
145441543|NCT03901963|524474569|FG000|Overall Study|Protocol Violation|1|||
145441544|NCT03901963|524474570|FG001|Overall Study|Protocol Violation|1|||
145441545|NCT03901963|524474569|FG000|Overall Study|Withdrawal by Subject|4|||
145441546|NCT03901963|524474570|FG001|Overall Study|Withdrawal by Subject|11|||
145441547|NCT03901963|524474569|FG000|Overall Study|Ongoing|84|||
145441548|NCT03901963|524474570|FG001|Overall Study|Ongoing|73|||
145441549|NCT03901963|524474569|FG000|Overall Study|Randomized but not treated|3|||
145441550|NCT03901963|524474570|FG001|Overall Study|Randomized but not treated|3|||
145584800|NCT01944046|524993622|FG001|Randomized to DB|Lost to Follow-up|3|||
145584801|NCT01944046|524993621|FG000|Randomized to DB|Withdrawal by Subject|2|||
145584802|NCT01944046|524993622|FG001|Randomized to DB|Withdrawal by Subject|4|||
145584803|NCT01944046|524993621|FG000|Randomized to DB|Physician Decision|1|||
145584804|NCT01944046|524993622|FG001|Randomized to DB|Physician Decision|2|||
145584805|NCT01944046|524993621|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
145584806|NCT01944046|524993622|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
145584807|NCT01944046|524993621|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
145584808|NCT01944046|524993622|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
145584809|NCT01944046|524993621|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
145584810|NCT01944046|524993622|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
145584811|NCT01944046|524993621|FG000|Open Label Eligible and Consented|Adverse Event|6|||
145584812|NCT01944046|524993622|FG001|Open Label Eligible and Consented|Adverse Event|1|||
145584813|NCT01944046|524993621|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
145584814|NCT01944046|524993622|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
145584815|NCT01944046|524993621|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
145584816|NCT01944046|524993622|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
145584817|NCT01985126|524993630|FG000|Overall Study|Death|15|||
145584818|NCT01985126|524993631|FG001|Overall Study|Death|69|||
145584819|NCT01985126|524993630|FG000|Overall Study|Lost to Follow-up|0|||
145584820|NCT01985126|524993631|FG001|Overall Study|Lost to Follow-up|8|||
145584821|NCT01985126|524993630|FG000|Overall Study|Study Terminated By Sponsor|1|||
145584822|NCT01985126|524993631|FG001|Overall Study|Study Terminated By Sponsor|22|||
145584823|NCT01985126|524993630|FG000|Overall Study|Withdrawal by Subject|2|||
145584824|NCT01985126|524993631|FG001|Overall Study|Withdrawal by Subject|7|||
145584825|NCT05799495|524993634|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
145584826|NCT05799495|524993635|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
145584827|NCT05799495|524993636|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
145584828|NCT05799495|524993637|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
145584829|NCT05799495|524993634|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
145584830|NCT05799495|524993635|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
145584831|NCT05799495|524993636|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
145584832|NCT05799495|524993637|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
145584833|NCT05799495|524993634|FG000|Treatment (Up to 5 Days)|Other|0|||
145584834|NCT05799495|524993635|FG001|Treatment (Up to 5 Days)|Other|1|||
145584835|NCT05799495|524993636|FG002|Treatment (Up to 5 Days)|Other|0|||
145584836|NCT05799495|524993637|FG003|Treatment (Up to 5 Days)|Other|0|||
145584837|NCT05799495|524993634|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
145584838|NCT05799495|524993635|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
145584839|NCT05799495|524993636|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
145584840|NCT05799495|524993637|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
145584841|NCT05799495|524993634|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
145584842|NCT05799495|524993635|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
145584843|NCT05799495|524993636|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
145584844|NCT05799495|524993637|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
145584845|NCT05799495|524993634|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145584846|NCT05799495|524993635|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145584847|NCT05799495|524993636|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
145584848|NCT05799495|524993637|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
145584849|NCT03694548|524993638|FG000|Part A Survey|Protocol Violation|3|||
145584850|NCT03694548|524993639|FG001|Part A Survey|Protocol Violation|3|||
145584851|NCT03694548|524993640|FG002|Part A Survey|Protocol Violation|0|||
145584852|NCT03694548|524993638|FG000|Part B Yoga Program|Protocol Violation|0|||
145584853|NCT03694548|524993639|FG001|Part B Yoga Program|Protocol Violation|0|||
145584854|NCT03694548|524993640|FG002|Part B Yoga Program|Protocol Violation|3|||
145584855|NCT03694548|524993638|FG000|Part B Yoga Program|Did not attend intervention|0|||
145584856|NCT03694548|524993639|FG001|Part B Yoga Program|Did not attend intervention|0|||
145584857|NCT03694548|524993640|FG002|Part B Yoga Program|Did not attend intervention|8|||
145584858|NCT00305058|524993641|FG000|Overall Study|Participant too young|1|||
145584859|NCT00305058|524993642|FG001|Overall Study|Participant too young|0|||
145584860|NCT00305058|524993641|FG000|Overall Study|Missing data collection instrument|3|||
145584861|NCT00305058|524993642|FG001|Overall Study|Missing data collection instrument|2|||
145584862|NCT00305058|524993641|FG000|Overall Study|Missing outcome data|3|||
145584863|NCT00305058|524993642|FG001|Overall Study|Missing outcome data|2|||
145584864|NCT01669343|524993643|FG000|Part A: All Patients|Withdrawal by Subject|7|||
145584865|NCT01669343|524993643|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
145584866|NCT01669343|524993643|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
145584867|NCT01669343|524993643|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
145584868|NCT01669343|524993643|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
145584869|NCT03864900|524993644|FG000|Overall Study|Withdrawal by Subject|1|||
145441551|NCT01206140|524474571|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
145441552|NCT01206140|524474572|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
145441553|NCT01803880|524474573|FG000|Overall Study|Adverse Event|1|||
145441554|NCT01803880|524474574|FG001|Overall Study|Adverse Event|0|||
145441555|NCT01803880|524474575|FG002|Overall Study|Adverse Event|0|||
145441556|NCT01803880|524474573|FG000|Overall Study|Withdrawal by Subject|1|||
145441557|NCT01803880|524474574|FG001|Overall Study|Withdrawal by Subject|1|||
145441558|NCT01803880|524474575|FG002|Overall Study|Withdrawal by Subject|4|||
145441559|NCT01803880|524474573|FG000|Overall Study|Physician Decision|0|||
145441560|NCT01803880|524474574|FG001|Overall Study|Physician Decision|0|||
145441561|NCT01803880|524474575|FG002|Overall Study|Physician Decision|1|||
145441562|NCT01803880|524474573|FG000|Overall Study|Unable to return for follow-up visits|0|||
145441563|NCT01803880|524474574|FG001|Overall Study|Unable to return for follow-up visits|1|||
145441564|NCT01803880|524474575|FG002|Overall Study|Unable to return for follow-up visits|2|||
145441565|NCT01803880|524474573|FG000|Overall Study|Lost to Follow-up|1|||
145441566|NCT01803880|524474574|FG001|Overall Study|Lost to Follow-up|2|||
145441567|NCT01803880|524474575|FG002|Overall Study|Lost to Follow-up|3|||
145441568|NCT01803880|524474573|FG000|Overall Study|Protocol Violation|1|||
145441569|NCT01803880|524474574|FG001|Overall Study|Protocol Violation|0|||
145441570|NCT01803880|524474575|FG002|Overall Study|Protocol Violation|0|||
145441571|NCT01803880|524474573|FG000|Overall Study|Early study termination|0|||
145441572|NCT01803880|524474574|FG001|Overall Study|Early study termination|6|||
145441573|NCT01803880|524474575|FG002|Overall Study|Early study termination|5|||
145441574|NCT01803880|524474573|FG000|Overall Study|Incomplete data entry by sites|2|||
145441575|NCT01803880|524474574|FG001|Overall Study|Incomplete data entry by sites|0|||
145441576|NCT01803880|524474575|FG002|Overall Study|Incomplete data entry by sites|0|||
145441577|NCT01766037|524474576|FG000|Overall Study|Adverse Event|1|||
145441578|NCT01766037|524474577|FG001|Overall Study|Adverse Event|0|||
145441579|NCT01766037|524474576|FG000|Overall Study|Lack of Efficacy|1|||
145441580|NCT01766037|524474577|FG001|Overall Study|Lack of Efficacy|0|||
145441581|NCT01766037|524474576|FG000|Overall Study|Lost to Follow-up|0|||
145441582|NCT01766037|524474577|FG001|Overall Study|Lost to Follow-up|10|||
145441583|NCT01766037|524474576|FG000|Overall Study|Physician Decision|0|||
145441584|NCT01766037|524474577|FG001|Overall Study|Physician Decision|1|||
145441585|NCT01766037|524474576|FG000|Overall Study|Withdrawal by Subject|18|||
145441586|NCT01766037|524474577|FG001|Overall Study|Withdrawal by Subject|16|||
145441587|NCT01766037|524474576|FG000|Overall Study|Moved from area|5|||
145441588|NCT01766037|524474577|FG001|Overall Study|Moved from area|0|||
145441589|NCT01766037|524474576|FG000|Overall Study|medical - unrelated|1|||
145441590|NCT01766037|524474577|FG001|Overall Study|medical - unrelated|2|||
145441591|NCT01766037|524474576|FG000|Overall Study|nausea / discomfort|3|||
145441592|NCT01766037|524474577|FG001|Overall Study|nausea / discomfort|0|||
145441593|NCT05384834|524474580|FG000|Overall Study|Lost to Follow-up|43|||
145441594|NCT05384834|524474580|FG000|Overall Study|Withdrawal by Subject|5|||
145441595|NCT01775553|524474581|FG000|Overall Study|Adverse Event|1|||
145441596|NCT01775553|524474581|FG000|Overall Study|Disease Progression|12|||
145441597|NCT03810014|524474589|FG000|Overall Study|Pregnancy|2|||
145441598|NCT03810014|524474590|FG001|Overall Study|Pregnancy|2|||
145441599|NCT03810014|524474591|FG002|Overall Study|Pregnancy|0|||
145441600|NCT03810014|524474592|FG003|Overall Study|Pregnancy|2|||
145441601|NCT00886769|524474594|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
145441602|NCT00886769|524474595|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
145441603|NCT00414076|524474596|FG000|Overall Study|Progression|1|||
145441604|NCT00414076|524474597|FG001|Overall Study|Progression|2|||
145441605|NCT00414076|524474596|FG000|Overall Study|Withdrawal by Subject|1|||
145441606|NCT00414076|524474597|FG001|Overall Study|Withdrawal by Subject|3|||
145441607|NCT00414076|524474596|FG000|Overall Study|Adverse Event|1|||
145441608|NCT00414076|524474597|FG001|Overall Study|Adverse Event|0|||
145441609|NCT00778336|524474598|FG000|Index Procedure-Discharge|Death|6|||
145441610|NCT00778336|524474599|FG001|Index Procedure-Discharge|Death|3|||
145441611|NCT00778336|524474600|FG002|Index Procedure-Discharge|Death|2|||
145441612|NCT00778336|524474601|FG003|Index Procedure-Discharge|Death|0|||
145441613|NCT00778336|524474598|FG000|3 Month Follow Up|Lost to Follow-up|15|||
145441614|NCT00778336|524474599|FG001|3 Month Follow Up|Lost to Follow-up|20|||
145625730|NCT05296629|525144070|FG000|Overall Study|Adverse Event|0|||
145625731|NCT05296629|525144071|FG001|Overall Study|Adverse Event|4|||
145625732|NCT05296629|525144072|FG002|Overall Study|Adverse Event|2|||
145441615|NCT00778336|524474600|FG002|3 Month Follow Up|Lost to Follow-up|3|||
145441616|NCT00778336|524474601|FG003|3 Month Follow Up|Lost to Follow-up|0|||
145441617|NCT00778336|524474598|FG000|3 Month Follow Up|Death|8|||
145441618|NCT00778336|524474599|FG001|3 Month Follow Up|Death|3|||
145441619|NCT00778336|524474600|FG002|3 Month Follow Up|Death|2|||
145441620|NCT00778336|524474601|FG003|3 Month Follow Up|Death|0|||
145441621|NCT04108208|524474602|FG000|Overall Study|Withdrawal by Subject|2|||
145625733|NCT05296629|525144070|FG000|Overall Study|Protocol Violation|0|||
145441622|NCT04108208|524474603|FG001|Overall Study|Withdrawal by Subject|6|||
145441623|NCT04108208|524474602|FG000|Overall Study|other-ongoing|20|||
145441624|NCT04108208|524474603|FG001|Overall Study|other-ongoing|40|||
145441625|NCT04108208|524474602|FG000|Overall Study|Death|1|||
145441626|NCT04108208|524474603|FG001|Overall Study|Death|4|||
145441627|NCT04108208|524474602|FG000|Overall Study|Lost to Follow-up|2|||
145441628|NCT04108208|524474603|FG001|Overall Study|Lost to Follow-up|0|||
145441629|NCT03670355|524474604|FG000|Overall Study|Adverse Event|1|||
145441630|NCT03670355|524474605|FG001|Overall Study|Adverse Event|0|||
145441631|NCT03670355|524474604|FG000|Overall Study|Unable to comply with study procedures|0|||
145441632|NCT03670355|524474605|FG001|Overall Study|Unable to comply with study procedures|1|||
145441633|NCT03670355|524474604|FG000|Overall Study|Participant refused|0|||
145441634|NCT03670355|524474605|FG001|Overall Study|Participant refused|1|||
145441635|NCT03517436|524474606|FG000|Overall Study|Death|3|||
145441636|NCT03517436|524474606|FG000|Overall Study|Withdrawal by Subject|4|||
145441637|NCT03517436|524474606|FG000|Overall Study|Did not receive study valve.|1|||
145441638|NCT04181827|524474607|FG000|Overall Study|Ongoing|124|||
145441639|NCT04181827|524474608|FG001|Overall Study|Ongoing|157|||
145441640|NCT04181827|524474607|FG000|Overall Study|Death|82|||
145441641|NCT04181827|524474608|FG001|Overall Study|Death|50|||
145441642|NCT04181827|524474607|FG000|Overall Study|Lost to Follow-up|0|||
145441643|NCT04181827|524474608|FG001|Overall Study|Lost to Follow-up|1|||
145441644|NCT04181827|524474607|FG000|Overall Study|Withdrawal by Subject|5|||
145441645|NCT04181827|524474608|FG001|Overall Study|Withdrawal by Subject|0|||
145441646|NCT04587869|524474609|FG000|Overall Study|Death|1|||
145441647|NCT04587869|524474610|FG001|Overall Study|Death|0|||
145441648|NCT04587869|524474609|FG000|Overall Study|Lost to Follow-up|27|||
145441649|NCT04587869|524474610|FG001|Overall Study|Lost to Follow-up|34|||
145441650|NCT04587869|524474609|FG000|Overall Study|Grant Termination|13|||
145441651|NCT04587869|524474610|FG001|Overall Study|Grant Termination|25|||
145441652|NCT04587869|524474609|FG000|Overall Study|too busy|2|||
145441653|NCT04587869|524474610|FG001|Overall Study|too busy|0|||
145441654|NCT04587869|524474609|FG000|Overall Study|Withdrawal by Subject|2|||
145441655|NCT04587869|524474610|FG001|Overall Study|Withdrawal by Subject|2|||
145441656|NCT04587869|524474609|FG000|Overall Study|Other|1|||
145441657|NCT04587869|524474610|FG001|Overall Study|Other|0|||
145441658|NCT04538664|524474616|FG000|Overall Study|Withdrawal by Subject|5|||
145441659|NCT04538664|524474617|FG001|Overall Study|Withdrawal by Subject|9|||
145441660|NCT04538664|524474616|FG000|Overall Study|Lost to Follow-up|2|||
145584870|NCT03864900|524993645|FG001|Overall Study|Withdrawal by Subject|1|||
145584871|NCT03864900|524993644|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
145584872|NCT03864900|524993645|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
145584873|NCT01866709|524993648|FG000|Overall Study|Adverse Event|1|||
145584874|NCT01866709|524993649|FG001|Overall Study|Adverse Event|0|||
145584875|NCT03191903|524993650|FG000|Overall Study|Withdrawal by Subject|6|||
145441661|NCT04538664|524474617|FG001|Overall Study|Lost to Follow-up|1|||
145441662|NCT04538664|524474616|FG000|Overall Study|Ongoing|106|||
145441663|NCT04538664|524474617|FG001|Overall Study|Ongoing|115|||
145441664|NCT03929913|524474618|FG000|Overall Study|Death|4|||
145441665|NCT03929913|524474618|FG000|Overall Study|Lost to Follow-up|1|||
145441666|NCT03929913|524474618|FG000|Overall Study|Failed Procedure|2|||
145441667|NCT00642707|524474619|FG000|Overall Study|Adverse Event|0|||
145441668|NCT00642707|524474620|FG001|Overall Study|Adverse Event|0|||
145441669|NCT00642707|524474621|FG002|Overall Study|Adverse Event|0|||
145441670|NCT00642707|524474622|FG003|Overall Study|Adverse Event|2|||
145441671|NCT00642707|524474619|FG000|Overall Study|Withdrawal by Subject|1|||
145441672|NCT00642707|524474620|FG001|Overall Study|Withdrawal by Subject|0|||
145441673|NCT00642707|524474621|FG002|Overall Study|Withdrawal by Subject|0|||
145441674|NCT00642707|524474622|FG003|Overall Study|Withdrawal by Subject|0|||
145441675|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
145441676|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
145441677|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
145441678|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145584876|NCT03191903|524993651|FG001|Overall Study|Withdrawal by Subject|5|||
145625734|NCT05296629|525144071|FG001|Overall Study|Protocol Violation|2|||
145441679|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441680|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145584877|NCT03191903|524993652|FG002|Overall Study|Withdrawal by Subject|4|||
145625735|NCT05296629|525144072|FG002|Overall Study|Protocol Violation|0|||
145441681|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441682|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441683|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441684|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441685|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441686|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441687|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441688|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441689|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145441690|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
145584878|NCT03191903|524993650|FG000|Overall Study|Adverse Event|1|||
145584879|NCT03191903|524993651|FG001|Overall Study|Adverse Event|0|||
145441691|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
145441692|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
145441693|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441694|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441695|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441696|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441697|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441698|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441699|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441700|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441701|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441702|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441703|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441704|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441705|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441706|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
145441707|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441708|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441709|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441710|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
145441711|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441712|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441713|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441714|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441715|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441716|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441717|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441718|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441719|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441720|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441721|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441722|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
145441723|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441724|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441725|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
145441726|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441727|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441728|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441729|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441730|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441731|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441732|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441733|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441734|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441735|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441736|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441737|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441738|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
145441739|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441740|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441741|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441742|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
145441743|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441744|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441745|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441746|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441747|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441748|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441749|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441750|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441751|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441752|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441753|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441754|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
145441755|NCT02891226|524474623|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145584880|NCT03191903|524993652|FG002|Overall Study|Adverse Event|0|||
145584881|NCT00503685|524993656|FG000|Overall Study|Adverse Event|0|||
145584882|NCT00503685|524993657|FG001|Overall Study|Adverse Event|0|||
145584883|NCT00503685|524993658|FG002|Overall Study|Adverse Event|2|||
145441756|NCT02891226|524474624|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441757|NCT02891226|524474625|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441758|NCT02891226|524474626|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
145441759|NCT02891226|524474627|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441760|NCT02891226|524474628|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441761|NCT02891226|524474629|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441762|NCT02891226|524474630|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441763|NCT02891226|524474631|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441764|NCT02891226|524474632|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441765|NCT02891226|524474633|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441766|NCT02891226|524474634|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441767|NCT02891226|524474635|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441768|NCT02891226|524474636|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441769|NCT02891226|524474637|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441770|NCT02891226|524474638|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
145441771|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441772|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441773|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441774|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145584884|NCT00503685|524993656|FG000|Overall Study|Withdrawal by Subject|0|||
145584885|NCT00503685|524993657|FG001|Overall Study|Withdrawal by Subject|1|||
145584886|NCT00503685|524993658|FG002|Overall Study|Withdrawal by Subject|0|||
145584887|NCT00503685|524993656|FG000|Overall Study|Protocol Violation|0|||
145584888|NCT00503685|524993657|FG001|Overall Study|Protocol Violation|1|||
145584889|NCT00503685|524993658|FG002|Overall Study|Protocol Violation|0|||
145584890|NCT00503685|524993656|FG000|Overall Study|Eligibility Criteria Not Met|0|||
145584891|NCT00503685|524993657|FG001|Overall Study|Eligibility Criteria Not Met|1|||
145584892|NCT00503685|524993658|FG002|Overall Study|Eligibility Criteria Not Met|0|||
145584893|NCT01110239|524993663|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
145584894|NCT01110239|524993664|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
145584895|NCT01110239|524993665|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
145584896|NCT01110239|524993666|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
145584897|NCT01110239|524993663|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
145584898|NCT01110239|524993664|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
145584899|NCT01110239|524993665|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
145584900|NCT01110239|524993666|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
145584901|NCT01898195|524993669|FG000|Smoking Abstinence|Did not have good measurements|35|||
145584902|NCT01898195|524993670|FG001|Smoking Abstinence|Did not have good measurements|38|||
145584903|NCT01898195|524993671|FG002|Smoking Abstinence|Did not have good measurements|36|||
145584904|NCT01337245|524993672|FG000|Overall Study|Lost to Follow-up|1|||
145584905|NCT03283670|524993673|FG000|Placebo Gas|Withdrawal by Subject|2|||
145584906|NCT03283670|524993673|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
145584907|NCT03283670|524993673|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
145584908|NCT00612313|524993674|FG000|Overall Study|Withdrawal by Subject|6|||
145584909|NCT00612313|524993675|FG001|Overall Study|Withdrawal by Subject|9|||
145584910|NCT00612313|524993674|FG000|Overall Study|Lost to Follow-up|11|||
145584911|NCT00612313|524993675|FG001|Overall Study|Lost to Follow-up|4|||
145584912|NCT03823651|524993676|FG000|Overall Study|Death|5|||
145584913|NCT03823651|524993677|FG001|Overall Study|Death|0|||
145584914|NCT03823651|524993676|FG000|Overall Study|Physician Decision|1|||
145584915|NCT03823651|524993677|FG001|Overall Study|Physician Decision|0|||
145584916|NCT03823651|524993676|FG000|Overall Study|Caregiver to patient who died|0|||
145584917|NCT03823651|524993677|FG001|Overall Study|Caregiver to patient who died|5|||
145584918|NCT03823651|524993676|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
145584919|NCT03823651|524993677|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
145584920|NCT01850004|524993678|FG000|Overall Study|Poor/Non-compliance|1|||
145584921|NCT01850004|524993678|FG000|Overall Study|Participant Withdrew Consent|9|||
145584922|NCT01850004|524993678|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
145584923|NCT01850004|524993678|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
145584924|NCT01850004|524993678|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
145584925|NCT01850004|524993678|FG000|Overall Study|Other Reasons|2|||
145584926|NCT01850004|524993678|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
145584927|NCT01850004|524993678|FG000|Overall Study|Maximum Clinical Benefit|4|||
145584928|NCT05350449|524993679|FG000|Overall Study|Withdrawal by Subject|4|||
145584929|NCT05350449|524993680|FG001|Overall Study|Withdrawal by Subject|8|||
145584930|NCT00136955|524995342|FG000|Overall Study|Adverse Event|8|||
145584931|NCT00136955|524995342|FG000|Overall Study|Lost to Follow-up|1|||
145584932|NCT00136955|524995342|FG000|Overall Study|Withdrawal by Subject|2|||
145584933|NCT00136955|524995342|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
145584934|NCT02280044|524995345|FG000|Overall Study|Planned alternate|0|||
145584935|NCT02280044|524995346|FG001|Overall Study|Planned alternate|2|||
145441775|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441776|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441777|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
145441778|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
145441779|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
145441780|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
145441781|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441782|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441783|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441784|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441785|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441786|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
145441787|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441788|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441789|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441790|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441791|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441792|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
145441793|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441794|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441795|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441796|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
145441797|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441798|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441799|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441800|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441801|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441802|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
145441803|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441804|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441805|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441806|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441807|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441808|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441809|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
145441810|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
145441811|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
145441812|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
145441813|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441814|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441815|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441816|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441817|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441818|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
145441819|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441820|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441821|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441822|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441823|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
145441824|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441825|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441826|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441827|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441828|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441829|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441830|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441831|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441832|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441833|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441834|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
145441835|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441836|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441837|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441838|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441839|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441840|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441841|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
145441842|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441843|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441844|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145625736|NCT02268396|525144073|FG000|Overall Study|Adverse Event|3|||
145441845|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441846|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441847|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441848|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441849|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441850|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
145441851|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441852|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441853|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441854|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441855|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441856|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441857|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441858|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
145441859|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
145441860|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
145441861|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441862|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441863|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441864|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441865|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441866|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
145441867|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441868|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441869|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441870|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441871|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441872|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441873|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441874|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
145441875|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441876|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441877|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441878|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441879|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441880|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441881|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441882|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
145441883|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441884|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441885|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441886|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441887|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441888|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441889|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441890|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441891|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
145441892|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441893|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441894|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441895|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441896|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441897|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441898|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
145441899|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441900|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441901|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441902|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441903|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441904|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441905|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145625737|NCT02268396|525144073|FG000|Overall Study|Administrative|2|||
145625738|NCT02268396|525144073|FG000|Overall Study|Withdrawal by Subject|1|||
145625739|NCT02268396|525144073|FG000|Overall Study|Lost to Follow-up|2|||
145625740|NCT02268396|525144073|FG000|Overall Study|Protocol-Specified Criteria|2|||
145625741|NCT02268396|525144073|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
145441906|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441907|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441908|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
145441909|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441910|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441911|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441912|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441913|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441914|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
145441915|NCT02891226|524474623|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441916|NCT02891226|524474624|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441917|NCT02891226|524474625|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441918|NCT02891226|524474626|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441919|NCT02891226|524474627|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441920|NCT02891226|524474628|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441921|NCT02891226|524474629|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441922|NCT02891226|524474630|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441923|NCT02891226|524474631|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441924|NCT02891226|524474632|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
145441925|NCT02891226|524474633|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441926|NCT02891226|524474634|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441927|NCT02891226|524474635|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441928|NCT02891226|524474636|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441929|NCT02891226|524474637|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441930|NCT02891226|524474638|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
145441931|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441932|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441933|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441934|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441935|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441936|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441937|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441938|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441939|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441940|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441941|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
145441942|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441943|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441944|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441945|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441946|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
145441947|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441948|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441949|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441950|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441951|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441952|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441953|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441954|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441955|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441956|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441957|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
145441958|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441959|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441960|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441961|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441962|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
145441963|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441964|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441965|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145625742|NCT01304706|525144074|FG000|Overall Study|Adverse Event|2|||
145625743|NCT01304706|525144074|FG000|Overall Study|Lack of Efficacy|1|||
145625744|NCT01304706|525144074|FG000|Overall Study|Death|3|||
145441966|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441967|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441968|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441969|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441970|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145625745|NCT01304706|525144074|FG000|Overall Study|Withdrawal by Subject|3|||
145625746|NCT01304706|525144074|FG000|Overall Study|Lost to Follow-up|7|||
145625747|NCT01304706|525144074|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
145625748|NCT04978363|525144080|FG000|Overall Study|Other medical issues unrelated to the study|0|||
145625749|NCT04978363|525144081|FG001|Overall Study|Other medical issues unrelated to the study|0|||
145625750|NCT04978363|525144082|FG002|Overall Study|Other medical issues unrelated to the study|0|||
145625751|NCT04978363|525144083|FG003|Overall Study|Other medical issues unrelated to the study|0|||
145625752|NCT04978363|525144084|FG004|Overall Study|Other medical issues unrelated to the study|1|||
145625753|NCT04978363|525144085|FG005|Overall Study|Other medical issues unrelated to the study|0|||
145625754|NCT04978363|525144086|FG006|Overall Study|Other medical issues unrelated to the study|0|||
145625755|NCT04978363|525144087|FG007|Overall Study|Other medical issues unrelated to the study|0|||
145625756|NCT04978363|525144088|FG008|Overall Study|Other medical issues unrelated to the study|0|||
145625757|NCT04978363|525144089|FG009|Overall Study|Other medical issues unrelated to the study|0|||
145625758|NCT04978363|525144090|FG010|Overall Study|Other medical issues unrelated to the study|0|||
145625759|NCT04978363|525144080|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
145625760|NCT04978363|525144081|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
145625761|NCT04978363|525144082|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
145625762|NCT04978363|525144083|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
145625763|NCT04978363|525144084|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
145625764|NCT04978363|525144085|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
145625765|NCT04978363|525144086|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
145441971|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441972|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441973|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
145441974|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441975|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441976|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441977|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441978|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
145441979|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441980|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441981|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441982|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441983|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441984|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441985|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441986|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441987|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441988|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441989|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
145441990|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441991|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441992|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441993|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441994|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
145441995|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145441996|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145441997|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145441998|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145441999|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442000|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442001|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442002|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442003|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442004|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442005|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
145442006|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442007|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442008|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442009|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442010|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
145442011|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442012|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442013|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442014|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442015|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442016|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442017|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442018|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442019|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442020|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442021|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
145442022|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442023|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442024|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442025|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442026|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
145442027|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442028|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442029|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442030|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442031|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442032|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442033|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442034|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442035|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442036|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442037|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
145442038|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442039|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442040|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442041|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442042|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
145442043|NCT02891226|524474623|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442044|NCT02891226|524474624|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442045|NCT02891226|524474625|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442046|NCT02891226|524474626|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442047|NCT02891226|524474627|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442048|NCT02891226|524474628|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442049|NCT02891226|524474629|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442050|NCT02891226|524474630|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442051|NCT02891226|524474631|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442052|NCT02891226|524474632|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442053|NCT02891226|524474633|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
145442054|NCT02891226|524474634|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442055|NCT02891226|524474635|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442056|NCT02891226|524474636|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442057|NCT02891226|524474637|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442058|NCT02891226|524474638|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
145442059|NCT02891226|524474623|FG000|Follow-up Period|Withdrawal by Subject|0|||
145442060|NCT02891226|524474624|FG001|Follow-up Period|Withdrawal by Subject|0|||
145442061|NCT02891226|524474625|FG002|Follow-up Period|Withdrawal by Subject|0|||
145442062|NCT02891226|524474626|FG003|Follow-up Period|Withdrawal by Subject|0|||
145442063|NCT02891226|524474627|FG004|Follow-up Period|Withdrawal by Subject|0|||
145442064|NCT02891226|524474628|FG005|Follow-up Period|Withdrawal by Subject|0|||
145442065|NCT02891226|524474629|FG006|Follow-up Period|Withdrawal by Subject|0|||
145442066|NCT02891226|524474630|FG007|Follow-up Period|Withdrawal by Subject|0|||
145442067|NCT02891226|524474631|FG008|Follow-up Period|Withdrawal by Subject|0|||
145442068|NCT02891226|524474632|FG009|Follow-up Period|Withdrawal by Subject|0|||
145442069|NCT02891226|524474633|FG010|Follow-up Period|Withdrawal by Subject|0|||
145442070|NCT02891226|524474634|FG011|Follow-up Period|Withdrawal by Subject|1|||
145442071|NCT02891226|524474635|FG012|Follow-up Period|Withdrawal by Subject|0|||
145442072|NCT02891226|524474636|FG013|Follow-up Period|Withdrawal by Subject|0|||
145584936|NCT02105116|524995349|FG000|Overall Study|not eligible for step 2 of trial|5|||
145584937|NCT02105116|524995349|FG000|Overall Study|Death|1|||
145584938|NCT02492100|524995350|FG000|Overall Study|Death|1|||
145584939|NCT03832010|524995351|FG000|Overall Study|Withdrawal by Subject|2|||
145584940|NCT03832010|524995352|FG001|Overall Study|Withdrawal by Subject|1|||
145442073|NCT02891226|524474637|FG014|Follow-up Period|Withdrawal by Subject|1|||
145442074|NCT02891226|524474638|FG015|Follow-up Period|Withdrawal by Subject|1|||
145442075|NCT03381287|524474642|FG000|Overall Study|Withdrawal by Subject|0|||
145442076|NCT03381287|524474643|FG001|Overall Study|Withdrawal by Subject|1|||
145442077|NCT03381287|524474644|FG002|Overall Study|Withdrawal by Subject|0|||
145442078|NCT03381287|524474645|FG003|Overall Study|Withdrawal by Subject|0|||
145442079|NCT03381287|524474642|FG000|Overall Study|Adverse Event|0|||
145442080|NCT03381287|524474643|FG001|Overall Study|Adverse Event|0|||
145442081|NCT03381287|524474644|FG002|Overall Study|Adverse Event|0|||
145442082|NCT03381287|524474645|FG003|Overall Study|Adverse Event|1|||
145442083|NCT03381287|524474642|FG000|Overall Study|Physician Decision|0|||
145442084|NCT03381287|524474643|FG001|Overall Study|Physician Decision|0|||
145442085|NCT03381287|524474644|FG002|Overall Study|Physician Decision|0|||
145442086|NCT03381287|524474645|FG003|Overall Study|Physician Decision|1|||
145442087|NCT02454530|524474648|FG000|Overall Study|Other|8|||
145442088|NCT02454530|524474649|FG001|Overall Study|Other|13|||
145442089|NCT02454530|524474648|FG000|Overall Study|Missing information|56|||
145442090|NCT02454530|524474649|FG001|Overall Study|Missing information|69|||
145442091|NCT02454530|524474648|FG000|Overall Study|Death|2|||
145442092|NCT02454530|524474649|FG001|Overall Study|Death|41|||
145442093|NCT02454530|524474648|FG000|Overall Study|Lost to Follow-up|4|||
145442094|NCT02454530|524474649|FG001|Overall Study|Lost to Follow-up|4|||
145442095|NCT02137070|524474650|FG000|Overall Study|Adverse Event|12|||
145442096|NCT02137070|524474651|FG001|Overall Study|Adverse Event|3|||
145442097|NCT02137070|524474650|FG000|Overall Study|Death|2|||
145442098|NCT02137070|524474651|FG001|Overall Study|Death|0|||
145442099|NCT02137070|524474650|FG000|Overall Study|Lost to Follow-up|24|||
145442100|NCT02137070|524474651|FG001|Overall Study|Lost to Follow-up|9|||
145442101|NCT02137070|524474650|FG000|Overall Study|Physician Decision|0|||
145584941|NCT03832010|524995353|FG002|Overall Study|Withdrawal by Subject|0|||
145584942|NCT03832010|524995351|FG000|Overall Study|Lost to Follow-up|2|||
145584943|NCT03832010|524995352|FG001|Overall Study|Lost to Follow-up|1|||
145584944|NCT03832010|524995353|FG002|Overall Study|Lost to Follow-up|1|||
145584945|NCT00987467|524995354|FG000|Overall Study|Lost to Follow-up|2|||
145584946|NCT02807948|524995355|FG000|Overall Study|Physician Decision|1|||
145584947|NCT02807948|524995356|FG001|Overall Study|Physician Decision|0|||
145584948|NCT01054820|524995360|FG000|Overall Study|Withdrawal by Subject|2|||
145584949|NCT02624804|524995361|FG000|Overall Study|Screen Failure|5|||
145584950|NCT02590354|524995362|FG000|Phase 1|Active hepatitis B or C infection|1|||
145584951|NCT02590354|524995362|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
145584952|NCT02590354|524995362|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
145584953|NCT02590354|524995362|FG000|Phase 1|Subject does not want to participate|20|||
145584954|NCT02590354|524995362|FG000|Phase 1|Lost to Follow-up|1|||
145584955|NCT02590354|524995362|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
145584956|NCT00996996|524995363|FG000|Overall Study|Progressive Disease|10|||
145584957|NCT00996996|524995363|FG000|Overall Study|Non-compliance|8|||
145584958|NCT00996996|524995363|FG000|Overall Study|Lost to Follow-up|9|||
145584959|NCT00996996|524995363|FG000|Overall Study|Death|5|||
145584960|NCT00996996|524995363|FG000|Overall Study|Did Not Receive Study Medications|1|||
145584961|NCT00760929|524995364|FG000|Overall Study|Adverse Event|2|||
145584962|NCT00760929|524995365|FG001|Overall Study|Adverse Event|0|||
145584963|NCT00760929|524995366|FG002|Overall Study|Adverse Event|6|||
145584964|NCT00760929|524995367|FG003|Overall Study|Adverse Event|10|||
145584965|NCT00760929|524995364|FG000|Overall Study|Lack of Efficacy|0|||
145584966|NCT00760929|524995365|FG001|Overall Study|Lack of Efficacy|2|||
145584967|NCT00760929|524995366|FG002|Overall Study|Lack of Efficacy|1|||
145584968|NCT00760929|524995367|FG003|Overall Study|Lack of Efficacy|0|||
145584969|NCT00760929|524995364|FG000|Overall Study|Withdrawal by Subject|1|||
145584970|NCT00760929|524995365|FG001|Overall Study|Withdrawal by Subject|0|||
145625766|NCT04978363|525144087|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
145625767|NCT04978363|525144088|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
145584971|NCT00760929|524995366|FG002|Overall Study|Withdrawal by Subject|9|||
145584972|NCT00760929|524995367|FG003|Overall Study|Withdrawal by Subject|1|||
145442102|NCT02137070|524474651|FG001|Overall Study|Physician Decision|1|||
145442103|NCT02137070|524474650|FG000|Overall Study|Protocol Violation|18|||
145442104|NCT02137070|524474651|FG001|Overall Study|Protocol Violation|4|||
145584973|NCT00760929|524995364|FG000|Overall Study|Lost to Follow-up|0|||
145584974|NCT00760929|524995365|FG001|Overall Study|Lost to Follow-up|0|||
145584975|NCT00760929|524995366|FG002|Overall Study|Lost to Follow-up|1|||
145584976|NCT00760929|524995367|FG003|Overall Study|Lost to Follow-up|0|||
145584977|NCT00760929|524995364|FG000|Overall Study|Progression of Disease|21|||
145442105|NCT02137070|524474650|FG000|Overall Study|Withdrawal by Subject|18|||
145442106|NCT02137070|524474651|FG001|Overall Study|Withdrawal by Subject|1|||
145442107|NCT04487080|524474661|FG000|Overall Study|Withdrawal by Subject|19|||
145442108|NCT04487080|524474662|FG001|Overall Study|Withdrawal by Subject|18|||
145442109|NCT04487080|524474663|FG002|Overall Study|Withdrawal by Subject|13|||
145442110|NCT04487080|524474661|FG000|Overall Study|Lost to Follow-up|3|||
145442111|NCT04487080|524474662|FG001|Overall Study|Lost to Follow-up|1|||
145442112|NCT04487080|524474663|FG002|Overall Study|Lost to Follow-up|0|||
145442113|NCT04487080|524474661|FG000|Overall Study|Ongoing|313|||
145442114|NCT04487080|524474662|FG001|Overall Study|Ongoing|297|||
145442115|NCT04487080|524474663|FG002|Overall Study|Ongoing|149|||
145442116|NCT00600106|524475973|FG000|Overall Study|Withdrawal by Subject|1|||
145442117|NCT00600106|524475974|FG001|Overall Study|Withdrawal by Subject|1|||
145442118|NCT04988295|524475977|FG000|Overall Study|Withdrawal by Subject|9|||
145442119|NCT04988295|524475978|FG001|Overall Study|Withdrawal by Subject|29|||
145442120|NCT04988295|524475979|FG002|Overall Study|Withdrawal by Subject|6|||
145442121|NCT04988295|524475980|FG003|Overall Study|Withdrawal by Subject|0|||
145442122|NCT04988295|524475977|FG000|Overall Study|Lost to Follow-up|1|||
145442123|NCT04988295|524475978|FG001|Overall Study|Lost to Follow-up|0|||
145442124|NCT04988295|524475979|FG002|Overall Study|Lost to Follow-up|0|||
145442125|NCT04988295|524475980|FG003|Overall Study|Lost to Follow-up|0|||
145442126|NCT04988295|524475977|FG000|Overall Study|Study participation ongoing|186|||
145442127|NCT04988295|524475978|FG001|Overall Study|Study participation ongoing|169|||
145442128|NCT04988295|524475979|FG002|Overall Study|Study participation ongoing|99|||
145442129|NCT04988295|524475980|FG003|Overall Study|Study participation ongoing|119|||
145442130|NCT01273038|524475985|FG000|Second Intervention (14 Days)|Adverse Event|0|||
145442131|NCT01273038|524475986|FG001|Second Intervention (14 Days)|Adverse Event|1|||
145442132|NCT01273038|524475985|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
145442133|NCT01273038|524475986|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
145442134|NCT02197572|524475991|FG000|Overall Study|Progressive Disease|28|||
145442135|NCT02197572|524475991|FG000|Overall Study|Withdrawal by Subject|9|||
145584978|NCT00760929|524995365|FG001|Overall Study|Progression of Disease|26|||
145584979|NCT00760929|524995366|FG002|Overall Study|Progression of Disease|38|||
145584980|NCT00760929|524995367|FG003|Overall Study|Progression of Disease|42|||
145584981|NCT00760929|524995364|FG000|Overall Study|Other|2|||
145584982|NCT00760929|524995365|FG001|Overall Study|Other|0|||
145584983|NCT00760929|524995366|FG002|Overall Study|Other|2|||
145584984|NCT00760929|524995367|FG003|Overall Study|Other|1|||
145584985|NCT00760929|524995364|FG000|Overall Study|Death|0|||
145584986|NCT00760929|524995365|FG001|Overall Study|Death|0|||
145584987|NCT00760929|524995366|FG002|Overall Study|Death|1|||
145584988|NCT00760929|524995367|FG003|Overall Study|Death|0|||
145584989|NCT00760929|524995364|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
145584990|NCT00760929|524995365|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
145584991|NCT00760929|524995366|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
145584992|NCT00760929|524995367|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
145584993|NCT02099838|524995368|FG000|Overall Study|Death|1|||
145584994|NCT02099838|524995369|FG001|Overall Study|Death|0|||
145584995|NCT02099838|524995368|FG000|Overall Study|Lost to Follow-up|3|||
145584996|NCT02099838|524995369|FG001|Overall Study|Lost to Follow-up|1|||
145584997|NCT02099838|524995368|FG000|Overall Study|Withdrawal by Subject|0|||
145584998|NCT02099838|524995369|FG001|Overall Study|Withdrawal by Subject|1|||
145584999|NCT02731131|524995370|FG000|Overall Study|Psychiatric Disorder|0|||
145585000|NCT02731131|524995371|FG001|Overall Study|Psychiatric Disorder|1|||
145585001|NCT02731131|524995370|FG000|Overall Study|Refused Therapy|0|||
145585002|NCT02731131|524995371|FG001|Overall Study|Refused Therapy|1|||
145585003|NCT02348216|524995376|FG000|Overall Study|Death|5|||
145585004|NCT02348216|524995377|FG001|Overall Study|Death|53|||
145585005|NCT02348216|524995378|FG002|Overall Study|Death|11|||
145585006|NCT02348216|524995379|FG003|Overall Study|Death|20|||
145585007|NCT02348216|524995380|FG004|Overall Study|Death|16|||
145585008|NCT02348216|524995381|FG005|Overall Study|Death|32|||
145585009|NCT02348216|524995382|FG006|Overall Study|Death|17|||
145585010|NCT02348216|524995376|FG000|Overall Study|Full consent withdrawal|0|||
145585011|NCT02348216|524995377|FG001|Overall Study|Full consent withdrawal|0|||
145585012|NCT02348216|524995378|FG002|Overall Study|Full consent withdrawal|0|||
145585013|NCT02348216|524995379|FG003|Overall Study|Full consent withdrawal|1|||
145585014|NCT02348216|524995380|FG004|Overall Study|Full consent withdrawal|3|||
145585015|NCT02348216|524995381|FG005|Overall Study|Full consent withdrawal|0|||
145585016|NCT02348216|524995382|FG006|Overall Study|Full consent withdrawal|3|||
145585017|NCT02348216|524995376|FG000|Overall Study|Lost to Follow-up|0|||
145585018|NCT02348216|524995377|FG001|Overall Study|Lost to Follow-up|5|||
145585019|NCT02348216|524995378|FG002|Overall Study|Lost to Follow-up|2|||
145585020|NCT02348216|524995379|FG003|Overall Study|Lost to Follow-up|0|||
145585021|NCT02348216|524995380|FG004|Overall Study|Lost to Follow-up|1|||
145585022|NCT02348216|524995381|FG005|Overall Study|Lost to Follow-up|1|||
145442136|NCT02197572|524475991|FG000|Overall Study|Adverse Event|3|||
145585023|NCT02348216|524995382|FG006|Overall Study|Lost to Follow-up|1|||
145585024|NCT02348216|524995376|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
145585025|NCT02348216|524995377|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
145442137|NCT02197572|524475991|FG000|Overall Study|Reason Not Specified|4|||
145585026|NCT02348216|524995378|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
145585027|NCT02348216|524995379|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
145442138|NCT01465386|524475993|FG000|Overall Study|Lack of Efficacy|3|||
145442139|NCT01465386|524475993|FG000|Overall Study|Adverse Event|1|||
145442140|NCT01279044|524475996|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
145442141|NCT01279044|524475997|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
145442142|NCT01279044|524475998|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
145442143|NCT01279044|524475996|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
145442144|NCT01279044|524475997|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
145442145|NCT01279044|524475998|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
145442146|NCT01279044|524475996|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
145442147|NCT01279044|524475997|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
145442148|NCT01279044|524475998|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
145442149|NCT01408277|524476000|FG000|Overall Study|Adverse Event|3|||
145442150|NCT01408277|524476001|FG001|Overall Study|Adverse Event|4|||
145442151|NCT01408277|524476000|FG000|Overall Study|Lost to Follow-up|1|||
145442152|NCT01408277|524476001|FG001|Overall Study|Lost to Follow-up|0|||
145442153|NCT01408277|524476000|FG000|Overall Study|Withdrawal by Subject|2|||
145442154|NCT01408277|524476001|FG001|Overall Study|Withdrawal by Subject|0|||
145442155|NCT01408277|524476000|FG000|Overall Study|Protocol Violation|2|||
145442156|NCT01408277|524476001|FG001|Overall Study|Protocol Violation|0|||
145442157|NCT02840253|524476002|FG000|Overall Study|Unsuccessful block|4|||
145442158|NCT03783962|524476003|FG000|Overall Study|Lost to Follow-up|3|||
145442159|NCT03783962|524476004|FG001|Overall Study|Lost to Follow-up|6|||
145442160|NCT03783962|524476003|FG000|Overall Study|Protocol Violation|0|||
145442161|NCT03783962|524476004|FG001|Overall Study|Protocol Violation|1|||
145442162|NCT03458325|524476005|FG000|Overall Study|Withdrawal by Subject|1|||
145442163|NCT02168101|524476006|FG000|Overall Study|Death|2|||
145442164|NCT02168101|524476007|FG001|Overall Study|Death|2|||
145442165|NCT02168101|524476008|FG002|Overall Study|Death|1|||
145442166|NCT05507567|524476009|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
145442167|NCT05507567|524476010|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
145442168|NCT05507567|524476011|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
145442169|NCT05507567|524476009|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
145442170|NCT05507567|524476010|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
145442171|NCT05507567|524476011|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
145442172|NCT05507567|524476009|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
145442173|NCT05507567|524476010|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
145442174|NCT05507567|524476011|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
145442175|NCT05507567|524476009|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
145442176|NCT05507567|524476010|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
145442177|NCT05507567|524476011|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
145442178|NCT01722994|524476014|FG000|Overall Study|Missing data|25|||
145442179|NCT01722994|524476015|FG001|Overall Study|Missing data|17|||
145442180|NCT05226598|524476020|FG000|Overall Study|Death|186|||
145442181|NCT05226598|524476021|FG001|Overall Study|Death|191|||
145442182|NCT05226598|524476020|FG000|Overall Study|Withdrawal by Subject|6|||
145442183|NCT05226598|524476021|FG001|Overall Study|Withdrawal by Subject|6|||
145442184|NCT05226598|524476020|FG000|Overall Study|Ongoing|174|||
145442185|NCT05226598|524476021|FG001|Overall Study|Ongoing|176|||
145442186|NCT02959463|524476022|FG000|Overall Study|Adverse Event|1|||
145442187|NCT02959463|524476023|FG001|Overall Study|Adverse Event|1|||
145442188|NCT02959463|524476022|FG000|Overall Study|Death|1|||
145442189|NCT02959463|524476023|FG001|Overall Study|Death|0|||
145442190|NCT02959463|524476022|FG000|Overall Study|Withdrawal by Subject|1|||
145442191|NCT02959463|524476023|FG001|Overall Study|Withdrawal by Subject|0|||
145442192|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
145442193|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
145442194|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
145442195|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
145442196|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
145442197|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
145442198|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
145442199|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
145585028|NCT02348216|524995380|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
145585029|NCT02348216|524995381|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
145585030|NCT02348216|524995382|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
145585031|NCT02348216|524995376|FG000|Overall Study|Reason not specified|2|||
145585032|NCT02348216|524995377|FG001|Overall Study|Reason not specified|19|||
145442200|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
145442201|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
145585033|NCT02348216|524995378|FG002|Overall Study|Reason not specified|11|||
145442202|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
145442203|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
145442204|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
145442205|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
145442206|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
145442207|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
145442208|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
145442209|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
145442210|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
145442211|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
145442212|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
145442213|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
145442214|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
145442215|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
145442216|NCT01672879|524476024|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
145442217|NCT01672879|524476025|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
145442218|NCT01672879|524476026|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
145442219|NCT01672879|524476024|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
145442220|NCT01672879|524476025|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
145442221|NCT01672879|524476026|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
145442222|NCT01672879|524476024|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
145442223|NCT01672879|524476025|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
145442224|NCT01672879|524476026|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
145442225|NCT01672879|524476024|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
145442226|NCT01672879|524476025|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
145442227|NCT01672879|524476026|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
145442228|NCT01672879|524476024|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
145442229|NCT01672879|524476025|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
145442230|NCT01672879|524476026|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
145442231|NCT03951766|524476031|FG000|Treatment Phase|Lost to Follow-up|1|||
145442232|NCT03951766|524476031|FG000|Follow-up Phase|Lost to Follow-up|10|||
145442233|NCT01871545|524476032|FG000|Overall Study|Death|2|||
145442234|NCT01871545|524476033|FG001|Overall Study|Death|0|||
145442235|NCT01871545|524476032|FG000|Overall Study|Lack of Efficacy|11|||
145442236|NCT01871545|524476033|FG001|Overall Study|Lack of Efficacy|2|||
145442237|NCT01871545|524476032|FG000|Overall Study|Physician Decision|4|||
145442238|NCT01871545|524476033|FG001|Overall Study|Physician Decision|0|||
145442239|NCT01871545|524476032|FG000|Overall Study|Withdrawal by Subject|0|||
145442240|NCT01871545|524476033|FG001|Overall Study|Withdrawal by Subject|1|||
145442241|NCT01523743|524476034|FG000|Period 1|Adverse Event|1|||
145442242|NCT01523743|524476035|FG001|Period 1|Adverse Event|0|||
145442243|NCT01523743|524476034|FG000|Period 1|Withdrawal by Subject|6|||
145442244|NCT01523743|524476035|FG001|Period 1|Withdrawal by Subject|2|||
145442245|NCT01523743|524476034|FG000|Period 1|Lost to Follow-up|1|||
145442246|NCT01523743|524476035|FG001|Period 1|Lost to Follow-up|0|||
145442247|NCT01523743|524476034|FG000|Period 1|Lack of Efficacy|1|||
145442248|NCT01523743|524476035|FG001|Period 1|Lack of Efficacy|0|||
145442249|NCT01523743|524476034|FG000|Period 1|Felt unable to empty bladder|1|||
145442250|NCT01523743|524476035|FG001|Period 1|Felt unable to empty bladder|0|||
145442251|NCT01523743|524476034|FG000|Period 2|Withdrawal by Subject|0|||
145442252|NCT01523743|524476035|FG001|Period 2|Withdrawal by Subject|2|||
145442253|NCT01523743|524476034|FG000|Period 2|Adverse Event|1|||
145442254|NCT01523743|524476035|FG001|Period 2|Adverse Event|0|||
145442255|NCT04188509|524476036|FG000|Overall Study|Adverse Event|2|||
145442256|NCT04188509|524476036|FG000|Overall Study|Lost to Follow-up|1|||
145442257|NCT04188509|524476036|FG000|Overall Study|Withdrawal of Consent|1|||
145442258|NCT04188509|524476036|FG000|Overall Study|Discretion of Investigator|1|||
145442259|NCT04188509|524476036|FG000|Overall Study|Noncompliance|3|||
145442260|NCT04188509|524476036|FG000|Overall Study|Sponsor Decision|127|||
145442261|NCT04188509|524476036|FG000|Overall Study|Other|2|||
145442262|NCT01152788|524476038|FG000|Overall Study|Withdrawal by Subject|0|||
145442263|NCT01152788|524476039|FG001|Overall Study|Withdrawal by Subject|3|||
145442264|NCT01152788|524476038|FG000|Overall Study|No treatment|0|||
145442265|NCT01152788|524476039|FG001|Overall Study|No treatment|1|||
145442266|NCT01282866|524476046|FG000|Overall Study|Adverse Event|1|||
145442267|NCT01541865|524476048|FG000|Overall Study|Lost to Follow-up|11|||
145442268|NCT01541865|524476048|FG000|Overall Study|Withdrawal by Subject|9|||
145442269|NCT01541865|524476048|FG000|Overall Study|Adverse Event|1|||
145442270|NCT01541865|524476048|FG000|Overall Study|Protocol Violation|1|||
145442271|NCT01393899|524476054|FG000|Overall Study|Study terminated by sponsor|1|||
145442272|NCT01393899|524476055|FG001|Overall Study|Study terminated by sponsor|0|||
145442273|NCT01393899|524476056|FG002|Overall Study|Study terminated by sponsor|1|||
145442274|NCT01393899|524476054|FG000|Overall Study|Other|1|||
145442275|NCT01393899|524476055|FG001|Overall Study|Other|0|||
145442276|NCT01393899|524476056|FG002|Overall Study|Other|0|||
145442277|NCT01393899|524476054|FG000|Overall Study|Withdrawal by Subject|2|||
145442278|NCT01393899|524476055|FG001|Overall Study|Withdrawal by Subject|2|||
145442279|NCT01393899|524476056|FG002|Overall Study|Withdrawal by Subject|1|||
145442280|NCT01393899|524476054|FG000|Overall Study|Lost to Follow-up|0|||
145442281|NCT01393899|524476055|FG001|Overall Study|Lost to Follow-up|0|||
145442282|NCT01393899|524476056|FG002|Overall Study|Lost to Follow-up|1|||
145442283|NCT01393899|524476054|FG000|Overall Study|Does not meet entrance criteria|1|||
145442284|NCT01393899|524476055|FG001|Overall Study|Does not meet entrance criteria|0|||
145442285|NCT01393899|524476056|FG002|Overall Study|Does not meet entrance criteria|1|||
145442286|NCT01393899|524476054|FG000|Overall Study|Lack of Efficacy|26|||
145442287|NCT01393899|524476055|FG001|Overall Study|Lack of Efficacy|21|||
145442288|NCT01393899|524476056|FG002|Overall Study|Lack of Efficacy|16|||
145442289|NCT01393899|524476054|FG000|Overall Study|Adverse Event|1|||
145442290|NCT01393899|524476055|FG001|Overall Study|Adverse Event|5|||
145442291|NCT01393899|524476056|FG002|Overall Study|Adverse Event|3|||
145442292|NCT00049257|524476057|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
145442293|NCT00049257|524476057|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
145442294|NCT00049257|524476057|FG000|Carboplatin, Paclitaxel|Death|2|||
145442295|NCT00049257|524476057|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
145442296|NCT04721158|524476058|FG000|Overall Study|Lost to Follow-up|4|||
145442297|NCT04721158|524476058|FG000|Overall Study|Device did not connect|1|||
145442298|NCT00132301|524476059|FG000|Overall Study|Death|7|||
145442299|NCT00132301|524476060|FG001|Overall Study|Death|6|||
145442300|NCT00132301|524476059|FG000|Overall Study|Withdrawal by Subject|5|||
145442301|NCT00132301|524476060|FG001|Overall Study|Withdrawal by Subject|2|||
145442302|NCT00132301|524476059|FG000|Overall Study|Physician Decision|1|||
145442303|NCT00132301|524476060|FG001|Overall Study|Physician Decision|1|||
145442304|NCT00132301|524476059|FG000|Overall Study|Lost to Follow-up|5|||
145442305|NCT00132301|524476060|FG001|Overall Study|Lost to Follow-up|3|||
145442306|NCT00132301|524476059|FG000|Overall Study|Other|1|||
145442307|NCT00132301|524476060|FG001|Overall Study|Other|1|||
145442308|NCT00132301|524476059|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
145442309|NCT00132301|524476060|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
145442310|NCT01890265|524476065|FG000|Overall Study|Other (Unspecified reason)|0|||
145442311|NCT01890265|524476066|FG001|Overall Study|Other (Unspecified reason)|1|||
145442312|NCT01890265|524476067|FG002|Overall Study|Other (Unspecified reason)|0|||
145442313|NCT01890265|524476068|FG003|Overall Study|Other (Unspecified reason)|0|||
145442314|NCT01890265|524476069|FG004|Overall Study|Other (Unspecified reason)|0|||
145442315|NCT01890265|524476070|FG005|Overall Study|Other (Unspecified reason)|0|||
145442316|NCT01890265|524476065|FG000|Overall Study|Progressive disease|6|||
145442317|NCT01890265|524476066|FG001|Overall Study|Progressive disease|6|||
145442318|NCT01890265|524476067|FG002|Overall Study|Progressive disease|0|||
145442319|NCT01890265|524476068|FG003|Overall Study|Progressive disease|0|||
145442320|NCT01890265|524476069|FG004|Overall Study|Progressive disease|0|||
145442321|NCT01890265|524476070|FG005|Overall Study|Progressive disease|0|||
145442322|NCT01890265|524476065|FG000|Overall Study|Adverse Event|2|||
145442323|NCT01890265|524476066|FG001|Overall Study|Adverse Event|1|||
145442324|NCT01890265|524476067|FG002|Overall Study|Adverse Event|0|||
145442325|NCT01890265|524476068|FG003|Overall Study|Adverse Event|0|||
145442326|NCT01890265|524476069|FG004|Overall Study|Adverse Event|0|||
145442327|NCT01890265|524476070|FG005|Overall Study|Adverse Event|0|||
145442328|NCT01890265|524476065|FG000|Overall Study|Death|2|||
145442329|NCT01890265|524476066|FG001|Overall Study|Death|3|||
145442330|NCT01890265|524476067|FG002|Overall Study|Death|1|||
145442331|NCT01890265|524476068|FG003|Overall Study|Death|0|||
145442332|NCT01890265|524476069|FG004|Overall Study|Death|0|||
145442333|NCT01890265|524476070|FG005|Overall Study|Death|0|||
145442334|NCT01890265|524476065|FG000|Overall Study|Withdrawal by Subject|0|||
145442335|NCT01890265|524476066|FG001|Overall Study|Withdrawal by Subject|2|||
145442336|NCT01890265|524476067|FG002|Overall Study|Withdrawal by Subject|3|||
145442337|NCT01890265|524476068|FG003|Overall Study|Withdrawal by Subject|0|||
145442338|NCT01890265|524476069|FG004|Overall Study|Withdrawal by Subject|2|||
145442339|NCT01890265|524476070|FG005|Overall Study|Withdrawal by Subject|0|||
145442340|NCT03462719|524476078|FG000|Overall Study|Withdrawal by Subject|4|||
145442341|NCT03462719|524476079|FG001|Overall Study|Withdrawal by Subject|3|||
145442342|NCT03462719|524476078|FG000|Overall Study|Ongoing|87|||
145442343|NCT03462719|524476079|FG001|Overall Study|Ongoing|72|||
145442344|NCT01402869|524476082|FG000|Overall Study|Required Tooth Extraction|0|||
145442345|NCT01402869|524476083|FG001|Overall Study|Required Tooth Extraction|0|||
145442346|NCT01402869|524476084|FG002|Overall Study|Required Tooth Extraction|1|||
145442347|NCT00100802|524476088|FG000|Overall Study|Adverse Event|9|||
145585034|NCT02348216|524995379|FG003|Overall Study|Reason not specified|17|||
145442348|NCT00100802|524476088|FG000|Overall Study|Death|1|||
145442349|NCT00100802|524476088|FG000|Overall Study|Lack of Efficacy|47|||
145442350|NCT00100802|524476088|FG000|Overall Study|Physician Decision|5|||
145442351|NCT00100802|524476088|FG000|Overall Study|Protocol Violation|1|||
145442352|NCT00100802|524476088|FG000|Overall Study|Withdrawal by Subject|5|||
145442353|NCT00100802|524476088|FG000|Overall Study|Ineligible|12|||
145442354|NCT00325130|524476120|FG000|Overall Study|Lost to Follow-up|6|||
145442355|NCT00325130|524476121|FG001|Overall Study|Lost to Follow-up|14|||
145585035|NCT02348216|524995380|FG004|Overall Study|Reason not specified|21|||
145442356|NCT00325130|524476120|FG000|Overall Study|Withdrawal by Subject|12|||
145442357|NCT00325130|524476121|FG001|Overall Study|Withdrawal by Subject|14|||
145442358|NCT00325130|524476120|FG000|Overall Study|Protocol Deviation|0|||
145442359|NCT00325130|524476121|FG001|Overall Study|Protocol Deviation|1|||
145442360|NCT00325130|524476120|FG000|Overall Study|Moved|0|||
145442361|NCT00325130|524476121|FG001|Overall Study|Moved|1|||
145442362|NCT00325130|524476120|FG000|Overall Study|Patient Discontinued for Other|1|||
145442363|NCT00325130|524476121|FG001|Overall Study|Patient Discontinued for Other|0|||
145442364|NCT00928187|524476123|FG000|Overall Study|Death|1|||
145442365|NCT00928187|524476124|FG001|Overall Study|Death|2|||
145442366|NCT00928187|524476125|FG002|Overall Study|Death|3|||
145442367|NCT00928187|524476123|FG000|Overall Study|Lost to Follow-up|1|||
145442368|NCT00928187|524476124|FG001|Overall Study|Lost to Follow-up|2|||
145442369|NCT00928187|524476125|FG002|Overall Study|Lost to Follow-up|1|||
145442370|NCT00928187|524476123|FG000|Overall Study|Withdrawal by Subject|0|||
145442371|NCT00928187|524476124|FG001|Overall Study|Withdrawal by Subject|1|||
145442372|NCT00928187|524476125|FG002|Overall Study|Withdrawal by Subject|1|||
145442373|NCT00928187|524476123|FG000|Overall Study|Protocol Violation|0|||
145442374|NCT00928187|524476124|FG001|Overall Study|Protocol Violation|1|||
145442375|NCT00928187|524476125|FG002|Overall Study|Protocol Violation|0|||
145442376|NCT02524145|524476129|FG000|Overall Study|Withdrawal by Subject|2|||
145442377|NCT02524145|524476130|FG001|Overall Study|Withdrawal by Subject|2|||
145442378|NCT02524145|524476131|FG002|Overall Study|Withdrawal by Subject|3|||
145442379|NCT01142388|524478734|FG000|Overall Study|Lack of Efficacy|21|||
145442380|NCT01142388|524478735|FG001|Overall Study|Lack of Efficacy|31|||
145442381|NCT01142388|524478734|FG000|Overall Study|Adverse Event|9|||
145442382|NCT01142388|524478735|FG001|Overall Study|Adverse Event|5|||
145442383|NCT01142388|524478734|FG000|Overall Study|Death|3|||
145442384|NCT01142388|524478735|FG001|Overall Study|Death|2|||
145442385|NCT01142388|524478734|FG000|Overall Study|Withdrawal by Subject|5|||
145442386|NCT01142388|524478735|FG001|Overall Study|Withdrawal by Subject|3|||
145442387|NCT01142388|524478734|FG000|Overall Study|Alternative therapy|1|||
145442388|NCT01142388|524478735|FG001|Overall Study|Alternative therapy|0|||
145442389|NCT01142388|524478734|FG000|Overall Study|Other complications|0|||
145442390|NCT01142388|524478735|FG001|Overall Study|Other complications|2|||
145442391|NCT01142388|524478734|FG000|Overall Study|Other|1|||
145442392|NCT01142388|524478735|FG001|Overall Study|Other|1|||
145442393|NCT01142388|524478734|FG000|Overall Study|Never started therapy|7|||
145442394|NCT01142388|524478735|FG001|Overall Study|Never started therapy|3|||
145585036|NCT02348216|524995381|FG005|Overall Study|Reason not specified|17|||
145585037|NCT02348216|524995382|FG006|Overall Study|Reason not specified|19|||
145585038|NCT01666002|524995384|FG000|Overall Study|Lost to Follow-up|5|||
145585039|NCT01666002|524995385|FG001|Overall Study|Lost to Follow-up|0|||
145585040|NCT02265705|524995398|FG000|Treatment Period Week 0-24|Adverse Event|3|||
145585041|NCT02265705|524995399|FG001|Treatment Period Week 0-24|Adverse Event|2|||
145442455|NCT05730725|524478744|FG000|Overall Study|Withdrawal by Subject|3|||
145442456|NCT05730725|524478745|FG001|Overall Study|Withdrawal by Subject|0|||
145442457|NCT05730725|524478746|FG002|Overall Study|Withdrawal by Subject|0|||
145442458|NCT05730725|524478747|FG003|Overall Study|Withdrawal by Subject|1|||
145442459|NCT05730725|524478744|FG000|Overall Study|Not Reported|1|||
145442460|NCT05730725|524478745|FG001|Overall Study|Not Reported|1|||
145442461|NCT05730725|524478746|FG002|Overall Study|Not Reported|1|||
145442462|NCT05730725|524478747|FG003|Overall Study|Not Reported|1|||
145442463|NCT05265728|524478748|FG000|Overall Study|Adverse Event|1|||
145442464|NCT05265728|524478748|FG000|Overall Study|Study Terminated by Sponsor|5|||
145442465|NCT05265728|524478748|FG000|Overall Study|Withdrawal by Subject|2|||
145442478|NCT03687957|524478754|FG000|Overall Study|Withdrawal by Subject|0|||
145442479|NCT03687957|524478755|FG001|Overall Study|Withdrawal by Subject|0|||
145442480|NCT03687957|524478756|FG002|Overall Study|Withdrawal by Subject|0|||
145442481|NCT03687957|524478757|FG003|Overall Study|Withdrawal by Subject|2|||
145442482|NCT03687957|524478758|FG004|Overall Study|Withdrawal by Subject|0|||
145442483|NCT03687957|524478759|FG005|Overall Study|Withdrawal by Subject|0|||
145442484|NCT03687957|524478760|FG006|Overall Study|Withdrawal by Subject|3|||
145442485|NCT03687957|524478761|FG007|Overall Study|Withdrawal by Subject|1|||
145442486|NCT03687957|524478762|FG008|Overall Study|Withdrawal by Subject|1|||
145442487|NCT03687957|524478763|FG009|Overall Study|Withdrawal by Subject|0|||
145442488|NCT03687957|524478754|FG000|Overall Study|Disease progression|0|||
145442489|NCT03687957|524478755|FG001|Overall Study|Disease progression|1|||
145625768|NCT04978363|525144089|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
145442490|NCT03687957|524478756|FG002|Overall Study|Disease progression|1|||
145442491|NCT03687957|524478757|FG003|Overall Study|Disease progression|2|||
145442492|NCT03687957|524478758|FG004|Overall Study|Disease progression|2|||
145442493|NCT03687957|524478759|FG005|Overall Study|Disease progression|0|||
145442494|NCT03687957|524478760|FG006|Overall Study|Disease progression|2|||
145442495|NCT03687957|524478761|FG007|Overall Study|Disease progression|1|||
145442496|NCT03687957|524478762|FG008|Overall Study|Disease progression|0|||
145442497|NCT03687957|524478763|FG009|Overall Study|Disease progression|0|||
145442498|NCT03687957|524478754|FG000|Overall Study|Physician Decision|0|||
145442499|NCT03687957|524478755|FG001|Overall Study|Physician Decision|0|||
145442500|NCT03687957|524478756|FG002|Overall Study|Physician Decision|0|||
145442501|NCT03687957|524478757|FG003|Overall Study|Physician Decision|2|||
145442502|NCT03687957|524478758|FG004|Overall Study|Physician Decision|1|||
145442503|NCT03687957|524478759|FG005|Overall Study|Physician Decision|0|||
145442504|NCT03687957|524478760|FG006|Overall Study|Physician Decision|1|||
145442505|NCT03687957|524478761|FG007|Overall Study|Physician Decision|0|||
145442506|NCT03687957|524478762|FG008|Overall Study|Physician Decision|0|||
145442507|NCT03687957|524478763|FG009|Overall Study|Physician Decision|0|||
145442508|NCT03687957|524478754|FG000|Overall Study|New malignancy|0|||
145442509|NCT03687957|524478755|FG001|Overall Study|New malignancy|0|||
145442510|NCT03687957|524478756|FG002|Overall Study|New malignancy|0|||
145442511|NCT03687957|524478757|FG003|Overall Study|New malignancy|0|||
145442512|NCT03687957|524478758|FG004|Overall Study|New malignancy|1|||
145442513|NCT03687957|524478759|FG005|Overall Study|New malignancy|0|||
145442514|NCT03687957|524478760|FG006|Overall Study|New malignancy|0|||
145442515|NCT03687957|524478761|FG007|Overall Study|New malignancy|0|||
145442516|NCT03687957|524478762|FG008|Overall Study|New malignancy|0|||
145442517|NCT03687957|524478763|FG009|Overall Study|New malignancy|0|||
145442518|NCT03687957|524478754|FG000|Overall Study|Adverse Event|0|||
145442519|NCT03687957|524478755|FG001|Overall Study|Adverse Event|0|||
145442520|NCT03687957|524478756|FG002|Overall Study|Adverse Event|0|||
145442521|NCT03687957|524478757|FG003|Overall Study|Adverse Event|0|||
145442522|NCT03687957|524478758|FG004|Overall Study|Adverse Event|0|||
145442523|NCT03687957|524478759|FG005|Overall Study|Adverse Event|2|||
145442524|NCT03687957|524478760|FG006|Overall Study|Adverse Event|0|||
145442525|NCT03687957|524478761|FG007|Overall Study|Adverse Event|3|||
145442526|NCT03687957|524478762|FG008|Overall Study|Adverse Event|0|||
145442527|NCT03687957|524478763|FG009|Overall Study|Adverse Event|0|||
145442528|NCT03687957|524478754|FG000|Overall Study|Patient went on hospice|0|||
145442529|NCT03687957|524478755|FG001|Overall Study|Patient went on hospice|0|||
145442530|NCT03687957|524478756|FG002|Overall Study|Patient went on hospice|0|||
145442531|NCT03687957|524478757|FG003|Overall Study|Patient went on hospice|0|||
145442532|NCT03687957|524478758|FG004|Overall Study|Patient went on hospice|0|||
145442533|NCT03687957|524478759|FG005|Overall Study|Patient went on hospice|0|||
145442534|NCT03687957|524478760|FG006|Overall Study|Patient went on hospice|1|||
145442535|NCT03687957|524478761|FG007|Overall Study|Patient went on hospice|0|||
145442536|NCT03687957|524478762|FG008|Overall Study|Patient went on hospice|0|||
145442537|NCT03687957|524478763|FG009|Overall Study|Patient went on hospice|0|||
145442538|NCT03687957|524478754|FG000|Overall Study|Death|0|||
145442539|NCT03687957|524478755|FG001|Overall Study|Death|0|||
145442540|NCT03687957|524478756|FG002|Overall Study|Death|0|||
145442541|NCT03687957|524478757|FG003|Overall Study|Death|0|||
145442542|NCT03687957|524478758|FG004|Overall Study|Death|0|||
145442543|NCT03687957|524478759|FG005|Overall Study|Death|0|||
145442544|NCT03687957|524478760|FG006|Overall Study|Death|0|||
145442545|NCT03687957|524478761|FG007|Overall Study|Death|1|||
145442546|NCT03687957|524478762|FG008|Overall Study|Death|0|||
145442547|NCT03687957|524478763|FG009|Overall Study|Death|0|||
145442558|NCT04609553|524478767|FG000|Overall Study|Lost to Follow-up|27|||
145442559|NCT04609553|524478768|FG001|Overall Study|Lost to Follow-up|31|||
145442560|NCT04609553|524478769|FG002|Overall Study|Lost to Follow-up|24|||
145442561|NCT04609553|524478767|FG000|Overall Study|Discontinued|12|||
145442562|NCT04609553|524478768|FG001|Overall Study|Discontinued|10|||
145585042|NCT02265705|524995400|FG002|Treatment Period Week 0-24|Adverse Event|0|||
145585043|NCT02265705|524995401|FG003|Treatment Period Week 0-24|Adverse Event|0|||
145585044|NCT02265705|524995402|FG004|Treatment Period Week 0-24|Adverse Event|0|||
145442563|NCT04609553|524478769|FG002|Overall Study|Discontinued|9|||
145442577|NCT03584152|524478789|FG000|Overall Study|Discontinued intervention|7|||
145442578|NCT03584152|524478790|FG001|Overall Study|Discontinued intervention|4|||
145442579|NCT03052608|524478792|FG000|Treatment Phase|Adverse Event|10|||
145442580|NCT03052608|524478793|FG001|Treatment Phase|Adverse Event|12|||
145442581|NCT03052608|524478792|FG000|Treatment Phase|Death|6|||
145442582|NCT03052608|524478793|FG001|Treatment Phase|Death|4|||
145442583|NCT03052608|524478792|FG000|Treatment Phase|Withdrawal by Subject|4|||
145442584|NCT03052608|524478793|FG001|Treatment Phase|Withdrawal by Subject|12|||
145442585|NCT03052608|524478792|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
145442586|NCT03052608|524478793|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
145442587|NCT03052608|524478792|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
145442588|NCT03052608|524478793|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
145442589|NCT03052608|524478792|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
145442590|NCT03052608|524478793|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
145442591|NCT03052608|524478792|FG000|Treatment Phase|Ongoing|103|||
145442592|NCT03052608|524478793|FG001|Treatment Phase|Ongoing|31|||
145442593|NCT03052608|524478792|FG000|Long-Term Follow-up Phase|Death|23|||
145442594|NCT03052608|524478793|FG001|Long-Term Follow-up Phase|Death|28|||
145442595|NCT03052608|524478792|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
145442596|NCT03052608|524478793|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
145442597|NCT03052608|524478792|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
145442598|NCT03052608|524478793|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
145442599|NCT03052608|524478792|FG000|Long-Term Follow-up Phase|Ongoing|122|||
145442600|NCT03052608|524478793|FG001|Long-Term Follow-up Phase|Ongoing|99|||
145442635|NCT01147965|524478810|FG000|Overall Study|Progressive Disease|3|||
145442636|NCT01147965|524478811|FG001|Overall Study|Progressive Disease|3|||
145442637|NCT01147965|524478812|FG002|Overall Study|Progressive Disease|5|||
145442638|NCT01147965|524478813|FG003|Overall Study|Progressive Disease|9|||
145442639|NCT01147965|524478814|FG004|Overall Study|Progressive Disease|5|||
145442640|NCT01147965|524478815|FG005|Overall Study|Progressive Disease|5|||
145585045|NCT02265705|524995403|FG005|Treatment Period Week 0-24|Adverse Event|0|||
145585046|NCT02265705|524995404|FG006|Treatment Period Week 0-24|Adverse Event|0|||
145585047|NCT02265705|524995398|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
145442641|NCT01147965|524478810|FG000|Overall Study|Death|0|||
145442642|NCT01147965|524478811|FG001|Overall Study|Death|0|||
145442643|NCT01147965|524478812|FG002|Overall Study|Death|1|||
145442644|NCT01147965|524478813|FG003|Overall Study|Death|1|||
145442645|NCT01147965|524478814|FG004|Overall Study|Death|0|||
145585048|NCT02265705|524995399|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
145442646|NCT01147965|524478815|FG005|Overall Study|Death|2|||
145442647|NCT01147965|524478810|FG000|Overall Study|Withdrawal by Subject|0|||
145442648|NCT01147965|524478811|FG001|Overall Study|Withdrawal by Subject|0|||
145442649|NCT01147965|524478812|FG002|Overall Study|Withdrawal by Subject|1|||
145442650|NCT01147965|524478813|FG003|Overall Study|Withdrawal by Subject|1|||
145442651|NCT01147965|524478814|FG004|Overall Study|Withdrawal by Subject|0|||
145585049|NCT02265705|524995400|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
145585050|NCT02265705|524995401|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
145442652|NCT01147965|524478815|FG005|Overall Study|Withdrawal by Subject|0|||
145442653|NCT01147965|524478810|FG000|Overall Study|Administration Of Alternative Therapy|0|||
145442654|NCT01147965|524478811|FG001|Overall Study|Administration Of Alternative Therapy|0|||
145442655|NCT01147965|524478812|FG002|Overall Study|Administration Of Alternative Therapy|0|||
145442656|NCT01147965|524478813|FG003|Overall Study|Administration Of Alternative Therapy|0|||
145442657|NCT01147965|524478814|FG004|Overall Study|Administration Of Alternative Therapy|0|||
145442658|NCT01147965|524478815|FG005|Overall Study|Administration Of Alternative Therapy|1|||
145442659|NCT01147965|524478810|FG000|Overall Study|Other|0|||
145442660|NCT01147965|524478811|FG001|Overall Study|Other|0|||
145442661|NCT01147965|524478812|FG002|Overall Study|Other|0|||
145442662|NCT01147965|524478813|FG003|Overall Study|Other|3|||
145442663|NCT01147965|524478814|FG004|Overall Study|Other|1|||
145442664|NCT01147965|524478815|FG005|Overall Study|Other|0|||
145442699|NCT04667949|524478838|FG000|Overall Study|Adverse Event|0|||
145442700|NCT04667949|524478839|FG001|Overall Study|Adverse Event|2|||
145442701|NCT04667949|524478838|FG000|Overall Study|Lost to Follow-up|0|||
145442702|NCT04667949|524478839|FG001|Overall Study|Lost to Follow-up|1|||
145442703|NCT04667949|524478838|FG000|Overall Study|Physician Decision|0|||
145442704|NCT04667949|524478839|FG001|Overall Study|Physician Decision|2|||
145442705|NCT04667949|524478838|FG000|Overall Study|Subject decision|1|||
145442706|NCT04667949|524478839|FG001|Overall Study|Subject decision|7|||
145442707|NCT02213926|524478840|FG000|Overall Study|Death|59|||
145442708|NCT02213926|524478840|FG000|Overall Study|Withdrawal by Subject|10|||
145442709|NCT02213926|524478840|FG000|Overall Study|study terminated by sponsor|51|||
145442710|NCT02213926|524478840|FG000|Overall Study|Lost to Follow-up|3|||
145442711|NCT02213926|524478840|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
145585051|NCT02265705|524995402|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
145442712|NCT05887908|524478841|FG000|Overall Study|Adverse Event|6|||
145442713|NCT05887908|524478842|FG001|Overall Study|Adverse Event|1|||
145442714|NCT05887908|524478843|FG002|Overall Study|Adverse Event|1|||
145442715|NCT05887908|524478841|FG000|Overall Study|Physician Decision|4|||
145442716|NCT05887908|524478842|FG001|Overall Study|Physician Decision|1|||
145442717|NCT05887908|524478843|FG002|Overall Study|Physician Decision|0|||
145442718|NCT05887908|524478841|FG000|Overall Study|Withdrawal by Subject|3|||
145442719|NCT05887908|524478842|FG001|Overall Study|Withdrawal by Subject|2|||
145442720|NCT05887908|524478843|FG002|Overall Study|Withdrawal by Subject|3|||
145442721|NCT05887908|524478841|FG000|Overall Study|Ineligibility after the start of the study|4|||
145442722|NCT05887908|524478842|FG001|Overall Study|Ineligibility after the start of the study|1|||
145442723|NCT05887908|524478843|FG002|Overall Study|Ineligibility after the start of the study|0|||
145442724|NCT05887908|524478841|FG000|Overall Study|Subject non-compliance|4|||
145585052|NCT02265705|524995403|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
145442725|NCT05887908|524478842|FG001|Overall Study|Subject non-compliance|0|||
145442726|NCT05887908|524478843|FG002|Overall Study|Subject non-compliance|4|||
145442727|NCT05887908|524478841|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
145442728|NCT05887908|524478842|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
145442729|NCT05887908|524478843|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
145442730|NCT05887908|524478841|FG000|Overall Study|Pregnancy|0|||
145442731|NCT05887908|524478842|FG001|Overall Study|Pregnancy|1|||
145442732|NCT05887908|524478843|FG002|Overall Study|Pregnancy|0|||
145442733|NCT05887908|524478841|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
145442734|NCT05887908|524478842|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
145442735|NCT05887908|524478843|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
145442736|NCT05887908|524478841|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
145442737|NCT05887908|524478842|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
145442738|NCT05887908|524478843|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
145442739|NCT05887908|524478841|FG000|Overall Study|Other Reason|3|||
145442740|NCT05887908|524478842|FG001|Overall Study|Other Reason|3|||
145442741|NCT05887908|524478843|FG002|Overall Study|Other Reason|3|||
145625769|NCT04978363|525144090|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
145625770|NCT04978363|525144080|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625771|NCT04978363|525144081|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
145625772|NCT04978363|525144082|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625773|NCT04978363|525144083|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145442860|NCT02630693|524478859|FG000|Overall Study|No receive treatment|0|||
145442861|NCT02630693|524478860|FG001|Overall Study|No receive treatment|1|||
145442862|NCT04423939|524478862|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
145442863|NCT04423939|524478863|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
145442864|NCT04423939|524478862|FG000|Overall Study|Death|3|||
145442865|NCT04423939|524478863|FG001|Overall Study|Death|0|||
145442866|NCT04423939|524478862|FG000|Overall Study|Withdrawal by Subject|3|||
145442867|NCT04423939|524478863|FG001|Overall Study|Withdrawal by Subject|0|||
145442868|NCT04423939|524478862|FG000|Overall Study|Caregiver to patient who died|0|||
145442869|NCT04423939|524478863|FG001|Overall Study|Caregiver to patient who died|3|||
145442870|NCT04423939|524478862|FG000|Overall Study|Caregiver to patient who withdrew|0|||
145442871|NCT04423939|524478863|FG001|Overall Study|Caregiver to patient who withdrew|3|||
145442886|NCT01169337|524478868|FG000|Overall Study|Lack of Efficacy|5|||
145442887|NCT01169337|524478869|FG001|Overall Study|Lack of Efficacy|7|||
145442888|NCT01169337|524478870|FG002|Overall Study|Lack of Efficacy|0|||
145442889|NCT01169337|524478868|FG000|Overall Study|Adverse Event|12|||
145442890|NCT01169337|524478869|FG001|Overall Study|Adverse Event|18|||
145442891|NCT01169337|524478870|FG002|Overall Study|Adverse Event|0|||
145442892|NCT01169337|524478868|FG000|Overall Study|Death|2|||
145442893|NCT01169337|524478869|FG001|Overall Study|Death|0|||
145442894|NCT01169337|524478870|FG002|Overall Study|Death|0|||
145442895|NCT01169337|524478868|FG000|Overall Study|Withdrawal by Subject|11|||
145442896|NCT01169337|524478869|FG001|Overall Study|Withdrawal by Subject|11|||
145442897|NCT01169337|524478870|FG002|Overall Study|Withdrawal by Subject|6|||
145442898|NCT01169337|524478868|FG000|Overall Study|Noncompliance|2|||
145442899|NCT01169337|524478869|FG001|Overall Study|Noncompliance|0|||
145442900|NCT01169337|524478870|FG002|Overall Study|Noncompliance|0|||
145442901|NCT01169337|524478868|FG000|Overall Study|Other complicating disease|1|||
145442902|NCT01169337|524478869|FG001|Overall Study|Other complicating disease|1|||
145442903|NCT01169337|524478870|FG002|Overall Study|Other complicating disease|0|||
145442904|NCT01169337|524478868|FG000|Overall Study|Physician Decision|1|||
145442905|NCT01169337|524478869|FG001|Overall Study|Physician Decision|5|||
145442906|NCT01169337|524478870|FG002|Overall Study|Physician Decision|0|||
145442907|NCT01169337|524478868|FG000|Overall Study|Alternative therapy|0|||
145442908|NCT01169337|524478869|FG001|Overall Study|Alternative therapy|2|||
145442909|NCT01169337|524478870|FG002|Overall Study|Alternative therapy|0|||
145442910|NCT01169337|524478868|FG000|Overall Study|Changed hospital|0|||
145442911|NCT01169337|524478869|FG001|Overall Study|Changed hospital|1|||
145442912|NCT01169337|524478870|FG002|Overall Study|Changed hospital|0|||
145442913|NCT01169337|524478868|FG000|Overall Study|Never started treatment|0|||
145442914|NCT01169337|524478869|FG001|Overall Study|Never started treatment|2|||
145442915|NCT01169337|524478870|FG002|Overall Study|Never started treatment|0|||
145442916|NCT01169337|524478868|FG000|Overall Study|Reason not reported|1|||
145442917|NCT01169337|524478869|FG001|Overall Study|Reason not reported|0|||
145442918|NCT01169337|524478870|FG002|Overall Study|Reason not reported|0|||
145442919|NCT01169337|524478868|FG000|Overall Study|Continuing lenalidomide|9|||
145442920|NCT01169337|524478869|FG001|Overall Study|Continuing lenalidomide|43|||
145442921|NCT01169337|524478870|FG002|Overall Study|Continuing lenalidomide|0|||
145442922|NCT01134614|524478871|FG000|Overall Study|Still on treatment as of March 2013|21|||
145442923|NCT01134614|524478872|FG001|Overall Study|Still on treatment as of March 2013|13|||
145442924|NCT01134614|524478871|FG000|Overall Study|Progressive disease|60|||
145442925|NCT01134614|524478872|FG001|Overall Study|Progressive disease|54|||
145442926|NCT01134614|524478871|FG000|Overall Study|Adverse Event|26|||
145442927|NCT01134614|524478872|FG001|Overall Study|Adverse Event|39|||
145442928|NCT01134614|524478871|FG000|Overall Study|Death|5|||
145442929|NCT01134614|524478872|FG001|Overall Study|Death|8|||
145442930|NCT01134614|524478871|FG000|Overall Study|Withdrawal by Subject|3|||
145442931|NCT01134614|524478872|FG001|Overall Study|Withdrawal by Subject|2|||
145442932|NCT01134614|524478871|FG000|Overall Study|Alternative therapy|2|||
145442933|NCT01134614|524478872|FG001|Overall Study|Alternative therapy|0|||
145442934|NCT01134614|524478871|FG000|Overall Study|Complicating disease|2|||
145442935|NCT01134614|524478872|FG001|Overall Study|Complicating disease|1|||
145442936|NCT01134614|524478871|FG000|Overall Study|Physician's decision|0|||
145442937|NCT01134614|524478872|FG001|Overall Study|Physician's decision|1|||
145442938|NCT01134614|524478871|FG000|Overall Study|Never started treatment|4|||
145585053|NCT02265705|524995404|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
145442939|NCT01134614|524478872|FG001|Overall Study|Never started treatment|1|||
145442940|NCT01134614|524478871|FG000|Overall Study|Pt received tx not allowed on study|0|||
145442941|NCT01134614|524478872|FG001|Overall Study|Pt received tx not allowed on study|1|||
145442942|NCT01134614|524478871|FG000|Overall Study|Symptomatic deterioration|0|||
145442943|NCT01134614|524478872|FG001|Overall Study|Symptomatic deterioration|1|||
145442944|NCT01134614|524478871|FG000|Overall Study|Patient in hospice care|0|||
145442945|NCT01134614|524478872|FG001|Overall Study|Patient in hospice care|1|||
145442980|NCT05338710|524478887|FG000|Overall Study|Withdrawal by Subject|3|||
145442981|NCT04503551|524478888|FG000|Overall Study|Withdrawal by Subject|5|||
145442982|NCT04503551|524478889|FG001|Overall Study|Withdrawal by Subject|3|||
145442983|NCT04503551|524478888|FG000|Overall Study|Physician Decision|1|||
145442984|NCT04503551|524478889|FG001|Overall Study|Physician Decision|0|||
145442985|NCT04503551|524478888|FG000|Overall Study|Death|0|||
145442986|NCT04503551|524478889|FG001|Overall Study|Death|1|||
145442987|NCT04503551|524478888|FG000|Overall Study|Lost to Follow-up|1|||
145442988|NCT04503551|524478889|FG001|Overall Study|Lost to Follow-up|2|||
145442989|NCT04503551|524478888|FG000|Overall Study|Ongoing at Week 52|99|||
145442990|NCT04503551|524478889|FG001|Overall Study|Ongoing at Week 52|62|||
145585054|NCT02265705|524995398|FG000|Treatment Period Week 0-24|Physician Decision|1|||
145585055|NCT02265705|524995399|FG001|Treatment Period Week 0-24|Physician Decision|0|||
145585056|NCT02265705|524995400|FG002|Treatment Period Week 0-24|Physician Decision|0|||
145585057|NCT02265705|524995401|FG003|Treatment Period Week 0-24|Physician Decision|0|||
145585058|NCT02265705|524995402|FG004|Treatment Period Week 0-24|Physician Decision|0|||
145585059|NCT02265705|524995403|FG005|Treatment Period Week 0-24|Physician Decision|0|||
145625774|NCT04978363|525144084|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625775|NCT04978363|525144085|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625776|NCT04978363|525144086|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625777|NCT04978363|525144087|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625778|NCT04978363|525144088|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145625779|NCT04978363|525144089|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145443176|NCT05710640|524478923|FG000|Overall Study|Physician Decision|0|||
145443177|NCT05710640|524478924|FG001|Overall Study|Physician Decision|1|||
145443178|NCT05710640|524478923|FG000|Overall Study|Withdrawal by Subject|1|||
145443179|NCT05710640|524478924|FG001|Overall Study|Withdrawal by Subject|0|||
145443180|NCT05710640|524478923|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
145443181|NCT05710640|524478924|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
145585060|NCT02265705|524995404|FG006|Treatment Period Week 0-24|Physician Decision|0|||
145585061|NCT02265705|524995398|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
145585062|NCT02265705|524995399|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
145625780|NCT04978363|525144090|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
145585063|NCT02265705|524995400|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
145585064|NCT02265705|524995401|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
145585065|NCT02265705|524995402|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
145585066|NCT02265705|524995403|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
145585067|NCT02265705|524995404|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
145585068|NCT02265705|524995398|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
145625781|NCT01251614|525144091|FG000|Overall Study|Adverse Event|1|||
145625782|NCT01251614|525144092|FG001|Overall Study|Adverse Event|0|||
145625783|NCT01251614|525144093|FG002|Overall Study|Adverse Event|1|||
145625784|NCT01251614|525144091|FG000|Overall Study|Lack of Efficacy|1|||
145625785|NCT01251614|525144092|FG001|Overall Study|Lack of Efficacy|9|||
145625786|NCT01251614|525144093|FG002|Overall Study|Lack of Efficacy|4|||
145625787|NCT01251614|525144091|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
145625788|NCT01251614|525144092|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
145625789|NCT01251614|525144093|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
145625790|NCT01251614|525144091|FG000|Overall Study|Pregnancy|0|||
145625791|NCT01251614|525144092|FG001|Overall Study|Pregnancy|0|||
145625792|NCT01251614|525144093|FG002|Overall Study|Pregnancy|2|||
145625793|NCT01251614|525144091|FG000|Overall Study|Loss of Disease Control|0|||
145585069|NCT02265705|524995399|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
145585070|NCT02265705|524995400|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
145585071|NCT02265705|524995401|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
145585072|NCT02265705|524995402|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
145585073|NCT02265705|524995403|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
145585074|NCT02265705|524995404|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
145585075|NCT02265705|524995398|FG000|Rescue Period|Withdrawal by Subject|0|||
145585076|NCT02265705|524995399|FG001|Rescue Period|Withdrawal by Subject|0|||
145585077|NCT02265705|524995400|FG002|Rescue Period|Withdrawal by Subject|1|||
145585078|NCT02265705|524995401|FG003|Rescue Period|Withdrawal by Subject|0|||
145585079|NCT02265705|524995402|FG004|Rescue Period|Withdrawal by Subject|0|||
145585080|NCT02265705|524995403|FG005|Rescue Period|Withdrawal by Subject|0|||
145585081|NCT02265705|524995404|FG006|Rescue Period|Withdrawal by Subject|0|||
145585082|NCT02265705|524995398|FG000|Rescue Period|Death|0|||
145585083|NCT02265705|524995399|FG001|Rescue Period|Death|0|||
145585084|NCT02265705|524995400|FG002|Rescue Period|Death|1|||
145585085|NCT02265705|524995401|FG003|Rescue Period|Death|0|||
145585086|NCT02265705|524995402|FG004|Rescue Period|Death|0|||
145585087|NCT02265705|524995403|FG005|Rescue Period|Death|0|||
145585088|NCT02265705|524995404|FG006|Rescue Period|Death|0|||
145585089|NCT02265705|524995398|FG000|Rescue Period|Lack of Efficacy|0|||
145585090|NCT02265705|524995399|FG001|Rescue Period|Lack of Efficacy|0|||
145585091|NCT02265705|524995400|FG002|Rescue Period|Lack of Efficacy|1|||
145585092|NCT02265705|524995401|FG003|Rescue Period|Lack of Efficacy|0|||
145585093|NCT02265705|524995402|FG004|Rescue Period|Lack of Efficacy|0|||
145585094|NCT02265705|524995403|FG005|Rescue Period|Lack of Efficacy|0|||
145585095|NCT02265705|524995404|FG006|Rescue Period|Lack of Efficacy|0|||
145585096|NCT02265705|524995398|FG000|Open Label Period|Adverse Event|0|||
145585097|NCT02265705|524995399|FG001|Open Label Period|Adverse Event|0|||
145585098|NCT02265705|524995400|FG002|Open Label Period|Adverse Event|0|||
145585099|NCT02265705|524995401|FG003|Open Label Period|Adverse Event|2|||
145585100|NCT02265705|524995402|FG004|Open Label Period|Adverse Event|2|||
145585101|NCT02265705|524995403|FG005|Open Label Period|Adverse Event|0|||
145625794|NCT01251614|525144092|FG001|Overall Study|Loss of Disease Control|1|||
145625795|NCT01251614|525144093|FG002|Overall Study|Loss of Disease Control|0|||
145625796|NCT01251614|525144091|FG000|Overall Study|Withdrawal by Subject|0|||
145585102|NCT02265705|524995404|FG006|Open Label Period|Adverse Event|0|||
145625797|NCT01251614|525144092|FG001|Overall Study|Withdrawal by Subject|2|||
145585103|NCT02265705|524995398|FG000|Open Label Period|Physician Decision|0|||
145585104|NCT02265705|524995399|FG001|Open Label Period|Physician Decision|0|||
145625798|NCT01251614|525144093|FG002|Overall Study|Withdrawal by Subject|1|||
145585105|NCT02265705|524995400|FG002|Open Label Period|Physician Decision|0|||
145585106|NCT02265705|524995401|FG003|Open Label Period|Physician Decision|0|||
145585107|NCT02265705|524995402|FG004|Open Label Period|Physician Decision|1|||
145585108|NCT02265705|524995403|FG005|Open Label Period|Physician Decision|0|||
145585109|NCT02265705|524995404|FG006|Open Label Period|Physician Decision|0|||
145625799|NCT01251614|525144091|FG000|Overall Study|Lost to Follow-up|0|||
145625800|NCT01251614|525144092|FG001|Overall Study|Lost to Follow-up|1|||
145585110|NCT02265705|524995398|FG000|Open Label Period|Withdrawal by Subject|0|||
145585111|NCT02265705|524995399|FG001|Open Label Period|Withdrawal by Subject|0|||
145585112|NCT02265705|524995400|FG002|Open Label Period|Withdrawal by Subject|0|||
145585113|NCT02265705|524995401|FG003|Open Label Period|Withdrawal by Subject|0|||
145585114|NCT02265705|524995402|FG004|Open Label Period|Withdrawal by Subject|2|||
145585115|NCT02265705|524995403|FG005|Open Label Period|Withdrawal by Subject|0|||
145585116|NCT02265705|524995404|FG006|Open Label Period|Withdrawal by Subject|0|||
145585117|NCT02265705|524995398|FG000|Follow-up Period|Sponsor Decision|0|||
145585118|NCT02265705|524995399|FG001|Follow-up Period|Sponsor Decision|0|||
145585119|NCT02265705|524995400|FG002|Follow-up Period|Sponsor Decision|0|||
145585120|NCT02265705|524995401|FG003|Follow-up Period|Sponsor Decision|0|||
145585121|NCT02265705|524995402|FG004|Follow-up Period|Sponsor Decision|0|||
145585122|NCT02265705|524995403|FG005|Follow-up Period|Sponsor Decision|1|||
145585123|NCT02265705|524995404|FG006|Follow-up Period|Sponsor Decision|6|||
145585124|NCT02265705|524995398|FG000|Follow-up Period|Adverse Event|0|||
145585125|NCT02265705|524995399|FG001|Follow-up Period|Adverse Event|0|||
145585126|NCT02265705|524995400|FG002|Follow-up Period|Adverse Event|0|||
145585127|NCT02265705|524995401|FG003|Follow-up Period|Adverse Event|0|||
145585128|NCT02265705|524995402|FG004|Follow-up Period|Adverse Event|0|||
145585129|NCT02265705|524995403|FG005|Follow-up Period|Adverse Event|0|||
145585130|NCT02265705|524995404|FG006|Follow-up Period|Adverse Event|3|||
145585131|NCT02265705|524995398|FG000|Follow-up Period|Physician Decision|0|||
145585132|NCT02265705|524995399|FG001|Follow-up Period|Physician Decision|0|||
145585133|NCT02265705|524995400|FG002|Follow-up Period|Physician Decision|0|||
145585134|NCT02265705|524995401|FG003|Follow-up Period|Physician Decision|0|||
145585135|NCT02265705|524995402|FG004|Follow-up Period|Physician Decision|0|||
145585136|NCT02265705|524995403|FG005|Follow-up Period|Physician Decision|0|||
145585137|NCT02265705|524995404|FG006|Follow-up Period|Physician Decision|1|||
145585138|NCT02265705|524995398|FG000|Follow-up Period|Withdrawal by Subject|0|||
145625801|NCT01251614|525144093|FG002|Overall Study|Lost to Follow-up|0|||
145585139|NCT02265705|524995399|FG001|Follow-up Period|Withdrawal by Subject|0|||
145585140|NCT02265705|524995400|FG002|Follow-up Period|Withdrawal by Subject|0|||
145585141|NCT02265705|524995401|FG003|Follow-up Period|Withdrawal by Subject|0|||
145585142|NCT02265705|524995402|FG004|Follow-up Period|Withdrawal by Subject|0|||
145585143|NCT02265705|524995403|FG005|Follow-up Period|Withdrawal by Subject|0|||
145585144|NCT02265705|524995404|FG006|Follow-up Period|Withdrawal by Subject|1|||
145625802|NCT00049517|525144094|FG000|Induction|Disease progression|0|||
145625803|NCT00049517|525144095|FG001|Induction|Disease progression|0|||
145625804|NCT00049517|525144096|FG002|Induction|Disease progression|0|||
145625805|NCT00049517|525144097|FG003|Induction|Disease progression|0|||
145625806|NCT00049517|525144098|FG004|Induction|Disease progression|18|||
145625807|NCT00049517|525144099|FG005|Induction|Disease progression|11|||
145625808|NCT00049517|525144094|FG000|Induction|Adverse Event|0|||
145625809|NCT00049517|525144095|FG001|Induction|Adverse Event|0|||
145625810|NCT00049517|525144096|FG002|Induction|Adverse Event|0|||
145625811|NCT00049517|525144097|FG003|Induction|Adverse Event|0|||
145625812|NCT00049517|525144098|FG004|Induction|Adverse Event|5|||
145625813|NCT00049517|525144099|FG005|Induction|Adverse Event|7|||
145625814|NCT00049517|525144094|FG000|Induction|Death|0|||
145625815|NCT00049517|525144095|FG001|Induction|Death|0|||
145625816|NCT00049517|525144096|FG002|Induction|Death|0|||
145625817|NCT00049517|525144097|FG003|Induction|Death|0|||
145625818|NCT00049517|525144098|FG004|Induction|Death|9|||
145625819|NCT00049517|525144099|FG005|Induction|Death|6|||
145625820|NCT00049517|525144094|FG000|Induction|Withdrawal by Subject|0|||
145625821|NCT00049517|525144095|FG001|Induction|Withdrawal by Subject|0|||
145625822|NCT00049517|525144096|FG002|Induction|Withdrawal by Subject|0|||
145625823|NCT00049517|525144097|FG003|Induction|Withdrawal by Subject|0|||
145625824|NCT00049517|525144098|FG004|Induction|Withdrawal by Subject|1|||
145625825|NCT00049517|525144099|FG005|Induction|Withdrawal by Subject|3|||
145625826|NCT00049517|525144094|FG000|Induction|Alternative therapy|0|||
145625827|NCT00049517|525144095|FG001|Induction|Alternative therapy|0|||
145625828|NCT00049517|525144096|FG002|Induction|Alternative therapy|0|||
145625829|NCT00049517|525144097|FG003|Induction|Alternative therapy|0|||
145625830|NCT00049517|525144098|FG004|Induction|Alternative therapy|2|||
145625831|NCT00049517|525144099|FG005|Induction|Alternative therapy|2|||
145625832|NCT00049517|525144094|FG000|Induction|Other complicating disease|0|||
145625833|NCT00049517|525144095|FG001|Induction|Other complicating disease|0|||
145625834|NCT00049517|525144096|FG002|Induction|Other complicating disease|0|||
145625835|NCT00049517|525144097|FG003|Induction|Other complicating disease|0|||
145625836|NCT00049517|525144098|FG004|Induction|Other complicating disease|3|||
145625837|NCT00049517|525144099|FG005|Induction|Other complicating disease|0|||
145625838|NCT00049517|525144094|FG000|Induction|Reasons not reported|0|||
145625839|NCT00049517|525144095|FG001|Induction|Reasons not reported|0|||
145625840|NCT00049517|525144096|FG002|Induction|Reasons not reported|0|||
145625841|NCT00049517|525144097|FG003|Induction|Reasons not reported|0|||
145625842|NCT00049517|525144098|FG004|Induction|Reasons not reported|22|||
145625843|NCT00049517|525144099|FG005|Induction|Reasons not reported|25|||
145625844|NCT00049517|525144094|FG000|Conditioning/Transplant|Disease progression|14|||
145625845|NCT00049517|525144095|FG001|Conditioning/Transplant|Disease progression|6|||
145625846|NCT00049517|525144096|FG002|Conditioning/Transplant|Disease progression|10|||
145625847|NCT00049517|525144097|FG003|Conditioning/Transplant|Disease progression|6|||
145625848|NCT00049517|525144098|FG004|Conditioning/Transplant|Disease progression|0|||
145625849|NCT00049517|525144099|FG005|Conditioning/Transplant|Disease progression|0|||
145625850|NCT00049517|525144094|FG000|Conditioning/Transplant|Adverse Event|2|||
145625851|NCT00049517|525144095|FG001|Conditioning/Transplant|Adverse Event|1|||
145625852|NCT00049517|525144096|FG002|Conditioning/Transplant|Adverse Event|4|||
145625853|NCT00049517|525144097|FG003|Conditioning/Transplant|Adverse Event|8|||
145625854|NCT00049517|525144098|FG004|Conditioning/Transplant|Adverse Event|0|||
145625855|NCT00049517|525144099|FG005|Conditioning/Transplant|Adverse Event|0|||
145625856|NCT00049517|525144094|FG000|Conditioning/Transplant|Death|1|||
145625857|NCT00049517|525144095|FG001|Conditioning/Transplant|Death|0|||
145625858|NCT00049517|525144096|FG002|Conditioning/Transplant|Death|0|||
145625859|NCT00049517|525144097|FG003|Conditioning/Transplant|Death|2|||
145625860|NCT00049517|525144098|FG004|Conditioning/Transplant|Death|0|||
145625861|NCT00049517|525144099|FG005|Conditioning/Transplant|Death|0|||
145625862|NCT00049517|525144094|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
145625863|NCT00049517|525144095|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
145625864|NCT00049517|525144096|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
145625865|NCT00049517|525144097|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
145625866|NCT00049517|525144098|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
145625867|NCT00049517|525144099|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
145625868|NCT00049517|525144094|FG000|Conditioning/Transplant|Alternative therapy|4|||
145625869|NCT00049517|525144095|FG001|Conditioning/Transplant|Alternative therapy|4|||
145625870|NCT00049517|525144096|FG002|Conditioning/Transplant|Alternative therapy|2|||
145625871|NCT00049517|525144097|FG003|Conditioning/Transplant|Alternative therapy|1|||
145625872|NCT00049517|525144098|FG004|Conditioning/Transplant|Alternative therapy|1|||
145625873|NCT00049517|525144099|FG005|Conditioning/Transplant|Alternative therapy|0|||
145625874|NCT00049517|525144094|FG000|Conditioning/Transplant|Other complicating disease|2|||
145625875|NCT00049517|525144095|FG001|Conditioning/Transplant|Other complicating disease|0|||
145625876|NCT00049517|525144096|FG002|Conditioning/Transplant|Other complicating disease|0|||
145625877|NCT00049517|525144097|FG003|Conditioning/Transplant|Other complicating disease|4|||
145625878|NCT00049517|525144098|FG004|Conditioning/Transplant|Other complicating disease|0|||
145625879|NCT00049517|525144099|FG005|Conditioning/Transplant|Other complicating disease|1|||
145625880|NCT00049517|525144094|FG000|Conditioning/Transplant|Reasons not reported|25|||
145625881|NCT00049517|525144095|FG001|Conditioning/Transplant|Reasons not reported|31|||
145625882|NCT00049517|525144096|FG002|Conditioning/Transplant|Reasons not reported|18|||
145625883|NCT00049517|525144097|FG003|Conditioning/Transplant|Reasons not reported|15|||
145625884|NCT00049517|525144098|FG004|Conditioning/Transplant|Reasons not reported|5|||
145625885|NCT00049517|525144099|FG005|Conditioning/Transplant|Reasons not reported|5|||
145625886|NCT00940017|525144100|FG000|Overall Study|did not meet entrance criteria|3|||
145625887|NCT00940017|525144100|FG000|Overall Study|Adverse Event|1|||
145625888|NCT01684046|525144101|FG000|Period 1, First 30 Days|Adverse Event|0|||
145625889|NCT01684046|525144102|FG001|Period 1, First 30 Days|Adverse Event|2|||
145625890|NCT00498186|525144107|FG000|Overall Study|Protocol Violation|10|||
145625891|NCT00498186|525144107|FG000|Overall Study|Lack of Efficacy|31|||
145625892|NCT00498186|525144107|FG000|Overall Study|Adverse Event|89|||
145625893|NCT00498186|525144107|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
145625894|NCT00498186|525144107|FG000|Overall Study|Withdrawal by Subject|18|||
145625895|NCT00498186|525144107|FG000|Overall Study|Lost to Follow-up|3|||
145625896|NCT00498186|525144107|FG000|Overall Study|Other|10|||
145625897|NCT03929302|525144108|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
145625898|NCT03929302|525144109|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
145625899|NCT03929302|525144110|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
145625900|NCT03929302|525144108|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
145625901|NCT03929302|525144109|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
145625902|NCT03929302|525144110|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
145625903|NCT03929302|525144108|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
145625904|NCT03929302|525144109|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
145625905|NCT03929302|525144110|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
145625906|NCT02321540|525144111|FG000|Overall Study|Death|0|||
145625907|NCT02321540|525144112|FG001|Overall Study|Death|1|||
145625908|NCT02321540|525144111|FG000|Overall Study|Progression|3|||
145625909|NCT02321540|525144112|FG001|Overall Study|Progression|9|||
145625910|NCT00372567|525144113|FG000|Phase 3 Study|Adverse Event|5|||
145625911|NCT00372567|525144114|FG001|Phase 3 Study|Adverse Event|1|||
145625912|NCT00372567|525144115|FG002|Phase 3 Study|Adverse Event|1|||
145625913|NCT00372567|525144113|FG000|Phase 3 Study|Death|1|||
145625914|NCT00372567|525144114|FG001|Phase 3 Study|Death|1|||
145625915|NCT00372567|525144115|FG002|Phase 3 Study|Death|0|||
145625916|NCT00372567|525144113|FG000|Phase 3 Study|Protocol Violation|0|||
145625917|NCT00372567|525144114|FG001|Phase 3 Study|Protocol Violation|0|||
145625918|NCT00372567|525144115|FG002|Phase 3 Study|Protocol Violation|1|||
145625919|NCT00372567|525144113|FG000|Phase 3 Study|Objective progression or relapse|10|||
145625920|NCT00372567|525144114|FG001|Phase 3 Study|Objective progression or relapse|13|||
145625921|NCT00372567|525144115|FG002|Phase 3 Study|Objective progression or relapse|4|||
145625922|NCT00372567|525144113|FG000|Phase 3 Study|Global deterioration of health status|0|||
145625923|NCT00372567|525144114|FG001|Phase 3 Study|Global deterioration of health status|1|||
145625924|NCT00372567|525144115|FG002|Phase 3 Study|Global deterioration of health status|0|||
145625925|NCT00372567|525144113|FG000|Phase 3 Study|Other|2|||
145625926|NCT00372567|525144114|FG001|Phase 3 Study|Other|2|||
145625927|NCT00372567|525144115|FG002|Phase 3 Study|Other|1|||
145625928|NCT00372567|525144113|FG000|Phase 3 Study|study terminated by sponsor|13|||
145625929|NCT00372567|525144114|FG001|Phase 3 Study|study terminated by sponsor|8|||
145625930|NCT00372567|525144115|FG002|Phase 3 Study|study terminated by sponsor|5|||
145625931|NCT02347943|525144116|FG000|Overall Study|Study was cancelled|140|||
145625932|NCT02347943|525144117|FG001|Overall Study|Study was cancelled|67|||
145625933|NCT02347943|525144118|FG002|Overall Study|Study was cancelled|45|||
145625934|NCT00691028|525144119|FG000|Open-label Period|Adverse Event|0|||
145625935|NCT00691028|525144120|FG001|Open-label Period|Adverse Event|0|||
145625936|NCT00691028|525144121|FG002|Open-label Period|Adverse Event|0|||
145625937|NCT00691028|525144122|FG003|Open-label Period|Adverse Event|16|||
145625938|NCT00691028|525144119|FG000|Open-label Period|Withdrawal by Subject|0|||
145625939|NCT00691028|525144120|FG001|Open-label Period|Withdrawal by Subject|0|||
145625940|NCT00691028|525144121|FG002|Open-label Period|Withdrawal by Subject|0|||
145625941|NCT00691028|525144122|FG003|Open-label Period|Withdrawal by Subject|3|||
145625942|NCT00691028|525144119|FG000|Open-label Period|not come to a hospital|0|||
145625943|NCT00691028|525144120|FG001|Open-label Period|not come to a hospital|0|||
145443766|NCT04158375|524478947|FG000|Overall Study|Withdrawal by Subject|0|||
145443767|NCT04158375|524478948|FG001|Overall Study|Withdrawal by Subject|3|||
145443768|NCT04158375|524478949|FG002|Overall Study|Withdrawal by Subject|0|||
145443839|NCT04847843|524478959|FG000|Overall Study|Scheduling Conflicts|6|||
145443840|NCT04847843|524478960|FG001|Overall Study|Scheduling Conflicts|9|||
145443841|NCT04847843|524478959|FG000|Overall Study|Withdrawal by Subject|1|||
145443842|NCT04847843|524478960|FG001|Overall Study|Withdrawal by Subject|0|||
145443843|NCT04847843|524478959|FG000|Overall Study|Lost to Follow-up|1|||
145443844|NCT04847843|524478960|FG001|Overall Study|Lost to Follow-up|1|||
145443845|NCT04847843|524478959|FG000|Overall Study|Pregnancy|0|||
145443846|NCT04847843|524478960|FG001|Overall Study|Pregnancy|2|||
145443847|NCT04847843|524478959|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
145443848|NCT04847843|524478960|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
145443849|NCT02734004|524478961|FG000|Overall Study|Death|36|||
145443850|NCT02734004|524478962|FG001|Overall Study|Death|24|||
145443851|NCT02734004|524478963|FG002|Overall Study|Death|26|||
145443852|NCT02734004|524478964|FG003|Overall Study|Death|35|||
145443853|NCT02734004|524478965|FG004|Overall Study|Death|13|||
145443854|NCT02734004|524478966|FG005|Overall Study|Death|17|||
145443855|NCT02734004|524478967|FG006|Overall Study|Death|20|||
145443856|NCT02734004|524478961|FG000|Overall Study|Lost to Follow-up|1|||
145443857|NCT02734004|524478962|FG001|Overall Study|Lost to Follow-up|1|||
145443858|NCT02734004|524478963|FG002|Overall Study|Lost to Follow-up|0|||
145443859|NCT02734004|524478964|FG003|Overall Study|Lost to Follow-up|0|||
145443860|NCT02734004|524478965|FG004|Overall Study|Lost to Follow-up|1|||
145585145|NCT00346034|524995406|FG000|Overall Study|Adverse Event|34|||
145585146|NCT00346034|524995406|FG000|Overall Study|Lack of Efficacy|8|||
145443861|NCT02734004|524478966|FG005|Overall Study|Lost to Follow-up|0|||
145443862|NCT02734004|524478967|FG006|Overall Study|Lost to Follow-up|0|||
145443863|NCT02734004|524478961|FG000|Overall Study|Withdrawal by Subject|3|||
145443864|NCT02734004|524478962|FG001|Overall Study|Withdrawal by Subject|1|||
145443865|NCT02734004|524478963|FG002|Overall Study|Withdrawal by Subject|1|||
145443866|NCT02734004|524478964|FG003|Overall Study|Withdrawal by Subject|1|||
145443867|NCT02734004|524478965|FG004|Overall Study|Withdrawal by Subject|3|||
145443868|NCT02734004|524478966|FG005|Overall Study|Withdrawal by Subject|0|||
145443869|NCT02734004|524478967|FG006|Overall Study|Withdrawal by Subject|2|||
145443870|NCT02734004|524478961|FG000|Overall Study|Other|0|||
145443871|NCT02734004|524478962|FG001|Overall Study|Other|8|||
145443872|NCT02734004|524478963|FG002|Overall Study|Other|7|||
145443873|NCT02734004|524478964|FG003|Overall Study|Other|4|||
145443874|NCT02734004|524478965|FG004|Overall Study|Other|34|||
145443875|NCT02734004|524478966|FG005|Overall Study|Other|14|||
145443876|NCT02734004|524478967|FG006|Overall Study|Other|10|||
145443884|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
145443885|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
145443886|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
145443887|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
145443888|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
145443889|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
145443890|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
145443891|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
145443892|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
145443893|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
145443894|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
145443895|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
145443896|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
145443897|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
145443898|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
145443899|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
145443900|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
145443901|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
145585147|NCT00346034|524995406|FG000|Overall Study|Withdrawal by Subject|13|||
145585148|NCT00346034|524995406|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
145443902|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
145443903|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
145443904|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
145443905|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
145585149|NCT00346034|524995406|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
145585150|NCT04000165|524995407|FG000|Overall Study|Physician Decision|1|||
145443906|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
145443907|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
145585151|NCT04000165|524995407|FG000|Overall Study|Withdrawal by Subject|1|||
145585152|NCT00941603|524995411|FG000|Overall Study|Adverse Event|10|||
145443908|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Other|6|||
145443909|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Other|0|||
145443910|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Other|0|||
145443911|NCT05615220|524478970|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
145443912|NCT05615220|524478971|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
145443913|NCT05615220|524478972|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
145443914|NCT05615220|524478970|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
145443915|NCT05615220|524478971|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
145443916|NCT05615220|524478972|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
145443917|NCT05615220|524478970|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
145443918|NCT05615220|524478971|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
145443919|NCT05615220|524478972|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
145443920|NCT05615220|524478970|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
145443921|NCT05615220|524478971|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
145443922|NCT05615220|524478972|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
145443923|NCT05615220|524478970|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
145443924|NCT05615220|524478971|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
145443925|NCT05615220|524478972|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
145443926|NCT05615220|524478970|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
145443927|NCT05615220|524478971|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
145443928|NCT05615220|524478972|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
145443937|NCT01272037|524478986|FG000|Overall Study|Death|25|||
145443938|NCT01272037|524478987|FG001|Overall Study|Death|28|||
145443939|NCT01272037|524478986|FG000|Overall Study|Adverse Event|12|||
145443940|NCT01272037|524478987|FG001|Overall Study|Adverse Event|7|||
145443941|NCT01272037|524478986|FG000|Overall Study|Withdrawal by Subject|175|||
145443942|NCT01272037|524478987|FG001|Overall Study|Withdrawal by Subject|93|||
145443943|NCT01272037|524478986|FG000|Overall Study|Disease progression|70|||
145443944|NCT01272037|524478987|FG001|Overall Study|Disease progression|111|||
145443945|NCT01272037|524478986|FG000|Overall Study|Other reason|42|||
145443946|NCT01272037|524478987|FG001|Overall Study|Other reason|41|||
145443947|NCT01272037|524478986|FG000|Overall Study|Delinquent data|24|||
145443948|NCT01272037|524478987|FG001|Overall Study|Delinquent data|19|||
145443949|NCT01272037|524478986|FG000|Overall Study|Reason under review|33|||
145443950|NCT01272037|524478987|FG001|Overall Study|Reason under review|29|||
145443951|NCT01272037|524478986|FG000|Overall Study|On treatment|626|||
145443952|NCT01272037|524478987|FG001|Overall Study|On treatment|632|||
145585153|NCT00941603|524995412|FG001|Overall Study|Adverse Event|15|||
145585154|NCT00941603|524995413|FG002|Overall Study|Adverse Event|5|||
145585155|NCT00941603|524995414|FG003|Overall Study|Adverse Event|1|||
145585156|NCT00941603|524995415|FG004|Overall Study|Adverse Event|4|||
145585157|NCT00941603|524995416|FG005|Overall Study|Adverse Event|0|||
145585158|NCT00941603|524995411|FG000|Overall Study|Lost to Follow-up|0|||
145585159|NCT00941603|524995412|FG001|Overall Study|Lost to Follow-up|0|||
145585160|NCT00941603|524995413|FG002|Overall Study|Lost to Follow-up|0|||
145585161|NCT00941603|524995414|FG003|Overall Study|Lost to Follow-up|1|||
145585162|NCT00941603|524995415|FG004|Overall Study|Lost to Follow-up|0|||
145585163|NCT00941603|524995416|FG005|Overall Study|Lost to Follow-up|2|||
145585164|NCT00941603|524995411|FG000|Overall Study|Withdrawal by Subject|0|||
145625944|NCT00691028|525144121|FG002|Open-label Period|not come to a hospital|0|||
145625945|NCT00691028|525144122|FG003|Open-label Period|not come to a hospital|1|||
145625946|NCT00691028|525144119|FG000|Double-blind Period|Adverse Event|8|||
145625947|NCT00691028|525144120|FG001|Double-blind Period|Adverse Event|9|||
145625948|NCT00691028|525144121|FG002|Double-blind Period|Adverse Event|6|||
145625949|NCT00691028|525144122|FG003|Double-blind Period|Adverse Event|0|||
145625950|NCT00691028|525144119|FG000|Double-blind Period|Lack of Efficacy|4|||
145443987|NCT04585269|524480532|FG000|Intervention|Withdrawal by Subject|9|||
145443988|NCT04585269|524480533|FG001|Intervention|Withdrawal by Subject|0|||
145443989|NCT04585269|524480532|FG000|Intervention|Unable to schedule|15|||
145443990|NCT04585269|524480533|FG001|Intervention|Unable to schedule|0|||
145443991|NCT04585269|524480532|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
145443992|NCT04585269|524480533|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
145443993|NCT04585269|524480532|FG000|FU Time 2 (3 months)|Death|2|||
145443994|NCT04585269|524480533|FG001|FU Time 2 (3 months)|Death|2|||
145443995|NCT04585269|524480532|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
145443996|NCT04585269|524480533|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
145443997|NCT04585269|524480532|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
145443998|NCT04585269|524480533|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
145443999|NCT04585269|524480532|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
145444000|NCT04585269|524480533|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
145444001|NCT04585269|524480532|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
145444002|NCT04585269|524480533|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
145444003|NCT04585269|524480532|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
145444004|NCT04585269|524480533|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
145625951|NCT00691028|525144120|FG001|Double-blind Period|Lack of Efficacy|3|||
145625952|NCT00691028|525144121|FG002|Double-blind Period|Lack of Efficacy|2|||
145625953|NCT00691028|525144122|FG003|Double-blind Period|Lack of Efficacy|0|||
145625954|NCT00691028|525144119|FG000|Double-blind Period|Withdrawal by Subject|1|||
145585165|NCT00941603|524995412|FG001|Overall Study|Withdrawal by Subject|0|||
145585166|NCT00941603|524995413|FG002|Overall Study|Withdrawal by Subject|0|||
145444134|NCT04271540|524480545|FG000|Overall Study|Lost to Follow-up|1|||
145444135|NCT04271540|524480545|FG000|Overall Study|Screen Fail|5|||
145444136|NCT03307785|524480546|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
145444137|NCT03307785|524480547|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444138|NCT03307785|524480548|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444139|NCT03307785|524480549|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444140|NCT03307785|524480550|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444141|NCT03307785|524480551|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444142|NCT03307785|524480552|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444143|NCT03307785|524480553|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444144|NCT03307785|524480554|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444145|NCT03307785|524480555|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444146|NCT03307785|524480556|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444147|NCT03307785|524480557|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444148|NCT03307785|524480558|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
145444149|NCT03307785|524480546|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
145444150|NCT03307785|524480547|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
145444151|NCT03307785|524480548|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444152|NCT03307785|524480549|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444153|NCT03307785|524480550|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444154|NCT03307785|524480551|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444155|NCT03307785|524480552|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444156|NCT03307785|524480553|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444157|NCT03307785|524480554|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444158|NCT03307785|524480555|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444159|NCT03307785|524480556|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444160|NCT03307785|524480557|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444161|NCT03307785|524480558|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
145444162|NCT03307785|524480546|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
145444163|NCT03307785|524480547|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
145444164|NCT03307785|524480548|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444165|NCT03307785|524480549|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444166|NCT03307785|524480550|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444167|NCT03307785|524480551|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444168|NCT03307785|524480552|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444169|NCT03307785|524480553|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444170|NCT03307785|524480554|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444171|NCT03307785|524480555|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444172|NCT03307785|524480556|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444173|NCT03307785|524480557|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444174|NCT03307785|524480558|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
145444175|NCT03307785|524480546|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
145444176|NCT03307785|524480547|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
145444177|NCT03307785|524480548|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444178|NCT03307785|524480549|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444179|NCT03307785|524480550|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444180|NCT03307785|524480551|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444181|NCT03307785|524480552|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444182|NCT03307785|524480553|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444183|NCT03307785|524480554|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444184|NCT03307785|524480555|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444185|NCT03307785|524480556|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444186|NCT03307785|524480557|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444187|NCT03307785|524480558|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
145444188|NCT03307785|524480546|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444189|NCT03307785|524480547|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444190|NCT03307785|524480548|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
145444191|NCT03307785|524480549|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444192|NCT03307785|524480550|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444193|NCT03307785|524480551|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444194|NCT03307785|524480552|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444195|NCT03307785|524480553|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444196|NCT03307785|524480554|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444197|NCT03307785|524480555|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444198|NCT03307785|524480556|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444199|NCT03307785|524480557|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444200|NCT03307785|524480558|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
145444201|NCT03307785|524480546|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444202|NCT03307785|524480547|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444203|NCT03307785|524480548|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
145444204|NCT03307785|524480549|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444205|NCT03307785|524480550|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444206|NCT03307785|524480551|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444207|NCT03307785|524480552|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444208|NCT03307785|524480553|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444209|NCT03307785|524480554|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444210|NCT03307785|524480555|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444211|NCT03307785|524480556|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444212|NCT03307785|524480557|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444213|NCT03307785|524480558|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
145444214|NCT03307785|524480546|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444215|NCT03307785|524480547|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444216|NCT03307785|524480548|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
145444217|NCT03307785|524480549|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444218|NCT03307785|524480550|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444219|NCT03307785|524480551|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444220|NCT03307785|524480552|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444221|NCT03307785|524480553|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444222|NCT03307785|524480554|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444223|NCT03307785|524480555|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444224|NCT03307785|524480556|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444225|NCT03307785|524480557|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444226|NCT03307785|524480558|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
145444227|NCT03307785|524480546|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444228|NCT03307785|524480547|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444229|NCT03307785|524480548|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
145444230|NCT03307785|524480549|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444231|NCT03307785|524480550|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444232|NCT03307785|524480551|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444233|NCT03307785|524480552|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444234|NCT03307785|524480553|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444235|NCT03307785|524480554|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444236|NCT03307785|524480555|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444237|NCT03307785|524480556|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444238|NCT03307785|524480557|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444239|NCT03307785|524480558|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
145444240|NCT03307785|524480546|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444241|NCT03307785|524480547|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444242|NCT03307785|524480548|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
145444243|NCT03307785|524480549|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444244|NCT03307785|524480550|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444245|NCT03307785|524480551|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444246|NCT03307785|524480552|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444247|NCT03307785|524480553|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444248|NCT03307785|524480554|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444249|NCT03307785|524480555|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444250|NCT03307785|524480556|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444251|NCT03307785|524480557|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444252|NCT03307785|524480558|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
145444253|NCT03307785|524480546|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444254|NCT03307785|524480547|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444255|NCT03307785|524480548|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444256|NCT03307785|524480549|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
145444257|NCT03307785|524480550|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
145444258|NCT03307785|524480551|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444259|NCT03307785|524480552|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444260|NCT03307785|524480553|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444261|NCT03307785|524480554|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444262|NCT03307785|524480555|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444263|NCT03307785|524480556|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145585167|NCT00941603|524995414|FG003|Overall Study|Withdrawal by Subject|2|||
145585168|NCT00941603|524995415|FG004|Overall Study|Withdrawal by Subject|0|||
145585169|NCT00941603|524995416|FG005|Overall Study|Withdrawal by Subject|1|||
145585170|NCT00941603|524995411|FG000|Overall Study|Protocol Violation|0|||
145444264|NCT03307785|524480557|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444265|NCT03307785|524480558|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
145444266|NCT03307785|524480546|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444267|NCT03307785|524480547|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444268|NCT03307785|524480548|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444269|NCT03307785|524480549|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
145444270|NCT03307785|524480550|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
145444271|NCT03307785|524480551|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444272|NCT03307785|524480552|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444273|NCT03307785|524480553|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444274|NCT03307785|524480554|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444275|NCT03307785|524480555|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444276|NCT03307785|524480556|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444277|NCT03307785|524480557|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444278|NCT03307785|524480558|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
145444279|NCT03307785|524480546|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444280|NCT03307785|524480547|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444281|NCT03307785|524480548|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444282|NCT03307785|524480549|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
145444283|NCT03307785|524480550|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444284|NCT03307785|524480551|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444285|NCT03307785|524480552|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444286|NCT03307785|524480553|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444287|NCT03307785|524480554|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444288|NCT03307785|524480555|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444289|NCT03307785|524480556|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444290|NCT03307785|524480557|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444291|NCT03307785|524480558|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
145444292|NCT03307785|524480546|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444293|NCT03307785|524480547|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444294|NCT03307785|524480548|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444295|NCT03307785|524480549|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444296|NCT03307785|524480550|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
145444297|NCT03307785|524480551|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444298|NCT03307785|524480552|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444299|NCT03307785|524480553|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444300|NCT03307785|524480554|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444301|NCT03307785|524480555|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444302|NCT03307785|524480556|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444303|NCT03307785|524480557|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145444304|NCT03307785|524480558|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
145585171|NCT00941603|524995412|FG001|Overall Study|Protocol Violation|1|||
145585172|NCT00941603|524995413|FG002|Overall Study|Protocol Violation|0|||
145585173|NCT00941603|524995414|FG003|Overall Study|Protocol Violation|0|||
145585174|NCT00941603|524995415|FG004|Overall Study|Protocol Violation|0|||
145444305|NCT03307785|524480546|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444306|NCT03307785|524480547|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444307|NCT03307785|524480548|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444308|NCT03307785|524480549|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444309|NCT03307785|524480550|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444310|NCT03307785|524480551|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
145444311|NCT03307785|524480552|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444312|NCT03307785|524480553|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444313|NCT03307785|524480554|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444314|NCT03307785|524480555|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444315|NCT03307785|524480556|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444316|NCT03307785|524480557|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444317|NCT03307785|524480558|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
145444318|NCT03307785|524480546|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444319|NCT03307785|524480547|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444320|NCT03307785|524480548|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444321|NCT03307785|524480549|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444322|NCT03307785|524480550|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444323|NCT03307785|524480551|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
145444324|NCT03307785|524480552|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444325|NCT03307785|524480553|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444326|NCT03307785|524480554|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444327|NCT03307785|524480555|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444328|NCT03307785|524480556|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444329|NCT03307785|524480557|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444330|NCT03307785|524480558|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
145444331|NCT03307785|524480546|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444332|NCT03307785|524480547|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444333|NCT03307785|524480548|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444334|NCT03307785|524480549|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444335|NCT03307785|524480550|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444336|NCT03307785|524480551|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
145444337|NCT03307785|524480552|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444338|NCT03307785|524480553|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444339|NCT03307785|524480554|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444340|NCT03307785|524480555|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444341|NCT03307785|524480556|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444342|NCT03307785|524480557|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444343|NCT03307785|524480558|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
145444344|NCT03307785|524480546|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444345|NCT03307785|524480547|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444346|NCT03307785|524480548|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444347|NCT03307785|524480549|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444348|NCT03307785|524480550|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444349|NCT03307785|524480551|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
145444350|NCT03307785|524480552|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444351|NCT03307785|524480553|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444352|NCT03307785|524480554|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444353|NCT03307785|524480555|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444354|NCT03307785|524480556|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444355|NCT03307785|524480557|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444356|NCT03307785|524480558|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
145444357|NCT03307785|524480546|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444358|NCT03307785|524480547|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444359|NCT03307785|524480548|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444360|NCT03307785|524480549|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444361|NCT03307785|524480550|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444362|NCT03307785|524480551|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
145444363|NCT03307785|524480552|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444364|NCT03307785|524480553|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444365|NCT03307785|524480554|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444366|NCT03307785|524480555|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444367|NCT03307785|524480556|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444368|NCT03307785|524480557|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444369|NCT03307785|524480558|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
145444370|NCT03307785|524480546|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444371|NCT03307785|524480547|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444372|NCT03307785|524480548|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444373|NCT03307785|524480549|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444374|NCT03307785|524480550|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444375|NCT03307785|524480551|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444376|NCT03307785|524480552|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
145444377|NCT03307785|524480553|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444378|NCT03307785|524480554|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444379|NCT03307785|524480555|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444380|NCT03307785|524480556|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444381|NCT03307785|524480557|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444382|NCT03307785|524480558|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
145444383|NCT03307785|524480546|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444384|NCT03307785|524480547|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444385|NCT03307785|524480548|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444386|NCT03307785|524480549|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444387|NCT03307785|524480550|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444388|NCT03307785|524480551|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444389|NCT03307785|524480552|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
145444390|NCT03307785|524480553|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444391|NCT03307785|524480554|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444392|NCT03307785|524480555|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444393|NCT03307785|524480556|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444394|NCT03307785|524480557|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444395|NCT03307785|524480558|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
145444396|NCT03307785|524480546|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444397|NCT03307785|524480547|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444398|NCT03307785|524480548|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444399|NCT03307785|524480549|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444400|NCT03307785|524480550|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444401|NCT03307785|524480551|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444402|NCT03307785|524480552|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444403|NCT03307785|524480553|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
145444404|NCT03307785|524480554|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444405|NCT03307785|524480555|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444406|NCT03307785|524480556|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444407|NCT03307785|524480557|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444408|NCT03307785|524480558|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
145444409|NCT03307785|524480546|FG000|PACT Phase: Up to 19 Months|Death|0|||
145444410|NCT03307785|524480547|FG001|PACT Phase: Up to 19 Months|Death|0|||
145444411|NCT03307785|524480548|FG002|PACT Phase: Up to 19 Months|Death|0|||
145444412|NCT03307785|524480549|FG003|PACT Phase: Up to 19 Months|Death|0|||
145444413|NCT03307785|524480550|FG004|PACT Phase: Up to 19 Months|Death|0|||
145444414|NCT03307785|524480551|FG005|PACT Phase: Up to 19 Months|Death|0|||
145444415|NCT03307785|524480552|FG006|PACT Phase: Up to 19 Months|Death|0|||
145444416|NCT03307785|524480553|FG007|PACT Phase: Up to 19 Months|Death|0|||
145444417|NCT03307785|524480554|FG008|PACT Phase: Up to 19 Months|Death|0|||
145444418|NCT03307785|524480555|FG009|PACT Phase: Up to 19 Months|Death|0|||
145585175|NCT00941603|524995416|FG005|Overall Study|Protocol Violation|0|||
145585176|NCT00941603|524995411|FG000|Overall Study|Did not meet protocol eligibility|1|||
145585177|NCT00941603|524995412|FG001|Overall Study|Did not meet protocol eligibility|0|||
145585178|NCT00941603|524995413|FG002|Overall Study|Did not meet protocol eligibility|0|||
145585179|NCT00941603|524995414|FG003|Overall Study|Did not meet protocol eligibility|0|||
145585180|NCT00941603|524995415|FG004|Overall Study|Did not meet protocol eligibility|0|||
145585181|NCT00941603|524995416|FG005|Overall Study|Did not meet protocol eligibility|0|||
145444419|NCT03307785|524480556|FG010|PACT Phase: Up to 19 Months|Death|0|||
145444420|NCT03307785|524480557|FG011|PACT Phase: Up to 19 Months|Death|0|||
145444421|NCT03307785|524480558|FG012|PACT Phase: Up to 19 Months|Death|1|||
145625955|NCT00691028|525144120|FG001|Double-blind Period|Withdrawal by Subject|0|||
145585182|NCT01753193|524995417|FG000|Overall Study|Withdrawal by Subject|23|||
145585183|NCT01753193|524995417|FG000|Overall Study|Lost to Follow-up|6|||
145625956|NCT00691028|525144121|FG002|Double-blind Period|Withdrawal by Subject|1|||
145625957|NCT00691028|525144122|FG003|Double-blind Period|Withdrawal by Subject|0|||
145625958|NCT00691028|525144119|FG000|Double-blind Period|not come to a hospital.|0|||
145625959|NCT00691028|525144120|FG001|Double-blind Period|not come to a hospital.|1|||
145625960|NCT00691028|525144121|FG002|Double-blind Period|not come to a hospital.|0|||
145625961|NCT00691028|525144122|FG003|Double-blind Period|not come to a hospital.|0|||
145625962|NCT02680756|525144136|FG000|Overall Study|Adverse Event|10|||
145625963|NCT02680756|525144137|FG001|Overall Study|Adverse Event|2|||
145625964|NCT02680756|525144136|FG000|Overall Study|Lost to Follow-up|7|||
145625965|NCT02680756|525144137|FG001|Overall Study|Lost to Follow-up|6|||
145625966|NCT02680756|525144136|FG000|Overall Study|Withdrawal by Subject|5|||
145625967|NCT02680756|525144137|FG001|Overall Study|Withdrawal by Subject|5|||
145625968|NCT02680756|525144136|FG000|Overall Study|Physician Decision|4|||
145625969|NCT02680756|525144137|FG001|Overall Study|Physician Decision|1|||
145625970|NCT02680756|525144136|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
145625971|NCT02680756|525144137|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
145625972|NCT02680756|525144136|FG000|Overall Study|Blood transfusion for any reason|0|||
145625973|NCT02680756|525144137|FG001|Overall Study|Blood transfusion for any reason|1|||
145625974|NCT02680756|525144136|FG000|Overall Study|Death|1|||
145625975|NCT02680756|525144137|FG001|Overall Study|Death|0|||
145444507|NCT05526521|524480590|FG000|Overall Study|Withdrawal by Subject|0|||
145444508|NCT05526521|524480591|FG001|Overall Study|Withdrawal by Subject|1|||
145444509|NCT05526521|524480592|FG002|Overall Study|Withdrawal by Subject|0|||
145444510|NCT05526521|524480593|FG003|Overall Study|Withdrawal by Subject|0|||
145444527|NCT03919929|524480600|FG000|Overall Study|Withdrawal by Subject|0|||
145444528|NCT03919929|524480601|FG001|Overall Study|Withdrawal by Subject|4|||
145444529|NCT03919929|524480600|FG000|Overall Study|Screen Failure|0|||
145444530|NCT03919929|524480601|FG001|Overall Study|Screen Failure|5|||
145585184|NCT01753193|524995417|FG000|Overall Study|Death|1|||
145585185|NCT01753193|524995417|FG000|Overall Study|Other|16|||
145585186|NCT00583557|524995418|FG000|Overall Study|Withdrawal by Subject|18|||
145585187|NCT00583557|524995418|FG000|Overall Study|Adverse Event|9|||
145444600|NCT01671956|524480625|FG000|Overall Study|Disease progression|0|||
145444601|NCT01671956|524480626|FG001|Overall Study|Disease progression|1|||
145444602|NCT01671956|524480625|FG000|Overall Study|Withdrawal by Subject|1|||
145444603|NCT01671956|524480626|FG001|Overall Study|Withdrawal by Subject|1|||
145444604|NCT01671956|524480625|FG000|Overall Study|Adverse Event|1|||
145444605|NCT01671956|524480626|FG001|Overall Study|Adverse Event|0|||
145585188|NCT00583557|524995418|FG000|Overall Study|Lack of Efficacy|31|||
145444644|NCT04266912|524480665|FG000|Overall Study|Withdrawal by Subject|1|||
145444645|NCT04266912|524480666|FG001|Overall Study|Withdrawal by Subject|0|||
145444646|NCT04266912|524480667|FG002|Overall Study|Withdrawal by Subject|0|||
145444647|NCT04266912|524480668|FG003|Overall Study|Withdrawal by Subject|0|||
145444648|NCT04266912|524480665|FG000|Overall Study|Progression|6|||
145444649|NCT04266912|524480666|FG001|Overall Study|Progression|6|||
145444650|NCT04266912|524480667|FG002|Overall Study|Progression|0|||
145444651|NCT04266912|524480668|FG003|Overall Study|Progression|10|||
145585189|NCT00583557|524995418|FG000|Overall Study|Lack of Compliance|5|||
145585190|NCT00583557|524995418|FG000|Overall Study|Other|5|||
145585191|NCT00583557|524995418|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
145585192|NCT03625570|524995419|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
145585193|NCT03625570|524995420|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
145585194|NCT03625570|524995419|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
145585195|NCT03625570|524995420|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
145585196|NCT03625570|524995419|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
145585197|NCT03625570|524995420|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
145585198|NCT03264989|524995421|FG000|Overall Study|Lost to Follow-up|1|||
145585199|NCT03264989|524995422|FG001|Overall Study|Lost to Follow-up|0|||
145585200|NCT03264989|524995421|FG000|Overall Study|New Therapy for study Indication|1|||
145585201|NCT03264989|524995422|FG001|Overall Study|New Therapy for study Indication|0|||
145585202|NCT03264989|524995421|FG000|Overall Study|Protocol Violation|0|||
145585203|NCT03264989|524995422|FG001|Overall Study|Protocol Violation|1|||
145444703|NCT00980460|524481055|FG000|Overall Study|Death|0|||
145444704|NCT00980460|524481056|FG001|Overall Study|Death|0|||
145444705|NCT00980460|524481057|FG002|Overall Study|Death|1|||
145444706|NCT00980460|524481058|FG003|Overall Study|Death|2|||
145444707|NCT00980460|524481059|FG004|Overall Study|Death|1|||
145444708|NCT00980460|524481055|FG000|Overall Study|Lack of Efficacy|0|||
145444709|NCT00980460|524481056|FG001|Overall Study|Lack of Efficacy|0|||
145444710|NCT00980460|524481057|FG002|Overall Study|Lack of Efficacy|10|||
145444711|NCT00980460|524481058|FG003|Overall Study|Lack of Efficacy|6|||
145444712|NCT00980460|524481059|FG004|Overall Study|Lack of Efficacy|8|||
145444713|NCT00980460|524481055|FG000|Overall Study|Lost to Follow-up|0|||
145444714|NCT00980460|524481056|FG001|Overall Study|Lost to Follow-up|0|||
145444715|NCT00980460|524481057|FG002|Overall Study|Lost to Follow-up|0|||
145444716|NCT00980460|524481058|FG003|Overall Study|Lost to Follow-up|1|||
145444717|NCT00980460|524481059|FG004|Overall Study|Lost to Follow-up|0|||
145444718|NCT00980460|524481055|FG000|Overall Study|Physician Decision|0|||
145444719|NCT00980460|524481056|FG001|Overall Study|Physician Decision|0|||
145444720|NCT00980460|524481057|FG002|Overall Study|Physician Decision|11|||
145444721|NCT00980460|524481058|FG003|Overall Study|Physician Decision|5|||
145444722|NCT00980460|524481059|FG004|Overall Study|Physician Decision|3|||
145444723|NCT00980460|524481055|FG000|Overall Study|Withdrawal by Subject|0|||
145444724|NCT00980460|524481056|FG001|Overall Study|Withdrawal by Subject|0|||
145444725|NCT00980460|524481057|FG002|Overall Study|Withdrawal by Subject|1|||
145444726|NCT00980460|524481058|FG003|Overall Study|Withdrawal by Subject|0|||
145444727|NCT00980460|524481059|FG004|Overall Study|Withdrawal by Subject|0|||
145444728|NCT00980460|524481055|FG000|Overall Study|Ineligible|0|||
145444729|NCT00980460|524481056|FG001|Overall Study|Ineligible|2|||
145444730|NCT00980460|524481057|FG002|Overall Study|Ineligible|3|||
145444731|NCT00980460|524481058|FG003|Overall Study|Ineligible|1|||
145444732|NCT00980460|524481059|FG004|Overall Study|Ineligible|4|||
145444733|NCT00980460|524481055|FG000|Overall Study|Refusal of further therapy|0|||
145444734|NCT00980460|524481056|FG001|Overall Study|Refusal of further therapy|2|||
145444735|NCT00980460|524481057|FG002|Overall Study|Refusal of further therapy|3|||
145444736|NCT00980460|524481058|FG003|Overall Study|Refusal of further therapy|2|||
145444737|NCT00980460|524481059|FG004|Overall Study|Refusal of further therapy|0|||
145444738|NCT00980460|524481055|FG000|Overall Study|No therapy within 42 days of resection|0|||
145444739|NCT00980460|524481056|FG001|Overall Study|No therapy within 42 days of resection|0|||
145444740|NCT00980460|524481057|FG002|Overall Study|No therapy within 42 days of resection|3|||
145444741|NCT00980460|524481058|FG003|Overall Study|No therapy within 42 days of resection|1|||
145444742|NCT00980460|524481059|FG004|Overall Study|No therapy within 42 days of resection|0|||
145444743|NCT00980460|524481055|FG000|Overall Study|No transplant by protocol timepoints|0|||
145444744|NCT00980460|524481056|FG001|Overall Study|No transplant by protocol timepoints|0|||
145444745|NCT00980460|524481057|FG002|Overall Study|No transplant by protocol timepoints|3|||
145444746|NCT00980460|524481058|FG003|Overall Study|No transplant by protocol timepoints|0|||
145444747|NCT00980460|524481059|FG004|Overall Study|No transplant by protocol timepoints|0|||
145444768|NCT05696444|524481062|FG000|Treatment|Physician Decision|0|||
145444769|NCT05696444|524481063|FG001|Treatment|Physician Decision|1|||
145444770|NCT05696444|524481064|FG002|Treatment|Physician Decision|0|||
145444771|NCT05696444|524481062|FG000|30 Days|Death|1|||
145444772|NCT05696444|524481063|FG001|30 Days|Death|1|||
145444773|NCT05696444|524481064|FG002|30 Days|Death|0|||
145444774|NCT05696444|524481062|FG000|30 Days|Missed Visit|1|||
145444775|NCT05696444|524481063|FG001|30 Days|Missed Visit|1|||
145444776|NCT05696444|524481064|FG002|30 Days|Missed Visit|1|||
145444777|NCT05200572|524481065|FG000|Overall Study|Withdrawal by Subject|14|||
145489805|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
145489806|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
145489807|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
145489808|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
145489809|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
145489810|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
145489811|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
145489812|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
145489813|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
145489814|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
145489815|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
145489816|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
145489817|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
145489818|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
145489819|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
145489820|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
145489821|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
145489822|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
145489823|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
145489824|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
145489825|NCT02586623|524647613|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
145489826|NCT02586623|524647614|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
145489827|NCT02586623|524647615|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
145489828|NCT05051579|524647619|FG000|Overall Study|Withdrawal by Subject|3|||
145489829|NCT05051579|524647620|FG001|Overall Study|Withdrawal by Subject|5|||
145489830|NCT05051579|524647621|FG002|Overall Study|Withdrawal by Subject|2|||
145489831|NCT05051579|524647622|FG003|Overall Study|Withdrawal by Subject|1|||
145489832|NCT05051579|524647623|FG004|Overall Study|Withdrawal by Subject|4|||
145489833|NCT05051579|524647624|FG005|Overall Study|Withdrawal by Subject|0|||
145489834|NCT05051579|524647625|FG006|Overall Study|Withdrawal by Subject|4|||
145489835|NCT05051579|524647619|FG000|Overall Study|Lost to Follow-up|1|||
145489836|NCT05051579|524647620|FG001|Overall Study|Lost to Follow-up|0|||
145489837|NCT05051579|524647621|FG002|Overall Study|Lost to Follow-up|0|||
145489838|NCT05051579|524647622|FG003|Overall Study|Lost to Follow-up|0|||
145489839|NCT05051579|524647623|FG004|Overall Study|Lost to Follow-up|1|||
145489840|NCT05051579|524647624|FG005|Overall Study|Lost to Follow-up|0|||
145489841|NCT05051579|524647625|FG006|Overall Study|Lost to Follow-up|1|||
145489842|NCT05051579|524647619|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489843|NCT05051579|524647620|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489844|NCT05051579|524647621|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489845|NCT05051579|524647622|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489846|NCT05051579|524647623|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489847|NCT05051579|524647624|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
145489848|NCT05051579|524647625|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
145444805|NCT00316706|524482599|FG000|Overall Study|Lost to Follow-up|38|||
145444806|NCT00316706|524482600|FG001|Overall Study|Lost to Follow-up|48|||
145444807|NCT01127607|524482603|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
145444808|NCT01127607|524482604|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
145444809|NCT01127607|524482603|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
145444810|NCT01127607|524482604|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
145444811|NCT03640325|524482605|FG000|Overall Study|Withdrawal by Subject|4|||
145444812|NCT03640325|524482606|FG001|Overall Study|Withdrawal by Subject|1|||
145444813|NCT03640325|524482607|FG002|Overall Study|Withdrawal by Subject|0|||
145444814|NCT03640325|524482605|FG000|Overall Study|Lost to Follow-up|4|||
145444815|NCT03640325|524482606|FG001|Overall Study|Lost to Follow-up|5|||
145444816|NCT03640325|524482607|FG002|Overall Study|Lost to Follow-up|21|||
145444817|NCT03640325|524482605|FG000|Overall Study|Death|5|||
145444818|NCT03640325|524482606|FG001|Overall Study|Death|5|||
145444819|NCT03640325|524482607|FG002|Overall Study|Death|0|||
145444820|NCT03493451|524482608|FG000|Overall Study|Death|11|||
145444821|NCT03493451|524482609|FG001|Overall Study|Death|26|||
145444822|NCT03493451|524482610|FG002|Overall Study|Death|3|||
145444823|NCT03493451|524482608|FG000|Overall Study|Lost to Follow-up|1|||
145444824|NCT03493451|524482609|FG001|Overall Study|Lost to Follow-up|4|||
145444825|NCT03493451|524482610|FG002|Overall Study|Lost to Follow-up|1|||
145444826|NCT03493451|524482608|FG000|Overall Study|Withdrawal by Subject|1|||
145444827|NCT03493451|524482609|FG001|Overall Study|Withdrawal by Subject|1|||
145444828|NCT03493451|524482610|FG002|Overall Study|Withdrawal by Subject|2|||
145444829|NCT03493451|524482608|FG000|Overall Study|Progressive Disease|1|||
145444830|NCT03493451|524482609|FG001|Overall Study|Progressive Disease|0|||
145444831|NCT03493451|524482610|FG002|Overall Study|Progressive Disease|0|||
145444832|NCT03493451|524482608|FG000|Overall Study|Transferred to long term extension study|8|||
145444833|NCT03493451|524482609|FG001|Overall Study|Transferred to long term extension study|13|||
145444834|NCT03493451|524482610|FG002|Overall Study|Transferred to long term extension study|5|||
145444835|NCT01133756|524482614|FG000|Overall Study|Adverse Event|1|||
145444836|NCT01133756|524482615|FG001|Overall Study|Adverse Event|2|||
145444837|NCT01133756|524482616|FG002|Overall Study|Adverse Event|1|||
145444838|NCT01133756|524482614|FG000|Overall Study|Investigator Decision|1|||
145444839|NCT01133756|524482615|FG001|Overall Study|Investigator Decision|0|||
145444840|NCT01133756|524482616|FG002|Overall Study|Investigator Decision|0|||
145444841|NCT01133756|524482614|FG000|Overall Study|Withdrawal by Subject|0|||
145444842|NCT01133756|524482615|FG001|Overall Study|Withdrawal by Subject|1|||
145444843|NCT01133756|524482616|FG002|Overall Study|Withdrawal by Subject|0|||
145444844|NCT01133756|524482614|FG000|Overall Study|Progression of Disease|0|||
145444845|NCT01133756|524482615|FG001|Overall Study|Progression of Disease|0|||
145444846|NCT01133756|524482616|FG002|Overall Study|Progression of Disease|1|||
145444847|NCT01566149|524482617|FG000|Overall Study|Adverse Event|0|||
145444848|NCT01566149|524482618|FG001|Overall Study|Adverse Event|1|||
145444849|NCT01566149|524482617|FG000|Overall Study|Non-compliance with study medication|2|||
145444850|NCT01566149|524482618|FG001|Overall Study|Non-compliance with study medication|0|||
145444851|NCT01566149|524482617|FG000|Overall Study|Protocol Violation|0|||
145444852|NCT01566149|524482618|FG001|Overall Study|Protocol Violation|1|||
145444853|NCT01566149|524482617|FG000|Overall Study|Withdrawal by Subject|1|||
145444854|NCT01566149|524482618|FG001|Overall Study|Withdrawal by Subject|0|||
145444855|NCT01693250|524482624|FG000|Overall Study|Lost to Follow-up|2|||
145444856|NCT01693250|524482625|FG001|Overall Study|Lost to Follow-up|2|||
145444857|NCT02297815|524482629|FG000|Overall Study|Lost to Follow-up|236|||
145444858|NCT02297815|524482630|FG001|Overall Study|Lost to Follow-up|140|||
145444859|NCT00620373|524482635|FG000|Overall Study|Unverified cancer status|33|||
145444860|NCT01897727|524482636|FG000|Overall Study|Exclusion: central sleep apnea|0|||
145444861|NCT01897727|524482637|FG001|Overall Study|Exclusion: central sleep apnea|1|||
145585204|NCT03264989|524995421|FG000|Overall Study|Patient decision|13|||
145585205|NCT03264989|524995422|FG001|Overall Study|Patient decision|0|||
145585206|NCT03264989|524995421|FG000|Overall Study|Physician Decision|6|||
145585207|NCT03264989|524995422|FG001|Overall Study|Physician Decision|4|||
145585208|NCT03264989|524995421|FG000|Overall Study|Adverse Event|2|||
145585209|NCT03264989|524995422|FG001|Overall Study|Adverse Event|1|||
145444862|NCT01061723|524482638|FG000|Overall Study|Adverse Event|0|||
145444863|NCT01061723|524482639|FG001|Overall Study|Adverse Event|2|||
145444864|NCT01061723|524482640|FG002|Overall Study|Adverse Event|5|||
145444865|NCT01061723|524482641|FG003|Overall Study|Adverse Event|5|||
145444866|NCT01061723|524482642|FG004|Overall Study|Adverse Event|2|||
145444867|NCT01061723|524482643|FG005|Overall Study|Adverse Event|6|||
145444868|NCT01061723|524482638|FG000|Overall Study|Lack of Efficacy|2|||
145444869|NCT01061723|524482639|FG001|Overall Study|Lack of Efficacy|3|||
145444870|NCT01061723|524482640|FG002|Overall Study|Lack of Efficacy|4|||
145585210|NCT03264989|524995421|FG000|Overall Study|Death|1|||
145585211|NCT03264989|524995422|FG001|Overall Study|Death|1|||
145444871|NCT01061723|524482641|FG003|Overall Study|Lack of Efficacy|2|||
145444872|NCT01061723|524482642|FG004|Overall Study|Lack of Efficacy|1|||
145444873|NCT01061723|524482643|FG005|Overall Study|Lack of Efficacy|1|||
145444874|NCT01061723|524482638|FG000|Overall Study|Randomized but not treated|0|||
145585212|NCT03264989|524995421|FG000|Overall Study|Pregnancy|2|||
145585213|NCT03264989|524995422|FG001|Overall Study|Pregnancy|0|||
145585214|NCT03264989|524995421|FG000|Overall Study|End of Study|19|||
145585215|NCT03264989|524995422|FG001|Overall Study|End of Study|5|||
145585216|NCT01343056|524995425|FG000|Overall Study|Lost to Follow-up|7|||
145585217|NCT01343056|524995426|FG001|Overall Study|Lost to Follow-up|5|||
145585218|NCT01343056|524995427|FG002|Overall Study|Lost to Follow-up|3|||
145585219|NCT01343056|524995428|FG003|Overall Study|Lost to Follow-up|9|||
145585220|NCT00345579|524995429|FG000|Overall Study|Adverse Event|9|||
145585221|NCT00345579|524995430|FG001|Overall Study|Adverse Event|6|||
145585222|NCT00345579|524995429|FG000|Overall Study|Protocol Violation|14|||
145585223|NCT00345579|524995430|FG001|Overall Study|Protocol Violation|5|||
145585224|NCT00345579|524995429|FG000|Overall Study|Withdrawal by Subject|50|||
145585225|NCT00345579|524995430|FG001|Overall Study|Withdrawal by Subject|17|||
145585226|NCT00345579|524995429|FG000|Overall Study|Lost to Follow-up|82|||
145585227|NCT00345579|524995430|FG001|Overall Study|Lost to Follow-up|36|||
145585228|NCT00345579|524995429|FG000|Overall Study|Other|9|||
145585229|NCT00345579|524995430|FG001|Overall Study|Other|1|||
145585230|NCT03029208|524995431|FG000|Overall Study|Withdrawal by Subject|2|||
145585231|NCT03029208|524995432|FG001|Overall Study|Withdrawal by Subject|3|||
145585232|NCT03029208|524995431|FG000|Overall Study|Lost to Follow-up|0|||
145585233|NCT03029208|524995432|FG001|Overall Study|Lost to Follow-up|1|||
145585234|NCT01732835|524995435|FG000|6-month Primary Endpoint|Did not receive device|19|||
145585235|NCT01732835|524995435|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
145585236|NCT01732835|524995435|FG000|6-month Primary Endpoint|Adverse Event|3|||
145625976|NCT02680756|525144136|FG000|Overall Study|Protocol Violation|1|||
145625977|NCT02680756|525144137|FG001|Overall Study|Protocol Violation|0|||
145444875|NCT01061723|524482639|FG001|Overall Study|Randomized but not treated|0|||
145444876|NCT01061723|524482640|FG002|Overall Study|Randomized but not treated|0|||
145444877|NCT01061723|524482641|FG003|Overall Study|Randomized but not treated|0|||
145444878|NCT01061723|524482642|FG004|Overall Study|Randomized but not treated|0|||
145444879|NCT01061723|524482643|FG005|Overall Study|Randomized but not treated|1|||
145444880|NCT01061723|524482638|FG000|Overall Study|Other than specified above|2|||
145444881|NCT01061723|524482639|FG001|Overall Study|Other than specified above|1|||
145444882|NCT01061723|524482640|FG002|Overall Study|Other than specified above|1|||
145444883|NCT01061723|524482641|FG003|Overall Study|Other than specified above|1|||
145444884|NCT01061723|524482642|FG004|Overall Study|Other than specified above|0|||
145444885|NCT01061723|524482643|FG005|Overall Study|Other than specified above|1|||
145444886|NCT00293813|524482644|FG000|Overall Study|Physician Decision|0|||
145444887|NCT00293813|524482645|FG001|Overall Study|Physician Decision|1|||
145444888|NCT00293813|524482646|FG002|Overall Study|Physician Decision|0|||
145444889|NCT00293813|524482644|FG000|Overall Study|Adverse Event|3|||
145444890|NCT00293813|524482645|FG001|Overall Study|Adverse Event|1|||
145444891|NCT00293813|524482646|FG002|Overall Study|Adverse Event|1|||
145444892|NCT00293813|524482644|FG000|Overall Study|Withdrawal by Subject|7|||
145444893|NCT00293813|524482645|FG001|Overall Study|Withdrawal by Subject|4|||
145444894|NCT00293813|524482646|FG002|Overall Study|Withdrawal by Subject|4|||
145444895|NCT00293813|524482644|FG000|Overall Study|Lost to Follow-up|3|||
145444896|NCT00293813|524482645|FG001|Overall Study|Lost to Follow-up|2|||
145444897|NCT00293813|524482646|FG002|Overall Study|Lost to Follow-up|3|||
145444898|NCT00293813|524482644|FG000|Overall Study|Noncompliance|0|||
145444899|NCT00293813|524482645|FG001|Overall Study|Noncompliance|1|||
145444900|NCT00293813|524482646|FG002|Overall Study|Noncompliance|0|||
145444901|NCT00460655|524482651|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
145444902|NCT00460655|524482652|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145444903|NCT00460655|524482653|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145444904|NCT00460655|524482654|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145444905|NCT00460655|524482651|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
145444906|NCT00460655|524482652|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145444907|NCT00460655|524482653|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145444908|NCT00460655|524482654|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145444909|NCT00460655|524482651|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
145585237|NCT01732835|524995435|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
145625978|NCT02680756|525144136|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
145444910|NCT00460655|524482652|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
145444911|NCT00460655|524482653|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
145444912|NCT00460655|524482654|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
145444913|NCT00460655|524482651|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145585238|NCT01732835|524995435|FG000|2-year Extended Follow-up|Adverse Event|3|||
145444914|NCT00460655|524482652|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145444915|NCT00460655|524482653|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
145444916|NCT00460655|524482654|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
145444917|NCT00460655|524482651|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145585239|NCT01732835|524995435|FG000|2-year Extended Follow-up|Death|1|||
145585240|NCT03207750|524995436|FG000|Overall Study|Adverse Event|3|||
145585241|NCT03207750|524995437|FG001|Overall Study|Adverse Event|2|||
145444918|NCT00460655|524482652|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145444919|NCT00460655|524482653|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
145444920|NCT00460655|524482654|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
145444921|NCT00460655|524482651|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
145444922|NCT00460655|524482652|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
145444923|NCT00460655|524482653|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
145444924|NCT00460655|524482654|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
145444925|NCT03650413|524482655|FG000|Overall Study|Adverse Event|1|||
145444926|NCT03650413|524482655|FG000|Overall Study|Lack of Efficacy|17|||
145444927|NCT03650413|524482655|FG000|Overall Study|Other|9|||
145444928|NCT03650413|524482655|FG000|Overall Study|Physician Decision|2|||
145444929|NCT03650413|524482655|FG000|Overall Study|Study Terminated By Sponsor|16|||
145444930|NCT03650413|524482655|FG000|Overall Study|Withdrawal by Subject|16|||
145444931|NCT00310375|524482656|FG000|Primary Reporting Phase|Adverse Event|28|||
145444932|NCT00310375|524482657|FG001|Primary Reporting Phase|Adverse Event|22|||
145444933|NCT00310375|524482658|FG002|Primary Reporting Phase|Adverse Event|0|||
145444934|NCT00310375|524482656|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
145444935|NCT00310375|524482657|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
145444936|NCT00310375|524482658|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
145444937|NCT00310375|524482656|FG000|Primary Reporting Phase|Pregnancy|2|||
145444938|NCT00310375|524482657|FG001|Primary Reporting Phase|Pregnancy|2|||
145444939|NCT00310375|524482658|FG002|Primary Reporting Phase|Pregnancy|0|||
145444940|NCT00310375|524482656|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
145444941|NCT00310375|524482657|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
145444942|NCT00310375|524482658|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
145444943|NCT00310375|524482656|FG000|Primary Reporting Phase|Protocol Violation|8|||
145444944|NCT00310375|524482657|FG001|Primary Reporting Phase|Protocol Violation|5|||
145444945|NCT00310375|524482658|FG002|Primary Reporting Phase|Protocol Violation|0|||
145444946|NCT00310375|524482656|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
145444947|NCT00310375|524482657|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
145444948|NCT00310375|524482658|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
145444949|NCT00310375|524482656|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
145444950|NCT00310375|524482657|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
145444951|NCT00310375|524482658|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
145444952|NCT00310375|524482656|FG000|Primary Reporting Phase|Physician Decision|5|||
145444953|NCT00310375|524482657|FG001|Primary Reporting Phase|Physician Decision|3|||
145444954|NCT00310375|524482658|FG002|Primary Reporting Phase|Physician Decision|0|||
145444955|NCT00310375|524482656|FG000|Primary Reporting Phase|Request of the sponsor|2|||
145444956|NCT00310375|524482657|FG001|Primary Reporting Phase|Request of the sponsor|2|||
145444957|NCT00310375|524482658|FG002|Primary Reporting Phase|Request of the sponsor|0|||
145444958|NCT00310375|524482656|FG000|Primary Reporting Phase|Failed to return|1|||
145444959|NCT00310375|524482657|FG001|Primary Reporting Phase|Failed to return|3|||
145444960|NCT00310375|524482658|FG002|Primary Reporting Phase|Failed to return|0|||
145444961|NCT00310375|524482656|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
145444962|NCT00310375|524482657|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
145444963|NCT00310375|524482658|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
145444964|NCT00310375|524482656|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
145444965|NCT00310375|524482657|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
145444966|NCT00310375|524482658|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
145444967|NCT00310375|524482656|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
145444968|NCT00310375|524482657|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
145444969|NCT00310375|524482658|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
145444970|NCT00310375|524482656|FG000|Primary Reporting Phase|Site closure|3|||
145444971|NCT00310375|524482657|FG001|Primary Reporting Phase|Site closure|0|||
145444972|NCT00310375|524482658|FG002|Primary Reporting Phase|Site closure|0|||
145444973|NCT00310375|524482656|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
145444974|NCT00310375|524482657|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
145444975|NCT00310375|524482658|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
145444976|NCT00310375|524482656|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
145444977|NCT00310375|524482657|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
145444978|NCT00310375|524482658|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
145444979|NCT00310375|524482656|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
145625979|NCT02680756|525144137|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
145444980|NCT00310375|524482657|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
145444981|NCT00310375|524482658|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
145625980|NCT02680756|525144136|FG000|Overall Study|None of above or not recorded|3|||
145444982|NCT00310375|524482656|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
145444983|NCT00310375|524482657|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
145444984|NCT00310375|524482658|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
145444985|NCT00910910|524482659|FG000|Overall Study|Adverse Event|63|||
145444986|NCT00910910|524482660|FG001|Overall Study|Adverse Event|35|||
145444987|NCT00910910|524482659|FG000|Overall Study|PD without histologic change|27|||
145444988|NCT00910910|524482660|FG001|Overall Study|PD without histologic change|23|||
145444989|NCT00910910|524482659|FG000|Overall Study|PD with histologic change|0|||
145444990|NCT00910910|524482660|FG001|Overall Study|PD with histologic change|2|||
145444991|NCT00910910|524482659|FG000|Overall Study|Withdrawal by Subject|7|||
145444992|NCT00910910|524482660|FG001|Overall Study|Withdrawal by Subject|5|||
145444993|NCT00910910|524482659|FG000|Overall Study|Lost to Follow-up|2|||
145444994|NCT00910910|524482660|FG001|Overall Study|Lost to Follow-up|2|||
145444995|NCT00910910|524482659|FG000|Overall Study|Death|9|||
145444996|NCT00910910|524482660|FG001|Overall Study|Death|3|||
145444997|NCT00910910|524482659|FG000|Overall Study|Protocol Violation|2|||
145444998|NCT00910910|524482660|FG001|Overall Study|Protocol Violation|2|||
145444999|NCT00910910|524482659|FG000|Overall Study|Completed 13 cycles of treatment|0|||
145445000|NCT00910910|524482660|FG001|Overall Study|Completed 13 cycles of treatment|118|||
145445001|NCT00910910|524482659|FG000|Overall Study|Other|114|||
145445002|NCT00910910|524482660|FG001|Overall Study|Other|32|||
145445003|NCT00910910|524482659|FG000|Overall Study|Untreated before cycle 1|1|||
145445004|NCT00910910|524482660|FG001|Overall Study|Untreated before cycle 1|2|||
145445005|NCT01973231|524482661|FG000|Overall Study|Protocol Violation|1|||
145445006|NCT01973231|524482662|FG001|Overall Study|Protocol Violation|1|||
145445007|NCT01973231|524482661|FG000|Overall Study|Lost to Follow-up|1|||
145445008|NCT01973231|524482662|FG001|Overall Study|Lost to Follow-up|1|||
145585242|NCT03207750|524995436|FG000|Overall Study|Lost to Follow-up|21|||
145585243|NCT03207750|524995437|FG001|Overall Study|Lost to Follow-up|29|||
145445009|NCT01973231|524482661|FG000|Overall Study|unclassified|2|||
145445010|NCT01973231|524482662|FG001|Overall Study|unclassified|1|||
145445011|NCT01973231|524482661|FG000|Overall Study|Withdrawal by Subject|7|||
145445012|NCT01973231|524482662|FG001|Overall Study|Withdrawal by Subject|9|||
145445013|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
145445014|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
145445015|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445016|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445017|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445018|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445019|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445020|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445021|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445022|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
145445023|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
145445024|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
145445025|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445026|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445027|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445028|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445029|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445030|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445031|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445032|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
145445033|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
145585244|NCT03207750|524995436|FG000|Overall Study|Protocol Violation|0|||
145585245|NCT03207750|524995437|FG001|Overall Study|Protocol Violation|1|||
145445034|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145585246|NCT03207750|524995436|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
145585247|NCT03207750|524995437|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
145585248|NCT03207750|524995436|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
145585249|NCT03207750|524995437|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
145585250|NCT03207750|524995436|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
145585251|NCT03207750|524995437|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
145585252|NCT03207750|524995436|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
145585253|NCT03207750|524995437|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
145585254|NCT03207750|524995436|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
145445035|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445036|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445037|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445038|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145585255|NCT03207750|524995437|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
145585256|NCT02493361|524995438|FG000|Overall Study|Withdrawal by Subject|3|||
145445039|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445040|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445041|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445042|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
145445043|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
145445044|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
145445045|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445046|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445047|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445048|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445049|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445050|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445051|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445052|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
145445053|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445054|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
145445055|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445056|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445057|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445058|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445059|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445060|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445061|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445062|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
145445063|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
145445064|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
145445065|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445066|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445067|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445068|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445069|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445070|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445071|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445072|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
145445073|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
145445074|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
145445075|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445076|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445077|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445078|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445079|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445080|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445081|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445082|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
145445083|NCT01194219|524482664|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
145445084|NCT01194219|524482665|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
145445085|NCT01194219|524482666|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445086|NCT01194219|524482667|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445087|NCT01194219|524482668|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445088|NCT01194219|524482669|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445089|NCT01194219|524482670|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445090|NCT01194219|524482671|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445091|NCT01194219|524482672|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445092|NCT01194219|524482673|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
145445093|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445094|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445095|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
145445096|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
145445097|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445098|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445099|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445100|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445101|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445102|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
145445103|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445104|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445105|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
145445106|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
145445107|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445108|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445109|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445110|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445111|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445112|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
145445113|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445114|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445115|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
145445116|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
145445117|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445118|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445119|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445120|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445121|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445122|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
145445123|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445124|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445125|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
145445126|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
145445127|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445128|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445129|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445130|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445131|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445132|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
145445133|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445134|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445135|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
145445136|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445137|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445138|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445139|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445140|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445141|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445142|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
145445143|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445144|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445145|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445146|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
145445147|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445148|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445149|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445150|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445151|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445152|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
145445153|NCT01194219|524482664|FG000|Maintenance Phase Weeks16-32|Other|0|||
145445154|NCT01194219|524482665|FG001|Maintenance Phase Weeks16-32|Other|0|||
145445155|NCT01194219|524482666|FG002|Maintenance Phase Weeks16-32|Other|2|||
145445156|NCT01194219|524482667|FG003|Maintenance Phase Weeks16-32|Other|1|||
145445157|NCT01194219|524482668|FG004|Maintenance Phase Weeks16-32|Other|0|||
145445158|NCT01194219|524482669|FG005|Maintenance Phase Weeks16-32|Other|0|||
145445159|NCT01194219|524482670|FG006|Maintenance Phase Weeks16-32|Other|0|||
145445160|NCT01194219|524482671|FG007|Maintenance Phase Weeks16-32|Other|0|||
145445161|NCT01194219|524482672|FG008|Maintenance Phase Weeks16-32|Other|0|||
145445162|NCT01194219|524482673|FG009|Maintenance Phase Weeks16-32|Other|0|||
145445163|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445164|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445165|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445166|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445167|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445168|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
145445169|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
145445170|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
145445171|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445172|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
145445173|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445174|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445175|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445176|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445177|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
145445178|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
145445179|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
145445180|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
145445181|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445182|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
145445183|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445184|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445185|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445186|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445187|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
145445188|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445189|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
145445190|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445191|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445192|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
145445193|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445194|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445195|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445196|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445197|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
145445198|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445199|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
145445200|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
145445201|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445202|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
145445203|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445204|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445205|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445206|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445207|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
145445208|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
145445209|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
145445210|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445211|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445212|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
145445213|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445214|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445215|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445216|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445217|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445218|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445219|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445220|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
145445221|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445222|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
145445223|NCT01194219|524482664|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445224|NCT01194219|524482665|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445225|NCT01194219|524482666|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445226|NCT01194219|524482667|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445227|NCT01194219|524482668|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445228|NCT01194219|524482669|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445229|NCT01194219|524482670|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
145445230|NCT01194219|524482671|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445231|NCT01194219|524482672|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445232|NCT01194219|524482673|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
145445233|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445234|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445235|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445236|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445237|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445238|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445239|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445240|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
145445241|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
145445242|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
145445243|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445244|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445245|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445246|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445247|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445248|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445249|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445250|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
145445251|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
145445252|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
145445253|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445254|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445255|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445256|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445257|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445258|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445259|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445260|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
145445261|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
145445262|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
145445263|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445264|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445265|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445266|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445267|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445268|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445269|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445270|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
145445271|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
145445272|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
145445273|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
145445274|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
145445275|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
145445276|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
145445277|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
145445278|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
145445279|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
145445280|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
145445281|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
145445282|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
145445283|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445284|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445285|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445286|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445287|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445288|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445289|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445290|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
145445291|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
145445292|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
145445293|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445294|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445295|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445296|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445297|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445298|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445299|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445300|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445301|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
145445302|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
145445303|NCT01194219|524482664|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445304|NCT01194219|524482665|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445305|NCT01194219|524482666|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445306|NCT01194219|524482667|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445307|NCT01194219|524482668|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445308|NCT01194219|524482669|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445309|NCT01194219|524482670|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445310|NCT01194219|524482671|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
145445311|NCT01194219|524482672|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
145445312|NCT01194219|524482673|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
145445313|NCT01081951|524482674|FG000|Overall Study|Death|54|||
145445314|NCT01081951|524482675|FG001|Overall Study|Death|47|||
145445315|NCT01081951|524482674|FG000|Overall Study|Withdrawal by Subject|2|||
145445316|NCT01081951|524482675|FG001|Overall Study|Withdrawal by Subject|6|||
145445317|NCT01081951|524482674|FG000|Overall Study|Allocated treatment but did not take it|0|||
145445318|NCT01081951|524482675|FG001|Overall Study|Allocated treatment but did not take it|1|||
145445319|NCT01081951|524482674|FG000|Overall Study|Lost to Follow-up|0|||
145445320|NCT01081951|524482675|FG001|Overall Study|Lost to Follow-up|1|||
145445321|NCT03726658|524482679|FG000|Overall Study|Lost to Follow-up|0|||
145445322|NCT03726658|524482680|FG001|Overall Study|Lost to Follow-up|0|||
145445323|NCT03726658|524482681|FG002|Overall Study|Lost to Follow-up|2|||
145445324|NCT03726658|524482682|FG003|Overall Study|Lost to Follow-up|0|||
145445325|NCT03726658|524482683|FG004|Overall Study|Lost to Follow-up|0|||
145445326|NCT03726658|524482684|FG005|Overall Study|Lost to Follow-up|1|||
145445327|NCT03726658|524482685|FG006|Overall Study|Lost to Follow-up|1|||
145445328|NCT03726658|524482679|FG000|Overall Study|Withdrawal by Subject|1|||
145445329|NCT03726658|524482680|FG001|Overall Study|Withdrawal by Subject|0|||
145445330|NCT03726658|524482681|FG002|Overall Study|Withdrawal by Subject|0|||
145445331|NCT03726658|524482682|FG003|Overall Study|Withdrawal by Subject|0|||
145445332|NCT03726658|524482683|FG004|Overall Study|Withdrawal by Subject|6|||
145445333|NCT03726658|524482684|FG005|Overall Study|Withdrawal by Subject|4|||
145445334|NCT03726658|524482685|FG006|Overall Study|Withdrawal by Subject|2|||
145445335|NCT03726658|524482679|FG000|Overall Study|Pregnancy|0|||
145445336|NCT03726658|524482680|FG001|Overall Study|Pregnancy|0|||
145445337|NCT03726658|524482681|FG002|Overall Study|Pregnancy|0|||
145445338|NCT03726658|524482682|FG003|Overall Study|Pregnancy|0|||
145445339|NCT03726658|524482683|FG004|Overall Study|Pregnancy|0|||
145445340|NCT03726658|524482684|FG005|Overall Study|Pregnancy|0|||
145445341|NCT03726658|524482685|FG006|Overall Study|Pregnancy|1|||
145445342|NCT03726658|524482679|FG000|Overall Study|Not Reported|0|||
145445343|NCT03726658|524482680|FG001|Overall Study|Not Reported|0|||
145445344|NCT03726658|524482681|FG002|Overall Study|Not Reported|0|||
145445345|NCT03726658|524482682|FG003|Overall Study|Not Reported|0|||
145445346|NCT03726658|524482683|FG004|Overall Study|Not Reported|0|||
145445347|NCT03726658|524482684|FG005|Overall Study|Not Reported|0|||
145445348|NCT03726658|524482685|FG006|Overall Study|Not Reported|1|||
145445349|NCT00412958|524482686|FG000|Overall Study|Withdrawal by Subject|3|||
145445350|NCT00412958|524482687|FG001|Overall Study|Withdrawal by Subject|0|||
145445351|NCT00412958|524482688|FG002|Overall Study|Withdrawal by Subject|0|||
145445352|NCT00412958|524482689|FG003|Overall Study|Withdrawal by Subject|1|||
145445353|NCT00412958|524482686|FG000|Overall Study|Adverse Event|0|||
145445354|NCT00412958|524482687|FG001|Overall Study|Adverse Event|1|||
145445355|NCT00412958|524482688|FG002|Overall Study|Adverse Event|0|||
145445356|NCT00412958|524482689|FG003|Overall Study|Adverse Event|0|||
145445357|NCT00412958|524482686|FG000|Overall Study|Lost to Follow-up|0|||
145445358|NCT00412958|524482687|FG001|Overall Study|Lost to Follow-up|1|||
145445359|NCT00412958|524482688|FG002|Overall Study|Lost to Follow-up|0|||
145445360|NCT00412958|524482689|FG003|Overall Study|Lost to Follow-up|0|||
145445361|NCT00412958|524482686|FG000|Overall Study|Death|0|||
145445362|NCT00412958|524482687|FG001|Overall Study|Death|1|||
145445363|NCT00412958|524482688|FG002|Overall Study|Death|0|||
145445364|NCT00412958|524482689|FG003|Overall Study|Death|0|||
145445365|NCT00412958|524482686|FG000|Overall Study|Transport issue|0|||
145445366|NCT00412958|524482687|FG001|Overall Study|Transport issue|1|||
145445367|NCT00412958|524482688|FG002|Overall Study|Transport issue|0|||
145445368|NCT00412958|524482689|FG003|Overall Study|Transport issue|0|||
145445369|NCT01318135|524482690|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
145445370|NCT01318135|524482691|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445371|NCT01318135|524482692|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445372|NCT01318135|524482693|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445373|NCT01318135|524482694|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445374|NCT01318135|524482695|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445375|NCT01318135|524482696|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445376|NCT01318135|524482697|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145445377|NCT01318135|524482690|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
145445378|NCT01318135|524482691|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445379|NCT01318135|524482692|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445380|NCT01318135|524482693|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445381|NCT01318135|524482694|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445382|NCT01318135|524482695|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445383|NCT01318135|524482696|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445384|NCT01318135|524482697|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
145445385|NCT01318135|524482690|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
145445386|NCT01318135|524482691|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
145445387|NCT01318135|524482692|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
145445388|NCT01318135|524482693|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
145445389|NCT01318135|524482694|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
145445390|NCT01318135|524482695|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
145445391|NCT01318135|524482696|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
145445392|NCT01318135|524482697|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
145445393|NCT01318135|524482690|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
145445394|NCT01318135|524482691|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
145445395|NCT01318135|524482692|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
145445396|NCT01318135|524482693|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
145445397|NCT01318135|524482694|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
145445398|NCT01318135|524482695|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
145445399|NCT01318135|524482696|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
145445400|NCT01318135|524482697|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
145445401|NCT01318135|524482690|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145445402|NCT01318135|524482691|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145445403|NCT01318135|524482692|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145445404|NCT01318135|524482693|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145445405|NCT01318135|524482694|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145445406|NCT01318135|524482695|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145445407|NCT01318135|524482696|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145445408|NCT01318135|524482697|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145445409|NCT01318135|524482690|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
145445410|NCT01318135|524482691|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
145445411|NCT01318135|524482692|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
145445412|NCT01318135|524482693|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
145445413|NCT01318135|524482694|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
145445414|NCT01318135|524482695|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
145445415|NCT01318135|524482696|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145445416|NCT01318135|524482697|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145445417|NCT01318135|524482690|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445418|NCT01318135|524482691|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445419|NCT01318135|524482692|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445420|NCT01318135|524482693|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445421|NCT01318135|524482694|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445422|NCT01318135|524482695|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445423|NCT01318135|524482696|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
145445424|NCT01318135|524482697|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
145445425|NCT01071954|524482699|FG000|Overall Study|Noncompliance|4|||
145445426|NCT01071954|524482699|FG000|Overall Study|Adverse Event|1|||
145445427|NCT01071954|524482699|FG000|Overall Study|Withdrawal by Subject|11|||
145445428|NCT01071954|524482699|FG000|Overall Study|Requirement for Alternative Therapy|5|||
145445429|NCT01071954|524482699|FG000|Overall Study|Administrative Decision|5|||
145445430|NCT01071954|524482699|FG000|Overall Study|Protocol Specified Criteria|1|||
145445431|NCT03782064|524482703|FG000|Overall Study|Lack of Efficacy|2|||
145445432|NCT03782064|524482703|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
145445433|NCT00363142|524482704|FG000|Overall Study|Adverse Event|2|||
145445434|NCT00363142|524482705|FG001|Overall Study|Adverse Event|0|||
145445435|NCT00363142|524482704|FG000|Overall Study|Lack of Efficacy|0|||
145445436|NCT00363142|524482705|FG001|Overall Study|Lack of Efficacy|1|||
145445437|NCT00363142|524482704|FG000|Overall Study|Lost to Follow-up|1|||
145445438|NCT00363142|524482705|FG001|Overall Study|Lost to Follow-up|0|||
145445439|NCT00363142|524482704|FG000|Overall Study|Non-compliance|1|||
145445440|NCT00363142|524482705|FG001|Overall Study|Non-compliance|1|||
145445441|NCT00363142|524482704|FG000|Overall Study|Withdrawal by Subject|3|||
145445442|NCT00363142|524482705|FG001|Overall Study|Withdrawal by Subject|1|||
145445443|NCT00049322|524482709|FG000|Overall Study|disease burden|0|||
145445444|NCT00049322|524482710|FG001|Overall Study|disease burden|3|||
145445445|NCT00049322|524482709|FG000|Overall Study|Adverse Event|1|||
145445446|NCT00049322|524482710|FG001|Overall Study|Adverse Event|0|||
145445447|NCT00049322|524482709|FG000|Overall Study|refused angio|0|||
145445448|NCT00049322|524482710|FG001|Overall Study|refused angio|3|||
145445449|NCT03994211|524482711|FG000|Core Phase|Adverse Event|0|||
145445450|NCT03994211|524482712|FG001|Core Phase|Adverse Event|1|||
145445451|NCT03994211|524482713|FG002|Core Phase|Adverse Event|0|||
145445452|NCT03994211|524482711|FG000|Extension Phase|Adverse Event|0|||
145445453|NCT03994211|524482712|FG001|Extension Phase|Adverse Event|0|||
145445454|NCT03994211|524482713|FG002|Extension Phase|Adverse Event|1|||
145445455|NCT03994211|524482711|FG000|Extension Phase|Physician Decision|0|||
145445456|NCT03994211|524482712|FG001|Extension Phase|Physician Decision|0|||
145445457|NCT03994211|524482713|FG002|Extension Phase|Physician Decision|1|||
145445458|NCT03994211|524482711|FG000|Extension Phase|Progressive Disease|0|||
145445459|NCT03994211|524482712|FG001|Extension Phase|Progressive Disease|0|||
145445460|NCT03994211|524482713|FG002|Extension Phase|Progressive Disease|20|||
145445461|NCT03994211|524482711|FG000|Extension Phase|Withdrawal by Subject|0|||
145445462|NCT03994211|524482712|FG001|Extension Phase|Withdrawal by Subject|0|||
145445463|NCT03994211|524482713|FG002|Extension Phase|Withdrawal by Subject|2|||
145445464|NCT02625220|524482714|FG000|Overall Study|Adverse Event|2|||
145445465|NCT02625220|524482714|FG000|Overall Study|Lost to Follow-up|2|||
145445466|NCT02625220|524482714|FG000|Overall Study|Protocol Violation|1|||
145445467|NCT02625220|524482714|FG000|Overall Study|Study discontinued at site|2|||
145445468|NCT01140867|524482715|FG000|Overall Study|Adverse Event|22|||
145445469|NCT01140867|524482715|FG000|Overall Study|Lack of Efficacy|3|||
145445470|NCT01140867|524482715|FG000|Overall Study|Lost to Follow-up|2|||
145445471|NCT01140867|524482715|FG000|Overall Study|Withdrawal by Subject|1|||
145445472|NCT01140867|524482715|FG000|Overall Study|Protocol Violation|1|||
145445473|NCT01140867|524482715|FG000|Overall Study|Uncooperative patient|2|||
145445474|NCT01140867|524482715|FG000|Overall Study|Medication Noncompliance|2|||
145445475|NCT01926444|524482716|FG000|Overall Study|Colonoscopy not performed|0|||
145445476|NCT01926444|524482717|FG001|Overall Study|Colonoscopy not performed|0|||
145445477|NCT01926444|524482718|FG002|Overall Study|Colonoscopy not performed|4|||
145445478|NCT01926444|524482719|FG003|Overall Study|Colonoscopy not performed|2|||
145445479|NCT01232127|524482721|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
145445480|NCT01232127|524482722|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
145445481|NCT01232127|524482723|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
145445482|NCT03035864|524482726|FG000|Treatment Period|Adverse Event|1|||
145445483|NCT03035864|524482727|FG001|Treatment Period|Adverse Event|0|||
145445484|NCT03035864|524482726|FG000|Treatment Period|Other|3|||
145445485|NCT03035864|524482727|FG001|Treatment Period|Other|1|||
145445486|NCT03035864|524482726|FG000|Follow-up Period|Adverse Event|1|||
145445487|NCT03035864|524482727|FG001|Follow-up Period|Adverse Event|0|||
145445488|NCT03035864|524482726|FG000|Follow-up Period|Lost to Follow-up|6|||
145445489|NCT03035864|524482727|FG001|Follow-up Period|Lost to Follow-up|2|||
145445490|NCT03035864|524482726|FG000|Follow-up Period|Physician Decision|1|||
145445491|NCT03035864|524482727|FG001|Follow-up Period|Physician Decision|0|||
145445492|NCT03035864|524482726|FG000|Follow-up Period|Other|3|||
145445493|NCT03035864|524482727|FG001|Follow-up Period|Other|2|||
145445494|NCT02720523|524482728|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
145445495|NCT02720523|524482729|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
145445496|NCT02720523|524482730|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
145445497|NCT02720523|524482731|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
145445498|NCT02720523|524482732|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
145445499|NCT02720523|524482733|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
145445500|NCT02720523|524482734|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
145445501|NCT02720523|524482728|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
145445502|NCT02720523|524482729|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445503|NCT02720523|524482730|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445504|NCT02720523|524482731|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445505|NCT02720523|524482732|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445506|NCT02720523|524482733|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445507|NCT02720523|524482734|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
145445508|NCT02720523|524482728|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
145445509|NCT02720523|524482729|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445510|NCT02720523|524482730|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445511|NCT02720523|524482731|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445512|NCT02720523|524482732|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445513|NCT02720523|524482733|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445514|NCT02720523|524482734|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
145445515|NCT02720523|524482728|FG000|Period 1: Placebo-controlled Period|Other|0|||
145445516|NCT02720523|524482729|FG001|Period 1: Placebo-controlled Period|Other|0|||
145445517|NCT02720523|524482730|FG002|Period 1: Placebo-controlled Period|Other|1|||
145445518|NCT02720523|524482731|FG003|Period 1: Placebo-controlled Period|Other|1|||
145445519|NCT02720523|524482732|FG004|Period 1: Placebo-controlled Period|Other|0|||
145445520|NCT02720523|524482733|FG005|Period 1: Placebo-controlled Period|Other|0|||
145445521|NCT02720523|524482734|FG006|Period 1: Placebo-controlled Period|Other|0|||
145445522|NCT02720523|524482728|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
145445523|NCT02720523|524482729|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
145445524|NCT02720523|524482730|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
145445525|NCT02720523|524482731|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
145445526|NCT02720523|524482732|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
145445527|NCT02720523|524482733|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
145445528|NCT02720523|524482734|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
145445529|NCT02720523|524482728|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
145445530|NCT02720523|524482729|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
145445531|NCT02720523|524482730|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
145445532|NCT02720523|524482731|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
145445533|NCT02720523|524482732|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
145445534|NCT02720523|524482733|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
145445535|NCT02720523|524482734|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
145445536|NCT02720523|524482728|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
145445537|NCT02720523|524482729|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
145445538|NCT02720523|524482730|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
145445539|NCT02720523|524482731|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
145445540|NCT02720523|524482732|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
145445541|NCT02720523|524482733|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
145445542|NCT02720523|524482734|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
145445543|NCT02720523|524482728|FG000|Period 2: Long-term Extension Period|Other|0|||
145445544|NCT02720523|524482729|FG001|Period 2: Long-term Extension Period|Other|0|||
145445545|NCT02720523|524482730|FG002|Period 2: Long-term Extension Period|Other|0|||
145445546|NCT02720523|524482731|FG003|Period 2: Long-term Extension Period|Other|0|||
145445547|NCT02720523|524482732|FG004|Period 2: Long-term Extension Period|Other|2|||
145445548|NCT02720523|524482733|FG005|Period 2: Long-term Extension Period|Other|0|||
145445549|NCT02720523|524482734|FG006|Period 2: Long-term Extension Period|Other|3|||
145445550|NCT00577707|524482739|FG000|Overall Study|Withdrawal by Subject|3|||
145445551|NCT03299244|524482740|FG000|Overall Study|Withdrawal by Subject|34|||
145445552|NCT03299244|524482741|FG001|Overall Study|Withdrawal by Subject|29|||
145445553|NCT03299244|524482740|FG000|Overall Study|Decision by Sponsor|4|||
145445554|NCT03299244|524482741|FG001|Overall Study|Decision by Sponsor|5|||
145445555|NCT03299244|524482740|FG000|Overall Study|Death|9|||
145445556|NCT03299244|524482741|FG001|Overall Study|Death|4|||
145445557|NCT03146663|524482742|FG000|Overall Study|Did not receive study treatment|1|||
145445558|NCT03146663|524482743|FG001|Overall Study|Did not receive study treatment|1|||
145445559|NCT03666988|524482744|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
145445560|NCT03666988|524482745|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
145445561|NCT03666988|524482746|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
145445562|NCT03666988|524482747|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
145445563|NCT03666988|524482748|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
145445564|NCT03666988|524482749|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
145445565|NCT03666988|524482744|FG000|Part 1 (Up to 28 Months)|Other|0|||
145445566|NCT03666988|524482745|FG001|Part 1 (Up to 28 Months)|Other|1|||
145445567|NCT03666988|524482746|FG002|Part 1 (Up to 28 Months)|Other|1|||
145445568|NCT03666988|524482747|FG003|Part 1 (Up to 28 Months)|Other|0|||
145445569|NCT03666988|524482748|FG004|Part 1 (Up to 28 Months)|Other|0|||
145445570|NCT03666988|524482749|FG005|Part 1 (Up to 28 Months)|Other|0|||
145445571|NCT03666988|524482744|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
145445572|NCT03666988|524482745|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
145445573|NCT03666988|524482746|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
145445574|NCT03666988|524482747|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
145445575|NCT03666988|524482748|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
145445576|NCT03666988|524482749|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
145445577|NCT03666988|524482744|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
145445578|NCT03666988|524482745|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
145445579|NCT03666988|524482746|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
145445580|NCT03666988|524482747|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
145445581|NCT03666988|524482748|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
145445582|NCT03666988|524482749|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
145445583|NCT03666988|524482744|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
145445584|NCT03666988|524482745|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
145445585|NCT03666988|524482746|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
145445586|NCT03666988|524482747|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
145445587|NCT03666988|524482748|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
145445588|NCT03666988|524482749|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
145445589|NCT05588440|524482756|FG000|Overall Study|Sponsor Decision|2|||
145585257|NCT02334748|524995439|FG000|Overall Study|Adverse Event|1|||
145585258|NCT02334748|524995439|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
145445590|NCT05588440|524482757|FG001|Overall Study|Sponsor Decision|0|||
145445591|NCT05588440|524482758|FG002|Overall Study|Sponsor Decision|1|||
145445592|NCT05588440|524482756|FG000|Overall Study|Death|1|||
145445593|NCT05588440|524482757|FG001|Overall Study|Death|1|||
145445594|NCT05588440|524482758|FG002|Overall Study|Death|1|||
145585259|NCT02334748|524995439|FG000|Overall Study|Patient no longer required study drug|2|||
145585260|NCT02334748|524995439|FG000|Overall Study|Lack of Efficacy|4|||
145445595|NCT05588440|524482756|FG000|Overall Study|Screen Fail|0|||
145445596|NCT05588440|524482757|FG001|Overall Study|Screen Fail|1|||
145445597|NCT05588440|524482758|FG002|Overall Study|Screen Fail|1|||
145445598|NCT05588440|524482756|FG000|Overall Study|Withdrawal by Subject|0|||
145445599|NCT05588440|524482757|FG001|Overall Study|Withdrawal by Subject|0|||
145445600|NCT05588440|524482758|FG002|Overall Study|Withdrawal by Subject|1|||
145445601|NCT02142803|524482759|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
145445602|NCT02142803|524482760|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
145445603|NCT02142803|524482761|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
145445604|NCT02142803|524482762|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
145445605|NCT01154452|524482763|FG000|Phase Ib|Not Treated|1|||
145445606|NCT01154452|524482764|FG001|Phase Ib|Not Treated|0|||
145445607|NCT01154452|524482765|FG002|Phase Ib|Not Treated|0|||
145445608|NCT01154452|524482766|FG003|Phase Ib|Not Treated|0|||
145445609|NCT01154452|524482763|FG000|Phase Ib|Adverse Event|2|||
145445610|NCT01154452|524482764|FG001|Phase Ib|Adverse Event|1|||
145445611|NCT01154452|524482765|FG002|Phase Ib|Adverse Event|0|||
145445612|NCT01154452|524482766|FG003|Phase Ib|Adverse Event|0|||
145445613|NCT01154452|524482763|FG000|Phase II|Withdrawal by Subject|0|||
145445614|NCT01154452|524482764|FG001|Phase II|Withdrawal by Subject|0|||
145445615|NCT01154452|524482765|FG002|Phase II|Withdrawal by Subject|1|||
145445616|NCT01154452|524482766|FG003|Phase II|Withdrawal by Subject|2|||
145445617|NCT01154452|524482763|FG000|Phase II|Adverse Event|0|||
145445618|NCT01154452|524482764|FG001|Phase II|Adverse Event|0|||
145445619|NCT01154452|524482765|FG002|Phase II|Adverse Event|4|||
145445620|NCT01154452|524482766|FG003|Phase II|Adverse Event|4|||
145445621|NCT03706430|524482767|FG000|Overall Study|No A-Line placed|5|||
145445622|NCT03706430|524482767|FG000|Overall Study|Subject had gel nail polish|1|||
145445623|NCT03706430|524482767|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
145445624|NCT03706430|524482767|FG000|Overall Study|Cancelled Case|6|||
145445625|NCT03706430|524482767|FG000|Overall Study|Physician Decision|2|||
145445626|NCT00145626|524482768|FG000|Overall Study|Did not have NK infusions|2|||
145445627|NCT00145626|524482768|FG000|Overall Study|Turned 2 years old before treatment|1|||
145445628|NCT00145626|524482768|FG000|Overall Study|Death|1|||
145445629|NCT00145626|524482768|FG000|Overall Study|Withdrawal by Subject|1|||
145445630|NCT01392573|524482769|FG000|Overall Study|Adverse Event|1|||
145445631|NCT01392573|524482770|FG001|Overall Study|Adverse Event|3|||
145445632|NCT01392573|524482769|FG000|Overall Study|Lack of Efficacy|1|||
145445633|NCT01392573|524482770|FG001|Overall Study|Lack of Efficacy|2|||
145445634|NCT01392573|524482769|FG000|Overall Study|Protocol Violation|0|||
145445635|NCT01392573|524482770|FG001|Overall Study|Protocol Violation|2|||
145445636|NCT01392573|524482769|FG000|Overall Study|Withdrawal Criteria|13|||
145445637|NCT01392573|524482770|FG001|Overall Study|Withdrawal Criteria|15|||
145445638|NCT01392573|524482769|FG000|Overall Study|Site closure|8|||
145445639|NCT01392573|524482770|FG001|Overall Study|Site closure|7|||
145445640|NCT01392573|524482769|FG000|Overall Study|Unclassified|9|||
145445641|NCT01392573|524482770|FG001|Overall Study|Unclassified|6|||
145445642|NCT00436436|524482771|FG000|Overall Study|Progression|4|||
145445643|NCT00436436|524482771|FG000|Overall Study|Adverse Event|2|||
145445644|NCT00436436|524482771|FG000|Overall Study|Death|6|||
145445645|NCT02709720|524482772|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
145445646|NCT02709720|524482772|FG000|Overall Study|Protocol Violation|1|||
145445647|NCT02709720|524482772|FG000|Overall Study|Not take study medication|1|||
145445648|NCT00200967|524482773|FG000|First Treatment Period|Withdrawal by Subject|5|||
145445649|NCT00200967|524482774|FG001|First Treatment Period|Withdrawal by Subject|1|||
145445650|NCT00200967|524482773|FG000|First Treatment Period|Pregnancy|1|||
145445651|NCT00200967|524482774|FG001|First Treatment Period|Pregnancy|0|||
145445652|NCT00200967|524482773|FG000|Wash-out Period|Lost to Follow-up|0|||
145445653|NCT00200967|524482774|FG001|Wash-out Period|Lost to Follow-up|1|||
145445654|NCT00200967|524482773|FG000|Second Treatment Period|Withdrawal by Subject|1|||
145445655|NCT00200967|524482774|FG001|Second Treatment Period|Withdrawal by Subject|2|||
145585261|NCT01046643|524995440|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
145585262|NCT01046643|524995441|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
145445656|NCT00200967|524482773|FG000|Run-out Period|Lost to Follow-up|1|||
145445657|NCT00200967|524482774|FG001|Run-out Period|Lost to Follow-up|0|||
145445658|NCT03276728|524484309|FG000|Overall Study|Lost to Follow-up|0|||
145445659|NCT03276728|524484310|FG001|Overall Study|Lost to Follow-up|0|||
145445660|NCT03276728|524484311|FG002|Overall Study|Lost to Follow-up|2|||
145445661|NCT03276728|524484312|FG003|Overall Study|Lost to Follow-up|2|||
145445662|NCT03276728|524484313|FG004|Overall Study|Lost to Follow-up|0|||
145445663|NCT03276728|524484314|FG005|Overall Study|Lost to Follow-up|0|||
145445664|NCT03276728|524484315|FG006|Overall Study|Lost to Follow-up|0|||
145445665|NCT03276728|524484316|FG007|Overall Study|Lost to Follow-up|0|||
145445666|NCT03276728|524484309|FG000|Overall Study|Withdrawal by Subject|0|||
145445667|NCT03276728|524484310|FG001|Overall Study|Withdrawal by Subject|0|||
145445668|NCT03276728|524484311|FG002|Overall Study|Withdrawal by Subject|0|||
145445669|NCT03276728|524484312|FG003|Overall Study|Withdrawal by Subject|3|||
145445670|NCT03276728|524484313|FG004|Overall Study|Withdrawal by Subject|0|||
145445671|NCT03276728|524484314|FG005|Overall Study|Withdrawal by Subject|0|||
145445672|NCT03276728|524484315|FG006|Overall Study|Withdrawal by Subject|0|||
145445673|NCT03276728|524484316|FG007|Overall Study|Withdrawal by Subject|0|||
145445674|NCT03276728|524484309|FG000|Overall Study|Decision by sponsor|0|||
145445675|NCT03276728|524484310|FG001|Overall Study|Decision by sponsor|0|||
145445676|NCT03276728|524484311|FG002|Overall Study|Decision by sponsor|0|||
145445677|NCT03276728|524484312|FG003|Overall Study|Decision by sponsor|0|||
145445678|NCT03276728|524484313|FG004|Overall Study|Decision by sponsor|1|||
145445679|NCT03276728|524484314|FG005|Overall Study|Decision by sponsor|0|||
145445680|NCT03276728|524484315|FG006|Overall Study|Decision by sponsor|2|||
145445681|NCT03276728|524484316|FG007|Overall Study|Decision by sponsor|1|||
145445682|NCT00283803|524484320|FG000|Overall Study|Physician Decision|9|||
145445683|NCT00283803|524484320|FG000|Overall Study|Withdrawal by Subject|4|||
145445684|NCT03941873|524484331|FG000|Overall Study|Death|0|||
145445685|NCT03941873|524484332|FG001|Overall Study|Death|12|||
145445686|NCT03941873|524484333|FG002|Overall Study|Death|2|||
145445687|NCT03941873|524484334|FG003|Overall Study|Death|53|||
145445688|NCT03941873|524484331|FG000|Overall Study|Withdrawal by Subject|1|||
145445689|NCT03941873|524484332|FG001|Overall Study|Withdrawal by Subject|1|||
145445690|NCT03941873|524484333|FG002|Overall Study|Withdrawal by Subject|0|||
145445691|NCT03941873|524484334|FG003|Overall Study|Withdrawal by Subject|5|||
145445692|NCT03941873|524484331|FG000|Overall Study|Lost to Follow-up|1|||
145445693|NCT03941873|524484332|FG001|Overall Study|Lost to Follow-up|2|||
145445694|NCT03941873|524484333|FG002|Overall Study|Lost to Follow-up|0|||
145445695|NCT03941873|524484334|FG003|Overall Study|Lost to Follow-up|0|||
145445696|NCT03941873|524484331|FG000|Overall Study|Sponsor Decision|0|||
145445697|NCT03941873|524484332|FG001|Overall Study|Sponsor Decision|6|||
145445698|NCT03941873|524484333|FG002|Overall Study|Sponsor Decision|0|||
145445699|NCT03941873|524484334|FG003|Overall Study|Sponsor Decision|15|||
145445700|NCT02982772|524484337|FG000|Intervention|Lost to Follow-up|19|||
145445701|NCT02982772|524484338|FG001|Intervention|Lost to Follow-up|13|||
145445702|NCT02982772|524484337|FG000|1M Follow-Up|Lost to Follow-up|21|||
145445703|NCT02982772|524484338|FG001|1M Follow-Up|Lost to Follow-up|18|||
145445704|NCT02982772|524484337|FG000|3M Follow-Up|Lost to Follow-up|17|||
145445705|NCT02982772|524484338|FG001|3M Follow-Up|Lost to Follow-up|11|||
145445706|NCT02982772|524484337|FG000|6M Follow-Up|Lost to Follow-up|11|||
145445707|NCT02982772|524484338|FG001|6M Follow-Up|Lost to Follow-up|9|||
145445708|NCT02982772|524484337|FG000|12M Follow-Up|Lost to Follow-up|11|||
145445709|NCT02982772|524484338|FG001|12M Follow-Up|Lost to Follow-up|5|||
145445710|NCT01234480|524484339|FG000|Overall Study|Pregnancy|88|||
145445711|NCT01234480|524484339|FG000|Overall Study|>36/Normal History|50|||
145445712|NCT01234480|524484339|FG000|Overall Study|Age|3|||
145445713|NCT01234480|524484339|FG000|Overall Study|HPV Vaccine History|28|||
145445714|NCT01234480|524484339|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
145445715|NCT01234480|524484339|FG000|Overall Study|Hysterectomy|2|||
145445716|NCT01234480|524484339|FG000|Overall Study|Hysterectomy post enrollment|1|||
145445717|NCT01234480|524484339|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
145445718|NCT01234480|524484339|FG000|Overall Study|Informed Consent Form Violation|30|||
145445719|NCT01234480|524484339|FG000|Overall Study|Incorrect Visit|3|||
145445720|NCT01234480|524484339|FG000|Overall Study|No Florida Lab License|20|||
145445721|NCT01234480|524484339|FG000|Overall Study|Out of Window|42|||
145445722|NCT01234480|524484339|FG000|Overall Study|Sample Processing/Storage|92|||
145445723|NCT01234480|524484339|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
145445724|NCT01234480|524484339|FG000|Overall Study|Site/Subject non-compliance|44|||
145445725|NCT01234480|524484339|FG000|Overall Study|Missing Sample|9|||
145445726|NCT02974140|524484340|FG000|Overall Study|Adverse Event|2|||
145445727|NCT02974140|524484340|FG000|Overall Study|Lost to Follow-up|1|||
145445728|NCT02974140|524484340|FG000|Overall Study|Study Terminated by Sponsor|36|||
145445729|NCT00617084|524484341|FG000|Overall Study|Withdrawal by Subject|5|||
145445730|NCT00617084|524484342|FG001|Overall Study|Withdrawal by Subject|7|||
145445731|NCT00617084|524484341|FG000|Overall Study|Missed 12 Months visit|16|||
145445732|NCT00617084|524484342|FG001|Overall Study|Missed 12 Months visit|19|||
145445733|NCT03370419|524484343|FG000|Overall Study|Lost to Follow-up|16|||
145445734|NCT00662831|524484358|FG000|Overall Study|Death|4|||
145445735|NCT00662831|524484359|FG001|Overall Study|Death|1|||
145585263|NCT01046643|524995442|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
145585264|NCT01046643|524995443|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
145445736|NCT00662831|524484358|FG000|Overall Study|Lack of Efficacy|6|||
145445737|NCT00662831|524484359|FG001|Overall Study|Lack of Efficacy|6|||
145445738|NCT00662831|524484358|FG000|Overall Study|Lost to Follow-up|1|||
145445739|NCT00662831|524484359|FG001|Overall Study|Lost to Follow-up|0|||
145445740|NCT00662831|524484358|FG000|Overall Study|Withdrawal by Subject|2|||
145445741|NCT00662831|524484359|FG001|Overall Study|Withdrawal by Subject|1|||
145445742|NCT00662831|524484358|FG000|Overall Study|Other|62|||
145445743|NCT00662831|524484359|FG001|Overall Study|Other|31|||
145445744|NCT00662831|524484358|FG000|Overall Study|Protocol Violation|8|||
145445745|NCT00662831|524484359|FG001|Overall Study|Protocol Violation|4|||
145445746|NCT00662831|524484358|FG000|Overall Study|Adverse Event|23|||
145445747|NCT00662831|524484359|FG001|Overall Study|Adverse Event|16|||
145445748|NCT01734785|524484360|FG000|Open-Label Period|Adverse Event|0|||
145445749|NCT01734785|524484361|FG001|Open-Label Period|Adverse Event|0|||
145445750|NCT01734785|524484362|FG002|Open-Label Period|Adverse Event|0|||
145445751|NCT01734785|524484363|FG003|Open-Label Period|Adverse Event|9|||
145445752|NCT01734785|524484360|FG000|Open-Label Period|Lack of Efficacy|0|||
145445753|NCT01734785|524484361|FG001|Open-Label Period|Lack of Efficacy|0|||
145445754|NCT01734785|524484362|FG002|Open-Label Period|Lack of Efficacy|0|||
145445755|NCT01734785|524484363|FG003|Open-Label Period|Lack of Efficacy|1|||
145445756|NCT01734785|524484360|FG000|Open-Label Period|Protocol Violation|0|||
145445757|NCT01734785|524484361|FG001|Open-Label Period|Protocol Violation|0|||
145445758|NCT01734785|524484362|FG002|Open-Label Period|Protocol Violation|0|||
145445759|NCT01734785|524484363|FG003|Open-Label Period|Protocol Violation|13|||
145445760|NCT01734785|524484360|FG000|Open-Label Period|Lost to Follow-up|0|||
145445761|NCT01734785|524484361|FG001|Open-Label Period|Lost to Follow-up|0|||
145445762|NCT01734785|524484362|FG002|Open-Label Period|Lost to Follow-up|0|||
145445763|NCT01734785|524484363|FG003|Open-Label Period|Lost to Follow-up|14|||
145445764|NCT01734785|524484360|FG000|Open-Label Period|Withdrawal by Subject|0|||
145445765|NCT01734785|524484361|FG001|Open-Label Period|Withdrawal by Subject|0|||
145445766|NCT01734785|524484362|FG002|Open-Label Period|Withdrawal by Subject|0|||
145445767|NCT01734785|524484363|FG003|Open-Label Period|Withdrawal by Subject|12|||
145445768|NCT01734785|524484360|FG000|Open-Label Period|Other Reasons|0|||
145445769|NCT01734785|524484361|FG001|Open-Label Period|Other Reasons|0|||
145445770|NCT01734785|524484362|FG002|Open-Label Period|Other Reasons|0|||
145445771|NCT01734785|524484363|FG003|Open-Label Period|Other Reasons|224|||
145445772|NCT01734785|524484360|FG000|Double-Blind Period|Adverse Event|0|||
145445773|NCT01734785|524484361|FG001|Double-Blind Period|Adverse Event|3|||
145445774|NCT01734785|524484362|FG002|Double-Blind Period|Adverse Event|2|||
145445775|NCT01734785|524484363|FG003|Double-Blind Period|Adverse Event|0|||
145445776|NCT01734785|524484360|FG000|Double-Blind Period|Lack of Efficacy|0|||
145445777|NCT01734785|524484361|FG001|Double-Blind Period|Lack of Efficacy|1|||
145445778|NCT01734785|524484362|FG002|Double-Blind Period|Lack of Efficacy|0|||
145445779|NCT01734785|524484363|FG003|Double-Blind Period|Lack of Efficacy|0|||
145445780|NCT01734785|524484360|FG000|Double-Blind Period|Protocol Violation|0|||
145445781|NCT01734785|524484361|FG001|Double-Blind Period|Protocol Violation|1|||
145445782|NCT01734785|524484362|FG002|Double-Blind Period|Protocol Violation|1|||
145445783|NCT01734785|524484363|FG003|Double-Blind Period|Protocol Violation|0|||
145445784|NCT01734785|524484360|FG000|Double-Blind Period|Lost to Follow-up|2|||
145445785|NCT01734785|524484361|FG001|Double-Blind Period|Lost to Follow-up|4|||
145445786|NCT01734785|524484362|FG002|Double-Blind Period|Lost to Follow-up|2|||
145445787|NCT01734785|524484363|FG003|Double-Blind Period|Lost to Follow-up|0|||
145445788|NCT01734785|524484360|FG000|Double-Blind Period|Withdrawal by Subject|2|||
145445789|NCT01734785|524484361|FG001|Double-Blind Period|Withdrawal by Subject|0|||
145445790|NCT01734785|524484362|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145445791|NCT01734785|524484363|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145445792|NCT01734785|524484360|FG000|Double-Blind Period|Not treated|1|||
145445793|NCT01734785|524484361|FG001|Double-Blind Period|Not treated|0|||
145445794|NCT01734785|524484362|FG002|Double-Blind Period|Not treated|0|||
145445795|NCT01734785|524484363|FG003|Double-Blind Period|Not treated|0|||
145445796|NCT02013778|524484369|FG000|Overall Study|Death|4|||
145445797|NCT02013778|524484369|FG000|Overall Study|Withdrawal by Subject|1|||
145585265|NCT03893448|524995450|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
145585266|NCT03893448|524995451|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
145445798|NCT02013778|524484369|FG000|Overall Study|Physician Decision|1|||
145445799|NCT02013778|524484369|FG000|Overall Study|Adverse Event|1|||
145445800|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
145445801|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
145445802|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
145445803|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
145445804|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
145445805|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
145445806|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
145445807|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
145445808|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
145445809|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
145445810|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
145445811|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
145445812|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
145445813|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
145445814|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
145445815|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
145445816|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
145445817|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
145585267|NCT03893448|524995450|FG000|Overall Study|Physician Decision|8|||
145445818|NCT03308968|524484370|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
145445819|NCT03308968|524484371|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
145585268|NCT03893448|524995451|FG001|Overall Study|Physician Decision|14|||
145585269|NCT03893448|524995450|FG000|Overall Study|Lost to Follow-up|34|||
145585270|NCT03893448|524995451|FG001|Overall Study|Lost to Follow-up|27|||
145445820|NCT03308968|524484372|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
145445821|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
145445822|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
145445823|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
145445824|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
145445825|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
145445826|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
145445827|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
145445828|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
145445829|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
145445830|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
145445831|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
145445832|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
145445833|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
145445834|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
145445835|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
145445836|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
145445837|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
145445838|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
145445839|NCT03308968|524484370|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
145445840|NCT03308968|524484371|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
145445841|NCT03308968|524484372|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
145445842|NCT01961297|524484373|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
145445843|NCT01961297|524484374|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
145445844|NCT02482298|524484375|FG000|Overall Study|Withdrawal by Subject|2|||
145445845|NCT02482298|524484376|FG001|Overall Study|Withdrawal by Subject|1|||
145445846|NCT02482298|524484377|FG002|Overall Study|Withdrawal by Subject|2|||
145445847|NCT02482298|524484375|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
145445848|NCT02482298|524484376|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
145445849|NCT02482298|524484377|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
145445850|NCT02482298|524484375|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
145445851|NCT02482298|524484376|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
145445852|NCT02482298|524484377|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
145445853|NCT02482298|524484375|FG000|Overall Study|Lost to Follow-up|0|||
145445854|NCT02482298|524484376|FG001|Overall Study|Lost to Follow-up|1|||
145445855|NCT02482298|524484377|FG002|Overall Study|Lost to Follow-up|0|||
145445856|NCT01582009|524484380|FG000|Overall Study|Withdrawal by Subject|1|||
145445857|NCT01582009|524484380|FG000|Overall Study|Physician Decision|1|||
145445858|NCT03050450|524484383|FG000|Overall Study|Physician Decision|1|||
145445859|NCT03050450|524484384|FG001|Overall Study|Physician Decision|0|||
145445860|NCT03050450|524484385|FG002|Overall Study|Physician Decision|0|||
145445861|NCT03050450|524484386|FG003|Overall Study|Physician Decision|0|||
145445862|NCT03050450|524484387|FG004|Overall Study|Physician Decision|0|||
145445863|NCT03592771|524484388|FG000|Overall Study|Adverse Event|2|||
145445864|NCT03592771|524484389|FG001|Overall Study|Adverse Event|0|||
145445865|NCT03592771|524484390|FG002|Overall Study|Adverse Event|1|||
145445866|NCT03592771|524484388|FG000|Overall Study|Death|0|||
145445867|NCT03592771|524484389|FG001|Overall Study|Death|1|||
145445868|NCT03592771|524484390|FG002|Overall Study|Death|1|||
145445869|NCT03592771|524484388|FG000|Overall Study|Lost to Follow-up|5|||
145445870|NCT03592771|524484389|FG001|Overall Study|Lost to Follow-up|11|||
145445871|NCT03592771|524484390|FG002|Overall Study|Lost to Follow-up|15|||
145445872|NCT03592771|524484388|FG000|Overall Study|Withdrawal by Subject|0|||
145445873|NCT03592771|524484389|FG001|Overall Study|Withdrawal by Subject|2|||
145445874|NCT03592771|524484390|FG002|Overall Study|Withdrawal by Subject|0|||
145445875|NCT00735553|524484391|FG000|Overall Study|Study prematurely terminated|77|||
145445876|NCT02705105|524484392|FG000|Treatment|Objective Disease Progression|1|||
145445877|NCT02705105|524484393|FG001|Treatment|Objective Disease Progression|50|||
145445878|NCT02705105|524484392|FG000|Treatment|Withdrawal by Subject|3|||
145445879|NCT02705105|524484393|FG001|Treatment|Withdrawal by Subject|5|||
145445880|NCT02705105|524484392|FG000|Treatment|Adverse Event|0|||
145445881|NCT02705105|524484393|FG001|Treatment|Adverse Event|17|||
145445882|NCT02705105|524484392|FG000|Treatment|Clinical Disease Progression|0|||
145445883|NCT02705105|524484393|FG001|Treatment|Clinical Disease Progression|32|||
145445884|NCT02705105|524484392|FG000|Treatment|Physician Decision|0|||
145445885|NCT02705105|524484393|FG001|Treatment|Physician Decision|3|||
145445886|NCT02705105|524484392|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
145445887|NCT02705105|524484393|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
145445888|NCT02705105|524484392|FG000|Follow-Up|Death|3|||
145445889|NCT02705105|524484393|FG001|Follow-Up|Death|68|||
145445890|NCT02705105|524484392|FG000|Follow-Up|Withdrawal by Subject|1|||
145585271|NCT03893448|524995450|FG000|Overall Study|Death|1|||
145445891|NCT02705105|524484393|FG001|Follow-Up|Withdrawal by Subject|14|||
145445892|NCT02705105|524484392|FG000|Follow-Up|Study Terminated|0|||
145445893|NCT02705105|524484393|FG001|Follow-Up|Study Terminated|26|||
145445894|NCT02705105|524484392|FG000|Follow-Up|Discontinued per Amendment 3|0|||
145445895|NCT02705105|524484393|FG001|Follow-Up|Discontinued per Amendment 3|2|||
145445896|NCT04556591|524484395|FG000|Overall Study|Lost to Follow-up|1|||
145445897|NCT04556591|524484396|FG001|Overall Study|Lost to Follow-up|0|||
145445898|NCT04556591|524484395|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
145445899|NCT04556591|524484396|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
145445900|NCT03332173|524484397|FG000|Overall Study|Death|7|||
145445901|NCT03332173|524484397|FG000|Overall Study|Withdrawal by Subject|6|||
145445902|NCT03332173|524484397|FG000|Overall Study|Lost to Follow-up|2|||
145445903|NCT03332173|524484397|FG000|Overall Study|Transferred to long-term extension study|29|||
145445904|NCT01485796|524484398|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
145445905|NCT01485796|524484398|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
145445906|NCT01485796|524484398|FG000|Period 2: Epoch 2|Adverse Event|3|||
145445907|NCT01485796|524484398|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
145445908|NCT01485796|524484398|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
145445909|NCT01485796|524484398|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
145445910|NCT01485796|524484398|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
145445911|NCT01485796|524484398|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
145445912|NCT04830215|524484399|FG000|Overall Study|Adverse Event|6|||
145445913|NCT04830215|524484399|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
145445914|NCT04830215|524484399|FG000|Overall Study|Withdrawal by Subject|3|||
145445915|NCT04830215|524484399|FG000|Overall Study|Protocol Deviation|1|||
145445916|NCT00211172|524484404|FG000|Overall Study|Died or lost health plan eligibility|39|||
145445917|NCT00211172|524484405|FG001|Overall Study|Died or lost health plan eligibility|32|||
145445918|NCT00770562|524484406|FG000|Overall Study|Did not take treatment|1|||
145445919|NCT00770562|524484407|FG001|Overall Study|Did not take treatment|1|||
145445920|NCT01643408|524484408|FG000|Overall Study|Adverse Event|12|||
145445921|NCT01643408|524484408|FG000|Overall Study|Other|2|||
145445922|NCT00292045|524484412|FG000|Core Study (Through Week 13)|Adverse Event|1|||
145445923|NCT00292045|524484412|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
145445924|NCT04474197|524484413|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
145445925|NCT04474197|524484414|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
145445926|NCT04474197|524484415|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
145445927|NCT04474197|524484416|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
145445928|NCT01637584|524484419|FG000|Overall Study|Withdrawal by Subject|1|||
145445929|NCT01637584|524484420|FG001|Overall Study|Withdrawal by Subject|3|||
145445930|NCT04396795|524484421|FG000|Month 1|Lost to Follow-up|2|||
145445931|NCT04396795|524484422|FG001|Month 1|Lost to Follow-up|3|||
145445932|NCT04396795|524484421|FG000|Month 3|Lost to Follow-up|1|||
145445933|NCT04396795|524484422|FG001|Month 3|Lost to Follow-up|3|||
145445934|NCT04396795|524484421|FG000|Month 6|Lost to Follow-up|3|||
145445935|NCT04396795|524484422|FG001|Month 6|Lost to Follow-up|3|||
145585272|NCT03893448|524995451|FG001|Overall Study|Death|0|||
145585273|NCT04102501|524995455|FG000|Overall Study|Withdrawal by Subject|7|||
145585274|NCT04102501|524995456|FG001|Overall Study|Withdrawal by Subject|9|||
145585275|NCT04102501|524995455|FG000|Overall Study|Adverse Event|1|||
145585276|NCT04102501|524995456|FG001|Overall Study|Adverse Event|3|||
145585277|NCT02338362|524995457|FG000|Overall Study|Withdrawal by Subject|1|||
145585278|NCT02338362|524995458|FG001|Overall Study|Withdrawal by Subject|1|||
145585279|NCT04798586|524995461|FG000|Overall Study|Death|2|||
145445936|NCT02366923|524484423|FG000|Overall Study|Withdrawal by Subject|1|||
145445937|NCT02366923|524484423|FG000|Overall Study|Positive Slit Lamp Findings|2|||
145445938|NCT02366923|524484423|FG000|Overall Study|High Astigmatism|3|||
145445939|NCT00995436|524484427|FG000|Overall Study|Withdrawal by Subject|2|||
145489849|NCT05051579|524647619|FG000|Overall Study|Adverse Event|2|||
145489850|NCT05051579|524647620|FG001|Overall Study|Adverse Event|1|||
145489851|NCT05051579|524647621|FG002|Overall Study|Adverse Event|0|||
145489852|NCT05051579|524647622|FG003|Overall Study|Adverse Event|4|||
145489853|NCT05051579|524647623|FG004|Overall Study|Adverse Event|1|||
145489854|NCT05051579|524647624|FG005|Overall Study|Adverse Event|2|||
145489855|NCT05051579|524647625|FG006|Overall Study|Adverse Event|0|||
145489856|NCT05051579|524647619|FG000|Overall Study|Inadvertent Enrollment|0|||
145489857|NCT05051579|524647620|FG001|Overall Study|Inadvertent Enrollment|0|||
145489858|NCT05051579|524647621|FG002|Overall Study|Inadvertent Enrollment|0|||
145489859|NCT05051579|524647622|FG003|Overall Study|Inadvertent Enrollment|0|||
145489860|NCT05051579|524647623|FG004|Overall Study|Inadvertent Enrollment|0|||
145489861|NCT05051579|524647624|FG005|Overall Study|Inadvertent Enrollment|0|||
145489862|NCT05051579|524647625|FG006|Overall Study|Inadvertent Enrollment|1|||
145489863|NCT05051579|524647619|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489864|NCT05051579|524647620|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
145445940|NCT00995436|524484428|FG001|Overall Study|Withdrawal by Subject|5|||
145445941|NCT00995436|524484429|FG002|Overall Study|Withdrawal by Subject|0|||
145445942|NCT02725476|524484430|FG000|Overall Study|Physician Decision|2|||
145445943|NCT02725476|524484431|FG001|Overall Study|Physician Decision|0|||
145445944|NCT02725476|524484430|FG000|Overall Study|Adverse Event|1|||
145445945|NCT02725476|524484431|FG001|Overall Study|Adverse Event|1|||
145445946|NCT02517398|524484448|FG000|Overall Study|Death|2|||
145445947|NCT02517398|524484449|FG001|Overall Study|Death|3|||
145445948|NCT02517398|524484450|FG002|Overall Study|Death|4|||
145445949|NCT02517398|524484451|FG003|Overall Study|Death|2|||
145445950|NCT02517398|524484452|FG004|Overall Study|Death|3|||
145445951|NCT02517398|524484453|FG005|Overall Study|Death|8|||
145445952|NCT02517398|524484454|FG006|Overall Study|Death|3|||
145445953|NCT02517398|524484455|FG007|Overall Study|Death|2|||
145445954|NCT02517398|524484456|FG008|Overall Study|Death|6|||
145445955|NCT02517398|524484457|FG009|Overall Study|Death|24|||
145445956|NCT02517398|524484458|FG010|Overall Study|Death|53|||
145445957|NCT02517398|524484459|FG011|Overall Study|Death|25|||
145445958|NCT02517398|524484460|FG012|Overall Study|Death|73|||
145445959|NCT02517398|524484461|FG013|Overall Study|Death|29|||
145445960|NCT02517398|524484462|FG014|Overall Study|Death|26|||
145445961|NCT02517398|524484463|FG015|Overall Study|Death|23|||
145445962|NCT02517398|524484464|FG016|Overall Study|Death|26|||
145445963|NCT02517398|524484465|FG017|Overall Study|Death|25|||
145445964|NCT02517398|524484466|FG018|Overall Study|Death|22|||
145445965|NCT02517398|524484467|FG019|Overall Study|Death|7|||
145445966|NCT02517398|524484468|FG020|Overall Study|Death|26|||
145445967|NCT02517398|524484469|FG021|Overall Study|Death|30|||
145445968|NCT02517398|524484470|FG022|Overall Study|Death|20|||
145445969|NCT02517398|524484448|FG000|Overall Study|Other|0|||
145445970|NCT02517398|524484449|FG001|Overall Study|Other|0|||
145445971|NCT02517398|524484450|FG002|Overall Study|Other|0|||
145445972|NCT02517398|524484451|FG003|Overall Study|Other|1|||
145445973|NCT02517398|524484452|FG004|Overall Study|Other|0|||
145445974|NCT02517398|524484453|FG005|Overall Study|Other|0|||
145445975|NCT02517398|524484454|FG006|Overall Study|Other|0|||
145445976|NCT02517398|524484455|FG007|Overall Study|Other|0|||
145445977|NCT02517398|524484456|FG008|Overall Study|Other|0|||
145445978|NCT02517398|524484457|FG009|Overall Study|Other|1|||
145445979|NCT02517398|524484458|FG010|Overall Study|Other|0|||
145445980|NCT02517398|524484459|FG011|Overall Study|Other|0|||
145445981|NCT02517398|524484460|FG012|Overall Study|Other|0|||
145445982|NCT02517398|524484461|FG013|Overall Study|Other|1|||
145445983|NCT02517398|524484462|FG014|Overall Study|Other|0|||
145445984|NCT02517398|524484463|FG015|Overall Study|Other|1|||
145445985|NCT02517398|524484464|FG016|Overall Study|Other|1|||
145445986|NCT02517398|524484465|FG017|Overall Study|Other|0|||
145445987|NCT02517398|524484466|FG018|Overall Study|Other|0|||
145445988|NCT02517398|524484467|FG019|Overall Study|Other|1|||
145445989|NCT02517398|524484468|FG020|Overall Study|Other|0|||
145445990|NCT02517398|524484469|FG021|Overall Study|Other|0|||
145445991|NCT02517398|524484470|FG022|Overall Study|Other|0|||
145445992|NCT02517398|524484448|FG000|Overall Study|Lost to Follow-up|0|||
145445993|NCT02517398|524484449|FG001|Overall Study|Lost to Follow-up|0|||
145445994|NCT02517398|524484450|FG002|Overall Study|Lost to Follow-up|0|||
145445995|NCT02517398|524484451|FG003|Overall Study|Lost to Follow-up|0|||
145445996|NCT02517398|524484452|FG004|Overall Study|Lost to Follow-up|0|||
145445997|NCT02517398|524484453|FG005|Overall Study|Lost to Follow-up|0|||
145445998|NCT02517398|524484454|FG006|Overall Study|Lost to Follow-up|0|||
145445999|NCT02517398|524484455|FG007|Overall Study|Lost to Follow-up|0|||
145446000|NCT02517398|524484456|FG008|Overall Study|Lost to Follow-up|0|||
145446001|NCT02517398|524484457|FG009|Overall Study|Lost to Follow-up|1|||
145446002|NCT02517398|524484458|FG010|Overall Study|Lost to Follow-up|0|||
145446003|NCT02517398|524484459|FG011|Overall Study|Lost to Follow-up|2|||
145585280|NCT04433767|524995462|FG000|Overall Study|Adverse Event|1|||
145585281|NCT02371369|524995467|FG000|Part 1|Physician Decision|0|||
145446004|NCT02517398|524484460|FG012|Overall Study|Lost to Follow-up|2|||
145446005|NCT02517398|524484461|FG013|Overall Study|Lost to Follow-up|0|||
145446006|NCT02517398|524484462|FG014|Overall Study|Lost to Follow-up|1|||
145446007|NCT02517398|524484463|FG015|Overall Study|Lost to Follow-up|1|||
145446008|NCT02517398|524484464|FG016|Overall Study|Lost to Follow-up|0|||
145446009|NCT02517398|524484465|FG017|Overall Study|Lost to Follow-up|3|||
145446010|NCT02517398|524484466|FG018|Overall Study|Lost to Follow-up|1|||
145585282|NCT02371369|524995468|FG001|Part 1|Physician Decision|3|||
145585283|NCT02371369|524995467|FG000|Part 1|Adverse Event|8|||
145446011|NCT02517398|524484467|FG019|Overall Study|Lost to Follow-up|0|||
145446012|NCT02517398|524484468|FG020|Overall Study|Lost to Follow-up|1|||
145446013|NCT02517398|524484469|FG021|Overall Study|Lost to Follow-up|0|||
145446014|NCT02517398|524484470|FG022|Overall Study|Lost to Follow-up|2|||
145446015|NCT02517398|524484448|FG000|Overall Study|Withdrew Consent|0|||
145446016|NCT02517398|524484449|FG001|Overall Study|Withdrew Consent|0|||
145446017|NCT02517398|524484450|FG002|Overall Study|Withdrew Consent|0|||
145446018|NCT02517398|524484451|FG003|Overall Study|Withdrew Consent|0|||
145446019|NCT02517398|524484452|FG004|Overall Study|Withdrew Consent|0|||
145585284|NCT02371369|524995468|FG001|Part 1|Adverse Event|0|||
145625981|NCT02680756|525144137|FG001|Overall Study|None of above or not recorded|2|||
145625982|NCT00480441|525144138|FG000|Screening|Not Eligible|37|||
145625983|NCT00480441|525144139|FG001|Screening|Not Eligible|0|||
145625984|NCT00480441|525144140|FG002|Screening|Not Eligible|0|||
145625985|NCT00480441|525144138|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
145625986|NCT00480441|525144139|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
145625987|NCT00480441|525144140|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
145625988|NCT00480441|525144138|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
145625989|NCT00480441|525144139|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
145625990|NCT00480441|525144140|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
145446020|NCT02517398|524484453|FG005|Overall Study|Withdrew Consent|0|||
145446021|NCT02517398|524484454|FG006|Overall Study|Withdrew Consent|1|||
145446022|NCT02517398|524484455|FG007|Overall Study|Withdrew Consent|0|||
145446023|NCT02517398|524484456|FG008|Overall Study|Withdrew Consent|0|||
145446024|NCT02517398|524484457|FG009|Overall Study|Withdrew Consent|2|||
145446025|NCT02517398|524484458|FG010|Overall Study|Withdrew Consent|7|||
145446026|NCT02517398|524484459|FG011|Overall Study|Withdrew Consent|1|||
145446027|NCT02517398|524484460|FG012|Overall Study|Withdrew Consent|5|||
145446028|NCT02517398|524484461|FG013|Overall Study|Withdrew Consent|4|||
145446029|NCT02517398|524484462|FG014|Overall Study|Withdrew Consent|2|||
145446030|NCT02517398|524484463|FG015|Overall Study|Withdrew Consent|5|||
145446031|NCT02517398|524484464|FG016|Overall Study|Withdrew Consent|4|||
145446032|NCT02517398|524484465|FG017|Overall Study|Withdrew Consent|2|||
145446033|NCT02517398|524484466|FG018|Overall Study|Withdrew Consent|3|||
145446034|NCT02517398|524484467|FG019|Overall Study|Withdrew Consent|2|||
145585285|NCT02371369|524995467|FG000|Part 1|Withdrawal by Subject|1|||
145585286|NCT02371369|524995468|FG001|Part 1|Withdrawal by Subject|6|||
145585287|NCT02371369|524995467|FG000|Part 1|Disease progression|0|||
145585288|NCT02371369|524995468|FG001|Part 1|Disease progression|1|||
145585289|NCT02371369|524995467|FG000|Part 1|Protocol Violation|0|||
145585290|NCT02371369|524995468|FG001|Part 1|Protocol Violation|1|||
145585291|NCT02371369|524995467|FG000|Part 2|Adverse Event|6|||
145585292|NCT02371369|524995468|FG001|Part 2|Adverse Event|5|||
145585293|NCT02371369|524995467|FG000|Part 2|Withdrawal by Subject|16|||
145585294|NCT02371369|524995468|FG001|Part 2|Withdrawal by Subject|6|||
145585295|NCT02371369|524995467|FG000|Part 2|Investigator decision|1|||
145585296|NCT02371369|524995468|FG001|Part 2|Investigator decision|2|||
145585297|NCT02371369|524995467|FG000|Part 2|Death|0|||
145585298|NCT02371369|524995468|FG001|Part 2|Death|1|||
145585299|NCT02371369|524995467|FG000|Part 2|Disease progression|1|||
145585300|NCT02371369|524995468|FG001|Part 2|Disease progression|0|||
145585301|NCT02371369|524995467|FG000|Part 2|Subject Noncompliance|1|||
145585302|NCT02371369|524995468|FG001|Part 2|Subject Noncompliance|0|||
145585303|NCT02371369|524995467|FG000|Part 2|Lost to Follow-up|1|||
145585304|NCT02371369|524995468|FG001|Part 2|Lost to Follow-up|1|||
145585305|NCT02371369|524995467|FG000|Part 2|Subject transitioned to commercial supply|6|||
145585306|NCT02371369|524995468|FG001|Part 2|Subject transitioned to commercial supply|4|||
145585307|NCT02371369|524995467|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
145585308|NCT02371369|524995468|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
145585309|NCT02371369|524995467|FG000|Part 2|Surgical resection of tumor|1|||
145585310|NCT02371369|524995468|FG001|Part 2|Surgical resection of tumor|1|||
145585311|NCT02371369|524995467|FG000|Part 2|Other|0|||
145585312|NCT02371369|524995468|FG001|Part 2|Other|1|||
145585313|NCT06281548|524995471|FG000|Overall Study|Lost to Follow-up|3|||
145585314|NCT01618838|524995472|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
145585315|NCT01764945|524995473|FG000|Overall Study|Adverse Event|0|||
145585316|NCT01764945|524995474|FG001|Overall Study|Adverse Event|1|||
145446035|NCT02517398|524484468|FG020|Overall Study|Withdrew Consent|9|||
145446036|NCT02517398|524484469|FG021|Overall Study|Withdrew Consent|3|||
145446037|NCT02517398|524484470|FG022|Overall Study|Withdrew Consent|1|||
145446038|NCT02131662|524484471|FG000|Overall Study|Protocol Violation|1|||
145585317|NCT01764945|524995475|FG002|Overall Study|Adverse Event|0|||
145585318|NCT01764945|524995476|FG003|Overall Study|Adverse Event|0|||
145585319|NCT01764945|524995477|FG004|Overall Study|Adverse Event|0|||
145585320|NCT01764945|524995478|FG005|Overall Study|Adverse Event|0|||
145585321|NCT01764945|524995479|FG006|Overall Study|Adverse Event|1|||
145585322|NCT01764945|524995480|FG007|Overall Study|Adverse Event|0|||
145585323|NCT01587651|524995483|FG000|Overall Study|Adverse Event|0|||
145585324|NCT01587651|524995484|FG001|Overall Study|Adverse Event|1|||
145585325|NCT01587651|524995485|FG002|Overall Study|Adverse Event|0|||
145585326|NCT01587651|524995483|FG000|Overall Study|Protocol Violation|0|||
145585327|NCT01587651|524995484|FG001|Overall Study|Protocol Violation|1|||
145625991|NCT00480441|525144138|FG000|Baseline Functional MRI|physical contraindication|4|||
145585328|NCT01587651|524995485|FG002|Overall Study|Protocol Violation|1|||
145585329|NCT01587651|524995483|FG000|Overall Study|Withdrawal by Subject|0|||
145585330|NCT01587651|524995484|FG001|Overall Study|Withdrawal by Subject|1|||
145585331|NCT01587651|524995485|FG002|Overall Study|Withdrawal by Subject|0|||
145585332|NCT01136291|524995487|FG000|Overall Study|Lost to Follow-up|1|||
145585333|NCT01136291|524995488|FG001|Overall Study|Lost to Follow-up|1|||
145585334|NCT03165045|524995496|FG000|Visit 1|No registration after visit 1|9|||
145446039|NCT02131662|524484472|FG001|Overall Study|Protocol Violation|0|||
145446040|NCT02131662|524484473|FG002|Overall Study|Protocol Violation|0|||
145446041|NCT02131662|524484474|FG003|Overall Study|Protocol Violation|0|||
145446042|NCT02131662|524484475|FG004|Overall Study|Protocol Violation|0|||
145446043|NCT02131662|524484471|FG000|Overall Study|Other|2|||
145446044|NCT02131662|524484472|FG001|Overall Study|Other|4|||
145446045|NCT02131662|524484473|FG002|Overall Study|Other|3|||
145446046|NCT02131662|524484474|FG003|Overall Study|Other|3|||
145446047|NCT02131662|524484475|FG004|Overall Study|Other|4|||
145446048|NCT02131662|524484471|FG000|Overall Study|Adverse Event|0|||
145446049|NCT02131662|524484472|FG001|Overall Study|Adverse Event|1|||
145446050|NCT02131662|524484473|FG002|Overall Study|Adverse Event|1|||
145446051|NCT02131662|524484474|FG003|Overall Study|Adverse Event|1|||
145446052|NCT02131662|524484475|FG004|Overall Study|Adverse Event|3|||
145446053|NCT02131662|524484471|FG000|Overall Study|Pregnancy|0|||
145446054|NCT02131662|524484472|FG001|Overall Study|Pregnancy|1|||
145446055|NCT02131662|524484473|FG002|Overall Study|Pregnancy|0|||
145446056|NCT02131662|524484474|FG003|Overall Study|Pregnancy|1|||
145446057|NCT02131662|524484475|FG004|Overall Study|Pregnancy|0|||
145446058|NCT02131662|524484471|FG000|Overall Study|Wish for pregnancy|0|||
145446059|NCT02131662|524484472|FG001|Overall Study|Wish for pregnancy|0|||
145446060|NCT02131662|524484473|FG002|Overall Study|Wish for pregnancy|0|||
145446061|NCT02131662|524484474|FG003|Overall Study|Wish for pregnancy|0|||
145446062|NCT02131662|524484475|FG004|Overall Study|Wish for pregnancy|1|||
145446063|NCT02131662|524484471|FG000|Overall Study|Lack of Efficacy|1|||
145446064|NCT02131662|524484472|FG001|Overall Study|Lack of Efficacy|0|||
145446065|NCT02131662|524484473|FG002|Overall Study|Lack of Efficacy|0|||
145446066|NCT02131662|524484474|FG003|Overall Study|Lack of Efficacy|0|||
145446067|NCT02131662|524484475|FG004|Overall Study|Lack of Efficacy|1|||
145446068|NCT02131662|524484471|FG000|Overall Study|Withdrawal by Subject|1|||
145446069|NCT02131662|524484472|FG001|Overall Study|Withdrawal by Subject|5|||
145446070|NCT02131662|524484473|FG002|Overall Study|Withdrawal by Subject|1|||
145446071|NCT02131662|524484474|FG003|Overall Study|Withdrawal by Subject|5|||
145446072|NCT02131662|524484475|FG004|Overall Study|Withdrawal by Subject|6|||
145446073|NCT02131662|524484471|FG000|Overall Study|Lost to Follow-up|1|||
145446074|NCT02131662|524484472|FG001|Overall Study|Lost to Follow-up|3|||
145446075|NCT02131662|524484473|FG002|Overall Study|Lost to Follow-up|0|||
145446076|NCT02131662|524484474|FG003|Overall Study|Lost to Follow-up|9|||
145446077|NCT02131662|524484475|FG004|Overall Study|Lost to Follow-up|0|||
145446078|NCT02131662|524484471|FG000|Overall Study|Not treated|2|||
145446079|NCT02131662|524484472|FG001|Overall Study|Not treated|0|||
145446080|NCT02131662|524484473|FG002|Overall Study|Not treated|2|||
145446081|NCT02131662|524484474|FG003|Overall Study|Not treated|2|||
145446082|NCT02131662|524484475|FG004|Overall Study|Not treated|3|||
145446083|NCT00130039|524484480|FG000|Overall Study|Withdrawal by Subject|15|||
145446084|NCT00130039|524484481|FG001|Overall Study|Withdrawal by Subject|11|||
145446085|NCT00130039|524484480|FG000|Overall Study|Lost to Follow-up|3|||
145446086|NCT00130039|524484481|FG001|Overall Study|Lost to Follow-up|1|||
145585335|NCT03165045|524995496|FG000|Visit 1|No treatment documented|10|||
145585336|NCT03165045|524995496|FG000|Visit 1|No visit 1|10|||
145585337|NCT03165045|524995496|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
145585338|NCT03165045|524995496|FG000|Visit 2|No available total CCQ score at all|29|||
145585339|NCT03165045|524995496|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
145585340|NCT00499889|524995500|FG000|Overall Study|Infection prior to treatment|1|||
145585341|NCT04369469|524995503|FG000|Overall Study|Lost to Follow-up|2|||
145585342|NCT04369469|524995504|FG001|Overall Study|Lost to Follow-up|4|||
145585343|NCT04369469|524995503|FG000|Overall Study|Physician Decision|2|||
145585344|NCT04369469|524995504|FG001|Overall Study|Physician Decision|1|||
145585345|NCT04369469|524995503|FG000|Overall Study|Withdrawal by Subject|2|||
145585346|NCT04369469|524995504|FG001|Overall Study|Withdrawal by Subject|3|||
145585347|NCT04369469|524995503|FG000|Overall Study|Adverse Event|1|||
145585348|NCT04369469|524995504|FG001|Overall Study|Adverse Event|0|||
145585349|NCT04369469|524995503|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
145446087|NCT00130039|524484480|FG000|Overall Study|Adverse Event|4|||
145446088|NCT00130039|524484481|FG001|Overall Study|Adverse Event|2|||
145446089|NCT00130039|524484480|FG000|Overall Study|Physician Decision|3|||
145446090|NCT00130039|524484481|FG001|Overall Study|Physician Decision|0|||
145585350|NCT04369469|524995504|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
145446091|NCT00130039|524484480|FG000|Overall Study|clinical events without follow up MRI|5|||
145446092|NCT00130039|524484481|FG001|Overall Study|clinical events without follow up MRI|4|||
145446093|NCT01928433|524484482|FG000|Overall Study|Adverse Event|5|||
145446094|NCT01928433|524484483|FG001|Overall Study|Adverse Event|2|||
145446095|NCT01928433|524484484|FG002|Overall Study|Adverse Event|5|||
145446096|NCT01928433|524484482|FG000|Overall Study|Protocol Violation|0|||
145446097|NCT01928433|524484483|FG001|Overall Study|Protocol Violation|0|||
145446098|NCT01928433|524484484|FG002|Overall Study|Protocol Violation|2|||
145585351|NCT04369469|524995503|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
145585352|NCT04369469|524995504|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
145585353|NCT04369469|524995503|FG000|Overall Study|Unable to Provide Consent|0|||
145446099|NCT01928433|524484482|FG000|Overall Study|Lack of Efficacy|5|||
145446100|NCT01928433|524484483|FG001|Overall Study|Lack of Efficacy|4|||
145446101|NCT01928433|524484484|FG002|Overall Study|Lack of Efficacy|4|||
145446102|NCT01928433|524484482|FG000|Overall Study|Withdrawal by Subject|0|||
145446103|NCT01928433|524484483|FG001|Overall Study|Withdrawal by Subject|4|||
145446104|NCT01928433|524484484|FG002|Overall Study|Withdrawal by Subject|0|||
145446105|NCT01928433|524484482|FG000|Overall Study|Negative screening urine culture|7|||
145446106|NCT01928433|524484483|FG001|Overall Study|Negative screening urine culture|6|||
145446107|NCT01928433|524484484|FG002|Overall Study|Negative screening urine culture|10|||
145446108|NCT01928433|524484482|FG000|Overall Study|Lost to Follow-up|0|||
145446109|NCT01928433|524484483|FG001|Overall Study|Lost to Follow-up|2|||
145446110|NCT01928433|524484484|FG002|Overall Study|Lost to Follow-up|3|||
145446111|NCT01928433|524484482|FG000|Overall Study|Other reasons|3|||
145446112|NCT01928433|524484483|FG001|Overall Study|Other reasons|3|||
145446113|NCT01928433|524484484|FG002|Overall Study|Other reasons|4|||
145446114|NCT01016132|524484485|FG000|Overall Study|Discomfort|1|||
145446115|NCT01198574|524484486|FG000|Overall Study|Resigned from schools|4|||
145446116|NCT01198574|524484487|FG001|Overall Study|Resigned from schools|1|||
145446117|NCT01198574|524484488|FG002|Overall Study|Resigned from schools|1|||
145446118|NCT01198574|524484489|FG003|Overall Study|Resigned from schools|4|||
145446119|NCT00556439|524484490|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
145446120|NCT00556439|524484491|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
145446121|NCT00556439|524484492|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
145446122|NCT00556439|524484493|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
145446123|NCT00556439|524484490|FG000|Study Entry to Week 12|Physician Decision|1|||
145446124|NCT00556439|524484491|FG001|Study Entry to Week 12|Physician Decision|0|||
145446125|NCT00556439|524484492|FG002|Study Entry to Week 12|Physician Decision|0|||
145446126|NCT00556439|524484493|FG003|Study Entry to Week 12|Physician Decision|0|||
145446127|NCT00556439|524484490|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
145446128|NCT00556439|524484491|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
145446129|NCT00556439|524484492|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
145446130|NCT00556439|524484493|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
145446131|NCT00556439|524484490|FG000|Study Entry to Week 12|Recurrent infection|1|||
145446132|NCT00556439|524484491|FG001|Study Entry to Week 12|Recurrent infection|0|||
145446133|NCT00556439|524484492|FG002|Study Entry to Week 12|Recurrent infection|0|||
145446134|NCT00556439|524484493|FG003|Study Entry to Week 12|Recurrent infection|0|||
145446135|NCT00556439|524484490|FG000|Study Entry to Week 12|Malignancy|0|||
145446136|NCT00556439|524484491|FG001|Study Entry to Week 12|Malignancy|0|||
145446137|NCT00556439|524484492|FG002|Study Entry to Week 12|Malignancy|1|||
145446138|NCT00556439|524484493|FG003|Study Entry to Week 12|Malignancy|0|||
145446139|NCT00556439|524484490|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
145446140|NCT00556439|524484491|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
145446141|NCT00556439|524484492|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
145446142|NCT00556439|524484493|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
145446143|NCT00556439|524484490|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
145446144|NCT00556439|524484491|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
145446145|NCT00556439|524484492|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
145446146|NCT00556439|524484493|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
145446147|NCT00556439|524484490|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
145446148|NCT00556439|524484491|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
145446149|NCT00556439|524484492|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
145446150|NCT00556439|524484493|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
145446151|NCT00556439|524484490|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
145446152|NCT00556439|524484491|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
145446153|NCT00556439|524484492|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
145446154|NCT00556439|524484493|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
145446155|NCT02100423|524484494|FG000|Overall Study|Death|1|||
145446156|NCT02100423|524484494|FG000|Overall Study|Withdrawal by Subject|3|||
145446157|NCT02100423|524484494|FG000|Overall Study|Adverse Event|1|||
145446158|NCT02100423|524484494|FG000|Overall Study|Physician Decision|1|||
145446159|NCT05823974|524486237|FG000|Overall Study|Lost to Follow-up|0|||
145446160|NCT05823974|524486238|FG001|Overall Study|Lost to Follow-up|3|||
145446161|NCT05823974|524486239|FG002|Overall Study|Lost to Follow-up|1|||
145446162|NCT05823974|524486240|FG003|Overall Study|Lost to Follow-up|0|||
145446163|NCT05823974|524486241|FG004|Overall Study|Lost to Follow-up|1|||
145446164|NCT05823974|524486242|FG005|Overall Study|Lost to Follow-up|0|||
145446165|NCT05823974|524486243|FG006|Overall Study|Lost to Follow-up|1|||
145446166|NCT05823974|524486244|FG007|Overall Study|Lost to Follow-up|0|||
145446167|NCT05823974|524486245|FG008|Overall Study|Lost to Follow-up|0|||
145446168|NCT05823974|524486246|FG009|Overall Study|Lost to Follow-up|1|||
145446169|NCT05823974|524486247|FG010|Overall Study|Lost to Follow-up|1|||
145446170|NCT05823974|524486248|FG011|Overall Study|Lost to Follow-up|0|||
145446171|NCT05823974|524486249|FG012|Overall Study|Lost to Follow-up|1|||
145446172|NCT05823974|524486250|FG013|Overall Study|Lost to Follow-up|2|||
145446173|NCT05823974|524486251|FG014|Overall Study|Lost to Follow-up|1|||
145446174|NCT05823974|524486252|FG015|Overall Study|Lost to Follow-up|1|||
145446175|NCT05823974|524486253|FG016|Overall Study|Lost to Follow-up|1|||
145446176|NCT05823974|524486254|FG017|Overall Study|Lost to Follow-up|0|||
145446177|NCT05823974|524486255|FG018|Overall Study|Lost to Follow-up|0|||
145446178|NCT05823974|524486256|FG019|Overall Study|Lost to Follow-up|2|||
145446179|NCT05823974|524486257|FG020|Overall Study|Lost to Follow-up|0|||
145446180|NCT05823974|524486237|FG000|Overall Study|Physician Decision|0|||
145446181|NCT05823974|524486238|FG001|Overall Study|Physician Decision|0|||
145446182|NCT05823974|524486239|FG002|Overall Study|Physician Decision|0|||
145446183|NCT05823974|524486240|FG003|Overall Study|Physician Decision|0|||
145446184|NCT05823974|524486241|FG004|Overall Study|Physician Decision|0|||
145446185|NCT05823974|524486242|FG005|Overall Study|Physician Decision|0|||
145446186|NCT05823974|524486243|FG006|Overall Study|Physician Decision|0|||
145446187|NCT05823974|524486244|FG007|Overall Study|Physician Decision|0|||
145446188|NCT05823974|524486245|FG008|Overall Study|Physician Decision|0|||
145446189|NCT05823974|524486246|FG009|Overall Study|Physician Decision|0|||
145446190|NCT05823974|524486247|FG010|Overall Study|Physician Decision|0|||
145446191|NCT05823974|524486248|FG011|Overall Study|Physician Decision|0|||
145446192|NCT05823974|524486249|FG012|Overall Study|Physician Decision|0|||
145446193|NCT05823974|524486250|FG013|Overall Study|Physician Decision|0|||
145446194|NCT05823974|524486251|FG014|Overall Study|Physician Decision|0|||
145446195|NCT05823974|524486252|FG015|Overall Study|Physician Decision|1|||
145446196|NCT05823974|524486253|FG016|Overall Study|Physician Decision|0|||
145446197|NCT05823974|524486254|FG017|Overall Study|Physician Decision|1|||
145446198|NCT05823974|524486255|FG018|Overall Study|Physician Decision|1|||
145446199|NCT05823974|524486256|FG019|Overall Study|Physician Decision|0|||
145446200|NCT05823974|524486257|FG020|Overall Study|Physician Decision|0|||
145446201|NCT05823974|524486237|FG000|Overall Study|Withdrawal by Subject|1|||
145446202|NCT05823974|524486238|FG001|Overall Study|Withdrawal by Subject|1|||
145446203|NCT05823974|524486239|FG002|Overall Study|Withdrawal by Subject|2|||
145446204|NCT05823974|524486240|FG003|Overall Study|Withdrawal by Subject|0|||
145446205|NCT05823974|524486241|FG004|Overall Study|Withdrawal by Subject|2|||
145446206|NCT05823974|524486242|FG005|Overall Study|Withdrawal by Subject|3|||
145446207|NCT05823974|524486243|FG006|Overall Study|Withdrawal by Subject|1|||
145446208|NCT05823974|524486244|FG007|Overall Study|Withdrawal by Subject|1|||
145446209|NCT05823974|524486245|FG008|Overall Study|Withdrawal by Subject|2|||
145446210|NCT05823974|524486246|FG009|Overall Study|Withdrawal by Subject|1|||
145446211|NCT05823974|524486247|FG010|Overall Study|Withdrawal by Subject|1|||
145446212|NCT05823974|524486248|FG011|Overall Study|Withdrawal by Subject|0|||
145446213|NCT05823974|524486249|FG012|Overall Study|Withdrawal by Subject|0|||
145446214|NCT05823974|524486250|FG013|Overall Study|Withdrawal by Subject|1|||
145446215|NCT05823974|524486251|FG014|Overall Study|Withdrawal by Subject|1|||
145446216|NCT05823974|524486252|FG015|Overall Study|Withdrawal by Subject|3|||
145446217|NCT05823974|524486253|FG016|Overall Study|Withdrawal by Subject|0|||
145446218|NCT05823974|524486254|FG017|Overall Study|Withdrawal by Subject|2|||
145446219|NCT05823974|524486255|FG018|Overall Study|Withdrawal by Subject|2|||
145446220|NCT05823974|524486256|FG019|Overall Study|Withdrawal by Subject|0|||
145446221|NCT05823974|524486257|FG020|Overall Study|Withdrawal by Subject|1|||
145446222|NCT05823974|524486237|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446223|NCT05823974|524486238|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446224|NCT05823974|524486239|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145446225|NCT05823974|524486240|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446226|NCT05823974|524486241|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145585354|NCT04369469|524995504|FG001|Overall Study|Unable to Provide Consent|1|||
145585355|NCT03135522|524995505|FG000|Overall Study|Adverse Event|1|||
145585356|NCT03135522|524995506|FG001|Overall Study|Adverse Event|0|||
145585357|NCT00499369|524995507|FG000|Overall Study|Adverse Event|2|||
145585358|NCT00499369|524995508|FG001|Overall Study|Adverse Event|2|||
145585359|NCT00499369|524995509|FG002|Overall Study|Adverse Event|3|||
145585360|NCT00499369|524995510|FG003|Overall Study|Adverse Event|1|||
145585361|NCT00499369|524995511|FG004|Overall Study|Adverse Event|2|||
145446227|NCT05823974|524486242|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446228|NCT05823974|524486243|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446229|NCT05823974|524486244|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446230|NCT05823974|524486245|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446231|NCT05823974|524486246|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446232|NCT05823974|524486247|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446233|NCT05823974|524486248|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446234|NCT05823974|524486249|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446235|NCT05823974|524486250|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145585362|NCT00499369|524995507|FG000|Overall Study|Withdrawal by Subject|0|||
145585363|NCT00499369|524995508|FG001|Overall Study|Withdrawal by Subject|1|||
145585364|NCT00499369|524995509|FG002|Overall Study|Withdrawal by Subject|1|||
145585365|NCT00499369|524995510|FG003|Overall Study|Withdrawal by Subject|0|||
145585366|NCT00499369|524995511|FG004|Overall Study|Withdrawal by Subject|0|||
145585367|NCT00499369|524995507|FG000|Overall Study|Progression|10|||
145585368|NCT00499369|524995508|FG001|Overall Study|Progression|12|||
145585369|NCT00499369|524995509|FG002|Overall Study|Progression|9|||
145585370|NCT00499369|524995510|FG003|Overall Study|Progression|6|||
145585371|NCT00499369|524995511|FG004|Overall Study|Progression|10|||
145585372|NCT00499369|524995507|FG000|Overall Study|Death|0|||
145585373|NCT00499369|524995508|FG001|Overall Study|Death|1|||
145585374|NCT00499369|524995509|FG002|Overall Study|Death|0|||
145585375|NCT00499369|524995510|FG003|Overall Study|Death|0|||
145585376|NCT00499369|524995511|FG004|Overall Study|Death|0|||
145585377|NCT00499369|524995507|FG000|Overall Study|Not protocol specified|2|||
145585378|NCT00499369|524995508|FG001|Overall Study|Not protocol specified|0|||
145585379|NCT00499369|524995509|FG002|Overall Study|Not protocol specified|3|||
145585380|NCT00499369|524995510|FG003|Overall Study|Not protocol specified|1|||
145585381|NCT00499369|524995511|FG004|Overall Study|Not protocol specified|0|||
145446236|NCT05823974|524486251|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
145446237|NCT05823974|524486252|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446238|NCT05823974|524486253|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446239|NCT05823974|524486254|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446240|NCT05823974|524486255|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446241|NCT05823974|524486256|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446242|NCT05823974|524486257|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
145446243|NCT05823974|524486237|FG000|Overall Study|Other|0|||
145446244|NCT05823974|524486238|FG001|Overall Study|Other|1|||
145446245|NCT05823974|524486239|FG002|Overall Study|Other|1|||
145446246|NCT05823974|524486240|FG003|Overall Study|Other|1|||
145446247|NCT05823974|524486241|FG004|Overall Study|Other|0|||
145446248|NCT05823974|524486242|FG005|Overall Study|Other|1|||
145446249|NCT05823974|524486243|FG006|Overall Study|Other|1|||
145446250|NCT05823974|524486244|FG007|Overall Study|Other|1|||
145446251|NCT05823974|524486245|FG008|Overall Study|Other|1|||
145446252|NCT05823974|524486246|FG009|Overall Study|Other|0|||
145446253|NCT05823974|524486247|FG010|Overall Study|Other|0|||
145446254|NCT05823974|524486248|FG011|Overall Study|Other|0|||
145446255|NCT05823974|524486249|FG012|Overall Study|Other|2|||
145446256|NCT05823974|524486250|FG013|Overall Study|Other|1|||
145446257|NCT05823974|524486251|FG014|Overall Study|Other|0|||
145446258|NCT05823974|524486252|FG015|Overall Study|Other|1|||
145446259|NCT05823974|524486253|FG016|Overall Study|Other|0|||
145446260|NCT05823974|524486254|FG017|Overall Study|Other|0|||
145446261|NCT05823974|524486255|FG018|Overall Study|Other|0|||
145446262|NCT05823974|524486256|FG019|Overall Study|Other|0|||
145446263|NCT05823974|524486257|FG020|Overall Study|Other|0|||
145585382|NCT00499369|524995507|FG000|Overall Study|Ineligible|2|||
145446264|NCT01238991|524486262|FG000|Overall Study|Adverse Event|1|||
145446265|NCT01238991|524486263|FG001|Overall Study|Adverse Event|0|||
145446266|NCT01238991|524486264|FG002|Overall Study|Adverse Event|3|||
145446267|NCT01238991|524486265|FG003|Overall Study|Adverse Event|1|||
145446268|NCT01238991|524486266|FG004|Overall Study|Adverse Event|1|||
145446269|NCT01238991|524486267|FG005|Overall Study|Adverse Event|0|||
145446270|NCT01238991|524486268|FG006|Overall Study|Adverse Event|1|||
145446271|NCT01238991|524486269|FG007|Overall Study|Adverse Event|1|||
145446272|NCT01238991|524486270|FG008|Overall Study|Adverse Event|0|||
145585383|NCT00499369|524995508|FG001|Overall Study|Ineligible|2|||
145585384|NCT00499369|524995509|FG002|Overall Study|Ineligible|1|||
145585385|NCT00499369|524995510|FG003|Overall Study|Ineligible|1|||
145585386|NCT00499369|524995511|FG004|Overall Study|Ineligible|0|||
145585387|NCT01660906|524995512|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
145585388|NCT01773226|524997516|FG000|Overall Study|Withdrawal by Subject|1|||
145585389|NCT00993447|524997523|FG000|Overall Study|Withdrawal by Subject|23|||
145585390|NCT00993447|524997524|FG001|Overall Study|Withdrawal by Subject|8|||
145585391|NCT00993447|524997523|FG000|Overall Study|Protocol Violation|12|||
145585392|NCT00993447|524997524|FG001|Overall Study|Protocol Violation|8|||
145585393|NCT00993447|524997523|FG000|Overall Study|Lost to Follow-up|1|||
145585394|NCT00993447|524997524|FG001|Overall Study|Lost to Follow-up|3|||
145585395|NCT00993447|524997523|FG000|Overall Study|Adverse Event|1|||
145585396|NCT00993447|524997524|FG001|Overall Study|Adverse Event|0|||
145585397|NCT00970502|524997525|FG000|Overall Study|Withdrawal by Subject|1|||
145585398|NCT02041195|524997526|FG000|Overall Study|Adverse Event|1|||
145585399|NCT02041195|524997527|FG001|Overall Study|Adverse Event|2|||
145585400|NCT02041195|524997528|FG002|Overall Study|Adverse Event|0|||
145585401|NCT02041195|524997529|FG003|Overall Study|Adverse Event|0|||
145585402|NCT02041195|524997530|FG004|Overall Study|Adverse Event|0|||
145585403|NCT02041195|524997531|FG005|Overall Study|Adverse Event|0|||
145585404|NCT02041195|524997532|FG006|Overall Study|Adverse Event|3|||
145585405|NCT02041195|524997533|FG007|Overall Study|Adverse Event|0|||
145585406|NCT02041195|524997526|FG000|Overall Study|Withdrawal by Subject|1|||
145585407|NCT02041195|524997527|FG001|Overall Study|Withdrawal by Subject|0|||
145446273|NCT01238991|524486271|FG009|Overall Study|Adverse Event|0|||
145446274|NCT01238991|524486262|FG000|Overall Study|Death|0|||
145446275|NCT01238991|524486263|FG001|Overall Study|Death|0|||
145446276|NCT01238991|524486264|FG002|Overall Study|Death|0|||
145446277|NCT01238991|524486265|FG003|Overall Study|Death|1|||
145446278|NCT01238991|524486266|FG004|Overall Study|Death|0|||
145446279|NCT01238991|524486267|FG005|Overall Study|Death|0|||
145446280|NCT01238991|524486268|FG006|Overall Study|Death|0|||
145446281|NCT01238991|524486269|FG007|Overall Study|Death|0|||
145446282|NCT01238991|524486270|FG008|Overall Study|Death|0|||
145446283|NCT01238991|524486271|FG009|Overall Study|Death|0|||
145446284|NCT01238991|524486262|FG000|Overall Study|Lack of Efficacy|0|||
145446285|NCT01238991|524486263|FG001|Overall Study|Lack of Efficacy|0|||
145446286|NCT01238991|524486264|FG002|Overall Study|Lack of Efficacy|1|||
145446287|NCT01238991|524486265|FG003|Overall Study|Lack of Efficacy|0|||
145446288|NCT01238991|524486266|FG004|Overall Study|Lack of Efficacy|0|||
145446289|NCT01238991|524486267|FG005|Overall Study|Lack of Efficacy|0|||
145446290|NCT01238991|524486268|FG006|Overall Study|Lack of Efficacy|0|||
145446291|NCT01238991|524486269|FG007|Overall Study|Lack of Efficacy|0|||
145446292|NCT01238991|524486270|FG008|Overall Study|Lack of Efficacy|1|||
145446293|NCT01238991|524486271|FG009|Overall Study|Lack of Efficacy|0|||
145446294|NCT01238991|524486262|FG000|Overall Study|Withdrawal by Subject|0|||
145446295|NCT01238991|524486263|FG001|Overall Study|Withdrawal by Subject|0|||
145446296|NCT01238991|524486264|FG002|Overall Study|Withdrawal by Subject|1|||
145446297|NCT01238991|524486265|FG003|Overall Study|Withdrawal by Subject|0|||
145446298|NCT01238991|524486266|FG004|Overall Study|Withdrawal by Subject|0|||
145446299|NCT01238991|524486267|FG005|Overall Study|Withdrawal by Subject|0|||
145446300|NCT01238991|524486268|FG006|Overall Study|Withdrawal by Subject|0|||
145446301|NCT01238991|524486269|FG007|Overall Study|Withdrawal by Subject|0|||
145446302|NCT01238991|524486270|FG008|Overall Study|Withdrawal by Subject|0|||
145446303|NCT01238991|524486271|FG009|Overall Study|Withdrawal by Subject|0|||
145446304|NCT01238991|524486262|FG000|Overall Study|Study Terminated by Sponsor|0|||
145446305|NCT01238991|524486263|FG001|Overall Study|Study Terminated by Sponsor|0|||
145446306|NCT01238991|524486264|FG002|Overall Study|Study Terminated by Sponsor|0|||
145446307|NCT01238991|524486265|FG003|Overall Study|Study Terminated by Sponsor|0|||
145446308|NCT01238991|524486266|FG004|Overall Study|Study Terminated by Sponsor|1|||
145446309|NCT01238991|524486267|FG005|Overall Study|Study Terminated by Sponsor|0|||
145446310|NCT01238991|524486268|FG006|Overall Study|Study Terminated by Sponsor|7|||
145446311|NCT01238991|524486269|FG007|Overall Study|Study Terminated by Sponsor|4|||
145446312|NCT01238991|524486270|FG008|Overall Study|Study Terminated by Sponsor|2|||
145446313|NCT01238991|524486271|FG009|Overall Study|Study Terminated by Sponsor|2|||
145446314|NCT01238991|524486262|FG000|Overall Study|Caregiver's request|0|||
145446315|NCT01238991|524486263|FG001|Overall Study|Caregiver's request|0|||
145446316|NCT01238991|524486264|FG002|Overall Study|Caregiver's request|0|||
145446317|NCT01238991|524486265|FG003|Overall Study|Caregiver's request|0|||
145446318|NCT01238991|524486266|FG004|Overall Study|Caregiver's request|0|||
145446319|NCT01238991|524486267|FG005|Overall Study|Caregiver's request|0|||
145446320|NCT01238991|524486268|FG006|Overall Study|Caregiver's request|0|||
145446321|NCT01238991|524486269|FG007|Overall Study|Caregiver's request|0|||
145446322|NCT01238991|524486270|FG008|Overall Study|Caregiver's request|1|||
145446323|NCT01238991|524486271|FG009|Overall Study|Caregiver's request|0|||
145446324|NCT01238991|524486262|FG000|Overall Study|Admission to a nursing home|1|||
145446325|NCT01238991|524486263|FG001|Overall Study|Admission to a nursing home|0|||
145446326|NCT01238991|524486264|FG002|Overall Study|Admission to a nursing home|1|||
145446327|NCT01238991|524486265|FG003|Overall Study|Admission to a nursing home|0|||
145446328|NCT01238991|524486266|FG004|Overall Study|Admission to a nursing home|0|||
145446329|NCT01238991|524486267|FG005|Overall Study|Admission to a nursing home|0|||
145446330|NCT01238991|524486268|FG006|Overall Study|Admission to a nursing home|0|||
145446331|NCT01238991|524486269|FG007|Overall Study|Admission to a nursing home|0|||
145446332|NCT01238991|524486270|FG008|Overall Study|Admission to a nursing home|0|||
145446333|NCT01238991|524486271|FG009|Overall Study|Admission to a nursing home|0|||
145585408|NCT02041195|524997528|FG002|Overall Study|Withdrawal by Subject|0|||
145446334|NCT02222688|524486275|FG000|Overall Study|Withdrawal by Subject|0|||
145446335|NCT02222688|524486276|FG001|Overall Study|Withdrawal by Subject|0|||
145446336|NCT02222688|524486277|FG002|Overall Study|Withdrawal by Subject|0|||
145446337|NCT02222688|524486278|FG003|Overall Study|Withdrawal by Subject|2|||
145446338|NCT02222688|524486279|FG004|Overall Study|Withdrawal by Subject|1|||
145446339|NCT02222688|524486280|FG005|Overall Study|Withdrawal by Subject|0|||
145585409|NCT02041195|524997529|FG003|Overall Study|Withdrawal by Subject|0|||
145446340|NCT02222688|524486281|FG006|Overall Study|Withdrawal by Subject|1|||
145446341|NCT02222688|524486275|FG000|Overall Study|Disease progression|1|||
145446342|NCT02222688|524486276|FG001|Overall Study|Disease progression|0|||
145446343|NCT02222688|524486277|FG002|Overall Study|Disease progression|0|||
145446344|NCT02222688|524486278|FG003|Overall Study|Disease progression|0|||
145446345|NCT02222688|524486279|FG004|Overall Study|Disease progression|0|||
145446346|NCT02222688|524486280|FG005|Overall Study|Disease progression|0|||
145446347|NCT02222688|524486281|FG006|Overall Study|Disease progression|0|||
145446348|NCT00294671|524486284|FG000|Overall Study|Lack of Efficacy|11|||
145585410|NCT02041195|524997530|FG004|Overall Study|Withdrawal by Subject|0|||
145446349|NCT00294671|524486285|FG001|Overall Study|Lack of Efficacy|23|||
145446350|NCT00294671|524486284|FG000|Overall Study|Liver transplant|7|||
145446351|NCT00294671|524486285|FG001|Overall Study|Liver transplant|9|||
145446352|NCT00294671|524486284|FG000|Overall Study|Drug related adverse event (AE)|4|||
145446353|NCT00294671|524486285|FG001|Overall Study|Drug related adverse event (AE)|2|||
145446354|NCT00294671|524486284|FG000|Overall Study|Non-drug related AE|3|||
145446355|NCT00294671|524486285|FG001|Overall Study|Non-drug related AE|2|||
145446356|NCT00294671|524486284|FG000|Overall Study|Lost to Follow-up|1|||
145625992|NCT00480441|525144139|FG001|Baseline Functional MRI|physical contraindication|0|||
145446357|NCT00294671|524486285|FG001|Overall Study|Lost to Follow-up|3|||
145446358|NCT00294671|524486284|FG000|Overall Study|Non-compliance|1|||
145446359|NCT00294671|524486285|FG001|Overall Study|Non-compliance|0|||
145446360|NCT00294671|524486284|FG000|Overall Study|Death|0|||
145446361|NCT00294671|524486285|FG001|Overall Study|Death|1|||
145446362|NCT01188551|524486293|FG000|Overall Study|Pharmacy issues|1|||
145446363|NCT01188551|524486294|FG001|Overall Study|Pharmacy issues|0|||
145446364|NCT01188551|524486295|FG002|Overall Study|Pharmacy issues|0|||
145446365|NCT01188551|524486296|FG003|Overall Study|Pharmacy issues|0|||
145446366|NCT00391053|524486297|FG000|Overall Study|Serious Adverse Events|1|||
145446367|NCT00391053|524486298|FG001|Overall Study|Serious Adverse Events|0|||
145446368|NCT00391053|524486299|FG002|Overall Study|Serious Adverse Events|1|||
145446369|NCT00391053|524486300|FG003|Overall Study|Serious Adverse Events|4|||
145446370|NCT00391053|524486297|FG000|Overall Study|Protocol Violation|2|||
145446371|NCT00391053|524486298|FG001|Overall Study|Protocol Violation|0|||
145446372|NCT00391053|524486299|FG002|Overall Study|Protocol Violation|0|||
145446373|NCT00391053|524486300|FG003|Overall Study|Protocol Violation|0|||
145446374|NCT00391053|524486297|FG000|Overall Study|Lost to Follow-up|1|||
145446375|NCT00391053|524486298|FG001|Overall Study|Lost to Follow-up|0|||
145446376|NCT00391053|524486299|FG002|Overall Study|Lost to Follow-up|0|||
145446377|NCT00391053|524486300|FG003|Overall Study|Lost to Follow-up|5|||
145446378|NCT00391053|524486297|FG000|Overall Study|Withdrawal by Subject|5|||
145446379|NCT00391053|524486298|FG001|Overall Study|Withdrawal by Subject|1|||
145446380|NCT00391053|524486299|FG002|Overall Study|Withdrawal by Subject|1|||
145446381|NCT00391053|524486300|FG003|Overall Study|Withdrawal by Subject|1|||
145446382|NCT00473889|524486301|FG000|Overall Study|Did not receive study medication|1|||
145446383|NCT00473889|524486302|FG001|Overall Study|Did not receive study medication|4|||
145446384|NCT00473889|524486301|FG000|Overall Study|Adverse Event|30|||
145446385|NCT00473889|524486302|FG001|Overall Study|Adverse Event|17|||
145446386|NCT00473889|524486301|FG000|Overall Study|Protocol Violation|4|||
145446387|NCT00473889|524486302|FG001|Overall Study|Protocol Violation|2|||
145446388|NCT00473889|524486301|FG000|Overall Study|Lack of Efficacy|28|||
145446389|NCT00473889|524486302|FG001|Overall Study|Lack of Efficacy|29|||
145446390|NCT00473889|524486301|FG000|Overall Study|Lost to Follow-up|2|||
145446391|NCT00473889|524486302|FG001|Overall Study|Lost to Follow-up|1|||
145446392|NCT00473889|524486301|FG000|Overall Study|Physician Decision|10|||
145446393|NCT00473889|524486302|FG001|Overall Study|Physician Decision|5|||
145446394|NCT00473889|524486301|FG000|Overall Study|Trial Terminated|3|||
145446395|NCT00473889|524486302|FG001|Overall Study|Trial Terminated|6|||
145446396|NCT00473889|524486301|FG000|Overall Study|Withdrawal by Subject|5|||
145446397|NCT00473889|524486302|FG001|Overall Study|Withdrawal by Subject|0|||
145446398|NCT02140970|524486303|FG000|Overall Study|Lost to Follow-up|1|||
145446399|NCT02140970|524486304|FG001|Overall Study|Lost to Follow-up|2|||
145446400|NCT02140970|524486303|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
145446401|NCT02140970|524486304|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
145446402|NCT02140970|524486303|FG000|Overall Study|Did not meet inclusion criteria|0|||
145446403|NCT02140970|524486304|FG001|Overall Study|Did not meet inclusion criteria|1|||
145446404|NCT01947283|524486305|FG000|Overall Study|Death|1|||
145446405|NCT01947283|524486306|FG001|Overall Study|Death|1|||
145446406|NCT01947283|524486307|FG002|Overall Study|Death|1|||
145446407|NCT01947283|524486308|FG003|Overall Study|Death|0|||
145446408|NCT01947283|524486309|FG004|Overall Study|Death|0|||
145446409|NCT01947283|524486310|FG005|Overall Study|Death|0|||
145446410|NCT01947283|524486311|FG006|Overall Study|Death|0|||
145446411|NCT01947283|524486305|FG000|Overall Study|Lost to Follow-up|4|||
145446412|NCT01947283|524486306|FG001|Overall Study|Lost to Follow-up|6|||
145446413|NCT01947283|524486307|FG002|Overall Study|Lost to Follow-up|5|||
145446414|NCT01947283|524486308|FG003|Overall Study|Lost to Follow-up|5|||
145446415|NCT01947283|524486309|FG004|Overall Study|Lost to Follow-up|0|||
145446416|NCT01947283|524486310|FG005|Overall Study|Lost to Follow-up|2|||
145446417|NCT01947283|524486311|FG006|Overall Study|Lost to Follow-up|5|||
145446418|NCT01947283|524486305|FG000|Overall Study|Withdrawal by Subject|10|||
145446419|NCT01947283|524486306|FG001|Overall Study|Withdrawal by Subject|8|||
145446420|NCT01947283|524486307|FG002|Overall Study|Withdrawal by Subject|4|||
145446421|NCT01947283|524486308|FG003|Overall Study|Withdrawal by Subject|1|||
145446422|NCT01947283|524486309|FG004|Overall Study|Withdrawal by Subject|0|||
145446423|NCT01947283|524486310|FG005|Overall Study|Withdrawal by Subject|0|||
145446424|NCT01947283|524486311|FG006|Overall Study|Withdrawal by Subject|2|||
145446425|NCT01947283|524486305|FG000|Overall Study|No Clinical Recording|12|||
145446426|NCT01947283|524486306|FG001|Overall Study|No Clinical Recording|6|||
145585411|NCT02041195|524997531|FG005|Overall Study|Withdrawal by Subject|0|||
145585412|NCT02041195|524997532|FG006|Overall Study|Withdrawal by Subject|4|||
145585413|NCT02041195|524997533|FG007|Overall Study|Withdrawal by Subject|3|||
145585414|NCT02041195|524997526|FG000|Overall Study|Unable to comply with study visits|0|||
145585415|NCT02041195|524997527|FG001|Overall Study|Unable to comply with study visits|1|||
145585416|NCT02041195|524997528|FG002|Overall Study|Unable to comply with study visits|0|||
145585417|NCT02041195|524997529|FG003|Overall Study|Unable to comply with study visits|0|||
145585418|NCT02041195|524997530|FG004|Overall Study|Unable to comply with study visits|1|||
145585419|NCT02041195|524997531|FG005|Overall Study|Unable to comply with study visits|0|||
145585420|NCT02041195|524997532|FG006|Overall Study|Unable to comply with study visits|0|||
145585421|NCT02041195|524997533|FG007|Overall Study|Unable to comply with study visits|0|||
145585422|NCT03564496|524997534|FG000|Overall Study|Withdrawal by Subject|1|||
145585423|NCT03564496|524997535|FG001|Overall Study|Withdrawal by Subject|1|||
145585424|NCT03564496|524997536|FG002|Overall Study|Withdrawal by Subject|0|||
145446427|NCT01947283|524486307|FG002|Overall Study|No Clinical Recording|8|||
145446428|NCT01947283|524486308|FG003|Overall Study|No Clinical Recording|10|||
145446429|NCT01947283|524486309|FG004|Overall Study|No Clinical Recording|0|||
145446430|NCT01947283|524486310|FG005|Overall Study|No Clinical Recording|0|||
145446431|NCT01947283|524486311|FG006|Overall Study|No Clinical Recording|0|||
145446432|NCT01947283|524486305|FG000|Overall Study|Non-coding Clinical Recording language|0|||
145446433|NCT01947283|524486306|FG001|Overall Study|Non-coding Clinical Recording language|0|||
145446434|NCT01947283|524486307|FG002|Overall Study|Non-coding Clinical Recording language|0|||
145446435|NCT01947283|524486308|FG003|Overall Study|Non-coding Clinical Recording language|1|||
145446436|NCT01947283|524486309|FG004|Overall Study|Non-coding Clinical Recording language|0|||
145446437|NCT01947283|524486310|FG005|Overall Study|Non-coding Clinical Recording language|0|||
145446438|NCT01947283|524486311|FG006|Overall Study|Non-coding Clinical Recording language|0|||
145446439|NCT01947283|524486305|FG000|Overall Study|Missing Follow-up Assessment|2|||
145446440|NCT01947283|524486306|FG001|Overall Study|Missing Follow-up Assessment|2|||
145446441|NCT01947283|524486307|FG002|Overall Study|Missing Follow-up Assessment|3|||
145446442|NCT01947283|524486308|FG003|Overall Study|Missing Follow-up Assessment|0|||
145446443|NCT01947283|524486309|FG004|Overall Study|Missing Follow-up Assessment|0|||
145446444|NCT01947283|524486310|FG005|Overall Study|Missing Follow-up Assessment|2|||
145446445|NCT01947283|524486311|FG006|Overall Study|Missing Follow-up Assessment|0|||
145446446|NCT01947283|524486305|FG000|Overall Study|No patients were enrolled in study|0|||
145446447|NCT01947283|524486306|FG001|Overall Study|No patients were enrolled in study|0|||
145446448|NCT01947283|524486307|FG002|Overall Study|No patients were enrolled in study|0|||
145446449|NCT01947283|524486308|FG003|Overall Study|No patients were enrolled in study|0|||
145446450|NCT01947283|524486309|FG004|Overall Study|No patients were enrolled in study|0|||
145446451|NCT01947283|524486310|FG005|Overall Study|No patients were enrolled in study|3|||
145446452|NCT01947283|524486311|FG006|Overall Study|No patients were enrolled in study|1|||
145446453|NCT00430989|524486312|FG000|Overall Study|Lost to Follow-up|2|||
145446454|NCT00430989|524486313|FG001|Overall Study|Lost to Follow-up|3|||
145446455|NCT00430989|524486312|FG000|Overall Study|Withdrawal by Subject|15|||
145446456|NCT00430989|524486313|FG001|Overall Study|Withdrawal by Subject|14|||
145446457|NCT00430989|524486312|FG000|Overall Study|Protocol Violation|30|||
145446458|NCT00430989|524486313|FG001|Overall Study|Protocol Violation|37|||
145446459|NCT00430989|524486312|FG000|Overall Study|Not eligible|13|||
145446460|NCT00430989|524486313|FG001|Overall Study|Not eligible|6|||
145446461|NCT03782259|524486314|FG000|Overall Study|Lost to Follow-up|1|||
145446462|NCT03782259|524486315|FG001|Overall Study|Lost to Follow-up|1|||
145446463|NCT03782259|524486314|FG000|Overall Study|Moved out of state|0|||
145446464|NCT03782259|524486315|FG001|Overall Study|Moved out of state|2|||
145446465|NCT03782259|524486314|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
145446466|NCT03782259|524486315|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
145446467|NCT03782259|524486314|FG000|Overall Study|Subject discontinued intervention|1|||
145446468|NCT03782259|524486315|FG001|Overall Study|Subject discontinued intervention|0|||
145585425|NCT03564496|524997534|FG000|Overall Study|Screen failure|0|||
145585426|NCT03564496|524997535|FG001|Overall Study|Screen failure|3|||
145585427|NCT03564496|524997536|FG002|Overall Study|Screen failure|0|||
145585428|NCT00674986|524997537|FG000|Overall Study|Adverse Event|2|||
145446469|NCT05069597|524486316|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145446470|NCT05069597|524486317|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
145446471|NCT01014767|524486318|FG000|Overall Study|PI left institution, data unavailable|12|||
145446472|NCT01014767|524486319|FG001|Overall Study|PI left institution, data unavailable|1|||
145446473|NCT01014767|524486320|FG002|Overall Study|PI left institution, data unavailable|4|||
145446474|NCT01014767|524486321|FG003|Overall Study|PI left institution, data unavailable|1|||
145446475|NCT00131352|524486325|FG000|Initial Treatment Period|Adverse Event|1|||
145446476|NCT00131352|524486326|FG001|Initial Treatment Period|Adverse Event|3|||
145446477|NCT00131352|524486325|FG000|Initial Treatment Period|Non-compliant|1|||
145585429|NCT00674986|524997538|FG001|Overall Study|Adverse Event|1|||
145585430|NCT00674986|524997537|FG000|Overall Study|Subject withdrew consent|12|||
145585431|NCT00674986|524997538|FG001|Overall Study|Subject withdrew consent|19|||
145446478|NCT00131352|524486326|FG001|Initial Treatment Period|Non-compliant|2|||
145446479|NCT00131352|524486325|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
145446480|NCT00131352|524486326|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
145446481|NCT00131352|524486325|FG000|Initial Treatment Period|Lack of Efficacy|6|||
145446482|NCT00131352|524486326|FG001|Initial Treatment Period|Lack of Efficacy|4|||
145446483|NCT00131352|524486325|FG000|Initial Treatment Period|Other|0|||
145446484|NCT00131352|524486326|FG001|Initial Treatment Period|Other|2|||
145446485|NCT00131352|524486325|FG000|Repeat Treatment Period|Adverse Event|1|||
145446486|NCT00131352|524486326|FG001|Repeat Treatment Period|Adverse Event|0|||
145446487|NCT00131352|524486325|FG000|Repeat Treatment Period|Other|1|||
145446488|NCT00131352|524486326|FG001|Repeat Treatment Period|Other|0|||
145446489|NCT02553928|524486327|FG000|Overall Study|Adverse Event|2|||
145446490|NCT02553928|524486328|FG001|Overall Study|Adverse Event|1|||
145446491|NCT02553928|524486327|FG000|Overall Study|Lost to Follow-up|0|||
145446492|NCT02553928|524486328|FG001|Overall Study|Lost to Follow-up|1|||
145446493|NCT02553928|524486327|FG000|Overall Study|Administrative reason(s)|0|||
145446494|NCT02553928|524486328|FG001|Overall Study|Administrative reason(s)|1|||
145446495|NCT02526212|524486331|FG000|Overall Study|Incarceration|1|||
145446496|NCT02526212|524486332|FG001|Overall Study|Incarceration|0|||
145446497|NCT02526212|524486331|FG000|Overall Study|Lost to Follow-up|1|||
145446498|NCT02526212|524486332|FG001|Overall Study|Lost to Follow-up|0|||
145446499|NCT02526212|524486331|FG000|Overall Study|Death|0|||
145446500|NCT02526212|524486332|FG001|Overall Study|Death|1|||
145446501|NCT00606411|524486333|FG000|Overall Study|Adverse Event|1|||
145446502|NCT00606411|524486334|FG001|Overall Study|Adverse Event|2|||
145446503|NCT00606411|524486333|FG000|Overall Study|Lack of Adherence|1|||
145446504|NCT00606411|524486334|FG001|Overall Study|Lack of Adherence|1|||
145446505|NCT00606411|524486333|FG000|Overall Study|Lack of Efficacy|1|||
145446506|NCT00606411|524486334|FG001|Overall Study|Lack of Efficacy|1|||
145446507|NCT00606411|524486333|FG000|Overall Study|Withdrawal by Subject|2|||
145446508|NCT00606411|524486334|FG001|Overall Study|Withdrawal by Subject|0|||
145446509|NCT00606411|524486333|FG000|Overall Study|Lost to Follow-up|1|||
145446510|NCT00606411|524486334|FG001|Overall Study|Lost to Follow-up|2|||
145446511|NCT00606411|524486333|FG000|Overall Study|Move out of state|0|||
145446512|NCT00606411|524486334|FG001|Overall Study|Move out of state|1|||
145446513|NCT02443337|524486336|FG000|Overall Study|Adverse Event|0|||
145446514|NCT02443337|524486337|FG001|Overall Study|Adverse Event|1|||
145446515|NCT02443337|524486336|FG000|Overall Study|Clinical Progressive Disease|3|||
145446516|NCT02443337|524486337|FG001|Overall Study|Clinical Progressive Disease|0|||
145446517|NCT02443337|524486336|FG000|Overall Study|Withdrawal by Subject|2|||
145446518|NCT02443337|524486337|FG001|Overall Study|Withdrawal by Subject|1|||
145446519|NCT02096952|524486338|FG000|Overall Study|Adverse Event|1|||
145446520|NCT00040742|524486339|FG000|Overall Study|Death|0|||
145446521|NCT00040742|524486340|FG001|Overall Study|Death|0|||
145446522|NCT00040742|524486341|FG002|Overall Study|Death|1|||
145446523|NCT00040742|524486342|FG003|Overall Study|Death|0|||
145446524|NCT00040742|524486339|FG000|Overall Study|Adverse Event|15|||
145446525|NCT00040742|524486340|FG001|Overall Study|Adverse Event|16|||
145446526|NCT00040742|524486341|FG002|Overall Study|Adverse Event|21|||
145446527|NCT00040742|524486342|FG003|Overall Study|Adverse Event|9|||
145446528|NCT00040742|524486339|FG000|Overall Study|Withdrawal by Subject|7|||
145446529|NCT00040742|524486340|FG001|Overall Study|Withdrawal by Subject|15|||
145446530|NCT00040742|524486341|FG002|Overall Study|Withdrawal by Subject|10|||
145446531|NCT00040742|524486342|FG003|Overall Study|Withdrawal by Subject|13|||
145446532|NCT00040742|524486339|FG000|Overall Study|Chemotoxicity|4|||
145446533|NCT00040742|524486340|FG001|Overall Study|Chemotoxicity|3|||
145446534|NCT00040742|524486341|FG002|Overall Study|Chemotoxicity|5|||
145446535|NCT00040742|524486342|FG003|Overall Study|Chemotoxicity|2|||
145446536|NCT00040742|524486339|FG000|Overall Study|Incomplete Forms|6|||
145446537|NCT00040742|524486340|FG001|Overall Study|Incomplete Forms|10|||
145585432|NCT00674986|524997537|FG000|Overall Study|Lost to Follow-up|25|||
145585433|NCT00674986|524997538|FG001|Overall Study|Lost to Follow-up|53|||
145585434|NCT00674986|524997537|FG000|Overall Study|Other reasons|4|||
145446538|NCT00040742|524486341|FG002|Overall Study|Incomplete Forms|4|||
145446539|NCT00040742|524486342|FG003|Overall Study|Incomplete Forms|5|||
145446540|NCT00040742|524486339|FG000|Overall Study|Other medical|7|||
145446541|NCT00040742|524486340|FG001|Overall Study|Other medical|5|||
145446542|NCT00040742|524486341|FG002|Overall Study|Other medical|5|||
145446543|NCT00040742|524486342|FG003|Overall Study|Other medical|5|||
145446544|NCT00624468|524486343|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
145446545|NCT00624468|524486344|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
145446546|NCT00624468|524486345|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
145446547|NCT00624468|524486346|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
145446548|NCT00624468|524486343|FG000|Double-blind Period|Withdrew Prematurely|1|||
145446549|NCT00624468|524486344|FG001|Double-blind Period|Withdrew Prematurely|1|||
145446550|NCT00624468|524486345|FG002|Double-blind Period|Withdrew Prematurely|0|||
145446551|NCT00624468|524486346|FG003|Double-blind Period|Withdrew Prematurely|0|||
145446552|NCT00624468|524486343|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
145446553|NCT00624468|524486344|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
145446554|NCT00624468|524486345|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
145446555|NCT00624468|524486346|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
145446556|NCT00624468|524486343|FG000|Safety Follow-up (SFU) Period|Other|0|||
145446557|NCT00624468|524486344|FG001|Safety Follow-up (SFU) Period|Other|0|||
145446558|NCT00624468|524486345|FG002|Safety Follow-up (SFU) Period|Other|1|||
145446559|NCT00624468|524486346|FG003|Safety Follow-up (SFU) Period|Other|1|||
145446560|NCT00635349|524486348|FG000|Overall Study|Other|8|||
145446561|NCT00635349|524486349|FG001|Overall Study|Other|6|||
145446562|NCT00635349|524486348|FG000|Overall Study|Protocol Violation|18|||
145446563|NCT00635349|524486349|FG001|Overall Study|Protocol Violation|22|||
145446564|NCT00635349|524486348|FG000|Overall Study|Withdrawal by Subject|3|||
145446565|NCT00635349|524486349|FG001|Overall Study|Withdrawal by Subject|8|||
145446566|NCT00635349|524486348|FG000|Overall Study|Lost to Follow-up|4|||
145446567|NCT00635349|524486349|FG001|Overall Study|Lost to Follow-up|3|||
145446568|NCT00635349|524486348|FG000|Overall Study|Adverse Event|11|||
145446569|NCT00635349|524486349|FG001|Overall Study|Adverse Event|9|||
145446570|NCT00988052|524486361|FG000|Overall Study|Missing|1|||
145446571|NCT00988052|524486362|FG001|Overall Study|Missing|0|||
145446572|NCT00988052|524486361|FG000|Overall Study|Teva requested subject withdrawal|3|||
145446573|NCT00988052|524486362|FG001|Overall Study|Teva requested subject withdrawal|1|||
145446574|NCT00988052|524486361|FG000|Overall Study|Death|1|||
145446575|NCT00988052|524486362|FG001|Overall Study|Death|3|||
145446576|NCT00988052|524486361|FG000|Overall Study|Protocol Violation|6|||
145446577|NCT00988052|524486362|FG001|Overall Study|Protocol Violation|5|||
145446578|NCT00988052|524486361|FG000|Overall Study|Pregnancy|6|||
145446579|NCT00988052|524486362|FG001|Overall Study|Pregnancy|6|||
145446580|NCT00988052|524486361|FG000|Overall Study|Lack of Efficacy|8|||
145446581|NCT00988052|524486362|FG001|Overall Study|Lack of Efficacy|7|||
145446582|NCT00988052|524486361|FG000|Overall Study|Lost to Follow-up|6|||
145446583|NCT00988052|524486362|FG001|Overall Study|Lost to Follow-up|11|||
145446584|NCT00988052|524486361|FG000|Overall Study|Physician Decision|27|||
145446585|NCT00988052|524486362|FG001|Overall Study|Physician Decision|28|||
145446586|NCT00988052|524486361|FG000|Overall Study|Adverse Event|35|||
145446587|NCT00988052|524486362|FG001|Overall Study|Adverse Event|28|||
145446588|NCT00988052|524486361|FG000|Overall Study|Withdrawal by Subject|90|||
145446589|NCT00988052|524486362|FG001|Overall Study|Withdrawal by Subject|91|||
145446590|NCT00988052|524486361|FG000|Overall Study|Study terminated by sponsor|240|||
145446591|NCT00988052|524486362|FG001|Overall Study|Study terminated by sponsor|236|||
145446592|NCT02569476|524486363|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
145446593|NCT02569476|524486363|FG000|Overall Study|Death|33|||
145446594|NCT02569476|524486363|FG000|Overall Study|Withdrawal by Subject|9|||
145446595|NCT02569476|524486363|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
145446596|NCT02569476|524486363|FG000|Overall Study|Palliative care|1|||
145446597|NCT02569476|524486363|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
145446598|NCT02569476|524486363|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
145446599|NCT01434654|524486364|FG000|Overall Study|Withdrawal by Subject|1|||
145446600|NCT01434654|524486365|FG001|Overall Study|Withdrawal by Subject|0|||
145446601|NCT01434654|524486364|FG000|Overall Study|Lost to Follow-up|1|||
145446602|NCT01434654|524486365|FG001|Overall Study|Lost to Follow-up|0|||
145446603|NCT00703963|524486367|FG000|Overall Study|Withdrawal by Subject|7|||
145446604|NCT00703963|524486368|FG001|Overall Study|Withdrawal by Subject|13|||
145446605|NCT00703963|524486367|FG000|Overall Study|Physician Decision|0|||
145446606|NCT00703963|524486368|FG001|Overall Study|Physician Decision|1|||
145446607|NCT00645840|524486369|FG000|Overall Study|Protocol Violation|3|||
145446608|NCT01340664|524486370|FG000|Overall Study|Adverse Event|0|||
145446609|NCT01340664|524486371|FG001|Overall Study|Adverse Event|1|||
145585435|NCT00674986|524997538|FG001|Overall Study|Other reasons|8|||
145585436|NCT01880424|524997539|FG000|Overall Study|Adverse Event|7|||
145585437|NCT01880424|524997540|FG001|Overall Study|Adverse Event|6|||
145585438|NCT01880424|524997539|FG000|Overall Study|Lack of Efficacy|1|||
145585439|NCT01880424|524997540|FG001|Overall Study|Lack of Efficacy|4|||
145585440|NCT01880424|524997539|FG000|Overall Study|Lost to Follow-up|3|||
145446610|NCT01340664|524486372|FG002|Overall Study|Adverse Event|7|||
145446611|NCT01340664|524486370|FG000|Overall Study|Lost to Follow-up|2|||
145446612|NCT01340664|524486371|FG001|Overall Study|Lost to Follow-up|0|||
145446613|NCT01340664|524486372|FG002|Overall Study|Lost to Follow-up|2|||
145446614|NCT01340664|524486370|FG000|Overall Study|Withdrawal by Subject|2|||
145446615|NCT01340664|524486371|FG001|Overall Study|Withdrawal by Subject|4|||
145446616|NCT01340664|524486372|FG002|Overall Study|Withdrawal by Subject|0|||
145446617|NCT01340664|524486370|FG000|Overall Study|Glycemic withdrawal criteria|2|||
145446618|NCT01340664|524486371|FG001|Overall Study|Glycemic withdrawal criteria|0|||
145585441|NCT01880424|524997540|FG001|Overall Study|Lost to Follow-up|2|||
145446619|NCT01340664|524486372|FG002|Overall Study|Glycemic withdrawal criteria|0|||
145446620|NCT01340664|524486370|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
145446621|NCT01340664|524486371|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
145585442|NCT01880424|524997539|FG000|Overall Study|Protocol Violation|11|||
145585443|NCT01880424|524997540|FG001|Overall Study|Protocol Violation|13|||
145446622|NCT01340664|524486372|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
145446623|NCT01340664|524486370|FG000|Overall Study|Other|1|||
145446624|NCT01340664|524486371|FG001|Overall Study|Other|2|||
145446625|NCT01340664|524486372|FG002|Overall Study|Other|2|||
145446626|NCT00402324|524486373|FG000|Overall Study|Lost to Follow-up|11|||
145446627|NCT00402324|524486374|FG001|Overall Study|Lost to Follow-up|11|||
145446628|NCT00402324|524486373|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
145446629|NCT00402324|524486374|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
145446630|NCT00402324|524486373|FG000|Overall Study|Protocol Violation|8|||
145446631|NCT00402324|524486374|FG001|Overall Study|Protocol Violation|7|||
145446632|NCT00402324|524486373|FG000|Overall Study|Withdrawal by Subject|5|||
145446633|NCT00402324|524486374|FG001|Overall Study|Withdrawal by Subject|2|||
145446634|NCT00402324|524486373|FG000|Overall Study|Physician Decision|2|||
145446635|NCT00402324|524486374|FG001|Overall Study|Physician Decision|4|||
145446636|NCT00402324|524486373|FG000|Overall Study|Sponsor Decision|4|||
145446637|NCT00402324|524486374|FG001|Overall Study|Sponsor Decision|5|||
145446638|NCT00402324|524486373|FG000|Overall Study|Lack of Efficacy|1|||
145446639|NCT00402324|524486374|FG001|Overall Study|Lack of Efficacy|4|||
145446640|NCT00402324|524486373|FG000|Overall Study|Adverse Event|6|||
145446641|NCT00402324|524486374|FG001|Overall Study|Adverse Event|4|||
145446642|NCT00402324|524486373|FG000|Overall Study|Death|1|||
145446643|NCT00402324|524486374|FG001|Overall Study|Death|0|||
145446644|NCT01823198|524486376|FG000|Overall Study|Physician Decision|0|||
145446645|NCT01823198|524486377|FG001|Overall Study|Physician Decision|1|||
145446646|NCT01823198|524486378|FG002|Overall Study|Physician Decision|0|||
145446647|NCT01823198|524486379|FG003|Overall Study|Physician Decision|0|||
145446648|NCT01823198|524486380|FG004|Overall Study|Physician Decision|0|||
145446649|NCT01823198|524486381|FG005|Overall Study|Physician Decision|3|||
145446650|NCT01823198|524486382|FG006|Overall Study|Physician Decision|3|||
145446651|NCT01119066|524486383|FG000|Overall Study|Withdrawal by Subject|4|||
145446652|NCT01119066|524486384|FG001|Overall Study|Withdrawal by Subject|6|||
145446653|NCT01119066|524486385|FG002|Overall Study|Withdrawal by Subject|0|||
145446654|NCT01119066|524486386|FG003|Overall Study|Withdrawal by Subject|0|||
145446655|NCT01119066|524486383|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
145446656|NCT01119066|524486384|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
145446657|NCT01119066|524486385|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
145446658|NCT01119066|524486386|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
145446659|NCT01119066|524486383|FG000|Overall Study|Relapse identified before transplant|1|||
145446660|NCT01119066|524486384|FG001|Overall Study|Relapse identified before transplant|0|||
145446661|NCT01119066|524486385|FG002|Overall Study|Relapse identified before transplant|0|||
145446662|NCT01119066|524486386|FG003|Overall Study|Relapse identified before transplant|0|||
145446663|NCT01119066|524486383|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
145446664|NCT01119066|524486384|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
145446665|NCT01119066|524486385|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
145446666|NCT01119066|524486386|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
145446667|NCT01119066|524486383|FG000|Overall Study|Relapse identified before transplant|0|||
145446668|NCT01119066|524486384|FG001|Overall Study|Relapse identified before transplant|4|||
145446669|NCT01119066|524486385|FG002|Overall Study|Relapse identified before transplant|0|||
145446670|NCT01119066|524486386|FG003|Overall Study|Relapse identified before transplant|0|||
145446671|NCT02441101|524486389|FG000|Overall Study|Withdrawal by Subject|1|||
145446672|NCT02441101|524486390|FG001|Overall Study|Withdrawal by Subject|0|||
145446673|NCT02441101|524486389|FG000|Overall Study|Lost to Follow-up|1|||
145446674|NCT02441101|524486390|FG001|Overall Study|Lost to Follow-up|0|||
145446675|NCT02441101|524486389|FG000|Overall Study|PI relocated and study terminated|1|||
145446676|NCT02441101|524486390|FG001|Overall Study|PI relocated and study terminated|0|||
145446677|NCT02528942|524486391|FG000|Overall Study|Did not meet imaging criteria|9|||
145446678|NCT02528942|524486391|FG000|Overall Study|Lost to Follow-up|25|||
145446679|NCT04599803|524486392|FG000|Overall Study|Withdrawal by Subject|5|||
145446680|NCT04599803|524486392|FG000|Overall Study|Lost to Follow-up|26|||
145446681|NCT00881530|524486393|FG000|Overall Study|Adverse Event|5|||
145446682|NCT00881530|524486394|FG001|Overall Study|Adverse Event|1|||
145446683|NCT00881530|524486395|FG002|Overall Study|Adverse Event|1|||
145446684|NCT00881530|524486396|FG003|Overall Study|Adverse Event|4|||
145446685|NCT00881530|524486397|FG004|Overall Study|Adverse Event|10|||
145446686|NCT00881530|524486398|FG005|Overall Study|Adverse Event|2|||
145446687|NCT00881530|524486393|FG000|Overall Study|Lack of Efficacy|1|||
145446688|NCT00881530|524486394|FG001|Overall Study|Lack of Efficacy|0|||
145446689|NCT00881530|524486395|FG002|Overall Study|Lack of Efficacy|0|||
145446690|NCT00881530|524486396|FG003|Overall Study|Lack of Efficacy|0|||
145446691|NCT00881530|524486397|FG004|Overall Study|Lack of Efficacy|1|||
145446692|NCT00881530|524486398|FG005|Overall Study|Lack of Efficacy|1|||
145446693|NCT00881530|524486393|FG000|Overall Study|Not compliant with the protocol|0|||
145446694|NCT00881530|524486394|FG001|Overall Study|Not compliant with the protocol|0|||
145446695|NCT00881530|524486395|FG002|Overall Study|Not compliant with the protocol|0|||
145446696|NCT00881530|524486396|FG003|Overall Study|Not compliant with the protocol|0|||
145446697|NCT00881530|524486397|FG004|Overall Study|Not compliant with the protocol|2|||
145446698|NCT00881530|524486398|FG005|Overall Study|Not compliant with the protocol|0|||
145446699|NCT00881530|524486393|FG000|Overall Study|Lost to Follow-up|0|||
145446700|NCT00881530|524486394|FG001|Overall Study|Lost to Follow-up|1|||
145446701|NCT00881530|524486395|FG002|Overall Study|Lost to Follow-up|1|||
145446702|NCT00881530|524486396|FG003|Overall Study|Lost to Follow-up|3|||
145446703|NCT00881530|524486397|FG004|Overall Study|Lost to Follow-up|1|||
145446704|NCT00881530|524486398|FG005|Overall Study|Lost to Follow-up|0|||
145446705|NCT00881530|524486393|FG000|Overall Study|Refused to continue medication|7|||
145446706|NCT00881530|524486394|FG001|Overall Study|Refused to continue medication|2|||
145446707|NCT00881530|524486395|FG002|Overall Study|Refused to continue medication|1|||
145446708|NCT00881530|524486396|FG003|Overall Study|Refused to continue medication|2|||
145446709|NCT00881530|524486397|FG004|Overall Study|Refused to continue medication|0|||
145446710|NCT00881530|524486398|FG005|Overall Study|Refused to continue medication|0|||
145446711|NCT00881530|524486393|FG000|Overall Study|Other reason not defined above|1|||
145446712|NCT00881530|524486394|FG001|Overall Study|Other reason not defined above|1|||
145446713|NCT00881530|524486395|FG002|Overall Study|Other reason not defined above|2|||
145446714|NCT00881530|524486396|FG003|Overall Study|Other reason not defined above|0|||
145446715|NCT00881530|524486397|FG004|Overall Study|Other reason not defined above|0|||
145446716|NCT00881530|524486398|FG005|Overall Study|Other reason not defined above|2|||
145446717|NCT01509846|524486399|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
145446718|NCT01509846|524486400|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
145446719|NCT01509846|524486401|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
145446720|NCT01509846|524486402|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
145446721|NCT01509846|524486403|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
145446722|NCT01509846|524486399|FG000|Received Vaccination 2|Illness|0|||
145446723|NCT01509846|524486400|FG001|Received Vaccination 2|Illness|0|||
145446724|NCT01509846|524486401|FG002|Received Vaccination 2|Illness|0|||
145446725|NCT01509846|524486402|FG003|Received Vaccination 2|Illness|0|||
145446726|NCT01509846|524486403|FG004|Received Vaccination 2|Illness|1|||
145446727|NCT01509846|524486399|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
145446728|NCT01509846|524486400|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
145446729|NCT01509846|524486401|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
145446730|NCT01509846|524486402|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
145446731|NCT01509846|524486403|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
145446732|NCT01509846|524486399|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
145446733|NCT01509846|524486400|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
145446734|NCT01509846|524486401|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
145446735|NCT01509846|524486402|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
145446736|NCT01509846|524486403|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
145446737|NCT01509846|524486399|FG000|Received Vaccination 3|Pregnancy|0|||
145446738|NCT01509846|524486400|FG001|Received Vaccination 3|Pregnancy|0|||
145446739|NCT01509846|524486401|FG002|Received Vaccination 3|Pregnancy|0|||
145446740|NCT01509846|524486402|FG003|Received Vaccination 3|Pregnancy|1|||
145446741|NCT01509846|524486403|FG004|Received Vaccination 3|Pregnancy|0|||
145446742|NCT01509846|524486399|FG000|Received Vaccination 3|Lost to Follow-up|0|||
145446743|NCT01509846|524486400|FG001|Received Vaccination 3|Lost to Follow-up|0|||
145446744|NCT01509846|524486401|FG002|Received Vaccination 3|Lost to Follow-up|1|||
145446745|NCT01509846|524486402|FG003|Received Vaccination 3|Lost to Follow-up|0|||
145446746|NCT01509846|524486403|FG004|Received Vaccination 3|Lost to Follow-up|0|||
145446747|NCT00763256|524486404|FG000|Overall Study|Didn't return for appointments|7|||
145446748|NCT00763256|524486405|FG001|Overall Study|Didn't return for appointments|10|||
145446749|NCT02595866|524486406|FG000|Overall Study|Adverse Event|2|||
145446750|NCT02595866|524486407|FG001|Overall Study|Adverse Event|5|||
145446751|NCT02595866|524486406|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
145446752|NCT02595866|524486407|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
145446753|NCT02595866|524486406|FG000|Overall Study|Death|0|||
145446754|NCT02595866|524486407|FG001|Overall Study|Death|1|||
145625993|NCT00480441|525144140|FG002|Baseline Functional MRI|physical contraindication|0|||
145446755|NCT02595866|524486406|FG000|Overall Study|Incarceration|1|||
145446756|NCT02595866|524486407|FG001|Overall Study|Incarceration|0|||
145446757|NCT02595866|524486406|FG000|Overall Study|Lack of Efficacy|17|||
145446758|NCT02595866|524486407|FG001|Overall Study|Lack of Efficacy|7|||
145446759|NCT02595866|524486406|FG000|Overall Study|Physician Decision|4|||
145446760|NCT02595866|524486407|FG001|Overall Study|Physician Decision|3|||
145446761|NCT02595866|524486406|FG000|Overall Study|Switched to Alternative Treatment|1|||
145446762|NCT02595866|524486407|FG001|Overall Study|Switched to Alternative Treatment|0|||
145446763|NCT02595866|524486406|FG000|Overall Study|Study Terminated|0|||
145446764|NCT02595866|524486407|FG001|Overall Study|Study Terminated|4|||
145446765|NCT02595866|524486406|FG000|Overall Study|Withdrawal by Subject|6|||
145446766|NCT02595866|524486407|FG001|Overall Study|Withdrawal by Subject|1|||
145446767|NCT00289289|524486408|FG000|Overall Study|Withdrawal by Subject|5|||
145625994|NCT00480441|525144138|FG000|Randomization|Lost to Follow-up|0|||
145446768|NCT00289289|524486409|FG001|Overall Study|Withdrawal by Subject|3|||
145446769|NCT00289289|524486410|FG002|Overall Study|Withdrawal by Subject|15|||
145446770|NCT00289289|524486408|FG000|Overall Study|Lost to Follow-up|1|||
145446771|NCT00289289|524486409|FG001|Overall Study|Lost to Follow-up|0|||
145446772|NCT00289289|524486410|FG002|Overall Study|Lost to Follow-up|1|||
145446773|NCT00289289|524486408|FG000|Overall Study|Death|4|||
145446774|NCT00289289|524486409|FG001|Overall Study|Death|2|||
145446775|NCT00289289|524486410|FG002|Overall Study|Death|5|||
145446776|NCT00289289|524486408|FG000|Overall Study|No implant attempted|0|||
145446777|NCT00289289|524486409|FG001|Overall Study|No implant attempted|0|||
145446778|NCT00289289|524486410|FG002|Overall Study|No implant attempted|1|||
145446779|NCT00289289|524486408|FG000|Overall Study|Physician Decision|1|||
145446780|NCT00289289|524486409|FG001|Overall Study|Physician Decision|0|||
145446781|NCT00289289|524486410|FG002|Overall Study|Physician Decision|6|||
145446782|NCT00289289|524486408|FG000|Overall Study|Non-study device implanted|2|||
145446783|NCT00289289|524486409|FG001|Overall Study|Non-study device implanted|1|||
145446784|NCT00289289|524486410|FG002|Overall Study|Non-study device implanted|3|||
145446785|NCT00289289|524486408|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
145446786|NCT00289289|524486409|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
145446787|NCT00289289|524486410|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
145446788|NCT00289289|524486408|FG000|Overall Study|Other Exit Reason|6|||
145446789|NCT00289289|524486409|FG001|Overall Study|Other Exit Reason|4|||
145446790|NCT00289289|524486410|FG002|Overall Study|Other Exit Reason|12|||
145446791|NCT01445613|524486411|FG000|30-day Follow-up|Withdrawal by Subject|6|||
145446792|NCT01445613|524486411|FG000|30-day Follow-up|Physician Decision|3|||
145446793|NCT01445613|524486411|FG000|30-day Follow-up|Missed visit|23|||
145446794|NCT01445613|524486411|FG000|30-day Follow-up|Death|3|||
145446795|NCT01445613|524486411|FG000|1-year Follow-up|Withdrawal by Subject|12|||
145446796|NCT01445613|524486411|FG000|1-year Follow-up|Missed visit|29|||
145446797|NCT01445613|524486411|FG000|1-year Follow-up|Lost to Follow-up|2|||
145446798|NCT01445613|524486411|FG000|1-year Follow-up|Death|30|||
145446799|NCT01445613|524486411|FG000|1-year Follow-up|Physician Decision|2|||
145446800|NCT01445613|524486411|FG000|1-year Follow-up|Received a non-study stent|2|||
145446801|NCT00407602|524486412|FG000|Overall Study|Death - unrelated to device|1|||
145446802|NCT00407602|524486412|FG000|Overall Study|Device explanted|5|||
145446803|NCT00407602|524486412|FG000|Overall Study|Withdrawal by Subject|1|||
145446804|NCT00431444|524486413|FG000|Overall Study|Protocol Violation|1|||
145446805|NCT00431444|524486414|FG001|Overall Study|Protocol Violation|4|||
145446806|NCT00431444|524486413|FG000|Overall Study|Adverse Event|2|||
145446807|NCT00431444|524486414|FG001|Overall Study|Adverse Event|1|||
145446808|NCT00431444|524486413|FG000|Overall Study|Withdrawal by Subject|1|||
145446809|NCT00431444|524486414|FG001|Overall Study|Withdrawal by Subject|1|||
145446810|NCT00431444|524486413|FG000|Overall Study|Lost to Follow-up|1|||
145446811|NCT00431444|524486414|FG001|Overall Study|Lost to Follow-up|0|||
145446812|NCT00431444|524486413|FG000|Overall Study|Administrative Problems|0|||
145446813|NCT00431444|524486414|FG001|Overall Study|Administrative Problems|1|||
145446814|NCT03554018|524486415|FG000|Overall Study|Lost to Follow-up|3|||
145446815|NCT03554018|524486416|FG001|Overall Study|Lost to Follow-up|7|||
145446816|NCT01740687|524486417|FG000|Overall Study|Lost to Follow-up|11|||
145446817|NCT01740687|524486417|FG000|Overall Study|Withdrawal by Subject|2|||
145446818|NCT01740687|524486417|FG000|Overall Study|other reason|22|||
145446819|NCT01740687|524486417|FG000|Overall Study|treatment not received|2|||
145446820|NCT02220855|524488600|FG000|Overall Study|Adverse Event|8|||
145446821|NCT02220855|524488600|FG000|Overall Study|Disease Progression|5|||
145446822|NCT02220855|524488600|FG000|Overall Study|Withdrawal by Subject|1|||
145446823|NCT03280303|524488601|FG000|Overall Study|Death|505|||
145446824|NCT03280303|524488601|FG000|Overall Study|Study terminated by sponsor|383|||
145446825|NCT03280303|524488601|FG000|Overall Study|Other|148|||
145446826|NCT03280303|524488601|FG000|Overall Study|No longer willing to participate in study|101|||
145446827|NCT03280303|524488601|FG000|Overall Study|Lost to follow up|39|||
145446828|NCT03280303|524488601|FG000|Overall Study|Adverse Event|20|||
145446829|NCT03419897|524488602|FG000|Overall Study|Death|180|||
145446830|NCT03419897|524488602|FG000|Overall Study|Lost to Follow-up|1|||
145446831|NCT03419897|524488602|FG000|Overall Study|Withdrawal by Subject|6|||
145446832|NCT03419897|524488602|FG000|Overall Study|Sponsor Decision|61|||
145446833|NCT03419897|524488602|FG000|Overall Study|Physician Decision|1|||
145446834|NCT01945216|524488605|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
145446835|NCT01945216|524488605|FG000|Overall Study|Protocol Violation|42|||
145446836|NCT01945216|524488605|FG000|Overall Study|CRF not assured by investigators|5|||
145446837|NCT01905943|524488609|FG000|Overall Study|Withdrawal of consent|90|||
145446838|NCT01905943|524488609|FG000|Overall Study|Lost to Follow-up|16|||
145446839|NCT01905943|524488609|FG000|Overall Study|Investigator discretion|7|||
145446840|NCT01905943|524488609|FG000|Overall Study|Death|186|||
145446841|NCT01905943|524488609|FG000|Overall Study|Adverse Event|3|||
145446842|NCT01905943|524488609|FG000|Overall Study|Other|12|||
145446843|NCT05935878|524488610|FG000|Overall Study|Death|1|||
145446844|NCT05935878|524488611|FG001|Overall Study|Death|2|||
145446845|NCT05935878|524488610|FG000|Overall Study|Withdrawal by Subject|5|||
145446846|NCT05935878|524488611|FG001|Overall Study|Withdrawal by Subject|5|||
145446847|NCT05935878|524488610|FG000|Overall Study|Revision of implant|1|||
145446848|NCT05935878|524488611|FG001|Overall Study|Revision of implant|1|||
145446849|NCT05935878|524488610|FG000|Overall Study|Mobile bearing dislocation|0|||
145446850|NCT05935878|524488611|FG001|Overall Study|Mobile bearing dislocation|1|||
145446851|NCT03107052|524488618|FG000|Overall Study|Adverse Event|6|||
145446852|NCT03107052|524488619|FG001|Overall Study|Adverse Event|1|||
145446853|NCT03107052|524488620|FG002|Overall Study|Adverse Event|2|||
145446854|NCT03107052|524488618|FG000|Overall Study|Withdrawal by Subject|9|||
145446855|NCT03107052|524488619|FG001|Overall Study|Withdrawal by Subject|5|||
145446856|NCT03107052|524488620|FG002|Overall Study|Withdrawal by Subject|8|||
145446857|NCT03107052|524488618|FG000|Overall Study|Protocol Violation|6|||
145446858|NCT03107052|524488619|FG001|Overall Study|Protocol Violation|0|||
145446859|NCT03107052|524488620|FG002|Overall Study|Protocol Violation|3|||
145446860|NCT03107052|524488618|FG000|Overall Study|Lost to Follow-up|4|||
145446861|NCT03107052|524488619|FG001|Overall Study|Lost to Follow-up|0|||
145446862|NCT03107052|524488620|FG002|Overall Study|Lost to Follow-up|1|||
145446863|NCT03107052|524488618|FG000|Overall Study|Lack of Efficacy|23|||
145446864|NCT03107052|524488619|FG001|Overall Study|Lack of Efficacy|7|||
145446865|NCT03107052|524488620|FG002|Overall Study|Lack of Efficacy|4|||
145446866|NCT03107052|524488618|FG000|Overall Study|Other than specified|4|||
145446867|NCT03107052|524488619|FG001|Overall Study|Other than specified|2|||
145446868|NCT03107052|524488620|FG002|Overall Study|Other than specified|0|||
145446869|NCT03107052|524488618|FG000|Overall Study|Study terminated due to futility|67|||
145446870|NCT03107052|524488619|FG001|Overall Study|Study terminated due to futility|31|||
145446871|NCT03107052|524488620|FG002|Overall Study|Study terminated due to futility|23|||
145446872|NCT03015363|524488621|FG000|Overall Study|Physician Decision|14|||
145446873|NCT03015363|524488621|FG000|Overall Study|Withdrawal by Subject|3|||
145446874|NCT00958360|524488622|FG000|Overall Study|Withdrawal by Subject|3|||
145446875|NCT00958360|524488623|FG001|Overall Study|Withdrawal by Subject|1|||
145446876|NCT00958360|524488622|FG000|Overall Study|Death|6|||
145446877|NCT00958360|524488623|FG001|Overall Study|Death|7|||
145446878|NCT00958360|524488622|FG000|Overall Study|Physician Decision|2|||
145446879|NCT00958360|524488623|FG001|Overall Study|Physician Decision|1|||
145446880|NCT00958360|524488622|FG000|Overall Study|Lost to Follow-up|0|||
145446881|NCT00958360|524488623|FG001|Overall Study|Lost to Follow-up|1|||
145446882|NCT02263326|524488624|FG000|Overall Study|Lost to Follow-up|1|||
145446883|NCT02263326|524488625|FG001|Overall Study|Lost to Follow-up|1|||
145446884|NCT00078806|524488626|FG000|Part 1A|Adverse Event|2|||
145446885|NCT00078806|524488627|FG001|Part 1A|Adverse Event|0|||
145446886|NCT00078806|524488628|FG002|Part 1A|Adverse Event|0|||
145446887|NCT00078806|524488629|FG003|Part 1A|Adverse Event|0|||
145446888|NCT00078806|524488626|FG000|Part 1A|Lack of Efficacy|7|||
145446889|NCT00078806|524488627|FG001|Part 1A|Lack of Efficacy|0|||
145446890|NCT00078806|524488628|FG002|Part 1A|Lack of Efficacy|0|||
145446891|NCT00078806|524488629|FG003|Part 1A|Lack of Efficacy|0|||
145446892|NCT00078806|524488626|FG000|Part 1A|Other|1|||
145446893|NCT00078806|524488627|FG001|Part 1A|Other|0|||
145446894|NCT00078806|524488628|FG002|Part 1A|Other|0|||
145446895|NCT00078806|524488629|FG003|Part 1A|Other|0|||
145446896|NCT00078806|524488626|FG000|Part 1B|Adverse Event|1|||
145446897|NCT00078806|524488627|FG001|Part 1B|Adverse Event|0|||
145446898|NCT00078806|524488628|FG002|Part 1B|Adverse Event|0|||
145446899|NCT00078806|524488629|FG003|Part 1B|Adverse Event|0|||
145446900|NCT00078806|524488626|FG000|Part 1B|Lack of Efficacy|7|||
145446901|NCT00078806|524488627|FG001|Part 1B|Lack of Efficacy|0|||
145446902|NCT00078806|524488628|FG002|Part 1B|Lack of Efficacy|0|||
145446903|NCT00078806|524488629|FG003|Part 1B|Lack of Efficacy|0|||
145446904|NCT00078806|524488626|FG000|Part 2|Adverse Event|0|||
145446905|NCT00078806|524488627|FG001|Part 2|Adverse Event|1|||
145446906|NCT00078806|524488628|FG002|Part 2|Adverse Event|0|||
145446907|NCT00078806|524488629|FG003|Part 2|Adverse Event|0|||
145446908|NCT01893411|524488632|FG000|Overall Study|Protocol Violation|1|||
145446909|NCT01893411|524488633|FG001|Overall Study|Protocol Violation|0|||
145446910|NCT01893411|524488634|FG002|Overall Study|Protocol Violation|0|||
145446911|NCT01893411|524488632|FG000|Overall Study|Physician Decision|1|||
145446912|NCT01893411|524488633|FG001|Overall Study|Physician Decision|1|||
145585444|NCT01880424|524997539|FG000|Overall Study|Withdrawal by Subject|10|||
145585445|NCT01880424|524997540|FG001|Overall Study|Withdrawal by Subject|30|||
145446913|NCT01893411|524488634|FG002|Overall Study|Physician Decision|2|||
145446914|NCT01893411|524488632|FG000|Overall Study|Lack of Efficacy|2|||
145446915|NCT01893411|524488633|FG001|Overall Study|Lack of Efficacy|1|||
145585446|NCT01880424|524997539|FG000|Overall Study|Other|1|||
145585447|NCT01880424|524997540|FG001|Overall Study|Other|0|||
145446916|NCT01893411|524488634|FG002|Overall Study|Lack of Efficacy|0|||
145446917|NCT01893411|524488632|FG000|Overall Study|Other|3|||
145446918|NCT01893411|524488633|FG001|Overall Study|Other|1|||
145446919|NCT01893411|524488634|FG002|Overall Study|Other|3|||
145446920|NCT01893411|524488632|FG000|Overall Study|Adverse Event|1|||
145446921|NCT01893411|524488633|FG001|Overall Study|Adverse Event|0|||
145446922|NCT01893411|524488634|FG002|Overall Study|Adverse Event|0|||
145446923|NCT01893411|524488632|FG000|Overall Study|Withdrawal by Subject|7|||
145446924|NCT01893411|524488633|FG001|Overall Study|Withdrawal by Subject|4|||
145446925|NCT01893411|524488634|FG002|Overall Study|Withdrawal by Subject|3|||
145446926|NCT01893411|524488632|FG000|Overall Study|Lost to Follow-up|2|||
145446927|NCT01893411|524488633|FG001|Overall Study|Lost to Follow-up|0|||
145446928|NCT01893411|524488634|FG002|Overall Study|Lost to Follow-up|1|||
145446929|NCT03292874|524488635|FG000|Overall Study|Due to pandemic|5|||
145446930|NCT00368745|524488636|FG000|Double-blind Treatment Period|Adverse Event|6|||
145446931|NCT00368745|524488637|FG001|Double-blind Treatment Period|Adverse Event|6|||
145446932|NCT00368745|524488636|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
145446933|NCT00368745|524488637|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
145446934|NCT00368745|524488636|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
145446935|NCT00368745|524488637|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145446936|NCT00368745|524488636|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
145446937|NCT00368745|524488637|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
145446938|NCT00368745|524488636|FG000|Double-blind Treatment Period|Other|7|||
145446939|NCT00368745|524488637|FG001|Double-blind Treatment Period|Other|6|||
145446940|NCT00161616|524488638|FG000|Overall Study|Withdrawal by Subject|6|||
145446941|NCT00161616|524488639|FG001|Overall Study|Withdrawal by Subject|5|||
145446942|NCT00161616|524488638|FG000|Overall Study|Physician Decision|1|||
145446943|NCT00161616|524488639|FG001|Overall Study|Physician Decision|0|||
145446944|NCT00161616|524488638|FG000|Overall Study|Death|1|||
145446945|NCT00161616|524488639|FG001|Overall Study|Death|1|||
145446946|NCT00161616|524488638|FG000|Overall Study|Lost to Follow-up|17|||
145446947|NCT00161616|524488639|FG001|Overall Study|Lost to Follow-up|13|||
145446948|NCT00161616|524488638|FG000|Overall Study|Protocol deviation|1|||
145446949|NCT00161616|524488639|FG001|Overall Study|Protocol deviation|0|||
145446950|NCT02719691|524488643|FG000|Overall Study|Physician Decision|0|||
145446951|NCT02719691|524488644|FG001|Overall Study|Physician Decision|0|||
145446952|NCT02719691|524488645|FG002|Overall Study|Physician Decision|1|||
145446953|NCT02719691|524488646|FG003|Overall Study|Physician Decision|0|||
145446954|NCT02719691|524488647|FG004|Overall Study|Physician Decision|0|||
145446955|NCT02719691|524488648|FG005|Overall Study|Physician Decision|0|||
145446956|NCT02719691|524488649|FG006|Overall Study|Physician Decision|0|||
145446957|NCT02719691|524488643|FG000|Overall Study|Withdrawal by Subject|0|||
145446958|NCT02719691|524488644|FG001|Overall Study|Withdrawal by Subject|0|||
145446959|NCT02719691|524488645|FG002|Overall Study|Withdrawal by Subject|0|||
145446960|NCT02719691|524488646|FG003|Overall Study|Withdrawal by Subject|0|||
145446961|NCT02719691|524488647|FG004|Overall Study|Withdrawal by Subject|0|||
145446962|NCT02719691|524488648|FG005|Overall Study|Withdrawal by Subject|1|||
145446963|NCT02719691|524488649|FG006|Overall Study|Withdrawal by Subject|0|||
145446964|NCT00336284|524488650|FG000|Overall Study|Death|52|||
145446965|NCT00336284|524488651|FG001|Overall Study|Death|26|||
145446966|NCT00336284|524488650|FG000|Overall Study|Lost to Follow-up|82|||
145585448|NCT02053350|524997543|FG000|Overall Study|Withdrawal by Subject|1|||
145446967|NCT00336284|524488651|FG001|Overall Study|Lost to Follow-up|61|||
145446968|NCT00336284|524488650|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
145446969|NCT00336284|524488651|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
145446970|NCT01521923|524488659|FG000|Overall Study|AE, serious fatal|1|||
145446971|NCT01521923|524488660|FG001|Overall Study|AE, serious fatal|0|||
145446972|NCT01521923|524488661|FG002|Overall Study|AE, serious fatal|0|||
145446973|NCT01521923|524488662|FG003|Overall Study|AE, serious fatal|0|||
145446974|NCT01521923|524488659|FG000|Overall Study|SAE, non-fatal|0|||
145446975|NCT01521923|524488660|FG001|Overall Study|SAE, non-fatal|2|||
145446976|NCT01521923|524488661|FG002|Overall Study|SAE, non-fatal|2|||
145446977|NCT01521923|524488662|FG003|Overall Study|SAE, non-fatal|0|||
145446978|NCT01521923|524488659|FG000|Overall Study|AE, non-serious, non-fatal|1|||
145446979|NCT01521923|524488660|FG001|Overall Study|AE, non-serious, non-fatal|3|||
145446980|NCT01521923|524488661|FG002|Overall Study|AE, non-serious, non-fatal|6|||
145446981|NCT01521923|524488662|FG003|Overall Study|AE, non-serious, non-fatal|2|||
145446982|NCT01521923|524488659|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
145446983|NCT01521923|524488660|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
145446984|NCT01521923|524488661|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
145446985|NCT01521923|524488662|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
145446986|NCT01521923|524488659|FG000|Overall Study|Lack of Efficacy|1|||
145446987|NCT01521923|524488660|FG001|Overall Study|Lack of Efficacy|1|||
145446988|NCT01521923|524488661|FG002|Overall Study|Lack of Efficacy|0|||
145446989|NCT01521923|524488662|FG003|Overall Study|Lack of Efficacy|0|||
145446990|NCT01521923|524488659|FG000|Overall Study|Protocol Violation|0|||
145446991|NCT01521923|524488660|FG001|Overall Study|Protocol Violation|0|||
145446992|NCT01521923|524488661|FG002|Overall Study|Protocol Violation|1|||
145446993|NCT01521923|524488662|FG003|Overall Study|Protocol Violation|0|||
145446994|NCT01521923|524488659|FG000|Overall Study|Lost to Follow-up|1|||
145446995|NCT01521923|524488660|FG001|Overall Study|Lost to Follow-up|0|||
145446996|NCT01521923|524488661|FG002|Overall Study|Lost to Follow-up|2|||
145446997|NCT01521923|524488662|FG003|Overall Study|Lost to Follow-up|1|||
145446998|NCT01521923|524488659|FG000|Overall Study|Withdrawal by Subject|1|||
145446999|NCT01521923|524488660|FG001|Overall Study|Withdrawal by Subject|1|||
145447000|NCT01521923|524488661|FG002|Overall Study|Withdrawal by Subject|1|||
145447001|NCT01521923|524488662|FG003|Overall Study|Withdrawal by Subject|2|||
145447002|NCT01521923|524488659|FG000|Overall Study|Other|2|||
145447003|NCT01521923|524488660|FG001|Overall Study|Other|1|||
145447004|NCT01521923|524488661|FG002|Overall Study|Other|3|||
145447005|NCT01521923|524488662|FG003|Overall Study|Other|6|||
145447006|NCT01521923|524488659|FG000|Overall Study|AE, captured in Period 1|0|||
145447007|NCT01521923|524488660|FG001|Overall Study|AE, captured in Period 1|1|||
145447008|NCT01521923|524488661|FG002|Overall Study|AE, captured in Period 1|0|||
145447009|NCT01521923|524488662|FG003|Overall Study|AE, captured in Period 1|1|||
145447010|NCT03037476|524488663|FG000|Overall Study|Lost to Follow-up|63|||
145447011|NCT03037476|524488664|FG001|Overall Study|Lost to Follow-up|46|||
145447012|NCT02141633|524488665|FG000|Overall Study|Physician Decision|1|||
145447013|NCT02141633|524488666|FG001|Overall Study|Physician Decision|0|||
145447014|NCT03053440|524488669|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
145447015|NCT03053440|524488670|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
145447016|NCT03053440|524488669|FG000|Overall Study|Death|18|||
145447017|NCT03053440|524488670|FG001|Overall Study|Death|14|||
145447018|NCT03053440|524488669|FG000|Overall Study|Withdrawal by Subject|9|||
145447019|NCT03053440|524488670|FG001|Overall Study|Withdrawal by Subject|8|||
145447020|NCT03053440|524488669|FG000|Overall Study|Lost to Follow-up|1|||
145447021|NCT03053440|524488670|FG001|Overall Study|Lost to Follow-up|0|||
145447022|NCT03053440|524488669|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
145447023|NCT03053440|524488670|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
145447024|NCT03053440|524488669|FG000|Overall Study|Physician Decision|2|||
145447025|NCT03053440|524488670|FG001|Overall Study|Physician Decision|1|||
145447026|NCT03053440|524488669|FG000|Overall Study|Participant Randomized but died before dosing|1|||
145447027|NCT03053440|524488670|FG001|Overall Study|Participant Randomized but died before dosing|0|||
145447028|NCT04908384|524488675|FG000|Overall Study|Lost to Follow-up|4|||
145447029|NCT04908384|524488676|FG001|Overall Study|Lost to Follow-up|4|||
145447030|NCT04908384|524488677|FG002|Overall Study|Lost to Follow-up|0|||
145447031|NCT04908384|524488678|FG003|Overall Study|Lost to Follow-up|0|||
145447032|NCT02446769|524488679|FG000|Screening Period|Screen Failure|11|||
145447033|NCT02446769|524488680|FG001|Screening Period|Screen Failure|0|||
145447034|NCT02446769|524488681|FG002|Screening Period|Screen Failure|0|||
145447035|NCT02446769|524488679|FG000|Study Period|Randomized in Error|0|||
145447036|NCT02446769|524488680|FG001|Study Period|Randomized in Error|2|||
145447037|NCT02446769|524488681|FG002|Study Period|Randomized in Error|0|||
145447038|NCT04482439|524488682|FG000|Overall Study|Lost to Follow-up|1|||
145447039|NCT04482439|524488682|FG000|Overall Study|Unrelated illness|1|||
145447040|NCT03072043|524488685|FG000|Overall Study|Death|0|||
145447041|NCT03072043|524488686|FG001|Overall Study|Death|0|||
145447042|NCT03072043|524488687|FG002|Overall Study|Death|3|||
145447043|NCT03072043|524488685|FG000|Overall Study|Adverse Event|0|||
145447044|NCT03072043|524488686|FG001|Overall Study|Adverse Event|0|||
145447045|NCT03072043|524488687|FG002|Overall Study|Adverse Event|2|||
145447046|NCT03072043|524488685|FG000|Overall Study|Withdrawal by Subject|0|||
145447047|NCT03072043|524488686|FG001|Overall Study|Withdrawal by Subject|0|||
145447048|NCT03072043|524488687|FG002|Overall Study|Withdrawal by Subject|4|||
145447049|NCT01277822|524488688|FG000|Overall Study|Adverse Event|2|||
145447050|NCT01277822|524488689|FG001|Overall Study|Adverse Event|1|||
145447051|NCT01277822|524488688|FG000|Overall Study|Withdrawal by Subject|6|||
145447052|NCT01277822|524488689|FG001|Overall Study|Withdrawal by Subject|7|||
145447053|NCT01277822|524488688|FG000|Overall Study|Physician Decision|1|||
145447054|NCT01277822|524488689|FG001|Overall Study|Physician Decision|1|||
145447055|NCT01277822|524488688|FG000|Overall Study|Protocol Violation|1|||
145447056|NCT01277822|524488689|FG001|Overall Study|Protocol Violation|0|||
145447057|NCT01277822|524488688|FG000|Overall Study|Lost to Follow-up|2|||
145447058|NCT01277822|524488689|FG001|Overall Study|Lost to Follow-up|1|||
145447059|NCT01277822|524488688|FG000|Overall Study|Contraindicated medication used|2|||
145447060|NCT01277822|524488689|FG001|Overall Study|Contraindicated medication used|1|||
145447061|NCT01277822|524488688|FG000|Overall Study|Participant moved|1|||
145447062|NCT01277822|524488689|FG001|Overall Study|Participant moved|0|||
145447063|NCT02923531|524488690|FG000|Overall Study|Adverse Event|4|||
145447064|NCT02923531|524488690|FG000|Overall Study|Clinical Deterioration|1|||
145447065|NCT02923531|524488690|FG000|Overall Study|Disease Progression|3|||
145447066|NCT02923531|524488690|FG000|Overall Study|Study Termination|1|||
145447067|NCT00997984|524488691|FG000|Overall Study|Adverse Event|1|||
145447068|NCT00997984|524488692|FG001|Overall Study|Adverse Event|8|||
145447069|NCT00997984|524488693|FG002|Overall Study|Adverse Event|8|||
145447070|NCT00997984|524488691|FG000|Overall Study|Protocol Violation|1|||
145447071|NCT00997984|524488692|FG001|Overall Study|Protocol Violation|3|||
145447072|NCT00997984|524488693|FG002|Overall Study|Protocol Violation|0|||
145447073|NCT00997984|524488691|FG000|Overall Study|Withdrawal by Subject|6|||
145447074|NCT00997984|524488692|FG001|Overall Study|Withdrawal by Subject|9|||
145447075|NCT00997984|524488693|FG002|Overall Study|Withdrawal by Subject|5|||
145447076|NCT00997984|524488691|FG000|Overall Study|Lost to Follow-up|8|||
145447077|NCT00997984|524488692|FG001|Overall Study|Lost to Follow-up|5|||
145447078|NCT00997984|524488693|FG002|Overall Study|Lost to Follow-up|4|||
145447079|NCT00997984|524488691|FG000|Overall Study|Lack of Efficacy|20|||
145447080|NCT00997984|524488692|FG001|Overall Study|Lack of Efficacy|6|||
145447081|NCT00997984|524488693|FG002|Overall Study|Lack of Efficacy|3|||
145447082|NCT00997984|524488691|FG000|Overall Study|Met exclusion criteria|1|||
145447083|NCT00997984|524488692|FG001|Overall Study|Met exclusion criteria|0|||
145447084|NCT00997984|524488693|FG002|Overall Study|Met exclusion criteria|0|||
145447085|NCT00997984|524488691|FG000|Overall Study|non-compliance|0|||
145447086|NCT00997984|524488692|FG001|Overall Study|non-compliance|2|||
145447087|NCT00997984|524488693|FG002|Overall Study|non-compliance|3|||
145447088|NCT00997984|524488691|FG000|Overall Study|Wrong medication dispensed|0|||
145447089|NCT00997984|524488692|FG001|Overall Study|Wrong medication dispensed|1|||
145447090|NCT00997984|524488693|FG002|Overall Study|Wrong medication dispensed|0|||
145447091|NCT00997984|524488691|FG000|Overall Study|Suicidal ideation|0|||
145447092|NCT00997984|524488692|FG001|Overall Study|Suicidal ideation|0|||
145447093|NCT00997984|524488693|FG002|Overall Study|Suicidal ideation|1|||
145447094|NCT00997984|524488691|FG000|Overall Study|Work schedule|0|||
145447095|NCT00997984|524488692|FG001|Overall Study|Work schedule|0|||
145447096|NCT00997984|524488693|FG002|Overall Study|Work schedule|2|||
145447097|NCT02997865|524488695|FG000|Overall Study|Death|2|||
145447098|NCT02997865|524488696|FG001|Overall Study|Death|1|||
145447099|NCT02997865|524488695|FG000|Overall Study|Lost to Follow-up|6|||
145447100|NCT02997865|524488696|FG001|Overall Study|Lost to Follow-up|3|||
145447101|NCT02997865|524488695|FG000|Overall Study|Withdrawal by Subject|5|||
145447102|NCT02997865|524488696|FG001|Overall Study|Withdrawal by Subject|0|||
145447103|NCT00295646|524488699|FG000|Overall Study|Protocol Violation|18|||
145447104|NCT00295646|524488700|FG001|Overall Study|Protocol Violation|20|||
145447105|NCT00295646|524488701|FG002|Overall Study|Protocol Violation|20|||
145447106|NCT00295646|524488702|FG003|Overall Study|Protocol Violation|18|||
145447107|NCT00295646|524488699|FG000|Overall Study|Withdrawal by Subject|8|||
145447108|NCT00295646|524488700|FG001|Overall Study|Withdrawal by Subject|9|||
145447109|NCT00295646|524488701|FG002|Overall Study|Withdrawal by Subject|11|||
145447110|NCT00295646|524488702|FG003|Overall Study|Withdrawal by Subject|14|||
145447111|NCT00295646|524488699|FG000|Overall Study|Lost to Follow-up|0|||
145447112|NCT00295646|524488700|FG001|Overall Study|Lost to Follow-up|5|||
145447113|NCT00295646|524488701|FG002|Overall Study|Lost to Follow-up|1|||
145447114|NCT00295646|524488702|FG003|Overall Study|Lost to Follow-up|5|||
145447115|NCT00295646|524488699|FG000|Overall Study|Death|9|||
145447116|NCT00295646|524488700|FG001|Overall Study|Death|7|||
145447117|NCT00295646|524488701|FG002|Overall Study|Death|18|||
145447118|NCT00295646|524488702|FG003|Overall Study|Death|8|||
145447119|NCT02243371|524488707|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
145447120|NCT02243371|524488708|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
145447121|NCT02243371|524488707|FG000|Overall Study|Death (unrelated)|2|||
145447122|NCT02243371|524488708|FG001|Overall Study|Death (unrelated)|4|||
145447123|NCT02243371|524488707|FG000|Overall Study|Adverse Event (unrelated)|0|||
145447124|NCT02243371|524488708|FG001|Overall Study|Adverse Event (unrelated)|1|||
145447125|NCT02243371|524488707|FG000|Overall Study|Lack of Clinical Benefit|0|||
145447126|NCT02243371|524488708|FG001|Overall Study|Lack of Clinical Benefit|1|||
145447127|NCT02243371|524488707|FG000|Overall Study|Withdrawal by Subject|0|||
145447128|NCT02243371|524488708|FG001|Overall Study|Withdrawal by Subject|2|||
145447129|NCT01945996|524488710|FG000|Overall Study|Lost to Follow-up|3|||
145447130|NCT01945996|524488711|FG001|Overall Study|Lost to Follow-up|5|||
145447131|NCT00271856|524488712|FG000|Overall Study|Withdrawal by Subject|1|||
145447132|NCT00271856|524488713|FG001|Overall Study|Withdrawal by Subject|7|||
145447133|NCT00271856|524488712|FG000|Overall Study|Lost to Follow-up|10|||
145447134|NCT00271856|524488713|FG001|Overall Study|Lost to Follow-up|11|||
145447135|NCT03012828|524488714|FG000|Overall Study|Lost to Follow-up|1|||
145447136|NCT03012828|524488715|FG001|Overall Study|Lost to Follow-up|0|||
145447137|NCT03012828|524488716|FG002|Overall Study|Lost to Follow-up|1|||
145447138|NCT03012828|524488717|FG003|Overall Study|Lost to Follow-up|0|||
145447139|NCT03012828|524488718|FG004|Overall Study|Lost to Follow-up|1|||
145447140|NCT03012828|524488719|FG005|Overall Study|Lost to Follow-up|0|||
145447141|NCT03012828|524488714|FG000|Overall Study|Withdrawal by Subject|0|||
145447142|NCT03012828|524488715|FG001|Overall Study|Withdrawal by Subject|0|||
145447143|NCT03012828|524488716|FG002|Overall Study|Withdrawal by Subject|1|||
145447144|NCT03012828|524488717|FG003|Overall Study|Withdrawal by Subject|0|||
145447145|NCT03012828|524488718|FG004|Overall Study|Withdrawal by Subject|0|||
145447146|NCT03012828|524488719|FG005|Overall Study|Withdrawal by Subject|1|||
145447147|NCT03012828|524488714|FG000|Overall Study|Non-compliance with protocol|0|||
145447148|NCT03012828|524488715|FG001|Overall Study|Non-compliance with protocol|0|||
145447149|NCT03012828|524488716|FG002|Overall Study|Non-compliance with protocol|0|||
145585449|NCT02053350|524997543|FG000|Overall Study|Adverse Event|4|||
145585450|NCT03521635|524997544|FG000|Overall Study|Adverse Event|1|||
145447150|NCT03012828|524488717|FG003|Overall Study|Non-compliance with protocol|0|||
145447151|NCT03012828|524488718|FG004|Overall Study|Non-compliance with protocol|1|||
145447152|NCT03012828|524488719|FG005|Overall Study|Non-compliance with protocol|0|||
145447153|NCT03012828|524488714|FG000|Overall Study|Delay to last visit would delay DBL|0|||
145447154|NCT03012828|524488715|FG001|Overall Study|Delay to last visit would delay DBL|0|||
145447155|NCT03012828|524488716|FG002|Overall Study|Delay to last visit would delay DBL|0|||
145447156|NCT03012828|524488717|FG003|Overall Study|Delay to last visit would delay DBL|0|||
145447157|NCT03012828|524488718|FG004|Overall Study|Delay to last visit would delay DBL|0|||
145447158|NCT03012828|524488719|FG005|Overall Study|Delay to last visit would delay DBL|1|||
145447159|NCT03900728|524488720|FG000|Overall Study|No text responses|0|||
145447160|NCT03900728|524488721|FG001|Overall Study|No text responses|0|||
145447161|NCT03900728|524488722|FG002|Overall Study|No text responses|4|||
145447162|NCT02544750|524488724|FG000|Overall Study|Physician Decision|3|||
145447163|NCT02544750|524488725|FG001|Overall Study|Physician Decision|1|||
145447164|NCT02544750|524488724|FG000|Overall Study|Other reasons|69|||
145447165|NCT02544750|524488725|FG001|Overall Study|Other reasons|39|||
145447166|NCT02544750|524488724|FG000|Overall Study|Met withdrawal criteria|2|||
145447167|NCT02544750|524488725|FG001|Overall Study|Met withdrawal criteria|2|||
145447168|NCT02544750|524488724|FG000|Overall Study|Transition To Commercial Product|1|||
145447169|NCT02544750|524488725|FG001|Overall Study|Transition To Commercial Product|0|||
145447170|NCT02544750|524488724|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
145447171|NCT02544750|524488725|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
145447172|NCT02544750|524488724|FG000|Overall Study|Adverse Event|8|||
145447173|NCT02544750|524488725|FG001|Overall Study|Adverse Event|10|||
145447174|NCT02544750|524488724|FG000|Overall Study|Withdrawal by Subject|10|||
145447175|NCT02544750|524488725|FG001|Overall Study|Withdrawal by Subject|4|||
145447176|NCT02544750|524488724|FG000|Overall Study|Lost to Follow-up|1|||
145447177|NCT02544750|524488725|FG001|Overall Study|Lost to Follow-up|0|||
145447178|NCT02484443|524488728|FG000|Overall Study|Lack of Efficacy|28|||
145447179|NCT02484443|524488728|FG000|Overall Study|Physician Decision|2|||
145447180|NCT02484443|524488728|FG000|Overall Study|Ineligible|2|||
145447181|NCT04677543|524488729|FG000|Overall Study|Withdrawal by Subject|4|||
145447182|NCT04677543|524488730|FG001|Overall Study|Withdrawal by Subject|1|||
145447183|NCT04677543|524488729|FG000|Overall Study|Physician Decision|0|||
145447184|NCT04677543|524488730|FG001|Overall Study|Physician Decision|1|||
145447185|NCT04677543|524488729|FG000|Overall Study|Adverse Event|0|||
145447186|NCT04677543|524488730|FG001|Overall Study|Adverse Event|1|||
145447187|NCT02969915|524488731|FG000|Overall Study|Death|104|||
145447188|NCT02969915|524488732|FG001|Overall Study|Death|125|||
145447189|NCT02969915|524488731|FG000|Overall Study|Lost to Follow-up|108|||
145447190|NCT02969915|524488732|FG001|Overall Study|Lost to Follow-up|112|||
145447191|NCT02969915|524488731|FG000|Overall Study|Censored due to COVID-19|481|||
145447192|NCT02969915|524488732|FG001|Overall Study|Censored due to COVID-19|471|||
145447193|NCT02520388|524488733|FG000|Overall Study|Physician Decision|1|||
145447194|NCT02520388|524488734|FG001|Overall Study|Physician Decision|0|||
145447195|NCT02520388|524488733|FG000|Overall Study|Subject or parent/guardian request|0|||
145447196|NCT02520388|524488734|FG001|Overall Study|Subject or parent/guardian request|6|||
145447197|NCT02520388|524488733|FG000|Overall Study|Adverse Event|1|||
145447198|NCT02520388|524488734|FG001|Overall Study|Adverse Event|4|||
145447199|NCT02520388|524488733|FG000|Overall Study|Lost to Follow-up|3|||
145447200|NCT02520388|524488734|FG001|Overall Study|Lost to Follow-up|2|||
145447201|NCT02520388|524488733|FG000|Overall Study|Other (reason not defined)|4|||
145447202|NCT02520388|524488734|FG001|Overall Study|Other (reason not defined)|4|||
145447203|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
145447204|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
145447205|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
145447206|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
145447207|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
145447208|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
145447209|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
145447210|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
145447211|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
145447212|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
145447213|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
145447214|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
145447215|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
145447216|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
145447217|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
145447218|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
145447219|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
145447220|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
145447221|NCT03162796|524488737|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
145447222|NCT03162796|524488738|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
145447223|NCT03162796|524488739|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
145447224|NCT03162796|524488737|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
145447225|NCT03162796|524488738|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
145447226|NCT03162796|524488739|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
145447227|NCT03162796|524488737|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
145585451|NCT03521635|524997545|FG001|Overall Study|Adverse Event|1|||
145447228|NCT03162796|524488738|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
145447229|NCT03162796|524488739|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
145447230|NCT03162796|524488737|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
145447231|NCT03162796|524488738|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
145447232|NCT03162796|524488739|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
145447233|NCT03162796|524488737|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
145447234|NCT03162796|524488738|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
145447235|NCT03162796|524488739|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
145447236|NCT02342288|524488740|FG000|Overall Study|no protocol anesthesiologist available|3|||
145447237|NCT02342288|524488741|FG001|Overall Study|no protocol anesthesiologist available|2|||
145447238|NCT02342288|524488740|FG000|Overall Study|anesthesia leak in system|1|||
145447239|NCT02342288|524488741|FG001|Overall Study|anesthesia leak in system|0|||
145447240|NCT02342288|524488740|FG000|Overall Study|Withdrawal by Subject|1|||
145447241|NCT02342288|524488741|FG001|Overall Study|Withdrawal by Subject|0|||
145447242|NCT02342288|524488740|FG000|Overall Study|coordinator contaminated with blood|0|||
145447243|NCT02342288|524488741|FG001|Overall Study|coordinator contaminated with blood|1|||
145447244|NCT02342288|524488740|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
145447245|NCT02342288|524488741|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
145447246|NCT02342288|524488740|FG000|Overall Study|coordinator not available|0|||
145447247|NCT02342288|524488741|FG001|Overall Study|coordinator not available|2|||
145447248|NCT02375373|524488742|FG000|Overall Study|Withdrawal by Subject|11|||
145447249|NCT00809926|524488747|FG000|Overall Study|Adverse Event|18|||
145447250|NCT00809926|524488748|FG001|Overall Study|Adverse Event|10|||
145447251|NCT00809926|524488747|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145447252|NCT00809926|524488748|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145447253|NCT00809926|524488747|FG000|Overall Study|Patient withdrew consent|8|||
145447254|NCT00809926|524488748|FG001|Overall Study|Patient withdrew consent|6|||
145447255|NCT00809926|524488747|FG000|Overall Study|Lost to Follow-up|2|||
145447256|NCT00809926|524488748|FG001|Overall Study|Lost to Follow-up|1|||
145447257|NCT00809926|524488747|FG000|Overall Study|Administrative Problems|0|||
145447258|NCT00809926|524488748|FG001|Overall Study|Administrative Problems|1|||
145447259|NCT00809926|524488747|FG000|Overall Study|Protocol deviation|0|||
145447260|NCT00809926|524488748|FG001|Overall Study|Protocol deviation|2|||
145447261|NCT01963767|524488764|FG000|Overall Study|Withdrawal by Subject|4|||
145447262|NCT01963767|524488765|FG001|Overall Study|Withdrawal by Subject|2|||
145447263|NCT01963767|524488764|FG000|Overall Study|Adverse Event|2|||
145447264|NCT01963767|524488765|FG001|Overall Study|Adverse Event|0|||
145447265|NCT01082081|524488768|FG000|Overall Study|Lost to Follow-up|0|||
145447266|NCT01082081|524488769|FG001|Overall Study|Lost to Follow-up|0|||
145447267|NCT01082081|524488770|FG002|Overall Study|Lost to Follow-up|1|||
145447268|NCT01082081|524488768|FG000|Overall Study|Withdrawal by Subject|0|||
145447269|NCT01082081|524488769|FG001|Overall Study|Withdrawal by Subject|0|||
145447270|NCT01082081|524488770|FG002|Overall Study|Withdrawal by Subject|1|||
145447271|NCT01082081|524488768|FG000|Overall Study|Other Reason|0|||
145447272|NCT01082081|524488769|FG001|Overall Study|Other Reason|1|||
145447273|NCT01082081|524488770|FG002|Overall Study|Other Reason|0|||
145447274|NCT00670930|524488771|FG000|Overall Study|Adminstrative Problem|0|||
145447275|NCT00670930|524488772|FG001|Overall Study|Adminstrative Problem|1|||
145447276|NCT00670930|524488771|FG000|Overall Study|Lost to Follow-up|1|||
145447277|NCT00670930|524488772|FG001|Overall Study|Lost to Follow-up|0|||
145447278|NCT03159468|524488777|FG000|Overall Study|Withdrawal by Subject|0|||
145447279|NCT03159468|524488778|FG001|Overall Study|Withdrawal by Subject|0|||
145447280|NCT03159468|524488779|FG002|Overall Study|Withdrawal by Subject|3|||
145447281|NCT03159468|524488780|FG003|Overall Study|Withdrawal by Subject|0|||
145447282|NCT03159468|524488781|FG004|Overall Study|Withdrawal by Subject|0|||
145447283|NCT03159468|524488782|FG005|Overall Study|Withdrawal by Subject|0|||
145447284|NCT03744910|524490356|FG000|Overall Study|Withdrew Consent|1|||
145447285|NCT03744910|524490357|FG001|Overall Study|Withdrew Consent|8|||
145447286|NCT03744910|524490356|FG000|Overall Study|Physician Decision|5|||
145447287|NCT03744910|524490357|FG001|Overall Study|Physician Decision|4|||
145447288|NCT03744910|524490356|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
145447289|NCT03744910|524490357|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
145585452|NCT03521635|524997544|FG000|Overall Study|Refused to complete study visit|1|||
145585453|NCT03521635|524997545|FG001|Overall Study|Refused to complete study visit|0|||
145447290|NCT03744910|524490356|FG000|Overall Study|Lost to Follow-up|0|||
145447291|NCT03744910|524490357|FG001|Overall Study|Lost to Follow-up|1|||
145585454|NCT03521635|524997544|FG000|Overall Study|Refused to continue trial medication|2|||
145585455|NCT03521635|524997545|FG001|Overall Study|Refused to continue trial medication|2|||
145447292|NCT03744910|524490356|FG000|Overall Study|Other-unspecified|4|||
145447293|NCT03744910|524490357|FG001|Overall Study|Other-unspecified|1|||
145447294|NCT02744612|524490358|FG000|Overall Study|Withdrawal by Subject|0|||
145447295|NCT02744612|524490359|FG001|Overall Study|Withdrawal by Subject|2|||
145585456|NCT03521635|524997544|FG000|Overall Study|Lost to Follow-up|0|||
145585457|NCT03521635|524997545|FG001|Overall Study|Lost to Follow-up|1|||
145447296|NCT02574078|524490361|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447297|NCT02574078|524490362|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447298|NCT02574078|524490363|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447299|NCT02574078|524490364|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447300|NCT02574078|524490365|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447301|NCT02574078|524490366|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145447302|NCT02574078|524490367|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
145447303|NCT02574078|524490368|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447304|NCT02574078|524490369|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145447305|NCT02574078|524490370|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447306|NCT02574078|524490371|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447307|NCT02574078|524490372|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447308|NCT02574078|524490373|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145447309|NCT02574078|524490361|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
145447310|NCT02574078|524490362|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145447311|NCT02574078|524490363|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
145447312|NCT02574078|524490364|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
145447313|NCT02574078|524490365|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
145447314|NCT02574078|524490366|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
145447315|NCT02574078|524490367|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
145447316|NCT02574078|524490368|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
145447317|NCT02574078|524490369|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
145447318|NCT02574078|524490370|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
145447319|NCT02574078|524490371|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
145447320|NCT02574078|524490372|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
145447321|NCT02574078|524490373|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
145447322|NCT02574078|524490361|FG000|Pre-Treatment Period|Other reasons|0|||
145447323|NCT02574078|524490362|FG001|Pre-Treatment Period|Other reasons|0|||
145447324|NCT02574078|524490363|FG002|Pre-Treatment Period|Other reasons|0|||
145447325|NCT02574078|524490364|FG003|Pre-Treatment Period|Other reasons|0|||
145447326|NCT02574078|524490365|FG004|Pre-Treatment Period|Other reasons|0|||
145447327|NCT02574078|524490366|FG005|Pre-Treatment Period|Other reasons|0|||
145447328|NCT02574078|524490367|FG006|Pre-Treatment Period|Other reasons|2|||
145447329|NCT02574078|524490368|FG007|Pre-Treatment Period|Other reasons|0|||
145447330|NCT02574078|524490369|FG008|Pre-Treatment Period|Other reasons|0|||
145447331|NCT02574078|524490370|FG009|Pre-Treatment Period|Other reasons|0|||
145447332|NCT02574078|524490371|FG010|Pre-Treatment Period|Other reasons|2|||
145447333|NCT02574078|524490372|FG011|Pre-Treatment Period|Other reasons|0|||
145447334|NCT02574078|524490373|FG012|Pre-Treatment Period|Other reasons|0|||
145447335|NCT02574078|524490361|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
145447336|NCT02574078|524490362|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
145447337|NCT02574078|524490363|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
145447338|NCT02574078|524490364|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
145447339|NCT02574078|524490365|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
145447340|NCT02574078|524490366|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
145447341|NCT02574078|524490367|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
145447342|NCT02574078|524490368|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
145447343|NCT02574078|524490369|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
145447344|NCT02574078|524490370|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
145447345|NCT02574078|524490371|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
145447346|NCT02574078|524490372|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
145447347|NCT02574078|524490373|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
145447348|NCT02574078|524490361|FG000|Treatment Period|Disease progression|6|||
145447349|NCT02574078|524490362|FG001|Treatment Period|Disease progression|4|||
145447350|NCT02574078|524490363|FG002|Treatment Period|Disease progression|7|||
145447351|NCT02574078|524490364|FG003|Treatment Period|Disease progression|18|||
145447352|NCT02574078|524490365|FG004|Treatment Period|Disease progression|16|||
145447353|NCT02574078|524490366|FG005|Treatment Period|Disease progression|26|||
145447354|NCT02574078|524490367|FG006|Treatment Period|Disease progression|5|||
145447355|NCT02574078|524490368|FG007|Treatment Period|Disease progression|9|||
145447356|NCT02574078|524490369|FG008|Treatment Period|Disease progression|8|||
145447357|NCT02574078|524490370|FG009|Treatment Period|Disease progression|5|||
145447358|NCT02574078|524490371|FG010|Treatment Period|Disease progression|20|||
145447359|NCT02574078|524490372|FG011|Treatment Period|Disease progression|29|||
145447360|NCT02574078|524490373|FG012|Treatment Period|Disease progression|2|||
145447361|NCT02574078|524490361|FG000|Treatment Period|Study drug toxicity|1|||
145447362|NCT02574078|524490362|FG001|Treatment Period|Study drug toxicity|1|||
145447363|NCT02574078|524490363|FG002|Treatment Period|Study drug toxicity|0|||
145447364|NCT02574078|524490364|FG003|Treatment Period|Study drug toxicity|5|||
145447365|NCT02574078|524490365|FG004|Treatment Period|Study drug toxicity|3|||
145447366|NCT02574078|524490366|FG005|Treatment Period|Study drug toxicity|1|||
145447367|NCT02574078|524490367|FG006|Treatment Period|Study drug toxicity|2|||
145447368|NCT02574078|524490368|FG007|Treatment Period|Study drug toxicity|0|||
145447369|NCT02574078|524490369|FG008|Treatment Period|Study drug toxicity|2|||
145447370|NCT02574078|524490370|FG009|Treatment Period|Study drug toxicity|1|||
145447371|NCT02574078|524490371|FG010|Treatment Period|Study drug toxicity|16|||
145447372|NCT02574078|524490372|FG011|Treatment Period|Study drug toxicity|2|||
145447373|NCT02574078|524490373|FG012|Treatment Period|Study drug toxicity|4|||
145447374|NCT02574078|524490361|FG000|Treatment Period|Death|2|||
145447375|NCT02574078|524490362|FG001|Treatment Period|Death|0|||
145447376|NCT02574078|524490363|FG002|Treatment Period|Death|0|||
145447377|NCT02574078|524490364|FG003|Treatment Period|Death|0|||
145447378|NCT02574078|524490365|FG004|Treatment Period|Death|1|||
145447379|NCT02574078|524490366|FG005|Treatment Period|Death|1|||
145447380|NCT02574078|524490367|FG006|Treatment Period|Death|1|||
145447381|NCT02574078|524490368|FG007|Treatment Period|Death|1|||
145447382|NCT02574078|524490369|FG008|Treatment Period|Death|7|||
145447383|NCT02574078|524490370|FG009|Treatment Period|Death|1|||
145447384|NCT02574078|524490371|FG010|Treatment Period|Death|0|||
145447385|NCT02574078|524490372|FG011|Treatment Period|Death|2|||
145447386|NCT02574078|524490373|FG012|Treatment Period|Death|1|||
145447387|NCT02574078|524490361|FG000|Treatment Period|Adverse event unrelated to drug|0|||
145447388|NCT02574078|524490362|FG001|Treatment Period|Adverse event unrelated to drug|0|||
145447389|NCT02574078|524490363|FG002|Treatment Period|Adverse event unrelated to drug|1|||
145447390|NCT02574078|524490364|FG003|Treatment Period|Adverse event unrelated to drug|0|||
145447391|NCT02574078|524490365|FG004|Treatment Period|Adverse event unrelated to drug|2|||
145447392|NCT02574078|524490366|FG005|Treatment Period|Adverse event unrelated to drug|3|||
145447393|NCT02574078|524490367|FG006|Treatment Period|Adverse event unrelated to drug|0|||
145447394|NCT02574078|524490368|FG007|Treatment Period|Adverse event unrelated to drug|0|||
145447395|NCT02574078|524490369|FG008|Treatment Period|Adverse event unrelated to drug|1|||
145447396|NCT02574078|524490370|FG009|Treatment Period|Adverse event unrelated to drug|2|||
145447397|NCT02574078|524490371|FG010|Treatment Period|Adverse event unrelated to drug|4|||
145447398|NCT02574078|524490372|FG011|Treatment Period|Adverse event unrelated to drug|1|||
145447399|NCT02574078|524490373|FG012|Treatment Period|Adverse event unrelated to drug|0|||
145447400|NCT02574078|524490361|FG000|Treatment Period|Administrative reason by Sponsor|0|||
145447401|NCT02574078|524490362|FG001|Treatment Period|Administrative reason by Sponsor|1|||
145447402|NCT02574078|524490363|FG002|Treatment Period|Administrative reason by Sponsor|0|||
145447403|NCT02574078|524490364|FG003|Treatment Period|Administrative reason by Sponsor|0|||
145447404|NCT02574078|524490365|FG004|Treatment Period|Administrative reason by Sponsor|0|||
145447405|NCT02574078|524490366|FG005|Treatment Period|Administrative reason by Sponsor|0|||
145447406|NCT02574078|524490367|FG006|Treatment Period|Administrative reason by Sponsor|1|||
145447407|NCT02574078|524490368|FG007|Treatment Period|Administrative reason by Sponsor|0|||
145447408|NCT02574078|524490369|FG008|Treatment Period|Administrative reason by Sponsor|0|||
145447409|NCT02574078|524490370|FG009|Treatment Period|Administrative reason by Sponsor|0|||
145447410|NCT02574078|524490371|FG010|Treatment Period|Administrative reason by Sponsor|0|||
145447411|NCT02574078|524490372|FG011|Treatment Period|Administrative reason by Sponsor|0|||
145447412|NCT02574078|524490373|FG012|Treatment Period|Administrative reason by Sponsor|3|||
145447413|NCT02574078|524490361|FG000|Treatment Period|Other reasons|1|||
145447414|NCT02574078|524490362|FG001|Treatment Period|Other reasons|0|||
145447415|NCT02574078|524490363|FG002|Treatment Period|Other reasons|1|||
145447416|NCT02574078|524490364|FG003|Treatment Period|Other reasons|3|||
145447417|NCT02574078|524490365|FG004|Treatment Period|Other reasons|3|||
145447418|NCT02574078|524490366|FG005|Treatment Period|Other reasons|1|||
145447419|NCT02574078|524490367|FG006|Treatment Period|Other reasons|2|||
145447420|NCT02574078|524490368|FG007|Treatment Period|Other reasons|1|||
145447421|NCT02574078|524490369|FG008|Treatment Period|Other reasons|3|||
145447422|NCT02574078|524490370|FG009|Treatment Period|Other reasons|1|||
145447423|NCT02574078|524490371|FG010|Treatment Period|Other reasons|1|||
145447424|NCT02574078|524490372|FG011|Treatment Period|Other reasons|3|||
145447425|NCT02574078|524490373|FG012|Treatment Period|Other reasons|1|||
145447426|NCT02574078|524490361|FG000|Treatment Period|Participant request to stop drug|0|||
145447427|NCT02574078|524490362|FG001|Treatment Period|Participant request to stop drug|0|||
145447428|NCT02574078|524490363|FG002|Treatment Period|Participant request to stop drug|0|||
145447429|NCT02574078|524490364|FG003|Treatment Period|Participant request to stop drug|2|||
145447430|NCT02574078|524490365|FG004|Treatment Period|Participant request to stop drug|4|||
145447431|NCT02574078|524490366|FG005|Treatment Period|Participant request to stop drug|0|||
145447432|NCT02574078|524490367|FG006|Treatment Period|Participant request to stop drug|1|||
145447433|NCT02574078|524490368|FG007|Treatment Period|Participant request to stop drug|0|||
145447434|NCT02574078|524490369|FG008|Treatment Period|Participant request to stop drug|3|||
145447435|NCT02574078|524490370|FG009|Treatment Period|Participant request to stop drug|2|||
145447436|NCT02574078|524490371|FG010|Treatment Period|Participant request to stop drug|2|||
145447437|NCT02574078|524490372|FG011|Treatment Period|Participant request to stop drug|4|||
145447438|NCT02574078|524490373|FG012|Treatment Period|Participant request to stop drug|1|||
145447439|NCT02574078|524490361|FG000|Treatment Period|Participant withdrew consent|0|||
145447440|NCT02574078|524490362|FG001|Treatment Period|Participant withdrew consent|0|||
145447441|NCT02574078|524490363|FG002|Treatment Period|Participant withdrew consent|0|||
145447442|NCT02574078|524490364|FG003|Treatment Period|Participant withdrew consent|0|||
145447443|NCT02574078|524490365|FG004|Treatment Period|Participant withdrew consent|1|||
145447444|NCT02574078|524490366|FG005|Treatment Period|Participant withdrew consent|1|||
145447445|NCT02574078|524490367|FG006|Treatment Period|Participant withdrew consent|0|||
145447446|NCT02574078|524490368|FG007|Treatment Period|Participant withdrew consent|1|||
145447447|NCT02574078|524490369|FG008|Treatment Period|Participant withdrew consent|0|||
145447448|NCT02574078|524490370|FG009|Treatment Period|Participant withdrew consent|2|||
145447449|NCT02574078|524490371|FG010|Treatment Period|Participant withdrew consent|1|||
145447450|NCT02574078|524490372|FG011|Treatment Period|Participant withdrew consent|4|||
145447451|NCT02574078|524490373|FG012|Treatment Period|Participant withdrew consent|1|||
145447452|NCT02574078|524490361|FG000|Treatment Period|Participant no longer meets criteria|0|||
145447453|NCT02574078|524490362|FG001|Treatment Period|Participant no longer meets criteria|0|||
145447454|NCT02574078|524490363|FG002|Treatment Period|Participant no longer meets criteria|0|||
145447455|NCT02574078|524490364|FG003|Treatment Period|Participant no longer meets criteria|0|||
145447456|NCT02574078|524490365|FG004|Treatment Period|Participant no longer meets criteria|1|||
145447457|NCT02574078|524490366|FG005|Treatment Period|Participant no longer meets criteria|0|||
145447458|NCT02574078|524490367|FG006|Treatment Period|Participant no longer meets criteria|0|||
145447459|NCT02574078|524490368|FG007|Treatment Period|Participant no longer meets criteria|0|||
145447460|NCT02574078|524490369|FG008|Treatment Period|Participant no longer meets criteria|0|||
145447461|NCT02574078|524490370|FG009|Treatment Period|Participant no longer meets criteria|1|||
145447462|NCT02574078|524490371|FG010|Treatment Period|Participant no longer meets criteria|1|||
145447463|NCT02574078|524490372|FG011|Treatment Period|Participant no longer meets criteria|1|||
145447464|NCT02574078|524490373|FG012|Treatment Period|Participant no longer meets criteria|0|||
145447465|NCT02574078|524490361|FG000|Treatment Period|Lost to Follow-up|0|||
145447466|NCT02574078|524490362|FG001|Treatment Period|Lost to Follow-up|0|||
145447467|NCT02574078|524490363|FG002|Treatment Period|Lost to Follow-up|0|||
145447468|NCT02574078|524490364|FG003|Treatment Period|Lost to Follow-up|0|||
145447469|NCT02574078|524490365|FG004|Treatment Period|Lost to Follow-up|0|||
145447470|NCT02574078|524490366|FG005|Treatment Period|Lost to Follow-up|0|||
145447471|NCT02574078|524490367|FG006|Treatment Period|Lost to Follow-up|0|||
145447472|NCT02574078|524490368|FG007|Treatment Period|Lost to Follow-up|0|||
145447473|NCT02574078|524490369|FG008|Treatment Period|Lost to Follow-up|0|||
145447474|NCT02574078|524490370|FG009|Treatment Period|Lost to Follow-up|1|||
145447475|NCT02574078|524490371|FG010|Treatment Period|Lost to Follow-up|0|||
145447476|NCT02574078|524490372|FG011|Treatment Period|Lost to Follow-up|1|||
145447477|NCT02574078|524490373|FG012|Treatment Period|Lost to Follow-up|0|||
145447478|NCT02574078|524490361|FG000|Treatment Period|Maximum clinical benefit|0|||
145447479|NCT02574078|524490362|FG001|Treatment Period|Maximum clinical benefit|0|||
145447480|NCT02574078|524490363|FG002|Treatment Period|Maximum clinical benefit|0|||
145447481|NCT02574078|524490364|FG003|Treatment Period|Maximum clinical benefit|0|||
145447482|NCT02574078|524490365|FG004|Treatment Period|Maximum clinical benefit|0|||
145447483|NCT02574078|524490366|FG005|Treatment Period|Maximum clinical benefit|0|||
145447484|NCT02574078|524490367|FG006|Treatment Period|Maximum clinical benefit|0|||
145447485|NCT02574078|524490368|FG007|Treatment Period|Maximum clinical benefit|0|||
145447486|NCT02574078|524490369|FG008|Treatment Period|Maximum clinical benefit|0|||
145447487|NCT02574078|524490370|FG009|Treatment Period|Maximum clinical benefit|1|||
145447488|NCT02574078|524490371|FG010|Treatment Period|Maximum clinical benefit|0|||
145447489|NCT02574078|524490372|FG011|Treatment Period|Maximum clinical benefit|0|||
145447490|NCT02574078|524490373|FG012|Treatment Period|Maximum clinical benefit|0|||
145447491|NCT00500357|524490376|FG000|Overall Study|Death|1|||
145447492|NCT02397915|524490377|FG000|Period 1|Protocol Violation|0|||
145447493|NCT02397915|524490378|FG001|Period 1|Protocol Violation|1|||
145447494|NCT02397915|524490379|FG002|Period 1|Protocol Violation|0|||
145447495|NCT02397915|524490380|FG003|Period 1|Protocol Violation|0|||
145447496|NCT02397915|524490377|FG000|Period 1|Physician Decision|1|||
145447497|NCT02397915|524490378|FG001|Period 1|Physician Decision|0|||
145447498|NCT02397915|524490379|FG002|Period 1|Physician Decision|0|||
145447499|NCT02397915|524490380|FG003|Period 1|Physician Decision|0|||
145447500|NCT00933608|524490381|FG000|Overall Study|Adverse Event|4|||
145447501|NCT00933608|524490382|FG001|Overall Study|Adverse Event|2|||
145447502|NCT00933608|524490381|FG000|Overall Study|Physician Decision|1|||
145447503|NCT00933608|524490382|FG001|Overall Study|Physician Decision|0|||
145447504|NCT00861757|524490385|FG000|Overall Study|Adverse Event|1|||
145447505|NCT00861757|524490386|FG001|Overall Study|Adverse Event|5|||
145447506|NCT00861757|524490387|FG002|Overall Study|Adverse Event|7|||
145447507|NCT00861757|524490388|FG003|Overall Study|Adverse Event|2|||
145447508|NCT00861757|524490385|FG000|Overall Study|Entry Criteria Not Met|1|||
145447509|NCT00861757|524490386|FG001|Overall Study|Entry Criteria Not Met|2|||
145447510|NCT00861757|524490387|FG002|Overall Study|Entry Criteria Not Met|1|||
145447511|NCT00861757|524490388|FG003|Overall Study|Entry Criteria Not Met|1|||
145447512|NCT00861757|524490385|FG000|Overall Study|Lack of Efficacy|3|||
145447513|NCT00861757|524490386|FG001|Overall Study|Lack of Efficacy|1|||
145447514|NCT00861757|524490387|FG002|Overall Study|Lack of Efficacy|0|||
145447515|NCT00861757|524490388|FG003|Overall Study|Lack of Efficacy|1|||
145447516|NCT00861757|524490385|FG000|Overall Study|Lost to Follow-up|1|||
145585458|NCT03521635|524997544|FG000|Overall Study|Meet exclusion criteria|0|||
145585459|NCT03521635|524997545|FG001|Overall Study|Meet exclusion criteria|1|||
145585460|NCT03521635|524997544|FG000|Overall Study|Patient not taken study medicine|0|||
145585461|NCT03521635|524997545|FG001|Overall Study|Patient not taken study medicine|1|||
145585462|NCT01747772|524997546|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
145585463|NCT02367911|524997547|FG000|Overall Study|Withdrawal by Subject|3|||
145585464|NCT02367911|524997548|FG001|Overall Study|Withdrawal by Subject|2|||
145585465|NCT02367911|524997547|FG000|Overall Study|Lost to Follow-up|2|||
145585466|NCT02367911|524997548|FG001|Overall Study|Lost to Follow-up|2|||
145585467|NCT00512135|524997549|FG000|Overall Study|Not Treated|5|||
145585468|NCT00512135|524997549|FG000|Overall Study|Lack of Efficacy|2|||
145585469|NCT00512135|524997549|FG000|Overall Study|Adverse Event|6|||
145585470|NCT00512135|524997549|FG000|Overall Study|Withdrawal by Subject|22|||
145585471|NCT00512135|524997549|FG000|Overall Study|Lost to Follow-up|27|||
145585472|NCT00512135|524997549|FG000|Overall Study|Other|22|||
145585473|NCT04495374|524997550|FG000|Overall Study|Protocol Violation|2|||
145585474|NCT04495374|524997551|FG001|Overall Study|Protocol Violation|1|||
145585475|NCT04535037|524997555|FG000|Overall Study|Protocol Violation|1|||
145585476|NCT04535037|524997556|FG001|Overall Study|Protocol Violation|0|||
145585477|NCT04535037|524997555|FG000|Overall Study|Withdrawal by Subject|8|||
145585478|NCT04535037|524997556|FG001|Overall Study|Withdrawal by Subject|9|||
145585479|NCT04535037|524997555|FG000|Overall Study|Migrated / moved from the study area|1|||
145585480|NCT04535037|524997556|FG001|Overall Study|Migrated / moved from the study area|4|||
145585481|NCT04535037|524997555|FG000|Overall Study|Other|2|||
145447517|NCT00861757|524490386|FG001|Overall Study|Lost to Follow-up|0|||
145447518|NCT00861757|524490387|FG002|Overall Study|Lost to Follow-up|1|||
145447519|NCT00861757|524490388|FG003|Overall Study|Lost to Follow-up|1|||
145447520|NCT00861757|524490385|FG000|Overall Study|Physician Decision|0|||
145447521|NCT00861757|524490386|FG001|Overall Study|Physician Decision|0|||
145447522|NCT00861757|524490387|FG002|Overall Study|Physician Decision|0|||
145447523|NCT00861757|524490388|FG003|Overall Study|Physician Decision|1|||
145447524|NCT00861757|524490385|FG000|Overall Study|Protocol Violation|2|||
145447525|NCT00861757|524490386|FG001|Overall Study|Protocol Violation|2|||
145447526|NCT00861757|524490387|FG002|Overall Study|Protocol Violation|4|||
145447527|NCT00861757|524490388|FG003|Overall Study|Protocol Violation|1|||
145447528|NCT00861757|524490385|FG000|Overall Study|Withdrawal by Subject|1|||
145447529|NCT00861757|524490386|FG001|Overall Study|Withdrawal by Subject|5|||
145447530|NCT00861757|524490387|FG002|Overall Study|Withdrawal by Subject|5|||
145447531|NCT00861757|524490388|FG003|Overall Study|Withdrawal by Subject|2|||
145447532|NCT02403817|524490391|FG000|Overall Study|Withdrawal by Subject|5|||
145447533|NCT02403817|524490392|FG001|Overall Study|Withdrawal by Subject|0|||
145447534|NCT05002985|524490393|FG000|Overall Study|Withdrawal by Subject|1|||
145447535|NCT00833469|524490397|FG000|Overall Study|Withdrawal by Subject|1|||
145447536|NCT00833469|524490397|FG000|Overall Study|Lost to Follow-up|1|||
145447537|NCT00603941|524490398|FG000|Overall Study|Disease progression|6|||
145447538|NCT00603941|524490399|FG001|Overall Study|Disease progression|7|||
145447539|NCT00603941|524490400|FG002|Overall Study|Disease progression|1|||
145447540|NCT00603941|524490398|FG000|Overall Study|Adverse Event|1|||
145447541|NCT00603941|524490399|FG001|Overall Study|Adverse Event|0|||
145447542|NCT00603941|524490400|FG002|Overall Study|Adverse Event|1|||
145447543|NCT00603941|524490398|FG000|Overall Study|Physician Decision|0|||
145447544|NCT00603941|524490399|FG001|Overall Study|Physician Decision|1|||
145447545|NCT00603941|524490400|FG002|Overall Study|Physician Decision|0|||
145447546|NCT00603941|524490398|FG000|Overall Study|Withdrawal by Subject|0|||
145447547|NCT00603941|524490399|FG001|Overall Study|Withdrawal by Subject|2|||
145447548|NCT00603941|524490400|FG002|Overall Study|Withdrawal by Subject|0|||
145447549|NCT01642901|524490401|FG000|12-month Follow-up|Withdrawal by Subject|1|||
145447550|NCT01642901|524490402|FG001|12-month Follow-up|Withdrawal by Subject|0|||
145585482|NCT04535037|524997556|FG001|Overall Study|Other|5|||
145585483|NCT01148810|524997557|FG000|Overall Study|Adverse Event|0|||
145447551|NCT02707965|524490403|FG000|Overall Study|Withdrawal by Subject|0|||
145447552|NCT02707965|524490404|FG001|Overall Study|Withdrawal by Subject|0|||
145447553|NCT02707965|524490405|FG002|Overall Study|Withdrawal by Subject|1|||
145447554|NCT02707965|524490406|FG003|Overall Study|Withdrawal by Subject|0|||
145585484|NCT01148810|524997558|FG001|Overall Study|Adverse Event|2|||
145585485|NCT01148810|524997557|FG000|Overall Study|Lack of Efficacy|0|||
145447555|NCT02707965|524490407|FG004|Overall Study|Withdrawal by Subject|0|||
145447556|NCT02707965|524490408|FG005|Overall Study|Withdrawal by Subject|0|||
145447557|NCT02707965|524490409|FG006|Overall Study|Withdrawal by Subject|0|||
145585486|NCT01148810|524997558|FG001|Overall Study|Lack of Efficacy|1|||
145585487|NCT01148810|524997557|FG000|Overall Study|Withdrawal by Subject|0|||
145585488|NCT01148810|524997558|FG001|Overall Study|Withdrawal by Subject|2|||
145585489|NCT01148810|524997557|FG000|Overall Study|Protocol Violation|1|||
145585490|NCT01148810|524997558|FG001|Overall Study|Protocol Violation|0|||
145585491|NCT02417246|524997564|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
145585492|NCT02417246|524997565|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
145625995|NCT00480441|525144139|FG001|Randomization|Lost to Follow-up|7|||
145585493|NCT02417246|524997564|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
145585494|NCT02417246|524997565|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
145585495|NCT02417246|524997564|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
145585496|NCT02417246|524997565|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
145585497|NCT02417246|524997564|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
145447558|NCT02707965|524490410|FG007|Overall Study|Withdrawal by Subject|2|||
145447559|NCT02707965|524490411|FG008|Overall Study|Withdrawal by Subject|0|||
145447560|NCT02707965|524490412|FG009|Overall Study|Withdrawal by Subject|0|||
145447561|NCT02707965|524490413|FG010|Overall Study|Withdrawal by Subject|0|||
145447562|NCT02707965|524490414|FG011|Overall Study|Withdrawal by Subject|0|||
145447563|NCT02707965|524490415|FG012|Overall Study|Withdrawal by Subject|0|||
145447564|NCT02707965|524490416|FG013|Overall Study|Withdrawal by Subject|0|||
145447565|NCT02707965|524490417|FG014|Overall Study|Withdrawal by Subject|0|||
145447566|NCT02707965|524490418|FG015|Overall Study|Withdrawal by Subject|0|||
145447567|NCT02707965|524490403|FG000|Overall Study|PI decisions|0|||
145447568|NCT02707965|524490404|FG001|Overall Study|PI decisions|0|||
145447569|NCT02707965|524490405|FG002|Overall Study|PI decisions|0|||
145447570|NCT02707965|524490406|FG003|Overall Study|PI decisions|0|||
145447571|NCT02707965|524490407|FG004|Overall Study|PI decisions|0|||
145585498|NCT02417246|524997565|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
145447572|NCT02707965|524490408|FG005|Overall Study|PI decisions|0|||
145447573|NCT02707965|524490409|FG006|Overall Study|PI decisions|0|||
145447574|NCT02707965|524490410|FG007|Overall Study|PI decisions|0|||
145447575|NCT02707965|524490411|FG008|Overall Study|PI decisions|0|||
145447576|NCT02707965|524490412|FG009|Overall Study|PI decisions|0|||
145447577|NCT02707965|524490413|FG010|Overall Study|PI decisions|0|||
145447578|NCT02707965|524490414|FG011|Overall Study|PI decisions|0|||
145447579|NCT02707965|524490415|FG012|Overall Study|PI decisions|0|||
145447580|NCT02707965|524490416|FG013|Overall Study|PI decisions|0|||
145447581|NCT02707965|524490417|FG014|Overall Study|PI decisions|2|||
145447582|NCT02707965|524490418|FG015|Overall Study|PI decisions|0|||
145447583|NCT02707965|524490403|FG000|Overall Study|Protocol deviation|1|||
145447584|NCT02707965|524490404|FG001|Overall Study|Protocol deviation|1|||
145447585|NCT02707965|524490405|FG002|Overall Study|Protocol deviation|0|||
145447586|NCT02707965|524490406|FG003|Overall Study|Protocol deviation|0|||
145447587|NCT02707965|524490407|FG004|Overall Study|Protocol deviation|0|||
145447588|NCT02707965|524490408|FG005|Overall Study|Protocol deviation|0|||
145447589|NCT02707965|524490409|FG006|Overall Study|Protocol deviation|0|||
145447590|NCT02707965|524490410|FG007|Overall Study|Protocol deviation|1|||
145447591|NCT02707965|524490411|FG008|Overall Study|Protocol deviation|0|||
145447592|NCT02707965|524490412|FG009|Overall Study|Protocol deviation|0|||
145447593|NCT02707965|524490413|FG010|Overall Study|Protocol deviation|0|||
145447594|NCT02707965|524490414|FG011|Overall Study|Protocol deviation|0|||
145447595|NCT02707965|524490415|FG012|Overall Study|Protocol deviation|0|||
145447596|NCT02707965|524490416|FG013|Overall Study|Protocol deviation|0|||
145447597|NCT02707965|524490417|FG014|Overall Study|Protocol deviation|0|||
145447598|NCT02707965|524490418|FG015|Overall Study|Protocol deviation|0|||
145447599|NCT02943070|524490419|FG000|Overall Study|Physician Decision|1|||
145447600|NCT02943070|524490419|FG000|Overall Study|Adverse Event|2|||
145447601|NCT02943070|524490419|FG000|Overall Study|Death|2|||
145447602|NCT02943070|524490419|FG000|Overall Study|Withdrawal by Subject|3|||
145447603|NCT02943070|524490419|FG000|Overall Study|Lost to Follow-up|4|||
145447604|NCT02943070|524490419|FG000|Overall Study|Retreatment or TURP|13|||
145447605|NCT02943070|524490419|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
145447606|NCT00570778|524490420|FG000|Overall Study|Protocol deviation|2|||
145447607|NCT00570778|524490421|FG001|Overall Study|Protocol deviation|1|||
145447608|NCT00570778|524490422|FG002|Overall Study|Protocol deviation|2|||
145447609|NCT00570778|524490423|FG003|Overall Study|Protocol deviation|2|||
145447610|NCT00570778|524490420|FG000|Overall Study|Adverse Event|0|||
145447611|NCT00570778|524490421|FG001|Overall Study|Adverse Event|1|||
145585499|NCT04408469|524997568|FG000|Overall Study|Lost to Follow-up|6|||
145447612|NCT00570778|524490422|FG002|Overall Study|Adverse Event|4|||
145447613|NCT00570778|524490423|FG003|Overall Study|Adverse Event|1|||
145447614|NCT00570778|524490420|FG000|Overall Study|Subject withdrew consent|0|||
145447615|NCT00570778|524490421|FG001|Overall Study|Subject withdrew consent|1|||
145447616|NCT00570778|524490422|FG002|Overall Study|Subject withdrew consent|0|||
145447617|NCT00570778|524490423|FG003|Overall Study|Subject withdrew consent|1|||
145447618|NCT00570778|524490420|FG000|Overall Study|Abnormal test procedure|1|||
145447619|NCT00570778|524490421|FG001|Overall Study|Abnormal test procedure|0|||
145447620|NCT00570778|524490422|FG002|Overall Study|Abnormal test procedure|0|||
145585500|NCT04408469|524997569|FG001|Overall Study|Lost to Follow-up|9|||
145585501|NCT04408469|524997568|FG000|Overall Study|Withdrawal by Subject|6|||
145585502|NCT04408469|524997569|FG001|Overall Study|Withdrawal by Subject|1|||
145447621|NCT00570778|524490423|FG003|Overall Study|Abnormal test procedure|0|||
145585503|NCT04408469|524997568|FG000|Overall Study|Dismissal due to ineligibility|0|||
145585504|NCT04408469|524997569|FG001|Overall Study|Dismissal due to ineligibility|1|||
145447622|NCT00570778|524490420|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145447623|NCT00570778|524490421|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145447624|NCT00570778|524490422|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145447625|NCT00570778|524490423|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145447626|NCT00570778|524490420|FG000|Overall Study|Lost to Follow-up|0|||
145447627|NCT00570778|524490421|FG001|Overall Study|Lost to Follow-up|0|||
145447628|NCT00570778|524490422|FG002|Overall Study|Lost to Follow-up|1|||
145447629|NCT00570778|524490423|FG003|Overall Study|Lost to Follow-up|0|||
145447630|NCT00570778|524490420|FG000|Overall Study|Subject no longer requires study drug|0|||
145447631|NCT00570778|524490421|FG001|Overall Study|Subject no longer requires study drug|1|||
145447632|NCT00570778|524490422|FG002|Overall Study|Subject no longer requires study drug|0|||
145447633|NCT00570778|524490423|FG003|Overall Study|Subject no longer requires study drug|0|||
145447634|NCT00711594|524490424|FG000|Overall Study|Progressive disease|2|||
145447635|NCT00711594|524490425|FG001|Overall Study|Progressive disease|2|||
145585505|NCT04321460|524997570|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
145585506|NCT04321460|524997571|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
145585507|NCT01308749|524997572|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
145585508|NCT01308749|524997573|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
145585509|NCT01308749|524997572|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
145585510|NCT01308749|524997573|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
145585511|NCT01308749|524997572|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
145585512|NCT01308749|524997573|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
145625996|NCT00480441|525144140|FG002|Randomization|Lost to Follow-up|2|||
145625997|NCT00465985|525144141|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
145625998|NCT00465985|525144142|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
145447636|NCT00711594|524490426|FG002|Overall Study|Progressive disease|6|||
145447637|NCT00711594|524490427|FG003|Overall Study|Progressive disease|44|||
145447638|NCT00711594|524490424|FG000|Overall Study|Other Adverse Event|1|||
145447639|NCT00711594|524490425|FG001|Overall Study|Other Adverse Event|0|||
145447640|NCT00711594|524490426|FG002|Overall Study|Other Adverse Event|0|||
145447641|NCT00711594|524490427|FG003|Overall Study|Other Adverse Event|16|||
145447642|NCT00711594|524490424|FG000|Overall Study|Withdrawal by Subject|0|||
145447643|NCT00711594|524490425|FG001|Overall Study|Withdrawal by Subject|1|||
145447644|NCT00711594|524490426|FG002|Overall Study|Withdrawal by Subject|0|||
145447645|NCT00711594|524490427|FG003|Overall Study|Withdrawal by Subject|2|||
145447646|NCT03654040|524490428|FG000|Overall Study|Death|1|||
145447647|NCT03654040|524490429|FG001|Overall Study|Death|0|||
145447648|NCT03654040|524490428|FG000|Overall Study|Withdrawal by Subject|1|||
145447649|NCT03654040|524490429|FG001|Overall Study|Withdrawal by Subject|0|||
145447650|NCT03654040|524490428|FG000|Overall Study|Study terminated by sponsor|8|||
145447651|NCT03654040|524490429|FG001|Overall Study|Study terminated by sponsor|2|||
145447652|NCT03654040|524490428|FG000|Overall Study|Failure to initiate study therapy|2|||
145447653|NCT03654040|524490429|FG001|Overall Study|Failure to initiate study therapy|0|||
145447654|NCT03654040|524490428|FG000|Overall Study|Transplanted at another center|2|||
145447655|NCT03654040|524490429|FG001|Overall Study|Transplanted at another center|0|||
145447656|NCT03654040|524490428|FG000|Overall Study|Failure to meet eligibility criteria|14|||
145447657|NCT03654040|524490429|FG001|Overall Study|Failure to meet eligibility criteria|2|||
145447658|NCT03654040|524490428|FG000|Overall Study|No longer transplant candidate|1|||
145447659|NCT03654040|524490429|FG001|Overall Study|No longer transplant candidate|0|||
145447660|NCT03654040|524490428|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
145447661|NCT03654040|524490429|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
145447662|NCT03654040|524490428|FG000|Overall Study|Recipient ineligible|0|||
145447663|NCT03654040|524490429|FG001|Overall Study|Recipient ineligible|2|||
145447664|NCT03654040|524490428|FG000|Overall Study|Received deceased liver|0|||
145447665|NCT03654040|524490429|FG001|Overall Study|Received deceased liver|1|||
145447666|NCT01709110|524490430|FG000|Overall Study|Adverse Event|56|||
145447667|NCT01709110|524490431|FG001|Overall Study|Adverse Event|48|||
145447668|NCT01709110|524490430|FG000|Overall Study|Death|14|||
145447669|NCT01709110|524490431|FG001|Overall Study|Death|6|||
145447670|NCT01709110|524490430|FG000|Overall Study|Lost to Follow-up|7|||
145585513|NCT00784810|524997586|FG000|Overall Study|Adverse Event|32|||
145585514|NCT00784810|524997587|FG001|Overall Study|Adverse Event|20|||
145447671|NCT01709110|524490431|FG001|Overall Study|Lost to Follow-up|5|||
145447672|NCT01709110|524490430|FG000|Overall Study|Protocol Violation|4|||
145585515|NCT00784810|524997586|FG000|Overall Study|Lack of Efficacy|14|||
145585516|NCT00784810|524997587|FG001|Overall Study|Lack of Efficacy|11|||
145585517|NCT00784810|524997586|FG000|Overall Study|Withdrawal by Subject|11|||
145447673|NCT01709110|524490431|FG001|Overall Study|Protocol Violation|6|||
145447674|NCT01709110|524490430|FG000|Overall Study|Withdrawal by Subject|96|||
145447675|NCT01709110|524490431|FG001|Overall Study|Withdrawal by Subject|89|||
145447676|NCT01709110|524490430|FG000|Overall Study|Physician Decision|4|||
145447677|NCT01709110|524490431|FG001|Overall Study|Physician Decision|10|||
145447678|NCT01709110|524490430|FG000|Overall Study|Sponsor Decision|2|||
145585518|NCT00784810|524997587|FG001|Overall Study|Withdrawal by Subject|9|||
145585519|NCT00784810|524997586|FG000|Overall Study|Administrative|5|||
145585520|NCT00784810|524997587|FG001|Overall Study|Administrative|8|||
145585521|NCT00784810|524997586|FG000|Overall Study|Lost to Follow-up|1|||
145447679|NCT01709110|524490431|FG001|Overall Study|Sponsor Decision|2|||
145447680|NCT01709110|524490430|FG000|Overall Study|Lack of Efficacy|1|||
145447681|NCT01709110|524490431|FG001|Overall Study|Lack of Efficacy|1|||
145447682|NCT01709110|524490430|FG000|Overall Study|Caregiver Decision|1|||
145447683|NCT01709110|524490431|FG001|Overall Study|Caregiver Decision|1|||
145447684|NCT00485758|524490439|FG000|Overall Study|Adverse Event|102|||
145447685|NCT00485758|524490440|FG001|Overall Study|Adverse Event|31|||
145447686|NCT00485758|524490439|FG000|Overall Study|Death|0|||
145447687|NCT00485758|524490440|FG001|Overall Study|Death|1|||
145447688|NCT00485758|524490439|FG000|Overall Study|Lost to Follow-up|5|||
145447689|NCT00485758|524490440|FG001|Overall Study|Lost to Follow-up|1|||
145447690|NCT00485758|524490439|FG000|Overall Study|Physician Decision|3|||
145447691|NCT00485758|524490440|FG001|Overall Study|Physician Decision|3|||
145447692|NCT00485758|524490439|FG000|Overall Study|Protocol Violation|11|||
145447693|NCT00485758|524490440|FG001|Overall Study|Protocol Violation|2|||
145447694|NCT00485758|524490439|FG000|Overall Study|Withdrawal by Subject|32|||
145447695|NCT00485758|524490440|FG001|Overall Study|Withdrawal by Subject|27|||
145447696|NCT00485758|524490439|FG000|Overall Study|Study Terminated by Sponsor|3|||
145447697|NCT00485758|524490440|FG001|Overall Study|Study Terminated by Sponsor|0|||
145447698|NCT04123093|524490441|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
145447699|NCT04123093|524490442|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
145447700|NCT04123093|524490441|FG000|Phase 2|Physician Decision|0|||
145447701|NCT04123093|524490442|FG001|Phase 2|Physician Decision|1|||
145447702|NCT04123093|524490441|FG000|Phase 2|Withdrawal by Subject|0|||
145447703|NCT04123093|524490442|FG001|Phase 2|Withdrawal by Subject|1|||
145447704|NCT00984165|524490443|FG000|Overall Study|Death on study|2|||
145447705|NCT00984165|524490444|FG001|Overall Study|Death on study|0|||
145447706|NCT00984165|524490445|FG002|Overall Study|Death on study|0|||
145447707|NCT00984165|524490446|FG003|Overall Study|Death on study|0|||
145447708|NCT00984165|524490443|FG000|Overall Study|Disease progression on study|5|||
145447709|NCT00984165|524490444|FG001|Overall Study|Disease progression on study|1|||
145447710|NCT00984165|524490445|FG002|Overall Study|Disease progression on study|0|||
145447711|NCT00984165|524490446|FG003|Overall Study|Disease progression on study|0|||
145447712|NCT00984165|524490443|FG000|Overall Study|Death of recipient|0|||
145447713|NCT00984165|524490444|FG001|Overall Study|Death of recipient|0|||
145447714|NCT00984165|524490445|FG002|Overall Study|Death of recipient|0|||
145447715|NCT00984165|524490446|FG003|Overall Study|Death of recipient|1|||
145447716|NCT00984165|524490443|FG000|Overall Study|New protocol|0|||
145447717|NCT00984165|524490444|FG001|Overall Study|New protocol|0|||
145447718|NCT00984165|524490445|FG002|Overall Study|New protocol|0|||
145447719|NCT00984165|524490446|FG003|Overall Study|New protocol|1|||
145447720|NCT00984165|524490443|FG000|Overall Study|P+/donor pair removed from protocol|0|||
145447721|NCT00984165|524490444|FG001|Overall Study|P+/donor pair removed from protocol|0|||
145447722|NCT00984165|524490445|FG002|Overall Study|P+/donor pair removed from protocol|0|||
145447723|NCT00984165|524490446|FG003|Overall Study|P+/donor pair removed from protocol|1|||
145447724|NCT00984165|524490443|FG000|Overall Study|removed with a pair recipient|0|||
145447725|NCT00984165|524490444|FG001|Overall Study|removed with a pair recipient|0|||
145447726|NCT00984165|524490445|FG002|Overall Study|removed with a pair recipient|0|||
145447727|NCT00984165|524490446|FG003|Overall Study|removed with a pair recipient|1|||
145447728|NCT00135330|524490447|FG000|Overall Study|Adverse Event|2|||
145447729|NCT00135330|524490448|FG001|Overall Study|Adverse Event|5|||
145447730|NCT00135330|524490449|FG002|Overall Study|Adverse Event|1|||
145447731|NCT00135330|524490447|FG000|Overall Study|Lost to Follow-up|0|||
145447732|NCT00135330|524490448|FG001|Overall Study|Lost to Follow-up|2|||
145447733|NCT00135330|524490449|FG002|Overall Study|Lost to Follow-up|3|||
145447734|NCT00135330|524490447|FG000|Overall Study|Physician Decision|1|||
145447735|NCT00135330|524490448|FG001|Overall Study|Physician Decision|1|||
145447736|NCT00135330|524490449|FG002|Overall Study|Physician Decision|0|||
145447737|NCT00135330|524490447|FG000|Overall Study|Protocol Violation|4|||
145447738|NCT00135330|524490448|FG001|Overall Study|Protocol Violation|3|||
145447739|NCT00135330|524490449|FG002|Overall Study|Protocol Violation|3|||
145447740|NCT00135330|524490447|FG000|Overall Study|Patient Decision|5|||
145447741|NCT00135330|524490448|FG001|Overall Study|Patient Decision|1|||
145447742|NCT00135330|524490449|FG002|Overall Study|Patient Decision|4|||
145447743|NCT00135330|524490447|FG000|Overall Study|Sponsor Decision|0|||
145585522|NCT00784810|524997587|FG001|Overall Study|Lost to Follow-up|1|||
145447744|NCT00135330|524490448|FG001|Overall Study|Sponsor Decision|1|||
145447745|NCT00135330|524490449|FG002|Overall Study|Sponsor Decision|0|||
145447746|NCT02229825|524490455|FG000|Overall Study|Personal Reasons|0|||
145447747|NCT02229825|524490456|FG001|Overall Study|Personal Reasons|1|||
145447748|NCT02229825|524490455|FG000|Overall Study|Refused continuing medication|7|||
145447749|NCT02229825|524490456|FG001|Overall Study|Refused continuing medication|6|||
145447750|NCT02229825|524490455|FG000|Overall Study|Lost to Follow-up|1|||
145447751|NCT02229825|524490456|FG001|Overall Study|Lost to Follow-up|2|||
145585523|NCT04137380|524997588|FG000|Overall Study|Physician Decision|0|||
145447752|NCT02229825|524490455|FG000|Overall Study|Protocol Violation|1|||
145447753|NCT02229825|524490456|FG001|Overall Study|Protocol Violation|1|||
145447754|NCT02229825|524490455|FG000|Overall Study|Lack of Efficacy|4|||
145447755|NCT02229825|524490456|FG001|Overall Study|Lack of Efficacy|10|||
145447756|NCT02229825|524490455|FG000|Overall Study|Adverse Event|11|||
145447757|NCT02229825|524490456|FG001|Overall Study|Adverse Event|9|||
145447758|NCT02229825|524490455|FG000|Overall Study|Not treated|0|||
145447759|NCT02229825|524490456|FG001|Overall Study|Not treated|1|||
145447760|NCT01390298|524490461|FG000|Overall Study|Death|1|||
145447761|NCT01390298|524490461|FG000|Overall Study|long term ICU admission|1|||
145447762|NCT01390298|524490461|FG000|Overall Study|Withdrawal by Subject|14|||
145447763|NCT01390298|524490461|FG000|Overall Study|Lost to Follow-up|7|||
145447764|NCT01390298|524490461|FG000|Overall Study|Surgery cancelled|1|||
145447765|NCT03520920|524490470|FG000|Overall Study|Death|13|||
145447766|NCT03520920|524490471|FG001|Overall Study|Death|1|||
145447767|NCT03520920|524490472|FG002|Overall Study|Death|0|||
145447768|NCT03520920|524490470|FG000|Overall Study|Withdrawal by Subject|2|||
145447769|NCT03520920|524490471|FG001|Overall Study|Withdrawal by Subject|1|||
145447770|NCT03520920|524490472|FG002|Overall Study|Withdrawal by Subject|0|||
145447771|NCT03520920|524490470|FG000|Overall Study|Study Terminated by the Sponsor|5|||
145447772|NCT03520920|524490471|FG001|Overall Study|Study Terminated by the Sponsor|14|||
145447773|NCT03520920|524490472|FG002|Overall Study|Study Terminated by the Sponsor|5|||
145447774|NCT00405392|524490473|FG000|Overall Study|Adverse Event|15|||
145447775|NCT00405392|524490474|FG001|Overall Study|Adverse Event|14|||
145447776|NCT00405392|524490473|FG000|Overall Study|Did not meet Eligibility criteria|7|||
145447777|NCT00405392|524490474|FG001|Overall Study|Did not meet Eligibility criteria|2|||
145447778|NCT00405392|524490473|FG000|Overall Study|Withdrawal by Subject|4|||
145447779|NCT00405392|524490474|FG001|Overall Study|Withdrawal by Subject|3|||
145447780|NCT00405392|524490473|FG000|Overall Study|Lost to Follow-up|1|||
145447781|NCT00405392|524490474|FG001|Overall Study|Lost to Follow-up|2|||
145447782|NCT00405392|524490473|FG000|Overall Study|Data missing|2|||
145447783|NCT00405392|524490474|FG001|Overall Study|Data missing|0|||
145447784|NCT00405392|524490473|FG000|Overall Study|Non-compliance|0|||
145447785|NCT00405392|524490474|FG001|Overall Study|Non-compliance|1|||
145447786|NCT00405392|524490473|FG000|Overall Study|Other|1|||
145447787|NCT00405392|524490474|FG001|Overall Study|Other|5|||
145447788|NCT05420961|524490477|FG000|Overall Study|Withdrawal by Subject|2|||
145447789|NCT05420961|524490478|FG001|Overall Study|Withdrawal by Subject|1|||
145447790|NCT05420961|524490479|FG002|Overall Study|Withdrawal by Subject|1|||
145447791|NCT05420961|524490480|FG003|Overall Study|Withdrawal by Subject|0|||
145447792|NCT05420961|524490481|FG004|Overall Study|Withdrawal by Subject|0|||
145447793|NCT05420961|524490477|FG000|Overall Study|Lost to Follow-up|0|||
145447794|NCT05420961|524490478|FG001|Overall Study|Lost to Follow-up|0|||
145447795|NCT05420961|524490479|FG002|Overall Study|Lost to Follow-up|1|||
145447796|NCT05420961|524490480|FG003|Overall Study|Lost to Follow-up|0|||
145447797|NCT05420961|524490481|FG004|Overall Study|Lost to Follow-up|0|||
145447798|NCT05420961|524490477|FG000|Overall Study|Randomized by mistake without study treatment|0|||
145447799|NCT05420961|524490478|FG001|Overall Study|Randomized by mistake without study treatment|0|||
145447800|NCT05420961|524490479|FG002|Overall Study|Randomized by mistake without study treatment|1|||
145447801|NCT05420961|524490480|FG003|Overall Study|Randomized by mistake without study treatment|0|||
145447802|NCT05420961|524490481|FG004|Overall Study|Randomized by mistake without study treatment|1|||
145447803|NCT00803361|524490482|FG000|Overall Study|Adverse Event|13|||
145447804|NCT00803361|524490483|FG001|Overall Study|Adverse Event|3|||
145447805|NCT00803361|524490482|FG000|Overall Study|Lack of Efficacy|4|||
145447806|NCT00803361|524490483|FG001|Overall Study|Lack of Efficacy|13|||
145447807|NCT00803361|524490482|FG000|Overall Study|Lost to Follow-up|1|||
145447808|NCT00803361|524490483|FG001|Overall Study|Lost to Follow-up|2|||
145447809|NCT00803361|524490482|FG000|Overall Study|Physician Decision|1|||
145447810|NCT00803361|524490483|FG001|Overall Study|Physician Decision|0|||
145447811|NCT00803361|524490482|FG000|Overall Study|Protocol Violation|2|||
145447812|NCT00803361|524490483|FG001|Overall Study|Protocol Violation|4|||
145447813|NCT00803361|524490482|FG000|Overall Study|Withdrawal by Subject|5|||
145447814|NCT00803361|524490483|FG001|Overall Study|Withdrawal by Subject|6|||
145447815|NCT01437111|524490485|FG000|Overall Study|Adverse Event|2|||
145447816|NCT01437111|524490485|FG000|Overall Study|Withdrawal by Subject|4|||
145447817|NCT01437111|524490485|FG000|Overall Study|Not reported|5|||
145447818|NCT01437111|524490485|FG000|Overall Study|Physician Decision|1|||
145447819|NCT01437111|524490485|FG000|Overall Study|Lost to Follow-up|5|||
145447820|NCT01437111|524490485|FG000|Overall Study|Protocol Violation|1|||
145447821|NCT02131311|524490486|FG000|Overall Study|Adverse Event|2|||
145447822|NCT02131311|524490486|FG000|Overall Study|Protocol Violation|1|||
145447823|NCT02131311|524490486|FG000|Overall Study|Lost to Follow-up|1|||
145447824|NCT02473471|524490490|FG000|Overall Study|poor oral hygiene|2|||
145447825|NCT02473471|524490490|FG000|Overall Study|Lost to Follow-up|1|||
145447826|NCT00255723|524490496|FG000|Overall Study|Adverse Event|1|||
145447827|NCT00255723|524490497|FG001|Overall Study|Adverse Event|1|||
145447828|NCT00255723|524490496|FG000|Overall Study|Death|0|||
145447829|NCT00255723|524490497|FG001|Overall Study|Death|1|||
145447830|NCT00255723|524490496|FG000|Overall Study|Response Data Not Available|1|||
145447831|NCT00255723|524490497|FG001|Overall Study|Response Data Not Available|0|||
145447832|NCT03711370|524490499|FG000|Overall Study|Lost to Follow-up|16|||
145447833|NCT03711370|524490500|FG001|Overall Study|Lost to Follow-up|10|||
145447834|NCT03711370|524490499|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
145447835|NCT03711370|524490500|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
145447836|NCT01169701|524490502|FG000|Overall Study|Lost to Follow-up|1|||
145447837|NCT01169701|524490503|FG001|Overall Study|Lost to Follow-up|1|||
145447838|NCT01169701|524490502|FG000|Overall Study|Withdrawal by Subject|1|||
145447839|NCT01169701|524490503|FG001|Overall Study|Withdrawal by Subject|3|||
145447840|NCT01169701|524490502|FG000|Overall Study|Adverse Event|1|||
145447841|NCT01169701|524490503|FG001|Overall Study|Adverse Event|2|||
145447842|NCT01169701|524490502|FG000|Overall Study|Exclusion criteria|2|||
145447843|NCT01169701|524490503|FG001|Overall Study|Exclusion criteria|0|||
145447844|NCT01169701|524490502|FG000|Overall Study|Death|0|||
145447845|NCT01169701|524490503|FG001|Overall Study|Death|1|||
145447846|NCT01169701|524490502|FG000|Overall Study|Administrative problems|0|||
145447847|NCT01169701|524490503|FG001|Overall Study|Administrative problems|1|||
145447848|NCT01169701|524490502|FG000|Overall Study|Serious adverse event|0|||
145447849|NCT01169701|524490503|FG001|Overall Study|Serious adverse event|1|||
145447850|NCT01169701|524490502|FG000|Overall Study|Sponsor decision|0|||
145447851|NCT01169701|524490503|FG001|Overall Study|Sponsor decision|1|||
145447852|NCT04188834|524490504|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
145447853|NCT01030952|524490505|FG000|Overall Study|Protocol Violation|0|||
145447854|NCT01030952|524490506|FG001|Overall Study|Protocol Violation|1|||
145447855|NCT01030952|524490505|FG000|Overall Study|Informed consent withdrawal|1|||
145447856|NCT01030952|524490506|FG001|Overall Study|Informed consent withdrawal|0|||
145447857|NCT01030952|524490505|FG000|Overall Study|Lost to Follow-up|0|||
145447858|NCT01030952|524490506|FG001|Overall Study|Lost to Follow-up|1|||
145447859|NCT01030952|524490505|FG000|Overall Study|Unexplained|1|||
145447860|NCT01030952|524490506|FG001|Overall Study|Unexplained|1|||
145447861|NCT02455336|524490509|FG000|Overall Study|Withdrawal by Subject|0|||
145447862|NCT02455336|524490510|FG001|Overall Study|Withdrawal by Subject|2|||
145447863|NCT02455336|524490509|FG000|Overall Study|Adverse Event|3|||
145447864|NCT02455336|524490510|FG001|Overall Study|Adverse Event|0|||
145447865|NCT02455336|524490509|FG000|Overall Study|Non-responder to treatment|2|||
145447866|NCT02455336|524490510|FG001|Overall Study|Non-responder to treatment|0|||
145447867|NCT02467192|524490511|FG000|Overall Study|Death|1|||
145447868|NCT02467192|524490511|FG000|Overall Study|revealed to have pneumonia before|2|||
145447869|NCT04532294|524490512|FG000|Overall Study|Withdrawal by Subject|0|||
145447870|NCT04532294|524490513|FG001|Overall Study|Withdrawal by Subject|0|||
145447871|NCT04532294|524490514|FG002|Overall Study|Withdrawal by Subject|1|||
145447872|NCT04532294|524490512|FG000|Overall Study|Participants Not Dosed|0|||
145447873|NCT04532294|524490513|FG001|Overall Study|Participants Not Dosed|0|||
145447874|NCT04532294|524490514|FG002|Overall Study|Participants Not Dosed|2|||
145447875|NCT03497039|524490518|FG000|Overall Study|Withdrawal by Subject|1|||
145447876|NCT03497039|524490519|FG001|Overall Study|Withdrawal by Subject|0|||
145447877|NCT03497039|524490518|FG000|Overall Study|Protocol Violation|0|||
145447878|NCT03497039|524490519|FG001|Overall Study|Protocol Violation|1|||
145447879|NCT01451749|524490523|FG000|Overall Study|Protocol Violation|14|||
145447880|NCT01451749|524490524|FG001|Overall Study|Protocol Violation|7|||
145585524|NCT04137380|524997589|FG001|Overall Study|Physician Decision|0|||
145585525|NCT04137380|524997590|FG002|Overall Study|Physician Decision|0|||
145585526|NCT04137380|524997591|FG003|Overall Study|Physician Decision|1|||
145585527|NCT04137380|524997592|FG004|Overall Study|Physician Decision|0|||
145585528|NCT04137380|524997593|FG005|Overall Study|Physician Decision|0|||
145585529|NCT04137380|524997594|FG006|Overall Study|Physician Decision|0|||
145585530|NCT00779246|524997595|FG000|Overall Study|Missing sufficient data for analysis|33|||
145585531|NCT00779246|524997596|FG001|Overall Study|Missing sufficient data for analysis|53|||
145585532|NCT03579459|524997597|FG000|Overall Study|Adverse Event|7|||
145585533|NCT03579459|524997598|FG001|Overall Study|Adverse Event|6|||
145585534|NCT03579459|524997599|FG002|Overall Study|Adverse Event|2|||
145585535|NCT03579459|524997600|FG003|Overall Study|Adverse Event|6|||
145585536|NCT03579459|524997597|FG000|Overall Study|Death|1|||
145585537|NCT03579459|524997598|FG001|Overall Study|Death|0|||
145585538|NCT03579459|524997599|FG002|Overall Study|Death|1|||
145585539|NCT03579459|524997600|FG003|Overall Study|Death|2|||
145585540|NCT03579459|524997597|FG000|Overall Study|Lost to Follow-up|6|||
145585541|NCT03579459|524997598|FG001|Overall Study|Lost to Follow-up|2|||
145447881|NCT01451749|524490523|FG000|Overall Study|Lost to Follow-up|15|||
145447882|NCT01451749|524490524|FG001|Overall Study|Lost to Follow-up|5|||
145447883|NCT01451749|524490523|FG000|Overall Study|Meet the exclusion criteria,and|1|||
145447884|NCT01451749|524490524|FG001|Overall Study|Meet the exclusion criteria,and|1|||
145447885|NCT01451749|524490523|FG000|Overall Study|Adverse Event|2|||
145447886|NCT01451749|524490524|FG001|Overall Study|Adverse Event|0|||
145585542|NCT03579459|524997599|FG002|Overall Study|Lost to Follow-up|4|||
145585543|NCT03579459|524997600|FG003|Overall Study|Lost to Follow-up|1|||
145585544|NCT03579459|524997597|FG000|Overall Study|Physician Decision|0|||
145585545|NCT03579459|524997598|FG001|Overall Study|Physician Decision|1|||
145447887|NCT01451749|524490523|FG000|Overall Study|Withdrawal by Subject|0|||
145447888|NCT01451749|524490524|FG001|Overall Study|Withdrawal by Subject|1|||
145447889|NCT02949024|524490525|FG000|Overall Study|Withdrawal by Subject|0|||
145447890|NCT02949024|524490526|FG001|Overall Study|Withdrawal by Subject|1|||
145447891|NCT01027650|524490527|FG000|Overall Study|Personal Reasons|0|||
145447892|NCT01027650|524490528|FG001|Overall Study|Personal Reasons|0|||
145447893|NCT01027650|524490529|FG002|Overall Study|Personal Reasons|0|||
145447894|NCT01027650|524490530|FG003|Overall Study|Personal Reasons|0|||
145447895|NCT01027650|524490531|FG004|Overall Study|Personal Reasons|2|||
145447896|NCT01027650|524490532|FG005|Overall Study|Personal Reasons|1|||
145447897|NCT01027650|524490533|FG006|Overall Study|Personal Reasons|0|||
145447898|NCT01027650|524490534|FG007|Overall Study|Personal Reasons|0|||
145447899|NCT01027650|524490527|FG000|Overall Study|Lost to Follow-up|0|||
145447900|NCT01027650|524490528|FG001|Overall Study|Lost to Follow-up|0|||
145447901|NCT01027650|524490529|FG002|Overall Study|Lost to Follow-up|0|||
145447902|NCT01027650|524490530|FG003|Overall Study|Lost to Follow-up|0|||
145447903|NCT01027650|524490531|FG004|Overall Study|Lost to Follow-up|0|||
145447904|NCT01027650|524490532|FG005|Overall Study|Lost to Follow-up|0|||
145447905|NCT01027650|524490533|FG006|Overall Study|Lost to Follow-up|1|||
145447906|NCT01027650|524490534|FG007|Overall Study|Lost to Follow-up|0|||
145447907|NCT01027650|524490527|FG000|Overall Study|Lack of Efficacy|0|||
145447908|NCT01027650|524490528|FG001|Overall Study|Lack of Efficacy|0|||
145447909|NCT01027650|524490529|FG002|Overall Study|Lack of Efficacy|0|||
145447910|NCT01027650|524490530|FG003|Overall Study|Lack of Efficacy|0|||
145447911|NCT01027650|524490531|FG004|Overall Study|Lack of Efficacy|0|||
145447912|NCT01027650|524490532|FG005|Overall Study|Lack of Efficacy|1|||
145447913|NCT01027650|524490533|FG006|Overall Study|Lack of Efficacy|0|||
145447914|NCT01027650|524490534|FG007|Overall Study|Lack of Efficacy|0|||
145447915|NCT00912782|524490535|FG000|Overall Study|Death|2|||
145447916|NCT00912782|524490536|FG001|Overall Study|Death|1|||
145447917|NCT00912782|524490535|FG000|Overall Study|Lost to Follow-up|0|||
145447918|NCT00912782|524490536|FG001|Overall Study|Lost to Follow-up|1|||
145447919|NCT00912782|524490535|FG000|Overall Study|Did not receive vascular access type|1|||
145447920|NCT00912782|524490536|FG001|Overall Study|Did not receive vascular access type|2|||
145447921|NCT00912782|524490535|FG000|Overall Study|Relocated before study completion|0|||
145447922|NCT00912782|524490536|FG001|Overall Study|Relocated before study completion|1|||
145447923|NCT02712983|524492601|FG000|Treatment Phase|Adverse Event|3|||
145447924|NCT02712983|524492602|FG001|Treatment Phase|Adverse Event|1|||
145447925|NCT02712983|524492603|FG002|Treatment Phase|Adverse Event|1|||
145447926|NCT02712983|524492604|FG003|Treatment Phase|Adverse Event|4|||
145447927|NCT02712983|524492605|FG004|Treatment Phase|Adverse Event|3|||
145447928|NCT02712983|524492606|FG005|Treatment Phase|Adverse Event|0|||
145585546|NCT03579459|524997599|FG002|Overall Study|Physician Decision|0|||
145585547|NCT03579459|524997600|FG003|Overall Study|Physician Decision|1|||
145585548|NCT03579459|524997597|FG000|Overall Study|Protocol Violation|1|||
145585549|NCT03579459|524997598|FG001|Overall Study|Protocol Violation|2|||
145585550|NCT03579459|524997599|FG002|Overall Study|Protocol Violation|3|||
145585551|NCT03579459|524997600|FG003|Overall Study|Protocol Violation|5|||
145585552|NCT03579459|524997597|FG000|Overall Study|Withdrawal by Subject|12|||
145585553|NCT03579459|524997598|FG001|Overall Study|Withdrawal by Subject|8|||
145585554|NCT03579459|524997599|FG002|Overall Study|Withdrawal by Subject|11|||
145585555|NCT03579459|524997600|FG003|Overall Study|Withdrawal by Subject|8|||
145585556|NCT03579459|524997597|FG000|Overall Study|Medication error without associated adverse event|2|||
145585557|NCT03579459|524997598|FG001|Overall Study|Medication error without associated adverse event|1|||
145447929|NCT02712983|524492607|FG006|Treatment Phase|Adverse Event|6|||
145447930|NCT02712983|524492608|FG007|Treatment Phase|Adverse Event|6|||
145447931|NCT02712983|524492609|FG008|Treatment Phase|Adverse Event|1|||
145447932|NCT02712983|524492601|FG000|Treatment Phase|Protocol Deviation|0|||
145447933|NCT02712983|524492602|FG001|Treatment Phase|Protocol Deviation|0|||
145447934|NCT02712983|524492603|FG002|Treatment Phase|Protocol Deviation|0|||
145447935|NCT02712983|524492604|FG003|Treatment Phase|Protocol Deviation|2|||
145447936|NCT02712983|524492605|FG004|Treatment Phase|Protocol Deviation|0|||
145447937|NCT02712983|524492606|FG005|Treatment Phase|Protocol Deviation|0|||
145447938|NCT02712983|524492607|FG006|Treatment Phase|Protocol Deviation|1|||
145447939|NCT02712983|524492608|FG007|Treatment Phase|Protocol Deviation|0|||
145447940|NCT02712983|524492609|FG008|Treatment Phase|Protocol Deviation|0|||
145585558|NCT03579459|524997599|FG002|Overall Study|Medication error without associated adverse event|1|||
145585559|NCT03579459|524997600|FG003|Overall Study|Medication error without associated adverse event|0|||
145585560|NCT03579459|524997597|FG000|Overall Study|Other|0|||
145585561|NCT03579459|524997598|FG001|Overall Study|Other|1|||
145447941|NCT02712983|524492601|FG000|Treatment Phase|Technical Problems|0|||
145447942|NCT02712983|524492602|FG001|Treatment Phase|Technical Problems|0|||
145585562|NCT03579459|524997599|FG002|Overall Study|Other|1|||
145585563|NCT03579459|524997600|FG003|Overall Study|Other|0|||
145585564|NCT03579459|524997597|FG000|Overall Study|Randomized not vaccinated|0|||
145585565|NCT03579459|524997598|FG001|Overall Study|Randomized not vaccinated|2|||
145585566|NCT03579459|524997599|FG002|Overall Study|Randomized not vaccinated|0|||
145585567|NCT03579459|524997600|FG003|Overall Study|Randomized not vaccinated|1|||
145447943|NCT02712983|524492603|FG002|Treatment Phase|Technical Problems|0|||
145447944|NCT02712983|524492604|FG003|Treatment Phase|Technical Problems|0|||
145447945|NCT02712983|524492605|FG004|Treatment Phase|Technical Problems|0|||
145447946|NCT02712983|524492606|FG005|Treatment Phase|Technical Problems|0|||
145447947|NCT02712983|524492607|FG006|Treatment Phase|Technical Problems|1|||
145447948|NCT02712983|524492608|FG007|Treatment Phase|Technical Problems|0|||
145447949|NCT02712983|524492609|FG008|Treatment Phase|Technical Problems|0|||
145447950|NCT02712983|524492601|FG000|Treatment Phase|Physician Decision|0|||
145447951|NCT02712983|524492602|FG001|Treatment Phase|Physician Decision|0|||
145447952|NCT02712983|524492603|FG002|Treatment Phase|Physician Decision|0|||
145447953|NCT02712983|524492604|FG003|Treatment Phase|Physician Decision|0|||
145447954|NCT02712983|524492605|FG004|Treatment Phase|Physician Decision|0|||
145447955|NCT02712983|524492606|FG005|Treatment Phase|Physician Decision|0|||
145447956|NCT02712983|524492607|FG006|Treatment Phase|Physician Decision|0|||
145447957|NCT02712983|524492608|FG007|Treatment Phase|Physician Decision|1|||
145447958|NCT02712983|524492609|FG008|Treatment Phase|Physician Decision|1|||
145447959|NCT02712983|524492601|FG000|Treatment Phase|Subject Decision|2|||
145447960|NCT02712983|524492602|FG001|Treatment Phase|Subject Decision|0|||
145447961|NCT02712983|524492603|FG002|Treatment Phase|Subject Decision|0|||
145447962|NCT02712983|524492604|FG003|Treatment Phase|Subject Decision|2|||
145447963|NCT02712983|524492605|FG004|Treatment Phase|Subject Decision|1|||
145447964|NCT02712983|524492606|FG005|Treatment Phase|Subject Decision|0|||
145447965|NCT02712983|524492607|FG006|Treatment Phase|Subject Decision|1|||
145447966|NCT02712983|524492608|FG007|Treatment Phase|Subject Decision|2|||
145447967|NCT02712983|524492609|FG008|Treatment Phase|Subject Decision|0|||
145447968|NCT02712983|524492601|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447969|NCT02712983|524492602|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
145447970|NCT02712983|524492603|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447971|NCT02712983|524492604|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447972|NCT02712983|524492605|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447973|NCT02712983|524492606|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447974|NCT02712983|524492607|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
145447975|NCT02712983|524492608|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
145447976|NCT02712983|524492609|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
145447977|NCT02712983|524492601|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447978|NCT02712983|524492602|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447979|NCT02712983|524492603|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447980|NCT02712983|524492604|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
145447981|NCT02712983|524492605|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447982|NCT02712983|524492606|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447983|NCT02712983|524492607|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447984|NCT02712983|524492608|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447985|NCT02712983|524492609|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
145447986|NCT02712983|524492601|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
145447987|NCT02712983|524492602|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
145447988|NCT02712983|524492603|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
145447989|NCT02712983|524492604|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
145447990|NCT02712983|524492605|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
145447991|NCT02712983|524492606|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
145447992|NCT02712983|524492607|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
145447993|NCT02712983|524492608|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
145447994|NCT02712983|524492609|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
145447995|NCT05360966|524492614|FG000|Overall Study|Adverse Event|5|||
145447996|NCT05360966|524492615|FG001|Overall Study|Adverse Event|5|||
145447997|NCT05360966|524492614|FG000|Overall Study|Withdrawal of Consent|5|||
145447998|NCT05360966|524492615|FG001|Overall Study|Withdrawal of Consent|3|||
145447999|NCT05360966|524492614|FG000|Overall Study|Noncompliance|2|||
145448000|NCT05360966|524492615|FG001|Overall Study|Noncompliance|1|||
145448001|NCT05360966|524492614|FG000|Overall Study|Lost to Follow-up|2|||
145448002|NCT05360966|524492615|FG001|Overall Study|Lost to Follow-up|3|||
145448003|NCT05360966|524492614|FG000|Overall Study|Protocol Deviation|2|||
145448004|NCT05360966|524492615|FG001|Overall Study|Protocol Deviation|1|||
145448005|NCT05360966|524492614|FG000|Overall Study|As specified in the Clinical Study Report|1|||
145448006|NCT05360966|524492615|FG001|Overall Study|As specified in the Clinical Study Report|3|||
145448007|NCT05258890|524492617|FG000|Overall Study|Patient withdrawal|6|||
145448008|NCT05258890|524492618|FG001|Overall Study|Patient withdrawal|7|||
145448009|NCT05258890|524492617|FG000|Overall Study|Patient lost to follow-up|10|||
145448010|NCT05258890|524492618|FG001|Overall Study|Patient lost to follow-up|3|||
145448011|NCT05258890|524492617|FG000|Overall Study|Social network member withdrawal|1|||
145448012|NCT05258890|524492618|FG001|Overall Study|Social network member withdrawal|0|||
145448013|NCT05258890|524492617|FG000|Overall Study|Social network member lost to follow-up|5|||
145448014|NCT05258890|524492618|FG001|Overall Study|Social network member lost to follow-up|0|||
145448015|NCT00566982|524492619|FG000|Overall Study|Adverse Event|6|||
145448016|NCT00566982|524492620|FG001|Overall Study|Adverse Event|48|||
145448017|NCT00566982|524492619|FG000|Overall Study|Withdrawal by Subject|1|||
145448018|NCT00566982|524492620|FG001|Overall Study|Withdrawal by Subject|14|||
145448019|NCT00566982|524492619|FG000|Overall Study|Protocol Violation|1|||
145448020|NCT00566982|524492620|FG001|Overall Study|Protocol Violation|4|||
145448021|NCT00566982|524492619|FG000|Overall Study|Lost to Follow-up|0|||
145448022|NCT00566982|524492620|FG001|Overall Study|Lost to Follow-up|1|||
145448023|NCT00566982|524492619|FG000|Overall Study|Other-family problems & doctor's request|0|||
145448024|NCT00566982|524492620|FG001|Overall Study|Other-family problems & doctor's request|2|||
145448025|NCT00854724|524492621|FG000|First Intervention|Withdrawal by Subject|1|||
145448026|NCT00854724|524492622|FG001|First Intervention|Withdrawal by Subject|1|||
145448027|NCT00854724|524492621|FG000|Washout|Protocol Violation|1|||
145448028|NCT00854724|524492622|FG001|Washout|Protocol Violation|0|||
145448029|NCT00854724|524492621|FG000|Washout|Withdrawal by Subject|0|||
145448030|NCT00854724|524492622|FG001|Washout|Withdrawal by Subject|1|||
145448031|NCT00854724|524492621|FG000|Second Intervention|Protocol Violation|1|||
145448032|NCT00854724|524492622|FG001|Second Intervention|Protocol Violation|0|||
145448033|NCT00854724|524492621|FG000|Second Intervention|Physician Decision|0|||
145448034|NCT00854724|524492622|FG001|Second Intervention|Physician Decision|1|||
145448035|NCT01498692|524492631|FG000|Overall Study|Death|4|||
145448036|NCT01498692|524492631|FG000|Overall Study|Withdrawal by Subject|1|||
145448037|NCT01498692|524492631|FG000|Overall Study|Missed 12-month visit|3|||
145448038|NCT04729972|524492632|FG000|Overall Study|Adverse Event|1|||
145448039|NCT00590122|524492633|FG000|Overall Study|swallowed oral dissolving dose|1|||
145448040|NCT00590122|524492634|FG001|Overall Study|swallowed oral dissolving dose|0|||
145448041|NCT01208324|524492635|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
145448042|NCT01208324|524492636|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
145448043|NCT01208324|524492637|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
145448044|NCT01208324|524492638|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
145448045|NCT01701362|524492639|FG000|Overall Study|Adverse events not related to study drug|1|||
145448046|NCT01701362|524492640|FG001|Overall Study|Adverse events not related to study drug|6|||
145448047|NCT01701362|524492639|FG000|Overall Study|Adverse events related to study drug|12|||
145448048|NCT01701362|524492640|FG001|Overall Study|Adverse events related to study drug|10|||
145448049|NCT01701362|524492639|FG000|Overall Study|Protocol Violation|5|||
145448050|NCT01701362|524492640|FG001|Overall Study|Protocol Violation|3|||
145448051|NCT01701362|524492639|FG000|Overall Study|No longer willing to participate|8|||
145448052|NCT01701362|524492640|FG001|Overall Study|No longer willing to participate|14|||
145448053|NCT01701362|524492639|FG000|Overall Study|Lost to Follow-up|6|||
145448054|NCT01701362|524492640|FG001|Overall Study|Lost to Follow-up|9|||
145448055|NCT01701362|524492639|FG000|Overall Study|Insufficient clinical response|6|||
145448056|NCT01701362|524492640|FG001|Overall Study|Insufficient clinical response|6|||
145448057|NCT01701362|524492639|FG000|Overall Study|Death|0|||
145448058|NCT01701362|524492640|FG001|Overall Study|Death|1|||
145448059|NCT01701362|524492639|FG000|Overall Study|Randomized but not treated|1|||
145448060|NCT01701362|524492640|FG001|Overall Study|Randomized but not treated|2|||
145448061|NCT01701362|524492639|FG000|Overall Study|Reasons other than those mentioned above|3|||
145448062|NCT01701362|524492640|FG001|Overall Study|Reasons other than those mentioned above|5|||
145448063|NCT00249808|524492641|FG000|Overall Study|Other|27|||
145448064|NCT00249808|524492641|FG000|Overall Study|Protocol Violation|3|||
145448065|NCT00249808|524492641|FG000|Overall Study|Lost to Follow-up|8|||
145448066|NCT00249808|524492641|FG000|Overall Study|Adverse Event|81|||
145448067|NCT00249808|524492641|FG000|Overall Study|Lack of Efficacy|52|||
145448068|NCT00249808|524492641|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
145448069|NCT02789345|524492644|FG000|Overall Study|Adverse Event|0|||
145448070|NCT02789345|524492645|FG001|Overall Study|Adverse Event|0|||
145448071|NCT02789345|524492646|FG002|Overall Study|Adverse Event|1|||
145448072|NCT02789345|524492644|FG000|Overall Study|Death|0|||
145448073|NCT02789345|524492645|FG001|Overall Study|Death|0|||
145448074|NCT02789345|524492646|FG002|Overall Study|Death|1|||
145585568|NCT02844946|524997602|FG000|Overall Study|Lost to Follow-up|7|||
145585569|NCT02844946|524997603|FG001|Overall Study|Lost to Follow-up|0|||
145585570|NCT02806986|524997604|FG000|Treatment Stage 1|Adverse Event|1|||
145585571|NCT02806986|524997604|FG000|Treatment Stage 2|Adverse Event|3|||
145585572|NCT02806986|524997604|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
145448075|NCT02789345|524492644|FG000|Overall Study|Physician Decision|2|||
145448076|NCT02789345|524492645|FG001|Overall Study|Physician Decision|0|||
145448077|NCT02789345|524492646|FG002|Overall Study|Physician Decision|1|||
145448078|NCT02789345|524492644|FG000|Overall Study|Progressive Disease|1|||
145448079|NCT02789345|524492645|FG001|Overall Study|Progressive Disease|3|||
145448080|NCT02789345|524492646|FG002|Overall Study|Progressive Disease|14|||
145448081|NCT00383331|524492652|FG000|Overall Study|Protocol Violation|0|||
145448082|NCT00383331|524492653|FG001|Overall Study|Protocol Violation|1|||
145448083|NCT02253433|524492655|FG000|Overall Study|Unable to Contact|9|||
145585573|NCT00407537|524997605|FG000|Overall Study|Death|5|||
145448084|NCT02253433|524492656|FG001|Overall Study|Unable to Contact|16|||
145585574|NCT00407537|524997606|FG001|Overall Study|Death|2|||
145448085|NCT02253433|524492655|FG000|Overall Study|Death|1|||
145448086|NCT02253433|524492656|FG001|Overall Study|Death|1|||
145448087|NCT02253433|524492655|FG000|Overall Study|No Longer Interested|3|||
145448088|NCT02253433|524492656|FG001|Overall Study|No Longer Interested|15|||
145448089|NCT02253433|524492655|FG000|Overall Study|Out of Study Area|2|||
145448090|NCT02253433|524492656|FG001|Overall Study|Out of Study Area|7|||
145448091|NCT02253433|524492655|FG000|Overall Study|Uncomfortable with home visitors|0|||
145448092|NCT02253433|524492656|FG001|Overall Study|Uncomfortable with home visitors|3|||
145448093|NCT02253433|524492655|FG000|Overall Study|Unstable Housing/Homeless|0|||
145448094|NCT02253433|524492656|FG001|Overall Study|Unstable Housing/Homeless|7|||
145448095|NCT02253433|524492655|FG000|Overall Study|Too Busy|0|||
145448096|NCT02253433|524492656|FG001|Overall Study|Too Busy|4|||
145448097|NCT02253433|524492655|FG000|Overall Study|Medical or Other Concerns|1|||
145448098|NCT02253433|524492656|FG001|Overall Study|Medical or Other Concerns|2|||
145448099|NCT00372619|524492662|FG000|Overall Study|Ineligible|0|||
145448100|NCT00372619|524492663|FG001|Overall Study|Ineligible|0|||
145448101|NCT00372619|524492664|FG002|Overall Study|Ineligible|0|||
145448102|NCT00372619|524492665|FG003|Overall Study|Ineligible|0|||
145448103|NCT00372619|524492666|FG004|Overall Study|Ineligible|0|||
145448104|NCT00372619|524492667|FG005|Overall Study|Ineligible|2|||
145448105|NCT00372619|524492668|FG006|Overall Study|Ineligible|0|||
145448106|NCT00372619|524492662|FG000|Overall Study|Inevaluable|0|||
145448107|NCT00372619|524492663|FG001|Overall Study|Inevaluable|0|||
145448108|NCT00372619|524492664|FG002|Overall Study|Inevaluable|0|||
145448109|NCT00372619|524492665|FG003|Overall Study|Inevaluable|0|||
145448110|NCT00372619|524492666|FG004|Overall Study|Inevaluable|0|||
145448111|NCT00372619|524492667|FG005|Overall Study|Inevaluable|1|||
145448112|NCT00372619|524492668|FG006|Overall Study|Inevaluable|0|||
145448113|NCT00066222|524492669|FG000|Overall Study|No protocol treatment received|1|||
145448114|NCT01703091|524492681|FG000|Overall Study|Adverse Event|5|||
145448115|NCT01703091|524492682|FG001|Overall Study|Adverse Event|3|||
145448116|NCT01703091|524492681|FG000|Overall Study|Physician Decision|2|||
145448117|NCT01703091|524492682|FG001|Overall Study|Physician Decision|1|||
145448118|NCT01703091|524492681|FG000|Overall Study|Withdrawal by Subject|1|||
145448119|NCT01703091|524492682|FG001|Overall Study|Withdrawal by Subject|0|||
145448120|NCT01703091|524492681|FG000|Overall Study|Sponsor Decision|1|||
145448121|NCT01703091|524492682|FG001|Overall Study|Sponsor Decision|0|||
145448122|NCT03902392|524492683|FG000|Overall Study|Lost to Follow-up|7|||
145448123|NCT03902392|524492684|FG001|Overall Study|Lost to Follow-up|7|||
145448124|NCT00244725|524492685|FG000|Overall Study|Lost to Follow-up|3|||
145448125|NCT00244725|524492686|FG001|Overall Study|Lost to Follow-up|4|||
145448126|NCT00244725|524492687|FG002|Overall Study|Lost to Follow-up|9|||
145448127|NCT00244725|524492688|FG003|Overall Study|Lost to Follow-up|2|||
145448128|NCT00244725|524492685|FG000|Overall Study|Withdrawal by Subject|9|||
145448129|NCT00244725|524492686|FG001|Overall Study|Withdrawal by Subject|7|||
145448130|NCT00244725|524492687|FG002|Overall Study|Withdrawal by Subject|7|||
145448131|NCT00244725|524492688|FG003|Overall Study|Withdrawal by Subject|8|||
145448132|NCT00244725|524492685|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
145448133|NCT00244725|524492686|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
145448134|NCT00244725|524492687|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
145448135|NCT00244725|524492688|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
145448136|NCT00244725|524492685|FG000|Overall Study|Physician Decision|3|||
145448137|NCT00244725|524492686|FG001|Overall Study|Physician Decision|0|||
145448138|NCT00244725|524492687|FG002|Overall Study|Physician Decision|1|||
145448139|NCT00244725|524492688|FG003|Overall Study|Physician Decision|2|||
145448140|NCT00244725|524492685|FG000|Overall Study|Adverse Events|3|||
145448141|NCT00244725|524492686|FG001|Overall Study|Adverse Events|1|||
145448142|NCT00244725|524492687|FG002|Overall Study|Adverse Events|4|||
145448143|NCT00244725|524492688|FG003|Overall Study|Adverse Events|4|||
145448144|NCT00244725|524492685|FG000|Overall Study|Withdrwal by participant|1|||
145448145|NCT00244725|524492686|FG001|Overall Study|Withdrwal by participant|0|||
145448146|NCT00244725|524492687|FG002|Overall Study|Withdrwal by participant|0|||
145448147|NCT00244725|524492688|FG003|Overall Study|Withdrwal by participant|1|||
145448148|NCT00244725|524492685|FG000|Overall Study|Liver function test abnormality|2|||
145448149|NCT00244725|524492686|FG001|Overall Study|Liver function test abnormality|0|||
145448150|NCT00244725|524492687|FG002|Overall Study|Liver function test abnormality|0|||
145448151|NCT00244725|524492688|FG003|Overall Study|Liver function test abnormality|1|||
145448152|NCT00244725|524492685|FG000|Overall Study|Sponsor withdrew the participant|1|||
145448153|NCT00244725|524492686|FG001|Overall Study|Sponsor withdrew the participant|0|||
145448154|NCT00244725|524492687|FG002|Overall Study|Sponsor withdrew the participant|0|||
145448155|NCT00244725|524492688|FG003|Overall Study|Sponsor withdrew the participant|1|||
145448156|NCT00244725|524492685|FG000|Overall Study|Mediciation Error|0|||
145448157|NCT00244725|524492686|FG001|Overall Study|Mediciation Error|1|||
145448158|NCT00244725|524492687|FG002|Overall Study|Mediciation Error|0|||
145448159|NCT00244725|524492688|FG003|Overall Study|Mediciation Error|0|||
145448160|NCT00244725|524492685|FG000|Overall Study|Rehab Refused to allow participantion|0|||
145448161|NCT00244725|524492686|FG001|Overall Study|Rehab Refused to allow participantion|1|||
145625999|NCT00465985|525144141|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
145448162|NCT00244725|524492687|FG002|Overall Study|Rehab Refused to allow participantion|0|||
145448163|NCT00244725|524492688|FG003|Overall Study|Rehab Refused to allow participantion|0|||
145448164|NCT00244725|524492685|FG000|Overall Study|Headache|0|||
145448165|NCT00244725|524492686|FG001|Overall Study|Headache|1|||
145448166|NCT00244725|524492687|FG002|Overall Study|Headache|0|||
145448167|NCT00244725|524492688|FG003|Overall Study|Headache|0|||
145448168|NCT00244725|524492685|FG000|Overall Study|Received prohibited medication|0|||
145448169|NCT00244725|524492686|FG001|Overall Study|Received prohibited medication|1|||
145448170|NCT00244725|524492687|FG002|Overall Study|Received prohibited medication|0|||
145448171|NCT00244725|524492688|FG003|Overall Study|Received prohibited medication|1|||
145448172|NCT00244725|524492685|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
145448173|NCT00244725|524492686|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
145448174|NCT00244725|524492687|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
145448175|NCT00244725|524492688|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
145448176|NCT00244725|524492685|FG000|Overall Study|Administrative reason|0|||
145448177|NCT00244725|524492686|FG001|Overall Study|Administrative reason|0|||
145448178|NCT00244725|524492687|FG002|Overall Study|Administrative reason|1|||
145448179|NCT00244725|524492688|FG003|Overall Study|Administrative reason|0|||
145448180|NCT00244725|524492685|FG000|Overall Study|Vomit|0|||
145448181|NCT00244725|524492686|FG001|Overall Study|Vomit|0|||
145448182|NCT00244725|524492687|FG002|Overall Study|Vomit|1|||
145448183|NCT00244725|524492688|FG003|Overall Study|Vomit|0|||
145448184|NCT00244725|524492685|FG000|Overall Study|Failed to follow-up|0|||
145448185|NCT00244725|524492686|FG001|Overall Study|Failed to follow-up|0|||
145448186|NCT00244725|524492687|FG002|Overall Study|Failed to follow-up|1|||
145448187|NCT00244725|524492688|FG003|Overall Study|Failed to follow-up|1|||
145448188|NCT03799952|524492689|FG000|Overall Study|Program was too easy, discontinued|1|||
145448189|NCT03799952|524492690|FG001|Overall Study|Program was too easy, discontinued|0|||
145448190|NCT03799952|524492689|FG000|Overall Study|Lost to Follow-up|0|||
145448191|NCT03799952|524492690|FG001|Overall Study|Lost to Follow-up|2|||
145448192|NCT03248167|524492691|FG000|Overall Study|Withdrawal by Subject|2|||
145448193|NCT03248167|524492692|FG001|Overall Study|Withdrawal by Subject|2|||
145448194|NCT03248167|524492691|FG000|Overall Study|Physician Decision|0|||
145448195|NCT03248167|524492692|FG001|Overall Study|Physician Decision|1|||
145448196|NCT03248167|524492691|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
145448197|NCT03248167|524492692|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
145448198|NCT03248167|524492691|FG000|Overall Study|Lost to Follow-up|1|||
145448199|NCT03248167|524492692|FG001|Overall Study|Lost to Follow-up|0|||
145448200|NCT02122146|524492693|FG000|Part 1: Dose Escalation|Death|0|||
145448201|NCT02122146|524492694|FG001|Part 1: Dose Escalation|Death|1|||
145448202|NCT02122146|524492695|FG002|Part 1: Dose Escalation|Death|1|||
145448203|NCT02122146|524492696|FG003|Part 1: Dose Escalation|Death|0|||
145448204|NCT02122146|524492697|FG004|Part 1: Dose Escalation|Death|0|||
145448205|NCT02122146|524492698|FG005|Part 1: Dose Escalation|Death|0|||
145448206|NCT02122146|524492699|FG006|Part 1: Dose Escalation|Death|0|||
145448207|NCT02122146|524492700|FG007|Part 1: Dose Escalation|Death|0|||
145448208|NCT02122146|524492693|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448209|NCT02122146|524492694|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448210|NCT02122146|524492695|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
145448211|NCT02122146|524492696|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448212|NCT02122146|524492697|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
145448213|NCT02122146|524492698|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448214|NCT02122146|524492699|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448215|NCT02122146|524492700|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
145448216|NCT02122146|524492693|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448217|NCT02122146|524492694|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448218|NCT02122146|524492695|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448219|NCT02122146|524492696|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
145448220|NCT02122146|524492697|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448221|NCT02122146|524492698|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448222|NCT02122146|524492699|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448223|NCT02122146|524492700|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145448224|NCT02122146|524492693|FG000|Part 1: Dose Escalation|Other|1|||
145448225|NCT02122146|524492694|FG001|Part 1: Dose Escalation|Other|0|||
145448226|NCT02122146|524492695|FG002|Part 1: Dose Escalation|Other|0|||
145448227|NCT02122146|524492696|FG003|Part 1: Dose Escalation|Other|0|||
145448228|NCT02122146|524492697|FG004|Part 1: Dose Escalation|Other|0|||
145448229|NCT02122146|524492698|FG005|Part 1: Dose Escalation|Other|1|||
145448230|NCT02122146|524492699|FG006|Part 1: Dose Escalation|Other|1|||
145448231|NCT02122146|524492700|FG007|Part 1: Dose Escalation|Other|2|||
145448232|NCT03472495|524492701|FG000|Overall Study|Treatment no longer indicated|1|||
145448233|NCT03472495|524492702|FG001|Overall Study|Treatment no longer indicated|2|||
145448234|NCT03472495|524492701|FG000|Overall Study|Physician Decision|0|||
145448235|NCT03472495|524492702|FG001|Overall Study|Physician Decision|2|||
145448236|NCT02623205|524492706|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
145585575|NCT00407537|524997605|FG000|Overall Study|Adverse Event|36|||
145626000|NCT00465985|525144142|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
145626001|NCT00465985|525144141|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
145626002|NCT00465985|525144142|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
145626003|NCT00465985|525144141|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
145626004|NCT00465985|525144142|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
145448237|NCT02623205|524492707|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
145448238|NCT03082677|524492708|FG000|Overall Study|Not Treated|2|||
145448239|NCT01667133|524492709|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
145448240|NCT01667133|524492710|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
145448241|NCT01667133|524492711|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
145448242|NCT01667133|524492712|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
145448243|NCT01667133|524492713|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
145448244|NCT01667133|524492714|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
145448245|NCT01667133|524492715|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
145448246|NCT01667133|524492716|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
145448247|NCT01667133|524492717|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
145448248|NCT01667133|524492718|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
145448249|NCT01667133|524492719|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
145448250|NCT01667133|524492720|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
145448251|NCT01667133|524492709|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448252|NCT01667133|524492710|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448253|NCT01667133|524492711|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
145448254|NCT01667133|524492712|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448255|NCT01667133|524492713|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448256|NCT01667133|524492714|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448257|NCT01667133|524492715|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448258|NCT01667133|524492716|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448259|NCT01667133|524492717|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448260|NCT01667133|524492718|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448261|NCT01667133|524492719|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448262|NCT01667133|524492720|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
145448263|NCT01667133|524492709|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
145448264|NCT01667133|524492710|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
145448265|NCT01667133|524492711|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
145448266|NCT01667133|524492712|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
145448267|NCT01667133|524492713|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
145448268|NCT01667133|524492714|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
145448269|NCT01667133|524492715|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
145448270|NCT01667133|524492716|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
145448271|NCT01667133|524492717|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
145448272|NCT01667133|524492718|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
145448273|NCT01667133|524492719|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
145448274|NCT01667133|524492720|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
145448275|NCT01667133|524492709|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448276|NCT01667133|524492710|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448277|NCT01667133|524492711|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448278|NCT01667133|524492712|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
145448279|NCT01667133|524492713|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448280|NCT01667133|524492714|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448281|NCT01667133|524492715|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448282|NCT01667133|524492716|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448283|NCT01667133|524492717|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448284|NCT01667133|524492718|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448285|NCT01667133|524492719|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448286|NCT01667133|524492720|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
145448287|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
145448288|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
145448289|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
145448290|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
145448291|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
145448292|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
145448293|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
145448294|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
145448295|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
145448296|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
145448297|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
145448298|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
145448299|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448300|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448301|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448302|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448303|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448304|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448305|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448306|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448307|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448308|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
145448309|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448310|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
145448311|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
145448312|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
145448313|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
145448314|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
145448315|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
145448316|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
145448317|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
145448318|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
145448319|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
145448320|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
145448321|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
145448322|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
145448323|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448324|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448325|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448326|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448327|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448328|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448329|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448330|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448331|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448332|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
145448333|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448334|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
145448335|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Death|0|||
145448336|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Death|0|||
145448337|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Death|0|||
145448338|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Death|0|||
145448339|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Death|0|||
145448340|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Death|0|||
145448341|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Death|0|||
145448342|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Death|0|||
145448343|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Death|0|||
145448344|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Death|1|||
145448345|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Death|0|||
145448346|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Death|0|||
145448347|NCT01667133|524492709|FG000|Phase 2: Dose-expansion|Other|0|||
145448348|NCT01667133|524492710|FG001|Phase 2: Dose-expansion|Other|0|||
145448349|NCT01667133|524492711|FG002|Phase 2: Dose-expansion|Other|0|||
145448350|NCT01667133|524492712|FG003|Phase 2: Dose-expansion|Other|0|||
145448351|NCT01667133|524492713|FG004|Phase 2: Dose-expansion|Other|0|||
145448352|NCT01667133|524492714|FG005|Phase 2: Dose-expansion|Other|0|||
145448353|NCT01667133|524492715|FG006|Phase 2: Dose-expansion|Other|0|||
145448354|NCT01667133|524492716|FG007|Phase 2: Dose-expansion|Other|0|||
145448355|NCT01667133|524492717|FG008|Phase 2: Dose-expansion|Other|0|||
145448356|NCT01667133|524492718|FG009|Phase 2: Dose-expansion|Other|0|||
145448357|NCT01667133|524492719|FG010|Phase 2: Dose-expansion|Other|0|||
145448358|NCT01667133|524492720|FG011|Phase 2: Dose-expansion|Other|1|||
145448359|NCT00191945|524492722|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
145448360|NCT00191945|524492723|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
145448361|NCT00191945|524492722|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
145448362|NCT00191945|524492723|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
145448363|NCT00191945|524492722|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
145448364|NCT00191945|524492723|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
145448365|NCT00191945|524492722|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
145585576|NCT00407537|524997606|FG001|Overall Study|Adverse Event|0|||
145585577|NCT00407537|524997605|FG000|Overall Study|Lost to Follow-up|12|||
145585578|NCT00407537|524997606|FG001|Overall Study|Lost to Follow-up|19|||
145585579|NCT00407537|524997605|FG000|Overall Study|Other|6|||
145585580|NCT00407537|524997606|FG001|Overall Study|Other|7|||
145585581|NCT00407537|524997605|FG000|Overall Study|Withdrawal by Subject|34|||
145448366|NCT00191945|524492723|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
145448367|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
145448368|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
145448369|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
145585582|NCT00407537|524997606|FG001|Overall Study|Withdrawal by Subject|16|||
145448370|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
145448371|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
145448372|NCT01536561|524492725|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
145448373|NCT00553436|524492726|FG000|Overall Study|Conversion to another procedure|1|||
145448374|NCT00391430|524492727|FG000|Overall Study|Withdrawal by Subject|3|||
145448375|NCT00391430|524492728|FG001|Overall Study|Withdrawal by Subject|0|||
145448376|NCT00391430|524492729|FG002|Overall Study|Withdrawal by Subject|12|||
145448377|NCT01603043|524492730|FG000|Overall Study|Study Futility|7|||
145448378|NCT01603043|524492731|FG001|Overall Study|Study Futility|3|||
145448379|NCT03089047|524492732|FG000|Overall Study|Lost to Follow-up|1|||
145448380|NCT03089047|524492733|FG001|Overall Study|Lost to Follow-up|0|||
145448381|NCT03599518|524492734|FG000|Overall Study|Clinical progression|0|||
145448382|NCT03599518|524492735|FG001|Overall Study|Clinical progression|0|||
145448383|NCT03599518|524492736|FG002|Overall Study|Clinical progression|0|||
145448384|NCT03599518|524492737|FG003|Overall Study|Clinical progression|0|||
145448385|NCT03599518|524492738|FG004|Overall Study|Clinical progression|1|||
145448386|NCT03599518|524492734|FG000|Overall Study|Adverse Event|0|||
145448387|NCT03599518|524492735|FG001|Overall Study|Adverse Event|0|||
145448388|NCT03599518|524492736|FG002|Overall Study|Adverse Event|0|||
145448389|NCT03599518|524492737|FG003|Overall Study|Adverse Event|0|||
145448390|NCT03599518|524492738|FG004|Overall Study|Adverse Event|1|||
145448391|NCT03599518|524492734|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
145448392|NCT03599518|524492735|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
145448393|NCT03599518|524492736|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
145448394|NCT03599518|524492737|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
145448395|NCT03599518|524492738|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
145448396|NCT03599518|524492734|FG000|Overall Study|Participant withdrawal from study treatment|0|||
145448397|NCT03599518|524492735|FG001|Overall Study|Participant withdrawal from study treatment|0|||
145448398|NCT03599518|524492736|FG002|Overall Study|Participant withdrawal from study treatment|1|||
145448399|NCT03599518|524492737|FG003|Overall Study|Participant withdrawal from study treatment|0|||
145448400|NCT03599518|524492738|FG004|Overall Study|Participant withdrawal from study treatment|0|||
145448401|NCT00375505|524492739|FG000|Overall Study|Adverse Event|1|||
145448402|NCT00375505|524492740|FG001|Overall Study|Adverse Event|2|||
145448403|NCT00429182|524492743|FG000|Overall Study|Not evaluable, Disease Progression|2|||
145448404|NCT00429182|524492743|FG000|Overall Study|Not eligible|5|||
145448405|NCT00861692|524492745|FG000|Overall Study|Death|6|||
145448406|NCT03292640|524492746|FG000|Overall Study|Withdrawal by Subject|17|||
145448407|NCT03292640|524492747|FG001|Overall Study|Withdrawal by Subject|16|||
145448408|NCT03292640|524492746|FG000|Overall Study|Adverse Event|20|||
145448409|NCT03292640|524492747|FG001|Overall Study|Adverse Event|2|||
145448410|NCT03292640|524492746|FG000|Overall Study|Lost to Follow-up|24|||
145448411|NCT03292640|524492747|FG001|Overall Study|Lost to Follow-up|24|||
145448412|NCT05111002|524492752|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
145448413|NCT05111002|524492753|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
145448414|NCT05111002|524492752|FG000|Secondary Outcome|Lost to Follow-up|1|||
145448415|NCT05111002|524492753|FG001|Secondary Outcome|Lost to Follow-up|0|||
145448416|NCT04380753|524492754|FG000|Overall Study|Participants continuing study|4|||
145448417|NCT04380753|524492754|FG000|Overall Study|Death|2|||
145448418|NCT04776720|524492759|FG000|Overall Study|COVID Related|4|||
145448419|NCT04776720|524492760|FG001|Overall Study|COVID Related|2|||
145448420|NCT04776720|524492759|FG000|Overall Study|Adverse Event|2|||
145448421|NCT04776720|524492760|FG001|Overall Study|Adverse Event|0|||
145448422|NCT04776720|524492759|FG000|Overall Study|Serious Adverse Event|0|||
145448423|NCT04776720|524492760|FG001|Overall Study|Serious Adverse Event|1|||
145448424|NCT04776720|524492759|FG000|Overall Study|Too Busy|3|||
145448425|NCT04776720|524492760|FG001|Overall Study|Too Busy|1|||
145448426|NCT04776720|524492759|FG000|Overall Study|Lost to Follow-up|1|||
145448427|NCT04776720|524492760|FG001|Overall Study|Lost to Follow-up|2|||
145448428|NCT04776720|524492759|FG000|Overall Study|Family|2|||
145448429|NCT04776720|524492760|FG001|Overall Study|Family|2|||
145448430|NCT04776720|524492759|FG000|Overall Study|No remote technology access|0|||
145448431|NCT04776720|524492760|FG001|Overall Study|No remote technology access|1|||
145448432|NCT04776720|524492759|FG000|Overall Study|Withdrawal by Subject|1|||
145448433|NCT04776720|524492760|FG001|Overall Study|Withdrawal by Subject|0|||
145448434|NCT04776720|524492759|FG000|Overall Study|Cannot tolerate intervention|1|||
145448435|NCT04776720|524492760|FG001|Overall Study|Cannot tolerate intervention|0|||
145448436|NCT04776720|524492759|FG000|Overall Study|Incomplete outcome data|6|||
145448437|NCT04776720|524492760|FG001|Overall Study|Incomplete outcome data|1|||
145448438|NCT02712996|524492762|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
145448439|NCT02712996|524492763|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
145448440|NCT02311881|524492769|FG000|Overall Study|Did not meet the study criteria|2|||
145448441|NCT02311881|524492770|FG001|Overall Study|Did not meet the study criteria|2|||
145448442|NCT02311881|524492771|FG002|Overall Study|Did not meet the study criteria|0|||
145448443|NCT02311881|524492769|FG000|Overall Study|Adverse Event|7|||
145448444|NCT02311881|524492770|FG001|Overall Study|Adverse Event|15|||
145448445|NCT02311881|524492771|FG002|Overall Study|Adverse Event|8|||
145448446|NCT02311881|524492769|FG000|Overall Study|Lost to Follow-up|3|||
145448447|NCT02311881|524492770|FG001|Overall Study|Lost to Follow-up|3|||
145448448|NCT02311881|524492771|FG002|Overall Study|Lost to Follow-up|2|||
145448449|NCT02311881|524492769|FG000|Overall Study|Protocol Violation|1|||
145448450|NCT02311881|524492770|FG001|Overall Study|Protocol Violation|2|||
145448451|NCT02311881|524492771|FG002|Overall Study|Protocol Violation|3|||
145448452|NCT02311881|524492769|FG000|Overall Study|Withdrawal of consent|14|||
145448453|NCT02311881|524492770|FG001|Overall Study|Withdrawal of consent|16|||
145448454|NCT02311881|524492771|FG002|Overall Study|Withdrawal of consent|17|||
145448455|NCT02311881|524492769|FG000|Overall Study|Other|0|||
145448456|NCT02311881|524492770|FG001|Overall Study|Other|0|||
145448457|NCT02311881|524492771|FG002|Overall Study|Other|1|||
145448458|NCT02311881|524492769|FG000|Overall Study|Lack of Efficacy|1|||
145448459|NCT02311881|524492770|FG001|Overall Study|Lack of Efficacy|2|||
145448460|NCT02311881|524492771|FG002|Overall Study|Lack of Efficacy|0|||
145448461|NCT02311881|524492769|FG000|Overall Study|Subject has border line pregnancy test|1|||
145448462|NCT02311881|524492770|FG001|Overall Study|Subject has border line pregnancy test|0|||
145448463|NCT02311881|524492771|FG002|Overall Study|Subject has border line pregnancy test|0|||
145448464|NCT02311881|524492769|FG000|Overall Study|Withdrawal by Subject|3|||
145448465|NCT02311881|524492770|FG001|Overall Study|Withdrawal by Subject|1|||
145448466|NCT02311881|524492771|FG002|Overall Study|Withdrawal by Subject|4|||
145448467|NCT02311881|524492769|FG000|Overall Study|Sponsor Decision|1|||
145448468|NCT02311881|524492770|FG001|Overall Study|Sponsor Decision|1|||
145448469|NCT02311881|524492771|FG002|Overall Study|Sponsor Decision|1|||
145448470|NCT02311881|524492769|FG000|Overall Study|Protocol Deviation|1|||
145448471|NCT02311881|524492770|FG001|Overall Study|Protocol Deviation|0|||
145448472|NCT02311881|524492771|FG002|Overall Study|Protocol Deviation|0|||
145448473|NCT02311881|524492769|FG000|Overall Study|Non-Compliance|1|||
145448474|NCT02311881|524492770|FG001|Overall Study|Non-Compliance|0|||
145448475|NCT02311881|524492771|FG002|Overall Study|Non-Compliance|2|||
145448476|NCT02311881|524492769|FG000|Overall Study|Physician Decision|0|||
145448477|NCT02311881|524492770|FG001|Overall Study|Physician Decision|0|||
145448478|NCT02311881|524492771|FG002|Overall Study|Physician Decision|1|||
145448479|NCT02311881|524492769|FG000|Overall Study|Medical Monitor Discretion|0|||
145448480|NCT02311881|524492770|FG001|Overall Study|Medical Monitor Discretion|0|||
145448481|NCT02311881|524492771|FG002|Overall Study|Medical Monitor Discretion|1|||
145448482|NCT02311881|524492769|FG000|Overall Study|Participant taking another medication|0|||
145448483|NCT02311881|524492770|FG001|Overall Study|Participant taking another medication|0|||
145448484|NCT02311881|524492771|FG002|Overall Study|Participant taking another medication|1|||
145448485|NCT02311881|524492769|FG000|Overall Study|Serious Adverse Event|0|||
145448486|NCT02311881|524492770|FG001|Overall Study|Serious Adverse Event|1|||
145448487|NCT02311881|524492771|FG002|Overall Study|Serious Adverse Event|0|||
145448488|NCT00790582|524492776|FG000|Overall Study|Death|14|||
145448489|NCT00790582|524492777|FG001|Overall Study|Death|32|||
145448490|NCT00790582|524492776|FG000|Overall Study|Physician Decision|7|||
145448491|NCT00790582|524492777|FG001|Overall Study|Physician Decision|1|||
145448492|NCT00790582|524492776|FG000|Overall Study|Lost to Follow-up|3|||
145448493|NCT00790582|524492777|FG001|Overall Study|Lost to Follow-up|3|||
145448494|NCT00790582|524492776|FG000|Overall Study|Withdrawal by Subject|7|||
145448495|NCT00790582|524492777|FG001|Overall Study|Withdrawal by Subject|51|||
145448496|NCT01597908|524492780|FG000|Randomized Phase|Death|217|||
145448497|NCT01597908|524492781|FG001|Randomized Phase|Death|238|||
145448498|NCT01597908|524492782|FG002|Randomized Phase|Death|0|||
145448499|NCT01597908|524492780|FG000|Randomized Phase|Sponsor Decision|93|||
145448500|NCT01597908|524492781|FG001|Randomized Phase|Sponsor Decision|39|||
145448501|NCT01597908|524492782|FG002|Randomized Phase|Sponsor Decision|0|||
145448502|NCT01597908|524492780|FG000|Randomized Phase|Lost to Follow-up|9|||
145448503|NCT01597908|524492781|FG001|Randomized Phase|Lost to Follow-up|16|||
145448504|NCT01597908|524492782|FG002|Randomized Phase|Lost to Follow-up|0|||
145448505|NCT01597908|524492780|FG000|Randomized Phase|Physician Decision|6|||
145448506|NCT01597908|524492781|FG001|Randomized Phase|Physician Decision|3|||
145448507|NCT01597908|524492782|FG002|Randomized Phase|Physician Decision|0|||
145448508|NCT01597908|524492780|FG000|Randomized Phase|Withdrawal by Subject|26|||
145448509|NCT01597908|524492781|FG001|Randomized Phase|Withdrawal by Subject|22|||
145448510|NCT01597908|524492782|FG002|Randomized Phase|Withdrawal by Subject|0|||
145448511|NCT01597908|524492780|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
145448512|NCT01597908|524492781|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
145448513|NCT01597908|524492782|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
145448514|NCT01597908|524492780|FG000|Crossover Phase|Death|0|||
145448515|NCT01597908|524492781|FG001|Crossover Phase|Death|0|||
145448516|NCT01597908|524492782|FG002|Crossover Phase|Death|11|||
145448517|NCT01597908|524492780|FG000|Crossover Phase|Withdrawal by Subject|0|||
145448518|NCT01597908|524492781|FG001|Crossover Phase|Withdrawal by Subject|0|||
145448519|NCT01597908|524492782|FG002|Crossover Phase|Withdrawal by Subject|3|||
145448520|NCT01597908|524492780|FG000|Crossover Phase|Sponsor Decision|0|||
145448521|NCT01597908|524492781|FG001|Crossover Phase|Sponsor Decision|0|||
145448522|NCT01597908|524492782|FG002|Crossover Phase|Sponsor Decision|20|||
145448523|NCT03062280|524494481|FG000|Overall Study|Adverse Event|1|||
145585583|NCT00413413|524997610|FG000|Single-Blind|Adverse Event|0|||
145448524|NCT03062280|524494481|FG000|Overall Study|Death|1|||
145448525|NCT03062280|524494481|FG000|Overall Study|Fertility Treatment|2|||
145448526|NCT03062280|524494481|FG000|Overall Study|Physician Decision|2|||
145448527|NCT03062280|524494481|FG000|Overall Study|Pregnancy|5|||
145448528|NCT03062280|524494481|FG000|Overall Study|Withdrawal by Subject|11|||
145448529|NCT05959447|524494482|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
145448530|NCT05959447|524494483|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
145448531|NCT05959447|524494482|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
145448532|NCT05959447|524494483|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
145448533|NCT05959447|524494482|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
145448534|NCT05959447|524494483|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
145448535|NCT05959447|524494482|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
145448536|NCT05959447|524494483|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
145448537|NCT00443872|524494484|FG000|Overall Study|Protocol Violation|7|||
145448538|NCT00443872|524494484|FG000|Overall Study|Lost to Follow-up|2|||
145448539|NCT00443872|524494484|FG000|Overall Study|Adverse Event|8|||
145448540|NCT04551963|524494491|FG000|Overall Study|Physician Decision|1|||
145448541|NCT04551963|524494492|FG001|Overall Study|Physician Decision|1|||
145448542|NCT04551963|524494491|FG000|Overall Study|Death|1|||
145448543|NCT04551963|524494492|FG001|Overall Study|Death|0|||
145448544|NCT03379259|524494493|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
145448545|NCT03379259|524494494|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
145448546|NCT03379259|524494495|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
145448547|NCT03379259|524494496|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
145448548|NCT03379259|524494497|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
145448549|NCT03379259|524494498|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
145448550|NCT03379259|524494493|FG000|Overall Study|Death|0|||
145448551|NCT03379259|524494494|FG001|Overall Study|Death|1|||
145448552|NCT03379259|524494495|FG002|Overall Study|Death|2|||
145448553|NCT03379259|524494496|FG003|Overall Study|Death|1|||
145448554|NCT03379259|524494497|FG004|Overall Study|Death|4|||
145448555|NCT03379259|524494498|FG005|Overall Study|Death|2|||
145448556|NCT03379259|524494493|FG000|Overall Study|Withdrawal by Subject|0|||
145448557|NCT03379259|524494494|FG001|Overall Study|Withdrawal by Subject|0|||
145448558|NCT03379259|524494495|FG002|Overall Study|Withdrawal by Subject|1|||
145448559|NCT03379259|524494496|FG003|Overall Study|Withdrawal by Subject|0|||
145448560|NCT03379259|524494497|FG004|Overall Study|Withdrawal by Subject|2|||
145448561|NCT03379259|524494498|FG005|Overall Study|Withdrawal by Subject|0|||
145448562|NCT03379259|524494493|FG000|Overall Study|Study terminated by sponsor|0|||
145448563|NCT03379259|524494494|FG001|Overall Study|Study terminated by sponsor|0|||
145448564|NCT03379259|524494495|FG002|Overall Study|Study terminated by sponsor|0|||
145448565|NCT03379259|524494496|FG003|Overall Study|Study terminated by sponsor|1|||
145448566|NCT03379259|524494497|FG004|Overall Study|Study terminated by sponsor|1|||
145448567|NCT03379259|524494498|FG005|Overall Study|Study terminated by sponsor|4|||
145448568|NCT03379259|524494493|FG000|Overall Study|Disease progression|0|||
145448569|NCT03379259|524494494|FG001|Overall Study|Disease progression|0|||
145448570|NCT03379259|524494495|FG002|Overall Study|Disease progression|0|||
145448571|NCT03379259|524494496|FG003|Overall Study|Disease progression|1|||
145448572|NCT03379259|524494497|FG004|Overall Study|Disease progression|0|||
145448573|NCT03379259|524494498|FG005|Overall Study|Disease progression|1|||
145448574|NCT03379259|524494493|FG000|Overall Study|Lost to Follow-up|0|||
145448575|NCT03379259|524494494|FG001|Overall Study|Lost to Follow-up|0|||
145448576|NCT03379259|524494495|FG002|Overall Study|Lost to Follow-up|0|||
145448577|NCT03379259|524494496|FG003|Overall Study|Lost to Follow-up|0|||
145448578|NCT03379259|524494497|FG004|Overall Study|Lost to Follow-up|1|||
145448579|NCT03379259|524494498|FG005|Overall Study|Lost to Follow-up|0|||
145448580|NCT03379259|524494493|FG000|Overall Study|Deteriorating condition|0|||
145448581|NCT03379259|524494494|FG001|Overall Study|Deteriorating condition|0|||
145448582|NCT03379259|524494495|FG002|Overall Study|Deteriorating condition|0|||
145448583|NCT03379259|524494496|FG003|Overall Study|Deteriorating condition|0|||
145585584|NCT00413413|524997611|FG001|Single-Blind|Adverse Event|9|||
145448584|NCT03379259|524494497|FG004|Overall Study|Deteriorating condition|1|||
145448585|NCT03379259|524494498|FG005|Overall Study|Deteriorating condition|0|||
145448586|NCT00700622|524494499|FG000|Overall Study|Adverse Event|4|||
145448587|NCT00700622|524494500|FG001|Overall Study|Adverse Event|0|||
145448588|NCT00700622|524494499|FG000|Overall Study|Lost to Follow-up|0|||
145448589|NCT00700622|524494500|FG001|Overall Study|Lost to Follow-up|1|||
145448590|NCT00700622|524494499|FG000|Overall Study|Physician Decision|2|||
145448591|NCT00700622|524494500|FG001|Overall Study|Physician Decision|1|||
145448592|NCT00700622|524494499|FG000|Overall Study|Protocol Violation|0|||
145448593|NCT00700622|524494500|FG001|Overall Study|Protocol Violation|1|||
145448594|NCT00700622|524494499|FG000|Overall Study|Withdrawal by Subject|4|||
145448595|NCT00700622|524494500|FG001|Overall Study|Withdrawal by Subject|1|||
145448596|NCT00700622|524494499|FG000|Overall Study|Other|3|||
145448597|NCT00700622|524494500|FG001|Overall Study|Other|1|||
145448598|NCT03850093|524494501|FG000|Overall Study|Withdrawal by Subject|1|||
145585585|NCT00413413|524997612|FG002|Single-Blind|Adverse Event|0|||
145585586|NCT00413413|524997610|FG000|Single-Blind|Lack of Efficacy|0|||
145585587|NCT00413413|524997611|FG001|Single-Blind|Lack of Efficacy|5|||
145585588|NCT00413413|524997612|FG002|Single-Blind|Lack of Efficacy|0|||
145448599|NCT03850093|524494502|FG001|Overall Study|Withdrawal by Subject|0|||
145448600|NCT03850093|524494503|FG002|Overall Study|Withdrawal by Subject|2|||
145448601|NCT02836717|524494508|FG000|Test Phase|Lack of Efficacy|14|||
145448602|NCT02836717|524494509|FG001|Test Phase|Lack of Efficacy|8|||
145448603|NCT02836717|524494510|FG002|Test Phase|Lack of Efficacy|0|||
145448604|NCT02836717|524494508|FG000|Study Phase|Adverse Event|2|||
145448605|NCT02836717|524494509|FG001|Study Phase|Adverse Event|0|||
145448606|NCT02836717|524494510|FG002|Study Phase|Adverse Event|0|||
145448607|NCT02836717|524494508|FG000|Study Phase|Lack of Efficacy|8|||
145448608|NCT02836717|524494509|FG001|Study Phase|Lack of Efficacy|6|||
145448609|NCT02836717|524494510|FG002|Study Phase|Lack of Efficacy|1|||
145448610|NCT02836717|524494508|FG000|Study Phase|Withdrawal by Subject|1|||
145448611|NCT02836717|524494509|FG001|Study Phase|Withdrawal by Subject|0|||
145448612|NCT02836717|524494510|FG002|Study Phase|Withdrawal by Subject|0|||
145448613|NCT02836717|524494508|FG000|Study Phase|Death|1|||
145448614|NCT02836717|524494509|FG001|Study Phase|Death|0|||
145448615|NCT02836717|524494510|FG002|Study Phase|Death|0|||
145448616|NCT02836717|524494508|FG000|Study Phase|abdominal surgeries|2|||
145448617|NCT02836717|524494509|FG001|Study Phase|abdominal surgeries|1|||
145448618|NCT02836717|524494510|FG002|Study Phase|abdominal surgeries|0|||
145448619|NCT01309997|524494513|FG000|Overall Study|Adverse Event|1|||
145448620|NCT01309997|524494514|FG001|Overall Study|Adverse Event|0|||
145448621|NCT01309997|524494513|FG000|Overall Study|Death|1|||
145448622|NCT01309997|524494514|FG001|Overall Study|Death|3|||
145448623|NCT01309997|524494513|FG000|Overall Study|Lack of Efficacy|2|||
145448624|NCT01309997|524494514|FG001|Overall Study|Lack of Efficacy|2|||
145448625|NCT01309997|524494513|FG000|Overall Study|Withdrawal by Subject|1|||
145448626|NCT01309997|524494514|FG001|Overall Study|Withdrawal by Subject|1|||
145448627|NCT00282087|524494515|FG000|Overall Study|Death|1|||
145448628|NCT03226249|524494516|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
145448629|NCT03226249|524494516|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
145448630|NCT03226249|524494516|FG000|Survival Follow-up|Patients still in follow-up.|30|||
145448631|NCT01532921|524494519|FG000|Overall Study|Death|3|||
145448632|NCT01532921|524494519|FG000|Overall Study|Withdrawal by Subject|2|||
145448633|NCT01532921|524494519|FG000|Overall Study|Lost to Follow-up|3|||
145448634|NCT01532921|524494519|FG000|Overall Study|Physician Decision|7|||
145448635|NCT01532921|524494519|FG000|Overall Study|Device was explanted during procedure|1|||
145448636|NCT03462641|524494520|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
145448637|NCT03462641|524494521|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
145448638|NCT03462641|524494520|FG000|Visit 2|Withdrawal by Subject|0|||
145448639|NCT03462641|524494521|FG001|Visit 2|Withdrawal by Subject|1|||
145448640|NCT01804049|524494522|FG000|Overall Study|Adverse Event|2|||
145448641|NCT01804049|524494523|FG001|Overall Study|Adverse Event|10|||
145448642|NCT01804049|524494522|FG000|Overall Study|Lost to Follow-up|2|||
145448643|NCT01804049|524494523|FG001|Overall Study|Lost to Follow-up|1|||
145448644|NCT01804049|524494522|FG000|Overall Study|Decreased interest/personal|4|||
145448645|NCT01804049|524494523|FG001|Overall Study|Decreased interest/personal|5|||
145448646|NCT01804049|524494522|FG000|Overall Study|Other health concerns|2|||
145448647|NCT01804049|524494523|FG001|Overall Study|Other health concerns|7|||
145448648|NCT01804049|524494522|FG000|Overall Study|Moved out of area|0|||
145448649|NCT01804049|524494523|FG001|Overall Study|Moved out of area|7|||
145448650|NCT01804049|524494522|FG000|Overall Study|other MD recommended|1|||
145448651|NCT01804049|524494523|FG001|Overall Study|other MD recommended|1|||
145448652|NCT01804049|524494522|FG000|Overall Study|Enrollment in dual studies|0|||
145448653|NCT01804049|524494523|FG001|Overall Study|Enrollment in dual studies|1|||
145448654|NCT00070109|524494524|FG000|Overall Study|Death|1|||
145448655|NCT00070109|524494525|FG001|Overall Study|Death|1|||
145585589|NCT00413413|524997610|FG000|Single-Blind|Subject no longer requires study drug|0|||
145585590|NCT00413413|524997611|FG001|Single-Blind|Subject no longer requires study drug|151|||
145585591|NCT00413413|524997612|FG002|Single-Blind|Subject no longer requires study drug|0|||
145448656|NCT00070109|524494526|FG002|Overall Study|Death|0|||
145448657|NCT00070109|524494527|FG003|Overall Study|Death|0|||
145448658|NCT00070109|524494528|FG004|Overall Study|Death|1|||
145448659|NCT00070109|524494524|FG000|Overall Study|Lack of Efficacy|6|||
145448660|NCT00070109|524494525|FG001|Overall Study|Lack of Efficacy|4|||
145448661|NCT00070109|524494526|FG002|Overall Study|Lack of Efficacy|5|||
145448662|NCT00070109|524494527|FG003|Overall Study|Lack of Efficacy|15|||
145448663|NCT00070109|524494528|FG004|Overall Study|Lack of Efficacy|5|||
145448664|NCT00070109|524494524|FG000|Overall Study|Physician Decision|1|||
145448665|NCT00070109|524494525|FG001|Overall Study|Physician Decision|0|||
145448666|NCT00070109|524494526|FG002|Overall Study|Physician Decision|0|||
145448667|NCT00070109|524494527|FG003|Overall Study|Physician Decision|0|||
145448668|NCT00070109|524494528|FG004|Overall Study|Physician Decision|0|||
145448669|NCT00070109|524494524|FG000|Overall Study|Withdrawal by Subject|0|||
145448670|NCT00070109|524494525|FG001|Overall Study|Withdrawal by Subject|1|||
145448671|NCT00070109|524494526|FG002|Overall Study|Withdrawal by Subject|1|||
145448672|NCT00070109|524494527|FG003|Overall Study|Withdrawal by Subject|0|||
145448673|NCT00070109|524494528|FG004|Overall Study|Withdrawal by Subject|0|||
145448674|NCT00070109|524494524|FG000|Overall Study|Adverse Event|0|||
145448675|NCT00070109|524494525|FG001|Overall Study|Adverse Event|0|||
145448676|NCT00070109|524494526|FG002|Overall Study|Adverse Event|2|||
145448677|NCT00070109|524494527|FG003|Overall Study|Adverse Event|4|||
145448678|NCT00070109|524494528|FG004|Overall Study|Adverse Event|2|||
145448679|NCT00070109|524494524|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
145448680|NCT00070109|524494525|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
145448681|NCT00070109|524494526|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
145448682|NCT00070109|524494527|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
145448683|NCT00070109|524494528|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
145448684|NCT00588237|524494534|FG000|Overall Study|Evaluable for toxicity only|3|||
145448685|NCT00588237|524494534|FG000|Overall Study|Patien not treated|1|||
145448686|NCT02201329|524494537|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
145448687|NCT02201329|524494537|FG000|Overall Study|Withdrawal by Subject|2|||
145448688|NCT01262638|524494538|FG000|Overall Study|Adverse Event|3|||
145448689|NCT01262638|524494539|FG001|Overall Study|Adverse Event|4|||
145448690|NCT01262638|524494540|FG002|Overall Study|Adverse Event|3|||
145448691|NCT01262638|524494541|FG003|Overall Study|Adverse Event|4|||
145448692|NCT01262638|524494538|FG000|Overall Study|Protocol Violation|1|||
145448693|NCT01262638|524494539|FG001|Overall Study|Protocol Violation|0|||
145448694|NCT01262638|524494540|FG002|Overall Study|Protocol Violation|0|||
145448695|NCT01262638|524494541|FG003|Overall Study|Protocol Violation|1|||
145448696|NCT01262638|524494538|FG000|Overall Study|Withdrawal by Subject|2|||
145448697|NCT01262638|524494539|FG001|Overall Study|Withdrawal by Subject|1|||
145448698|NCT01262638|524494540|FG002|Overall Study|Withdrawal by Subject|0|||
145448699|NCT01262638|524494541|FG003|Overall Study|Withdrawal by Subject|1|||
145448700|NCT01262638|524494538|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
145448701|NCT01262638|524494539|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
145448702|NCT01262638|524494540|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
145448703|NCT01262638|524494541|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
145448704|NCT01262638|524494538|FG000|Overall Study|Lost to Follow-up|1|||
145448705|NCT01262638|524494539|FG001|Overall Study|Lost to Follow-up|1|||
145448706|NCT01262638|524494540|FG002|Overall Study|Lost to Follow-up|1|||
145448707|NCT01262638|524494541|FG003|Overall Study|Lost to Follow-up|1|||
145585592|NCT00413413|524997610|FG000|Single-Blind|Protocol Violation|0|||
145585593|NCT00413413|524997611|FG001|Single-Blind|Protocol Violation|16|||
145585594|NCT00413413|524997612|FG002|Single-Blind|Protocol Violation|0|||
145585595|NCT00413413|524997610|FG000|Single-Blind|Withdrawal by Subject|0|||
145585596|NCT00413413|524997611|FG001|Single-Blind|Withdrawal by Subject|27|||
145585597|NCT00413413|524997612|FG002|Single-Blind|Withdrawal by Subject|0|||
145585598|NCT00413413|524997610|FG000|Single-Blind|Lost to Follow-up|0|||
145585599|NCT00413413|524997611|FG001|Single-Blind|Lost to Follow-up|8|||
145585600|NCT00413413|524997612|FG002|Single-Blind|Lost to Follow-up|0|||
145585601|NCT00413413|524997610|FG000|Double-Blind|Adverse Event|6|||
145585602|NCT00413413|524997611|FG001|Double-Blind|Adverse Event|0|||
145585603|NCT00413413|524997612|FG002|Double-Blind|Adverse Event|5|||
145585604|NCT00413413|524997610|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
145585605|NCT00413413|524997611|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
145585606|NCT00413413|524997612|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
145585607|NCT00413413|524997610|FG000|Double-Blind|Protocol deviation|1|||
145585608|NCT00413413|524997611|FG001|Double-Blind|Protocol deviation|2|||
145585609|NCT00413413|524997612|FG002|Double-Blind|Protocol deviation|1|||
145585610|NCT00413413|524997610|FG000|Double-Blind|Subject withdrew consent|4|||
145585611|NCT00413413|524997611|FG001|Double-Blind|Subject withdrew consent|6|||
145585612|NCT00413413|524997612|FG002|Double-Blind|Subject withdrew consent|9|||
145585613|NCT00413413|524997610|FG000|Double-Blind|Lost to Follow-up|3|||
145585614|NCT00413413|524997611|FG001|Double-Blind|Lost to Follow-up|4|||
145585615|NCT00413413|524997612|FG002|Double-Blind|Lost to Follow-up|2|||
145585616|NCT01040130|524997613|FG000|Overall Study|Adverse Event|1|||
145585617|NCT01040130|524997614|FG001|Overall Study|Adverse Event|1|||
145585618|NCT01040130|524997615|FG002|Overall Study|Adverse Event|0|||
145585619|NCT01040130|524997616|FG003|Overall Study|Adverse Event|5|||
145585620|NCT01040130|524997617|FG004|Overall Study|Adverse Event|0|||
145585621|NCT01040130|524997618|FG005|Overall Study|Adverse Event|3|||
145585622|NCT01040130|524997613|FG000|Overall Study|Protocol Violation|0|||
145585623|NCT01040130|524997614|FG001|Overall Study|Protocol Violation|0|||
145585624|NCT01040130|524997615|FG002|Overall Study|Protocol Violation|2|||
145585625|NCT01040130|524997616|FG003|Overall Study|Protocol Violation|0|||
145585626|NCT01040130|524997617|FG004|Overall Study|Protocol Violation|0|||
145585627|NCT01040130|524997618|FG005|Overall Study|Protocol Violation|0|||
145585628|NCT01040130|524997613|FG000|Overall Study|Withdrawal by Subject|0|||
145585629|NCT01040130|524997614|FG001|Overall Study|Withdrawal by Subject|2|||
145585630|NCT01040130|524997615|FG002|Overall Study|Withdrawal by Subject|0|||
145585631|NCT01040130|524997616|FG003|Overall Study|Withdrawal by Subject|0|||
145585632|NCT01040130|524997617|FG004|Overall Study|Withdrawal by Subject|0|||
145448708|NCT01262638|524494538|FG000|Overall Study|Participant Went Out of Town|0|||
145448709|NCT01262638|524494539|FG001|Overall Study|Participant Went Out of Town|0|||
145448710|NCT01262638|524494540|FG002|Overall Study|Participant Went Out of Town|1|||
145448711|NCT01262638|524494541|FG003|Overall Study|Participant Went Out of Town|0|||
145448712|NCT01369199|524494542|FG000|Overall Study|Withdrawal by Subject|1|||
145448713|NCT01369199|524494542|FG000|Overall Study|Lost to Follow-up|2|||
145448714|NCT01970241|524494550|FG000|Overall Study|Withdrawal by Subject|2|||
145448715|NCT01970241|524494551|FG001|Overall Study|Withdrawal by Subject|0|||
145448716|NCT01970241|524494550|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
145448717|NCT01970241|524494551|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
145448718|NCT01001767|524494556|FG000|Overall Study|no baseline study performed|1|||
145448719|NCT01001767|524494557|FG001|Overall Study|no baseline study performed|0|||
145448720|NCT01001767|524494556|FG000|Overall Study|Protocol Violation|1|||
145448721|NCT01001767|524494557|FG001|Overall Study|Protocol Violation|0|||
145448722|NCT01001767|524494556|FG000|Overall Study|Lost to Follow-up|1|||
145448723|NCT01001767|524494557|FG001|Overall Study|Lost to Follow-up|0|||
145448724|NCT01001767|524494556|FG000|Overall Study|Physician Decision|1|||
145448725|NCT01001767|524494557|FG001|Overall Study|Physician Decision|0|||
145448726|NCT01107392|524494558|FG000|Overall Study|Adverse Event|2|||
145448727|NCT01107392|524494559|FG001|Overall Study|Adverse Event|0|||
145448728|NCT01107392|524494558|FG000|Overall Study|Personal Reasons|2|||
145448729|NCT01107392|524494559|FG001|Overall Study|Personal Reasons|3|||
145448730|NCT01107392|524494558|FG000|Overall Study|Administrative decision|1|||
145448731|NCT01107392|524494559|FG001|Overall Study|Administrative decision|0|||
145448732|NCT02584452|524494560|FG000|Overall Study|Physician Decision|1|||
145448733|NCT02584452|524494561|FG001|Overall Study|Physician Decision|1|||
145448734|NCT02584452|524494560|FG000|Overall Study|Lost to Follow-up|1|||
145448735|NCT02584452|524494561|FG001|Overall Study|Lost to Follow-up|1|||
145448736|NCT00851552|524494562|FG000|Overall Study|Death|2|||
145448737|NCT00851552|524494562|FG000|Overall Study|Adverse Event|1|||
145448738|NCT00851552|524494562|FG000|Overall Study|Disease Progression|4|||
145448739|NCT02689206|524494563|FG000|Overall Study|Adverse Event|0|||
145448740|NCT02689206|524494564|FG001|Overall Study|Adverse Event|0|||
145448741|NCT02689206|524494565|FG002|Overall Study|Adverse Event|1|||
145448742|NCT02689206|524494566|FG003|Overall Study|Adverse Event|0|||
145448743|NCT02689206|524494567|FG004|Overall Study|Adverse Event|2|||
145448744|NCT02689206|524494563|FG000|Overall Study|Protocol Violation|1|||
145448745|NCT02689206|524494564|FG001|Overall Study|Protocol Violation|0|||
145448746|NCT02689206|524494565|FG002|Overall Study|Protocol Violation|0|||
145448747|NCT02689206|524494566|FG003|Overall Study|Protocol Violation|1|||
145448748|NCT02689206|524494567|FG004|Overall Study|Protocol Violation|2|||
145448749|NCT02689206|524494563|FG000|Overall Study|Other: Reached stopping criteria|0|||
145448750|NCT02689206|524494564|FG001|Overall Study|Other: Reached stopping criteria|1|||
145448751|NCT02689206|524494565|FG002|Overall Study|Other: Reached stopping criteria|2|||
145448752|NCT02689206|524494566|FG003|Overall Study|Other: Reached stopping criteria|3|||
145448753|NCT02689206|524494567|FG004|Overall Study|Other: Reached stopping criteria|4|||
145448754|NCT02689206|524494563|FG000|Overall Study|Physician Decision|1|||
145448755|NCT02689206|524494564|FG001|Overall Study|Physician Decision|0|||
145448756|NCT02689206|524494565|FG002|Overall Study|Physician Decision|0|||
145448757|NCT02689206|524494566|FG003|Overall Study|Physician Decision|0|||
145448758|NCT02689206|524494567|FG004|Overall Study|Physician Decision|0|||
145448759|NCT02689206|524494563|FG000|Overall Study|Withdrawal by Subject|1|||
145448760|NCT02689206|524494564|FG001|Overall Study|Withdrawal by Subject|0|||
145448761|NCT02689206|524494565|FG002|Overall Study|Withdrawal by Subject|1|||
145448762|NCT02689206|524494566|FG003|Overall Study|Withdrawal by Subject|0|||
145448763|NCT02689206|524494567|FG004|Overall Study|Withdrawal by Subject|0|||
145448764|NCT00177294|524494568|FG000|Overall Study|Withdrawal by Subject|7|||
145448765|NCT00177294|524494569|FG001|Overall Study|Withdrawal by Subject|5|||
145448766|NCT02998671|524494570|FG000|Period 1|Study Terminated By Sponsor|2|||
145448767|NCT02998671|524494571|FG001|Period 1|Study Terminated By Sponsor|1|||
145448768|NCT02998671|524494572|FG002|Period 1|Study Terminated By Sponsor|0|||
145448769|NCT02998671|524494573|FG003|Period 1|Study Terminated By Sponsor|0|||
145448770|NCT02998671|524494574|FG004|Period 1|Study Terminated By Sponsor|1|||
145448771|NCT02998671|524494570|FG000|Period 1|Withdrawal by Subject|1|||
145448772|NCT02998671|524494571|FG001|Period 1|Withdrawal by Subject|2|||
145448773|NCT02998671|524494572|FG002|Period 1|Withdrawal by Subject|0|||
145448774|NCT02998671|524494573|FG003|Period 1|Withdrawal by Subject|0|||
145448775|NCT02998671|524494574|FG004|Period 1|Withdrawal by Subject|2|||
145448776|NCT02998671|524494570|FG000|Period 1|Pregnancy|1|||
145448777|NCT02998671|524494571|FG001|Period 1|Pregnancy|0|||
145448778|NCT02998671|524494572|FG002|Period 1|Pregnancy|0|||
145448779|NCT02998671|524494573|FG003|Period 1|Pregnancy|0|||
145448780|NCT02998671|524494574|FG004|Period 1|Pregnancy|0|||
145448781|NCT02998671|524494570|FG000|Period 1|Adverse Event|0|||
145448782|NCT02998671|524494571|FG001|Period 1|Adverse Event|0|||
145448783|NCT02998671|524494572|FG002|Period 1|Adverse Event|0|||
145448784|NCT02998671|524494573|FG003|Period 1|Adverse Event|0|||
145448785|NCT02998671|524494574|FG004|Period 1|Adverse Event|1|||
145448786|NCT02998671|524494570|FG000|Period 2|Adverse Event|0|||
145448787|NCT02998671|524494571|FG001|Period 2|Adverse Event|1|||
145448788|NCT02998671|524494572|FG002|Period 2|Adverse Event|0|||
145448789|NCT02998671|524494573|FG003|Period 2|Adverse Event|0|||
145448790|NCT02998671|524494574|FG004|Period 2|Adverse Event|0|||
145448791|NCT02998671|524494570|FG000|Period 2|Study Terminated By Sponsor|3|||
145448792|NCT02998671|524494571|FG001|Period 2|Study Terminated By Sponsor|5|||
145448793|NCT02998671|524494572|FG002|Period 2|Study Terminated By Sponsor|1|||
145448794|NCT02998671|524494573|FG003|Period 2|Study Terminated By Sponsor|3|||
145448795|NCT02998671|524494574|FG004|Period 2|Study Terminated By Sponsor|0|||
145448796|NCT02998671|524494570|FG000|Period 2|Withdrawal by Subject|0|||
145448797|NCT02998671|524494571|FG001|Period 2|Withdrawal by Subject|1|||
145448798|NCT02998671|524494572|FG002|Period 2|Withdrawal by Subject|0|||
145448799|NCT02998671|524494573|FG003|Period 2|Withdrawal by Subject|0|||
145448800|NCT02998671|524494574|FG004|Period 2|Withdrawal by Subject|0|||
145448801|NCT02998671|524494570|FG000|Period 2|Lost to Follow-up|0|||
145448802|NCT02998671|524494571|FG001|Period 2|Lost to Follow-up|0|||
145448803|NCT02998671|524494572|FG002|Period 2|Lost to Follow-up|0|||
145448804|NCT02998671|524494573|FG003|Period 2|Lost to Follow-up|1|||
145448805|NCT02998671|524494574|FG004|Period 2|Lost to Follow-up|0|||
145448806|NCT00771927|524494577|FG000|Overall Study|Adverse Event|100|||
145448807|NCT00771927|524494578|FG001|Overall Study|Adverse Event|105|||
145448808|NCT00771927|524494577|FG000|Overall Study|Lack of Efficacy|70|||
145585633|NCT01040130|524997618|FG005|Overall Study|Withdrawal by Subject|1|||
145585634|NCT01040130|524997613|FG000|Overall Study|Other reasons not listed above|2|||
145626005|NCT01687270|525144143|FG000|Overall Study|Lack of Efficacy|11|||
145626006|NCT01687270|525144143|FG000|Overall Study|Lost to Follow-up|1|||
145626007|NCT03532178|525144144|FG000|First Period|Withdrawal by Subject|1|||
145626008|NCT03532178|525144145|FG001|First Period|Withdrawal by Subject|3|||
145626009|NCT03532178|525144144|FG000|First Period|technical issues in data collection Technical issues|0|||
145626010|NCT03532178|525144145|FG001|First Period|technical issues in data collection Technical issues|1|||
145626011|NCT03532178|525144144|FG000|Second Period|Withdrawal by Subject|1|||
145626012|NCT03532178|525144145|FG001|Second Period|Withdrawal by Subject|1|||
145626013|NCT03532178|525144144|FG000|Second Period|Technical issues|0|||
145626014|NCT03532178|525144145|FG001|Second Period|Technical issues|1|||
145626015|NCT03635112|525144146|FG000|Overall Study|Adverse Event|5|||
145626016|NCT03635112|525144147|FG001|Overall Study|Adverse Event|9|||
145585635|NCT01040130|524997614|FG001|Overall Study|Other reasons not listed above|0|||
145626017|NCT03635112|525144148|FG002|Overall Study|Adverse Event|14|||
145626018|NCT03635112|525144146|FG000|Overall Study|Lost to Follow-up|1|||
145626019|NCT03635112|525144147|FG001|Overall Study|Lost to Follow-up|0|||
145626020|NCT03635112|525144148|FG002|Overall Study|Lost to Follow-up|1|||
145585636|NCT01040130|524997615|FG002|Overall Study|Other reasons not listed above|0|||
145585637|NCT01040130|524997616|FG003|Overall Study|Other reasons not listed above|0|||
145585638|NCT01040130|524997617|FG004|Overall Study|Other reasons not listed above|0|||
145585639|NCT01040130|524997618|FG005|Overall Study|Other reasons not listed above|0|||
145585640|NCT01175668|524997619|FG000|Overall Study|Withdrawal by Subject|2|||
145585641|NCT01175668|524997620|FG001|Overall Study|Withdrawal by Subject|0|||
145585642|NCT00096135|524997621|FG000|Overall Study|Physician Decision|20|||
145585643|NCT00096135|524997622|FG001|Overall Study|Physician Decision|4|||
145585644|NCT00096135|524997621|FG000|Overall Study|Refusal of further protocol therapy|4|||
145585645|NCT00096135|524997622|FG001|Overall Study|Refusal of further protocol therapy|1|||
145585646|NCT00096135|524997621|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
145585647|NCT00096135|524997622|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
145585648|NCT00096135|524997621|FG000|Overall Study|Other, specify|15|||
145585649|NCT00096135|524997622|FG001|Overall Study|Other, specify|3|||
145585650|NCT00096135|524997621|FG000|Overall Study|Ineligible|2|||
145585651|NCT00096135|524997622|FG001|Overall Study|Ineligible|0|||
145585652|NCT01568047|524997623|FG000|Overall Study|Ineligibility|1|||
145585653|NCT01568047|524997624|FG001|Overall Study|Ineligibility|0|||
145585654|NCT01568047|524997625|FG002|Overall Study|Ineligibility|0|||
145585655|NCT01568047|524997626|FG003|Overall Study|Ineligibility|0|||
145585656|NCT01568047|524997623|FG000|Overall Study|Withdrawal by Subject|0|||
145626021|NCT03635112|525144146|FG000|Overall Study|Physician Decision|5|||
145626022|NCT03635112|525144147|FG001|Overall Study|Physician Decision|7|||
145626023|NCT03635112|525144148|FG002|Overall Study|Physician Decision|5|||
145626024|NCT03635112|525144146|FG000|Overall Study|Protocol Violation|0|||
145626025|NCT03635112|525144147|FG001|Overall Study|Protocol Violation|0|||
145626026|NCT03635112|525144148|FG002|Overall Study|Protocol Violation|1|||
145448809|NCT00771927|524494578|FG001|Overall Study|Lack of Efficacy|42|||
145448810|NCT00771927|524494577|FG000|Overall Study|Lost to Follow-up|46|||
145448811|NCT00771927|524494578|FG001|Overall Study|Lost to Follow-up|46|||
145448812|NCT00771927|524494577|FG000|Overall Study|Withdrawal by Subject|16|||
145585657|NCT01568047|524997624|FG001|Overall Study|Withdrawal by Subject|1|||
145585658|NCT01568047|524997625|FG002|Overall Study|Withdrawal by Subject|0|||
145585659|NCT01568047|524997626|FG003|Overall Study|Withdrawal by Subject|0|||
145585660|NCT01568047|524997623|FG000|Overall Study|Adverse Event|0|||
145585661|NCT01568047|524997624|FG001|Overall Study|Adverse Event|0|||
145448813|NCT00771927|524494578|FG001|Overall Study|Withdrawal by Subject|17|||
145448814|NCT00771927|524494577|FG000|Overall Study|Other reason|23|||
145448815|NCT00771927|524494578|FG001|Overall Study|Other reason|27|||
145448816|NCT02063984|524494581|FG000|Overall Study|Lost to Follow-up|6|||
145448817|NCT02063984|524494582|FG001|Overall Study|Lost to Follow-up|5|||
145448818|NCT00958347|524494586|FG000|Overall Study|Death|43|||
145448819|NCT00958347|524494586|FG000|Overall Study|Withdrawal by Subject|23|||
145448820|NCT00958347|524494586|FG000|Overall Study|Lost to Follow-up|15|||
145448821|NCT00958347|524494586|FG000|Overall Study|revision/removal|10|||
145448822|NCT00958347|524494586|FG000|Overall Study|study termination|135|||
145448823|NCT02218697|524494587|FG000|Overall Study|Adverse Event|0|||
145448824|NCT02218697|524494588|FG001|Overall Study|Adverse Event|2|||
145448825|NCT02218697|524494587|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
145448826|NCT02218697|524494588|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
145448827|NCT02218697|524494587|FG000|Overall Study|Withdrawal by Subject|2|||
145448828|NCT02218697|524494588|FG001|Overall Study|Withdrawal by Subject|3|||
145448829|NCT00972517|524494589|FG000|Overall Study|Adverse Event|0|||
145448830|NCT00972517|524494590|FG001|Overall Study|Adverse Event|0|||
145448831|NCT00972517|524494591|FG002|Overall Study|Adverse Event|0|||
145448832|NCT00972517|524494592|FG003|Overall Study|Adverse Event|1|||
145448833|NCT00972517|524494593|FG004|Overall Study|Adverse Event|0|||
145448834|NCT00972517|524494594|FG005|Overall Study|Adverse Event|0|||
145448835|NCT00972517|524494589|FG000|Overall Study|Withdrawal by Subject|0|||
145448836|NCT00972517|524494590|FG001|Overall Study|Withdrawal by Subject|1|||
145448837|NCT00972517|524494591|FG002|Overall Study|Withdrawal by Subject|0|||
145448838|NCT00972517|524494592|FG003|Overall Study|Withdrawal by Subject|2|||
145448839|NCT00972517|524494593|FG004|Overall Study|Withdrawal by Subject|1|||
145448840|NCT00972517|524494594|FG005|Overall Study|Withdrawal by Subject|0|||
145448841|NCT03306433|524494597|FG000|Overall Study|Lost to Follow-up|3|||
145448842|NCT03306433|524494597|FG000|Overall Study|Patient did not have teeth extracted|1|||
145448843|NCT03306433|524494597|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
145448844|NCT00819156|524494598|FG000|Overall Study|Adverse Event|1|||
145448845|NCT00819156|524494599|FG001|Overall Study|Adverse Event|4|||
145448846|NCT00819156|524494600|FG002|Overall Study|Adverse Event|2|||
145448847|NCT00819156|524494601|FG003|Overall Study|Adverse Event|1|||
145448848|NCT00819156|524494602|FG004|Overall Study|Adverse Event|2|||
145448849|NCT00819156|524494603|FG005|Overall Study|Adverse Event|3|||
145448850|NCT00819156|524494598|FG000|Overall Study|Withdrawal by Subject|0|||
145448851|NCT00819156|524494599|FG001|Overall Study|Withdrawal by Subject|3|||
145448852|NCT00819156|524494600|FG002|Overall Study|Withdrawal by Subject|2|||
145448853|NCT00819156|524494601|FG003|Overall Study|Withdrawal by Subject|0|||
145448854|NCT00819156|524494602|FG004|Overall Study|Withdrawal by Subject|1|||
145448855|NCT00819156|524494603|FG005|Overall Study|Withdrawal by Subject|0|||
145448856|NCT00819156|524494598|FG000|Overall Study|Protocol Violation|1|||
145448857|NCT00819156|524494599|FG001|Overall Study|Protocol Violation|0|||
145448858|NCT00819156|524494600|FG002|Overall Study|Protocol Violation|1|||
145448859|NCT00819156|524494601|FG003|Overall Study|Protocol Violation|0|||
145448860|NCT00819156|524494602|FG004|Overall Study|Protocol Violation|0|||
145448861|NCT00819156|524494603|FG005|Overall Study|Protocol Violation|1|||
145448862|NCT00819156|524494598|FG000|Overall Study|Lost to Follow-up|0|||
145448863|NCT00819156|524494599|FG001|Overall Study|Lost to Follow-up|1|||
145448864|NCT00819156|524494600|FG002|Overall Study|Lost to Follow-up|0|||
145448865|NCT00819156|524494601|FG003|Overall Study|Lost to Follow-up|0|||
145448866|NCT00819156|524494602|FG004|Overall Study|Lost to Follow-up|0|||
145448867|NCT00819156|524494603|FG005|Overall Study|Lost to Follow-up|2|||
145448868|NCT00819156|524494598|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
145448869|NCT00819156|524494599|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
145448870|NCT00819156|524494600|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
145448871|NCT00819156|524494601|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
145448872|NCT00819156|524494602|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
145448873|NCT00819156|524494603|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
145448874|NCT00819156|524494598|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
145448875|NCT00819156|524494599|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
145448876|NCT00819156|524494600|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
145585662|NCT01568047|524997625|FG002|Overall Study|Adverse Event|1|||
145448877|NCT00819156|524494601|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
145448878|NCT00819156|524494602|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
145448879|NCT00819156|524494603|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
145448880|NCT00819156|524494598|FG000|Overall Study|Prostate-specific antigen progression|0|||
145448881|NCT00819156|524494599|FG001|Overall Study|Prostate-specific antigen progression|0|||
145448882|NCT00819156|524494600|FG002|Overall Study|Prostate-specific antigen progression|0|||
145448883|NCT00819156|524494601|FG003|Overall Study|Prostate-specific antigen progression|0|||
145448884|NCT00819156|524494602|FG004|Overall Study|Prostate-specific antigen progression|1|||
145585663|NCT01568047|524997626|FG003|Overall Study|Adverse Event|1|||
145585664|NCT00874029|524997627|FG000|Overall Study|Withdrawal by Subject|10|||
145585665|NCT00874029|524997627|FG000|Overall Study|Pregnancy|4|||
145585666|NCT00874029|524997627|FG000|Overall Study|Physician Decision|1|||
145448885|NCT00819156|524494603|FG005|Overall Study|Prostate-specific antigen progression|0|||
145448886|NCT02195700|524494604|FG000|Overall Study|Protocol Violation|0|||
145448887|NCT02195700|524494605|FG001|Overall Study|Protocol Violation|2|||
145448888|NCT02195700|524494604|FG000|Overall Study|Noncompliance|1|||
145448889|NCT02195700|524494605|FG001|Overall Study|Noncompliance|0|||
145448890|NCT02195700|524494604|FG000|Overall Study|Adverse Event|1|||
145448891|NCT02195700|524494605|FG001|Overall Study|Adverse Event|2|||
145448892|NCT02195700|524494604|FG000|Overall Study|Withdrawal by Subject|3|||
145448893|NCT02195700|524494605|FG001|Overall Study|Withdrawal by Subject|2|||
145448894|NCT02195700|524494604|FG000|Overall Study|Lost to Follow-up|1|||
145448895|NCT02195700|524494605|FG001|Overall Study|Lost to Follow-up|1|||
145448896|NCT02931838|524494606|FG000|Overall Study|Reason not provided by investigator|1|||
145448897|NCT02931838|524494607|FG001|Overall Study|Reason not provided by investigator|0|||
145448898|NCT02931838|524494608|FG002|Overall Study|Reason not provided by investigator|1|||
145448899|NCT02931838|524494609|FG003|Overall Study|Reason not provided by investigator|0|||
145448900|NCT02931838|524494610|FG004|Overall Study|Reason not provided by investigator|0|||
145448901|NCT02931838|524494611|FG005|Overall Study|Reason not provided by investigator|0|||
145448902|NCT02931838|524494606|FG000|Overall Study|Poor/non-compliance|0|||
145448903|NCT02931838|524494607|FG001|Overall Study|Poor/non-compliance|0|||
145448904|NCT02931838|524494608|FG002|Overall Study|Poor/non-compliance|1|||
145448905|NCT02931838|524494609|FG003|Overall Study|Poor/non-compliance|0|||
145448906|NCT02931838|524494610|FG004|Overall Study|Poor/non-compliance|0|||
145448907|NCT02931838|524494611|FG005|Overall Study|Poor/non-compliance|0|||
145448908|NCT02931838|524494606|FG000|Overall Study|Lack of Efficacy|5|||
145448909|NCT02931838|524494607|FG001|Overall Study|Lack of Efficacy|4|||
145448910|NCT02931838|524494608|FG002|Overall Study|Lack of Efficacy|0|||
145448911|NCT02931838|524494609|FG003|Overall Study|Lack of Efficacy|0|||
145448912|NCT02931838|524494610|FG004|Overall Study|Lack of Efficacy|0|||
145448913|NCT02931838|524494611|FG005|Overall Study|Lack of Efficacy|1|||
145448914|NCT02931838|524494606|FG000|Overall Study|Lost to Follow-up|1|||
145448915|NCT02931838|524494607|FG001|Overall Study|Lost to Follow-up|0|||
145448916|NCT02931838|524494608|FG002|Overall Study|Lost to Follow-up|1|||
145448917|NCT02931838|524494609|FG003|Overall Study|Lost to Follow-up|1|||
145448918|NCT02931838|524494610|FG004|Overall Study|Lost to Follow-up|2|||
145448919|NCT02931838|524494611|FG005|Overall Study|Lost to Follow-up|0|||
145448920|NCT02931838|524494606|FG000|Overall Study|Subject request to discontinue treatment|4|||
145448921|NCT02931838|524494607|FG001|Overall Study|Subject request to discontinue treatment|3|||
145448922|NCT02931838|524494608|FG002|Overall Study|Subject request to discontinue treatment|3|||
145448923|NCT02931838|524494609|FG003|Overall Study|Subject request to discontinue treatment|0|||
145448924|NCT02931838|524494610|FG004|Overall Study|Subject request to discontinue treatment|1|||
145448925|NCT02931838|524494611|FG005|Overall Study|Subject request to discontinue treatment|0|||
145448926|NCT02931838|524494606|FG000|Overall Study|Withdrawal by Subject|1|||
145448927|NCT02931838|524494607|FG001|Overall Study|Withdrawal by Subject|2|||
145448928|NCT02931838|524494608|FG002|Overall Study|Withdrawal by Subject|0|||
145448929|NCT02931838|524494609|FG003|Overall Study|Withdrawal by Subject|1|||
145448930|NCT02931838|524494610|FG004|Overall Study|Withdrawal by Subject|0|||
145448931|NCT02931838|524494611|FG005|Overall Study|Withdrawal by Subject|0|||
145448932|NCT02931838|524494606|FG000|Overall Study|Adverse Event|2|||
145448933|NCT02931838|524494607|FG001|Overall Study|Adverse Event|1|||
145448934|NCT02931838|524494608|FG002|Overall Study|Adverse Event|2|||
145448935|NCT02931838|524494609|FG003|Overall Study|Adverse Event|1|||
145448936|NCT02931838|524494610|FG004|Overall Study|Adverse Event|3|||
145448937|NCT02931838|524494611|FG005|Overall Study|Adverse Event|1|||
145448938|NCT00104728|524494612|FG000|Overall Study|screen failures|19|||
145448939|NCT02709577|524494613|FG000|Overall Study|non-accommodating anatomy|0|||
145448940|NCT02709577|524494614|FG001|Overall Study|non-accommodating anatomy|1|||
145448941|NCT02709577|524494615|FG002|Overall Study|non-accommodating anatomy|0|||
145448942|NCT02709577|524494616|FG003|Overall Study|non-accommodating anatomy|0|||
145448943|NCT02709577|524494613|FG000|Overall Study|procedural complication|0|||
145448944|NCT02709577|524494614|FG001|Overall Study|procedural complication|1|||
145448945|NCT02709577|524494615|FG002|Overall Study|procedural complication|0|||
145448946|NCT02709577|524494616|FG003|Overall Study|procedural complication|0|||
145585667|NCT00874029|524997627|FG000|Overall Study|Adverse Event|1|||
145448947|NCT02709577|524494613|FG000|Overall Study|Withdrawal by Subject|2|||
145448948|NCT02709577|524494614|FG001|Overall Study|Withdrawal by Subject|3|||
145448949|NCT02709577|524494615|FG002|Overall Study|Withdrawal by Subject|2|||
145448950|NCT02709577|524494616|FG003|Overall Study|Withdrawal by Subject|0|||
145448951|NCT01042158|524494617|FG000|Overall Study|Physician Decision|1|||
145448952|NCT01575808|524494618|FG000|Overall Study|Death|2|||
145448953|NCT01575808|524494619|FG001|Overall Study|Death|0|||
145448954|NCT01575808|524494618|FG000|Overall Study|Withdrawal by Subject|1|||
145448955|NCT01575808|524494619|FG001|Overall Study|Withdrawal by Subject|0|||
145585668|NCT00874029|524997627|FG000|Overall Study|Lost to Follow-up|5|||
145448956|NCT00064259|524496431|FG000|Overall Study|Adverse Event|1|||
145448957|NCT00064259|524496432|FG001|Overall Study|Adverse Event|0|||
145585669|NCT02937545|524997634|FG000|Overall Study|Withdrawal by Subject|1|||
145585670|NCT02937545|524997635|FG001|Overall Study|Withdrawal by Subject|2|||
145448958|NCT00064259|524496433|FG002|Overall Study|Adverse Event|0|||
145448959|NCT00064259|524496434|FG003|Overall Study|Adverse Event|1|||
145448960|NCT01132651|524496437|FG000|Overall Study|Lost to Follow-up|1|||
145626027|NCT03635112|525144146|FG000|Overall Study|Study Terminated by Sponsor|11|||
145626028|NCT03635112|525144147|FG001|Overall Study|Study Terminated by Sponsor|17|||
145626029|NCT03635112|525144148|FG002|Overall Study|Study Terminated by Sponsor|21|||
145626030|NCT03635112|525144146|FG000|Overall Study|Withdrawal by Subject|4|||
145626031|NCT03635112|525144147|FG001|Overall Study|Withdrawal by Subject|9|||
145626032|NCT03635112|525144148|FG002|Overall Study|Withdrawal by Subject|7|||
145626033|NCT03635112|525144146|FG000|Overall Study|Miscellaneous|0|||
145626034|NCT03635112|525144147|FG001|Overall Study|Miscellaneous|0|||
145626035|NCT03635112|525144148|FG002|Overall Study|Miscellaneous|1|||
145626036|NCT01360840|525144149|FG000|Overall Study|Ongoing at data cut-off|10|||
145448961|NCT01132651|524496438|FG001|Overall Study|Lost to Follow-up|1|||
145448962|NCT00948857|524496439|FG000|Overall Study|Lost to Follow-up|1|||
145448963|NCT00948857|524496440|FG001|Overall Study|Lost to Follow-up|0|||
145448964|NCT03430843|524496444|FG000|Overall Study|Death|233|||
145448965|NCT03430843|524496445|FG001|Overall Study|Death|233|||
145448966|NCT03430843|524496444|FG000|Overall Study|Sponsor Decision|17|||
145448967|NCT03430843|524496445|FG001|Overall Study|Sponsor Decision|6|||
145448968|NCT03430843|524496444|FG000|Overall Study|Withdrawal by Subject|5|||
145448969|NCT03430843|524496445|FG001|Overall Study|Withdrawal by Subject|14|||
145448970|NCT03430843|524496444|FG000|Overall Study|Lost to Follow-up|1|||
145448971|NCT03430843|524496445|FG001|Overall Study|Lost to Follow-up|3|||
145448972|NCT05396014|524496450|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
145448973|NCT05396014|524496451|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448974|NCT05396014|524496452|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448975|NCT05396014|524496453|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448976|NCT05396014|524496454|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448977|NCT05396014|524496455|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448978|NCT05396014|524496456|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448979|NCT05396014|524496457|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448980|NCT05396014|524496458|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448981|NCT05396014|524496459|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448982|NCT05396014|524496460|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448983|NCT05396014|524496461|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448984|NCT05396014|524496462|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448985|NCT05396014|524496463|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
145448986|NCT05396014|524496464|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448987|NCT05396014|524496465|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448988|NCT05396014|524496466|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448989|NCT05396014|524496467|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448990|NCT05396014|524496468|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448991|NCT05396014|524496469|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448992|NCT05396014|524496470|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448993|NCT05396014|524496471|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448994|NCT05396014|524496472|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448995|NCT05396014|524496473|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448996|NCT05396014|524496474|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448997|NCT05396014|524496475|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145448998|NCT05396014|524496476|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
145448999|NCT05396014|524496477|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449000|NCT05396014|524496478|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449001|NCT05396014|524496479|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449002|NCT05396014|524496480|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449003|NCT05396014|524496481|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449004|NCT05396014|524496482|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449005|NCT05396014|524496483|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449006|NCT05396014|524496484|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449007|NCT05396014|524496485|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449008|NCT05396014|524496486|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449009|NCT05396014|524496487|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449010|NCT05396014|524496488|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449011|NCT05396014|524496489|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
145626037|NCT01360840|525144150|FG001|Overall Study|Ongoing at data cut-off|10|||
145626038|NCT01360840|525144151|FG002|Overall Study|Ongoing at data cut-off|9|||
145449012|NCT05396014|524496490|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449013|NCT05396014|524496491|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449014|NCT05396014|524496492|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
145449015|NCT05396014|524496450|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
145449016|NCT05396014|524496451|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449017|NCT05396014|524496452|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449018|NCT05396014|524496453|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449019|NCT05396014|524496454|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449020|NCT05396014|524496455|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449021|NCT05396014|524496456|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449022|NCT05396014|524496457|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449023|NCT05396014|524496458|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449024|NCT05396014|524496459|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449025|NCT05396014|524496460|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449026|NCT05396014|524496461|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449027|NCT05396014|524496462|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449028|NCT05396014|524496463|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
145449029|NCT05396014|524496464|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449030|NCT05396014|524496465|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449031|NCT05396014|524496466|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449032|NCT05396014|524496467|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449033|NCT05396014|524496468|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449034|NCT05396014|524496469|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449035|NCT05396014|524496470|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449036|NCT05396014|524496471|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449037|NCT05396014|524496472|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449038|NCT05396014|524496473|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449039|NCT05396014|524496474|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449040|NCT05396014|524496475|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449041|NCT05396014|524496476|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
145449042|NCT05396014|524496477|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449043|NCT05396014|524496478|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449044|NCT05396014|524496479|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449045|NCT05396014|524496480|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449046|NCT05396014|524496481|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449047|NCT05396014|524496482|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449048|NCT05396014|524496483|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449049|NCT05396014|524496484|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449050|NCT05396014|524496485|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449051|NCT05396014|524496486|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449052|NCT05396014|524496487|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449053|NCT05396014|524496488|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449054|NCT05396014|524496489|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
145449055|NCT05396014|524496490|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449056|NCT05396014|524496491|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449057|NCT05396014|524496492|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
145449058|NCT05396014|524496450|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
145449059|NCT05396014|524496451|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449060|NCT05396014|524496452|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449061|NCT05396014|524496453|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449062|NCT05396014|524496454|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449063|NCT05396014|524496455|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449064|NCT05396014|524496456|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449065|NCT05396014|524496457|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449066|NCT05396014|524496458|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449067|NCT05396014|524496459|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449068|NCT05396014|524496460|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449069|NCT05396014|524496461|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449070|NCT05396014|524496462|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449071|NCT05396014|524496463|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
145449072|NCT05396014|524496464|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449073|NCT05396014|524496465|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449074|NCT05396014|524496466|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145626039|NCT04296942|525144152|FG000|Overall Study|Study closure by sponsor|1|||
145449075|NCT05396014|524496467|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449076|NCT05396014|524496468|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449077|NCT05396014|524496469|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449078|NCT05396014|524496470|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449079|NCT05396014|524496471|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449080|NCT05396014|524496472|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145626040|NCT04296942|525144153|FG001|Overall Study|Study closure by sponsor|0|||
145449081|NCT05396014|524496473|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449082|NCT05396014|524496474|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449083|NCT05396014|524496475|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449084|NCT05396014|524496476|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
145449085|NCT05396014|524496477|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449086|NCT05396014|524496478|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449087|NCT05396014|524496479|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449088|NCT05396014|524496480|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449089|NCT05396014|524496481|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449090|NCT05396014|524496482|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449091|NCT05396014|524496483|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449092|NCT05396014|524496484|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449093|NCT05396014|524496485|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449094|NCT05396014|524496486|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449095|NCT05396014|524496487|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449096|NCT05396014|524496488|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449097|NCT05396014|524496489|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
145449098|NCT05396014|524496490|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449099|NCT05396014|524496491|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449100|NCT05396014|524496492|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
145449101|NCT05396014|524496450|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449102|NCT05396014|524496451|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449103|NCT05396014|524496452|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449104|NCT05396014|524496453|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449105|NCT05396014|524496454|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449106|NCT05396014|524496455|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449107|NCT05396014|524496456|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449108|NCT05396014|524496457|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449109|NCT05396014|524496458|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449110|NCT05396014|524496459|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449111|NCT05396014|524496460|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145585671|NCT02937545|524997636|FG002|Overall Study|Withdrawal by Subject|6|||
145585672|NCT02937545|524997637|FG003|Overall Study|Withdrawal by Subject|7|||
145585673|NCT02937545|524997634|FG000|Overall Study|Lost to Follow-up|1|||
145585674|NCT02937545|524997635|FG001|Overall Study|Lost to Follow-up|0|||
145585675|NCT02937545|524997636|FG002|Overall Study|Lost to Follow-up|0|||
145585676|NCT02937545|524997637|FG003|Overall Study|Lost to Follow-up|0|||
145449112|NCT05396014|524496461|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449113|NCT05396014|524496462|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449114|NCT05396014|524496463|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449115|NCT05396014|524496464|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449116|NCT05396014|524496465|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449117|NCT05396014|524496466|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449118|NCT05396014|524496467|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449119|NCT05396014|524496468|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449120|NCT05396014|524496469|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449121|NCT05396014|524496470|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449122|NCT05396014|524496471|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449123|NCT05396014|524496472|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449124|NCT05396014|524496473|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449125|NCT05396014|524496474|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449126|NCT05396014|524496475|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449127|NCT05396014|524496476|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
145449128|NCT05396014|524496477|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449129|NCT05396014|524496478|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449130|NCT05396014|524496479|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449131|NCT05396014|524496480|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449132|NCT05396014|524496481|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449133|NCT05396014|524496482|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449134|NCT05396014|524496483|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449135|NCT05396014|524496484|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449136|NCT05396014|524496485|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449137|NCT05396014|524496486|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449138|NCT05396014|524496487|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449139|NCT05396014|524496488|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145585677|NCT02007577|524997640|FG000|Overall Study|Adverse Event|1|||
145585678|NCT02007577|524997641|FG001|Overall Study|Adverse Event|0|||
145585679|NCT02007577|524997640|FG000|Overall Study|Withdrawal by Subject|0|||
145449140|NCT05396014|524496489|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
145449141|NCT05396014|524496490|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449142|NCT05396014|524496491|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449143|NCT05396014|524496492|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
145449144|NCT05396014|524496450|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449145|NCT05396014|524496451|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449146|NCT05396014|524496452|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449147|NCT05396014|524496453|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449148|NCT05396014|524496454|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449149|NCT05396014|524496455|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449150|NCT05396014|524496456|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449151|NCT05396014|524496457|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449152|NCT05396014|524496458|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449153|NCT05396014|524496459|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449154|NCT05396014|524496460|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449155|NCT05396014|524496461|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449156|NCT05396014|524496462|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449157|NCT05396014|524496463|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449158|NCT05396014|524496464|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449159|NCT05396014|524496465|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449160|NCT05396014|524496466|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449161|NCT05396014|524496467|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449162|NCT05396014|524496468|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449163|NCT05396014|524496469|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449164|NCT05396014|524496470|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449165|NCT05396014|524496471|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449166|NCT05396014|524496472|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449167|NCT05396014|524496473|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449168|NCT05396014|524496474|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449169|NCT05396014|524496475|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449170|NCT05396014|524496476|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
145449171|NCT05396014|524496477|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449172|NCT05396014|524496478|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449173|NCT05396014|524496479|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449174|NCT05396014|524496480|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449175|NCT05396014|524496481|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449176|NCT05396014|524496482|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449177|NCT05396014|524496483|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449178|NCT05396014|524496484|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449179|NCT05396014|524496485|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449180|NCT05396014|524496486|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449181|NCT05396014|524496487|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449182|NCT05396014|524496488|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449183|NCT05396014|524496489|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449184|NCT05396014|524496490|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449185|NCT05396014|524496491|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449186|NCT05396014|524496492|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
145449187|NCT05396014|524496450|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449188|NCT05396014|524496451|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449189|NCT05396014|524496452|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449190|NCT05396014|524496453|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449191|NCT05396014|524496454|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449192|NCT05396014|524496455|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449193|NCT05396014|524496456|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449194|NCT05396014|524496457|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449195|NCT05396014|524496458|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449196|NCT05396014|524496459|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449197|NCT05396014|524496460|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449198|NCT05396014|524496461|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449199|NCT05396014|524496462|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449200|NCT05396014|524496463|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
145449201|NCT05396014|524496464|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449202|NCT05396014|524496465|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449203|NCT05396014|524496466|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449204|NCT05396014|524496467|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145585680|NCT02007577|524997641|FG001|Overall Study|Withdrawal by Subject|1|||
145585681|NCT00968669|524997642|FG000|Overall Study|Lost to Follow-up|5|||
145585682|NCT00968669|524997643|FG001|Overall Study|Lost to Follow-up|2|||
145585683|NCT00968669|524997644|FG002|Overall Study|Lost to Follow-up|1|||
145585684|NCT00968669|524997645|FG003|Overall Study|Lost to Follow-up|4|||
145585685|NCT00968669|524997642|FG000|Overall Study|Withdrawal by Subject|9|||
145585686|NCT00968669|524997643|FG001|Overall Study|Withdrawal by Subject|7|||
145449205|NCT05396014|524496468|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449206|NCT05396014|524496469|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449207|NCT05396014|524496470|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449208|NCT05396014|524496471|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449209|NCT05396014|524496472|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449210|NCT05396014|524496473|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449211|NCT05396014|524496474|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449212|NCT05396014|524496475|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449213|NCT05396014|524496476|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449214|NCT05396014|524496477|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449215|NCT05396014|524496478|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449216|NCT05396014|524496479|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449217|NCT05396014|524496480|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449218|NCT05396014|524496481|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449219|NCT05396014|524496482|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449220|NCT05396014|524496483|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449221|NCT05396014|524496484|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449222|NCT05396014|524496485|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449223|NCT05396014|524496486|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449224|NCT05396014|524496487|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449225|NCT05396014|524496488|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449226|NCT05396014|524496489|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449227|NCT05396014|524496490|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449228|NCT05396014|524496491|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449229|NCT05396014|524496492|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
145449230|NCT05396014|524496450|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
145449231|NCT05396014|524496451|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449232|NCT05396014|524496452|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449233|NCT05396014|524496453|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449234|NCT05396014|524496454|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449235|NCT05396014|524496455|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449236|NCT05396014|524496456|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449237|NCT05396014|524496457|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449238|NCT05396014|524496458|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449239|NCT05396014|524496459|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449240|NCT05396014|524496460|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449241|NCT05396014|524496461|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449242|NCT05396014|524496462|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449243|NCT05396014|524496463|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
145449244|NCT05396014|524496464|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449245|NCT05396014|524496465|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449246|NCT05396014|524496466|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449247|NCT05396014|524496467|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449248|NCT05396014|524496468|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449249|NCT05396014|524496469|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449250|NCT05396014|524496470|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449251|NCT05396014|524496471|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449252|NCT05396014|524496472|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449253|NCT05396014|524496473|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449254|NCT05396014|524496474|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449255|NCT05396014|524496475|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449256|NCT05396014|524496476|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449257|NCT05396014|524496477|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449258|NCT05396014|524496478|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449259|NCT05396014|524496479|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449260|NCT05396014|524496480|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145585687|NCT00968669|524997644|FG002|Overall Study|Withdrawal by Subject|5|||
145449261|NCT05396014|524496481|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449262|NCT05396014|524496482|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449263|NCT05396014|524496483|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449264|NCT05396014|524496484|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449265|NCT05396014|524496485|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449266|NCT05396014|524496486|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449267|NCT05396014|524496487|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449268|NCT05396014|524496488|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449269|NCT05396014|524496489|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
145449270|NCT05396014|524496490|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449271|NCT05396014|524496491|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449272|NCT05396014|524496492|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
145449273|NCT05396014|524496450|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
145449274|NCT05396014|524496451|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449275|NCT05396014|524496452|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449276|NCT05396014|524496453|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449277|NCT05396014|524496454|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449278|NCT05396014|524496455|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449279|NCT05396014|524496456|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449280|NCT05396014|524496457|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449281|NCT05396014|524496458|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449282|NCT05396014|524496459|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449283|NCT05396014|524496460|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449284|NCT05396014|524496461|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449285|NCT05396014|524496462|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449286|NCT05396014|524496463|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449287|NCT05396014|524496464|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449288|NCT05396014|524496465|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449289|NCT05396014|524496466|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449290|NCT05396014|524496467|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449291|NCT05396014|524496468|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449292|NCT05396014|524496469|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449293|NCT05396014|524496470|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449294|NCT05396014|524496471|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449295|NCT05396014|524496472|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449296|NCT05396014|524496473|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449297|NCT05396014|524496474|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449298|NCT05396014|524496475|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449299|NCT05396014|524496476|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
145449300|NCT05396014|524496477|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449301|NCT05396014|524496478|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449302|NCT05396014|524496479|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449303|NCT05396014|524496480|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449304|NCT05396014|524496481|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449305|NCT05396014|524496482|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449306|NCT05396014|524496483|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449307|NCT05396014|524496484|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449308|NCT05396014|524496485|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449309|NCT05396014|524496486|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449310|NCT05396014|524496487|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449311|NCT05396014|524496488|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449312|NCT05396014|524496489|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449313|NCT05396014|524496490|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449314|NCT05396014|524496491|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449315|NCT05396014|524496492|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
145449316|NCT05396014|524496450|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449317|NCT05396014|524496451|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449318|NCT05396014|524496452|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449319|NCT05396014|524496453|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449320|NCT05396014|524496454|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449321|NCT05396014|524496455|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145585688|NCT00968669|524997645|FG003|Overall Study|Withdrawal by Subject|3|||
145449322|NCT05396014|524496456|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449323|NCT05396014|524496457|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145585689|NCT00968669|524997642|FG000|Overall Study|Pregnancy|0|||
145585690|NCT00968669|524997643|FG001|Overall Study|Pregnancy|0|||
145449324|NCT05396014|524496458|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449325|NCT05396014|524496459|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449326|NCT05396014|524496460|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449327|NCT05396014|524496461|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449328|NCT05396014|524496462|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449329|NCT05396014|524496463|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
145449330|NCT05396014|524496464|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449331|NCT05396014|524496465|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449332|NCT05396014|524496466|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449333|NCT05396014|524496467|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449334|NCT05396014|524496468|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449335|NCT05396014|524496469|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449336|NCT05396014|524496470|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449337|NCT05396014|524496471|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449338|NCT05396014|524496472|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449339|NCT05396014|524496473|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449340|NCT05396014|524496474|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449341|NCT05396014|524496475|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449342|NCT05396014|524496476|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449343|NCT05396014|524496477|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449344|NCT05396014|524496478|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449345|NCT05396014|524496479|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449346|NCT05396014|524496480|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145626041|NCT04296942|525144154|FG002|Overall Study|Study closure by sponsor|0|||
145626042|NCT00530777|525144160|FG000|Overall Study|Lost to Follow-up|0|||
145626043|NCT00530777|525144161|FG001|Overall Study|Lost to Follow-up|1|||
145626044|NCT00530777|525144160|FG000|Overall Study|Death|1|||
145626045|NCT00530777|525144161|FG001|Overall Study|Death|2|||
145626046|NCT00530777|525144160|FG000|Overall Study|Physician Decision|1|||
145626047|NCT00530777|525144161|FG001|Overall Study|Physician Decision|0|||
145626048|NCT00530777|525144160|FG000|Overall Study|Withdrawal by Subject|0|||
145626049|NCT00530777|525144161|FG001|Overall Study|Withdrawal by Subject|1|||
145626050|NCT00530777|525144160|FG000|Overall Study|Unable to adhere to visit schedule|5|||
145626051|NCT00530777|525144161|FG001|Overall Study|Unable to adhere to visit schedule|1|||
145626052|NCT01582243|525144166|FG000|Overall Study|Withdrawal by Subject|1|||
145626053|NCT01582243|525144166|FG000|Overall Study|Adverse Event|1|||
145626054|NCT01582243|525144166|FG000|Overall Study|Lost to Follow-up|1|||
145449347|NCT05396014|524496481|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449348|NCT05396014|524496482|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449349|NCT05396014|524496483|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449350|NCT05396014|524496484|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449351|NCT05396014|524496485|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449352|NCT05396014|524496486|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449353|NCT05396014|524496487|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449354|NCT05396014|524496488|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449355|NCT05396014|524496489|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449356|NCT05396014|524496490|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449357|NCT05396014|524496491|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449358|NCT05396014|524496492|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
145449359|NCT05396014|524496450|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449360|NCT05396014|524496451|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449361|NCT05396014|524496452|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449362|NCT05396014|524496453|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
145449363|NCT05396014|524496454|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449364|NCT05396014|524496455|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449365|NCT05396014|524496456|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449366|NCT05396014|524496457|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449367|NCT05396014|524496458|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
145449368|NCT05396014|524496459|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449369|NCT05396014|524496460|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449370|NCT05396014|524496461|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449371|NCT05396014|524496462|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449372|NCT05396014|524496463|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449373|NCT05396014|524496464|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449374|NCT05396014|524496465|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145626055|NCT03382821|525144167|FG000|Overall Study|Did not receive allocated intervention.|0|||
145626056|NCT03382821|525144168|FG001|Overall Study|Did not receive allocated intervention.|3|||
145626057|NCT02096003|525144170|FG000|Overall Study|Protocol Violation|0|||
145449375|NCT05396014|524496466|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449376|NCT05396014|524496467|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449377|NCT05396014|524496468|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449378|NCT05396014|524496469|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449379|NCT05396014|524496470|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449380|NCT05396014|524496471|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449381|NCT05396014|524496472|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449382|NCT05396014|524496473|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449383|NCT05396014|524496474|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449384|NCT05396014|524496475|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
145449385|NCT05396014|524496476|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449386|NCT05396014|524496477|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449387|NCT05396014|524496478|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449388|NCT05396014|524496479|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449389|NCT05396014|524496480|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449390|NCT05396014|524496481|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449391|NCT05396014|524496482|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449392|NCT05396014|524496483|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449393|NCT05396014|524496484|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449394|NCT05396014|524496485|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449395|NCT05396014|524496486|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449396|NCT05396014|524496487|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449397|NCT05396014|524496488|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449398|NCT05396014|524496489|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
145449399|NCT05396014|524496490|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
145449400|NCT05396014|524496491|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
145449401|NCT05396014|524496492|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
145449402|NCT05396014|524496450|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449403|NCT05396014|524496451|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449404|NCT05396014|524496452|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449405|NCT05396014|524496453|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449406|NCT05396014|524496454|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449407|NCT05396014|524496455|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449408|NCT05396014|524496456|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449409|NCT05396014|524496457|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449410|NCT05396014|524496458|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
145449411|NCT05396014|524496459|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449412|NCT05396014|524496460|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449413|NCT05396014|524496461|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449414|NCT05396014|524496462|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449415|NCT05396014|524496463|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449416|NCT05396014|524496464|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449417|NCT05396014|524496465|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449418|NCT05396014|524496466|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449419|NCT05396014|524496467|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449420|NCT05396014|524496468|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449421|NCT05396014|524496469|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449422|NCT05396014|524496470|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449423|NCT05396014|524496471|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449424|NCT05396014|524496472|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
145449425|NCT05396014|524496473|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449426|NCT05396014|524496474|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449427|NCT05396014|524496475|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449428|NCT05396014|524496476|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449429|NCT05396014|524496477|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449430|NCT05396014|524496478|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449431|NCT05396014|524496479|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145585691|NCT00968669|524997644|FG002|Overall Study|Pregnancy|2|||
145585692|NCT00968669|524997645|FG003|Overall Study|Pregnancy|0|||
145585693|NCT00968669|524997642|FG000|Overall Study|AE|1|||
145585694|NCT00968669|524997643|FG001|Overall Study|AE|0|||
145449432|NCT05396014|524496480|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449433|NCT05396014|524496481|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449434|NCT05396014|524496482|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145585695|NCT00968669|524997644|FG002|Overall Study|AE|0|||
145449435|NCT05396014|524496483|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145585696|NCT00968669|524997645|FG003|Overall Study|AE|0|||
145449436|NCT05396014|524496484|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449437|NCT05396014|524496485|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
145449438|NCT05396014|524496486|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449439|NCT05396014|524496487|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449440|NCT05396014|524496488|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449441|NCT05396014|524496489|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
145449442|NCT05396014|524496490|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449443|NCT05396014|524496491|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
145449444|NCT05396014|524496492|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
145449445|NCT05396014|524496450|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449446|NCT05396014|524496451|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449447|NCT05396014|524496452|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449448|NCT05396014|524496453|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449449|NCT05396014|524496454|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449450|NCT05396014|524496455|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449451|NCT05396014|524496456|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449452|NCT05396014|524496457|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449453|NCT05396014|524496458|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449454|NCT05396014|524496459|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449455|NCT05396014|524496460|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449456|NCT05396014|524496461|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449457|NCT05396014|524496462|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449458|NCT05396014|524496463|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
145449459|NCT05396014|524496464|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449460|NCT05396014|524496465|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449461|NCT05396014|524496466|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449462|NCT05396014|524496467|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449463|NCT05396014|524496468|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449464|NCT05396014|524496469|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449465|NCT05396014|524496470|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449466|NCT05396014|524496471|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449467|NCT05396014|524496472|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449468|NCT05396014|524496473|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449469|NCT05396014|524496474|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449470|NCT05396014|524496475|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449471|NCT05396014|524496476|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
145449472|NCT05396014|524496477|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449473|NCT05396014|524496478|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449474|NCT05396014|524496479|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449475|NCT05396014|524496480|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449476|NCT05396014|524496481|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449477|NCT05396014|524496482|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449478|NCT05396014|524496483|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449479|NCT05396014|524496484|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
145585697|NCT00968669|524997642|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
145585698|NCT00968669|524997643|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
145585699|NCT00968669|524997644|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
145585700|NCT00968669|524997645|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
145585701|NCT00968669|524997642|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
145585702|NCT00968669|524997643|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
145585703|NCT00968669|524997644|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
145585704|NCT00968669|524997645|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
145585705|NCT00968669|524997642|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
145585706|NCT00968669|524997643|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
145585707|NCT00968669|524997644|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
145585708|NCT00968669|524997645|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
145585709|NCT00968669|524997642|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
145585710|NCT00968669|524997643|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
145585711|NCT00968669|524997644|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
145585712|NCT00968669|524997645|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
145585713|NCT00968669|524997642|FG000|Overall Study|EARLY WITHDRAWAL|0|||
145585714|NCT00968669|524997643|FG001|Overall Study|EARLY WITHDRAWAL|1|||
145585715|NCT00968669|524997644|FG002|Overall Study|EARLY WITHDRAWAL|0|||
145585716|NCT00968669|524997645|FG003|Overall Study|EARLY WITHDRAWAL|0|||
145449480|NCT05396014|524496485|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449481|NCT05396014|524496486|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449482|NCT05396014|524496487|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449483|NCT05396014|524496488|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449484|NCT05396014|524496489|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145626058|NCT02096003|525144171|FG001|Overall Study|Protocol Violation|2|||
145626059|NCT02096003|525144170|FG000|Overall Study|additional surgery|2|||
145626060|NCT02096003|525144171|FG001|Overall Study|additional surgery|1|||
145626061|NCT03178201|525144172|FG000|Overall Study|Off study|5|||
145626062|NCT02487446|525144186|FG000|Period 1|Physician Decision|0|||
145626063|NCT02487446|525144187|FG001|Period 1|Physician Decision|1|||
145626064|NCT02487446|525144186|FG000|Period 1|Lack of Efficacy|1|||
145626065|NCT02487446|525144187|FG001|Period 1|Lack of Efficacy|0|||
145626066|NCT02487446|525144186|FG000|Period 1|Protocol deviation|3|||
145626067|NCT02487446|525144187|FG001|Period 1|Protocol deviation|2|||
145626068|NCT02487446|525144186|FG000|Period 1|Lost to Follow-up|2|||
145626069|NCT02487446|525144187|FG001|Period 1|Lost to Follow-up|0|||
145626070|NCT02487446|525144186|FG000|Period 1|Withdrawal by Subject|2|||
145626071|NCT02487446|525144187|FG001|Period 1|Withdrawal by Subject|0|||
145626072|NCT02487446|525144186|FG000|Period 1|Adverse Event|5|||
145626073|NCT02487446|525144187|FG001|Period 1|Adverse Event|5|||
145626074|NCT02487446|525144186|FG000|Washout|Lost to Follow-up|0|||
145626075|NCT02487446|525144187|FG001|Washout|Lost to Follow-up|2|||
145626076|NCT02487446|525144186|FG000|Washout|Withdrawal by Subject|1|||
145626077|NCT02487446|525144187|FG001|Washout|Withdrawal by Subject|4|||
145626078|NCT02487446|525144186|FG000|Washout|Adverse Event|2|||
145626079|NCT02487446|525144187|FG001|Washout|Adverse Event|2|||
145626080|NCT02487446|525144186|FG000|Period 2|Protocol deviation|0|||
145626081|NCT02487446|525144187|FG001|Period 2|Protocol deviation|1|||
145626082|NCT02487446|525144186|FG000|Period 2|Lost to Follow-up|1|||
145626083|NCT02487446|525144187|FG001|Period 2|Lost to Follow-up|1|||
145626084|NCT02487446|525144186|FG000|Period 2|Withdrawal by Subject|1|||
145626085|NCT02487446|525144187|FG001|Period 2|Withdrawal by Subject|1|||
145626086|NCT02487446|525144186|FG000|Period 2|Adverse Event|6|||
145626087|NCT02487446|525144187|FG001|Period 2|Adverse Event|2|||
145626088|NCT01822821|525144188|FG000|Overall Study|Eligible surgery cancelled|1|||
145626089|NCT01822821|525144189|FG001|Overall Study|Eligible surgery cancelled|1|||
145626090|NCT01822821|525144188|FG000|Overall Study|Other reasons|1|||
145626091|NCT01822821|525144189|FG001|Overall Study|Other reasons|0|||
145626092|NCT02320253|525144190|FG000|Overall Study|Withdrawal by Subject|3|||
145626093|NCT02320253|525144191|FG001|Overall Study|Withdrawal by Subject|0|||
145626094|NCT02320253|525144192|FG002|Overall Study|Withdrawal by Subject|0|||
145626095|NCT02320253|525144190|FG000|Overall Study|Lost to Follow-up|2|||
145626096|NCT02320253|525144191|FG001|Overall Study|Lost to Follow-up|2|||
145626097|NCT02320253|525144192|FG002|Overall Study|Lost to Follow-up|1|||
145626098|NCT02320253|525144190|FG000|Overall Study|Death|1|||
145626099|NCT02320253|525144191|FG001|Overall Study|Death|0|||
145626100|NCT02320253|525144192|FG002|Overall Study|Death|1|||
145626101|NCT05750745|525144193|FG000|Overall Study|Adverse Event|1|||
145626102|NCT05750745|525144194|FG001|Overall Study|Adverse Event|0|||
145626103|NCT05750745|525144195|FG002|Overall Study|Adverse Event|0|||
145626104|NCT05750745|525144193|FG000|Overall Study|Protocol Violation|1|||
145626105|NCT05750745|525144194|FG001|Overall Study|Protocol Violation|0|||
145626106|NCT05750745|525144195|FG002|Overall Study|Protocol Violation|0|||
145626107|NCT05750745|525144193|FG000|Overall Study|Withdrawal by Subject|0|||
145626108|NCT05750745|525144194|FG001|Overall Study|Withdrawal by Subject|1|||
145626109|NCT05750745|525144195|FG002|Overall Study|Withdrawal by Subject|0|||
145626110|NCT05780047|525144197|FG000|Overall Study|Did not submit baseline urine test kit|226|||
145626111|NCT05780047|525144197|FG000|Overall Study|Lost to Follow-up|34|||
145626112|NCT05780047|525144197|FG000|Overall Study|Did not submit second urine test kit|124|||
145626113|NCT00783692|525144207|FG000|Induction Phase|Adverse Event|7|||
145626114|NCT00783692|525144208|FG001|Induction Phase|Adverse Event|9|||
145626115|NCT00783692|525144209|FG002|Induction Phase|Adverse Event|24|||
145626116|NCT00783692|525144210|FG003|Induction Phase|Adverse Event|0|||
145626117|NCT00783692|525144211|FG004|Induction Phase|Adverse Event|0|||
145626118|NCT00783692|525144212|FG005|Induction Phase|Adverse Event|0|||
145626119|NCT00783692|525144213|FG006|Induction Phase|Adverse Event|0|||
145626120|NCT00783692|525144207|FG000|Induction Phase|Protocol Violation|0|||
145626121|NCT00783692|525144208|FG001|Induction Phase|Protocol Violation|0|||
145626122|NCT00783692|525144209|FG002|Induction Phase|Protocol Violation|1|||
145626123|NCT00783692|525144210|FG003|Induction Phase|Protocol Violation|0|||
145626124|NCT00783692|525144211|FG004|Induction Phase|Protocol Violation|0|||
145626125|NCT00783692|525144212|FG005|Induction Phase|Protocol Violation|0|||
145626126|NCT00783692|525144213|FG006|Induction Phase|Protocol Violation|0|||
145626127|NCT00783692|525144207|FG000|Induction Phase|Lack of Efficacy|1|||
145626128|NCT00783692|525144208|FG001|Induction Phase|Lack of Efficacy|3|||
145626129|NCT00783692|525144209|FG002|Induction Phase|Lack of Efficacy|28|||
145626130|NCT00783692|525144210|FG003|Induction Phase|Lack of Efficacy|0|||
145626131|NCT00783692|525144211|FG004|Induction Phase|Lack of Efficacy|0|||
145626132|NCT00783692|525144212|FG005|Induction Phase|Lack of Efficacy|0|||
145626133|NCT00783692|525144213|FG006|Induction Phase|Lack of Efficacy|0|||
145626134|NCT00783692|525144207|FG000|Induction Phase|Withdrawal by Subject|3|||
145626135|NCT00783692|525144208|FG001|Induction Phase|Withdrawal by Subject|9|||
145626136|NCT00783692|525144209|FG002|Induction Phase|Withdrawal by Subject|16|||
145626137|NCT00783692|525144210|FG003|Induction Phase|Withdrawal by Subject|0|||
145449485|NCT05396014|524496490|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449486|NCT05396014|524496491|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
145449487|NCT05396014|524496492|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
145449488|NCT05396014|524496450|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449489|NCT05396014|524496451|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449490|NCT05396014|524496452|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449491|NCT05396014|524496453|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449492|NCT05396014|524496454|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449493|NCT05396014|524496455|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449494|NCT05396014|524496456|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449495|NCT05396014|524496457|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449496|NCT05396014|524496458|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449497|NCT05396014|524496459|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449498|NCT05396014|524496460|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449499|NCT05396014|524496461|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449500|NCT05396014|524496462|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449501|NCT05396014|524496463|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449502|NCT05396014|524496464|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449503|NCT05396014|524496465|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449504|NCT05396014|524496466|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449505|NCT05396014|524496467|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449506|NCT05396014|524496468|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449507|NCT05396014|524496469|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449508|NCT05396014|524496470|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449509|NCT05396014|524496471|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145585717|NCT00968669|524997642|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
145585718|NCT00968669|524997643|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
145585719|NCT00968669|524997644|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
145585720|NCT00968669|524997645|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
145585721|NCT00968669|524997642|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
145585722|NCT00968669|524997643|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
145585723|NCT00968669|524997644|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
145585724|NCT00968669|524997645|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
145585725|NCT00968669|524997642|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
145585726|NCT00968669|524997643|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
145585727|NCT00968669|524997644|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
145585728|NCT00968669|524997645|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
145585729|NCT00968669|524997642|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
145585730|NCT00968669|524997643|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
145585731|NCT00968669|524997644|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
145585732|NCT00968669|524997645|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
145585733|NCT00968669|524997642|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
145585734|NCT00968669|524997643|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
145585735|NCT00968669|524997644|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
145585736|NCT00968669|524997645|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
145585737|NCT00968669|524997642|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
145585738|NCT00968669|524997643|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
145585739|NCT00968669|524997644|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
145585740|NCT00968669|524997645|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
145585741|NCT00968669|524997642|FG000|Overall Study|SPONSOR DECISION|0|||
145585742|NCT00968669|524997643|FG001|Overall Study|SPONSOR DECISION|1|||
145585743|NCT00968669|524997644|FG002|Overall Study|SPONSOR DECISION|0|||
145585744|NCT00968669|524997645|FG003|Overall Study|SPONSOR DECISION|0|||
145585745|NCT00968669|524997642|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
145585746|NCT00968669|524997643|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
145585747|NCT00968669|524997644|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
145585748|NCT00968669|524997645|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
145585749|NCT00968669|524997642|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
145585750|NCT00968669|524997643|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
145585751|NCT00968669|524997644|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
145585752|NCT00968669|524997645|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
145585753|NCT00968669|524997642|FG000|Overall Study|SUBJECT INCARCERATED|0|||
145585754|NCT00968669|524997643|FG001|Overall Study|SUBJECT INCARCERATED|1|||
145449510|NCT05396014|524496472|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145585755|NCT00968669|524997644|FG002|Overall Study|SUBJECT INCARCERATED|0|||
145585756|NCT00968669|524997645|FG003|Overall Study|SUBJECT INCARCERATED|0|||
145585757|NCT00968669|524997642|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
145585758|NCT00968669|524997643|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
145449511|NCT05396014|524496473|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449512|NCT05396014|524496474|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449513|NCT05396014|524496475|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449514|NCT05396014|524496476|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
145449515|NCT05396014|524496477|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449516|NCT05396014|524496478|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449517|NCT05396014|524496479|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449518|NCT05396014|524496480|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449519|NCT05396014|524496481|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449520|NCT05396014|524496482|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449521|NCT05396014|524496483|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449522|NCT05396014|524496484|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449523|NCT05396014|524496485|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449524|NCT05396014|524496486|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449525|NCT05396014|524496487|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449526|NCT05396014|524496488|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449527|NCT05396014|524496489|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449528|NCT05396014|524496490|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449529|NCT05396014|524496491|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449530|NCT05396014|524496492|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
145449531|NCT04439539|524496495|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
145449532|NCT04439539|524496496|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
145449533|NCT04439539|524496497|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
145449534|NCT04439539|524496495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
145449535|NCT04439539|524496496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
145449536|NCT04439539|524496497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
145449537|NCT04439539|524496495|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
145449538|NCT04439539|524496496|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
145449539|NCT04439539|524496497|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
145449540|NCT01519791|524496504|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
145449541|NCT01519791|524496505|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
145449542|NCT01519791|524496504|FG000|Overall Study|Protocol Violation|6|||
145449543|NCT01519791|524496505|FG001|Overall Study|Protocol Violation|19|||
145449544|NCT01519791|524496504|FG000|Overall Study|Other Reason|87|||
145449545|NCT01519791|524496505|FG001|Overall Study|Other Reason|222|||
145449546|NCT01519791|524496504|FG000|Overall Study|subjects randomized in error|2|||
145449547|NCT01519791|524496505|FG001|Overall Study|subjects randomized in error|0|||
145449548|NCT01519791|524496504|FG000|Overall Study|Lack of Efficacy|16|||
145449549|NCT01519791|524496505|FG001|Overall Study|Lack of Efficacy|20|||
145449550|NCT01519791|524496504|FG000|Overall Study|SAE, non-fatal|6|||
145449551|NCT01519791|524496505|FG001|Overall Study|SAE, non-fatal|22|||
145449552|NCT01519791|524496504|FG000|Overall Study|AE, serious fatal|0|||
145449553|NCT01519791|524496505|FG001|Overall Study|AE, serious fatal|1|||
145449554|NCT01519791|524496504|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
145449555|NCT01519791|524496505|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
145449556|NCT01519791|524496504|FG000|Overall Study|AE, non-serious non-fatal|12|||
145449557|NCT01519791|524496505|FG001|Overall Study|AE, non-serious non-fatal|31|||
145449558|NCT01519791|524496504|FG000|Overall Study|Withdrawal by Subject|15|||
145449559|NCT01519791|524496505|FG001|Overall Study|Withdrawal by Subject|37|||
145449560|NCT01519791|524496504|FG000|Overall Study|Lost to Follow-up|6|||
145449561|NCT01519791|524496505|FG001|Overall Study|Lost to Follow-up|14|||
145449562|NCT03206970|524496508|FG000|Overall Study|Death|21|||
145449563|NCT03206970|524496508|FG000|Overall Study|Withdrawal by Subject|13|||
145449564|NCT03206970|524496508|FG000|Overall Study|Lost to Follow-up|3|||
145449565|NCT03206970|524496508|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
145449566|NCT03645421|524496509|FG000|Overall Study|Adverse Event|0|||
145449567|NCT03645421|524496510|FG001|Overall Study|Adverse Event|0|||
145449568|NCT03645421|524496511|FG002|Overall Study|Adverse Event|4|||
145449569|NCT03645421|524496512|FG003|Overall Study|Adverse Event|1|||
145449570|NCT03645421|524496509|FG000|Overall Study|Withdrawal by patient|0|||
145449571|NCT03645421|524496510|FG001|Overall Study|Withdrawal by patient|0|||
145449572|NCT03645421|524496511|FG002|Overall Study|Withdrawal by patient|0|||
145449573|NCT03645421|524496512|FG003|Overall Study|Withdrawal by patient|3|||
145449574|NCT03645421|524496509|FG000|Overall Study|Study specific withdrawal criteria|0|||
145449575|NCT03645421|524496510|FG001|Overall Study|Study specific withdrawal criteria|0|||
145449576|NCT03645421|524496511|FG002|Overall Study|Study specific withdrawal criteria|1|||
145449577|NCT03645421|524496512|FG003|Overall Study|Study specific withdrawal criteria|0|||
145449578|NCT00375427|524496513|FG000|Overall Study|Adverse Event|21|||
145449579|NCT00375427|524496514|FG001|Overall Study|Adverse Event|27|||
145449580|NCT00375427|524496513|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145449581|NCT00375427|524496514|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145449582|NCT00375427|524496513|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145449583|NCT00375427|524496514|FG001|Overall Study|Abnormal laboratory value(s)|2|||
145449584|NCT00375427|524496513|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145449585|NCT00375427|524496514|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145449586|NCT00375427|524496513|FG000|Overall Study|Patient no longer requires study drug|3|||
145449587|NCT00375427|524496514|FG001|Overall Study|Patient no longer requires study drug|7|||
145449588|NCT00375427|524496513|FG000|Overall Study|Protocol Violation|10|||
145449589|NCT00375427|524496514|FG001|Overall Study|Protocol Violation|8|||
145449590|NCT00375427|524496513|FG000|Overall Study|Withdrawal by Subject|9|||
145449591|NCT00375427|524496514|FG001|Overall Study|Withdrawal by Subject|13|||
145449592|NCT00375427|524496513|FG000|Overall Study|Lost to Follow-up|1|||
145449593|NCT00375427|524496514|FG001|Overall Study|Lost to Follow-up|1|||
145449594|NCT00375427|524496513|FG000|Overall Study|Administrative reasons|0|||
145449595|NCT00375427|524496514|FG001|Overall Study|Administrative reasons|1|||
145449596|NCT00375427|524496513|FG000|Overall Study|Death|11|||
145449597|NCT00375427|524496514|FG001|Overall Study|Death|10|||
145449598|NCT03636893|524496520|FG000|Overall Study|Death|0|||
145449599|NCT03636893|524496521|FG001|Overall Study|Death|1|||
145449600|NCT03636893|524496520|FG000|Overall Study|Protocol Violation|0|||
145449601|NCT03636893|524496521|FG001|Overall Study|Protocol Violation|3|||
145449602|NCT03636893|524496520|FG000|Overall Study|Withdrawal by Subject|1|||
145449603|NCT03636893|524496521|FG001|Overall Study|Withdrawal by Subject|2|||
145449604|NCT03636893|524496520|FG000|Overall Study|Refusal to surgery|4|||
145449605|NCT03636893|524496521|FG001|Overall Study|Refusal to surgery|3|||
145449606|NCT03636893|524496520|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
145449607|NCT03636893|524496521|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
145449608|NCT03636893|524496520|FG000|Overall Study|Adverse Event|1|||
145449609|NCT03636893|524496521|FG001|Overall Study|Adverse Event|1|||
145449610|NCT00224120|524496522|FG000|Overall Study|Adverse Event|10|||
145449611|NCT00224120|524496523|FG001|Overall Study|Adverse Event|4|||
145449612|NCT00224120|524496522|FG000|Overall Study|Protocol Violation|1|||
145449613|NCT00224120|524496523|FG001|Overall Study|Protocol Violation|0|||
145449614|NCT00224120|524496522|FG000|Overall Study|Withdrawal by Subject|5|||
145449615|NCT00224120|524496523|FG001|Overall Study|Withdrawal by Subject|10|||
145449616|NCT00224120|524496522|FG000|Overall Study|Lack of Efficacy|0|||
145449617|NCT00224120|524496523|FG001|Overall Study|Lack of Efficacy|2|||
145449618|NCT00224120|524496522|FG000|Overall Study|Lost to Follow-up|2|||
145449619|NCT00224120|524496523|FG001|Overall Study|Lost to Follow-up|3|||
145449620|NCT00224120|524496522|FG000|Overall Study|Other|4|||
145449621|NCT00224120|524496523|FG001|Overall Study|Other|5|||
145449622|NCT04560816|524496524|FG000|Overall Study|Withdrawal by Subject|1|||
145449623|NCT04560816|524496525|FG001|Overall Study|Withdrawal by Subject|1|||
145449624|NCT04560816|524496526|FG002|Overall Study|Withdrawal by Subject|1|||
145449625|NCT04560816|524496527|FG003|Overall Study|Withdrawal by Subject|0|||
145449626|NCT04560816|524496528|FG004|Overall Study|Withdrawal by Subject|3|||
145449627|NCT04560816|524496529|FG005|Overall Study|Withdrawal by Subject|0|||
145449628|NCT04560816|524496524|FG000|Overall Study|Lost to Follow-up|1|||
145449629|NCT04560816|524496525|FG001|Overall Study|Lost to Follow-up|0|||
145449630|NCT04560816|524496526|FG002|Overall Study|Lost to Follow-up|0|||
145449631|NCT04560816|524496527|FG003|Overall Study|Lost to Follow-up|0|||
145449632|NCT04560816|524496528|FG004|Overall Study|Lost to Follow-up|0|||
145449633|NCT04560816|524496529|FG005|Overall Study|Lost to Follow-up|0|||
145449634|NCT04560816|524496524|FG000|Overall Study|Protocol Violation|1|||
145449635|NCT04560816|524496525|FG001|Overall Study|Protocol Violation|0|||
145449636|NCT04560816|524496526|FG002|Overall Study|Protocol Violation|0|||
145449637|NCT04560816|524496527|FG003|Overall Study|Protocol Violation|0|||
145449638|NCT04560816|524496528|FG004|Overall Study|Protocol Violation|0|||
145449639|NCT04560816|524496529|FG005|Overall Study|Protocol Violation|0|||
145449640|NCT00716482|524496537|FG000|Overall Study|Lost to Follow-up|6|||
145449641|NCT00716482|524496537|FG000|Overall Study|Inadequate acquisition or analysis|50|||
145449642|NCT00716482|524496537|FG000|Overall Study|no pathology obtained|10|||
145449643|NCT00716482|524496537|FG000|Overall Study|technical/machine error|28|||
145449644|NCT00716482|524496537|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
145449645|NCT03248531|524496538|FG000|Overall Study|Adverse Event|0|||
145449646|NCT03248531|524496539|FG001|Overall Study|Adverse Event|0|||
145449647|NCT03248531|524496540|FG002|Overall Study|Adverse Event|1|||
145449648|NCT03248531|524496538|FG000|Overall Study|Lost to Follow-up|1|||
145449649|NCT03248531|524496539|FG001|Overall Study|Lost to Follow-up|0|||
145449650|NCT03248531|524496540|FG002|Overall Study|Lost to Follow-up|5|||
145449651|NCT03248531|524496538|FG000|Overall Study|Withdrawal by Subject|3|||
145449652|NCT03248531|524496539|FG001|Overall Study|Withdrawal by Subject|3|||
145449653|NCT03248531|524496540|FG002|Overall Study|Withdrawal by Subject|2|||
145449654|NCT03248531|524496538|FG000|Overall Study|Sponsor Request|0|||
145449655|NCT03248531|524496539|FG001|Overall Study|Sponsor Request|2|||
145449656|NCT03248531|524496540|FG002|Overall Study|Sponsor Request|0|||
145449657|NCT04075513|524496541|FG000|Overall Study|Withdrawal by Subject|2|||
145449658|NCT04075513|524496542|FG001|Overall Study|Withdrawal by Subject|2|||
145449659|NCT04075513|524496541|FG000|Overall Study|Lack of Efficacy|1|||
145449660|NCT04075513|524496542|FG001|Overall Study|Lack of Efficacy|0|||
145449661|NCT04075513|524496541|FG000|Overall Study|Lost to Follow-up|4|||
145449662|NCT04075513|524496542|FG001|Overall Study|Lost to Follow-up|2|||
145449663|NCT04075513|524496541|FG000|Overall Study|Switch to insulin pump|1|||
145449664|NCT04075513|524496542|FG001|Overall Study|Switch to insulin pump|0|||
145449665|NCT02550288|524496543|FG000|Overall Study|Adverse Event|0|||
145449666|NCT02550288|524496544|FG001|Overall Study|Adverse Event|1|||
145449667|NCT02550288|524496545|FG002|Overall Study|Adverse Event|0|||
145585759|NCT00968669|524997644|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
145585760|NCT00968669|524997645|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
145585761|NCT00968669|524997642|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
145585762|NCT00968669|524997643|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
145585763|NCT00968669|524997644|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
145585764|NCT00968669|524997645|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
145585765|NCT00968617|524997649|FG000|Overall Study|Study terminated by sponsor|6|||
145585766|NCT00288587|524997653|FG000|Overall Study|Death|4|||
145585767|NCT00288587|524997654|FG001|Overall Study|Death|4|||
145585768|NCT00288587|524997653|FG000|Overall Study|Transplant|0|||
145585769|NCT00288587|524997654|FG001|Overall Study|Transplant|3|||
145585770|NCT00288587|524997653|FG000|Overall Study|Adverse Event|0|||
145585771|NCT00288587|524997654|FG001|Overall Study|Adverse Event|1|||
145449668|NCT02550288|524496546|FG003|Overall Study|Adverse Event|0|||
145449669|NCT02550288|524496547|FG004|Overall Study|Adverse Event|0|||
145449670|NCT02550288|524496543|FG000|Overall Study|Physician Decision|0|||
145449671|NCT02550288|524496544|FG001|Overall Study|Physician Decision|0|||
145449672|NCT02550288|524496545|FG002|Overall Study|Physician Decision|0|||
145449673|NCT02550288|524496546|FG003|Overall Study|Physician Decision|1|||
145449674|NCT02550288|524496547|FG004|Overall Study|Physician Decision|0|||
145449675|NCT02550288|524496543|FG000|Overall Study|Protocol Violation|2|||
145449676|NCT02550288|524496544|FG001|Overall Study|Protocol Violation|2|||
145449677|NCT02550288|524496545|FG002|Overall Study|Protocol Violation|1|||
145449678|NCT02550288|524496546|FG003|Overall Study|Protocol Violation|0|||
145449679|NCT02550288|524496547|FG004|Overall Study|Protocol Violation|3|||
145449680|NCT02550288|524496543|FG000|Overall Study|Participant moved|0|||
145449681|NCT02550288|524496544|FG001|Overall Study|Participant moved|0|||
145449682|NCT02550288|524496545|FG002|Overall Study|Participant moved|0|||
145449683|NCT02550288|524496546|FG003|Overall Study|Participant moved|1|||
145449684|NCT02550288|524496547|FG004|Overall Study|Participant moved|0|||
145449685|NCT02550288|524496543|FG000|Overall Study|Withdrawal by Subject|0|||
145449686|NCT02550288|524496544|FG001|Overall Study|Withdrawal by Subject|0|||
145449687|NCT02550288|524496545|FG002|Overall Study|Withdrawal by Subject|0|||
145449688|NCT02550288|524496546|FG003|Overall Study|Withdrawal by Subject|1|||
145449689|NCT02550288|524496547|FG004|Overall Study|Withdrawal by Subject|0|||
145449690|NCT01901614|524496549|FG000|Overall Study|Adverse Event|0|||
145449691|NCT01901614|524496550|FG001|Overall Study|Adverse Event|1|||
145449692|NCT01901614|524496549|FG000|Overall Study|Lost to Follow-up|1|||
145449693|NCT01901614|524496550|FG001|Overall Study|Lost to Follow-up|0|||
145449694|NCT01901614|524496549|FG000|Overall Study|Screen Fail|1|||
145449695|NCT01901614|524496550|FG001|Overall Study|Screen Fail|0|||
145449696|NCT03629223|524496551|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
145449697|NCT03629223|524496552|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
145449698|NCT03629223|524496553|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
145449699|NCT03629223|524496554|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
145449700|NCT03629223|524496555|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
145449701|NCT03629223|524496556|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
145449702|NCT03629223|524496551|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
145449703|NCT03629223|524496552|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
145449704|NCT03629223|524496553|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
145449705|NCT03629223|524496554|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
145449706|NCT03629223|524496555|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
145449707|NCT03629223|524496556|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
145449708|NCT03629223|524496551|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
145449709|NCT03629223|524496552|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
145585772|NCT00288587|524997653|FG000|Overall Study|Physician Decision|0|||
145449710|NCT03629223|524496553|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
145449711|NCT03629223|524496554|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
145449712|NCT03629223|524496555|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
145585773|NCT00288587|524997654|FG001|Overall Study|Physician Decision|2|||
145585774|NCT00288587|524997653|FG000|Overall Study|Severe Aortic Stenosis|1|||
145585775|NCT00288587|524997654|FG001|Overall Study|Severe Aortic Stenosis|0|||
145585776|NCT01434602|524997655|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
145585777|NCT01434602|524997656|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
145449713|NCT03629223|524496556|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
145449714|NCT03629223|524496551|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
145449715|NCT03629223|524496552|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
145449716|NCT03629223|524496553|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
145449717|NCT03629223|524496554|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
145449718|NCT03629223|524496555|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
145449719|NCT03629223|524496556|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
145449720|NCT03629223|524496551|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
145449721|NCT03629223|524496552|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
145449722|NCT03629223|524496553|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
145449723|NCT03629223|524496554|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
145449724|NCT03629223|524496555|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
145449725|NCT03629223|524496556|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
145449726|NCT01555073|524496557|FG000|Overall Study|Lost to Follow-up|1|||
145449727|NCT01555073|524496558|FG001|Overall Study|Lost to Follow-up|2|||
145449728|NCT01555073|524496559|FG002|Overall Study|Lost to Follow-up|0|||
145449729|NCT01555073|524496560|FG003|Overall Study|Lost to Follow-up|5|||
145449730|NCT01071252|524496563|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
145449731|NCT01071252|524496564|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
145449732|NCT01071252|524496565|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
145449733|NCT01071252|524496566|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
145449734|NCT01071252|524496567|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
145449735|NCT01071252|524496563|FG000|Overall Study|Withdrawal by Subject|8|||
145449736|NCT01071252|524496564|FG001|Overall Study|Withdrawal by Subject|2|||
145449737|NCT01071252|524496565|FG002|Overall Study|Withdrawal by Subject|1|||
145449738|NCT01071252|524496566|FG003|Overall Study|Withdrawal by Subject|2|||
145449739|NCT01071252|524496567|FG004|Overall Study|Withdrawal by Subject|3|||
145449740|NCT01071252|524496563|FG000|Overall Study|administrative problems|1|||
145449741|NCT01071252|524496564|FG001|Overall Study|administrative problems|1|||
145449742|NCT01071252|524496565|FG002|Overall Study|administrative problems|0|||
145449743|NCT01071252|524496566|FG003|Overall Study|administrative problems|2|||
145449744|NCT01071252|524496567|FG004|Overall Study|administrative problems|1|||
145449745|NCT01071252|524496563|FG000|Overall Study|Lost to Follow-up|1|||
145449746|NCT01071252|524496564|FG001|Overall Study|Lost to Follow-up|0|||
145449747|NCT01071252|524496565|FG002|Overall Study|Lost to Follow-up|1|||
145449748|NCT01071252|524496566|FG003|Overall Study|Lost to Follow-up|2|||
145449749|NCT01071252|524496567|FG004|Overall Study|Lost to Follow-up|0|||
145449750|NCT01071252|524496563|FG000|Overall Study|Adverse Event|1|||
145449751|NCT01071252|524496564|FG001|Overall Study|Adverse Event|1|||
145449752|NCT01071252|524496565|FG002|Overall Study|Adverse Event|0|||
145449753|NCT01071252|524496566|FG003|Overall Study|Adverse Event|1|||
145449754|NCT01071252|524496567|FG004|Overall Study|Adverse Event|0|||
145449755|NCT01071252|524496563|FG000|Overall Study|Death|0|||
145449756|NCT01071252|524496564|FG001|Overall Study|Death|0|||
145449757|NCT01071252|524496565|FG002|Overall Study|Death|0|||
145449758|NCT01071252|524496566|FG003|Overall Study|Death|0|||
145449759|NCT01071252|524496567|FG004|Overall Study|Death|1|||
145449760|NCT01066104|524496568|FG000|Overall Study|Adverse Event|1|||
145449761|NCT01066104|524496569|FG001|Overall Study|Adverse Event|1|||
145449762|NCT01066104|524496568|FG000|Overall Study|Protocol Violation|1|||
145449763|NCT01066104|524496569|FG001|Overall Study|Protocol Violation|0|||
145449764|NCT00470262|524496570|FG000|Overall Study|Withdrawal by Subject|2|||
145449765|NCT00470262|524496571|FG001|Overall Study|Withdrawal by Subject|0|||
145449766|NCT04004221|524496572|FG000|Overall Study|Death|89|||
145449767|NCT04004221|524496572|FG000|Overall Study|Withdrawal by Subject|5|||
145449768|NCT04004221|524496572|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
145449769|NCT04004221|524496572|FG000|Overall Study|Sponsor Decision|9|||
145449770|NCT04004221|524496572|FG000|Overall Study|Participant refused to enter LTE|1|||
145449771|NCT02036580|524496575|FG000|Overall Study|Withdrawal by Subject|0|||
145449772|NCT02036580|524496576|FG001|Overall Study|Withdrawal by Subject|1|||
145585778|NCT01434602|524997657|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
145585779|NCT01434602|524997658|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
145585780|NCT01434602|524997659|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
145585781|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
145449773|NCT02036580|524496577|FG002|Overall Study|Withdrawal by Subject|0|||
145449774|NCT02036580|524496575|FG000|Overall Study|Adverse Event|1|||
145449775|NCT02036580|524496576|FG001|Overall Study|Adverse Event|0|||
145449776|NCT02036580|524496577|FG002|Overall Study|Adverse Event|0|||
145449777|NCT00992056|524496578|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
145449778|NCT00992056|524496579|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
145449779|NCT00992056|524496578|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
145449780|NCT00992056|524496579|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
145449781|NCT02038946|524496582|FG000|Overall Study|Death|5|||
145449782|NCT02038946|524496582|FG000|Overall Study|Withdrawal by Subject|3|||
145449783|NCT02038946|524496582|FG000|Overall Study|Lost to Follow-up|2|||
145449784|NCT02038946|524496582|FG000|Overall Study|Other reasons|2|||
145449785|NCT01558596|524496583|FG000|Overall Study|Withdrawal by Subject|1|||
145449786|NCT01558596|524496584|FG001|Overall Study|Withdrawal by Subject|0|||
145449787|NCT01558596|524496583|FG000|Overall Study|surgery elsewhere or cancelled|1|||
145449788|NCT01558596|524496584|FG001|Overall Study|surgery elsewhere or cancelled|1|||
145449789|NCT01558596|524496583|FG000|Overall Study|Protocol Violation|1|||
145449790|NCT01558596|524496584|FG001|Overall Study|Protocol Violation|0|||
145449791|NCT01479764|524496585|FG000|Randomized|Adverse Event|1|||
145449792|NCT01479764|524496586|FG001|Randomized|Adverse Event|1|||
145449793|NCT01479764|524496585|FG000|Randomized|Withdrawal by Subject|1|||
145449794|NCT01479764|524496586|FG001|Randomized|Withdrawal by Subject|0|||
145449795|NCT01479764|524496585|FG000|Treated|Lost to Follow-up|0|||
145449796|NCT01479764|524496586|FG001|Treated|Lost to Follow-up|2|||
145449797|NCT01916824|524496589|FG000|Overall Study|Lost to Follow-up|3|||
145449798|NCT01916824|524496590|FG001|Overall Study|Lost to Follow-up|6|||
145449799|NCT01916824|524496589|FG000|Overall Study|Physician Decision|2|||
145449800|NCT01916824|524496590|FG001|Overall Study|Physician Decision|0|||
145449801|NCT01916824|524496589|FG000|Overall Study|Withdrawal by Subject|2|||
145449802|NCT01916824|524496590|FG001|Overall Study|Withdrawal by Subject|3|||
145449803|NCT03835481|524496595|FG000|Double-blind Period|Other not stated below|0|||
145449804|NCT03835481|524496596|FG001|Double-blind Period|Other not stated below|0|||
145449805|NCT03835481|524496597|FG002|Double-blind Period|Other not stated below|0|||
145449806|NCT03835481|524496598|FG003|Double-blind Period|Other not stated below|1|||
145449807|NCT03835481|524496599|FG004|Double-blind Period|Other not stated below|1|||
145449808|NCT03835481|524496595|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
145449809|NCT03835481|524496596|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
145449810|NCT03835481|524496597|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
145449811|NCT03835481|524496598|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
145449812|NCT03835481|524496599|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
145449813|NCT03835481|524496595|FG000|Double-blind Period|Withdrawal by Subject|0|||
145449814|NCT03835481|524496596|FG001|Double-blind Period|Withdrawal by Subject|0|||
145449815|NCT03835481|524496597|FG002|Double-blind Period|Withdrawal by Subject|1|||
145449816|NCT03835481|524496598|FG003|Double-blind Period|Withdrawal by Subject|0|||
145449817|NCT03835481|524496599|FG004|Double-blind Period|Withdrawal by Subject|5|||
145449818|NCT03835481|524496595|FG000|Double-blind Period|Lost to Follow-up|0|||
145449819|NCT03835481|524496596|FG001|Double-blind Period|Lost to Follow-up|0|||
145449820|NCT03835481|524496597|FG002|Double-blind Period|Lost to Follow-up|0|||
145449821|NCT03835481|524496598|FG003|Double-blind Period|Lost to Follow-up|1|||
145449822|NCT03835481|524496599|FG004|Double-blind Period|Lost to Follow-up|0|||
145449823|NCT03835481|524496595|FG000|Double-blind Period|Protocol Violation|0|||
145449824|NCT03835481|524496596|FG001|Double-blind Period|Protocol Violation|2|||
145449825|NCT03835481|524496597|FG002|Double-blind Period|Protocol Violation|0|||
145449826|NCT03835481|524496598|FG003|Double-blind Period|Protocol Violation|1|||
145449827|NCT03835481|524496599|FG004|Double-blind Period|Protocol Violation|0|||
145449828|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
145449829|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
145449830|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
145449831|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
145449832|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
145449833|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
145449834|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
145449835|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
145449836|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
145449837|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
145449838|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
145449839|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
145449840|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
145449841|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
145449842|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
145449843|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
145449844|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
145449845|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
145449846|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
145449847|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
145449848|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
145449849|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
145449850|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
145449851|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
145449852|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
145449853|NCT03835481|524496595|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
145449854|NCT03835481|524496596|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
145449855|NCT03835481|524496597|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
145449856|NCT03835481|524496598|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
145449857|NCT03835481|524496599|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
145449858|NCT01221753|524496611|FG000|Overall Study|Adverse Event|1|||
145449859|NCT04552288|524496612|FG000|Overall Study|Death|3|||
145449860|NCT04552288|524496612|FG000|Overall Study|Lost to Follow-up|6|||
145449861|NCT04552288|524496612|FG000|Overall Study|Physician Decision|3|||
145449862|NCT04552288|524496612|FG000|Overall Study|Protocol Violation|9|||
145449863|NCT04552288|524496612|FG000|Overall Study|Withdrawal by Subject|6|||
145449864|NCT04552288|524496612|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
145449865|NCT01831466|524496613|FG000|Overall Study|Protocol Violation|1|||
145449866|NCT01831466|524496614|FG001|Overall Study|Protocol Violation|1|||
145449867|NCT01831466|524496615|FG002|Overall Study|Protocol Violation|2|||
145449868|NCT01831466|524496616|FG003|Overall Study|Protocol Violation|0|||
145449869|NCT01831466|524496617|FG004|Overall Study|Protocol Violation|0|||
145449870|NCT01831466|524496618|FG005|Overall Study|Protocol Violation|1|||
145449871|NCT01831466|524496619|FG006|Overall Study|Protocol Violation|0|||
145449872|NCT01831466|524496620|FG007|Overall Study|Protocol Violation|0|||
145449873|NCT01831466|524496621|FG008|Overall Study|Protocol Violation|0|||
145449874|NCT01831466|524496622|FG009|Overall Study|Protocol Violation|0|||
145449875|NCT01831466|524496623|FG010|Overall Study|Protocol Violation|0|||
145449876|NCT01831466|524496624|FG011|Overall Study|Protocol Violation|0|||
145449877|NCT01831466|524496613|FG000|Overall Study|Other|2|||
145449878|NCT01831466|524496614|FG001|Overall Study|Other|3|||
145449879|NCT01831466|524496615|FG002|Overall Study|Other|2|||
145449880|NCT01831466|524496616|FG003|Overall Study|Other|2|||
145449881|NCT01831466|524496617|FG004|Overall Study|Other|2|||
145449882|NCT01831466|524496618|FG005|Overall Study|Other|1|||
145449883|NCT01831466|524496619|FG006|Overall Study|Other|0|||
145449884|NCT01831466|524496620|FG007|Overall Study|Other|0|||
145449885|NCT01831466|524496621|FG008|Overall Study|Other|0|||
145449886|NCT01831466|524496622|FG009|Overall Study|Other|0|||
145449887|NCT01831466|524496623|FG010|Overall Study|Other|0|||
145449888|NCT01831466|524496624|FG011|Overall Study|Other|0|||
145449889|NCT01831466|524496613|FG000|Overall Study|Non-compliance with study treatment|2|||
145449890|NCT01831466|524496614|FG001|Overall Study|Non-compliance with study treatment|1|||
145449891|NCT01831466|524496615|FG002|Overall Study|Non-compliance with study treatment|1|||
145449892|NCT01831466|524496616|FG003|Overall Study|Non-compliance with study treatment|0|||
145449893|NCT01831466|524496617|FG004|Overall Study|Non-compliance with study treatment|0|||
145449894|NCT01831466|524496618|FG005|Overall Study|Non-compliance with study treatment|1|||
145449895|NCT01831466|524496619|FG006|Overall Study|Non-compliance with study treatment|0|||
145449896|NCT01831466|524496620|FG007|Overall Study|Non-compliance with study treatment|0|||
145449897|NCT01831466|524496621|FG008|Overall Study|Non-compliance with study treatment|0|||
145449898|NCT01831466|524496622|FG009|Overall Study|Non-compliance with study treatment|0|||
145449899|NCT01831466|524496623|FG010|Overall Study|Non-compliance with study treatment|0|||
145449900|NCT01831466|524496624|FG011|Overall Study|Non-compliance with study treatment|0|||
145449901|NCT01831466|524496613|FG000|Overall Study|Death|0|||
145449902|NCT01831466|524496614|FG001|Overall Study|Death|1|||
145449903|NCT01831466|524496615|FG002|Overall Study|Death|0|||
145449904|NCT01831466|524496616|FG003|Overall Study|Death|0|||
145449905|NCT01831466|524496617|FG004|Overall Study|Death|0|||
145449906|NCT01831466|524496618|FG005|Overall Study|Death|0|||
145449907|NCT01831466|524496619|FG006|Overall Study|Death|0|||
145449908|NCT01831466|524496620|FG007|Overall Study|Death|0|||
145449909|NCT01831466|524496621|FG008|Overall Study|Death|0|||
145449910|NCT01831466|524496622|FG009|Overall Study|Death|0|||
145449911|NCT01831466|524496623|FG010|Overall Study|Death|0|||
145449912|NCT01831466|524496624|FG011|Overall Study|Death|0|||
145449913|NCT01831466|524496613|FG000|Overall Study|Withdrawal by Subject|6|||
145449914|NCT01831466|524496614|FG001|Overall Study|Withdrawal by Subject|3|||
145449915|NCT01831466|524496615|FG002|Overall Study|Withdrawal by Subject|3|||
145449916|NCT01831466|524496616|FG003|Overall Study|Withdrawal by Subject|3|||
145449917|NCT01831466|524496617|FG004|Overall Study|Withdrawal by Subject|3|||
145449918|NCT01831466|524496618|FG005|Overall Study|Withdrawal by Subject|5|||
145449919|NCT01831466|524496619|FG006|Overall Study|Withdrawal by Subject|0|||
145449920|NCT01831466|524496620|FG007|Overall Study|Withdrawal by Subject|0|||
145449921|NCT01831466|524496621|FG008|Overall Study|Withdrawal by Subject|0|||
145449922|NCT01831466|524496622|FG009|Overall Study|Withdrawal by Subject|1|||
145449923|NCT01831466|524496623|FG010|Overall Study|Withdrawal by Subject|0|||
145449924|NCT01831466|524496624|FG011|Overall Study|Withdrawal by Subject|1|||
145449925|NCT01831466|524496613|FG000|Overall Study|Lost to Follow-up|0|||
145449926|NCT01831466|524496614|FG001|Overall Study|Lost to Follow-up|1|||
145449927|NCT01831466|524496615|FG002|Overall Study|Lost to Follow-up|4|||
145449928|NCT01831466|524496616|FG003|Overall Study|Lost to Follow-up|2|||
145449929|NCT01831466|524496617|FG004|Overall Study|Lost to Follow-up|0|||
145449930|NCT01831466|524496618|FG005|Overall Study|Lost to Follow-up|3|||
145449931|NCT01831466|524496619|FG006|Overall Study|Lost to Follow-up|0|||
145449932|NCT01831466|524496620|FG007|Overall Study|Lost to Follow-up|0|||
145449933|NCT01831466|524496621|FG008|Overall Study|Lost to Follow-up|0|||
145449934|NCT01831466|524496622|FG009|Overall Study|Lost to Follow-up|1|||
145449935|NCT01831466|524496623|FG010|Overall Study|Lost to Follow-up|0|||
145449936|NCT01831466|524496624|FG011|Overall Study|Lost to Follow-up|1|||
145449937|NCT01831466|524496613|FG000|Overall Study|Lack of Efficacy|5|||
145449938|NCT01831466|524496614|FG001|Overall Study|Lack of Efficacy|8|||
145449939|NCT01831466|524496615|FG002|Overall Study|Lack of Efficacy|7|||
145449940|NCT01831466|524496616|FG003|Overall Study|Lack of Efficacy|6|||
145449941|NCT01831466|524496617|FG004|Overall Study|Lack of Efficacy|9|||
145449942|NCT01831466|524496618|FG005|Overall Study|Lack of Efficacy|8|||
145449943|NCT01831466|524496619|FG006|Overall Study|Lack of Efficacy|1|||
145449944|NCT01831466|524496620|FG007|Overall Study|Lack of Efficacy|1|||
145449945|NCT01831466|524496621|FG008|Overall Study|Lack of Efficacy|2|||
145449946|NCT01831466|524496622|FG009|Overall Study|Lack of Efficacy|2|||
145449947|NCT01831466|524496623|FG010|Overall Study|Lack of Efficacy|2|||
145449948|NCT01831466|524496624|FG011|Overall Study|Lack of Efficacy|0|||
145449949|NCT01831466|524496613|FG000|Overall Study|Adverse Event|0|||
145449950|NCT01831466|524496614|FG001|Overall Study|Adverse Event|0|||
145449951|NCT01831466|524496615|FG002|Overall Study|Adverse Event|4|||
145449952|NCT01831466|524496616|FG003|Overall Study|Adverse Event|6|||
145449953|NCT01831466|524496617|FG004|Overall Study|Adverse Event|3|||
145449954|NCT01831466|524496618|FG005|Overall Study|Adverse Event|7|||
145449955|NCT01831466|524496619|FG006|Overall Study|Adverse Event|0|||
145449956|NCT01831466|524496620|FG007|Overall Study|Adverse Event|1|||
145449957|NCT01831466|524496621|FG008|Overall Study|Adverse Event|1|||
145449958|NCT01831466|524496622|FG009|Overall Study|Adverse Event|1|||
145449959|NCT01831466|524496623|FG010|Overall Study|Adverse Event|0|||
145449960|NCT01831466|524496624|FG011|Overall Study|Adverse Event|2|||
145449961|NCT02798315|524496625|FG000|Overall Study|Failure to return|1|||
145449962|NCT00005947|524496626|FG000|Overall Study|Death|54|||
145449963|NCT00005947|524496627|FG001|Overall Study|Death|40|||
145449964|NCT00005947|524496626|FG000|Overall Study|Patient Refused to Continue|2|||
145449965|NCT00005947|524496627|FG001|Overall Study|Patient Refused to Continue|1|||
145449966|NCT00005947|524496626|FG000|Overall Study|Site Closure|1|||
145449967|NCT00005947|524496627|FG001|Overall Study|Site Closure|0|||
145449968|NCT02146131|524496629|FG000|Overall Study|Physician Decision|61|||
145449969|NCT02146131|524496630|FG001|Overall Study|Physician Decision|56|||
145449970|NCT02567799|524496631|FG000|Concurrent Chemoradiotherapy|Death|1|||
145449971|NCT02567799|524496632|FG001|Concurrent Chemoradiotherapy|Death|0|||
145449972|NCT02567799|524496633|FG002|Concurrent Chemoradiotherapy|Death|0|||
145449973|NCT02567799|524496631|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
145449974|NCT02567799|524496632|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
145449975|NCT02567799|524496633|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
145449976|NCT02567799|524496631|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
145449977|NCT02567799|524496632|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
145449978|NCT02567799|524496633|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
145449979|NCT02567799|524496631|FG000|Follow-up|Death|1|||
145449980|NCT02567799|524496632|FG001|Follow-up|Death|0|||
145449981|NCT02567799|524496633|FG002|Follow-up|Death|1|||
145449982|NCT02567799|524496631|FG000|Follow-up|Progressive Disease|1|||
145449983|NCT02567799|524496632|FG001|Follow-up|Progressive Disease|1|||
145449984|NCT02567799|524496633|FG002|Follow-up|Progressive Disease|3|||
145449985|NCT03335150|524496636|FG000|Overall Study|Withdrawal by Subject|10|||
145449986|NCT03335150|524496637|FG001|Overall Study|Withdrawal by Subject|4|||
145449987|NCT03335150|524496636|FG000|Overall Study|Adverse Event|0|||
145449988|NCT03335150|524496637|FG001|Overall Study|Adverse Event|1|||
145449989|NCT05356910|524496644|FG000|Overall Study|Lost to Follow-up|10|||
145449990|NCT05356910|524496645|FG001|Overall Study|Lost to Follow-up|19|||
145449991|NCT05356910|524496646|FG002|Overall Study|Lost to Follow-up|0|||
145585782|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
145585783|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
145585784|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
145449992|NCT05356910|524496647|FG003|Overall Study|Lost to Follow-up|0|||
145449993|NCT05356910|524496644|FG000|Overall Study|Withdrawal by Subject|4|||
145449994|NCT05356910|524496645|FG001|Overall Study|Withdrawal by Subject|2|||
145449995|NCT05356910|524496646|FG002|Overall Study|Withdrawal by Subject|0|||
145449996|NCT05356910|524496647|FG003|Overall Study|Withdrawal by Subject|0|||
145449997|NCT00803595|524496648|FG000|Overall Study|Adverse Event|3|||
145449998|NCT00803595|524496649|FG001|Overall Study|Adverse Event|4|||
145449999|NCT00803595|524496650|FG002|Overall Study|Adverse Event|1|||
145450000|NCT00803595|524496648|FG000|Overall Study|Protocol Violation|7|||
145450001|NCT00803595|524496649|FG001|Overall Study|Protocol Violation|2|||
145450002|NCT00803595|524496650|FG002|Overall Study|Protocol Violation|12|||
145450003|NCT00803595|524496648|FG000|Overall Study|Withdrawal by Subject|5|||
145450004|NCT00803595|524496649|FG001|Overall Study|Withdrawal by Subject|2|||
145450005|NCT00803595|524496650|FG002|Overall Study|Withdrawal by Subject|3|||
145450006|NCT02482428|524498141|FG000|Overall Study|Lost to Follow-up|4|||
145450007|NCT02482428|524498142|FG001|Overall Study|Lost to Follow-up|9|||
145450008|NCT02482428|524498143|FG002|Overall Study|Lost to Follow-up|1|||
145450009|NCT02482428|524498144|FG003|Overall Study|Lost to Follow-up|2|||
145450010|NCT02482428|524498145|FG004|Overall Study|Lost to Follow-up|4|||
145450011|NCT02482428|524498141|FG000|Overall Study|Physician Decision|0|||
145450012|NCT02482428|524498142|FG001|Overall Study|Physician Decision|0|||
145450013|NCT02482428|524498143|FG002|Overall Study|Physician Decision|0|||
145450014|NCT02482428|524498144|FG003|Overall Study|Physician Decision|0|||
145450015|NCT02482428|524498145|FG004|Overall Study|Physician Decision|1|||
145450016|NCT02482428|524498141|FG000|Overall Study|protocol deviation|1|||
145450017|NCT02482428|524498142|FG001|Overall Study|protocol deviation|1|||
145450018|NCT02482428|524498143|FG002|Overall Study|protocol deviation|0|||
145450019|NCT02482428|524498144|FG003|Overall Study|protocol deviation|0|||
145450020|NCT02482428|524498145|FG004|Overall Study|protocol deviation|0|||
145450021|NCT02482428|524498141|FG000|Overall Study|subject/guardian decision|4|||
145450022|NCT02482428|524498142|FG001|Overall Study|subject/guardian decision|2|||
145450023|NCT02482428|524498143|FG002|Overall Study|subject/guardian decision|0|||
145450024|NCT02482428|524498144|FG003|Overall Study|subject/guardian decision|0|||
145450025|NCT02482428|524498145|FG004|Overall Study|subject/guardian decision|2|||
145450026|NCT00516893|524498146|FG000|Overall Study|Lost to Follow-up|4|||
145450027|NCT00516893|524498146|FG000|Overall Study|Adverse Event|3|||
145450028|NCT00516893|524498146|FG000|Overall Study|Withdrawal by Subject|2|||
145450029|NCT00516893|524498146|FG000|Overall Study|Noncompliance|2|||
145450030|NCT00516893|524498146|FG000|Overall Study|Death|1|||
145450031|NCT00516893|524498146|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
145450032|NCT00516893|524498146|FG000|Overall Study|Relocated|1|||
145450033|NCT00516893|524498146|FG000|Overall Study|Pregnancy|1|||
145450034|NCT00516893|524498146|FG000|Overall Study|Received Medication From Another Study|1|||
145450035|NCT00301262|524498149|FG000|Double Blind Phase (DB)|Adverse Event|1|||
145450036|NCT00301262|524498150|FG001|Double Blind Phase (DB)|Adverse Event|0|||
145450037|NCT00301262|524498149|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
145450038|NCT00301262|524498150|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
145450039|NCT00301262|524498149|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
145450040|NCT00301262|524498150|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
145450041|NCT00301262|524498149|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
145450042|NCT00301262|524498150|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
145450043|NCT00301262|524498149|FG000|Double Blind Phase (DB)|Other|1|||
145450044|NCT00301262|524498150|FG001|Double Blind Phase (DB)|Other|4|||
145450045|NCT00301262|524498149|FG000|Open Label Phase (OL)|Adverse Event|1|||
145450046|NCT00301262|524498150|FG001|Open Label Phase (OL)|Adverse Event|0|||
145450047|NCT00301262|524498149|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
145450048|NCT00301262|524498150|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
145450049|NCT00301262|524498149|FG000|Open Label Phase (OL)|Other|2|||
145450050|NCT00301262|524498150|FG001|Open Label Phase (OL)|Other|0|||
145450051|NCT01443364|524498151|FG000|Overall Study|Lack of Efficacy|14|||
145450052|NCT01443364|524498151|FG000|Overall Study|Lost to Follow-up|3|||
145450053|NCT01443364|524498151|FG000|Overall Study|Withdrawal by Subject|5|||
145450054|NCT01443364|524498151|FG000|Overall Study|Other Reason|4|||
145450055|NCT01443364|524498151|FG000|Overall Study|SAE, non-fatal|6|||
145450056|NCT01443364|524498151|FG000|Overall Study|AE, non-serious non-fatal|8|||
145450057|NCT01443364|524498151|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
145450058|NCT01951586|524498152|FG000|Overall Study|Death|61|||
145450059|NCT01951586|524498153|FG001|Overall Study|Death|120|||
145450060|NCT01951586|524498152|FG000|Overall Study|Withdrawal by Subject|8|||
145450061|NCT01951586|524498153|FG001|Overall Study|Withdrawal by Subject|17|||
145450062|NCT01951586|524498152|FG000|Overall Study|Lost to Follow-up|0|||
145450063|NCT01951586|524498153|FG001|Overall Study|Lost to Follow-up|1|||
145450064|NCT01951586|524498152|FG000|Overall Study|Sponsor Decision|9|||
145450065|NCT01951586|524498153|FG001|Overall Study|Sponsor Decision|10|||
145450066|NCT00962741|524498154|FG000|Overall Study|Failed to return|3|||
145450067|NCT00962741|524498154|FG000|Overall Study|Lost to Follow-up|2|||
145450068|NCT00962741|524498154|FG000|Overall Study|Withdrawal by Subject|1|||
145450069|NCT00962741|524498154|FG000|Overall Study|Lack of Efficacy|1|||
145450070|NCT00962741|524498154|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
145450071|NCT01995526|524498157|FG000|Overall Study|Physician Decision|1|||
145450072|NCT01977729|524498159|FG000|Overall Study|Study terminated|1|||
145450073|NCT00104416|524498160|FG000|Double-Blind Phase|Adverse Event|2|||
145450074|NCT00104416|524498161|FG001|Double-Blind Phase|Adverse Event|1|||
145450075|NCT00104416|524498162|FG002|Double-Blind Phase|Adverse Event|0|||
145450076|NCT00104416|524498163|FG003|Double-Blind Phase|Adverse Event|0|||
145450077|NCT00104416|524498164|FG004|Double-Blind Phase|Adverse Event|0|||
145450078|NCT00104416|524498160|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145450079|NCT00104416|524498161|FG001|Double-Blind Phase|Lost to Follow-up|1|||
145450080|NCT00104416|524498162|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145450081|NCT00104416|524498163|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145450082|NCT00104416|524498164|FG004|Double-Blind Phase|Lost to Follow-up|0|||
145450083|NCT00104416|524498160|FG000|Double-Blind Phase|Protocol Violation|0|||
145450084|NCT00104416|524498161|FG001|Double-Blind Phase|Protocol Violation|1|||
145450085|NCT00104416|524498162|FG002|Double-Blind Phase|Protocol Violation|0|||
145450086|NCT00104416|524498163|FG003|Double-Blind Phase|Protocol Violation|0|||
145450087|NCT00104416|524498164|FG004|Double-Blind Phase|Protocol Violation|0|||
145450088|NCT00104416|524498160|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
145450089|NCT00104416|524498161|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
145450090|NCT00104416|524498162|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145450091|NCT00104416|524498163|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145450092|NCT00104416|524498164|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145450093|NCT00104416|524498160|FG000|Double-Blind Phase|Pregnancy|1|||
145450094|NCT00104416|524498161|FG001|Double-Blind Phase|Pregnancy|0|||
145450095|NCT00104416|524498162|FG002|Double-Blind Phase|Pregnancy|0|||
145450096|NCT00104416|524498163|FG003|Double-Blind Phase|Pregnancy|0|||
145450097|NCT00104416|524498164|FG004|Double-Blind Phase|Pregnancy|0|||
145450098|NCT00104416|524498160|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
145450099|NCT00104416|524498161|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
145450100|NCT00104416|524498162|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
145450101|NCT00104416|524498163|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
145450102|NCT00104416|524498164|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
145450103|NCT00104416|524498160|FG000|Continuation Phase|Adverse Event|0|||
145450104|NCT00104416|524498161|FG001|Continuation Phase|Adverse Event|0|||
145450105|NCT00104416|524498162|FG002|Continuation Phase|Adverse Event|2|||
145450106|NCT00104416|524498163|FG003|Continuation Phase|Adverse Event|0|||
145450107|NCT00104416|524498164|FG004|Continuation Phase|Adverse Event|2|||
145450108|NCT00104416|524498160|FG000|Continuation Phase|Lost to Follow-up|0|||
145450109|NCT00104416|524498161|FG001|Continuation Phase|Lost to Follow-up|0|||
145450110|NCT00104416|524498162|FG002|Continuation Phase|Lost to Follow-up|1|||
145450111|NCT00104416|524498163|FG003|Continuation Phase|Lost to Follow-up|0|||
145450112|NCT00104416|524498164|FG004|Continuation Phase|Lost to Follow-up|1|||
145450113|NCT00104416|524498160|FG000|Continuation Phase|Withdrawal by Subject|0|||
145450114|NCT00104416|524498161|FG001|Continuation Phase|Withdrawal by Subject|0|||
145450115|NCT00104416|524498162|FG002|Continuation Phase|Withdrawal by Subject|2|||
145450116|NCT00104416|524498163|FG003|Continuation Phase|Withdrawal by Subject|1|||
145450117|NCT00104416|524498164|FG004|Continuation Phase|Withdrawal by Subject|1|||
145450118|NCT00104416|524498160|FG000|Continuation Phase|Pregnancy|0|||
145450119|NCT00104416|524498161|FG001|Continuation Phase|Pregnancy|0|||
145450120|NCT00104416|524498162|FG002|Continuation Phase|Pregnancy|1|||
145450121|NCT00104416|524498163|FG003|Continuation Phase|Pregnancy|1|||
145450122|NCT00104416|524498164|FG004|Continuation Phase|Pregnancy|0|||
145450123|NCT00104416|524498160|FG000|Continuation Phase|Non-compliance|0|||
145450124|NCT00104416|524498161|FG001|Continuation Phase|Non-compliance|0|||
145626138|NCT00783692|525144211|FG004|Induction Phase|Withdrawal by Subject|0|||
145626139|NCT00783692|525144212|FG005|Induction Phase|Withdrawal by Subject|0|||
145626140|NCT00783692|525144213|FG006|Induction Phase|Withdrawal by Subject|0|||
145626141|NCT00783692|525144207|FG000|Induction Phase|Lost to Follow-up|0|||
145626142|NCT00783692|525144208|FG001|Induction Phase|Lost to Follow-up|0|||
145626143|NCT00783692|525144209|FG002|Induction Phase|Lost to Follow-up|3|||
145626144|NCT00783692|525144210|FG003|Induction Phase|Lost to Follow-up|0|||
145626145|NCT00783692|525144211|FG004|Induction Phase|Lost to Follow-up|0|||
145626146|NCT00783692|525144212|FG005|Induction Phase|Lost to Follow-up|0|||
145626147|NCT00783692|525144213|FG006|Induction Phase|Lost to Follow-up|0|||
145626148|NCT00783692|525144207|FG000|Induction Phase|Other|0|||
145626149|NCT00783692|525144208|FG001|Induction Phase|Other|0|||
145626150|NCT00783692|525144209|FG002|Induction Phase|Other|2|||
145626151|NCT00783692|525144210|FG003|Induction Phase|Other|0|||
145626152|NCT00783692|525144211|FG004|Induction Phase|Other|0|||
145450125|NCT00104416|524498162|FG002|Continuation Phase|Non-compliance|0|||
145450126|NCT00104416|524498163|FG003|Continuation Phase|Non-compliance|0|||
145450127|NCT00104416|524498164|FG004|Continuation Phase|Non-compliance|1|||
145450128|NCT00438360|524498165|FG000|Overall Study|Adverse Event|6|||
145450129|NCT00438360|524498166|FG001|Overall Study|Adverse Event|1|||
145450130|NCT00438360|524498165|FG000|Overall Study|Lack of Efficacy|42|||
145450131|NCT00438360|524498166|FG001|Overall Study|Lack of Efficacy|27|||
145450132|NCT00438360|524498165|FG000|Overall Study|Other|24|||
145450133|NCT00438360|524498166|FG001|Overall Study|Other|15|||
145450134|NCT00758069|524498168|FG000|Overall Study|Lack of Efficacy|0|||
145450135|NCT00758069|524498169|FG001|Overall Study|Lack of Efficacy|0|||
145450136|NCT00758069|524498170|FG002|Overall Study|Lack of Efficacy|1|||
145450137|NCT00758069|524498168|FG000|Overall Study|Incorrect Study Drug|1|||
145450138|NCT00758069|524498169|FG001|Overall Study|Incorrect Study Drug|0|||
145450139|NCT00758069|524498170|FG002|Overall Study|Incorrect Study Drug|0|||
145450140|NCT02277691|524498171|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
145450141|NCT02277691|524498171|FG000|Overall Study|Voluntary Withdrawal|7|||
145450142|NCT02277691|524498171|FG000|Overall Study|Lack of Efficacy|5|||
145450143|NCT02277691|524498171|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
145626153|NCT00783692|525144212|FG005|Induction Phase|Other|0|||
145626154|NCT00783692|525144213|FG006|Induction Phase|Other|0|||
145450144|NCT01147250|524498174|FG000|Overall Study|Lost to Follow-up|14|||
145450145|NCT01147250|524498175|FG001|Overall Study|Lost to Follow-up|11|||
145626155|NCT00783692|525144207|FG000|Maintenance Phase|Adverse Event|7|||
145626156|NCT00783692|525144208|FG001|Maintenance Phase|Adverse Event|0|||
145626157|NCT00783692|525144209|FG002|Maintenance Phase|Adverse Event|0|||
145450146|NCT01147250|524498174|FG000|Overall Study|Withdrawal by Subject|83|||
145450147|NCT01147250|524498175|FG001|Overall Study|Withdrawal by Subject|88|||
145450148|NCT01147250|524498174|FG000|Overall Study|Site termination by sponsor|13|||
145450149|NCT01147250|524498175|FG001|Overall Study|Site termination by sponsor|5|||
145450150|NCT01147250|524498174|FG000|Overall Study|Other than specified|0|||
145450151|NCT01147250|524498175|FG001|Overall Study|Other than specified|1|||
145450152|NCT02684617|524498176|FG000|Overall Study|Adverse Event|1|||
145450153|NCT02684617|524498177|FG001|Overall Study|Adverse Event|0|||
145450154|NCT02684617|524498178|FG002|Overall Study|Adverse Event|1|||
145450155|NCT02684617|524498176|FG000|Overall Study|Death|8|||
145450156|NCT02684617|524498177|FG001|Overall Study|Death|16|||
145450157|NCT02684617|524498178|FG002|Overall Study|Death|28|||
145450158|NCT02684617|524498176|FG000|Overall Study|Withdrawal by Subject|2|||
145450159|NCT02684617|524498177|FG001|Overall Study|Withdrawal by Subject|0|||
145450160|NCT02684617|524498178|FG002|Overall Study|Withdrawal by Subject|4|||
145450161|NCT02684617|524498176|FG000|Overall Study|Screen Failure|1|||
145450162|NCT02684617|524498177|FG001|Overall Study|Screen Failure|0|||
145450163|NCT02684617|524498178|FG002|Overall Study|Screen Failure|2|||
145450164|NCT02684617|524498176|FG000|Overall Study|Study Terminated by Sponsor|6|||
145450165|NCT02684617|524498177|FG001|Overall Study|Study Terminated by Sponsor|1|||
145450166|NCT02684617|524498178|FG002|Overall Study|Study Terminated by Sponsor|5|||
145450167|NCT01164891|524498179|FG000|Overall Study|Disease Progression|5|||
145450168|NCT01164891|524498179|FG000|Overall Study|Adverse Event|1|||
145450169|NCT00441142|524498180|FG000|Overall Study|Adverse Event|2|||
145450170|NCT00441142|524498181|FG001|Overall Study|Adverse Event|3|||
145450171|NCT00441142|524498182|FG002|Overall Study|Adverse Event|3|||
145450172|NCT00441142|524498183|FG003|Overall Study|Adverse Event|22|||
145450173|NCT00441142|524498180|FG000|Overall Study|Lack of Efficacy|3|||
145450174|NCT00441142|524498181|FG001|Overall Study|Lack of Efficacy|3|||
145450175|NCT00441142|524498182|FG002|Overall Study|Lack of Efficacy|17|||
145450176|NCT00441142|524498183|FG003|Overall Study|Lack of Efficacy|32|||
145450177|NCT00441142|524498180|FG000|Overall Study|Withdrawal by Subject|0|||
145450178|NCT00441142|524498181|FG001|Overall Study|Withdrawal by Subject|0|||
145450179|NCT00441142|524498182|FG002|Overall Study|Withdrawal by Subject|2|||
145450180|NCT00441142|524498183|FG003|Overall Study|Withdrawal by Subject|10|||
145450181|NCT00441142|524498180|FG000|Overall Study|Patient still receiving active study tx|1|||
145450182|NCT00441142|524498181|FG001|Overall Study|Patient still receiving active study tx|0|||
145450183|NCT00441142|524498182|FG002|Overall Study|Patient still receiving active study tx|0|||
145450184|NCT00441142|524498183|FG003|Overall Study|Patient still receiving active study tx|2|||
145450185|NCT00441142|524498180|FG000|Overall Study|Physician Decision|0|||
145450186|NCT00441142|524498181|FG001|Overall Study|Physician Decision|1|||
145450187|NCT00441142|524498182|FG002|Overall Study|Physician Decision|0|||
145450188|NCT00441142|524498183|FG003|Overall Study|Physician Decision|1|||
145450189|NCT00441142|524498180|FG000|Overall Study|Death|0|||
145450190|NCT00441142|524498181|FG001|Overall Study|Death|0|||
145450191|NCT00441142|524498182|FG002|Overall Study|Death|0|||
145450192|NCT00441142|524498183|FG003|Overall Study|Death|1|||
145450193|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
145450194|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
145450195|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
145450196|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
145450197|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
145450198|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
145450199|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
145450200|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
145450201|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145450202|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145450203|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145450204|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145450205|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
145450206|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
145450207|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145450208|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145450209|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145450210|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145450211|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
145450212|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
145450213|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
145450214|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
145450215|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
145450216|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
145450217|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145450218|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
145585785|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
145585786|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
145585787|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
145585788|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
145585789|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
145585790|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
145585791|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
145585792|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
145585793|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
145585794|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
145585795|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
145585796|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
145585797|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
145585798|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
145585799|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
145585800|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
145585801|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
145585802|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
145585803|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
145585804|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
145450219|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145450220|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145450221|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145450222|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145450223|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
145450224|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
145450225|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
145450226|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
145450227|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
145450228|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
145450229|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
145450230|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
145450231|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
145450232|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
145450233|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
145450234|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
145450235|NCT03985943|524498184|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
145450236|NCT03985943|524498185|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
145450237|NCT03985943|524498186|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
145450238|NCT03985943|524498187|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
145450239|NCT03985943|524498188|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
145450240|NCT03985943|524498189|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
145450241|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145450242|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145450243|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
145450244|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
145450245|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
145450246|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
145450247|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145450248|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145450249|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
145450250|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
145450251|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
145450252|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
145450253|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
145450254|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
145450255|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
145450256|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
145450257|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
145626158|NCT00783692|525144210|FG003|Maintenance Phase|Adverse Event|15|||
145450258|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
145450259|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145450260|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145450261|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145450262|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
145450263|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
145450264|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
145450265|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
145450266|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
145450267|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
145450268|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
145450269|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
145450270|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
145450271|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
145450272|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
145450273|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
145450274|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
145450275|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
145450276|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
145450277|NCT03985943|524498184|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
145450278|NCT03985943|524498185|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
145450279|NCT03985943|524498186|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
145450280|NCT03985943|524498187|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
145450281|NCT03985943|524498188|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
145450282|NCT03985943|524498189|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
145450283|NCT00338286|524498190|FG000|Overall Study|Withdrawal by Subject|50|||
145450284|NCT00338286|524498191|FG001|Overall Study|Withdrawal by Subject|54|||
145450285|NCT00338286|524498190|FG000|Overall Study|Lost to Follow-up|80|||
145450286|NCT00338286|524498191|FG001|Overall Study|Lost to Follow-up|66|||
145450287|NCT00338286|524498190|FG000|Overall Study|Other|103|||
145450288|NCT00338286|524498191|FG001|Overall Study|Other|93|||
145450289|NCT01265563|524498192|FG000|Overall Study|Withdrawal by Subject|0|||
145450290|NCT01265563|524498193|FG001|Overall Study|Withdrawal by Subject|1|||
145450291|NCT01265563|524498194|FG002|Overall Study|Withdrawal by Subject|1|||
145450292|NCT01265563|524498195|FG003|Overall Study|Withdrawal by Subject|0|||
145450293|NCT01265563|524498196|FG004|Overall Study|Withdrawal by Subject|2|||
145450294|NCT01524224|524498199|FG000|Overall Study|Progressive Disease|1|||
145450295|NCT01524224|524498200|FG001|Overall Study|Progressive Disease|0|||
145450296|NCT01524224|524498201|FG002|Overall Study|Progressive Disease|2|||
145450297|NCT01524224|524498202|FG003|Overall Study|Progressive Disease|1|||
145450298|NCT01524224|524498203|FG004|Overall Study|Progressive Disease|2|||
145450299|NCT01524224|524498204|FG005|Overall Study|Progressive Disease|1|||
145450300|NCT01524224|524498205|FG006|Overall Study|Progressive Disease|1|||
145450301|NCT01524224|524498206|FG007|Overall Study|Progressive Disease|5|||
145450302|NCT01524224|524498199|FG000|Overall Study|Withdrawal by Subject|2|||
145450303|NCT01524224|524498200|FG001|Overall Study|Withdrawal by Subject|0|||
145450304|NCT01524224|524498201|FG002|Overall Study|Withdrawal by Subject|0|||
145450305|NCT01524224|524498202|FG003|Overall Study|Withdrawal by Subject|0|||
145450306|NCT01524224|524498203|FG004|Overall Study|Withdrawal by Subject|0|||
145450307|NCT01524224|524498204|FG005|Overall Study|Withdrawal by Subject|0|||
145450308|NCT01524224|524498205|FG006|Overall Study|Withdrawal by Subject|2|||
145450309|NCT01524224|524498206|FG007|Overall Study|Withdrawal by Subject|0|||
145450310|NCT01524224|524498199|FG000|Overall Study|Adverse Event|0|||
145450311|NCT01524224|524498200|FG001|Overall Study|Adverse Event|1|||
145450312|NCT01524224|524498201|FG002|Overall Study|Adverse Event|0|||
145450313|NCT01524224|524498202|FG003|Overall Study|Adverse Event|0|||
145450314|NCT01524224|524498203|FG004|Overall Study|Adverse Event|0|||
145450315|NCT01524224|524498204|FG005|Overall Study|Adverse Event|1|||
145626159|NCT00783692|525144211|FG004|Maintenance Phase|Adverse Event|12|||
145626160|NCT00783692|525144212|FG005|Maintenance Phase|Adverse Event|9|||
145626161|NCT00783692|525144213|FG006|Maintenance Phase|Adverse Event|38|||
145626162|NCT00783692|525144207|FG000|Maintenance Phase|Protocol Violation|0|||
145450316|NCT01524224|524498205|FG006|Overall Study|Adverse Event|0|||
145450317|NCT01524224|524498206|FG007|Overall Study|Adverse Event|0|||
145450318|NCT01524224|524498199|FG000|Overall Study|Physician Decision|0|||
145450319|NCT01524224|524498200|FG001|Overall Study|Physician Decision|0|||
145450320|NCT01524224|524498201|FG002|Overall Study|Physician Decision|0|||
145450321|NCT01524224|524498202|FG003|Overall Study|Physician Decision|1|||
145450322|NCT01524224|524498203|FG004|Overall Study|Physician Decision|1|||
145450323|NCT01524224|524498204|FG005|Overall Study|Physician Decision|0|||
145450324|NCT01524224|524498205|FG006|Overall Study|Physician Decision|0|||
145450325|NCT01524224|524498206|FG007|Overall Study|Physician Decision|1|||
145626163|NCT00783692|525144208|FG001|Maintenance Phase|Protocol Violation|0|||
145450326|NCT01524224|524498199|FG000|Overall Study|Sponsor Decision|0|||
145450327|NCT01524224|524498200|FG001|Overall Study|Sponsor Decision|0|||
145450328|NCT01524224|524498201|FG002|Overall Study|Sponsor Decision|0|||
145450329|NCT01524224|524498202|FG003|Overall Study|Sponsor Decision|0|||
145450330|NCT01524224|524498203|FG004|Overall Study|Sponsor Decision|1|||
145450331|NCT01524224|524498204|FG005|Overall Study|Sponsor Decision|0|||
145450332|NCT01524224|524498205|FG006|Overall Study|Sponsor Decision|0|||
145450333|NCT01524224|524498206|FG007|Overall Study|Sponsor Decision|0|||
145450334|NCT03517371|524498208|FG000|Overall Study|Adverse Event|8|||
145450335|NCT03517371|524498209|FG001|Overall Study|Adverse Event|9|||
145450336|NCT03517371|524498208|FG000|Overall Study|Lost to Follow-up|1|||
145450337|NCT03517371|524498209|FG001|Overall Study|Lost to Follow-up|2|||
145450338|NCT03517371|524498208|FG000|Overall Study|Withdrawal by Subject|4|||
145450339|NCT03517371|524498209|FG001|Overall Study|Withdrawal by Subject|4|||
145450340|NCT03517371|524498208|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
145450341|NCT03517371|524498209|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
145450342|NCT03517371|524498208|FG000|Overall Study|COVID restrictions|2|||
145450343|NCT03517371|524498209|FG001|Overall Study|COVID restrictions|0|||
145450344|NCT03517371|524498208|FG000|Overall Study|Receiving DBS Surgery|0|||
145450345|NCT03517371|524498209|FG001|Overall Study|Receiving DBS Surgery|1|||
145450346|NCT05411822|524498210|FG000|Overall Study|Withdrawal by Subject|2|||
145450347|NCT05411822|524498211|FG001|Overall Study|Withdrawal by Subject|1|||
145450348|NCT05312697|524498212|FG000|Overall Study|Sponsor Terminated Trial|2|||
145450349|NCT04283656|524498213|FG000|Overall Study|Adverse Event|1|||
145450350|NCT04283656|524498214|FG001|Overall Study|Adverse Event|0|||
145450351|NCT04283656|524498213|FG000|Overall Study|Lost to Follow-up|0|||
145450352|NCT04283656|524498214|FG001|Overall Study|Lost to Follow-up|1|||
145450353|NCT02318368|524498215|FG000|Overall Study|Withdrawal by Subject|2|||
145450354|NCT02318368|524498216|FG001|Overall Study|Withdrawal by Subject|0|||
145450355|NCT02318368|524498215|FG000|Overall Study|Study terminated by the sponsor|5|||
145450356|NCT02318368|524498216|FG001|Overall Study|Study terminated by the sponsor|2|||
145450357|NCT02318368|524498215|FG000|Overall Study|Death|0|||
145450358|NCT02318368|524498216|FG001|Overall Study|Death|1|||
145450359|NCT02674464|524498217|FG000|Overall Study|Death|10|||
145450360|NCT02674464|524498218|FG001|Overall Study|Death|21|||
145450361|NCT02674464|524498217|FG000|Overall Study|Withdrawal by Subject|24|||
145450362|NCT02674464|524498218|FG001|Overall Study|Withdrawal by Subject|44|||
145450363|NCT02674464|524498217|FG000|Overall Study|Lost to Follow-up|97|||
145450364|NCT02674464|524498218|FG001|Overall Study|Lost to Follow-up|92|||
145450365|NCT02674464|524498217|FG000|Overall Study|Outside survey window|6|||
145450366|NCT02674464|524498218|FG001|Overall Study|Outside survey window|3|||
145450367|NCT00783835|524498219|FG000|Overall Study|Adverse Event|3|||
145450368|NCT00783835|524498219|FG000|Overall Study|Medical Criteria|1|||
145450369|NCT00783835|524498219|FG000|Overall Study|Withdrawal by Subject|2|||
145450370|NCT00783835|524498219|FG000|Overall Study|Lost to Follow-up|1|||
145450371|NCT00783835|524498219|FG000|Overall Study|Participant not Adherent|3|||
145450372|NCT04660552|524498220|FG000|Overall Study|Withdrawal by Subject|3|||
145450373|NCT04660552|524498221|FG001|Overall Study|Withdrawal by Subject|1|||
145450374|NCT01270880|524498227|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
145450375|NCT00976716|524498228|FG000|Overall Study|Adverse Event|1|||
145450376|NCT04222699|524498229|FG000|Overall Study|Lost to Follow-up|2|||
145450377|NCT03583359|524498235|FG000|Overall Study|Withdrawal by Subject|15|||
145450378|NCT03583359|524498236|FG001|Overall Study|Withdrawal by Subject|6|||
145450379|NCT03583359|524498235|FG000|Overall Study|Lost to Follow-up|12|||
145450380|NCT03583359|524498236|FG001|Overall Study|Lost to Follow-up|3|||
145450381|NCT03583359|524498235|FG000|Overall Study|Adverse Event|0|||
145450382|NCT03583359|524498236|FG001|Overall Study|Adverse Event|1|||
145450383|NCT03583359|524498235|FG000|Overall Study|Protocol Violation|0|||
145450384|NCT03583359|524498236|FG001|Overall Study|Protocol Violation|1|||
145450385|NCT03583359|524498235|FG000|Overall Study|Other|2|||
145450386|NCT03583359|524498236|FG001|Overall Study|Other|1|||
145450387|NCT00703846|524498242|FG000|Overall Study|Adverse Event|8|||
145450388|NCT00703846|524498242|FG000|Overall Study|Lost to Follow-up|55|||
145450389|NCT00703846|524498242|FG000|Overall Study|Lack of Efficacy|15|||
145450390|NCT00703846|524498242|FG000|Overall Study|Noncompliance with Study Treatment|2|||
145450391|NCT00703846|524498242|FG000|Overall Study|Withdrawal by Subject|40|||
145450392|NCT00703846|524498242|FG000|Overall Study|Death|1|||
145450393|NCT00703846|524498242|FG000|Overall Study|Other|14|||
145450394|NCT00703846|524498242|FG000|Overall Study|Did Not Receive Study Drug|2|||
145450395|NCT04601532|524498243|FG000|Overall Study|Lost to Follow-up|1|||
145450396|NCT04601532|524498244|FG001|Overall Study|Lost to Follow-up|2|||
145450397|NCT04601532|524498243|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
145450398|NCT04601532|524498244|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
145450399|NCT02566785|524498245|FG000|Overall Study|Lost to Follow-up|0|||
145450400|NCT02566785|524498246|FG001|Overall Study|Lost to Follow-up|2|||
145450401|NCT02566785|524498245|FG000|Overall Study|Worsening condition|1|||
145450402|NCT02566785|524498246|FG001|Overall Study|Worsening condition|1|||
145450403|NCT00837161|524498249|FG000|Overall Study|refused hysterectomy|2|||
145450404|NCT01659996|524498250|FG000|Overall Study|Protocol Violation|3|||
145450405|NCT01659996|524498251|FG001|Overall Study|Protocol Violation|3|||
145450406|NCT01659996|524498252|FG002|Overall Study|Protocol Violation|3|||
145450407|NCT01659996|524498250|FG000|Overall Study|Lost to Follow-up|1|||
145450408|NCT01659996|524498251|FG001|Overall Study|Lost to Follow-up|3|||
145450409|NCT01659996|524498252|FG002|Overall Study|Lost to Follow-up|2|||
145585805|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
145585806|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
145585807|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
145585808|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
145585809|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
145585810|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
145585811|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
145585812|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
145585813|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
145585814|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
145585815|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
145585816|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
145585817|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
145585818|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
145585819|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
145585820|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
145585821|NCT01434602|524997655|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
145585822|NCT01434602|524997656|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
145585823|NCT01434602|524997657|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
145585824|NCT01434602|524997658|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
145585825|NCT01434602|524997659|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
145585826|NCT05077267|524997665|FG000|Treatment Period|Lost to Follow-up|0|||
145585827|NCT05077267|524997666|FG001|Treatment Period|Lost to Follow-up|1|||
145585828|NCT05077267|524997667|FG002|Treatment Period|Lost to Follow-up|0|||
145585829|NCT05077267|524997665|FG000|Treatment Period|Withdrawal by Subject|0|||
145585830|NCT05077267|524997666|FG001|Treatment Period|Withdrawal by Subject|1|||
145585831|NCT05077267|524997667|FG002|Treatment Period|Withdrawal by Subject|0|||
145585832|NCT05077267|524997665|FG000|Follow-up Period|Lost to Follow-up|0|||
145585833|NCT05077267|524997666|FG001|Follow-up Period|Lost to Follow-up|5|||
145585834|NCT05077267|524997667|FG002|Follow-up Period|Lost to Follow-up|7|||
145585835|NCT05077267|524997665|FG000|Follow-up Period|Withdrawal by Subject|0|||
145626164|NCT00783692|525144209|FG002|Maintenance Phase|Protocol Violation|0|||
145626165|NCT00783692|525144210|FG003|Maintenance Phase|Protocol Violation|1|||
145626166|NCT00783692|525144211|FG004|Maintenance Phase|Protocol Violation|2|||
145450410|NCT01659996|524498250|FG000|Overall Study|Adverse Event|0|||
145450411|NCT01659996|524498251|FG001|Overall Study|Adverse Event|0|||
145450412|NCT01659996|524498252|FG002|Overall Study|Adverse Event|1|||
145450413|NCT01659996|524498250|FG000|Overall Study|Withdrawal by Subject|4|||
145450414|NCT01659996|524498251|FG001|Overall Study|Withdrawal by Subject|1|||
145450415|NCT01659996|524498252|FG002|Overall Study|Withdrawal by Subject|5|||
145450416|NCT03206918|524498253|FG000|Overall Study|Death|11|||
145450417|NCT03206918|524498253|FG000|Overall Study|Withdrawal by Subject|5|||
145450418|NCT03206918|524498253|FG000|Overall Study|Study terminated by sponsor|12|||
145450419|NCT03206918|524498253|FG000|Overall Study|Lost to Follow-up|3|||
145450420|NCT03206918|524498253|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
145450421|NCT02701764|524498254|FG000|Overall Study|Lost to Follow-up|0|||
145450422|NCT02701764|524498255|FG001|Overall Study|Lost to Follow-up|1|||
145450423|NCT03823287|524498256|FG000|Overall Study|Withdrawal by Subject|25|||
145450424|NCT03823287|524498257|FG001|Overall Study|Withdrawal by Subject|17|||
145450425|NCT03823287|524498256|FG000|Overall Study|Death|13|||
145450426|NCT03823287|524498257|FG001|Overall Study|Death|7|||
145450427|NCT03823287|524498256|FG000|Overall Study|Lost to Follow-up|7|||
145450428|NCT03823287|524498257|FG001|Overall Study|Lost to Follow-up|8|||
145450429|NCT03823287|524498256|FG000|Overall Study|Adverse Event|6|||
145450430|NCT03823287|524498257|FG001|Overall Study|Adverse Event|8|||
145450431|NCT03823287|524498256|FG000|Overall Study|Physician Decision|5|||
145450432|NCT03823287|524498257|FG001|Overall Study|Physician Decision|2|||
145450433|NCT03823287|524498256|FG000|Overall Study|Lack of Efficacy|2|||
145450434|NCT03823287|524498257|FG001|Overall Study|Lack of Efficacy|0|||
145585836|NCT05077267|524997666|FG001|Follow-up Period|Withdrawal by Subject|2|||
145585837|NCT05077267|524997667|FG002|Follow-up Period|Withdrawal by Subject|5|||
145585838|NCT05077267|524997665|FG000|Follow-up Period|Study terminated by sponsor|0|||
145626167|NCT00783692|525144212|FG005|Maintenance Phase|Protocol Violation|3|||
145450435|NCT03823287|524498256|FG000|Overall Study|Other|2|||
145450436|NCT03823287|524498257|FG001|Overall Study|Other|4|||
145450437|NCT01059864|524498264|FG000|Open-Label Run-In Phase|Adverse Event|7|||
145450438|NCT01059864|524498265|FG001|Open-Label Run-In Phase|Adverse Event|0|||
145450439|NCT01059864|524498266|FG002|Open-Label Run-In Phase|Adverse Event|0|||
145450440|NCT01059864|524498264|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
145450441|NCT01059864|524498265|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
145450442|NCT01059864|524498266|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
145450443|NCT01059864|524498264|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
145450444|NCT01059864|524498265|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
145450445|NCT01059864|524498266|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
145450446|NCT01059864|524498264|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
145450447|NCT01059864|524498265|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
145450448|NCT01059864|524498266|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
145450449|NCT01059864|524498264|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
145450450|NCT01059864|524498265|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
145450451|NCT01059864|524498266|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
145450452|NCT01059864|524498264|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145450453|NCT01059864|524498265|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
145450454|NCT01059864|524498266|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
145450455|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Adverse Event|21|||
145450456|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Adverse Event|34|||
145450457|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Adverse Event|14|||
145450458|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Adverse Event|17|||
145450459|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Adverse Event|0|||
145450460|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
145450461|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
145450462|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
145450463|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
145450464|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
145450465|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
145450466|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
145450467|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
145450468|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
145450469|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
145450470|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Physician Decision|2|||
145450471|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Physician Decision|4|||
145450472|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Physician Decision|4|||
145450473|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Physician Decision|4|||
145450474|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Physician Decision|0|||
145450475|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
145450476|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
145450477|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
145450478|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
145450479|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
145450480|NCT00451958|524498267|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
145450481|NCT00451958|524498268|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
145450482|NCT00451958|524498269|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
145450483|NCT00451958|524498270|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
145450484|NCT00451958|524498271|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
145450485|NCT03110029|524498272|FG000|Overall Study|Withdrawal by Subject|1|||
145450486|NCT03110029|524498273|FG001|Overall Study|Withdrawal by Subject|1|||
145450487|NCT03281629|524498274|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
145450488|NCT03281629|524498275|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
145450489|NCT03281629|524498274|FG000|Overall Study|Death|0|||
145450490|NCT03281629|524498275|FG001|Overall Study|Death|1|||
145450491|NCT03281629|524498274|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
145450492|NCT03281629|524498275|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
145450493|NCT02175277|524498276|FG000|Overall Study|Protocol-specified Criteria|1|||
145450494|NCT00782171|524499865|FG000|Overall Study|Lost to Follow-up|2|||
145585839|NCT05077267|524997666|FG001|Follow-up Period|Study terminated by sponsor|27|||
145585840|NCT05077267|524997667|FG002|Follow-up Period|Study terminated by sponsor|23|||
145585841|NCT05077267|524997665|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
145585842|NCT05077267|524997666|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
145585843|NCT05077267|524997667|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
145585844|NCT05077267|524997665|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
145450495|NCT00782171|524499866|FG001|Overall Study|Lost to Follow-up|2|||
145450496|NCT00782171|524499865|FG000|Overall Study|Withdrawal by Subject|2|||
145450497|NCT00782171|524499866|FG001|Overall Study|Withdrawal by Subject|1|||
145450498|NCT00782171|524499865|FG000|Overall Study|complications|3|||
145450499|NCT00782171|524499866|FG001|Overall Study|complications|1|||
145450500|NCT00782171|524499865|FG000|Overall Study|others|7|||
145450501|NCT00782171|524499866|FG001|Overall Study|others|9|||
145450502|NCT00782171|524499865|FG000|Overall Study|not eligible|8|||
145450503|NCT00782171|524499866|FG001|Overall Study|not eligible|6|||
145450504|NCT02547038|524499869|FG000|Overall Study|Lost to Follow-up|3|||
145450505|NCT02547038|524499870|FG001|Overall Study|Lost to Follow-up|2|||
145450506|NCT00623233|524499871|FG000|Overall Study|Adverse Event|10|||
145450507|NCT00623233|524499871|FG000|Overall Study|Physician Decision|10|||
145450508|NCT00623233|524499871|FG000|Overall Study|Lost to Follow-up|1|||
145450509|NCT00623233|524499871|FG000|Overall Study|Withdrawal by Subject|3|||
145450510|NCT00559845|524499872|FG000|Overall Study|Withdrew Consent|1|||
145450511|NCT00559845|524499872|FG000|Overall Study|Disease Progression|1|||
145450512|NCT00559845|524499872|FG000|Overall Study|Adverse Event|3|||
145450513|NCT00559845|524499872|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
145450514|NCT00559845|524499872|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
145450515|NCT00459875|524499873|FG000|Overall Study|Ineligible participant|1|||
145450516|NCT00459875|524499873|FG000|Overall Study|Adverse Event|2|||
145450517|NCT02150057|524499874|FG000|Overall Study|Lost to Follow-up|6|||
145450518|NCT02150057|524499875|FG001|Overall Study|Lost to Follow-up|4|||
145450519|NCT01558115|524499876|FG000|Overall Study|Withdrawal by Subject|3|||
145450520|NCT01558115|524499876|FG000|Overall Study|Study closed due to poor enrollment|4|||
145450521|NCT01696994|524499877|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
145450522|NCT01696994|524499878|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
145450523|NCT01696994|524499877|FG000|Overall Study|Died Before Randomization|1|||
145450524|NCT01696994|524499878|FG001|Overall Study|Died Before Randomization|2|||
145450525|NCT01696994|524499877|FG000|Overall Study|Died Before ASU (Control)|73|||
145450526|NCT01696994|524499878|FG001|Overall Study|Died Before ASU (Control)|0|||
145450527|NCT01696994|524499877|FG000|Overall Study|No Ovaries at Baseline|4807|||
145450528|NCT01696994|524499878|FG001|Overall Study|No Ovaries at Baseline|4851|||
145450529|NCT01696994|524499877|FG000|Overall Study|Refused ASU (Control)|311|||
145450530|NCT01696994|524499878|FG001|Overall Study|Refused ASU (Control)|0|||
145450531|NCT01696994|524499877|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
145450532|NCT01696994|524499878|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
145450533|NCT00576628|524499881|FG000|Overall Study|Adverse Event|11|||
145450534|NCT00576628|524499881|FG000|Overall Study|Death|2|||
145450535|NCT00576628|524499881|FG000|Overall Study|Failure to return|1|||
145450536|NCT00576628|524499881|FG000|Overall Study|Refused Treatment|8|||
145450537|NCT00576628|524499881|FG000|Overall Study|Pregnancy|1|||
145450538|NCT00576628|524499881|FG000|Overall Study|RBC transfusion|1|||
145450539|NCT00576628|524499881|FG000|Overall Study|Progression of Kidney Disease|1|||
145450540|NCT00576628|524499881|FG000|Overall Study|Progression of Renal Failure|1|||
145450541|NCT00576628|524499881|FG000|Overall Study|The patient move into other town|1|||
145450542|NCT00576628|524499881|FG000|Overall Study|Transplantation|1|||
145450543|NCT00576628|524499881|FG000|Overall Study|Dialysis|15|||
145450544|NCT02516982|524499882|FG000|Overall Study|Called in to antenatal appointment|32|||
145450545|NCT02516982|524499883|FG001|Overall Study|Called in to antenatal appointment|35|||
145450546|NCT02516982|524499884|FG002|Overall Study|Called in to antenatal appointment|0|||
145450547|NCT02516982|524499885|FG003|Overall Study|Called in to antenatal appointment|0|||
145450548|NCT02516982|524499882|FG000|Overall Study|Withdrawal by Subject|0|||
145450549|NCT02516982|524499883|FG001|Overall Study|Withdrawal by Subject|0|||
145450550|NCT02516982|524499884|FG002|Overall Study|Withdrawal by Subject|1|||
145450551|NCT02516982|524499885|FG003|Overall Study|Withdrawal by Subject|2|||
145450552|NCT02516982|524499882|FG000|Overall Study|Protocol Violation|0|||
145450553|NCT02516982|524499883|FG001|Overall Study|Protocol Violation|0|||
145450554|NCT02516982|524499884|FG002|Overall Study|Protocol Violation|1|||
145450555|NCT02516982|524499885|FG003|Overall Study|Protocol Violation|1|||
145450556|NCT02516982|524499882|FG000|Overall Study|Did not install the app|0|||
145450557|NCT02516982|524499883|FG001|Overall Study|Did not install the app|0|||
145450558|NCT02516982|524499884|FG002|Overall Study|Did not install the app|46|||
145450559|NCT02516982|524499885|FG003|Overall Study|Did not install the app|47|||
145450560|NCT02120781|524499892|FG000|Overall Study|Physician Decision|2|||
145450561|NCT02120781|524499893|FG001|Overall Study|Physician Decision|0|||
145450562|NCT02120781|524499892|FG000|Overall Study|Completion not documented|2|||
145450563|NCT02120781|524499893|FG001|Overall Study|Completion not documented|1|||
145450564|NCT00654745|524499896|FG000|Overall Study|Adverse Event|12|||
145450565|NCT00654745|524499896|FG000|Overall Study|Lost to Follow-up|7|||
145450566|NCT00654745|524499896|FG000|Overall Study|Protocol Violation|11|||
145450567|NCT00654745|524499896|FG000|Overall Study|Withdrawal by Subject|10|||
145626168|NCT00783692|525144213|FG006|Maintenance Phase|Protocol Violation|4|||
145626169|NCT00783692|525144207|FG000|Maintenance Phase|Lack of Efficacy|79|||
145450568|NCT00654745|524499896|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
145450569|NCT00748618|524499897|FG000|Overall Study|Adverse Event|1|||
145450570|NCT00748618|524499898|FG001|Overall Study|Adverse Event|0|||
145450571|NCT00466947|524499899|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
145450572|NCT00466947|524499900|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
145450573|NCT00466947|524499899|FG000|Study End Analysis Period|Adverse Event|35|||
145450574|NCT00466947|524499900|FG001|Study End Analysis Period|Adverse Event|43|||
145450575|NCT00466947|524499899|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
145450576|NCT00466947|524499900|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
145450577|NCT00466947|524499899|FG000|Study End Analysis Period|Physician Decision|29|||
145450578|NCT00466947|524499900|FG001|Study End Analysis Period|Physician Decision|29|||
145450579|NCT00466947|524499899|FG000|Study End Analysis Period|Protocol Violation|9|||
145450580|NCT00466947|524499900|FG001|Study End Analysis Period|Protocol Violation|17|||
145450581|NCT00466947|524499899|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
145450582|NCT00466947|524499900|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
145450583|NCT00466947|524499899|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
145450584|NCT00466947|524499900|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
145450585|NCT00466947|524499899|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
145450586|NCT00466947|524499900|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
145450587|NCT00466947|524499899|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
145450588|NCT00466947|524499900|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
145450589|NCT03286543|524499903|FG000|Consented|Screen failure before randomization|2|||
145450590|NCT03286543|524499904|FG001|Consented|Screen failure before randomization|0|||
145450591|NCT03286543|524499905|FG002|Consented|Screen failure before randomization|0|||
145450592|NCT03286543|524499903|FG000|Consented|Screen failure before enrollment|4|||
145450593|NCT03286543|524499904|FG001|Consented|Screen failure before enrollment|0|||
145450594|NCT03286543|524499905|FG002|Consented|Screen failure before enrollment|0|||
145450595|NCT03286543|524499903|FG000|Consented|TKA cancelled after enrollment|1|||
145450596|NCT03286543|524499904|FG001|Consented|TKA cancelled after enrollment|0|||
145450597|NCT03286543|524499905|FG002|Consented|TKA cancelled after enrollment|0|||
145450598|NCT03286543|524499903|FG000|Consented|Withdrawn from study|12|||
145450599|NCT03286543|524499904|FG001|Consented|Withdrawn from study|0|||
145450600|NCT03286543|524499905|FG002|Consented|Withdrawn from study|0|||
145450601|NCT03286543|524499903|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
145450602|NCT03286543|524499904|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
145450603|NCT03286543|524499905|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
145450604|NCT03286543|524499903|FG000|Study Enrollment|Withdrawn from study|0|||
145450605|NCT03286543|524499904|FG001|Study Enrollment|Withdrawn from study|6|||
145450606|NCT03286543|524499905|FG002|Study Enrollment|Withdrawn from study|6|||
145450607|NCT04952597|524499909|FG000|Overall Study|Death|12|||
145450608|NCT04952597|524499910|FG001|Overall Study|Death|13|||
145450609|NCT04952597|524499911|FG002|Overall Study|Death|14|||
145450610|NCT04952597|524499909|FG000|Overall Study|Withdrawal by Subject|1|||
145450611|NCT04952597|524499910|FG001|Overall Study|Withdrawal by Subject|0|||
145450612|NCT04952597|524499911|FG002|Overall Study|Withdrawal by Subject|3|||
145450613|NCT04952597|524499909|FG000|Overall Study|Lost to Follow-up|0|||
145450614|NCT04952597|524499910|FG001|Overall Study|Lost to Follow-up|1|||
145450615|NCT04952597|524499911|FG002|Overall Study|Lost to Follow-up|1|||
145450616|NCT00022763|524499919|FG000|Overall Study|Adverse Event|1|||
145450617|NCT00022763|524499920|FG001|Overall Study|Adverse Event|2|||
145450618|NCT00022763|524499919|FG000|Overall Study|Injection Site Reactions|0|||
145450619|NCT00022763|524499920|FG001|Overall Study|Injection Site Reactions|2|||
145450620|NCT00022763|524499919|FG000|Overall Study|Death|0|||
145450621|NCT00022763|524499920|FG001|Overall Study|Death|1|||
145450622|NCT00022763|524499919|FG000|Overall Study|Lost to Follow-up|0|||
145450623|NCT00022763|524499920|FG001|Overall Study|Lost to Follow-up|3|||
145450624|NCT00022763|524499919|FG000|Overall Study|Withdrawal by Subject|4|||
145450625|NCT00022763|524499920|FG001|Overall Study|Withdrawal by Subject|7|||
145450626|NCT00022763|524499919|FG000|Overall Study|Insufficient Therapy|1|||
145450627|NCT00022763|524499920|FG001|Overall Study|Insufficient Therapy|0|||
145450628|NCT00022763|524499919|FG000|Overall Study|Admin|3|||
145450629|NCT00022763|524499920|FG001|Overall Study|Admin|2|||
145450630|NCT04908865|524499921|FG000|Overall Study|Adverse Event|2|||
145450631|NCT04908865|524499921|FG000|Overall Study|Lack of Efficacy|5|||
145450632|NCT04908865|524499921|FG000|Overall Study|Lost to Follow-up|1|||
145450633|NCT02141399|524499922|FG000|Overall Study|Adverse Event|158|||
145450634|NCT02141399|524499922|FG000|Overall Study|Lack of Efficacy|62|||
145450635|NCT02141399|524499922|FG000|Overall Study|Lost to Follow-up|151|||
145450636|NCT02141399|524499922|FG000|Overall Study|Non-compliance with study drug|18|||
145450637|NCT02141399|524499922|FG000|Overall Study|Other|45|||
145450638|NCT02141399|524499922|FG000|Overall Study|Physician Decision|17|||
145585845|NCT05077267|524997666|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
145585846|NCT05077267|524997667|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
145450639|NCT02141399|524499922|FG000|Overall Study|Pregnancy|3|||
145450640|NCT02141399|524499922|FG000|Overall Study|Protocol Violation|38|||
145450641|NCT02141399|524499922|FG000|Overall Study|Withdrawal by Subject|238|||
145450642|NCT02141399|524499922|FG000|Overall Study|Failure to meet eligibility criteria|14|||
145450643|NCT04445519|524499923|FG000|Overall Study|Due to adaptive design|3|||
145450644|NCT04445519|524499924|FG001|Overall Study|Due to adaptive design|0|||
145450645|NCT04445519|524499925|FG002|Overall Study|Due to adaptive design|0|||
145450646|NCT04445519|524499923|FG000|Overall Study|Lost to Follow-up|0|||
145450647|NCT04445519|524499924|FG001|Overall Study|Lost to Follow-up|1|||
145450648|NCT04445519|524499925|FG002|Overall Study|Lost to Follow-up|4|||
145450649|NCT04445519|524499923|FG000|Overall Study|Sponsor or IRB Decision|0|||
145450650|NCT04445519|524499924|FG001|Overall Study|Sponsor or IRB Decision|1|||
145450651|NCT04445519|524499925|FG002|Overall Study|Sponsor or IRB Decision|2|||
145450652|NCT04445519|524499923|FG000|Overall Study|Withdrawal by Subject|0|||
145585847|NCT02308033|524997668|FG000|Overall Study|Normal Gram stain at Baseline|13|||
145450653|NCT04445519|524499924|FG001|Overall Study|Withdrawal by Subject|3|||
145450654|NCT04445519|524499925|FG002|Overall Study|Withdrawal by Subject|3|||
145450655|NCT04445519|524499923|FG000|Overall Study|Adverse Event|0|||
145450656|NCT04445519|524499924|FG001|Overall Study|Adverse Event|8|||
145450657|NCT04445519|524499925|FG002|Overall Study|Adverse Event|6|||
145450658|NCT04445519|524499923|FG000|Overall Study|Other Reason|0|||
145450659|NCT04445519|524499924|FG001|Overall Study|Other Reason|1|||
145450660|NCT04445519|524499925|FG002|Overall Study|Other Reason|1|||
145450661|NCT04445519|524499923|FG000|Overall Study|Protocol Violation|0|||
145450662|NCT04445519|524499924|FG001|Overall Study|Protocol Violation|0|||
145450663|NCT04445519|524499925|FG002|Overall Study|Protocol Violation|1|||
145450664|NCT01345929|524499926|FG000|Overall Study|Withdrawal by Subject|9|||
145450665|NCT01345929|524499927|FG001|Overall Study|Withdrawal by Subject|8|||
145450666|NCT01345929|524499926|FG000|Overall Study|Lost to Follow-up|9|||
145450667|NCT01345929|524499927|FG001|Overall Study|Lost to Follow-up|9|||
145450668|NCT01345929|524499926|FG000|Overall Study|Adverse Event|0|||
145450669|NCT01345929|524499927|FG001|Overall Study|Adverse Event|1|||
145450670|NCT01345929|524499926|FG000|Overall Study|Didn't meet eligibility criteria|2|||
145450671|NCT01345929|524499927|FG001|Overall Study|Didn't meet eligibility criteria|0|||
145450672|NCT01345929|524499926|FG000|Overall Study|40,000 CFU/ML|1|||
145450673|NCT01345929|524499927|FG001|Overall Study|40,000 CFU/ML|0|||
145450674|NCT01345929|524499926|FG000|Overall Study|Patient withdrawal|0|||
145450675|NCT01345929|524499927|FG001|Overall Study|Patient withdrawal|1|||
145450676|NCT02819297|524499932|FG000|Overall Study|Withdrawal by Subject|25|||
145450677|NCT02819297|524499933|FG001|Overall Study|Withdrawal by Subject|13|||
145450678|NCT02819297|524499932|FG000|Overall Study|Lost to Follow-up|12|||
145450679|NCT02819297|524499933|FG001|Overall Study|Lost to Follow-up|14|||
145450680|NCT02819297|524499932|FG000|Overall Study|Adverse Event|12|||
145450681|NCT02819297|524499933|FG001|Overall Study|Adverse Event|10|||
145450682|NCT02819297|524499932|FG000|Overall Study|Physician Decision|5|||
145450683|NCT02819297|524499933|FG001|Overall Study|Physician Decision|5|||
145450684|NCT02819297|524499932|FG000|Overall Study|Lack of Efficacy|5|||
145450685|NCT02819297|524499933|FG001|Overall Study|Lack of Efficacy|8|||
145450686|NCT02819297|524499932|FG000|Overall Study|Protocol Violation|1|||
145450687|NCT02819297|524499933|FG001|Overall Study|Protocol Violation|2|||
145450688|NCT02858440|524499934|FG000|Overall Study|Lost to Follow-up|3|||
145450689|NCT02858440|524499934|FG000|Overall Study|Protocol Violation|2|||
145450690|NCT02858440|524499934|FG000|Overall Study|Consent withdrawal|3|||
145450691|NCT02858440|524499934|FG000|Overall Study|Migrated/moved from study area|4|||
145450692|NCT01670279|524499935|FG000|Overall Study|Adverse Event|0|||
145450693|NCT01670279|524499936|FG001|Overall Study|Adverse Event|1|||
145450694|NCT01670279|524499937|FG002|Overall Study|Adverse Event|0|||
145450695|NCT01670279|524499938|FG003|Overall Study|Adverse Event|0|||
145450696|NCT01670279|524499935|FG000|Overall Study|Physician Decision|0|||
145450697|NCT01670279|524499936|FG001|Overall Study|Physician Decision|1|||
145450698|NCT01670279|524499937|FG002|Overall Study|Physician Decision|0|||
145450699|NCT01670279|524499938|FG003|Overall Study|Physician Decision|0|||
145450700|NCT01670279|524499935|FG000|Overall Study|Participant met withdrawal criteria|0|||
145450701|NCT01670279|524499936|FG001|Overall Study|Participant met withdrawal criteria|0|||
145450702|NCT01670279|524499937|FG002|Overall Study|Participant met withdrawal criteria|0|||
145450703|NCT01670279|524499938|FG003|Overall Study|Participant met withdrawal criteria|1|||
145450704|NCT01534351|524499941|FG000|Overall Study|Study Terminated Early|1|||
145585848|NCT02308033|524997669|FG001|Overall Study|Normal Gram stain at Baseline|10|||
145585849|NCT02308033|524997668|FG000|Overall Study|Positive for STD at Baseline|7|||
145585850|NCT02308033|524997669|FG001|Overall Study|Positive for STD at Baseline|4|||
145585851|NCT02308033|524997668|FG000|Overall Study|Lost to Follow-up|6|||
145585852|NCT02308033|524997669|FG001|Overall Study|Lost to Follow-up|5|||
145585853|NCT00345397|524997673|FG000|Overall Study|Death|1|||
145585854|NCT01870843|524997674|FG000|Overall Study|Adverse Event|10|||
145585855|NCT01870843|524997674|FG000|Overall Study|Lost to Follow-up|24|||
145585856|NCT01870843|524997674|FG000|Overall Study|Death|1|||
145585857|NCT01870843|524997674|FG000|Overall Study|Withdrawal by Subject|18|||
145585858|NCT03325712|524997675|FG000|Overall Study|Protocol Violation|0|||
145585859|NCT03325712|524997676|FG001|Overall Study|Protocol Violation|0|||
145450705|NCT01534351|524499942|FG001|Overall Study|Study Terminated Early|0|||
145450706|NCT01534351|524499943|FG002|Overall Study|Study Terminated Early|0|||
145450707|NCT02702609|524499944|FG000|Overall Study|Lost to Follow-up|8|||
145450708|NCT02702609|524499945|FG001|Overall Study|Lost to Follow-up|4|||
145450709|NCT02702609|524499944|FG000|Overall Study|Physician Decision|1|||
145450710|NCT02702609|524499945|FG001|Overall Study|Physician Decision|0|||
145450711|NCT00935493|524499946|FG000|Overall Study|Lost to Follow-up|1|||
145450712|NCT00935493|524499947|FG001|Overall Study|Lost to Follow-up|1|||
145450713|NCT00935493|524499948|FG002|Overall Study|Lost to Follow-up|1|||
145450714|NCT00935493|524499946|FG000|Overall Study|Treatment Discontinued|0|||
145585860|NCT03325712|524997677|FG002|Overall Study|Protocol Violation|0|||
145450715|NCT00935493|524499947|FG001|Overall Study|Treatment Discontinued|1|||
145450716|NCT00935493|524499948|FG002|Overall Study|Treatment Discontinued|0|||
145450717|NCT04153981|524499949|FG000|Overall Study|Death|1|||
145585861|NCT03325712|524997678|FG003|Overall Study|Protocol Violation|0|||
145585862|NCT03325712|524997679|FG004|Overall Study|Protocol Violation|1|||
145585863|NCT03325712|524997680|FG005|Overall Study|Protocol Violation|0|||
145585864|NCT03325712|524997681|FG006|Overall Study|Protocol Violation|0|||
145585865|NCT03325712|524997682|FG007|Overall Study|Protocol Violation|0|||
145585866|NCT03325712|524997675|FG000|Overall Study|Adverse Event|0|||
145585867|NCT03325712|524997676|FG001|Overall Study|Adverse Event|0|||
145585868|NCT03325712|524997677|FG002|Overall Study|Adverse Event|0|||
145585869|NCT03325712|524997678|FG003|Overall Study|Adverse Event|0|||
145585870|NCT03325712|524997679|FG004|Overall Study|Adverse Event|1|||
145585871|NCT03325712|524997680|FG005|Overall Study|Adverse Event|0|||
145585872|NCT03325712|524997681|FG006|Overall Study|Adverse Event|0|||
145585873|NCT03325712|524997682|FG007|Overall Study|Adverse Event|0|||
145585874|NCT01297062|524997684|FG000|Overall Study|Adverse Event|2|||
145585875|NCT01297062|524997685|FG001|Overall Study|Adverse Event|0|||
145585876|NCT01297062|524997686|FG002|Overall Study|Adverse Event|1|||
145585877|NCT01297062|524997687|FG003|Overall Study|Adverse Event|0|||
145585878|NCT01297062|524997688|FG004|Overall Study|Adverse Event|0|||
145585879|NCT01297062|524997689|FG005|Overall Study|Adverse Event|0|||
145585880|NCT01297062|524997690|FG006|Overall Study|Adverse Event|0|||
145585881|NCT01297062|524997684|FG000|Overall Study|Physician Decision|1|||
145585882|NCT01297062|524997685|FG001|Overall Study|Physician Decision|0|||
145585883|NCT01297062|524997686|FG002|Overall Study|Physician Decision|1|||
145585884|NCT01297062|524997687|FG003|Overall Study|Physician Decision|0|||
145585885|NCT01297062|524997688|FG004|Overall Study|Physician Decision|0|||
145585886|NCT01297062|524997689|FG005|Overall Study|Physician Decision|0|||
145585887|NCT01297062|524997690|FG006|Overall Study|Physician Decision|6|||
145585888|NCT01297062|524997684|FG000|Overall Study|Protocol Violation|0|||
145585889|NCT01297062|524997685|FG001|Overall Study|Protocol Violation|0|||
145585890|NCT01297062|524997686|FG002|Overall Study|Protocol Violation|0|||
145585891|NCT01297062|524997687|FG003|Overall Study|Protocol Violation|0|||
145585892|NCT01297062|524997688|FG004|Overall Study|Protocol Violation|1|||
145585893|NCT01297062|524997689|FG005|Overall Study|Protocol Violation|0|||
145585894|NCT01297062|524997690|FG006|Overall Study|Protocol Violation|0|||
145585895|NCT01297062|524997684|FG000|Overall Study|Subject Decision|1|||
145585896|NCT01297062|524997685|FG001|Overall Study|Subject Decision|1|||
145585897|NCT01297062|524997686|FG002|Overall Study|Subject Decision|0|||
145585898|NCT01297062|524997687|FG003|Overall Study|Subject Decision|1|||
145585899|NCT01297062|524997688|FG004|Overall Study|Subject Decision|1|||
145585900|NCT01297062|524997689|FG005|Overall Study|Subject Decision|1|||
145585901|NCT01297062|524997690|FG006|Overall Study|Subject Decision|2|||
145585902|NCT04782323|524997691|FG000|Overall Study|Death|1|||
145585903|NCT04782323|524997692|FG001|Overall Study|Death|0|||
145585904|NCT04782323|524997693|FG002|Overall Study|Death|0|||
145626170|NCT00783692|525144208|FG001|Maintenance Phase|Lack of Efficacy|0|||
145626171|NCT00783692|525144209|FG002|Maintenance Phase|Lack of Efficacy|0|||
145626172|NCT00783692|525144210|FG003|Maintenance Phase|Lack of Efficacy|64|||
145626173|NCT00783692|525144211|FG004|Maintenance Phase|Lack of Efficacy|58|||
145450718|NCT04153981|524499949|FG000|Overall Study|Withdrawal by Subject|24|||
145450719|NCT04153981|524499949|FG000|Overall Study|Lost to Follow-up|1|||
145450720|NCT04153981|524499949|FG000|Overall Study|Physician Decision|1|||
145450721|NCT04153981|524499949|FG000|Overall Study|Due to Unavailable Glucometer|1|||
145450722|NCT04153981|524499949|FG000|Overall Study|Covid 19|52|||
145450723|NCT04153981|524499949|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
145450724|NCT04153981|524499949|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
145450725|NCT03928418|524499952|FG000|Overall Study|Lost to Follow-up|5|||
145450726|NCT03928418|524499953|FG001|Overall Study|Lost to Follow-up|3|||
145450727|NCT03928418|524499954|FG002|Overall Study|Lost to Follow-up|5|||
145450728|NCT03928418|524499952|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
145450729|NCT03928418|524499953|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
145450730|NCT03928418|524499954|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
145450731|NCT00964002|524499955|FG000|Overall Study|Protocol Violation|8|||
145585905|NCT04782323|524997694|FG003|Overall Study|Death|0|||
145585906|NCT04782323|524997695|FG004|Overall Study|Death|1|||
145585907|NCT04782323|524997696|FG005|Overall Study|Death|1|||
145585908|NCT04782323|524997697|FG006|Overall Study|Death|1|||
145585909|NCT04782323|524997698|FG007|Overall Study|Death|0|||
145585910|NCT04782323|524997691|FG000|Overall Study|Withdrawal by Subject|0|||
145585911|NCT04782323|524997692|FG001|Overall Study|Withdrawal by Subject|0|||
145585912|NCT04782323|524997693|FG002|Overall Study|Withdrawal by Subject|1|||
145585913|NCT04782323|524997694|FG003|Overall Study|Withdrawal by Subject|0|||
145585914|NCT04782323|524997695|FG004|Overall Study|Withdrawal by Subject|0|||
145585915|NCT04782323|524997696|FG005|Overall Study|Withdrawal by Subject|1|||
145450732|NCT02091362|524499965|FG000|Period 1|Protocol Violation|1|||
145450733|NCT02091362|524499966|FG001|Period 1|Protocol Violation|0|||
145585916|NCT04782323|524997697|FG006|Overall Study|Withdrawal by Subject|0|||
145585917|NCT04782323|524997698|FG007|Overall Study|Withdrawal by Subject|1|||
145585918|NCT04782323|524997691|FG000|Overall Study|Lost to Follow-up|0|||
145585919|NCT04782323|524997692|FG001|Overall Study|Lost to Follow-up|1|||
145450734|NCT02091362|524499965|FG000|Period 1|Withdrawal by Subject|2|||
145450735|NCT02091362|524499966|FG001|Period 1|Withdrawal by Subject|3|||
145450736|NCT02091362|524499965|FG000|Period 1|Lost to Follow-up|0|||
145450737|NCT02091362|524499966|FG001|Period 1|Lost to Follow-up|1|||
145450738|NCT02091362|524499965|FG000|Period 1|Adverse Event|2|||
145450739|NCT02091362|524499966|FG001|Period 1|Adverse Event|0|||
145450740|NCT02091362|524499965|FG000|Wash-out|Lost to Follow-up|1|||
145450741|NCT02091362|524499966|FG001|Wash-out|Lost to Follow-up|1|||
145450742|NCT02091362|524499965|FG000|Wash-out|Withdrawal by Subject|0|||
145450743|NCT02091362|524499966|FG001|Wash-out|Withdrawal by Subject|2|||
145450744|NCT02091362|524499965|FG000|Period 2|Adverse Event|1|||
145450745|NCT02091362|524499966|FG001|Period 2|Adverse Event|0|||
145450746|NCT02091362|524499965|FG000|Period 2|Lost to Follow-up|0|||
145450747|NCT02091362|524499966|FG001|Period 2|Lost to Follow-up|1|||
145450748|NCT02091362|524499965|FG000|Period 2|Withdrawal by Subject|1|||
145450749|NCT02091362|524499966|FG001|Period 2|Withdrawal by Subject|1|||
145450750|NCT02565147|524499967|FG000|Overall Study|Withdrawal by Subject|5|||
145450751|NCT02565147|524499968|FG001|Overall Study|Withdrawal by Subject|1|||
145450752|NCT02565147|524499967|FG000|Overall Study|Lost to Follow-up|0|||
145450753|NCT02565147|524499968|FG001|Overall Study|Lost to Follow-up|1|||
145450754|NCT02565147|524499967|FG000|Overall Study|Death|1|||
145450755|NCT02565147|524499968|FG001|Overall Study|Death|1|||
145450756|NCT00902850|524499969|FG000|Overall Study|Physician Decision|2|||
145450757|NCT00902850|524499970|FG001|Overall Study|Physician Decision|2|||
145450758|NCT00260832|524499971|FG000|Overall Study|Adverse Event|26|||
145450759|NCT00260832|524499972|FG001|Overall Study|Adverse Event|19|||
145450760|NCT00260832|524499971|FG000|Overall Study|Progression|116|||
145450761|NCT00260832|524499972|FG001|Overall Study|Progression|96|||
145450762|NCT00260832|524499971|FG000|Overall Study|Withdrawal by Subject|15|||
145450763|NCT00260832|524499972|FG001|Overall Study|Withdrawal by Subject|17|||
145450764|NCT00260832|524499971|FG000|Overall Study|Physician Decision|15|||
145450765|NCT00260832|524499972|FG001|Overall Study|Physician Decision|9|||
145450766|NCT00260832|524499971|FG000|Overall Study|Death|43|||
145450767|NCT00260832|524499972|FG001|Overall Study|Death|62|||
145450768|NCT00260832|524499971|FG000|Overall Study|Other|10|||
145450769|NCT00260832|524499972|FG001|Overall Study|Other|7|||
145450770|NCT00260832|524499971|FG000|Overall Study|Protocol Violation|3|||
145450771|NCT00260832|524499972|FG001|Overall Study|Protocol Violation|1|||
145450772|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
145450773|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
145450774|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
145450775|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145450776|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145450777|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145450778|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145450779|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
145450780|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450781|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450782|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450783|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450784|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450785|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
145450786|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
145450787|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
145450788|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
145450789|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145450790|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145450791|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145450792|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145450793|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
145450794|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
145450795|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145450796|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145450797|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145450798|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145450799|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145450800|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
145450801|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145450802|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145450803|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145450804|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145450805|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145585920|NCT04782323|524997693|FG002|Overall Study|Lost to Follow-up|1|||
145585921|NCT04782323|524997694|FG003|Overall Study|Lost to Follow-up|0|||
145585922|NCT04782323|524997695|FG004|Overall Study|Lost to Follow-up|0|||
145585923|NCT04782323|524997696|FG005|Overall Study|Lost to Follow-up|1|||
145585924|NCT04782323|524997697|FG006|Overall Study|Lost to Follow-up|1|||
145585925|NCT04782323|524997698|FG007|Overall Study|Lost to Follow-up|2|||
145585926|NCT04782323|524997691|FG000|Overall Study|randomization in error|1|||
145585927|NCT04782323|524997692|FG001|Overall Study|randomization in error|0|||
145450806|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
145450807|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450808|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
145450809|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450810|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450811|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450812|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450813|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145450814|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
145450815|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
145450816|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
145450817|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145450818|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145450819|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145450820|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145450821|NCT03745638|524499973|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
145450822|NCT03745638|524499974|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
145450823|NCT03745638|524499975|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
145450824|NCT03745638|524499976|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
145450825|NCT03745638|524499977|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
145450826|NCT03745638|524499978|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
145450827|NCT03745638|524499979|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
145450828|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145450829|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145450830|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145450831|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145450832|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145450833|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
145450834|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
145450835|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145450836|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145450837|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145450838|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
145450839|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145450840|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
145450841|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
145450842|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145585928|NCT04782323|524997693|FG002|Overall Study|randomization in error|0|||
145585929|NCT04782323|524997694|FG003|Overall Study|randomization in error|0|||
145585930|NCT04782323|524997695|FG004|Overall Study|randomization in error|0|||
145585931|NCT04782323|524997696|FG005|Overall Study|randomization in error|0|||
145585932|NCT04782323|524997697|FG006|Overall Study|randomization in error|0|||
145585933|NCT04782323|524997698|FG007|Overall Study|randomization in error|0|||
145585934|NCT00927927|524997701|FG000|Overall Study|Withdrawal by Subject|0|||
145585935|NCT00927927|524997702|FG001|Overall Study|Withdrawal by Subject|0|||
145585936|NCT00927927|524997703|FG002|Overall Study|Withdrawal by Subject|0|||
145585937|NCT00927927|524997704|FG003|Overall Study|Withdrawal by Subject|0|||
145585938|NCT00927927|524997705|FG004|Overall Study|Withdrawal by Subject|0|||
145585939|NCT00927927|524997706|FG005|Overall Study|Withdrawal by Subject|0|||
145585940|NCT00927927|524997707|FG006|Overall Study|Withdrawal by Subject|0|||
145585941|NCT00927927|524997708|FG007|Overall Study|Withdrawal by Subject|2|||
145585942|NCT00927927|524997709|FG008|Overall Study|Withdrawal by Subject|0|||
145585943|NCT00927927|524997710|FG009|Overall Study|Withdrawal by Subject|0|||
145585944|NCT00927927|524997711|FG010|Overall Study|Withdrawal by Subject|0|||
145585945|NCT00927927|524997712|FG011|Overall Study|Withdrawal by Subject|2|||
145585946|NCT00927927|524997713|FG012|Overall Study|Withdrawal by Subject|0|||
145585947|NCT00927927|524997714|FG013|Overall Study|Withdrawal by Subject|0|||
145585948|NCT00927927|524997715|FG014|Overall Study|Withdrawal by Subject|0|||
145585949|NCT01165281|524997716|FG000|Overall Study|Adverse Event|12|||
145585950|NCT01165281|524997717|FG001|Overall Study|Adverse Event|14|||
145585951|NCT01165281|524997716|FG000|Overall Study|Death|3|||
145585952|NCT01165281|524997717|FG001|Overall Study|Death|4|||
145450843|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145450844|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145450845|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
145450846|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
145450847|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
145450848|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
145450849|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145450850|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145450851|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145450852|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145450853|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
145450854|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
145450855|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145450856|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450857|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450858|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450859|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450860|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450861|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
145450862|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145450863|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145450864|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145450865|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145450866|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
145450867|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
145450868|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
145450869|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
145450870|NCT03745638|524499973|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
145450871|NCT03745638|524499974|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
145450872|NCT03745638|524499975|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
145450873|NCT03745638|524499976|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
145450874|NCT03745638|524499977|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
145450875|NCT03745638|524499978|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
145450876|NCT03745638|524499979|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
145450877|NCT01814046|524499984|FG000|Drug Administration|Death due to complications of RSV|1|||
145450878|NCT01814046|524499985|FG001|Drug Administration|Death due to complications of RSV|0|||
145450879|NCT01814046|524499986|FG002|Drug Administration|Death due to complications of RSV|0|||
145450880|NCT00564902|524499987|FG000|Overall Study|Withdrawal by Subject|0|||
145450881|NCT00564902|524499988|FG001|Overall Study|Withdrawal by Subject|3|||
145450882|NCT00564902|524499989|FG002|Overall Study|Withdrawal by Subject|4|||
145450883|NCT00564902|524499987|FG000|Overall Study|Death|1|||
145450884|NCT00564902|524499988|FG001|Overall Study|Death|1|||
145450885|NCT00564902|524499989|FG002|Overall Study|Death|0|||
145450886|NCT02097719|524499993|FG000|Overall Study|Subject Withdrew Consent|1|||
145450887|NCT02097719|524499994|FG001|Overall Study|Subject Withdrew Consent|0|||
145450888|NCT02097719|524499993|FG000|Overall Study|Lost to Follow-up|0|||
145450889|NCT02097719|524499994|FG001|Overall Study|Lost to Follow-up|1|||
145450890|NCT02097719|524499993|FG000|Overall Study|Adverse Event|2|||
145450891|NCT02097719|524499994|FG001|Overall Study|Adverse Event|0|||
145450892|NCT01854775|524499997|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
145450893|NCT01854775|524499998|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
145450894|NCT01854775|524499999|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
145450895|NCT01854775|524499997|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
145450896|NCT01854775|524499998|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
145450897|NCT01854775|524499999|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
145450898|NCT01854775|524499997|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
145450899|NCT01854775|524499998|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
145450900|NCT01854775|524499999|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
145450901|NCT01854775|524499997|FG000|Extension Phase|Pregnancy|3|||
145450902|NCT01854775|524499998|FG001|Extension Phase|Pregnancy|0|||
145450903|NCT01854775|524499999|FG002|Extension Phase|Pregnancy|0|||
145450904|NCT01854775|524499997|FG000|Extension Phase|Investigator's Discretion|1|||
145450905|NCT01854775|524499998|FG001|Extension Phase|Investigator's Discretion|0|||
145450906|NCT01854775|524499999|FG002|Extension Phase|Investigator's Discretion|0|||
145450907|NCT01854775|524499997|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
145585953|NCT01165281|524997716|FG000|Overall Study|Lack of Efficacy|4|||
145585954|NCT01165281|524997717|FG001|Overall Study|Lack of Efficacy|1|||
145585955|NCT01165281|524997716|FG000|Overall Study|Lost to Follow-up|0|||
145450908|NCT01854775|524499998|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
145450909|NCT01854775|524499999|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
145450910|NCT01854775|524499997|FG000|Extension Phase|Lost to Follow-up|2|||
145450911|NCT01854775|524499998|FG001|Extension Phase|Lost to Follow-up|0|||
145450912|NCT01854775|524499999|FG002|Extension Phase|Lost to Follow-up|0|||
145450913|NCT01854775|524499997|FG000|Extension Phase|Still on Study|32|||
145450914|NCT01854775|524499998|FG001|Extension Phase|Still on Study|47|||
145450915|NCT01854775|524499999|FG002|Extension Phase|Still on Study|18|||
145450916|NCT00984594|524500001|FG000|Overall Study|Lost to Follow-up|1|||
145450917|NCT00984594|524500002|FG001|Overall Study|Lost to Follow-up|0|||
145450918|NCT00984594|524500001|FG000|Overall Study|Withdrawal by Subject|0|||
145450919|NCT00984594|524500002|FG001|Overall Study|Withdrawal by Subject|1|||
145450920|NCT03135431|524500003|FG000|Overall Study|Study Surgeon not available|2|||
145450921|NCT03135431|524500004|FG001|Overall Study|Study Surgeon not available|0|||
145450922|NCT03122145|524500006|FG000|Overall Study|Concurrent respiratory disease|3|||
145450923|NCT03122145|524500007|FG001|Overall Study|Concurrent respiratory disease|0|||
145450924|NCT03108521|524500011|FG000|Overall Study|Lost to Follow-up|3|||
145450925|NCT03108521|524500012|FG001|Overall Study|Lost to Follow-up|0|||
145450926|NCT03108521|524500011|FG000|Overall Study|Lack of Efficacy|2|||
145450927|NCT03108521|524500012|FG001|Overall Study|Lack of Efficacy|0|||
145450928|NCT03108521|524500011|FG000|Overall Study|Physician Decision|4|||
145450929|NCT03108521|524500012|FG001|Overall Study|Physician Decision|0|||
145450930|NCT03108521|524500011|FG000|Overall Study|Adverse Event|3|||
145450931|NCT03108521|524500012|FG001|Overall Study|Adverse Event|0|||
145450932|NCT00375674|524500019|FG000|Overall Study|Other|26|||
145450933|NCT00375674|524500020|FG001|Overall Study|Other|18|||
145450934|NCT00375674|524500019|FG000|Overall Study|Death|67|||
145450935|NCT00375674|524500020|FG001|Overall Study|Death|76|||
145450936|NCT00375674|524500019|FG000|Overall Study|Participants refused further follow-up|31|||
145450937|NCT00375674|524500020|FG001|Overall Study|Participants refused further follow-up|30|||
145450938|NCT00375674|524500019|FG000|Overall Study|Lost to Follow-up|17|||
145450939|NCT00375674|524500020|FG001|Overall Study|Lost to Follow-up|15|||
145450940|NCT00375674|524500019|FG000|Overall Study|Enrolled but not treated|3|||
145450941|NCT00375674|524500020|FG001|Overall Study|Enrolled but not treated|2|||
145450942|NCT00875485|524502244|FG000|Challenge Dose Epoch|Pregnancy|1|||
145450943|NCT00875485|524502245|FG001|Challenge Dose Epoch|Pregnancy|0|||
145450944|NCT01271010|524502246|FG000|Overall Study|Reason not specified|11|||
145450945|NCT01271010|524502246|FG000|Overall Study|Start of new CLL therapy|1|||
145450946|NCT01271010|524502246|FG000|Overall Study|Protocol Violation|1|||
145450947|NCT01271010|524502246|FG000|Overall Study|Death|2|||
145450948|NCT01271010|524502246|FG000|Overall Study|Progression and relapse of disease|1|||
145450949|NCT01271010|524502246|FG000|Overall Study|Withdrawal by Subject|18|||
145450950|NCT01271010|524502246|FG000|Overall Study|Disease progression|27|||
145450951|NCT01631747|524502247|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
145450952|NCT01631747|524502248|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
145450953|NCT01631747|524502247|FG000|Live Birth|Pregnancy Termination|1|||
145450954|NCT01631747|524502248|FG001|Live Birth|Pregnancy Termination|0|||
145450955|NCT01631747|524502247|FG000|Live Birth|MIscarriage|2|||
145450956|NCT01631747|524502248|FG001|Live Birth|MIscarriage|0|||
145450957|NCT01631747|524502247|FG000|Live Birth|Stillbirth|1|||
145450958|NCT01631747|524502248|FG001|Live Birth|Stillbirth|1|||
145450959|NCT01631747|524502247|FG000|One Year Infant Outcomes|Patient Refused|13|||
145450960|NCT01631747|524502248|FG001|One Year Infant Outcomes|Patient Refused|9|||
145450961|NCT01456195|524502249|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145450962|NCT01456195|524502250|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
145450963|NCT01456195|524502251|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
145450964|NCT01456195|524502249|FG000|Overall Study|Lost to Follow-up|3|||
145450965|NCT01456195|524502250|FG001|Overall Study|Lost to Follow-up|1|||
145450966|NCT01456195|524502251|FG002|Overall Study|Lost to Follow-up|3|||
145450967|NCT01456195|524502249|FG000|Overall Study|Voluntary Withdrawal|5|||
145450968|NCT01456195|524502250|FG001|Overall Study|Voluntary Withdrawal|3|||
145450969|NCT01456195|524502251|FG002|Overall Study|Voluntary Withdrawal|7|||
145585956|NCT01165281|524997717|FG001|Overall Study|Lost to Follow-up|1|||
145450970|NCT01456195|524502249|FG000|Overall Study|Lack of Efficacy|0|||
145450971|NCT01456195|524502250|FG001|Overall Study|Lack of Efficacy|1|||
145450972|NCT01456195|524502251|FG002|Overall Study|Lack of Efficacy|0|||
145450973|NCT01456195|524502249|FG000|Overall Study|Other Reasons|2|||
145450974|NCT01456195|524502250|FG001|Overall Study|Other Reasons|1|||
145450975|NCT01456195|524502251|FG002|Overall Study|Other Reasons|3|||
145450976|NCT02109432|524502252|FG000|Overall Study|Withdrawal by Subject|1|||
145450977|NCT02908685|524502259|FG000|Part 1 OLE|Withdrawal by Subject|0|||
145450978|NCT02908685|524502260|FG001|Part 1 OLE|Withdrawal by Subject|0|||
145450979|NCT02908685|524502261|FG002|Part 1 OLE|Withdrawal by Subject|0|||
145450980|NCT02908685|524502262|FG003|Part 1 OLE|Withdrawal by Subject|0|||
145450981|NCT02908685|524502263|FG004|Part 1 OLE|Withdrawal by Subject|0|||
145450982|NCT02908685|524502264|FG005|Part 1 OLE|Withdrawal by Subject|0|||
145450983|NCT02908685|524502265|FG006|Part 1 OLE|Withdrawal by Subject|0|||
145450984|NCT02908685|524502266|FG007|Part 1 OLE|Withdrawal by Subject|0|||
145450985|NCT02908685|524502267|FG008|Part 1 OLE|Withdrawal by Subject|0|||
145450986|NCT02908685|524502268|FG009|Part 1 OLE|Withdrawal by Subject|0|||
145450987|NCT02908685|524502269|FG010|Part 1 OLE|Withdrawal by Subject|2|||
145450988|NCT02908685|524502270|FG011|Part 1 OLE|Withdrawal by Subject|1|||
145450989|NCT02908685|524502271|FG012|Part 1 OLE|Withdrawal by Subject|0|||
145450990|NCT02908685|524502272|FG013|Part 1 OLE|Withdrawal by Subject|0|||
145450991|NCT02908685|524502259|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450992|NCT02908685|524502260|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450993|NCT02908685|524502261|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450994|NCT02908685|524502262|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450995|NCT02908685|524502263|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450996|NCT02908685|524502264|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450997|NCT02908685|524502265|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450998|NCT02908685|524502266|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145450999|NCT02908685|524502267|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145451000|NCT02908685|524502268|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145451001|NCT02908685|524502269|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145451002|NCT02908685|524502270|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
145451003|NCT02908685|524502271|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
145451004|NCT02908685|524502272|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
145451005|NCT02908685|524502259|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451006|NCT02908685|524502260|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451007|NCT02908685|524502261|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451008|NCT02908685|524502262|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451009|NCT02908685|524502263|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451010|NCT02908685|524502264|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451011|NCT02908685|524502265|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451012|NCT02908685|524502266|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451013|NCT02908685|524502267|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451014|NCT02908685|524502268|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451015|NCT02908685|524502269|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451016|NCT02908685|524502270|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451017|NCT02908685|524502271|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
145451018|NCT02908685|524502272|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
145451019|NCT02908685|524502259|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451020|NCT02908685|524502260|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451021|NCT02908685|524502261|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451022|NCT02908685|524502262|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451023|NCT02908685|524502263|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451024|NCT02908685|524502264|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451025|NCT02908685|524502265|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451026|NCT02908685|524502266|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451027|NCT02908685|524502267|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451028|NCT02908685|524502268|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451029|NCT02908685|524502269|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451030|NCT02908685|524502270|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451031|NCT02908685|524502271|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
145451032|NCT02908685|524502272|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
145451033|NCT02908685|524502259|FG000|Part 2 OLE: > Month 24|Death|0|||
145451034|NCT02908685|524502260|FG001|Part 2 OLE: > Month 24|Death|0|||
145451035|NCT02908685|524502261|FG002|Part 2 OLE: > Month 24|Death|0|||
145451036|NCT02908685|524502262|FG003|Part 2 OLE: > Month 24|Death|0|||
145451037|NCT02908685|524502263|FG004|Part 2 OLE: > Month 24|Death|0|||
145451038|NCT02908685|524502264|FG005|Part 2 OLE: > Month 24|Death|0|||
145451039|NCT02908685|524502265|FG006|Part 2 OLE: > Month 24|Death|0|||
145451040|NCT02908685|524502266|FG007|Part 2 OLE: > Month 24|Death|0|||
145451041|NCT02908685|524502267|FG008|Part 2 OLE: > Month 24|Death|0|||
145451042|NCT02908685|524502268|FG009|Part 2 OLE: > Month 24|Death|0|||
145451043|NCT02908685|524502269|FG010|Part 2 OLE: > Month 24|Death|0|||
145585957|NCT01165281|524997716|FG000|Overall Study|Physician Decision|8|||
145451044|NCT02908685|524502270|FG011|Part 2 OLE: > Month 24|Death|0|||
145451045|NCT02908685|524502271|FG012|Part 2 OLE: > Month 24|Death|1|||
145451046|NCT02908685|524502272|FG013|Part 2 OLE: > Month 24|Death|0|||
145451047|NCT02908685|524502259|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
145451048|NCT02908685|524502260|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
145451049|NCT02908685|524502261|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
145451050|NCT02908685|524502262|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
145451051|NCT02908685|524502263|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
145585958|NCT01165281|524997717|FG001|Overall Study|Physician Decision|1|||
145585959|NCT01165281|524997716|FG000|Overall Study|Protocol Violation|6|||
145451052|NCT02908685|524502264|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
145451053|NCT02908685|524502265|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
145451054|NCT02908685|524502266|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
145451055|NCT02908685|524502267|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
145451056|NCT02908685|524502268|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
145451057|NCT02908685|524502269|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
145451058|NCT02908685|524502270|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
145451059|NCT02908685|524502271|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
145451060|NCT02908685|524502272|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
145451061|NCT02908685|524502259|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451062|NCT02908685|524502260|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451063|NCT02908685|524502261|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451064|NCT02908685|524502262|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451065|NCT02908685|524502263|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451066|NCT02908685|524502264|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451067|NCT02908685|524502265|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451068|NCT02908685|524502266|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451069|NCT02908685|524502267|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451070|NCT02908685|524502268|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451071|NCT02908685|524502269|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451072|NCT02908685|524502270|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
145451073|NCT02908685|524502271|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
145451074|NCT02908685|524502272|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
145451075|NCT02954406|524502273|FG000|Overall Study|Adverse Event|0|||
145451076|NCT02954406|524502274|FG001|Overall Study|Adverse Event|1|||
145451077|NCT02954406|524502275|FG002|Overall Study|Adverse Event|0|||
145451078|NCT02954406|524502276|FG003|Overall Study|Adverse Event|0|||
145451079|NCT02954406|524502277|FG004|Overall Study|Adverse Event|1|||
145451080|NCT02954406|524502278|FG005|Overall Study|Adverse Event|0|||
145451081|NCT02954406|524502279|FG006|Overall Study|Adverse Event|0|||
145451082|NCT02954406|524502280|FG007|Overall Study|Adverse Event|0|||
145451083|NCT02954406|524502281|FG008|Overall Study|Adverse Event|1|||
145451084|NCT02954406|524502282|FG009|Overall Study|Adverse Event|1|||
145451085|NCT02954406|524502283|FG010|Overall Study|Adverse Event|0|||
145451086|NCT02954406|524502273|FG000|Overall Study|Progressive Disease|3|||
145585960|NCT01165281|524997717|FG001|Overall Study|Protocol Violation|5|||
145585961|NCT01165281|524997716|FG000|Overall Study|Withdrawal by Subject|8|||
145585962|NCT01165281|524997717|FG001|Overall Study|Withdrawal by Subject|7|||
145585963|NCT01165281|524997716|FG000|Overall Study|Noncompliance with Study Drug|1|||
145585964|NCT01165281|524997717|FG001|Overall Study|Noncompliance with Study Drug|4|||
145585965|NCT01165281|524997716|FG000|Overall Study|Progressive Disease|10|||
145585966|NCT01165281|524997717|FG001|Overall Study|Progressive Disease|14|||
145585967|NCT01165281|524997716|FG000|Overall Study|Other|6|||
145585968|NCT01165281|524997717|FG001|Overall Study|Other|0|||
145585969|NCT02863991|524997718|FG000|Overall Study|Death|0|||
145585970|NCT02863991|524997719|FG001|Overall Study|Death|3|||
145585971|NCT02863991|524997718|FG000|Overall Study|Lack of Efficacy|0|||
145585972|NCT02863991|524997719|FG001|Overall Study|Lack of Efficacy|1|||
145585973|NCT02863991|524997718|FG000|Overall Study|Study Terminated|2|||
145585974|NCT02863991|524997719|FG001|Overall Study|Study Terminated|8|||
145585975|NCT00364858|524997724|FG000|Overall Study|Adverse Event|1|||
145585976|NCT00364858|524997725|FG001|Overall Study|Adverse Event|5|||
145585977|NCT00364858|524997724|FG000|Overall Study|Withdrawal by Subject|1|||
145585978|NCT00364858|524997725|FG001|Overall Study|Withdrawal by Subject|1|||
145585979|NCT00364858|524997724|FG000|Overall Study|Pregnancy|1|||
145585980|NCT00364858|524997725|FG001|Overall Study|Pregnancy|1|||
145585981|NCT00364858|524997724|FG000|Overall Study|Clinical failure|2|||
145585982|NCT00364858|524997725|FG001|Overall Study|Clinical failure|13|||
145451087|NCT02954406|524502274|FG001|Overall Study|Progressive Disease|4|||
145585983|NCT00364858|524997724|FG000|Overall Study|Discontinuation at baseline|1|||
145585984|NCT00364858|524997725|FG001|Overall Study|Discontinuation at baseline|0|||
145585985|NCT00364858|524997724|FG000|Overall Study|Non-compliant|1|||
145585986|NCT00364858|524997725|FG001|Overall Study|Non-compliant|0|||
145585987|NCT00364858|524997724|FG000|Overall Study|Return to Q2 regimen|0|||
145585988|NCT00364858|524997725|FG001|Overall Study|Return to Q2 regimen|1|||
145451088|NCT02954406|524502275|FG002|Overall Study|Progressive Disease|3|||
145451089|NCT02954406|524502276|FG003|Overall Study|Progressive Disease|4|||
145451090|NCT02954406|524502277|FG004|Overall Study|Progressive Disease|3|||
145451091|NCT02954406|524502278|FG005|Overall Study|Progressive Disease|3|||
145451092|NCT02954406|524502279|FG006|Overall Study|Progressive Disease|2|||
145451093|NCT02954406|524502280|FG007|Overall Study|Progressive Disease|2|||
145451094|NCT02954406|524502281|FG008|Overall Study|Progressive Disease|1|||
145585989|NCT00364858|524997724|FG000|Overall Study|Clinical baseline issue|0|||
145585990|NCT00364858|524997725|FG001|Overall Study|Clinical baseline issue|1|||
145585991|NCT01307501|524997726|FG000|Overall Study|Treatment Failure|1|||
145585992|NCT01307501|524997726|FG000|Overall Study|Death|20|||
145585993|NCT01307501|524997726|FG000|Overall Study|Lost to Follow-up|1|||
145451095|NCT02954406|524502282|FG009|Overall Study|Progressive Disease|1|||
145451096|NCT02954406|524502283|FG010|Overall Study|Progressive Disease|0|||
145451097|NCT02954406|524502273|FG000|Overall Study|Symptomatic Deterioration|0|||
145451098|NCT02954406|524502274|FG001|Overall Study|Symptomatic Deterioration|1|||
145451099|NCT02954406|524502275|FG002|Overall Study|Symptomatic Deterioration|0|||
145451100|NCT02954406|524502276|FG003|Overall Study|Symptomatic Deterioration|0|||
145451101|NCT02954406|524502277|FG004|Overall Study|Symptomatic Deterioration|0|||
145451102|NCT02954406|524502278|FG005|Overall Study|Symptomatic Deterioration|0|||
145451103|NCT02954406|524502279|FG006|Overall Study|Symptomatic Deterioration|0|||
145451104|NCT02954406|524502280|FG007|Overall Study|Symptomatic Deterioration|0|||
145451105|NCT02954406|524502281|FG008|Overall Study|Symptomatic Deterioration|0|||
145451106|NCT02954406|524502282|FG009|Overall Study|Symptomatic Deterioration|0|||
145451107|NCT02954406|524502283|FG010|Overall Study|Symptomatic Deterioration|0|||
145451108|NCT02954406|524502273|FG000|Overall Study|Death|0|||
145451109|NCT02954406|524502274|FG001|Overall Study|Death|0|||
145451110|NCT02954406|524502275|FG002|Overall Study|Death|0|||
145451111|NCT02954406|524502276|FG003|Overall Study|Death|0|||
145451112|NCT02954406|524502277|FG004|Overall Study|Death|1|||
145451113|NCT02954406|524502278|FG005|Overall Study|Death|0|||
145451114|NCT02954406|524502279|FG006|Overall Study|Death|0|||
145451115|NCT02954406|524502280|FG007|Overall Study|Death|0|||
145451116|NCT02954406|524502281|FG008|Overall Study|Death|1|||
145451117|NCT02954406|524502282|FG009|Overall Study|Death|1|||
145451118|NCT02954406|524502283|FG010|Overall Study|Death|0|||
145451119|NCT02954406|524502273|FG000|Overall Study|Reason Not Specified|0|||
145451120|NCT02954406|524502274|FG001|Overall Study|Reason Not Specified|0|||
145451121|NCT02954406|524502275|FG002|Overall Study|Reason Not Specified|3|||
145451122|NCT02954406|524502276|FG003|Overall Study|Reason Not Specified|2|||
145451123|NCT02954406|524502277|FG004|Overall Study|Reason Not Specified|2|||
145451124|NCT02954406|524502278|FG005|Overall Study|Reason Not Specified|0|||
145451125|NCT02954406|524502279|FG006|Overall Study|Reason Not Specified|1|||
145451126|NCT02954406|524502280|FG007|Overall Study|Reason Not Specified|0|||
145451127|NCT02954406|524502281|FG008|Overall Study|Reason Not Specified|1|||
145585994|NCT01307501|524997726|FG000|Overall Study|Starting Hospice|1|||
145585995|NCT00363766|524997727|FG000|Overall Study|Progressive Disease|15|||
145585996|NCT00363766|524997728|FG001|Overall Study|Progressive Disease|9|||
145585997|NCT00363766|524997727|FG000|Overall Study|Adverse Event|10|||
145585998|NCT00363766|524997728|FG001|Overall Study|Adverse Event|2|||
145585999|NCT00363766|524997727|FG000|Overall Study|Disease Related Death|1|||
145586000|NCT00363766|524997728|FG001|Overall Study|Disease Related Death|3|||
145586001|NCT00363766|524997727|FG000|Overall Study|Not Disease Related Death|3|||
145586002|NCT00363766|524997728|FG001|Overall Study|Not Disease Related Death|4|||
145586003|NCT00363766|524997727|FG000|Overall Study|Withdrawal by Subject|2|||
145586004|NCT00363766|524997728|FG001|Overall Study|Withdrawal by Subject|0|||
145586005|NCT00363766|524997727|FG000|Overall Study|Physician Decision|1|||
145586006|NCT00363766|524997728|FG001|Overall Study|Physician Decision|2|||
145586007|NCT02345512|524997732|FG000|Overall Study|Adverse Event|1|||
145586008|NCT02345512|524997732|FG000|Overall Study|Withdrawal by Subject|1|||
145586009|NCT03478891|524997735|FG000|Overall Study|Enrolled, but product never administered|0|||
145586010|NCT03478891|524997736|FG001|Overall Study|Enrolled, but product never administered|0|||
145586011|NCT03478891|524997737|FG002|Overall Study|Enrolled, but product never administered|1|||
145586012|NCT03478891|524997735|FG000|Overall Study|Moved from area|0|||
145586013|NCT03478891|524997736|FG001|Overall Study|Moved from area|0|||
145586014|NCT03478891|524997737|FG002|Overall Study|Moved from area|1|||
145586015|NCT03478891|524997735|FG000|Overall Study|Lost to Follow-up|1|||
145586016|NCT03478891|524997736|FG001|Overall Study|Lost to Follow-up|0|||
145586017|NCT03478891|524997737|FG002|Overall Study|Lost to Follow-up|1|||
145586018|NCT04827576|524999548|FG000|Overall Study|Death|5|||
145586019|NCT04827576|524999549|FG001|Overall Study|Death|17|||
145586020|NCT04827576|524999550|FG002|Overall Study|Death|17|||
145586021|NCT04827576|524999551|FG003|Overall Study|Death|32|||
145586022|NCT04827576|524999548|FG000|Overall Study|Study Terminated by Sponsor|2|||
145586023|NCT04827576|524999549|FG001|Overall Study|Study Terminated by Sponsor|9|||
145586024|NCT04827576|524999550|FG002|Overall Study|Study Terminated by Sponsor|7|||
145586025|NCT04827576|524999551|FG003|Overall Study|Study Terminated by Sponsor|5|||
145586026|NCT04827576|524999548|FG000|Overall Study|Investigator's Discretion|1|||
145586027|NCT04827576|524999549|FG001|Overall Study|Investigator's Discretion|0|||
145586028|NCT04827576|524999550|FG002|Overall Study|Investigator's Discretion|2|||
145451128|NCT02954406|524502282|FG009|Overall Study|Reason Not Specified|0|||
145451129|NCT02954406|524502283|FG010|Overall Study|Reason Not Specified|0|||
145451130|NCT03522246|524502290|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
145451131|NCT03522246|524502291|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
145586029|NCT04827576|524999551|FG003|Overall Study|Investigator's Discretion|5|||
145586030|NCT04827576|524999548|FG000|Overall Study|Withdrew Consent|0|||
145586031|NCT04827576|524999549|FG001|Overall Study|Withdrew Consent|3|||
145451132|NCT03522246|524502292|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
145451133|NCT03522246|524502293|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
145586032|NCT04827576|524999550|FG002|Overall Study|Withdrew Consent|0|||
145626174|NCT00783692|525144212|FG005|Maintenance Phase|Lack of Efficacy|48|||
145626175|NCT00783692|525144213|FG006|Maintenance Phase|Lack of Efficacy|177|||
145626176|NCT00783692|525144207|FG000|Maintenance Phase|Withdrawal by Subject|7|||
145626177|NCT00783692|525144208|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145626178|NCT00783692|525144209|FG002|Maintenance Phase|Withdrawal by Subject|0|||
145626179|NCT00783692|525144210|FG003|Maintenance Phase|Withdrawal by Subject|7|||
145626180|NCT00783692|525144211|FG004|Maintenance Phase|Withdrawal by Subject|6|||
145626181|NCT00783692|525144212|FG005|Maintenance Phase|Withdrawal by Subject|9|||
145626182|NCT00783692|525144213|FG006|Maintenance Phase|Withdrawal by Subject|24|||
145626183|NCT00783692|525144207|FG000|Maintenance Phase|Lost to Follow-up|2|||
145626184|NCT00783692|525144208|FG001|Maintenance Phase|Lost to Follow-up|0|||
145626185|NCT00783692|525144209|FG002|Maintenance Phase|Lost to Follow-up|0|||
145626186|NCT00783692|525144210|FG003|Maintenance Phase|Lost to Follow-up|1|||
145626187|NCT00783692|525144211|FG004|Maintenance Phase|Lost to Follow-up|3|||
145626188|NCT00783692|525144212|FG005|Maintenance Phase|Lost to Follow-up|2|||
145626189|NCT00783692|525144213|FG006|Maintenance Phase|Lost to Follow-up|5|||
145626190|NCT00783692|525144207|FG000|Maintenance Phase|Other|0|||
145626191|NCT00783692|525144208|FG001|Maintenance Phase|Other|0|||
145626192|NCT00783692|525144209|FG002|Maintenance Phase|Other|0|||
145626193|NCT00783692|525144210|FG003|Maintenance Phase|Other|1|||
145626194|NCT00783692|525144211|FG004|Maintenance Phase|Other|0|||
145626195|NCT00783692|525144212|FG005|Maintenance Phase|Other|1|||
145626196|NCT00783692|525144213|FG006|Maintenance Phase|Other|1|||
145626197|NCT00209274|525144218|FG000|Overall Study|Missed visit|3|||
145626198|NCT00209274|525144219|FG001|Overall Study|Missed visit|2|||
145451134|NCT03522246|524502294|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
145451135|NCT04683029|524502295|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
145451136|NCT04683029|524502296|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
145451137|NCT04683029|524502297|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
145451138|NCT04683029|524502298|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
145451139|NCT04683029|524502295|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
145451140|NCT04683029|524502296|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
145451141|NCT04683029|524502297|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
145451142|NCT04683029|524502298|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
145451143|NCT04683029|524502295|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
145451144|NCT04683029|524502296|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
145451145|NCT04683029|524502297|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
145451146|NCT04683029|524502298|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
145451147|NCT04299308|524502299|FG000|Overall Study|Withdrawal by Subject|1|||
145451148|NCT04299308|524502300|FG001|Overall Study|Withdrawal by Subject|0|||
145451149|NCT04299308|524502299|FG000|Overall Study|issue with PET image (1)|1|||
145451150|NCT04299308|524502300|FG001|Overall Study|issue with PET image (1)|0|||
145451151|NCT00814580|524502301|FG000|Overall Study|Adverse Event|6|||
145451152|NCT00814580|524502302|FG001|Overall Study|Adverse Event|15|||
145451153|NCT00814580|524502301|FG000|Overall Study|Lack of Efficacy|18|||
145451154|NCT00814580|524502302|FG001|Overall Study|Lack of Efficacy|25|||
145451155|NCT00814580|524502301|FG000|Overall Study|Protocol Violation|2|||
145451156|NCT00814580|524502302|FG001|Overall Study|Protocol Violation|0|||
145451157|NCT00814580|524502301|FG000|Overall Study|Withdrawal by Subject|2|||
145451158|NCT00814580|524502302|FG001|Overall Study|Withdrawal by Subject|2|||
145451159|NCT00814580|524502301|FG000|Overall Study|Other|1|||
145451160|NCT00814580|524502302|FG001|Overall Study|Other|3|||
145451161|NCT00814580|524502301|FG000|Overall Study|Did Not Take Drug|2|||
145451162|NCT00814580|524502302|FG001|Overall Study|Did Not Take Drug|2|||
145451163|NCT02920528|524502307|FG000|Overall Study|Incomplete Data|1|||
145451164|NCT02920528|524502308|FG001|Overall Study|Incomplete Data|1|||
145451165|NCT02920528|524502309|FG002|Overall Study|Incomplete Data|1|||
145451166|NCT02920528|524502307|FG000|Overall Study|Adverse Event|0|||
145451167|NCT02920528|524502308|FG001|Overall Study|Adverse Event|0|||
145451168|NCT02920528|524502309|FG002|Overall Study|Adverse Event|3|||
145451169|NCT02920528|524502307|FG000|Overall Study|Did not meet inclusion criteria|2|||
145451170|NCT02920528|524502308|FG001|Overall Study|Did not meet inclusion criteria|0|||
145451171|NCT02920528|524502309|FG002|Overall Study|Did not meet inclusion criteria|1|||
145451172|NCT01340625|524502310|FG000|First Intervention|Adverse Event|1|||
145626199|NCT00209274|525144218|FG000|Overall Study|Death|32|||
145626200|NCT00209274|525144219|FG001|Overall Study|Death|15|||
145451173|NCT01340625|524502311|FG001|First Intervention|Adverse Event|0|||
145451174|NCT01340625|524502310|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
145451175|NCT01340625|524502311|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
145626201|NCT00209274|525144218|FG000|Overall Study|Withdrawal by Subject|30|||
145626202|NCT00209274|525144219|FG001|Overall Study|Withdrawal by Subject|15|||
145626203|NCT00209274|525144218|FG000|Overall Study|Randomized not treated (RNT)|6|||
145626204|NCT00209274|525144219|FG001|Overall Study|Randomized not treated (RNT)|15|||
145451176|NCT01986231|524502312|FG000|Overall Study|Adverse Event|1|||
145451177|NCT00489424|524502315|FG000|Overall Study|Adverse Event|3|||
145626205|NCT02753530|525144220|FG000|Overall Study|Adverse Event|7|||
145451178|NCT00489424|524502316|FG001|Overall Study|Adverse Event|3|||
145451179|NCT00489424|524502317|FG002|Overall Study|Adverse Event|4|||
145451180|NCT00489424|524502315|FG000|Overall Study|Lack of Efficacy|1|||
145451181|NCT00489424|524502316|FG001|Overall Study|Lack of Efficacy|0|||
145451182|NCT00489424|524502317|FG002|Overall Study|Lack of Efficacy|0|||
145451183|NCT00489424|524502315|FG000|Overall Study|Administrative problems|0|||
145451184|NCT00489424|524502316|FG001|Overall Study|Administrative problems|2|||
145451185|NCT00489424|524502317|FG002|Overall Study|Administrative problems|1|||
145451186|NCT01436656|524502318|FG000|Dose Escalation|Death|1|||
145451187|NCT01436656|524502319|FG001|Dose Escalation|Death|3|||
145451188|NCT01436656|524502320|FG002|Dose Escalation|Death|1|||
145451189|NCT01436656|524502321|FG003|Dose Escalation|Death|0|||
145451190|NCT01436656|524502322|FG004|Dose Escalation|Death|2|||
145451191|NCT01436656|524502323|FG005|Dose Escalation|Death|1|||
145451192|NCT01436656|524502324|FG006|Dose Escalation|Death|1|||
145451193|NCT01436656|524502325|FG007|Dose Escalation|Death|1|||
145451194|NCT01436656|524502326|FG008|Dose Escalation|Death|1|||
145451195|NCT01436656|524502327|FG009|Dose Escalation|Death|0|||
145451196|NCT01436656|524502328|FG010|Dose Escalation|Death|0|||
145451197|NCT01436656|524502329|FG011|Dose Escalation|Death|0|||
145451198|NCT01436656|524502330|FG012|Dose Escalation|Death|0|||
145451199|NCT01436656|524502331|FG013|Dose Escalation|Death|0|||
145451200|NCT01436656|524502332|FG014|Dose Escalation|Death|0|||
145451201|NCT01436656|524502333|FG015|Dose Escalation|Death|0|||
145451202|NCT01436656|524502334|FG016|Dose Escalation|Death|0|||
145451203|NCT01436656|524502335|FG017|Dose Escalation|Death|0|||
145451204|NCT01436656|524502318|FG000|Dose Escalation|Protocol Violation|0|||
145451205|NCT01436656|524502319|FG001|Dose Escalation|Protocol Violation|0|||
145451206|NCT01436656|524502320|FG002|Dose Escalation|Protocol Violation|0|||
145451207|NCT01436656|524502321|FG003|Dose Escalation|Protocol Violation|0|||
145451208|NCT01436656|524502322|FG004|Dose Escalation|Protocol Violation|0|||
145451209|NCT01436656|524502323|FG005|Dose Escalation|Protocol Violation|1|||
145451210|NCT01436656|524502324|FG006|Dose Escalation|Protocol Violation|0|||
145451211|NCT01436656|524502325|FG007|Dose Escalation|Protocol Violation|0|||
145451212|NCT01436656|524502326|FG008|Dose Escalation|Protocol Violation|0|||
145451213|NCT01436656|524502327|FG009|Dose Escalation|Protocol Violation|0|||
145451214|NCT01436656|524502328|FG010|Dose Escalation|Protocol Violation|0|||
145451215|NCT01436656|524502329|FG011|Dose Escalation|Protocol Violation|0|||
145451216|NCT01436656|524502330|FG012|Dose Escalation|Protocol Violation|0|||
145451217|NCT01436656|524502331|FG013|Dose Escalation|Protocol Violation|0|||
145451218|NCT01436656|524502332|FG014|Dose Escalation|Protocol Violation|0|||
145451219|NCT01436656|524502333|FG015|Dose Escalation|Protocol Violation|0|||
145451220|NCT01436656|524502334|FG016|Dose Escalation|Protocol Violation|0|||
145451221|NCT01436656|524502335|FG017|Dose Escalation|Protocol Violation|0|||
145451222|NCT01436656|524502318|FG000|Dose Escalation|Withdrawal by Subject|0|||
145451223|NCT01436656|524502319|FG001|Dose Escalation|Withdrawal by Subject|0|||
145451224|NCT01436656|524502320|FG002|Dose Escalation|Withdrawal by Subject|0|||
145451225|NCT01436656|524502321|FG003|Dose Escalation|Withdrawal by Subject|0|||
145451226|NCT01436656|524502322|FG004|Dose Escalation|Withdrawal by Subject|1|||
145451227|NCT01436656|524502323|FG005|Dose Escalation|Withdrawal by Subject|0|||
145451228|NCT01436656|524502324|FG006|Dose Escalation|Withdrawal by Subject|0|||
145451229|NCT01436656|524502325|FG007|Dose Escalation|Withdrawal by Subject|2|||
145451230|NCT01436656|524502326|FG008|Dose Escalation|Withdrawal by Subject|0|||
145451231|NCT01436656|524502327|FG009|Dose Escalation|Withdrawal by Subject|1|||
145451232|NCT01436656|524502328|FG010|Dose Escalation|Withdrawal by Subject|1|||
145451233|NCT01436656|524502329|FG011|Dose Escalation|Withdrawal by Subject|0|||
145451234|NCT01436656|524502330|FG012|Dose Escalation|Withdrawal by Subject|0|||
145451235|NCT01436656|524502331|FG013|Dose Escalation|Withdrawal by Subject|0|||
145451236|NCT01436656|524502332|FG014|Dose Escalation|Withdrawal by Subject|0|||
145451237|NCT01436656|524502333|FG015|Dose Escalation|Withdrawal by Subject|0|||
145451238|NCT01436656|524502334|FG016|Dose Escalation|Withdrawal by Subject|0|||
145451239|NCT01436656|524502335|FG017|Dose Escalation|Withdrawal by Subject|0|||
145451240|NCT01436656|524502318|FG000|Dose Escalation|Administrative problems|0|||
145451241|NCT01436656|524502319|FG001|Dose Escalation|Administrative problems|1|||
145586033|NCT04827576|524999551|FG003|Overall Study|Withdrew Consent|0|||
145451242|NCT01436656|524502320|FG002|Dose Escalation|Administrative problems|0|||
145451243|NCT01436656|524502321|FG003|Dose Escalation|Administrative problems|0|||
145451244|NCT01436656|524502322|FG004|Dose Escalation|Administrative problems|0|||
145451245|NCT01436656|524502323|FG005|Dose Escalation|Administrative problems|0|||
145451246|NCT01436656|524502324|FG006|Dose Escalation|Administrative problems|0|||
145451247|NCT01436656|524502325|FG007|Dose Escalation|Administrative problems|0|||
145451248|NCT01436656|524502326|FG008|Dose Escalation|Administrative problems|0|||
145451249|NCT01436656|524502327|FG009|Dose Escalation|Administrative problems|0|||
145451250|NCT01436656|524502328|FG010|Dose Escalation|Administrative problems|0|||
145451251|NCT01436656|524502329|FG011|Dose Escalation|Administrative problems|0|||
145451252|NCT01436656|524502330|FG012|Dose Escalation|Administrative problems|0|||
145451253|NCT01436656|524502331|FG013|Dose Escalation|Administrative problems|0|||
145451254|NCT01436656|524502332|FG014|Dose Escalation|Administrative problems|0|||
145451255|NCT01436656|524502333|FG015|Dose Escalation|Administrative problems|0|||
145451256|NCT01436656|524502334|FG016|Dose Escalation|Administrative problems|0|||
145451257|NCT01436656|524502335|FG017|Dose Escalation|Administrative problems|0|||
145451258|NCT01436656|524502318|FG000|Dose Escalation|Lost to Follow-up|1|||
145451259|NCT01436656|524502319|FG001|Dose Escalation|Lost to Follow-up|0|||
145451260|NCT01436656|524502320|FG002|Dose Escalation|Lost to Follow-up|0|||
145451261|NCT01436656|524502321|FG003|Dose Escalation|Lost to Follow-up|0|||
145451262|NCT01436656|524502322|FG004|Dose Escalation|Lost to Follow-up|1|||
145451263|NCT01436656|524502323|FG005|Dose Escalation|Lost to Follow-up|0|||
145451264|NCT01436656|524502324|FG006|Dose Escalation|Lost to Follow-up|0|||
145451265|NCT01436656|524502325|FG007|Dose Escalation|Lost to Follow-up|0|||
145451266|NCT01436656|524502326|FG008|Dose Escalation|Lost to Follow-up|0|||
145451267|NCT01436656|524502327|FG009|Dose Escalation|Lost to Follow-up|0|||
145451268|NCT01436656|524502328|FG010|Dose Escalation|Lost to Follow-up|0|||
145451269|NCT01436656|524502329|FG011|Dose Escalation|Lost to Follow-up|0|||
145451270|NCT01436656|524502330|FG012|Dose Escalation|Lost to Follow-up|0|||
145451271|NCT01436656|524502331|FG013|Dose Escalation|Lost to Follow-up|0|||
145451272|NCT01436656|524502332|FG014|Dose Escalation|Lost to Follow-up|0|||
145451273|NCT01436656|524502333|FG015|Dose Escalation|Lost to Follow-up|0|||
145451274|NCT01436656|524502334|FG016|Dose Escalation|Lost to Follow-up|0|||
145451275|NCT01436656|524502335|FG017|Dose Escalation|Lost to Follow-up|0|||
145451276|NCT01436656|524502318|FG000|Dose Escalation|New anti-cancer therapy|1|||
145451277|NCT01436656|524502319|FG001|Dose Escalation|New anti-cancer therapy|0|||
145451278|NCT01436656|524502320|FG002|Dose Escalation|New anti-cancer therapy|0|||
145451279|NCT01436656|524502321|FG003|Dose Escalation|New anti-cancer therapy|0|||
145451280|NCT01436656|524502322|FG004|Dose Escalation|New anti-cancer therapy|0|||
145451281|NCT01436656|524502323|FG005|Dose Escalation|New anti-cancer therapy|0|||
145451282|NCT01436656|524502324|FG006|Dose Escalation|New anti-cancer therapy|0|||
145451283|NCT01436656|524502325|FG007|Dose Escalation|New anti-cancer therapy|0|||
145451284|NCT01436656|524502326|FG008|Dose Escalation|New anti-cancer therapy|1|||
145451285|NCT01436656|524502327|FG009|Dose Escalation|New anti-cancer therapy|1|||
145451286|NCT01436656|524502328|FG010|Dose Escalation|New anti-cancer therapy|0|||
145451287|NCT01436656|524502329|FG011|Dose Escalation|New anti-cancer therapy|0|||
145451288|NCT01436656|524502330|FG012|Dose Escalation|New anti-cancer therapy|0|||
145451289|NCT01436656|524502331|FG013|Dose Escalation|New anti-cancer therapy|0|||
145451290|NCT01436656|524502332|FG014|Dose Escalation|New anti-cancer therapy|0|||
145451291|NCT01436656|524502333|FG015|Dose Escalation|New anti-cancer therapy|0|||
145451292|NCT01436656|524502334|FG016|Dose Escalation|New anti-cancer therapy|0|||
145451293|NCT01436656|524502335|FG017|Dose Escalation|New anti-cancer therapy|0|||
145451294|NCT01436656|524502318|FG000|Dose Expansion|Adverse Event|0|||
145451295|NCT01436656|524502319|FG001|Dose Expansion|Adverse Event|0|||
145451296|NCT01436656|524502320|FG002|Dose Expansion|Adverse Event|0|||
145451297|NCT01436656|524502321|FG003|Dose Expansion|Adverse Event|0|||
145451298|NCT01436656|524502322|FG004|Dose Expansion|Adverse Event|0|||
145451299|NCT01436656|524502323|FG005|Dose Expansion|Adverse Event|0|||
145451300|NCT01436656|524502324|FG006|Dose Expansion|Adverse Event|0|||
145451301|NCT01436656|524502325|FG007|Dose Expansion|Adverse Event|0|||
145451302|NCT01436656|524502326|FG008|Dose Expansion|Adverse Event|0|||
145451303|NCT01436656|524502327|FG009|Dose Expansion|Adverse Event|0|||
145451304|NCT01436656|524502328|FG010|Dose Expansion|Adverse Event|0|||
145451305|NCT01436656|524502329|FG011|Dose Expansion|Adverse Event|1|||
145451306|NCT01436656|524502330|FG012|Dose Expansion|Adverse Event|0|||
145451307|NCT01436656|524502331|FG013|Dose Expansion|Adverse Event|0|||
145451308|NCT01436656|524502332|FG014|Dose Expansion|Adverse Event|0|||
145451309|NCT01436656|524502333|FG015|Dose Expansion|Adverse Event|0|||
145451310|NCT01436656|524502334|FG016|Dose Expansion|Adverse Event|0|||
145451311|NCT01436656|524502335|FG017|Dose Expansion|Adverse Event|0|||
145451312|NCT01436656|524502318|FG000|Dose Expansion|Withdrawal by Subject|0|||
145451313|NCT01436656|524502319|FG001|Dose Expansion|Withdrawal by Subject|0|||
145451314|NCT01436656|524502320|FG002|Dose Expansion|Withdrawal by Subject|0|||
145451315|NCT01436656|524502321|FG003|Dose Expansion|Withdrawal by Subject|0|||
145451316|NCT01436656|524502322|FG004|Dose Expansion|Withdrawal by Subject|0|||
145626206|NCT02753530|525144221|FG001|Overall Study|Adverse Event|1|||
145451317|NCT01436656|524502323|FG005|Dose Expansion|Withdrawal by Subject|0|||
145451318|NCT01436656|524502324|FG006|Dose Expansion|Withdrawal by Subject|0|||
145451319|NCT01436656|524502325|FG007|Dose Expansion|Withdrawal by Subject|0|||
145451320|NCT01436656|524502326|FG008|Dose Expansion|Withdrawal by Subject|0|||
145451321|NCT01436656|524502327|FG009|Dose Expansion|Withdrawal by Subject|0|||
145451322|NCT01436656|524502328|FG010|Dose Expansion|Withdrawal by Subject|0|||
145451323|NCT01436656|524502329|FG011|Dose Expansion|Withdrawal by Subject|1|||
145451324|NCT01436656|524502330|FG012|Dose Expansion|Withdrawal by Subject|3|||
145451325|NCT01436656|524502331|FG013|Dose Expansion|Withdrawal by Subject|1|||
145451326|NCT01436656|524502332|FG014|Dose Expansion|Withdrawal by Subject|2|||
145451327|NCT01436656|524502333|FG015|Dose Expansion|Withdrawal by Subject|0|||
145451328|NCT01436656|524502334|FG016|Dose Expansion|Withdrawal by Subject|1|||
145451329|NCT01436656|524502335|FG017|Dose Expansion|Withdrawal by Subject|1|||
145451330|NCT01436656|524502318|FG000|Dose Expansion|Death|0|||
145451331|NCT01436656|524502319|FG001|Dose Expansion|Death|0|||
145451332|NCT01436656|524502320|FG002|Dose Expansion|Death|0|||
145451333|NCT01436656|524502321|FG003|Dose Expansion|Death|0|||
145451334|NCT01436656|524502322|FG004|Dose Expansion|Death|0|||
145451335|NCT01436656|524502323|FG005|Dose Expansion|Death|0|||
145586034|NCT04827576|524999548|FG000|Overall Study|Lost to Follow-up|1|||
145586035|NCT04827576|524999549|FG001|Overall Study|Lost to Follow-up|0|||
145586036|NCT04827576|524999550|FG002|Overall Study|Lost to Follow-up|0|||
145586037|NCT04827576|524999551|FG003|Overall Study|Lost to Follow-up|0|||
145586038|NCT04295564|524999552|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
145586039|NCT04295564|524999553|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
145586040|NCT02527798|524999554|FG000|Overall Study|Physician Decision|1|||
145586041|NCT02527798|524999555|FG001|Overall Study|Physician Decision|0|||
145586042|NCT02527798|524999556|FG002|Overall Study|Physician Decision|1|||
145586043|NCT02527798|524999557|FG003|Overall Study|Physician Decision|1|||
145586044|NCT02527798|524999558|FG004|Overall Study|Physician Decision|0|||
145586045|NCT02527798|524999559|FG005|Overall Study|Physician Decision|0|||
145586046|NCT02527798|524999554|FG000|Overall Study|Death|0|||
145586047|NCT02527798|524999555|FG001|Overall Study|Death|0|||
145586048|NCT02527798|524999556|FG002|Overall Study|Death|1|||
145586049|NCT02527798|524999557|FG003|Overall Study|Death|0|||
145586050|NCT02527798|524999558|FG004|Overall Study|Death|0|||
145586051|NCT02527798|524999559|FG005|Overall Study|Death|0|||
145586052|NCT02527798|524999554|FG000|Overall Study|Withdrawal by Subject|0|||
145586053|NCT02527798|524999555|FG001|Overall Study|Withdrawal by Subject|1|||
145586054|NCT02527798|524999556|FG002|Overall Study|Withdrawal by Subject|2|||
145586055|NCT02527798|524999557|FG003|Overall Study|Withdrawal by Subject|0|||
145586056|NCT02527798|524999558|FG004|Overall Study|Withdrawal by Subject|0|||
145586057|NCT02527798|524999559|FG005|Overall Study|Withdrawal by Subject|0|||
145586058|NCT02527798|524999554|FG000|Overall Study|Reason undisclosed|1|||
145586059|NCT02527798|524999555|FG001|Overall Study|Reason undisclosed|0|||
145586060|NCT02527798|524999556|FG002|Overall Study|Reason undisclosed|1|||
145586061|NCT02527798|524999557|FG003|Overall Study|Reason undisclosed|0|||
145586062|NCT02527798|524999558|FG004|Overall Study|Reason undisclosed|0|||
145586063|NCT02527798|524999559|FG005|Overall Study|Reason undisclosed|0|||
145586064|NCT02527798|524999554|FG000|Overall Study|Did not receive intervention|1|||
145586065|NCT02527798|524999555|FG001|Overall Study|Did not receive intervention|1|||
145451336|NCT01436656|524502324|FG006|Dose Expansion|Death|0|||
145451337|NCT01436656|524502325|FG007|Dose Expansion|Death|0|||
145451338|NCT01436656|524502326|FG008|Dose Expansion|Death|0|||
145451339|NCT01436656|524502327|FG009|Dose Expansion|Death|0|||
145451340|NCT01436656|524502328|FG010|Dose Expansion|Death|0|||
145451341|NCT01436656|524502329|FG011|Dose Expansion|Death|0|||
145451342|NCT01436656|524502330|FG012|Dose Expansion|Death|1|||
145451343|NCT01436656|524502331|FG013|Dose Expansion|Death|0|||
145451344|NCT01436656|524502332|FG014|Dose Expansion|Death|3|||
145451345|NCT01436656|524502333|FG015|Dose Expansion|Death|0|||
145451346|NCT01436656|524502334|FG016|Dose Expansion|Death|3|||
145451347|NCT01436656|524502335|FG017|Dose Expansion|Death|3|||
145451348|NCT01436656|524502318|FG000|Dose Expansion|Lost to Follow-up|0|||
145451349|NCT01436656|524502319|FG001|Dose Expansion|Lost to Follow-up|0|||
145451350|NCT01436656|524502320|FG002|Dose Expansion|Lost to Follow-up|0|||
145451351|NCT01436656|524502321|FG003|Dose Expansion|Lost to Follow-up|0|||
145451352|NCT01436656|524502322|FG004|Dose Expansion|Lost to Follow-up|0|||
145451353|NCT01436656|524502323|FG005|Dose Expansion|Lost to Follow-up|0|||
145451354|NCT01436656|524502324|FG006|Dose Expansion|Lost to Follow-up|0|||
145451355|NCT01436656|524502325|FG007|Dose Expansion|Lost to Follow-up|0|||
145451356|NCT01436656|524502326|FG008|Dose Expansion|Lost to Follow-up|0|||
145451357|NCT01436656|524502327|FG009|Dose Expansion|Lost to Follow-up|0|||
145451358|NCT01436656|524502328|FG010|Dose Expansion|Lost to Follow-up|0|||
145451359|NCT01436656|524502329|FG011|Dose Expansion|Lost to Follow-up|0|||
145451360|NCT01436656|524502330|FG012|Dose Expansion|Lost to Follow-up|0|||
145586066|NCT02527798|524999556|FG002|Overall Study|Did not receive intervention|0|||
145586067|NCT02527798|524999557|FG003|Overall Study|Did not receive intervention|0|||
145586068|NCT02527798|524999558|FG004|Overall Study|Did not receive intervention|0|||
145586069|NCT02527798|524999559|FG005|Overall Study|Did not receive intervention|0|||
145451361|NCT01436656|524502331|FG013|Dose Expansion|Lost to Follow-up|0|||
145451362|NCT01436656|524502332|FG014|Dose Expansion|Lost to Follow-up|0|||
145451363|NCT01436656|524502333|FG015|Dose Expansion|Lost to Follow-up|0|||
145451364|NCT01436656|524502334|FG016|Dose Expansion|Lost to Follow-up|0|||
145451365|NCT01436656|524502335|FG017|Dose Expansion|Lost to Follow-up|3|||
145451366|NCT01436656|524502318|FG000|Dose Expansion|Disease progression|0|||
145451367|NCT01436656|524502319|FG001|Dose Expansion|Disease progression|0|||
145451368|NCT01436656|524502320|FG002|Dose Expansion|Disease progression|0|||
145586070|NCT04745169|524999560|FG000|Overall Study|Kidney transplantation|1|||
145586071|NCT04745169|524999560|FG000|Overall Study|Participant health problems|3|||
145586072|NCT04745169|524999560|FG000|Overall Study|Physician Decision|2|||
145626207|NCT02753530|525144220|FG000|Overall Study|Death|0|||
145451369|NCT01436656|524502321|FG003|Dose Expansion|Disease progression|0|||
145451370|NCT01436656|524502322|FG004|Dose Expansion|Disease progression|0|||
145451371|NCT01436656|524502323|FG005|Dose Expansion|Disease progression|0|||
145451372|NCT01436656|524502324|FG006|Dose Expansion|Disease progression|0|||
145451373|NCT01436656|524502325|FG007|Dose Expansion|Disease progression|0|||
145451374|NCT01436656|524502326|FG008|Dose Expansion|Disease progression|0|||
145451375|NCT01436656|524502327|FG009|Dose Expansion|Disease progression|0|||
145451376|NCT01436656|524502328|FG010|Dose Expansion|Disease progression|0|||
145451377|NCT01436656|524502329|FG011|Dose Expansion|Disease progression|3|||
145451378|NCT01436656|524502330|FG012|Dose Expansion|Disease progression|1|||
145451379|NCT01436656|524502331|FG013|Dose Expansion|Disease progression|0|||
145451380|NCT01436656|524502332|FG014|Dose Expansion|Disease progression|1|||
145451381|NCT01436656|524502333|FG015|Dose Expansion|Disease progression|0|||
145451382|NCT01436656|524502334|FG016|Dose Expansion|Disease progression|0|||
145451383|NCT01436656|524502335|FG017|Dose Expansion|Disease progression|1|||
145451384|NCT01436656|524502318|FG000|Dose Expansion|New cancer therapy|0|||
145451385|NCT01436656|524502319|FG001|Dose Expansion|New cancer therapy|0|||
145451386|NCT01436656|524502320|FG002|Dose Expansion|New cancer therapy|0|||
145451387|NCT01436656|524502321|FG003|Dose Expansion|New cancer therapy|0|||
145451388|NCT01436656|524502322|FG004|Dose Expansion|New cancer therapy|0|||
145451389|NCT01436656|524502323|FG005|Dose Expansion|New cancer therapy|0|||
145451390|NCT01436656|524502324|FG006|Dose Expansion|New cancer therapy|0|||
145451391|NCT01436656|524502325|FG007|Dose Expansion|New cancer therapy|0|||
145451392|NCT01436656|524502326|FG008|Dose Expansion|New cancer therapy|0|||
145451393|NCT01436656|524502327|FG009|Dose Expansion|New cancer therapy|0|||
145451394|NCT01436656|524502328|FG010|Dose Expansion|New cancer therapy|0|||
145451395|NCT01436656|524502329|FG011|Dose Expansion|New cancer therapy|1|||
145451396|NCT01436656|524502330|FG012|Dose Expansion|New cancer therapy|1|||
145451397|NCT01436656|524502331|FG013|Dose Expansion|New cancer therapy|0|||
145451398|NCT01436656|524502332|FG014|Dose Expansion|New cancer therapy|2|||
145451399|NCT01436656|524502333|FG015|Dose Expansion|New cancer therapy|0|||
145451400|NCT01436656|524502334|FG016|Dose Expansion|New cancer therapy|0|||
145451401|NCT01436656|524502335|FG017|Dose Expansion|New cancer therapy|0|||
145451402|NCT00880269|524502336|FG000|Overall Study|Protocol Violation|1|||
145451403|NCT00880269|524502337|FG001|Overall Study|Protocol Violation|0|||
145451404|NCT00880269|524502336|FG000|Overall Study|Disease Progression|13|||
145451405|NCT00880269|524502337|FG001|Overall Study|Disease Progression|11|||
145451406|NCT00880269|524502336|FG000|Overall Study|New Cancer Therapy|1|||
145451407|NCT00880269|524502337|FG001|Overall Study|New Cancer Therapy|0|||
145451408|NCT00880269|524502336|FG000|Overall Study|Death|4|||
145586073|NCT00724282|524999562|FG000|Overall Study|Withdrawal by Subject|3|||
145586074|NCT00724282|524999562|FG000|Overall Study|Physician Decision|1|||
145586075|NCT01808690|524999563|FG000|Overall Study|Withdrawal by Subject|1|||
145586076|NCT01808690|524999564|FG001|Overall Study|Withdrawal by Subject|2|||
145586077|NCT02244944|524999567|FG000|Overall Study|Withdrawal by Subject|1|||
145586078|NCT02244944|524999567|FG000|Overall Study|Study Terminated|1|||
145586079|NCT01928719|524999570|FG000|Overall Study|Lost to Follow-up|26|||
145586080|NCT01928719|524999571|FG001|Overall Study|Lost to Follow-up|11|||
145586081|NCT01928719|524999570|FG000|Overall Study|Withdrawal by Subject|22|||
145586082|NCT01928719|524999571|FG001|Overall Study|Withdrawal by Subject|7|||
145586083|NCT01928719|524999570|FG000|Overall Study|Protocol Violation|3|||
145586084|NCT01928719|524999571|FG001|Overall Study|Protocol Violation|1|||
145586085|NCT01928719|524999570|FG000|Overall Study|Adverse Event|1|||
145586086|NCT01928719|524999571|FG001|Overall Study|Adverse Event|0|||
145586087|NCT00263666|524999572|FG000|Overall Study|Adverse Event|6|||
145586088|NCT00263666|524999573|FG001|Overall Study|Adverse Event|8|||
145586089|NCT00263666|524999572|FG000|Overall Study|Lost to Follow-up|1|||
145586090|NCT00263666|524999573|FG001|Overall Study|Lost to Follow-up|2|||
145586091|NCT00263666|524999572|FG000|Overall Study|Withdrawal by Subject|0|||
145586092|NCT00263666|524999573|FG001|Overall Study|Withdrawal by Subject|1|||
145586093|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
145451409|NCT00880269|524502337|FG001|Overall Study|Death|2|||
145451410|NCT00880269|524502336|FG000|Overall Study|Lost to Follow-up|0|||
145451411|NCT00880269|524502337|FG001|Overall Study|Lost to Follow-up|1|||
145451412|NCT00880269|524502336|FG000|Overall Study|Withdrawal by Subject|3|||
145451413|NCT00880269|524502337|FG001|Overall Study|Withdrawal by Subject|4|||
145451414|NCT00880269|524502336|FG000|Overall Study|Adverse Event|10|||
145451415|NCT00880269|524502337|FG001|Overall Study|Adverse Event|9|||
145451416|NCT00842153|524502343|FG000|Overall Study|Adverse Event|0|||
145451417|NCT00842153|524502344|FG001|Overall Study|Adverse Event|1|||
145451418|NCT00842153|524502343|FG000|Overall Study|Lost to Follow-up|1|||
145451419|NCT00842153|524502344|FG001|Overall Study|Lost to Follow-up|2|||
145586094|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
145586095|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
145586096|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
145451420|NCT01355679|524502346|FG000|Overall Study|benign tumor types found at biopsy|2|||
145451421|NCT02027311|524502347|FG000|Overall Study|Protocol Violation|3|||
145451422|NCT02027311|524502348|FG001|Overall Study|Protocol Violation|2|||
145626208|NCT02753530|525144221|FG001|Overall Study|Death|1|||
145451423|NCT05319600|524502349|FG000|Overall Study|Withdrawal by Subject|1|||
145451424|NCT05319600|524502350|FG001|Overall Study|Withdrawal by Subject|0|||
145451425|NCT05319600|524502349|FG000|Overall Study|Lost to Follow-up|0|||
145451426|NCT05319600|524502350|FG001|Overall Study|Lost to Follow-up|4|||
145451427|NCT00690430|524502353|FG000|Core Phase|Abnormal Laboratory value|0|||
145451428|NCT00690430|524502354|FG001|Core Phase|Abnormal Laboratory value|1|||
145451429|NCT00690430|524502355|FG002|Core Phase|Abnormal Laboratory value|0|||
145451430|NCT00690430|524502353|FG000|Core Phase|Adverse Event|5|||
145451431|NCT00690430|524502354|FG001|Core Phase|Adverse Event|1|||
145451432|NCT00690430|524502355|FG002|Core Phase|Adverse Event|0|||
145451433|NCT00690430|524502353|FG000|Core Phase|Death|0|||
145451434|NCT00690430|524502354|FG001|Core Phase|Death|2|||
145451435|NCT00690430|524502355|FG002|Core Phase|Death|0|||
145451436|NCT00690430|524502353|FG000|Core Phase|Protocol Violation|1|||
145451437|NCT00690430|524502354|FG001|Core Phase|Protocol Violation|0|||
145451438|NCT00690430|524502355|FG002|Core Phase|Protocol Violation|0|||
145451439|NCT00690430|524502353|FG000|Core Phase|Withdrawal by Subject|3|||
145451440|NCT00690430|524502354|FG001|Core Phase|Withdrawal by Subject|3|||
145451441|NCT00690430|524502355|FG002|Core Phase|Withdrawal by Subject|0|||
145451442|NCT00690430|524502353|FG000|Core Phase|Subject no longer requires study drug|1|||
145451443|NCT00690430|524502354|FG001|Core Phase|Subject no longer requires study drug|0|||
145451444|NCT00690430|524502355|FG002|Core Phase|Subject no longer requires study drug|0|||
145451445|NCT00690430|524502353|FG000|Core Phase|Lack of Efficacy|8|||
145451446|NCT00690430|524502354|FG001|Core Phase|Lack of Efficacy|10|||
145451447|NCT00690430|524502355|FG002|Core Phase|Lack of Efficacy|0|||
145451448|NCT00690430|524502353|FG000|Core Phase|Administrative Problems|0|||
145451449|NCT00690430|524502354|FG001|Core Phase|Administrative Problems|1|||
145451450|NCT00690430|524502355|FG002|Core Phase|Administrative Problems|0|||
145451451|NCT00690430|524502353|FG000|Core Phase|Early Termination|0|||
145451452|NCT00690430|524502354|FG001|Core Phase|Early Termination|5|||
145451453|NCT00690430|524502355|FG002|Core Phase|Early Termination|0|||
145451454|NCT00690430|524502353|FG000|Extension Phase|Lack of Efficacy|3|||
145451455|NCT00690430|524502354|FG001|Extension Phase|Lack of Efficacy|1|||
145451456|NCT00690430|524502355|FG002|Extension Phase|Lack of Efficacy|4|||
145451457|NCT00690430|524502353|FG000|Extension Phase|Abnormal Lab Values|1|||
145451458|NCT00690430|524502354|FG001|Extension Phase|Abnormal Lab Values|0|||
145451459|NCT00690430|524502355|FG002|Extension Phase|Abnormal Lab Values|0|||
145451460|NCT00690430|524502353|FG000|Extension Phase|Abnormal test procedure results|1|||
145451461|NCT00690430|524502354|FG001|Extension Phase|Abnormal test procedure results|0|||
145451462|NCT00690430|524502355|FG002|Extension Phase|Abnormal test procedure results|0|||
145451463|NCT00690430|524502353|FG000|Extension Phase|Administrative Problems|0|||
145451464|NCT00690430|524502354|FG001|Extension Phase|Administrative Problems|1|||
145451465|NCT00690430|524502355|FG002|Extension Phase|Administrative Problems|1|||
145451466|NCT00690430|524502353|FG000|Extension Phase|Adverse Event|2|||
145451467|NCT00690430|524502354|FG001|Extension Phase|Adverse Event|1|||
145451468|NCT00690430|524502355|FG002|Extension Phase|Adverse Event|2|||
145451469|NCT00690430|524502353|FG000|Extension Phase|Death|1|||
145451470|NCT00690430|524502354|FG001|Extension Phase|Death|1|||
145451471|NCT00690430|524502355|FG002|Extension Phase|Death|1|||
145451472|NCT00690430|524502353|FG000|Extension Phase|Withdrawal by Subject|0|||
145451473|NCT00690430|524502354|FG001|Extension Phase|Withdrawal by Subject|0|||
145451474|NCT00690430|524502355|FG002|Extension Phase|Withdrawal by Subject|2|||
145451475|NCT00690430|524502353|FG000|Extension Phase|Early Termination|10|||
145451476|NCT00690430|524502354|FG001|Extension Phase|Early Termination|1|||
145451477|NCT00690430|524502355|FG002|Extension Phase|Early Termination|3|||
145586097|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
145451478|NCT02125838|524502364|FG000|Overall Study|Lost to Follow-up|4|||
145451479|NCT02125838|524502365|FG001|Overall Study|Lost to Follow-up|4|||
145451480|NCT00787839|524502366|FG000|Overall Study|Failure to have the OGTT was most common|404|||
145451481|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
145451482|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
145451483|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
145451484|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
145451485|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Death|58|||
145586098|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
145586099|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
145451486|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Death|65|||
145451487|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Adverse Event|28|||
145451488|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Adverse Event|40|||
145451489|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Disease Progression|22|||
145451490|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Disease Progression|35|||
145451491|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Other|25|||
145451492|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Other|33|||
145451493|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
145451494|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
145451495|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Noncompliance|8|||
145451496|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Noncompliance|8|||
145451497|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
145451498|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
145451499|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
145451500|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
145451501|NCT00286091|524502373|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
145451502|NCT00286091|524502374|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
145451503|NCT00286091|524502373|FG000|Open-label Treatment Phase|Physician Decision|24|||
145451504|NCT00286091|524502374|FG001|Open-label Treatment Phase|Physician Decision|21|||
145451505|NCT00286091|524502373|FG000|Open-label Treatment Phase|Adverse Event|5|||
145451506|NCT00286091|524502374|FG001|Open-label Treatment Phase|Adverse Event|16|||
145451507|NCT00286091|524502373|FG000|Open-label Treatment Phase|Other|11|||
145451508|NCT00286091|524502374|FG001|Open-label Treatment Phase|Other|11|||
145451509|NCT00286091|524502373|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
145451510|NCT00286091|524502374|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
145451511|NCT00286091|524502373|FG000|Open-label Treatment Phase|Death|10|||
145451512|NCT00286091|524502374|FG001|Open-label Treatment Phase|Death|7|||
145451513|NCT00286091|524502373|FG000|Open-label Treatment Phase|Disease Progression|9|||
145451514|NCT00286091|524502374|FG001|Open-label Treatment Phase|Disease Progression|3|||
145451515|NCT00286091|524502373|FG000|Open-label Treatment Phase|Noncompliance|3|||
145451516|NCT00286091|524502374|FG001|Open-label Treatment Phase|Noncompliance|1|||
145451517|NCT00286091|524502373|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
145451518|NCT00286091|524502374|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
145451519|NCT00286091|524502373|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
145451520|NCT00286091|524502374|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
145451521|NCT00286091|524502373|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
145451522|NCT00286091|524502374|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
145451523|NCT02936869|524502377|FG000|Overall Study|Lost to Follow-up|1|||
145451524|NCT02936869|524502378|FG001|Overall Study|Lost to Follow-up|3|||
145451525|NCT02936869|524502377|FG000|Overall Study|Death|0|||
145451526|NCT02936869|524502378|FG001|Overall Study|Death|1|||
145451527|NCT02936869|524502377|FG000|Overall Study|Legal Case|0|||
145451528|NCT02936869|524502378|FG001|Overall Study|Legal Case|1|||
145451529|NCT02936869|524502377|FG000|Overall Study|Protocol Violation|1|||
145451530|NCT02936869|524502378|FG001|Overall Study|Protocol Violation|0|||
145451531|NCT00335738|524502379|FG000|Overall Study|Physician Decision|6|||
145451532|NCT00335738|524502380|FG001|Overall Study|Physician Decision|0|||
145451533|NCT00335738|524502379|FG000|Overall Study|Withdrawal by Subject|2|||
145451534|NCT00335738|524502380|FG001|Overall Study|Withdrawal by Subject|0|||
145451535|NCT00335738|524502379|FG000|Overall Study|Ineligible|3|||
145451536|NCT00335738|524502380|FG001|Overall Study|Ineligible|4|||
145451537|NCT03423238|524502387|FG000|Overall Study|Lost to Follow-up|1|||
145451538|NCT03423238|524502388|FG001|Overall Study|Lost to Follow-up|0|||
145451539|NCT03423238|524502387|FG000|Overall Study|Withdrawal by Subject|1|||
145451540|NCT03423238|524502388|FG001|Overall Study|Withdrawal by Subject|0|||
145451541|NCT00506454|524502392|FG000|Overall Study|Withdrawal by Subject|1|||
145451542|NCT00506454|524502393|FG001|Overall Study|Withdrawal by Subject|1|||
145451543|NCT03098433|524502397|FG000|Overall Study|Withdrawal by Subject|10|||
145451544|NCT04470050|524502398|FG000|Double-blind Treatment Phase|Adverse Event|0|||
145451545|NCT04470050|524502399|FG001|Double-blind Treatment Phase|Adverse Event|0|||
145451546|NCT04470050|524502400|FG002|Double-blind Treatment Phase|Adverse Event|0|||
145451547|NCT04470050|524502401|FG003|Double-blind Treatment Phase|Adverse Event|1|||
145451548|NCT04470050|524502402|FG004|Double-blind Treatment Phase|Adverse Event|0|||
145451549|NCT04470050|524502403|FG005|Double-blind Treatment Phase|Adverse Event|0|||
145451550|NCT04470050|524502404|FG006|Double-blind Treatment Phase|Adverse Event|0|||
145451551|NCT04470050|524502398|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451552|NCT04470050|524502399|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451553|NCT04470050|524502400|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451554|NCT04470050|524502401|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451555|NCT04470050|524502402|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
145451556|NCT04470050|524502403|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451557|NCT04470050|524502404|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
145451558|NCT04470050|524502398|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
145451559|NCT04470050|524502399|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
145451560|NCT04470050|524502400|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
145451561|NCT04470050|524502401|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
145451562|NCT04470050|524502402|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
145451563|NCT04470050|524502403|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
145451564|NCT04470050|524502404|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
145451565|NCT01104545|524502405|FG000|Overall Study|Adverse Event|0|||
145451566|NCT01104545|524502406|FG001|Overall Study|Adverse Event|1|||
145451567|NCT01104545|524502407|FG002|Overall Study|Adverse Event|2|||
145451568|NCT03640507|524502408|FG000|Overall Study|Withdrawal by Subject|0|||
145451569|NCT03640507|524502409|FG001|Overall Study|Withdrawal by Subject|0|||
145451570|NCT03640507|524502410|FG002|Overall Study|Withdrawal by Subject|1|||
145451571|NCT03604172|524502411|FG000|Overall Study|Lost to Follow-up|1|||
145451572|NCT03604172|524502412|FG001|Overall Study|Lost to Follow-up|2|||
145451573|NCT02676895|524502413|FG000|Overall Study|Administrative reason|1|||
145451574|NCT02676895|524502414|FG001|Overall Study|Administrative reason|0|||
145451575|NCT02676895|524502415|FG002|Overall Study|Administrative reason|0|||
145451576|NCT02676895|524502413|FG000|Overall Study|Protocol Violation|1|||
145451577|NCT02676895|524502414|FG001|Overall Study|Protocol Violation|0|||
145451578|NCT02676895|524502415|FG002|Overall Study|Protocol Violation|0|||
145451579|NCT02676895|524502413|FG000|Overall Study|Adverse Event|0|||
145451580|NCT02676895|524502414|FG001|Overall Study|Adverse Event|3|||
145451581|NCT02676895|524502415|FG002|Overall Study|Adverse Event|1|||
145451582|NCT02676895|524502413|FG000|Overall Study|Lost to Follow-up|0|||
145451583|NCT02676895|524502414|FG001|Overall Study|Lost to Follow-up|0|||
145451584|NCT02676895|524502415|FG002|Overall Study|Lost to Follow-up|1|||
145451585|NCT02676895|524502413|FG000|Overall Study|Withdrawal by Subject|0|||
145451586|NCT02676895|524502414|FG001|Overall Study|Withdrawal by Subject|0|||
145451587|NCT02676895|524502415|FG002|Overall Study|Withdrawal by Subject|1|||
145451588|NCT03028129|524502421|FG000|Overall Study|Adverse Event|13|||
145451589|NCT03028129|524502422|FG001|Overall Study|Adverse Event|2|||
145451590|NCT03028129|524502421|FG000|Overall Study|Lost to Follow-up|50|||
145451591|NCT03028129|524502422|FG001|Overall Study|Lost to Follow-up|38|||
145451592|NCT03028129|524502421|FG000|Overall Study|Physician Decision|0|||
145451593|NCT03028129|524502422|FG001|Overall Study|Physician Decision|1|||
145451594|NCT03028129|524502421|FG000|Overall Study|Protocol Violation|1|||
145451595|NCT03028129|524502422|FG001|Overall Study|Protocol Violation|1|||
145451596|NCT03028129|524502421|FG000|Overall Study|Withdrawal by Subject|62|||
145451597|NCT03028129|524502422|FG001|Overall Study|Withdrawal by Subject|45|||
145451598|NCT00923351|524502423|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
145451599|NCT00923351|524502424|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
145451600|NCT00923351|524502425|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
145451601|NCT00182078|524502426|FG000|Overall Study|Withdrawal by Subject|1|||
145451602|NCT00182078|524502427|FG001|Overall Study|Withdrawal by Subject|0|||
145451603|NCT00395486|524502432|FG000|Overall Study|Adverse Event|1|||
145451604|NCT00395486|524502433|FG001|Overall Study|Adverse Event|2|||
145451605|NCT00395486|524502432|FG000|Overall Study|Withdrawal by Subject|5|||
145451606|NCT00395486|524502433|FG001|Overall Study|Withdrawal by Subject|2|||
145451607|NCT00395486|524502432|FG000|Overall Study|Lost to Follow-up|0|||
145451608|NCT00395486|524502433|FG001|Overall Study|Lost to Follow-up|1|||
145451609|NCT01076205|524502434|FG000|Overall Study|Adverse Drug Reaction|299|||
145451610|NCT01076205|524502434|FG000|Overall Study|Lack of Effectiveness|1423|||
145451611|NCT01076205|524502434|FG000|Overall Study|Other Reason|1075|||
145451612|NCT01076205|524502434|FG000|Overall Study|Unknown Reason|71|||
145451613|NCT01076205|524502434|FG000|Overall Study|Lost to Follow-up|3151|||
145451614|NCT02993822|524502439|FG000|Overall Study|Lack of Efficacy|1|||
145451615|NCT02993822|524502440|FG001|Overall Study|Lack of Efficacy|1|||
145451616|NCT02993822|524502441|FG002|Overall Study|Lack of Efficacy|0|||
145451617|NCT02993822|524502442|FG003|Overall Study|Lack of Efficacy|0|||
145451618|NCT02993822|524502439|FG000|Overall Study|Protocol Violation|1|||
145451619|NCT02993822|524502440|FG001|Overall Study|Protocol Violation|0|||
145451620|NCT02993822|524502441|FG002|Overall Study|Protocol Violation|0|||
145451621|NCT02993822|524502442|FG003|Overall Study|Protocol Violation|0|||
145451622|NCT02993822|524502439|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
145451623|NCT02993822|524502440|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
145451624|NCT02993822|524502441|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
145451625|NCT02993822|524502442|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
145451626|NCT02993822|524502439|FG000|Overall Study|Adverse Event|3|||
145451627|NCT02993822|524502440|FG001|Overall Study|Adverse Event|1|||
145451628|NCT02993822|524502441|FG002|Overall Study|Adverse Event|7|||
145451629|NCT02993822|524502442|FG003|Overall Study|Adverse Event|0|||
145451630|NCT02993822|524502439|FG000|Overall Study|Withdrawal by Subject|4|||
145451631|NCT02993822|524502440|FG001|Overall Study|Withdrawal by Subject|2|||
145451632|NCT02993822|524502441|FG002|Overall Study|Withdrawal by Subject|2|||
145451633|NCT02993822|524502442|FG003|Overall Study|Withdrawal by Subject|3|||
145451634|NCT02993822|524502439|FG000|Overall Study|Lost to Follow-up|1|||
145451635|NCT02993822|524502440|FG001|Overall Study|Lost to Follow-up|0|||
145451636|NCT02993822|524502441|FG002|Overall Study|Lost to Follow-up|1|||
145451637|NCT02993822|524502442|FG003|Overall Study|Lost to Follow-up|0|||
145451638|NCT01696981|524502443|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
145451639|NCT01696981|524502444|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
145451640|NCT01696981|524502443|FG000|Overall Study|Died Before Randomization|3|||
145451641|NCT01696981|524502444|FG001|Overall Study|Died Before Randomization|8|||
145451642|NCT01696981|524502443|FG000|Overall Study|Died Before ASU (Control)|278|||
145451643|NCT01696981|524502444|FG001|Overall Study|Died Before ASU (Control)|0|||
145451644|NCT01696981|524502443|FG000|Overall Study|Refused ASU (Control)|920|||
145451645|NCT01696981|524502444|FG001|Overall Study|Refused ASU (Control)|0|||
145451646|NCT01696981|524502443|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
145451647|NCT01696981|524502444|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
145451648|NCT00851890|524502445|FG000|Overall Study|Lost to Follow-up|0|||
145451649|NCT00851890|524502446|FG001|Overall Study|Lost to Follow-up|1|||
145451650|NCT00851890|524502447|FG002|Overall Study|Lost to Follow-up|0|||
145451651|NCT00851890|524502448|FG003|Overall Study|Lost to Follow-up|1|||
145451652|NCT02597452|524502449|FG000|Overall Study|testing incomplete|30|||
145451653|NCT00281099|524502450|FG000|Overall Study|Death|46|||
145451654|NCT00281099|524502451|FG001|Overall Study|Death|57|||
145451655|NCT00281099|524502450|FG000|Overall Study|Lost to Follow-up|10|||
145451656|NCT00281099|524502451|FG001|Overall Study|Lost to Follow-up|19|||
145451657|NCT00281099|524502450|FG000|Overall Study|Withdrawal by Subject|65|||
145451658|NCT00281099|524502451|FG001|Overall Study|Withdrawal by Subject|70|||
145451659|NCT00281099|524502450|FG000|Overall Study|Physician Decision|79|||
145451660|NCT00281099|524502451|FG001|Overall Study|Physician Decision|72|||
145451661|NCT00281099|524502450|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
145451662|NCT00281099|524502451|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
145451663|NCT01170273|524502453|FG000|Overall Study|Lost to Follow-up|6|||
145451664|NCT01170273|524502454|FG001|Overall Study|Lost to Follow-up|8|||
145451665|NCT01170273|524502453|FG000|Overall Study|Protocol Violation|1|||
145451666|NCT01170273|524502454|FG001|Overall Study|Protocol Violation|0|||
145451667|NCT01170273|524502453|FG000|Overall Study|Death|1|||
145451668|NCT01170273|524502454|FG001|Overall Study|Death|0|||
145451669|NCT01170273|524502453|FG000|Overall Study|Adverse Event|0|||
145451670|NCT01170273|524502454|FG001|Overall Study|Adverse Event|1|||
145451671|NCT00334737|524502455|FG000|Hospital Phase|Death|1|||
145451672|NCT00334737|524502456|FG001|Hospital Phase|Death|2|||
145451673|NCT00334737|524502457|FG002|Hospital Phase|Death|3|||
145451674|NCT00334737|524502455|FG000|Hospital Phase|Withdrawal by Subject|0|||
145451675|NCT00334737|524502456|FG001|Hospital Phase|Withdrawal by Subject|0|||
145451676|NCT00334737|524502457|FG002|Hospital Phase|Withdrawal by Subject|1|||
145451677|NCT00334737|524502455|FG000|Hospital Phase|Did not receive study drug|1|||
145451678|NCT00334737|524502456|FG001|Hospital Phase|Did not receive study drug|0|||
145451679|NCT00334737|524502457|FG002|Hospital Phase|Did not receive study drug|0|||
145451680|NCT00334737|524502455|FG000|Follow up Phase|Lost to Follow-up|5|||
145451681|NCT00334737|524502456|FG001|Follow up Phase|Lost to Follow-up|3|||
145451682|NCT00334737|524502457|FG002|Follow up Phase|Lost to Follow-up|6|||
145451683|NCT01691014|524504012|FG000|Overall Study|Premature Termination|1|||
145451684|NCT01691014|524504013|FG001|Overall Study|Premature Termination|6|||
145451685|NCT01691014|524504014|FG002|Overall Study|Premature Termination|0|||
145451686|NCT01691014|524504015|FG003|Overall Study|Premature Termination|3|||
145451687|NCT01691014|524504012|FG000|Overall Study|Other|0|||
145451688|NCT01691014|524504013|FG001|Overall Study|Other|0|||
145451689|NCT01691014|524504014|FG002|Overall Study|Other|2|||
145451690|NCT01691014|524504015|FG003|Overall Study|Other|0|||
145451691|NCT01691014|524504012|FG000|Overall Study|Withdrawal by Subject|0|||
145451692|NCT01691014|524504013|FG001|Overall Study|Withdrawal by Subject|1|||
145451693|NCT01691014|524504014|FG002|Overall Study|Withdrawal by Subject|1|||
145451694|NCT01691014|524504015|FG003|Overall Study|Withdrawal by Subject|1|||
145451695|NCT01691014|524504012|FG000|Overall Study|Adverse Event|0|||
145451696|NCT01691014|524504013|FG001|Overall Study|Adverse Event|5|||
145451697|NCT01691014|524504014|FG002|Overall Study|Adverse Event|1|||
145451698|NCT01691014|524504015|FG003|Overall Study|Adverse Event|1|||
145451699|NCT01691014|524504012|FG000|Overall Study|Lack of Efficacy|2|||
145451700|NCT01691014|524504013|FG001|Overall Study|Lack of Efficacy|3|||
145586100|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
145586101|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
145586102|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
145586103|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
145586104|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
145586105|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
145586106|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
145451701|NCT01691014|524504014|FG002|Overall Study|Lack of Efficacy|7|||
145451702|NCT01691014|524504015|FG003|Overall Study|Lack of Efficacy|0|||
145451703|NCT03372551|524504016|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
145586107|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
145586108|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
145586109|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
145451704|NCT03372551|524504017|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
145451705|NCT00066703|524504018|FG000|Overall Study|Adverse Event|80|||
145451706|NCT00066703|524504019|FG001|Overall Study|Adverse Event|111|||
145586110|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
145586111|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
145586112|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
145451707|NCT00066703|524504018|FG000|Overall Study|Death|3|||
145451708|NCT00066703|524504019|FG001|Overall Study|Death|0|||
145451709|NCT00066703|524504018|FG000|Overall Study|Lack of Efficacy|114|||
145451710|NCT00066703|524504019|FG001|Overall Study|Lack of Efficacy|69|||
145451711|NCT00066703|524504018|FG000|Overall Study|Lost to Follow-up|31|||
145451712|NCT00066703|524504019|FG001|Overall Study|Lost to Follow-up|28|||
145451713|NCT00066703|524504018|FG000|Overall Study|Withdrawal by Subject|38|||
145451714|NCT00066703|524504019|FG001|Overall Study|Withdrawal by Subject|63|||
145451715|NCT00066703|524504018|FG000|Overall Study|Treatment ongoing|346|||
145451716|NCT00066703|524504019|FG001|Overall Study|Treatment ongoing|311|||
145451717|NCT01696968|524504020|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
145451718|NCT01696968|524504021|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
145451719|NCT01696968|524504020|FG000|Overall Study|Died Before Randomization|3|||
145451720|NCT01696968|524504021|FG001|Overall Study|Died Before Randomization|8|||
145451721|NCT01696968|524504020|FG000|Overall Study|Died Before ASU (Control)|278|||
145451722|NCT01696968|524504021|FG001|Overall Study|Died Before ASU (Control)|0|||
145451723|NCT01696968|524504020|FG000|Overall Study|Refused ASU (Control)|920|||
145451724|NCT01696968|524504021|FG001|Overall Study|Refused ASU (Control)|0|||
145451725|NCT01696968|524504020|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
145451726|NCT01696968|524504021|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
145451727|NCT03727646|524504022|FG000|Overall Study|Adverse Event|1|||
145451728|NCT03727646|524504023|FG001|Overall Study|Adverse Event|0|||
145451729|NCT04753658|524504024|FG000|Overall Study|Progressive disease|7|||
145451730|NCT04753658|524504024|FG000|Overall Study|Other|7|||
145451731|NCT04753658|524504024|FG000|Overall Study|Adverse Event|1|||
145451732|NCT05659719|524504025|FG000|Overall Study|At sponsor's request|0|||
145451733|NCT05659719|524504026|FG001|Overall Study|At sponsor's request|0|||
145451734|NCT05659719|524504027|FG002|Overall Study|At sponsor's request|0|||
145451735|NCT05659719|524504028|FG003|Overall Study|At sponsor's request|95|||
145451736|NCT05659719|524504025|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
145451737|NCT05659719|524504026|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
145451738|NCT05659719|524504027|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
145451739|NCT05659719|524504028|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
145451740|NCT05659719|524504025|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
145451741|NCT05659719|524504026|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
145451742|NCT05659719|524504027|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
145451743|NCT05659719|524504028|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
145451744|NCT05659719|524504025|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
145451745|NCT05659719|524504026|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
145451746|NCT05659719|524504027|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
145451747|NCT05659719|524504028|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
145451748|NCT05659719|524504025|FG000|Overall Study|Lost to Follow-up|0|||
145451749|NCT05659719|524504026|FG001|Overall Study|Lost to Follow-up|0|||
145451750|NCT05659719|524504027|FG002|Overall Study|Lost to Follow-up|0|||
145451751|NCT05659719|524504028|FG003|Overall Study|Lost to Follow-up|2|||
145451752|NCT05659719|524504025|FG000|Overall Study|Moved to another observational study|0|||
145451753|NCT05659719|524504026|FG001|Overall Study|Moved to another observational study|0|||
145451754|NCT05659719|524504027|FG002|Overall Study|Moved to another observational study|0|||
145451755|NCT05659719|524504028|FG003|Overall Study|Moved to another observational study|1|||
145451756|NCT05659719|524504025|FG000|Overall Study|The child was enrolled in an interventional study|0|||
145451757|NCT05659719|524504026|FG001|Overall Study|The child was enrolled in an interventional study|0|||
145451758|NCT05659719|524504027|FG002|Overall Study|The child was enrolled in an interventional study|0|||
145451759|NCT05659719|524504028|FG003|Overall Study|The child was enrolled in an interventional study|55|||
145451760|NCT05659719|524504025|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
145451761|NCT05659719|524504026|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
145451762|NCT05659719|524504027|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
145451763|NCT05659719|524504028|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
145451764|NCT05659719|524504025|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
145451765|NCT05659719|524504026|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
145451766|NCT05659719|524504027|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
145451767|NCT05659719|524504028|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
145451768|NCT05924165|524504035|FG000|Overall Study|Physician Decision|2|||
145451769|NCT05924165|524504036|FG001|Overall Study|Physician Decision|3|||
145451770|NCT04308239|524504037|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
145451771|NCT04308239|524504038|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
145451772|NCT04308239|524504037|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
145451773|NCT04308239|524504038|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
145451774|NCT04308239|524504037|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
145451775|NCT04308239|524504038|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
145451776|NCT04308239|524504037|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
145451777|NCT04308239|524504038|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
145451778|NCT01814878|524504041|FG000|Overall Study|Adverse Event|16|||
145451779|NCT01814878|524504042|FG001|Overall Study|Adverse Event|5|||
145451780|NCT01814878|524504041|FG000|Overall Study|Withdrawal by Subject|20|||
145451781|NCT01814878|524504042|FG001|Overall Study|Withdrawal by Subject|16|||
145451782|NCT01814878|524504041|FG000|Overall Study|Protocol Violation|5|||
145451783|NCT01814878|524504042|FG001|Overall Study|Protocol Violation|5|||
145451784|NCT01814878|524504041|FG000|Overall Study|Physician Decision|3|||
145451785|NCT01814878|524504042|FG001|Overall Study|Physician Decision|1|||
145451786|NCT01814878|524504041|FG000|Overall Study|Screening failure (drop-out)|0|||
145451787|NCT01814878|524504042|FG001|Overall Study|Screening failure (drop-out)|3|||
145451788|NCT01814878|524504041|FG000|Overall Study|Other|2|||
145451789|NCT01814878|524504042|FG001|Overall Study|Other|0|||
145451790|NCT03654404|524504043|FG000|Overall Study|Death|1|||
145451791|NCT03654404|524504043|FG000|Overall Study|Lost to Follow-up|2|||
145451792|NCT03654404|524504043|FG000|Overall Study|Withdrawal by Subject|5|||
145451793|NCT02003638|524504048|FG000|Overall Study|Withdrawal by Subject|1|||
145451794|NCT02003638|524504049|FG001|Overall Study|Withdrawal by Subject|0|||
145451795|NCT00878254|524504050|FG000|Overall Study|Physician Decision|1|||
145451796|NCT00878254|524504050|FG000|Overall Study|Death|1|||
145451797|NCT00878254|524504050|FG000|Overall Study|Withdrawal by Subject|1|||
145451798|NCT00194077|524504054|FG000|Overall Study|Lack of Efficacy|22|||
145451799|NCT00194077|524504055|FG001|Overall Study|Lack of Efficacy|29|||
145451800|NCT00194077|524504054|FG000|Overall Study|Study nonadherence|1|||
145451801|NCT00194077|524504055|FG001|Overall Study|Study nonadherence|0|||
145451802|NCT00194077|524504054|FG000|Overall Study|Withdrawal by Subject|1|||
145451803|NCT00194077|524504055|FG001|Overall Study|Withdrawal by Subject|1|||
145451804|NCT03470194|524504058|FG000|Overall Study|Lost to Follow-up|11|||
145451805|NCT03470194|524504059|FG001|Overall Study|Lost to Follow-up|17|||
145451806|NCT01822899|524504060|FG000|Overall Study|Adverse Event|6|||
145451807|NCT01822899|524504061|FG001|Overall Study|Adverse Event|5|||
145451808|NCT01822899|524504060|FG000|Overall Study|Lack of Efficacy|6|||
145451809|NCT01822899|524504061|FG001|Overall Study|Lack of Efficacy|3|||
145451810|NCT01822899|524504060|FG000|Overall Study|Protocol Violation|6|||
145451811|NCT01822899|524504061|FG001|Overall Study|Protocol Violation|3|||
145451812|NCT01822899|524504060|FG000|Overall Study|Lost to Follow-up|1|||
145451813|NCT01822899|524504061|FG001|Overall Study|Lost to Follow-up|0|||
145451814|NCT01822899|524504060|FG000|Overall Study|Withdrawal by Subject|5|||
145451815|NCT01822899|524504061|FG001|Overall Study|Withdrawal by Subject|7|||
145451816|NCT05332392|524504062|FG000|Overall Study|Did not meet inclusion criteria|25|||
145451817|NCT05332392|524504062|FG000|Overall Study|Principal Investigator's decision|17|||
145451818|NCT05332392|524504062|FG000|Overall Study|Adverse Event|1|||
145451819|NCT05332392|524504062|FG000|Overall Study|Subject's decision|1|||
145451820|NCT01268046|524504063|FG000|Overall Study|Withdrawal by Subject|1|||
145451821|NCT01268046|524504064|FG001|Overall Study|Withdrawal by Subject|0|||
145451822|NCT01268046|524504065|FG002|Overall Study|Withdrawal by Subject|0|||
145451823|NCT01268046|524504066|FG003|Overall Study|Withdrawal by Subject|1|||
145451824|NCT01268046|524504063|FG000|Overall Study|Lost to Follow-up|0|||
145451825|NCT01268046|524504064|FG001|Overall Study|Lost to Follow-up|0|||
145451826|NCT01268046|524504065|FG002|Overall Study|Lost to Follow-up|1|||
145451827|NCT01268046|524504066|FG003|Overall Study|Lost to Follow-up|0|||
145451828|NCT02314156|524504068|FG000|Overall Study|Adverse Event|1|||
145451829|NCT02314156|524504069|FG001|Overall Study|Adverse Event|0|||
145451830|NCT02314156|524504068|FG000|Overall Study|Withdrawal by Subject|1|||
145451831|NCT02314156|524504069|FG001|Overall Study|Withdrawal by Subject|0|||
145451832|NCT01450696|524504070|FG000|Overall Study|Never Treated|1|||
145451833|NCT01450696|524504071|FG001|Overall Study|Never Treated|1|||
145451834|NCT01450696|524504070|FG000|Overall Study|Death|77|||
145451835|NCT01450696|524504071|FG001|Overall Study|Death|84|||
145451836|NCT01450696|524504070|FG000|Overall Study|Lost to Follow-up|3|||
145586113|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
145586114|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
145586115|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
145586116|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
145586117|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145451837|NCT01450696|524504071|FG001|Overall Study|Lost to Follow-up|3|||
145451838|NCT01450696|524504070|FG000|Overall Study|Non-Compliance|1|||
145586118|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145451839|NCT01450696|524504071|FG001|Overall Study|Non-Compliance|0|||
145451840|NCT01450696|524504070|FG000|Overall Study|Withdrawal by Subject|13|||
145451841|NCT01450696|524504071|FG001|Overall Study|Withdrawal by Subject|2|||
145451842|NCT01450696|524504070|FG000|Overall Study|Study Terminated by Sponsor|53|||
145451843|NCT01450696|524504071|FG001|Overall Study|Study Terminated by Sponsor|58|||
145451844|NCT03818607|524504072|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
145451845|NCT03818607|524504073|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
145451846|NCT03818607|524504072|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
145451847|NCT03818607|524504073|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
145586119|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586120|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586121|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586122|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586123|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586124|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586125|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586126|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586127|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586128|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586129|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586130|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586131|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586132|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
145586133|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586134|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586135|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
145586136|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
145586137|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
145586138|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586139|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586140|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586141|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586142|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586143|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586144|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586145|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586146|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586147|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586148|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586149|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586150|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586151|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586152|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
145586153|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
145586154|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
145586155|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
145586156|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
145586157|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
145586158|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
145586159|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
145586160|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
145586161|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
145586162|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
145586163|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
145586164|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
145586165|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
145586166|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
145586167|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
145586168|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
145586169|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
145586170|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
145586171|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
145586172|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
145586173|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
145586174|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586175|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586176|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586177|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586178|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586179|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586180|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586181|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586182|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586183|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586184|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586185|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586186|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586187|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586188|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586189|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586190|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586191|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586192|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
145586193|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
145586194|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
145586195|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586196|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
145586197|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
145586198|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586199|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586200|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586201|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586202|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586203|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586204|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586205|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586206|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586207|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586208|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586209|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586210|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586211|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586212|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
145586213|NCT01490632|524999574|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586214|NCT01490632|524999575|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586215|NCT01490632|524999576|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586216|NCT01490632|524999577|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586217|NCT01490632|524999578|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
145586218|NCT01490632|524999579|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586219|NCT01490632|524999580|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586220|NCT01490632|524999581|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586221|NCT01490632|524999582|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586222|NCT01490632|524999583|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586223|NCT01490632|524999584|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586224|NCT01490632|524999585|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586225|NCT01490632|524999586|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586226|NCT01490632|524999587|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586227|NCT01490632|524999588|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586228|NCT01490632|524999589|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586229|NCT01490632|524999590|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586230|NCT01490632|524999591|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586231|NCT01490632|524999592|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586232|NCT01490632|524999593|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
145586233|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586234|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586235|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586236|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586237|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586238|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
145586239|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
145626209|NCT02753530|525144220|FG000|Overall Study|Physician Decision|0|||
145626210|NCT02753530|525144221|FG001|Overall Study|Physician Decision|1|||
145626211|NCT02753530|525144220|FG000|Overall Study|Protocol Violation|1|||
145626212|NCT02753530|525144221|FG001|Overall Study|Protocol Violation|0|||
145626213|NCT02753530|525144220|FG000|Overall Study|Withdrawal by Subject|4|||
145626214|NCT02753530|525144221|FG001|Overall Study|Withdrawal by Subject|3|||
145626215|NCT02696226|525144222|FG000|Overall Study|Study terminated - lack of enrollment|1|||
145586240|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
145626216|NCT02696226|525144223|FG001|Overall Study|Study terminated - lack of enrollment|0|||
145626217|NCT02696226|525144224|FG002|Overall Study|Study terminated - lack of enrollment|2|||
145626218|NCT02696226|525144225|FG003|Overall Study|Study terminated - lack of enrollment|0|||
145586241|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586242|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
145586243|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
145586244|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
145586245|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586246|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586247|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586248|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586249|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586250|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586251|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586252|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
145586253|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586254|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586255|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586256|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586257|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586258|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586259|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
145586260|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586261|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
145586262|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
145586263|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
145586264|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586265|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586266|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586267|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586268|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586269|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586270|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586271|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586272|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
145586273|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586274|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586275|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586276|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586277|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586278|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586279|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
145586280|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586281|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586282|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
145586283|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586284|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586285|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586286|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586287|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586288|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145451848|NCT03818607|524504072|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
145451849|NCT03818607|524504073|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
145451850|NCT05059301|524504076|FG000|Overall Study|Adverse Event|0|||
145451851|NCT05059301|524504077|FG001|Overall Study|Adverse Event|2|||
145451852|NCT05059301|524504078|FG002|Overall Study|Adverse Event|2|||
145451853|NCT05059301|524504076|FG000|Overall Study|Lost to Follow-up|2|||
145451854|NCT05059301|524504077|FG001|Overall Study|Lost to Follow-up|3|||
145451855|NCT05059301|524504078|FG002|Overall Study|Lost to Follow-up|3|||
145451856|NCT05730335|524504081|FG000|Overall Study|Lost to Follow-up|8|||
145451857|NCT05730335|524504081|FG000|Overall Study|Withdrawal by Subject|6|||
145451858|NCT03249909|524504088|FG000|Overall Study|Withdrawal by Subject|3|||
145451859|NCT03249909|524504089|FG001|Overall Study|Withdrawal by Subject|0|||
145586289|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586290|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586291|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586292|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
145586293|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586294|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586295|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
145451860|NCT03249909|524504090|FG002|Overall Study|Withdrawal by Subject|0|||
145586296|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586297|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586298|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586299|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
145586300|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586301|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586302|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586303|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586304|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586305|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586306|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586307|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586308|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586309|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586310|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586311|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586312|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
145586313|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586314|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586315|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586316|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586317|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586318|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
145586319|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586320|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586321|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586322|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586323|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586324|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586325|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586326|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586327|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586328|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586329|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586330|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586331|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586332|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
145586333|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586334|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586335|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586336|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586337|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586338|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586339|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
145586340|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586341|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
145586342|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586343|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
145586344|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
145586345|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586346|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586347|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586348|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586349|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586350|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586351|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586352|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
145586353|NCT01490632|524999574|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586354|NCT01490632|524999575|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586355|NCT01490632|524999576|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586356|NCT01490632|524999577|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586357|NCT01490632|524999578|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586358|NCT01490632|524999579|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
145586359|NCT01490632|524999580|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
145586360|NCT01490632|524999581|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
145586361|NCT01490632|524999582|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
145586362|NCT01490632|524999583|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
145586363|NCT01490632|524999584|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
145586364|NCT01490632|524999585|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
145586365|NCT01490632|524999586|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586366|NCT01490632|524999587|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586367|NCT01490632|524999588|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586368|NCT01490632|524999589|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586369|NCT01490632|524999590|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586370|NCT01490632|524999591|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586371|NCT01490632|524999592|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586372|NCT01490632|524999593|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
145586373|NCT01490632|524999574|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586374|NCT01490632|524999575|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586375|NCT01490632|524999576|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586376|NCT01490632|524999577|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586377|NCT01490632|524999578|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586378|NCT01490632|524999579|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586379|NCT01490632|524999580|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586380|NCT01490632|524999581|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586381|NCT01490632|524999582|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586382|NCT01490632|524999583|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586383|NCT01490632|524999584|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586384|NCT01490632|524999585|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586385|NCT01490632|524999586|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586386|NCT01490632|524999587|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586387|NCT01490632|524999588|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
145586388|NCT01490632|524999589|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
145586389|NCT01490632|524999590|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586390|NCT01490632|524999591|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586391|NCT01490632|524999592|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586392|NCT01490632|524999593|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
145586393|NCT01490632|524999574|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586394|NCT01490632|524999575|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586395|NCT01490632|524999576|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586396|NCT01490632|524999577|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586397|NCT01490632|524999578|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586398|NCT01490632|524999579|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586399|NCT01490632|524999580|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586400|NCT01490632|524999581|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586401|NCT01490632|524999582|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586402|NCT01490632|524999583|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586403|NCT01490632|524999584|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586404|NCT01490632|524999585|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586405|NCT01490632|524999586|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586406|NCT01490632|524999587|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
145586407|NCT01490632|524999588|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586408|NCT01490632|524999589|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586409|NCT01490632|524999590|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586410|NCT01490632|524999591|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586411|NCT01490632|524999592|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586412|NCT01490632|524999593|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
145586413|NCT01490632|524999574|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586414|NCT01490632|524999575|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586415|NCT01490632|524999576|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586416|NCT01490632|524999577|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586417|NCT01490632|524999578|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586418|NCT01490632|524999579|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586419|NCT01490632|524999580|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145451861|NCT03249909|524504088|FG000|Overall Study|Adverse Event|3|||
145586420|NCT01490632|524999581|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586421|NCT01490632|524999582|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145451862|NCT03249909|524504089|FG001|Overall Study|Adverse Event|0|||
145586422|NCT01490632|524999583|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586423|NCT01490632|524999584|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586424|NCT01490632|524999585|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586425|NCT01490632|524999586|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586426|NCT01490632|524999587|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586427|NCT01490632|524999588|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
145586428|NCT01490632|524999589|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
145586429|NCT01490632|524999590|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586430|NCT01490632|524999591|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586431|NCT01490632|524999592|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586432|NCT01490632|524999593|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
145586433|NCT01490632|524999574|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586434|NCT01490632|524999575|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586435|NCT01490632|524999576|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586436|NCT01490632|524999577|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586437|NCT01490632|524999578|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586438|NCT01490632|524999579|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586439|NCT01490632|524999580|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586440|NCT01490632|524999581|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586441|NCT01490632|524999582|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586442|NCT01490632|524999583|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586443|NCT01490632|524999584|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586444|NCT01490632|524999585|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586445|NCT01490632|524999586|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
145586446|NCT01490632|524999587|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
145586447|NCT01490632|524999588|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
145586448|NCT01490632|524999589|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
145586449|NCT01490632|524999590|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586450|NCT01490632|524999591|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586451|NCT01490632|524999592|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586452|NCT01490632|524999593|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
145586453|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
145586454|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
145586455|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
145586456|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
145586457|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
145586458|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
145586459|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
145586460|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
145586461|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
145586462|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
145586463|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
145586464|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
145586465|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
145586466|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
145586467|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
145586468|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
145586469|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
145586470|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
145586471|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
145586472|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
145626219|NCT00097370|525144232|FG000|Stage 1|Adverse Event|3|||
145626220|NCT00097370|525144232|FG000|Stage 1|Withdrawal by Subject|1|||
145626221|NCT00097370|525144232|FG000|Stage 1|Lack of Efficacy|2|||
145626222|NCT00097370|525144232|FG000|Stage 2|Adverse Event|5|||
145451863|NCT03249909|524504090|FG002|Overall Study|Adverse Event|0|||
145451864|NCT03249909|524504088|FG000|Overall Study|Lost to Follow-up|0|||
145451865|NCT03249909|524504089|FG001|Overall Study|Lost to Follow-up|1|||
145451866|NCT03249909|524504090|FG002|Overall Study|Lost to Follow-up|0|||
145451867|NCT00606034|524504091|FG000|Overall Study|incarceration|1|||
145451868|NCT05286658|524504093|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
145451869|NCT05286658|524504093|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
145451870|NCT00615719|524504094|FG000|Overall Study|Physician Decision|5|||
145451871|NCT03748706|524504095|FG000|Overall Study|Lost to Follow-up|1|||
145451872|NCT05141175|524504096|FG000|Overall Study|Withdrawal by Subject|1|||
145451873|NCT01939977|524504099|FG000|Overall Study|Adverse Event|4|||
145451874|NCT01939977|524504100|FG001|Overall Study|Adverse Event|3|||
145451875|NCT01939977|524504099|FG000|Overall Study|Lack of Efficacy|3|||
145451876|NCT01939977|524504100|FG001|Overall Study|Lack of Efficacy|0|||
145451877|NCT01939977|524504099|FG000|Overall Study|Physician Decision|1|||
145451878|NCT01939977|524504100|FG001|Overall Study|Physician Decision|1|||
145451879|NCT01939977|524504099|FG000|Overall Study|Withdrawal by Subject|0|||
145451880|NCT01939977|524504100|FG001|Overall Study|Withdrawal by Subject|2|||
145451881|NCT01939977|524504099|FG000|Overall Study|Did not meet inclusion criteria|1|||
145451882|NCT01939977|524504100|FG001|Overall Study|Did not meet inclusion criteria|0|||
145451883|NCT01939977|524504099|FG000|Overall Study|Did not receive study medication|0|||
145451884|NCT01939977|524504100|FG001|Overall Study|Did not receive study medication|1|||
145451885|NCT01262560|524504112|FG000|Overall Study|Protocol Violation|0|||
145451886|NCT01262560|524504113|FG001|Overall Study|Protocol Violation|1|||
145451887|NCT01262560|524504114|FG002|Overall Study|Protocol Violation|2|||
145451888|NCT02443116|524504119|FG000|Part 1|Adverse Event|2|||
145451889|NCT02443116|524504120|FG001|Part 1|Adverse Event|3|||
145451890|NCT02443116|524504121|FG002|Part 1|Adverse Event|0|||
145451891|NCT02443116|524504122|FG003|Part 1|Adverse Event|0|||
145451892|NCT02443116|524504123|FG004|Part 1|Adverse Event|0|||
145451893|NCT02443116|524504124|FG005|Part 1|Adverse Event|0|||
145451894|NCT02443116|524504125|FG006|Part 1|Adverse Event|0|||
145451895|NCT02443116|524504126|FG007|Part 1|Adverse Event|0|||
145451896|NCT02443116|524504127|FG008|Part 1|Adverse Event|0|||
145451897|NCT02443116|524504119|FG000|Part 1|Withdrew informed consent|0|||
145451898|NCT02443116|524504120|FG001|Part 1|Withdrew informed consent|1|||
145451899|NCT02443116|524504121|FG002|Part 1|Withdrew informed consent|0|||
145451900|NCT02443116|524504122|FG003|Part 1|Withdrew informed consent|0|||
145451901|NCT02443116|524504123|FG004|Part 1|Withdrew informed consent|0|||
145451902|NCT02443116|524504124|FG005|Part 1|Withdrew informed consent|0|||
145451903|NCT02443116|524504125|FG006|Part 1|Withdrew informed consent|0|||
145451904|NCT02443116|524504126|FG007|Part 1|Withdrew informed consent|0|||
145451905|NCT02443116|524504127|FG008|Part 1|Withdrew informed consent|0|||
145451906|NCT02443116|524504119|FG000|Part 1|Lost to Follow-up|0|||
145451907|NCT02443116|524504120|FG001|Part 1|Lost to Follow-up|0|||
145451908|NCT02443116|524504121|FG002|Part 1|Lost to Follow-up|2|||
145451909|NCT02443116|524504122|FG003|Part 1|Lost to Follow-up|0|||
145451910|NCT02443116|524504123|FG004|Part 1|Lost to Follow-up|0|||
145451911|NCT02443116|524504124|FG005|Part 1|Lost to Follow-up|0|||
145451912|NCT02443116|524504125|FG006|Part 1|Lost to Follow-up|0|||
145451913|NCT02443116|524504126|FG007|Part 1|Lost to Follow-up|0|||
145451914|NCT02443116|524504127|FG008|Part 1|Lost to Follow-up|0|||
145451915|NCT02443116|524504119|FG000|Part 1|Participant moved out of state|0|||
145451916|NCT02443116|524504120|FG001|Part 1|Participant moved out of state|0|||
145451917|NCT02443116|524504121|FG002|Part 1|Participant moved out of state|1|||
145451918|NCT02443116|524504122|FG003|Part 1|Participant moved out of state|0|||
145451919|NCT02443116|524504123|FG004|Part 1|Participant moved out of state|0|||
145451920|NCT02443116|524504124|FG005|Part 1|Participant moved out of state|0|||
145451921|NCT02443116|524504125|FG006|Part 1|Participant moved out of state|0|||
145451922|NCT02443116|524504126|FG007|Part 1|Participant moved out of state|0|||
145451923|NCT02443116|524504127|FG008|Part 1|Participant moved out of state|0|||
145451924|NCT02443116|524504119|FG000|Part 1|Participant enrolled in another clinical trial|0|||
145451925|NCT02443116|524504120|FG001|Part 1|Participant enrolled in another clinical trial|0|||
145451926|NCT02443116|524504121|FG002|Part 1|Participant enrolled in another clinical trial|1|||
145451927|NCT02443116|524504122|FG003|Part 1|Participant enrolled in another clinical trial|0|||
145451928|NCT02443116|524504123|FG004|Part 1|Participant enrolled in another clinical trial|0|||
145451929|NCT02443116|524504124|FG005|Part 1|Participant enrolled in another clinical trial|0|||
145451930|NCT02443116|524504125|FG006|Part 1|Participant enrolled in another clinical trial|0|||
145451931|NCT02443116|524504126|FG007|Part 1|Participant enrolled in another clinical trial|0|||
145451932|NCT02443116|524504127|FG008|Part 1|Participant enrolled in another clinical trial|0|||
145451933|NCT02443116|524504119|FG000|Part 2|Adverse Event|0|||
145586473|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Death|0|||
145586474|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Death|0|||
145586475|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Death|0|||
145586476|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Death|0|||
145586477|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Death|0|||
145451934|NCT02443116|524504120|FG001|Part 2|Adverse Event|0|||
145451935|NCT02443116|524504121|FG002|Part 2|Adverse Event|0|||
145451936|NCT02443116|524504122|FG003|Part 2|Adverse Event|0|||
145451937|NCT02443116|524504123|FG004|Part 2|Adverse Event|1|||
145451938|NCT02443116|524504124|FG005|Part 2|Adverse Event|1|||
145451939|NCT02443116|524504125|FG006|Part 2|Adverse Event|2|||
145451940|NCT02443116|524504126|FG007|Part 2|Adverse Event|0|||
145451941|NCT02443116|524504127|FG008|Part 2|Adverse Event|0|||
145451942|NCT02443116|524504119|FG000|Part 2|Withdrew informed consent|0|||
145451943|NCT02443116|524504120|FG001|Part 2|Withdrew informed consent|0|||
145451944|NCT02443116|524504121|FG002|Part 2|Withdrew informed consent|0|||
145451945|NCT02443116|524504122|FG003|Part 2|Withdrew informed consent|0|||
145451946|NCT02443116|524504123|FG004|Part 2|Withdrew informed consent|0|||
145586478|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Death|0|||
145586479|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Death|0|||
145586480|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Death|0|||
145586481|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Death|0|||
145586482|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Death|0|||
145586483|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Death|0|||
145586484|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Death|0|||
145586485|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Death|0|||
145586486|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Death|0|||
145586487|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Death|0|||
145586488|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Death|0|||
145586489|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Death|0|||
145586490|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Death|0|||
145586491|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Death|1|||
145586492|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Death|0|||
145586493|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586494|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586495|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586496|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586497|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586498|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586499|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586500|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586501|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586502|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586503|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586504|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586505|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586506|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586507|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586508|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586509|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
145586510|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
145586511|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
145586512|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
145586513|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586514|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586515|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586516|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586517|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586518|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586519|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586520|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586521|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586522|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586523|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586524|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586525|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586526|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586527|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586528|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145626223|NCT00097370|525144232|FG000|Stage 2|Withdrawal by Subject|1|||
145626224|NCT00097370|525144232|FG000|Stage 2|Lack of Efficacy|3|||
145626225|NCT00097370|525144232|FG000|Stage 2|Pregnancy|1|||
145626226|NCT00097370|525144232|FG000|Stage 2|Sponsor Terminated Study|2|||
145626227|NCT00097370|525144232|FG000|Stage 2|Lost to Follow-up|1|||
145451947|NCT02443116|524504124|FG005|Part 2|Withdrew informed consent|1|||
145451948|NCT02443116|524504125|FG006|Part 2|Withdrew informed consent|1|||
145451949|NCT02443116|524504126|FG007|Part 2|Withdrew informed consent|0|||
145451950|NCT02443116|524504127|FG008|Part 2|Withdrew informed consent|0|||
145451951|NCT02443116|524504119|FG000|Part 2|Inability to comply with protocol|0|||
145586529|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586530|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586531|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
145586532|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
145586533|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
145626228|NCT00097370|525144232|FG000|Stage 3|Adverse Event|2|||
145626229|NCT00097370|525144232|FG000|Stage 3|Withdrawal by Subject|3|||
145586534|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
145586535|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
145586536|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
145586537|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
145626230|NCT00097370|525144232|FG000|Stage 3|Lack of Efficacy|1|||
145626231|NCT00097370|525144232|FG000|Stage 3|Sponsor Terminated Study|52|||
145451952|NCT02443116|524504120|FG001|Part 2|Inability to comply with protocol|0|||
145451953|NCT02443116|524504121|FG002|Part 2|Inability to comply with protocol|0|||
145586538|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
145586539|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
145586540|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
145586541|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
145586542|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
145586543|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
145586544|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
145586545|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
145586546|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
145586547|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
145586548|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
145586549|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
145586550|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
145586551|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
145586552|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
145586553|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
145586554|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
145586555|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
145586556|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
145586557|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
145586558|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
145586559|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
145586560|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
145586561|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
145586562|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
145586563|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
145586564|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
145586565|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
145586566|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
145586567|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
145586568|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
145586569|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
145586570|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
145586571|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
145586572|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
145586573|NCT01490632|524999574|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586574|NCT01490632|524999575|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586575|NCT01490632|524999576|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586576|NCT01490632|524999577|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586577|NCT01490632|524999578|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586578|NCT01490632|524999579|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586579|NCT01490632|524999580|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586580|NCT01490632|524999581|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586581|NCT01490632|524999582|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586582|NCT01490632|524999583|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586583|NCT01490632|524999584|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586584|NCT01490632|524999585|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586585|NCT01490632|524999586|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586586|NCT01490632|524999587|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586587|NCT01490632|524999588|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586588|NCT01490632|524999589|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586589|NCT01490632|524999590|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
145586590|NCT01490632|524999591|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
145586591|NCT01490632|524999592|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
145586592|NCT01490632|524999593|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
145586593|NCT05732454|524999594|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
145586594|NCT05732454|524999595|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
145586595|NCT05732454|524999594|FG000|Part 1: DB Period|Adverse Event|1|||
145586596|NCT05732454|524999595|FG001|Part 1: DB Period|Adverse Event|0|||
145586597|NCT05732454|524999594|FG000|Part 1: DB Period|Lost to Follow-up|1|||
145586598|NCT05732454|524999595|FG001|Part 1: DB Period|Lost to Follow-up|0|||
145586599|NCT05732454|524999594|FG000|Part 1: DB Period|Protocol Violation|0|||
145586600|NCT05732454|524999595|FG001|Part 1: DB Period|Protocol Violation|1|||
145586601|NCT05732454|524999594|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
145586602|NCT05732454|524999595|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
145586603|NCT05732454|524999594|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
145586604|NCT05732454|524999595|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
145586605|NCT05732454|524999594|FG000|Part 1: OLE Period|Adverse Event|0|||
145586606|NCT05732454|524999595|FG001|Part 1: OLE Period|Adverse Event|1|||
145586607|NCT05732454|524999594|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
145626232|NCT00097370|525144232|FG000|Stage 3|Lost to Follow-up|1|||
145626233|NCT00062868|525144240|FG000|Dose Level 1|Death|2|||
145586608|NCT05732454|524999595|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
145586609|NCT01153633|524999596|FG000|Overall Study|Protocol Violation|1|||
145586610|NCT01153633|524999597|FG001|Overall Study|Protocol Violation|1|||
145586611|NCT01153633|524999596|FG000|Overall Study|Therapeutic failure|3|||
145586612|NCT01153633|524999597|FG001|Overall Study|Therapeutic failure|3|||
145586613|NCT01003899|524999602|FG000|Overall Study|Other Adverse Event|8|||
145586614|NCT01003899|524999602|FG000|Overall Study|Not entered|4|||
145586615|NCT01003899|524999602|FG000|Overall Study|Not treated|1|||
145586616|NCT01003899|524999602|FG000|Overall Study|Progressive disease|34|||
145586617|NCT00352365|524999603|FG000|Induction Therapy|Adverse Event|7|||
145586618|NCT00352365|524999603|FG000|Induction Therapy|Progression/Relapse|8|||
145586619|NCT00352365|524999603|FG000|Induction Therapy|Death|7|||
145586620|NCT00352365|524999603|FG000|Induction Therapy|Not protocol specified|1|||
145586621|NCT00352365|524999603|FG000|Induction Therapy|Not eligible|3|||
145586622|NCT00352365|524999603|FG000|Induction Therapy|Death before starting protocol therapy|1|||
145586623|NCT00352365|524999603|FG000|Maintenance Therapy|Progression/Relapse|3|||
145586624|NCT00352365|524999603|FG000|Maintenance Therapy|Death|2|||
145586625|NCT00352365|524999603|FG000|Maintenance Therapy|Not protocol specified|3|||
145586626|NCT00352365|524999603|FG000|Maintenance Therapy|Not eligible|4|||
145586627|NCT01262651|524999604|FG000|Overall Study|Adverse Event|40|||
145586628|NCT01262651|524999605|FG001|Overall Study|Adverse Event|35|||
145586629|NCT01262651|524999604|FG000|Overall Study|Withdrawal by Subject|15|||
145586630|NCT01262651|524999605|FG001|Overall Study|Withdrawal by Subject|11|||
145586631|NCT01262651|524999604|FG000|Overall Study|Withdrawal by Investigator|2|||
145586632|NCT01262651|524999605|FG001|Overall Study|Withdrawal by Investigator|2|||
145586633|NCT01262651|524999604|FG000|Overall Study|Met Withdrawal Criteria|1|||
145586634|NCT01262651|524999605|FG001|Overall Study|Met Withdrawal Criteria|0|||
145586635|NCT04969783|524999606|FG000|Overall Study|Lost to Follow-up|2|||
145586636|NCT04969783|524999607|FG001|Overall Study|Lost to Follow-up|0|||
145586637|NCT04969783|524999606|FG000|Overall Study|Withdrawal by Subject|4|||
145586638|NCT04969783|524999607|FG001|Overall Study|Withdrawal by Subject|0|||
145586639|NCT04969783|524999606|FG000|Overall Study|Physician Decision|6|||
145586640|NCT04969783|524999607|FG001|Overall Study|Physician Decision|0|||
145586641|NCT03422250|524999608|FG000|Intervention|Adverse Event|0|||
145586642|NCT03422250|524999609|FG001|Intervention|Adverse Event|1|||
145586643|NCT03422250|524999610|FG002|Intervention|Adverse Event|0|||
145586644|NCT03422250|524999611|FG003|Intervention|Adverse Event|1|||
145586645|NCT03422250|524999608|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
145586646|NCT03422250|524999609|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
145586647|NCT03422250|524999610|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
145586648|NCT03422250|524999611|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
145586649|NCT03422250|524999608|FG000|Follow-up|Withdrawal by Subject|0|||
145586650|NCT03422250|524999609|FG001|Follow-up|Withdrawal by Subject|0|||
145586651|NCT03422250|524999610|FG002|Follow-up|Withdrawal by Subject|0|||
145586652|NCT03422250|524999611|FG003|Follow-up|Withdrawal by Subject|1|||
145586653|NCT03422250|524999608|FG000|Follow-up|Adverse Event|0|||
145586654|NCT03422250|524999609|FG001|Follow-up|Adverse Event|0|||
145586655|NCT03422250|524999610|FG002|Follow-up|Adverse Event|0|||
145586656|NCT03422250|524999611|FG003|Follow-up|Adverse Event|1|||
145586657|NCT00377819|524999612|FG000|Overall Study|Adverse Event|2|||
145586658|NCT00377819|524999613|FG001|Overall Study|Adverse Event|3|||
145586659|NCT00377819|524999612|FG000|Overall Study|Withdrawal by Subject|10|||
145586660|NCT00377819|524999613|FG001|Overall Study|Withdrawal by Subject|4|||
145586661|NCT00377819|524999612|FG000|Overall Study|Death|0|||
145586662|NCT00377819|524999613|FG001|Overall Study|Death|1|||
145586663|NCT00377819|524999612|FG000|Overall Study|Lost to Follow-up|0|||
145586664|NCT00377819|524999613|FG001|Overall Study|Lost to Follow-up|1|||
145586665|NCT00377819|524999612|FG000|Overall Study|Protocol Violation|1|||
145586666|NCT00377819|524999613|FG001|Overall Study|Protocol Violation|1|||
145586667|NCT02553330|524999623|FG000|Overall Study|Study Terminated by Sponsor|2|||
145586668|NCT02553330|524999624|FG001|Overall Study|Study Terminated by Sponsor|13|||
145586669|NCT02553330|524999625|FG002|Overall Study|Study Terminated by Sponsor|12|||
145586670|NCT02553330|524999623|FG000|Overall Study|Withdrawal by Subject|3|||
145586671|NCT02553330|524999624|FG001|Overall Study|Withdrawal by Subject|19|||
145586672|NCT02553330|524999625|FG002|Overall Study|Withdrawal by Subject|21|||
145586673|NCT02553330|524999623|FG000|Overall Study|Other|0|||
145586674|NCT02553330|524999624|FG001|Overall Study|Other|1|||
145586675|NCT02553330|524999625|FG002|Overall Study|Other|0|||
145586676|NCT02553330|524999623|FG000|Overall Study|Non compliance to study treatment|0|||
145586677|NCT02553330|524999624|FG001|Overall Study|Non compliance to study treatment|1|||
145586678|NCT02553330|524999625|FG002|Overall Study|Non compliance to study treatment|0|||
145586679|NCT02553330|524999623|FG000|Overall Study|Adverse Event|0|||
145586680|NCT02553330|524999624|FG001|Overall Study|Adverse Event|1|||
145626234|NCT00062868|525144241|FG001|Dose Level 1|Death|0|||
145586681|NCT02553330|524999625|FG002|Overall Study|Adverse Event|0|||
145586682|NCT02553330|524999623|FG000|Overall Study|Lost to Follow-up|0|||
145586683|NCT02553330|524999624|FG001|Overall Study|Lost to Follow-up|4|||
145586684|NCT02553330|524999625|FG002|Overall Study|Lost to Follow-up|4|||
145586685|NCT02896855|524999626|FG000|Overall Study|Death|50|||
145586686|NCT02896855|524999627|FG001|Overall Study|Death|40|||
145586687|NCT02896855|524999626|FG000|Overall Study|Lost to Follow-up|15|||
145586688|NCT02896855|524999627|FG001|Overall Study|Lost to Follow-up|9|||
145586689|NCT02896855|524999626|FG000|Overall Study|Withdrawal by Subject|7|||
145586690|NCT02896855|524999627|FG001|Overall Study|Withdrawal by Subject|4|||
145586691|NCT01205685|524999628|FG000|Overall Study|Disease Progression|10|||
145586692|NCT01205685|524999628|FG000|Overall Study|Withdrawal by Subject|1|||
145586693|NCT02169674|524999629|FG000|Overall Study|Withdrawal by Subject|2|||
145586694|NCT02169674|524999630|FG001|Overall Study|Withdrawal by Subject|1|||
145586695|NCT02169674|524999629|FG000|Overall Study|Seroprotected|30|||
145586696|NCT02169674|524999630|FG001|Overall Study|Seroprotected|76|||
145586697|NCT02169674|524999629|FG000|Overall Study|Lost to Follow-up|0|||
145586698|NCT02169674|524999630|FG001|Overall Study|Lost to Follow-up|1|||
145586699|NCT04827212|524999636|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
145586700|NCT04827212|524999637|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
145586701|NCT04827212|524999636|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
145586702|NCT04827212|524999637|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
145586703|NCT03058679|524999638|FG000|Baseline to Week 6|Lost to Follow-up|3|||
145586704|NCT03058679|524999639|FG001|Baseline to Week 6|Lost to Follow-up|2|||
145586705|NCT03058679|524999638|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
145586706|NCT03058679|524999639|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
145586707|NCT03058679|524999638|FG000|Baseline to Week 6|Adverse Event|6|||
145586708|NCT03058679|524999639|FG001|Baseline to Week 6|Adverse Event|6|||
145586709|NCT03058679|524999638|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
145586710|NCT03058679|524999639|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
145586711|NCT03058679|524999638|FG000|Baseline to Week 6|Difficulty following the diet|0|||
145586712|NCT03058679|524999639|FG001|Baseline to Week 6|Difficulty following the diet|2|||
145586713|NCT03058679|524999638|FG000|Baseline to Week 6|Physician Decision|1|||
145586714|NCT03058679|524999639|FG001|Baseline to Week 6|Physician Decision|0|||
145586715|NCT03058679|524999638|FG000|Week 6 to Week 12|Change in medication|5|||
145586716|NCT03058679|524999639|FG001|Week 6 to Week 12|Change in medication|7|||
145586717|NCT03058679|524999638|FG000|Week 6 to Week 12|Adverse Event|4|||
145586718|NCT03058679|524999639|FG001|Week 6 to Week 12|Adverse Event|3|||
145586719|NCT03058679|524999638|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
145586720|NCT03058679|524999639|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
145586721|NCT03058679|524999638|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
145586722|NCT03058679|524999639|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
145586723|NCT00599326|524999640|FG000|Overall Study|Lost to Follow-up|1|||
145586724|NCT00599326|524999640|FG000|Overall Study|Noncompliant|1|||
145586725|NCT00563784|524999643|FG000|Overall Study|Withdrawal by Subject|2|||
145586726|NCT00563784|524999643|FG000|Overall Study|Screen Failures|20|||
145586727|NCT00148343|524999644|FG000|Overall Study|Withdrawal by Subject|12|||
145586728|NCT00148343|524999645|FG001|Overall Study|Withdrawal by Subject|7|||
145586729|NCT00148343|524999644|FG000|Overall Study|Physician Decision|3|||
145586730|NCT00148343|524999645|FG001|Overall Study|Physician Decision|4|||
145586731|NCT02528214|524999648|FG000|Overall Study|Protocol Violation|0|||
145586732|NCT02528214|524999649|FG001|Overall Study|Protocol Violation|1|||
145586733|NCT02528214|524999648|FG000|Overall Study|Adverse Event|0|||
145586734|NCT02528214|524999649|FG001|Overall Study|Adverse Event|1|||
145586735|NCT02528214|524999648|FG000|Overall Study|Other than specified above|0|||
145586736|NCT02528214|524999649|FG001|Overall Study|Other than specified above|1|||
145586737|NCT01380327|524999650|FG000|Overall Study|Lost to Follow-up|0|||
145586738|NCT01380327|524999651|FG001|Overall Study|Lost to Follow-up|1|||
145586739|NCT01380327|524999652|FG002|Overall Study|Lost to Follow-up|1|||
145586740|NCT01380327|524999650|FG000|Overall Study|Protocol Violation|3|||
145586741|NCT01380327|524999651|FG001|Overall Study|Protocol Violation|2|||
145586742|NCT01380327|524999652|FG002|Overall Study|Protocol Violation|3|||
145586743|NCT01380327|524999650|FG000|Overall Study|Withdrawal by Subject|0|||
145586744|NCT01380327|524999651|FG001|Overall Study|Withdrawal by Subject|0|||
145586745|NCT01380327|524999652|FG002|Overall Study|Withdrawal by Subject|1|||
145586746|NCT01380327|524999650|FG000|Overall Study|Housing situation precluded ability to k|0|||
145586747|NCT01380327|524999651|FG001|Overall Study|Housing situation precluded ability to k|0|||
145586748|NCT01380327|524999652|FG002|Overall Study|Housing situation precluded ability to k|1|||
145586749|NCT01380327|524999650|FG000|Overall Study|Questionable onset of epilepsy|0|||
145586750|NCT01380327|524999651|FG001|Overall Study|Questionable onset of epilepsy|0|||
145586751|NCT01380327|524999652|FG002|Overall Study|Questionable onset of epilepsy|1|||
145586752|NCT02504294|524999653|FG000|Overall Study|Adverse Event|15|||
145586753|NCT02504294|524999654|FG001|Overall Study|Adverse Event|12|||
145586754|NCT02504294|524999653|FG000|Overall Study|Withdrawal by Subject|7|||
145586755|NCT02504294|524999654|FG001|Overall Study|Withdrawal by Subject|1|||
145586756|NCT02504294|524999653|FG000|Overall Study|Protocol Violation|27|||
145586757|NCT02504294|524999654|FG001|Overall Study|Protocol Violation|26|||
145586758|NCT02504294|524999653|FG000|Overall Study|Physician Decision|1|||
145586759|NCT02504294|524999654|FG001|Overall Study|Physician Decision|2|||
145586760|NCT02504294|524999653|FG000|Overall Study|Lost to Follow-up|6|||
145586761|NCT02504294|524999654|FG001|Overall Study|Lost to Follow-up|7|||
145586762|NCT01953926|524999655|FG000|Overall Study|Withdrawal by Subject|23|||
145586763|NCT01953926|524999656|FG001|Overall Study|Withdrawal by Subject|3|||
145586764|NCT01953926|524999657|FG002|Overall Study|Withdrawal by Subject|3|||
145586765|NCT01953926|524999658|FG003|Overall Study|Withdrawal by Subject|5|||
145586766|NCT01953926|524999659|FG004|Overall Study|Withdrawal by Subject|6|||
145586767|NCT01953926|524999660|FG005|Overall Study|Withdrawal by Subject|0|||
145586768|NCT01953926|524999661|FG006|Overall Study|Withdrawal by Subject|1|||
145586769|NCT01953926|524999655|FG000|Overall Study|Physician Decision|1|||
145586770|NCT01953926|524999656|FG001|Overall Study|Physician Decision|0|||
145586771|NCT01953926|524999657|FG002|Overall Study|Physician Decision|0|||
145586772|NCT01953926|524999658|FG003|Overall Study|Physician Decision|0|||
145586773|NCT01953926|524999659|FG004|Overall Study|Physician Decision|2|||
145586774|NCT01953926|524999660|FG005|Overall Study|Physician Decision|0|||
145586775|NCT01953926|524999661|FG006|Overall Study|Physician Decision|0|||
145586776|NCT01953926|524999655|FG000|Overall Study|Lost to Follow-up|18|||
145586777|NCT01953926|524999656|FG001|Overall Study|Lost to Follow-up|3|||
145586778|NCT01953926|524999657|FG002|Overall Study|Lost to Follow-up|0|||
145586779|NCT01953926|524999658|FG003|Overall Study|Lost to Follow-up|5|||
145586780|NCT01953926|524999659|FG004|Overall Study|Lost to Follow-up|3|||
145586781|NCT01953926|524999660|FG005|Overall Study|Lost to Follow-up|0|||
145586782|NCT01953926|524999661|FG006|Overall Study|Lost to Follow-up|0|||
145586783|NCT01953926|524999655|FG000|Overall Study|Protocol Violation|1|||
145586784|NCT01953926|524999656|FG001|Overall Study|Protocol Violation|0|||
145586785|NCT01953926|524999657|FG002|Overall Study|Protocol Violation|0|||
145586786|NCT01953926|524999658|FG003|Overall Study|Protocol Violation|0|||
145586787|NCT01953926|524999659|FG004|Overall Study|Protocol Violation|0|||
145586788|NCT01953926|524999660|FG005|Overall Study|Protocol Violation|0|||
145586789|NCT01953926|524999661|FG006|Overall Study|Protocol Violation|0|||
145586790|NCT01953926|524999655|FG000|Overall Study|Other, Disease progression|2|||
145586791|NCT01953926|524999656|FG001|Overall Study|Other, Disease progression|1|||
145586792|NCT01953926|524999657|FG002|Overall Study|Other, Disease progression|0|||
145586793|NCT01953926|524999658|FG003|Overall Study|Other, Disease progression|0|||
145586794|NCT01953926|524999659|FG004|Overall Study|Other, Disease progression|1|||
145586795|NCT01953926|524999660|FG005|Overall Study|Other, Disease progression|0|||
145586796|NCT01953926|524999661|FG006|Overall Study|Other, Disease progression|0|||
145586797|NCT01953926|524999655|FG000|Overall Study|Discontinuation of study by sponsor|41|||
145586798|NCT01953926|524999656|FG001|Overall Study|Discontinuation of study by sponsor|7|||
145586799|NCT01953926|524999657|FG002|Overall Study|Discontinuation of study by sponsor|5|||
145586800|NCT01953926|524999658|FG003|Overall Study|Discontinuation of study by sponsor|12|||
145586801|NCT01953926|524999659|FG004|Overall Study|Discontinuation of study by sponsor|46|||
145586802|NCT01953926|524999660|FG005|Overall Study|Discontinuation of study by sponsor|5|||
145586803|NCT01953926|524999661|FG006|Overall Study|Discontinuation of study by sponsor|6|||
145586804|NCT01953926|524999655|FG000|Overall Study|Not Treated|1|||
145586805|NCT01953926|524999656|FG001|Overall Study|Not Treated|0|||
145586806|NCT01953926|524999657|FG002|Overall Study|Not Treated|1|||
145586807|NCT01953926|524999658|FG003|Overall Study|Not Treated|0|||
145586808|NCT01953926|524999659|FG004|Overall Study|Not Treated|0|||
145586809|NCT01953926|524999660|FG005|Overall Study|Not Treated|0|||
145586810|NCT01953926|524999661|FG006|Overall Study|Not Treated|0|||
145586811|NCT01949480|524999662|FG000|Overall Study|Physician Decision|5|||
145586812|NCT01949480|524999663|FG001|Overall Study|Physician Decision|8|||
145586813|NCT00144339|524999664|FG000|Overall Study|Adverse Event|746|||
145586814|NCT00144339|524999665|FG001|Overall Study|Adverse Event|627|||
145586815|NCT00144339|524999664|FG000|Overall Study|Protocol Violation|75|||
145586816|NCT00144339|524999665|FG001|Overall Study|Protocol Violation|48|||
145586817|NCT00144339|524999664|FG000|Overall Study|Withdrawal by Subject|403|||
145586818|NCT00144339|524999665|FG001|Overall Study|Withdrawal by Subject|300|||
145586819|NCT00144339|524999664|FG000|Overall Study|Lost to Follow-up|76|||
145586820|NCT00144339|524999665|FG001|Overall Study|Lost to Follow-up|64|||
145586821|NCT00144339|524999664|FG000|Overall Study|Other|58|||
145586822|NCT00144339|524999665|FG001|Overall Study|Other|60|||
145586823|NCT01827904|524999675|FG000|Main Study|Withdrawal by Subject|1|||
145586824|NCT01827904|524999676|FG001|Main Study|Withdrawal by Subject|0|||
145586825|NCT01827904|524999677|FG002|Main Study|Withdrawal by Subject|0|||
145586826|NCT01827904|524999675|FG000|Main Study|Adverse Event|1|||
145586827|NCT01827904|524999676|FG001|Main Study|Adverse Event|0|||
145586828|NCT01827904|524999677|FG002|Main Study|Adverse Event|0|||
145586829|NCT01827904|524999675|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
145586830|NCT01827904|524999676|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
145451954|NCT02443116|524504122|FG003|Part 2|Inability to comply with protocol|1|||
145586831|NCT01827904|524999677|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
145586832|NCT01827904|524999675|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
145586833|NCT01827904|524999676|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
145586834|NCT01827904|524999677|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
145451955|NCT02443116|524504123|FG004|Part 2|Inability to comply with protocol|0|||
145451956|NCT02443116|524504124|FG005|Part 2|Inability to comply with protocol|0|||
145586835|NCT01827904|524999675|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
145586836|NCT01827904|524999676|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
145451957|NCT02443116|524504125|FG006|Part 2|Inability to comply with protocol|0|||
145451958|NCT02443116|524504126|FG007|Part 2|Inability to comply with protocol|0|||
145451959|NCT02443116|524504127|FG008|Part 2|Inability to comply with protocol|0|||
145451960|NCT02443116|524504119|FG000|Part 2|Lost to Follow-up|0|||
145451961|NCT02443116|524504120|FG001|Part 2|Lost to Follow-up|0|||
145451962|NCT02443116|524504121|FG002|Part 2|Lost to Follow-up|0|||
145451963|NCT02443116|524504122|FG003|Part 2|Lost to Follow-up|1|||
145451964|NCT02443116|524504123|FG004|Part 2|Lost to Follow-up|0|||
145451965|NCT02443116|524504124|FG005|Part 2|Lost to Follow-up|0|||
145451966|NCT02443116|524504125|FG006|Part 2|Lost to Follow-up|0|||
145451967|NCT02443116|524504126|FG007|Part 2|Lost to Follow-up|0|||
145451968|NCT02443116|524504127|FG008|Part 2|Lost to Follow-up|0|||
145451969|NCT02443116|524504119|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451970|NCT02443116|524504120|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451971|NCT02443116|524504121|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451972|NCT02443116|524504122|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451973|NCT02443116|524504123|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451974|NCT02443116|524504124|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
145451975|NCT02443116|524504125|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451976|NCT02443116|524504126|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451977|NCT02443116|524504127|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
145451978|NCT02443116|524504119|FG000|Part 3|Adverse Event|0|||
145451979|NCT02443116|524504120|FG001|Part 3|Adverse Event|0|||
145451980|NCT02443116|524504121|FG002|Part 3|Adverse Event|0|||
145451981|NCT02443116|524504122|FG003|Part 3|Adverse Event|0|||
145451982|NCT02443116|524504123|FG004|Part 3|Adverse Event|0|||
145451983|NCT02443116|524504124|FG005|Part 3|Adverse Event|0|||
145451984|NCT02443116|524504125|FG006|Part 3|Adverse Event|0|||
145451985|NCT02443116|524504126|FG007|Part 3|Adverse Event|0|||
145451986|NCT02443116|524504127|FG008|Part 3|Adverse Event|1|||
145451987|NCT02443116|524504119|FG000|Part 3|Withdrew informed consent|0|||
145451988|NCT02443116|524504120|FG001|Part 3|Withdrew informed consent|0|||
145451989|NCT02443116|524504121|FG002|Part 3|Withdrew informed consent|0|||
145451990|NCT02443116|524504122|FG003|Part 3|Withdrew informed consent|0|||
145451991|NCT02443116|524504123|FG004|Part 3|Withdrew informed consent|0|||
145451992|NCT02443116|524504124|FG005|Part 3|Withdrew informed consent|0|||
145451993|NCT02443116|524504125|FG006|Part 3|Withdrew informed consent|0|||
145451994|NCT02443116|524504126|FG007|Part 3|Withdrew informed consent|3|||
145451995|NCT02443116|524504127|FG008|Part 3|Withdrew informed consent|2|||
145451996|NCT02443116|524504119|FG000|Part 3|Lost to Follow-up|0|||
145451997|NCT02443116|524504120|FG001|Part 3|Lost to Follow-up|0|||
145451998|NCT02443116|524504121|FG002|Part 3|Lost to Follow-up|0|||
145451999|NCT02443116|524504122|FG003|Part 3|Lost to Follow-up|0|||
145452000|NCT02443116|524504123|FG004|Part 3|Lost to Follow-up|0|||
145452001|NCT02443116|524504124|FG005|Part 3|Lost to Follow-up|0|||
145452002|NCT02443116|524504125|FG006|Part 3|Lost to Follow-up|0|||
145452003|NCT02443116|524504126|FG007|Part 3|Lost to Follow-up|1|||
145452004|NCT02443116|524504127|FG008|Part 3|Lost to Follow-up|2|||
145452005|NCT04295759|524504128|FG000|Overall Study|Lack of Efficacy|9|||
145452006|NCT04295759|524504128|FG000|Overall Study|Death|1|||
145452007|NCT04295759|524504128|FG000|Overall Study|Withdrawal by Subject|2|||
145452008|NCT04295759|524504128|FG000|Overall Study|Deemed ineligible|1|||
145452009|NCT02470585|524504131|FG000|Overall Study|Death|224|||
145452010|NCT02470585|524504132|FG001|Overall Study|Death|227|||
145452011|NCT02470585|524504133|FG002|Overall Study|Death|199|||
145452012|NCT02470585|524504131|FG000|Overall Study|Withdrew consent|21|||
145452013|NCT02470585|524504132|FG001|Overall Study|Withdrew consent|22|||
145452014|NCT02470585|524504133|FG002|Overall Study|Withdrew consent|31|||
145452015|NCT02470585|524504131|FG000|Overall Study|Lost to Follow-up|8|||
145452016|NCT02470585|524504132|FG001|Overall Study|Lost to Follow-up|15|||
145452017|NCT02470585|524504133|FG002|Overall Study|Lost to Follow-up|13|||
145586837|NCT01827904|524999677|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
145586838|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
145586839|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
145452018|NCT02470585|524504131|FG000|Overall Study|Sponsor discontinued study|117|||
145452019|NCT02470585|524504132|FG001|Overall Study|Sponsor discontinued study|110|||
145452020|NCT02470585|524504133|FG002|Overall Study|Sponsor discontinued study|122|||
145452021|NCT02470585|524504131|FG000|Overall Study|Other, not specified|5|||
145452022|NCT02470585|524504132|FG001|Overall Study|Other, not specified|7|||
145452023|NCT02470585|524504133|FG002|Overall Study|Other, not specified|14|||
145452024|NCT02470585|524504131|FG000|Overall Study|Missing due to site non-compliance|0|||
145452025|NCT02470585|524504132|FG001|Overall Study|Missing due to site non-compliance|2|||
145452026|NCT02470585|524504133|FG002|Overall Study|Missing due to site non-compliance|3|||
145452027|NCT00465972|524504134|FG000|Overall Study|Withdrawal by Subject|2|||
145452028|NCT00465972|524504135|FG001|Overall Study|Withdrawal by Subject|1|||
145452029|NCT00349349|524504136|FG000|Overall Study|Adverse Event|5|||
145586840|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
145586841|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
145586842|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
145586843|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
145586844|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
145586845|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
145586846|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
145586847|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
145586848|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
145586849|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
145586850|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Physician Decision|1|||
145586851|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Physician Decision|0|||
145586852|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Physician Decision|0|||
145586853|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
145586854|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
145586855|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
145586856|NCT01827904|524999675|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
145586857|NCT01827904|524999676|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
145586858|NCT01827904|524999677|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
145586859|NCT00142909|524999683|FG000|Randomization|Various Reasons|7|||
145586860|NCT00142909|524999684|FG001|Randomization|Various Reasons|10|||
145586861|NCT00142909|524999683|FG000|Medications Begin|Protocol Violation|2|||
145586862|NCT00142909|524999684|FG001|Medications Begin|Protocol Violation|0|||
145452030|NCT00349349|524504137|FG001|Overall Study|Adverse Event|6|||
145452031|NCT00349349|524504138|FG002|Overall Study|Adverse Event|2|||
145452032|NCT00349349|524504136|FG000|Overall Study|Withdrawal by Subject|5|||
145452033|NCT00349349|524504137|FG001|Overall Study|Withdrawal by Subject|2|||
145452034|NCT00349349|524504138|FG002|Overall Study|Withdrawal by Subject|1|||
145452035|NCT00349349|524504136|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
145452036|NCT00349349|524504137|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
145452037|NCT00349349|524504138|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
145452038|NCT00349349|524504136|FG000|Overall Study|Death|13|||
145452039|NCT00349349|524504137|FG001|Overall Study|Death|10|||
145452040|NCT00349349|524504138|FG002|Overall Study|Death|1|||
145452041|NCT00349349|524504136|FG000|Overall Study|Other Treatment Selected|2|||
145452042|NCT00349349|524504137|FG001|Overall Study|Other Treatment Selected|0|||
145452043|NCT00349349|524504138|FG002|Overall Study|Other Treatment Selected|0|||
145626235|NCT00062868|525144242|FG002|Dose Level 1|Death|0|||
145626236|NCT00062868|525144243|FG003|Dose Level 1|Death|2|||
145452044|NCT00349349|524504136|FG000|Overall Study|Participant Reduced General Condition|0|||
145452045|NCT00349349|524504137|FG001|Overall Study|Participant Reduced General Condition|1|||
145452046|NCT00349349|524504138|FG002|Overall Study|Participant Reduced General Condition|0|||
145452047|NCT00349349|524504136|FG000|Overall Study|Physician Decision|1|||
145452048|NCT00349349|524504137|FG001|Overall Study|Physician Decision|2|||
145452049|NCT00349349|524504138|FG002|Overall Study|Physician Decision|1|||
145452050|NCT00349349|524504136|FG000|Overall Study|No Response|0|||
145452051|NCT00349349|524504137|FG001|Overall Study|No Response|3|||
145452052|NCT00349349|524504138|FG002|Overall Study|No Response|0|||
145452053|NCT00349349|524504136|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
145452054|NCT00349349|524504137|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
145452055|NCT00349349|524504138|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
145452056|NCT02095873|524504146|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145452057|NCT02095873|524504147|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
145452058|NCT02095873|524504146|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
145452059|NCT02095873|524504147|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
145452060|NCT02095873|524504146|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
145452061|NCT02095873|524504147|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
145452062|NCT00792740|524504148|FG000|Overall Study|Disease Worsening|3|||
145452063|NCT00792740|524504149|FG001|Overall Study|Disease Worsening|2|||
145452064|NCT00792740|524504148|FG000|Overall Study|Personal Reason|1|||
145452065|NCT00792740|524504149|FG001|Overall Study|Personal Reason|0|||
145452066|NCT00792740|524504148|FG000|Overall Study|Adverse Event|1|||
145452067|NCT00792740|524504149|FG001|Overall Study|Adverse Event|3|||
145452068|NCT00792740|524504148|FG000|Overall Study|Patient's withdrawal of consent|0|||
145586863|NCT00142909|524999683|FG000|Medications Begin|Withdrawal by Subject|5|||
145586864|NCT00142909|524999684|FG001|Medications Begin|Withdrawal by Subject|3|||
145586865|NCT00142909|524999683|FG000|Medications Begin|Withdrawal by Subject|2|||
145626237|NCT00062868|525144244|FG004|Dose Level 1|Death|0|||
145626238|NCT00062868|525144245|FG005|Dose Level 1|Death|0|||
145452069|NCT00792740|524504149|FG001|Overall Study|Patient's withdrawal of consent|1|||
145452070|NCT00792740|524504148|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
145452071|NCT00792740|524504149|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
145452072|NCT00792740|524504148|FG000|Overall Study|Other reasons|0|||
145452073|NCT00792740|524504149|FG001|Overall Study|Other reasons|1|||
145586866|NCT00142909|524999684|FG001|Medications Begin|Withdrawal by Subject|0|||
145586867|NCT02265237|524999685|FG000|As Treated (Overall Study)|Adverse Event|1|||
145586868|NCT02265237|524999686|FG001|As Treated (Overall Study)|Adverse Event|1|||
145586869|NCT02265237|524999687|FG002|As Treated (Overall Study)|Adverse Event|0|||
145586870|NCT02265237|524999688|FG003|As Treated (Overall Study)|Adverse Event|0|||
145586871|NCT02265237|524999685|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
145586872|NCT02265237|524999686|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
145586873|NCT02265237|524999687|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
145586874|NCT02265237|524999688|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
145586875|NCT02265237|524999685|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
145586876|NCT02265237|524999686|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
145586877|NCT02265237|524999687|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
145586878|NCT02265237|524999688|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
145586879|NCT02265237|524999685|FG000|As Treated (Overall Study)|Other|2|||
145586880|NCT02265237|524999686|FG001|As Treated (Overall Study)|Other|0|||
145586881|NCT02265237|524999687|FG002|As Treated (Overall Study)|Other|3|||
145586882|NCT02265237|524999688|FG003|As Treated (Overall Study)|Other|1|||
145586883|NCT01178853|524999690|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
145586884|NCT01178853|524999691|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
145586885|NCT01178853|524999690|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
145586886|NCT01178853|524999691|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
145586887|NCT01178853|524999690|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
145586888|NCT01178853|524999691|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
145586889|NCT01178853|524999690|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
145586890|NCT01178853|524999691|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
145586891|NCT01178853|524999690|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
145586892|NCT01178853|524999691|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
145586893|NCT03550313|524999692|FG000|Overall Study|Adverse Event|0|||
145586894|NCT03550313|524999693|FG001|Overall Study|Adverse Event|1|||
145586895|NCT03550313|524999694|FG002|Overall Study|Adverse Event|0|||
145586896|NCT03550313|524999692|FG000|Overall Study|Lost to Follow-up|5|||
145586897|NCT03550313|524999693|FG001|Overall Study|Lost to Follow-up|7|||
145586898|NCT03550313|524999694|FG002|Overall Study|Lost to Follow-up|12|||
145586899|NCT03550313|524999692|FG000|Overall Study|Study terminated by sponsor|44|||
145586900|NCT03550313|524999693|FG001|Overall Study|Study terminated by sponsor|37|||
145586901|NCT03550313|524999694|FG002|Overall Study|Study terminated by sponsor|48|||
145586902|NCT03550313|524999692|FG000|Overall Study|No longer met eligibility criteria|3|||
145586903|NCT03550313|524999693|FG001|Overall Study|No longer met eligibility criteria|5|||
145586904|NCT03550313|524999694|FG002|Overall Study|No longer met eligibility criteria|6|||
145586905|NCT03550313|524999692|FG000|Overall Study|Withdrawal by parent/guardian|20|||
145586906|NCT03550313|524999693|FG001|Overall Study|Withdrawal by parent/guardian|18|||
145586907|NCT03550313|524999694|FG002|Overall Study|Withdrawal by parent/guardian|26|||
145586908|NCT03550313|524999692|FG000|Overall Study|Other|4|||
145586909|NCT03550313|524999693|FG001|Overall Study|Other|2|||
145586910|NCT03550313|524999694|FG002|Overall Study|Other|2|||
145586911|NCT03550313|524999692|FG000|Overall Study|Randomized but not vaccinated|3|||
145586912|NCT03550313|524999693|FG001|Overall Study|Randomized but not vaccinated|23|||
145586913|NCT03550313|524999694|FG002|Overall Study|Randomized but not vaccinated|2|||
145586914|NCT03550313|524999692|FG000|Overall Study|Sites terminated due to quality issues|18|||
145586915|NCT03550313|524999693|FG001|Overall Study|Sites terminated due to quality issues|17|||
145586916|NCT03550313|524999694|FG002|Overall Study|Sites terminated due to quality issues|18|||
145586917|NCT00839072|524999695|FG000|First Intervention Period|Withdrawal by Subject|1|||
145586918|NCT00839072|524999696|FG001|First Intervention Period|Withdrawal by Subject|0|||
145586919|NCT00839072|524999695|FG000|First Intervention Period|Adverse Event|1|||
145586920|NCT00839072|524999696|FG001|First Intervention Period|Adverse Event|1|||
145586921|NCT00839072|524999695|FG000|Second Intervention Period|Withdrawal by Subject|1|||
145586922|NCT00839072|524999696|FG001|Second Intervention Period|Withdrawal by Subject|0|||
145586923|NCT02720484|524999700|FG000|Treatment on Study|Adverse Event|1|||
145586924|NCT02720484|524999700|FG000|Treatment on Study|Withdrawal by Subject|1|||
145586925|NCT02720484|524999700|FG000|Treatment on Study|Progressive Disease|4|||
145586926|NCT02720484|524999700|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
145586927|NCT02720484|524999700|FG000|Follow Up for 2 Years|Death|3|||
145586928|NCT02720484|524999700|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
145586929|NCT05070897|524999703|FG000|Overall Study|Protocol Violation|123|||
145586930|NCT05070897|524999704|FG001|Overall Study|Protocol Violation|68|||
145586931|NCT01663636|524999705|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
145586932|NCT01663636|524999706|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
145586933|NCT02838017|524999708|FG000|Overall Study|Lost to Follow-up|14|||
145452074|NCT01063062|524504150|FG000|Overall Study|Patient withdrew consent|0|||
145586934|NCT02838017|524999709|FG001|Overall Study|Lost to Follow-up|11|||
145586935|NCT01692197|524999710|FG000|Overall Study|Failed Screening|3|||
145586936|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
145586937|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
145586938|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
145586939|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
145586940|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
145586941|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
145586942|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
145586943|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
145586944|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
145586945|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
145586946|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
145586947|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
145586948|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
145586949|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
145586950|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
145586951|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
145586952|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
145586953|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
145586954|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
145586955|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
145586956|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
145586957|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
145586958|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
145586959|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
145586960|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
145586961|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
145586962|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
145586963|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
145586964|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
145586965|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
145586966|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
145586967|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
145586968|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
145586969|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
145586970|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
145586971|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
145586972|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
145586973|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
145586974|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
145586975|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
145586976|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
145586977|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
145586978|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
145586979|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
145586980|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
145586981|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
145586982|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
145586983|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
145586984|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
145586985|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
145586986|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
145586987|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
145586988|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
145586989|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
145586990|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
145586991|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
145586992|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
145586993|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
145586994|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
145586995|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
145586996|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
145586997|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
145626239|NCT00062868|525144246|FG006|Dose Level 1|Death|3|||
145626240|NCT00062868|525144247|FG007|Dose Level 1|Death|0|||
145452075|NCT01063062|524504151|FG001|Overall Study|Patient withdrew consent|1|||
145452076|NCT01063062|524504150|FG000|Overall Study|Adverse Event|2|||
145452077|NCT01063062|524504151|FG001|Overall Study|Adverse Event|4|||
145452078|NCT01063062|524504150|FG000|Overall Study|Protocol Violation|5|||
145452079|NCT01063062|524504151|FG001|Overall Study|Protocol Violation|4|||
145452080|NCT01063062|524504150|FG000|Overall Study|Investigator's request|1|||
145452081|NCT01063062|524504151|FG001|Overall Study|Investigator's request|0|||
145452082|NCT01063062|524504150|FG000|Overall Study|Lost to Follow-up|0|||
145452083|NCT01063062|524504151|FG001|Overall Study|Lost to Follow-up|2|||
145452084|NCT01063062|524504150|FG000|Overall Study|Miscellaneous reason|0|||
145452085|NCT01063062|524504151|FG001|Overall Study|Miscellaneous reason|1|||
145452086|NCT02015481|524504152|FG000|Overall Study|Death|1|||
145452087|NCT01352221|524504159|FG000|Double-blind Phase|Adverse Event|6|||
145452088|NCT01352221|524504160|FG001|Double-blind Phase|Adverse Event|4|||
145452089|NCT01352221|524504161|FG002|Double-blind Phase|Adverse Event|0|||
145452090|NCT01352221|524504162|FG003|Double-blind Phase|Adverse Event|0|||
145452091|NCT01352221|524504159|FG000|Double-blind Phase|Withdrawal by Subject|3|||
145452092|NCT01352221|524504160|FG001|Double-blind Phase|Withdrawal by Subject|5|||
145452093|NCT01352221|524504161|FG002|Double-blind Phase|Withdrawal by Subject|0|||
145452094|NCT01352221|524504162|FG003|Double-blind Phase|Withdrawal by Subject|0|||
145452095|NCT01352221|524504159|FG000|Double-blind Phase|Lost to Follow-up|0|||
145452096|NCT01352221|524504160|FG001|Double-blind Phase|Lost to Follow-up|1|||
145452097|NCT01352221|524504161|FG002|Double-blind Phase|Lost to Follow-up|0|||
145452098|NCT01352221|524504162|FG003|Double-blind Phase|Lost to Follow-up|0|||
145452099|NCT01352221|524504159|FG000|Double-blind Phase|Protocol Violation|0|||
145452100|NCT01352221|524504160|FG001|Double-blind Phase|Protocol Violation|1|||
145452101|NCT01352221|524504161|FG002|Double-blind Phase|Protocol Violation|0|||
145452102|NCT01352221|524504162|FG003|Double-blind Phase|Protocol Violation|0|||
145452103|NCT01352221|524504159|FG000|Open-label Phase|Physician Decision|0|||
145452104|NCT01352221|524504160|FG001|Open-label Phase|Physician Decision|0|||
145452105|NCT01352221|524504161|FG002|Open-label Phase|Physician Decision|2|||
145452106|NCT01352221|524504162|FG003|Open-label Phase|Physician Decision|1|||
145452107|NCT01352221|524504159|FG000|Open-label Phase|Pregnancy|0|||
145452108|NCT01352221|524504160|FG001|Open-label Phase|Pregnancy|0|||
145452109|NCT01352221|524504161|FG002|Open-label Phase|Pregnancy|1|||
145452110|NCT01352221|524504162|FG003|Open-label Phase|Pregnancy|0|||
145452111|NCT01352221|524504159|FG000|Open-label Phase|Adverse Event|0|||
145452112|NCT01352221|524504160|FG001|Open-label Phase|Adverse Event|0|||
145452113|NCT01352221|524504161|FG002|Open-label Phase|Adverse Event|8|||
145452114|NCT01352221|524504162|FG003|Open-label Phase|Adverse Event|4|||
145452115|NCT01352221|524504159|FG000|Open-label Phase|Withdrawal by Subject|0|||
145452116|NCT01352221|524504160|FG001|Open-label Phase|Withdrawal by Subject|0|||
145452117|NCT01352221|524504161|FG002|Open-label Phase|Withdrawal by Subject|1|||
145452118|NCT01352221|524504162|FG003|Open-label Phase|Withdrawal by Subject|6|||
145452119|NCT01352221|524504159|FG000|Open-label Phase|Worsening of IBD|0|||
145452120|NCT01352221|524504160|FG001|Open-label Phase|Worsening of IBD|0|||
145452121|NCT01352221|524504161|FG002|Open-label Phase|Worsening of IBD|1|||
145452122|NCT01352221|524504162|FG003|Open-label Phase|Worsening of IBD|0|||
145452123|NCT02016716|524504163|FG000|Overall Study|Withdrawal by Subject|5|||
145452124|NCT02016716|524504164|FG001|Overall Study|Withdrawal by Subject|5|||
145452125|NCT02016716|524504165|FG002|Overall Study|Withdrawal by Subject|5|||
145452126|NCT02016716|524504163|FG000|Overall Study|Protocol-specified Criteria|0|||
145452127|NCT02016716|524504164|FG001|Overall Study|Protocol-specified Criteria|1|||
145452128|NCT02016716|524504165|FG002|Overall Study|Protocol-specified Criteria|0|||
145452129|NCT02016716|524504163|FG000|Overall Study|Lost to Follow-up|1|||
145452130|NCT02016716|524504164|FG001|Overall Study|Lost to Follow-up|2|||
145586998|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
145586999|NCT01884350|524999711|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
145587000|NCT01884350|524999712|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
145587001|NCT01884350|524999713|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
145587002|NCT00558285|524999714|FG000|Overall Study|Adverse Event|1|||
145587003|NCT00558285|524999715|FG001|Overall Study|Adverse Event|1|||
145587004|NCT00558285|524999716|FG002|Overall Study|Adverse Event|4|||
145452131|NCT02016716|524504165|FG002|Overall Study|Lost to Follow-up|1|||
145452132|NCT06899737|524504172|FG000|Overall Study|Lost to Follow-up|19|||
145452133|NCT06899737|524504173|FG001|Overall Study|Lost to Follow-up|7|||
145452134|NCT02316353|524504174|FG000|Overall Study|Pregnancy|1|||
145452135|NCT02316353|524504175|FG001|Overall Study|Pregnancy|3|||
145452136|NCT02316353|524504174|FG000|Overall Study|Adverse Event|1|||
145452137|NCT02316353|524504175|FG001|Overall Study|Adverse Event|3|||
145452138|NCT02316353|524504174|FG000|Overall Study|Withdrawal by Subject|6|||
145452139|NCT02316353|524504175|FG001|Overall Study|Withdrawal by Subject|2|||
145452140|NCT01681186|524506186|FG000|Washout Period From Second Intervention|Adverse Event|0|||
145452141|NCT01681186|524506187|FG001|Washout Period From Second Intervention|Adverse Event|0|||
145452142|NCT01681186|524506188|FG002|Washout Period From Second Intervention|Adverse Event|0|||
145452143|NCT01681186|524506189|FG003|Washout Period From Second Intervention|Adverse Event|0|||
145587005|NCT00558285|524999717|FG003|Overall Study|Adverse Event|1|||
145587006|NCT00558285|524999718|FG004|Overall Study|Adverse Event|2|||
145587007|NCT00558285|524999714|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145587008|NCT00558285|524999715|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145587009|NCT00558285|524999716|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145587010|NCT00558285|524999717|FG003|Overall Study|Abnormal test procedure result(s)|0|||
145587011|NCT00558285|524999718|FG004|Overall Study|Abnormal test procedure result(s)|0|||
145587012|NCT00558285|524999714|FG000|Overall Study|Subject withdrew consent|2|||
145587013|NCT00558285|524999715|FG001|Overall Study|Subject withdrew consent|0|||
145587014|NCT00558285|524999716|FG002|Overall Study|Subject withdrew consent|1|||
145587015|NCT00558285|524999717|FG003|Overall Study|Subject withdrew consent|1|||
145587016|NCT00558285|524999718|FG004|Overall Study|Subject withdrew consent|1|||
145587017|NCT00558285|524999714|FG000|Overall Study|Lost to Follow-up|1|||
145587018|NCT00558285|524999715|FG001|Overall Study|Lost to Follow-up|1|||
145587019|NCT00558285|524999716|FG002|Overall Study|Lost to Follow-up|0|||
145587020|NCT00558285|524999717|FG003|Overall Study|Lost to Follow-up|0|||
145587021|NCT00558285|524999718|FG004|Overall Study|Lost to Follow-up|0|||
145587022|NCT00558285|524999714|FG000|Overall Study|Administrative problems|0|||
145587023|NCT00558285|524999715|FG001|Overall Study|Administrative problems|0|||
145587024|NCT00558285|524999716|FG002|Overall Study|Administrative problems|0|||
145587025|NCT00558285|524999717|FG003|Overall Study|Administrative problems|1|||
145587026|NCT00558285|524999718|FG004|Overall Study|Administrative problems|1|||
145587027|NCT00558285|524999714|FG000|Overall Study|Protocol deviation|1|||
145587028|NCT00558285|524999715|FG001|Overall Study|Protocol deviation|1|||
145587029|NCT00558285|524999716|FG002|Overall Study|Protocol deviation|0|||
145587030|NCT00558285|524999717|FG003|Overall Study|Protocol deviation|1|||
145587031|NCT00558285|524999718|FG004|Overall Study|Protocol deviation|0|||
145587032|NCT03712917|524999722|FG000|Overall Study|Pregnancy|0|||
145587033|NCT03712917|524999723|FG001|Overall Study|Pregnancy|0|||
145587034|NCT03712917|524999724|FG002|Overall Study|Pregnancy|1|||
145587035|NCT03712917|524999722|FG000|Overall Study|Adverse Event|0|||
145587036|NCT03712917|524999723|FG001|Overall Study|Adverse Event|4|||
145587037|NCT03712917|524999724|FG002|Overall Study|Adverse Event|3|||
145587038|NCT03712917|524999722|FG000|Overall Study|Lost to Follow-up|9|||
145587039|NCT03712917|524999723|FG001|Overall Study|Lost to Follow-up|4|||
145587040|NCT03712917|524999724|FG002|Overall Study|Lost to Follow-up|5|||
145587041|NCT04537923|525001645|FG000|Overall Study|Adverse Event|2|||
145587042|NCT04537923|525001646|FG001|Overall Study|Adverse Event|1|||
145587043|NCT04537923|525001647|FG002|Overall Study|Adverse Event|2|||
145587044|NCT04537923|525001648|FG003|Overall Study|Adverse Event|4|||
145587045|NCT04537923|525001645|FG000|Overall Study|Death|3|||
145587046|NCT04537923|525001646|FG001|Overall Study|Death|3|||
145587047|NCT04537923|525001647|FG002|Overall Study|Death|1|||
145587048|NCT04537923|525001648|FG003|Overall Study|Death|11|||
145587049|NCT04537923|525001645|FG000|Overall Study|Lost to Follow-up|1|||
145587050|NCT04537923|525001646|FG001|Overall Study|Lost to Follow-up|2|||
145587051|NCT04537923|525001647|FG002|Overall Study|Lost to Follow-up|1|||
145587052|NCT04537923|525001648|FG003|Overall Study|Lost to Follow-up|6|||
145587053|NCT04537923|525001645|FG000|Overall Study|Physician Decision|1|||
145587054|NCT04537923|525001646|FG001|Overall Study|Physician Decision|0|||
145587055|NCT04537923|525001647|FG002|Overall Study|Physician Decision|2|||
145587056|NCT04537923|525001648|FG003|Overall Study|Physician Decision|5|||
145587057|NCT04537923|525001645|FG000|Overall Study|Pregnancy|1|||
145587058|NCT04537923|525001646|FG001|Overall Study|Pregnancy|0|||
145587059|NCT04537923|525001647|FG002|Overall Study|Pregnancy|0|||
145587060|NCT04537923|525001648|FG003|Overall Study|Pregnancy|0|||
145587061|NCT04537923|525001645|FG000|Overall Study|Withdrawal by Subject|4|||
145626241|NCT00062868|525144248|FG008|Dose Level 1|Death|0|||
145626242|NCT00062868|525144249|FG009|Dose Level 1|Death|0|||
145626243|NCT00062868|525144250|FG010|Dose Level 1|Death|0|||
145587062|NCT04537923|525001646|FG001|Overall Study|Withdrawal by Subject|4|||
145587063|NCT04537923|525001647|FG002|Overall Study|Withdrawal by Subject|4|||
145587064|NCT04537923|525001648|FG003|Overall Study|Withdrawal by Subject|58|||
145626244|NCT00062868|525144251|FG011|Dose Level 1|Death|0|||
145587065|NCT04537923|525001645|FG000|Overall Study|Missed study visits|2|||
145626245|NCT00062868|525144252|FG012|Dose Level 1|Death|0|||
145626246|NCT00062868|525144253|FG013|Dose Level 1|Death|0|||
145626247|NCT00062868|525144254|FG014|Dose Level 1|Death|0|||
145626248|NCT00062868|525144255|FG015|Dose Level 1|Death|0|||
145626249|NCT00062868|525144256|FG016|Dose Level 1|Death|0|||
145626250|NCT00062868|525144257|FG017|Dose Level 1|Death|0|||
145587066|NCT04537923|525001646|FG001|Overall Study|Missed study visits|0|||
145587067|NCT04537923|525001647|FG002|Overall Study|Missed study visits|0|||
145587068|NCT04537923|525001648|FG003|Overall Study|Missed study visits|3|||
145587069|NCT04537923|525001645|FG000|Overall Study|Sponsor's decision|0|||
145587070|NCT04537923|525001646|FG001|Overall Study|Sponsor's decision|0|||
145587071|NCT04537923|525001647|FG002|Overall Study|Sponsor's decision|1|||
145587072|NCT04537923|525001648|FG003|Overall Study|Sponsor's decision|1|||
145587073|NCT04537923|525001645|FG000|Overall Study|Safety reasons|1|||
145587074|NCT04537923|525001646|FG001|Overall Study|Safety reasons|0|||
145626251|NCT00062868|525144258|FG018|Dose Level 1|Death|7|||
145587075|NCT04537923|525001647|FG002|Overall Study|Safety reasons|0|||
145587076|NCT04537923|525001648|FG003|Overall Study|Safety reasons|0|||
145587077|NCT03586648|525001650|FG000|Period 1|Withdrawal by Subject|0|||
145587078|NCT03586648|525001651|FG001|Period 1|Withdrawal by Subject|1|||
145587079|NCT03586648|525001650|FG000|Period 1|Lost to Follow-up|1|||
145587080|NCT03586648|525001651|FG001|Period 1|Lost to Follow-up|1|||
145587081|NCT03586648|525001650|FG000|Period 1|Adverse Event|1|||
145587082|NCT03586648|525001651|FG001|Period 1|Adverse Event|0|||
145587083|NCT03586648|525001650|FG000|Period 1|Study related symptoms or complaints|2|||
145587084|NCT03586648|525001651|FG001|Period 1|Study related symptoms or complaints|1|||
145587085|NCT03586648|525001650|FG000|Period 1|Physician Decision|0|||
145587086|NCT03586648|525001651|FG001|Period 1|Physician Decision|1|||
145587087|NCT03586648|525001650|FG000|Period 2|Adverse Event|1|||
145587088|NCT03586648|525001651|FG001|Period 2|Adverse Event|0|||
145587089|NCT02395120|525001652|FG000|Overall Study|Missed follow-up dental exam|57|||
145587090|NCT02395120|525001653|FG001|Overall Study|Missed follow-up dental exam|62|||
145587091|NCT02395120|525001654|FG002|Overall Study|Missed follow-up dental exam|6|||
145587092|NCT02395120|525001655|FG003|Overall Study|Missed follow-up dental exam|6|||
145587093|NCT02395120|525001656|FG004|Overall Study|Missed follow-up dental exam|51|||
145587094|NCT00377234|525001657|FG000|Overall Study|Adverse Event|14|||
145587095|NCT00377234|525001658|FG001|Overall Study|Adverse Event|17|||
145587096|NCT00377234|525001657|FG000|Overall Study|Withdrawal by Subject|11|||
145587097|NCT00377234|525001658|FG001|Overall Study|Withdrawal by Subject|9|||
145587098|NCT00377234|525001657|FG000|Overall Study|Lost to Follow-up|4|||
145587099|NCT00377234|525001658|FG001|Overall Study|Lost to Follow-up|2|||
145587100|NCT00377234|525001657|FG000|Overall Study|Administrative|2|||
145587101|NCT00377234|525001658|FG001|Overall Study|Administrative|1|||
145587102|NCT00377234|525001657|FG000|Overall Study|Not assigned|3|||
145587103|NCT00377234|525001658|FG001|Overall Study|Not assigned|2|||
145587104|NCT01159691|525001662|FG000|Overall Study|Lost to Follow-up|2|||
145587105|NCT01159691|525001662|FG000|Overall Study|Unknown reasons|1|||
145587106|NCT01159691|525001662|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
145587107|NCT01159691|525001662|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
145587108|NCT01159691|525001662|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
145587109|NCT01159691|525001662|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
145587110|NCT01159691|525001662|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
145587111|NCT01159691|525001662|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
145587112|NCT00896168|525001663|FG000|Overall Study|Adverse Event|4|||
145587113|NCT00896168|525001664|FG001|Overall Study|Adverse Event|7|||
145587114|NCT00896168|525001663|FG000|Overall Study|Treatment failure|8|||
145587115|NCT00896168|525001664|FG001|Overall Study|Treatment failure|10|||
145587116|NCT00896168|525001663|FG000|Overall Study|Lost to Follow-up|1|||
145587117|NCT00896168|525001664|FG001|Overall Study|Lost to Follow-up|1|||
145587118|NCT00896168|525001663|FG000|Overall Study|Other|1|||
145587119|NCT00896168|525001664|FG001|Overall Study|Other|1|||
145587120|NCT00384085|525001666|FG000|Overall Study|Adverse Event|5|||
145587121|NCT00384085|525001667|FG001|Overall Study|Adverse Event|5|||
145587122|NCT00384085|525001668|FG002|Overall Study|Adverse Event|4|||
145587123|NCT00384085|525001666|FG000|Overall Study|Lack of Efficacy|0|||
145587124|NCT00384085|525001667|FG001|Overall Study|Lack of Efficacy|3|||
145587125|NCT00384085|525001668|FG002|Overall Study|Lack of Efficacy|2|||
145587126|NCT00384085|525001666|FG000|Overall Study|No longer Requires Study Treatment|1|||
145587127|NCT00384085|525001667|FG001|Overall Study|No longer Requires Study Treatment|0|||
145587128|NCT00384085|525001668|FG002|Overall Study|No longer Requires Study Treatment|1|||
145587129|NCT00384085|525001666|FG000|Overall Study|Protocol Violation|2|||
145587130|NCT00384085|525001667|FG001|Overall Study|Protocol Violation|2|||
145587131|NCT00384085|525001668|FG002|Overall Study|Protocol Violation|2|||
145587132|NCT00384085|525001666|FG000|Overall Study|Lost to Follow-up|9|||
145587133|NCT00384085|525001667|FG001|Overall Study|Lost to Follow-up|9|||
145587134|NCT00384085|525001668|FG002|Overall Study|Lost to Follow-up|10|||
145587135|NCT00384085|525001666|FG000|Overall Study|Progressive Disease|0|||
145587136|NCT00384085|525001667|FG001|Overall Study|Progressive Disease|1|||
145587137|NCT00384085|525001668|FG002|Overall Study|Progressive Disease|0|||
145587138|NCT00384085|525001666|FG000|Overall Study|Withdrawal by Subject|14|||
145587139|NCT00384085|525001667|FG001|Overall Study|Withdrawal by Subject|19|||
145587140|NCT00384085|525001668|FG002|Overall Study|Withdrawal by Subject|29|||
145587141|NCT00384085|525001666|FG000|Overall Study|Patient non-compliant|4|||
145587142|NCT00384085|525001667|FG001|Overall Study|Patient non-compliant|4|||
145587143|NCT00384085|525001668|FG002|Overall Study|Patient non-compliant|5|||
145587144|NCT00384085|525001666|FG000|Overall Study|Physician Decision|1|||
145587145|NCT00384085|525001667|FG001|Overall Study|Physician Decision|0|||
145587146|NCT00384085|525001668|FG002|Overall Study|Physician Decision|0|||
145587147|NCT00384085|525001666|FG000|Overall Study|Loss of site personnel|1|||
145587148|NCT00384085|525001667|FG001|Overall Study|Loss of site personnel|0|||
145587149|NCT00384085|525001668|FG002|Overall Study|Loss of site personnel|1|||
145587150|NCT00384085|525001666|FG000|Overall Study|Sponsor decision|1|||
145587151|NCT00384085|525001667|FG001|Overall Study|Sponsor decision|2|||
145587152|NCT00384085|525001668|FG002|Overall Study|Sponsor decision|1|||
145587153|NCT00384085|525001666|FG000|Overall Study|Patient moved|1|||
145587154|NCT00384085|525001667|FG001|Overall Study|Patient moved|0|||
145587155|NCT00384085|525001668|FG002|Overall Study|Patient moved|1|||
145587156|NCT00384085|525001666|FG000|Overall Study|Patient required surgery|0|||
145587157|NCT00384085|525001667|FG001|Overall Study|Patient required surgery|1|||
145587158|NCT00384085|525001668|FG002|Overall Study|Patient required surgery|0|||
145587159|NCT03725982|525001669|FG000|First Intervention|Withdrawal by Subject|0|||
145587160|NCT03725982|525001670|FG001|First Intervention|Withdrawal by Subject|1|||
145587161|NCT03725982|525001669|FG000|First Intervention|Physician Decision|1|||
145587162|NCT03725982|525001670|FG001|First Intervention|Physician Decision|1|||
145587163|NCT01944631|525001672|FG000|Overall Study|Adverse Event|1|||
145587164|NCT01944631|525001673|FG001|Overall Study|Adverse Event|0|||
145587165|NCT01944631|525001672|FG000|Overall Study|Lost to Follow-up|3|||
145587166|NCT01944631|525001673|FG001|Overall Study|Lost to Follow-up|1|||
145587167|NCT01944631|525001672|FG000|Overall Study|Withdrawal by Subject|0|||
145587168|NCT01944631|525001673|FG001|Overall Study|Withdrawal by Subject|1|||
145587169|NCT00838110|525001674|FG000|Overall Study|Death|0|||
145587170|NCT00838110|525001675|FG001|Overall Study|Death|0|||
145587171|NCT00838110|525001676|FG002|Overall Study|Death|1|||
145587172|NCT00838110|525001677|FG003|Overall Study|Death|2|||
145587173|NCT00838110|525001674|FG000|Overall Study|Adverse Event|11|||
145587174|NCT00838110|525001675|FG001|Overall Study|Adverse Event|10|||
145587175|NCT00838110|525001676|FG002|Overall Study|Adverse Event|8|||
145587176|NCT00838110|525001677|FG003|Overall Study|Adverse Event|7|||
145587177|NCT00838110|525001674|FG000|Overall Study|Withdrawal by Subject|5|||
145587178|NCT00838110|525001675|FG001|Overall Study|Withdrawal by Subject|6|||
145587179|NCT00838110|525001676|FG002|Overall Study|Withdrawal by Subject|3|||
145587180|NCT00838110|525001677|FG003|Overall Study|Withdrawal by Subject|4|||
145587181|NCT00838110|525001674|FG000|Overall Study|Other|3|||
145587182|NCT00838110|525001675|FG001|Overall Study|Other|3|||
145587183|NCT00838110|525001676|FG002|Overall Study|Other|3|||
145587184|NCT00838110|525001677|FG003|Overall Study|Other|2|||
145587185|NCT00838110|525001674|FG000|Overall Study|Protocol Violation|0|||
145587186|NCT00838110|525001675|FG001|Overall Study|Protocol Violation|2|||
145587187|NCT00838110|525001676|FG002|Overall Study|Protocol Violation|1|||
145587188|NCT00838110|525001677|FG003|Overall Study|Protocol Violation|1|||
145587189|NCT00838110|525001674|FG000|Overall Study|Lost to Follow-up|3|||
145587190|NCT00838110|525001675|FG001|Overall Study|Lost to Follow-up|0|||
145587191|NCT00838110|525001676|FG002|Overall Study|Lost to Follow-up|0|||
145587192|NCT00838110|525001677|FG003|Overall Study|Lost to Follow-up|0|||
145587193|NCT00838110|525001674|FG000|Overall Study|Did not meet eligibility criteria|0|||
145587194|NCT00838110|525001675|FG001|Overall Study|Did not meet eligibility criteria|0|||
145587195|NCT00838110|525001676|FG002|Overall Study|Did not meet eligibility criteria|1|||
145587196|NCT00838110|525001677|FG003|Overall Study|Did not meet eligibility criteria|2|||
145587197|NCT00838110|525001674|FG000|Overall Study|Randomized but not treated|0|||
145587198|NCT00838110|525001675|FG001|Overall Study|Randomized but not treated|1|||
145587199|NCT00838110|525001676|FG002|Overall Study|Randomized but not treated|0|||
145587200|NCT00838110|525001677|FG003|Overall Study|Randomized but not treated|0|||
145587201|NCT02811861|525001678|FG000|Overall Study|Radiological Disease Progression|123|||
145587202|NCT02811861|525001679|FG001|Overall Study|Radiological Disease Progression|97|||
145587203|NCT02811861|525001680|FG002|Overall Study|Radiological Disease Progression|174|||
145587204|NCT02811861|525001678|FG000|Overall Study|Clinical Disease Progression|20|||
145587205|NCT02811861|525001679|FG001|Overall Study|Clinical Disease Progression|19|||
145587206|NCT02811861|525001680|FG002|Overall Study|Clinical Disease Progression|22|||
145587207|NCT02811861|525001678|FG000|Overall Study|Adverse Event|63|||
145452144|NCT01681186|524506190|FG004|Washout Period From Second Intervention|Adverse Event|0|||
145587208|NCT02811861|525001679|FG001|Overall Study|Adverse Event|60|||
145587209|NCT02811861|525001680|FG002|Overall Study|Adverse Event|41|||
145587210|NCT02811861|525001678|FG000|Overall Study|Lost to Follow-up|0|||
145587211|NCT02811861|525001679|FG001|Overall Study|Lost to Follow-up|0|||
145587212|NCT02811861|525001680|FG002|Overall Study|Lost to Follow-up|1|||
145587213|NCT02811861|525001678|FG000|Overall Study|Subject Choice|29|||
145587214|NCT02811861|525001679|FG001|Overall Study|Subject Choice|17|||
145587215|NCT02811861|525001680|FG002|Overall Study|Subject Choice|23|||
145587216|NCT02811861|525001678|FG000|Overall Study|Withdrawal by Subject|4|||
145587217|NCT02811861|525001679|FG001|Overall Study|Withdrawal by Subject|4|||
145587218|NCT02811861|525001680|FG002|Overall Study|Withdrawal by Subject|9|||
145587219|NCT02811861|525001678|FG000|Overall Study|Other|4|||
145587220|NCT02811861|525001679|FG001|Overall Study|Other|13|||
145587221|NCT02811861|525001680|FG002|Overall Study|Other|3|||
145587222|NCT02811861|525001678|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
145587223|NCT02811861|525001679|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
145587224|NCT02811861|525001680|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
145587225|NCT02811861|525001678|FG000|Overall Study|Randomized but not treated|2|||
145587226|NCT02811861|525001679|FG001|Overall Study|Randomized but not treated|3|||
145587227|NCT02811861|525001680|FG002|Overall Study|Randomized but not treated|17|||
145587228|NCT04743908|525001681|FG000|Overall Study|Death|1|||
145587229|NCT04743908|525001682|FG001|Overall Study|Death|0|||
145587230|NCT04743908|525001681|FG000|Overall Study|Lost to Follow-up|181|||
145587231|NCT04743908|525001682|FG001|Overall Study|Lost to Follow-up|180|||
145587232|NCT04743908|525001681|FG000|Overall Study|Withdrawal by Subject|1|||
145587233|NCT04743908|525001682|FG001|Overall Study|Withdrawal by Subject|2|||
145587234|NCT00467870|525001688|FG000|Overall Study|Adverse Event|13|||
145587235|NCT00467870|525001689|FG001|Overall Study|Adverse Event|9|||
145587236|NCT00467870|525001690|FG002|Overall Study|Adverse Event|1|||
145587237|NCT00467870|525001691|FG003|Overall Study|Adverse Event|15|||
145587238|NCT00467870|525001692|FG004|Overall Study|Adverse Event|15|||
145587239|NCT00467870|525001693|FG005|Overall Study|Adverse Event|1|||
145587240|NCT00467870|525001688|FG000|Overall Study|Protocol Violation|2|||
145587241|NCT00467870|525001689|FG001|Overall Study|Protocol Violation|1|||
145587242|NCT00467870|525001690|FG002|Overall Study|Protocol Violation|1|||
145587243|NCT00467870|525001691|FG003|Overall Study|Protocol Violation|2|||
145587244|NCT00467870|525001692|FG004|Overall Study|Protocol Violation|0|||
145587245|NCT00467870|525001693|FG005|Overall Study|Protocol Violation|0|||
145587246|NCT00467870|525001688|FG000|Overall Study|Withdrawal by Subject|14|||
145587247|NCT00467870|525001689|FG001|Overall Study|Withdrawal by Subject|21|||
145587248|NCT00467870|525001690|FG002|Overall Study|Withdrawal by Subject|0|||
145587249|NCT00467870|525001691|FG003|Overall Study|Withdrawal by Subject|9|||
145587250|NCT00467870|525001692|FG004|Overall Study|Withdrawal by Subject|10|||
145587251|NCT00467870|525001693|FG005|Overall Study|Withdrawal by Subject|1|||
145587252|NCT00467870|525001688|FG000|Overall Study|Lost to Follow-up|5|||
145587253|NCT00467870|525001689|FG001|Overall Study|Lost to Follow-up|3|||
145587254|NCT00467870|525001690|FG002|Overall Study|Lost to Follow-up|1|||
145587255|NCT00467870|525001691|FG003|Overall Study|Lost to Follow-up|1|||
145587256|NCT00467870|525001692|FG004|Overall Study|Lost to Follow-up|3|||
145587257|NCT00467870|525001693|FG005|Overall Study|Lost to Follow-up|0|||
145587258|NCT00467870|525001688|FG000|Overall Study|Subject Non-compliance|3|||
145587259|NCT00467870|525001689|FG001|Overall Study|Subject Non-compliance|4|||
145587260|NCT00467870|525001690|FG002|Overall Study|Subject Non-compliance|0|||
145587261|NCT00467870|525001691|FG003|Overall Study|Subject Non-compliance|1|||
145587262|NCT00467870|525001692|FG004|Overall Study|Subject Non-compliance|5|||
145587263|NCT00467870|525001693|FG005|Overall Study|Subject Non-compliance|0|||
145587264|NCT00467870|525001688|FG000|Overall Study|Other/Unknown|8|||
145587265|NCT00467870|525001689|FG001|Overall Study|Other/Unknown|5|||
145587266|NCT00467870|525001690|FG002|Overall Study|Other/Unknown|1|||
145587267|NCT00467870|525001691|FG003|Overall Study|Other/Unknown|5|||
145587268|NCT00467870|525001692|FG004|Overall Study|Other/Unknown|4|||
145587269|NCT00467870|525001693|FG005|Overall Study|Other/Unknown|0|||
145587270|NCT01917526|525001694|FG000|Overall Study|Protocol Violation|1|||
145587271|NCT01917526|525001695|FG001|Overall Study|Protocol Violation|1|||
145587272|NCT02261363|525001696|FG000|Overall Study|Lost to Follow-up|21|||
145587273|NCT01517802|525001697|FG000|Overall Study|Death|1|||
145587274|NCT03268811|525001702|FG000|Overall Study|Adverse Event|0|||
145587275|NCT03268811|525001703|FG001|Overall Study|Adverse Event|1|||
145587276|NCT02031276|525001704|FG000|Period 1 Double-blind IV|Adverse Event|6|||
145587277|NCT02031276|525001705|FG001|Period 1 Double-blind IV|Adverse Event|5|||
145587278|NCT02031276|525001706|FG002|Period 1 Double-blind IV|Adverse Event|1|||
145587279|NCT02031276|525001704|FG000|Period 1 Double-blind IV|Other|0|||
145587280|NCT02031276|525001705|FG001|Period 1 Double-blind IV|Other|1|||
145587281|NCT02031276|525001706|FG002|Period 1 Double-blind IV|Other|0|||
145587282|NCT02031276|525001704|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
145587283|NCT02031276|525001705|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
145587284|NCT02031276|525001706|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
145587285|NCT02031276|525001704|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
145587286|NCT02031276|525001705|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
145587287|NCT02031276|525001706|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
145587288|NCT02031276|525001704|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
145587289|NCT02031276|525001705|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
145587290|NCT02031276|525001706|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
145587291|NCT02031276|525001704|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
145587292|NCT02031276|525001705|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
145587293|NCT02031276|525001706|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
145587294|NCT02031276|525001704|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
145587295|NCT02031276|525001705|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
145587296|NCT02031276|525001706|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
145587297|NCT02031276|525001704|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
145587298|NCT02031276|525001705|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
145587299|NCT02031276|525001706|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
145587300|NCT02031276|525001704|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
145587301|NCT02031276|525001705|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
145587302|NCT02031276|525001706|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
145587303|NCT04726709|525001713|FG000|Overall Study|Withdrawal by Subject|2|||
145587304|NCT04726709|525001714|FG001|Overall Study|Withdrawal by Subject|2|||
145587305|NCT03073603|525001716|FG000|Overall Study|Noncompliance|3|||
145587306|NCT03073603|525001717|FG001|Overall Study|Noncompliance|1|||
145587307|NCT03073603|525001716|FG000|Overall Study|Adverse Event|5|||
145587308|NCT03073603|525001717|FG001|Overall Study|Adverse Event|3|||
145587309|NCT03073603|525001716|FG000|Overall Study|Physician Decision|1|||
145587310|NCT03073603|525001717|FG001|Overall Study|Physician Decision|2|||
145587311|NCT03073603|525001716|FG000|Overall Study|Required treatment not allowed by protocol|1|||
145587312|NCT03073603|525001717|FG001|Overall Study|Required treatment not allowed by protocol|0|||
145587313|NCT03073603|525001716|FG000|Overall Study|Financial or insurance-related|8|||
145587314|NCT03073603|525001717|FG001|Overall Study|Financial or insurance-related|0|||
145587315|NCT03073603|525001716|FG000|Overall Study|Withdrawal by Subject|0|||
145587316|NCT03073603|525001717|FG001|Overall Study|Withdrawal by Subject|1|||
145587317|NCT03073603|525001716|FG000|Overall Study|Discontinued DMT|4|||
145587318|NCT03073603|525001717|FG001|Overall Study|Discontinued DMT|0|||
145587319|NCT03073603|525001716|FG000|Overall Study|Restarted DMT|0|||
145587320|NCT03073603|525001717|FG001|Overall Study|Restarted DMT|1|||
145587321|NCT04757649|525001718|FG000|Overall Study|Withdrawal by Subject|1|||
145587322|NCT04757649|525001718|FG000|Overall Study|Adverse Event|1|||
145587323|NCT01286779|525001719|FG000|Overall Study|Withdrawal by Subject|9|||
145587324|NCT01286779|525001719|FG000|Overall Study|Protocol Violation|5|||
145587325|NCT01286779|525001719|FG000|Overall Study|Physician Decision|2|||
145587326|NCT01286779|525001719|FG000|Overall Study|Participant had scheduled surgery|1|||
145587327|NCT01286779|525001719|FG000|Overall Study|Participant moved to another country|1|||
145587328|NCT01286779|525001719|FG000|Overall Study|Discontinued by sponsor|1|||
145587329|NCT00574080|525001724|FG000|Overall Study|Death|10|||
145587330|NCT00574080|525001725|FG001|Overall Study|Death|10|||
145587331|NCT02862106|525001726|FG000|Overall Study|Adverse Event|4|||
145587332|NCT02862106|525001727|FG001|Overall Study|Adverse Event|0|||
145587333|NCT02862106|525001726|FG000|Overall Study|Protocol Violation|16|||
145587334|NCT02862106|525001727|FG001|Overall Study|Protocol Violation|1|||
145587335|NCT02862106|525001726|FG000|Overall Study|Lost to Follow-up|15|||
145587336|NCT02862106|525001727|FG001|Overall Study|Lost to Follow-up|5|||
145587337|NCT02862106|525001726|FG000|Overall Study|Withdrawal by Subject|2|||
145587338|NCT02862106|525001727|FG001|Overall Study|Withdrawal by Subject|0|||
145587339|NCT02862106|525001726|FG000|Overall Study|Subjects moved to other city|1|||
145587340|NCT02862106|525001727|FG001|Overall Study|Subjects moved to other city|0|||
145587341|NCT04360824|525001728|FG000|Overall Study|Withdrawal by Subject|2|||
145587342|NCT04360824|525001729|FG001|Overall Study|Withdrawal by Subject|1|||
145587343|NCT04360824|525001728|FG000|Overall Study|Did not receive assigned treatment|1|||
145587344|NCT04360824|525001729|FG001|Overall Study|Did not receive assigned treatment|3|||
145587345|NCT00304070|525001730|FG000|Overall Study|Death|0|||
145587346|NCT00304070|525001731|FG001|Overall Study|Death|0|||
145587347|NCT00304070|525001732|FG002|Overall Study|Death|3|||
145587348|NCT00304070|525001730|FG000|Overall Study|Lost to Follow-up|0|||
145587349|NCT00304070|525001731|FG001|Overall Study|Lost to Follow-up|0|||
145587350|NCT00304070|525001732|FG002|Overall Study|Lost to Follow-up|1|||
145587351|NCT00304070|525001730|FG000|Overall Study|Physician Decision|0|||
145587352|NCT00304070|525001731|FG001|Overall Study|Physician Decision|0|||
145587353|NCT00304070|525001732|FG002|Overall Study|Physician Decision|3|||
145587354|NCT00304070|525001730|FG000|Overall Study|Withdrawal by Subject|0|||
145587355|NCT00304070|525001731|FG001|Overall Study|Withdrawal by Subject|0|||
145587356|NCT00304070|525001732|FG002|Overall Study|Withdrawal by Subject|1|||
145626252|NCT00062868|525144259|FG019|Dose Level 1|Death|0|||
145626253|NCT00062868|525144260|FG020|Dose Level 1|Death|1|||
145587357|NCT00304070|525001730|FG000|Overall Study|Progressive Disease|3|||
145587358|NCT00304070|525001731|FG001|Overall Study|Progressive Disease|7|||
145587359|NCT00304070|525001732|FG002|Overall Study|Progressive Disease|4|||
145587360|NCT00377676|525001733|FG000|Overall Study|Adverse Event|498|||
145587361|NCT00377676|525001734|FG001|Overall Study|Adverse Event|107|||
145587362|NCT00377676|525001733|FG000|Overall Study|Protocol Violation|33|||
145587363|NCT00377676|525001734|FG001|Overall Study|Protocol Violation|27|||
145587364|NCT00377676|525001733|FG000|Overall Study|Death|5|||
145587365|NCT00377676|525001734|FG001|Overall Study|Death|2|||
145587366|NCT00377676|525001733|FG000|Overall Study|Withdrawal by Subject|187|||
145626254|NCT00062868|525144240|FG000|Dose Level 1|Lost to Follow-up|0|||
145626255|NCT00062868|525144241|FG001|Dose Level 1|Lost to Follow-up|0|||
145587367|NCT00377676|525001734|FG001|Overall Study|Withdrawal by Subject|72|||
145587368|NCT00377676|525001733|FG000|Overall Study|Lost to Follow-up|120|||
145587369|NCT00377676|525001734|FG001|Overall Study|Lost to Follow-up|56|||
145587370|NCT00377676|525001733|FG000|Overall Study|Other|118|||
145587371|NCT00377676|525001734|FG001|Overall Study|Other|58|||
145587372|NCT06027216|525001743|FG000|Overall Study|Did not qualify|8|||
145587373|NCT05348681|525001744|FG000|Overall Study|Study terminated by Sponsor|8|||
145587374|NCT05348681|525001745|FG001|Overall Study|Study terminated by Sponsor|3|||
145587375|NCT05348681|525001744|FG000|Overall Study|Withdrawal by Subject|1|||
145587376|NCT05348681|525001745|FG001|Overall Study|Withdrawal by Subject|1|||
145587377|NCT05348681|525001744|FG000|Overall Study|Lost to Follow-up|1|||
145587378|NCT05348681|525001745|FG001|Overall Study|Lost to Follow-up|1|||
145626256|NCT00062868|525144242|FG002|Dose Level 1|Lost to Follow-up|0|||
145626257|NCT00062868|525144243|FG003|Dose Level 1|Lost to Follow-up|0|||
145587379|NCT05348681|525001744|FG000|Overall Study|Adverse Event|1|||
145587380|NCT05348681|525001745|FG001|Overall Study|Adverse Event|0|||
145452145|NCT01681186|524506191|FG005|Washout Period From Second Intervention|Adverse Event|0|||
145452146|NCT01681186|524506192|FG006|Washout Period From Second Intervention|Adverse Event|1|||
145587381|NCT05348681|525001744|FG000|Overall Study|Other|2|||
145587382|NCT05348681|525001745|FG001|Overall Study|Other|1|||
145587383|NCT03646513|525001746|FG000|Overall Study|Premature study termination|4|||
145587384|NCT00782340|525001747|FG000|Open Label Titration|Adverse Event|12|||
145587385|NCT00782340|525001748|FG001|Open Label Titration|Adverse Event|0|||
145587386|NCT00782340|525001749|FG002|Open Label Titration|Adverse Event|0|||
145452147|NCT01681186|524506193|FG007|Washout Period From Second Intervention|Adverse Event|0|||
145452148|NCT01681186|524506186|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
145452149|NCT01681186|524506187|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
145452150|NCT01681186|524506188|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
145452151|NCT01681186|524506189|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
145452152|NCT01681186|524506190|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
145452153|NCT01681186|524506191|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
145452154|NCT01681186|524506192|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
145452155|NCT01681186|524506193|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
145452156|NCT01681186|524506186|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452157|NCT01681186|524506187|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452158|NCT01681186|524506188|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452159|NCT01681186|524506189|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452160|NCT01681186|524506190|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452161|NCT01681186|524506191|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452162|NCT01681186|524506192|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
145452163|NCT01681186|524506193|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
145452164|NCT01681186|524506186|FG000|Fourth Intervention|Protocol Violation|0|||
145452165|NCT01681186|524506187|FG001|Fourth Intervention|Protocol Violation|0|||
145452166|NCT01681186|524506188|FG002|Fourth Intervention|Protocol Violation|0|||
145452167|NCT01681186|524506189|FG003|Fourth Intervention|Protocol Violation|0|||
145452168|NCT01681186|524506190|FG004|Fourth Intervention|Protocol Violation|0|||
145452169|NCT01681186|524506191|FG005|Fourth Intervention|Protocol Violation|0|||
145452170|NCT01681186|524506192|FG006|Fourth Intervention|Protocol Violation|0|||
145452171|NCT01681186|524506193|FG007|Fourth Intervention|Protocol Violation|1|||
145452172|NCT05160415|524506194|FG000|Overall Study|Withdrawal by Subject|3|||
145452173|NCT02582814|524506201|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145452174|NCT02582814|524506202|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145452175|NCT02582814|524506201|FG000|Overall Study|Withdrawal by Subject|4|||
145452176|NCT02582814|524506202|FG001|Overall Study|Withdrawal by Subject|3|||
145452177|NCT02582814|524506201|FG000|Overall Study|Adverse Event|4|||
145452178|NCT02582814|524506202|FG001|Overall Study|Adverse Event|4|||
145452179|NCT04848220|524506209|FG000|Overall Study|Unable to proceed to study procedure|0|||
145452180|NCT04848220|524506210|FG001|Overall Study|Unable to proceed to study procedure|1|||
145452181|NCT04848220|524506211|FG002|Overall Study|Unable to proceed to study procedure|0|||
145452182|NCT04848220|524506209|FG000|Overall Study|Fractional flow not significant|0|||
145452183|NCT04848220|524506210|FG001|Overall Study|Fractional flow not significant|1|||
145452184|NCT04848220|524506211|FG002|Overall Study|Fractional flow not significant|0|||
145452185|NCT02923830|524506212|FG000|Overall Study|Physician Decision|13|||
145452186|NCT02923830|524506213|FG001|Overall Study|Physician Decision|15|||
145452187|NCT01751906|524506216|FG000|Overall Study|Lost to Follow-up|151|||
145452188|NCT01751906|524506217|FG001|Overall Study|Lost to Follow-up|68|||
145452189|NCT01751906|524506216|FG000|Overall Study|Withdrawal by Subject|22|||
145452190|NCT01751906|524506217|FG001|Overall Study|Withdrawal by Subject|18|||
145452191|NCT01751906|524506216|FG000|Overall Study|Physician Decision|5|||
145452192|NCT01751906|524506217|FG001|Overall Study|Physician Decision|2|||
145452193|NCT01751906|524506216|FG000|Overall Study|Death|84|||
145452194|NCT01751906|524506217|FG001|Overall Study|Death|43|||
145452195|NCT01751906|524506216|FG000|Overall Study|Denied on premises for follow-up by law|1|||
145452196|NCT01751906|524506217|FG001|Overall Study|Denied on premises for follow-up by law|0|||
145452197|NCT02557100|524506226|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
145452198|NCT02557100|524506227|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
145452199|NCT02557100|524506228|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
145452200|NCT02557100|524506226|FG000|Single Blind Treatment Period|Death|0|||
145452201|NCT02557100|524506227|FG001|Single Blind Treatment Period|Death|1|||
145452202|NCT02557100|524506228|FG002|Single Blind Treatment Period|Death|0|||
145452203|NCT02557100|524506226|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
145452204|NCT02557100|524506227|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
145452205|NCT02557100|524506228|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
145452206|NCT02557100|524506226|FG000|Single Blind Treatment Period|Adverse Event|0|||
145452207|NCT02557100|524506227|FG001|Single Blind Treatment Period|Adverse Event|1|||
145587387|NCT00782340|525001747|FG000|Open Label Titration|Treatment failure|50|||
145587388|NCT00782340|525001748|FG001|Open Label Titration|Treatment failure|0|||
145587389|NCT00782340|525001749|FG002|Open Label Titration|Treatment failure|0|||
145587390|NCT00782340|525001747|FG000|Open Label Titration|Protocol Violation|5|||
145587391|NCT00782340|525001748|FG001|Open Label Titration|Protocol Violation|0|||
145587392|NCT00782340|525001749|FG002|Open Label Titration|Protocol Violation|0|||
145587393|NCT00782340|525001747|FG000|Open Label Titration|Withdrawal by Subject|5|||
145587394|NCT00782340|525001748|FG001|Open Label Titration|Withdrawal by Subject|0|||
145587395|NCT00782340|525001749|FG002|Open Label Titration|Withdrawal by Subject|0|||
145587396|NCT00782340|525001747|FG000|Open Label Titration|Enrollment capped|16|||
145587397|NCT00782340|525001748|FG001|Open Label Titration|Enrollment capped|0|||
145587398|NCT00782340|525001749|FG002|Open Label Titration|Enrollment capped|0|||
145587399|NCT00782340|525001747|FG000|Open Label Titration|Did not meet responder criteria|2|||
145587400|NCT00782340|525001748|FG001|Open Label Titration|Did not meet responder criteria|0|||
145587401|NCT00782340|525001749|FG002|Open Label Titration|Did not meet responder criteria|0|||
145587402|NCT00782340|525001747|FG000|Open Label Titration|Lost to Follow-up|5|||
145587403|NCT00782340|525001748|FG001|Open Label Titration|Lost to Follow-up|0|||
145587404|NCT00782340|525001749|FG002|Open Label Titration|Lost to Follow-up|0|||
145587405|NCT00782340|525001747|FG000|Open Label Titration|Randomized in error|6|||
145587406|NCT00782340|525001748|FG001|Open Label Titration|Randomized in error|0|||
145587407|NCT00782340|525001749|FG002|Open Label Titration|Randomized in error|0|||
145587408|NCT03359096|525001754|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
145587409|NCT03359096|525001755|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
145587410|NCT03359096|525001754|FG000|First Intervention (4 Weeks)|Death|1|||
145587411|NCT03359096|525001755|FG001|First Intervention (4 Weeks)|Death|0|||
145587412|NCT03359096|525001754|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
145587413|NCT03359096|525001755|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
145587414|NCT01306162|525001756|FG000|Period 1|Adverse Event|0|||
145587415|NCT01306162|525001757|FG001|Period 1|Adverse Event|0|||
145587416|NCT01306162|525001758|FG002|Period 1|Adverse Event|0|||
145587417|NCT01306162|525001759|FG003|Period 1|Adverse Event|1|||
145587418|NCT01306162|525001756|FG000|Washout 1|Non-compliance to protocol|0|||
145587419|NCT01306162|525001757|FG001|Washout 1|Non-compliance to protocol|1|||
145587420|NCT01306162|525001758|FG002|Washout 1|Non-compliance to protocol|0|||
145587421|NCT01306162|525001759|FG003|Washout 1|Non-compliance to protocol|0|||
145587422|NCT02252211|525001766|FG000|Overall Study|Adverse Event|0|||
145587423|NCT02252211|525001767|FG001|Overall Study|Adverse Event|1|||
145587424|NCT02252211|525001768|FG002|Overall Study|Adverse Event|0|||
145587425|NCT02252211|525001766|FG000|Overall Study|Progressive disease|3|||
145587426|NCT02252211|525001767|FG001|Overall Study|Progressive disease|2|||
145587427|NCT02252211|525001768|FG002|Overall Study|Progressive disease|0|||
145587428|NCT02252211|525001766|FG000|Overall Study|Withdrawal by Subject|1|||
145587429|NCT02252211|525001767|FG001|Overall Study|Withdrawal by Subject|0|||
145587430|NCT02252211|525001768|FG002|Overall Study|Withdrawal by Subject|0|||
145587431|NCT02252211|525001766|FG000|Overall Study|Serious Adverse Event During Screening|1|||
145587432|NCT02252211|525001767|FG001|Overall Study|Serious Adverse Event During Screening|0|||
145587433|NCT02252211|525001768|FG002|Overall Study|Serious Adverse Event During Screening|1|||
145587434|NCT00759109|525001777|FG000|Overall Study|Adverse Event|17|||
145587435|NCT00759109|525001778|FG001|Overall Study|Adverse Event|12|||
145587436|NCT00759109|525001777|FG000|Overall Study|Inability to comply|1|||
145587437|NCT00759109|525001778|FG001|Overall Study|Inability to comply|1|||
145587438|NCT00759109|525001777|FG000|Overall Study|Withdrawal by Subject|9|||
145587439|NCT00759109|525001778|FG001|Overall Study|Withdrawal by Subject|5|||
145587440|NCT00759109|525001777|FG000|Overall Study|Death|4|||
145587441|NCT00759109|525001778|FG001|Overall Study|Death|3|||
145587442|NCT00759109|525001777|FG000|Overall Study|Lost to Follow-up|4|||
145587443|NCT00759109|525001778|FG001|Overall Study|Lost to Follow-up|6|||
145587444|NCT00759109|525001777|FG000|Overall Study|Started new therapy|2|||
145587445|NCT00759109|525001778|FG001|Overall Study|Started new therapy|6|||
145587446|NCT00759109|525001777|FG000|Overall Study|HCV RNA negative|1|||
145587447|NCT00759109|525001778|FG001|Overall Study|HCV RNA negative|0|||
145587448|NCT00759109|525001777|FG000|Overall Study|Participant moved to a different city|0|||
145587449|NCT00759109|525001778|FG001|Overall Study|Participant moved to a different city|1|||
145587450|NCT00759109|525001777|FG000|Overall Study|Participant had a liver transplant|0|||
145587451|NCT00759109|525001778|FG001|Overall Study|Participant had a liver transplant|1|||
145587452|NCT00759109|525001777|FG000|Overall Study|Lost during study|1|||
145587453|NCT00759109|525001778|FG001|Overall Study|Lost during study|0|||
145587454|NCT01660763|525001781|FG000|Overall Study|Lack of Efficacy|45|||
145587455|NCT01660763|525001782|FG001|Overall Study|Lack of Efficacy|50|||
145587456|NCT01660763|525001781|FG000|Overall Study|Adverse Event|22|||
145587457|NCT01660763|525001782|FG001|Overall Study|Adverse Event|7|||
145587458|NCT01660763|525001781|FG000|Overall Study|Protocol Violation|1|||
145587459|NCT01660763|525001782|FG001|Overall Study|Protocol Violation|0|||
145587460|NCT01660763|525001781|FG000|Overall Study|Withdrawal by Subject|4|||
145587461|NCT01660763|525001782|FG001|Overall Study|Withdrawal by Subject|0|||
145587462|NCT01660763|525001781|FG000|Overall Study|Patient ready for early discharge|28|||
145587463|NCT01660763|525001782|FG001|Overall Study|Patient ready for early discharge|4|||
145587464|NCT01910519|525001783|FG000|Overall Study|Withdrawal by Subject|2|||
145587465|NCT01910519|525001784|FG001|Overall Study|Withdrawal by Subject|0|||
145587466|NCT01910519|525001783|FG000|Overall Study|Adverse Event|2|||
145587467|NCT01910519|525001784|FG001|Overall Study|Adverse Event|0|||
145587468|NCT04266028|525001785|FG000|Overall Study|Adverse Event|0|||
145587469|NCT04266028|525001786|FG001|Overall Study|Adverse Event|0|||
145587470|NCT04266028|525001787|FG002|Overall Study|Adverse Event|1|||
145587471|NCT04266028|525001788|FG003|Overall Study|Adverse Event|0|||
145587472|NCT04266028|525001789|FG004|Overall Study|Adverse Event|1|||
145587473|NCT04266028|525001790|FG005|Overall Study|Adverse Event|0|||
145587474|NCT04266028|525001791|FG006|Overall Study|Adverse Event|2|||
145587475|NCT04266028|525001792|FG007|Overall Study|Adverse Event|0|||
145587476|NCT04266028|525001785|FG000|Overall Study|temporary halt of the study|0|||
145587477|NCT04266028|525001786|FG001|Overall Study|temporary halt of the study|0|||
145587478|NCT04266028|525001787|FG002|Overall Study|temporary halt of the study|0|||
145587479|NCT04266028|525001788|FG003|Overall Study|temporary halt of the study|0|||
145587480|NCT04266028|525001789|FG004|Overall Study|temporary halt of the study|0|||
145587481|NCT04266028|525001790|FG005|Overall Study|temporary halt of the study|0|||
145587482|NCT04266028|525001791|FG006|Overall Study|temporary halt of the study|2|||
145587483|NCT04266028|525001792|FG007|Overall Study|temporary halt of the study|1|||
145587484|NCT04266028|525001785|FG000|Overall Study|Onset of birch pollen season|0|||
145587485|NCT04266028|525001786|FG001|Overall Study|Onset of birch pollen season|0|||
145587486|NCT04266028|525001787|FG002|Overall Study|Onset of birch pollen season|0|||
145587487|NCT04266028|525001788|FG003|Overall Study|Onset of birch pollen season|0|||
145587488|NCT04266028|525001789|FG004|Overall Study|Onset of birch pollen season|1|||
145587489|NCT04266028|525001790|FG005|Overall Study|Onset of birch pollen season|0|||
145587490|NCT04266028|525001791|FG006|Overall Study|Onset of birch pollen season|0|||
145587491|NCT04266028|525001792|FG007|Overall Study|Onset of birch pollen season|0|||
145587492|NCT01458574|525001794|FG000|Overall Study|Adverse Event|5|||
145587493|NCT01458574|525001795|FG001|Overall Study|Adverse Event|9|||
145587494|NCT01458574|525001796|FG002|Overall Study|Adverse Event|7|||
145587495|NCT01458574|525001794|FG000|Overall Study|Lack of Efficacy|70|||
145587496|NCT01458574|525001795|FG001|Overall Study|Lack of Efficacy|53|||
145587497|NCT01458574|525001796|FG002|Overall Study|Lack of Efficacy|132|||
145587498|NCT01458574|525001794|FG000|Overall Study|Lost to Follow-up|3|||
145587499|NCT01458574|525001795|FG001|Overall Study|Lost to Follow-up|2|||
145587500|NCT01458574|525001796|FG002|Overall Study|Lost to Follow-up|1|||
145587501|NCT01458574|525001794|FG000|Overall Study|Pregnancy|1|||
145587502|NCT01458574|525001795|FG001|Overall Study|Pregnancy|1|||
145587503|NCT01458574|525001796|FG002|Overall Study|Pregnancy|0|||
145587504|NCT01458574|525001794|FG000|Overall Study|Protocol Violation|0|||
145587505|NCT01458574|525001795|FG001|Overall Study|Protocol Violation|1|||
145587506|NCT01458574|525001796|FG002|Overall Study|Protocol Violation|0|||
145587507|NCT01458574|525001794|FG000|Overall Study|Withdrawal by Subject|6|||
145587508|NCT01458574|525001795|FG001|Overall Study|Withdrawal by Subject|3|||
145587509|NCT01458574|525001796|FG002|Overall Study|Withdrawal by Subject|5|||
145587510|NCT01458574|525001794|FG000|Overall Study|Other|2|||
145587511|NCT01458574|525001795|FG001|Overall Study|Other|1|||
145587512|NCT01458574|525001796|FG002|Overall Study|Other|0|||
145587513|NCT01458574|525001794|FG000|Overall Study|Randomized but not treated|0|||
145587514|NCT01458574|525001795|FG001|Overall Study|Randomized but not treated|1|||
145587515|NCT01458574|525001796|FG002|Overall Study|Randomized but not treated|0|||
145587516|NCT02125786|525001797|FG000|Overall Study|Still in Follow-up|3|||
145587517|NCT02125786|525001797|FG000|Overall Study|Screen Failure|2|||
145587518|NCT02125786|525001797|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
145587519|NCT02125786|525001797|FG000|Overall Study|Progressive Disease|44|||
145587520|NCT02125786|525001797|FG000|Overall Study|Death|8|||
145587521|NCT04964089|525001800|FG000|Overall Study|Adverse Event|8|||
145587522|NCT04964089|525001801|FG001|Overall Study|Adverse Event|6|||
145587523|NCT04964089|525001800|FG000|Overall Study|Non-compliance with study schedule|1|||
145587524|NCT04964089|525001801|FG001|Overall Study|Non-compliance with study schedule|0|||
145587525|NCT04964089|525001800|FG000|Overall Study|Withdrawal by Subject|6|||
145587526|NCT04964089|525001801|FG001|Overall Study|Withdrawal by Subject|5|||
145587527|NCT04964089|525001800|FG000|Overall Study|Lost to Follow-up|1|||
145587528|NCT04964089|525001801|FG001|Overall Study|Lost to Follow-up|1|||
145587529|NCT04964089|525001800|FG000|Overall Study|Progressive disease|4|||
145587530|NCT04964089|525001801|FG001|Overall Study|Progressive disease|0|||
145587531|NCT04964089|525001800|FG000|Overall Study|Physician Decision|1|||
145587532|NCT04964089|525001801|FG001|Overall Study|Physician Decision|0|||
145587533|NCT04964089|525001800|FG000|Overall Study|Participant did not want to continue study treatment|1|||
145587534|NCT04964089|525001801|FG001|Overall Study|Participant did not want to continue study treatment|0|||
145587535|NCT04964089|525001800|FG000|Overall Study|Participant moved to different state|1|||
145587536|NCT04964089|525001801|FG001|Overall Study|Participant moved to different state|0|||
145587537|NCT04964089|525001800|FG000|Overall Study|Participant decided to discontinue|0|||
145587538|NCT04964089|525001801|FG001|Overall Study|Participant decided to discontinue|1|||
145587539|NCT01682837|525001802|FG000|Baseline|Withdrawal by Subject|5|||
145452208|NCT02557100|524506228|FG002|Single Blind Treatment Period|Adverse Event|0|||
145452209|NCT02557100|524506226|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
145452210|NCT02557100|524506227|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
145452211|NCT02557100|524506228|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
145452212|NCT02557100|524506226|FG000|Cumulative Abatacept Period|Other Reasons|0|||
145452213|NCT02557100|524506227|FG001|Cumulative Abatacept Period|Other Reasons|0|||
145452214|NCT02557100|524506228|FG002|Cumulative Abatacept Period|Other Reasons|1|||
145452215|NCT02557100|524506226|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
145452216|NCT02557100|524506227|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
145452217|NCT02557100|524506228|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
145452218|NCT02557100|524506226|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
145452219|NCT02557100|524506227|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
145452220|NCT02557100|524506228|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
145452221|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
145452222|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
145452223|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
145452224|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
145452225|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
145452226|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
145452227|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
145452228|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
145452229|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
145452230|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
145452231|NCT00510718|524506229|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
145452232|NCT00510718|524506230|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
145452233|NCT00394251|524506238|FG000|Overall Study|Adverse Event|7|||
145452234|NCT00394251|524506239|FG001|Overall Study|Adverse Event|5|||
145587540|NCT01664078|525001805|FG000|Overall Study|Death|9|||
145452235|NCT00394251|524506238|FG000|Overall Study|Unacceptable Toxicity|20|||
145452236|NCT00394251|524506239|FG001|Overall Study|Unacceptable Toxicity|18|||
145452237|NCT00394251|524506238|FG000|Overall Study|Physician Decision|1|||
145452238|NCT00394251|524506239|FG001|Overall Study|Physician Decision|1|||
145452239|NCT00394251|524506238|FG000|Overall Study|Protocol Violation|0|||
145452240|NCT00394251|524506239|FG001|Overall Study|Protocol Violation|1|||
145452241|NCT00394251|524506238|FG000|Overall Study|Withdrawal by Subject|7|||
145452242|NCT00394251|524506239|FG001|Overall Study|Withdrawal by Subject|11|||
145452243|NCT00394251|524506238|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
145452244|NCT00394251|524506239|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
145452245|NCT05791565|524506240|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
145452246|NCT05791565|524506241|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
145452247|NCT02388165|524506242|FG000|Overall Study|Study terminated by sponsor|5|||
145452248|NCT02388165|524506243|FG001|Overall Study|Study terminated by sponsor|5|||
145452249|NCT02388165|524506242|FG000|Overall Study|Other|11|||
145452250|NCT02388165|524506243|FG001|Overall Study|Other|13|||
145452251|NCT02388165|524506242|FG000|Overall Study|No longer meet eligibility criteria|40|||
145452252|NCT02388165|524506243|FG001|Overall Study|No longer meet eligibility criteria|43|||
145452253|NCT02388165|524506242|FG000|Overall Study|Withdrawal of consent|31|||
145452254|NCT02388165|524506243|FG001|Overall Study|Withdrawal of consent|32|||
145452255|NCT02388165|524506242|FG000|Overall Study|Lost to Follow-up|19|||
145452256|NCT02388165|524506243|FG001|Overall Study|Lost to Follow-up|20|||
145452257|NCT02388165|524506242|FG000|Overall Study|Death|13|||
145452258|NCT02388165|524506243|FG001|Overall Study|Death|10|||
145452259|NCT02388165|524506242|FG000|Overall Study|Adverse Event|3|||
145452260|NCT02388165|524506243|FG001|Overall Study|Adverse Event|5|||
145452261|NCT02388165|524506242|FG000|Overall Study|Did not meet entrance criteria|5|||
145452262|NCT02388165|524506243|FG001|Overall Study|Did not meet entrance criteria|2|||
145452263|NCT00705250|524506244|FG000|Overall Study|Withdrawal by Subject|1|||
145452264|NCT00705250|524506244|FG000|Overall Study|Patient died in car accident|1|||
145452265|NCT01406938|524506245|FG000|Induction Period|Subject/guardian decision|6|||
145452266|NCT01406938|524506246|FG001|Induction Period|Subject/guardian decision|8|||
145452267|NCT01406938|524506247|FG002|Induction Period|Subject/guardian decision|0|||
145587541|NCT01664078|525001805|FG000|Overall Study|Withdrawal by Subject|4|||
145587542|NCT01664078|525001805|FG000|Overall Study|Lost to Follow-up|2|||
145452268|NCT01406938|524506248|FG003|Induction Period|Subject/guardian decision|0|||
145452269|NCT01406938|524506249|FG004|Induction Period|Subject/guardian decision|0|||
145452270|NCT01406938|524506250|FG005|Induction Period|Subject/guardian decision|0|||
145452271|NCT01406938|524506245|FG000|Induction Period|Protocol deviation|1|||
145452272|NCT01406938|524506246|FG001|Induction Period|Protocol deviation|0|||
145452273|NCT01406938|524506247|FG002|Induction Period|Protocol deviation|0|||
145452274|NCT01406938|524506248|FG003|Induction Period|Protocol deviation|0|||
145452275|NCT01406938|524506249|FG004|Induction Period|Protocol deviation|0|||
145452276|NCT01406938|524506250|FG005|Induction Period|Protocol deviation|0|||
145452277|NCT01406938|524506245|FG000|Induction Period|Adverse Event|8|||
145452278|NCT01406938|524506246|FG001|Induction Period|Adverse Event|9|||
145452279|NCT01406938|524506247|FG002|Induction Period|Adverse Event|0|||
145452280|NCT01406938|524506248|FG003|Induction Period|Adverse Event|0|||
145452281|NCT01406938|524506249|FG004|Induction Period|Adverse Event|0|||
145452282|NCT01406938|524506250|FG005|Induction Period|Adverse Event|0|||
145452283|NCT01406938|524506245|FG000|Induction Period|Lack of Efficacy|1|||
145452284|NCT01406938|524506246|FG001|Induction Period|Lack of Efficacy|0|||
145452285|NCT01406938|524506247|FG002|Induction Period|Lack of Efficacy|0|||
145452286|NCT01406938|524506248|FG003|Induction Period|Lack of Efficacy|0|||
145452287|NCT01406938|524506249|FG004|Induction Period|Lack of Efficacy|0|||
145452288|NCT01406938|524506250|FG005|Induction Period|Lack of Efficacy|0|||
145452289|NCT01406938|524506245|FG000|Induction Period|Lost to Follow-up|2|||
145452290|NCT01406938|524506246|FG001|Induction Period|Lost to Follow-up|3|||
145452291|NCT01406938|524506247|FG002|Induction Period|Lost to Follow-up|0|||
145452292|NCT01406938|524506248|FG003|Induction Period|Lost to Follow-up|0|||
145452293|NCT01406938|524506249|FG004|Induction Period|Lost to Follow-up|0|||
145452294|NCT01406938|524506250|FG005|Induction Period|Lost to Follow-up|0|||
145452295|NCT01406938|524506245|FG000|Maintenance Period|Adverse Event|0|||
145452296|NCT01406938|524506246|FG001|Maintenance Period|Adverse Event|0|||
145452297|NCT01406938|524506247|FG002|Maintenance Period|Adverse Event|2|||
145452298|NCT01406938|524506248|FG003|Maintenance Period|Adverse Event|8|||
145452299|NCT01406938|524506249|FG004|Maintenance Period|Adverse Event|4|||
145452300|NCT01406938|524506250|FG005|Maintenance Period|Adverse Event|2|||
145452301|NCT01406938|524506245|FG000|Maintenance Period|Death|0|||
145452302|NCT01406938|524506246|FG001|Maintenance Period|Death|0|||
145452303|NCT01406938|524506247|FG002|Maintenance Period|Death|0|||
145452304|NCT01406938|524506248|FG003|Maintenance Period|Death|0|||
145452305|NCT01406938|524506249|FG004|Maintenance Period|Death|1|||
145452306|NCT01406938|524506250|FG005|Maintenance Period|Death|0|||
145452307|NCT01406938|524506245|FG000|Maintenance Period|Subject/guardian decision|0|||
145452308|NCT01406938|524506246|FG001|Maintenance Period|Subject/guardian decision|0|||
145452309|NCT01406938|524506247|FG002|Maintenance Period|Subject/guardian decision|11|||
145452310|NCT01406938|524506248|FG003|Maintenance Period|Subject/guardian decision|7|||
145452311|NCT01406938|524506249|FG004|Maintenance Period|Subject/guardian decision|10|||
145452312|NCT01406938|524506250|FG005|Maintenance Period|Subject/guardian decision|7|||
145452313|NCT01406938|524506245|FG000|Maintenance Period|Protocol Violation|0|||
145452314|NCT01406938|524506246|FG001|Maintenance Period|Protocol Violation|0|||
145452315|NCT01406938|524506247|FG002|Maintenance Period|Protocol Violation|2|||
145452316|NCT01406938|524506248|FG003|Maintenance Period|Protocol Violation|2|||
145452317|NCT01406938|524506249|FG004|Maintenance Period|Protocol Violation|2|||
145452318|NCT01406938|524506250|FG005|Maintenance Period|Protocol Violation|2|||
145452319|NCT01406938|524506245|FG000|Maintenance Period|Pregnancy|0|||
145452320|NCT01406938|524506246|FG001|Maintenance Period|Pregnancy|0|||
145452321|NCT01406938|524506247|FG002|Maintenance Period|Pregnancy|0|||
145452322|NCT01406938|524506248|FG003|Maintenance Period|Pregnancy|0|||
145452323|NCT01406938|524506249|FG004|Maintenance Period|Pregnancy|1|||
145452324|NCT01406938|524506250|FG005|Maintenance Period|Pregnancy|0|||
145452325|NCT01406938|524506245|FG000|Maintenance Period|Lost to Follow-up|0|||
145452326|NCT01406938|524506246|FG001|Maintenance Period|Lost to Follow-up|0|||
145452327|NCT01406938|524506247|FG002|Maintenance Period|Lost to Follow-up|0|||
145452328|NCT01406938|524506248|FG003|Maintenance Period|Lost to Follow-up|0|||
145452329|NCT01406938|524506249|FG004|Maintenance Period|Lost to Follow-up|4|||
145452330|NCT01406938|524506250|FG005|Maintenance Period|Lost to Follow-up|0|||
145452331|NCT01406938|524506245|FG000|Maintenance Period|Lack of Efficacy|0|||
145452332|NCT01406938|524506246|FG001|Maintenance Period|Lack of Efficacy|0|||
145452333|NCT01406938|524506247|FG002|Maintenance Period|Lack of Efficacy|2|||
145452334|NCT01406938|524506248|FG003|Maintenance Period|Lack of Efficacy|1|||
145452335|NCT01406938|524506249|FG004|Maintenance Period|Lack of Efficacy|3|||
145452336|NCT01406938|524506250|FG005|Maintenance Period|Lack of Efficacy|5|||
145452337|NCT01406938|524506245|FG000|Follow up|Lack of Efficacy|3|||
145452338|NCT01406938|524506246|FG001|Follow up|Lack of Efficacy|2|||
145452339|NCT01406938|524506247|FG002|Follow up|Lack of Efficacy|1|||
145452340|NCT01406938|524506248|FG003|Follow up|Lack of Efficacy|0|||
145452341|NCT01406938|524506249|FG004|Follow up|Lack of Efficacy|0|||
145452342|NCT01406938|524506250|FG005|Follow up|Lack of Efficacy|0|||
145452343|NCT01406938|524506245|FG000|Follow up|Patient/guardian decision|4|||
145452344|NCT01406938|524506246|FG001|Follow up|Patient/guardian decision|2|||
145452345|NCT01406938|524506247|FG002|Follow up|Patient/guardian decision|4|||
145452346|NCT01406938|524506248|FG003|Follow up|Patient/guardian decision|2|||
145452347|NCT01406938|524506249|FG004|Follow up|Patient/guardian decision|4|||
145452348|NCT01406938|524506250|FG005|Follow up|Patient/guardian decision|1|||
145452349|NCT01406938|524506245|FG000|Follow up|Protocol Violation|0|||
145452350|NCT01406938|524506246|FG001|Follow up|Protocol Violation|0|||
145452351|NCT01406938|524506247|FG002|Follow up|Protocol Violation|1|||
145452352|NCT01406938|524506248|FG003|Follow up|Protocol Violation|0|||
145452353|NCT01406938|524506249|FG004|Follow up|Protocol Violation|0|||
145452354|NCT01406938|524506250|FG005|Follow up|Protocol Violation|0|||
145587543|NCT01664078|525001805|FG000|Overall Study|missed 5 year visit|1|||
145587544|NCT01664078|525001805|FG000|Overall Study|Other|53|||
145587545|NCT01617629|525001811|FG000|Overall Study|Death|2|||
145587546|NCT01617629|525001811|FG000|Overall Study|Investigator's Clinical Judgement|1|||
145587547|NCT01617629|525001811|FG000|Overall Study|Reason Not Specified|1|||
145587548|NCT01617629|525001811|FG000|Overall Study|Participant Withdrew Consent|2|||
145587549|NCT03832946|525001812|FG000|Overall Study|Adverse Event|3|||
145587550|NCT03832946|525001813|FG001|Overall Study|Adverse Event|1|||
145587551|NCT03832946|525001812|FG000|Overall Study|Lost to Follow-up|1|||
145587552|NCT03832946|525001813|FG001|Overall Study|Lost to Follow-up|0|||
145587553|NCT03832946|525001812|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
145587554|NCT03832946|525001813|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
145587555|NCT03832946|525001812|FG000|Overall Study|Lack of Efficacy|1|||
145587556|NCT03832946|525001813|FG001|Overall Study|Lack of Efficacy|0|||
145587557|NCT03832946|525001812|FG000|Overall Study|Withdrawal by Subject|12|||
145587558|NCT03832946|525001813|FG001|Overall Study|Withdrawal by Subject|9|||
145587559|NCT02715765|525001814|FG000|Overall Study|Study Termination|3|||
145587560|NCT02715765|525001815|FG001|Overall Study|Study Termination|0|||
145587561|NCT02715765|525001816|FG002|Overall Study|Study Termination|0|||
145587562|NCT02120924|525001817|FG000|Overall Study|Lack of Efficacy|1|||
145587563|NCT02120924|525001818|FG001|Overall Study|Lack of Efficacy|2|||
145587564|NCT02120924|525001819|FG002|Overall Study|Lack of Efficacy|3|||
145587565|NCT02120924|525001817|FG000|Overall Study|Adverse Event|0|||
145587566|NCT02120924|525001818|FG001|Overall Study|Adverse Event|1|||
145587567|NCT02120924|525001819|FG002|Overall Study|Adverse Event|3|||
145587568|NCT02120924|525001817|FG000|Overall Study|Withdrawal by Subject|16|||
145587569|NCT02120924|525001818|FG001|Overall Study|Withdrawal by Subject|20|||
145587570|NCT02120924|525001819|FG002|Overall Study|Withdrawal by Subject|8|||
145587571|NCT02120924|525001817|FG000|Overall Study|Lost to Follow-up|14|||
145587572|NCT02120924|525001818|FG001|Overall Study|Lost to Follow-up|14|||
145587573|NCT02120924|525001819|FG002|Overall Study|Lost to Follow-up|11|||
145587574|NCT02120924|525001817|FG000|Overall Study|Pregnancy|2|||
145587575|NCT02120924|525001818|FG001|Overall Study|Pregnancy|0|||
145587576|NCT02120924|525001819|FG002|Overall Study|Pregnancy|0|||
145587577|NCT02120924|525001817|FG000|Overall Study|Protocol Violation|3|||
145587578|NCT02120924|525001818|FG001|Overall Study|Protocol Violation|7|||
145587579|NCT02120924|525001819|FG002|Overall Study|Protocol Violation|2|||
145587580|NCT02120924|525001817|FG000|Overall Study|Physician Decision|0|||
145587581|NCT02120924|525001818|FG001|Overall Study|Physician Decision|1|||
145587582|NCT02120924|525001819|FG002|Overall Study|Physician Decision|1|||
145587583|NCT02120924|525001817|FG000|Overall Study|Death|1|||
145587584|NCT02120924|525001818|FG001|Overall Study|Death|0|||
145587585|NCT02120924|525001819|FG002|Overall Study|Death|0|||
145587586|NCT02120924|525001817|FG000|Overall Study|Compliance with IP|5|||
145587587|NCT02120924|525001818|FG001|Overall Study|Compliance with IP|1|||
145587588|NCT02120924|525001819|FG002|Overall Study|Compliance with IP|1|||
145587589|NCT03588572|525001826|FG000|Visitation 1|Lack of Efficacy|1|||
145587590|NCT03588572|525001827|FG001|Visitation 1|Lack of Efficacy|1|||
145587591|NCT03588572|525001826|FG000|Visitation 2|Lost to Follow-up|1|||
145587592|NCT03588572|525001827|FG001|Visitation 2|Lost to Follow-up|1|||
145587593|NCT03588572|525001826|FG000|Visitation 2|Lack of Efficacy|0|||
145587594|NCT03588572|525001827|FG001|Visitation 2|Lack of Efficacy|1|||
145587595|NCT03588572|525001826|FG000|Visitation 2|Withdrawal by Subject|1|||
145587596|NCT03588572|525001827|FG001|Visitation 2|Withdrawal by Subject|0|||
145587597|NCT03588572|525001826|FG000|Visitation 3|Lost to Follow-up|1|||
145587598|NCT03588572|525001827|FG001|Visitation 3|Lost to Follow-up|1|||
145587599|NCT03588572|525001826|FG000|Visitation 3|Physician Decision|1|||
145587600|NCT03588572|525001827|FG001|Visitation 3|Physician Decision|1|||
145587601|NCT03588572|525001826|FG000|Visitation 3|Withdrawal by Subject|1|||
145452355|NCT01406938|524506245|FG000|Follow up|Physician Decision|0|||
145587602|NCT03588572|525001827|FG001|Visitation 3|Withdrawal by Subject|0|||
145587603|NCT02663817|525001828|FG000|Overall Study|Screen failure|2|||
145587604|NCT01308580|525001830|FG000|Overall Study|Lost to Follow-up|12|||
145587605|NCT01308580|525001831|FG001|Overall Study|Lost to Follow-up|7|||
145587606|NCT01261611|525004263|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
145587607|NCT01261611|525004264|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
145587608|NCT01261611|525004265|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
145587609|NCT01261611|525004263|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
145587610|NCT01261611|525004264|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
145587611|NCT01261611|525004265|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
145587612|NCT01261611|525004263|FG000|Treatment Cycle 1|Adverse Event|0|||
145587613|NCT01261611|525004264|FG001|Treatment Cycle 1|Adverse Event|1|||
145587614|NCT01261611|525004265|FG002|Treatment Cycle 1|Adverse Event|0|||
145587615|NCT01261611|525004263|FG000|Treatment Cycle 1|Protocol Violation|0|||
145587616|NCT01261611|525004264|FG001|Treatment Cycle 1|Protocol Violation|0|||
145626258|NCT00062868|525144244|FG004|Dose Level 1|Lost to Follow-up|0|||
145587617|NCT01261611|525004265|FG002|Treatment Cycle 1|Protocol Violation|2|||
145626259|NCT00062868|525144245|FG005|Dose Level 1|Lost to Follow-up|0|||
145587618|NCT01261611|525004263|FG000|Treatment Cycle 2|Completed study|4|||
145452356|NCT01406938|524506246|FG001|Follow up|Physician Decision|0|||
145452357|NCT01406938|524506247|FG002|Follow up|Physician Decision|2|||
145452358|NCT01406938|524506248|FG003|Follow up|Physician Decision|0|||
145452359|NCT01406938|524506249|FG004|Follow up|Physician Decision|3|||
145452360|NCT01406938|524506250|FG005|Follow up|Physician Decision|1|||
145452361|NCT01406938|524506245|FG000|Follow up|Lost to Follow-up|1|||
145452362|NCT01406938|524506246|FG001|Follow up|Lost to Follow-up|1|||
145452363|NCT01406938|524506247|FG002|Follow up|Lost to Follow-up|0|||
145452364|NCT01406938|524506248|FG003|Follow up|Lost to Follow-up|1|||
145452365|NCT01406938|524506249|FG004|Follow up|Lost to Follow-up|2|||
145452366|NCT01406938|524506250|FG005|Follow up|Lost to Follow-up|1|||
145452367|NCT01576146|524506255|FG000|Extension Period 1|Adverse Event|2|||
145452368|NCT01576146|524506255|FG000|Extension Period 1|Death|2|||
145452369|NCT01576146|524506255|FG000|Extension Period 1|Physician Decision|2|||
145452370|NCT01576146|524506255|FG000|Extension Period 1|Withdrawal by Subject|1|||
145452371|NCT01576146|524506255|FG000|Extension Period 1|Lost to Follow-up|1|||
145452372|NCT01576146|524506255|FG000|Extension Period 1|Parathyroidectomy|1|||
145452373|NCT01576146|524506255|FG000|Extension Period 1|Renal Transplant|1|||
145452374|NCT01576146|524506255|FG000|Extension Period 2|Sponsor Decision|13|||
145452375|NCT01576146|524506255|FG000|Extension Period 2|Death|1|||
145452376|NCT01576146|524506255|FG000|Extension Period 2|Adverse Event|1|||
145452377|NCT01576146|524506255|FG000|Extension Period 2|Renal Transplant|1|||
145452378|NCT01576146|524506255|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
145452379|NCT01667224|524506258|FG000|Overall Study|Withdrawal by Subject|3|||
145452380|NCT01667224|524506259|FG001|Overall Study|Withdrawal by Subject|1|||
145452381|NCT01667224|524506258|FG000|Overall Study|Protocol Violation|1|||
145452382|NCT01667224|524506259|FG001|Overall Study|Protocol Violation|1|||
145452383|NCT00316225|524506262|FG000|Overall Study|Adverse Event|2|||
145452384|NCT00316225|524506262|FG000|Overall Study|Physician Decision|3|||
145452385|NCT00316225|524506262|FG000|Overall Study|Progressive Disease|15|||
145452386|NCT00316225|524506262|FG000|Overall Study|Withdrawal by Subject|3|||
145452387|NCT00316225|524506262|FG000|Overall Study|Death|2|||
145452388|NCT01811485|524506263|FG000|Overall Study|Adverse Event|1|||
145452389|NCT01811485|524506264|FG001|Overall Study|Adverse Event|3|||
145452390|NCT01811485|524506265|FG002|Overall Study|Adverse Event|2|||
145452391|NCT01811485|524506263|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145452392|NCT01811485|524506264|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145452393|NCT01811485|524506265|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
145452394|NCT01811485|524506263|FG000|Overall Study|Administrative problems|1|||
145452395|NCT01811485|524506264|FG001|Overall Study|Administrative problems|0|||
145452396|NCT01811485|524506265|FG002|Overall Study|Administrative problems|0|||
145452397|NCT01811485|524506263|FG000|Overall Study|Protocol Deviation|0|||
145452398|NCT01811485|524506264|FG001|Overall Study|Protocol Deviation|1|||
145452399|NCT01811485|524506265|FG002|Overall Study|Protocol Deviation|0|||
145452400|NCT01545934|524506266|FG000|Overall Study|Withdrawal by Subject|4|||
145452401|NCT01545934|524506267|FG001|Overall Study|Withdrawal by Subject|3|||
145452402|NCT01545934|524506266|FG000|Overall Study|Lost to Follow-up|1|||
145452403|NCT01545934|524506267|FG001|Overall Study|Lost to Follow-up|0|||
145452404|NCT03299881|524506268|FG000|Overall Study|Study Termination|17|||
145452405|NCT03299881|524506269|FG001|Overall Study|Study Termination|13|||
145452406|NCT01474772|524506270|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
145452407|NCT01474772|524506271|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
145452408|NCT01474772|524506270|FG000|Period 1|AE not Related to Study Drug|1|||
145452409|NCT01474772|524506271|FG001|Period 1|AE not Related to Study Drug|0|||
145626260|NCT00062868|525144246|FG006|Dose Level 1|Lost to Follow-up|0|||
145626261|NCT00062868|525144247|FG007|Dose Level 1|Lost to Follow-up|0|||
145452410|NCT01474772|524506270|FG000|Period 1|Withdrawal by Subject|3|||
145452411|NCT01474772|524506271|FG001|Period 1|Withdrawal by Subject|1|||
145452412|NCT01474772|524506270|FG000|Period 1|Lost to Follow-up|1|||
145452413|NCT01474772|524506271|FG001|Period 1|Lost to Follow-up|0|||
145452414|NCT01474772|524506270|FG000|Period 1|Reason not Specified|1|||
145452415|NCT01474772|524506271|FG001|Period 1|Reason not Specified|1|||
145452416|NCT01474772|524506270|FG000|Washout|AE not Related to Study Drug|2|||
145452417|NCT01474772|524506271|FG001|Washout|AE not Related to Study Drug|0|||
145452418|NCT01474772|524506270|FG000|Washout|Withdrawal by Subject|1|||
145452419|NCT01474772|524506271|FG001|Washout|Withdrawal by Subject|0|||
145452420|NCT01474772|524506270|FG000|Washout|Lost to Follow-up|0|||
145452421|NCT01474772|524506271|FG001|Washout|Lost to Follow-up|1|||
145452422|NCT01474772|524506270|FG000|Washout|Reason not Specified|0|||
145452423|NCT01474772|524506271|FG001|Washout|Reason not Specified|1|||
145452424|NCT01474772|524506270|FG000|Period 2|Death|0|||
145452425|NCT01474772|524506271|FG001|Period 2|Death|1|||
145452426|NCT01474772|524506270|FG000|Period 2|AE Related to Study Drug|0|||
145452427|NCT01474772|524506271|FG001|Period 2|AE Related to Study Drug|1|||
145452428|NCT01474772|524506270|FG000|Period 2|AE not Related to Study Drug|4|||
145452429|NCT01474772|524506271|FG001|Period 2|AE not Related to Study Drug|1|||
145452430|NCT01474772|524506270|FG000|Period 2|Lack of Efficacy|1|||
145452431|NCT01474772|524506271|FG001|Period 2|Lack of Efficacy|0|||
145626262|NCT00062868|525144248|FG008|Dose Level 1|Lost to Follow-up|0|||
145587619|NCT01261611|525004264|FG001|Treatment Cycle 2|Completed study|0|||
145587620|NCT01261611|525004265|FG002|Treatment Cycle 2|Completed study|0|||
145587621|NCT01261611|525004263|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
145587622|NCT01261611|525004264|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
145587623|NCT01261611|525004265|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
145587624|NCT01261611|525004263|FG000|Treatment Cycle 2|Adverse Event|1|||
145587625|NCT01261611|525004264|FG001|Treatment Cycle 2|Adverse Event|0|||
145587626|NCT01261611|525004265|FG002|Treatment Cycle 2|Adverse Event|0|||
145587627|NCT01261611|525004263|FG000|Treatment Cycle 2|Protocol Violation|2|||
145587628|NCT01261611|525004264|FG001|Treatment Cycle 2|Protocol Violation|0|||
145587629|NCT01261611|525004265|FG002|Treatment Cycle 2|Protocol Violation|0|||
145587630|NCT01261611|525004263|FG000|Treatment Cycle 2|Not otherwise specified|2|||
145587631|NCT01261611|525004264|FG001|Treatment Cycle 2|Not otherwise specified|0|||
145587632|NCT01261611|525004265|FG002|Treatment Cycle 2|Not otherwise specified|0|||
145587633|NCT01261611|525004263|FG000|Treatment Cycle 3|Completed study|24|||
145587634|NCT01261611|525004264|FG001|Treatment Cycle 3|Completed study|0|||
145587635|NCT01261611|525004265|FG002|Treatment Cycle 3|Completed study|0|||
145587636|NCT01261611|525004263|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
145587637|NCT01261611|525004264|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
145587638|NCT01261611|525004265|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
145587639|NCT01261611|525004263|FG000|Treatment Cycle 3|Adverse Event|1|||
145587640|NCT01261611|525004264|FG001|Treatment Cycle 3|Adverse Event|0|||
145587641|NCT01261611|525004265|FG002|Treatment Cycle 3|Adverse Event|0|||
145587642|NCT01261611|525004263|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
145587643|NCT01261611|525004264|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
145587644|NCT01261611|525004265|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
145587645|NCT01261611|525004263|FG000|Treatment Cycle 4|Completed study|87|||
145587646|NCT01261611|525004264|FG001|Treatment Cycle 4|Completed study|0|||
145587647|NCT01261611|525004265|FG002|Treatment Cycle 4|Completed study|0|||
145587648|NCT01261611|525004263|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
145587649|NCT01261611|525004264|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
145587650|NCT01261611|525004265|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
145587651|NCT01261611|525004263|FG000|Treatment Cycle 4|Adverse Event|1|||
145587652|NCT01261611|525004264|FG001|Treatment Cycle 4|Adverse Event|0|||
145587653|NCT01261611|525004265|FG002|Treatment Cycle 4|Adverse Event|0|||
145587654|NCT01261611|525004263|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
145587655|NCT01261611|525004264|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
145587656|NCT01261611|525004265|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
145587657|NCT01261611|525004263|FG000|Treatment Cycle 4|Not otherwise specified|3|||
145587658|NCT01261611|525004264|FG001|Treatment Cycle 4|Not otherwise specified|0|||
145587659|NCT01261611|525004265|FG002|Treatment Cycle 4|Not otherwise specified|0|||
145587660|NCT01261611|525004263|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
145587661|NCT01261611|525004264|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
145587662|NCT01261611|525004265|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
145587663|NCT01261611|525004263|FG000|Treatment Cycle 5|Adverse Event|1|||
145587664|NCT01261611|525004264|FG001|Treatment Cycle 5|Adverse Event|0|||
145587665|NCT01261611|525004265|FG002|Treatment Cycle 5|Adverse Event|0|||
145587666|NCT01261611|525004263|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
145587667|NCT01261611|525004264|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
145587668|NCT01261611|525004265|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
145587669|NCT03822533|525004268|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
145587670|NCT03822533|525004269|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
145587671|NCT03822533|525004268|FG000|3 Month Follow-up|Lost to Follow-up|2|||
145587672|NCT03822533|525004269|FG001|3 Month Follow-up|Lost to Follow-up|2|||
145587673|NCT03822533|525004268|FG000|6 Month Follow-up|Lost to Follow-up|3|||
145587674|NCT03822533|525004269|FG001|6 Month Follow-up|Lost to Follow-up|0|||
145587675|NCT03822533|525004268|FG000|12 Month Follow-up|Lost to Follow-up|2|||
145587676|NCT03822533|525004269|FG001|12 Month Follow-up|Lost to Follow-up|3|||
145587677|NCT03822533|525004268|FG000|12 Month Follow-up|Pregnancy|0|||
145587678|NCT03822533|525004269|FG001|12 Month Follow-up|Pregnancy|1|||
145587679|NCT03822533|525004268|FG000|12 Month Follow-up|Surgery|2|||
145587680|NCT03822533|525004269|FG001|12 Month Follow-up|Surgery|0|||
145587681|NCT03822533|525004268|FG000|12 Month Follow-up|Wrong address|1|||
145587682|NCT03822533|525004269|FG001|12 Month Follow-up|Wrong address|0|||
145587683|NCT03822533|525004268|FG000|12 Month Follow-up|No symptoms|1|||
145587684|NCT03822533|525004269|FG001|12 Month Follow-up|No symptoms|0|||
145587685|NCT03822533|525004268|FG000|12 Month Follow-up|Changed primary care center|0|||
145587686|NCT03822533|525004269|FG001|12 Month Follow-up|Changed primary care center|1|||
145587687|NCT02489500|525004270|FG000|Overall Study|Death|1|||
145587688|NCT02489500|525004271|FG001|Overall Study|Death|1|||
145587689|NCT02863926|525004272|FG000|Overall Study|Physician Decision|1|||
145587690|NCT02863926|525004273|FG001|Overall Study|Physician Decision|0|||
145587691|NCT02863926|525004272|FG000|Overall Study|Lost to Follow-up|1|||
145587692|NCT02863926|525004273|FG001|Overall Study|Lost to Follow-up|1|||
145587693|NCT03434119|525004275|FG000|Overall Study|Randomized but not treated|1|||
145587694|NCT03434119|525004276|FG001|Overall Study|Randomized but not treated|0|||
145587695|NCT03434119|525004275|FG000|Overall Study|Adverse Event|1|||
145587696|NCT03434119|525004276|FG001|Overall Study|Adverse Event|0|||
145452432|NCT01474772|524506270|FG000|Period 2|Withdrawal by Subject|3|||
145452433|NCT01474772|524506271|FG001|Period 2|Withdrawal by Subject|4|||
145452434|NCT01474772|524506270|FG000|Period 2|Lost to Follow-up|1|||
145452435|NCT01474772|524506271|FG001|Period 2|Lost to Follow-up|1|||
145452436|NCT01474772|524506270|FG000|Period 2|Reason not Specified|0|||
145452437|NCT01474772|524506271|FG001|Period 2|Reason not Specified|2|||
145452438|NCT01474772|524506270|FG000|Follow-up|AE not Related to Study Drug|0|||
145452439|NCT01474772|524506271|FG001|Follow-up|AE not Related to Study Drug|1|||
145452440|NCT03195660|524506272|FG000|Overall Study|The study was terminated|2|||
145452441|NCT03367403|524506273|FG000|Overall Study|Adverse Event|20|||
145452442|NCT03367403|524506274|FG001|Overall Study|Adverse Event|6|||
145452443|NCT03367403|524506275|FG002|Overall Study|Adverse Event|2|||
145452444|NCT03367403|524506273|FG000|Overall Study|Withdrawal by Subject|12|||
145452445|NCT03367403|524506274|FG001|Overall Study|Withdrawal by Subject|13|||
145452446|NCT03367403|524506275|FG002|Overall Study|Withdrawal by Subject|1|||
145452447|NCT03367403|524506273|FG000|Overall Study|Death|1|||
145452448|NCT03367403|524506274|FG001|Overall Study|Death|2|||
145452449|NCT03367403|524506275|FG002|Overall Study|Death|0|||
145452450|NCT03367403|524506273|FG000|Overall Study|Physician Decision|0|||
145452451|NCT03367403|524506274|FG001|Overall Study|Physician Decision|1|||
145452452|NCT03367403|524506275|FG002|Overall Study|Physician Decision|0|||
145452453|NCT03367403|524506273|FG000|Overall Study|Protocol Violation|1|||
145452454|NCT03367403|524506274|FG001|Overall Study|Protocol Violation|1|||
145452455|NCT03367403|524506275|FG002|Overall Study|Protocol Violation|0|||
145452456|NCT03367403|524506273|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
145452457|NCT03367403|524506274|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
145452458|NCT03367403|524506275|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
145452459|NCT03367403|524506273|FG000|Overall Study|COVID-19|3|||
145452460|NCT03367403|524506274|FG001|Overall Study|COVID-19|6|||
145452461|NCT03367403|524506275|FG002|Overall Study|COVID-19|0|||
145452462|NCT03367403|524506273|FG000|Overall Study|Abuse of Alcohol Intake|0|||
145452463|NCT03367403|524506274|FG001|Overall Study|Abuse of Alcohol Intake|1|||
145452464|NCT03367403|524506275|FG002|Overall Study|Abuse of Alcohol Intake|0|||
145452465|NCT03367403|524506273|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
145452466|NCT03367403|524506274|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
145452467|NCT03367403|524506275|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
145452468|NCT00759876|524506276|FG000|Overall Study|Sponsor terminated study early|36|||
145452469|NCT00853242|524506278|FG000|Overall Study|Adverse Event|0|||
145452470|NCT00853242|524506279|FG001|Overall Study|Adverse Event|1|||
145452471|NCT00853242|524506280|FG002|Overall Study|Adverse Event|1|||
145452472|NCT00853242|524506281|FG003|Overall Study|Adverse Event|0|||
145452473|NCT00853242|524506282|FG004|Overall Study|Adverse Event|3|||
145452474|NCT00853242|524506283|FG005|Overall Study|Adverse Event|1|||
145452475|NCT00853242|524506284|FG006|Overall Study|Adverse Event|1|||
145452476|NCT00853242|524506278|FG000|Overall Study|Noncompliant|0|||
145452477|NCT00853242|524506279|FG001|Overall Study|Noncompliant|0|||
145452478|NCT00853242|524506280|FG002|Overall Study|Noncompliant|0|||
145452479|NCT00853242|524506281|FG003|Overall Study|Noncompliant|0|||
145452480|NCT00853242|524506282|FG004|Overall Study|Noncompliant|1|||
145452481|NCT00853242|524506283|FG005|Overall Study|Noncompliant|0|||
145452482|NCT00853242|524506284|FG006|Overall Study|Noncompliant|0|||
145452483|NCT00853242|524506278|FG000|Overall Study|Withdrawal by Subject|1|||
145452484|NCT00853242|524506279|FG001|Overall Study|Withdrawal by Subject|2|||
145452485|NCT00853242|524506280|FG002|Overall Study|Withdrawal by Subject|0|||
145452486|NCT00853242|524506281|FG003|Overall Study|Withdrawal by Subject|4|||
145452487|NCT00853242|524506282|FG004|Overall Study|Withdrawal by Subject|0|||
145452488|NCT00853242|524506283|FG005|Overall Study|Withdrawal by Subject|0|||
145452489|NCT00853242|524506284|FG006|Overall Study|Withdrawal by Subject|2|||
145452490|NCT00853242|524506278|FG000|Overall Study|Other|2|||
145452491|NCT00853242|524506279|FG001|Overall Study|Other|0|||
145587697|NCT03434119|525004275|FG000|Overall Study|Poor Compliance to Protocol|0|||
145452492|NCT00853242|524506280|FG002|Overall Study|Other|2|||
145452493|NCT00853242|524506281|FG003|Overall Study|Other|0|||
145452494|NCT00853242|524506282|FG004|Overall Study|Other|0|||
145452495|NCT00853242|524506283|FG005|Overall Study|Other|1|||
145452496|NCT00853242|524506284|FG006|Overall Study|Other|2|||
145452497|NCT02957747|524506285|FG000|Overall Study|Withdrawal by Subject|0|||
145452498|NCT02957747|524506286|FG001|Overall Study|Withdrawal by Subject|3|||
145452499|NCT02957747|524506285|FG000|Overall Study|Lost to Follow-up|10|||
145452500|NCT02957747|524506286|FG001|Overall Study|Lost to Follow-up|5|||
145452501|NCT04026009|524506291|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145452502|NCT04026009|524506292|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145452503|NCT04026009|524506293|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145587698|NCT03434119|525004276|FG001|Overall Study|Poor Compliance to Protocol|1|||
145452504|NCT04026009|524506294|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145626263|NCT00062868|525144249|FG009|Dose Level 1|Lost to Follow-up|0|||
145452505|NCT04026009|524506295|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
145452506|NCT04026009|524506291|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
145452507|NCT04026009|524506292|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
145452508|NCT04026009|524506293|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
145452509|NCT04026009|524506294|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
145452510|NCT04026009|524506295|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
145452511|NCT02466425|524506299|FG000|Overall Study|Adverse Event|3|||
145452512|NCT02466425|524506300|FG001|Overall Study|Adverse Event|11|||
145452513|NCT02466425|524506299|FG000|Overall Study|Lack of Efficacy|4|||
145452514|NCT02466425|524506300|FG001|Overall Study|Lack of Efficacy|1|||
145452515|NCT02466425|524506299|FG000|Overall Study|Lost to Follow-up|3|||
145452516|NCT02466425|524506300|FG001|Overall Study|Lost to Follow-up|0|||
145452517|NCT02466425|524506299|FG000|Overall Study|Protocol Violation|1|||
145452518|NCT02466425|524506300|FG001|Overall Study|Protocol Violation|0|||
145452519|NCT02466425|524506299|FG000|Overall Study|Withdrawal by Subject|0|||
145452520|NCT02466425|524506300|FG001|Overall Study|Withdrawal by Subject|1|||
145452521|NCT02466425|524506299|FG000|Overall Study|Other|1|||
145452522|NCT02466425|524506300|FG001|Overall Study|Other|3|||
145452523|NCT02466425|524506299|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145452524|NCT02466425|524506300|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145452525|NCT01721486|524506305|FG000|Overall Study|Protocol Violation|1|||
145452526|NCT01721486|524506306|FG001|Overall Study|Protocol Violation|0|||
145452527|NCT01721486|524506305|FG000|Overall Study|Physician Decision|0|||
145452528|NCT01721486|524506306|FG001|Overall Study|Physician Decision|1|||
145452529|NCT00582712|524506307|FG000|Overall Study|Adverse Event|1|||
145452530|NCT00582712|524506307|FG000|Overall Study|Lack of Efficacy|1|||
145452531|NCT00582712|524506307|FG000|Overall Study|Withdrawal by Subject|1|||
145452532|NCT00582712|524506307|FG000|Overall Study|Complicating disease requiring treatment|1|||
145452533|NCT01901289|524506308|FG000|Overall Study|Death|32|||
145452534|NCT01901289|524506308|FG000|Overall Study|Lost to Follow-up|16|||
145452535|NCT01901289|524506308|FG000|Overall Study|Withdrawal by Subject|35|||
145452536|NCT01901289|524506308|FG000|Overall Study|Other type of endpoint met|2|||
145452537|NCT01813058|524506313|FG000|Overall Study|Withdrawal by Subject|5|||
145452538|NCT01813058|524506314|FG001|Overall Study|Withdrawal by Subject|4|||
145452539|NCT03585764|524506315|FG000|Overall Study|Death|3|||
145452540|NCT03585764|524506316|FG001|Overall Study|Death|2|||
145452541|NCT03585764|524506317|FG002|Overall Study|Death|3|||
145452542|NCT03585764|524506318|FG003|Overall Study|Death|0|||
145452543|NCT03585764|524506315|FG000|Overall Study|Lost to Follow-up|0|||
145452544|NCT03585764|524506316|FG001|Overall Study|Lost to Follow-up|1|||
145452545|NCT03585764|524506317|FG002|Overall Study|Lost to Follow-up|0|||
145452546|NCT03585764|524506318|FG003|Overall Study|Lost to Follow-up|0|||
145452547|NCT03585764|524506315|FG000|Overall Study|Physician Decision|0|||
145452548|NCT03585764|524506316|FG001|Overall Study|Physician Decision|0|||
145452549|NCT03585764|524506317|FG002|Overall Study|Physician Decision|2|||
145452550|NCT03585764|524506318|FG003|Overall Study|Physician Decision|0|||
145452551|NCT01581021|524506319|FG000|Overall Study|Lost to Follow-up|4|||
145452552|NCT01581021|524506320|FG001|Overall Study|Lost to Follow-up|6|||
145452553|NCT01581021|524506319|FG000|Overall Study|More than 2 hooks in thoracic|3|||
145452554|NCT01581021|524506320|FG001|Overall Study|More than 2 hooks in thoracic|0|||
145452555|NCT01581021|524506319|FG000|Overall Study|Neuromuscular|2|||
145452556|NCT01581021|524506320|FG001|Overall Study|Neuromuscular|1|||
145452557|NCT01581021|524506319|FG000|Overall Study|Not Randomized|1|||
145452558|NCT01581021|524506320|FG001|Overall Study|Not Randomized|2|||
145452559|NCT01581021|524506319|FG000|Overall Study|Lenke 6 Classification|0|||
145452560|NCT01581021|524506320|FG001|Overall Study|Lenke 6 Classification|1|||
145452561|NCT01581021|524506319|FG000|Overall Study|Lack of Efficacy|0|||
145452562|NCT01581021|524506320|FG001|Overall Study|Lack of Efficacy|1|||
145452563|NCT03403361|524506321|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
145452564|NCT01932372|524506322|FG000|Overall Study|Not meeting eligibility criteria|33|||
145452565|NCT01932372|524506323|FG001|Overall Study|Not meeting eligibility criteria|179|||
145452566|NCT01917929|524506328|FG000|Overall Study|Death|8|||
145452567|NCT01917929|524506328|FG000|Overall Study|Lost to Follow-up|19|||
145452568|NCT01917929|524506328|FG000|Overall Study|Withdrawal by Subject|33|||
145452569|NCT01917929|524506328|FG000|Overall Study|Adverse Event|6|||
145452570|NCT01917929|524506328|FG000|Overall Study|Investigative Site Terminated|35|||
145452571|NCT01917929|524506328|FG000|Overall Study|Censored because study device not implanted|6|||
145452572|NCT01917929|524506328|FG000|Overall Study|Censored because surgery not performed|3|||
145452573|NCT01917929|524506328|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
145452574|NCT01917929|524506328|FG000|Overall Study|Sponsor terminated study|175|||
145452575|NCT00673231|524506329|FG000|Overall Study|Withdrawal by Subject|14|||
145452576|NCT00673231|524506330|FG001|Overall Study|Withdrawal by Subject|10|||
145452577|NCT00673231|524506331|FG002|Overall Study|Withdrawal by Subject|8|||
145452578|NCT00673231|524506332|FG003|Overall Study|Withdrawal by Subject|6|||
145452579|NCT00673231|524506329|FG000|Overall Study|Adverse Event|6|||
145452580|NCT00673231|524506330|FG001|Overall Study|Adverse Event|5|||
145452581|NCT00673231|524506331|FG002|Overall Study|Adverse Event|9|||
145452582|NCT00673231|524506332|FG003|Overall Study|Adverse Event|6|||
145452583|NCT00673231|524506329|FG000|Overall Study|Lost to Follow-up|1|||
145452584|NCT00673231|524506330|FG001|Overall Study|Lost to Follow-up|2|||
145452585|NCT00673231|524506331|FG002|Overall Study|Lost to Follow-up|1|||
145452586|NCT00673231|524506332|FG003|Overall Study|Lost to Follow-up|2|||
145452587|NCT00673231|524506329|FG000|Overall Study|Death|0|||
145452588|NCT00673231|524506330|FG001|Overall Study|Death|0|||
145452589|NCT00673231|524506331|FG002|Overall Study|Death|1|||
145452590|NCT00673231|524506332|FG003|Overall Study|Death|0|||
145452591|NCT00673231|524506329|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
145452592|NCT00673231|524506330|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
145452593|NCT00673231|524506331|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
145452594|NCT00673231|524506332|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
145452595|NCT03594747|524506336|FG000|Overall Study|Death|78|||
145452596|NCT03594747|524506337|FG001|Overall Study|Death|86|||
145452597|NCT03594747|524506338|FG002|Overall Study|Death|87|||
145452598|NCT03594747|524506336|FG000|Overall Study|Withdrawal by Subject|5|||
145452599|NCT03594747|524506337|FG001|Overall Study|Withdrawal by Subject|2|||
145452600|NCT03594747|524506338|FG002|Overall Study|Withdrawal by Subject|11|||
145452601|NCT03594747|524506336|FG000|Overall Study|Lost to Follow-up|4|||
145452602|NCT03594747|524506337|FG001|Overall Study|Lost to Follow-up|1|||
145452603|NCT03594747|524506338|FG002|Overall Study|Lost to Follow-up|1|||
145452604|NCT03594747|524506336|FG000|Overall Study|Physician Decision|0|||
145452605|NCT03594747|524506337|FG001|Overall Study|Physician Decision|1|||
145452606|NCT03594747|524506338|FG002|Overall Study|Physician Decision|0|||
145452607|NCT03594747|524506336|FG000|Overall Study|Sponsor decision|23|||
145452608|NCT03594747|524506337|FG001|Overall Study|Sponsor decision|17|||
145452609|NCT03594747|524506338|FG002|Overall Study|Sponsor decision|16|||
145452610|NCT03594747|524506336|FG000|Overall Study|Did not meet inclusion criteria|0|||
145452611|NCT03594747|524506337|FG001|Overall Study|Did not meet inclusion criteria|0|||
145452612|NCT03594747|524506338|FG002|Overall Study|Did not meet inclusion criteria|1|||
145452613|NCT03594747|524506336|FG000|Overall Study|Transfer to long term extension study|10|||
145452614|NCT03594747|524506337|FG001|Overall Study|Transfer to long term extension study|12|||
145452615|NCT03594747|524506338|FG002|Overall Study|Transfer to long term extension study|5|||
145452616|NCT03028415|524506339|FG000|Overall Study|Lost to Follow-up|6|||
145452617|NCT03028415|524506340|FG001|Overall Study|Lost to Follow-up|3|||
145452618|NCT03028415|524506339|FG000|Overall Study|Withdrawal by Subject|1|||
145452619|NCT03028415|524506340|FG001|Overall Study|Withdrawal by Subject|0|||
145452620|NCT03028415|524506339|FG000|Overall Study|Discontinued due to COVID-19|1|||
145452621|NCT03028415|524506340|FG001|Overall Study|Discontinued due to COVID-19|0|||
145452622|NCT02907216|524506341|FG000|Overall Study|No benefit to be obtained by continuing|0|||
145452623|NCT02907216|524506342|FG001|Overall Study|No benefit to be obtained by continuing|1|||
145452624|NCT02907216|524506341|FG000|Overall Study|Withdrawal by Subject|1|||
145452625|NCT02907216|524506342|FG001|Overall Study|Withdrawal by Subject|0|||
145452626|NCT01108731|524506344|FG000|Overall Study|Withdrawal by Subject|1|||
145452627|NCT01108731|524506345|FG001|Overall Study|Withdrawal by Subject|1|||
145452628|NCT01108731|524506344|FG000|Overall Study|Adverse Event|3|||
145452629|NCT01108731|524506345|FG001|Overall Study|Adverse Event|3|||
145452630|NCT02485639|524506350|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
145452631|NCT02485639|524506350|FG000|Overall Study|Early termination|4|||
145452632|NCT02485639|524506350|FG000|Overall Study|Withdrawal by Subject|4|||
145452633|NCT03479541|524506353|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
145452634|NCT03479541|524506354|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
145452635|NCT03479541|524506355|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
145452636|NCT03479541|524506356|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
145452637|NCT03479541|524506353|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
145452638|NCT03479541|524506354|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
145452639|NCT03479541|524506355|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
145452640|NCT03479541|524506356|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
145452641|NCT03479541|524506353|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
145452642|NCT03479541|524506354|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
145452643|NCT03479541|524506355|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
145452644|NCT03479541|524506356|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
145452645|NCT03479541|524506353|FG000|Home Monitoring|Lost to Follow-up|0|||
145452646|NCT03479541|524506354|FG001|Home Monitoring|Lost to Follow-up|0|||
145452647|NCT03479541|524506355|FG002|Home Monitoring|Lost to Follow-up|8|||
145452648|NCT03479541|524506356|FG003|Home Monitoring|Lost to Follow-up|12|||
145452649|NCT03479541|524506353|FG000|Home Monitoring|Withdrawal by Subject|0|||
145452650|NCT03479541|524506354|FG001|Home Monitoring|Withdrawal by Subject|0|||
145452651|NCT03479541|524506355|FG002|Home Monitoring|Withdrawal by Subject|17|||
145452652|NCT03479541|524506356|FG003|Home Monitoring|Withdrawal by Subject|30|||
145452653|NCT03479541|524506353|FG000|Home Monitoring|Early Termination - PI Decision|0|||
145452654|NCT03479541|524506354|FG001|Home Monitoring|Early Termination - PI Decision|0|||
145452655|NCT03479541|524506355|FG002|Home Monitoring|Early Termination - PI Decision|4|||
145626264|NCT00062868|525144250|FG010|Dose Level 1|Lost to Follow-up|0|||
145587699|NCT03434119|525004275|FG000|Overall Study|Study Terminated by Sponsor|91|||
145587700|NCT03434119|525004276|FG001|Overall Study|Study Terminated by Sponsor|102|||
145587701|NCT03434119|525004275|FG000|Overall Study|Withdrawal by Subject|7|||
145587702|NCT03434119|525004276|FG001|Overall Study|Withdrawal by Subject|5|||
145587703|NCT03434119|525004275|FG000|Overall Study|Other than specified|7|||
145587704|NCT03434119|525004276|FG001|Overall Study|Other than specified|5|||
145587705|NCT00320216|525004277|FG000|Overall Study|Adverse Event|0|||
145587706|NCT00320216|525004278|FG001|Overall Study|Adverse Event|6|||
145587707|NCT00320216|525004279|FG002|Overall Study|Adverse Event|0|||
145587708|NCT00320216|525004280|FG003|Overall Study|Adverse Event|2|||
145587709|NCT00320216|525004281|FG004|Overall Study|Adverse Event|2|||
145587710|NCT00320216|525004277|FG000|Overall Study|Lack of Efficacy|6|||
145587711|NCT00320216|525004278|FG001|Overall Study|Lack of Efficacy|2|||
145587712|NCT00320216|525004279|FG002|Overall Study|Lack of Efficacy|1|||
145587713|NCT00320216|525004280|FG003|Overall Study|Lack of Efficacy|0|||
145587714|NCT00320216|525004281|FG004|Overall Study|Lack of Efficacy|1|||
145587715|NCT00320216|525004277|FG000|Overall Study|Lost to Follow-up|3|||
145587716|NCT00320216|525004278|FG001|Overall Study|Lost to Follow-up|0|||
145587717|NCT00320216|525004279|FG002|Overall Study|Lost to Follow-up|0|||
145587718|NCT00320216|525004280|FG003|Overall Study|Lost to Follow-up|0|||
145587719|NCT00320216|525004281|FG004|Overall Study|Lost to Follow-up|0|||
145587720|NCT00320216|525004277|FG000|Overall Study|Other|7|||
145587721|NCT00320216|525004278|FG001|Overall Study|Other|2|||
145587722|NCT00320216|525004279|FG002|Overall Study|Other|5|||
145587723|NCT00320216|525004280|FG003|Overall Study|Other|1|||
145587724|NCT00320216|525004281|FG004|Overall Study|Other|3|||
145587725|NCT00553267|525004287|FG000|Overall Study|Adverse Event|8|||
145587726|NCT00553267|525004288|FG001|Overall Study|Adverse Event|10|||
145587727|NCT00553267|525004289|FG002|Overall Study|Adverse Event|5|||
145587728|NCT00553267|525004287|FG000|Overall Study|Non compliant with protocol|3|||
145587729|NCT00553267|525004288|FG001|Overall Study|Non compliant with protocol|3|||
145587730|NCT00553267|525004289|FG002|Overall Study|Non compliant with protocol|2|||
145452656|NCT03479541|524506356|FG003|Home Monitoring|Early Termination - PI Decision|6|||
145452657|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
145452658|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
145452659|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
145452660|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
145452661|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
145452662|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
145452663|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
145452664|NCT01673854|524506358|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
145452665|NCT01673854|524506358|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
145452666|NCT01673854|524506358|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
145452667|NCT01673854|524506358|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
145452668|NCT01673854|524506358|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
145452669|NCT00107900|524506361|FG000|Overall Study|Adverse Event|3|||
145452670|NCT00107900|524506362|FG001|Overall Study|Adverse Event|2|||
145452671|NCT00107900|524506363|FG002|Overall Study|Adverse Event|10|||
145452672|NCT00107900|524506364|FG003|Overall Study|Adverse Event|3|||
145452673|NCT00107900|524506365|FG004|Overall Study|Adverse Event|5|||
145452674|NCT00107900|524506366|FG005|Overall Study|Adverse Event|3|||
145452675|NCT00107900|524506361|FG000|Overall Study|Death|0|||
145452676|NCT00107900|524506362|FG001|Overall Study|Death|0|||
145452677|NCT00107900|524506363|FG002|Overall Study|Death|0|||
145452678|NCT00107900|524506364|FG003|Overall Study|Death|0|||
145452679|NCT00107900|524506365|FG004|Overall Study|Death|1|||
145452680|NCT00107900|524506366|FG005|Overall Study|Death|0|||
145452681|NCT00107900|524506361|FG000|Overall Study|Lost to Follow-up|4|||
145452682|NCT00107900|524506362|FG001|Overall Study|Lost to Follow-up|1|||
145452683|NCT00107900|524506363|FG002|Overall Study|Lost to Follow-up|3|||
145452684|NCT00107900|524506364|FG003|Overall Study|Lost to Follow-up|2|||
145452685|NCT00107900|524506365|FG004|Overall Study|Lost to Follow-up|5|||
145452686|NCT00107900|524506366|FG005|Overall Study|Lost to Follow-up|5|||
145587731|NCT00553267|525004287|FG000|Overall Study|Lost to Follow-up|0|||
145587732|NCT00553267|525004288|FG001|Overall Study|Lost to Follow-up|0|||
145452687|NCT00107900|524506361|FG000|Overall Study|Protocol Violation|1|||
145452688|NCT00107900|524506362|FG001|Overall Study|Protocol Violation|0|||
145452689|NCT00107900|524506363|FG002|Overall Study|Protocol Violation|5|||
145452690|NCT00107900|524506364|FG003|Overall Study|Protocol Violation|5|||
145452691|NCT00107900|524506365|FG004|Overall Study|Protocol Violation|7|||
145587733|NCT00553267|525004289|FG002|Overall Study|Lost to Follow-up|1|||
145587734|NCT00553267|525004287|FG000|Overall Study|Consent withdrawn|2|||
145587735|NCT00553267|525004288|FG001|Overall Study|Consent withdrawn|3|||
145587736|NCT00553267|525004289|FG002|Overall Study|Consent withdrawn|1|||
145587737|NCT00553267|525004287|FG000|Overall Study|Specified category|1|||
145587738|NCT00553267|525004288|FG001|Overall Study|Specified category|2|||
145587739|NCT00553267|525004289|FG002|Overall Study|Specified category|1|||
145587740|NCT04389840|525004290|FG000|Overall Study|Adverse Event|0|||
145626265|NCT00062868|525144251|FG011|Dose Level 1|Lost to Follow-up|0|||
145626266|NCT00062868|525144252|FG012|Dose Level 1|Lost to Follow-up|1|||
145626267|NCT00062868|525144253|FG013|Dose Level 1|Lost to Follow-up|0|||
145626268|NCT00062868|525144254|FG014|Dose Level 1|Lost to Follow-up|0|||
145626269|NCT00062868|525144255|FG015|Dose Level 1|Lost to Follow-up|0|||
145626270|NCT00062868|525144256|FG016|Dose Level 1|Lost to Follow-up|0|||
145626271|NCT00062868|525144257|FG017|Dose Level 1|Lost to Follow-up|0|||
145626272|NCT00062868|525144258|FG018|Dose Level 1|Lost to Follow-up|2|||
145626273|NCT00062868|525144259|FG019|Dose Level 1|Lost to Follow-up|0|||
145626274|NCT00062868|525144260|FG020|Dose Level 1|Lost to Follow-up|1|||
145626275|NCT00062868|525144240|FG000|Dose Level 2|Death|0|||
145626276|NCT00062868|525144241|FG001|Dose Level 2|Death|3|||
145626277|NCT00062868|525144242|FG002|Dose Level 2|Death|0|||
145626278|NCT00062868|525144243|FG003|Dose Level 2|Death|0|||
145626279|NCT00062868|525144244|FG004|Dose Level 2|Death|2|||
145626280|NCT00062868|525144245|FG005|Dose Level 2|Death|0|||
145626281|NCT00062868|525144246|FG006|Dose Level 2|Death|0|||
145626282|NCT00062868|525144247|FG007|Dose Level 2|Death|0|||
145626283|NCT00062868|525144248|FG008|Dose Level 2|Death|0|||
145626284|NCT00062868|525144249|FG009|Dose Level 2|Death|0|||
145626285|NCT00062868|525144250|FG010|Dose Level 2|Death|1|||
145626286|NCT00062868|525144251|FG011|Dose Level 2|Death|0|||
145626287|NCT00062868|525144252|FG012|Dose Level 2|Death|0|||
145626288|NCT00062868|525144253|FG013|Dose Level 2|Death|0|||
145626289|NCT00062868|525144254|FG014|Dose Level 2|Death|0|||
145626290|NCT00062868|525144255|FG015|Dose Level 2|Death|0|||
145626291|NCT00062868|525144256|FG016|Dose Level 2|Death|2|||
145626292|NCT00062868|525144257|FG017|Dose Level 2|Death|0|||
145626293|NCT00062868|525144258|FG018|Dose Level 2|Death|0|||
145626294|NCT00062868|525144259|FG019|Dose Level 2|Death|0|||
145626295|NCT00062868|525144260|FG020|Dose Level 2|Death|0|||
145626296|NCT00062868|525144240|FG000|Dose Level 2|Lost to Follow-up|0|||
145626297|NCT00062868|525144241|FG001|Dose Level 2|Lost to Follow-up|0|||
145626298|NCT00062868|525144242|FG002|Dose Level 2|Lost to Follow-up|0|||
145626299|NCT00062868|525144243|FG003|Dose Level 2|Lost to Follow-up|0|||
145626300|NCT00062868|525144244|FG004|Dose Level 2|Lost to Follow-up|0|||
145626301|NCT00062868|525144245|FG005|Dose Level 2|Lost to Follow-up|0|||
145452692|NCT00107900|524506366|FG005|Overall Study|Protocol Violation|0|||
145452693|NCT00107900|524506361|FG000|Overall Study|Withdrawal by Subject|1|||
145452694|NCT00107900|524506362|FG001|Overall Study|Withdrawal by Subject|0|||
145452695|NCT00107900|524506363|FG002|Overall Study|Withdrawal by Subject|5|||
145452696|NCT00107900|524506364|FG003|Overall Study|Withdrawal by Subject|0|||
145452697|NCT00107900|524506365|FG004|Overall Study|Withdrawal by Subject|1|||
145452698|NCT00107900|524506366|FG005|Overall Study|Withdrawal by Subject|1|||
145452699|NCT00107900|524506361|FG000|Overall Study|Administrative Reasons|1|||
145452700|NCT00107900|524506362|FG001|Overall Study|Administrative Reasons|0|||
145452701|NCT00107900|524506363|FG002|Overall Study|Administrative Reasons|2|||
145452702|NCT00107900|524506364|FG003|Overall Study|Administrative Reasons|2|||
145452703|NCT00107900|524506365|FG004|Overall Study|Administrative Reasons|2|||
145452704|NCT00107900|524506366|FG005|Overall Study|Administrative Reasons|0|||
145452705|NCT02147197|524506370|FG000|Overall Study|Adverse Event|1|||
145452706|NCT02147197|524506371|FG001|Overall Study|Adverse Event|0|||
145452707|NCT02147197|524506372|FG002|Overall Study|Adverse Event|0|||
145452708|NCT02147197|524506370|FG000|Overall Study|Withdrawal of Consent|4|||
145452709|NCT02147197|524506371|FG001|Overall Study|Withdrawal of Consent|3|||
145452710|NCT02147197|524506372|FG002|Overall Study|Withdrawal of Consent|2|||
145452711|NCT02147197|524506370|FG000|Overall Study|Lost to Follow-up|2|||
145452712|NCT02147197|524506371|FG001|Overall Study|Lost to Follow-up|3|||
145452713|NCT02147197|524506372|FG002|Overall Study|Lost to Follow-up|1|||
145452714|NCT02147197|524506370|FG000|Overall Study|Protocol Violation|1|||
145452715|NCT02147197|524506371|FG001|Overall Study|Protocol Violation|0|||
145452716|NCT02147197|524506372|FG002|Overall Study|Protocol Violation|3|||
145452717|NCT02147197|524506370|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145452718|NCT02147197|524506371|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145452719|NCT02147197|524506372|FG002|Overall Study|Other Miscellaneous Reasons|3|||
145452720|NCT05897242|524508257|FG000|Overall Study|Lost to Follow-up|6|||
145452721|NCT05897242|524508258|FG001|Overall Study|Lost to Follow-up|1|||
145452722|NCT05897242|524508257|FG000|Overall Study|Incomplete|1|||
145452723|NCT05897242|524508258|FG001|Overall Study|Incomplete|0|||
145452724|NCT05897242|524508257|FG000|Overall Study|Withdrawal by Subject|1|||
145626302|NCT00062868|525144246|FG006|Dose Level 2|Lost to Follow-up|0|||
145626303|NCT00062868|525144247|FG007|Dose Level 2|Lost to Follow-up|0|||
145626304|NCT00062868|525144248|FG008|Dose Level 2|Lost to Follow-up|0|||
145626305|NCT00062868|525144249|FG009|Dose Level 2|Lost to Follow-up|0|||
145626306|NCT00062868|525144250|FG010|Dose Level 2|Lost to Follow-up|0|||
145626307|NCT00062868|525144251|FG011|Dose Level 2|Lost to Follow-up|0|||
145626308|NCT00062868|525144252|FG012|Dose Level 2|Lost to Follow-up|0|||
145626309|NCT00062868|525144253|FG013|Dose Level 2|Lost to Follow-up|1|||
145626310|NCT00062868|525144254|FG014|Dose Level 2|Lost to Follow-up|0|||
145626311|NCT00062868|525144255|FG015|Dose Level 2|Lost to Follow-up|0|||
145626312|NCT00062868|525144256|FG016|Dose Level 2|Lost to Follow-up|1|||
145626313|NCT00062868|525144257|FG017|Dose Level 2|Lost to Follow-up|0|||
145452725|NCT05897242|524508258|FG001|Overall Study|Withdrawal by Subject|0|||
145452726|NCT00809835|524508259|FG000|Overall Study|Lost to Follow-up|7|||
145452727|NCT00809835|524508260|FG001|Overall Study|Lost to Follow-up|6|||
145452728|NCT00809835|524508261|FG002|Overall Study|Lost to Follow-up|10|||
145452729|NCT00809835|524508262|FG003|Overall Study|Lost to Follow-up|2|||
145452730|NCT00809835|524508259|FG000|Overall Study|Withdrawal by Subject|1|||
145452731|NCT00809835|524508260|FG001|Overall Study|Withdrawal by Subject|1|||
145452732|NCT00809835|524508261|FG002|Overall Study|Withdrawal by Subject|1|||
145452733|NCT00809835|524508262|FG003|Overall Study|Withdrawal by Subject|0|||
145452734|NCT03530995|524508266|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
145452735|NCT03530995|524508267|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
145452736|NCT03530995|524508266|FG000|Part 1 Period 3|Protocol Violation|1|||
145452737|NCT03530995|524508267|FG001|Part 1 Period 3|Protocol Violation|0|||
145452738|NCT03530995|524508266|FG000|Part 1 Period 4|Physician Decision|1|||
145452739|NCT03530995|524508267|FG001|Part 1 Period 4|Physician Decision|0|||
145452740|NCT03530995|524508266|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
145452741|NCT03530995|524508267|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
145452742|NCT04644276|524508268|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
145452743|NCT04644276|524508269|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
145452744|NCT04644276|524508270|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
145452745|NCT02846389|524508271|FG000|Overall Study|Withdrawal by Subject|1|||
145452746|NCT02846389|524508272|FG001|Overall Study|Withdrawal by Subject|1|||
145452747|NCT02321319|524508273|FG000|Overall Study|Product discontinued|5|||
145452748|NCT02249091|524508274|FG000|Overall Study|Lack of Efficacy|8|||
145452749|NCT02249091|524508275|FG001|Overall Study|Lack of Efficacy|3|||
145452750|NCT02249091|524508274|FG000|Overall Study|Physician Decision|4|||
145452751|NCT02249091|524508275|FG001|Overall Study|Physician Decision|1|||
145452752|NCT02249091|524508274|FG000|Overall Study|Withdrawal by Subject|2|||
145452753|NCT02249091|524508275|FG001|Overall Study|Withdrawal by Subject|2|||
145452754|NCT02249091|524508274|FG000|Overall Study|Death|3|||
145452755|NCT02249091|524508275|FG001|Overall Study|Death|4|||
145452756|NCT02249091|524508274|FG000|Overall Study|Adverse Event|1|||
145452757|NCT02249091|524508275|FG001|Overall Study|Adverse Event|0|||
145452758|NCT02249091|524508274|FG000|Overall Study|Stable disease with following SCT|0|||
145452759|NCT02249091|524508275|FG001|Overall Study|Stable disease with following SCT|1|||
145452760|NCT02249091|524508274|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
145452761|NCT02249091|524508275|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
145452762|NCT02249091|524508274|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
145452763|NCT02249091|524508275|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
145452764|NCT02249091|524508274|FG000|Overall Study|Refractory AML|1|||
145452765|NCT02249091|524508275|FG001|Overall Study|Refractory AML|1|||
145452766|NCT01035463|524508276|FG000|Overall Study|Adverse Event|0|||
145452767|NCT01035463|524508277|FG001|Overall Study|Adverse Event|0|||
145452768|NCT01035463|524508278|FG002|Overall Study|Adverse Event|4|||
145452769|NCT01035463|524508279|FG003|Overall Study|Adverse Event|1|||
145452770|NCT01035463|524508280|FG004|Overall Study|Adverse Event|5|||
145452771|NCT01035463|524508281|FG005|Overall Study|Adverse Event|7|||
145452772|NCT01035463|524508276|FG000|Overall Study|Withdrawal by Subject|0|||
145452773|NCT01035463|524508277|FG001|Overall Study|Withdrawal by Subject|2|||
145452774|NCT01035463|524508278|FG002|Overall Study|Withdrawal by Subject|1|||
145452775|NCT01035463|524508279|FG003|Overall Study|Withdrawal by Subject|0|||
145452776|NCT01035463|524508280|FG004|Overall Study|Withdrawal by Subject|1|||
145452777|NCT01035463|524508281|FG005|Overall Study|Withdrawal by Subject|4|||
145452778|NCT01035463|524508276|FG000|Overall Study|Disease progression|0|||
145452779|NCT01035463|524508277|FG001|Overall Study|Disease progression|0|||
145452780|NCT01035463|524508278|FG002|Overall Study|Disease progression|0|||
145452781|NCT01035463|524508279|FG003|Overall Study|Disease progression|0|||
145452782|NCT01035463|524508280|FG004|Overall Study|Disease progression|0|||
145452783|NCT01035463|524508281|FG005|Overall Study|Disease progression|3|||
145452784|NCT01035463|524508276|FG000|Overall Study|Other Malignancy|0|||
145452785|NCT01035463|524508277|FG001|Overall Study|Other Malignancy|0|||
145452786|NCT01035463|524508278|FG002|Overall Study|Other Malignancy|0|||
145452787|NCT01035463|524508279|FG003|Overall Study|Other Malignancy|0|||
145452788|NCT01035463|524508280|FG004|Overall Study|Other Malignancy|0|||
145452789|NCT01035463|524508281|FG005|Overall Study|Other Malignancy|2|||
145452790|NCT01035463|524508276|FG000|Overall Study|Other|0|||
145452791|NCT01035463|524508277|FG001|Overall Study|Other|0|||
145452792|NCT01035463|524508278|FG002|Overall Study|Other|0|||
145452793|NCT01035463|524508279|FG003|Overall Study|Other|1|||
145452794|NCT01035463|524508280|FG004|Overall Study|Other|0|||
145452795|NCT01035463|524508281|FG005|Overall Study|Other|2|||
145452796|NCT02516098|524508282|FG000|Period 1|Protocol Violation|1|||
145452797|NCT02516098|524508283|FG001|Period 1|Protocol Violation|0|||
145452798|NCT02516098|524508282|FG000|Washout After Period 1|Adverse Event|0|||
145452799|NCT02516098|524508283|FG001|Washout After Period 1|Adverse Event|1|||
145452800|NCT02516098|524508282|FG000|Period 2|Withdrawal by Subject|0|||
145452801|NCT02516098|524508283|FG001|Period 2|Withdrawal by Subject|1|||
145452802|NCT01092780|524508284|FG000|Washout Period 1|Adverse Event|0|||
145452803|NCT01092780|524508285|FG001|Washout Period 1|Adverse Event|1|||
145452804|NCT01092780|524508286|FG002|Washout Period 1|Adverse Event|0|||
145452805|NCT01092780|524508287|FG003|Washout Period 1|Adverse Event|0|||
145452806|NCT01092780|524508284|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
145452807|NCT01092780|524508285|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
145452808|NCT01092780|524508286|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
145452809|NCT01092780|524508287|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
145452810|NCT01092780|524508284|FG000|Washout Period 2|Adverse Event|0|||
145452811|NCT01092780|524508285|FG001|Washout Period 2|Adverse Event|1|||
145452812|NCT01092780|524508286|FG002|Washout Period 2|Adverse Event|1|||
145452813|NCT01092780|524508287|FG003|Washout Period 2|Adverse Event|0|||
145452814|NCT01734395|524508288|FG000|Overall Study|Other|65|||
145452815|NCT01734395|524508288|FG000|Overall Study|Lost to Follow-up|287|||
145452816|NCT01734395|524508288|FG000|Overall Study|Lack of Efficacy|5|||
145452817|NCT01734395|524508288|FG000|Overall Study|Adverse Event|40|||
145452818|NCT01734395|524508288|FG000|Overall Study|Withdrawal by Subject|10|||
145452819|NCT01734395|524508288|FG000|Overall Study|Missing the reasons for not completed|3|||
145452820|NCT01257230|524508289|FG000|Overall Study|Not Treated|0|||
145452821|NCT01257230|524508290|FG001|Overall Study|Not Treated|0|||
145452822|NCT01257230|524508291|FG002|Overall Study|Not Treated|1|||
145452823|NCT01257230|524508289|FG000|Overall Study|Adverse Event|2|||
145452824|NCT01257230|524508290|FG001|Overall Study|Adverse Event|0|||
145452825|NCT01257230|524508291|FG002|Overall Study|Adverse Event|0|||
145452826|NCT01257230|524508289|FG000|Overall Study|Lack of Efficacy|0|||
145452827|NCT01257230|524508290|FG001|Overall Study|Lack of Efficacy|1|||
145452828|NCT01257230|524508291|FG002|Overall Study|Lack of Efficacy|0|||
145452829|NCT01257230|524508289|FG000|Overall Study|Protocol Violation|3|||
145452830|NCT01257230|524508290|FG001|Overall Study|Protocol Violation|0|||
145452831|NCT01257230|524508291|FG002|Overall Study|Protocol Violation|1|||
145452832|NCT01257230|524508289|FG000|Overall Study|Withdrawal by Subject|0|||
145452833|NCT01257230|524508290|FG001|Overall Study|Withdrawal by Subject|4|||
145452834|NCT01257230|524508291|FG002|Overall Study|Withdrawal by Subject|1|||
145452835|NCT01257230|524508289|FG000|Overall Study|Other reason not defined above|1|||
145452836|NCT01257230|524508290|FG001|Overall Study|Other reason not defined above|5|||
145452837|NCT01257230|524508291|FG002|Overall Study|Other reason not defined above|3|||
145452838|NCT01205061|524508297|FG000|Overall Study|Adverse Event|4|||
145452839|NCT01205061|524508297|FG000|Overall Study|Withdrawal by Subject|11|||
145452840|NCT01205061|524508297|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
145452841|NCT01205061|524508297|FG000|Overall Study|Lost to Follow-up|9|||
145452842|NCT01205061|524508297|FG000|Overall Study|Other|1|||
145452843|NCT01126268|524508298|FG000|Overall Study|Adverse Event|1|||
145452844|NCT00765037|524508299|FG000|Overall Study|Lost to Follow-up|5|||
145452845|NCT00765037|524508299|FG000|Overall Study|Adverse Event|1|||
145452846|NCT01988662|524508304|FG000|Overall Study|Subject/guardian decision|1|||
145452847|NCT01988662|524508305|FG001|Overall Study|Subject/guardian decision|1|||
145452848|NCT01988662|524508304|FG000|Overall Study|Adverse Event|3|||
145452849|NCT01988662|524508305|FG001|Overall Study|Adverse Event|1|||
145452850|NCT03425006|524508306|FG000|Overall Study|Withdrawal by Subject|1|||
145452851|NCT03425006|524508306|FG000|Overall Study|Physician Decision|1|||
145452852|NCT03425006|524508306|FG000|Overall Study|Death|1|||
145452853|NCT02300558|524508317|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
145452854|NCT02300558|524508317|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
145452855|NCT02300558|524508317|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
145452856|NCT02300558|524508317|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
145452857|NCT00610857|524508321|FG000|Overall Study|Not evaluable for response|2|||
145452858|NCT01626118|524508324|FG000|Overall Study|Lack of Efficacy|1|||
145452859|NCT01626118|524508325|FG001|Overall Study|Lack of Efficacy|0|||
145452860|NCT01626118|524508326|FG002|Overall Study|Lack of Efficacy|1|||
145452861|NCT01626118|524508327|FG003|Overall Study|Lack of Efficacy|3|||
145452862|NCT01626118|524508324|FG000|Overall Study|Lost to Follow-up|1|||
145452863|NCT01626118|524508325|FG001|Overall Study|Lost to Follow-up|0|||
145452864|NCT01626118|524508326|FG002|Overall Study|Lost to Follow-up|0|||
145452865|NCT01626118|524508327|FG003|Overall Study|Lost to Follow-up|0|||
145452866|NCT01626118|524508324|FG000|Overall Study|Adverse Event|0|||
145452867|NCT01626118|524508325|FG001|Overall Study|Adverse Event|1|||
145452868|NCT01626118|524508326|FG002|Overall Study|Adverse Event|1|||
145452869|NCT01626118|524508327|FG003|Overall Study|Adverse Event|0|||
145452870|NCT01626118|524508324|FG000|Overall Study|Investigator Decision|0|||
145452871|NCT01626118|524508325|FG001|Overall Study|Investigator Decision|1|||
145452872|NCT01626118|524508326|FG002|Overall Study|Investigator Decision|0|||
145452873|NCT01626118|524508327|FG003|Overall Study|Investigator Decision|0|||
145452874|NCT00888329|524508328|FG000|Overall Study|Physician Decision|6|||
145452875|NCT00888329|524508329|FG001|Overall Study|Physician Decision|9|||
145452876|NCT00002540|524508330|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
145452877|NCT00002540|524508331|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
145452878|NCT00002540|524508330|FG000|Overall Study|Died Before Randomization|2|||
145626314|NCT00062868|525144258|FG018|Dose Level 2|Lost to Follow-up|0|||
145626315|NCT00062868|525144259|FG019|Dose Level 2|Lost to Follow-up|0|||
145626316|NCT00062868|525144260|FG020|Dose Level 2|Lost to Follow-up|0|||
145626317|NCT00062868|525144240|FG000|Dose Level 3|Death|0|||
145626318|NCT00062868|525144241|FG001|Dose Level 3|Death|0|||
145626319|NCT00062868|525144242|FG002|Dose Level 3|Death|0|||
145626320|NCT00062868|525144243|FG003|Dose Level 3|Death|0|||
145452879|NCT00002540|524508331|FG001|Overall Study|Died Before Randomization|6|||
145452880|NCT00002540|524508330|FG000|Overall Study|Died Before ASU (Control)|202|||
145452881|NCT00002540|524508331|FG001|Overall Study|Died Before ASU (Control)|0|||
145452882|NCT00002540|524508330|FG000|Overall Study|Refused ASU (Control)|597|||
145452883|NCT00002540|524508331|FG001|Overall Study|Refused ASU (Control)|0|||
145452884|NCT00002540|524508330|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
145452885|NCT00002540|524508331|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
145452886|NCT01864148|524508332|FG000|Overall Study|Other|2|||
145452887|NCT01864148|524508333|FG001|Overall Study|Other|1|||
145452888|NCT01864148|524508334|FG002|Overall Study|Other|1|||
145452889|NCT01864148|524508335|FG003|Overall Study|Other|3|||
145452890|NCT01864148|524508336|FG004|Overall Study|Other|1|||
145452891|NCT01864148|524508332|FG000|Overall Study|Death|0|||
145452892|NCT01864148|524508333|FG001|Overall Study|Death|0|||
145452893|NCT01864148|524508334|FG002|Overall Study|Death|0|||
145452894|NCT01864148|524508335|FG003|Overall Study|Death|1|||
145452895|NCT01864148|524508336|FG004|Overall Study|Death|0|||
145452896|NCT01864148|524508332|FG000|Overall Study|Investigator Decision|5|||
145452897|NCT01864148|524508333|FG001|Overall Study|Investigator Decision|0|||
145452898|NCT01864148|524508334|FG002|Overall Study|Investigator Decision|0|||
145452899|NCT01864148|524508335|FG003|Overall Study|Investigator Decision|4|||
145452900|NCT01864148|524508336|FG004|Overall Study|Investigator Decision|6|||
145452901|NCT01864148|524508332|FG000|Overall Study|Withdrawal by Subject|9|||
145452902|NCT01864148|524508333|FG001|Overall Study|Withdrawal by Subject|2|||
145452903|NCT01864148|524508334|FG002|Overall Study|Withdrawal by Subject|6|||
145452904|NCT01864148|524508335|FG003|Overall Study|Withdrawal by Subject|8|||
145452905|NCT01864148|524508336|FG004|Overall Study|Withdrawal by Subject|8|||
145452906|NCT01864148|524508332|FG000|Overall Study|Lost to Follow-up|0|||
145452907|NCT01864148|524508333|FG001|Overall Study|Lost to Follow-up|0|||
145452908|NCT01864148|524508334|FG002|Overall Study|Lost to Follow-up|0|||
145452909|NCT01864148|524508335|FG003|Overall Study|Lost to Follow-up|2|||
145452910|NCT01864148|524508336|FG004|Overall Study|Lost to Follow-up|1|||
145452911|NCT01864148|524508332|FG000|Overall Study|Adverse Event|4|||
145452912|NCT01864148|524508333|FG001|Overall Study|Adverse Event|2|||
145452913|NCT01864148|524508334|FG002|Overall Study|Adverse Event|4|||
145452914|NCT01864148|524508335|FG003|Overall Study|Adverse Event|7|||
145452915|NCT01864148|524508336|FG004|Overall Study|Adverse Event|7|||
145452916|NCT01864148|524508332|FG000|Overall Study|Not Dosed|0|||
145452917|NCT01864148|524508333|FG001|Overall Study|Not Dosed|0|||
145452918|NCT01864148|524508334|FG002|Overall Study|Not Dosed|0|||
145452919|NCT01864148|524508335|FG003|Overall Study|Not Dosed|1|||
145452920|NCT01864148|524508336|FG004|Overall Study|Not Dosed|0|||
145452921|NCT03490292|524508337|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
145452922|NCT03490292|524508338|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
145452923|NCT03490292|524508337|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
145452924|NCT03490292|524508338|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
145452925|NCT03490292|524508337|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
145452926|NCT03490292|524508338|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
145452927|NCT03490292|524508337|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
145452928|NCT03490292|524508338|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
145452929|NCT03490292|524508337|FG000|1 Year Follow Up Post Last Dose|Death|1|||
145452930|NCT03490292|524508338|FG001|1 Year Follow Up Post Last Dose|Death|1|||
145452931|NCT00778375|524508339|FG000|Overall Study|Ineligible|3|||
145452932|NCT00054327|524508342|FG000|Overall Study|Engraftment failure|1|||
145452933|NCT00054327|524508343|FG001|Overall Study|Engraftment failure|0|||
145452934|NCT00054327|524508344|FG002|Overall Study|Engraftment failure|0|||
145452935|NCT00054327|524508345|FG003|Overall Study|Engraftment failure|0|||
145452936|NCT00054327|524508346|FG004|Overall Study|Engraftment failure|0|||
145452937|NCT00054327|524508347|FG005|Overall Study|Engraftment failure|0|||
145452938|NCT00613327|524508351|FG000|Overall Study|Adverse Event|38|||
145626321|NCT00062868|525144244|FG004|Dose Level 3|Death|0|||
145452939|NCT00613327|524508351|FG000|Overall Study|Lost to Follow-up|8|||
145452940|NCT00613327|524508351|FG000|Overall Study|Withdrawal by Subject|6|||
145452941|NCT00613327|524508351|FG000|Overall Study|Protocol Violation|2|||
145452942|NCT00613327|524508351|FG000|Overall Study|Other|47|||
145452943|NCT00344318|524508352|FG000|Overall Study|Adverse Event|0|||
145452944|NCT00344318|524508353|FG001|Overall Study|Adverse Event|3|||
145452945|NCT00344318|524508354|FG002|Overall Study|Adverse Event|0|||
145452946|NCT00344318|524508355|FG003|Overall Study|Adverse Event|1|||
145452947|NCT00344318|524508352|FG000|Overall Study|Withdrawal by Subject|2|||
145626322|NCT00062868|525144245|FG005|Dose Level 3|Death|0|||
145626323|NCT00062868|525144246|FG006|Dose Level 3|Death|0|||
145452948|NCT00344318|524508353|FG001|Overall Study|Withdrawal by Subject|2|||
145452949|NCT00344318|524508354|FG002|Overall Study|Withdrawal by Subject|0|||
145452950|NCT00344318|524508355|FG003|Overall Study|Withdrawal by Subject|2|||
145452951|NCT00344318|524508352|FG000|Overall Study|Lost to Follow-up|2|||
145452952|NCT00344318|524508353|FG001|Overall Study|Lost to Follow-up|0|||
145452953|NCT00344318|524508354|FG002|Overall Study|Lost to Follow-up|1|||
145452954|NCT00344318|524508355|FG003|Overall Study|Lost to Follow-up|0|||
145452955|NCT01606176|524508359|FG000|Overall Study|Adverse Event|2|||
145452956|NCT01606176|524508360|FG001|Overall Study|Adverse Event|3|||
145452957|NCT01606176|524508359|FG000|Overall Study|Disease progression|1|||
145452958|NCT01606176|524508360|FG001|Overall Study|Disease progression|0|||
145452959|NCT01606176|524508359|FG000|Overall Study|Withdrawal by Subject|1|||
145452960|NCT01606176|524508360|FG001|Overall Study|Withdrawal by Subject|0|||
145452961|NCT00361231|524508362|FG000|Overall Study|Physician Decision|3|||
145452962|NCT00361231|524508362|FG000|Overall Study|Symptomatic deterioration|5|||
145452963|NCT00361231|524508362|FG000|Overall Study|Radiographic disease progression|16|||
145452964|NCT00361231|524508362|FG000|Overall Study|Withdrawal by Subject|4|||
145452965|NCT00361231|524508362|FG000|Overall Study|Adverse Event|6|||
145452966|NCT01814397|524508365|FG000|Overall Study|Adverse Event|7|||
145452967|NCT01814397|524508365|FG000|Overall Study|Withdrawal by Subject|7|||
145452968|NCT00244933|524508366|FG000|Overall Study|Not response evaluable|2|||
145452969|NCT04731298|524508367|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
145452970|NCT04731298|524508368|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
145452971|NCT01208961|524508369|FG000|High-Fat Period III|Protocol Violation|1|||
145452972|NCT01208961|524508370|FG001|High-Fat Period III|Protocol Violation|0|||
145452973|NCT03213938|524508371|FG000|Overall Study|Lost to Follow-up|4|||
145452974|NCT03213938|524508372|FG001|Overall Study|Lost to Follow-up|3|||
145452975|NCT03213938|524508371|FG000|Overall Study|Lack of Efficacy|1|||
145452976|NCT03213938|524508372|FG001|Overall Study|Lack of Efficacy|0|||
145452977|NCT03213938|524508371|FG000|Overall Study|Decline to participate|5|||
145452978|NCT03213938|524508372|FG001|Overall Study|Decline to participate|4|||
145452979|NCT03213938|524508371|FG000|Overall Study|Without reason|4|||
145452980|NCT03213938|524508372|FG001|Overall Study|Without reason|5|||
145452981|NCT02487654|524508374|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
145452982|NCT02487654|524508375|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
145452983|NCT02487654|524508374|FG000|Overall Study|Withdrawal by Subject|3|||
145452984|NCT02487654|524508375|FG001|Overall Study|Withdrawal by Subject|7|||
145452985|NCT04238481|524508376|FG000|Overall Study|Miscellaneous|0|||
145452986|NCT04238481|524508377|FG001|Overall Study|Miscellaneous|1|||
145452987|NCT04238481|524508378|FG002|Overall Study|Miscellaneous|0|||
145452988|NCT04238481|524508379|FG003|Overall Study|Miscellaneous|0|||
145452989|NCT02152371|524508380|FG000|Overall Study|Adverse Event|6|||
145452990|NCT02152371|524508381|FG001|Overall Study|Adverse Event|2|||
145452991|NCT02152371|524508380|FG000|Overall Study|Withdrawal by Subject|3|||
145452992|NCT02152371|524508381|FG001|Overall Study|Withdrawal by Subject|7|||
145452993|NCT02152371|524508380|FG000|Overall Study|Protocol Violation|2|||
145452994|NCT02152371|524508381|FG001|Overall Study|Protocol Violation|3|||
145452995|NCT02152371|524508380|FG000|Overall Study|Lost to Follow-up|1|||
145452996|NCT02152371|524508381|FG001|Overall Study|Lost to Follow-up|0|||
145452997|NCT02152371|524508380|FG000|Overall Study|Lack of Efficacy|0|||
145452998|NCT02152371|524508381|FG001|Overall Study|Lack of Efficacy|1|||
145452999|NCT02152371|524508380|FG000|Overall Study|Physician Decision|0|||
145453000|NCT02152371|524508381|FG001|Overall Study|Physician Decision|2|||
145453001|NCT02152371|524508380|FG000|Overall Study|Reason Not Given|0|||
145453002|NCT02152371|524508381|FG001|Overall Study|Reason Not Given|1|||
145453003|NCT00350870|524508382|FG000|Overall Study|Withdrawal by Subject|21|||
145453004|NCT00350870|524508383|FG001|Overall Study|Withdrawal by Subject|17|||
145453005|NCT00350870|524508384|FG002|Overall Study|Withdrawal by Subject|15|||
145453006|NCT00350870|524508385|FG003|Overall Study|Withdrawal by Subject|14|||
145453007|NCT00350870|524508382|FG000|Overall Study|Physician Decision|1|||
145453008|NCT00350870|524508383|FG001|Overall Study|Physician Decision|0|||
145453009|NCT00350870|524508384|FG002|Overall Study|Physician Decision|1|||
145453010|NCT00350870|524508385|FG003|Overall Study|Physician Decision|1|||
145453011|NCT00349921|524508386|FG000|First Spinal Injection|Physician Decision|1|||
145453012|NCT00349921|524508387|FG001|First Spinal Injection|Physician Decision|0|||
145453013|NCT00349921|524508388|FG002|First Spinal Injection|Physician Decision|0|||
145453014|NCT00349921|524508389|FG003|First Spinal Injection|Physician Decision|0|||
145587741|NCT04389840|525004291|FG001|Overall Study|Adverse Event|0|||
145453015|NCT00349921|524508386|FG000|First Spinal Injection|Adverse Event|0|||
145453016|NCT00349921|524508387|FG001|First Spinal Injection|Adverse Event|0|||
145453017|NCT00349921|524508388|FG002|First Spinal Injection|Adverse Event|1|||
145453018|NCT00349921|524508389|FG003|First Spinal Injection|Adverse Event|0|||
145453019|NCT05285644|524508390|FG000|Overall Study|Adverse Event|3|||
145453020|NCT05285644|524508391|FG001|Overall Study|Adverse Event|3|||
145453021|NCT05285644|524508390|FG000|Overall Study|Withdrawal of Consent|2|||
145453022|NCT05285644|524508391|FG001|Overall Study|Withdrawal of Consent|5|||
145453023|NCT05285644|524508390|FG000|Overall Study|Noncompliance|0|||
145453024|NCT05285644|524508391|FG001|Overall Study|Noncompliance|4|||
145453025|NCT05285644|524508390|FG000|Overall Study|Lost to Follow-up|4|||
145453026|NCT05285644|524508391|FG001|Overall Study|Lost to Follow-up|6|||
145453027|NCT05285644|524508390|FG000|Overall Study|Disallowed Concurrent Medication|1|||
145453028|NCT05285644|524508391|FG001|Overall Study|Disallowed Concurrent Medication|1|||
145453029|NCT05285644|524508390|FG000|Overall Study|Investigator Decision|2|||
145453030|NCT05285644|524508391|FG001|Overall Study|Investigator Decision|0|||
145453031|NCT05285644|524508390|FG000|Overall Study|Protocol Deviation|1|||
145453032|NCT05285644|524508391|FG001|Overall Study|Protocol Deviation|0|||
145453033|NCT05285644|524508390|FG000|Overall Study|As specified in the Clinical Study Report|7|||
145453034|NCT05285644|524508391|FG001|Overall Study|As specified in the Clinical Study Report|3|||
145453035|NCT02952313|524508392|FG000|Primary Endpoint|Lost to Follow-up|4|||
145453036|NCT02952313|524508392|FG000|Primary Endpoint|Withdrawal by Subject|1|||
145453037|NCT02952313|524508392|FG000|Primary Endpoint|Lack of Efficacy|1|||
145453038|NCT02952313|524508392|FG000|Primary Endpoint|Missed visit|1|||
145453039|NCT02952313|524508392|FG000|Long-term Follow-up|Lost to Follow-up|12|||
145453040|NCT02952313|524508392|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
145453041|NCT02952313|524508392|FG000|Long-term Follow-up|Lack of Efficacy|6|||
145453042|NCT02952313|524508392|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
145453043|NCT02952313|524508392|FG000|Long-term Follow-up|Physician Decision|1|||
145453044|NCT02952313|524508392|FG000|Long-term Follow-up|Death|1|||
145453045|NCT04382586|524508393|FG000|Overall Study|Death|3|||
145453046|NCT04382586|524508394|FG001|Overall Study|Death|4|||
145453047|NCT04382586|524508393|FG000|Overall Study|Lost to Follow-up|11|||
145453048|NCT04382586|524508394|FG001|Overall Study|Lost to Follow-up|8|||
145453049|NCT04382586|524508393|FG000|Overall Study|Withdrawal by Subject|3|||
145453050|NCT04382586|524508394|FG001|Overall Study|Withdrawal by Subject|1|||
145453051|NCT04382586|524508393|FG000|Overall Study|Physician Decision|0|||
145453052|NCT04382586|524508394|FG001|Overall Study|Physician Decision|3|||
145453053|NCT00079391|524508395|FG000|Overall Study|Withdrawal by Subject|1|||
145453054|NCT00583752|524508396|FG000|Overall Study|Lost to Follow-up|5|||
145453055|NCT00583752|524508397|FG001|Overall Study|Lost to Follow-up|5|||
145453056|NCT01700959|524508398|FG000|Overall Study|Adverse Event|0|||
145453057|NCT01700959|524508399|FG001|Overall Study|Adverse Event|1|||
145453058|NCT01700959|524508400|FG002|Overall Study|Adverse Event|1|||
145453059|NCT01700959|524508401|FG003|Overall Study|Adverse Event|2|||
145453060|NCT01700959|524508402|FG004|Overall Study|Adverse Event|0|||
145453061|NCT01700959|524508403|FG005|Overall Study|Adverse Event|2|||
145453062|NCT01700959|524508398|FG000|Overall Study|Withdrawal by Subject|15|||
145453063|NCT01700959|524508399|FG001|Overall Study|Withdrawal by Subject|9|||
145453064|NCT01700959|524508400|FG002|Overall Study|Withdrawal by Subject|12|||
145453065|NCT01700959|524508401|FG003|Overall Study|Withdrawal by Subject|11|||
145453066|NCT01700959|524508402|FG004|Overall Study|Withdrawal by Subject|8|||
145453067|NCT01700959|524508403|FG005|Overall Study|Withdrawal by Subject|12|||
145453068|NCT01700959|524508398|FG000|Overall Study|Ineligible|2|||
145453069|NCT01700959|524508399|FG001|Overall Study|Ineligible|1|||
145453070|NCT01700959|524508400|FG002|Overall Study|Ineligible|2|||
145453071|NCT01700959|524508401|FG003|Overall Study|Ineligible|0|||
145453072|NCT01700959|524508402|FG004|Overall Study|Ineligible|0|||
145453073|NCT01700959|524508403|FG005|Overall Study|Ineligible|1|||
145453074|NCT01700959|524508398|FG000|Overall Study|Noncompliant|9|||
145453075|NCT01700959|524508399|FG001|Overall Study|Noncompliant|9|||
145453076|NCT01700959|524508400|FG002|Overall Study|Noncompliant|17|||
145453077|NCT01700959|524508401|FG003|Overall Study|Noncompliant|18|||
145453078|NCT01700959|524508402|FG004|Overall Study|Noncompliant|15|||
145453079|NCT01700959|524508403|FG005|Overall Study|Noncompliant|9|||
145453080|NCT01700959|524508398|FG000|Overall Study|Side effects|1|||
145453081|NCT01700959|524508399|FG001|Overall Study|Side effects|4|||
145453082|NCT01700959|524508400|FG002|Overall Study|Side effects|8|||
145453083|NCT01700959|524508401|FG003|Overall Study|Side effects|4|||
145453084|NCT01700959|524508402|FG004|Overall Study|Side effects|4|||
145453085|NCT01700959|524508403|FG005|Overall Study|Side effects|1|||
145453086|NCT00830375|524508404|FG000|Overall Study|Lost to Follow-up|1|||
145453087|NCT01331837|524508405|FG000|Overall Study|Death|30|||
145453088|NCT01331837|524508406|FG001|Overall Study|Death|34|||
145453089|NCT01331837|524508405|FG000|Overall Study|Lost to Follow-up|3|||
145453090|NCT01331837|524508406|FG001|Overall Study|Lost to Follow-up|1|||
145453091|NCT01331837|524508405|FG000|Overall Study|Info not recorded|10|||
145453092|NCT01331837|524508406|FG001|Overall Study|Info not recorded|16|||
145453093|NCT01331837|524508405|FG000|Overall Study|Withdrawal by Subject|13|||
145453094|NCT01331837|524508406|FG001|Overall Study|Withdrawal by Subject|16|||
145626324|NCT00062868|525144247|FG007|Dose Level 3|Death|0|||
145453095|NCT02640625|524510597|FG000|Overall Study|Adverse Event|1|||
145453096|NCT00511433|524510598|FG000|Overall Study|Adverse Event|5|||
145453097|NCT00511433|524510599|FG001|Overall Study|Adverse Event|0|||
145453098|NCT00511433|524510598|FG000|Overall Study|Other Reason|1|||
145453099|NCT00511433|524510599|FG001|Overall Study|Other Reason|1|||
145453100|NCT01380535|524510600|FG000|Overall Study|Adverse Event|3|||
145453101|NCT01380535|524510601|FG001|Overall Study|Adverse Event|3|||
145626325|NCT00062868|525144248|FG008|Dose Level 3|Death|0|||
145453102|NCT01380535|524510600|FG000|Overall Study|Death|3|||
145453103|NCT01380535|524510601|FG001|Overall Study|Death|0|||
145453104|NCT01380535|524510600|FG000|Overall Study|Study site closed|0|||
145453105|NCT01380535|524510601|FG001|Overall Study|Study site closed|5|||
145453106|NCT01380535|524510600|FG000|Overall Study|Withdrawal by Subject|1|||
145453107|NCT01380535|524510601|FG001|Overall Study|Withdrawal by Subject|2|||
145453108|NCT01380535|524510600|FG000|Overall Study|Protocol Violation|0|||
145453109|NCT01380535|524510601|FG001|Overall Study|Protocol Violation|2|||
145453110|NCT01380535|524510600|FG000|Overall Study|Lack of Efficacy|0|||
145453111|NCT01380535|524510601|FG001|Overall Study|Lack of Efficacy|3|||
145453112|NCT02242435|524510618|FG000|Overall Study|Lost to Follow-up|3|||
145453113|NCT02242435|524510619|FG001|Overall Study|Lost to Follow-up|4|||
145453114|NCT02242435|524510618|FG000|Overall Study|Adverse Event|3|||
145453115|NCT02242435|524510619|FG001|Overall Study|Adverse Event|2|||
145453116|NCT02242435|524510618|FG000|Overall Study|Withdrawal by Subject|13|||
145453117|NCT02242435|524510619|FG001|Overall Study|Withdrawal by Subject|8|||
145453118|NCT02242435|524510618|FG000|Overall Study|Death|0|||
145453119|NCT02242435|524510619|FG001|Overall Study|Death|1|||
145453120|NCT02242435|524510618|FG000|Overall Study|Protocol Violation|1|||
145453121|NCT02242435|524510619|FG001|Overall Study|Protocol Violation|0|||
145453122|NCT02242435|524510618|FG000|Overall Study|Physician Decision|0|||
145453123|NCT02242435|524510619|FG001|Overall Study|Physician Decision|1|||
145453124|NCT01110330|524510620|FG000|Overall Study|Adverse Event|0|||
145453125|NCT01110330|524510621|FG001|Overall Study|Adverse Event|4|||
145453126|NCT01110330|524510622|FG002|Overall Study|Adverse Event|3|||
145453127|NCT01110330|524510620|FG000|Overall Study|Lack of Efficacy|3|||
145453128|NCT01110330|524510621|FG001|Overall Study|Lack of Efficacy|1|||
145453129|NCT01110330|524510622|FG002|Overall Study|Lack of Efficacy|1|||
145453130|NCT01110330|524510620|FG000|Overall Study|Lost to Follow-up|9|||
145453131|NCT01110330|524510621|FG001|Overall Study|Lost to Follow-up|10|||
145453132|NCT01110330|524510622|FG002|Overall Study|Lost to Follow-up|15|||
145453133|NCT01110330|524510620|FG000|Overall Study|Physician Decision|0|||
145453134|NCT01110330|524510621|FG001|Overall Study|Physician Decision|1|||
145453135|NCT01110330|524510622|FG002|Overall Study|Physician Decision|0|||
145453136|NCT01110330|524510620|FG000|Overall Study|Protocol Violation|2|||
145453137|NCT01110330|524510621|FG001|Overall Study|Protocol Violation|0|||
145453138|NCT01110330|524510622|FG002|Overall Study|Protocol Violation|4|||
145453139|NCT01110330|524510620|FG000|Overall Study|Withdrawal by Subject|0|||
145453140|NCT01110330|524510621|FG001|Overall Study|Withdrawal by Subject|6|||
145453141|NCT01110330|524510622|FG002|Overall Study|Withdrawal by Subject|2|||
145453142|NCT01110330|524510620|FG000|Overall Study|Other|1|||
145453143|NCT01110330|524510621|FG001|Overall Study|Other|1|||
145453144|NCT01110330|524510622|FG002|Overall Study|Other|1|||
145453145|NCT03895086|524510624|FG000|Overall Study|Early termination study|1|||
145453146|NCT03895086|524510625|FG001|Overall Study|Early termination study|0|||
145453147|NCT02513485|524510637|FG000|Overall Study|Adverse Event|1|||
145453148|NCT02513485|524510638|FG001|Overall Study|Adverse Event|0|||
145453149|NCT04115748|524510648|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
145453150|NCT04115748|524510649|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
145453151|NCT04115748|524510650|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
145453152|NCT04115748|524510651|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
145453153|NCT04115748|524510652|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453154|NCT04115748|524510653|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453155|NCT04115748|524510654|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453156|NCT04115748|524510655|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453157|NCT04115748|524510656|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453158|NCT04115748|524510657|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
145453159|NCT04115748|524510648|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453160|NCT04115748|524510649|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453161|NCT04115748|524510650|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453162|NCT04115748|524510651|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
145453163|NCT04115748|524510652|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453164|NCT04115748|524510653|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453165|NCT04115748|524510654|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453166|NCT04115748|524510655|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453167|NCT04115748|524510656|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453168|NCT04115748|524510657|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
145453169|NCT04115748|524510648|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
145453170|NCT04115748|524510649|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
145453171|NCT04115748|524510650|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
145453172|NCT04115748|524510651|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
145453173|NCT04115748|524510652|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
145453174|NCT04115748|524510653|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
145453175|NCT04115748|524510654|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
145587742|NCT04389840|525004292|FG002|Overall Study|Adverse Event|0|||
145453176|NCT04115748|524510655|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
145453177|NCT04115748|524510656|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
145453178|NCT04115748|524510657|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
145453179|NCT04115748|524510648|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453180|NCT04115748|524510649|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453181|NCT04115748|524510650|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453182|NCT04115748|524510651|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453183|NCT04115748|524510652|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453184|NCT04115748|524510653|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453185|NCT04115748|524510654|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453186|NCT04115748|524510655|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453187|NCT04115748|524510656|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
145453188|NCT04115748|524510657|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
145453189|NCT00713349|524510658|FG000|Overall Study|Protocol Violation|1|||
145453190|NCT03764631|524510659|FG000|Overall Study|Personal Reasons|3|||
145453191|NCT03764631|524510660|FG001|Overall Study|Personal Reasons|2|||
145453192|NCT03764631|524510659|FG000|Overall Study|Switching Therapy|3|||
145453193|NCT03764631|524510660|FG001|Overall Study|Switching Therapy|3|||
145453194|NCT03764631|524510659|FG000|Overall Study|Adverse Event|0|||
145453195|NCT03764631|524510660|FG001|Overall Study|Adverse Event|1|||
145453196|NCT03764631|524510659|FG000|Overall Study|Lost to Follow-up|33|||
145453197|NCT03764631|524510660|FG001|Overall Study|Lost to Follow-up|41|||
145453198|NCT03764631|524510659|FG000|Overall Study|No data as study site was closed|2|||
145453199|NCT03764631|524510660|FG001|Overall Study|No data as study site was closed|6|||
145453200|NCT01200407|524510661|FG000|Overall Study|Lost to Follow-up|56|||
145453201|NCT01200407|524510661|FG000|Overall Study|Adverse Event|3|||
145453202|NCT01200407|524510661|FG000|Overall Study|Withdrawal by Subject|4|||
145453203|NCT01200407|524510661|FG000|Overall Study|Other|19|||
145453204|NCT02752633|524510664|FG000|Overall Study|Withdrawal by Subject|1|||
145453205|NCT03275246|524510665|FG000|Overall Study|Protocol Violation|5|||
145453206|NCT03275246|524510665|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
145453207|NCT00433966|524510668|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
145453208|NCT00433966|524510669|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
145453209|NCT00433966|524510670|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
145453210|NCT00433966|524510671|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
145453211|NCT00433966|524510668|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
145453212|NCT00433966|524510669|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
145453213|NCT00433966|524510670|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
145453214|NCT00433966|524510671|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
145453215|NCT00433966|524510668|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
145453216|NCT00433966|524510669|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
145453217|NCT00433966|524510670|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
145453218|NCT00433966|524510671|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
145453219|NCT00433966|524510668|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
145453220|NCT00433966|524510669|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
145453221|NCT00433966|524510670|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
145453222|NCT00433966|524510671|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
145453223|NCT00433966|524510668|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
145453224|NCT00433966|524510669|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
145453225|NCT00433966|524510670|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
145453226|NCT00433966|524510671|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
145453227|NCT03497975|524510673|FG000|Overall Study|Withdrew Consent|34|||
145453228|NCT03497975|524510674|FG001|Overall Study|Withdrew Consent|35|||
145453229|NCT03497975|524510673|FG000|Overall Study|Lost to Follow-up|7|||
145453230|NCT03497975|524510674|FG001|Overall Study|Lost to Follow-up|7|||
145453231|NCT03497975|524510673|FG000|Overall Study|Physician Decision|4|||
145453232|NCT03497975|524510674|FG001|Overall Study|Physician Decision|5|||
145453233|NCT03497975|524510673|FG000|Overall Study|Discontinued|42|||
145453234|NCT03497975|524510674|FG001|Overall Study|Discontinued|39|||
145453235|NCT03497975|524510673|FG000|Overall Study|Reason Not Specified|15|||
145453236|NCT03497975|524510674|FG001|Overall Study|Reason Not Specified|14|||
145453237|NCT01296711|524510675|FG000|Overall Study|Adverse Event|3|||
145453238|NCT01296711|524510676|FG001|Overall Study|Adverse Event|1|||
145453239|NCT01296711|524510677|FG002|Overall Study|Adverse Event|4|||
145453240|NCT01296711|524510678|FG003|Overall Study|Adverse Event|3|||
145453241|NCT01296711|524510679|FG004|Overall Study|Adverse Event|1|||
145453242|NCT01296711|524510680|FG005|Overall Study|Adverse Event|6|||
145453243|NCT01296711|524510681|FG006|Overall Study|Adverse Event|11|||
145453244|NCT01296711|524510682|FG007|Overall Study|Adverse Event|3|||
145453245|NCT01296711|524510675|FG000|Overall Study|Lack of Efficacy|1|||
145453246|NCT01296711|524510676|FG001|Overall Study|Lack of Efficacy|4|||
145453247|NCT01296711|524510677|FG002|Overall Study|Lack of Efficacy|1|||
145453248|NCT01296711|524510678|FG003|Overall Study|Lack of Efficacy|1|||
145453249|NCT01296711|524510679|FG004|Overall Study|Lack of Efficacy|1|||
145453250|NCT01296711|524510680|FG005|Overall Study|Lack of Efficacy|0|||
145453251|NCT01296711|524510681|FG006|Overall Study|Lack of Efficacy|2|||
145453252|NCT01296711|524510682|FG007|Overall Study|Lack of Efficacy|3|||
145453253|NCT01296711|524510675|FG000|Overall Study|Lost to Follow-up|0|||
145453254|NCT01296711|524510676|FG001|Overall Study|Lost to Follow-up|0|||
145453255|NCT01296711|524510677|FG002|Overall Study|Lost to Follow-up|1|||
145453256|NCT01296711|524510678|FG003|Overall Study|Lost to Follow-up|1|||
145453257|NCT01296711|524510679|FG004|Overall Study|Lost to Follow-up|2|||
145453258|NCT01296711|524510680|FG005|Overall Study|Lost to Follow-up|0|||
145453259|NCT01296711|524510681|FG006|Overall Study|Lost to Follow-up|4|||
145453260|NCT01296711|524510682|FG007|Overall Study|Lost to Follow-up|2|||
145453261|NCT01296711|524510675|FG000|Overall Study|Protocol Violation|0|||
145453262|NCT01296711|524510676|FG001|Overall Study|Protocol Violation|0|||
145453263|NCT01296711|524510677|FG002|Overall Study|Protocol Violation|0|||
145453264|NCT01296711|524510678|FG003|Overall Study|Protocol Violation|1|||
145453265|NCT01296711|524510679|FG004|Overall Study|Protocol Violation|1|||
145453266|NCT01296711|524510680|FG005|Overall Study|Protocol Violation|0|||
145453267|NCT01296711|524510681|FG006|Overall Study|Protocol Violation|0|||
145453268|NCT01296711|524510682|FG007|Overall Study|Protocol Violation|0|||
145453269|NCT01296711|524510675|FG000|Overall Study|Withdrawal by Subject|4|||
145453270|NCT01296711|524510676|FG001|Overall Study|Withdrawal by Subject|2|||
145453271|NCT01296711|524510677|FG002|Overall Study|Withdrawal by Subject|2|||
145453272|NCT01296711|524510678|FG003|Overall Study|Withdrawal by Subject|1|||
145453273|NCT01296711|524510679|FG004|Overall Study|Withdrawal by Subject|1|||
145453274|NCT01296711|524510680|FG005|Overall Study|Withdrawal by Subject|1|||
145453275|NCT01296711|524510681|FG006|Overall Study|Withdrawal by Subject|2|||
145453276|NCT01296711|524510682|FG007|Overall Study|Withdrawal by Subject|1|||
145453277|NCT01296711|524510675|FG000|Overall Study|Study termination|8|||
145453278|NCT01296711|524510676|FG001|Overall Study|Study termination|1|||
145453279|NCT01296711|524510677|FG002|Overall Study|Study termination|5|||
145453280|NCT01296711|524510678|FG003|Overall Study|Study termination|4|||
145453281|NCT01296711|524510679|FG004|Overall Study|Study termination|4|||
145453282|NCT01296711|524510680|FG005|Overall Study|Study termination|4|||
145453283|NCT01296711|524510681|FG006|Overall Study|Study termination|8|||
145453284|NCT01296711|524510682|FG007|Overall Study|Study termination|10|||
145453285|NCT01296711|524510675|FG000|Overall Study|Continued elevated liver enzymes|0|||
145453286|NCT01296711|524510676|FG001|Overall Study|Continued elevated liver enzymes|0|||
145453287|NCT01296711|524510677|FG002|Overall Study|Continued elevated liver enzymes|0|||
145453288|NCT01296711|524510678|FG003|Overall Study|Continued elevated liver enzymes|1|||
145453289|NCT01296711|524510679|FG004|Overall Study|Continued elevated liver enzymes|0|||
145453290|NCT01296711|524510680|FG005|Overall Study|Continued elevated liver enzymes|0|||
145453291|NCT01296711|524510681|FG006|Overall Study|Continued elevated liver enzymes|0|||
145453292|NCT01296711|524510682|FG007|Overall Study|Continued elevated liver enzymes|0|||
145453293|NCT01296711|524510675|FG000|Overall Study|Methotrexate discontinued|0|||
145453294|NCT01296711|524510676|FG001|Overall Study|Methotrexate discontinued|0|||
145453295|NCT01296711|524510677|FG002|Overall Study|Methotrexate discontinued|0|||
145453296|NCT01296711|524510678|FG003|Overall Study|Methotrexate discontinued|1|||
145453297|NCT01296711|524510679|FG004|Overall Study|Methotrexate discontinued|0|||
145453298|NCT01296711|524510680|FG005|Overall Study|Methotrexate discontinued|0|||
145453299|NCT01296711|524510681|FG006|Overall Study|Methotrexate discontinued|0|||
145453300|NCT01296711|524510682|FG007|Overall Study|Methotrexate discontinued|0|||
145453301|NCT01296711|524510675|FG000|Overall Study|Investigator discretion|0|||
145453302|NCT01296711|524510676|FG001|Overall Study|Investigator discretion|0|||
145453303|NCT01296711|524510677|FG002|Overall Study|Investigator discretion|0|||
145453304|NCT01296711|524510678|FG003|Overall Study|Investigator discretion|0|||
145453305|NCT01296711|524510679|FG004|Overall Study|Investigator discretion|0|||
145453306|NCT01296711|524510680|FG005|Overall Study|Investigator discretion|0|||
145453307|NCT01296711|524510681|FG006|Overall Study|Investigator discretion|1|||
145453308|NCT01296711|524510682|FG007|Overall Study|Investigator discretion|0|||
145453309|NCT01296711|524510675|FG000|Overall Study|Other|0|||
145453310|NCT01296711|524510676|FG001|Overall Study|Other|0|||
145453311|NCT01296711|524510677|FG002|Overall Study|Other|0|||
145453312|NCT01296711|524510678|FG003|Overall Study|Other|0|||
145453313|NCT01296711|524510679|FG004|Overall Study|Other|0|||
145453314|NCT01296711|524510680|FG005|Overall Study|Other|0|||
145453315|NCT01296711|524510681|FG006|Overall Study|Other|1|||
145453316|NCT01296711|524510682|FG007|Overall Study|Other|0|||
145453317|NCT01296711|524510675|FG000|Overall Study|Required restricted steroid injections|0|||
145453318|NCT01296711|524510676|FG001|Overall Study|Required restricted steroid injections|0|||
145453319|NCT01296711|524510677|FG002|Overall Study|Required restricted steroid injections|0|||
145453320|NCT01296711|524510678|FG003|Overall Study|Required restricted steroid injections|0|||
145453321|NCT01296711|524510679|FG004|Overall Study|Required restricted steroid injections|0|||
145453322|NCT01296711|524510680|FG005|Overall Study|Required restricted steroid injections|0|||
145453323|NCT01296711|524510681|FG006|Overall Study|Required restricted steroid injections|1|||
145453324|NCT01296711|524510682|FG007|Overall Study|Required restricted steroid injections|0|||
145453325|NCT01296711|524510675|FG000|Overall Study|Ongoing missed appointments|0|||
145453326|NCT01296711|524510676|FG001|Overall Study|Ongoing missed appointments|0|||
145453327|NCT01296711|524510677|FG002|Overall Study|Ongoing missed appointments|0|||
145453328|NCT01296711|524510678|FG003|Overall Study|Ongoing missed appointments|0|||
145453329|NCT01296711|524510679|FG004|Overall Study|Ongoing missed appointments|0|||
145453330|NCT01296711|524510680|FG005|Overall Study|Ongoing missed appointments|0|||
145453331|NCT01296711|524510681|FG006|Overall Study|Ongoing missed appointments|1|||
145453332|NCT01296711|524510682|FG007|Overall Study|Ongoing missed appointments|0|||
145453333|NCT01296711|524510675|FG000|Overall Study|Failure to comply with visits|0|||
145453334|NCT01296711|524510676|FG001|Overall Study|Failure to comply with visits|0|||
145453335|NCT01296711|524510677|FG002|Overall Study|Failure to comply with visits|0|||
145453336|NCT01296711|524510678|FG003|Overall Study|Failure to comply with visits|0|||
145453337|NCT01296711|524510679|FG004|Overall Study|Failure to comply with visits|0|||
145453338|NCT01296711|524510680|FG005|Overall Study|Failure to comply with visits|0|||
145453339|NCT01296711|524510681|FG006|Overall Study|Failure to comply with visits|0|||
145453340|NCT01296711|524510682|FG007|Overall Study|Failure to comply with visits|1|||
145453341|NCT01296711|524510675|FG000|Overall Study|Patient decision due to transport|0|||
145453342|NCT01296711|524510676|FG001|Overall Study|Patient decision due to transport|0|||
145453343|NCT01296711|524510677|FG002|Overall Study|Patient decision due to transport|0|||
145453344|NCT01296711|524510678|FG003|Overall Study|Patient decision due to transport|0|||
145453345|NCT01296711|524510679|FG004|Overall Study|Patient decision due to transport|0|||
145453346|NCT01296711|524510680|FG005|Overall Study|Patient decision due to transport|0|||
145453347|NCT01296711|524510681|FG006|Overall Study|Patient decision due to transport|0|||
145453348|NCT01296711|524510682|FG007|Overall Study|Patient decision due to transport|1|||
145453349|NCT00923975|524510686|FG000|Overall Study|Did not meet inclusion criteria|1|||
145453350|NCT01005316|524510689|FG000|Overall Study|Adverse Event|0|||
145453351|NCT01005316|524510690|FG001|Overall Study|Adverse Event|0|||
145453352|NCT01005316|524510691|FG002|Overall Study|Adverse Event|0|||
145453353|NCT01005316|524510692|FG003|Overall Study|Adverse Event|1|||
145453354|NCT01005316|524510689|FG000|Overall Study|Death|20|||
145453355|NCT01005316|524510690|FG001|Overall Study|Death|5|||
145453356|NCT01005316|524510691|FG002|Overall Study|Death|1|||
145453357|NCT01005316|524510692|FG003|Overall Study|Death|15|||
145453358|NCT01005316|524510689|FG000|Overall Study|Study Termination|5|||
145453359|NCT01005316|524510690|FG001|Overall Study|Study Termination|63|||
145453360|NCT01005316|524510691|FG002|Overall Study|Study Termination|9|||
145453361|NCT01005316|524510692|FG003|Overall Study|Study Termination|85|||
145453362|NCT01005316|524510689|FG000|Overall Study|Lost to Follow-up|1|||
145453363|NCT01005316|524510690|FG001|Overall Study|Lost to Follow-up|3|||
145453364|NCT01005316|524510691|FG002|Overall Study|Lost to Follow-up|0|||
145453365|NCT01005316|524510692|FG003|Overall Study|Lost to Follow-up|2|||
145453366|NCT01005316|524510689|FG000|Overall Study|Physician Decision|6|||
145453367|NCT01005316|524510690|FG001|Overall Study|Physician Decision|0|||
145453368|NCT01005316|524510691|FG002|Overall Study|Physician Decision|0|||
145453369|NCT01005316|524510692|FG003|Overall Study|Physician Decision|0|||
145453370|NCT01005316|524510689|FG000|Overall Study|Sponsor Decision|6|||
145453371|NCT01005316|524510690|FG001|Overall Study|Sponsor Decision|3|||
145453372|NCT01005316|524510691|FG002|Overall Study|Sponsor Decision|0|||
145453373|NCT01005316|524510692|FG003|Overall Study|Sponsor Decision|0|||
145453374|NCT01005316|524510689|FG000|Overall Study|Withdrawal by Subject|1|||
145453375|NCT01005316|524510690|FG001|Overall Study|Withdrawal by Subject|1|||
145453376|NCT01005316|524510691|FG002|Overall Study|Withdrawal by Subject|0|||
145453377|NCT01005316|524510692|FG003|Overall Study|Withdrawal by Subject|2|||
145453378|NCT01005316|524510689|FG000|Overall Study|Consented to Another Study|2|||
145453379|NCT01005316|524510690|FG001|Overall Study|Consented to Another Study|0|||
145453380|NCT01005316|524510691|FG002|Overall Study|Consented to Another Study|0|||
145453381|NCT01005316|524510692|FG003|Overall Study|Consented to Another Study|0|||
145453382|NCT01005316|524510689|FG000|Overall Study|Delisted|8|||
145453383|NCT01005316|524510690|FG001|Overall Study|Delisted|0|||
145453384|NCT01005316|524510691|FG002|Overall Study|Delisted|0|||
145453385|NCT01005316|524510692|FG003|Overall Study|Delisted|0|||
145453386|NCT01005316|524510689|FG000|Overall Study|Transferred Care|1|||
145453387|NCT01005316|524510690|FG001|Overall Study|Transferred Care|0|||
145453388|NCT01005316|524510691|FG002|Overall Study|Transferred Care|1|||
145453389|NCT01005316|524510692|FG003|Overall Study|Transferred Care|3|||
145453390|NCT01005316|524510689|FG000|Overall Study|Retransplanted|0|||
145453391|NCT01005316|524510690|FG001|Overall Study|Retransplanted|1|||
145453392|NCT01005316|524510691|FG002|Overall Study|Retransplanted|0|||
145453393|NCT01005316|524510692|FG003|Overall Study|Retransplanted|0|||
145453394|NCT00632827|524510693|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
145453395|NCT00632827|524510693|FG000|Overall Study|Death|2|||
145453396|NCT00632827|524510693|FG000|Overall Study|Adverse Event|5|||
145453397|NCT00632827|524510693|FG000|Overall Study|Lost to Follow-up|1|||
145453398|NCT01177553|524510696|FG000|Overall Study|babies not yet 6 months of age|1|||
145453399|NCT01177553|524510697|FG001|Overall Study|babies not yet 6 months of age|0|||
145453400|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
145453401|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
145453402|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
145453403|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
145453404|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
145453405|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
145453406|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
145453407|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
145453408|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
145453409|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
145453410|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
145453411|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
145453412|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
145453413|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
145453414|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
145453415|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
145453416|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
145453417|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453418|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453419|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453420|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453421|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453422|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453423|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453424|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453425|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453426|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453427|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453428|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453429|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145453430|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
145453431|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
145453432|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
145453433|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
145453434|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
145453435|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
145453436|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
145453437|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
145453438|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
145453439|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
145453440|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
145453441|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
145453442|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
145453443|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
145453444|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
145453445|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
145453446|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
145453447|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
145453448|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
145453449|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
145453450|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
145453451|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
145453452|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
145453453|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
145453454|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
145453455|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
145453456|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
145453457|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
145453458|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
145453459|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
145453460|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
145453461|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
145453462|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
145453463|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
145453464|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453465|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453466|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453467|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453468|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453469|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453470|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145587743|NCT04389840|525004293|FG003|Overall Study|Adverse Event|1|||
145587744|NCT04389840|525004294|FG004|Overall Study|Adverse Event|0|||
145587745|NCT04389840|525004295|FG005|Overall Study|Adverse Event|0|||
145453471|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453472|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453473|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453474|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145453475|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
145453476|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
145453477|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
145453478|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
145453479|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453480|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453481|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453482|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453483|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453484|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453485|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453486|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453487|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453488|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453489|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
145453490|NCT03831191|524510701|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453491|NCT03831191|524510702|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453492|NCT03831191|524510703|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453493|NCT03831191|524510704|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
145453494|NCT03831191|524510705|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453495|NCT03831191|524510706|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453496|NCT03831191|524510707|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453497|NCT03831191|524510708|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453498|NCT03831191|524510709|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453499|NCT03831191|524510710|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453500|NCT03831191|524510711|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453501|NCT03831191|524510712|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453502|NCT03831191|524510713|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453503|NCT03831191|524510714|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453504|NCT03831191|524510715|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
145453505|NCT03831191|524510701|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
145453506|NCT03831191|524510702|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
145453507|NCT03831191|524510703|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
145453508|NCT03831191|524510704|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
145453509|NCT03831191|524510705|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
145453510|NCT03831191|524510706|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
145453511|NCT03831191|524510707|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
145453512|NCT03831191|524510708|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
145453513|NCT03831191|524510709|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
145453514|NCT03831191|524510710|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
145453515|NCT03831191|524510711|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
145453516|NCT03831191|524510712|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
145453517|NCT03831191|524510713|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
145453518|NCT03831191|524510714|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
145453519|NCT03831191|524510715|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
145453520|NCT03831191|524510701|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453521|NCT03831191|524510702|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453522|NCT03831191|524510703|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453523|NCT03831191|524510704|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453524|NCT03831191|524510705|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453525|NCT03831191|524510706|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453526|NCT03831191|524510707|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453527|NCT03831191|524510708|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453528|NCT03831191|524510709|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453529|NCT03831191|524510710|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453530|NCT03831191|524510711|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453531|NCT03831191|524510712|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453532|NCT03831191|524510713|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453533|NCT03831191|524510714|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145453534|NCT03831191|524510715|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
145453535|NCT03831191|524510701|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453536|NCT03831191|524510702|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453537|NCT03831191|524510703|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453538|NCT03831191|524510704|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453539|NCT03831191|524510705|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453540|NCT03831191|524510706|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453541|NCT03831191|524510707|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453542|NCT03831191|524510708|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453543|NCT03831191|524510709|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453544|NCT03831191|524510710|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453545|NCT03831191|524510711|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453546|NCT03831191|524510712|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453547|NCT03831191|524510713|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453548|NCT03831191|524510714|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145453549|NCT03831191|524510715|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
145453550|NCT03070171|524510718|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
145453551|NCT03070171|524510719|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
145453552|NCT03070171|524510718|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
145453553|NCT03070171|524510719|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
145453554|NCT01471028|524510720|FG000|VTI-208|Adverse Event|39|||
145453555|NCT01471028|524510721|FG001|VTI-208|Adverse Event|41|||
145453556|NCT01471028|524510720|FG000|VTI-208|Withdrawal by Subject|0|||
145453557|NCT01471028|524510721|FG001|VTI-208|Withdrawal by Subject|2|||
145453558|NCT01471028|524510720|FG000|VTI-208|Lost to Follow-up|1|||
145453559|NCT01471028|524510721|FG001|VTI-208|Lost to Follow-up|1|||
145453560|NCT01471028|524510720|FG000|VTI-208E|Death|7|||
145453561|NCT01471028|524510721|FG001|VTI-208E|Death|10|||
145453562|NCT01471028|524510720|FG000|VTI-208E|Withdrawal by Subject|1|||
145453563|NCT01471028|524510721|FG001|VTI-208E|Withdrawal by Subject|0|||
145453564|NCT01471028|524510720|FG000|VTI-208E|Lost to Follow-up|0|||
145453565|NCT01471028|524510721|FG001|VTI-208E|Lost to Follow-up|2|||
145453566|NCT00695955|524510722|FG000|Cohort 1|Adverse Event|26|||
145453567|NCT00695955|524510722|FG000|Cohort 1|Protocol Violation|2|||
145453568|NCT00695955|524510722|FG000|Cohort 1|Lost to Follow-up|30|||
145453569|NCT00695955|524510722|FG000|Cohort 1|Withdrawal by Subject|25|||
145453570|NCT00695955|524510722|FG000|Cohort 1|Lack of Efficacy|3|||
145453571|NCT00695955|524510722|FG000|Cohort 1|Other|16|||
145453572|NCT00695955|524510722|FG000|Cohort 2|Adverse Event|24|||
145453573|NCT00695955|524510722|FG000|Cohort 2|Protocol Violation|5|||
145453574|NCT00695955|524510722|FG000|Cohort 2|Lost to Follow-up|38|||
145453575|NCT00695955|524510722|FG000|Cohort 2|Withdrawal by Subject|28|||
145453576|NCT00695955|524510722|FG000|Cohort 2|Lack of Efficacy|4|||
145453577|NCT00695955|524510722|FG000|Cohort 2|Other|5|||
145453578|NCT04826094|524510723|FG000|Overall Study|Lost to Follow-up|2|||
145453579|NCT04826094|524510724|FG001|Overall Study|Lost to Follow-up|1|||
145453580|NCT04826094|524510725|FG002|Overall Study|Lost to Follow-up|0|||
145453581|NCT04826094|524510726|FG003|Overall Study|Lost to Follow-up|0|||
145453582|NCT04826094|524510727|FG004|Overall Study|Lost to Follow-up|1|||
145453583|NCT04826094|524510728|FG005|Overall Study|Lost to Follow-up|3|||
145453584|NCT04826094|524510729|FG006|Overall Study|Lost to Follow-up|1|||
145453585|NCT04826094|524510730|FG007|Overall Study|Lost to Follow-up|1|||
145453586|NCT04826094|524510723|FG000|Overall Study|Participant withdrew consent|1|||
145453587|NCT04826094|524510724|FG001|Overall Study|Participant withdrew consent|0|||
145453588|NCT04826094|524510725|FG002|Overall Study|Participant withdrew consent|0|||
145453589|NCT04826094|524510726|FG003|Overall Study|Participant withdrew consent|1|||
145453590|NCT04826094|524510727|FG004|Overall Study|Participant withdrew consent|1|||
145453591|NCT04826094|524510728|FG005|Overall Study|Participant withdrew consent|1|||
145453592|NCT04826094|524510729|FG006|Overall Study|Participant withdrew consent|0|||
145453593|NCT04826094|524510730|FG007|Overall Study|Participant withdrew consent|1|||
145453594|NCT04826094|524510723|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
145453595|NCT04826094|524510724|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
145453596|NCT04826094|524510725|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
145453597|NCT04826094|524510726|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
145453598|NCT04826094|524510727|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
145453599|NCT04826094|524510728|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
145453600|NCT04826094|524510729|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
145626326|NCT00062868|525144249|FG009|Dose Level 3|Death|0|||
145453601|NCT04826094|524510730|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
145453602|NCT04826094|524510723|FG000|Overall Study|Withdrawn by Investigator|0|||
145453603|NCT04826094|524510724|FG001|Overall Study|Withdrawn by Investigator|0|||
145453604|NCT04826094|524510725|FG002|Overall Study|Withdrawn by Investigator|0|||
145453605|NCT04826094|524510726|FG003|Overall Study|Withdrawn by Investigator|0|||
145453606|NCT04826094|524510727|FG004|Overall Study|Withdrawn by Investigator|0|||
145453607|NCT04826094|524510728|FG005|Overall Study|Withdrawn by Investigator|1|||
145453608|NCT04826094|524510729|FG006|Overall Study|Withdrawn by Investigator|0|||
145453609|NCT04826094|524510730|FG007|Overall Study|Withdrawn by Investigator|1|||
145453610|NCT04826094|524510723|FG000|Overall Study|Other: Moved from area|1|||
145453611|NCT04826094|524510724|FG001|Overall Study|Other: Moved from area|1|||
145453612|NCT04826094|524510725|FG002|Overall Study|Other: Moved from area|1|||
145453613|NCT04826094|524510726|FG003|Overall Study|Other: Moved from area|0|||
145453614|NCT04826094|524510727|FG004|Overall Study|Other: Moved from area|0|||
145453615|NCT04826094|524510728|FG005|Overall Study|Other: Moved from area|0|||
145453616|NCT04826094|524510729|FG006|Overall Study|Other: Moved from area|0|||
145453617|NCT04826094|524510730|FG007|Overall Study|Other: Moved from area|0|||
145453618|NCT04826094|524510723|FG000|Overall Study|Other: Declined|0|||
145453619|NCT04826094|524510724|FG001|Overall Study|Other: Declined|0|||
145453620|NCT04826094|524510725|FG002|Overall Study|Other: Declined|0|||
145453621|NCT04826094|524510726|FG003|Overall Study|Other: Declined|0|||
145453622|NCT04826094|524510727|FG004|Overall Study|Other: Declined|1|||
145453623|NCT04826094|524510728|FG005|Overall Study|Other: Declined|0|||
145453624|NCT04826094|524510729|FG006|Overall Study|Other: Declined|0|||
145453625|NCT04826094|524510730|FG007|Overall Study|Other: Declined|0|||
145453626|NCT04826094|524510723|FG000|Overall Study|Other: Vaccine not administered|0|||
145453627|NCT04826094|524510724|FG001|Overall Study|Other: Vaccine not administered|0|||
145453628|NCT04826094|524510725|FG002|Overall Study|Other: Vaccine not administered|1|||
145453629|NCT04826094|524510726|FG003|Overall Study|Other: Vaccine not administered|0|||
145453630|NCT04826094|524510727|FG004|Overall Study|Other: Vaccine not administered|0|||
145453631|NCT04826094|524510728|FG005|Overall Study|Other: Vaccine not administered|1|||
145453632|NCT04826094|524510729|FG006|Overall Study|Other: Vaccine not administered|1|||
145453633|NCT04826094|524510730|FG007|Overall Study|Other: Vaccine not administered|3|||
145453634|NCT02151903|524510731|FG000|Overall Study|Withdrawal by Subject|1|||
145453635|NCT02151903|524510732|FG001|Overall Study|Withdrawal by Subject|0|||
145453636|NCT02151903|524510731|FG000|Overall Study|Progressive disease|2|||
145453637|NCT02151903|524510732|FG001|Overall Study|Progressive disease|1|||
145453638|NCT01500252|524510733|FG000|Overall Study|Death|4|||
145453639|NCT01500252|524510734|FG001|Overall Study|Death|2|||
145453640|NCT01500252|524510733|FG000|Overall Study|Lost to Follow-up|5|||
145453641|NCT01500252|524510734|FG001|Overall Study|Lost to Follow-up|4|||
145453642|NCT01421303|524510736|FG000|Overall Study|Lost to Follow-up|13|||
145453643|NCT01421303|524510736|FG000|Overall Study|Non compliance with study procedure|1|||
145453644|NCT01421303|524510736|FG000|Overall Study|Other|7|||
145453645|NCT01421303|524510736|FG000|Overall Study|Withdrawal by Subject|1|||
145453646|NCT06003777|524510737|FG000|Period 1|Adverse Event|0|||
145453647|NCT06003777|524510738|FG001|Period 1|Adverse Event|0|||
145453648|NCT06003777|524510739|FG002|Period 1|Adverse Event|1|||
145453649|NCT06003777|524510740|FG003|Period 1|Adverse Event|0|||
145453650|NCT06003777|524510741|FG004|Period 1|Adverse Event|0|||
145453651|NCT06003777|524510742|FG005|Period 1|Adverse Event|0|||
145453652|NCT06003777|524510743|FG006|Period 1|Adverse Event|0|||
145453653|NCT06003777|524510744|FG007|Period 1|Adverse Event|0|||
145453654|NCT06003777|524510745|FG008|Period 1|Adverse Event|0|||
145453655|NCT06003777|524510746|FG009|Period 1|Adverse Event|0|||
145453656|NCT06003777|524510747|FG010|Period 1|Adverse Event|0|||
145453657|NCT06003777|524510748|FG011|Period 1|Adverse Event|0|||
145453658|NCT06003777|524510737|FG000|Period 1|Withdrawal by Subject|0|||
145453659|NCT06003777|524510738|FG001|Period 1|Withdrawal by Subject|0|||
145453660|NCT06003777|524510739|FG002|Period 1|Withdrawal by Subject|0|||
145453661|NCT06003777|524510740|FG003|Period 1|Withdrawal by Subject|0|||
145453662|NCT06003777|524510741|FG004|Period 1|Withdrawal by Subject|1|||
145453663|NCT06003777|524510742|FG005|Period 1|Withdrawal by Subject|0|||
145453664|NCT06003777|524510743|FG006|Period 1|Withdrawal by Subject|0|||
145453665|NCT06003777|524510744|FG007|Period 1|Withdrawal by Subject|0|||
145453666|NCT06003777|524510745|FG008|Period 1|Withdrawal by Subject|0|||
145453667|NCT06003777|524510746|FG009|Period 1|Withdrawal by Subject|0|||
145453668|NCT06003777|524510747|FG010|Period 1|Withdrawal by Subject|0|||
145453669|NCT06003777|524510748|FG011|Period 1|Withdrawal by Subject|0|||
145453670|NCT06003777|524510737|FG000|Period 2|Withdrawal by Subject|0|||
145453671|NCT06003777|524510738|FG001|Period 2|Withdrawal by Subject|0|||
145453672|NCT06003777|524510739|FG002|Period 2|Withdrawal by Subject|0|||
145453673|NCT06003777|524510740|FG003|Period 2|Withdrawal by Subject|0|||
145453674|NCT06003777|524510741|FG004|Period 2|Withdrawal by Subject|0|||
145453675|NCT06003777|524510742|FG005|Period 2|Withdrawal by Subject|0|||
145453676|NCT06003777|524510743|FG006|Period 2|Withdrawal by Subject|0|||
145453677|NCT06003777|524510744|FG007|Period 2|Withdrawal by Subject|0|||
145453678|NCT06003777|524510745|FG008|Period 2|Withdrawal by Subject|1|||
145453679|NCT06003777|524510746|FG009|Period 2|Withdrawal by Subject|0|||
145453680|NCT06003777|524510747|FG010|Period 2|Withdrawal by Subject|0|||
145453681|NCT06003777|524510748|FG011|Period 2|Withdrawal by Subject|0|||
145453682|NCT06003777|524510737|FG000|Period 3|Adverse Event|0|||
145453683|NCT06003777|524510738|FG001|Period 3|Adverse Event|0|||
145453684|NCT06003777|524510739|FG002|Period 3|Adverse Event|0|||
145453685|NCT06003777|524510740|FG003|Period 3|Adverse Event|0|||
145453686|NCT06003777|524510741|FG004|Period 3|Adverse Event|0|||
145453687|NCT06003777|524510742|FG005|Period 3|Adverse Event|0|||
145453688|NCT06003777|524510743|FG006|Period 3|Adverse Event|1|||
145453689|NCT06003777|524510744|FG007|Period 3|Adverse Event|0|||
145453690|NCT06003777|524510745|FG008|Period 3|Adverse Event|0|||
145453691|NCT06003777|524510746|FG009|Period 3|Adverse Event|0|||
145453692|NCT06003777|524510747|FG010|Period 3|Adverse Event|0|||
145453693|NCT06003777|524510748|FG011|Period 3|Adverse Event|0|||
145453694|NCT06003777|524510737|FG000|Period 4|No longer met eligibility criteria|0|||
145453695|NCT06003777|524510738|FG001|Period 4|No longer met eligibility criteria|0|||
145453696|NCT06003777|524510739|FG002|Period 4|No longer met eligibility criteria|1|||
145453697|NCT06003777|524510740|FG003|Period 4|No longer met eligibility criteria|0|||
145453698|NCT06003777|524510741|FG004|Period 4|No longer met eligibility criteria|0|||
145453699|NCT06003777|524510742|FG005|Period 4|No longer met eligibility criteria|0|||
145453700|NCT06003777|524510743|FG006|Period 4|No longer met eligibility criteria|0|||
145453701|NCT06003777|524510744|FG007|Period 4|No longer met eligibility criteria|0|||
145453702|NCT06003777|524510745|FG008|Period 4|No longer met eligibility criteria|0|||
145453703|NCT06003777|524510746|FG009|Period 4|No longer met eligibility criteria|0|||
145453704|NCT06003777|524510747|FG010|Period 4|No longer met eligibility criteria|0|||
145453705|NCT06003777|524510748|FG011|Period 4|No longer met eligibility criteria|0|||
145453706|NCT06003777|524510737|FG000|Period 4|Withdrawal by Subject|0|||
145453707|NCT06003777|524510738|FG001|Period 4|Withdrawal by Subject|1|||
145453708|NCT06003777|524510739|FG002|Period 4|Withdrawal by Subject|0|||
145453709|NCT06003777|524510740|FG003|Period 4|Withdrawal by Subject|0|||
145453710|NCT06003777|524510741|FG004|Period 4|Withdrawal by Subject|0|||
145453711|NCT06003777|524510742|FG005|Period 4|Withdrawal by Subject|0|||
145453712|NCT06003777|524510743|FG006|Period 4|Withdrawal by Subject|0|||
145453713|NCT06003777|524510744|FG007|Period 4|Withdrawal by Subject|0|||
145453714|NCT06003777|524510745|FG008|Period 4|Withdrawal by Subject|0|||
145453715|NCT06003777|524510746|FG009|Period 4|Withdrawal by Subject|0|||
145453716|NCT06003777|524510747|FG010|Period 4|Withdrawal by Subject|0|||
145453717|NCT06003777|524510748|FG011|Period 4|Withdrawal by Subject|0|||
145453718|NCT00904670|524510749|FG000|Open Label Phase|Withdrawal by Subject|2|||
145453719|NCT00904670|524510750|FG001|Open Label Phase|Withdrawal by Subject|0|||
145453720|NCT00904670|524510749|FG000|Open Label Phase|Adverse Event|2|||
145453721|NCT00904670|524510750|FG001|Open Label Phase|Adverse Event|0|||
145453722|NCT00904670|524510749|FG000|Open Label Phase|Lack of Efficacy|1|||
145453723|NCT00904670|524510750|FG001|Open Label Phase|Lack of Efficacy|0|||
145453724|NCT00904670|524510749|FG000|Open Label Phase|Lost to Follow-up|1|||
145453725|NCT00904670|524510750|FG001|Open Label Phase|Lost to Follow-up|0|||
145453726|NCT02120300|524510753|FG000|Overall Study|Enrolled but Never Treated|2|||
145453727|NCT02120300|524510754|FG001|Overall Study|Enrolled but Never Treated|0|||
145453728|NCT02120300|524510755|FG002|Overall Study|Enrolled but Never Treated|0|||
145453729|NCT02120300|524510756|FG003|Overall Study|Enrolled but Never Treated|0|||
145453730|NCT02120300|524510753|FG000|Overall Study|Lack of Efficacy|0|||
145453731|NCT02120300|524510754|FG001|Overall Study|Lack of Efficacy|0|||
145453732|NCT02120300|524510755|FG002|Overall Study|Lack of Efficacy|0|||
145453733|NCT02120300|524510756|FG003|Overall Study|Lack of Efficacy|1|||
145453734|NCT02120300|524510753|FG000|Overall Study|Lost to Follow-up|1|||
145453735|NCT02120300|524510754|FG001|Overall Study|Lost to Follow-up|0|||
145453736|NCT02120300|524510755|FG002|Overall Study|Lost to Follow-up|0|||
145453737|NCT02120300|524510756|FG003|Overall Study|Lost to Follow-up|0|||
145453738|NCT00700882|524510759|FG000|Overall Study|Never received treatment|6|||
145453739|NCT00700882|524510759|FG000|Overall Study|Ineligible|2|||
145453740|NCT00700882|524510759|FG000|Overall Study|No KIT mutation|51|||
145453741|NCT01832493|524510763|FG000|Overall Study|Physician Decision|2|||
145453742|NCT01832493|524510763|FG000|Overall Study|Protocol Violation|4|||
145453743|NCT01832493|524510763|FG000|Overall Study|Unable to place LV lead|2|||
145453744|NCT01732510|524510764|FG000|Overall Study|Adverse Event|0|||
145453745|NCT01732510|524510765|FG001|Overall Study|Adverse Event|1|||
145453746|NCT01732510|524510766|FG002|Overall Study|Adverse Event|1|||
145453747|NCT01732510|524510767|FG003|Overall Study|Adverse Event|0|||
145453748|NCT01732510|524510768|FG004|Overall Study|Adverse Event|0|||
145453749|NCT01732510|524510769|FG005|Overall Study|Adverse Event|0|||
145453750|NCT01732510|524510770|FG006|Overall Study|Adverse Event|1|||
145453751|NCT01732510|524510764|FG000|Overall Study|Protocol Violation|0|||
145453752|NCT01732510|524510765|FG001|Overall Study|Protocol Violation|0|||
145453753|NCT01732510|524510766|FG002|Overall Study|Protocol Violation|0|||
145453754|NCT01732510|524510767|FG003|Overall Study|Protocol Violation|1|||
145453755|NCT01732510|524510768|FG004|Overall Study|Protocol Violation|0|||
145453756|NCT01732510|524510769|FG005|Overall Study|Protocol Violation|0|||
145453757|NCT01732510|524510770|FG006|Overall Study|Protocol Violation|0|||
145453758|NCT01732510|524510764|FG000|Overall Study|Withdrawal by Subject|1|||
145453759|NCT01732510|524510765|FG001|Overall Study|Withdrawal by Subject|3|||
145453760|NCT01732510|524510766|FG002|Overall Study|Withdrawal by Subject|2|||
145453761|NCT01732510|524510767|FG003|Overall Study|Withdrawal by Subject|1|||
145453762|NCT01732510|524510768|FG004|Overall Study|Withdrawal by Subject|5|||
145453763|NCT01732510|524510769|FG005|Overall Study|Withdrawal by Subject|0|||
145453764|NCT01732510|524510770|FG006|Overall Study|Withdrawal by Subject|1|||
145453765|NCT01732510|524510764|FG000|Overall Study|Lost to Follow-up|0|||
145453766|NCT01732510|524510765|FG001|Overall Study|Lost to Follow-up|0|||
145453767|NCT01732510|524510766|FG002|Overall Study|Lost to Follow-up|1|||
145453768|NCT01732510|524510767|FG003|Overall Study|Lost to Follow-up|1|||
145453769|NCT01732510|524510768|FG004|Overall Study|Lost to Follow-up|0|||
145453770|NCT01732510|524510769|FG005|Overall Study|Lost to Follow-up|1|||
145453771|NCT01732510|524510770|FG006|Overall Study|Lost to Follow-up|0|||
145453772|NCT01732510|524510764|FG000|Overall Study|Physician Decision|0|||
145453773|NCT01732510|524510765|FG001|Overall Study|Physician Decision|1|||
145453774|NCT01732510|524510766|FG002|Overall Study|Physician Decision|0|||
145453775|NCT01732510|524510767|FG003|Overall Study|Physician Decision|0|||
145453776|NCT01732510|524510768|FG004|Overall Study|Physician Decision|0|||
145453777|NCT01732510|524510769|FG005|Overall Study|Physician Decision|0|||
145453778|NCT01732510|524510770|FG006|Overall Study|Physician Decision|0|||
145453779|NCT01732510|524510764|FG000|Overall Study|Pregnancy|0|||
145453780|NCT01732510|524510765|FG001|Overall Study|Pregnancy|0|||
145453781|NCT01732510|524510766|FG002|Overall Study|Pregnancy|0|||
145453782|NCT01732510|524510767|FG003|Overall Study|Pregnancy|1|||
145453783|NCT01732510|524510768|FG004|Overall Study|Pregnancy|0|||
145453784|NCT01732510|524510769|FG005|Overall Study|Pregnancy|0|||
145453785|NCT01732510|524510770|FG006|Overall Study|Pregnancy|0|||
145453786|NCT01732510|524510764|FG000|Overall Study|Study Terminated By Sponsor|0|||
145453787|NCT01732510|524510765|FG001|Overall Study|Study Terminated By Sponsor|0|||
145453788|NCT01732510|524510766|FG002|Overall Study|Study Terminated By Sponsor|0|||
145453789|NCT01732510|524510767|FG003|Overall Study|Study Terminated By Sponsor|1|||
145453790|NCT01732510|524510768|FG004|Overall Study|Study Terminated By Sponsor|0|||
145453791|NCT01732510|524510769|FG005|Overall Study|Study Terminated By Sponsor|12|||
145453792|NCT01732510|524510770|FG006|Overall Study|Study Terminated By Sponsor|6|||
145453793|NCT00313144|524510771|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
145453794|NCT00313144|524510771|FG000|Overall Study|Death|7|||
145453795|NCT00313144|524510771|FG000|Overall Study|Lost to Follow-up|5|||
145453796|NCT00313144|524510771|FG000|Overall Study|Withdrawal by Subject|4|||
145453797|NCT00313144|524510771|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
145453798|NCT00313144|524510771|FG000|Overall Study|Physician Decision|4|||
145453799|NCT00313144|524510771|FG000|Overall Study|Adverse event - transient|5|||
145453800|NCT00313144|524510771|FG000|Overall Study|Liver transplant|1|||
145453801|NCT00313144|524510771|FG000|Overall Study|Insurance (homecare provider) change|1|||
145453802|NCT00313144|524510771|FG000|Overall Study|Change to different product|1|||
145453803|NCT00313144|524510771|FG000|Overall Study|Due to termination of the study|66|||
145453804|NCT00656058|524510776|FG000|Overall Study|Withdrawal by Subject|2|||
145453805|NCT00656058|524510776|FG000|Overall Study|Withdrawal by Subject|4|||
145453806|NCT00404755|524510777|FG000|Phase I (Bupropion)|Adverse Event|3|||
145453807|NCT00404755|524510777|FG000|Phase I (Bupropion)|Other|1|||
145453808|NCT00404755|524510777|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
145453809|NCT02265536|524510778|FG000|Overall Study|Adverse Event|1|||
145453810|NCT02265536|524510779|FG001|Overall Study|Adverse Event|0|||
145453811|NCT02265536|524510780|FG002|Overall Study|Adverse Event|0|||
145453812|NCT02265536|524510781|FG003|Overall Study|Adverse Event|0|||
145453813|NCT02265536|524510782|FG004|Overall Study|Adverse Event|1|||
145453814|NCT02265536|524510783|FG005|Overall Study|Adverse Event|0|||
145453815|NCT02265536|524510778|FG000|Overall Study|Physician Decision|0|||
145453816|NCT02265536|524510779|FG001|Overall Study|Physician Decision|0|||
145453817|NCT02265536|524510780|FG002|Overall Study|Physician Decision|0|||
145453818|NCT02265536|524510781|FG003|Overall Study|Physician Decision|0|||
145453819|NCT02265536|524510782|FG004|Overall Study|Physician Decision|2|||
145453820|NCT02265536|524510783|FG005|Overall Study|Physician Decision|0|||
145453821|NCT02265536|524510778|FG000|Overall Study|Withdrawal by Subject|0|||
145453822|NCT02265536|524510779|FG001|Overall Study|Withdrawal by Subject|3|||
145453823|NCT02265536|524510780|FG002|Overall Study|Withdrawal by Subject|0|||
145453824|NCT02265536|524510781|FG003|Overall Study|Withdrawal by Subject|0|||
145453825|NCT02265536|524510782|FG004|Overall Study|Withdrawal by Subject|0|||
145453826|NCT02265536|524510783|FG005|Overall Study|Withdrawal by Subject|0|||
145453827|NCT01252186|524510788|FG000|Overall Study|Adverse Event|9|||
145453828|NCT01252186|524510789|FG001|Overall Study|Adverse Event|6|||
145453829|NCT01252186|524510790|FG002|Overall Study|Adverse Event|8|||
145453830|NCT01252186|524510788|FG000|Overall Study|Withdrawal by Subject|2|||
145453831|NCT01252186|524510789|FG001|Overall Study|Withdrawal by Subject|5|||
145453832|NCT01252186|524510790|FG002|Overall Study|Withdrawal by Subject|2|||
145453833|NCT01252186|524510788|FG000|Overall Study|Physician Decision|0|||
145453834|NCT01252186|524510789|FG001|Overall Study|Physician Decision|0|||
145453835|NCT01252186|524510790|FG002|Overall Study|Physician Decision|1|||
145453836|NCT01252186|524510788|FG000|Overall Study|Non-compliance|0|||
145453837|NCT01252186|524510789|FG001|Overall Study|Non-compliance|3|||
145453838|NCT01252186|524510790|FG002|Overall Study|Non-compliance|4|||
145453839|NCT01252186|524510788|FG000|Overall Study|Protocol Violation|0|||
145453840|NCT01252186|524510789|FG001|Overall Study|Protocol Violation|0|||
145453841|NCT01252186|524510790|FG002|Overall Study|Protocol Violation|1|||
145453842|NCT01252186|524510788|FG000|Overall Study|Pregnancy|2|||
145453843|NCT01252186|524510789|FG001|Overall Study|Pregnancy|2|||
145453844|NCT01252186|524510790|FG002|Overall Study|Pregnancy|0|||
145453845|NCT01252186|524510788|FG000|Overall Study|Sponsor Request|2|||
145453846|NCT01252186|524510789|FG001|Overall Study|Sponsor Request|1|||
145453847|NCT01252186|524510790|FG002|Overall Study|Sponsor Request|0|||
145453848|NCT01252186|524510788|FG000|Overall Study|Lost to Follow-up|10|||
145453849|NCT01252186|524510789|FG001|Overall Study|Lost to Follow-up|10|||
145453850|NCT01252186|524510790|FG002|Overall Study|Lost to Follow-up|11|||
145626327|NCT00062868|525144250|FG010|Dose Level 3|Death|0|||
145453851|NCT01252186|524510788|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
145453852|NCT01252186|524510789|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
145453853|NCT01252186|524510790|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
145453854|NCT02791516|524510791|FG000|Overall Study|Withdrawal by Subject|1|||
145453855|NCT02791516|524510792|FG001|Overall Study|Withdrawal by Subject|1|||
145453856|NCT02524275|524510793|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
145453857|NCT04283994|524510794|FG000|Overall Study|Death|11|||
145453858|NCT04283994|524510795|FG001|Overall Study|Death|20|||
145453859|NCT04283994|524510796|FG002|Overall Study|Death|11|||
145453860|NCT04283994|524510797|FG003|Overall Study|Death|0|||
145453861|NCT04283994|524510798|FG004|Overall Study|Death|0|||
145453862|NCT04283994|524510799|FG005|Overall Study|Death|0|||
145453863|NCT04283994|524510800|FG006|Overall Study|Death|0|||
145453864|NCT04283994|524510794|FG000|Overall Study|Withdrawal by Subject|16|||
145453865|NCT04283994|524510795|FG001|Overall Study|Withdrawal by Subject|4|||
145453866|NCT04283994|524510796|FG002|Overall Study|Withdrawal by Subject|6|||
145453867|NCT04283994|524510797|FG003|Overall Study|Withdrawal by Subject|1|||
145453868|NCT04283994|524510798|FG004|Overall Study|Withdrawal by Subject|0|||
145453869|NCT04283994|524510799|FG005|Overall Study|Withdrawal by Subject|1|||
145453870|NCT04283994|524510800|FG006|Overall Study|Withdrawal by Subject|0|||
145453871|NCT03763656|524510801|FG000|Overall Study|Physician Decision|1|||
145453872|NCT03763656|524510801|FG000|Overall Study|Protocol Violation|1|||
145453873|NCT03763656|524510801|FG000|Overall Study|Withdrawal by Subject|7|||
145453874|NCT00197145|524513501|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
145453875|NCT00197145|524513502|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
145453876|NCT00197145|524513501|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
145453877|NCT00197145|524513502|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
145453878|NCT00197145|524513501|FG000|Period 1: Randomized Treatment Phase|Other|2|||
145453879|NCT00197145|524513502|FG001|Period 1: Randomized Treatment Phase|Other|2|||
145453880|NCT00197145|524513501|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
145453881|NCT00197145|524513502|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
145453882|NCT00197145|524513501|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
145453883|NCT00197145|524513502|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
145453884|NCT00197145|524513501|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
145453885|NCT00197145|524513502|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
145453886|NCT00197145|524513501|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
145453887|NCT00197145|524513502|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
145453888|NCT00197145|524513501|FG000|Period 2 : Open Label Phase|Other|1|||
145453889|NCT00197145|524513502|FG001|Period 2 : Open Label Phase|Other|0|||
145453890|NCT02370537|524513503|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
145453891|NCT02370537|524513504|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
145453892|NCT02370537|524513505|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
145453893|NCT02370537|524513503|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
145453894|NCT02370537|524513504|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
145453895|NCT02370537|524513505|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
145453896|NCT02370537|524513503|FG000|Part B|Not randomised to receive treatment|1|||
145453897|NCT02370537|524513504|FG001|Part B|Not randomised to receive treatment|2|||
145453898|NCT02370537|524513505|FG002|Part B|Not randomised to receive treatment|259|||
145453899|NCT02370537|524513503|FG000|Part B|Withdrawal by Subject|0|||
145453900|NCT02370537|524513504|FG001|Part B|Withdrawal by Subject|1|||
145453901|NCT02370537|524513505|FG002|Part B|Withdrawal by Subject|0|||
145453902|NCT03100539|524513510|FG000|Overall Study|Lost to Follow-up|60|||
145453903|NCT03100539|524513511|FG001|Overall Study|Lost to Follow-up|54|||
145453904|NCT03100539|524513512|FG002|Overall Study|Lost to Follow-up|17|||
145453905|NCT03100539|524513510|FG000|Overall Study|Uncollected|8|||
145453906|NCT03100539|524513511|FG001|Overall Study|Uncollected|8|||
145453907|NCT03100539|524513512|FG002|Overall Study|Uncollected|0|||
145453908|NCT03100539|524513510|FG000|Overall Study|Ally Health|0|||
145453909|NCT03100539|524513511|FG001|Overall Study|Ally Health|0|||
145453910|NCT03100539|524513512|FG002|Overall Study|Ally Health|3|||
145453911|NCT03100539|524513510|FG000|Overall Study|Disinterest|0|||
145453912|NCT03100539|524513511|FG001|Overall Study|Disinterest|0|||
145453913|NCT03100539|524513512|FG002|Overall Study|Disinterest|22|||
145453914|NCT03100539|524513510|FG000|Overall Study|Veteran Health|0|||
145453915|NCT03100539|524513511|FG001|Overall Study|Veteran Health|0|||
145453916|NCT03100539|524513512|FG002|Overall Study|Veteran Health|8|||
145453917|NCT03100539|524513510|FG000|Overall Study|Moved|0|||
145453918|NCT03100539|524513511|FG001|Overall Study|Moved|0|||
145453919|NCT03100539|524513512|FG002|Overall Study|Moved|1|||
145453920|NCT03100539|524513510|FG000|Overall Study|Scheduling Conflicts|0|||
145453921|NCT03100539|524513511|FG001|Overall Study|Scheduling Conflicts|0|||
145453922|NCT03100539|524513512|FG002|Overall Study|Scheduling Conflicts|12|||
145453923|NCT02596958|524513516|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
145453924|NCT02596958|524513516|FG000|Overall Study|Cancer Progression|441|||
145453925|NCT02596958|524513516|FG000|Overall Study|Death From Cancer|112|||
145453926|NCT02596958|524513516|FG000|Overall Study|Death From Other Cause|33|||
145453927|NCT02596958|524513516|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
145453928|NCT02596958|524513516|FG000|Overall Study|Administrative Reasons/Other|231|||
145453929|NCT02596958|524513516|FG000|Overall Study|Lost to Follow-up|33|||
145453930|NCT02596958|524513516|FG000|Overall Study|Missing|32|||
145453931|NCT02596958|524513516|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
145453932|NCT03596047|524513517|FG000|Overall Study|Withdrawal by Subject|7|||
145453933|NCT03596047|524513518|FG001|Overall Study|Withdrawal by Subject|4|||
145453934|NCT03596047|524513517|FG000|Overall Study|Lost to Follow-up|0|||
145453935|NCT03596047|524513518|FG001|Overall Study|Lost to Follow-up|2|||
145453936|NCT00837265|524513522|FG000|Pilot Phase|Withdrawal by Subject|0|||
145453937|NCT00837265|524513523|FG001|Pilot Phase|Withdrawal by Subject|2|||
145453938|NCT00837265|524513524|FG002|Pilot Phase|Withdrawal by Subject|3|||
145453939|NCT00837265|524513525|FG003|Pilot Phase|Withdrawal by Subject|2|||
145453940|NCT00837265|524513526|FG004|Pilot Phase|Withdrawal by Subject|0|||
145453941|NCT00837265|524513527|FG005|Pilot Phase|Withdrawal by Subject|0|||
145453942|NCT00837265|524513528|FG006|Pilot Phase|Withdrawal by Subject|0|||
145453943|NCT00837265|524513522|FG000|Pilot Phase|Decision of the investigator|2|||
145453944|NCT00837265|524513523|FG001|Pilot Phase|Decision of the investigator|1|||
145453945|NCT00837265|524513524|FG002|Pilot Phase|Decision of the investigator|0|||
145453946|NCT00837265|524513525|FG003|Pilot Phase|Decision of the investigator|0|||
145453947|NCT00837265|524513526|FG004|Pilot Phase|Decision of the investigator|0|||
145453948|NCT00837265|524513527|FG005|Pilot Phase|Decision of the investigator|0|||
145453949|NCT00837265|524513528|FG006|Pilot Phase|Decision of the investigator|0|||
145453950|NCT00837265|524513522|FG000|Pilot Phase|Adverse Event|1|||
145453951|NCT00837265|524513523|FG001|Pilot Phase|Adverse Event|0|||
145453952|NCT00837265|524513524|FG002|Pilot Phase|Adverse Event|0|||
145453953|NCT00837265|524513525|FG003|Pilot Phase|Adverse Event|0|||
145453954|NCT00837265|524513526|FG004|Pilot Phase|Adverse Event|0|||
145453955|NCT00837265|524513527|FG005|Pilot Phase|Adverse Event|0|||
145453956|NCT00837265|524513528|FG006|Pilot Phase|Adverse Event|0|||
145453957|NCT00837265|524513522|FG000|Pilot Phase|Disease progression|0|||
145453958|NCT00837265|524513523|FG001|Pilot Phase|Disease progression|0|||
145453959|NCT00837265|524513524|FG002|Pilot Phase|Disease progression|0|||
145453960|NCT00837265|524513525|FG003|Pilot Phase|Disease progression|1|||
145453961|NCT00837265|524513526|FG004|Pilot Phase|Disease progression|0|||
145453962|NCT00837265|524513527|FG005|Pilot Phase|Disease progression|0|||
145453963|NCT00837265|524513528|FG006|Pilot Phase|Disease progression|0|||
145453964|NCT00837265|524513522|FG000|Pilot Phase|Participant left the city|0|||
145453965|NCT00837265|524513523|FG001|Pilot Phase|Participant left the city|0|||
145453966|NCT00837265|524513524|FG002|Pilot Phase|Participant left the city|0|||
145453967|NCT00837265|524513525|FG003|Pilot Phase|Participant left the city|1|||
145453968|NCT00837265|524513526|FG004|Pilot Phase|Participant left the city|0|||
145453969|NCT00837265|524513527|FG005|Pilot Phase|Participant left the city|0|||
145453970|NCT00837265|524513528|FG006|Pilot Phase|Participant left the city|0|||
145453971|NCT00837265|524513522|FG000|Main Phase|Withdrawal by Subject|0|||
145453972|NCT00837265|524513523|FG001|Main Phase|Withdrawal by Subject|0|||
145453973|NCT00837265|524513524|FG002|Main Phase|Withdrawal by Subject|0|||
145453974|NCT00837265|524513525|FG003|Main Phase|Withdrawal by Subject|0|||
145453975|NCT00837265|524513526|FG004|Main Phase|Withdrawal by Subject|4|||
145453976|NCT00837265|524513527|FG005|Main Phase|Withdrawal by Subject|2|||
145453977|NCT00837265|524513528|FG006|Main Phase|Withdrawal by Subject|1|||
145453978|NCT00837265|524513522|FG000|Main Phase|Decision of the investigator|0|||
145453979|NCT00837265|524513523|FG001|Main Phase|Decision of the investigator|0|||
145453980|NCT00837265|524513524|FG002|Main Phase|Decision of the investigator|0|||
145453981|NCT00837265|524513525|FG003|Main Phase|Decision of the investigator|0|||
145453982|NCT00837265|524513526|FG004|Main Phase|Decision of the investigator|0|||
145453983|NCT00837265|524513527|FG005|Main Phase|Decision of the investigator|2|||
145453984|NCT00837265|524513528|FG006|Main Phase|Decision of the investigator|1|||
145453985|NCT00837265|524513522|FG000|Main Phase|Adverse Event|0|||
145453986|NCT00837265|524513523|FG001|Main Phase|Adverse Event|0|||
145453987|NCT00837265|524513524|FG002|Main Phase|Adverse Event|0|||
145453988|NCT00837265|524513525|FG003|Main Phase|Adverse Event|0|||
145453989|NCT00837265|524513526|FG004|Main Phase|Adverse Event|0|||
145453990|NCT00837265|524513527|FG005|Main Phase|Adverse Event|1|||
145453991|NCT00837265|524513528|FG006|Main Phase|Adverse Event|0|||
145626328|NCT00062868|525144251|FG011|Dose Level 3|Death|1|||
145626329|NCT00062868|525144252|FG012|Dose Level 3|Death|0|||
145453992|NCT00837265|524513522|FG000|Main Phase|Death|0|||
145453993|NCT00837265|524513523|FG001|Main Phase|Death|0|||
145453994|NCT00837265|524513524|FG002|Main Phase|Death|0|||
145453995|NCT00837265|524513525|FG003|Main Phase|Death|0|||
145453996|NCT00837265|524513526|FG004|Main Phase|Death|2|||
145453997|NCT00837265|524513527|FG005|Main Phase|Death|0|||
145453998|NCT00837265|524513528|FG006|Main Phase|Death|1|||
145453999|NCT00837265|524513522|FG000|Main Phase|Lost to Follow-up|0|||
145454000|NCT00837265|524513523|FG001|Main Phase|Lost to Follow-up|0|||
145454001|NCT00837265|524513524|FG002|Main Phase|Lost to Follow-up|0|||
145454002|NCT00837265|524513525|FG003|Main Phase|Lost to Follow-up|0|||
145454003|NCT00837265|524513526|FG004|Main Phase|Lost to Follow-up|1|||
145626330|NCT00062868|525144253|FG013|Dose Level 3|Death|0|||
145454004|NCT00837265|524513527|FG005|Main Phase|Lost to Follow-up|0|||
145454005|NCT00837265|524513528|FG006|Main Phase|Lost to Follow-up|0|||
145454006|NCT00837265|524513522|FG000|Main Phase|Principal investigator resignation|0|||
145454007|NCT00837265|524513523|FG001|Main Phase|Principal investigator resignation|0|||
145454008|NCT00837265|524513524|FG002|Main Phase|Principal investigator resignation|0|||
145454009|NCT00837265|524513525|FG003|Main Phase|Principal investigator resignation|0|||
145454010|NCT00837265|524513526|FG004|Main Phase|Principal investigator resignation|2|||
145454011|NCT00837265|524513527|FG005|Main Phase|Principal investigator resignation|0|||
145454012|NCT00837265|524513528|FG006|Main Phase|Principal investigator resignation|0|||
145454013|NCT00837265|524513522|FG000|Main Phase|Participant's personal reason|0|||
145454014|NCT00837265|524513523|FG001|Main Phase|Participant's personal reason|0|||
145454015|NCT00837265|524513524|FG002|Main Phase|Participant's personal reason|0|||
145454016|NCT00837265|524513525|FG003|Main Phase|Participant's personal reason|0|||
145454017|NCT00837265|524513526|FG004|Main Phase|Participant's personal reason|1|||
145454018|NCT00837265|524513527|FG005|Main Phase|Participant's personal reason|0|||
145454019|NCT00837265|524513528|FG006|Main Phase|Participant's personal reason|0|||
145454020|NCT00420004|524513530|FG000|Overall Study|Adverse Event|4|||
145454021|NCT00420004|524513531|FG001|Overall Study|Adverse Event|1|||
145454022|NCT00420004|524513532|FG002|Overall Study|Adverse Event|1|||
145454023|NCT00420004|524513530|FG000|Overall Study|Lack of Efficacy|5|||
145454024|NCT00420004|524513531|FG001|Overall Study|Lack of Efficacy|4|||
145454025|NCT00420004|524513532|FG002|Overall Study|Lack of Efficacy|1|||
145454026|NCT00420004|524513530|FG000|Overall Study|Lost to Follow-up|31|||
145454027|NCT00420004|524513531|FG001|Overall Study|Lost to Follow-up|12|||
145454028|NCT00420004|524513532|FG002|Overall Study|Lost to Follow-up|10|||
145454029|NCT00420004|524513530|FG000|Overall Study|Entry Criteria Not Met|0|||
145454030|NCT00420004|524513531|FG001|Overall Study|Entry Criteria Not Met|1|||
145454031|NCT00420004|524513532|FG002|Overall Study|Entry Criteria Not Met|0|||
145454032|NCT00420004|524513530|FG000|Overall Study|Physician Decision|14|||
145454033|NCT00420004|524513531|FG001|Overall Study|Physician Decision|4|||
145454034|NCT00420004|524513532|FG002|Overall Study|Physician Decision|2|||
145454035|NCT00420004|524513530|FG000|Overall Study|Protocol Violation|5|||
145454036|NCT00420004|524513531|FG001|Overall Study|Protocol Violation|4|||
145454037|NCT00420004|524513532|FG002|Overall Study|Protocol Violation|3|||
145454038|NCT00420004|524513530|FG000|Overall Study|Withdrawal by Subject|67|||
145454039|NCT00420004|524513531|FG001|Overall Study|Withdrawal by Subject|42|||
145454040|NCT00420004|524513532|FG002|Overall Study|Withdrawal by Subject|14|||
145454041|NCT00420004|524513530|FG000|Overall Study|Sponsor Decision|3|||
145454042|NCT00420004|524513531|FG001|Overall Study|Sponsor Decision|3|||
145454043|NCT00420004|524513532|FG002|Overall Study|Sponsor Decision|1|||
145454044|NCT03350035|524513535|FG000|Overall Study|Lack of Efficacy|2|||
145454045|NCT03350035|524513536|FG001|Overall Study|Lack of Efficacy|0|||
145454046|NCT03350035|524513537|FG002|Overall Study|Lack of Efficacy|0|||
145454047|NCT03350035|524513535|FG000|Overall Study|Subject discharged to hospice|0|||
145454048|NCT03350035|524513536|FG001|Overall Study|Subject discharged to hospice|0|||
145454049|NCT03350035|524513537|FG002|Overall Study|Subject discharged to hospice|1|||
145454050|NCT03215758|524513543|FG000|Overall Study|Technical Problems|1|||
145454051|NCT03215758|524513544|FG001|Overall Study|Technical Problems|0|||
145454052|NCT03215758|524513543|FG000|Overall Study|Protocol deviation|0|||
145454053|NCT03215758|524513544|FG001|Overall Study|Protocol deviation|1|||
145454054|NCT03215758|524513543|FG000|Overall Study|Physician Decision|0|||
145454055|NCT03215758|524513544|FG001|Overall Study|Physician Decision|1|||
145454056|NCT03215758|524513543|FG000|Overall Study|Death|0|||
145454057|NCT03215758|524513544|FG001|Overall Study|Death|1|||
145587746|NCT04389840|525004290|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
145587747|NCT04389840|525004291|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
145587748|NCT04389840|525004292|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
145587749|NCT04389840|525004293|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
145587750|NCT04389840|525004294|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
145587751|NCT04389840|525004295|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
145587752|NCT04389840|525004290|FG000|Overall Study|Death|0|||
145587753|NCT04389840|525004291|FG001|Overall Study|Death|1|||
145587754|NCT04389840|525004292|FG002|Overall Study|Death|0|||
145587755|NCT04389840|525004293|FG003|Overall Study|Death|0|||
145587756|NCT04389840|525004294|FG004|Overall Study|Death|0|||
145587757|NCT04389840|525004295|FG005|Overall Study|Death|0|||
145587758|NCT02365467|525004301|FG000|Overall Study|Death|3|||
145587759|NCT02043782|525004302|FG000|Period 1|Adverse Event|0|||
145587760|NCT02043782|525004303|FG001|Period 1|Adverse Event|0|||
145587761|NCT02043782|525004304|FG002|Period 1|Adverse Event|1|||
145587762|NCT02043782|525004305|FG003|Period 1|Adverse Event|0|||
145587763|NCT02043782|525004306|FG004|Period 1|Adverse Event|0|||
145454058|NCT03215758|524513543|FG000|Overall Study|Adverse Event|1|||
145454059|NCT03215758|524513544|FG001|Overall Study|Adverse Event|2|||
145587764|NCT02043782|525004307|FG005|Period 1|Adverse Event|0|||
145587765|NCT00709722|525004308|FG000|Overall Study|Adverse Event|1|||
145454060|NCT03215758|524513543|FG000|Overall Study|Subject/Guardian Decision|3|||
145454061|NCT03215758|524513544|FG001|Overall Study|Subject/Guardian Decision|3|||
145454062|NCT02974855|524513549|FG000|Overall Study|Adverse Event|0|||
145454063|NCT02974855|524513550|FG001|Overall Study|Adverse Event|1|||
145454064|NCT02974855|524513551|FG002|Overall Study|Adverse Event|0|||
145454065|NCT02974855|524513552|FG003|Overall Study|Adverse Event|1|||
145454066|NCT00633074|524513553|FG000|Overall Study|Adverse Event|1|||
145454067|NCT00633074|524513554|FG001|Overall Study|Adverse Event|0|||
145454068|NCT01843673|524513556|FG000|Overall Study|Lack of Efficacy|2|||
145454069|NCT01843673|524513556|FG000|Overall Study|Withdrawal by Subject|4|||
145454070|NCT02570152|524513557|FG000|Overall Study|Protocol Violation|2|||
145454071|NCT02570152|524513557|FG000|Overall Study|Migrated/moved from study area|13|||
145454072|NCT01106651|524513563|FG000|Overall Study|Adverse Event|17|||
145454073|NCT01106651|524513564|FG001|Overall Study|Adverse Event|9|||
145454074|NCT01106651|524513565|FG002|Overall Study|Adverse Event|23|||
145454075|NCT01106651|524513563|FG000|Overall Study|Lost to Follow-up|8|||
145454076|NCT01106651|524513564|FG001|Overall Study|Lost to Follow-up|2|||
145454077|NCT01106651|524513565|FG002|Overall Study|Lost to Follow-up|6|||
145454078|NCT01106651|524513563|FG000|Overall Study|Physician Decision|4|||
145454079|NCT01106651|524513564|FG001|Overall Study|Physician Decision|3|||
145454080|NCT01106651|524513565|FG002|Overall Study|Physician Decision|1|||
145454081|NCT01106651|524513563|FG000|Overall Study|Protocol Violation|1|||
145454082|NCT01106651|524513564|FG001|Overall Study|Protocol Violation|2|||
145454083|NCT01106651|524513565|FG002|Overall Study|Protocol Violation|1|||
145454084|NCT01106651|524513563|FG000|Overall Study|Withdrawal by Subject|14|||
145454085|NCT01106651|524513564|FG001|Overall Study|Withdrawal by Subject|7|||
145454086|NCT01106651|524513565|FG002|Overall Study|Withdrawal by Subject|4|||
145454087|NCT01106651|524513563|FG000|Overall Study|Noncompliance with study drug|1|||
145454088|NCT01106651|524513564|FG001|Overall Study|Noncompliance with study drug|0|||
145454089|NCT01106651|524513565|FG002|Overall Study|Noncompliance with study drug|2|||
145454090|NCT01106651|524513563|FG000|Overall Study|Other|34|||
145454091|NCT01106651|524513564|FG001|Overall Study|Other|31|||
145454092|NCT01106651|524513565|FG002|Overall Study|Other|21|||
145454093|NCT01106651|524513563|FG000|Overall Study|Death|0|||
145454094|NCT01106651|524513564|FG001|Overall Study|Death|3|||
145454095|NCT01106651|524513565|FG002|Overall Study|Death|0|||
145454096|NCT03768089|524513566|FG000|Part A|Lost to Follow-up|0|||
145454097|NCT03768089|524513567|FG001|Part A|Lost to Follow-up|0|||
145454098|NCT03768089|524513568|FG002|Part A|Lost to Follow-up|0|||
145454099|NCT03768089|524513569|FG003|Part A|Lost to Follow-up|0|||
145454100|NCT03768089|524513570|FG004|Part A|Lost to Follow-up|1|||
145454101|NCT03768089|524513571|FG005|Part A|Lost to Follow-up|0|||
145454102|NCT03768089|524513572|FG006|Part A|Lost to Follow-up|0|||
145454103|NCT03768089|524513573|FG007|Part A|Lost to Follow-up|0|||
145454104|NCT03768089|524513574|FG008|Part A|Lost to Follow-up|0|||
145454105|NCT03768089|524513575|FG009|Part A|Lost to Follow-up|0|||
145454106|NCT03768089|524513576|FG010|Part A|Lost to Follow-up|0|||
145454107|NCT03768089|524513577|FG011|Part A|Lost to Follow-up|0|||
145454108|NCT03768089|524513578|FG012|Part A|Lost to Follow-up|0|||
145454109|NCT03768089|524513579|FG013|Part A|Lost to Follow-up|0|||
145454110|NCT03768089|524513580|FG014|Part A|Lost to Follow-up|0|||
145454111|NCT03768089|524513581|FG015|Part A|Lost to Follow-up|0|||
145454112|NCT03768089|524513582|FG016|Part A|Lost to Follow-up|0|||
145454113|NCT03768089|524513583|FG017|Part A|Lost to Follow-up|0|||
145454114|NCT03768089|524513566|FG000|Part C|Randomized, Never Dosed|0|||
145454115|NCT03768089|524513567|FG001|Part C|Randomized, Never Dosed|0|||
145454116|NCT03768089|524513568|FG002|Part C|Randomized, Never Dosed|0|||
145454117|NCT03768089|524513569|FG003|Part C|Randomized, Never Dosed|0|||
145454118|NCT03768089|524513570|FG004|Part C|Randomized, Never Dosed|0|||
145454119|NCT03768089|524513571|FG005|Part C|Randomized, Never Dosed|0|||
145454120|NCT03768089|524513572|FG006|Part C|Randomized, Never Dosed|0|||
145454121|NCT03768089|524513573|FG007|Part C|Randomized, Never Dosed|0|||
145587766|NCT04667117|525004309|FG000|Investigational Period|Lost to Follow-up|0|||
145587767|NCT04667117|525004310|FG001|Investigational Period|Lost to Follow-up|0|||
145454122|NCT03768089|524513574|FG008|Part C|Randomized, Never Dosed|0|||
145454123|NCT03768089|524513575|FG009|Part C|Randomized, Never Dosed|0|||
145454124|NCT03768089|524513576|FG010|Part C|Randomized, Never Dosed|0|||
145454125|NCT03768089|524513577|FG011|Part C|Randomized, Never Dosed|0|||
145454126|NCT03768089|524513578|FG012|Part C|Randomized, Never Dosed|0|||
145454127|NCT03768089|524513579|FG013|Part C|Randomized, Never Dosed|0|||
145454128|NCT03768089|524513580|FG014|Part C|Randomized, Never Dosed|1|||
145454129|NCT03768089|524513581|FG015|Part C|Randomized, Never Dosed|0|||
145454130|NCT03768089|524513582|FG016|Part C|Randomized, Never Dosed|0|||
145454131|NCT03768089|524513583|FG017|Part C|Randomized, Never Dosed|0|||
145454132|NCT00675441|524513588|FG000|Overall Study|Withdrawal by Subject|2|||
145454133|NCT00675441|524513588|FG000|Overall Study|Death|1|||
145454134|NCT05145322|524513593|FG000|Overall Study|Lost to Follow-up|4|||
145454135|NCT05145322|524513594|FG001|Overall Study|Lost to Follow-up|5|||
145454136|NCT06359028|524513595|FG000|Overall Study|Adverse Event|1|||
145454137|NCT06359028|524513596|FG001|Overall Study|Adverse Event|0|||
145454138|NCT06359028|524513595|FG000|Overall Study|Withdrawal by Subject|1|||
145454139|NCT06359028|524513596|FG001|Overall Study|Withdrawal by Subject|0|||
145587768|NCT04667117|525004311|FG002|Investigational Period|Lost to Follow-up|1|||
145454140|NCT04700540|524513597|FG000|Overall Study|Withdrawal by Subject|12|||
145454141|NCT04700540|524513598|FG001|Overall Study|Withdrawal by Subject|8|||
145454142|NCT04700540|524513597|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
145454143|NCT04700540|524513598|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
145454144|NCT03194568|524513599|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
145454145|NCT03515551|524513602|FG000|Overall Study|Death|4|||
145454146|NCT03515551|524513603|FG001|Overall Study|Death|1|||
145454147|NCT03515551|524513604|FG002|Overall Study|Death|2|||
145454148|NCT03515551|524513605|FG003|Overall Study|Death|2|||
145454149|NCT03515551|524513606|FG004|Overall Study|Death|2|||
145454150|NCT03515551|524513607|FG005|Overall Study|Death|4|||
145454151|NCT03515551|524513608|FG006|Overall Study|Death|1|||
145454152|NCT03515551|524513602|FG000|Overall Study|Lost to Follow-up|0|||
145454153|NCT03515551|524513603|FG001|Overall Study|Lost to Follow-up|0|||
145454154|NCT03515551|524513604|FG002|Overall Study|Lost to Follow-up|1|||
145454155|NCT03515551|524513605|FG003|Overall Study|Lost to Follow-up|0|||
145454156|NCT03515551|524513606|FG004|Overall Study|Lost to Follow-up|0|||
145454157|NCT03515551|524513607|FG005|Overall Study|Lost to Follow-up|0|||
145454158|NCT03515551|524513608|FG006|Overall Study|Lost to Follow-up|0|||
145454159|NCT03515551|524513602|FG000|Overall Study|Withdrawal by Subject|0|||
145454160|NCT03515551|524513603|FG001|Overall Study|Withdrawal by Subject|1|||
145454161|NCT03515551|524513604|FG002|Overall Study|Withdrawal by Subject|0|||
145454162|NCT03515551|524513605|FG003|Overall Study|Withdrawal by Subject|0|||
145454163|NCT03515551|524513606|FG004|Overall Study|Withdrawal by Subject|0|||
145454164|NCT03515551|524513607|FG005|Overall Study|Withdrawal by Subject|0|||
145454165|NCT03515551|524513608|FG006|Overall Study|Withdrawal by Subject|1|||
145454166|NCT03515551|524513602|FG000|Overall Study|Study ended by sponsor|0|||
145626331|NCT00062868|525144254|FG014|Dose Level 3|Death|0|||
145454167|NCT03515551|524513603|FG001|Overall Study|Study ended by sponsor|0|||
145454168|NCT03515551|524513604|FG002|Overall Study|Study ended by sponsor|2|||
145454169|NCT03515551|524513605|FG003|Overall Study|Study ended by sponsor|1|||
145454170|NCT03515551|524513606|FG004|Overall Study|Study ended by sponsor|3|||
145454171|NCT03515551|524513607|FG005|Overall Study|Study ended by sponsor|0|||
145454172|NCT03515551|524513608|FG006|Overall Study|Study ended by sponsor|3|||
145454173|NCT03515551|524513602|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454174|NCT03515551|524513603|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
145454175|NCT03515551|524513604|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454176|NCT03515551|524513605|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454177|NCT03515551|524513606|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454178|NCT03515551|524513607|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454179|NCT03515551|524513608|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
145454180|NCT00920387|524513616|FG000|Stage 1|Adverse Event|1|||
145454181|NCT00920387|524513617|FG001|Stage 1|Adverse Event|0|||
145454182|NCT00920387|524513618|FG002|Stage 1|Adverse Event|0|||
145454183|NCT02241733|524513629|FG000|Overall Study|Lost to Follow-up|9|||
145454184|NCT02241733|524513630|FG001|Overall Study|Lost to Follow-up|4|||
145454185|NCT02241733|524513629|FG000|Overall Study|Physician Decision|6|||
145454186|NCT02241733|524513630|FG001|Overall Study|Physician Decision|2|||
145454187|NCT02241733|524513629|FG000|Overall Study|Withdrawal by Subject|0|||
145454188|NCT02241733|524513630|FG001|Overall Study|Withdrawal by Subject|2|||
145454189|NCT02241733|524513629|FG000|Overall Study|Death|0|||
145454190|NCT02241733|524513630|FG001|Overall Study|Death|2|||
145454191|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
145454192|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
145454193|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
145454194|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
145454195|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
145454196|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
145454197|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
145454198|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
145454199|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
145454200|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
145454201|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
145454202|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
145454203|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
145454204|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
145454205|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
145454206|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
145454207|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
145454208|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
145454209|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
145626332|NCT00062868|525144255|FG015|Dose Level 3|Death|0|||
145454210|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
145454211|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
145454212|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
145454213|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
145454214|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
145454215|NCT01866111|524513631|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
145454216|NCT01866111|524513632|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
145454217|NCT01866111|524513633|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
145454218|NCT01866111|524513634|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
145454219|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
145454220|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
145454221|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
145454222|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
145454223|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
145454224|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
145454225|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
145454226|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
145454227|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
145454228|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
145454229|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
145454230|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
145454231|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
145454232|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
145454233|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
145454234|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
145454235|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Death|1|||
145454236|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Death|1|||
145454237|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Death|3|||
145454238|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Death|2|||
145454239|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
145454240|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
145454241|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
145454242|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
145454243|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
145454244|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
145454245|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
145454246|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
145454247|NCT01866111|524513631|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
145454248|NCT01866111|524513632|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
145454249|NCT01866111|524513633|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
145454250|NCT01866111|524513634|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
145454251|NCT00157196|524513635|FG000|Overall Study|Ongoing at data cut-off|9|||
145454252|NCT01439971|524513636|FG000|Overall Study|Required number in cohort dosed|0|||
145454253|NCT01439971|524513637|FG001|Overall Study|Required number in cohort dosed|1|||
145454254|NCT01439971|524513638|FG002|Overall Study|Required number in cohort dosed|2|||
145454255|NCT01439971|524513639|FG003|Overall Study|Required number in cohort dosed|0|||
145454256|NCT01439971|524513640|FG004|Overall Study|Required number in cohort dosed|1|||
145454257|NCT02628600|524513641|FG000|Overall Study|Death|2|||
145454258|NCT02628600|524513642|FG001|Overall Study|Death|1|||
145454259|NCT02628600|524513641|FG000|Overall Study|Adverse Event|3|||
145454260|NCT02628600|524513642|FG001|Overall Study|Adverse Event|20|||
145454261|NCT02628600|524513641|FG000|Overall Study|Protocol Violation|0|||
145454262|NCT02628600|524513642|FG001|Overall Study|Protocol Violation|1|||
145454263|NCT02628600|524513641|FG000|Overall Study|Lack of Efficacy|2|||
145454264|NCT02628600|524513642|FG001|Overall Study|Lack of Efficacy|0|||
145454265|NCT02628600|524513641|FG000|Overall Study|Withdrawal by Subject|13|||
145454266|NCT02628600|524513642|FG001|Overall Study|Withdrawal by Subject|8|||
145454267|NCT02628600|524513641|FG000|Overall Study|Lost to Follow-up|1|||
145454268|NCT02628600|524513642|FG001|Overall Study|Lost to Follow-up|0|||
145454269|NCT02628600|524513641|FG000|Overall Study|Physician Decision|2|||
145626333|NCT00062868|525144256|FG016|Dose Level 3|Death|0|||
145626334|NCT00062868|525144257|FG017|Dose Level 3|Death|1|||
145454270|NCT02628600|524513642|FG001|Overall Study|Physician Decision|2|||
145454271|NCT02628600|524513641|FG000|Overall Study|Other not specified|1|||
145454272|NCT02628600|524513642|FG001|Overall Study|Other not specified|0|||
145454273|NCT01221623|524513649|FG000|Overall Study|Withdrawal by Subject|19|||
145454274|NCT01221623|524513650|FG001|Overall Study|Withdrawal by Subject|8|||
145626335|NCT00062868|525144258|FG018|Dose Level 3|Death|0|||
145626336|NCT00062868|525144259|FG019|Dose Level 3|Death|0|||
145626337|NCT00062868|525144260|FG020|Dose Level 3|Death|0|||
145454275|NCT01221623|524513649|FG000|Overall Study|Lost to Follow-up|7|||
145454276|NCT01221623|524513650|FG001|Overall Study|Lost to Follow-up|1|||
145454277|NCT01221623|524513649|FG000|Overall Study|Adverse Event|6|||
145454278|NCT01221623|524513650|FG001|Overall Study|Adverse Event|3|||
145454279|NCT01221623|524513649|FG000|Overall Study|Death|1|||
145454280|NCT01221623|524513650|FG001|Overall Study|Death|0|||
145454281|NCT01221623|524513649|FG000|Overall Study|Other|5|||
145454282|NCT01221623|524513650|FG001|Overall Study|Other|2|||
145454283|NCT00780143|524513651|FG000|Overall Study|Progressive disease|1|||
145454284|NCT00780143|524513651|FG000|Overall Study|Toxicity|1|||
145454285|NCT00780143|524513651|FG000|Overall Study|Adverse Event|1|||
145454286|NCT04091581|524513652|FG000|Overall Study|Lost to Follow-up|0|||
145454287|NCT04091581|524513653|FG001|Overall Study|Lost to Follow-up|1|||
145454288|NCT02438384|524513654|FG000|Overall Study|Lost to Follow-up|8|||
145454289|NCT02438384|524513655|FG001|Overall Study|Lost to Follow-up|6|||
145454290|NCT02438384|524513656|FG002|Overall Study|Lost to Follow-up|4|||
145454291|NCT03315793|524513657|FG000|Overall Study|Adverse Event|4|||
145454292|NCT03315793|524513658|FG001|Overall Study|Adverse Event|2|||
145454293|NCT03315793|524513657|FG000|Overall Study|Protocol Deviation|1|||
145454294|NCT03315793|524513658|FG001|Overall Study|Protocol Deviation|0|||
145454295|NCT03315793|524513657|FG000|Overall Study|Difficult for regular visit|0|||
145454296|NCT03315793|524513658|FG001|Overall Study|Difficult for regular visit|1|||
145454297|NCT03724981|524515157|FG000|First Device|Protocol Violation|1|||
145454298|NCT03724981|524515158|FG001|First Device|Protocol Violation|1|||
145454299|NCT00882583|524515160|FG000|Overall Study|Physician Decision|1|||
145454300|NCT00882583|524515161|FG001|Overall Study|Physician Decision|0|||
145454301|NCT00882583|524515160|FG000|Overall Study|Adverse Event|0|||
145454302|NCT00882583|524515161|FG001|Overall Study|Adverse Event|1|||
145454303|NCT02589665|524515162|FG000|Induction Period|Did not receive drug|0|||
145454304|NCT02589665|524515163|FG001|Induction Period|Did not receive drug|0|||
145454305|NCT02589665|524515164|FG002|Induction Period|Did not receive drug|0|||
145454306|NCT02589665|524515165|FG003|Induction Period|Did not receive drug|1|||
145454307|NCT02589665|524515166|FG004|Induction Period|Did not receive drug|0|||
145454308|NCT02589665|524515167|FG005|Induction Period|Did not receive drug|0|||
145454309|NCT02589665|524515168|FG006|Induction Period|Did not receive drug|0|||
145454310|NCT02589665|524515169|FG007|Induction Period|Did not receive drug|0|||
145454311|NCT02589665|524515170|FG008|Induction Period|Did not receive drug|0|||
145454312|NCT02589665|524515171|FG009|Induction Period|Did not receive drug|0|||
145454313|NCT02589665|524515162|FG000|Induction Period|Adverse Event|3|||
145454314|NCT02589665|524515163|FG001|Induction Period|Adverse Event|0|||
145454315|NCT02589665|524515164|FG002|Induction Period|Adverse Event|2|||
145454316|NCT02589665|524515165|FG003|Induction Period|Adverse Event|2|||
145454317|NCT02589665|524515166|FG004|Induction Period|Adverse Event|0|||
145454318|NCT02589665|524515167|FG005|Induction Period|Adverse Event|0|||
145454319|NCT02589665|524515168|FG006|Induction Period|Adverse Event|0|||
145454320|NCT02589665|524515169|FG007|Induction Period|Adverse Event|0|||
145454321|NCT02589665|524515170|FG008|Induction Period|Adverse Event|0|||
145454322|NCT02589665|524515171|FG009|Induction Period|Adverse Event|0|||
145454323|NCT02589665|524515162|FG000|Induction Period|Withdrawal by Subject|0|||
145454324|NCT02589665|524515163|FG001|Induction Period|Withdrawal by Subject|1|||
145454325|NCT02589665|524515164|FG002|Induction Period|Withdrawal by Subject|0|||
145454326|NCT02589665|524515165|FG003|Induction Period|Withdrawal by Subject|1|||
145454327|NCT02589665|524515166|FG004|Induction Period|Withdrawal by Subject|0|||
145454328|NCT02589665|524515167|FG005|Induction Period|Withdrawal by Subject|0|||
145454329|NCT02589665|524515168|FG006|Induction Period|Withdrawal by Subject|0|||
145454330|NCT02589665|524515169|FG007|Induction Period|Withdrawal by Subject|0|||
145454331|NCT02589665|524515170|FG008|Induction Period|Withdrawal by Subject|0|||
145454332|NCT02589665|524515171|FG009|Induction Period|Withdrawal by Subject|0|||
145454333|NCT02589665|524515162|FG000|Induction Period|Protocol Violation|0|||
145454334|NCT02589665|524515163|FG001|Induction Period|Protocol Violation|1|||
145454335|NCT02589665|524515164|FG002|Induction Period|Protocol Violation|0|||
145454336|NCT02589665|524515165|FG003|Induction Period|Protocol Violation|0|||
145454337|NCT02589665|524515166|FG004|Induction Period|Protocol Violation|0|||
145454338|NCT02589665|524515167|FG005|Induction Period|Protocol Violation|0|||
145454339|NCT02589665|524515168|FG006|Induction Period|Protocol Violation|0|||
145454340|NCT02589665|524515169|FG007|Induction Period|Protocol Violation|0|||
145454341|NCT02589665|524515170|FG008|Induction Period|Protocol Violation|0|||
145454342|NCT02589665|524515171|FG009|Induction Period|Protocol Violation|0|||
145454343|NCT02589665|524515162|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454344|NCT02589665|524515163|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454345|NCT02589665|524515164|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454346|NCT02589665|524515165|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454347|NCT02589665|524515166|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
145454348|NCT02589665|524515167|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
145454349|NCT02589665|524515168|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
145454350|NCT02589665|524515169|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454351|NCT02589665|524515170|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454352|NCT02589665|524515171|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454353|NCT02589665|524515162|FG000|Maintenance Period|Withdrawal by Subject|0|||
145454354|NCT02589665|524515163|FG001|Maintenance Period|Withdrawal by Subject|0|||
145454355|NCT02589665|524515164|FG002|Maintenance Period|Withdrawal by Subject|0|||
145454356|NCT02589665|524515165|FG003|Maintenance Period|Withdrawal by Subject|0|||
145454357|NCT02589665|524515166|FG004|Maintenance Period|Withdrawal by Subject|4|||
145454358|NCT02589665|524515167|FG005|Maintenance Period|Withdrawal by Subject|2|||
145454359|NCT02589665|524515168|FG006|Maintenance Period|Withdrawal by Subject|4|||
145454360|NCT02589665|524515169|FG007|Maintenance Period|Withdrawal by Subject|0|||
145454361|NCT02589665|524515170|FG008|Maintenance Period|Withdrawal by Subject|0|||
145454362|NCT02589665|524515171|FG009|Maintenance Period|Withdrawal by Subject|0|||
145454363|NCT02589665|524515162|FG000|Maintenance Period|Lack of Efficacy|0|||
145454364|NCT02589665|524515163|FG001|Maintenance Period|Lack of Efficacy|0|||
145454365|NCT02589665|524515164|FG002|Maintenance Period|Lack of Efficacy|0|||
145454366|NCT02589665|524515165|FG003|Maintenance Period|Lack of Efficacy|0|||
145454367|NCT02589665|524515166|FG004|Maintenance Period|Lack of Efficacy|2|||
145454368|NCT02589665|524515167|FG005|Maintenance Period|Lack of Efficacy|1|||
145454369|NCT02589665|524515168|FG006|Maintenance Period|Lack of Efficacy|0|||
145454370|NCT02589665|524515169|FG007|Maintenance Period|Lack of Efficacy|0|||
145454371|NCT02589665|524515170|FG008|Maintenance Period|Lack of Efficacy|0|||
145454372|NCT02589665|524515171|FG009|Maintenance Period|Lack of Efficacy|0|||
145454373|NCT02589665|524515162|FG000|Maintenance Period|Adverse Event|0|||
145454374|NCT02589665|524515163|FG001|Maintenance Period|Adverse Event|0|||
145454375|NCT02589665|524515164|FG002|Maintenance Period|Adverse Event|0|||
145454376|NCT02589665|524515165|FG003|Maintenance Period|Adverse Event|0|||
145454377|NCT02589665|524515166|FG004|Maintenance Period|Adverse Event|0|||
145454378|NCT02589665|524515167|FG005|Maintenance Period|Adverse Event|0|||
145454379|NCT02589665|524515168|FG006|Maintenance Period|Adverse Event|2|||
145454380|NCT02589665|524515169|FG007|Maintenance Period|Adverse Event|0|||
145454381|NCT02589665|524515170|FG008|Maintenance Period|Adverse Event|0|||
145454382|NCT02589665|524515171|FG009|Maintenance Period|Adverse Event|0|||
145454383|NCT02589665|524515162|FG000|Maintenance Period|Lost to Follow-up|0|||
145454384|NCT02589665|524515163|FG001|Maintenance Period|Lost to Follow-up|0|||
145454385|NCT02589665|524515164|FG002|Maintenance Period|Lost to Follow-up|0|||
145454386|NCT02589665|524515165|FG003|Maintenance Period|Lost to Follow-up|0|||
145454387|NCT02589665|524515166|FG004|Maintenance Period|Lost to Follow-up|0|||
145454388|NCT02589665|524515167|FG005|Maintenance Period|Lost to Follow-up|1|||
145454389|NCT02589665|524515168|FG006|Maintenance Period|Lost to Follow-up|0|||
145454390|NCT02589665|524515169|FG007|Maintenance Period|Lost to Follow-up|0|||
145454391|NCT02589665|524515170|FG008|Maintenance Period|Lost to Follow-up|0|||
145454392|NCT02589665|524515171|FG009|Maintenance Period|Lost to Follow-up|0|||
145454393|NCT02589665|524515162|FG000|Maintenance Period|Physician Decision|0|||
145454394|NCT02589665|524515163|FG001|Maintenance Period|Physician Decision|0|||
145454395|NCT02589665|524515164|FG002|Maintenance Period|Physician Decision|0|||
145454396|NCT02589665|524515165|FG003|Maintenance Period|Physician Decision|0|||
145454397|NCT02589665|524515166|FG004|Maintenance Period|Physician Decision|0|||
145454398|NCT02589665|524515167|FG005|Maintenance Period|Physician Decision|1|||
145454399|NCT02589665|524515168|FG006|Maintenance Period|Physician Decision|0|||
145454400|NCT02589665|524515169|FG007|Maintenance Period|Physician Decision|0|||
145454401|NCT02589665|524515170|FG008|Maintenance Period|Physician Decision|0|||
145454402|NCT02589665|524515171|FG009|Maintenance Period|Physician Decision|0|||
145454403|NCT02589665|524515162|FG000|Maintenance Period|Reason Not Collected|0|||
145454404|NCT02589665|524515163|FG001|Maintenance Period|Reason Not Collected|0|||
145454405|NCT02589665|524515164|FG002|Maintenance Period|Reason Not Collected|0|||
145454406|NCT02589665|524515165|FG003|Maintenance Period|Reason Not Collected|0|||
145454407|NCT02589665|524515166|FG004|Maintenance Period|Reason Not Collected|0|||
145454408|NCT02589665|524515167|FG005|Maintenance Period|Reason Not Collected|1|||
145454409|NCT02589665|524515168|FG006|Maintenance Period|Reason Not Collected|1|||
145454410|NCT02589665|524515169|FG007|Maintenance Period|Reason Not Collected|0|||
145454411|NCT02589665|524515170|FG008|Maintenance Period|Reason Not Collected|0|||
145454412|NCT02589665|524515171|FG009|Maintenance Period|Reason Not Collected|0|||
145454413|NCT02589665|524515162|FG000|Induction Extension Period|Adverse Event|0|||
145454414|NCT02589665|524515163|FG001|Induction Extension Period|Adverse Event|0|||
145454415|NCT02589665|524515164|FG002|Induction Extension Period|Adverse Event|0|||
145454416|NCT02589665|524515165|FG003|Induction Extension Period|Adverse Event|0|||
145454417|NCT02589665|524515166|FG004|Induction Extension Period|Adverse Event|0|||
145454418|NCT02589665|524515167|FG005|Induction Extension Period|Adverse Event|0|||
145454419|NCT02589665|524515168|FG006|Induction Extension Period|Adverse Event|0|||
145454420|NCT02589665|524515169|FG007|Induction Extension Period|Adverse Event|0|||
145454421|NCT02589665|524515170|FG008|Induction Extension Period|Adverse Event|4|||
145454422|NCT02589665|524515171|FG009|Induction Extension Period|Adverse Event|0|||
145454423|NCT02589665|524515162|FG000|Induction Extension Period|Lack of Efficacy|0|||
145454424|NCT02589665|524515163|FG001|Induction Extension Period|Lack of Efficacy|0|||
145454425|NCT02589665|524515164|FG002|Induction Extension Period|Lack of Efficacy|0|||
145454426|NCT02589665|524515165|FG003|Induction Extension Period|Lack of Efficacy|0|||
145454427|NCT02589665|524515166|FG004|Induction Extension Period|Lack of Efficacy|0|||
145454428|NCT02589665|524515167|FG005|Induction Extension Period|Lack of Efficacy|0|||
145454429|NCT02589665|524515168|FG006|Induction Extension Period|Lack of Efficacy|0|||
145454430|NCT02589665|524515169|FG007|Induction Extension Period|Lack of Efficacy|0|||
145454431|NCT02589665|524515170|FG008|Induction Extension Period|Lack of Efficacy|3|||
145454432|NCT02589665|524515171|FG009|Induction Extension Period|Lack of Efficacy|0|||
145454433|NCT02589665|524515162|FG000|Induction Extension Period|Withdrawal by Subject|0|||
145454434|NCT02589665|524515163|FG001|Induction Extension Period|Withdrawal by Subject|0|||
145454435|NCT02589665|524515164|FG002|Induction Extension Period|Withdrawal by Subject|0|||
145454436|NCT02589665|524515165|FG003|Induction Extension Period|Withdrawal by Subject|0|||
145454437|NCT02589665|524515166|FG004|Induction Extension Period|Withdrawal by Subject|0|||
145454438|NCT02589665|524515167|FG005|Induction Extension Period|Withdrawal by Subject|0|||
145454439|NCT02589665|524515168|FG006|Induction Extension Period|Withdrawal by Subject|0|||
145454440|NCT02589665|524515169|FG007|Induction Extension Period|Withdrawal by Subject|2|||
145454441|NCT02589665|524515170|FG008|Induction Extension Period|Withdrawal by Subject|3|||
145454442|NCT02589665|524515171|FG009|Induction Extension Period|Withdrawal by Subject|0|||
145454443|NCT02589665|524515162|FG000|Induction Extension Period|Physician Decision|0|||
145454444|NCT02589665|524515163|FG001|Induction Extension Period|Physician Decision|0|||
145454445|NCT02589665|524515164|FG002|Induction Extension Period|Physician Decision|0|||
145454446|NCT02589665|524515165|FG003|Induction Extension Period|Physician Decision|0|||
145454447|NCT02589665|524515166|FG004|Induction Extension Period|Physician Decision|0|||
145454448|NCT02589665|524515167|FG005|Induction Extension Period|Physician Decision|0|||
145454449|NCT02589665|524515168|FG006|Induction Extension Period|Physician Decision|0|||
145454450|NCT02589665|524515169|FG007|Induction Extension Period|Physician Decision|0|||
145454451|NCT02589665|524515170|FG008|Induction Extension Period|Physician Decision|1|||
145454452|NCT02589665|524515171|FG009|Induction Extension Period|Physician Decision|0|||
145454453|NCT02589665|524515162|FG000|Induction Extension Period|Reason Not Collected|0|||
145454454|NCT02589665|524515163|FG001|Induction Extension Period|Reason Not Collected|0|||
145454455|NCT02589665|524515164|FG002|Induction Extension Period|Reason Not Collected|0|||
145454456|NCT02589665|524515165|FG003|Induction Extension Period|Reason Not Collected|0|||
145454457|NCT02589665|524515166|FG004|Induction Extension Period|Reason Not Collected|0|||
145454458|NCT02589665|524515167|FG005|Induction Extension Period|Reason Not Collected|0|||
145454459|NCT02589665|524515168|FG006|Induction Extension Period|Reason Not Collected|0|||
145454460|NCT02589665|524515169|FG007|Induction Extension Period|Reason Not Collected|0|||
145454461|NCT02589665|524515170|FG008|Induction Extension Period|Reason Not Collected|1|||
145454462|NCT02589665|524515171|FG009|Induction Extension Period|Reason Not Collected|0|||
145454463|NCT02589665|524515162|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454464|NCT02589665|524515163|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454465|NCT02589665|524515164|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454466|NCT02589665|524515165|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454467|NCT02589665|524515166|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454468|NCT02589665|524515167|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454469|NCT02589665|524515168|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454470|NCT02589665|524515169|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454471|NCT02589665|524515170|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
145454472|NCT02589665|524515171|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
145454473|NCT02589665|524515162|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
145454474|NCT02589665|524515163|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
145454475|NCT02589665|524515164|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
145454476|NCT02589665|524515165|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
145454477|NCT02589665|524515166|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
145454478|NCT02589665|524515167|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
145454479|NCT02589665|524515168|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
145454480|NCT02589665|524515169|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
145454481|NCT02589665|524515170|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
145454482|NCT02589665|524515171|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
145454483|NCT02589665|524515162|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
145454484|NCT02589665|524515163|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
145454485|NCT02589665|524515164|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
145454486|NCT02589665|524515165|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
145454487|NCT02589665|524515166|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
145454488|NCT02589665|524515167|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
145454489|NCT02589665|524515168|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
145454490|NCT02589665|524515169|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
145454491|NCT02589665|524515170|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
145454492|NCT02589665|524515171|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
145454493|NCT02589665|524515162|FG000|Maintenance Extension Period|Adverse Event|0|||
145454494|NCT02589665|524515163|FG001|Maintenance Extension Period|Adverse Event|0|||
145454495|NCT02589665|524515164|FG002|Maintenance Extension Period|Adverse Event|0|||
145454496|NCT02589665|524515165|FG003|Maintenance Extension Period|Adverse Event|0|||
145454497|NCT02589665|524515166|FG004|Maintenance Extension Period|Adverse Event|0|||
145454498|NCT02589665|524515167|FG005|Maintenance Extension Period|Adverse Event|0|||
145454499|NCT02589665|524515168|FG006|Maintenance Extension Period|Adverse Event|0|||
145454500|NCT02589665|524515169|FG007|Maintenance Extension Period|Adverse Event|0|||
145454501|NCT02589665|524515170|FG008|Maintenance Extension Period|Adverse Event|0|||
145454502|NCT02589665|524515171|FG009|Maintenance Extension Period|Adverse Event|2|||
145454503|NCT02589665|524515162|FG000|Maintenance Extension Period|Non-responder|0|||
145454504|NCT02589665|524515163|FG001|Maintenance Extension Period|Non-responder|0|||
145454505|NCT02589665|524515164|FG002|Maintenance Extension Period|Non-responder|0|||
145454506|NCT02589665|524515165|FG003|Maintenance Extension Period|Non-responder|0|||
145454507|NCT02589665|524515166|FG004|Maintenance Extension Period|Non-responder|0|||
145454508|NCT02589665|524515167|FG005|Maintenance Extension Period|Non-responder|0|||
145454509|NCT02589665|524515168|FG006|Maintenance Extension Period|Non-responder|0|||
145454510|NCT02589665|524515169|FG007|Maintenance Extension Period|Non-responder|0|||
145454511|NCT02589665|524515170|FG008|Maintenance Extension Period|Non-responder|0|||
145454512|NCT02589665|524515171|FG009|Maintenance Extension Period|Non-responder|1|||
145454513|NCT00176488|524515174|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
145454514|NCT00327015|524515175|FG000|Overall Study|Lack of Efficacy|18|||
145454515|NCT00327015|524515176|FG001|Overall Study|Lack of Efficacy|18|||
145454516|NCT00327015|524515177|FG002|Overall Study|Lack of Efficacy|35|||
145454517|NCT00327015|524515178|FG003|Overall Study|Lack of Efficacy|29|||
145454518|NCT00327015|524515175|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
145454519|NCT00327015|524515176|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
145454520|NCT00327015|524515177|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
145454521|NCT00327015|524515178|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
145454522|NCT00327015|524515175|FG000|Overall Study|Lost to Follow-up|22|||
145454523|NCT00327015|524515176|FG001|Overall Study|Lost to Follow-up|23|||
145454524|NCT00327015|524515177|FG002|Overall Study|Lost to Follow-up|29|||
145454525|NCT00327015|524515178|FG003|Overall Study|Lost to Follow-up|22|||
145454526|NCT00327015|524515175|FG000|Overall Study|Adverse Event|14|||
145454527|NCT00327015|524515176|FG001|Overall Study|Adverse Event|10|||
145454528|NCT00327015|524515177|FG002|Overall Study|Adverse Event|14|||
145454529|NCT00327015|524515178|FG003|Overall Study|Adverse Event|14|||
145454530|NCT00327015|524515175|FG000|Overall Study|Subject no longer meets study criteria|4|||
145454531|NCT00327015|524515176|FG001|Overall Study|Subject no longer meets study criteria|2|||
145454532|NCT00327015|524515177|FG002|Overall Study|Subject no longer meets study criteria|8|||
145454533|NCT00327015|524515178|FG003|Overall Study|Subject no longer meets study criteria|7|||
145454534|NCT00327015|524515175|FG000|Overall Study|Poor/Noncompliance|11|||
145454535|NCT00327015|524515176|FG001|Overall Study|Poor/Noncompliance|8|||
145454536|NCT00327015|524515177|FG002|Overall Study|Poor/Noncompliance|4|||
145454537|NCT00327015|524515178|FG003|Overall Study|Poor/Noncompliance|5|||
145454538|NCT00327015|524515175|FG000|Overall Study|Physician Decision|0|||
145454539|NCT00327015|524515176|FG001|Overall Study|Physician Decision|1|||
145454540|NCT00327015|524515177|FG002|Overall Study|Physician Decision|3|||
145454541|NCT00327015|524515178|FG003|Overall Study|Physician Decision|2|||
145454542|NCT00327015|524515175|FG000|Overall Study|Death|1|||
145454543|NCT00327015|524515176|FG001|Overall Study|Death|2|||
145454544|NCT00327015|524515177|FG002|Overall Study|Death|2|||
145454545|NCT00327015|524515178|FG003|Overall Study|Death|3|||
145454546|NCT00327015|524515175|FG000|Overall Study|Pregnancy|0|||
145454547|NCT00327015|524515176|FG001|Overall Study|Pregnancy|2|||
145454548|NCT00327015|524515177|FG002|Overall Study|Pregnancy|1|||
145454549|NCT00327015|524515178|FG003|Overall Study|Pregnancy|1|||
145454550|NCT00327015|524515175|FG000|Overall Study|Administrative Reason by Sponsor|1|||
145454551|NCT00327015|524515176|FG001|Overall Study|Administrative Reason by Sponsor|2|||
145454552|NCT00327015|524515177|FG002|Overall Study|Administrative Reason by Sponsor|2|||
145454553|NCT00327015|524515178|FG003|Overall Study|Administrative Reason by Sponsor|1|||
145454554|NCT02650804|524515179|FG000|Overall Study|Adverse Event|3|||
145454555|NCT02650804|524515180|FG001|Overall Study|Adverse Event|2|||
145454556|NCT02650804|524515179|FG000|Overall Study|Death|1|||
145454557|NCT02650804|524515180|FG001|Overall Study|Death|2|||
145454558|NCT02650804|524515179|FG000|Overall Study|Progressive Disease|7|||
145454559|NCT02650804|524515180|FG001|Overall Study|Progressive Disease|10|||
145454560|NCT02650804|524515179|FG000|Overall Study|Physician Decision|0|||
145454561|NCT02650804|524515180|FG001|Overall Study|Physician Decision|2|||
145454562|NCT02650804|524515179|FG000|Overall Study|Withdrawal by Subject|1|||
145454563|NCT02650804|524515180|FG001|Overall Study|Withdrawal by Subject|4|||
145626338|NCT00062868|525144240|FG000|Dose Level 3|Lost to Follow-up|0|||
145454564|NCT02650804|524515179|FG000|Overall Study|Symptomatic deterioration|5|||
145454565|NCT02650804|524515180|FG001|Overall Study|Symptomatic deterioration|7|||
145454566|NCT02650804|524515179|FG000|Overall Study|Protocol Violation|0|||
145454567|NCT02650804|524515180|FG001|Overall Study|Protocol Violation|1|||
145454568|NCT01159171|524515183|FG000|Overall Study|Adverse Event|11|||
145454569|NCT01159171|524515183|FG000|Overall Study|Progression of Disease|28|||
145454570|NCT01159171|524515183|FG000|Overall Study|Protocol Violation|1|||
145454571|NCT01159171|524515183|FG000|Overall Study|Need for Surgery|5|||
145454572|NCT01159171|524515183|FG000|Overall Study|Medical Decision|4|||
145454573|NCT01159171|524515183|FG000|Overall Study|Death|1|||
145454574|NCT01892436|524515184|FG000|Overall Study|Withdrawal by Subject|8|||
145454575|NCT01892436|524515185|FG001|Overall Study|Withdrawal by Subject|15|||
145454576|NCT01892436|524515186|FG002|Overall Study|Withdrawal by Subject|4|||
145454577|NCT01892436|524515187|FG003|Overall Study|Withdrawal by Subject|4|||
145454578|NCT01892436|524515184|FG000|Overall Study|Death|1|||
145454579|NCT01892436|524515185|FG001|Overall Study|Death|1|||
145454580|NCT01892436|524515186|FG002|Overall Study|Death|0|||
145454581|NCT01892436|524515187|FG003|Overall Study|Death|0|||
145454582|NCT01892436|524515184|FG000|Overall Study|Physician Decision|2|||
145454583|NCT01892436|524515185|FG001|Overall Study|Physician Decision|1|||
145454584|NCT01892436|524515186|FG002|Overall Study|Physician Decision|0|||
145454585|NCT01892436|524515187|FG003|Overall Study|Physician Decision|1|||
145454586|NCT01892436|524515184|FG000|Overall Study|Pregnancy|0|||
145454587|NCT01892436|524515185|FG001|Overall Study|Pregnancy|2|||
145454588|NCT01892436|524515186|FG002|Overall Study|Pregnancy|1|||
145454589|NCT01892436|524515187|FG003|Overall Study|Pregnancy|0|||
145454590|NCT01892436|524515184|FG000|Overall Study|Technical problems|2|||
145454591|NCT01892436|524515185|FG001|Overall Study|Technical problems|1|||
145454592|NCT01892436|524515186|FG002|Overall Study|Technical problems|1|||
145454593|NCT01892436|524515187|FG003|Overall Study|Technical problems|1|||
145454594|NCT01892436|524515184|FG000|Overall Study|Lack of Efficacy|1|||
145454595|NCT01892436|524515185|FG001|Overall Study|Lack of Efficacy|2|||
145454596|NCT01892436|524515186|FG002|Overall Study|Lack of Efficacy|2|||
145454597|NCT01892436|524515187|FG003|Overall Study|Lack of Efficacy|2|||
145454598|NCT01892436|524515184|FG000|Overall Study|Lost to Follow-up|1|||
145454599|NCT01892436|524515185|FG001|Overall Study|Lost to Follow-up|1|||
145454600|NCT01892436|524515186|FG002|Overall Study|Lost to Follow-up|1|||
145454601|NCT01892436|524515187|FG003|Overall Study|Lost to Follow-up|3|||
145454602|NCT01892436|524515184|FG000|Overall Study|non-compliance with treatment|1|||
145454603|NCT01892436|524515185|FG001|Overall Study|non-compliance with treatment|0|||
145454604|NCT01892436|524515186|FG002|Overall Study|non-compliance with treatment|0|||
145454605|NCT01892436|524515187|FG003|Overall Study|non-compliance with treatment|0|||
145454606|NCT01892436|524515184|FG000|Overall Study|Adverse Event|7|||
145454607|NCT01892436|524515185|FG001|Overall Study|Adverse Event|6|||
145454608|NCT01892436|524515186|FG002|Overall Study|Adverse Event|2|||
145454609|NCT01892436|524515187|FG003|Overall Study|Adverse Event|3|||
145454610|NCT00733291|524515188|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
145454611|NCT00733291|524515189|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
145454612|NCT00733291|524515190|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
145454613|NCT00733291|524515191|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
145454614|NCT02759107|524515192|FG000|Overall Study|Adverse Event|0|||
145454615|NCT02759107|524515193|FG001|Overall Study|Adverse Event|0|||
145454616|NCT02759107|524515194|FG002|Overall Study|Adverse Event|0|||
145454617|NCT02759107|524515195|FG003|Overall Study|Adverse Event|0|||
145454618|NCT02759107|524515196|FG004|Overall Study|Adverse Event|0|||
145454619|NCT02759107|524515197|FG005|Overall Study|Adverse Event|0|||
145454620|NCT02759107|524515198|FG006|Overall Study|Adverse Event|0|||
145454621|NCT02759107|524515199|FG007|Overall Study|Adverse Event|0|||
145454622|NCT02759107|524515200|FG008|Overall Study|Adverse Event|0|||
145454623|NCT02759107|524515201|FG009|Overall Study|Adverse Event|0|||
145454624|NCT02759107|524515202|FG010|Overall Study|Adverse Event|0|||
145454625|NCT02759107|524515203|FG011|Overall Study|Adverse Event|0|||
145454626|NCT02759107|524515204|FG012|Overall Study|Adverse Event|2|||
145454627|NCT02759107|524515205|FG013|Overall Study|Adverse Event|0|||
145454628|NCT02759107|524515206|FG014|Overall Study|Adverse Event|0|||
145454629|NCT02759107|524515207|FG015|Overall Study|Adverse Event|1|||
145454630|NCT02759107|524515208|FG016|Overall Study|Adverse Event|0|||
145454631|NCT02759107|524515209|FG017|Overall Study|Adverse Event|2|||
145454632|NCT02759107|524515192|FG000|Overall Study|Scheduling Conflict|0|||
145454633|NCT02759107|524515193|FG001|Overall Study|Scheduling Conflict|0|||
145454634|NCT02759107|524515194|FG002|Overall Study|Scheduling Conflict|0|||
145454635|NCT02759107|524515195|FG003|Overall Study|Scheduling Conflict|0|||
145454636|NCT02759107|524515196|FG004|Overall Study|Scheduling Conflict|0|||
145454637|NCT02759107|524515197|FG005|Overall Study|Scheduling Conflict|0|||
145454638|NCT02759107|524515198|FG006|Overall Study|Scheduling Conflict|0|||
145454639|NCT02759107|524515199|FG007|Overall Study|Scheduling Conflict|0|||
145454640|NCT02759107|524515200|FG008|Overall Study|Scheduling Conflict|0|||
145454641|NCT02759107|524515201|FG009|Overall Study|Scheduling Conflict|1|||
145454642|NCT02759107|524515202|FG010|Overall Study|Scheduling Conflict|0|||
145454643|NCT02759107|524515203|FG011|Overall Study|Scheduling Conflict|0|||
145454644|NCT02759107|524515204|FG012|Overall Study|Scheduling Conflict|0|||
145454645|NCT02759107|524515205|FG013|Overall Study|Scheduling Conflict|0|||
145454646|NCT02759107|524515206|FG014|Overall Study|Scheduling Conflict|0|||
145454647|NCT02759107|524515207|FG015|Overall Study|Scheduling Conflict|0|||
145454648|NCT02759107|524515208|FG016|Overall Study|Scheduling Conflict|0|||
145454649|NCT02759107|524515209|FG017|Overall Study|Scheduling Conflict|0|||
145454650|NCT01089413|524515213|FG000|Overall Study|Lost to Follow-up|1|||
145454651|NCT01089413|524515213|FG000|Overall Study|Progressive Disease|93|||
145454652|NCT01089413|524515213|FG000|Overall Study|Participant Withdrew Consent|1|||
145454653|NCT01089413|524515213|FG000|Overall Study|Unacceptable Toxicity|12|||
145454654|NCT01089413|524515213|FG000|Overall Study|Death|10|||
145454655|NCT01089413|524515213|FG000|Overall Study|Metastasectomy|13|||
145454656|NCT01089413|524515213|FG000|Overall Study|Other|71|||
145454657|NCT02526524|524515217|FG000|Overall Study|Withdrawal by Subject|3|||
145454658|NCT02526524|524515218|FG001|Overall Study|Withdrawal by Subject|3|||
145454659|NCT02526524|524515219|FG002|Overall Study|Withdrawal by Subject|6|||
145454660|NCT02526524|524515220|FG003|Overall Study|Withdrawal by Subject|1|||
145454661|NCT02526524|524515221|FG004|Overall Study|Withdrawal by Subject|9|||
145454662|NCT02526524|524515222|FG005|Overall Study|Withdrawal by Subject|5|||
145454663|NCT02526524|524515217|FG000|Overall Study|Adverse Event|3|||
145454664|NCT02526524|524515218|FG001|Overall Study|Adverse Event|2|||
145454665|NCT02526524|524515219|FG002|Overall Study|Adverse Event|4|||
145454666|NCT02526524|524515220|FG003|Overall Study|Adverse Event|2|||
145454667|NCT02526524|524515221|FG004|Overall Study|Adverse Event|6|||
145454668|NCT02526524|524515222|FG005|Overall Study|Adverse Event|8|||
145454669|NCT02526524|524515217|FG000|Overall Study|Lost to Follow-up|2|||
145454670|NCT02526524|524515218|FG001|Overall Study|Lost to Follow-up|3|||
145454671|NCT02526524|524515219|FG002|Overall Study|Lost to Follow-up|8|||
145454672|NCT02526524|524515220|FG003|Overall Study|Lost to Follow-up|1|||
145454673|NCT02526524|524515221|FG004|Overall Study|Lost to Follow-up|2|||
145454674|NCT02526524|524515222|FG005|Overall Study|Lost to Follow-up|5|||
145454675|NCT02526524|524515217|FG000|Overall Study|Protocol Violation|3|||
145454676|NCT02526524|524515218|FG001|Overall Study|Protocol Violation|1|||
145454677|NCT02526524|524515219|FG002|Overall Study|Protocol Violation|5|||
145454678|NCT02526524|524515220|FG003|Overall Study|Protocol Violation|3|||
145454679|NCT02526524|524515221|FG004|Overall Study|Protocol Violation|4|||
145454680|NCT02526524|524515222|FG005|Overall Study|Protocol Violation|3|||
145454681|NCT02526524|524515217|FG000|Overall Study|Loss of Glucose Control|0|||
145454682|NCT02526524|524515218|FG001|Overall Study|Loss of Glucose Control|0|||
145454683|NCT02526524|524515219|FG002|Overall Study|Loss of Glucose Control|3|||
145454684|NCT02526524|524515220|FG003|Overall Study|Loss of Glucose Control|0|||
145454685|NCT02526524|524515221|FG004|Overall Study|Loss of Glucose Control|2|||
145454686|NCT02526524|524515222|FG005|Overall Study|Loss of Glucose Control|0|||
145454687|NCT02526524|524515217|FG000|Overall Study|Physician Decision|0|||
145454688|NCT02526524|524515218|FG001|Overall Study|Physician Decision|0|||
145454689|NCT02526524|524515219|FG002|Overall Study|Physician Decision|0|||
145454690|NCT02526524|524515220|FG003|Overall Study|Physician Decision|0|||
145454691|NCT02526524|524515221|FG004|Overall Study|Physician Decision|1|||
145454692|NCT02526524|524515222|FG005|Overall Study|Physician Decision|0|||
145454693|NCT02526524|524515217|FG000|Overall Study|Sponsor Decision|1|||
145454694|NCT02526524|524515218|FG001|Overall Study|Sponsor Decision|0|||
145454695|NCT02526524|524515219|FG002|Overall Study|Sponsor Decision|0|||
145454696|NCT02526524|524515220|FG003|Overall Study|Sponsor Decision|0|||
145454697|NCT02526524|524515221|FG004|Overall Study|Sponsor Decision|0|||
145454698|NCT02526524|524515222|FG005|Overall Study|Sponsor Decision|0|||
145454699|NCT00470093|524515224|FG000|Overall Study|Adverse Event|2|||
145454700|NCT00664560|524515225|FG000|Overall Study|Adverse Event|19|||
145454701|NCT00664560|524515226|FG001|Overall Study|Adverse Event|16|||
145454702|NCT00664560|524515227|FG002|Overall Study|Adverse Event|7|||
145454703|NCT00664560|524515225|FG000|Overall Study|Withdrawal by Subject|9|||
145454704|NCT00664560|524515226|FG001|Overall Study|Withdrawal by Subject|13|||
145454705|NCT00664560|524515227|FG002|Overall Study|Withdrawal by Subject|7|||
145454706|NCT00664560|524515225|FG000|Overall Study|Lost to Follow-up|0|||
145454707|NCT00664560|524515226|FG001|Overall Study|Lost to Follow-up|2|||
145454708|NCT00664560|524515227|FG002|Overall Study|Lost to Follow-up|0|||
145587769|NCT04667117|525004309|FG000|Investigational Period|Protocol Deviation|0|||
145587770|NCT04667117|525004310|FG001|Investigational Period|Protocol Deviation|1|||
145587771|NCT04667117|525004311|FG002|Investigational Period|Protocol Deviation|0|||
145454709|NCT00664560|524515225|FG000|Overall Study|Other|11|||
145454710|NCT00664560|524515226|FG001|Overall Study|Other|4|||
145454711|NCT00664560|524515227|FG002|Overall Study|Other|5|||
145454712|NCT01610557|524515230|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
145454713|NCT01610557|524515231|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
145454714|NCT01610557|524515232|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
145454715|NCT01610557|524515233|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
145454716|NCT01610557|524515234|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
145454717|NCT01610557|524515230|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
145454718|NCT01610557|524515231|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
145454719|NCT01610557|524515232|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
145454720|NCT01610557|524515233|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
145587772|NCT04667117|525004309|FG000|Extension Period|Lost to Follow-up|1|||
145454721|NCT01610557|524515234|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
145454722|NCT01289353|524515235|FG000|Overall Study|Lost to Follow-up|2|||
145454723|NCT01549886|524515236|FG000|Overall Study|Sponsor's decision|2|||
145454724|NCT01549886|524515237|FG001|Overall Study|Sponsor's decision|3|||
145454725|NCT00473668|524515238|FG000|Overall Study|Withdrawal by Subject|0|||
145454726|NCT00473668|524515239|FG001|Overall Study|Withdrawal by Subject|2|||
145454727|NCT00473668|524515240|FG002|Overall Study|Withdrawal by Subject|0|||
145454728|NCT00473668|524515238|FG000|Overall Study|Migrated/moved from study area|3|||
145454729|NCT00473668|524515239|FG001|Overall Study|Migrated/moved from study area|2|||
145454730|NCT00473668|524515240|FG002|Overall Study|Migrated/moved from study area|0|||
145454731|NCT00473668|524515238|FG000|Overall Study|Lost to Follow-up|0|||
145454732|NCT00473668|524515239|FG001|Overall Study|Lost to Follow-up|4|||
145454733|NCT00473668|524515240|FG002|Overall Study|Lost to Follow-up|6|||
145454734|NCT00473668|524515238|FG000|Overall Study|Other|2|||
145454735|NCT00473668|524515239|FG001|Overall Study|Other|3|||
145454736|NCT00473668|524515240|FG002|Overall Study|Other|4|||
145454737|NCT02039219|524515241|FG000|Treatment|Withdrawal by Subject|1|||
145454738|NCT02039219|524515242|FG001|Treatment|Withdrawal by Subject|0|||
145454739|NCT02039219|524515241|FG000|Treatment|Adverse Event|0|||
145454740|NCT02039219|524515242|FG001|Treatment|Adverse Event|1|||
145454741|NCT02039219|524515241|FG000|Treatment|Physician Decision|1|||
145454742|NCT02039219|524515242|FG001|Treatment|Physician Decision|0|||
145454743|NCT02039219|524515241|FG000|Treatment|Lost to Follow-up|0|||
145454744|NCT02039219|524515242|FG001|Treatment|Lost to Follow-up|1|||
145454745|NCT02039219|524515241|FG000|Treatment|Protocol Violation|1|||
145454746|NCT02039219|524515242|FG001|Treatment|Protocol Violation|0|||
145454747|NCT02039219|524515241|FG000|Treatment|Death|1|||
145454748|NCT02039219|524515242|FG001|Treatment|Death|0|||
145454749|NCT02039219|524515241|FG000|Follow up|Adverse Event|0|||
145454750|NCT02039219|524515242|FG001|Follow up|Adverse Event|1|||
145454751|NCT02226562|524515243|FG000|Overall Study|Lost to Follow-up|0|||
145454752|NCT02226562|524515244|FG001|Overall Study|Lost to Follow-up|1|||
145454753|NCT04569136|524515245|FG000|Overall Study|Lost to Follow-up|2|||
145454754|NCT04569136|524515246|FG001|Overall Study|Lost to Follow-up|0|||
145454755|NCT04569136|524515247|FG002|Overall Study|Lost to Follow-up|1|||
145454756|NCT01466660|524515249|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
145454757|NCT01466660|524515250|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
145454758|NCT01466660|524515249|FG000|Overall Study|Worsening of underlying cancer disease|5|||
145454759|NCT01466660|524515250|FG001|Overall Study|Worsening of underlying cancer disease|2|||
145454760|NCT01466660|524515249|FG000|Overall Study|Other adverse event|19|||
145454761|NCT01466660|524515250|FG001|Overall Study|Other adverse event|18|||
145454762|NCT01466660|524515249|FG000|Overall Study|Protocol Violation|2|||
145454763|NCT01466660|524515250|FG001|Overall Study|Protocol Violation|1|||
145454764|NCT01466660|524515249|FG000|Overall Study|Refused continuation of trial medication|4|||
145454765|NCT01466660|524515250|FG001|Overall Study|Refused continuation of trial medication|3|||
145454766|NCT01466660|524515249|FG000|Overall Study|Other reason not defined above|10|||
145454767|NCT01466660|524515250|FG001|Overall Study|Other reason not defined above|8|||
145454768|NCT00129701|524515251|FG000|Overall Study|Withdrawal by Subject|33|||
145454769|NCT02750345|524515252|FG000|Intervention 1|Adverse Event|0|||
145454770|NCT02750345|524515253|FG001|Intervention 1|Adverse Event|0|||
145454771|NCT02750345|524515254|FG002|Intervention 1|Adverse Event|0|||
145454772|NCT02750345|524515255|FG003|Intervention 1|Adverse Event|0|||
145454773|NCT02750345|524515256|FG004|Intervention 1|Adverse Event|1|||
145454774|NCT02750345|524515257|FG005|Intervention 1|Adverse Event|0|||
145454775|NCT00006164|524515258|FG000|Overall Study|Withdrew or lost to follow-up|70|||
145454776|NCT00006164|524515259|FG001|Overall Study|Withdrew or lost to follow-up|81|||
145454777|NCT00223808|524515260|FG000|Overall Study|<5 hrs therapy before discharge|3|||
145454778|NCT00223808|524515261|FG001|Overall Study|<5 hrs therapy before discharge|5|||
145454779|NCT00223808|524515262|FG002|Overall Study|<5 hrs therapy before discharge|5|||
145626339|NCT00062868|525144241|FG001|Dose Level 3|Lost to Follow-up|0|||
145626340|NCT00062868|525144242|FG002|Dose Level 3|Lost to Follow-up|0|||
145626341|NCT00062868|525144243|FG003|Dose Level 3|Lost to Follow-up|0|||
145454780|NCT00608023|524515263|FG000|Overall Study|Withdrawal by Subject|8|||
145454781|NCT00608023|524515264|FG001|Overall Study|Withdrawal by Subject|10|||
145454782|NCT00608023|524515265|FG002|Overall Study|Withdrawal by Subject|7|||
145454783|NCT00608023|524515263|FG000|Overall Study|Adverse Event|1|||
145454784|NCT00608023|524515264|FG001|Overall Study|Adverse Event|4|||
145454785|NCT00608023|524515265|FG002|Overall Study|Adverse Event|5|||
145454786|NCT00608023|524515263|FG000|Overall Study|Lost to Follow-up|2|||
145454787|NCT00608023|524515264|FG001|Overall Study|Lost to Follow-up|2|||
145454788|NCT00608023|524515265|FG002|Overall Study|Lost to Follow-up|1|||
145454789|NCT00608023|524515263|FG000|Overall Study|Protocol Violation|1|||
145454790|NCT00608023|524515264|FG001|Overall Study|Protocol Violation|3|||
145454791|NCT00608023|524515265|FG002|Overall Study|Protocol Violation|1|||
145454792|NCT00608023|524515263|FG000|Overall Study|Unknown reason|0|||
145454793|NCT00608023|524515264|FG001|Overall Study|Unknown reason|3|||
145454794|NCT00608023|524515265|FG002|Overall Study|Unknown reason|0|||
145626342|NCT00062868|525144244|FG004|Dose Level 3|Lost to Follow-up|0|||
145454795|NCT00758264|524515268|FG000|Active Phase|Withdrawal by Subject|0|||
145454796|NCT00758264|524515269|FG001|Active Phase|Withdrawal by Subject|0|||
145454797|NCT00758264|524515270|FG002|Active Phase|Withdrawal by Subject|1|||
145454798|NCT00758264|524515268|FG000|Active Phase|Lost to Follow-up|1|||
145454799|NCT00758264|524515269|FG001|Active Phase|Lost to Follow-up|0|||
145454800|NCT00758264|524515270|FG002|Active Phase|Lost to Follow-up|0|||
145454801|NCT00758264|524515268|FG000|Active Phase|Other|0|||
145454802|NCT00758264|524515269|FG001|Active Phase|Other|0|||
145454803|NCT00758264|524515270|FG002|Active Phase|Other|4|||
145454804|NCT03931382|524515273|FG000|Overall Study|Equipment malfunction|2|||
145454805|NCT03931382|524515274|FG001|Overall Study|Equipment malfunction|0|||
145454806|NCT03931382|524515275|FG002|Overall Study|Equipment malfunction|2|||
145454807|NCT03931382|524515273|FG000|Overall Study|Withdrawal by Subject|0|||
145454808|NCT03931382|524515274|FG001|Overall Study|Withdrawal by Subject|1|||
145454809|NCT03931382|524515275|FG002|Overall Study|Withdrawal by Subject|0|||
145454810|NCT01054560|524515278|FG000|Overall Study|Death|10|||
145454811|NCT01054560|524515279|FG001|Overall Study|Death|21|||
145454812|NCT01054560|524515278|FG000|Overall Study|Lost to Follow-up|2|||
145454813|NCT01054560|524515279|FG001|Overall Study|Lost to Follow-up|5|||
145454814|NCT01054560|524515278|FG000|Overall Study|Withdrawal by Subject|0|||
145454815|NCT01054560|524515279|FG001|Overall Study|Withdrawal by Subject|2|||
145454816|NCT01054560|524515278|FG000|Overall Study|Physician Decision|1|||
145454817|NCT01054560|524515279|FG001|Overall Study|Physician Decision|0|||
145454818|NCT02135029|524515284|FG000|Overall Study|Adverse Event|2|||
145454819|NCT02135029|524515285|FG001|Overall Study|Adverse Event|2|||
145454820|NCT02135029|524515286|FG002|Overall Study|Adverse Event|2|||
145454821|NCT02135029|524515284|FG000|Overall Study|Lost to Follow-up|0|||
145454822|NCT02135029|524515285|FG001|Overall Study|Lost to Follow-up|1|||
145454823|NCT02135029|524515286|FG002|Overall Study|Lost to Follow-up|0|||
145454824|NCT02135029|524515284|FG000|Overall Study|Withdrawal by Subject|2|||
145454825|NCT02135029|524515285|FG001|Overall Study|Withdrawal by Subject|0|||
145454826|NCT02135029|524515286|FG002|Overall Study|Withdrawal by Subject|1|||
145454827|NCT02135029|524515284|FG000|Overall Study|Other|0|||
145454828|NCT02135029|524515285|FG001|Overall Study|Other|1|||
145454829|NCT02135029|524515286|FG002|Overall Study|Other|0|||
145454830|NCT02135029|524515284|FG000|Overall Study|Death|0|||
145454831|NCT02135029|524515285|FG001|Overall Study|Death|1|||
145454832|NCT02135029|524515286|FG002|Overall Study|Death|0|||
145454833|NCT00712725|524515287|FG000|Overall Study|Adverse Event|1|||
145454834|NCT00712725|524515288|FG001|Overall Study|Adverse Event|0|||
145454835|NCT00712725|524515289|FG002|Overall Study|Adverse Event|0|||
145454836|NCT00712725|524515290|FG003|Overall Study|Adverse Event|1|||
145454837|NCT00712725|524515291|FG004|Overall Study|Adverse Event|0|||
145454838|NCT00712725|524515292|FG005|Overall Study|Adverse Event|0|||
145454839|NCT00712725|524515293|FG006|Overall Study|Adverse Event|0|||
145454840|NCT00712725|524515294|FG007|Overall Study|Adverse Event|0|||
145454841|NCT00712725|524515287|FG000|Overall Study|Lost to Follow-up|3|||
145454842|NCT00712725|524515288|FG001|Overall Study|Lost to Follow-up|2|||
145454843|NCT00712725|524515289|FG002|Overall Study|Lost to Follow-up|1|||
145454844|NCT00712725|524515290|FG003|Overall Study|Lost to Follow-up|1|||
145454845|NCT00712725|524515291|FG004|Overall Study|Lost to Follow-up|2|||
145454846|NCT00712725|524515292|FG005|Overall Study|Lost to Follow-up|2|||
145454847|NCT00712725|524515293|FG006|Overall Study|Lost to Follow-up|3|||
145454848|NCT00712725|524515294|FG007|Overall Study|Lost to Follow-up|1|||
145454849|NCT00712725|524515287|FG000|Overall Study|Physician Decision|2|||
145454850|NCT00712725|524515288|FG001|Overall Study|Physician Decision|0|||
145454851|NCT00712725|524515289|FG002|Overall Study|Physician Decision|0|||
145454852|NCT00712725|524515290|FG003|Overall Study|Physician Decision|0|||
145454853|NCT00712725|524515291|FG004|Overall Study|Physician Decision|1|||
145454854|NCT00712725|524515292|FG005|Overall Study|Physician Decision|0|||
145454855|NCT00712725|524515293|FG006|Overall Study|Physician Decision|2|||
145454856|NCT00712725|524515294|FG007|Overall Study|Physician Decision|0|||
145454857|NCT00712725|524515287|FG000|Overall Study|Pregnancy|0|||
145454858|NCT00712725|524515288|FG001|Overall Study|Pregnancy|1|||
145454859|NCT00712725|524515289|FG002|Overall Study|Pregnancy|0|||
145454860|NCT00712725|524515290|FG003|Overall Study|Pregnancy|0|||
145454861|NCT00712725|524515291|FG004|Overall Study|Pregnancy|1|||
145454862|NCT00712725|524515292|FG005|Overall Study|Pregnancy|0|||
145454863|NCT00712725|524515293|FG006|Overall Study|Pregnancy|2|||
145454864|NCT00712725|524515294|FG007|Overall Study|Pregnancy|0|||
145454865|NCT00712725|524515287|FG000|Overall Study|Protocol Violation|2|||
145454866|NCT00712725|524515288|FG001|Overall Study|Protocol Violation|0|||
145454867|NCT00712725|524515289|FG002|Overall Study|Protocol Violation|1|||
145454868|NCT00712725|524515290|FG003|Overall Study|Protocol Violation|3|||
145454869|NCT00712725|524515291|FG004|Overall Study|Protocol Violation|2|||
145454870|NCT00712725|524515292|FG005|Overall Study|Protocol Violation|0|||
145454871|NCT00712725|524515293|FG006|Overall Study|Protocol Violation|1|||
145454872|NCT00712725|524515294|FG007|Overall Study|Protocol Violation|1|||
145454873|NCT00712725|524515287|FG000|Overall Study|Withdrawal by Subject|2|||
145454874|NCT00712725|524515288|FG001|Overall Study|Withdrawal by Subject|1|||
145454875|NCT00712725|524515289|FG002|Overall Study|Withdrawal by Subject|1|||
145454876|NCT00712725|524515290|FG003|Overall Study|Withdrawal by Subject|2|||
145454877|NCT00712725|524515291|FG004|Overall Study|Withdrawal by Subject|1|||
145454878|NCT00712725|524515292|FG005|Overall Study|Withdrawal by Subject|1|||
145454879|NCT00712725|524515293|FG006|Overall Study|Withdrawal by Subject|1|||
145454880|NCT00712725|524515294|FG007|Overall Study|Withdrawal by Subject|2|||
145454881|NCT00712725|524515287|FG000|Overall Study|Lack of Qualifying Event|16|||
145454882|NCT00712725|524515288|FG001|Overall Study|Lack of Qualifying Event|2|||
145454883|NCT00712725|524515289|FG002|Overall Study|Lack of Qualifying Event|6|||
145454884|NCT00712725|524515290|FG003|Overall Study|Lack of Qualifying Event|8|||
145454885|NCT00712725|524515291|FG004|Overall Study|Lack of Qualifying Event|11|||
145454886|NCT00712725|524515292|FG005|Overall Study|Lack of Qualifying Event|13|||
145454887|NCT00712725|524515293|FG006|Overall Study|Lack of Qualifying Event|11|||
145454888|NCT00712725|524515294|FG007|Overall Study|Lack of Qualifying Event|6|||
145454889|NCT00712725|524515287|FG000|Overall Study|Protocol Specified Criteria|3|||
145454890|NCT00712725|524515288|FG001|Overall Study|Protocol Specified Criteria|0|||
145454891|NCT00712725|524515289|FG002|Overall Study|Protocol Specified Criteria|1|||
145454892|NCT00712725|524515290|FG003|Overall Study|Protocol Specified Criteria|2|||
145454893|NCT00712725|524515291|FG004|Overall Study|Protocol Specified Criteria|1|||
145454894|NCT00712725|524515292|FG005|Overall Study|Protocol Specified Criteria|0|||
145454895|NCT00712725|524515293|FG006|Overall Study|Protocol Specified Criteria|2|||
145454896|NCT00712725|524515294|FG007|Overall Study|Protocol Specified Criteria|1|||
145454897|NCT03466099|524515295|FG000|Overall Study|Adverse Event|1|||
145454898|NCT03466099|524515296|FG001|Overall Study|Adverse Event|1|||
145454899|NCT03466099|524515297|FG002|Overall Study|Adverse Event|1|||
145454900|NCT03466099|524515295|FG000|Overall Study|Withdrawal by Subject|2|||
145454901|NCT03466099|524515296|FG001|Overall Study|Withdrawal by Subject|3|||
145454902|NCT03466099|524515297|FG002|Overall Study|Withdrawal by Subject|1|||
145454903|NCT03466099|524515295|FG000|Overall Study|Use of rescue medication|8|||
145454904|NCT03466099|524515296|FG001|Overall Study|Use of rescue medication|9|||
145454905|NCT03466099|524515297|FG002|Overall Study|Use of rescue medication|13|||
145454906|NCT03466099|524515295|FG000|Overall Study|Rescued without meeting criteria|4|||
145454907|NCT03466099|524515296|FG001|Overall Study|Rescued without meeting criteria|1|||
145454908|NCT03466099|524515297|FG002|Overall Study|Rescued without meeting criteria|1|||
145454909|NCT03466099|524515295|FG000|Overall Study|Subject compliance|2|||
145454910|NCT03466099|524515296|FG001|Overall Study|Subject compliance|0|||
145454911|NCT03466099|524515297|FG002|Overall Study|Subject compliance|0|||
145454912|NCT03466099|524515295|FG000|Overall Study|Worsening disease|0|||
145454913|NCT03466099|524515296|FG001|Overall Study|Worsening disease|0|||
145454914|NCT03466099|524515297|FG002|Overall Study|Worsening disease|1|||
145454915|NCT04590404|524515300|FG000|Overall Study|Death|16|||
145454916|NCT04590404|524515301|FG001|Overall Study|Death|17|||
145454917|NCT04590404|524515300|FG000|Overall Study|Withdrawal by Subject|7|||
145454918|NCT04590404|524515301|FG001|Overall Study|Withdrawal by Subject|2|||
145454919|NCT04154605|524515302|FG000|Overall Study|Procedure Canceled|1|||
145454920|NCT04154605|524515303|FG001|Overall Study|Procedure Canceled|1|||
145454921|NCT04154605|524515302|FG000|Overall Study|Missed follow up|1|||
145454922|NCT04154605|524515303|FG001|Overall Study|Missed follow up|1|||
145454923|NCT04154605|524515302|FG000|Overall Study|Withdrawal by Subject|1|||
145454924|NCT04154605|524515303|FG001|Overall Study|Withdrawal by Subject|0|||
145454925|NCT03525600|524515304|FG000|Overall Study|Adverse Event|9|||
145454926|NCT03525600|524515305|FG001|Overall Study|Adverse Event|6|||
145454927|NCT03525600|524515306|FG002|Overall Study|Adverse Event|5|||
145454928|NCT03525600|524515307|FG003|Overall Study|Adverse Event|3|||
145454929|NCT03525600|524515304|FG000|Overall Study|Lost to Follow-up|2|||
145454930|NCT03525600|524515305|FG001|Overall Study|Lost to Follow-up|4|||
145454931|NCT03525600|524515306|FG002|Overall Study|Lost to Follow-up|4|||
145454932|NCT03525600|524515307|FG003|Overall Study|Lost to Follow-up|0|||
145454933|NCT03525600|524515304|FG000|Overall Study|Physician Decision|1|||
145454934|NCT03525600|524515305|FG001|Overall Study|Physician Decision|0|||
145454935|NCT03525600|524515306|FG002|Overall Study|Physician Decision|2|||
145454936|NCT03525600|524515307|FG003|Overall Study|Physician Decision|0|||
145454937|NCT03525600|524515304|FG000|Overall Study|Consent withdrawal|36|||
145454938|NCT03525600|524515305|FG001|Overall Study|Consent withdrawal|20|||
145454939|NCT03525600|524515306|FG002|Overall Study|Consent withdrawal|6|||
145454940|NCT03525600|524515307|FG003|Overall Study|Consent withdrawal|13|||
145454941|NCT03525600|524515304|FG000|Overall Study|Death|7|||
145454942|NCT03525600|524515305|FG001|Overall Study|Death|6|||
145454943|NCT03525600|524515306|FG002|Overall Study|Death|4|||
145454944|NCT03525600|524515307|FG003|Overall Study|Death|3|||
145454945|NCT03525600|524515304|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
145454946|NCT03525600|524515305|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
145454947|NCT03525600|524515306|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
145454948|NCT03525600|524515307|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
145454949|NCT03525600|524515304|FG000|Overall Study|Other|0|||
145454950|NCT03525600|524515305|FG001|Overall Study|Other|1|||
145454951|NCT03525600|524515306|FG002|Overall Study|Other|0|||
145454952|NCT03525600|524515307|FG003|Overall Study|Other|0|||
145454953|NCT01923363|524515310|FG000|Overall Study|Protocol Violation|1|||
145454954|NCT00290771|524515311|FG000|Overall Study|Disease progression|95|||
145454955|NCT00290771|524515312|FG001|Overall Study|Disease progression|73|||
145454956|NCT00290771|524515311|FG000|Overall Study|Death|11|||
145454957|NCT00290771|524515312|FG001|Overall Study|Death|10|||
145454958|NCT00290771|524515311|FG000|Overall Study|Adverse Event|12|||
145454959|NCT00290771|524515312|FG001|Overall Study|Adverse Event|6|||
145454960|NCT00290771|524515311|FG000|Overall Study|Withdrawal by Subject|5|||
145454961|NCT00290771|524515312|FG001|Overall Study|Withdrawal by Subject|6|||
145454962|NCT00290771|524515311|FG000|Overall Study|Administrative problems|2|||
145454963|NCT00290771|524515312|FG001|Overall Study|Administrative problems|1|||
145454964|NCT00290771|524515311|FG000|Overall Study|Protocol Violation|2|||
145454965|NCT00290771|524515312|FG001|Overall Study|Protocol Violation|0|||
145454966|NCT00290771|524515311|FG000|Overall Study|Lost to Follow-up|0|||
145454967|NCT00290771|524515312|FG001|Overall Study|Lost to Follow-up|1|||
145454968|NCT04154293|524515315|FG000|Overall Study|Withdrawal by Subject|2|||
145454969|NCT04154293|524515316|FG001|Overall Study|Withdrawal by Subject|3|||
145454970|NCT04154293|524515317|FG002|Overall Study|Withdrawal by Subject|1|||
145454971|NCT04154293|524515315|FG000|Overall Study|Physician Decision|0|||
145454972|NCT04154293|524515316|FG001|Overall Study|Physician Decision|0|||
145454973|NCT04154293|524515317|FG002|Overall Study|Physician Decision|1|||
145454974|NCT03703817|524515319|FG000|Overall Study|Not meeting eligibility criteria|7|||
145454975|NCT03703817|524515320|FG001|Overall Study|Not meeting eligibility criteria|4|||
145454976|NCT05129449|524515321|FG000|Overall Study|Protocol Violation|1|||
145454977|NCT01818258|524515325|FG000|Overall Study|Death|3|||
145454978|NCT01818258|524515326|FG001|Overall Study|Death|0|||
145454979|NCT01818258|524515325|FG000|Overall Study|Withdrawal by Subject|0|||
145454980|NCT01818258|524515326|FG001|Overall Study|Withdrawal by Subject|1|||
145454981|NCT01818258|524515325|FG000|Overall Study|Lost to Follow-up|0|||
145454982|NCT01818258|524515326|FG001|Overall Study|Lost to Follow-up|1|||
145454983|NCT01818258|524515325|FG000|Overall Study|Unable to Travel to Clinic|0|||
145454984|NCT01818258|524515326|FG001|Overall Study|Unable to Travel to Clinic|1|||
145454985|NCT02099344|524515327|FG000|Overall Study|Physician Decision|1|||
145454986|NCT02099344|524515328|FG001|Overall Study|Physician Decision|0|||
145454987|NCT03802630|524515333|FG000|Overall Study|Study terminated by sponsor|130|||
145454988|NCT03802630|524515334|FG001|Overall Study|Study terminated by sponsor|134|||
145454989|NCT03802630|524515333|FG000|Overall Study|Subject decision|16|||
145454990|NCT03802630|524515334|FG001|Overall Study|Subject decision|9|||
145454991|NCT03802630|524515333|FG000|Overall Study|Adverse Event|3|||
145454992|NCT03802630|524515334|FG001|Overall Study|Adverse Event|1|||
145454993|NCT03802630|524515333|FG000|Overall Study|Lost to Follow-up|2|||
145454994|NCT03802630|524515334|FG001|Overall Study|Lost to Follow-up|2|||
145454995|NCT03802630|524515333|FG000|Overall Study|Physician Decision|2|||
145454996|NCT03802630|524515334|FG001|Overall Study|Physician Decision|0|||
145454997|NCT03802630|524515333|FG000|Overall Study|Death|0|||
145454998|NCT03802630|524515334|FG001|Overall Study|Death|2|||
145454999|NCT00661726|524515335|FG000|Overall Study|Adverse Event|1|||
145455000|NCT02644096|524515336|FG000|Overall Study|Withdrawal by Subject|28|||
145455001|NCT02644096|524515337|FG001|Overall Study|Withdrawal by Subject|25|||
145455002|NCT00322452|524515338|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145455003|NCT00322452|524515339|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145455004|NCT00322452|524515338|FG000|Overall Study|Lost to Follow-up|5|||
145455005|NCT00322452|524515339|FG001|Overall Study|Lost to Follow-up|2|||
145455006|NCT00322452|524515338|FG000|Overall Study|Withdrawal by Subject|19|||
145455007|NCT00322452|524515339|FG001|Overall Study|Withdrawal by Subject|46|||
145455008|NCT00322452|524515338|FG000|Overall Study|Death|223|||
145455009|NCT00322452|524515339|FG001|Overall Study|Death|227|||
145455010|NCT00526656|524515340|FG000|Overall Study|Death|1|||
145455011|NCT00526656|524515340|FG000|Overall Study|Refused surgery|1|||
145455012|NCT03319953|524515341|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
145455013|NCT03319953|524515342|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
145587773|NCT04667117|525004310|FG001|Extension Period|Lost to Follow-up|0|||
145587774|NCT04667117|525004311|FG002|Extension Period|Lost to Follow-up|0|||
145587775|NCT00833989|525004312|FG000|Overall Study|Physician Decision|0|||
145587776|NCT00833989|525004313|FG001|Overall Study|Physician Decision|0|||
145587777|NCT00833989|525004314|FG002|Overall Study|Physician Decision|0|||
145587778|NCT00833989|525004315|FG003|Overall Study|Physician Decision|1|||
145587779|NCT00833989|525004312|FG000|Overall Study|Withdrawal by Subject|3|||
145587780|NCT00833989|525004313|FG001|Overall Study|Withdrawal by Subject|0|||
145455014|NCT03319953|524515343|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
145455015|NCT03319953|524515344|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
145455016|NCT03319953|524515341|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
145455017|NCT03319953|524515342|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
145455018|NCT03319953|524515343|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
145455019|NCT03319953|524515344|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
145455020|NCT01795495|524515346|FG000|Overall Study|Protocol Violation|1|||
145455021|NCT01795495|524515347|FG001|Overall Study|Protocol Violation|0|||
145587781|NCT00833989|525004314|FG002|Overall Study|Withdrawal by Subject|1|||
145587782|NCT00833989|525004315|FG003|Overall Study|Withdrawal by Subject|1|||
145455022|NCT01795495|524515348|FG002|Overall Study|Protocol Violation|1|||
145455023|NCT01795495|524515346|FG000|Overall Study|Physician Decision|0|||
145455024|NCT01795495|524515347|FG001|Overall Study|Physician Decision|0|||
145455025|NCT01795495|524515348|FG002|Overall Study|Physician Decision|1|||
145455026|NCT00790868|524517047|FG000|Overall Study|Withdrawal by Subject|4|||
145455027|NCT00790868|524517048|FG001|Overall Study|Withdrawal by Subject|5|||
145455028|NCT00790868|524517047|FG000|Overall Study|Lost to Follow-up|2|||
145455029|NCT00790868|524517048|FG001|Overall Study|Lost to Follow-up|12|||
145455030|NCT01579565|524517049|FG000|Randomized|Adverse Event|1|||
145455031|NCT01579565|524517050|FG001|Randomized|Adverse Event|3|||
145455032|NCT01579565|524517049|FG000|Randomized|Withdrawal by Subject|3|||
145455033|NCT01579565|524517050|FG001|Randomized|Withdrawal by Subject|0|||
145455034|NCT01579565|524517049|FG000|Randomized|inadequate preoperative pupil dilation|0|||
145455035|NCT01579565|524517050|FG001|Randomized|inadequate preoperative pupil dilation|1|||
145455036|NCT01579565|524517049|FG000|Randomized|prohibited preoperative eating|1|||
145455037|NCT01579565|524517050|FG001|Randomized|prohibited preoperative eating|0|||
145455038|NCT01579565|524517049|FG000|Randomized|prohibited preoperative medication|0|||
145455039|NCT01579565|524517050|FG001|Randomized|prohibited preoperative medication|1|||
145455040|NCT01579565|524517049|FG000|Treated|Physician Decision|0|||
145455041|NCT01579565|524517050|FG001|Treated|Physician Decision|1|||
145455042|NCT01579565|524517049|FG000|Treated|Lost to Follow-up|2|||
145455043|NCT01579565|524517050|FG001|Treated|Lost to Follow-up|1|||
145455044|NCT01579565|524517049|FG000|Treated|declined to return for final visit|0|||
145455045|NCT01579565|524517050|FG001|Treated|declined to return for final visit|1|||
145455046|NCT02791191|524517053|FG000|Overall Study|Adverse Event|2|||
145455047|NCT02791191|524517054|FG001|Overall Study|Adverse Event|4|||
145455048|NCT02791191|524517055|FG002|Overall Study|Adverse Event|5|||
145455049|NCT02791191|524517053|FG000|Overall Study|Lack of Efficacy|0|||
145455050|NCT02791191|524517054|FG001|Overall Study|Lack of Efficacy|1|||
145455051|NCT02791191|524517055|FG002|Overall Study|Lack of Efficacy|0|||
145455052|NCT02791191|524517053|FG000|Overall Study|Study Drug Non-Compliance|0|||
145455053|NCT02791191|524517054|FG001|Overall Study|Study Drug Non-Compliance|2|||
145455054|NCT02791191|524517055|FG002|Overall Study|Study Drug Non-Compliance|0|||
145455055|NCT02791191|524517053|FG000|Overall Study|Site Closed by Sponsor|1|||
145455056|NCT02791191|524517054|FG001|Overall Study|Site Closed by Sponsor|1|||
145455057|NCT02791191|524517055|FG002|Overall Study|Site Closed by Sponsor|3|||
145455058|NCT02791191|524517053|FG000|Overall Study|Progressive Disease|1|||
145455059|NCT02791191|524517054|FG001|Overall Study|Progressive Disease|0|||
145455060|NCT02791191|524517055|FG002|Overall Study|Progressive Disease|0|||
145455061|NCT02791191|524517053|FG000|Overall Study|Study Terminated by Sponsor|29|||
145455062|NCT02791191|524517054|FG001|Overall Study|Study Terminated by Sponsor|101|||
145455063|NCT02791191|524517055|FG002|Overall Study|Study Terminated by Sponsor|109|||
145455064|NCT02791191|524517053|FG000|Overall Study|Withdrawal by Subject|3|||
145455065|NCT02791191|524517054|FG001|Overall Study|Withdrawal by Subject|1|||
145455066|NCT02791191|524517055|FG002|Overall Study|Withdrawal by Subject|3|||
145455067|NCT02791191|524517053|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
145455068|NCT02791191|524517054|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
145455069|NCT02791191|524517055|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
145455070|NCT02578680|524517058|FG000|Overall Study|Death|329|||
145455071|NCT02578680|524517059|FG001|Overall Study|Death|181|||
145455072|NCT02578680|524517058|FG000|Overall Study|Lost to Follow-up|3|||
145455073|NCT02578680|524517059|FG001|Overall Study|Lost to Follow-up|1|||
145455074|NCT02578680|524517058|FG000|Overall Study|Physician Decision|0|||
145455075|NCT02578680|524517059|FG001|Overall Study|Physician Decision|1|||
145455076|NCT02578680|524517058|FG000|Overall Study|Protocol Violation|1|||
145455077|NCT02578680|524517059|FG001|Overall Study|Protocol Violation|1|||
145455078|NCT02578680|524517058|FG000|Overall Study|Sponsor Decision|64|||
145455079|NCT02578680|524517059|FG001|Overall Study|Sponsor Decision|13|||
145455080|NCT02578680|524517058|FG000|Overall Study|Withdrawal by Subject|13|||
145455081|NCT02578680|524517059|FG001|Overall Study|Withdrawal by Subject|9|||
145455082|NCT02290691|524517061|FG000|Overall Study|Noncompliance|0|||
145455083|NCT02290691|524517062|FG001|Overall Study|Noncompliance|1|||
145455084|NCT02290691|524517061|FG000|Overall Study|Withdrawal by Subject|1|||
145455085|NCT02290691|524517062|FG001|Overall Study|Withdrawal by Subject|1|||
145455086|NCT02290691|524517061|FG000|Overall Study|Lost to Follow-up|7|||
145455087|NCT02290691|524517062|FG001|Overall Study|Lost to Follow-up|7|||
145455088|NCT00306293|524517064|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
145455089|NCT00306293|524517065|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
145455090|NCT00306293|524517064|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
145455091|NCT00306293|524517065|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
145455092|NCT00306293|524517064|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
145455093|NCT00306293|524517065|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
145455094|NCT00306293|524517064|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
145455095|NCT00306293|524517065|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
145455096|NCT00306293|524517064|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
145455097|NCT00306293|524517065|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
145455098|NCT00306293|524517064|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
145455099|NCT00306293|524517065|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
145455100|NCT00306293|524517064|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
145455101|NCT00306293|524517065|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
145455102|NCT00306293|524517064|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
145455103|NCT00306293|524517065|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
145455104|NCT00185380|524517069|FG000|Overall Study|Adverse Event|41|||
145455105|NCT00185380|524517070|FG001|Overall Study|Adverse Event|43|||
145455106|NCT00185380|524517071|FG002|Overall Study|Adverse Event|48|||
145455107|NCT00185380|524517069|FG000|Overall Study|Lost to Follow-up|0|||
145455108|NCT00185380|524517070|FG001|Overall Study|Lost to Follow-up|4|||
145455109|NCT00185380|524517071|FG002|Overall Study|Lost to Follow-up|3|||
145455110|NCT00185380|524517069|FG000|Overall Study|Pregnancy|1|||
145455111|NCT00185380|524517070|FG001|Overall Study|Pregnancy|4|||
145455112|NCT00185380|524517071|FG002|Overall Study|Pregnancy|0|||
145455113|NCT00185380|524517069|FG000|Overall Study|Protocol Violation|2|||
145455114|NCT00185380|524517070|FG001|Overall Study|Protocol Violation|2|||
145455115|NCT00185380|524517071|FG002|Overall Study|Protocol Violation|1|||
145455116|NCT00185380|524517069|FG000|Overall Study|Withdrawal by Subject|1|||
145455117|NCT00185380|524517070|FG001|Overall Study|Withdrawal by Subject|2|||
145455118|NCT00185380|524517071|FG002|Overall Study|Withdrawal by Subject|0|||
145455119|NCT00185380|524517069|FG000|Overall Study|Failed insertion|1|||
145455120|NCT00185380|524517070|FG001|Overall Study|Failed insertion|1|||
145455121|NCT00185380|524517071|FG002|Overall Study|Failed insertion|2|||
145455122|NCT00185380|524517069|FG000|Overall Study|Planned pregnancy|9|||
145455123|NCT00185380|524517070|FG001|Overall Study|Planned pregnancy|12|||
145455124|NCT00185380|524517071|FG002|Overall Study|Planned pregnancy|12|||
145455125|NCT00185380|524517069|FG000|Overall Study|No need for contraception|3|||
145455126|NCT00185380|524517070|FG001|Overall Study|No need for contraception|3|||
145455127|NCT00185380|524517071|FG002|Overall Study|No need for contraception|3|||
145455128|NCT00185380|524517069|FG000|Overall Study|Could not attend visits|2|||
145455129|NCT00185380|524517070|FG001|Overall Study|Could not attend visits|0|||
145455130|NCT00185380|524517071|FG002|Overall Study|Could not attend visits|4|||
145455131|NCT00185380|524517069|FG000|Overall Study|personal reason|6|||
145455132|NCT00185380|524517070|FG001|Overall Study|personal reason|1|||
145455133|NCT00185380|524517071|FG002|Overall Study|personal reason|1|||
145455134|NCT00978380|524517072|FG000|Overall Study|Protocol Violation|2|||
145455135|NCT00978380|524517072|FG000|Overall Study|Withdrawal criteria|9|||
145455136|NCT00978380|524517072|FG000|Overall Study|Unclassified|8|||
145455137|NCT02199314|524517073|FG000|Overall Study|Withdrawal by Subject|6|||
145455138|NCT02199314|524517073|FG000|Overall Study|Physician Decision|10|||
145455139|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Adverse Event|76|||
145455140|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Adverse Event|0|||
145455141|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Adverse Event|0|||
145455142|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Death|3|||
145455143|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Death|0|||
145455144|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Death|0|||
145455145|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
145455146|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
145455147|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
145455148|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Physician Decision|9|||
145455149|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Physician Decision|0|||
145455150|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Physician Decision|0|||
145455151|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
145455152|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
145455153|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
145455154|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Disease progression|45|||
145455155|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Disease progression|0|||
145455156|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Disease progression|0|||
145455157|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
145455158|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
145455159|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
145455160|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
145455161|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
145455162|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
145455163|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
145455164|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
145455165|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
145455166|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
145455167|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
145455168|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
145455169|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
145455170|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
145455171|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
145455172|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
145455173|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
145455174|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
145455175|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
145455176|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
145455177|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
145455178|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
145455179|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
145455180|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
145455181|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
145455182|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
145455183|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
145455184|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Promotor request|1|||
145455185|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Promotor request|0|||
145455186|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Promotor request|0|||
145455187|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
145455188|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
145455189|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
145455190|NCT01461928|524517074|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
145455191|NCT01461928|524517075|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
145455192|NCT01461928|524517076|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
145455193|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Death|3|||
145455194|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Death|0|||
145455195|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Death|0|||
145455196|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
145455197|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
145455198|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
145455199|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
145455200|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
145455201|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
145455202|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Diseases progression|91|||
145455203|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Diseases progression|0|||
145455204|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Diseases progression|0|||
145455205|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Adverse Event|70|||
145455206|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Adverse Event|0|||
145455207|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Adverse Event|0|||
145455208|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Physician Decision|9|||
145455209|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Physician Decision|0|||
145455210|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Physician Decision|0|||
145455211|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
145455212|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
145455213|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
145455214|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
145455215|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
145455216|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
145455217|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
145455218|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
145455219|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
145455220|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Not compliant|1|||
145455221|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Not compliant|0|||
145455222|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Not compliant|0|||
145455223|NCT01461928|524517074|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
145455224|NCT01461928|524517075|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
145455225|NCT01461928|524517076|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
145455226|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Adverse Event|0|||
145455227|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Adverse Event|2|||
145455228|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Adverse Event|0|||
145455229|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Death|0|||
145455230|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Death|10|||
145455231|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Death|8|||
145455232|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Physician Decision|0|||
145455233|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Physician Decision|0|||
145455234|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Physician Decision|4|||
145455235|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
145455236|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
145587783|NCT01109992|525004316|FG000|Overall Study|Withdrawal by Subject|0|||
145587784|NCT01109992|525004317|FG001|Overall Study|Withdrawal by Subject|1|||
145455237|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
145587785|NCT01109992|525004316|FG000|Overall Study|Movement during rest scan.|0|||
145455238|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Moved to another town|0|||
145455239|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Moved to another town|1|||
145455240|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Moved to another town|0|||
145455241|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Disease progression|0|||
145455242|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Disease progression|0|||
145455243|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Disease progression|3|||
145455244|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
145455245|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
145455246|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
145455247|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
145455248|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
145455249|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
145455250|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
145455251|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
145455252|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
145455253|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
145455254|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
145455255|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
145455256|NCT01461928|524517074|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
145455257|NCT01461928|524517075|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
145455258|NCT01461928|524517076|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
145455259|NCT00365105|524517079|FG000|Overall Study|Protocol Violation|5|||
145455260|NCT00365105|524517080|FG001|Overall Study|Protocol Violation|8|||
145455261|NCT00191724|524517081|FG000|Overall Study|Adverse Event|0|||
145455262|NCT00191724|524517082|FG001|Overall Study|Adverse Event|0|||
145455263|NCT00191724|524517083|FG002|Overall Study|Adverse Event|1|||
145455264|NCT00191724|524517084|FG003|Overall Study|Adverse Event|0|||
145455265|NCT00191724|524517085|FG004|Overall Study|Adverse Event|0|||
145455266|NCT00191724|524517081|FG000|Overall Study|Lost to Follow-up|1|||
145455267|NCT00191724|524517082|FG001|Overall Study|Lost to Follow-up|1|||
145455268|NCT00191724|524517083|FG002|Overall Study|Lost to Follow-up|0|||
145455269|NCT00191724|524517084|FG003|Overall Study|Lost to Follow-up|2|||
145455270|NCT00191724|524517085|FG004|Overall Study|Lost to Follow-up|3|||
145455271|NCT00191724|524517081|FG000|Overall Study|Withdrawal by Subject|0|||
145455272|NCT00191724|524517082|FG001|Overall Study|Withdrawal by Subject|0|||
145455273|NCT00191724|524517083|FG002|Overall Study|Withdrawal by Subject|0|||
145455274|NCT00191724|524517084|FG003|Overall Study|Withdrawal by Subject|1|||
145455275|NCT00191724|524517085|FG004|Overall Study|Withdrawal by Subject|0|||
145455276|NCT05260073|524517086|FG000|Overall Study|Physician Decision|1|||
145455277|NCT05260073|524517086|FG000|Overall Study|Withdrawal by Subject|6|||
145455278|NCT05260073|524517086|FG000|Overall Study|Lost to Follow-up|14|||
145455279|NCT03458910|524517087|FG000|Overall Study|Withdrawal by Subject|7|||
145455280|NCT03458910|524517088|FG001|Overall Study|Withdrawal by Subject|8|||
145455281|NCT03458910|524517089|FG002|Overall Study|Withdrawal by Subject|6|||
145455282|NCT03458910|524517090|FG003|Overall Study|Withdrawal by Subject|4|||
145455283|NCT03458910|524517087|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
145455284|NCT03458910|524517088|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
145455285|NCT03458910|524517089|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
145455286|NCT03458910|524517090|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
145455287|NCT00425698|524517100|FG000|Overall Study|Adverse Event|3|||
145455288|NCT00425698|524517101|FG001|Overall Study|Adverse Event|1|||
145455289|NCT00425698|524517100|FG000|Overall Study|Withdrawal by Subject|0|||
145455290|NCT00425698|524517101|FG001|Overall Study|Withdrawal by Subject|1|||
145455291|NCT03905265|524517109|FG000|Overall Study|Withdrawal by Subject|1|||
145455292|NCT03905265|524517110|FG001|Overall Study|Withdrawal by Subject|1|||
145455293|NCT03905265|524517111|FG002|Overall Study|Withdrawal by Subject|0|||
145455294|NCT03905265|524517112|FG003|Overall Study|Withdrawal by Subject|0|||
145455295|NCT01328535|524517113|FG000|Overall Study|Ineligible|1|||
145455296|NCT00960011|524517114|FG000|Overall Study|Death|5|||
145455297|NCT00960011|524517115|FG001|Overall Study|Death|0|||
145455298|NCT00960011|524517114|FG000|Overall Study|Lost to Follow-up|6|||
145455299|NCT00960011|524517115|FG001|Overall Study|Lost to Follow-up|2|||
145455300|NCT03655054|524517116|FG000|Overall Study|Lost to Follow-up|1|||
145455301|NCT03832322|524517120|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
145455302|NCT03832322|524517121|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
145455303|NCT02901054|524517122|FG000|Overall Study|Physician Decision|1|||
145455304|NCT02901054|524517122|FG000|Overall Study|Withdrawal by Subject|3|||
145455305|NCT00616018|524517126|FG000|Overall Study|Protocol Violation|3|||
145587786|NCT01109992|525004317|FG001|Overall Study|Movement during rest scan.|1|||
145455306|NCT03718884|524517127|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
145455307|NCT03718884|524517128|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
145455308|NCT03718884|524517127|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
145455309|NCT03718884|524517128|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
145455310|NCT02839720|524517129|FG000|Overall Study|Adverse Event|2|||
145455311|NCT02839720|524517129|FG000|Overall Study|Non-compliance|2|||
145455312|NCT02839720|524517129|FG000|Overall Study|Intercurrent Illness|1|||
145455313|NCT02839720|524517129|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
145455314|NCT04113018|524517136|FG000|Overall Study|Death|2|||
145455315|NCT04113018|524517136|FG000|Overall Study|Lost to Follow-up|1|||
145455316|NCT04113018|524517136|FG000|Overall Study|Still On Study (on study treatment)|24|||
145455317|NCT04113018|524517136|FG000|Overall Study|Still On Study (in follow up)|12|||
145455318|NCT05005013|524517137|FG000|Overall Study|Withdrawal by Subject|5|||
145455319|NCT05005013|524517138|FG001|Overall Study|Withdrawal by Subject|1|||
145455320|NCT05005013|524517137|FG000|Overall Study|Lost to Follow-up|3|||
145455321|NCT05005013|524517138|FG001|Overall Study|Lost to Follow-up|1|||
145455322|NCT05005013|524517137|FG000|Overall Study|Ineligibility|1|||
145455323|NCT05005013|524517138|FG001|Overall Study|Ineligibility|1|||
145455324|NCT02059499|524517139|FG000|Upto Week 20|Lost to Follow-up|2|||
145455325|NCT02059499|524517140|FG001|Upto Week 20|Lost to Follow-up|6|||
145455326|NCT02059499|524517141|FG002|Upto Week 20|Lost to Follow-up|0|||
145455327|NCT02059499|524517139|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
145455328|NCT02059499|524517140|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
145455329|NCT02059499|524517141|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
145455330|NCT02059499|524517139|FG000|Upto Week 20|Withdrawal by Subject|1|||
145455331|NCT02059499|524517140|FG001|Upto Week 20|Withdrawal by Subject|1|||
145455332|NCT02059499|524517141|FG002|Upto Week 20|Withdrawal by Subject|0|||
145455333|NCT02059499|524517139|FG000|Upto Week 20|No treatment per protocol criteria|0|||
145455334|NCT02059499|524517140|FG001|Upto Week 20|No treatment per protocol criteria|0|||
145455335|NCT02059499|524517141|FG002|Upto Week 20|No treatment per protocol criteria|5|||
145455336|NCT02059499|524517139|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
145455337|NCT02059499|524517140|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
145455338|NCT02059499|524517141|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
145455339|NCT02059499|524517139|FG000|Post-week 20|Lost to Follow-up|0|||
145455340|NCT02059499|524517140|FG001|Post-week 20|Lost to Follow-up|2|||
145455341|NCT02059499|524517141|FG002|Post-week 20|Lost to Follow-up|0|||
145455342|NCT02059499|524517139|FG000|Post-week 20|Withdrawal by Subject|0|||
145455343|NCT02059499|524517140|FG001|Post-week 20|Withdrawal by Subject|1|||
145455344|NCT02059499|524517141|FG002|Post-week 20|Withdrawal by Subject|0|||
145455345|NCT02059499|524517139|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
145455346|NCT02059499|524517140|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
145455347|NCT02059499|524517141|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
145455348|NCT04210245|524517142|FG000|Overall Study|Adverse Event|0|||
145455349|NCT04210245|524517143|FG001|Overall Study|Adverse Event|3|||
145455350|NCT04210245|524517144|FG002|Overall Study|Adverse Event|6|||
145455351|NCT04210245|524517145|FG003|Overall Study|Adverse Event|0|||
145455352|NCT04210245|524517142|FG000|Overall Study|Withdrawal by Subject|0|||
145455353|NCT04210245|524517143|FG001|Overall Study|Withdrawal by Subject|1|||
145455354|NCT04210245|524517144|FG002|Overall Study|Withdrawal by Subject|4|||
145455355|NCT04210245|524517145|FG003|Overall Study|Withdrawal by Subject|4|||
145455356|NCT04210245|524517142|FG000|Overall Study|Lost to Follow-up|0|||
145455357|NCT04210245|524517143|FG001|Overall Study|Lost to Follow-up|1|||
145455358|NCT04210245|524517144|FG002|Overall Study|Lost to Follow-up|1|||
145455359|NCT04210245|524517145|FG003|Overall Study|Lost to Follow-up|1|||
145455360|NCT04210245|524517142|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
145455361|NCT04210245|524517143|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
145455362|NCT04210245|524517144|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
145455363|NCT04210245|524517145|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
145455364|NCT06099223|524517146|FG000|Overall Study|Preoperative surveys missed|0|||
145455365|NCT06099223|524517147|FG001|Overall Study|Preoperative surveys missed|1|||
145455366|NCT02248649|524517148|FG000|Overall Study|Death|7|||
145455367|NCT02248649|524517149|FG001|Overall Study|Death|11|||
145455368|NCT02248649|524517148|FG000|Overall Study|Lost to Follow-up|14|||
145455369|NCT02248649|524517149|FG001|Overall Study|Lost to Follow-up|10|||
145455370|NCT03255967|524517150|FG000|Overall Study|Adverse Event|26|||
145455371|NCT03255967|524517151|FG001|Overall Study|Adverse Event|30|||
145455372|NCT03255967|524517150|FG000|Overall Study|Withdrawal by Subject|6|||
145455373|NCT03255967|524517151|FG001|Overall Study|Withdrawal by Subject|6|||
145455374|NCT03255967|524517150|FG000|Overall Study|Schedule conflict|6|||
145455375|NCT03255967|524517151|FG001|Overall Study|Schedule conflict|4|||
145455376|NCT03255967|524517150|FG000|Overall Study|POA did not sign consent form|2|||
145455377|NCT03255967|524517151|FG001|Overall Study|POA did not sign consent form|0|||
145455378|NCT04621240|524517162|FG000|Overall Study|Withdrawal by Subject|36|||
145455379|NCT01202188|524517164|FG000|Overall Study|Protocol deviation|14|||
145455380|NCT01202188|524517165|FG001|Overall Study|Protocol deviation|8|||
145455381|NCT01202188|524517166|FG002|Overall Study|Protocol deviation|12|||
145455382|NCT01202188|524517167|FG003|Overall Study|Protocol deviation|10|||
145455383|NCT01202188|524517168|FG004|Overall Study|Protocol deviation|11|||
145455384|NCT01202188|524517164|FG000|Overall Study|Subject withdrew consent|12|||
145455385|NCT01202188|524517165|FG001|Overall Study|Subject withdrew consent|13|||
145455386|NCT01202188|524517166|FG002|Overall Study|Subject withdrew consent|22|||
145455387|NCT01202188|524517167|FG003|Overall Study|Subject withdrew consent|11|||
145455388|NCT01202188|524517168|FG004|Overall Study|Subject withdrew consent|13|||
145455389|NCT01202188|524517164|FG000|Overall Study|Adverse Event|5|||
145455390|NCT01202188|524517165|FG001|Overall Study|Adverse Event|23|||
145455391|NCT01202188|524517166|FG002|Overall Study|Adverse Event|13|||
145455392|NCT01202188|524517167|FG003|Overall Study|Adverse Event|10|||
145455393|NCT01202188|524517168|FG004|Overall Study|Adverse Event|10|||
145455394|NCT01202188|524517164|FG000|Overall Study|Administrative problems|3|||
145455395|NCT01202188|524517165|FG001|Overall Study|Administrative problems|2|||
145455396|NCT01202188|524517166|FG002|Overall Study|Administrative problems|1|||
145455397|NCT01202188|524517167|FG003|Overall Study|Administrative problems|1|||
145455398|NCT01202188|524517168|FG004|Overall Study|Administrative problems|2|||
145455399|NCT01202188|524517164|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145455400|NCT01202188|524517165|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
145455401|NCT01202188|524517166|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145455402|NCT01202188|524517167|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
145455403|NCT01202188|524517168|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
145455404|NCT01202188|524517164|FG000|Overall Study|Lost to Follow-up|1|||
145455405|NCT01202188|524517165|FG001|Overall Study|Lost to Follow-up|1|||
145455406|NCT01202188|524517166|FG002|Overall Study|Lost to Follow-up|0|||
145455407|NCT01202188|524517167|FG003|Overall Study|Lost to Follow-up|4|||
145455408|NCT01202188|524517168|FG004|Overall Study|Lost to Follow-up|1|||
145455409|NCT01202188|524517164|FG000|Overall Study|Death|1|||
145455410|NCT01202188|524517165|FG001|Overall Study|Death|1|||
145455411|NCT01202188|524517166|FG002|Overall Study|Death|1|||
145455412|NCT01202188|524517167|FG003|Overall Study|Death|1|||
145455413|NCT01202188|524517168|FG004|Overall Study|Death|0|||
145455414|NCT01202188|524517164|FG000|Overall Study|Abnormal test procedure result (s)|0|||
145455415|NCT01202188|524517165|FG001|Overall Study|Abnormal test procedure result (s)|0|||
145455416|NCT01202188|524517166|FG002|Overall Study|Abnormal test procedure result (s)|2|||
145455417|NCT01202188|524517167|FG003|Overall Study|Abnormal test procedure result (s)|0|||
145455418|NCT01202188|524517168|FG004|Overall Study|Abnormal test procedure result (s)|0|||
145455419|NCT00487942|524517171|FG000|Overall Study|Adverse Event|1|||
145455420|NCT00487942|524517172|FG001|Overall Study|Adverse Event|1|||
145455421|NCT00487942|524517173|FG002|Overall Study|Adverse Event|1|||
145455422|NCT00487942|524517174|FG003|Overall Study|Adverse Event|1|||
145455423|NCT00487942|524517171|FG000|Overall Study|Lost to Follow-up|1|||
145455424|NCT00487942|524517172|FG001|Overall Study|Lost to Follow-up|0|||
145455425|NCT00487942|524517173|FG002|Overall Study|Lost to Follow-up|0|||
145455426|NCT00487942|524517174|FG003|Overall Study|Lost to Follow-up|1|||
145455427|NCT00487942|524517171|FG000|Overall Study|Protocol Violation|1|||
145455428|NCT00487942|524517172|FG001|Overall Study|Protocol Violation|1|||
145455429|NCT00487942|524517173|FG002|Overall Study|Protocol Violation|0|||
145455430|NCT00487942|524517174|FG003|Overall Study|Protocol Violation|0|||
145455431|NCT00487942|524517171|FG000|Overall Study|Withdrawal by Subject|0|||
145455432|NCT00487942|524517172|FG001|Overall Study|Withdrawal by Subject|1|||
145455433|NCT00487942|524517173|FG002|Overall Study|Withdrawal by Subject|2|||
145455434|NCT00487942|524517174|FG003|Overall Study|Withdrawal by Subject|0|||
145455435|NCT00211757|524517175|FG000|Overall Study|Withdrawal by Subject|1|||
145455436|NCT00211757|524517176|FG001|Overall Study|Withdrawal by Subject|1|||
145455437|NCT00211757|524517175|FG000|Overall Study|Lack of Efficacy|0|||
145455438|NCT00211757|524517176|FG001|Overall Study|Lack of Efficacy|1|||
145455439|NCT01457014|524517180|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
145455440|NCT01457014|524517181|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
145455441|NCT01457014|524517182|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
145455442|NCT01457014|524517183|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
145455443|NCT01457014|524517180|FG000|First Night|Withdrawal by Subject|3|||
145455444|NCT01457014|524517181|FG001|First Night|Withdrawal by Subject|0|||
145455445|NCT01457014|524517182|FG002|First Night|Withdrawal by Subject|0|||
145455446|NCT01457014|524517183|FG003|First Night|Withdrawal by Subject|0|||
145455447|NCT02461290|524517184|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
145455448|NCT02461290|524517184|FG000|Overall Study|Lost to Follow-up|3|||
145455449|NCT02650128|524517185|FG000|Overall Study|Death|2|||
145455450|NCT01537081|524518708|FG000|Overall Study|Adverse Event|5|||
145455451|NCT01537081|524518709|FG001|Overall Study|Adverse Event|2|||
145455452|NCT01537081|524518710|FG002|Overall Study|Adverse Event|2|||
145455453|NCT01537081|524518708|FG000|Overall Study|Lack of Efficacy|2|||
145455454|NCT01537081|524518709|FG001|Overall Study|Lack of Efficacy|1|||
145455455|NCT01537081|524518710|FG002|Overall Study|Lack of Efficacy|0|||
145455456|NCT01537081|524518708|FG000|Overall Study|Lost to Follow-up|17|||
145455457|NCT01537081|524518709|FG001|Overall Study|Lost to Follow-up|15|||
145455458|NCT01537081|524518710|FG002|Overall Study|Lost to Follow-up|9|||
145455459|NCT01537081|524518708|FG000|Overall Study|Protocol Violation|3|||
145455460|NCT01537081|524518709|FG001|Overall Study|Protocol Violation|2|||
145455461|NCT01537081|524518710|FG002|Overall Study|Protocol Violation|2|||
145455462|NCT01537081|524518708|FG000|Overall Study|Withdrawal by Subject|6|||
145455463|NCT01537081|524518709|FG001|Overall Study|Withdrawal by Subject|11|||
145455464|NCT01537081|524518710|FG002|Overall Study|Withdrawal by Subject|3|||
145455465|NCT01537081|524518708|FG000|Overall Study|Physician Decision|5|||
145455466|NCT01537081|524518709|FG001|Overall Study|Physician Decision|6|||
145455467|NCT01537081|524518710|FG002|Overall Study|Physician Decision|0|||
145455468|NCT01537081|524518708|FG000|Overall Study|Sponsor decision|0|||
145455469|NCT01537081|524518709|FG001|Overall Study|Sponsor decision|1|||
145455470|NCT01537081|524518710|FG002|Overall Study|Sponsor decision|0|||
145455471|NCT01537081|524518708|FG000|Overall Study|Assigned but never dosed|1|||
145455472|NCT01537081|524518709|FG001|Overall Study|Assigned but never dosed|0|||
145455473|NCT01537081|524518710|FG002|Overall Study|Assigned but never dosed|0|||
145455474|NCT00218634|524518713|FG000|Overall Study|Lost to Follow-up|8|||
145455475|NCT00218634|524518714|FG001|Overall Study|Lost to Follow-up|15|||
145455476|NCT00734604|524518715|FG000|Overall Study|Adverse Event|0|||
145455477|NCT00734604|524518716|FG001|Overall Study|Adverse Event|2|||
145455478|NCT00734604|524518717|FG002|Overall Study|Adverse Event|0|||
145455479|NCT00734604|524518718|FG003|Overall Study|Adverse Event|2|||
145455480|NCT00734604|524518719|FG004|Overall Study|Adverse Event|1|||
145455481|NCT00734604|524518720|FG005|Overall Study|Adverse Event|1|||
145455482|NCT00734604|524518715|FG000|Overall Study|Serious Adverse Event|1|||
145455483|NCT00734604|524518716|FG001|Overall Study|Serious Adverse Event|0|||
145455484|NCT00734604|524518717|FG002|Overall Study|Serious Adverse Event|1|||
145455485|NCT00734604|524518718|FG003|Overall Study|Serious Adverse Event|2|||
145455486|NCT00734604|524518719|FG004|Overall Study|Serious Adverse Event|0|||
145455487|NCT00734604|524518720|FG005|Overall Study|Serious Adverse Event|1|||
145455488|NCT00734604|524518715|FG000|Overall Study|Lost to Follow-up|1|||
145455489|NCT00734604|524518716|FG001|Overall Study|Lost to Follow-up|2|||
145455490|NCT00734604|524518717|FG002|Overall Study|Lost to Follow-up|2|||
145455491|NCT00734604|524518718|FG003|Overall Study|Lost to Follow-up|4|||
145455492|NCT00734604|524518719|FG004|Overall Study|Lost to Follow-up|2|||
145455493|NCT00734604|524518720|FG005|Overall Study|Lost to Follow-up|3|||
145455494|NCT00734604|524518715|FG000|Overall Study|Physician Decision|0|||
145455495|NCT00734604|524518716|FG001|Overall Study|Physician Decision|1|||
145455496|NCT00734604|524518717|FG002|Overall Study|Physician Decision|1|||
145455497|NCT00734604|524518718|FG003|Overall Study|Physician Decision|0|||
145455498|NCT00734604|524518719|FG004|Overall Study|Physician Decision|0|||
145455499|NCT00734604|524518720|FG005|Overall Study|Physician Decision|0|||
145455500|NCT00734604|524518715|FG000|Overall Study|Protocol Violation|0|||
145455501|NCT00734604|524518716|FG001|Overall Study|Protocol Violation|2|||
145455502|NCT00734604|524518717|FG002|Overall Study|Protocol Violation|0|||
145455503|NCT00734604|524518718|FG003|Overall Study|Protocol Violation|0|||
145455504|NCT00734604|524518719|FG004|Overall Study|Protocol Violation|1|||
145455505|NCT00734604|524518720|FG005|Overall Study|Protocol Violation|0|||
145455506|NCT00734604|524518715|FG000|Overall Study|Sponsor Decision|1|||
145455507|NCT00734604|524518716|FG001|Overall Study|Sponsor Decision|2|||
145455508|NCT00734604|524518717|FG002|Overall Study|Sponsor Decision|1|||
145455509|NCT00734604|524518718|FG003|Overall Study|Sponsor Decision|0|||
145455510|NCT00734604|524518719|FG004|Overall Study|Sponsor Decision|2|||
145455511|NCT00734604|524518720|FG005|Overall Study|Sponsor Decision|0|||
145455512|NCT00734604|524518715|FG000|Overall Study|Withdrawal by Subject|0|||
145455513|NCT00734604|524518716|FG001|Overall Study|Withdrawal by Subject|2|||
145455514|NCT00734604|524518717|FG002|Overall Study|Withdrawal by Subject|0|||
145455515|NCT00734604|524518718|FG003|Overall Study|Withdrawal by Subject|1|||
145455516|NCT00734604|524518719|FG004|Overall Study|Withdrawal by Subject|2|||
145455517|NCT00734604|524518720|FG005|Overall Study|Withdrawal by Subject|1|||
145455518|NCT00734604|524518715|FG000|Overall Study|Lack of Efficacy|0|||
145455519|NCT00734604|524518716|FG001|Overall Study|Lack of Efficacy|1|||
145455520|NCT00734604|524518717|FG002|Overall Study|Lack of Efficacy|1|||
145455521|NCT00734604|524518718|FG003|Overall Study|Lack of Efficacy|0|||
145455522|NCT00734604|524518719|FG004|Overall Study|Lack of Efficacy|0|||
145455523|NCT00734604|524518720|FG005|Overall Study|Lack of Efficacy|0|||
145626343|NCT00062868|525144245|FG005|Dose Level 3|Lost to Follow-up|0|||
145626344|NCT00062868|525144246|FG006|Dose Level 3|Lost to Follow-up|0|||
145626345|NCT00062868|525144247|FG007|Dose Level 3|Lost to Follow-up|0|||
145455524|NCT01044745|524518721|FG000|Overall Study|Ineiligible|2|||
145455525|NCT00591149|524518728|FG000|Overall Study|Adverse Event|4|||
145455526|NCT00591149|524518728|FG000|Overall Study|Withdrawal by Subject|1|||
145455527|NCT02456636|524518729|FG000|Overall Study|Death|0|||
145455528|NCT02456636|524518730|FG001|Overall Study|Death|3|||
145455529|NCT02456636|524518731|FG002|Overall Study|Death|0|||
145455530|NCT02456636|524518729|FG000|Overall Study|Pregnancy|1|||
145455531|NCT02456636|524518730|FG001|Overall Study|Pregnancy|3|||
145455532|NCT02456636|524518731|FG002|Overall Study|Pregnancy|5|||
145455533|NCT02456636|524518729|FG000|Overall Study|Physician Decision|4|||
145455534|NCT02456636|524518730|FG001|Overall Study|Physician Decision|5|||
145455535|NCT02456636|524518731|FG002|Overall Study|Physician Decision|4|||
145455536|NCT02456636|524518729|FG000|Overall Study|Withdrawal by Subject|13|||
145455537|NCT02456636|524518730|FG001|Overall Study|Withdrawal by Subject|14|||
145455538|NCT02456636|524518731|FG002|Overall Study|Withdrawal by Subject|16|||
145455539|NCT02456636|524518729|FG000|Overall Study|Lost to Follow-up|50|||
145455540|NCT02456636|524518730|FG001|Overall Study|Lost to Follow-up|44|||
145455541|NCT02456636|524518731|FG002|Overall Study|Lost to Follow-up|50|||
145455542|NCT02379221|524518732|FG000|Overall Study|Lost to Follow-up|1|||
145455543|NCT02019108|524518733|FG000|Overall Study|Lost to Follow-up|5|||
145455544|NCT02019108|524518734|FG001|Overall Study|Lost to Follow-up|7|||
145455545|NCT00519376|524518737|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455546|NCT00519376|524518738|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455547|NCT00519376|524518739|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455548|NCT00519376|524518740|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455549|NCT00519376|524518741|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455550|NCT00519376|524518742|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455551|NCT00519376|524518743|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455552|NCT00519376|524518744|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455553|NCT00519376|524518745|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455554|NCT00519376|524518746|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455555|NCT00519376|524518747|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455556|NCT00519376|524518748|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455557|NCT00519376|524518749|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
145455558|NCT00519376|524518750|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455559|NCT00519376|524518751|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455560|NCT00519376|524518752|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
145455561|NCT00519376|524518737|FG000|Treatment Period 4|Lost to Follow-up|0|||
145455562|NCT00519376|524518738|FG001|Treatment Period 4|Lost to Follow-up|0|||
145455563|NCT00519376|524518739|FG002|Treatment Period 4|Lost to Follow-up|1|||
145455564|NCT00519376|524518740|FG003|Treatment Period 4|Lost to Follow-up|0|||
145455565|NCT00519376|524518741|FG004|Treatment Period 4|Lost to Follow-up|0|||
145455566|NCT00519376|524518742|FG005|Treatment Period 4|Lost to Follow-up|0|||
145455567|NCT00519376|524518743|FG006|Treatment Period 4|Lost to Follow-up|0|||
145455568|NCT00519376|524518744|FG007|Treatment Period 4|Lost to Follow-up|0|||
145455569|NCT00519376|524518745|FG008|Treatment Period 4|Lost to Follow-up|0|||
145455570|NCT00519376|524518746|FG009|Treatment Period 4|Lost to Follow-up|0|||
145455571|NCT00519376|524518747|FG010|Treatment Period 4|Lost to Follow-up|0|||
145455572|NCT00519376|524518748|FG011|Treatment Period 4|Lost to Follow-up|0|||
145455573|NCT00519376|524518749|FG012|Treatment Period 4|Lost to Follow-up|0|||
145455574|NCT00519376|524518750|FG013|Treatment Period 4|Lost to Follow-up|0|||
145455575|NCT00519376|524518751|FG014|Treatment Period 4|Lost to Follow-up|0|||
145455576|NCT00519376|524518752|FG015|Treatment Period 4|Lost to Follow-up|0|||
145455577|NCT03576066|524518758|FG000|Overall Study|Noncompliance with study drug|0|||
145455578|NCT03576066|524518759|FG001|Overall Study|Noncompliance with study drug|1|||
145455579|NCT06422364|524518762|FG000|Overall Study|Withdrawn due to study closure|0|||
145455580|NCT06422364|524518763|FG001|Overall Study|Withdrawn due to study closure|2|||
145455581|NCT05275010|524518765|FG000|Overall Study|Reason Not Specified|4|||
145455582|NCT05275010|524518766|FG001|Overall Study|Reason Not Specified|1|||
145455583|NCT05275010|524518765|FG000|Overall Study|Withdrawal by Subject|1|||
145455584|NCT05275010|524518766|FG001|Overall Study|Withdrawal by Subject|0|||
145455585|NCT05275010|524518765|FG000|Overall Study|Lost to Follow-up|0|||
145455586|NCT05275010|524518766|FG001|Overall Study|Lost to Follow-up|1|||
145455587|NCT06004895|524518769|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
145455588|NCT06004895|524518769|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
145455589|NCT04484649|524518770|FG000|Overall Study|Lost to Follow-up|2|||
145455590|NCT04484649|524518771|FG001|Overall Study|Lost to Follow-up|1|||
145455591|NCT04484649|524518770|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
145455592|NCT04484649|524518771|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
145455593|NCT01463696|524518775|FG000|Overall Study|Adverse Event|0|||
145455594|NCT01463696|524518776|FG001|Overall Study|Adverse Event|1|||
145455595|NCT01463696|524518777|FG002|Overall Study|Adverse Event|0|||
145455596|NCT01463696|524518778|FG003|Overall Study|Adverse Event|2|||
145455597|NCT01463696|524518779|FG004|Overall Study|Adverse Event|0|||
145455598|NCT01463696|524518780|FG005|Overall Study|Adverse Event|1|||
145587787|NCT00690755|525004320|FG000|Overall Study|Physician Decision|2|||
145587788|NCT00690755|525004321|FG001|Overall Study|Physician Decision|0|||
145587789|NCT00690755|525004322|FG002|Overall Study|Physician Decision|46|||
145587790|NCT00690755|525004323|FG003|Overall Study|Physician Decision|5|||
145587791|NCT00690755|525004324|FG004|Overall Study|Physician Decision|0|||
145587792|NCT00690755|525004325|FG005|Overall Study|Physician Decision|4|||
145455599|NCT01463696|524518781|FG006|Overall Study|Adverse Event|3|||
145455600|NCT01463696|524518782|FG007|Overall Study|Adverse Event|2|||
145455601|NCT01463696|524518775|FG000|Overall Study|Lost to Follow-up|0|||
145587793|NCT00690755|525004326|FG006|Overall Study|Physician Decision|0|||
145587794|NCT00214136|525004329|FG000|Overall Study|Death|5|||
145455602|NCT01463696|524518776|FG001|Overall Study|Lost to Follow-up|0|||
145455603|NCT01463696|524518777|FG002|Overall Study|Lost to Follow-up|1|||
145455604|NCT01463696|524518778|FG003|Overall Study|Lost to Follow-up|0|||
145455605|NCT01463696|524518779|FG004|Overall Study|Lost to Follow-up|0|||
145455606|NCT01463696|524518780|FG005|Overall Study|Lost to Follow-up|0|||
145455607|NCT01463696|524518781|FG006|Overall Study|Lost to Follow-up|0|||
145455608|NCT01463696|524518782|FG007|Overall Study|Lost to Follow-up|0|||
145455609|NCT01463696|524518775|FG000|Overall Study|Progressive Disease|0|||
145455610|NCT01463696|524518776|FG001|Overall Study|Progressive Disease|1|||
145455611|NCT01463696|524518777|FG002|Overall Study|Progressive Disease|0|||
145455612|NCT01463696|524518778|FG003|Overall Study|Progressive Disease|1|||
145455613|NCT01463696|524518779|FG004|Overall Study|Progressive Disease|0|||
145455614|NCT01463696|524518780|FG005|Overall Study|Progressive Disease|1|||
145455615|NCT01463696|524518781|FG006|Overall Study|Progressive Disease|4|||
145455616|NCT01463696|524518782|FG007|Overall Study|Progressive Disease|2|||
145455617|NCT01463696|524518775|FG000|Overall Study|Withdrawal by Subject|0|||
145455618|NCT01463696|524518776|FG001|Overall Study|Withdrawal by Subject|0|||
145455619|NCT01463696|524518777|FG002|Overall Study|Withdrawal by Subject|0|||
145455620|NCT01463696|524518778|FG003|Overall Study|Withdrawal by Subject|1|||
145455621|NCT01463696|524518779|FG004|Overall Study|Withdrawal by Subject|1|||
145455622|NCT01463696|524518780|FG005|Overall Study|Withdrawal by Subject|1|||
145455623|NCT01463696|524518781|FG006|Overall Study|Withdrawal by Subject|2|||
145455624|NCT01463696|524518782|FG007|Overall Study|Withdrawal by Subject|0|||
145455625|NCT01463696|524518775|FG000|Overall Study|Not Treated|0|||
145455626|NCT01463696|524518776|FG001|Overall Study|Not Treated|0|||
145455627|NCT01463696|524518777|FG002|Overall Study|Not Treated|0|||
145455628|NCT01463696|524518778|FG003|Overall Study|Not Treated|0|||
145455629|NCT01463696|524518779|FG004|Overall Study|Not Treated|0|||
145455630|NCT01463696|524518780|FG005|Overall Study|Not Treated|0|||
145455631|NCT01463696|524518781|FG006|Overall Study|Not Treated|1|||
145455632|NCT01463696|524518782|FG007|Overall Study|Not Treated|0|||
145455633|NCT00967694|524518788|FG000|Overall Study|Withdrawal by Subject|6|||
145455634|NCT00152477|524518789|FG000|Chemotherapy Period|Adverse Event|9|||
145455635|NCT00152477|524518790|FG001|Chemotherapy Period|Adverse Event|4|||
145455636|NCT00152477|524518791|FG002|Chemotherapy Period|Adverse Event|5|||
145455637|NCT00152477|524518789|FG000|Chemotherapy Period|Death|1|||
145455638|NCT00152477|524518790|FG001|Chemotherapy Period|Death|3|||
145455639|NCT00152477|524518791|FG002|Chemotherapy Period|Death|3|||
145455640|NCT00152477|524518789|FG000|Chemotherapy Period|Lack of Efficacy|4|||
145455641|NCT00152477|524518790|FG001|Chemotherapy Period|Lack of Efficacy|5|||
145455642|NCT00152477|524518791|FG002|Chemotherapy Period|Lack of Efficacy|6|||
145455643|NCT00152477|524518789|FG000|Chemotherapy Period|Lost to Follow-up|1|||
145455644|NCT00152477|524518790|FG001|Chemotherapy Period|Lost to Follow-up|0|||
145455645|NCT00152477|524518791|FG002|Chemotherapy Period|Lost to Follow-up|1|||
145455646|NCT00152477|524518789|FG000|Chemotherapy Period|Protocol Violation|1|||
145455647|NCT00152477|524518790|FG001|Chemotherapy Period|Protocol Violation|1|||
145455648|NCT00152477|524518791|FG002|Chemotherapy Period|Protocol Violation|0|||
145455649|NCT00152477|524518789|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
145455650|NCT00152477|524518790|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
145455651|NCT00152477|524518791|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
145455652|NCT00152477|524518789|FG000|Chemotherapy Period|Progression of Disease|6|||
145455653|NCT00152477|524518790|FG001|Chemotherapy Period|Progression of Disease|8|||
145455654|NCT00152477|524518791|FG002|Chemotherapy Period|Progression of Disease|4|||
145455655|NCT00152477|524518789|FG000|Chemotherapy Period|Investigator decision|0|||
145455656|NCT00152477|524518790|FG001|Chemotherapy Period|Investigator decision|0|||
145455657|NCT00152477|524518791|FG002|Chemotherapy Period|Investigator decision|1|||
145455658|NCT00152477|524518789|FG000|Chemotherapy Period|Patient condition worsened|1|||
145455659|NCT00152477|524518790|FG001|Chemotherapy Period|Patient condition worsened|0|||
145455660|NCT00152477|524518791|FG002|Chemotherapy Period|Patient condition worsened|0|||
145587795|NCT04287920|525004330|FG000|Overall Study|Lost to Follow-up|1|||
145587796|NCT04287920|525004331|FG001|Overall Study|Lost to Follow-up|1|||
145587797|NCT04287920|525004330|FG000|Overall Study|Withdrawal by Subject|0|||
145587798|NCT04287920|525004331|FG001|Overall Study|Withdrawal by Subject|3|||
145587799|NCT02310750|525004332|FG000|HP Period 1|Lost to Follow-up|0|||
145587800|NCT02310750|525004333|FG001|HP Period 1|Lost to Follow-up|0|||
145587801|NCT02310750|525004334|FG002|HP Period 1|Lost to Follow-up|0|||
145587802|NCT02310750|525004335|FG003|HP Period 1|Lost to Follow-up|0|||
145587803|NCT02310750|525004336|FG004|HP Period 1|Lost to Follow-up|0|||
145587804|NCT02310750|525004337|FG005|HP Period 1|Lost to Follow-up|0|||
145587805|NCT02310750|525004338|FG006|HP Period 1|Lost to Follow-up|1|||
145455661|NCT00152477|524518789|FG000|Monotherapy Period|Adverse Event|1|||
145455662|NCT00152477|524518790|FG001|Monotherapy Period|Adverse Event|0|||
145455663|NCT00152477|524518791|FG002|Monotherapy Period|Adverse Event|5|||
145455664|NCT00152477|524518789|FG000|Monotherapy Period|Death|2|||
145455665|NCT00152477|524518790|FG001|Monotherapy Period|Death|0|||
145455666|NCT00152477|524518791|FG002|Monotherapy Period|Death|1|||
145455667|NCT00152477|524518789|FG000|Monotherapy Period|Lack of Efficacy|7|||
145587806|NCT02310750|525004339|FG007|HP Period 1|Lost to Follow-up|0|||
145587807|NCT02310750|525004340|FG008|HP Period 1|Lost to Follow-up|0|||
145455668|NCT00152477|524518790|FG001|Monotherapy Period|Lack of Efficacy|16|||
145455669|NCT00152477|524518791|FG002|Monotherapy Period|Lack of Efficacy|10|||
145455670|NCT00152477|524518789|FG000|Monotherapy Period|Protocol Violation|0|||
145455671|NCT00152477|524518790|FG001|Monotherapy Period|Protocol Violation|1|||
145455672|NCT00152477|524518791|FG002|Monotherapy Period|Protocol Violation|0|||
145455673|NCT00152477|524518789|FG000|Monotherapy Period|Withdrawal by Subject|0|||
145455674|NCT00152477|524518790|FG001|Monotherapy Period|Withdrawal by Subject|0|||
145455675|NCT00152477|524518791|FG002|Monotherapy Period|Withdrawal by Subject|4|||
145455676|NCT00152477|524518789|FG000|Monotherapy Period|Progression of Disease|5|||
145455677|NCT00152477|524518790|FG001|Monotherapy Period|Progression of Disease|11|||
145455678|NCT00152477|524518791|FG002|Monotherapy Period|Progression of Disease|12|||
145455679|NCT00152477|524518789|FG000|Monotherapy Period|Patient decision|0|||
145455680|NCT00152477|524518790|FG001|Monotherapy Period|Patient decision|1|||
145455681|NCT00152477|524518791|FG002|Monotherapy Period|Patient decision|1|||
145455682|NCT00152477|524518789|FG000|Monotherapy Period|Study personel decision|0|||
145455683|NCT00152477|524518790|FG001|Monotherapy Period|Study personel decision|0|||
145455684|NCT00152477|524518791|FG002|Monotherapy Period|Study personel decision|1|||
145455685|NCT01082874|524518795|FG000|Overall Study|Lost to Follow-up|10|||
145455686|NCT01082874|524518796|FG001|Overall Study|Lost to Follow-up|10|||
145455687|NCT01082874|524518797|FG002|Overall Study|Lost to Follow-up|6|||
145455688|NCT01082874|524518798|FG003|Overall Study|Lost to Follow-up|10|||
145455689|NCT01082874|524518795|FG000|Overall Study|Withdrawal by Subject|1|||
145455690|NCT01082874|524518796|FG001|Overall Study|Withdrawal by Subject|2|||
145455691|NCT01082874|524518797|FG002|Overall Study|Withdrawal by Subject|5|||
145455692|NCT01082874|524518798|FG003|Overall Study|Withdrawal by Subject|3|||
145455693|NCT03888235|524518802|FG000|Overall Study|Lost to Follow-up|1|||
145455694|NCT03888235|524518803|FG001|Overall Study|Lost to Follow-up|1|||
145455695|NCT03888235|524518804|FG002|Overall Study|Lost to Follow-up|0|||
145455696|NCT00939029|524518807|FG000|Overall Study|Withdrawal by Subject|3|||
145455697|NCT00939029|524518808|FG001|Overall Study|Withdrawal by Subject|7|||
145455698|NCT00939029|524518807|FG000|Overall Study|Lost to Follow-up|3|||
145455699|NCT00939029|524518808|FG001|Overall Study|Lost to Follow-up|4|||
145455700|NCT00939029|524518807|FG000|Overall Study|Adverse Event|0|||
145455701|NCT00939029|524518808|FG001|Overall Study|Adverse Event|1|||
145455702|NCT03305419|524518820|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455703|NCT03305419|524518821|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
145455704|NCT03305419|524518822|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455705|NCT03305419|524518823|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455706|NCT03305419|524518824|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455707|NCT03305419|524518825|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455708|NCT03305419|524518826|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455709|NCT03305419|524518827|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
145455710|NCT03305419|524518820|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
145455711|NCT03305419|524518821|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455712|NCT03305419|524518822|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455713|NCT03305419|524518823|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455714|NCT03305419|524518824|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455715|NCT03305419|524518825|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145626346|NCT00062868|525144248|FG008|Dose Level 3|Lost to Follow-up|0|||
145626347|NCT00062868|525144249|FG009|Dose Level 3|Lost to Follow-up|0|||
145626348|NCT00062868|525144250|FG010|Dose Level 3|Lost to Follow-up|0|||
145626349|NCT00062868|525144251|FG011|Dose Level 3|Lost to Follow-up|0|||
145626350|NCT00062868|525144252|FG012|Dose Level 3|Lost to Follow-up|0|||
145626351|NCT00062868|525144253|FG013|Dose Level 3|Lost to Follow-up|0|||
145626352|NCT00062868|525144254|FG014|Dose Level 3|Lost to Follow-up|1|||
145626353|NCT00062868|525144255|FG015|Dose Level 3|Lost to Follow-up|0|||
145455716|NCT03305419|524518826|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455717|NCT03305419|524518827|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
145455718|NCT03305419|524518820|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
145455719|NCT03305419|524518821|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455720|NCT03305419|524518822|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455721|NCT03305419|524518823|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455722|NCT03305419|524518824|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455723|NCT03305419|524518825|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455724|NCT03305419|524518826|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145455725|NCT03305419|524518827|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
145626354|NCT00062868|525144256|FG016|Dose Level 3|Lost to Follow-up|0|||
145455726|NCT03305419|524518820|FG000|Part B (14 Days)|Adverse Event|0|||
145455727|NCT03305419|524518821|FG001|Part B (14 Days)|Adverse Event|0|||
145455728|NCT03305419|524518822|FG002|Part B (14 Days)|Adverse Event|0|||
145626355|NCT00062868|525144257|FG017|Dose Level 3|Lost to Follow-up|0|||
145626356|NCT00062868|525144258|FG018|Dose Level 3|Lost to Follow-up|0|||
145626357|NCT00062868|525144259|FG019|Dose Level 3|Lost to Follow-up|0|||
145455729|NCT03305419|524518823|FG003|Part B (14 Days)|Adverse Event|0|||
145455730|NCT03305419|524518824|FG004|Part B (14 Days)|Adverse Event|1|||
145455731|NCT03305419|524518825|FG005|Part B (14 Days)|Adverse Event|2|||
145455732|NCT03305419|524518826|FG006|Part B (14 Days)|Adverse Event|4|||
145455733|NCT03305419|524518827|FG007|Part B (14 Days)|Adverse Event|0|||
145455734|NCT03305419|524518820|FG000|Part B (14 Days)|Physician Decision|0|||
145455735|NCT03305419|524518821|FG001|Part B (14 Days)|Physician Decision|0|||
145455736|NCT03305419|524518822|FG002|Part B (14 Days)|Physician Decision|0|||
145455737|NCT03305419|524518823|FG003|Part B (14 Days)|Physician Decision|0|||
145455738|NCT03305419|524518824|FG004|Part B (14 Days)|Physician Decision|2|||
145455739|NCT03305419|524518825|FG005|Part B (14 Days)|Physician Decision|8|||
145455740|NCT03305419|524518826|FG006|Part B (14 Days)|Physician Decision|1|||
145455741|NCT03305419|524518827|FG007|Part B (14 Days)|Physician Decision|0|||
145455742|NCT00075946|524518828|FG000|Overall Study|Path ineligible: undetermined histology|0|||
145455743|NCT00075946|524518829|FG001|Overall Study|Path ineligible: undetermined histology|0|||
145455744|NCT00075946|524518830|FG002|Overall Study|Path ineligible: undetermined histology|0|||
145455745|NCT00075946|524518831|FG003|Overall Study|Path ineligible: undetermined histology|0|||
145455746|NCT00075946|524518832|FG004|Overall Study|Path ineligible: undetermined histology|6|||
145455747|NCT00075946|524518828|FG000|Overall Study|Did not achieve response after induction|0|||
145455748|NCT00075946|524518829|FG001|Overall Study|Did not achieve response after induction|0|||
145455749|NCT00075946|524518830|FG002|Overall Study|Did not achieve response after induction|0|||
145455750|NCT00075946|524518831|FG003|Overall Study|Did not achieve response after induction|0|||
145455751|NCT00075946|524518832|FG004|Overall Study|Did not achieve response after induction|182|||
145455752|NCT00075946|524518828|FG000|Overall Study|Incorrectly randomized (no response)|5|||
145455753|NCT00075946|524518829|FG001|Overall Study|Incorrectly randomized (no response)|5|||
145455754|NCT00075946|524518830|FG002|Overall Study|Incorrectly randomized (no response)|5|||
145455755|NCT00075946|524518831|FG003|Overall Study|Incorrectly randomized (no response)|1|||
145455756|NCT00075946|524518832|FG004|Overall Study|Incorrectly randomized (no response)|0|||
145455757|NCT00075946|524518828|FG000|Overall Study|Adverse Event|2|||
145455758|NCT00075946|524518829|FG001|Overall Study|Adverse Event|10|||
145455759|NCT00075946|524518830|FG002|Overall Study|Adverse Event|0|||
145455760|NCT00075946|524518831|FG003|Overall Study|Adverse Event|2|||
145455761|NCT00075946|524518832|FG004|Overall Study|Adverse Event|0|||
145455762|NCT00075946|524518828|FG000|Overall Study|Death|0|||
145455763|NCT00075946|524518829|FG001|Overall Study|Death|1|||
145455764|NCT00075946|524518830|FG002|Overall Study|Death|0|||
145455765|NCT00075946|524518831|FG003|Overall Study|Death|0|||
145455766|NCT00075946|524518832|FG004|Overall Study|Death|0|||
145455767|NCT00075946|524518828|FG000|Overall Study|Withdrawal by Subject|23|||
145455768|NCT00075946|524518829|FG001|Overall Study|Withdrawal by Subject|58|||
145455769|NCT00075946|524518830|FG002|Overall Study|Withdrawal by Subject|4|||
145455770|NCT00075946|524518831|FG003|Overall Study|Withdrawal by Subject|9|||
145455771|NCT00075946|524518832|FG004|Overall Study|Withdrawal by Subject|0|||
145455772|NCT00075946|524518828|FG000|Overall Study|Alternative therapy|16|||
145455773|NCT00075946|524518829|FG001|Overall Study|Alternative therapy|2|||
145455774|NCT00075946|524518830|FG002|Overall Study|Alternative therapy|5|||
145455775|NCT00075946|524518831|FG003|Overall Study|Alternative therapy|0|||
145455776|NCT00075946|524518832|FG004|Overall Study|Alternative therapy|0|||
145455777|NCT00075946|524518828|FG000|Overall Study|Other complicating disease|7|||
145455778|NCT00075946|524518829|FG001|Overall Study|Other complicating disease|13|||
145455779|NCT00075946|524518830|FG002|Overall Study|Other complicating disease|1|||
145455780|NCT00075946|524518831|FG003|Overall Study|Other complicating disease|4|||
145455781|NCT00075946|524518832|FG004|Overall Study|Other complicating disease|0|||
145455782|NCT00075946|524518828|FG000|Overall Study|No response to retreatment|23|||
145455783|NCT00075946|524518829|FG001|Overall Study|No response to retreatment|0|||
145455784|NCT00075946|524518830|FG002|Overall Study|No response to retreatment|2|||
145455785|NCT00075946|524518831|FG003|Overall Study|No response to retreatment|0|||
145455786|NCT00075946|524518832|FG004|Overall Study|No response to retreatment|0|||
145455787|NCT00075946|524518828|FG000|Overall Study|Time to progression less than 6 months|15|||
145455788|NCT00075946|524518829|FG001|Overall Study|Time to progression less than 6 months|30|||
145455789|NCT00075946|524518830|FG002|Overall Study|Time to progression less than 6 months|8|||
145455790|NCT00075946|524518831|FG003|Overall Study|Time to progression less than 6 months|3|||
145455791|NCT00075946|524518832|FG004|Overall Study|Time to progression less than 6 months|0|||
145455792|NCT00075946|524518828|FG000|Overall Study|Other|57|||
145455793|NCT00075946|524518829|FG001|Overall Study|Other|32|||
145455794|NCT00075946|524518830|FG002|Overall Study|Other|3|||
145455795|NCT00075946|524518831|FG003|Overall Study|Other|11|||
145455796|NCT00075946|524518832|FG004|Overall Study|Other|0|||
145455797|NCT02210689|524518833|FG000|Overall Study|Withdrawal by Subject|7|||
145455798|NCT02210689|524518834|FG001|Overall Study|Withdrawal by Subject|4|||
145455799|NCT02210689|524518835|FG002|Overall Study|Withdrawal by Subject|2|||
145455800|NCT02210689|524518833|FG000|Overall Study|Adverse Event|0|||
145455801|NCT02210689|524518834|FG001|Overall Study|Adverse Event|1|||
145455802|NCT02210689|524518835|FG002|Overall Study|Adverse Event|0|||
145455803|NCT02210689|524518833|FG000|Overall Study|Protocol Violation|1|||
145455804|NCT02210689|524518834|FG001|Overall Study|Protocol Violation|0|||
145455805|NCT02210689|524518835|FG002|Overall Study|Protocol Violation|0|||
145455806|NCT02210689|524518833|FG000|Overall Study|Lost to Follow-up|11|||
145455807|NCT02210689|524518834|FG001|Overall Study|Lost to Follow-up|9|||
145455808|NCT02210689|524518835|FG002|Overall Study|Lost to Follow-up|5|||
145455809|NCT02210689|524518833|FG000|Overall Study|Pregnancy|0|||
145455810|NCT02210689|524518834|FG001|Overall Study|Pregnancy|1|||
145455811|NCT02210689|524518835|FG002|Overall Study|Pregnancy|0|||
145455812|NCT02210689|524518833|FG000|Overall Study|Lack of Efficacy|0|||
145455813|NCT02210689|524518834|FG001|Overall Study|Lack of Efficacy|1|||
145455814|NCT02210689|524518835|FG002|Overall Study|Lack of Efficacy|5|||
145455815|NCT02210689|524518833|FG000|Overall Study|Prohibited medication|2|||
145455816|NCT02210689|524518834|FG001|Overall Study|Prohibited medication|8|||
145455817|NCT02210689|524518835|FG002|Overall Study|Prohibited medication|1|||
145455818|NCT02210689|524518833|FG000|Overall Study|Negative Nugent score at baseline|6|||
145455819|NCT02210689|524518834|FG001|Overall Study|Negative Nugent score at baseline|2|||
145455820|NCT02210689|524518835|FG002|Overall Study|Negative Nugent score at baseline|2|||
145455821|NCT02210689|524518833|FG000|Overall Study|Other|25|||
145455822|NCT02210689|524518834|FG001|Overall Study|Other|21|||
145455823|NCT02210689|524518835|FG002|Overall Study|Other|8|||
145455824|NCT00889603|524518836|FG000|Overall Study|Adverse Event|7|||
145455825|NCT00889603|524518836|FG000|Overall Study|Death|3|||
145455826|NCT00889603|524518836|FG000|Overall Study|Lost to Follow-up|19|||
145455827|NCT00889603|524518836|FG000|Overall Study|No longer willing to participant in stud|4|||
145455828|NCT00889603|524518836|FG000|Overall Study|Other|4|||
145455829|NCT02231892|524518837|FG000|Overall Study|Lost to Follow-up|1|||
145455830|NCT02231892|524518838|FG001|Overall Study|Lost to Follow-up|0|||
145455831|NCT02231892|524518839|FG002|Overall Study|Lost to Follow-up|3|||
145455832|NCT02231892|524518837|FG000|Overall Study|Withdrawal by Subject|4|||
145455833|NCT02231892|524518838|FG001|Overall Study|Withdrawal by Subject|3|||
145455834|NCT02231892|524518839|FG002|Overall Study|Withdrawal by Subject|15|||
145455835|NCT02231892|524518837|FG000|Overall Study|Physician Decision|0|||
145455836|NCT02231892|524518838|FG001|Overall Study|Physician Decision|2|||
145455837|NCT02231892|524518839|FG002|Overall Study|Physician Decision|4|||
145455838|NCT02231892|524518837|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
145455839|NCT02231892|524518838|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
145455840|NCT02231892|524518839|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
145455841|NCT02231892|524518837|FG000|Overall Study|Participant motor threshold was >83%|0|||
145455842|NCT02231892|524518838|FG001|Overall Study|Participant motor threshold was >83%|0|||
145455843|NCT02231892|524518839|FG002|Overall Study|Participant motor threshold was >83%|9|||
145455844|NCT02231892|524518837|FG000|Overall Study|Could not find motor threshold|2|||
145455845|NCT02231892|524518838|FG001|Overall Study|Could not find motor threshold|0|||
145455846|NCT02231892|524518839|FG002|Overall Study|Could not find motor threshold|1|||
145455847|NCT02231892|524518837|FG000|Overall Study|Could not find reliable motor hotspot|0|||
145455848|NCT02231892|524518838|FG001|Overall Study|Could not find reliable motor hotspot|0|||
145455849|NCT02231892|524518839|FG002|Overall Study|Could not find reliable motor hotspot|1|||
145455850|NCT02186652|524518852|FG000|Overall Study|Lost to Follow-up|2|||
145455851|NCT02186652|524518853|FG001|Overall Study|Lost to Follow-up|0|||
145455852|NCT00503776|524518854|FG000|Overall Study|Withdrawal by Subject|1|||
145455853|NCT00503776|524518855|FG001|Overall Study|Withdrawal by Subject|0|||
145455854|NCT00503776|524518856|FG002|Overall Study|Withdrawal by Subject|1|||
145455855|NCT00503776|524518857|FG003|Overall Study|Withdrawal by Subject|1|||
145455856|NCT00503776|524518854|FG000|Overall Study|Physician Decision|0|||
145455857|NCT00503776|524518855|FG001|Overall Study|Physician Decision|0|||
145455858|NCT00503776|524518856|FG002|Overall Study|Physician Decision|1|||
145455859|NCT00503776|524518857|FG003|Overall Study|Physician Decision|1|||
145626358|NCT00062868|525144260|FG020|Dose Level 3|Lost to Follow-up|0|||
145626359|NCT00062868|525144240|FG000|Dose Level 3|Withdrew|0|||
145626360|NCT00062868|525144241|FG001|Dose Level 3|Withdrew|0|||
145455860|NCT02247011|524518860|FG000|Overall Study|Poor quality of radiological results|125|||
145455861|NCT05248997|524518863|FG000|Overall Study|Lost to Follow-up|1|||
145455862|NCT05248997|524518864|FG001|Overall Study|Lost to Follow-up|1|||
145455863|NCT05248997|524518863|FG000|Overall Study|Randomized but not treated|32|||
145455864|NCT05248997|524518864|FG001|Overall Study|Randomized but not treated|25|||
145455865|NCT01453205|524518865|FG000|Overall Study|Lost to Follow-up|3|||
145455866|NCT01453205|524518866|FG001|Overall Study|Lost to Follow-up|0|||
145455867|NCT01453205|524518867|FG002|Overall Study|Lost to Follow-up|1|||
145455868|NCT01453205|524518865|FG000|Overall Study|Withdrawal by Subject|8|||
145455869|NCT01453205|524518866|FG001|Overall Study|Withdrawal by Subject|3|||
145455870|NCT01453205|524518867|FG002|Overall Study|Withdrawal by Subject|0|||
145455871|NCT01453205|524518865|FG000|Overall Study|Death|24|||
145455872|NCT01453205|524518866|FG001|Overall Study|Death|22|||
145455873|NCT01453205|524518867|FG002|Overall Study|Death|18|||
145626361|NCT00062868|525144242|FG002|Dose Level 3|Withdrew|2|||
145626362|NCT00062868|525144243|FG003|Dose Level 3|Withdrew|0|||
145626363|NCT00062868|525144244|FG004|Dose Level 3|Withdrew|0|||
145626364|NCT00062868|525144245|FG005|Dose Level 3|Withdrew|0|||
145626365|NCT00062868|525144246|FG006|Dose Level 3|Withdrew|0|||
145455874|NCT01453205|524518865|FG000|Overall Study|Other|45|||
145455875|NCT01453205|524518866|FG001|Overall Study|Other|27|||
145455876|NCT01453205|524518867|FG002|Overall Study|Other|35|||
145455877|NCT05593913|524518868|FG000|Overall Study|Insufficient image quality|39|||
145455878|NCT02602275|524518871|FG000|Day 1|Physician Decision|0|||
145455879|NCT02602275|524518872|FG001|Day 1|Physician Decision|1|||
145455880|NCT01974206|524518873|FG000|Overall Study|Did Not Take Study Drug|0|||
145455881|NCT01974206|524518874|FG001|Overall Study|Did Not Take Study Drug|1|||
145455882|NCT01974206|524518873|FG000|Overall Study|Physician Decision|1|||
145455883|NCT01974206|524518874|FG001|Overall Study|Physician Decision|0|||
145455884|NCT01974206|524518873|FG000|Overall Study|Withdrawal by Subject|3|||
145455885|NCT01974206|524518874|FG001|Overall Study|Withdrawal by Subject|0|||
145455886|NCT01974206|524518873|FG000|Overall Study|Lost to Follow-up|1|||
145455887|NCT01974206|524518874|FG001|Overall Study|Lost to Follow-up|0|||
145455888|NCT01974206|524518873|FG000|Overall Study|Death|1|||
145455889|NCT01974206|524518874|FG001|Overall Study|Death|0|||
145455890|NCT04027049|524518879|FG000|Overall Study|Withdrawn by family|1|||
145455891|NCT04027049|524518880|FG001|Overall Study|Withdrawn by family|0|||
145455892|NCT04027049|524518879|FG000|Overall Study|Participant safety|1|||
145455893|NCT04027049|524518880|FG001|Overall Study|Participant safety|0|||
145455894|NCT02867813|524520818|FG000|Overall Study|Withdrawal by Subject|57|||
145455895|NCT02867813|524520819|FG001|Overall Study|Withdrawal by Subject|56|||
145455896|NCT02867813|524520818|FG000|Overall Study|Decision by Sponsor|7|||
145455897|NCT02867813|524520819|FG001|Overall Study|Decision by Sponsor|7|||
145455898|NCT02867813|524520818|FG000|Overall Study|Lost to Follow-up|91|||
145455899|NCT02867813|524520819|FG001|Overall Study|Lost to Follow-up|78|||
145455900|NCT02867813|524520818|FG000|Overall Study|Missing|2|||
145455901|NCT02867813|524520819|FG001|Overall Study|Missing|1|||
145455902|NCT02867813|524520818|FG000|Overall Study|Death|294|||
145455903|NCT02867813|524520819|FG001|Overall Study|Death|268|||
145455904|NCT02013206|524520820|FG000|Overall Study|Progressive disease (PD)|14|||
145455905|NCT02013206|524520821|FG001|Overall Study|Progressive disease (PD)|17|||
145455906|NCT02013206|524520820|FG000|Overall Study|Symptomatic deterioration|3|||
145455907|NCT02013206|524520821|FG001|Overall Study|Symptomatic deterioration|1|||
145455908|NCT02013206|524520820|FG000|Overall Study|Adverse Event|1|||
145455909|NCT02013206|524520821|FG001|Overall Study|Adverse Event|0|||
145455910|NCT02013206|524520820|FG000|Overall Study|Patient refusal|2|||
145455911|NCT02013206|524520821|FG001|Overall Study|Patient refusal|0|||
145455912|NCT02013206|524520820|FG000|Overall Study|Patient non-compliance|1|||
145455913|NCT02013206|524520821|FG001|Overall Study|Patient non-compliance|0|||
145455914|NCT02013206|524520820|FG000|Overall Study|Death|1|||
145455915|NCT02013206|524520821|FG001|Overall Study|Death|2|||
145455916|NCT02013206|524520820|FG000|Overall Study|Other reasons off treatment|5|||
145455917|NCT02013206|524520821|FG001|Overall Study|Other reasons off treatment|2|||
145455918|NCT01952665|524520825|FG000|Overall Study|Physician Decision|3|||
145455919|NCT01952665|524520826|FG001|Overall Study|Physician Decision|2|||
145455920|NCT01952665|524520825|FG000|Overall Study|Lost to Follow-up|1|||
145455921|NCT01952665|524520826|FG001|Overall Study|Lost to Follow-up|2|||
145455922|NCT01952665|524520825|FG000|Overall Study|Adverse Event|2|||
145455923|NCT01952665|524520826|FG001|Overall Study|Adverse Event|1|||
145455924|NCT01952665|524520825|FG000|Overall Study|Protocol Violation|0|||
145455925|NCT01952665|524520826|FG001|Overall Study|Protocol Violation|1|||
145455926|NCT01463111|524520829|FG000|Overall Study|Withdrawal by Subject|2|||
145455927|NCT01463111|524520829|FG000|Overall Study|Lost to Follow-up|5|||
145455928|NCT01463111|524520829|FG000|Overall Study|Physician Decision|2|||
145455929|NCT01559259|524520839|FG000|Overall Study|Withdrawal by Subject|0|||
145455930|NCT01559259|524520840|FG001|Overall Study|Withdrawal by Subject|0|||
145455931|NCT01559259|524520841|FG002|Overall Study|Withdrawal by Subject|0|||
145455932|NCT01559259|524520842|FG003|Overall Study|Withdrawal by Subject|1|||
145455933|NCT01559259|524520843|FG004|Overall Study|Withdrawal by Subject|0|||
145455934|NCT01559259|524520839|FG000|Overall Study|Adverse Event|0|||
145455935|NCT01559259|524520840|FG001|Overall Study|Adverse Event|1|||
145455936|NCT01559259|524520841|FG002|Overall Study|Adverse Event|1|||
145455937|NCT01559259|524520842|FG003|Overall Study|Adverse Event|0|||
145455938|NCT01559259|524520843|FG004|Overall Study|Adverse Event|0|||
145455939|NCT01995669|524520844|FG000|Overall Study|Progression|2|||
145455940|NCT01995669|524520845|FG001|Overall Study|Progression|1|||
145455941|NCT01995669|524520846|FG002|Overall Study|Progression|1|||
145455942|NCT01995669|524520847|FG003|Overall Study|Progression|13|||
145455943|NCT01995669|524520844|FG000|Overall Study|Adverse Event|0|||
145455944|NCT01995669|524520845|FG001|Overall Study|Adverse Event|0|||
145455945|NCT01995669|524520846|FG002|Overall Study|Adverse Event|0|||
145455946|NCT01995669|524520847|FG003|Overall Study|Adverse Event|3|||
145455947|NCT01995669|524520844|FG000|Overall Study|Death|0|||
145455948|NCT01995669|524520845|FG001|Overall Study|Death|0|||
145455949|NCT01995669|524520846|FG002|Overall Study|Death|0|||
145455950|NCT01995669|524520847|FG003|Overall Study|Death|6|||
145455951|NCT01995669|524520844|FG000|Overall Study|Withdrawal by Subject|0|||
145455952|NCT01995669|524520845|FG001|Overall Study|Withdrawal by Subject|0|||
145455953|NCT01995669|524520846|FG002|Overall Study|Withdrawal by Subject|0|||
145455954|NCT01995669|524520847|FG003|Overall Study|Withdrawal by Subject|6|||
145455955|NCT01995669|524520844|FG000|Overall Study|Insurance Expired|0|||
145455956|NCT01995669|524520845|FG001|Overall Study|Insurance Expired|0|||
145455957|NCT01995669|524520846|FG002|Overall Study|Insurance Expired|0|||
145455958|NCT01995669|524520847|FG003|Overall Study|Insurance Expired|1|||
145455959|NCT05425732|524520848|FG000|Overall Study|Death|4|||
145455960|NCT05425732|524520849|FG001|Overall Study|Death|2|||
145455961|NCT05425732|524520850|FG002|Overall Study|Death|0|||
145455962|NCT05425732|524520851|FG003|Overall Study|Death|0|||
145455963|NCT05425732|524520848|FG000|Overall Study|Lost to Follow-up|10|||
145455964|NCT05425732|524520849|FG001|Overall Study|Lost to Follow-up|15|||
145455965|NCT05425732|524520850|FG002|Overall Study|Lost to Follow-up|5|||
145455966|NCT05425732|524520851|FG003|Overall Study|Lost to Follow-up|3|||
145455967|NCT05425732|524520848|FG000|Overall Study|Physician Decision|0|||
145455968|NCT05425732|524520849|FG001|Overall Study|Physician Decision|2|||
145455969|NCT05425732|524520850|FG002|Overall Study|Physician Decision|0|||
145455970|NCT05425732|524520851|FG003|Overall Study|Physician Decision|0|||
145455971|NCT05425732|524520848|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145455972|NCT05425732|524520849|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
145455973|NCT05425732|524520850|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145455974|NCT05425732|524520851|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145455975|NCT05425732|524520848|FG000|Overall Study|Withdrawal by Subject|4|||
145455976|NCT05425732|524520849|FG001|Overall Study|Withdrawal by Subject|8|||
145455977|NCT05425732|524520850|FG002|Overall Study|Withdrawal by Subject|1|||
145455978|NCT05425732|524520851|FG003|Overall Study|Withdrawal by Subject|1|||
145455979|NCT05425732|524520848|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
145455980|NCT05425732|524520849|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
145455981|NCT05425732|524520850|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
145455982|NCT05425732|524520851|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
145455983|NCT00539513|524520853|FG000|Overall Study|Withdrawal by Subject|2|||
145455984|NCT00539513|524520854|FG001|Overall Study|Withdrawal by Subject|1|||
145455985|NCT00539513|524520853|FG000|Overall Study|Lost to Follow-up|0|||
145455986|NCT00539513|524520854|FG001|Overall Study|Lost to Follow-up|1|||
145455987|NCT01328041|524520855|FG000|Overall Study|Adverse Event|7|||
145455988|NCT01328041|524520855|FG000|Overall Study|Lack of Efficacy|27|||
145455989|NCT01328041|524520855|FG000|Overall Study|Protocol Violation|7|||
145455990|NCT01328041|524520855|FG000|Overall Study|Lost to Follow-up|7|||
145455991|NCT01328041|524520855|FG000|Overall Study|Physician Decision|2|||
145455992|NCT01328041|524520855|FG000|Overall Study|Withdrawal by Subject|7|||
145455993|NCT00711113|524520856|FG000|Overall Study|Lost to Follow-up|9|||
145455994|NCT00711113|524520856|FG000|Overall Study|Implant lost|2|||
145455995|NCT02688088|524520861|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
145455996|NCT02688088|524520862|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
145455997|NCT02688088|524520863|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
145455998|NCT02688088|524520864|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
145455999|NCT02688088|524520865|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
145456000|NCT02688088|524520861|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
145456001|NCT02688088|524520862|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
145456002|NCT02688088|524520863|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
145456003|NCT02688088|524520864|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
145456004|NCT02688088|524520865|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
145456005|NCT02688088|524520861|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
145456006|NCT02688088|524520862|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
145456007|NCT02688088|524520863|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
145626366|NCT00062868|525144247|FG007|Dose Level 3|Withdrew|0|||
145626367|NCT00062868|525144248|FG008|Dose Level 3|Withdrew|0|||
145626368|NCT00062868|525144249|FG009|Dose Level 3|Withdrew|0|||
145456008|NCT02688088|524520864|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
145456009|NCT02688088|524520865|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
145456010|NCT02688088|524520861|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
145456011|NCT02688088|524520862|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
145456012|NCT02688088|524520863|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
145456013|NCT02688088|524520864|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
145456014|NCT02688088|524520865|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
145456015|NCT02688088|524520861|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
145626369|NCT00062868|525144250|FG010|Dose Level 3|Withdrew|0|||
145626370|NCT00062868|525144251|FG011|Dose Level 3|Withdrew|0|||
145626371|NCT00062868|525144252|FG012|Dose Level 3|Withdrew|0|||
145456016|NCT02688088|524520862|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
145456017|NCT02688088|524520863|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
145456018|NCT02688088|524520864|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
145626372|NCT00062868|525144253|FG013|Dose Level 3|Withdrew|0|||
145626373|NCT00062868|525144254|FG014|Dose Level 3|Withdrew|0|||
145456019|NCT02688088|524520865|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
145456020|NCT02688088|524520861|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
145456021|NCT02688088|524520862|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
145456022|NCT02688088|524520863|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
145456023|NCT02688088|524520864|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
145456024|NCT02688088|524520865|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
145456025|NCT02688088|524520861|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
145456026|NCT02688088|524520862|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
145456027|NCT02688088|524520863|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
145456028|NCT02688088|524520864|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
145456029|NCT02688088|524520865|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
145456030|NCT02688088|524520861|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
145456031|NCT02688088|524520862|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
145456032|NCT02688088|524520863|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
145456033|NCT02688088|524520864|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
145456034|NCT02688088|524520865|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
145456035|NCT02688088|524520861|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
145456036|NCT02688088|524520862|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
145456037|NCT02688088|524520863|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
145456038|NCT02688088|524520864|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
145456039|NCT02688088|524520865|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
145456040|NCT01231321|524520869|FG000|Overall Study|Adverse Event|3|||
145456041|NCT01231321|524520869|FG000|Overall Study|Lack of Efficacy|2|||
145456042|NCT04021524|524520870|FG000|Overall Study|Change in surgical intervention|0|||
145456043|NCT04021524|524520871|FG001|Overall Study|Change in surgical intervention|1|||
145456044|NCT00730041|524520877|FG000|Overall Study|Lost to Follow-up|0|||
145456045|NCT00730041|524520878|FG001|Overall Study|Lost to Follow-up|2|||
145456046|NCT02447250|524520883|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
145456047|NCT02447250|524520883|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
145456048|NCT02447250|524520883|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
145456049|NCT03632993|524520884|FG000|Overall Study|Withdrawal by Subject|1|||
145456050|NCT03632993|524520885|FG001|Overall Study|Withdrawal by Subject|0|||
145456051|NCT03632993|524520886|FG002|Overall Study|Withdrawal by Subject|0|||
145456052|NCT03632993|524520887|FG003|Overall Study|Withdrawal by Subject|0|||
145456053|NCT03632993|524520888|FG004|Overall Study|Withdrawal by Subject|0|||
145456054|NCT03632993|524520889|FG005|Overall Study|Withdrawal by Subject|0|||
145456055|NCT03632993|524520890|FG006|Overall Study|Withdrawal by Subject|0|||
145456056|NCT03632993|524520891|FG007|Overall Study|Withdrawal by Subject|0|||
145456057|NCT03632993|524520892|FG008|Overall Study|Withdrawal by Subject|0|||
145456058|NCT03632993|524520893|FG009|Overall Study|Withdrawal by Subject|1|||
145456059|NCT03632993|524520884|FG000|Overall Study|Protocol Non-compliance|0|||
145456060|NCT03632993|524520885|FG001|Overall Study|Protocol Non-compliance|1|||
145456061|NCT03632993|524520886|FG002|Overall Study|Protocol Non-compliance|0|||
145456062|NCT03632993|524520887|FG003|Overall Study|Protocol Non-compliance|0|||
145456063|NCT03632993|524520888|FG004|Overall Study|Protocol Non-compliance|0|||
145456064|NCT03632993|524520889|FG005|Overall Study|Protocol Non-compliance|0|||
145456065|NCT03632993|524520890|FG006|Overall Study|Protocol Non-compliance|0|||
145456066|NCT03632993|524520891|FG007|Overall Study|Protocol Non-compliance|0|||
145456067|NCT03632993|524520892|FG008|Overall Study|Protocol Non-compliance|0|||
145456068|NCT03632993|524520893|FG009|Overall Study|Protocol Non-compliance|0|||
145456069|NCT03632993|524520884|FG000|Overall Study|Lost to Follow-up|0|||
145456070|NCT03632993|524520885|FG001|Overall Study|Lost to Follow-up|0|||
145456071|NCT03632993|524520886|FG002|Overall Study|Lost to Follow-up|0|||
145456072|NCT03632993|524520887|FG003|Overall Study|Lost to Follow-up|0|||
145456073|NCT03632993|524520888|FG004|Overall Study|Lost to Follow-up|0|||
145456074|NCT03632993|524520889|FG005|Overall Study|Lost to Follow-up|1|||
145456075|NCT03632993|524520890|FG006|Overall Study|Lost to Follow-up|0|||
145456076|NCT03632993|524520891|FG007|Overall Study|Lost to Follow-up|1|||
145456077|NCT03632993|524520892|FG008|Overall Study|Lost to Follow-up|0|||
145456078|NCT03632993|524520893|FG009|Overall Study|Lost to Follow-up|0|||
145456079|NCT03632993|524520884|FG000|Overall Study|Adverse Event|0|||
145456080|NCT03632993|524520885|FG001|Overall Study|Adverse Event|0|||
145456081|NCT03632993|524520886|FG002|Overall Study|Adverse Event|0|||
145456082|NCT03632993|524520887|FG003|Overall Study|Adverse Event|0|||
145456083|NCT03632993|524520888|FG004|Overall Study|Adverse Event|0|||
145456084|NCT03632993|524520889|FG005|Overall Study|Adverse Event|1|||
145456085|NCT03632993|524520890|FG006|Overall Study|Adverse Event|0|||
145456086|NCT03632993|524520891|FG007|Overall Study|Adverse Event|1|||
145456087|NCT03632993|524520892|FG008|Overall Study|Adverse Event|0|||
145456088|NCT03632993|524520893|FG009|Overall Study|Adverse Event|0|||
145456089|NCT04417218|524520894|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
145587808|NCT02310750|525004341|FG009|HP Period 1|Lost to Follow-up|0|||
145456090|NCT04417218|524520895|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
145456091|NCT00873041|524520896|FG000|Core Study|Adverse Event|2|||
145456092|NCT00873041|524520897|FG001|Core Study|Adverse Event|3|||
145456093|NCT00873041|524520898|FG002|Core Study|Adverse Event|1|||
145456094|NCT00873041|524520896|FG000|Core Study|Withdrawal by Subject|1|||
145456095|NCT00873041|524520897|FG001|Core Study|Withdrawal by Subject|2|||
145456096|NCT00873041|524520898|FG002|Core Study|Withdrawal by Subject|2|||
145456097|NCT00873041|524520896|FG000|Core Study|Lost to Follow-up|3|||
145456098|NCT00873041|524520897|FG001|Core Study|Lost to Follow-up|1|||
145456099|NCT00873041|524520898|FG002|Core Study|Lost to Follow-up|0|||
145456100|NCT00873041|524520896|FG000|Core Study|Abnormal laboratory value|0|||
145456101|NCT00873041|524520897|FG001|Core Study|Abnormal laboratory value|0|||
145456102|NCT00873041|524520898|FG002|Core Study|Abnormal laboratory value|1|||
145456103|NCT00873041|524520896|FG000|Core Study|Protocol deviation|1|||
145456104|NCT00873041|524520897|FG001|Core Study|Protocol deviation|0|||
145456105|NCT00873041|524520898|FG002|Core Study|Protocol deviation|1|||
145456106|NCT00873041|524520896|FG000|Extension Study|Adverse Event|1|||
145456107|NCT00873041|524520897|FG001|Extension Study|Adverse Event|0|||
145456108|NCT00873041|524520898|FG002|Extension Study|Adverse Event|1|||
145456109|NCT00873041|524520896|FG000|Extension Study|Administrative reasons|0|||
145456110|NCT00873041|524520897|FG001|Extension Study|Administrative reasons|0|||
145456111|NCT00873041|524520898|FG002|Extension Study|Administrative reasons|1|||
145456112|NCT00313313|524520899|FG000|Overall Study|Lack of Efficacy|14|||
145456113|NCT00313313|524520900|FG001|Overall Study|Lack of Efficacy|9|||
145456114|NCT00313313|524520901|FG002|Overall Study|Lack of Efficacy|20|||
145456115|NCT00313313|524520899|FG000|Overall Study|Withdrawal of consent by subject|18|||
145456116|NCT00313313|524520900|FG001|Overall Study|Withdrawal of consent by subject|17|||
145456117|NCT00313313|524520901|FG002|Overall Study|Withdrawal of consent by subject|31|||
145456118|NCT00313313|524520899|FG000|Overall Study|Lost to Follow-up|10|||
145456119|NCT00313313|524520900|FG001|Overall Study|Lost to Follow-up|7|||
145456120|NCT00313313|524520901|FG002|Overall Study|Lost to Follow-up|9|||
145456121|NCT00313313|524520899|FG000|Overall Study|Adverse Event|15|||
145456122|NCT00313313|524520900|FG001|Overall Study|Adverse Event|16|||
145456123|NCT00313313|524520901|FG002|Overall Study|Adverse Event|12|||
145456124|NCT00313313|524520899|FG000|Overall Study|Physician Decision|2|||
145456125|NCT00313313|524520900|FG001|Overall Study|Physician Decision|6|||
145456126|NCT00313313|524520901|FG002|Overall Study|Physician Decision|4|||
145456127|NCT00313313|524520899|FG000|Overall Study|Poor/Noncompliance|3|||
145456128|NCT00313313|524520900|FG001|Overall Study|Poor/Noncompliance|6|||
145456129|NCT00313313|524520901|FG002|Overall Study|Poor/Noncompliance|2|||
145456130|NCT00313313|524520899|FG000|Overall Study|Pregnancy|1|||
145456131|NCT00313313|524520900|FG001|Overall Study|Pregnancy|2|||
145456132|NCT00313313|524520901|FG002|Overall Study|Pregnancy|0|||
145456133|NCT00313313|524520899|FG000|Overall Study|Death|0|||
145456134|NCT00313313|524520900|FG001|Overall Study|Death|0|||
145456135|NCT00313313|524520901|FG002|Overall Study|Death|2|||
145456136|NCT00313313|524520899|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
145456137|NCT00313313|524520900|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
145456138|NCT00313313|524520901|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
145456139|NCT00368836|524520904|FG000|Phase II|Screen Failure|1|||
145456140|NCT00368836|524520904|FG000|Phase II|Withdrawal by Subject|1|||
145456141|NCT00368836|524520904|FG000|Phase II|unable to collect blood and/or breath|17|||
145456142|NCT00368836|524520904|FG000|Phase II|Protocol Violation|2|||
145456143|NCT01345591|524520914|FG000|Overall Study|Lost to Follow-up|1|||
145456144|NCT00090142|524520915|FG000|Treatment Period I|Lost to Follow-up|1|||
145456145|NCT00090142|524520916|FG001|Treatment Period I|Lost to Follow-up|2|||
145456146|NCT00090142|524520915|FG000|Treatment Period I|Protocol Violation|2|||
145456147|NCT00090142|524520916|FG001|Treatment Period I|Protocol Violation|0|||
145456148|NCT00090142|524520915|FG000|Treatment Period I|Withdrawal by Subject|2|||
145456149|NCT00090142|524520916|FG001|Treatment Period I|Withdrawal by Subject|0|||
145456150|NCT00090142|524520915|FG000|Treatment Period I|Other|0|||
145456151|NCT00090142|524520916|FG001|Treatment Period I|Other|1|||
145456152|NCT00090142|524520915|FG000|Treatment Period II|Other|1|||
145587809|NCT02310750|525004342|FG010|HP Period 1|Lost to Follow-up|0|||
145456153|NCT00090142|524520916|FG001|Treatment Period II|Other|0|||
145456154|NCT02442310|524520917|FG000|Overall Study|Adverse Event|2|||
145456155|NCT02442310|524520917|FG000|Overall Study|Withdrawal by Subject|1|||
145456156|NCT01126437|524520918|FG000|Overall Study|Not treated|11|||
145456157|NCT01126437|524520919|FG001|Overall Study|Not treated|18|||
145456158|NCT01126437|524520920|FG002|Overall Study|Not treated|19|||
145456159|NCT01126437|524520918|FG000|Overall Study|Sites with data irregularities/fraud|6|||
145456160|NCT01126437|524520919|FG001|Overall Study|Sites with data irregularities/fraud|6|||
145456161|NCT01126437|524520920|FG002|Overall Study|Sites with data irregularities/fraud|7|||
145456162|NCT01126437|524520918|FG000|Overall Study|Adverse Event|602|||
145456163|NCT01126437|524520919|FG001|Overall Study|Adverse Event|606|||
145456164|NCT01126437|524520920|FG002|Overall Study|Adverse Event|635|||
145456165|NCT01126437|524520918|FG000|Overall Study|Lack of Efficacy|65|||
145456166|NCT01126437|524520919|FG001|Overall Study|Lack of Efficacy|60|||
145456167|NCT01126437|524520920|FG002|Overall Study|Lack of Efficacy|59|||
145456168|NCT01126437|524520918|FG000|Overall Study|Protocol Violation|64|||
145456169|NCT01126437|524520919|FG001|Overall Study|Protocol Violation|66|||
145456170|NCT01126437|524520920|FG002|Overall Study|Protocol Violation|41|||
145456171|NCT01126437|524520918|FG000|Overall Study|Lost to Follow-up|52|||
145456172|NCT01126437|524520919|FG001|Overall Study|Lost to Follow-up|63|||
145456173|NCT01126437|524520920|FG002|Overall Study|Lost to Follow-up|55|||
145456174|NCT01126437|524520918|FG000|Overall Study|Withdrawal by Subject|331|||
145456175|NCT01126437|524520919|FG001|Overall Study|Withdrawal by Subject|335|||
145456176|NCT01126437|524520920|FG002|Overall Study|Withdrawal by Subject|319|||
145456177|NCT01126437|524520918|FG000|Overall Study|Other reason not specified|210|||
145456178|NCT01126437|524520919|FG001|Overall Study|Other reason not specified|176|||
145456179|NCT01126437|524520920|FG002|Overall Study|Other reason not specified|178|||
145456180|NCT00006046|524520926|FG000|Overall Study|Adverse Event|3|||
145456181|NCT00006046|524520927|FG001|Overall Study|Adverse Event|0|||
145456182|NCT00006046|524520928|FG002|Overall Study|Adverse Event|0|||
145456183|NCT00006046|524520929|FG003|Overall Study|Adverse Event|0|||
145456184|NCT00006046|524520930|FG004|Overall Study|Adverse Event|0|||
145456185|NCT00006046|524520926|FG000|Overall Study|Disease Progression|2|||
145456186|NCT00006046|524520927|FG001|Overall Study|Disease Progression|0|||
145456187|NCT00006046|524520928|FG002|Overall Study|Disease Progression|0|||
145456188|NCT00006046|524520929|FG003|Overall Study|Disease Progression|0|||
145456189|NCT00006046|524520930|FG004|Overall Study|Disease Progression|0|||
145456190|NCT00596154|524520931|FG000|Overall Study|Not Evaluable|2|||
145456191|NCT01846663|524520936|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
145456192|NCT01846663|524520937|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
145456193|NCT01846663|524520936|FG000|Overall Study|Withdrawal by Subject|1|||
145456194|NCT01846663|524520937|FG001|Overall Study|Withdrawal by Subject|0|||
145456195|NCT01846663|524520936|FG000|Overall Study|Adverse Event|1|||
145456196|NCT01846663|524520937|FG001|Overall Study|Adverse Event|2|||
145456197|NCT01229254|524520956|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
145456198|NCT01229254|524520957|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
145456199|NCT01229254|524520958|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
145456200|NCT01229254|524520956|FG000|Overall Study|Adverse Event|4|||
145456201|NCT01229254|524520957|FG001|Overall Study|Adverse Event|5|||
145456202|NCT01229254|524520958|FG002|Overall Study|Adverse Event|3|||
145456203|NCT01229254|524520956|FG000|Overall Study|Lost to Follow-up|3|||
145456204|NCT01229254|524520957|FG001|Overall Study|Lost to Follow-up|0|||
145456205|NCT01229254|524520958|FG002|Overall Study|Lost to Follow-up|1|||
145456206|NCT01229254|524520956|FG000|Overall Study|Physician Decision|0|||
145456207|NCT01229254|524520957|FG001|Overall Study|Physician Decision|3|||
145456208|NCT01229254|524520958|FG002|Overall Study|Physician Decision|0|||
145456209|NCT01229254|524520956|FG000|Overall Study|Protocol Violation|4|||
145456210|NCT01229254|524520957|FG001|Overall Study|Protocol Violation|6|||
145456211|NCT01229254|524520958|FG002|Overall Study|Protocol Violation|5|||
145456212|NCT01229254|524520956|FG000|Overall Study|Withdrawal by Subject|1|||
145456213|NCT01229254|524520957|FG001|Overall Study|Withdrawal by Subject|0|||
145456214|NCT01229254|524520958|FG002|Overall Study|Withdrawal by Subject|1|||
145456215|NCT01229254|524520956|FG000|Overall Study|Non-compliance with Study Drug|0|||
145456216|NCT01229254|524520957|FG001|Overall Study|Non-compliance with Study Drug|1|||
145456217|NCT01229254|524520958|FG002|Overall Study|Non-compliance with Study Drug|1|||
145456218|NCT05427539|524520961|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
145456219|NCT05427539|524520962|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
145456220|NCT05427539|524520961|FG000|Period 1|Withdrawal by Subject|1|||
145456221|NCT05427539|524520962|FG001|Period 1|Withdrawal by Subject|0|||
145456222|NCT03359785|524520963|FG000|Overall Study|Protocol Violation|0|||
145456223|NCT03359785|524520964|FG001|Overall Study|Protocol Violation|1|||
145456224|NCT03359785|524520965|FG002|Overall Study|Protocol Violation|0|||
145456225|NCT03359785|524520966|FG003|Overall Study|Protocol Violation|0|||
145456226|NCT03359785|524520963|FG000|Overall Study|Early study termination due to study pause|0|||
145456227|NCT03359785|524520964|FG001|Overall Study|Early study termination due to study pause|0|||
145456228|NCT03359785|524520965|FG002|Overall Study|Early study termination due to study pause|2|||
145456229|NCT03359785|524520966|FG003|Overall Study|Early study termination due to study pause|0|||
145456230|NCT03359785|524520963|FG000|Overall Study|Withdrawal by Subject|2|||
145456231|NCT03359785|524520964|FG001|Overall Study|Withdrawal by Subject|2|||
145456232|NCT03359785|524520965|FG002|Overall Study|Withdrawal by Subject|0|||
145456233|NCT03359785|524520966|FG003|Overall Study|Withdrawal by Subject|0|||
145456234|NCT02649218|524520971|FG000|Overall Study|Adverse Event|8|||
145456235|NCT02649218|524520971|FG000|Overall Study|Lack of Efficacy|8|||
145456236|NCT02649218|524520971|FG000|Overall Study|Pregnancy|3|||
145456237|NCT02649218|524520971|FG000|Overall Study|Protocol Violation|3|||
145456238|NCT02649218|524520971|FG000|Overall Study|Physician Decision|1|||
145456239|NCT02649218|524520971|FG000|Overall Study|Withdrawal by Subject|2|||
145456240|NCT04470908|524520974|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
145456241|NCT01301066|524520976|FG000|Overall Study|Lost to Follow-up|5|||
145456242|NCT01301066|524520977|FG001|Overall Study|Lost to Follow-up|11|||
145456243|NCT01301066|524520976|FG000|Overall Study|Protocol Violation|8|||
145456244|NCT01301066|524520977|FG001|Overall Study|Protocol Violation|7|||
145456245|NCT01301066|524520976|FG000|Overall Study|Withdrawal by Subject|4|||
145456246|NCT01301066|524520977|FG001|Overall Study|Withdrawal by Subject|9|||
145456247|NCT01301066|524520976|FG000|Overall Study|Adverse Event|6|||
145456248|NCT01301066|524520977|FG001|Overall Study|Adverse Event|6|||
145456249|NCT01301066|524520976|FG000|Overall Study|Sponsor Decision|2|||
145456250|NCT01301066|524520977|FG001|Overall Study|Sponsor Decision|1|||
145456251|NCT01301066|524520976|FG000|Overall Study|Physician Decision|0|||
145456252|NCT01301066|524520977|FG001|Overall Study|Physician Decision|1|||
145456253|NCT01301066|524520976|FG000|Overall Study|Other|2|||
145456254|NCT01301066|524520977|FG001|Overall Study|Other|0|||
145456255|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
145456256|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145456257|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145456258|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145456259|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145456260|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
145456261|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
145456262|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
145456263|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145456264|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145456265|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145456266|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
145456267|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
145456268|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
145456269|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
145456270|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
145456271|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
145456272|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
145456273|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
145456274|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
145456275|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145456276|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145456277|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145456278|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
145456279|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
145456280|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
145456281|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
145456282|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
145456283|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
145456284|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
145456285|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
145456286|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
145456287|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
145456288|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
145456289|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
145456290|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
145456291|NCT03989349|524520980|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
145456292|NCT03989349|524520981|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
145456293|NCT03989349|524520982|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
145456294|NCT03989349|524520983|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
145456295|NCT03989349|524520984|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
145456296|NCT03989349|524520985|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
145456297|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145456298|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
145456299|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
145456300|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
145456301|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
145456302|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
145456303|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145456304|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
145456305|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
145456306|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
145456307|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
145456308|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
145456309|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
145456310|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
145456311|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
145456312|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
145456313|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
145456314|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
145456315|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145456316|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145456317|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
145456318|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145456319|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
145456320|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
145456321|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145456322|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145456323|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
145456324|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
145456325|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
145456326|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
145456327|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
145456328|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
145456329|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
145456330|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
145456331|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
145456332|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
145456333|NCT03989349|524520980|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
145456334|NCT03989349|524520981|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
145456335|NCT03989349|524520982|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
145456336|NCT03989349|524520983|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
145456337|NCT03989349|524520984|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
145456338|NCT03989349|524520985|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
145456339|NCT01802580|524520986|FG000|Overall Study|Physician Decision|1|||
145456340|NCT01802580|524520987|FG001|Overall Study|Physician Decision|0|||
145456341|NCT01802580|524520986|FG000|Overall Study|Protocol Violation|2|||
145456342|NCT01802580|524520987|FG001|Overall Study|Protocol Violation|0|||
145456343|NCT01802580|524520986|FG000|Overall Study|Withdrawal by Subject|5|||
145456344|NCT01802580|524520987|FG001|Overall Study|Withdrawal by Subject|6|||
145456345|NCT01802580|524520986|FG000|Overall Study|Other|1|||
145456346|NCT01802580|524520987|FG001|Overall Study|Other|3|||
145456347|NCT01802580|524520986|FG000|Overall Study|Lack of Efficacy|0|||
145456348|NCT01802580|524520987|FG001|Overall Study|Lack of Efficacy|2|||
145456349|NCT00778258|524520988|FG000|Overall Study|Adverse Event|1|||
145456350|NCT00778258|524520989|FG001|Overall Study|Adverse Event|0|||
145456351|NCT00778258|524520990|FG002|Overall Study|Adverse Event|0|||
145456352|NCT00778258|524520991|FG003|Overall Study|Adverse Event|0|||
145456353|NCT00778258|524520992|FG004|Overall Study|Adverse Event|0|||
145456354|NCT00778258|524520993|FG005|Overall Study|Adverse Event|1|||
145456355|NCT00778258|524520994|FG006|Overall Study|Adverse Event|0|||
145456356|NCT00778258|524520995|FG007|Overall Study|Adverse Event|0|||
145456357|NCT00778258|524520996|FG008|Overall Study|Adverse Event|0|||
145456358|NCT00778258|524520988|FG000|Overall Study|Lost to Follow-up|0|||
145456359|NCT00778258|524520989|FG001|Overall Study|Lost to Follow-up|0|||
145456360|NCT00778258|524520990|FG002|Overall Study|Lost to Follow-up|2|||
145456361|NCT00778258|524520991|FG003|Overall Study|Lost to Follow-up|0|||
145456362|NCT00778258|524520992|FG004|Overall Study|Lost to Follow-up|0|||
145456363|NCT00778258|524520993|FG005|Overall Study|Lost to Follow-up|3|||
145456364|NCT00778258|524520994|FG006|Overall Study|Lost to Follow-up|2|||
145456365|NCT00778258|524520995|FG007|Overall Study|Lost to Follow-up|2|||
145456366|NCT00778258|524520996|FG008|Overall Study|Lost to Follow-up|0|||
145456367|NCT00778258|524520988|FG000|Overall Study|Withdrawal by Subject|6|||
145456368|NCT00778258|524520989|FG001|Overall Study|Withdrawal by Subject|2|||
145456369|NCT00778258|524520990|FG002|Overall Study|Withdrawal by Subject|8|||
145456370|NCT00778258|524520991|FG003|Overall Study|Withdrawal by Subject|2|||
145456371|NCT00778258|524520992|FG004|Overall Study|Withdrawal by Subject|0|||
145456372|NCT00778258|524520993|FG005|Overall Study|Withdrawal by Subject|6|||
145456373|NCT00778258|524520994|FG006|Overall Study|Withdrawal by Subject|12|||
145456374|NCT00778258|524520995|FG007|Overall Study|Withdrawal by Subject|12|||
145456375|NCT00778258|524520996|FG008|Overall Study|Withdrawal by Subject|4|||
145456376|NCT00778258|524520988|FG000|Overall Study|New Contraindication|0|||
145456377|NCT00778258|524520989|FG001|Overall Study|New Contraindication|0|||
145456378|NCT00778258|524520990|FG002|Overall Study|New Contraindication|0|||
145456379|NCT00778258|524520991|FG003|Overall Study|New Contraindication|0|||
145587810|NCT02310750|525004343|FG011|HP Period 1|Lost to Follow-up|0|||
145456380|NCT00778258|524520992|FG004|Overall Study|New Contraindication|0|||
145456381|NCT00778258|524520993|FG005|Overall Study|New Contraindication|0|||
145456382|NCT00778258|524520994|FG006|Overall Study|New Contraindication|0|||
145456383|NCT00778258|524520995|FG007|Overall Study|New Contraindication|1|||
145456384|NCT00778258|524520996|FG008|Overall Study|New Contraindication|0|||
145456385|NCT00778258|524520988|FG000|Overall Study|Non-compliance|0|||
145456386|NCT00778258|524520989|FG001|Overall Study|Non-compliance|0|||
145456387|NCT00778258|524520990|FG002|Overall Study|Non-compliance|0|||
145456388|NCT00778258|524520991|FG003|Overall Study|Non-compliance|1|||
145456389|NCT00778258|524520992|FG004|Overall Study|Non-compliance|0|||
145456390|NCT00778258|524520993|FG005|Overall Study|Non-compliance|0|||
145456391|NCT00778258|524520994|FG006|Overall Study|Non-compliance|0|||
145456392|NCT00778258|524520995|FG007|Overall Study|Non-compliance|0|||
145456393|NCT00778258|524520996|FG008|Overall Study|Non-compliance|0|||
145456394|NCT00778258|524520988|FG000|Overall Study|Other|0|||
145456395|NCT00778258|524520989|FG001|Overall Study|Other|0|||
145456396|NCT00778258|524520990|FG002|Overall Study|Other|0|||
145456397|NCT00778258|524520991|FG003|Overall Study|Other|0|||
145456398|NCT00778258|524520992|FG004|Overall Study|Other|0|||
145456399|NCT00778258|524520993|FG005|Overall Study|Other|0|||
145456400|NCT00778258|524520994|FG006|Overall Study|Other|1|||
145456401|NCT00778258|524520995|FG007|Overall Study|Other|0|||
145456402|NCT00778258|524520996|FG008|Overall Study|Other|0|||
145456403|NCT02438683|524520997|FG000|Overall Study|Adverse Event|1|||
145456404|NCT02438683|524520998|FG001|Overall Study|Adverse Event|0|||
145456405|NCT02438683|524520999|FG002|Overall Study|Adverse Event|0|||
145456406|NCT02438683|524521000|FG003|Overall Study|Adverse Event|0|||
145456407|NCT02438683|524521001|FG004|Overall Study|Adverse Event|0|||
145456408|NCT02438683|524521002|FG005|Overall Study|Adverse Event|0|||
145456409|NCT00082368|524521007|FG000|Overall Study|Not treated-pt had poor IV access|1|||
145456410|NCT01846299|524521008|FG000|Overall Study|Physician Decision|4|||
145456411|NCT01846299|524521009|FG001|Overall Study|Physician Decision|2|||
145456412|NCT01846299|524521008|FG000|Overall Study|Protocol deviation|1|||
145456413|NCT01846299|524521009|FG001|Overall Study|Protocol deviation|0|||
145456414|NCT01846299|524521008|FG000|Overall Study|Death|1|||
145456415|NCT01846299|524521009|FG001|Overall Study|Death|2|||
145456416|NCT01846299|524521008|FG000|Overall Study|Lost to Follow-up|3|||
145456417|NCT01846299|524521009|FG001|Overall Study|Lost to Follow-up|0|||
145456418|NCT01846299|524521008|FG000|Overall Study|Withdrawal by Subject|1|||
145456419|NCT01846299|524521009|FG001|Overall Study|Withdrawal by Subject|6|||
145456420|NCT01846299|524521008|FG000|Overall Study|Adverse Event|2|||
145456421|NCT01846299|524521009|FG001|Overall Study|Adverse Event|0|||
145456422|NCT03559517|524521010|FG000|Overall Study|Withdrawal by Subject|1|||
145456423|NCT03559517|524521011|FG001|Overall Study|Withdrawal by Subject|0|||
145456424|NCT03559517|524521012|FG002|Overall Study|Withdrawal by Subject|0|||
145456425|NCT01330628|524521013|FG000|Overall Study|Death|2|||
145456426|NCT01330628|524521014|FG001|Overall Study|Death|3|||
145456427|NCT01330628|524521013|FG000|Overall Study|Lost to Follow-up|5|||
145456428|NCT01330628|524521014|FG001|Overall Study|Lost to Follow-up|6|||
145456429|NCT01330628|524521013|FG000|Overall Study|Adverse Event|44|||
145456430|NCT01330628|524521014|FG001|Overall Study|Adverse Event|25|||
145456431|NCT01330628|524521013|FG000|Overall Study|Withdrawn|18|||
145456432|NCT01330628|524521014|FG001|Overall Study|Withdrawn|6|||
145456433|NCT01330628|524521013|FG000|Overall Study|Didn't receive study treatment|1|||
145456434|NCT01330628|524521014|FG001|Overall Study|Didn't receive study treatment|0|||
145456435|NCT01740089|524523121|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
145456436|NCT01740089|524523122|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
145456437|NCT01740089|524523123|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
145456438|NCT01740089|524523121|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
145456439|NCT01740089|524523122|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
145456440|NCT01740089|524523123|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
145456441|NCT01740089|524523121|FG000|After 12 Weeks|Lack of Efficacy|3|||
145456442|NCT01740089|524523122|FG001|After 12 Weeks|Lack of Efficacy|1|||
145456443|NCT01740089|524523123|FG002|After 12 Weeks|Lack of Efficacy|4|||
145456444|NCT01740089|524523121|FG000|After 12 Weeks|Adverse Event|2|||
145456445|NCT01740089|524523122|FG001|After 12 Weeks|Adverse Event|0|||
145456446|NCT01740089|524523123|FG002|After 12 Weeks|Adverse Event|5|||
145456447|NCT01740089|524523121|FG000|After 12 Weeks|Protocol Violation|1|||
145456448|NCT01740089|524523122|FG001|After 12 Weeks|Protocol Violation|1|||
145456449|NCT01740089|524523123|FG002|After 12 Weeks|Protocol Violation|1|||
145456450|NCT01740089|524523121|FG000|After 12 Weeks|Withdrawal by Subject|1|||
145456451|NCT01740089|524523122|FG001|After 12 Weeks|Withdrawal by Subject|1|||
145456452|NCT01740089|524523123|FG002|After 12 Weeks|Withdrawal by Subject|1|||
145456453|NCT01448824|524523126|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456454|NCT01448824|524523127|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456455|NCT01448824|524523128|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456456|NCT01448824|524523129|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456457|NCT01448824|524523130|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145626374|NCT00062868|525144255|FG015|Dose Level 3|Withdrew|0|||
145456458|NCT01448824|524523131|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456459|NCT01448824|524523132|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
145456460|NCT01448824|524523133|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
145456461|NCT01448824|524523126|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
145456462|NCT01448824|524523127|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
145456463|NCT01448824|524523128|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
145456464|NCT01448824|524523129|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
145456465|NCT01448824|524523130|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
145456466|NCT01448824|524523131|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
145456467|NCT01448824|524523132|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
145456468|NCT01448824|524523133|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
145456469|NCT01448824|524523126|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456470|NCT01448824|524523127|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456471|NCT01448824|524523128|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456472|NCT01448824|524523129|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456473|NCT01448824|524523130|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456474|NCT01448824|524523131|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
145456475|NCT01448824|524523132|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456476|NCT01448824|524523133|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
145456477|NCT01448824|524523126|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
145456478|NCT01448824|524523127|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
145456479|NCT01448824|524523128|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
145456480|NCT01448824|524523129|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
145456481|NCT01448824|524523130|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
145456482|NCT01448824|524523131|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
145456483|NCT01448824|524523132|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
145456484|NCT01448824|524523133|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
145456485|NCT01448824|524523126|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456486|NCT01448824|524523127|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456487|NCT01448824|524523128|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456488|NCT01448824|524523129|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456489|NCT01448824|524523130|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456490|NCT01448824|524523131|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456491|NCT01448824|524523132|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
145456492|NCT01448824|524523133|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
145456493|NCT01448824|524523126|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456494|NCT01448824|524523127|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456495|NCT01448824|524523128|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456496|NCT01448824|524523129|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456497|NCT01448824|524523130|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456498|NCT01448824|524523131|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456499|NCT01448824|524523132|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
145456500|NCT01448824|524523133|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
145456501|NCT01448824|524523126|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456502|NCT01448824|524523127|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456503|NCT01448824|524523128|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456504|NCT01448824|524523129|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456505|NCT01448824|524523130|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456506|NCT01448824|524523131|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456507|NCT01448824|524523132|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
145456508|NCT01448824|524523133|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
145456509|NCT01448824|524523126|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456510|NCT01448824|524523127|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145587811|NCT02310750|525004344|FG012|HP Period 1|Lost to Follow-up|0|||
145587812|NCT02310750|525004345|FG013|HP Period 1|Lost to Follow-up|0|||
145587813|NCT02310750|525004346|FG014|HP Period 1|Lost to Follow-up|0|||
145587814|NCT02310750|525004347|FG015|HP Period 1|Lost to Follow-up|0|||
145587815|NCT02310750|525004332|FG000|HP Period 1|Withdrawal by Subject|1|||
145587816|NCT02310750|525004333|FG001|HP Period 1|Withdrawal by Subject|0|||
145587817|NCT02310750|525004334|FG002|HP Period 1|Withdrawal by Subject|0|||
145587818|NCT02310750|525004335|FG003|HP Period 1|Withdrawal by Subject|1|||
145587819|NCT02310750|525004336|FG004|HP Period 1|Withdrawal by Subject|0|||
145587820|NCT02310750|525004337|FG005|HP Period 1|Withdrawal by Subject|0|||
145587821|NCT02310750|525004338|FG006|HP Period 1|Withdrawal by Subject|0|||
145587822|NCT02310750|525004339|FG007|HP Period 1|Withdrawal by Subject|0|||
145587823|NCT02310750|525004340|FG008|HP Period 1|Withdrawal by Subject|0|||
145587824|NCT02310750|525004341|FG009|HP Period 1|Withdrawal by Subject|0|||
145587825|NCT02310750|525004342|FG010|HP Period 1|Withdrawal by Subject|0|||
145626375|NCT00062868|525144256|FG016|Dose Level 3|Withdrew|0|||
145626376|NCT00062868|525144257|FG017|Dose Level 3|Withdrew|0|||
145626377|NCT00062868|525144258|FG018|Dose Level 3|Withdrew|0|||
145626378|NCT00062868|525144259|FG019|Dose Level 3|Withdrew|0|||
145626379|NCT00062868|525144260|FG020|Dose Level 3|Withdrew|0|||
145626380|NCT00670540|525144263|FG000|Overall Study|ineligible|17|||
145626381|NCT00670540|525144263|FG000|Overall Study|not living in France|348|||
145626382|NCT00670540|525144263|FG000|Overall Study|refused to participate|189|||
145626383|NCT00670540|525144263|FG000|Overall Study|controls randomised for no follow up|2770|||
145626384|NCT00670540|525144263|FG000|Overall Study|missing information inclusion criteria|1|||
145626385|NCT01866917|525144264|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
145626386|NCT01866917|525144265|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
145626387|NCT01140347|525144272|FG000|Overall Study|Lost to Follow-up|5|||
145626388|NCT01140347|525144273|FG001|Overall Study|Lost to Follow-up|6|||
145626389|NCT01140347|525144272|FG000|Overall Study|Withdrawal by Subject|13|||
145626390|NCT01140347|525144273|FG001|Overall Study|Withdrawal by Subject|8|||
145587826|NCT02310750|525004343|FG011|HP Period 1|Withdrawal by Subject|0|||
145587827|NCT02310750|525004344|FG012|HP Period 1|Withdrawal by Subject|0|||
145587828|NCT02310750|525004345|FG013|HP Period 1|Withdrawal by Subject|0|||
145587829|NCT02310750|525004346|FG014|HP Period 1|Withdrawal by Subject|0|||
145587830|NCT02310750|525004347|FG015|HP Period 1|Withdrawal by Subject|0|||
145587831|NCT02310750|525004332|FG000|HP Washout 1|Lost to Follow-up|0|||
145587832|NCT02310750|525004333|FG001|HP Washout 1|Lost to Follow-up|0|||
145587833|NCT02310750|525004334|FG002|HP Washout 1|Lost to Follow-up|1|||
145587834|NCT02310750|525004335|FG003|HP Washout 1|Lost to Follow-up|1|||
145587835|NCT02310750|525004336|FG004|HP Washout 1|Lost to Follow-up|2|||
145587836|NCT02310750|525004337|FG005|HP Washout 1|Lost to Follow-up|2|||
145587837|NCT02310750|525004338|FG006|HP Washout 1|Lost to Follow-up|3|||
145587838|NCT02310750|525004339|FG007|HP Washout 1|Lost to Follow-up|0|||
145587839|NCT02310750|525004340|FG008|HP Washout 1|Lost to Follow-up|0|||
145587840|NCT02310750|525004341|FG009|HP Washout 1|Lost to Follow-up|0|||
145587841|NCT02310750|525004342|FG010|HP Washout 1|Lost to Follow-up|0|||
145587842|NCT02310750|525004343|FG011|HP Washout 1|Lost to Follow-up|0|||
145587843|NCT02310750|525004344|FG012|HP Washout 1|Lost to Follow-up|0|||
145587844|NCT02310750|525004345|FG013|HP Washout 1|Lost to Follow-up|0|||
145587845|NCT02310750|525004346|FG014|HP Washout 1|Lost to Follow-up|0|||
145587846|NCT02310750|525004347|FG015|HP Washout 1|Lost to Follow-up|0|||
145587847|NCT02310750|525004332|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587848|NCT02310750|525004333|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587849|NCT02310750|525004334|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587850|NCT02310750|525004335|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
145587851|NCT02310750|525004336|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587852|NCT02310750|525004337|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
145587853|NCT02310750|525004338|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587854|NCT02310750|525004339|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587855|NCT02310750|525004340|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
145587856|NCT02310750|525004341|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
145587857|NCT02310750|525004342|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587858|NCT02310750|525004343|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587859|NCT02310750|525004344|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587860|NCT02310750|525004345|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587861|NCT02310750|525004346|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587862|NCT02310750|525004347|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
145587863|NCT02310750|525004332|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587864|NCT02310750|525004333|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587865|NCT02310750|525004334|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587866|NCT02310750|525004335|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145626391|NCT00901485|525144274|FG000|Overall Study|Lack of Efficacy|0|||
145587867|NCT02310750|525004336|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587868|NCT02310750|525004337|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587869|NCT02310750|525004338|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587870|NCT02310750|525004339|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587871|NCT02310750|525004340|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587872|NCT02310750|525004341|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
145587873|NCT02310750|525004342|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587874|NCT02310750|525004343|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587875|NCT02310750|525004344|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587876|NCT02310750|525004345|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587877|NCT02310750|525004346|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145587878|NCT02310750|525004347|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
145626392|NCT00901485|525144275|FG001|Overall Study|Lack of Efficacy|2|||
145626393|NCT00901485|525144274|FG000|Overall Study|Withdrawal by Subject|1|||
145626394|NCT00901485|525144275|FG001|Overall Study|Withdrawal by Subject|2|||
145626395|NCT01959880|525144276|FG000|Overall Study|Withdrawal by Subject|11|||
145587879|NCT02310750|525004332|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587880|NCT02310750|525004333|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587881|NCT02310750|525004334|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587882|NCT02310750|525004335|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587883|NCT02310750|525004336|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587884|NCT02310750|525004337|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587885|NCT02310750|525004338|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587886|NCT02310750|525004339|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
145587887|NCT02310750|525004340|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
145587888|NCT02310750|525004341|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
145587889|NCT02310750|525004342|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587890|NCT02310750|525004343|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587891|NCT02310750|525004344|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587892|NCT02310750|525004345|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587893|NCT02310750|525004346|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587894|NCT02310750|525004347|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
145587895|NCT02310750|525004332|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587896|NCT02310750|525004333|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587897|NCT02310750|525004334|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587898|NCT02310750|525004335|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587899|NCT02310750|525004336|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587900|NCT02310750|525004337|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587901|NCT02310750|525004338|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587902|NCT02310750|525004339|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
145587903|NCT02310750|525004340|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
145587904|NCT02310750|525004341|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587905|NCT02310750|525004342|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587906|NCT02310750|525004343|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587907|NCT02310750|525004344|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587908|NCT02310750|525004345|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587909|NCT02310750|525004346|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587910|NCT02310750|525004347|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
145587911|NCT02310750|525004332|FG000|HP Washout 2|Lost to Follow-up|0|||
145587912|NCT02310750|525004333|FG001|HP Washout 2|Lost to Follow-up|0|||
145587913|NCT02310750|525004334|FG002|HP Washout 2|Lost to Follow-up|0|||
145587914|NCT02310750|525004335|FG003|HP Washout 2|Lost to Follow-up|0|||
145587915|NCT02310750|525004336|FG004|HP Washout 2|Lost to Follow-up|1|||
145587916|NCT02310750|525004337|FG005|HP Washout 2|Lost to Follow-up|0|||
145587917|NCT02310750|525004338|FG006|HP Washout 2|Lost to Follow-up|7|||
145587918|NCT02310750|525004339|FG007|HP Washout 2|Lost to Follow-up|0|||
145587919|NCT02310750|525004340|FG008|HP Washout 2|Lost to Follow-up|0|||
145587920|NCT02310750|525004341|FG009|HP Washout 2|Lost to Follow-up|0|||
145587921|NCT02310750|525004342|FG010|HP Washout 2|Lost to Follow-up|0|||
145587922|NCT02310750|525004343|FG011|HP Washout 2|Lost to Follow-up|0|||
145587923|NCT02310750|525004344|FG012|HP Washout 2|Lost to Follow-up|0|||
145587924|NCT02310750|525004345|FG013|HP Washout 2|Lost to Follow-up|0|||
145587925|NCT02310750|525004346|FG014|HP Washout 2|Lost to Follow-up|0|||
145587926|NCT02310750|525004347|FG015|HP Washout 2|Lost to Follow-up|0|||
145587927|NCT02952924|525004348|FG000|Overall Study|Protocol Violation|0|||
145587928|NCT02952924|525004349|FG001|Overall Study|Protocol Violation|0|||
145587929|NCT02952924|525004350|FG002|Overall Study|Protocol Violation|0|||
145587930|NCT02952924|525004351|FG003|Overall Study|Protocol Violation|0|||
145587931|NCT02952924|525004352|FG004|Overall Study|Protocol Violation|0|||
145587932|NCT02952924|525004353|FG005|Overall Study|Protocol Violation|0|||
145587933|NCT02952924|525004354|FG006|Overall Study|Protocol Violation|0|||
145587934|NCT02952924|525004355|FG007|Overall Study|Protocol Violation|0|||
145587935|NCT02952924|525004356|FG008|Overall Study|Protocol Violation|0|||
145587936|NCT02952924|525004357|FG009|Overall Study|Protocol Violation|0|||
145587937|NCT02952924|525004358|FG010|Overall Study|Protocol Violation|0|||
145587938|NCT02952924|525004359|FG011|Overall Study|Protocol Violation|0|||
145587939|NCT02952924|525004360|FG012|Overall Study|Protocol Violation|0|||
145587940|NCT02952924|525004361|FG013|Overall Study|Protocol Violation|0|||
145587941|NCT02952924|525004362|FG014|Overall Study|Protocol Violation|0|||
145587942|NCT02952924|525004363|FG015|Overall Study|Protocol Violation|0|||
145587943|NCT02952924|525004364|FG016|Overall Study|Protocol Violation|0|||
145626396|NCT01959880|525144277|FG001|Overall Study|Withdrawal by Subject|13|||
145587944|NCT02952924|525004365|FG017|Overall Study|Protocol Violation|0|||
145587945|NCT02952924|525004366|FG018|Overall Study|Protocol Violation|0|||
145587946|NCT02952924|525004367|FG019|Overall Study|Protocol Violation|1|||
145587947|NCT02952924|525004368|FG020|Overall Study|Protocol Violation|0|||
145587948|NCT02952924|525004369|FG021|Overall Study|Protocol Violation|0|||
145626397|NCT01959880|525144278|FG002|Overall Study|Withdrawal by Subject|8|||
145587949|NCT02952924|525004348|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
145626398|NCT01959880|525144279|FG003|Overall Study|Withdrawal by Subject|7|||
145626399|NCT01959880|525144276|FG000|Overall Study|Death|1|||
145626400|NCT01959880|525144277|FG001|Overall Study|Death|10|||
145626401|NCT01959880|525144278|FG002|Overall Study|Death|1|||
145626402|NCT01959880|525144279|FG003|Overall Study|Death|2|||
145626403|NCT01959880|525144276|FG000|Overall Study|Lost to Follow-up|95|||
145626404|NCT01959880|525144277|FG001|Overall Study|Lost to Follow-up|18|||
145626405|NCT01959880|525144278|FG002|Overall Study|Lost to Follow-up|15|||
145626406|NCT01959880|525144279|FG003|Overall Study|Lost to Follow-up|8|||
145626407|NCT01959880|525144276|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
145626408|NCT01959880|525144277|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
145626409|NCT01959880|525144278|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
145626410|NCT01959880|525144279|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
145626411|NCT01959880|525144276|FG000|Overall Study|Study completed early-FDA approved|1003|||
145626412|NCT01959880|525144277|FG001|Overall Study|Study completed early-FDA approved|311|||
145626413|NCT01959880|525144278|FG002|Overall Study|Study completed early-FDA approved|179|||
145626414|NCT01959880|525144279|FG003|Overall Study|Study completed early-FDA approved|152|||
145626415|NCT01919619|525144280|FG000|Overall Study|Physician Decision|1|||
145626416|NCT01919619|525144281|FG001|Overall Study|Physician Decision|1|||
145626417|NCT00359619|525145662|FG000|Overall Study|Adverse Event|0|||
145626418|NCT00359619|525145663|FG001|Overall Study|Adverse Event|0|||
145626419|NCT00359619|525145664|FG002|Overall Study|Adverse Event|1|||
145626420|NCT00359619|525145665|FG003|Overall Study|Adverse Event|0|||
145626421|NCT00359619|525145666|FG004|Overall Study|Adverse Event|0|||
145626422|NCT00359619|525145667|FG005|Overall Study|Adverse Event|0|||
145626423|NCT00359619|525145668|FG006|Overall Study|Adverse Event|1|||
145626424|NCT00359619|525145662|FG000|Overall Study|Withdrawal by Subject|3|||
145626425|NCT00359619|525145663|FG001|Overall Study|Withdrawal by Subject|1|||
145626426|NCT00359619|525145664|FG002|Overall Study|Withdrawal by Subject|4|||
145626427|NCT00359619|525145665|FG003|Overall Study|Withdrawal by Subject|2|||
145626428|NCT00359619|525145666|FG004|Overall Study|Withdrawal by Subject|2|||
145626429|NCT00359619|525145667|FG005|Overall Study|Withdrawal by Subject|0|||
145626430|NCT00359619|525145668|FG006|Overall Study|Withdrawal by Subject|3|||
145626431|NCT00359619|525145662|FG000|Overall Study|Other|1|||
145626432|NCT00359619|525145663|FG001|Overall Study|Other|0|||
145626433|NCT00359619|525145664|FG002|Overall Study|Other|0|||
145626434|NCT00359619|525145665|FG003|Overall Study|Other|0|||
145626435|NCT00359619|525145666|FG004|Overall Study|Other|0|||
145626436|NCT00359619|525145667|FG005|Overall Study|Other|0|||
145626437|NCT00359619|525145668|FG006|Overall Study|Other|0|||
145626438|NCT00359619|525145662|FG000|Overall Study|Lost to Follow-up|4|||
145626439|NCT00359619|525145663|FG001|Overall Study|Lost to Follow-up|4|||
145626440|NCT00359619|525145664|FG002|Overall Study|Lost to Follow-up|2|||
145626441|NCT00359619|525145665|FG003|Overall Study|Lost to Follow-up|1|||
145456511|NCT01448824|524523128|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456512|NCT01448824|524523129|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456513|NCT01448824|524523130|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456514|NCT01448824|524523131|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456515|NCT01448824|524523132|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
145456516|NCT01448824|524523133|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
145456517|NCT03285958|524523135|FG000|Overall Study|Lost to Follow-up|1|||
145456518|NCT03285958|524523136|FG001|Overall Study|Lost to Follow-up|1|||
145456519|NCT03285958|524523135|FG000|Overall Study|Withdrawal by Subject|1|||
145456520|NCT03285958|524523136|FG001|Overall Study|Withdrawal by Subject|0|||
145456521|NCT03285958|524523135|FG000|Overall Study|Not able to attend required orientation|3|||
145456522|NCT03285958|524523136|FG001|Overall Study|Not able to attend required orientation|0|||
145456523|NCT03116828|524523137|FG000|Overall Study|Adverse Event|1|||
145456524|NCT03116828|524523138|FG001|Overall Study|Adverse Event|10|||
145456525|NCT03116828|524523137|FG000|Overall Study|Withdrawal by Subject|4|||
145456526|NCT03116828|524523138|FG001|Overall Study|Withdrawal by Subject|8|||
145456527|NCT03116828|524523137|FG000|Overall Study|OTHER|3|||
145456528|NCT03116828|524523138|FG001|Overall Study|OTHER|3|||
145456529|NCT03002818|524523139|FG000|Overall Study|Decision of the investigator|1|||
145456530|NCT01606787|524523141|FG000|Overall Study|Withdrawal by Subject|4|||
145456531|NCT01606787|524523142|FG001|Overall Study|Withdrawal by Subject|5|||
145456532|NCT01606787|524523141|FG000|Overall Study|Surgery canceled|0|||
145456533|NCT01606787|524523142|FG001|Overall Study|Surgery canceled|2|||
145456534|NCT05312632|524523146|FG000|Overall Study|Adverse Event|12|||
145626442|NCT00359619|525145666|FG004|Overall Study|Lost to Follow-up|1|||
145626443|NCT00359619|525145667|FG005|Overall Study|Lost to Follow-up|5|||
145626444|NCT00359619|525145668|FG006|Overall Study|Lost to Follow-up|0|||
145626445|NCT01419717|525145669|FG000|Overall Study|Protocol-specified Criteria|62|||
145626446|NCT01419717|525145669|FG000|Overall Study|Adverse Event|19|||
145626447|NCT01419717|525145669|FG000|Overall Study|Death|17|||
145626448|NCT01419717|525145669|FG000|Overall Study|Withdrawal by Subject|10|||
145626449|NCT01419717|525145669|FG000|Overall Study|Disease Progression|9|||
145626450|NCT01419717|525145669|FG000|Overall Study|Other|4|||
145456535|NCT05312632|524523146|FG000|Overall Study|Withdrawal by Subject|10|||
145456536|NCT05312632|524523146|FG000|Overall Study|Lack of Efficacy|4|||
145456537|NCT05312632|524523146|FG000|Overall Study|Non-compliance with study procedures|9|||
145456538|NCT05312632|524523146|FG000|Overall Study|Other|4|||
145456539|NCT01681069|524523147|FG000|Overall Study|Withdrawal by Subject|4|||
145456540|NCT01681069|524523148|FG001|Overall Study|Withdrawal by Subject|5|||
145456541|NCT01681069|524523147|FG000|Overall Study|Protocol Violation|1|||
145456542|NCT01681069|524523148|FG001|Overall Study|Protocol Violation|1|||
145456543|NCT01681069|524523147|FG000|Overall Study|Adverse Event|0|||
145456544|NCT01681069|524523148|FG001|Overall Study|Adverse Event|1|||
145456545|NCT03883165|524523149|FG000|Overall Study|Withdrawal by Subject|4|||
145456546|NCT03883165|524523150|FG001|Overall Study|Withdrawal by Subject|3|||
145456547|NCT00245050|524523151|FG000|Overall Study|Adverse Event|3|||
145456548|NCT00245050|524523152|FG001|Overall Study|Adverse Event|2|||
145456549|NCT02301546|524523153|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
145456550|NCT02301546|524523154|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
145456551|NCT02301546|524523153|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
145456552|NCT02301546|524523154|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
145456553|NCT02301546|524523153|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
145456554|NCT02301546|524523154|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
145456555|NCT02301546|524523153|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
145456556|NCT02301546|524523154|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
145456557|NCT02301546|524523153|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
145456558|NCT02301546|524523154|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
145456559|NCT02301546|524523153|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
145456560|NCT02301546|524523154|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
145456561|NCT02301546|524523153|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
145456562|NCT02301546|524523154|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
145456563|NCT05526781|524523155|FG000|Overall Study|Lost to Follow-up|1|||
145456564|NCT01801436|524523156|FG000|Overall Study|Withdrawal by Subject|3|||
145456565|NCT01801436|524523156|FG000|Overall Study|Adverse Event|2|||
145626451|NCT01419717|525145669|FG000|Overall Study|Lost to Follow-up|2|||
145626452|NCT01419717|525145669|FG000|Overall Study|Administrative Decision|1|||
145626453|NCT01419717|525145669|FG000|Overall Study|Noncompliance|1|||
145626454|NCT02857283|525145670|FG000|First Exposure|Withdrawal by Subject|1|||
145626455|NCT02857283|525145671|FG001|First Exposure|Withdrawal by Subject|0|||
145626456|NCT00093795|525145672|FG000|Overall Study|No follow up data|20|||
145626457|NCT00093795|525145673|FG001|Overall Study|No follow up data|16|||
145626458|NCT00093795|525145674|FG002|Overall Study|No follow up data|17|||
145626459|NCT00613301|525145675|FG000|Overall Study|Adverse Event|49|||
145626460|NCT00613301|525145675|FG000|Overall Study|Lost to Follow-up|88|||
145626461|NCT00613301|525145675|FG000|Overall Study|Withdrawal by Subject|5|||
145626462|NCT00613301|525145675|FG000|Overall Study|Death|6|||
145626463|NCT00613301|525145675|FG000|Overall Study|Lack of Efficacy|13|||
145626464|NCT00613301|525145675|FG000|Overall Study|Physician Decision|2|||
145626465|NCT00613301|525145675|FG000|Overall Study|No data was collected|53|||
145626466|NCT00613301|525145675|FG000|Overall Study|Irregularly enrolled patients|12|||
145626467|NCT00587288|525145678|FG000|Overall Study|Adverse Event|0|||
145626468|NCT00587288|525145679|FG001|Overall Study|Adverse Event|1|||
145626469|NCT00587288|525145678|FG000|Overall Study|Lack of Efficacy|2|||
145626470|NCT00587288|525145679|FG001|Overall Study|Lack of Efficacy|8|||
145626471|NCT00587288|525145678|FG000|Overall Study|Protocol Violation|1|||
145626472|NCT00587288|525145679|FG001|Overall Study|Protocol Violation|0|||
145626473|NCT02790606|525145687|FG000|Overall Study|Death|27|||
145626474|NCT02790606|525145687|FG000|Overall Study|Lost to Follow-up|4|||
145626475|NCT02790606|525145687|FG000|Overall Study|Physician Decision|3|||
145626476|NCT02790606|525145687|FG000|Overall Study|Withdrawal by Subject|1|||
145626477|NCT02735915|525145688|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
145626478|NCT02735915|525145688|FG000|Overall Study|Withdrawal following SAE|2|||
145626479|NCT02735915|525145688|FG000|Overall Study|Withdrawal by Subject|1|||
145626480|NCT05328973|525145689|FG000|Overall Study|Withdrawal by Subject|0|||
145626481|NCT05328973|525145690|FG001|Overall Study|Withdrawal by Subject|1|||
145626482|NCT00409708|525145695|FG000|Treatment|Abnormal test procedure result(s)|1|||
145626483|NCT00409708|525145696|FG001|Treatment|Abnormal test procedure result(s)|0|||
145626484|NCT00409708|525145695|FG000|Treatment|Lack of Efficacy|0|||
145626485|NCT00409708|525145696|FG001|Treatment|Lack of Efficacy|1|||
145626486|NCT00409708|525145695|FG000|Treatment|Protocol Violation|6|||
145626487|NCT00409708|525145696|FG001|Treatment|Protocol Violation|2|||
145626488|NCT00409708|525145695|FG000|Treatment|Withdrawal by Subject|3|||
145456566|NCT01801436|524523156|FG000|Overall Study|Progressive disease|4|||
145456567|NCT02743949|524523159|FG000|Overall Study|Adverse Event|0|||
145456568|NCT02743949|524523160|FG001|Overall Study|Adverse Event|0|||
145626489|NCT00409708|525145696|FG001|Treatment|Withdrawal by Subject|8|||
145456569|NCT02743949|524523161|FG002|Overall Study|Adverse Event|2|||
145626490|NCT00409708|525145695|FG000|Treatment|Lost to Follow-up|0|||
145626491|NCT00409708|525145696|FG001|Treatment|Lost to Follow-up|6|||
145626492|NCT00409708|525145695|FG000|Treatment|Administrative problems|5|||
145456570|NCT02743949|524523159|FG000|Overall Study|Significant Protocol Deviation|2|||
145456571|NCT02743949|524523160|FG001|Overall Study|Significant Protocol Deviation|0|||
145456572|NCT02743949|524523161|FG002|Overall Study|Significant Protocol Deviation|1|||
145456573|NCT02743949|524523159|FG000|Overall Study|Voluntary Withdrawal|2|||
145456574|NCT02743949|524523160|FG001|Overall Study|Voluntary Withdrawal|1|||
145456575|NCT02743949|524523161|FG002|Overall Study|Voluntary Withdrawal|0|||
145456576|NCT00920218|524523162|FG000|Overall Study|Serious Adverse Event|2|||
145456577|NCT00920218|524523163|FG001|Overall Study|Serious Adverse Event|0|||
145456578|NCT00920218|524523164|FG002|Overall Study|Serious Adverse Event|2|||
145456579|NCT00920218|524523165|FG003|Overall Study|Serious Adverse Event|1|||
145456580|NCT00920218|524523162|FG000|Overall Study|Withdrawal by Subject|0|||
145456581|NCT00920218|524523163|FG001|Overall Study|Withdrawal by Subject|3|||
145456582|NCT00920218|524523164|FG002|Overall Study|Withdrawal by Subject|2|||
145456583|NCT00920218|524523165|FG003|Overall Study|Withdrawal by Subject|0|||
145456584|NCT00920218|524523162|FG000|Overall Study|Migrated/moved from study area|0|||
145456585|NCT00920218|524523163|FG001|Overall Study|Migrated/moved from study area|0|||
145456586|NCT00920218|524523164|FG002|Overall Study|Migrated/moved from study area|1|||
145456587|NCT00920218|524523165|FG003|Overall Study|Migrated/moved from study area|0|||
145456588|NCT00920218|524523162|FG000|Overall Study|Lost to Follow-up|0|||
145456589|NCT00920218|524523163|FG001|Overall Study|Lost to Follow-up|1|||
145456590|NCT00920218|524523164|FG002|Overall Study|Lost to Follow-up|0|||
145456591|NCT00920218|524523165|FG003|Overall Study|Lost to Follow-up|3|||
145456592|NCT00920218|524523162|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
145456593|NCT00920218|524523163|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
145456594|NCT00920218|524523164|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
145456595|NCT00920218|524523165|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
145456596|NCT00920218|524523162|FG000|Overall Study|Other|0|||
145456597|NCT00920218|524523163|FG001|Overall Study|Other|0|||
145456598|NCT00920218|524523164|FG002|Overall Study|Other|1|||
145456599|NCT00920218|524523165|FG003|Overall Study|Other|0|||
145456600|NCT01972308|524523172|FG000|Overall Study|Withdrawal by Subject|0|||
145456601|NCT01972308|524523173|FG001|Overall Study|Withdrawal by Subject|1|||
145456602|NCT01972308|524523172|FG000|Overall Study|Lost to Follow-up|4|||
145456603|NCT01972308|524523173|FG001|Overall Study|Lost to Follow-up|6|||
145456604|NCT01972308|524523172|FG000|Overall Study|Death|4|||
145456605|NCT01972308|524523173|FG001|Overall Study|Death|1|||
145456606|NCT00847665|524523179|FG000|Overall Study|Withdrawal by Subject|1|||
145456607|NCT00847665|524523180|FG001|Overall Study|Withdrawal by Subject|0|||
145456608|NCT01562314|524523187|FG000|Overall Study|Adverse Event|10|||
145456609|NCT01562314|524523188|FG001|Overall Study|Adverse Event|5|||
145456610|NCT01562314|524523187|FG000|Overall Study|Met Withdrawal Criteria|3|||
145456611|NCT01562314|524523188|FG001|Overall Study|Met Withdrawal Criteria|2|||
145456612|NCT01562314|524523187|FG000|Overall Study|Withdrawal by Subject|0|||
145456613|NCT01562314|524523188|FG001|Overall Study|Withdrawal by Subject|1|||
145456614|NCT00585546|524523189|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
145456615|NCT00585546|524523189|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
145456616|NCT02851797|524523190|FG000|Overall Study|Withdrawal by Subject|4|||
145456617|NCT02851797|524523191|FG001|Overall Study|Withdrawal by Subject|2|||
145456618|NCT02851797|524523190|FG000|Overall Study|Adverse Event|3|||
145456619|NCT02851797|524523191|FG001|Overall Study|Adverse Event|0|||
145456620|NCT00813865|524523192|FG000|Overall Study|Failure to Respond|3|||
145456621|NCT00813865|524523192|FG000|Overall Study|Lost to Follow-up|3|||
145456622|NCT00813865|524523192|FG000|Overall Study|Withdrawal by Subject|1|||
145456623|NCT02256384|524523195|FG000|Overall Study|Withdrawal by Subject|12|||
145626493|NCT00409708|525145696|FG001|Treatment|Administrative problems|0|||
145456624|NCT02256384|524523195|FG000|Overall Study|Equipment not capturing data|2|||
145456625|NCT00624585|524523196|FG000|Overall Study|Death|3|||
145456626|NCT00624585|524523196|FG000|Overall Study|Disease Progression|6|||
145456627|NCT00624585|524523196|FG000|Overall Study|Adverse Event|3|||
145456628|NCT04295681|524523197|FG000|Overall Study|Eligibility error|1|||
145456629|NCT04295681|524523198|FG001|Overall Study|Eligibility error|3|||
145456630|NCT01535599|524523202|FG000|Overall Study|Adverse Event|6|||
145456631|NCT01535599|524523203|FG001|Overall Study|Adverse Event|15|||
145456632|NCT01535599|524523202|FG000|Overall Study|Lost to Follow-up|3|||
145456633|NCT01535599|524523203|FG001|Overall Study|Lost to Follow-up|4|||
145456634|NCT01535599|524523202|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
145456635|NCT01535599|524523203|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
145456636|NCT01535599|524523202|FG000|Overall Study|Treatment Failure|33|||
145456637|NCT01535599|524523203|FG001|Overall Study|Treatment Failure|66|||
145456638|NCT01535599|524523202|FG000|Overall Study|BL Culture + for Group A Strep|0|||
145456639|NCT01535599|524523203|FG001|Overall Study|BL Culture + for Group A Strep|1|||
145456640|NCT01535599|524523202|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
145456641|NCT01535599|524523203|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
145456642|NCT01535599|524523202|FG000|Overall Study|Randomized in Error|2|||
145456643|NCT01535599|524523203|FG001|Overall Study|Randomized in Error|4|||
145456644|NCT01535599|524523202|FG000|Overall Study|Did not use product|1|||
145456645|NCT01535599|524523203|FG001|Overall Study|Did not use product|0|||
145456646|NCT01535599|524523202|FG000|Overall Study|Other|1|||
145456647|NCT01535599|524523203|FG001|Overall Study|Other|0|||
145456648|NCT01535599|524523202|FG000|Overall Study|Stopped medication|0|||
145456649|NCT01535599|524523203|FG001|Overall Study|Stopped medication|1|||
145456650|NCT01535599|524523202|FG000|Overall Study|Noncompliance|0|||
145456651|NCT01535599|524523203|FG001|Overall Study|Noncompliance|1|||
145456652|NCT01425359|524523204|FG000|Overall Study|Randomized but Not Treated|2|||
145456653|NCT01425359|524523205|FG001|Overall Study|Randomized but Not Treated|3|||
145456654|NCT01425359|524523204|FG000|Overall Study|Adverse Event|9|||
145456655|NCT01425359|524523205|FG001|Overall Study|Adverse Event|8|||
145456656|NCT01425359|524523204|FG000|Overall Study|Revascularization|0|||
145456657|NCT01425359|524523205|FG001|Overall Study|Revascularization|1|||
145456658|NCT01425359|524523204|FG000|Overall Study|Death|0|||
145456659|NCT01425359|524523205|FG001|Overall Study|Death|1|||
145456660|NCT01425359|524523204|FG000|Overall Study|Unsatisfactory Response|1|||
145456661|NCT01425359|524523205|FG001|Overall Study|Unsatisfactory Response|0|||
145456662|NCT01425359|524523204|FG000|Overall Study|Protocol Violation|1|||
145456663|NCT01425359|524523205|FG001|Overall Study|Protocol Violation|2|||
145456664|NCT01425359|524523204|FG000|Overall Study|Subject Withdrew Consent|1|||
145456665|NCT01425359|524523205|FG001|Overall Study|Subject Withdrew Consent|2|||
145456666|NCT01425359|524523204|FG000|Overall Study|Investigator's Discretion|2|||
145456667|NCT01425359|524523205|FG001|Overall Study|Investigator's Discretion|0|||
145456668|NCT01425359|524523204|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
145456669|NCT01425359|524523205|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
145456670|NCT03172325|524523206|FG000|Overall Study|Adverse Event|2|||
145456671|NCT03172325|524523207|FG001|Overall Study|Adverse Event|3|||
145456672|NCT03172325|524523206|FG000|Overall Study|Positive PPD|1|||
145456673|NCT03172325|524523207|FG001|Overall Study|Positive PPD|0|||
145456674|NCT03172325|524523206|FG000|Overall Study|Poor Compliance|1|||
145456675|NCT03172325|524523207|FG001|Overall Study|Poor Compliance|1|||
145456676|NCT01694121|524523214|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
145456677|NCT01694121|524523215|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
145456678|NCT00744978|524523218|FG000|Period 1|Lost to Follow-up|1|||
145456679|NCT00744978|524523219|FG001|Period 1|Lost to Follow-up|0|||
145456680|NCT00744978|524523218|FG000|Period 1|Withdrawal by Subject|0|||
145456681|NCT00744978|524523219|FG001|Period 1|Withdrawal by Subject|2|||
145456682|NCT00744978|524523218|FG000|Period 1|Other|0|||
145456683|NCT00744978|524523219|FG001|Period 1|Other|2|||
145456684|NCT00744978|524523218|FG000|Period 1|Adverse Event|4|||
145456685|NCT00744978|524523219|FG001|Period 1|Adverse Event|0|||
145456686|NCT00744978|524523218|FG000|Period 1|Randomized but not Treated|1|||
145456687|NCT00744978|524523219|FG001|Period 1|Randomized but not Treated|1|||
145456688|NCT00744978|524523218|FG000|Period 2|Adverse Event|0|||
145456689|NCT00744978|524523219|FG001|Period 2|Adverse Event|1|||
145456690|NCT02928029|524523220|FG000|Overall Study|Withdrawal by Subject|0|||
145456691|NCT02928029|524523221|FG001|Overall Study|Withdrawal by Subject|1|||
145456692|NCT02928029|524523220|FG000|Overall Study|Radiological progression|1|||
145456693|NCT02928029|524523221|FG001|Overall Study|Radiological progression|0|||
145456694|NCT02928029|524523220|FG000|Overall Study|Clinical progression|1|||
145456695|NCT02928029|524523221|FG001|Overall Study|Clinical progression|2|||
145456696|NCT02928029|524523220|FG000|Overall Study|AE not related to clinical progression|1|||
145456697|NCT02928029|524523221|FG001|Overall Study|AE not related to clinical progression|1|||
145456698|NCT00223977|524523224|FG000|Overall Study|Adverse Event|7|||
145456699|NCT00223977|524523225|FG001|Overall Study|Adverse Event|10|||
145456700|NCT00223977|524523226|FG002|Overall Study|Adverse Event|0|||
145456701|NCT00223977|524523224|FG000|Overall Study|Protocol Violation|0|||
145456702|NCT00223977|524523225|FG001|Overall Study|Protocol Violation|0|||
145456703|NCT00223977|524523226|FG002|Overall Study|Protocol Violation|1|||
145456704|NCT00223977|524523224|FG000|Overall Study|Withdrawal by Subject|1|||
145456705|NCT00223977|524523225|FG001|Overall Study|Withdrawal by Subject|1|||
145456706|NCT00223977|524523226|FG002|Overall Study|Withdrawal by Subject|2|||
145456707|NCT00223977|524523224|FG000|Overall Study|Other|1|||
145456708|NCT00223977|524523225|FG001|Overall Study|Other|0|||
145456709|NCT00223977|524523226|FG002|Overall Study|Other|0|||
145456710|NCT01895543|524523227|FG000|Overall Study|Withdrawal by Subject|43|||
145456711|NCT01895543|524523227|FG000|Overall Study|Lost to Follow-up|25|||
145456712|NCT01895543|524523227|FG000|Overall Study|Adverse Event|28|||
145456713|NCT01895543|524523227|FG000|Overall Study|Subject's substantial non-compliance|6|||
145456714|NCT01895543|524523227|FG000|Overall Study|Protocol Violation|1|||
145456715|NCT01895543|524523227|FG000|Overall Study|Physician Decision|2|||
145456716|NCT01895543|524523227|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
145456717|NCT04659174|524523235|FG000|Overall Study|Sponsor decision to discontinue study|0|||
145456718|NCT04659174|524523236|FG001|Overall Study|Sponsor decision to discontinue study|2|||
145456719|NCT04659174|524523235|FG000|Overall Study|Lost to Follow-up|9|||
145456720|NCT04659174|524523236|FG001|Overall Study|Lost to Follow-up|11|||
145456721|NCT04659174|524523235|FG000|Overall Study|Adverse Event|8|||
145456722|NCT04659174|524523236|FG001|Overall Study|Adverse Event|5|||
145456723|NCT04659174|524523235|FG000|Overall Study|Withdrawal by Subject|17|||
145456724|NCT04659174|524523236|FG001|Overall Study|Withdrawal by Subject|33|||
145456725|NCT04659174|524523235|FG000|Overall Study|Progressive disease|0|||
145456726|NCT04659174|524523236|FG001|Overall Study|Progressive disease|2|||
145456727|NCT04659174|524523235|FG000|Overall Study|Other reasons|0|||
145456728|NCT04659174|524523236|FG001|Overall Study|Other reasons|2|||
145456729|NCT04659174|524523235|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
145456730|NCT04659174|524523236|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
145456731|NCT04659174|524523235|FG000|Overall Study|Alcohol or illegal drug use|0|||
145456732|NCT04659174|524523236|FG001|Overall Study|Alcohol or illegal drug use|3|||
145456733|NCT04659174|524523235|FG000|Overall Study|Violation of entry criteria|1|||
145456734|NCT04659174|524523236|FG001|Overall Study|Violation of entry criteria|0|||
145456735|NCT04659174|524523235|FG000|Overall Study|Death|0|||
145456736|NCT04659174|524523236|FG001|Overall Study|Death|1|||
145456737|NCT03276026|524523239|FG000|Overall Study|Protocol Violation|1|||
145456738|NCT03276026|524523240|FG001|Overall Study|Protocol Violation|0|||
145456739|NCT03650803|524523242|FG000|Overall Study|Lost to Follow-up|6|||
145456740|NCT01534260|524523243|FG000|Overall Study|Adverse Event|1|||
145456741|NCT01534260|524523244|FG001|Overall Study|Adverse Event|8|||
145456742|NCT01534260|524523243|FG000|Overall Study|Death|2|||
145456743|NCT01534260|524523244|FG001|Overall Study|Death|0|||
145456744|NCT01534260|524523243|FG000|Overall Study|Lack of Efficacy|1|||
145456745|NCT01534260|524523244|FG001|Overall Study|Lack of Efficacy|1|||
145456746|NCT01534260|524523243|FG000|Overall Study|Withdrawal by Subject|1|||
145456747|NCT01534260|524523244|FG001|Overall Study|Withdrawal by Subject|3|||
145456748|NCT01534260|524523243|FG000|Overall Study|Disease Progression|8|||
145456749|NCT01534260|524523244|FG001|Overall Study|Disease Progression|6|||
145456750|NCT01534260|524523243|FG000|Overall Study|Physician Decision|3|||
145456751|NCT01534260|524523244|FG001|Overall Study|Physician Decision|1|||
145456752|NCT01534260|524523243|FG000|Overall Study|No treatment, per protocol|0|||
145456753|NCT01534260|524523244|FG001|Overall Study|No treatment, per protocol|1|||
145456754|NCT02359045|524523245|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
145456755|NCT02359045|524523246|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145456756|NCT02359045|524523245|FG000|Overall Study|Lost to Follow-up|1|||
145456757|NCT02359045|524523246|FG001|Overall Study|Lost to Follow-up|1|||
145456758|NCT02359045|524523245|FG000|Overall Study|Adverse Event|0|||
145456759|NCT02359045|524523246|FG001|Overall Study|Adverse Event|1|||
145456760|NCT04376684|524523248|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
145456761|NCT04376684|524523249|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
145456762|NCT04376684|524523250|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
145456763|NCT04376684|524523251|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
145456764|NCT04376684|524523248|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
145456765|NCT04376684|524523249|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
145456766|NCT04376684|524523250|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
145456767|NCT04376684|524523251|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
145456768|NCT04376684|524523248|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
145456769|NCT04376684|524523249|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
145456770|NCT04376684|524523250|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
145456771|NCT04376684|524523251|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
145456772|NCT04376684|524523248|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
145456773|NCT04376684|524523249|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
145456774|NCT04376684|524523250|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
145456775|NCT04376684|524523251|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
145456776|NCT04376684|524523248|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
145456777|NCT04376684|524523249|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
145456778|NCT04376684|524523250|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
145456779|NCT04376684|524523251|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
145456780|NCT04376684|524523248|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
145456781|NCT04376684|524523249|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
145456782|NCT04376684|524523250|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
145456783|NCT04376684|524523251|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
145456784|NCT04376684|524523248|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
145626494|NCT00409708|525145695|FG000|Washout|Lack of Efficacy|9|||
145626495|NCT00409708|525145696|FG001|Washout|Lack of Efficacy|1|||
145626496|NCT00409708|525145695|FG000|Washout|Protocol Violation|0|||
145456785|NCT04376684|524523249|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
145456786|NCT04376684|524523250|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
145456787|NCT04376684|524523251|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
145456788|NCT05596734|524523258|FG000|Substudy A|Withdrawal by Subject|1|||
145456789|NCT05596734|524523259|FG001|Substudy A|Withdrawal by Subject|0|||
145456790|NCT05596734|524523260|FG002|Substudy A|Withdrawal by Subject|0|||
145456791|NCT05596734|524523261|FG003|Substudy A|Withdrawal by Subject|0|||
145456792|NCT05596734|524523262|FG004|Substudy A|Withdrawal by Subject|0|||
145626497|NCT00409708|525145696|FG001|Washout|Protocol Violation|1|||
145456793|NCT05596734|524523263|FG005|Substudy A|Withdrawal by Subject|0|||
145626498|NCT00409708|525145695|FG000|Washout|Withdrawal by Subject|11|||
145626499|NCT00409708|525145696|FG001|Washout|Withdrawal by Subject|5|||
145456794|NCT05596734|524523264|FG006|Substudy A|Withdrawal by Subject|1|||
145456795|NCT05596734|524523265|FG007|Substudy A|Withdrawal by Subject|0|||
145456796|NCT05596734|524523266|FG008|Substudy A|Withdrawal by Subject|0|||
145456797|NCT05596734|524523267|FG009|Substudy A|Withdrawal by Subject|0|||
145456798|NCT05596734|524523268|FG010|Substudy A|Withdrawal by Subject|0|||
145456799|NCT05596734|524523269|FG011|Substudy A|Withdrawal by Subject|0|||
145456800|NCT05596734|524523270|FG012|Substudy A|Withdrawal by Subject|0|||
145456801|NCT05596734|524523271|FG013|Substudy A|Withdrawal by Subject|0|||
145456802|NCT05596734|524523272|FG014|Substudy A|Withdrawal by Subject|0|||
145456803|NCT05596734|524523273|FG015|Substudy A|Withdrawal by Subject|0|||
145456804|NCT05596734|524523274|FG016|Substudy A|Withdrawal by Subject|0|||
145456805|NCT05596734|524523275|FG017|Substudy A|Withdrawal by Subject|0|||
145456806|NCT05596734|524523276|FG018|Substudy A|Withdrawal by Subject|0|||
145456807|NCT05596734|524523277|FG019|Substudy A|Withdrawal by Subject|0|||
145456808|NCT05596734|524523278|FG020|Substudy A|Withdrawal by Subject|0|||
145456809|NCT05596734|524523279|FG021|Substudy A|Withdrawal by Subject|0|||
145456810|NCT05596734|524523280|FG022|Substudy A|Withdrawal by Subject|0|||
145456811|NCT05596734|524523281|FG023|Substudy A|Withdrawal by Subject|0|||
145456812|NCT05596734|524523258|FG000|Substudy A|Lost to Follow-up|1|||
145456813|NCT05596734|524523259|FG001|Substudy A|Lost to Follow-up|0|||
145456814|NCT05596734|524523260|FG002|Substudy A|Lost to Follow-up|1|||
145456815|NCT05596734|524523261|FG003|Substudy A|Lost to Follow-up|0|||
145626500|NCT00409708|525145695|FG000|Washout|Lost to Follow-up|1|||
145626501|NCT00409708|525145696|FG001|Washout|Lost to Follow-up|3|||
145626502|NCT00946114|525145697|FG000|Overall Study|Death|5|||
145626503|NCT00946114|525145698|FG001|Overall Study|Death|2|||
145626504|NCT00946114|525145697|FG000|Overall Study|Other|1|||
145626505|NCT00946114|525145698|FG001|Overall Study|Other|0|||
145626506|NCT00946114|525145697|FG000|Overall Study|Withdrawal by Subject|2|||
145626507|NCT00946114|525145698|FG001|Overall Study|Withdrawal by Subject|0|||
145626508|NCT00723294|525145699|FG000|Overall Study|Lobular histology|2|||
145626509|NCT00723294|525145699|FG000|Overall Study|>25% intraductal component|1|||
145626510|NCT00723294|525145699|FG000|Overall Study|No MRI tumor enhancement|1|||
145626511|NCT00723294|525145699|FG000|Overall Study|1.0-Tesla MRI|1|||
145626512|NCT00723294|525145699|FG000|Overall Study|No cryoabalation|2|||
145626513|NCT00723294|525145699|FG000|Overall Study|Did not undergo surgery|1|||
145626514|NCT00723294|525145699|FG000|Overall Study|Treated prior to registration|1|||
145626515|NCT00723294|525145699|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
145456816|NCT05596734|524523262|FG004|Substudy A|Lost to Follow-up|0|||
145456817|NCT05596734|524523263|FG005|Substudy A|Lost to Follow-up|0|||
145456818|NCT05596734|524523264|FG006|Substudy A|Lost to Follow-up|0|||
145456819|NCT05596734|524523265|FG007|Substudy A|Lost to Follow-up|0|||
145587950|NCT02952924|525004349|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
145587951|NCT02952924|525004350|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
145587952|NCT02952924|525004351|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
145587953|NCT02952924|525004352|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
145587954|NCT02952924|525004353|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
145587955|NCT02952924|525004354|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
145587956|NCT02952924|525004355|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
145587957|NCT02952924|525004356|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
145587958|NCT02952924|525004357|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
145587959|NCT02952924|525004358|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
145587960|NCT02952924|525004359|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
145587961|NCT02952924|525004360|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
145587962|NCT02952924|525004361|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
145587963|NCT02952924|525004362|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
145626516|NCT00723294|525145699|FG000|Overall Study|Benign lesion|1|||
145626517|NCT00723294|525145699|FG000|Overall Study|Withdrawal by Subject|1|||
145626518|NCT00723294|525145699|FG000|Overall Study|No treatment due to probe failure|1|||
145626519|NCT01211665|525145700|FG000|Overall Study|Withdrawal by Subject|1|||
145626520|NCT01211665|525145701|FG001|Overall Study|Withdrawal by Subject|0|||
145626521|NCT01211665|525145700|FG000|Overall Study|Death|1|||
145626522|NCT01211665|525145701|FG001|Overall Study|Death|0|||
145626523|NCT00088465|525145706|FG000|Overall Study|Withdrawal by Subject|290|||
145626524|NCT00088465|525145706|FG000|Overall Study|Adverse Event|77|||
145456820|NCT05596734|524523266|FG008|Substudy A|Lost to Follow-up|0|||
145626525|NCT00088465|525145706|FG000|Overall Study|Lost to Follow-up|57|||
145587964|NCT02952924|525004363|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
145626526|NCT00088465|525145706|FG000|Overall Study|Physician Decision|45|||
145626527|NCT00088465|525145706|FG000|Overall Study|Sponsor Decision|37|||
145626528|NCT00088465|525145706|FG000|Overall Study|Lack of Efficacy|27|||
145626529|NCT00088465|525145706|FG000|Overall Study|Protocol Violation|17|||
145626530|NCT00088465|525145706|FG000|Overall Study|Death|11|||
145456821|NCT05596734|524523267|FG009|Substudy A|Lost to Follow-up|0|||
145626531|NCT00448864|525145707|FG000|Overall Study|Death|1|||
145456822|NCT05596734|524523268|FG010|Substudy A|Lost to Follow-up|0|||
145587965|NCT02952924|525004364|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
145587966|NCT02952924|525004365|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
145587967|NCT02952924|525004366|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
145587968|NCT02952924|525004367|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
145587969|NCT02952924|525004368|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
145587970|NCT02952924|525004369|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
145587971|NCT02952924|525004348|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587972|NCT02952924|525004349|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587973|NCT02952924|525004350|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587974|NCT02952924|525004351|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587975|NCT02952924|525004352|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587976|NCT02952924|525004353|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587977|NCT02952924|525004354|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587978|NCT02952924|525004355|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587979|NCT02952924|525004356|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587980|NCT02952924|525004357|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587981|NCT02952924|525004358|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587982|NCT02952924|525004359|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587983|NCT02952924|525004360|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587984|NCT02952924|525004361|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587985|NCT02952924|525004362|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587986|NCT02952924|525004363|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587987|NCT02952924|525004364|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587988|NCT02952924|525004365|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
145626532|NCT00448864|525145708|FG001|Overall Study|Death|0|||
145626533|NCT00448864|525145709|FG002|Overall Study|Death|0|||
145626534|NCT00448864|525145707|FG000|Overall Study|Lost to Follow-up|3|||
145626535|NCT00448864|525145708|FG001|Overall Study|Lost to Follow-up|1|||
145626536|NCT00448864|525145709|FG002|Overall Study|Lost to Follow-up|0|||
145626537|NCT00448864|525145707|FG000|Overall Study|Physician Decision|1|||
145626538|NCT00448864|525145708|FG001|Overall Study|Physician Decision|0|||
145626539|NCT00448864|525145709|FG002|Overall Study|Physician Decision|1|||
145626540|NCT00448864|525145707|FG000|Overall Study|Withdrawal by Subject|0|||
145626541|NCT00448864|525145708|FG001|Overall Study|Withdrawal by Subject|2|||
145626542|NCT00448864|525145709|FG002|Overall Study|Withdrawal by Subject|0|||
145626543|NCT00448864|525145707|FG000|Overall Study|Protocol Violation|0|||
145626544|NCT00448864|525145708|FG001|Overall Study|Protocol Violation|2|||
145626545|NCT00448864|525145709|FG002|Overall Study|Protocol Violation|0|||
145626546|NCT01390857|525145710|FG000|Overall Study|Protocol Violation|2|||
145626547|NCT01390857|525145710|FG000|Overall Study|Lost to Follow-up|1|||
145626548|NCT01390857|525145710|FG000|Overall Study|No Visit after the First Visit|7|||
145626549|NCT02757885|525145711|FG000|Overall Study|Screen Failures|4|||
145626550|NCT00984282|525145712|FG000|Double Blind Treatment|Adverse Event|40|||
145626551|NCT00984282|525145713|FG001|Double Blind Treatment|Adverse Event|6|||
145626552|NCT00984282|525145712|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
145626553|NCT00984282|525145713|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
145626554|NCT00984282|525145712|FG000|Double Blind Treatment|Physician Decision|1|||
145626555|NCT00984282|525145713|FG001|Double Blind Treatment|Physician Decision|2|||
145626556|NCT00984282|525145712|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
145626557|NCT00984282|525145713|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
145626558|NCT00984282|525145712|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
145626559|NCT00984282|525145713|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
145626560|NCT00984282|525145712|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
145626561|NCT00984282|525145713|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
145626562|NCT00984282|525145712|FG000|Double Blind Treatment|Lost to Follow-up|3|||
145626563|NCT00984282|525145713|FG001|Double Blind Treatment|Lost to Follow-up|0|||
145626564|NCT00984282|525145712|FG000|Double Blind Treatment|Death|8|||
145626565|NCT00984282|525145713|FG001|Double Blind Treatment|Death|4|||
145626566|NCT00984282|525145712|FG000|Double Blind Treatment|Not treated|0|||
145626567|NCT00984282|525145713|FG001|Double Blind Treatment|Not treated|1|||
145626568|NCT00984282|525145712|FG000|Double Blind Treatment|Switched to commercial drug|6|||
145626569|NCT00984282|525145713|FG001|Double Blind Treatment|Switched to commercial drug|1|||
145626570|NCT00984282|525145712|FG000|Double Blind Treatment|protocol driven decision point|1|||
145626571|NCT00984282|525145713|FG001|Double Blind Treatment|protocol driven decision point|1|||
145626572|NCT00984282|525145712|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
145626573|NCT00984282|525145713|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
145456823|NCT05596734|524523269|FG011|Substudy A|Lost to Follow-up|0|||
145456824|NCT05596734|524523270|FG012|Substudy A|Lost to Follow-up|0|||
145587989|NCT02952924|525004366|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587990|NCT02952924|525004367|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587991|NCT02952924|525004368|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
145587992|NCT02952924|525004369|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
145587993|NCT02952924|525004348|FG000|Overall Study|Noncompliance with study drug|0|||
145587994|NCT02952924|525004349|FG001|Overall Study|Noncompliance with study drug|0|||
145587995|NCT02952924|525004350|FG002|Overall Study|Noncompliance with study drug|0|||
145587996|NCT02952924|525004351|FG003|Overall Study|Noncompliance with study drug|0|||
145587997|NCT02952924|525004352|FG004|Overall Study|Noncompliance with study drug|0|||
145587998|NCT02952924|525004353|FG005|Overall Study|Noncompliance with study drug|0|||
145587999|NCT02952924|525004354|FG006|Overall Study|Noncompliance with study drug|0|||
145588000|NCT02952924|525004355|FG007|Overall Study|Noncompliance with study drug|0|||
145588001|NCT02952924|525004356|FG008|Overall Study|Noncompliance with study drug|0|||
145588002|NCT02952924|525004357|FG009|Overall Study|Noncompliance with study drug|0|||
145588003|NCT02952924|525004358|FG010|Overall Study|Noncompliance with study drug|0|||
145588004|NCT02952924|525004359|FG011|Overall Study|Noncompliance with study drug|0|||
145588005|NCT02952924|525004360|FG012|Overall Study|Noncompliance with study drug|0|||
145588006|NCT02952924|525004361|FG013|Overall Study|Noncompliance with study drug|0|||
145588007|NCT02952924|525004362|FG014|Overall Study|Noncompliance with study drug|0|||
145588008|NCT02952924|525004363|FG015|Overall Study|Noncompliance with study drug|0|||
145588009|NCT02952924|525004364|FG016|Overall Study|Noncompliance with study drug|0|||
145588010|NCT02952924|525004365|FG017|Overall Study|Noncompliance with study drug|0|||
145588011|NCT02952924|525004366|FG018|Overall Study|Noncompliance with study drug|0|||
145588012|NCT02952924|525004367|FG019|Overall Study|Noncompliance with study drug|0|||
145588013|NCT02952924|525004368|FG020|Overall Study|Noncompliance with study drug|0|||
145588014|NCT02952924|525004369|FG021|Overall Study|Noncompliance with study drug|1|||
145588015|NCT01226745|525004370|FG000|Overall Study|Did not complete schedule of assessments|8|||
145588016|NCT01226745|525004371|FG001|Overall Study|Did not complete schedule of assessments|3|||
145588017|NCT01226745|525004372|FG002|Overall Study|Did not complete schedule of assessments|6|||
145588018|NCT01226745|525004373|FG003|Overall Study|Did not complete schedule of assessments|0|||
145588019|NCT01226745|525004374|FG004|Overall Study|Did not complete schedule of assessments|0|||
145588020|NCT01226745|525004375|FG005|Overall Study|Did not complete schedule of assessments|1|||
145588021|NCT01226745|525004370|FG000|Overall Study|Lost to Follow-up|2|||
145588022|NCT01226745|525004371|FG001|Overall Study|Lost to Follow-up|6|||
145588023|NCT01226745|525004372|FG002|Overall Study|Lost to Follow-up|6|||
145588024|NCT01226745|525004373|FG003|Overall Study|Lost to Follow-up|1|||
145588025|NCT01226745|525004374|FG004|Overall Study|Lost to Follow-up|1|||
145588026|NCT01226745|525004375|FG005|Overall Study|Lost to Follow-up|2|||
145588027|NCT01226745|525004370|FG000|Overall Study|Death|1|||
145588028|NCT01226745|525004371|FG001|Overall Study|Death|0|||
145588029|NCT01226745|525004372|FG002|Overall Study|Death|0|||
145588030|NCT01226745|525004373|FG003|Overall Study|Death|0|||
145588031|NCT01226745|525004374|FG004|Overall Study|Death|0|||
145588032|NCT01226745|525004375|FG005|Overall Study|Death|1|||
145588033|NCT01226745|525004370|FG000|Overall Study|Other|6|||
145588034|NCT01226745|525004371|FG001|Overall Study|Other|7|||
145588035|NCT01226745|525004372|FG002|Overall Study|Other|8|||
145588036|NCT01226745|525004373|FG003|Overall Study|Other|4|||
145588037|NCT01226745|525004374|FG004|Overall Study|Other|3|||
145588038|NCT01226745|525004375|FG005|Overall Study|Other|1|||
145588039|NCT01934218|525004379|FG000|Double-blind Phase|Adverse Event|8|||
145588040|NCT01934218|525004380|FG001|Double-blind Phase|Adverse Event|8|||
145588041|NCT01934218|525004379|FG000|Double-blind Phase|Lack of Efficacy|6|||
145588042|NCT01934218|525004380|FG001|Double-blind Phase|Lack of Efficacy|7|||
145588043|NCT01934218|525004379|FG000|Double-blind Phase|Lost to Follow-up|7|||
145588044|NCT01934218|525004380|FG001|Double-blind Phase|Lost to Follow-up|14|||
145588045|NCT01934218|525004379|FG000|Double-blind Phase|Physician Decision|1|||
145588046|NCT01934218|525004380|FG001|Double-blind Phase|Physician Decision|2|||
145588047|NCT01934218|525004379|FG000|Double-blind Phase|Protocol Violation|4|||
145588048|NCT01934218|525004380|FG001|Double-blind Phase|Protocol Violation|0|||
145588049|NCT01934218|525004379|FG000|Double-blind Phase|Withdrawal by Subject|16|||
145588050|NCT01934218|525004380|FG001|Double-blind Phase|Withdrawal by Subject|13|||
145588051|NCT01934218|525004379|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
145588052|NCT01934218|525004380|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
145588053|NCT01934218|525004379|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
145588054|NCT01934218|525004380|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
145588055|NCT01934218|525004379|FG000|Open-Label Phase|Adverse Event|2|||
145588056|NCT01934218|525004380|FG001|Open-Label Phase|Adverse Event|4|||
145588057|NCT01934218|525004379|FG000|Open-Label Phase|Lack of Efficacy|1|||
145588058|NCT01934218|525004380|FG001|Open-Label Phase|Lack of Efficacy|4|||
145588059|NCT01934218|525004379|FG000|Open-Label Phase|Lost to Follow-up|4|||
145588060|NCT01934218|525004380|FG001|Open-Label Phase|Lost to Follow-up|2|||
145456825|NCT05596734|524523271|FG013|Substudy A|Lost to Follow-up|0|||
145588061|NCT01934218|525004379|FG000|Open-Label Phase|Physician Decision|1|||
145588062|NCT01934218|525004380|FG001|Open-Label Phase|Physician Decision|0|||
145588063|NCT01934218|525004379|FG000|Open-Label Phase|Protocol Violation|1|||
145588064|NCT01934218|525004380|FG001|Open-Label Phase|Protocol Violation|0|||
145588065|NCT01934218|525004379|FG000|Open-Label Phase|Withdrawal by Subject|13|||
145588066|NCT01934218|525004380|FG001|Open-Label Phase|Withdrawal by Subject|11|||
145588067|NCT01934218|525004379|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
145588068|NCT01934218|525004380|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
145588069|NCT01934218|525004379|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
145588070|NCT01934218|525004380|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
145588071|NCT03538626|525004381|FG000|Overall Study|Withdrawal by Subject|0|||
145588072|NCT03538626|525004382|FG001|Overall Study|Withdrawal by Subject|1|||
145588073|NCT03538626|525004383|FG002|Overall Study|Withdrawal by Subject|0|||
145588074|NCT03538626|525004384|FG003|Overall Study|Withdrawal by Subject|0|||
145588075|NCT03538626|525004385|FG004|Overall Study|Withdrawal by Subject|0|||
145588076|NCT03538626|525004386|FG005|Overall Study|Withdrawal by Subject|0|||
145588077|NCT03538626|525004387|FG006|Overall Study|Withdrawal by Subject|0|||
145588078|NCT03538626|525004388|FG007|Overall Study|Withdrawal by Subject|0|||
145588079|NCT03538626|525004381|FG000|Overall Study|Lost to Follow-up|0|||
145588080|NCT03538626|525004382|FG001|Overall Study|Lost to Follow-up|0|||
145588081|NCT03538626|525004383|FG002|Overall Study|Lost to Follow-up|0|||
145588082|NCT03538626|525004384|FG003|Overall Study|Lost to Follow-up|0|||
145588083|NCT03538626|525004385|FG004|Overall Study|Lost to Follow-up|0|||
145588084|NCT03538626|525004386|FG005|Overall Study|Lost to Follow-up|0|||
145588085|NCT03538626|525004387|FG006|Overall Study|Lost to Follow-up|1|||
145588086|NCT03538626|525004388|FG007|Overall Study|Lost to Follow-up|0|||
145588087|NCT02232893|525004394|FG000|Overall Study|Withdrawal by Subject|4|||
145588088|NCT02232893|525004395|FG001|Overall Study|Withdrawal by Subject|1|||
145588089|NCT02232893|525004394|FG000|Overall Study|Adverse Event|0|||
145588090|NCT02232893|525004395|FG001|Overall Study|Adverse Event|1|||
145588091|NCT02232893|525004394|FG000|Overall Study|Sponsor request early termination|0|||
145588092|NCT02232893|525004395|FG001|Overall Study|Sponsor request early termination|1|||
145588093|NCT02232893|525004394|FG000|Overall Study|Developed exclusion criteria|0|||
145588094|NCT02232893|525004395|FG001|Overall Study|Developed exclusion criteria|1|||
145588095|NCT02232893|525004394|FG000|Overall Study|Other|0|||
145588096|NCT02232893|525004395|FG001|Overall Study|Other|3|||
145588097|NCT02911948|525004396|FG000|Overall Study|Protocol Violation|0|||
145588098|NCT02911948|525004397|FG001|Overall Study|Protocol Violation|1|||
145588099|NCT02911948|525004396|FG000|Overall Study|Withdrawal by Subject|0|||
145588100|NCT02911948|525004397|FG001|Overall Study|Withdrawal by Subject|2|||
145588101|NCT02911948|525004396|FG000|Overall Study|Lack of Efficacy|0|||
145588102|NCT02911948|525004397|FG001|Overall Study|Lack of Efficacy|1|||
145588103|NCT02911948|525004396|FG000|Overall Study|Unclassified|0|||
145588104|NCT02911948|525004397|FG001|Overall Study|Unclassified|3|||
145588105|NCT03867734|525004400|FG000|Overall Study|Lost to Follow-up|2|||
145588106|NCT03965052|525004401|FG000|Overall Study|Protocol Violation|1|||
145588107|NCT03965052|525004402|FG001|Overall Study|Protocol Violation|0|||
145588108|NCT04323436|525004408|FG000|Overall Study|Adverse Event|7|||
145588109|NCT04323436|525004409|FG001|Overall Study|Adverse Event|0|||
145588110|NCT04323436|525004410|FG002|Overall Study|Adverse Event|0|||
145588111|NCT04323436|525004408|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
145588112|NCT04323436|525004409|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
145588113|NCT04323436|525004410|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
145588114|NCT04323436|525004408|FG000|Overall Study|Death|1|||
145588115|NCT04323436|525004409|FG001|Overall Study|Death|0|||
145588116|NCT04323436|525004410|FG002|Overall Study|Death|0|||
145588117|NCT04323436|525004408|FG000|Overall Study|Physician Decision|2|||
145588118|NCT04323436|525004409|FG001|Overall Study|Physician Decision|0|||
145588119|NCT04323436|525004410|FG002|Overall Study|Physician Decision|0|||
145588120|NCT04323436|525004408|FG000|Overall Study|Progressive disease|10|||
145588121|NCT04323436|525004409|FG001|Overall Study|Progressive disease|0|||
145588122|NCT04323436|525004410|FG002|Overall Study|Progressive disease|0|||
145588123|NCT04323436|525004408|FG000|Overall Study|Subject decision|3|||
145588124|NCT04323436|525004409|FG001|Overall Study|Subject decision|0|||
145588125|NCT04323436|525004410|FG002|Overall Study|Subject decision|0|||
145588126|NCT00380068|525004411|FG000|Overall Study|Adverse Event|40|||
145588127|NCT00380068|525004411|FG000|Overall Study|Withdrawal by Subject|10|||
145588128|NCT00380068|525004411|FG000|Overall Study|Not compliant|6|||
145588129|NCT00380068|525004411|FG000|Overall Study|Lost to Follow-up|1|||
145588130|NCT00380068|525004411|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
145588131|NCT00380068|525004411|FG000|Overall Study|Lung transplant|3|||
145588132|NCT00380068|525004411|FG000|Overall Study|Physician Decision|2|||
145588133|NCT00380068|525004411|FG000|Overall Study|Partipant moved away|1|||
145588134|NCT00380068|525004411|FG000|Overall Study|Lack of Efficacy|5|||
145588135|NCT01365494|525004412|FG000|Overall Study|Adverse Event|1|||
145588136|NCT01365494|525004413|FG001|Overall Study|Adverse Event|0|||
145456826|NCT05596734|524523272|FG014|Substudy A|Lost to Follow-up|0|||
145456827|NCT05596734|524523273|FG015|Substudy A|Lost to Follow-up|0|||
145456828|NCT05596734|524523274|FG016|Substudy A|Lost to Follow-up|0|||
145456829|NCT05596734|524523275|FG017|Substudy A|Lost to Follow-up|0|||
145456830|NCT05596734|524523276|FG018|Substudy A|Lost to Follow-up|0|||
145456831|NCT05596734|524523277|FG019|Substudy A|Lost to Follow-up|0|||
145456832|NCT05596734|524523278|FG020|Substudy A|Lost to Follow-up|0|||
145456833|NCT05596734|524523279|FG021|Substudy A|Lost to Follow-up|0|||
145456834|NCT05596734|524523280|FG022|Substudy A|Lost to Follow-up|0|||
145456835|NCT05596734|524523281|FG023|Substudy A|Lost to Follow-up|0|||
145456836|NCT05596734|524523258|FG000|Substudy B|Withdrawal by Subject|0|||
145456837|NCT05596734|524523259|FG001|Substudy B|Withdrawal by Subject|0|||
145456838|NCT05596734|524523260|FG002|Substudy B|Withdrawal by Subject|0|||
145456839|NCT05596734|524523261|FG003|Substudy B|Withdrawal by Subject|0|||
145456840|NCT05596734|524523262|FG004|Substudy B|Withdrawal by Subject|0|||
145456841|NCT05596734|524523263|FG005|Substudy B|Withdrawal by Subject|0|||
145456842|NCT05596734|524523264|FG006|Substudy B|Withdrawal by Subject|0|||
145456843|NCT05596734|524523265|FG007|Substudy B|Withdrawal by Subject|0|||
145456844|NCT05596734|524523266|FG008|Substudy B|Withdrawal by Subject|0|||
145456845|NCT05596734|524523267|FG009|Substudy B|Withdrawal by Subject|0|||
145456846|NCT05596734|524523268|FG010|Substudy B|Withdrawal by Subject|0|||
145456847|NCT05596734|524523269|FG011|Substudy B|Withdrawal by Subject|0|||
145456848|NCT05596734|524523270|FG012|Substudy B|Withdrawal by Subject|1|||
145456849|NCT05596734|524523271|FG013|Substudy B|Withdrawal by Subject|0|||
145456850|NCT05596734|524523272|FG014|Substudy B|Withdrawal by Subject|1|||
145456851|NCT05596734|524523273|FG015|Substudy B|Withdrawal by Subject|2|||
145456852|NCT05596734|524523274|FG016|Substudy B|Withdrawal by Subject|2|||
145456853|NCT05596734|524523275|FG017|Substudy B|Withdrawal by Subject|1|||
145456854|NCT05596734|524523276|FG018|Substudy B|Withdrawal by Subject|2|||
145456855|NCT05596734|524523277|FG019|Substudy B|Withdrawal by Subject|0|||
145456856|NCT05596734|524523278|FG020|Substudy B|Withdrawal by Subject|0|||
145456857|NCT05596734|524523279|FG021|Substudy B|Withdrawal by Subject|0|||
145456858|NCT05596734|524523280|FG022|Substudy B|Withdrawal by Subject|0|||
145456859|NCT05596734|524523281|FG023|Substudy B|Withdrawal by Subject|1|||
145456860|NCT05596734|524523258|FG000|Substudy B|Physician Decision|0|||
145456861|NCT05596734|524523259|FG001|Substudy B|Physician Decision|0|||
145456862|NCT05596734|524523260|FG002|Substudy B|Physician Decision|0|||
145456863|NCT05596734|524523261|FG003|Substudy B|Physician Decision|0|||
145456864|NCT05596734|524523262|FG004|Substudy B|Physician Decision|0|||
145456865|NCT05596734|524523263|FG005|Substudy B|Physician Decision|0|||
145456866|NCT05596734|524523264|FG006|Substudy B|Physician Decision|0|||
145456867|NCT05596734|524523265|FG007|Substudy B|Physician Decision|0|||
145456868|NCT05596734|524523266|FG008|Substudy B|Physician Decision|0|||
145456869|NCT05596734|524523267|FG009|Substudy B|Physician Decision|0|||
145456870|NCT05596734|524523268|FG010|Substudy B|Physician Decision|0|||
145456871|NCT05596734|524523269|FG011|Substudy B|Physician Decision|0|||
145456872|NCT05596734|524523270|FG012|Substudy B|Physician Decision|0|||
145456873|NCT05596734|524523271|FG013|Substudy B|Physician Decision|0|||
145456874|NCT05596734|524523272|FG014|Substudy B|Physician Decision|0|||
145456875|NCT05596734|524523273|FG015|Substudy B|Physician Decision|1|||
145456876|NCT05596734|524523274|FG016|Substudy B|Physician Decision|0|||
145456877|NCT05596734|524523275|FG017|Substudy B|Physician Decision|0|||
145456878|NCT05596734|524523276|FG018|Substudy B|Physician Decision|0|||
145456879|NCT05596734|524523277|FG019|Substudy B|Physician Decision|0|||
145456880|NCT05596734|524523278|FG020|Substudy B|Physician Decision|0|||
145456881|NCT05596734|524523279|FG021|Substudy B|Physician Decision|0|||
145456882|NCT05596734|524523280|FG022|Substudy B|Physician Decision|0|||
145456883|NCT05596734|524523281|FG023|Substudy B|Physician Decision|0|||
145456884|NCT05596734|524523258|FG000|Substudy B|Lost to Follow-up|0|||
145456885|NCT05596734|524523259|FG001|Substudy B|Lost to Follow-up|0|||
145456886|NCT05596734|524523260|FG002|Substudy B|Lost to Follow-up|0|||
145588137|NCT01365494|525004412|FG000|Overall Study|Withdrawal by Subject|0|||
145588138|NCT01365494|525004413|FG001|Overall Study|Withdrawal by Subject|1|||
145456887|NCT05596734|524523261|FG003|Substudy B|Lost to Follow-up|0|||
145456888|NCT05596734|524523262|FG004|Substudy B|Lost to Follow-up|0|||
145456889|NCT05596734|524523263|FG005|Substudy B|Lost to Follow-up|0|||
145456890|NCT05596734|524523264|FG006|Substudy B|Lost to Follow-up|0|||
145456891|NCT05596734|524523265|FG007|Substudy B|Lost to Follow-up|0|||
145588139|NCT01365494|525004412|FG000|Overall Study|Lost to Follow-up|1|||
145588140|NCT01365494|525004413|FG001|Overall Study|Lost to Follow-up|2|||
145456892|NCT05596734|524523266|FG008|Substudy B|Lost to Follow-up|0|||
145456893|NCT05596734|524523267|FG009|Substudy B|Lost to Follow-up|0|||
145456894|NCT05596734|524523268|FG010|Substudy B|Lost to Follow-up|0|||
145456895|NCT05596734|524523269|FG011|Substudy B|Lost to Follow-up|0|||
145456896|NCT05596734|524523270|FG012|Substudy B|Lost to Follow-up|1|||
145456897|NCT05596734|524523271|FG013|Substudy B|Lost to Follow-up|0|||
145456898|NCT05596734|524523272|FG014|Substudy B|Lost to Follow-up|1|||
145456899|NCT05596734|524523273|FG015|Substudy B|Lost to Follow-up|1|||
145456900|NCT05596734|524523274|FG016|Substudy B|Lost to Follow-up|0|||
145456901|NCT05596734|524523275|FG017|Substudy B|Lost to Follow-up|0|||
145456902|NCT05596734|524523276|FG018|Substudy B|Lost to Follow-up|0|||
145588141|NCT03351049|525004414|FG000|Overall Study|Withdrawal|26|||
145588142|NCT03351049|525004415|FG001|Overall Study|Withdrawal|22|||
145588143|NCT02730819|525004425|FG000|Overall Study|Lost to Follow-up|9|||
145588144|NCT02121847|525004426|FG000|Overall Study|Administrative Reasons|1|||
145588145|NCT02121847|525004426|FG000|Overall Study|Adverse Event|2|||
145588146|NCT01410448|525004432|FG000|Overall Study|No conversion to everolimus|0|||
145588147|NCT01410448|525004433|FG001|Overall Study|No conversion to everolimus|24|||
145588148|NCT01410448|525004432|FG000|Overall Study|Graft loss|4|||
145588149|NCT01410448|525004433|FG001|Overall Study|Graft loss|1|||
145588150|NCT01410448|525004432|FG000|Overall Study|Administrative issues|2|||
145588151|NCT01410448|525004433|FG001|Overall Study|Administrative issues|1|||
145588152|NCT01410448|525004432|FG000|Overall Study|Lost to Follow-up|1|||
145588153|NCT01410448|525004433|FG001|Overall Study|Lost to Follow-up|0|||
145588154|NCT01410448|525004432|FG000|Overall Study|Withdrawal by Subject|3|||
145588155|NCT01410448|525004433|FG001|Overall Study|Withdrawal by Subject|2|||
145588156|NCT01410448|525004432|FG000|Overall Study|Protocol Violation|0|||
145588157|NCT01410448|525004433|FG001|Overall Study|Protocol Violation|4|||
145588158|NCT01410448|525004432|FG000|Overall Study|Death|2|||
145588159|NCT01410448|525004433|FG001|Overall Study|Death|3|||
145588160|NCT00360529|525004434|FG000|Overall Study|Adverse Event|10|||
145588161|NCT00360529|525004435|FG001|Overall Study|Adverse Event|23|||
145588162|NCT00360529|525004436|FG002|Overall Study|Adverse Event|33|||
145588163|NCT00360529|525004434|FG000|Overall Study|Protocol Violation|3|||
145588164|NCT00360529|525004435|FG001|Overall Study|Protocol Violation|3|||
145588165|NCT00360529|525004436|FG002|Overall Study|Protocol Violation|11|||
145588166|NCT00360529|525004434|FG000|Overall Study|Lost to Follow-up|14|||
145588167|NCT00360529|525004435|FG001|Overall Study|Lost to Follow-up|10|||
145588168|NCT00360529|525004436|FG002|Overall Study|Lost to Follow-up|13|||
145588169|NCT00360529|525004434|FG000|Overall Study|Withdrawal by Subject|22|||
145588170|NCT00360529|525004435|FG001|Overall Study|Withdrawal by Subject|14|||
145588171|NCT00360529|525004436|FG002|Overall Study|Withdrawal by Subject|18|||
145588172|NCT00360529|525004434|FG000|Overall Study|Lack of Efficacy|8|||
145588173|NCT00360529|525004435|FG001|Overall Study|Lack of Efficacy|6|||
145588174|NCT00360529|525004436|FG002|Overall Study|Lack of Efficacy|5|||
145588175|NCT00360529|525004434|FG000|Overall Study|Reason discontinued not explained above|4|||
145588176|NCT00360529|525004435|FG001|Overall Study|Reason discontinued not explained above|9|||
145588177|NCT00360529|525004436|FG002|Overall Study|Reason discontinued not explained above|11|||
145588178|NCT02535065|525004437|FG000|Overall Study|Death|13|||
145588179|NCT02535065|525004437|FG000|Overall Study|Lost to Follow-up|1|||
145588180|NCT02535065|525004437|FG000|Overall Study|Withdrawal by Subject|6|||
145588181|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
145588182|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
145588183|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
145588184|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
145588185|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
145588186|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
145588187|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
145588188|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
145588189|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
145588190|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
145588191|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
145588192|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
145588193|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
145588194|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
145588195|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
145588196|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
145588197|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
145588198|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
145588199|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
145588200|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
145588201|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
145588202|NCT01781572|525004438|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
145588203|NCT01781572|525004439|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
145588204|NCT01781572|525004440|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
145588205|NCT01781572|525004438|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
145588206|NCT01781572|525004439|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
145588207|NCT01781572|525004440|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
145588208|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
145588209|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
145588210|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
145588211|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
145588212|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
145588213|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
145588214|NCT01781572|525004438|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
145456903|NCT05596734|524523277|FG019|Substudy B|Lost to Follow-up|0|||
145456904|NCT05596734|524523278|FG020|Substudy B|Lost to Follow-up|0|||
145456905|NCT05596734|524523279|FG021|Substudy B|Lost to Follow-up|0|||
145456906|NCT05596734|524523280|FG022|Substudy B|Lost to Follow-up|0|||
145456907|NCT05596734|524523281|FG023|Substudy B|Lost to Follow-up|0|||
145456908|NCT03219034|524523284|FG000|Overall Study|Lost to Follow-up|9|||
145456909|NCT03219034|524523285|FG001|Overall Study|Lost to Follow-up|13|||
145456910|NCT03219034|524523284|FG000|Overall Study|Additional dental work needed|1|||
145456911|NCT03219034|524523285|FG001|Overall Study|Additional dental work needed|0|||
145456912|NCT03219034|524523284|FG000|Overall Study|UPPP Surgery|1|||
145456913|NCT03219034|524523285|FG001|Overall Study|UPPP Surgery|0|||
145456914|NCT03219034|524523284|FG000|Overall Study|Dental sensitivity|0|||
145456915|NCT03219034|524523285|FG001|Overall Study|Dental sensitivity|1|||
145456916|NCT03219034|524523284|FG000|Overall Study|Death in family|0|||
145456917|NCT03219034|524523285|FG001|Overall Study|Death in family|1|||
145456918|NCT02136680|524523289|FG000|Overall Study|No Longer Interested|1|||
145456919|NCT02136680|524523290|FG001|Overall Study|No Longer Interested|1|||
145456920|NCT02136680|524523289|FG000|Overall Study|No longer receiving care at clinic|3|||
145456921|NCT02136680|524523290|FG001|Overall Study|No longer receiving care at clinic|5|||
145456922|NCT02136680|524523289|FG000|Overall Study|Moved away|5|||
145456923|NCT02136680|524523290|FG001|Overall Study|Moved away|4|||
145456924|NCT02136680|524523289|FG000|Overall Study|Unable to schedule|17|||
145456925|NCT02136680|524523290|FG001|Overall Study|Unable to schedule|16|||
145456926|NCT02136680|524523289|FG000|Overall Study|Study ended before interview due|6|||
145456927|NCT02136680|524523290|FG001|Overall Study|Study ended before interview due|3|||
145456928|NCT02825420|524523294|FG000|Overall Study|Death|30|||
145456929|NCT02825420|524523295|FG001|Overall Study|Death|12|||
145456930|NCT02825420|524523294|FG000|Overall Study|Progressive disease|6|||
145456931|NCT02825420|524523295|FG001|Overall Study|Progressive disease|1|||
145456932|NCT02825420|524523294|FG000|Overall Study|Lost to Follow-up|2|||
145456933|NCT02825420|524523295|FG001|Overall Study|Lost to Follow-up|2|||
145456934|NCT02825420|524523294|FG000|Overall Study|Withdrawal by Subject|1|||
145456935|NCT02825420|524523295|FG001|Overall Study|Withdrawal by Subject|1|||
145456936|NCT02825420|524523294|FG000|Overall Study|Protocol amendment not signed|1|||
145456937|NCT02825420|524523295|FG001|Overall Study|Protocol amendment not signed|1|||
145456938|NCT02825420|524523294|FG000|Overall Study|Physician Decision|1|||
145456939|NCT02825420|524523295|FG001|Overall Study|Physician Decision|0|||
145456940|NCT02825420|524523294|FG000|Overall Study|Did not receive PLD|2|||
145456941|NCT02825420|524523295|FG001|Overall Study|Did not receive PLD|0|||
145456942|NCT05243745|524525063|FG000|Overall Study|Withdrawal by Subject|0|||
145456943|NCT05243745|524525064|FG001|Overall Study|Withdrawal by Subject|0|||
145456944|NCT05243745|524525065|FG002|Overall Study|Withdrawal by Subject|0|||
145456945|NCT05243745|524525066|FG003|Overall Study|Withdrawal by Subject|1|||
145456946|NCT05243745|524525063|FG000|Overall Study|Unable to Attend Visit 6|0|||
145456947|NCT05243745|524525064|FG001|Overall Study|Unable to Attend Visit 6|0|||
145456948|NCT05243745|524525065|FG002|Overall Study|Unable to Attend Visit 6|1|||
145456949|NCT05243745|524525066|FG003|Overall Study|Unable to Attend Visit 6|0|||
145456950|NCT02998203|524525067|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
145456951|NCT02998203|524525068|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
145456952|NCT02998203|524525067|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
145456953|NCT02998203|524525068|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
145456954|NCT03842969|524525079|FG000|Overall Study|Participant declined follow-up visit|0|||
145456955|NCT03842969|524525080|FG001|Overall Study|Participant declined follow-up visit|1|||
145456956|NCT03842969|524525081|FG002|Overall Study|Participant declined follow-up visit|0|||
145456957|NCT03842969|524525079|FG000|Overall Study|Sponsor's decision|12|||
145456958|NCT03842969|524525080|FG001|Overall Study|Sponsor's decision|99|||
145456959|NCT03842969|524525081|FG002|Overall Study|Sponsor's decision|61|||
145456960|NCT03842969|524525079|FG000|Overall Study|Pregnancy|0|||
145456961|NCT03842969|524525080|FG001|Overall Study|Pregnancy|0|||
145456962|NCT03842969|524525081|FG002|Overall Study|Pregnancy|1|||
145456963|NCT03842969|524525079|FG000|Overall Study|Death|1|||
145456964|NCT03842969|524525080|FG001|Overall Study|Death|0|||
145456965|NCT03842969|524525081|FG002|Overall Study|Death|1|||
145456966|NCT03842969|524525079|FG000|Overall Study|Withdrawal by Subject|3|||
145456967|NCT03842969|524525080|FG001|Overall Study|Withdrawal by Subject|30|||
145456968|NCT03842969|524525081|FG002|Overall Study|Withdrawal by Subject|18|||
145456969|NCT03842969|524525079|FG000|Overall Study|Protocol Violation|1|||
145456970|NCT03842969|524525080|FG001|Overall Study|Protocol Violation|1|||
145456971|NCT03842969|524525081|FG002|Overall Study|Protocol Violation|0|||
145456972|NCT03842969|524525079|FG000|Overall Study|Physician Decision|0|||
145456973|NCT03842969|524525080|FG001|Overall Study|Physician Decision|3|||
145588215|NCT01781572|525004439|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
145588216|NCT01781572|525004440|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
145588217|NCT01781572|525004438|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
145456974|NCT03842969|524525081|FG002|Overall Study|Physician Decision|0|||
145456975|NCT03842969|524525079|FG000|Overall Study|Lost to Follow-up|0|||
145456976|NCT03842969|524525080|FG001|Overall Study|Lost to Follow-up|2|||
145588218|NCT01781572|525004439|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
145626574|NCT00984282|525145712|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
145626575|NCT00984282|525145713|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
145626576|NCT00984282|525145712|FG000|Open-label Treatment|Adverse Event|20|||
145626577|NCT00984282|525145713|FG001|Open-label Treatment|Adverse Event|30|||
145626578|NCT00984282|525145712|FG000|Open-label Treatment|Withdrawal by Subject|6|||
145626579|NCT00984282|525145713|FG001|Open-label Treatment|Withdrawal by Subject|21|||
145626580|NCT00984282|525145712|FG000|Open-label Treatment|Death|7|||
145626581|NCT00984282|525145713|FG001|Open-label Treatment|Death|15|||
145626582|NCT00984282|525145712|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
145626583|NCT00984282|525145713|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
145626584|NCT00984282|525145712|FG000|Open-label Treatment|Lost to Follow-up|1|||
145626585|NCT00984282|525145713|FG001|Open-label Treatment|Lost to Follow-up|1|||
145626586|NCT00984282|525145712|FG000|Open-label Treatment|Patient convenience|1|||
145626587|NCT00984282|525145713|FG001|Open-label Treatment|Patient convenience|0|||
145626588|NCT00984282|525145712|FG000|Open-label Treatment|Non-compliant with study medication|1|||
145626589|NCT00984282|525145713|FG001|Open-label Treatment|Non-compliant with study medication|0|||
145626590|NCT00984282|525145712|FG000|Open-label Treatment|Target lesion removed|0|||
145626591|NCT00984282|525145713|FG001|Open-label Treatment|Target lesion removed|1|||
145626592|NCT00984282|525145712|FG000|Open-label Treatment|Protocol driven decision point|1|||
145626593|NCT00984282|525145713|FG001|Open-label Treatment|Protocol driven decision point|1|||
145626594|NCT00984282|525145712|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
145626595|NCT00984282|525145713|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
145456977|NCT03842969|524525081|FG002|Overall Study|Lost to Follow-up|0|||
145456978|NCT03842969|524525079|FG000|Overall Study|Adverse Event|0|||
145456979|NCT03842969|524525080|FG001|Overall Study|Adverse Event|2|||
145456980|NCT03842969|524525081|FG002|Overall Study|Adverse Event|0|||
145588219|NCT01781572|525004440|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
145588220|NCT01781572|525004438|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
145588221|NCT01781572|525004439|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
145588222|NCT01781572|525004440|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
145588223|NCT01781572|525004438|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
145588224|NCT01781572|525004439|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
145588225|NCT01781572|525004440|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
145588226|NCT01781572|525004438|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
145588227|NCT01781572|525004439|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
145588228|NCT01781572|525004440|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
145588229|NCT01781572|525004438|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
145588230|NCT01781572|525004439|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
145588231|NCT01781572|525004440|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
145588232|NCT01781572|525004438|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
145456981|NCT04187144|524525082|FG000|Overall Study|Lost to Follow-up|12|||
145456982|NCT04187144|524525083|FG001|Overall Study|Lost to Follow-up|11|||
145456983|NCT04187144|524525082|FG000|Overall Study|Withdrawal by Subject|20|||
145456984|NCT04187144|524525083|FG001|Overall Study|Withdrawal by Subject|18|||
145456985|NCT04187144|524525082|FG000|Overall Study|Adverse Event|19|||
145456986|NCT04187144|524525083|FG001|Overall Study|Adverse Event|4|||
145456987|NCT04187144|524525082|FG000|Overall Study|Physician Decision|5|||
145456988|NCT04187144|524525083|FG001|Overall Study|Physician Decision|3|||
145456989|NCT04187144|524525082|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
145456990|NCT04187144|524525083|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
145456991|NCT04187144|524525082|FG000|Overall Study|Protocol Deviation|1|||
145456992|NCT04187144|524525083|FG001|Overall Study|Protocol Deviation|4|||
145456993|NCT00789581|524525086|FG000|AC Therapy|Adverse Event|2|||
145456994|NCT00789581|524525087|FG001|AC Therapy|Adverse Event|3|||
145456995|NCT00789581|524525086|FG000|AC Therapy|Withdrawal by Subject|4|||
145456996|NCT00789581|524525087|FG001|AC Therapy|Withdrawal by Subject|7|||
145456997|NCT00789581|524525086|FG000|AC Therapy|Disease recurrence|3|||
145456998|NCT00789581|524525087|FG001|AC Therapy|Disease recurrence|1|||
145456999|NCT00789581|524525086|FG000|AC Therapy|Intercurrent Illness|1|||
145457000|NCT00789581|524525087|FG001|AC Therapy|Intercurrent Illness|0|||
145457001|NCT00789581|524525086|FG000|AC Therapy|Never Treated|1|||
145457002|NCT00789581|524525087|FG001|AC Therapy|Never Treated|4|||
145457003|NCT00789581|524525086|FG000|AC Therapy|Other|0|||
145457004|NCT00789581|524525087|FG001|AC Therapy|Other|2|||
145457005|NCT00789581|524525086|FG000|Adjuvant Therapy|Never treated|2|||
145457006|NCT00789581|524525087|FG001|Adjuvant Therapy|Never treated|2|||
145588233|NCT01781572|525004439|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
145588234|NCT01781572|525004440|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
145588235|NCT01438541|525004441|FG000|Overall Study|Physician Decision|1|||
145588236|NCT01438541|525004441|FG000|Overall Study|Withdrawal by Subject|1|||
145457007|NCT00789581|524525086|FG000|Adjuvant Therapy|Adverse Event|20|||
145457008|NCT00789581|524525087|FG001|Adjuvant Therapy|Adverse Event|44|||
145588237|NCT01438541|525004441|FG000|Overall Study|discharge from the hospital|5|||
145588238|NCT02091167|525004442|FG000|Overall Study|Lost to Follow-up|0|||
145588239|NCT02091167|525004443|FG001|Overall Study|Lost to Follow-up|2|||
145588240|NCT03096782|525004446|FG000|Overall Study|Death|1|||
145588241|NCT03096782|525004446|FG000|Overall Study|Participant Relapsed|1|||
145588242|NCT03156023|525004447|FG000|Overall Study|Withdrawal by Subject|1|||
145588243|NCT03156023|525004448|FG001|Overall Study|Withdrawal by Subject|0|||
145588244|NCT03156023|525004449|FG002|Overall Study|Withdrawal by Subject|2|||
145588245|NCT03156023|525004450|FG003|Overall Study|Withdrawal by Subject|1|||
145588246|NCT03156023|525004451|FG004|Overall Study|Withdrawal by Subject|1|||
145588247|NCT03156023|525004447|FG000|Overall Study|Lost to Follow-up|0|||
145588248|NCT03156023|525004448|FG001|Overall Study|Lost to Follow-up|0|||
145588249|NCT03156023|525004449|FG002|Overall Study|Lost to Follow-up|0|||
145588250|NCT03156023|525004450|FG003|Overall Study|Lost to Follow-up|0|||
145588251|NCT03156023|525004451|FG004|Overall Study|Lost to Follow-up|1|||
145588252|NCT00932893|525004452|FG000|Overall Study|Death|115|||
145588253|NCT00932893|525004453|FG001|Overall Study|Death|24|||
145588254|NCT00932893|525004452|FG000|Overall Study|Lost to Follow-up|8|||
145588255|NCT00932893|525004453|FG001|Overall Study|Lost to Follow-up|0|||
145588256|NCT00932893|525004452|FG000|Overall Study|Withdrawal by Subject|5|||
145588257|NCT00932893|525004453|FG001|Overall Study|Withdrawal by Subject|2|||
145588258|NCT00932893|525004452|FG000|Overall Study|Other|5|||
145588259|NCT00932893|525004453|FG001|Overall Study|Other|144|||
145588260|NCT02526693|525005893|FG000|Overall Study|Physician Decision|3|||
145588261|NCT02526693|525005894|FG001|Overall Study|Physician Decision|1|||
145588262|NCT01585103|525005896|FG000|Overall Study|Unable to swallow Cytosponge|6|||
145588263|NCT03581305|525005897|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
145588264|NCT03581305|525005898|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
145588265|NCT03581305|525005897|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
145588266|NCT03581305|525005898|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
145588267|NCT03581305|525005897|FG000|Serotonergic Study|Withdrawal by Subject|5|||
145588268|NCT03581305|525005898|FG001|Serotonergic Study|Withdrawal by Subject|1|||
145588269|NCT01798927|525005899|FG000|Overall Study|Withdrawal by Subject|1|||
145588270|NCT00328510|525005901|FG000|Overall Study|Gag disorder, could not use frame|4|||
145588271|NCT00328510|525005902|FG001|Overall Study|Gag disorder, could not use frame|0|||
145588272|NCT00328510|525005901|FG000|Overall Study|Dentition problems, could not use frame|1|||
145588273|NCT00328510|525005902|FG001|Overall Study|Dentition problems, could not use frame|0|||
145588274|NCT00328510|525005901|FG000|Overall Study|Withdrawal by Subject|4|||
145588275|NCT00328510|525005902|FG001|Overall Study|Withdrawal by Subject|2|||
145588276|NCT00328510|525005901|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
145588277|NCT00328510|525005902|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
145588278|NCT00328510|525005901|FG000|Overall Study|Treatment changed to a single fraction|1|||
145588279|NCT00328510|525005902|FG001|Overall Study|Treatment changed to a single fraction|1|||
145588280|NCT01990950|525005904|FG000|Overall Study|Death|3|||
145588281|NCT01990950|525005904|FG000|Overall Study|Lost to Follow-up|2|||
145588282|NCT01990950|525005904|FG000|Overall Study|Withdrawal by Subject|6|||
145588283|NCT02349295|525005905|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
145588284|NCT02349295|525005906|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
145588285|NCT02349295|525005907|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
145588286|NCT02349295|525005908|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588287|NCT02349295|525005909|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588288|NCT02349295|525005910|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588289|NCT02349295|525005911|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588290|NCT02349295|525005912|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588291|NCT02349295|525005913|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588292|NCT02349295|525005914|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588293|NCT02349295|525005915|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588294|NCT02349295|525005916|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588295|NCT02349295|525005917|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588296|NCT02349295|525005918|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
145588297|NCT02349295|525005905|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
145588298|NCT02349295|525005906|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
145457009|NCT00789581|524525086|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
145457010|NCT00789581|524525087|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
145457011|NCT00789581|524525086|FG000|Adjuvant Therapy|Disease recurrence|2|||
145457012|NCT00789581|524525087|FG001|Adjuvant Therapy|Disease recurrence|1|||
145457013|NCT00789581|524525086|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
145588299|NCT02349295|525005907|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
145588300|NCT02349295|525005908|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588301|NCT02349295|525005909|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588302|NCT02349295|525005910|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588303|NCT02349295|525005911|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588304|NCT02349295|525005912|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588305|NCT02349295|525005913|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588306|NCT02349295|525005914|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588307|NCT02349295|525005915|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588308|NCT02349295|525005916|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588309|NCT02349295|525005917|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588310|NCT02349295|525005918|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
145588311|NCT02349295|525005905|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
145588312|NCT02349295|525005906|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
145588313|NCT02349295|525005907|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
145588314|NCT02349295|525005908|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588315|NCT02349295|525005909|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588316|NCT02349295|525005910|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588317|NCT02349295|525005911|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588318|NCT02349295|525005912|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588319|NCT02349295|525005913|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588320|NCT02349295|525005914|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588321|NCT02349295|525005915|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588322|NCT02349295|525005916|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588323|NCT02349295|525005917|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588324|NCT02349295|525005918|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
145588325|NCT02349295|525005905|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
145588326|NCT02349295|525005906|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
145588327|NCT02349295|525005907|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
145588328|NCT02349295|525005908|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588329|NCT02349295|525005909|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588330|NCT02349295|525005910|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588331|NCT02349295|525005911|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588332|NCT02349295|525005912|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588333|NCT02349295|525005913|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588334|NCT02349295|525005914|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588335|NCT02349295|525005915|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588336|NCT02349295|525005916|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588337|NCT02349295|525005917|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588338|NCT02349295|525005918|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
145588339|NCT02349295|525005905|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588340|NCT02349295|525005906|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
145588341|NCT02349295|525005907|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
145588342|NCT02349295|525005908|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588343|NCT02349295|525005909|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588344|NCT02349295|525005910|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588345|NCT02349295|525005911|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588346|NCT02349295|525005912|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588347|NCT02349295|525005913|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588348|NCT02349295|525005914|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588349|NCT02349295|525005915|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588350|NCT02349295|525005916|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588351|NCT02349295|525005917|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588352|NCT02349295|525005918|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
145588353|NCT02349295|525005905|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
145588354|NCT02349295|525005906|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
145588355|NCT02349295|525005907|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
145588356|NCT02349295|525005908|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
145588357|NCT02349295|525005909|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
145588358|NCT02349295|525005910|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
145588359|NCT02349295|525005911|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
145588360|NCT02349295|525005912|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
145588361|NCT02349295|525005913|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
145588362|NCT02349295|525005914|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
145588363|NCT02349295|525005915|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
145588364|NCT02349295|525005916|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
145588365|NCT02349295|525005917|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
145588366|NCT02349295|525005918|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
145588367|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588368|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588369|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588370|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588371|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588372|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588373|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588374|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
145588375|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
145588376|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
145588377|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
145588378|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588379|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588380|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
145588381|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588382|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588383|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588384|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588385|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588386|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588387|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588388|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
145588389|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
145588390|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
145588391|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
145588392|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588393|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588394|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
145588395|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588396|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588397|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588398|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588399|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588400|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588401|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588402|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
145588403|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588404|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
145588405|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588406|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145457014|NCT00789581|524525087|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
145457015|NCT00789581|524525086|FG000|Adjuvant Therapy|Protocol Violation|1|||
145457016|NCT00789581|524525087|FG001|Adjuvant Therapy|Protocol Violation|1|||
145457017|NCT00789581|524525086|FG000|Adjuvant Therapy|Other|0|||
145457018|NCT00789581|524525087|FG001|Adjuvant Therapy|Other|1|||
145457019|NCT01468207|524525088|FG000|Treatment Period 1|Adverse Event|1|||
145457020|NCT01468207|524525089|FG001|Treatment Period 1|Adverse Event|0|||
145457021|NCT01468207|524525090|FG002|Treatment Period 1|Adverse Event|0|||
145457022|NCT01468207|524525091|FG003|Treatment Period 1|Adverse Event|0|||
145457023|NCT01468207|524525092|FG004|Treatment Period 1|Adverse Event|0|||
145457024|NCT01468207|524525093|FG005|Treatment Period 1|Adverse Event|0|||
145457025|NCT01468207|524525088|FG000|Treatment Period 1|Protocol Violation|1|||
145457026|NCT01468207|524525089|FG001|Treatment Period 1|Protocol Violation|1|||
145457027|NCT01468207|524525090|FG002|Treatment Period 1|Protocol Violation|0|||
145457028|NCT01468207|524525091|FG003|Treatment Period 1|Protocol Violation|0|||
145457029|NCT01468207|524525092|FG004|Treatment Period 1|Protocol Violation|0|||
145457030|NCT01468207|524525093|FG005|Treatment Period 1|Protocol Violation|0|||
145457031|NCT01468207|524525088|FG000|Treatment Period 1|Withdrawal by Subject|5|||
145457032|NCT01468207|524525089|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145457033|NCT01468207|524525090|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145457034|NCT01468207|524525091|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145457035|NCT01468207|524525092|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145457036|NCT01468207|524525093|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145457037|NCT01468207|524525088|FG000|Treatment Period 1|Lost to Follow-up|2|||
145457038|NCT01468207|524525089|FG001|Treatment Period 1|Lost to Follow-up|1|||
145457039|NCT01468207|524525090|FG002|Treatment Period 1|Lost to Follow-up|0|||
145588407|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145588408|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
145457040|NCT01468207|524525091|FG003|Treatment Period 1|Lost to Follow-up|0|||
145457041|NCT01468207|524525092|FG004|Treatment Period 1|Lost to Follow-up|0|||
145588409|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
145588410|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
145588411|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
145588412|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
145588413|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
145588414|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
145457042|NCT01468207|524525093|FG005|Treatment Period 1|Lost to Follow-up|0|||
145457043|NCT01468207|524525088|FG000|Treatment Period 1|Other|0|||
145457044|NCT01468207|524525089|FG001|Treatment Period 1|Other|2|||
145457045|NCT01468207|524525090|FG002|Treatment Period 1|Other|0|||
145457046|NCT01468207|524525091|FG003|Treatment Period 1|Other|0|||
145457047|NCT01468207|524525092|FG004|Treatment Period 1|Other|0|||
145457048|NCT01468207|524525093|FG005|Treatment Period 1|Other|0|||
145457049|NCT01468207|524525088|FG000|Treatment Period 2|Adverse Event|0|||
145457050|NCT01468207|524525089|FG001|Treatment Period 2|Adverse Event|0|||
145457051|NCT01468207|524525090|FG002|Treatment Period 2|Adverse Event|6|||
145457052|NCT01468207|524525091|FG003|Treatment Period 2|Adverse Event|1|||
145457053|NCT01468207|524525092|FG004|Treatment Period 2|Adverse Event|2|||
145457054|NCT01468207|524525093|FG005|Treatment Period 2|Adverse Event|1|||
145457055|NCT01468207|524525088|FG000|Treatment Period 2|Lack of Efficacy|0|||
145457056|NCT01468207|524525089|FG001|Treatment Period 2|Lack of Efficacy|0|||
145457057|NCT01468207|524525090|FG002|Treatment Period 2|Lack of Efficacy|1|||
145457058|NCT01468207|524525091|FG003|Treatment Period 2|Lack of Efficacy|1|||
145457059|NCT01468207|524525092|FG004|Treatment Period 2|Lack of Efficacy|0|||
145457060|NCT01468207|524525093|FG005|Treatment Period 2|Lack of Efficacy|2|||
145457061|NCT01468207|524525088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145457062|NCT01468207|524525089|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145457063|NCT01468207|524525090|FG002|Treatment Period 2|Withdrawal by Subject|5|||
145457064|NCT01468207|524525091|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145457065|NCT01468207|524525092|FG004|Treatment Period 2|Withdrawal by Subject|0|||
145457066|NCT01468207|524525093|FG005|Treatment Period 2|Withdrawal by Subject|2|||
145457067|NCT01468207|524525088|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
145457068|NCT01468207|524525089|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
145457069|NCT01468207|524525090|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
145457070|NCT01468207|524525091|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
145457071|NCT01468207|524525092|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
145457072|NCT01468207|524525093|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
145457073|NCT01468207|524525088|FG000|Treatment Period 2|Lost to Follow-up|0|||
145457074|NCT01468207|524525089|FG001|Treatment Period 2|Lost to Follow-up|0|||
145457075|NCT01468207|524525090|FG002|Treatment Period 2|Lost to Follow-up|5|||
145457076|NCT01468207|524525091|FG003|Treatment Period 2|Lost to Follow-up|1|||
145457077|NCT01468207|524525092|FG004|Treatment Period 2|Lost to Follow-up|0|||
145457078|NCT01468207|524525093|FG005|Treatment Period 2|Lost to Follow-up|0|||
145457079|NCT01468207|524525088|FG000|Treatment Period 2|Other|0|||
145457080|NCT01468207|524525089|FG001|Treatment Period 2|Other|0|||
145457081|NCT01468207|524525090|FG002|Treatment Period 2|Other|5|||
145457082|NCT01468207|524525091|FG003|Treatment Period 2|Other|1|||
145457083|NCT01468207|524525092|FG004|Treatment Period 2|Other|1|||
145457084|NCT01468207|524525093|FG005|Treatment Period 2|Other|2|||
145457085|NCT00489736|524525097|FG000|Overall Study|Lack of Efficacy|53|||
145457086|NCT00489736|524525098|FG001|Overall Study|Lack of Efficacy|14|||
145457087|NCT00489736|524525097|FG000|Overall Study|Adverse Event|32|||
145457088|NCT00489736|524525098|FG001|Overall Study|Adverse Event|45|||
145457089|NCT00489736|524525097|FG000|Overall Study|Poor compliance|6|||
145457090|NCT00489736|524525098|FG001|Overall Study|Poor compliance|2|||
145457091|NCT00489736|524525097|FG000|Overall Study|Not coded/ Not pre-specified|5|||
145457092|NCT00489736|524525098|FG001|Overall Study|Not coded/ Not pre-specified|8|||
145457093|NCT04085458|524525099|FG000|Overall Study|Other|1|||
145457094|NCT04085458|524525099|FG000|Overall Study|Withdrawal by Subject|2|||
145457095|NCT04085458|524525099|FG000|Overall Study|Adverse Event|2|||
145457096|NCT01921218|524525100|FG000|Overall Study|Death|2|||
145457097|NCT01921218|524525101|FG001|Overall Study|Death|1|||
145457098|NCT01921218|524525100|FG000|Overall Study|Withdrawal by Subject|0|||
145457099|NCT01921218|524525101|FG001|Overall Study|Withdrawal by Subject|2|||
145457100|NCT01921218|524525100|FG000|Overall Study|Kidney transplant|1|||
145457101|NCT01921218|524525101|FG001|Overall Study|Kidney transplant|1|||
145457102|NCT03389555|524525102|FG000|Overall Study|Protocol Violation|1|||
145457103|NCT03389555|524525103|FG001|Overall Study|Protocol Violation|3|||
145457104|NCT03389555|524525102|FG000|Overall Study|Death|1|||
145457105|NCT03389555|524525103|FG001|Overall Study|Death|0|||
145457106|NCT01885208|524525104|FG000|Overall Study|Unclassified|32|||
145457107|NCT01885208|524525105|FG001|Overall Study|Unclassified|38|||
145457108|NCT03224507|524525109|FG000|Overall Study|Death|3|||
145457109|NCT03224507|524525110|FG001|Overall Study|Death|0|||
145457110|NCT03224507|524525109|FG000|Overall Study|Lack of Efficacy|6|||
145457111|NCT03224507|524525110|FG001|Overall Study|Lack of Efficacy|0|||
145457112|NCT03224507|524525109|FG000|Overall Study|Withdrawal by Subject|6|||
145457113|NCT03224507|524525110|FG001|Overall Study|Withdrawal by Subject|0|||
145457114|NCT01032291|524525111|FG000|Safety Lead-in|Adverse Event|1|||
145457115|NCT01032291|524525112|FG001|Safety Lead-in|Adverse Event|0|||
145457116|NCT01032291|524525113|FG002|Safety Lead-in|Adverse Event|0|||
145457117|NCT01032291|524525111|FG000|Safety Lead-in|Death|1|||
145457118|NCT01032291|524525112|FG001|Safety Lead-in|Death|0|||
145588415|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
145457119|NCT01032291|524525113|FG002|Safety Lead-in|Death|0|||
145457120|NCT01032291|524525111|FG000|Proof of Concept|Adverse Event|0|||
145457121|NCT01032291|524525112|FG001|Proof of Concept|Adverse Event|5|||
145457122|NCT01032291|524525113|FG002|Proof of Concept|Adverse Event|1|||
145457123|NCT01032291|524525111|FG000|Proof of Concept|Death|0|||
145457124|NCT01032291|524525112|FG001|Proof of Concept|Death|1|||
145457125|NCT01032291|524525113|FG002|Proof of Concept|Death|2|||
145457126|NCT01032291|524525111|FG000|Proof of Concept|Lack of Efficacy|0|||
145457127|NCT01032291|524525112|FG001|Proof of Concept|Lack of Efficacy|1|||
145457128|NCT01032291|524525113|FG002|Proof of Concept|Lack of Efficacy|0|||
145457129|NCT01032291|524525111|FG000|Proof of Concept|Never Received Study Drug|0|||
145457130|NCT01032291|524525112|FG001|Proof of Concept|Never Received Study Drug|1|||
145457131|NCT01032291|524525113|FG002|Proof of Concept|Never Received Study Drug|0|||
145457132|NCT02449889|524525114|FG000|Overall Study|Adverse Event|1|||
145457133|NCT02449889|524525115|FG001|Overall Study|Adverse Event|2|||
145457134|NCT02449889|524525116|FG002|Overall Study|Adverse Event|0|||
145457135|NCT02449889|524525114|FG000|Overall Study|Protocol Violation|0|||
145457136|NCT02449889|524525115|FG001|Overall Study|Protocol Violation|4|||
145457137|NCT02449889|524525116|FG002|Overall Study|Protocol Violation|1|||
145457138|NCT01973387|524525117|FG000|Overall Study|Adverse Event|14|||
145457139|NCT01973387|524525118|FG001|Overall Study|Adverse Event|4|||
145457140|NCT01973387|524525117|FG000|Overall Study|Withdrawal by Subject|7|||
145457141|NCT01973387|524525118|FG001|Overall Study|Withdrawal by Subject|4|||
145457142|NCT01973387|524525117|FG000|Overall Study|Study terminated by sponsor|63|||
145457143|NCT01973387|524525118|FG001|Overall Study|Study terminated by sponsor|0|||
145457144|NCT01973387|524525117|FG000|Overall Study|Progressive disease or relapse|16|||
145457145|NCT01973387|524525118|FG001|Overall Study|Progressive disease or relapse|5|||
145457146|NCT01973387|524525117|FG000|Overall Study|Death|4|||
145457147|NCT01973387|524525118|FG001|Overall Study|Death|3|||
145457148|NCT01973387|524525117|FG000|Overall Study|Randomized, not treated|2|||
145457149|NCT01973387|524525118|FG001|Overall Study|Randomized, not treated|2|||
145457150|NCT03327220|524525119|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
145457151|NCT03327220|524525120|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
145457152|NCT03327220|524525119|FG000|Overall Study|Investigator Decision|2|||
145457153|NCT03327220|524525120|FG001|Overall Study|Investigator Decision|0|||
145457154|NCT03327220|524525119|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
145457155|NCT03327220|524525120|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
145457156|NCT03327220|524525119|FG000|Overall Study|Fungal infection|1|||
145457157|NCT03327220|524525120|FG001|Overall Study|Fungal infection|0|||
145457158|NCT03327220|524525119|FG000|Overall Study|Discharged to Rehabilitation|0|||
145457159|NCT03327220|524525120|FG001|Overall Study|Discharged to Rehabilitation|1|||
145457160|NCT03327220|524525119|FG000|Overall Study|Missing|1|||
145457161|NCT03327220|524525120|FG001|Overall Study|Missing|0|||
145457162|NCT01498575|524525121|FG000|Overall Sample|Withdrawal by Subject|60|||
145457163|NCT01498575|524525122|FG001|Overall Sample|Withdrawal by Subject|14|||
145457164|NCT01498575|524525121|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
145457165|NCT01498575|524525122|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
145457166|NCT01498575|524525121|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
145457167|NCT01498575|524525122|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
145457168|NCT00693017|524525124|FG000|Overall Study|Sponsor Decision|2|||
145457169|NCT00693017|524525125|FG001|Overall Study|Sponsor Decision|1|||
145457170|NCT00693017|524525124|FG000|Overall Study|Death|0|||
145588416|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
145588417|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
145588418|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
145588419|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
145588420|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
145588421|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
145588422|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
145588423|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145457171|NCT00693017|524525125|FG001|Overall Study|Death|1|||
145457172|NCT00688324|524525127|FG000|Overall Study|Withdrawal by Subject|2|||
145457173|NCT00688324|524525127|FG000|Overall Study|Physician Decision|5|||
145457174|NCT00688324|524525127|FG000|Overall Study|Lost to Follow-up|1|||
145457175|NCT03176472|524525130|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
145457176|NCT03176472|524525131|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
145457177|NCT03176472|524525130|FG000|Double Blind Treatment Period|Adverse Event|0|||
145457178|NCT03176472|524525131|FG001|Double Blind Treatment Period|Adverse Event|5|||
145588424|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145457179|NCT03176472|524525130|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
145457180|NCT03176472|524525131|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
145457181|NCT03176472|524525130|FG000|Double Blind Treatment Period|Physician Decision|0|||
145457182|NCT03176472|524525131|FG001|Double Blind Treatment Period|Physician Decision|1|||
145457183|NCT03176472|524525130|FG000|Double Blind Treatment Period|Protocol Violation|1|||
145457184|NCT03176472|524525131|FG001|Double Blind Treatment Period|Protocol Violation|0|||
145457185|NCT03176472|524525130|FG000|Double Blind Treatment Period|Not Provided|1|||
145457186|NCT03176472|524525131|FG001|Double Blind Treatment Period|Not Provided|0|||
145457187|NCT03176472|524525130|FG000|Open Label Extension|Withdrawal by Subject|3|||
145457188|NCT03176472|524525131|FG001|Open Label Extension|Withdrawal by Subject|4|||
145457189|NCT03176472|524525130|FG000|Open Label Extension|Adverse Event|2|||
145457190|NCT03176472|524525131|FG001|Open Label Extension|Adverse Event|4|||
145457191|NCT03176472|524525130|FG000|Open Label Extension|Lost to Follow-up|1|||
145457192|NCT03176472|524525131|FG001|Open Label Extension|Lost to Follow-up|2|||
145457193|NCT03176472|524525130|FG000|Open Label Extension|Protocol Violation|0|||
145457194|NCT03176472|524525131|FG001|Open Label Extension|Protocol Violation|1|||
145457195|NCT03176472|524525130|FG000|Open Label Extension|Not Provided|2|||
145457196|NCT03176472|524525131|FG001|Open Label Extension|Not Provided|1|||
145457197|NCT03272828|524525132|FG000|Overall Study|Lost to Follow-up|7|||
145457198|NCT03272828|524525133|FG001|Overall Study|Lost to Follow-up|7|||
145457199|NCT03272828|524525132|FG000|Overall Study|Withdrawal by Subject|2|||
145457200|NCT03272828|524525133|FG001|Overall Study|Withdrawal by Subject|0|||
145457201|NCT03272828|524525132|FG000|Overall Study|Deceased|1|||
145457202|NCT03272828|524525133|FG001|Overall Study|Deceased|1|||
145457203|NCT03272828|524525132|FG000|Overall Study|Failed implant|1|||
145457204|NCT03272828|524525133|FG001|Overall Study|Failed implant|2|||
145457205|NCT03077438|524525134|FG000|Overall Study|Protocol Violation|3|||
145457206|NCT03077438|524525135|FG001|Overall Study|Protocol Violation|5|||
145457207|NCT03077438|524525134|FG000|Overall Study|Withdrawal by Subject|3|||
145457208|NCT03077438|524525135|FG001|Overall Study|Withdrawal by Subject|6|||
145457209|NCT03077438|524525134|FG000|Overall Study|Lost to Follow-up|6|||
145457210|NCT03077438|524525135|FG001|Overall Study|Lost to Follow-up|3|||
145457211|NCT04154345|524525140|FG000|Overall Study|Covid-19 pandemic|4|||
145457212|NCT00866047|524525142|FG000|Treatment Period|Progressive disease|13|||
145457213|NCT00866047|524525142|FG000|Treatment Period|Adverse Event|16|||
145457214|NCT00866047|524525142|FG000|Treatment Period|Physician Decision|14|||
145457215|NCT00866047|524525142|FG000|Treatment Period|Withdrawal by Subject|5|||
145457216|NCT00866047|524525142|FG000|Follow-up Period|Lost to Follow-up|5|||
145457217|NCT03773133|524525143|FG000|Overall Study|Screen Failure|8|||
145457218|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
145457219|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
145457220|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
145457221|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
145457222|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
145457223|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
145457224|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
145457225|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
145457226|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
145457227|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
145457228|NCT01639339|524525147|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
145457229|NCT01639339|524525148|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
145457230|NCT01639339|524525147|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
145457231|NCT01639339|524525148|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
145457232|NCT01639339|524525147|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
145457233|NCT01639339|524525148|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
145457234|NCT01639339|524525147|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
145457235|NCT01639339|524525148|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
145457236|NCT01639339|524525147|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
145457237|NCT01639339|524525148|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
145457238|NCT00367744|524525149|FG000|Overall Study|Lost to Follow-up|4|||
145457239|NCT00367744|524525150|FG001|Overall Study|Lost to Follow-up|5|||
145457240|NCT00503581|524525157|FG000|Overall Study|Study closed|3|||
145457241|NCT00503581|524525158|FG001|Overall Study|Study closed|4|||
145457242|NCT00503581|524525159|FG002|Overall Study|Study closed|2|||
145457243|NCT01666119|524525160|FG000|Overall Study|Adverse Event|6|||
145457244|NCT01666119|524525160|FG000|Overall Study|Withdrawal by Subject|16|||
145457245|NCT01666119|524525160|FG000|Overall Study|Lost to Follow-up|7|||
145457246|NCT01666119|524525160|FG000|Overall Study|non compliance with study medication, pa|18|||
145457247|NCT01666119|524525160|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
145457248|NCT02979093|524525171|FG000|First Scan Session|Scanning data problems|1|||
145457249|NCT02979093|524525172|FG001|First Scan Session|Scanning data problems|2|||
145457250|NCT02979093|524525173|FG002|First Scan Session|Scanning data problems|2|||
145457251|NCT02979093|524525174|FG003|First Scan Session|Scanning data problems|0|||
145457252|NCT02979093|524525171|FG000|Second Scan Session|Scanning data problems|3|||
145457253|NCT02979093|524525172|FG001|Second Scan Session|Scanning data problems|0|||
145457254|NCT02979093|524525173|FG002|Second Scan Session|Scanning data problems|1|||
145457255|NCT02979093|524525174|FG003|Second Scan Session|Scanning data problems|3|||
145457256|NCT06107803|524525175|FG000|Overall Study|Adverse Event|1|||
145457257|NCT06107803|524525175|FG000|Overall Study|Withdrawal by Subject|2|||
145457258|NCT06107803|524525175|FG000|Overall Study|Protocol Violation|1|||
145457259|NCT04730635|524525176|FG000|Overall Study|Lost to Follow-up|1|||
145457260|NCT04730635|524525177|FG001|Overall Study|Lost to Follow-up|0|||
145457261|NCT04730635|524525176|FG000|Overall Study|Withdrawal by Subject|0|||
145457262|NCT04730635|524525177|FG001|Overall Study|Withdrawal by Subject|1|||
145457263|NCT03070223|524525178|FG000|Overall Study|Lost to Follow-up|34|||
145457264|NCT03070223|524525179|FG001|Overall Study|Lost to Follow-up|27|||
145457265|NCT03070223|524525178|FG000|Overall Study|Withdrawal by Subject|12|||
145588425|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588426|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588427|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588428|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588429|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588430|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
145588431|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
145588432|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
145588433|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
145588434|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588435|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588436|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
145588437|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588438|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588439|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588440|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588441|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588442|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588443|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588444|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
145588445|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
145588446|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588447|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588448|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588449|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588450|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
145588451|NCT02349295|525005905|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588452|NCT02349295|525005906|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588453|NCT02349295|525005907|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588454|NCT02349295|525005908|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588455|NCT02349295|525005909|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588456|NCT02349295|525005910|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588457|NCT02349295|525005911|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588458|NCT02349295|525005912|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
145588459|NCT02349295|525005913|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
145588460|NCT02349295|525005914|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588461|NCT02349295|525005915|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588462|NCT02349295|525005916|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588463|NCT02349295|525005917|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588464|NCT02349295|525005918|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
145588465|NCT02349295|525005905|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588466|NCT02349295|525005906|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588467|NCT02349295|525005907|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588468|NCT02349295|525005908|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588469|NCT02349295|525005909|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588470|NCT02349295|525005910|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588471|NCT02349295|525005911|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588472|NCT02349295|525005912|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588473|NCT02349295|525005913|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145457266|NCT03070223|524525179|FG001|Overall Study|Withdrawal by Subject|22|||
145457267|NCT03070223|524525178|FG000|Overall Study|Protocol Violation|0|||
145457268|NCT03070223|524525179|FG001|Overall Study|Protocol Violation|1|||
145457269|NCT04934800|524525180|FG000|Overall Study|Other|1|||
145457270|NCT04934800|524525180|FG000|Overall Study|Withdrawal by Subject|5|||
145457271|NCT04934800|524525180|FG000|Overall Study|Lack of Efficacy|1|||
145457272|NCT04934800|524525180|FG000|Overall Study|Adverse Event|9|||
145457273|NCT04934800|524525180|FG000|Overall Study|Lost to Follow-up|5|||
145457274|NCT04934800|524525180|FG000|Overall Study|Enrolled but not treated|1|||
145588474|NCT02349295|525005914|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588475|NCT02349295|525005915|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
145588476|NCT02349295|525005916|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
145588477|NCT02349295|525005917|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
145588478|NCT02349295|525005918|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
145588479|NCT02349295|525005905|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588480|NCT02349295|525005906|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588481|NCT02349295|525005907|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588482|NCT02349295|525005908|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588483|NCT02349295|525005909|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588484|NCT02349295|525005910|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588485|NCT02349295|525005911|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588486|NCT02349295|525005912|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588487|NCT02349295|525005913|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588488|NCT02349295|525005914|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588489|NCT02349295|525005915|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588490|NCT02349295|525005916|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
145588491|NCT02349295|525005917|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
145588492|NCT02349295|525005918|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
145588493|NCT02349295|525005905|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588494|NCT02349295|525005906|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588495|NCT02349295|525005907|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588496|NCT02349295|525005908|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588497|NCT02349295|525005909|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588498|NCT02349295|525005910|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588499|NCT02349295|525005911|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588500|NCT02349295|525005912|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588501|NCT02349295|525005913|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588502|NCT02349295|525005914|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588503|NCT02349295|525005915|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588504|NCT02349295|525005916|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
145588505|NCT02349295|525005917|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
145588506|NCT02349295|525005918|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
145588507|NCT02349295|525005905|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588508|NCT02349295|525005906|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588509|NCT02349295|525005907|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588510|NCT02349295|525005908|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588511|NCT02349295|525005909|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588512|NCT02349295|525005910|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588513|NCT02349295|525005911|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588514|NCT02349295|525005912|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588515|NCT02349295|525005913|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588516|NCT02349295|525005914|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588517|NCT02349295|525005915|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588518|NCT02349295|525005916|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
145588519|NCT02349295|525005917|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588520|NCT02349295|525005918|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
145588521|NCT02349295|525005905|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588522|NCT02349295|525005906|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588523|NCT02349295|525005907|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588524|NCT02349295|525005908|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588525|NCT02349295|525005909|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588526|NCT02349295|525005910|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588527|NCT02349295|525005911|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588528|NCT02349295|525005912|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588529|NCT02349295|525005913|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588530|NCT02349295|525005914|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588531|NCT02349295|525005915|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588532|NCT02349295|525005916|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
145457275|NCT00516906|524525181|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
145457276|NCT00516906|524525182|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
145588533|NCT02349295|525005917|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588534|NCT02349295|525005918|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
145588535|NCT06111742|525005927|FG000|Overall Study|Did not receive intervention|1|||
145588536|NCT06111742|525005928|FG001|Overall Study|Did not receive intervention|0|||
145588537|NCT06111742|525005929|FG002|Overall Study|Did not receive intervention|0|||
145588538|NCT06111742|525005927|FG000|Overall Study|Withdrawal by Subject|2|||
145588539|NCT06111742|525005928|FG001|Overall Study|Withdrawal by Subject|0|||
145588540|NCT06111742|525005929|FG002|Overall Study|Withdrawal by Subject|0|||
145588541|NCT01914926|525005930|FG000|Overall Study|Adverse Event|1|||
145588542|NCT01914926|525005931|FG001|Overall Study|Adverse Event|0|||
145588543|NCT01914926|525005930|FG000|Overall Study|uncooperative, agitated and removed|0|||
145588544|NCT01914926|525005931|FG001|Overall Study|uncooperative, agitated and removed|1|||
145588545|NCT03489304|525005932|FG000|Overall Study|Lost to Follow-up|4|||
145588546|NCT02605954|525005934|FG000|Overall Study|Adverse Event|5|||
145588547|NCT02605954|525005935|FG001|Overall Study|Adverse Event|1|||
145588548|NCT02605954|525005934|FG000|Overall Study|Investigator's Discretion|1|||
145588549|NCT02605954|525005935|FG001|Overall Study|Investigator's Discretion|0|||
145588550|NCT02605954|525005934|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145588551|NCT02605954|525005935|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145588552|NCT02605954|525005934|FG000|Overall Study|Withdrew Consent|2|||
145588553|NCT02605954|525005935|FG001|Overall Study|Withdrew Consent|2|||
145588554|NCT02605954|525005934|FG000|Overall Study|Lost to Follow-up|3|||
145588555|NCT02605954|525005935|FG001|Overall Study|Lost to Follow-up|0|||
145588556|NCT02605954|525005934|FG000|Overall Study|Randomized but not treated|0|||
145588557|NCT02605954|525005935|FG001|Overall Study|Randomized but not treated|1|||
145588558|NCT02301143|525005936|FG000|Induction Period|Enrolled But Not Treated|1|||
145588559|NCT02301143|525005937|FG001|Induction Period|Enrolled But Not Treated|0|||
145588560|NCT02301143|525005936|FG000|Induction Period|Death|1|||
145588561|NCT02301143|525005937|FG001|Induction Period|Death|0|||
145588562|NCT02301143|525005936|FG000|Induction Period|Adverse Event|22|||
145588563|NCT02301143|525005937|FG001|Induction Period|Adverse Event|0|||
145588564|NCT02301143|525005936|FG000|Induction Period|Progressive Disease|8|||
145588565|NCT02301143|525005937|FG001|Induction Period|Progressive Disease|0|||
145588566|NCT02301143|525005936|FG000|Induction Period|Withdrawal by Subject|3|||
145588567|NCT02301143|525005937|FG001|Induction Period|Withdrawal by Subject|0|||
145626596|NCT00984282|525145712|FG000|Open-label Treatment|Switched to commercial drug|6|||
145626597|NCT00984282|525145713|FG001|Open-label Treatment|Switched to commercial drug|7|||
145626598|NCT00984282|525145712|FG000|Open-label Treatment|Physician Decision|1|||
145626599|NCT00984282|525145713|FG001|Open-label Treatment|Physician Decision|0|||
145626600|NCT00984282|525145712|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
145626601|NCT00984282|525145713|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
145626602|NCT00984282|525145712|FG000|Long Term Follow-up|Death|27|||
145626603|NCT00984282|525145713|FG001|Long Term Follow-up|Death|68|||
145626604|NCT00984282|525145712|FG000|Long Term Follow-up|Lost to Follow-up|3|||
145626605|NCT00984282|525145713|FG001|Long Term Follow-up|Lost to Follow-up|6|||
145626606|NCT00984282|525145712|FG000|Long Term Follow-up|Protocol driven decision point|25|||
145626607|NCT00984282|525145713|FG001|Long Term Follow-up|Protocol driven decision point|26|||
145626608|NCT00984282|525145712|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
145626609|NCT00984282|525145713|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
145626610|NCT00984282|525145712|FG000|Long Term Follow-up|Switched to commercial drug|4|||
145626611|NCT00984282|525145713|FG001|Long Term Follow-up|Switched to commercial drug|2|||
145626612|NCT00984282|525145712|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
145626613|NCT00984282|525145713|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
145626614|NCT03255018|525145716|FG000|Overall Study|Death on study|0|||
145626615|NCT03255018|525145717|FG001|Overall Study|Death on study|5|||
145626616|NCT03255018|525145716|FG000|Overall Study|Withdrawal by Subject|0|||
145626617|NCT03255018|525145717|FG001|Overall Study|Withdrawal by Subject|2|||
145626618|NCT02950545|525145722|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
145626619|NCT02950545|525145723|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
145626620|NCT02950545|525145724|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
145626621|NCT02950545|525145725|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
145626622|NCT02950545|525145726|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
145626623|NCT02950545|525145727|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
145626624|NCT02950545|525145722|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
145626625|NCT02950545|525145723|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
145626626|NCT02950545|525145724|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
145626627|NCT02950545|525145725|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
145626628|NCT02950545|525145726|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
145588568|NCT02301143|525005936|FG000|Induction Period|Noncompliance with Study Drug|1|||
145588569|NCT02301143|525005937|FG001|Induction Period|Noncompliance with Study Drug|0|||
145588570|NCT02301143|525005936|FG000|Induction Period|Physician Decision|4|||
145626629|NCT02950545|525145727|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
145588571|NCT02301143|525005937|FG001|Induction Period|Physician Decision|0|||
145588572|NCT02301143|525005936|FG000|Induction Period|Symptomatic Deterioration|2|||
145588573|NCT02301143|525005937|FG001|Induction Period|Symptomatic Deterioration|0|||
145626630|NCT02950545|525145722|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
145626631|NCT02950545|525145723|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
145626632|NCT02950545|525145724|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
145588574|NCT02301143|525005936|FG000|Induction Period|Protocol Violation|2|||
145588575|NCT02301143|525005937|FG001|Induction Period|Protocol Violation|0|||
145588576|NCT02301143|525005936|FG000|Induction Period|Other|1|||
145588577|NCT02301143|525005937|FG001|Induction Period|Other|0|||
145588578|NCT02301143|525005936|FG000|Investigator's Choice|Adverse Event|0|||
145588579|NCT02301143|525005937|FG001|Investigator's Choice|Adverse Event|3|||
145588580|NCT02301143|525005936|FG000|Investigator's Choice|Progressive Disease|0|||
145588581|NCT02301143|525005937|FG001|Investigator's Choice|Progressive Disease|3|||
145588582|NCT02301143|525005936|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
145588583|NCT02301143|525005937|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
145588584|NCT02301143|525005936|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
145588585|NCT02301143|525005937|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
145588586|NCT02301143|525005936|FG000|Investigator's Choice|Other|0|||
145588587|NCT02301143|525005937|FG001|Investigator's Choice|Other|1|||
145588588|NCT02301143|525005936|FG000|Investigator's Choice|Unresectable Surgery|0|||
145588589|NCT02301143|525005937|FG001|Investigator's Choice|Unresectable Surgery|1|||
145588590|NCT03214367|525005938|FG000|Lead-in Period|Withdrawal by Subject|50|||
145588591|NCT03214367|525005939|FG001|Lead-in Period|Withdrawal by Subject|0|||
145588592|NCT03214367|525005940|FG002|Lead-in Period|Withdrawal by Subject|0|||
145588593|NCT03214367|525005941|FG003|Lead-in Period|Withdrawal by Subject|0|||
145588594|NCT03214367|525005942|FG004|Lead-in Period|Withdrawal by Subject|2|||
145588595|NCT03214367|525005943|FG005|Lead-in Period|Withdrawal by Subject|0|||
145588596|NCT03214367|525005944|FG006|Lead-in Period|Withdrawal by Subject|0|||
145588597|NCT03214367|525005945|FG007|Lead-in Period|Withdrawal by Subject|0|||
145588598|NCT03214367|525005938|FG000|Lead-in Period|Adverse Event|3|||
145588599|NCT03214367|525005939|FG001|Lead-in Period|Adverse Event|0|||
145588600|NCT03214367|525005940|FG002|Lead-in Period|Adverse Event|0|||
145588601|NCT03214367|525005941|FG003|Lead-in Period|Adverse Event|0|||
145588602|NCT03214367|525005942|FG004|Lead-in Period|Adverse Event|0|||
145588603|NCT03214367|525005943|FG005|Lead-in Period|Adverse Event|0|||
145588604|NCT03214367|525005944|FG006|Lead-in Period|Adverse Event|0|||
145588605|NCT03214367|525005945|FG007|Lead-in Period|Adverse Event|0|||
145588606|NCT03214367|525005938|FG000|Lead-in Period|Lost to Follow-up|12|||
145588607|NCT03214367|525005939|FG001|Lead-in Period|Lost to Follow-up|0|||
145588608|NCT03214367|525005940|FG002|Lead-in Period|Lost to Follow-up|0|||
145588609|NCT03214367|525005941|FG003|Lead-in Period|Lost to Follow-up|0|||
145588610|NCT03214367|525005942|FG004|Lead-in Period|Lost to Follow-up|0|||
145588611|NCT03214367|525005943|FG005|Lead-in Period|Lost to Follow-up|0|||
145588612|NCT03214367|525005944|FG006|Lead-in Period|Lost to Follow-up|0|||
145588613|NCT03214367|525005945|FG007|Lead-in Period|Lost to Follow-up|0|||
145588614|NCT03214367|525005938|FG000|Lead-in Period|Sponsor Decision|11|||
145588615|NCT03214367|525005939|FG001|Lead-in Period|Sponsor Decision|0|||
145588616|NCT03214367|525005940|FG002|Lead-in Period|Sponsor Decision|0|||
145588617|NCT03214367|525005941|FG003|Lead-in Period|Sponsor Decision|0|||
145588618|NCT03214367|525005942|FG004|Lead-in Period|Sponsor Decision|0|||
145457277|NCT02684058|524525190|FG000|Treatment Period|Progressive disease|4|||
145457278|NCT02684058|524525191|FG001|Treatment Period|Progressive disease|10|||
145457279|NCT02684058|524525192|FG002|Treatment Period|Progressive disease|19|||
145457280|NCT02684058|524525190|FG000|Treatment Period|Adverse Event|3|||
145457281|NCT02684058|524525191|FG001|Treatment Period|Adverse Event|8|||
145457282|NCT02684058|524525192|FG002|Treatment Period|Adverse Event|1|||
145457283|NCT02684058|524525190|FG000|Treatment Period|Physician Decision|5|||
145457284|NCT02684058|524525191|FG001|Treatment Period|Physician Decision|1|||
145457285|NCT02684058|524525192|FG002|Treatment Period|Physician Decision|2|||
145457286|NCT02684058|524525190|FG000|Treatment Period|New therapy for study indication|1|||
145457287|NCT02684058|524525191|FG001|Treatment Period|New therapy for study indication|0|||
145457288|NCT02684058|524525192|FG002|Treatment Period|New therapy for study indication|0|||
145457289|NCT02684058|524525190|FG000|Treatment Period|Protocol deviation|0|||
145457290|NCT02684058|524525191|FG001|Treatment Period|Protocol deviation|1|||
145457291|NCT02684058|524525192|FG002|Treatment Period|Protocol deviation|0|||
145457292|NCT02684058|524525190|FG000|Treatment Period|Subject/guardian decision|4|||
145457293|NCT02684058|524525191|FG001|Treatment Period|Subject/guardian decision|3|||
145588619|NCT03214367|525005943|FG005|Lead-in Period|Sponsor Decision|0|||
145588620|NCT03214367|525005944|FG006|Lead-in Period|Sponsor Decision|0|||
145588621|NCT03214367|525005945|FG007|Lead-in Period|Sponsor Decision|0|||
145626633|NCT02950545|525145725|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
145457294|NCT02684058|524525192|FG002|Treatment Period|Subject/guardian decision|0|||
145457295|NCT02684058|524525190|FG000|Treatment Period|Death|0|||
145457296|NCT02684058|524525191|FG001|Treatment Period|Death|0|||
145588622|NCT03214367|525005938|FG000|Lead-in Period|Physician Decision|12|||
145588623|NCT03214367|525005939|FG001|Lead-in Period|Physician Decision|0|||
145588624|NCT03214367|525005940|FG002|Lead-in Period|Physician Decision|0|||
145588625|NCT03214367|525005941|FG003|Lead-in Period|Physician Decision|0|||
145588626|NCT03214367|525005942|FG004|Lead-in Period|Physician Decision|0|||
145588627|NCT03214367|525005943|FG005|Lead-in Period|Physician Decision|0|||
145588628|NCT03214367|525005944|FG006|Lead-in Period|Physician Decision|0|||
145588629|NCT03214367|525005945|FG007|Lead-in Period|Physician Decision|0|||
145588630|NCT03214367|525005938|FG000|Lead-in Period|Protocol Violation|5|||
145588631|NCT03214367|525005939|FG001|Lead-in Period|Protocol Violation|0|||
145588632|NCT03214367|525005940|FG002|Lead-in Period|Protocol Violation|0|||
145588633|NCT03214367|525005941|FG003|Lead-in Period|Protocol Violation|0|||
145588634|NCT03214367|525005942|FG004|Lead-in Period|Protocol Violation|0|||
145588635|NCT03214367|525005943|FG005|Lead-in Period|Protocol Violation|0|||
145588636|NCT03214367|525005944|FG006|Lead-in Period|Protocol Violation|0|||
145588637|NCT03214367|525005945|FG007|Lead-in Period|Protocol Violation|0|||
145588638|NCT03214367|525005938|FG000|Lead-in Period|Treatment Interruption|1|||
145588639|NCT03214367|525005939|FG001|Lead-in Period|Treatment Interruption|0|||
145588640|NCT03214367|525005940|FG002|Lead-in Period|Treatment Interruption|0|||
145588641|NCT03214367|525005941|FG003|Lead-in Period|Treatment Interruption|0|||
145588642|NCT03214367|525005942|FG004|Lead-in Period|Treatment Interruption|0|||
145588643|NCT03214367|525005943|FG005|Lead-in Period|Treatment Interruption|0|||
145588644|NCT03214367|525005944|FG006|Lead-in Period|Treatment Interruption|0|||
145588645|NCT03214367|525005945|FG007|Lead-in Period|Treatment Interruption|0|||
145588646|NCT03214367|525005938|FG000|Treatment Period|Adverse Event|0|||
145588647|NCT03214367|525005939|FG001|Treatment Period|Adverse Event|1|||
145588648|NCT03214367|525005940|FG002|Treatment Period|Adverse Event|4|||
145588649|NCT03214367|525005941|FG003|Treatment Period|Adverse Event|2|||
145588650|NCT03214367|525005942|FG004|Treatment Period|Adverse Event|0|||
145588651|NCT03214367|525005943|FG005|Treatment Period|Adverse Event|0|||
145588652|NCT03214367|525005944|FG006|Treatment Period|Adverse Event|0|||
145588653|NCT03214367|525005945|FG007|Treatment Period|Adverse Event|0|||
145588654|NCT03214367|525005938|FG000|Treatment Period|Death|0|||
145588655|NCT03214367|525005939|FG001|Treatment Period|Death|1|||
145588656|NCT03214367|525005940|FG002|Treatment Period|Death|1|||
145588657|NCT03214367|525005941|FG003|Treatment Period|Death|1|||
145588658|NCT03214367|525005942|FG004|Treatment Period|Death|0|||
145588659|NCT03214367|525005943|FG005|Treatment Period|Death|0|||
145588660|NCT03214367|525005944|FG006|Treatment Period|Death|0|||
145588661|NCT03214367|525005945|FG007|Treatment Period|Death|0|||
145588662|NCT03214367|525005938|FG000|Treatment Period|Lost to Follow-up|0|||
145588663|NCT03214367|525005939|FG001|Treatment Period|Lost to Follow-up|5|||
145588664|NCT03214367|525005940|FG002|Treatment Period|Lost to Follow-up|3|||
145588665|NCT03214367|525005941|FG003|Treatment Period|Lost to Follow-up|2|||
145588666|NCT03214367|525005942|FG004|Treatment Period|Lost to Follow-up|0|||
145588667|NCT03214367|525005943|FG005|Treatment Period|Lost to Follow-up|2|||
145588668|NCT03214367|525005944|FG006|Treatment Period|Lost to Follow-up|1|||
145588669|NCT03214367|525005945|FG007|Treatment Period|Lost to Follow-up|0|||
145588670|NCT03214367|525005938|FG000|Treatment Period|Sponsor Decision|0|||
145588671|NCT03214367|525005939|FG001|Treatment Period|Sponsor Decision|3|||
145588672|NCT03214367|525005940|FG002|Treatment Period|Sponsor Decision|0|||
145588673|NCT03214367|525005941|FG003|Treatment Period|Sponsor Decision|0|||
145588674|NCT03214367|525005942|FG004|Treatment Period|Sponsor Decision|0|||
145588675|NCT03214367|525005943|FG005|Treatment Period|Sponsor Decision|0|||
145588676|NCT03214367|525005944|FG006|Treatment Period|Sponsor Decision|0|||
145588677|NCT03214367|525005945|FG007|Treatment Period|Sponsor Decision|0|||
145588678|NCT03214367|525005938|FG000|Treatment Period|Physician Decision|0|||
145588679|NCT03214367|525005939|FG001|Treatment Period|Physician Decision|1|||
145588680|NCT03214367|525005940|FG002|Treatment Period|Physician Decision|2|||
145588681|NCT03214367|525005941|FG003|Treatment Period|Physician Decision|0|||
145588682|NCT03214367|525005942|FG004|Treatment Period|Physician Decision|0|||
145588683|NCT03214367|525005943|FG005|Treatment Period|Physician Decision|0|||
145588684|NCT03214367|525005944|FG006|Treatment Period|Physician Decision|0|||
145588685|NCT03214367|525005945|FG007|Treatment Period|Physician Decision|0|||
145588686|NCT03214367|525005938|FG000|Treatment Period|Protocol Violation|0|||
145588687|NCT03214367|525005939|FG001|Treatment Period|Protocol Violation|3|||
145588688|NCT03214367|525005940|FG002|Treatment Period|Protocol Violation|0|||
145588689|NCT03214367|525005941|FG003|Treatment Period|Protocol Violation|0|||
145626634|NCT02950545|525145726|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
145626635|NCT02950545|525145727|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
145588690|NCT03214367|525005942|FG004|Treatment Period|Protocol Violation|0|||
145588691|NCT03214367|525005943|FG005|Treatment Period|Protocol Violation|0|||
145588692|NCT03214367|525005944|FG006|Treatment Period|Protocol Violation|0|||
145588693|NCT03214367|525005945|FG007|Treatment Period|Protocol Violation|0|||
145588694|NCT03214367|525005938|FG000|Treatment Period|Withdrawal by Subject|0|||
145588695|NCT03214367|525005939|FG001|Treatment Period|Withdrawal by Subject|20|||
145588696|NCT03214367|525005940|FG002|Treatment Period|Withdrawal by Subject|23|||
145588697|NCT03214367|525005941|FG003|Treatment Period|Withdrawal by Subject|14|||
145588698|NCT03214367|525005942|FG004|Treatment Period|Withdrawal by Subject|0|||
145626636|NCT02950545|525145722|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
145588699|NCT03214367|525005943|FG005|Treatment Period|Withdrawal by Subject|1|||
145588700|NCT03214367|525005944|FG006|Treatment Period|Withdrawal by Subject|1|||
145588701|NCT03214367|525005945|FG007|Treatment Period|Withdrawal by Subject|1|||
145588702|NCT04717596|525005946|FG000|Overall Study|Withdrawal by Subject|4|||
145588703|NCT03555396|525005947|FG000|Overall Study|Death|3|||
145588704|NCT03555396|525005948|FG001|Overall Study|Death|1|||
145588705|NCT03555396|525005947|FG000|Overall Study|Lost to Follow-up|0|||
145588706|NCT03555396|525005948|FG001|Overall Study|Lost to Follow-up|2|||
145588707|NCT02536508|525005949|FG000|Overall Study|Withdrawal by Subject|18|||
145588708|NCT02536508|525005950|FG001|Overall Study|Withdrawal by Subject|13|||
145588709|NCT02536508|525005951|FG002|Overall Study|Withdrawal by Subject|7|||
145588710|NCT02536508|525005949|FG000|Overall Study|Adverse Event|14|||
145588711|NCT02536508|525005950|FG001|Overall Study|Adverse Event|13|||
145588712|NCT02536508|525005951|FG002|Overall Study|Adverse Event|6|||
145588713|NCT02536508|525005949|FG000|Overall Study|Lost to Follow-up|12|||
145588714|NCT02536508|525005950|FG001|Overall Study|Lost to Follow-up|4|||
145588715|NCT02536508|525005951|FG002|Overall Study|Lost to Follow-up|0|||
145588716|NCT02536508|525005949|FG000|Overall Study|Lack of Efficacy|3|||
145588717|NCT02536508|525005950|FG001|Overall Study|Lack of Efficacy|5|||
145588718|NCT02536508|525005951|FG002|Overall Study|Lack of Efficacy|4|||
145588719|NCT02536508|525005949|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
145588720|NCT02536508|525005950|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
145588721|NCT02536508|525005951|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
145588722|NCT02536508|525005949|FG000|Overall Study|Physician Decision|0|||
145588723|NCT02536508|525005950|FG001|Overall Study|Physician Decision|4|||
145588724|NCT02536508|525005951|FG002|Overall Study|Physician Decision|2|||
145588725|NCT02536508|525005949|FG000|Overall Study|Major Protocol Deviation|2|||
145588726|NCT02536508|525005950|FG001|Overall Study|Major Protocol Deviation|2|||
145588727|NCT02536508|525005951|FG002|Overall Study|Major Protocol Deviation|2|||
145588728|NCT02536508|525005949|FG000|Overall Study|Administrative Reasons|0|||
145588729|NCT02536508|525005950|FG001|Overall Study|Administrative Reasons|1|||
145588730|NCT02536508|525005951|FG002|Overall Study|Administrative Reasons|0|||
145588731|NCT02473952|525005953|FG000|Overall Study|Adverse Event|2|||
145588732|NCT02473952|525005954|FG001|Overall Study|Adverse Event|2|||
145588733|NCT02473952|525005953|FG000|Overall Study|Withdrawal by Subject|0|||
145588734|NCT02473952|525005954|FG001|Overall Study|Withdrawal by Subject|6|||
145588735|NCT00823719|525005955|FG000|Overall Study|Adverse Event|1|||
145588736|NCT00823719|525005956|FG001|Overall Study|Adverse Event|2|||
145588737|NCT00823719|525005955|FG000|Overall Study|Physician Decision|1|||
145588738|NCT00823719|525005956|FG001|Overall Study|Physician Decision|4|||
145588739|NCT00823719|525005955|FG000|Overall Study|Withdrawal by Subject|0|||
145588740|NCT00823719|525005956|FG001|Overall Study|Withdrawal by Subject|1|||
145588741|NCT00823719|525005955|FG000|Overall Study|Disease Progression|4|||
145588742|NCT00823719|525005956|FG001|Overall Study|Disease Progression|4|||
145588743|NCT04955639|525005957|FG000|Overall Study|Withdrawal by Subject|2|||
145588744|NCT04955639|525005958|FG001|Overall Study|Withdrawal by Subject|2|||
145588745|NCT04955639|525005957|FG000|Overall Study|Week 26 survey not completed|2|||
145588746|NCT04955639|525005958|FG001|Overall Study|Week 26 survey not completed|2|||
145588747|NCT01369342|525005959|FG000|Overall Study|Withdrawal by Subject|7|||
145588748|NCT01369342|525005960|FG001|Overall Study|Withdrawal by Subject|7|||
145588749|NCT01369342|525005961|FG002|Overall Study|Withdrawal by Subject|2|||
145588750|NCT01369342|525005959|FG000|Overall Study|Lost to Follow-up|5|||
145588751|NCT01369342|525005960|FG001|Overall Study|Lost to Follow-up|2|||
145588752|NCT01369342|525005961|FG002|Overall Study|Lost to Follow-up|1|||
145588753|NCT01369342|525005959|FG000|Overall Study|Not Treated|1|||
145588754|NCT01369342|525005960|FG001|Overall Study|Not Treated|0|||
145588755|NCT01369342|525005961|FG002|Overall Study|Not Treated|0|||
145626637|NCT02950545|525145723|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
145626638|NCT02950545|525145724|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
145626639|NCT02950545|525145725|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
145588756|NCT03204279|525005965|FG000|Overall Study|Withdrawal by Subject|0|||
145588757|NCT03204279|525005966|FG001|Overall Study|Withdrawal by Subject|1|||
145588758|NCT04969250|525005971|FG000|Overall Study|Protocol Violation|0|||
145588759|NCT04969250|525005972|FG001|Overall Study|Protocol Violation|2|||
145588760|NCT04969250|525005973|FG002|Overall Study|Protocol Violation|3|||
145588761|NCT04969250|525005974|FG003|Overall Study|Protocol Violation|8|||
145588762|NCT04969250|525005971|FG000|Overall Study|Withdrawal by Subject|0|||
145588763|NCT04969250|525005972|FG001|Overall Study|Withdrawal by Subject|1|||
145588764|NCT04969250|525005973|FG002|Overall Study|Withdrawal by Subject|0|||
145588765|NCT04969250|525005974|FG003|Overall Study|Withdrawal by Subject|0|||
145588766|NCT02119416|525005975|FG000|Overall Study|Protocol Violation|1|||
145626640|NCT02950545|525145726|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
145588767|NCT02119416|525005976|FG001|Overall Study|Protocol Violation|1|||
145588768|NCT02119416|525005977|FG002|Overall Study|Protocol Violation|1|||
145588769|NCT02119416|525005975|FG000|Overall Study|wrong pubertal stage|1|||
145588770|NCT02119416|525005976|FG001|Overall Study|wrong pubertal stage|0|||
145588771|NCT02119416|525005977|FG002|Overall Study|wrong pubertal stage|1|||
145588772|NCT02278328|525005978|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
145588773|NCT02278328|525005979|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
145588774|NCT02278328|525005980|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
145588775|NCT02278328|525005978|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
145588776|NCT02278328|525005979|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
145588777|NCT02278328|525005980|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
145588778|NCT02278328|525005978|FG000|Neuropsych Screening|incomplete consent|0|||
145588779|NCT02278328|525005979|FG001|Neuropsych Screening|incomplete consent|0|||
145588780|NCT02278328|525005980|FG002|Neuropsych Screening|incomplete consent|2|||
145588781|NCT00130533|525005981|FG000|Overall Study|Withdrawal by Subject|33|||
145588782|NCT00130533|525005982|FG001|Overall Study|Withdrawal by Subject|6|||
145588783|NCT00130533|525005981|FG000|Overall Study|Adverse Event|34|||
145588784|NCT00130533|525005982|FG001|Overall Study|Adverse Event|1|||
145588785|NCT00130533|525005981|FG000|Overall Study|Disease relapse|9|||
145588786|NCT00130533|525005982|FG001|Overall Study|Disease relapse|13|||
145588787|NCT00130533|525005981|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
145588788|NCT00130533|525005982|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
145588789|NCT00130533|525005981|FG000|Overall Study|Death|4|||
145588790|NCT00130533|525005982|FG001|Overall Study|Death|2|||
145588791|NCT00130533|525005981|FG000|Overall Study|Protocol Violation|5|||
145588792|NCT00130533|525005982|FG001|Overall Study|Protocol Violation|1|||
145588793|NCT00130533|525005981|FG000|Overall Study|Lost to Follow-up|1|||
145588794|NCT00130533|525005982|FG001|Overall Study|Lost to Follow-up|1|||
145588795|NCT00130533|525005981|FG000|Overall Study|Sponsor´s decision|2|||
145588796|NCT00130533|525005982|FG001|Overall Study|Sponsor´s decision|0|||
145588797|NCT00130533|525005981|FG000|Overall Study|Second Primary Malignancy|0|||
145588798|NCT00130533|525005982|FG001|Overall Study|Second Primary Malignancy|1|||
145588799|NCT00130533|525005981|FG000|Overall Study|Other|12|||
145588800|NCT00130533|525005982|FG001|Overall Study|Other|5|||
145588801|NCT02384759|525005990|FG000|Overall Study|Patients not treated|3|||
145588802|NCT02384759|525005991|FG001|Overall Study|Patients not treated|2|||
145588803|NCT01605617|525005992|FG000|First Intervention|Adverse Event|0|||
145588804|NCT01605617|525005993|FG001|First Intervention|Adverse Event|1|||
145588805|NCT01605617|525005992|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
145588806|NCT01605617|525005993|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
145588807|NCT02014116|525005995|FG000|Overall Study|Progressive Disease|3|||
145588808|NCT02014116|525005996|FG001|Overall Study|Progressive Disease|4|||
145588809|NCT02014116|525005997|FG002|Overall Study|Progressive Disease|2|||
145588810|NCT02014116|525005998|FG003|Overall Study|Progressive Disease|6|||
145588811|NCT02014116|525005999|FG004|Overall Study|Progressive Disease|1|||
145588812|NCT02014116|525006000|FG005|Overall Study|Progressive Disease|13|||
145588813|NCT02014116|525006001|FG006|Overall Study|Progressive Disease|1|||
145588814|NCT02014116|525006002|FG007|Overall Study|Progressive Disease|3|||
145588815|NCT02014116|525006003|FG008|Overall Study|Progressive Disease|7|||
145588816|NCT02014116|525005995|FG000|Overall Study|Adverse Event|0|||
145588817|NCT02014116|525005996|FG001|Overall Study|Adverse Event|0|||
145588818|NCT02014116|525005997|FG002|Overall Study|Adverse Event|0|||
145588819|NCT02014116|525005998|FG003|Overall Study|Adverse Event|0|||
145588820|NCT02014116|525005999|FG004|Overall Study|Adverse Event|1|||
145588821|NCT02014116|525006000|FG005|Overall Study|Adverse Event|0|||
145588822|NCT02014116|525006001|FG006|Overall Study|Adverse Event|0|||
145588823|NCT02014116|525006002|FG007|Overall Study|Adverse Event|1|||
145588824|NCT02014116|525006003|FG008|Overall Study|Adverse Event|0|||
145588825|NCT02014116|525005995|FG000|Overall Study|Lost to Follow-up|0|||
145588826|NCT02014116|525005996|FG001|Overall Study|Lost to Follow-up|0|||
145588827|NCT02014116|525005997|FG002|Overall Study|Lost to Follow-up|0|||
145588828|NCT02014116|525005998|FG003|Overall Study|Lost to Follow-up|0|||
145588829|NCT02014116|525005999|FG004|Overall Study|Lost to Follow-up|0|||
145588830|NCT02014116|525006000|FG005|Overall Study|Lost to Follow-up|1|||
145588831|NCT02014116|525006001|FG006|Overall Study|Lost to Follow-up|0|||
145588832|NCT02014116|525006002|FG007|Overall Study|Lost to Follow-up|0|||
145588833|NCT02014116|525006003|FG008|Overall Study|Lost to Follow-up|1|||
145588834|NCT02014116|525005995|FG000|Overall Study|Death|0|||
145588835|NCT02014116|525005996|FG001|Overall Study|Death|0|||
145588836|NCT02014116|525005997|FG002|Overall Study|Death|0|||
145588837|NCT02014116|525005998|FG003|Overall Study|Death|0|||
145588838|NCT02014116|525005999|FG004|Overall Study|Death|0|||
145588839|NCT02014116|525006000|FG005|Overall Study|Death|0|||
145588840|NCT02014116|525006001|FG006|Overall Study|Death|0|||
145588841|NCT02014116|525006002|FG007|Overall Study|Death|1|||
145588842|NCT02014116|525006003|FG008|Overall Study|Death|1|||
145588843|NCT02014116|525005995|FG000|Overall Study|Withdrawal by Subject|0|||
145588844|NCT02014116|525005996|FG001|Overall Study|Withdrawal by Subject|0|||
145588845|NCT02014116|525005997|FG002|Overall Study|Withdrawal by Subject|1|||
145588846|NCT02014116|525005998|FG003|Overall Study|Withdrawal by Subject|1|||
145588847|NCT02014116|525005999|FG004|Overall Study|Withdrawal by Subject|0|||
145588848|NCT02014116|525006000|FG005|Overall Study|Withdrawal by Subject|1|||
145588849|NCT02014116|525006001|FG006|Overall Study|Withdrawal by Subject|0|||
145588850|NCT02014116|525006002|FG007|Overall Study|Withdrawal by Subject|0|||
145588851|NCT02014116|525006003|FG008|Overall Study|Withdrawal by Subject|0|||
145588852|NCT02014116|525005995|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
145588853|NCT02014116|525005996|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
145588854|NCT02014116|525005997|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
145588855|NCT02014116|525005998|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
145588856|NCT02014116|525005999|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
145588857|NCT02014116|525006000|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
145588858|NCT02014116|525006001|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
145588859|NCT02014116|525006002|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
145588860|NCT02014116|525006003|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
145588861|NCT02014116|525005995|FG000|Overall Study|Physician Decision|0|||
145588862|NCT02014116|525005996|FG001|Overall Study|Physician Decision|0|||
145588863|NCT02014116|525005997|FG002|Overall Study|Physician Decision|0|||
145588864|NCT02014116|525005998|FG003|Overall Study|Physician Decision|0|||
145588865|NCT02014116|525005999|FG004|Overall Study|Physician Decision|0|||
145588866|NCT02014116|525006000|FG005|Overall Study|Physician Decision|0|||
145588867|NCT02014116|525006001|FG006|Overall Study|Physician Decision|0|||
145588868|NCT02014116|525006002|FG007|Overall Study|Physician Decision|0|||
145588869|NCT02014116|525006003|FG008|Overall Study|Physician Decision|1|||
145588870|NCT05046795|525006004|FG000|Overall Study|Adverse Event|13|||
145588871|NCT05046795|525006005|FG001|Overall Study|Adverse Event|15|||
145588872|NCT05046795|525006004|FG000|Overall Study|Withdrawal by Subject|4|||
145588873|NCT05046795|525006005|FG001|Overall Study|Withdrawal by Subject|7|||
145588874|NCT05046795|525006004|FG000|Overall Study|Physician Decision|1|||
145588875|NCT05046795|525006005|FG001|Overall Study|Physician Decision|2|||
145588876|NCT05046795|525006004|FG000|Overall Study|Protocol Violation|1|||
145588877|NCT05046795|525006005|FG001|Overall Study|Protocol Violation|2|||
145588878|NCT05046795|525006004|FG000|Overall Study|Death|1|||
145588879|NCT05046795|525006005|FG001|Overall Study|Death|0|||
145588880|NCT05046795|525006004|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
145588881|NCT05046795|525006005|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
145588882|NCT01127178|525006006|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
145588883|NCT01127178|525006007|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
145588884|NCT01127178|525006006|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
145588885|NCT01127178|525006007|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
145588886|NCT01127178|525006006|FG000|Dose Escalation: Treatment Phase|Other|2|||
145588887|NCT01127178|525006007|FG001|Dose Escalation: Treatment Phase|Other|0|||
145588888|NCT01127178|525006006|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
145588889|NCT01127178|525006007|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
145588890|NCT01127178|525006006|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
145588891|NCT01127178|525006007|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
145588892|NCT01127178|525006006|FG000|Dose Escalation: Extension Phase|Other|1|||
145588893|NCT01127178|525006007|FG001|Dose Escalation: Extension Phase|Other|0|||
145588894|NCT04139317|525006008|FG000|Overall Study|Adverse Event|10|||
145588895|NCT04139317|525006009|FG001|Overall Study|Adverse Event|2|||
145588896|NCT04139317|525006008|FG000|Overall Study|Death|6|||
145588897|NCT04139317|525006009|FG001|Overall Study|Death|4|||
145588898|NCT04139317|525006008|FG000|Overall Study|Lost to Follow-up|1|||
145588899|NCT04139317|525006009|FG001|Overall Study|Lost to Follow-up|0|||
145588900|NCT04139317|525006008|FG000|Overall Study|Physician Decision|3|||
145588901|NCT04139317|525006009|FG001|Overall Study|Physician Decision|1|||
145588902|NCT04139317|525006008|FG000|Overall Study|Progressive Disease|19|||
145588903|NCT04139317|525006009|FG001|Overall Study|Progressive Disease|9|||
145588904|NCT04139317|525006008|FG000|Overall Study|Subject Decision|2|||
145588905|NCT04139317|525006009|FG001|Overall Study|Subject Decision|2|||
145588906|NCT00093145|525006015|FG000|Overall Study|Unacceptable Toxicity Only|2|||
145588907|NCT00093145|525006015|FG000|Overall Study|Physician Decision|5|||
145588908|NCT00093145|525006015|FG000|Overall Study|Withdrawal by Subject|9|||
145588909|NCT00093145|525006015|FG000|Overall Study|Other|1|||
145588910|NCT01310036|525006016|FG000|Overall Study|Administrative/other|10|||
145588911|NCT01310036|525006016|FG000|Overall Study|Withdrew Consent|11|||
145588912|NCT01310036|525006016|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
145588913|NCT01310036|525006016|FG000|Overall Study|Progression of Disease|164|||
145588914|NCT01310036|525006016|FG000|Overall Study|Death|1|||
145588915|NCT01310036|525006016|FG000|Overall Study|Adverse event or intercurrent illness|12|||
145588916|NCT01435577|525006019|FG000|Overall Study|Adverse Event|10|||
145588917|NCT01435577|525006020|FG001|Overall Study|Adverse Event|0|||
145588918|NCT01435577|525006019|FG000|Overall Study|Lack of Efficacy|7|||
145588919|NCT01435577|525006020|FG001|Overall Study|Lack of Efficacy|51|||
145588920|NCT01435577|525006019|FG000|Overall Study|Alternative treatment started|0|||
145588921|NCT01435577|525006020|FG001|Overall Study|Alternative treatment started|1|||
145588922|NCT01090453|525006021|FG000|Overall Study|Withdrawal by Subject|1|||
145588923|NCT01090453|525006022|FG001|Overall Study|Withdrawal by Subject|2|||
145588924|NCT01090453|525006021|FG000|Overall Study|Lost to Follow-up|7|||
145588925|NCT01090453|525006022|FG001|Overall Study|Lost to Follow-up|7|||
145457297|NCT02684058|524525192|FG002|Treatment Period|Death|2|||
145588926|NCT01090453|525006021|FG000|Overall Study|Non serious AEs|1|||
145588927|NCT01090453|525006022|FG001|Overall Study|Non serious AEs|0|||
145588928|NCT01090453|525006021|FG000|Overall Study|Protocol Violation|2|||
145588929|NCT01090453|525006022|FG001|Overall Study|Protocol Violation|0|||
145588930|NCT01090453|525006021|FG000|Overall Study|Other|2|||
145588931|NCT01090453|525006022|FG001|Overall Study|Other|4|||
145588932|NCT01090453|525006021|FG000|Overall Study|Eligibility Criteria|0|||
145588933|NCT01090453|525006022|FG001|Overall Study|Eligibility Criteria|1|||
145588934|NCT00522275|525006023|FG000|Overall Study|Adverse Event|35|||
145588935|NCT00522275|525006023|FG000|Overall Study|Lack of Efficacy|80|||
145588936|NCT00522275|525006023|FG000|Overall Study|Subject withdrew consent|16|||
145588937|NCT00522275|525006023|FG000|Overall Study|Protocol deviation|1|||
145588938|NCT00522275|525006023|FG000|Overall Study|Unsatisfactory compliance|11|||
145588939|NCT00522275|525006023|FG000|Overall Study|Lost to Follow-up|8|||
145588940|NCT00522275|525006023|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
145588941|NCT00522275|525006023|FG000|Overall Study|Other: Subject is pregnant|2|||
145588942|NCT00522275|525006023|FG000|Overall Study|Other: Subject relocated|2|||
145588943|NCT00522275|525006023|FG000|Overall Study|Other: Subject arrested|1|||
145588944|NCT00522275|525006023|FG000|Overall Study|Other: Site / clinic closed|4|||
145588945|NCT00522275|525006023|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
145588946|NCT00522275|525006023|FG000|Overall Study|Other: Sponsor request|2|||
145588947|NCT00522275|525006023|FG000|Overall Study|Other: Subject ran out of medication|1|||
145588948|NCT00522275|525006023|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
145588949|NCT03832192|525006027|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
145588950|NCT03832192|525006028|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
145588951|NCT02663128|525006029|FG000|Period 2|Physician Decision|0|||
145588952|NCT02663128|525006030|FG001|Period 2|Physician Decision|0|||
145588953|NCT02663128|525006031|FG002|Period 2|Physician Decision|0|||
145588954|NCT02663128|525006032|FG003|Period 2|Physician Decision|0|||
145588955|NCT02663128|525006033|FG004|Period 2|Physician Decision|1|||
145588956|NCT02663128|525006034|FG005|Period 2|Physician Decision|0|||
145588957|NCT03394924|525006037|FG000|Overall Study|Adverse Event|0|||
145588958|NCT03394924|525006038|FG001|Overall Study|Adverse Event|5|||
145588959|NCT03394924|525006039|FG002|Overall Study|Adverse Event|0|||
145588960|NCT03394924|525006037|FG000|Overall Study|Withdrawal by Subject|2|||
145588961|NCT03394924|525006038|FG001|Overall Study|Withdrawal by Subject|0|||
145588962|NCT03394924|525006039|FG002|Overall Study|Withdrawal by Subject|0|||
145588963|NCT03394924|525006037|FG000|Overall Study|Lost to Follow-up|0|||
145588964|NCT03394924|525006038|FG001|Overall Study|Lost to Follow-up|1|||
145588965|NCT03394924|525006039|FG002|Overall Study|Lost to Follow-up|0|||
145588966|NCT03394924|525006037|FG000|Overall Study|Did not meet all inclusion criteria|1|||
145588967|NCT03394924|525006038|FG001|Overall Study|Did not meet all inclusion criteria|0|||
145588968|NCT03394924|525006039|FG002|Overall Study|Did not meet all inclusion criteria|0|||
145588969|NCT02276482|525006042|FG000|Overall Study|Adverse Event|1|||
145588970|NCT02276482|525006043|FG001|Overall Study|Adverse Event|0|||
145588971|NCT02276482|525006042|FG000|Overall Study|Withdrawal by Subject|1|||
145588972|NCT02276482|525006043|FG001|Overall Study|Withdrawal by Subject|0|||
145588973|NCT02276482|525006042|FG000|Overall Study|Gram-negative infection|1|||
145588974|NCT02276482|525006043|FG001|Overall Study|Gram-negative infection|0|||
145588975|NCT02276482|525006042|FG000|Overall Study|Reason not specified|0|||
145588976|NCT02276482|525006043|FG001|Overall Study|Reason not specified|1|||
145588977|NCT03277313|525006046|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
145588978|NCT03277313|525006047|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
145588979|NCT03277313|525006046|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
145588980|NCT03277313|525006047|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
145588981|NCT03277313|525006046|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
145588982|NCT03277313|525006047|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
145588983|NCT03277313|525006046|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
145588984|NCT03277313|525006047|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
145588985|NCT03277313|525006046|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
145588986|NCT03277313|525006047|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
145588987|NCT02005471|525006048|FG000|Main Study|Adverse Event|0|||
145588988|NCT02005471|525006049|FG001|Main Study|Adverse Event|1|||
145588989|NCT02005471|525006050|FG002|Main Study|Adverse Event|0|||
145588990|NCT02005471|525006051|FG003|Main Study|Adverse Event|0|||
145588991|NCT02005471|525006048|FG000|Main Study|Death|83|||
145588992|NCT02005471|525006049|FG001|Main Study|Death|52|||
145588993|NCT02005471|525006050|FG002|Main Study|Death|0|||
145457298|NCT02684058|524525190|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145457299|NCT02684058|524525191|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145457300|NCT02684058|524525192|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145457301|NCT02684058|524525190|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
145457302|NCT02684058|524525191|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
145588994|NCT02005471|525006051|FG003|Main Study|Death|0|||
145588995|NCT02005471|525006048|FG000|Main Study|Lost to Follow-up|4|||
145588996|NCT02005471|525006049|FG001|Main Study|Lost to Follow-up|5|||
145588997|NCT02005471|525006050|FG002|Main Study|Lost to Follow-up|0|||
145588998|NCT02005471|525006051|FG003|Main Study|Lost to Follow-up|0|||
145588999|NCT02005471|525006048|FG000|Main Study|Physician Decision|3|||
145589000|NCT02005471|525006049|FG001|Main Study|Physician Decision|1|||
145589001|NCT02005471|525006050|FG002|Main Study|Physician Decision|0|||
145589002|NCT02005471|525006051|FG003|Main Study|Physician Decision|0|||
145589003|NCT02005471|525006048|FG000|Main Study|Withdrawal by Subject|26|||
145589004|NCT02005471|525006049|FG001|Main Study|Withdrawal by Subject|11|||
145589005|NCT02005471|525006050|FG002|Main Study|Withdrawal by Subject|0|||
145589006|NCT02005471|525006051|FG003|Main Study|Withdrawal by Subject|0|||
145589007|NCT02005471|525006048|FG000|Main Study|Reason not Specified|0|||
145589008|NCT02005471|525006049|FG001|Main Study|Reason not Specified|6|||
145589009|NCT02005471|525006050|FG002|Main Study|Reason not Specified|0|||
145589010|NCT02005471|525006051|FG003|Main Study|Reason not Specified|0|||
145589011|NCT02005471|525006048|FG000|Main Study|Randomized but not Dosed|8|||
145589012|NCT02005471|525006049|FG001|Main Study|Randomized but not Dosed|0|||
145589013|NCT02005471|525006050|FG002|Main Study|Randomized but not Dosed|0|||
145589014|NCT02005471|525006051|FG003|Main Study|Randomized but not Dosed|0|||
145589015|NCT02005471|525006048|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
145589016|NCT02005471|525006049|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
145589017|NCT02005471|525006050|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
145589018|NCT02005471|525006051|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
145589019|NCT02005471|525006048|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
145589020|NCT02005471|525006049|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
145589021|NCT02005471|525006050|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
145589022|NCT02005471|525006051|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
145589023|NCT02005471|525006048|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
145589024|NCT02005471|525006049|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
145589025|NCT02005471|525006050|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
145589026|NCT02005471|525006051|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
145589027|NCT00627705|525006053|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
145589028|NCT00627705|525006054|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
145589029|NCT00627705|525006053|FG000|Overall Study|Adverse Event|1|||
145589030|NCT00627705|525006054|FG001|Overall Study|Adverse Event|0|||
145589031|NCT00627705|525006053|FG000|Overall Study|Withdrawal by Subject|0|||
145589032|NCT00627705|525006054|FG001|Overall Study|Withdrawal by Subject|2|||
145589033|NCT00627705|525006053|FG000|Overall Study|Lost to Follow-up|0|||
145589034|NCT00627705|525006054|FG001|Overall Study|Lost to Follow-up|1|||
145589035|NCT01625897|525007809|FG000|Overall Study|Adverse Event|27|||
145589036|NCT01625897|525007810|FG001|Overall Study|Adverse Event|10|||
145589037|NCT01625897|525007809|FG000|Overall Study|Physician Decision|0|||
145589038|NCT01625897|525007810|FG001|Overall Study|Physician Decision|1|||
145589039|NCT01625897|525007809|FG000|Overall Study|Withdrawal by Subject|25|||
145589040|NCT01625897|525007810|FG001|Overall Study|Withdrawal by Subject|3|||
145589041|NCT00156065|525007811|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
145589042|NCT00156065|525007812|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
145589043|NCT00156065|525007813|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
145589044|NCT00156065|525007811|FG000|Overall Study|Adverse Event|8|||
145589045|NCT00156065|525007812|FG001|Overall Study|Adverse Event|11|||
145589046|NCT00156065|525007813|FG002|Overall Study|Adverse Event|4|||
145589047|NCT00156065|525007811|FG000|Overall Study|Lack of Efficacy|2|||
145589048|NCT00156065|525007812|FG001|Overall Study|Lack of Efficacy|9|||
145626641|NCT02950545|525145727|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
145626642|NCT02950545|525145722|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
145457303|NCT02684058|524525192|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
145457304|NCT02684058|524525190|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145457305|NCT02684058|524525191|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
145457306|NCT02684058|524525192|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
145589049|NCT00156065|525007813|FG002|Overall Study|Lack of Efficacy|3|||
145589050|NCT00156065|525007811|FG000|Overall Study|Withdrawal by Subject|13|||
145589051|NCT00156065|525007812|FG001|Overall Study|Withdrawal by Subject|26|||
145589052|NCT00156065|525007813|FG002|Overall Study|Withdrawal by Subject|16|||
145589053|NCT00156065|525007811|FG000|Overall Study|Lost to Follow-up|5|||
145589054|NCT00156065|525007812|FG001|Overall Study|Lost to Follow-up|7|||
145589055|NCT00156065|525007813|FG002|Overall Study|Lost to Follow-up|1|||
145589056|NCT00156065|525007811|FG000|Overall Study|Other|2|||
145589057|NCT00156065|525007812|FG001|Overall Study|Other|9|||
145589058|NCT00156065|525007813|FG002|Overall Study|Other|3|||
145589059|NCT01432366|525007814|FG000|Overall Study|Non-Responder|7|||
145626643|NCT02950545|525145723|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
145589060|NCT01432366|525007814|FG000|Overall Study|Adverse Event|8|||
145589061|NCT01432366|525007814|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
145589062|NCT01432366|525007814|FG000|Overall Study|Pregnancy|1|||
145589063|NCT01432366|525007814|FG000|Overall Study|Lost to Follow-up|13|||
145589064|NCT01432366|525007814|FG000|Overall Study|Lack of Efficacy|1|||
145589065|NCT01432366|525007814|FG000|Overall Study|Site Closed|20|||
145589066|NCT01432366|525007814|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
145589067|NCT01432366|525007814|FG000|Overall Study|Other|14|||
145589068|NCT04546581|525007815|FG000|Overall Study|Adverse Event|9|||
145626644|NCT02950545|525145724|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
145457307|NCT02684058|524525190|FG000|Post-treatment Efficacy Follow-up|Death|0|||
145457308|NCT02684058|524525191|FG001|Post-treatment Efficacy Follow-up|Death|0|||
145457309|NCT02684058|524525192|FG002|Post-treatment Efficacy Follow-up|Death|3|||
145457310|NCT02684058|524525190|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
145457311|NCT02684058|524525191|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
145626645|NCT02950545|525145725|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
145457312|NCT02684058|524525192|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
145457313|NCT02684058|524525190|FG000|Post-treatment Survival Follow-up|Death|0|||
145457314|NCT02684058|524525191|FG001|Post-treatment Survival Follow-up|Death|0|||
145457315|NCT02684058|524525192|FG002|Post-treatment Survival Follow-up|Death|7|||
145457316|NCT02684058|524525190|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
145457317|NCT02684058|524525191|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
145457318|NCT02684058|524525192|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
145457319|NCT02684058|524525190|FG000|Crossover Treatment Period|Progressive disease|0|||
145457320|NCT02684058|524525191|FG001|Crossover Treatment Period|Progressive disease|1|||
145457321|NCT02684058|524525192|FG002|Crossover Treatment Period|Progressive disease|0|||
145457322|NCT05032690|524525193|FG000|Period 1|Adverse Event|0|||
145457323|NCT05032690|524525194|FG001|Period 1|Adverse Event|1|||
145457324|NCT05032690|524525195|FG002|Period 1|Adverse Event|0|||
145457325|NCT05032690|524525196|FG003|Period 1|Adverse Event|0|||
145457326|NCT05032690|524525193|FG000|Period 1|Withdrawal by Subject|1|||
145457327|NCT05032690|524525194|FG001|Period 1|Withdrawal by Subject|0|||
145457328|NCT05032690|524525195|FG002|Period 1|Withdrawal by Subject|0|||
145457329|NCT05032690|524525196|FG003|Period 1|Withdrawal by Subject|0|||
145457330|NCT05032690|524525193|FG000|Period 1|No longer meets eligibility criteria|0|||
145457331|NCT05032690|524525194|FG001|Period 1|No longer meets eligibility criteria|1|||
145457332|NCT05032690|524525195|FG002|Period 1|No longer meets eligibility criteria|0|||
145457333|NCT05032690|524525196|FG003|Period 1|No longer meets eligibility criteria|0|||
145457334|NCT05032690|524525193|FG000|Period 2|Adverse Event|1|||
145457335|NCT05032690|524525194|FG001|Period 2|Adverse Event|0|||
145457336|NCT05032690|524525195|FG002|Period 2|Adverse Event|0|||
145457337|NCT05032690|524525196|FG003|Period 2|Adverse Event|0|||
145457338|NCT05032690|524525193|FG000|Period 2|Withdrawal by Subject|0|||
145457339|NCT05032690|524525194|FG001|Period 2|Withdrawal by Subject|1|||
145457340|NCT05032690|524525195|FG002|Period 2|Withdrawal by Subject|0|||
145457341|NCT05032690|524525196|FG003|Period 2|Withdrawal by Subject|0|||
145457342|NCT05032690|524525193|FG000|Period 2|No longer meets eligibility criteria|0|||
145457343|NCT05032690|524525194|FG001|Period 2|No longer meets eligibility criteria|1|||
145457344|NCT05032690|524525195|FG002|Period 2|No longer meets eligibility criteria|0|||
145457345|NCT05032690|524525196|FG003|Period 2|No longer meets eligibility criteria|0|||
145457346|NCT05032690|524525193|FG000|Period 3|Adverse Event|0|||
145457347|NCT05032690|524525194|FG001|Period 3|Adverse Event|1|||
145457348|NCT05032690|524525195|FG002|Period 3|Adverse Event|0|||
145457349|NCT05032690|524525196|FG003|Period 3|Adverse Event|0|||
145457350|NCT05151445|524525197|FG000|Overall Study|Withdrawal by Subject|3|||
145457351|NCT02298179|524525198|FG000|Overall Study|Lost to Follow-up|0|||
145457352|NCT02298179|524525199|FG001|Overall Study|Lost to Follow-up|0|||
145457353|NCT02298179|524525200|FG002|Overall Study|Lost to Follow-up|1|||
145457354|NCT02298179|524525201|FG003|Overall Study|Lost to Follow-up|0|||
145457355|NCT02298179|524525202|FG004|Overall Study|Lost to Follow-up|0|||
145457356|NCT02298179|524525203|FG005|Overall Study|Lost to Follow-up|0|||
145457357|NCT02298179|524525204|FG006|Overall Study|Lost to Follow-up|0|||
145457358|NCT02298179|524525205|FG007|Overall Study|Lost to Follow-up|1|||
145457359|NCT02298179|524525206|FG008|Overall Study|Lost to Follow-up|0|||
145457360|NCT02298179|524525207|FG009|Overall Study|Lost to Follow-up|0|||
145457361|NCT02298179|524525208|FG010|Overall Study|Lost to Follow-up|0|||
145457362|NCT02298179|524525209|FG011|Overall Study|Lost to Follow-up|0|||
145457363|NCT02264665|524527458|FG000|Overall Study|Other|0|||
145457364|NCT02264665|524527459|FG001|Overall Study|Other|0|||
145457365|NCT02264665|524527460|FG002|Overall Study|Other|3|||
145457366|NCT02264665|524527461|FG003|Overall Study|Other|0|||
145457367|NCT02264665|524527462|FG004|Overall Study|Other|0|||
145457368|NCT02264665|524527463|FG005|Overall Study|Other|0|||
145457369|NCT02264665|524527464|FG006|Overall Study|Other|0|||
145457370|NCT02264665|524527458|FG000|Overall Study|Death|9|||
145457371|NCT02264665|524527459|FG001|Overall Study|Death|8|||
145457372|NCT02264665|524527460|FG002|Overall Study|Death|13|||
145457373|NCT02264665|524527461|FG003|Overall Study|Death|5|||
145457374|NCT02264665|524527462|FG004|Overall Study|Death|0|||
145457375|NCT02264665|524527463|FG005|Overall Study|Death|0|||
145457376|NCT02264665|524527464|FG006|Overall Study|Death|1|||
145457377|NCT02264665|524527458|FG000|Overall Study|Lost to Follow-up|1|||
145457378|NCT02264665|524527459|FG001|Overall Study|Lost to Follow-up|0|||
145457379|NCT02264665|524527460|FG002|Overall Study|Lost to Follow-up|2|||
145457380|NCT02264665|524527461|FG003|Overall Study|Lost to Follow-up|1|||
145457381|NCT02264665|524527462|FG004|Overall Study|Lost to Follow-up|0|||
145457382|NCT02264665|524527463|FG005|Overall Study|Lost to Follow-up|0|||
145457383|NCT02264665|524527464|FG006|Overall Study|Lost to Follow-up|0|||
145457384|NCT02264665|524527458|FG000|Overall Study|Participant decision|0|||
145457385|NCT02264665|524527459|FG001|Overall Study|Participant decision|0|||
145457386|NCT02264665|524527460|FG002|Overall Study|Participant decision|0|||
145457387|NCT02264665|524527461|FG003|Overall Study|Participant decision|1|||
145457388|NCT02264665|524527462|FG004|Overall Study|Participant decision|0|||
145457389|NCT02264665|524527463|FG005|Overall Study|Participant decision|0|||
145457390|NCT02264665|524527464|FG006|Overall Study|Participant decision|0|||
145457391|NCT02264665|524527458|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
145457392|NCT02264665|524527459|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
145457393|NCT02264665|524527460|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
145457394|NCT02264665|524527461|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
145457395|NCT02264665|524527462|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
145457396|NCT02264665|524527463|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
145457397|NCT02264665|524527464|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
145457398|NCT02264665|524527458|FG000|Overall Study|Data Missing|0|||
145457399|NCT02264665|524527459|FG001|Overall Study|Data Missing|0|||
145457400|NCT02264665|524527460|FG002|Overall Study|Data Missing|1|||
145457401|NCT02264665|524527461|FG003|Overall Study|Data Missing|0|||
145457402|NCT02264665|524527462|FG004|Overall Study|Data Missing|0|||
145457403|NCT02264665|524527463|FG005|Overall Study|Data Missing|0|||
145457404|NCT02264665|524527464|FG006|Overall Study|Data Missing|0|||
145457405|NCT04225676|524527471|FG000|Overall Study|Physician Decision|1|||
145457406|NCT04225676|524527471|FG000|Overall Study|Lack of Efficacy|1|||
145457407|NCT04225676|524527471|FG000|Overall Study|Study terminated by sponsor|3|||
145457408|NCT01942161|524527472|FG000|Overall Study|Adverse Event|1|||
145457409|NCT01942161|524527473|FG001|Overall Study|Adverse Event|2|||
145457410|NCT01942161|524527474|FG002|Overall Study|Adverse Event|5|||
145457411|NCT01942161|524527472|FG000|Overall Study|Physician Decision|3|||
145457412|NCT01942161|524527473|FG001|Overall Study|Physician Decision|1|||
145457413|NCT01942161|524527474|FG002|Overall Study|Physician Decision|0|||
145457414|NCT01942161|524527472|FG000|Overall Study|Protocol Violation|1|||
145457415|NCT01942161|524527473|FG001|Overall Study|Protocol Violation|0|||
145457416|NCT01942161|524527474|FG002|Overall Study|Protocol Violation|0|||
145457417|NCT01942161|524527472|FG000|Overall Study|Withdrawal by Subject|3|||
145457418|NCT01942161|524527473|FG001|Overall Study|Withdrawal by Subject|3|||
145457419|NCT01942161|524527474|FG002|Overall Study|Withdrawal by Subject|1|||
145457420|NCT00416715|524527478|FG000|Overall Study|Not evaluable for joint aches|7|||
145457421|NCT00416715|524527478|FG000|Overall Study|Vitamin D levels not evaluable|8|||
145457422|NCT03812185|524527482|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
145457423|NCT01007435|524527485|FG000|Overall Study|Adverse Event|16|||
145457424|NCT01007435|524527486|FG001|Overall Study|Adverse Event|25|||
145457425|NCT01007435|524527487|FG002|Overall Study|Adverse Event|47|||
145457426|NCT01007435|524527488|FG003|Overall Study|Adverse Event|31|||
145457427|NCT01007435|524527485|FG000|Overall Study|Death|2|||
145457428|NCT01007435|524527486|FG001|Overall Study|Death|4|||
145457429|NCT01007435|524527487|FG002|Overall Study|Death|2|||
145457430|NCT01007435|524527488|FG003|Overall Study|Death|1|||
145457431|NCT01007435|524527485|FG000|Overall Study|Insufficient Therapeutic Response|21|||
145457432|NCT01007435|524527486|FG001|Overall Study|Insufficient Therapeutic Response|7|||
145457433|NCT01007435|524527487|FG002|Overall Study|Insufficient Therapeutic Response|2|||
145457434|NCT01007435|524527488|FG003|Overall Study|Insufficient Therapeutic Response|9|||
145457435|NCT01007435|524527485|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
145457436|NCT01007435|524527486|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
145457437|NCT01007435|524527487|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
145457438|NCT01007435|524527488|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
145457439|NCT01007435|524527485|FG000|Overall Study|Other Protocol Violation|2|||
145457440|NCT01007435|524527486|FG001|Overall Study|Other Protocol Violation|0|||
145457441|NCT01007435|524527487|FG002|Overall Study|Other Protocol Violation|1|||
145457442|NCT01007435|524527488|FG003|Overall Study|Other Protocol Violation|0|||
145457443|NCT01007435|524527485|FG000|Overall Study|Refused Treatment|13|||
145457444|NCT01007435|524527486|FG001|Overall Study|Refused Treatment|13|||
145457445|NCT01007435|524527487|FG002|Overall Study|Refused Treatment|5|||
145457446|NCT01007435|524527488|FG003|Overall Study|Refused Treatment|8|||
145457447|NCT01007435|524527485|FG000|Overall Study|Failure to Return|5|||
145457448|NCT01007435|524527486|FG001|Overall Study|Failure to Return|4|||
145457449|NCT01007435|524527487|FG002|Overall Study|Failure to Return|3|||
145457450|NCT01007435|524527488|FG003|Overall Study|Failure to Return|6|||
145457451|NCT01007435|524527485|FG000|Overall Study|Reason not Specified|1|||
145457452|NCT01007435|524527486|FG001|Overall Study|Reason not Specified|1|||
145457453|NCT01007435|524527487|FG002|Overall Study|Reason not Specified|2|||
145589069|NCT04546581|525007816|FG001|Overall Study|Adverse Event|3|||
145457454|NCT01007435|524527488|FG003|Overall Study|Reason not Specified|1|||
145457455|NCT00347438|524527489|FG000|Overall Study|Withdrawal by Subject|1|||
145457456|NCT00347438|524527489|FG000|Overall Study|Physician Decision|1|||
145457457|NCT02545517|524527490|FG000|Overall Study|Death|2|||
145457458|NCT02545517|524527491|FG001|Overall Study|Death|2|||
145457459|NCT02545517|524527492|FG002|Overall Study|Death|1|||
145589070|NCT04546581|525007815|FG000|Overall Study|Physician Decision|0|||
145589071|NCT04546581|525007816|FG001|Overall Study|Physician Decision|1|||
145589072|NCT04546581|525007815|FG000|Overall Study|Protocol Violation|1|||
145589073|NCT04546581|525007816|FG001|Overall Study|Protocol Violation|2|||
145589074|NCT04546581|525007815|FG000|Overall Study|Withdrawal by Subject|3|||
145589075|NCT04546581|525007816|FG001|Overall Study|Withdrawal by Subject|7|||
145589076|NCT01275625|525007817|FG000|Overall Study|Death|1|||
145589077|NCT01275625|525007817|FG000|Overall Study|Lack of Efficacy|2|||
145589078|NCT01275625|525007817|FG000|Overall Study|Lost to Follow-up|1|||
145589079|NCT01275625|525007817|FG000|Overall Study|Withdrawal by Subject|3|||
145589080|NCT01275625|525007817|FG000|Overall Study|Protocol Violation|1|||
145589081|NCT01275625|525007817|FG000|Overall Study|Adverse Event|4|||
145589082|NCT01275625|525007817|FG000|Overall Study|Other|1|||
145589083|NCT01349569|525007818|FG000|Overall Study|Lack of Efficacy|4|||
145589084|NCT00626522|525007819|FG000|Overall Study|Protocol Violation|0|||
145589085|NCT00626522|525007820|FG001|Overall Study|Protocol Violation|0|||
145589086|NCT00626522|525007821|FG002|Overall Study|Protocol Violation|0|||
145589087|NCT00626522|525007822|FG003|Overall Study|Protocol Violation|0|||
145589088|NCT00626522|525007823|FG004|Overall Study|Protocol Violation|1|||
145589089|NCT00626522|525007824|FG005|Overall Study|Protocol Violation|0|||
145589090|NCT00626522|525007819|FG000|Overall Study|Adverse Event|2|||
145589091|NCT00626522|525007820|FG001|Overall Study|Adverse Event|1|||
145589092|NCT00626522|525007821|FG002|Overall Study|Adverse Event|2|||
145589093|NCT00626522|525007822|FG003|Overall Study|Adverse Event|0|||
145589094|NCT00626522|525007823|FG004|Overall Study|Adverse Event|1|||
145589095|NCT00626522|525007824|FG005|Overall Study|Adverse Event|1|||
145589096|NCT00626522|525007819|FG000|Overall Study|Withdrawal by Subject|2|||
145589097|NCT00626522|525007820|FG001|Overall Study|Withdrawal by Subject|5|||
145589098|NCT00626522|525007821|FG002|Overall Study|Withdrawal by Subject|5|||
145589099|NCT00626522|525007822|FG003|Overall Study|Withdrawal by Subject|0|||
145589100|NCT00626522|525007823|FG004|Overall Study|Withdrawal by Subject|4|||
145589101|NCT00626522|525007824|FG005|Overall Study|Withdrawal by Subject|1|||
145589102|NCT00626522|525007819|FG000|Overall Study|COPD exacerbation|0|||
145589103|NCT00626522|525007820|FG001|Overall Study|COPD exacerbation|0|||
145589104|NCT00626522|525007821|FG002|Overall Study|COPD exacerbation|0|||
145589105|NCT00626522|525007822|FG003|Overall Study|COPD exacerbation|1|||
145589106|NCT00626522|525007823|FG004|Overall Study|COPD exacerbation|1|||
145589107|NCT00626522|525007824|FG005|Overall Study|COPD exacerbation|0|||
145589108|NCT00626522|525007819|FG000|Overall Study|Lost to Follow-up|0|||
145589109|NCT00626522|525007820|FG001|Overall Study|Lost to Follow-up|1|||
145589110|NCT00626522|525007821|FG002|Overall Study|Lost to Follow-up|0|||
145589111|NCT00626522|525007822|FG003|Overall Study|Lost to Follow-up|0|||
145589112|NCT00626522|525007823|FG004|Overall Study|Lost to Follow-up|0|||
145589113|NCT00626522|525007824|FG005|Overall Study|Lost to Follow-up|0|||
145589114|NCT00626522|525007819|FG000|Overall Study|Inconsistent reason reported|1|||
145457460|NCT02545517|524527490|FG000|Overall Study|Lost to Follow-up|14|||
145457461|NCT02545517|524527491|FG001|Overall Study|Lost to Follow-up|13|||
145457462|NCT02545517|524527492|FG002|Overall Study|Lost to Follow-up|17|||
145457463|NCT02545517|524527490|FG000|Overall Study|Protocol Violation|0|||
145457464|NCT02545517|524527491|FG001|Overall Study|Protocol Violation|1|||
145457465|NCT02545517|524527492|FG002|Overall Study|Protocol Violation|1|||
145457466|NCT02545517|524527490|FG000|Overall Study|Withdrawal by Subject|5|||
145457467|NCT02545517|524527491|FG001|Overall Study|Withdrawal by Subject|8|||
145457468|NCT02545517|524527492|FG002|Overall Study|Withdrawal by Subject|9|||
145457469|NCT02545517|524527490|FG000|Overall Study|Administrative reason|5|||
145457470|NCT02545517|524527491|FG001|Overall Study|Administrative reason|6|||
145457471|NCT02545517|524527492|FG002|Overall Study|Administrative reason|10|||
145589115|NCT00626522|525007820|FG001|Overall Study|Inconsistent reason reported|0|||
145589116|NCT00626522|525007821|FG002|Overall Study|Inconsistent reason reported|0|||
145589117|NCT00626522|525007822|FG003|Overall Study|Inconsistent reason reported|0|||
145589118|NCT00626522|525007823|FG004|Overall Study|Inconsistent reason reported|0|||
145589119|NCT00626522|525007824|FG005|Overall Study|Inconsistent reason reported|0|||
145589120|NCT00626522|525007819|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
145589121|NCT00626522|525007820|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
145457472|NCT02545517|524527490|FG000|Overall Study|Other|2|||
145457473|NCT02545517|524527491|FG001|Overall Study|Other|4|||
145589122|NCT00626522|525007821|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
145589123|NCT00626522|525007822|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
145589124|NCT00626522|525007823|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
145589125|NCT00626522|525007824|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
145589126|NCT04579757|525007832|FG000|Overall Study|Adverse Event|0|||
145589127|NCT04579757|525007833|FG001|Overall Study|Adverse Event|0|||
145589128|NCT04579757|525007834|FG002|Overall Study|Adverse Event|0|||
145589129|NCT04579757|525007835|FG003|Overall Study|Adverse Event|2|||
145589130|NCT04579757|525007836|FG004|Overall Study|Adverse Event|1|||
145589131|NCT04579757|525007837|FG005|Overall Study|Adverse Event|1|||
145457474|NCT02545517|524527492|FG002|Overall Study|Other|3|||
145457475|NCT01529515|524527493|FG000|TRANSITION PHASE|Adverse Event|16|||
145457476|NCT01529515|524527494|FG001|TRANSITION PHASE|Adverse Event|0|||
145457477|NCT01529515|524527495|FG002|TRANSITION PHASE|Adverse Event|0|||
145457478|NCT01529515|524527496|FG003|TRANSITION PHASE|Adverse Event|0|||
145457479|NCT01529515|524527493|FG000|TRANSITION PHASE|Death|1|||
145457480|NCT01529515|524527494|FG001|TRANSITION PHASE|Death|0|||
145457481|NCT01529515|524527495|FG002|TRANSITION PHASE|Death|0|||
145457482|NCT01529515|524527496|FG003|TRANSITION PHASE|Death|0|||
145457483|NCT01529515|524527493|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
145457484|NCT01529515|524527494|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
145457485|NCT01529515|524527495|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
145457486|NCT01529515|524527496|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
145457487|NCT01529515|524527493|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
145457488|NCT01529515|524527494|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
145457489|NCT01529515|524527495|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
145457490|NCT01529515|524527496|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
145457491|NCT01529515|524527493|FG000|TRANSITION PHASE|Protocol Violation|4|||
145457492|NCT01529515|524527494|FG001|TRANSITION PHASE|Protocol Violation|0|||
145457493|NCT01529515|524527495|FG002|TRANSITION PHASE|Protocol Violation|0|||
145457494|NCT01529515|524527496|FG003|TRANSITION PHASE|Protocol Violation|0|||
145457495|NCT01529515|524527493|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
145589132|NCT04579757|525007838|FG006|Overall Study|Adverse Event|0|||
145589133|NCT04579757|525007839|FG007|Overall Study|Adverse Event|0|||
145589134|NCT04579757|525007840|FG008|Overall Study|Adverse Event|0|||
145589135|NCT04579757|525007832|FG000|Overall Study|Death|4|||
145589136|NCT04579757|525007833|FG001|Overall Study|Death|1|||
145589137|NCT04579757|525007834|FG002|Overall Study|Death|14|||
145589138|NCT04579757|525007835|FG003|Overall Study|Death|3|||
145589139|NCT04579757|525007836|FG004|Overall Study|Death|2|||
145589140|NCT04579757|525007837|FG005|Overall Study|Death|7|||
145589141|NCT04579757|525007838|FG006|Overall Study|Death|0|||
145589142|NCT04579757|525007839|FG007|Overall Study|Death|1|||
145589143|NCT04579757|525007840|FG008|Overall Study|Death|3|||
145589144|NCT04579757|525007832|FG000|Overall Study|Physician Decision|0|||
145589145|NCT04579757|525007833|FG001|Overall Study|Physician Decision|0|||
145589146|NCT04579757|525007834|FG002|Overall Study|Physician Decision|0|||
145589147|NCT04579757|525007835|FG003|Overall Study|Physician Decision|2|||
145589148|NCT04579757|525007836|FG004|Overall Study|Physician Decision|1|||
145589149|NCT04579757|525007837|FG005|Overall Study|Physician Decision|1|||
145589150|NCT04579757|525007838|FG006|Overall Study|Physician Decision|1|||
145589151|NCT04579757|525007839|FG007|Overall Study|Physician Decision|0|||
145589152|NCT04579757|525007840|FG008|Overall Study|Physician Decision|0|||
145589153|NCT04579757|525007832|FG000|Overall Study|Study Terminated By Sponsor|0|||
145589154|NCT04579757|525007833|FG001|Overall Study|Study Terminated By Sponsor|0|||
145589155|NCT04579757|525007834|FG002|Overall Study|Study Terminated By Sponsor|0|||
145589156|NCT04579757|525007835|FG003|Overall Study|Study Terminated By Sponsor|0|||
145589157|NCT04579757|525007836|FG004|Overall Study|Study Terminated By Sponsor|2|||
145589158|NCT04579757|525007837|FG005|Overall Study|Study Terminated By Sponsor|0|||
145589159|NCT04579757|525007838|FG006|Overall Study|Study Terminated By Sponsor|0|||
145589160|NCT04579757|525007839|FG007|Overall Study|Study Terminated By Sponsor|2|||
145589161|NCT04579757|525007840|FG008|Overall Study|Study Terminated By Sponsor|0|||
145589162|NCT04579757|525007832|FG000|Overall Study|Withdrawal by Subject|1|||
145589163|NCT04579757|525007833|FG001|Overall Study|Withdrawal by Subject|1|||
145589164|NCT04579757|525007834|FG002|Overall Study|Withdrawal by Subject|0|||
145589165|NCT04579757|525007835|FG003|Overall Study|Withdrawal by Subject|0|||
145589166|NCT04579757|525007836|FG004|Overall Study|Withdrawal by Subject|2|||
145589167|NCT04579757|525007837|FG005|Overall Study|Withdrawal by Subject|1|||
145589168|NCT04579757|525007838|FG006|Overall Study|Withdrawal by Subject|0|||
145589169|NCT04579757|525007839|FG007|Overall Study|Withdrawal by Subject|3|||
145589170|NCT04579757|525007840|FG008|Overall Study|Withdrawal by Subject|0|||
145589171|NCT04579757|525007832|FG000|Overall Study|Radiological or Clinical PD|1|||
145457496|NCT01529515|524527494|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
145457497|NCT01529515|524527495|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
145457498|NCT01529515|524527496|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
145457499|NCT01529515|524527493|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
145457500|NCT01529515|524527494|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
145589172|NCT04579757|525007833|FG001|Overall Study|Radiological or Clinical PD|4|||
145626646|NCT02950545|525145726|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
145457501|NCT01529515|524527495|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
145457502|NCT01529515|524527496|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
145589173|NCT04579757|525007834|FG002|Overall Study|Radiological or Clinical PD|1|||
145589174|NCT04579757|525007835|FG003|Overall Study|Radiological or Clinical PD|3|||
145589175|NCT04579757|525007836|FG004|Overall Study|Radiological or Clinical PD|9|||
145589176|NCT04579757|525007837|FG005|Overall Study|Radiological or Clinical PD|4|||
145589177|NCT04579757|525007838|FG006|Overall Study|Radiological or Clinical PD|2|||
145589178|NCT04579757|525007839|FG007|Overall Study|Radiological or Clinical PD|2|||
145457503|NCT01529515|524527493|FG000|TRANSITION PHASE|Other|9|||
145457504|NCT01529515|524527494|FG001|TRANSITION PHASE|Other|0|||
145589179|NCT04579757|525007840|FG008|Overall Study|Radiological or Clinical PD|0|||
145589180|NCT04579757|525007832|FG000|Overall Study|Start of New Therapy|0|||
145589181|NCT04579757|525007833|FG001|Overall Study|Start of New Therapy|0|||
145589182|NCT04579757|525007834|FG002|Overall Study|Start of New Therapy|0|||
145589183|NCT04579757|525007835|FG003|Overall Study|Start of New Therapy|0|||
145589184|NCT04579757|525007836|FG004|Overall Study|Start of New Therapy|2|||
145589185|NCT04579757|525007837|FG005|Overall Study|Start of New Therapy|1|||
145589186|NCT04579757|525007838|FG006|Overall Study|Start of New Therapy|0|||
145589187|NCT04579757|525007839|FG007|Overall Study|Start of New Therapy|0|||
145589188|NCT04579757|525007840|FG008|Overall Study|Start of New Therapy|0|||
145589189|NCT02207816|525007841|FG000|Overall Study|Serious Adverse Event|0|||
145589190|NCT02207816|525007842|FG001|Overall Study|Serious Adverse Event|5|||
145589191|NCT02207816|525007843|FG002|Overall Study|Serious Adverse Event|2|||
145589192|NCT02207816|525007841|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
145589193|NCT02207816|525007842|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
145589194|NCT02207816|525007843|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
145589195|NCT02207816|525007841|FG000|Overall Study|Withdrawal by Subject|4|||
145589196|NCT02207816|525007842|FG001|Overall Study|Withdrawal by Subject|9|||
145589197|NCT02207816|525007843|FG002|Overall Study|Withdrawal by Subject|7|||
145457505|NCT01529515|524527495|FG002|TRANSITION PHASE|Other|0|||
145457506|NCT01529515|524527496|FG003|TRANSITION PHASE|Other|0|||
145457507|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Adverse Event|0|||
145457508|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Adverse Event|10|||
145457509|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Adverse Event|0|||
145457510|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Adverse Event|0|||
145457511|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
145457512|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
145457513|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
145457514|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
145457515|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
145457516|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
145457517|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
145457518|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
145457519|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
145457520|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
145457521|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
145457522|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
145457523|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
145457524|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
145457525|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
145457526|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
145457527|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
145457528|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
145457529|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
145457530|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
145457531|NCT01529515|524527493|FG000|MAINTENANCE PHASE|Other|0|||
145457532|NCT01529515|524527494|FG001|MAINTENANCE PHASE|Other|10|||
145457533|NCT01529515|524527495|FG002|MAINTENANCE PHASE|Other|0|||
145457534|NCT01529515|524527496|FG003|MAINTENANCE PHASE|Other|0|||
145457535|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
145457536|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
145457537|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
145457538|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
145457539|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
145457540|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
145457541|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
145457542|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
145457543|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
145457544|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
145457545|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
145457546|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
145457547|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
145457548|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
145626647|NCT02950545|525145727|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
145457549|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
145457550|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
145457551|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
145457552|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
145589198|NCT02207816|525007841|FG000|Overall Study|Migrated/Moved From Study Area|41|||
145626648|NCT03398356|525145728|FG000|Before Treatment|Lost to Follow-up|1|||
145457553|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
145457554|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
145457555|NCT01529515|524527493|FG000|DOUBLE BLIND PHASE|Other|0|||
145457556|NCT01529515|524527494|FG001|DOUBLE BLIND PHASE|Other|0|||
145589199|NCT02207816|525007842|FG001|Overall Study|Migrated/Moved From Study Area|60|||
145589200|NCT02207816|525007843|FG002|Overall Study|Migrated/Moved From Study Area|51|||
145457557|NCT01529515|524527495|FG002|DOUBLE BLIND PHASE|Other|9|||
145457558|NCT01529515|524527496|FG003|DOUBLE BLIND PHASE|Other|2|||
145589201|NCT02207816|525007841|FG000|Overall Study|Lost to Follow-up|3|||
145589202|NCT02207816|525007842|FG001|Overall Study|Lost to Follow-up|9|||
145589203|NCT02207816|525007843|FG002|Overall Study|Lost to Follow-up|1|||
145589204|NCT02207816|525007841|FG000|Overall Study|Other|1|||
145589205|NCT02207816|525007842|FG001|Overall Study|Other|2|||
145589206|NCT02207816|525007843|FG002|Overall Study|Other|4|||
145589207|NCT01412944|525007846|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
145589208|NCT01412944|525007847|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
145589209|NCT01412944|525007848|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
145589210|NCT01412944|525007849|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
145589211|NCT01412944|525007850|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
145589212|NCT01412944|525007851|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
145589213|NCT01412944|525007846|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
145589214|NCT01412944|525007847|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
145589215|NCT01412944|525007848|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
145589216|NCT01412944|525007849|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
145589217|NCT01412944|525007850|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
145589218|NCT01412944|525007851|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
145589219|NCT01412944|525007846|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
145589220|NCT01412944|525007847|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
145589221|NCT01412944|525007848|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
145589222|NCT01412944|525007849|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
145589223|NCT01412944|525007850|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
145589224|NCT01412944|525007851|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
145589225|NCT01412944|525007846|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
145589226|NCT01412944|525007847|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
145589227|NCT01412944|525007848|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
145589228|NCT01412944|525007849|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
145589229|NCT01412944|525007850|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
145589230|NCT01412944|525007851|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
145589231|NCT01412944|525007846|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
145589232|NCT01412944|525007847|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
145589233|NCT01412944|525007848|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
145589234|NCT01412944|525007849|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
145589235|NCT01412944|525007850|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
145589236|NCT01412944|525007851|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
145589237|NCT01412944|525007846|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
145589238|NCT01412944|525007847|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
145589239|NCT01412944|525007848|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
145589240|NCT01412944|525007849|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
145589241|NCT01412944|525007850|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
145589242|NCT01412944|525007851|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
145589243|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589244|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589245|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
145589246|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
145589247|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
145589248|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589249|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Adverse Event|0|||
145589250|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Adverse Event|0|||
145589251|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Adverse Event|0|||
145589252|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Adverse Event|0|||
145589253|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Adverse Event|1|||
145589254|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Adverse Event|0|||
145589255|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
145589256|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
145589257|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
145589258|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
145589259|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
145589260|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
145589261|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589262|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589263|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589264|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
145457559|NCT03334851|524527498|FG000|Overall Study|Other|0|||
145457560|NCT03334851|524527499|FG001|Overall Study|Other|0|||
145589265|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589266|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
145589267|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589268|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589269|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589270|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589271|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
145589272|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589273|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
145589274|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
145589275|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589276|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589277|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589278|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
145589279|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
145589280|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
145589281|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
145589282|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
145589283|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
145589284|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
145589285|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589286|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
145589287|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589288|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589289|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589290|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
145589291|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589292|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
145589293|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589294|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589295|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589296|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
145589297|NCT01412944|525007846|FG000|Entire: IV + Maintenance|Adverse Event|0|||
145589298|NCT01412944|525007847|FG001|Entire: IV + Maintenance|Adverse Event|1|||
145589299|NCT01412944|525007848|FG002|Entire: IV + Maintenance|Adverse Event|0|||
145589300|NCT01412944|525007849|FG003|Entire: IV + Maintenance|Adverse Event|0|||
145589301|NCT01412944|525007850|FG004|Entire: IV + Maintenance|Adverse Event|0|||
145589302|NCT01412944|525007851|FG005|Entire: IV + Maintenance|Adverse Event|0|||
145589303|NCT03240588|525007852|FG000|Overall Study|Death|3|||
145589304|NCT03240588|525007853|FG001|Overall Study|Death|0|||
145589305|NCT03240588|525007854|FG002|Overall Study|Death|0|||
145589306|NCT03240588|525007852|FG000|Overall Study|Adverse Event|5|||
145589307|NCT03240588|525007853|FG001|Overall Study|Adverse Event|4|||
145589308|NCT03240588|525007854|FG002|Overall Study|Adverse Event|0|||
145589309|NCT03240588|525007852|FG000|Overall Study|Lost to Follow-up|9|||
145589310|NCT03240588|525007853|FG001|Overall Study|Lost to Follow-up|4|||
145589311|NCT03240588|525007854|FG002|Overall Study|Lost to Follow-up|0|||
145589312|NCT03240588|525007852|FG000|Overall Study|Physician Decision|3|||
145589313|NCT03240588|525007853|FG001|Overall Study|Physician Decision|2|||
145589314|NCT03240588|525007854|FG002|Overall Study|Physician Decision|0|||
145589315|NCT03240588|525007852|FG000|Overall Study|Did not meet eligibility criteria|0|||
145589316|NCT03240588|525007853|FG001|Overall Study|Did not meet eligibility criteria|6|||
145589317|NCT03240588|525007854|FG002|Overall Study|Did not meet eligibility criteria|0|||
145589318|NCT03240588|525007852|FG000|Overall Study|No longer meets protocol criteria|12|||
145589319|NCT03240588|525007853|FG001|Overall Study|No longer meets protocol criteria|7|||
145589320|NCT03240588|525007854|FG002|Overall Study|No longer meets protocol criteria|0|||
145589321|NCT03240588|525007852|FG000|Overall Study|Withdrawal by Subject|60|||
145589322|NCT03240588|525007853|FG001|Overall Study|Withdrawal by Subject|52|||
145589323|NCT03240588|525007854|FG002|Overall Study|Withdrawal by Subject|7|||
145589324|NCT03240588|525007852|FG000|Overall Study|Other, additional details not available.|0|||
145589325|NCT03240588|525007853|FG001|Overall Study|Other, additional details not available.|12|||
145589326|NCT03240588|525007854|FG002|Overall Study|Other, additional details not available.|1|||
145589327|NCT03240588|525007852|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
145589328|NCT03240588|525007853|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
145589329|NCT03240588|525007854|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
145589330|NCT03240588|525007852|FG000|Overall Study|Closure of study|55|||
145589331|NCT03240588|525007853|FG001|Overall Study|Closure of study|3|||
145589332|NCT03240588|525007854|FG002|Overall Study|Closure of study|0|||
145589333|NCT03240588|525007852|FG000|Overall Study|Subject non-compliance|23|||
145589334|NCT03240588|525007853|FG001|Overall Study|Subject non-compliance|2|||
145589335|NCT03240588|525007854|FG002|Overall Study|Subject non-compliance|1|||
145589336|NCT03240588|525007852|FG000|Overall Study|Device Deficiency|1|||
145589337|NCT03240588|525007853|FG001|Overall Study|Device Deficiency|0|||
145589338|NCT03240588|525007854|FG002|Overall Study|Device Deficiency|0|||
145589339|NCT03240588|525007852|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
145589340|NCT03240588|525007853|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
145589341|NCT03240588|525007854|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
145589342|NCT02091726|525007856|FG000|Overall Study|Lost to Follow-up|6|||
145589343|NCT02239679|525007857|FG000|Overall Study|Lost to Follow-up|1|||
145589344|NCT02239679|525007858|FG001|Overall Study|Lost to Follow-up|0|||
145589345|NCT02239679|525007859|FG002|Overall Study|Lost to Follow-up|0|||
145457561|NCT03334851|524527500|FG002|Overall Study|Other|0|||
145457562|NCT03334851|524527501|FG003|Overall Study|Other|0|||
145457563|NCT03334851|524527502|FG004|Overall Study|Other|0|||
145457564|NCT03334851|524527503|FG005|Overall Study|Other|0|||
145457565|NCT03334851|524527504|FG006|Overall Study|Other|0|||
145457566|NCT03334851|524527505|FG007|Overall Study|Other|1|||
145457567|NCT03334851|524527506|FG008|Overall Study|Other|0|||
145457568|NCT03334851|524527507|FG009|Overall Study|Other|0|||
145457569|NCT03334851|524527508|FG010|Overall Study|Other|0|||
145457570|NCT03334851|524527509|FG011|Overall Study|Other|0|||
145457571|NCT03334851|524527510|FG012|Overall Study|Other|0|||
145457572|NCT03334851|524527498|FG000|Overall Study|Adverse Event|0|||
145457573|NCT03334851|524527499|FG001|Overall Study|Adverse Event|0|||
145457574|NCT03334851|524527500|FG002|Overall Study|Adverse Event|0|||
145457575|NCT03334851|524527501|FG003|Overall Study|Adverse Event|0|||
145457576|NCT03334851|524527502|FG004|Overall Study|Adverse Event|0|||
145457577|NCT03334851|524527503|FG005|Overall Study|Adverse Event|0|||
145457578|NCT03334851|524527504|FG006|Overall Study|Adverse Event|0|||
145457579|NCT03334851|524527505|FG007|Overall Study|Adverse Event|1|||
145457580|NCT03334851|524527506|FG008|Overall Study|Adverse Event|0|||
145457581|NCT03334851|524527507|FG009|Overall Study|Adverse Event|0|||
145457582|NCT03334851|524527508|FG010|Overall Study|Adverse Event|0|||
145457583|NCT03334851|524527509|FG011|Overall Study|Adverse Event|0|||
145457584|NCT03334851|524527510|FG012|Overall Study|Adverse Event|0|||
145457585|NCT03334851|524527498|FG000|Overall Study|Withdrawal by Subject|0|||
145457586|NCT03334851|524527499|FG001|Overall Study|Withdrawal by Subject|0|||
145457587|NCT03334851|524527500|FG002|Overall Study|Withdrawal by Subject|0|||
145457588|NCT03334851|524527501|FG003|Overall Study|Withdrawal by Subject|0|||
145457589|NCT03334851|524527502|FG004|Overall Study|Withdrawal by Subject|0|||
145457590|NCT03334851|524527503|FG005|Overall Study|Withdrawal by Subject|0|||
145457591|NCT03334851|524527504|FG006|Overall Study|Withdrawal by Subject|0|||
145457592|NCT03334851|524527505|FG007|Overall Study|Withdrawal by Subject|0|||
145457593|NCT03334851|524527506|FG008|Overall Study|Withdrawal by Subject|0|||
145457594|NCT03334851|524527507|FG009|Overall Study|Withdrawal by Subject|0|||
145457595|NCT03334851|524527508|FG010|Overall Study|Withdrawal by Subject|1|||
145457596|NCT03334851|524527509|FG011|Overall Study|Withdrawal by Subject|0|||
145457597|NCT03334851|524527510|FG012|Overall Study|Withdrawal by Subject|1|||
145457598|NCT03334851|524527498|FG000|Overall Study|Lost to Follow-up|0|||
145457599|NCT03334851|524527499|FG001|Overall Study|Lost to Follow-up|0|||
145457600|NCT03334851|524527500|FG002|Overall Study|Lost to Follow-up|0|||
145457601|NCT03334851|524527501|FG003|Overall Study|Lost to Follow-up|0|||
145457602|NCT03334851|524527502|FG004|Overall Study|Lost to Follow-up|0|||
145457603|NCT03334851|524527503|FG005|Overall Study|Lost to Follow-up|0|||
145457604|NCT03334851|524527504|FG006|Overall Study|Lost to Follow-up|0|||
145457605|NCT03334851|524527505|FG007|Overall Study|Lost to Follow-up|0|||
145457606|NCT03334851|524527506|FG008|Overall Study|Lost to Follow-up|0|||
145457607|NCT03334851|524527507|FG009|Overall Study|Lost to Follow-up|0|||
145457608|NCT03334851|524527508|FG010|Overall Study|Lost to Follow-up|2|||
145457609|NCT03334851|524527509|FG011|Overall Study|Lost to Follow-up|1|||
145457610|NCT03334851|524527510|FG012|Overall Study|Lost to Follow-up|0|||
145457611|NCT00523705|524527511|FG000|Overall Study|No time for study.|0|||
145457612|NCT00523705|524527512|FG001|Overall Study|No time for study.|1|||
145457613|NCT00642369|524527514|FG000|Overall Study|Adverse Event|2|||
145457614|NCT00642369|524527515|FG001|Overall Study|Adverse Event|3|||
145457615|NCT00642369|524527514|FG000|Overall Study|Withdrawal by Subject|1|||
145457616|NCT00642369|524527515|FG001|Overall Study|Withdrawal by Subject|0|||
145457617|NCT00642369|524527514|FG000|Overall Study|misdiagnosis|0|||
145457618|NCT00642369|524527515|FG001|Overall Study|misdiagnosis|1|||
145457619|NCT00642369|524527514|FG000|Overall Study|Lack of Efficacy|2|||
145457620|NCT00642369|524527515|FG001|Overall Study|Lack of Efficacy|2|||
145589346|NCT02239679|525007857|FG000|Overall Study|Withdrawal by Subject|2|||
145457621|NCT01190475|524527522|FG000|Overall Study|Withdrawal by Subject|0|||
145457622|NCT01190475|524527523|FG001|Overall Study|Withdrawal by Subject|0|||
145457623|NCT01190475|524527524|FG002|Overall Study|Withdrawal by Subject|1|||
145589347|NCT02239679|525007858|FG001|Overall Study|Withdrawal by Subject|3|||
145457624|NCT00543803|524527525|FG000|Overall Study|Adverse Event|14|||
145457625|NCT00543803|524527525|FG000|Overall Study|Lack of Efficacy|22|||
145457626|NCT00543803|524527525|FG000|Overall Study|Lost to Follow-up|20|||
145457627|NCT00543803|524527525|FG000|Overall Study|Other|86|||
145457628|NCT04686084|524527527|FG000|Overall Study|Lost to Follow-up|1|||
145457629|NCT01779856|524527529|FG000|Overall Study|Withdrawal by Subject|15|||
145457630|NCT01779856|524527529|FG000|Overall Study|Death|3|||
145457631|NCT01779856|524527529|FG000|Overall Study|Physician Decision|1|||
145457632|NCT01779856|524527529|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
145589348|NCT02239679|525007859|FG002|Overall Study|Withdrawal by Subject|1|||
145589349|NCT03508843|525007860|FG000|Overall Study|Withdrawal by Subject|1|||
145589350|NCT03508843|525007860|FG000|Overall Study|technical difficulties|2|||
145589351|NCT04066114|525007861|FG000|Overall Study|Adverse Event|1|||
145589352|NCT04066114|525007862|FG001|Overall Study|Adverse Event|0|||
145589353|NCT04066114|525007863|FG002|Overall Study|Adverse Event|0|||
145589354|NCT04066114|525007861|FG000|Overall Study|Withdrawal by Subject|1|||
145589355|NCT04066114|525007862|FG001|Overall Study|Withdrawal by Subject|0|||
145589356|NCT04066114|525007863|FG002|Overall Study|Withdrawal by Subject|0|||
145589357|NCT04066114|525007861|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
145589358|NCT04066114|525007862|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
145589359|NCT04066114|525007863|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
145589360|NCT00434057|525007865|FG000|Overall Study|Withdrawal by Subject|1|||
145589361|NCT00455195|525007868|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
145589362|NCT00455195|525007869|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
145589363|NCT00455195|525007868|FG000|Double-blind Study AGLU02704|Death|1|||
145589364|NCT00455195|525007869|FG001|Double-blind Study AGLU02704|Death|0|||
145589365|NCT00455195|525007868|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
145589366|NCT00455195|525007869|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
145589367|NCT00455195|525007868|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
145589368|NCT00455195|525007869|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
145589369|NCT02148250|525007872|FG000|Screening|Withdrawal by Subject|5|||
145589370|NCT02148250|525007873|FG001|Screening|Withdrawal by Subject|0|||
145589371|NCT03043664|525007876|FG000|Overall Study|Lost to Follow-up|1|||
145589372|NCT03593655|525007877|FG000|First Product Use Period|Withdrawal by Subject|1|||
145589373|NCT03593655|525007878|FG001|First Product Use Period|Withdrawal by Subject|1|||
145589374|NCT03593655|525007877|FG000|First Product Use Period|Lost to Follow-up|1|||
145589375|NCT03593655|525007878|FG001|First Product Use Period|Lost to Follow-up|3|||
145589376|NCT03593655|525007877|FG000|Second Product Use Period|Withdrawal by Subject|1|||
145589377|NCT03593655|525007878|FG001|Second Product Use Period|Withdrawal by Subject|1|||
145589378|NCT03593655|525007877|FG000|Second Product Use Period|Lost to Follow-up|1|||
145589379|NCT03593655|525007878|FG001|Second Product Use Period|Lost to Follow-up|0|||
145589380|NCT03593655|525007877|FG000|Third Product Use Period|Lost to Follow-up|1|||
145589381|NCT03593655|525007878|FG001|Third Product Use Period|Lost to Follow-up|2|||
145589382|NCT03593655|525007877|FG000|Third Product Use Period|Physician Decision|0|||
145589383|NCT03593655|525007878|FG001|Third Product Use Period|Physician Decision|1|||
145589384|NCT03593655|525007877|FG000|Third Product Use Period|Withdrawal by Subject|0|||
145589385|NCT03593655|525007878|FG001|Third Product Use Period|Withdrawal by Subject|1|||
145589386|NCT03732209|525007879|FG000|Overall Study|Lost to Follow-up|4|||
145589387|NCT03732209|525007880|FG001|Overall Study|Lost to Follow-up|4|||
145589388|NCT03732209|525007879|FG000|Overall Study|Withdrawal by Subject|8|||
145589389|NCT03732209|525007880|FG001|Overall Study|Withdrawal by Subject|9|||
145589390|NCT02864082|525007881|FG000|Overall Study|Adverse Event|1|||
145589391|NCT02864082|525007882|FG001|Overall Study|Adverse Event|1|||
145589392|NCT02864082|525007881|FG000|Overall Study|Lost to Follow-up|0|||
145589393|NCT02864082|525007882|FG001|Overall Study|Lost to Follow-up|1|||
145589394|NCT02864082|525007881|FG000|Overall Study|Withdrawal by Subject|2|||
145589395|NCT02864082|525007882|FG001|Overall Study|Withdrawal by Subject|2|||
145589396|NCT03621696|525007883|FG000|Overall Study|Not eligible|0|||
145589397|NCT03621696|525007884|FG001|Overall Study|Not eligible|0|||
145589398|NCT03621696|525007885|FG002|Overall Study|Not eligible|0|||
145589399|NCT03621696|525007886|FG003|Overall Study|Not eligible|5|||
145589400|NCT03621696|525007883|FG000|Overall Study|Withdrawal by Subject|1|||
145589401|NCT03621696|525007884|FG001|Overall Study|Withdrawal by Subject|1|||
145589402|NCT03621696|525007885|FG002|Overall Study|Withdrawal by Subject|1|||
145589403|NCT03621696|525007886|FG003|Overall Study|Withdrawal by Subject|0|||
145589404|NCT03621696|525007883|FG000|Overall Study|Physician Decision|0|||
145589405|NCT03621696|525007884|FG001|Overall Study|Physician Decision|0|||
145589406|NCT03621696|525007885|FG002|Overall Study|Physician Decision|1|||
145589407|NCT03621696|525007886|FG003|Overall Study|Physician Decision|0|||
145589408|NCT03585244|525007889|FG000|Overall Study|Withdrawal by Subject|15|||
145589409|NCT02105948|525007890|FG000|Overall Study|Adverse Event|10|||
145626649|NCT03398356|525145729|FG001|Before Treatment|Lost to Follow-up|2|||
145589410|NCT02105948|525007891|FG001|Overall Study|Adverse Event|7|||
145589411|NCT02105948|525007892|FG002|Overall Study|Adverse Event|11|||
145589412|NCT02105948|525007893|FG003|Overall Study|Adverse Event|11|||
145589413|NCT02105948|525007890|FG000|Overall Study|Lack of Efficacy|0|||
145589414|NCT02105948|525007891|FG001|Overall Study|Lack of Efficacy|1|||
145589415|NCT02105948|525007892|FG002|Overall Study|Lack of Efficacy|3|||
145589416|NCT02105948|525007893|FG003|Overall Study|Lack of Efficacy|2|||
145589417|NCT02105948|525007890|FG000|Overall Study|Lost to Follow-up|0|||
145589418|NCT02105948|525007891|FG001|Overall Study|Lost to Follow-up|0|||
145589419|NCT02105948|525007892|FG002|Overall Study|Lost to Follow-up|2|||
145589420|NCT02105948|525007893|FG003|Overall Study|Lost to Follow-up|1|||
145589421|NCT02105948|525007890|FG000|Overall Study|Physician Decision|2|||
145589422|NCT02105948|525007891|FG001|Overall Study|Physician Decision|2|||
145589423|NCT02105948|525007892|FG002|Overall Study|Physician Decision|2|||
145589424|NCT02105948|525007893|FG003|Overall Study|Physician Decision|2|||
145589425|NCT02105948|525007890|FG000|Overall Study|Withdrawal by Subject|15|||
145589426|NCT02105948|525007891|FG001|Overall Study|Withdrawal by Subject|10|||
145589427|NCT02105948|525007892|FG002|Overall Study|Withdrawal by Subject|10|||
145589428|NCT02105948|525007893|FG003|Overall Study|Withdrawal by Subject|11|||
145589429|NCT03273946|525007898|FG000|Overall Study|Withdrawal by Subject|5|||
145589430|NCT03273946|525007898|FG000|Overall Study|Unwillingness of the guardian|1|||
145589431|NCT03273946|525007898|FG000|Overall Study|Participant refused to use the drug|2|||
145589432|NCT03273946|525007898|FG000|Overall Study|Participant relative refused to use drug|1|||
145589433|NCT01220557|525007900|FG000|Overall Study|Lost to Follow-up|5|||
145589434|NCT01220557|525007901|FG001|Overall Study|Lost to Follow-up|3|||
145589435|NCT01220557|525007900|FG000|Overall Study|attended less than 6 lessons|1|||
145589436|NCT01220557|525007901|FG001|Overall Study|attended less than 6 lessons|2|||
145589437|NCT04072159|525007904|FG000|Overall Study|Lost to Follow-up|6|||
145589438|NCT04072159|525007905|FG001|Overall Study|Lost to Follow-up|6|||
145589439|NCT04072159|525007904|FG000|Overall Study|Withdrawal by Subject|2|||
145589440|NCT04072159|525007905|FG001|Overall Study|Withdrawal by Subject|0|||
145589441|NCT01196975|525007907|FG000|Overall Study|Adverse Event|2|||
145589442|NCT01196975|525007908|FG001|Overall Study|Adverse Event|2|||
145589443|NCT01196975|525007909|FG002|Overall Study|Adverse Event|0|||
145589444|NCT01196975|525007910|FG003|Overall Study|Adverse Event|0|||
145589445|NCT01196975|525007911|FG004|Overall Study|Adverse Event|2|||
145589446|NCT01196975|525007907|FG000|Overall Study|Withdrawal by Subject|2|||
145589447|NCT01196975|525007908|FG001|Overall Study|Withdrawal by Subject|1|||
145589448|NCT01196975|525007909|FG002|Overall Study|Withdrawal by Subject|0|||
145589449|NCT01196975|525007910|FG003|Overall Study|Withdrawal by Subject|1|||
145589450|NCT01196975|525007911|FG004|Overall Study|Withdrawal by Subject|0|||
145589451|NCT01196975|525007907|FG000|Overall Study|Lost to Follow-up|11|||
145589452|NCT01196975|525007908|FG001|Overall Study|Lost to Follow-up|6|||
145589453|NCT01196975|525007909|FG002|Overall Study|Lost to Follow-up|5|||
145589454|NCT01196975|525007910|FG003|Overall Study|Lost to Follow-up|5|||
145589455|NCT01196975|525007911|FG004|Overall Study|Lost to Follow-up|11|||
145589456|NCT03021187|525007912|FG000|Overall Study|Death|0|||
145589457|NCT03021187|525007913|FG001|Overall Study|Death|0|||
145589458|NCT03021187|525007914|FG002|Overall Study|Death|3|||
145589459|NCT03021187|525007915|FG003|Overall Study|Death|0|||
145589460|NCT03021187|525007912|FG000|Overall Study|Withdrawal by Subject|0|||
145589461|NCT03021187|525007913|FG001|Overall Study|Withdrawal by Subject|6|||
145589462|NCT03021187|525007914|FG002|Overall Study|Withdrawal by Subject|2|||
145589463|NCT03021187|525007915|FG003|Overall Study|Withdrawal by Subject|5|||
145589464|NCT03021187|525007912|FG000|Overall Study|Lost to Follow-up|10|||
145589465|NCT03021187|525007913|FG001|Overall Study|Lost to Follow-up|3|||
145589466|NCT03021187|525007914|FG002|Overall Study|Lost to Follow-up|1|||
145589467|NCT03021187|525007915|FG003|Overall Study|Lost to Follow-up|4|||
145589468|NCT00718718|525007916|FG000|Prior to Week 12|Adverse Event|0|||
145589469|NCT00718718|525007917|FG001|Prior to Week 12|Adverse Event|0|||
145589470|NCT00718718|525007918|FG002|Prior to Week 12|Adverse Event|0|||
145589471|NCT00718718|525007919|FG003|Prior to Week 12|Adverse Event|0|||
145589472|NCT00718718|525007920|FG004|Prior to Week 12|Adverse Event|0|||
145589473|NCT00718718|525007921|FG005|Prior to Week 12|Adverse Event|0|||
145589474|NCT00718718|525007922|FG006|Prior to Week 12|Adverse Event|0|||
145589475|NCT00718718|525007923|FG007|Prior to Week 12|Adverse Event|1|||
145589476|NCT00718718|525007924|FG008|Prior to Week 12|Adverse Event|1|||
145589477|NCT00718718|525007925|FG009|Prior to Week 12|Adverse Event|0|||
145589478|NCT00718718|525007916|FG000|Prior to Week 12|Withdrawal by Subject|0|||
145589479|NCT00718718|525007917|FG001|Prior to Week 12|Withdrawal by Subject|0|||
145589480|NCT00718718|525007918|FG002|Prior to Week 12|Withdrawal by Subject|0|||
145589481|NCT00718718|525007919|FG003|Prior to Week 12|Withdrawal by Subject|0|||
145589482|NCT00718718|525007920|FG004|Prior to Week 12|Withdrawal by Subject|3|||
145589483|NCT00718718|525007921|FG005|Prior to Week 12|Withdrawal by Subject|0|||
145589484|NCT00718718|525007922|FG006|Prior to Week 12|Withdrawal by Subject|1|||
145589485|NCT00718718|525007923|FG007|Prior to Week 12|Withdrawal by Subject|1|||
145589486|NCT00718718|525007924|FG008|Prior to Week 12|Withdrawal by Subject|1|||
145589487|NCT00718718|525007925|FG009|Prior to Week 12|Withdrawal by Subject|0|||
145589488|NCT00718718|525007916|FG000|Prior to Week 12|Other|1|||
145589489|NCT00718718|525007917|FG001|Prior to Week 12|Other|0|||
145589490|NCT00718718|525007918|FG002|Prior to Week 12|Other|1|||
145589491|NCT00718718|525007919|FG003|Prior to Week 12|Other|0|||
145589492|NCT00718718|525007920|FG004|Prior to Week 12|Other|0|||
145589493|NCT00718718|525007921|FG005|Prior to Week 12|Other|0|||
145589494|NCT00718718|525007922|FG006|Prior to Week 12|Other|0|||
145589495|NCT00718718|525007923|FG007|Prior to Week 12|Other|0|||
145589496|NCT00718718|525007924|FG008|Prior to Week 12|Other|0|||
145589497|NCT00718718|525007925|FG009|Prior to Week 12|Other|0|||
145589498|NCT00718718|525007916|FG000|Week 12 to End of Study|Adverse Event|0|||
145589499|NCT00718718|525007917|FG001|Week 12 to End of Study|Adverse Event|0|||
145589500|NCT00718718|525007918|FG002|Week 12 to End of Study|Adverse Event|0|||
145589501|NCT00718718|525007919|FG003|Week 12 to End of Study|Adverse Event|0|||
145589502|NCT00718718|525007920|FG004|Week 12 to End of Study|Adverse Event|0|||
145589503|NCT00718718|525007921|FG005|Week 12 to End of Study|Adverse Event|0|||
145589504|NCT00718718|525007922|FG006|Week 12 to End of Study|Adverse Event|0|||
145589505|NCT00718718|525007923|FG007|Week 12 to End of Study|Adverse Event|1|||
145589506|NCT00718718|525007924|FG008|Week 12 to End of Study|Adverse Event|0|||
145589507|NCT00718718|525007925|FG009|Week 12 to End of Study|Adverse Event|0|||
145589508|NCT00718718|525007916|FG000|Week 12 to End of Study|Death|0|||
145589509|NCT00718718|525007917|FG001|Week 12 to End of Study|Death|0|||
145589510|NCT00718718|525007918|FG002|Week 12 to End of Study|Death|0|||
145589511|NCT00718718|525007919|FG003|Week 12 to End of Study|Death|0|||
145589512|NCT00718718|525007920|FG004|Week 12 to End of Study|Death|0|||
145589513|NCT00718718|525007921|FG005|Week 12 to End of Study|Death|1|||
145589514|NCT00718718|525007922|FG006|Week 12 to End of Study|Death|0|||
145589515|NCT00718718|525007923|FG007|Week 12 to End of Study|Death|0|||
145589516|NCT00718718|525007924|FG008|Week 12 to End of Study|Death|0|||
145589517|NCT00718718|525007925|FG009|Week 12 to End of Study|Death|0|||
145589518|NCT00718718|525007916|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
145589519|NCT00718718|525007917|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
145589520|NCT00718718|525007918|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
145589521|NCT00718718|525007919|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
145589522|NCT00718718|525007920|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
145589523|NCT00718718|525007921|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
145589524|NCT00718718|525007922|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
145589525|NCT00718718|525007923|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
145589526|NCT00718718|525007924|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
145589527|NCT00718718|525007925|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
145589528|NCT00718718|525007916|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
145589529|NCT00718718|525007917|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
145589530|NCT00718718|525007918|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
145589531|NCT00718718|525007919|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
145589532|NCT00718718|525007920|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
145589533|NCT00718718|525007921|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
145589534|NCT00718718|525007922|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
145589535|NCT00718718|525007923|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
145589536|NCT00718718|525007924|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
145589537|NCT00718718|525007925|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
145589538|NCT00718718|525007916|FG000|Week 12 to End of Study|Other|0|||
145589539|NCT00718718|525007917|FG001|Week 12 to End of Study|Other|1|||
145589540|NCT00718718|525007918|FG002|Week 12 to End of Study|Other|0|||
145589541|NCT00718718|525007919|FG003|Week 12 to End of Study|Other|1|||
145589542|NCT00718718|525007920|FG004|Week 12 to End of Study|Other|0|||
145589543|NCT00718718|525007921|FG005|Week 12 to End of Study|Other|0|||
145589544|NCT00718718|525007922|FG006|Week 12 to End of Study|Other|1|||
145589545|NCT00718718|525007923|FG007|Week 12 to End of Study|Other|0|||
145589546|NCT00718718|525007924|FG008|Week 12 to End of Study|Other|0|||
145589547|NCT00718718|525007925|FG009|Week 12 to End of Study|Other|0|||
145589548|NCT03738150|525007926|FG000|Base Study|Withdrawal by Subject|1|||
145589549|NCT03738150|525007926|FG000|Extension Study|Withdrawal by Subject|1|||
145589550|NCT01358526|525007935|FG000|Open-label Titration Period|Adverse Event|95|||
145589551|NCT01358526|525007936|FG001|Open-label Titration Period|Adverse Event|0|||
145589552|NCT01358526|525007937|FG002|Open-label Titration Period|Adverse Event|0|||
145589553|NCT01358526|525007935|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
145589554|NCT01358526|525007936|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
145589555|NCT01358526|525007937|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
145589556|NCT01358526|525007935|FG000|Open-label Titration Period|Lost to Follow-up|25|||
145589557|NCT01358526|525007936|FG001|Open-label Titration Period|Lost to Follow-up|0|||
145589558|NCT01358526|525007937|FG002|Open-label Titration Period|Lost to Follow-up|0|||
145589559|NCT01358526|525007935|FG000|Open-label Titration Period|Lack of Efficacy|107|||
145589560|NCT01358526|525007936|FG001|Open-label Titration Period|Lack of Efficacy|0|||
145589561|NCT01358526|525007937|FG002|Open-label Titration Period|Lack of Efficacy|0|||
145589562|NCT01358526|525007935|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
145589563|NCT01358526|525007936|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
145589564|NCT01358526|525007937|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
145626650|NCT03398356|525145730|FG002|Before Treatment|Lost to Follow-up|0|||
145626651|NCT03398356|525145728|FG000|Before Treatment|drug intolerance|2|||
145457633|NCT01779856|524527529|FG000|Overall Study|Delays in scheduling implant|1|||
145457634|NCT01779856|524527529|FG000|Overall Study|Subject ineligible for Implant|2|||
145589565|NCT01358526|525007935|FG000|Open-label Titration Period|Administrative|8|||
145589566|NCT01358526|525007936|FG001|Open-label Titration Period|Administrative|0|||
145589567|NCT01358526|525007937|FG002|Open-label Titration Period|Administrative|0|||
145589568|NCT01358526|525007935|FG000|Open-label Titration Period|Did not qualify|178|||
145589569|NCT01358526|525007936|FG001|Open-label Titration Period|Did not qualify|0|||
145589570|NCT01358526|525007937|FG002|Open-label Titration Period|Did not qualify|0|||
145626652|NCT03398356|525145729|FG001|Before Treatment|drug intolerance|1|||
145457635|NCT00676520|524527533|FG000|Overall Study|Withdrawal by Subject|163|||
145457636|NCT00676520|524527533|FG000|Overall Study|Lost to Follow-up|162|||
145589571|NCT01358526|525007935|FG000|Double-blind Phase|Adverse Event|0|||
145589572|NCT01358526|525007936|FG001|Double-blind Phase|Adverse Event|24|||
145589573|NCT01358526|525007937|FG002|Double-blind Phase|Adverse Event|23|||
145589574|NCT01358526|525007935|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145589575|NCT01358526|525007936|FG001|Double-blind Phase|Withdrawal by Subject|10|||
145589576|NCT01358526|525007937|FG002|Double-blind Phase|Withdrawal by Subject|8|||
145589577|NCT01358526|525007935|FG000|Double-blind Phase|Lost to Follow-up|0|||
145589578|NCT01358526|525007936|FG001|Double-blind Phase|Lost to Follow-up|4|||
145589579|NCT01358526|525007937|FG002|Double-blind Phase|Lost to Follow-up|1|||
145589580|NCT01358526|525007935|FG000|Double-blind Phase|Lack of Efficacy|0|||
145589581|NCT01358526|525007936|FG001|Double-blind Phase|Lack of Efficacy|31|||
145589582|NCT01358526|525007937|FG002|Double-blind Phase|Lack of Efficacy|73|||
145589583|NCT01358526|525007935|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
145589584|NCT01358526|525007936|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
145589585|NCT01358526|525007937|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
145589586|NCT01358526|525007935|FG000|Double-blind Phase|Administrative|0|||
145589587|NCT01358526|525007936|FG001|Double-blind Phase|Administrative|6|||
145589588|NCT01358526|525007937|FG002|Double-blind Phase|Administrative|10|||
145589589|NCT01462344|525007938|FG000|Overall Study|Withdrawal by Subject|245|||
145589590|NCT01462344|525007939|FG001|Overall Study|Withdrawal by Subject|226|||
145589591|NCT01462344|525007938|FG000|Overall Study|Adverse Event|24|||
145589592|NCT01462344|525007939|FG001|Overall Study|Adverse Event|23|||
145589593|NCT01462344|525007938|FG000|Overall Study|Asthma Exacerbation|34|||
145589594|NCT01462344|525007939|FG001|Overall Study|Asthma Exacerbation|35|||
145589595|NCT01462344|525007938|FG000|Overall Study|Lack of Efficacy|5|||
145589596|NCT01462344|525007939|FG001|Overall Study|Lack of Efficacy|6|||
145589597|NCT01462344|525007938|FG000|Overall Study|Protocol Violation|68|||
145589598|NCT01462344|525007939|FG001|Overall Study|Protocol Violation|53|||
145589599|NCT01462344|525007938|FG000|Overall Study|Lost to Follow-up|7|||
145589600|NCT01462344|525007939|FG001|Overall Study|Lost to Follow-up|7|||
145589601|NCT00809757|525007942|FG000|Overall Study|Adverse Event|2|||
145589602|NCT00809757|525007943|FG001|Overall Study|Adverse Event|3|||
145457637|NCT00676520|524527533|FG000|Overall Study|Death|159|||
145457638|NCT00676520|524527533|FG000|Overall Study|Physician Decision|20|||
145589603|NCT00809757|525007944|FG002|Overall Study|Adverse Event|3|||
145589604|NCT00809757|525007942|FG000|Overall Study|Lost to Follow-up|0|||
145589605|NCT00809757|525007943|FG001|Overall Study|Lost to Follow-up|0|||
145589606|NCT00809757|525007944|FG002|Overall Study|Lost to Follow-up|1|||
145589607|NCT00809757|525007942|FG000|Overall Study|Protocol Violation|1|||
145589608|NCT00809757|525007943|FG001|Overall Study|Protocol Violation|1|||
145589609|NCT00809757|525007944|FG002|Overall Study|Protocol Violation|1|||
145589610|NCT00809757|525007942|FG000|Overall Study|Withdrawal by Subject|2|||
145589611|NCT00809757|525007943|FG001|Overall Study|Withdrawal by Subject|1|||
145589612|NCT00809757|525007944|FG002|Overall Study|Withdrawal by Subject|3|||
145589613|NCT00809757|525007942|FG000|Overall Study|Subject Uncooperative|1|||
145589614|NCT00809757|525007943|FG001|Overall Study|Subject Uncooperative|0|||
145589615|NCT00809757|525007944|FG002|Overall Study|Subject Uncooperative|2|||
145589616|NCT00809757|525007942|FG000|Overall Study|Noncompliance with Medication|0|||
145589617|NCT00809757|525007943|FG001|Overall Study|Noncompliance with Medication|0|||
145589618|NCT00809757|525007944|FG002|Overall Study|Noncompliance with Medication|1|||
145589619|NCT00110617|525007950|FG000|Overall Study|Adverse Event|2|||
145589620|NCT00110617|525007951|FG001|Overall Study|Adverse Event|4|||
145589621|NCT00110617|525007950|FG000|Overall Study|Abnormal Laboratory Value|4|||
145589622|NCT00110617|525007951|FG001|Overall Study|Abnormal Laboratory Value|2|||
145589623|NCT00110617|525007950|FG000|Overall Study|Lack of Efficacy|1|||
145457639|NCT00676520|524527533|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
145457640|NCT00676520|524527533|FG000|Overall Study|Other Reason|18|||
145457641|NCT00666588|524527536|FG000|Overall Study|ineligible|2|||
145457642|NCT00666588|524527537|FG001|Overall Study|ineligible|0|||
145457643|NCT00666588|524527538|FG002|Overall Study|ineligible|0|||
145589624|NCT00110617|525007951|FG001|Overall Study|Lack of Efficacy|0|||
145589625|NCT00110617|525007950|FG000|Overall Study|Patient no longer requires study drug|1|||
145589626|NCT00110617|525007951|FG001|Overall Study|Patient no longer requires study drug|0|||
145589627|NCT00110617|525007950|FG000|Overall Study|Protocol Violation|5|||
145589628|NCT00110617|525007951|FG001|Overall Study|Protocol Violation|0|||
145589629|NCT00110617|525007950|FG000|Overall Study|Withdrawal by Subject|10|||
145589630|NCT00110617|525007951|FG001|Overall Study|Withdrawal by Subject|4|||
145589631|NCT00110617|525007950|FG000|Overall Study|Lost to Follow-up|9|||
145589632|NCT00110617|525007951|FG001|Overall Study|Lost to Follow-up|1|||
145589633|NCT00110617|525007950|FG000|Overall Study|Administrative problems|6|||
145589634|NCT00110617|525007951|FG001|Overall Study|Administrative problems|5|||
145589635|NCT00110617|525007950|FG000|Overall Study|Death|1|||
145589636|NCT00110617|525007951|FG001|Overall Study|Death|1|||
145589637|NCT00110617|525007950|FG000|Overall Study|Did not receive study drug|0|||
145626653|NCT03398356|525145730|FG002|Before Treatment|drug intolerance|0|||
145457644|NCT00666588|524527539|FG003|Overall Study|ineligible|2|||
145589638|NCT00110617|525007951|FG001|Overall Study|Did not receive study drug|12|||
145589639|NCT00045110|525007954|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
145589640|NCT00045110|525007955|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
145589641|NCT00045110|525007956|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
145589642|NCT00045110|525007954|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
145589643|NCT00045110|525007955|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
145589644|NCT00045110|525007956|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
145589645|NCT00045110|525007954|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
145589646|NCT00045110|525007955|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
145589647|NCT00045110|525007956|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
145589648|NCT03662750|525007960|FG000|Overall Study|Withdrawal by Subject|1|||
145589649|NCT03069482|525010531|FG000|Overall Study|Lost to Follow-up|0|||
145589650|NCT03069482|525010532|FG001|Overall Study|Lost to Follow-up|1|||
145589651|NCT03069482|525010531|FG000|Overall Study|Physician Decision|1|||
145589652|NCT03069482|525010532|FG001|Overall Study|Physician Decision|0|||
145589653|NCT00791765|525010533|FG000|Weeks 1 to 12|Adverse Event|0|||
145589654|NCT00791765|525010534|FG001|Weeks 1 to 12|Adverse Event|1|||
145589655|NCT00791765|525010533|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
145589656|NCT00791765|525010534|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
145589657|NCT00791765|525010533|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
145589658|NCT00791765|525010534|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
145589659|NCT00791765|525010533|FG000|Weeks 1 to 12|Physician Decision|1|||
145589660|NCT00791765|525010534|FG001|Weeks 1 to 12|Physician Decision|0|||
145589661|NCT00791765|525010533|FG000|Weeks 1 to 12|Disease progression|3|||
145589662|NCT00791765|525010534|FG001|Weeks 1 to 12|Disease progression|0|||
145589663|NCT00791765|525010533|FG000|Weeks 1 to 12|Ineligibility determined|0|||
145589664|NCT00791765|525010534|FG001|Weeks 1 to 12|Ineligibility determined|3|||
145589665|NCT00791765|525010533|FG000|Weeks 13 to 24|Protocol deviation|2|||
145589666|NCT00791765|525010534|FG001|Weeks 13 to 24|Protocol deviation|0|||
145589667|NCT00791765|525010533|FG000|Weeks 13 to 24|Adverse Event|0|||
145589668|NCT00791765|525010534|FG001|Weeks 13 to 24|Adverse Event|3|||
145589669|NCT00791765|525010533|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
145589670|NCT00791765|525010534|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
145589671|NCT00791765|525010533|FG000|Weeks 13 to 24|Disease progression|0|||
145589672|NCT00791765|525010534|FG001|Weeks 13 to 24|Disease progression|1|||
145589673|NCT00791765|525010533|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
145589674|NCT00791765|525010534|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
145589675|NCT00791765|525010533|FG000|Weeks 13 to 24|Other|0|||
145589676|NCT00791765|525010534|FG001|Weeks 13 to 24|Other|1|||
145589677|NCT00924287|525010536|FG000|Overall Study|Death|1|||
145589678|NCT02891187|525010541|FG000|Overall Study|Lost to Follow-up|1|||
145589679|NCT02891187|525010542|FG001|Overall Study|Lost to Follow-up|2|||
145589680|NCT01983293|525010548|FG000|Overall Study|Withdrawal by Subject|29|||
145589681|NCT01983293|525010549|FG001|Overall Study|Withdrawal by Subject|15|||
145589682|NCT01983293|525010548|FG000|Overall Study|Missing 12-month visit|3|||
145589683|NCT01983293|525010549|FG001|Overall Study|Missing 12-month visit|3|||
145589684|NCT01983293|525010548|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
145589685|NCT01983293|525010549|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
145589686|NCT02047045|525010553|FG000|Baseline|Withdrawal by Subject|3|||
145589687|NCT02047045|525010554|FG001|Baseline|Withdrawal by Subject|2|||
145589688|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
145589689|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
145589690|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
145589691|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
145589692|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
145589693|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
145589694|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
145589695|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
145589696|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
145589697|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
145589698|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
145589699|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
145589700|NCT02047045|525010553|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
145626654|NCT03398356|525145728|FG000|Before Treatment|Withdrawal by Subject|0|||
145589701|NCT02047045|525010554|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
145589702|NCT02047045|525010553|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
145589703|NCT02047045|525010554|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
145589704|NCT02117570|525010555|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
145589705|NCT02117570|525010556|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
145589706|NCT02117570|525010557|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
145589707|NCT02117570|525010555|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
145589708|NCT02117570|525010556|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
145589709|NCT02117570|525010557|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
145589710|NCT02117570|525010555|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
145589711|NCT02117570|525010556|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
145589712|NCT02117570|525010557|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
145589713|NCT02117570|525010555|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
145589714|NCT02117570|525010556|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
145589715|NCT02117570|525010557|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
145589716|NCT02117570|525010555|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
145589717|NCT02117570|525010556|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
145589718|NCT02117570|525010557|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
145589719|NCT02117570|525010555|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
145589720|NCT02117570|525010556|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
145589721|NCT02117570|525010557|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
145589722|NCT02117570|525010555|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
145589723|NCT02117570|525010556|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
145589724|NCT02117570|525010557|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
145589725|NCT00922428|525010558|FG000|Overall Study|retrospective/extremely implausible data|2|||
145589726|NCT00922428|525010558|FG000|Overall Study|no medication use or questionable use|13|||
145589727|NCT03701555|525010570|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
145589728|NCT03701555|525010571|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
145589729|NCT03701555|525010572|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
145589730|NCT03701555|525010573|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
145589731|NCT03701555|525010574|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
145589732|NCT03701555|525010575|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
145589733|NCT03701555|525010576|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
145589734|NCT03701555|525010577|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
145589735|NCT03701555|525010578|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
145589736|NCT03701555|525010579|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
145589737|NCT03701555|525010580|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
145589738|NCT03701555|525010581|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
145589739|NCT03701555|525010582|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
145589740|NCT03701555|525010583|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
145589741|NCT03701555|525010584|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
145589742|NCT03701555|525010585|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
145589743|NCT03701555|525010586|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
145589744|NCT03701555|525010587|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
145589745|NCT03701555|525010588|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
145589746|NCT03701555|525010589|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
145589747|NCT03701555|525010590|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
145589748|NCT03701555|525010591|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
145589749|NCT03701555|525010592|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
145589750|NCT03701555|525010593|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
145589751|NCT03701555|525010594|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
145589752|NCT03701555|525010595|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
145589753|NCT03701555|525010596|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
145589754|NCT03701555|525010597|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
145589755|NCT03701555|525010598|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
145589756|NCT03701555|525010599|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
145589757|NCT03701555|525010600|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
145589758|NCT03701555|525010601|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
145589759|NCT03701555|525010602|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
145589760|NCT03701555|525010603|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
145589761|NCT03701555|525010604|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
145589762|NCT03701555|525010605|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
145589763|NCT03701555|525010570|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
145589764|NCT03701555|525010571|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
145589765|NCT03701555|525010572|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
145589766|NCT03701555|525010573|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
145589767|NCT03701555|525010574|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
145589768|NCT03701555|525010575|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
145589769|NCT03701555|525010576|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
145589770|NCT03701555|525010577|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
145589771|NCT03701555|525010578|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
145589772|NCT03701555|525010579|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
145589773|NCT03701555|525010580|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
145589774|NCT03701555|525010581|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
145589775|NCT03701555|525010582|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
145589776|NCT03701555|525010583|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
145589777|NCT03701555|525010584|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
145589778|NCT03701555|525010585|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
145589779|NCT03701555|525010586|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
145589780|NCT03701555|525010587|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
145589781|NCT03701555|525010588|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
145589782|NCT03701555|525010589|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
145589783|NCT03701555|525010590|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
145589784|NCT03701555|525010591|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
145589785|NCT03701555|525010592|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
145589786|NCT03701555|525010593|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
145589787|NCT03701555|525010594|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
145589788|NCT03701555|525010595|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
145589789|NCT03701555|525010596|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
145589790|NCT03701555|525010597|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
145589791|NCT03701555|525010598|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
145589792|NCT03701555|525010599|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
145589793|NCT03701555|525010600|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
145589794|NCT03701555|525010601|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
145589795|NCT03701555|525010602|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
145589796|NCT03701555|525010603|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
145589797|NCT03701555|525010604|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
145589798|NCT03701555|525010605|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
145589799|NCT03701555|525010570|FG000|Part 2 (Day 1)|Other|0|||
145589800|NCT03701555|525010571|FG001|Part 2 (Day 1)|Other|0|||
145589801|NCT03701555|525010572|FG002|Part 2 (Day 1)|Other|0|||
145589802|NCT03701555|525010573|FG003|Part 2 (Day 1)|Other|0|||
145589803|NCT03701555|525010574|FG004|Part 2 (Day 1)|Other|0|||
145589804|NCT03701555|525010575|FG005|Part 2 (Day 1)|Other|0|||
145589805|NCT03701555|525010576|FG006|Part 2 (Day 1)|Other|0|||
145589806|NCT03701555|525010577|FG007|Part 2 (Day 1)|Other|0|||
145589807|NCT03701555|525010578|FG008|Part 2 (Day 1)|Other|0|||
145589808|NCT03701555|525010579|FG009|Part 2 (Day 1)|Other|0|||
145589809|NCT03701555|525010580|FG010|Part 2 (Day 1)|Other|3|||
145589810|NCT03701555|525010581|FG011|Part 2 (Day 1)|Other|1|||
145589811|NCT03701555|525010582|FG012|Part 2 (Day 1)|Other|0|||
145589812|NCT03701555|525010583|FG013|Part 2 (Day 1)|Other|1|||
145589813|NCT03701555|525010584|FG014|Part 2 (Day 1)|Other|0|||
145589814|NCT03701555|525010585|FG015|Part 2 (Day 1)|Other|2|||
145589815|NCT03701555|525010586|FG016|Part 2 (Day 1)|Other|2|||
145589816|NCT03701555|525010587|FG017|Part 2 (Day 1)|Other|0|||
145589817|NCT03701555|525010588|FG018|Part 2 (Day 1)|Other|0|||
145589818|NCT03701555|525010589|FG019|Part 2 (Day 1)|Other|0|||
145589819|NCT03701555|525010590|FG020|Part 2 (Day 1)|Other|0|||
145589820|NCT03701555|525010591|FG021|Part 2 (Day 1)|Other|0|||
145589821|NCT03701555|525010592|FG022|Part 2 (Day 1)|Other|0|||
145589822|NCT03701555|525010593|FG023|Part 2 (Day 1)|Other|0|||
145589823|NCT03701555|525010594|FG024|Part 2 (Day 1)|Other|0|||
145589824|NCT03701555|525010595|FG025|Part 2 (Day 1)|Other|0|||
145589825|NCT03701555|525010596|FG026|Part 2 (Day 1)|Other|0|||
145589826|NCT03701555|525010597|FG027|Part 2 (Day 1)|Other|0|||
145589827|NCT03701555|525010598|FG028|Part 2 (Day 1)|Other|0|||
145589828|NCT03701555|525010599|FG029|Part 2 (Day 1)|Other|0|||
145589829|NCT03701555|525010600|FG030|Part 2 (Day 1)|Other|0|||
145589830|NCT03701555|525010601|FG031|Part 2 (Day 1)|Other|0|||
145589831|NCT03701555|525010602|FG032|Part 2 (Day 1)|Other|0|||
145589832|NCT03701555|525010603|FG033|Part 2 (Day 1)|Other|0|||
145589833|NCT03701555|525010604|FG034|Part 2 (Day 1)|Other|0|||
145589834|NCT03701555|525010605|FG035|Part 2 (Day 1)|Other|0|||
145589835|NCT03701555|525010570|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
145589836|NCT03701555|525010571|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
145589837|NCT03701555|525010572|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
145589838|NCT03701555|525010573|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
145589839|NCT03701555|525010574|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
145589840|NCT03701555|525010575|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
145589841|NCT03701555|525010576|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
145589842|NCT03701555|525010577|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
145589843|NCT03701555|525010578|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
145626655|NCT03398356|525145729|FG001|Before Treatment|Withdrawal by Subject|5|||
145626656|NCT03398356|525145730|FG002|Before Treatment|Withdrawal by Subject|0|||
145457645|NCT00666588|524527536|FG000|Overall Study|inevaluable|2|||
145589844|NCT03701555|525010579|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
145589845|NCT03701555|525010580|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
145626657|NCT03398356|525145728|FG000|Before Treatment|Physician Decision|0|||
145626658|NCT03398356|525145729|FG001|Before Treatment|Physician Decision|0|||
145589846|NCT03701555|525010581|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
145589847|NCT03701555|525010582|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
145589848|NCT03701555|525010583|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
145589849|NCT03701555|525010584|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
145589850|NCT03701555|525010585|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
145589851|NCT03701555|525010586|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
145589852|NCT03701555|525010587|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
145589853|NCT03701555|525010588|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
145589854|NCT03701555|525010589|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
145589855|NCT03701555|525010590|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
145589856|NCT03701555|525010591|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
145589857|NCT03701555|525010592|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
145589858|NCT03701555|525010593|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
145589859|NCT03701555|525010594|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
145589860|NCT03701555|525010595|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
145589861|NCT03701555|525010596|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
145589862|NCT03701555|525010597|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
145589863|NCT03701555|525010598|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
145589864|NCT03701555|525010599|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
145589865|NCT03701555|525010600|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
145589866|NCT03701555|525010601|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
145589867|NCT03701555|525010602|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
145589868|NCT03701555|525010603|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
145589869|NCT03701555|525010604|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
145589870|NCT03701555|525010605|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
145589871|NCT03701555|525010570|FG000|Part 3 (Day 1)|Subject Decision|0|||
145589872|NCT03701555|525010571|FG001|Part 3 (Day 1)|Subject Decision|0|||
145589873|NCT03701555|525010572|FG002|Part 3 (Day 1)|Subject Decision|0|||
145589874|NCT03701555|525010573|FG003|Part 3 (Day 1)|Subject Decision|0|||
145589875|NCT03701555|525010574|FG004|Part 3 (Day 1)|Subject Decision|0|||
145589876|NCT03701555|525010575|FG005|Part 3 (Day 1)|Subject Decision|0|||
145589877|NCT03701555|525010576|FG006|Part 3 (Day 1)|Subject Decision|0|||
145589878|NCT03701555|525010577|FG007|Part 3 (Day 1)|Subject Decision|0|||
145589879|NCT03701555|525010578|FG008|Part 3 (Day 1)|Subject Decision|0|||
145589880|NCT03701555|525010579|FG009|Part 3 (Day 1)|Subject Decision|0|||
145589881|NCT03701555|525010580|FG010|Part 3 (Day 1)|Subject Decision|0|||
145589882|NCT03701555|525010581|FG011|Part 3 (Day 1)|Subject Decision|0|||
145589883|NCT03701555|525010582|FG012|Part 3 (Day 1)|Subject Decision|0|||
145589884|NCT03701555|525010583|FG013|Part 3 (Day 1)|Subject Decision|0|||
145589885|NCT03701555|525010584|FG014|Part 3 (Day 1)|Subject Decision|0|||
145589886|NCT03701555|525010585|FG015|Part 3 (Day 1)|Subject Decision|0|||
145589887|NCT03701555|525010586|FG016|Part 3 (Day 1)|Subject Decision|0|||
145589888|NCT03701555|525010587|FG017|Part 3 (Day 1)|Subject Decision|0|||
145589889|NCT03701555|525010588|FG018|Part 3 (Day 1)|Subject Decision|0|||
145589890|NCT03701555|525010589|FG019|Part 3 (Day 1)|Subject Decision|0|||
145589891|NCT03701555|525010590|FG020|Part 3 (Day 1)|Subject Decision|0|||
145589892|NCT03701555|525010591|FG021|Part 3 (Day 1)|Subject Decision|0|||
145589893|NCT03701555|525010592|FG022|Part 3 (Day 1)|Subject Decision|0|||
145589894|NCT03701555|525010593|FG023|Part 3 (Day 1)|Subject Decision|0|||
145589895|NCT03701555|525010594|FG024|Part 3 (Day 1)|Subject Decision|0|||
145589896|NCT03701555|525010595|FG025|Part 3 (Day 1)|Subject Decision|0|||
145589897|NCT03701555|525010596|FG026|Part 3 (Day 1)|Subject Decision|1|||
145589898|NCT03701555|525010597|FG027|Part 3 (Day 1)|Subject Decision|0|||
145589899|NCT03701555|525010598|FG028|Part 3 (Day 1)|Subject Decision|0|||
145589900|NCT03701555|525010599|FG029|Part 3 (Day 1)|Subject Decision|0|||
145589901|NCT03701555|525010600|FG030|Part 3 (Day 1)|Subject Decision|0|||
145589902|NCT03701555|525010601|FG031|Part 3 (Day 1)|Subject Decision|2|||
145589903|NCT03701555|525010602|FG032|Part 3 (Day 1)|Subject Decision|1|||
145589904|NCT03701555|525010603|FG033|Part 3 (Day 1)|Subject Decision|1|||
145589905|NCT03701555|525010604|FG034|Part 3 (Day 1)|Subject Decision|0|||
145589906|NCT03701555|525010605|FG035|Part 3 (Day 1)|Subject Decision|0|||
145589907|NCT03701555|525010570|FG000|Part 3 (Day 1)|Other|0|||
145589908|NCT03701555|525010571|FG001|Part 3 (Day 1)|Other|0|||
145589909|NCT03701555|525010572|FG002|Part 3 (Day 1)|Other|0|||
145589910|NCT03701555|525010573|FG003|Part 3 (Day 1)|Other|0|||
145589911|NCT03701555|525010574|FG004|Part 3 (Day 1)|Other|0|||
145589912|NCT03701555|525010575|FG005|Part 3 (Day 1)|Other|0|||
145589913|NCT03701555|525010576|FG006|Part 3 (Day 1)|Other|0|||
145589914|NCT03701555|525010577|FG007|Part 3 (Day 1)|Other|0|||
145589915|NCT03701555|525010578|FG008|Part 3 (Day 1)|Other|0|||
145589916|NCT03701555|525010579|FG009|Part 3 (Day 1)|Other|0|||
145589917|NCT03701555|525010580|FG010|Part 3 (Day 1)|Other|0|||
145457646|NCT00666588|524527537|FG001|Overall Study|inevaluable|0|||
145457647|NCT00666588|524527538|FG002|Overall Study|inevaluable|0|||
145589918|NCT03701555|525010581|FG011|Part 3 (Day 1)|Other|0|||
145589919|NCT03701555|525010582|FG012|Part 3 (Day 1)|Other|0|||
145589920|NCT03701555|525010583|FG013|Part 3 (Day 1)|Other|0|||
145589921|NCT03701555|525010584|FG014|Part 3 (Day 1)|Other|0|||
145589922|NCT03701555|525010585|FG015|Part 3 (Day 1)|Other|0|||
145589923|NCT03701555|525010586|FG016|Part 3 (Day 1)|Other|0|||
145589924|NCT03701555|525010587|FG017|Part 3 (Day 1)|Other|0|||
145589925|NCT03701555|525010588|FG018|Part 3 (Day 1)|Other|0|||
145589926|NCT03701555|525010589|FG019|Part 3 (Day 1)|Other|0|||
145589927|NCT03701555|525010590|FG020|Part 3 (Day 1)|Other|0|||
145589928|NCT03701555|525010591|FG021|Part 3 (Day 1)|Other|0|||
145589929|NCT03701555|525010592|FG022|Part 3 (Day 1)|Other|0|||
145589930|NCT03701555|525010593|FG023|Part 3 (Day 1)|Other|0|||
145589931|NCT03701555|525010594|FG024|Part 3 (Day 1)|Other|1|||
145457648|NCT00666588|524527539|FG003|Overall Study|inevaluable|0|||
145589932|NCT03701555|525010595|FG025|Part 3 (Day 1)|Other|1|||
145589933|NCT03701555|525010596|FG026|Part 3 (Day 1)|Other|0|||
145589934|NCT03701555|525010597|FG027|Part 3 (Day 1)|Other|0|||
145589935|NCT03701555|525010598|FG028|Part 3 (Day 1)|Other|0|||
145589936|NCT03701555|525010599|FG029|Part 3 (Day 1)|Other|1|||
145589937|NCT03701555|525010600|FG030|Part 3 (Day 1)|Other|1|||
145589938|NCT03701555|525010601|FG031|Part 3 (Day 1)|Other|0|||
145589939|NCT03701555|525010602|FG032|Part 3 (Day 1)|Other|1|||
145626659|NCT03398356|525145730|FG002|Before Treatment|Physician Decision|11|||
145626660|NCT03398356|525145728|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
145626661|NCT03398356|525145729|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
145626662|NCT03398356|525145730|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
145626663|NCT00647348|525145732|FG000|Overall Study|Lost to Follow-up|3|||
145626664|NCT00647348|525145733|FG001|Overall Study|Lost to Follow-up|6|||
145626665|NCT00619151|525145734|FG000|Overall Study|Study terminated prior to followup|1|||
145626666|NCT00619151|525145735|FG001|Overall Study|Study terminated prior to followup|0|||
145626667|NCT04889118|525145736|FG000|Overall Study|Death|33|||
145626668|NCT04889118|525145737|FG001|Overall Study|Death|37|||
145626669|NCT04889118|525145736|FG000|Overall Study|Ongoing in Study|31|||
145626670|NCT04889118|525145737|FG001|Overall Study|Ongoing in Study|30|||
145626671|NCT01982760|525145738|FG000|Overall Study|Physician Decision|1|||
145626672|NCT01982760|525145739|FG001|Overall Study|Physician Decision|0|||
145626673|NCT00821236|525145740|FG000|Overall Study|Lost to Follow-up|3|||
145626674|NCT00282438|525145742|FG000|Overall Study|Lack of Efficacy|1|||
145457649|NCT04043234|524527540|FG000|Overall Study|Lost to Follow-up|1|||
145457650|NCT04043234|524527540|FG000|Overall Study|Withdrawal by Subject|1|||
145457651|NCT03622112|524527544|FG000|Overall Study|Withdrawal by Subject|6|||
145457652|NCT03622112|524527545|FG001|Overall Study|Withdrawal by Subject|2|||
145457653|NCT03622112|524527546|FG002|Overall Study|Withdrawal by Subject|4|||
145457654|NCT03622112|524527547|FG003|Overall Study|Withdrawal by Subject|2|||
145457655|NCT03622112|524527548|FG004|Overall Study|Withdrawal by Subject|1|||
145457656|NCT03622112|524527549|FG005|Overall Study|Withdrawal by Subject|2|||
145457657|NCT03622112|524527550|FG006|Overall Study|Withdrawal by Subject|2|||
145457658|NCT03622112|524527544|FG000|Overall Study|Death|0|||
145457659|NCT03622112|524527545|FG001|Overall Study|Death|0|||
145457660|NCT03622112|524527546|FG002|Overall Study|Death|0|||
145457661|NCT03622112|524527547|FG003|Overall Study|Death|1|||
145457662|NCT03622112|524527548|FG004|Overall Study|Death|0|||
145457663|NCT03622112|524527549|FG005|Overall Study|Death|0|||
145457664|NCT03622112|524527550|FG006|Overall Study|Death|0|||
145457665|NCT03622112|524527544|FG000|Overall Study|Lost to Follow-up|1|||
145457666|NCT03622112|524527545|FG001|Overall Study|Lost to Follow-up|1|||
145457667|NCT03622112|524527546|FG002|Overall Study|Lost to Follow-up|0|||
145457668|NCT03622112|524527547|FG003|Overall Study|Lost to Follow-up|0|||
145457669|NCT03622112|524527548|FG004|Overall Study|Lost to Follow-up|0|||
145457670|NCT03622112|524527549|FG005|Overall Study|Lost to Follow-up|0|||
145457671|NCT03622112|524527550|FG006|Overall Study|Lost to Follow-up|0|||
145457672|NCT03622112|524527544|FG000|Overall Study|Study-specific withdrawal criteria|10|||
145457673|NCT03622112|524527545|FG001|Overall Study|Study-specific withdrawal criteria|8|||
145457674|NCT03622112|524527546|FG002|Overall Study|Study-specific withdrawal criteria|7|||
145457675|NCT03622112|524527547|FG003|Overall Study|Study-specific withdrawal criteria|6|||
145457676|NCT03622112|524527548|FG004|Overall Study|Study-specific withdrawal criteria|4|||
145457677|NCT03622112|524527549|FG005|Overall Study|Study-specific withdrawal criteria|18|||
145457678|NCT03622112|524527550|FG006|Overall Study|Study-specific withdrawal criteria|4|||
145457679|NCT03622112|524527544|FG000|Overall Study|Protocol Violation|2|||
145457680|NCT03622112|524527545|FG001|Overall Study|Protocol Violation|0|||
145457681|NCT03622112|524527546|FG002|Overall Study|Protocol Violation|1|||
145457682|NCT03622112|524527547|FG003|Overall Study|Protocol Violation|1|||
145457683|NCT03622112|524527548|FG004|Overall Study|Protocol Violation|0|||
145457684|NCT03622112|524527549|FG005|Overall Study|Protocol Violation|0|||
145457685|NCT03622112|524527550|FG006|Overall Study|Protocol Violation|0|||
145457686|NCT03622112|524527544|FG000|Overall Study|Adverse Event|6|||
145457687|NCT03622112|524527545|FG001|Overall Study|Adverse Event|8|||
145457688|NCT03622112|524527546|FG002|Overall Study|Adverse Event|4|||
145457689|NCT03622112|524527547|FG003|Overall Study|Adverse Event|11|||
145457690|NCT03622112|524527548|FG004|Overall Study|Adverse Event|4|||
145457691|NCT03622112|524527549|FG005|Overall Study|Adverse Event|20|||
145457692|NCT03622112|524527550|FG006|Overall Study|Adverse Event|2|||
145457693|NCT03622112|524527544|FG000|Overall Study|Reason not specified|0|||
145457694|NCT03622112|524527545|FG001|Overall Study|Reason not specified|1|||
145457695|NCT03622112|524527546|FG002|Overall Study|Reason not specified|0|||
145457696|NCT03622112|524527547|FG003|Overall Study|Reason not specified|1|||
145457697|NCT03622112|524527548|FG004|Overall Study|Reason not specified|1|||
145457698|NCT03622112|524527549|FG005|Overall Study|Reason not specified|2|||
145457699|NCT03622112|524527550|FG006|Overall Study|Reason not specified|1|||
145457700|NCT01165320|524527551|FG000|Overall Study|Clinical adverse experience|2|||
145457701|NCT01165320|524527552|FG001|Overall Study|Clinical adverse experience|1|||
145457702|NCT01165320|524527553|FG002|Overall Study|Clinical adverse experience|0|||
145457703|NCT01165320|524527551|FG000|Overall Study|Laboratory adverse experience|1|||
145457704|NCT01165320|524527552|FG001|Overall Study|Laboratory adverse experience|0|||
145457705|NCT01165320|524527553|FG002|Overall Study|Laboratory adverse experience|0|||
145626675|NCT00282438|525145743|FG001|Overall Study|Lack of Efficacy|0|||
145626676|NCT00282438|525145742|FG000|Overall Study|Death|0|||
145626677|NCT00282438|525145743|FG001|Overall Study|Death|1|||
145457706|NCT01165320|524527551|FG000|Overall Study|Lack of Efficacy|0|||
145457707|NCT01165320|524527552|FG001|Overall Study|Lack of Efficacy|2|||
145589940|NCT03701555|525010603|FG033|Part 3 (Day 1)|Other|1|||
145589941|NCT03701555|525010604|FG034|Part 3 (Day 1)|Other|0|||
145589942|NCT03701555|525010605|FG035|Part 3 (Day 1)|Other|0|||
145589943|NCT00237744|525010612|FG000|Overall Study|Withdrawal by Subject|3|||
145589944|NCT00237744|525010613|FG001|Overall Study|Withdrawal by Subject|1|||
145589945|NCT00237744|525010614|FG002|Overall Study|Withdrawal by Subject|0|||
145589946|NCT04447404|525010615|FG000|Overall Study|Death|2|||
145589947|NCT04447404|525010616|FG001|Overall Study|Death|0|||
145589948|NCT00321854|525010619|FG000|Overall Study|Adverse Event|41|||
145589949|NCT00321854|525010620|FG001|Overall Study|Adverse Event|43|||
145589950|NCT00321854|525010619|FG000|Overall Study|Lack of Efficacy|9|||
145589951|NCT00321854|525010620|FG001|Overall Study|Lack of Efficacy|14|||
145589952|NCT00321854|525010619|FG000|Overall Study|Protocol Violation|6|||
145589953|NCT00321854|525010620|FG001|Overall Study|Protocol Violation|5|||
145589954|NCT00321854|525010619|FG000|Overall Study|Lost to Follow-up|0|||
145589955|NCT00321854|525010620|FG001|Overall Study|Lost to Follow-up|2|||
145589956|NCT00321854|525010619|FG000|Overall Study|Withdrawal by Subject|6|||
145589957|NCT00321854|525010620|FG001|Overall Study|Withdrawal by Subject|17|||
145589958|NCT00321854|525010619|FG000|Overall Study|Other|1|||
145589959|NCT00321854|525010620|FG001|Overall Study|Other|1|||
145589960|NCT04723576|525010621|FG000|Overall Study|Withdrawal by Subject|2133|||
145589961|NCT04723576|525010622|FG001|Overall Study|Withdrawal by Subject|3234|||
145589962|NCT00413153|525010623|FG000|Overall Study|Withdrawal by Subject|1|||
145589963|NCT00413153|525010624|FG001|Overall Study|Withdrawal by Subject|1|||
145589964|NCT00413153|525010623|FG000|Overall Study|Adverse Event|1|||
145589965|NCT00413153|525010624|FG001|Overall Study|Adverse Event|0|||
145589966|NCT01064739|525010625|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
145589967|NCT00454051|525010628|FG000|Overall Study|Adverse Event|1|||
145589968|NCT00454051|525010629|FG001|Overall Study|Adverse Event|2|||
145589969|NCT00454051|525010628|FG000|Overall Study|Withdrawal by Subject|1|||
145589970|NCT00454051|525010629|FG001|Overall Study|Withdrawal by Subject|0|||
145589971|NCT00454051|525010628|FG000|Overall Study|Protocol Violation|1|||
145589972|NCT00454051|525010629|FG001|Overall Study|Protocol Violation|1|||
145589973|NCT04258020|525010630|FG000|Overall Study|Withdrawal by Subject|1|||
145589974|NCT04258020|525010631|FG001|Overall Study|Withdrawal by Subject|0|||
145589975|NCT02097472|525010632|FG000|Received Vaccination 2|Adverse Event|0|||
145589976|NCT02097472|525010633|FG001|Received Vaccination 2|Adverse Event|0|||
145589977|NCT02097472|525010634|FG002|Received Vaccination 2|Adverse Event|0|||
145589978|NCT02097472|525010635|FG003|Received Vaccination 2|Adverse Event|0|||
145589979|NCT02097472|525010636|FG004|Received Vaccination 2|Adverse Event|0|||
145589980|NCT02097472|525010637|FG005|Received Vaccination 2|Adverse Event|0|||
145589981|NCT02097472|525010638|FG006|Received Vaccination 2|Adverse Event|1|||
145589982|NCT02097472|525010639|FG007|Received Vaccination 2|Adverse Event|0|||
145589983|NCT03966157|525010640|FG000|Overall Study|Physician Decision|1|||
145589984|NCT03966157|525010641|FG001|Overall Study|Physician Decision|0|||
145589985|NCT03305016|525010642|FG000|Overall Study|Withdrawal by Subject|2|||
145589986|NCT04004611|525010643|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589987|NCT04004611|525010644|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589988|NCT04004611|525010645|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589989|NCT04004611|525010646|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589990|NCT04004611|525010647|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589991|NCT04004611|525010648|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589992|NCT04004611|525010649|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589993|NCT04004611|525010650|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
145589994|NCT04004611|525010651|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
145589995|NCT04004611|525010643|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145589996|NCT04004611|525010644|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145457708|NCT01165320|524527553|FG002|Overall Study|Lack of Efficacy|0|||
145457709|NCT01165320|524527551|FG000|Overall Study|Reason unknown|0|||
145457710|NCT01165320|524527552|FG001|Overall Study|Reason unknown|1|||
145457711|NCT01165320|524527553|FG002|Overall Study|Reason unknown|0|||
145457712|NCT00385944|524527554|FG000|1st Maintenance Dose Period|Physician Decision|1|||
145457713|NCT00385944|524527555|FG001|1st Maintenance Dose Period|Physician Decision|0|||
145589997|NCT04004611|525010645|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145589998|NCT04004611|525010646|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145589999|NCT04004611|525010647|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145590000|NCT04004611|525010648|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
145590001|NCT04004611|525010649|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
145590002|NCT04004611|525010650|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
145590003|NCT04004611|525010651|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
145590004|NCT04004611|525010643|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590005|NCT04004611|525010644|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590006|NCT04004611|525010645|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590007|NCT04004611|525010646|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590008|NCT04004611|525010647|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
145457714|NCT00385944|524527556|FG002|1st Maintenance Dose Period|Physician Decision|0|||
145457715|NCT00385944|524527554|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
145457716|NCT00385944|524527555|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
145457717|NCT00385944|524527556|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
145457718|NCT00385944|524527554|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
145457719|NCT00385944|524527555|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
145457720|NCT00385944|524527556|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
145457721|NCT00385944|524527554|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
145457722|NCT00385944|524527555|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
145457723|NCT00385944|524527556|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
145457724|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
145457725|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
145457726|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
145457727|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
145457728|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
145457729|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
145457730|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
145457731|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
145457732|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
145457733|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
145457734|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Other|1|||
145457735|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Other|1|||
145457736|NCT02075047|524527557|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
145457737|NCT02075047|524527558|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
145457738|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
145457739|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
145457740|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
145457741|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
145457742|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
145457743|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
145457744|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
145457745|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
145457746|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
145457747|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
145457748|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Other|1|||
145457749|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Other|2|||
145457750|NCT02075047|524527557|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
145457751|NCT02075047|524527558|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
145457752|NCT01155466|524527559|FG000|Overall Study|Adverse Event|13|||
145457753|NCT01155466|524527560|FG001|Overall Study|Adverse Event|15|||
145457754|NCT01155466|524527561|FG002|Overall Study|Adverse Event|6|||
145457755|NCT01155466|524527562|FG003|Overall Study|Adverse Event|17|||
145457756|NCT01155466|524527563|FG004|Overall Study|Adverse Event|18|||
145457757|NCT01155466|524527559|FG000|Overall Study|Lost to Follow-up|0|||
145457758|NCT01155466|524527560|FG001|Overall Study|Lost to Follow-up|0|||
145626678|NCT02397889|525145744|FG000|Overall Study|Physician Decision|1|||
145626679|NCT02397889|525145745|FG001|Overall Study|Physician Decision|0|||
145626680|NCT01928940|525145755|FG000|Overall Study|Adverse Event|0|||
145626681|NCT01928940|525145756|FG001|Overall Study|Adverse Event|1|||
145626682|NCT02954055|525145757|FG000|Overall Study|Did not initiate therapy|6|||
145626683|NCT02954055|525145758|FG001|Overall Study|Did not initiate therapy|1|||
145626684|NCT01352507|525145761|FG000|Treatment Period 1|Adverse Event|3|||
145626685|NCT01352507|525145762|FG001|Treatment Period 1|Adverse Event|0|||
145457759|NCT01155466|524527561|FG002|Overall Study|Lost to Follow-up|0|||
145457760|NCT01155466|524527562|FG003|Overall Study|Lost to Follow-up|0|||
145457761|NCT01155466|524527563|FG004|Overall Study|Lost to Follow-up|2|||
145457762|NCT01155466|524527559|FG000|Overall Study|Withdrawal by Subject|7|||
145457763|NCT01155466|524527560|FG001|Overall Study|Withdrawal by Subject|5|||
145457764|NCT01155466|524527561|FG002|Overall Study|Withdrawal by Subject|9|||
145457765|NCT01155466|524527562|FG003|Overall Study|Withdrawal by Subject|4|||
145457766|NCT01155466|524527563|FG004|Overall Study|Withdrawal by Subject|4|||
145457767|NCT01155466|524527559|FG000|Overall Study|Protocol Violation|0|||
145457768|NCT01155466|524527560|FG001|Overall Study|Protocol Violation|0|||
145457769|NCT01155466|524527561|FG002|Overall Study|Protocol Violation|2|||
145457770|NCT01155466|524527562|FG003|Overall Study|Protocol Violation|0|||
145457771|NCT01155466|524527563|FG004|Overall Study|Protocol Violation|1|||
145457772|NCT01155466|524527559|FG000|Overall Study|Administrative|0|||
145626686|NCT01352507|525145761|FG000|Treatment Period 1|Lost to Follow-up|3|||
145626687|NCT01352507|525145762|FG001|Treatment Period 1|Lost to Follow-up|4|||
145457773|NCT01155466|524527560|FG001|Overall Study|Administrative|3|||
145457774|NCT01155466|524527561|FG002|Overall Study|Administrative|0|||
145457775|NCT01155466|524527562|FG003|Overall Study|Administrative|0|||
145626688|NCT01352507|525145761|FG000|Treatment Period 1|Withdrawal by Subject|7|||
145590009|NCT04004611|525010648|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590010|NCT04004611|525010649|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590011|NCT04004611|525010650|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590012|NCT04004611|525010651|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
145590013|NCT04004611|525010643|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
145590014|NCT04004611|525010644|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
145590015|NCT04004611|525010645|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
145590016|NCT04004611|525010646|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
145590017|NCT04004611|525010647|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
145590018|NCT04004611|525010648|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
145590019|NCT04004611|525010649|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
145590020|NCT04004611|525010650|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
145590021|NCT04004611|525010651|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
145590022|NCT04004611|525010643|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
145590023|NCT04004611|525010644|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590024|NCT04004611|525010645|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
145590025|NCT04004611|525010646|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590026|NCT04004611|525010647|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590027|NCT04004611|525010648|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590028|NCT04004611|525010649|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590029|NCT04004611|525010650|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145590030|NCT04004611|525010651|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
145457776|NCT01155466|524527563|FG004|Overall Study|Administrative|0|||
145457777|NCT01155466|524527559|FG000|Overall Study|Randomized not treated|2|||
145457778|NCT01155466|524527560|FG001|Overall Study|Randomized not treated|2|||
145457779|NCT01155466|524527561|FG002|Overall Study|Randomized not treated|3|||
145457780|NCT01155466|524527562|FG003|Overall Study|Randomized not treated|0|||
145457781|NCT01155466|524527563|FG004|Overall Study|Randomized not treated|2|||
145457782|NCT00590824|524527564|FG000|Overall Study|Disease could not be resected|0|||
145457783|NCT00590824|524527565|FG001|Overall Study|Disease could not be resected|2|||
145457784|NCT00590824|524527566|FG002|Overall Study|Disease could not be resected|1|||
145457785|NCT00590824|524527567|FG003|Overall Study|Disease could not be resected|0|||
145457786|NCT00590824|524527564|FG000|Overall Study|Adverse Event|0|||
145457787|NCT00590824|524527565|FG001|Overall Study|Adverse Event|0|||
145457788|NCT00590824|524527566|FG002|Overall Study|Adverse Event|0|||
145457789|NCT00590824|524527567|FG003|Overall Study|Adverse Event|1|||
145457790|NCT01778049|524527575|FG000|Open Label Treatment Period|Adverse Event|5|||
145457791|NCT01778049|524527576|FG001|Open Label Treatment Period|Adverse Event|15|||
145457792|NCT01778049|524527577|FG002|Open Label Treatment Period|Adverse Event|0|||
145457793|NCT01778049|524527578|FG003|Open Label Treatment Period|Adverse Event|0|||
145590031|NCT04004611|525010643|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590032|NCT04004611|525010644|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
145590033|NCT04004611|525010645|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590034|NCT04004611|525010646|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590035|NCT04004611|525010647|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590036|NCT04004611|525010648|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590037|NCT04004611|525010649|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590038|NCT04004611|525010650|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590039|NCT04004611|525010651|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
145590040|NCT03834779|525010654|FG000|Overall Study|Death|1|||
145590041|NCT03834779|525010655|FG001|Overall Study|Death|2|||
145590042|NCT03834779|525010654|FG000|Overall Study|Lost to Follow-up|6|||
145590043|NCT03834779|525010655|FG001|Overall Study|Lost to Follow-up|4|||
145590044|NCT01059565|525010660|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
145590045|NCT01059565|525010661|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
145590046|NCT01059565|525010660|FG000|24-Week Randomized Phase|Adverse Event|5|||
145590047|NCT01059565|525010661|FG001|24-Week Randomized Phase|Adverse Event|0|||
145590048|NCT01059565|525010660|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
145590049|NCT01059565|525010661|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
145590050|NCT01059565|525010660|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
145590051|NCT01059565|525010661|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
145590052|NCT01059565|525010660|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
145590053|NCT01059565|525010661|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
145590054|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Adverse Event|2|||
145590055|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Adverse Event|0|||
145457794|NCT01778049|524527579|FG004|Open Label Treatment Period|Adverse Event|0|||
145457795|NCT01778049|524527580|FG005|Open Label Treatment Period|Adverse Event|0|||
145457796|NCT01778049|524527575|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
145457797|NCT01778049|524527576|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
145457798|NCT01778049|524527577|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
145457799|NCT01778049|524527578|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
145457800|NCT01778049|524527579|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
145457801|NCT01778049|524527580|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
145457802|NCT01778049|524527575|FG000|Open Label Treatment Period|Protocol Violation|5|||
145457803|NCT01778049|524527576|FG001|Open Label Treatment Period|Protocol Violation|5|||
145457804|NCT01778049|524527577|FG002|Open Label Treatment Period|Protocol Violation|0|||
145626689|NCT01352507|525145762|FG001|Treatment Period 1|Withdrawal by Subject|5|||
145626690|NCT01352507|525145761|FG000|Treatment Period 1|Physician Decision|1|||
145626691|NCT01352507|525145762|FG001|Treatment Period 1|Physician Decision|0|||
145626692|NCT01352507|525145761|FG000|Washout Period|Withdrawal by Subject|0|||
145626693|NCT01352507|525145762|FG001|Washout Period|Withdrawal by Subject|1|||
145626694|NCT01352507|525145761|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
145626695|NCT01352507|525145762|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
145457805|NCT01778049|524527578|FG003|Open Label Treatment Period|Protocol Violation|0|||
145457806|NCT01778049|524527579|FG004|Open Label Treatment Period|Protocol Violation|0|||
145457807|NCT01778049|524527580|FG005|Open Label Treatment Period|Protocol Violation|0|||
145457808|NCT01778049|524527575|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
145457809|NCT01778049|524527576|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
145457810|NCT01778049|524527577|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
145457811|NCT01778049|524527578|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
145457812|NCT01778049|524527579|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
145457813|NCT01778049|524527580|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
145457814|NCT01778049|524527575|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
145457815|NCT01778049|524527576|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
145457816|NCT01778049|524527577|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
145457817|NCT01778049|524527578|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
145457818|NCT01778049|524527579|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
145457819|NCT01778049|524527580|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
145457820|NCT01778049|524527575|FG000|Open Label Treatment Period|Not treated|2|||
145457821|NCT01778049|524527576|FG001|Open Label Treatment Period|Not treated|1|||
145457822|NCT01778049|524527577|FG002|Open Label Treatment Period|Not treated|0|||
145457823|NCT01778049|524527578|FG003|Open Label Treatment Period|Not treated|0|||
145457824|NCT01778049|524527579|FG004|Open Label Treatment Period|Not treated|0|||
145457825|NCT01778049|524527580|FG005|Open Label Treatment Period|Not treated|0|||
145457826|NCT01778049|524527575|FG000|Open Label Treatment Period|Other reason not defined above|77|||
145457827|NCT01778049|524527576|FG001|Open Label Treatment Period|Other reason not defined above|94|||
145457828|NCT01778049|524527577|FG002|Open Label Treatment Period|Other reason not defined above|0|||
145457829|NCT01778049|524527578|FG003|Open Label Treatment Period|Other reason not defined above|0|||
145457830|NCT01778049|524527579|FG004|Open Label Treatment Period|Other reason not defined above|0|||
145457831|NCT01778049|524527580|FG005|Open Label Treatment Period|Other reason not defined above|0|||
145457832|NCT01778049|524527575|FG000|Double Blind Treatment Period|Adverse Event|0|||
145457833|NCT01778049|524527576|FG001|Double Blind Treatment Period|Adverse Event|0|||
145626696|NCT01352507|525145761|FG000|Treatment Period 2|Withdrawal by Subject|4|||
145626697|NCT01352507|525145762|FG001|Treatment Period 2|Withdrawal by Subject|3|||
145626698|NCT01352507|525145761|FG000|Treatment Period 2|Lack of Efficacy|1|||
145626699|NCT01352507|525145762|FG001|Treatment Period 2|Lack of Efficacy|0|||
145626700|NCT01119703|525145763|FG000|Overall Study|Adverse Event|0|||
145457834|NCT01778049|524527577|FG002|Double Blind Treatment Period|Adverse Event|4|||
145457835|NCT01778049|524527578|FG003|Double Blind Treatment Period|Adverse Event|5|||
145457836|NCT01778049|524527579|FG004|Double Blind Treatment Period|Adverse Event|3|||
145457837|NCT01778049|524527580|FG005|Double Blind Treatment Period|Adverse Event|2|||
145457838|NCT01778049|524527575|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
145457839|NCT01778049|524527576|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
145457840|NCT01778049|524527577|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
145457841|NCT01778049|524527578|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
145457842|NCT01778049|524527579|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
145457843|NCT01778049|524527580|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
145457844|NCT01778049|524527575|FG000|Double Blind Treatment Period|Protocol Violation|0|||
145457845|NCT01778049|524527576|FG001|Double Blind Treatment Period|Protocol Violation|0|||
145457846|NCT01778049|524527577|FG002|Double Blind Treatment Period|Protocol Violation|2|||
145457847|NCT01778049|524527578|FG003|Double Blind Treatment Period|Protocol Violation|0|||
145457848|NCT01778049|524527579|FG004|Double Blind Treatment Period|Protocol Violation|0|||
145457849|NCT01778049|524527580|FG005|Double Blind Treatment Period|Protocol Violation|0|||
145457850|NCT01778049|524527575|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
145457851|NCT01778049|524527576|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
145457852|NCT01778049|524527577|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
145457853|NCT01778049|524527578|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
145626701|NCT01119703|525145764|FG001|Overall Study|Adverse Event|1|||
145626702|NCT04668144|525145765|FG000|Overall Study|Protocol Violation|0|||
145590056|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
145590057|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
145590058|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
145590059|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
145590060|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
145590061|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
145590062|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
145590063|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
145590064|NCT01059565|525010660|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
145590065|NCT01059565|525010661|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
145590066|NCT03927950|525010662|FG000|Overall Study|Adverse Event|9|||
145590067|NCT03263429|525010663|FG000|Overall Study|Withdrawal by Subject|0|||
145590068|NCT03263429|525010664|FG001|Overall Study|Withdrawal by Subject|1|||
145590069|NCT03263429|525010665|FG002|Overall Study|Withdrawal by Subject|0|||
145590070|NCT03263429|525010663|FG000|Overall Study|Follow-Up Period Completed|0|||
145590071|NCT03263429|525010664|FG001|Overall Study|Follow-Up Period Completed|2|||
145590072|NCT03263429|525010665|FG002|Overall Study|Follow-Up Period Completed|0|||
145590073|NCT03263429|525010663|FG000|Overall Study|Death|3|||
145590074|NCT03263429|525010664|FG001|Overall Study|Death|5|||
145590075|NCT03263429|525010665|FG002|Overall Study|Death|16|||
145590076|NCT03263429|525010663|FG000|Overall Study|Participant unable to return|0|||
145590077|NCT03263429|525010664|FG001|Overall Study|Participant unable to return|0|||
145590078|NCT03263429|525010665|FG002|Overall Study|Participant unable to return|1|||
145590079|NCT03263429|525010663|FG000|Overall Study|Study Closed|0|||
145590080|NCT03263429|525010664|FG001|Overall Study|Study Closed|0|||
145590081|NCT03263429|525010665|FG002|Overall Study|Study Closed|1|||
145590082|NCT00121238|525010666|FG000|Overall Study|disease progression before intervention|1|||
145590083|NCT00121238|525010666|FG000|Overall Study|Protocol Violation|2|||
145590084|NCT01540851|525010667|FG000|Overall Study|Lost to Follow-up|14|||
145590085|NCT01540851|525010668|FG001|Overall Study|Lost to Follow-up|15|||
145590086|NCT01540851|525010667|FG000|Overall Study|Withdrawal by Subject|7|||
145590087|NCT01540851|525010668|FG001|Overall Study|Withdrawal by Subject|3|||
145590088|NCT00325468|525010669|FG000|Overall Study|Adverse Event|1|||
145590089|NCT00325468|525010670|FG001|Overall Study|Adverse Event|1|||
145590090|NCT00325468|525010671|FG002|Overall Study|Adverse Event|0|||
145590091|NCT00325468|525010672|FG003|Overall Study|Adverse Event|5|||
145590092|NCT00325468|525010673|FG004|Overall Study|Adverse Event|1|||
145590093|NCT00325468|525010669|FG000|Overall Study|Death|2|||
145590094|NCT00325468|525010670|FG001|Overall Study|Death|0|||
145590095|NCT00325468|525010671|FG002|Overall Study|Death|2|||
145590096|NCT00325468|525010672|FG003|Overall Study|Death|4|||
145590097|NCT00325468|525010673|FG004|Overall Study|Death|0|||
145590098|NCT00325468|525010669|FG000|Overall Study|Lost to Follow-up|0|||
145590099|NCT00325468|525010670|FG001|Overall Study|Lost to Follow-up|0|||
145590100|NCT00325468|525010671|FG002|Overall Study|Lost to Follow-up|1|||
145590101|NCT00325468|525010672|FG003|Overall Study|Lost to Follow-up|2|||
145590102|NCT00325468|525010673|FG004|Overall Study|Lost to Follow-up|2|||
145590103|NCT00325468|525010669|FG000|Overall Study|Physician Decision|1|||
145590104|NCT00325468|525010670|FG001|Overall Study|Physician Decision|1|||
145590105|NCT00325468|525010671|FG002|Overall Study|Physician Decision|0|||
145590106|NCT00325468|525010672|FG003|Overall Study|Physician Decision|1|||
145590107|NCT00325468|525010673|FG004|Overall Study|Physician Decision|0|||
145590108|NCT00325468|525010669|FG000|Overall Study|Withdrawal by Subject|3|||
145590109|NCT00325468|525010670|FG001|Overall Study|Withdrawal by Subject|1|||
145590110|NCT00325468|525010671|FG002|Overall Study|Withdrawal by Subject|0|||
145590111|NCT00325468|525010672|FG003|Overall Study|Withdrawal by Subject|14|||
145590112|NCT00325468|525010673|FG004|Overall Study|Withdrawal by Subject|4|||
145590113|NCT00325468|525010669|FG000|Overall Study|site closure etc|4|||
145590114|NCT00325468|525010670|FG001|Overall Study|site closure etc|2|||
145590115|NCT00325468|525010671|FG002|Overall Study|site closure etc|1|||
145590116|NCT00325468|525010672|FG003|Overall Study|site closure etc|8|||
145590117|NCT00325468|525010673|FG004|Overall Study|site closure etc|1|||
145590118|NCT03579563|525010677|FG000|Overall Study|Lost to Follow-up|0|||
145590119|NCT03579563|525010678|FG001|Overall Study|Lost to Follow-up|0|||
145590120|NCT03579563|525010679|FG002|Overall Study|Lost to Follow-up|0|||
145457854|NCT01778049|524527579|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
145590121|NCT03579563|525010680|FG003|Overall Study|Lost to Follow-up|0|||
145590122|NCT03579563|525010681|FG004|Overall Study|Lost to Follow-up|1|||
145590123|NCT03579563|525010682|FG005|Overall Study|Lost to Follow-up|0|||
145457855|NCT01778049|524527580|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
145590124|NCT03579563|525010677|FG000|Overall Study|Lack of Efficacy|1|||
145590125|NCT03579563|525010678|FG001|Overall Study|Lack of Efficacy|1|||
145590126|NCT03579563|525010679|FG002|Overall Study|Lack of Efficacy|4|||
145590127|NCT03579563|525010680|FG003|Overall Study|Lack of Efficacy|1|||
145590128|NCT03579563|525010681|FG004|Overall Study|Lack of Efficacy|2|||
145590129|NCT03579563|525010682|FG005|Overall Study|Lack of Efficacy|3|||
145590130|NCT03579563|525010677|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
145457856|NCT01778049|524527575|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
145457857|NCT01778049|524527576|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
145457858|NCT01778049|524527577|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
145457859|NCT01778049|524527578|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
145457860|NCT01778049|524527579|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
145457861|NCT01778049|524527580|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
145457862|NCT01778049|524527575|FG000|Double Blind Treatment Period|Not treated|0|||
145457863|NCT01778049|524527576|FG001|Double Blind Treatment Period|Not treated|0|||
145457864|NCT01778049|524527577|FG002|Double Blind Treatment Period|Not treated|0|||
145457865|NCT01778049|524527578|FG003|Double Blind Treatment Period|Not treated|2|||
145457866|NCT01778049|524527579|FG004|Double Blind Treatment Period|Not treated|2|||
145457867|NCT01778049|524527580|FG005|Double Blind Treatment Period|Not treated|0|||
145457868|NCT01778049|524527575|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
145457869|NCT01778049|524527576|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
145457870|NCT01778049|524527577|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
145457871|NCT01778049|524527578|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
145457872|NCT01778049|524527579|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
145457873|NCT01778049|524527580|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
145457874|NCT00515294|524527584|FG000|Overall Study|Lost to Follow-up|3|||
145457875|NCT00515294|524527585|FG001|Overall Study|Lost to Follow-up|2|||
145457876|NCT00515294|524527586|FG002|Overall Study|Lost to Follow-up|3|||
145457877|NCT00515294|524527587|FG003|Overall Study|Lost to Follow-up|1|||
145457878|NCT00515294|524527584|FG000|Overall Study|Driver simulator problems|1|||
145457879|NCT00515294|524527585|FG001|Overall Study|Driver simulator problems|1|||
145457880|NCT00515294|524527586|FG002|Overall Study|Driver simulator problems|1|||
145457881|NCT00515294|524527587|FG003|Overall Study|Driver simulator problems|3|||
145457882|NCT00515294|524527584|FG000|Overall Study|Caffeine amount inaccurate|5|||
145457883|NCT00515294|524527585|FG001|Overall Study|Caffeine amount inaccurate|0|||
145457884|NCT00515294|524527586|FG002|Overall Study|Caffeine amount inaccurate|7|||
145457885|NCT00515294|524527587|FG003|Overall Study|Caffeine amount inaccurate|0|||
145457886|NCT03770728|524527590|FG000|Overall Study|Adverse Event|1|||
145457887|NCT03770728|524527591|FG001|Overall Study|Adverse Event|0|||
145457888|NCT03770728|524527592|FG002|Overall Study|Adverse Event|1|||
145457889|NCT03770728|524527593|FG003|Overall Study|Adverse Event|0|||
145457890|NCT03770728|524527590|FG000|Overall Study|Poor compliance to protocol|0|||
145457891|NCT03770728|524527591|FG001|Overall Study|Poor compliance to protocol|0|||
145457892|NCT03770728|524527592|FG002|Overall Study|Poor compliance to protocol|1|||
145457893|NCT03770728|524527593|FG003|Overall Study|Poor compliance to protocol|0|||
145457894|NCT03770728|524527590|FG000|Overall Study|Withdrawal by Subject|13|||
145457895|NCT03770728|524527591|FG001|Overall Study|Withdrawal by Subject|8|||
145457896|NCT03770728|524527592|FG002|Overall Study|Withdrawal by Subject|9|||
145457897|NCT03770728|524527593|FG003|Overall Study|Withdrawal by Subject|13|||
145457898|NCT03770728|524527590|FG000|Overall Study|Other than specified|24|||
145457899|NCT03770728|524527591|FG001|Overall Study|Other than specified|23|||
145457900|NCT03770728|524527592|FG002|Overall Study|Other than specified|21|||
145457901|NCT03770728|524527593|FG003|Overall Study|Other than specified|22|||
145457902|NCT02778555|524527597|FG000|Overall Study|Withdrawal by Subject|55|||
145457903|NCT02778555|524527598|FG001|Overall Study|Withdrawal by Subject|32|||
145457904|NCT02778555|524527599|FG002|Overall Study|Withdrawal by Subject|107|||
145457905|NCT02379988|524527600|FG000|Overall Study|Not eligible|1|||
145457906|NCT00107315|524527601|FG000|Overall Study|Disease Progression|9|||
145457907|NCT00107315|524527601|FG000|Overall Study|Adverse Event|4|||
145457908|NCT00107315|524527601|FG000|Overall Study|Withdrawal by Subject|2|||
145590131|NCT03579563|525010678|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
145590132|NCT03579563|525010679|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
145590133|NCT03579563|525010680|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
145590134|NCT03579563|525010681|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
145590135|NCT03579563|525010682|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
145590136|NCT03579563|525010677|FG000|Overall Study|Time/distance concern|0|||
145590137|NCT03579563|525010678|FG001|Overall Study|Time/distance concern|0|||
145590138|NCT03579563|525010679|FG002|Overall Study|Time/distance concern|1|||
145590139|NCT03579563|525010680|FG003|Overall Study|Time/distance concern|0|||
145590140|NCT03579563|525010681|FG004|Overall Study|Time/distance concern|0|||
145590141|NCT03579563|525010682|FG005|Overall Study|Time/distance concern|1|||
145457909|NCT02509039|524527602|FG000|Overall Study|Adverse Event|0|||
145457910|NCT02509039|524527603|FG001|Overall Study|Adverse Event|1|||
145457911|NCT02509039|524527604|FG002|Overall Study|Adverse Event|1|||
145457912|NCT02509039|524527605|FG003|Overall Study|Adverse Event|1|||
145457913|NCT02509039|524527602|FG000|Overall Study|Withdrawal by Subject|0|||
145457914|NCT02509039|524527603|FG001|Overall Study|Withdrawal by Subject|0|||
145590142|NCT03579563|525010677|FG000|Overall Study|COVID shutdown|2|||
145457915|NCT02509039|524527604|FG002|Overall Study|Withdrawal by Subject|1|||
145590143|NCT03579563|525010678|FG001|Overall Study|COVID shutdown|3|||
145590144|NCT03579563|525010679|FG002|Overall Study|COVID shutdown|4|||
145590145|NCT03579563|525010680|FG003|Overall Study|COVID shutdown|3|||
145590146|NCT03579563|525010681|FG004|Overall Study|COVID shutdown|1|||
145590147|NCT03579563|525010682|FG005|Overall Study|COVID shutdown|2|||
145590148|NCT03579563|525010677|FG000|Overall Study|Protocol administration error|1|||
145590149|NCT03579563|525010678|FG001|Overall Study|Protocol administration error|0|||
145590150|NCT03579563|525010679|FG002|Overall Study|Protocol administration error|1|||
145590151|NCT03579563|525010680|FG003|Overall Study|Protocol administration error|0|||
145590152|NCT03579563|525010681|FG004|Overall Study|Protocol administration error|1|||
145590153|NCT03579563|525010682|FG005|Overall Study|Protocol administration error|5|||
145590154|NCT02219932|525010683|FG000|Overall Study|Other|5|||
145590155|NCT02219932|525010684|FG001|Overall Study|Other|11|||
145590156|NCT02219932|525010683|FG000|Overall Study|Death|1|||
145590157|NCT02219932|525010684|FG001|Overall Study|Death|1|||
145590158|NCT02219932|525010683|FG000|Overall Study|Investigator Decision|0|||
145590159|NCT02219932|525010684|FG001|Overall Study|Investigator Decision|1|||
145590160|NCT02219932|525010683|FG000|Overall Study|Consent Withdrawn|11|||
145590161|NCT02219932|525010684|FG001|Overall Study|Consent Withdrawn|7|||
145590162|NCT02219932|525010683|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
145590163|NCT02219932|525010684|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
145590164|NCT02219932|525010683|FG000|Overall Study|Protocol Violation|10|||
145590165|NCT02219932|525010684|FG001|Overall Study|Protocol Violation|6|||
145590166|NCT02219932|525010683|FG000|Overall Study|Pregnancy|1|||
145590167|NCT02219932|525010684|FG001|Overall Study|Pregnancy|0|||
145590168|NCT02219932|525010683|FG000|Overall Study|Lost to Follow-up|4|||
145590169|NCT02219932|525010684|FG001|Overall Study|Lost to Follow-up|2|||
145590170|NCT02219932|525010683|FG000|Overall Study|Adverse Event|23|||
145590171|NCT02219932|525010684|FG001|Overall Study|Adverse Event|21|||
145590172|NCT01618864|525010685|FG000|Overall Study|Withdrawal by Subject|2|||
145590173|NCT01618864|525010685|FG000|Overall Study|Lost to Follow-up|2|||
145590174|NCT05177770|525010686|FG000|Overall Study|Death|4|||
145590175|NCT05177770|525010686|FG000|Overall Study|Withdrawal by Subject|1|||
145590176|NCT05177770|525010686|FG000|Overall Study|Adverse Event prior to dosing|1|||
145590177|NCT02372396|525010692|FG000|Overall Study|Lost to Follow-up|7|||
145590178|NCT02372396|525010693|FG001|Overall Study|Lost to Follow-up|9|||
145590179|NCT01272934|525010694|FG000|Overall Study|Adverse Event|0|||
145590180|NCT01272934|525010695|FG001|Overall Study|Adverse Event|1|||
145590181|NCT01272934|525010694|FG000|Overall Study|Abnormal Laboratory Value|0|||
145590182|NCT01272934|525010695|FG001|Overall Study|Abnormal Laboratory Value|1|||
145590183|NCT04313634|525010696|FG000|Overall Study|Adverse Event|2|||
145590184|NCT04313634|525010697|FG001|Overall Study|Adverse Event|2|||
145590185|NCT04313634|525010698|FG002|Overall Study|Adverse Event|0|||
145590186|NCT04313634|525010696|FG000|Overall Study|Withdrawal by Subject|1|||
145590187|NCT04313634|525010697|FG001|Overall Study|Withdrawal by Subject|0|||
145590188|NCT04313634|525010698|FG002|Overall Study|Withdrawal by Subject|1|||
145590189|NCT04313634|525010696|FG000|Overall Study|Protocol Violation|0|||
145590190|NCT04313634|525010697|FG001|Overall Study|Protocol Violation|0|||
145590191|NCT04313634|525010698|FG002|Overall Study|Protocol Violation|1|||
145590192|NCT02199028|525010713|FG000|Week 1|Adverse Event|1|||
145590193|NCT02199028|525010714|FG001|Week 1|Adverse Event|0|||
145590194|NCT02199028|525010713|FG000|Week 3|Adverse Event|1|||
145590195|NCT02199028|525010714|FG001|Week 3|Adverse Event|0|||
145590196|NCT01881126|525010715|FG000|Overall Study|Non-compliance|1|||
145590197|NCT01881126|525010716|FG001|Overall Study|Non-compliance|1|||
145590198|NCT01881126|525010715|FG000|Overall Study|Adverse Event|0|||
145590199|NCT01881126|525010716|FG001|Overall Study|Adverse Event|1|||
145590200|NCT00695669|525010719|FG000|Overall Study|Adverse Event|0|||
145590201|NCT00695669|525010720|FG001|Overall Study|Adverse Event|0|||
145590202|NCT00695669|525010721|FG002|Overall Study|Adverse Event|2|||
145590203|NCT00695669|525010722|FG003|Overall Study|Adverse Event|0|||
145590204|NCT00695669|525010719|FG000|Overall Study|Lost to Follow-up|4|||
145590205|NCT00695669|525010720|FG001|Overall Study|Lost to Follow-up|4|||
145590206|NCT00695669|525010721|FG002|Overall Study|Lost to Follow-up|1|||
145590207|NCT00695669|525010722|FG003|Overall Study|Lost to Follow-up|4|||
145590208|NCT05045625|525010723|FG000|Overall Study|Lost to Follow-up|3|||
145590209|NCT00047879|525010724|FG000|Overall Study|Progressive disease|4|||
145590210|NCT00047879|525010725|FG001|Overall Study|Progressive disease|3|||
145590211|NCT04558346|525010733|FG000|Overall Study|Withdrawal by Subject|2|||
145590212|NCT04558346|525010734|FG001|Overall Study|Withdrawal by Subject|0|||
145590213|NCT04558346|525010733|FG000|Overall Study|Lost to Follow-up|0|||
145590214|NCT04558346|525010734|FG001|Overall Study|Lost to Follow-up|1|||
145590215|NCT04558346|525010733|FG000|Overall Study|Adverse Event|0|||
145590216|NCT04558346|525010734|FG001|Overall Study|Adverse Event|1|||
145590217|NCT01962974|525010737|FG000|Overall Study|Study termination|7|||
145590218|NCT03086447|525010738|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145590219|NCT03086447|525010739|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
145590220|NCT03086447|525010738|FG000|Overall Study|Lost Lens|2|||
145590221|NCT03086447|525010739|FG001|Overall Study|Lost Lens|5|||
145590222|NCT03086447|525010738|FG000|Overall Study|Product quality complaint|0|||
145457916|NCT02509039|524527605|FG003|Overall Study|Withdrawal by Subject|0|||
145457917|NCT02509039|524527602|FG000|Overall Study|Progressive disease|2|||
145457918|NCT02509039|524527603|FG001|Overall Study|Progressive disease|2|||
145457919|NCT02509039|524527604|FG002|Overall Study|Progressive disease|1|||
145457920|NCT02509039|524527605|FG003|Overall Study|Progressive disease|5|||
145457921|NCT02509039|524527602|FG000|Overall Study|Study terminated by Sponsor|1|||
145457922|NCT02509039|524527603|FG001|Overall Study|Study terminated by Sponsor|0|||
145457923|NCT02509039|524527604|FG002|Overall Study|Study terminated by Sponsor|0|||
145457924|NCT02509039|524527605|FG003|Overall Study|Study terminated by Sponsor|0|||
145457925|NCT03943550|524527610|FG000|Overall Study|Adverse Event|0|||
145457926|NCT03943550|524527611|FG001|Overall Study|Adverse Event|0|||
145457927|NCT03943550|524527612|FG002|Overall Study|Adverse Event|1|||
145457928|NCT03943550|524527610|FG000|Overall Study|Lost to Follow-up|0|||
145457929|NCT03943550|524527611|FG001|Overall Study|Lost to Follow-up|0|||
145457930|NCT03943550|524527612|FG002|Overall Study|Lost to Follow-up|1|||
145457931|NCT03943550|524527610|FG000|Overall Study|Progressive Disease|0|||
145457932|NCT03943550|524527611|FG001|Overall Study|Progressive Disease|0|||
145457933|NCT03943550|524527612|FG002|Overall Study|Progressive Disease|2|||
145457934|NCT03943550|524527610|FG000|Overall Study|Participant Moved Out of the Country|0|||
145457935|NCT03943550|524527611|FG001|Overall Study|Participant Moved Out of the Country|1|||
145457936|NCT03943550|524527612|FG002|Overall Study|Participant Moved Out of the Country|0|||
145457937|NCT00096226|524527613|FG000|Overall Study|Ineligible|2|||
145457938|NCT00096226|524527613|FG000|Overall Study|Protocol treatment not started|1|||
145457939|NCT04262882|524527614|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
145457940|NCT04262882|524527615|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
145457941|NCT04262882|524527614|FG000|Overall Study|Lost to Follow-up|1|||
145457942|NCT04262882|524527615|FG001|Overall Study|Lost to Follow-up|0|||
145457943|NCT01327053|524527621|FG000|Overall Study|Adverse Event|23|||
145457944|NCT01327053|524527622|FG001|Overall Study|Adverse Event|57|||
145457945|NCT01327053|524527621|FG000|Overall Study|Patient/guardian decision|11|||
145457946|NCT01327053|524527622|FG001|Overall Study|Patient/guardian decision|35|||
145457947|NCT01327053|524527621|FG000|Overall Study|Physician Decision|10|||
145457948|NCT01327053|524527622|FG001|Overall Study|Physician Decision|14|||
145457949|NCT01327053|524527621|FG000|Overall Study|Death|1|||
145457950|NCT01327053|524527622|FG001|Overall Study|Death|5|||
145457951|NCT01327053|524527621|FG000|Overall Study|Lost to Follow-up|2|||
145457952|NCT01327053|524527622|FG001|Overall Study|Lost to Follow-up|4|||
145457953|NCT01327053|524527621|FG000|Overall Study|Non-compliance with study treatment|0|||
145457954|NCT01327053|524527622|FG001|Overall Study|Non-compliance with study treatment|5|||
145457955|NCT01327053|524527621|FG000|Overall Study|Study terminated by Sponsor|1|||
145457956|NCT01327053|524527622|FG001|Overall Study|Study terminated by Sponsor|3|||
145457957|NCT01327053|524527621|FG000|Overall Study|Progressive disease|31|||
145457958|NCT01327053|524527622|FG001|Overall Study|Progressive disease|26|||
145457959|NCT01327053|524527621|FG000|Overall Study|Protocol Violation|0|||
145457960|NCT01327053|524527622|FG001|Overall Study|Protocol Violation|1|||
145457961|NCT01327053|524527621|FG000|Overall Study|Untreated|0|||
145457962|NCT01327053|524527622|FG001|Overall Study|Untreated|1|||
145457963|NCT00721578|524527623|FG000|Overall Study|Death|1|||
145457964|NCT00721578|524527624|FG001|Overall Study|Death|1|||
145457965|NCT00721578|524527623|FG000|Overall Study|Withdrawal by Subject|1|||
145457966|NCT00721578|524527624|FG001|Overall Study|Withdrawal by Subject|1|||
145457967|NCT01638013|524527633|FG000|Overall Study|Adverse Event|36|||
145457968|NCT01638013|524527634|FG001|Overall Study|Adverse Event|29|||
145457969|NCT01638013|524527635|FG002|Overall Study|Adverse Event|48|||
145457970|NCT01638013|524527633|FG000|Overall Study|Lack of Efficacy|39|||
145457971|NCT01638013|524527634|FG001|Overall Study|Lack of Efficacy|11|||
145457972|NCT01638013|524527635|FG002|Overall Study|Lack of Efficacy|14|||
145457973|NCT01638013|524527633|FG000|Overall Study|Protocol Violation|10|||
145457974|NCT01638013|524527634|FG001|Overall Study|Protocol Violation|7|||
145457975|NCT01638013|524527635|FG002|Overall Study|Protocol Violation|11|||
145457976|NCT01638013|524527633|FG000|Overall Study|Met discontinuation criteria|4|||
145457977|NCT01638013|524527634|FG001|Overall Study|Met discontinuation criteria|0|||
145457978|NCT01638013|524527635|FG002|Overall Study|Met discontinuation criteria|7|||
145457979|NCT01638013|524527633|FG000|Overall Study|Subject Lost to Follow up|1|||
145457980|NCT01638013|524527634|FG001|Overall Study|Subject Lost to Follow up|0|||
145590223|NCT03086447|525010739|FG001|Overall Study|Product quality complaint|1|||
145590224|NCT03086447|525010738|FG000|Overall Study|Lens Damage|1|||
145590225|NCT03086447|525010739|FG001|Overall Study|Lens Damage|6|||
145590226|NCT03086447|525010738|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
145590227|NCT03086447|525010739|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
145590228|NCT03086447|525010738|FG000|Overall Study|Test Article No Longer Available|1|||
145457981|NCT01638013|524527635|FG002|Overall Study|Subject Lost to Follow up|1|||
145457982|NCT01638013|524527633|FG000|Overall Study|Miscellaneous|25|||
145457983|NCT01638013|524527634|FG001|Overall Study|Miscellaneous|19|||
145457984|NCT01638013|524527635|FG002|Overall Study|Miscellaneous|23|||
145457985|NCT01638013|524527633|FG000|Overall Study|Withdrawal of Consent|16|||
145457986|NCT01638013|524527634|FG001|Overall Study|Withdrawal of Consent|12|||
145590229|NCT03086447|525010739|FG001|Overall Study|Test Article No Longer Available|0|||
145590230|NCT03086447|525010738|FG000|Overall Study|Protocol Violation|2|||
145590231|NCT03086447|525010739|FG001|Overall Study|Protocol Violation|4|||
145590232|NCT03086447|525010738|FG000|Overall Study|Lost to Follow-up|0|||
145590233|NCT03086447|525010739|FG001|Overall Study|Lost to Follow-up|1|||
145590234|NCT03086447|525010738|FG000|Overall Study|Adverse Event|3|||
145590235|NCT03086447|525010739|FG001|Overall Study|Adverse Event|0|||
145590236|NCT03086447|525010738|FG000|Overall Study|Lens Discomfort|2|||
145590237|NCT03086447|525010739|FG001|Overall Study|Lens Discomfort|1|||
145590238|NCT00253864|525010741|FG000|Overall Study|Lost to Follow-up|5|||
145590239|NCT00253864|525010742|FG001|Overall Study|Lost to Follow-up|8|||
145590240|NCT00659334|525010743|FG000|Overall Study|Screen Failure|8|||
145590241|NCT00659334|525010744|FG001|Overall Study|Screen Failure|5|||
145590242|NCT00659334|525010745|FG002|Overall Study|Screen Failure|0|||
145590243|NCT00659334|525010746|FG003|Overall Study|Screen Failure|0|||
145590244|NCT00659334|525010747|FG004|Overall Study|Screen Failure|0|||
145590245|NCT00659334|525010748|FG005|Overall Study|Screen Failure|0|||
145590246|NCT00659334|525010749|FG006|Overall Study|Screen Failure|1|||
145590247|NCT01174342|525010750|FG000|Overall Study|Conversion to cesarean section|4|||
145590248|NCT01218438|525010753|FG000|Epoch 1|Physician Decision|2|||
145590249|NCT01218438|525010753|FG000|Epoch 1|Adverse Event|1|||
145590250|NCT01218438|525010753|FG000|Epoch 3|Withdrawal by Subject|3|||
145590251|NCT01218438|525010753|FG000|Epoch 3|Adverse Event|1|||
145590252|NCT01218438|525010753|FG000|Epoch 4|Physician Decision|1|||
145590253|NCT01218438|525010753|FG000|Epoch 4|Withdrawal by Subject|2|||
145590254|NCT02075593|525010754|FG000|Overall Study|Withdrawal by Subject|1|||
145590255|NCT03147248|525012944|FG000|Overall Study|Adverse Event|0|||
145590256|NCT03147248|525012945|FG001|Overall Study|Adverse Event|2|||
145590257|NCT03147248|525012946|FG002|Overall Study|Adverse Event|2|||
145590258|NCT03147248|525012947|FG003|Overall Study|Adverse Event|2|||
145590259|NCT03147248|525012948|FG004|Overall Study|Adverse Event|6|||
145590260|NCT03147248|525012949|FG005|Overall Study|Adverse Event|11|||
145590261|NCT03147248|525012944|FG000|Overall Study|Disease progression|1|||
145590262|NCT03147248|525012945|FG001|Overall Study|Disease progression|0|||
145590263|NCT03147248|525012946|FG002|Overall Study|Disease progression|0|||
145590264|NCT03147248|525012947|FG003|Overall Study|Disease progression|0|||
145590265|NCT03147248|525012948|FG004|Overall Study|Disease progression|0|||
145590266|NCT03147248|525012949|FG005|Overall Study|Disease progression|2|||
145590267|NCT03147248|525012944|FG000|Overall Study|Withdrawal by Subject|0|||
145590268|NCT03147248|525012945|FG001|Overall Study|Withdrawal by Subject|0|||
145590269|NCT03147248|525012946|FG002|Overall Study|Withdrawal by Subject|0|||
145590270|NCT03147248|525012947|FG003|Overall Study|Withdrawal by Subject|0|||
145590271|NCT03147248|525012948|FG004|Overall Study|Withdrawal by Subject|12|||
145590272|NCT03147248|525012949|FG005|Overall Study|Withdrawal by Subject|9|||
145590273|NCT03147248|525012944|FG000|Overall Study|Protocol Violation|0|||
145590274|NCT03147248|525012945|FG001|Overall Study|Protocol Violation|0|||
145590275|NCT03147248|525012946|FG002|Overall Study|Protocol Violation|0|||
145590276|NCT03147248|525012947|FG003|Overall Study|Protocol Violation|0|||
145590277|NCT03147248|525012948|FG004|Overall Study|Protocol Violation|2|||
145590278|NCT03147248|525012949|FG005|Overall Study|Protocol Violation|0|||
145590279|NCT03147248|525012944|FG000|Overall Study|Lost to Follow-up|0|||
145590280|NCT03147248|525012945|FG001|Overall Study|Lost to Follow-up|0|||
145590281|NCT03147248|525012946|FG002|Overall Study|Lost to Follow-up|0|||
145590282|NCT03147248|525012947|FG003|Overall Study|Lost to Follow-up|0|||
145590283|NCT03147248|525012948|FG004|Overall Study|Lost to Follow-up|2|||
145590284|NCT03147248|525012949|FG005|Overall Study|Lost to Follow-up|0|||
145590285|NCT03147248|525012944|FG000|Overall Study|Pregnancy|0|||
145590286|NCT03147248|525012945|FG001|Overall Study|Pregnancy|0|||
145590287|NCT03147248|525012946|FG002|Overall Study|Pregnancy|0|||
145590288|NCT03147248|525012947|FG003|Overall Study|Pregnancy|0|||
145590289|NCT03147248|525012948|FG004|Overall Study|Pregnancy|1|||
145590290|NCT03147248|525012949|FG005|Overall Study|Pregnancy|0|||
145590291|NCT03147248|525012944|FG000|Overall Study|Death|0|||
145590292|NCT03147248|525012945|FG001|Overall Study|Death|0|||
145590293|NCT03147248|525012946|FG002|Overall Study|Death|0|||
145590294|NCT03147248|525012947|FG003|Overall Study|Death|0|||
145590295|NCT03147248|525012948|FG004|Overall Study|Death|0|||
145590296|NCT03147248|525012949|FG005|Overall Study|Death|4|||
145590297|NCT03147248|525012944|FG000|Overall Study|Physician Decision|0|||
145590298|NCT03147248|525012945|FG001|Overall Study|Physician Decision|0|||
145590299|NCT03147248|525012946|FG002|Overall Study|Physician Decision|0|||
145590300|NCT03147248|525012947|FG003|Overall Study|Physician Decision|0|||
145590301|NCT03147248|525012948|FG004|Overall Study|Physician Decision|2|||
145590302|NCT03147248|525012949|FG005|Overall Study|Physician Decision|4|||
145590303|NCT03147248|525012944|FG000|Overall Study|Prolonged Dosing Interval|0|||
145590304|NCT03147248|525012945|FG001|Overall Study|Prolonged Dosing Interval|0|||
145590305|NCT03147248|525012946|FG002|Overall Study|Prolonged Dosing Interval|0|||
145590306|NCT03147248|525012947|FG003|Overall Study|Prolonged Dosing Interval|0|||
145590307|NCT03147248|525012948|FG004|Overall Study|Prolonged Dosing Interval|1|||
145590308|NCT03147248|525012949|FG005|Overall Study|Prolonged Dosing Interval|1|||
145590309|NCT03750552|525012950|FG000|Overall Study|Adverse Event|5|||
145457987|NCT01638013|524527635|FG002|Overall Study|Withdrawal of Consent|16|||
145457988|NCT01638013|524527633|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
145457989|NCT01638013|524527634|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
145457990|NCT01638013|524527635|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
145457991|NCT02226198|524529158|FG000|Lead-in Phase|Protocol Violation|1|||
145457992|NCT02226198|524529159|FG001|Lead-in Phase|Protocol Violation|0|||
145457993|NCT02226198|524529160|FG002|Lead-in Phase|Protocol Violation|0|||
145457994|NCT02226198|524529158|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
145457995|NCT02226198|524529159|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
145457996|NCT02226198|524529160|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
145457997|NCT01440517|524529164|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
145457998|NCT01288612|524529166|FG000|Overall Study|Unable to contact|11|||
145457999|NCT01288612|524529167|FG001|Overall Study|Unable to contact|16|||
145458000|NCT01288612|524529168|FG002|Overall Study|Unable to contact|20|||
145458001|NCT01288612|524529166|FG000|Overall Study|Declined|78|||
145458002|NCT01288612|524529167|FG001|Overall Study|Declined|63|||
145458003|NCT01288612|524529168|FG002|Overall Study|Declined|62|||
145458004|NCT01288612|524529166|FG000|Overall Study|Unable to intubate|0|||
145458005|NCT01288612|524529167|FG001|Overall Study|Unable to intubate|3|||
145458006|NCT01288612|524529168|FG002|Overall Study|Unable to intubate|0|||
145458007|NCT00840060|524529169|FG000|Overall Study|Withdrawal by Subject|1|||
145458008|NCT00840060|524529170|FG001|Overall Study|Withdrawal by Subject|0|||
145458009|NCT00840060|524529169|FG000|Overall Study|Change in emotional/behavioral status|0|||
145458010|NCT00840060|524529170|FG001|Overall Study|Change in emotional/behavioral status|1|||
145458011|NCT00871923|524529171|FG000|Overall Study|Death|1|||
145458012|NCT00871923|524529171|FG000|Overall Study|Withdrawal by Subject|1|||
145458013|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
145458014|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
145458015|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
145458016|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
145458017|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
145458018|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
145458019|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
145458020|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
145458021|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
145458022|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
145458023|NCT01263015|524529176|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
145458024|NCT01263015|524529177|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
145458025|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
145458026|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
145458027|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
145458028|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
145458029|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
145458030|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
145458031|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
145458032|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
145458033|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
145458034|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
145458035|NCT01263015|524529176|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
145458036|NCT01263015|524529177|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
145458037|NCT05599451|524529178|FG000|Overall Study|Not randomized|11|||
145458038|NCT05599451|524529179|FG001|Overall Study|Not randomized|0|||
145458039|NCT05599451|524529180|FG002|Overall Study|Not randomized|0|||
145458040|NCT05599451|524529181|FG003|Overall Study|Not randomized|0|||
145458041|NCT05599451|524529182|FG004|Overall Study|Not randomized|0|||
145458042|NCT05599451|524529178|FG000|Overall Study|Physician Decision|0|||
145458043|NCT05599451|524529179|FG001|Overall Study|Physician Decision|0|||
145458044|NCT05599451|524529180|FG002|Overall Study|Physician Decision|0|||
145458045|NCT05599451|524529181|FG003|Overall Study|Physician Decision|1|||
145458046|NCT05599451|524529182|FG004|Overall Study|Physician Decision|0|||
145458047|NCT02723006|524529183|FG000|Overall Study|Withdrawal by Subject|0|||
145590310|NCT03750552|525012951|FG001|Overall Study|Adverse Event|1|||
145590311|NCT03750552|525012950|FG000|Overall Study|Withdrawal by Subject|1|||
145590312|NCT03750552|525012951|FG001|Overall Study|Withdrawal by Subject|1|||
145590313|NCT03750552|525012950|FG000|Overall Study|Other|2|||
145590314|NCT03750552|525012951|FG001|Overall Study|Other|0|||
145458048|NCT02723006|524529184|FG001|Overall Study|Withdrawal by Subject|1|||
145458049|NCT02723006|524529185|FG002|Overall Study|Withdrawal by Subject|1|||
145458050|NCT02723006|524529183|FG000|Overall Study|Study Terminated by Sponsor|1|||
145458051|NCT02723006|524529184|FG001|Overall Study|Study Terminated by Sponsor|6|||
145458052|NCT02723006|524529185|FG002|Overall Study|Study Terminated by Sponsor|6|||
145458053|NCT00303446|524529186|FG000|Overall Study|Withdrawal by Subject|2|||
145590315|NCT02062632|525012952|FG000|Overall Study|No treatment data|1|||
145590316|NCT00773968|525012955|FG000|Overall Study|Adverse Event|2|||
145590317|NCT00773968|525012955|FG000|Overall Study|Death|1|||
145590318|NCT00773968|525012955|FG000|Overall Study|Failure to Return|2|||
145590319|NCT00773968|525012955|FG000|Overall Study|Lack of Efficacy|3|||
145590320|NCT00773968|525012955|FG000|Overall Study|Protocol Violation|1|||
145590321|NCT00773968|525012955|FG000|Overall Study|Withdrawal by Subject|11|||
145590322|NCT00773968|525012955|FG000|Overall Study|Screen Failure|17|||
145590323|NCT00773968|525012955|FG000|Overall Study|Other|8|||
145590324|NCT02008890|525012963|FG000|Period 1|Withdrawal by Subject|7|||
145590325|NCT02008890|525012964|FG001|Period 1|Withdrawal by Subject|7|||
145590326|NCT02008890|525012965|FG002|Period 1|Withdrawal by Subject|5|||
145590327|NCT02008890|525012966|FG003|Period 1|Withdrawal by Subject|0|||
145590328|NCT02008890|525012967|FG004|Period 1|Withdrawal by Subject|0|||
145590329|NCT02008890|525012963|FG000|Period 1|Pregnancy|1|||
145590330|NCT02008890|525012964|FG001|Period 1|Pregnancy|0|||
145590331|NCT02008890|525012965|FG002|Period 1|Pregnancy|0|||
145590332|NCT02008890|525012966|FG003|Period 1|Pregnancy|0|||
145590333|NCT02008890|525012967|FG004|Period 1|Pregnancy|0|||
145590334|NCT02008890|525012963|FG000|Period 1|Physician Decision|1|||
145590335|NCT02008890|525012964|FG001|Period 1|Physician Decision|0|||
145590336|NCT02008890|525012965|FG002|Period 1|Physician Decision|1|||
145590337|NCT02008890|525012966|FG003|Period 1|Physician Decision|0|||
145590338|NCT02008890|525012967|FG004|Period 1|Physician Decision|0|||
145590339|NCT02008890|525012963|FG000|Period 1|Adverse Event|6|||
145590340|NCT02008890|525012964|FG001|Period 1|Adverse Event|8|||
145590341|NCT02008890|525012965|FG002|Period 1|Adverse Event|6|||
145590342|NCT02008890|525012966|FG003|Period 1|Adverse Event|0|||
145590343|NCT02008890|525012967|FG004|Period 1|Adverse Event|0|||
145590344|NCT02008890|525012963|FG000|Period 2|Adverse Event|12|||
145590345|NCT02008890|525012964|FG001|Period 2|Adverse Event|7|||
145590346|NCT02008890|525012965|FG002|Period 2|Adverse Event|0|||
145590347|NCT02008890|525012966|FG003|Period 2|Adverse Event|5|||
145590348|NCT02008890|525012967|FG004|Period 2|Adverse Event|5|||
145590349|NCT02008890|525012963|FG000|Period 2|Withdrawal by Subject|11|||
145590350|NCT02008890|525012964|FG001|Period 2|Withdrawal by Subject|8|||
145590351|NCT02008890|525012965|FG002|Period 2|Withdrawal by Subject|0|||
145590352|NCT02008890|525012966|FG003|Period 2|Withdrawal by Subject|7|||
145590353|NCT02008890|525012967|FG004|Period 2|Withdrawal by Subject|2|||
145590354|NCT02008890|525012963|FG000|Period 2|Physician Decision|4|||
145590355|NCT02008890|525012964|FG001|Period 2|Physician Decision|0|||
145590356|NCT02008890|525012965|FG002|Period 2|Physician Decision|0|||
145590357|NCT02008890|525012966|FG003|Period 2|Physician Decision|2|||
145590358|NCT02008890|525012967|FG004|Period 2|Physician Decision|1|||
145590359|NCT02008890|525012963|FG000|Period 2|Lost to Follow-up|0|||
145590360|NCT02008890|525012964|FG001|Period 2|Lost to Follow-up|0|||
145590361|NCT02008890|525012965|FG002|Period 2|Lost to Follow-up|1|||
145590362|NCT02008890|525012966|FG003|Period 2|Lost to Follow-up|0|||
145590363|NCT02008890|525012967|FG004|Period 2|Lost to Follow-up|0|||
145590364|NCT02008890|525012963|FG000|Extension Period|Withdrawal by Subject|3|||
145590365|NCT02008890|525012964|FG001|Extension Period|Withdrawal by Subject|2|||
145590366|NCT02008890|525012965|FG002|Extension Period|Withdrawal by Subject|0|||
145590367|NCT02008890|525012966|FG003|Extension Period|Withdrawal by Subject|4|||
145590368|NCT02008890|525012967|FG004|Extension Period|Withdrawal by Subject|2|||
145590369|NCT02008890|525012963|FG000|Extension Period|Lost to Follow-up|1|||
145590370|NCT02008890|525012964|FG001|Extension Period|Lost to Follow-up|0|||
145590371|NCT02008890|525012965|FG002|Extension Period|Lost to Follow-up|0|||
145590372|NCT02008890|525012966|FG003|Extension Period|Lost to Follow-up|0|||
145590373|NCT02008890|525012967|FG004|Extension Period|Lost to Follow-up|0|||
145590374|NCT02008890|525012963|FG000|Extension Period|Adverse Event|1|||
145590375|NCT02008890|525012964|FG001|Extension Period|Adverse Event|3|||
145590376|NCT02008890|525012965|FG002|Extension Period|Adverse Event|0|||
145590377|NCT02008890|525012966|FG003|Extension Period|Adverse Event|0|||
145590378|NCT02008890|525012967|FG004|Extension Period|Adverse Event|2|||
145590379|NCT02332720|525012968|FG000|Part A and Part B|Lost to Follow-up|1|||
145590380|NCT02332720|525012969|FG001|Part A and Part B|Lost to Follow-up|0|||
145590381|NCT02332720|525012970|FG002|Part A and Part B|Lost to Follow-up|0|||
145590382|NCT02332720|525012971|FG003|Part A and Part B|Lost to Follow-up|0|||
145590383|NCT02332720|525012972|FG004|Part A and Part B|Lost to Follow-up|0|||
145590384|NCT02332720|525012973|FG005|Part A and Part B|Lost to Follow-up|2|||
145590385|NCT02332720|525012974|FG006|Part A and Part B|Lost to Follow-up|1|||
145590386|NCT02332720|525012975|FG007|Part A and Part B|Lost to Follow-up|1|||
145590387|NCT02332720|525012976|FG008|Part A and Part B|Lost to Follow-up|0|||
145590388|NCT02332720|525012977|FG009|Part A and Part B|Lost to Follow-up|0|||
145590389|NCT02332720|525012978|FG010|Part A and Part B|Lost to Follow-up|0|||
145590390|NCT02332720|525012979|FG011|Part A and Part B|Lost to Follow-up|0|||
145590391|NCT02332720|525012980|FG012|Part A and Part B|Lost to Follow-up|0|||
145590392|NCT02332720|525012981|FG013|Part A and Part B|Lost to Follow-up|0|||
145590393|NCT02332720|525012982|FG014|Part A and Part B|Lost to Follow-up|0|||
145590394|NCT02332720|525012983|FG015|Part A and Part B|Lost to Follow-up|1|||
145458054|NCT00303446|524529187|FG001|Overall Study|Withdrawal by Subject|2|||
145458055|NCT00303446|524529186|FG000|Overall Study|Death|0|||
145458056|NCT00303446|524529187|FG001|Overall Study|Death|1|||
145590395|NCT02332720|525012984|FG016|Part A and Part B|Lost to Follow-up|0|||
145590396|NCT02332720|525012985|FG017|Part A and Part B|Lost to Follow-up|0|||
145590397|NCT02332720|525012986|FG018|Part A and Part B|Lost to Follow-up|0|||
145590398|NCT02332720|525012987|FG019|Part A and Part B|Lost to Follow-up|0|||
145590399|NCT02332720|525012988|FG020|Part A and Part B|Lost to Follow-up|0|||
145590400|NCT02332720|525012989|FG021|Part A and Part B|Lost to Follow-up|0|||
145590401|NCT02332720|525012990|FG022|Part A and Part B|Lost to Follow-up|0|||
145590402|NCT02332720|525012968|FG000|Part A and Part B|Adverse Event|0|||
145590403|NCT02332720|525012969|FG001|Part A and Part B|Adverse Event|0|||
145590404|NCT02332720|525012970|FG002|Part A and Part B|Adverse Event|0|||
145590405|NCT02332720|525012971|FG003|Part A and Part B|Adverse Event|0|||
145590406|NCT02332720|525012972|FG004|Part A and Part B|Adverse Event|0|||
145590407|NCT02332720|525012973|FG005|Part A and Part B|Adverse Event|0|||
145590408|NCT02332720|525012974|FG006|Part A and Part B|Adverse Event|0|||
145590409|NCT02332720|525012975|FG007|Part A and Part B|Adverse Event|0|||
145590410|NCT02332720|525012976|FG008|Part A and Part B|Adverse Event|0|||
145590411|NCT02332720|525012977|FG009|Part A and Part B|Adverse Event|0|||
145590412|NCT02332720|525012978|FG010|Part A and Part B|Adverse Event|0|||
145590413|NCT02332720|525012979|FG011|Part A and Part B|Adverse Event|0|||
145590414|NCT02332720|525012980|FG012|Part A and Part B|Adverse Event|0|||
145590415|NCT02332720|525012981|FG013|Part A and Part B|Adverse Event|0|||
145590416|NCT02332720|525012982|FG014|Part A and Part B|Adverse Event|0|||
145590417|NCT02332720|525012983|FG015|Part A and Part B|Adverse Event|0|||
145590418|NCT02332720|525012984|FG016|Part A and Part B|Adverse Event|0|||
145590419|NCT02332720|525012985|FG017|Part A and Part B|Adverse Event|1|||
145590420|NCT02332720|525012986|FG018|Part A and Part B|Adverse Event|0|||
145590421|NCT02332720|525012987|FG019|Part A and Part B|Adverse Event|0|||
145590422|NCT02332720|525012988|FG020|Part A and Part B|Adverse Event|0|||
145590423|NCT02332720|525012989|FG021|Part A and Part B|Adverse Event|0|||
145590424|NCT02332720|525012990|FG022|Part A and Part B|Adverse Event|0|||
145590425|NCT02332720|525012968|FG000|Part A and Part B|Physician Decision|0|||
145590426|NCT02332720|525012969|FG001|Part A and Part B|Physician Decision|0|||
145590427|NCT02332720|525012970|FG002|Part A and Part B|Physician Decision|0|||
145590428|NCT02332720|525012971|FG003|Part A and Part B|Physician Decision|0|||
145590429|NCT02332720|525012972|FG004|Part A and Part B|Physician Decision|0|||
145590430|NCT02332720|525012973|FG005|Part A and Part B|Physician Decision|0|||
145590431|NCT02332720|525012974|FG006|Part A and Part B|Physician Decision|0|||
145590432|NCT02332720|525012975|FG007|Part A and Part B|Physician Decision|0|||
145590433|NCT02332720|525012976|FG008|Part A and Part B|Physician Decision|0|||
145590434|NCT02332720|525012977|FG009|Part A and Part B|Physician Decision|0|||
145590435|NCT02332720|525012978|FG010|Part A and Part B|Physician Decision|0|||
145590436|NCT02332720|525012979|FG011|Part A and Part B|Physician Decision|0|||
145590437|NCT02332720|525012980|FG012|Part A and Part B|Physician Decision|0|||
145590438|NCT02332720|525012981|FG013|Part A and Part B|Physician Decision|0|||
145590439|NCT02332720|525012982|FG014|Part A and Part B|Physician Decision|0|||
145590440|NCT02332720|525012983|FG015|Part A and Part B|Physician Decision|0|||
145590441|NCT02332720|525012984|FG016|Part A and Part B|Physician Decision|0|||
145590442|NCT02332720|525012985|FG017|Part A and Part B|Physician Decision|0|||
145590443|NCT02332720|525012986|FG018|Part A and Part B|Physician Decision|1|||
145590444|NCT02332720|525012987|FG019|Part A and Part B|Physician Decision|0|||
145590445|NCT02332720|525012988|FG020|Part A and Part B|Physician Decision|0|||
145590446|NCT02332720|525012989|FG021|Part A and Part B|Physician Decision|0|||
145590447|NCT02332720|525012990|FG022|Part A and Part B|Physician Decision|0|||
145458057|NCT00303446|524529186|FG000|Overall Study|Physician Decision|0|||
145590448|NCT02332720|525012968|FG000|Part A and Part B|Withdrawal by Subject|0|||
145590449|NCT02332720|525012969|FG001|Part A and Part B|Withdrawal by Subject|0|||
145590450|NCT02332720|525012970|FG002|Part A and Part B|Withdrawal by Subject|0|||
145590451|NCT02332720|525012971|FG003|Part A and Part B|Withdrawal by Subject|0|||
145590452|NCT02332720|525012972|FG004|Part A and Part B|Withdrawal by Subject|0|||
145590453|NCT02332720|525012973|FG005|Part A and Part B|Withdrawal by Subject|1|||
145590454|NCT02332720|525012974|FG006|Part A and Part B|Withdrawal by Subject|0|||
145590455|NCT02332720|525012975|FG007|Part A and Part B|Withdrawal by Subject|0|||
145590456|NCT02332720|525012976|FG008|Part A and Part B|Withdrawal by Subject|0|||
145458058|NCT00303446|524529187|FG001|Overall Study|Physician Decision|1|||
145590457|NCT02332720|525012977|FG009|Part A and Part B|Withdrawal by Subject|0|||
145590458|NCT02332720|525012978|FG010|Part A and Part B|Withdrawal by Subject|0|||
145590459|NCT02332720|525012979|FG011|Part A and Part B|Withdrawal by Subject|0|||
145590460|NCT02332720|525012980|FG012|Part A and Part B|Withdrawal by Subject|0|||
145590461|NCT02332720|525012981|FG013|Part A and Part B|Withdrawal by Subject|0|||
145590462|NCT02332720|525012982|FG014|Part A and Part B|Withdrawal by Subject|0|||
145590463|NCT02332720|525012983|FG015|Part A and Part B|Withdrawal by Subject|0|||
145590464|NCT02332720|525012984|FG016|Part A and Part B|Withdrawal by Subject|0|||
145458059|NCT04258995|524529188|FG000|Overall Study|Lost to Follow-up|1|||
145458060|NCT04258995|524529189|FG001|Overall Study|Lost to Follow-up|1|||
145458061|NCT00983515|524529195|FG000|Ritonavir Alone|liver panel out of range|6|||
145458062|NCT00983515|524529195|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
145458063|NCT01962987|524529198|FG000|Overall Study|Adverse Event|4|||
145458064|NCT01962987|524529199|FG001|Overall Study|Adverse Event|4|||
145458065|NCT01962987|524529200|FG002|Overall Study|Adverse Event|0|||
145458066|NCT01962987|524529198|FG000|Overall Study|Lost to Follow-up|0|||
145458067|NCT01962987|524529199|FG001|Overall Study|Lost to Follow-up|0|||
145458068|NCT01962987|524529200|FG002|Overall Study|Lost to Follow-up|1|||
145458069|NCT01962987|524529198|FG000|Overall Study|Non compliance with dosing requirements|4|||
145458070|NCT01962987|524529199|FG001|Overall Study|Non compliance with dosing requirements|2|||
145458071|NCT01962987|524529200|FG002|Overall Study|Non compliance with dosing requirements|0|||
145458072|NCT01962987|524529198|FG000|Overall Study|Miscellaneous|1|||
145458073|NCT01962987|524529199|FG001|Overall Study|Miscellaneous|9|||
145458074|NCT01962987|524529200|FG002|Overall Study|Miscellaneous|2|||
145458075|NCT01962987|524529198|FG000|Overall Study|Restricted medication|5|||
145458076|NCT01962987|524529199|FG001|Overall Study|Restricted medication|1|||
145458077|NCT01962987|524529200|FG002|Overall Study|Restricted medication|1|||
145458078|NCT01962987|524529198|FG000|Overall Study|Serious Adverse Event|1|||
145458079|NCT01962987|524529199|FG001|Overall Study|Serious Adverse Event|0|||
145458080|NCT01962987|524529200|FG002|Overall Study|Serious Adverse Event|0|||
145458081|NCT01962987|524529198|FG000|Overall Study|Withdrawal by Subject|11|||
145458082|NCT01962987|524529199|FG001|Overall Study|Withdrawal by Subject|10|||
145458083|NCT01962987|524529200|FG002|Overall Study|Withdrawal by Subject|6|||
145458084|NCT01962987|524529198|FG000|Overall Study|Randomized in Error|4|||
145458085|NCT01962987|524529199|FG001|Overall Study|Randomized in Error|2|||
145458086|NCT01962987|524529200|FG002|Overall Study|Randomized in Error|2|||
145458087|NCT01967823|524529201|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
145458088|NCT00413894|524529202|FG000|Overall Study|Withdrawal by Subject|10|||
145458089|NCT00413894|524529202|FG000|Overall Study|Administrative Reasons|1|||
145458090|NCT00413894|524529202|FG000|Overall Study|Hb <10 grams/deciliter|12|||
145458091|NCT00413894|524529202|FG000|Overall Study|Adverse Event|28|||
145458092|NCT00413894|524529202|FG000|Overall Study|Protocol Violation|11|||
145458093|NCT00413894|524529202|FG000|Overall Study|Other|18|||
145458094|NCT05289271|524529203|FG000|Overall Study|Mistakenly allocated, untreated|1|||
145458095|NCT05289271|524529204|FG001|Overall Study|Mistakenly allocated, untreated|0|||
145458096|NCT01257568|524529205|FG000|Overall Study|Lost to Follow-up|2|||
145458097|NCT01257568|524529205|FG000|Overall Study|Withdrawal by Subject|6|||
145458098|NCT01257568|524529205|FG000|Overall Study|Terminated|1|||
145458099|NCT01257568|524529205|FG000|Overall Study|Component Revision|24|||
145458100|NCT03392883|524529206|FG000|Overall Study|Lost to Follow-up|122|||
145458101|NCT03392883|524529207|FG001|Overall Study|Lost to Follow-up|13|||
145458102|NCT03392883|524529208|FG002|Overall Study|Lost to Follow-up|9|||
145458103|NCT03392883|524529206|FG000|Overall Study|Death|4|||
145458104|NCT03392883|524529207|FG001|Overall Study|Death|0|||
145458105|NCT03392883|524529208|FG002|Overall Study|Death|0|||
145458106|NCT03392883|524529206|FG000|Overall Study|Lack of Efficacy|29|||
145458107|NCT03392883|524529207|FG001|Overall Study|Lack of Efficacy|0|||
145458108|NCT03392883|524529208|FG002|Overall Study|Lack of Efficacy|0|||
145458109|NCT03392883|524529206|FG000|Overall Study|Withdrawal by Subject|180|||
145458110|NCT03392883|524529207|FG001|Overall Study|Withdrawal by Subject|0|||
145458111|NCT03392883|524529208|FG002|Overall Study|Withdrawal by Subject|0|||
145458112|NCT03392883|524529206|FG000|Overall Study|Adverse Event|1|||
145458113|NCT03392883|524529207|FG001|Overall Study|Adverse Event|0|||
145458114|NCT03392883|524529208|FG002|Overall Study|Adverse Event|0|||
145458115|NCT01739933|524529218|FG000|Overall Study|Death|89|||
145458116|NCT01739933|524529219|FG001|Overall Study|Death|86|||
145458117|NCT01739933|524529218|FG000|Overall Study|Withdrawal by Subject|10|||
145458118|NCT01739933|524529219|FG001|Overall Study|Withdrawal by Subject|8|||
145458119|NCT01739933|524529218|FG000|Overall Study|Lost to Follow-up|3|||
145458120|NCT01739933|524529219|FG001|Overall Study|Lost to Follow-up|10|||
145458121|NCT01739933|524529218|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
145458122|NCT01739933|524529219|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
145458123|NCT03356977|524529220|FG000|Overall Study|Lost to Follow-up|3|||
145458124|NCT03356977|524529220|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145458125|NCT00908115|524529226|FG000|Overall Study|Other|14|||
145590465|NCT02332720|525012985|FG017|Part A and Part B|Withdrawal by Subject|0|||
145590466|NCT02332720|525012986|FG018|Part A and Part B|Withdrawal by Subject|0|||
145590467|NCT02332720|525012987|FG019|Part A and Part B|Withdrawal by Subject|1|||
145590468|NCT02332720|525012988|FG020|Part A and Part B|Withdrawal by Subject|0|||
145590469|NCT02332720|525012989|FG021|Part A and Part B|Withdrawal by Subject|0|||
145590470|NCT02332720|525012990|FG022|Part A and Part B|Withdrawal by Subject|0|||
145590471|NCT05912400|525012991|FG000|Overall Study|Lost to Follow-up|1|||
145590472|NCT05912400|525012992|FG001|Overall Study|Lost to Follow-up|0|||
145590473|NCT05912400|525012991|FG000|Overall Study|Physician Decision|6|||
145590474|NCT05912400|525012992|FG001|Overall Study|Physician Decision|0|||
145590475|NCT05912400|525012991|FG000|Overall Study|Withdrawal by Subject|1|||
145458126|NCT01728077|524529228|FG000|Overall Study|Lack of Efficacy|3|||
145458127|NCT01728077|524529229|FG001|Overall Study|Lack of Efficacy|1|||
145458128|NCT01728077|524529228|FG000|Overall Study|Lost to Follow-up|1|||
145458129|NCT01728077|524529229|FG001|Overall Study|Lost to Follow-up|0|||
145458130|NCT01728077|524529228|FG000|Overall Study|Subject choice|2|||
145458131|NCT01728077|524529229|FG001|Overall Study|Subject choice|3|||
145458132|NCT01728077|524529228|FG000|Overall Study|Death|0|||
145458133|NCT01728077|524529229|FG001|Overall Study|Death|1|||
145458134|NCT01728077|524529228|FG000|Overall Study|Patient moving|1|||
145458135|NCT01728077|524529229|FG001|Overall Study|Patient moving|0|||
145458136|NCT01728077|524529228|FG000|Overall Study|Non compliance|1|||
145458137|NCT01728077|524529229|FG001|Overall Study|Non compliance|0|||
145458138|NCT02680041|524529232|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
145458139|NCT02680041|524529232|FG000|Overall Study|Lost to Follow-up|2|||
145458140|NCT00521599|524529233|FG000|Overall Study|Adverse Event|5|||
145458141|NCT00521599|524529234|FG001|Overall Study|Adverse Event|7|||
145458142|NCT00521599|524529235|FG002|Overall Study|Adverse Event|6|||
145458143|NCT00521599|524529233|FG000|Overall Study|Treatment Failure|8|||
145458144|NCT00521599|524529234|FG001|Overall Study|Treatment Failure|9|||
145458145|NCT00521599|524529235|FG002|Overall Study|Treatment Failure|22|||
145458146|NCT00521599|524529233|FG000|Overall Study|Lost to Follow-up|2|||
145458147|NCT00521599|524529234|FG001|Overall Study|Lost to Follow-up|1|||
145458148|NCT00521599|524529235|FG002|Overall Study|Lost to Follow-up|2|||
145458149|NCT00521599|524529233|FG000|Overall Study|Withdrawal by Subject|3|||
145458150|NCT00521599|524529234|FG001|Overall Study|Withdrawal by Subject|5|||
145458151|NCT00521599|524529235|FG002|Overall Study|Withdrawal by Subject|1|||
145458152|NCT00521599|524529233|FG000|Overall Study|Withdrawal by subject treatment related|3|||
145458153|NCT00521599|524529234|FG001|Overall Study|Withdrawal by subject treatment related|1|||
145458154|NCT00521599|524529235|FG002|Overall Study|Withdrawal by subject treatment related|2|||
145458155|NCT00521599|524529233|FG000|Overall Study|Protocol Violation|2|||
145458156|NCT00521599|524529234|FG001|Overall Study|Protocol Violation|4|||
145458157|NCT00521599|524529235|FG002|Overall Study|Protocol Violation|2|||
145458158|NCT00521599|524529233|FG000|Overall Study|Did not meet protocol eligibility|2|||
145458159|NCT00521599|524529234|FG001|Overall Study|Did not meet protocol eligibility|2|||
145458160|NCT00521599|524529235|FG002|Overall Study|Did not meet protocol eligibility|1|||
145458161|NCT01610713|524529236|FG000|Overall Study|Adverse Event|3|||
145458162|NCT01610713|524529237|FG001|Overall Study|Adverse Event|0|||
145458163|NCT01610713|524529236|FG000|Overall Study|Lack of Efficacy|1|||
145458164|NCT01610713|524529237|FG001|Overall Study|Lack of Efficacy|0|||
145458165|NCT01610713|524529236|FG000|Overall Study|low mood and poor motivation|1|||
145458166|NCT01610713|524529237|FG001|Overall Study|low mood and poor motivation|0|||
145458167|NCT01610713|524529236|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
145458168|NCT01610713|524529237|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
145458169|NCT01610713|524529236|FG000|Overall Study|Lost to Follow-up|0|||
145458170|NCT01610713|524529237|FG001|Overall Study|Lost to Follow-up|1|||
145458171|NCT01774097|524529242|FG000|Overall Study|Withdrawal by Subject|1|||
145458172|NCT01774097|524529243|FG001|Overall Study|Withdrawal by Subject|1|||
145458173|NCT01774097|524529242|FG000|Overall Study|Adverse Event|1|||
145458174|NCT01774097|524529243|FG001|Overall Study|Adverse Event|1|||
145458175|NCT00557310|524529244|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
145458176|NCT00557310|524529244|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
145458177|NCT00557310|524529244|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
145458178|NCT00557310|524529244|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
145458179|NCT00557310|524529244|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
145458180|NCT00557310|524529244|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
145458181|NCT01271712|524529251|FG000|Double Blind Treatment|Death|2|||
145458182|NCT01271712|524529252|FG001|Double Blind Treatment|Death|0|||
145458183|NCT01271712|524529251|FG000|Double Blind Treatment|Lack of Efficacy|1|||
145458184|NCT01271712|524529252|FG001|Double Blind Treatment|Lack of Efficacy|0|||
145458185|NCT01271712|524529251|FG000|Double Blind Treatment|Adverse Event|9|||
145458186|NCT01271712|524529252|FG001|Double Blind Treatment|Adverse Event|4|||
145590476|NCT05912400|525012992|FG001|Overall Study|Withdrawal by Subject|0|||
145590477|NCT02522494|525012995|FG000|Overall Study|Lost to Follow-up|6|||
145590478|NCT02522494|525012996|FG001|Overall Study|Lost to Follow-up|2|||
145590479|NCT02522494|525012995|FG000|Overall Study|Withdrawal by Subject|1|||
145590480|NCT02522494|525012996|FG001|Overall Study|Withdrawal by Subject|0|||
145458187|NCT01271712|524529251|FG000|Double Blind Treatment|Progressive disease|23|||
145458188|NCT01271712|524529252|FG001|Double Blind Treatment|Progressive disease|3|||
145458189|NCT01271712|524529251|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
145458190|NCT01271712|524529252|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
145458191|NCT01271712|524529251|FG000|Double Blind Treatment|Non compliance with study drug|2|||
145458192|NCT01271712|524529252|FG001|Double Blind Treatment|Non compliance with study drug|0|||
145458193|NCT01271712|524529251|FG000|Double Blind Treatment|receive no study drug|1|||
145458194|NCT01271712|524529252|FG001|Double Blind Treatment|receive no study drug|0|||
145458195|NCT01271712|524529251|FG000|Open Label Treatment|Death|6|||
145458196|NCT01271712|524529252|FG001|Open Label Treatment|Death|5|||
145626703|NCT04668144|525145766|FG001|Overall Study|Protocol Violation|1|||
145590481|NCT02522494|525012995|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
145590482|NCT02522494|525012996|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
145590483|NCT02522494|525012995|FG000|Overall Study|Participant did not watch the video|1|||
145590484|NCT02522494|525012996|FG001|Overall Study|Participant did not watch the video|0|||
145590485|NCT02522494|525012995|FG000|Overall Study|Death|0|||
145590486|NCT02522494|525012996|FG001|Overall Study|Death|1|||
145590487|NCT03461003|525013001|FG000|Overall Study|Lost to Follow-up|2|||
145590488|NCT03461003|525013002|FG001|Overall Study|Lost to Follow-up|2|||
145590489|NCT03461003|525013001|FG000|Overall Study|Withdrawal by Subject|3|||
145590490|NCT03461003|525013002|FG001|Overall Study|Withdrawal by Subject|1|||
145590491|NCT00856856|525013005|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
145590492|NCT00856856|525013005|FG000|4-year Clinical Follow-up|Missed visit|1|||
145590493|NCT02508311|525013008|FG000|Overall Study|Withdrawal by Subject|1|||
145590494|NCT02508311|525013009|FG001|Overall Study|Withdrawal by Subject|0|||
145590495|NCT00448539|525013010|FG000|Overall Study|Medication non-compliance|4|||
145590496|NCT00448539|525013011|FG001|Overall Study|Medication non-compliance|1|||
145590497|NCT00448539|525013010|FG000|Overall Study|Protocol Violation|1|||
145590498|NCT00448539|525013011|FG001|Overall Study|Protocol Violation|0|||
145590499|NCT00448539|525013010|FG000|Overall Study|Request of the investigator or sponsor|67|||
145590500|NCT00448539|525013011|FG001|Overall Study|Request of the investigator or sponsor|54|||
145590501|NCT00448539|525013010|FG000|Overall Study|Withdrawal by Subject|20|||
145590502|NCT00448539|525013011|FG001|Overall Study|Withdrawal by Subject|24|||
145590503|NCT00448539|525013010|FG000|Overall Study|Diary non-compliance|1|||
145590504|NCT00448539|525013011|FG001|Overall Study|Diary non-compliance|0|||
145590505|NCT00448539|525013010|FG000|Overall Study|Adverse Event|9|||
145590506|NCT00448539|525013011|FG001|Overall Study|Adverse Event|26|||
145590507|NCT00448539|525013010|FG000|Overall Study|Lack of Efficacy|27|||
145590508|NCT00448539|525013011|FG001|Overall Study|Lack of Efficacy|40|||
145590509|NCT00448539|525013010|FG000|Overall Study|Miscellaneous|2|||
145590510|NCT00448539|525013011|FG001|Overall Study|Miscellaneous|1|||
145590511|NCT00448539|525013010|FG000|Overall Study|Change of meds|2|||
145590512|NCT00448539|525013011|FG001|Overall Study|Change of meds|3|||
145590513|NCT00448539|525013010|FG000|Overall Study|Lost to Follow-up|1|||
145590514|NCT00448539|525013011|FG001|Overall Study|Lost to Follow-up|3|||
145590515|NCT04862143|525013012|FG000|Overall Study|Adverse Event|1|||
145590516|NCT04862143|525013012|FG000|Overall Study|Study terminated by sponsor|1|||
145590517|NCT02103439|525013013|FG000|Overall Study|Adverse Event|0|||
145590518|NCT02103439|525013014|FG001|Overall Study|Adverse Event|2|||
145590519|NCT02103439|525013013|FG000|Overall Study|Withdrawal by Subject|3|||
145590520|NCT02103439|525013014|FG001|Overall Study|Withdrawal by Subject|1|||
145590521|NCT02370602|525013015|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145590522|NCT02370602|525013016|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
145590523|NCT02370602|525013017|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145590524|NCT02370602|525013018|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
145590525|NCT02370602|525013019|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
145590526|NCT02370602|525013020|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
145590527|NCT03349710|525013021|FG000|Treatment Period|Death|0|||
145590528|NCT03349710|525013022|FG001|Treatment Period|Death|0|||
145590529|NCT03349710|525013023|FG002|Treatment Period|Death|1|||
145590530|NCT03349710|525013024|FG003|Treatment Period|Death|0|||
145590531|NCT03349710|525013021|FG000|Treatment Period|Disease Progression|0|||
145590532|NCT03349710|525013022|FG001|Treatment Period|Disease Progression|2|||
145590533|NCT03349710|525013023|FG002|Treatment Period|Disease Progression|0|||
145590534|NCT03349710|525013024|FG003|Treatment Period|Disease Progression|1|||
145590535|NCT03349710|525013021|FG000|Treatment Period|Study Drug Toxicity|1|||
145590536|NCT03349710|525013022|FG001|Treatment Period|Study Drug Toxicity|0|||
145590537|NCT03349710|525013023|FG002|Treatment Period|Study Drug Toxicity|1|||
145590538|NCT03349710|525013024|FG003|Treatment Period|Study Drug Toxicity|1|||
145590539|NCT03349710|525013021|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
145590540|NCT03349710|525013022|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
145590541|NCT03349710|525013023|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
145590542|NCT03349710|525013024|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
145626704|NCT04668144|525145767|FG002|Overall Study|Protocol Violation|2|||
145626705|NCT02282527|525145771|FG000|Overall Study|Lost to Follow-up|0|||
145590543|NCT03349710|525013021|FG000|Treatment Period|admin reason by sponsor|0|||
145590544|NCT03349710|525013022|FG001|Treatment Period|admin reason by sponsor|7|||
145590545|NCT03349710|525013023|FG002|Treatment Period|admin reason by sponsor|0|||
145590546|NCT03349710|525013024|FG003|Treatment Period|admin reason by sponsor|19|||
145590547|NCT03349710|525013021|FG000|Treatment Period|Other Reason|2|||
145590548|NCT03349710|525013022|FG001|Treatment Period|Other Reason|0|||
145590549|NCT03349710|525013023|FG002|Treatment Period|Other Reason|2|||
145590550|NCT03349710|525013024|FG003|Treatment Period|Other Reason|1|||
145590551|NCT03349710|525013021|FG000|Treatment Period|completed|6|||
145590552|NCT03349710|525013022|FG001|Treatment Period|completed|0|||
145590553|NCT03349710|525013023|FG002|Treatment Period|completed|18|||
145590554|NCT03349710|525013024|FG003|Treatment Period|completed|1|||
145458197|NCT01271712|524529251|FG000|Open Label Treatment|Withdrawal by Subject|6|||
145458198|NCT01271712|524529252|FG001|Open Label Treatment|Withdrawal by Subject|11|||
145458199|NCT01271712|524529251|FG000|Open Label Treatment|Physician Decision|2|||
145458200|NCT01271712|524529252|FG001|Open Label Treatment|Physician Decision|0|||
145458201|NCT01271712|524529251|FG000|Open Label Treatment|Adverse Event|14|||
145458202|NCT01271712|524529252|FG001|Open Label Treatment|Adverse Event|8|||
145458203|NCT01271712|524529251|FG000|Open Label Treatment|Progressive disease|59|||
145458204|NCT01271712|524529252|FG001|Open Label Treatment|Progressive disease|32|||
145458205|NCT01271712|524529251|FG000|Open Label Treatment|transferred to rollover study|1|||
145458206|NCT01271712|524529252|FG001|Open Label Treatment|transferred to rollover study|0|||
145458207|NCT01271712|524529251|FG000|Open Label Treatment|Non-compliance with study drug|1|||
145458208|NCT01271712|524529252|FG001|Open Label Treatment|Non-compliance with study drug|0|||
145458209|NCT01271712|524529251|FG000|Open Label Treatment|Protocol Violation|0|||
145458210|NCT01271712|524529252|FG001|Open Label Treatment|Protocol Violation|1|||
145458211|NCT01271712|524529251|FG000|Open Label Treatment|Switching to other therapy|2|||
145458212|NCT01271712|524529252|FG001|Open Label Treatment|Switching to other therapy|1|||
145458213|NCT01271712|524529251|FG000|Safety Follow-up|Death|11|||
145458214|NCT01271712|524529252|FG001|Safety Follow-up|Death|7|||
145458215|NCT01271712|524529251|FG000|Safety Follow-up|Withdrawal by Subject|4|||
145458216|NCT01271712|524529252|FG001|Safety Follow-up|Withdrawal by Subject|2|||
145458217|NCT01271712|524529251|FG000|Safety Follow-up|Protocol Violation|1|||
145458218|NCT01271712|524529252|FG001|Safety Follow-up|Protocol Violation|1|||
145458219|NCT01271712|524529251|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
145458220|NCT01271712|524529252|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
145458221|NCT01271712|524529251|FG000|Safety Follow-up|No follow-up|1|||
145458222|NCT01271712|524529252|FG001|Safety Follow-up|No follow-up|1|||
145458223|NCT01271712|524529251|FG000|Safety Follow-up|Progressive disease|1|||
145458224|NCT01271712|524529252|FG001|Safety Follow-up|Progressive disease|0|||
145458225|NCT01271712|524529251|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
145458226|NCT01271712|524529252|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
145458227|NCT03099174|524529253|FG000|Overall Study|Withdrawal by Subject|0|||
145458228|NCT03099174|524529254|FG001|Overall Study|Withdrawal by Subject|0|||
145458229|NCT03099174|524529255|FG002|Overall Study|Withdrawal by Subject|1|||
145458230|NCT03099174|524529256|FG003|Overall Study|Withdrawal by Subject|0|||
145458231|NCT03099174|524529257|FG004|Overall Study|Withdrawal by Subject|2|||
145458232|NCT03099174|524529258|FG005|Overall Study|Withdrawal by Subject|2|||
145458233|NCT03099174|524529259|FG006|Overall Study|Withdrawal by Subject|1|||
145458234|NCT03099174|524529260|FG007|Overall Study|Withdrawal by Subject|4|||
145458235|NCT03099174|524529253|FG000|Overall Study|Adverse Event|0|||
145458236|NCT03099174|524529254|FG001|Overall Study|Adverse Event|1|||
145458237|NCT03099174|524529255|FG002|Overall Study|Adverse Event|1|||
145458238|NCT03099174|524529256|FG003|Overall Study|Adverse Event|2|||
145458239|NCT03099174|524529257|FG004|Overall Study|Adverse Event|5|||
145458240|NCT03099174|524529258|FG005|Overall Study|Adverse Event|3|||
145458241|NCT03099174|524529259|FG006|Overall Study|Adverse Event|6|||
145458242|NCT03099174|524529260|FG007|Overall Study|Adverse Event|4|||
145458243|NCT03099174|524529253|FG000|Overall Study|Other than listed|6|||
145458244|NCT03099174|524529254|FG001|Overall Study|Other than listed|6|||
145458245|NCT03099174|524529255|FG002|Overall Study|Other than listed|5|||
145458246|NCT03099174|524529256|FG003|Overall Study|Other than listed|6|||
145458247|NCT03099174|524529257|FG004|Overall Study|Other than listed|19|||
145458248|NCT03099174|524529258|FG005|Overall Study|Other than listed|10|||
145590555|NCT03349710|525013021|FG000|Treatment Period|participant request to discontinue|0|||
145590556|NCT03349710|525013022|FG001|Treatment Period|participant request to discontinue|0|||
145590557|NCT03349710|525013023|FG002|Treatment Period|participant request to discontinue|4|||
145590558|NCT03349710|525013024|FG003|Treatment Period|participant request to discontinue|0|||
145590559|NCT03349710|525013021|FG000|Treatment Period|participant withdrew consent|1|||
145590560|NCT03349710|525013022|FG001|Treatment Period|participant withdrew consent|0|||
145590561|NCT03349710|525013023|FG002|Treatment Period|participant withdrew consent|0|||
145590562|NCT03349710|525013024|FG003|Treatment Period|participant withdrew consent|0|||
145590563|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
145590564|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
145590565|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
145590566|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
145590567|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
145590568|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
145590569|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
145458249|NCT03099174|524529259|FG006|Overall Study|Other than listed|26|||
145458250|NCT03099174|524529260|FG007|Overall Study|Other than listed|23|||
145458251|NCT02118766|524529262|FG000|Overall Study|Adverse Event|7|||
145590570|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
145458252|NCT02118766|524529263|FG001|Overall Study|Adverse Event|2|||
145458253|NCT02118766|524529262|FG000|Overall Study|Withdrawal by Subject|3|||
145590571|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
145590572|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
145590573|NCT00695903|525013025|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
145590574|NCT00695903|525013026|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
145590575|NCT00695903|525013025|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
145590576|NCT00695903|525013026|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
145590577|NCT00695903|525013025|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
145590578|NCT00695903|525013026|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
145590579|NCT00695903|525013025|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
145590580|NCT00695903|525013026|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
145590581|NCT02696317|525013027|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
145590582|NCT02696317|525013028|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
145590583|NCT02696317|525013027|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
145590584|NCT02696317|525013028|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
145590585|NCT01343368|525013029|FG000|Overall Study|Death|1|||
145590586|NCT01343368|525013030|FG001|Overall Study|Death|0|||
145590587|NCT01343368|525013029|FG000|Overall Study|Lost to Follow-up|1|||
145590588|NCT01343368|525013030|FG001|Overall Study|Lost to Follow-up|0|||
145590589|NCT01296568|525013033|FG000|Continued Access Phase|Lost to Follow-up|1|||
145590590|NCT01296568|525013033|FG000|Continued Access Phase|Withdrawal by Subject|1|||
145590591|NCT01296568|525013033|FG000|Continued Access Phase|Disease Progression|1|||
145590592|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
145590593|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
145590594|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
145590595|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
145590596|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
145590597|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
145590598|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
145590599|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
145590600|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
145590601|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
145590602|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
145590603|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
145458254|NCT02118766|524529263|FG001|Overall Study|Withdrawal by Subject|6|||
145458255|NCT02118766|524529262|FG000|Overall Study|Lost to Follow-up|5|||
145458256|NCT02118766|524529263|FG001|Overall Study|Lost to Follow-up|4|||
145458257|NCT02118766|524529262|FG000|Overall Study|Withdrawal by parent/guardian|12|||
145458258|NCT02118766|524529263|FG001|Overall Study|Withdrawal by parent/guardian|18|||
145458259|NCT02118766|524529262|FG000|Overall Study|Other|3|||
145458260|NCT02118766|524529263|FG001|Overall Study|Other|1|||
145458261|NCT03941964|524529264|FG000|Overall Study|Adverse Event|1|||
145458262|NCT03941964|524529265|FG001|Overall Study|Adverse Event|8|||
145458263|NCT03941964|524529264|FG000|Overall Study|Progressive disease|7|||
145458264|NCT03941964|524529265|FG001|Overall Study|Progressive disease|3|||
145458265|NCT03941964|524529264|FG000|Overall Study|Lack of Efficacy|0|||
145458266|NCT03941964|524529265|FG001|Overall Study|Lack of Efficacy|1|||
145458267|NCT03941964|524529264|FG000|Overall Study|Death|3|||
145458268|NCT03941964|524529265|FG001|Overall Study|Death|1|||
145458269|NCT03941964|524529264|FG000|Overall Study|Withdrew consent|1|||
145458270|NCT03941964|524529265|FG001|Overall Study|Withdrew consent|3|||
145458271|NCT03941964|524529264|FG000|Overall Study|Physician Decision|9|||
145458272|NCT03941964|524529265|FG001|Overall Study|Physician Decision|2|||
145458273|NCT03941964|524529264|FG000|Overall Study|Other, not specified|2|||
145458274|NCT03941964|524529265|FG001|Overall Study|Other, not specified|1|||
145458275|NCT00118846|524529268|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
145458276|NCT00118846|524529269|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
145458277|NCT00118846|524529268|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
145458278|NCT00118846|524529269|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
145458279|NCT00118846|524529268|FG000|Overall Study|Physician Decision|1|||
145458280|NCT00118846|524529269|FG001|Overall Study|Physician Decision|0|||
145458281|NCT00118846|524529268|FG000|Overall Study|Medical condition|2|||
145590604|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
145458282|NCT00118846|524529269|FG001|Overall Study|Medical condition|2|||
145458283|NCT00118846|524529268|FG000|Overall Study|Lost to Follow-up|0|||
145458284|NCT00118846|524529269|FG001|Overall Study|Lost to Follow-up|2|||
145458285|NCT00118846|524529268|FG000|Overall Study|Personal reason|4|||
145458286|NCT00118846|524529269|FG001|Overall Study|Personal reason|5|||
145458287|NCT00541866|524529272|FG000|Overall Study|Adverse Event|3|||
145590605|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
145590606|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
145626706|NCT02282527|525145772|FG001|Overall Study|Lost to Follow-up|1|||
145458288|NCT00541866|524529273|FG001|Overall Study|Adverse Event|0|||
145458289|NCT00541866|524529274|FG002|Overall Study|Adverse Event|0|||
145458290|NCT00541866|524529275|FG003|Overall Study|Adverse Event|0|||
145458291|NCT00541866|524529276|FG004|Overall Study|Adverse Event|0|||
145458292|NCT00541866|524529272|FG000|Overall Study|Death|1|||
145458293|NCT00541866|524529273|FG001|Overall Study|Death|0|||
145458294|NCT00541866|524529274|FG002|Overall Study|Death|0|||
145458295|NCT00541866|524529275|FG003|Overall Study|Death|0|||
145458296|NCT00541866|524529276|FG004|Overall Study|Death|0|||
145458297|NCT00541866|524529272|FG000|Overall Study|Lack of Efficacy|19|||
145458298|NCT00541866|524529273|FG001|Overall Study|Lack of Efficacy|15|||
145458299|NCT00541866|524529274|FG002|Overall Study|Lack of Efficacy|10|||
145458300|NCT00541866|524529275|FG003|Overall Study|Lack of Efficacy|12|||
145458301|NCT00541866|524529276|FG004|Overall Study|Lack of Efficacy|14|||
145458302|NCT00541866|524529272|FG000|Overall Study|Not Reported or Other|11|||
145458303|NCT00541866|524529273|FG001|Overall Study|Not Reported or Other|3|||
145458304|NCT00541866|524529274|FG002|Overall Study|Not Reported or Other|3|||
145590607|NCT01571362|525013037|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
145590608|NCT01571362|525013038|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
145590609|NCT01571362|525013039|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
145590610|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145590611|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
145590612|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
145590613|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145590614|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
145590615|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
145590616|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145590617|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Adverse Event|9|||
145590618|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Adverse Event|14|||
145590619|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145590620|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
145590621|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
145590622|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
145590623|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
145590624|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
145590625|NCT01571362|525013037|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
145590626|NCT01571362|525013038|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
145590627|NCT01571362|525013039|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
145590628|NCT03117738|525013040|FG000|Overall Study|Withdrawal by Subject|3|||
145590629|NCT03117738|525013041|FG001|Overall Study|Withdrawal by Subject|1|||
145590630|NCT03117738|525013040|FG000|Overall Study|Lost to Follow-up|1|||
145590631|NCT03117738|525013041|FG001|Overall Study|Lost to Follow-up|4|||
145590632|NCT01669629|525013042|FG000|Period 1|protocol deviation|1|||
145458305|NCT00541866|524529275|FG003|Overall Study|Not Reported or Other|3|||
145458306|NCT00541866|524529276|FG004|Overall Study|Not Reported or Other|1|||
145458307|NCT00541866|524529272|FG000|Overall Study|Physician Decision|0|||
145458308|NCT00541866|524529273|FG001|Overall Study|Physician Decision|0|||
145458309|NCT00541866|524529274|FG002|Overall Study|Physician Decision|2|||
145458310|NCT00541866|524529275|FG003|Overall Study|Physician Decision|1|||
145458311|NCT00541866|524529276|FG004|Overall Study|Physician Decision|0|||
145458312|NCT04669262|524529277|FG000|Overall Study|Withdrawal by Subject|0|||
145458313|NCT04669262|524529278|FG001|Overall Study|Withdrawal by Subject|0|||
145458314|NCT04669262|524529279|FG002|Overall Study|Withdrawal by Subject|0|||
145458315|NCT04669262|524529280|FG003|Overall Study|Withdrawal by Subject|1|||
145458316|NCT04669262|524529277|FG000|Overall Study|Randomized but Not Treated|0|||
145458317|NCT04669262|524529278|FG001|Overall Study|Randomized but Not Treated|1|||
145458318|NCT04669262|524529279|FG002|Overall Study|Randomized but Not Treated|0|||
145458319|NCT04669262|524529280|FG003|Overall Study|Randomized but Not Treated|0|||
145458320|NCT05463744|524529282|FG000|Treatment Period|Withdrawal by Subject|19|||
145458321|NCT05463744|524529283|FG001|Treatment Period|Withdrawal by Subject|16|||
145458322|NCT05463744|524529282|FG000|Treatment Period|Adverse Event|4|||
145626707|NCT02282527|525145771|FG000|Overall Study|Lack of home health aid|1|||
145626708|NCT02282527|525145772|FG001|Overall Study|Lack of home health aid|0|||
145626709|NCT01872611|525145773|FG000|Overall Study|Adverse Event|3|||
145458323|NCT05463744|524529283|FG001|Treatment Period|Adverse Event|4|||
145590633|NCT01669629|525013043|FG001|Period 1|protocol deviation|2|||
145590634|NCT01221597|525013044|FG000|Overall Study|Adverse Event|4|||
145458324|NCT05463744|524529282|FG000|Treatment Period|Pregnancy|0|||
145458325|NCT05463744|524529283|FG001|Treatment Period|Pregnancy|3|||
145458326|NCT05463744|524529282|FG000|Treatment Period|Lost to Follow-up|1|||
145458327|NCT05463744|524529283|FG001|Treatment Period|Lost to Follow-up|3|||
145458328|NCT05463744|524529282|FG000|Treatment Period|Inadvertent enrollment|2|||
145458329|NCT05463744|524529283|FG001|Treatment Period|Inadvertent enrollment|1|||
145590635|NCT01221597|525013045|FG001|Overall Study|Adverse Event|1|||
145458330|NCT05463744|524529282|FG000|Treatment Period|Death|0|||
145458331|NCT05463744|524529283|FG001|Treatment Period|Death|1|||
145590636|NCT01221597|525013044|FG000|Overall Study|Withdrawal by Subject|20|||
145590637|NCT01221597|525013045|FG001|Overall Study|Withdrawal by Subject|6|||
145590638|NCT01221597|525013044|FG000|Overall Study|Lost to Follow-up|6|||
145590639|NCT01221597|525013045|FG001|Overall Study|Lost to Follow-up|5|||
145590640|NCT01221597|525013044|FG000|Overall Study|Protocol Violation|1|||
145590641|NCT01221597|525013045|FG001|Overall Study|Protocol Violation|0|||
145590642|NCT01221597|525013044|FG000|Overall Study|Other|3|||
145590643|NCT01221597|525013045|FG001|Overall Study|Other|4|||
145590644|NCT01221597|525013044|FG000|Overall Study|Death|2|||
145590645|NCT01221597|525013045|FG001|Overall Study|Death|0|||
145590646|NCT04420689|525013047|FG000|Overall Study|COVID-19 related hospitalization|0|||
145590647|NCT04420689|525013048|FG001|Overall Study|COVID-19 related hospitalization|0|||
145590648|NCT04420689|525013049|FG002|Overall Study|COVID-19 related hospitalization|0|||
145590649|NCT04420689|525013050|FG003|Overall Study|COVID-19 related hospitalization|0|||
145590650|NCT04420689|525013051|FG004|Overall Study|COVID-19 related hospitalization|1|||
145590651|NCT04420689|525013052|FG005|Overall Study|COVID-19 related hospitalization|0|||
145590652|NCT04420689|525013053|FG006|Overall Study|COVID-19 related hospitalization|0|||
145590653|NCT04420689|525013047|FG000|Overall Study|Physician Decision|0|||
145590654|NCT04420689|525013048|FG001|Overall Study|Physician Decision|0|||
145590655|NCT04420689|525013049|FG002|Overall Study|Physician Decision|0|||
145590656|NCT04420689|525013050|FG003|Overall Study|Physician Decision|0|||
145590657|NCT04420689|525013051|FG004|Overall Study|Physician Decision|0|||
145590658|NCT04420689|525013052|FG005|Overall Study|Physician Decision|1|||
145590659|NCT04420689|525013053|FG006|Overall Study|Physician Decision|0|||
145590660|NCT01292928|525013063|FG000|Overall Study|Death|8|||
145590661|NCT01292928|525013063|FG000|Overall Study|Withdrawal by Subject|8|||
145590662|NCT01292928|525013063|FG000|Overall Study|Lost to Follow-up|6|||
145590663|NCT01292928|525013063|FG000|Overall Study|Physician Decision|2|||
145590664|NCT01519206|525013064|FG000|Overall Study|Lost to Follow-up|3|||
145590665|NCT01519206|525013064|FG000|Overall Study|Missed Visit|2|||
145590666|NCT04349553|525013068|FG000|Overall Study|Withdrawal by Subject|1|||
145590667|NCT04349553|525013069|FG001|Overall Study|Withdrawal by Subject|0|||
145590668|NCT04349553|525013070|FG002|Overall Study|Withdrawal by Subject|1|||
145590669|NCT04349553|525013071|FG003|Overall Study|Withdrawal by Subject|0|||
145590670|NCT03526250|525013072|FG000|Overall Study|Adverse Event|4|||
145590671|NCT03526250|525013072|FG000|Overall Study|Progressive Disease|16|||
145590672|NCT03526250|525013072|FG000|Overall Study|No Treatment|3|||
145590673|NCT04420221|525013073|FG000|Overall Study|Withdrawal by Subject|0|||
145590674|NCT04420221|525013074|FG001|Overall Study|Withdrawal by Subject|0|||
145590675|NCT04420221|525013075|FG002|Overall Study|Withdrawal by Subject|0|||
145590676|NCT04420221|525013076|FG003|Overall Study|Withdrawal by Subject|0|||
145590677|NCT04420221|525013077|FG004|Overall Study|Withdrawal by Subject|0|||
145590678|NCT04420221|525013078|FG005|Overall Study|Withdrawal by Subject|20|||
145590679|NCT04420221|525013079|FG006|Overall Study|Withdrawal by Subject|5|||
145590680|NCT04420221|525013073|FG000|Overall Study|Other|0|||
145590681|NCT04420221|525013074|FG001|Overall Study|Other|0|||
145590682|NCT04420221|525013075|FG002|Overall Study|Other|0|||
145590683|NCT04420221|525013076|FG003|Overall Study|Other|0|||
145590684|NCT04420221|525013077|FG004|Overall Study|Other|0|||
145590685|NCT04420221|525013078|FG005|Overall Study|Other|1|||
145590686|NCT04420221|525013079|FG006|Overall Study|Other|1|||
145590687|NCT04420221|525013073|FG000|Overall Study|Lost to Follow-up|0|||
145590688|NCT04420221|525013074|FG001|Overall Study|Lost to Follow-up|0|||
145590689|NCT04420221|525013075|FG002|Overall Study|Lost to Follow-up|0|||
145590690|NCT04420221|525013076|FG003|Overall Study|Lost to Follow-up|0|||
145590691|NCT04420221|525013077|FG004|Overall Study|Lost to Follow-up|0|||
145590692|NCT04420221|525013078|FG005|Overall Study|Lost to Follow-up|3|||
145590693|NCT04420221|525013079|FG006|Overall Study|Lost to Follow-up|2|||
145590694|NCT04420221|525013073|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
145590695|NCT04420221|525013074|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
145590696|NCT04420221|525013075|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
145590697|NCT04420221|525013076|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
145590698|NCT04420221|525013077|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
145590699|NCT04420221|525013078|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
145590700|NCT04420221|525013079|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
145590701|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
145626710|NCT01872611|525145774|FG001|Overall Study|Adverse Event|1|||
145626711|NCT01872611|525145773|FG000|Overall Study|Adverse Event, prior to treatment|0|||
145626712|NCT01872611|525145774|FG001|Overall Study|Adverse Event, prior to treatment|1|||
145626713|NCT01872611|525145773|FG000|Overall Study|Death|0|||
145626714|NCT01872611|525145774|FG001|Overall Study|Death|1|||
145626715|NCT01872611|525145773|FG000|Overall Study|Death, prior to treatment|0|||
145590702|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
145590703|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
145626716|NCT01872611|525145774|FG001|Overall Study|Death, prior to treatment|1|||
145590704|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
145590705|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
145590706|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
145590707|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
145590708|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
145590709|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
145590710|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
145590711|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
145590712|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
145590713|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
145590714|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
145590715|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
145590716|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
145590717|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
145590718|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
145590719|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
145590720|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
145590721|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
145590722|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
145590723|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
145590724|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
145590725|NCT01715805|525013080|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
145590726|NCT01715805|525013081|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
145590727|NCT01715805|525013082|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
145590728|NCT01715805|525013083|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
145590729|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
145590730|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
145590731|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
145590732|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
145590733|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
145590734|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
145590735|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
145590736|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
145590737|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
145590738|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
145590739|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
145590740|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
145590741|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
145590742|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
145590743|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
145590744|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
145590745|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
145590746|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
145590747|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
145590748|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
145590749|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
145590750|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
145590751|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
145590752|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
145590753|NCT01715805|525013080|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
145590754|NCT01715805|525013081|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
145590755|NCT01715805|525013082|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
145590756|NCT01715805|525013083|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
145590757|NCT02647359|525013086|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
145590758|NCT02647359|525013087|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
145590759|NCT02647359|525013086|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
145590760|NCT02647359|525013087|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
145590761|NCT02647359|525013086|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
145590762|NCT02647359|525013087|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
145590763|NCT02647359|525013086|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
145590764|NCT02647359|525013087|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
145590765|NCT02647359|525013086|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
145590766|NCT02647359|525013087|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
145590767|NCT02647359|525013086|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
145590768|NCT02647359|525013087|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
145626717|NCT01872611|525145773|FG000|Overall Study|Lost to Follow-up|8|||
145626718|NCT01872611|525145774|FG001|Overall Study|Lost to Follow-up|1|||
145590769|NCT00511004|525013088|FG000|Overall Study|Lost to Follow-up|0|||
145590770|NCT00511004|525013089|FG001|Overall Study|Lost to Follow-up|0|||
145590771|NCT00511004|525013090|FG002|Overall Study|Lost to Follow-up|4|||
145590772|NCT04642638|525013091|FG000|Overall Study|Withdrawal by Subject|23|||
145590773|NCT04642638|525013092|FG001|Overall Study|Withdrawal by Subject|29|||
145590774|NCT04642638|525013093|FG002|Overall Study|Withdrawal by Subject|9|||
145590775|NCT04642638|525013094|FG003|Overall Study|Withdrawal by Subject|7|||
145590776|NCT04642638|525013095|FG004|Overall Study|Withdrawal by Subject|61|||
145590777|NCT04642638|525013096|FG005|Overall Study|Withdrawal by Subject|27|||
145590778|NCT04642638|525013091|FG000|Overall Study|Lost to Follow-up|17|||
145590779|NCT04642638|525013092|FG001|Overall Study|Lost to Follow-up|18|||
145590780|NCT04642638|525013093|FG002|Overall Study|Lost to Follow-up|5|||
145590781|NCT04642638|525013094|FG003|Overall Study|Lost to Follow-up|5|||
145590782|NCT04642638|525013095|FG004|Overall Study|Lost to Follow-up|6|||
145590783|NCT04642638|525013096|FG005|Overall Study|Lost to Follow-up|3|||
145590784|NCT04642638|525013091|FG000|Overall Study|Adverse Event|0|||
145590785|NCT04642638|525013092|FG001|Overall Study|Adverse Event|0|||
145590786|NCT04642638|525013093|FG002|Overall Study|Adverse Event|1|||
145590787|NCT04642638|525013094|FG003|Overall Study|Adverse Event|0|||
145590788|NCT04642638|525013095|FG004|Overall Study|Adverse Event|10|||
145590789|NCT04642638|525013096|FG005|Overall Study|Adverse Event|3|||
145590790|NCT04642638|525013091|FG000|Overall Study|Reason Not Specified|1|||
145590791|NCT04642638|525013092|FG001|Overall Study|Reason Not Specified|4|||
145590792|NCT04642638|525013093|FG002|Overall Study|Reason Not Specified|0|||
145590793|NCT04642638|525013094|FG003|Overall Study|Reason Not Specified|0|||
145590794|NCT04642638|525013095|FG004|Overall Study|Reason Not Specified|38|||
145590795|NCT04642638|525013096|FG005|Overall Study|Reason Not Specified|16|||
145590796|NCT04642638|525013091|FG000|Overall Study|Physician Decision|0|||
145590797|NCT04642638|525013092|FG001|Overall Study|Physician Decision|0|||
145590798|NCT04642638|525013093|FG002|Overall Study|Physician Decision|0|||
145590799|NCT04642638|525013094|FG003|Overall Study|Physician Decision|0|||
145590800|NCT04642638|525013095|FG004|Overall Study|Physician Decision|2|||
145590801|NCT04642638|525013096|FG005|Overall Study|Physician Decision|1|||
145590802|NCT04642638|525013091|FG000|Overall Study|Protocol Deviation|0|||
145590803|NCT04642638|525013092|FG001|Overall Study|Protocol Deviation|0|||
145590804|NCT04642638|525013093|FG002|Overall Study|Protocol Deviation|0|||
145458332|NCT05463744|524529282|FG000|Treatment Period|Non-compliance with Study Drug|1|||
145458333|NCT05463744|524529283|FG001|Treatment Period|Non-compliance with Study Drug|0|||
145458334|NCT05463744|524529282|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
145458335|NCT05463744|524529283|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
145458336|NCT05463744|524529282|FG000|Treatment Period|Physician Decision|0|||
145458337|NCT05463744|524529283|FG001|Treatment Period|Physician Decision|1|||
145458338|NCT05463744|524529282|FG000|Follow-Up Period|Withdrawal by Subject|3|||
145458339|NCT05463744|524529283|FG001|Follow-Up Period|Withdrawal by Subject|1|||
145458340|NCT05463744|524529282|FG000|Follow-Up Period|Lost to Follow-up|1|||
145458341|NCT05463744|524529283|FG001|Follow-Up Period|Lost to Follow-up|1|||
145458342|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
145458343|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
145458344|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Death|1|||
145458345|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Death|0|||
145458346|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
145458347|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
145458348|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
145458349|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
145458350|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
145590805|NCT04642638|525013094|FG003|Overall Study|Protocol Deviation|0|||
145590806|NCT04642638|525013095|FG004|Overall Study|Protocol Deviation|1|||
145590807|NCT04642638|525013096|FG005|Overall Study|Protocol Deviation|3|||
145590808|NCT04642638|525013091|FG000|Overall Study|Study Terminated|0|||
145458351|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
145458352|NCT00350272|524529284|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
145458353|NCT00350272|524529285|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
145458354|NCT00350272|524529284|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
145458355|NCT00350272|524529285|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
145458356|NCT00350272|524529284|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
145458357|NCT00350272|524529285|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
145458358|NCT00350272|524529284|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
145590809|NCT04642638|525013092|FG001|Overall Study|Study Terminated|0|||
145458359|NCT00350272|524529285|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
145590810|NCT04642638|525013093|FG002|Overall Study|Study Terminated|0|||
145590811|NCT04642638|525013094|FG003|Overall Study|Study Terminated|0|||
145458360|NCT00350272|524529284|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
145458361|NCT00350272|524529285|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
145458362|NCT00350272|524529284|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
145590812|NCT04642638|525013095|FG004|Overall Study|Study Terminated|484|||
145590813|NCT04642638|525013096|FG005|Overall Study|Study Terminated|250|||
145458363|NCT00350272|524529285|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
145590814|NCT04642638|525013091|FG000|Overall Study|Pregnancy|0|||
145590815|NCT04642638|525013092|FG001|Overall Study|Pregnancy|0|||
145590816|NCT04642638|525013093|FG002|Overall Study|Pregnancy|0|||
145590817|NCT04642638|525013094|FG003|Overall Study|Pregnancy|0|||
145590818|NCT04642638|525013095|FG004|Overall Study|Pregnancy|1|||
145590819|NCT04642638|525013096|FG005|Overall Study|Pregnancy|0|||
145590820|NCT00990652|525013097|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
145590821|NCT00990652|525013097|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
145590822|NCT01672801|525013098|FG000|Overall Study|Screen Failure|0|||
145590823|NCT01672801|525013099|FG001|Overall Study|Screen Failure|1|||
145590824|NCT02384954|525013106|FG000|Phase 1|Progressive Disease|2|||
145590825|NCT02384954|525013107|FG001|Phase 1|Progressive Disease|0|||
145590826|NCT02384954|525013108|FG002|Phase 1|Progressive Disease|1|||
145590827|NCT02384954|525013109|FG003|Phase 1|Progressive Disease|1|||
145590828|NCT02384954|525013110|FG004|Phase 1|Progressive Disease|0|||
145590829|NCT02384954|525013111|FG005|Phase 1|Progressive Disease|0|||
145590830|NCT02384954|525013112|FG006|Phase 1|Progressive Disease|0|||
145590831|NCT02384954|525013113|FG007|Phase 1|Progressive Disease|0|||
145590832|NCT02384954|525013114|FG008|Phase 1|Progressive Disease|0|||
145590833|NCT02384954|525013106|FG000|Phase 1|Adverse Event|0|||
145590834|NCT02384954|525013107|FG001|Phase 1|Adverse Event|0|||
145590835|NCT02384954|525013108|FG002|Phase 1|Adverse Event|1|||
145590836|NCT02384954|525013109|FG003|Phase 1|Adverse Event|0|||
145590837|NCT02384954|525013110|FG004|Phase 1|Adverse Event|0|||
145590838|NCT02384954|525013111|FG005|Phase 1|Adverse Event|0|||
145590839|NCT02384954|525013112|FG006|Phase 1|Adverse Event|0|||
145590840|NCT02384954|525013113|FG007|Phase 1|Adverse Event|0|||
145590841|NCT02384954|525013114|FG008|Phase 1|Adverse Event|0|||
145590842|NCT02384954|525013106|FG000|Phase 2|Progressive Disease|0|||
145590843|NCT02384954|525013107|FG001|Phase 2|Progressive Disease|0|||
145590844|NCT02384954|525013108|FG002|Phase 2|Progressive Disease|0|||
145590845|NCT02384954|525013109|FG003|Phase 2|Progressive Disease|0|||
145590846|NCT02384954|525013110|FG004|Phase 2|Progressive Disease|0|||
145590847|NCT02384954|525013111|FG005|Phase 2|Progressive Disease|0|||
145590848|NCT02384954|525013112|FG006|Phase 2|Progressive Disease|0|||
145590849|NCT02384954|525013113|FG007|Phase 2|Progressive Disease|1|||
145590850|NCT02384954|525013114|FG008|Phase 2|Progressive Disease|2|||
145590851|NCT02384954|525013106|FG000|Phase 2|Adverse Event|0|||
145590852|NCT02384954|525013107|FG001|Phase 2|Adverse Event|0|||
145590853|NCT02384954|525013108|FG002|Phase 2|Adverse Event|0|||
145590854|NCT02384954|525013109|FG003|Phase 2|Adverse Event|0|||
145590855|NCT02384954|525013110|FG004|Phase 2|Adverse Event|0|||
145590856|NCT02384954|525013111|FG005|Phase 2|Adverse Event|0|||
145590857|NCT02384954|525013112|FG006|Phase 2|Adverse Event|0|||
145590858|NCT02384954|525013113|FG007|Phase 2|Adverse Event|1|||
145590859|NCT02384954|525013114|FG008|Phase 2|Adverse Event|1|||
145590860|NCT02384954|525013106|FG000|Phase 2|Failure to meet continuation criteria|0|||
145590861|NCT02384954|525013107|FG001|Phase 2|Failure to meet continuation criteria|0|||
145590862|NCT02384954|525013108|FG002|Phase 2|Failure to meet continuation criteria|0|||
145590863|NCT02384954|525013109|FG003|Phase 2|Failure to meet continuation criteria|0|||
145590864|NCT02384954|525013110|FG004|Phase 2|Failure to meet continuation criteria|0|||
145590865|NCT02384954|525013111|FG005|Phase 2|Failure to meet continuation criteria|0|||
145590866|NCT02384954|525013112|FG006|Phase 2|Failure to meet continuation criteria|0|||
145590867|NCT02384954|525013113|FG007|Phase 2|Failure to meet continuation criteria|1|||
145590868|NCT02384954|525013114|FG008|Phase 2|Failure to meet continuation criteria|0|||
145590869|NCT03595904|525013120|FG000|Overall Study|Protocol Violation|3|||
145590870|NCT03595904|525013121|FG001|Overall Study|Protocol Violation|1|||
145590871|NCT03595904|525013120|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
145590872|NCT03595904|525013121|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
145590873|NCT03595904|525013120|FG000|Overall Study|Insurance complications|1|||
145590874|NCT03595904|525013121|FG001|Overall Study|Insurance complications|0|||
145590875|NCT03595904|525013120|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
145458364|NCT00098748|524529287|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
145458365|NCT00098748|524529288|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
145458366|NCT00098748|524529289|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
145458367|NCT00098748|524529287|FG000|Received Study Treatment|Death|2|||
145590876|NCT03595904|525013121|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
145590877|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
145590878|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
145590879|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
145590880|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
145458368|NCT00098748|524529288|FG001|Received Study Treatment|Death|1|||
145590881|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
145590882|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
145590883|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
145590884|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
145626719|NCT01872611|525145773|FG000|Overall Study|Physician Decision|1|||
145626720|NCT01872611|525145774|FG001|Overall Study|Physician Decision|0|||
145626721|NCT01872611|525145773|FG000|Overall Study|Withdrawal by Subject|6|||
145626722|NCT01872611|525145774|FG001|Overall Study|Withdrawal by Subject|1|||
145626723|NCT01872611|525145773|FG000|Overall Study|Reason not provided|6|||
145626724|NCT01872611|525145774|FG001|Overall Study|Reason not provided|6|||
145626725|NCT03537651|525145775|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
145626726|NCT03537651|525145775|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
145626727|NCT03537651|525145775|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
145626728|NCT03537651|525145775|FG000|Part A (Up to 96 Weeks)|Other|1|||
145626729|NCT03537651|525145775|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
145626730|NCT03537651|525145775|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
145626731|NCT03537651|525145775|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
145626732|NCT03537651|525145775|FG000|Part B (Up to 192 Weeks)|Other|1|||
145626733|NCT01076335|525145776|FG000|Overall Study|Withdrawal by Subject|3|||
145626734|NCT01076335|525145776|FG000|Overall Study|Withdrawal without treatment|1|||
145626735|NCT02939183|525145777|FG000|Overall Study|Death|0|||
145626736|NCT02939183|525145778|FG001|Overall Study|Death|0|||
145626737|NCT02939183|525145779|FG002|Overall Study|Death|1|||
145626738|NCT02939183|525145780|FG003|Overall Study|Death|0|||
145626739|NCT02939183|525145781|FG004|Overall Study|Death|0|||
145458369|NCT00098748|524529289|FG002|Received Study Treatment|Death|2|||
145458370|NCT00098748|524529287|FG000|Received Study Treatment|Adverse Event|1|||
145458371|NCT00098748|524529288|FG001|Received Study Treatment|Adverse Event|2|||
145458372|NCT00098748|524529289|FG002|Received Study Treatment|Adverse Event|5|||
145458373|NCT00098748|524529287|FG000|Received Study Treatment|Lack of Efficacy|40|||
145458374|NCT00098748|524529288|FG001|Received Study Treatment|Lack of Efficacy|27|||
145458375|NCT00098748|524529289|FG002|Received Study Treatment|Lack of Efficacy|27|||
145458376|NCT00098748|524529287|FG000|Received Study Treatment|Other|2|||
145590885|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
145590886|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
145590887|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
145590888|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
145590889|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
145590890|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
145590891|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
145590892|NCT00355082|525013122|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
145590893|NCT00355082|525013123|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
145590894|NCT00355082|525013124|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
145590895|NCT00355082|525013122|FG000|Continuation Phase|Adverse Event|2|||
145590896|NCT00355082|525013123|FG001|Continuation Phase|Adverse Event|0|||
145590897|NCT00355082|525013124|FG002|Continuation Phase|Adverse Event|1|||
145590898|NCT00355082|525013122|FG000|Continuation Phase|Lost to Follow-up|2|||
145590899|NCT00355082|525013123|FG001|Continuation Phase|Lost to Follow-up|0|||
145590900|NCT00355082|525013124|FG002|Continuation Phase|Lost to Follow-up|1|||
145590901|NCT00355082|525013122|FG000|Continuation Phase|Protocol Violation|1|||
145590902|NCT00355082|525013123|FG001|Continuation Phase|Protocol Violation|0|||
145590903|NCT00355082|525013124|FG002|Continuation Phase|Protocol Violation|1|||
145590904|NCT00355082|525013122|FG000|Continuation Phase|Withdrawal by Subject|4|||
145590905|NCT00355082|525013123|FG001|Continuation Phase|Withdrawal by Subject|0|||
145590906|NCT00355082|525013124|FG002|Continuation Phase|Withdrawal by Subject|0|||
145590907|NCT00355082|525013122|FG000|Continuation Phase|Lack of Efficacy|5|||
145590908|NCT00355082|525013123|FG001|Continuation Phase|Lack of Efficacy|0|||
145590909|NCT00355082|525013124|FG002|Continuation Phase|Lack of Efficacy|0|||
145590910|NCT00355082|525013122|FG000|Continuation Phase|Site Closed by Sponsor|8|||
145590911|NCT00355082|525013123|FG001|Continuation Phase|Site Closed by Sponsor|0|||
145590912|NCT00355082|525013124|FG002|Continuation Phase|Site Closed by Sponsor|0|||
145590913|NCT00355082|525013122|FG000|Continuation Phase|Scheduling Error|1|||
145590914|NCT00355082|525013123|FG001|Continuation Phase|Scheduling Error|0|||
145590915|NCT00355082|525013124|FG002|Continuation Phase|Scheduling Error|0|||
145590916|NCT00355082|525013122|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
145590917|NCT00355082|525013123|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
145626740|NCT02939183|525145782|FG005|Overall Study|Death|2|||
145626741|NCT02939183|525145783|FG006|Overall Study|Death|1|||
145626742|NCT02939183|525145784|FG007|Overall Study|Death|0|||
145626743|NCT02939183|525145785|FG008|Overall Study|Death|0|||
145626744|NCT02939183|525145777|FG000|Overall Study|Sponsor decision|0|||
145458377|NCT00098748|524529288|FG001|Received Study Treatment|Other|2|||
145590918|NCT00355082|525013124|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
145590919|NCT00724971|525013132|FG000|Overall Study|Adverse Event|5|||
145626745|NCT02939183|525145778|FG001|Overall Study|Sponsor decision|1|||
145590920|NCT00724971|525013132|FG000|Overall Study|Withdrawal by Subject|1|||
145626746|NCT02939183|525145779|FG002|Overall Study|Sponsor decision|0|||
145626747|NCT02939183|525145780|FG003|Overall Study|Sponsor decision|1|||
145626748|NCT02939183|525145781|FG004|Overall Study|Sponsor decision|2|||
145590921|NCT01003249|525013133|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145590922|NCT01003249|525013134|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145590923|NCT01003249|525013133|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
145590924|NCT01003249|525013134|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
145590925|NCT01003249|525013133|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
145590926|NCT01003249|525013134|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145590927|NCT01003249|525013133|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
145590928|NCT01003249|525013134|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
145590929|NCT02132611|525013139|FG000|Overall Study|Death|2|||
145590930|NCT03387852|525013140|FG000|Overall Study|Adverse event (AE)|3|||
145590931|NCT03387852|525013141|FG001|Overall Study|Adverse event (AE)|0|||
145590932|NCT03387852|525013142|FG002|Overall Study|Adverse event (AE)|2|||
145590933|NCT03387852|525013143|FG003|Overall Study|Adverse event (AE)|0|||
145590934|NCT03387852|525013140|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
145590935|NCT03387852|525013141|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
145590936|NCT03387852|525013142|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
145590937|NCT03387852|525013143|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
145590938|NCT03387852|525013140|FG000|Overall Study|Withdrawal by participant|1|||
145590939|NCT03387852|525013141|FG001|Overall Study|Withdrawal by participant|1|||
145590940|NCT03387852|525013142|FG002|Overall Study|Withdrawal by participant|3|||
145590941|NCT03387852|525013143|FG003|Overall Study|Withdrawal by participant|2|||
145590942|NCT03387852|525013140|FG000|Overall Study|Other- Unspecified|1|||
145590943|NCT03387852|525013141|FG001|Overall Study|Other- Unspecified|1|||
145590944|NCT03387852|525013142|FG002|Overall Study|Other- Unspecified|2|||
145590945|NCT03387852|525013143|FG003|Overall Study|Other- Unspecified|1|||
145590946|NCT03387852|525013140|FG000|Overall Study|Poor compliance to protocol|0|||
145590947|NCT03387852|525013141|FG001|Overall Study|Poor compliance to protocol|0|||
145590948|NCT03387852|525013142|FG002|Overall Study|Poor compliance to protocol|0|||
145590949|NCT03387852|525013143|FG003|Overall Study|Poor compliance to protocol|1|||
145590950|NCT03387852|525013140|FG000|Overall Study|Randomized and not treated|0|||
145590951|NCT03387852|525013141|FG001|Overall Study|Randomized and not treated|0|||
145590952|NCT03387852|525013142|FG002|Overall Study|Randomized and not treated|0|||
145590953|NCT03387852|525013143|FG003|Overall Study|Randomized and not treated|1|||
145590954|NCT02194621|525013144|FG000|Overall Study|6 withdrew prior to randomization|2|||
145590955|NCT02194621|525013145|FG001|Overall Study|6 withdrew prior to randomization|2|||
145590956|NCT02194621|525013146|FG002|Overall Study|6 withdrew prior to randomization|2|||
145590957|NCT02194621|525013144|FG000|Overall Study|Withdrawal by Subject|4|||
145590958|NCT02194621|525013145|FG001|Overall Study|Withdrawal by Subject|4|||
145590959|NCT02194621|525013146|FG002|Overall Study|Withdrawal by Subject|7|||
145590960|NCT02493127|525013154|FG000|Overall Study|Lost to Follow-up|1|||
145590961|NCT02493127|525013155|FG001|Overall Study|Lost to Follow-up|1|||
145590962|NCT02763384|525013156|FG000|Overall Study|Physician Decision|1|||
145590963|NCT02763384|525013156|FG000|Overall Study|Rapid decline - went on hospice|1|||
145590964|NCT02096900|525013157|FG000|Overall Study|Did not receive medication|3|||
145590965|NCT02096900|525013158|FG001|Overall Study|Did not receive medication|1|||
145590966|NCT02096900|525013157|FG000|Overall Study|Surgery cancelled- medication received|1|||
145590967|NCT02096900|525013158|FG001|Overall Study|Surgery cancelled- medication received|1|||
145590968|NCT02298192|525013162|FG000|Overall Study|Unclassified|3|||
145590969|NCT02298192|525013163|FG001|Overall Study|Unclassified|2|||
145590970|NCT02298192|525013162|FG000|Overall Study|Withdrawal criteria|2|||
145590971|NCT02298192|525013163|FG001|Overall Study|Withdrawal criteria|0|||
145590972|NCT02298192|525013162|FG000|Overall Study|Withdrawal by Subject|6|||
145590973|NCT02298192|525013163|FG001|Overall Study|Withdrawal by Subject|1|||
145590974|NCT02298192|525013162|FG000|Overall Study|Lost to Follow-up|2|||
145590975|NCT02298192|525013163|FG001|Overall Study|Lost to Follow-up|1|||
145590976|NCT02298192|525013162|FG000|Overall Study|Adverse Event|6|||
145590977|NCT02298192|525013163|FG001|Overall Study|Adverse Event|2|||
145590978|NCT01218646|525013165|FG000|Overall Study|Adverse Event|0|||
145590979|NCT01218646|525013166|FG001|Overall Study|Adverse Event|0|||
145590980|NCT01218646|525013167|FG002|Overall Study|Adverse Event|1|||
145590981|NCT01218646|525013168|FG003|Overall Study|Adverse Event|0|||
145590982|NCT01218646|525013165|FG000|Overall Study|Lost to Follow-up|1|||
145590983|NCT01218646|525013166|FG001|Overall Study|Lost to Follow-up|0|||
145590984|NCT01218646|525013167|FG002|Overall Study|Lost to Follow-up|0|||
145590985|NCT01218646|525013168|FG003|Overall Study|Lost to Follow-up|0|||
145590986|NCT01218646|525013165|FG000|Overall Study|Protocol Violation|0|||
145590987|NCT01218646|525013166|FG001|Overall Study|Protocol Violation|0|||
145590988|NCT01218646|525013167|FG002|Overall Study|Protocol Violation|1|||
145590989|NCT01218646|525013168|FG003|Overall Study|Protocol Violation|1|||
145626749|NCT02939183|525145782|FG005|Overall Study|Sponsor decision|0|||
145590990|NCT00722761|525013169|FG000|Overall Study|Lost to Follow-up|1|||
145590991|NCT00722761|525013170|FG001|Overall Study|Lost to Follow-up|4|||
145590992|NCT00722761|525013169|FG000|Overall Study|Withdrawal by Subject|5|||
145590993|NCT00722761|525013170|FG001|Overall Study|Withdrawal by Subject|2|||
145590994|NCT04414696|525013173|FG000|3-month Follow up|Withdrawal by Subject|1|||
145626750|NCT02939183|525145783|FG006|Overall Study|Sponsor decision|3|||
145590995|NCT04414696|525013174|FG001|3-month Follow up|Withdrawal by Subject|0|||
145590996|NCT04414696|525013173|FG000|3-month Follow up|Lost to Follow-up|22|||
145590997|NCT04414696|525013174|FG001|3-month Follow up|Lost to Follow-up|23|||
145590998|NCT04414696|525013173|FG000|6-month Follow up|Withdrawal by Subject|1|||
145590999|NCT04414696|525013174|FG001|6-month Follow up|Withdrawal by Subject|2|||
145591000|NCT04414696|525013173|FG000|6-month Follow up|Lost to Follow-up|5|||
145458378|NCT00098748|524529289|FG002|Received Study Treatment|Other|6|||
145458379|NCT00098748|524529287|FG000|Received Study Treatment|Subject defaulted|3|||
145591001|NCT04414696|525013174|FG001|6-month Follow up|Lost to Follow-up|2|||
145591002|NCT05819749|525013175|FG000|Overall Study|Lost to Follow-up|1|||
145591003|NCT00726752|525013176|FG000|Overall Study|Lack of Efficacy|6|||
145591004|NCT01877408|525016264|FG000|Overall Study|Lost to Follow-up|0|||
145591005|NCT01877408|525016265|FG001|Overall Study|Lost to Follow-up|2|||
145591006|NCT02621931|525016266|FG000|Overall Study|Death|0|||
145591007|NCT02621931|525016267|FG001|Overall Study|Death|1|||
145591008|NCT02621931|525016268|FG002|Overall Study|Death|0|||
145591009|NCT02621931|525016266|FG000|Overall Study|Adverse Event|8|||
145591010|NCT02621931|525016267|FG001|Overall Study|Adverse Event|5|||
145591011|NCT02621931|525016268|FG002|Overall Study|Adverse Event|7|||
145591012|NCT02621931|525016266|FG000|Overall Study|Withdrawal by Subject|12|||
145591013|NCT02621931|525016267|FG001|Overall Study|Withdrawal by Subject|10|||
145591014|NCT02621931|525016268|FG002|Overall Study|Withdrawal by Subject|11|||
145591015|NCT02621931|525016266|FG000|Overall Study|Protocol Violation|2|||
145591016|NCT02621931|525016267|FG001|Overall Study|Protocol Violation|2|||
145591017|NCT02621931|525016268|FG002|Overall Study|Protocol Violation|2|||
145591018|NCT02621931|525016266|FG000|Overall Study|Pregnancy|2|||
145591019|NCT02621931|525016267|FG001|Overall Study|Pregnancy|0|||
145591020|NCT02621931|525016268|FG002|Overall Study|Pregnancy|0|||
145591021|NCT02621931|525016266|FG000|Overall Study|Noncompliance to study procedures|0|||
145591022|NCT02621931|525016267|FG001|Overall Study|Noncompliance to study procedures|1|||
145591023|NCT02621931|525016268|FG002|Overall Study|Noncompliance to study procedures|2|||
145591024|NCT02621931|525016266|FG000|Overall Study|Lost to Follow-up|8|||
145591025|NCT02621931|525016267|FG001|Overall Study|Lost to Follow-up|7|||
145591026|NCT02621931|525016268|FG002|Overall Study|Lost to Follow-up|10|||
145591027|NCT02621931|525016266|FG000|Overall Study|Lack of Efficacy|0|||
145591028|NCT02621931|525016267|FG001|Overall Study|Lack of Efficacy|0|||
145591029|NCT02621931|525016268|FG002|Overall Study|Lack of Efficacy|1|||
145591030|NCT02621931|525016266|FG000|Overall Study|Other|1|||
145591031|NCT02621931|525016267|FG001|Overall Study|Other|1|||
145591032|NCT02621931|525016268|FG002|Overall Study|Other|3|||
145591033|NCT00920426|525016269|FG000|ITZ111451|Adverse Event|1|||
145591034|NCT00920426|525016270|FG001|ITZ111451|Adverse Event|0|||
145591035|NCT00920426|525016271|FG002|ITZ111451|Adverse Event|0|||
145591036|NCT00920426|525016272|FG003|ITZ111451|Adverse Event|0|||
145591037|NCT01292603|525016273|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
145591038|NCT01292603|525016274|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
145591039|NCT01292603|525016275|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
145591040|NCT01292603|525016276|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
145591041|NCT01292603|525016277|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
145591042|NCT01292603|525016278|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
145591043|NCT01292603|525016273|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
145458380|NCT00098748|524529288|FG001|Received Study Treatment|Subject defaulted|4|||
145458381|NCT00098748|524529289|FG002|Received Study Treatment|Subject defaulted|4|||
145458382|NCT00098748|524529287|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
145458383|NCT00098748|524529288|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
145458384|NCT00098748|524529289|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
145458385|NCT00098748|524529287|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
145458386|NCT00098748|524529288|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
145458387|NCT00098748|524529289|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
145458388|NCT00098748|524529287|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
145458389|NCT00098748|524529288|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
145458390|NCT00098748|524529289|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
145458391|NCT00098748|524529287|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
145591044|NCT01292603|525016274|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
145591045|NCT01292603|525016275|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
145591046|NCT01292603|525016276|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
145591047|NCT01292603|525016277|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
145591048|NCT01292603|525016278|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
145591049|NCT01292603|525016273|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
145591050|NCT01292603|525016274|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
145591051|NCT01292603|525016275|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
145591052|NCT01292603|525016276|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
145591053|NCT01292603|525016277|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
145591054|NCT01292603|525016278|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
145626751|NCT02939183|525145784|FG007|Overall Study|Sponsor decision|1|||
145591055|NCT01292603|525016273|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
145591056|NCT01292603|525016274|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
145591057|NCT01292603|525016275|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
145591058|NCT01292603|525016276|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
145591059|NCT01292603|525016277|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
145591060|NCT01292603|525016278|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
145591061|NCT01292603|525016273|FG000|Part 1: Regular Follow-Up Period|Death|3|||
145591062|NCT01292603|525016274|FG001|Part 1: Regular Follow-Up Period|Death|1|||
145591063|NCT01292603|525016275|FG002|Part 1: Regular Follow-Up Period|Death|3|||
145591064|NCT01292603|525016276|FG003|Part 1: Regular Follow-Up Period|Death|1|||
145591065|NCT01292603|525016277|FG004|Part 1: Regular Follow-Up Period|Death|0|||
145591066|NCT01292603|525016278|FG005|Part 1: Regular Follow-Up Period|Death|0|||
145591067|NCT01292603|525016273|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
145591068|NCT01292603|525016274|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
145591069|NCT01292603|525016275|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
145591070|NCT01292603|525016276|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
145591071|NCT01292603|525016277|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
145591072|NCT01292603|525016278|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
145591073|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Death|0|||
145591074|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Death|0|||
145591075|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Death|0|||
145591076|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Death|0|||
145591077|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Death|1|||
145591078|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Death|0|||
145591079|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
145591080|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
145591081|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
145591082|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
145591083|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
145591084|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
145591085|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
145591086|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
145591087|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
145591088|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
145591089|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
145591090|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
145591091|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
145591092|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
145591093|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
145591094|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
145591095|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
145591096|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
145591097|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
145591098|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
145591099|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
145591100|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
145591101|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
145591102|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
145591103|NCT01292603|525016273|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
145591104|NCT01292603|525016274|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
145591105|NCT01292603|525016275|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
145591106|NCT01292603|525016276|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
145591107|NCT01292603|525016277|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
145591108|NCT01292603|525016278|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
145591109|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Death|0|||
145591110|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Death|0|||
145591111|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Death|0|||
145591112|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Death|0|||
145591113|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Death|6|||
145591114|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Death|3|||
145591115|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
145591116|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
145591117|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
145591118|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
145591119|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
145458392|NCT00098748|524529288|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
145458393|NCT00098748|524529289|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
145458394|NCT00098748|524529287|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
145591120|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
145591121|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
145591122|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
145591123|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
145591124|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
145591125|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
145591126|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
145591127|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
145591128|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
145591129|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
145591130|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
145591131|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
145591132|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
145591133|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
145591134|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
145591135|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
145591136|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
145591137|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
145591138|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
145591139|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
145591140|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
145591141|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
145591142|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
145591143|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
145591144|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
145591145|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
145591146|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
145591147|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
145591148|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
145591149|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
145591150|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
145591151|NCT01292603|525016273|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
145591152|NCT01292603|525016274|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
145591153|NCT01292603|525016275|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
145591154|NCT01292603|525016276|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
145591155|NCT01292603|525016277|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
145591156|NCT01292603|525016278|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
145591157|NCT01292603|525016273|FG000|Overall Survival Status|Death|3|||
145591158|NCT01292603|525016274|FG001|Overall Survival Status|Death|1|||
145591159|NCT01292603|525016275|FG002|Overall Survival Status|Death|3|||
145591160|NCT01292603|525016276|FG003|Overall Survival Status|Death|1|||
145591161|NCT01292603|525016277|FG004|Overall Survival Status|Death|16|||
145591162|NCT01292603|525016278|FG005|Overall Survival Status|Death|10|||
145591163|NCT03870763|525016279|FG000|Overall Study|Study terminated by sponsor|0|||
145591164|NCT03870763|525016280|FG001|Overall Study|Study terminated by sponsor|2|||
145591165|NCT03870763|525016281|FG002|Overall Study|Study terminated by sponsor|0|||
145591166|NCT03870763|525016279|FG000|Overall Study|Withdrawal by Subject|0|||
145591167|NCT03870763|525016280|FG001|Overall Study|Withdrawal by Subject|1|||
145591168|NCT03870763|525016281|FG002|Overall Study|Withdrawal by Subject|0|||
145591169|NCT03870763|525016279|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
145591170|NCT03870763|525016280|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
145591171|NCT03870763|525016281|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
145591172|NCT01912612|525016290|FG000|Overall Study|Adverse Event|4|||
145591173|NCT01912612|525016291|FG001|Overall Study|Adverse Event|0|||
145591174|NCT01912612|525016292|FG002|Overall Study|Adverse Event|0|||
145591175|NCT01912612|525016290|FG000|Overall Study|Withdrew consent|1|||
145591176|NCT01912612|525016291|FG001|Overall Study|Withdrew consent|0|||
145591177|NCT01912612|525016292|FG002|Overall Study|Withdrew consent|0|||
145591178|NCT01912612|525016290|FG000|Overall Study|Study design change|0|||
145591179|NCT01912612|525016291|FG001|Overall Study|Study design change|0|||
145591180|NCT01912612|525016292|FG002|Overall Study|Study design change|3|||
145591181|NCT01588184|525016293|FG000|Overall Study|Death|1|||
145458395|NCT00098748|524529288|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
145458396|NCT00098748|524529289|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
145591182|NCT01588184|525016294|FG001|Overall Study|Death|0|||
145591183|NCT01588184|525016295|FG002|Overall Study|Death|0|||
145591184|NCT01588184|525016296|FG003|Overall Study|Death|1|||
145591185|NCT01588184|525016297|FG004|Overall Study|Death|1|||
145591186|NCT01588184|525016298|FG005|Overall Study|Death|1|||
145458397|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
145591187|NCT01588184|525016293|FG000|Overall Study|Withdrawal by Subject|2|||
145591188|NCT01588184|525016294|FG001|Overall Study|Withdrawal by Subject|4|||
145591189|NCT01588184|525016295|FG002|Overall Study|Withdrawal by Subject|0|||
145591190|NCT01588184|525016296|FG003|Overall Study|Withdrawal by Subject|1|||
145626752|NCT02939183|525145785|FG008|Overall Study|Sponsor decision|4|||
145591191|NCT01588184|525016297|FG004|Overall Study|Withdrawal by Subject|0|||
145591192|NCT01588184|525016298|FG005|Overall Study|Withdrawal by Subject|0|||
145591193|NCT01588184|525016293|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
145591194|NCT01588184|525016294|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
145591195|NCT01588184|525016295|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
145591196|NCT01588184|525016296|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
145591197|NCT01588184|525016297|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
145591198|NCT01588184|525016298|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
145591199|NCT01588184|525016293|FG000|Overall Study|multiple reasons|0|||
145591200|NCT01588184|525016294|FG001|Overall Study|multiple reasons|3|||
145591201|NCT01588184|525016295|FG002|Overall Study|multiple reasons|0|||
145591202|NCT01588184|525016296|FG003|Overall Study|multiple reasons|1|||
145591203|NCT01588184|525016297|FG004|Overall Study|multiple reasons|0|||
145591204|NCT01588184|525016298|FG005|Overall Study|multiple reasons|0|||
145591205|NCT00907153|525016299|FG000|Overall Study|Lost to Follow-up|1|||
145591206|NCT00907153|525016300|FG001|Overall Study|Lost to Follow-up|1|||
145591207|NCT00907153|525016299|FG000|Overall Study|Withdrawal by Subject|1|||
145591208|NCT00907153|525016300|FG001|Overall Study|Withdrawal by Subject|3|||
145591209|NCT01843192|525016303|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
145591210|NCT01843192|525016304|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
145591211|NCT01843192|525016305|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
145591212|NCT01559844|525016306|FG000|Overall Study|Consent Withdrawn|7|||
145591213|NCT01559844|525016306|FG000|Overall Study|Death|5|||
145591214|NCT01559844|525016306|FG000|Overall Study|Efficacy Failure|10|||
145591215|NCT01559844|525016306|FG000|Overall Study|No Longer A Transplant Candidate|3|||
145591216|NCT00951041|525016307|FG000|Overall Study|Withdrawal by Subject|1|||
145591217|NCT00951041|525016308|FG001|Overall Study|Withdrawal by Subject|1|||
145591218|NCT00951041|525016307|FG000|Overall Study|Lost to Follow-up|1|||
145591219|NCT00951041|525016308|FG001|Overall Study|Lost to Follow-up|0|||
145591220|NCT00951041|525016307|FG000|Overall Study|Other|3|||
145591221|NCT00951041|525016308|FG001|Overall Study|Other|0|||
145591222|NCT01259713|525016309|FG000|Overall Study|Adverse Event|54|||
145591223|NCT01259713|525016310|FG001|Overall Study|Adverse Event|23|||
145591224|NCT01259713|525016309|FG000|Overall Study|Death Not Related to IFI|8|||
145591225|NCT01259713|525016310|FG001|Overall Study|Death Not Related to IFI|1|||
145591226|NCT01259713|525016309|FG000|Overall Study|Investigators Discretion|14|||
145591227|NCT01259713|525016310|FG001|Overall Study|Investigators Discretion|6|||
145591228|NCT01259713|525016309|FG000|Overall Study|Lack of Efficacy|2|||
145591229|NCT01259713|525016310|FG001|Overall Study|Lack of Efficacy|0|||
145591230|NCT01259713|525016309|FG000|Overall Study|Protocol Violation|5|||
145591231|NCT01259713|525016310|FG001|Overall Study|Protocol Violation|4|||
145591232|NCT01259713|525016309|FG000|Overall Study|Subject Withdrew Consent|12|||
145591233|NCT01259713|525016310|FG001|Overall Study|Subject Withdrew Consent|7|||
145591234|NCT02388724|525016312|FG000|Overall Study|Reason not Specified|0|||
145591235|NCT02388724|525016313|FG001|Overall Study|Reason not Specified|1|||
145591236|NCT02388724|525016312|FG000|Overall Study|Major Protocol Deviation|3|||
145591237|NCT02388724|525016313|FG001|Overall Study|Major Protocol Deviation|3|||
145591238|NCT02388724|525016312|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
145591239|NCT02388724|525016313|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
145591240|NCT02388724|525016312|FG000|Overall Study|Voluntary Withdrawal|6|||
145591241|NCT02388724|525016313|FG001|Overall Study|Voluntary Withdrawal|5|||
145591242|NCT02388724|525016312|FG000|Overall Study|Randomized but not Treated|0|||
145591243|NCT02388724|525016313|FG001|Overall Study|Randomized but not Treated|2|||
145591244|NCT01217073|525016314|FG000|Base Period|Adverse Event|1|||
145591245|NCT01217073|525016315|FG001|Base Period|Adverse Event|0|||
145591246|NCT01217073|525016316|FG002|Base Period|Adverse Event|1|||
145591247|NCT01217073|525016317|FG003|Base Period|Adverse Event|0|||
145591248|NCT01217073|525016318|FG004|Base Period|Adverse Event|4|||
145591249|NCT01217073|525016319|FG005|Base Period|Adverse Event|1|||
145591250|NCT01217073|525016320|FG006|Base Period|Adverse Event|0|||
145591251|NCT01217073|525016321|FG007|Base Period|Adverse Event|0|||
145591252|NCT01217073|525016314|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
145591253|NCT01217073|525016315|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591254|NCT01217073|525016316|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591255|NCT01217073|525016317|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591256|NCT01217073|525016318|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591257|NCT01217073|525016319|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591258|NCT01217073|525016320|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591259|NCT01217073|525016321|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
145591260|NCT01217073|525016314|FG000|Base Period|Excluded medication|0|||
145591261|NCT01217073|525016315|FG001|Base Period|Excluded medication|0|||
145591262|NCT01217073|525016316|FG002|Base Period|Excluded medication|0|||
145626753|NCT02939183|525145777|FG000|Overall Study|Withdrawal by Subject|0|||
145591263|NCT01217073|525016317|FG003|Base Period|Excluded medication|0|||
145591264|NCT01217073|525016318|FG004|Base Period|Excluded medication|1|||
145591265|NCT01217073|525016319|FG005|Base Period|Excluded medication|0|||
145591266|NCT01217073|525016320|FG006|Base Period|Excluded medication|0|||
145591267|NCT01217073|525016321|FG007|Base Period|Excluded medication|0|||
145591268|NCT01217073|525016314|FG000|Base Period|Lack of Efficacy|0|||
145591269|NCT01217073|525016315|FG001|Base Period|Lack of Efficacy|0|||
145591270|NCT01217073|525016316|FG002|Base Period|Lack of Efficacy|0|||
145591271|NCT01217073|525016317|FG003|Base Period|Lack of Efficacy|0|||
145591272|NCT01217073|525016318|FG004|Base Period|Lack of Efficacy|0|||
145591273|NCT01217073|525016319|FG005|Base Period|Lack of Efficacy|1|||
145591274|NCT01217073|525016320|FG006|Base Period|Lack of Efficacy|0|||
145591275|NCT01217073|525016321|FG007|Base Period|Lack of Efficacy|0|||
145591276|NCT01217073|525016314|FG000|Base Period|Lost to Follow-up|0|||
145591277|NCT01217073|525016315|FG001|Base Period|Lost to Follow-up|0|||
145591278|NCT01217073|525016316|FG002|Base Period|Lost to Follow-up|1|||
145591279|NCT01217073|525016317|FG003|Base Period|Lost to Follow-up|1|||
145591280|NCT01217073|525016318|FG004|Base Period|Lost to Follow-up|3|||
145591281|NCT01217073|525016319|FG005|Base Period|Lost to Follow-up|0|||
145591282|NCT01217073|525016320|FG006|Base Period|Lost to Follow-up|0|||
145591283|NCT01217073|525016321|FG007|Base Period|Lost to Follow-up|0|||
145591284|NCT01217073|525016314|FG000|Base Period|Physician Decision|0|||
145591285|NCT01217073|525016315|FG001|Base Period|Physician Decision|0|||
145591286|NCT01217073|525016316|FG002|Base Period|Physician Decision|0|||
145591287|NCT01217073|525016317|FG003|Base Period|Physician Decision|0|||
145591288|NCT01217073|525016318|FG004|Base Period|Physician Decision|1|||
145626754|NCT02939183|525145778|FG001|Overall Study|Withdrawal by Subject|2|||
145626755|NCT02939183|525145779|FG002|Overall Study|Withdrawal by Subject|0|||
145458398|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
145458399|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Death|0|||
145458400|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Death|0|||
145458401|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
145458402|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
145458403|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
145458404|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
145458405|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
145458406|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
145458407|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
145458408|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
145458409|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
145458410|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
145458411|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
145458412|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
145458413|NCT00433160|524529294|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
145458414|NCT00433160|524529295|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
145458415|NCT00433160|524529294|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
145458416|NCT00433160|524529295|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
145458417|NCT00433160|524529294|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
145458418|NCT00433160|524529295|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
145458419|NCT00433160|524529294|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
145458420|NCT00433160|524529295|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
145458421|NCT00433160|524529294|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
145458422|NCT00433160|524529295|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
145458423|NCT00433160|524529294|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
145458424|NCT00433160|524529295|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
145458425|NCT00433160|524529294|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
145458426|NCT00433160|524529295|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
145458427|NCT00433160|524529294|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
145458428|NCT00433160|524529295|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
145458429|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
145458430|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
145458431|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
145458432|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
145458433|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
145458434|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
145458435|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
145591289|NCT01217073|525016319|FG005|Base Period|Physician Decision|0|||
145591290|NCT01217073|525016320|FG006|Base Period|Physician Decision|0|||
145626756|NCT02939183|525145780|FG003|Overall Study|Withdrawal by Subject|1|||
145458436|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
145591291|NCT01217073|525016321|FG007|Base Period|Physician Decision|0|||
145591292|NCT01217073|525016314|FG000|Base Period|Protocol Violation|1|||
145591293|NCT01217073|525016315|FG001|Base Period|Protocol Violation|0|||
145591294|NCT01217073|525016316|FG002|Base Period|Protocol Violation|0|||
145591295|NCT01217073|525016317|FG003|Base Period|Protocol Violation|0|||
145591296|NCT01217073|525016318|FG004|Base Period|Protocol Violation|1|||
145591297|NCT01217073|525016319|FG005|Base Period|Protocol Violation|2|||
145591298|NCT01217073|525016320|FG006|Base Period|Protocol Violation|0|||
145591299|NCT01217073|525016321|FG007|Base Period|Protocol Violation|0|||
145591300|NCT01217073|525016314|FG000|Base Period|Withdrawal by Subject|4|||
145591301|NCT01217073|525016315|FG001|Base Period|Withdrawal by Subject|5|||
145591302|NCT01217073|525016316|FG002|Base Period|Withdrawal by Subject|5|||
145591303|NCT01217073|525016317|FG003|Base Period|Withdrawal by Subject|1|||
145591304|NCT01217073|525016318|FG004|Base Period|Withdrawal by Subject|5|||
145591305|NCT01217073|525016319|FG005|Base Period|Withdrawal by Subject|5|||
145591306|NCT01217073|525016320|FG006|Base Period|Withdrawal by Subject|0|||
145591307|NCT01217073|525016321|FG007|Base Period|Withdrawal by Subject|0|||
145591308|NCT01217073|525016314|FG000|Extension Period|Adverse Event|0|||
145591309|NCT01217073|525016315|FG001|Extension Period|Adverse Event|0|||
145591310|NCT01217073|525016316|FG002|Extension Period|Adverse Event|0|||
145591311|NCT01217073|525016317|FG003|Extension Period|Adverse Event|0|||
145591312|NCT01217073|525016318|FG004|Extension Period|Adverse Event|0|||
145591313|NCT01217073|525016319|FG005|Extension Period|Adverse Event|0|||
145591314|NCT01217073|525016320|FG006|Extension Period|Adverse Event|19|||
145591315|NCT01217073|525016321|FG007|Extension Period|Adverse Event|5|||
145591316|NCT01217073|525016314|FG000|Extension Period|ALT/AST|0|||
145591317|NCT01217073|525016315|FG001|Extension Period|ALT/AST|0|||
145591318|NCT01217073|525016316|FG002|Extension Period|ALT/AST|0|||
145591319|NCT01217073|525016317|FG003|Extension Period|ALT/AST|0|||
145591320|NCT01217073|525016318|FG004|Extension Period|ALT/AST|0|||
145591321|NCT01217073|525016319|FG005|Extension Period|ALT/AST|0|||
145591322|NCT01217073|525016320|FG006|Extension Period|ALT/AST|2|||
145591323|NCT01217073|525016321|FG007|Extension Period|ALT/AST|0|||
145591324|NCT01217073|525016314|FG000|Extension Period|Contraindication to study medication|0|||
145591325|NCT01217073|525016315|FG001|Extension Period|Contraindication to study medication|0|||
145591326|NCT01217073|525016316|FG002|Extension Period|Contraindication to study medication|0|||
145591327|NCT01217073|525016317|FG003|Extension Period|Contraindication to study medication|0|||
145591328|NCT01217073|525016318|FG004|Extension Period|Contraindication to study medication|0|||
145591329|NCT01217073|525016319|FG005|Extension Period|Contraindication to study medication|0|||
145591330|NCT01217073|525016320|FG006|Extension Period|Contraindication to study medication|1|||
145591331|NCT01217073|525016321|FG007|Extension Period|Contraindication to study medication|0|||
145591332|NCT01217073|525016314|FG000|Extension Period|Creatinine/eGFR|0|||
145591333|NCT01217073|525016315|FG001|Extension Period|Creatinine/eGFR|0|||
145591334|NCT01217073|525016316|FG002|Extension Period|Creatinine/eGFR|0|||
145591335|NCT01217073|525016317|FG003|Extension Period|Creatinine/eGFR|0|||
145591336|NCT01217073|525016318|FG004|Extension Period|Creatinine/eGFR|0|||
145591337|NCT01217073|525016319|FG005|Extension Period|Creatinine/eGFR|0|||
145591338|NCT01217073|525016320|FG006|Extension Period|Creatinine/eGFR|11|||
145591339|NCT01217073|525016321|FG007|Extension Period|Creatinine/eGFR|1|||
145591340|NCT01217073|525016314|FG000|Extension Period|Death|0|||
145591341|NCT01217073|525016315|FG001|Extension Period|Death|0|||
145591342|NCT01217073|525016316|FG002|Extension Period|Death|0|||
145591343|NCT01217073|525016317|FG003|Extension Period|Death|0|||
145591344|NCT01217073|525016318|FG004|Extension Period|Death|0|||
145591345|NCT01217073|525016319|FG005|Extension Period|Death|0|||
145591346|NCT01217073|525016320|FG006|Extension Period|Death|1|||
145591347|NCT01217073|525016321|FG007|Extension Period|Death|0|||
145591348|NCT01217073|525016314|FG000|Extension Period|Excluded medication|0|||
145591349|NCT01217073|525016315|FG001|Extension Period|Excluded medication|0|||
145591350|NCT01217073|525016316|FG002|Extension Period|Excluded medication|0|||
145591351|NCT01217073|525016317|FG003|Extension Period|Excluded medication|0|||
145591352|NCT01217073|525016318|FG004|Extension Period|Excluded medication|0|||
145591353|NCT01217073|525016319|FG005|Extension Period|Excluded medication|0|||
145591354|NCT01217073|525016320|FG006|Extension Period|Excluded medication|2|||
145591355|NCT01217073|525016321|FG007|Extension Period|Excluded medication|0|||
145591356|NCT01217073|525016314|FG000|Extension Period|Lack of Efficacy|0|||
145591357|NCT01217073|525016315|FG001|Extension Period|Lack of Efficacy|0|||
145591358|NCT01217073|525016316|FG002|Extension Period|Lack of Efficacy|0|||
145591359|NCT01217073|525016317|FG003|Extension Period|Lack of Efficacy|0|||
145591360|NCT01217073|525016318|FG004|Extension Period|Lack of Efficacy|0|||
145591361|NCT01217073|525016319|FG005|Extension Period|Lack of Efficacy|0|||
145591362|NCT01217073|525016320|FG006|Extension Period|Lack of Efficacy|3|||
145591363|NCT01217073|525016321|FG007|Extension Period|Lack of Efficacy|0|||
145591364|NCT01217073|525016314|FG000|Extension Period|Lost to Follow-up|0|||
145591365|NCT01217073|525016315|FG001|Extension Period|Lost to Follow-up|0|||
145591366|NCT01217073|525016316|FG002|Extension Period|Lost to Follow-up|0|||
145591367|NCT01217073|525016317|FG003|Extension Period|Lost to Follow-up|0|||
145591368|NCT01217073|525016318|FG004|Extension Period|Lost to Follow-up|0|||
145591369|NCT01217073|525016319|FG005|Extension Period|Lost to Follow-up|0|||
145591370|NCT01217073|525016320|FG006|Extension Period|Lost to Follow-up|9|||
145591371|NCT01217073|525016321|FG007|Extension Period|Lost to Follow-up|1|||
145591372|NCT01217073|525016314|FG000|Extension Period|Non-compliance with study drug|0|||
145591373|NCT01217073|525016315|FG001|Extension Period|Non-compliance with study drug|0|||
145591374|NCT01217073|525016316|FG002|Extension Period|Non-compliance with study drug|0|||
145591375|NCT01217073|525016317|FG003|Extension Period|Non-compliance with study drug|0|||
145591376|NCT01217073|525016318|FG004|Extension Period|Non-compliance with study drug|0|||
145591377|NCT01217073|525016319|FG005|Extension Period|Non-compliance with study drug|0|||
145591378|NCT01217073|525016320|FG006|Extension Period|Non-compliance with study drug|0|||
145591379|NCT01217073|525016321|FG007|Extension Period|Non-compliance with study drug|1|||
145591380|NCT01217073|525016314|FG000|Extension Period|Physician Decision|0|||
145591381|NCT01217073|525016315|FG001|Extension Period|Physician Decision|0|||
145591382|NCT01217073|525016316|FG002|Extension Period|Physician Decision|0|||
145591383|NCT01217073|525016317|FG003|Extension Period|Physician Decision|0|||
145591384|NCT01217073|525016318|FG004|Extension Period|Physician Decision|0|||
145591385|NCT01217073|525016319|FG005|Extension Period|Physician Decision|0|||
145591386|NCT01217073|525016320|FG006|Extension Period|Physician Decision|4|||
145591387|NCT01217073|525016321|FG007|Extension Period|Physician Decision|1|||
145591388|NCT01217073|525016314|FG000|Extension Period|Protocol Violation|0|||
145591389|NCT01217073|525016315|FG001|Extension Period|Protocol Violation|0|||
145591390|NCT01217073|525016316|FG002|Extension Period|Protocol Violation|0|||
145591391|NCT01217073|525016317|FG003|Extension Period|Protocol Violation|0|||
145591392|NCT01217073|525016318|FG004|Extension Period|Protocol Violation|0|||
145591393|NCT01217073|525016319|FG005|Extension Period|Protocol Violation|0|||
145591394|NCT01217073|525016320|FG006|Extension Period|Protocol Violation|2|||
145591395|NCT01217073|525016321|FG007|Extension Period|Protocol Violation|1|||
145591396|NCT01217073|525016314|FG000|Extension Period|Site discontinued study participation|0|||
145591397|NCT01217073|525016315|FG001|Extension Period|Site discontinued study participation|0|||
145591398|NCT01217073|525016316|FG002|Extension Period|Site discontinued study participation|0|||
145591399|NCT01217073|525016317|FG003|Extension Period|Site discontinued study participation|0|||
145591400|NCT01217073|525016318|FG004|Extension Period|Site discontinued study participation|0|||
145591401|NCT01217073|525016319|FG005|Extension Period|Site discontinued study participation|0|||
145591402|NCT01217073|525016320|FG006|Extension Period|Site discontinued study participation|7|||
145591403|NCT01217073|525016321|FG007|Extension Period|Site discontinued study participation|2|||
145591404|NCT01217073|525016314|FG000|Extension Period|Withdrawal by Subject|0|||
145591405|NCT01217073|525016315|FG001|Extension Period|Withdrawal by Subject|0|||
145591406|NCT01217073|525016316|FG002|Extension Period|Withdrawal by Subject|0|||
145591407|NCT01217073|525016317|FG003|Extension Period|Withdrawal by Subject|0|||
145591408|NCT01217073|525016318|FG004|Extension Period|Withdrawal by Subject|0|||
145591409|NCT01217073|525016319|FG005|Extension Period|Withdrawal by Subject|0|||
145591410|NCT01217073|525016320|FG006|Extension Period|Withdrawal by Subject|30|||
145591411|NCT01217073|525016321|FG007|Extension Period|Withdrawal by Subject|8|||
145591412|NCT00620750|525016322|FG000|Overall Study|Lost to Follow-up|25|||
145591413|NCT04477187|525016323|FG000|Overall Study|Lost to Follow-up|2|||
145591414|NCT00765843|525016325|FG000|Overall Study|Lost to Follow-up|1|||
145591415|NCT00765843|525016326|FG001|Overall Study|Lost to Follow-up|3|||
145591416|NCT00765843|525016327|FG002|Overall Study|Lost to Follow-up|2|||
145591417|NCT00765843|525016325|FG000|Overall Study|did not return to receive intervention|0|||
145591418|NCT00765843|525016326|FG001|Overall Study|did not return to receive intervention|1|||
145591419|NCT00765843|525016327|FG002|Overall Study|did not return to receive intervention|0|||
145591420|NCT00765843|525016325|FG000|Overall Study|Adverse Event|0|||
145591421|NCT00765843|525016326|FG001|Overall Study|Adverse Event|0|||
145591422|NCT00765843|525016327|FG002|Overall Study|Adverse Event|1|||
145591423|NCT02460991|525016328|FG000|Overall Study|Withdrawal by Subject|0|||
145591424|NCT02460991|525016329|FG001|Overall Study|Withdrawal by Subject|2|||
145591425|NCT02564523|525016330|FG000|Overall Study|Withdrawal by Subject|3|||
145591426|NCT02564523|525016331|FG001|Overall Study|Withdrawal by Subject|0|||
145591427|NCT02564523|525016332|FG002|Overall Study|Withdrawal by Subject|1|||
145591428|NCT02564523|525016333|FG003|Overall Study|Withdrawal by Subject|0|||
145591429|NCT02564523|525016334|FG004|Overall Study|Withdrawal by Subject|1|||
145591430|NCT02564523|525016335|FG005|Overall Study|Withdrawal by Subject|0|||
145591431|NCT02564523|525016336|FG006|Overall Study|Withdrawal by Subject|1|||
145591432|NCT02564523|525016337|FG007|Overall Study|Withdrawal by Subject|0|||
145591433|NCT02564523|525016338|FG008|Overall Study|Withdrawal by Subject|0|||
145591434|NCT02564523|525016339|FG009|Overall Study|Withdrawal by Subject|0|||
145591435|NCT02564523|525016340|FG010|Overall Study|Withdrawal by Subject|1|||
145591436|NCT02564523|525016341|FG011|Overall Study|Withdrawal by Subject|0|||
145591437|NCT02564523|525016342|FG012|Overall Study|Withdrawal by Subject|1|||
145591438|NCT02564523|525016343|FG013|Overall Study|Withdrawal by Subject|0|||
145591439|NCT02564523|525016344|FG014|Overall Study|Withdrawal by Subject|0|||
145591440|NCT02564523|525016345|FG015|Overall Study|Withdrawal by Subject|0|||
145591441|NCT02564523|525016346|FG016|Overall Study|Withdrawal by Subject|0|||
145591442|NCT02564523|525016347|FG017|Overall Study|Withdrawal by Subject|0|||
145591443|NCT02564523|525016330|FG000|Overall Study|Adverse Event|0|||
145591444|NCT02564523|525016331|FG001|Overall Study|Adverse Event|0|||
145591445|NCT02564523|525016332|FG002|Overall Study|Adverse Event|0|||
145591446|NCT02564523|525016333|FG003|Overall Study|Adverse Event|0|||
145591447|NCT02564523|525016334|FG004|Overall Study|Adverse Event|0|||
145591448|NCT02564523|525016335|FG005|Overall Study|Adverse Event|0|||
145458437|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
145458438|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
145458439|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
145458440|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
145458441|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
145458442|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
145458443|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
145458444|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
145458445|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
145458446|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
145458447|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
145458448|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
145458449|NCT03222973|524529304|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
145458450|NCT03222973|524529305|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
145458451|NCT03222973|524529306|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
145458452|NCT03222973|524529307|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
145458453|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
145458454|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
145458455|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
145458456|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
145458457|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
145458458|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
145458459|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
145458460|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
145458461|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
145458462|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
145458463|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
145458464|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
145458465|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
145458466|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
145458467|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
145458468|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
145458469|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
145458470|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
145458471|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
145458472|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
145458473|NCT03222973|524529304|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
145458474|NCT03222973|524529305|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
145458475|NCT03222973|524529306|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
145458476|NCT03222973|524529307|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
145458477|NCT02080481|524529308|FG000|Overall Study|Never received a block.|1|||
145458478|NCT02080481|524529309|FG001|Overall Study|Never received a block.|0|||
145458479|NCT01730339|524531443|FG000|Overall Study|Withdrawal by Subject|3|||
145458480|NCT01730339|524531444|FG001|Overall Study|Withdrawal by Subject|2|||
145458481|NCT01730339|524531443|FG000|Overall Study|Lost to Follow-up|1|||
145458482|NCT01730339|524531444|FG001|Overall Study|Lost to Follow-up|1|||
145458483|NCT01730339|524531443|FG000|Overall Study|Un-specified|1|||
145458484|NCT01730339|524531444|FG001|Overall Study|Un-specified|0|||
145458485|NCT04143217|524531447|FG000|Overall Study|Withdrawal by Subject|42|||
145458486|NCT04143217|524531447|FG000|Overall Study|Adverse Event|29|||
145458487|NCT04143217|524531447|FG000|Overall Study|Lost to Follow-up|29|||
145458488|NCT04143217|524531447|FG000|Overall Study|Lack of Efficacy|15|||
145458489|NCT04143217|524531447|FG000|Overall Study|Physician Decision|1|||
145458490|NCT04143217|524531447|FG000|Overall Study|Non-Compliance With Study Drug|6|||
145458491|NCT04143217|524531447|FG000|Overall Study|Other, Multiple Categories|11|||
145458492|NCT00316693|524531448|FG000|Overall Study|Adverse Event|6|||
145458493|NCT00316693|524531449|FG001|Overall Study|Adverse Event|1|||
145458494|NCT00316693|524531448|FG000|Overall Study|Protocol Violation|1|||
145458495|NCT00316693|524531449|FG001|Overall Study|Protocol Violation|0|||
145458496|NCT00316693|524531448|FG000|Overall Study|Withdrawal by Subject|6|||
145458497|NCT00316693|524531449|FG001|Overall Study|Withdrawal by Subject|6|||
145591449|NCT02564523|525016336|FG006|Overall Study|Adverse Event|0|||
145591450|NCT02564523|525016337|FG007|Overall Study|Adverse Event|0|||
145591451|NCT02564523|525016338|FG008|Overall Study|Adverse Event|0|||
145458498|NCT00316693|524531448|FG000|Overall Study|Lost to Follow-up|26|||
145591452|NCT02564523|525016339|FG009|Overall Study|Adverse Event|0|||
145591453|NCT02564523|525016340|FG010|Overall Study|Adverse Event|0|||
145458499|NCT00316693|524531449|FG001|Overall Study|Lost to Follow-up|34|||
145458500|NCT00316693|524531448|FG000|Overall Study|Other|38|||
145458501|NCT00316693|524531449|FG001|Overall Study|Other|44|||
145458502|NCT02982018|524531450|FG000|Overall Study|Incorrect Lens Dispensed|1|||
145458503|NCT02982018|524531451|FG001|Overall Study|Incorrect Lens Dispensed|0|||
145458504|NCT02982018|524531450|FG000|Overall Study|Protocol Violation|1|||
145458505|NCT02982018|524531451|FG001|Overall Study|Protocol Violation|1|||
145458506|NCT02982018|524531450|FG000|Overall Study|Adverse Event|1|||
145591454|NCT02564523|525016341|FG011|Overall Study|Adverse Event|0|||
145591455|NCT02564523|525016342|FG012|Overall Study|Adverse Event|0|||
145591456|NCT02564523|525016343|FG013|Overall Study|Adverse Event|0|||
145591457|NCT02564523|525016344|FG014|Overall Study|Adverse Event|0|||
145591458|NCT02564523|525016345|FG015|Overall Study|Adverse Event|0|||
145591459|NCT02564523|525016346|FG016|Overall Study|Adverse Event|0|||
145591460|NCT02564523|525016347|FG017|Overall Study|Adverse Event|1|||
145591461|NCT02564523|525016330|FG000|Overall Study|Death|0|||
145591462|NCT02564523|525016331|FG001|Overall Study|Death|0|||
145591463|NCT02564523|525016332|FG002|Overall Study|Death|0|||
145591464|NCT02564523|525016333|FG003|Overall Study|Death|0|||
145591465|NCT02564523|525016334|FG004|Overall Study|Death|0|||
145591466|NCT02564523|525016335|FG005|Overall Study|Death|0|||
145591467|NCT02564523|525016336|FG006|Overall Study|Death|1|||
145591468|NCT02564523|525016337|FG007|Overall Study|Death|0|||
145591469|NCT02564523|525016338|FG008|Overall Study|Death|0|||
145591470|NCT02564523|525016339|FG009|Overall Study|Death|0|||
145591471|NCT02564523|525016340|FG010|Overall Study|Death|1|||
145591472|NCT02564523|525016341|FG011|Overall Study|Death|0|||
145591473|NCT02564523|525016342|FG012|Overall Study|Death|0|||
145591474|NCT02564523|525016343|FG013|Overall Study|Death|0|||
145591475|NCT02564523|525016344|FG014|Overall Study|Death|0|||
145591476|NCT02564523|525016345|FG015|Overall Study|Death|0|||
145591477|NCT02564523|525016346|FG016|Overall Study|Death|0|||
145591478|NCT02564523|525016347|FG017|Overall Study|Death|0|||
145591479|NCT02564523|525016330|FG000|Overall Study|Lost to Follow-up|2|||
145591480|NCT02564523|525016331|FG001|Overall Study|Lost to Follow-up|1|||
145591481|NCT02564523|525016332|FG002|Overall Study|Lost to Follow-up|4|||
145591482|NCT02564523|525016333|FG003|Overall Study|Lost to Follow-up|0|||
145591483|NCT02564523|525016334|FG004|Overall Study|Lost to Follow-up|1|||
145591484|NCT02564523|525016335|FG005|Overall Study|Lost to Follow-up|0|||
145591485|NCT02564523|525016336|FG006|Overall Study|Lost to Follow-up|1|||
145591486|NCT02564523|525016337|FG007|Overall Study|Lost to Follow-up|0|||
145591487|NCT02564523|525016338|FG008|Overall Study|Lost to Follow-up|0|||
145591488|NCT02564523|525016339|FG009|Overall Study|Lost to Follow-up|0|||
145591489|NCT02564523|525016340|FG010|Overall Study|Lost to Follow-up|0|||
145591490|NCT02564523|525016341|FG011|Overall Study|Lost to Follow-up|1|||
145591491|NCT02564523|525016342|FG012|Overall Study|Lost to Follow-up|1|||
145591492|NCT02564523|525016343|FG013|Overall Study|Lost to Follow-up|0|||
145591493|NCT02564523|525016344|FG014|Overall Study|Lost to Follow-up|0|||
145591494|NCT02564523|525016345|FG015|Overall Study|Lost to Follow-up|0|||
145591495|NCT02564523|525016346|FG016|Overall Study|Lost to Follow-up|0|||
145591496|NCT02564523|525016347|FG017|Overall Study|Lost to Follow-up|0|||
145591497|NCT02564523|525016330|FG000|Overall Study|Physician Decision|0|||
145591498|NCT02564523|525016331|FG001|Overall Study|Physician Decision|0|||
145591499|NCT02564523|525016332|FG002|Overall Study|Physician Decision|0|||
145591500|NCT02564523|525016333|FG003|Overall Study|Physician Decision|0|||
145591501|NCT02564523|525016334|FG004|Overall Study|Physician Decision|1|||
145591502|NCT02564523|525016335|FG005|Overall Study|Physician Decision|0|||
145591503|NCT02564523|525016336|FG006|Overall Study|Physician Decision|0|||
145591504|NCT02564523|525016337|FG007|Overall Study|Physician Decision|0|||
145591505|NCT02564523|525016338|FG008|Overall Study|Physician Decision|0|||
145591506|NCT02564523|525016339|FG009|Overall Study|Physician Decision|0|||
145591507|NCT02564523|525016340|FG010|Overall Study|Physician Decision|1|||
145591508|NCT02564523|525016341|FG011|Overall Study|Physician Decision|0|||
145591509|NCT02564523|525016342|FG012|Overall Study|Physician Decision|0|||
145591510|NCT02564523|525016343|FG013|Overall Study|Physician Decision|0|||
145591511|NCT02564523|525016344|FG014|Overall Study|Physician Decision|0|||
145591512|NCT02564523|525016345|FG015|Overall Study|Physician Decision|0|||
145591513|NCT02564523|525016346|FG016|Overall Study|Physician Decision|0|||
145591514|NCT02564523|525016347|FG017|Overall Study|Physician Decision|0|||
145591515|NCT02564523|525016330|FG000|Overall Study|Protocol Violation|2|||
145591516|NCT02564523|525016331|FG001|Overall Study|Protocol Violation|2|||
145591517|NCT02564523|525016332|FG002|Overall Study|Protocol Violation|5|||
145591518|NCT02564523|525016333|FG003|Overall Study|Protocol Violation|0|||
145591519|NCT02564523|525016334|FG004|Overall Study|Protocol Violation|1|||
145591520|NCT02564523|525016335|FG005|Overall Study|Protocol Violation|0|||
145626757|NCT02939183|525145781|FG004|Overall Study|Withdrawal by Subject|0|||
145458507|NCT02982018|524531451|FG001|Overall Study|Adverse Event|1|||
145591521|NCT02564523|525016336|FG006|Overall Study|Protocol Violation|0|||
145591522|NCT02564523|525016337|FG007|Overall Study|Protocol Violation|0|||
145591523|NCT02564523|525016338|FG008|Overall Study|Protocol Violation|0|||
145591524|NCT02564523|525016339|FG009|Overall Study|Protocol Violation|0|||
145591525|NCT02564523|525016340|FG010|Overall Study|Protocol Violation|0|||
145591526|NCT02564523|525016341|FG011|Overall Study|Protocol Violation|0|||
145591527|NCT02564523|525016342|FG012|Overall Study|Protocol Violation|0|||
145591528|NCT02564523|525016343|FG013|Overall Study|Protocol Violation|0|||
145591529|NCT02564523|525016344|FG014|Overall Study|Protocol Violation|0|||
145591530|NCT02564523|525016345|FG015|Overall Study|Protocol Violation|0|||
145591531|NCT02564523|525016346|FG016|Overall Study|Protocol Violation|0|||
145591532|NCT02564523|525016347|FG017|Overall Study|Protocol Violation|0|||
145591533|NCT02564523|525016330|FG000|Overall Study|Other|3|||
145591534|NCT02564523|525016331|FG001|Overall Study|Other|0|||
145591535|NCT02564523|525016332|FG002|Overall Study|Other|0|||
145458508|NCT02982018|524531450|FG000|Overall Study|Lens Discomfort|2|||
145458509|NCT02982018|524531451|FG001|Overall Study|Lens Discomfort|0|||
145458510|NCT02982018|524531450|FG000|Overall Study|Withdrawal by Subject|0|||
145458511|NCT02982018|524531451|FG001|Overall Study|Withdrawal by Subject|1|||
145458512|NCT04098367|524531458|FG000|Overall Study|Adverse Event|0|||
145458513|NCT04098367|524531459|FG001|Overall Study|Adverse Event|0|||
145458514|NCT04098367|524531460|FG002|Overall Study|Adverse Event|1|||
145458515|NCT04098367|524531458|FG000|Overall Study|Lost to Follow-up|1|||
145458516|NCT04098367|524531459|FG001|Overall Study|Lost to Follow-up|5|||
145458517|NCT04098367|524531460|FG002|Overall Study|Lost to Follow-up|2|||
145458518|NCT04098367|524531458|FG000|Overall Study|Withdrawal by Subject|0|||
145458519|NCT04098367|524531459|FG001|Overall Study|Withdrawal by Subject|0|||
145458520|NCT04098367|524531460|FG002|Overall Study|Withdrawal by Subject|1|||
145458521|NCT04098367|524531458|FG000|Overall Study|Sick . Could not attend visit|1|||
145458522|NCT04098367|524531459|FG001|Overall Study|Sick . Could not attend visit|0|||
145458523|NCT04098367|524531460|FG002|Overall Study|Sick . Could not attend visit|0|||
145458524|NCT02251717|524531461|FG000|Overall Study|Adverse Event|0|||
145458525|NCT02251717|524531462|FG001|Overall Study|Adverse Event|1|||
145458526|NCT02251717|524531461|FG000|Overall Study|Withdrew Consent|1|||
145458527|NCT02251717|524531462|FG001|Overall Study|Withdrew Consent|0|||
145458528|NCT00378599|524531463|FG000|Overall Study|Adverse Event|38|||
145458529|NCT00378599|524531463|FG000|Overall Study|Protocol Violation|2|||
145458530|NCT00378599|524531463|FG000|Overall Study|Treatment failure|7|||
145458531|NCT00378599|524531463|FG000|Overall Study|Withdrawal by Subject|5|||
145458532|NCT03920293|524531464|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
145458533|NCT03920293|524531465|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
145458534|NCT03920293|524531464|FG000|Randomized-Controlled Period|Physician Decision|1|||
145458535|NCT03920293|524531465|FG001|Randomized-Controlled Period|Physician Decision|2|||
145458536|NCT03920293|524531464|FG000|Randomized-Controlled Period|Adverse Event|0|||
145458537|NCT03920293|524531465|FG001|Randomized-Controlled Period|Adverse Event|2|||
145458538|NCT03920293|524531464|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
145458539|NCT03920293|524531465|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
145458540|NCT03920293|524531464|FG000|Randomized-Controlled Period|Death|2|||
145458541|NCT03920293|524531465|FG001|Randomized-Controlled Period|Death|0|||
145458542|NCT03920293|524531464|FG000|Randomized-Controlled Period|Protocol Violation|1|||
145458543|NCT03920293|524531465|FG001|Randomized-Controlled Period|Protocol Violation|0|||
145458544|NCT03920293|524531464|FG000|Randomized-Controlled Period|Noncompliance|1|||
145458545|NCT03920293|524531465|FG001|Randomized-Controlled Period|Noncompliance|0|||
145458546|NCT03920293|524531464|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
145458547|NCT03920293|524531465|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
145458548|NCT03920293|524531464|FG000|Open- Label Extension Period|Death|3|||
145458549|NCT03920293|524531465|FG001|Open- Label Extension Period|Death|3|||
145458550|NCT03920293|524531464|FG000|Open- Label Extension Period|Physician Decision|5|||
145458551|NCT03920293|524531465|FG001|Open- Label Extension Period|Physician Decision|3|||
145458552|NCT03920293|524531464|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
145458553|NCT03920293|524531465|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
145458554|NCT01691885|524531471|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
145458555|NCT01691885|524531472|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
145458556|NCT01691885|524531471|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
145458557|NCT01691885|524531472|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
145458558|NCT00996281|524531474|FG000|Overall Study|Adverse Event|75|||
145458559|NCT00996281|524531475|FG001|Overall Study|Adverse Event|37|||
145458560|NCT00996281|524531474|FG000|Overall Study|Major Protocol Deviation|6|||
145458561|NCT00996281|524531475|FG001|Overall Study|Major Protocol Deviation|7|||
145458562|NCT00996281|524531474|FG000|Overall Study|Lost to Follow-up|14|||
145458563|NCT00996281|524531475|FG001|Overall Study|Lost to Follow-up|16|||
145458564|NCT00996281|524531474|FG000|Overall Study|Withdrawal by Subject|31|||
145458565|NCT00996281|524531475|FG001|Overall Study|Withdrawal by Subject|20|||
145458566|NCT00996281|524531474|FG000|Overall Study|Lack of Efficacy|0|||
145458567|NCT00996281|524531475|FG001|Overall Study|Lack of Efficacy|2|||
145591536|NCT02564523|525016333|FG003|Overall Study|Other|1|||
145458568|NCT00996281|524531474|FG000|Overall Study|Other|5|||
145458569|NCT00996281|524531475|FG001|Overall Study|Other|7|||
145458570|NCT03505788|524531478|FG000|Overall Study|Lost to Follow-up|2|||
145458571|NCT03505788|524531479|FG001|Overall Study|Lost to Follow-up|1|||
145458572|NCT03505788|524531478|FG000|Overall Study|Withdrawal by Subject|1|||
145458573|NCT03505788|524531479|FG001|Overall Study|Withdrawal by Subject|3|||
145458574|NCT03505788|524531478|FG000|Overall Study|Physician Decision|0|||
145458575|NCT03505788|524531479|FG001|Overall Study|Physician Decision|1|||
145458576|NCT03575065|524531480|FG000|Overall Study|Death|31|||
145591537|NCT02564523|525016334|FG004|Overall Study|Other|0|||
145591538|NCT02564523|525016335|FG005|Overall Study|Other|0|||
145458577|NCT03575065|524531481|FG001|Overall Study|Death|12|||
145458578|NCT03575065|524531480|FG000|Overall Study|Sponsor's Decision|28|||
145458579|NCT03575065|524531481|FG001|Overall Study|Sponsor's Decision|13|||
145591539|NCT02564523|525016336|FG006|Overall Study|Other|0|||
145591540|NCT02564523|525016337|FG007|Overall Study|Other|0|||
145591541|NCT02564523|525016338|FG008|Overall Study|Other|0|||
145591542|NCT02564523|525016339|FG009|Overall Study|Other|0|||
145591543|NCT02564523|525016340|FG010|Overall Study|Other|0|||
145591544|NCT02564523|525016341|FG011|Overall Study|Other|0|||
145591545|NCT02564523|525016342|FG012|Overall Study|Other|0|||
145591546|NCT02564523|525016343|FG013|Overall Study|Other|0|||
145591547|NCT02564523|525016344|FG014|Overall Study|Other|0|||
145591548|NCT02564523|525016345|FG015|Overall Study|Other|0|||
145591549|NCT02564523|525016346|FG016|Overall Study|Other|0|||
145591550|NCT02564523|525016347|FG017|Overall Study|Other|0|||
145591551|NCT01816594|525016350|FG000|Overall Study|Local Progress|0|||
145591552|NCT01816594|525016351|FG001|Overall Study|Local Progress|2|||
145591553|NCT01816594|525016350|FG000|Overall Study|Adverse Event|9|||
145591554|NCT01816594|525016351|FG001|Overall Study|Adverse Event|0|||
145591555|NCT01816594|525016350|FG000|Overall Study|Withdrawal by Subject|1|||
145591556|NCT01816594|525016351|FG001|Overall Study|Withdrawal by Subject|0|||
145591557|NCT01816594|525016350|FG000|Overall Study|Physician Decision|1|||
145591558|NCT01816594|525016351|FG001|Overall Study|Physician Decision|0|||
145591559|NCT03905655|525016352|FG000|Overall Study|Adverse Event|1|||
145591560|NCT03905655|525016353|FG001|Overall Study|Adverse Event|0|||
145591561|NCT03905655|525016354|FG002|Overall Study|Adverse Event|1|||
145591562|NCT03905655|525016355|FG003|Overall Study|Adverse Event|1|||
145591563|NCT02566031|525016356|FG000|Overall Study|Patient/guardian decision|14|||
145591564|NCT02566031|525016357|FG001|Overall Study|Patient/guardian decision|7|||
145591565|NCT02566031|525016356|FG000|Overall Study|Protocol deviation|2|||
145591566|NCT02566031|525016357|FG001|Overall Study|Protocol deviation|3|||
145591567|NCT02566031|525016356|FG000|Overall Study|Adverse Event|3|||
145591568|NCT02566031|525016357|FG001|Overall Study|Adverse Event|1|||
145591569|NCT02566031|525016356|FG000|Overall Study|Lost to Follow-up|1|||
145591570|NCT02566031|525016357|FG001|Overall Study|Lost to Follow-up|1|||
145591571|NCT02277106|525016358|FG000|Stage 2|Adverse Event|0|||
145591572|NCT02277106|525016359|FG001|Stage 2|Adverse Event|0|||
145591573|NCT02277106|525016360|FG002|Stage 2|Adverse Event|1|||
145591574|NCT03031938|525016361|FG000|Overall Study|Death|1|||
145591575|NCT03031938|525016362|FG001|Overall Study|Death|0|||
145591576|NCT02479412|525016365|FG000|Overall Study|Adverse Event|0|||
145591577|NCT02479412|525016366|FG001|Overall Study|Adverse Event|0|||
145591578|NCT02479412|525016367|FG002|Overall Study|Adverse Event|1|||
145591579|NCT02479412|525016368|FG003|Overall Study|Adverse Event|0|||
145591580|NCT02479412|525016369|FG004|Overall Study|Adverse Event|0|||
145591581|NCT02479412|525016370|FG005|Overall Study|Adverse Event|0|||
145591582|NCT02479412|525016371|FG006|Overall Study|Adverse Event|0|||
145591583|NCT02479412|525016372|FG007|Overall Study|Adverse Event|0|||
145591584|NCT02479412|525016373|FG008|Overall Study|Adverse Event|0|||
145591585|NCT02479412|525016365|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145591586|NCT02479412|525016366|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145591587|NCT02479412|525016367|FG002|Overall Study|Study-specific withdrawal criteria|1|||
145591588|NCT02479412|525016368|FG003|Overall Study|Study-specific withdrawal criteria|1|||
145591589|NCT02479412|525016369|FG004|Overall Study|Study-specific withdrawal criteria|0|||
145591590|NCT02479412|525016370|FG005|Overall Study|Study-specific withdrawal criteria|0|||
145591591|NCT02479412|525016371|FG006|Overall Study|Study-specific withdrawal criteria|0|||
145591592|NCT02479412|525016372|FG007|Overall Study|Study-specific withdrawal criteria|1|||
145591593|NCT02479412|525016373|FG008|Overall Study|Study-specific withdrawal criteria|1|||
145591594|NCT02479412|525016365|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
145591595|NCT02479412|525016366|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
145591596|NCT02479412|525016367|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
145591597|NCT02479412|525016368|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
145591598|NCT02479412|525016369|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
145591599|NCT02479412|525016370|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
145591600|NCT02479412|525016371|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
145591601|NCT02479412|525016372|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
145591602|NCT02479412|525016373|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
145591603|NCT00515502|525016374|FG000|Treatment Period 1|Adverse Event|0|||
145591604|NCT00515502|525016375|FG001|Treatment Period 1|Adverse Event|0|||
145591605|NCT00515502|525016376|FG002|Treatment Period 1|Adverse Event|0|||
145591606|NCT00515502|525016377|FG003|Treatment Period 1|Adverse Event|0|||
145591607|NCT00515502|525016378|FG004|Treatment Period 1|Adverse Event|0|||
145591608|NCT00515502|525016379|FG005|Treatment Period 1|Adverse Event|0|||
145591609|NCT00515502|525016380|FG006|Treatment Period 1|Adverse Event|1|||
145591610|NCT00515502|525016381|FG007|Treatment Period 1|Adverse Event|0|||
145591611|NCT00515502|525016382|FG008|Treatment Period 1|Adverse Event|1|||
145591612|NCT00515502|525016383|FG009|Treatment Period 1|Adverse Event|0|||
145591613|NCT00515502|525016384|FG010|Treatment Period 1|Adverse Event|0|||
145591614|NCT00515502|525016385|FG011|Treatment Period 1|Adverse Event|1|||
145591615|NCT00515502|525016374|FG000|Treatment Period 2|Adverse Event|0|||
145591616|NCT00515502|525016375|FG001|Treatment Period 2|Adverse Event|1|||
145591617|NCT00515502|525016376|FG002|Treatment Period 2|Adverse Event|0|||
145591618|NCT00515502|525016377|FG003|Treatment Period 2|Adverse Event|0|||
145591619|NCT00515502|525016378|FG004|Treatment Period 2|Adverse Event|0|||
145591620|NCT00515502|525016379|FG005|Treatment Period 2|Adverse Event|0|||
145591621|NCT00515502|525016380|FG006|Treatment Period 2|Adverse Event|0|||
145591622|NCT00515502|525016381|FG007|Treatment Period 2|Adverse Event|0|||
145591623|NCT00515502|525016382|FG008|Treatment Period 2|Adverse Event|0|||
145591624|NCT00515502|525016383|FG009|Treatment Period 2|Adverse Event|0|||
145591625|NCT00515502|525016384|FG010|Treatment Period 2|Adverse Event|0|||
145591626|NCT00515502|525016385|FG011|Treatment Period 2|Adverse Event|0|||
145591627|NCT02732938|525016389|FG000|Overall Study|Death|0|||
145591628|NCT02732938|525016390|FG001|Overall Study|Death|11|||
145591629|NCT02732938|525016391|FG002|Overall Study|Death|0|||
145591630|NCT02732938|525016389|FG000|Overall Study|Randomized but did not receive treatment|0|||
145591631|NCT02732938|525016390|FG001|Overall Study|Randomized but did not receive treatment|1|||
145591632|NCT02732938|525016391|FG002|Overall Study|Randomized but did not receive treatment|0|||
145458580|NCT03575065|524531480|FG000|Overall Study|Withdrawal by Subject|2|||
145458581|NCT03575065|524531481|FG001|Overall Study|Withdrawal by Subject|1|||
145458582|NCT03575065|524531480|FG000|Overall Study|Lost to Follow-up|1|||
145458583|NCT03575065|524531481|FG001|Overall Study|Lost to Follow-up|0|||
145458584|NCT03344549|524531486|FG000|Overall Study|Withdrawal by Subject|3|||
145458585|NCT03344549|524531487|FG001|Overall Study|Withdrawal by Subject|2|||
145458586|NCT03344549|524531486|FG000|Overall Study|Dialysis|2|||
145458587|NCT03344549|524531487|FG001|Overall Study|Dialysis|0|||
145458588|NCT03344549|524531486|FG000|Overall Study|Cancer|1|||
145458589|NCT03344549|524531487|FG001|Overall Study|Cancer|0|||
145458590|NCT03344549|524531486|FG000|Overall Study|Lack of electronic device|1|||
145458591|NCT03344549|524531487|FG001|Overall Study|Lack of electronic device|0|||
145458592|NCT03344549|524531486|FG000|Overall Study|Transportation difficulty|0|||
145458593|NCT03344549|524531487|FG001|Overall Study|Transportation difficulty|13|||
145458594|NCT00113399|524531488|FG000|Overall Study|Death|1|||
145458595|NCT00113399|524531489|FG001|Overall Study|Death|1|||
145458596|NCT00113399|524531488|FG000|Overall Study|Withdrawal by Subject|1|||
145458597|NCT00113399|524531489|FG001|Overall Study|Withdrawal by Subject|2|||
145458598|NCT00113399|524531488|FG000|Overall Study|Complete Response|0|||
145458599|NCT00113399|524531489|FG001|Overall Study|Complete Response|1|||
145458600|NCT00113399|524531488|FG000|Overall Study|Other|0|||
145458601|NCT00113399|524531489|FG001|Overall Study|Other|1|||
145458602|NCT00396136|524531490|FG000|Overall Study|Death|43|||
145458603|NCT00396136|524531490|FG000|Overall Study|Withdrawal by Subject|59|||
145458604|NCT00396136|524531490|FG000|Overall Study|Lost to Follow-up|15|||
145458605|NCT00396136|524531490|FG000|Overall Study|Study device explanted|8|||
145458606|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
145458607|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
145458608|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
145458609|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
145458610|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
145458611|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
145458612|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
145458613|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458614|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458615|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458616|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
145458617|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
145458618|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458619|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458620|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458621|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145591633|NCT02732938|525016389|FG000|Overall Study|Refused further follow-up|1|||
145591634|NCT02732938|525016390|FG001|Overall Study|Refused further follow-up|0|||
145591635|NCT02732938|525016391|FG002|Overall Study|Refused further follow-up|0|||
145458622|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458623|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
145458624|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
145458625|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458626|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
145458627|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458628|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458629|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
145458630|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
145591636|NCT02732938|525016389|FG000|Overall Study|Study terminated by sponsor|3|||
145591637|NCT02732938|525016390|FG001|Overall Study|Study terminated by sponsor|6|||
145591638|NCT02732938|525016391|FG002|Overall Study|Study terminated by sponsor|0|||
145458631|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458632|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145591639|NCT04530448|525016392|FG000|Overall Study|Physician Decision|3|||
145591640|NCT04530448|525016393|FG001|Overall Study|Physician Decision|0|||
145591641|NCT01613248|525016394|FG000|Overall Study|Adverse Event|0|||
145591642|NCT01613248|525016395|FG001|Overall Study|Adverse Event|0|||
145591643|NCT01613248|525016396|FG002|Overall Study|Adverse Event|0|||
145591644|NCT01613248|525016397|FG003|Overall Study|Adverse Event|1|||
145591645|NCT01613248|525016398|FG004|Overall Study|Adverse Event|0|||
145591646|NCT01613248|525016399|FG005|Overall Study|Adverse Event|0|||
145591647|NCT01613248|525016394|FG000|Overall Study|Withdrawal by Subject|3|||
145591648|NCT01613248|525016395|FG001|Overall Study|Withdrawal by Subject|2|||
145591649|NCT01613248|525016396|FG002|Overall Study|Withdrawal by Subject|2|||
145591650|NCT01613248|525016397|FG003|Overall Study|Withdrawal by Subject|5|||
145591651|NCT01613248|525016398|FG004|Overall Study|Withdrawal by Subject|0|||
145591652|NCT01613248|525016399|FG005|Overall Study|Withdrawal by Subject|1|||
145591653|NCT01613248|525016394|FG000|Overall Study|Lost to Follow-up|5|||
145591654|NCT01613248|525016395|FG001|Overall Study|Lost to Follow-up|7|||
145591655|NCT01613248|525016396|FG002|Overall Study|Lost to Follow-up|4|||
145591656|NCT01613248|525016397|FG003|Overall Study|Lost to Follow-up|8|||
145591657|NCT01613248|525016398|FG004|Overall Study|Lost to Follow-up|4|||
145591658|NCT01613248|525016399|FG005|Overall Study|Lost to Follow-up|2|||
145591659|NCT01613248|525016394|FG000|Overall Study|Study Terminated by Sponsor|4|||
145591660|NCT01613248|525016395|FG001|Overall Study|Study Terminated by Sponsor|6|||
145591661|NCT01613248|525016396|FG002|Overall Study|Study Terminated by Sponsor|8|||
145591662|NCT01613248|525016397|FG003|Overall Study|Study Terminated by Sponsor|8|||
145591663|NCT01613248|525016398|FG004|Overall Study|Study Terminated by Sponsor|9|||
145591664|NCT01613248|525016399|FG005|Overall Study|Study Terminated by Sponsor|11|||
145591665|NCT01613248|525016394|FG000|Overall Study|Physician Decision|8|||
145591666|NCT01613248|525016395|FG001|Overall Study|Physician Decision|8|||
145591667|NCT01613248|525016396|FG002|Overall Study|Physician Decision|9|||
145591668|NCT01613248|525016397|FG003|Overall Study|Physician Decision|4|||
145591669|NCT01613248|525016398|FG004|Overall Study|Physician Decision|7|||
145591670|NCT01613248|525016399|FG005|Overall Study|Physician Decision|6|||
145591671|NCT01613248|525016394|FG000|Overall Study|Lack of Qualifying Event|9|||
145591672|NCT01613248|525016395|FG001|Overall Study|Lack of Qualifying Event|11|||
145591673|NCT01613248|525016396|FG002|Overall Study|Lack of Qualifying Event|10|||
145591674|NCT01613248|525016397|FG003|Overall Study|Lack of Qualifying Event|11|||
145591675|NCT01613248|525016398|FG004|Overall Study|Lack of Qualifying Event|15|||
145591676|NCT01613248|525016399|FG005|Overall Study|Lack of Qualifying Event|18|||
145591677|NCT01613248|525016394|FG000|Overall Study|Pregnancy|0|||
145591678|NCT01613248|525016395|FG001|Overall Study|Pregnancy|0|||
145591679|NCT01613248|525016396|FG002|Overall Study|Pregnancy|0|||
145591680|NCT01613248|525016397|FG003|Overall Study|Pregnancy|1|||
145591681|NCT01613248|525016398|FG004|Overall Study|Pregnancy|0|||
145591682|NCT01613248|525016399|FG005|Overall Study|Pregnancy|0|||
145591683|NCT01491854|525016401|FG000|Overall Study|mainly due to premature termination|93|||
145591684|NCT01491854|525016401|FG000|Overall Study|Death|1|||
145591685|NCT01491854|525016401|FG000|Overall Study|Withdrawal by Subject|3|||
145591686|NCT01491854|525016401|FG000|Overall Study|Lost to Follow-up|33|||
145591687|NCT01026974|525016413|FG000|Overall Study|Withdrawal by Subject|0|||
145591688|NCT01026974|525016414|FG001|Overall Study|Withdrawal by Subject|1|||
145591689|NCT01026974|525016415|FG002|Overall Study|Withdrawal by Subject|7|||
145591690|NCT01026974|525016416|FG003|Overall Study|Withdrawal by Subject|2|||
145591691|NCT01026974|525016413|FG000|Overall Study|Lost to Follow-up|1|||
145591692|NCT01026974|525016414|FG001|Overall Study|Lost to Follow-up|1|||
145591693|NCT01026974|525016415|FG002|Overall Study|Lost to Follow-up|4|||
145591694|NCT01026974|525016416|FG003|Overall Study|Lost to Follow-up|0|||
145591695|NCT01026974|525016413|FG000|Overall Study|Adverse Event|0|||
145591696|NCT01026974|525016414|FG001|Overall Study|Adverse Event|0|||
145591697|NCT01026974|525016415|FG002|Overall Study|Adverse Event|0|||
145591698|NCT01026974|525016416|FG003|Overall Study|Adverse Event|1|||
145591699|NCT01026974|525016413|FG000|Overall Study|Inappropriate enrollment|0|||
145591700|NCT01026974|525016414|FG001|Overall Study|Inappropriate enrollment|0|||
145591701|NCT01026974|525016415|FG002|Overall Study|Inappropriate enrollment|1|||
145591702|NCT01026974|525016416|FG003|Overall Study|Inappropriate enrollment|0|||
145591703|NCT03449030|525016434|FG000|Overall Study|Withdrawal by Subject|0|||
145591704|NCT03449030|525016435|FG001|Overall Study|Withdrawal by Subject|0|||
145591705|NCT03449030|525016436|FG002|Overall Study|Withdrawal by Subject|0|||
145591706|NCT03449030|525016437|FG003|Overall Study|Withdrawal by Subject|1|||
145591707|NCT03449030|525016438|FG004|Overall Study|Withdrawal by Subject|1|||
145591708|NCT03449030|525016439|FG005|Overall Study|Withdrawal by Subject|1|||
145591709|NCT03449030|525016440|FG006|Overall Study|Withdrawal by Subject|1|||
145591710|NCT03449030|525016441|FG007|Overall Study|Withdrawal by Subject|2|||
145591711|NCT03449030|525016442|FG008|Overall Study|Withdrawal by Subject|0|||
145591712|NCT03449030|525016443|FG009|Overall Study|Withdrawal by Subject|0|||
145591713|NCT03449030|525016434|FG000|Overall Study|Symptomatic Deterioration|0|||
145591714|NCT03449030|525016435|FG001|Overall Study|Symptomatic Deterioration|1|||
145591715|NCT03449030|525016436|FG002|Overall Study|Symptomatic Deterioration|0|||
145591716|NCT03449030|525016437|FG003|Overall Study|Symptomatic Deterioration|0|||
145591717|NCT03449030|525016438|FG004|Overall Study|Symptomatic Deterioration|0|||
145591718|NCT03449030|525016439|FG005|Overall Study|Symptomatic Deterioration|1|||
145591719|NCT03449030|525016440|FG006|Overall Study|Symptomatic Deterioration|1|||
145591720|NCT03449030|525016441|FG007|Overall Study|Symptomatic Deterioration|0|||
145591721|NCT03449030|525016442|FG008|Overall Study|Symptomatic Deterioration|2|||
145591722|NCT03449030|525016443|FG009|Overall Study|Symptomatic Deterioration|0|||
145591723|NCT03449030|525016434|FG000|Overall Study|Progressive Disease|1|||
145591724|NCT03449030|525016435|FG001|Overall Study|Progressive Disease|0|||
145591725|NCT03449030|525016436|FG002|Overall Study|Progressive Disease|1|||
145591726|NCT03449030|525016437|FG003|Overall Study|Progressive Disease|4|||
145591727|NCT03449030|525016438|FG004|Overall Study|Progressive Disease|5|||
145591728|NCT03449030|525016439|FG005|Overall Study|Progressive Disease|3|||
145591729|NCT03449030|525016440|FG006|Overall Study|Progressive Disease|0|||
145591730|NCT03449030|525016441|FG007|Overall Study|Progressive Disease|1|||
145591731|NCT03449030|525016442|FG008|Overall Study|Progressive Disease|1|||
145591732|NCT03449030|525016443|FG009|Overall Study|Progressive Disease|1|||
145591733|NCT03449030|525016434|FG000|Overall Study|Adverse Event|0|||
145591734|NCT03449030|525016435|FG001|Overall Study|Adverse Event|0|||
145591735|NCT03449030|525016436|FG002|Overall Study|Adverse Event|0|||
145591736|NCT03449030|525016437|FG003|Overall Study|Adverse Event|0|||
145591737|NCT03449030|525016438|FG004|Overall Study|Adverse Event|0|||
145591738|NCT03449030|525016439|FG005|Overall Study|Adverse Event|2|||
145591739|NCT03449030|525016440|FG006|Overall Study|Adverse Event|0|||
145591740|NCT03449030|525016441|FG007|Overall Study|Adverse Event|0|||
145591741|NCT03449030|525016442|FG008|Overall Study|Adverse Event|0|||
145591742|NCT03449030|525016443|FG009|Overall Study|Adverse Event|0|||
145591743|NCT03449030|525016434|FG000|Overall Study|Death|0|||
145591744|NCT03449030|525016435|FG001|Overall Study|Death|0|||
145591745|NCT03449030|525016436|FG002|Overall Study|Death|0|||
145591746|NCT03449030|525016437|FG003|Overall Study|Death|0|||
145591747|NCT03449030|525016438|FG004|Overall Study|Death|1|||
145591748|NCT03449030|525016439|FG005|Overall Study|Death|0|||
145591749|NCT03449030|525016440|FG006|Overall Study|Death|0|||
145591750|NCT03449030|525016441|FG007|Overall Study|Death|0|||
145591751|NCT03449030|525016442|FG008|Overall Study|Death|0|||
145591752|NCT03449030|525016443|FG009|Overall Study|Death|0|||
145591753|NCT00700401|525016451|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
145591754|NCT00700401|525016451|FG000|Overall Study|Adverse Event|5|||
145591755|NCT00700401|525016451|FG000|Overall Study|Refused Treatment|2|||
145591756|NCT00700401|525016451|FG000|Overall Study|Lost to Follow-up|1|||
145591757|NCT00700401|525016451|FG000|Overall Study|Treatment never started|1|||
145591758|NCT00700401|525016451|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
145591759|NCT00700401|525016451|FG000|Overall Study|Withdrawal by Subject|2|||
145591760|NCT00295750|525016452|FG000|Overall Study|Adverse Event|19|||
145591761|NCT00295750|525016453|FG001|Overall Study|Adverse Event|15|||
145591762|NCT00295750|525016454|FG002|Overall Study|Adverse Event|12|||
145591763|NCT00295750|525016452|FG000|Overall Study|Lack of Efficacy|1|||
145591764|NCT00295750|525016453|FG001|Overall Study|Lack of Efficacy|1|||
145591765|NCT00295750|525016454|FG002|Overall Study|Lack of Efficacy|0|||
145591766|NCT00295750|525016452|FG000|Overall Study|Lost to Follow-up|1|||
145591767|NCT00295750|525016453|FG001|Overall Study|Lost to Follow-up|4|||
145591768|NCT00295750|525016454|FG002|Overall Study|Lost to Follow-up|1|||
145591769|NCT00295750|525016452|FG000|Overall Study|Taking prohibited therapy|2|||
145591770|NCT00295750|525016453|FG001|Overall Study|Taking prohibited therapy|3|||
145591771|NCT00295750|525016454|FG002|Overall Study|Taking prohibited therapy|2|||
145591772|NCT00295750|525016452|FG000|Overall Study|Administrative errors|2|||
145591773|NCT00295750|525016453|FG001|Overall Study|Administrative errors|4|||
145591774|NCT00295750|525016454|FG002|Overall Study|Administrative errors|5|||
145591775|NCT00295750|525016452|FG000|Overall Study|Trial drug errors|1|||
145591776|NCT00295750|525016453|FG001|Overall Study|Trial drug errors|1|||
145591777|NCT00295750|525016454|FG002|Overall Study|Trial drug errors|0|||
145591778|NCT00295750|525016452|FG000|Overall Study|Disease progression|2|||
145591779|NCT00295750|525016453|FG001|Overall Study|Disease progression|1|||
145591780|NCT00295750|525016454|FG002|Overall Study|Disease progression|0|||
145591781|NCT00295750|525016452|FG000|Overall Study|Personal reasons|0|||
145591782|NCT00295750|525016453|FG001|Overall Study|Personal reasons|1|||
145591783|NCT00295750|525016454|FG002|Overall Study|Personal reasons|0|||
145591784|NCT00295750|525016452|FG000|Overall Study|Randomized but never received trial drug|4|||
145591785|NCT00295750|525016453|FG001|Overall Study|Randomized but never received trial drug|3|||
145591786|NCT00295750|525016454|FG002|Overall Study|Randomized but never received trial drug|3|||
145591787|NCT00295750|525016452|FG000|Overall Study|Withdrawal by Subject|9|||
145591788|NCT00295750|525016453|FG001|Overall Study|Withdrawal by Subject|4|||
145591789|NCT00295750|525016454|FG002|Overall Study|Withdrawal by Subject|7|||
145591790|NCT00295750|525016452|FG000|Overall Study|Protocol Violation|2|||
145591791|NCT00295750|525016453|FG001|Overall Study|Protocol Violation|4|||
145591792|NCT00295750|525016454|FG002|Overall Study|Protocol Violation|2|||
145591793|NCT01650259|525016455|FG000|Overall Study|Improvement|105|||
145591794|NCT01650259|525016456|FG001|Overall Study|Improvement|0|||
145591795|NCT01650259|525016455|FG000|Overall Study|Adverse Event|127|||
145591796|NCT01650259|525016456|FG001|Overall Study|Adverse Event|0|||
145591797|NCT01650259|525016455|FG000|Overall Study|Lack of Efficacy|143|||
145591798|NCT01650259|525016456|FG001|Overall Study|Lack of Efficacy|0|||
145591799|NCT01650259|525016455|FG000|Overall Study|Lost to Follow-up|435|||
145591800|NCT01650259|525016456|FG001|Overall Study|Lost to Follow-up|0|||
145591801|NCT01650259|525016455|FG000|Overall Study|Patients had no visit after entry|70|||
145591802|NCT01650259|525016456|FG001|Overall Study|Patients had no visit after entry|0|||
145591803|NCT01650259|525016455|FG000|Overall Study|CRF not collected|98|||
145591804|NCT01650259|525016456|FG001|Overall Study|CRF not collected|82|||
145591805|NCT01650259|525016455|FG000|Overall Study|Not treated|1|||
145591806|NCT01650259|525016456|FG001|Overall Study|Not treated|7|||
145591807|NCT01650259|525016455|FG000|Overall Study|Other than listed|64|||
145591808|NCT01650259|525016456|FG001|Overall Study|Other than listed|146|||
145591809|NCT00808808|525016464|FG000|Overall Study|Vaccinated; survey not completed|131|||
145591810|NCT00808808|525016465|FG001|Overall Study|Vaccinated; survey not completed|169|||
145591811|NCT00808808|525016466|FG002|Overall Study|Vaccinated; survey not completed|302|||
145591812|NCT00808808|525016464|FG000|Overall Study|Employee was not vaccinated.|2686|||
145591813|NCT00808808|525016465|FG001|Overall Study|Employee was not vaccinated.|2268|||
145591814|NCT00808808|525016466|FG002|Overall Study|Employee was not vaccinated.|2255|||
145591815|NCT04764396|525016469|FG000|Overall Study|Physician Decision|1|||
145591816|NCT04764396|525016470|FG001|Overall Study|Physician Decision|0|||
145591817|NCT03230916|525016471|FG000|Overall Study|Withdrawal by Subject|0|||
145591818|NCT03230916|525016472|FG001|Overall Study|Withdrawal by Subject|0|||
145591819|NCT03230916|525016473|FG002|Overall Study|Withdrawal by Subject|0|||
145591820|NCT03230916|525016474|FG003|Overall Study|Withdrawal by Subject|0|||
145591821|NCT03230916|525016475|FG004|Overall Study|Withdrawal by Subject|0|||
145591822|NCT03230916|525016476|FG005|Overall Study|Withdrawal by Subject|1|||
145591823|NCT03230916|525016477|FG006|Overall Study|Withdrawal by Subject|0|||
145591824|NCT03230916|525016478|FG007|Overall Study|Withdrawal by Subject|0|||
145591825|NCT03230916|525016479|FG008|Overall Study|Withdrawal by Subject|0|||
145591826|NCT03230916|525016480|FG009|Overall Study|Withdrawal by Subject|0|||
145591827|NCT03230916|525016481|FG010|Overall Study|Withdrawal by Subject|0|||
145591828|NCT01128413|525016482|FG000|Overall Study|Withdrawal by Subject|1|||
145591829|NCT01128413|525016483|FG001|Overall Study|Withdrawal by Subject|0|||
145591830|NCT01128413|525016482|FG000|Overall Study|NICOM Monitor Problems|2|||
145591831|NCT01128413|525016483|FG001|Overall Study|NICOM Monitor Problems|1|||
145591832|NCT01128413|525016482|FG000|Overall Study|Pt made DNR|1|||
145591833|NCT01128413|525016483|FG001|Overall Study|Pt made DNR|0|||
145591834|NCT02693665|525016486|FG000|Overall Study|Death|3|||
145591835|NCT02693665|525016487|FG001|Overall Study|Death|2|||
145591836|NCT02693665|525016486|FG000|Overall Study|Lost to Follow-up|7|||
145591837|NCT02693665|525016487|FG001|Overall Study|Lost to Follow-up|3|||
145591838|NCT02693665|525016486|FG000|Overall Study|Protocol Violation|1|||
145591839|NCT02693665|525016487|FG001|Overall Study|Protocol Violation|0|||
145591840|NCT02693665|525016486|FG000|Overall Study|Withdrawal by Subject|2|||
145591841|NCT02693665|525016487|FG001|Overall Study|Withdrawal by Subject|0|||
145591842|NCT02693665|525016486|FG000|Overall Study|patient wanted to leave it behind|1|||
145591843|NCT02693665|525016487|FG001|Overall Study|patient wanted to leave it behind|0|||
145591844|NCT02693665|525016486|FG000|Overall Study|anxiety|1|||
145591845|NCT02693665|525016487|FG001|Overall Study|anxiety|0|||
145591846|NCT02693665|525016486|FG000|Overall Study|family issues|1|||
145591847|NCT02693665|525016487|FG001|Overall Study|family issues|0|||
145591848|NCT02693665|525016486|FG000|Overall Study|no reason given|1|||
145591849|NCT02693665|525016487|FG001|Overall Study|no reason given|0|||
145591850|NCT06273774|525016489|FG000|Overall Study|Participant was out of state.|0|||
145591851|NCT06273774|525016490|FG001|Overall Study|Participant was out of state.|0|||
145591852|NCT06273774|525016491|FG002|Overall Study|Participant was out of state.|0|||
145591853|NCT06273774|525016492|FG003|Overall Study|Participant was out of state.|0|||
145591854|NCT06273774|525016493|FG004|Overall Study|Participant was out of state.|0|||
145591855|NCT06273774|525016494|FG005|Overall Study|Participant was out of state.|1|||
145591856|NCT06273774|525016489|FG000|Overall Study|Lost to Follow-up|0|||
145591857|NCT06273774|525016490|FG001|Overall Study|Lost to Follow-up|0|||
145591858|NCT06273774|525016491|FG002|Overall Study|Lost to Follow-up|0|||
145591859|NCT06273774|525016492|FG003|Overall Study|Lost to Follow-up|0|||
145591860|NCT06273774|525016493|FG004|Overall Study|Lost to Follow-up|1|||
145591861|NCT06273774|525016494|FG005|Overall Study|Lost to Follow-up|0|||
145591862|NCT02010060|525016495|FG000|Overall Study|Lost to Follow-up|1|||
145591863|NCT02010060|525016496|FG001|Overall Study|Lost to Follow-up|2|||
145591864|NCT02010060|525016497|FG002|Overall Study|Lost to Follow-up|2|||
145591865|NCT02010060|525016495|FG000|Overall Study|Injury|0|||
145591866|NCT02010060|525016496|FG001|Overall Study|Injury|1|||
145591867|NCT02010060|525016497|FG002|Overall Study|Injury|0|||
145591868|NCT06167031|525016500|FG000|Overall Study|Lost to Follow-up|5|||
145591869|NCT06167031|525016501|FG001|Overall Study|Lost to Follow-up|1|||
145591870|NCT00844857|525018255|FG000|Overall Study|Adverse Event|24|||
145591871|NCT00844857|525018256|FG001|Overall Study|Adverse Event|5|||
145591872|NCT00844857|525018255|FG000|Overall Study|Sponsor Decision|1|||
145591873|NCT00844857|525018256|FG001|Overall Study|Sponsor Decision|1|||
145591874|NCT00844857|525018255|FG000|Overall Study|Physician Decision|2|||
145458633|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458634|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458635|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458636|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458637|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458638|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458639|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458640|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458641|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
145458642|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458643|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458644|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
145458645|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458646|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458647|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458648|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458649|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458650|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458651|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458652|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458653|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458654|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458655|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458656|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458657|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458658|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458659|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
145458660|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458661|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458662|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
145458663|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458664|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458665|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458666|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458667|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458668|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458669|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458670|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458671|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458672|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458673|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458674|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458675|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458676|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458677|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
145458678|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458679|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458680|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458681|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458682|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458683|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458684|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458685|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458686|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458687|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458688|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
145458689|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458690|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145591875|NCT00844857|525018256|FG001|Overall Study|Physician Decision|0|||
145591876|NCT00844857|525018255|FG000|Overall Study|Parent/Caregiver Decision|6|||
145458691|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458692|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458693|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458694|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458695|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
145458696|NCT03447314|524531493|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458697|NCT03447314|524531494|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458698|NCT03447314|524531495|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458699|NCT03447314|524531496|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
145458700|NCT03447314|524531497|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458701|NCT03447314|524531498|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
145458702|NCT03447314|524531499|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458703|NCT03447314|524531500|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458704|NCT03447314|524531501|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458705|NCT03447314|524531502|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458706|NCT03447314|524531503|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458707|NCT03447314|524531504|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458708|NCT03447314|524531505|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458709|NCT03447314|524531506|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458710|NCT03447314|524531507|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458711|NCT03447314|524531508|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458712|NCT03447314|524531509|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458713|NCT03447314|524531510|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
145458714|NCT01703208|524531511|FG000|Overall Study|Death|61|||
145458715|NCT01703208|524531512|FG001|Overall Study|Death|48|||
145458716|NCT01703208|524531511|FG000|Overall Study|Lack of Efficacy|1|||
145458717|NCT01703208|524531512|FG001|Overall Study|Lack of Efficacy|2|||
145458718|NCT01703208|524531511|FG000|Overall Study|Lost to Follow-up|68|||
145458719|NCT01703208|524531512|FG001|Overall Study|Lost to Follow-up|62|||
145458720|NCT01703208|524531511|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145458721|NCT01703208|524531512|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145458722|NCT01703208|524531511|FG000|Overall Study|Excluded Medication|1|||
145458723|NCT01703208|524531512|FG001|Overall Study|Excluded Medication|2|||
145458724|NCT01703208|524531511|FG000|Overall Study|Site Discontinued Study Participation|23|||
145458725|NCT01703208|524531512|FG001|Overall Study|Site Discontinued Study Participation|27|||
145458726|NCT01703208|524531511|FG000|Overall Study|Physician Decision|11|||
145458727|NCT01703208|524531512|FG001|Overall Study|Physician Decision|13|||
145458728|NCT01703208|524531511|FG000|Overall Study|Progressive disease|2|||
145458729|NCT01703208|524531512|FG001|Overall Study|Progressive disease|2|||
145458730|NCT01703208|524531511|FG000|Overall Study|Protocol Violation|1|||
145458731|NCT01703208|524531512|FG001|Overall Study|Protocol Violation|1|||
145458732|NCT01703208|524531511|FG000|Overall Study|Study Terminated by Sponsor|1710|||
145458733|NCT01703208|524531512|FG001|Overall Study|Study Terminated by Sponsor|1716|||
145458734|NCT01703208|524531511|FG000|Overall Study|Withdrawal by Subject|205|||
145458735|NCT01703208|524531512|FG001|Overall Study|Withdrawal by Subject|209|||
145458736|NCT01703208|524531511|FG000|Overall Study|Adverse Event|14|||
145458737|NCT01703208|524531512|FG001|Overall Study|Adverse Event|19|||
145458738|NCT01703208|524531511|FG000|Overall Study|Technical Problems|0|||
145458739|NCT01703208|524531512|FG001|Overall Study|Technical Problems|1|||
145458740|NCT01703208|524531511|FG000|Overall Study|Protocol Deviation|2|||
145458741|NCT01703208|524531512|FG001|Overall Study|Protocol Deviation|0|||
145458742|NCT04003207|524531515|FG000|Overall Study|Protocol Violation|1|||
145458743|NCT04173260|524531516|FG000|Overall Study|Early termination|4|||
145458744|NCT02308163|524531517|FG000|Overall Study|Not fulfill eligible criteria|1|||
145458745|NCT02308163|524531518|FG001|Overall Study|Not fulfill eligible criteria|2|||
145458746|NCT02308163|524531519|FG002|Overall Study|Not fulfill eligible criteria|0|||
145458747|NCT02308163|524531520|FG003|Overall Study|Not fulfill eligible criteria|1|||
145458748|NCT02308163|524531521|FG004|Overall Study|Not fulfill eligible criteria|1|||
145458749|NCT02308163|524531517|FG000|Overall Study|Adverse Event|9|||
145458750|NCT02308163|524531518|FG001|Overall Study|Adverse Event|5|||
145458751|NCT02308163|524531519|FG002|Overall Study|Adverse Event|2|||
145458752|NCT02308163|524531520|FG003|Overall Study|Adverse Event|2|||
145458753|NCT02308163|524531521|FG004|Overall Study|Adverse Event|11|||
145458754|NCT02308163|524531517|FG000|Overall Study|Lack of Efficacy|11|||
145458755|NCT02308163|524531518|FG001|Overall Study|Lack of Efficacy|3|||
145458756|NCT02308163|524531519|FG002|Overall Study|Lack of Efficacy|8|||
145458757|NCT02308163|524531520|FG003|Overall Study|Lack of Efficacy|4|||
145458758|NCT02308163|524531521|FG004|Overall Study|Lack of Efficacy|6|||
145458759|NCT02308163|524531517|FG000|Overall Study|Withdrawal of consent|2|||
145458760|NCT02308163|524531518|FG001|Overall Study|Withdrawal of consent|3|||
145591877|NCT00844857|525018256|FG001|Overall Study|Parent/Caregiver Decision|2|||
145591878|NCT00844857|525018255|FG000|Overall Study|Withdrawal by Subject|8|||
145591879|NCT00844857|525018256|FG001|Overall Study|Withdrawal by Subject|7|||
145591880|NCT00844857|525018255|FG000|Overall Study|Protocol Violation|6|||
145591881|NCT00844857|525018256|FG001|Overall Study|Protocol Violation|0|||
145591882|NCT00844857|525018255|FG000|Overall Study|Lack of Efficacy|5|||
145591883|NCT00844857|525018256|FG001|Overall Study|Lack of Efficacy|5|||
145591884|NCT00844857|525018255|FG000|Overall Study|Clinical Relapse|0|||
145591885|NCT00844857|525018256|FG001|Overall Study|Clinical Relapse|1|||
145591886|NCT00844857|525018255|FG000|Overall Study|Entry Criteria Not Met|0|||
145591887|NCT00844857|525018256|FG001|Overall Study|Entry Criteria Not Met|1|||
145591888|NCT00844857|525018255|FG000|Overall Study|Lost to Follow-up|2|||
145591889|NCT00844857|525018256|FG001|Overall Study|Lost to Follow-up|3|||
145591890|NCT00844857|525018255|FG000|Overall Study|Did Not Take Study Drug|3|||
145591891|NCT00844857|525018256|FG001|Overall Study|Did Not Take Study Drug|1|||
145591892|NCT00844857|525018255|FG000|Overall Study|Good Clinical Practice Violations|21|||
145591893|NCT00844857|525018256|FG001|Overall Study|Good Clinical Practice Violations|11|||
145591894|NCT00570674|525018257|FG000|Overall Study|Withdrawal by Subject|0|||
145591895|NCT00570674|525018258|FG001|Overall Study|Withdrawal by Subject|0|||
145591896|NCT00570674|525018259|FG002|Overall Study|Withdrawal by Subject|1|||
145591897|NCT00570674|525018260|FG003|Overall Study|Withdrawal by Subject|0|||
145591898|NCT00570674|525018261|FG004|Overall Study|Withdrawal by Subject|0|||
145591899|NCT00570674|525018262|FG005|Overall Study|Withdrawal by Subject|0|||
145591900|NCT00570674|525018263|FG006|Overall Study|Withdrawal by Subject|0|||
145591901|NCT02120027|525018266|FG000|Overall Study|Adverse Event|4|||
145591902|NCT02120027|525018267|FG001|Overall Study|Adverse Event|5|||
145591903|NCT02120027|525018266|FG000|Overall Study|Lack of Efficacy|3|||
145591904|NCT02120027|525018267|FG001|Overall Study|Lack of Efficacy|5|||
145591905|NCT02120027|525018266|FG000|Overall Study|Lost to Follow-up|5|||
145591906|NCT02120027|525018267|FG001|Overall Study|Lost to Follow-up|13|||
145591907|NCT02120027|525018266|FG000|Overall Study|Other|4|||
145591908|NCT02120027|525018267|FG001|Overall Study|Other|0|||
145591909|NCT02120027|525018266|FG000|Overall Study|Physician Decision|4|||
145591910|NCT02120027|525018267|FG001|Overall Study|Physician Decision|3|||
145591911|NCT02120027|525018266|FG000|Overall Study|Protocol Violation|18|||
145591912|NCT02120027|525018267|FG001|Overall Study|Protocol Violation|21|||
145591913|NCT02120027|525018266|FG000|Overall Study|Study terminated by Sponsor|45|||
145591914|NCT02120027|525018267|FG001|Overall Study|Study terminated by Sponsor|47|||
145591915|NCT02120027|525018266|FG000|Overall Study|Withdrawal by Subject|33|||
145591916|NCT02120027|525018267|FG001|Overall Study|Withdrawal by Subject|25|||
145591917|NCT03393000|525018270|FG000|Overall Study|Death|11|||
145591918|NCT03393000|525018270|FG000|Overall Study|Withdrawal by Subject|2|||
145591919|NCT03393000|525018270|FG000|Overall Study|Physician Decision|1|||
145591920|NCT01773070|525018271|FG000|Overall Study|Withdrawal by Subject|24|||
145591921|NCT01773070|525018271|FG000|Overall Study|Lost to Follow-up|39|||
145591922|NCT01773070|525018271|FG000|Overall Study|Other|15|||
145591923|NCT01773070|525018271|FG000|Overall Study|Death (unrelated to study procedures)|3|||
145591924|NCT01471054|525018272|FG000|Overall Study|Study terminated prematurely|4|||
145591925|NCT01471054|525018273|FG001|Overall Study|Study terminated prematurely|0|||
145591926|NCT02181803|525018274|FG000|Overall Study|Withdrawal by Subject|0|||
145591927|NCT02181803|525018275|FG001|Overall Study|Withdrawal by Subject|2|||
145591928|NCT02181803|525018276|FG002|Overall Study|Withdrawal by Subject|0|||
145591929|NCT02181803|525018277|FG003|Overall Study|Withdrawal by Subject|0|||
145591930|NCT02181803|525018278|FG004|Overall Study|Withdrawal by Subject|0|||
145591931|NCT02181803|525018279|FG005|Overall Study|Withdrawal by Subject|0|||
145591932|NCT02181803|525018280|FG006|Overall Study|Withdrawal by Subject|0|||
145591933|NCT02181803|525018281|FG007|Overall Study|Withdrawal by Subject|0|||
145591934|NCT02181803|525018282|FG008|Overall Study|Withdrawal by Subject|0|||
145591935|NCT02181803|525018274|FG000|Overall Study|Physician Decision|0|||
145591936|NCT02181803|525018275|FG001|Overall Study|Physician Decision|0|||
145591937|NCT02181803|525018276|FG002|Overall Study|Physician Decision|0|||
145591938|NCT02181803|525018277|FG003|Overall Study|Physician Decision|1|||
145591939|NCT02181803|525018278|FG004|Overall Study|Physician Decision|0|||
145591940|NCT02181803|525018279|FG005|Overall Study|Physician Decision|0|||
145591941|NCT02181803|525018280|FG006|Overall Study|Physician Decision|0|||
145591942|NCT02181803|525018281|FG007|Overall Study|Physician Decision|1|||
145591943|NCT02181803|525018282|FG008|Overall Study|Physician Decision|0|||
145591944|NCT02181803|525018274|FG000|Overall Study|Adverse Event|0|||
145591945|NCT02181803|525018275|FG001|Overall Study|Adverse Event|2|||
145591946|NCT02181803|525018276|FG002|Overall Study|Adverse Event|0|||
145591947|NCT02181803|525018277|FG003|Overall Study|Adverse Event|1|||
145591948|NCT02181803|525018278|FG004|Overall Study|Adverse Event|0|||
145591949|NCT02181803|525018279|FG005|Overall Study|Adverse Event|0|||
145591950|NCT02181803|525018280|FG006|Overall Study|Adverse Event|1|||
145591951|NCT02181803|525018281|FG007|Overall Study|Adverse Event|0|||
145591952|NCT02181803|525018282|FG008|Overall Study|Adverse Event|0|||
145591953|NCT03280121|525018283|FG000|Overall Study|Physician Decision|1|||
145591954|NCT03280121|525018283|FG000|Overall Study|Lost to Follow-up|1|||
145458761|NCT02308163|524531519|FG002|Overall Study|Withdrawal of consent|0|||
145458762|NCT02308163|524531520|FG003|Overall Study|Withdrawal of consent|2|||
145458763|NCT02308163|524531521|FG004|Overall Study|Withdrawal of consent|6|||
145458764|NCT02308163|524531517|FG000|Overall Study|Protocol Violation|3|||
145458765|NCT02308163|524531518|FG001|Overall Study|Protocol Violation|3|||
145458766|NCT02308163|524531519|FG002|Overall Study|Protocol Violation|3|||
145458767|NCT02308163|524531520|FG003|Overall Study|Protocol Violation|2|||
145458768|NCT02308163|524531521|FG004|Overall Study|Protocol Violation|5|||
145458769|NCT02308163|524531517|FG000|Overall Study|Lab data met discontinuation criteria|3|||
145458770|NCT02308163|524531518|FG001|Overall Study|Lab data met discontinuation criteria|0|||
145458771|NCT02308163|524531519|FG002|Overall Study|Lab data met discontinuation criteria|0|||
145458772|NCT02308163|524531520|FG003|Overall Study|Lab data met discontinuation criteria|2|||
145458773|NCT02308163|524531521|FG004|Overall Study|Lab data met discontinuation criteria|0|||
145458774|NCT02308163|524531517|FG000|Overall Study|Miscellaneous|2|||
145458775|NCT02308163|524531518|FG001|Overall Study|Miscellaneous|2|||
145458776|NCT02308163|524531519|FG002|Overall Study|Miscellaneous|1|||
145458777|NCT02308163|524531520|FG003|Overall Study|Miscellaneous|0|||
145458778|NCT02308163|524531521|FG004|Overall Study|Miscellaneous|5|||
145458779|NCT00443053|524531526|FG000|Overall Study|Adverse Event|2|||
145458780|NCT00443053|524531527|FG001|Overall Study|Adverse Event|1|||
145458781|NCT00443053|524531526|FG000|Overall Study|Withdrawal by Subject|9|||
145458782|NCT00443053|524531527|FG001|Overall Study|Withdrawal by Subject|18|||
145591955|NCT03280121|525018283|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
145626758|NCT02939183|525145782|FG005|Overall Study|Withdrawal by Subject|0|||
145626759|NCT02939183|525145783|FG006|Overall Study|Withdrawal by Subject|2|||
145626760|NCT02939183|525145784|FG007|Overall Study|Withdrawal by Subject|2|||
145626761|NCT02939183|525145785|FG008|Overall Study|Withdrawal by Subject|2|||
145626762|NCT02939183|525145777|FG000|Overall Study|Not treated due to adverse event|0|||
145591956|NCT03638141|525018293|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
145591957|NCT03996473|525018294|FG000|Treatment Assignment|Withdrawal by Subject|1|||
145591958|NCT03996473|525018294|FG000|Treatment Assignment|Progressive disease|6|||
145591959|NCT03996473|525018294|FG000|Treatment Assignment|Study drug never administered|1|||
145591960|NCT03996473|525018294|FG000|Active Follow-up|Death|1|||
145591961|NCT03996473|525018294|FG000|Long-term Follow-up|Death|5|||
145591962|NCT03759873|525018295|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
145591963|NCT03759873|525018296|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
145591964|NCT03759873|525018297|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
145591965|NCT03759873|525018298|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
145591966|NCT03759873|525018295|FG000|Overall Study|Moved outside eligible area|0|||
145591967|NCT03759873|525018296|FG001|Overall Study|Moved outside eligible area|2|||
145591968|NCT03759873|525018297|FG002|Overall Study|Moved outside eligible area|0|||
145591969|NCT03759873|525018298|FG003|Overall Study|Moved outside eligible area|0|||
145591970|NCT03759873|525018295|FG000|Overall Study|Withdrawal by Subject|0|||
145591971|NCT03759873|525018296|FG001|Overall Study|Withdrawal by Subject|0|||
145591972|NCT03759873|525018297|FG002|Overall Study|Withdrawal by Subject|1|||
145591973|NCT03759873|525018298|FG003|Overall Study|Withdrawal by Subject|0|||
145591974|NCT06116591|525018301|FG000|Overall Study|No longer met eligibility criteria|0|||
145591975|NCT06116591|525018302|FG001|Overall Study|No longer met eligibility criteria|1|||
145591976|NCT06116591|525018301|FG000|Overall Study|Other: Change in life situation|0|||
145591977|NCT06116591|525018302|FG001|Overall Study|Other: Change in life situation|1|||
145591978|NCT05585307|525018303|FG000|Overall Study|Lost to Follow-up|0|||
145591979|NCT05585307|525018304|FG001|Overall Study|Lost to Follow-up|0|||
145626763|NCT02939183|525145778|FG001|Overall Study|Not treated due to adverse event|0|||
145458783|NCT00443053|524531526|FG000|Overall Study|Lost to Follow-up|4|||
145591980|NCT05585307|525018305|FG002|Overall Study|Lost to Follow-up|0|||
145591981|NCT05585307|525018306|FG003|Overall Study|Lost to Follow-up|0|||
145591982|NCT05585307|525018307|FG004|Overall Study|Lost to Follow-up|0|||
145591983|NCT05585307|525018308|FG005|Overall Study|Lost to Follow-up|0|||
145591984|NCT05585307|525018309|FG006|Overall Study|Lost to Follow-up|1|||
145591985|NCT05585307|525018310|FG007|Overall Study|Lost to Follow-up|0|||
145458784|NCT00443053|524531527|FG001|Overall Study|Lost to Follow-up|5|||
145458785|NCT00443053|524531526|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
145458786|NCT00443053|524531527|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
145591986|NCT01869491|525018311|FG000|Overall Study|Adverse Event|3|||
145591987|NCT01869491|525018312|FG001|Overall Study|Adverse Event|5|||
145591988|NCT01869491|525018311|FG000|Overall Study|Lack of Efficacy|0|||
145591989|NCT01869491|525018312|FG001|Overall Study|Lack of Efficacy|3|||
145591990|NCT01869491|525018311|FG000|Overall Study|Withdrawal by Subject|6|||
145458787|NCT00443053|524531526|FG000|Overall Study|Noncompliance|2|||
145458788|NCT00443053|524531527|FG001|Overall Study|Noncompliance|1|||
145458789|NCT00443053|524531526|FG000|Overall Study|Other|3|||
145458790|NCT00443053|524531527|FG001|Overall Study|Other|4|||
145458791|NCT00443053|524531526|FG000|Overall Study|Physician Decision|0|||
145591991|NCT01869491|525018312|FG001|Overall Study|Withdrawal by Subject|7|||
145591992|NCT01869491|525018311|FG000|Overall Study|Lost to Follow-up|11|||
145591993|NCT01869491|525018312|FG001|Overall Study|Lost to Follow-up|9|||
145591994|NCT01869491|525018311|FG000|Overall Study|No further need of investigational product|1|||
145591995|NCT01869491|525018312|FG001|Overall Study|No further need of investigational product|0|||
145591996|NCT01362140|525018313|FG000|Overall Study|Noncompliance|1|||
145591997|NCT01362140|525018314|FG001|Overall Study|Noncompliance|0|||
145591998|NCT01362140|525018313|FG000|Overall Study|Adverse Event|2|||
145591999|NCT01362140|525018314|FG001|Overall Study|Adverse Event|2|||
145592000|NCT01362140|525018313|FG000|Overall Study|Withdrawal by Subject|3|||
145592001|NCT01362140|525018314|FG001|Overall Study|Withdrawal by Subject|3|||
145458792|NCT00443053|524531527|FG001|Overall Study|Physician Decision|4|||
145458793|NCT00522418|524531528|FG000|Overall Study|Local IRB Consent Violation|5|||
145592002|NCT01362140|525018313|FG000|Overall Study|Administrative Decision|0|||
145592003|NCT01362140|525018314|FG001|Overall Study|Administrative Decision|1|||
145592004|NCT01362140|525018313|FG000|Overall Study|Death|2|||
145592005|NCT01362140|525018314|FG001|Overall Study|Death|1|||
145592006|NCT01362140|525018313|FG000|Overall Study|Other|1|||
145592007|NCT01362140|525018314|FG001|Overall Study|Other|1|||
145592008|NCT01362140|525018313|FG000|Overall Study|Protocol-specified Criteria|1|||
145592009|NCT01362140|525018314|FG001|Overall Study|Protocol-specified Criteria|2|||
145592010|NCT01362140|525018313|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
145592011|NCT01362140|525018314|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
145458794|NCT00522418|524531529|FG001|Overall Study|Local IRB Consent Violation|5|||
145458795|NCT00522418|524531528|FG000|Overall Study|Early Study Termination|46|||
145458796|NCT00522418|524531529|FG001|Overall Study|Early Study Termination|47|||
145458797|NCT00522418|524531528|FG000|Overall Study|Noncompliance|2|||
145458798|NCT00522418|524531529|FG001|Overall Study|Noncompliance|2|||
145458799|NCT00522418|524531528|FG000|Overall Study|Reason Not Specified|3|||
145458800|NCT00522418|524531529|FG001|Overall Study|Reason Not Specified|1|||
145458801|NCT00522418|524531528|FG000|Overall Study|Consent Withdraw|1|||
145458802|NCT00522418|524531529|FG001|Overall Study|Consent Withdraw|2|||
145458803|NCT00522418|524531528|FG000|Overall Study|Lack of Efficacy|0|||
145458804|NCT00522418|524531529|FG001|Overall Study|Lack of Efficacy|1|||
145458805|NCT01574157|524531530|FG000|Overall Study|Withdrawal by Subject|4|||
145458806|NCT01574157|524531531|FG001|Overall Study|Withdrawal by Subject|5|||
145458807|NCT01574157|524531530|FG000|Overall Study|Lost to Follow-up|0|||
145458808|NCT01574157|524531531|FG001|Overall Study|Lost to Follow-up|3|||
145458809|NCT00578877|524531534|FG000|Overall Study|Lost to Follow-up|8|||
145458810|NCT00578877|524531535|FG001|Overall Study|Lost to Follow-up|10|||
145458811|NCT00578877|524531534|FG000|Overall Study|early discontinue|61|||
145458812|NCT00578877|524531535|FG001|Overall Study|early discontinue|101|||
145458813|NCT00578877|524531534|FG000|Overall Study|did not provide follow-up data|12|||
145458814|NCT00578877|524531535|FG001|Overall Study|did not provide follow-up data|17|||
145458815|NCT01944098|524531540|FG000|Overall Study|Physician Decision|1|||
145458816|NCT01944098|524531541|FG001|Overall Study|Physician Decision|0|||
145458817|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
145458818|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
145458819|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
145458820|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
145458821|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
145458822|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
145458823|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
145458824|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
145458825|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
145592012|NCT06476366|525018315|FG000|Overall Study|Lost to Follow-up|1|||
145592013|NCT06476366|525018316|FG001|Overall Study|Lost to Follow-up|3|||
145592014|NCT06476366|525018315|FG000|Overall Study|Adverse Event|1|||
145592015|NCT06476366|525018316|FG001|Overall Study|Adverse Event|0|||
145592016|NCT01910129|525018319|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
145592017|NCT01910129|525018320|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
145592018|NCT01910129|525018321|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
145592019|NCT01910129|525018319|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
145592020|NCT01910129|525018320|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
145592021|NCT01910129|525018321|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
145458826|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
145458827|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
145458828|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
145458829|NCT01632241|524531542|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
145458830|NCT01632241|524531543|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
145458831|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
145592022|NCT02195986|525018322|FG000|Overall Study|Adverse Event|3|||
145592023|NCT02195986|525018323|FG001|Overall Study|Adverse Event|0|||
145458832|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
145458833|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
145592024|NCT02195986|525018324|FG002|Overall Study|Adverse Event|0|||
145592025|NCT02195986|525018322|FG000|Overall Study|Withdrawal by Subject|0|||
145592026|NCT02195986|525018323|FG001|Overall Study|Withdrawal by Subject|3|||
145592027|NCT02195986|525018324|FG002|Overall Study|Withdrawal by Subject|0|||
145592028|NCT02195986|525018322|FG000|Overall Study|Family Emergency|0|||
145592029|NCT02195986|525018323|FG001|Overall Study|Family Emergency|0|||
145592030|NCT02195986|525018324|FG002|Overall Study|Family Emergency|1|||
145592031|NCT02195986|525018322|FG000|Overall Study|Protocol Violation|0|||
145592032|NCT02195986|525018323|FG001|Overall Study|Protocol Violation|1|||
145592033|NCT02195986|525018324|FG002|Overall Study|Protocol Violation|1|||
145592034|NCT02195986|525018322|FG000|Overall Study|Non-compliance|0|||
145592035|NCT02195986|525018323|FG001|Overall Study|Non-compliance|1|||
145592036|NCT02195986|525018324|FG002|Overall Study|Non-compliance|0|||
145592037|NCT00965523|525018325|FG000|Study 221|Progressive Disease|4|||
145592038|NCT00965523|525018325|FG000|Study 221|Physician Decision|3|||
145592039|NCT00965523|525018325|FG000|Study 224|Progressive Disease|5|||
145592040|NCT00965523|525018325|FG000|Study 224|Physician Decision|1|||
145592041|NCT02415400|525018326|FG000|Overall Study|Adverse Event|0|||
145592042|NCT02415400|525018327|FG001|Overall Study|Adverse Event|1|||
145592043|NCT02415400|525018328|FG002|Overall Study|Adverse Event|1|||
145592044|NCT02415400|525018329|FG003|Overall Study|Adverse Event|2|||
145592045|NCT02415400|525018326|FG000|Overall Study|Participant request to stop therapy|4|||
145592046|NCT02415400|525018327|FG001|Overall Study|Participant request to stop therapy|3|||
145592047|NCT02415400|525018328|FG002|Overall Study|Participant request to stop therapy|8|||
145592048|NCT02415400|525018329|FG003|Overall Study|Participant request to stop therapy|6|||
145592049|NCT02415400|525018326|FG000|Overall Study|Participant withdrew consent|14|||
145592050|NCT02415400|525018327|FG001|Overall Study|Participant withdrew consent|12|||
145592051|NCT02415400|525018328|FG002|Overall Study|Participant withdrew consent|30|||
145592052|NCT02415400|525018329|FG003|Overall Study|Participant withdrew consent|21|||
145592053|NCT02415400|525018326|FG000|Overall Study|Death|39|||
145592054|NCT02415400|525018327|FG001|Overall Study|Death|41|||
145592055|NCT02415400|525018328|FG002|Overall Study|Death|35|||
145592056|NCT02415400|525018329|FG003|Overall Study|Death|42|||
145592057|NCT02415400|525018326|FG000|Overall Study|Lost to Follow-up|3|||
145592058|NCT02415400|525018327|FG001|Overall Study|Lost to Follow-up|3|||
145592059|NCT02415400|525018328|FG002|Overall Study|Lost to Follow-up|2|||
145592060|NCT02415400|525018329|FG003|Overall Study|Lost to Follow-up|5|||
145592061|NCT02415400|525018326|FG000|Overall Study|Poor/Non-Compliance|0|||
145592062|NCT02415400|525018327|FG001|Overall Study|Poor/Non-Compliance|1|||
145592063|NCT02415400|525018328|FG002|Overall Study|Poor/Non-Compliance|3|||
145592064|NCT02415400|525018329|FG003|Overall Study|Poor/Non-Compliance|4|||
145592065|NCT02415400|525018326|FG000|Overall Study|Participant no longer meets criteria|2|||
145592066|NCT02415400|525018327|FG001|Overall Study|Participant no longer meets criteria|0|||
145592067|NCT02415400|525018328|FG002|Overall Study|Participant no longer meets criteria|0|||
145592068|NCT02415400|525018329|FG003|Overall Study|Participant no longer meets criteria|1|||
145592069|NCT02415400|525018326|FG000|Overall Study|Participant doesn't answer phone|1|||
145592070|NCT02415400|525018327|FG001|Overall Study|Participant doesn't answer phone|0|||
145592071|NCT02415400|525018328|FG002|Overall Study|Participant doesn't answer phone|0|||
145592072|NCT02415400|525018329|FG003|Overall Study|Participant doesn't answer phone|0|||
145592073|NCT02415400|525018326|FG000|Overall Study|Participant wanted home visits|1|||
145592074|NCT02415400|525018327|FG001|Overall Study|Participant wanted home visits|0|||
145592075|NCT02415400|525018328|FG002|Overall Study|Participant wanted home visits|0|||
145592076|NCT02415400|525018329|FG003|Overall Study|Participant wanted home visits|0|||
145592077|NCT02415400|525018326|FG000|Overall Study|Randomized in error|2|||
145592078|NCT02415400|525018327|FG001|Overall Study|Randomized in error|0|||
145592079|NCT02415400|525018328|FG002|Overall Study|Randomized in error|0|||
145592080|NCT02415400|525018329|FG003|Overall Study|Randomized in error|0|||
145592081|NCT02415400|525018326|FG000|Overall Study|No study drug on site|0|||
145592082|NCT02415400|525018327|FG001|Overall Study|No study drug on site|1|||
145592083|NCT02415400|525018328|FG002|Overall Study|No study drug on site|0|||
145592084|NCT02415400|525018329|FG003|Overall Study|No study drug on site|0|||
145592085|NCT02415400|525018326|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
145592086|NCT02415400|525018327|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
145592087|NCT02415400|525018328|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
145592088|NCT02415400|525018329|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
145592089|NCT02415400|525018326|FG000|Overall Study|Coagulation values cannot be set|0|||
145592090|NCT02415400|525018327|FG001|Overall Study|Coagulation values cannot be set|0|||
145592091|NCT02415400|525018328|FG002|Overall Study|Coagulation values cannot be set|1|||
145592092|NCT02415400|525018329|FG003|Overall Study|Coagulation values cannot be set|0|||
145592093|NCT02415400|525018326|FG000|Overall Study|State regulations prevent participation|0|||
145592094|NCT02415400|525018327|FG001|Overall Study|State regulations prevent participation|0|||
145592095|NCT02415400|525018328|FG002|Overall Study|State regulations prevent participation|1|||
145592096|NCT02415400|525018329|FG003|Overall Study|State regulations prevent participation|0|||
145592097|NCT02415400|525018326|FG000|Overall Study|Poor treatment monitoring|0|||
145592098|NCT02415400|525018327|FG001|Overall Study|Poor treatment monitoring|0|||
145592099|NCT02415400|525018328|FG002|Overall Study|Poor treatment monitoring|1|||
145592100|NCT02415400|525018329|FG003|Overall Study|Poor treatment monitoring|0|||
145592101|NCT02415400|525018326|FG000|Overall Study|Participant in jail|0|||
145592102|NCT02415400|525018327|FG001|Overall Study|Participant in jail|0|||
145592103|NCT02415400|525018328|FG002|Overall Study|Participant in jail|1|||
145592104|NCT02415400|525018329|FG003|Overall Study|Participant in jail|0|||
145592105|NCT02415400|525018326|FG000|Overall Study|Investigator decision|0|||
145592106|NCT02415400|525018327|FG001|Overall Study|Investigator decision|0|||
145592107|NCT02415400|525018328|FG002|Overall Study|Investigator decision|1|||
145592108|NCT02415400|525018329|FG003|Overall Study|Investigator decision|1|||
145592109|NCT02415400|525018326|FG000|Overall Study|Site closure; participant won't transfer|0|||
145592110|NCT02415400|525018327|FG001|Overall Study|Site closure; participant won't transfer|0|||
145592111|NCT02415400|525018328|FG002|Overall Study|Site closure; participant won't transfer|0|||
145592112|NCT02415400|525018329|FG003|Overall Study|Site closure; participant won't transfer|1|||
145592113|NCT01581281|525018332|FG000|Overall Study|Early Study Closure|15|||
145592114|NCT01581281|525018333|FG001|Overall Study|Early Study Closure|6|||
145592115|NCT01581281|525018334|FG002|Overall Study|Early Study Closure|12|||
145592116|NCT02187991|525018336|FG000|Overall Study|Adverse Event|13|||
145592117|NCT02187991|525018337|FG001|Overall Study|Adverse Event|14|||
145592118|NCT02187991|525018338|FG002|Overall Study|Adverse Event|3|||
145592119|NCT02187991|525018339|FG003|Overall Study|Adverse Event|2|||
145592120|NCT02187991|525018336|FG000|Overall Study|Withdrawal by Subject|9|||
145592121|NCT02187991|525018337|FG001|Overall Study|Withdrawal by Subject|6|||
145592122|NCT02187991|525018338|FG002|Overall Study|Withdrawal by Subject|3|||
145458834|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
145458835|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
145458836|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
145458837|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
145458838|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
145458839|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
145458840|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
145458841|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
145458842|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
145458843|NCT01632241|524531542|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
145458844|NCT01632241|524531543|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
145458845|NCT01904149|524531546|FG000|Overall Study|Adverse Event|3|||
145458846|NCT01904149|524531547|FG001|Overall Study|Adverse Event|4|||
145458847|NCT01904149|524531548|FG002|Overall Study|Adverse Event|0|||
145458848|NCT01904149|524531549|FG003|Overall Study|Adverse Event|1|||
145458849|NCT01904149|524531550|FG004|Overall Study|Adverse Event|1|||
145458850|NCT01904149|524531551|FG005|Overall Study|Adverse Event|2|||
145458851|NCT01904149|524531546|FG000|Overall Study|Lack of Efficacy|0|||
145458852|NCT01904149|524531547|FG001|Overall Study|Lack of Efficacy|3|||
145458853|NCT01904149|524531548|FG002|Overall Study|Lack of Efficacy|1|||
145458854|NCT01904149|524531549|FG003|Overall Study|Lack of Efficacy|3|||
145458855|NCT01904149|524531550|FG004|Overall Study|Lack of Efficacy|3|||
145458856|NCT01904149|524531551|FG005|Overall Study|Lack of Efficacy|1|||
145458857|NCT01904149|524531546|FG000|Overall Study|Withdrawal by Subject|1|||
145458858|NCT01904149|524531547|FG001|Overall Study|Withdrawal by Subject|3|||
145458859|NCT01904149|524531548|FG002|Overall Study|Withdrawal by Subject|1|||
145458860|NCT01904149|524531549|FG003|Overall Study|Withdrawal by Subject|0|||
145458861|NCT01904149|524531550|FG004|Overall Study|Withdrawal by Subject|1|||
145458862|NCT01904149|524531551|FG005|Overall Study|Withdrawal by Subject|0|||
145458863|NCT01904149|524531546|FG000|Overall Study|Protocol Violation|0|||
145458864|NCT01904149|524531547|FG001|Overall Study|Protocol Violation|1|||
145458865|NCT01904149|524531548|FG002|Overall Study|Protocol Violation|0|||
145458866|NCT01904149|524531549|FG003|Overall Study|Protocol Violation|0|||
145458867|NCT01904149|524531550|FG004|Overall Study|Protocol Violation|0|||
145458868|NCT01904149|524531551|FG005|Overall Study|Protocol Violation|0|||
145458869|NCT01904149|524531546|FG000|Overall Study|non compliance with study drug|1|||
145458870|NCT01904149|524531547|FG001|Overall Study|non compliance with study drug|0|||
145458871|NCT01904149|524531548|FG002|Overall Study|non compliance with study drug|0|||
145592123|NCT02187991|525018339|FG003|Overall Study|Withdrawal by Subject|2|||
145458872|NCT01904149|524531549|FG003|Overall Study|non compliance with study drug|0|||
145458873|NCT01904149|524531550|FG004|Overall Study|non compliance with study drug|0|||
145458874|NCT01904149|524531551|FG005|Overall Study|non compliance with study drug|0|||
145458875|NCT01357161|524531552|FG000|Part 1 (Open Label Run-in)|Death|5|||
145458876|NCT01357161|524531553|FG001|Part 1 (Open Label Run-in)|Death|0|||
145458877|NCT01357161|524531554|FG002|Part 1 (Open Label Run-in)|Death|0|||
145458878|NCT01357161|524531552|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
145458879|NCT01357161|524531553|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
145458880|NCT01357161|524531554|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
145592124|NCT02187991|525018336|FG000|Overall Study|Physician Decision|4|||
145592125|NCT02187991|525018337|FG001|Overall Study|Physician Decision|4|||
145592126|NCT02187991|525018338|FG002|Overall Study|Physician Decision|0|||
145592127|NCT02187991|525018339|FG003|Overall Study|Physician Decision|2|||
145592128|NCT02187991|525018336|FG000|Overall Study|Other, unrelated complication|7|||
145592129|NCT02187991|525018337|FG001|Overall Study|Other, unrelated complication|1|||
145592130|NCT02187991|525018338|FG002|Overall Study|Other, unrelated complication|1|||
145592131|NCT02187991|525018339|FG003|Overall Study|Other, unrelated complication|2|||
145592132|NCT02187991|525018336|FG000|Overall Study|Death|1|||
145592133|NCT02187991|525018337|FG001|Overall Study|Death|3|||
145592134|NCT02187991|525018338|FG002|Overall Study|Death|0|||
145592135|NCT02187991|525018339|FG003|Overall Study|Death|0|||
145592136|NCT01392560|525018340|FG000|Overall Study|Adverse Event|2|||
145592137|NCT01392560|525018340|FG000|Overall Study|not entered|8|||
145592138|NCT01392560|525018340|FG000|Overall Study|discontinued during placebo run-in|2|||
145592139|NCT02081846|525018341|FG000|Overall Study|Withdrawal by Subject|1|||
145592140|NCT02081846|525018342|FG001|Overall Study|Withdrawal by Subject|0|||
145592141|NCT02081846|525018341|FG000|Overall Study|invalid consent|1|||
145592142|NCT02081846|525018342|FG001|Overall Study|invalid consent|0|||
145592143|NCT00092131|525018350|FG000|Treatment Period I|Adverse Event|1|||
145592144|NCT00092131|525018351|FG001|Treatment Period I|Adverse Event|0|||
145592145|NCT00092131|525018350|FG000|Treatment Period II|Adverse Event|0|||
145592146|NCT00092131|525018351|FG001|Treatment Period II|Adverse Event|1|||
145592147|NCT02372409|525018354|FG000|Overall Study|Lost to Follow-up|1|||
145592148|NCT02372409|525018355|FG001|Overall Study|Lost to Follow-up|0|||
145592149|NCT02372409|525018354|FG000|Overall Study|Disease progression|1|||
145592150|NCT02372409|525018355|FG001|Overall Study|Disease progression|1|||
145592151|NCT01808313|525018356|FG000|Overall Study|Adverse Event|5|||
145592152|NCT01808313|525018356|FG000|Overall Study|Protocol Violation|2|||
145592153|NCT01808313|525018356|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145592154|NCT01808313|525018356|FG000|Overall Study|Lost to Follow-up|1|||
145592155|NCT01808313|525018356|FG000|Overall Study|Physician Decision|1|||
145592156|NCT03943095|525018359|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
145592157|NCT03943095|525018360|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
145592158|NCT03943095|525018359|FG000|Overall Study|Withdrawal by Subject|1|||
145592159|NCT03943095|525018360|FG001|Overall Study|Withdrawal by Subject|0|||
145592160|NCT03034577|525018371|FG000|Overall Study|Withdrawal by Subject|6|||
145592161|NCT03034577|525018372|FG001|Overall Study|Withdrawal by Subject|9|||
145592162|NCT03034577|525018371|FG000|Overall Study|Lost to Follow-up|25|||
145592163|NCT03034577|525018372|FG001|Overall Study|Lost to Follow-up|26|||
145592164|NCT04177758|525018373|FG000|Overall Study|Lost to Follow-up|19|||
145592165|NCT04177758|525018374|FG001|Overall Study|Lost to Follow-up|11|||
145592166|NCT02625623|525018375|FG000|Overall Study|Participants randomized but not treated|9|||
145592167|NCT02625623|525018376|FG001|Overall Study|Participants randomized but not treated|1|||
145592168|NCT03826667|525018377|FG000|Overall Study|Protocol deviation|21|||
145592169|NCT02352948|525018381|FG000|Overall Study|Death|47|||
145592170|NCT02352948|525018382|FG001|Overall Study|Death|48|||
145592171|NCT02352948|525018383|FG002|Overall Study|Death|114|||
145592172|NCT02352948|525018384|FG003|Overall Study|Death|74|||
145592173|NCT02352948|525018385|FG004|Overall Study|Death|77|||
145592174|NCT02352948|525018386|FG005|Overall Study|Death|44|||
145592175|NCT02352948|525018381|FG000|Overall Study|Lost to Follow-up|1|||
145592176|NCT02352948|525018382|FG001|Overall Study|Lost to Follow-up|0|||
145592177|NCT02352948|525018383|FG002|Overall Study|Lost to Follow-up|2|||
145592178|NCT02352948|525018384|FG003|Overall Study|Lost to Follow-up|1|||
145592179|NCT02352948|525018385|FG004|Overall Study|Lost to Follow-up|2|||
145592180|NCT02352948|525018386|FG005|Overall Study|Lost to Follow-up|1|||
145592181|NCT02352948|525018381|FG000|Overall Study|Withdrawal by Subject|1|||
145626764|NCT02939183|525145779|FG002|Overall Study|Not treated due to adverse event|0|||
145592182|NCT02352948|525018382|FG001|Overall Study|Withdrawal by Subject|10|||
145592183|NCT02352948|525018383|FG002|Overall Study|Withdrawal by Subject|11|||
145592184|NCT02352948|525018384|FG003|Overall Study|Withdrawal by Subject|23|||
145592185|NCT02352948|525018385|FG004|Overall Study|Withdrawal by Subject|9|||
145592186|NCT02352948|525018386|FG005|Overall Study|Withdrawal by Subject|4|||
145626765|NCT02939183|525145780|FG003|Overall Study|Not treated due to adverse event|1|||
145626766|NCT02939183|525145781|FG004|Overall Study|Not treated due to adverse event|0|||
145592187|NCT02352948|525018381|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145592188|NCT02352948|525018382|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145592189|NCT02352948|525018383|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
145626767|NCT02939183|525145782|FG005|Overall Study|Not treated due to adverse event|0|||
145592190|NCT02352948|525018384|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145592191|NCT02352948|525018385|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
145592192|NCT02352948|525018386|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
145592193|NCT02352948|525018381|FG000|Overall Study|Other|0|||
145592194|NCT02352948|525018382|FG001|Overall Study|Other|0|||
145592195|NCT02352948|525018383|FG002|Overall Study|Other|2|||
145592196|NCT02352948|525018384|FG003|Overall Study|Other|0|||
145592197|NCT02352948|525018385|FG004|Overall Study|Other|0|||
145592198|NCT02352948|525018386|FG005|Overall Study|Other|0|||
145592199|NCT00679939|525018388|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
145592200|NCT00679939|525018389|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
145592201|NCT00679939|525018388|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
145626768|NCT02939183|525145783|FG006|Overall Study|Not treated due to adverse event|1|||
145592202|NCT00679939|525018389|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
145592203|NCT00679939|525018388|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
145592204|NCT00679939|525018389|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
145592205|NCT00679939|525018388|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
145592206|NCT00679939|525018389|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
145592207|NCT00679939|525018388|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
145592208|NCT00679939|525018389|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
145592209|NCT00679939|525018388|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
145592210|NCT00679939|525018389|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
145592211|NCT00679939|525018388|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
145592212|NCT00679939|525018389|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
145592213|NCT00679939|525018388|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
145592214|NCT00679939|525018389|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
145592215|NCT00679939|525018388|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
145592216|NCT00679939|525018389|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
145592217|NCT00679939|525018388|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
145592218|NCT00679939|525018389|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
145592219|NCT02653482|525018394|FG000|Overall Study|Death|1|||
145592220|NCT02653482|525018395|FG001|Overall Study|Death|1|||
145592221|NCT00660010|525018396|FG000|Overall Study|Withdrawal by Subject|2|||
145592222|NCT00660010|525018396|FG000|Overall Study|Lost to Follow-up|3|||
145592223|NCT00660010|525018396|FG000|Overall Study|Adverse Event|1|||
145592224|NCT00660010|525018396|FG000|Overall Study|Noncompliance with visit schedule|3|||
145592225|NCT02979639|525020676|FG000|Overall Study|Withdrawal based on medical judgement|1|||
145592226|NCT02979639|525020676|FG000|Overall Study|Lost to Follow-up|8|||
145592227|NCT02979639|525020676|FG000|Overall Study|Withdrawal by Subject|3|||
145592228|NCT02979639|525020676|FG000|Overall Study|Adverse Event|2|||
145592229|NCT02985866|525020682|FG000|Overall Study|Poor CGM data|1|||
145592230|NCT02985866|525020683|FG001|Overall Study|Poor CGM data|1|||
145592231|NCT03667053|525020687|FG000|Overall Study|Withdrawal by Subject|1|||
145592232|NCT03667053|525020688|FG001|Overall Study|Withdrawal by Subject|0|||
145592233|NCT03667053|525020689|FG002|Overall Study|Withdrawal by Subject|0|||
145592234|NCT03647501|525020690|FG000|Overall Study|Lost to Follow-up|1|||
145592235|NCT03647501|525020691|FG001|Overall Study|Lost to Follow-up|1|||
145592236|NCT03647501|525020690|FG000|Overall Study|Withdrawal by Subject|0|||
145592237|NCT03647501|525020691|FG001|Overall Study|Withdrawal by Subject|1|||
145592238|NCT01324271|525020692|FG000|Overall Study|Lost to Follow-up|3|||
145592239|NCT01324271|525020693|FG001|Overall Study|Lost to Follow-up|0|||
145592240|NCT01324271|525020692|FG000|Overall Study|Physician Decision|1|||
145592241|NCT01324271|525020693|FG001|Overall Study|Physician Decision|0|||
145592242|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
145592243|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
145592244|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
145592245|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
145592246|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
145592247|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
145592248|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
145592249|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
145592250|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
145592251|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
145592252|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
145592253|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
145592254|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
145592255|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
145592256|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
145592257|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
145592258|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
145592259|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
145592260|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
145592261|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
145458881|NCT01357161|524531552|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
145458882|NCT01357161|524531553|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
145592262|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
145592263|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
145458883|NCT01357161|524531554|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
145592264|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
145592265|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
145592266|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
145458884|NCT01357161|524531552|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
145458885|NCT01357161|524531553|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
145458886|NCT01357161|524531554|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
145458887|NCT01357161|524531552|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
145458888|NCT01357161|524531553|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
145458889|NCT01357161|524531554|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
145458890|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
145458891|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
145458892|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
145458893|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
145458894|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
145458895|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
145458896|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
145458897|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
145458898|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
145458899|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
145458900|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
145458901|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
145458902|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
145458903|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
145458904|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
145458905|NCT01357161|524531552|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
145458906|NCT01357161|524531553|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
145458907|NCT01357161|524531554|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
145458908|NCT00068250|524531555|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
145458909|NCT00068250|524531556|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
145458910|NCT00068250|524531557|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
145458911|NCT00068250|524531558|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
145458912|NCT01824823|524531559|FG000|Overall Study|Lack of Efficacy|1|||
145458913|NCT01824823|524531560|FG001|Overall Study|Lack of Efficacy|1|||
145458914|NCT01824823|524531559|FG000|Overall Study|Off-treatment reason not submitted|1|||
145458915|NCT01824823|524531560|FG001|Overall Study|Off-treatment reason not submitted|0|||
145458916|NCT03349645|524531563|FG000|Overall Study|Sponsor Terminated Study|75|||
145458917|NCT03349645|524531563|FG000|Overall Study|Withdrawal by Subject|4|||
145458918|NCT03349645|524531563|FG000|Overall Study|Protocol Violation|1|||
145458919|NCT03349645|524531563|FG000|Overall Study|Other|2|||
145458920|NCT01939002|524531575|FG000|Overall Study|Adverse Event|13|||
145458921|NCT01939002|524531576|FG001|Overall Study|Adverse Event|13|||
145458922|NCT01939002|524531575|FG000|Overall Study|Withdrawal by Subject|5|||
145458923|NCT01939002|524531576|FG001|Overall Study|Withdrawal by Subject|3|||
145458924|NCT01939002|524531575|FG000|Overall Study|Other|1|||
145458925|NCT01939002|524531576|FG001|Overall Study|Other|2|||
145458926|NCT02910401|524531579|FG000|Overall Study|Study closure Study closure|0|||
145458927|NCT02910401|524531580|FG001|Overall Study|Study closure Study closure|0|||
145458928|NCT02910401|524531581|FG002|Overall Study|Study closure Study closure|2|||
145458929|NCT02910401|524531579|FG000|Overall Study|Physician Decision|1|||
145458930|NCT02910401|524531580|FG001|Overall Study|Physician Decision|0|||
145458931|NCT02910401|524531581|FG002|Overall Study|Physician Decision|0|||
145458932|NCT01774253|524531583|FG000|Overall Study|Lack of Efficacy|4|||
145458933|NCT01774253|524531583|FG000|Overall Study|Physician Decision|2|||
145458934|NCT01774253|524531583|FG000|Overall Study|Withdrawal by Subject|2|||
145458935|NCT01774253|524531583|FG000|Overall Study|Death|1|||
145458936|NCT02240368|524531584|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
145458937|NCT02240368|524531585|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
145458938|NCT02240368|524531586|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
145458939|NCT02240368|524531584|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
145458940|NCT02240368|524531585|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
145458941|NCT02240368|524531586|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
145458942|NCT00871117|524531587|FG000|Overall Study|Lost to Follow-up|5|||
145458943|NCT00871117|524531588|FG001|Overall Study|Lost to Follow-up|6|||
145458944|NCT00871117|524531587|FG000|Overall Study|Other|0|||
145458945|NCT00871117|524531588|FG001|Overall Study|Other|4|||
145458946|NCT01170065|524531591|FG000|Overall Study|Adverse Event|17|||
145458947|NCT01170065|524531592|FG001|Overall Study|Adverse Event|50|||
145458948|NCT01170065|524531593|FG002|Overall Study|Adverse Event|10|||
145458949|NCT01170065|524531591|FG000|Overall Study|Lost to Follow-up|1|||
145458950|NCT01170065|524531592|FG001|Overall Study|Lost to Follow-up|4|||
145458951|NCT01170065|524531593|FG002|Overall Study|Lost to Follow-up|1|||
145458952|NCT01170065|524531591|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
145458953|NCT01170065|524531592|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
145458954|NCT01170065|524531593|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
145458955|NCT01170065|524531591|FG000|Overall Study|Reason other than specified|3|||
145458956|NCT01170065|524531592|FG001|Overall Study|Reason other than specified|8|||
145458957|NCT01170065|524531593|FG002|Overall Study|Reason other than specified|3|||
145592267|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
145592268|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
145592269|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
145592270|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
145592271|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
145592272|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
145592273|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
145592274|NCT04818346|525020694|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
145592275|NCT04818346|525020695|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
145592276|NCT04818346|525020696|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
145592277|NCT04818346|525020697|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
145592278|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
145592279|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
145592280|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
145592281|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
145592282|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
145592283|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
145592284|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
145592285|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
145592286|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
145592287|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
145592288|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
145592289|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
145592290|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
145592291|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
145592292|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
145592293|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
145592294|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
145592295|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
145592296|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
145592297|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
145592298|NCT04818346|525020694|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
145592299|NCT04818346|525020695|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
145592300|NCT04818346|525020696|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
145592301|NCT04818346|525020697|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
145592302|NCT00492284|525020698|FG000|Overall Study|Adverse Event|0|||
145592303|NCT00492284|525020699|FG001|Overall Study|Adverse Event|1|||
145592304|NCT00492284|525020700|FG002|Overall Study|Adverse Event|1|||
145592305|NCT00492284|525020701|FG003|Overall Study|Adverse Event|2|||
145592306|NCT00492284|525020698|FG000|Overall Study|Lost to Follow-up|0|||
145592307|NCT00492284|525020699|FG001|Overall Study|Lost to Follow-up|0|||
145592308|NCT00492284|525020700|FG002|Overall Study|Lost to Follow-up|3|||
145592309|NCT00492284|525020701|FG003|Overall Study|Lost to Follow-up|1|||
145592310|NCT00492284|525020698|FG000|Overall Study|Death|0|||
145592311|NCT00492284|525020699|FG001|Overall Study|Death|3|||
145592312|NCT00492284|525020700|FG002|Overall Study|Death|2|||
145592313|NCT00492284|525020701|FG003|Overall Study|Death|5|||
145592314|NCT00492284|525020698|FG000|Overall Study|Withdrawal by Subject|1|||
145592315|NCT00492284|525020699|FG001|Overall Study|Withdrawal by Subject|0|||
145592316|NCT00492284|525020700|FG002|Overall Study|Withdrawal by Subject|0|||
145592317|NCT00492284|525020701|FG003|Overall Study|Withdrawal by Subject|2|||
145592318|NCT03695172|525020702|FG000|Overall Study|Withdrawal by Subject|1|||
145592319|NCT03695172|525020703|FG001|Overall Study|Withdrawal by Subject|1|||
145592320|NCT03695172|525020704|FG002|Overall Study|Withdrawal by Subject|0|||
145592321|NCT02734212|525020705|FG000|Overall Study|Lost to Follow-up|5|||
145592322|NCT02734212|525020706|FG001|Overall Study|Lost to Follow-up|10|||
145592323|NCT04313881|525020709|FG000|Overall Study|Death|138|||
145592324|NCT04313881|525020710|FG001|Overall Study|Death|126|||
145592325|NCT04313881|525020709|FG000|Overall Study|Study terminated by sponsor|108|||
145592326|NCT04313881|525020710|FG001|Overall Study|Study terminated by sponsor|129|||
145592327|NCT04313881|525020709|FG000|Overall Study|Consent withdrawn|19|||
145592328|NCT04313881|525020710|FG001|Overall Study|Consent withdrawn|15|||
145592329|NCT04313881|525020709|FG000|Overall Study|Reason not Specified|3|||
145592330|NCT04313881|525020710|FG001|Overall Study|Reason not Specified|1|||
145592331|NCT00727272|525020711|FG000|Washout Period A|Adverse Event|0|||
145592332|NCT00727272|525020712|FG001|Washout Period A|Adverse Event|0|||
145592333|NCT00727272|525020713|FG002|Washout Period A|Adverse Event|1|||
145458958|NCT01170065|524531591|FG000|Overall Study|Ongoing after planned observation time|5|||
145458959|NCT01170065|524531592|FG001|Overall Study|Ongoing after planned observation time|26|||
145458960|NCT01170065|524531593|FG002|Overall Study|Ongoing after planned observation time|10|||
145458961|NCT01444027|524531594|FG000|Overall Study|Withdrawal by Subject|4|||
145458962|NCT01444027|524531595|FG001|Overall Study|Withdrawal by Subject|10|||
145458963|NCT01444027|524531596|FG002|Overall Study|Withdrawal by Subject|24|||
145458964|NCT01444027|524531594|FG000|Overall Study|Lost to Follow-up|26|||
145458965|NCT01444027|524531595|FG001|Overall Study|Lost to Follow-up|20|||
145458966|NCT01444027|524531596|FG002|Overall Study|Lost to Follow-up|14|||
145458967|NCT03551665|524531597|FG000|Overall Study|Lost to Follow-up|11|||
145458968|NCT03551665|524531598|FG001|Overall Study|Lost to Follow-up|2|||
145458969|NCT00642174|524532774|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
145458970|NCT00642174|524532775|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
145458971|NCT00896363|524532776|FG000|Overall Study|Adverse Event|3|||
145458972|NCT00896363|524532777|FG001|Overall Study|Adverse Event|4|||
145458973|NCT00896363|524532778|FG002|Overall Study|Adverse Event|2|||
145458974|NCT00896363|524532776|FG000|Overall Study|Lack of Efficacy|0|||
145458975|NCT00896363|524532777|FG001|Overall Study|Lack of Efficacy|2|||
145458976|NCT00896363|524532778|FG002|Overall Study|Lack of Efficacy|1|||
145458977|NCT00896363|524532776|FG000|Overall Study|Withdrawal by Subject|3|||
145458978|NCT00896363|524532777|FG001|Overall Study|Withdrawal by Subject|5|||
145458979|NCT00896363|524532778|FG002|Overall Study|Withdrawal by Subject|5|||
145458980|NCT01145352|524532781|FG000|Overall Study|Found to have been registered twice|6|||
145458981|NCT01145352|524532781|FG000|Overall Study|Treated before marketing approval|4|||
145458982|NCT01145352|524532781|FG000|Overall Study|Syringe formulation was used|1|||
145458983|NCT03095027|524532782|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
145458984|NCT03095027|524532783|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
145458985|NCT00445939|524532786|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
145458986|NCT00445939|524532787|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
145458987|NCT00445939|524532788|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
145458988|NCT00445939|524532789|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
145458989|NCT00445939|524532786|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
145458990|NCT00445939|524532787|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
145458991|NCT00445939|524532788|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
145458992|NCT00445939|524532789|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
145458993|NCT02576535|524532805|FG000|Overall Study|Withdrawal by Subject|2|||
145458994|NCT00322023|524532808|FG000|Overall Study|various|0|||
145458995|NCT00322023|524532809|FG001|Overall Study|various|2|||
145458996|NCT00322023|524532810|FG002|Overall Study|various|6|||
145458997|NCT03555981|524532811|FG000|Overall Study|Lost to Follow-up|0|||
145458998|NCT03555981|524532812|FG001|Overall Study|Lost to Follow-up|2|||
145458999|NCT00354107|524532813|FG000|Overall Study|Adverse Event|2|||
145459000|NCT00354107|524532813|FG000|Overall Study|Physician Decision|2|||
145459001|NCT00354107|524532813|FG000|Overall Study|Withdrawal by Subject|1|||
145459002|NCT04035564|524532814|FG000|Overall Study|Protocol Violation|1|||
145459003|NCT04035564|524532815|FG001|Overall Study|Protocol Violation|2|||
145459004|NCT04035564|524532814|FG000|Overall Study|No laboratory available|2|||
145459005|NCT04035564|524532815|FG001|Overall Study|No laboratory available|2|||
145459006|NCT04035564|524532814|FG000|Overall Study|Guardian declined consent|1|||
145459007|NCT04035564|524532815|FG001|Overall Study|Guardian declined consent|2|||
145459008|NCT03361189|524532819|FG000|Overall Study|Received heart transplant|1|||
145459009|NCT03361189|524532820|FG001|Overall Study|Received heart transplant|0|||
145459010|NCT03361189|524532819|FG000|Overall Study|Pacemake replacement|0|||
145459011|NCT03361189|524532820|FG001|Overall Study|Pacemake replacement|1|||
145459012|NCT00791479|524532821|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
145459013|NCT00791479|524532822|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
145459014|NCT00791479|524532823|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
145459015|NCT00791479|524532824|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
145459016|NCT00791479|524532825|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
145459017|NCT00791479|524532826|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
145459018|NCT00791479|524532821|FG000|Overall Study|Adverse Event|0|||
145592334|NCT00727272|525020711|FG000|Washout Period B|Withdrawal by Subject|0|||
145592335|NCT00727272|525020712|FG001|Washout Period B|Withdrawal by Subject|0|||
145592336|NCT00727272|525020713|FG002|Washout Period B|Withdrawal by Subject|1|||
145459019|NCT00791479|524532822|FG001|Overall Study|Adverse Event|1|||
145459020|NCT00791479|524532823|FG002|Overall Study|Adverse Event|0|||
145459021|NCT00791479|524532824|FG003|Overall Study|Adverse Event|2|||
145459022|NCT00791479|524532825|FG004|Overall Study|Adverse Event|0|||
145459023|NCT00791479|524532826|FG005|Overall Study|Adverse Event|1|||
145592337|NCT00651664|525020714|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
145459024|NCT00791479|524532821|FG000|Overall Study|Lost to Follow-up|0|||
145459025|NCT00791479|524532822|FG001|Overall Study|Lost to Follow-up|1|||
145459026|NCT00791479|524532823|FG002|Overall Study|Lost to Follow-up|0|||
145459027|NCT00791479|524532824|FG003|Overall Study|Lost to Follow-up|0|||
145459028|NCT00791479|524532825|FG004|Overall Study|Lost to Follow-up|0|||
145592338|NCT00651664|525020715|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
145459029|NCT00791479|524532826|FG005|Overall Study|Lost to Follow-up|1|||
145459030|NCT00791479|524532821|FG000|Overall Study|Protocol Violation|2|||
145459031|NCT00791479|524532822|FG001|Overall Study|Protocol Violation|1|||
145459032|NCT00791479|524532823|FG002|Overall Study|Protocol Violation|0|||
145459033|NCT00791479|524532824|FG003|Overall Study|Protocol Violation|1|||
145459034|NCT00791479|524532825|FG004|Overall Study|Protocol Violation|0|||
145459035|NCT00791479|524532826|FG005|Overall Study|Protocol Violation|0|||
145459036|NCT00791479|524532821|FG000|Overall Study|Withdrawal by Subject|0|||
145459037|NCT00791479|524532822|FG001|Overall Study|Withdrawal by Subject|0|||
145459038|NCT00791479|524532823|FG002|Overall Study|Withdrawal by Subject|0|||
145459039|NCT00791479|524532824|FG003|Overall Study|Withdrawal by Subject|1|||
145459040|NCT00791479|524532825|FG004|Overall Study|Withdrawal by Subject|0|||
145459041|NCT00791479|524532826|FG005|Overall Study|Withdrawal by Subject|1|||
145459042|NCT00543296|524532831|FG000|Overall Study|Physician Decision|7|||
145459043|NCT00934947|524532832|FG000|Overall Study|Adverse Event|0|||
145459044|NCT00934947|524532833|FG001|Overall Study|Adverse Event|2|||
145459045|NCT01920568|524532834|FG000|Overall Study|Adverse Event|27|||
145459046|NCT01920568|524532835|FG001|Overall Study|Adverse Event|8|||
145459047|NCT01920568|524532834|FG000|Overall Study|Protocol Violation|5|||
145459048|NCT01920568|524532835|FG001|Overall Study|Protocol Violation|3|||
145459049|NCT01920568|524532834|FG000|Overall Study|Lost to Follow-up|2|||
145459050|NCT01920568|524532835|FG001|Overall Study|Lost to Follow-up|2|||
145459051|NCT01920568|524532834|FG000|Overall Study|Physician Decision|13|||
145459052|NCT01920568|524532835|FG001|Overall Study|Physician Decision|4|||
145459053|NCT01920568|524532834|FG000|Overall Study|Withdrawal by Subject|79|||
145459054|NCT01920568|524532835|FG001|Overall Study|Withdrawal by Subject|55|||
145459055|NCT01920568|524532834|FG000|Overall Study|Death due to disease progression|25|||
145459056|NCT01920568|524532835|FG001|Overall Study|Death due to disease progression|12|||
145459057|NCT00252694|524532838|FG000|Overall Study|Withdrawal by Subject|83|||
145459058|NCT00252694|524532839|FG001|Overall Study|Withdrawal by Subject|91|||
145459059|NCT00252694|524532838|FG000|Overall Study|Death|36|||
145459060|NCT00252694|524532839|FG001|Overall Study|Death|34|||
145459061|NCT00252694|524532838|FG000|Overall Study|Mostly Lost to Follow Up|8|||
145459062|NCT00252694|524532839|FG001|Overall Study|Mostly Lost to Follow Up|13|||
145459063|NCT00252694|524532838|FG000|Overall Study|Patient Moving|17|||
145459064|NCT00252694|524532839|FG001|Overall Study|Patient Moving|16|||
145459065|NCT03664674|524532841|FG000|Overall Study|Adverse Event|1|||
145459066|NCT03664674|524532842|FG001|Overall Study|Adverse Event|1|||
145459067|NCT03664674|524532841|FG000|Overall Study|Physician Decision|0|||
145459068|NCT03664674|524532842|FG001|Overall Study|Physician Decision|1|||
145459069|NCT03664674|524532841|FG000|Overall Study|Withdrawal by Subject|2|||
145459070|NCT03664674|524532842|FG001|Overall Study|Withdrawal by Subject|0|||
145459071|NCT01342965|524532843|FG000|Overall Study|Death|58|||
145459072|NCT01342965|524532844|FG001|Overall Study|Death|57|||
145459073|NCT01342965|524532843|FG000|Overall Study|Lost to Follow-up|5|||
145459074|NCT01342965|524532844|FG001|Overall Study|Lost to Follow-up|3|||
145459075|NCT01342965|524532843|FG000|Overall Study|Other Reasons- Unspecified|44|||
145459076|NCT01342965|524532844|FG001|Overall Study|Other Reasons- Unspecified|38|||
145459077|NCT01342965|524532843|FG000|Overall Study|Withdrawal by Subject|2|||
145459078|NCT01342965|524532844|FG001|Overall Study|Withdrawal by Subject|9|||
145459079|NCT01170598|524532845|FG000|Overall Study|Withdrawal by Subject|1|||
145459080|NCT01170598|524532845|FG000|Overall Study|Death|3|||
145459081|NCT01170598|524532845|FG000|Overall Study|Lost to Follow-up|1|||
145459082|NCT01170598|524532845|FG000|Overall Study|Refused|1|||
145459083|NCT03022097|524532846|FG000|Overall Study|Adverse Event|3|||
145459084|NCT03022097|524532847|FG001|Overall Study|Adverse Event|4|||
145459085|NCT03022097|524532848|FG002|Overall Study|Adverse Event|1|||
145459086|NCT03022097|524532849|FG003|Overall Study|Adverse Event|3|||
145459087|NCT03022097|524532846|FG000|Overall Study|Progressive Disease|2|||
145459088|NCT03022097|524532847|FG001|Overall Study|Progressive Disease|0|||
145459089|NCT03022097|524532848|FG002|Overall Study|Progressive Disease|5|||
145459090|NCT03022097|524532849|FG003|Overall Study|Progressive Disease|2|||
145459091|NCT03022097|524532846|FG000|Overall Study|Lack of Efficacy|0|||
145459092|NCT03022097|524532847|FG001|Overall Study|Lack of Efficacy|0|||
145459093|NCT03022097|524532848|FG002|Overall Study|Lack of Efficacy|3|||
145459094|NCT03022097|524532849|FG003|Overall Study|Lack of Efficacy|3|||
145459095|NCT03022097|524532846|FG000|Overall Study|Protocol Violation|1|||
145459096|NCT03022097|524532847|FG001|Overall Study|Protocol Violation|0|||
145459097|NCT03022097|524532848|FG002|Overall Study|Protocol Violation|1|||
145459098|NCT03022097|524532849|FG003|Overall Study|Protocol Violation|0|||
145459099|NCT03022097|524532846|FG000|Overall Study|Withdrawal by Subject|11|||
145459100|NCT03022097|524532847|FG001|Overall Study|Withdrawal by Subject|13|||
145459101|NCT03022097|524532848|FG002|Overall Study|Withdrawal by Subject|15|||
145459102|NCT03022097|524532849|FG003|Overall Study|Withdrawal by Subject|21|||
145459103|NCT03022097|524532846|FG000|Overall Study|Lost to Follow-up|0|||
145459104|NCT03022097|524532847|FG001|Overall Study|Lost to Follow-up|0|||
145459105|NCT03022097|524532848|FG002|Overall Study|Lost to Follow-up|1|||
145459106|NCT03022097|524532849|FG003|Overall Study|Lost to Follow-up|1|||
145459107|NCT03022097|524532846|FG000|Overall Study|Other|4|||
145459108|NCT03022097|524532847|FG001|Overall Study|Other|1|||
145592339|NCT00651664|525020716|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
145592340|NCT00651664|525020717|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
145592341|NCT00651664|525020718|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
145592342|NCT00651664|525020719|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
145592343|NCT00651664|525020720|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
145592344|NCT00651664|525020721|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
145592345|NCT00651664|525020722|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
145592346|NCT00651664|525020723|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
145592347|NCT00651664|525020714|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592348|NCT00651664|525020715|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592349|NCT00651664|525020716|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592350|NCT00651664|525020717|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592351|NCT00651664|525020718|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
145592352|NCT00651664|525020719|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
145592353|NCT00651664|525020720|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592354|NCT00651664|525020721|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
145592355|NCT00651664|525020722|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
145592356|NCT00651664|525020723|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
145592357|NCT00651664|525020714|FG000|Overall Study|Progressive Disease|3|||
145592358|NCT00651664|525020715|FG001|Overall Study|Progressive Disease|3|||
145592359|NCT00651664|525020716|FG002|Overall Study|Progressive Disease|3|||
145592360|NCT00651664|525020717|FG003|Overall Study|Progressive Disease|12|||
145592361|NCT00651664|525020718|FG004|Overall Study|Progressive Disease|4|||
145592362|NCT00651664|525020719|FG005|Overall Study|Progressive Disease|1|||
145592363|NCT00651664|525020720|FG006|Overall Study|Progressive Disease|3|||
145592364|NCT00651664|525020721|FG007|Overall Study|Progressive Disease|6|||
145592365|NCT00651664|525020722|FG008|Overall Study|Progressive Disease|5|||
145592366|NCT00651664|525020723|FG009|Overall Study|Progressive Disease|5|||
145592367|NCT00651664|525020714|FG000|Overall Study|Patient Declined Further Treatment|0|||
145592368|NCT00651664|525020715|FG001|Overall Study|Patient Declined Further Treatment|0|||
145592369|NCT00651664|525020716|FG002|Overall Study|Patient Declined Further Treatment|0|||
145592370|NCT00651664|525020717|FG003|Overall Study|Patient Declined Further Treatment|1|||
145592371|NCT00651664|525020718|FG004|Overall Study|Patient Declined Further Treatment|1|||
145592372|NCT00651664|525020719|FG005|Overall Study|Patient Declined Further Treatment|1|||
145592373|NCT00651664|525020720|FG006|Overall Study|Patient Declined Further Treatment|0|||
145592374|NCT00651664|525020721|FG007|Overall Study|Patient Declined Further Treatment|0|||
145592375|NCT00651664|525020722|FG008|Overall Study|Patient Declined Further Treatment|0|||
145592376|NCT00651664|525020723|FG009|Overall Study|Patient Declined Further Treatment|1|||
145592377|NCT00651664|525020714|FG000|Overall Study|Symptomatic Deterioration|0|||
145592378|NCT00651664|525020715|FG001|Overall Study|Symptomatic Deterioration|0|||
145592379|NCT00651664|525020716|FG002|Overall Study|Symptomatic Deterioration|0|||
145592380|NCT00651664|525020717|FG003|Overall Study|Symptomatic Deterioration|1|||
145592381|NCT00651664|525020718|FG004|Overall Study|Symptomatic Deterioration|0|||
145592382|NCT00651664|525020719|FG005|Overall Study|Symptomatic Deterioration|0|||
145592383|NCT00651664|525020720|FG006|Overall Study|Symptomatic Deterioration|1|||
145592384|NCT00651664|525020721|FG007|Overall Study|Symptomatic Deterioration|0|||
145592385|NCT00651664|525020722|FG008|Overall Study|Symptomatic Deterioration|1|||
145592386|NCT00651664|525020723|FG009|Overall Study|Symptomatic Deterioration|0|||
145592387|NCT00651664|525020714|FG000|Overall Study|Reason not Specified|0|||
145592388|NCT00651664|525020715|FG001|Overall Study|Reason not Specified|0|||
145592389|NCT00651664|525020716|FG002|Overall Study|Reason not Specified|0|||
145592390|NCT00651664|525020717|FG003|Overall Study|Reason not Specified|0|||
145592391|NCT00651664|525020718|FG004|Overall Study|Reason not Specified|0|||
145592392|NCT00651664|525020719|FG005|Overall Study|Reason not Specified|0|||
145592393|NCT00651664|525020720|FG006|Overall Study|Reason not Specified|1|||
145592394|NCT00651664|525020721|FG007|Overall Study|Reason not Specified|0|||
145592395|NCT00651664|525020722|FG008|Overall Study|Reason not Specified|0|||
145592396|NCT00651664|525020723|FG009|Overall Study|Reason not Specified|0|||
145592397|NCT00688636|525020724|FG000|Overall Study|Adverse Event|2|||
145592398|NCT00688636|525020725|FG001|Overall Study|Adverse Event|1|||
145592399|NCT01572727|525020726|FG000|Overall Study|Adverse Event|43|||
145592400|NCT01572727|525020727|FG001|Overall Study|Adverse Event|15|||
145592401|NCT01572727|525020726|FG000|Overall Study|Lost to Follow-up|1|||
145459109|NCT03022097|524532848|FG002|Overall Study|Other|6|||
145592402|NCT01572727|525020727|FG001|Overall Study|Lost to Follow-up|1|||
145459110|NCT03022097|524532849|FG003|Overall Study|Other|4|||
145459111|NCT03022097|524532846|FG000|Overall Study|Due to COVID-19 pandemic|0|||
145459112|NCT03022097|524532847|FG001|Overall Study|Due to COVID-19 pandemic|1|||
145592403|NCT01572727|525020726|FG000|Overall Study|Physician Decision|23|||
145592404|NCT01572727|525020727|FG001|Overall Study|Physician Decision|9|||
145592405|NCT01572727|525020726|FG000|Overall Study|Progressive disease|59|||
145592406|NCT01572727|525020727|FG001|Overall Study|Progressive disease|82|||
145592407|NCT01572727|525020726|FG000|Overall Study|Protocol Violation|0|||
145626769|NCT02939183|525145784|FG007|Overall Study|Not treated due to adverse event|0|||
145592408|NCT01572727|525020727|FG001|Overall Study|Protocol Violation|1|||
145459113|NCT03022097|524532848|FG002|Overall Study|Due to COVID-19 pandemic|0|||
145459114|NCT03022097|524532849|FG003|Overall Study|Due to COVID-19 pandemic|0|||
145459115|NCT01451931|524532850|FG000|Overall Study|Lost to Follow-up|17|||
145459116|NCT01451931|524532851|FG001|Overall Study|Lost to Follow-up|36|||
145459117|NCT01451931|524532852|FG002|Overall Study|Lost to Follow-up|21|||
145459118|NCT01451931|524532850|FG000|Overall Study|Withdrawal by Subject|16|||
145459119|NCT01451931|524532851|FG001|Overall Study|Withdrawal by Subject|22|||
145459120|NCT01451931|524532852|FG002|Overall Study|Withdrawal by Subject|22|||
145459121|NCT00855933|524532859|FG000|Overall Study|Withdrawal by Subject|0|||
145459122|NCT00855933|524532860|FG001|Overall Study|Withdrawal by Subject|1|||
145459123|NCT00951080|524532861|FG000|Overall Study|Adverse Event|3|||
145459124|NCT00951080|524532862|FG001|Overall Study|Adverse Event|3|||
145459125|NCT00951080|524532861|FG000|Overall Study|Lost to Follow-up|0|||
145459126|NCT00951080|524532862|FG001|Overall Study|Lost to Follow-up|1|||
145459127|NCT00951080|524532861|FG000|Overall Study|Physician Decision|4|||
145459128|NCT00951080|524532862|FG001|Overall Study|Physician Decision|1|||
145459129|NCT00951080|524532861|FG000|Overall Study|Other|19|||
145459130|NCT00951080|524532862|FG001|Overall Study|Other|22|||
145459131|NCT01960998|524532863|FG000|Overall Study|Lost to Follow-up|3|||
145459132|NCT01960998|524532864|FG001|Overall Study|Lost to Follow-up|7|||
145459133|NCT01960998|524532863|FG000|Overall Study|Death|0|||
145459134|NCT01960998|524532864|FG001|Overall Study|Death|1|||
145459135|NCT01960998|524532863|FG000|Overall Study|Withdrawal by Subject|8|||
145459136|NCT01960998|524532864|FG001|Overall Study|Withdrawal by Subject|2|||
145459137|NCT01960998|524532863|FG000|Overall Study|lost computer access|0|||
145459138|NCT01960998|524532864|FG001|Overall Study|lost computer access|1|||
145459139|NCT00835640|524532865|FG000|Second Intervention|Protocol Violation|1|||
145459140|NCT00835640|524532866|FG001|Second Intervention|Protocol Violation|0|||
145459141|NCT00812006|524532867|FG000|Overall Study|Lost to Follow-up|0|||
145459142|NCT00812006|524532868|FG001|Overall Study|Lost to Follow-up|0|||
145459143|NCT00812006|524532869|FG002|Overall Study|Lost to Follow-up|2|||
145459144|NCT00812006|524532867|FG000|Overall Study|Physician Decision|0|||
145459145|NCT00812006|524532868|FG001|Overall Study|Physician Decision|0|||
145459146|NCT00812006|524532869|FG002|Overall Study|Physician Decision|1|||
145459147|NCT00812006|524532867|FG000|Overall Study|Withdrawal by Subject|2|||
145459148|NCT00812006|524532868|FG001|Overall Study|Withdrawal by Subject|1|||
145459149|NCT00812006|524532869|FG002|Overall Study|Withdrawal by Subject|1|||
145459150|NCT00812006|524532867|FG000|Overall Study|Lack of Qualifying Event|4|||
145459151|NCT00812006|524532868|FG001|Overall Study|Lack of Qualifying Event|2|||
145459152|NCT00812006|524532869|FG002|Overall Study|Lack of Qualifying Event|2|||
145459153|NCT00235391|524532870|FG000|Overall Study|Adverse Event|4|||
145459154|NCT00235391|524532871|FG001|Overall Study|Adverse Event|5|||
145459155|NCT00235391|524532872|FG002|Overall Study|Adverse Event|10|||
145459156|NCT00235391|524532873|FG003|Overall Study|Adverse Event|72|||
145459157|NCT00235391|524532874|FG004|Overall Study|Adverse Event|5|||
145459158|NCT00235391|524532875|FG005|Overall Study|Adverse Event|2|||
145459159|NCT00235391|524532870|FG000|Overall Study|Abnormal laboratory value(s)|3|||
145459160|NCT00235391|524532871|FG001|Overall Study|Abnormal laboratory value(s)|5|||
145459161|NCT00235391|524532872|FG002|Overall Study|Abnormal laboratory value(s)|4|||
145459162|NCT00235391|524532873|FG003|Overall Study|Abnormal laboratory value(s)|27|||
145459163|NCT00235391|524532874|FG004|Overall Study|Abnormal laboratory value(s)|1|||
145459164|NCT00235391|524532875|FG005|Overall Study|Abnormal laboratory value(s)|2|||
145459165|NCT00235391|524532870|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145459166|NCT00235391|524532871|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145459167|NCT00235391|524532872|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145459168|NCT00235391|524532873|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
145459169|NCT00235391|524532874|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
145459170|NCT00235391|524532875|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
145459171|NCT00235391|524532870|FG000|Overall Study|Condition no longer requires treatment|3|||
145459172|NCT00235391|524532871|FG001|Overall Study|Condition no longer requires treatment|0|||
145459173|NCT00235391|524532872|FG002|Overall Study|Condition no longer requires treatment|0|||
145459174|NCT00235391|524532873|FG003|Overall Study|Condition no longer requires treatment|11|||
145626770|NCT02939183|525145785|FG008|Overall Study|Not treated due to adverse event|0|||
145459175|NCT00235391|524532874|FG004|Overall Study|Condition no longer requires treatment|1|||
145459176|NCT00235391|524532875|FG005|Overall Study|Condition no longer requires treatment|0|||
145459177|NCT00235391|524532870|FG000|Overall Study|Protocol deviation|0|||
145459178|NCT00235391|524532871|FG001|Overall Study|Protocol deviation|0|||
145459179|NCT00235391|524532872|FG002|Overall Study|Protocol deviation|1|||
145459180|NCT00235391|524532873|FG003|Overall Study|Protocol deviation|11|||
145459181|NCT00235391|524532874|FG004|Overall Study|Protocol deviation|0|||
145459182|NCT00235391|524532875|FG005|Overall Study|Protocol deviation|0|||
145459183|NCT00235391|524532870|FG000|Overall Study|Withdrawal by Subject|2|||
145459184|NCT00235391|524532871|FG001|Overall Study|Withdrawal by Subject|3|||
145459185|NCT00235391|524532872|FG002|Overall Study|Withdrawal by Subject|3|||
145459186|NCT00235391|524532873|FG003|Overall Study|Withdrawal by Subject|61|||
145459187|NCT00235391|524532874|FG004|Overall Study|Withdrawal by Subject|5|||
145592409|NCT01572727|525020726|FG000|Overall Study|Study terminated by sponsor|61|||
145592410|NCT01572727|525020727|FG001|Overall Study|Study terminated by sponsor|83|||
145592411|NCT01572727|525020726|FG000|Overall Study|Parent/guardian decision|14|||
145592412|NCT01572727|525020727|FG001|Overall Study|Parent/guardian decision|9|||
145592413|NCT01572727|525020726|FG000|Overall Study|Death|2|||
145592414|NCT01572727|525020727|FG001|Overall Study|Death|2|||
145592415|NCT01572727|525020726|FG000|Overall Study|Untreated|4|||
145592416|NCT01572727|525020727|FG001|Overall Study|Untreated|7|||
145592417|NCT04053764|525020728|FG000|Overall Study|Withdrawal by Subject|6|||
145592418|NCT04053764|525020729|FG001|Overall Study|Withdrawal by Subject|2|||
145592419|NCT04053764|525020728|FG000|Overall Study|Physician Decision|2|||
145592420|NCT04053764|525020729|FG001|Overall Study|Physician Decision|1|||
145592421|NCT04053764|525020728|FG000|Overall Study|Adverse Event|1|||
145592422|NCT04053764|525020729|FG001|Overall Study|Adverse Event|0|||
145592423|NCT04053764|525020728|FG000|Overall Study|Pregnancy|1|||
145592424|NCT04053764|525020729|FG001|Overall Study|Pregnancy|0|||
145592425|NCT04732286|525020730|FG000|Overall Study|Progressive Disease|2|||
145592426|NCT04732286|525020730|FG000|Overall Study|Physician Decision|1|||
145592427|NCT04732286|525020730|FG000|Overall Study|Study Terminated by Sponsor|31|||
145592428|NCT04732286|525020730|FG000|Overall Study|Withdrawal by Subject|10|||
145592429|NCT04732286|525020730|FG000|Overall Study|Non-compliance With Study Drug|1|||
145592430|NCT04732286|525020730|FG000|Overall Study|Lost to Follow-up|4|||
145592431|NCT04732286|525020730|FG000|Overall Study|Death|51|||
145592432|NCT01474681|525020731|FG000|Overall Study|Death|0|||
145592433|NCT01474681|525020732|FG001|Overall Study|Death|3|||
145592434|NCT01474681|525020733|FG002|Overall Study|Death|2|||
145592435|NCT01474681|525020734|FG003|Overall Study|Death|6|||
145592436|NCT00319098|525020737|FG000|Overall Study|Serious adverse event|3|||
145592437|NCT00319098|525020738|FG001|Overall Study|Serious adverse event|0|||
145592438|NCT00319098|525020737|FG000|Overall Study|Adverse Event|20|||
145592439|NCT00319098|525020738|FG001|Overall Study|Adverse Event|1|||
145592440|NCT00319098|525020737|FG000|Overall Study|Withdrawal by Subject|37|||
145592441|NCT00319098|525020738|FG001|Overall Study|Withdrawal by Subject|8|||
145592442|NCT00319098|525020737|FG000|Overall Study|Migrated/moved from study area|2|||
145592443|NCT00319098|525020738|FG001|Overall Study|Migrated/moved from study area|1|||
145592444|NCT00319098|525020737|FG000|Overall Study|Lost to Follow-up|37|||
145592445|NCT00319098|525020738|FG001|Overall Study|Lost to Follow-up|13|||
145592446|NCT00319098|525020737|FG000|Overall Study|Others|33|||
145592447|NCT00319098|525020738|FG001|Overall Study|Others|8|||
145592448|NCT00319098|525020737|FG000|Overall Study|Protocol Violation|3|||
145592449|NCT00319098|525020738|FG001|Overall Study|Protocol Violation|1|||
145592450|NCT02834780|525020739|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
145592451|NCT02834780|525020740|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
145592452|NCT02834780|525020741|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
145592453|NCT02834780|525020742|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
145592454|NCT02834780|525020743|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
145592455|NCT02834780|525020744|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
145592456|NCT02834780|525020745|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
145592457|NCT02834780|525020746|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
145592458|NCT02834780|525020747|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
145592459|NCT02834780|525020748|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
145592460|NCT02834780|525020749|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
145592461|NCT02834780|525020750|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
145592462|NCT02834780|525020751|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
145592463|NCT02834780|525020739|FG000|Overall Study|Withdrawal by Subject|0|||
145592464|NCT02834780|525020740|FG001|Overall Study|Withdrawal by Subject|0|||
145592465|NCT02834780|525020741|FG002|Overall Study|Withdrawal by Subject|1|||
145592466|NCT02834780|525020742|FG003|Overall Study|Withdrawal by Subject|0|||
145592467|NCT02834780|525020743|FG004|Overall Study|Withdrawal by Subject|0|||
145459188|NCT00235391|524532875|FG005|Overall Study|Withdrawal by Subject|0|||
145459189|NCT00235391|524532870|FG000|Overall Study|Lost to Follow-up|0|||
145459190|NCT00235391|524532871|FG001|Overall Study|Lost to Follow-up|3|||
145459191|NCT00235391|524532872|FG002|Overall Study|Lost to Follow-up|3|||
145459192|NCT00235391|524532873|FG003|Overall Study|Lost to Follow-up|16|||
145459193|NCT00235391|524532874|FG004|Overall Study|Lost to Follow-up|0|||
145459194|NCT00235391|524532875|FG005|Overall Study|Lost to Follow-up|0|||
145592468|NCT02834780|525020744|FG005|Overall Study|Withdrawal by Subject|0|||
145592469|NCT02834780|525020745|FG006|Overall Study|Withdrawal by Subject|0|||
145592470|NCT02834780|525020746|FG007|Overall Study|Withdrawal by Subject|0|||
145592471|NCT02834780|525020747|FG008|Overall Study|Withdrawal by Subject|0|||
145592472|NCT02834780|525020748|FG009|Overall Study|Withdrawal by Subject|0|||
145592473|NCT02834780|525020749|FG010|Overall Study|Withdrawal by Subject|1|||
145592474|NCT02834780|525020750|FG011|Overall Study|Withdrawal by Subject|0|||
145592475|NCT02834780|525020751|FG012|Overall Study|Withdrawal by Subject|0|||
145459195|NCT00235391|524532870|FG000|Overall Study|Administrative problems|0|||
145592476|NCT02834780|525020739|FG000|Overall Study|Adverse Event|0|||
145592477|NCT02834780|525020740|FG001|Overall Study|Adverse Event|0|||
145592478|NCT02834780|525020741|FG002|Overall Study|Adverse Event|0|||
145592479|NCT02834780|525020742|FG003|Overall Study|Adverse Event|0|||
145592480|NCT02834780|525020743|FG004|Overall Study|Adverse Event|1|||
145592481|NCT02834780|525020744|FG005|Overall Study|Adverse Event|0|||
145592482|NCT02834780|525020745|FG006|Overall Study|Adverse Event|1|||
145592483|NCT02834780|525020746|FG007|Overall Study|Adverse Event|1|||
145592484|NCT02834780|525020747|FG008|Overall Study|Adverse Event|0|||
145592485|NCT02834780|525020748|FG009|Overall Study|Adverse Event|2|||
145592486|NCT02834780|525020749|FG010|Overall Study|Adverse Event|0|||
145592487|NCT02834780|525020750|FG011|Overall Study|Adverse Event|3|||
145592488|NCT02834780|525020751|FG012|Overall Study|Adverse Event|2|||
145592489|NCT02834780|525020739|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592490|NCT02834780|525020740|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
145592491|NCT02834780|525020741|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
145592492|NCT02834780|525020742|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592493|NCT02834780|525020743|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592494|NCT02834780|525020744|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592495|NCT02834780|525020745|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592496|NCT02834780|525020746|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
145592497|NCT02834780|525020747|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
145592498|NCT02834780|525020748|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
145592499|NCT02834780|525020749|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
145592500|NCT02834780|525020750|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
145592501|NCT02834780|525020751|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
145592502|NCT02834780|525020739|FG000|Overall Study|Other|1|||
145592503|NCT02834780|525020740|FG001|Overall Study|Other|0|||
145592504|NCT02834780|525020741|FG002|Overall Study|Other|1|||
145592505|NCT02834780|525020742|FG003|Overall Study|Other|2|||
145592506|NCT02834780|525020743|FG004|Overall Study|Other|0|||
145592507|NCT02834780|525020744|FG005|Overall Study|Other|0|||
145592508|NCT02834780|525020745|FG006|Overall Study|Other|0|||
145592509|NCT02834780|525020746|FG007|Overall Study|Other|0|||
145592510|NCT02834780|525020747|FG008|Overall Study|Other|0|||
145592511|NCT02834780|525020748|FG009|Overall Study|Other|0|||
145592512|NCT02834780|525020749|FG010|Overall Study|Other|0|||
145592513|NCT02834780|525020750|FG011|Overall Study|Other|0|||
145592514|NCT02834780|525020751|FG012|Overall Study|Other|1|||
145592515|NCT03150056|525020752|FG000|Overall Study|Withdrawal by Subject|0|||
145592516|NCT03150056|525020753|FG001|Overall Study|Withdrawal by Subject|0|||
145459196|NCT00235391|524532871|FG001|Overall Study|Administrative problems|0|||
145459197|NCT00235391|524532872|FG002|Overall Study|Administrative problems|0|||
145459198|NCT00235391|524532873|FG003|Overall Study|Administrative problems|1|||
145459199|NCT00235391|524532874|FG004|Overall Study|Administrative problems|0|||
145459200|NCT00235391|524532875|FG005|Overall Study|Administrative problems|0|||
145459201|NCT00235391|524532870|FG000|Overall Study|Death|0|||
145459202|NCT00235391|524532871|FG001|Overall Study|Death|0|||
145459203|NCT00235391|524532872|FG002|Overall Study|Death|1|||
145459204|NCT00235391|524532873|FG003|Overall Study|Death|4|||
145459205|NCT00235391|524532874|FG004|Overall Study|Death|0|||
145459206|NCT00235391|524532875|FG005|Overall Study|Death|0|||
145459207|NCT02927925|524532880|FG000|Overall Study|Death|16|||
145459208|NCT02927925|524532880|FG000|Overall Study|Physician Decision|1|||
145459209|NCT02927925|524532880|FG000|Overall Study|Withdrawal by Subject|11|||
145459210|NCT02927925|524532880|FG000|Overall Study|Other|3|||
145459211|NCT02927925|524532880|FG000|Overall Study|Disease progression at clinical cutoff|1|||
145459212|NCT00580034|524532881|FG000|Overall Study|Toxicity|10|||
145459213|NCT00580034|524532882|FG001|Overall Study|Toxicity|0|||
145459214|NCT00772369|524532884|FG000|Overall Study|Did not return record release form|1|||
145459215|NCT03372460|524532885|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
145459216|NCT03372460|524532886|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
145459217|NCT02499900|524532887|FG000|Core Study Period|Other|1|||
145592517|NCT03150056|525020754|FG002|Overall Study|Withdrawal by Subject|0|||
145592518|NCT03150056|525020755|FG003|Overall Study|Withdrawal by Subject|0|||
145592519|NCT03150056|525020756|FG004|Overall Study|Withdrawal by Subject|0|||
145592520|NCT03150056|525020757|FG005|Overall Study|Withdrawal by Subject|2|||
145592521|NCT03150056|525020752|FG000|Overall Study|Study terminated by Sponsor|1|||
145592522|NCT03150056|525020753|FG001|Overall Study|Study terminated by Sponsor|3|||
145592523|NCT03150056|525020754|FG002|Overall Study|Study terminated by Sponsor|1|||
145459218|NCT02499900|524532888|FG001|Core Study Period|Other|4|||
145459219|NCT02499900|524532887|FG000|Core Study Period|Lost to Follow-up|1|||
145459220|NCT02499900|524532888|FG001|Core Study Period|Lost to Follow-up|2|||
145459221|NCT02499900|524532887|FG000|Core Study Period|Per sponsor request|0|||
145459222|NCT02499900|524532888|FG001|Core Study Period|Per sponsor request|1|||
145459223|NCT02499900|524532887|FG000|Core Study Period|Pregnancy|1|||
145459224|NCT02499900|524532888|FG001|Core Study Period|Pregnancy|0|||
145459225|NCT02499900|524532887|FG000|Core Study Period|Protocol Violation|3|||
145459226|NCT02499900|524532888|FG001|Core Study Period|Protocol Violation|0|||
145459227|NCT02499900|524532887|FG000|Core Study Period|Withdrawal by Subject|11|||
145459228|NCT02499900|524532888|FG001|Core Study Period|Withdrawal by Subject|10|||
145459229|NCT02499900|524532887|FG000|Core Study Period|Adverse Event|18|||
145459230|NCT02499900|524532888|FG001|Core Study Period|Adverse Event|14|||
145459231|NCT02499900|524532887|FG000|Core Study Period|Death|0|||
145459232|NCT02499900|524532888|FG001|Core Study Period|Death|1|||
145459233|NCT02499900|524532887|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
145459234|NCT02499900|524532888|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
145459235|NCT02499900|524532887|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
145459236|NCT02499900|524532888|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
145459237|NCT02499900|524532887|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
145459238|NCT02499900|524532888|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
145459239|NCT02499900|524532887|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
145459240|NCT02499900|524532888|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
145459241|NCT02499900|524532887|FG000|Extension Study Period|Adverse Event|2|||
145459242|NCT02499900|524532888|FG001|Extension Study Period|Adverse Event|4|||
145459243|NCT02499900|524532887|FG000|Extension Study Period|Withdrawal by Subject|5|||
145459244|NCT02499900|524532888|FG001|Extension Study Period|Withdrawal by Subject|2|||
145459245|NCT02499900|524532887|FG000|Extension Study Period|Physician Decision|2|||
145459246|NCT02499900|524532888|FG001|Extension Study Period|Physician Decision|5|||
145459247|NCT02499900|524532887|FG000|Extension Study Period|Pregnancy|1|||
145459248|NCT02499900|524532888|FG001|Extension Study Period|Pregnancy|2|||
145459249|NCT02499900|524532887|FG000|Extension Study Period|Lost to Follow-up|2|||
145459250|NCT02499900|524532888|FG001|Extension Study Period|Lost to Follow-up|5|||
145459251|NCT02499900|524532887|FG000|Extension Study Period|Other|0|||
145459252|NCT02499900|524532888|FG001|Extension Study Period|Other|2|||
145459253|NCT00916058|524532889|FG000|Phase 1|Screen Failure|0|||
145459254|NCT00916058|524532890|FG001|Phase 1|Screen Failure|0|||
145459255|NCT00916058|524532891|FG002|Phase 1|Screen Failure|0|||
145459256|NCT00916058|524532892|FG003|Phase 1|Screen Failure|0|||
145459257|NCT00916058|524532893|FG004|Phase 1|Screen Failure|0|||
145459258|NCT00916058|524532894|FG005|Phase 1|Screen Failure|1|||
145459259|NCT00916058|524532895|FG006|Phase 1|Screen Failure|0|||
145459260|NCT00916058|524532889|FG000|Phase 2|Screen Failure|0|||
145459261|NCT00916058|524532890|FG001|Phase 2|Screen Failure|0|||
145459262|NCT00916058|524532891|FG002|Phase 2|Screen Failure|0|||
145459263|NCT00916058|524532892|FG003|Phase 2|Screen Failure|0|||
145459264|NCT00916058|524532893|FG004|Phase 2|Screen Failure|0|||
145459265|NCT00916058|524532894|FG005|Phase 2|Screen Failure|0|||
145459266|NCT00916058|524532895|FG006|Phase 2|Screen Failure|3|||
145459267|NCT02439450|524532896|FG000|Overall Study|Adverse Event|4|||
145459268|NCT02439450|524532897|FG001|Overall Study|Adverse Event|1|||
145459269|NCT02439450|524532898|FG002|Overall Study|Adverse Event|0|||
145459270|NCT02439450|524532899|FG003|Overall Study|Adverse Event|0|||
145459271|NCT02439450|524532896|FG000|Overall Study|Withdrawal by Subject|1|||
145459272|NCT02439450|524532897|FG001|Overall Study|Withdrawal by Subject|2|||
145459273|NCT02439450|524532898|FG002|Overall Study|Withdrawal by Subject|0|||
145459274|NCT02439450|524532899|FG003|Overall Study|Withdrawal by Subject|0|||
145459275|NCT02439450|524532896|FG000|Overall Study|Death|3|||
145459276|NCT02439450|524532897|FG001|Overall Study|Death|0|||
145459277|NCT02439450|524532898|FG002|Overall Study|Death|0|||
145459278|NCT02439450|524532899|FG003|Overall Study|Death|1|||
145459279|NCT02439450|524532896|FG000|Overall Study|Progressive Disease|18|||
145459280|NCT02439450|524532897|FG001|Overall Study|Progressive Disease|41|||
145459281|NCT02439450|524532898|FG002|Overall Study|Progressive Disease|2|||
145459282|NCT02439450|524532899|FG003|Overall Study|Progressive Disease|3|||
145459283|NCT01071200|524532900|FG000|Overall Study|Lack of ovarian response|1|||
145459284|NCT01071200|524532901|FG001|Overall Study|Lack of ovarian response|1|||
145459285|NCT01071200|524532900|FG000|Overall Study|No fertilization|4|||
145459286|NCT01071200|524532901|FG001|Overall Study|No fertilization|0|||
145459287|NCT01071200|524532900|FG000|Overall Study|No oocytes retrieved|1|||
145459288|NCT01071200|524532901|FG001|Overall Study|No oocytes retrieved|1|||
145459289|NCT01071200|524532900|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
145459290|NCT01071200|524532901|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
145459291|NCT01071200|524532900|FG000|Overall Study|No viable embryos|0|||
145459292|NCT01071200|524532901|FG001|Overall Study|No viable embryos|1|||
145459293|NCT01646645|524532908|FG000|Overall Study|No Treated|1|||
145459294|NCT01646645|524532908|FG000|Overall Study|Inevaluable Donor|29|||
145459295|NCT00717522|524532909|FG000|Overall Study|Disease Progression|5|||
145459296|NCT00717522|524532909|FG000|Overall Study|Adverse Event|1|||
145459297|NCT00717522|524532909|FG000|Overall Study|Death|1|||
145459298|NCT00496483|524534844|FG000|Overall Study|Not dosed|9|||
145459299|NCT00496483|524534844|FG000|Overall Study|Adverse Event|2|||
145459300|NCT00496483|524534844|FG000|Overall Study|Lack of Efficacy|1|||
145459301|NCT00428220|524534845|FG000|Overall Study|Participant died|8|||
145459302|NCT00428220|524534845|FG000|Overall Study|Global deterioration of health status|7|||
145592524|NCT03150056|525020755|FG003|Overall Study|Study terminated by Sponsor|1|||
145592525|NCT03150056|525020756|FG004|Overall Study|Study terminated by Sponsor|5|||
145592526|NCT03150056|525020757|FG005|Overall Study|Study terminated by Sponsor|6|||
145592527|NCT03150056|525020752|FG000|Overall Study|Death|9|||
145592528|NCT03150056|525020753|FG001|Overall Study|Death|2|||
145592529|NCT03150056|525020754|FG002|Overall Study|Death|2|||
145592530|NCT03150056|525020755|FG003|Overall Study|Death|7|||
145592531|NCT03150056|525020756|FG004|Overall Study|Death|8|||
145592532|NCT03150056|525020757|FG005|Overall Study|Death|10|||
145592533|NCT02270450|525020760|FG000|Overall Study|Refusal unrelated to adverse event|3|||
145592534|NCT02270450|525020761|FG001|Overall Study|Refusal unrelated to adverse event|1|||
145592535|NCT02270450|525020762|FG002|Overall Study|Refusal unrelated to adverse event|5|||
145592536|NCT02270450|525020763|FG003|Overall Study|Refusal unrelated to adverse event|14|||
145592537|NCT02270450|525020760|FG000|Overall Study|Progression/relapse|1|||
145592538|NCT02270450|525020761|FG001|Overall Study|Progression/relapse|2|||
145592539|NCT02270450|525020762|FG002|Overall Study|Progression/relapse|4|||
145592540|NCT02270450|525020763|FG003|Overall Study|Progression/relapse|9|||
145592541|NCT02270450|525020760|FG000|Overall Study|Death|19|||
145592542|NCT02270450|525020761|FG001|Overall Study|Death|19|||
145592543|NCT02270450|525020762|FG002|Overall Study|Death|31|||
145592544|NCT02270450|525020763|FG003|Overall Study|Death|59|||
145592545|NCT02363738|525020764|FG000|Overall Study|Adverse Event|5|||
145592546|NCT02363738|525020765|FG001|Overall Study|Adverse Event|2|||
145592547|NCT02363738|525020764|FG000|Overall Study|Lack of Efficacy|1|||
145592548|NCT02363738|525020765|FG001|Overall Study|Lack of Efficacy|2|||
145592549|NCT02363738|525020764|FG000|Overall Study|Lost to Follow-up|2|||
145592550|NCT02363738|525020765|FG001|Overall Study|Lost to Follow-up|1|||
145592551|NCT01939028|525020769|FG000|Overall Study|Withdrawal by Subject|5|||
145592552|NCT01939028|525020769|FG000|Overall Study|Physician Decision|7|||
145592553|NCT00322348|525020772|FG000|Overall Study|Adverse Event|0|||
145592554|NCT00322348|525020773|FG001|Overall Study|Adverse Event|1|||
145592555|NCT00322348|525020772|FG000|Overall Study|Withdrawal by Subject|1|||
145592556|NCT00322348|525020773|FG001|Overall Study|Withdrawal by Subject|4|||
145592557|NCT00322348|525020772|FG000|Overall Study|Lost to Follow-up|1|||
145592558|NCT00322348|525020773|FG001|Overall Study|Lost to Follow-up|0|||
145592559|NCT00322348|525020772|FG000|Overall Study|Death|0|||
145592560|NCT00322348|525020773|FG001|Overall Study|Death|2|||
145592561|NCT00322348|525020772|FG000|Overall Study|Disease Progression|30|||
145592562|NCT00322348|525020773|FG001|Overall Study|Disease Progression|25|||
145592563|NCT00322348|525020772|FG000|Overall Study|Reasons not specified|5|||
145592564|NCT00322348|525020773|FG001|Overall Study|Reasons not specified|1|||
145592565|NCT00936858|525020774|FG000|Overall Study|Death|3|||
145592566|NCT00936858|525020774|FG000|Overall Study|Progression|29|||
145592567|NCT00936858|525020774|FG000|Overall Study|Withdrawal by Subject|5|||
145592568|NCT00936858|525020774|FG000|Overall Study|Adverse Event|1|||
145592569|NCT00936858|525020774|FG000|Overall Study|Physician Decision|7|||
145592570|NCT00936858|525020774|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
145592571|NCT00936858|525020774|FG000|Overall Study|Lost to Follow-up|1|||
145592572|NCT00989287|525020786|FG000|Overall Study|Adverse Event|1|||
145592573|NCT00989287|525020787|FG001|Overall Study|Adverse Event|0|||
145592574|NCT00989287|525020786|FG000|Overall Study|Lost to Follow-up|0|||
145592575|NCT00989287|525020787|FG001|Overall Study|Lost to Follow-up|1|||
145592576|NCT02341417|525020788|FG000|Overall Study|Withdrawal by Subject|0|||
145592577|NCT02341417|525020789|FG001|Overall Study|Withdrawal by Subject|2|||
145592578|NCT02341417|525020790|FG002|Overall Study|Withdrawal by Subject|0|||
145592579|NCT02341417|525020788|FG000|Overall Study|Decision by sponsor|2|||
145592580|NCT02341417|525020789|FG001|Overall Study|Decision by sponsor|0|||
145592581|NCT02341417|525020790|FG002|Overall Study|Decision by sponsor|0|||
145592582|NCT02341417|525020788|FG000|Overall Study|Death|0|||
145592583|NCT02341417|525020789|FG001|Overall Study|Death|0|||
145592584|NCT02341417|525020790|FG002|Overall Study|Death|1|||
145592585|NCT01857531|525020804|FG000|Overall Study|Withdrawal by Subject|4|||
145592586|NCT02576067|525020805|FG000|Overall Study|Death|0|||
145592587|NCT02576067|525020806|FG001|Overall Study|Death|1|||
145592588|NCT02576067|525020805|FG000|Overall Study|Lack of Efficacy|1|||
145592589|NCT02576067|525020806|FG001|Overall Study|Lack of Efficacy|0|||
145592590|NCT02576067|525020805|FG000|Overall Study|Lost to Follow-up|11|||
145592591|NCT02576067|525020806|FG001|Overall Study|Lost to Follow-up|0|||
145592592|NCT02576067|525020805|FG000|Overall Study|Withdrawal by Subject|11|||
145592593|NCT02576067|525020806|FG001|Overall Study|Withdrawal by Subject|2|||
145592594|NCT02576067|525020805|FG000|Overall Study|study closure of main CIRT trial)|0|||
145592595|NCT02576067|525020806|FG001|Overall Study|study closure of main CIRT trial)|8|||
145592596|NCT02576067|525020805|FG000|Overall Study|not randomized, failed run-in|7|||
145592597|NCT02576067|525020806|FG001|Overall Study|not randomized, failed run-in|0|||
145592598|NCT02576067|525020805|FG000|Overall Study|screen failure/ re-enrolled|0|||
145592599|NCT02576067|525020806|FG001|Overall Study|screen failure/ re-enrolled|25|||
145592600|NCT02576067|525020805|FG000|Overall Study|Physician Decision|4|||
145592601|NCT02576067|525020806|FG001|Overall Study|Physician Decision|0|||
145592602|NCT03570619|525020807|FG000|Overall Study|Adverse Event|2|||
145592603|NCT03570619|525020808|FG001|Overall Study|Adverse Event|0|||
145592604|NCT03570619|525020809|FG002|Overall Study|Adverse Event|1|||
145592605|NCT03570619|525020807|FG000|Overall Study|new diagnosis of new malignancy|1|||
145592606|NCT03570619|525020808|FG001|Overall Study|new diagnosis of new malignancy|0|||
145592607|NCT03570619|525020809|FG002|Overall Study|new diagnosis of new malignancy|0|||
145592608|NCT03570619|525020807|FG000|Overall Study|Physician Decision|1|||
145592609|NCT03570619|525020808|FG001|Overall Study|Physician Decision|1|||
145592610|NCT03570619|525020809|FG002|Overall Study|Physician Decision|0|||
145592611|NCT03570619|525020807|FG000|Overall Study|Withdrawal by Subject|0|||
145592612|NCT03570619|525020808|FG001|Overall Study|Withdrawal by Subject|2|||
145592613|NCT03570619|525020809|FG002|Overall Study|Withdrawal by Subject|0|||
145592614|NCT04773587|525020810|FG000|Overall Study|Lost to Follow-up|11|||
145626771|NCT02909101|525145787|FG000|Overall Study|Lost to Follow-up|1|||
145626772|NCT02909101|525145788|FG001|Overall Study|Lost to Follow-up|1|||
145626773|NCT02698436|525145789|FG000|Overall Study|Adverse Event|1|||
145626774|NCT02698436|525145790|FG001|Overall Study|Adverse Event|0|||
145626775|NCT02698436|525145789|FG000|Overall Study|Withdrawal by Subject|3|||
145626776|NCT02698436|525145790|FG001|Overall Study|Withdrawal by Subject|3|||
145459303|NCT00428220|524534845|FG000|Overall Study|Lost to Follow-up|4|||
145459304|NCT00428220|524534845|FG000|Overall Study|Objective progression or relapse|123|||
145459305|NCT00428220|524534845|FG000|Overall Study|Participant refused continued treatment|7|||
145459306|NCT00428220|524534845|FG000|Overall Study|Adverse Event|51|||
145459307|NCT00428220|524534845|FG000|Overall Study|Other|23|||
145459308|NCT03245736|524534846|FG000|Overall Study|Adverse Event|1|||
145459309|NCT03245736|524534846|FG000|Overall Study|Progressive Disease|4|||
145459310|NCT00132691|524534848|FG000|Overall Study|Lost to Follow-up|5|||
145459311|NCT00132691|524534849|FG001|Overall Study|Lost to Follow-up|8|||
145459312|NCT00132691|524534848|FG000|Overall Study|Missed 2-year visit|4|||
145459313|NCT00132691|524534849|FG001|Overall Study|Missed 2-year visit|4|||
145459314|NCT00132691|524534848|FG000|Overall Study|Death|2|||
145459315|NCT00132691|524534849|FG001|Overall Study|Death|0|||
145459316|NCT02323126|524534850|FG000|Overall Study|Patient / guardian decision|0|||
145459317|NCT02323126|524534851|FG001|Overall Study|Patient / guardian decision|1|||
145459318|NCT02323126|524534852|FG002|Overall Study|Patient / guardian decision|2|||
145459319|NCT02323126|524534850|FG000|Overall Study|Progressive disease|14|||
145459320|NCT02323126|524534851|FG001|Overall Study|Progressive disease|8|||
145459321|NCT02323126|524534852|FG002|Overall Study|Progressive disease|14|||
145459322|NCT02323126|524534850|FG000|Overall Study|Physician Decision|0|||
145459323|NCT02323126|524534851|FG001|Overall Study|Physician Decision|1|||
145459324|NCT02323126|524534852|FG002|Overall Study|Physician Decision|3|||
145459325|NCT02323126|524534850|FG000|Overall Study|Death|1|||
145459326|NCT02323126|524534851|FG001|Overall Study|Death|1|||
145459327|NCT02323126|524534852|FG002|Overall Study|Death|4|||
145459328|NCT02323126|524534850|FG000|Overall Study|Adverse Event|3|||
145459329|NCT02323126|524534851|FG001|Overall Study|Adverse Event|5|||
145459330|NCT02323126|524534852|FG002|Overall Study|Adverse Event|7|||
145459331|NCT03333252|524534853|FG000|Overall Study|Adverse Event|10|||
145459332|NCT03333252|524534854|FG001|Overall Study|Adverse Event|6|||
145459333|NCT03333252|524534855|FG002|Overall Study|Adverse Event|5|||
145459334|NCT03333252|524534856|FG003|Overall Study|Adverse Event|2|||
145459335|NCT03333252|524534853|FG000|Overall Study|Death|1|||
145459336|NCT03333252|524534854|FG001|Overall Study|Death|3|||
145459337|NCT03333252|524534855|FG002|Overall Study|Death|0|||
145459338|NCT03333252|524534856|FG003|Overall Study|Death|0|||
145459339|NCT03333252|524534853|FG000|Overall Study|Lack of Efficacy|8|||
145459340|NCT03333252|524534854|FG001|Overall Study|Lack of Efficacy|4|||
145592615|NCT04773587|525020811|FG001|Overall Study|Lost to Follow-up|3|||
145626777|NCT02698436|525145789|FG000|Overall Study|Lost to Follow-up|2|||
145459341|NCT03333252|524534855|FG002|Overall Study|Lack of Efficacy|0|||
145459342|NCT03333252|524534856|FG003|Overall Study|Lack of Efficacy|7|||
145459343|NCT03333252|524534853|FG000|Overall Study|Lost to Follow-up|0|||
145459344|NCT03333252|524534854|FG001|Overall Study|Lost to Follow-up|5|||
145459345|NCT03333252|524534855|FG002|Overall Study|Lost to Follow-up|9|||
145459346|NCT03333252|524534856|FG003|Overall Study|Lost to Follow-up|3|||
145459347|NCT03333252|524534853|FG000|Overall Study|Withdrawal by Subject|14|||
145459348|NCT03333252|524534854|FG001|Overall Study|Withdrawal by Subject|24|||
145459349|NCT03333252|524534855|FG002|Overall Study|Withdrawal by Subject|11|||
145459350|NCT03333252|524534856|FG003|Overall Study|Withdrawal by Subject|17|||
145459351|NCT01685801|524534862|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
145459352|NCT01685801|524534863|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
145459353|NCT01685801|524534864|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
145459354|NCT01685801|524534865|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
145459355|NCT01685801|524534862|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
145459356|NCT01685801|524534863|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
145459357|NCT01685801|524534864|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
145459358|NCT01685801|524534865|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
145592616|NCT04773587|525020810|FG000|Overall Study|Adverse Event|6|||
145592617|NCT04773587|525020811|FG001|Overall Study|Adverse Event|3|||
145626778|NCT02698436|525145790|FG001|Overall Study|Lost to Follow-up|4|||
145626779|NCT02698436|525145789|FG000|Overall Study|Non-compliance with study regimen|1|||
145592618|NCT04773587|525020810|FG000|Overall Study|Lack of Efficacy|5|||
145592619|NCT04773587|525020811|FG001|Overall Study|Lack of Efficacy|2|||
145592620|NCT04773587|525020810|FG000|Overall Study|Withdrawal by Subject|4|||
145592621|NCT04773587|525020811|FG001|Overall Study|Withdrawal by Subject|5|||
145592622|NCT04773587|525020810|FG000|Overall Study|Noncompliance|1|||
145592623|NCT04773587|525020811|FG001|Overall Study|Noncompliance|0|||
145592624|NCT04773587|525020810|FG000|Overall Study|Protocol Violation|1|||
145592625|NCT04773587|525020811|FG001|Overall Study|Protocol Violation|0|||
145592626|NCT04773587|525020810|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
145592627|NCT04773587|525020811|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
145592628|NCT04656847|525020814|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
145592629|NCT03301051|525020815|FG000|Overall Study|Adverse Event|0|||
145592630|NCT03301051|525020816|FG001|Overall Study|Adverse Event|4|||
145592631|NCT03301051|525020815|FG000|Overall Study|Withdrawal by Subject|59|||
145592632|NCT03301051|525020816|FG001|Overall Study|Withdrawal by Subject|65|||
145592633|NCT03301051|525020815|FG000|Overall Study|Lost to Follow-up|263|||
145592634|NCT03301051|525020816|FG001|Overall Study|Lost to Follow-up|282|||
145592635|NCT03301051|525020815|FG000|Overall Study|Protocol Violation|1|||
145592636|NCT03301051|525020816|FG001|Overall Study|Protocol Violation|3|||
145592637|NCT03301051|525020815|FG000|Overall Study|Physician Decision|1|||
145592638|NCT03301051|525020816|FG001|Overall Study|Physician Decision|3|||
145592639|NCT03301051|525020815|FG000|Overall Study|Death|1|||
145592640|NCT03301051|525020816|FG001|Overall Study|Death|1|||
145592641|NCT03301051|525020815|FG000|Overall Study|Miscellaneous|8|||
145592642|NCT03301051|525020816|FG001|Overall Study|Miscellaneous|4|||
145592643|NCT03301051|525020815|FG000|Overall Study|Randomized, not vaccinated|13|||
145592644|NCT03301051|525020816|FG001|Overall Study|Randomized, not vaccinated|10|||
145592645|NCT00622167|525020817|FG000|Overall Study|Did not meet angiographic criteria|20|||
145592646|NCT02820623|525020818|FG000|Overall Study|Withdrawal by Subject|1|||
145592647|NCT02820623|525020819|FG001|Overall Study|Withdrawal by Subject|3|||
145592648|NCT02820623|525020820|FG002|Overall Study|Withdrawal by Subject|3|||
145592649|NCT02820623|525020818|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
145592650|NCT02820623|525020819|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
145592651|NCT02820623|525020820|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
145459359|NCT03350256|524534866|FG000|Overall Study|Inclusion/exclusion violation|4|||
145459360|NCT03350256|524534866|FG000|Overall Study|Recommended for other therapies|2|||
145459361|NCT03350256|524534866|FG000|Overall Study|Protocol Violation|3|||
145459362|NCT03350256|524534866|FG000|Overall Study|Non compliance|2|||
145459363|NCT03350256|524534866|FG000|Overall Study|Denial by insurance|1|||
145459364|NCT03350256|524534866|FG000|Overall Study|Adverse Event|2|||
145459365|NCT03350256|524534866|FG000|Overall Study|Trial failure|12|||
145459366|NCT03350256|524534866|FG000|Overall Study|Did not proceed to permanent implant|3|||
145459367|NCT03350256|524534866|FG000|Overall Study|Withdrawal by Subject|3|||
145459368|NCT03350256|524534866|FG000|Overall Study|Subject moving out of state|1|||
145459369|NCT03350256|524534866|FG000|Overall Study|Lost to Follow-up|1|||
145459370|NCT03350256|524534866|FG000|Overall Study|Lack of Efficacy|2|||
145459371|NCT03960580|524534867|FG000|Overall Study|Adverse Event|2|||
145459372|NCT03960580|524534868|FG001|Overall Study|Adverse Event|1|||
145459373|NCT03960580|524534869|FG002|Overall Study|Adverse Event|1|||
145459374|NCT03960580|524534867|FG000|Overall Study|Lost to Follow-up|1|||
145592652|NCT02820623|525020818|FG000|Overall Study|Therapist unable to enroll clients|1|||
145592653|NCT02820623|525020819|FG001|Overall Study|Therapist unable to enroll clients|1|||
145592654|NCT02820623|525020820|FG002|Overall Study|Therapist unable to enroll clients|3|||
145592655|NCT02820623|525020818|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
145592656|NCT02820623|525020819|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
145592657|NCT02820623|525020820|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
145592658|NCT01954017|525020832|FG000|Overall Study|Adverse Event|0|||
145592659|NCT01954017|525020833|FG001|Overall Study|Adverse Event|0|||
145592660|NCT01954017|525020834|FG002|Overall Study|Adverse Event|1|||
145592661|NCT01954017|525020832|FG000|Overall Study|Death|2|||
145592662|NCT01954017|525020833|FG001|Overall Study|Death|1|||
145592663|NCT01954017|525020834|FG002|Overall Study|Death|1|||
145592664|NCT01954017|525020832|FG000|Overall Study|Withdrawal by Subject|0|||
145592665|NCT01954017|525020833|FG001|Overall Study|Withdrawal by Subject|1|||
145592666|NCT01954017|525020834|FG002|Overall Study|Withdrawal by Subject|0|||
145592667|NCT01954017|525020832|FG000|Overall Study|Protocol Violation|0|||
145592668|NCT01954017|525020833|FG001|Overall Study|Protocol Violation|3|||
145459375|NCT03960580|524534868|FG001|Overall Study|Lost to Follow-up|0|||
145592669|NCT01954017|525020834|FG002|Overall Study|Protocol Violation|2|||
145592670|NCT01954017|525020832|FG000|Overall Study|Necrotizing enterocolitis|1|||
145592671|NCT01954017|525020833|FG001|Overall Study|Necrotizing enterocolitis|0|||
145459376|NCT03960580|524534869|FG002|Overall Study|Lost to Follow-up|0|||
145459377|NCT03960580|524534867|FG000|Overall Study|Lack of Efficacy|2|||
145459378|NCT03960580|524534868|FG001|Overall Study|Lack of Efficacy|1|||
145459379|NCT03960580|524534869|FG002|Overall Study|Lack of Efficacy|0|||
145592672|NCT01954017|525020834|FG002|Overall Study|Necrotizing enterocolitis|1|||
145592673|NCT01954017|525020832|FG000|Overall Study|Enteral intake stopped >7 days|0|||
145592674|NCT01954017|525020833|FG001|Overall Study|Enteral intake stopped >7 days|1|||
145592675|NCT01954017|525020834|FG002|Overall Study|Enteral intake stopped >7 days|1|||
145592676|NCT01954017|525020832|FG000|Overall Study|All other reasons|2|||
145592677|NCT01954017|525020833|FG001|Overall Study|All other reasons|2|||
145592678|NCT01954017|525020834|FG002|Overall Study|All other reasons|7|||
145592679|NCT04598152|525020835|FG000|Overall Study|Lost to Follow-up|0|||
145592680|NCT04598152|525020836|FG001|Overall Study|Lost to Follow-up|1|||
145592681|NCT03346759|525020837|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
145592682|NCT03346759|525020838|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
145592683|NCT03346759|525020837|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
145592684|NCT03346759|525020838|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
145592685|NCT03346759|525020837|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
145592686|NCT03346759|525020838|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
145592687|NCT00435370|525020839|FG000|Overall Study|Adverse Event|8|||
145592688|NCT00435370|525020840|FG001|Overall Study|Adverse Event|8|||
145592689|NCT00435370|525020839|FG000|Overall Study|Withdrawal by Subject|10|||
145592690|NCT00435370|525020840|FG001|Overall Study|Withdrawal by Subject|10|||
145592691|NCT00435370|525020839|FG000|Overall Study|Antipsychotic medication changed|4|||
145592692|NCT00435370|525020840|FG001|Overall Study|Antipsychotic medication changed|2|||
145592693|NCT03674177|525020842|FG000|Overall Study|Lost to Follow-up|2|||
145592694|NCT03674177|525020843|FG001|Overall Study|Lost to Follow-up|1|||
145592695|NCT03674177|525020844|FG002|Overall Study|Lost to Follow-up|0|||
145592696|NCT03674177|525020845|FG003|Overall Study|Lost to Follow-up|2|||
145592697|NCT00714168|525020846|FG000|Overall Study|Pregnancy|5|||
145592698|NCT00714168|525020847|FG001|Overall Study|Pregnancy|4|||
145592699|NCT00714168|525020846|FG000|Overall Study|Lost to Follow-up|32|||
145592700|NCT00714168|525020847|FG001|Overall Study|Lost to Follow-up|50|||
145592701|NCT00714168|525020846|FG000|Overall Study|Relocation|4|||
145592702|NCT00714168|525020847|FG001|Overall Study|Relocation|3|||
145592703|NCT00714168|525020846|FG000|Overall Study|Non-study medical condition|3|||
145592704|NCT00714168|525020847|FG001|Overall Study|Non-study medical condition|2|||
145592705|NCT04988308|525020848|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
145592706|NCT04988308|525020849|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
145459380|NCT03960580|524534867|FG000|Overall Study|Protocol Violation|0|||
145459381|NCT03960580|524534868|FG001|Overall Study|Protocol Violation|0|||
145459382|NCT03960580|524534869|FG002|Overall Study|Protocol Violation|1|||
145459383|NCT03960580|524534867|FG000|Overall Study|Withdrawal by Subject|1|||
145459384|NCT03960580|524534868|FG001|Overall Study|Withdrawal by Subject|1|||
145459385|NCT03960580|524534869|FG002|Overall Study|Withdrawal by Subject|1|||
145459386|NCT03960580|524534867|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
145459387|NCT03960580|524534868|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
145592707|NCT04988308|525020850|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
145592708|NCT04988308|525020851|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145592709|NCT04988308|525020852|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145592710|NCT04988308|525020853|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
145592711|NCT04988308|525020848|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
145592712|NCT04988308|525020849|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
145592713|NCT04988308|525020850|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
145592714|NCT04988308|525020851|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
145592715|NCT04988308|525020852|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
145592716|NCT04988308|525020853|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
145592717|NCT04988308|525020848|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
145592718|NCT04988308|525020849|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
145592719|NCT04988308|525020850|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
145459388|NCT03960580|524534869|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
145592720|NCT04988308|525020851|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
145592721|NCT04988308|525020852|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
145592722|NCT04988308|525020853|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
145592723|NCT04988308|525020848|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
145592724|NCT04988308|525020849|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
145592725|NCT04988308|525020850|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
145592726|NCT04988308|525020851|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145592727|NCT04988308|525020852|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145592728|NCT04988308|525020853|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
145592729|NCT04988308|525020848|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
145459389|NCT04049266|524534878|FG000|Overall Study|Adverse Event|16|||
145459390|NCT04049266|524534879|FG001|Overall Study|Adverse Event|9|||
145459391|NCT04049266|524534878|FG000|Overall Study|Non-compliance with study drug|0|||
145459392|NCT04049266|524534879|FG001|Overall Study|Non-compliance with study drug|3|||
145459393|NCT04049266|524534878|FG000|Overall Study|Withdrawal by Subject|6|||
145459394|NCT04049266|524534879|FG001|Overall Study|Withdrawal by Subject|10|||
145459395|NCT04049266|524534878|FG000|Overall Study|Lost to Follow-up|2|||
145459396|NCT04049266|524534879|FG001|Overall Study|Lost to Follow-up|2|||
145459397|NCT04049266|524534878|FG000|Overall Study|Progressive disease|11|||
145459398|NCT04049266|524534879|FG001|Overall Study|Progressive disease|2|||
145459399|NCT04049266|524534878|FG000|Overall Study|Physician Decision|1|||
145459400|NCT04049266|524534879|FG001|Overall Study|Physician Decision|0|||
145459401|NCT04049266|524534878|FG000|Overall Study|Patient moved out of state|1|||
145459402|NCT04049266|524534879|FG001|Overall Study|Patient moved out of state|0|||
145459403|NCT04600076|524534881|FG000|Overall Study|Lost to Follow-up|3|||
145459404|NCT02891681|524534882|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
145459405|NCT02891681|524534883|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
145459406|NCT02891681|524534884|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
145459407|NCT02891681|524534882|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
145459408|NCT02891681|524534883|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
145459409|NCT02891681|524534884|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
145459410|NCT02891681|524534882|FG000|Overall Study|Taken off study after first imaging appointment|1|||
145459411|NCT02891681|524534883|FG001|Overall Study|Taken off study after first imaging appointment|0|||
145459412|NCT02891681|524534884|FG002|Overall Study|Taken off study after first imaging appointment|0|||
145459413|NCT02174523|524534885|FG000|Overall Study|Withdrawal by Subject|1|||
145459414|NCT02174523|524534886|FG001|Overall Study|Withdrawal by Subject|0|||
145459415|NCT02780856|524534895|FG000|Overall Study|Lost to Follow-up|1|||
145459416|NCT05479097|524534898|FG000|Overall Study|Withdrawal by Subject|2|||
145459417|NCT03894969|524534902|FG000|Overall Study|Adverse Event|0|||
145459418|NCT03894969|524534903|FG001|Overall Study|Adverse Event|2|||
145459419|NCT03894969|524534904|FG002|Overall Study|Adverse Event|0|||
145459420|NCT03894969|524534905|FG003|Overall Study|Adverse Event|1|||
145459421|NCT03894969|524534906|FG004|Overall Study|Adverse Event|2|||
145459422|NCT03894969|524534902|FG000|Overall Study|Lost to Follow-up|3|||
145459423|NCT03894969|524534903|FG001|Overall Study|Lost to Follow-up|1|||
145459424|NCT03894969|524534904|FG002|Overall Study|Lost to Follow-up|1|||
145459425|NCT03894969|524534905|FG003|Overall Study|Lost to Follow-up|0|||
145459426|NCT03894969|524534906|FG004|Overall Study|Lost to Follow-up|0|||
145459427|NCT03894969|524534902|FG000|Overall Study|Withdrawal by Subject|2|||
145459428|NCT03894969|524534903|FG001|Overall Study|Withdrawal by Subject|1|||
145459429|NCT03894969|524534904|FG002|Overall Study|Withdrawal by Subject|3|||
145459430|NCT03894969|524534905|FG003|Overall Study|Withdrawal by Subject|4|||
145459431|NCT03894969|524534906|FG004|Overall Study|Withdrawal by Subject|8|||
145459432|NCT03894969|524534902|FG000|Overall Study|Other|0|||
145459433|NCT03894969|524534903|FG001|Overall Study|Other|0|||
145459434|NCT03894969|524534904|FG002|Overall Study|Other|0|||
145459435|NCT03894969|524534905|FG003|Overall Study|Other|0|||
145459436|NCT03894969|524534906|FG004|Overall Study|Other|3|||
145459437|NCT03894969|524534902|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
145459438|NCT03894969|524534903|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
145459439|NCT03894969|524534904|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
145459440|NCT03894969|524534905|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
145459441|NCT03894969|524534906|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
145459442|NCT03894969|524534902|FG000|Overall Study|Solicited Adverse Event|0|||
145459443|NCT03894969|524534903|FG001|Overall Study|Solicited Adverse Event|1|||
145459444|NCT03894969|524534904|FG002|Overall Study|Solicited Adverse Event|0|||
145459445|NCT03894969|524534905|FG003|Overall Study|Solicited Adverse Event|0|||
145459446|NCT03894969|524534906|FG004|Overall Study|Solicited Adverse Event|0|||
145459447|NCT00468676|524534907|FG000|Overall Study|Lost to Follow-up|14|||
145459448|NCT00468676|524534908|FG001|Overall Study|Lost to Follow-up|11|||
145459449|NCT00468676|524534907|FG000|Overall Study|Death|2|||
145459450|NCT00468676|524534908|FG001|Overall Study|Death|1|||
145459451|NCT02378298|524534911|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
145459452|NCT02378298|524534912|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
145459453|NCT02378298|524534913|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
145459454|NCT02378298|524534911|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
145459455|NCT02378298|524534912|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
145459456|NCT02378298|524534913|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
145459457|NCT02378298|524534911|FG000|Surveillance (19-68 Weeks)|Death|1|||
145459458|NCT02378298|524534912|FG001|Surveillance (19-68 Weeks)|Death|0|||
145459459|NCT02378298|524534913|FG002|Surveillance (19-68 Weeks)|Death|0|||
145459460|NCT01779869|524534916|FG000|Overall Study|Physician Decision|2|||
145459461|NCT03006458|524534919|FG000|First Intervention|Unsatisfied Vision|0|||
145459462|NCT03006458|524534920|FG001|First Intervention|Unsatisfied Vision|3|||
145459463|NCT00957944|524534921|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
145459464|NCT00957944|524534922|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
145459465|NCT01482169|524534924|FG000|Overall Study|Physician Decision|2|||
145459466|NCT01468233|524534925|FG000|Treatment Period 1|Adverse Event|5|||
145592730|NCT04988308|525020849|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
145592731|NCT04988308|525020850|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
145592732|NCT04988308|525020851|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
145592733|NCT04988308|525020852|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
145592734|NCT04988308|525020853|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
145592735|NCT04988308|525020848|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145592736|NCT04988308|525020849|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145592737|NCT04988308|525020850|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
145592738|NCT04988308|525020851|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
145592739|NCT04988308|525020852|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
145592740|NCT04988308|525020853|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
145592741|NCT04988308|525020848|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145592742|NCT04988308|525020849|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145592743|NCT04988308|525020850|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
145592744|NCT04988308|525020851|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
145592745|NCT04988308|525020852|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
145592746|NCT04988308|525020853|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
145592747|NCT04988308|525020848|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145592748|NCT04988308|525020849|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145592749|NCT04988308|525020850|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
145592750|NCT04988308|525020851|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
145592751|NCT04988308|525020852|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
145592752|NCT04988308|525020853|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
145592753|NCT04988308|525020848|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
145592754|NCT04988308|525020849|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
145592755|NCT04988308|525020850|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
145592756|NCT04988308|525020851|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
145592757|NCT04988308|525020852|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
145592758|NCT04988308|525020853|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
145592759|NCT01453595|525020855|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145592760|NCT01453595|525020856|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145592761|NCT01453595|525020857|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145592762|NCT01864564|525020860|FG000|Overall Study|Lost to Follow-up|17|||
145592763|NCT01864564|525020861|FG001|Overall Study|Lost to Follow-up|23|||
145592764|NCT01864564|525020860|FG000|Overall Study|Withdrawal by Subject|20|||
145592765|NCT01864564|525020861|FG001|Overall Study|Withdrawal by Subject|11|||
145592766|NCT01864564|525020860|FG000|Overall Study|Protocol Violation|0|||
145592767|NCT01864564|525020861|FG001|Overall Study|Protocol Violation|27|||
145592768|NCT01864564|525020860|FG000|Overall Study|not reported|0|||
145592769|NCT01864564|525020861|FG001|Overall Study|not reported|34|||
145592770|NCT03077724|525020862|FG000|Overall Study|Lost to Follow-up|5|||
145592771|NCT03077724|525020863|FG001|Overall Study|Lost to Follow-up|1|||
145592772|NCT03077724|525020862|FG000|Overall Study|Withdrawal by Subject|3|||
145592773|NCT03077724|525020863|FG001|Overall Study|Withdrawal by Subject|1|||
145592774|NCT02313428|525020864|FG000|Overall Study|Lost to Follow-up|1|||
145592775|NCT02313428|525020865|FG001|Overall Study|Lost to Follow-up|1|||
145592776|NCT05374421|525020866|FG000|Overall Study|Withdrawal by Subject|3|||
145592777|NCT05374421|525020867|FG001|Overall Study|Withdrawal by Subject|4|||
145592778|NCT04370054|525020870|FG000|Treatment Phase|Lost to Follow-up|1|||
145592779|NCT04370054|525020870|FG000|Treatment Phase|Withdrawal by Subject|1|||
145592780|NCT04370054|525020870|FG000|Follow-Up Phase|Ongoing|75|||
145592781|NCT04657211|525020871|FG000|Overall Study|Withdrawal by Subject|21|||
145592782|NCT04657211|525020871|FG000|Overall Study|Lost to Follow-up|113|||
145592783|NCT04657211|525020871|FG000|Overall Study|Death|47|||
145592784|NCT04657211|525020871|FG000|Overall Study|Transfer to another institution|21|||
145592785|NCT04657211|525020871|FG000|Overall Study|Other|29|||
145592786|NCT00710424|525020873|FG000|Overall Study|Adverse Event|30|||
145592787|NCT00710424|525020874|FG001|Overall Study|Adverse Event|12|||
145592788|NCT00710424|525020873|FG000|Overall Study|Lack of Efficacy|4|||
145592789|NCT00710424|525020874|FG001|Overall Study|Lack of Efficacy|5|||
145592790|NCT00710424|525020873|FG000|Overall Study|Withdrawal by Subject|5|||
145592791|NCT00710424|525020874|FG001|Overall Study|Withdrawal by Subject|3|||
145592792|NCT00710424|525020873|FG000|Overall Study|Lost to Follow-up|0|||
145459467|NCT01468233|524534926|FG001|Treatment Period 1|Adverse Event|3|||
145592793|NCT00710424|525020874|FG001|Overall Study|Lost to Follow-up|1|||
145592794|NCT00710424|525020873|FG000|Overall Study|Refused medication, no side effects|1|||
145459468|NCT01468233|524534927|FG002|Treatment Period 1|Adverse Event|0|||
145626780|NCT02698436|525145790|FG001|Overall Study|Non-compliance with study regimen|0|||
145459469|NCT01468233|524534928|FG003|Treatment Period 1|Adverse Event|0|||
145459470|NCT01468233|524534929|FG004|Treatment Period 1|Adverse Event|0|||
145459471|NCT01468233|524534930|FG005|Treatment Period 1|Adverse Event|0|||
145459472|NCT01468233|524534925|FG000|Treatment Period 1|Withdrawal by Subject|3|||
145459473|NCT01468233|524534926|FG001|Treatment Period 1|Withdrawal by Subject|4|||
145459474|NCT01468233|524534927|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145459475|NCT01468233|524534928|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145459476|NCT01468233|524534929|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145459477|NCT01468233|524534930|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145459478|NCT01468233|524534925|FG000|Treatment Period 1|Lost to Follow-up|3|||
145459479|NCT01468233|524534926|FG001|Treatment Period 1|Lost to Follow-up|0|||
145459480|NCT01468233|524534927|FG002|Treatment Period 1|Lost to Follow-up|0|||
145459481|NCT01468233|524534928|FG003|Treatment Period 1|Lost to Follow-up|0|||
145459482|NCT01468233|524534929|FG004|Treatment Period 1|Lost to Follow-up|0|||
145459483|NCT01468233|524534930|FG005|Treatment Period 1|Lost to Follow-up|0|||
145459484|NCT01468233|524534925|FG000|Treatment Period 1|Other|1|||
145459485|NCT01468233|524534926|FG001|Treatment Period 1|Other|1|||
145459486|NCT01468233|524534927|FG002|Treatment Period 1|Other|0|||
145459487|NCT01468233|524534928|FG003|Treatment Period 1|Other|0|||
145459488|NCT01468233|524534929|FG004|Treatment Period 1|Other|0|||
145459489|NCT01468233|524534930|FG005|Treatment Period 1|Other|0|||
145459490|NCT01468233|524534925|FG000|Treatment Period 2|Adverse Event|0|||
145459491|NCT01468233|524534926|FG001|Treatment Period 2|Adverse Event|0|||
145459492|NCT01468233|524534927|FG002|Treatment Period 2|Adverse Event|3|||
145459493|NCT01468233|524534928|FG003|Treatment Period 2|Adverse Event|0|||
145459494|NCT01468233|524534929|FG004|Treatment Period 2|Adverse Event|2|||
145459495|NCT01468233|524534930|FG005|Treatment Period 2|Adverse Event|1|||
145459496|NCT01468233|524534925|FG000|Treatment Period 2|Lack of Efficacy|0|||
145459497|NCT01468233|524534926|FG001|Treatment Period 2|Lack of Efficacy|0|||
145459498|NCT01468233|524534927|FG002|Treatment Period 2|Lack of Efficacy|9|||
145459499|NCT01468233|524534928|FG003|Treatment Period 2|Lack of Efficacy|2|||
145459500|NCT01468233|524534929|FG004|Treatment Period 2|Lack of Efficacy|0|||
145459501|NCT01468233|524534930|FG005|Treatment Period 2|Lack of Efficacy|1|||
145459502|NCT01468233|524534925|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145459503|NCT01468233|524534926|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145459504|NCT01468233|524534927|FG002|Treatment Period 2|Withdrawal by Subject|9|||
145459505|NCT01468233|524534928|FG003|Treatment Period 2|Withdrawal by Subject|1|||
145459506|NCT01468233|524534929|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145459507|NCT01468233|524534930|FG005|Treatment Period 2|Withdrawal by Subject|1|||
145459508|NCT01468233|524534925|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
145459509|NCT01468233|524534926|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
145459510|NCT01468233|524534927|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
145459511|NCT01468233|524534928|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
145459512|NCT01468233|524534929|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
145459513|NCT01468233|524534930|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
145459514|NCT01468233|524534925|FG000|Treatment Period 2|Lost to Follow-up|0|||
145459515|NCT01468233|524534926|FG001|Treatment Period 2|Lost to Follow-up|0|||
145459516|NCT01468233|524534927|FG002|Treatment Period 2|Lost to Follow-up|3|||
145459517|NCT01468233|524534928|FG003|Treatment Period 2|Lost to Follow-up|0|||
145459518|NCT01468233|524534929|FG004|Treatment Period 2|Lost to Follow-up|2|||
145459519|NCT01468233|524534930|FG005|Treatment Period 2|Lost to Follow-up|0|||
145459520|NCT01468233|524534925|FG000|Treatment Period 2|Other|0|||
145459521|NCT01468233|524534926|FG001|Treatment Period 2|Other|0|||
145459522|NCT01468233|524534927|FG002|Treatment Period 2|Other|3|||
145459523|NCT01468233|524534928|FG003|Treatment Period 2|Other|0|||
145626781|NCT04949399|525145791|FG000|Overall Study|Lost to Follow-up|11|||
145459524|NCT01468233|524534929|FG004|Treatment Period 2|Other|1|||
145459525|NCT01468233|524534930|FG005|Treatment Period 2|Other|0|||
145459526|NCT00457821|524534936|FG000|Part 2|Withdrawal by Subject|0|||
145459527|NCT00457821|524534937|FG001|Part 2|Withdrawal by Subject|0|||
145459528|NCT00457821|524534938|FG002|Part 2|Withdrawal by Subject|0|||
145459529|NCT00457821|524534939|FG003|Part 2|Withdrawal by Subject|0|||
145459530|NCT00457821|524534940|FG004|Part 2|Withdrawal by Subject|0|||
145459531|NCT00457821|524534941|FG005|Part 2|Withdrawal by Subject|0|||
145459532|NCT00457821|524534942|FG006|Part 2|Withdrawal by Subject|0|||
145459533|NCT00457821|524534943|FG007|Part 2|Withdrawal by Subject|1|||
145459534|NCT02437409|524534946|FG000|Overall Study|Withdrawal by Subject|3|||
145459535|NCT02437409|524534946|FG000|Overall Study|Screening failure|12|||
145459536|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
145459537|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
145459538|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
145459539|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
145459540|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
145459541|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
145459542|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
145459543|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
145592795|NCT00710424|525020874|FG001|Overall Study|Refused medication, no side effects|0|||
145592796|NCT00710424|525020873|FG000|Overall Study|Non-compliance with stable analgesia|1|||
145592797|NCT00710424|525020874|FG001|Overall Study|Non-compliance with stable analgesia|0|||
145592798|NCT00710424|525020873|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
145592799|NCT00710424|525020874|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
145592800|NCT00710424|525020873|FG000|Overall Study|Subject thought medication changed|1|||
145592801|NCT00710424|525020874|FG001|Overall Study|Subject thought medication changed|0|||
145592802|NCT00710424|525020873|FG000|Overall Study|Ceased treatment due to travel|1|||
145592803|NCT00710424|525020874|FG001|Overall Study|Ceased treatment due to travel|0|||
145592804|NCT00710424|525020873|FG000|Overall Study|Subject preferred paracetamol|0|||
145592805|NCT00710424|525020874|FG001|Overall Study|Subject preferred paracetamol|1|||
145592806|NCT00710424|525020873|FG000|Overall Study|Felt good so stopped treatment|0|||
145459544|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
145459545|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
145459546|NCT00737568|524534964|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
145459547|NCT00737568|524534965|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
145459548|NCT00737568|524534964|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
145459549|NCT00737568|524534965|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
145459550|NCT00737568|524534964|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
145459551|NCT00737568|524534965|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
145459552|NCT00737568|524534964|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
145459553|NCT00737568|524534965|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
145459554|NCT00759356|524534966|FG000|Overall Study|Adverse Event|0|||
145459555|NCT00759356|524534967|FG001|Overall Study|Adverse Event|1|||
145459556|NCT00759356|524534966|FG000|Overall Study|Withdrawal by Subject|0|||
145459557|NCT00759356|524534967|FG001|Overall Study|Withdrawal by Subject|2|||
145459558|NCT00759356|524534966|FG000|Overall Study|Subject was unable to return|1|||
145459559|NCT00759356|524534967|FG001|Overall Study|Subject was unable to return|0|||
145459560|NCT01713283|524534971|FG000|Overall Study|Lack of Efficacy|10|||
145459561|NCT01713283|524534972|FG001|Overall Study|Lack of Efficacy|2|||
145459562|NCT01713283|524534971|FG000|Overall Study|Lost to Follow-up|1|||
145459563|NCT01713283|524534972|FG001|Overall Study|Lost to Follow-up|1|||
145459564|NCT01080768|524534974|FG000|Overall Study|Protocol Deviation|2|||
145459565|NCT01080768|524534975|FG001|Overall Study|Protocol Deviation|1|||
145459566|NCT03730961|524534998|FG000|Overall Study|Adverse Event|0|||
145459567|NCT03730961|524534999|FG001|Overall Study|Adverse Event|1|||
145459568|NCT04508751|524535002|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
145459569|NCT04508751|524535003|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
145459570|NCT04508751|524535004|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
145459571|NCT02752958|524535005|FG000|Overall Study|Adverse Event|3|||
145459572|NCT02752958|524535005|FG000|Overall Study|Lost to Follow-up|1|||
145592807|NCT00710424|525020874|FG001|Overall Study|Felt good so stopped treatment|1|||
145592808|NCT01962493|525020875|FG000|Overall Study|Adverse Event|1|||
145592809|NCT01962493|525020876|FG001|Overall Study|Adverse Event|2|||
145592810|NCT01962493|525020875|FG000|Overall Study|Protocol Violation|0|||
145592811|NCT01962493|525020876|FG001|Overall Study|Protocol Violation|1|||
145592812|NCT01962493|525020875|FG000|Overall Study|Withdrawal by Subject|4|||
145592813|NCT01962493|525020876|FG001|Overall Study|Withdrawal by Subject|2|||
145459573|NCT02752958|524535005|FG000|Overall Study|Protocol Violation|1|||
145459574|NCT02752958|524535005|FG000|Overall Study|Withdrawal by Subject|2|||
145459575|NCT02752958|524535005|FG000|Overall Study|Other (Reason not specified)|2|||
145459576|NCT00853125|524535006|FG000|Overall Study|Study participant's donor was CMV +|1|||
145459577|NCT03023826|524535008|FG000|Period 1|Withdrawal by Subject|0|||
145459578|NCT03023826|524535009|FG001|Period 1|Withdrawal by Subject|0|||
145459579|NCT03023826|524535010|FG002|Period 1|Withdrawal by Subject|0|||
145459580|NCT03023826|524535011|FG003|Period 1|Withdrawal by Subject|0|||
145459581|NCT03023826|524535012|FG004|Period 1|Withdrawal by Subject|1|||
145459582|NCT03023826|524535013|FG005|Period 1|Withdrawal by Subject|0|||
145459583|NCT00072293|524535014|FG000|Overall Study|Lost to Follow-up|1|||
145459584|NCT00072293|524535015|FG001|Overall Study|Lost to Follow-up|1|||
145592814|NCT01738984|525022387|FG000|Overall Study|Pregnancy|4|||
145592815|NCT01738984|525022388|FG001|Overall Study|Pregnancy|0|||
145459585|NCT00072293|524535014|FG000|Overall Study|Withdrawal by Subject|0|||
145459586|NCT00072293|524535015|FG001|Overall Study|Withdrawal by Subject|1|||
145459587|NCT04209114|524535016|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
145592816|NCT01738984|525022387|FG000|Overall Study|Withdrawal by Subject|1|||
145592817|NCT01738984|525022388|FG001|Overall Study|Withdrawal by Subject|0|||
145592818|NCT01738984|525022387|FG000|Overall Study|Lost to Follow-up|59|||
145459588|NCT04209114|524535017|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
145459589|NCT04209114|524535018|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
145459590|NCT04209114|524535016|FG000|Pre-Treatment Phase|Other reasons|0|||
145592819|NCT01738984|525022388|FG001|Overall Study|Lost to Follow-up|39|||
145592820|NCT00955357|525022394|FG000|Titration Phase|Adverse Event|9|||
145592821|NCT00955357|525022395|FG001|Titration Phase|Adverse Event|46|||
145592822|NCT00955357|525022394|FG000|Titration Phase|Lack of Efficacy|0|||
145592823|NCT00955357|525022395|FG001|Titration Phase|Lack of Efficacy|2|||
145592824|NCT00955357|525022394|FG000|Titration Phase|Protocol Violation|3|||
145592825|NCT00955357|525022395|FG001|Titration Phase|Protocol Violation|7|||
145592826|NCT00955357|525022394|FG000|Titration Phase|Lost to Follow-up|1|||
145592827|NCT00955357|525022395|FG001|Titration Phase|Lost to Follow-up|3|||
145592828|NCT00955357|525022394|FG000|Titration Phase|Withdrawal by Subject|3|||
145592829|NCT00955357|525022395|FG001|Titration Phase|Withdrawal by Subject|5|||
145592830|NCT00955357|525022394|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
145592831|NCT00955357|525022395|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
145592832|NCT00955357|525022394|FG000|Titration Phase|Study medication not tolerated|0|||
145592833|NCT00955357|525022395|FG001|Titration Phase|Study medication not tolerated|1|||
145592834|NCT00955357|525022394|FG000|Titration Phase|Non compliance to study procedures|0|||
145592835|NCT00955357|525022395|FG001|Titration Phase|Non compliance to study procedures|1|||
145592836|NCT00955357|525022394|FG000|Maintenance Phase|Adverse Event|3|||
145592837|NCT00955357|525022395|FG001|Maintenance Phase|Adverse Event|23|||
145592838|NCT00955357|525022394|FG000|Maintenance Phase|Lack of Efficacy|0|||
145592839|NCT00955357|525022395|FG001|Maintenance Phase|Lack of Efficacy|4|||
145592840|NCT00955357|525022394|FG000|Maintenance Phase|Protocol Violation|2|||
145592841|NCT00955357|525022395|FG001|Maintenance Phase|Protocol Violation|6|||
145592842|NCT00955357|525022394|FG000|Maintenance Phase|Lost to Follow-up|2|||
145592843|NCT00955357|525022395|FG001|Maintenance Phase|Lost to Follow-up|7|||
145592844|NCT00955357|525022394|FG000|Maintenance Phase|Withdrawal by Subject|4|||
145592845|NCT00955357|525022395|FG001|Maintenance Phase|Withdrawal by Subject|4|||
145592846|NCT00955357|525022394|FG000|Maintenance Phase|Patient moving out of area|0|||
145592847|NCT00955357|525022395|FG001|Maintenance Phase|Patient moving out of area|1|||
145592848|NCT00955357|525022394|FG000|Maintenance Phase|Non compliance to study procedures|1|||
145592849|NCT00955357|525022395|FG001|Maintenance Phase|Non compliance to study procedures|0|||
145592850|NCT01258608|525022396|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
145592851|NCT01258608|525022397|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
145592852|NCT01258608|525022396|FG000|Overall Study|Clinical progression|1|||
145592853|NCT01258608|525022397|FG001|Overall Study|Clinical progression|0|||
145592854|NCT01258608|525022396|FG000|Overall Study|Sponsor decision|0|||
145592855|NCT01258608|525022397|FG001|Overall Study|Sponsor decision|1|||
145592856|NCT01258608|525022396|FG000|Overall Study|Physician Decision|6|||
145592857|NCT01258608|525022397|FG001|Overall Study|Physician Decision|1|||
145592858|NCT01258608|525022396|FG000|Overall Study|Lost to Follow-up|0|||
145592859|NCT01258608|525022397|FG001|Overall Study|Lost to Follow-up|1|||
145592860|NCT01258608|525022396|FG000|Overall Study|Lack of compliance|1|||
145592861|NCT01258608|525022397|FG001|Overall Study|Lack of compliance|0|||
145592862|NCT01258608|525022396|FG000|Overall Study|Lack of Efficacy|0|||
145592863|NCT01258608|525022397|FG001|Overall Study|Lack of Efficacy|1|||
145592864|NCT01258608|525022396|FG000|Overall Study|Adverse Event|6|||
145592865|NCT01258608|525022397|FG001|Overall Study|Adverse Event|10|||
145592866|NCT01258608|525022396|FG000|Overall Study|Withdrawal by Subject|6|||
145592867|NCT01258608|525022397|FG001|Overall Study|Withdrawal by Subject|5|||
145592868|NCT02943408|525022408|FG000|Overall Study|Lost to Follow-up|7|||
145592869|NCT02943408|525022409|FG001|Overall Study|Lost to Follow-up|1|||
145592870|NCT02943408|525022408|FG000|Overall Study|Withdrawal by Subject|0|||
145592871|NCT02943408|525022409|FG001|Overall Study|Withdrawal by Subject|1|||
145592872|NCT01621126|525022414|FG000|Overall Study|Physician Decision|6|||
145592873|NCT01949311|525022415|FG000|Overall Study|Lost to Follow-up|73|||
145592874|NCT01949311|525022415|FG000|Overall Study|Terminated by Sponsor|708|||
145592875|NCT01949311|525022415|FG000|Overall Study|Withdrawal by Subject|375|||
145592876|NCT01949311|525022415|FG000|Overall Study|Lack of Efficacy|50|||
145592877|NCT01949311|525022415|FG000|Overall Study|Protocol Deviation|34|||
145592878|NCT01949311|525022415|FG000|Overall Study|Pregnancy|20|||
145592879|NCT01949311|525022415|FG000|Overall Study|Physician Decision|9|||
145592880|NCT01949311|525022415|FG000|Overall Study|Other|4|||
145592881|NCT01949311|525022415|FG000|Overall Study|Adverse Event|107|||
145592882|NCT02338154|525022416|FG000|Overall Study|Death|46|||
145592883|NCT02338154|525022416|FG000|Overall Study|Valve Implant Failure|17|||
145592884|NCT02338154|525022416|FG000|Overall Study|Valve Explant|11|||
145592885|NCT02338154|525022416|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
145592886|NCT02338154|525022416|FG000|Overall Study|Lost to Follow-up|8|||
145592887|NCT02338154|525022416|FG000|Overall Study|Other Reason|3|||
145592888|NCT02338154|525022416|FG000|Overall Study|Patients Without Exit Form|47|||
145592889|NCT02338154|525022416|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
145592890|NCT04279314|525022417|FG000|Overall Study|Adverse Event|55|||
145592891|NCT04279314|525022417|FG000|Overall Study|Withdrawal by Subject|5|||
145592892|NCT04279314|525022417|FG000|Overall Study|Lack of Efficacy|5|||
145592893|NCT04279314|525022417|FG000|Overall Study|Protocol Violation|3|||
145592894|NCT04279314|525022417|FG000|Overall Study|Other (not COVID-19 related)|2|||
145592895|NCT03166618|525022422|FG000|Overall Study|Study was Terminated|0|||
145592896|NCT03166618|525022423|FG001|Overall Study|Study was Terminated|1|||
145592897|NCT01925950|525022424|FG000|Part 2|Withdrawal by Subject|1|||
145592898|NCT01925950|525022425|FG001|Part 2|Withdrawal by Subject|0|||
145592899|NCT03137303|525022427|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
145592900|NCT03137303|525022428|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
145592901|NCT03137303|525022427|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
145592902|NCT03137303|525022428|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
145592903|NCT03137303|525022427|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
145592904|NCT03137303|525022428|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
145592905|NCT03137303|525022427|FG000|T3: 9-month Follow-up|Death|1|||
145592906|NCT03137303|525022428|FG001|T3: 9-month Follow-up|Death|0|||
145592907|NCT03137303|525022427|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
145592908|NCT03137303|525022428|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
145592909|NCT03137303|525022427|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
145592910|NCT03137303|525022428|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
145592911|NCT03137303|525022427|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
145592912|NCT03137303|525022428|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
145592913|NCT03561090|525022429|FG000|Overall Study|Adverse Event|11|||
145592914|NCT03561090|525022430|FG001|Overall Study|Adverse Event|7|||
145592915|NCT03561090|525022429|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145592916|NCT03561090|525022430|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145592917|NCT03561090|525022429|FG000|Overall Study|Protocol Violation|2|||
145592918|NCT03561090|525022430|FG001|Overall Study|Protocol Violation|2|||
145592919|NCT03561090|525022429|FG000|Overall Study|Withdrawal by Subject|7|||
145592920|NCT03561090|525022430|FG001|Overall Study|Withdrawal by Subject|7|||
145592921|NCT03561090|525022429|FG000|Overall Study|Lost to Follow-up|7|||
145592922|NCT03561090|525022430|FG001|Overall Study|Lost to Follow-up|2|||
145592923|NCT03561090|525022429|FG000|Overall Study|Study Terminated by Sponsor|10|||
145592924|NCT03561090|525022430|FG001|Overall Study|Study Terminated by Sponsor|15|||
145592925|NCT03561090|525022429|FG000|Overall Study|Randomized by Mistake|1|||
145592926|NCT03561090|525022430|FG001|Overall Study|Randomized by Mistake|1|||
145592927|NCT03561090|525022429|FG000|Overall Study|Other Not Specified|0|||
145592928|NCT03561090|525022430|FG001|Overall Study|Other Not Specified|2|||
145592929|NCT04402866|525022445|FG000|Overall Study|Discontinued Prior to Treatment|0|||
145592930|NCT04402866|525022446|FG001|Overall Study|Discontinued Prior to Treatment|0|||
145592931|NCT04402866|525022447|FG002|Overall Study|Discontinued Prior to Treatment|0|||
145592932|NCT04402866|525022448|FG003|Overall Study|Discontinued Prior to Treatment|0|||
145592933|NCT04402866|525022449|FG004|Overall Study|Discontinued Prior to Treatment|2|||
145592934|NCT04402866|525022450|FG005|Overall Study|Discontinued Prior to Treatment|3|||
145592935|NCT04402866|525022445|FG000|Overall Study|Adverse Event|2|||
145592936|NCT04402866|525022446|FG001|Overall Study|Adverse Event|1|||
145592937|NCT04402866|525022447|FG002|Overall Study|Adverse Event|0|||
145592938|NCT04402866|525022448|FG003|Overall Study|Adverse Event|0|||
145592939|NCT04402866|525022449|FG004|Overall Study|Adverse Event|13|||
145592940|NCT04402866|525022450|FG005|Overall Study|Adverse Event|8|||
145592941|NCT04402866|525022445|FG000|Overall Study|Miscellaneous|0|||
145592942|NCT04402866|525022446|FG001|Overall Study|Miscellaneous|0|||
145592943|NCT04402866|525022447|FG002|Overall Study|Miscellaneous|1|||
145592944|NCT04402866|525022448|FG003|Overall Study|Miscellaneous|0|||
145592945|NCT04402866|525022449|FG004|Overall Study|Miscellaneous|0|||
145592946|NCT04402866|525022450|FG005|Overall Study|Miscellaneous|0|||
145592947|NCT04402866|525022445|FG000|Overall Study|Lost to Follow-up|0|||
145592948|NCT04402866|525022446|FG001|Overall Study|Lost to Follow-up|0|||
145592949|NCT04402866|525022447|FG002|Overall Study|Lost to Follow-up|0|||
145592950|NCT04402866|525022448|FG003|Overall Study|Lost to Follow-up|0|||
145592951|NCT04402866|525022449|FG004|Overall Study|Lost to Follow-up|0|||
145592952|NCT04402866|525022450|FG005|Overall Study|Lost to Follow-up|1|||
145592953|NCT04402866|525022445|FG000|Overall Study|Withdrawal by Subject|0|||
145592954|NCT04402866|525022446|FG001|Overall Study|Withdrawal by Subject|0|||
145592955|NCT04402866|525022447|FG002|Overall Study|Withdrawal by Subject|0|||
145592956|NCT04402866|525022448|FG003|Overall Study|Withdrawal by Subject|0|||
145592957|NCT04402866|525022449|FG004|Overall Study|Withdrawal by Subject|0|||
145592958|NCT04402866|525022450|FG005|Overall Study|Withdrawal by Subject|2|||
145592959|NCT02015676|525022451|FG000|Overall Study|Adverse Event|2|||
145592960|NCT02015676|525022452|FG001|Overall Study|Adverse Event|18|||
145592961|NCT02015676|525022453|FG002|Overall Study|Adverse Event|0|||
145592962|NCT02015676|525022451|FG000|Overall Study|Lack of Efficacy|2|||
145592963|NCT02015676|525022452|FG001|Overall Study|Lack of Efficacy|4|||
145592964|NCT02015676|525022453|FG002|Overall Study|Lack of Efficacy|0|||
145592965|NCT02015676|525022451|FG000|Overall Study|Protocol Violation|1|||
145592966|NCT02015676|525022452|FG001|Overall Study|Protocol Violation|0|||
145592967|NCT02015676|525022453|FG002|Overall Study|Protocol Violation|0|||
145592968|NCT02015676|525022451|FG000|Overall Study|Withdrawal by Subject|1|||
145592969|NCT02015676|525022452|FG001|Overall Study|Withdrawal by Subject|7|||
145592970|NCT02015676|525022453|FG002|Overall Study|Withdrawal by Subject|1|||
145592971|NCT02015676|525022451|FG000|Overall Study|Administrative reasons|0|||
145592972|NCT02015676|525022452|FG001|Overall Study|Administrative reasons|3|||
145592973|NCT02015676|525022453|FG002|Overall Study|Administrative reasons|1|||
145459591|NCT04209114|524535017|FG001|Pre-Treatment Phase|Other reasons|0|||
145459592|NCT04209114|524535018|FG002|Pre-Treatment Phase|Other reasons|1|||
145459593|NCT04209114|524535016|FG000|Pre-Treatment Phase|Death|0|||
145459594|NCT04209114|524535017|FG001|Pre-Treatment Phase|Death|0|||
145459595|NCT04209114|524535018|FG002|Pre-Treatment Phase|Death|1|||
145459596|NCT04209114|524535016|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
145459597|NCT04209114|524535017|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
145459598|NCT04209114|524535018|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
145459599|NCT04209114|524535016|FG000|Treatment Phase|Other reasons|5|||
145459600|NCT04209114|524535017|FG001|Treatment Phase|Other reasons|3|||
145459601|NCT04209114|524535018|FG002|Treatment Phase|Other reasons|0|||
145459602|NCT04209114|524535016|FG000|Treatment Phase|Lost to Follow-up|1|||
145459603|NCT04209114|524535017|FG001|Treatment Phase|Lost to Follow-up|0|||
145459604|NCT04209114|524535018|FG002|Treatment Phase|Lost to Follow-up|0|||
145459605|NCT04209114|524535016|FG000|Treatment Phase|Participant withdrew consent|1|||
145459606|NCT04209114|524535017|FG001|Treatment Phase|Participant withdrew consent|0|||
145459607|NCT04209114|524535018|FG002|Treatment Phase|Participant withdrew consent|0|||
145459608|NCT04209114|524535016|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
145459609|NCT04209114|524535017|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
145459610|NCT04209114|524535018|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
145459611|NCT04209114|524535016|FG000|Treatment Phase|Death|4|||
145459612|NCT04209114|524535017|FG001|Treatment Phase|Death|1|||
145459613|NCT04209114|524535018|FG002|Treatment Phase|Death|0|||
145459614|NCT04209114|524535016|FG000|Treatment Phase|Study drug toxicity|4|||
145459615|NCT04209114|524535017|FG001|Treatment Phase|Study drug toxicity|6|||
145459616|NCT04209114|524535018|FG002|Treatment Phase|Study drug toxicity|0|||
145459617|NCT04209114|524535016|FG000|Treatment Phase|Disease progression|6|||
145459618|NCT04209114|524535017|FG001|Treatment Phase|Disease progression|9|||
145459619|NCT04209114|524535018|FG002|Treatment Phase|Disease progression|0|||
145459620|NCT01514240|524536433|FG000|Overall Study|Adverse Event|4|||
145459621|NCT01514240|524536434|FG001|Overall Study|Adverse Event|4|||
145459622|NCT01514240|524536433|FG000|Overall Study|Subject Decision|2|||
145459623|NCT01514240|524536434|FG001|Overall Study|Subject Decision|7|||
145459624|NCT00509093|524536435|FG000|Overall Study|Adverse Event|10|||
145459625|NCT00509093|524536435|FG000|Overall Study|Disease Progression|9|||
145459626|NCT00509093|524536435|FG000|Overall Study|Transformed into MDS|1|||
145459627|NCT00509093|524536435|FG000|Overall Study|Withdrawal by Subject|3|||
145459628|NCT00509093|524536435|FG000|Overall Study|Physician Decision|1|||
145459629|NCT01103063|524536436|FG000|Overall Study|Adverse Event|3|||
145459630|NCT01103063|524536437|FG001|Overall Study|Adverse Event|1|||
145459631|NCT01103063|524536436|FG000|Overall Study|Lost to Follow-up|68|||
145459632|NCT01103063|524536437|FG001|Overall Study|Lost to Follow-up|51|||
145459633|NCT01103063|524536436|FG000|Overall Study|Withdrawal by Subject|60|||
145459634|NCT01103063|524536437|FG001|Overall Study|Withdrawal by Subject|15|||
145459635|NCT01103063|524536436|FG000|Overall Study|Other|16|||
145459636|NCT01103063|524536437|FG001|Overall Study|Other|11|||
145459637|NCT01103063|524536436|FG000|Overall Study|Protocol Violation|1|||
145459638|NCT01103063|524536437|FG001|Overall Study|Protocol Violation|0|||
145459639|NCT01103063|524536436|FG000|Overall Study|Study terminated by Sponsor|326|||
145459640|NCT01103063|524536437|FG001|Overall Study|Study terminated by Sponsor|342|||
145459641|NCT01103063|524536436|FG000|Overall Study|Death|3|||
145459642|NCT01103063|524536437|FG001|Overall Study|Death|1|||
145459643|NCT05320393|524536438|FG000|Overall Study|Withdrawal by Subject|1|||
145459644|NCT05320393|524536439|FG001|Overall Study|Withdrawal by Subject|0|||
145459645|NCT05320393|524536440|FG002|Overall Study|Withdrawal by Subject|2|||
145459646|NCT05320393|524536438|FG000|Overall Study|Lost to Follow-up|1|||
145459647|NCT05320393|524536439|FG001|Overall Study|Lost to Follow-up|2|||
145459648|NCT05320393|524536440|FG002|Overall Study|Lost to Follow-up|1|||
145459649|NCT05320393|524536438|FG000|Overall Study|Moved; too much driving|0|||
145459650|NCT05320393|524536439|FG001|Overall Study|Moved; too much driving|0|||
145459651|NCT05320393|524536440|FG002|Overall Study|Moved; too much driving|2|||
145459652|NCT05320393|524536438|FG000|Overall Study|Did not receive treatment|0|||
145459653|NCT05320393|524536439|FG001|Overall Study|Did not receive treatment|0|||
145459654|NCT05320393|524536440|FG002|Overall Study|Did not receive treatment|1|||
145459655|NCT03283098|524536441|FG000|Overall Study|Withdrawal by Subject|0|||
145459656|NCT03283098|524536442|FG001|Overall Study|Withdrawal by Subject|1|||
145459657|NCT00798317|524536443|FG000|Overall Study|Physician Decision|0|||
145459658|NCT00798317|524536444|FG001|Overall Study|Physician Decision|1|||
145459659|NCT00798317|524536443|FG000|Overall Study|Withdrawal by Subject|5|||
145459660|NCT00798317|524536444|FG001|Overall Study|Withdrawal by Subject|4|||
145459661|NCT00798317|524536443|FG000|Overall Study|Lost to Follow-up|2|||
145459662|NCT00798317|524536444|FG001|Overall Study|Lost to Follow-up|2|||
145459663|NCT00798317|524536443|FG000|Overall Study|Adverse Event|2|||
145459664|NCT00798317|524536444|FG001|Overall Study|Adverse Event|0|||
145459665|NCT00798317|524536443|FG000|Overall Study|Death|1|||
145459666|NCT00798317|524536444|FG001|Overall Study|Death|0|||
145459667|NCT01069861|524536446|FG000|Overall Study|Death|1|||
145459668|NCT01069861|524536446|FG000|Overall Study|Adverse Event|1|||
145592974|NCT02015676|525022451|FG000|Overall Study|Death|0|||
145459669|NCT01069861|524536446|FG000|Overall Study|Did not meet entrance criteria|1|||
145459670|NCT01187446|524536447|FG000|Overall Study|Patient started non-protocol therapy|0|||
145459671|NCT01187446|524536448|FG001|Overall Study|Patient started non-protocol therapy|1|||
145592975|NCT02015676|525022452|FG001|Overall Study|Death|1|||
145592976|NCT02015676|525022453|FG002|Overall Study|Death|0|||
145592977|NCT02015676|525022451|FG000|Overall Study|Disease progression|3|||
145592978|NCT02015676|525022452|FG001|Overall Study|Disease progression|1|||
145592979|NCT02015676|525022453|FG002|Overall Study|Disease progression|1|||
145592980|NCT03321396|525022462|FG000|Overall Study|Physician Decision|1|||
145592981|NCT01654549|525022463|FG000|Overall Study|H.pylori eradication not successful|0|||
145592982|NCT01654549|525022464|FG001|Overall Study|H.pylori eradication not successful|1|||
145592983|NCT01972841|525022465|FG000|Overall Study|Randomized but Never Received Treatment|2|||
145592984|NCT01972841|525022466|FG001|Overall Study|Randomized but Never Received Treatment|5|||
145592985|NCT01972841|525022467|FG002|Overall Study|Randomized but Never Received Treatment|4|||
145592986|NCT01972841|525022468|FG003|Overall Study|Randomized but Never Received Treatment|2|||
145592987|NCT01972841|525022469|FG004|Overall Study|Randomized but Never Received Treatment|6|||
145592988|NCT01972841|525022470|FG005|Overall Study|Randomized but Never Received Treatment|13|||
145592989|NCT01972841|525022465|FG000|Overall Study|Adverse Event|13|||
145592990|NCT01972841|525022466|FG001|Overall Study|Adverse Event|8|||
145592991|NCT01972841|525022467|FG002|Overall Study|Adverse Event|12|||
145592992|NCT01972841|525022468|FG003|Overall Study|Adverse Event|9|||
145592993|NCT01972841|525022469|FG004|Overall Study|Adverse Event|21|||
145592994|NCT01972841|525022470|FG005|Overall Study|Adverse Event|26|||
145592995|NCT01972841|525022465|FG000|Overall Study|Lack of Efficacy|1|||
145592996|NCT01972841|525022466|FG001|Overall Study|Lack of Efficacy|0|||
145592997|NCT01972841|525022467|FG002|Overall Study|Lack of Efficacy|0|||
145592998|NCT01972841|525022468|FG003|Overall Study|Lack of Efficacy|2|||
145592999|NCT01972841|525022469|FG004|Overall Study|Lack of Efficacy|4|||
145593000|NCT01972841|525022470|FG005|Overall Study|Lack of Efficacy|1|||
145593001|NCT01972841|525022465|FG000|Overall Study|Lost to Follow-up|4|||
145593002|NCT01972841|525022466|FG001|Overall Study|Lost to Follow-up|2|||
145593003|NCT01972841|525022467|FG002|Overall Study|Lost to Follow-up|4|||
145593004|NCT01972841|525022468|FG003|Overall Study|Lost to Follow-up|2|||
145593005|NCT01972841|525022469|FG004|Overall Study|Lost to Follow-up|9|||
145593006|NCT01972841|525022470|FG005|Overall Study|Lost to Follow-up|3|||
145593007|NCT01972841|525022465|FG000|Overall Study|Protocol Violation|2|||
145593008|NCT01972841|525022466|FG001|Overall Study|Protocol Violation|2|||
145593009|NCT01972841|525022467|FG002|Overall Study|Protocol Violation|3|||
145593010|NCT01972841|525022468|FG003|Overall Study|Protocol Violation|5|||
145593011|NCT01972841|525022469|FG004|Overall Study|Protocol Violation|9|||
145593012|NCT01972841|525022470|FG005|Overall Study|Protocol Violation|4|||
145593013|NCT01972841|525022465|FG000|Overall Study|Withdrawal by participants|21|||
145593014|NCT01972841|525022466|FG001|Overall Study|Withdrawal by participants|27|||
145593015|NCT01972841|525022467|FG002|Overall Study|Withdrawal by participants|23|||
145593016|NCT01972841|525022468|FG003|Overall Study|Withdrawal by participants|16|||
145593017|NCT01972841|525022469|FG004|Overall Study|Withdrawal by participants|33|||
145593018|NCT01972841|525022470|FG005|Overall Study|Withdrawal by participants|34|||
145593019|NCT01972841|525022465|FG000|Overall Study|Miscellaneous|0|||
145593020|NCT01972841|525022466|FG001|Overall Study|Miscellaneous|0|||
145593021|NCT01972841|525022467|FG002|Overall Study|Miscellaneous|4|||
145593022|NCT01972841|525022468|FG003|Overall Study|Miscellaneous|1|||
145593023|NCT01972841|525022469|FG004|Overall Study|Miscellaneous|0|||
145593024|NCT01972841|525022470|FG005|Overall Study|Miscellaneous|4|||
145593025|NCT01972841|525022465|FG000|Overall Study|Did not have end of treatment page|0|||
145593026|NCT01972841|525022466|FG001|Overall Study|Did not have end of treatment page|0|||
145593027|NCT01972841|525022467|FG002|Overall Study|Did not have end of treatment page|0|||
145593028|NCT01972841|525022468|FG003|Overall Study|Did not have end of treatment page|0|||
145593029|NCT01972841|525022469|FG004|Overall Study|Did not have end of treatment page|1|||
145593030|NCT01972841|525022470|FG005|Overall Study|Did not have end of treatment page|0|||
145593031|NCT04969198|525022473|FG000|Overall Study|Withdrawal by Subject|20|||
145593032|NCT04969198|525022473|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
145593033|NCT04969198|525022473|FG000|Overall Study|Lost to Follow-up|20|||
145593034|NCT04009291|525022474|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
145593035|NCT04009291|525022475|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
145593036|NCT04009291|525022476|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
145593037|NCT04009291|525022477|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
145593038|NCT04009291|525022478|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
145459672|NCT00823212|524536449|FG000|Overall Study|Death|8|||
145459673|NCT00823212|524536450|FG001|Overall Study|Death|10|||
145593039|NCT04009291|525022474|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
145593040|NCT04009291|525022475|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
145593041|NCT04009291|525022476|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
145459674|NCT00823212|524536449|FG000|Overall Study|Withdrawal by Subject|6|||
145593042|NCT04009291|525022477|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
145593043|NCT04009291|525022478|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
145593044|NCT01270347|525022479|FG000|Core Phase|Adverse Event|1|||
145593045|NCT01270347|525022480|FG001|Core Phase|Adverse Event|6|||
145593046|NCT01270347|525022479|FG000|Core Phase|Withdrawal by Subject|1|||
145593047|NCT01270347|525022480|FG001|Core Phase|Withdrawal by Subject|2|||
145593048|NCT01270347|525022479|FG000|Core Phase|Lost to Follow-up|0|||
145593049|NCT01270347|525022480|FG001|Core Phase|Lost to Follow-up|1|||
145593050|NCT01270347|525022479|FG000|Core Phase|Miscellaneous|8|||
145593051|NCT01270347|525022480|FG001|Core Phase|Miscellaneous|14|||
145593052|NCT01270347|525022479|FG000|Extension Phase|Adverse Event|1|||
145593053|NCT01270347|525022480|FG001|Extension Phase|Adverse Event|3|||
145593054|NCT01270347|525022479|FG000|Extension Phase|Withdrawal by Subject|3|||
145593055|NCT01270347|525022480|FG001|Extension Phase|Withdrawal by Subject|4|||
145593056|NCT01270347|525022479|FG000|Extension Phase|Miscellaneous|2|||
145593057|NCT01270347|525022480|FG001|Extension Phase|Miscellaneous|2|||
145593058|NCT01556438|525022483|FG000|Overall Study|Adverse Event|4|||
145593059|NCT01556438|525022484|FG001|Overall Study|Adverse Event|2|||
145593060|NCT01556438|525022483|FG000|Overall Study|Sponsor Decision|0|||
145593061|NCT01556438|525022484|FG001|Overall Study|Sponsor Decision|2|||
145593062|NCT01556438|525022483|FG000|Overall Study|Progressive Disease|0|||
145593063|NCT01556438|525022484|FG001|Overall Study|Progressive Disease|6|||
145593064|NCT01556438|525022483|FG000|Overall Study|Death|0|||
145593065|NCT01556438|525022484|FG001|Overall Study|Death|1|||
145593066|NCT03282227|525022486|FG000|Overall Study|Exposure Goals Achieved|60|||
145593067|NCT03282227|525022486|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
145593068|NCT03282227|525022486|FG000|Overall Study|Adverse Event|15|||
145593069|NCT03282227|525022486|FG000|Overall Study|Lost to Follow-up|21|||
145593070|NCT03282227|525022486|FG000|Overall Study|Withdrawal by Subject|20|||
145593071|NCT03282227|525022486|FG000|Overall Study|Lack of Efficacy|12|||
145593072|NCT03282227|525022486|FG000|Overall Study|Sponsor decision|3|||
145593073|NCT03282227|525022486|FG000|Overall Study|Physician Decision|2|||
145593074|NCT03282227|525022486|FG000|Overall Study|Pregnancy|2|||
145593075|NCT03282227|525022486|FG000|Overall Study|Other|1|||
145593076|NCT02491671|525022487|FG000|Overall Study|Adverse Event|6|||
145593077|NCT02491671|525022488|FG001|Overall Study|Adverse Event|8|||
145593078|NCT02491671|525022487|FG000|Overall Study|Death|0|||
145593079|NCT02491671|525022488|FG001|Overall Study|Death|2|||
145593080|NCT02491671|525022487|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
145593081|NCT02491671|525022488|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
145593082|NCT02251990|525022489|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
145593083|NCT02251990|525022490|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
145593084|NCT02251990|525022489|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
145593085|NCT02251990|525022490|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
145593086|NCT02251990|525022489|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
145593087|NCT02251990|525022490|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
145593088|NCT02251990|525022489|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
145593089|NCT02251990|525022490|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
145593090|NCT02251990|525022489|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
145593091|NCT02251990|525022490|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
145593092|NCT02251990|525022489|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
145593093|NCT02251990|525022490|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
145593094|NCT03265600|525022491|FG000|Overall Study|Lost to Follow-up|17|||
145593095|NCT03265600|525022492|FG001|Overall Study|Lost to Follow-up|5|||
145593096|NCT03265600|525022491|FG000|Overall Study|Withdrawal by Subject|4|||
145593097|NCT03265600|525022492|FG001|Overall Study|Withdrawal by Subject|2|||
145593098|NCT03265600|525022491|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
145593099|NCT03265600|525022492|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
145593100|NCT00535730|525022493|FG000|Overall Study|Adverse Event|1|||
145593101|NCT00535730|525022494|FG001|Overall Study|Adverse Event|1|||
145459675|NCT00823212|524536450|FG001|Overall Study|Withdrawal by Subject|1|||
145593102|NCT00535730|525022493|FG000|Overall Study|Lost to Follow-up|0|||
145593103|NCT00535730|525022494|FG001|Overall Study|Lost to Follow-up|1|||
145459676|NCT00823212|524536449|FG000|Overall Study|Incarcerated|0|||
145459677|NCT00823212|524536450|FG001|Overall Study|Incarcerated|1|||
145593104|NCT00535730|525022493|FG000|Overall Study|Physician Decision|0|||
145459678|NCT00823212|524536449|FG000|Overall Study|Missed 12-month visit|21|||
145459679|NCT00823212|524536450|FG001|Overall Study|Missed 12-month visit|21|||
145593105|NCT00535730|525022494|FG001|Overall Study|Physician Decision|1|||
145593106|NCT00535730|525022493|FG000|Overall Study|Protocol Violation|1|||
145593107|NCT00535730|525022494|FG001|Overall Study|Protocol Violation|0|||
145593108|NCT00535730|525022493|FG000|Overall Study|Withdrawal by Subject|0|||
145459680|NCT00496197|524536451|FG000|Overall Study|Discontinued study due to death|43|||
145593109|NCT00535730|525022494|FG001|Overall Study|Withdrawal by Subject|4|||
145593110|NCT04330638|525022495|FG000|Overall Study|Adverse Event|9|||
145593111|NCT04330638|525022496|FG001|Overall Study|Adverse Event|10|||
145593112|NCT04330638|525022497|FG002|Overall Study|Adverse Event|15|||
145593113|NCT04330638|525022498|FG003|Overall Study|Adverse Event|6|||
145593114|NCT04330638|525022499|FG004|Overall Study|Adverse Event|10|||
145593115|NCT04330638|525022500|FG005|Overall Study|Adverse Event|5|||
145459681|NCT00496197|524536451|FG000|Overall Study|Adverse Event|13|||
145459682|NCT00496197|524536451|FG000|Overall Study|Does not meet entrance criteria|5|||
145459683|NCT00496197|524536451|FG000|Overall Study|Insufficient clinical response|3|||
145459684|NCT00496197|524536451|FG000|Overall Study|Insufficient bacteriological response|10|||
145459685|NCT00496197|524536451|FG000|Overall Study|Lost to Follow-up|11|||
145459686|NCT00496197|524536451|FG000|Overall Study|Withdrawal by Subject|11|||
145459687|NCT00496197|524536451|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
145459688|NCT00496197|524536451|FG000|Overall Study|Other|14|||
145459689|NCT00496197|524536451|FG000|Overall Study|Protocol Violation|8|||
145459690|NCT04431713|524536452|FG000|Overall Study|Withdrawal by Subject|2|||
145459691|NCT04431713|524536453|FG001|Overall Study|Withdrawal by Subject|0|||
145459692|NCT04431713|524536452|FG000|Overall Study|Death|2|||
145459693|NCT04431713|524536453|FG001|Overall Study|Death|2|||
145459694|NCT00149994|524536454|FG000|Overall Study|Administrative problems:|1|||
145459695|NCT00149994|524536455|FG001|Overall Study|Administrative problems:|0|||
145459696|NCT00149994|524536454|FG000|Overall Study|Protocol Violation|0|||
145459697|NCT00149994|524536455|FG001|Overall Study|Protocol Violation|1|||
145459698|NCT01344538|524536456|FG000|Overall Study|Adverse Event|1|||
145459699|NCT01344538|524536457|FG001|Overall Study|Adverse Event|1|||
145459700|NCT01344538|524536456|FG000|Overall Study|Lost to Follow-up|1|||
145459701|NCT01344538|524536457|FG001|Overall Study|Lost to Follow-up|0|||
145459702|NCT01655381|524536460|FG000|Overall Study|Investigator Decision|1|||
145459703|NCT01655381|524536460|FG000|Overall Study|Moved to Another City|1|||
145459704|NCT01655381|524536460|FG000|Overall Study|Insufficient Treatment Response|1|||
145459705|NCT02324205|524536461|FG000|Overall Study|Withdrawal by Subject|37|||
145459706|NCT04195438|524536462|FG000|Overall Study|Withdrawal by Subject|1|||
145459707|NCT00613925|524536463|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
145459708|NCT00613925|524536464|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
145459709|NCT03136497|524536465|FG000|Overall Study|Screen Failure|1|||
145459710|NCT03136497|524536466|FG001|Overall Study|Screen Failure|0|||
145459711|NCT03136497|524536467|FG002|Overall Study|Screen Failure|0|||
145459712|NCT00794365|524536469|FG000|Overall Study|Lost to Follow-up|38|||
145459713|NCT00794365|524536469|FG000|Overall Study|Other|17|||
145459714|NCT00794365|524536469|FG000|Overall Study|Poor Compliance|11|||
145459715|NCT00794365|524536469|FG000|Overall Study|Adverse Event|10|||
145459716|NCT00794365|524536469|FG000|Overall Study|Lack of Efficacy|3|||
145459717|NCT00856206|524536470|FG000|Overall Study|Protocol Violation|6|||
145459718|NCT00856206|524536471|FG001|Overall Study|Protocol Violation|18|||
145459719|NCT00856206|524536470|FG000|Overall Study|Adverse Event|10|||
145459720|NCT00856206|524536471|FG001|Overall Study|Adverse Event|46|||
145459721|NCT00856206|524536470|FG000|Overall Study|Lack of Efficacy|1|||
145459722|NCT00856206|524536471|FG001|Overall Study|Lack of Efficacy|2|||
145459723|NCT00856206|524536470|FG000|Overall Study|Withdrawal by Subject|15|||
145459724|NCT00856206|524536471|FG001|Overall Study|Withdrawal by Subject|36|||
145459725|NCT00856206|524536470|FG000|Overall Study|Lost to Follow-up|13|||
145459726|NCT00856206|524536471|FG001|Overall Study|Lost to Follow-up|39|||
145459727|NCT00856206|524536470|FG000|Overall Study|Death|2|||
145459728|NCT00856206|524536471|FG001|Overall Study|Death|2|||
145459729|NCT00856206|524536470|FG000|Overall Study|Decision by the Sponsor|4|||
145459730|NCT00856206|524536471|FG001|Overall Study|Decision by the Sponsor|8|||
145459731|NCT00856206|524536470|FG000|Overall Study|Other than specified above|3|||
145459732|NCT00856206|524536471|FG001|Overall Study|Other than specified above|10|||
145459733|NCT03538444|524536485|FG000|Overall Study|opioid withdrawal|1|||
145459734|NCT03538444|524536486|FG001|Overall Study|opioid withdrawal|0|||
145459735|NCT04584346|524536487|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
145459736|NCT04584346|524536488|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
145459737|NCT00790647|524536491|FG000|Overall Study|Adverse Event|1|||
145459738|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
145459739|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
145459740|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
145459741|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
145459742|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
145459743|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
145459744|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
145459745|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
145459746|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
145459747|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
145459748|NCT03549871|524536492|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
145593116|NCT04330638|525022495|FG000|Overall Study|Other|2|||
145593117|NCT04330638|525022496|FG001|Overall Study|Other|2|||
145459749|NCT03549871|524536493|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
145459750|NCT03549871|524536492|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
145459751|NCT03549871|524536493|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
145593118|NCT04330638|525022497|FG002|Overall Study|Other|5|||
145593119|NCT04330638|525022498|FG003|Overall Study|Other|1|||
145593120|NCT04330638|525022499|FG004|Overall Study|Other|3|||
145593121|NCT04330638|525022500|FG005|Overall Study|Other|2|||
145593122|NCT04330638|525022495|FG000|Overall Study|Withdrawal by Subject|4|||
145593123|NCT04330638|525022496|FG001|Overall Study|Withdrawal by Subject|0|||
145593124|NCT04330638|525022497|FG002|Overall Study|Withdrawal by Subject|0|||
145593125|NCT04330638|525022498|FG003|Overall Study|Withdrawal by Subject|0|||
145593126|NCT04330638|525022499|FG004|Overall Study|Withdrawal by Subject|0|||
145593127|NCT04330638|525022500|FG005|Overall Study|Withdrawal by Subject|0|||
145593128|NCT04330638|525022495|FG000|Overall Study|Lost to Follow-up|3|||
145593129|NCT04330638|525022496|FG001|Overall Study|Lost to Follow-up|2|||
145593130|NCT04330638|525022497|FG002|Overall Study|Lost to Follow-up|3|||
145593131|NCT04330638|525022498|FG003|Overall Study|Lost to Follow-up|2|||
145593132|NCT04330638|525022499|FG004|Overall Study|Lost to Follow-up|3|||
145593133|NCT04330638|525022500|FG005|Overall Study|Lost to Follow-up|0|||
145593134|NCT02293538|525022501|FG000|Overall Study|Adverse Event|0|||
145593135|NCT02293538|525022502|FG001|Overall Study|Adverse Event|1|||
145593136|NCT02293538|525022501|FG000|Overall Study|Lost to Follow-up|1|||
145593137|NCT02293538|525022502|FG001|Overall Study|Lost to Follow-up|0|||
145593138|NCT02293538|525022501|FG000|Overall Study|Withdrawal by Subject|0|||
145593139|NCT02293538|525022502|FG001|Overall Study|Withdrawal by Subject|1|||
145593140|NCT03336619|525022504|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
145593141|NCT03336619|525022505|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
145593142|NCT03336619|525022504|FG000|Overall Study|Withdrawal by Subject|17|||
145593143|NCT03336619|525022505|FG001|Overall Study|Withdrawal by Subject|16|||
145593144|NCT03336619|525022504|FG000|Overall Study|Adverse Event|2|||
145593145|NCT03336619|525022505|FG001|Overall Study|Adverse Event|5|||
145593146|NCT03336619|525022504|FG000|Overall Study|Physician Decision|3|||
145593147|NCT03336619|525022505|FG001|Overall Study|Physician Decision|0|||
145593148|NCT01965834|525022506|FG000|Overall Study|Lack of Efficacy|4|||
145593149|NCT00744653|525022513|FG000|Overall Study|antineoplastic treatment|11|||
145593150|NCT00744653|525022513|FG000|Overall Study|Death|1|||
145593151|NCT00744653|525022513|FG000|Overall Study|Lost to Follow-up|1|||
145593152|NCT00744653|525022513|FG000|Overall Study|Physician Decision|3|||
145593153|NCT00983073|525022514|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
145593154|NCT00983073|525022514|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
145593155|NCT00983073|525022514|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
145593156|NCT00983073|525022514|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
145593157|NCT00983073|525022514|FG000|Titration and Optimal Dose Period|Other reason|4|||
145593158|NCT00983073|525022514|FG000|Maintenance Period|Adverse Event|5|||
145593159|NCT00983073|525022514|FG000|Maintenance Period|Withdrawal by Subject|2|||
145593160|NCT00983073|525022514|FG000|Maintenance Period|Lack of Efficacy|2|||
145593161|NCT00983073|525022514|FG000|Maintenance Period|Other Reason|7|||
145593162|NCT02269670|525022518|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
145593163|NCT05557942|525022519|FG000|Overall Study|Death|0|||
145593164|NCT05557942|525022520|FG001|Overall Study|Death|0|||
145593165|NCT05557942|525022521|FG002|Overall Study|Death|0|||
145593166|NCT05557942|525022522|FG003|Overall Study|Death|2|||
145593167|NCT05557942|525022523|FG004|Overall Study|Death|1|||
145593168|NCT05557942|525022524|FG005|Overall Study|Death|1|||
145593169|NCT05557942|525022519|FG000|Overall Study|Physician Decision|1|||
145593170|NCT05557942|525022520|FG001|Overall Study|Physician Decision|1|||
145593171|NCT05557942|525022521|FG002|Overall Study|Physician Decision|2|||
145593172|NCT05557942|525022522|FG003|Overall Study|Physician Decision|3|||
145593173|NCT05557942|525022523|FG004|Overall Study|Physician Decision|0|||
145593174|NCT05557942|525022524|FG005|Overall Study|Physician Decision|2|||
145593175|NCT05557942|525022519|FG000|Overall Study|Study terminated by sponsor|17|||
145593176|NCT05557942|525022520|FG001|Overall Study|Study terminated by sponsor|17|||
145593177|NCT05557942|525022521|FG002|Overall Study|Study terminated by sponsor|14|||
145593178|NCT05557942|525022522|FG003|Overall Study|Study terminated by sponsor|40|||
145593179|NCT05557942|525022523|FG004|Overall Study|Study terminated by sponsor|45|||
145593180|NCT05557942|525022524|FG005|Overall Study|Study terminated by sponsor|37|||
145593181|NCT05557942|525022519|FG000|Overall Study|Protocol Violation|0|||
145593182|NCT05557942|525022520|FG001|Overall Study|Protocol Violation|0|||
145593183|NCT05557942|525022521|FG002|Overall Study|Protocol Violation|0|||
145593184|NCT05557942|525022522|FG003|Overall Study|Protocol Violation|0|||
145593185|NCT05557942|525022523|FG004|Overall Study|Protocol Violation|0|||
145593186|NCT05557942|525022524|FG005|Overall Study|Protocol Violation|1|||
145593187|NCT05557942|525022519|FG000|Overall Study|Withdrawal by Subject|0|||
145593188|NCT05557942|525022520|FG001|Overall Study|Withdrawal by Subject|0|||
145593189|NCT05557942|525022521|FG002|Overall Study|Withdrawal by Subject|0|||
145593190|NCT05557942|525022522|FG003|Overall Study|Withdrawal by Subject|0|||
145593191|NCT05557942|525022523|FG004|Overall Study|Withdrawal by Subject|2|||
145593192|NCT05557942|525022524|FG005|Overall Study|Withdrawal by Subject|0|||
145593193|NCT03776136|525022527|FG000|Overall Study|Death|85|||
145593194|NCT03776136|525022527|FG000|Overall Study|Withdrawal by Subject|3|||
145593195|NCT03776136|525022527|FG000|Overall Study|Sponsor Decision|15|||
145593196|NCT02057874|525024202|FG000|Overall Study|participant did not return for scan|1|||
145593197|NCT02925455|525024203|FG000|Overall Study|Withdrawal by Subject|2|||
145593198|NCT02925455|525024204|FG001|Overall Study|Withdrawal by Subject|0|||
145593199|NCT00686166|525024205|FG000|Overall Study|Adverse Event|7|||
145593200|NCT00686166|525024205|FG000|Overall Study|Withdrawal by Subject|1|||
145593201|NCT00686166|525024205|FG000|Overall Study|Progression/Relapse|1|||
145593202|NCT00686166|525024205|FG000|Overall Study|Death|1|||
145593203|NCT00686166|525024205|FG000|Overall Study|Not Protocol Specified|1|||
145593204|NCT00686166|525024205|FG000|Overall Study|Ineligible|5|||
145593205|NCT00686166|525024205|FG000|Overall Study|Did not begin protocol therapy|4|||
145593206|NCT01514448|525024206|FG000|Overall Study|Death|7|||
145593207|NCT01514448|525024207|FG001|Overall Study|Death|8|||
145593208|NCT01514448|525024206|FG000|Overall Study|Withdrawal by Subject|2|||
145593209|NCT01514448|525024207|FG001|Overall Study|Withdrawal by Subject|0|||
145593210|NCT01514448|525024206|FG000|Overall Study|Lost to Follow-up|2|||
145593211|NCT01514448|525024207|FG001|Overall Study|Lost to Follow-up|0|||
145593212|NCT01514448|525024206|FG000|Overall Study|New Cancer Therapy|1|||
145593213|NCT01514448|525024207|FG001|Overall Study|New Cancer Therapy|0|||
145593214|NCT02314624|525024208|FG000|Overall Study|No participating patient|16|||
145593215|NCT02314624|525024209|FG001|Overall Study|No participating patient|13|||
145593216|NCT02314624|525024208|FG000|Overall Study|Participant withdrew|7|||
145593217|NCT02314624|525024209|FG001|Overall Study|Participant withdrew|2|||
145593218|NCT02314624|525024208|FG000|Overall Study|Lost to Follow-up|2|||
145593219|NCT02314624|525024209|FG001|Overall Study|Lost to Follow-up|5|||
145593220|NCT02314624|525024208|FG000|Overall Study|Dropped/Excluded by PI|6|||
145593221|NCT02314624|525024209|FG001|Overall Study|Dropped/Excluded by PI|6|||
145593222|NCT03912259|525024210|FG000|Overall Study|Adverse Event (AE)|2|||
145593223|NCT03912259|525024211|FG001|Overall Study|Adverse Event (AE)|4|||
145593224|NCT03912259|525024210|FG000|Overall Study|Lack of Efficacy|4|||
145593225|NCT03912259|525024211|FG001|Overall Study|Lack of Efficacy|1|||
145593226|NCT03912259|525024210|FG000|Overall Study|Withdrawal by Subject|11|||
145593227|NCT03912259|525024211|FG001|Overall Study|Withdrawal by Subject|1|||
145593228|NCT00360308|525024212|FG000|Overall Study|Adverse Event|15|||
145593229|NCT00360308|525024213|FG001|Overall Study|Adverse Event|14|||
145593230|NCT00360308|525024214|FG002|Overall Study|Adverse Event|25|||
145593231|NCT00360308|525024212|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
145593232|NCT00360308|525024213|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
145593233|NCT00360308|525024214|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
145593234|NCT00360308|525024212|FG000|Overall Study|Protocol Violation|2|||
145593235|NCT00360308|525024213|FG001|Overall Study|Protocol Violation|1|||
145593236|NCT00360308|525024214|FG002|Overall Study|Protocol Violation|2|||
145593237|NCT00360308|525024212|FG000|Overall Study|Withdrawal by Subject|11|||
145593238|NCT00360308|525024213|FG001|Overall Study|Withdrawal by Subject|7|||
145593239|NCT00360308|525024214|FG002|Overall Study|Withdrawal by Subject|14|||
145593240|NCT00360308|525024212|FG000|Overall Study|Lack of Efficacy|3|||
145593241|NCT00360308|525024213|FG001|Overall Study|Lack of Efficacy|0|||
145593242|NCT00360308|525024214|FG002|Overall Study|Lack of Efficacy|2|||
145593243|NCT00360308|525024212|FG000|Overall Study|Other|2|||
145593244|NCT00360308|525024213|FG001|Overall Study|Other|1|||
145593245|NCT00360308|525024214|FG002|Overall Study|Other|1|||
145593246|NCT00360308|525024212|FG000|Overall Study|Study termination by sponsor|43|||
145593247|NCT00360308|525024213|FG001|Overall Study|Study termination by sponsor|55|||
145593248|NCT00360308|525024214|FG002|Overall Study|Study termination by sponsor|44|||
145593249|NCT04786444|525024215|FG000|Overall Study|Withdrawal by Subject|4|||
145593250|NCT04786444|525024216|FG001|Overall Study|Withdrawal by Subject|7|||
145593251|NCT04786444|525024217|FG002|Overall Study|Withdrawal by Subject|2|||
145593252|NCT04786444|525024215|FG000|Overall Study|Lost to Follow-up|11|||
145593253|NCT04786444|525024216|FG001|Overall Study|Lost to Follow-up|9|||
145593254|NCT04786444|525024217|FG002|Overall Study|Lost to Follow-up|10|||
145593255|NCT04786444|525024215|FG000|Overall Study|Subject would like to become pregnant|0|||
145593256|NCT04786444|525024216|FG001|Overall Study|Subject would like to become pregnant|1|||
145593257|NCT04786444|525024217|FG002|Overall Study|Subject would like to become pregnant|0|||
145593258|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
145593259|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
145593260|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
145459752|NCT03549871|524536492|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
145593261|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
145459753|NCT03549871|524536493|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
145593262|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
145593263|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
145593264|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
145593265|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
145593266|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
145593267|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
145593268|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
145593269|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
145593270|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
145593271|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
145593272|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
145593273|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
145593274|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
145593275|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
145593276|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
145593277|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
145593278|NCT04162769|525024218|FG000|Double-blind Treatment (12-Week)|Other|0|||
145593279|NCT04162769|525024219|FG001|Double-blind Treatment (12-Week)|Other|1|||
145593280|NCT04162769|525024220|FG002|Double-blind Treatment (12-Week)|Other|1|||
145593281|NCT04162769|525024221|FG003|Double-blind Treatment (12-Week)|Other|0|||
145593282|NCT04162769|525024218|FG000|OLE Period (52-Week)|Adverse Event|0|||
145593283|NCT04162769|525024219|FG001|OLE Period (52-Week)|Adverse Event|0|||
145593284|NCT04162769|525024220|FG002|OLE Period (52-Week)|Adverse Event|0|||
145593285|NCT04162769|525024221|FG003|OLE Period (52-Week)|Adverse Event|5|||
145593286|NCT04162769|525024218|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
145593287|NCT04162769|525024219|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
145593288|NCT04162769|525024220|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
145593289|NCT04162769|525024221|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
145593290|NCT04162769|525024218|FG000|OLE Period (52-Week)|Physician Decision|0|||
145593291|NCT04162769|525024219|FG001|OLE Period (52-Week)|Physician Decision|0|||
145593292|NCT04162769|525024220|FG002|OLE Period (52-Week)|Physician Decision|0|||
145593293|NCT04162769|525024221|FG003|OLE Period (52-Week)|Physician Decision|1|||
145593294|NCT04162769|525024218|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
145593295|NCT04162769|525024219|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
145593296|NCT04162769|525024220|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
145593297|NCT04162769|525024221|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
145593298|NCT04162769|525024218|FG000|OLE Period (52-Week)|Protocol deviation|0|||
145593299|NCT04162769|525024219|FG001|OLE Period (52-Week)|Protocol deviation|0|||
145593300|NCT04162769|525024220|FG002|OLE Period (52-Week)|Protocol deviation|0|||
145593301|NCT04162769|525024221|FG003|OLE Period (52-Week)|Protocol deviation|2|||
145593302|NCT00713648|525024222|FG000|Overall Study|Adverse Event|1|||
145593303|NCT00713648|525024222|FG000|Overall Study|Unclassified|2|||
145593304|NCT00713648|525024222|FG000|Overall Study|According to Protocol|2|||
145593305|NCT00713648|525024222|FG000|Overall Study|Development of antibodies|3|||
145593306|NCT00082173|525024223|FG000|Overall Study|Withdrawal by Subject|3|||
145593307|NCT00082173|525024224|FG001|Overall Study|Withdrawal by Subject|5|||
145593308|NCT00082173|525024223|FG000|Overall Study|Lost to Follow-up|1|||
145593309|NCT00082173|525024224|FG001|Overall Study|Lost to Follow-up|0|||
145593310|NCT00082173|525024223|FG000|Overall Study|Adverse Event|1|||
145593311|NCT00082173|525024224|FG001|Overall Study|Adverse Event|0|||
145593312|NCT00082173|525024223|FG000|Overall Study|Culture negative or resistant at baselin|5|||
145593313|NCT00082173|525024224|FG001|Overall Study|Culture negative or resistant at baselin|6|||
145593314|NCT00464815|525024227|FG000|Overall Study|Withdrawal by Subject|6|||
145593315|NCT00464815|525024228|FG001|Overall Study|Withdrawal by Subject|3|||
145593316|NCT00487162|525024232|FG000|Overall Study|Adverse Event|0|||
145593317|NCT00487162|525024233|FG001|Overall Study|Adverse Event|1|||
145593318|NCT00487162|525024232|FG000|Overall Study|Physician Decision|0|||
145593319|NCT00487162|525024233|FG001|Overall Study|Physician Decision|1|||
145593320|NCT00487162|525024232|FG000|Overall Study|Withdrawal by Subject|2|||
145593321|NCT00487162|525024233|FG001|Overall Study|Withdrawal by Subject|3|||
145593322|NCT00815295|525024236|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
145459754|NCT03549871|524536492|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
145459755|NCT03549871|524536493|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
145459756|NCT03549871|524536492|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
145459757|NCT03549871|524536493|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
145459758|NCT03549871|524536492|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
145459759|NCT03549871|524536493|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
145459760|NCT01369680|524536494|FG000|Overall Study|Lost to Follow-up|0|||
145459761|NCT01369680|524536495|FG001|Overall Study|Lost to Follow-up|0|||
145459762|NCT01369680|524536496|FG002|Overall Study|Lost to Follow-up|1|||
145593323|NCT00815295|525024237|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
145593324|NCT00815295|525024238|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
145593325|NCT01433354|525024243|FG000|Overall Study|Adverse Event|6|||
145459763|NCT01369680|524536497|FG003|Overall Study|Lost to Follow-up|2|||
145593326|NCT01433354|525024243|FG000|Overall Study|Lost to Follow-up|1|||
145593327|NCT01433354|525024243|FG000|Overall Study|Administrative problems|90|||
145593328|NCT01433354|525024243|FG000|Overall Study|Protocol Violation|2|||
145593329|NCT01433354|525024243|FG000|Overall Study|Lack of Efficacy|17|||
145593330|NCT01433354|525024243|FG000|Overall Study|Subject Withdrew Consent|3|||
145459764|NCT01133626|524536499|FG000|Overall Study|Adverse Event|0|||
145459765|NCT01133626|524536500|FG001|Overall Study|Adverse Event|1|||
145459766|NCT01133626|524536501|FG002|Overall Study|Adverse Event|0|||
145459767|NCT01133626|524536499|FG000|Overall Study|Withdrawal by Subject|1|||
145459768|NCT01133626|524536500|FG001|Overall Study|Withdrawal by Subject|2|||
145459769|NCT01133626|524536501|FG002|Overall Study|Withdrawal by Subject|2|||
145459770|NCT01133626|524536499|FG000|Overall Study|Other|0|||
145459771|NCT01133626|524536500|FG001|Overall Study|Other|2|||
145459772|NCT01133626|524536501|FG002|Overall Study|Other|0|||
145459773|NCT02851407|524536502|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145459774|NCT02851407|524536503|FG001|Overall Study|Withdrawal by parent/guardian|7|||
145459775|NCT02851407|524536502|FG000|Overall Study|Protocol deviation|0|||
145459776|NCT02851407|524536503|FG001|Overall Study|Protocol deviation|1|||
145459777|NCT02851407|524536502|FG000|Overall Study|Transferred to another hospital to continue|1|||
145459778|NCT02851407|524536503|FG001|Overall Study|Transferred to another hospital to continue|0|||
145459779|NCT02851407|524536502|FG000|Overall Study|Other Death|30|||
145459780|NCT02851407|524536503|FG001|Overall Study|Other Death|20|||
145459781|NCT02851407|524536502|FG000|Overall Study|Adverse event, serious fatal|6|||
145459782|NCT02851407|524536503|FG001|Overall Study|Adverse event, serious fatal|8|||
145459783|NCT02851407|524536502|FG000|Overall Study|Consent withdrawn by participant|5|||
145459784|NCT02851407|524536503|FG001|Overall Study|Consent withdrawn by participant|3|||
145459785|NCT02851407|524536502|FG000|Overall Study|Screen failure|2|||
145459786|NCT02851407|524536503|FG001|Overall Study|Screen failure|1|||
145459787|NCT02851407|524536502|FG000|Overall Study|Disease relapse|9|||
145459788|NCT02851407|524536503|FG001|Overall Study|Disease relapse|6|||
145459789|NCT02851407|524536502|FG000|Overall Study|Physician Decision|7|||
145459790|NCT02851407|524536503|FG001|Overall Study|Physician Decision|6|||
145459791|NCT02851407|524536502|FG000|Overall Study|Transferred to hospital closer to home|0|||
145459792|NCT02851407|524536503|FG001|Overall Study|Transferred to hospital closer to home|1|||
145459793|NCT02851407|524536502|FG000|Overall Study|Enrolled in an investigational study|0|||
145459794|NCT02851407|524536503|FG001|Overall Study|Enrolled in an investigational study|1|||
145459795|NCT02851407|524536502|FG000|Overall Study|Early recovery|1|||
145459796|NCT02851407|524536503|FG001|Overall Study|Early recovery|0|||
145459797|NCT02851407|524536502|FG000|Overall Study|Adverse event, non-fatal|7|||
145459798|NCT02851407|524536503|FG001|Overall Study|Adverse event, non-fatal|5|||
145459799|NCT02851407|524536502|FG000|Overall Study|Lost to Follow-up|0|||
145459800|NCT02851407|524536503|FG001|Overall Study|Lost to Follow-up|2|||
145459801|NCT03761394|524536504|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
145459802|NCT03761394|524536505|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
145459803|NCT03761394|524536506|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
145459804|NCT03761394|524536507|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
145459805|NCT03761394|524536504|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
145459806|NCT03761394|524536505|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
145459807|NCT03761394|524536506|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
145459808|NCT03761394|524536507|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
145459809|NCT03761394|524536504|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
145459810|NCT03761394|524536505|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
145459811|NCT03761394|524536506|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
145459812|NCT03761394|524536507|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
145459813|NCT03761394|524536504|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
145459814|NCT03761394|524536505|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
145459815|NCT03761394|524536506|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
145459816|NCT03761394|524536507|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
145459817|NCT03054350|524536509|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
145459818|NCT03054350|524536510|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
145459819|NCT03054350|524536511|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
145459820|NCT03054350|524536512|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
145459821|NCT03054350|524536513|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
145459822|NCT03054350|524536514|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
145459823|NCT03054350|524536509|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
145459824|NCT03054350|524536510|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
145459825|NCT03054350|524536511|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
145459826|NCT03054350|524536512|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
145459827|NCT03054350|524536513|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
145459828|NCT03054350|524536514|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
145459829|NCT03054350|524536509|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
145459830|NCT03054350|524536510|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
145459831|NCT03054350|524536511|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
145459832|NCT03054350|524536512|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
145626782|NCT04949399|525145792|FG001|Overall Study|Lost to Follow-up|6|||
145459833|NCT03054350|524536513|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
145459834|NCT03054350|524536514|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
145459835|NCT03054350|524536509|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
145459836|NCT03054350|524536510|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
145459837|NCT03054350|524536511|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
145459838|NCT03054350|524536512|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
145459839|NCT03054350|524536513|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
145459840|NCT03054350|524536514|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
145459841|NCT03510468|524536515|FG000|Overall Study|Lost to Follow-up|1|||
145459842|NCT03510468|524536515|FG000|Overall Study|Adverse Event|5|||
145459843|NCT03510468|524536515|FG000|Overall Study|Physician Decision|1|||
145459844|NCT03510468|524536515|FG000|Overall Study|non-compliant with treatment|2|||
145459845|NCT03510468|524536515|FG000|Overall Study|Missed visit|1|||
145459846|NCT02437305|524536517|FG000|Overall Study|Lost to Follow-up|18|||
145459847|NCT02437305|524536518|FG001|Overall Study|Lost to Follow-up|12|||
145459848|NCT00919867|524536519|FG000|First Intervention|Withdrawal by Subject|0|||
145459849|NCT00919867|524536520|FG001|First Intervention|Withdrawal by Subject|0|||
145459850|NCT00919867|524536521|FG002|First Intervention|Withdrawal by Subject|1|||
145459851|NCT00919867|524536522|FG003|First Intervention|Withdrawal by Subject|0|||
145459852|NCT00919867|524536523|FG004|First Intervention|Withdrawal by Subject|0|||
145459853|NCT00919867|524536524|FG005|First Intervention|Withdrawal by Subject|0|||
145459854|NCT00919867|524536519|FG000|First Intervention|Physician Decision|0|||
145459855|NCT00919867|524536520|FG001|First Intervention|Physician Decision|0|||
145459856|NCT00919867|524536521|FG002|First Intervention|Physician Decision|0|||
145459857|NCT00919867|524536522|FG003|First Intervention|Physician Decision|0|||
145459858|NCT00919867|524536523|FG004|First Intervention|Physician Decision|0|||
145459859|NCT00919867|524536524|FG005|First Intervention|Physician Decision|1|||
145459860|NCT02323204|524536528|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
145459861|NCT02323204|524536529|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
145459862|NCT02323204|524536530|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
145459863|NCT02323204|524536531|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
145459864|NCT02323204|524536528|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
145459865|NCT02323204|524536529|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
145459866|NCT02323204|524536530|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
145459867|NCT02323204|524536531|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
145459868|NCT02323204|524536528|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
145459869|NCT02323204|524536529|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
145459870|NCT02323204|524536530|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
145459871|NCT02323204|524536531|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
145459872|NCT02323204|524536528|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
145459873|NCT02323204|524536529|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
145459874|NCT02323204|524536530|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
145459875|NCT02323204|524536531|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
145459876|NCT02323204|524536528|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
145459877|NCT02323204|524536529|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
145459878|NCT02323204|524536530|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
145459879|NCT02323204|524536531|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
145459880|NCT02323204|524536528|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
145459881|NCT02323204|524536529|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
145459882|NCT02323204|524536530|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
145459883|NCT02323204|524536531|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
145459884|NCT02323204|524536528|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
145459885|NCT02323204|524536529|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
145459886|NCT02323204|524536530|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
145459887|NCT02323204|524536531|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
145459888|NCT02323204|524536528|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
145459889|NCT02323204|524536529|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
145459890|NCT02323204|524536530|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
145459891|NCT02323204|524536531|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
145459892|NCT02323204|524536528|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
145459893|NCT02323204|524536529|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
145459894|NCT02323204|524536530|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
145459895|NCT02323204|524536531|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
145459896|NCT01396265|524536543|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
145459897|NCT01767493|524536544|FG000|Overall Study|screen failures|3|||
145459898|NCT03746600|524536545|FG000|Overall Study|Withdrawal by Subject|3|||
145459899|NCT03746600|524536546|FG001|Overall Study|Withdrawal by Subject|3|||
145459900|NCT03746600|524536545|FG000|Overall Study|dismissed from study|1|||
145459901|NCT03746600|524536546|FG001|Overall Study|dismissed from study|0|||
145593331|NCT00937924|525024251|FG000|Overall Study|Lost to Follow-up|44|||
145593332|NCT00937924|525024252|FG001|Overall Study|Lost to Follow-up|44|||
145593333|NCT00937924|525024253|FG002|Overall Study|Lost to Follow-up|41|||
145593334|NCT02633137|525024272|FG000|Overall Study|Adverse Event|1|||
145593335|NCT02633137|525024272|FG000|Overall Study|Lack of Efficacy|2|||
145593336|NCT02633137|525024272|FG000|Overall Study|Withdrawal by Subject|1|||
145593337|NCT03152526|525024273|FG000|Overall Study|Withdrawal by Subject|0|||
145593338|NCT03152526|525024274|FG001|Overall Study|Withdrawal by Subject|1|||
145593339|NCT04307004|525024275|FG000|Randomization 1|Withdrawal by Subject|25|||
145593340|NCT04307004|525024276|FG001|Randomization 1|Withdrawal by Subject|26|||
145593341|NCT04307004|525024277|FG002|Randomization 1|Withdrawal by Subject|0|||
145593342|NCT04307004|525024278|FG003|Randomization 1|Withdrawal by Subject|0|||
145593343|NCT04307004|525024275|FG000|Randomization 2|Withdrawal by Subject|0|||
145593344|NCT04307004|525024276|FG001|Randomization 2|Withdrawal by Subject|0|||
145593345|NCT04307004|525024277|FG002|Randomization 2|Withdrawal by Subject|28|||
145593346|NCT04307004|525024278|FG003|Randomization 2|Withdrawal by Subject|23|||
145593347|NCT05545072|525024279|FG000|Overall Study|Lost to Follow-up|1|||
145593348|NCT05545072|525024280|FG001|Overall Study|Lost to Follow-up|0|||
145593349|NCT05545072|525024279|FG000|Overall Study|Study ended prematurely due to funding|2|||
145593350|NCT05545072|525024280|FG001|Overall Study|Study ended prematurely due to funding|2|||
145593351|NCT02395042|525024281|FG000|Treatment 1 Period|Adverse Event|1|||
145593352|NCT02395042|525024282|FG001|Treatment 1 Period|Adverse Event|3|||
145593353|NCT02395042|525024283|FG002|Treatment 1 Period|Adverse Event|1|||
145593354|NCT02395042|525024281|FG000|Treatment 1 Period|Lack of Efficacy|1|||
145593355|NCT02395042|525024282|FG001|Treatment 1 Period|Lack of Efficacy|1|||
145593356|NCT02395042|525024283|FG002|Treatment 1 Period|Lack of Efficacy|0|||
145593357|NCT02395042|525024281|FG000|Treatment 1 Period|Lost to Follow-up|1|||
145593358|NCT02395042|525024282|FG001|Treatment 1 Period|Lost to Follow-up|0|||
145593359|NCT02395042|525024283|FG002|Treatment 1 Period|Lost to Follow-up|0|||
145593360|NCT02395042|525024281|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
145593361|NCT02395042|525024282|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
145593362|NCT02395042|525024283|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
145593363|NCT02395042|525024281|FG000|Treatment 2 Period|Lack of Efficacy|1|||
145593364|NCT02395042|525024282|FG001|Treatment 2 Period|Lack of Efficacy|1|||
145593365|NCT02395042|525024283|FG002|Treatment 2 Period|Lack of Efficacy|0|||
145593366|NCT02807558|525024284|FG000|Overall Study|Consent withdrawn by participant|4|||
145593367|NCT02807558|525024285|FG001|Overall Study|Consent withdrawn by participant|0|||
145593368|NCT02807558|525024286|FG002|Overall Study|Consent withdrawn by participant|4|||
145593369|NCT02807558|525024287|FG003|Overall Study|Consent withdrawn by participant|2|||
145593370|NCT02807558|525024288|FG004|Overall Study|Consent withdrawn by participant|1|||
145593371|NCT02807558|525024289|FG005|Overall Study|Consent withdrawn by participant|0|||
145593372|NCT02807558|525024284|FG000|Overall Study|Non-compliance with Study Drug|0|||
145593373|NCT02807558|525024285|FG001|Overall Study|Non-compliance with Study Drug|0|||
145593374|NCT02807558|525024286|FG002|Overall Study|Non-compliance with Study Drug|1|||
145593375|NCT02807558|525024287|FG003|Overall Study|Non-compliance with Study Drug|0|||
145593376|NCT02807558|525024288|FG004|Overall Study|Non-compliance with Study Drug|0|||
145593377|NCT02807558|525024289|FG005|Overall Study|Non-compliance with Study Drug|0|||
145593378|NCT02807558|525024284|FG000|Overall Study|Adverse Event|0|||
145593379|NCT02807558|525024285|FG001|Overall Study|Adverse Event|0|||
145593380|NCT02807558|525024286|FG002|Overall Study|Adverse Event|9|||
145593381|NCT02807558|525024287|FG003|Overall Study|Adverse Event|0|||
145593382|NCT02807558|525024288|FG004|Overall Study|Adverse Event|0|||
145593383|NCT02807558|525024289|FG005|Overall Study|Adverse Event|0|||
145593384|NCT02807558|525024284|FG000|Overall Study|Death|23|||
145459902|NCT03746600|524536545|FG000|Overall Study|Lost to Follow-up|1|||
145459903|NCT03746600|524536546|FG001|Overall Study|Lost to Follow-up|0|||
145593385|NCT02807558|525024285|FG001|Overall Study|Death|2|||
145593386|NCT02807558|525024286|FG002|Overall Study|Death|3|||
145593387|NCT02807558|525024287|FG003|Overall Study|Death|43|||
145593388|NCT02807558|525024288|FG004|Overall Study|Death|24|||
145593389|NCT02807558|525024289|FG005|Overall Study|Death|15|||
145593390|NCT02807558|525024284|FG000|Overall Study|Progressive Disease|0|||
145593391|NCT02807558|525024285|FG001|Overall Study|Progressive Disease|0|||
145593392|NCT02807558|525024286|FG002|Overall Study|Progressive Disease|1|||
145593393|NCT02807558|525024287|FG003|Overall Study|Progressive Disease|0|||
145593394|NCT02807558|525024288|FG004|Overall Study|Progressive Disease|0|||
145593395|NCT02807558|525024289|FG005|Overall Study|Progressive Disease|0|||
145593396|NCT02807558|525024284|FG000|Overall Study|Other than specified|1|||
145593397|NCT02807558|525024285|FG001|Overall Study|Other than specified|0|||
145593398|NCT02807558|525024286|FG002|Overall Study|Other than specified|2|||
145593399|NCT02807558|525024287|FG003|Overall Study|Other than specified|0|||
145593400|NCT02807558|525024288|FG004|Overall Study|Other than specified|1|||
145593401|NCT02807558|525024289|FG005|Overall Study|Other than specified|1|||
145593402|NCT02807558|525024284|FG000|Overall Study|Lack of Efficacy|0|||
145593403|NCT02807558|525024285|FG001|Overall Study|Lack of Efficacy|0|||
145593404|NCT02807558|525024286|FG002|Overall Study|Lack of Efficacy|9|||
145593405|NCT02807558|525024287|FG003|Overall Study|Lack of Efficacy|0|||
145593406|NCT02807558|525024288|FG004|Overall Study|Lack of Efficacy|0|||
145593407|NCT02807558|525024289|FG005|Overall Study|Lack of Efficacy|0|||
145593408|NCT03644186|525024290|FG000|Overall Study|Withdrawal by Subject|1|||
145593409|NCT03644186|525024291|FG001|Overall Study|Withdrawal by Subject|1|||
145593410|NCT02701985|525024294|FG000|Overall Study|Withdrawal by Subject|1|||
145593411|NCT02701985|525024295|FG001|Overall Study|Withdrawal by Subject|1|||
145593412|NCT02701985|525024294|FG000|Overall Study|Lost to Follow-up|1|||
145593413|NCT02701985|525024295|FG001|Overall Study|Lost to Follow-up|0|||
145593414|NCT02701985|525024294|FG000|Overall Study|Death|1|||
145593415|NCT02701985|525024295|FG001|Overall Study|Death|0|||
145593416|NCT02701985|525024294|FG000|Overall Study|Adverse Event|0|||
145593417|NCT02701985|525024295|FG001|Overall Study|Adverse Event|5|||
145593418|NCT04391023|525024296|FG000|Overall Study|Withdrawal by Subject|2|||
145593419|NCT04391023|525024297|FG001|Overall Study|Withdrawal by Subject|2|||
145593420|NCT02085408|525024301|FG000|Step 1: Induction|Disease Progression|19|||
145593421|NCT02085408|525024302|FG001|Step 1: Induction|Disease Progression|19|||
145593422|NCT02085408|525024301|FG000|Step 1: Induction|Adverse Event|18|||
145593423|NCT02085408|525024302|FG001|Step 1: Induction|Adverse Event|17|||
145593424|NCT02085408|525024301|FG000|Step 1: Induction|Death|33|||
145593425|NCT02085408|525024302|FG001|Step 1: Induction|Death|30|||
145593426|NCT02085408|525024301|FG000|Step 1: Induction|Withdrawal by Subject|16|||
145593427|NCT02085408|525024302|FG001|Step 1: Induction|Withdrawal by Subject|8|||
145593428|NCT02085408|525024301|FG000|Step 1: Induction|Alternative Therapy|15|||
145593429|NCT02085408|525024302|FG001|Step 1: Induction|Alternative Therapy|19|||
145593430|NCT02085408|525024301|FG000|Step 1: Induction|Complicating Disease|2|||
145593431|NCT02085408|525024302|FG001|Step 1: Induction|Complicating Disease|3|||
145593432|NCT02085408|525024301|FG000|Step 1: Induction|Other|27|||
145593433|NCT02085408|525024302|FG001|Step 1: Induction|Other|39|||
145593434|NCT02085408|525024301|FG000|Step 1: Induction|Never started treatment|6|||
145593435|NCT02085408|525024302|FG001|Step 1: Induction|Never started treatment|4|||
145593436|NCT02085408|525024301|FG000|Step 2: Consolidation|Disease Progression|5|||
145593437|NCT02085408|525024302|FG001|Step 2: Consolidation|Disease Progression|20|||
145593438|NCT02085408|525024301|FG000|Step 2: Consolidation|Adverse Event|9|||
145593439|NCT02085408|525024302|FG001|Step 2: Consolidation|Adverse Event|8|||
145593440|NCT02085408|525024301|FG000|Step 2: Consolidation|Death|4|||
145593441|NCT02085408|525024302|FG001|Step 2: Consolidation|Death|3|||
145593442|NCT02085408|525024301|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
145593443|NCT02085408|525024302|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
145593444|NCT02085408|525024301|FG000|Step 2: Consolidation|Alternative Therapy|9|||
145593445|NCT02085408|525024302|FG001|Step 2: Consolidation|Alternative Therapy|3|||
145593446|NCT02085408|525024301|FG000|Step 2: Consolidation|Complicating Disease|0|||
145593447|NCT02085408|525024302|FG001|Step 2: Consolidation|Complicating Disease|2|||
145593448|NCT02085408|525024301|FG000|Step 2: Consolidation|Other|6|||
145593449|NCT02085408|525024302|FG001|Step 2: Consolidation|Other|6|||
145459904|NCT00884039|524536547|FG000|Overall Study|Withdrawal by Subject|0|||
145459905|NCT00884039|524536548|FG001|Overall Study|Withdrawal by Subject|1|||
145459906|NCT00884039|524536547|FG000|Overall Study|Lack of Efficacy|2|||
145459907|NCT00884039|524536548|FG001|Overall Study|Lack of Efficacy|0|||
145459908|NCT02981407|524536552|FG000|Overall Study|Withdrawal by Subject|2|||
145459909|NCT02981407|524536553|FG001|Overall Study|Withdrawal by Subject|0|||
145459910|NCT01896271|524536560|FG000|Overall Study|Physician Decision|10|||
145459911|NCT00953680|524536561|FG000|Period 1|Withdrawal by Subject|0|||
145459912|NCT00953680|524536562|FG001|Period 1|Withdrawal by Subject|1|||
145459913|NCT00549900|524538725|FG000|Overall Study|Adverse Event|1|||
145459914|NCT02210832|524538727|FG000|Overall Study|Pregnancy termination .|3|||
145459915|NCT02210832|524538728|FG001|Overall Study|Pregnancy termination .|4|||
145459916|NCT02210832|524538729|FG002|Overall Study|Pregnancy termination .|1|||
145459917|NCT02210832|524538727|FG000|Overall Study|Lost to Follow-up|26|||
145459918|NCT02210832|524538728|FG001|Overall Study|Lost to Follow-up|32|||
145459919|NCT02210832|524538729|FG002|Overall Study|Lost to Follow-up|17|||
145459920|NCT02754141|524538734|FG000|Overall Study|Disease progression|11|||
145459921|NCT02754141|524538735|FG001|Overall Study|Disease progression|7|||
145459922|NCT02754141|524538736|FG002|Overall Study|Disease progression|8|||
145459923|NCT02754141|524538737|FG003|Overall Study|Disease progression|5|||
145459924|NCT02754141|524538738|FG004|Overall Study|Disease progression|7|||
145459925|NCT02754141|524538739|FG005|Overall Study|Disease progression|7|||
145459926|NCT02754141|524538740|FG006|Overall Study|Disease progression|7|||
145459927|NCT02754141|524538741|FG007|Overall Study|Disease progression|6|||
145459928|NCT02754141|524538742|FG008|Overall Study|Disease progression|11|||
145459929|NCT02754141|524538743|FG009|Overall Study|Disease progression|16|||
145459930|NCT02754141|524538744|FG010|Overall Study|Disease progression|18|||
145593450|NCT02085408|525024301|FG000|Step 2: Consolidation|Never started treatment|4|||
145459931|NCT02754141|524538745|FG011|Overall Study|Disease progression|13|||
145593451|NCT02085408|525024302|FG001|Step 2: Consolidation|Never started treatment|3|||
145593452|NCT02085408|525024301|FG000|Step 3: Maintenance|Disease Progression|13|||
145593453|NCT02085408|525024302|FG001|Step 3: Maintenance|Disease Progression|11|||
145593454|NCT02085408|525024301|FG000|Step 3: Maintenance|Adverse Event|2|||
145459932|NCT02754141|524538746|FG012|Overall Study|Disease progression|10|||
145459933|NCT02754141|524538747|FG013|Overall Study|Disease progression|12|||
145459934|NCT02754141|524538748|FG014|Overall Study|Disease progression|12|||
145459935|NCT02754141|524538749|FG015|Overall Study|Disease progression|14|||
145459936|NCT02754141|524538750|FG016|Overall Study|Disease progression|0|||
145459937|NCT02754141|524538751|FG017|Overall Study|Disease progression|1|||
145459938|NCT02754141|524538734|FG000|Overall Study|Study drug toxicity|1|||
145459939|NCT02754141|524538735|FG001|Overall Study|Study drug toxicity|1|||
145459940|NCT02754141|524538736|FG002|Overall Study|Study drug toxicity|0|||
145459941|NCT02754141|524538737|FG003|Overall Study|Study drug toxicity|0|||
145459942|NCT02754141|524538738|FG004|Overall Study|Study drug toxicity|0|||
145459943|NCT02754141|524538739|FG005|Overall Study|Study drug toxicity|0|||
145459944|NCT02754141|524538740|FG006|Overall Study|Study drug toxicity|0|||
145459945|NCT02754141|524538741|FG007|Overall Study|Study drug toxicity|0|||
145459946|NCT02754141|524538742|FG008|Overall Study|Study drug toxicity|0|||
145459947|NCT02754141|524538743|FG009|Overall Study|Study drug toxicity|0|||
145626783|NCT04949399|525145791|FG000|Overall Study|Withdrawal by Subject|2|||
145626784|NCT04949399|525145792|FG001|Overall Study|Withdrawal by Subject|3|||
145459948|NCT02754141|524538744|FG010|Overall Study|Study drug toxicity|2|||
145459949|NCT02754141|524538745|FG011|Overall Study|Study drug toxicity|1|||
145459950|NCT02754141|524538746|FG012|Overall Study|Study drug toxicity|1|||
145459951|NCT02754141|524538747|FG013|Overall Study|Study drug toxicity|0|||
145459952|NCT02754141|524538748|FG014|Overall Study|Study drug toxicity|0|||
145459953|NCT02754141|524538749|FG015|Overall Study|Study drug toxicity|0|||
145459954|NCT02754141|524538750|FG016|Overall Study|Study drug toxicity|0|||
145459955|NCT02754141|524538751|FG017|Overall Study|Study drug toxicity|0|||
145459956|NCT02754141|524538734|FG000|Overall Study|AE unrelated to study drug|1|||
145459957|NCT02754141|524538735|FG001|Overall Study|AE unrelated to study drug|1|||
145459958|NCT02754141|524538736|FG002|Overall Study|AE unrelated to study drug|0|||
145459959|NCT02754141|524538737|FG003|Overall Study|AE unrelated to study drug|1|||
145459960|NCT02754141|524538738|FG004|Overall Study|AE unrelated to study drug|3|||
145459961|NCT02754141|524538739|FG005|Overall Study|AE unrelated to study drug|2|||
145459962|NCT02754141|524538740|FG006|Overall Study|AE unrelated to study drug|1|||
145459963|NCT02754141|524538741|FG007|Overall Study|AE unrelated to study drug|0|||
145459964|NCT02754141|524538742|FG008|Overall Study|AE unrelated to study drug|0|||
145459965|NCT02754141|524538743|FG009|Overall Study|AE unrelated to study drug|0|||
145459966|NCT02754141|524538744|FG010|Overall Study|AE unrelated to study drug|0|||
145459967|NCT02754141|524538745|FG011|Overall Study|AE unrelated to study drug|0|||
145459968|NCT02754141|524538746|FG012|Overall Study|AE unrelated to study drug|0|||
145459969|NCT02754141|524538747|FG013|Overall Study|AE unrelated to study drug|0|||
145459970|NCT02754141|524538748|FG014|Overall Study|AE unrelated to study drug|0|||
145459971|NCT02754141|524538749|FG015|Overall Study|AE unrelated to study drug|0|||
145459972|NCT02754141|524538750|FG016|Overall Study|AE unrelated to study drug|0|||
145459973|NCT02754141|524538751|FG017|Overall Study|AE unrelated to study drug|0|||
145459974|NCT02754141|524538734|FG000|Overall Study|Request to discontinue|0|||
145459975|NCT02754141|524538735|FG001|Overall Study|Request to discontinue|0|||
145459976|NCT02754141|524538736|FG002|Overall Study|Request to discontinue|0|||
145459977|NCT02754141|524538737|FG003|Overall Study|Request to discontinue|0|||
145459978|NCT02754141|524538738|FG004|Overall Study|Request to discontinue|0|||
145459979|NCT02754141|524538739|FG005|Overall Study|Request to discontinue|0|||
145459980|NCT02754141|524538740|FG006|Overall Study|Request to discontinue|0|||
145459981|NCT02754141|524538741|FG007|Overall Study|Request to discontinue|0|||
145459982|NCT02754141|524538742|FG008|Overall Study|Request to discontinue|1|||
145459983|NCT02754141|524538743|FG009|Overall Study|Request to discontinue|0|||
145459984|NCT02754141|524538744|FG010|Overall Study|Request to discontinue|0|||
145459985|NCT02754141|524538745|FG011|Overall Study|Request to discontinue|0|||
145459986|NCT02754141|524538746|FG012|Overall Study|Request to discontinue|0|||
145459987|NCT02754141|524538747|FG013|Overall Study|Request to discontinue|1|||
145459988|NCT02754141|524538748|FG014|Overall Study|Request to discontinue|1|||
145459989|NCT02754141|524538749|FG015|Overall Study|Request to discontinue|0|||
145459990|NCT02754141|524538750|FG016|Overall Study|Request to discontinue|0|||
145459991|NCT02754141|524538751|FG017|Overall Study|Request to discontinue|0|||
145459992|NCT02754141|524538734|FG000|Overall Study|Withdrew consent|0|||
145459993|NCT02754141|524538735|FG001|Overall Study|Withdrew consent|0|||
145459994|NCT02754141|524538736|FG002|Overall Study|Withdrew consent|0|||
145459995|NCT02754141|524538737|FG003|Overall Study|Withdrew consent|0|||
145459996|NCT02754141|524538738|FG004|Overall Study|Withdrew consent|0|||
145459997|NCT02754141|524538739|FG005|Overall Study|Withdrew consent|0|||
145459998|NCT02754141|524538740|FG006|Overall Study|Withdrew consent|0|||
145459999|NCT02754141|524538741|FG007|Overall Study|Withdrew consent|0|||
145626785|NCT01474538|525147072|FG000|Treatment Period 1|Death|1|||
145460000|NCT02754141|524538742|FG008|Overall Study|Withdrew consent|0|||
145460001|NCT02754141|524538743|FG009|Overall Study|Withdrew consent|1|||
145460002|NCT02754141|524538744|FG010|Overall Study|Withdrew consent|0|||
145460003|NCT02754141|524538745|FG011|Overall Study|Withdrew consent|0|||
145460004|NCT02754141|524538746|FG012|Overall Study|Withdrew consent|0|||
145460005|NCT02754141|524538747|FG013|Overall Study|Withdrew consent|0|||
145460006|NCT02754141|524538748|FG014|Overall Study|Withdrew consent|0|||
145460007|NCT02754141|524538749|FG015|Overall Study|Withdrew consent|0|||
145460008|NCT02754141|524538750|FG016|Overall Study|Withdrew consent|0|||
145460009|NCT02754141|524538751|FG017|Overall Study|Withdrew consent|0|||
145460010|NCT02754141|524538734|FG000|Overall Study|Maximum clinical benefit|0|||
145460011|NCT02754141|524538735|FG001|Overall Study|Maximum clinical benefit|0|||
145460012|NCT02754141|524538736|FG002|Overall Study|Maximum clinical benefit|0|||
145460013|NCT02754141|524538737|FG003|Overall Study|Maximum clinical benefit|1|||
145460014|NCT02754141|524538738|FG004|Overall Study|Maximum clinical benefit|0|||
145460015|NCT02754141|524538739|FG005|Overall Study|Maximum clinical benefit|0|||
145460016|NCT02754141|524538740|FG006|Overall Study|Maximum clinical benefit|0|||
145460017|NCT02754141|524538741|FG007|Overall Study|Maximum clinical benefit|0|||
145460018|NCT02754141|524538742|FG008|Overall Study|Maximum clinical benefit|0|||
145460019|NCT02754141|524538743|FG009|Overall Study|Maximum clinical benefit|0|||
145460020|NCT02754141|524538744|FG010|Overall Study|Maximum clinical benefit|0|||
145460021|NCT02754141|524538745|FG011|Overall Study|Maximum clinical benefit|0|||
145460022|NCT02754141|524538746|FG012|Overall Study|Maximum clinical benefit|0|||
145460023|NCT02754141|524538747|FG013|Overall Study|Maximum clinical benefit|0|||
145460024|NCT02754141|524538748|FG014|Overall Study|Maximum clinical benefit|0|||
145460025|NCT02754141|524538749|FG015|Overall Study|Maximum clinical benefit|0|||
145460026|NCT02754141|524538750|FG016|Overall Study|Maximum clinical benefit|0|||
145460027|NCT02754141|524538751|FG017|Overall Study|Maximum clinical benefit|0|||
145460028|NCT02754141|524538734|FG000|Overall Study|No longer meets study criteria|0|||
145460029|NCT02754141|524538735|FG001|Overall Study|No longer meets study criteria|0|||
145460030|NCT02754141|524538736|FG002|Overall Study|No longer meets study criteria|0|||
145460031|NCT02754141|524538737|FG003|Overall Study|No longer meets study criteria|1|||
145460032|NCT02754141|524538738|FG004|Overall Study|No longer meets study criteria|0|||
145460033|NCT02754141|524538739|FG005|Overall Study|No longer meets study criteria|0|||
145460034|NCT02754141|524538740|FG006|Overall Study|No longer meets study criteria|0|||
145460035|NCT02754141|524538741|FG007|Overall Study|No longer meets study criteria|0|||
145460036|NCT02754141|524538742|FG008|Overall Study|No longer meets study criteria|0|||
145460037|NCT02754141|524538743|FG009|Overall Study|No longer meets study criteria|0|||
145460038|NCT02754141|524538744|FG010|Overall Study|No longer meets study criteria|0|||
145460039|NCT02754141|524538745|FG011|Overall Study|No longer meets study criteria|0|||
145460040|NCT02754141|524538746|FG012|Overall Study|No longer meets study criteria|0|||
145460041|NCT02754141|524538747|FG013|Overall Study|No longer meets study criteria|0|||
145460042|NCT02754141|524538748|FG014|Overall Study|No longer meets study criteria|0|||
145460043|NCT02754141|524538749|FG015|Overall Study|No longer meets study criteria|0|||
145460044|NCT02754141|524538750|FG016|Overall Study|No longer meets study criteria|0|||
145460045|NCT02754141|524538751|FG017|Overall Study|No longer meets study criteria|0|||
145460046|NCT02754141|524538734|FG000|Overall Study|Other reasons|0|||
145460047|NCT02754141|524538735|FG001|Overall Study|Other reasons|0|||
145460048|NCT02754141|524538736|FG002|Overall Study|Other reasons|0|||
145460049|NCT02754141|524538737|FG003|Overall Study|Other reasons|0|||
145460050|NCT02754141|524538738|FG004|Overall Study|Other reasons|0|||
145460051|NCT02754141|524538739|FG005|Overall Study|Other reasons|0|||
145460052|NCT02754141|524538740|FG006|Overall Study|Other reasons|0|||
145460053|NCT02754141|524538741|FG007|Overall Study|Other reasons|1|||
145460054|NCT02754141|524538742|FG008|Overall Study|Other reasons|0|||
145460055|NCT02754141|524538743|FG009|Overall Study|Other reasons|0|||
145460056|NCT02754141|524538744|FG010|Overall Study|Other reasons|0|||
145460057|NCT02754141|524538745|FG011|Overall Study|Other reasons|0|||
145460058|NCT02754141|524538746|FG012|Overall Study|Other reasons|2|||
145460059|NCT02754141|524538747|FG013|Overall Study|Other reasons|0|||
145460060|NCT02754141|524538748|FG014|Overall Study|Other reasons|0|||
145460061|NCT02754141|524538749|FG015|Overall Study|Other reasons|0|||
145460062|NCT02754141|524538750|FG016|Overall Study|Other reasons|0|||
145460063|NCT02754141|524538751|FG017|Overall Study|Other reasons|0|||
145460064|NCT02754141|524538734|FG000|Overall Study|Completed treatment as per protocol|0|||
145460065|NCT02754141|524538735|FG001|Overall Study|Completed treatment as per protocol|1|||
145460066|NCT02754141|524538736|FG002|Overall Study|Completed treatment as per protocol|0|||
145460067|NCT02754141|524538737|FG003|Overall Study|Completed treatment as per protocol|0|||
145460068|NCT02754141|524538738|FG004|Overall Study|Completed treatment as per protocol|0|||
145460069|NCT02754141|524538739|FG005|Overall Study|Completed treatment as per protocol|0|||
145460070|NCT02754141|524538740|FG006|Overall Study|Completed treatment as per protocol|0|||
145460071|NCT02754141|524538741|FG007|Overall Study|Completed treatment as per protocol|0|||
145460072|NCT02754141|524538742|FG008|Overall Study|Completed treatment as per protocol|0|||
145460073|NCT02754141|524538743|FG009|Overall Study|Completed treatment as per protocol|0|||
145460074|NCT02754141|524538744|FG010|Overall Study|Completed treatment as per protocol|0|||
145460075|NCT02754141|524538745|FG011|Overall Study|Completed treatment as per protocol|0|||
145460076|NCT02754141|524538746|FG012|Overall Study|Completed treatment as per protocol|1|||
145460077|NCT02754141|524538747|FG013|Overall Study|Completed treatment as per protocol|0|||
145460078|NCT02754141|524538748|FG014|Overall Study|Completed treatment as per protocol|0|||
145593455|NCT02085408|525024302|FG001|Step 3: Maintenance|Adverse Event|4|||
145460079|NCT02754141|524538749|FG015|Overall Study|Completed treatment as per protocol|0|||
145460080|NCT02754141|524538750|FG016|Overall Study|Completed treatment as per protocol|0|||
145460081|NCT02754141|524538751|FG017|Overall Study|Completed treatment as per protocol|0|||
145460082|NCT02754141|524538734|FG000|Overall Study|Not completing monotherapy|0|||
145460083|NCT02754141|524538735|FG001|Overall Study|Not completing monotherapy|0|||
145460084|NCT02754141|524538736|FG002|Overall Study|Not completing monotherapy|0|||
145460085|NCT02754141|524538737|FG003|Overall Study|Not completing monotherapy|0|||
145460086|NCT02754141|524538738|FG004|Overall Study|Not completing monotherapy|0|||
145460087|NCT02754141|524538739|FG005|Overall Study|Not completing monotherapy|0|||
145460088|NCT02754141|524538740|FG006|Overall Study|Not completing monotherapy|0|||
145460089|NCT02754141|524538741|FG007|Overall Study|Not completing monotherapy|0|||
145460090|NCT02754141|524538742|FG008|Overall Study|Not completing monotherapy|0|||
145460091|NCT02754141|524538743|FG009|Overall Study|Not completing monotherapy|0|||
145460092|NCT02754141|524538744|FG010|Overall Study|Not completing monotherapy|0|||
145593456|NCT02085408|525024301|FG000|Step 3: Maintenance|Death|1|||
145593457|NCT02085408|525024302|FG001|Step 3: Maintenance|Death|2|||
145593458|NCT02085408|525024301|FG000|Step 3: Maintenance|Alternative Therapy|1|||
145593459|NCT02085408|525024302|FG001|Step 3: Maintenance|Alternative Therapy|1|||
145593460|NCT02085408|525024301|FG000|Step 3: Maintenance|Complicating Disease|0|||
145593461|NCT02085408|525024302|FG001|Step 3: Maintenance|Complicating Disease|1|||
145593462|NCT02085408|525024301|FG000|Step 3: Maintenance|Other|3|||
145593463|NCT02085408|525024302|FG001|Step 3: Maintenance|Other|2|||
145593464|NCT02085408|525024301|FG000|Step 3: Maintenance|Never started treatment|5|||
145593465|NCT02085408|525024302|FG001|Step 3: Maintenance|Never started treatment|1|||
145593466|NCT02189798|525024303|FG000|Extended Use Phase|Withdrawal by Subject|0|||
145593467|NCT02189798|525024304|FG001|Extended Use Phase|Withdrawal by Subject|4|||
145593468|NCT02189798|525024303|FG000|Extended Use Phase|Physician Decision|1|||
145593469|NCT02189798|525024304|FG001|Extended Use Phase|Physician Decision|0|||
145593470|NCT02189798|525024303|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
145593471|NCT02189798|525024304|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
145593472|NCT02189798|525024303|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
145593473|NCT02189798|525024304|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
145593474|NCT02189798|525024303|FG000|Extended Use Phase|Travel Issues|2|||
145593475|NCT02189798|525024304|FG001|Extended Use Phase|Travel Issues|1|||
145593476|NCT02189798|525024303|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
145593477|NCT02189798|525024304|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
145593478|NCT05553808|525024307|FG000|Overall Study|Death|25|||
145593479|NCT05553808|525024308|FG001|Overall Study|Death|62|||
145593480|NCT05553808|525024307|FG000|Overall Study|Site Closed|6|||
145593481|NCT05553808|525024308|FG001|Overall Study|Site Closed|6|||
145593482|NCT05553808|525024307|FG000|Overall Study|Lost to Follow-up|1|||
145593483|NCT05553808|525024308|FG001|Overall Study|Lost to Follow-up|0|||
145593484|NCT05553808|525024307|FG000|Overall Study|Withdrawal by Subject|3|||
145593485|NCT05553808|525024308|FG001|Overall Study|Withdrawal by Subject|2|||
145593486|NCT02273141|525024309|FG000|Overall Study|Adverse Event|0|||
145593487|NCT02273141|525024310|FG001|Overall Study|Adverse Event|1|||
145593488|NCT02273141|525024309|FG000|Overall Study|Lost to Follow-up|1|||
145593489|NCT02273141|525024310|FG001|Overall Study|Lost to Follow-up|3|||
145593490|NCT02273141|525024309|FG000|Overall Study|Withdrawal by Subject|10|||
145593491|NCT02273141|525024310|FG001|Overall Study|Withdrawal by Subject|15|||
145593492|NCT02273141|525024309|FG000|Overall Study|Various|6|||
145593493|NCT02273141|525024310|FG001|Overall Study|Various|6|||
145593494|NCT00529399|525024311|FG000|Overall Study|Lost to Follow-up|1|||
145593495|NCT00529399|525024312|FG001|Overall Study|Lost to Follow-up|0|||
145593496|NCT00529399|525024313|FG002|Overall Study|Lost to Follow-up|1|||
145593497|NCT00529399|525024311|FG000|Overall Study|Withdrawal by Subject|1|||
145593498|NCT00529399|525024312|FG001|Overall Study|Withdrawal by Subject|0|||
145593499|NCT00529399|525024313|FG002|Overall Study|Withdrawal by Subject|1|||
145593500|NCT00529399|525024311|FG000|Overall Study|Non-compliant|0|||
145593501|NCT00529399|525024312|FG001|Overall Study|Non-compliant|1|||
145593502|NCT00529399|525024313|FG002|Overall Study|Non-compliant|0|||
145593503|NCT03206203|525024330|FG000|Treatment|Death|38|||
145593504|NCT03206203|525024331|FG001|Treatment|Death|26|||
145593505|NCT03206203|525024332|FG002|Treatment|Death|0|||
145460093|NCT02754141|524538745|FG011|Overall Study|Not completing monotherapy|0|||
145460094|NCT02754141|524538746|FG012|Overall Study|Not completing monotherapy|0|||
145593506|NCT03206203|525024330|FG000|Treatment|Withdrawal by Subject|1|||
145593507|NCT03206203|525024331|FG001|Treatment|Withdrawal by Subject|0|||
145593508|NCT03206203|525024332|FG002|Treatment|Withdrawal by Subject|0|||
145460095|NCT02754141|524538747|FG013|Overall Study|Not completing monotherapy|1|||
145460096|NCT02754141|524538748|FG014|Overall Study|Not completing monotherapy|0|||
145460097|NCT02754141|524538749|FG015|Overall Study|Not completing monotherapy|0|||
145593509|NCT03206203|525024330|FG000|Treatment|Lost to Follow-up|4|||
145593510|NCT03206203|525024331|FG001|Treatment|Lost to Follow-up|0|||
145593511|NCT03206203|525024332|FG002|Treatment|Lost to Follow-up|0|||
145593512|NCT03206203|525024330|FG000|Treatment|N/A in Follow-Up|8|||
145593513|NCT03206203|525024331|FG001|Treatment|N/A in Follow-Up|1|||
145593514|NCT03206203|525024332|FG002|Treatment|N/A in Follow-Up|0|||
145593515|NCT03206203|525024330|FG000|Treatment|Disease progression|0|||
145626786|NCT01474538|525147073|FG001|Treatment Period 1|Death|0|||
145626787|NCT01474538|525147072|FG000|Treatment Period 1|Physician Decision|1|||
145626788|NCT01474538|525147073|FG001|Treatment Period 1|Physician Decision|0|||
145626789|NCT01474538|525147072|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145460098|NCT02754141|524538750|FG016|Overall Study|Not completing monotherapy|0|||
145460099|NCT02754141|524538751|FG017|Overall Study|Not completing monotherapy|0|||
145460100|NCT03640052|524538760|FG000|Overall Study|Lost to Follow-up|0|||
145460101|NCT03640052|524538761|FG001|Overall Study|Lost to Follow-up|1|||
145460102|NCT03640052|524538762|FG002|Overall Study|Lost to Follow-up|0|||
145460103|NCT03640052|524538763|FG003|Overall Study|Lost to Follow-up|0|||
145460104|NCT03640052|524538764|FG004|Overall Study|Lost to Follow-up|0|||
145460105|NCT00623545|524538765|FG000|Overall Study|Adverse Event|6|||
145460106|NCT00623545|524538765|FG000|Overall Study|Withdrawal by Subject|4|||
145460107|NCT04239222|524538766|FG000|Baseline|Withdrawal by Subject|0|||
145460108|NCT04239222|524538767|FG001|Baseline|Withdrawal by Subject|0|||
145460109|NCT04239222|524538768|FG002|Baseline|Withdrawal by Subject|1|||
145460110|NCT04239222|524538769|FG003|Baseline|Withdrawal by Subject|1|||
145460111|NCT04239222|524538766|FG000|First Foot Assignment|Withdrawal by Subject|0|||
145460112|NCT04239222|524538767|FG001|First Foot Assignment|Withdrawal by Subject|0|||
145460113|NCT04239222|524538768|FG002|First Foot Assignment|Withdrawal by Subject|1|||
145460114|NCT04239222|524538769|FG003|First Foot Assignment|Withdrawal by Subject|0|||
145460115|NCT04239222|524538766|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
145460116|NCT04239222|524538767|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
145460117|NCT04239222|524538768|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
145460118|NCT04239222|524538769|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
145460119|NCT00937404|524538775|FG000|Overall Study|Protocol Violation|1|||
145460120|NCT00937404|524538775|FG000|Overall Study|Withdrawal by Subject|1|||
145460121|NCT00230282|524538780|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
145460122|NCT00230282|524538780|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
145460123|NCT00230282|524538780|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
145460124|NCT00230282|524538780|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
145460125|NCT00445848|524538783|FG000|Overall Study|Adverse Event|14|||
145460126|NCT00445848|524538783|FG000|Overall Study|Withdrawal by Subject|4|||
145460127|NCT00445848|524538783|FG000|Overall Study|Progression|62|||
145460128|NCT00445848|524538783|FG000|Overall Study|Other-Not protocol specified|5|||
145460129|NCT00027378|524538786|FG000|Overall Study|Physician Decision|0|||
145460130|NCT00027378|524538787|FG001|Overall Study|Physician Decision|3|||
145460131|NCT02701777|524538791|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
145460132|NCT02701777|524538792|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
145460133|NCT02701777|524538793|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
145460134|NCT02701777|524538794|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
145460135|NCT02701777|524538791|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
145460136|NCT02701777|524538792|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
145460137|NCT02701777|524538793|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
145460138|NCT02701777|524538794|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
145460139|NCT03199053|524538797|FG000|ST Period|Withdrawal by Subject|2|||
145460140|NCT03199053|524538798|FG001|ST Period|Withdrawal by Subject|4|||
145460141|NCT03199053|524538799|FG002|ST Period|Withdrawal by Subject|6|||
145460142|NCT03199053|524538797|FG000|ST Period|Withdrawal by parent/guardian|1|||
145460143|NCT03199053|524538798|FG001|ST Period|Withdrawal by parent/guardian|1|||
145460144|NCT03199053|524538799|FG002|ST Period|Withdrawal by parent/guardian|1|||
145460145|NCT03199053|524538797|FG000|ST Period|Lost to Follow-up|2|||
145460146|NCT03199053|524538798|FG001|ST Period|Lost to Follow-up|0|||
145460147|NCT03199053|524538799|FG002|ST Period|Lost to Follow-up|1|||
145460148|NCT03199053|524538797|FG000|LT Period|Withdrawal by Subject|1|||
145460149|NCT03199053|524538798|FG001|LT Period|Withdrawal by Subject|3|||
145460150|NCT03199053|524538799|FG002|LT Period|Withdrawal by Subject|3|||
145460151|NCT03199053|524538797|FG000|LT Period|Withdrawal by parent/guardian|0|||
145460152|NCT03199053|524538798|FG001|LT Period|Withdrawal by parent/guardian|0|||
145626790|NCT01474538|525147073|FG001|Treatment Period 1|Withdrawal by Subject|3|||
145460153|NCT03199053|524538799|FG002|LT Period|Withdrawal by parent/guardian|1|||
145460154|NCT03199053|524538797|FG000|LT Period|Lost to Follow-up|0|||
145460155|NCT03199053|524538798|FG001|LT Period|Lost to Follow-up|1|||
145460156|NCT03199053|524538799|FG002|LT Period|Lost to Follow-up|1|||
145460157|NCT03199053|524538797|FG000|LT Period|Miscellaneous|0|||
145460158|NCT03199053|524538798|FG001|LT Period|Miscellaneous|0|||
145460159|NCT03199053|524538799|FG002|LT Period|Miscellaneous|2|||
145460160|NCT03199053|524538797|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
145460161|NCT03199053|524538798|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
145460162|NCT03199053|524538799|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
145460163|NCT03199053|524538797|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
145460164|NCT03199053|524538798|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
145626791|NCT01474538|525147072|FG000|Treatment Period 1|Protocol Violation|0|||
145626792|NCT01474538|525147073|FG001|Treatment Period 1|Protocol Violation|1|||
145593516|NCT03206203|525024331|FG001|Treatment|Disease progression|1|||
145593517|NCT03206203|525024332|FG002|Treatment|Disease progression|0|||
145593518|NCT03206203|525024330|FG000|Treatment|Refused follow-up|0|||
145593519|NCT03206203|525024331|FG001|Treatment|Refused follow-up|1|||
145593520|NCT03206203|525024332|FG002|Treatment|Refused follow-up|0|||
145593521|NCT03206203|525024330|FG000|Treatment|Cross over to Arm 1|0|||
145593522|NCT03206203|525024331|FG001|Treatment|Cross over to Arm 1|19|||
145593523|NCT03206203|525024332|FG002|Treatment|Cross over to Arm 1|0|||
145593524|NCT03206203|525024330|FG000|Optional Cross-Over|Death|0|||
145593525|NCT03206203|525024331|FG001|Optional Cross-Over|Death|0|||
145593526|NCT03206203|525024332|FG002|Optional Cross-Over|Death|14|||
145593527|NCT03206203|525024330|FG000|Optional Cross-Over|Refused follow-up|0|||
145593528|NCT03206203|525024331|FG001|Optional Cross-Over|Refused follow-up|0|||
145593529|NCT03206203|525024332|FG002|Optional Cross-Over|Refused follow-up|2|||
145593530|NCT03998618|525024333|FG000|Overall Study|Death|7|||
145593531|NCT03998618|525024334|FG001|Overall Study|Death|11|||
145593532|NCT03998618|525024333|FG000|Overall Study|hospice enrollment|3|||
145593533|NCT03998618|525024334|FG001|Overall Study|hospice enrollment|3|||
145593534|NCT03998618|525024333|FG000|Overall Study|Not feeling well/health problems|3|||
145593535|NCT03998618|525024334|FG001|Overall Study|Not feeling well/health problems|5|||
145593536|NCT03998618|525024333|FG000|Overall Study|Lost to Follow-up|6|||
145593537|NCT03998618|525024334|FG001|Overall Study|Lost to Follow-up|6|||
145593538|NCT03998618|525024333|FG000|Overall Study|Withdrawal by Subject|0|||
145593539|NCT03998618|525024334|FG001|Overall Study|Withdrawal by Subject|4|||
145593540|NCT01483924|525024335|FG000|Overall Study|Withdrawal by Subject|2|||
145593541|NCT01483924|525024336|FG001|Overall Study|Withdrawal by Subject|0|||
145593542|NCT01483924|525024337|FG002|Overall Study|Withdrawal by Subject|0|||
145593543|NCT01483924|525024338|FG003|Overall Study|Withdrawal by Subject|1|||
145593544|NCT01483924|525024339|FG004|Overall Study|Withdrawal by Subject|1|||
145593545|NCT01483924|525024335|FG000|Overall Study|Adverse Event|0|||
145593546|NCT01483924|525024336|FG001|Overall Study|Adverse Event|0|||
145593547|NCT01483924|525024337|FG002|Overall Study|Adverse Event|1|||
145593548|NCT01483924|525024338|FG003|Overall Study|Adverse Event|1|||
145593549|NCT01483924|525024339|FG004|Overall Study|Adverse Event|0|||
145593550|NCT01483924|525024335|FG000|Overall Study|Non-compliance|0|||
145593551|NCT01483924|525024336|FG001|Overall Study|Non-compliance|0|||
145593552|NCT01483924|525024337|FG002|Overall Study|Non-compliance|0|||
145593553|NCT01483924|525024338|FG003|Overall Study|Non-compliance|1|||
145593554|NCT01483924|525024339|FG004|Overall Study|Non-compliance|1|||
145593555|NCT01483924|525024335|FG000|Overall Study|Sponsor concern over ECG result|0|||
145593556|NCT01483924|525024336|FG001|Overall Study|Sponsor concern over ECG result|0|||
145593557|NCT01483924|525024337|FG002|Overall Study|Sponsor concern over ECG result|0|||
145593558|NCT01483924|525024338|FG003|Overall Study|Sponsor concern over ECG result|1|||
145593559|NCT01483924|525024339|FG004|Overall Study|Sponsor concern over ECG result|0|||
145593560|NCT00003298|525024340|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
145593561|NCT00003298|525024340|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
145593562|NCT00003298|525024340|FG000|Surgery|Unresectable at surgery|3|||
145593563|NCT00003298|525024340|FG000|Surgery|Progression before surgery|2|||
145593564|NCT00003298|525024340|FG000|Surgery|Unevaluable and off study|2|||
145593565|NCT00003298|525024340|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
145593566|NCT00003298|525024340|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
145593567|NCT00003298|525024340|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
145593568|NCT00003298|525024340|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
145593569|NCT00003298|525024340|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
145593570|NCT00003298|525024340|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
145593571|NCT00003298|525024340|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
145593572|NCT00003298|525024340|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
145593573|NCT00003298|525024340|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
145593574|NCT00003298|525024340|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
145593575|NCT00335322|525024342|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
145593576|NCT00335322|525024343|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
145593577|NCT00335322|525024344|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
145593578|NCT00584727|525024347|FG000|First Intervention|Discontinuation|0|||
145593579|NCT00584727|525024348|FG001|First Intervention|Discontinuation|0|||
145626793|NCT01474538|525147072|FG000|Treatment Period 2|Death|1|||
145626794|NCT01474538|525147073|FG001|Treatment Period 2|Death|0|||
145626795|NCT01474538|525147072|FG000|Treatment Period 2|Adverse Event|1|||
145593580|NCT00584727|525024349|FG002|First Intervention|Discontinuation|1|||
145593581|NCT00584727|525024350|FG003|First Intervention|Discontinuation|0|||
145593582|NCT00584727|525024351|FG004|First Intervention|Discontinuation|0|||
145593583|NCT00584727|525024352|FG005|First Intervention|Discontinuation|0|||
145593584|NCT00584727|525024347|FG000|Third Intervention|Protocol Violation|0|||
145593585|NCT00584727|525024348|FG001|Third Intervention|Protocol Violation|0|||
145593586|NCT00584727|525024349|FG002|Third Intervention|Protocol Violation|1|||
145593587|NCT00584727|525024350|FG003|Third Intervention|Protocol Violation|0|||
145593588|NCT00584727|525024351|FG004|Third Intervention|Protocol Violation|4|||
145593589|NCT00584727|525024352|FG005|Third Intervention|Protocol Violation|2|||
145593590|NCT00729833|525024355|FG000|Overall Study|Death|5|||
145593591|NCT00729833|525024356|FG001|Overall Study|Death|1|||
145593592|NCT00729833|525024357|FG002|Overall Study|Death|3|||
145593593|NCT00729833|525024358|FG003|Overall Study|Death|5|||
145593594|NCT00729833|525024355|FG000|Overall Study|Study Terminated by Sponsor|0|||
145593595|NCT00729833|525024356|FG001|Overall Study|Study Terminated by Sponsor|0|||
145593596|NCT00729833|525024357|FG002|Overall Study|Study Terminated by Sponsor|1|||
145593597|NCT00729833|525024358|FG003|Overall Study|Study Terminated by Sponsor|0|||
145593598|NCT00729833|525024355|FG000|Overall Study|Lost to Follow-up|1|||
145593599|NCT00729833|525024356|FG001|Overall Study|Lost to Follow-up|0|||
145593600|NCT00729833|525024357|FG002|Overall Study|Lost to Follow-up|0|||
145593601|NCT00729833|525024358|FG003|Overall Study|Lost to Follow-up|0|||
145593602|NCT00729833|525024355|FG000|Overall Study|Withdrawal by Subject|3|||
145593603|NCT00729833|525024356|FG001|Overall Study|Withdrawal by Subject|1|||
145593604|NCT00729833|525024357|FG002|Overall Study|Withdrawal by Subject|3|||
145593605|NCT00729833|525024358|FG003|Overall Study|Withdrawal by Subject|0|||
145593606|NCT00729833|525024355|FG000|Overall Study|Unspecified Reasons|11|||
145593607|NCT00729833|525024356|FG001|Overall Study|Unspecified Reasons|5|||
145593608|NCT00729833|525024357|FG002|Overall Study|Unspecified Reasons|5|||
145593609|NCT00729833|525024358|FG003|Overall Study|Unspecified Reasons|1|||
145593610|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
145593611|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
145593612|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
145593613|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
145593614|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
145593615|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
145593616|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
145593617|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
145593618|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
145593619|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
145593620|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
145593621|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
145593622|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
145593623|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
145593624|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
145593625|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145593626|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145593627|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
145593628|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145593629|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
145593630|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
145593631|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
145593632|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
145593633|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
145593634|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
145593635|NCT03152552|525024359|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
145593636|NCT03152552|525024360|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
145593637|NCT03152552|525024361|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
145593638|NCT03152552|525024362|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
145593639|NCT03152552|525024363|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
145593640|NCT03152552|525024359|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
145593641|NCT03152552|525024360|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
145593642|NCT03152552|525024361|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
145593643|NCT03152552|525024362|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
145593644|NCT03152552|525024363|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
145593645|NCT01300546|525024366|FG000|Overall Study|Withdrawal by Subject|1|||
145593646|NCT01300546|525024367|FG001|Overall Study|Withdrawal by Subject|0|||
145593647|NCT01300546|525024366|FG000|Overall Study|Lost to Follow-up|0|||
145593648|NCT01300546|525024367|FG001|Overall Study|Lost to Follow-up|2|||
145593649|NCT01300546|525024366|FG000|Overall Study|Lack of Efficacy|0|||
145593650|NCT01300546|525024367|FG001|Overall Study|Lack of Efficacy|3|||
145593651|NCT01300546|525024366|FG000|Overall Study|Adverse Event|0|||
145593652|NCT01300546|525024367|FG001|Overall Study|Adverse Event|1|||
145593653|NCT00234065|525024375|FG000|Overall Study|Adverse Event|268|||
145593654|NCT00234065|525024376|FG001|Overall Study|Adverse Event|166|||
145593655|NCT00234065|525024375|FG000|Overall Study|Withdrawal by Subject|73|||
145593656|NCT00234065|525024376|FG001|Overall Study|Withdrawal by Subject|56|||
145593657|NCT00234065|525024375|FG000|Overall Study|Physician Decision|23|||
145593658|NCT00234065|525024376|FG001|Overall Study|Physician Decision|22|||
145626796|NCT01474538|525147073|FG001|Treatment Period 2|Adverse Event|1|||
145593659|NCT00234065|525024375|FG000|Overall Study|Not Classified|111|||
145593660|NCT00234065|525024376|FG001|Overall Study|Not Classified|112|||
145593661|NCT05245864|525024383|FG000|Overall Study|Withdrawal by Subject|1|||
145593662|NCT05245864|525024384|FG001|Overall Study|Withdrawal by Subject|1|||
145593663|NCT01986881|525026376|FG000|Overall Study|Death|228|||
145593664|NCT01986881|525026377|FG001|Overall Study|Death|233|||
145593665|NCT01986881|525026378|FG002|Overall Study|Death|247|||
145593666|NCT01986881|525026376|FG000|Overall Study|Lost to Follow-up|51|||
145593667|NCT01986881|525026377|FG001|Overall Study|Lost to Follow-up|44|||
145593668|NCT01986881|525026378|FG002|Overall Study|Lost to Follow-up|55|||
145593669|NCT01986881|525026376|FG000|Overall Study|Physician Decision|7|||
145593670|NCT01986881|525026377|FG001|Overall Study|Physician Decision|4|||
145593671|NCT01986881|525026378|FG002|Overall Study|Physician Decision|6|||
145593672|NCT01986881|525026376|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
145593673|NCT01986881|525026377|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
145593674|NCT01986881|525026378|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
145593675|NCT01986881|525026376|FG000|Overall Study|Withdrawal by Subject|41|||
145593676|NCT01986881|525026377|FG001|Overall Study|Withdrawal by Subject|60|||
145593677|NCT01986881|525026378|FG002|Overall Study|Withdrawal by Subject|45|||
145593678|NCT01986881|525026376|FG000|Overall Study|Subject Moved|0|||
145593679|NCT01986881|525026377|FG001|Overall Study|Subject Moved|1|||
145593680|NCT01986881|525026378|FG002|Overall Study|Subject Moved|0|||
145593681|NCT01986881|525026376|FG000|Overall Study|Other|1|||
145593682|NCT01986881|525026377|FG001|Overall Study|Other|2|||
145593683|NCT01986881|525026378|FG002|Overall Study|Other|2|||
145593684|NCT04205630|525026379|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
145593685|NCT04205630|525026379|FG000|Overall Study|Disease clinical progression|7|||
145593686|NCT04205630|525026379|FG000|Overall Study|Withdrawal by Subject|2|||
145593687|NCT04205630|525026379|FG000|Overall Study|Adverse Event|17|||
145593688|NCT04205630|525026379|FG000|Overall Study|Other|1|||
145593689|NCT00886340|525026380|FG000|Overall Study|Withdrawal by Subject|0|||
145593690|NCT00886340|525026381|FG001|Overall Study|Withdrawal by Subject|7|||
145593691|NCT03224182|525026382|FG000|Overall Study|Study Drug Not Instilled|6|||
145593692|NCT03224182|525026383|FG001|Overall Study|Study Drug Not Instilled|1|||
145593693|NCT03224182|525026382|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
145593694|NCT03224182|525026383|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
145593695|NCT03224182|525026382|FG000|Overall Study|Withdrew of Consent|4|||
145593696|NCT03224182|525026383|FG001|Overall Study|Withdrew of Consent|2|||
145593697|NCT03224182|525026382|FG000|Overall Study|Investigator Decision|3|||
145593698|NCT03224182|525026383|FG001|Overall Study|Investigator Decision|1|||
145593699|NCT03224182|525026382|FG000|Overall Study|Sponsor Decision|26|||
145593700|NCT03224182|525026383|FG001|Overall Study|Sponsor Decision|12|||
145593701|NCT03224182|525026382|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
145593702|NCT03224182|525026383|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
145593703|NCT03224182|525026382|FG000|Overall Study|Lost to Follow-up|1|||
145593704|NCT03224182|525026383|FG001|Overall Study|Lost to Follow-up|0|||
145593705|NCT03224182|525026382|FG000|Overall Study|Participant Had Recurrence|11|||
145593706|NCT03224182|525026383|FG001|Overall Study|Participant Had Recurrence|5|||
145593707|NCT03224182|525026382|FG000|Overall Study|Death|0|||
145593708|NCT03224182|525026383|FG001|Overall Study|Death|1|||
145593709|NCT03224182|525026382|FG000|Overall Study|Reason not Specified|3|||
145593710|NCT03224182|525026383|FG001|Overall Study|Reason not Specified|3|||
145593711|NCT03224182|525026382|FG000|Overall Study|Other|1|||
145593712|NCT03224182|525026383|FG001|Overall Study|Other|0|||
145593713|NCT02481310|525026384|FG000|Follow up|Still in follow up|0|||
145593714|NCT02481310|525026385|FG001|Follow up|Still in follow up|3|||
145593715|NCT02481310|525026386|FG002|Follow up|Still in follow up|0|||
145593716|NCT01549613|525026401|FG000|Overall Study|Lost to Follow-up|11|||
145593717|NCT01549613|525026402|FG001|Overall Study|Lost to Follow-up|11|||
145593718|NCT02216123|525026403|FG000|Overall Study|Lost to Follow-up|4|||
145593719|NCT02216123|525026404|FG001|Overall Study|Lost to Follow-up|2|||
145593720|NCT02216123|525026403|FG000|Overall Study|Withdrawal by Subject|2|||
145593721|NCT02216123|525026404|FG001|Overall Study|Withdrawal by Subject|0|||
145593722|NCT02131272|525026405|FG000|Overall Study|Withdrawal by parent|0|||
145593723|NCT02131272|525026406|FG001|Overall Study|Withdrawal by parent|1|||
145593724|NCT02131272|525026405|FG000|Overall Study|Withdrawal by Subject|0|||
145593725|NCT02131272|525026406|FG001|Overall Study|Withdrawal by Subject|1|||
145593726|NCT02131272|525026405|FG000|Overall Study|Withdrawal Criteria|1|||
145593727|NCT02131272|525026406|FG001|Overall Study|Withdrawal Criteria|0|||
145593728|NCT00381940|525026407|FG000|Overall Study|Lack of Efficacy|3|||
145593729|NCT00381940|525026407|FG000|Overall Study|Protocol Violation|1|||
145593730|NCT00381940|525026407|FG000|Overall Study|Ineligible|1|||
145593731|NCT03162224|525026408|FG000|Overall Study|Death|4|||
145593732|NCT03162224|525026409|FG001|Overall Study|Death|5|||
145593733|NCT03162224|525026410|FG002|Overall Study|Death|8|||
145593734|NCT03162224|525026408|FG000|Overall Study|Withdrawal by Subject|1|||
145626797|NCT01474538|525147072|FG000|Treatment Period 2|Withdrawal by Subject|2|||
145593735|NCT03162224|525026409|FG001|Overall Study|Withdrawal by Subject|0|||
145626798|NCT01474538|525147073|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145593736|NCT03162224|525026410|FG002|Overall Study|Withdrawal by Subject|1|||
145593737|NCT03162224|525026408|FG000|Overall Study|Lost to Follow-up|0|||
145593738|NCT03162224|525026409|FG001|Overall Study|Lost to Follow-up|1|||
145593739|NCT03162224|525026410|FG002|Overall Study|Lost to Follow-up|0|||
145593740|NCT03162224|525026408|FG000|Overall Study|Other|6|||
145593741|NCT03162224|525026409|FG001|Overall Study|Other|2|||
145593742|NCT03162224|525026410|FG002|Overall Study|Other|1|||
145593743|NCT05159622|525026411|FG000|Overall Study|Lost to Follow-up|4|||
145593744|NCT05159622|525026412|FG001|Overall Study|Lost to Follow-up|5|||
145593745|NCT00725452|525026413|FG000|Overall Study|Adverse Event|3|||
145593746|NCT00725452|525026413|FG000|Overall Study|Lack of Efficacy|2|||
145593747|NCT00725452|525026413|FG000|Overall Study|Reason not specified|1|||
145593748|NCT00725452|525026413|FG000|Overall Study|Physician Decision|1|||
145593749|NCT00725452|525026413|FG000|Overall Study|Withdrawal by Subject|3|||
145593750|NCT00725452|525026413|FG000|Overall Study|Lost to Follow-up|1|||
145593751|NCT02163733|525026415|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
145593752|NCT02163733|525026416|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
145593753|NCT02163733|525026417|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
145593754|NCT02163733|525026415|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
145593755|NCT02163733|525026416|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
145593756|NCT02163733|525026417|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
145593757|NCT02723864|525026418|FG000|Overall Study|Refused further treatment|1|||
145593758|NCT02723864|525026419|FG001|Overall Study|Refused further treatment|0|||
145593759|NCT02723864|525026420|FG002|Overall Study|Refused further treatment|0|||
145593760|NCT02723864|525026421|FG003|Overall Study|Refused further treatment|0|||
145593761|NCT02723864|525026422|FG004|Overall Study|Refused further treatment|1|||
145593762|NCT02723864|525026423|FG005|Overall Study|Refused further treatment|2|||
145593763|NCT02723864|525026424|FG006|Overall Study|Refused further treatment|0|||
145593764|NCT02723864|525026418|FG000|Overall Study|Exceed treatment hold time|0|||
145593765|NCT02723864|525026419|FG001|Overall Study|Exceed treatment hold time|1|||
145593766|NCT02723864|525026420|FG002|Overall Study|Exceed treatment hold time|0|||
145593767|NCT02723864|525026421|FG003|Overall Study|Exceed treatment hold time|0|||
145593768|NCT02723864|525026422|FG004|Overall Study|Exceed treatment hold time|0|||
145460165|NCT03199053|524538799|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
145460166|NCT03199053|524538797|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
145460167|NCT03199053|524538798|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
145460168|NCT03199053|524538799|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
145460169|NCT03199053|524538797|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
145460170|NCT03199053|524538798|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
145460171|NCT03199053|524538799|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
145460172|NCT03298984|524538800|FG000|Overall Study|Physician Decision|1|||
145460173|NCT03298984|524538801|FG001|Overall Study|Physician Decision|0|||
145460174|NCT03298984|524538802|FG002|Overall Study|Physician Decision|0|||
145460175|NCT03298984|524538803|FG003|Overall Study|Physician Decision|6|||
145460176|NCT03298984|524538800|FG000|Overall Study|Lack of Efficacy|0|||
145460177|NCT03298984|524538801|FG001|Overall Study|Lack of Efficacy|1|||
145460178|NCT03298984|524538802|FG002|Overall Study|Lack of Efficacy|1|||
145460179|NCT03298984|524538803|FG003|Overall Study|Lack of Efficacy|4|||
145460180|NCT03298984|524538800|FG000|Overall Study|Relapsed disease (following remission)|0|||
145460181|NCT03298984|524538801|FG001|Overall Study|Relapsed disease (following remission)|0|||
145460182|NCT03298984|524538802|FG002|Overall Study|Relapsed disease (following remission)|1|||
145460183|NCT03298984|524538803|FG003|Overall Study|Relapsed disease (following remission)|1|||
145460184|NCT03298984|524538800|FG000|Overall Study|Adverse Event|0|||
145460185|NCT03298984|524538801|FG001|Overall Study|Adverse Event|0|||
145460186|NCT03298984|524538802|FG002|Overall Study|Adverse Event|0|||
145460187|NCT03298984|524538803|FG003|Overall Study|Adverse Event|1|||
145460188|NCT03298984|524538800|FG000|Overall Study|Death|0|||
145460189|NCT03298984|524538801|FG001|Overall Study|Death|0|||
145460190|NCT03298984|524538802|FG002|Overall Study|Death|0|||
145460191|NCT03298984|524538803|FG003|Overall Study|Death|2|||
145460192|NCT03298984|524538800|FG000|Overall Study|Insurance Company Decision|0|||
145460193|NCT03298984|524538801|FG001|Overall Study|Insurance Company Decision|0|||
145460194|NCT03298984|524538802|FG002|Overall Study|Insurance Company Decision|0|||
145460195|NCT03298984|524538803|FG003|Overall Study|Insurance Company Decision|1|||
145460196|NCT02403635|524538804|FG000|Overall Study|Not eligible|9|||
145460197|NCT02585830|524538810|FG000|Overall Study|Withdrawal by Subject|3|||
145593769|NCT02723864|525026423|FG005|Overall Study|Exceed treatment hold time|0|||
145593770|NCT02723864|525026424|FG006|Overall Study|Exceed treatment hold time|0|||
145460198|NCT02509052|524538811|FG000|Overall Study|Non compliance|0|||
145460199|NCT02509052|524538812|FG001|Overall Study|Non compliance|0|||
145460200|NCT02509052|524538813|FG002|Overall Study|Non compliance|1|||
145593771|NCT02723864|525026418|FG000|Overall Study|Clinical progression|0|||
145593772|NCT02723864|525026419|FG001|Overall Study|Clinical progression|0|||
145593773|NCT02723864|525026420|FG002|Overall Study|Clinical progression|1|||
145593774|NCT02723864|525026421|FG003|Overall Study|Clinical progression|0|||
145593775|NCT02723864|525026422|FG004|Overall Study|Clinical progression|0|||
145460201|NCT00585221|524538814|FG000|Overall Study|Protocol Violation|8|||
145460202|NCT03263923|524538815|FG000|Overall Study|Withdrawal by Subject|10|||
145460203|NCT03263923|524538816|FG001|Overall Study|Withdrawal by Subject|8|||
145460204|NCT03263923|524538815|FG000|Overall Study|Lost to Follow-up|15|||
145460205|NCT03263923|524538816|FG001|Overall Study|Lost to Follow-up|13|||
145460206|NCT02098369|524538817|FG000|Overall Study|Withdrawal by Subject|1|||
145460207|NCT02098369|524538818|FG001|Overall Study|Withdrawal by Subject|5|||
145460208|NCT02098369|524538819|FG002|Overall Study|Withdrawal by Subject|0|||
145460209|NCT02098369|524538817|FG000|Overall Study|Lost to Follow-up|5|||
145460210|NCT02098369|524538818|FG001|Overall Study|Lost to Follow-up|1|||
145460211|NCT02098369|524538819|FG002|Overall Study|Lost to Follow-up|3|||
145460212|NCT02098369|524538817|FG000|Overall Study|Death|1|||
145460213|NCT02098369|524538818|FG001|Overall Study|Death|1|||
145460214|NCT02098369|524538819|FG002|Overall Study|Death|1|||
145460215|NCT02098369|524538817|FG000|Overall Study|Other|0|||
145460216|NCT02098369|524538818|FG001|Overall Study|Other|2|||
145460217|NCT02098369|524538819|FG002|Overall Study|Other|1|||
145460218|NCT03362931|524538821|FG000|Overall Study|Adverse Event|1|||
145460219|NCT03362931|524538821|FG000|Overall Study|Death|2|||
145460220|NCT01323270|524538822|FG000|Overall Study|Withdrawal by Subject|19|||
145460221|NCT01323270|524538823|FG001|Overall Study|Withdrawal by Subject|10|||
145460222|NCT01323270|524538822|FG000|Overall Study|Protocol Violation|9|||
145460223|NCT01323270|524538823|FG001|Overall Study|Protocol Violation|7|||
145460224|NCT01323270|524538822|FG000|Overall Study|Lost to Follow-up|4|||
145460225|NCT01323270|524538823|FG001|Overall Study|Lost to Follow-up|6|||
145460226|NCT01323270|524538822|FG000|Overall Study|Adverse Event|8|||
145460227|NCT01323270|524538823|FG001|Overall Study|Adverse Event|0|||
145460228|NCT01323270|524538822|FG000|Overall Study|Other|0|||
145460229|NCT01323270|524538823|FG001|Overall Study|Other|3|||
145460230|NCT01323270|524538822|FG000|Overall Study|Physician Decision|0|||
145460231|NCT01323270|524538823|FG001|Overall Study|Physician Decision|2|||
145460232|NCT01323270|524538822|FG000|Overall Study|Not eligible|1|||
145460233|NCT01323270|524538823|FG001|Overall Study|Not eligible|1|||
145460234|NCT01323270|524538822|FG000|Overall Study|Death|1|||
145460235|NCT01323270|524538823|FG001|Overall Study|Death|0|||
145460236|NCT01323270|524538822|FG000|Overall Study|Randomized, but not vaccinated|1|||
145460237|NCT01323270|524538823|FG001|Overall Study|Randomized, but not vaccinated|0|||
145460238|NCT02229214|524538831|FG000|Overall Study|Adverse Event|2|||
145460239|NCT02229214|524538832|FG001|Overall Study|Adverse Event|0|||
145460240|NCT02229214|524538831|FG000|Overall Study|Withdrawal by Subject|4|||
145460241|NCT02229214|524538832|FG001|Overall Study|Withdrawal by Subject|0|||
145460242|NCT00075725|524538840|FG000|Overall Study|Adverse Event|6|||
145460243|NCT00075725|524538841|FG001|Overall Study|Adverse Event|6|||
145460244|NCT00075725|524538842|FG002|Overall Study|Adverse Event|20|||
145460245|NCT00075725|524538843|FG003|Overall Study|Adverse Event|8|||
145460246|NCT00075725|524538844|FG004|Overall Study|Adverse Event|4|||
145460247|NCT00075725|524538845|FG005|Overall Study|Adverse Event|38|||
145460248|NCT00075725|524538846|FG006|Overall Study|Adverse Event|3|||
145460249|NCT00075725|524538847|FG007|Overall Study|Adverse Event|51|||
145460250|NCT00075725|524538848|FG008|Overall Study|Adverse Event|15|||
145460251|NCT00075725|524538849|FG009|Overall Study|Adverse Event|4|||
145460252|NCT00075725|524538850|FG010|Overall Study|Adverse Event|2|||
145460253|NCT00075725|524538851|FG011|Overall Study|Adverse Event|2|||
145460254|NCT00075725|524538840|FG000|Overall Study|Death|3|||
145460255|NCT00075725|524538841|FG001|Overall Study|Death|5|||
145460256|NCT00075725|524538842|FG002|Overall Study|Death|10|||
145460257|NCT00075725|524538843|FG003|Overall Study|Death|2|||
145460258|NCT00075725|524538844|FG004|Overall Study|Death|3|||
145460259|NCT00075725|524538845|FG005|Overall Study|Death|25|||
145460260|NCT00075725|524538846|FG006|Overall Study|Death|4|||
145460261|NCT00075725|524538847|FG007|Overall Study|Death|22|||
145460262|NCT00075725|524538848|FG008|Overall Study|Death|14|||
145460263|NCT00075725|524538849|FG009|Overall Study|Death|4|||
145460264|NCT00075725|524538850|FG010|Overall Study|Death|3|||
145460265|NCT00075725|524538851|FG011|Overall Study|Death|0|||
145460266|NCT00075725|524538840|FG000|Overall Study|Lost to Follow-up|1|||
145460267|NCT00075725|524538841|FG001|Overall Study|Lost to Follow-up|1|||
145460268|NCT00075725|524538842|FG002|Overall Study|Lost to Follow-up|4|||
145460269|NCT00075725|524538843|FG003|Overall Study|Lost to Follow-up|1|||
145460270|NCT00075725|524538844|FG004|Overall Study|Lost to Follow-up|0|||
145460271|NCT00075725|524538845|FG005|Overall Study|Lost to Follow-up|13|||
145460272|NCT00075725|524538846|FG006|Overall Study|Lost to Follow-up|2|||
145460273|NCT00075725|524538847|FG007|Overall Study|Lost to Follow-up|4|||
145460274|NCT00075725|524538848|FG008|Overall Study|Lost to Follow-up|1|||
145460275|NCT00075725|524538849|FG009|Overall Study|Lost to Follow-up|0|||
145460276|NCT00075725|524538850|FG010|Overall Study|Lost to Follow-up|0|||
145460277|NCT00075725|524538851|FG011|Overall Study|Lost to Follow-up|0|||
145460278|NCT00075725|524538840|FG000|Overall Study|Physician Decision|2|||
145460279|NCT00075725|524538841|FG001|Overall Study|Physician Decision|6|||
145460280|NCT00075725|524538842|FG002|Overall Study|Physician Decision|5|||
145460281|NCT00075725|524538843|FG003|Overall Study|Physician Decision|8|||
145460282|NCT00075725|524538844|FG004|Overall Study|Physician Decision|4|||
145460283|NCT00075725|524538845|FG005|Overall Study|Physician Decision|19|||
145460284|NCT00075725|524538846|FG006|Overall Study|Physician Decision|3|||
145593776|NCT02723864|525026423|FG005|Overall Study|Clinical progression|3|||
145593777|NCT02723864|525026424|FG006|Overall Study|Clinical progression|1|||
145593778|NCT02723864|525026418|FG000|Overall Study|Physician Decision|0|||
145593779|NCT02723864|525026419|FG001|Overall Study|Physician Decision|0|||
145593780|NCT02723864|525026420|FG002|Overall Study|Physician Decision|0|||
145593781|NCT02723864|525026421|FG003|Overall Study|Physician Decision|0|||
145593782|NCT02723864|525026422|FG004|Overall Study|Physician Decision|0|||
145593783|NCT02723864|525026423|FG005|Overall Study|Physician Decision|0|||
145593784|NCT02723864|525026424|FG006|Overall Study|Physician Decision|1|||
145593785|NCT02723864|525026418|FG000|Overall Study|Changes in patient condition|0|||
145593786|NCT02723864|525026419|FG001|Overall Study|Changes in patient condition|0|||
145593787|NCT02723864|525026420|FG002|Overall Study|Changes in patient condition|0|||
145593788|NCT02723864|525026421|FG003|Overall Study|Changes in patient condition|0|||
145593789|NCT02723864|525026422|FG004|Overall Study|Changes in patient condition|0|||
145593790|NCT02723864|525026423|FG005|Overall Study|Changes in patient condition|1|||
145593791|NCT02723864|525026424|FG006|Overall Study|Changes in patient condition|0|||
145593792|NCT02723864|525026418|FG000|Overall Study|Patient choice|0|||
145593793|NCT02723864|525026419|FG001|Overall Study|Patient choice|0|||
145593794|NCT02723864|525026420|FG002|Overall Study|Patient choice|0|||
145593795|NCT02723864|525026421|FG003|Overall Study|Patient choice|0|||
145593796|NCT02723864|525026422|FG004|Overall Study|Patient choice|0|||
145593797|NCT02723864|525026423|FG005|Overall Study|Patient choice|1|||
145593798|NCT02723864|525026424|FG006|Overall Study|Patient choice|0|||
145593799|NCT02723864|525026418|FG000|Overall Study|Adverse Event|0|||
145593800|NCT02723864|525026419|FG001|Overall Study|Adverse Event|0|||
145593801|NCT02723864|525026420|FG002|Overall Study|Adverse Event|0|||
145593802|NCT02723864|525026421|FG003|Overall Study|Adverse Event|0|||
145593803|NCT02723864|525026422|FG004|Overall Study|Adverse Event|0|||
145593804|NCT02723864|525026423|FG005|Overall Study|Adverse Event|1|||
145593805|NCT02723864|525026424|FG006|Overall Study|Adverse Event|0|||
145593806|NCT02723864|525026418|FG000|Overall Study|Started new treatment|0|||
145593807|NCT02723864|525026419|FG001|Overall Study|Started new treatment|0|||
145593808|NCT02723864|525026420|FG002|Overall Study|Started new treatment|0|||
145593809|NCT02723864|525026421|FG003|Overall Study|Started new treatment|0|||
145593810|NCT02723864|525026422|FG004|Overall Study|Started new treatment|0|||
145593811|NCT02723864|525026423|FG005|Overall Study|Started new treatment|1|||
145593812|NCT02723864|525026424|FG006|Overall Study|Started new treatment|0|||
145593813|NCT02723864|525026418|FG000|Overall Study|Switched to alternative treatment|0|||
145593814|NCT02723864|525026419|FG001|Overall Study|Switched to alternative treatment|0|||
145593815|NCT02723864|525026420|FG002|Overall Study|Switched to alternative treatment|0|||
145593816|NCT02723864|525026421|FG003|Overall Study|Switched to alternative treatment|0|||
145593817|NCT02723864|525026422|FG004|Overall Study|Switched to alternative treatment|0|||
145593818|NCT02723864|525026423|FG005|Overall Study|Switched to alternative treatment|1|||
145593819|NCT02723864|525026424|FG006|Overall Study|Switched to alternative treatment|0|||
145593820|NCT02723864|525026418|FG000|Overall Study|Late determination of ineligibility|0|||
145593821|NCT02723864|525026419|FG001|Overall Study|Late determination of ineligibility|0|||
145593822|NCT02723864|525026420|FG002|Overall Study|Late determination of ineligibility|0|||
145593823|NCT02723864|525026421|FG003|Overall Study|Late determination of ineligibility|0|||
145593824|NCT02723864|525026422|FG004|Overall Study|Late determination of ineligibility|0|||
145593825|NCT02723864|525026423|FG005|Overall Study|Late determination of ineligibility|1|||
145593826|NCT02723864|525026424|FG006|Overall Study|Late determination of ineligibility|0|||
145593827|NCT02633800|525026429|FG000|Overall Study|Death|3|||
145593828|NCT02633800|525026430|FG001|Overall Study|Death|3|||
145593829|NCT02633800|525026429|FG000|Overall Study|Reason not provided|1|||
145593830|NCT02633800|525026430|FG001|Overall Study|Reason not provided|0|||
145593831|NCT02633800|525026429|FG000|Overall Study|Radiologic(al) progression|23|||
145593832|NCT02633800|525026430|FG001|Overall Study|Radiologic(al) progression|23|||
145593833|NCT02633800|525026429|FG000|Overall Study|Clinical progression|3|||
145460285|NCT00075725|524538847|FG007|Overall Study|Physician Decision|17|||
145460286|NCT00075725|524538848|FG008|Overall Study|Physician Decision|5|||
145460287|NCT00075725|524538849|FG009|Overall Study|Physician Decision|0|||
145460288|NCT00075725|524538850|FG010|Overall Study|Physician Decision|1|||
145460289|NCT00075725|524538851|FG011|Overall Study|Physician Decision|0|||
145593834|NCT02633800|525026430|FG001|Overall Study|Clinical progression|6|||
145593835|NCT02633800|525026429|FG000|Overall Study|Study terminated by sponsor|6|||
145593836|NCT02633800|525026430|FG001|Overall Study|Study terminated by sponsor|5|||
145593837|NCT02633800|525026429|FG000|Overall Study|Adverse event, non-fatal|7|||
145593838|NCT02633800|525026430|FG001|Overall Study|Adverse event, non-fatal|2|||
145593839|NCT02633800|525026429|FG000|Overall Study|Withdrawal by Subject|0|||
145593840|NCT02633800|525026430|FG001|Overall Study|Withdrawal by Subject|3|||
145593841|NCT02633800|525026429|FG000|Overall Study|Patient Request|1|||
145593842|NCT02633800|525026430|FG001|Overall Study|Patient Request|1|||
145593843|NCT01733732|525026431|FG000|Overall Study|Adverse Event|1|||
145593844|NCT01733732|525026432|FG001|Overall Study|Adverse Event|0|||
145460290|NCT00075725|524538840|FG000|Overall Study|Pregnancy|0|||
145460291|NCT00075725|524538841|FG001|Overall Study|Pregnancy|0|||
145460292|NCT00075725|524538842|FG002|Overall Study|Pregnancy|0|||
145460293|NCT00075725|524538843|FG003|Overall Study|Pregnancy|0|||
145460294|NCT00075725|524538844|FG004|Overall Study|Pregnancy|0|||
145460295|NCT00075725|524538845|FG005|Overall Study|Pregnancy|1|||
145460296|NCT00075725|524538846|FG006|Overall Study|Pregnancy|0|||
145460297|NCT00075725|524538847|FG007|Overall Study|Pregnancy|1|||
145460298|NCT00075725|524538848|FG008|Overall Study|Pregnancy|0|||
145460299|NCT00075725|524538849|FG009|Overall Study|Pregnancy|0|||
145460300|NCT00075725|524538850|FG010|Overall Study|Pregnancy|0|||
145460301|NCT00075725|524538851|FG011|Overall Study|Pregnancy|0|||
145460302|NCT00075725|524538840|FG000|Overall Study|Protocol Violation|1|||
145460303|NCT00075725|524538841|FG001|Overall Study|Protocol Violation|1|||
145460304|NCT00075725|524538842|FG002|Overall Study|Protocol Violation|0|||
145460305|NCT00075725|524538843|FG003|Overall Study|Protocol Violation|3|||
145460306|NCT00075725|524538844|FG004|Overall Study|Protocol Violation|3|||
145460307|NCT00075725|524538845|FG005|Overall Study|Protocol Violation|2|||
145460308|NCT00075725|524538846|FG006|Overall Study|Protocol Violation|1|||
145460309|NCT00075725|524538847|FG007|Overall Study|Protocol Violation|2|||
145460310|NCT00075725|524538848|FG008|Overall Study|Protocol Violation|3|||
145460311|NCT00075725|524538849|FG009|Overall Study|Protocol Violation|0|||
145460312|NCT00075725|524538850|FG010|Overall Study|Protocol Violation|0|||
145460313|NCT00075725|524538851|FG011|Overall Study|Protocol Violation|1|||
145460314|NCT00075725|524538840|FG000|Overall Study|Withdrawal by Subject|12|||
145460315|NCT00075725|524538841|FG001|Overall Study|Withdrawal by Subject|3|||
145460316|NCT00075725|524538842|FG002|Overall Study|Withdrawal by Subject|6|||
145460317|NCT00075725|524538843|FG003|Overall Study|Withdrawal by Subject|10|||
145460318|NCT00075725|524538844|FG004|Overall Study|Withdrawal by Subject|6|||
145460319|NCT00075725|524538845|FG005|Overall Study|Withdrawal by Subject|27|||
145460320|NCT00075725|524538846|FG006|Overall Study|Withdrawal by Subject|7|||
145460321|NCT00075725|524538847|FG007|Overall Study|Withdrawal by Subject|31|||
145460322|NCT00075725|524538848|FG008|Overall Study|Withdrawal by Subject|10|||
145460323|NCT00075725|524538849|FG009|Overall Study|Withdrawal by Subject|2|||
145460324|NCT00075725|524538850|FG010|Overall Study|Withdrawal by Subject|0|||
145460325|NCT00075725|524538851|FG011|Overall Study|Withdrawal by Subject|0|||
145460326|NCT00075725|524538840|FG000|Overall Study|Disease Progression, all other reasons|17|||
145460327|NCT00075725|524538841|FG001|Overall Study|Disease Progression, all other reasons|5|||
145460328|NCT00075725|524538842|FG002|Overall Study|Disease Progression, all other reasons|33|||
145460329|NCT00075725|524538843|FG003|Overall Study|Disease Progression, all other reasons|6|||
145460330|NCT00075725|524538844|FG004|Overall Study|Disease Progression, all other reasons|21|||
145460331|NCT00075725|524538845|FG005|Overall Study|Disease Progression, all other reasons|59|||
145460332|NCT00075725|524538846|FG006|Overall Study|Disease Progression, all other reasons|20|||
145460333|NCT00075725|524538847|FG007|Overall Study|Disease Progression, all other reasons|46|||
145460334|NCT00075725|524538848|FG008|Overall Study|Disease Progression, all other reasons|21|||
145460335|NCT00075725|524538849|FG009|Overall Study|Disease Progression, all other reasons|4|||
145460336|NCT00075725|524538850|FG010|Overall Study|Disease Progression, all other reasons|0|||
145460337|NCT00075725|524538851|FG011|Overall Study|Disease Progression, all other reasons|5|||
145460338|NCT00075725|524538840|FG000|Overall Study|Patient off treatment|0|||
145460339|NCT00075725|524538841|FG001|Overall Study|Patient off treatment|0|||
145460340|NCT00075725|524538842|FG002|Overall Study|Patient off treatment|1|||
145460341|NCT00075725|524538843|FG003|Overall Study|Patient off treatment|2|||
145460342|NCT00075725|524538844|FG004|Overall Study|Patient off treatment|1|||
145460343|NCT00075725|524538845|FG005|Overall Study|Patient off treatment|0|||
145460344|NCT00075725|524538846|FG006|Overall Study|Patient off treatment|0|||
145460345|NCT00075725|524538847|FG007|Overall Study|Patient off treatment|2|||
145460346|NCT00075725|524538848|FG008|Overall Study|Patient off treatment|1|||
145460347|NCT00075725|524538849|FG009|Overall Study|Patient off treatment|0|||
145460348|NCT00075725|524538850|FG010|Overall Study|Patient off treatment|0|||
145460349|NCT00075725|524538851|FG011|Overall Study|Patient off treatment|0|||
145460350|NCT00075725|524538840|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
145460351|NCT00075725|524538841|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
145460352|NCT00075725|524538842|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
145460353|NCT00075725|524538843|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
145460354|NCT00075725|524538844|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
145460355|NCT00075725|524538845|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
145460356|NCT00075725|524538846|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
145460357|NCT00075725|524538847|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
145460358|NCT00075725|524538848|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
145460359|NCT00075725|524538849|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
145460360|NCT00075725|524538850|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
145460361|NCT00075725|524538851|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
145460362|NCT00075725|524538840|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
145460363|NCT00075725|524538841|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
145460364|NCT00075725|524538842|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
145460365|NCT00075725|524538843|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
145460366|NCT00075725|524538844|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
145460367|NCT00075725|524538845|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
145460368|NCT00075725|524538846|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
145460369|NCT00075725|524538847|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
145460370|NCT00075725|524538848|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
145460371|NCT00075725|524538849|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
145460372|NCT00075725|524538850|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
145593845|NCT01733732|525026431|FG000|Overall Study|Did not attend all study visits|1|||
145593846|NCT01733732|525026432|FG001|Overall Study|Did not attend all study visits|0|||
145593847|NCT00746590|525026433|FG000|Overall Study|Death|1|||
145593848|NCT00254982|525026436|FG000|Overall Study|Other|2|||
145593849|NCT00254982|525026437|FG001|Overall Study|Other|1|||
145593850|NCT00254982|525026436|FG000|Overall Study|Lack of Efficacy|5|||
145593851|NCT00254982|525026437|FG001|Overall Study|Lack of Efficacy|3|||
145593852|NCT00254982|525026436|FG000|Overall Study|Lost to Follow-up|5|||
145593853|NCT00254982|525026437|FG001|Overall Study|Lost to Follow-up|3|||
145593854|NCT00254982|525026436|FG000|Overall Study|Adverse Event|18|||
145593855|NCT00254982|525026437|FG001|Overall Study|Adverse Event|16|||
145593856|NCT00254982|525026436|FG000|Overall Study|Withdrawal by Subject|1|||
145593857|NCT00254982|525026437|FG001|Overall Study|Withdrawal by Subject|1|||
145593858|NCT00254982|525026436|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
145593859|NCT00254982|525026437|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
145593860|NCT00254982|525026436|FG000|Overall Study|Protocol deviation|1|||
145593861|NCT00254982|525026437|FG001|Overall Study|Protocol deviation|1|||
145593862|NCT00254982|525026436|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
145593863|NCT00254982|525026437|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
145593864|NCT00254982|525026436|FG000|Overall Study|Malignancy|0|||
145593865|NCT00254982|525026437|FG001|Overall Study|Malignancy|2|||
145593866|NCT00254982|525026436|FG000|Overall Study|Opportunistic infection|1|||
145593867|NCT00254982|525026437|FG001|Overall Study|Opportunistic infection|0|||
145593868|NCT00254982|525026436|FG000|Overall Study|Abnormal liver function tests|2|||
145593869|NCT00254982|525026437|FG001|Overall Study|Abnormal liver function tests|1|||
145593870|NCT03643952|525026440|FG000|Overall Study|Lack of Efficacy|1|||
145593871|NCT01358968|525026441|FG000|Period 2|Adverse Event|0|||
145593872|NCT01358968|525026442|FG001|Period 2|Adverse Event|1|||
145593873|NCT01358968|525026443|FG002|Period 2|Adverse Event|0|||
145593874|NCT01358968|525026444|FG003|Period 2|Adverse Event|0|||
145593875|NCT01358968|525026441|FG000|Continued Access Phase|Progression of Disease|0|||
145626799|NCT01474538|525147072|FG000|Treatment Period 2|Sponsor decision|1|||
145626800|NCT01474538|525147073|FG001|Treatment Period 2|Sponsor decision|0|||
145460373|NCT00075725|524538851|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
145460374|NCT00075725|524538840|FG000|Overall Study|Pt non compliant with therapy|2|||
145460375|NCT00075725|524538841|FG001|Overall Study|Pt non compliant with therapy|1|||
145460376|NCT00075725|524538842|FG002|Overall Study|Pt non compliant with therapy|1|||
145460377|NCT00075725|524538843|FG003|Overall Study|Pt non compliant with therapy|0|||
145460378|NCT00075725|524538844|FG004|Overall Study|Pt non compliant with therapy|2|||
145460379|NCT00075725|524538845|FG005|Overall Study|Pt non compliant with therapy|14|||
145460380|NCT00075725|524538846|FG006|Overall Study|Pt non compliant with therapy|2|||
145460381|NCT00075725|524538847|FG007|Overall Study|Pt non compliant with therapy|5|||
145460382|NCT00075725|524538848|FG008|Overall Study|Pt non compliant with therapy|3|||
145460383|NCT00075725|524538849|FG009|Overall Study|Pt non compliant with therapy|0|||
145460384|NCT00075725|524538850|FG010|Overall Study|Pt non compliant with therapy|0|||
145460385|NCT00075725|524538851|FG011|Overall Study|Pt non compliant with therapy|0|||
145460386|NCT00075725|524538840|FG000|Overall Study|Pt age out of range for treatment|0|||
145460387|NCT00075725|524538841|FG001|Overall Study|Pt age out of range for treatment|1|||
145460388|NCT00075725|524538842|FG002|Overall Study|Pt age out of range for treatment|0|||
145460389|NCT00075725|524538843|FG003|Overall Study|Pt age out of range for treatment|0|||
145460390|NCT00075725|524538844|FG004|Overall Study|Pt age out of range for treatment|0|||
145460391|NCT00075725|524538845|FG005|Overall Study|Pt age out of range for treatment|1|||
145460392|NCT00075725|524538846|FG006|Overall Study|Pt age out of range for treatment|0|||
145460393|NCT00075725|524538847|FG007|Overall Study|Pt age out of range for treatment|1|||
145460394|NCT00075725|524538848|FG008|Overall Study|Pt age out of range for treatment|0|||
145593876|NCT01358968|525026442|FG001|Continued Access Phase|Progression of Disease|0|||
145593877|NCT01358968|525026443|FG002|Continued Access Phase|Progression of Disease|8|||
145593878|NCT01358968|525026444|FG003|Continued Access Phase|Progression of Disease|4|||
145460395|NCT00075725|524538849|FG009|Overall Study|Pt age out of range for treatment|0|||
145460396|NCT00075725|524538850|FG010|Overall Study|Pt age out of range for treatment|0|||
145460397|NCT00075725|524538851|FG011|Overall Study|Pt age out of range for treatment|0|||
145460398|NCT00075725|524538840|FG000|Overall Study|Insurance issues|0|||
145460399|NCT00075725|524538841|FG001|Overall Study|Insurance issues|1|||
145593879|NCT01358968|525026441|FG000|Continued Access Phase|Protocol Violation|0|||
145593880|NCT01358968|525026442|FG001|Continued Access Phase|Protocol Violation|0|||
145593881|NCT01358968|525026443|FG002|Continued Access Phase|Protocol Violation|0|||
145593882|NCT01358968|525026444|FG003|Continued Access Phase|Protocol Violation|2|||
145593883|NCT01358968|525026441|FG000|Continued Access Phase|Withdrawal by Subject|0|||
145593884|NCT01358968|525026442|FG001|Continued Access Phase|Withdrawal by Subject|0|||
145593885|NCT01358968|525026443|FG002|Continued Access Phase|Withdrawal by Subject|3|||
145593886|NCT01358968|525026444|FG003|Continued Access Phase|Withdrawal by Subject|0|||
145593887|NCT01358968|525026441|FG000|Continued Access Phase|Death|0|||
145593888|NCT01358968|525026442|FG001|Continued Access Phase|Death|0|||
145593889|NCT01358968|525026443|FG002|Continued Access Phase|Death|1|||
145593890|NCT01358968|525026444|FG003|Continued Access Phase|Death|1|||
145593891|NCT04052204|525026447|FG000|Overall Study|Death|1|||
145593892|NCT04052204|525026448|FG001|Overall Study|Death|0|||
145593893|NCT04052204|525026449|FG002|Overall Study|Death|0|||
145593894|NCT04052204|525026447|FG000|Overall Study|Progressive disease|1|||
145593895|NCT04052204|525026448|FG001|Overall Study|Progressive disease|0|||
145593896|NCT04052204|525026449|FG002|Overall Study|Progressive disease|0|||
145593897|NCT04052204|525026447|FG000|Overall Study|Other|1|||
145593898|NCT04052204|525026448|FG001|Overall Study|Other|0|||
145593899|NCT04052204|525026449|FG002|Overall Study|Other|0|||
145593900|NCT01618162|525026468|FG000|Overall Study|Protocol Violation|13|||
145593901|NCT01618162|525026469|FG001|Overall Study|Protocol Violation|10|||
145593902|NCT01618162|525026468|FG000|Overall Study|Adverse Event|9|||
145593903|NCT01618162|525026469|FG001|Overall Study|Adverse Event|2|||
145593904|NCT01618162|525026468|FG000|Overall Study|Withdrawal Criteria|2|||
145593905|NCT01618162|525026469|FG001|Overall Study|Withdrawal Criteria|10|||
145593906|NCT01618162|525026468|FG000|Overall Study|Unclassified|14|||
145593907|NCT01618162|525026469|FG001|Overall Study|Unclassified|13|||
145593908|NCT00476476|525026470|FG000|Overall Study|Adverse Event|2|||
145593909|NCT00476476|525026471|FG001|Overall Study|Adverse Event|7|||
145593910|NCT00476476|525026470|FG000|Overall Study|Progressive Disease|0|||
145593911|NCT00476476|525026471|FG001|Overall Study|Progressive Disease|17|||
145593912|NCT04794803|525026472|FG000|Overall Study|Death|1|||
145593913|NCT04794803|525026473|FG001|Overall Study|Death|3|||
145593914|NCT04794803|525026472|FG000|Overall Study|Lost to Follow-up|2|||
145593915|NCT04794803|525026473|FG001|Overall Study|Lost to Follow-up|2|||
145593916|NCT04794803|525026472|FG000|Overall Study|Withdrawal by Subject|1|||
145593917|NCT04794803|525026473|FG001|Overall Study|Withdrawal by Subject|0|||
145593918|NCT04794803|525026472|FG000|Overall Study|Physician Decision|1|||
145593919|NCT04794803|525026473|FG001|Overall Study|Physician Decision|1|||
145593920|NCT04794803|525026472|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
145593921|NCT04794803|525026473|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
145593922|NCT04794803|525026472|FG000|Overall Study|Refused to continue the treatment|1|||
145593923|NCT04794803|525026473|FG001|Overall Study|Refused to continue the treatment|0|||
145593924|NCT04794803|525026472|FG000|Overall Study|Patient admitted to ICU|0|||
145593925|NCT04794803|525026473|FG001|Overall Study|Patient admitted to ICU|1|||
145593926|NCT04124926|525026474|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
145593927|NCT04124926|525026475|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
145593928|NCT04124926|525026476|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
145593929|NCT04124926|525026477|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
145593930|NCT04124926|525026478|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
145593931|NCT04124926|525026474|FG000|Healing Phase|Protocol Violation|0|||
145593932|NCT04124926|525026475|FG001|Healing Phase|Protocol Violation|1|||
145593933|NCT04124926|525026476|FG002|Healing Phase|Protocol Violation|0|||
145593934|NCT04124926|525026477|FG003|Healing Phase|Protocol Violation|0|||
145593935|NCT04124926|525026478|FG004|Healing Phase|Protocol Violation|0|||
145593936|NCT04124926|525026474|FG000|Healing Phase|Lost to Follow-up|5|||
145593937|NCT04124926|525026475|FG001|Healing Phase|Lost to Follow-up|4|||
145593938|NCT04124926|525026476|FG002|Healing Phase|Lost to Follow-up|0|||
145593939|NCT04124926|525026477|FG003|Healing Phase|Lost to Follow-up|0|||
145593940|NCT04124926|525026478|FG004|Healing Phase|Lost to Follow-up|0|||
145593941|NCT04124926|525026474|FG000|Healing Phase|Voluntary Withdrawal|10|||
145593942|NCT04124926|525026475|FG001|Healing Phase|Voluntary Withdrawal|7|||
145626801|NCT01474538|525147072|FG000|Treatment Period 2|Physician Decision|0|||
145626802|NCT01474538|525147073|FG001|Treatment Period 2|Physician Decision|1|||
145626803|NCT01474538|525147072|FG000|Treatment Period 2|Protocol Violation|1|||
145593943|NCT04124926|525026476|FG002|Healing Phase|Voluntary Withdrawal|0|||
145626804|NCT01474538|525147073|FG001|Treatment Period 2|Protocol Violation|0|||
145460400|NCT00075725|524538842|FG002|Overall Study|Insurance issues|0|||
145593944|NCT04124926|525026477|FG003|Healing Phase|Voluntary Withdrawal|0|||
145593945|NCT04124926|525026478|FG004|Healing Phase|Voluntary Withdrawal|0|||
145593946|NCT04124926|525026474|FG000|Healing Phase|Withdrawal of Consent|5|||
145593947|NCT04124926|525026475|FG001|Healing Phase|Withdrawal of Consent|3|||
145593948|NCT04124926|525026476|FG002|Healing Phase|Withdrawal of Consent|0|||
145593949|NCT04124926|525026477|FG003|Healing Phase|Withdrawal of Consent|0|||
145593950|NCT04124926|525026478|FG004|Healing Phase|Withdrawal of Consent|0|||
145593951|NCT04124926|525026474|FG000|Healing Phase|Miscellaneous|8|||
145593952|NCT04124926|525026475|FG001|Healing Phase|Miscellaneous|7|||
145593953|NCT04124926|525026476|FG002|Healing Phase|Miscellaneous|0|||
145593954|NCT04124926|525026477|FG003|Healing Phase|Miscellaneous|0|||
145593955|NCT04124926|525026478|FG004|Healing Phase|Miscellaneous|0|||
145593956|NCT04124926|525026474|FG000|Healing Phase|Randomized but not Treated|0|||
145593957|NCT04124926|525026475|FG001|Healing Phase|Randomized but not Treated|3|||
145593958|NCT04124926|525026476|FG002|Healing Phase|Randomized but not Treated|0|||
145593959|NCT04124926|525026477|FG003|Healing Phase|Randomized but not Treated|0|||
145593960|NCT04124926|525026478|FG004|Healing Phase|Randomized but not Treated|0|||
145593961|NCT04124926|525026474|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
145593962|NCT04124926|525026475|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
145593963|NCT04124926|525026476|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
145593964|NCT04124926|525026477|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
145593965|NCT04124926|525026478|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
145593966|NCT04124926|525026474|FG000|Maintenance Phase|Protocol Violation|0|||
145593967|NCT04124926|525026475|FG001|Maintenance Phase|Protocol Violation|0|||
145593968|NCT04124926|525026476|FG002|Maintenance Phase|Protocol Violation|3|||
145593969|NCT04124926|525026477|FG003|Maintenance Phase|Protocol Violation|0|||
145593970|NCT04124926|525026478|FG004|Maintenance Phase|Protocol Violation|0|||
145593971|NCT04124926|525026474|FG000|Maintenance Phase|Lost to Follow-up|0|||
145593972|NCT04124926|525026475|FG001|Maintenance Phase|Lost to Follow-up|0|||
145593973|NCT04124926|525026476|FG002|Maintenance Phase|Lost to Follow-up|7|||
145593974|NCT04124926|525026477|FG003|Maintenance Phase|Lost to Follow-up|8|||
145593975|NCT04124926|525026478|FG004|Maintenance Phase|Lost to Follow-up|9|||
145593976|NCT04124926|525026474|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
145593977|NCT04124926|525026475|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
145593978|NCT04124926|525026476|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
145593979|NCT04124926|525026477|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
145593980|NCT04124926|525026478|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
145593981|NCT04124926|525026474|FG000|Maintenance Phase|Pregnancy|0|||
145593982|NCT04124926|525026475|FG001|Maintenance Phase|Pregnancy|0|||
145593983|NCT04124926|525026476|FG002|Maintenance Phase|Pregnancy|0|||
145593984|NCT04124926|525026477|FG003|Maintenance Phase|Pregnancy|1|||
145593985|NCT04124926|525026478|FG004|Maintenance Phase|Pregnancy|0|||
145593986|NCT04124926|525026474|FG000|Maintenance Phase|Lack of Efficacy|0|||
145593987|NCT04124926|525026475|FG001|Maintenance Phase|Lack of Efficacy|0|||
145593988|NCT04124926|525026476|FG002|Maintenance Phase|Lack of Efficacy|0|||
145593989|NCT04124926|525026477|FG003|Maintenance Phase|Lack of Efficacy|0|||
145593990|NCT04124926|525026478|FG004|Maintenance Phase|Lack of Efficacy|1|||
145593991|NCT04124926|525026474|FG000|Maintenance Phase|Withdrawal of Consent|0|||
145593992|NCT04124926|525026475|FG001|Maintenance Phase|Withdrawal of Consent|0|||
145593993|NCT04124926|525026476|FG002|Maintenance Phase|Withdrawal of Consent|5|||
145593994|NCT04124926|525026477|FG003|Maintenance Phase|Withdrawal of Consent|5|||
145593995|NCT04124926|525026478|FG004|Maintenance Phase|Withdrawal of Consent|5|||
145593996|NCT04124926|525026474|FG000|Maintenance Phase|Miscellaneous|0|||
145593997|NCT04124926|525026475|FG001|Maintenance Phase|Miscellaneous|0|||
145593998|NCT04124926|525026476|FG002|Maintenance Phase|Miscellaneous|1|||
145593999|NCT04124926|525026477|FG003|Maintenance Phase|Miscellaneous|2|||
145594000|NCT04124926|525026478|FG004|Maintenance Phase|Miscellaneous|4|||
145594001|NCT04124926|525026474|FG000|Maintenance Phase|Randomized but not Treated|0|||
145594002|NCT04124926|525026475|FG001|Maintenance Phase|Randomized but not Treated|0|||
145594003|NCT04124926|525026476|FG002|Maintenance Phase|Randomized but not Treated|2|||
145594004|NCT04124926|525026477|FG003|Maintenance Phase|Randomized but not Treated|2|||
145594005|NCT04124926|525026478|FG004|Maintenance Phase|Randomized but not Treated|0|||
145594006|NCT00971048|525026479|FG000|Overall Study|Protocol Violation|1|||
145594007|NCT00971048|525026480|FG001|Overall Study|Protocol Violation|2|||
145594008|NCT00971048|525026481|FG002|Overall Study|Protocol Violation|0|||
145594009|NCT00971048|525026482|FG003|Overall Study|Protocol Violation|1|||
145594010|NCT00971048|525026479|FG000|Overall Study|Adverse Event|0|||
145594011|NCT00971048|525026480|FG001|Overall Study|Adverse Event|0|||
145594012|NCT00971048|525026481|FG002|Overall Study|Adverse Event|1|||
145594013|NCT00971048|525026482|FG003|Overall Study|Adverse Event|0|||
145594014|NCT00971048|525026479|FG000|Overall Study|Physician Decision|0|||
145594015|NCT00971048|525026480|FG001|Overall Study|Physician Decision|0|||
145594016|NCT00971048|525026481|FG002|Overall Study|Physician Decision|0|||
145594017|NCT00971048|525026482|FG003|Overall Study|Physician Decision|1|||
145594018|NCT02013622|525026493|FG000|Overall Study|Lost to Follow-up|10|||
145594019|NCT02013622|525026493|FG000|Overall Study|Adverse Event|3|||
145594020|NCT02013622|525026493|FG000|Overall Study|Met Withdrawal Criteria|3|||
145594021|NCT02013622|525026493|FG000|Overall Study|Withdrawal by Subject|6|||
145594022|NCT02013622|525026493|FG000|Overall Study|Protocol Deviation|1|||
145626805|NCT01456780|525147074|FG000|Overall Study|Lost to Follow-up|3|||
145594023|NCT02013622|525026493|FG000|Overall Study|Lack of Efficacy|1|||
145594024|NCT05130970|525026496|FG000|Overall Study|Adverse Event|1|||
145594025|NCT05130970|525026497|FG001|Overall Study|Adverse Event|1|||
145594026|NCT05130970|525026496|FG000|Overall Study|Death|0|||
145594027|NCT05130970|525026497|FG001|Overall Study|Death|1|||
145594028|NCT05130970|525026496|FG000|Overall Study|Lost to Follow-up|0|||
145594029|NCT05130970|525026497|FG001|Overall Study|Lost to Follow-up|1|||
145594030|NCT05130970|525026496|FG000|Overall Study|Physician Decision|0|||
145594031|NCT05130970|525026497|FG001|Overall Study|Physician Decision|1|||
145594032|NCT05130970|525026496|FG000|Overall Study|Withdrawal by Subject|1|||
145594033|NCT05130970|525026497|FG001|Overall Study|Withdrawal by Subject|1|||
145594034|NCT01388816|525026498|FG000|Overall Study|Adverse Event|0|||
145594035|NCT01388816|525026499|FG001|Overall Study|Adverse Event|2|||
145594036|NCT01388816|525026500|FG002|Overall Study|Adverse Event|0|||
145594037|NCT01388816|525026501|FG003|Overall Study|Adverse Event|0|||
145594038|NCT01388816|525026498|FG000|Overall Study|Lost to Follow-up|0|||
145594039|NCT01388816|525026499|FG001|Overall Study|Lost to Follow-up|1|||
145594040|NCT01388816|525026500|FG002|Overall Study|Lost to Follow-up|0|||
145594041|NCT01388816|525026501|FG003|Overall Study|Lost to Follow-up|0|||
145594042|NCT01388816|525026498|FG000|Overall Study|Withdrawal by Subject|2|||
145594043|NCT01388816|525026499|FG001|Overall Study|Withdrawal by Subject|1|||
145594044|NCT01388816|525026500|FG002|Overall Study|Withdrawal by Subject|1|||
145594045|NCT01388816|525026501|FG003|Overall Study|Withdrawal by Subject|0|||
145594046|NCT01388816|525026498|FG000|Overall Study|Protocol Violation|0|||
145594047|NCT01388816|525026499|FG001|Overall Study|Protocol Violation|0|||
145594048|NCT01388816|525026500|FG002|Overall Study|Protocol Violation|2|||
145594049|NCT01388816|525026501|FG003|Overall Study|Protocol Violation|0|||
145594050|NCT00743366|525026502|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
145594051|NCT00743366|525026503|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
145594052|NCT02308748|525026506|FG000|Period 1|Withdrawal by Subject|0|||
145594053|NCT02308748|525026507|FG001|Period 1|Withdrawal by Subject|0|||
145594054|NCT02308748|525026508|FG002|Period 1|Withdrawal by Subject|1|||
145594055|NCT02308748|525026509|FG003|Period 1|Withdrawal by Subject|0|||
145594056|NCT02308748|525026510|FG004|Period 1|Withdrawal by Subject|0|||
145594057|NCT02308748|525026511|FG005|Period 1|Withdrawal by Subject|0|||
145594058|NCT02308748|525026512|FG006|Period 1|Withdrawal by Subject|0|||
145594059|NCT02308748|525026513|FG007|Period 1|Withdrawal by Subject|0|||
145594060|NCT02308748|525026514|FG008|Period 1|Withdrawal by Subject|0|||
145594061|NCT02308748|525026515|FG009|Period 1|Withdrawal by Subject|0|||
145594062|NCT02308748|525026506|FG000|Period 2|Adverse Event|0|||
145594063|NCT02308748|525026507|FG001|Period 2|Adverse Event|0|||
145594064|NCT02308748|525026508|FG002|Period 2|Adverse Event|0|||
145594065|NCT02308748|525026509|FG003|Period 2|Adverse Event|0|||
145594066|NCT02308748|525026510|FG004|Period 2|Adverse Event|0|||
145594067|NCT02308748|525026511|FG005|Period 2|Adverse Event|0|||
145594068|NCT02308748|525026512|FG006|Period 2|Adverse Event|0|||
145594069|NCT02308748|525026513|FG007|Period 2|Adverse Event|1|||
145594070|NCT02308748|525026514|FG008|Period 2|Adverse Event|0|||
145594071|NCT02308748|525026515|FG009|Period 2|Adverse Event|0|||
145594072|NCT02308748|525026506|FG000|Period 3|Protocol Violation|0|||
145594073|NCT02308748|525026507|FG001|Period 3|Protocol Violation|0|||
145594074|NCT02308748|525026508|FG002|Period 3|Protocol Violation|0|||
145594075|NCT02308748|525026509|FG003|Period 3|Protocol Violation|0|||
145594076|NCT02308748|525026510|FG004|Period 3|Protocol Violation|0|||
145594077|NCT02308748|525026511|FG005|Period 3|Protocol Violation|0|||
145594078|NCT02308748|525026512|FG006|Period 3|Protocol Violation|0|||
145594079|NCT02308748|525026513|FG007|Period 3|Protocol Violation|0|||
145594080|NCT02308748|525026514|FG008|Period 3|Protocol Violation|0|||
145594081|NCT02308748|525026515|FG009|Period 3|Protocol Violation|1|||
145594082|NCT02308748|525026506|FG000|Period 5|Adverse Event|1|||
145594083|NCT02308748|525026507|FG001|Period 5|Adverse Event|0|||
145594084|NCT02308748|525026508|FG002|Period 5|Adverse Event|0|||
145460401|NCT00075725|524538843|FG003|Overall Study|Insurance issues|1|||
145460402|NCT00075725|524538844|FG004|Overall Study|Insurance issues|1|||
145626806|NCT01456780|525147075|FG001|Overall Study|Lost to Follow-up|3|||
145460403|NCT00075725|524538845|FG005|Overall Study|Insurance issues|1|||
145594085|NCT02308748|525026509|FG003|Period 5|Adverse Event|0|||
145594086|NCT02308748|525026510|FG004|Period 5|Adverse Event|0|||
145594087|NCT02308748|525026511|FG005|Period 5|Adverse Event|0|||
145594088|NCT02308748|525026512|FG006|Period 5|Adverse Event|0|||
145594089|NCT02308748|525026513|FG007|Period 5|Adverse Event|0|||
145594090|NCT02308748|525026514|FG008|Period 5|Adverse Event|1|||
145594091|NCT02308748|525026515|FG009|Period 5|Adverse Event|0|||
145460404|NCT00075725|524538846|FG006|Overall Study|Insurance issues|0|||
145594092|NCT01994954|525026520|FG000|Overall Study|Death|1|||
145594093|NCT01994954|525026521|FG001|Overall Study|Death|0|||
145594094|NCT01994954|525026520|FG000|Overall Study|Withdrawal by Subject|9|||
145594095|NCT01994954|525026521|FG001|Overall Study|Withdrawal by Subject|14|||
145594096|NCT01994954|525026520|FG000|Overall Study|Physician Decision|2|||
145594097|NCT01994954|525026521|FG001|Overall Study|Physician Decision|2|||
145594098|NCT01994954|525026520|FG000|Overall Study|Lost to Follow-up|8|||
145594099|NCT01994954|525026521|FG001|Overall Study|Lost to Follow-up|10|||
145594100|NCT01994954|525026520|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
145594101|NCT01994954|525026521|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
145594102|NCT02576678|525026522|FG000|Overall Study|Adverse Event|0|||
145594103|NCT02576678|525026523|FG001|Overall Study|Adverse Event|0|||
145594104|NCT02576678|525026524|FG002|Overall Study|Adverse Event|2|||
145594105|NCT02576678|525026522|FG000|Overall Study|Withdrawal by Subject|3|||
145626807|NCT01456780|525147076|FG002|Overall Study|Lost to Follow-up|0|||
145594106|NCT02576678|525026523|FG001|Overall Study|Withdrawal by Subject|1|||
145594107|NCT02576678|525026524|FG002|Overall Study|Withdrawal by Subject|2|||
145594108|NCT02576678|525026522|FG000|Overall Study|Lost to Follow-up|0|||
145594109|NCT02576678|525026523|FG001|Overall Study|Lost to Follow-up|0|||
145594110|NCT02576678|525026524|FG002|Overall Study|Lost to Follow-up|1|||
145594111|NCT02576678|525026522|FG000|Overall Study|Miscellaneous|2|||
145594112|NCT02576678|525026523|FG001|Overall Study|Miscellaneous|0|||
145594113|NCT02576678|525026524|FG002|Overall Study|Miscellaneous|0|||
145594114|NCT01454583|525026525|FG000|1st Year|Lost to Follow-up|1057|||
145594115|NCT01454583|525026526|FG001|1st Year|Lost to Follow-up|318|||
145594116|NCT01454583|525026527|FG002|1st Year|Lost to Follow-up|180|||
145594117|NCT01454583|525026525|FG000|2nd Year|Lost to Follow-up|3965|||
145594118|NCT01454583|525026526|FG001|2nd Year|Lost to Follow-up|1049|||
145594119|NCT01454583|525026527|FG002|2nd Year|Lost to Follow-up|737|||
145594120|NCT01454583|525026525|FG000|3rd Year|Lost to Follow-up|1959|||
145594121|NCT01454583|525026526|FG001|3rd Year|Lost to Follow-up|512|||
145594122|NCT01454583|525026527|FG002|3rd Year|Lost to Follow-up|297|||
145594123|NCT01041638|525026538|FG000|Overall Study|Adverse Event|4|||
145594124|NCT01041638|525026538|FG000|Overall Study|Death|1|||
145594125|NCT01041638|525026538|FG000|Overall Study|Lack of Efficacy|7|||
145594126|NCT01041638|525026538|FG000|Overall Study|Physician Decision|4|||
145594127|NCT01041638|525026538|FG000|Overall Study|Withdrawal by Subject|11|||
145594128|NCT00417079|525026539|FG000|Overall Study|Disease progression|267|||
145594129|NCT00417079|525026540|FG001|Overall Study|Disease progression|180|||
145594130|NCT00417079|525026539|FG000|Overall Study|Adverse Event|32|||
145594131|NCT00417079|525026540|FG001|Overall Study|Adverse Event|67|||
145594132|NCT00417079|525026539|FG000|Overall Study|Non-compliance to protocol|0|||
145594133|NCT00417079|525026540|FG001|Overall Study|Non-compliance to protocol|1|||
145594134|NCT00417079|525026539|FG000|Overall Study|Lost to Follow-up|2|||
145594135|NCT00417079|525026540|FG001|Overall Study|Lost to Follow-up|0|||
145594136|NCT00417079|525026539|FG000|Overall Study|Withdrawal by Subject|17|||
145594137|NCT00417079|525026540|FG001|Overall Study|Withdrawal by Subject|8|||
145594138|NCT00417079|525026539|FG000|Overall Study|Not treated|6|||
145594139|NCT00417079|525026540|FG001|Overall Study|Not treated|7|||
145594140|NCT00417079|525026539|FG000|Overall Study|Screened failure|2|||
145594141|NCT00417079|525026540|FG001|Overall Study|Screened failure|1|||
145594142|NCT00417079|525026539|FG000|Overall Study|Investigator's decision|1|||
145594143|NCT00417079|525026540|FG001|Overall Study|Investigator's decision|4|||
145594144|NCT00417079|525026539|FG000|Overall Study|Non-confirmed Disease progression|1|||
145594145|NCT00417079|525026540|FG001|Overall Study|Non-confirmed Disease progression|1|||
145594146|NCT00417079|525026539|FG000|Overall Study|Clinical deterioration|1|||
145594147|NCT00417079|525026540|FG001|Overall Study|Clinical deterioration|0|||
145594148|NCT00417079|525026539|FG000|Overall Study|Screening error|2|||
145594149|NCT00417079|525026540|FG001|Overall Study|Screening error|1|||
145594150|NCT00417079|525026539|FG000|Overall Study|Withdrawal by subject's family|0|||
145594151|NCT00417079|525026540|FG001|Overall Study|Withdrawal by subject's family|1|||
145594152|NCT00417079|525026539|FG000|Overall Study|Patient unable to come to the clinic|0|||
145594153|NCT00417079|525026540|FG001|Overall Study|Patient unable to come to the clinic|1|||
145594154|NCT00417079|525026539|FG000|Overall Study|abnormal liver function tests|0|||
145594155|NCT00417079|525026540|FG001|Overall Study|abnormal liver function tests|1|||
145594156|NCT01022762|525026541|FG000|Overall Study|Adverse Event|3|||
145594157|NCT01022762|525026542|FG001|Overall Study|Adverse Event|1|||
145594158|NCT01022762|525026541|FG000|Overall Study|Lack of Efficacy|0|||
145594159|NCT01022762|525026542|FG001|Overall Study|Lack of Efficacy|1|||
145594160|NCT01022762|525026541|FG000|Overall Study|Protocol Violation|7|||
145594161|NCT01022762|525026542|FG001|Overall Study|Protocol Violation|6|||
145594162|NCT01022762|525026541|FG000|Overall Study|Unclassified|12|||
145594163|NCT01022762|525026542|FG001|Overall Study|Unclassified|20|||
145594164|NCT04084314|525026543|FG000|Overall Study|Subject/guardian decision|91|||
145594165|NCT04084314|525026543|FG000|Overall Study|Adverse Event|24|||
145594166|NCT04084314|525026543|FG000|Overall Study|Lost to Follow-up|19|||
145594167|NCT04084314|525026543|FG000|Overall Study|New therapy for study indication|9|||
145594168|NCT04084314|525026543|FG000|Overall Study|Pregnancy|9|||
145594169|NCT04084314|525026543|FG000|Overall Study|Withdrawal of informed consent|8|||
145594170|NCT04084314|525026543|FG000|Overall Study|Physician Decision|4|||
145594171|NCT04084314|525026543|FG000|Overall Study|Protocol Deviation|3|||
145594172|NCT01329029|525026544|FG000|Overall Study|Withdrawal by Subject|117|||
145594173|NCT01329029|525026545|FG001|Overall Study|Withdrawal by Subject|87|||
145594174|NCT01329029|525026544|FG000|Overall Study|Adverse Event|82|||
145594175|NCT01329029|525026545|FG001|Overall Study|Adverse Event|29|||
145594176|NCT01329029|525026544|FG000|Overall Study|Death|16|||
145594177|NCT01329029|525026545|FG001|Overall Study|Death|19|||
145594178|NCT01329029|525026544|FG000|Overall Study|Other|14|||
145594179|NCT01329029|525026545|FG001|Overall Study|Other|20|||
145594180|NCT01329029|525026544|FG000|Overall Study|COPD Exacerbation|11|||
145594181|NCT01329029|525026545|FG001|Overall Study|COPD Exacerbation|18|||
145594182|NCT01329029|525026544|FG000|Overall Study|Physician Decision|16|||
145594183|NCT01329029|525026545|FG001|Overall Study|Physician Decision|13|||
145594184|NCT01329029|525026544|FG000|Overall Study|Lost to Follow-up|8|||
145626808|NCT02688621|525147077|FG000|Overall Study|Pregnancy|1|||
145460405|NCT00075725|524538847|FG007|Overall Study|Insurance issues|1|||
145460406|NCT00075725|524538848|FG008|Overall Study|Insurance issues|0|||
145460407|NCT00075725|524538849|FG009|Overall Study|Insurance issues|0|||
145460408|NCT00075725|524538850|FG010|Overall Study|Insurance issues|0|||
145460409|NCT00075725|524538851|FG011|Overall Study|Insurance issues|0|||
145460410|NCT00075725|524538840|FG000|Overall Study|MRD positive after extended ind|0|||
145460411|NCT00075725|524538841|FG001|Overall Study|MRD positive after extended ind|1|||
145460412|NCT00075725|524538842|FG002|Overall Study|MRD positive after extended ind|1|||
145460413|NCT00075725|524538843|FG003|Overall Study|MRD positive after extended ind|0|||
145460414|NCT00075725|524538844|FG004|Overall Study|MRD positive after extended ind|1|||
145460415|NCT00075725|524538845|FG005|Overall Study|MRD positive after extended ind|2|||
145460416|NCT00075725|524538846|FG006|Overall Study|MRD positive after extended ind|0|||
145460417|NCT00075725|524538847|FG007|Overall Study|MRD positive after extended ind|1|||
145460418|NCT00075725|524538848|FG008|Overall Study|MRD positive after extended ind|0|||
145460419|NCT00075725|524538849|FG009|Overall Study|MRD positive after extended ind|0|||
145460420|NCT00075725|524538850|FG010|Overall Study|MRD positive after extended ind|0|||
145460421|NCT00075725|524538851|FG011|Overall Study|MRD positive after extended ind|0|||
145460422|NCT00075725|524538840|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
145460423|NCT00075725|524538841|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
145460424|NCT00075725|524538842|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
145460425|NCT00075725|524538843|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
145460426|NCT00075725|524538844|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
145460427|NCT00075725|524538845|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
145460428|NCT00075725|524538846|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
145460429|NCT00075725|524538847|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
145460430|NCT00075725|524538848|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
145460431|NCT00075725|524538849|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
145460432|NCT00075725|524538850|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
145460433|NCT00075725|524538851|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
145460434|NCT00075725|524538840|FG000|Overall Study|Inevaluable|1|||
145460435|NCT00075725|524538841|FG001|Overall Study|Inevaluable|1|||
145460436|NCT00075725|524538842|FG002|Overall Study|Inevaluable|4|||
145460437|NCT00075725|524538843|FG003|Overall Study|Inevaluable|2|||
145460438|NCT00075725|524538844|FG004|Overall Study|Inevaluable|2|||
145460439|NCT00075725|524538845|FG005|Overall Study|Inevaluable|9|||
145460440|NCT00075725|524538846|FG006|Overall Study|Inevaluable|1|||
145460441|NCT00075725|524538847|FG007|Overall Study|Inevaluable|11|||
145460442|NCT00075725|524538848|FG008|Overall Study|Inevaluable|2|||
145460443|NCT00075725|524538849|FG009|Overall Study|Inevaluable|0|||
145460444|NCT00075725|524538850|FG010|Overall Study|Inevaluable|1|||
145460445|NCT00075725|524538851|FG011|Overall Study|Inevaluable|0|||
145460446|NCT00075725|524538840|FG000|Overall Study|Other|4|||
145460447|NCT00075725|524538841|FG001|Overall Study|Other|2|||
145460448|NCT00075725|524538842|FG002|Overall Study|Other|1|||
145460449|NCT00075725|524538843|FG003|Overall Study|Other|1|||
145460450|NCT00075725|524538844|FG004|Overall Study|Other|1|||
145460451|NCT00075725|524538845|FG005|Overall Study|Other|4|||
145460452|NCT00075725|524538846|FG006|Overall Study|Other|2|||
145460453|NCT00075725|524538847|FG007|Overall Study|Other|9|||
145460454|NCT00075725|524538848|FG008|Overall Study|Other|2|||
145460455|NCT00075725|524538849|FG009|Overall Study|Other|1|||
145460456|NCT00075725|524538850|FG010|Overall Study|Other|0|||
145460457|NCT00075725|524538851|FG011|Overall Study|Other|3|||
145460458|NCT00075725|524538840|FG000|Overall Study|Pt trying to find a BM donor|0|||
145460459|NCT00075725|524538841|FG001|Overall Study|Pt trying to find a BM donor|1|||
145460460|NCT00075725|524538842|FG002|Overall Study|Pt trying to find a BM donor|0|||
145460461|NCT00075725|524538843|FG003|Overall Study|Pt trying to find a BM donor|0|||
145460462|NCT00075725|524538844|FG004|Overall Study|Pt trying to find a BM donor|0|||
145460463|NCT00075725|524538845|FG005|Overall Study|Pt trying to find a BM donor|0|||
145460464|NCT00075725|524538846|FG006|Overall Study|Pt trying to find a BM donor|0|||
145460465|NCT00075725|524538847|FG007|Overall Study|Pt trying to find a BM donor|0|||
145460466|NCT00075725|524538848|FG008|Overall Study|Pt trying to find a BM donor|0|||
145460467|NCT00075725|524538849|FG009|Overall Study|Pt trying to find a BM donor|0|||
145460468|NCT00075725|524538850|FG010|Overall Study|Pt trying to find a BM donor|0|||
145460469|NCT00075725|524538851|FG011|Overall Study|Pt trying to find a BM donor|0|||
145460470|NCT00075725|524538840|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
145460471|NCT00075725|524538841|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
145460472|NCT00075725|524538842|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
145460473|NCT00075725|524538843|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
145460474|NCT00075725|524538844|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
145460475|NCT00075725|524538845|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
145460476|NCT00075725|524538846|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
145460477|NCT00075725|524538847|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
145626809|NCT02688621|525147078|FG001|Overall Study|Pregnancy|3|||
145594185|NCT01329029|525026545|FG001|Overall Study|Lost to Follow-up|5|||
145594186|NCT01329029|525026544|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
145594187|NCT01329029|525026545|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
145594188|NCT00003508|525028090|FG000|Overall Study|Not evaluable|5|||
145594189|NCT02160314|525028091|FG000|Overall Study|Adverse Event|0|||
145594190|NCT02160314|525028092|FG001|Overall Study|Adverse Event|6|||
145594191|NCT02160314|525028091|FG000|Overall Study|Protocol Violation|0|||
145594192|NCT02160314|525028092|FG001|Overall Study|Protocol Violation|4|||
145594193|NCT02160314|525028091|FG000|Overall Study|Withdrawal by Subject|1|||
145594194|NCT02160314|525028092|FG001|Overall Study|Withdrawal by Subject|2|||
145594195|NCT02160314|525028091|FG000|Overall Study|Lost to Follow-up|0|||
145594196|NCT02160314|525028092|FG001|Overall Study|Lost to Follow-up|1|||
145594197|NCT00593567|525028093|FG000|Overall Study|Adverse Event|2|||
145594198|NCT00593567|525028094|FG001|Overall Study|Adverse Event|0|||
145594199|NCT00593567|525028093|FG000|Overall Study|Physician Decision|2|||
145594200|NCT00593567|525028094|FG001|Overall Study|Physician Decision|0|||
145460478|NCT00075725|524538848|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
145460479|NCT00075725|524538849|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
145460480|NCT00075725|524538850|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
145460481|NCT00075725|524538851|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
145460482|NCT00075725|524538840|FG000|Overall Study|Unsuccessful institutional transfer|0|||
145460483|NCT00075725|524538841|FG001|Overall Study|Unsuccessful institutional transfer|0|||
145460484|NCT00075725|524538842|FG002|Overall Study|Unsuccessful institutional transfer|2|||
145460485|NCT00075725|524538843|FG003|Overall Study|Unsuccessful institutional transfer|0|||
145460486|NCT00075725|524538844|FG004|Overall Study|Unsuccessful institutional transfer|0|||
145460487|NCT00075725|524538845|FG005|Overall Study|Unsuccessful institutional transfer|0|||
145460488|NCT00075725|524538846|FG006|Overall Study|Unsuccessful institutional transfer|0|||
145460489|NCT00075725|524538847|FG007|Overall Study|Unsuccessful institutional transfer|0|||
145460490|NCT00075725|524538848|FG008|Overall Study|Unsuccessful institutional transfer|0|||
145460491|NCT00075725|524538849|FG009|Overall Study|Unsuccessful institutional transfer|1|||
145460492|NCT00075725|524538850|FG010|Overall Study|Unsuccessful institutional transfer|0|||
145460493|NCT00075725|524538851|FG011|Overall Study|Unsuccessful institutional transfer|0|||
145460494|NCT00075725|524538840|FG000|Overall Study|specimen(s) not submitted|0|||
145460495|NCT00075725|524538841|FG001|Overall Study|specimen(s) not submitted|0|||
145460496|NCT00075725|524538842|FG002|Overall Study|specimen(s) not submitted|2|||
145460497|NCT00075725|524538843|FG003|Overall Study|specimen(s) not submitted|0|||
145460498|NCT00075725|524538844|FG004|Overall Study|specimen(s) not submitted|0|||
145460499|NCT00075725|524538845|FG005|Overall Study|specimen(s) not submitted|0|||
145460500|NCT00075725|524538846|FG006|Overall Study|specimen(s) not submitted|0|||
145460501|NCT00075725|524538847|FG007|Overall Study|specimen(s) not submitted|0|||
145460502|NCT00075725|524538848|FG008|Overall Study|specimen(s) not submitted|0|||
145460503|NCT00075725|524538849|FG009|Overall Study|specimen(s) not submitted|0|||
145460504|NCT00075725|524538850|FG010|Overall Study|specimen(s) not submitted|0|||
145460505|NCT00075725|524538851|FG011|Overall Study|specimen(s) not submitted|0|||
145460506|NCT00075725|524538840|FG000|Overall Study|Pt went to transplant|0|||
145460507|NCT00075725|524538841|FG001|Overall Study|Pt went to transplant|0|||
145460508|NCT00075725|524538842|FG002|Overall Study|Pt went to transplant|0|||
145460509|NCT00075725|524538843|FG003|Overall Study|Pt went to transplant|1|||
145460510|NCT00075725|524538844|FG004|Overall Study|Pt went to transplant|0|||
145460511|NCT00075725|524538845|FG005|Overall Study|Pt went to transplant|1|||
145460512|NCT00075725|524538846|FG006|Overall Study|Pt went to transplant|0|||
145460513|NCT00075725|524538847|FG007|Overall Study|Pt went to transplant|0|||
145460514|NCT00075725|524538848|FG008|Overall Study|Pt went to transplant|0|||
145460515|NCT00075725|524538849|FG009|Overall Study|Pt went to transplant|0|||
145460516|NCT00075725|524538850|FG010|Overall Study|Pt went to transplant|0|||
145460517|NCT00075725|524538851|FG011|Overall Study|Pt went to transplant|0|||
145460518|NCT00075725|524538840|FG000|Overall Study|Pt received additional steroids|0|||
145460519|NCT00075725|524538841|FG001|Overall Study|Pt received additional steroids|0|||
145460520|NCT00075725|524538842|FG002|Overall Study|Pt received additional steroids|0|||
145460521|NCT00075725|524538843|FG003|Overall Study|Pt received additional steroids|1|||
145460522|NCT00075725|524538844|FG004|Overall Study|Pt received additional steroids|0|||
145460523|NCT00075725|524538845|FG005|Overall Study|Pt received additional steroids|0|||
145460524|NCT00075725|524538846|FG006|Overall Study|Pt received additional steroids|0|||
145594201|NCT00593567|525028093|FG000|Overall Study|Protocol Violation|13|||
145460525|NCT00075725|524538847|FG007|Overall Study|Pt received additional steroids|0|||
145460526|NCT00075725|524538848|FG008|Overall Study|Pt received additional steroids|0|||
145460527|NCT00075725|524538849|FG009|Overall Study|Pt received additional steroids|0|||
145594202|NCT00593567|525028094|FG001|Overall Study|Protocol Violation|7|||
145594203|NCT00593567|525028093|FG000|Overall Study|Lack of Efficacy|2|||
145594204|NCT00593567|525028094|FG001|Overall Study|Lack of Efficacy|1|||
145594205|NCT00593567|525028093|FG000|Overall Study|Withdrawal by Subject|1|||
145594206|NCT00593567|525028094|FG001|Overall Study|Withdrawal by Subject|2|||
145594207|NCT03576768|525028098|FG000|Overall Study|Lost to Follow-up|3|||
145594208|NCT03576768|525028099|FG001|Overall Study|Lost to Follow-up|3|||
145594209|NCT03576768|525028100|FG002|Overall Study|Lost to Follow-up|0|||
145594210|NCT03576768|525028101|FG003|Overall Study|Lost to Follow-up|0|||
145594211|NCT00590902|525028102|FG000|Overall Study|Death|1|||
145594212|NCT00785291|525028103|FG000|Overall Study|Never began treatment|8|||
145594213|NCT00785291|525028104|FG001|Overall Study|Never began treatment|4|||
145594214|NCT00785291|525028105|FG002|Overall Study|Never began treatment|4|||
145594215|NCT00785291|525028103|FG000|Overall Study|Adverse Event|39|||
145594216|NCT00785291|525028104|FG001|Overall Study|Adverse Event|70|||
145594217|NCT00785291|525028105|FG002|Overall Study|Adverse Event|56|||
145594218|NCT00785291|525028103|FG000|Overall Study|Death|7|||
145594219|NCT00785291|525028104|FG001|Overall Study|Death|4|||
145594220|NCT00785291|525028105|FG002|Overall Study|Death|3|||
145594221|NCT00785291|525028103|FG000|Overall Study|Withdrawal by Subject|35|||
145594222|NCT00785291|525028104|FG001|Overall Study|Withdrawal by Subject|36|||
145594223|NCT00785291|525028105|FG002|Overall Study|Withdrawal by Subject|17|||
145594224|NCT00785291|525028103|FG000|Overall Study|Alternative Therapy|12|||
145594225|NCT00785291|525028104|FG001|Overall Study|Alternative Therapy|6|||
145594226|NCT00785291|525028105|FG002|Overall Study|Alternative Therapy|7|||
145594227|NCT00785291|525028103|FG000|Overall Study|Complicating illness|6|||
145594228|NCT00785291|525028104|FG001|Overall Study|Complicating illness|4|||
145594229|NCT00785291|525028105|FG002|Overall Study|Complicating illness|4|||
145594230|NCT00785291|525028103|FG000|Overall Study|Other Medical Reasons|29|||
145594231|NCT00785291|525028104|FG001|Overall Study|Other Medical Reasons|25|||
145594232|NCT00785291|525028105|FG002|Overall Study|Other Medical Reasons|15|||
145594233|NCT02119260|525028106|FG000|Overall Study|Adverse Event|1|||
145594234|NCT02119260|525028107|FG001|Overall Study|Adverse Event|0|||
145594235|NCT02119260|525028108|FG002|Overall Study|Adverse Event|0|||
145594236|NCT02119260|525028109|FG003|Overall Study|Adverse Event|0|||
145594237|NCT02119260|525028110|FG004|Overall Study|Adverse Event|0|||
145594238|NCT02119260|525028111|FG005|Overall Study|Adverse Event|0|||
145594239|NCT02119260|525028112|FG006|Overall Study|Adverse Event|0|||
145594240|NCT02119260|525028106|FG000|Overall Study|Withdrew consent|0|||
145594241|NCT02119260|525028107|FG001|Overall Study|Withdrew consent|1|||
145594242|NCT02119260|525028108|FG002|Overall Study|Withdrew consent|1|||
145594243|NCT02119260|525028109|FG003|Overall Study|Withdrew consent|0|||
145594244|NCT02119260|525028110|FG004|Overall Study|Withdrew consent|0|||
145594245|NCT02119260|525028111|FG005|Overall Study|Withdrew consent|0|||
145594246|NCT02119260|525028112|FG006|Overall Study|Withdrew consent|0|||
145594247|NCT00447057|525028124|FG000|Overall Study|Adverse Event|4|||
145594248|NCT00447057|525028125|FG001|Overall Study|Adverse Event|10|||
145594249|NCT00447057|525028126|FG002|Overall Study|Adverse Event|0|||
145594250|NCT00447057|525028127|FG003|Overall Study|Adverse Event|3|||
145594251|NCT00447057|525028124|FG000|Overall Study|Death due to study disease|6|||
145594252|NCT00447057|525028125|FG001|Overall Study|Death due to study disease|4|||
145594253|NCT00447057|525028126|FG002|Overall Study|Death due to study disease|1|||
145594254|NCT00447057|525028127|FG003|Overall Study|Death due to study disease|1|||
145594255|NCT00447057|525028124|FG000|Overall Study|Lost to Follow-up|0|||
145594256|NCT00447057|525028125|FG001|Overall Study|Lost to Follow-up|1|||
145594257|NCT00447057|525028126|FG002|Overall Study|Lost to Follow-up|0|||
145594258|NCT00447057|525028127|FG003|Overall Study|Lost to Follow-up|0|||
145594259|NCT00447057|525028124|FG000|Overall Study|Entry criteria not met|1|||
145594260|NCT00447057|525028125|FG001|Overall Study|Entry criteria not met|1|||
145594261|NCT00447057|525028126|FG002|Overall Study|Entry criteria not met|0|||
145594262|NCT00447057|525028127|FG003|Overall Study|Entry criteria not met|0|||
145594263|NCT00447057|525028124|FG000|Overall Study|Protocol Violation|0|||
145594264|NCT00447057|525028125|FG001|Overall Study|Protocol Violation|1|||
145594265|NCT00447057|525028126|FG002|Overall Study|Protocol Violation|0|||
145594266|NCT00447057|525028127|FG003|Overall Study|Protocol Violation|0|||
145594267|NCT00447057|525028124|FG000|Overall Study|Withdrawal by Subject|4|||
145594268|NCT00447057|525028125|FG001|Overall Study|Withdrawal by Subject|5|||
145594269|NCT00447057|525028126|FG002|Overall Study|Withdrawal by Subject|1|||
145594270|NCT00447057|525028127|FG003|Overall Study|Withdrawal by Subject|1|||
145594271|NCT00447057|525028124|FG000|Overall Study|Physician Decision|9|||
145594272|NCT00447057|525028125|FG001|Overall Study|Physician Decision|6|||
145594273|NCT00447057|525028126|FG002|Overall Study|Physician Decision|3|||
145594274|NCT00447057|525028127|FG003|Overall Study|Physician Decision|1|||
145594275|NCT00447057|525028124|FG000|Overall Study|Sponsor decision|1|||
145594276|NCT00447057|525028125|FG001|Overall Study|Sponsor decision|1|||
145594277|NCT00447057|525028126|FG002|Overall Study|Sponsor decision|0|||
145594278|NCT00447057|525028127|FG003|Overall Study|Sponsor decision|0|||
145594279|NCT00447057|525028124|FG000|Overall Study|Progressive disease|58|||
145594280|NCT00447057|525028125|FG001|Overall Study|Progressive disease|43|||
145594281|NCT00447057|525028126|FG002|Overall Study|Progressive disease|13|||
145594282|NCT00447057|525028127|FG003|Overall Study|Progressive disease|18|||
145594283|NCT00447057|525028124|FG000|Overall Study|Death due to adverse event|0|||
145594284|NCT00447057|525028125|FG001|Overall Study|Death due to adverse event|0|||
145594285|NCT00447057|525028126|FG002|Overall Study|Death due to adverse event|1|||
145594286|NCT00447057|525028127|FG003|Overall Study|Death due to adverse event|2|||
145594287|NCT00447057|525028124|FG000|Overall Study|Death, study drug related|0|||
145594288|NCT00447057|525028125|FG001|Overall Study|Death, study drug related|1|||
145594289|NCT00447057|525028126|FG002|Overall Study|Death, study drug related|0|||
145594290|NCT00447057|525028127|FG003|Overall Study|Death, study drug related|0|||
145594291|NCT00449176|525028134|FG000|Overall Study|Withdrawal by Subject|39|||
145460528|NCT00075725|524538850|FG010|Overall Study|Pt received additional steroids|0|||
145460529|NCT00075725|524538851|FG011|Overall Study|Pt received additional steroids|0|||
145460530|NCT00075725|524538840|FG000|Overall Study|Pt relocated|0|||
145460531|NCT00075725|524538841|FG001|Overall Study|Pt relocated|0|||
145460532|NCT00075725|524538842|FG002|Overall Study|Pt relocated|0|||
145460533|NCT00075725|524538843|FG003|Overall Study|Pt relocated|2|||
145460534|NCT00075725|524538844|FG004|Overall Study|Pt relocated|0|||
145460535|NCT00075725|524538845|FG005|Overall Study|Pt relocated|1|||
145460536|NCT00075725|524538846|FG006|Overall Study|Pt relocated|1|||
145460537|NCT00075725|524538847|FG007|Overall Study|Pt relocated|2|||
145460538|NCT00075725|524538848|FG008|Overall Study|Pt relocated|1|||
145460539|NCT00075725|524538849|FG009|Overall Study|Pt relocated|0|||
145460540|NCT00075725|524538850|FG010|Overall Study|Pt relocated|0|||
145460541|NCT00075725|524538851|FG011|Overall Study|Pt relocated|0|||
145460542|NCT00075725|524538840|FG000|Overall Study|Institution Terminated|0|||
145460543|NCT00075725|524538841|FG001|Overall Study|Institution Terminated|0|||
145460544|NCT00075725|524538842|FG002|Overall Study|Institution Terminated|0|||
145460545|NCT00075725|524538843|FG003|Overall Study|Institution Terminated|0|||
145460546|NCT00075725|524538844|FG004|Overall Study|Institution Terminated|1|||
145460547|NCT00075725|524538845|FG005|Overall Study|Institution Terminated|0|||
145460548|NCT00075725|524538846|FG006|Overall Study|Institution Terminated|0|||
145460549|NCT00075725|524538847|FG007|Overall Study|Institution Terminated|3|||
145460550|NCT00075725|524538848|FG008|Overall Study|Institution Terminated|0|||
145460551|NCT00075725|524538849|FG009|Overall Study|Institution Terminated|0|||
145460552|NCT00075725|524538850|FG010|Overall Study|Institution Terminated|0|||
145460553|NCT00075725|524538851|FG011|Overall Study|Institution Terminated|0|||
145460554|NCT00075725|524538840|FG000|Overall Study|Study Closure|1|||
145460555|NCT00075725|524538841|FG001|Overall Study|Study Closure|0|||
145460556|NCT00075725|524538842|FG002|Overall Study|Study Closure|0|||
145460557|NCT00075725|524538843|FG003|Overall Study|Study Closure|0|||
145460558|NCT00075725|524538844|FG004|Overall Study|Study Closure|1|||
145460559|NCT00075725|524538845|FG005|Overall Study|Study Closure|3|||
145460560|NCT00075725|524538846|FG006|Overall Study|Study Closure|0|||
145460561|NCT00075725|524538847|FG007|Overall Study|Study Closure|1|||
145460562|NCT00075725|524538848|FG008|Overall Study|Study Closure|0|||
145460563|NCT00075725|524538849|FG009|Overall Study|Study Closure|0|||
145460564|NCT00075725|524538850|FG010|Overall Study|Study Closure|0|||
145460565|NCT00075725|524538851|FG011|Overall Study|Study Closure|0|||
145460566|NCT00075725|524538840|FG000|Overall Study|Other complications|0|||
145460567|NCT00075725|524538841|FG001|Overall Study|Other complications|0|||
145460568|NCT00075725|524538842|FG002|Overall Study|Other complications|0|||
145460569|NCT00075725|524538843|FG003|Overall Study|Other complications|0|||
145460570|NCT00075725|524538844|FG004|Overall Study|Other complications|0|||
145460571|NCT00075725|524538845|FG005|Overall Study|Other complications|1|||
145460572|NCT00075725|524538846|FG006|Overall Study|Other complications|0|||
145460573|NCT00075725|524538847|FG007|Overall Study|Other complications|0|||
145460574|NCT00075725|524538848|FG008|Overall Study|Other complications|0|||
145460575|NCT00075725|524538849|FG009|Overall Study|Other complications|0|||
145460576|NCT00075725|524538850|FG010|Overall Study|Other complications|0|||
145460577|NCT00075725|524538851|FG011|Overall Study|Other complications|0|||
145460578|NCT00075725|524538840|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
145460579|NCT00075725|524538841|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
145460580|NCT00075725|524538842|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
145460581|NCT00075725|524538843|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
145460582|NCT00075725|524538844|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
145460583|NCT00075725|524538845|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
145460584|NCT00075725|524538846|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
145460585|NCT00075725|524538847|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
145460586|NCT00075725|524538848|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
145460587|NCT00075725|524538849|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
145594292|NCT00449176|525028135|FG001|Overall Study|Withdrawal by Subject|43|||
145594293|NCT00449176|525028136|FG002|Overall Study|Withdrawal by Subject|59|||
145594294|NCT00449176|525028134|FG000|Overall Study|Lost to Follow-up|13|||
145594295|NCT00449176|525028135|FG001|Overall Study|Lost to Follow-up|8|||
145460588|NCT00075725|524538850|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
145460589|NCT00075725|524538851|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
145460590|NCT00075725|524538840|FG000|Overall Study|Pt incarcerated|0|||
145460591|NCT00075725|524538841|FG001|Overall Study|Pt incarcerated|0|||
145594296|NCT00449176|525028136|FG002|Overall Study|Lost to Follow-up|12|||
145460592|NCT00075725|524538842|FG002|Overall Study|Pt incarcerated|0|||
145460593|NCT00075725|524538843|FG003|Overall Study|Pt incarcerated|0|||
145460594|NCT00075725|524538844|FG004|Overall Study|Pt incarcerated|0|||
145594297|NCT00449176|525028134|FG000|Overall Study|Adverse Event|51|||
145460595|NCT00075725|524538845|FG005|Overall Study|Pt incarcerated|0|||
145460596|NCT00075725|524538846|FG006|Overall Study|Pt incarcerated|0|||
145460597|NCT00075725|524538847|FG007|Overall Study|Pt incarcerated|1|||
145460598|NCT00075725|524538848|FG008|Overall Study|Pt incarcerated|0|||
145460599|NCT00075725|524538849|FG009|Overall Study|Pt incarcerated|0|||
145460600|NCT00075725|524538850|FG010|Overall Study|Pt incarcerated|0|||
145460601|NCT00075725|524538851|FG011|Overall Study|Pt incarcerated|0|||
145460602|NCT04677660|524538852|FG000|Overall Study|Lost to Follow-up|0|||
145460603|NCT04677660|524538853|FG001|Overall Study|Lost to Follow-up|2|||
145460604|NCT04677660|524538852|FG000|Overall Study|Withdrawal by Subject|0|||
145460605|NCT04677660|524538853|FG001|Overall Study|Withdrawal by Subject|1|||
145460606|NCT04677660|524538852|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
145460607|NCT04677660|524538853|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
145460608|NCT03242772|524538854|FG000|Overall Study|Lost to Follow-up|2|||
145460609|NCT03242772|524538855|FG001|Overall Study|Lost to Follow-up|0|||
145460610|NCT03242772|524538854|FG000|Overall Study|Physician Decision|0|||
145460611|NCT03242772|524538855|FG001|Overall Study|Physician Decision|1|||
145460612|NCT03242772|524538854|FG000|Overall Study|Withdrawal by Subject|1|||
145460613|NCT03242772|524538855|FG001|Overall Study|Withdrawal by Subject|0|||
145460614|NCT04065074|524538858|FG000|Overall Study|Adverse Event|1|||
145460615|NCT04065074|524538858|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
145460616|NCT03385265|524538859|FG000|Overall Study|Withdrawal by Subject|5|||
145460617|NCT03385265|524538860|FG001|Overall Study|Withdrawal by Subject|2|||
145460618|NCT03385265|524538861|FG002|Overall Study|Withdrawal by Subject|5|||
145460619|NCT03385265|524538862|FG003|Overall Study|Withdrawal by Subject|2|||
145460620|NCT01560637|524538863|FG000|Overall Study|Adverse Event|63|||
145460621|NCT01560637|524538863|FG000|Overall Study|Death|69|||
145460622|NCT01560637|524538863|FG000|Overall Study|Lost to Follow-up|8|||
145460623|NCT01560637|524538863|FG000|Overall Study|Protocol Violation|8|||
145460624|NCT01560637|524538863|FG000|Overall Study|Withdrawal by Subject|24|||
145460625|NCT01560637|524538863|FG000|Overall Study|Progressive Disease|20|||
145460626|NCT01560637|524538863|FG000|Overall Study|Other Reason Not Specified|6|||
145460627|NCT03220581|524538866|FG000|Overall Study|Withdrawal by Subject|0|||
145460628|NCT03220581|524538867|FG001|Overall Study|Withdrawal by Subject|1|||
145460629|NCT03220581|524538866|FG000|Overall Study|Lost to Follow-up|3|||
145460630|NCT03220581|524538867|FG001|Overall Study|Lost to Follow-up|6|||
145460631|NCT02434354|524538868|FG000|Overall Study|screen fail|3|||
145460632|NCT01185964|524538869|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
145460633|NCT01185964|524538870|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
145460634|NCT01185964|524538871|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
145460635|NCT01185964|524538872|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
145460636|NCT01185964|524538869|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
145460637|NCT01185964|524538870|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
145460638|NCT01185964|524538871|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
145460639|NCT01185964|524538872|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
145460640|NCT01185964|524538869|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
145460641|NCT01185964|524538870|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
145460642|NCT01185964|524538871|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
145460643|NCT01185964|524538872|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
145460644|NCT01185964|524538869|FG000|Phase 1b and Phase 2|Adverse Event|1|||
145460645|NCT01185964|524538870|FG001|Phase 1b and Phase 2|Adverse Event|0|||
145460646|NCT01185964|524538871|FG002|Phase 1b and Phase 2|Adverse Event|2|||
145460647|NCT01185964|524538872|FG003|Phase 1b and Phase 2|Adverse Event|0|||
145460648|NCT01185964|524538869|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
145460649|NCT01185964|524538870|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
145460650|NCT01185964|524538871|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
145460651|NCT01185964|524538872|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
145460652|NCT01185964|524538869|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
145460653|NCT01185964|524538870|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
145460654|NCT01185964|524538871|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
145460655|NCT01185964|524538872|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
145460656|NCT01185964|524538869|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
145460657|NCT01185964|524538870|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
145460658|NCT01185964|524538871|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
145460659|NCT01185964|524538872|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
145460660|NCT01185964|524538869|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
145460661|NCT01185964|524538870|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
145460662|NCT01185964|524538871|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
145460663|NCT01185964|524538872|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
145460664|NCT01920893|524538873|FG000|Overall Study|Adverse Event|5|||
145460665|NCT01920893|524538874|FG001|Overall Study|Adverse Event|2|||
145460666|NCT01920893|524538873|FG000|Overall Study|Lack of Efficacy|2|||
145460667|NCT01920893|524538874|FG001|Overall Study|Lack of Efficacy|0|||
145460668|NCT03440918|524538875|FG000|Overall Study|Protocol Violation|0|||
145460669|NCT03440918|524538876|FG001|Overall Study|Protocol Violation|16|||
145460670|NCT03576755|524538877|FG000|Overall Study|Withdrawal by Subject|1|||
145460671|NCT03576755|524538878|FG001|Overall Study|Withdrawal by Subject|0|||
145460672|NCT03576755|524538879|FG002|Overall Study|Withdrawal by Subject|0|||
145460673|NCT03576755|524538880|FG003|Overall Study|Withdrawal by Subject|0|||
145460674|NCT03444766|524538881|FG000|Overall Study|Other Reasons|2|||
145460675|NCT03444766|524538881|FG000|Overall Study|Participant Withdrew Consent|5|||
145460676|NCT03444766|524538881|FG000|Overall Study|Lost to Follow-up|2|||
145460677|NCT03444766|524538881|FG000|Overall Study|Death|2|||
145460678|NCT03444766|524538881|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
145460679|NCT03444766|524538881|FG000|Overall Study|Disease Progression|49|||
145460680|NCT04346108|524538882|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
145460681|NCT04346108|524538883|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
145460682|NCT04346108|524538884|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
145460683|NCT04346108|524538882|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
145460684|NCT04346108|524538883|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
145460685|NCT04346108|524538884|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
145460686|NCT01081301|524538885|FG000|Overall Study|Bereaved|3|||
145460687|NCT01081301|524538885|FG000|Overall Study|Too busy|5|||
145460688|NCT01081301|524538885|FG000|Overall Study|Patient too ill|2|||
145460689|NCT01081301|524538885|FG000|Overall Study|Lost to Follow-up|4|||
145460690|NCT00724854|524538886|FG000|Overall Study|Lack of Efficacy|187|||
145460691|NCT00724854|524538887|FG001|Overall Study|Lack of Efficacy|13|||
145460692|NCT00724854|524538886|FG000|Overall Study|Lost to Follow-up|87|||
145460693|NCT00724854|524538887|FG001|Overall Study|Lost to Follow-up|10|||
145460694|NCT00724854|524538886|FG000|Overall Study|Adverse Event|62|||
145460695|NCT00724854|524538887|FG001|Overall Study|Adverse Event|4|||
145460696|NCT00724854|524538886|FG000|Overall Study|Other|42|||
145460697|NCT00724854|524538887|FG001|Overall Study|Other|3|||
145460698|NCT00724854|524538886|FG000|Overall Study|Death|11|||
145460699|NCT00724854|524538887|FG001|Overall Study|Death|0|||
145460700|NCT00724854|524538886|FG000|Overall Study|Change of treatment|7|||
145460701|NCT00724854|524538887|FG001|Overall Study|Change of treatment|0|||
145460702|NCT00724854|524538886|FG000|Overall Study|Withdrawal by Subject|5|||
145460703|NCT00724854|524538887|FG001|Overall Study|Withdrawal by Subject|0|||
145460704|NCT00724854|524538886|FG000|Overall Study|Adverse event + lack of efficacy|2|||
145460705|NCT00724854|524538887|FG001|Overall Study|Adverse event + lack of efficacy|1|||
145460706|NCT01095653|524538888|FG000|Overall Study|Lack of Efficacy|3|||
145460707|NCT01095653|524538889|FG001|Overall Study|Lack of Efficacy|0|||
145460708|NCT01095653|524538890|FG002|Overall Study|Lack of Efficacy|0|||
145460709|NCT01095653|524538888|FG000|Overall Study|Adverse Event|1|||
145460710|NCT01095653|524538889|FG001|Overall Study|Adverse Event|4|||
145460711|NCT01095653|524538890|FG002|Overall Study|Adverse Event|4|||
145460712|NCT01095653|524538888|FG000|Overall Study|Lost to Follow-up|1|||
145460713|NCT01095653|524538889|FG001|Overall Study|Lost to Follow-up|0|||
145460714|NCT01095653|524538890|FG002|Overall Study|Lost to Follow-up|4|||
145460715|NCT01095653|524538888|FG000|Overall Study|Withdrawal by Subject|4|||
145460716|NCT01095653|524538889|FG001|Overall Study|Withdrawal by Subject|5|||
145460717|NCT01095653|524538890|FG002|Overall Study|Withdrawal by Subject|3|||
145460718|NCT01095653|524538888|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
145460719|NCT01095653|524538889|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
145460720|NCT01095653|524538890|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
145460721|NCT02046226|524538891|FG000|Overall Study|Lost to Follow-up|7|||
145460722|NCT00171925|524538892|FG000|Overall Study|Adverse Event|10|||
145460723|NCT00171925|524538893|FG001|Overall Study|Adverse Event|6|||
145460724|NCT00171925|524538892|FG000|Overall Study|Protocol Violation|1|||
145460725|NCT00171925|524538893|FG001|Overall Study|Protocol Violation|1|||
145460726|NCT00171925|524538892|FG000|Overall Study|Withdrawal by Subject|6|||
145460727|NCT00171925|524538893|FG001|Overall Study|Withdrawal by Subject|9|||
145460728|NCT00171925|524538892|FG000|Overall Study|Lost to Follow-up|2|||
145460729|NCT00171925|524538893|FG001|Overall Study|Lost to Follow-up|2|||
145460730|NCT00171925|524538892|FG000|Overall Study|Administrative problems|10|||
145460731|NCT00171925|524538893|FG001|Overall Study|Administrative problems|11|||
145460732|NCT00171925|524538892|FG000|Overall Study|Death|1|||
145460733|NCT00171925|524538893|FG001|Overall Study|Death|2|||
145460734|NCT02182440|524538894|FG000|Overall Study|Adverse Event|0|||
145460735|NCT02182440|524538895|FG001|Overall Study|Adverse Event|1|||
145460736|NCT02182440|524538896|FG002|Overall Study|Adverse Event|0|||
145594298|NCT00449176|525028135|FG001|Overall Study|Adverse Event|107|||
145460737|NCT02182440|524538897|FG003|Overall Study|Adverse Event|0|||
145460738|NCT02182440|524538894|FG000|Overall Study|Death|31|||
145460739|NCT02182440|524538895|FG001|Overall Study|Death|8|||
145460740|NCT02182440|524538896|FG002|Overall Study|Death|5|||
145460741|NCT02182440|524538897|FG003|Overall Study|Death|16|||
145460742|NCT02182440|524538894|FG000|Overall Study|Protocol Violation|0|||
145460743|NCT02182440|524538895|FG001|Overall Study|Protocol Violation|1|||
145460744|NCT02182440|524538896|FG002|Overall Study|Protocol Violation|0|||
145460745|NCT02182440|524538897|FG003|Overall Study|Protocol Violation|0|||
145460746|NCT02182440|524538894|FG000|Overall Study|Physician Decision|1|||
145460747|NCT02182440|524538895|FG001|Overall Study|Physician Decision|0|||
145460748|NCT02182440|524538896|FG002|Overall Study|Physician Decision|0|||
145460749|NCT02182440|524538897|FG003|Overall Study|Physician Decision|0|||
145460750|NCT02182440|524538894|FG000|Overall Study|Withdrawal by Subject|1|||
145460751|NCT02182440|524538895|FG001|Overall Study|Withdrawal by Subject|1|||
145460752|NCT02182440|524538896|FG002|Overall Study|Withdrawal by Subject|3|||
145460753|NCT02182440|524538897|FG003|Overall Study|Withdrawal by Subject|4|||
145460754|NCT02182440|524538894|FG000|Overall Study|different, e.g adm other hospital|12|||
145460755|NCT02182440|524538895|FG001|Overall Study|different, e.g adm other hospital|3|||
145460756|NCT02182440|524538896|FG002|Overall Study|different, e.g adm other hospital|3|||
145460757|NCT02182440|524538897|FG003|Overall Study|different, e.g adm other hospital|10|||
145460758|NCT01561755|524538900|FG000|Overall Study|Lost to Follow-up|0|||
145460759|NCT01561755|524538901|FG001|Overall Study|Lost to Follow-up|1|||
145460760|NCT01286987|524538903|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
145460761|NCT01286987|524538904|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
145460762|NCT01286987|524538905|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
145460763|NCT01286987|524538906|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
145460764|NCT01286987|524538907|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
145460765|NCT01286987|524538908|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
145460766|NCT01286987|524538909|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
145460767|NCT01286987|524538910|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
145460768|NCT01286987|524538911|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
145460769|NCT01286987|524538912|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
145460770|NCT01286987|524538913|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
145460771|NCT01286987|524538914|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
145460772|NCT01286987|524538915|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
145460773|NCT01286987|524538916|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
145460774|NCT01286987|524538917|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
145460775|NCT01286987|524538903|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
145460776|NCT01286987|524538904|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
145460777|NCT01286987|524538905|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
145460778|NCT01286987|524538906|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
145460779|NCT01286987|524538907|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
145460780|NCT01286987|524538908|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
145460781|NCT01286987|524538909|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
145460782|NCT01286987|524538910|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
145460783|NCT01286987|524538911|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
145460784|NCT01286987|524538912|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
145460785|NCT01286987|524538913|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
145460786|NCT01286987|524538914|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
145460787|NCT01286987|524538915|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
145460788|NCT01286987|524538916|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
145460789|NCT01286987|524538917|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
145460790|NCT01286987|524538903|FG000|Part 1: Dose Escalation|Physician Decision|0|||
145460791|NCT01286987|524538904|FG001|Part 1: Dose Escalation|Physician Decision|0|||
145460792|NCT01286987|524538905|FG002|Part 1: Dose Escalation|Physician Decision|0|||
145460793|NCT01286987|524538906|FG003|Part 1: Dose Escalation|Physician Decision|0|||
145460794|NCT01286987|524538907|FG004|Part 1: Dose Escalation|Physician Decision|1|||
145460795|NCT01286987|524538908|FG005|Part 1: Dose Escalation|Physician Decision|0|||
145460796|NCT01286987|524538909|FG006|Part 1: Dose Escalation|Physician Decision|0|||
145460797|NCT01286987|524538910|FG007|Part 1: Dose Escalation|Physician Decision|0|||
145460798|NCT01286987|524538911|FG008|Part 1: Dose Escalation|Physician Decision|0|||
145460799|NCT01286987|524538912|FG009|Part 1: Dose Escalation|Physician Decision|0|||
145460800|NCT01286987|524538913|FG010|Part 1: Dose Escalation|Physician Decision|0|||
145594299|NCT00449176|525028136|FG002|Overall Study|Adverse Event|15|||
145594300|NCT00449176|525028134|FG000|Overall Study|Lack of Efficacy|13|||
145594301|NCT00449176|525028135|FG001|Overall Study|Lack of Efficacy|7|||
145594302|NCT00449176|525028136|FG002|Overall Study|Lack of Efficacy|50|||
145594303|NCT00449176|525028134|FG000|Overall Study|Study drug non-compliant|14|||
145594304|NCT00449176|525028135|FG001|Overall Study|Study drug non-compliant|11|||
145594305|NCT00449176|525028136|FG002|Overall Study|Study drug non-compliant|11|||
145460801|NCT01286987|524538914|FG011|Part 1: Dose Escalation|Physician Decision|0|||
145460802|NCT01286987|524538915|FG012|Part 1: Dose Escalation|Physician Decision|0|||
145460803|NCT01286987|524538916|FG013|Part 1: Dose Escalation|Physician Decision|0|||
145460804|NCT01286987|524538917|FG014|Part 1: Dose Escalation|Physician Decision|0|||
145460805|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Death|0|||
145460806|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Death|0|||
145460807|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Death|0|||
145460808|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Death|0|||
145460809|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Death|0|||
145594306|NCT00449176|525028134|FG000|Overall Study|all other|22|||
145460810|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Death|0|||
145460811|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Death|0|||
145460812|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Death|0|||
145460813|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Death|0|||
145460814|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Death|0|||
145460815|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Death|0|||
145460816|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Death|0|||
145460817|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Death|1|||
145460818|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Death|1|||
145460819|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Death|0|||
145460820|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Physician Decision|0|||
145460821|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Physician Decision|0|||
145460822|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Physician Decision|0|||
145460823|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Physician Decision|0|||
145460824|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Physician Decision|0|||
145460825|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Physician Decision|0|||
145460826|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Physician Decision|0|||
145460827|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Physician Decision|0|||
145460828|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Physician Decision|0|||
145460829|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Physician Decision|0|||
145460830|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Physician Decision|1|||
145460831|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Physician Decision|1|||
145460832|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Physician Decision|0|||
145460833|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Physician Decision|1|||
145460834|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Physician Decision|0|||
145460835|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Other|0|||
145460836|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Other|0|||
145460837|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Other|0|||
145460838|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Other|0|||
145460839|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Other|0|||
145460840|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Other|0|||
145460841|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Other|0|||
145460842|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Other|0|||
145460843|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Other|0|||
145460844|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Other|0|||
145460845|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Other|0|||
145460846|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Other|0|||
145460847|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Other|0|||
145460848|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Other|1|||
145460849|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Other|0|||
145460850|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
145460851|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
145460852|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
145460853|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
145460854|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
145460855|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
145460856|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
145460857|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
145460858|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
145460859|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
145460860|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
145460861|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
145460862|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
145460863|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
145460864|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
145460865|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
145460866|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
145460867|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
145460868|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
145460869|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
145460870|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
145460871|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
145460872|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
145460873|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
145460874|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
145460875|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
145460876|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
145460877|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
145460878|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
145460879|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
145460880|NCT01286987|524538903|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460881|NCT01286987|524538904|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460882|NCT01286987|524538905|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460883|NCT01286987|524538906|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145594307|NCT00449176|525028135|FG001|Overall Study|all other|19|||
145460884|NCT01286987|524538907|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460885|NCT01286987|524538908|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460886|NCT01286987|524538909|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460887|NCT01286987|524538910|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460888|NCT01286987|524538911|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460889|NCT01286987|524538912|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460890|NCT01286987|524538913|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
145460891|NCT01286987|524538914|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460892|NCT01286987|524538915|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460893|NCT01286987|524538916|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460894|NCT01286987|524538917|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145460895|NCT00405964|524538918|FG000|Overall Study|Treatment Failure|17|||
145460896|NCT00405964|524538919|FG001|Overall Study|Treatment Failure|45|||
145460897|NCT00405964|524538918|FG000|Overall Study|Adverse Event|7|||
145460898|NCT00405964|524538919|FG001|Overall Study|Adverse Event|16|||
145460899|NCT00405964|524538918|FG000|Overall Study|Lost to Follow-up|5|||
145460900|NCT00405964|524538919|FG001|Overall Study|Lost to Follow-up|5|||
145460901|NCT00405964|524538918|FG000|Overall Study|Withdrawal by Subject|19|||
145460902|NCT00405964|524538919|FG001|Overall Study|Withdrawal by Subject|23|||
145460903|NCT00405964|524538918|FG000|Overall Study|Protocol Violation|11|||
145460904|NCT00405964|524538919|FG001|Overall Study|Protocol Violation|6|||
145460905|NCT00392808|524538921|FG000|Overall Study|Lost to Follow-up|3|||
145460906|NCT00392808|524538922|FG001|Overall Study|Lost to Follow-up|2|||
145460907|NCT00392808|524538923|FG002|Overall Study|Lost to Follow-up|1|||
145460908|NCT00392808|524538924|FG003|Overall Study|Lost to Follow-up|2|||
145460909|NCT00392808|524538921|FG000|Overall Study|Unable to withdraw blood|3|||
145460910|NCT00392808|524538922|FG001|Overall Study|Unable to withdraw blood|1|||
145460911|NCT00392808|524538923|FG002|Overall Study|Unable to withdraw blood|1|||
145460912|NCT00392808|524538924|FG003|Overall Study|Unable to withdraw blood|2|||
145460913|NCT02649855|524538925|FG000|Overall Study|Refused further treatment|2|||
145460914|NCT02649855|524538926|FG001|Overall Study|Refused further treatment|1|||
145460915|NCT02649855|524538927|FG002|Overall Study|Refused further treatment|1|||
145460916|NCT02649855|524538925|FG000|Overall Study|Withdrew consent|0|||
145460917|NCT02649855|524538926|FG001|Overall Study|Withdrew consent|1|||
145460918|NCT02649855|524538927|FG002|Overall Study|Withdrew consent|0|||
145460919|NCT02649855|524538925|FG000|Overall Study|Switched to alternative treatment|0|||
145460920|NCT02649855|524538926|FG001|Overall Study|Switched to alternative treatment|1|||
145460921|NCT02649855|524538927|FG002|Overall Study|Switched to alternative treatment|1|||
145460922|NCT02649855|524538925|FG000|Overall Study|Principal investigator discretion|0|||
145460923|NCT02649855|524538926|FG001|Overall Study|Principal investigator discretion|1|||
145460924|NCT02649855|524538927|FG002|Overall Study|Principal investigator discretion|1|||
145460925|NCT02649855|524538925|FG000|Overall Study|No treatment, per protocol|1|||
145460926|NCT02649855|524538926|FG001|Overall Study|No treatment, per protocol|0|||
145460927|NCT02649855|524538927|FG002|Overall Study|No treatment, per protocol|0|||
145460928|NCT02649855|524538925|FG000|Overall Study|Initiate new treatment|1|||
145460929|NCT02649855|524538926|FG001|Overall Study|Initiate new treatment|0|||
145460930|NCT02649855|524538927|FG002|Overall Study|Initiate new treatment|0|||
145460931|NCT01300819|524538928|FG000|Overall Study|Adverse Event|9|||
145460932|NCT01300819|524538929|FG001|Overall Study|Adverse Event|27|||
145460933|NCT01300819|524538928|FG000|Overall Study|Lack of Efficacy|2|||
145460934|NCT01300819|524538929|FG001|Overall Study|Lack of Efficacy|1|||
145460935|NCT01300819|524538928|FG000|Overall Study|Withdrawal by Subject|10|||
145460936|NCT01300819|524538929|FG001|Overall Study|Withdrawal by Subject|12|||
145460937|NCT01300819|524538928|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
145460938|NCT01300819|524538929|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
145460939|NCT01300819|524538928|FG000|Overall Study|Refusal to down titrate study drug|0|||
145460940|NCT01300819|524538929|FG001|Overall Study|Refusal to down titrate study drug|1|||
145460941|NCT01300819|524538928|FG000|Overall Study|Administrative reason|0|||
145460942|NCT01300819|524538929|FG001|Overall Study|Administrative reason|1|||
145460943|NCT01300819|524538928|FG000|Overall Study|Safety follow up not done by mistake|0|||
145460944|NCT01300819|524538929|FG001|Overall Study|Safety follow up not done by mistake|1|||
145460945|NCT01300819|524538928|FG000|Overall Study|Follow up call was not done|1|||
145460946|NCT01300819|524538929|FG001|Overall Study|Follow up call was not done|0|||
145460947|NCT02818036|524538930|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
145460948|NCT02818036|524538931|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
145460949|NCT02818036|524538930|FG000|Overall Study|Withdrawal by Subject|1|||
145460950|NCT02818036|524538931|FG001|Overall Study|Withdrawal by Subject|0|||
145460951|NCT01319721|524538939|FG000|Overall Study|Lost to Follow-up|1|||
145460952|NCT01319721|524538940|FG001|Overall Study|Lost to Follow-up|6|||
145460953|NCT02653495|524538942|FG000|Overall Study|Lost to Follow-up|2|||
145460954|NCT02653495|524538943|FG001|Overall Study|Lost to Follow-up|0|||
145460955|NCT02653495|524538942|FG000|Overall Study|Screening Failure|10|||
145460956|NCT02653495|524538943|FG001|Overall Study|Screening Failure|0|||
145460957|NCT00468845|524538944|FG000|Overall Study|Adverse Event|9|||
145460958|NCT00468845|524538945|FG001|Overall Study|Adverse Event|14|||
145460959|NCT00468845|524538946|FG002|Overall Study|Adverse Event|11|||
145460960|NCT00468845|524538944|FG000|Overall Study|Lost to Follow-up|2|||
145460961|NCT00468845|524538945|FG001|Overall Study|Lost to Follow-up|1|||
145460962|NCT00468845|524538946|FG002|Overall Study|Lost to Follow-up|2|||
145460963|NCT00468845|524538944|FG000|Overall Study|Other|4|||
145460964|NCT00468845|524538945|FG001|Overall Study|Other|9|||
145460965|NCT00468845|524538946|FG002|Overall Study|Other|5|||
145460966|NCT00468845|524538944|FG000|Overall Study|No longer willing to participate|5|||
145460967|NCT00468845|524538945|FG001|Overall Study|No longer willing to participate|6|||
145460968|NCT00468845|524538946|FG002|Overall Study|No longer willing to participate|10|||
145460969|NCT00468845|524538944|FG000|Overall Study|Randomized, not treated|1|||
145460970|NCT00468845|524538945|FG001|Overall Study|Randomized, not treated|4|||
145460971|NCT00468845|524538946|FG002|Overall Study|Randomized, not treated|2|||
145460972|NCT00461305|524538947|FG000|Treatment|Adverse Event|26|||
145460973|NCT00461305|524538948|FG001|Treatment|Adverse Event|3|||
145460974|NCT00461305|524538947|FG000|Treatment|Lost to Follow-up|4|||
145460975|NCT00461305|524538948|FG001|Treatment|Lost to Follow-up|2|||
145460976|NCT00461305|524538947|FG000|Treatment|Protocol Violation|13|||
145460977|NCT00461305|524538948|FG001|Treatment|Protocol Violation|2|||
145460978|NCT00461305|524538947|FG000|Treatment|Withdrawal by Subject|48|||
145460979|NCT00461305|524538948|FG001|Treatment|Withdrawal by Subject|2|||
145460980|NCT00461305|524538947|FG000|Treatment|Never dispensed|5|||
145460981|NCT00461305|524538948|FG001|Treatment|Never dispensed|0|||
145460982|NCT00461305|524538947|FG000|Treatment|Study drug not taken|1|||
145460983|NCT00461305|524538948|FG001|Treatment|Study drug not taken|0|||
145460984|NCT00461305|524538947|FG000|Treatment|Partially missing diary|2|||
145460985|NCT00461305|524538948|FG001|Treatment|Partially missing diary|0|||
145460986|NCT00461305|524538947|FG000|Treatment|Other (missing drug etc)|2|||
145460987|NCT00461305|524538948|FG001|Treatment|Other (missing drug etc)|0|||
145460988|NCT00461305|524538947|FG000|Continued Treatment|Adverse Event|26|||
145460989|NCT00461305|524538948|FG001|Continued Treatment|Adverse Event|0|||
145460990|NCT00461305|524538947|FG000|Continued Treatment|Lost to Follow-up|4|||
145594308|NCT00449176|525028136|FG002|Overall Study|all other|20|||
145594309|NCT00675766|525028137|FG000|Overall Study|Lost to Follow-up|6|||
145594310|NCT00675766|525028138|FG001|Overall Study|Lost to Follow-up|5|||
145594311|NCT00675766|525028139|FG002|Overall Study|Lost to Follow-up|21|||
145594312|NCT00675766|525028140|FG003|Overall Study|Lost to Follow-up|26|||
145594313|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
145594314|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
145594315|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|disease progression|58|||
145594316|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|disease progression|47|||
145594317|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Death|3|||
145594318|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Death|6|||
145594319|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
145594320|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
145594321|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
145594322|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
145594323|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
145594324|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
145594325|NCT02472964|525028141|FG000|Part 1 (up to Week 24)|Other|2|||
145594326|NCT02472964|525028142|FG001|Part 1 (up to Week 24)|Other|1|||
145594327|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
145594328|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
145594329|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
145594330|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
145626810|NCT02688621|525147077|FG000|Overall Study|Lost to Follow-up|38|||
145626811|NCT02688621|525147078|FG001|Overall Study|Lost to Follow-up|15|||
145460991|NCT00461305|524538948|FG001|Continued Treatment|Lost to Follow-up|0|||
145460992|NCT00461305|524538947|FG000|Continued Treatment|Protocol Violation|13|||
145460993|NCT00461305|524538948|FG001|Continued Treatment|Protocol Violation|0|||
145460994|NCT00461305|524538947|FG000|Continued Treatment|Withdrawal by Subject|48|||
145460995|NCT00461305|524538948|FG001|Continued Treatment|Withdrawal by Subject|0|||
145460996|NCT00461305|524538947|FG000|Continued Treatment|Partially missing diary|2|||
145594331|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Death|0|||
145594332|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Death|1|||
145594333|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
145594334|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
145594335|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
145594336|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
145626812|NCT02688621|525147077|FG000|Overall Study|Withdrawal by Subject|1|||
145460997|NCT00461305|524538948|FG001|Continued Treatment|Partially missing diary|0|||
145460998|NCT00461305|524538947|FG000|Continued Treatment|Other (missing drug etc)|2|||
145460999|NCT00461305|524538948|FG001|Continued Treatment|Other (missing drug etc)|0|||
145461000|NCT01007123|524541310|FG000|Overall Study|Adverse Event|3|||
145461001|NCT01007123|524541311|FG001|Overall Study|Adverse Event|4|||
145461002|NCT01007123|524541312|FG002|Overall Study|Adverse Event|7|||
145461003|NCT01007123|524541313|FG003|Overall Study|Adverse Event|1|||
145461004|NCT01007123|524541310|FG000|Overall Study|Lack of Efficacy|1|||
145461005|NCT01007123|524541311|FG001|Overall Study|Lack of Efficacy|0|||
145461006|NCT01007123|524541312|FG002|Overall Study|Lack of Efficacy|1|||
145461007|NCT01007123|524541313|FG003|Overall Study|Lack of Efficacy|4|||
145461008|NCT01007123|524541310|FG000|Overall Study|Protocol Violation|1|||
145461009|NCT01007123|524541311|FG001|Overall Study|Protocol Violation|1|||
145461010|NCT01007123|524541312|FG002|Overall Study|Protocol Violation|2|||
145626813|NCT02688621|525147078|FG001|Overall Study|Withdrawal by Subject|0|||
145461011|NCT01007123|524541313|FG003|Overall Study|Protocol Violation|1|||
145461012|NCT01007123|524541310|FG000|Overall Study|Withdrawal by Subject|1|||
145461013|NCT01007123|524541311|FG001|Overall Study|Withdrawal by Subject|0|||
145461014|NCT01007123|524541312|FG002|Overall Study|Withdrawal by Subject|1|||
145461015|NCT01007123|524541313|FG003|Overall Study|Withdrawal by Subject|0|||
145461016|NCT01007123|524541310|FG000|Overall Study|Lost to Follow-up|0|||
145461017|NCT01007123|524541311|FG001|Overall Study|Lost to Follow-up|1|||
145461018|NCT01007123|524541312|FG002|Overall Study|Lost to Follow-up|0|||
145461019|NCT01007123|524541313|FG003|Overall Study|Lost to Follow-up|0|||
145461020|NCT02838901|524541314|FG000|Overall Study|Withdrawal by Subject|1|||
145461021|NCT02838901|524541315|FG001|Overall Study|Withdrawal by Subject|1|||
145461022|NCT02838901|524541314|FG000|Overall Study|Lost to Follow-up|1|||
145461023|NCT02838901|524541315|FG001|Overall Study|Lost to Follow-up|1|||
145461024|NCT00320255|524541316|FG000|Overall Study|Lack of Efficacy|1|||
145461025|NCT00320255|524541317|FG001|Overall Study|Lack of Efficacy|0|||
145461026|NCT00320255|524541318|FG002|Overall Study|Lack of Efficacy|0|||
145461027|NCT00320255|524541319|FG003|Overall Study|Lack of Efficacy|0|||
145461028|NCT00320255|524541320|FG004|Overall Study|Lack of Efficacy|0|||
145461029|NCT00320255|524541321|FG005|Overall Study|Lack of Efficacy|0|||
145461030|NCT00320255|524541316|FG000|Overall Study|Adverse Event|5|||
145461031|NCT00320255|524541317|FG001|Overall Study|Adverse Event|2|||
145461032|NCT00320255|524541318|FG002|Overall Study|Adverse Event|3|||
145461033|NCT00320255|524541319|FG003|Overall Study|Adverse Event|2|||
145461034|NCT00320255|524541320|FG004|Overall Study|Adverse Event|0|||
145461035|NCT00320255|524541321|FG005|Overall Study|Adverse Event|0|||
145461036|NCT00320255|524541316|FG000|Overall Study|Withdrawal by Subject|1|||
145461037|NCT00320255|524541317|FG001|Overall Study|Withdrawal by Subject|2|||
145626814|NCT04565249|525147083|FG000|Overall Study|Death|0|||
145626815|NCT04565249|525147084|FG001|Overall Study|Death|0|||
145626816|NCT04565249|525147085|FG002|Overall Study|Death|0|||
145626817|NCT04565249|525147086|FG003|Overall Study|Death|1|||
145626818|NCT00886613|525147091|FG000|Overall Study|Protocol deviation (Part B)|1|||
145626819|NCT00886613|525147092|FG001|Overall Study|Protocol deviation (Part B)|0|||
145626820|NCT00886613|525147093|FG002|Overall Study|Protocol deviation (Part B)|0|||
145461038|NCT00320255|524541318|FG002|Overall Study|Withdrawal by Subject|2|||
145461039|NCT00320255|524541319|FG003|Overall Study|Withdrawal by Subject|4|||
145461040|NCT00320255|524541320|FG004|Overall Study|Withdrawal by Subject|0|||
145461041|NCT00320255|524541321|FG005|Overall Study|Withdrawal by Subject|0|||
145461042|NCT00320255|524541316|FG000|Overall Study|Poor compliance/noncompliance|1|||
145461043|NCT00320255|524541317|FG001|Overall Study|Poor compliance/noncompliance|1|||
145461044|NCT00320255|524541318|FG002|Overall Study|Poor compliance/noncompliance|0|||
145461045|NCT00320255|524541319|FG003|Overall Study|Poor compliance/noncompliance|1|||
145594337|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
145594338|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
145594339|NCT02472964|525028141|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
145594340|NCT02472964|525028142|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
145594341|NCT01749982|525028147|FG000|Overall Study|Physician Decision|0|||
145594342|NCT01749982|525028148|FG001|Overall Study|Physician Decision|0|||
145594343|NCT01749982|525028149|FG002|Overall Study|Physician Decision|0|||
145461046|NCT00320255|524541320|FG004|Overall Study|Poor compliance/noncompliance|0|||
145461047|NCT00320255|524541321|FG005|Overall Study|Poor compliance/noncompliance|0|||
145461048|NCT00320255|524541316|FG000|Overall Study|No longer meets study criteria|0|||
145461049|NCT00320255|524541317|FG001|Overall Study|No longer meets study criteria|0|||
145461050|NCT00320255|524541318|FG002|Overall Study|No longer meets study criteria|0|||
145461051|NCT00320255|524541319|FG003|Overall Study|No longer meets study criteria|1|||
145461052|NCT00320255|524541320|FG004|Overall Study|No longer meets study criteria|0|||
145461053|NCT00320255|524541321|FG005|Overall Study|No longer meets study criteria|0|||
145461054|NCT00320255|524541316|FG000|Overall Study|Other|3|||
145461055|NCT00320255|524541317|FG001|Overall Study|Other|2|||
145461056|NCT00320255|524541318|FG002|Overall Study|Other|1|||
145461057|NCT00320255|524541319|FG003|Overall Study|Other|0|||
145461058|NCT00320255|524541320|FG004|Overall Study|Other|0|||
145461059|NCT00320255|524541321|FG005|Overall Study|Other|0|||
145461060|NCT03405935|524541323|FG000|Overall Study|Adverse Event|3|||
145594344|NCT01749982|525028150|FG003|Overall Study|Physician Decision|1|||
145594345|NCT01749982|525028147|FG000|Overall Study|Lost to Follow-up|0|||
145594346|NCT01749982|525028148|FG001|Overall Study|Lost to Follow-up|0|||
145594347|NCT01749982|525028149|FG002|Overall Study|Lost to Follow-up|0|||
145594348|NCT01749982|525028150|FG003|Overall Study|Lost to Follow-up|1|||
145626821|NCT00886613|525147091|FG000|Overall Study|Lost to follow-up (Part B)|1|||
145461061|NCT03405935|524541323|FG000|Overall Study|Death|2|||
145461062|NCT03405935|524541323|FG000|Overall Study|Withdrawal by Subject|1|||
145461063|NCT03405935|524541323|FG000|Overall Study|Lost to Follow-up|2|||
145461064|NCT02781792|524541331|FG000|Overall Study|Adverse Event|1|||
145461065|NCT02781792|524541332|FG001|Overall Study|Adverse Event|2|||
145461066|NCT02781792|524541331|FG000|Overall Study|Withdrawal by Subject|3|||
145461067|NCT02781792|524541332|FG001|Overall Study|Withdrawal by Subject|1|||
145461068|NCT02781792|524541331|FG000|Overall Study|Lack of Efficacy|1|||
145461069|NCT02781792|524541332|FG001|Overall Study|Lack of Efficacy|1|||
145461070|NCT02781792|524541331|FG000|Overall Study|Hospice|0|||
145461071|NCT02781792|524541332|FG001|Overall Study|Hospice|1|||
145461072|NCT00683917|524541340|FG000|Overall Study|Study prematurely terminated|10|||
145461073|NCT04422561|524541344|FG000|Overall Study|Lost to Follow-up|25|||
145461074|NCT04422561|524541345|FG001|Overall Study|Lost to Follow-up|11|||
145461075|NCT02685748|524541346|FG000|Overall Study|Withdrawal by Subject|3|||
145461076|NCT02685748|524541347|FG001|Overall Study|Withdrawal by Subject|2|||
145461077|NCT03500172|524541348|FG000|Period 1: Baseline Randomization|Death|0|||
145461078|NCT03500172|524541349|FG001|Period 1: Baseline Randomization|Death|0|||
145461079|NCT03500172|524541350|FG002|Period 1: Baseline Randomization|Death|0|||
145461080|NCT03500172|524541351|FG003|Period 1: Baseline Randomization|Death|0|||
145461081|NCT03500172|524541352|FG004|Period 1: Baseline Randomization|Death|0|||
145461082|NCT03500172|524541353|FG005|Period 1: Baseline Randomization|Death|0|||
145461083|NCT03500172|524541354|FG006|Period 1: Baseline Randomization|Death|0|||
145461084|NCT03500172|524541355|FG007|Period 1: Baseline Randomization|Death|0|||
145461085|NCT03500172|524541356|FG008|Period 1: Baseline Randomization|Death|0|||
145461086|NCT03500172|524541357|FG009|Period 1: Baseline Randomization|Death|2|||
145461087|NCT03500172|524541358|FG010|Period 1: Baseline Randomization|Death|0|||
145461088|NCT03500172|524541348|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
145461089|NCT03500172|524541349|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
145461090|NCT03500172|524541350|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
145461091|NCT03500172|524541351|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
145461092|NCT03500172|524541352|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
145461093|NCT03500172|524541353|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
145461094|NCT03500172|524541354|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
145461095|NCT03500172|524541355|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
145461096|NCT03500172|524541356|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
145461097|NCT03500172|524541357|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
145461098|NCT03500172|524541358|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
145461099|NCT03500172|524541348|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
145461100|NCT03500172|524541349|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
145461101|NCT03500172|524541350|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
145461102|NCT03500172|524541351|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
145461103|NCT03500172|524541352|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
145461104|NCT03500172|524541353|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
145461105|NCT03500172|524541354|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
145461106|NCT03500172|524541355|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
145461107|NCT03500172|524541356|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
145461108|NCT03500172|524541357|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
145461109|NCT03500172|524541358|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
145461110|NCT03500172|524541348|FG000|Period 2: Re-Randomization|Death|0|||
145461111|NCT03500172|524541349|FG001|Period 2: Re-Randomization|Death|0|||
145461112|NCT03500172|524541350|FG002|Period 2: Re-Randomization|Death|0|||
145461113|NCT03500172|524541351|FG003|Period 2: Re-Randomization|Death|4|||
145461114|NCT03500172|524541352|FG004|Period 2: Re-Randomization|Death|2|||
145461115|NCT03500172|524541353|FG005|Period 2: Re-Randomization|Death|0|||
145626822|NCT00886613|525147092|FG001|Overall Study|Lost to follow-up (Part B)|0|||
145461116|NCT03500172|524541354|FG006|Period 2: Re-Randomization|Death|5|||
145461117|NCT03500172|524541355|FG007|Period 2: Re-Randomization|Death|2|||
145461118|NCT03500172|524541356|FG008|Period 2: Re-Randomization|Death|0|||
145461119|NCT03500172|524541357|FG009|Period 2: Re-Randomization|Death|0|||
145461120|NCT03500172|524541358|FG010|Period 2: Re-Randomization|Death|0|||
145461121|NCT00090233|524541363|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
145461122|NCT00090233|524541364|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
145461123|NCT00090233|524541363|FG000|Overall Study|Adverse Event|214|||
145461124|NCT00090233|524541364|FG001|Overall Study|Adverse Event|198|||
145461125|NCT00090233|524541363|FG000|Overall Study|Lost to Follow-up|68|||
145461126|NCT00090233|524541364|FG001|Overall Study|Lost to Follow-up|95|||
145461127|NCT00090233|524541363|FG000|Overall Study|Protocol Violation|960|||
145461128|NCT00090233|524541364|FG001|Overall Study|Protocol Violation|1022|||
145461129|NCT00090233|524541363|FG000|Overall Study|Withdrawal by Subject|182|||
145461130|NCT00090233|524541364|FG001|Overall Study|Withdrawal by Subject|211|||
145461131|NCT00090233|524541363|FG000|Overall Study|Moved|203|||
145461132|NCT00090233|524541364|FG001|Overall Study|Moved|189|||
145461133|NCT00090233|524541363|FG000|Overall Study|Other|1211|||
145461134|NCT00090233|524541364|FG001|Overall Study|Other|1160|||
145461135|NCT00090233|524541363|FG000|Overall Study|Data not available at data cut-off point|1552|||
145461136|NCT00090233|524541364|FG001|Overall Study|Data not available at data cut-off point|1563|||
145461137|NCT04863248|524541365|FG000|Overall Study|Sponsor Terminated|4|||
145461138|NCT04863248|524541366|FG001|Overall Study|Sponsor Terminated|1|||
145461139|NCT04863248|524541365|FG000|Overall Study|Death|0|||
145461140|NCT04863248|524541366|FG001|Overall Study|Death|1|||
145461141|NCT04863248|524541365|FG000|Overall Study|Withdrawal by Subject|0|||
145461142|NCT04863248|524541366|FG001|Overall Study|Withdrawal by Subject|1|||
145461143|NCT01691105|524541370|FG000|1 Month Follow-up|Lost to Follow-up|41|||
145461144|NCT01691105|524541371|FG001|1 Month Follow-up|Lost to Follow-up|38|||
145461145|NCT01691105|524541370|FG000|1 Month Follow-up|Death|2|||
145461146|NCT01691105|524541371|FG001|1 Month Follow-up|Death|3|||
145461147|NCT01691105|524541370|FG000|6 Month Follow-up|Lost to Follow-up|39|||
145461148|NCT01691105|524541371|FG001|6 Month Follow-up|Lost to Follow-up|58|||
145461149|NCT01691105|524541370|FG000|6 Month Follow-up|Death|13|||
145461150|NCT01691105|524541371|FG001|6 Month Follow-up|Death|13|||
145461151|NCT01691105|524541370|FG000|12 Month Follow-up|Lost to Follow-up|50|||
145461152|NCT01691105|524541371|FG001|12 Month Follow-up|Lost to Follow-up|71|||
145461153|NCT01691105|524541370|FG000|12 Month Follow-up|Death|22|||
145461154|NCT01691105|524541371|FG001|12 Month Follow-up|Death|30|||
145461155|NCT01691105|524541370|FG000|12 Month Biochemical Verification|Death|22|||
145461156|NCT01691105|524541371|FG001|12 Month Biochemical Verification|Death|30|||
145461157|NCT01691105|524541370|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
145461158|NCT01691105|524541371|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
145461159|NCT01691105|524541370|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
145461160|NCT01691105|524541371|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
145461161|NCT01777542|524541374|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
145461162|NCT01777542|524541375|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
145461163|NCT05605691|524541376|FG000|Overall Study|Lost to Follow-up|1|||
145461164|NCT02279719|524541377|FG000|Overall Study|Patients randomized but never treated|0|||
145461165|NCT02279719|524541378|FG001|Overall Study|Patients randomized but never treated|0|||
145461166|NCT02279719|524541379|FG002|Overall Study|Patients randomized but never treated|0|||
145461167|NCT02279719|524541380|FG003|Overall Study|Patients randomized but never treated|0|||
145461168|NCT02279719|524541381|FG004|Overall Study|Patients randomized but never treated|3|||
145461169|NCT02279719|524541382|FG005|Overall Study|Patients randomized but never treated|0|||
145461170|NCT02279719|524541383|FG006|Overall Study|Patients randomized but never treated|3|||
145461171|NCT04706273|524541384|FG000|Overall Study|Withdrawal by Subject|27|||
145461172|NCT04706273|524541384|FG000|Overall Study|Physician Decision|1|||
145461173|NCT04706273|524541384|FG000|Overall Study|Lost to Follow-up|42|||
145461174|NCT04706273|524541384|FG000|Overall Study|Death|85|||
145461175|NCT04706273|524541384|FG000|Overall Study|Amputation that removes study device|2|||
145461176|NCT04706273|524541384|FG000|Overall Study|Surgical bypass|3|||
145461177|NCT04706273|524541384|FG000|Overall Study|Changing hospital|23|||
145461178|NCT04706273|524541384|FG000|Overall Study|Unable to attend hospital|2|||
145461179|NCT03541187|524541385|FG000|Overall Study|Lost to Follow-up|2|||
145461180|NCT03541187|524541386|FG001|Overall Study|Lost to Follow-up|6|||
145461181|NCT03541187|524541385|FG000|Overall Study|Pregnancy|0|||
145461182|NCT03541187|524541386|FG001|Overall Study|Pregnancy|1|||
145461183|NCT03541187|524541385|FG000|Overall Study|Withdrawal by Subject|6|||
145461184|NCT03541187|524541386|FG001|Overall Study|Withdrawal by Subject|2|||
145461185|NCT03541187|524541385|FG000|Overall Study|Moved out of town|1|||
145461186|NCT03541187|524541386|FG001|Overall Study|Moved out of town|0|||
145461187|NCT03541187|524541385|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
145461188|NCT03541187|524541386|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
145461189|NCT03541187|524541385|FG000|Overall Study|Did not meet randomization criteria|1|||
145461190|NCT03541187|524541386|FG001|Overall Study|Did not meet randomization criteria|1|||
145461191|NCT03541187|524541385|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
145461192|NCT03541187|524541386|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
145461193|NCT03541187|524541385|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
145461194|NCT03541187|524541386|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
145461195|NCT00869050|524541387|FG000|Overall Study|Screen Failure|3|||
145461196|NCT00246025|524541391|FG000|Overall Study|Adverse Event|7|||
145461197|NCT00246025|524541392|FG001|Overall Study|Adverse Event|9|||
145461198|NCT00246025|524541393|FG002|Overall Study|Adverse Event|9|||
145461199|NCT00246025|524541394|FG003|Overall Study|Adverse Event|10|||
145461200|NCT00246025|524541391|FG000|Overall Study|Withdrawal by Subject|3|||
145461201|NCT00246025|524541392|FG001|Overall Study|Withdrawal by Subject|0|||
145461202|NCT00246025|524541393|FG002|Overall Study|Withdrawal by Subject|1|||
145461203|NCT00246025|524541394|FG003|Overall Study|Withdrawal by Subject|2|||
145461204|NCT00246025|524541391|FG000|Overall Study|unsuitable medical history was found|0|||
145461205|NCT00246025|524541392|FG001|Overall Study|unsuitable medical history was found|0|||
145461206|NCT00246025|524541393|FG002|Overall Study|unsuitable medical history was found|0|||
145461207|NCT00246025|524541394|FG003|Overall Study|unsuitable medical history was found|1|||
145461208|NCT01643850|524541395|FG000|Overall Study|Withdrawal by Subject|0|||
145461209|NCT01643850|524541396|FG001|Overall Study|Withdrawal by Subject|0|||
145461210|NCT01643850|524541397|FG002|Overall Study|Withdrawal by Subject|0|||
145461211|NCT01643850|524541398|FG003|Overall Study|Withdrawal by Subject|0|||
145461212|NCT01643850|524541399|FG004|Overall Study|Withdrawal by Subject|1|||
145461213|NCT01643850|524541400|FG005|Overall Study|Withdrawal by Subject|0|||
145461214|NCT01643850|524541401|FG006|Overall Study|Withdrawal by Subject|0|||
145461215|NCT01643850|524541402|FG007|Overall Study|Withdrawal by Subject|0|||
145461216|NCT01643850|524541403|FG008|Overall Study|Withdrawal by Subject|0|||
145461217|NCT01643850|524541395|FG000|Overall Study|Lost to Follow-up|0|||
145461218|NCT01643850|524541396|FG001|Overall Study|Lost to Follow-up|0|||
145461219|NCT01643850|524541397|FG002|Overall Study|Lost to Follow-up|0|||
145461220|NCT01643850|524541398|FG003|Overall Study|Lost to Follow-up|0|||
145461221|NCT01643850|524541399|FG004|Overall Study|Lost to Follow-up|0|||
145461222|NCT01643850|524541400|FG005|Overall Study|Lost to Follow-up|0|||
145461223|NCT01643850|524541401|FG006|Overall Study|Lost to Follow-up|1|||
145461224|NCT01643850|524541402|FG007|Overall Study|Lost to Follow-up|0|||
145461225|NCT01643850|524541403|FG008|Overall Study|Lost to Follow-up|1|||
145461226|NCT01643850|524541395|FG000|Overall Study|Adverse Event|0|||
145461227|NCT01643850|524541396|FG001|Overall Study|Adverse Event|0|||
145461228|NCT01643850|524541397|FG002|Overall Study|Adverse Event|0|||
145461229|NCT01643850|524541398|FG003|Overall Study|Adverse Event|0|||
145461230|NCT01643850|524541399|FG004|Overall Study|Adverse Event|1|||
145461231|NCT01643850|524541400|FG005|Overall Study|Adverse Event|0|||
145461232|NCT01643850|524541401|FG006|Overall Study|Adverse Event|0|||
145461233|NCT01643850|524541402|FG007|Overall Study|Adverse Event|0|||
145461234|NCT01643850|524541403|FG008|Overall Study|Adverse Event|0|||
145461235|NCT01643850|524541395|FG000|Overall Study|Administrative Problems|0|||
145461236|NCT01643850|524541396|FG001|Overall Study|Administrative Problems|0|||
145461237|NCT01643850|524541397|FG002|Overall Study|Administrative Problems|1|||
145461238|NCT01643850|524541398|FG003|Overall Study|Administrative Problems|0|||
145461239|NCT01643850|524541399|FG004|Overall Study|Administrative Problems|1|||
145461240|NCT01643850|524541400|FG005|Overall Study|Administrative Problems|0|||
145461241|NCT01643850|524541401|FG006|Overall Study|Administrative Problems|0|||
145461242|NCT01643850|524541402|FG007|Overall Study|Administrative Problems|0|||
145461243|NCT01643850|524541403|FG008|Overall Study|Administrative Problems|0|||
145461244|NCT00931723|524541406|FG000|Overall Study|Withdrawal by Subject|11|||
145461245|NCT00931723|524541407|FG001|Overall Study|Withdrawal by Subject|13|||
145461246|NCT00931723|524541406|FG000|Overall Study|Adverse Event|6|||
145461247|NCT00931723|524541407|FG001|Overall Study|Adverse Event|13|||
145461248|NCT00931723|524541406|FG000|Overall Study|Lithium found in blood|0|||
145461249|NCT00931723|524541407|FG001|Overall Study|Lithium found in blood|1|||
145461250|NCT00931723|524541406|FG000|Overall Study|Condition under investigation worsened|1|||
145461251|NCT00931723|524541407|FG001|Overall Study|Condition under investigation worsened|2|||
145461252|NCT00931723|524541406|FG000|Overall Study|Lost to Follow-up|1|||
145461253|NCT00931723|524541407|FG001|Overall Study|Lost to Follow-up|2|||
145461254|NCT00931723|524541406|FG000|Overall Study|Study-specific discontinuation criteria|1|||
145461255|NCT00931723|524541407|FG001|Overall Study|Study-specific discontinuation criteria|1|||
145461256|NCT00931723|524541406|FG000|Overall Study|Severe non-compliance to protocol|2|||
145461257|NCT00931723|524541407|FG001|Overall Study|Severe non-compliance to protocol|0|||
145461258|NCT00931723|524541406|FG000|Overall Study|Safety reasons|0|||
145461259|NCT00931723|524541407|FG001|Overall Study|Safety reasons|1|||
145461260|NCT00931723|524541406|FG000|Overall Study|Took prohibited concomitant medication|0|||
145461261|NCT00931723|524541407|FG001|Overall Study|Took prohibited concomitant medication|1|||
145461262|NCT00931723|524541406|FG000|Overall Study|Lack or insufficient theraputic response|2|||
145461263|NCT00931723|524541407|FG001|Overall Study|Lack or insufficient theraputic response|5|||
145461264|NCT00931723|524541406|FG000|Overall Study|Sponsor decision|1|||
145461265|NCT00931723|524541407|FG001|Overall Study|Sponsor decision|0|||
145461266|NCT00931723|524541406|FG000|Overall Study|Late hospital discharge|1|||
145461267|NCT00931723|524541407|FG001|Overall Study|Late hospital discharge|0|||
145461268|NCT03300024|524541408|FG000|Overall Study|Physician Decision|4|||
145461269|NCT03300024|524541409|FG001|Overall Study|Physician Decision|6|||
145461270|NCT03305081|524541410|FG000|Overall Study|Lost to Follow-up|10|||
145461271|NCT03305081|524541411|FG001|Overall Study|Lost to Follow-up|15|||
145461272|NCT00570037|524541412|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
145461273|NCT00570037|524541413|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
145461274|NCT00554619|524541414|FG000|Overall Study|Adverse Event|1|||
145461275|NCT00554619|524541414|FG000|Overall Study|Physician Decision|1|||
145461276|NCT00554619|524541414|FG000|Overall Study|Liver Function Test Abnormality|1|||
145461277|NCT01571284|524541415|FG000|Overall Study|Participant's decision|84|||
145461278|NCT01571284|524541415|FG000|Overall Study|Lost to Follow-up|3|||
145461279|NCT01571284|524541415|FG000|Overall Study|Enrolled but not treated|2|||
145461280|NCT01571284|524541415|FG000|Overall Study|Other than specified above|80|||
145461281|NCT04465877|524541416|FG000|Overall Study|Noncompliant with study requirements|0|||
145461282|NCT04465877|524541417|FG001|Overall Study|Noncompliant with study requirements|0|||
145461283|NCT04465877|524541418|FG002|Overall Study|Noncompliant with study requirements|1|||
145461284|NCT04465877|524541419|FG003|Overall Study|Noncompliant with study requirements|0|||
145461285|NCT01598753|524541427|FG000|Overall Study|Adverse Event|1|||
145461286|NCT01598753|524541428|FG001|Overall Study|Adverse Event|9|||
145461287|NCT01598753|524541429|FG002|Overall Study|Adverse Event|1|||
145461288|NCT01598753|524541430|FG003|Overall Study|Adverse Event|7|||
145461289|NCT01598753|524541427|FG000|Overall Study|Lost to Follow-up|4|||
145594349|NCT01749982|525028147|FG000|Overall Study|Withdrawal by Subject|0|||
145594350|NCT01749982|525028148|FG001|Overall Study|Withdrawal by Subject|0|||
145594351|NCT01749982|525028149|FG002|Overall Study|Withdrawal by Subject|0|||
145594352|NCT01749982|525028150|FG003|Overall Study|Withdrawal by Subject|1|||
145594353|NCT01967732|525028151|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
145594354|NCT01967732|525028152|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
145594355|NCT01967732|525028153|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
145594356|NCT01967732|525028154|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
145594357|NCT01967732|525028151|FG000|First Intervention (Day 1)|Poor venous access|0|||
145594358|NCT01967732|525028152|FG001|First Intervention (Day 1)|Poor venous access|1|||
145594359|NCT01967732|525028153|FG002|First Intervention (Day 1)|Poor venous access|0|||
145594360|NCT01967732|525028154|FG003|First Intervention (Day 1)|Poor venous access|0|||
145594361|NCT00377403|525028156|FG000|Overall Study|Unable to contact for telephone intervie|4|||
145594362|NCT00377403|525028157|FG001|Overall Study|Unable to contact for telephone intervie|7|||
145594363|NCT01687257|525028161|FG000|Overall Study|Efficacy Failure|6|||
145594364|NCT01687257|525028162|FG001|Overall Study|Efficacy Failure|0|||
145594365|NCT01687257|525028163|FG002|Overall Study|Efficacy Failure|5|||
145594366|NCT01687257|525028161|FG000|Overall Study|Subject Withdrew Consent|1|||
145594367|NCT01687257|525028162|FG001|Overall Study|Subject Withdrew Consent|1|||
145461290|NCT01598753|524541428|FG001|Overall Study|Lost to Follow-up|3|||
145461291|NCT01598753|524541429|FG002|Overall Study|Lost to Follow-up|7|||
145461292|NCT01598753|524541430|FG003|Overall Study|Lost to Follow-up|5|||
145461293|NCT01598753|524541427|FG000|Overall Study|Physician Decision|0|||
145461294|NCT01598753|524541428|FG001|Overall Study|Physician Decision|1|||
145461295|NCT01598753|524541429|FG002|Overall Study|Physician Decision|0|||
145461296|NCT01598753|524541430|FG003|Overall Study|Physician Decision|2|||
145461297|NCT01598753|524541427|FG000|Overall Study|Withdrawal by Subject|7|||
145461298|NCT01598753|524541428|FG001|Overall Study|Withdrawal by Subject|2|||
145461299|NCT01598753|524541429|FG002|Overall Study|Withdrawal by Subject|0|||
145461300|NCT01598753|524541430|FG003|Overall Study|Withdrawal by Subject|1|||
145461301|NCT02275117|524541431|FG000|Overall Study|Adverse Event|0|||
145461302|NCT02275117|524541432|FG001|Overall Study|Adverse Event|0|||
145461303|NCT02275117|524541433|FG002|Overall Study|Adverse Event|0|||
145461304|NCT02275117|524541434|FG003|Overall Study|Adverse Event|0|||
145461305|NCT02275117|524541435|FG004|Overall Study|Adverse Event|1|||
145461306|NCT02275117|524541431|FG000|Overall Study|Lack of Efficacy|6|||
145461307|NCT02275117|524541432|FG001|Overall Study|Lack of Efficacy|7|||
145461308|NCT02275117|524541433|FG002|Overall Study|Lack of Efficacy|5|||
145461309|NCT02275117|524541434|FG003|Overall Study|Lack of Efficacy|2|||
145461310|NCT02275117|524541435|FG004|Overall Study|Lack of Efficacy|10|||
145461311|NCT02275117|524541431|FG000|Overall Study|Lost to Follow-up|11|||
145461312|NCT02275117|524541432|FG001|Overall Study|Lost to Follow-up|16|||
145461313|NCT02275117|524541433|FG002|Overall Study|Lost to Follow-up|15|||
145461314|NCT02275117|524541434|FG003|Overall Study|Lost to Follow-up|16|||
145461315|NCT02275117|524541435|FG004|Overall Study|Lost to Follow-up|8|||
145461316|NCT02275117|524541431|FG000|Overall Study|Physician Decision|0|||
145461317|NCT02275117|524541432|FG001|Overall Study|Physician Decision|1|||
145461318|NCT02275117|524541433|FG002|Overall Study|Physician Decision|1|||
145461319|NCT02275117|524541434|FG003|Overall Study|Physician Decision|0|||
145461320|NCT02275117|524541435|FG004|Overall Study|Physician Decision|1|||
145461321|NCT02275117|524541431|FG000|Overall Study|Protocol Violation|1|||
145594368|NCT01687257|525028163|FG002|Overall Study|Subject Withdrew Consent|1|||
145594369|NCT01687257|525028161|FG000|Overall Study|Adverse Event|1|||
145594370|NCT01687257|525028162|FG001|Overall Study|Adverse Event|0|||
145594371|NCT01687257|525028163|FG002|Overall Study|Adverse Event|0|||
145594372|NCT01687257|525028161|FG000|Overall Study|Investigator's Discretion|0|||
145461322|NCT02275117|524541432|FG001|Overall Study|Protocol Violation|0|||
145594373|NCT01687257|525028162|FG001|Overall Study|Investigator's Discretion|3|||
145594374|NCT01687257|525028163|FG002|Overall Study|Investigator's Discretion|0|||
145594375|NCT04403698|525028164|FG000|Overall Study|Adverse Event|1|||
145594376|NCT04403698|525028165|FG001|Overall Study|Adverse Event|1|||
145594377|NCT04403698|525028164|FG000|Overall Study|Lost to Follow-up|1|||
145461323|NCT02275117|524541433|FG002|Overall Study|Protocol Violation|1|||
145461324|NCT02275117|524541434|FG003|Overall Study|Protocol Violation|1|||
145461325|NCT02275117|524541435|FG004|Overall Study|Protocol Violation|0|||
145461326|NCT02275117|524541431|FG000|Overall Study|Withdrawal by Subject|6|||
145461327|NCT02275117|524541432|FG001|Overall Study|Withdrawal by Subject|4|||
145461328|NCT02275117|524541433|FG002|Overall Study|Withdrawal by Subject|7|||
145461329|NCT02275117|524541434|FG003|Overall Study|Withdrawal by Subject|3|||
145461330|NCT02275117|524541435|FG004|Overall Study|Withdrawal by Subject|3|||
145461331|NCT02275117|524541431|FG000|Overall Study|Terminated by Sponsor|4|||
145461332|NCT02275117|524541432|FG001|Overall Study|Terminated by Sponsor|4|||
145461333|NCT02275117|524541433|FG002|Overall Study|Terminated by Sponsor|4|||
145461334|NCT02275117|524541434|FG003|Overall Study|Terminated by Sponsor|6|||
145461335|NCT02275117|524541435|FG004|Overall Study|Terminated by Sponsor|4|||
145461336|NCT02275117|524541431|FG000|Overall Study|Worsening of Study Indication|0|||
145461337|NCT02275117|524541432|FG001|Overall Study|Worsening of Study Indication|1|||
145461338|NCT02275117|524541433|FG002|Overall Study|Worsening of Study Indication|2|||
145461339|NCT02275117|524541434|FG003|Overall Study|Worsening of Study Indication|0|||
145461340|NCT02275117|524541435|FG004|Overall Study|Worsening of Study Indication|0|||
145461341|NCT02275117|524541431|FG000|Overall Study|Study Burden|5|||
145461342|NCT02275117|524541432|FG001|Overall Study|Study Burden|4|||
145461343|NCT02275117|524541433|FG002|Overall Study|Study Burden|7|||
145461344|NCT02275117|524541434|FG003|Overall Study|Study Burden|5|||
145461345|NCT02275117|524541435|FG004|Overall Study|Study Burden|7|||
145461346|NCT02275117|524541431|FG000|Overall Study|Other|1|||
145461347|NCT02275117|524541432|FG001|Overall Study|Other|0|||
145461348|NCT02275117|524541433|FG002|Overall Study|Other|0|||
145461349|NCT02275117|524541434|FG003|Overall Study|Other|0|||
145461350|NCT02275117|524541435|FG004|Overall Study|Other|2|||
145461351|NCT01865812|524541436|FG000|Primary Treatment Phase|Adverse Event|2|||
145461352|NCT01865812|524541437|FG001|Primary Treatment Phase|Adverse Event|0|||
145461353|NCT01865812|524541436|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
145461354|NCT01865812|524541437|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
145461355|NCT01865812|524541436|FG000|Long-term Safety Extension Phase|Pruritus|0|||
145461356|NCT01865812|524541437|FG001|Long-term Safety Extension Phase|Pruritus|3|||
145461357|NCT01865812|524541436|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
145461358|NCT01865812|524541437|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
145461359|NCT01865812|524541436|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
145461360|NCT01865812|524541437|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
145461361|NCT02142283|524541442|FG000|Overall Study|Death|20|||
145461362|NCT02142283|524541443|FG001|Overall Study|Death|18|||
145461363|NCT02142283|524541442|FG000|Overall Study|Withdrawal by Subject|1|||
145461364|NCT02142283|524541443|FG001|Overall Study|Withdrawal by Subject|3|||
145461365|NCT00747344|524541444|FG000|Controlled Period|Adverse Event|3|||
145461366|NCT00747344|524541445|FG001|Controlled Period|Adverse Event|0|||
145461367|NCT00747344|524541446|FG002|Controlled Period|Adverse Event|0|||
145461368|NCT00747344|524541447|FG003|Controlled Period|Adverse Event|0|||
145461369|NCT00747344|524541444|FG000|Controlled Period|Lack of Efficacy|2|||
145461370|NCT00747344|524541445|FG001|Controlled Period|Lack of Efficacy|1|||
145461371|NCT00747344|524541446|FG002|Controlled Period|Lack of Efficacy|0|||
145461372|NCT00747344|524541447|FG003|Controlled Period|Lack of Efficacy|0|||
145461373|NCT00747344|524541444|FG000|Controlled Period|Other|0|||
145461374|NCT00747344|524541445|FG001|Controlled Period|Other|3|||
145461375|NCT00747344|524541446|FG002|Controlled Period|Other|0|||
145461376|NCT00747344|524541447|FG003|Controlled Period|Other|0|||
145461377|NCT00747344|524541444|FG000|After Controlled Period|Adverse Event|0|||
145461378|NCT00747344|524541445|FG001|After Controlled Period|Adverse Event|0|||
145461379|NCT00747344|524541446|FG002|After Controlled Period|Adverse Event|0|||
145461380|NCT00747344|524541447|FG003|After Controlled Period|Adverse Event|1|||
145461381|NCT02374814|524541448|FG000|Overall Study|Lost to Follow-up|1|||
145461382|NCT02374814|524541449|FG001|Overall Study|Lost to Follow-up|1|||
145461383|NCT02374814|524541450|FG002|Overall Study|Lost to Follow-up|0|||
145461384|NCT02374814|524541451|FG003|Overall Study|Lost to Follow-up|1|||
145461385|NCT02374814|524541452|FG004|Overall Study|Lost to Follow-up|0|||
145461386|NCT02374814|524541453|FG005|Overall Study|Lost to Follow-up|0|||
145461387|NCT02374814|524541448|FG000|Overall Study|Withdrawal by Subject|0|||
145461388|NCT02374814|524541449|FG001|Overall Study|Withdrawal by Subject|0|||
145461389|NCT02374814|524541450|FG002|Overall Study|Withdrawal by Subject|1|||
145461390|NCT02374814|524541451|FG003|Overall Study|Withdrawal by Subject|1|||
145461391|NCT02374814|524541452|FG004|Overall Study|Withdrawal by Subject|0|||
145461392|NCT02374814|524541453|FG005|Overall Study|Withdrawal by Subject|0|||
145461393|NCT01799239|524541454|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
145461394|NCT01799239|524541455|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
145461395|NCT01799239|524541454|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
145461396|NCT01799239|524541455|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
145461397|NCT01799239|524541454|FG000|Period 1 (7 Days)|Protocol Violation|0|||
145461398|NCT01799239|524541455|FG001|Period 1 (7 Days)|Protocol Violation|1|||
145461399|NCT01799239|524541454|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
145461400|NCT01799239|524541455|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
145461401|NCT01799239|524541454|FG000|Period 2 (7 Days)|Protocol Violation|1|||
145461402|NCT01799239|524541455|FG001|Period 2 (7 Days)|Protocol Violation|0|||
145461403|NCT03754582|524541456|FG000|Treatment Phase|Adverse Event|0|||
145461404|NCT03754582|524541457|FG001|Treatment Phase|Adverse Event|1|||
145461405|NCT03754582|524541458|FG002|Treatment Phase|Adverse Event|0|||
145461406|NCT03754582|524541456|FG000|Follow-up Phase|Other|0|||
145461407|NCT03754582|524541457|FG001|Follow-up Phase|Other|0|||
145461408|NCT03754582|524541458|FG002|Follow-up Phase|Other|1|||
145461409|NCT02680574|524541459|FG000|Overall Study|Death|137|||
145461410|NCT02680574|524541460|FG001|Overall Study|Death|137|||
145461411|NCT02680574|524541459|FG000|Overall Study|Withdrawal by Subject|17|||
145461412|NCT02680574|524541460|FG001|Overall Study|Withdrawal by Subject|9|||
145461413|NCT02680574|524541459|FG000|Overall Study|Lost to Follow-up|4|||
145461414|NCT02680574|524541460|FG001|Overall Study|Lost to Follow-up|6|||
145461415|NCT01166958|524541461|FG000|Overall Study|Withdrawal by Subject|1|||
145461416|NCT01166958|524541462|FG001|Overall Study|Withdrawal by Subject|0|||
145461417|NCT00681564|524541465|FG000|Overall Study|Lost to Follow-up|6|||
145461418|NCT00681564|524541466|FG001|Overall Study|Lost to Follow-up|6|||
145461419|NCT00681564|524541465|FG000|Overall Study|Withdrawal by Subject|0|||
145461420|NCT00681564|524541466|FG001|Overall Study|Withdrawal by Subject|1|||
145461421|NCT00681564|524541465|FG000|Overall Study|Death|0|||
145461422|NCT00681564|524541466|FG001|Overall Study|Death|1|||
145461423|NCT02826421|524541469|FG000|Overall Study|Adverse Event|1|||
145461424|NCT02826421|524541470|FG001|Overall Study|Adverse Event|0|||
145461425|NCT02826421|524541471|FG002|Overall Study|Adverse Event|0|||
145461426|NCT02826421|524541472|FG003|Overall Study|Adverse Event|1|||
145461427|NCT02826421|524541469|FG000|Overall Study|Withdrawal by Subject|1|||
145461428|NCT02826421|524541470|FG001|Overall Study|Withdrawal by Subject|3|||
145461429|NCT02826421|524541471|FG002|Overall Study|Withdrawal by Subject|1|||
145461430|NCT02826421|524541472|FG003|Overall Study|Withdrawal by Subject|1|||
145461431|NCT02826421|524541469|FG000|Overall Study|Reason not given|1|||
145461432|NCT02826421|524541470|FG001|Overall Study|Reason not given|0|||
145461433|NCT02826421|524541471|FG002|Overall Study|Reason not given|1|||
145461434|NCT02826421|524541472|FG003|Overall Study|Reason not given|0|||
145461435|NCT02210221|524541475|FG000|Overall Study|Lack of Efficacy|7|||
145461436|NCT02210221|524541475|FG000|Overall Study|Withdrawal by Subject|43|||
145461437|NCT02185014|524541480|FG000|Overall Study|Adverse Event|18|||
145461438|NCT02185014|524541480|FG000|Overall Study|Withdrew Consent|8|||
145461439|NCT02185014|524541480|FG000|Overall Study|Lost to Follow-up|4|||
145461440|NCT02185014|524541480|FG000|Overall Study|Lack of Efficacy|14|||
145461441|NCT02185014|524541480|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
145461442|NCT02185014|524541480|FG000|Overall Study|Subject Noncompliance|1|||
145461443|NCT02185014|524541480|FG000|Overall Study|Other|4|||
145461444|NCT03093974|524541481|FG000|Overall Study|Withdrawal by Subject|32|||
145461445|NCT03093974|524541482|FG001|Overall Study|Withdrawal by Subject|27|||
145461446|NCT03093974|524541481|FG000|Overall Study|Adverse Event|17|||
145461447|NCT03093974|524541482|FG001|Overall Study|Adverse Event|24|||
145461448|NCT03093974|524541481|FG000|Overall Study|Death|0|||
145461449|NCT03093974|524541482|FG001|Overall Study|Death|1|||
145461450|NCT03093974|524541481|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145461451|NCT03093974|524541482|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145461452|NCT03093974|524541481|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
145461453|NCT03093974|524541482|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
145461454|NCT03093974|524541481|FG000|Overall Study|Lost to Follow-up|0|||
145461455|NCT03093974|524541482|FG001|Overall Study|Lost to Follow-up|1|||
145461456|NCT03093974|524541481|FG000|Overall Study|Other|1|||
145461457|NCT03093974|524541482|FG001|Overall Study|Other|2|||
145461458|NCT02141490|524541483|FG000|Overall Study|Screening failures|4|||
145461459|NCT02141490|524541484|FG001|Overall Study|Screening failures|0|||
145461460|NCT02141490|524541485|FG002|Overall Study|Screening failures|0|||
145461461|NCT00033540|524541488|FG000|Overall Study|Adverse Event|14|||
145461462|NCT00033540|524541488|FG000|Overall Study|Death|1|||
145461463|NCT00033540|524541488|FG000|Overall Study|Progression|26|||
145461464|NCT00033540|524541488|FG000|Overall Study|Withdrawal by Subject|6|||
145461465|NCT00033540|524541488|FG000|Overall Study|Other|5|||
145461466|NCT00033540|524541488|FG000|Overall Study|Ineligible|3|||
145461467|NCT00033540|524541488|FG000|Overall Study|Never received treatment|2|||
145461468|NCT01253265|524541491|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
145461469|NCT01253265|524541492|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
145461470|NCT01253265|524541493|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
145461471|NCT01253265|524541494|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
145461472|NCT01253265|524541495|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
145461473|NCT01253265|524541491|FG000|Overall Study|Withdrawal by Subject|0|||
145461474|NCT01253265|524541492|FG001|Overall Study|Withdrawal by Subject|0|||
145461475|NCT01253265|524541493|FG002|Overall Study|Withdrawal by Subject|0|||
145461476|NCT01253265|524541494|FG003|Overall Study|Withdrawal by Subject|0|||
145461477|NCT01253265|524541495|FG004|Overall Study|Withdrawal by Subject|1|||
145461478|NCT00434759|524541498|FG000|Overall Study|Lack of Efficacy|5|||
145461479|NCT00434759|524541499|FG001|Overall Study|Lack of Efficacy|4|||
145461480|NCT00434759|524541498|FG000|Overall Study|Withdrawal by Subject|17|||
145461481|NCT00434759|524541499|FG001|Overall Study|Withdrawal by Subject|1|||
145461482|NCT00434759|524541498|FG000|Overall Study|family affairs|2|||
145461483|NCT00434759|524541499|FG001|Overall Study|family affairs|0|||
145461484|NCT00495521|524541500|FG000|Overall Study|Physician Decision|0|||
145461485|NCT00495521|524541501|FG001|Overall Study|Physician Decision|1|||
145461486|NCT02410824|524541502|FG000|First Intervention (One Week)|Headache|0|||
145461487|NCT02410824|524541503|FG001|First Intervention (One Week)|Headache|1|||
145461488|NCT02782325|524541504|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
145461489|NCT02782325|524541505|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
145461490|NCT02782325|524541506|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
145461491|NCT02782325|524541504|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
145461492|NCT02782325|524541505|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
145461493|NCT02782325|524541506|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
145461494|NCT01038713|524541507|FG000|Overall Study|Patient to hospice|1|||
145461495|NCT01038713|524541508|FG001|Overall Study|Patient to hospice|1|||
145461496|NCT01038713|524541509|FG002|Overall Study|Patient to hospice|1|||
145461497|NCT01038713|524541507|FG000|Overall Study|Lost to Follow-up|3|||
145461498|NCT01038713|524541508|FG001|Overall Study|Lost to Follow-up|0|||
145461499|NCT01038713|524541509|FG002|Overall Study|Lost to Follow-up|0|||
145461500|NCT01038713|524541507|FG000|Overall Study|Neuroendocrine Tumor|0|||
145461501|NCT01038713|524541508|FG001|Overall Study|Neuroendocrine Tumor|1|||
145461502|NCT01038713|524541509|FG002|Overall Study|Neuroendocrine Tumor|0|||
145461503|NCT01038713|524541507|FG000|Overall Study|died from PEP|0|||
145461504|NCT01038713|524541508|FG001|Overall Study|died from PEP|1|||
145461505|NCT01038713|524541509|FG002|Overall Study|died from PEP|0|||
145461506|NCT01038713|524541507|FG000|Overall Study|Autoimmune Pancreatitis|1|||
145461507|NCT01038713|524541508|FG001|Overall Study|Autoimmune Pancreatitis|0|||
145461508|NCT01038713|524541509|FG002|Overall Study|Autoimmune Pancreatitis|0|||
145461509|NCT03777917|524541510|FG000|Overall Study|Withdrawal by Subject|1|||
145461510|NCT03777917|524541511|FG001|Overall Study|Withdrawal by Subject|0|||
145461511|NCT03777917|524541510|FG000|Overall Study|Physician Decision|1|||
145461512|NCT03777917|524541511|FG001|Overall Study|Physician Decision|0|||
145461513|NCT03777917|524541510|FG000|Overall Study|Lost to Follow-up|6|||
145461514|NCT03777917|524541511|FG001|Overall Study|Lost to Follow-up|2|||
145461515|NCT03777917|524541510|FG000|Overall Study|Other|1|||
145461516|NCT03777917|524541511|FG001|Overall Study|Other|0|||
145461517|NCT00930969|524541512|FG000|Overall Study|Death|5|||
145461518|NCT00930969|524541512|FG000|Overall Study|Lost to Follow-up|1|||
145461519|NCT00930969|524541512|FG000|Overall Study|Physician Decision|13|||
145461520|NCT00930969|524541512|FG000|Overall Study|Withdrawal by Subject|19|||
145461521|NCT00657150|524541513|FG000|Overall Study|Adverse Event|19|||
145461522|NCT00657150|524541514|FG001|Overall Study|Adverse Event|10|||
145461523|NCT00657150|524541513|FG000|Overall Study|Non-compliant with protocol|5|||
145461524|NCT00657150|524541514|FG001|Overall Study|Non-compliant with protocol|9|||
145461525|NCT00657150|524541513|FG000|Overall Study|Lost to Follow-up|2|||
145461526|NCT00657150|524541514|FG001|Overall Study|Lost to Follow-up|0|||
145461527|NCT00657150|524541513|FG000|Overall Study|Withdrawal by Subject|51|||
145461528|NCT00657150|524541514|FG001|Overall Study|Withdrawal by Subject|36|||
145461529|NCT00657150|524541513|FG000|Overall Study|Other|38|||
145461530|NCT00657150|524541514|FG001|Overall Study|Other|38|||
145461531|NCT00657150|524541513|FG000|Treatment|Adverse Event|60|||
145461532|NCT00657150|524541514|FG001|Treatment|Adverse Event|53|||
145461533|NCT00657150|524541513|FG000|Treatment|Non-compliant with protocol|10|||
145461534|NCT00657150|524541514|FG001|Treatment|Non-compliant with protocol|9|||
145461535|NCT00657150|524541513|FG000|Treatment|Lost to Follow-up|1|||
145461536|NCT00657150|524541514|FG001|Treatment|Lost to Follow-up|0|||
145461537|NCT00657150|524541513|FG000|Treatment|Withdrawal by Subject|23|||
145461538|NCT00657150|524541514|FG001|Treatment|Withdrawal by Subject|20|||
145461539|NCT00657150|524541513|FG000|Treatment|Other|13|||
145461540|NCT00657150|524541514|FG001|Treatment|Other|15|||
145461541|NCT02966795|524541515|FG000|Overall Study|Patient Left the Country|0|||
145461542|NCT02966795|524541516|FG001|Overall Study|Patient Left the Country|1|||
145461543|NCT00432744|524541517|FG000|Months 0-6|Withdrawal by Subject|4|||
145461544|NCT00432744|524541518|FG001|Months 0-6|Withdrawal by Subject|4|||
145461545|NCT00432744|524541517|FG000|Months 0-6|Too disabled to score|1|||
145461546|NCT00432744|524541518|FG001|Months 0-6|Too disabled to score|0|||
145461547|NCT00432744|524541517|FG000|Months 7 - 12|Withdrawal by Subject|1|||
145461548|NCT00432744|524541518|FG001|Months 7 - 12|Withdrawal by Subject|0|||
145461549|NCT00432744|524541517|FG000|Months 7 - 12|Too disabled to score|0|||
145461550|NCT00432744|524541518|FG001|Months 7 - 12|Too disabled to score|1|||
145461551|NCT01416441|524541519|FG000|Overall Study|Lost to Follow-up|5|||
145461552|NCT01416441|524541519|FG000|Overall Study|Adverse Event|6|||
145461553|NCT01416441|524541519|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
145461554|NCT01416441|524541519|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
145461555|NCT01416441|524541519|FG000|Overall Study|Investigator Withdrew Subject|2|||
145461556|NCT01416441|524541519|FG000|Overall Study|Subject Withdrew Consent|12|||
145461557|NCT01416441|524541519|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
145461558|NCT04030247|524543683|FG000|Overall Study|Withdrawal by Subject|4|||
145461559|NCT04030247|524543683|FG000|Overall Study|Lost to Follow-up|13|||
145461560|NCT03966885|524543684|FG000|Overall Study|Death|1|||
145461561|NCT03966885|524543685|FG001|Overall Study|Death|0|||
145461562|NCT03966885|524543684|FG000|Overall Study|Lost to Follow-up|1|||
145461563|NCT03966885|524543685|FG001|Overall Study|Lost to Follow-up|2|||
145461564|NCT03966885|524543684|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
145461565|NCT03966885|524543685|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
145461566|NCT03966885|524543684|FG000|Overall Study|Moved from study area.|0|||
145461567|NCT03966885|524543685|FG001|Overall Study|Moved from study area.|2|||
145461568|NCT03187834|524543686|FG000|Overall Study|Lost to Follow-up|0|||
145461569|NCT03187834|524543687|FG001|Overall Study|Lost to Follow-up|1|||
145461570|NCT03187834|524543688|FG002|Overall Study|Lost to Follow-up|2|||
145461571|NCT03187834|524543689|FG003|Overall Study|Lost to Follow-up|2|||
145461572|NCT03187834|524543686|FG000|Overall Study|Had invalid anthropometric measurements|5|||
145461573|NCT03187834|524543687|FG001|Overall Study|Had invalid anthropometric measurements|3|||
145461574|NCT03187834|524543688|FG002|Overall Study|Had invalid anthropometric measurements|4|||
145461575|NCT03187834|524543689|FG003|Overall Study|Had invalid anthropometric measurements|2|||
145461576|NCT01930890|524543690|FG000|Overall Study|Study Termination|14|||
145461577|NCT01930890|524543691|FG001|Overall Study|Study Termination|28|||
145461578|NCT01930890|524543692|FG002|Overall Study|Study Termination|13|||
145461579|NCT01930890|524543693|FG003|Overall Study|Study Termination|25|||
145461580|NCT01930890|524543690|FG000|Overall Study|Death|0|||
145461581|NCT01930890|524543691|FG001|Overall Study|Death|0|||
145461582|NCT01930890|524543692|FG002|Overall Study|Death|0|||
145461583|NCT01930890|524543693|FG003|Overall Study|Death|1|||
145461584|NCT01930890|524543690|FG000|Overall Study|Investigator Decision|0|||
145461585|NCT01930890|524543691|FG001|Overall Study|Investigator Decision|1|||
145461586|NCT01930890|524543692|FG002|Overall Study|Investigator Decision|0|||
145461587|NCT01930890|524543693|FG003|Overall Study|Investigator Decision|0|||
145461588|NCT01930890|524543690|FG000|Overall Study|Consent Withdrawn|0|||
145461589|NCT01930890|524543691|FG001|Overall Study|Consent Withdrawn|3|||
145461590|NCT01930890|524543692|FG002|Overall Study|Consent Withdrawn|0|||
145461591|NCT01930890|524543693|FG003|Overall Study|Consent Withdrawn|1|||
145461592|NCT01930890|524543690|FG000|Overall Study|Adverse Event|0|||
145461593|NCT01930890|524543691|FG001|Overall Study|Adverse Event|1|||
145461594|NCT01930890|524543692|FG002|Overall Study|Adverse Event|0|||
145461595|NCT01930890|524543693|FG003|Overall Study|Adverse Event|0|||
145461596|NCT03710876|524543694|FG000|Overall Study|Death|0|||
145461597|NCT03710876|524543695|FG001|Overall Study|Death|2|||
145461598|NCT03710876|524543694|FG000|Overall Study|Withdrawal by Subject|0|||
145461599|NCT03710876|524543695|FG001|Overall Study|Withdrawal by Subject|2|||
145461600|NCT04979897|524543699|FG000|Overall Study|Death|1|||
145461601|NCT04979897|524543700|FG001|Overall Study|Death|8|||
145461602|NCT04979897|524543699|FG000|Overall Study|Lost to Follow-up|111|||
145461603|NCT04979897|524543700|FG001|Overall Study|Lost to Follow-up|56|||
145461604|NCT04979897|524543699|FG000|Overall Study|Withdrawal by Subject|7|||
145461605|NCT04979897|524543700|FG001|Overall Study|Withdrawal by Subject|2|||
145461606|NCT03383783|524543702|FG000|Overall Study|Withdrawal by Subject|2|||
145461607|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
145461608|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
145461609|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
145461610|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
145461611|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
145461612|NCT01224821|524543704|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
145461613|NCT01224821|524543704|FG000|Long-Term Follow-Up|Death|2|||
145461614|NCT01224821|524543704|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
145461615|NCT00350623|524543707|FG000|Overall Study|Lost to Follow-up|8|||
145461616|NCT00350623|524543708|FG001|Overall Study|Lost to Follow-up|3|||
145461617|NCT00350623|524543709|FG002|Overall Study|Lost to Follow-up|4|||
145461618|NCT00350623|524543707|FG000|Overall Study|Withdrawal by Subject|0|||
145461619|NCT00350623|524543708|FG001|Overall Study|Withdrawal by Subject|1|||
145461620|NCT00350623|524543709|FG002|Overall Study|Withdrawal by Subject|1|||
145461621|NCT00350623|524543707|FG000|Overall Study|patient traveling outside the country|0|||
145461622|NCT00350623|524543708|FG001|Overall Study|patient traveling outside the country|0|||
145461623|NCT00350623|524543709|FG002|Overall Study|patient traveling outside the country|1|||
145461624|NCT00294645|524543714|FG000|Overall Study|Death|10|||
145461625|NCT00294645|524543715|FG001|Overall Study|Death|18|||
145461626|NCT00294645|524543714|FG000|Overall Study|Lost to Follow-up|1|||
145461627|NCT00294645|524543715|FG001|Overall Study|Lost to Follow-up|10|||
145461628|NCT00294645|524543714|FG000|Overall Study|Withdrawal by Subject|18|||
145461629|NCT00294645|524543715|FG001|Overall Study|Withdrawal by Subject|34|||
145461630|NCT00294645|524543714|FG000|Overall Study|Physician Decision|15|||
145461631|NCT00294645|524543715|FG001|Overall Study|Physician Decision|20|||
145461632|NCT00294645|524543714|FG000|Overall Study|Other|4|||
145461633|NCT00294645|524543715|FG001|Overall Study|Other|10|||
145461634|NCT01238835|524543722|FG000|Overall Study|Death|124|||
145461635|NCT01238835|524543722|FG000|Overall Study|Withdrawal by Subject|9|||
145461636|NCT01238835|524543722|FG000|Overall Study|Lost to Follow-up|1|||
145461637|NCT01238835|524543722|FG000|Overall Study|Site early discontinuation|2|||
145461638|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Death|1|||
145461639|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Death|1|||
145461640|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Death|0|||
145461641|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Death|0|||
145461642|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Death|1|||
145461643|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Death|0|||
145461644|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Death|0|||
145461645|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Death|0|||
145461646|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Death|0|||
145461647|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Death|0|||
145461648|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
145461649|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
145461650|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
145461651|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461652|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
145461653|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461654|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461655|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461656|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461657|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
145461658|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461659|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461660|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461661|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461662|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
145461663|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461664|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461665|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461666|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461667|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
145461668|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
145461669|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461670|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145594378|NCT04403698|525028165|FG001|Overall Study|Lost to Follow-up|0|||
145594379|NCT04403698|525028164|FG000|Overall Study|Protocol Violation|0|||
145594380|NCT04403698|525028165|FG001|Overall Study|Protocol Violation|1|||
145594381|NCT01922076|525028166|FG000|Overall Study|Adverse Event|0|||
145594382|NCT01922076|525028167|FG001|Overall Study|Adverse Event|0|||
145594383|NCT01922076|525028168|FG002|Overall Study|Adverse Event|0|||
145594384|NCT01922076|525028169|FG003|Overall Study|Adverse Event|0|||
145594385|NCT01922076|525028170|FG004|Overall Study|Adverse Event|1|||
145594386|NCT01922076|525028171|FG005|Overall Study|Adverse Event|0|||
145594387|NCT01922076|525028172|FG006|Overall Study|Adverse Event|0|||
145594388|NCT01922076|525028166|FG000|Overall Study|Physician Decision|0|||
145461671|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461672|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461673|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461674|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461675|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461676|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461677|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
145461678|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
145461679|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461680|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461681|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
145461682|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
145461683|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461684|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461685|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461686|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461687|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
145461688|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
145461689|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461690|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461691|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
145461692|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461693|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461694|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461695|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461696|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145594389|NCT01922076|525028167|FG001|Overall Study|Physician Decision|0|||
145594390|NCT01922076|525028168|FG002|Overall Study|Physician Decision|1|||
145594391|NCT01922076|525028169|FG003|Overall Study|Physician Decision|0|||
145594392|NCT01922076|525028170|FG004|Overall Study|Physician Decision|0|||
145461697|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
145461698|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
145461699|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
145461700|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
145461701|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
145461702|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
145461703|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
145461704|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
145461705|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
145461706|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
145461707|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
145461708|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
145461709|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
145461710|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
145461711|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461712|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
145461713|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461714|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461715|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461716|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461717|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461718|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
145461719|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461720|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461721|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
145461722|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
145461723|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461724|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461725|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461726|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461727|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
145461728|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461729|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461730|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461731|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461732|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461733|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461734|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461735|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461736|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461737|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461738|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461739|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461740|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
145461741|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461742|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
145461743|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461744|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461745|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461746|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461747|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461748|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
145461749|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
145461750|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
145461751|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
145461752|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
145461753|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
145461754|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
145461755|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
145461756|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
145461757|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
145461758|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461759|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461760|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461761|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
145461762|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
145461763|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461764|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461765|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461766|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461767|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461768|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
145461769|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461770|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
145461771|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
145461772|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
145461773|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461774|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461775|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461776|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461777|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461778|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
145461779|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461780|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461781|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461782|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
145461783|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461784|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461785|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461786|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461787|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
145461788|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461789|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461790|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461791|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461792|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
145461793|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461794|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461795|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461796|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461797|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461798|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461799|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
145461800|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461801|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461802|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
145461803|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461804|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461805|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461806|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461807|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
145461808|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
145461809|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461810|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461811|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461812|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
145461813|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461814|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461815|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461816|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461817|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
145461818|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
145461819|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461820|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
145461821|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461822|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
145461823|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461824|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461825|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461826|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461827|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
145461828|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Other|5|||
145461829|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Other|1|||
145461830|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Other|0|||
145461831|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Other|3|||
145461832|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Other|0|||
145461833|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Other|0|||
145461834|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Other|0|||
145461835|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Other|0|||
145461836|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Other|0|||
145461837|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Other|0|||
145461838|NCT03352557|524543726|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461839|NCT03352557|524543727|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461840|NCT03352557|524543728|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461841|NCT03352557|524543729|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461842|NCT03352557|524543730|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
145461843|NCT03352557|524543731|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461844|NCT03352557|524543732|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461845|NCT03352557|524543733|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461846|NCT03352557|524543734|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461847|NCT03352557|524543735|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
145461848|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Death|0|||
145461849|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Death|0|||
145461850|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Death|0|||
145461851|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Death|0|||
145461852|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Death|0|||
145461853|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Death|1|||
145461854|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Death|0|||
145461855|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Death|1|||
145461856|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Death|1|||
145461857|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Death|1|||
145461858|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461859|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461860|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461861|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461862|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461863|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
145461864|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461865|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461866|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461867|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
145461868|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461869|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461870|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461871|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461872|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461873|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461874|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461875|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461876|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
145461877|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
145461878|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
145461879|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
145461880|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
145461881|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
145461882|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
145461883|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
145461884|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
145461885|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
145461886|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
145461887|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
145461888|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461889|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461890|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461891|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461892|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461893|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
145461894|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
145461895|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
145461896|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
145461897|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
145461898|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461899|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461900|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461901|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461902|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461903|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461904|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461905|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461906|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
145461907|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
145461908|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461909|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461910|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461911|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461912|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461913|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
145461914|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
145461915|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
145461916|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
145461917|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
145461918|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461919|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461920|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461921|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461922|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461923|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461924|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461925|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
145461926|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
145461927|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
145594393|NCT01922076|525028171|FG005|Overall Study|Physician Decision|0|||
145461928|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461929|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461930|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461931|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461932|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461933|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461934|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461935|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
145461936|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461937|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
145461938|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461939|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461940|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461941|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461942|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461943|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461944|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461945|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
145461946|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461947|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
145461948|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461949|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461950|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461951|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461952|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461953|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461954|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461955|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
145461956|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
145461957|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
145461958|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461959|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461960|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461961|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461962|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461963|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
145461964|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461965|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461966|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
145461967|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
145461968|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461969|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461970|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461971|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461972|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461973|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461974|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461975|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461976|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
145461977|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
145461978|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461979|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461980|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461981|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461982|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461983|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461984|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461985|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
145461986|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
145461987|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
145461988|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461989|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461990|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461991|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461992|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461993|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461994|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461995|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
145461996|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
145461997|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
145461998|NCT03352557|524543726|FG000|LTE Period: Week 80 to Week 173|Other|0|||
145461999|NCT03352557|524543727|FG001|LTE Period: Week 80 to Week 173|Other|0|||
145462000|NCT03352557|524543728|FG002|LTE Period: Week 80 to Week 173|Other|0|||
145462001|NCT03352557|524543729|FG003|LTE Period: Week 80 to Week 173|Other|0|||
145462002|NCT03352557|524543730|FG004|LTE Period: Week 80 to Week 173|Other|0|||
145462003|NCT03352557|524543731|FG005|LTE Period: Week 80 to Week 173|Other|0|||
145462004|NCT03352557|524543732|FG006|LTE Period: Week 80 to Week 173|Other|0|||
145462005|NCT03352557|524543733|FG007|LTE Period: Week 80 to Week 173|Other|1|||
145462006|NCT03352557|524543734|FG008|LTE Period: Week 80 to Week 173|Other|0|||
145462007|NCT03352557|524543735|FG009|LTE Period: Week 80 to Week 173|Other|0|||
145462008|NCT00907803|524543736|FG000|Overall Study|Withdrawal of consent - long commute|1|||
145462009|NCT00907803|524543737|FG001|Overall Study|Withdrawal of consent - long commute|0|||
145462010|NCT00907803|524543738|FG002|Overall Study|Withdrawal of consent - long commute|0|||
145462011|NCT00907803|524543736|FG000|Overall Study|Adverse Event|2|||
145462012|NCT00907803|524543737|FG001|Overall Study|Adverse Event|0|||
145462013|NCT00907803|524543738|FG002|Overall Study|Adverse Event|0|||
145462014|NCT00907803|524543736|FG000|Overall Study|Withdrawal by Subject|0|||
145462015|NCT00907803|524543737|FG001|Overall Study|Withdrawal by Subject|1|||
145462016|NCT00907803|524543738|FG002|Overall Study|Withdrawal by Subject|0|||
145462017|NCT00907803|524543736|FG000|Overall Study|Lost to Follow-up|0|||
145462018|NCT00907803|524543737|FG001|Overall Study|Lost to Follow-up|1|||
145462019|NCT00907803|524543738|FG002|Overall Study|Lost to Follow-up|0|||
145462020|NCT00907803|524543736|FG000|Overall Study|Protocol Violation|0|||
145462021|NCT00907803|524543737|FG001|Overall Study|Protocol Violation|1|||
145462022|NCT00907803|524543738|FG002|Overall Study|Protocol Violation|0|||
145462023|NCT04612842|524543739|FG000|Overall Study|Lost to Follow-up|20|||
145462024|NCT04612842|524543740|FG001|Overall Study|Lost to Follow-up|11|||
145462025|NCT04612842|524543739|FG000|Overall Study|Withdrawal by Subject|26|||
145462026|NCT04612842|524543740|FG001|Overall Study|Withdrawal by Subject|15|||
145462027|NCT04612842|524543739|FG000|Overall Study|Death|2|||
145462028|NCT04612842|524543740|FG001|Overall Study|Death|2|||
145462029|NCT05426031|524543741|FG000|Overall Study|Circulatory Arrest|3|||
145462030|NCT05426031|524543742|FG001|Overall Study|Circulatory Arrest|2|||
145462031|NCT02419131|524543743|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
145462032|NCT02419131|524543744|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
145462033|NCT02419131|524543745|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
145462034|NCT02419131|524543743|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
145462035|NCT02419131|524543744|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
145462036|NCT02419131|524543745|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
145462037|NCT03060512|524543746|FG000|Overall Study|Adverse Event|4|||
145462038|NCT03060512|524543747|FG001|Overall Study|Adverse Event|6|||
145462039|NCT03060512|524543746|FG000|Overall Study|Lost to Follow-up|1|||
145462040|NCT03060512|524543747|FG001|Overall Study|Lost to Follow-up|1|||
145462041|NCT03060512|524543746|FG000|Overall Study|Withdrawal by Subject|1|||
145462042|NCT03060512|524543747|FG001|Overall Study|Withdrawal by Subject|0|||
145462043|NCT03060512|524543746|FG000|Overall Study|Non-compliance with study medication|1|||
145462044|NCT03060512|524543747|FG001|Overall Study|Non-compliance with study medication|2|||
145462045|NCT01218100|524543748|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
145462046|NCT01218100|524543749|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
145462047|NCT01218100|524543750|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
145462048|NCT01218100|524543751|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
145462049|NCT01218100|524543748|FG000|Overall Study|Adverse Event|4|||
145462050|NCT01218100|524543749|FG001|Overall Study|Adverse Event|6|||
145462051|NCT01218100|524543750|FG002|Overall Study|Adverse Event|6|||
145462052|NCT01218100|524543751|FG003|Overall Study|Adverse Event|7|||
145462053|NCT01218100|524543748|FG000|Overall Study|Lack of Efficacy|9|||
145462054|NCT01218100|524543749|FG001|Overall Study|Lack of Efficacy|6|||
145462055|NCT01218100|524543750|FG002|Overall Study|Lack of Efficacy|5|||
145462056|NCT01218100|524543751|FG003|Overall Study|Lack of Efficacy|12|||
145462057|NCT01218100|524543748|FG000|Overall Study|Protocol Violation|0|||
145462058|NCT01218100|524543749|FG001|Overall Study|Protocol Violation|0|||
145462059|NCT01218100|524543750|FG002|Overall Study|Protocol Violation|1|||
145462060|NCT01218100|524543751|FG003|Overall Study|Protocol Violation|1|||
145462061|NCT01218100|524543748|FG000|Overall Study|Withdrawal by Subject|5|||
145462062|NCT01218100|524543749|FG001|Overall Study|Withdrawal by Subject|2|||
145462063|NCT01218100|524543750|FG002|Overall Study|Withdrawal by Subject|6|||
145462064|NCT01218100|524543751|FG003|Overall Study|Withdrawal by Subject|7|||
145462065|NCT01218100|524543748|FG000|Overall Study|Lost to Follow-up|3|||
145462066|NCT01218100|524543749|FG001|Overall Study|Lost to Follow-up|8|||
145462067|NCT01218100|524543750|FG002|Overall Study|Lost to Follow-up|2|||
145462068|NCT01218100|524543751|FG003|Overall Study|Lost to Follow-up|1|||
145462069|NCT01218100|524543748|FG000|Overall Study|Other Reason|2|||
145462070|NCT01218100|524543749|FG001|Overall Study|Other Reason|2|||
145462071|NCT01218100|524543750|FG002|Overall Study|Other Reason|6|||
145462072|NCT01218100|524543751|FG003|Overall Study|Other Reason|4|||
145462073|NCT01118520|524543756|FG000|Overall Study|AAA repair|9|||
145462074|NCT01118520|524543757|FG001|Overall Study|AAA repair|7|||
145462075|NCT01118520|524543758|FG002|Overall Study|AAA repair|9|||
145462076|NCT01118520|524543756|FG000|Overall Study|Adverse Event|3|||
145462077|NCT01118520|524543757|FG001|Overall Study|Adverse Event|3|||
145462078|NCT01118520|524543758|FG002|Overall Study|Adverse Event|3|||
145462079|NCT01118520|524543756|FG000|Overall Study|Withdrawal by Subject|8|||
145462080|NCT01118520|524543757|FG001|Overall Study|Withdrawal by Subject|13|||
145462081|NCT01118520|524543758|FG002|Overall Study|Withdrawal by Subject|8|||
145462082|NCT01089023|524543759|FG000|Overall Study|Lost to Follow-up|3|||
145462083|NCT01089023|524543759|FG000|Overall Study|Adverse Event|1|||
145462084|NCT01089023|524543759|FG000|Overall Study|Withdrawal by Subject|1|||
145462085|NCT01089023|524543759|FG000|Overall Study|Protocol Violation|1|||
145462086|NCT01089023|524543759|FG000|Overall Study|Lack of Efficacy|1|||
145462087|NCT03883113|524543762|FG000|Overall Study|Physician Decision|4|||
145462088|NCT03883113|524543763|FG001|Overall Study|Physician Decision|2|||
145462089|NCT03883113|524543762|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
145462090|NCT03883113|524543763|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
145462091|NCT03883113|524543762|FG000|Overall Study|Pregnancy|1|||
145462092|NCT03883113|524543763|FG001|Overall Study|Pregnancy|0|||
145462093|NCT03883113|524543762|FG000|Overall Study|Adverse Event|0|||
145462094|NCT03883113|524543763|FG001|Overall Study|Adverse Event|1|||
145462095|NCT03883113|524543762|FG000|Overall Study|Withdrawal by Subject|1|||
145462096|NCT03883113|524543763|FG001|Overall Study|Withdrawal by Subject|2|||
145462097|NCT03883113|524543762|FG000|Overall Study|Lost to Follow-up|1|||
145462098|NCT03883113|524543763|FG001|Overall Study|Lost to Follow-up|0|||
145462099|NCT04962230|524543764|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
145462100|NCT04962230|524543764|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
145462101|NCT03831880|524543765|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
145462102|NCT03831880|524543766|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
145462103|NCT03831880|524543765|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
145462104|NCT03831880|524543766|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
145462105|NCT03958656|524543767|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
145462106|NCT03958656|524543768|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
145462107|NCT03958656|524543769|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
145462108|NCT03958656|524543770|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
145462109|NCT03958656|524543767|FG000|Overall Study|No longer meets eligibility criteria|0|||
145462110|NCT03958656|524543768|FG001|Overall Study|No longer meets eligibility criteria|0|||
145462111|NCT03958656|524543769|FG002|Overall Study|No longer meets eligibility criteria|1|||
145462112|NCT03958656|524543770|FG003|Overall Study|No longer meets eligibility criteria|0|||
145462113|NCT03958656|524543767|FG000|Overall Study|Started anti-cancer treatment|0|||
145462114|NCT03958656|524543768|FG001|Overall Study|Started anti-cancer treatment|0|||
145462115|NCT03958656|524543769|FG002|Overall Study|Started anti-cancer treatment|1|||
145462116|NCT03958656|524543770|FG003|Overall Study|Started anti-cancer treatment|0|||
145462117|NCT03158012|524543773|FG000|Overall Study|Withdrawal by Subject|0|||
145462118|NCT03158012|524543774|FG001|Overall Study|Withdrawal by Subject|1|||
145462119|NCT02014480|524543781|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145462120|NCT02014480|524543782|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145462121|NCT02014480|524543783|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
145462122|NCT02014480|524543784|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145462123|NCT02014480|524543785|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145626823|NCT00886613|525147093|FG002|Overall Study|Lost to follow-up (Part B)|1|||
145462124|NCT02014480|524543786|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
145462125|NCT02014480|524543781|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145462126|NCT02014480|524543782|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145462127|NCT02014480|524543783|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145462128|NCT02014480|524543784|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
145462129|NCT02014480|524543785|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145462130|NCT02014480|524543786|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145462131|NCT02014480|524543781|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145462132|NCT02014480|524543782|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145462133|NCT02014480|524543783|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
145462134|NCT02014480|524543784|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145462135|NCT02014480|524543785|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145462136|NCT02014480|524543786|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
145462137|NCT02014480|524543781|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145462138|NCT02014480|524543782|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145462139|NCT02014480|524543783|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
145462140|NCT02014480|524543784|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
145462141|NCT02014480|524543785|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145462142|NCT02014480|524543786|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
145462143|NCT02014480|524543781|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145462144|NCT02014480|524543782|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
145462145|NCT02014480|524543783|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145462146|NCT02014480|524543784|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145462147|NCT02014480|524543785|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145462148|NCT02014480|524543786|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
145462149|NCT02014480|524543781|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
145462150|NCT02014480|524543782|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
145462151|NCT02014480|524543783|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
145462152|NCT02014480|524543784|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
145462153|NCT02014480|524543785|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
145462154|NCT02014480|524543786|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
145462155|NCT02014480|524543781|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145462156|NCT02014480|524543782|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145462157|NCT02014480|524543783|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145462158|NCT02014480|524543784|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145462159|NCT02014480|524543785|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
145462160|NCT02014480|524543786|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
145462161|NCT01338610|524543787|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
145462162|NCT01338610|524543788|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
145462163|NCT01338610|524543789|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
145462164|NCT01338610|524543787|FG000|Overall Study|Protocol Violation|1|||
145462165|NCT01338610|524543788|FG001|Overall Study|Protocol Violation|0|||
145462166|NCT01338610|524543789|FG002|Overall Study|Protocol Violation|1|||
145462167|NCT01338610|524543787|FG000|Overall Study|Adverse Event|3|||
145462168|NCT01338610|524543788|FG001|Overall Study|Adverse Event|0|||
145462169|NCT01338610|524543789|FG002|Overall Study|Adverse Event|0|||
145462170|NCT02692040|524543790|FG000|Overall Study|Protocol Violation|0|||
145462171|NCT02692040|524543791|FG001|Overall Study|Protocol Violation|0|||
145462172|NCT02692040|524543792|FG002|Overall Study|Protocol Violation|0|||
145462173|NCT02692040|524543793|FG003|Overall Study|Protocol Violation|0|||
145462174|NCT02692040|524543794|FG004|Overall Study|Protocol Violation|0|||
145462175|NCT02692040|524543795|FG005|Overall Study|Protocol Violation|0|||
145462176|NCT02692040|524543796|FG006|Overall Study|Protocol Violation|0|||
145462177|NCT02692040|524543797|FG007|Overall Study|Protocol Violation|0|||
145462178|NCT02692040|524543798|FG008|Overall Study|Protocol Violation|0|||
145462179|NCT02692040|524543799|FG009|Overall Study|Protocol Violation|0|||
145462180|NCT02692040|524543800|FG010|Overall Study|Protocol Violation|0|||
145462181|NCT02692040|524543801|FG011|Overall Study|Protocol Violation|0|||
145462182|NCT02692040|524543802|FG012|Overall Study|Protocol Violation|1|||
145462183|NCT02692040|524543803|FG013|Overall Study|Protocol Violation|0|||
145462184|NCT02692040|524543804|FG014|Overall Study|Protocol Violation|0|||
145462185|NCT02692040|524543805|FG015|Overall Study|Protocol Violation|0|||
145462186|NCT02692040|524543806|FG016|Overall Study|Protocol Violation|0|||
145462187|NCT02692040|524543790|FG000|Overall Study|Adverse Event|0|||
145462188|NCT02692040|524543791|FG001|Overall Study|Adverse Event|0|||
145462189|NCT02692040|524543792|FG002|Overall Study|Adverse Event|0|||
145462190|NCT02692040|524543793|FG003|Overall Study|Adverse Event|0|||
145462191|NCT02692040|524543794|FG004|Overall Study|Adverse Event|0|||
145462192|NCT02692040|524543795|FG005|Overall Study|Adverse Event|0|||
145462193|NCT02692040|524543796|FG006|Overall Study|Adverse Event|0|||
145462194|NCT02692040|524543797|FG007|Overall Study|Adverse Event|0|||
145594394|NCT01922076|525028172|FG006|Overall Study|Physician Decision|0|||
145594395|NCT01922076|525028166|FG000|Overall Study|Withdrawal by Subject|0|||
145594396|NCT01922076|525028167|FG001|Overall Study|Withdrawal by Subject|0|||
145462195|NCT02692040|524543798|FG008|Overall Study|Adverse Event|0|||
145462196|NCT02692040|524543799|FG009|Overall Study|Adverse Event|0|||
145462197|NCT02692040|524543800|FG010|Overall Study|Adverse Event|0|||
145462198|NCT02692040|524543801|FG011|Overall Study|Adverse Event|0|||
145462199|NCT02692040|524543802|FG012|Overall Study|Adverse Event|0|||
145462200|NCT02692040|524543803|FG013|Overall Study|Adverse Event|3|||
145462201|NCT02692040|524543804|FG014|Overall Study|Adverse Event|1|||
145462202|NCT02692040|524543805|FG015|Overall Study|Adverse Event|1|||
145462203|NCT02692040|524543806|FG016|Overall Study|Adverse Event|0|||
145626824|NCT00886613|525147091|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
145626825|NCT00886613|525147092|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
145626826|NCT00886613|525147093|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
145626827|NCT02333630|525147098|FG000|Overall Study|Lost to Follow-up|5|||
145626828|NCT02333630|525147099|FG001|Overall Study|Lost to Follow-up|2|||
145626829|NCT05349864|525147100|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
145626830|NCT05349864|525147101|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
145626831|NCT02223793|525147102|FG000|Overall Study|Lost to Follow-up|10|||
145626832|NCT02223793|525147103|FG001|Overall Study|Lost to Follow-up|1|||
145626833|NCT02223793|525147104|FG002|Overall Study|Lost to Follow-up|2|||
145626834|NCT02223793|525147102|FG000|Overall Study|Withdrawal by Subject|3|||
145626835|NCT02223793|525147103|FG001|Overall Study|Withdrawal by Subject|2|||
145462204|NCT00435162|524543810|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
145462205|NCT00435162|524543811|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
145462206|NCT00435162|524543812|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
145462207|NCT00435162|524543813|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
145462208|NCT00435162|524543814|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
145462209|NCT00435162|524543815|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
145462210|NCT01819129|524543816|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
145462211|NCT01819129|524543817|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
145462212|NCT01819129|524543816|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
145462213|NCT01819129|524543817|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
145462214|NCT01819129|524543816|FG000|Overall Study|Other, Subject moved out of the country|0|||
145462215|NCT01819129|524543817|FG001|Overall Study|Other, Subject moved out of the country|1|||
145462216|NCT01819129|524543816|FG000|Overall Study|Withdrawal by Subject|15|||
145462217|NCT01819129|524543817|FG001|Overall Study|Withdrawal by Subject|15|||
145462218|NCT01819129|524543816|FG000|Overall Study|Lost to Follow-up|5|||
145462219|NCT01819129|524543817|FG001|Overall Study|Lost to Follow-up|2|||
145462220|NCT01819129|524543816|FG000|Overall Study|Lack of Efficacy|0|||
145462221|NCT01819129|524543817|FG001|Overall Study|Lack of Efficacy|1|||
145462222|NCT01819129|524543816|FG000|Overall Study|Adverse Event|1|||
145462223|NCT01819129|524543817|FG001|Overall Study|Adverse Event|4|||
145462224|NCT01819129|524543816|FG000|Overall Study|Death|1|||
145462225|NCT01819129|524543817|FG001|Overall Study|Death|1|||
145462226|NCT01819129|524543816|FG000|Overall Study|Withdrawal Criteria|20|||
145462227|NCT01819129|524543817|FG001|Overall Study|Withdrawal Criteria|15|||
145462228|NCT00054691|524543821|FG000|Overall Study|Unmeasurable Disease|2|||
145594397|NCT01922076|525028168|FG002|Overall Study|Withdrawal by Subject|0|||
145594398|NCT01922076|525028169|FG003|Overall Study|Withdrawal by Subject|1|||
145594399|NCT01922076|525028170|FG004|Overall Study|Withdrawal by Subject|0|||
145594400|NCT01922076|525028171|FG005|Overall Study|Withdrawal by Subject|1|||
145594401|NCT01922076|525028172|FG006|Overall Study|Withdrawal by Subject|1|||
145594402|NCT04899349|525028173|FG000|Overall Study|Study terminated by Sponsor|2|||
145594403|NCT04899349|525028174|FG001|Overall Study|Study terminated by Sponsor|0|||
145594404|NCT01018394|525028175|FG000|Overall Study|Withdrawal by Subject|5|||
145594405|NCT01018394|525028176|FG001|Overall Study|Withdrawal by Subject|5|||
145594406|NCT01018394|525028175|FG000|Overall Study|Lost to Follow-up|4|||
145594407|NCT01018394|525028176|FG001|Overall Study|Lost to Follow-up|3|||
145594408|NCT00683644|525028177|FG000|Overall Study|Withdrawal by Subject|4|||
145594409|NCT00683644|525028178|FG001|Overall Study|Withdrawal by Subject|2|||
145594410|NCT00683644|525028177|FG000|Overall Study|Lost to Follow-up|1|||
145594411|NCT00683644|525028178|FG001|Overall Study|Lost to Follow-up|4|||
145594412|NCT00683644|525028177|FG000|Overall Study|Adverse Event|1|||
145594413|NCT00683644|525028178|FG001|Overall Study|Adverse Event|2|||
145594414|NCT00683644|525028177|FG000|Overall Study|Low copper, other health problems,|7|||
145594415|NCT00683644|525028178|FG001|Overall Study|Low copper, other health problems,|6|||
145594416|NCT03085485|525028179|FG000|Overall Study|Death|1|||
145594417|NCT03085485|525028180|FG001|Overall Study|Death|0|||
145594418|NCT03085485|525028179|FG000|Overall Study|Lost to Follow-up|1|||
145594419|NCT03085485|525028180|FG001|Overall Study|Lost to Follow-up|0|||
145594420|NCT01302119|525028181|FG000|Overall Study|Withdrawal by Subject|30|||
145594421|NCT01302119|525028182|FG001|Overall Study|Withdrawal by Subject|20|||
145594422|NCT01302119|525028181|FG000|Overall Study|Lost to Follow-up|10|||
145594423|NCT01302119|525028182|FG001|Overall Study|Lost to Follow-up|4|||
145462229|NCT00054691|524543821|FG000|Overall Study|Noncompliant|1|||
145462230|NCT02836873|524543828|FG000|Overall Study|Protocol Violation|0|||
145462231|NCT02836873|524543829|FG001|Overall Study|Protocol Violation|1|||
145462232|NCT02836873|524543828|FG000|Overall Study|Adverse Event|1|||
145462233|NCT02836873|524543829|FG001|Overall Study|Adverse Event|4|||
145594424|NCT01302119|525028181|FG000|Overall Study|Adverse Event|2|||
145594425|NCT01302119|525028182|FG001|Overall Study|Adverse Event|1|||
145594426|NCT01302119|525028181|FG000|Overall Study|Non-compliance|4|||
145594427|NCT01302119|525028182|FG001|Overall Study|Non-compliance|2|||
145594428|NCT01302119|525028181|FG000|Overall Study|Non-specific|4|||
145594429|NCT01302119|525028182|FG001|Overall Study|Non-specific|1|||
145626836|NCT02223793|525147104|FG002|Overall Study|Withdrawal by Subject|3|||
145626837|NCT02223793|525147102|FG000|Overall Study|Moved/studycenter unable to participate|4|||
145462234|NCT02836873|524543828|FG000|Overall Study|Withdrawal by Subject|2|||
145462235|NCT02836873|524543829|FG001|Overall Study|Withdrawal by Subject|2|||
145462236|NCT02836873|524543828|FG000|Overall Study|Lost to Follow-up|1|||
145462237|NCT02836873|524543829|FG001|Overall Study|Lost to Follow-up|3|||
145462238|NCT02836873|524543828|FG000|Overall Study|Physician Decision|0|||
145462239|NCT02836873|524543829|FG001|Overall Study|Physician Decision|1|||
145462240|NCT02836873|524543828|FG000|Overall Study|Other|1|||
145462241|NCT02836873|524543829|FG001|Overall Study|Other|0|||
145462242|NCT00694096|524543830|FG000|Overall Study|Withdrawal by Subject|5|||
145462243|NCT02914548|524543840|FG000|Overall Study|Adverse Event|15|||
145462244|NCT02914548|524543841|FG001|Overall Study|Adverse Event|7|||
145462245|NCT02914548|524543842|FG002|Overall Study|Adverse Event|15|||
145462246|NCT02914548|524543840|FG000|Overall Study|Physician Decision|2|||
145462247|NCT02914548|524543841|FG001|Overall Study|Physician Decision|2|||
145462248|NCT02914548|524543842|FG002|Overall Study|Physician Decision|0|||
145462249|NCT02914548|524543840|FG000|Overall Study|Protocol Violation|1|||
145462250|NCT02914548|524543841|FG001|Overall Study|Protocol Violation|0|||
145462251|NCT02914548|524543842|FG002|Overall Study|Protocol Violation|0|||
145462252|NCT02914548|524543840|FG000|Overall Study|Withdrawal by Subject|3|||
145462253|NCT02914548|524543841|FG001|Overall Study|Withdrawal by Subject|4|||
145462254|NCT02914548|524543842|FG002|Overall Study|Withdrawal by Subject|4|||
145462255|NCT02914548|524543840|FG000|Overall Study|>40% of body surface area|0|||
145462256|NCT02914548|524543841|FG001|Overall Study|>40% of body surface area|1|||
145462257|NCT02914548|524543842|FG002|Overall Study|>40% of body surface area|1|||
145462258|NCT00977938|524543848|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
145462259|NCT00977938|524543849|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
145462260|NCT00977938|524543850|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
145462261|NCT00977938|524543851|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
145462262|NCT00977938|524543848|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
145462263|NCT00977938|524543849|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
145462264|NCT00977938|524543850|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
145462265|NCT00977938|524543851|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
145462266|NCT00977938|524543848|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
145462267|NCT00977938|524543849|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
145462268|NCT00977938|524543850|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
145462269|NCT00977938|524543851|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
145462270|NCT00977938|524543848|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
145462271|NCT00977938|524543849|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
145462272|NCT00977938|524543850|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
145462273|NCT00977938|524543851|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
145462274|NCT00977938|524543848|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
145462275|NCT00977938|524543849|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
145462276|NCT00977938|524543850|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
145462277|NCT00977938|524543851|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
145462278|NCT00977938|524543848|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
145462279|NCT00977938|524543849|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
145462280|NCT00977938|524543850|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
145462281|NCT00977938|524543851|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
145462282|NCT02460783|524543857|FG000|Overall Study|Withdrawal by Subject|1|||
145462283|NCT02460783|524543858|FG001|Overall Study|Withdrawal by Subject|3|||
145462284|NCT02460783|524543857|FG000|Overall Study|Lost to Follow-up|1|||
145462285|NCT02460783|524543858|FG001|Overall Study|Lost to Follow-up|1|||
145462286|NCT01484834|524543859|FG000|Overall Study|Lost to Follow-up|5|||
145462287|NCT01484834|524543860|FG001|Overall Study|Lost to Follow-up|8|||
145462288|NCT01484834|524543861|FG002|Overall Study|Lost to Follow-up|1|||
145462289|NCT01484834|524543862|FG003|Overall Study|Lost to Follow-up|4|||
145462290|NCT01371643|524543868|FG000|Overall Study|Withdrawal by Subject|3|||
145462291|NCT01371643|524543869|FG001|Overall Study|Withdrawal by Subject|0|||
145462292|NCT02214225|524543871|FG000|Overall Study|Lost to Follow-up|46|||
145462293|NCT02214225|524543872|FG001|Overall Study|Lost to Follow-up|18|||
145462294|NCT02214225|524543873|FG002|Overall Study|Lost to Follow-up|18|||
145462295|NCT02214225|524543871|FG000|Overall Study|Withdrawal by Subject|2|||
145462296|NCT02214225|524543872|FG001|Overall Study|Withdrawal by Subject|0|||
145462297|NCT02214225|524543873|FG002|Overall Study|Withdrawal by Subject|2|||
145462298|NCT02214225|524543871|FG000|Overall Study|Death|5|||
145462299|NCT02214225|524543872|FG001|Overall Study|Death|0|||
145462300|NCT02214225|524543873|FG002|Overall Study|Death|1|||
145462301|NCT02214225|524543871|FG000|Overall Study|randomized in error, not vaccinated|2|||
145462302|NCT02214225|524543872|FG001|Overall Study|randomized in error, not vaccinated|1|||
145462303|NCT02214225|524543873|FG002|Overall Study|randomized in error, not vaccinated|1|||
145462304|NCT03987932|524543877|FG000|Overall Study|Lost to Follow-up|2|||
145462305|NCT03987932|524543878|FG001|Overall Study|Lost to Follow-up|1|||
145462306|NCT03987932|524543879|FG002|Overall Study|Lost to Follow-up|1|||
145462307|NCT03987932|524543877|FG000|Overall Study|Non-study related elective surgery|0|||
145462308|NCT03987932|524543878|FG001|Overall Study|Non-study related elective surgery|0|||
145462309|NCT03987932|524543879|FG002|Overall Study|Non-study related elective surgery|1|||
145462310|NCT01605227|524543880|FG000|Overall Study|Did not receive study treatment|2|||
145462311|NCT01605227|524543881|FG001|Overall Study|Did not receive study treatment|3|||
145462312|NCT01605227|524543880|FG000|Overall Study|Adverse Event|228|||
145462313|NCT01605227|524543881|FG001|Overall Study|Adverse Event|42|||
145462314|NCT01605227|524543880|FG000|Overall Study|Progressive Disease|132|||
145462315|NCT01605227|524543881|FG001|Overall Study|Progressive Disease|128|||
145462316|NCT01605227|524543880|FG000|Overall Study|Clinical Deterioration|227|||
145462317|NCT01605227|524543881|FG001|Overall Study|Clinical Deterioration|133|||
145462318|NCT01605227|524543880|FG000|Overall Study|Lost to Follow-up|1|||
145462319|NCT01605227|524543881|FG001|Overall Study|Lost to Follow-up|0|||
145462320|NCT01605227|524543880|FG000|Overall Study|Protocol Violation|1|||
145462321|NCT01605227|524543881|FG001|Overall Study|Protocol Violation|0|||
145462322|NCT01605227|524543880|FG000|Overall Study|Physician Decision|9|||
145462323|NCT01605227|524543881|FG001|Overall Study|Physician Decision|7|||
145462324|NCT01605227|524543880|FG000|Overall Study|Withdrawal by Subject|18|||
145462325|NCT01605227|524543881|FG001|Overall Study|Withdrawal by Subject|14|||
145462326|NCT01605227|524543880|FG000|Overall Study|Sponsor Decision|2|||
145462327|NCT01605227|524543881|FG001|Overall Study|Sponsor Decision|0|||
145462328|NCT01605227|524543880|FG000|Overall Study|Started New Therapy|1|||
145462329|NCT01605227|524543881|FG001|Overall Study|Started New Therapy|0|||
145462330|NCT01605227|524543880|FG000|Overall Study|Subject Decision|0|||
145462331|NCT01605227|524543881|FG001|Overall Study|Subject Decision|1|||
145462332|NCT01605227|524543880|FG000|Overall Study|Dose Held >6 weeks|0|||
145462333|NCT01605227|524543881|FG001|Overall Study|Dose Held >6 weeks|1|||
145462334|NCT02847858|524543883|FG000|Overall Study|Lost to Follow-up|401|||
145462335|NCT02847858|524543884|FG001|Overall Study|Lost to Follow-up|269|||
145462336|NCT00624819|524543885|FG000|Follow-up Period: Year 4|Parents decision|0|||
145462337|NCT00624819|524543886|FG001|Follow-up Period: Year 4|Parents decision|0|||
145462338|NCT00624819|524543887|FG002|Follow-up Period: Year 4|Parents decision|1|||
145462339|NCT00624819|524543888|FG003|Follow-up Period: Year 4|Parents decision|0|||
145462340|NCT00624819|524543885|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
145462341|NCT00624819|524543886|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
145462342|NCT00624819|524543887|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
145462343|NCT00624819|524543888|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
145462344|NCT02387164|524543889|FG000|Overall Study|Lost to Follow-up|2|||
145462345|NCT02387164|524543890|FG001|Overall Study|Lost to Follow-up|0|||
145462346|NCT02387164|524543889|FG000|Overall Study|Diagnosed|1|||
145462347|NCT02387164|524543890|FG001|Overall Study|Diagnosed|2|||
145462348|NCT03271047|524543891|FG000|Phase 1b: Dose Finding Period|Death|8|||
145462349|NCT03271047|524543892|FG001|Phase 1b: Dose Finding Period|Death|8|||
145462350|NCT03271047|524543893|FG002|Phase 1b: Dose Finding Period|Death|0|||
145462351|NCT03271047|524543894|FG003|Phase 1b: Dose Finding Period|Death|0|||
145462352|NCT03271047|524543891|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
145462353|NCT03271047|524543892|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
145462354|NCT03271047|524543893|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
145462355|NCT03271047|524543894|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
145462356|NCT03271047|524543891|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
145462357|NCT03271047|524543892|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
145462358|NCT03271047|524543893|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
145462359|NCT03271047|524543894|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
145462360|NCT03271047|524543891|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
145462361|NCT03271047|524543892|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
145462362|NCT03271047|524543893|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
145462363|NCT03271047|524543894|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
145594430|NCT01775904|525028186|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
145594431|NCT01775904|525028186|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
145594432|NCT04891419|525028187|FG000|Overall Study|Withdrawal by Subject|4|||
145462364|NCT03271047|524543891|FG000|Randomized Phase 2 Period|Other|0|||
145462365|NCT03271047|524543892|FG001|Randomized Phase 2 Period|Other|0|||
145462366|NCT03271047|524543893|FG002|Randomized Phase 2 Period|Other|0|||
145462367|NCT03271047|524543894|FG003|Randomized Phase 2 Period|Other|1|||
145462368|NCT03271047|524543891|FG000|Randomized Phase 2 Period|Death|0|||
145462369|NCT03271047|524543892|FG001|Randomized Phase 2 Period|Death|0|||
145462370|NCT03271047|524543893|FG002|Randomized Phase 2 Period|Death|20|||
145462371|NCT03271047|524543894|FG003|Randomized Phase 2 Period|Death|21|||
145462372|NCT03271047|524543891|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
145462373|NCT03271047|524543892|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
145462374|NCT03271047|524543893|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
145462375|NCT03271047|524543894|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
145462376|NCT03271047|524543891|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
145462377|NCT03271047|524543892|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
145462378|NCT03271047|524543893|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
145594433|NCT04891419|525028188|FG001|Overall Study|Withdrawal by Subject|0|||
145462379|NCT03271047|524543894|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
145462380|NCT03271047|524543891|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
145462381|NCT03271047|524543892|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
145462382|NCT03271047|524543893|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
145462383|NCT03271047|524543894|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
145462384|NCT02436408|524543895|FG000|Overall Study|Death|1|||
145462385|NCT00042432|524543896|FG000|Overall Study|Adverse Event|4|||
145462386|NCT00042432|524543897|FG001|Overall Study|Adverse Event|1|||
145462387|NCT00042432|524543896|FG000|Overall Study|Withdrawal by Subject|1|||
145462388|NCT00042432|524543897|FG001|Overall Study|Withdrawal by Subject|3|||
145462389|NCT00042432|524543896|FG000|Overall Study|Death|0|||
145462390|NCT00042432|524543897|FG001|Overall Study|Death|2|||
145462391|NCT00042432|524543896|FG000|Overall Study|Ineligibility determined|1|||
145462392|NCT00042432|524543897|FG001|Overall Study|Ineligibility determined|0|||
145462393|NCT00042432|524543896|FG000|Overall Study|Initiation of maintenance dialysis|1|||
145462394|NCT00042432|524543897|FG001|Overall Study|Initiation of maintenance dialysis|1|||
145462395|NCT00042432|524543896|FG000|Overall Study|Other|2|||
145462396|NCT00042432|524543897|FG001|Overall Study|Other|0|||
145462397|NCT04070326|524543905|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
145462398|NCT04070326|524543906|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
145462399|NCT00526110|524543910|FG000|Overall Study|Adverse Event|2|||
145462400|NCT00526110|524543911|FG001|Overall Study|Adverse Event|9|||
145462401|NCT00526110|524543910|FG000|Overall Study|Disease Progression|0|||
145462402|NCT00526110|524543911|FG001|Overall Study|Disease Progression|19|||
145594434|NCT04891419|525028187|FG000|Overall Study|Lost to Follow-up|1|||
145594435|NCT04891419|525028188|FG001|Overall Study|Lost to Follow-up|3|||
145594436|NCT00802074|525028192|FG000|Overall Study|Adverse Event|1|||
145594437|NCT00802074|525028193|FG001|Overall Study|Adverse Event|1|||
145594438|NCT00802074|525028194|FG002|Overall Study|Adverse Event|1|||
145594439|NCT00802074|525028195|FG003|Overall Study|Adverse Event|0|||
145594440|NCT00802074|525028196|FG004|Overall Study|Adverse Event|0|||
145594441|NCT00802074|525028197|FG005|Overall Study|Adverse Event|0|||
145594442|NCT00802074|525028192|FG000|Overall Study|Withdrawal by Subject|1|||
145594443|NCT00802074|525028193|FG001|Overall Study|Withdrawal by Subject|0|||
145594444|NCT00802074|525028194|FG002|Overall Study|Withdrawal by Subject|0|||
145594445|NCT00802074|525028195|FG003|Overall Study|Withdrawal by Subject|0|||
145594446|NCT00802074|525028196|FG004|Overall Study|Withdrawal by Subject|0|||
145594447|NCT00802074|525028197|FG005|Overall Study|Withdrawal by Subject|0|||
145594448|NCT00827918|525028198|FG000|Overall Study|Adverse Event|4|||
145594449|NCT00827918|525028199|FG001|Overall Study|Adverse Event|0|||
145594450|NCT00827918|525028200|FG002|Overall Study|Adverse Event|0|||
145594451|NCT00827918|525028198|FG000|Overall Study|Lack of Efficacy|16|||
145594452|NCT00827918|525028199|FG001|Overall Study|Lack of Efficacy|4|||
145594453|NCT00827918|525028200|FG002|Overall Study|Lack of Efficacy|15|||
145594454|NCT00827918|525028198|FG000|Overall Study|Physician Decision|1|||
145594455|NCT00827918|525028199|FG001|Overall Study|Physician Decision|0|||
145594456|NCT00827918|525028200|FG002|Overall Study|Physician Decision|0|||
145594457|NCT00827918|525028198|FG000|Overall Study|Pregnancy|0|||
145594458|NCT00827918|525028199|FG001|Overall Study|Pregnancy|1|||
145594459|NCT00827918|525028200|FG002|Overall Study|Pregnancy|0|||
145594460|NCT00827918|525028198|FG000|Overall Study|Progressive Disease|1|||
145594461|NCT00827918|525028199|FG001|Overall Study|Progressive Disease|1|||
145594462|NCT00827918|525028200|FG002|Overall Study|Progressive Disease|0|||
145594463|NCT00827918|525028198|FG000|Overall Study|Protocol Violation|0|||
145594464|NCT00827918|525028199|FG001|Overall Study|Protocol Violation|1|||
145594465|NCT00827918|525028200|FG002|Overall Study|Protocol Violation|0|||
145594466|NCT00827918|525028198|FG000|Overall Study|Withdrawal by Subject|6|||
145594467|NCT00827918|525028199|FG001|Overall Study|Withdrawal by Subject|2|||
145594468|NCT00827918|525028200|FG002|Overall Study|Withdrawal by Subject|6|||
145594469|NCT03743038|525028201|FG000|Overall Study|Physician Decision|1|||
145594470|NCT01565707|525028202|FG000|Overall Study|Adverse Event|1|||
145594471|NCT01565707|525028203|FG001|Overall Study|Adverse Event|6|||
145594472|NCT01565707|525028204|FG002|Overall Study|Adverse Event|2|||
145594473|NCT01565707|525028205|FG003|Overall Study|Adverse Event|1|||
145462403|NCT00526110|524543910|FG000|Overall Study|Maximal Response|0|||
145462404|NCT00526110|524543911|FG001|Overall Study|Maximal Response|6|||
145462405|NCT00526110|524543910|FG000|Overall Study|Withdrawal by Subject|0|||
145462406|NCT00526110|524543911|FG001|Overall Study|Withdrawal by Subject|2|||
145462407|NCT00526110|524543910|FG000|Overall Study|Poor Tolerance|0|||
145594474|NCT01565707|525028202|FG000|Overall Study|Lost to Follow-up|1|||
145594475|NCT01565707|525028203|FG001|Overall Study|Lost to Follow-up|0|||
145594476|NCT01565707|525028204|FG002|Overall Study|Lost to Follow-up|0|||
145594477|NCT01565707|525028205|FG003|Overall Study|Lost to Follow-up|0|||
145594478|NCT01565707|525028202|FG000|Overall Study|Protocol Violation|1|||
145594479|NCT01565707|525028203|FG001|Overall Study|Protocol Violation|0|||
145594480|NCT01565707|525028204|FG002|Overall Study|Protocol Violation|0|||
145594481|NCT01565707|525028205|FG003|Overall Study|Protocol Violation|1|||
145594482|NCT01565707|525028202|FG000|Overall Study|Withdrawal by Subject|3|||
145626838|NCT02223793|525147103|FG001|Overall Study|Moved/studycenter unable to participate|6|||
145626839|NCT02223793|525147104|FG002|Overall Study|Moved/studycenter unable to participate|8|||
145626840|NCT02359435|525147105|FG000|Overall Study|Lost to Follow-up|4|||
145626841|NCT02359435|525147106|FG001|Overall Study|Lost to Follow-up|4|||
145462408|NCT00526110|524543911|FG001|Overall Study|Poor Tolerance|5|||
145462409|NCT01400243|524543912|FG000|Overall Study|Protocol Violation|8|||
145462410|NCT01400243|524543913|FG001|Overall Study|Protocol Violation|11|||
145462411|NCT02278614|524543917|FG000|Overall Study|Withdrawal by Subject|3|||
145462412|NCT02278614|524543918|FG001|Overall Study|Withdrawal by Subject|5|||
145462413|NCT02278614|524543917|FG000|Overall Study|Adverse Event|1|||
145462414|NCT02278614|524543918|FG001|Overall Study|Adverse Event|0|||
145462415|NCT02278614|524543917|FG000|Overall Study|left eye was not eligible|1|||
145462416|NCT02278614|524543918|FG001|Overall Study|left eye was not eligible|0|||
145462417|NCT03762616|524543920|FG000|Overall Study|Protocol Violation|2|||
145462418|NCT03959982|524546471|FG000|Overall Study|Withdrawal by Subject|1|||
145462419|NCT03959982|524546472|FG001|Overall Study|Withdrawal by Subject|0|||
145462420|NCT03959982|524546471|FG000|Overall Study|Physician Decision|2|||
145462421|NCT03959982|524546472|FG001|Overall Study|Physician Decision|0|||
145462422|NCT03959982|524546471|FG000|Overall Study|Lost to Follow-up|1|||
145462423|NCT03959982|524546472|FG001|Overall Study|Lost to Follow-up|0|||
145462424|NCT00262847|524546473|FG000|Overall Study|Disease Progression|309|||
145462425|NCT00262847|524546474|FG001|Overall Study|Disease Progression|274|||
145462426|NCT00262847|524546475|FG002|Overall Study|Disease Progression|195|||
145462427|NCT00262847|524546473|FG000|Overall Study|Patient Refusal|41|||
145462428|NCT00262847|524546474|FG001|Overall Study|Patient Refusal|52|||
145462429|NCT00262847|524546475|FG002|Overall Study|Patient Refusal|47|||
145462430|NCT00262847|524546473|FG000|Overall Study|Adverse Event|74|||
145462431|NCT00262847|524546474|FG001|Overall Study|Adverse Event|88|||
145462432|NCT00262847|524546475|FG002|Overall Study|Adverse Event|108|||
145462433|NCT00262847|524546473|FG000|Overall Study|Death|8|||
145462434|NCT00262847|524546474|FG001|Overall Study|Death|8|||
145462435|NCT00262847|524546475|FG002|Overall Study|Death|11|||
145462436|NCT00262847|524546473|FG000|Overall Study|Concomitant disease|3|||
145462437|NCT00262847|524546474|FG001|Overall Study|Concomitant disease|2|||
145462438|NCT00262847|524546475|FG002|Overall Study|Concomitant disease|4|||
145462439|NCT00262847|524546473|FG000|Overall Study|Other Reasons|79|||
145462440|NCT00262847|524546474|FG001|Overall Study|Other Reasons|88|||
145462441|NCT00262847|524546475|FG002|Overall Study|Other Reasons|27|||
145462442|NCT00262847|524546473|FG000|Overall Study|Did not receive study treatment|4|||
145462443|NCT00262847|524546474|FG001|Overall Study|Did not receive study treatment|1|||
145462444|NCT00262847|524546475|FG002|Overall Study|Did not receive study treatment|4|||
145462445|NCT01278407|524546479|FG000|Confirmatory Phase|Adverse Event|5|||
145462446|NCT01278407|524546480|FG001|Confirmatory Phase|Adverse Event|10|||
145462447|NCT01278407|524546481|FG002|Confirmatory Phase|Adverse Event|1|||
145462448|NCT01278407|524546482|FG003|Confirmatory Phase|Adverse Event|0|||
145462449|NCT01278407|524546483|FG004|Confirmatory Phase|Adverse Event|0|||
145462450|NCT01278407|524546479|FG000|Confirmatory Phase|Participant's Choice|3|||
145462451|NCT01278407|524546480|FG001|Confirmatory Phase|Participant's Choice|5|||
145462452|NCT01278407|524546481|FG002|Confirmatory Phase|Participant's Choice|3|||
145462453|NCT01278407|524546482|FG003|Confirmatory Phase|Participant's Choice|0|||
145626842|NCT00315055|525147107|FG000|Overall Study|Protocol Violation|2|||
145626843|NCT00315055|525147108|FG001|Overall Study|Protocol Violation|4|||
145462454|NCT01278407|524546483|FG004|Confirmatory Phase|Participant's Choice|0|||
145462455|NCT01278407|524546479|FG000|Confirmatory Phase|Other|1|||
145462456|NCT01278407|524546480|FG001|Confirmatory Phase|Other|1|||
145462457|NCT01278407|524546481|FG002|Confirmatory Phase|Other|2|||
145462458|NCT01278407|524546482|FG003|Confirmatory Phase|Other|0|||
145462459|NCT01278407|524546483|FG004|Confirmatory Phase|Other|0|||
145462460|NCT01278407|524546479|FG000|Extension Phase|Adverse Event|0|||
145462461|NCT01278407|524546480|FG001|Extension Phase|Adverse Event|0|||
145462462|NCT01278407|524546481|FG002|Extension Phase|Adverse Event|0|||
145462463|NCT01278407|524546482|FG003|Extension Phase|Adverse Event|7|||
145462464|NCT01278407|524546483|FG004|Extension Phase|Adverse Event|16|||
145462465|NCT01278407|524546479|FG000|Extension Phase|Participant's Choice|0|||
145462466|NCT01278407|524546480|FG001|Extension Phase|Participant's Choice|0|||
145462467|NCT01278407|524546481|FG002|Extension Phase|Participant's Choice|0|||
145462468|NCT01278407|524546482|FG003|Extension Phase|Participant's Choice|4|||
145462469|NCT01278407|524546483|FG004|Extension Phase|Participant's Choice|11|||
145462470|NCT01278407|524546479|FG000|Extension Phase|Other|0|||
145462471|NCT01278407|524546480|FG001|Extension Phase|Other|0|||
145462472|NCT01278407|524546481|FG002|Extension Phase|Other|0|||
145462473|NCT01278407|524546482|FG003|Extension Phase|Other|1|||
145462474|NCT01278407|524546483|FG004|Extension Phase|Other|3|||
145462475|NCT02534935|524546484|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
145462476|NCT02534935|524546485|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
145462477|NCT02534935|524546486|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
145462478|NCT02534935|524546484|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
145462479|NCT02534935|524546485|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
145626844|NCT00315055|525147107|FG000|Overall Study|Lost to Follow-up|1|||
145462480|NCT02534935|524546486|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
145462481|NCT02534935|524546484|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
145462482|NCT02534935|524546485|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
145462483|NCT02534935|524546486|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
145462484|NCT02534935|524546484|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
145462485|NCT02534935|524546485|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
145462486|NCT02534935|524546486|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
145462487|NCT02534935|524546484|FG000|Stage 1: 24 Months|Adverse Event|0|||
145462488|NCT02534935|524546485|FG001|Stage 1: 24 Months|Adverse Event|2|||
145462489|NCT02534935|524546486|FG002|Stage 1: 24 Months|Adverse Event|0|||
145462490|NCT02534935|524546484|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
145462491|NCT02534935|524546485|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
145462492|NCT02534935|524546486|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
145462493|NCT02534935|524546484|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
145462494|NCT02534935|524546485|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
145462495|NCT02534935|524546486|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
145462496|NCT01596335|524546487|FG000|Overall Study|exacerbation of primary disease|5|||
145462497|NCT01596335|524546488|FG001|Overall Study|exacerbation of primary disease|9|||
145462498|NCT01460719|524546489|FG000|Overall Study|Adverse Event|1|||
145462499|NCT01460719|524546489|FG000|Overall Study|Withdrawal by Subject|1|||
145462500|NCT04524455|524546496|FG000|Overall Study|Death|3|||
145462501|NCT04524455|524546497|FG001|Overall Study|Death|3|||
145462502|NCT04524455|524546496|FG000|Overall Study|Decision by Sponsor|0|||
145462503|NCT04524455|524546497|FG001|Overall Study|Decision by Sponsor|2|||
145462504|NCT04524455|524546496|FG000|Overall Study|Withdrawal of Consent From Study|1|||
145462505|NCT04524455|524546497|FG001|Overall Study|Withdrawal of Consent From Study|0|||
145462506|NCT04524455|524546496|FG000|Overall Study|Lost to Follow-up|0|||
145462507|NCT04524455|524546497|FG001|Overall Study|Lost to Follow-up|1|||
145462508|NCT01176565|524546502|FG000|Overall Study|Lost to Follow-up|12|||
145462509|NCT01176565|524546503|FG001|Overall Study|Lost to Follow-up|16|||
145462510|NCT01176565|524546502|FG000|Overall Study|Withdrawal by Subject|7|||
145462511|NCT01176565|524546503|FG001|Overall Study|Withdrawal by Subject|1|||
145462512|NCT01176565|524546502|FG000|Overall Study|Not Analyzed (any other reason)|1|||
145462513|NCT01176565|524546503|FG001|Overall Study|Not Analyzed (any other reason)|2|||
145462514|NCT03602885|524546505|FG000|Overall Study|Lost to Follow-up|3|||
145462515|NCT03602885|524546506|FG001|Overall Study|Lost to Follow-up|0|||
145462516|NCT02285114|524546508|FG000|Main Phase|Investigator's Discretion|0|||
145462517|NCT02285114|524546509|FG001|Main Phase|Investigator's Discretion|2|||
145462518|NCT02285114|524546510|FG002|Main Phase|Investigator's Discretion|0|||
145462519|NCT02285114|524546511|FG003|Main Phase|Investigator's Discretion|0|||
145462520|NCT02285114|524546512|FG004|Main Phase|Investigator's Discretion|0|||
145462521|NCT02285114|524546513|FG005|Main Phase|Investigator's Discretion|0|||
145462522|NCT02285114|524546508|FG000|Main Phase|Enrolled but Never Treated|1|||
145462523|NCT02285114|524546509|FG001|Main Phase|Enrolled but Never Treated|0|||
145462524|NCT02285114|524546510|FG002|Main Phase|Enrolled but Never Treated|0|||
145462525|NCT02285114|524546511|FG003|Main Phase|Enrolled but Never Treated|0|||
145462526|NCT02285114|524546512|FG004|Main Phase|Enrolled but Never Treated|0|||
145462527|NCT02285114|524546513|FG005|Main Phase|Enrolled but Never Treated|0|||
145594483|NCT01565707|525028203|FG001|Overall Study|Withdrawal by Subject|1|||
145594484|NCT01565707|525028204|FG002|Overall Study|Withdrawal by Subject|1|||
145594485|NCT01565707|525028205|FG003|Overall Study|Withdrawal by Subject|1|||
145594486|NCT01565707|525028202|FG000|Overall Study|Randomized but not evaluable|2|||
145594487|NCT01565707|525028203|FG001|Overall Study|Randomized but not evaluable|0|||
145462528|NCT02285114|524546508|FG000|Main Phase|Withdrew Consent|0|||
145462529|NCT02285114|524546509|FG001|Main Phase|Withdrew Consent|0|||
145462530|NCT02285114|524546510|FG002|Main Phase|Withdrew Consent|1|||
145462531|NCT02285114|524546511|FG003|Main Phase|Withdrew Consent|0|||
145462532|NCT02285114|524546512|FG004|Main Phase|Withdrew Consent|0|||
145462533|NCT02285114|524546513|FG005|Main Phase|Withdrew Consent|0|||
145462534|NCT02285114|524546508|FG000|Extension Phase|Investigator's Discretion|0|||
145462535|NCT02285114|524546509|FG001|Extension Phase|Investigator's Discretion|0|||
145462536|NCT02285114|524546510|FG002|Extension Phase|Investigator's Discretion|0|||
145462537|NCT02285114|524546511|FG003|Extension Phase|Investigator's Discretion|14|||
145462538|NCT02285114|524546512|FG004|Extension Phase|Investigator's Discretion|1|||
145462539|NCT02285114|524546513|FG005|Extension Phase|Investigator's Discretion|0|||
145462540|NCT02285114|524546508|FG000|Extension Phase|Lost to Follow-up|0|||
145462541|NCT02285114|524546509|FG001|Extension Phase|Lost to Follow-up|0|||
145462542|NCT02285114|524546510|FG002|Extension Phase|Lost to Follow-up|0|||
145594488|NCT01565707|525028204|FG002|Overall Study|Randomized but not evaluable|0|||
145594489|NCT01565707|525028205|FG003|Overall Study|Randomized but not evaluable|0|||
145594490|NCT01565707|525028202|FG000|Overall Study|Miscellaneous|1|||
145594491|NCT01565707|525028203|FG001|Overall Study|Miscellaneous|1|||
145462543|NCT02285114|524546511|FG003|Extension Phase|Lost to Follow-up|1|||
145462544|NCT02285114|524546512|FG004|Extension Phase|Lost to Follow-up|1|||
145462545|NCT02285114|524546513|FG005|Extension Phase|Lost to Follow-up|0|||
145462546|NCT02285114|524546508|FG000|Extension Phase|Non-compliance with Study Drug|0|||
145462547|NCT02285114|524546509|FG001|Extension Phase|Non-compliance with Study Drug|0|||
145462548|NCT02285114|524546510|FG002|Extension Phase|Non-compliance with Study Drug|0|||
145462549|NCT02285114|524546511|FG003|Extension Phase|Non-compliance with Study Drug|2|||
145626845|NCT00315055|525147108|FG001|Overall Study|Lost to Follow-up|1|||
145626846|NCT01289119|525147112|FG000|Overall Study|Adverse Event|2|||
145626847|NCT01289119|525147113|FG001|Overall Study|Adverse Event|1|||
145626848|NCT01289119|525147114|FG002|Overall Study|Adverse Event|0|||
145626849|NCT01289119|525147115|FG003|Overall Study|Adverse Event|2|||
145626850|NCT01289119|525147116|FG004|Overall Study|Adverse Event|1|||
145626851|NCT01289119|525147117|FG005|Overall Study|Adverse Event|0|||
145626852|NCT01289119|525147112|FG000|Overall Study|Major Protocol Deviation|2|||
145626853|NCT01289119|525147113|FG001|Overall Study|Major Protocol Deviation|1|||
145626854|NCT01289119|525147114|FG002|Overall Study|Major Protocol Deviation|3|||
145626855|NCT01289119|525147115|FG003|Overall Study|Major Protocol Deviation|0|||
145462550|NCT02285114|524546512|FG004|Extension Phase|Non-compliance with Study Drug|0|||
145462551|NCT02285114|524546513|FG005|Extension Phase|Non-compliance with Study Drug|0|||
145462552|NCT02285114|524546508|FG000|Extension Phase|Pregnancy|0|||
145462553|NCT02285114|524546509|FG001|Extension Phase|Pregnancy|0|||
145462554|NCT02285114|524546510|FG002|Extension Phase|Pregnancy|0|||
145462555|NCT02285114|524546511|FG003|Extension Phase|Pregnancy|1|||
145462556|NCT02285114|524546512|FG004|Extension Phase|Pregnancy|0|||
145462557|NCT02285114|524546513|FG005|Extension Phase|Pregnancy|0|||
145462558|NCT01156389|524546514|FG000|Overall Study|Elevated liver enzymes|4|||
145462559|NCT01156389|524546515|FG001|Overall Study|Elevated liver enzymes|0|||
145462560|NCT01156389|524546514|FG000|Overall Study|Vomiting|0|||
145462561|NCT01156389|524546515|FG001|Overall Study|Vomiting|1|||
145462562|NCT04126564|524546519|FG000|Overall Study|Withdrawal by Subject|0|||
145462563|NCT04126564|524546520|FG001|Overall Study|Withdrawal by Subject|2|||
145462564|NCT04126564|524546519|FG000|Overall Study|Lost to Follow-up|0|||
145462565|NCT04126564|524546520|FG001|Overall Study|Lost to Follow-up|1|||
145462566|NCT02536300|524546521|FG000|Overall Study|Investigator's Discretion|17|||
145462567|NCT02536300|524546522|FG001|Overall Study|Investigator's Discretion|11|||
145462568|NCT02536300|524546523|FG002|Overall Study|Investigator's Discretion|2|||
145462569|NCT02536300|524546521|FG000|Overall Study|Progressive Disease|11|||
145462570|NCT02536300|524546522|FG001|Overall Study|Progressive Disease|7|||
145462571|NCT02536300|524546523|FG002|Overall Study|Progressive Disease|6|||
145462572|NCT02536300|524546521|FG000|Overall Study|Study Terminated by Sponsor|6|||
145462573|NCT02536300|524546522|FG001|Overall Study|Study Terminated by Sponsor|4|||
145462574|NCT02536300|524546523|FG002|Overall Study|Study Terminated by Sponsor|7|||
145462575|NCT02536300|524546521|FG000|Overall Study|Death|7|||
145462576|NCT02536300|524546522|FG001|Overall Study|Death|0|||
145462577|NCT02536300|524546523|FG002|Overall Study|Death|5|||
145462578|NCT02536300|524546521|FG000|Overall Study|Withdrew Consent|4|||
145462579|NCT02536300|524546522|FG001|Overall Study|Withdrew Consent|2|||
145462580|NCT02536300|524546523|FG002|Overall Study|Withdrew Consent|0|||
145462581|NCT02536300|524546521|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
145462582|NCT02536300|524546522|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
145462583|NCT02536300|524546523|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
145462584|NCT02536300|524546521|FG000|Overall Study|Enrolled but Never Treated|0|||
145462585|NCT02536300|524546522|FG001|Overall Study|Enrolled but Never Treated|0|||
145462586|NCT02536300|524546523|FG002|Overall Study|Enrolled but Never Treated|1|||
145594492|NCT01565707|525028204|FG002|Overall Study|Miscellaneous|0|||
145594493|NCT01565707|525028205|FG003|Overall Study|Miscellaneous|2|||
145594494|NCT05207813|525028206|FG000|Overall Study|Lost to Follow-up|2|||
145594495|NCT01261338|525028212|FG000|Overall Study|Withdrawal by Subject|3|||
145594496|NCT01261338|525028213|FG001|Overall Study|Withdrawal by Subject|2|||
145594497|NCT00126438|525028214|FG000|Overall Study|Withdrawal due to adverse event|1|||
145594498|NCT00126438|525028215|FG001|Overall Study|Withdrawal due to adverse event|0|||
145594499|NCT00126438|525028214|FG000|Overall Study|Lost to Follow-up|22|||
145594500|NCT00126438|525028215|FG001|Overall Study|Lost to Follow-up|0|||
145594501|NCT00126438|525028214|FG000|Overall Study|Protocol Violation|8|||
145594502|NCT00126438|525028215|FG001|Overall Study|Protocol Violation|8|||
145594503|NCT00126438|525028214|FG000|Overall Study|Withdrawal by Subject|3|||
145594504|NCT00126438|525028215|FG001|Overall Study|Withdrawal by Subject|2|||
145594505|NCT02899728|525028219|FG000|Overall Study|Withdrawal by Subject|1|||
145594506|NCT02899728|525028220|FG001|Overall Study|Withdrawal by Subject|1|||
145594507|NCT04304833|525028221|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
145626856|NCT01289119|525147116|FG004|Overall Study|Major Protocol Deviation|2|||
145462587|NCT02536300|524546521|FG000|Overall Study|Non-compliance With Study Drug|1|||
145594508|NCT04304833|525028222|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
145594509|NCT01951625|525028223|FG000|Treatment Period|Protocol Violation|2|||
145462588|NCT02536300|524546522|FG001|Overall Study|Non-compliance With Study Drug|0|||
145594510|NCT01951625|525028224|FG001|Treatment Period|Protocol Violation|0|||
145462589|NCT02536300|524546523|FG002|Overall Study|Non-compliance With Study Drug|0|||
145462590|NCT02536300|524546521|FG000|Overall Study|Protocol Violation|0|||
145462591|NCT02536300|524546522|FG001|Overall Study|Protocol Violation|1|||
145462592|NCT02536300|524546523|FG002|Overall Study|Protocol Violation|0|||
145462593|NCT02233738|524546527|FG000|Overall Study|Lost to Follow-up|5|||
145462594|NCT02233738|524546528|FG001|Overall Study|Lost to Follow-up|12|||
145462595|NCT02233738|524546527|FG000|Overall Study|Death|0|||
145462596|NCT02233738|524546528|FG001|Overall Study|Death|1|||
145462597|NCT02233738|524546527|FG000|Overall Study|Withdrawal by Subject|0|||
145462598|NCT02233738|524546528|FG001|Overall Study|Withdrawal by Subject|1|||
145462599|NCT02233738|524546527|FG000|Overall Study|Did not return after Baseline|3|||
145462600|NCT02233738|524546528|FG001|Overall Study|Did not return after Baseline|2|||
145462601|NCT00096174|524546532|FG000|Overall Study|Lack of Efficacy|9|||
145462602|NCT00096174|524546532|FG000|Overall Study|Adverse Event|15|||
145462603|NCT00096174|524546532|FG000|Overall Study|Death|6|||
145462604|NCT00096174|524546532|FG000|Overall Study|Withdrawal by Subject|15|||
145462605|NCT00096174|524546532|FG000|Overall Study|Not started protocol therapy|3|||
145462606|NCT00096174|524546532|FG000|Overall Study|Ineligible|6|||
145462607|NCT00096174|524546532|FG000|Overall Study|other reason|8|||
145462608|NCT00330928|524546533|FG000|Overall Study|Lost to Follow-up|6|||
145462609|NCT00330928|524546533|FG000|Overall Study|Physician Decision|9|||
145462610|NCT00330928|524546533|FG000|Overall Study|Death|1|||
145462611|NCT00330928|524546533|FG000|Overall Study|IVUS could not be performed.|1|||
145462612|NCT03028480|524546536|FG000|Overall Study|No revisit after the first prescription date|2|||
145462613|NCT03028480|524546536|FG000|Overall Study|Did not use the drug|1|||
145462614|NCT03028480|524546536|FG000|Overall Study|Violation of the enrollment deadline|10|||
145462615|NCT03028480|524546536|FG000|Overall Study|Case report forms were not collected|21|||
145462616|NCT01030874|524546537|FG000|Overall Study|Withdrawal by Subject|1|||
145462617|NCT01030874|524546538|FG001|Overall Study|Withdrawal by Subject|0|||
145462618|NCT01030874|524546537|FG000|Overall Study|Discharged in first 2 weeks|17|||
145462619|NCT01030874|524546538|FG001|Overall Study|Discharged in first 2 weeks|16|||
145462620|NCT03554772|524546546|FG000|Overall Study|Lost to Follow-up|0|||
145462621|NCT03554772|524546547|FG001|Overall Study|Lost to Follow-up|0|||
145462622|NCT03554772|524546548|FG002|Overall Study|Lost to Follow-up|0|||
145462623|NCT03554772|524546549|FG003|Overall Study|Lost to Follow-up|2|||
145462624|NCT01133405|524546554|FG000|Period 1|Withdrawal by Subject|0|||
145462625|NCT01133405|524546555|FG001|Period 1|Withdrawal by Subject|1|||
145462626|NCT01133405|524546556|FG002|Period 1|Withdrawal by Subject|0|||
145462627|NCT01133405|524546557|FG003|Period 1|Withdrawal by Subject|1|||
145462628|NCT01133405|524546558|FG004|Period 1|Withdrawal by Subject|0|||
145462629|NCT01133405|524546559|FG005|Period 1|Withdrawal by Subject|1|||
145462630|NCT01133405|524546560|FG006|Period 1|Withdrawal by Subject|0|||
145462631|NCT01133405|524546561|FG007|Period 1|Withdrawal by Subject|0|||
145462632|NCT01133405|524546562|FG008|Period 1|Withdrawal by Subject|0|||
145462633|NCT01133405|524546563|FG009|Period 1|Withdrawal by Subject|0|||
145462634|NCT01133405|524546554|FG000|Period 1|Physician Decision|0|||
145462635|NCT01133405|524546555|FG001|Period 1|Physician Decision|0|||
145462636|NCT01133405|524546556|FG002|Period 1|Physician Decision|0|||
145462637|NCT01133405|524546557|FG003|Period 1|Physician Decision|1|||
145462638|NCT01133405|524546558|FG004|Period 1|Physician Decision|0|||
145462639|NCT01133405|524546559|FG005|Period 1|Physician Decision|0|||
145462640|NCT01133405|524546560|FG006|Period 1|Physician Decision|0|||
145462641|NCT01133405|524546561|FG007|Period 1|Physician Decision|0|||
145462642|NCT01133405|524546562|FG008|Period 1|Physician Decision|0|||
145462643|NCT01133405|524546563|FG009|Period 1|Physician Decision|0|||
145462644|NCT01133405|524546554|FG000|Period 1|Discontinued after randomization|1|||
145462645|NCT01133405|524546555|FG001|Period 1|Discontinued after randomization|0|||
145462646|NCT01133405|524546556|FG002|Period 1|Discontinued after randomization|0|||
145462647|NCT01133405|524546557|FG003|Period 1|Discontinued after randomization|0|||
145462648|NCT01133405|524546558|FG004|Period 1|Discontinued after randomization|0|||
145462649|NCT01133405|524546559|FG005|Period 1|Discontinued after randomization|0|||
145462650|NCT01133405|524546560|FG006|Period 1|Discontinued after randomization|1|||
145462651|NCT01133405|524546561|FG007|Period 1|Discontinued after randomization|0|||
145462652|NCT01133405|524546562|FG008|Period 1|Discontinued after randomization|0|||
145462653|NCT01133405|524546563|FG009|Period 1|Discontinued after randomization|0|||
145462654|NCT01133405|524546554|FG000|Period 1|Received drug only in period 2|0|||
145462655|NCT01133405|524546555|FG001|Period 1|Received drug only in period 2|1|||
145462656|NCT01133405|524546556|FG002|Period 1|Received drug only in period 2|0|||
145462657|NCT01133405|524546557|FG003|Period 1|Received drug only in period 2|2|||
145462658|NCT01133405|524546558|FG004|Period 1|Received drug only in period 2|0|||
145462659|NCT01133405|524546559|FG005|Period 1|Received drug only in period 2|1|||
145462660|NCT01133405|524546560|FG006|Period 1|Received drug only in period 2|0|||
145462661|NCT01133405|524546561|FG007|Period 1|Received drug only in period 2|0|||
145462662|NCT01133405|524546562|FG008|Period 1|Received drug only in period 2|0|||
145462663|NCT01133405|524546563|FG009|Period 1|Received drug only in period 2|0|||
145462664|NCT01133405|524546554|FG000|Period 1|Received drug only in period 3|0|||
145462665|NCT01133405|524546555|FG001|Period 1|Received drug only in period 3|1|||
145462666|NCT01133405|524546556|FG002|Period 1|Received drug only in period 3|1|||
145462667|NCT01133405|524546557|FG003|Period 1|Received drug only in period 3|0|||
145462668|NCT01133405|524546558|FG004|Period 1|Received drug only in period 3|0|||
145462669|NCT01133405|524546559|FG005|Period 1|Received drug only in period 3|0|||
145462670|NCT01133405|524546560|FG006|Period 1|Received drug only in period 3|0|||
145462671|NCT01133405|524546561|FG007|Period 1|Received drug only in period 3|0|||
145462672|NCT01133405|524546562|FG008|Period 1|Received drug only in period 3|0|||
145462673|NCT01133405|524546563|FG009|Period 1|Received drug only in period 3|0|||
145462674|NCT01133405|524546554|FG000|Period 2|Adverse Event|0|||
145462675|NCT01133405|524546555|FG001|Period 2|Adverse Event|0|||
145462676|NCT01133405|524546556|FG002|Period 2|Adverse Event|1|||
145462677|NCT01133405|524546557|FG003|Period 2|Adverse Event|0|||
145462678|NCT01133405|524546558|FG004|Period 2|Adverse Event|0|||
145462679|NCT01133405|524546559|FG005|Period 2|Adverse Event|0|||
145462680|NCT01133405|524546560|FG006|Period 2|Adverse Event|0|||
145462681|NCT01133405|524546561|FG007|Period 2|Adverse Event|0|||
145462682|NCT01133405|524546562|FG008|Period 2|Adverse Event|0|||
145462683|NCT01133405|524546563|FG009|Period 2|Adverse Event|0|||
145462684|NCT01133405|524546554|FG000|Period 2|Withdrawal by Subject|0|||
145462685|NCT01133405|524546555|FG001|Period 2|Withdrawal by Subject|0|||
145462686|NCT01133405|524546556|FG002|Period 2|Withdrawal by Subject|0|||
145462687|NCT01133405|524546557|FG003|Period 2|Withdrawal by Subject|1|||
145462688|NCT01133405|524546558|FG004|Period 2|Withdrawal by Subject|0|||
145462689|NCT01133405|524546559|FG005|Period 2|Withdrawal by Subject|1|||
145462690|NCT01133405|524546560|FG006|Period 2|Withdrawal by Subject|0|||
145462691|NCT01133405|524546561|FG007|Period 2|Withdrawal by Subject|0|||
145462692|NCT01133405|524546562|FG008|Period 2|Withdrawal by Subject|0|||
145462693|NCT01133405|524546563|FG009|Period 2|Withdrawal by Subject|0|||
145462694|NCT01133405|524546554|FG000|Period 2|Entry Criteria Not Met|0|||
145462695|NCT01133405|524546555|FG001|Period 2|Entry Criteria Not Met|1|||
145462696|NCT01133405|524546556|FG002|Period 2|Entry Criteria Not Met|0|||
145462697|NCT01133405|524546557|FG003|Period 2|Entry Criteria Not Met|0|||
145462698|NCT01133405|524546558|FG004|Period 2|Entry Criteria Not Met|0|||
145462699|NCT01133405|524546559|FG005|Period 2|Entry Criteria Not Met|0|||
145462700|NCT01133405|524546560|FG006|Period 2|Entry Criteria Not Met|0|||
145462701|NCT01133405|524546561|FG007|Period 2|Entry Criteria Not Met|0|||
145462702|NCT01133405|524546562|FG008|Period 2|Entry Criteria Not Met|0|||
145462703|NCT01133405|524546563|FG009|Period 2|Entry Criteria Not Met|0|||
145462704|NCT01133405|524546554|FG000|Period 2|Physician Decision|0|||
145462705|NCT01133405|524546555|FG001|Period 2|Physician Decision|0|||
145462706|NCT01133405|524546556|FG002|Period 2|Physician Decision|0|||
145462707|NCT01133405|524546557|FG003|Period 2|Physician Decision|0|||
145462708|NCT01133405|524546558|FG004|Period 2|Physician Decision|0|||
145462709|NCT01133405|524546559|FG005|Period 2|Physician Decision|1|||
145462710|NCT01133405|524546560|FG006|Period 2|Physician Decision|0|||
145462711|NCT01133405|524546561|FG007|Period 2|Physician Decision|0|||
145462712|NCT01133405|524546562|FG008|Period 2|Physician Decision|0|||
145462713|NCT01133405|524546563|FG009|Period 2|Physician Decision|0|||
145462714|NCT00089986|524546566|FG000|Overall Study|Adverse Event|6|||
145462715|NCT00089986|524546567|FG001|Overall Study|Adverse Event|9|||
145462716|NCT00089986|524546568|FG002|Overall Study|Adverse Event|6|||
145462717|NCT00089986|524546566|FG000|Overall Study|Lost to Follow-up|3|||
145462718|NCT00089986|524546567|FG001|Overall Study|Lost to Follow-up|1|||
145462719|NCT00089986|524546568|FG002|Overall Study|Lost to Follow-up|1|||
145462720|NCT00089986|524546566|FG000|Overall Study|Protocol Violation|0|||
145462721|NCT00089986|524546567|FG001|Overall Study|Protocol Violation|1|||
145462722|NCT00089986|524546568|FG002|Overall Study|Protocol Violation|0|||
145462723|NCT00089986|524546566|FG000|Overall Study|Patient transferred to another hospital|2|||
145462724|NCT00089986|524546567|FG001|Overall Study|Patient transferred to another hospital|1|||
145462725|NCT00089986|524546568|FG002|Overall Study|Patient transferred to another hospital|0|||
145462726|NCT00089986|524546566|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
145462727|NCT00089986|524546567|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
145462728|NCT00089986|524546568|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
145594511|NCT01951625|525028225|FG002|Treatment Period|Protocol Violation|1|||
145594512|NCT01951625|525028226|FG003|Treatment Period|Protocol Violation|3|||
145462729|NCT00089986|524546566|FG000|Overall Study|Hemohlobin stopping rule|0|||
145462730|NCT00089986|524546567|FG001|Overall Study|Hemohlobin stopping rule|1|||
145462731|NCT00089986|524546568|FG002|Overall Study|Hemohlobin stopping rule|0|||
145462732|NCT00089986|524546566|FG000|Overall Study|Investigator decision to withdrew|0|||
145462733|NCT00089986|524546567|FG001|Overall Study|Investigator decision to withdrew|1|||
145462734|NCT00089986|524546568|FG002|Overall Study|Investigator decision to withdrew|0|||
145462735|NCT00089986|524546566|FG000|Overall Study|Enrollment in another study|0|||
145462736|NCT00089986|524546567|FG001|Overall Study|Enrollment in another study|1|||
145462737|NCT00089986|524546568|FG002|Overall Study|Enrollment in another study|0|||
145462738|NCT00089986|524546566|FG000|Overall Study|Family decision|0|||
145462739|NCT00089986|524546567|FG001|Overall Study|Family decision|1|||
145462740|NCT00089986|524546568|FG002|Overall Study|Family decision|0|||
145594513|NCT01951625|525028227|FG004|Treatment Period|Protocol Violation|2|||
145462741|NCT00089986|524546566|FG000|Overall Study|Do not resuscitate (DNR)|0|||
145462742|NCT00089986|524546567|FG001|Overall Study|Do not resuscitate (DNR)|0|||
145462743|NCT00089986|524546568|FG002|Overall Study|Do not resuscitate (DNR)|1|||
145462744|NCT00089986|524546566|FG000|Overall Study|Withdrawal by Subject|3|||
145462745|NCT00089986|524546567|FG001|Overall Study|Withdrawal by Subject|6|||
145462746|NCT00089986|524546568|FG002|Overall Study|Withdrawal by Subject|2|||
145462747|NCT03946124|524546569|FG000|Overall Study|Withdrawal by Subject|19|||
145462748|NCT00241631|524546570|FG000|Run in (2 Weeks)|Physician Decision|3|||
145462749|NCT00241631|524546571|FG001|Run in (2 Weeks)|Physician Decision|3|||
145462750|NCT00241631|524546570|FG000|Phase 1 (4 Weeks)|sore throat|1|||
145462751|NCT00241631|524546571|FG001|Phase 1 (4 Weeks)|sore throat|0|||
145462752|NCT00241631|524546570|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
145462753|NCT00241631|524546571|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
145462754|NCT00241631|524546570|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
145462755|NCT00241631|524546571|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
145462756|NCT00241631|524546570|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
145462757|NCT00241631|524546571|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
145462758|NCT00413920|524546575|FG000|Overall Study|Adverse Event|9|||
145462759|NCT00413920|524546576|FG001|Overall Study|Adverse Event|11|||
145462760|NCT00413920|524546575|FG000|Overall Study|Lack of Efficacy|11|||
145462761|NCT00413920|524546576|FG001|Overall Study|Lack of Efficacy|9|||
145462762|NCT00413920|524546575|FG000|Overall Study|Death|3|||
145462763|NCT00413920|524546576|FG001|Overall Study|Death|5|||
145462764|NCT00413920|524546575|FG000|Overall Study|Graft Loss|5|||
145462765|NCT00413920|524546576|FG001|Overall Study|Graft Loss|3|||
145462766|NCT02788201|524546577|FG000|Overall Study|Death|1|||
145462767|NCT02788201|524546578|FG001|Overall Study|Death|1|||
145462768|NCT02788201|524546579|FG002|Overall Study|Death|1|||
145462769|NCT02788201|524546580|FG003|Overall Study|Death|1|||
145462770|NCT02788201|524546581|FG004|Overall Study|Death|0|||
145462771|NCT02788201|524546582|FG005|Overall Study|Death|1|||
145462772|NCT02788201|524546577|FG000|Overall Study|Ineligible|0|||
145462773|NCT02788201|524546578|FG001|Overall Study|Ineligible|0|||
145462774|NCT02788201|524546579|FG002|Overall Study|Ineligible|0|||
145462775|NCT02788201|524546580|FG003|Overall Study|Ineligible|0|||
145462776|NCT02788201|524546581|FG004|Overall Study|Ineligible|0|||
145462777|NCT02788201|524546582|FG005|Overall Study|Ineligible|1|||
145462778|NCT02788201|524546577|FG000|Overall Study|Withdrawal by Subject|0|||
145462779|NCT02788201|524546578|FG001|Overall Study|Withdrawal by Subject|0|||
145462780|NCT02788201|524546579|FG002|Overall Study|Withdrawal by Subject|0|||
145462781|NCT02788201|524546580|FG003|Overall Study|Withdrawal by Subject|0|||
145462782|NCT02788201|524546581|FG004|Overall Study|Withdrawal by Subject|0|||
145462783|NCT02788201|524546582|FG005|Overall Study|Withdrawal by Subject|1|||
145462784|NCT01852825|524546583|FG000|Overall Study|Withdrawal by Subject|2|||
145462785|NCT01852825|524546584|FG001|Overall Study|Withdrawal by Subject|0|||
145462786|NCT01852825|524546585|FG002|Overall Study|Withdrawal by Subject|0|||
145462787|NCT02446418|524546587|FG000|Overall Study|Adverse Event|4|||
145462788|NCT02446418|524546588|FG001|Overall Study|Adverse Event|8|||
145462789|NCT02446418|524546587|FG000|Overall Study|Physician Decision|5|||
145462790|NCT02446418|524546588|FG001|Overall Study|Physician Decision|1|||
145462791|NCT02446418|524546587|FG000|Overall Study|Withdrawal by Subject|3|||
145462792|NCT02446418|524546588|FG001|Overall Study|Withdrawal by Subject|3|||
145462793|NCT02446418|524546587|FG000|Overall Study|Lost to Follow-up|2|||
145462794|NCT02446418|524546588|FG001|Overall Study|Lost to Follow-up|2|||
145462795|NCT02446418|524546587|FG000|Overall Study|Protocol Violation|1|||
145462796|NCT02446418|524546588|FG001|Overall Study|Protocol Violation|2|||
145462797|NCT02446418|524546587|FG000|Overall Study|Lack of Efficacy|2|||
145462798|NCT02446418|524546588|FG001|Overall Study|Lack of Efficacy|0|||
145462799|NCT02446418|524546587|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
145462800|NCT02446418|524546588|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
145462801|NCT03421743|524546591|FG000|Overall Study|Lack of Efficacy|1|||
145462802|NCT03421743|524546592|FG001|Overall Study|Lack of Efficacy|0|||
145462803|NCT03421743|524546591|FG000|Overall Study|Adverse Event|2|||
145462804|NCT03421743|524546592|FG001|Overall Study|Adverse Event|1|||
145462805|NCT03421743|524546591|FG000|Overall Study|Withdrawal by Subject|0|||
145462806|NCT03421743|524546592|FG001|Overall Study|Withdrawal by Subject|1|||
145462807|NCT01457950|524546593|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
145462808|NCT01457950|524546594|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
145462809|NCT01457950|524546595|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
145462810|NCT01457950|524546596|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
145462811|NCT01457950|524546593|FG000|Double-Blind Phase|Protocol Violation|2|||
145462812|NCT01457950|524546594|FG001|Double-Blind Phase|Protocol Violation|1|||
145462813|NCT01457950|524546595|FG002|Double-Blind Phase|Protocol Violation|0|||
145462814|NCT01457950|524546596|FG003|Double-Blind Phase|Protocol Violation|0|||
145462815|NCT01457950|524546593|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
145462816|NCT01457950|524546594|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
145462817|NCT01457950|524546595|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145462818|NCT01457950|524546596|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145462819|NCT01457950|524546593|FG000|Open-Label Phase|Adverse Event|0|||
145462820|NCT01457950|524546594|FG001|Open-Label Phase|Adverse Event|0|||
145462821|NCT01457950|524546595|FG002|Open-Label Phase|Adverse Event|0|||
145462822|NCT01457950|524546596|FG003|Open-Label Phase|Adverse Event|1|||
145462823|NCT01457950|524546593|FG000|Open-Label Phase|Protocol Violation|0|||
145462824|NCT01457950|524546594|FG001|Open-Label Phase|Protocol Violation|0|||
145462825|NCT01457950|524546595|FG002|Open-Label Phase|Protocol Violation|0|||
145462826|NCT01457950|524546596|FG003|Open-Label Phase|Protocol Violation|1|||
145462827|NCT01457950|524546593|FG000|Open-Label Phase|Withdrawal by Subject|0|||
145462828|NCT01457950|524546594|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145462829|NCT01457950|524546595|FG002|Open-Label Phase|Withdrawal by Subject|2|||
145462830|NCT01457950|524546596|FG003|Open-Label Phase|Withdrawal by Subject|0|||
145462831|NCT01765426|524546597|FG000|Overall Study|Lost to Follow-up|0|||
145462832|NCT01765426|524546598|FG001|Overall Study|Lost to Follow-up|1|||
145462833|NCT01765426|524546599|FG002|Overall Study|Lost to Follow-up|0|||
145462834|NCT01765426|524546600|FG003|Overall Study|Lost to Follow-up|0|||
145462835|NCT01166373|524546601|FG000|Overall Study|Lost to Follow-up|3|||
145462836|NCT01166373|524546602|FG001|Overall Study|Lost to Follow-up|2|||
145462837|NCT01166373|524546603|FG002|Overall Study|Lost to Follow-up|2|||
145462838|NCT01166373|524546604|FG003|Overall Study|Lost to Follow-up|2|||
145462839|NCT01166373|524546601|FG000|Overall Study|Withdrawal by Subject|1|||
145462840|NCT01166373|524546602|FG001|Overall Study|Withdrawal by Subject|2|||
145462841|NCT01166373|524546603|FG002|Overall Study|Withdrawal by Subject|2|||
145462842|NCT01166373|524546604|FG003|Overall Study|Withdrawal by Subject|3|||
145462843|NCT01166373|524546601|FG000|Overall Study|Physician Decision|1|||
145462844|NCT01166373|524546602|FG001|Overall Study|Physician Decision|0|||
145462845|NCT01166373|524546603|FG002|Overall Study|Physician Decision|0|||
145462846|NCT01166373|524546604|FG003|Overall Study|Physician Decision|0|||
145462847|NCT01510184|524546605|FG000|Overall Study|Sponsor discretion|28|||
145462848|NCT01510184|524546606|FG001|Overall Study|Sponsor discretion|28|||
145462849|NCT01510184|524546605|FG000|Overall Study|Death|1|||
145462850|NCT01510184|524546606|FG001|Overall Study|Death|2|||
145462851|NCT01510184|524546605|FG000|Overall Study|Withdrawal by Subject|1|||
145462852|NCT01510184|524546606|FG001|Overall Study|Withdrawal by Subject|4|||
145462853|NCT01510184|524546605|FG000|Overall Study|Other|0|||
145462854|NCT01510184|524546606|FG001|Overall Study|Other|1|||
145462855|NCT02078102|524546610|FG000|Overall Study|Adverse Event|1|||
145462856|NCT02078102|524546611|FG001|Overall Study|Adverse Event|0|||
145462857|NCT02078102|524546610|FG000|Overall Study|Withdrawal by Subject|1|||
145462858|NCT02078102|524546611|FG001|Overall Study|Withdrawal by Subject|0|||
145462859|NCT02078102|524546610|FG000|Overall Study|Physician Decision|0|||
145462860|NCT02078102|524546611|FG001|Overall Study|Physician Decision|1|||
145462861|NCT02370641|524546614|FG000|Overall Study|dropped study|4|||
145462862|NCT02370641|524546615|FG001|Overall Study|dropped study|2|||
145462863|NCT05291936|524546619|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
145462864|NCT05291936|524546620|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
145462865|NCT05291936|524546619|FG000|Period 1|Withdrew Consent during study|1|||
145462866|NCT05291936|524546620|FG001|Period 1|Withdrew Consent during study|0|||
145462867|NCT05291936|524546619|FG000|Period 2|Adverse Event|0|||
145462868|NCT05291936|524546620|FG001|Period 2|Adverse Event|1|||
145462869|NCT05291936|524546619|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
145462870|NCT05291936|524546620|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145462871|NCT02761694|524546625|FG000|Overall Study|Lack of Efficacy|0|||
145462872|NCT02761694|524546626|FG001|Overall Study|Lack of Efficacy|0|||
145462873|NCT02761694|524546627|FG002|Overall Study|Lack of Efficacy|0|||
145462874|NCT02761694|524546628|FG003|Overall Study|Lack of Efficacy|0|||
145462875|NCT02761694|524546629|FG004|Overall Study|Lack of Efficacy|0|||
145462876|NCT02761694|524546630|FG005|Overall Study|Lack of Efficacy|0|||
145462877|NCT02761694|524546631|FG006|Overall Study|Lack of Efficacy|6|||
145462878|NCT02761694|524546632|FG007|Overall Study|Lack of Efficacy|0|||
145462879|NCT02761694|524546633|FG008|Overall Study|Lack of Efficacy|0|||
145462880|NCT02761694|524546634|FG009|Overall Study|Lack of Efficacy|1|||
145462881|NCT02761694|524546635|FG010|Overall Study|Lack of Efficacy|1|||
145462882|NCT02761694|524546636|FG011|Overall Study|Lack of Efficacy|4|||
145462883|NCT02761694|524546625|FG000|Overall Study|Death|0|||
145462884|NCT02761694|524546626|FG001|Overall Study|Death|0|||
145462885|NCT02761694|524546627|FG002|Overall Study|Death|0|||
145462886|NCT02761694|524546628|FG003|Overall Study|Death|0|||
145462887|NCT02761694|524546629|FG004|Overall Study|Death|0|||
145462888|NCT02761694|524546630|FG005|Overall Study|Death|0|||
145594514|NCT01951625|525028223|FG000|Treatment Period|Physician Decision|0|||
145594515|NCT01951625|525028224|FG001|Treatment Period|Physician Decision|0|||
145594516|NCT01951625|525028225|FG002|Treatment Period|Physician Decision|0|||
145594517|NCT01951625|525028226|FG003|Treatment Period|Physician Decision|0|||
145594518|NCT01951625|525028227|FG004|Treatment Period|Physician Decision|1|||
145594519|NCT01951625|525028223|FG000|Treatment Period|Protocol driven decision point|0|||
145594520|NCT01951625|525028224|FG001|Treatment Period|Protocol driven decision point|5|||
145462889|NCT02761694|524546631|FG006|Overall Study|Death|2|||
145462890|NCT02761694|524546632|FG007|Overall Study|Death|0|||
145594521|NCT01951625|525028225|FG002|Treatment Period|Protocol driven decision point|0|||
145462891|NCT02761694|524546633|FG008|Overall Study|Death|2|||
145462892|NCT02761694|524546634|FG009|Overall Study|Death|2|||
145462893|NCT02761694|524546635|FG010|Overall Study|Death|1|||
145462894|NCT02761694|524546636|FG011|Overall Study|Death|0|||
145462895|NCT02761694|524546625|FG000|Overall Study|Physician Decision|0|||
145462896|NCT02761694|524546626|FG001|Overall Study|Physician Decision|0|||
145462897|NCT02761694|524546627|FG002|Overall Study|Physician Decision|0|||
145462898|NCT02761694|524546628|FG003|Overall Study|Physician Decision|0|||
145462899|NCT02761694|524546629|FG004|Overall Study|Physician Decision|0|||
145462900|NCT02761694|524546630|FG005|Overall Study|Physician Decision|0|||
145462901|NCT02761694|524546631|FG006|Overall Study|Physician Decision|1|||
145462902|NCT02761694|524546632|FG007|Overall Study|Physician Decision|0|||
145462903|NCT02761694|524546633|FG008|Overall Study|Physician Decision|0|||
145462904|NCT02761694|524546634|FG009|Overall Study|Physician Decision|0|||
145462905|NCT02761694|524546635|FG010|Overall Study|Physician Decision|0|||
145462906|NCT02761694|524546636|FG011|Overall Study|Physician Decision|0|||
145462907|NCT02761694|524546625|FG000|Overall Study|Withdrawal by Subject|0|||
145462908|NCT02761694|524546626|FG001|Overall Study|Withdrawal by Subject|0|||
145462909|NCT02761694|524546627|FG002|Overall Study|Withdrawal by Subject|0|||
145462910|NCT02761694|524546628|FG003|Overall Study|Withdrawal by Subject|1|||
145462911|NCT02761694|524546629|FG004|Overall Study|Withdrawal by Subject|0|||
145462912|NCT02761694|524546630|FG005|Overall Study|Withdrawal by Subject|0|||
145462913|NCT02761694|524546631|FG006|Overall Study|Withdrawal by Subject|4|||
145462914|NCT02761694|524546632|FG007|Overall Study|Withdrawal by Subject|0|||
145462915|NCT02761694|524546633|FG008|Overall Study|Withdrawal by Subject|2|||
145462916|NCT02761694|524546634|FG009|Overall Study|Withdrawal by Subject|1|||
145462917|NCT02761694|524546635|FG010|Overall Study|Withdrawal by Subject|0|||
145462918|NCT02761694|524546636|FG011|Overall Study|Withdrawal by Subject|0|||
145462919|NCT02761694|524546625|FG000|Overall Study|Lost to Follow-up|0|||
145462920|NCT02761694|524546626|FG001|Overall Study|Lost to Follow-up|0|||
145462921|NCT02761694|524546627|FG002|Overall Study|Lost to Follow-up|0|||
145462922|NCT02761694|524546628|FG003|Overall Study|Lost to Follow-up|0|||
145462923|NCT02761694|524546629|FG004|Overall Study|Lost to Follow-up|0|||
145462924|NCT02761694|524546630|FG005|Overall Study|Lost to Follow-up|0|||
145462925|NCT02761694|524546631|FG006|Overall Study|Lost to Follow-up|1|||
145462926|NCT02761694|524546632|FG007|Overall Study|Lost to Follow-up|0|||
145462927|NCT02761694|524546633|FG008|Overall Study|Lost to Follow-up|0|||
145462928|NCT02761694|524546634|FG009|Overall Study|Lost to Follow-up|0|||
145462929|NCT02761694|524546635|FG010|Overall Study|Lost to Follow-up|0|||
145462930|NCT02761694|524546636|FG011|Overall Study|Lost to Follow-up|1|||
145462931|NCT02761694|524546625|FG000|Overall Study|Adverse Event|0|||
145462932|NCT02761694|524546626|FG001|Overall Study|Adverse Event|0|||
145462933|NCT02761694|524546627|FG002|Overall Study|Adverse Event|0|||
145462934|NCT02761694|524546628|FG003|Overall Study|Adverse Event|0|||
145462935|NCT02761694|524546629|FG004|Overall Study|Adverse Event|0|||
145462936|NCT02761694|524546630|FG005|Overall Study|Adverse Event|0|||
145462937|NCT02761694|524546631|FG006|Overall Study|Adverse Event|1|||
145462938|NCT02761694|524546632|FG007|Overall Study|Adverse Event|0|||
145462939|NCT02761694|524546633|FG008|Overall Study|Adverse Event|1|||
145462940|NCT02761694|524546634|FG009|Overall Study|Adverse Event|0|||
145462941|NCT02761694|524546635|FG010|Overall Study|Adverse Event|0|||
145462942|NCT02761694|524546636|FG011|Overall Study|Adverse Event|1|||
145462943|NCT02761694|524546625|FG000|Overall Study|Other|4|||
145462944|NCT02761694|524546626|FG001|Overall Study|Other|4|||
145462945|NCT02761694|524546627|FG002|Overall Study|Other|1|||
145462946|NCT02761694|524546628|FG003|Overall Study|Other|2|||
145462947|NCT02761694|524546629|FG004|Overall Study|Other|3|||
145462948|NCT02761694|524546630|FG005|Overall Study|Other|3|||
145462949|NCT02761694|524546631|FG006|Overall Study|Other|18|||
145462950|NCT02761694|524546632|FG007|Overall Study|Other|8|||
145462951|NCT02761694|524546633|FG008|Overall Study|Other|0|||
145462952|NCT02761694|524546634|FG009|Overall Study|Other|1|||
145462953|NCT02761694|524546635|FG010|Overall Study|Other|1|||
145462954|NCT02761694|524546636|FG011|Overall Study|Other|0|||
145462955|NCT02395055|524546637|FG000|Overall Study|Withdrawal by Subject|7|||
145462956|NCT02395055|524546638|FG001|Overall Study|Withdrawal by Subject|3|||
145462957|NCT00787930|524546639|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
145462958|NCT02513823|524546640|FG000|Overall Study|Lost to Follow-up|4|||
145462959|NCT02513823|524546640|FG000|Overall Study|Physician Decision|1|||
145462960|NCT02743780|524546642|FG000|Part 3 (7 Days)|Adverse Event|0|||
145462961|NCT02743780|524546643|FG001|Part 3 (7 Days)|Adverse Event|0|||
145462962|NCT02743780|524546644|FG002|Part 3 (7 Days)|Adverse Event|1|||
145462963|NCT02743780|524546645|FG003|Part 3 (7 Days)|Adverse Event|0|||
145462964|NCT02743780|524546646|FG004|Part 3 (7 Days)|Adverse Event|0|||
145462965|NCT01294462|524546647|FG000|Overall Study|Lost to Follow-up|1|||
145462966|NCT01294462|524546648|FG001|Overall Study|Lost to Follow-up|0|||
145462967|NCT01294462|524546647|FG000|Overall Study|Withdrawal by Subject|65|||
145462968|NCT01294462|524546648|FG001|Overall Study|Withdrawal by Subject|63|||
145462969|NCT04342689|524546656|FG000|Overall Study|Withdrawal by Subject|32|||
145462970|NCT04342689|524546657|FG001|Overall Study|Withdrawal by Subject|33|||
145462971|NCT04342689|524546656|FG000|Overall Study|Lost to Follow-up|10|||
145462972|NCT04342689|524546657|FG001|Overall Study|Lost to Follow-up|12|||
145462973|NCT01460407|524546658|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
145462974|NCT01460407|524546659|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
145462975|NCT01367704|524546662|FG000|Overall Study|Lost to Follow-up|47|||
145462976|NCT01367704|524546663|FG001|Overall Study|Lost to Follow-up|161|||
145462977|NCT02193087|524546664|FG000|Overall Study|Adverse Event|2|||
145462978|NCT02193087|524546665|FG001|Overall Study|Adverse Event|0|||
145462979|NCT02193087|524546666|FG002|Overall Study|Adverse Event|0|||
145462980|NCT02193087|524546667|FG003|Overall Study|Adverse Event|11|||
145462981|NCT02193087|524546664|FG000|Overall Study|Lost to Follow-up|14|||
145462982|NCT02193087|524546665|FG001|Overall Study|Lost to Follow-up|6|||
145462983|NCT02193087|524546666|FG002|Overall Study|Lost to Follow-up|4|||
145462984|NCT02193087|524546667|FG003|Overall Study|Lost to Follow-up|37|||
145462985|NCT02193087|524546664|FG000|Overall Study|Protocol Violation|2|||
145462986|NCT02193087|524546665|FG001|Overall Study|Protocol Violation|0|||
145462987|NCT02193087|524546666|FG002|Overall Study|Protocol Violation|1|||
145462988|NCT02193087|524546667|FG003|Overall Study|Protocol Violation|2|||
145462989|NCT02193087|524546664|FG000|Overall Study|Withdrawal by Subject|10|||
145462990|NCT02193087|524546665|FG001|Overall Study|Withdrawal by Subject|3|||
145462991|NCT02193087|524546666|FG002|Overall Study|Withdrawal by Subject|1|||
145462992|NCT02193087|524546667|FG003|Overall Study|Withdrawal by Subject|19|||
145462993|NCT02193087|524546664|FG000|Overall Study|Other Reason Not Specified|7|||
145462994|NCT02193087|524546665|FG001|Overall Study|Other Reason Not Specified|2|||
145462995|NCT02193087|524546666|FG002|Overall Study|Other Reason Not Specified|1|||
145462996|NCT02193087|524546667|FG003|Overall Study|Other Reason Not Specified|9|||
145462997|NCT02193087|524546664|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
145462998|NCT02193087|524546665|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
145462999|NCT02193087|524546666|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
145463000|NCT02193087|524546667|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
145463001|NCT01510145|524546668|FG000|Overall Study|Adverse Event|6|||
145463002|NCT01510145|524546668|FG000|Overall Study|Lost to Follow-up|5|||
145463003|NCT01510145|524546668|FG000|Overall Study|Withdrawal by Subject|6|||
145463004|NCT01510145|524546668|FG000|Overall Study|Relative reported subject withdrew|1|||
145463005|NCT02279498|524546672|FG000|Overall Study|Adverse Event|3|||
145463006|NCT02279498|524546673|FG001|Overall Study|Adverse Event|0|||
145463007|NCT02279498|524546672|FG000|Overall Study|Lack of Efficacy|4|||
145463008|NCT02279498|524546673|FG001|Overall Study|Lack of Efficacy|0|||
145463009|NCT02279498|524546672|FG000|Overall Study|Lost to Follow-up|0|||
145463010|NCT02279498|524546673|FG001|Overall Study|Lost to Follow-up|1|||
145463011|NCT02279498|524546672|FG000|Overall Study|Withdrawal by Subject|9|||
145463012|NCT02279498|524546673|FG001|Overall Study|Withdrawal by Subject|2|||
145463013|NCT02279498|524546672|FG000|Overall Study|Undefined|2|||
145463014|NCT02279498|524546673|FG001|Overall Study|Undefined|1|||
145463015|NCT00737711|524546674|FG000|Overall Study|Adverse Event|2|||
145463016|NCT00737711|524546674|FG000|Overall Study|Death|8|||
145463017|NCT00737711|524546674|FG000|Overall Study|Failure to return|4|||
145463018|NCT00737711|524546674|FG000|Overall Study|Protocol Violation|1|||
145463019|NCT00737711|524546674|FG000|Overall Study|Withdrawal by Subject|5|||
145463020|NCT00737711|524546674|FG000|Overall Study|Blood transfusion|6|||
145463021|NCT00737711|524546674|FG000|Overall Study|Other|5|||
145463022|NCT00624780|524546678|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
145463023|NCT00624780|524546679|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
145463024|NCT00624780|524546680|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
145463025|NCT00624780|524546681|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
145463026|NCT00624780|524546682|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
145463027|NCT00624780|524546683|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
145463028|NCT00624780|524546678|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
145463029|NCT00624780|524546679|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
145463030|NCT00624780|524546680|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
145463031|NCT00624780|524546681|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
145463032|NCT00624780|524546682|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
145463033|NCT00624780|524546683|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
145463034|NCT00624780|524546678|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
145463035|NCT00624780|524546679|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
145463036|NCT00624780|524546680|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
145463037|NCT00624780|524546681|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
145463038|NCT00624780|524546682|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
145463039|NCT00624780|524546683|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
145463040|NCT00624780|524546678|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
145463041|NCT00624780|524546679|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
145463042|NCT00624780|524546680|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
145463043|NCT00624780|524546681|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
145463044|NCT00624780|524546682|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
145463045|NCT00624780|524546683|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
145463046|NCT00624780|524546678|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
145463047|NCT00624780|524546679|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
145463048|NCT00624780|524546680|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
145463049|NCT00624780|524546681|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
145463050|NCT00624780|524546682|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
145463051|NCT00624780|524546683|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
145463052|NCT00624780|524546678|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
145463053|NCT00624780|524546679|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
145463054|NCT00624780|524546680|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
145463055|NCT00624780|524546681|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
145463056|NCT00624780|524546682|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
145463057|NCT00624780|524546683|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
145463058|NCT00624780|524546678|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
145463059|NCT00624780|524546679|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
145463060|NCT00624780|524546680|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
145463061|NCT00624780|524546681|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
145463062|NCT00624780|524546682|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
145463063|NCT00624780|524546683|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
145463064|NCT00624780|524546678|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
145463065|NCT00624780|524546679|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
145463066|NCT00624780|524546680|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
145463067|NCT00624780|524546681|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
145463068|NCT00624780|524546682|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
145463069|NCT00624780|524546683|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
145463070|NCT00624780|524546678|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
145463071|NCT00624780|524546679|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
145463072|NCT00624780|524546680|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
145463073|NCT00624780|524546681|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
145463074|NCT00624780|524546682|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
145463075|NCT00624780|524546683|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
145463076|NCT00624780|524546678|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
145463077|NCT00624780|524546679|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
145463078|NCT00624780|524546680|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
145463079|NCT00624780|524546681|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
145463080|NCT00624780|524546682|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
145463081|NCT00624780|524546683|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
145463082|NCT00624780|524546678|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
145463083|NCT00624780|524546679|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
145463084|NCT00624780|524546680|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
145463085|NCT00624780|524546681|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
145463086|NCT00624780|524546682|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
145463087|NCT00624780|524546683|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
145463088|NCT00624780|524546678|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
145463089|NCT00624780|524546679|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
145463090|NCT00624780|524546680|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
145463091|NCT00624780|524546681|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
145463092|NCT00624780|524546682|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
145463093|NCT00624780|524546683|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
145463094|NCT00624780|524546678|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
145463095|NCT00624780|524546679|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
145463096|NCT00624780|524546680|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
145463097|NCT00624780|524546681|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
145463098|NCT00624780|524546682|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
145463099|NCT00624780|524546683|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
145463100|NCT00624780|524546678|FG000|Follow-up (Week 26)|Death|0|||
145463101|NCT00624780|524546679|FG001|Follow-up (Week 26)|Death|0|||
145463102|NCT00624780|524546680|FG002|Follow-up (Week 26)|Death|1|||
145463103|NCT00624780|524546681|FG003|Follow-up (Week 26)|Death|0|||
145463104|NCT00624780|524546682|FG004|Follow-up (Week 26)|Death|0|||
145463105|NCT00624780|524546683|FG005|Follow-up (Week 26)|Death|0|||
145463106|NCT00624780|524546678|FG000|Follow-up (Week 26)|Adverse Event|0|||
145463107|NCT00624780|524546679|FG001|Follow-up (Week 26)|Adverse Event|0|||
145463108|NCT00624780|524546680|FG002|Follow-up (Week 26)|Adverse Event|0|||
145463109|NCT00624780|524546681|FG003|Follow-up (Week 26)|Adverse Event|0|||
145463110|NCT00624780|524546682|FG004|Follow-up (Week 26)|Adverse Event|1|||
145463111|NCT00624780|524546683|FG005|Follow-up (Week 26)|Adverse Event|0|||
145463112|NCT00624780|524546678|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
145463113|NCT00624780|524546679|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
145463114|NCT00624780|524546680|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
145463115|NCT00624780|524546681|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
145626857|NCT01289119|525147117|FG005|Overall Study|Major Protocol Deviation|1|||
145626858|NCT01289119|525147112|FG000|Overall Study|Lost to Follow-up|0|||
145463116|NCT00624780|524546682|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
145463117|NCT00624780|524546683|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
145463118|NCT00624780|524546678|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
145626859|NCT01289119|525147113|FG001|Overall Study|Lost to Follow-up|3|||
145626860|NCT01289119|525147114|FG002|Overall Study|Lost to Follow-up|0|||
145626861|NCT01289119|525147115|FG003|Overall Study|Lost to Follow-up|0|||
145626862|NCT01289119|525147116|FG004|Overall Study|Lost to Follow-up|0|||
145626863|NCT01289119|525147117|FG005|Overall Study|Lost to Follow-up|1|||
145626864|NCT01289119|525147112|FG000|Overall Study|Withdrawal by Subject|4|||
145626865|NCT01289119|525147113|FG001|Overall Study|Withdrawal by Subject|2|||
145463119|NCT00624780|524546679|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
145463120|NCT00624780|524546680|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
145463121|NCT00624780|524546681|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
145463122|NCT00624780|524546682|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
145463123|NCT00624780|524546683|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
145463124|NCT00624780|524546678|FG000|Follow-up (Week 26)|Other|1|||
145463125|NCT00624780|524546679|FG001|Follow-up (Week 26)|Other|1|||
145463126|NCT00624780|524546680|FG002|Follow-up (Week 26)|Other|0|||
145463127|NCT00624780|524546681|FG003|Follow-up (Week 26)|Other|0|||
145463128|NCT00624780|524546682|FG004|Follow-up (Week 26)|Other|0|||
145463129|NCT00624780|524546683|FG005|Follow-up (Week 26)|Other|0|||
145463130|NCT04068519|524546684|FG000|Dose Verification|Death|15|||
145463131|NCT04068519|524546684|FG000|Dose Verification|Withdrawal by Subject|1|||
145463132|NCT04068519|524546684|FG000|Pharmacokinetic Sub-study|Death|35|||
145463133|NCT04068519|524546684|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
145463134|NCT04068519|524546684|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
145463135|NCT04068519|524546684|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
145463136|NCT04068519|524546684|FG000|Indication Expansion|Death|152|||
145463137|NCT04068519|524546684|FG000|Indication Expansion|Withdrawal by Subject|10|||
145463138|NCT04068519|524546684|FG000|Indication Expansion|Lost to Follow-up|7|||
145463139|NCT00969761|524546685|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
145463140|NCT00969761|524546686|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463141|NCT00969761|524546687|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463142|NCT00969761|524546688|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
145463143|NCT00969761|524546689|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463144|NCT00969761|524546690|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463145|NCT00969761|524546691|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463146|NCT00969761|524546692|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463147|NCT00969761|524546693|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
145463148|NCT00969761|524546694|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
145463149|NCT00969761|524546695|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463150|NCT00969761|524546696|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
145463151|NCT00969761|524546685|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463152|NCT00969761|524546686|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463153|NCT00969761|524546687|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
145463154|NCT00969761|524546688|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463155|NCT00969761|524546689|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145594522|NCT01951625|525028226|FG003|Treatment Period|Protocol driven decision point|2|||
145594523|NCT01951625|525028227|FG004|Treatment Period|Protocol driven decision point|1|||
145594524|NCT01951625|525028223|FG000|Treatment Period|Non compliance with study drug|1|||
145594525|NCT01951625|525028224|FG001|Treatment Period|Non compliance with study drug|2|||
145594526|NCT01951625|525028225|FG002|Treatment Period|Non compliance with study drug|2|||
145594527|NCT01951625|525028226|FG003|Treatment Period|Non compliance with study drug|0|||
145594528|NCT01951625|525028227|FG004|Treatment Period|Non compliance with study drug|0|||
145594529|NCT01951625|525028223|FG000|Treatment Period|Death|3|||
145594530|NCT01951625|525028224|FG001|Treatment Period|Death|2|||
145594531|NCT01951625|525028225|FG002|Treatment Period|Death|2|||
145594532|NCT01951625|525028226|FG003|Treatment Period|Death|1|||
145594533|NCT01951625|525028227|FG004|Treatment Period|Death|2|||
145626866|NCT01289119|525147114|FG002|Overall Study|Withdrawal by Subject|4|||
145626867|NCT01289119|525147115|FG003|Overall Study|Withdrawal by Subject|3|||
145463156|NCT00969761|524546690|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463157|NCT00969761|524546691|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145594534|NCT01951625|525028223|FG000|Treatment Period|Adverse Event|7|||
145594535|NCT01951625|525028224|FG001|Treatment Period|Adverse Event|10|||
145463158|NCT00969761|524546692|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145594536|NCT01951625|525028225|FG002|Treatment Period|Adverse Event|9|||
145626868|NCT01289119|525147116|FG004|Overall Study|Withdrawal by Subject|1|||
145463159|NCT00969761|524546693|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145626869|NCT01289119|525147117|FG005|Overall Study|Withdrawal by Subject|1|||
145463160|NCT00969761|524546694|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463161|NCT00969761|524546695|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463162|NCT00969761|524546696|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
145463163|NCT00969761|524546685|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463164|NCT00969761|524546686|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463165|NCT00969761|524546687|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
145463166|NCT00969761|524546688|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463167|NCT00969761|524546689|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463168|NCT00969761|524546690|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463169|NCT00969761|524546691|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463170|NCT00969761|524546692|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463171|NCT00969761|524546693|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463172|NCT00969761|524546694|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463173|NCT00969761|524546695|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463174|NCT00969761|524546696|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
145463175|NCT00969761|524546685|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463176|NCT00969761|524546686|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463177|NCT00969761|524546687|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463178|NCT00969761|524546688|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463179|NCT00969761|524546689|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463180|NCT00969761|524546690|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463181|NCT00969761|524546691|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463182|NCT00969761|524546692|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463183|NCT00969761|524546693|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
145463184|NCT00969761|524546694|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463185|NCT00969761|524546695|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463186|NCT00969761|524546696|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
145463187|NCT00969761|524546685|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
145463188|NCT00969761|524546686|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463189|NCT00969761|524546687|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
145463190|NCT00969761|524546688|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463191|NCT00969761|524546689|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
145463192|NCT00969761|524546690|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463193|NCT00969761|524546691|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463194|NCT00969761|524546692|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
145463195|NCT00969761|524546693|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
145463196|NCT00969761|524546694|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
145463197|NCT00969761|524546695|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463198|NCT00969761|524546696|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
145463199|NCT00969761|524546685|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463200|NCT00969761|524546686|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463201|NCT00969761|524546687|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463202|NCT00969761|524546688|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
145463203|NCT00969761|524546689|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
145463204|NCT00969761|524546690|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463205|NCT00969761|524546691|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463206|NCT00969761|524546692|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463207|NCT00969761|524546693|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
145463208|NCT00969761|524546694|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463209|NCT00969761|524546695|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463210|NCT00969761|524546696|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
145463211|NCT00758589|524548769|FG000|Overall Study|Adverse Event|3|||
145463212|NCT00758589|524548770|FG001|Overall Study|Adverse Event|2|||
145463213|NCT00758589|524548771|FG002|Overall Study|Adverse Event|5|||
145463214|NCT00758589|524548772|FG003|Overall Study|Adverse Event|4|||
145463215|NCT00758589|524548769|FG000|Overall Study|Withdrawal by Subject|0|||
145463216|NCT00758589|524548770|FG001|Overall Study|Withdrawal by Subject|1|||
145463217|NCT00758589|524548771|FG002|Overall Study|Withdrawal by Subject|1|||
145463218|NCT00758589|524548772|FG003|Overall Study|Withdrawal by Subject|1|||
145463219|NCT00758589|524548769|FG000|Overall Study|Palm stopped to work|0|||
145463220|NCT00758589|524548770|FG001|Overall Study|Palm stopped to work|0|||
145463221|NCT00758589|524548771|FG002|Overall Study|Palm stopped to work|0|||
145463222|NCT00758589|524548772|FG003|Overall Study|Palm stopped to work|1|||
145463223|NCT05013424|524548787|FG000|Overall Study|Lost to Follow-up|1|||
145463224|NCT05013424|524548788|FG001|Overall Study|Lost to Follow-up|1|||
145463225|NCT05013424|524548789|FG002|Overall Study|Lost to Follow-up|1|||
145463226|NCT05013424|524548787|FG000|Overall Study|Withdrawal by Subject|0|||
145463227|NCT05013424|524548788|FG001|Overall Study|Withdrawal by Subject|1|||
145463228|NCT05013424|524548789|FG002|Overall Study|Withdrawal by Subject|0|||
145463229|NCT04411420|524548790|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
145463230|NCT04411420|524548791|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
145463231|NCT04411420|524548790|FG000|Survey Subset|Lost to Follow-up|134|||
145463232|NCT04411420|524548791|FG001|Survey Subset|Lost to Follow-up|120|||
145463233|NCT03899064|524548794|FG000|Overall Study|Lost to Follow-up|1|||
145463234|NCT03899064|524548794|FG000|Overall Study|Protocol Violation|2|||
145463235|NCT03899064|524548794|FG000|Overall Study|Withdrawal by Subject|2|||
145463236|NCT03899064|524548794|FG000|Overall Study|Other|2|||
145463237|NCT03559699|524548797|FG000|Overall Study|Withdrawal by Subject|6|||
145463238|NCT03559699|524548797|FG000|Overall Study|Lost to Follow-up|1|||
145463239|NCT00031460|524548798|FG000|Overall Study|Lost to Follow-up|0|||
145463240|NCT00031460|524548799|FG001|Overall Study|Lost to Follow-up|1|||
145463241|NCT00031460|524548798|FG000|Overall Study|Withdrawal by Subject|1|||
145463242|NCT00031460|524548799|FG001|Overall Study|Withdrawal by Subject|1|||
145463243|NCT00031460|524548798|FG000|Overall Study|Non-Compliant|1|||
145463244|NCT00031460|524548799|FG001|Overall Study|Non-Compliant|1|||
145463245|NCT00031460|524548798|FG000|Overall Study|Death|0|||
145463246|NCT00031460|524548799|FG001|Overall Study|Death|1|||
145463247|NCT00031460|524548798|FG000|Overall Study|Reactivation of Disease|5|||
145463248|NCT00031460|524548799|FG001|Overall Study|Reactivation of Disease|9|||
145463249|NCT00031460|524548798|FG000|Overall Study|Disruption of blinded drug supply|2|||
145463250|NCT00031460|524548799|FG001|Overall Study|Disruption of blinded drug supply|0|||
145463251|NCT00031460|524548798|FG000|Overall Study|Confirmed unevaluable|0|||
145463252|NCT00031460|524548799|FG001|Overall Study|Confirmed unevaluable|1|||
145463253|NCT00471887|524548803|FG000|Overall Study|Adverse Event|9|||
145463254|NCT05438602|524548804|FG000|Treatment (15 Days)|Adverse Event|2|||
145463255|NCT05438602|524548805|FG001|Treatment (15 Days)|Adverse Event|1|||
145463256|NCT05438602|524548806|FG002|Treatment (15 Days)|Adverse Event|3|||
145463257|NCT05438602|524548804|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
145463258|NCT05438602|524548805|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
145463259|NCT05438602|524548806|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
145463260|NCT05438602|524548804|FG000|Treatment (15 Days)|Other|0|||
145463261|NCT05438602|524548805|FG001|Treatment (15 Days)|Other|0|||
145463262|NCT05438602|524548806|FG002|Treatment (15 Days)|Other|1|||
145463263|NCT05438602|524548804|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
145463264|NCT05438602|524548805|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
145463265|NCT05438602|524548806|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
145463266|NCT05438602|524548804|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
145463267|NCT05438602|524548805|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
145463268|NCT05438602|524548806|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
145463269|NCT05438602|524548804|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
145463270|NCT05438602|524548805|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
145463271|NCT05438602|524548806|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
145463272|NCT05438602|524548804|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
145463273|NCT05438602|524548805|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
145463274|NCT05438602|524548806|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
145463275|NCT05438602|524548804|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
145463276|NCT05438602|524548805|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
145463277|NCT05438602|524548806|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
145463278|NCT05438602|524548804|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
145463279|NCT05438602|524548805|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
145463280|NCT05438602|524548806|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
145463281|NCT05438602|524548804|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
145463282|NCT05438602|524548805|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
145594537|NCT01951625|525028226|FG003|Treatment Period|Adverse Event|8|||
145463283|NCT05438602|524548806|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
145463284|NCT02091284|524548807|FG000|Overall Study|Withdrawal by Subject|2|||
145463285|NCT02091284|524548808|FG001|Overall Study|Withdrawal by Subject|1|||
145463286|NCT02091284|524548807|FG000|Overall Study|unreliable data|1|||
145463287|NCT02091284|524548808|FG001|Overall Study|unreliable data|0|||
145463288|NCT00076336|524548811|FG000|Overall Study|Death|13|||
145463289|NCT00076336|524548812|FG001|Overall Study|Death|17|||
145463290|NCT00076336|524548811|FG000|Overall Study|Adverse Event|4|||
145463291|NCT00076336|524548812|FG001|Overall Study|Adverse Event|4|||
145463292|NCT00076336|524548811|FG000|Overall Study|Lost to Follow-up|4|||
145463293|NCT00076336|524548812|FG001|Overall Study|Lost to Follow-up|4|||
145463294|NCT00076336|524548811|FG000|Overall Study|Non-Compliance|2|||
145463295|NCT00076336|524548812|FG001|Overall Study|Non-Compliance|0|||
145463296|NCT00076336|524548811|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
145463297|NCT00076336|524548812|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
145594538|NCT01951625|525028227|FG004|Treatment Period|Adverse Event|8|||
145594539|NCT01951625|525028223|FG000|Treatment Period|Withdrawal by Subject|5|||
145463298|NCT00076336|524548811|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
145463299|NCT00076336|524548812|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
145463300|NCT00076336|524548811|FG000|Overall Study|Liver Transplantation|3|||
145463301|NCT00076336|524548812|FG001|Overall Study|Liver Transplantation|3|||
145463302|NCT00076336|524548811|FG000|Overall Study|Virologic Breakthrough|14|||
145463303|NCT00076336|524548812|FG001|Overall Study|Virologic Breakthrough|16|||
145463304|NCT00076336|524548811|FG000|Overall Study|Treatment failure|4|||
145463305|NCT00076336|524548812|FG001|Overall Study|Treatment failure|5|||
145463306|NCT00098722|524548816|FG000|Double Blind Phase|Adverse Event|7|||
145463307|NCT00098722|524548817|FG001|Double Blind Phase|Adverse Event|7|||
145463308|NCT00098722|524548818|FG002|Double Blind Phase|Adverse Event|3|||
145463309|NCT00098722|524548819|FG003|Double Blind Phase|Adverse Event|0|||
145463310|NCT00098722|524548820|FG004|Double Blind Phase|Adverse Event|0|||
145463311|NCT00098722|524548821|FG005|Double Blind Phase|Adverse Event|0|||
145463312|NCT00098722|524548822|FG006|Double Blind Phase|Adverse Event|0|||
145463313|NCT00098722|524548816|FG000|Double Blind Phase|Death|2|||
145463314|NCT00098722|524548817|FG001|Double Blind Phase|Death|5|||
145463315|NCT00098722|524548818|FG002|Double Blind Phase|Death|0|||
145463316|NCT00098722|524548819|FG003|Double Blind Phase|Death|0|||
145463317|NCT00098722|524548820|FG004|Double Blind Phase|Death|0|||
145463318|NCT00098722|524548821|FG005|Double Blind Phase|Death|0|||
145463319|NCT00098722|524548822|FG006|Double Blind Phase|Death|0|||
145463320|NCT00098722|524548816|FG000|Double Blind Phase|Lack of Efficacy|21|||
145463321|NCT00098722|524548817|FG001|Double Blind Phase|Lack of Efficacy|23|||
145463322|NCT00098722|524548818|FG002|Double Blind Phase|Lack of Efficacy|15|||
145463323|NCT00098722|524548819|FG003|Double Blind Phase|Lack of Efficacy|0|||
145463324|NCT00098722|524548820|FG004|Double Blind Phase|Lack of Efficacy|0|||
145463325|NCT00098722|524548821|FG005|Double Blind Phase|Lack of Efficacy|0|||
145463326|NCT00098722|524548822|FG006|Double Blind Phase|Lack of Efficacy|0|||
145463327|NCT00098722|524548816|FG000|Double Blind Phase|Participant defaulted|16|||
145463328|NCT00098722|524548817|FG001|Double Blind Phase|Participant defaulted|11|||
145463329|NCT00098722|524548818|FG002|Double Blind Phase|Participant defaulted|9|||
145463330|NCT00098722|524548819|FG003|Double Blind Phase|Participant defaulted|0|||
145463331|NCT00098722|524548820|FG004|Double Blind Phase|Participant defaulted|0|||
145463332|NCT00098722|524548821|FG005|Double Blind Phase|Participant defaulted|0|||
145463333|NCT00098722|524548822|FG006|Double Blind Phase|Participant defaulted|0|||
145463334|NCT00098722|524548816|FG000|Double Blind Phase|Pregnancy|1|||
145463335|NCT00098722|524548817|FG001|Double Blind Phase|Pregnancy|0|||
145463336|NCT00098722|524548818|FG002|Double Blind Phase|Pregnancy|0|||
145463337|NCT00098722|524548819|FG003|Double Blind Phase|Pregnancy|0|||
145463338|NCT00098722|524548820|FG004|Double Blind Phase|Pregnancy|0|||
145463339|NCT00098722|524548821|FG005|Double Blind Phase|Pregnancy|0|||
145463340|NCT00098722|524548822|FG006|Double Blind Phase|Pregnancy|0|||
145463341|NCT00098722|524548816|FG000|Double Blind Phase|Randomized, not treated|4|||
145463342|NCT00098722|524548817|FG001|Double Blind Phase|Randomized, not treated|3|||
145463343|NCT00098722|524548818|FG002|Double Blind Phase|Randomized, not treated|3|||
145463344|NCT00098722|524548819|FG003|Double Blind Phase|Randomized, not treated|0|||
145463345|NCT00098722|524548820|FG004|Double Blind Phase|Randomized, not treated|0|||
145463346|NCT00098722|524548821|FG005|Double Blind Phase|Randomized, not treated|0|||
145463347|NCT00098722|524548822|FG006|Double Blind Phase|Randomized, not treated|0|||
145463348|NCT00098722|524548816|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
145463349|NCT00098722|524548817|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
145463350|NCT00098722|524548818|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
145463351|NCT00098722|524548819|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
145463352|NCT00098722|524548820|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
145463353|NCT00098722|524548821|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
145463354|NCT00098722|524548822|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
145463355|NCT00098722|524548816|FG000|Double Blind Phase|Other|7|||
145463356|NCT00098722|524548817|FG001|Double Blind Phase|Other|8|||
145463357|NCT00098722|524548818|FG002|Double Blind Phase|Other|7|||
145463358|NCT00098722|524548819|FG003|Double Blind Phase|Other|0|||
145463359|NCT00098722|524548820|FG004|Double Blind Phase|Other|0|||
145463360|NCT00098722|524548821|FG005|Double Blind Phase|Other|0|||
145463361|NCT00098722|524548822|FG006|Double Blind Phase|Other|0|||
145463362|NCT00098722|524548816|FG000|Open Label Phase|Adverse Event|0|||
145463363|NCT00098722|524548817|FG001|Open Label Phase|Adverse Event|0|||
145463364|NCT00098722|524548818|FG002|Open Label Phase|Adverse Event|0|||
145626870|NCT01289119|525147112|FG000|Overall Study|Pregnancy|0|||
145463365|NCT00098722|524548819|FG003|Open Label Phase|Adverse Event|5|||
145463366|NCT00098722|524548820|FG004|Open Label Phase|Adverse Event|0|||
145463367|NCT00098722|524548821|FG005|Open Label Phase|Adverse Event|0|||
145463368|NCT00098722|524548822|FG006|Open Label Phase|Adverse Event|0|||
145463369|NCT00098722|524548816|FG000|Open Label Phase|Death|0|||
145463370|NCT00098722|524548817|FG001|Open Label Phase|Death|0|||
145463371|NCT00098722|524548818|FG002|Open Label Phase|Death|0|||
145463372|NCT00098722|524548819|FG003|Open Label Phase|Death|2|||
145463373|NCT00098722|524548820|FG004|Open Label Phase|Death|0|||
145463374|NCT00098722|524548821|FG005|Open Label Phase|Death|0|||
145463375|NCT00098722|524548822|FG006|Open Label Phase|Death|0|||
145626871|NCT01289119|525147113|FG001|Overall Study|Pregnancy|1|||
145626872|NCT01289119|525147114|FG002|Overall Study|Pregnancy|0|||
145626873|NCT01289119|525147115|FG003|Overall Study|Pregnancy|0|||
145626874|NCT01289119|525147116|FG004|Overall Study|Pregnancy|0|||
145626875|NCT01289119|525147117|FG005|Overall Study|Pregnancy|0|||
145626876|NCT01289119|525147112|FG000|Overall Study|Lack of Efficacy|0|||
145626877|NCT01289119|525147113|FG001|Overall Study|Lack of Efficacy|1|||
145626878|NCT01289119|525147114|FG002|Overall Study|Lack of Efficacy|1|||
145626879|NCT01289119|525147115|FG003|Overall Study|Lack of Efficacy|1|||
145626880|NCT01289119|525147116|FG004|Overall Study|Lack of Efficacy|1|||
145626881|NCT01289119|525147117|FG005|Overall Study|Lack of Efficacy|1|||
145626882|NCT01289119|525147112|FG000|Overall Study|Other|1|||
145626883|NCT01289119|525147113|FG001|Overall Study|Other|0|||
145626884|NCT01289119|525147114|FG002|Overall Study|Other|1|||
145626885|NCT01289119|525147115|FG003|Overall Study|Other|0|||
145626886|NCT01289119|525147116|FG004|Overall Study|Other|0|||
145626887|NCT01289119|525147117|FG005|Overall Study|Other|0|||
145626888|NCT01704846|525147118|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145626889|NCT01704846|525147119|FG001|Treatment Period 2|Withdrawal by Subject|1|||
145626890|NCT00530335|525147123|FG000|Overall Study|Adverse Event|3|||
145626891|NCT00530335|525147123|FG000|Overall Study|Protocol Violation|1|||
145626892|NCT00530335|525147123|FG000|Overall Study|Withdrawal by Subject|1|||
145626893|NCT00530335|525147123|FG000|Overall Study|Physician Decision|1|||
145626894|NCT01244984|525147124|FG000|Overall Study|Adverse Event|2|||
145626895|NCT01244984|525147125|FG001|Overall Study|Adverse Event|11|||
145626896|NCT01244984|525147126|FG002|Overall Study|Adverse Event|2|||
145626897|NCT01244984|525147124|FG000|Overall Study|Protocol Violation|1|||
145626898|NCT01244984|525147125|FG001|Overall Study|Protocol Violation|0|||
145626899|NCT01244984|525147126|FG002|Overall Study|Protocol Violation|0|||
145626900|NCT01244984|525147124|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
145626901|NCT01244984|525147125|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
145626902|NCT01244984|525147126|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
145626903|NCT01244984|525147124|FG000|Overall Study|Withdrawal by Subject|1|||
145626904|NCT01244984|525147125|FG001|Overall Study|Withdrawal by Subject|2|||
145626905|NCT01244984|525147126|FG002|Overall Study|Withdrawal by Subject|2|||
145626906|NCT04577183|525147128|FG000|Overall Study|Death|1|||
145626907|NCT04577183|525147128|FG000|Overall Study|Withdrawal by Subject|3|||
145626908|NCT04577183|525147128|FG000|Overall Study|Early termination|2|||
145626909|NCT02072226|525147129|FG000|Overall Study|Lost to Follow-up|11|||
145626910|NCT02072226|525147130|FG001|Overall Study|Lost to Follow-up|7|||
145626911|NCT02072226|525147129|FG000|Overall Study|Patient Non-compliance|2|||
145626912|NCT02072226|525147130|FG001|Overall Study|Patient Non-compliance|3|||
145626913|NCT02072226|525147129|FG000|Overall Study|Death|1|||
145626914|NCT02072226|525147130|FG001|Overall Study|Death|0|||
145626915|NCT02072226|525147129|FG000|Overall Study|Patient Withdrawal of Consent|1|||
145626916|NCT02072226|525147130|FG001|Overall Study|Patient Withdrawal of Consent|0|||
145626917|NCT02095158|525147139|FG000|Overall Study|Adverse Event|14|||
145626918|NCT02095158|525147139|FG000|Overall Study|Lack of Efficacy|3|||
145626919|NCT02095158|525147139|FG000|Overall Study|Pregnancy|1|||
145626920|NCT02095158|525147139|FG000|Overall Study|Lost to Follow-up|20|||
145626921|NCT02095158|525147139|FG000|Overall Study|Personal Reasons|35|||
145626922|NCT02095158|525147139|FG000|Overall Study|Protocol Violation|1|||
145626923|NCT02095158|525147139|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145626924|NCT00941031|525147140|FG000|Induction Period|Lack of Efficacy|2|||
145626925|NCT00941031|525147141|FG001|Induction Period|Lack of Efficacy|1|||
145626926|NCT00941031|525147142|FG002|Induction Period|Lack of Efficacy|0|||
145626927|NCT00941031|525147143|FG003|Induction Period|Lack of Efficacy|5|||
145626928|NCT00941031|525147144|FG004|Induction Period|Lack of Efficacy|0|||
145626929|NCT00941031|525147145|FG005|Induction Period|Lack of Efficacy|0|||
145626930|NCT00941031|525147146|FG006|Induction Period|Lack of Efficacy|0|||
145626931|NCT00941031|525147140|FG000|Induction Period|Withdrawal by Subject|1|||
145626932|NCT00941031|525147141|FG001|Induction Period|Withdrawal by Subject|2|||
145626933|NCT00941031|525147142|FG002|Induction Period|Withdrawal by Subject|2|||
145626934|NCT00941031|525147143|FG003|Induction Period|Withdrawal by Subject|2|||
145626935|NCT00941031|525147144|FG004|Induction Period|Withdrawal by Subject|0|||
145463376|NCT00098722|524548816|FG000|Open Label Phase|Lack of Efficacy|0|||
145463377|NCT00098722|524548817|FG001|Open Label Phase|Lack of Efficacy|0|||
145463378|NCT00098722|524548818|FG002|Open Label Phase|Lack of Efficacy|0|||
145626936|NCT00941031|525147145|FG005|Induction Period|Withdrawal by Subject|0|||
145626937|NCT00941031|525147146|FG006|Induction Period|Withdrawal by Subject|0|||
145626938|NCT00941031|525147140|FG000|Induction Period|Adminstative Problems|1|||
145626939|NCT00941031|525147141|FG001|Induction Period|Adminstative Problems|1|||
145626940|NCT00941031|525147142|FG002|Induction Period|Adminstative Problems|1|||
145626941|NCT00941031|525147143|FG003|Induction Period|Adminstative Problems|0|||
145626942|NCT00941031|525147144|FG004|Induction Period|Adminstative Problems|0|||
145626943|NCT00941031|525147145|FG005|Induction Period|Adminstative Problems|0|||
145626944|NCT00941031|525147146|FG006|Induction Period|Adminstative Problems|0|||
145626945|NCT00941031|525147140|FG000|Induction Period|Adverse Event|1|||
145626946|NCT00941031|525147141|FG001|Induction Period|Adverse Event|0|||
145626947|NCT00941031|525147142|FG002|Induction Period|Adverse Event|3|||
145463379|NCT00098722|524548819|FG003|Open Label Phase|Lack of Efficacy|8|||
145463380|NCT00098722|524548820|FG004|Open Label Phase|Lack of Efficacy|0|||
145463381|NCT00098722|524548821|FG005|Open Label Phase|Lack of Efficacy|0|||
145463382|NCT00098722|524548822|FG006|Open Label Phase|Lack of Efficacy|0|||
145463383|NCT00098722|524548816|FG000|Open Label Phase|Pregnancy|0|||
145463384|NCT00098722|524548817|FG001|Open Label Phase|Pregnancy|0|||
145463385|NCT00098722|524548818|FG002|Open Label Phase|Pregnancy|0|||
145463386|NCT00098722|524548819|FG003|Open Label Phase|Pregnancy|1|||
145463387|NCT00098722|524548820|FG004|Open Label Phase|Pregnancy|0|||
145463388|NCT00098722|524548821|FG005|Open Label Phase|Pregnancy|0|||
145463389|NCT00098722|524548822|FG006|Open Label Phase|Pregnancy|0|||
145463390|NCT00098722|524548816|FG000|Open Label Phase|Participant defaulted|0|||
145463391|NCT00098722|524548817|FG001|Open Label Phase|Participant defaulted|0|||
145463392|NCT00098722|524548818|FG002|Open Label Phase|Participant defaulted|0|||
145463393|NCT00098722|524548819|FG003|Open Label Phase|Participant defaulted|18|||
145463394|NCT00098722|524548820|FG004|Open Label Phase|Participant defaulted|0|||
145463395|NCT00098722|524548821|FG005|Open Label Phase|Participant defaulted|0|||
145463396|NCT00098722|524548822|FG006|Open Label Phase|Participant defaulted|0|||
145463397|NCT00098722|524548816|FG000|Open Label Phase|Ongoing at cut-off date|0|||
145463398|NCT00098722|524548817|FG001|Open Label Phase|Ongoing at cut-off date|0|||
145463399|NCT00098722|524548818|FG002|Open Label Phase|Ongoing at cut-off date|0|||
145463400|NCT00098722|524548819|FG003|Open Label Phase|Ongoing at cut-off date|220|||
145463401|NCT00098722|524548820|FG004|Open Label Phase|Ongoing at cut-off date|50|||
145463402|NCT00098722|524548821|FG005|Open Label Phase|Ongoing at cut-off date|0|||
145463403|NCT00098722|524548822|FG006|Open Label Phase|Ongoing at cut-off date|0|||
145463404|NCT00098722|524548816|FG000|Open Label Phase|Other|0|||
145463405|NCT00098722|524548817|FG001|Open Label Phase|Other|0|||
145463406|NCT00098722|524548818|FG002|Open Label Phase|Other|0|||
145463407|NCT00098722|524548819|FG003|Open Label Phase|Other|18|||
145463408|NCT00098722|524548820|FG004|Open Label Phase|Other|0|||
145594540|NCT01951625|525028224|FG001|Treatment Period|Withdrawal by Subject|2|||
145594541|NCT01951625|525028225|FG002|Treatment Period|Withdrawal by Subject|1|||
145594542|NCT01951625|525028226|FG003|Treatment Period|Withdrawal by Subject|7|||
145594543|NCT01951625|525028227|FG004|Treatment Period|Withdrawal by Subject|3|||
145594544|NCT01951625|525028223|FG000|Treatment Period|Lost to Follow-up|1|||
145594545|NCT01951625|525028224|FG001|Treatment Period|Lost to Follow-up|0|||
145594546|NCT01951625|525028225|FG002|Treatment Period|Lost to Follow-up|0|||
145594547|NCT01951625|525028226|FG003|Treatment Period|Lost to Follow-up|1|||
145594548|NCT01951625|525028227|FG004|Treatment Period|Lost to Follow-up|0|||
145594549|NCT01951625|525028223|FG000|Follow Up Period|Non-compliance with study drug|1|||
145594550|NCT01951625|525028224|FG001|Follow Up Period|Non-compliance with study drug|0|||
145594551|NCT01951625|525028225|FG002|Follow Up Period|Non-compliance with study drug|0|||
145594552|NCT01951625|525028226|FG003|Follow Up Period|Non-compliance with study drug|0|||
145594553|NCT01951625|525028227|FG004|Follow Up Period|Non-compliance with study drug|0|||
145594554|NCT01951625|525028223|FG000|Follow Up Period|Death|1|||
145594555|NCT01951625|525028224|FG001|Follow Up Period|Death|3|||
145594556|NCT01951625|525028225|FG002|Follow Up Period|Death|2|||
145594557|NCT01951625|525028226|FG003|Follow Up Period|Death|2|||
145594558|NCT01951625|525028227|FG004|Follow Up Period|Death|1|||
145594559|NCT01951625|525028223|FG000|Follow Up Period|Logistical difficulties|1|||
145594560|NCT01951625|525028224|FG001|Follow Up Period|Logistical difficulties|2|||
145594561|NCT01951625|525028225|FG002|Follow Up Period|Logistical difficulties|0|||
145594562|NCT01951625|525028226|FG003|Follow Up Period|Logistical difficulties|0|||
145594563|NCT01951625|525028227|FG004|Follow Up Period|Logistical difficulties|0|||
145594564|NCT01951625|525028223|FG000|Follow Up Period|Adverse Event|0|||
145594565|NCT01951625|525028224|FG001|Follow Up Period|Adverse Event|3|||
145594566|NCT01951625|525028225|FG002|Follow Up Period|Adverse Event|2|||
145594567|NCT01951625|525028226|FG003|Follow Up Period|Adverse Event|3|||
145594568|NCT01951625|525028227|FG004|Follow Up Period|Adverse Event|5|||
145594569|NCT01951625|525028223|FG000|Follow Up Period|Withdrawal by Subject|4|||
145594570|NCT01951625|525028224|FG001|Follow Up Period|Withdrawal by Subject|1|||
145594571|NCT01951625|525028225|FG002|Follow Up Period|Withdrawal by Subject|0|||
145594572|NCT01951625|525028226|FG003|Follow Up Period|Withdrawal by Subject|5|||
145594573|NCT01951625|525028227|FG004|Follow Up Period|Withdrawal by Subject|3|||
145626948|NCT00941031|525147143|FG003|Induction Period|Adverse Event|2|||
145463409|NCT00098722|524548821|FG005|Open Label Phase|Other|0|||
145463410|NCT00098722|524548822|FG006|Open Label Phase|Other|0|||
145463411|NCT00098722|524548816|FG000|Observation Phase|Death|0|||
145463412|NCT00098722|524548817|FG001|Observation Phase|Death|0|||
145463413|NCT00098722|524548818|FG002|Observation Phase|Death|0|||
145594574|NCT01951625|525028223|FG000|Follow Up Period|Lost to Follow-up|1|||
145594575|NCT01951625|525028224|FG001|Follow Up Period|Lost to Follow-up|0|||
145594576|NCT01951625|525028225|FG002|Follow Up Period|Lost to Follow-up|0|||
145594577|NCT01951625|525028226|FG003|Follow Up Period|Lost to Follow-up|1|||
145594578|NCT01951625|525028227|FG004|Follow Up Period|Lost to Follow-up|1|||
145594579|NCT00613951|525028229|FG000|Overall Study|Adverse Event|1|||
145594580|NCT00613951|525028230|FG001|Overall Study|Adverse Event|0|||
145594581|NCT00613951|525028231|FG002|Overall Study|Adverse Event|1|||
145594582|NCT00613951|525028229|FG000|Overall Study|Lack of Efficacy|0|||
145463414|NCT00098722|524548819|FG003|Observation Phase|Death|0|||
145463415|NCT00098722|524548820|FG004|Observation Phase|Death|0|||
145463416|NCT00098722|524548821|FG005|Observation Phase|Death|5|||
145463417|NCT00098722|524548822|FG006|Observation Phase|Death|3|||
145463418|NCT00098722|524548816|FG000|Observation Phase|Lack of Efficacy|0|||
145463419|NCT00098722|524548817|FG001|Observation Phase|Lack of Efficacy|0|||
145463420|NCT00098722|524548818|FG002|Observation Phase|Lack of Efficacy|0|||
145463421|NCT00098722|524548819|FG003|Observation Phase|Lack of Efficacy|0|||
145463422|NCT00098722|524548820|FG004|Observation Phase|Lack of Efficacy|0|||
145463423|NCT00098722|524548821|FG005|Observation Phase|Lack of Efficacy|2|||
145463424|NCT00098722|524548822|FG006|Observation Phase|Lack of Efficacy|0|||
145463425|NCT00098722|524548816|FG000|Observation Phase|Participant defaulted|0|||
145463426|NCT00098722|524548817|FG001|Observation Phase|Participant defaulted|0|||
145463427|NCT00098722|524548818|FG002|Observation Phase|Participant defaulted|0|||
145463428|NCT00098722|524548819|FG003|Observation Phase|Participant defaulted|0|||
145463429|NCT00098722|524548820|FG004|Observation Phase|Participant defaulted|0|||
145463430|NCT00098722|524548821|FG005|Observation Phase|Participant defaulted|17|||
145463431|NCT00098722|524548822|FG006|Observation Phase|Participant defaulted|4|||
145463432|NCT00098722|524548816|FG000|Observation Phase|Other|0|||
145463433|NCT00098722|524548817|FG001|Observation Phase|Other|0|||
145463434|NCT00098722|524548818|FG002|Observation Phase|Other|0|||
145463435|NCT00098722|524548819|FG003|Observation Phase|Other|0|||
145463436|NCT00098722|524548820|FG004|Observation Phase|Other|0|||
145463437|NCT00098722|524548821|FG005|Observation Phase|Other|21|||
145463438|NCT00098722|524548822|FG006|Observation Phase|Other|10|||
145463439|NCT02351349|524548828|FG000|Overall Study|Withdrawal by Subject|2|||
145463440|NCT02351349|524548829|FG001|Overall Study|Withdrawal by Subject|3|||
145463441|NCT01703117|524548830|FG000|Overall Study|Adverse Event|4|||
145463442|NCT01703117|524548831|FG001|Overall Study|Adverse Event|3|||
145463443|NCT01703117|524548830|FG000|Overall Study|Withdrawal by Subject|0|||
145463444|NCT01703117|524548831|FG001|Overall Study|Withdrawal by Subject|1|||
145463445|NCT01340937|524548833|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
145463446|NCT01340937|524548834|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
145463447|NCT01340937|524548835|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
145463448|NCT01340937|524548836|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
145463449|NCT01340937|524548833|FG000|Period 1: Infant Series|Adverse Event|0|||
145463450|NCT01340937|524548834|FG001|Period 1: Infant Series|Adverse Event|1|||
145463451|NCT01340937|524548835|FG002|Period 1: Infant Series|Adverse Event|4|||
145463452|NCT01340937|524548836|FG003|Period 1: Infant Series|Adverse Event|0|||
145463453|NCT01340937|524548833|FG000|Period 1: Infant Series|Death|2|||
145463454|NCT01340937|524548834|FG001|Period 1: Infant Series|Death|0|||
145463455|NCT01340937|524548835|FG002|Period 1: Infant Series|Death|2|||
145463456|NCT01340937|524548836|FG003|Period 1: Infant Series|Death|0|||
145463457|NCT01340937|524548833|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
145463458|NCT01340937|524548834|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
145463459|NCT01340937|524548835|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
145463460|NCT01340937|524548836|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
145463461|NCT01340937|524548833|FG000|Period 1: Infant Series|Physician Decision|2|||
145463462|NCT01340937|524548834|FG001|Period 1: Infant Series|Physician Decision|3|||
145463463|NCT01340937|524548835|FG002|Period 1: Infant Series|Physician Decision|1|||
145463464|NCT01340937|524548836|FG003|Period 1: Infant Series|Physician Decision|0|||
145463465|NCT01340937|524548833|FG000|Period 1: Infant Series|Protocol Violation|1|||
145594583|NCT00613951|525028230|FG001|Overall Study|Lack of Efficacy|1|||
145594584|NCT00613951|525028231|FG002|Overall Study|Lack of Efficacy|1|||
145594585|NCT00613951|525028229|FG000|Overall Study|Protocol Violation|1|||
145594586|NCT00613951|525028230|FG001|Overall Study|Protocol Violation|1|||
145594587|NCT00613951|525028231|FG002|Overall Study|Protocol Violation|1|||
145594588|NCT00613951|525028229|FG000|Overall Study|Unclassified|5|||
145594589|NCT00613951|525028230|FG001|Overall Study|Unclassified|3|||
145594590|NCT00613951|525028231|FG002|Overall Study|Unclassified|2|||
145594591|NCT05540522|525028232|FG000|Overall Study|Adverse Event|1|||
145594592|NCT05540522|525028233|FG001|Overall Study|Adverse Event|0|||
145594593|NCT05540522|525028234|FG002|Overall Study|Adverse Event|2|||
145594594|NCT05540522|525028235|FG003|Overall Study|Adverse Event|5|||
145594595|NCT05540522|525028232|FG000|Overall Study|Lost to Follow-up|487|||
145594596|NCT05540522|525028233|FG001|Overall Study|Lost to Follow-up|427|||
145594597|NCT05540522|525028234|FG002|Overall Study|Lost to Follow-up|146|||
145594598|NCT05540522|525028235|FG003|Overall Study|Lost to Follow-up|166|||
145594599|NCT05540522|525028232|FG000|Overall Study|Physician Decision|11|||
145594600|NCT05540522|525028233|FG001|Overall Study|Physician Decision|19|||
145594601|NCT05540522|525028234|FG002|Overall Study|Physician Decision|8|||
145594602|NCT05540522|525028235|FG003|Overall Study|Physician Decision|13|||
145463466|NCT01340937|524548834|FG001|Period 1: Infant Series|Protocol Violation|4|||
145463467|NCT01340937|524548835|FG002|Period 1: Infant Series|Protocol Violation|4|||
145594603|NCT05540522|525028232|FG000|Overall Study|Pregnancy|1|||
145594604|NCT05540522|525028233|FG001|Overall Study|Pregnancy|0|||
145594605|NCT05540522|525028234|FG002|Overall Study|Pregnancy|0|||
145594606|NCT05540522|525028235|FG003|Overall Study|Pregnancy|0|||
145463468|NCT01340937|524548836|FG003|Period 1: Infant Series|Protocol Violation|3|||
145463469|NCT01340937|524548833|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
145463470|NCT01340937|524548834|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
145463471|NCT01340937|524548835|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
145463472|NCT01340937|524548836|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
145463473|NCT01340937|524548833|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
145463474|NCT01340937|524548834|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
145463475|NCT01340937|524548835|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
145463476|NCT01340937|524548836|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
145463477|NCT01340937|524548833|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
145463478|NCT01340937|524548834|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
145463479|NCT01340937|524548835|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
145463480|NCT01340937|524548836|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
145463481|NCT01340937|524548833|FG000|Period 2: Interim Period|Adverse Event|1|||
145463482|NCT01340937|524548834|FG001|Period 2: Interim Period|Adverse Event|0|||
145463483|NCT01340937|524548835|FG002|Period 2: Interim Period|Adverse Event|1|||
145463484|NCT01340937|524548836|FG003|Period 2: Interim Period|Adverse Event|0|||
145463485|NCT01340937|524548833|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
145463486|NCT01340937|524548834|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
145463487|NCT01340937|524548835|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
145594607|NCT05540522|525028232|FG000|Overall Study|Protocol Violation|3|||
145594608|NCT05540522|525028233|FG001|Overall Study|Protocol Violation|1|||
145594609|NCT05540522|525028234|FG002|Overall Study|Protocol Violation|9|||
145594610|NCT05540522|525028235|FG003|Overall Study|Protocol Violation|7|||
145594611|NCT05540522|525028232|FG000|Overall Study|Withdrawal by Subject|168|||
145594612|NCT05540522|525028233|FG001|Overall Study|Withdrawal by Subject|134|||
145594613|NCT05540522|525028234|FG002|Overall Study|Withdrawal by Subject|331|||
145594614|NCT05540522|525028235|FG003|Overall Study|Withdrawal by Subject|322|||
145594615|NCT05540522|525028232|FG000|Overall Study|Death|7|||
145594616|NCT05540522|525028233|FG001|Overall Study|Death|9|||
145594617|NCT05540522|525028234|FG002|Overall Study|Death|49|||
145594618|NCT05540522|525028235|FG003|Overall Study|Death|46|||
145594619|NCT05540522|525028232|FG000|Overall Study|Not vaccinated|34|||
145594620|NCT05540522|525028233|FG001|Overall Study|Not vaccinated|53|||
145594621|NCT05540522|525028234|FG002|Overall Study|Not vaccinated|57|||
145594622|NCT05540522|525028235|FG003|Overall Study|Not vaccinated|50|||
145594623|NCT05540522|525028232|FG000|Overall Study|No longer meets eligibility criteria|0|||
145594624|NCT05540522|525028233|FG001|Overall Study|No longer meets eligibility criteria|0|||
145594625|NCT05540522|525028234|FG002|Overall Study|No longer meets eligibility criteria|3|||
145594626|NCT05540522|525028235|FG003|Overall Study|No longer meets eligibility criteria|2|||
145594627|NCT05540522|525028232|FG000|Overall Study|Other (Unspecified)|8|||
145594628|NCT05540522|525028233|FG001|Overall Study|Other (Unspecified)|10|||
145594629|NCT05540522|525028234|FG002|Overall Study|Other (Unspecified)|4|||
145594630|NCT05540522|525028235|FG003|Overall Study|Other (Unspecified)|2|||
145594631|NCT03754803|525028236|FG000|Overall Study|Withdrawal by Subject|2|||
145594632|NCT04348604|525028239|FG000|Week 8|Withdrawal by Subject|1|||
145594633|NCT04348604|525028240|FG001|Week 8|Withdrawal by Subject|1|||
145594634|NCT04348604|525028239|FG000|Week 8|Lost to Follow-up|1|||
145594635|NCT04348604|525028240|FG001|Week 8|Lost to Follow-up|2|||
145594636|NCT04348604|525028239|FG000|Week 8|Suspended|0|||
145594637|NCT04348604|525028240|FG001|Week 8|Suspended|1|||
145594638|NCT04348604|525028239|FG000|Week 12|Lost to Follow-up|1|||
145594639|NCT04348604|525028240|FG001|Week 12|Lost to Follow-up|2|||
145594640|NCT04348604|525028239|FG000|Week 12|Withdrawal by Subject|1|||
145594641|NCT04348604|525028240|FG001|Week 12|Withdrawal by Subject|0|||
145594642|NCT04348604|525028239|FG000|Week 24|Lost to Follow-up|2|||
145594643|NCT04348604|525028240|FG001|Week 24|Lost to Follow-up|1|||
145594644|NCT02097108|525028241|FG000|Overall Study|Adverse Event|1|||
145594645|NCT02097108|525028241|FG000|Overall Study|patient was abroad for 6 months|1|||
145594646|NCT00127608|525028244|FG000|Overall Study|VZV DNA negative|1|||
145594647|NCT00680407|525028252|FG000|Overall Study|Lost to Follow-up|3|||
145594648|NCT00680407|525028253|FG001|Overall Study|Lost to Follow-up|3|||
145463488|NCT01340937|524548836|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
145463489|NCT01340937|524548833|FG000|Period 2: Interim Period|Physician Decision|0|||
145594649|NCT00680407|525028254|FG002|Overall Study|Lost to Follow-up|1|||
145594650|NCT00680407|525028252|FG000|Overall Study|Withdrawal by Subject|5|||
145594651|NCT00680407|525028253|FG001|Overall Study|Withdrawal by Subject|2|||
145594652|NCT00680407|525028254|FG002|Overall Study|Withdrawal by Subject|2|||
145594653|NCT00506493|525028255|FG000|Overall Study|Death|6|||
145594654|NCT00506493|525028255|FG000|Overall Study|Withdrawal by Subject|5|||
145594655|NCT04918784|525030157|FG000|Overall Study|Amputation - no longer eligible|1|||
145594656|NCT04918784|525030158|FG001|Overall Study|Amputation - no longer eligible|2|||
145594657|NCT04918784|525030157|FG000|Overall Study|Death|1|||
145594658|NCT04918784|525030158|FG001|Overall Study|Death|0|||
145594659|NCT04918784|525030157|FG000|Overall Study|patient non-compliance|3|||
145594660|NCT04918784|525030158|FG001|Overall Study|patient non-compliance|1|||
145594661|NCT04918784|525030157|FG000|Overall Study|Adverse Event|1|||
145463490|NCT01340937|524548834|FG001|Period 2: Interim Period|Physician Decision|1|||
145463491|NCT01340937|524548835|FG002|Period 2: Interim Period|Physician Decision|1|||
145463492|NCT01340937|524548836|FG003|Period 2: Interim Period|Physician Decision|0|||
145594662|NCT04918784|525030158|FG001|Overall Study|Adverse Event|0|||
145594663|NCT01712009|525030159|FG000|Overall Study|Withdrawal by Subject|24|||
145594664|NCT01712009|525030160|FG001|Overall Study|Withdrawal by Subject|15|||
145594665|NCT01712009|525030161|FG002|Overall Study|Withdrawal by Subject|8|||
145463493|NCT01340937|524548833|FG000|Period 2: Interim Period|Protocol Violation|5|||
145463494|NCT01340937|524548834|FG001|Period 2: Interim Period|Protocol Violation|3|||
145463495|NCT01340937|524548835|FG002|Period 2: Interim Period|Protocol Violation|6|||
145463496|NCT01340937|524548836|FG003|Period 2: Interim Period|Protocol Violation|3|||
145463497|NCT01340937|524548833|FG000|Period 2: Interim Period|Technical problems|4|||
145463498|NCT01340937|524548834|FG001|Period 2: Interim Period|Technical problems|4|||
145463499|NCT01340937|524548835|FG002|Period 2: Interim Period|Technical problems|6|||
145463500|NCT01340937|524548836|FG003|Period 2: Interim Period|Technical problems|3|||
145463501|NCT01340937|524548833|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
145463502|NCT01340937|524548834|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
145463503|NCT01340937|524548835|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
145463504|NCT01340937|524548836|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
145463505|NCT01340937|524548833|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
145463506|NCT01340937|524548834|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
145463507|NCT01340937|524548835|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
145463508|NCT01340937|524548836|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
145463509|NCT01340937|524548833|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
145463510|NCT01340937|524548834|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
145463511|NCT01340937|524548835|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
145463512|NCT01340937|524548836|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
145463513|NCT01340937|524548833|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
145463514|NCT01340937|524548834|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
145463515|NCT01340937|524548835|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
145463516|NCT01340937|524548836|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
145463517|NCT00440310|524548837|FG000|Overall Study|Lost to Follow-up|4|||
145463518|NCT00440310|524548838|FG001|Overall Study|Lost to Follow-up|5|||
145463519|NCT00440310|524548837|FG000|Overall Study|Protocol Violation|0|||
145463520|NCT00440310|524548838|FG001|Overall Study|Protocol Violation|1|||
145463521|NCT00440310|524548837|FG000|Overall Study|Withdrawal by Subject|15|||
145463522|NCT00440310|524548838|FG001|Overall Study|Withdrawal by Subject|14|||
145463523|NCT00440310|524548837|FG000|Overall Study|No Reply at EOS|7|||
145463524|NCT00440310|524548838|FG001|Overall Study|No Reply at EOS|7|||
145463525|NCT00440310|524548837|FG000|Overall Study|Other|1|||
145463526|NCT00440310|524548838|FG001|Overall Study|Other|0|||
145463527|NCT00440310|524548837|FG000|Overall Study|Status Unknown|1|||
145463528|NCT00440310|524548838|FG001|Overall Study|Status Unknown|3|||
145463529|NCT02119156|524548839|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
145463530|NCT02119156|524548840|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
145463531|NCT02119156|524548841|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
145463532|NCT02119156|524548839|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
145463533|NCT02119156|524548840|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
145463534|NCT02119156|524548841|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
145463535|NCT02119156|524548839|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
145463536|NCT02119156|524548840|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
145463537|NCT02119156|524548841|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
145463538|NCT02119156|524548839|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
145463539|NCT02119156|524548840|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
145463540|NCT02119156|524548841|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
145463541|NCT02119156|524548839|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
145463542|NCT02119156|524548840|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
145463543|NCT02119156|524548841|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
145594666|NCT01712009|525030159|FG000|Overall Study|Lost to Follow-up|2|||
145594667|NCT01712009|525030160|FG001|Overall Study|Lost to Follow-up|0|||
145594668|NCT01712009|525030161|FG002|Overall Study|Lost to Follow-up|1|||
145463544|NCT02469415|524548842|FG000|Overall Study|Withdrawal by Subject|1|||
145463545|NCT02469415|524548842|FG000|Overall Study|Investigational agent placed on hold|2|||
145463546|NCT04599166|524548854|FG000|Overall Study|Technological failure connecting to study app|80|||
145463547|NCT02317809|524548855|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
145594669|NCT01712009|525030159|FG000|Overall Study|Decision by Sponsor|12|||
145463548|NCT02317809|524548856|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
145463549|NCT02317809|524548855|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
145594670|NCT01712009|525030160|FG001|Overall Study|Decision by Sponsor|14|||
145594671|NCT01712009|525030161|FG002|Overall Study|Decision by Sponsor|12|||
145463550|NCT02317809|524548856|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
145463551|NCT01974752|524548857|FG000|Overall Study|Death|33|||
145463552|NCT01974752|524548858|FG001|Overall Study|Death|11|||
145463553|NCT01974752|524548857|FG000|Overall Study|Lost to Follow-up|2|||
145463554|NCT01974752|524548858|FG001|Overall Study|Lost to Follow-up|0|||
145463555|NCT01974752|524548857|FG000|Overall Study|Withdrawal by Subject|2|||
145463556|NCT01974752|524548858|FG001|Overall Study|Withdrawal by Subject|3|||
145463557|NCT01974752|524548857|FG000|Overall Study|Other Eligibility Criteria|0|||
145463558|NCT01974752|524548858|FG001|Overall Study|Other Eligibility Criteria|1|||
145463559|NCT02435680|524548860|FG000|Overall Study|Physician Decision|3|||
145463560|NCT02435680|524548861|FG001|Overall Study|Physician Decision|0|||
145463561|NCT02435680|524548862|FG002|Overall Study|Physician Decision|0|||
145463562|NCT02435680|524548860|FG000|Overall Study|subject / guardian decision|0|||
145463563|NCT02435680|524548861|FG001|Overall Study|subject / guardian decision|3|||
145463564|NCT02435680|524548862|FG002|Overall Study|subject / guardian decision|2|||
145463565|NCT02435680|524548860|FG000|Overall Study|Adverse Event|8|||
145463566|NCT02435680|524548861|FG001|Overall Study|Adverse Event|3|||
145463567|NCT02435680|524548862|FG002|Overall Study|Adverse Event|2|||
145463568|NCT02435680|524548860|FG000|Overall Study|progressive disease|10|||
145463569|NCT02435680|524548861|FG001|Overall Study|progressive disease|7|||
145463570|NCT02435680|524548862|FG002|Overall Study|progressive disease|11|||
145463571|NCT02435680|524548860|FG000|Overall Study|not treated|0|||
145463572|NCT02435680|524548861|FG001|Overall Study|not treated|0|||
145463573|NCT02435680|524548862|FG002|Overall Study|not treated|1|||
145463574|NCT00953524|524548863|FG000|Overall Study|Adverse Event|2|||
145463575|NCT00953524|524548864|FG001|Overall Study|Adverse Event|0|||
145463576|NCT00953524|524548865|FG002|Overall Study|Adverse Event|1|||
145463577|NCT00953524|524548866|FG003|Overall Study|Adverse Event|2|||
145463578|NCT00953524|524548863|FG000|Overall Study|Protocol Violation|18|||
145463579|NCT00953524|524548864|FG001|Overall Study|Protocol Violation|10|||
145463580|NCT00953524|524548865|FG002|Overall Study|Protocol Violation|11|||
145463581|NCT00953524|524548866|FG003|Overall Study|Protocol Violation|6|||
145463582|NCT00953524|524548863|FG000|Overall Study|Lost to Follow-up|0|||
145463583|NCT00953524|524548864|FG001|Overall Study|Lost to Follow-up|1|||
145463584|NCT00953524|524548865|FG002|Overall Study|Lost to Follow-up|1|||
145463585|NCT00953524|524548866|FG003|Overall Study|Lost to Follow-up|0|||
145463586|NCT00953524|524548863|FG000|Overall Study|Withdrawal by Subject|2|||
145463587|NCT00953524|524548864|FG001|Overall Study|Withdrawal by Subject|4|||
145463588|NCT00953524|524548865|FG002|Overall Study|Withdrawal by Subject|1|||
145463589|NCT00953524|524548866|FG003|Overall Study|Withdrawal by Subject|0|||
145463590|NCT01998893|524548875|FG000|Overall Study|Adverse Event|2|||
145463591|NCT01998893|524548875|FG000|Overall Study|Death|1|||
145463592|NCT01998893|524548875|FG000|Overall Study|Lost to Follow-up|8|||
145463593|NCT01998893|524548875|FG000|Overall Study|Physician Decision|2|||
145463594|NCT01998893|524548875|FG000|Overall Study|Protocol Violation|2|||
145463595|NCT01998893|524548875|FG000|Overall Study|Withdrawal by Subject|1|||
145463596|NCT01998893|524548875|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
145463597|NCT05136898|524548876|FG000|Overall Study|Adverse Event|2|||
145463598|NCT00867087|524548877|FG000|Overall Study|Other|1|||
145463599|NCT00867087|524548877|FG000|Overall Study|Withdrawal by Subject|4|||
145463600|NCT00867087|524548877|FG000|Overall Study|Death|37|||
145463601|NCT02334683|524548886|FG000|First 12 Week Period|Lost to Follow-up|1|||
145463602|NCT02334683|524548887|FG001|First 12 Week Period|Lost to Follow-up|0|||
145463603|NCT02334683|524548886|FG000|Second 12 Week Period|Adverse Event|0|||
145463604|NCT02334683|524548887|FG001|Second 12 Week Period|Adverse Event|1|||
145463605|NCT01891344|524548888|FG000|Overall Study|Ongoing|6|||
145463606|NCT01891344|524548889|FG001|Overall Study|Ongoing|2|||
145463607|NCT01891344|524548890|FG002|Overall Study|Ongoing|0|||
145463608|NCT01891344|524548891|FG003|Overall Study|Ongoing|1|||
145463609|NCT01891344|524548892|FG004|Overall Study|Ongoing|4|||
145463610|NCT01891344|524548893|FG005|Overall Study|Ongoing|1|||
145463611|NCT01891344|524548894|FG006|Overall Study|Ongoing|0|||
145463612|NCT01891344|524548895|FG007|Overall Study|Ongoing|0|||
145463613|NCT01414205|524548898|FG000|Overall Study|Death|5|||
145463614|NCT01414205|524548899|FG001|Overall Study|Death|1|||
145463615|NCT01414205|524548898|FG000|Overall Study|Lost to Follow-up|1|||
145463616|NCT01414205|524548899|FG001|Overall Study|Lost to Follow-up|4|||
145463617|NCT01414205|524548898|FG000|Overall Study|Physician Decision|0|||
145463618|NCT01414205|524548899|FG001|Overall Study|Physician Decision|1|||
145463619|NCT01414205|524548898|FG000|Overall Study|Randomized but not Treated|1|||
145463620|NCT01414205|524548899|FG001|Overall Study|Randomized but not Treated|1|||
145463621|NCT02310230|524548900|FG000|Overall Study|Physician Decision|1|||
145463622|NCT02310230|524548901|FG001|Overall Study|Physician Decision|3|||
145463623|NCT02310230|524548900|FG000|Overall Study|monitor baseline taken after induction|2|||
145463624|NCT02310230|524548901|FG001|Overall Study|monitor baseline taken after induction|7|||
145463625|NCT02310230|524548900|FG000|Overall Study|Poor signal quality|5|||
145463626|NCT02310230|524548901|FG001|Overall Study|Poor signal quality|8|||
145463627|NCT02310230|524548900|FG000|Overall Study|Case cancelled|1|||
145463628|NCT02310230|524548901|FG001|Overall Study|Case cancelled|0|||
145463629|NCT03593681|524548904|FG000|Overall Study|Inadequate sample collected|12|||
145463630|NCT03593681|524548904|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
145463631|NCT03593681|524548904|FG000|Overall Study|Protocol Violation|3|||
145463632|NCT03593681|524548904|FG000|Overall Study|Withdrawal by Subject|3|||
145463633|NCT03593681|524548904|FG000|Overall Study|Procedure not attempted|3|||
145463634|NCT03593681|524548904|FG000|Overall Study|Adverse Event|2|||
145463635|NCT03593681|524548904|FG000|Overall Study|Physician Decision|1|||
145463636|NCT00541099|524548908|FG000|Overall Study|Ineligible|3|||
145463637|NCT00066469|524548909|FG000|Overall Study|Death|3|||
145463638|NCT00066469|524548909|FG000|Overall Study|Lack of Efficacy|9|||
145463639|NCT00066469|524548909|FG000|Overall Study|Lost to Follow-up|1|||
145463640|NCT00066469|524548909|FG000|Overall Study|Physician Decision|1|||
145463641|NCT00066469|524548909|FG000|Overall Study|Withdrawal by Subject|1|||
145463642|NCT00066469|524548909|FG000|Overall Study|ineligible|1|||
145463643|NCT00711802|524548910|FG000|Overall Study|Not treated (no further detail)|2|||
145463644|NCT00711802|524548911|FG001|Overall Study|Not treated (no further detail)|1|||
145463645|NCT00711802|524548912|FG002|Overall Study|Not treated (no further detail)|2|||
145463646|NCT00711802|524548913|FG003|Overall Study|Not treated (no further detail)|0|||
145463647|NCT00711802|524548914|FG004|Overall Study|Not treated (no further detail)|2|||
145463648|NCT00711802|524548915|FG005|Overall Study|Not treated (no further detail)|0|||
145463649|NCT00711802|524548916|FG006|Overall Study|Not treated (no further detail)|0|||
145463650|NCT00711802|524548917|FG007|Overall Study|Not treated (no further detail)|0|||
145463651|NCT00711802|524548910|FG000|Overall Study|Adverse Event|0|||
145463652|NCT00711802|524548911|FG001|Overall Study|Adverse Event|0|||
145463653|NCT00711802|524548912|FG002|Overall Study|Adverse Event|0|||
145463654|NCT00711802|524548913|FG003|Overall Study|Adverse Event|0|||
145463655|NCT00711802|524548914|FG004|Overall Study|Adverse Event|1|||
145463656|NCT00711802|524548915|FG005|Overall Study|Adverse Event|1|||
145463657|NCT00711802|524548916|FG006|Overall Study|Adverse Event|0|||
145463658|NCT00711802|524548917|FG007|Overall Study|Adverse Event|0|||
145463659|NCT00711802|524548910|FG000|Overall Study|Microbiological failure|0|||
145463660|NCT00711802|524548911|FG001|Overall Study|Microbiological failure|1|||
145463661|NCT00711802|524548912|FG002|Overall Study|Microbiological failure|0|||
145463662|NCT00711802|524548913|FG003|Overall Study|Microbiological failure|0|||
145463663|NCT00711802|524548914|FG004|Overall Study|Microbiological failure|0|||
145463664|NCT00711802|524548915|FG005|Overall Study|Microbiological failure|1|||
145463665|NCT00711802|524548916|FG006|Overall Study|Microbiological failure|0|||
145463666|NCT00711802|524548917|FG007|Overall Study|Microbiological failure|0|||
145463667|NCT00711802|524548910|FG000|Overall Study|Protocol Violation|0|||
145463668|NCT00711802|524548911|FG001|Overall Study|Protocol Violation|0|||
145463669|NCT00711802|524548912|FG002|Overall Study|Protocol Violation|0|||
145463670|NCT00711802|524548913|FG003|Overall Study|Protocol Violation|1|||
145463671|NCT00711802|524548914|FG004|Overall Study|Protocol Violation|0|||
145463672|NCT00711802|524548915|FG005|Overall Study|Protocol Violation|0|||
145463673|NCT00711802|524548916|FG006|Overall Study|Protocol Violation|0|||
145463674|NCT00711802|524548917|FG007|Overall Study|Protocol Violation|0|||
145463675|NCT00711802|524548910|FG000|Overall Study|Physician Decision|0|||
145463676|NCT00711802|524548911|FG001|Overall Study|Physician Decision|2|||
145463677|NCT00711802|524548912|FG002|Overall Study|Physician Decision|0|||
145463678|NCT00711802|524548913|FG003|Overall Study|Physician Decision|0|||
145463679|NCT00711802|524548914|FG004|Overall Study|Physician Decision|0|||
145463680|NCT00711802|524548915|FG005|Overall Study|Physician Decision|0|||
145463681|NCT00711802|524548916|FG006|Overall Study|Physician Decision|0|||
145463682|NCT00711802|524548917|FG007|Overall Study|Physician Decision|0|||
145463683|NCT00711802|524548910|FG000|Overall Study|Withdrawal by Subject|0|||
145463684|NCT00711802|524548911|FG001|Overall Study|Withdrawal by Subject|1|||
145463685|NCT00711802|524548912|FG002|Overall Study|Withdrawal by Subject|0|||
145463686|NCT00711802|524548913|FG003|Overall Study|Withdrawal by Subject|1|||
145463687|NCT00711802|524548914|FG004|Overall Study|Withdrawal by Subject|0|||
145463688|NCT00711802|524548915|FG005|Overall Study|Withdrawal by Subject|0|||
145463689|NCT00711802|524548916|FG006|Overall Study|Withdrawal by Subject|0|||
145463690|NCT00711802|524548917|FG007|Overall Study|Withdrawal by Subject|0|||
145463691|NCT00711802|524548910|FG000|Overall Study|Lost to Follow-up|0|||
145463692|NCT00711802|524548911|FG001|Overall Study|Lost to Follow-up|0|||
145463693|NCT00711802|524548912|FG002|Overall Study|Lost to Follow-up|3|||
145463694|NCT00711802|524548913|FG003|Overall Study|Lost to Follow-up|1|||
145463695|NCT00711802|524548914|FG004|Overall Study|Lost to Follow-up|10|||
145463696|NCT00711802|524548915|FG005|Overall Study|Lost to Follow-up|6|||
145463697|NCT00711802|524548916|FG006|Overall Study|Lost to Follow-up|4|||
145463698|NCT00711802|524548917|FG007|Overall Study|Lost to Follow-up|2|||
145463699|NCT00711802|524548910|FG000|Overall Study|Reason not reported|0|||
145463700|NCT00711802|524548911|FG001|Overall Study|Reason not reported|1|||
145463701|NCT00711802|524548912|FG002|Overall Study|Reason not reported|1|||
145463702|NCT00711802|524548913|FG003|Overall Study|Reason not reported|0|||
145463703|NCT00711802|524548914|FG004|Overall Study|Reason not reported|1|||
145463704|NCT00711802|524548915|FG005|Overall Study|Reason not reported|0|||
145463705|NCT00711802|524548916|FG006|Overall Study|Reason not reported|1|||
145463706|NCT00711802|524548917|FG007|Overall Study|Reason not reported|0|||
145463707|NCT00581828|524548918|FG000|Overall Study|Protocol Violation|1|||
145463708|NCT02370095|524548919|FG000|Overall Study|Withdrawal by Subject|0|||
145463709|NCT02370095|524548920|FG001|Overall Study|Withdrawal by Subject|1|||
145463710|NCT01667562|524548921|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
145463711|NCT01667562|524548922|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
145463712|NCT01667562|524548921|FG000|Erlotinib Phase|Lost to Follow-up|0|||
145463713|NCT01667562|524548922|FG001|Erlotinib Phase|Lost to Follow-up|1|||
145463714|NCT01667562|524548921|FG000|Erlotinib Phase|Adverse Event|0|||
145463715|NCT01667562|524548922|FG001|Erlotinib Phase|Adverse Event|1|||
145463716|NCT01667562|524548921|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
145463717|NCT01667562|524548922|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
145463718|NCT01129882|524548923|FG000|Overall Study|Adverse Event|39|||
145463719|NCT01129882|524548923|FG000|Overall Study|Death|6|||
145463720|NCT01129882|524548923|FG000|Overall Study|Lack of Efficacy|5|||
145463721|NCT01129882|524548923|FG000|Overall Study|Lost to Follow-up|13|||
145463722|NCT01129882|524548923|FG000|Overall Study|Physician Decision|27|||
145463723|NCT01129882|524548923|FG000|Overall Study|Protocol Deviation|3|||
145463724|NCT01129882|524548923|FG000|Overall Study|Withdrawal Criteria Met|19|||
145463725|NCT01129882|524548923|FG000|Overall Study|Trial Termination by Sponsor|6|||
145463726|NCT01129882|524548923|FG000|Overall Study|Withdrawal by Subject|160|||
145463727|NCT02130986|524548924|FG000|Overall Study|Withdrawal by Subject|4|||
145463728|NCT02130986|524548925|FG001|Overall Study|Withdrawal by Subject|4|||
145463729|NCT02130986|524548924|FG000|Overall Study|Lost to Follow-up|151|||
145463730|NCT02130986|524548925|FG001|Overall Study|Lost to Follow-up|160|||
145463731|NCT02305849|524548926|FG000|Overall Study|Adverse Event|10|||
145463732|NCT02305849|524548927|FG001|Overall Study|Adverse Event|12|||
145463733|NCT02305849|524548928|FG002|Overall Study|Adverse Event|7|||
145463734|NCT02305849|524548929|FG003|Overall Study|Adverse Event|3|||
145463735|NCT02305849|524548926|FG000|Overall Study|Lack of Efficacy|10|||
145463736|NCT02305849|524548927|FG001|Overall Study|Lack of Efficacy|6|||
145463737|NCT02305849|524548928|FG002|Overall Study|Lack of Efficacy|3|||
145463738|NCT02305849|524548929|FG003|Overall Study|Lack of Efficacy|9|||
145463739|NCT02305849|524548926|FG000|Overall Study|Withdrawal by Subject|2|||
145463740|NCT02305849|524548927|FG001|Overall Study|Withdrawal by Subject|2|||
145463741|NCT02305849|524548928|FG002|Overall Study|Withdrawal by Subject|1|||
145463742|NCT02305849|524548929|FG003|Overall Study|Withdrawal by Subject|4|||
145463743|NCT02305849|524548926|FG000|Overall Study|Lost to Follow-up|0|||
145463744|NCT02305849|524548927|FG001|Overall Study|Lost to Follow-up|2|||
145463745|NCT02305849|524548928|FG002|Overall Study|Lost to Follow-up|0|||
145463746|NCT02305849|524548929|FG003|Overall Study|Lost to Follow-up|0|||
145463747|NCT02305849|524548926|FG000|Overall Study|Protocol Violation|3|||
145463748|NCT02305849|524548927|FG001|Overall Study|Protocol Violation|2|||
145463749|NCT02305849|524548928|FG002|Overall Study|Protocol Violation|1|||
145463750|NCT02305849|524548929|FG003|Overall Study|Protocol Violation|1|||
145463751|NCT02305849|524548926|FG000|Overall Study|Lab data met discontinuation criteria|0|||
145463752|NCT02305849|524548927|FG001|Overall Study|Lab data met discontinuation criteria|1|||
145463753|NCT02305849|524548928|FG002|Overall Study|Lab data met discontinuation criteria|2|||
145463754|NCT02305849|524548929|FG003|Overall Study|Lab data met discontinuation criteria|1|||
145463755|NCT02305849|524548926|FG000|Overall Study|Miscellaneous|1|||
145463756|NCT02305849|524548927|FG001|Overall Study|Miscellaneous|2|||
145463757|NCT02305849|524548928|FG002|Overall Study|Miscellaneous|4|||
145626949|NCT00941031|525147144|FG004|Induction Period|Adverse Event|0|||
145463758|NCT02305849|524548929|FG003|Overall Study|Miscellaneous|1|||
145594672|NCT04050865|525030169|FG000|Overall Study|Adverse Event|1|||
145594673|NCT04050865|525030170|FG001|Overall Study|Adverse Event|0|||
145594674|NCT04050865|525030169|FG000|Overall Study|no insert|1|||
145594675|NCT04050865|525030170|FG001|Overall Study|no insert|0|||
145594676|NCT04050865|525030169|FG000|Overall Study|Only 1 insert|2|||
145594677|NCT04050865|525030170|FG001|Overall Study|Only 1 insert|3|||
145463759|NCT02305849|524548926|FG000|Overall Study|Not fulfill eligibility criteria|1|||
145463760|NCT02305849|524548927|FG001|Overall Study|Not fulfill eligibility criteria|1|||
145463761|NCT02305849|524548928|FG002|Overall Study|Not fulfill eligibility criteria|0|||
145463762|NCT02305849|524548929|FG003|Overall Study|Not fulfill eligibility criteria|0|||
145463763|NCT00355342|524548930|FG000|Overall Study|Adverse Event|13|||
145463764|NCT00355342|524548931|FG001|Overall Study|Adverse Event|15|||
145463765|NCT00355342|524548930|FG000|Overall Study|Lost to Follow-up|4|||
145463766|NCT00355342|524548931|FG001|Overall Study|Lost to Follow-up|2|||
145463767|NCT00355342|524548930|FG000|Overall Study|Withdrawal by Subject|14|||
145463768|NCT00355342|524548931|FG001|Overall Study|Withdrawal by Subject|11|||
145594678|NCT04050865|525030169|FG000|Overall Study|Physician Decision|0|||
145463769|NCT00355342|524548930|FG000|Overall Study|Sponsor terminated study|2|||
145463770|NCT00355342|524548931|FG001|Overall Study|Sponsor terminated study|2|||
145594679|NCT04050865|525030170|FG001|Overall Study|Physician Decision|1|||
145594680|NCT04050865|525030169|FG000|Overall Study|Withdrawal by Subject|0|||
145594681|NCT04050865|525030170|FG001|Overall Study|Withdrawal by Subject|1|||
145594682|NCT00857207|525030171|FG000|Overall Study|Withdrawal by Subject|13|||
145594683|NCT00857207|525030172|FG001|Overall Study|Withdrawal by Subject|0|||
145594684|NCT00857207|525030171|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
145463771|NCT00355342|524548930|FG000|Overall Study|Overcompliant-PI discretion|1|||
145463772|NCT00355342|524548931|FG001|Overall Study|Overcompliant-PI discretion|0|||
145463773|NCT00355342|524548930|FG000|Overall Study|Use of prohibited medication|1|||
145463774|NCT00355342|524548931|FG001|Overall Study|Use of prohibited medication|0|||
145463775|NCT00355342|524548930|FG000|Overall Study|COPD exacerbation|1|||
145463776|NCT00355342|524548931|FG001|Overall Study|COPD exacerbation|1|||
145463777|NCT00355342|524548930|FG000|Overall Study|Dispensed wrong study drug kit|1|||
145463778|NCT00355342|524548931|FG001|Overall Study|Dispensed wrong study drug kit|0|||
145463779|NCT00355342|524548930|FG000|Overall Study|Non-compliance with Dexa scans|1|||
145463780|NCT00355342|524548931|FG001|Overall Study|Non-compliance with Dexa scans|0|||
145463781|NCT00355342|524548930|FG000|Overall Study|Withdrawal by participant and physician|1|||
145463782|NCT00355342|524548931|FG001|Overall Study|Withdrawal by participant and physician|0|||
145463783|NCT00355342|524548930|FG000|Overall Study|Participant relocated|0|||
145463784|NCT00355342|524548931|FG001|Overall Study|Participant relocated|1|||
145463785|NCT00355342|524548930|FG000|Overall Study|Participant discontinued study drug|0|||
145463786|NCT00355342|524548931|FG001|Overall Study|Participant discontinued study drug|1|||
145463787|NCT00355342|524548930|FG000|Overall Study|Study management|0|||
145463788|NCT00355342|524548931|FG001|Overall Study|Study management|1|||
145463789|NCT00355342|524548930|FG000|Overall Study|Protocol Violation|0|||
145463790|NCT00355342|524548931|FG001|Overall Study|Protocol Violation|1|||
145463791|NCT00355342|524548930|FG000|Overall Study|Use of protocol excluded medication|0|||
145463792|NCT00355342|524548931|FG001|Overall Study|Use of protocol excluded medication|1|||
145463793|NCT00536874|524548932|FG000|Overall Study|Adverse Event|1|||
145463794|NCT00536874|524548932|FG000|Overall Study|Death|2|||
145463795|NCT00536874|524548932|FG000|Overall Study|Withdrawal by Subject|1|||
145463796|NCT02084238|524548934|FG000|Overall Study|Lost to Follow-up|2|||
145463797|NCT00391391|524548935|FG000|Overall Study|Adverse Event|0|||
145463798|NCT00391391|524548936|FG001|Overall Study|Adverse Event|0|||
145463799|NCT00391391|524548937|FG002|Overall Study|Adverse Event|0|||
145463800|NCT00391391|524548938|FG003|Overall Study|Adverse Event|1|||
145463801|NCT00391391|524548935|FG000|Overall Study|Lost to Follow-up|1|||
145463802|NCT00391391|524548936|FG001|Overall Study|Lost to Follow-up|3|||
145463803|NCT00391391|524548937|FG002|Overall Study|Lost to Follow-up|7|||
145463804|NCT00391391|524548938|FG003|Overall Study|Lost to Follow-up|4|||
145463805|NCT00391391|524548935|FG000|Overall Study|Protocol Violation|2|||
145463806|NCT00391391|524548936|FG001|Overall Study|Protocol Violation|3|||
145463807|NCT00391391|524548937|FG002|Overall Study|Protocol Violation|6|||
145463808|NCT00391391|524548938|FG003|Overall Study|Protocol Violation|7|||
145463809|NCT00391391|524548935|FG000|Overall Study|Withdrawal by Subject|6|||
145463810|NCT00391391|524548936|FG001|Overall Study|Withdrawal by Subject|4|||
145463811|NCT00391391|524548937|FG002|Overall Study|Withdrawal by Subject|10|||
145463812|NCT00391391|524548938|FG003|Overall Study|Withdrawal by Subject|7|||
145463813|NCT01154283|524548939|FG000|0-6 Weeks|Withdrawal by Subject|7|||
145463814|NCT01154283|524548940|FG001|0-6 Weeks|Withdrawal by Subject|2|||
145463815|NCT01154283|524548939|FG000|0-6 Weeks|Death|0|||
145463816|NCT01154283|524548940|FG001|0-6 Weeks|Death|1|||
145463817|NCT01154283|524548939|FG000|7-12 Weeks|Death|1|||
145463818|NCT01154283|524548940|FG001|7-12 Weeks|Death|0|||
145463819|NCT01154283|524548939|FG000|7-12 Weeks|Withdrawal by Subject|0|||
145463820|NCT01154283|524548940|FG001|7-12 Weeks|Withdrawal by Subject|1|||
145463821|NCT00320372|524548941|FG000|Overall Study|Physician Decision|4|||
145463822|NCT00320372|524548942|FG001|Overall Study|Physician Decision|7|||
145463823|NCT00320372|524548941|FG000|Overall Study|Death|7|||
145463824|NCT00320372|524548942|FG001|Overall Study|Death|8|||
145463825|NCT00320372|524548941|FG000|Overall Study|Withdrawal by Subject|55|||
145463826|NCT00320372|524548942|FG001|Overall Study|Withdrawal by Subject|37|||
145463827|NCT00320372|524548941|FG000|Overall Study|Non-Compliance|40|||
145463828|NCT00320372|524548942|FG001|Overall Study|Non-Compliance|39|||
145463829|NCT00320372|524548941|FG000|Overall Study|Did not Meet (I/E)|3|||
145463830|NCT00320372|524548942|FG001|Overall Study|Did not Meet (I/E)|1|||
145463831|NCT00320372|524548941|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
145463832|NCT00320372|524548942|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
145463833|NCT01853072|524548943|FG000|Overall Study|Adverse event prior to treatment|0|||
145463834|NCT01853072|524548944|FG001|Overall Study|Adverse event prior to treatment|1|||
145463835|NCT01853072|524548943|FG000|Overall Study|Adverse Event|0|||
145463836|NCT01853072|524548944|FG001|Overall Study|Adverse Event|3|||
145463837|NCT01853072|524548943|FG000|Overall Study|Death|1|||
145463838|NCT01853072|524548944|FG001|Overall Study|Death|4|||
145463839|NCT01853072|524548943|FG000|Overall Study|Lost to Follow-up|0|||
145463840|NCT01853072|524548944|FG001|Overall Study|Lost to Follow-up|3|||
145463841|NCT01853072|524548943|FG000|Overall Study|Non-compliance with study drug|0|||
145463842|NCT01853072|524548944|FG001|Overall Study|Non-compliance with study drug|1|||
145463843|NCT01853072|524548943|FG000|Overall Study|Physician Decision|1|||
145463844|NCT01853072|524548944|FG001|Overall Study|Physician Decision|1|||
145463845|NCT01853072|524548943|FG000|Overall Study|Withdrawal by Subject|1|||
145626950|NCT00941031|525147145|FG005|Induction Period|Adverse Event|0|||
145463846|NCT01853072|524548944|FG001|Overall Study|Withdrawal by Subject|2|||
145463847|NCT01853072|524548943|FG000|Overall Study|Reason not specified|9|||
145463848|NCT01853072|524548944|FG001|Overall Study|Reason not specified|6|||
145463849|NCT01287221|524548945|FG000|Overall Study|Lack of Perceived Benefit|1|||
145463850|NCT01287221|524548946|FG001|Overall Study|Lack of Perceived Benefit|1|||
145463851|NCT01287221|524548945|FG000|Overall Study|Adverse Event|3|||
145463852|NCT01287221|524548946|FG001|Overall Study|Adverse Event|3|||
145463853|NCT01287221|524548945|FG000|Overall Study|Withdrawal by Subject|0|||
145463854|NCT01287221|524548946|FG001|Overall Study|Withdrawal by Subject|1|||
145463855|NCT03081858|524550293|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
145463856|NCT03081858|524550294|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
145463857|NCT03081858|524550295|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
145463858|NCT03081858|524550296|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
145463859|NCT00387647|524550301|FG000|Overall Study|Death|18|||
145463860|NCT02032407|524550302|FG000|Overall Study|Lost to Follow-up|2|||
145463861|NCT02032407|524550302|FG000|Overall Study|Pregnancy|1|||
145463862|NCT02032407|524550302|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145463863|NCT01309269|524550303|FG000|Overall Study|Adverse Event|56|||
145463864|NCT01309269|524550303|FG000|Overall Study|Withdrawal by Subject|25|||
145463865|NCT01309269|524550303|FG000|Overall Study|Lack of Acceptance|15|||
145463866|NCT01309269|524550303|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
145463867|NCT01309269|524550303|FG000|Overall Study|Kidney Transplant|25|||
145463868|NCT01309269|524550303|FG000|Overall Study|Administrative Problems|141|||
145463869|NCT01309269|524550303|FG000|Overall Study|Other|256|||
145463870|NCT01309269|524550303|FG000|Overall Study|Other|1|||
145463871|NCT01309269|524550303|FG000|Overall Study|Study Completion Data Not Recorded|95|||
145463872|NCT01309269|524550303|FG000|Overall Study|Enrolled but not Treated|107|||
145463873|NCT00524589|524550319|FG000|Overall Study|Withdrawal by Subject|2|||
145463874|NCT00524589|524550319|FG000|Overall Study|Disease Progression|16|||
145463875|NCT01519674|524550322|FG000|Overall Study|Adverse Event|3|||
145463876|NCT01519674|524550323|FG001|Overall Study|Adverse Event|3|||
145463877|NCT01519674|524550324|FG002|Overall Study|Adverse Event|0|||
145463878|NCT01519674|524550322|FG000|Overall Study|Lack of Efficacy|1|||
145463879|NCT01519674|524550323|FG001|Overall Study|Lack of Efficacy|1|||
145463880|NCT01519674|524550324|FG002|Overall Study|Lack of Efficacy|1|||
145463881|NCT01519674|524550322|FG000|Overall Study|Protocol Violation|0|||
145463882|NCT01519674|524550323|FG001|Overall Study|Protocol Violation|3|||
145463883|NCT01519674|524550324|FG002|Overall Study|Protocol Violation|1|||
145463884|NCT01519674|524550322|FG000|Overall Study|Withdrawal Criteria|7|||
145463885|NCT01519674|524550323|FG001|Overall Study|Withdrawal Criteria|2|||
145463886|NCT01519674|524550324|FG002|Overall Study|Withdrawal Criteria|7|||
145463887|NCT01519674|524550322|FG000|Overall Study|Unsclassified|10|||
145463888|NCT01519674|524550323|FG001|Overall Study|Unsclassified|4|||
145463889|NCT01519674|524550324|FG002|Overall Study|Unsclassified|3|||
145463890|NCT01610596|524550327|FG000|Overall Study|Lost to Follow-up|0|||
145463891|NCT01610596|524550328|FG001|Overall Study|Lost to Follow-up|1|||
145463892|NCT00799591|524550329|FG000|Overall Study|De-escalation of doses|20|||
145463893|NCT00799591|524550329|FG000|Overall Study|Death|14|||
145463894|NCT00799591|524550329|FG000|Overall Study|Technical failure|12|||
145463895|NCT00799591|524550329|FG000|Overall Study|Resistant germ|11|||
145463896|NCT00799591|524550329|FG000|Overall Study|New infection|4|||
145463897|NCT00799591|524550329|FG000|Overall Study|Resistance germ and technical failure|2|||
145463898|NCT00799591|524550329|FG000|Overall Study|Persistance of fever undetermined origin|1|||
145463899|NCT00799591|524550329|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
145463900|NCT00799591|524550329|FG000|Overall Study|Infectious origin not probable|1|||
145463901|NCT03276052|524550330|FG000|Overall Study|Withdrawal by Subject|5|||
145463902|NCT03276052|524550330|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
145463903|NCT01994863|524550331|FG000|Period 1|Adverse Event|4|||
145463904|NCT01994863|524550332|FG001|Period 1|Adverse Event|0|||
145463905|NCT01994863|524550331|FG000|Period 1|Withdrawal by Subject|1|||
145463906|NCT01994863|524550332|FG001|Period 1|Withdrawal by Subject|0|||
145463907|NCT01994863|524550331|FG000|Period 1|Trial stopped by sponsor|1|||
145463908|NCT01994863|524550332|FG001|Period 1|Trial stopped by sponsor|3|||
145463909|NCT01994863|524550331|FG000|Period 1|Lack of Efficacy|1|||
145463910|NCT01994863|524550332|FG001|Period 1|Lack of Efficacy|0|||
145463911|NCT01994863|524550331|FG000|Period 2|Adverse Event|0|||
145463912|NCT01994863|524550332|FG001|Period 2|Adverse Event|1|||
145594685|NCT00857207|525030172|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
145463913|NCT01994863|524550331|FG000|Period 2|Lack of Efficacy|0|||
145463914|NCT01994863|524550332|FG001|Period 2|Lack of Efficacy|2|||
145463915|NCT01994863|524550331|FG000|Period 2|Withdrawal by Subject|1|||
145463916|NCT01994863|524550332|FG001|Period 2|Withdrawal by Subject|1|||
145463917|NCT03784846|524550333|FG000|Pre-COVID Study|Lost to Follow-up|3|||
145463918|NCT03784846|524550334|FG001|Pre-COVID Study|Lost to Follow-up|3|||
145463919|NCT03784846|524550335|FG002|Pre-COVID Study|Lost to Follow-up|2|||
145463920|NCT03784846|524550333|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
145463921|NCT03784846|524550334|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
145463922|NCT03784846|524550335|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
145463923|NCT03784846|524550333|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
145463924|NCT03784846|524550334|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
145463925|NCT03784846|524550335|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
145463926|NCT03784846|524550333|FG000|Post-COVID Study|Lost to Follow-up|3|||
145463927|NCT03784846|524550334|FG001|Post-COVID Study|Lost to Follow-up|5|||
145463928|NCT03784846|524550335|FG002|Post-COVID Study|Lost to Follow-up|1|||
145463929|NCT03784846|524550333|FG000|Post-COVID Study|Withdrawal by Subject|1|||
145463930|NCT03784846|524550334|FG001|Post-COVID Study|Withdrawal by Subject|2|||
145463931|NCT03784846|524550335|FG002|Post-COVID Study|Withdrawal by Subject|0|||
145463932|NCT02046174|524550340|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
145463933|NCT02046174|524550341|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
145463934|NCT02969590|524550345|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
145463935|NCT02969590|524550346|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
145463936|NCT02969590|524550347|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
145463937|NCT03294135|524550348|FG000|Overall Study|Serious Adverse Event|1|||
145463938|NCT03294135|524550349|FG001|Overall Study|Serious Adverse Event|0|||
145463939|NCT03294135|524550350|FG002|Overall Study|Serious Adverse Event|0|||
145463940|NCT03294135|524550348|FG000|Overall Study|Lost to Follow-up|1|||
145463941|NCT03294135|524550349|FG001|Overall Study|Lost to Follow-up|0|||
145463942|NCT03294135|524550350|FG002|Overall Study|Lost to Follow-up|1|||
145463943|NCT03294135|524550348|FG000|Overall Study|Withdrawal by Subject|0|||
145463944|NCT03294135|524550349|FG001|Overall Study|Withdrawal by Subject|0|||
145463945|NCT03294135|524550350|FG002|Overall Study|Withdrawal by Subject|1|||
145463946|NCT03294135|524550348|FG000|Overall Study|Other|2|||
145463947|NCT03294135|524550349|FG001|Overall Study|Other|0|||
145463948|NCT03294135|524550350|FG002|Overall Study|Other|0|||
145463949|NCT00186537|524550351|FG000|Overall Study|Withdrawal by Subject|4|||
145463950|NCT00186537|524550352|FG001|Overall Study|Withdrawal by Subject|0|||
145463951|NCT00186537|524550353|FG002|Overall Study|Withdrawal by Subject|3|||
145463952|NCT00186537|524550351|FG000|Overall Study|ALT > 1.5 x ULN|3|||
145463953|NCT00186537|524550352|FG001|Overall Study|ALT > 1.5 x ULN|0|||
145463954|NCT00186537|524550353|FG002|Overall Study|ALT > 1.5 x ULN|0|||
145463955|NCT02763254|524550354|FG000|Overall Study|Adverse Event|1|||
145463956|NCT01143051|524550357|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
145463957|NCT01143051|524550358|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
145463958|NCT01143051|524550359|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
145463959|NCT01143051|524550360|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
145463960|NCT01143051|524550361|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
145463961|NCT01143051|524550362|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
145463962|NCT01143051|524550357|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
145463963|NCT01143051|524550358|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
145463964|NCT01143051|524550359|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
145463965|NCT01143051|524550360|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
145463966|NCT01143051|524550361|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
145463967|NCT01143051|524550362|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
145463968|NCT02498067|524550364|FG000|Overall Study|Lost to Follow-up|22|||
145463969|NCT02498067|524550364|FG000|Overall Study|Did not meet inclusion criteria|11|||
145463970|NCT02231762|524550367|FG000|Combination Phase|Adverse Event|10|||
145463971|NCT02231762|524550368|FG001|Combination Phase|Adverse Event|0|||
145463972|NCT02231762|524550369|FG002|Combination Phase|Adverse Event|0|||
145463973|NCT02231762|524550370|FG003|Combination Phase|Adverse Event|0|||
145463974|NCT02231762|524550367|FG000|Combination Phase|Withdrawal by Subject|2|||
145463975|NCT02231762|524550368|FG001|Combination Phase|Withdrawal by Subject|0|||
145463976|NCT02231762|524550369|FG002|Combination Phase|Withdrawal by Subject|0|||
145463977|NCT02231762|524550370|FG003|Combination Phase|Withdrawal by Subject|0|||
145463978|NCT02231762|524550367|FG000|Combination Phase|Disease Progression|6|||
145463979|NCT02231762|524550368|FG001|Combination Phase|Disease Progression|0|||
145463980|NCT02231762|524550369|FG002|Combination Phase|Disease Progression|0|||
145463981|NCT02231762|524550370|FG003|Combination Phase|Disease Progression|0|||
145463982|NCT02231762|524550367|FG000|Combination Phase|Did not meet inclusion criteria|1|||
145463983|NCT02231762|524550368|FG001|Combination Phase|Did not meet inclusion criteria|0|||
145463984|NCT02231762|524550369|FG002|Combination Phase|Did not meet inclusion criteria|0|||
145463985|NCT02231762|524550370|FG003|Combination Phase|Did not meet inclusion criteria|0|||
145463986|NCT02231762|524550367|FG000|Combination Phase|Protocol Violation|1|||
145626951|NCT00941031|525147146|FG006|Induction Period|Adverse Event|0|||
145463987|NCT02231762|524550368|FG001|Combination Phase|Protocol Violation|0|||
145626952|NCT00941031|525147140|FG000|Maintenance Period|Withdrawal by Subject|0|||
145463988|NCT02231762|524550369|FG002|Combination Phase|Protocol Violation|0|||
145463989|NCT02231762|524550370|FG003|Combination Phase|Protocol Violation|0|||
145463990|NCT02231762|524550367|FG000|Maintenance Phase|Disease progression|0|||
145626953|NCT00941031|525147141|FG001|Maintenance Period|Withdrawal by Subject|0|||
145463991|NCT02231762|524550368|FG001|Maintenance Phase|Disease progression|3|||
145463992|NCT02231762|524550369|FG002|Maintenance Phase|Disease progression|4|||
145463993|NCT02231762|524550370|FG003|Maintenance Phase|Disease progression|3|||
145626954|NCT00941031|525147142|FG002|Maintenance Period|Withdrawal by Subject|0|||
145463994|NCT02231762|524550367|FG000|Maintenance Phase|Adverse Event|0|||
145463995|NCT02231762|524550368|FG001|Maintenance Phase|Adverse Event|0|||
145463996|NCT02231762|524550369|FG002|Maintenance Phase|Adverse Event|1|||
145463997|NCT02231762|524550370|FG003|Maintenance Phase|Adverse Event|2|||
145463998|NCT01149486|524550373|FG000|First Intervention|Adverse Event|0|||
145463999|NCT01149486|524550374|FG001|First Intervention|Adverse Event|1|||
145464000|NCT01669421|524550375|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
145464001|NCT01669421|524550375|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
145464002|NCT02961790|524550380|FG000|Overall Study|Canceled|4|||
145464003|NCT02961790|524550381|FG001|Overall Study|Canceled|5|||
145464004|NCT02961790|524550382|FG002|Overall Study|Canceled|1|||
145464005|NCT02961790|524550383|FG003|Overall Study|Canceled|4|||
145464006|NCT02961790|524550380|FG000|Overall Study|without baseline data|4|||
145464007|NCT02961790|524550381|FG001|Overall Study|without baseline data|0|||
145464008|NCT02961790|524550382|FG002|Overall Study|without baseline data|1|||
145464009|NCT02961790|524550383|FG003|Overall Study|without baseline data|0|||
145464010|NCT02961790|524550380|FG000|Overall Study|without post baseline data|7|||
145464011|NCT02961790|524550381|FG001|Overall Study|without post baseline data|6|||
145464012|NCT02961790|524550382|FG002|Overall Study|without post baseline data|4|||
145464013|NCT02961790|524550383|FG003|Overall Study|without post baseline data|1|||
145464014|NCT01135914|524550386|FG000|Overall Study|Withdrawal by Subject|1|||
145464015|NCT01135914|524550387|FG001|Overall Study|Withdrawal by Subject|3|||
145464016|NCT01135914|524550388|FG002|Overall Study|Withdrawal by Subject|6|||
145464017|NCT01135914|524550386|FG000|Overall Study|Lost to Follow-up|1|||
145464018|NCT01135914|524550387|FG001|Overall Study|Lost to Follow-up|0|||
145464019|NCT01135914|524550388|FG002|Overall Study|Lost to Follow-up|1|||
145464020|NCT01135914|524550386|FG000|Overall Study|Protocol Violation|0|||
145464021|NCT01135914|524550387|FG001|Overall Study|Protocol Violation|0|||
145464022|NCT01135914|524550388|FG002|Overall Study|Protocol Violation|3|||
145464023|NCT01135914|524550386|FG000|Overall Study|Lack of Efficacy|2|||
145464024|NCT01135914|524550387|FG001|Overall Study|Lack of Efficacy|1|||
145464025|NCT01135914|524550388|FG002|Overall Study|Lack of Efficacy|10|||
145464026|NCT01135914|524550386|FG000|Overall Study|Adverse Event|0|||
145464027|NCT01135914|524550387|FG001|Overall Study|Adverse Event|1|||
145464028|NCT01135914|524550388|FG002|Overall Study|Adverse Event|2|||
145464029|NCT02594098|524550389|FG000|Overall Study|Lack of Efficacy|17|||
145464030|NCT02594098|524550390|FG001|Overall Study|Lack of Efficacy|6|||
145464031|NCT02594098|524550389|FG000|Overall Study|Withdrawal by Subject|1|||
145464032|NCT02594098|524550390|FG001|Overall Study|Withdrawal by Subject|3|||
145464033|NCT02594098|524550389|FG000|Overall Study|Terminated participation|6|||
145464034|NCT02594098|524550390|FG001|Overall Study|Terminated participation|2|||
145464035|NCT02594098|524550389|FG000|Overall Study|Seek alternative treatment|2|||
145464036|NCT02594098|524550390|FG001|Overall Study|Seek alternative treatment|1|||
145464037|NCT02594098|524550389|FG000|Overall Study|Other|0|||
145464038|NCT02594098|524550390|FG001|Overall Study|Other|1|||
145464039|NCT03412604|524550396|FG000|Overall Study|Withdrawal by Subject|1|||
145464040|NCT03464422|524550398|FG000|Overall Study|Lost to Follow-up|2|||
145464041|NCT03464422|524550398|FG000|Overall Study|Withdrawal by Subject|2|||
145464042|NCT00844805|524550402|FG000|Treatment Phase|Adverse Event|5|||
145464043|NCT00844805|524550403|FG001|Treatment Phase|Adverse Event|1|||
145464044|NCT00844805|524550404|FG002|Treatment Phase|Adverse Event|0|||
145464045|NCT00844805|524550405|FG003|Treatment Phase|Adverse Event|0|||
145464046|NCT00844805|524550402|FG000|Treatment Phase|Withdrawal by Subject|3|||
145464047|NCT00844805|524550403|FG001|Treatment Phase|Withdrawal by Subject|4|||
145464048|NCT00844805|524550404|FG002|Treatment Phase|Withdrawal by Subject|0|||
145464049|NCT00844805|524550405|FG003|Treatment Phase|Withdrawal by Subject|0|||
145464050|NCT00844805|524550402|FG000|Treatment Phase|Noncompliance With Protocol|1|||
145464051|NCT00844805|524550403|FG001|Treatment Phase|Noncompliance With Protocol|0|||
145464052|NCT00844805|524550404|FG002|Treatment Phase|Noncompliance With Protocol|0|||
145464053|NCT00844805|524550405|FG003|Treatment Phase|Noncompliance With Protocol|0|||
145464054|NCT00844805|524550402|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
145464055|NCT00844805|524550403|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
145464056|NCT00844805|524550404|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
145626955|NCT00941031|525147143|FG003|Maintenance Period|Withdrawal by Subject|0|||
145464057|NCT00844805|524550405|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
145464058|NCT00844805|524550402|FG000|Follow-Up Phase|Adverse Event|0|||
145464059|NCT00844805|524550403|FG001|Follow-Up Phase|Adverse Event|0|||
145464060|NCT00844805|524550404|FG002|Follow-Up Phase|Adverse Event|1|||
145464061|NCT00844805|524550405|FG003|Follow-Up Phase|Adverse Event|0|||
145464062|NCT00844805|524550402|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
145464063|NCT00844805|524550403|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
145464064|NCT00844805|524550404|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
145464065|NCT00844805|524550405|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
145626956|NCT00941031|525147144|FG004|Maintenance Period|Withdrawal by Subject|6|||
145464066|NCT00844805|524550402|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
145464067|NCT00844805|524550403|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
145464068|NCT00844805|524550404|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
145464069|NCT00844805|524550405|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
145464070|NCT00844805|524550402|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
145464071|NCT00844805|524550403|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
145464072|NCT00844805|524550404|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
145464073|NCT00844805|524550405|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
145464074|NCT00844805|524550402|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
145464075|NCT00844805|524550403|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
145464076|NCT00844805|524550404|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
145464077|NCT00844805|524550405|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
145464078|NCT04096820|524550406|FG000|Overall Study|Did not return for intervention|2|||
145464079|NCT04096820|524550406|FG000|Overall Study|Death|1|||
145464080|NCT00475865|524550407|FG000|Overall Study|Adverse Event|0|||
145464081|NCT00475865|524550408|FG001|Overall Study|Adverse Event|3|||
145464082|NCT00475865|524550409|FG002|Overall Study|Adverse Event|4|||
145464083|NCT00475865|524550407|FG000|Overall Study|Lack of Efficacy|1|||
145464084|NCT00475865|524550408|FG001|Overall Study|Lack of Efficacy|0|||
145464085|NCT00475865|524550409|FG002|Overall Study|Lack of Efficacy|0|||
145464086|NCT00475865|524550407|FG000|Overall Study|Progressive disease|0|||
145464087|NCT00475865|524550408|FG001|Overall Study|Progressive disease|1|||
145464088|NCT00475865|524550409|FG002|Overall Study|Progressive disease|2|||
145464089|NCT00475865|524550407|FG000|Overall Study|Participant did not wish to continue|1|||
145464090|NCT00475865|524550408|FG001|Overall Study|Participant did not wish to continue|0|||
145464091|NCT00475865|524550409|FG002|Overall Study|Participant did not wish to continue|0|||
145464092|NCT00475865|524550407|FG000|Overall Study|Other than above|0|||
145464093|NCT00475865|524550408|FG001|Overall Study|Other than above|1|||
145464094|NCT00475865|524550409|FG002|Overall Study|Other than above|0|||
145464095|NCT01360398|524550413|FG000|Overall Study|Withdrawal by Subject|14|||
145464096|NCT01360398|524550413|FG000|Overall Study|Other|7|||
145464097|NCT01360398|524550413|FG000|Overall Study|Migrated/moved from study area|1|||
145464098|NCT01453946|524550414|FG000|Overall Study|Did not receive drug for the taper phase|1|||
145464099|NCT01453946|524550414|FG000|Overall Study|Protocol Violation|2|||
145464100|NCT01453946|524550414|FG000|Overall Study|Lack of Efficacy|3|||
145464101|NCT01453946|524550414|FG000|Overall Study|Adverse Event|3|||
145464102|NCT00846040|524550415|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
145464103|NCT00846040|524550416|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
145464104|NCT00846040|524550417|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
145464105|NCT00846040|524550415|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
145464106|NCT00846040|524550416|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
145464107|NCT00846040|524550417|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
145464108|NCT03158272|524550421|FG000|Overall Study|Disease progression|3|||
145464109|NCT03158272|524550422|FG001|Overall Study|Disease progression|3|||
145464110|NCT03158272|524550423|FG002|Overall Study|Disease progression|4|||
145464111|NCT03158272|524550424|FG003|Overall Study|Disease progression|6|||
145464112|NCT03158272|524550421|FG000|Overall Study|Death|0|||
145464113|NCT03158272|524550422|FG001|Overall Study|Death|0|||
145464114|NCT03158272|524550423|FG002|Overall Study|Death|1|||
145464115|NCT03158272|524550424|FG003|Overall Study|Death|0|||
145464116|NCT03158272|524550421|FG000|Overall Study|Other reasons|0|||
145464117|NCT03158272|524550422|FG001|Overall Study|Other reasons|0|||
145464118|NCT03158272|524550423|FG002|Overall Study|Other reasons|1|||
145464119|NCT03158272|524550424|FG003|Overall Study|Other reasons|0|||
145464120|NCT03158272|524550421|FG000|Overall Study|Adverse event unrelated to the drug|0|||
145464121|NCT03158272|524550422|FG001|Overall Study|Adverse event unrelated to the drug|1|||
145464122|NCT03158272|524550423|FG002|Overall Study|Adverse event unrelated to the drug|0|||
145464123|NCT03158272|524550424|FG003|Overall Study|Adverse event unrelated to the drug|0|||
145464124|NCT01822535|524550425|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
145464125|NCT01822535|524550426|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
145594686|NCT00857207|525030171|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
145594687|NCT00857207|525030172|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
145594688|NCT02822222|525030173|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
145594689|NCT02822222|525030174|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
145594690|NCT00643916|525030175|FG000|Overall Study|Protocol Violation|0|||
145594691|NCT00643916|525030176|FG001|Overall Study|Protocol Violation|1|||
145464126|NCT01822535|524550425|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
145464127|NCT01822535|524550426|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
145464128|NCT01822535|524550425|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
145594692|NCT00643916|525030177|FG002|Overall Study|Protocol Violation|1|||
145594693|NCT00643916|525030178|FG003|Overall Study|Protocol Violation|1|||
145594694|NCT00643916|525030179|FG004|Overall Study|Protocol Violation|0|||
145464129|NCT01822535|524550426|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
145464130|NCT03697993|524550427|FG000|Overall Study|Became Ineligible after Enrollment|1|||
145464131|NCT03697993|524550428|FG001|Overall Study|Became Ineligible after Enrollment|3|||
145594695|NCT00643916|525030180|FG005|Overall Study|Protocol Violation|0|||
145594696|NCT00643916|525030175|FG000|Overall Study|Lost to Follow-up|0|||
145594697|NCT00643916|525030176|FG001|Overall Study|Lost to Follow-up|1|||
145464132|NCT03697993|524550427|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
145464133|NCT03697993|524550428|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
145464134|NCT03697993|524550427|FG000|Overall Study|Lost to Follow-up|3|||
145464135|NCT03697993|524550428|FG001|Overall Study|Lost to Follow-up|0|||
145464136|NCT03697993|524550427|FG000|Overall Study|Physician Decision|4|||
145464137|NCT03697993|524550428|FG001|Overall Study|Physician Decision|0|||
145464138|NCT03697993|524550427|FG000|Overall Study|Initial Urine Culture Negative|0|||
145464139|NCT03697993|524550428|FG001|Overall Study|Initial Urine Culture Negative|1|||
145464140|NCT01048866|524550429|FG000|Overall Study|Adverse Event|1|||
145464141|NCT01048866|524550430|FG001|Overall Study|Adverse Event|0|||
145464142|NCT01048866|524550429|FG000|Overall Study|Protocol Violation|1|||
145464143|NCT01048866|524550430|FG001|Overall Study|Protocol Violation|0|||
145464144|NCT01048866|524550429|FG000|Overall Study|Physician Decision|1|||
145464145|NCT01048866|524550430|FG001|Overall Study|Physician Decision|0|||
145464146|NCT01048866|524550429|FG000|Overall Study|Withdrawal by Subject|0|||
145464147|NCT01048866|524550430|FG001|Overall Study|Withdrawal by Subject|2|||
145464148|NCT01048866|524550429|FG000|Overall Study|Lost to Follow-up|0|||
145464149|NCT01048866|524550430|FG001|Overall Study|Lost to Follow-up|2|||
145464150|NCT01048866|524550429|FG000|Overall Study|Other|1|||
145464151|NCT01048866|524550430|FG001|Overall Study|Other|1|||
145464152|NCT03582813|524550431|FG000|Overall Study|Lost to Follow-up|18|||
145464153|NCT03582813|524550432|FG001|Overall Study|Lost to Follow-up|21|||
145464154|NCT03582813|524550431|FG000|Overall Study|Withdrawal by Subject|1|||
145464155|NCT03582813|524550432|FG001|Overall Study|Withdrawal by Subject|0|||
145464156|NCT02230683|524550433|FG000|Overall Study|Adverse Event|1|||
145464157|NCT02191605|524551868|FG000|Overall Study|Lost to Follow-up|9|||
145464158|NCT02191605|524551869|FG001|Overall Study|Lost to Follow-up|4|||
145464159|NCT02191605|524551870|FG002|Overall Study|Lost to Follow-up|7|||
145464160|NCT02191605|524551871|FG003|Overall Study|Lost to Follow-up|3|||
145464161|NCT02191605|524551872|FG004|Overall Study|Lost to Follow-up|4|||
145464162|NCT00583791|524551873|FG000|Overall Study|Other|67|||
145464163|NCT00583791|524551873|FG000|Overall Study|Death|6|||
145464164|NCT01062061|524551874|FG000|Overall Study|Enrolled more than once|2|||
145464165|NCT01062061|524551874|FG000|Overall Study|Investigated before study start|13|||
145464166|NCT01062061|524551874|FG000|Overall Study|Outside chief indications|10|||
145464167|NCT01062061|524551874|FG000|Overall Study|Failed to meet inclusion criteria|2|||
145464168|NCT01062841|524551876|FG000|Overall Study|Indwelling Device Removed|41|||
145464169|NCT01062841|524551877|FG001|Overall Study|Indwelling Device Removed|48|||
145464170|NCT01062841|524551876|FG000|Overall Study|Death|3|||
145464171|NCT01062841|524551877|FG001|Overall Study|Death|5|||
145464172|NCT01062841|524551876|FG000|Overall Study|Withdrawal by Subject|2|||
145464173|NCT01062841|524551877|FG001|Overall Study|Withdrawal by Subject|0|||
145464174|NCT01062841|524551876|FG000|Overall Study|Withdrawal by Study|3|||
145464175|NCT01062841|524551877|FG001|Overall Study|Withdrawal by Study|0|||
145464176|NCT00765882|524551879|FG000|Overall Study|Adverse Event|10|||
145464177|NCT00765882|524551880|FG001|Overall Study|Adverse Event|21|||
145464178|NCT00765882|524551881|FG002|Overall Study|Adverse Event|20|||
145464179|NCT00765882|524551879|FG000|Overall Study|Lack of Efficacy|4|||
145464180|NCT00765882|524551880|FG001|Overall Study|Lack of Efficacy|0|||
145464181|NCT00765882|524551881|FG002|Overall Study|Lack of Efficacy|1|||
145464182|NCT00765882|524551879|FG000|Overall Study|Protocol Violation|4|||
145464183|NCT00765882|524551880|FG001|Overall Study|Protocol Violation|3|||
145464184|NCT00765882|524551881|FG002|Overall Study|Protocol Violation|1|||
145464185|NCT00765882|524551879|FG000|Overall Study|Withdrawal by Subject|2|||
145464186|NCT00765882|524551880|FG001|Overall Study|Withdrawal by Subject|6|||
145464187|NCT00765882|524551881|FG002|Overall Study|Withdrawal by Subject|6|||
145464188|NCT00765882|524551879|FG000|Overall Study|Lost to Follow-up|1|||
145464189|NCT00765882|524551880|FG001|Overall Study|Lost to Follow-up|9|||
145464190|NCT00765882|524551881|FG002|Overall Study|Lost to Follow-up|6|||
145464191|NCT00765882|524551879|FG000|Overall Study|Other Reason|3|||
145464192|NCT00765882|524551880|FG001|Overall Study|Other Reason|1|||
145464193|NCT00765882|524551881|FG002|Overall Study|Other Reason|2|||
145464194|NCT03351114|524551885|FG000|Overall Study|Withdrawal by Subject|1|||
145464195|NCT01874275|524551886|FG000|Overall Study|Lost to Follow-up|1|||
145464196|NCT01874275|524551887|FG001|Overall Study|Lost to Follow-up|0|||
145464197|NCT01665430|524551888|FG000|Overall Study|Adverse Event|1|||
145464198|NCT01665430|524551888|FG000|Overall Study|Withdrawal by Subject|6|||
145464199|NCT01665430|524551888|FG000|Overall Study|Other Unspecified|2|||
145464200|NCT00989235|524551893|FG000|Overall Study|Death|0|||
145464201|NCT00989235|524551894|FG001|Overall Study|Death|1|||
145464202|NCT00989235|524551893|FG000|Overall Study|Adverse Event|0|||
145464203|NCT00989235|524551894|FG001|Overall Study|Adverse Event|1|||
145464204|NCT00989235|524551893|FG000|Overall Study|Lack of Efficacy|1|||
145464205|NCT00989235|524551894|FG001|Overall Study|Lack of Efficacy|0|||
145464206|NCT00989235|524551893|FG000|Overall Study|Withdrawal of Consent|1|||
145464207|NCT00989235|524551894|FG001|Overall Study|Withdrawal of Consent|1|||
145464208|NCT00989235|524551893|FG000|Overall Study|Desire to Become Pregnant|1|||
145464209|NCT00989235|524551894|FG001|Overall Study|Desire to Become Pregnant|0|||
145464210|NCT00989235|524551893|FG000|Overall Study|Randomized by Mistake|0|||
145464211|NCT00989235|524551894|FG001|Overall Study|Randomized by Mistake|2|||
145464212|NCT00989235|524551893|FG000|Overall Study|Lost to Follow-up|0|||
145464213|NCT00989235|524551894|FG001|Overall Study|Lost to Follow-up|1|||
145464214|NCT03249935|524551895|FG000|Overall Study|Discharged from facility early|36|||
145464215|NCT03249935|524551895|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
145464216|NCT03249935|524551895|FG000|Overall Study|Protocol Violation|5|||
145464217|NCT02813668|524551896|FG000|Overall Study|Death|4|||
145464218|NCT02813668|524551896|FG000|Overall Study|Lost to Follow-up|509|||
145464219|NCT02813668|524551896|FG000|Overall Study|Withdrawal by Subject|148|||
145464220|NCT02813668|524551896|FG000|Overall Study|No longer at worksite|85|||
145464221|NCT02813668|524551896|FG000|Overall Study|Medical reasons not related to the study|4|||
145464222|NCT04662073|524551897|FG000|Overall Study|Withdrawal by Subject|1|||
145464223|NCT04662073|524551898|FG001|Overall Study|Withdrawal by Subject|0|||
145464224|NCT00598078|524551903|FG000|Period 2 (Day 2)|Adverse Event|1|||
145464225|NCT00598078|524551904|FG001|Period 2 (Day 2)|Adverse Event|0|||
145464226|NCT01813721|524551905|FG000|Overall Study|Ineligibility determined|63|||
145464227|NCT01813721|524551905|FG000|Overall Study|Withdrawal by Subject|1|||
145464228|NCT01479595|524551908|FG000|Overall Study|Protocol deviation|0|||
145464229|NCT01479595|524551909|FG001|Overall Study|Protocol deviation|1|||
145464230|NCT01479595|524551908|FG000|Overall Study|Adverse Event|2|||
145464231|NCT01479595|524551909|FG001|Overall Study|Adverse Event|1|||
145464232|NCT00810901|524551910|FG000|Overall Study|Lost to Follow-up|88|||
145464233|NCT00810901|524551911|FG001|Overall Study|Lost to Follow-up|58|||
145464234|NCT02133664|524551912|FG000|Overall Study|Lost to Follow-up|2|||
145464235|NCT02133664|524551913|FG001|Overall Study|Lost to Follow-up|1|||
145464236|NCT02133664|524551912|FG000|Overall Study|Adverse Event|3|||
145464237|NCT02133664|524551913|FG001|Overall Study|Adverse Event|6|||
145464238|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
145464239|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
145464240|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
145464241|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
145464242|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
145464243|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
145464244|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
145464245|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
145464246|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
145464247|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
145464248|NCT03906656|524551916|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
145464249|NCT03906656|524551917|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
145464250|NCT03906656|524551916|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
145464251|NCT03906656|524551917|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
145464252|NCT03906656|524551916|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
145464253|NCT03906656|524551917|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
145464254|NCT03906656|524551916|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
145464255|NCT03906656|524551917|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
145464256|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
145464257|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
145464258|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
145464259|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
145464260|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
145464261|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
145464262|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
145464263|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
145464264|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
145464265|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
145464266|NCT03906656|524551916|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
145464267|NCT03906656|524551917|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
145464268|NCT03906656|524551916|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
145464269|NCT03906656|524551917|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
145464270|NCT03906656|524551916|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
145464271|NCT03906656|524551917|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
145464272|NCT03906656|524551916|FG000|Home Use 2 (3 Months)|Death|2|||
145464273|NCT03906656|524551917|FG001|Home Use 2 (3 Months)|Death|0|||
145464274|NCT03906656|524551916|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
145464275|NCT03906656|524551917|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
145464276|NCT03906656|524551916|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
145464277|NCT03906656|524551917|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
145464278|NCT03366103|524551918|FG000|Overall Study|Disease Progression|3|||
145464279|NCT03366103|524551919|FG001|Overall Study|Disease Progression|1|||
145464280|NCT03366103|524551920|FG002|Overall Study|Disease Progression|0|||
145626957|NCT00941031|525147145|FG005|Maintenance Period|Withdrawal by Subject|2|||
145464281|NCT03366103|524551918|FG000|Overall Study|Adverse Event|0|||
145464282|NCT03366103|524551919|FG001|Overall Study|Adverse Event|1|||
145464283|NCT03366103|524551920|FG002|Overall Study|Adverse Event|0|||
145464284|NCT01036529|524551921|FG000|Overall Study|Adverse Event|0|||
145464285|NCT01036529|524551922|FG001|Overall Study|Adverse Event|1|||
145464286|NCT01036529|524551921|FG000|Overall Study|Lost to Follow-up|0|||
145464287|NCT01036529|524551922|FG001|Overall Study|Lost to Follow-up|1|||
145464288|NCT01036529|524551921|FG000|Overall Study|Physician Decision|1|||
145464289|NCT01036529|524551922|FG001|Overall Study|Physician Decision|0|||
145464290|NCT01036529|524551921|FG000|Overall Study|Withdrawal by Subject|1|||
145464291|NCT01036529|524551922|FG001|Overall Study|Withdrawal by Subject|1|||
145464292|NCT01036529|524551921|FG000|Overall Study|Sponsor study termination|11|||
145464293|NCT01036529|524551922|FG001|Overall Study|Sponsor study termination|12|||
145464294|NCT02120365|524551929|FG000|Overall Study|Withdrawal by Subject|0|||
145464295|NCT02120365|524551930|FG001|Overall Study|Withdrawal by Subject|0|||
145464296|NCT02120365|524551931|FG002|Overall Study|Withdrawal by Subject|2|||
145464297|NCT02120365|524551932|FG003|Overall Study|Withdrawal by Subject|4|||
145464298|NCT02120365|524551933|FG004|Overall Study|Withdrawal by Subject|0|||
145464299|NCT02120365|524551934|FG005|Overall Study|Withdrawal by Subject|2|||
145464300|NCT00343915|524551935|FG000|Primary Study|Withdrawal by Subject|1|||
145464301|NCT00343915|524551936|FG001|Primary Study|Withdrawal by Subject|0|||
145464302|NCT00343915|524551935|FG000|Primary Study|Lost to Follow-up|2|||
145464303|NCT00343915|524551936|FG001|Primary Study|Lost to Follow-up|3|||
145464304|NCT00343915|524551935|FG000|Primary Study|Other|1|||
145464305|NCT00343915|524551936|FG001|Primary Study|Other|0|||
145464306|NCT01719003|524551941|FG000|Overall Study|Non compliant with protocol|1|||
145464307|NCT01719003|524551942|FG001|Overall Study|Non compliant with protocol|1|||
145464308|NCT01719003|524551943|FG002|Overall Study|Non compliant with protocol|0|||
145464309|NCT01719003|524551944|FG003|Overall Study|Non compliant with protocol|1|||
145464310|NCT01719003|524551945|FG004|Overall Study|Non compliant with protocol|2|||
145464311|NCT01719003|524551946|FG005|Overall Study|Non compliant with protocol|1|||
145464312|NCT01719003|524551947|FG006|Overall Study|Non compliant with protocol|2|||
145464313|NCT01719003|524551948|FG007|Overall Study|Non compliant with protocol|3|||
145464314|NCT01719003|524551949|FG008|Overall Study|Non compliant with protocol|0|||
145464315|NCT01719003|524551941|FG000|Overall Study|Adverse Event|6|||
145464316|NCT01719003|524551942|FG001|Overall Study|Adverse Event|5|||
145464317|NCT01719003|524551943|FG002|Overall Study|Adverse Event|4|||
145464318|NCT01719003|524551944|FG003|Overall Study|Adverse Event|3|||
145464319|NCT01719003|524551945|FG004|Overall Study|Adverse Event|4|||
145464320|NCT01719003|524551946|FG005|Overall Study|Adverse Event|3|||
145464321|NCT01719003|524551947|FG006|Overall Study|Adverse Event|6|||
145464322|NCT01719003|524551948|FG007|Overall Study|Adverse Event|5|||
145464323|NCT01719003|524551949|FG008|Overall Study|Adverse Event|0|||
145464324|NCT01719003|524551941|FG000|Overall Study|Lost to Follow-up|0|||
145464325|NCT01719003|524551942|FG001|Overall Study|Lost to Follow-up|6|||
145464326|NCT01719003|524551943|FG002|Overall Study|Lost to Follow-up|7|||
145464327|NCT01719003|524551944|FG003|Overall Study|Lost to Follow-up|2|||
145464328|NCT01719003|524551945|FG004|Overall Study|Lost to Follow-up|3|||
145464329|NCT01719003|524551946|FG005|Overall Study|Lost to Follow-up|4|||
145464330|NCT01719003|524551947|FG006|Overall Study|Lost to Follow-up|3|||
145464331|NCT01719003|524551948|FG007|Overall Study|Lost to Follow-up|2|||
145464332|NCT01719003|524551949|FG008|Overall Study|Lost to Follow-up|2|||
145464333|NCT01719003|524551941|FG000|Overall Study|Refusal to continue, not due to AE|2|||
145464334|NCT01719003|524551942|FG001|Overall Study|Refusal to continue, not due to AE|5|||
145464335|NCT01719003|524551943|FG002|Overall Study|Refusal to continue, not due to AE|4|||
145464336|NCT01719003|524551944|FG003|Overall Study|Refusal to continue, not due to AE|4|||
145464337|NCT01719003|524551945|FG004|Overall Study|Refusal to continue, not due to AE|4|||
145464338|NCT01719003|524551946|FG005|Overall Study|Refusal to continue, not due to AE|3|||
145464339|NCT01719003|524551947|FG006|Overall Study|Refusal to continue, not due to AE|8|||
145464340|NCT01719003|524551948|FG007|Overall Study|Refusal to continue, not due to AE|7|||
145464341|NCT01719003|524551949|FG008|Overall Study|Refusal to continue, not due to AE|1|||
145464342|NCT01719003|524551941|FG000|Overall Study|Reason other than those specified|0|||
145464343|NCT01719003|524551942|FG001|Overall Study|Reason other than those specified|0|||
145464344|NCT01719003|524551943|FG002|Overall Study|Reason other than those specified|2|||
145464345|NCT01719003|524551944|FG003|Overall Study|Reason other than those specified|3|||
145594698|NCT00643916|525030177|FG002|Overall Study|Lost to Follow-up|0|||
145464346|NCT01719003|524551945|FG004|Overall Study|Reason other than those specified|4|||
145594699|NCT00643916|525030178|FG003|Overall Study|Lost to Follow-up|0|||
145594700|NCT00643916|525030179|FG004|Overall Study|Lost to Follow-up|0|||
145464347|NCT01719003|524551946|FG005|Overall Study|Reason other than those specified|1|||
145594701|NCT00643916|525030180|FG005|Overall Study|Lost to Follow-up|0|||
145464348|NCT01719003|524551947|FG006|Overall Study|Reason other than those specified|0|||
145464349|NCT01719003|524551948|FG007|Overall Study|Reason other than those specified|3|||
145464350|NCT01719003|524551949|FG008|Overall Study|Reason other than those specified|1|||
145464351|NCT01719003|524551941|FG000|Overall Study|Lack of Efficacy|0|||
145464352|NCT01719003|524551942|FG001|Overall Study|Lack of Efficacy|0|||
145594702|NCT00643916|525030175|FG000|Overall Study|Withdrawal by Subject|2|||
145464353|NCT01719003|524551943|FG002|Overall Study|Lack of Efficacy|0|||
145464354|NCT01719003|524551944|FG003|Overall Study|Lack of Efficacy|0|||
145464355|NCT01719003|524551945|FG004|Overall Study|Lack of Efficacy|0|||
145464356|NCT01719003|524551946|FG005|Overall Study|Lack of Efficacy|0|||
145464357|NCT01719003|524551947|FG006|Overall Study|Lack of Efficacy|1|||
145464358|NCT01719003|524551948|FG007|Overall Study|Lack of Efficacy|0|||
145464359|NCT01719003|524551949|FG008|Overall Study|Lack of Efficacy|0|||
145464360|NCT00882908|524551950|FG000|Overall Study|Adverse Event|0|||
145464361|NCT00882908|524551951|FG001|Overall Study|Adverse Event|0|||
145464362|NCT00882908|524551952|FG002|Overall Study|Adverse Event|1|||
145464363|NCT00882908|524551953|FG003|Overall Study|Adverse Event|0|||
145464364|NCT00882908|524551954|FG004|Overall Study|Adverse Event|1|||
145464365|NCT00882908|524551950|FG000|Overall Study|Lost to Follow-up|3|||
145464366|NCT00882908|524551951|FG001|Overall Study|Lost to Follow-up|5|||
145464367|NCT00882908|524551952|FG002|Overall Study|Lost to Follow-up|3|||
145464368|NCT00882908|524551953|FG003|Overall Study|Lost to Follow-up|1|||
145464369|NCT00882908|524551954|FG004|Overall Study|Lost to Follow-up|2|||
145464370|NCT00882908|524551950|FG000|Overall Study|Protocol Violation|0|||
145464371|NCT00882908|524551951|FG001|Overall Study|Protocol Violation|1|||
145464372|NCT00882908|524551952|FG002|Overall Study|Protocol Violation|0|||
145464373|NCT00882908|524551953|FG003|Overall Study|Protocol Violation|0|||
145464374|NCT00882908|524551954|FG004|Overall Study|Protocol Violation|0|||
145464375|NCT00882908|524551950|FG000|Overall Study|Withdrawal by Subject|0|||
145464376|NCT00882908|524551951|FG001|Overall Study|Withdrawal by Subject|0|||
145464377|NCT00882908|524551952|FG002|Overall Study|Withdrawal by Subject|3|||
145464378|NCT00882908|524551953|FG003|Overall Study|Withdrawal by Subject|5|||
145464379|NCT00882908|524551954|FG004|Overall Study|Withdrawal by Subject|2|||
145464380|NCT00882908|524551950|FG000|Overall Study|Subject reached a virologic endpoint|0|||
145464381|NCT00882908|524551951|FG001|Overall Study|Subject reached a virologic endpoint|0|||
145464382|NCT00882908|524551952|FG002|Overall Study|Subject reached a virologic endpoint|0|||
145464383|NCT00882908|524551953|FG003|Overall Study|Subject reached a virologic endpoint|0|||
145464384|NCT00882908|524551954|FG004|Overall Study|Subject reached a virologic endpoint|1|||
145464385|NCT00882908|524551950|FG000|Overall Study|Study terminated in error|0|||
145464386|NCT00882908|524551951|FG001|Overall Study|Study terminated in error|0|||
145464387|NCT00882908|524551952|FG002|Overall Study|Study terminated in error|0|||
145464388|NCT00882908|524551953|FG003|Overall Study|Study terminated in error|1|||
145464389|NCT00882908|524551954|FG004|Overall Study|Study terminated in error|0|||
145464390|NCT01344629|524551956|FG000|Crossover Period 2|Withdrawal by Subject|0|||
145464391|NCT01344629|524551957|FG001|Crossover Period 2|Withdrawal by Subject|1|||
145464392|NCT05590000|524551961|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
145464393|NCT00762996|524551962|FG000|Period One|Protocol Violation|0|||
145464394|NCT00762996|524551963|FG001|Period One|Protocol Violation|0|||
145464395|NCT00762996|524551964|FG002|Period One|Protocol Violation|1|||
145464396|NCT00762996|524551965|FG003|Period One|Protocol Violation|0|||
145464397|NCT00762996|524551962|FG000|Period One|ineligible|0|||
145464398|NCT00762996|524551963|FG001|Period One|ineligible|0|||
145464399|NCT00762996|524551964|FG002|Period One|ineligible|1|||
145464400|NCT00762996|524551965|FG003|Period One|ineligible|1|||
145464401|NCT00762996|524551962|FG000|Period One|Adverse Event|0|||
145464402|NCT00762996|524551963|FG001|Period One|Adverse Event|0|||
145464403|NCT00762996|524551964|FG002|Period One|Adverse Event|1|||
145464404|NCT00762996|524551965|FG003|Period One|Adverse Event|0|||
145464405|NCT00762996|524551962|FG000|Period One|Withdrawal by Subject|0|||
145464406|NCT00762996|524551963|FG001|Period One|Withdrawal by Subject|0|||
145464407|NCT00762996|524551964|FG002|Period One|Withdrawal by Subject|1|||
145464408|NCT00762996|524551965|FG003|Period One|Withdrawal by Subject|0|||
145464409|NCT02689076|524551968|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
145464410|NCT02689076|524551969|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
145464411|NCT02689076|524551970|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
145464412|NCT02689076|524551968|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
145464413|NCT02689076|524551969|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
145464414|NCT02689076|524551970|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
145464415|NCT02689076|524551968|FG000|Overall Study|Did not have an HIE match|2|||
145626958|NCT00941031|525147146|FG006|Maintenance Period|Withdrawal by Subject|13|||
145626959|NCT00941031|525147140|FG000|Maintenance Period|Administrative Problems|0|||
145626960|NCT00941031|525147141|FG001|Maintenance Period|Administrative Problems|0|||
145626961|NCT00941031|525147142|FG002|Maintenance Period|Administrative Problems|0|||
145626962|NCT00941031|525147143|FG003|Maintenance Period|Administrative Problems|0|||
145464416|NCT02689076|524551969|FG001|Overall Study|Did not have an HIE match|0|||
145464417|NCT02689076|524551970|FG002|Overall Study|Did not have an HIE match|0|||
145464418|NCT02689076|524551968|FG000|Overall Study|Death during non-VA encounter|2|||
145464419|NCT02689076|524551969|FG001|Overall Study|Death during non-VA encounter|5|||
145464420|NCT02689076|524551970|FG002|Overall Study|Death during non-VA encounter|0|||
145626963|NCT00941031|525147144|FG004|Maintenance Period|Administrative Problems|1|||
145626964|NCT00941031|525147145|FG005|Maintenance Period|Administrative Problems|0|||
145626965|NCT00941031|525147146|FG006|Maintenance Period|Administrative Problems|1|||
145626966|NCT00941031|525147140|FG000|Maintenance Period|Protocol Violation|0|||
145626967|NCT00941031|525147141|FG001|Maintenance Period|Protocol Violation|0|||
145626968|NCT00941031|525147142|FG002|Maintenance Period|Protocol Violation|0|||
145626969|NCT00941031|525147143|FG003|Maintenance Period|Protocol Violation|0|||
145626970|NCT00941031|525147144|FG004|Maintenance Period|Protocol Violation|0|||
145626971|NCT00941031|525147145|FG005|Maintenance Period|Protocol Violation|0|||
145626972|NCT00941031|525147146|FG006|Maintenance Period|Protocol Violation|1|||
145626973|NCT00941031|525147140|FG000|Maintenance Period|Adverse Event|0|||
145626974|NCT00941031|525147141|FG001|Maintenance Period|Adverse Event|0|||
145626975|NCT00941031|525147142|FG002|Maintenance Period|Adverse Event|0|||
145626976|NCT00941031|525147143|FG003|Maintenance Period|Adverse Event|0|||
145626977|NCT00941031|525147144|FG004|Maintenance Period|Adverse Event|0|||
145626978|NCT00941031|525147145|FG005|Maintenance Period|Adverse Event|2|||
145626979|NCT00941031|525147146|FG006|Maintenance Period|Adverse Event|8|||
145626980|NCT00941031|525147140|FG000|Maintenance Period|Lost to Follow-up|0|||
145626981|NCT00941031|525147141|FG001|Maintenance Period|Lost to Follow-up|0|||
145626982|NCT00941031|525147142|FG002|Maintenance Period|Lost to Follow-up|0|||
145626983|NCT00941031|525147143|FG003|Maintenance Period|Lost to Follow-up|0|||
145626984|NCT00941031|525147144|FG004|Maintenance Period|Lost to Follow-up|2|||
145626985|NCT00941031|525147145|FG005|Maintenance Period|Lost to Follow-up|2|||
145626986|NCT00941031|525147146|FG006|Maintenance Period|Lost to Follow-up|7|||
145626987|NCT00941031|525147140|FG000|Maintenance Period|Lack of Efficacy|0|||
145626988|NCT00941031|525147141|FG001|Maintenance Period|Lack of Efficacy|0|||
145464421|NCT02689076|524551968|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
145464422|NCT02689076|524551969|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
145594703|NCT00643916|525030176|FG001|Overall Study|Withdrawal by Subject|2|||
145594704|NCT00643916|525030177|FG002|Overall Study|Withdrawal by Subject|2|||
145594705|NCT00643916|525030178|FG003|Overall Study|Withdrawal by Subject|1|||
145594706|NCT00643916|525030179|FG004|Overall Study|Withdrawal by Subject|0|||
145594707|NCT00643916|525030180|FG005|Overall Study|Withdrawal by Subject|1|||
145594708|NCT00643916|525030175|FG000|Overall Study|Not Vaccinated|2|||
145594709|NCT00643916|525030176|FG001|Overall Study|Not Vaccinated|2|||
145594710|NCT00643916|525030177|FG002|Overall Study|Not Vaccinated|3|||
145594711|NCT00643916|525030178|FG003|Overall Study|Not Vaccinated|0|||
145594712|NCT00643916|525030179|FG004|Overall Study|Not Vaccinated|2|||
145594713|NCT00643916|525030180|FG005|Overall Study|Not Vaccinated|0|||
145594714|NCT00428090|525030181|FG000|Overall Study|Adverse Event|10|||
145594715|NCT00428090|525030182|FG001|Overall Study|Adverse Event|8|||
145594716|NCT00428090|525030183|FG002|Overall Study|Adverse Event|10|||
145594717|NCT00428090|525030184|FG003|Overall Study|Adverse Event|11|||
145594718|NCT00428090|525030181|FG000|Overall Study|Lost to Follow-up|3|||
145594719|NCT00428090|525030182|FG001|Overall Study|Lost to Follow-up|6|||
145594720|NCT00428090|525030183|FG002|Overall Study|Lost to Follow-up|1|||
145594721|NCT00428090|525030184|FG003|Overall Study|Lost to Follow-up|4|||
145594722|NCT00428090|525030181|FG000|Overall Study|Protocol Violation|3|||
145594723|NCT00428090|525030182|FG001|Overall Study|Protocol Violation|1|||
145594724|NCT00428090|525030183|FG002|Overall Study|Protocol Violation|3|||
145594725|NCT00428090|525030184|FG003|Overall Study|Protocol Violation|3|||
145594726|NCT00428090|525030181|FG000|Overall Study|Withdrawal by Subject|10|||
145594727|NCT00428090|525030182|FG001|Overall Study|Withdrawal by Subject|12|||
145594728|NCT00428090|525030183|FG002|Overall Study|Withdrawal by Subject|15|||
145594729|NCT00428090|525030184|FG003|Overall Study|Withdrawal by Subject|5|||
145594730|NCT00428090|525030181|FG000|Overall Study|Sponsor terminated study|0|||
145594731|NCT00428090|525030182|FG001|Overall Study|Sponsor terminated study|1|||
145594732|NCT00428090|525030183|FG002|Overall Study|Sponsor terminated study|0|||
145594733|NCT00428090|525030184|FG003|Overall Study|Sponsor terminated study|0|||
145594734|NCT00428090|525030181|FG000|Overall Study|Non-compliance|4|||
145594735|NCT00428090|525030182|FG001|Overall Study|Non-compliance|0|||
145594736|NCT00428090|525030183|FG002|Overall Study|Non-compliance|1|||
145626989|NCT00941031|525147142|FG002|Maintenance Period|Lack of Efficacy|0|||
145626990|NCT00941031|525147143|FG003|Maintenance Period|Lack of Efficacy|0|||
145626991|NCT00941031|525147144|FG004|Maintenance Period|Lack of Efficacy|0|||
145626992|NCT00941031|525147145|FG005|Maintenance Period|Lack of Efficacy|0|||
145594737|NCT00428090|525030184|FG003|Overall Study|Non-compliance|3|||
145626993|NCT00941031|525147146|FG006|Maintenance Period|Lack of Efficacy|13|||
145594738|NCT00428090|525030181|FG000|Overall Study|Par. did not returned to visit|1|||
145594739|NCT00428090|525030182|FG001|Overall Study|Par. did not returned to visit|0|||
145594740|NCT00428090|525030183|FG002|Overall Study|Par. did not returned to visit|0|||
145594741|NCT00428090|525030184|FG003|Overall Study|Par. did not returned to visit|1|||
145594742|NCT00428090|525030181|FG000|Overall Study|Follow-Up visit not possible|1|||
145594743|NCT00428090|525030182|FG001|Overall Study|Follow-Up visit not possible|0|||
145594744|NCT00428090|525030183|FG002|Overall Study|Follow-Up visit not possible|0|||
145626994|NCT05487703|525147147|FG000|Overall Study|Other|19|||
145626995|NCT05487703|525147147|FG000|Overall Study|Participant not well|5|||
145626996|NCT05487703|525147147|FG000|Overall Study|Insurance Reasons|6|||
145626997|NCT05487703|525147147|FG000|Overall Study|Physician Decision|19|||
145626998|NCT05487703|525147147|FG000|Overall Study|Lack of Efficacy|60|||
145464423|NCT02689076|524551970|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
145464424|NCT02689076|524551968|FG000|Overall Study|Participant no longer active in VA system|1|||
145464425|NCT02689076|524551969|FG001|Overall Study|Participant no longer active in VA system|0|||
145464426|NCT02689076|524551970|FG002|Overall Study|Participant no longer active in VA system|0|||
145464427|NCT02689076|524551968|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
145464428|NCT02689076|524551969|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
145464429|NCT02689076|524551970|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
145464430|NCT00693472|524551976|FG000|Part 1|Adverse Event|1|||
145464431|NCT00693472|524551977|FG001|Part 1|Adverse Event|1|||
145464432|NCT00693472|524551978|FG002|Part 1|Adverse Event|0|||
145464433|NCT00693472|524551979|FG003|Part 1|Adverse Event|0|||
145464434|NCT00693472|524551976|FG000|Part 1|Lost to Follow-up|0|||
145464435|NCT00693472|524551977|FG001|Part 1|Lost to Follow-up|1|||
145464436|NCT00693472|524551978|FG002|Part 1|Lost to Follow-up|0|||
145464437|NCT00693472|524551979|FG003|Part 1|Lost to Follow-up|0|||
145464438|NCT00693472|524551976|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
145464439|NCT00693472|524551977|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
145464440|NCT00693472|524551978|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
145464441|NCT00693472|524551979|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
145464442|NCT00693472|524551976|FG000|Part 2|Adverse Event|0|||
145464443|NCT00693472|524551977|FG001|Part 2|Adverse Event|0|||
145464444|NCT00693472|524551978|FG002|Part 2|Adverse Event|1|||
145464445|NCT00693472|524551979|FG003|Part 2|Adverse Event|0|||
145464446|NCT00693472|524551976|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
145464447|NCT00693472|524551977|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
145464448|NCT00693472|524551978|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
145464449|NCT00693472|524551979|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
145464450|NCT04063787|524551980|FG000|Overall Study|Inadequate Doppler data|4|||
145464451|NCT04063787|524551980|FG000|Overall Study|Lost to Follow-up|2|||
145464452|NCT04063787|524551980|FG000|Overall Study|Death|3|||
145464453|NCT01816906|524551981|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
145464454|NCT01816906|524551982|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
145464455|NCT01816906|524551981|FG000|Six Months|Lost to Follow-up|14|||
145464456|NCT01816906|524551982|FG001|Six Months|Lost to Follow-up|16|||
145464457|NCT01816906|524551981|FG000|12 Months|Adverse Event|2|||
145464458|NCT01816906|524551982|FG001|12 Months|Adverse Event|2|||
145464459|NCT01816906|524551981|FG000|12 Months|Death|0|||
145464460|NCT01816906|524551982|FG001|12 Months|Death|2|||
145464461|NCT01816906|524551981|FG000|12 Months|Lost to Follow-up|2|||
145464462|NCT01816906|524551982|FG001|12 Months|Lost to Follow-up|1|||
145464463|NCT01527383|524551983|FG000|Overall Study|Adverse Event|5|||
145464464|NCT01527383|524551984|FG001|Overall Study|Adverse Event|0|||
145464465|NCT01527383|524551983|FG000|Overall Study|Lost to Follow-up|3|||
145464466|NCT01527383|524551984|FG001|Overall Study|Lost to Follow-up|0|||
145464467|NCT01527383|524551983|FG000|Overall Study|Physician Decision|2|||
145464468|NCT01527383|524551984|FG001|Overall Study|Physician Decision|0|||
145464469|NCT01527383|524551983|FG000|Overall Study|Pregnancy|1|||
145464470|NCT01527383|524551984|FG001|Overall Study|Pregnancy|0|||
145464471|NCT01527383|524551983|FG000|Overall Study|Protocol Violation|1|||
145464472|NCT01527383|524551984|FG001|Overall Study|Protocol Violation|0|||
145464473|NCT01527383|524551983|FG000|Overall Study|Screen failure|1|||
145464474|NCT01527383|524551984|FG001|Overall Study|Screen failure|0|||
145464475|NCT01527383|524551983|FG000|Overall Study|Participant moved|0|||
145464476|NCT01527383|524551984|FG001|Overall Study|Participant moved|1|||
145464477|NCT01527383|524551983|FG000|Overall Study|Withdrawal by Subject|2|||
145464478|NCT01527383|524551984|FG001|Overall Study|Withdrawal by Subject|3|||
145464479|NCT00746733|524551985|FG000|Second Intervention|Adverse Event|1|||
145464480|NCT00746733|524551986|FG001|Second Intervention|Adverse Event|0|||
145464481|NCT00746733|524551985|FG000|Third Intervention|Withdrawal by Subject|1|||
145464482|NCT00746733|524551986|FG001|Third Intervention|Withdrawal by Subject|1|||
145464483|NCT00993499|524551993|FG000|Run-in Period (8 Days)|Adverse Event|0|||
145464484|NCT00993499|524551994|FG001|Run-in Period (8 Days)|Adverse Event|1|||
145464485|NCT00993499|524551995|FG002|Run-in Period (8 Days)|Adverse Event|0|||
145464486|NCT00993499|524551996|FG003|Run-in Period (8 Days)|Adverse Event|0|||
145464487|NCT00993499|524551997|FG004|Run-in Period (8 Days)|Adverse Event|0|||
145464488|NCT00993499|524551998|FG005|Run-in Period (8 Days)|Adverse Event|0|||
145464489|NCT00993499|524551993|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
145464490|NCT00993499|524551994|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
145464491|NCT00993499|524551995|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
145464492|NCT00993499|524551996|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
145464493|NCT00993499|524551997|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
145626999|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
145594745|NCT00428090|525030184|FG003|Overall Study|Follow-Up visit not possible|0|||
145594746|NCT00428090|525030181|FG000|Overall Study|Prohibited medication used for SAE|1|||
145594747|NCT00428090|525030182|FG001|Overall Study|Prohibited medication used for SAE|0|||
145594748|NCT00428090|525030183|FG002|Overall Study|Prohibited medication used for SAE|0|||
145594749|NCT00428090|525030184|FG003|Overall Study|Prohibited medication used for SAE|0|||
145594750|NCT00428090|525030181|FG000|Overall Study|Death of par.|1|||
145594751|NCT00428090|525030182|FG001|Overall Study|Death of par.|0|||
145594752|NCT00428090|525030183|FG002|Overall Study|Death of par.|1|||
145594753|NCT00428090|525030184|FG003|Overall Study|Death of par.|0|||
145594754|NCT00428090|525030181|FG000|Overall Study|Visit 7 exceed the visit window|0|||
145594755|NCT00428090|525030182|FG001|Overall Study|Visit 7 exceed the visit window|1|||
145594756|NCT00428090|525030183|FG002|Overall Study|Visit 7 exceed the visit window|0|||
145594757|NCT00428090|525030184|FG003|Overall Study|Visit 7 exceed the visit window|0|||
145594758|NCT00428090|525030181|FG000|Overall Study|Medical monitor terminated par.|0|||
145594759|NCT00428090|525030182|FG001|Overall Study|Medical monitor terminated par.|1|||
145594760|NCT00428090|525030183|FG002|Overall Study|Medical monitor terminated par.|0|||
145464494|NCT00993499|524551998|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
145464495|NCT00993499|524551993|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
145464496|NCT00993499|524551994|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
145464497|NCT00993499|524551995|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
145464498|NCT00993499|524551996|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
145464499|NCT00993499|524551997|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
145464500|NCT00993499|524551998|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
145464501|NCT00993499|524551993|FG000|Run-in Period (8 Days)|Progressive disease|0|||
145464502|NCT00993499|524551994|FG001|Run-in Period (8 Days)|Progressive disease|1|||
145464503|NCT00993499|524551995|FG002|Run-in Period (8 Days)|Progressive disease|1|||
145464504|NCT00993499|524551996|FG003|Run-in Period (8 Days)|Progressive disease|0|||
145464505|NCT00993499|524551997|FG004|Run-in Period (8 Days)|Progressive disease|0|||
145464506|NCT00993499|524551998|FG005|Run-in Period (8 Days)|Progressive disease|0|||
145464507|NCT00993499|524551993|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
145464508|NCT00993499|524551994|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
145464509|NCT00993499|524551995|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
145464510|NCT00993499|524551996|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
145464511|NCT00993499|524551997|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
145464512|NCT00993499|524551998|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
145464513|NCT00993499|524551993|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
145464514|NCT00993499|524551994|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
145464515|NCT00993499|524551995|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
145464516|NCT00993499|524551996|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
145464517|NCT00993499|524551997|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
145464518|NCT00993499|524551998|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
145464519|NCT00993499|524551993|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
145464520|NCT00993499|524551994|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
145464521|NCT00993499|524551995|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
145464522|NCT00993499|524551996|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
145464523|NCT00993499|524551997|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
145464524|NCT00993499|524551998|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
145464525|NCT00993499|524551993|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
145464526|NCT00993499|524551994|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
145464527|NCT00993499|524551995|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
145464528|NCT00993499|524551996|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
145464529|NCT00993499|524551997|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
145464530|NCT00993499|524551998|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
145464531|NCT00993499|524551993|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
145464532|NCT00993499|524551994|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
145464533|NCT00993499|524551995|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
145464534|NCT00993499|524551996|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
145464535|NCT00993499|524551997|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
145464536|NCT00993499|524551998|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
145464537|NCT00993499|524551993|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
145594761|NCT00428090|525030184|FG003|Overall Study|Medical monitor terminated par.|0|||
145464538|NCT00993499|524551994|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
145594762|NCT00428090|525030181|FG000|Overall Study|Mental status of par. was|0|||
145594763|NCT00428090|525030182|FG001|Overall Study|Mental status of par. was|1|||
145594764|NCT00428090|525030183|FG002|Overall Study|Mental status of par. was|0|||
145594765|NCT00428090|525030184|FG003|Overall Study|Mental status of par. was|0|||
145464539|NCT00993499|524551995|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
145464540|NCT00993499|524551996|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
145464541|NCT00993499|524551997|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
145464542|NCT00993499|524551998|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
145464543|NCT00993499|524551993|FG000|Discontinued After Starting Course 3|DLT|1|||
145464544|NCT00993499|524551994|FG001|Discontinued After Starting Course 3|DLT|0|||
145464545|NCT00993499|524551995|FG002|Discontinued After Starting Course 3|DLT|2|||
145464546|NCT00993499|524551996|FG003|Discontinued After Starting Course 3|DLT|1|||
145464547|NCT00993499|524551997|FG004|Discontinued After Starting Course 3|DLT|0|||
145464548|NCT00993499|524551998|FG005|Discontinued After Starting Course 3|DLT|0|||
145464549|NCT00993499|524551993|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
145464550|NCT00993499|524551994|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
145464551|NCT00993499|524551995|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
145464552|NCT00993499|524551996|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
145464553|NCT00993499|524551997|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
145464554|NCT00993499|524551998|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
145464555|NCT01945775|524551999|FG000|Overall Study|Death|214|||
145464556|NCT01945775|524552000|FG001|Overall Study|Death|98|||
145464557|NCT01945775|524551999|FG000|Overall Study|Lost to Follow-up|12|||
145464558|NCT01945775|524552000|FG001|Overall Study|Lost to Follow-up|7|||
145464559|NCT01945775|524551999|FG000|Overall Study|Withdrawal by Subject|11|||
145464560|NCT01945775|524552000|FG001|Overall Study|Withdrawal by Subject|21|||
145464561|NCT01945775|524551999|FG000|Overall Study|Other|50|||
145464562|NCT01945775|524552000|FG001|Overall Study|Other|18|||
145464563|NCT02876328|524552001|FG000|Overall Study|Death|2|||
145464564|NCT02876328|524552002|FG001|Overall Study|Death|1|||
145464565|NCT02876328|524552003|FG002|Overall Study|Death|3|||
145464566|NCT02876328|524552004|FG003|Overall Study|Death|0|||
145464567|NCT02876328|524552005|FG004|Overall Study|Death|0|||
145464568|NCT02876328|524552006|FG005|Overall Study|Death|0|||
145464569|NCT02876328|524552007|FG006|Overall Study|Death|1|||
145464570|NCT02876328|524552008|FG007|Overall Study|Death|3|||
145464571|NCT02876328|524552009|FG008|Overall Study|Death|0|||
145464572|NCT02876328|524552010|FG009|Overall Study|Death|1|||
145464573|NCT02876328|524552011|FG010|Overall Study|Death|1|||
145464574|NCT02876328|524552012|FG011|Overall Study|Death|0|||
145464575|NCT02876328|524552013|FG012|Overall Study|Death|0|||
145464576|NCT02876328|524552014|FG013|Overall Study|Death|0|||
145464577|NCT02876328|524552015|FG014|Overall Study|Death|0|||
145464578|NCT02876328|524552016|FG015|Overall Study|Death|0|||
145464579|NCT02876328|524552017|FG016|Overall Study|Death|1|||
145464580|NCT02876328|524552018|FG017|Overall Study|Death|1|||
145464581|NCT02876328|524552019|FG018|Overall Study|Death|0|||
145464582|NCT02876328|524552020|FG019|Overall Study|Death|0|||
145464583|NCT02876328|524552021|FG020|Overall Study|Death|0|||
145464584|NCT02876328|524552022|FG021|Overall Study|Death|1|||
145464585|NCT02876328|524552023|FG022|Overall Study|Death|0|||
145464586|NCT02876328|524552024|FG023|Overall Study|Death|0|||
145464587|NCT02876328|524552001|FG000|Overall Study|Withdrawal by Subject|0|||
145464588|NCT02876328|524552002|FG001|Overall Study|Withdrawal by Subject|2|||
145464589|NCT02876328|524552003|FG002|Overall Study|Withdrawal by Subject|3|||
145464590|NCT02876328|524552004|FG003|Overall Study|Withdrawal by Subject|3|||
145464591|NCT02876328|524552005|FG004|Overall Study|Withdrawal by Subject|0|||
145464592|NCT02876328|524552006|FG005|Overall Study|Withdrawal by Subject|1|||
145464593|NCT02876328|524552007|FG006|Overall Study|Withdrawal by Subject|0|||
145464594|NCT02876328|524552008|FG007|Overall Study|Withdrawal by Subject|1|||
145464595|NCT02876328|524552009|FG008|Overall Study|Withdrawal by Subject|1|||
145464596|NCT02876328|524552010|FG009|Overall Study|Withdrawal by Subject|2|||
145464597|NCT02876328|524552011|FG010|Overall Study|Withdrawal by Subject|0|||
145464598|NCT02876328|524552012|FG011|Overall Study|Withdrawal by Subject|0|||
145464599|NCT02876328|524552013|FG012|Overall Study|Withdrawal by Subject|0|||
145464600|NCT02876328|524552014|FG013|Overall Study|Withdrawal by Subject|0|||
145464601|NCT02876328|524552015|FG014|Overall Study|Withdrawal by Subject|0|||
145464602|NCT02876328|524552016|FG015|Overall Study|Withdrawal by Subject|0|||
145464603|NCT02876328|524552017|FG016|Overall Study|Withdrawal by Subject|1|||
145464604|NCT02876328|524552018|FG017|Overall Study|Withdrawal by Subject|3|||
145464605|NCT02876328|524552019|FG018|Overall Study|Withdrawal by Subject|0|||
145464606|NCT02876328|524552020|FG019|Overall Study|Withdrawal by Subject|0|||
145464607|NCT02876328|524552021|FG020|Overall Study|Withdrawal by Subject|1|||
145464608|NCT02876328|524552022|FG021|Overall Study|Withdrawal by Subject|0|||
145464609|NCT02876328|524552023|FG022|Overall Study|Withdrawal by Subject|0|||
145464610|NCT02876328|524552024|FG023|Overall Study|Withdrawal by Subject|0|||
145464611|NCT02876328|524552001|FG000|Overall Study|Missed 12 Month Visit|15|||
145464612|NCT02876328|524552002|FG001|Overall Study|Missed 12 Month Visit|10|||
145464613|NCT02876328|524552003|FG002|Overall Study|Missed 12 Month Visit|11|||
145464614|NCT02876328|524552004|FG003|Overall Study|Missed 12 Month Visit|6|||
145464615|NCT02876328|524552005|FG004|Overall Study|Missed 12 Month Visit|10|||
145464616|NCT02876328|524552006|FG005|Overall Study|Missed 12 Month Visit|14|||
145594766|NCT00428090|525030181|FG000|Overall Study|Worsening of AD|0|||
145594767|NCT00428090|525030182|FG001|Overall Study|Worsening of AD|0|||
145594768|NCT00428090|525030183|FG002|Overall Study|Worsening of AD|1|||
145594769|NCT00428090|525030184|FG003|Overall Study|Worsening of AD|0|||
145594770|NCT00428090|525030181|FG000|Overall Study|Excluded for concerning QTc value|0|||
145594771|NCT00428090|525030182|FG001|Overall Study|Excluded for concerning QTc value|0|||
145594772|NCT00428090|525030183|FG002|Overall Study|Excluded for concerning QTc value|1|||
145594773|NCT00428090|525030184|FG003|Overall Study|Excluded for concerning QTc value|0|||
145594774|NCT00428090|525030181|FG000|Overall Study|Insufficient AD documentation|0|||
145594775|NCT00428090|525030182|FG001|Overall Study|Insufficient AD documentation|0|||
145594776|NCT00428090|525030183|FG002|Overall Study|Insufficient AD documentation|1|||
145594777|NCT00428090|525030184|FG003|Overall Study|Insufficient AD documentation|0|||
145594778|NCT00428090|525030181|FG000|Overall Study|High MMSE scores|0|||
145594779|NCT00428090|525030182|FG001|Overall Study|High MMSE scores|0|||
145594780|NCT00428090|525030183|FG002|Overall Study|High MMSE scores|1|||
145594781|NCT00428090|525030184|FG003|Overall Study|High MMSE scores|0|||
145594782|NCT00428090|525030181|FG000|Overall Study|Deterioration of cognitive status|0|||
145594783|NCT00428090|525030182|FG001|Overall Study|Deterioration of cognitive status|0|||
145594784|NCT00428090|525030183|FG002|Overall Study|Deterioration of cognitive status|1|||
145594785|NCT00428090|525030184|FG003|Overall Study|Deterioration of cognitive status|0|||
145594786|NCT00428090|525030181|FG000|Overall Study|Serious adverse event|0|||
145594787|NCT00428090|525030182|FG001|Overall Study|Serious adverse event|0|||
145594788|NCT00428090|525030183|FG002|Overall Study|Serious adverse event|1|||
145594789|NCT00428090|525030184|FG003|Overall Study|Serious adverse event|0|||
145594790|NCT00428090|525030181|FG000|Overall Study|Excluded for heart insufficiency|0|||
145594791|NCT00428090|525030182|FG001|Overall Study|Excluded for heart insufficiency|0|||
145594792|NCT00428090|525030183|FG002|Overall Study|Excluded for heart insufficiency|1|||
145594793|NCT00428090|525030184|FG003|Overall Study|Excluded for heart insufficiency|0|||
145594794|NCT00428090|525030181|FG000|Overall Study|Raised Creatinine Value|0|||
145594795|NCT00428090|525030182|FG001|Overall Study|Raised Creatinine Value|0|||
145594796|NCT00428090|525030183|FG002|Overall Study|Raised Creatinine Value|0|||
145594797|NCT00428090|525030184|FG003|Overall Study|Raised Creatinine Value|1|||
145594798|NCT00440531|525030187|FG000|Overall Study|Adverse Event|1|||
145594799|NCT00440531|525030188|FG001|Overall Study|Adverse Event|0|||
145594800|NCT00440531|525030189|FG002|Overall Study|Adverse Event|2|||
145594801|NCT00440531|525030187|FG000|Overall Study|Withdrawal by Subject|2|||
145594802|NCT00440531|525030188|FG001|Overall Study|Withdrawal by Subject|0|||
145594803|NCT00440531|525030189|FG002|Overall Study|Withdrawal by Subject|0|||
145594804|NCT00440531|525030187|FG000|Overall Study|Protocol Violation|1|||
145594805|NCT00440531|525030188|FG001|Overall Study|Protocol Violation|2|||
145594806|NCT00440531|525030189|FG002|Overall Study|Protocol Violation|0|||
145594807|NCT00440531|525030187|FG000|Overall Study|Lost to Follow-up|4|||
145594808|NCT00440531|525030188|FG001|Overall Study|Lost to Follow-up|3|||
145594809|NCT00440531|525030189|FG002|Overall Study|Lost to Follow-up|5|||
145594810|NCT00440531|525030187|FG000|Overall Study|see pre-assignment details|2|||
145594811|NCT00440531|525030188|FG001|Overall Study|see pre-assignment details|0|||
145594812|NCT00440531|525030189|FG002|Overall Study|see pre-assignment details|0|||
145594813|NCT00677833|525030192|FG000|Overall Study|Withdrawal by Subject|4|||
145594814|NCT00677833|525030193|FG001|Overall Study|Withdrawal by Subject|0|||
145594815|NCT00677833|525030194|FG002|Overall Study|Withdrawal by Subject|1|||
145594816|NCT00677833|525030195|FG003|Overall Study|Withdrawal by Subject|3|||
145594817|NCT00677833|525030192|FG000|Overall Study|Lost to Follow-up|0|||
145594818|NCT00677833|525030193|FG001|Overall Study|Lost to Follow-up|0|||
145594819|NCT00677833|525030194|FG002|Overall Study|Lost to Follow-up|1|||
145594820|NCT00677833|525030195|FG003|Overall Study|Lost to Follow-up|0|||
145594821|NCT02606279|525030196|FG000|Overall Study|Lost to Follow-up|0|||
145594822|NCT02606279|525030197|FG001|Overall Study|Lost to Follow-up|1|||
145594823|NCT02184611|525030198|FG000|Overall Study|Lack of Efficacy|11|||
145594824|NCT02184611|525030199|FG001|Overall Study|Lack of Efficacy|15|||
145594825|NCT02184611|525030198|FG000|Overall Study|Withdrawal by Subject|5|||
145594826|NCT02184611|525030199|FG001|Overall Study|Withdrawal by Subject|6|||
145594827|NCT02184611|525030198|FG000|Overall Study|Adverse Event|4|||
145594828|NCT02184611|525030199|FG001|Overall Study|Adverse Event|5|||
145594829|NCT02184611|525030198|FG000|Overall Study|Protocol Violation|1|||
145594830|NCT02184611|525030199|FG001|Overall Study|Protocol Violation|1|||
145594831|NCT02184611|525030198|FG000|Overall Study|Protocol defined stopping criteria|0|||
145594832|NCT02184611|525030199|FG001|Overall Study|Protocol defined stopping criteria|1|||
145594833|NCT00160680|525030200|FG000|Overall Study|Adverse Event|0|||
145594834|NCT00160680|525030201|FG001|Overall Study|Adverse Event|1|||
145594835|NCT00160680|525030200|FG000|Overall Study|Lack of Efficacy|2|||
145594836|NCT00160680|525030201|FG001|Overall Study|Lack of Efficacy|1|||
145594837|NCT00160680|525030200|FG000|Overall Study|Lost to Follow-up|3|||
145594838|NCT00160680|525030201|FG001|Overall Study|Lost to Follow-up|2|||
145594839|NCT00160680|525030200|FG000|Overall Study|Withdrawal by Subject|4|||
145594840|NCT00160680|525030201|FG001|Overall Study|Withdrawal by Subject|9|||
145594841|NCT04493216|525030202|FG000|Overall Study|Study terminated by sponsor|30|||
145594842|NCT04493216|525030203|FG001|Overall Study|Study terminated by sponsor|33|||
145594843|NCT04493216|525030204|FG002|Overall Study|Study terminated by sponsor|28|||
145594844|NCT04493216|525030205|FG003|Overall Study|Study terminated by sponsor|27|||
145594845|NCT04493216|525030202|FG000|Overall Study|Withdrawal by Subject|2|||
145594846|NCT04493216|525030203|FG001|Overall Study|Withdrawal by Subject|1|||
145594847|NCT04493216|525030204|FG002|Overall Study|Withdrawal by Subject|1|||
145594848|NCT04493216|525030205|FG003|Overall Study|Withdrawal by Subject|2|||
145594849|NCT04493216|525030202|FG000|Overall Study|Protocol Violation|1|||
145594850|NCT04493216|525030203|FG001|Overall Study|Protocol Violation|2|||
145594851|NCT04493216|525030204|FG002|Overall Study|Protocol Violation|0|||
145594852|NCT04493216|525030205|FG003|Overall Study|Protocol Violation|2|||
145594853|NCT04493216|525030202|FG000|Overall Study|Physician Decision|0|||
145594854|NCT04493216|525030203|FG001|Overall Study|Physician Decision|0|||
145594855|NCT04493216|525030204|FG002|Overall Study|Physician Decision|1|||
145594856|NCT04493216|525030205|FG003|Overall Study|Physician Decision|0|||
145594857|NCT04493216|525030202|FG000|Overall Study|Lost to Follow-up|2|||
145594858|NCT04493216|525030203|FG001|Overall Study|Lost to Follow-up|1|||
145594859|NCT04493216|525030204|FG002|Overall Study|Lost to Follow-up|0|||
145594860|NCT04493216|525030205|FG003|Overall Study|Lost to Follow-up|1|||
145594861|NCT04493216|525030202|FG000|Overall Study|Adverse Event|1|||
145464617|NCT02876328|524552007|FG006|Overall Study|Missed 12 Month Visit|3|||
145464618|NCT02876328|524552008|FG007|Overall Study|Missed 12 Month Visit|8|||
145464619|NCT02876328|524552009|FG008|Overall Study|Missed 12 Month Visit|9|||
145464620|NCT02876328|524552010|FG009|Overall Study|Missed 12 Month Visit|5|||
145464621|NCT02876328|524552011|FG010|Overall Study|Missed 12 Month Visit|4|||
145464622|NCT02876328|524552012|FG011|Overall Study|Missed 12 Month Visit|1|||
145464623|NCT02876328|524552013|FG012|Overall Study|Missed 12 Month Visit|5|||
145464624|NCT02876328|524552014|FG013|Overall Study|Missed 12 Month Visit|4|||
145464625|NCT02876328|524552015|FG014|Overall Study|Missed 12 Month Visit|4|||
145464626|NCT02876328|524552016|FG015|Overall Study|Missed 12 Month Visit|4|||
145464627|NCT02876328|524552017|FG016|Overall Study|Missed 12 Month Visit|3|||
145464628|NCT02876328|524552018|FG017|Overall Study|Missed 12 Month Visit|6|||
145464629|NCT02876328|524552019|FG018|Overall Study|Missed 12 Month Visit|2|||
145464630|NCT02876328|524552020|FG019|Overall Study|Missed 12 Month Visit|2|||
145464631|NCT02876328|524552021|FG020|Overall Study|Missed 12 Month Visit|11|||
145464632|NCT02876328|524552022|FG021|Overall Study|Missed 12 Month Visit|7|||
145464633|NCT02876328|524552023|FG022|Overall Study|Missed 12 Month Visit|1|||
145464634|NCT02876328|524552024|FG023|Overall Study|Missed 12 Month Visit|0|||
145464635|NCT02726880|524552031|FG000|Overall Study|Withdrawal by Subject|2|||
145464636|NCT02726880|524552032|FG001|Overall Study|Withdrawal by Subject|0|||
145464637|NCT02726880|524552031|FG000|Overall Study|Lost to Follow-up|1|||
145464638|NCT02726880|524552032|FG001|Overall Study|Lost to Follow-up|3|||
145464639|NCT04316741|524552033|FG000|Baseline Enrollment|Lost to Follow-up|1|||
145464640|NCT04316741|524552034|FG001|Baseline Enrollment|Lost to Follow-up|1|||
145464641|NCT04316741|524552033|FG000|Immediate Post-Test|Lost to Follow-up|5|||
145464642|NCT04316741|524552034|FG001|Immediate Post-Test|Lost to Follow-up|1|||
145464643|NCT04316741|524552033|FG000|1-month Post-test|Lost to Follow-up|7|||
145464644|NCT04316741|524552034|FG001|1-month Post-test|Lost to Follow-up|2|||
145464645|NCT04316741|524552033|FG000|3-month Follow-up|Lost to Follow-up|10|||
145464646|NCT04316741|524552034|FG001|3-month Follow-up|Lost to Follow-up|2|||
145464647|NCT00787202|524552035|FG000|Overall Study|Adverse Event|3|||
145594862|NCT04493216|525030203|FG001|Overall Study|Adverse Event|4|||
145594863|NCT04493216|525030204|FG002|Overall Study|Adverse Event|5|||
145594864|NCT04493216|525030205|FG003|Overall Study|Adverse Event|2|||
145594865|NCT04493216|525030202|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
145594866|NCT04493216|525030203|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
145594867|NCT04493216|525030204|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
145594868|NCT04493216|525030205|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
145594869|NCT00985725|525030208|FG000|Overall Study|Adverse Event|4|||
145594870|NCT00985725|525030209|FG001|Overall Study|Adverse Event|1|||
145594871|NCT00985725|525030208|FG000|Overall Study|Protocol Violation|1|||
145594872|NCT00985725|525030209|FG001|Overall Study|Protocol Violation|3|||
145594873|NCT00985725|525030208|FG000|Overall Study|Withdrawal by Subject|4|||
145594874|NCT00985725|525030209|FG001|Overall Study|Withdrawal by Subject|4|||
145594875|NCT00985725|525030208|FG000|Overall Study|Lost to Follow-up|1|||
145594876|NCT00985725|525030209|FG001|Overall Study|Lost to Follow-up|1|||
145594877|NCT00985725|525030208|FG000|Overall Study|Lack of Efficacy|0|||
145594878|NCT00985725|525030209|FG001|Overall Study|Lack of Efficacy|1|||
145464648|NCT00787202|524552036|FG001|Overall Study|Adverse Event|2|||
145464649|NCT00787202|524552037|FG002|Overall Study|Adverse Event|0|||
145594879|NCT00985725|525030208|FG000|Overall Study|Non-compliance|1|||
145594880|NCT00985725|525030209|FG001|Overall Study|Non-compliance|2|||
145594881|NCT00985725|525030208|FG000|Overall Study|Out-of-window visits|0|||
145594882|NCT00985725|525030209|FG001|Overall Study|Out-of-window visits|1|||
145464650|NCT00787202|524552038|FG003|Overall Study|Adverse Event|0|||
145464651|NCT00787202|524552039|FG004|Overall Study|Adverse Event|2|||
145594883|NCT03151005|525030213|FG000|Overall Study|Lost to Follow-up|5|||
145464652|NCT00787202|524552035|FG000|Overall Study|Lack of Efficacy|5|||
145464653|NCT00787202|524552036|FG001|Overall Study|Lack of Efficacy|6|||
145464654|NCT00787202|524552037|FG002|Overall Study|Lack of Efficacy|5|||
145464655|NCT00787202|524552038|FG003|Overall Study|Lack of Efficacy|2|||
145464656|NCT00787202|524552039|FG004|Overall Study|Lack of Efficacy|1|||
145464657|NCT00787202|524552035|FG000|Overall Study|Lost to Follow-up|1|||
145464658|NCT00787202|524552036|FG001|Overall Study|Lost to Follow-up|0|||
145464659|NCT00787202|524552037|FG002|Overall Study|Lost to Follow-up|0|||
145464660|NCT00787202|524552038|FG003|Overall Study|Lost to Follow-up|0|||
145464661|NCT00787202|524552039|FG004|Overall Study|Lost to Follow-up|0|||
145464662|NCT00787202|524552035|FG000|Overall Study|Withdrawal by Subject|2|||
145464663|NCT00787202|524552036|FG001|Overall Study|Withdrawal by Subject|2|||
145464664|NCT00787202|524552037|FG002|Overall Study|Withdrawal by Subject|2|||
145464665|NCT00787202|524552038|FG003|Overall Study|Withdrawal by Subject|0|||
145464666|NCT00787202|524552039|FG004|Overall Study|Withdrawal by Subject|0|||
145464667|NCT00787202|524552035|FG000|Overall Study|Protocol Violation|2|||
145464668|NCT00787202|524552036|FG001|Overall Study|Protocol Violation|1|||
145464669|NCT00787202|524552037|FG002|Overall Study|Protocol Violation|0|||
145464670|NCT00787202|524552038|FG003|Overall Study|Protocol Violation|0|||
145464671|NCT00787202|524552039|FG004|Overall Study|Protocol Violation|1|||
145464672|NCT00787202|524552035|FG000|Overall Study|Randomized, not treated|1|||
145464673|NCT00787202|524552036|FG001|Overall Study|Randomized, not treated|0|||
145464674|NCT00787202|524552037|FG002|Overall Study|Randomized, not treated|0|||
145464675|NCT00787202|524552038|FG003|Overall Study|Randomized, not treated|0|||
145464676|NCT00787202|524552039|FG004|Overall Study|Randomized, not treated|0|||
145464677|NCT02558400|524552040|FG000|Overall Study|Adverse Event|47|||
145464678|NCT02558400|524552041|FG001|Overall Study|Adverse Event|53|||
145464679|NCT02558400|524552042|FG002|Overall Study|Adverse Event|4|||
145464680|NCT02558400|524552040|FG000|Overall Study|Withdrawal by Subject|13|||
145464681|NCT02558400|524552041|FG001|Overall Study|Withdrawal by Subject|9|||
145464682|NCT02558400|524552042|FG002|Overall Study|Withdrawal by Subject|8|||
145464683|NCT02558400|524552040|FG000|Overall Study|Non-Compliant|0|||
145464684|NCT02558400|524552041|FG001|Overall Study|Non-Compliant|1|||
145464685|NCT02558400|524552042|FG002|Overall Study|Non-Compliant|3|||
145464686|NCT02558400|524552040|FG000|Overall Study|Lost to Follow-up|5|||
145464687|NCT02558400|524552041|FG001|Overall Study|Lost to Follow-up|5|||
145464688|NCT02558400|524552042|FG002|Overall Study|Lost to Follow-up|4|||
145464689|NCT02558400|524552040|FG000|Overall Study|Lack of Efficacy|0|||
145464690|NCT02558400|524552041|FG001|Overall Study|Lack of Efficacy|13|||
145464691|NCT02558400|524552042|FG002|Overall Study|Lack of Efficacy|1|||
145464692|NCT02558400|524552040|FG000|Overall Study|Disallowed Concurrent Medication|6|||
145464693|NCT02558400|524552041|FG001|Overall Study|Disallowed Concurrent Medication|7|||
145464694|NCT02558400|524552042|FG002|Overall Study|Disallowed Concurrent Medication|5|||
145464695|NCT02558400|524552040|FG000|Overall Study|Physician Decision|2|||
145464696|NCT02558400|524552041|FG001|Overall Study|Physician Decision|2|||
145464697|NCT02558400|524552042|FG002|Overall Study|Physician Decision|0|||
145464698|NCT02558400|524552040|FG000|Overall Study|Protocol Violation|6|||
145464699|NCT02558400|524552041|FG001|Overall Study|Protocol Violation|3|||
145464700|NCT02558400|524552042|FG002|Overall Study|Protocol Violation|8|||
145464701|NCT02558400|524552040|FG000|Overall Study|Death|0|||
145464702|NCT02558400|524552041|FG001|Overall Study|Death|1|||
145464703|NCT02558400|524552042|FG002|Overall Study|Death|0|||
145464704|NCT02558400|524552040|FG000|Overall Study|Ineligible for the study|0|||
145464705|NCT02558400|524552041|FG001|Overall Study|Ineligible for the study|2|||
145464706|NCT02558400|524552042|FG002|Overall Study|Ineligible for the study|0|||
145464707|NCT00456599|524552043|FG000|Overall Study|Non-compliance|1|||
145464708|NCT00456599|524552043|FG000|Overall Study|Withdrawal by Subject|2|||
145489865|NCT05051579|524647621|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489866|NCT05051579|524647622|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489867|NCT05051579|524647623|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489868|NCT05051579|524647624|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489869|NCT05051579|524647625|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
145489870|NCT05051579|524647619|FG000|Overall Study|Sponsor Decision|0|||
145489871|NCT05051579|524647620|FG001|Overall Study|Sponsor Decision|0|||
145489872|NCT05051579|524647621|FG002|Overall Study|Sponsor Decision|0|||
145489873|NCT05051579|524647622|FG003|Overall Study|Sponsor Decision|0|||
145489874|NCT05051579|524647623|FG004|Overall Study|Sponsor Decision|1|||
145489875|NCT05051579|524647624|FG005|Overall Study|Sponsor Decision|0|||
145489876|NCT05051579|524647625|FG006|Overall Study|Sponsor Decision|0|||
145489877|NCT05051579|524647619|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145489878|NCT05051579|524647620|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145489879|NCT05051579|524647621|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145489880|NCT05051579|524647622|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145594884|NCT03151005|525030214|FG001|Overall Study|Lost to Follow-up|5|||
145464709|NCT00734071|524554060|FG000|Overall Study|Adverse Event|4|||
145464710|NCT00734071|524554061|FG001|Overall Study|Adverse Event|3|||
145464711|NCT00734071|524554060|FG000|Overall Study|Lack of Efficacy|3|||
145464712|NCT00734071|524554061|FG001|Overall Study|Lack of Efficacy|1|||
145464713|NCT00734071|524554060|FG000|Overall Study|Noncompliance|2|||
145464714|NCT00734071|524554061|FG001|Overall Study|Noncompliance|2|||
145464715|NCT00734071|524554060|FG000|Overall Study|Protocol Deviations|3|||
145464716|NCT00734071|524554061|FG001|Overall Study|Protocol Deviations|4|||
145464717|NCT00734071|524554060|FG000|Overall Study|Voluntary Withdrawal|9|||
145464718|NCT00734071|524554061|FG001|Overall Study|Voluntary Withdrawal|7|||
145464719|NCT00734071|524554060|FG000|Overall Study|Lost to Follow-up|16|||
145464720|NCT00734071|524554061|FG001|Overall Study|Lost to Follow-up|8|||
145464721|NCT00734071|524554060|FG000|Overall Study|Other|1|||
145464722|NCT00734071|524554061|FG001|Overall Study|Other|2|||
145464723|NCT00240110|524554062|FG000|Overall Study|Lost to Follow-up|6|||
145464724|NCT00240110|524554063|FG001|Overall Study|Lost to Follow-up|7|||
145464725|NCT00203021|524554064|FG000|Overall Study|Death|4|||
145464726|NCT00203021|524554065|FG001|Overall Study|Death|1|||
145464727|NCT00203021|524554064|FG000|Overall Study|Adverse Event|10|||
145464728|NCT00203021|524554065|FG001|Overall Study|Adverse Event|5|||
145464729|NCT00203021|524554064|FG000|Overall Study|Withdrawal by Subject|45|||
145464730|NCT00203021|524554065|FG001|Overall Study|Withdrawal by Subject|48|||
145464731|NCT00203021|524554064|FG000|Overall Study|Lost to Follow-up|9|||
145464732|NCT00203021|524554065|FG001|Overall Study|Lost to Follow-up|7|||
145464733|NCT00203021|524554064|FG000|Overall Study|Other than specified|11|||
145464734|NCT00203021|524554065|FG001|Overall Study|Other than specified|16|||
145464735|NCT02080260|524554066|FG000|Overall Study|Death|18|||
145464736|NCT02080260|524554066|FG000|Overall Study|Withdrawal by Subject|1|||
145464737|NCT03747120|524554071|FG000|Overall Study|treatment related toxicity|3|||
145464738|NCT03747120|524554072|FG001|Overall Study|treatment related toxicity|0|||
145464739|NCT03747120|524554073|FG002|Overall Study|treatment related toxicity|0|||
145464740|NCT03747120|524554071|FG000|Overall Study|Withdrawal by Subject|0|||
145464741|NCT03747120|524554072|FG001|Overall Study|Withdrawal by Subject|1|||
145464742|NCT03747120|524554073|FG002|Overall Study|Withdrawal by Subject|2|||
145464743|NCT03627065|524554074|FG000|Overall Study|Study Terminated by sponsor|1|||
145464744|NCT03627065|524554074|FG000|Overall Study|Withdrawal by Subject|2|||
145464745|NCT00289198|524554075|FG000|Overall Study|Adverse Event|0|||
145464746|NCT00289198|524554076|FG001|Overall Study|Adverse Event|2|||
145464747|NCT00289198|524554075|FG000|Overall Study|Protocol Violation|2|||
145464748|NCT00289198|524554076|FG001|Overall Study|Protocol Violation|1|||
145464749|NCT00289198|524554075|FG000|Overall Study|Withdrawal by Subject|4|||
145464750|NCT00289198|524554076|FG001|Overall Study|Withdrawal by Subject|1|||
145464751|NCT00289198|524554075|FG000|Overall Study|Lack of Efficacy|2|||
145464752|NCT00289198|524554076|FG001|Overall Study|Lack of Efficacy|0|||
145464753|NCT00289198|524554075|FG000|Overall Study|Other: Low compliance|0|||
145464754|NCT00289198|524554076|FG001|Overall Study|Other: Low compliance|1|||
145464755|NCT00289198|524554075|FG000|Overall Study|Other: Physician's decision|0|||
145464756|NCT00289198|524554076|FG001|Overall Study|Other: Physician's decision|1|||
145464757|NCT00289198|524554075|FG000|Overall Study|Other: Unable to attend on schedule|2|||
145464758|NCT00289198|524554076|FG001|Overall Study|Other: Unable to attend on schedule|1|||
145464759|NCT00289198|524554075|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
145464760|NCT00289198|524554076|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
145464761|NCT00289198|524554075|FG000|Overall Study|Other: Impossible to come on visit|0|||
145464762|NCT00289198|524554076|FG001|Overall Study|Other: Impossible to come on visit|1|||
145464763|NCT01266317|524554077|FG000|Overall Study|Withdrawal by Subject|2|||
145464764|NCT00490776|524554078|FG000|Overall Study|Withdrawal by Subject|1|||
145464765|NCT00490776|524554078|FG000|Overall Study|Administrative Problems|1|||
145464766|NCT00490776|524554078|FG000|Overall Study|Death|1|||
145464767|NCT00490776|524554078|FG000|Overall Study|New Cancer Therapy|1|||
145464768|NCT00490776|524554078|FG000|Overall Study|Disease Progression|5|||
145464769|NCT00046930|524554079|FG000|Overall Study|Ineligible|12|||
145464770|NCT00046930|524554080|FG001|Overall Study|Ineligible|4|||
145594885|NCT03318523|525030215|FG000|PC Period: Up to Year 1|Adverse Event|1|||
145464771|NCT01657760|524554081|FG000|Overall Study|Withdrawal by Subject|0|||
145464772|NCT01657760|524554082|FG001|Overall Study|Withdrawal by Subject|0|||
145594886|NCT03318523|525030216|FG001|PC Period: Up to Year 1|Adverse Event|0|||
145464773|NCT01657760|524554083|FG002|Overall Study|Withdrawal by Subject|0|||
145464774|NCT01657760|524554084|FG003|Overall Study|Withdrawal by Subject|1|||
145464775|NCT01657760|524554081|FG000|Overall Study|Physician Decision|1|||
145464776|NCT01657760|524554082|FG001|Overall Study|Physician Decision|1|||
145464777|NCT01657760|524554083|FG002|Overall Study|Physician Decision|1|||
145464778|NCT01657760|524554084|FG003|Overall Study|Physician Decision|2|||
145594887|NCT03318523|525030217|FG002|PC Period: Up to Year 1|Adverse Event|2|||
145464779|NCT01145053|524554086|FG000|Overall Study|Adverse Event|22|||
145464780|NCT01145053|524554086|FG000|Overall Study|Lost to Follow-up|28|||
145464781|NCT01145053|524554086|FG000|Overall Study|Withdrawal by Subject|25|||
145464782|NCT01145053|524554086|FG000|Overall Study|Other|18|||
145464783|NCT02088073|524554087|FG000|Acute Phase|Withdrawal by Subject|5|||
145594888|NCT03318523|525030218|FG003|PC Period: Up to Year 1|Adverse Event|0|||
145594889|NCT03318523|525030219|FG004|PC Period: Up to Year 1|Adverse Event|0|||
145594890|NCT03318523|525030220|FG005|PC Period: Up to Year 1|Adverse Event|0|||
145594891|NCT03318523|525030221|FG006|PC Period: Up to Year 1|Adverse Event|0|||
145594892|NCT03318523|525030222|FG007|PC Period: Up to Year 1|Adverse Event|0|||
145594893|NCT03318523|525030223|FG008|PC Period: Up to Year 1|Adverse Event|0|||
145594894|NCT03318523|525030224|FG009|PC Period: Up to Year 1|Adverse Event|0|||
145594895|NCT03318523|525030215|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
145594896|NCT03318523|525030216|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
145594897|NCT03318523|525030217|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594898|NCT03318523|525030218|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
145594899|NCT03318523|525030219|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594900|NCT03318523|525030220|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594901|NCT03318523|525030221|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594902|NCT03318523|525030222|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594903|NCT03318523|525030223|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594904|NCT03318523|525030224|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
145594905|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594906|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594907|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594908|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594909|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
145594910|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594911|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594912|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
145594913|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
145594914|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
145594915|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594916|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594917|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594918|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594919|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
145594920|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594921|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
145594922|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
145594923|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
145594924|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
145594925|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594926|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594927|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594928|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594929|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594930|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
145594931|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594932|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594933|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594934|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
145594935|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594936|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594937|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594938|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594939|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594940|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594941|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594942|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594943|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
145594944|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
145594945|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
145594946|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
145594947|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
145594948|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
145594949|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
145594950|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
145594951|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
145594952|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
145594953|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
145627000|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
145627001|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
145627002|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Death|3|||
145627003|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Death|0|||
145627004|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Death|0|||
145464784|NCT02088073|524554088|FG001|Acute Phase|Withdrawal by Subject|0|||
145464785|NCT02088073|524554089|FG002|Acute Phase|Withdrawal by Subject|0|||
145464786|NCT02088073|524554090|FG003|Acute Phase|Withdrawal by Subject|0|||
145464787|NCT02088073|524554091|FG004|Acute Phase|Withdrawal by Subject|0|||
145464788|NCT02088073|524554087|FG000|Acute Phase|Hyperkalemia|2|||
145464789|NCT02088073|524554088|FG001|Acute Phase|Hyperkalemia|0|||
145464790|NCT02088073|524554089|FG002|Acute Phase|Hyperkalemia|0|||
145464791|NCT02088073|524554090|FG003|Acute Phase|Hyperkalemia|0|||
145464792|NCT02088073|524554091|FG004|Acute Phase|Hyperkalemia|0|||
145464793|NCT02088073|524554087|FG000|Maintanance Phase|Withdrawal by Subject|0|||
145464794|NCT02088073|524554088|FG001|Maintanance Phase|Withdrawal by Subject|2|||
145464795|NCT02088073|524554089|FG002|Maintanance Phase|Withdrawal by Subject|0|||
145464796|NCT02088073|524554090|FG003|Maintanance Phase|Withdrawal by Subject|0|||
145464797|NCT02088073|524554091|FG004|Maintanance Phase|Withdrawal by Subject|0|||
145464798|NCT02088073|524554087|FG000|Maintanance Phase|Adverse Event|0|||
145464799|NCT02088073|524554088|FG001|Maintanance Phase|Adverse Event|0|||
145464800|NCT02088073|524554089|FG002|Maintanance Phase|Adverse Event|3|||
145464801|NCT02088073|524554090|FG003|Maintanance Phase|Adverse Event|0|||
145464802|NCT02088073|524554091|FG004|Maintanance Phase|Adverse Event|1|||
145464803|NCT02088073|524554087|FG000|Maintanance Phase|Physician Decision|0|||
145464804|NCT02088073|524554088|FG001|Maintanance Phase|Physician Decision|0|||
145464805|NCT02088073|524554089|FG002|Maintanance Phase|Physician Decision|0|||
145464806|NCT02088073|524554090|FG003|Maintanance Phase|Physician Decision|0|||
145464807|NCT02088073|524554091|FG004|Maintanance Phase|Physician Decision|1|||
145464808|NCT02088073|524554087|FG000|Maintanance Phase|Sponsor's decision|0|||
145464809|NCT02088073|524554088|FG001|Maintanance Phase|Sponsor's decision|2|||
145464810|NCT02088073|524554089|FG002|Maintanance Phase|Sponsor's decision|0|||
145464811|NCT02088073|524554090|FG003|Maintanance Phase|Sponsor's decision|2|||
145464812|NCT02088073|524554091|FG004|Maintanance Phase|Sponsor's decision|1|||
145464813|NCT02088073|524554087|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
145464814|NCT02088073|524554088|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
145464815|NCT02088073|524554089|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
145464816|NCT02088073|524554090|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
145464817|NCT02088073|524554091|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
145464818|NCT02088073|524554087|FG000|Maintanance Phase|Miscellaneous|0|||
145464819|NCT02088073|524554088|FG001|Maintanance Phase|Miscellaneous|2|||
145464820|NCT02088073|524554089|FG002|Maintanance Phase|Miscellaneous|1|||
145464821|NCT02088073|524554090|FG003|Maintanance Phase|Miscellaneous|2|||
145464822|NCT02088073|524554091|FG004|Maintanance Phase|Miscellaneous|1|||
145464823|NCT02088073|524554087|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
145464824|NCT02088073|524554088|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
145464825|NCT02088073|524554089|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
145464826|NCT02088073|524554090|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
145464827|NCT02088073|524554091|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
145464828|NCT02088073|524554087|FG000|Maintanance Phase|Subject compliance|0|||
145464829|NCT02088073|524554088|FG001|Maintanance Phase|Subject compliance|1|||
145464830|NCT02088073|524554089|FG002|Maintanance Phase|Subject compliance|0|||
145464831|NCT02088073|524554090|FG003|Maintanance Phase|Subject compliance|0|||
145464832|NCT02088073|524554091|FG004|Maintanance Phase|Subject compliance|0|||
145464833|NCT00520013|524554092|FG000|Overall Study|Withdrawal by Subject|0|||
145464834|NCT00520013|524554093|FG001|Overall Study|Withdrawal by Subject|0|||
145464835|NCT00520013|524554094|FG002|Overall Study|Withdrawal by Subject|1|||
145464836|NCT00520013|524554092|FG000|Overall Study|Adverse Event|2|||
145464837|NCT00520013|524554093|FG001|Overall Study|Adverse Event|10|||
145464838|NCT00520013|524554094|FG002|Overall Study|Adverse Event|7|||
145464839|NCT00520013|524554092|FG000|Overall Study|Progressive Disease|7|||
145464840|NCT00520013|524554093|FG001|Overall Study|Progressive Disease|3|||
145464841|NCT00520013|524554094|FG002|Overall Study|Progressive Disease|0|||
145464842|NCT00520013|524554092|FG000|Overall Study|Clinical Progression|3|||
145464843|NCT00520013|524554093|FG001|Overall Study|Clinical Progression|1|||
145464844|NCT00520013|524554094|FG002|Overall Study|Clinical Progression|0|||
145464845|NCT00520013|524554092|FG000|Overall Study|Death|0|||
145464846|NCT00520013|524554093|FG001|Overall Study|Death|1|||
145464847|NCT00520013|524554094|FG002|Overall Study|Death|0|||
145464848|NCT00520013|524554092|FG000|Overall Study|Physician Decision|0|||
145464849|NCT00520013|524554093|FG001|Overall Study|Physician Decision|0|||
145464850|NCT00520013|524554094|FG002|Overall Study|Physician Decision|3|||
145464851|NCT03684304|524554095|FG000|Overall Study|Lost to Follow-up|19|||
145464852|NCT03684304|524554096|FG001|Overall Study|Lost to Follow-up|17|||
145464853|NCT01009346|524554097|FG000|Overall Study|Adverse Event|4|||
145464854|NCT02266875|524554102|FG000|Overall Study|Withdrawal by Subject|9|||
145464855|NCT02266875|524554103|FG001|Overall Study|Withdrawal by Subject|0|||
145464856|NCT02266875|524554102|FG000|Overall Study|Lost to Follow-up|2|||
145464857|NCT02266875|524554103|FG001|Overall Study|Lost to Follow-up|0|||
145464858|NCT02956850|524554105|FG000|Overall Study|Withdrawal by Subject|0|||
145464859|NCT02956850|524554106|FG001|Overall Study|Withdrawal by Subject|0|||
145464860|NCT02956850|524554107|FG002|Overall Study|Withdrawal by Subject|0|||
145464861|NCT02956850|524554108|FG003|Overall Study|Withdrawal by Subject|0|||
145464862|NCT02956850|524554109|FG004|Overall Study|Withdrawal by Subject|0|||
145464863|NCT02956850|524554110|FG005|Overall Study|Withdrawal by Subject|0|||
145464864|NCT02956850|524554111|FG006|Overall Study|Withdrawal by Subject|0|||
145464865|NCT02956850|524554112|FG007|Overall Study|Withdrawal by Subject|0|||
145464866|NCT02956850|524554113|FG008|Overall Study|Withdrawal by Subject|0|||
145464867|NCT02956850|524554114|FG009|Overall Study|Withdrawal by Subject|0|||
145464868|NCT02956850|524554115|FG010|Overall Study|Withdrawal by Subject|0|||
145464869|NCT02956850|524554116|FG011|Overall Study|Withdrawal by Subject|0|||
145464870|NCT02956850|524554117|FG012|Overall Study|Withdrawal by Subject|0|||
145464871|NCT02956850|524554118|FG013|Overall Study|Withdrawal by Subject|0|||
145464872|NCT02956850|524554119|FG014|Overall Study|Withdrawal by Subject|0|||
145464873|NCT02956850|524554120|FG015|Overall Study|Withdrawal by Subject|0|||
145464874|NCT02956850|524554121|FG016|Overall Study|Withdrawal by Subject|0|||
145464875|NCT02956850|524554122|FG017|Overall Study|Withdrawal by Subject|1|||
145464876|NCT01920152|524554123|FG000|Overall Study|Withdrawal by Subject|1|||
145464877|NCT01920152|524554124|FG001|Overall Study|Withdrawal by Subject|2|||
145464878|NCT00849875|524554128|FG000|Overall Study|Death|28|||
145464879|NCT00849875|524554128|FG000|Overall Study|Ongoing (unknown completion status)|11|||
145464880|NCT00849875|524554128|FG000|Overall Study|Others|6|||
145464881|NCT00849875|524554128|FG000|Overall Study|Lost to Follow-up|2|||
145464882|NCT01304329|524554129|FG000|Third Intervention (3 Days)|Adverse Event|0|||
145464883|NCT01304329|524554130|FG001|Third Intervention (3 Days)|Adverse Event|1|||
145464884|NCT01304329|524554131|FG002|Third Intervention (3 Days)|Adverse Event|0|||
145464885|NCT01304329|524554132|FG003|Third Intervention (3 Days)|Adverse Event|0|||
145464886|NCT01304329|524554133|FG004|Third Intervention (3 Days)|Adverse Event|0|||
145464887|NCT01304329|524554134|FG005|Third Intervention (3 Days)|Adverse Event|0|||
145464888|NCT03515941|524554144|FG000|Overall Study|Adverse Event|1|||
145464889|NCT03515941|524554145|FG001|Overall Study|Adverse Event|0|||
145464890|NCT00276094|524554148|FG000|Overall Study|Adverse Event|15|||
145464891|NCT00276094|524554149|FG001|Overall Study|Adverse Event|13|||
145464892|NCT00276094|524554150|FG002|Overall Study|Adverse Event|11|||
145464893|NCT00276094|524554148|FG000|Overall Study|Withdrawal by Subject|14|||
145464894|NCT00276094|524554149|FG001|Overall Study|Withdrawal by Subject|14|||
145464895|NCT00276094|524554150|FG002|Overall Study|Withdrawal by Subject|12|||
145464896|NCT00276094|524554148|FG000|Overall Study|Protocol Violation|16|||
145464897|NCT00276094|524554149|FG001|Overall Study|Protocol Violation|7|||
145464898|NCT00276094|524554150|FG002|Overall Study|Protocol Violation|10|||
145464899|NCT00276094|524554148|FG000|Overall Study|Lost to Follow-up|8|||
145464900|NCT00276094|524554149|FG001|Overall Study|Lost to Follow-up|6|||
145464901|NCT00276094|524554150|FG002|Overall Study|Lost to Follow-up|4|||
145464902|NCT00276094|524554148|FG000|Overall Study|Other-Subject moved out of country|1|||
145464903|NCT00276094|524554149|FG001|Overall Study|Other-Subject moved out of country|0|||
145464904|NCT00276094|524554150|FG002|Overall Study|Other-Subject moved out of country|0|||
145464905|NCT00276094|524554148|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
145464906|NCT00276094|524554149|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
145464907|NCT00276094|524554150|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
145464908|NCT00276094|524554148|FG000|Overall Study|Other-Lack of efficacy|1|||
145464909|NCT00276094|524554149|FG001|Overall Study|Other-Lack of efficacy|0|||
145464910|NCT00276094|524554150|FG002|Overall Study|Other-Lack of efficacy|0|||
145464911|NCT00276094|524554148|FG000|Overall Study|Other-Refused follow-up visit|1|||
145464912|NCT00276094|524554149|FG001|Overall Study|Other-Refused follow-up visit|0|||
145464913|NCT00276094|524554150|FG002|Overall Study|Other-Refused follow-up visit|0|||
145464914|NCT00276094|524554148|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
145464915|NCT00276094|524554149|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
145464916|NCT00276094|524554150|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
145464917|NCT00276094|524554148|FG000|Overall Study|Other-Relocation|0|||
145464918|NCT00276094|524554149|FG001|Overall Study|Other-Relocation|1|||
145464919|NCT00276094|524554150|FG002|Overall Study|Other-Relocation|0|||
145464920|NCT00276094|524554148|FG000|Overall Study|Other-Study medication lost|0|||
145464921|NCT00276094|524554149|FG001|Overall Study|Other-Study medication lost|0|||
145464922|NCT00276094|524554150|FG002|Overall Study|Other-Study medication lost|1|||
145464923|NCT02759315|524554151|FG000|Overall Study|Adverse Event|0|||
145464924|NCT02759315|524554152|FG001|Overall Study|Adverse Event|0|||
145464925|NCT02759315|524554153|FG002|Overall Study|Adverse Event|0|||
145464926|NCT02759315|524554154|FG003|Overall Study|Adverse Event|1|||
145464927|NCT02759315|524554155|FG004|Overall Study|Adverse Event|0|||
145464928|NCT02759315|524554151|FG000|Overall Study|Death|0|||
145464929|NCT02759315|524554152|FG001|Overall Study|Death|0|||
145464930|NCT02759315|524554153|FG002|Overall Study|Death|1|||
145464931|NCT02759315|524554154|FG003|Overall Study|Death|0|||
145464932|NCT02759315|524554155|FG004|Overall Study|Death|0|||
145594954|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
145594955|NCT03318523|525030215|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594956|NCT03318523|525030216|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594957|NCT03318523|525030217|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594958|NCT03318523|525030218|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594959|NCT03318523|525030219|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
145594960|NCT03318523|525030220|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594961|NCT03318523|525030221|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594962|NCT03318523|525030222|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
145594963|NCT03318523|525030223|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
145594964|NCT03318523|525030224|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
145594965|NCT03232983|525030227|FG000|Period 1|Physician Decision|0|||
145594966|NCT03232983|525030228|FG001|Period 1|Physician Decision|0|||
145594967|NCT03232983|525030229|FG002|Period 1|Physician Decision|1|||
145594968|NCT03232983|525030230|FG003|Period 1|Physician Decision|0|||
145594969|NCT03232983|525030227|FG000|Washout Period 2|Physician Decision|0|||
145594970|NCT03232983|525030228|FG001|Washout Period 2|Physician Decision|0|||
145594971|NCT03232983|525030229|FG002|Washout Period 2|Physician Decision|1|||
145594972|NCT03232983|525030230|FG003|Washout Period 2|Physician Decision|0|||
145594973|NCT03232983|525030227|FG000|Washout Period 2|Withdrawal by Subject|0|||
145594974|NCT03232983|525030228|FG001|Washout Period 2|Withdrawal by Subject|0|||
145594975|NCT03232983|525030229|FG002|Washout Period 2|Withdrawal by Subject|0|||
145594976|NCT03232983|525030230|FG003|Washout Period 2|Withdrawal by Subject|1|||
145594977|NCT03232983|525030227|FG000|Period 4|Withdrawal by Subject|1|||
145594978|NCT03232983|525030228|FG001|Period 4|Withdrawal by Subject|0|||
145594979|NCT03232983|525030229|FG002|Period 4|Withdrawal by Subject|0|||
145594980|NCT03232983|525030230|FG003|Period 4|Withdrawal by Subject|0|||
145594981|NCT01615328|525030231|FG000|Overall Study|Lost to Follow-up|3|||
145594982|NCT01615328|525030232|FG001|Overall Study|Lost to Follow-up|5|||
145594983|NCT00863655|525030233|FG000|Overall Study|Protocol Violation|4|||
145594984|NCT00863655|525030234|FG001|Overall Study|Protocol Violation|0|||
145594985|NCT00863655|525030233|FG000|Overall Study|Adverse Event|52|||
145594986|NCT00863655|525030234|FG001|Overall Study|Adverse Event|8|||
145594987|NCT00863655|525030233|FG000|Overall Study|Withdrawal by Subject|47|||
145594988|NCT00863655|525030234|FG001|Overall Study|Withdrawal by Subject|7|||
145594989|NCT00863655|525030233|FG000|Overall Study|Administrative problems|1|||
145594990|NCT00863655|525030234|FG001|Overall Study|Administrative problems|0|||
145594991|NCT00863655|525030233|FG000|Overall Study|Death|7|||
145594992|NCT00863655|525030234|FG001|Overall Study|Death|1|||
145594993|NCT00863655|525030233|FG000|Overall Study|New cancer therapy|5|||
145594994|NCT00863655|525030234|FG001|Overall Study|New cancer therapy|1|||
145594995|NCT00863655|525030233|FG000|Overall Study|Disease progression|364|||
145594996|NCT00863655|525030234|FG001|Overall Study|Disease progression|221|||
145594997|NCT00863655|525030233|FG000|Overall Study|Treatment completed as per protocol|5|||
145594998|NCT00863655|525030234|FG001|Overall Study|Treatment completed as per protocol|1|||
145594999|NCT02794285|525030235|FG000|Overall Study|Adverse Event|11|||
145595000|NCT02794285|525030236|FG001|Overall Study|Adverse Event|4|||
145595001|NCT02794285|525030237|FG002|Overall Study|Adverse Event|5|||
145595002|NCT02794285|525030238|FG003|Overall Study|Adverse Event|8|||
145595003|NCT02794285|525030235|FG000|Overall Study|Condition Under Investigation Improved|1|||
145595004|NCT02794285|525030236|FG001|Overall Study|Condition Under Investigation Improved|0|||
145595005|NCT02794285|525030237|FG002|Overall Study|Condition Under Investigation Improved|0|||
145595006|NCT02794285|525030238|FG003|Overall Study|Condition Under Investigation Improved|0|||
145595007|NCT02794285|525030235|FG000|Overall Study|Condition Under Investigation Worsened|0|||
145595008|NCT02794285|525030236|FG001|Overall Study|Condition Under Investigation Worsened|2|||
145595009|NCT02794285|525030237|FG002|Overall Study|Condition Under Investigation Worsened|1|||
145595010|NCT02794285|525030238|FG003|Overall Study|Condition Under Investigation Worsened|0|||
145595011|NCT02794285|525030235|FG000|Overall Study|Death|2|||
145595012|NCT02794285|525030236|FG001|Overall Study|Death|1|||
145595013|NCT02794285|525030237|FG002|Overall Study|Death|2|||
145595014|NCT02794285|525030238|FG003|Overall Study|Death|0|||
145595015|NCT02794285|525030235|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
145595016|NCT02794285|525030236|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
145464933|NCT02759315|524554151|FG000|Overall Study|Lost to Follow-up|2|||
145464934|NCT02759315|524554152|FG001|Overall Study|Lost to Follow-up|0|||
145595017|NCT02794285|525030237|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
145595018|NCT02794285|525030238|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
145595019|NCT02794285|525030235|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
145595020|NCT02794285|525030236|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
145595021|NCT02794285|525030237|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
145595022|NCT02794285|525030238|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
145595023|NCT02794285|525030235|FG000|Overall Study|Lack of Efficacy|10|||
145595024|NCT02794285|525030236|FG001|Overall Study|Lack of Efficacy|6|||
145464935|NCT02759315|524554153|FG002|Overall Study|Lost to Follow-up|4|||
145595025|NCT02794285|525030237|FG002|Overall Study|Lack of Efficacy|3|||
145595026|NCT02794285|525030238|FG003|Overall Study|Lack of Efficacy|3|||
145595027|NCT02794285|525030235|FG000|Overall Study|Lost to Follow-up|5|||
145595028|NCT02794285|525030236|FG001|Overall Study|Lost to Follow-up|6|||
145595029|NCT02794285|525030237|FG002|Overall Study|Lost to Follow-up|3|||
145595030|NCT02794285|525030238|FG003|Overall Study|Lost to Follow-up|1|||
145595031|NCT02794285|525030235|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
145595032|NCT02794285|525030236|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
145595033|NCT02794285|525030237|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
145595034|NCT02794285|525030238|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
145595035|NCT02794285|525030235|FG000|Overall Study|Withdrawal by Subject|38|||
145595036|NCT02794285|525030236|FG001|Overall Study|Withdrawal by Subject|29|||
145595037|NCT02794285|525030237|FG002|Overall Study|Withdrawal by Subject|20|||
145595038|NCT02794285|525030238|FG003|Overall Study|Withdrawal by Subject|12|||
145595039|NCT02794285|525030235|FG000|Overall Study|Missing|1|||
145595040|NCT02794285|525030236|FG001|Overall Study|Missing|0|||
145595041|NCT02794285|525030237|FG002|Overall Study|Missing|0|||
145595042|NCT02794285|525030238|FG003|Overall Study|Missing|0|||
145595043|NCT02794285|525030235|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
145595044|NCT02794285|525030236|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
145595045|NCT02794285|525030237|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
145595046|NCT02794285|525030238|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
145595047|NCT02794285|525030235|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
145595048|NCT02794285|525030236|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
145595049|NCT02794285|525030237|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
145595050|NCT02794285|525030238|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
145595051|NCT03252587|525030239|FG000|Overall Study|Adverse Event|3|||
145595052|NCT03252587|525030240|FG001|Overall Study|Adverse Event|8|||
145595053|NCT03252587|525030241|FG002|Overall Study|Adverse Event|6|||
145595054|NCT03252587|525030242|FG003|Overall Study|Adverse Event|12|||
145595055|NCT03252587|525030239|FG000|Overall Study|Lack of Efficacy|7|||
145595056|NCT03252587|525030240|FG001|Overall Study|Lack of Efficacy|2|||
145595057|NCT03252587|525030241|FG002|Overall Study|Lack of Efficacy|2|||
145595058|NCT03252587|525030242|FG003|Overall Study|Lack of Efficacy|4|||
145595059|NCT03252587|525030239|FG000|Overall Study|Lost to Follow-up|2|||
145595060|NCT03252587|525030240|FG001|Overall Study|Lost to Follow-up|0|||
145595061|NCT03252587|525030241|FG002|Overall Study|Lost to Follow-up|0|||
145595062|NCT03252587|525030242|FG003|Overall Study|Lost to Follow-up|2|||
145595063|NCT03252587|525030239|FG000|Overall Study|Pregnancy|2|||
145595064|NCT03252587|525030240|FG001|Overall Study|Pregnancy|1|||
145595065|NCT03252587|525030241|FG002|Overall Study|Pregnancy|0|||
145595066|NCT03252587|525030242|FG003|Overall Study|Pregnancy|1|||
145595067|NCT03252587|525030239|FG000|Overall Study|Withdrawal by Subject|8|||
145595068|NCT03252587|525030240|FG001|Overall Study|Withdrawal by Subject|4|||
145595069|NCT03252587|525030241|FG002|Overall Study|Withdrawal by Subject|4|||
145595070|NCT03252587|525030242|FG003|Overall Study|Withdrawal by Subject|4|||
145595071|NCT03252587|525030239|FG000|Overall Study|Other Reasons|2|||
145595072|NCT03252587|525030240|FG001|Overall Study|Other Reasons|5|||
145595073|NCT03252587|525030241|FG002|Overall Study|Other Reasons|5|||
145595074|NCT03252587|525030242|FG003|Overall Study|Other Reasons|4|||
145595075|NCT00423176|525030246|FG000|Overall Study|Adverse Event|4|||
145595076|NCT00423176|525030247|FG001|Overall Study|Adverse Event|6|||
145595077|NCT00423176|525030246|FG000|Overall Study|Treatment Failure|1|||
145595078|NCT00423176|525030247|FG001|Overall Study|Treatment Failure|6|||
145595079|NCT00423176|525030246|FG000|Overall Study|Lost to Follow-up|4|||
145464936|NCT02759315|524554154|FG003|Overall Study|Lost to Follow-up|0|||
145464937|NCT02759315|524554155|FG004|Overall Study|Lost to Follow-up|0|||
145464938|NCT02759315|524554151|FG000|Overall Study|Protocol Violation|0|||
145464939|NCT02759315|524554152|FG001|Overall Study|Protocol Violation|1|||
145464940|NCT02759315|524554153|FG002|Overall Study|Protocol Violation|0|||
145464941|NCT02759315|524554154|FG003|Overall Study|Protocol Violation|0|||
145464942|NCT02759315|524554155|FG004|Overall Study|Protocol Violation|0|||
145464943|NCT02759315|524554151|FG000|Overall Study|Study terminated prior to completion|2|||
145464944|NCT02759315|524554152|FG001|Overall Study|Study terminated prior to completion|0|||
145595080|NCT00423176|525030247|FG001|Overall Study|Lost to Follow-up|7|||
145595081|NCT00423176|525030246|FG000|Overall Study|Withdrawal by Subject|4|||
145595082|NCT00423176|525030247|FG001|Overall Study|Withdrawal by Subject|3|||
145595083|NCT00423176|525030246|FG000|Overall Study|Protocol Violation|1|||
145595084|NCT00423176|525030247|FG001|Overall Study|Protocol Violation|3|||
145595085|NCT00423176|525030246|FG000|Overall Study|Did not meet protocol eligibility|2|||
145595086|NCT00423176|525030247|FG001|Overall Study|Did not meet protocol eligibility|4|||
145595087|NCT05072080|525030248|FG000|Overall Study|Death|0|||
145464945|NCT02759315|524554153|FG002|Overall Study|Study terminated prior to completion|5|||
145595088|NCT05072080|525030249|FG001|Overall Study|Death|0|||
145595089|NCT05072080|525030250|FG002|Overall Study|Death|1|||
145595090|NCT05072080|525030251|FG003|Overall Study|Death|0|||
145595091|NCT05072080|525030248|FG000|Overall Study|Lost to Follow-up|65|||
145464946|NCT02759315|524554154|FG003|Overall Study|Study terminated prior to completion|0|||
145595092|NCT05072080|525030249|FG001|Overall Study|Lost to Follow-up|70|||
145595093|NCT05072080|525030250|FG002|Overall Study|Lost to Follow-up|58|||
145595094|NCT05072080|525030251|FG003|Overall Study|Lost to Follow-up|23|||
145595095|NCT05072080|525030248|FG000|Overall Study|Physician Decision|2|||
145595096|NCT05072080|525030249|FG001|Overall Study|Physician Decision|1|||
145595097|NCT05072080|525030250|FG002|Overall Study|Physician Decision|1|||
145595098|NCT05072080|525030251|FG003|Overall Study|Physician Decision|0|||
145595099|NCT05072080|525030248|FG000|Overall Study|Withdrawal by Subject|45|||
145595100|NCT05072080|525030249|FG001|Overall Study|Withdrawal by Subject|30|||
145595101|NCT05072080|525030250|FG002|Overall Study|Withdrawal by Subject|27|||
145595102|NCT05072080|525030251|FG003|Overall Study|Withdrawal by Subject|7|||
145595103|NCT05072080|525030248|FG000|Overall Study|Sponsor Decision|0|||
145595104|NCT05072080|525030249|FG001|Overall Study|Sponsor Decision|1|||
145595105|NCT05072080|525030250|FG002|Overall Study|Sponsor Decision|0|||
145595106|NCT05072080|525030251|FG003|Overall Study|Sponsor Decision|0|||
145595107|NCT05072080|525030248|FG000|Overall Study|Subject moved|1|||
145595108|NCT05072080|525030249|FG001|Overall Study|Subject moved|3|||
145595109|NCT05072080|525030250|FG002|Overall Study|Subject moved|5|||
145595110|NCT05072080|525030251|FG003|Overall Study|Subject moved|2|||
145595111|NCT05072080|525030248|FG000|Overall Study|Withdrawal by parent|0|||
145595112|NCT05072080|525030249|FG001|Overall Study|Withdrawal by parent|0|||
145595113|NCT05072080|525030250|FG002|Overall Study|Withdrawal by parent|1|||
145595114|NCT05072080|525030251|FG003|Overall Study|Withdrawal by parent|0|||
145595115|NCT05072080|525030248|FG000|Overall Study|Subject was deployed|0|||
145595116|NCT05072080|525030249|FG001|Overall Study|Subject was deployed|1|||
145595117|NCT05072080|525030250|FG002|Overall Study|Subject was deployed|0|||
145595118|NCT05072080|525030251|FG003|Overall Study|Subject was deployed|0|||
145595119|NCT05072080|525030248|FG000|Overall Study|Subject left site without receiving dose|0|||
145595120|NCT05072080|525030249|FG001|Overall Study|Subject left site without receiving dose|1|||
145595121|NCT05072080|525030250|FG002|Overall Study|Subject left site without receiving dose|0|||
145595122|NCT05072080|525030251|FG003|Overall Study|Subject left site without receiving dose|0|||
145595123|NCT05072080|525030248|FG000|Overall Study|Subject incarcerated|0|||
145595124|NCT05072080|525030249|FG001|Overall Study|Subject incarcerated|1|||
145595125|NCT05072080|525030250|FG002|Overall Study|Subject incarcerated|0|||
145595126|NCT05072080|525030251|FG003|Overall Study|Subject incarcerated|1|||
145595127|NCT05072080|525030248|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
145595128|NCT05072080|525030249|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
145595129|NCT05072080|525030250|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
145595130|NCT05072080|525030251|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
145595131|NCT05072080|525030248|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
145595132|NCT05072080|525030249|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
145595133|NCT05072080|525030250|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
145595134|NCT05072080|525030251|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
145595135|NCT01640808|525030253|FG000|Overall Study|Unable to continue dynamic CT|14|||
145595136|NCT01640808|525030254|FG001|Overall Study|Unable to continue dynamic CT|4|||
145595137|NCT01640808|525030253|FG000|Overall Study|Withdrawal by Subject|12|||
145595138|NCT01640808|525030254|FG001|Overall Study|Withdrawal by Subject|4|||
145595139|NCT01640808|525030253|FG000|Overall Study|Lost to Follow-up|4|||
145595140|NCT01640808|525030254|FG001|Overall Study|Lost to Follow-up|0|||
145595141|NCT01640808|525030253|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
145595142|NCT01640808|525030254|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
145595143|NCT01640808|525030253|FG000|Overall Study|Administration of anticancer drugs|2|||
145595144|NCT01640808|525030254|FG001|Overall Study|Administration of anticancer drugs|1|||
145595145|NCT01640808|525030253|FG000|Overall Study|Physician Decision|19|||
145595146|NCT01640808|525030254|FG001|Overall Study|Physician Decision|5|||
145595147|NCT01640808|525030253|FG000|Overall Study|Randomized but not treated|4|||
145595148|NCT01640808|525030254|FG001|Overall Study|Randomized but not treated|2|||
145595149|NCT02192502|525030256|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
145595150|NCT02192502|525030257|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
145595151|NCT02192502|525030256|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
145595152|NCT02192502|525030257|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
145464947|NCT02759315|524554155|FG004|Overall Study|Study terminated prior to completion|1|||
145464948|NCT01406015|524554158|FG000|Overall Study|Withdrawal by Subject|3|||
145595153|NCT02192502|525030256|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
145595154|NCT02192502|525030257|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
145595155|NCT01381692|525030258|FG000|Overall Study|Adverse Event|1|||
145595156|NCT01381692|525030259|FG001|Overall Study|Adverse Event|0|||
145595157|NCT01381692|525030260|FG002|Overall Study|Adverse Event|0|||
145595158|NCT01381692|525030261|FG003|Overall Study|Adverse Event|0|||
145595159|NCT01381692|525030262|FG004|Overall Study|Adverse Event|0|||
145595160|NCT01381692|525030263|FG005|Overall Study|Adverse Event|0|||
145595161|NCT03896035|525030264|FG000|Overall Study|Lost to Follow-up|2|||
145595162|NCT03896035|525030265|FG001|Overall Study|Lost to Follow-up|6|||
145595163|NCT03896035|525030264|FG000|Overall Study|Withdrawal by Subject|0|||
145595164|NCT03896035|525030265|FG001|Overall Study|Withdrawal by Subject|1|||
145595165|NCT03896035|525030264|FG000|Overall Study|Health/family health issues during COVID|0|||
145595166|NCT03896035|525030265|FG001|Overall Study|Health/family health issues during COVID|4|||
145595167|NCT01506193|525030268|FG000|Overall Study|Protocol Violation|1|||
145595168|NCT01506193|525030269|FG001|Overall Study|Protocol Violation|0|||
145595169|NCT01506193|525030270|FG002|Overall Study|Protocol Violation|1|||
145595170|NCT01506193|525030268|FG000|Overall Study|Migrated/moved from study area|0|||
145595171|NCT01506193|525030269|FG001|Overall Study|Migrated/moved from study area|0|||
145595172|NCT01506193|525030270|FG002|Overall Study|Migrated/moved from study area|1|||
145595173|NCT01506193|525030268|FG000|Overall Study|Adverse event, non-fatal|0|||
145595174|NCT01506193|525030269|FG001|Overall Study|Adverse event, non-fatal|0|||
145595175|NCT01506193|525030270|FG002|Overall Study|Adverse event, non-fatal|1|||
145595176|NCT01506193|525030268|FG000|Overall Study|Withdrawal by Subject|5|||
145595177|NCT01506193|525030269|FG001|Overall Study|Withdrawal by Subject|1|||
145595178|NCT01506193|525030270|FG002|Overall Study|Withdrawal by Subject|8|||
145595179|NCT01506193|525030268|FG000|Overall Study|Lost to Follow-up|8|||
145595180|NCT01506193|525030269|FG001|Overall Study|Lost to Follow-up|3|||
145595181|NCT01506193|525030270|FG002|Overall Study|Lost to Follow-up|3|||
145595182|NCT01328574|525030274|FG000|Overall Study|Refused further treatment|1|||
145595183|NCT01152580|525030277|FG000|Overall Study|Withdrawal by Subject|0|||
145595184|NCT01152580|525030278|FG001|Overall Study|Withdrawal by Subject|1|||
145595185|NCT00113568|525030286|FG000|Overall Study|Adverse Event|97|||
145595186|NCT00113568|525030286|FG000|Overall Study|Death|1|||
145595187|NCT00113568|525030286|FG000|Overall Study|Lack of Efficacy|30|||
145595188|NCT00113568|525030286|FG000|Overall Study|Lost to Follow-up|156|||
145595189|NCT00113568|525030286|FG000|Overall Study|Protocol Violation|32|||
145595190|NCT00113568|525030286|FG000|Overall Study|Withdrawal by Subject|117|||
145595191|NCT00113568|525030286|FG000|Overall Study|Other|112|||
145595192|NCT01988779|525030287|FG000|Overall Study|Withdrawal by Subject|2|||
145595193|NCT01988779|525030288|FG001|Overall Study|Withdrawal by Subject|2|||
145595194|NCT01988779|525030287|FG000|Overall Study|Protocol Violation|1|||
145595195|NCT01988779|525030288|FG001|Overall Study|Protocol Violation|0|||
145595196|NCT00736645|525030289|FG000|Overall Study|Adverse Event|0|||
145595197|NCT00736645|525030290|FG001|Overall Study|Adverse Event|2|||
145595198|NCT00736645|525030291|FG002|Overall Study|Adverse Event|0|||
145595199|NCT00736645|525030292|FG003|Overall Study|Adverse Event|0|||
145595200|NCT03792126|525030295|FG000|Overall Study|Adverse Event|1|||
145595201|NCT03792126|525030296|FG001|Overall Study|Adverse Event|2|||
145595202|NCT03792126|525030295|FG000|Overall Study|Death|0|||
145595203|NCT03792126|525030296|FG001|Overall Study|Death|1|||
145595204|NCT03792126|525030295|FG000|Overall Study|Lost to Follow-up|1|||
145595205|NCT03792126|525030296|FG001|Overall Study|Lost to Follow-up|0|||
145595206|NCT03792126|525030295|FG000|Overall Study|Withdrawal by Subject|0|||
145595207|NCT03792126|525030296|FG001|Overall Study|Withdrawal by Subject|1|||
145595208|NCT03792126|525030295|FG000|Overall Study|COVID-19 Restrictions|1|||
145595209|NCT03792126|525030296|FG001|Overall Study|COVID-19 Restrictions|3|||
145595210|NCT03792126|525030295|FG000|Overall Study|Symptoms resolved|0|||
145595211|NCT03792126|525030296|FG001|Overall Study|Symptoms resolved|3|||
145595212|NCT00441090|525030298|FG000|Overall Study|Adverse Event|0|||
145595213|NCT00441090|525030299|FG001|Overall Study|Adverse Event|1|||
145595214|NCT00441090|525030300|FG002|Overall Study|Adverse Event|1|||
145595215|NCT00441090|525030301|FG003|Overall Study|Adverse Event|0|||
145595216|NCT00441090|525030302|FG004|Overall Study|Adverse Event|0|||
145595217|NCT00441090|525030298|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
145595218|NCT00441090|525030299|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
145595219|NCT00441090|525030300|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
145595220|NCT00441090|525030301|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
145595221|NCT00441090|525030302|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
145595222|NCT00441090|525030298|FG000|Overall Study|Withdrawal by Subject|1|||
145595223|NCT00441090|525030299|FG001|Overall Study|Withdrawal by Subject|0|||
145595224|NCT00441090|525030300|FG002|Overall Study|Withdrawal by Subject|1|||
145595225|NCT00441090|525030301|FG003|Overall Study|Withdrawal by Subject|0|||
145595226|NCT00441090|525030302|FG004|Overall Study|Withdrawal by Subject|0|||
145595227|NCT00441090|525030298|FG000|Overall Study|Lack of Efficacy|1|||
145595228|NCT00441090|525030299|FG001|Overall Study|Lack of Efficacy|0|||
145595229|NCT00441090|525030300|FG002|Overall Study|Lack of Efficacy|0|||
145595230|NCT00441090|525030301|FG003|Overall Study|Lack of Efficacy|0|||
145595231|NCT00441090|525030302|FG004|Overall Study|Lack of Efficacy|0|||
145595232|NCT01441102|525030303|FG000|Overall Study|Adverse Event|1|||
145595233|NCT01441102|525030303|FG000|Overall Study|Withdrawal by Subject|2|||
145595234|NCT00518115|525030304|FG000|Overall Study|Adverse Event|6|||
145595235|NCT00518115|525030305|FG001|Overall Study|Adverse Event|1|||
145595236|NCT00518115|525030306|FG002|Overall Study|Adverse Event|5|||
145595237|NCT00518115|525030307|FG003|Overall Study|Adverse Event|6|||
145595238|NCT00518115|525030308|FG004|Overall Study|Adverse Event|5|||
145595239|NCT00518115|525030309|FG005|Overall Study|Adverse Event|5|||
145464949|NCT01406015|524554159|FG001|Overall Study|Withdrawal by Subject|3|||
145464950|NCT00787137|524554160|FG000|Overall Study|Study Termination|0|||
145464951|NCT00787137|524554161|FG001|Overall Study|Study Termination|0|||
145464952|NCT00787137|524554162|FG002|Overall Study|Study Termination|1|||
145464953|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
145464954|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
145464955|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
145464956|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
145464957|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
145464958|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
145464959|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
145464960|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
145464961|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
145464962|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
145464963|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
145464964|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
145464965|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
145464966|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
145464967|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
145464968|NCT00554099|524554166|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
145464969|NCT00554099|524554167|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
145464970|NCT00554099|524554168|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
145464971|NCT00554099|524554166|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
145464972|NCT00554099|524554167|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
145464973|NCT00554099|524554168|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
145464974|NCT00554099|524554166|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
145464975|NCT00554099|524554167|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
145464976|NCT00554099|524554168|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
145464977|NCT00554099|524554166|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
145464978|NCT00554099|524554167|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
145464979|NCT00554099|524554168|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
145464980|NCT02075632|524554172|FG000|Overall Study|Adverse Event|1|||
145464981|NCT02075632|524554173|FG001|Overall Study|Adverse Event|1|||
145464982|NCT02075632|524554172|FG000|Overall Study|Lost to Follow-up|0|||
145464983|NCT02075632|524554173|FG001|Overall Study|Lost to Follow-up|3|||
145464984|NCT02075632|524554172|FG000|Overall Study|Withdrawal by Subject|0|||
145464985|NCT02075632|524554173|FG001|Overall Study|Withdrawal by Subject|1|||
145464986|NCT01628367|524554178|FG000|Overall Study|Adverse Event|1|||
145464987|NCT01628367|524554179|FG001|Overall Study|Adverse Event|0|||
145464988|NCT03353922|524554180|FG000|Overall Study|Withdrawal by Subject|1|||
145464989|NCT03353922|524554181|FG001|Overall Study|Withdrawal by Subject|0|||
145464990|NCT03353922|524554182|FG002|Overall Study|Withdrawal by Subject|1|||
145464991|NCT03353922|524554183|FG003|Overall Study|Withdrawal by Subject|1|||
145464992|NCT03353922|524554184|FG004|Overall Study|Withdrawal by Subject|0|||
145464993|NCT03353922|524554185|FG005|Overall Study|Withdrawal by Subject|0|||
145464994|NCT03353922|524554180|FG000|Overall Study|Adverse Event|0|||
145464995|NCT03353922|524554181|FG001|Overall Study|Adverse Event|1|||
145464996|NCT03353922|524554182|FG002|Overall Study|Adverse Event|0|||
145464997|NCT03353922|524554183|FG003|Overall Study|Adverse Event|0|||
145464998|NCT03353922|524554184|FG004|Overall Study|Adverse Event|0|||
145464999|NCT03353922|524554185|FG005|Overall Study|Adverse Event|0|||
145465000|NCT00740714|524554186|FG000|Overall Study|Withdrawal by Subject|17|||
145465001|NCT00740714|524554187|FG001|Overall Study|Withdrawal by Subject|19|||
145465002|NCT00740714|524554188|FG002|Overall Study|Withdrawal by Subject|29|||
145465003|NCT03688555|524554189|FG000|Treatment Period|Adverse Event|0|||
145465004|NCT03688555|524554190|FG001|Treatment Period|Adverse Event|0|||
145465005|NCT03688555|524554191|FG002|Treatment Period|Adverse Event|1|||
145465006|NCT00886119|524554196|FG000|Period 1|Did not meet inclusion criteria|1|||
145465007|NCT00886119|524554197|FG001|Period 1|Did not meet inclusion criteria|0|||
145465008|NCT00394901|524554198|FG000|Baseline Phase|Protocol Violation|0|||
145465009|NCT00394901|524554199|FG001|Baseline Phase|Protocol Violation|0|||
145465010|NCT00394901|524554200|FG002|Baseline Phase|Protocol Violation|1|||
145465011|NCT00394901|524554201|FG003|Baseline Phase|Protocol Violation|0|||
145465012|NCT00394901|524554198|FG000|Double-blind Phase|Adverse Event|5|||
145465013|NCT00394901|524554199|FG001|Double-blind Phase|Adverse Event|7|||
145465014|NCT00394901|524554200|FG002|Double-blind Phase|Adverse Event|16|||
145465015|NCT00394901|524554201|FG003|Double-blind Phase|Adverse Event|20|||
145465016|NCT00394901|524554198|FG000|Double-blind Phase|Lack of Efficacy|6|||
145465017|NCT00394901|524554199|FG001|Double-blind Phase|Lack of Efficacy|4|||
145465018|NCT00394901|524554200|FG002|Double-blind Phase|Lack of Efficacy|1|||
145465019|NCT00394901|524554201|FG003|Double-blind Phase|Lack of Efficacy|3|||
145465020|NCT00394901|524554198|FG000|Double-blind Phase|Withdrawal by Subject|2|||
145465021|NCT00394901|524554199|FG001|Double-blind Phase|Withdrawal by Subject|0|||
145465022|NCT00394901|524554200|FG002|Double-blind Phase|Withdrawal by Subject|0|||
145465023|NCT00394901|524554201|FG003|Double-blind Phase|Withdrawal by Subject|0|||
145595240|NCT00518115|525030310|FG006|Overall Study|Adverse Event|5|||
145595241|NCT00518115|525030311|FG007|Overall Study|Adverse Event|10|||
145595242|NCT00518115|525030312|FG008|Overall Study|Adverse Event|2|||
145595243|NCT00518115|525030313|FG009|Overall Study|Adverse Event|9|||
145595244|NCT00518115|525030304|FG000|Overall Study|Lost to Follow-up|0|||
145595245|NCT00518115|525030305|FG001|Overall Study|Lost to Follow-up|0|||
145595246|NCT00518115|525030306|FG002|Overall Study|Lost to Follow-up|2|||
145595247|NCT00518115|525030307|FG003|Overall Study|Lost to Follow-up|3|||
145595248|NCT00518115|525030308|FG004|Overall Study|Lost to Follow-up|1|||
145595249|NCT00518115|525030309|FG005|Overall Study|Lost to Follow-up|3|||
145595250|NCT00518115|525030310|FG006|Overall Study|Lost to Follow-up|0|||
145595251|NCT00518115|525030311|FG007|Overall Study|Lost to Follow-up|1|||
145595252|NCT00518115|525030312|FG008|Overall Study|Lost to Follow-up|1|||
145595253|NCT00518115|525030313|FG009|Overall Study|Lost to Follow-up|1|||
145595254|NCT00518115|525030304|FG000|Overall Study|Protocol Violation|1|||
145595255|NCT00518115|525030305|FG001|Overall Study|Protocol Violation|3|||
145595256|NCT00518115|525030306|FG002|Overall Study|Protocol Violation|1|||
145595257|NCT00518115|525030307|FG003|Overall Study|Protocol Violation|0|||
145595258|NCT00518115|525030308|FG004|Overall Study|Protocol Violation|0|||
145595259|NCT00518115|525030309|FG005|Overall Study|Protocol Violation|0|||
145595260|NCT00518115|525030310|FG006|Overall Study|Protocol Violation|0|||
145595261|NCT00518115|525030311|FG007|Overall Study|Protocol Violation|0|||
145595262|NCT00518115|525030312|FG008|Overall Study|Protocol Violation|0|||
145595263|NCT00518115|525030313|FG009|Overall Study|Protocol Violation|0|||
145595264|NCT00518115|525030304|FG000|Overall Study|Withdrawal by Subject|1|||
145595265|NCT00518115|525030305|FG001|Overall Study|Withdrawal by Subject|1|||
145595266|NCT00518115|525030306|FG002|Overall Study|Withdrawal by Subject|5|||
145595267|NCT00518115|525030307|FG003|Overall Study|Withdrawal by Subject|0|||
145595268|NCT00518115|525030308|FG004|Overall Study|Withdrawal by Subject|2|||
145595269|NCT00518115|525030309|FG005|Overall Study|Withdrawal by Subject|1|||
145595270|NCT00518115|525030310|FG006|Overall Study|Withdrawal by Subject|0|||
145595271|NCT00518115|525030311|FG007|Overall Study|Withdrawal by Subject|2|||
145595272|NCT00518115|525030312|FG008|Overall Study|Withdrawal by Subject|1|||
145595273|NCT00518115|525030313|FG009|Overall Study|Withdrawal by Subject|3|||
145595274|NCT00518115|525030304|FG000|Overall Study|Lack of Efficacy|1|||
145595275|NCT00518115|525030305|FG001|Overall Study|Lack of Efficacy|0|||
145595276|NCT00518115|525030306|FG002|Overall Study|Lack of Efficacy|1|||
145595277|NCT00518115|525030307|FG003|Overall Study|Lack of Efficacy|1|||
145595278|NCT00518115|525030308|FG004|Overall Study|Lack of Efficacy|0|||
145595279|NCT00518115|525030309|FG005|Overall Study|Lack of Efficacy|0|||
145595280|NCT00518115|525030310|FG006|Overall Study|Lack of Efficacy|0|||
145595281|NCT00518115|525030311|FG007|Overall Study|Lack of Efficacy|1|||
145595282|NCT00518115|525030312|FG008|Overall Study|Lack of Efficacy|0|||
145595283|NCT00518115|525030313|FG009|Overall Study|Lack of Efficacy|0|||
145595284|NCT00518115|525030304|FG000|Overall Study|Non-Compliance|1|||
145595285|NCT00518115|525030305|FG001|Overall Study|Non-Compliance|0|||
145595286|NCT00518115|525030306|FG002|Overall Study|Non-Compliance|1|||
145595287|NCT00518115|525030307|FG003|Overall Study|Non-Compliance|0|||
145595288|NCT00518115|525030308|FG004|Overall Study|Non-Compliance|1|||
145595289|NCT00518115|525030309|FG005|Overall Study|Non-Compliance|1|||
145595290|NCT00518115|525030310|FG006|Overall Study|Non-Compliance|1|||
145595291|NCT00518115|525030311|FG007|Overall Study|Non-Compliance|1|||
145595292|NCT00518115|525030312|FG008|Overall Study|Non-Compliance|0|||
145595293|NCT00518115|525030313|FG009|Overall Study|Non-Compliance|1|||
145595294|NCT00518115|525030304|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
145595295|NCT00518115|525030305|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
145595296|NCT00518115|525030306|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595297|NCT00518115|525030307|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595298|NCT00518115|525030308|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595299|NCT00518115|525030309|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
145595300|NCT00518115|525030310|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145465024|NCT00394901|524554198|FG000|Double-blind Phase|Lost to Follow-up|0|||
145465025|NCT00394901|524554199|FG001|Double-blind Phase|Lost to Follow-up|0|||
145465026|NCT00394901|524554200|FG002|Double-blind Phase|Lost to Follow-up|0|||
145595301|NCT00518115|525030311|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595302|NCT00518115|525030312|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595303|NCT00518115|525030313|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
145595304|NCT00518115|525030304|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
145595305|NCT00518115|525030305|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145465027|NCT00394901|524554201|FG003|Double-blind Phase|Lost to Follow-up|1|||
145465028|NCT00394901|524554198|FG000|Double-blind Phase|Protocol Violation|0|||
145595306|NCT00518115|525030306|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595307|NCT00518115|525030307|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595308|NCT00518115|525030308|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595309|NCT00518115|525030309|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595310|NCT00518115|525030310|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145465029|NCT00394901|524554199|FG001|Double-blind Phase|Protocol Violation|0|||
145465030|NCT00394901|524554200|FG002|Double-blind Phase|Protocol Violation|0|||
145465031|NCT00394901|524554201|FG003|Double-blind Phase|Protocol Violation|1|||
145465032|NCT00394901|524554198|FG000|Double-blind Phase|Death|1|||
145465033|NCT00394901|524554199|FG001|Double-blind Phase|Death|0|||
145465034|NCT00394901|524554200|FG002|Double-blind Phase|Death|0|||
145465035|NCT00394901|524554201|FG003|Double-blind Phase|Death|0|||
145465036|NCT00394901|524554198|FG000|Double-blind Phase|Subject's Personal Reason|1|||
145465037|NCT00394901|524554199|FG001|Double-blind Phase|Subject's Personal Reason|0|||
145465038|NCT00394901|524554200|FG002|Double-blind Phase|Subject's Personal Reason|0|||
145465039|NCT00394901|524554201|FG003|Double-blind Phase|Subject's Personal Reason|1|||
145465040|NCT00394901|524554198|FG000|Double-blind Phase|Lack of Compliance|0|||
145465041|NCT00394901|524554199|FG001|Double-blind Phase|Lack of Compliance|3|||
145465042|NCT00394901|524554200|FG002|Double-blind Phase|Lack of Compliance|0|||
145465043|NCT00394901|524554201|FG003|Double-blind Phase|Lack of Compliance|0|||
145465044|NCT00394901|524554198|FG000|Double-blind Phase|Entry into another study was found|0|||
145465045|NCT00394901|524554199|FG001|Double-blind Phase|Entry into another study was found|0|||
145465046|NCT00394901|524554200|FG002|Double-blind Phase|Entry into another study was found|1|||
145465047|NCT00394901|524554201|FG003|Double-blind Phase|Entry into another study was found|0|||
145465048|NCT00394901|524554198|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
145465049|NCT00394901|524554199|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
145465050|NCT00394901|524554200|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
145465051|NCT00394901|524554201|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
145465052|NCT03002623|524554202|FG000|Overall Study|Lost to Follow-up|1|||
145465053|NCT03002623|524554203|FG001|Overall Study|Lost to Follow-up|0|||
145465054|NCT03002623|524554202|FG000|Overall Study|Physician Decision|1|||
145465055|NCT03002623|524554203|FG001|Overall Study|Physician Decision|1|||
145465056|NCT02256267|524554204|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
145465057|NCT02256267|524554204|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
145465058|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
145465059|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
145465060|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
145465061|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
145465062|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
145465063|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
145465064|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
145465065|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
145465066|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
145465067|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
145465068|NCT01352741|524554206|FG000|Open-label Tapentadol Titration Period|Other|4|||
145465069|NCT01352741|524554207|FG001|Open-label Tapentadol Titration Period|Other|0|||
145465070|NCT01352741|524554206|FG000|Double-blind Comparative Period|Protocol Violation|2|||
145465071|NCT01352741|524554207|FG001|Double-blind Comparative Period|Protocol Violation|0|||
145465072|NCT01352741|524554206|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
145465073|NCT01352741|524554207|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
145465074|NCT01352741|524554206|FG000|Double-blind Comparative Period|Adverse Event|16|||
145465075|NCT01352741|524554207|FG001|Double-blind Comparative Period|Adverse Event|17|||
145465076|NCT01352741|524554206|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
145465077|NCT01352741|524554207|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
145465078|NCT01352741|524554206|FG000|Double-blind Comparative Period|Death|0|||
145465079|NCT01352741|524554207|FG001|Double-blind Comparative Period|Death|1|||
145465080|NCT01352741|524554206|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
145465081|NCT01352741|524554207|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
145465082|NCT01352741|524554206|FG000|Double-blind Comparative Period|Other|1|||
145465083|NCT01352741|524554207|FG001|Double-blind Comparative Period|Other|2|||
145465084|NCT01352741|524554206|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
145465085|NCT01352741|524554207|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
145465086|NCT01352741|524554206|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
145465087|NCT01352741|524554207|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
145465088|NCT01352741|524554206|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
145465089|NCT01352741|524554207|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
145595311|NCT00518115|525030311|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595312|NCT00518115|525030312|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145465090|NCT01352741|524554206|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
145465091|NCT01352741|524554207|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
145465092|NCT00259298|524554209|FG000|Overall Study|Withdrawal by Subject|1|||
145465093|NCT00259298|524554209|FG000|Overall Study|Physician Decision|2|||
145465094|NCT00645528|524554210|FG000|Overall Study|Did not show up for Visit 2|7|||
145465095|NCT03618628|524554214|FG000|Overall Study|Death|1|||
145465096|NCT03618628|524554214|FG000|Overall Study|Lost to Follow-up|1|||
145465097|NCT01969500|524554215|FG000|Overall Study|Death|0|||
145465098|NCT01969500|524554216|FG001|Overall Study|Death|1|||
145465099|NCT01969500|524554215|FG000|Overall Study|extended hospitalization|1|||
145465100|NCT01969500|524554216|FG001|Overall Study|extended hospitalization|1|||
145465101|NCT02463032|524554217|FG000|Overall Study|Lack of Efficacy|61|||
145465102|NCT02463032|524554218|FG001|Overall Study|Lack of Efficacy|50|||
145465103|NCT02463032|524554217|FG000|Overall Study|Death|8|||
145465104|NCT02463032|524554218|FG001|Overall Study|Death|8|||
145465105|NCT02463032|524554217|FG000|Overall Study|Adverse Event|2|||
145465106|NCT02463032|524554218|FG001|Overall Study|Adverse Event|6|||
145465107|NCT01741532|524554219|FG000|Overall Study|Adverse Event|4|||
145465108|NCT01741532|524554220|FG001|Overall Study|Adverse Event|0|||
145465109|NCT01741532|524554219|FG000|Overall Study|Withdrawal by Subject|1|||
145465110|NCT01741532|524554220|FG001|Overall Study|Withdrawal by Subject|1|||
145465111|NCT01741532|524554219|FG000|Overall Study|Protocol Violation|0|||
145465112|NCT01741532|524554220|FG001|Overall Study|Protocol Violation|1|||
145465113|NCT01741532|524554219|FG000|Overall Study|Worsening of the disease|3|||
145465114|NCT01741532|524554220|FG001|Overall Study|Worsening of the disease|1|||
145465115|NCT01741532|524554219|FG000|Overall Study|Sponsor decision|1|||
145465116|NCT01741532|524554220|FG001|Overall Study|Sponsor decision|0|||
145465117|NCT01741532|524554219|FG000|Overall Study|Medical event|1|||
145465118|NCT01741532|524554220|FG001|Overall Study|Medical event|0|||
145465119|NCT00613080|524554221|FG000|Overall Study|Ineligible / no protocol treatment|11|||
145465120|NCT00612508|524554222|FG000|Overall Study|Withdrawal by Subject|3|||
145465121|NCT00612508|524554223|FG001|Overall Study|Withdrawal by Subject|4|||
145465122|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
145465123|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
145465124|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
145465125|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
145465126|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
145465127|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
145465128|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
145465129|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
145465130|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
145465131|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
145465132|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
145465133|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
145465134|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
145465135|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
145465136|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
145465137|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
145465138|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
145465139|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
145465140|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
145465141|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
145465142|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
145465143|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
145465144|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
145465145|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
145465146|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
145465147|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
145465148|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
145465149|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
145465150|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
145465151|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
145465152|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
145465153|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
145465154|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
145465155|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
145465156|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
145465157|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
145465158|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
145465159|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
145465160|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
145595313|NCT00518115|525030313|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
145595314|NCT00518115|525030304|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595315|NCT00518115|525030305|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595316|NCT00518115|525030306|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
145595317|NCT00518115|525030307|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595318|NCT00518115|525030308|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595319|NCT00518115|525030309|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595320|NCT00518115|525030310|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595321|NCT00518115|525030311|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595322|NCT00518115|525030312|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
145595323|NCT00518115|525030313|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
145595324|NCT00518115|525030304|FG000|Overall Study|Wrong Monotherapy Administered|0|||
145595325|NCT00518115|525030305|FG001|Overall Study|Wrong Monotherapy Administered|0|||
145595326|NCT00518115|525030306|FG002|Overall Study|Wrong Monotherapy Administered|1|||
145595327|NCT00518115|525030307|FG003|Overall Study|Wrong Monotherapy Administered|0|||
145595328|NCT00518115|525030308|FG004|Overall Study|Wrong Monotherapy Administered|0|||
145595329|NCT00518115|525030309|FG005|Overall Study|Wrong Monotherapy Administered|0|||
145595330|NCT00518115|525030310|FG006|Overall Study|Wrong Monotherapy Administered|1|||
145595331|NCT00518115|525030311|FG007|Overall Study|Wrong Monotherapy Administered|0|||
145595332|NCT00518115|525030312|FG008|Overall Study|Wrong Monotherapy Administered|0|||
145595333|NCT00518115|525030313|FG009|Overall Study|Wrong Monotherapy Administered|0|||
145595334|NCT00518115|525030304|FG000|Overall Study|Violation of Exclusion Criteria|0|||
145595335|NCT00518115|525030305|FG001|Overall Study|Violation of Exclusion Criteria|0|||
145595336|NCT00518115|525030306|FG002|Overall Study|Violation of Exclusion Criteria|0|||
145595337|NCT00518115|525030307|FG003|Overall Study|Violation of Exclusion Criteria|1|||
145595338|NCT00518115|525030308|FG004|Overall Study|Violation of Exclusion Criteria|0|||
145595339|NCT00518115|525030309|FG005|Overall Study|Violation of Exclusion Criteria|0|||
145595340|NCT00518115|525030310|FG006|Overall Study|Violation of Exclusion Criteria|1|||
145595341|NCT00518115|525030311|FG007|Overall Study|Violation of Exclusion Criteria|0|||
145595342|NCT00518115|525030312|FG008|Overall Study|Violation of Exclusion Criteria|0|||
145595343|NCT00518115|525030313|FG009|Overall Study|Violation of Exclusion Criteria|0|||
145595344|NCT00518115|525030304|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
145595345|NCT00518115|525030305|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
145595346|NCT00518115|525030306|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
145595347|NCT00518115|525030307|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
145595348|NCT00518115|525030308|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
145595349|NCT00518115|525030309|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
145595350|NCT00518115|525030310|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
145595351|NCT00518115|525030311|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
145595352|NCT00518115|525030312|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
145595353|NCT00518115|525030313|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
145595354|NCT00518115|525030304|FG000|Overall Study|Withdrew Consent|0|||
145595355|NCT00518115|525030305|FG001|Overall Study|Withdrew Consent|0|||
145595356|NCT00518115|525030306|FG002|Overall Study|Withdrew Consent|0|||
145595357|NCT00518115|525030307|FG003|Overall Study|Withdrew Consent|0|||
145595358|NCT00518115|525030308|FG004|Overall Study|Withdrew Consent|0|||
145595359|NCT00518115|525030309|FG005|Overall Study|Withdrew Consent|1|||
145595360|NCT00518115|525030310|FG006|Overall Study|Withdrew Consent|0|||
145595361|NCT00518115|525030311|FG007|Overall Study|Withdrew Consent|0|||
145595362|NCT00518115|525030312|FG008|Overall Study|Withdrew Consent|0|||
145595363|NCT00518115|525030313|FG009|Overall Study|Withdrew Consent|0|||
145595364|NCT00518115|525030304|FG000|Overall Study|Moved Out of State|0|||
145595365|NCT00518115|525030305|FG001|Overall Study|Moved Out of State|0|||
145595366|NCT00518115|525030306|FG002|Overall Study|Moved Out of State|0|||
145595367|NCT00518115|525030307|FG003|Overall Study|Moved Out of State|0|||
145595368|NCT00518115|525030308|FG004|Overall Study|Moved Out of State|0|||
145595369|NCT00518115|525030309|FG005|Overall Study|Moved Out of State|0|||
145595370|NCT00518115|525030310|FG006|Overall Study|Moved Out of State|0|||
145595371|NCT00518115|525030311|FG007|Overall Study|Moved Out of State|0|||
145595372|NCT00518115|525030312|FG008|Overall Study|Moved Out of State|0|||
145595373|NCT00518115|525030313|FG009|Overall Study|Moved Out of State|1|||
145595374|NCT00843167|525030316|FG000|Treatment Period|Adverse Event|1|||
145595375|NCT00843167|525030317|FG001|Treatment Period|Adverse Event|5|||
145595376|NCT00843167|525030316|FG000|Treatment Period|Withdrawal by Subject|2|||
145595377|NCT00843167|525030317|FG001|Treatment Period|Withdrawal by Subject|3|||
145595378|NCT00617344|525030321|FG000|Overall Study|Serious adverse event|1|||
145595379|NCT00617344|525030322|FG001|Overall Study|Serious adverse event|0|||
145595380|NCT00617344|525030323|FG002|Overall Study|Serious adverse event|0|||
145595381|NCT00617344|525030321|FG000|Overall Study|Other Adverse Event|1|||
145595382|NCT00617344|525030322|FG001|Overall Study|Other Adverse Event|1|||
145595383|NCT00617344|525030323|FG002|Overall Study|Other Adverse Event|0|||
145595384|NCT00617344|525030321|FG000|Overall Study|Protocol Violation|10|||
145595385|NCT00617344|525030322|FG001|Overall Study|Protocol Violation|8|||
145595386|NCT00617344|525030323|FG002|Overall Study|Protocol Violation|5|||
145627005|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
145595387|NCT00617344|525030321|FG000|Overall Study|Lost to Follow-up|5|||
145595388|NCT00617344|525030322|FG001|Overall Study|Lost to Follow-up|4|||
145595389|NCT00617344|525030323|FG002|Overall Study|Lost to Follow-up|1|||
145595390|NCT00617344|525030321|FG000|Overall Study|Withdrawal by Subject|8|||
145595391|NCT00617344|525030322|FG001|Overall Study|Withdrawal by Subject|9|||
145595392|NCT00617344|525030323|FG002|Overall Study|Withdrawal by Subject|2|||
145595393|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
145595394|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
145595395|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
145595396|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
145595397|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
145595398|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
145595399|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
145595400|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
145595401|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
145595402|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
145595403|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
145595404|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
145595405|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
145595406|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
145595407|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
145595408|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
145595409|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
145595410|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
145595411|NCT00833638|525030324|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
145595412|NCT00833638|525030325|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
145595413|NCT00833638|525030326|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
145595414|NCT00833638|525030324|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
145595415|NCT00833638|525030325|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
145595416|NCT00833638|525030326|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
145595417|NCT00833638|525030324|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
145595418|NCT00833638|525030325|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
145595419|NCT00833638|525030326|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
145595420|NCT00490646|525030327|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
145595421|NCT00490646|525030328|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
145595422|NCT00490646|525030327|FG000|Overall Study|Never Treated (had an adverse event)|1|||
145595423|NCT00490646|525030328|FG001|Overall Study|Never Treated (had an adverse event)|0|||
145595424|NCT00490646|525030327|FG000|Overall Study|Never Treated (withdrew consent)|0|||
145595425|NCT00490646|525030328|FG001|Overall Study|Never Treated (withdrew consent)|1|||
145595426|NCT01178086|525030329|FG000|Overall Study|Participant refusal|7|||
145595427|NCT01178086|525030329|FG000|Overall Study|Physician Decision|44|||
145595428|NCT01178086|525030329|FG000|Overall Study|Switch to other CLL therapy|113|||
145595429|NCT01178086|525030329|FG000|Overall Study|Death|59|||
145595430|NCT01178086|525030329|FG000|Overall Study|Other unspecified|89|||
145595431|NCT01178086|525030329|FG000|Overall Study|Excluded from EAS|20|||
145595432|NCT02137369|525030330|FG000|Overall Study|Withdrawal by Subject|3|||
145595433|NCT02137369|525030331|FG001|Overall Study|Withdrawal by Subject|2|||
145595434|NCT02137369|525030330|FG000|Overall Study|Adverse Event|2|||
145595435|NCT02137369|525030331|FG001|Overall Study|Adverse Event|0|||
145595436|NCT02137369|525030330|FG000|Overall Study|Lost to Follow-up|1|||
145595437|NCT02137369|525030331|FG001|Overall Study|Lost to Follow-up|0|||
145595438|NCT02137369|525030330|FG000|Overall Study|Moved away|2|||
145595439|NCT02137369|525030331|FG001|Overall Study|Moved away|0|||
145595440|NCT03762473|525030333|FG000|Overall Study|Death|1|||
145595441|NCT03762473|525030334|FG001|Overall Study|Death|0|||
145595442|NCT02962908|525030335|FG000|Overall Study|Lost to Follow-up|0|||
145595443|NCT02962908|525030336|FG001|Overall Study|Lost to Follow-up|3|||
145595444|NCT02962908|525030337|FG002|Overall Study|Lost to Follow-up|0|||
145595445|NCT02962908|525030338|FG003|Overall Study|Lost to Follow-up|1|||
145595446|NCT02962908|525030335|FG000|Overall Study|Withdrawal by Subject|0|||
145595447|NCT02962908|525030336|FG001|Overall Study|Withdrawal by Subject|3|||
145627006|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
145627007|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
145627008|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
145627009|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
145595448|NCT02962908|525030337|FG002|Overall Study|Withdrawal by Subject|0|||
145595449|NCT02962908|525030338|FG003|Overall Study|Withdrawal by Subject|2|||
145595450|NCT02962908|525030335|FG000|Overall Study|Protocol Violation|0|||
145595451|NCT02962908|525030336|FG001|Overall Study|Protocol Violation|1|||
145595452|NCT02962908|525030337|FG002|Overall Study|Protocol Violation|0|||
145595453|NCT02962908|525030338|FG003|Overall Study|Protocol Violation|0|||
145595454|NCT02962908|525030335|FG000|Overall Study|Physician Decision|0|||
145595455|NCT02962908|525030336|FG001|Overall Study|Physician Decision|1|||
145595456|NCT02962908|525030337|FG002|Overall Study|Physician Decision|0|||
145595457|NCT02962908|525030338|FG003|Overall Study|Physician Decision|0|||
145595458|NCT02626780|525030340|FG000|Overall Study|Withdrawal by Subject|3|||
145595459|NCT01266850|525032597|FG000|Overall Study|Lost to Follow-up|19|||
145595460|NCT01266850|525032598|FG001|Overall Study|Lost to Follow-up|19|||
145595461|NCT01266850|525032599|FG002|Overall Study|Lost to Follow-up|13|||
145595462|NCT01266850|525032600|FG003|Overall Study|Lost to Follow-up|13|||
145595463|NCT01266850|525032601|FG004|Overall Study|Lost to Follow-up|12|||
145595464|NCT01266850|525032597|FG000|Overall Study|Withdrawal by Subject|8|||
145595465|NCT01266850|525032598|FG001|Overall Study|Withdrawal by Subject|9|||
145595466|NCT01266850|525032599|FG002|Overall Study|Withdrawal by Subject|6|||
145595467|NCT01266850|525032600|FG003|Overall Study|Withdrawal by Subject|9|||
145595468|NCT01266850|525032601|FG004|Overall Study|Withdrawal by Subject|12|||
145595469|NCT01266850|525032597|FG000|Overall Study|Physician Decision|3|||
145595470|NCT01266850|525032598|FG001|Overall Study|Physician Decision|6|||
145595471|NCT01266850|525032599|FG002|Overall Study|Physician Decision|4|||
145595472|NCT01266850|525032600|FG003|Overall Study|Physician Decision|4|||
145595473|NCT01266850|525032601|FG004|Overall Study|Physician Decision|3|||
145595474|NCT01266850|525032597|FG000|Overall Study|Protocol Violation|0|||
145595475|NCT01266850|525032598|FG001|Overall Study|Protocol Violation|1|||
145595476|NCT01266850|525032599|FG002|Overall Study|Protocol Violation|0|||
145595477|NCT01266850|525032600|FG003|Overall Study|Protocol Violation|1|||
145595478|NCT01266850|525032601|FG004|Overall Study|Protocol Violation|2|||
145595479|NCT01266850|525032597|FG000|Overall Study|Adverse Event|0|||
145595480|NCT01266850|525032598|FG001|Overall Study|Adverse Event|0|||
145595481|NCT01266850|525032599|FG002|Overall Study|Adverse Event|0|||
145595482|NCT01266850|525032600|FG003|Overall Study|Adverse Event|0|||
145595483|NCT01266850|525032601|FG004|Overall Study|Adverse Event|1|||
145595484|NCT01266850|525032597|FG000|Overall Study|Site Closure|0|||
145595485|NCT01266850|525032598|FG001|Overall Study|Site Closure|1|||
145595486|NCT01266850|525032599|FG002|Overall Study|Site Closure|1|||
145595487|NCT01266850|525032600|FG003|Overall Study|Site Closure|1|||
145595488|NCT01266850|525032601|FG004|Overall Study|Site Closure|0|||
145595489|NCT03409666|525032602|FG000|Overall Study|Physician Decision|0|||
145595490|NCT03409666|525032603|FG001|Overall Study|Physician Decision|1|||
145595491|NCT03409666|525032602|FG000|Overall Study|Protocol Violation|0|||
145595492|NCT03409666|525032603|FG001|Overall Study|Protocol Violation|3|||
145595493|NCT03563716|525032607|FG000|Overall Study|Death|20|||
145595494|NCT03563716|525032608|FG001|Overall Study|Death|14|||
145595495|NCT03563716|525032607|FG000|Overall Study|Withdrawal by Subject|3|||
145595496|NCT03563716|525032608|FG001|Overall Study|Withdrawal by Subject|3|||
145595497|NCT03563716|525032607|FG000|Overall Study|Still on Study|45|||
145595498|NCT03563716|525032608|FG001|Overall Study|Still on Study|50|||
145595499|NCT04605978|525032609|FG000|Overall Study|Adverse Event|2|||
145595500|NCT04605978|525032610|FG001|Overall Study|Adverse Event|1|||
145595501|NCT04605978|525032609|FG000|Overall Study|Withdrawal nonmedical reason|1|||
145595502|NCT04605978|525032610|FG001|Overall Study|Withdrawal nonmedical reason|1|||
145595503|NCT02583425|525032611|FG000|Screening|Did not meet entry criteria|12|||
145595504|NCT02583425|525032611|FG000|Baseline|Did not meet continued criteria|5|||
145595505|NCT02583425|525032611|FG000|Treatment Period|Adverse Event|1|||
145595506|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
145595507|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
145595508|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
145595509|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
145595510|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
145595511|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
145595512|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
145595513|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
145595514|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
145595515|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
145595516|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
145595517|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
145465161|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
145465162|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
145465163|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
145595518|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Death|6|||
145465164|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
145595519|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Death|3|||
145465165|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
145595520|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Death|0|||
145595521|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Death|1|||
145595522|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Death|1|||
145595523|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Death|0|||
145595524|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
145595525|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
145595526|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
145595527|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
145595528|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
145595529|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
145595530|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
145595531|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
145595532|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
145595533|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
145595534|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
145595535|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
145595536|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
145595537|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
145595538|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
145595539|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
145595540|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
145595541|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
145595542|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
145595543|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
145595544|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
145465166|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
145465167|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
145465168|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
145465169|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
145465170|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
145465171|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
145465172|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
145465173|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
145465174|NCT02008357|524554224|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
145465175|NCT02008357|524554225|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
145465176|NCT02008357|524554224|FG000|Open-label Extension Period|Adverse Event|8|||
145465177|NCT02008357|524554225|FG001|Open-label Extension Period|Adverse Event|7|||
145465178|NCT02008357|524554224|FG000|Open-label Extension Period|Death|7|||
145465179|NCT02008357|524554225|FG001|Open-label Extension Period|Death|4|||
145465180|NCT02008357|524554224|FG000|Open-label Extension Period|Lack of Efficacy|9|||
145465181|NCT02008357|524554225|FG001|Open-label Extension Period|Lack of Efficacy|5|||
145465182|NCT02008357|524554224|FG000|Open-label Extension Period|Lost to Follow-up|2|||
145465183|NCT02008357|524554225|FG001|Open-label Extension Period|Lost to Follow-up|2|||
145465184|NCT02008357|524554224|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
145465185|NCT02008357|524554225|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
145465186|NCT02008357|524554224|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
145465187|NCT02008357|524554225|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
145465188|NCT02008357|524554224|FG000|Open-label Extension Period|Safety Risk|2|||
145465189|NCT02008357|524554225|FG001|Open-label Extension Period|Safety Risk|1|||
145465190|NCT02008357|524554224|FG000|Open-label Extension Period|Non-Compliance|0|||
145465191|NCT02008357|524554225|FG001|Open-label Extension Period|Non-Compliance|1|||
145465192|NCT02008357|524554224|FG000|Open-label Extension Period|Investigator Recommendation|0|||
145465193|NCT02008357|524554225|FG001|Open-label Extension Period|Investigator Recommendation|1|||
145465194|NCT02008357|524554224|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
145465195|NCT02008357|524554225|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
145465196|NCT02008357|524554224|FG000|Open-label Extension Period|Coordinating Center Request|2|||
145465197|NCT02008357|524554225|FG001|Open-label Extension Period|Coordinating Center Request|4|||
145465198|NCT02008357|524554224|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
145465199|NCT02008357|524554225|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
145465200|NCT02008357|524554224|FG000|Open-label Extension Period|Study Ended|20|||
145465201|NCT02008357|524554225|FG001|Open-label Extension Period|Study Ended|25|||
145465202|NCT02008357|524554224|FG000|Open-label Extension Period|Personal Reasons|0|||
145465203|NCT02008357|524554225|FG001|Open-label Extension Period|Personal Reasons|1|||
145465204|NCT02008357|524554224|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
145465205|NCT02008357|524554225|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
145595545|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
145595546|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
145595547|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
145595548|NCT03104699|525032612|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
145595549|NCT03104699|525032613|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
145595550|NCT03104699|525032614|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
145465206|NCT02008357|524554224|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
145465207|NCT02008357|524554225|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
145465208|NCT02008357|524554224|FG000|Open-label Extension Period|Other|2|||
145465209|NCT02008357|524554225|FG001|Open-label Extension Period|Other|0|||
145465210|NCT01442064|524554226|FG000|Overall Study|Adverse Event|2|||
145465211|NCT01442064|524554227|FG001|Overall Study|Adverse Event|2|||
145465212|NCT01442064|524554228|FG002|Overall Study|Adverse Event|2|||
145465213|NCT01442064|524554229|FG003|Overall Study|Adverse Event|1|||
145465214|NCT01442064|524554230|FG004|Overall Study|Adverse Event|2|||
145465215|NCT01442064|524554231|FG005|Overall Study|Adverse Event|0|||
145465216|NCT01442064|524554226|FG000|Overall Study|Death|0|||
145465217|NCT01442064|524554227|FG001|Overall Study|Death|1|||
145465218|NCT01442064|524554228|FG002|Overall Study|Death|3|||
145465219|NCT01442064|524554229|FG003|Overall Study|Death|3|||
145465220|NCT01442064|524554230|FG004|Overall Study|Death|1|||
145465221|NCT01442064|524554231|FG005|Overall Study|Death|3|||
145465222|NCT01442064|524554226|FG000|Overall Study|Lost to Follow-up|5|||
145465223|NCT01442064|524554227|FG001|Overall Study|Lost to Follow-up|5|||
145465224|NCT01442064|524554228|FG002|Overall Study|Lost to Follow-up|1|||
145465225|NCT01442064|524554229|FG003|Overall Study|Lost to Follow-up|1|||
145465226|NCT01442064|524554230|FG004|Overall Study|Lost to Follow-up|3|||
145465227|NCT01442064|524554231|FG005|Overall Study|Lost to Follow-up|3|||
145465228|NCT01442064|524554226|FG000|Overall Study|Physician Decision|1|||
145465229|NCT01442064|524554227|FG001|Overall Study|Physician Decision|1|||
145465230|NCT01442064|524554228|FG002|Overall Study|Physician Decision|2|||
145465231|NCT01442064|524554229|FG003|Overall Study|Physician Decision|3|||
145465232|NCT01442064|524554230|FG004|Overall Study|Physician Decision|3|||
145465233|NCT01442064|524554231|FG005|Overall Study|Physician Decision|1|||
145465234|NCT01442064|524554226|FG000|Overall Study|Withdrawal by Subject|6|||
145465235|NCT01442064|524554227|FG001|Overall Study|Withdrawal by Subject|3|||
145465236|NCT01442064|524554228|FG002|Overall Study|Withdrawal by Subject|2|||
145465237|NCT01442064|524554229|FG003|Overall Study|Withdrawal by Subject|2|||
145465238|NCT01442064|524554230|FG004|Overall Study|Withdrawal by Subject|2|||
145465239|NCT01442064|524554231|FG005|Overall Study|Withdrawal by Subject|1|||
145465240|NCT01442064|524554226|FG000|Overall Study|Sponsor decision|82|||
145465241|NCT01442064|524554227|FG001|Overall Study|Sponsor decision|88|||
145465242|NCT01442064|524554228|FG002|Overall Study|Sponsor decision|92|||
145465243|NCT01442064|524554229|FG003|Overall Study|Sponsor decision|88|||
145465244|NCT01442064|524554230|FG004|Overall Study|Sponsor decision|95|||
145465245|NCT01442064|524554231|FG005|Overall Study|Sponsor decision|87|||
145465246|NCT01442064|524554226|FG000|Overall Study|Subject non-compliance|0|||
145465247|NCT01442064|524554227|FG001|Overall Study|Subject non-compliance|0|||
145465248|NCT01442064|524554228|FG002|Overall Study|Subject non-compliance|0|||
145465249|NCT01442064|524554229|FG003|Overall Study|Subject non-compliance|0|||
145465250|NCT01442064|524554230|FG004|Overall Study|Subject non-compliance|0|||
145465251|NCT01442064|524554231|FG005|Overall Study|Subject non-compliance|2|||
145465252|NCT01442064|524554226|FG000|Overall Study|Condition mandated other intervention|1|||
145465253|NCT01442064|524554227|FG001|Overall Study|Condition mandated other intervention|1|||
145465254|NCT01442064|524554228|FG002|Overall Study|Condition mandated other intervention|2|||
145465255|NCT01442064|524554229|FG003|Overall Study|Condition mandated other intervention|0|||
145465256|NCT01442064|524554230|FG004|Overall Study|Condition mandated other intervention|0|||
145465257|NCT01442064|524554231|FG005|Overall Study|Condition mandated other intervention|2|||
145465258|NCT02312219|524554232|FG000|Overall Study|Withdrawal by Subject|1|||
145465259|NCT02312219|524554233|FG001|Overall Study|Withdrawal by Subject|2|||
145465260|NCT02312219|524554232|FG000|Overall Study|could not schedule imaging in time|0|||
145465261|NCT02312219|524554233|FG001|Overall Study|could not schedule imaging in time|2|||
145465262|NCT02312219|524554232|FG000|Overall Study|Other|0|||
145465263|NCT02312219|524554233|FG001|Overall Study|Other|1|||
145465264|NCT02312219|524554232|FG000|Overall Study|Not randomized. Ineligible|0|||
145465265|NCT02312219|524554233|FG001|Overall Study|Not randomized. Ineligible|1|||
145465266|NCT02153346|524554234|FG000|Overall Study|Lost to Follow-up|11|||
145465267|NCT01522404|524554239|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
145465268|NCT01522404|524554240|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
145465269|NCT01522404|524554239|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
145465270|NCT01522404|524554240|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
145465271|NCT01522404|524554239|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
145465272|NCT01522404|524554240|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
145465273|NCT01591863|524554241|FG000|Overall Study|Adverse Event|3|||
145465274|NCT01591863|524554241|FG000|Overall Study|Withdrawal by Subject|1|||
145465275|NCT01591863|524554241|FG000|Overall Study|recurrence|9|||
145465276|NCT01591863|524554241|FG000|Overall Study|Lack of Efficacy|1|||
145465277|NCT02366767|524554244|FG000|Overall Study|left for home after 1 day at camp|1|||
145465278|NCT02366767|524554245|FG001|Overall Study|left for home after 1 day at camp|0|||
145465279|NCT00260065|524554248|FG000|Overall Study|Progressive Disease|22|||
145465280|NCT00260065|524554248|FG000|Overall Study|Adverse Event|17|||
145465281|NCT00260065|524554248|FG000|Overall Study|Death|13|||
145465282|NCT00260065|524554248|FG000|Overall Study|Withdrawal by Subject|13|||
145595551|NCT03104699|525032615|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
145595552|NCT03104699|525032616|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
145595553|NCT03104699|525032617|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
145595554|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145595555|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145595556|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145595557|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145595558|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
145595559|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
145595560|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Death|0|||
145595561|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Death|0|||
145595562|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Death|0|||
145595563|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Death|0|||
145595564|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Death|0|||
145595565|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Death|107|||
145595566|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
145595567|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
145595568|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
145595569|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
145595570|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
145595571|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
145595572|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145595573|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145595574|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145595575|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145595576|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
145595577|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
145595578|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145595579|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145595580|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145595581|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145595582|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
145595583|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
145595584|NCT03104699|525032612|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
145465283|NCT00260065|524554248|FG000|Overall Study|Physician Decision|19|||
145465284|NCT00260065|524554248|FG000|Overall Study|Not otherwise specified|8|||
145465285|NCT00260065|524554248|FG000|Overall Study|Medication Noncompliance|1|||
145465286|NCT00664326|524556297|FG000|Overall Study|Adverse Event|14|||
145465287|NCT00664326|524556297|FG000|Overall Study|Noncompliance with study medication|3|||
145465288|NCT00664326|524556297|FG000|Overall Study|Withdrawal by Subject|1|||
145465289|NCT00664326|524556297|FG000|Overall Study|Physician Decision|1|||
145465290|NCT00664326|524556297|FG000|Overall Study|Other Reasons|3|||
145465291|NCT00664326|524556297|FG000|Overall Study|Death|2|||
145465292|NCT00664326|524556297|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
145465293|NCT05079477|524556300|FG000|Overall Study|Lost to Follow-up|2|||
145465294|NCT05079477|524556301|FG001|Overall Study|Lost to Follow-up|0|||
145465295|NCT05079477|524556300|FG000|Overall Study|Withdrawal by Subject|1|||
145465296|NCT05079477|524556301|FG001|Overall Study|Withdrawal by Subject|0|||
145465297|NCT05079477|524556300|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
145465298|NCT05079477|524556301|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
145465299|NCT05079477|524556300|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
145465300|NCT05079477|524556301|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
145465301|NCT05275582|524556306|FG000|Overall Study|Lost to Follow-up|1|||
145465302|NCT05275582|524556307|FG001|Overall Study|Lost to Follow-up|0|||
145465303|NCT05275582|524556306|FG000|Overall Study|Withdrawal by Subject|0|||
145465304|NCT05275582|524556307|FG001|Overall Study|Withdrawal by Subject|2|||
145465305|NCT05275582|524556306|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
145465306|NCT05275582|524556307|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
145465307|NCT05275582|524556306|FG000|Overall Study|Death|1|||
145465308|NCT05275582|524556307|FG001|Overall Study|Death|0|||
145465309|NCT05275582|524556306|FG000|Overall Study|Protocol Violation|1|||
145465310|NCT05275582|524556307|FG001|Overall Study|Protocol Violation|0|||
145465311|NCT03204890|524556312|FG000|Overall Study|Withdrawal by Subject|1|||
145465312|NCT03769311|524556313|FG000|Overall Study|Withdrawal by Subject|1|||
145595585|NCT03104699|525032613|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
145595586|NCT03104699|525032614|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
145595587|NCT03104699|525032615|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
145627010|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
145627011|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
145465313|NCT02853435|524556314|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
145465314|NCT02853435|524556315|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
145465315|NCT02853435|524556316|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
145465316|NCT02853435|524556317|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
145465317|NCT02853435|524556318|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
145465318|NCT02853435|524556319|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
145465319|NCT01688739|524556320|FG000|Overall Study|Administrative Decision|1|||
145465320|NCT01688739|524556321|FG001|Overall Study|Administrative Decision|0|||
145465321|NCT01688739|524556322|FG002|Overall Study|Administrative Decision|0|||
145465322|NCT01688739|524556323|FG003|Overall Study|Administrative Decision|0|||
145465323|NCT01688739|524556324|FG004|Overall Study|Administrative Decision|0|||
145465324|NCT01688739|524556325|FG005|Overall Study|Administrative Decision|0|||
145465325|NCT01688739|524556326|FG006|Overall Study|Administrative Decision|0|||
145465326|NCT01688739|524556327|FG007|Overall Study|Administrative Decision|0|||
145465327|NCT01688739|524556328|FG008|Overall Study|Administrative Decision|0|||
145465328|NCT01688739|524556329|FG009|Overall Study|Administrative Decision|0|||
145465329|NCT00996801|524556330|FG000|Overall Study|Adverse Event|6|||
145465330|NCT00996801|524556331|FG001|Overall Study|Adverse Event|4|||
145465331|NCT00996801|524556332|FG002|Overall Study|Adverse Event|12|||
145465332|NCT00996801|524556333|FG003|Overall Study|Adverse Event|17|||
145465333|NCT00996801|524556334|FG004|Overall Study|Adverse Event|31|||
145465334|NCT00996801|524556335|FG005|Overall Study|Adverse Event|3|||
145465335|NCT00996801|524556330|FG000|Overall Study|Lack of Efficacy|3|||
145465336|NCT00996801|524556331|FG001|Overall Study|Lack of Efficacy|0|||
145465337|NCT00996801|524556332|FG002|Overall Study|Lack of Efficacy|1|||
145465338|NCT00996801|524556333|FG003|Overall Study|Lack of Efficacy|3|||
145465339|NCT00996801|524556334|FG004|Overall Study|Lack of Efficacy|0|||
145465340|NCT00996801|524556335|FG005|Overall Study|Lack of Efficacy|1|||
145465341|NCT00996801|524556330|FG000|Overall Study|Lost to Follow-up|0|||
145465342|NCT00996801|524556331|FG001|Overall Study|Lost to Follow-up|0|||
145465343|NCT00996801|524556332|FG002|Overall Study|Lost to Follow-up|0|||
145465344|NCT00996801|524556333|FG003|Overall Study|Lost to Follow-up|3|||
145465345|NCT00996801|524556334|FG004|Overall Study|Lost to Follow-up|3|||
145465346|NCT00996801|524556335|FG005|Overall Study|Lost to Follow-up|2|||
145465347|NCT00996801|524556330|FG000|Overall Study|Physician Decision|0|||
145465348|NCT00996801|524556331|FG001|Overall Study|Physician Decision|0|||
145465349|NCT00996801|524556332|FG002|Overall Study|Physician Decision|0|||
145465350|NCT00996801|524556333|FG003|Overall Study|Physician Decision|1|||
145465351|NCT00996801|524556334|FG004|Overall Study|Physician Decision|0|||
145465352|NCT00996801|524556335|FG005|Overall Study|Physician Decision|0|||
145465353|NCT00996801|524556330|FG000|Overall Study|Progressive Disease|0|||
145465354|NCT00996801|524556331|FG001|Overall Study|Progressive Disease|1|||
145465355|NCT00996801|524556332|FG002|Overall Study|Progressive Disease|0|||
145465356|NCT00996801|524556333|FG003|Overall Study|Progressive Disease|0|||
145465357|NCT00996801|524556334|FG004|Overall Study|Progressive Disease|0|||
145465358|NCT00996801|524556335|FG005|Overall Study|Progressive Disease|0|||
145465359|NCT00996801|524556330|FG000|Overall Study|Protocol Violation|3|||
145465360|NCT00996801|524556331|FG001|Overall Study|Protocol Violation|4|||
145465361|NCT00996801|524556332|FG002|Overall Study|Protocol Violation|1|||
145465362|NCT00996801|524556333|FG003|Overall Study|Protocol Violation|2|||
145465363|NCT00996801|524556334|FG004|Overall Study|Protocol Violation|3|||
145465364|NCT00996801|524556335|FG005|Overall Study|Protocol Violation|4|||
145465365|NCT00996801|524556330|FG000|Overall Study|Study Terminated by Sponsor|0|||
145465366|NCT00996801|524556331|FG001|Overall Study|Study Terminated by Sponsor|1|||
145465367|NCT00996801|524556332|FG002|Overall Study|Study Terminated by Sponsor|0|||
145465368|NCT00996801|524556333|FG003|Overall Study|Study Terminated by Sponsor|0|||
145465369|NCT00996801|524556334|FG004|Overall Study|Study Terminated by Sponsor|46|||
145465370|NCT00996801|524556335|FG005|Overall Study|Study Terminated by Sponsor|0|||
145465371|NCT00996801|524556330|FG000|Overall Study|Withdrawal by Subject|8|||
145465372|NCT00996801|524556331|FG001|Overall Study|Withdrawal by Subject|6|||
145465373|NCT00996801|524556332|FG002|Overall Study|Withdrawal by Subject|9|||
145465374|NCT00996801|524556333|FG003|Overall Study|Withdrawal by Subject|5|||
145595588|NCT03104699|525032616|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
145595589|NCT03104699|525032617|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
145595590|NCT01644734|525032618|FG000|Overall Study|Adverse Event|4|||
145595591|NCT01644734|525032618|FG000|Overall Study|Lost to Follow-up|17|||
145465375|NCT00996801|524556334|FG004|Overall Study|Withdrawal by Subject|5|||
145465376|NCT00996801|524556335|FG005|Overall Study|Withdrawal by Subject|9|||
145465377|NCT03369431|524556337|FG000|Overall Study|Lost to Follow-up|1|||
145465378|NCT03369431|524556338|FG001|Overall Study|Lost to Follow-up|3|||
145465379|NCT03369431|524556337|FG000|Overall Study|Withdrawal by Subject|2|||
145465380|NCT03369431|524556338|FG001|Overall Study|Withdrawal by Subject|3|||
145465381|NCT03369431|524556337|FG000|Overall Study|Protocol Violation|1|||
145465382|NCT03369431|524556338|FG001|Overall Study|Protocol Violation|1|||
145465383|NCT01113580|524556345|FG000|Overall Study|Protocol Violation|1|||
145465384|NCT01113580|524556346|FG001|Overall Study|Protocol Violation|0|||
145465385|NCT04912895|524556356|FG000|Overall Study|Unable to provide specimen|2|||
145595592|NCT01644734|525032618|FG000|Overall Study|Reasons other than stated above|7|||
145595593|NCT01644734|525032618|FG000|Overall Study|Missing documentation|238|||
145595594|NCT02548455|525032624|FG000|Overall Study|Withdrawal by Subject|27|||
145595595|NCT02548455|525032624|FG000|Overall Study|Death|26|||
145595596|NCT02548455|525032624|FG000|Overall Study|Lost to Follow-up|14|||
145595597|NCT02548455|525032624|FG000|Overall Study|Visit not completed|173|||
145595598|NCT02261493|525032625|FG000|Overall Study|Noncompliance|0|||
145595599|NCT02261493|525032626|FG001|Overall Study|Noncompliance|0|||
145595600|NCT02261493|525032627|FG002|Overall Study|Noncompliance|2|||
145595601|NCT02261493|525032625|FG000|Overall Study|Physician Decision|0|||
145595602|NCT02261493|525032626|FG001|Overall Study|Physician Decision|1|||
145595603|NCT02261493|525032627|FG002|Overall Study|Physician Decision|0|||
145595604|NCT02261493|525032625|FG000|Overall Study|Undisclosed alcohol abuse|0|||
145595605|NCT02261493|525032626|FG001|Overall Study|Undisclosed alcohol abuse|1|||
145595606|NCT02261493|525032627|FG002|Overall Study|Undisclosed alcohol abuse|0|||
145595607|NCT02261493|525032625|FG000|Overall Study|Protocol Violation|1|||
145595608|NCT02261493|525032626|FG001|Overall Study|Protocol Violation|0|||
145595609|NCT02261493|525032627|FG002|Overall Study|Protocol Violation|0|||
145595610|NCT02261493|525032625|FG000|Overall Study|Personal Reasons|14|||
145595611|NCT02261493|525032626|FG001|Overall Study|Personal Reasons|14|||
145595612|NCT02261493|525032627|FG002|Overall Study|Personal Reasons|16|||
145595613|NCT02261493|525032625|FG000|Overall Study|Lost to Follow-up|14|||
145595614|NCT02261493|525032626|FG001|Overall Study|Lost to Follow-up|27|||
145595615|NCT02261493|525032627|FG002|Overall Study|Lost to Follow-up|8|||
145595616|NCT02261493|525032625|FG000|Overall Study|Pregnancy|1|||
145595617|NCT02261493|525032626|FG001|Overall Study|Pregnancy|2|||
145595618|NCT02261493|525032627|FG002|Overall Study|Pregnancy|0|||
145595619|NCT02261493|525032625|FG000|Overall Study|Lack of Efficacy|0|||
145595620|NCT02261493|525032626|FG001|Overall Study|Lack of Efficacy|1|||
145595621|NCT02261493|525032627|FG002|Overall Study|Lack of Efficacy|0|||
145595622|NCT02261493|525032625|FG000|Overall Study|Adverse Event|0|||
145595623|NCT02261493|525032626|FG001|Overall Study|Adverse Event|1|||
145595624|NCT02261493|525032627|FG002|Overall Study|Adverse Event|0|||
145595625|NCT01597050|525032628|FG000|Overall Study|Withdrawal by Subject|1|||
145595626|NCT01597050|525032629|FG001|Overall Study|Withdrawal by Subject|0|||
145595627|NCT00483184|525032630|FG000|Overall Study|Withdrawal by Subject|2|||
145595628|NCT00483184|525032631|FG001|Overall Study|Withdrawal by Subject|2|||
145595629|NCT00483184|525032632|FG002|Overall Study|Withdrawal by Subject|0|||
145595630|NCT00483184|525032630|FG000|Overall Study|Lost to Follow-up|1|||
145595631|NCT00483184|525032631|FG001|Overall Study|Lost to Follow-up|0|||
145595632|NCT00483184|525032632|FG002|Overall Study|Lost to Follow-up|0|||
145595633|NCT00483184|525032630|FG000|Overall Study|Adverse Event|1|||
145595634|NCT00483184|525032631|FG001|Overall Study|Adverse Event|2|||
145595635|NCT00483184|525032632|FG002|Overall Study|Adverse Event|2|||
145595636|NCT00483184|525032630|FG000|Overall Study|Protocol Violation|1|||
145595637|NCT00483184|525032631|FG001|Overall Study|Protocol Violation|0|||
145595638|NCT00483184|525032632|FG002|Overall Study|Protocol Violation|1|||
145595639|NCT02065336|525032636|FG000|Extension Phase|Study Terminated by Sponsor|0|||
145595640|NCT02065336|525032637|FG001|Extension Phase|Study Terminated by Sponsor|0|||
145595641|NCT02065336|525032638|FG002|Extension Phase|Study Terminated by Sponsor|0|||
145595642|NCT02065336|525032639|FG003|Extension Phase|Study Terminated by Sponsor|0|||
145595643|NCT02065336|525032640|FG004|Extension Phase|Study Terminated by Sponsor|0|||
145595644|NCT02065336|525032641|FG005|Extension Phase|Study Terminated by Sponsor|0|||
145595645|NCT02065336|525032642|FG006|Extension Phase|Study Terminated by Sponsor|0|||
145595646|NCT02065336|525032643|FG007|Extension Phase|Study Terminated by Sponsor|0|||
145595647|NCT02065336|525032644|FG008|Extension Phase|Study Terminated by Sponsor|2|||
145595648|NCT02065336|525032645|FG009|Extension Phase|Study Terminated by Sponsor|8|||
145595649|NCT00530855|525032646|FG000|Overall Study|Lack of Efficacy|20|||
145595650|NCT00530855|525032646|FG000|Overall Study|Withdrawal by Subject|30|||
145595651|NCT00530855|525032646|FG000|Overall Study|Fatal Serious AE|3|||
145595652|NCT00530855|525032646|FG000|Overall Study|Non Fatal Serious AE|7|||
145595653|NCT00530855|525032646|FG000|Overall Study|Non Fatal Non Serious AE|12|||
145595654|NCT00530855|525032646|FG000|Overall Study|Protocol Violation|3|||
145595655|NCT00530855|525032646|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
145595656|NCT00530855|525032646|FG000|Overall Study|Lost to Follow-up|9|||
145595657|NCT00530855|525032646|FG000|Overall Study|Other reason for premature termination|17|||
145595658|NCT01292876|525032647|FG000|Overall Study|Physician Decision|4|||
145595659|NCT01627327|525032648|FG000|Overall Study|Adverse Event|6|||
145595660|NCT01627327|525032649|FG001|Overall Study|Adverse Event|12|||
145595661|NCT01627327|525032648|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
145595662|NCT01627327|525032649|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
145595663|NCT01627327|525032648|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
145595664|NCT01627327|525032649|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
145595665|NCT01627327|525032648|FG000|Overall Study|Protocol Violation|4|||
145595666|NCT01627327|525032649|FG001|Overall Study|Protocol Violation|10|||
145595667|NCT01627327|525032648|FG000|Overall Study|Lost to Follow-up|1|||
145595668|NCT01627327|525032649|FG001|Overall Study|Lost to Follow-up|3|||
145465386|NCT04912895|524556357|FG001|Overall Study|Unable to provide specimen|0|||
145465387|NCT04912895|524556358|FG002|Overall Study|Unable to provide specimen|0|||
145465388|NCT01146652|524556359|FG000|Overall Study|Adverse Event|506|||
145465389|NCT01146652|524556360|FG001|Overall Study|Adverse Event|15|||
145465390|NCT01146652|524556359|FG000|Overall Study|Lack of Efficacy|91|||
145465391|NCT01146652|524556360|FG001|Overall Study|Lack of Efficacy|7|||
145465392|NCT01146652|524556359|FG000|Overall Study|Poor compliance to protocol|38|||
145465393|NCT01146652|524556360|FG001|Overall Study|Poor compliance to protocol|1|||
145465394|NCT01146652|524556359|FG000|Overall Study|Other unspecified reasons|314|||
145465395|NCT01146652|524556360|FG001|Overall Study|Other unspecified reasons|22|||
145465396|NCT01146652|524556359|FG000|Overall Study|Enrolled but not treated|2|||
145465397|NCT01146652|524556360|FG001|Overall Study|Enrolled but not treated|0|||
145465398|NCT02118597|524556361|FG000|Overall Study|Sponsor terminated the study|14|||
145465399|NCT02118597|524556361|FG000|Overall Study|Serious Adverse Event|1|||
145465400|NCT02118597|524556361|FG000|Overall Study|Investigator's decision|1|||
145465401|NCT02590562|524556366|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
145465402|NCT02255565|524556367|FG000|Overall Study|Withdrawal by Subject|0|||
145465403|NCT02255565|524556368|FG001|Overall Study|Withdrawal by Subject|1|||
145465404|NCT02255565|524556369|FG002|Overall Study|Withdrawal by Subject|0|||
145465405|NCT02699450|524556370|FG000|Overall Study|Death|2|||
145465406|NCT02699450|524556371|FG001|Overall Study|Death|1|||
145465407|NCT02699450|524556372|FG002|Overall Study|Death|2|||
145465408|NCT02699450|524556370|FG000|Overall Study|Met Criteria for Study Exit|0|||
145465409|NCT02699450|524556371|FG001|Overall Study|Met Criteria for Study Exit|0|||
145465410|NCT02699450|524556372|FG002|Overall Study|Met Criteria for Study Exit|1|||
145465411|NCT02699450|524556370|FG000|Overall Study|Protocol Violation|4|||
145465412|NCT02699450|524556371|FG001|Overall Study|Protocol Violation|3|||
145465413|NCT02699450|524556372|FG002|Overall Study|Protocol Violation|5|||
145465414|NCT02699450|524556370|FG000|Overall Study|Lost to Follow-up|3|||
145465415|NCT02699450|524556371|FG001|Overall Study|Lost to Follow-up|0|||
145465416|NCT02699450|524556372|FG002|Overall Study|Lost to Follow-up|5|||
145465417|NCT02699450|524556370|FG000|Overall Study|Physician Decision|2|||
145465418|NCT02699450|524556371|FG001|Overall Study|Physician Decision|0|||
145465419|NCT02699450|524556372|FG002|Overall Study|Physician Decision|0|||
145465420|NCT02699450|524556370|FG000|Overall Study|Withdrawal by Subject|3|||
145465421|NCT02699450|524556371|FG001|Overall Study|Withdrawal by Subject|1|||
145465422|NCT02699450|524556372|FG002|Overall Study|Withdrawal by Subject|2|||
145465423|NCT02699450|524556370|FG000|Overall Study|Adverse Event|1|||
145465424|NCT02699450|524556371|FG001|Overall Study|Adverse Event|0|||
145465425|NCT02699450|524556372|FG002|Overall Study|Adverse Event|0|||
145465426|NCT00900146|524556375|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
145465427|NCT00900146|524556376|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
145465428|NCT00900146|524556377|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
145465429|NCT00900146|524556378|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
145465430|NCT00900146|524556379|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
145465431|NCT00900146|524556375|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
145465432|NCT00900146|524556376|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
145465433|NCT00900146|524556377|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
145465434|NCT00900146|524556378|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
145465435|NCT00900146|524556379|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
145465436|NCT00900146|524556375|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
145465437|NCT00900146|524556376|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
145465438|NCT00900146|524556377|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
145465439|NCT00900146|524556378|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
145465440|NCT00900146|524556379|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
145465441|NCT00900146|524556375|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
145465442|NCT00900146|524556376|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
145465443|NCT00900146|524556377|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
145465444|NCT00900146|524556378|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
145465445|NCT00900146|524556379|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
145465446|NCT00900146|524556375|FG000|Intermediate: Period III|Lost to Follow-up|2|||
145465447|NCT00900146|524556376|FG001|Intermediate: Period III|Lost to Follow-up|0|||
145465448|NCT00900146|524556377|FG002|Intermediate: Period III|Lost to Follow-up|0|||
145465449|NCT00900146|524556378|FG003|Intermediate: Period III|Lost to Follow-up|0|||
145465450|NCT00900146|524556379|FG004|Intermediate: Period III|Lost to Follow-up|1|||
145465451|NCT00900146|524556375|FG000|Intermediate: Period III|Administrative problems|85|||
145465452|NCT00900146|524556376|FG001|Intermediate: Period III|Administrative problems|92|||
145465453|NCT00900146|524556377|FG002|Intermediate: Period III|Administrative problems|84|||
145465454|NCT00900146|524556378|FG003|Intermediate: Period III|Administrative problems|90|||
145465455|NCT00900146|524556379|FG004|Intermediate: Period III|Administrative problems|163|||
145465456|NCT00700102|524556380|FG000|Overall Study|Died|394|||
145465457|NCT00700102|524556381|FG001|Overall Study|Died|385|||
145465458|NCT00700102|524556380|FG000|Overall Study|Lost to Follow-up|8|||
145595669|NCT01627327|525032648|FG000|Overall Study|Physician Decision|1|||
145595670|NCT01627327|525032649|FG001|Overall Study|Physician Decision|0|||
145595671|NCT01627327|525032648|FG000|Overall Study|Withdrawal by Subject|3|||
145595672|NCT01627327|525032649|FG001|Overall Study|Withdrawal by Subject|3|||
145595673|NCT04528069|525032655|FG000|Overall Study|Adverse Event|1|||
145595674|NCT04528069|525032655|FG000|Overall Study|Lost to Follow-up|1|||
145595675|NCT04528069|525032655|FG000|Overall Study|Patient Unable to Come|1|||
145595676|NCT04528069|525032655|FG000|Overall Study|Patient Unable to Attend|1|||
145595677|NCT01137474|525032656|FG000|Overall Study|Adverse Event|3|||
145595678|NCT01137474|525032657|FG001|Overall Study|Adverse Event|5|||
145595679|NCT01137474|525032658|FG002|Overall Study|Adverse Event|1|||
145595680|NCT01137474|525032659|FG003|Overall Study|Adverse Event|3|||
145595681|NCT01137474|525032656|FG000|Overall Study|Withdrawal by Subject|7|||
145595682|NCT01137474|525032657|FG001|Overall Study|Withdrawal by Subject|2|||
145595683|NCT01137474|525032658|FG002|Overall Study|Withdrawal by Subject|6|||
145595684|NCT01137474|525032659|FG003|Overall Study|Withdrawal by Subject|9|||
145595685|NCT01137474|525032656|FG000|Overall Study|No longer met study criteria|6|||
145595686|NCT01137474|525032657|FG001|Overall Study|No longer met study criteria|1|||
145595687|NCT01137474|525032658|FG002|Overall Study|No longer met study criteria|0|||
145595688|NCT01137474|525032659|FG003|Overall Study|No longer met study criteria|5|||
145595689|NCT01137474|525032656|FG000|Overall Study|Lost to Follow-up|5|||
145595690|NCT01137474|525032657|FG001|Overall Study|Lost to Follow-up|1|||
145595691|NCT01137474|525032658|FG002|Overall Study|Lost to Follow-up|0|||
145595692|NCT01137474|525032659|FG003|Overall Study|Lost to Follow-up|2|||
145595693|NCT01137474|525032656|FG000|Overall Study|Lack of Efficacy|0|||
145595694|NCT01137474|525032657|FG001|Overall Study|Lack of Efficacy|0|||
145595695|NCT01137474|525032658|FG002|Overall Study|Lack of Efficacy|0|||
145595696|NCT01137474|525032659|FG003|Overall Study|Lack of Efficacy|2|||
145595697|NCT01137474|525032656|FG000|Overall Study|Other|3|||
145595698|NCT01137474|525032657|FG001|Overall Study|Other|1|||
145595699|NCT01137474|525032658|FG002|Overall Study|Other|0|||
145595700|NCT01137474|525032659|FG003|Overall Study|Other|0|||
145595701|NCT01137474|525032656|FG000|Overall Study|Pregnancy|0|||
145595702|NCT01137474|525032657|FG001|Overall Study|Pregnancy|1|||
145595703|NCT01137474|525032658|FG002|Overall Study|Pregnancy|0|||
145595704|NCT01137474|525032659|FG003|Overall Study|Pregnancy|0|||
145595705|NCT01137474|525032656|FG000|Overall Study|Administrative reason by sponsor|0|||
145595706|NCT01137474|525032657|FG001|Overall Study|Administrative reason by sponsor|1|||
145595707|NCT01137474|525032658|FG002|Overall Study|Administrative reason by sponsor|0|||
145595708|NCT01137474|525032659|FG003|Overall Study|Administrative reason by sponsor|0|||
145595709|NCT02525874|525032662|FG000|Overall Study|Other|1|||
145595710|NCT02525874|525032662|FG000|Overall Study|Investigator Decision|1|||
145595711|NCT02525874|525032662|FG000|Overall Study|Consent withdrawn|22|||
145465459|NCT00700102|524556381|FG001|Overall Study|Lost to Follow-up|10|||
145465460|NCT02525939|524556386|FG000|Overall Study|Lost to Follow-up|27|||
145465461|NCT02525939|524556387|FG001|Overall Study|Lost to Follow-up|24|||
145465462|NCT02525939|524556386|FG000|Overall Study|Physician Decision|0|||
145465463|NCT02525939|524556387|FG001|Overall Study|Physician Decision|1|||
145465464|NCT02525939|524556386|FG000|Overall Study|Withdrawal by Subject|24|||
145465465|NCT02525939|524556387|FG001|Overall Study|Withdrawal by Subject|39|||
145465466|NCT02525939|524556386|FG000|Overall Study|Death|180|||
145465467|NCT02525939|524556387|FG001|Overall Study|Death|179|||
145465468|NCT01635764|524556388|FG000|Overall Study|Adverse Event|46|||
145465469|NCT01635764|524556388|FG000|Overall Study|Lack of Efficacy|76|||
145465470|NCT01635764|524556388|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
145465471|NCT01635764|524556388|FG000|Overall Study|Protocol Deviation|1|||
145465472|NCT01635764|524556388|FG000|Overall Study|Withdrew Consent|67|||
145465473|NCT01635764|524556388|FG000|Overall Study|Lost to Follow-up|53|||
145465474|NCT01635764|524556388|FG000|Overall Study|Other|28|||
145465475|NCT01174004|524556389|FG000|Overall Study|Adverse Event|2|||
145465476|NCT01174004|524556390|FG001|Overall Study|Adverse Event|10|||
145465477|NCT01174004|524556389|FG000|Overall Study|Withdrawal by Subject|2|||
145465478|NCT01174004|524556390|FG001|Overall Study|Withdrawal by Subject|3|||
145595712|NCT02525874|525032662|FG000|Overall Study|Non-compliance with study drug|3|||
145595713|NCT02525874|525032662|FG000|Overall Study|Adverse Event|17|||
145595714|NCT02525874|525032662|FG000|Overall Study|Lost to Follow-up|7|||
145595715|NCT02525874|525032662|FG000|Overall Study|Disease progression, defined by protocol|2|||
145595716|NCT02525874|525032662|FG000|Overall Study|Disease relapse|4|||
145465479|NCT01174004|524556389|FG000|Overall Study|At Discretion of Sponsor|2|||
145595717|NCT02525874|525032662|FG000|Overall Study|Alternative Treatment for MS|2|||
145595718|NCT02525874|525032662|FG000|Overall Study|New lesions in Brain|1|||
145595719|NCT01814371|525032663|FG000|Overall Study|Lost to Follow-up|30|||
145465480|NCT01174004|524556390|FG001|Overall Study|At Discretion of Sponsor|2|||
145465481|NCT01174004|524556389|FG000|Overall Study|Protocol Violation|0|||
145465482|NCT01174004|524556390|FG001|Overall Study|Protocol Violation|1|||
145595720|NCT01814371|525032664|FG001|Overall Study|Lost to Follow-up|27|||
145465483|NCT01174004|524556389|FG000|Overall Study|Physician Decision|1|||
145595721|NCT01692782|525032665|FG000|Overall Study|Adverse Event|12|||
145595722|NCT01692782|525032666|FG001|Overall Study|Adverse Event|32|||
145595723|NCT01692782|525032667|FG002|Overall Study|Adverse Event|2|||
145595724|NCT01692782|525032665|FG000|Overall Study|Lack of Efficacy|1|||
145595725|NCT01692782|525032666|FG001|Overall Study|Lack of Efficacy|2|||
145595726|NCT01692782|525032667|FG002|Overall Study|Lack of Efficacy|0|||
145595727|NCT01692782|525032665|FG000|Overall Study|Lost to Follow-up|2|||
145595728|NCT01692782|525032666|FG001|Overall Study|Lost to Follow-up|7|||
145595729|NCT01692782|525032667|FG002|Overall Study|Lost to Follow-up|1|||
145595730|NCT01692782|525032665|FG000|Overall Study|Pregnancy|1|||
145595731|NCT01692782|525032666|FG001|Overall Study|Pregnancy|0|||
145595732|NCT01692782|525032667|FG002|Overall Study|Pregnancy|0|||
145595733|NCT01692782|525032665|FG000|Overall Study|Protocol Violation|1|||
145595734|NCT01692782|525032666|FG001|Overall Study|Protocol Violation|0|||
145595735|NCT01692782|525032667|FG002|Overall Study|Protocol Violation|2|||
145595736|NCT01692782|525032665|FG000|Overall Study|Non-complance with study drug|0|||
145595737|NCT01692782|525032666|FG001|Overall Study|Non-complance with study drug|4|||
145595738|NCT01692782|525032667|FG002|Overall Study|Non-complance with study drug|1|||
145595739|NCT01692782|525032665|FG000|Overall Study|Non-compliant with study visits|0|||
145595740|NCT01692782|525032666|FG001|Overall Study|Non-compliant with study visits|0|||
145595741|NCT01692782|525032667|FG002|Overall Study|Non-compliant with study visits|1|||
145595742|NCT01692782|525032665|FG000|Overall Study|SAE not related to study drug|0|||
145595743|NCT01692782|525032666|FG001|Overall Study|SAE not related to study drug|1|||
145595744|NCT01692782|525032667|FG002|Overall Study|SAE not related to study drug|0|||
145595745|NCT01692782|525032665|FG000|Overall Study|Withdrawal by Subject|3|||
145595746|NCT01692782|525032666|FG001|Overall Study|Withdrawal by Subject|10|||
145595747|NCT01692782|525032667|FG002|Overall Study|Withdrawal by Subject|3|||
145595748|NCT03945188|525032673|FG000|Overall Study|Protocol Violation|1|||
145595749|NCT03945188|525032674|FG001|Overall Study|Protocol Violation|0|||
145595750|NCT03945188|525032673|FG000|Overall Study|Disease worsening|79|||
145595751|NCT03945188|525032674|FG001|Overall Study|Disease worsening|73|||
145595752|NCT03945188|525032673|FG000|Overall Study|Physician Decision|2|||
145595753|NCT03945188|525032674|FG001|Overall Study|Physician Decision|2|||
145595754|NCT03945188|525032673|FG000|Overall Study|Lack of Efficacy|7|||
145595755|NCT03945188|525032674|FG001|Overall Study|Lack of Efficacy|4|||
145595756|NCT03945188|525032673|FG000|Overall Study|Pregnancy|2|||
145595757|NCT03945188|525032674|FG001|Overall Study|Pregnancy|0|||
145595758|NCT03945188|525032673|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
145595759|NCT03945188|525032674|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
145595760|NCT03945188|525032673|FG000|Overall Study|Adverse Event|10|||
145595761|NCT03945188|525032674|FG001|Overall Study|Adverse Event|5|||
145595762|NCT03945188|525032673|FG000|Overall Study|Other|2|||
145595763|NCT03945188|525032674|FG001|Overall Study|Other|2|||
145595764|NCT03945188|525032673|FG000|Overall Study|Lost to Follow-up|1|||
145595765|NCT03945188|525032674|FG001|Overall Study|Lost to Follow-up|2|||
145465484|NCT01174004|524556390|FG001|Overall Study|Physician Decision|0|||
145465485|NCT00933244|524556391|FG000|Overall Study|Withdrawal by Subject|5|||
145465486|NCT00933244|524556392|FG001|Overall Study|Withdrawal by Subject|1|||
145465487|NCT00933244|524556393|FG002|Overall Study|Withdrawal by Subject|3|||
145465488|NCT01995552|524556394|FG000|Overall Study|Protocol Violation|1|||
145465489|NCT01995552|524556394|FG000|Overall Study|Lack of Efficacy|15|||
145465490|NCT01995552|524556394|FG000|Overall Study|Death|1|||
145465491|NCT02639338|524556400|FG000|Overall Study|Lost to Follow-up|2|||
145465492|NCT02639338|524556401|FG001|Overall Study|Lost to Follow-up|2|||
145465493|NCT02639338|524556400|FG000|Overall Study|Withdrew Consent|1|||
145465494|NCT02639338|524556401|FG001|Overall Study|Withdrew Consent|2|||
145465495|NCT02639338|524556400|FG000|Overall Study|Death|1|||
145595766|NCT00868439|525032684|FG000|Overall Study|Adverse Event|4|||
145595767|NCT00868439|525032685|FG001|Overall Study|Adverse Event|3|||
145595768|NCT00868439|525032684|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
145595769|NCT00868439|525032685|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
145595770|NCT00868439|525032684|FG000|Overall Study|Death|0|||
145595771|NCT00868439|525032685|FG001|Overall Study|Death|1|||
145465496|NCT02639338|524556401|FG001|Overall Study|Death|0|||
145595772|NCT00868439|525032684|FG000|Overall Study|Protocol Violation|1|||
145595773|NCT00868439|525032685|FG001|Overall Study|Protocol Violation|1|||
145595774|NCT00868439|525032684|FG000|Overall Study|Physician Decision|1|||
145595775|NCT00868439|525032685|FG001|Overall Study|Physician Decision|0|||
145595776|NCT00868439|525032684|FG000|Overall Study|Withdrawal by Subject|0|||
145595777|NCT00868439|525032685|FG001|Overall Study|Withdrawal by Subject|1|||
145595778|NCT00224874|525032690|FG000|Overall Study|Withdrawal by Subject|0|||
145595779|NCT00224874|525032691|FG001|Overall Study|Withdrawal by Subject|0|||
145595780|NCT00224874|525032692|FG002|Overall Study|Withdrawal by Subject|1|||
145595781|NCT00224874|525032693|FG003|Overall Study|Withdrawal by Subject|0|||
145595782|NCT00911534|525032694|FG000|Overall Study|Adverse Event|4|||
145465497|NCT02639338|524556400|FG000|Overall Study|Randomized but Not Treated|0|||
145595783|NCT00911534|525032695|FG001|Overall Study|Adverse Event|4|||
145595784|NCT00911534|525032694|FG000|Overall Study|Lost to Follow-up|2|||
145465498|NCT02639338|524556401|FG001|Overall Study|Randomized but Not Treated|1|||
145465499|NCT02360293|524556405|FG000|Overall Study|Lost to Follow-up|73|||
145465500|NCT02360293|524556406|FG001|Overall Study|Lost to Follow-up|95|||
145465501|NCT02360293|524556405|FG000|Overall Study|Withdrawal by Subject|2|||
145465502|NCT02360293|524556406|FG001|Overall Study|Withdrawal by Subject|1|||
145465503|NCT02360293|524556405|FG000|Overall Study|Excluded|1|||
145465504|NCT02360293|524556406|FG001|Overall Study|Excluded|0|||
145465505|NCT02226549|524556407|FG000|Overall Study|Randomized but Never Treated|1|||
145465506|NCT02226549|524556408|FG001|Overall Study|Randomized but Never Treated|0|||
145465507|NCT02226549|524556407|FG000|Overall Study|Lost to Follow-up|0|||
145465508|NCT02226549|524556408|FG001|Overall Study|Lost to Follow-up|1|||
145465509|NCT02741570|524556411|FG000|Pre-Treatment Period|Other reasons|0|||
145465510|NCT02741570|524556412|FG001|Pre-Treatment Period|Other reasons|3|||
145465511|NCT02741570|524556411|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
145465512|NCT02741570|524556412|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
145465513|NCT02741570|524556411|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
145465514|NCT02741570|524556412|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
145465515|NCT02741570|524556411|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
145465516|NCT02741570|524556412|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
145465517|NCT02741570|524556411|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
145465518|NCT02741570|524556412|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
145465519|NCT02741570|524556411|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
145465520|NCT02741570|524556412|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
145465521|NCT02741570|524556411|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
145465522|NCT02741570|524556412|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145465523|NCT02741570|524556411|FG000|Pre-Treatment Period|Death|0|||
145465524|NCT02741570|524556412|FG001|Pre-Treatment Period|Death|1|||
145465525|NCT02741570|524556411|FG000|Pre-Treatment Period|Disease progression|0|||
145465526|NCT02741570|524556412|FG001|Pre-Treatment Period|Disease progression|1|||
145465527|NCT02741570|524556411|FG000|Treatment Period|Other reasons|47|||
145465528|NCT02741570|524556412|FG001|Treatment Period|Other reasons|12|||
145465529|NCT02741570|524556411|FG000|Treatment Period|Poor/non-compliance|0|||
145465530|NCT02741570|524556412|FG001|Treatment Period|Poor/non-compliance|2|||
145465531|NCT02741570|524556411|FG000|Treatment Period|Maximum clinical benefit|4|||
145465532|NCT02741570|524556412|FG001|Treatment Period|Maximum clinical benefit|6|||
145465533|NCT02741570|524556411|FG000|Treatment Period|Lost to Follow-up|1|||
145465534|NCT02741570|524556412|FG001|Treatment Period|Lost to Follow-up|3|||
145465535|NCT02741570|524556411|FG000|Treatment Period|Participant withdrew consent|9|||
145465536|NCT02741570|524556412|FG001|Treatment Period|Participant withdrew consent|13|||
145465537|NCT02741570|524556411|FG000|Treatment Period|Participant request to discontinue treatment|8|||
145465538|NCT02741570|524556412|FG001|Treatment Period|Participant request to discontinue treatment|23|||
145465539|NCT02741570|524556411|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
145465540|NCT02741570|524556412|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
145465541|NCT02741570|524556411|FG000|Treatment Period|Death|9|||
145465542|NCT02741570|524556412|FG001|Treatment Period|Death|7|||
145465543|NCT02741570|524556411|FG000|Treatment Period|Study drug toxicity|55|||
145465544|NCT02741570|524556412|FG001|Treatment Period|Study drug toxicity|47|||
145465545|NCT02741570|524556411|FG000|Treatment Period|Disease progression|294|||
145465546|NCT02741570|524556412|FG001|Treatment Period|Disease progression|301|||
145465547|NCT02741570|524556411|FG000|Treatment Period|Administrative reason by sponsor|0|||
145465548|NCT02741570|524556412|FG001|Treatment Period|Administrative reason by sponsor|1|||
145465549|NCT00946322|524556413|FG000|Pre-treatment|participant failure to follow up|1|||
145465550|NCT00946322|524556413|FG000|Post-treatment|participant failure to follow up|2|||
145465551|NCT04384107|524556417|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
145465552|NCT04384107|524556418|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
145465553|NCT04384107|524556417|FG000|Overall Study|Lost to Follow-up|1|||
145465554|NCT04384107|524556418|FG001|Overall Study|Lost to Follow-up|0|||
145465555|NCT00276614|524556419|FG000|Overall Study|Progression of disease under study|3|||
145465556|NCT00459537|524556431|FG000|Overall Study|Adverse Event|1|||
145465557|NCT00459537|524556432|FG001|Overall Study|Adverse Event|6|||
145465558|NCT00459537|524556431|FG000|Overall Study|Lack of Efficacy|10|||
145465559|NCT00459537|524556432|FG001|Overall Study|Lack of Efficacy|11|||
145465560|NCT00459537|524556431|FG000|Overall Study|Withdrawal by Subject|20|||
145465561|NCT00459537|524556432|FG001|Overall Study|Withdrawal by Subject|26|||
145465562|NCT00459537|524556431|FG000|Overall Study|Lost to Follow-up|27|||
145465563|NCT00459537|524556432|FG001|Overall Study|Lost to Follow-up|30|||
145465564|NCT00459537|524556431|FG000|Overall Study|Administrative problems|3|||
145465565|NCT00459537|524556432|FG001|Overall Study|Administrative problems|0|||
145465566|NCT00459537|524556431|FG000|Overall Study|Protocol Violation|4|||
145465567|NCT00459537|524556432|FG001|Overall Study|Protocol Violation|3|||
145465568|NCT00459537|524556431|FG000|Overall Study|Missing|1|||
145465569|NCT00459537|524556432|FG001|Overall Study|Missing|0|||
145465570|NCT01831817|524556433|FG000|Overall Study|Lost to Follow-up|1|||
145465571|NCT01831817|524556434|FG001|Overall Study|Lost to Follow-up|0|||
145465572|NCT01831817|524556435|FG002|Overall Study|Lost to Follow-up|0|||
145595785|NCT00911534|525032695|FG001|Overall Study|Lost to Follow-up|4|||
145595786|NCT00911534|525032694|FG000|Overall Study|Withdrawal by Subject|2|||
145595787|NCT00911534|525032695|FG001|Overall Study|Withdrawal by Subject|1|||
145595788|NCT00911534|525032694|FG000|Overall Study|Lack of Efficacy|4|||
145595789|NCT00911534|525032695|FG001|Overall Study|Lack of Efficacy|1|||
145595790|NCT00911534|525032694|FG000|Overall Study|Withdrawal of consent|1|||
145595791|NCT00911534|525032695|FG001|Overall Study|Withdrawal of consent|4|||
145595792|NCT00911534|525032694|FG000|Overall Study|Other|2|||
145595793|NCT00911534|525032695|FG001|Overall Study|Other|2|||
145595794|NCT04867369|525032696|FG000|Overall Study|Withdrawal by Subject|1|||
145595795|NCT04867369|525032697|FG001|Overall Study|Withdrawal by Subject|0|||
145595796|NCT05554237|525032698|FG000|Part 2 (7 Days)|Adverse Event|0|||
145595797|NCT05554237|525032699|FG001|Part 2 (7 Days)|Adverse Event|0|||
145595798|NCT05554237|525032700|FG002|Part 2 (7 Days)|Adverse Event|0|||
145595799|NCT05554237|525032701|FG003|Part 2 (7 Days)|Adverse Event|0|||
145595800|NCT05554237|525032702|FG004|Part 2 (7 Days)|Adverse Event|2|||
145595801|NCT05554237|525032703|FG005|Part 2 (7 Days)|Adverse Event|0|||
145595802|NCT05554237|525032704|FG006|Part 2 (7 Days)|Adverse Event|0|||
145595803|NCT05554237|525032705|FG007|Part 2 (7 Days)|Adverse Event|0|||
145595804|NCT05554237|525032706|FG008|Part 2 (7 Days)|Adverse Event|0|||
145595805|NCT05554237|525032707|FG009|Part 2 (7 Days)|Adverse Event|1|||
145595806|NCT05554237|525032708|FG010|Part 2 (7 Days)|Adverse Event|0|||
145595807|NCT05554237|525032709|FG011|Part 2 (7 Days)|Adverse Event|0|||
145595808|NCT05554237|525032710|FG012|Part 2 (7 Days)|Adverse Event|1|||
145595809|NCT05554237|525032711|FG013|Part 2 (7 Days)|Adverse Event|0|||
145595810|NCT02477111|525032712|FG000|Overall Study|Death|28|||
145595811|NCT02477111|525032712|FG000|Overall Study|Withdrawal by Subject|19|||
145595812|NCT02477111|525032712|FG000|Overall Study|Lost to Follow-up|4|||
145595813|NCT04575467|525032714|FG000|Overall Study|Adverse Event|0|||
145595814|NCT04575467|525032715|FG001|Overall Study|Adverse Event|1|||
145595815|NCT04575467|525032716|FG002|Overall Study|Adverse Event|0|||
145595816|NCT04575467|525032717|FG003|Overall Study|Adverse Event|0|||
145595817|NCT02677116|525032720|FG000|Overall Study|Adverse Event|0|||
145595818|NCT02677116|525032721|FG001|Overall Study|Adverse Event|1|||
145595819|NCT02677116|525032722|FG002|Overall Study|Adverse Event|0|||
145595820|NCT02677116|525032723|FG003|Overall Study|Adverse Event|0|||
145595821|NCT02677116|525032724|FG004|Overall Study|Adverse Event|0|||
145595822|NCT02677116|525032725|FG005|Overall Study|Adverse Event|1|||
145595823|NCT02677116|525032726|FG006|Overall Study|Adverse Event|1|||
145595824|NCT02677116|525032727|FG007|Overall Study|Adverse Event|0|||
145595825|NCT02677116|525032728|FG008|Overall Study|Adverse Event|0|||
145595826|NCT02677116|525032720|FG000|Overall Study|Physician Decision|0|||
145595827|NCT02677116|525032721|FG001|Overall Study|Physician Decision|2|||
145595828|NCT02677116|525032722|FG002|Overall Study|Physician Decision|3|||
145595829|NCT02677116|525032723|FG003|Overall Study|Physician Decision|2|||
145595830|NCT02677116|525032724|FG004|Overall Study|Physician Decision|1|||
145595831|NCT02677116|525032725|FG005|Overall Study|Physician Decision|3|||
145595832|NCT02677116|525032726|FG006|Overall Study|Physician Decision|1|||
145595833|NCT02677116|525032727|FG007|Overall Study|Physician Decision|1|||
145595834|NCT02677116|525032728|FG008|Overall Study|Physician Decision|2|||
145595835|NCT02677116|525032720|FG000|Overall Study|Withdrawal by parent or guardian|2|||
145595836|NCT02677116|525032721|FG001|Overall Study|Withdrawal by parent or guardian|1|||
145595837|NCT02677116|525032722|FG002|Overall Study|Withdrawal by parent or guardian|0|||
145595838|NCT02677116|525032723|FG003|Overall Study|Withdrawal by parent or guardian|1|||
145595839|NCT02677116|525032724|FG004|Overall Study|Withdrawal by parent or guardian|0|||
145595840|NCT02677116|525032725|FG005|Overall Study|Withdrawal by parent or guardian|0|||
145595841|NCT02677116|525032726|FG006|Overall Study|Withdrawal by parent or guardian|2|||
145595842|NCT02677116|525032727|FG007|Overall Study|Withdrawal by parent or guardian|1|||
145595843|NCT02677116|525032728|FG008|Overall Study|Withdrawal by parent or guardian|0|||
145595844|NCT02677116|525032720|FG000|Overall Study|Withdrawal by Subject|1|||
145595845|NCT02677116|525032721|FG001|Overall Study|Withdrawal by Subject|0|||
145595846|NCT02677116|525032722|FG002|Overall Study|Withdrawal by Subject|0|||
145595847|NCT02677116|525032723|FG003|Overall Study|Withdrawal by Subject|0|||
145595848|NCT02677116|525032724|FG004|Overall Study|Withdrawal by Subject|0|||
145595849|NCT02677116|525032725|FG005|Overall Study|Withdrawal by Subject|0|||
145595850|NCT02677116|525032726|FG006|Overall Study|Withdrawal by Subject|0|||
145595851|NCT02677116|525032727|FG007|Overall Study|Withdrawal by Subject|0|||
145595852|NCT02677116|525032728|FG008|Overall Study|Withdrawal by Subject|0|||
145595853|NCT03182868|525032729|FG000|Overall Study|Protocol Violation|3|||
145595854|NCT03182868|525032730|FG001|Overall Study|Protocol Violation|0|||
145595855|NCT03182868|525032731|FG002|Overall Study|Protocol Violation|4|||
145595856|NCT03182868|525032732|FG003|Overall Study|Protocol Violation|1|||
145595857|NCT03182868|525032733|FG004|Overall Study|Protocol Violation|8|||
145595858|NCT03213158|525032736|FG000|Overall Study|Withdrawal by Subject|1|||
145595859|NCT03213158|525032736|FG000|Overall Study|Physician Decision|2|||
145595860|NCT01569438|525032740|FG000|Overall Study|Lack of Efficacy|1|||
145465573|NCT01831817|524556436|FG003|Overall Study|Lost to Follow-up|0|||
145595861|NCT01569438|525032741|FG001|Overall Study|Lack of Efficacy|2|||
145595862|NCT01569438|525032740|FG000|Overall Study|Withdrawal by Subject|0|||
145595863|NCT01569438|525032741|FG001|Overall Study|Withdrawal by Subject|3|||
145595864|NCT01569438|525032740|FG000|Overall Study|Adverse Event|2|||
145595865|NCT01569438|525032741|FG001|Overall Study|Adverse Event|15|||
145595866|NCT01569438|525032740|FG000|Overall Study|Protocol Violation|2|||
145595867|NCT01569438|525032741|FG001|Overall Study|Protocol Violation|0|||
145595868|NCT01569438|525032740|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
145595869|NCT01569438|525032741|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
145595870|NCT01569438|525032740|FG000|Overall Study|Sponsor/Physician decision|1|||
145595871|NCT01569438|525032741|FG001|Overall Study|Sponsor/Physician decision|1|||
145595872|NCT01569438|525032740|FG000|Overall Study|Unable to adhere to study schedule|0|||
145595873|NCT01569438|525032741|FG001|Overall Study|Unable to adhere to study schedule|1|||
145595874|NCT01207102|525032742|FG000|Overall Study|Withdrawal by Subject|5|||
145595875|NCT01207102|525032742|FG000|Overall Study|Adverse Event|2|||
145595876|NCT01207102|525032742|FG000|Overall Study|progression|2|||
145595877|NCT01207102|525032742|FG000|Overall Study|Withdrawal by Treating Physician|1|||
145595878|NCT03649230|525032743|FG000|Overall Study|Adverse Event|12|||
145595879|NCT03649230|525032743|FG000|Overall Study|Death|8|||
145595880|NCT03649230|525032743|FG000|Overall Study|Withdrawal by Subject|6|||
145595881|NCT03649230|525032743|FG000|Overall Study|Physician Decision|5|||
145595882|NCT03649230|525032743|FG000|Overall Study|Disease progression|5|||
145595883|NCT03649230|525032743|FG000|Overall Study|Switched to non-HEC|5|||
145595884|NCT03649230|525032743|FG000|Overall Study|Chemotherapy discontinued|4|||
145595885|NCT03649230|525032743|FG000|Overall Study|Received only 3 HEC cycles|4|||
145595886|NCT03649230|525032743|FG000|Overall Study|Screen Failure|3|||
145595887|NCT03649230|525032743|FG000|Overall Study|Patient stopped treatment|2|||
145595888|NCT03649230|525032743|FG000|Overall Study|Protocol Violation|1|||
145595889|NCT03649230|525032743|FG000|Overall Study|Non-compliance|1|||
145595890|NCT03649230|525032743|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
145595891|NCT01693068|525032744|FG000|Randomization Period|On-study|2|||
145595892|NCT01693068|525032745|FG001|Randomization Period|On-study|5|||
145595893|NCT01693068|525032746|FG002|Randomization Period|On-study|0|||
145595894|NCT01693068|525032744|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
145595895|NCT01693068|525032745|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
145595896|NCT01693068|525032746|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
145595897|NCT00295022|525032747|FG000|Overall Study|Adverse Event|1|||
145595898|NCT00295022|525032748|FG001|Overall Study|Adverse Event|1|||
145595899|NCT00295022|525032749|FG002|Overall Study|Adverse Event|2|||
145595900|NCT00295022|525032747|FG000|Overall Study|Lost to Follow-up|0|||
145595901|NCT00295022|525032748|FG001|Overall Study|Lost to Follow-up|0|||
145595902|NCT00295022|525032749|FG002|Overall Study|Lost to Follow-up|1|||
145595903|NCT00295022|525032747|FG000|Overall Study|Withdrawal by Subject|0|||
145595904|NCT00295022|525032748|FG001|Overall Study|Withdrawal by Subject|0|||
145595905|NCT00295022|525032749|FG002|Overall Study|Withdrawal by Subject|2|||
145595906|NCT00734630|525032751|FG000|Overall Study|Lack of Efficacy|4|||
145595907|NCT00734630|525032752|FG001|Overall Study|Lack of Efficacy|4|||
145595908|NCT00734630|525032751|FG000|Overall Study|Withdrawal by Subject|7|||
145595909|NCT00734630|525032752|FG001|Overall Study|Withdrawal by Subject|9|||
145595910|NCT00734630|525032751|FG000|Overall Study|Lost to Follow-up|13|||
145595911|NCT00734630|525032752|FG001|Overall Study|Lost to Follow-up|7|||
145595912|NCT00734630|525032751|FG000|Overall Study|Protocol Violation|0|||
145595913|NCT00734630|525032752|FG001|Overall Study|Protocol Violation|3|||
145595914|NCT00734630|525032751|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
145595915|NCT00734630|525032752|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
145595916|NCT00734630|525032751|FG000|Overall Study|Adverse Event|3|||
145595917|NCT00734630|525032752|FG001|Overall Study|Adverse Event|6|||
145595918|NCT00734630|525032751|FG000|Overall Study|Randomized in Error|0|||
145595919|NCT00734630|525032752|FG001|Overall Study|Randomized in Error|1|||
145595920|NCT00734630|525032751|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
145595921|NCT00734630|525032752|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
145595922|NCT00734630|525032751|FG000|Overall Study|Poor Compliance|1|||
145595923|NCT00734630|525032752|FG001|Overall Study|Poor Compliance|1|||
145595924|NCT01239030|525032753|FG000|Double Blind|Adverse Event|0|||
145595925|NCT01239030|525032754|FG001|Double Blind|Adverse Event|1|||
145595926|NCT01239030|525032755|FG002|Double Blind|Adverse Event|0|||
145595927|NCT01239030|525032756|FG003|Double Blind|Adverse Event|2|||
145595928|NCT01239030|525032757|FG004|Double Blind|Adverse Event|0|||
145595929|NCT01239030|525032753|FG000|Double Blind|Withdrawal by Subject|0|||
145595930|NCT01239030|525032754|FG001|Double Blind|Withdrawal by Subject|1|||
145595931|NCT01239030|525032755|FG002|Double Blind|Withdrawal by Subject|1|||
145595932|NCT01239030|525032756|FG003|Double Blind|Withdrawal by Subject|0|||
145595933|NCT01239030|525032757|FG004|Double Blind|Withdrawal by Subject|1|||
145595934|NCT01239030|525032753|FG000|Double Blind|Lost to Follow-up|1|||
145595935|NCT01239030|525032754|FG001|Double Blind|Lost to Follow-up|1|||
145595936|NCT01239030|525032755|FG002|Double Blind|Lost to Follow-up|0|||
145595937|NCT01239030|525032756|FG003|Double Blind|Lost to Follow-up|0|||
145595938|NCT01239030|525032757|FG004|Double Blind|Lost to Follow-up|0|||
145595939|NCT01239030|525032753|FG000|Double Blind|Physician Decision|0|||
145465574|NCT01831817|524556433|FG000|Overall Study|Withdrawl of Consent|3|||
145465575|NCT01831817|524556434|FG001|Overall Study|Withdrawl of Consent|0|||
145465576|NCT01831817|524556435|FG002|Overall Study|Withdrawl of Consent|0|||
145465577|NCT01831817|524556436|FG003|Overall Study|Withdrawl of Consent|0|||
145465578|NCT03159104|524556437|FG000|Overall Study|Violation of inclusion criteria|1|||
145465579|NCT03159104|524556438|FG001|Overall Study|Violation of inclusion criteria|2|||
145465580|NCT00958217|524556439|FG000|Overall Study|Death|2|||
145465581|NCT00958217|524556440|FG001|Overall Study|Death|1|||
145465582|NCT00958217|524556439|FG000|Overall Study|Withdrawal by Subject|4|||
145465583|NCT00958217|524556440|FG001|Overall Study|Withdrawal by Subject|3|||
145465584|NCT00958217|524556439|FG000|Overall Study|Lost to Follow-up|17|||
145465585|NCT00958217|524556440|FG001|Overall Study|Lost to Follow-up|19|||
145465586|NCT00958217|524556439|FG000|Overall Study|Moved out of area|1|||
145465587|NCT00958217|524556440|FG001|Overall Study|Moved out of area|1|||
145465588|NCT00958217|524556439|FG000|Overall Study|Inpatient hospitalization|0|||
145465589|NCT00958217|524556440|FG001|Overall Study|Inpatient hospitalization|1|||
145465590|NCT02198235|524556442|FG000|Overall Study|Lost to Follow-up|3|||
145465591|NCT02198235|524556443|FG001|Overall Study|Lost to Follow-up|2|||
145465592|NCT02198235|524556444|FG002|Overall Study|Lost to Follow-up|2|||
145465593|NCT04573881|524556447|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
145465594|NCT01999218|524556448|FG000|Overall Study|Hyperglycemia|18|||
145465595|NCT01999218|524556449|FG001|Overall Study|Hyperglycemia|17|||
145465596|NCT01999218|524556450|FG002|Overall Study|Hyperglycemia|17|||
145465597|NCT01999218|524556448|FG000|Overall Study|Lack of Efficacy|1|||
145465598|NCT01999218|524556449|FG001|Overall Study|Lack of Efficacy|0|||
145465599|NCT01999218|524556450|FG002|Overall Study|Lack of Efficacy|1|||
145465600|NCT01999218|524556448|FG000|Overall Study|Lost to Follow-up|22|||
145465601|NCT01999218|524556449|FG001|Overall Study|Lost to Follow-up|17|||
145465602|NCT01999218|524556450|FG002|Overall Study|Lost to Follow-up|18|||
145465603|NCT01999218|524556448|FG000|Overall Study|Non-Compliance With Study Drug|6|||
145465604|NCT01999218|524556449|FG001|Overall Study|Non-Compliance With Study Drug|4|||
145465605|NCT01999218|524556450|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145465606|NCT01999218|524556448|FG000|Overall Study|Physician Decision|1|||
145465607|NCT01999218|524556449|FG001|Overall Study|Physician Decision|4|||
145465608|NCT01999218|524556450|FG002|Overall Study|Physician Decision|6|||
145465609|NCT01999218|524556448|FG000|Overall Study|Protocol Violation|4|||
145465610|NCT01999218|524556449|FG001|Overall Study|Protocol Violation|5|||
145465611|NCT01999218|524556450|FG002|Overall Study|Protocol Violation|4|||
145465612|NCT01999218|524556448|FG000|Overall Study|Screen failure|0|||
145465613|NCT01999218|524556449|FG001|Overall Study|Screen failure|1|||
145465614|NCT01999218|524556450|FG002|Overall Study|Screen failure|0|||
145465615|NCT01999218|524556448|FG000|Overall Study|Study Terminated By Sponsor|7|||
145465616|NCT01999218|524556449|FG001|Overall Study|Study Terminated By Sponsor|5|||
145465617|NCT01999218|524556450|FG002|Overall Study|Study Terminated By Sponsor|12|||
145465618|NCT01999218|524556448|FG000|Overall Study|Participant moves|2|||
145465619|NCT01999218|524556449|FG001|Overall Study|Participant moves|5|||
145465620|NCT01999218|524556450|FG002|Overall Study|Participant moves|3|||
145465621|NCT01999218|524556448|FG000|Overall Study|Withdrawal by Subject|28|||
145465622|NCT01999218|524556449|FG001|Overall Study|Withdrawal by Subject|29|||
145465623|NCT01999218|524556450|FG002|Overall Study|Withdrawal by Subject|34|||
145465624|NCT01999218|524556448|FG000|Overall Study|Creatinine/eGFR|0|||
145465625|NCT01999218|524556449|FG001|Overall Study|Creatinine/eGFR|0|||
145465626|NCT01999218|524556450|FG002|Overall Study|Creatinine/eGFR|1|||
145465627|NCT01999218|524556448|FG000|Overall Study|Death|7|||
145465628|NCT01999218|524556449|FG001|Overall Study|Death|1|||
145465629|NCT01999218|524556450|FG002|Overall Study|Death|2|||
145465630|NCT01999218|524556448|FG000|Overall Study|Excluded Medication|1|||
145465631|NCT01999218|524556449|FG001|Overall Study|Excluded Medication|1|||
145465632|NCT01999218|524556450|FG002|Overall Study|Excluded Medication|2|||
145465633|NCT01999218|524556448|FG000|Overall Study|Adverse Event|9|||
145465634|NCT01999218|524556449|FG001|Overall Study|Adverse Event|7|||
145465635|NCT01999218|524556450|FG002|Overall Study|Adverse Event|7|||
145465636|NCT01999218|524556448|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
145465637|NCT01999218|524556449|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
145465638|NCT01999218|524556450|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
145465639|NCT03647267|524557980|FG000|Overall Study|Lost to Follow-up|1|||
145465640|NCT03647267|524557981|FG001|Overall Study|Lost to Follow-up|0|||
145465641|NCT03131596|524557982|FG000|Overall Study|Protocol Violation|3|||
145465642|NCT03131596|524557983|FG001|Overall Study|Protocol Violation|3|||
145595940|NCT01239030|525032754|FG001|Double Blind|Physician Decision|1|||
145465643|NCT03131596|524557982|FG000|Overall Study|Lost to Follow-up|3|||
145465644|NCT03131596|524557983|FG001|Overall Study|Lost to Follow-up|0|||
145465645|NCT03654885|524557984|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
145465646|NCT03654885|524557985|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
145465647|NCT03654885|524557984|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
145465648|NCT03654885|524557985|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
145465649|NCT03654885|524557984|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
145595941|NCT01239030|525032755|FG002|Double Blind|Physician Decision|0|||
145595942|NCT01239030|525032756|FG003|Double Blind|Physician Decision|0|||
145595943|NCT01239030|525032757|FG004|Double Blind|Physician Decision|0|||
145595944|NCT01239030|525032753|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
145595945|NCT01239030|525032754|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
145595946|NCT01239030|525032755|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
145595947|NCT01239030|525032756|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
145595948|NCT01239030|525032757|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
145595949|NCT01239030|525032753|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
145595950|NCT01239030|525032754|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
145595951|NCT01239030|525032755|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
145595952|NCT01239030|525032756|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
145595953|NCT01239030|525032757|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
145595954|NCT01239030|525032753|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
145595955|NCT01239030|525032754|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
145595956|NCT01239030|525032755|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
145595957|NCT01239030|525032756|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
145595958|NCT01239030|525032757|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
145595959|NCT01239030|525032753|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
145595960|NCT01239030|525032754|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
145595961|NCT01239030|525032755|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
145595962|NCT01239030|525032756|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
145595963|NCT01239030|525032757|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
145595964|NCT01330433|525032758|FG000|Overall Study|Death|1|||
145595965|NCT01330433|525032759|FG001|Overall Study|Death|3|||
145595966|NCT01330433|525032758|FG000|Overall Study|Lost to Follow-up|1|||
145595967|NCT01330433|525032759|FG001|Overall Study|Lost to Follow-up|0|||
145595968|NCT03240692|525032770|FG000|Overall Study|Physician Decision|1|||
145595969|NCT03240692|525032770|FG000|Overall Study|Withdrawal by Subject|1|||
145595970|NCT02300220|525032771|FG000|Overall Study|Lost to Follow-up|1|||
145595971|NCT02300220|525032772|FG001|Overall Study|Lost to Follow-up|2|||
145595972|NCT02300220|525032771|FG000|Overall Study|Death|1|||
145595973|NCT02300220|525032772|FG001|Overall Study|Death|1|||
145595974|NCT02300220|525032771|FG000|Overall Study|Adverse Event|1|||
145595975|NCT02300220|525032772|FG001|Overall Study|Adverse Event|1|||
145595976|NCT02300220|525032771|FG000|Overall Study|Protocol Violation|1|||
145595977|NCT02300220|525032772|FG001|Overall Study|Protocol Violation|0|||
145595978|NCT02300220|525032771|FG000|Overall Study|Withdrawal by Subject|0|||
145595979|NCT02300220|525032772|FG001|Overall Study|Withdrawal by Subject|2|||
145595980|NCT02300220|525032771|FG000|Overall Study|Did not tolerate IMP|0|||
145595981|NCT02300220|525032772|FG001|Overall Study|Did not tolerate IMP|1|||
145595982|NCT02238379|525032773|FG000|Overall Study|Lost to Follow-up|1|||
145595983|NCT02238379|525032774|FG001|Overall Study|Lost to Follow-up|0|||
145595984|NCT04123067|525032775|FG000|Overall Study|Lost to Follow-up|0|||
145595985|NCT04123067|525032776|FG001|Overall Study|Lost to Follow-up|1|||
145595986|NCT00605280|525032777|FG000|Year 1|Protocol Violation|0|||
145595987|NCT00605280|525032778|FG001|Year 1|Protocol Violation|0|||
145595988|NCT00605280|525032779|FG002|Year 1|Protocol Violation|0|||
145595989|NCT00605280|525032780|FG003|Year 1|Protocol Violation|1|||
145595990|NCT00605280|525032777|FG000|Year 1|Adverse Event|3|||
145595991|NCT00605280|525032778|FG001|Year 1|Adverse Event|1|||
145595992|NCT00605280|525032779|FG002|Year 1|Adverse Event|1|||
145595993|NCT00605280|525032780|FG003|Year 1|Adverse Event|5|||
145595994|NCT00605280|525032777|FG000|Year 1|Physician Decision|7|||
145595995|NCT00605280|525032778|FG001|Year 1|Physician Decision|4|||
145595996|NCT00605280|525032779|FG002|Year 1|Physician Decision|0|||
145595997|NCT00605280|525032780|FG003|Year 1|Physician Decision|6|||
145595998|NCT00605280|525032777|FG000|Year 1|Withdrawal by Subject|2|||
145595999|NCT00605280|525032778|FG001|Year 1|Withdrawal by Subject|4|||
145596000|NCT00605280|525032779|FG002|Year 1|Withdrawal by Subject|0|||
145596001|NCT00605280|525032780|FG003|Year 1|Withdrawal by Subject|4|||
145596002|NCT00605280|525032777|FG000|Year 1|Other|2|||
145596003|NCT00605280|525032778|FG001|Year 1|Other|1|||
145596004|NCT00605280|525032779|FG002|Year 1|Other|0|||
145596005|NCT00605280|525032780|FG003|Year 1|Other|1|||
145596006|NCT00605280|525032777|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
145596007|NCT00605280|525032778|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
145596008|NCT00605280|525032779|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
145596009|NCT00605280|525032780|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
145596010|NCT00605280|525032777|FG000|Year 2|Adverse Event|4|||
145596011|NCT00605280|525032778|FG001|Year 2|Adverse Event|0|||
145596012|NCT00605280|525032779|FG002|Year 2|Adverse Event|2|||
145596013|NCT00605280|525032780|FG003|Year 2|Adverse Event|4|||
145596014|NCT00605280|525032777|FG000|Year 2|Physician Decision|11|||
145596015|NCT00605280|525032778|FG001|Year 2|Physician Decision|6|||
145596016|NCT00605280|525032779|FG002|Year 2|Physician Decision|4|||
145596017|NCT00605280|525032780|FG003|Year 2|Physician Decision|11|||
145596018|NCT00605280|525032777|FG000|Year 2|Withdrawal by Subject|4|||
145596019|NCT00605280|525032778|FG001|Year 2|Withdrawal by Subject|0|||
145596020|NCT00605280|525032779|FG002|Year 2|Withdrawal by Subject|0|||
145596021|NCT00605280|525032780|FG003|Year 2|Withdrawal by Subject|4|||
145596022|NCT00605280|525032777|FG000|Year 2|Other|1|||
145596023|NCT00605280|525032778|FG001|Year 2|Other|0|||
145596024|NCT00605280|525032779|FG002|Year 2|Other|0|||
145596025|NCT00605280|525032780|FG003|Year 2|Other|1|||
145596026|NCT00605280|525032777|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
145596027|NCT00605280|525032778|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
145596028|NCT00605280|525032779|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
145596029|NCT00605280|525032780|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
145596030|NCT00605280|525032777|FG000|Year 3 Extension|Adverse Event|2|||
145596031|NCT00605280|525032778|FG001|Year 3 Extension|Adverse Event|0|||
145596032|NCT00605280|525032779|FG002|Year 3 Extension|Adverse Event|0|||
145596033|NCT00605280|525032780|FG003|Year 3 Extension|Adverse Event|2|||
145596034|NCT00605280|525032777|FG000|Year 3 Extension|Physician Decision|0|||
145596035|NCT00605280|525032778|FG001|Year 3 Extension|Physician Decision|0|||
145596036|NCT00605280|525032779|FG002|Year 3 Extension|Physician Decision|0|||
145596037|NCT00605280|525032780|FG003|Year 3 Extension|Physician Decision|2|||
145596038|NCT00605280|525032777|FG000|Year 3 Extension|Withdrawal by Subject|2|||
145596039|NCT00605280|525032778|FG001|Year 3 Extension|Withdrawal by Subject|0|||
145596040|NCT00605280|525032779|FG002|Year 3 Extension|Withdrawal by Subject|0|||
145596041|NCT00605280|525032780|FG003|Year 3 Extension|Withdrawal by Subject|5|||
145596042|NCT00605280|525032777|FG000|Year 3 Extension|Other|2|||
145596043|NCT00605280|525032778|FG001|Year 3 Extension|Other|0|||
145596044|NCT00605280|525032779|FG002|Year 3 Extension|Other|0|||
145596045|NCT00605280|525032780|FG003|Year 3 Extension|Other|0|||
145596046|NCT00605280|525032777|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
145596047|NCT00605280|525032778|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
145596048|NCT00605280|525032779|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
145596049|NCT00605280|525032780|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
145596050|NCT00127101|525032781|FG000|Base Protocol|Adverse Event|0|||
145596051|NCT00127101|525032782|FG001|Base Protocol|Adverse Event|2|||
145596052|NCT00127101|525032783|FG002|Base Protocol|Adverse Event|1|||
145596053|NCT00127101|525032784|FG003|Base Protocol|Adverse Event|0|||
145596054|NCT00127101|525032785|FG004|Base Protocol|Adverse Event|0|||
145596055|NCT00127101|525032786|FG005|Base Protocol|Adverse Event|0|||
145596056|NCT00127101|525032781|FG000|Base Protocol|Lack of Efficacy|1|||
145596057|NCT00127101|525032782|FG001|Base Protocol|Lack of Efficacy|0|||
145596058|NCT00127101|525032783|FG002|Base Protocol|Lack of Efficacy|0|||
145596059|NCT00127101|525032784|FG003|Base Protocol|Lack of Efficacy|0|||
145596060|NCT00127101|525032785|FG004|Base Protocol|Lack of Efficacy|2|||
145596061|NCT00127101|525032786|FG005|Base Protocol|Lack of Efficacy|0|||
145596062|NCT00127101|525032781|FG000|Base Protocol|Withdrawal by Subject|1|||
145596063|NCT00127101|525032782|FG001|Base Protocol|Withdrawal by Subject|2|||
145596064|NCT00127101|525032783|FG002|Base Protocol|Withdrawal by Subject|1|||
145596065|NCT00127101|525032784|FG003|Base Protocol|Withdrawal by Subject|0|||
145596066|NCT00127101|525032785|FG004|Base Protocol|Withdrawal by Subject|0|||
145596067|NCT00127101|525032786|FG005|Base Protocol|Withdrawal by Subject|1|||
145596068|NCT00127101|525032781|FG000|Continuation Phase|Adverse Event|0|||
145596069|NCT00127101|525032782|FG001|Continuation Phase|Adverse Event|0|||
145627012|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
145465650|NCT03654885|524557985|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
145465651|NCT03654885|524557984|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
145465652|NCT03654885|524557985|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
145465653|NCT03654885|524557984|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
145465654|NCT03654885|524557985|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
145465655|NCT03654885|524557984|FG000|Overall Study|Adverse Event in Study Eye|3|||
145465656|NCT03654885|524557985|FG001|Overall Study|Adverse Event in Study Eye|0|||
145465657|NCT03654885|524557984|FG000|Overall Study|Consent Withdrawn|1|||
145465658|NCT03654885|524557985|FG001|Overall Study|Consent Withdrawn|0|||
145465659|NCT03654885|524557984|FG000|Overall Study|Death|3|||
145465660|NCT03654885|524557985|FG001|Overall Study|Death|1|||
145465661|NCT03654885|524557984|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
145465662|NCT03654885|524557985|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
145465663|NCT03654885|524557984|FG000|Overall Study|Lost to Follow-up|3|||
145596070|NCT00127101|525032783|FG002|Continuation Phase|Adverse Event|0|||
145596071|NCT00127101|525032784|FG003|Continuation Phase|Adverse Event|0|||
145596072|NCT00127101|525032785|FG004|Continuation Phase|Adverse Event|1|||
145596073|NCT00127101|525032786|FG005|Continuation Phase|Adverse Event|1|||
145596074|NCT00127101|525032781|FG000|Continuation Phase|Lack of Efficacy|0|||
145596075|NCT00127101|525032782|FG001|Continuation Phase|Lack of Efficacy|0|||
145596076|NCT00127101|525032783|FG002|Continuation Phase|Lack of Efficacy|0|||
145596077|NCT00127101|525032784|FG003|Continuation Phase|Lack of Efficacy|0|||
145596078|NCT00127101|525032785|FG004|Continuation Phase|Lack of Efficacy|0|||
145596079|NCT00127101|525032786|FG005|Continuation Phase|Lack of Efficacy|1|||
145465664|NCT03654885|524557985|FG001|Overall Study|Lost to Follow-up|3|||
145465665|NCT00004445|524557986|FG000|Overall Study|Physician Decision|2|||
145596080|NCT00127101|525032781|FG000|Continuation Phase|Withdrawal by Subject|0|||
145596081|NCT00127101|525032782|FG001|Continuation Phase|Withdrawal by Subject|0|||
145596082|NCT00127101|525032783|FG002|Continuation Phase|Withdrawal by Subject|1|||
145596083|NCT00127101|525032784|FG003|Continuation Phase|Withdrawal by Subject|0|||
145596084|NCT00127101|525032785|FG004|Continuation Phase|Withdrawal by Subject|2|||
145596085|NCT00127101|525032786|FG005|Continuation Phase|Withdrawal by Subject|1|||
145596086|NCT02291614|525032787|FG000|Overall Study|Lost to Follow-up|0|||
145596087|NCT02291614|525032788|FG001|Overall Study|Lost to Follow-up|0|||
145596088|NCT02291614|525032789|FG002|Overall Study|Lost to Follow-up|0|||
145596089|NCT02291614|525032790|FG003|Overall Study|Lost to Follow-up|0|||
145596090|NCT02291614|525032791|FG004|Overall Study|Lost to Follow-up|0|||
145596091|NCT02291614|525032792|FG005|Overall Study|Lost to Follow-up|0|||
145596092|NCT02291614|525032793|FG006|Overall Study|Lost to Follow-up|0|||
145596093|NCT02291614|525032794|FG007|Overall Study|Lost to Follow-up|1|||
145596094|NCT02291614|525032795|FG008|Overall Study|Lost to Follow-up|0|||
145596095|NCT02291614|525032796|FG009|Overall Study|Lost to Follow-up|0|||
145596096|NCT02291614|525032797|FG010|Overall Study|Lost to Follow-up|0|||
145596097|NCT02291614|525032787|FG000|Overall Study|Withdrawal by Subject|0|||
145596098|NCT02291614|525032788|FG001|Overall Study|Withdrawal by Subject|1|||
145596099|NCT02291614|525032789|FG002|Overall Study|Withdrawal by Subject|0|||
145596100|NCT02291614|525032790|FG003|Overall Study|Withdrawal by Subject|0|||
145596101|NCT02291614|525032791|FG004|Overall Study|Withdrawal by Subject|0|||
145596102|NCT02291614|525032792|FG005|Overall Study|Withdrawal by Subject|0|||
145596103|NCT02291614|525032793|FG006|Overall Study|Withdrawal by Subject|0|||
145596104|NCT02291614|525032794|FG007|Overall Study|Withdrawal by Subject|0|||
145596105|NCT02291614|525032795|FG008|Overall Study|Withdrawal by Subject|0|||
145596106|NCT02291614|525032796|FG009|Overall Study|Withdrawal by Subject|2|||
145596107|NCT02291614|525032797|FG010|Overall Study|Withdrawal by Subject|2|||
145596108|NCT02291614|525032787|FG000|Overall Study|Decision by sponsor|0|||
145596109|NCT02291614|525032788|FG001|Overall Study|Decision by sponsor|0|||
145596110|NCT02291614|525032789|FG002|Overall Study|Decision by sponsor|0|||
145596111|NCT02291614|525032790|FG003|Overall Study|Decision by sponsor|1|||
145596112|NCT02291614|525032791|FG004|Overall Study|Decision by sponsor|0|||
145596113|NCT02291614|525032792|FG005|Overall Study|Decision by sponsor|0|||
145596114|NCT02291614|525032793|FG006|Overall Study|Decision by sponsor|0|||
145596115|NCT02291614|525032794|FG007|Overall Study|Decision by sponsor|0|||
145596116|NCT02291614|525032795|FG008|Overall Study|Decision by sponsor|0|||
145596117|NCT02291614|525032796|FG009|Overall Study|Decision by sponsor|0|||
145596118|NCT02291614|525032797|FG010|Overall Study|Decision by sponsor|0|||
145596119|NCT02291614|525032787|FG000|Overall Study|Death|0|||
145596120|NCT02291614|525032788|FG001|Overall Study|Death|0|||
145596121|NCT02291614|525032789|FG002|Overall Study|Death|1|||
145596122|NCT02291614|525032790|FG003|Overall Study|Death|0|||
145596123|NCT02291614|525032791|FG004|Overall Study|Death|1|||
145596124|NCT02291614|525032792|FG005|Overall Study|Death|1|||
145596125|NCT02291614|525032793|FG006|Overall Study|Death|1|||
145596126|NCT02291614|525032794|FG007|Overall Study|Death|0|||
145596127|NCT02291614|525032795|FG008|Overall Study|Death|0|||
145596128|NCT02291614|525032796|FG009|Overall Study|Death|0|||
145596129|NCT02291614|525032797|FG010|Overall Study|Death|0|||
145596130|NCT01669122|525032798|FG000|Period I|Lost to Follow-up|1|||
145596131|NCT01669122|525032798|FG000|Washout Period II|Protocol Violation|2|||
145596132|NCT03543254|525032799|FG000|Overall Study|Lost to Follow-up|1|||
145596133|NCT02077166|525032800|FG000|Overall Study|Death|6|||
145596134|NCT02077166|525032801|FG001|Overall Study|Death|7|||
145596135|NCT02077166|525032802|FG002|Overall Study|Death|5|||
145596136|NCT02077166|525032803|FG003|Overall Study|Death|6|||
145596137|NCT02077166|525032804|FG004|Overall Study|Death|4|||
145596138|NCT02077166|525032805|FG005|Overall Study|Death|32|||
145596139|NCT02077166|525032806|FG006|Overall Study|Death|22|||
145596140|NCT02077166|525032800|FG000|Overall Study|Study Closure by Sponsor|3|||
145596141|NCT02077166|525032801|FG001|Overall Study|Study Closure by Sponsor|0|||
145596142|NCT02077166|525032802|FG002|Overall Study|Study Closure by Sponsor|2|||
145596143|NCT02077166|525032803|FG003|Overall Study|Study Closure by Sponsor|2|||
145596144|NCT02077166|525032804|FG004|Overall Study|Study Closure by Sponsor|2|||
145596145|NCT02077166|525032805|FG005|Overall Study|Study Closure by Sponsor|12|||
145596146|NCT02077166|525032806|FG006|Overall Study|Study Closure by Sponsor|4|||
145596147|NCT02077166|525032800|FG000|Overall Study|Lost to Follow-up|0|||
145596148|NCT02077166|525032801|FG001|Overall Study|Lost to Follow-up|0|||
145596149|NCT02077166|525032802|FG002|Overall Study|Lost to Follow-up|0|||
145465666|NCT00004445|524557986|FG000|Overall Study|Withdrawal by Subject|1|||
145596150|NCT02077166|525032803|FG003|Overall Study|Lost to Follow-up|0|||
145596151|NCT02077166|525032804|FG004|Overall Study|Lost to Follow-up|0|||
145596152|NCT02077166|525032805|FG005|Overall Study|Lost to Follow-up|1|||
145596153|NCT02077166|525032806|FG006|Overall Study|Lost to Follow-up|0|||
145596154|NCT02077166|525032800|FG000|Overall Study|Withdrawal by Subject|3|||
145596155|NCT02077166|525032801|FG001|Overall Study|Withdrawal by Subject|0|||
145596156|NCT02077166|525032802|FG002|Overall Study|Withdrawal by Subject|1|||
145465667|NCT02753127|524557987|FG000|Overall Study|Lost to Follow-up|13|||
145465668|NCT02753127|524557988|FG001|Overall Study|Lost to Follow-up|11|||
145465669|NCT02753127|524557987|FG000|Overall Study|Withdrawal by Subject|37|||
145465670|NCT02753127|524557988|FG001|Overall Study|Withdrawal by Subject|47|||
145465671|NCT02753127|524557987|FG000|Overall Study|Other|3|||
145465672|NCT02753127|524557988|FG001|Overall Study|Other|8|||
145465673|NCT02753127|524557987|FG000|Overall Study|Hospice|0|||
145465674|NCT02753127|524557988|FG001|Overall Study|Hospice|2|||
145465675|NCT00293709|524557991|FG000|Overall Study|Other|47|||
145465676|NCT02785458|524557992|FG000|1 Month|Withdrawal by Subject|2|||
145465677|NCT02785458|524557993|FG001|1 Month|Withdrawal by Subject|1|||
145465678|NCT02785458|524557992|FG000|1 Month|Lost to Follow-up|38|||
145465679|NCT02785458|524557993|FG001|1 Month|Lost to Follow-up|31|||
145465680|NCT02785458|524557992|FG000|1 Month|Deemed Ineligible|1|||
145465681|NCT02785458|524557993|FG001|1 Month|Deemed Ineligible|0|||
145465682|NCT02785458|524557992|FG000|1 Month|Completed Evaluation by Baseline|42|||
145465683|NCT02785458|524557993|FG001|1 Month|Completed Evaluation by Baseline|39|||
145465684|NCT02785458|524557992|FG000|1 Month|Partial Interview|0|||
145465685|NCT02785458|524557993|FG001|1 Month|Partial Interview|4|||
145465686|NCT02785458|524557992|FG000|3 Months|Withdrawal by Subject|3|||
145465687|NCT02785458|524557993|FG001|3 Months|Withdrawal by Subject|1|||
145465688|NCT02785458|524557992|FG000|3 Months|Lost to Follow-up|25|||
145465689|NCT02785458|524557993|FG001|3 Months|Lost to Follow-up|21|||
145465690|NCT02785458|524557992|FG000|3 Months|Completed Evaluation at 1 Month|100|||
145465691|NCT02785458|524557993|FG001|3 Months|Completed Evaluation at 1 Month|89|||
145465692|NCT00824005|524557995|FG000|Overall Study|Death|0|||
145465693|NCT00824005|524557996|FG001|Overall Study|Death|1|||
145465694|NCT00824005|524557995|FG000|Overall Study|Lost to Follow-up|0|||
145465695|NCT00824005|524557996|FG001|Overall Study|Lost to Follow-up|1|||
145465696|NCT01866423|524557997|FG000|Overall Study|Lack of Efficacy|3|||
145465697|NCT01866423|524557997|FG000|Overall Study|Sponsor Decision|1|||
145465698|NCT05545644|524557998|FG000|Overall Study|Lost to Follow-up|4|||
145465699|NCT05545644|524557999|FG001|Overall Study|Lost to Follow-up|3|||
145465700|NCT00610441|524558000|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
145465701|NCT00610441|524558001|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
145465702|NCT00610441|524558002|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
145465703|NCT00610441|524558003|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
145465704|NCT00610441|524558000|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
145465705|NCT00610441|524558001|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
145465706|NCT00610441|524558002|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
145465707|NCT00610441|524558003|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
145465708|NCT00610441|524558000|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
145465709|NCT00610441|524558001|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
145465710|NCT00610441|524558002|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
145465711|NCT00610441|524558003|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
145465712|NCT00610441|524558000|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
145465713|NCT00610441|524558001|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
145465714|NCT00610441|524558002|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
145465715|NCT00610441|524558003|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
145465716|NCT00610441|524558000|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
145465717|NCT00610441|524558001|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
145465718|NCT00610441|524558002|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
145465719|NCT00610441|524558003|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
145465720|NCT00610441|524558000|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
145465721|NCT00610441|524558001|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
145465722|NCT00610441|524558002|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
145465723|NCT00610441|524558003|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
145465724|NCT00610441|524558000|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
145465725|NCT00610441|524558001|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
145465726|NCT00610441|524558002|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
145465727|NCT00610441|524558003|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
145465728|NCT00610441|524558000|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
145465729|NCT00610441|524558001|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
145465730|NCT00610441|524558002|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
145465731|NCT00610441|524558003|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
145465732|NCT00610441|524558000|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
145465733|NCT00610441|524558001|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
145465734|NCT00610441|524558002|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
145465735|NCT00610441|524558003|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
145465736|NCT01842581|524558008|FG000|Overall Study|Adverse Event|6|||
145465737|NCT01842581|524558009|FG001|Overall Study|Adverse Event|4|||
145465738|NCT01842581|524558008|FG000|Overall Study|HE breakthrough|26|||
145465739|NCT01842581|524558009|FG001|Overall Study|HE breakthrough|13|||
145465740|NCT01842581|524558008|FG000|Overall Study|Liver transplant|2|||
145465741|NCT01842581|524558009|FG001|Overall Study|Liver transplant|0|||
145465742|NCT01842581|524558008|FG000|Overall Study|Lost to Follow-up|2|||
145596157|NCT02077166|525032803|FG003|Overall Study|Withdrawal by Subject|1|||
145596158|NCT02077166|525032804|FG004|Overall Study|Withdrawal by Subject|1|||
145596159|NCT02077166|525032805|FG005|Overall Study|Withdrawal by Subject|3|||
145596160|NCT02077166|525032806|FG006|Overall Study|Withdrawal by Subject|0|||
145596161|NCT02077166|525032800|FG000|Overall Study|Other, Not Specified|0|||
145596162|NCT02077166|525032801|FG001|Overall Study|Other, Not Specified|0|||
145596163|NCT02077166|525032802|FG002|Overall Study|Other, Not Specified|1|||
145596164|NCT02077166|525032803|FG003|Overall Study|Other, Not Specified|0|||
145596165|NCT02077166|525032804|FG004|Overall Study|Other, Not Specified|1|||
145596166|NCT02077166|525032805|FG005|Overall Study|Other, Not Specified|7|||
145596167|NCT02077166|525032806|FG006|Overall Study|Other, Not Specified|8|||
145596168|NCT03519854|525032807|FG000|Overall Study|Technical Error|0|||
145596169|NCT03519854|525032808|FG001|Overall Study|Technical Error|0|||
145596170|NCT03519854|525032809|FG002|Overall Study|Technical Error|1|||
145596171|NCT03519854|525032810|FG003|Overall Study|Technical Error|0|||
145596172|NCT03519854|525032811|FG004|Overall Study|Technical Error|0|||
145596173|NCT03519854|525032812|FG005|Overall Study|Technical Error|0|||
145596174|NCT03519854|525032813|FG006|Overall Study|Technical Error|0|||
145596175|NCT03519854|525032814|FG007|Overall Study|Technical Error|0|||
145596176|NCT03519854|525032815|FG008|Overall Study|Technical Error|0|||
145596177|NCT03519854|525032816|FG009|Overall Study|Technical Error|0|||
145596178|NCT03519854|525032817|FG010|Overall Study|Technical Error|0|||
145596179|NCT03519854|525032818|FG011|Overall Study|Technical Error|0|||
145596180|NCT03519854|525032819|FG012|Overall Study|Technical Error|0|||
145596181|NCT03519854|525032820|FG013|Overall Study|Technical Error|0|||
145596182|NCT03519854|525032821|FG014|Overall Study|Technical Error|0|||
145596183|NCT03519854|525032822|FG015|Overall Study|Technical Error|0|||
145596184|NCT03519854|525032823|FG016|Overall Study|Technical Error|0|||
145596185|NCT03519854|525032824|FG017|Overall Study|Technical Error|0|||
145596186|NCT00941330|525032825|FG000|Overall Study|Other|1|||
145596187|NCT00941330|525032826|FG001|Overall Study|Other|0|||
145596188|NCT00941330|525032825|FG000|Overall Study|Physician Decision|0|||
145596189|NCT00941330|525032826|FG001|Overall Study|Physician Decision|2|||
145596190|NCT02747238|525032827|FG000|Overall Study|Lack of Efficacy|0|||
145596191|NCT02747238|525032828|FG001|Overall Study|Lack of Efficacy|1|||
145596192|NCT02747238|525032827|FG000|Overall Study|Data lost|3|||
145596193|NCT02747238|525032828|FG001|Overall Study|Data lost|5|||
145596194|NCT05132699|525032829|FG000|Overall Study|Withdrawal by Subject|3|||
145596195|NCT05132699|525032830|FG001|Overall Study|Withdrawal by Subject|0|||
145596196|NCT05338333|525032833|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
145596197|NCT05338333|525032834|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
145596198|NCT01475136|525032835|FG000|Overall Study|Sponsor Decision|0|||
145596199|NCT01475136|525032836|FG001|Overall Study|Sponsor Decision|1|||
145596200|NCT01475136|525032837|FG002|Overall Study|Sponsor Decision|0|||
145596201|NCT01475136|525032838|FG003|Overall Study|Sponsor Decision|0|||
145596202|NCT01475136|525032835|FG000|Overall Study|Entry Criteria Not Met|0|||
145596203|NCT01475136|525032836|FG001|Overall Study|Entry Criteria Not Met|2|||
145596204|NCT01475136|525032837|FG002|Overall Study|Entry Criteria Not Met|3|||
145596205|NCT01475136|525032838|FG003|Overall Study|Entry Criteria Not Met|1|||
145596206|NCT01475136|525032835|FG000|Overall Study|Withdrawal by Subject|0|||
145596207|NCT01475136|525032836|FG001|Overall Study|Withdrawal by Subject|0|||
145596208|NCT01475136|525032837|FG002|Overall Study|Withdrawal by Subject|0|||
145596209|NCT01475136|525032838|FG003|Overall Study|Withdrawal by Subject|2|||
145596210|NCT01475136|525032835|FG000|Overall Study|Adverse Event|1|||
145465743|NCT01842581|524558009|FG001|Overall Study|Lost to Follow-up|5|||
145596211|NCT01475136|525032836|FG001|Overall Study|Adverse Event|0|||
145596212|NCT01475136|525032837|FG002|Overall Study|Adverse Event|0|||
145596213|NCT01475136|525032838|FG003|Overall Study|Adverse Event|1|||
145596214|NCT01475136|525032835|FG000|Overall Study|Death|0|||
145596215|NCT01475136|525032836|FG001|Overall Study|Death|0|||
145596216|NCT01475136|525032837|FG002|Overall Study|Death|0|||
145596217|NCT01475136|525032838|FG003|Overall Study|Death|1|||
145596218|NCT01323530|525034439|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
145596219|NCT01323530|525034440|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145465744|NCT01842581|524558008|FG000|Overall Study|Withdrawal by Subject|5|||
145596220|NCT01323530|525034441|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145596221|NCT01323530|525034442|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145596222|NCT01323530|525034443|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145596223|NCT01323530|525034444|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
145465745|NCT01842581|524558009|FG001|Overall Study|Withdrawal by Subject|7|||
145596224|NCT01323530|525034445|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
145596225|NCT01323530|525034439|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
145596226|NCT01323530|525034440|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
145596227|NCT01323530|525034441|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
145596228|NCT01323530|525034442|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145596229|NCT01323530|525034443|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
145596230|NCT01323530|525034444|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145596231|NCT01323530|525034445|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
145596232|NCT01323530|525034439|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
145596233|NCT01323530|525034440|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
145596234|NCT01323530|525034441|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
145596235|NCT01323530|525034442|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
145596236|NCT01323530|525034443|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
145596237|NCT01323530|525034444|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
145596238|NCT01323530|525034445|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
145596239|NCT01323530|525034439|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596240|NCT01323530|525034440|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596241|NCT01323530|525034441|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596242|NCT01323530|525034442|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596243|NCT01323530|525034443|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596244|NCT01323530|525034444|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
145596245|NCT01323530|525034445|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
145596246|NCT01323530|525034439|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596247|NCT01323530|525034440|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596248|NCT01323530|525034441|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596249|NCT01323530|525034442|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596250|NCT01323530|525034443|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596251|NCT01323530|525034444|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
145596252|NCT01323530|525034445|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
145596253|NCT01323530|525034439|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596254|NCT01323530|525034440|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596255|NCT01323530|525034441|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596256|NCT01323530|525034442|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596257|NCT01323530|525034443|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596258|NCT01323530|525034444|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
145596259|NCT01323530|525034445|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
145596260|NCT01323530|525034439|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596261|NCT01323530|525034440|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596262|NCT01323530|525034441|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596263|NCT01323530|525034442|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596264|NCT01323530|525034443|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596265|NCT01323530|525034444|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
145596266|NCT01323530|525034445|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
145596267|NCT01323530|525034439|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596268|NCT01323530|525034440|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596269|NCT01323530|525034441|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596270|NCT01323530|525034442|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596271|NCT01323530|525034443|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596272|NCT01323530|525034444|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
145596273|NCT01323530|525034445|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
145596274|NCT01194570|525034446|FG000|Overall Study|Adverse Event|22|||
145596275|NCT01194570|525034447|FG001|Overall Study|Adverse Event|40|||
145596276|NCT01194570|525034446|FG000|Overall Study|Death|6|||
145596277|NCT01194570|525034447|FG001|Overall Study|Death|20|||
145596278|NCT01194570|525034446|FG000|Overall Study|Lack of Efficacy|32|||
145596279|NCT01194570|525034447|FG001|Overall Study|Lack of Efficacy|33|||
145596280|NCT01194570|525034446|FG000|Overall Study|Lost to Follow-up|4|||
145596281|NCT01194570|525034447|FG001|Overall Study|Lost to Follow-up|15|||
145596282|NCT01194570|525034446|FG000|Overall Study|Non-Compliance|2|||
145596283|NCT01194570|525034447|FG001|Overall Study|Non-Compliance|2|||
145596284|NCT01194570|525034446|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145596285|NCT01194570|525034447|FG001|Overall Study|Non-Compliance With Study Drug|2|||
145596286|NCT01194570|525034446|FG000|Overall Study|Other|18|||
145596287|NCT01194570|525034447|FG001|Overall Study|Other|47|||
145596288|NCT01194570|525034446|FG000|Overall Study|Physician Decision|10|||
145596289|NCT01194570|525034447|FG001|Overall Study|Physician Decision|25|||
145596290|NCT01194570|525034446|FG000|Overall Study|Protocol Violation|1|||
145596291|NCT01194570|525034447|FG001|Overall Study|Protocol Violation|2|||
145596292|NCT01194570|525034446|FG000|Overall Study|Study Terminated By Sponsor|0|||
145596293|NCT01194570|525034447|FG001|Overall Study|Study Terminated By Sponsor|1|||
145596294|NCT01194570|525034446|FG000|Overall Study|Withdrawal by Subject|57|||
145596295|NCT01194570|525034447|FG001|Overall Study|Withdrawal by Subject|82|||
145596296|NCT01194570|525034446|FG000|Overall Study|Pregnancy|1|||
145596297|NCT01194570|525034447|FG001|Overall Study|Pregnancy|1|||
145596298|NCT00289887|525034449|FG000|Overall Study|Adverse Event|3|||
145596299|NCT00289887|525034450|FG001|Overall Study|Adverse Event|3|||
145465746|NCT01842581|524558008|FG000|Overall Study|Other than specified|3|||
145596300|NCT00289887|525034449|FG000|Overall Study|Lack of Efficacy|3|||
145596301|NCT00289887|525034450|FG001|Overall Study|Lack of Efficacy|11|||
145596302|NCT00289887|525034449|FG000|Overall Study|Lost to Follow-up|3|||
145596303|NCT00289887|525034450|FG001|Overall Study|Lost to Follow-up|3|||
145596304|NCT00289887|525034449|FG000|Overall Study|Protocol Violation|3|||
145596305|NCT00289887|525034450|FG001|Overall Study|Protocol Violation|1|||
145465747|NCT01842581|524558009|FG001|Overall Study|Other than specified|1|||
145465748|NCT01287195|524558010|FG000|Overall Study|Withdrawal by Subject|2|||
145465749|NCT02068118|524558014|FG000|18-month Comparative Study Period|Death|90|||
145465750|NCT02068118|524558015|FG001|18-month Comparative Study Period|Death|97|||
145465751|NCT02068118|524558014|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
145465752|NCT02068118|524558015|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
145465753|NCT02068118|524558014|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
145465754|NCT02068118|524558015|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
145465755|NCT02068118|524558014|FG000|18-month Comparative Study Period|Heart transplant|9|||
145465756|NCT02068118|524558015|FG001|18-month Comparative Study Period|Heart transplant|15|||
145465757|NCT02068118|524558014|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
145465758|NCT02068118|524558015|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
145465759|NCT02068118|524558014|FG000|18-month Comparative Study Period|Hemiplegia|0|||
145465760|NCT02068118|524558015|FG001|18-month Comparative Study Period|Hemiplegia|1|||
145465761|NCT02068118|524558014|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
145465762|NCT02068118|524558015|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
145465763|NCT02068118|524558014|FG000|18-month Comparative Study Period|Move|0|||
145465764|NCT02068118|524558015|FG001|18-month Comparative Study Period|Move|1|||
145465765|NCT02068118|524558014|FG000|18-month Comparative Study Period|Hearing loss|0|||
145465766|NCT02068118|524558015|FG001|18-month Comparative Study Period|Hearing loss|1|||
145465767|NCT02068118|524558014|FG000|Extension Period|Death|0|||
145465768|NCT02068118|524558015|FG001|Extension Period|Death|2|||
145465769|NCT02068118|524558014|FG000|Extension Period|Withdrawal by Subject|1|||
145465770|NCT02068118|524558015|FG001|Extension Period|Withdrawal by Subject|0|||
145465771|NCT02068118|524558014|FG000|Extension Period|Heart transplant|1|||
145465772|NCT02068118|524558015|FG001|Extension Period|Heart transplant|0|||
145465773|NCT02068118|524558014|FG000|Extension Period|Wrong device use|0|||
145465774|NCT02068118|524558015|FG001|Extension Period|Wrong device use|1|||
145465775|NCT00334282|524558016|FG000|Overall Study|Lost to Follow-up|11|||
145465776|NCT00334282|524558017|FG001|Overall Study|Lost to Follow-up|5|||
145465777|NCT00334282|524558016|FG000|Overall Study|Withdrawal by Subject|17|||
145465778|NCT00334282|524558017|FG001|Overall Study|Withdrawal by Subject|3|||
145465779|NCT00334282|524558016|FG000|Overall Study|Death|194|||
145465780|NCT00334282|524558017|FG001|Overall Study|Death|100|||
145465781|NCT00283868|524558018|FG000|Overall Study|Lost to Follow-up|7|||
145465782|NCT00283868|524558019|FG001|Overall Study|Lost to Follow-up|8|||
145465783|NCT01515475|524558020|FG000|Overall Study|Lost to Follow-up|20|||
145465784|NCT01515475|524558021|FG001|Overall Study|Lost to Follow-up|15|||
145465785|NCT01515475|524558022|FG002|Overall Study|Lost to Follow-up|12|||
145465786|NCT01515475|524558023|FG003|Overall Study|Lost to Follow-up|12|||
145465787|NCT01420627|524558025|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
145465788|NCT00837876|524558026|FG000|Overall Study|Death|2|||
145465789|NCT00837876|524558026|FG000|Overall Study|Adverse Event|7|||
145465790|NCT00837876|524558026|FG000|Overall Study|Physician Decision|1|||
145465791|NCT00837876|524558026|FG000|Overall Study|Withdrawal by Subject|3|||
145465792|NCT00837876|524558026|FG000|Overall Study|disease progression|24|||
145465793|NCT00453973|524558029|FG000|Overall Study|Adverse Event|4|||
145465794|NCT00453973|524558030|FG001|Overall Study|Adverse Event|9|||
145465795|NCT00453973|524558029|FG000|Overall Study|Withdrawal by Subject|7|||
145465796|NCT00453973|524558030|FG001|Overall Study|Withdrawal by Subject|6|||
145465797|NCT00453973|524558029|FG000|Overall Study|PI Decision|0|||
145465798|NCT00453973|524558030|FG001|Overall Study|PI Decision|2|||
145465799|NCT00453973|524558029|FG000|Overall Study|Relocation|1|||
145465800|NCT00453973|524558030|FG001|Overall Study|Relocation|0|||
145465801|NCT00453973|524558029|FG000|Overall Study|Renal transplant|1|||
145465802|NCT00453973|524558030|FG001|Overall Study|Renal transplant|1|||
145465803|NCT00453973|524558029|FG000|Overall Study|Site closed by sponsor|3|||
145465804|NCT00453973|524558030|FG001|Overall Study|Site closed by sponsor|0|||
145465805|NCT00453973|524558029|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
145465806|NCT00453973|524558030|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
145465807|NCT01996592|524558037|FG000|Overall Study|no response to text/no diary entry|32|||
145465808|NCT01996592|524558037|FG000|Overall Study|change in surgical date|4|||
145465809|NCT01996592|524558037|FG000|Overall Study|Withdrawal by Subject|5|||
145465810|NCT01996592|524558037|FG000|Overall Study|change in mode of delivery|4|||
145465811|NCT00870194|524558038|FG000|Overall Study|Adverse Event|10|||
145465812|NCT00870194|524558039|FG001|Overall Study|Adverse Event|5|||
145465813|NCT00870194|524558038|FG000|Overall Study|Lack of Efficacy|0|||
145465814|NCT00870194|524558039|FG001|Overall Study|Lack of Efficacy|1|||
145596306|NCT00289887|525034449|FG000|Overall Study|Withdrawal by Subject|3|||
145596307|NCT00289887|525034450|FG001|Overall Study|Withdrawal by Subject|8|||
145596308|NCT00289887|525034449|FG000|Overall Study|Other|7|||
145596309|NCT00289887|525034450|FG001|Overall Study|Other|3|||
145596310|NCT02035332|525034452|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
145596311|NCT02030015|525034455|FG000|Overall Study|Withdrawal by Subject|3|||
145596312|NCT02030015|525034455|FG000|Overall Study|Death|13|||
145596313|NCT00833560|525034456|FG000|Overall Study|Toxicity|13|||
145596314|NCT00833560|525034456|FG000|Overall Study|Adverse Event|11|||
145596315|NCT00833560|525034456|FG000|Overall Study|Protocol Violation|6|||
145596316|NCT00833560|525034456|FG000|Overall Study|Lack of Efficacy|4|||
145596317|NCT00833560|525034456|FG000|Overall Study|Death|2|||
145596318|NCT00833560|525034456|FG000|Overall Study|Pregression of other disease|1|||
145596319|NCT00833560|525034456|FG000|Overall Study|Other|5|||
145596320|NCT00499031|525034457|FG000|Overall Study|Improper pre-protocol treatment|1|||
145596321|NCT00499031|525034457|FG000|Overall Study|Required test not done|1|||
145596322|NCT00499031|525034457|FG000|Overall Study|Never treated|1|||
145596323|NCT00512148|525034466|FG000|Primay Study Period|Withdrawal by Subject|1|||
145596324|NCT02690974|525034473|FG000|Overall Study|Adverse Event|16|||
145596325|NCT02690974|525034473|FG000|Overall Study|Death|9|||
145596326|NCT02690974|525034473|FG000|Overall Study|Subject/guardian decision|4|||
145596327|NCT02690974|525034473|FG000|Overall Study|Lost to Follow-up|3|||
145596328|NCT02690974|525034473|FG000|Overall Study|Withdrawal of Informed Consent|3|||
145596329|NCT02690974|525034473|FG000|Overall Study|Physician Decision|2|||
145596330|NCT02690974|525034473|FG000|Overall Study|Non-compliance with study treatment|1|||
145596331|NCT02690974|525034473|FG000|Overall Study|Protocol-defined stopping criteria|1|||
145596332|NCT02690974|525034473|FG000|Overall Study|Protocol Deviation|1|||
145596333|NCT01666951|525034480|FG000|Overall Study|Not dosed|1|||
145596334|NCT01666951|525034481|FG001|Overall Study|Not dosed|1|||
145596335|NCT02623322|525034485|FG000|Overall Study|Lost to Follow-up|2|||
145596336|NCT02623322|525034486|FG001|Overall Study|Lost to Follow-up|1|||
145596337|NCT02623322|525034487|FG002|Overall Study|Lost to Follow-up|0|||
145596338|NCT03284788|525034488|FG000|Overall Study|Withdrawal by Subject|2|||
145596339|NCT01690130|525034492|FG000|Overall Study|Subject have cancelled visit.|1|||
145596340|NCT01690130|525034493|FG001|Overall Study|Subject have cancelled visit.|0|||
145596341|NCT02462876|525034494|FG000|Overall Study|Death|3|||
145596342|NCT02462876|525034494|FG000|Overall Study|Lost to Follow-up|7|||
145596343|NCT02462876|525034494|FG000|Overall Study|Surgical Bypass|9|||
145596344|NCT02462876|525034494|FG000|Overall Study|Amputation Above the Metatarsals|1|||
145596345|NCT02462876|525034494|FG000|Overall Study|36 months follow-up visit missed|1|||
145596346|NCT02462876|525034494|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
145596347|NCT02462876|525034494|FG000|Overall Study|Patient did not come back to the vascular department|1|||
145596348|NCT02462876|525034494|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
145596349|NCT02462876|525034494|FG000|Overall Study|Patient refused to come back|1|||
145596350|NCT02462876|525034494|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
145596351|NCT02462876|525034494|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
145596352|NCT01786512|525034495|FG000|Overall Study|Lost to Follow-up|0|||
145596353|NCT01786512|525034496|FG001|Overall Study|Lost to Follow-up|0|||
145596354|NCT01786512|525034497|FG002|Overall Study|Lost to Follow-up|0|||
145596355|NCT01786512|525034498|FG003|Overall Study|Lost to Follow-up|0|||
145596356|NCT01786512|525034499|FG004|Overall Study|Lost to Follow-up|0|||
145596357|NCT01786512|525034500|FG005|Overall Study|Lost to Follow-up|0|||
145596358|NCT01786512|525034501|FG006|Overall Study|Lost to Follow-up|0|||
145596359|NCT01786512|525034502|FG007|Overall Study|Lost to Follow-up|0|||
145596360|NCT01786512|525034503|FG008|Overall Study|Lost to Follow-up|0|||
145596361|NCT01786512|525034504|FG009|Overall Study|Lost to Follow-up|1|||
145596362|NCT01786512|525034505|FG010|Overall Study|Lost to Follow-up|0|||
145596363|NCT01786512|525034495|FG000|Overall Study|Decision by sponsor|0|||
145596364|NCT01786512|525034496|FG001|Overall Study|Decision by sponsor|0|||
145596365|NCT01786512|525034497|FG002|Overall Study|Decision by sponsor|0|||
145596366|NCT01786512|525034498|FG003|Overall Study|Decision by sponsor|0|||
145596367|NCT01786512|525034499|FG004|Overall Study|Decision by sponsor|0|||
145596368|NCT01786512|525034500|FG005|Overall Study|Decision by sponsor|0|||
145596369|NCT01786512|525034501|FG006|Overall Study|Decision by sponsor|0|||
145596370|NCT01786512|525034502|FG007|Overall Study|Decision by sponsor|0|||
145596371|NCT01786512|525034503|FG008|Overall Study|Decision by sponsor|0|||
145596372|NCT01786512|525034504|FG009|Overall Study|Decision by sponsor|0|||
145596373|NCT01786512|525034505|FG010|Overall Study|Decision by sponsor|2|||
145465815|NCT00870194|524558038|FG000|Overall Study|Lost to Follow-up|2|||
145596374|NCT01786512|525034495|FG000|Overall Study|Withdrawal by Subject|0|||
145596375|NCT01786512|525034496|FG001|Overall Study|Withdrawal by Subject|1|||
145596376|NCT01786512|525034497|FG002|Overall Study|Withdrawal by Subject|0|||
145596377|NCT01786512|525034498|FG003|Overall Study|Withdrawal by Subject|0|||
145596378|NCT01786512|525034499|FG004|Overall Study|Withdrawal by Subject|0|||
145596379|NCT01786512|525034500|FG005|Overall Study|Withdrawal by Subject|0|||
145596380|NCT01786512|525034501|FG006|Overall Study|Withdrawal by Subject|1|||
145596381|NCT01786512|525034502|FG007|Overall Study|Withdrawal by Subject|0|||
145596382|NCT01786512|525034503|FG008|Overall Study|Withdrawal by Subject|0|||
145596383|NCT01786512|525034504|FG009|Overall Study|Withdrawal by Subject|3|||
145465816|NCT00870194|524558039|FG001|Overall Study|Lost to Follow-up|0|||
145465817|NCT00870194|524558038|FG000|Overall Study|Physician Decision|3|||
145465818|NCT00870194|524558039|FG001|Overall Study|Physician Decision|1|||
145465819|NCT00870194|524558038|FG000|Overall Study|Protocol Violation|3|||
145465820|NCT00870194|524558039|FG001|Overall Study|Protocol Violation|3|||
145465821|NCT00870194|524558038|FG000|Overall Study|Entry Criteria Not Met|1|||
145465822|NCT00870194|524558039|FG001|Overall Study|Entry Criteria Not Met|2|||
145465823|NCT00870194|524558038|FG000|Overall Study|Subject Decision|7|||
145465824|NCT00870194|524558039|FG001|Overall Study|Subject Decision|2|||
145465825|NCT04957758|524558040|FG000|Overall Study|Adverse Event|1|||
145465826|NCT04957758|524558041|FG001|Overall Study|Adverse Event|0|||
145465827|NCT04957758|524558040|FG000|Overall Study|Lost to Follow-up|0|||
145465828|NCT04957758|524558041|FG001|Overall Study|Lost to Follow-up|2|||
145465829|NCT04957758|524558040|FG000|Overall Study|Withdrawal by Subject|4|||
145465830|NCT04957758|524558041|FG001|Overall Study|Withdrawal by Subject|2|||
145465831|NCT04957758|524558040|FG000|Overall Study|Protocol Violation|0|||
145465832|NCT04957758|524558041|FG001|Overall Study|Protocol Violation|1|||
145465833|NCT00707746|524558042|FG000|Treatment Period|Adverse Event|2|||
145465834|NCT00707746|524558043|FG001|Treatment Period|Adverse Event|4|||
145465835|NCT00707746|524558042|FG000|Treatment Period|Ineligibility|0|||
145465836|NCT00707746|524558043|FG001|Treatment Period|Ineligibility|1|||
145465837|NCT01685983|524558045|FG000|Overall Study|Adverse Event|7|||
145465838|NCT01685983|524558045|FG000|Overall Study|Death|1|||
145465839|NCT01685983|524558045|FG000|Overall Study|Withdrawal by Subject|19|||
145465840|NCT01685983|524558045|FG000|Overall Study|Protocol Violation|2|||
145465841|NCT01685983|524558045|FG000|Overall Study|Physician Decision|13|||
145465842|NCT01685983|524558045|FG000|Overall Study|Other|7|||
145465843|NCT01685983|524558045|FG000|Overall Study|Progressive Disease|32|||
145465844|NCT01685983|524558045|FG000|Overall Study|Noncompliance with Study Drug|1|||
145465845|NCT02642965|524558048|FG000|Overall Study|Lack of Efficacy|4|||
145465846|NCT02642965|524558048|FG000|Overall Study|Physician Decision|9|||
145465847|NCT01167907|524558055|FG000|Overall Study|Protocol Violation|1|||
145465848|NCT01167907|524558056|FG001|Overall Study|Protocol Violation|0|||
145465849|NCT01167907|524558055|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
145465850|NCT01167907|524558056|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
145465851|NCT03077698|524558057|FG000|Progestin Monotherapy|Stable Disease|8|||
145465852|NCT03077698|524558058|FG001|Progestin Monotherapy|Stable Disease|0|||
145465853|NCT03077698|524558057|FG000|Progestin Monotherapy|Adverse Event|1|||
145465854|NCT03077698|524558058|FG001|Progestin Monotherapy|Adverse Event|0|||
145465855|NCT03077698|524558057|FG000|Progestin Monotherapy|Death|1|||
145465856|NCT03077698|524558058|FG001|Progestin Monotherapy|Death|0|||
145465857|NCT03077698|524558057|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
145465858|NCT03077698|524558058|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
145465859|NCT03077698|524558057|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
145465860|NCT03077698|524558058|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
145465861|NCT03077698|524558057|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
145465862|NCT03077698|524558058|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
145465863|NCT03077698|524558057|FG000|Safety Follow Up|Withdrawal by Subject|2|||
145465864|NCT03077698|524558058|FG001|Safety Follow Up|Withdrawal by Subject|1|||
145465865|NCT03077698|524558057|FG000|Safety Follow Up|Transfer of care to hospice|1|||
145465866|NCT03077698|524558058|FG001|Safety Follow Up|Transfer of care to hospice|0|||
145465867|NCT01439074|524558059|FG000|Overall Study|Lost to Follow-up|3|||
145465868|NCT01439074|524558060|FG001|Overall Study|Lost to Follow-up|4|||
145465869|NCT01439074|524558059|FG000|Overall Study|Subject shedding|1|||
145465870|NCT01439074|524558060|FG001|Overall Study|Subject shedding|0|||
145465871|NCT01439074|524558059|FG000|Overall Study|Withdrawal by Subject|1|||
145465872|NCT01439074|524558060|FG001|Overall Study|Withdrawal by Subject|5|||
145465873|NCT01439074|524558059|FG000|Overall Study|Other|4|||
145465874|NCT01439074|524558060|FG001|Overall Study|Other|4|||
145465875|NCT01140568|524558061|FG000|Overall Study|disease progression|31|||
145465876|NCT01140568|524558061|FG000|Overall Study|Withdrawal by Subject|1|||
145465877|NCT01140568|524558061|FG000|Overall Study|Screen Fail|4|||
145465878|NCT00815191|524558062|FG000|Overall Study|Protocol Violation|1|||
145465879|NCT00815191|524558063|FG001|Overall Study|Protocol Violation|1|||
145465880|NCT00493636|524558064|FG000|Overall Study|Withdrawal by Subject|1|||
145465881|NCT00493636|524558065|FG001|Overall Study|Withdrawal by Subject|0|||
145465882|NCT00493636|524558064|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
145465883|NCT00493636|524558065|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
145465884|NCT00493636|524558064|FG000|Overall Study|Mis-randomization|1|||
145465885|NCT00493636|524558065|FG001|Overall Study|Mis-randomization|1|||
145627013|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
145627014|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
145465886|NCT01873729|524558067|FG000|Overall Study|Withdrawal by Subject|1|||
145465887|NCT01066780|524558068|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
145465888|NCT01066780|524558069|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
145465889|NCT03099148|524558070|FG000|Wash-out|scheduling conflict|0|||
145596384|NCT01786512|525034505|FG010|Overall Study|Withdrawal by Subject|7|||
145596385|NCT01786512|525034495|FG000|Overall Study|Death|0|||
145596386|NCT01786512|525034496|FG001|Overall Study|Death|0|||
145596387|NCT01786512|525034497|FG002|Overall Study|Death|0|||
145596388|NCT01786512|525034498|FG003|Overall Study|Death|0|||
145596389|NCT01786512|525034499|FG004|Overall Study|Death|0|||
145596390|NCT01786512|525034500|FG005|Overall Study|Death|0|||
145596391|NCT01786512|525034501|FG006|Overall Study|Death|0|||
145596392|NCT01786512|525034502|FG007|Overall Study|Death|0|||
145596393|NCT01786512|525034503|FG008|Overall Study|Death|4|||
145596394|NCT01786512|525034504|FG009|Overall Study|Death|1|||
145596395|NCT01786512|525034505|FG010|Overall Study|Death|3|||
145596396|NCT02450331|525034506|FG000|Overall Study|Death|162|||
145596397|NCT02450331|525034507|FG001|Overall Study|Death|171|||
145596398|NCT02450331|525034506|FG000|Overall Study|Lost to Follow-up|14|||
145596399|NCT02450331|525034507|FG001|Overall Study|Lost to Follow-up|12|||
145596400|NCT02450331|525034506|FG000|Overall Study|Withdrawal by Subject|55|||
145596401|NCT02450331|525034507|FG001|Overall Study|Withdrawal by Subject|44|||
145596402|NCT02450331|525034506|FG000|Overall Study|Non-specified other|1|||
145596403|NCT02450331|525034507|FG001|Overall Study|Non-specified other|1|||
145596404|NCT03581981|525034508|FG000|Overall Study|Withdrawal by Subject|12|||
145596405|NCT03581981|525034509|FG001|Overall Study|Withdrawal by Subject|13|||
145596406|NCT03581981|525034508|FG000|Overall Study|Physician Decision|1|||
145596407|NCT03581981|525034509|FG001|Overall Study|Physician Decision|2|||
145596408|NCT03581981|525034508|FG000|Overall Study|Lost to Follow-up|0|||
145596409|NCT03581981|525034509|FG001|Overall Study|Lost to Follow-up|4|||
145596410|NCT02157779|525034518|FG000|Overall Study|Logistical|9|||
145596411|NCT02157779|525034519|FG001|Overall Study|Logistical|3|||
145596412|NCT02157779|525034518|FG000|Overall Study|Stopped attending, reason unknown|11|||
145596413|NCT02157779|525034519|FG001|Overall Study|Stopped attending, reason unknown|7|||
145596414|NCT02157779|525034518|FG000|Overall Study|No response to outreach after Baseline|1|||
145596415|NCT02157779|525034519|FG001|Overall Study|No response to outreach after Baseline|1|||
145596416|NCT02157779|525034518|FG000|Overall Study|Moved|1|||
145596417|NCT02157779|525034519|FG001|Overall Study|Moved|0|||
145596418|NCT02157779|525034518|FG000|Overall Study|Medical|1|||
145596419|NCT02157779|525034519|FG001|Overall Study|Medical|0|||
145596420|NCT02157779|525034518|FG000|Overall Study|Legal issue|1|||
145596421|NCT02157779|525034519|FG001|Overall Study|Legal issue|0|||
145596422|NCT02275065|525034524|FG000|Overall Study|Randomized but not treated|1|||
145596423|NCT02275065|525034525|FG001|Overall Study|Randomized but not treated|0|||
145596424|NCT02275065|525034526|FG002|Overall Study|Randomized but not treated|1|||
145596425|NCT02275065|525034527|FG003|Overall Study|Randomized but not treated|1|||
145596426|NCT02275065|525034528|FG004|Overall Study|Randomized but not treated|0|||
145596427|NCT00977665|525034536|FG000|Overall Study|Withdrawal by Subject|1|||
145596428|NCT00977665|525034537|FG001|Overall Study|Withdrawal by Subject|3|||
145596429|NCT00977665|525034536|FG000|Overall Study|Physician Decision|2|||
145596430|NCT00977665|525034537|FG001|Overall Study|Physician Decision|1|||
145596431|NCT00977665|525034536|FG000|Overall Study|Sponsor requested withdrawal|0|||
145596432|NCT00977665|525034537|FG001|Overall Study|Sponsor requested withdrawal|1|||
145596433|NCT00977665|525034536|FG000|Overall Study|Lost to Follow-up|1|||
145596434|NCT00977665|525034537|FG001|Overall Study|Lost to Follow-up|0|||
145596435|NCT00977665|525034536|FG000|Overall Study|Death|3|||
145596436|NCT00977665|525034537|FG001|Overall Study|Death|2|||
145596437|NCT00977665|525034536|FG000|Overall Study|Adverse Event|14|||
145596438|NCT00977665|525034537|FG001|Overall Study|Adverse Event|7|||
145596439|NCT00977665|525034536|FG000|Overall Study|Treatment failure|0|||
145596440|NCT00977665|525034537|FG001|Overall Study|Treatment failure|1|||
145596441|NCT04322682|525034538|FG000|Overall Study|Withdrawal by Subject|33|||
145596442|NCT04322682|525034539|FG001|Overall Study|Withdrawal by Subject|47|||
145596443|NCT04322682|525034538|FG000|Overall Study|Death|5|||
145596444|NCT04322682|525034539|FG001|Overall Study|Death|9|||
145596445|NCT04322682|525034538|FG000|Overall Study|Lost to Follow-up|4|||
145596446|NCT04322682|525034539|FG001|Overall Study|Lost to Follow-up|8|||
145596447|NCT04322682|525034538|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
145596448|NCT04322682|525034539|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
145596449|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
145596450|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
145596451|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
145596452|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
145596453|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
145596454|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
145596455|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
145627015|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
145596456|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
145596457|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
145596458|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
145596459|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
145596460|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
145596461|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
145596462|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
145596463|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
145596464|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
145596465|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
145596466|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
145596467|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
145596468|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
145596469|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
145596470|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
145596471|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
145596472|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
145596473|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
145596474|NCT01662310|525034540|FG000|Run-In or Stabilization Phase|Other|1|||
145596475|NCT01662310|525034541|FG001|Run-In or Stabilization Phase|Other|0|||
145596476|NCT01662310|525034542|FG002|Run-In or Stabilization Phase|Other|0|||
145596477|NCT01662310|525034543|FG003|Run-In or Stabilization Phase|Other|0|||
145596478|NCT01662310|525034544|FG004|Run-In or Stabilization Phase|Other|0|||
145596479|NCT01662310|525034540|FG000|Double-Blind Phase|Adverse Event|0|||
145596480|NCT01662310|525034541|FG001|Double-Blind Phase|Adverse Event|0|||
145596481|NCT01662310|525034542|FG002|Double-Blind Phase|Adverse Event|1|||
145596482|NCT01662310|525034543|FG003|Double-Blind Phase|Adverse Event|0|||
145596483|NCT01662310|525034544|FG004|Double-Blind Phase|Adverse Event|0|||
145596484|NCT01662310|525034540|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145596485|NCT01662310|525034541|FG001|Double-Blind Phase|Lost to Follow-up|3|||
145596486|NCT01662310|525034542|FG002|Double-Blind Phase|Lost to Follow-up|0|||
145596487|NCT01662310|525034543|FG003|Double-Blind Phase|Lost to Follow-up|0|||
145596488|NCT01662310|525034544|FG004|Double-Blind Phase|Lost to Follow-up|0|||
145596489|NCT01662310|525034540|FG000|Double-Blind Phase|Pregnancy|0|||
145596490|NCT01662310|525034541|FG001|Double-Blind Phase|Pregnancy|2|||
145596491|NCT01662310|525034542|FG002|Double-Blind Phase|Pregnancy|0|||
145596492|NCT01662310|525034543|FG003|Double-Blind Phase|Pregnancy|0|||
145596493|NCT01662310|525034544|FG004|Double-Blind Phase|Pregnancy|0|||
145596494|NCT01662310|525034540|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
145596495|NCT01662310|525034541|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
145596496|NCT01662310|525034542|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
145596497|NCT01662310|525034543|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145596498|NCT01662310|525034544|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
145596499|NCT01662310|525034540|FG000|Double-Blind Phase|Other|0|||
145596500|NCT01662310|525034541|FG001|Double-Blind Phase|Other|0|||
145596501|NCT01662310|525034542|FG002|Double-Blind Phase|Other|1|||
145596502|NCT01662310|525034543|FG003|Double-Blind Phase|Other|0|||
145596503|NCT01662310|525034544|FG004|Double-Blind Phase|Other|0|||
145596504|NCT01662310|525034540|FG000|Double-Blind Phase|Randomized but not treated|0|||
145596505|NCT01662310|525034541|FG001|Double-Blind Phase|Randomized but not treated|1|||
145596506|NCT01662310|525034542|FG002|Double-Blind Phase|Randomized but not treated|0|||
145596507|NCT01662310|525034543|FG003|Double-Blind Phase|Randomized but not treated|0|||
145596508|NCT01662310|525034544|FG004|Double-Blind Phase|Randomized but not treated|0|||
145596509|NCT01662310|525034540|FG000|Open-Label Extension Phase|Adverse Event|0|||
145596510|NCT01662310|525034541|FG001|Open-Label Extension Phase|Adverse Event|0|||
145596511|NCT01662310|525034542|FG002|Open-Label Extension Phase|Adverse Event|0|||
145596512|NCT01662310|525034543|FG003|Open-Label Extension Phase|Adverse Event|3|||
145596513|NCT01662310|525034544|FG004|Open-Label Extension Phase|Adverse Event|0|||
145596514|NCT01662310|525034540|FG000|Open-Label Extension Phase|Death|0|||
145596515|NCT01662310|525034541|FG001|Open-Label Extension Phase|Death|0|||
145596516|NCT01662310|525034542|FG002|Open-Label Extension Phase|Death|0|||
145596517|NCT01662310|525034543|FG003|Open-Label Extension Phase|Death|1|||
145596518|NCT01662310|525034544|FG004|Open-Label Extension Phase|Death|0|||
145596519|NCT01662310|525034540|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
145596520|NCT01662310|525034541|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
145596521|NCT01662310|525034542|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
145596522|NCT01662310|525034543|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
145596523|NCT01662310|525034544|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
145596524|NCT01662310|525034540|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145596525|NCT01662310|525034541|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145596526|NCT01662310|525034542|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
145596527|NCT01662310|525034543|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
145596528|NCT01662310|525034544|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
145596529|NCT01662310|525034540|FG000|Open-Label Extension Phase|Pregnancy|0|||
145596530|NCT01662310|525034541|FG001|Open-Label Extension Phase|Pregnancy|0|||
145596531|NCT01662310|525034542|FG002|Open-Label Extension Phase|Pregnancy|0|||
145596532|NCT01662310|525034543|FG003|Open-Label Extension Phase|Pregnancy|1|||
145596533|NCT01662310|525034544|FG004|Open-Label Extension Phase|Pregnancy|0|||
145596534|NCT01662310|525034540|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
145596535|NCT01662310|525034541|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
145596536|NCT01662310|525034542|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
145596537|NCT01662310|525034543|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
145596538|NCT01662310|525034544|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
145596539|NCT02432105|525034546|FG000|Overall Study|Lost to Follow-up|1|||
145596540|NCT02432105|525034547|FG001|Overall Study|Lost to Follow-up|1|||
145596541|NCT02432105|525034548|FG002|Overall Study|Lost to Follow-up|0|||
145596542|NCT02432105|525034546|FG000|Overall Study|Withdrawal by Subject|1|||
145596543|NCT02432105|525034547|FG001|Overall Study|Withdrawal by Subject|0|||
145596544|NCT02432105|525034548|FG002|Overall Study|Withdrawal by Subject|1|||
145596545|NCT02432105|525034546|FG000|Overall Study|Culture positive for yeast|0|||
145596546|NCT02432105|525034547|FG001|Overall Study|Culture positive for yeast|1|||
145596547|NCT02432105|525034548|FG002|Overall Study|Culture positive for yeast|0|||
145596548|NCT02432105|525034546|FG000|Overall Study|Randomized in error|0|||
145596549|NCT02432105|525034547|FG001|Overall Study|Randomized in error|0|||
145596550|NCT02432105|525034548|FG002|Overall Study|Randomized in error|2|||
145596551|NCT04302350|525034550|FG000|Overall Study|Physician Decision|1|||
145596552|NCT04302350|525034551|FG001|Overall Study|Physician Decision|1|||
145596553|NCT04302350|525034552|FG002|Overall Study|Physician Decision|2|||
145596554|NCT04302350|525034550|FG000|Overall Study|Lack of Efficacy|1|||
145596555|NCT04302350|525034551|FG001|Overall Study|Lack of Efficacy|1|||
145596556|NCT04302350|525034552|FG002|Overall Study|Lack of Efficacy|4|||
145596557|NCT04302350|525034550|FG000|Overall Study|Adverse Event|0|||
145596558|NCT04302350|525034551|FG001|Overall Study|Adverse Event|1|||
145596559|NCT04302350|525034552|FG002|Overall Study|Adverse Event|2|||
145596560|NCT02012491|525034555|FG000|Overall Study|Lost to Follow-up|1|||
145596561|NCT02012491|525034556|FG001|Overall Study|Lost to Follow-up|0|||
145596562|NCT02012491|525034555|FG000|Overall Study|Protocol Violation|0|||
145596563|NCT02012491|525034556|FG001|Overall Study|Protocol Violation|1|||
145596564|NCT02012491|525034555|FG000|Overall Study|Withdrawal by Subject|1|||
145596565|NCT02012491|525034556|FG001|Overall Study|Withdrawal by Subject|0|||
145596566|NCT05608629|525034567|FG000|Overall Study|Lost to Follow-up|2|||
145596567|NCT03969719|525034568|FG000|Overall Study|Other reasons not specified|1|||
145596568|NCT03969719|525034569|FG001|Overall Study|Other reasons not specified|1|||
145596569|NCT03969719|525034570|FG002|Overall Study|Other reasons not specified|3|||
145596570|NCT03969719|525034568|FG000|Overall Study|Withdrawal by Subject|2|||
145596571|NCT03969719|525034569|FG001|Overall Study|Withdrawal by Subject|3|||
145596572|NCT03969719|525034570|FG002|Overall Study|Withdrawal by Subject|2|||
145596573|NCT03969719|525034568|FG000|Overall Study|Protocol Violation|1|||
145596574|NCT03969719|525034569|FG001|Overall Study|Protocol Violation|2|||
145596575|NCT03969719|525034570|FG002|Overall Study|Protocol Violation|0|||
145596576|NCT03969719|525034568|FG000|Overall Study|Adverse Event|0|||
145596577|NCT03969719|525034569|FG001|Overall Study|Adverse Event|2|||
145596578|NCT03969719|525034570|FG002|Overall Study|Adverse Event|0|||
145596579|NCT03969719|525034568|FG000|Overall Study|Lost to Follow-up|0|||
145596580|NCT03969719|525034569|FG001|Overall Study|Lost to Follow-up|1|||
145596581|NCT03969719|525034570|FG002|Overall Study|Lost to Follow-up|0|||
145596582|NCT01400503|525034571|FG000|Overall Study|Withdrawal by Subject|1|||
145596583|NCT01400503|525034571|FG000|Overall Study|Study Terminated by Sponsor|58|||
145596584|NCT01400503|525034571|FG000|Overall Study|Other|1|||
145596585|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
145596586|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
145596587|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
145596588|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596589|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596590|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596591|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596592|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596593|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145596594|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
145596595|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
145596596|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
145596597|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596598|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596599|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596600|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596601|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596602|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145596603|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
145596604|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
145596605|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
145596606|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596607|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596608|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596609|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596610|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596611|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145596612|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
145596613|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145465890|NCT03099148|524558071|FG001|Wash-out|scheduling conflict|1|||
145465891|NCT03099148|524558072|FG002|Wash-out|scheduling conflict|0|||
145465892|NCT03099148|524558073|FG003|Wash-out|scheduling conflict|0|||
145465893|NCT03099148|524558070|FG000|Wash-out|Adverse Event|0|||
145465894|NCT03099148|524558071|FG001|Wash-out|Adverse Event|1|||
145465895|NCT03099148|524558072|FG002|Wash-out|Adverse Event|0|||
145465896|NCT03099148|524558073|FG003|Wash-out|Adverse Event|0|||
145465897|NCT01269385|524558074|FG000|Overall Study|Adverse Event|1|||
145465898|NCT01269385|524558075|FG001|Overall Study|Adverse Event|1|||
145465899|NCT01269385|524558076|FG002|Overall Study|Adverse Event|0|||
145465900|NCT01269385|524558077|FG003|Overall Study|Adverse Event|0|||
145465901|NCT01498185|524558078|FG000|Overall Study|Adverse Event|0|||
145465902|NCT01498185|524558079|FG001|Overall Study|Adverse Event|0|||
145465903|NCT01498185|524558080|FG002|Overall Study|Adverse Event|0|||
145465904|NCT01498185|524558081|FG003|Overall Study|Adverse Event|1|||
145465905|NCT01498185|524558082|FG004|Overall Study|Adverse Event|0|||
145465906|NCT01498185|524558078|FG000|Overall Study|Withdrawal by Subject|1|||
145465907|NCT01498185|524558079|FG001|Overall Study|Withdrawal by Subject|1|||
145465908|NCT01498185|524558080|FG002|Overall Study|Withdrawal by Subject|0|||
145465909|NCT01498185|524558081|FG003|Overall Study|Withdrawal by Subject|2|||
145465910|NCT01498185|524558082|FG004|Overall Study|Withdrawal by Subject|1|||
145465911|NCT01498185|524558078|FG000|Overall Study|No longer met criteria, etc|0|||
145465912|NCT01498185|524558079|FG001|Overall Study|No longer met criteria, etc|0|||
145465913|NCT01498185|524558080|FG002|Overall Study|No longer met criteria, etc|0|||
145465914|NCT01498185|524558081|FG003|Overall Study|No longer met criteria, etc|0|||
145465915|NCT01498185|524558082|FG004|Overall Study|No longer met criteria, etc|2|||
145465916|NCT01827332|524558084|FG000|Overall Study|Lost to Follow-up|2|||
145465917|NCT01827332|524558085|FG001|Overall Study|Lost to Follow-up|1|||
145465918|NCT03352453|524558088|FG000|Overall Study|Miscellaneous Reasons|1|||
145465919|NCT03352453|524558089|FG001|Overall Study|Miscellaneous Reasons|2|||
145465920|NCT03352453|524558088|FG000|Overall Study|Lack of Efficacy|1|||
145465921|NCT03352453|524558089|FG001|Overall Study|Lack of Efficacy|0|||
145465922|NCT03352453|524558088|FG000|Overall Study|Withdrawal by Subject|8|||
145465923|NCT03352453|524558089|FG001|Overall Study|Withdrawal by Subject|14|||
145465924|NCT03352453|524558088|FG000|Overall Study|Study Terminated by Sponsor|2|||
145465925|NCT03352453|524558089|FG001|Overall Study|Study Terminated by Sponsor|1|||
145465926|NCT03352453|524558088|FG000|Overall Study|Protocol Deviation|1|||
145465927|NCT03352453|524558089|FG001|Overall Study|Protocol Deviation|0|||
145465928|NCT03352453|524558088|FG000|Overall Study|Lost to Follow-up|7|||
145465929|NCT03352453|524558089|FG001|Overall Study|Lost to Follow-up|6|||
145465930|NCT03352453|524558088|FG000|Overall Study|Adverse Event|2|||
145465931|NCT03352453|524558089|FG001|Overall Study|Adverse Event|9|||
145465932|NCT01241760|524558090|FG000|Overall Study|Adverse Event|1|||
145465933|NCT01241760|524558091|FG001|Overall Study|Adverse Event|0|||
145465934|NCT01241760|524558090|FG000|Overall Study|Lost to Follow-up|18|||
145465935|NCT01241760|524558091|FG001|Overall Study|Lost to Follow-up|22|||
145465936|NCT01241760|524558090|FG000|Overall Study|Withdrawal by Subject|13|||
145465937|NCT01241760|524558091|FG001|Overall Study|Withdrawal by Subject|13|||
145465938|NCT01241760|524558090|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
145465939|NCT01241760|524558091|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
145465940|NCT01241760|524558090|FG000|Overall Study|Other|1|||
145465941|NCT01241760|524558091|FG001|Overall Study|Other|1|||
145465942|NCT00514020|524558092|FG000|Overall Study|Adverse Event|6|||
145465943|NCT00514020|524558092|FG000|Overall Study|Withdrawal by Subject|3|||
145465944|NCT00514020|524558092|FG000|Overall Study|Physician Decision|1|||
145465945|NCT00514020|524558092|FG000|Overall Study|disease progression|9|||
145596614|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
145596615|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145596616|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145596617|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145465946|NCT00514020|524558092|FG000|Overall Study|other complicating disease|2|||
145465947|NCT00514020|524558092|FG000|Overall Study|patient went to radiation treatment|1|||
145465948|NCT00514020|524558092|FG000|Overall Study|"patients moved to the no tx group"|6|||
145465949|NCT02725593|524558093|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
145465950|NCT02725593|524558094|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
145465951|NCT02725593|524558093|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
145465952|NCT02725593|524558094|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
145465953|NCT02725593|524558093|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
145465954|NCT02725593|524558094|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
145596618|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145596619|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145596620|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145596621|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596622|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596623|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
145596624|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596625|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596626|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596627|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596628|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596629|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145596630|NCT01212770|525034572|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
145596631|NCT01212770|525034573|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
145596632|NCT01212770|525034574|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
145596633|NCT01212770|525034575|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596634|NCT01212770|525034576|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596635|NCT01212770|525034577|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596636|NCT01212770|525034578|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596637|NCT01212770|525034579|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596638|NCT01212770|525034580|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
145596639|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
145596640|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
145596641|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
145596642|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
145596643|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
145596644|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
145596645|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
145596646|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
145596647|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
145596648|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
145596649|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
145596650|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
145596651|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
145596652|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
145596653|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
145596654|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
145596655|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
145596656|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
145596657|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
145596658|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
145596659|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
145596660|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
145596661|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
145596662|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
145596663|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
145596664|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
145596665|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
145596666|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596667|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596668|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
145596669|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596670|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596671|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596672|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596673|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596674|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
145596675|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596676|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145465955|NCT02725593|524558093|FG000|Long Term Extension|Withdrawal by Subject|1|||
145465956|NCT02725593|524558094|FG001|Long Term Extension|Withdrawal by Subject|3|||
145465957|NCT01688921|524558095|FG000|Overall Study|Lost to Follow-up|7|||
145465958|NCT01688921|524558096|FG001|Overall Study|Lost to Follow-up|13|||
145465959|NCT01688921|524558095|FG000|Overall Study|Physician Decision|6|||
145465960|NCT01688921|524558096|FG001|Overall Study|Physician Decision|1|||
145465961|NCT01688921|524558095|FG000|Overall Study|Protocol Violation|0|||
145465962|NCT01688921|524558096|FG001|Overall Study|Protocol Violation|1|||
145465963|NCT01688921|524558095|FG000|Overall Study|informed consent|3|||
145465964|NCT01688921|524558096|FG001|Overall Study|informed consent|0|||
145465965|NCT02644356|524558107|FG000|Overall Study|Withdrawal by Subject|2|||
145465966|NCT02210091|524558109|FG000|Overall Study|Physician Decision|0|||
145465967|NCT02210091|524558110|FG001|Overall Study|Physician Decision|1|||
145465968|NCT02210091|524558109|FG000|Overall Study|Withdrawal by Sponsor|0|||
145465969|NCT02210091|524558110|FG001|Overall Study|Withdrawal by Sponsor|1|||
145465970|NCT01711866|524558111|FG000|Overall Study|Noncompliant|3|||
145465971|NCT01711866|524558111|FG000|Overall Study|Withdrawal by Subject|3|||
145465972|NCT01711866|524558111|FG000|Overall Study|Adverse Event|2|||
145465973|NCT00897390|524558112|FG000|Overall Study|Adverse Event|2|||
145465974|NCT00897390|524558112|FG000|Overall Study|No Longer Met Study Criteria|1|||
145465975|NCT00897390|524558112|FG000|Overall Study|Personal Reasons|1|||
145465976|NCT00897390|524558112|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
145465977|NCT00546260|524558117|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
145465978|NCT00546260|524558118|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
145465979|NCT03780959|524558119|FG000|Part 1|Adverse Event|1|||
145465980|NCT03780959|524558120|FG001|Part 1|Adverse Event|0|||
145465981|NCT03780959|524558121|FG002|Part 1|Adverse Event|0|||
145465982|NCT03780959|524558119|FG000|Part 1|Withdrawal by Subject|1|||
145465983|NCT03780959|524558120|FG001|Part 1|Withdrawal by Subject|0|||
145465984|NCT03780959|524558121|FG002|Part 1|Withdrawal by Subject|0|||
145465985|NCT03780959|524558119|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
145465986|NCT03780959|524558120|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
145465987|NCT03780959|524558121|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
145465988|NCT03780959|524558119|FG000|Part 1|Response Status|2|||
145465989|NCT03780959|524558120|FG001|Part 1|Response Status|0|||
145465990|NCT03780959|524558121|FG002|Part 1|Response Status|0|||
145465991|NCT03780959|524558119|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
145465992|NCT03780959|524558120|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
145465993|NCT03780959|524558121|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
145465994|NCT03780959|524558119|FG000|Part 2|Response Status|0|||
145465995|NCT03780959|524558120|FG001|Part 2|Response Status|18|||
145465996|NCT03780959|524558121|FG002|Part 2|Response Status|6|||
145465997|NCT02559414|524559956|FG000|Overall Study|Lost to Follow-up|0|||
145465998|NCT02559414|524559957|FG001|Overall Study|Lost to Follow-up|1|||
145465999|NCT02559414|524559958|FG002|Overall Study|Lost to Follow-up|0|||
145466000|NCT02559414|524559956|FG000|Overall Study|Withdrawal by Subject|1|||
145466001|NCT02559414|524559957|FG001|Overall Study|Withdrawal by Subject|0|||
145466002|NCT02559414|524559958|FG002|Overall Study|Withdrawal by Subject|1|||
145466003|NCT02559414|524559956|FG000|Overall Study|Other|0|||
145466004|NCT02559414|524559957|FG001|Overall Study|Other|1|||
145466005|NCT02559414|524559958|FG002|Overall Study|Other|1|||
145466006|NCT04271475|524559959|FG000|DB Period: Day 1 up to EODBT|Death|1|||
145466007|NCT04271475|524559960|FG001|DB Period: Day 1 up to EODBT|Death|0|||
145466008|NCT04271475|524559961|FG002|DB Period: Day 1 up to EODBT|Death|0|||
145466009|NCT04271475|524559962|FG003|DB Period: Day 1 up to EODBT|Death|0|||
145466010|NCT04271475|524559959|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
145466011|NCT04271475|524559960|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
145466012|NCT04271475|524559961|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
145466013|NCT04271475|524559962|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
145466014|NCT04271475|524559959|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
145466015|NCT04271475|524559960|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
145466016|NCT04271475|524559961|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
145466017|NCT04271475|524559962|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
145466018|NCT04271475|524559959|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
145466019|NCT04271475|524559960|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
145466020|NCT04271475|524559961|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
145466021|NCT04271475|524559962|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
145466022|NCT04271475|524559959|FG000|DB Period: Day 1 up to EODBT|Other|8|||
145466023|NCT04271475|524559960|FG001|DB Period: Day 1 up to EODBT|Other|5|||
145466024|NCT04271475|524559961|FG002|DB Period: Day 1 up to EODBT|Other|0|||
145466025|NCT04271475|524559962|FG003|DB Period: Day 1 up to EODBT|Other|0|||
145466026|NCT04271475|524559959|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
145466027|NCT04271475|524559960|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
145466028|NCT04271475|524559961|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
145466029|NCT04271475|524559962|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
145466030|NCT04271475|524559959|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
145466031|NCT04271475|524559960|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
145466032|NCT04271475|524559961|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
145466033|NCT04271475|524559962|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
145466034|NCT06250738|524559963|FG000|Overall Study|Lost to Follow-up|1|||
145466035|NCT02936284|524559965|FG000|Overall Study|Withdrawal by Subject|3|||
145466036|NCT02936284|524559966|FG001|Overall Study|Withdrawal by Subject|1|||
145596677|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596678|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
145596679|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596680|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596681|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596682|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596683|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
145596684|NCT01212770|525034572|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596685|NCT01212770|525034573|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596686|NCT01212770|525034574|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
145596687|NCT01212770|525034575|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
145596688|NCT01212770|525034576|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596689|NCT01212770|525034577|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596690|NCT01212770|525034578|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596691|NCT01212770|525034579|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596692|NCT01212770|525034580|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
145596693|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596694|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
145596695|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
145596696|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596697|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596698|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596699|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596700|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
145596701|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
145596702|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145596703|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
145596704|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
145596705|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145596706|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145596707|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145596708|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
145596709|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
145596710|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
145596711|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596712|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
145596713|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596714|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596715|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596716|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596717|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596718|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596719|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
145596720|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145596721|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
145596722|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
145596723|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145596724|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145596725|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145596726|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145596727|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
145596728|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
145596729|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
145596730|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
145596731|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
145596732|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
145596733|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
145596734|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
145596735|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
145596736|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
145596737|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
145596738|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145596739|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
145596740|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
145596741|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145596742|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145596743|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145596744|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145466037|NCT02936284|524559965|FG000|Overall Study|Lost to Follow-up|7|||
145466038|NCT02936284|524559966|FG001|Overall Study|Lost to Follow-up|8|||
145466039|NCT04619004|524559969|FG000|Overall Study|Death|114|||
145466040|NCT04619004|524559970|FG001|Overall Study|Death|28|||
145466041|NCT04619004|524559969|FG000|Overall Study|Lost to Follow-up|1|||
145466042|NCT04619004|524559970|FG001|Overall Study|Lost to Follow-up|1|||
145466043|NCT04619004|524559969|FG000|Overall Study|Withdrawal by Subject|24|||
145466044|NCT04619004|524559970|FG001|Overall Study|Withdrawal by Subject|7|||
145466045|NCT04619004|524559969|FG000|Overall Study|Other - Not specified|0|||
145466046|NCT04619004|524559970|FG001|Overall Study|Other - Not specified|1|||
145466047|NCT01114360|524559973|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
145466048|NCT01114360|524559974|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
145466049|NCT02981524|524559979|FG000|Overall Study|Progressive Disease|14|||
145466050|NCT02981524|524559979|FG000|Overall Study|Death (unrelated)|1|||
145466051|NCT02981524|524559979|FG000|Overall Study|Treatment Related Toxicity|1|||
145466052|NCT02981524|524559979|FG000|Overall Study|Withdrawal by Subject|1|||
145466053|NCT01146288|524559981|FG000|First Intervention(1 Day)|Adverse Event|0|||
145466054|NCT01146288|524559982|FG001|First Intervention(1 Day)|Adverse Event|1|||
145466055|NCT02677844|524559983|FG000|Period 3|Withdrawal by Subject|0|||
145466056|NCT02677844|524559984|FG001|Period 3|Withdrawal by Subject|0|||
145466057|NCT02677844|524559985|FG002|Period 3|Withdrawal by Subject|0|||
145466058|NCT02677844|524559986|FG003|Period 3|Withdrawal by Subject|1|||
145466059|NCT02677844|524559987|FG004|Period 3|Withdrawal by Subject|0|||
145466060|NCT02677844|524559988|FG005|Period 3|Withdrawal by Subject|0|||
145466061|NCT02677844|524559989|FG006|Period 3|Withdrawal by Subject|0|||
145466062|NCT03458702|524559990|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
145466063|NCT03458702|524559991|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
145466064|NCT03458702|524559990|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
145466065|NCT03458702|524559991|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
145466066|NCT01390779|524559992|FG000|Overall Study|Physician Decision|1|||
145466067|NCT03455829|524559993|FG000|Overall Study|Death|2|||
145466068|NCT03455829|524559994|FG001|Overall Study|Death|3|||
145466069|NCT03455829|524559995|FG002|Overall Study|Death|2|||
145466070|NCT03455829|524559996|FG003|Overall Study|Death|4|||
145466071|NCT03455829|524559997|FG004|Overall Study|Death|2|||
145466072|NCT03455829|524559993|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
145466073|NCT03455829|524559994|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
145466074|NCT03455829|524559995|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
145466075|NCT03455829|524559996|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
145466076|NCT03455829|524559997|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
145466077|NCT03455829|524559993|FG000|Overall Study|Disease progression|0|||
145466078|NCT03455829|524559994|FG001|Overall Study|Disease progression|0|||
145466079|NCT03455829|524559995|FG002|Overall Study|Disease progression|0|||
145466080|NCT03455829|524559996|FG003|Overall Study|Disease progression|1|||
145466081|NCT03455829|524559997|FG004|Overall Study|Disease progression|1|||
145466082|NCT01697462|524559998|FG000|Overall Study|Disease Progression|1|||
145466083|NCT01697462|524559998|FG000|Overall Study|Adverse Event|6|||
145466084|NCT01697462|524559998|FG000|Overall Study|Lost to Follow-up|21|||
145466085|NCT01697462|524559998|FG000|Overall Study|Withdrawal by Subject|12|||
145466086|NCT01697462|524559998|FG000|Overall Study|Investigator Decision|21|||
145466087|NCT01697462|524559998|FG000|Overall Study|Death|1|||
145466088|NCT01697462|524559998|FG000|Overall Study|Other|10|||
145466089|NCT01697462|524559998|FG000|Overall Study|Missing|5|||
145466090|NCT00168103|524559999|FG000|Overall Study|Withdrawal by Subject|1|||
145466091|NCT00168103|524560000|FG001|Overall Study|Withdrawal by Subject|2|||
145466092|NCT00168103|524560001|FG002|Overall Study|Withdrawal by Subject|1|||
145466093|NCT00168103|524560002|FG003|Overall Study|Withdrawal by Subject|0|||
145466094|NCT00168103|524559999|FG000|Overall Study|Lost to Follow-up|1|||
145466095|NCT00168103|524560000|FG001|Overall Study|Lost to Follow-up|3|||
145466096|NCT00168103|524560001|FG002|Overall Study|Lost to Follow-up|0|||
145466097|NCT00168103|524560002|FG003|Overall Study|Lost to Follow-up|0|||
145466098|NCT00545532|524560003|FG000|Overall Study|Withdrawal by Subject|1|||
145466099|NCT00545532|524560004|FG001|Overall Study|Withdrawal by Subject|3|||
145466100|NCT00545532|524560003|FG000|Overall Study|Lost to Follow-up|5|||
145466101|NCT00545532|524560004|FG001|Overall Study|Lost to Follow-up|6|||
145466102|NCT00545532|524560003|FG000|Overall Study|Death|0|||
145466103|NCT00545532|524560004|FG001|Overall Study|Death|1|||
145466104|NCT03630302|524560005|FG000|Surgery|hardware issue prevented LFP recordings|1|||
145466105|NCT03630302|524560005|FG000|3 Month Visit|Adverse Event|2|||
145466106|NCT03630302|524560005|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
145596745|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
145466107|NCT03532932|524560009|FG000|Overall Study|Protocol Deviation|33|||
145466108|NCT03532932|524560010|FG001|Overall Study|Protocol Deviation|31|||
145466109|NCT03532932|524560009|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
145596746|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
145596747|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145596748|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
145596749|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
145596750|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145596751|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145596752|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145596753|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
145596754|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
145596755|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
145596756|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145596757|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
145596758|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
145596759|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145596760|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145596761|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145596762|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
145596763|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
145596764|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
145596765|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145596766|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
145596767|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
145596768|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145596769|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145596770|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145596771|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145596772|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
145596773|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
145596774|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596775|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
145596776|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596777|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596778|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596779|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596780|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596781|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596782|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
145596783|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596784|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596785|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596786|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596787|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596788|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596789|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596790|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
145596791|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
145596792|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145596793|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
145596794|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
145596795|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145596796|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145596797|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145596798|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
145596799|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
145596800|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
145596801|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596802|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
145596803|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
145596804|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596805|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596806|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596807|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596808|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
145596809|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
145596810|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145596811|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
145596812|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
145596813|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145466110|NCT03532932|524560010|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
145596814|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145596815|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145596816|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145596817|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
145596818|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
145596819|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596820|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
145596821|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
145596822|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596823|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596824|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596825|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596826|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
145596827|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
145596828|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596829|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
145596830|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
145596831|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596832|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596833|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596834|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596835|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596836|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145596837|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596838|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596839|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
145596840|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596841|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596842|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596843|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596844|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596845|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
145596846|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596847|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
145596848|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596849|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596850|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596851|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596852|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596853|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
145596854|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
145596855|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
145596856|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
145596857|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
145596858|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
145596859|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
145596860|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
145596861|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
145596862|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
145596863|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
145596864|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596865|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596866|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
145596867|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596868|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596869|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596870|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596871|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596872|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
145596873|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596874|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596875|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
145596876|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596877|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145466111|NCT03532932|524560009|FG000|Overall Study|Withdrawal by Subject|2|||
145466112|NCT03532932|524560010|FG001|Overall Study|Withdrawal by Subject|0|||
145466113|NCT03532932|524560009|FG000|Overall Study|Lost to Follow-up|15|||
145596878|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596879|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596880|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
145596881|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
145596882|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596883|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596884|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
145596885|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596886|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596887|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596888|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596889|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596890|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
145596891|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596892|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
145596893|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
145596894|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596895|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596896|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596897|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596898|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
145596899|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145596900|NCT01212770|525034572|FG000|Long-term Safety Phase (Year 5)|Death|0|||
145596901|NCT01212770|525034573|FG001|Long-term Safety Phase (Year 5)|Death|0|||
145596902|NCT01212770|525034574|FG002|Long-term Safety Phase (Year 5)|Death|0|||
145596903|NCT01212770|525034575|FG003|Long-term Safety Phase (Year 5)|Death|0|||
145596904|NCT01212770|525034576|FG004|Long-term Safety Phase (Year 5)|Death|0|||
145596905|NCT01212770|525034577|FG005|Long-term Safety Phase (Year 5)|Death|0|||
145596906|NCT01212770|525034578|FG006|Long-term Safety Phase (Year 5)|Death|0|||
145596907|NCT01212770|525034579|FG007|Long-term Safety Phase (Year 5)|Death|1|||
145596908|NCT01212770|525034580|FG008|Long-term Safety Phase (Year 5)|Death|0|||
145596909|NCT00829387|525034585|FG000|Overall Study|Withdrawal by Subject|2|||
145596910|NCT00829387|525034586|FG001|Overall Study|Withdrawal by Subject|3|||
145596911|NCT00829387|525034585|FG000|Overall Study|Disqualified by PI|1|||
145596912|NCT00829387|525034586|FG001|Overall Study|Disqualified by PI|0|||
145596913|NCT00707031|525034587|FG000|Overall Study|Adverse Event|45|||
145596914|NCT00707031|525034588|FG001|Overall Study|Adverse Event|45|||
145596915|NCT00707031|525034587|FG000|Overall Study|Lack of Efficacy|19|||
145596916|NCT00707031|525034588|FG001|Overall Study|Lack of Efficacy|6|||
145596917|NCT00707031|525034587|FG000|Overall Study|Lost to Follow-up|2|||
145596918|NCT00707031|525034588|FG001|Overall Study|Lost to Follow-up|1|||
145596919|NCT00707031|525034587|FG000|Overall Study|Protocol Violation|1|||
145596920|NCT00707031|525034588|FG001|Overall Study|Protocol Violation|0|||
145596921|NCT00707031|525034587|FG000|Overall Study|Withdrawal by Subject|7|||
145596922|NCT00707031|525034588|FG001|Overall Study|Withdrawal by Subject|8|||
145596923|NCT00707031|525034587|FG000|Overall Study|Poor Compliance to Protocol|7|||
145596924|NCT00707031|525034588|FG001|Overall Study|Poor Compliance to Protocol|13|||
145596925|NCT00707031|525034587|FG000|Overall Study|Familial or Personal Reasons|12|||
145596926|NCT00707031|525034588|FG001|Overall Study|Familial or Personal Reasons|15|||
145596927|NCT00707031|525034587|FG000|Overall Study|Serious Noncompliance|2|||
145596928|NCT00707031|525034588|FG001|Overall Study|Serious Noncompliance|3|||
145596929|NCT00707031|525034587|FG000|Overall Study|Sponsor Decision|9|||
145596930|NCT00707031|525034588|FG001|Overall Study|Sponsor Decision|8|||
145596931|NCT00951275|525034589|FG000|Overall Study|Administrative Reason|1|||
145596932|NCT00951275|525034589|FG000|Overall Study|Adverse Event|7|||
145596933|NCT00951275|525034589|FG000|Overall Study|Withdrawal by Subject|4|||
145596934|NCT00951275|525034589|FG000|Overall Study|Protocol Violation|1|||
145596935|NCT03645759|525034593|FG000|Overall Study|Lost to Follow-up|3|||
145596936|NCT03645759|525034594|FG001|Overall Study|Lost to Follow-up|2|||
145596937|NCT00655980|525034597|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
145596938|NCT00655980|525034598|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
145596939|NCT00655980|525034599|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
145596940|NCT02858895|525034601|FG000|Overall Study|Disease progression|31|||
145596941|NCT02858895|525034601|FG000|Overall Study|Death|2|||
145596942|NCT02858895|525034601|FG000|Overall Study|Adverse Event|1|||
145596943|NCT02858895|525034601|FG000|Overall Study|Withdrawal by Subject|3|||
145596944|NCT02858895|525034601|FG000|Overall Study|hospice,|1|||
145596945|NCT02858895|525034601|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
145596946|NCT01266642|525034609|FG000|Overall Study|Protocol Violation|0|||
145596947|NCT01266642|525034610|FG001|Overall Study|Protocol Violation|1|||
145596948|NCT01377480|525036469|FG000|Overall Study|Protocol Violation|0|||
145596949|NCT01377480|525036470|FG001|Overall Study|Protocol Violation|0|||
145596950|NCT01377480|525036471|FG002|Overall Study|Protocol Violation|0|||
145596951|NCT01377480|525036472|FG003|Overall Study|Protocol Violation|4|||
145596952|NCT01377480|525036469|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
145596953|NCT01377480|525036470|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
145596954|NCT01377480|525036471|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
145596955|NCT01377480|525036472|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
145596956|NCT01377480|525036469|FG000|Overall Study|Withdrawal by Subject|0|||
145596957|NCT01377480|525036470|FG001|Overall Study|Withdrawal by Subject|0|||
145596958|NCT01377480|525036471|FG002|Overall Study|Withdrawal by Subject|1|||
145596959|NCT01377480|525036472|FG003|Overall Study|Withdrawal by Subject|0|||
145596960|NCT01377480|525036469|FG000|Overall Study|Serious adverse event|0|||
145596961|NCT01377480|525036470|FG001|Overall Study|Serious adverse event|0|||
145596962|NCT01377480|525036471|FG002|Overall Study|Serious adverse event|1|||
145596963|NCT01377480|525036472|FG003|Overall Study|Serious adverse event|1|||
145596964|NCT01377480|525036469|FG000|Overall Study|Other|0|||
145596965|NCT01377480|525036470|FG001|Overall Study|Other|0|||
145596966|NCT01377480|525036471|FG002|Overall Study|Other|7|||
145596967|NCT01377480|525036472|FG003|Overall Study|Other|6|||
145596968|NCT01735201|525036476|FG000|Overall Study|Adverse Event|1|||
145596969|NCT01735201|525036477|FG001|Overall Study|Adverse Event|1|||
145596970|NCT01735201|525036478|FG002|Overall Study|Adverse Event|0|||
145596971|NCT01735201|525036479|FG003|Overall Study|Adverse Event|1|||
145596972|NCT01735201|525036480|FG004|Overall Study|Adverse Event|1|||
145596973|NCT01735201|525036481|FG005|Overall Study|Adverse Event|3|||
145596974|NCT01735201|525036482|FG006|Overall Study|Adverse Event|2|||
145596975|NCT01735201|525036483|FG007|Overall Study|Adverse Event|1|||
145596976|NCT01735201|525036476|FG000|Overall Study|Personal Reasons|1|||
145596977|NCT01735201|525036477|FG001|Overall Study|Personal Reasons|0|||
145596978|NCT01735201|525036478|FG002|Overall Study|Personal Reasons|0|||
145596979|NCT01735201|525036479|FG003|Overall Study|Personal Reasons|0|||
145596980|NCT01735201|525036480|FG004|Overall Study|Personal Reasons|0|||
145596981|NCT01735201|525036481|FG005|Overall Study|Personal Reasons|0|||
145596982|NCT01735201|525036482|FG006|Overall Study|Personal Reasons|0|||
145596983|NCT01735201|525036483|FG007|Overall Study|Personal Reasons|0|||
145596984|NCT01735201|525036476|FG000|Overall Study|Protocol Violation|1|||
145596985|NCT01735201|525036477|FG001|Overall Study|Protocol Violation|0|||
145596986|NCT01735201|525036478|FG002|Overall Study|Protocol Violation|0|||
145596987|NCT01735201|525036479|FG003|Overall Study|Protocol Violation|0|||
145596988|NCT01735201|525036480|FG004|Overall Study|Protocol Violation|0|||
145596989|NCT01735201|525036481|FG005|Overall Study|Protocol Violation|0|||
145596990|NCT01735201|525036482|FG006|Overall Study|Protocol Violation|0|||
145596991|NCT01735201|525036483|FG007|Overall Study|Protocol Violation|0|||
145596992|NCT01735201|525036476|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145596993|NCT01735201|525036477|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145596994|NCT01735201|525036478|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145596995|NCT01735201|525036479|FG003|Overall Study|Other Miscellaneous Reasons|1|||
145596996|NCT01735201|525036480|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145596997|NCT01735201|525036481|FG005|Overall Study|Other Miscellaneous Reasons|2|||
145596998|NCT01735201|525036482|FG006|Overall Study|Other Miscellaneous Reasons|1|||
145596999|NCT01735201|525036483|FG007|Overall Study|Other Miscellaneous Reasons|1|||
145597000|NCT04128293|525036486|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
145597001|NCT04128293|525036487|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
145597002|NCT04128293|525036488|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
145597003|NCT04128293|525036489|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
145597004|NCT02080871|525036490|FG000|Overall Study|Death|1|||
145597005|NCT02080871|525036490|FG000|Overall Study|Lost to Follow-up|1|||
145597006|NCT00234052|525036491|FG000|Treatment|Withdrawal by Subject|3|||
145597007|NCT00234052|525036491|FG000|Treatment|Adverse Event|5|||
145597008|NCT00234052|525036491|FG000|Treatment|Death|2|||
145597009|NCT00234052|525036491|FG000|Treatment|Progressive Disease|11|||
145597010|NCT00234052|525036491|FG000|Follow-up for 5 Years|Death|41|||
145597011|NCT00234052|525036491|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
145597012|NCT00234052|525036491|FG000|Follow-up for 5 Years|Other|7|||
145597013|NCT00420199|525036492|FG000|Overall Study|Participant no longer met study criteria|1|||
145597014|NCT00420199|525036493|FG001|Overall Study|Participant no longer met study criteria|0|||
145597015|NCT00002558|525036501|FG000|Overall Study|Withdrawal by Subject|0|||
145597016|NCT00002558|525036502|FG001|Overall Study|Withdrawal by Subject|1|||
145597017|NCT01260350|525036505|FG000|Overall Study|Lack of Efficacy|0|||
145597018|NCT01260350|525036506|FG001|Overall Study|Lack of Efficacy|0|||
145597019|NCT01260350|525036507|FG002|Overall Study|Lack of Efficacy|0|||
145597020|NCT01260350|525036508|FG003|Overall Study|Lack of Efficacy|0|||
145597021|NCT01260350|525036509|FG004|Overall Study|Lack of Efficacy|0|||
145597022|NCT01260350|525036510|FG005|Overall Study|Lack of Efficacy|0|||
145597023|NCT01260350|525036511|FG006|Overall Study|Lack of Efficacy|0|||
145597024|NCT01260350|525036512|FG007|Overall Study|Lack of Efficacy|0|||
145597025|NCT01260350|525036513|FG008|Overall Study|Lack of Efficacy|0|||
145597026|NCT01260350|525036514|FG009|Overall Study|Lack of Efficacy|0|||
145597027|NCT01260350|525036515|FG010|Overall Study|Lack of Efficacy|0|||
145597028|NCT01260350|525036516|FG011|Overall Study|Lack of Efficacy|0|||
145597029|NCT01260350|525036517|FG012|Overall Study|Lack of Efficacy|0|||
145597030|NCT01260350|525036518|FG013|Overall Study|Lack of Efficacy|0|||
145597031|NCT01260350|525036519|FG014|Overall Study|Lack of Efficacy|0|||
145597032|NCT01260350|525036520|FG015|Overall Study|Lack of Efficacy|0|||
145597033|NCT01260350|525036521|FG016|Overall Study|Lack of Efficacy|0|||
145597034|NCT01260350|525036522|FG017|Overall Study|Lack of Efficacy|1|||
145597035|NCT01260350|525036523|FG018|Overall Study|Lack of Efficacy|0|||
145597036|NCT01260350|525036524|FG019|Overall Study|Lack of Efficacy|0|||
145597037|NCT01260350|525036525|FG020|Overall Study|Lack of Efficacy|3|||
145597038|NCT01260350|525036526|FG021|Overall Study|Lack of Efficacy|0|||
145597039|NCT01260350|525036505|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597040|NCT01260350|525036506|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597041|NCT01260350|525036507|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597042|NCT01260350|525036508|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597043|NCT01260350|525036509|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597044|NCT01260350|525036510|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597045|NCT01260350|525036511|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597046|NCT01260350|525036512|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597047|NCT01260350|525036513|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
145597048|NCT01260350|525036514|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597049|NCT01260350|525036515|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597050|NCT01260350|525036516|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597051|NCT01260350|525036517|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597052|NCT01260350|525036518|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597053|NCT01260350|525036519|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597054|NCT01260350|525036520|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597055|NCT01260350|525036521|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597056|NCT01260350|525036522|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597057|NCT01260350|525036523|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597058|NCT01260350|525036524|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597059|NCT01260350|525036525|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597060|NCT01260350|525036526|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
145597061|NCT00558428|525036527|FG000|Overall Study|Adverse Event|6|||
145597062|NCT00558428|525036528|FG001|Overall Study|Adverse Event|22|||
145597063|NCT00558428|525036529|FG002|Overall Study|Adverse Event|3|||
145597064|NCT00558428|525036530|FG003|Overall Study|Adverse Event|4|||
145597065|NCT00558428|525036527|FG000|Overall Study|Lost to Follow-up|0|||
145597066|NCT00558428|525036528|FG001|Overall Study|Lost to Follow-up|1|||
145627016|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
145627017|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
145627018|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
145466114|NCT03532932|524560010|FG001|Overall Study|Lost to Follow-up|9|||
145466115|NCT03532932|524560009|FG000|Overall Study|Adverse Event|4|||
145466116|NCT03532932|524560010|FG001|Overall Study|Adverse Event|3|||
145466117|NCT03532932|524560009|FG000|Overall Study|Death|0|||
145466118|NCT03532932|524560010|FG001|Overall Study|Death|2|||
145466119|NCT03532932|524560009|FG000|Overall Study|Other|11|||
145466120|NCT03532932|524560010|FG001|Overall Study|Other|16|||
145466121|NCT00931801|524560014|FG000|Overall Study|Adverse Event|0|||
145466122|NCT00931801|524560015|FG001|Overall Study|Adverse Event|0|||
145466123|NCT00931801|524560016|FG002|Overall Study|Adverse Event|1|||
145466124|NCT00931801|524560014|FG000|Overall Study|Lost to Follow-up|0|||
145466125|NCT00931801|524560015|FG001|Overall Study|Lost to Follow-up|1|||
145466126|NCT00931801|524560016|FG002|Overall Study|Lost to Follow-up|0|||
145466127|NCT00931801|524560014|FG000|Overall Study|Withdrawal by Subject|1|||
145466128|NCT00931801|524560015|FG001|Overall Study|Withdrawal by Subject|0|||
145466129|NCT00931801|524560016|FG002|Overall Study|Withdrawal by Subject|0|||
145466130|NCT00931801|524560014|FG000|Overall Study|Confirmed Virologic Failure|0|||
145466131|NCT00931801|524560015|FG001|Overall Study|Confirmed Virologic Failure|0|||
145466132|NCT00931801|524560016|FG002|Overall Study|Confirmed Virologic Failure|3|||
145466133|NCT03283150|524560017|FG000|Overall Study|Withdrawal by Subject|6|||
145466134|NCT03283150|524560018|FG001|Overall Study|Withdrawal by Subject|0|||
145466135|NCT03283150|524560019|FG002|Overall Study|Withdrawal by Subject|0|||
145466136|NCT01133275|524560020|FG000|Overall Study|Withdrawal by Subject|1|||
145466137|NCT01133275|524560020|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
145466138|NCT01028716|524560021|FG000|Overall Study|Physician Decision|1|||
145466139|NCT01143896|524560022|FG000|Overall Study|Did not complete Baseline Interview|5|||
145597067|NCT00558428|525036529|FG002|Overall Study|Lost to Follow-up|0|||
145597068|NCT00558428|525036530|FG003|Overall Study|Lost to Follow-up|0|||
145597069|NCT00558428|525036527|FG000|Overall Study|Lack of Efficacy|0|||
145597070|NCT00558428|525036528|FG001|Overall Study|Lack of Efficacy|0|||
145597071|NCT00558428|525036529|FG002|Overall Study|Lack of Efficacy|1|||
145466140|NCT01143896|524560023|FG001|Overall Study|Did not complete Baseline Interview|4|||
145466141|NCT01143896|524560022|FG000|Overall Study|Lost to Follow-up|18|||
145466142|NCT01143896|524560023|FG001|Overall Study|Lost to Follow-up|13|||
145466143|NCT01143896|524560022|FG000|Overall Study|Withdrawal by Subject|13|||
145466144|NCT01143896|524560023|FG001|Overall Study|Withdrawal by Subject|5|||
145466145|NCT01143896|524560022|FG000|Overall Study|Death|6|||
145466146|NCT01143896|524560023|FG001|Overall Study|Death|3|||
145597072|NCT00558428|525036530|FG003|Overall Study|Lack of Efficacy|2|||
145597073|NCT00558428|525036527|FG000|Overall Study|Non compliant with protocol|1|||
145597074|NCT00558428|525036528|FG001|Overall Study|Non compliant with protocol|0|||
145597075|NCT00558428|525036529|FG002|Overall Study|Non compliant with protocol|0|||
145597076|NCT00558428|525036530|FG003|Overall Study|Non compliant with protocol|3|||
145597077|NCT00558428|525036527|FG000|Overall Study|Consent withdrawn|2|||
145597078|NCT00558428|525036528|FG001|Overall Study|Consent withdrawn|1|||
145597079|NCT00558428|525036529|FG002|Overall Study|Consent withdrawn|0|||
145597080|NCT00558428|525036530|FG003|Overall Study|Consent withdrawn|1|||
145597081|NCT00558428|525036527|FG000|Overall Study|Other|3|||
145597082|NCT00558428|525036528|FG001|Overall Study|Other|0|||
145597083|NCT00558428|525036529|FG002|Overall Study|Other|0|||
145597084|NCT00558428|525036530|FG003|Overall Study|Other|1|||
145597085|NCT00626028|525036531|FG000|Overall Study|Adverse Event|1|||
145597086|NCT00626028|525036532|FG001|Overall Study|Adverse Event|1|||
145597087|NCT00626028|525036531|FG000|Overall Study|Device Failure|0|||
145597088|NCT00626028|525036532|FG001|Overall Study|Device Failure|1|||
145597089|NCT00626028|525036531|FG000|Overall Study|Physician Decision|2|||
145597090|NCT00626028|525036532|FG001|Overall Study|Physician Decision|1|||
145597091|NCT00626028|525036531|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
145597092|NCT00626028|525036532|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
145597093|NCT05224050|525036533|FG000|Overall Study|Withdrawal by Subject|9|||
145597094|NCT05224050|525036533|FG000|Overall Study|Lost to Follow-up|3|||
145597095|NCT02436330|525036534|FG000|Cohort 1|Lost to Follow-up|5|||
145597096|NCT02436330|525036535|FG001|Cohort 1|Lost to Follow-up|2|||
145597097|NCT02436330|525036534|FG000|Cohort 1|Withdrawal by Subject|0|||
145466147|NCT01318070|524560024|FG000|Overall Study|Adverse Event|1|||
145466148|NCT01318070|524560025|FG001|Overall Study|Adverse Event|1|||
145466149|NCT01318070|524560026|FG002|Overall Study|Adverse Event|5|||
145466150|NCT01318070|524560024|FG000|Overall Study|Withdrawal by Subject|0|||
145466151|NCT01318070|524560025|FG001|Overall Study|Withdrawal by Subject|1|||
145597098|NCT02436330|525036535|FG001|Cohort 1|Withdrawal by Subject|1|||
145597099|NCT02436330|525036534|FG000|Cohort 2|Lost to Follow-up|2|||
145597100|NCT02436330|525036535|FG001|Cohort 2|Lost to Follow-up|0|||
145597101|NCT02436330|525036534|FG000|Cohort 2|Withdrawal by Subject|2|||
145597102|NCT02436330|525036535|FG001|Cohort 2|Withdrawal by Subject|3|||
145597103|NCT02436330|525036534|FG000|Cohort 3|Lost to Follow-up|1|||
145597104|NCT02436330|525036535|FG001|Cohort 3|Lost to Follow-up|0|||
145597105|NCT02436330|525036534|FG000|Cohort 3|Withdrawal by Subject|4|||
145597106|NCT02436330|525036535|FG001|Cohort 3|Withdrawal by Subject|0|||
145597107|NCT02436330|525036534|FG000|Cohort 4|Lost to Follow-up|1|||
145597108|NCT02436330|525036535|FG001|Cohort 4|Lost to Follow-up|0|||
145597109|NCT02436330|525036534|FG000|Cohort 4|Withdrawal by Subject|1|||
145466152|NCT01318070|524560026|FG002|Overall Study|Withdrawal by Subject|1|||
145466153|NCT01318070|524560024|FG000|Overall Study|Lack of Efficacy|0|||
145466154|NCT01318070|524560025|FG001|Overall Study|Lack of Efficacy|0|||
145466155|NCT01318070|524560026|FG002|Overall Study|Lack of Efficacy|1|||
145466156|NCT01318070|524560024|FG000|Overall Study|Principal Investigator Discretion|1|||
145466157|NCT01318070|524560025|FG001|Overall Study|Principal Investigator Discretion|0|||
145466158|NCT01318070|524560026|FG002|Overall Study|Principal Investigator Discretion|0|||
145466159|NCT04375397|524560029|FG000|Overall Study|Death|1|||
145466160|NCT04375397|524560030|FG001|Overall Study|Death|1|||
145466161|NCT04375397|524560029|FG000|Overall Study|Withdrew consent|2|||
145597110|NCT02436330|525036535|FG001|Cohort 4|Withdrawal by Subject|0|||
145597111|NCT02436330|525036534|FG000|Cohort 5|Lost to Follow-up|3|||
145597112|NCT02436330|525036535|FG001|Cohort 5|Lost to Follow-up|2|||
145597113|NCT02436330|525036534|FG000|Cohort 5|Withdrawal by Subject|3|||
145597114|NCT02436330|525036535|FG001|Cohort 5|Withdrawal by Subject|2|||
145597115|NCT02436330|525036534|FG000|Cohort 6|Lost to Follow-up|2|||
145597116|NCT02436330|525036535|FG001|Cohort 6|Lost to Follow-up|0|||
145597117|NCT02436330|525036534|FG000|Cohort 6|Withdrawal by Subject|1|||
145597118|NCT02436330|525036535|FG001|Cohort 6|Withdrawal by Subject|1|||
145597119|NCT00338884|525036536|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
145597120|NCT00338884|525036536|FG000|Overall Study|Adverse Event|14|||
145627019|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
145627020|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Other|1|||
145597121|NCT00338884|525036536|FG000|Overall Study|Death|8|||
145597122|NCT00338884|525036536|FG000|Overall Study|Other|4|||
145597123|NCT00338884|525036536|FG000|Overall Study|Global Deterioration of Health Status|3|||
145597124|NCT00338884|525036536|FG000|Overall Study|Withdrawal by Subject|3|||
145597125|NCT00338884|525036536|FG000|Overall Study|Lost to Follow-up|1|||
145466162|NCT04375397|524560030|FG001|Overall Study|Withdrew consent|0|||
145597126|NCT00338884|525036536|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
145597127|NCT04535947|525036537|FG000|Overall Study|Adverse Event|1|||
145597128|NCT04535947|525036538|FG001|Overall Study|Adverse Event|4|||
145597129|NCT04535947|525036537|FG000|Overall Study|Other reasons not specified|2|||
145597130|NCT04535947|525036538|FG001|Overall Study|Other reasons not specified|0|||
145597131|NCT04535947|525036537|FG000|Overall Study|Withdrawal by Subject|1|||
145597132|NCT04535947|525036538|FG001|Overall Study|Withdrawal by Subject|1|||
145466163|NCT04375397|524560029|FG000|Overall Study|Lost to Follow-up|6|||
145466164|NCT04375397|524560030|FG001|Overall Study|Lost to Follow-up|4|||
145466165|NCT04375397|524560029|FG000|Overall Study|Other, not specified|0|||
145466166|NCT04375397|524560030|FG001|Overall Study|Other, not specified|1|||
145466167|NCT00086502|524560031|FG000|Overall Study|Adverse Event|11|||
145466168|NCT00086502|524560032|FG001|Overall Study|Adverse Event|2|||
145466169|NCT00086502|524560031|FG000|Overall Study|Lack of Efficacy|0|||
145466170|NCT00086502|524560032|FG001|Overall Study|Lack of Efficacy|2|||
145466171|NCT00086502|524560031|FG000|Overall Study|Lost to Follow-up|3|||
145466172|NCT00086502|524560032|FG001|Overall Study|Lost to Follow-up|1|||
145466173|NCT00086502|524560031|FG000|Overall Study|Physician Decision|1|||
145466174|NCT00086502|524560032|FG001|Overall Study|Physician Decision|1|||
145466175|NCT00086502|524560031|FG000|Overall Study|Pregnancy|0|||
145466176|NCT00086502|524560032|FG001|Overall Study|Pregnancy|1|||
145466177|NCT00086502|524560031|FG000|Overall Study|Protocol Violation|3|||
145466178|NCT00086502|524560032|FG001|Overall Study|Protocol Violation|3|||
145466179|NCT00086502|524560031|FG000|Overall Study|Withdrawal by Subject|5|||
145466180|NCT00086502|524560032|FG001|Overall Study|Withdrawal by Subject|6|||
145466181|NCT00086502|524560031|FG000|Overall Study|Patient Moved|1|||
145466182|NCT00086502|524560032|FG001|Overall Study|Patient Moved|1|||
145466183|NCT00086502|524560031|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
145466184|NCT00086502|524560032|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
145466185|NCT00086502|524560031|FG000|Overall Study|Patient Accidentally Unblinded|1|||
145466186|NCT00086502|524560032|FG001|Overall Study|Patient Accidentally Unblinded|0|||
145466187|NCT01443130|524560037|FG000|Overall Study|Lost to Follow-up|44|||
145466188|NCT01443130|524560038|FG001|Overall Study|Lost to Follow-up|42|||
145466189|NCT01443130|524560039|FG002|Overall Study|Lost to Follow-up|50|||
145466190|NCT01443130|524560040|FG003|Overall Study|Lost to Follow-up|23|||
145466191|NCT01443130|524560041|FG004|Overall Study|Lost to Follow-up|25|||
145466192|NCT01443130|524560042|FG005|Overall Study|Lost to Follow-up|21|||
145466193|NCT01443130|524560037|FG000|Overall Study|Death|0|||
145466194|NCT01443130|524560038|FG001|Overall Study|Death|1|||
145466195|NCT01443130|524560039|FG002|Overall Study|Death|0|||
145466196|NCT01443130|524560040|FG003|Overall Study|Death|7|||
145466197|NCT01443130|524560041|FG004|Overall Study|Death|10|||
145466198|NCT01443130|524560042|FG005|Overall Study|Death|8|||
145466199|NCT01443130|524560037|FG000|Overall Study|Adverse Event|2|||
145466200|NCT01443130|524560038|FG001|Overall Study|Adverse Event|1|||
145466201|NCT01443130|524560039|FG002|Overall Study|Adverse Event|1|||
145466202|NCT01443130|524560040|FG003|Overall Study|Adverse Event|0|||
145466203|NCT01443130|524560041|FG004|Overall Study|Adverse Event|0|||
145466204|NCT01443130|524560042|FG005|Overall Study|Adverse Event|0|||
145466205|NCT01443130|524560037|FG000|Overall Study|Protocol Violation|2|||
145466206|NCT01443130|524560038|FG001|Overall Study|Protocol Violation|1|||
145466207|NCT01443130|524560039|FG002|Overall Study|Protocol Violation|3|||
145466208|NCT01443130|524560040|FG003|Overall Study|Protocol Violation|2|||
145466209|NCT01443130|524560041|FG004|Overall Study|Protocol Violation|2|||
145466210|NCT01443130|524560042|FG005|Overall Study|Protocol Violation|3|||
145466211|NCT01443130|524560037|FG000|Overall Study|Withdrawal by Subject|15|||
145466212|NCT01443130|524560038|FG001|Overall Study|Withdrawal by Subject|14|||
145466213|NCT01443130|524560039|FG002|Overall Study|Withdrawal by Subject|12|||
145466214|NCT01443130|524560040|FG003|Overall Study|Withdrawal by Subject|7|||
145466215|NCT01443130|524560041|FG004|Overall Study|Withdrawal by Subject|7|||
145466216|NCT01443130|524560042|FG005|Overall Study|Withdrawal by Subject|2|||
145466217|NCT01443130|524560037|FG000|Overall Study|Death of Subject's Infant|5|||
145466218|NCT01443130|524560038|FG001|Overall Study|Death of Subject's Infant|10|||
145466219|NCT01443130|524560039|FG002|Overall Study|Death of Subject's Infant|11|||
145466220|NCT01443130|524560040|FG003|Overall Study|Death of Subject's Infant|0|||
145466221|NCT01443130|524560041|FG004|Overall Study|Death of Subject's Infant|0|||
145466222|NCT01443130|524560042|FG005|Overall Study|Death of Subject's Infant|0|||
145466223|NCT00364533|524560043|FG000|Overall Study|Adverse Event|8|||
145466224|NCT00364533|524560044|FG001|Overall Study|Adverse Event|7|||
145466225|NCT00364533|524560045|FG002|Overall Study|Adverse Event|15|||
145466226|NCT00364533|524560046|FG003|Overall Study|Adverse Event|5|||
145466227|NCT00364533|524560047|FG004|Overall Study|Adverse Event|2|||
145466228|NCT00364533|524560043|FG000|Overall Study|Withdrawal by Subject|4|||
145466229|NCT00364533|524560044|FG001|Overall Study|Withdrawal by Subject|8|||
145466230|NCT00364533|524560045|FG002|Overall Study|Withdrawal by Subject|6|||
145466231|NCT00364533|524560046|FG003|Overall Study|Withdrawal by Subject|6|||
145466232|NCT00364533|524560047|FG004|Overall Study|Withdrawal by Subject|6|||
145466233|NCT00364533|524560043|FG000|Overall Study|Lack of Efficacy|22|||
145466234|NCT00364533|524560044|FG001|Overall Study|Lack of Efficacy|22|||
145466235|NCT00364533|524560045|FG002|Overall Study|Lack of Efficacy|21|||
145466236|NCT00364533|524560046|FG003|Overall Study|Lack of Efficacy|17|||
145466237|NCT00364533|524560047|FG004|Overall Study|Lack of Efficacy|42|||
145466238|NCT00364533|524560043|FG000|Overall Study|Subject discharged from hospital|4|||
145466239|NCT00364533|524560044|FG001|Overall Study|Subject discharged from hospital|1|||
145466240|NCT00364533|524560045|FG002|Overall Study|Subject discharged from hospital|2|||
145466241|NCT00364533|524560046|FG003|Overall Study|Subject discharged from hospital|3|||
145597133|NCT02355002|525036541|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
145597134|NCT02355002|525036542|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
145597135|NCT02355002|525036541|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
145597136|NCT02355002|525036542|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
145597137|NCT02355002|525036541|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
145597138|NCT02355002|525036542|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
145597139|NCT02355002|525036541|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
145597140|NCT02355002|525036542|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
145466242|NCT00364533|524560047|FG004|Overall Study|Subject discharged from hospital|1|||
145597141|NCT02355002|525036541|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
145597142|NCT02355002|525036542|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
145597143|NCT02355002|525036541|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
145597144|NCT02355002|525036542|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
145597145|NCT02355002|525036541|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
145597146|NCT02355002|525036542|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
145597147|NCT03205371|525036548|FG000|Overall Study|Withdrawal by Subject|4|||
145597148|NCT03205371|525036549|FG001|Overall Study|Withdrawal by Subject|1|||
145597149|NCT03205371|525036550|FG002|Overall Study|Withdrawal by Subject|0|||
145597150|NCT03205371|525036551|FG003|Overall Study|Withdrawal by Subject|0|||
145597151|NCT03205371|525036552|FG004|Overall Study|Withdrawal by Subject|0|||
145597152|NCT03205371|525036553|FG005|Overall Study|Withdrawal by Subject|0|||
145597153|NCT03205371|525036554|FG006|Overall Study|Withdrawal by Subject|4|||
145597154|NCT03205371|525036555|FG007|Overall Study|Withdrawal by Subject|0|||
145597155|NCT03205371|525036556|FG008|Overall Study|Withdrawal by Subject|2|||
145597156|NCT03205371|525036557|FG009|Overall Study|Withdrawal by Subject|0|||
145597157|NCT03205371|525036558|FG010|Overall Study|Withdrawal by Subject|0|||
145597158|NCT03205371|525036559|FG011|Overall Study|Withdrawal by Subject|1|||
145597159|NCT03205371|525036548|FG000|Overall Study|Lost to Follow-up|0|||
145597160|NCT03205371|525036549|FG001|Overall Study|Lost to Follow-up|0|||
145597161|NCT03205371|525036550|FG002|Overall Study|Lost to Follow-up|0|||
145597162|NCT03205371|525036551|FG003|Overall Study|Lost to Follow-up|0|||
145597163|NCT03205371|525036552|FG004|Overall Study|Lost to Follow-up|0|||
145597164|NCT03205371|525036553|FG005|Overall Study|Lost to Follow-up|0|||
145597165|NCT03205371|525036554|FG006|Overall Study|Lost to Follow-up|5|||
145597166|NCT03205371|525036555|FG007|Overall Study|Lost to Follow-up|2|||
145597167|NCT03205371|525036556|FG008|Overall Study|Lost to Follow-up|3|||
145597168|NCT03205371|525036557|FG009|Overall Study|Lost to Follow-up|0|||
145597169|NCT03205371|525036558|FG010|Overall Study|Lost to Follow-up|0|||
145597170|NCT03205371|525036559|FG011|Overall Study|Lost to Follow-up|0|||
145597171|NCT03205371|525036548|FG000|Overall Study|Protocol Violation|0|||
145597172|NCT03205371|525036549|FG001|Overall Study|Protocol Violation|0|||
145597173|NCT03205371|525036550|FG002|Overall Study|Protocol Violation|0|||
145597174|NCT03205371|525036551|FG003|Overall Study|Protocol Violation|0|||
145597175|NCT03205371|525036552|FG004|Overall Study|Protocol Violation|0|||
145597176|NCT03205371|525036553|FG005|Overall Study|Protocol Violation|0|||
145597177|NCT03205371|525036554|FG006|Overall Study|Protocol Violation|1|||
145597178|NCT03205371|525036555|FG007|Overall Study|Protocol Violation|0|||
145597179|NCT03205371|525036556|FG008|Overall Study|Protocol Violation|0|||
145597180|NCT03205371|525036557|FG009|Overall Study|Protocol Violation|0|||
145597181|NCT03205371|525036558|FG010|Overall Study|Protocol Violation|0|||
145597182|NCT03205371|525036559|FG011|Overall Study|Protocol Violation|0|||
145597183|NCT03205371|525036548|FG000|Overall Study|Adverse Event|0|||
145597184|NCT03205371|525036549|FG001|Overall Study|Adverse Event|0|||
145466243|NCT00364533|524560043|FG000|Overall Study|Variations in drug compliance|2|||
145597185|NCT03205371|525036550|FG002|Overall Study|Adverse Event|0|||
145597186|NCT03205371|525036551|FG003|Overall Study|Adverse Event|0|||
145597187|NCT03205371|525036552|FG004|Overall Study|Adverse Event|0|||
145597188|NCT03205371|525036553|FG005|Overall Study|Adverse Event|0|||
145597189|NCT03205371|525036554|FG006|Overall Study|Adverse Event|0|||
145597190|NCT03205371|525036555|FG007|Overall Study|Adverse Event|1|||
145597191|NCT03205371|525036556|FG008|Overall Study|Adverse Event|0|||
145597192|NCT03205371|525036557|FG009|Overall Study|Adverse Event|0|||
145597193|NCT03205371|525036558|FG010|Overall Study|Adverse Event|0|||
145597194|NCT03205371|525036559|FG011|Overall Study|Adverse Event|0|||
145597195|NCT05711641|525036561|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
145597196|NCT05711641|525036562|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
145597197|NCT05711641|525036561|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
145597198|NCT05711641|525036562|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
145597199|NCT03342638|525036567|FG000|Overall Study|Withdrawal by Subject|1|||
145597200|NCT03342638|525036568|FG001|Overall Study|Withdrawal by Subject|0|||
145597201|NCT03342638|525036567|FG000|Overall Study|Physician Decision|0|||
145597202|NCT03342638|525036568|FG001|Overall Study|Physician Decision|1|||
145466244|NCT00364533|524560044|FG001|Overall Study|Variations in drug compliance|1|||
145466245|NCT00364533|524560045|FG002|Overall Study|Variations in drug compliance|1|||
145466246|NCT00364533|524560046|FG003|Overall Study|Variations in drug compliance|0|||
145466247|NCT00364533|524560047|FG004|Overall Study|Variations in drug compliance|0|||
145466248|NCT00364533|524560043|FG000|Overall Study|Non-compliance|1|||
145466249|NCT00364533|524560044|FG001|Overall Study|Non-compliance|0|||
145466250|NCT00364533|524560045|FG002|Overall Study|Non-compliance|0|||
145466251|NCT00364533|524560046|FG003|Overall Study|Non-compliance|0|||
145466252|NCT00364533|524560047|FG004|Overall Study|Non-compliance|0|||
145466253|NCT00364533|524560043|FG000|Overall Study|Protocol Violation|1|||
145466254|NCT00364533|524560044|FG001|Overall Study|Protocol Violation|1|||
145466255|NCT00364533|524560045|FG002|Overall Study|Protocol Violation|0|||
145466256|NCT00364533|524560046|FG003|Overall Study|Protocol Violation|0|||
145466257|NCT00364533|524560047|FG004|Overall Study|Protocol Violation|0|||
145466258|NCT00582738|524560048|FG000|Overall Study|Administrative Problems|7|||
145466259|NCT00582738|524560049|FG001|Overall Study|Administrative Problems|8|||
145466260|NCT00582738|524560048|FG000|Overall Study|Adverse Event|0|||
145466261|NCT00582738|524560049|FG001|Overall Study|Adverse Event|5|||
145466262|NCT00582738|524560048|FG000|Overall Study|Graft Lost|0|||
145466263|NCT00582738|524560049|FG001|Overall Study|Graft Lost|1|||
145466264|NCT00582738|524560048|FG000|Overall Study|Other|1|||
145466265|NCT00582738|524560049|FG001|Overall Study|Other|0|||
145466266|NCT00582738|524560048|FG000|Overall Study|Protocol Violation|1|||
145466267|NCT00582738|524560049|FG001|Overall Study|Protocol Violation|1|||
145466268|NCT00582738|524560048|FG000|Overall Study|Withdrawal by Subject|0|||
145466269|NCT00582738|524560049|FG001|Overall Study|Withdrawal by Subject|3|||
145466270|NCT02758301|524560050|FG000|Overall Study|Death|12|||
145466271|NCT02758301|524560051|FG001|Overall Study|Death|0|||
145466272|NCT02758301|524560050|FG000|Overall Study|Physician Decision|10|||
145466273|NCT02758301|524560051|FG001|Overall Study|Physician Decision|1|||
145466274|NCT02758301|524560050|FG000|Overall Study|Withdrawal by Subject|5|||
145466275|NCT02758301|524560051|FG001|Overall Study|Withdrawal by Subject|6|||
145466276|NCT02758301|524560050|FG000|Overall Study|Lost to Follow-up|7|||
145466277|NCT02758301|524560051|FG001|Overall Study|Lost to Follow-up|0|||
145466278|NCT02758301|524560050|FG000|Overall Study|Protocol Violation|0|||
145466279|NCT02758301|524560051|FG001|Overall Study|Protocol Violation|1|||
145466280|NCT01011933|524560053|FG000|Overall Study|Wrong cell type|1|||
145466281|NCT01011933|524560053|FG000|Overall Study|Improper pre-protocol Rx|1|||
145466282|NCT01011933|524560053|FG000|Overall Study|Inadequate pathology|1|||
145466283|NCT01011933|524560053|FG000|Overall Study|Never treated|1|||
145466284|NCT03461406|524560054|FG000|Overall Study|Death|1|||
145466285|NCT03461406|524560055|FG001|Overall Study|Death|2|||
145466286|NCT03461406|524560054|FG000|Overall Study|Consent Withdrawn by Participant|0|||
145466287|NCT03461406|524560055|FG001|Overall Study|Consent Withdrawn by Participant|1|||
145466288|NCT03461406|524560054|FG000|Overall Study|Screen Failure|3|||
145466289|NCT03461406|524560055|FG001|Overall Study|Screen Failure|1|||
145466290|NCT03461406|524560054|FG000|Overall Study|Reason not Specified|1|||
145466291|NCT03461406|524560055|FG001|Overall Study|Reason not Specified|3|||
145466292|NCT03461406|524560054|FG000|Overall Study|Lost to Follow-up|3|||
145466293|NCT03461406|524560055|FG001|Overall Study|Lost to Follow-up|0|||
145466294|NCT01886690|524560056|FG000|Overall Study|Protocol Violation|0|||
145466295|NCT01886690|524560057|FG001|Overall Study|Protocol Violation|1|||
145466296|NCT01886690|524560056|FG000|Overall Study|Personal Reasons|0|||
145466297|NCT01886690|524560057|FG001|Overall Study|Personal Reasons|1|||
145466298|NCT02900170|524560060|FG000|Overall Study|Lost to Follow-up|8|||
145466299|NCT02012686|524560064|FG000|Overall Study|muscle contraction|0|||
145466300|NCT02012686|524560065|FG001|Overall Study|muscle contraction|1|||
145466301|NCT02012686|524560064|FG000|Overall Study|electrocardiography monitoring noise|0|||
145466302|NCT02012686|524560065|FG001|Overall Study|electrocardiography monitoring noise|1|||
145466303|NCT00966719|524560066|FG000|Overall Study|Lost to Follow-up|6|||
145466304|NCT00966719|524560067|FG001|Overall Study|Lost to Follow-up|11|||
145466305|NCT00160199|524560068|FG000|Overall Study|Adverse Event|5|||
145466306|NCT00160199|524560069|FG001|Overall Study|Adverse Event|14|||
145466307|NCT00160199|524560068|FG000|Overall Study|Lack of Efficacy|0|||
145466308|NCT00160199|524560069|FG001|Overall Study|Lack of Efficacy|1|||
145466309|NCT00160199|524560068|FG000|Overall Study|Lost to Follow-up|7|||
145466310|NCT00160199|524560069|FG001|Overall Study|Lost to Follow-up|7|||
145466311|NCT00160199|524560068|FG000|Overall Study|Withdrawal by Subject|4|||
145466312|NCT00160199|524560069|FG001|Overall Study|Withdrawal by Subject|6|||
145466313|NCT00160199|524560068|FG000|Overall Study|Administrative|0|||
145466314|NCT00160199|524560069|FG001|Overall Study|Administrative|1|||
145466315|NCT00160199|524560068|FG000|Overall Study|Protocol Violation|8|||
145466316|NCT00160199|524560069|FG001|Overall Study|Protocol Violation|8|||
145466317|NCT01710527|524560070|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
145466318|NCT01710527|524560071|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
145466319|NCT02124772|524560072|FG000|Overall Study|Lack of Efficacy|2|||
145466320|NCT02124772|524560073|FG001|Overall Study|Lack of Efficacy|0|||
145466321|NCT02124772|524560074|FG002|Overall Study|Lack of Efficacy|0|||
145466322|NCT02124772|524560075|FG003|Overall Study|Lack of Efficacy|1|||
145597203|NCT00262821|525036569|FG000|Overall Study|Ineligible - wrong stage|0|||
145597204|NCT00262821|525036570|FG001|Overall Study|Ineligible - wrong stage|3|||
145597205|NCT00262821|525036569|FG000|Overall Study|Ineligible - wrong cell type|2|||
145597206|NCT00262821|525036570|FG001|Overall Study|Ineligible - wrong cell type|2|||
145597207|NCT00262821|525036569|FG000|Overall Study|Ineligible - wrong primary|0|||
145597208|NCT00262821|525036570|FG001|Overall Study|Ineligible - wrong primary|1|||
145597209|NCT00262821|525036569|FG000|Overall Study|Ineligible - inadequate pathology|1|||
145597210|NCT00262821|525036570|FG001|Overall Study|Ineligible - inadequate pathology|3|||
145597211|NCT00262821|525036569|FG000|Overall Study|Ineligible - elevated creatinine|0|||
145597212|NCT00262821|525036570|FG001|Overall Study|Ineligible - elevated creatinine|2|||
145597213|NCT00262821|525036569|FG000|Overall Study|Ineligible - required test not done|1|||
145597214|NCT00262821|525036570|FG001|Overall Study|Ineligible - required test not done|4|||
145597215|NCT00262821|525036569|FG000|Overall Study|Inevaluable - inadequate data|0|||
145597216|NCT00262821|525036570|FG001|Overall Study|Inevaluable - inadequate data|4|||
145597217|NCT00587964|525036572|FG000|Overall Study|Withdrawal by Subject|1|||
145597218|NCT00587964|525036572|FG000|Overall Study|Lost to Follow-up|1|||
145597219|NCT00587964|525036572|FG000|Overall Study|Patient found to be ineligible|1|||
145597220|NCT00587964|525036572|FG000|Overall Study|Patient did not receive intervention|5|||
145597221|NCT00587964|525036572|FG000|Overall Study|Progression of Disease|4|||
145597222|NCT01302847|525036580|FG000|Overall Study|Death|0|||
145597223|NCT01302847|525036581|FG001|Overall Study|Death|1|||
145597224|NCT01302847|525036582|FG002|Overall Study|Death|0|||
145597225|NCT01302847|525036583|FG003|Overall Study|Death|0|||
145597226|NCT01302847|525036584|FG004|Overall Study|Death|0|||
145597227|NCT01302847|525036585|FG005|Overall Study|Death|1|||
145597228|NCT01302847|525036586|FG006|Overall Study|Death|1|||
145597229|NCT01302847|525036587|FG007|Overall Study|Death|0|||
145597230|NCT01302847|525036580|FG000|Overall Study|Pregnancy|2|||
145597231|NCT01302847|525036581|FG001|Overall Study|Pregnancy|0|||
145597232|NCT01302847|525036582|FG002|Overall Study|Pregnancy|0|||
145597233|NCT01302847|525036583|FG003|Overall Study|Pregnancy|0|||
145597234|NCT01302847|525036584|FG004|Overall Study|Pregnancy|0|||
145597235|NCT01302847|525036585|FG005|Overall Study|Pregnancy|0|||
145597236|NCT01302847|525036586|FG006|Overall Study|Pregnancy|0|||
145597237|NCT01302847|525036587|FG007|Overall Study|Pregnancy|0|||
145597238|NCT01302847|525036580|FG000|Overall Study|Virologic failure|0|||
145597239|NCT01302847|525036581|FG001|Overall Study|Virologic failure|2|||
145597240|NCT01302847|525036582|FG002|Overall Study|Virologic failure|0|||
145597241|NCT01302847|525036583|FG003|Overall Study|Virologic failure|2|||
145597242|NCT01302847|525036584|FG004|Overall Study|Virologic failure|1|||
145597243|NCT01302847|525036585|FG005|Overall Study|Virologic failure|3|||
145597244|NCT01302847|525036586|FG006|Overall Study|Virologic failure|1|||
145597245|NCT01302847|525036587|FG007|Overall Study|Virologic failure|2|||
145597246|NCT01302847|525036580|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145597247|NCT01302847|525036581|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145597248|NCT01302847|525036582|FG002|Overall Study|Severe debilitation, unable to continue|0|||
145597249|NCT01302847|525036583|FG003|Overall Study|Severe debilitation, unable to continue|0|||
145597250|NCT01302847|525036584|FG004|Overall Study|Severe debilitation, unable to continue|0|||
145597251|NCT01302847|525036585|FG005|Overall Study|Severe debilitation, unable to continue|1|||
145597252|NCT01302847|525036586|FG006|Overall Study|Severe debilitation, unable to continue|1|||
145597253|NCT01302847|525036587|FG007|Overall Study|Severe debilitation, unable to continue|0|||
145597254|NCT01302847|525036580|FG000|Overall Study|Not able to get to clinic|1|||
145597255|NCT01302847|525036581|FG001|Overall Study|Not able to get to clinic|1|||
145597256|NCT01302847|525036582|FG002|Overall Study|Not able to get to clinic|0|||
145597257|NCT01302847|525036583|FG003|Overall Study|Not able to get to clinic|0|||
145597258|NCT01302847|525036584|FG004|Overall Study|Not able to get to clinic|0|||
145597259|NCT01302847|525036585|FG005|Overall Study|Not able to get to clinic|0|||
145597260|NCT01302847|525036586|FG006|Overall Study|Not able to get to clinic|0|||
145597261|NCT01302847|525036587|FG007|Overall Study|Not able to get to clinic|0|||
145597262|NCT01302847|525036580|FG000|Overall Study|Site closing|2|||
145597263|NCT01302847|525036581|FG001|Overall Study|Site closing|2|||
145597264|NCT01302847|525036582|FG002|Overall Study|Site closing|0|||
145597265|NCT01302847|525036583|FG003|Overall Study|Site closing|0|||
145597266|NCT01302847|525036584|FG004|Overall Study|Site closing|0|||
145597267|NCT01302847|525036585|FG005|Overall Study|Site closing|0|||
145597268|NCT01302847|525036586|FG006|Overall Study|Site closing|0|||
145597269|NCT01302847|525036587|FG007|Overall Study|Site closing|0|||
145597270|NCT01302847|525036580|FG000|Overall Study|Withdrawal by Subject|1|||
145597271|NCT01302847|525036581|FG001|Overall Study|Withdrawal by Subject|0|||
145597272|NCT01302847|525036582|FG002|Overall Study|Withdrawal by Subject|0|||
145597273|NCT01302847|525036583|FG003|Overall Study|Withdrawal by Subject|0|||
145597274|NCT01302847|525036584|FG004|Overall Study|Withdrawal by Subject|1|||
145597275|NCT01302847|525036585|FG005|Overall Study|Withdrawal by Subject|0|||
145597276|NCT01302847|525036586|FG006|Overall Study|Withdrawal by Subject|0|||
145597277|NCT01302847|525036587|FG007|Overall Study|Withdrawal by Subject|1|||
145597278|NCT01302847|525036580|FG000|Overall Study|Not willing to adhere to requirements|5|||
145627021|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Other|0|||
145627022|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Other|0|||
145627023|NCT02403323|525147148|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
145627024|NCT02403323|525147149|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
145627025|NCT02403323|525147150|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
145627026|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
145627027|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
145627028|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
145627029|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
145627030|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
145627031|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
145627032|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
145627033|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
145627034|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
145627035|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
145627036|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
145627037|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
145627038|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
145627039|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
145627040|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
145627041|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
145627042|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
145627043|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
145627044|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
145627045|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
145627046|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
145627047|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
145627048|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
145627049|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
145627050|NCT02403323|525147148|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
145627051|NCT02403323|525147149|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
145627052|NCT02403323|525147150|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
145627053|NCT00197236|525147151|FG000|Overall Study|Adverse Event|1|||
145627054|NCT00197236|525147152|FG001|Overall Study|Adverse Event|0|||
145627055|NCT00197236|525147153|FG002|Overall Study|Adverse Event|1|||
145627056|NCT00197236|525147151|FG000|Overall Study|Lost to Follow-up|5|||
145627057|NCT00197236|525147152|FG001|Overall Study|Lost to Follow-up|14|||
145627058|NCT00197236|525147153|FG002|Overall Study|Lost to Follow-up|6|||
145627059|NCT00197236|525147151|FG000|Overall Study|Protocol Violation|0|||
145627060|NCT00197236|525147152|FG001|Overall Study|Protocol Violation|0|||
145627061|NCT00197236|525147153|FG002|Overall Study|Protocol Violation|1|||
145627062|NCT00197236|525147151|FG000|Overall Study|Withdrawal by Subject|7|||
145627063|NCT00197236|525147152|FG001|Overall Study|Withdrawal by Subject|3|||
145627064|NCT00197236|525147153|FG002|Overall Study|Withdrawal by Subject|11|||
145627065|NCT00197236|525147151|FG000|Overall Study|Study drug/medication expiration|1|||
145627066|NCT00197236|525147152|FG001|Overall Study|Study drug/medication expiration|0|||
145627067|NCT00197236|525147153|FG002|Overall Study|Study drug/medication expiration|3|||
145627068|NCT00197236|525147151|FG000|Overall Study|Returned out of specified time window|0|||
145627069|NCT00197236|525147152|FG001|Overall Study|Returned out of specified time window|0|||
145627070|NCT00197236|525147153|FG002|Overall Study|Returned out of specified time window|1|||
145627071|NCT03885596|525147154|FG000|Overall Study|Withdrawal by Subject|2|||
145597279|NCT01302847|525036581|FG001|Overall Study|Not willing to adhere to requirements|0|||
145597280|NCT01302847|525036582|FG002|Overall Study|Not willing to adhere to requirements|1|||
145597281|NCT01302847|525036583|FG003|Overall Study|Not willing to adhere to requirements|0|||
145597282|NCT01302847|525036584|FG004|Overall Study|Not willing to adhere to requirements|0|||
145597283|NCT01302847|525036585|FG005|Overall Study|Not willing to adhere to requirements|0|||
145597284|NCT01302847|525036586|FG006|Overall Study|Not willing to adhere to requirements|0|||
145597285|NCT01302847|525036587|FG007|Overall Study|Not willing to adhere to requirements|2|||
145597286|NCT01302847|525036580|FG000|Overall Study|Site unable to contact participant|2|||
145597287|NCT01302847|525036581|FG001|Overall Study|Site unable to contact participant|1|||
145597288|NCT01302847|525036582|FG002|Overall Study|Site unable to contact participant|0|||
145597289|NCT01302847|525036583|FG003|Overall Study|Site unable to contact participant|0|||
145627072|NCT03885596|525147155|FG001|Overall Study|Withdrawal by Subject|1|||
145627073|NCT03885596|525147156|FG002|Overall Study|Withdrawal by Subject|0|||
145627074|NCT03885596|525147157|FG003|Overall Study|Withdrawal by Subject|0|||
145627075|NCT02616263|525147158|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
145597290|NCT01302847|525036584|FG004|Overall Study|Site unable to contact participant|0|||
145627076|NCT02616263|525147159|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
145627077|NCT02616263|525147158|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
145597291|NCT01302847|525036585|FG005|Overall Study|Site unable to contact participant|0|||
145597292|NCT01302847|525036586|FG006|Overall Study|Site unable to contact participant|2|||
145597293|NCT01302847|525036587|FG007|Overall Study|Site unable to contact participant|0|||
145597294|NCT01371851|525036588|FG000|Overall Study|Lost to Follow-up|5|||
145597295|NCT01371851|525036589|FG001|Overall Study|Lost to Follow-up|8|||
145597296|NCT01371851|525036588|FG000|Overall Study|was arrested and put in jail|0|||
145597297|NCT01371851|525036589|FG001|Overall Study|was arrested and put in jail|1|||
145597298|NCT01371851|525036588|FG000|Overall Study|non study related adverse event|1|||
145597299|NCT01371851|525036589|FG001|Overall Study|non study related adverse event|0|||
145597300|NCT01371851|525036588|FG000|Overall Study|Blood Pressure outside study parameters|2|||
145597301|NCT01371851|525036589|FG001|Overall Study|Blood Pressure outside study parameters|0|||
145597302|NCT00450411|525036590|FG000|Overall Study|Protocol Violation|6|||
145597303|NCT00450411|525036590|FG000|Overall Study|No protocol treatment|2|||
145597304|NCT02130193|525036591|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
145597305|NCT02130193|525036592|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
145597306|NCT02130193|525036593|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
145597307|NCT02130193|525036591|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
145597308|NCT02130193|525036592|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
145597309|NCT02130193|525036593|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
145597310|NCT02130193|525036591|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
145597311|NCT02130193|525036592|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
145597312|NCT02130193|525036593|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
145597313|NCT02130193|525036591|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
145597314|NCT02130193|525036592|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
145597315|NCT02130193|525036593|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
145597316|NCT00344461|525036594|FG000|Overall Study|Adverse Event|6|||
145597317|NCT00344461|525036594|FG000|Overall Study|Death|1|||
145597318|NCT00344461|525036594|FG000|Overall Study|Lack of Efficacy|2|||
145597319|NCT00344461|525036594|FG000|Overall Study|Lost to Follow-up|2|||
145597320|NCT00344461|525036594|FG000|Overall Study|Physician Decision|2|||
145597321|NCT00344461|525036594|FG000|Overall Study|Protocol Violation|6|||
145597322|NCT00344461|525036594|FG000|Overall Study|Withdrawal by Subject|2|||
145597323|NCT00541450|525036604|FG000|Phase A|Adverse Event|3|||
145597324|NCT00541450|525036605|FG001|Phase A|Adverse Event|0|||
145597325|NCT00541450|525036604|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
145597326|NCT00541450|525036605|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
145597327|NCT00541450|525036604|FG000|Phase A|Hyperglycemia|0|||
145597328|NCT00541450|525036605|FG001|Phase A|Hyperglycemia|1|||
145597329|NCT00541450|525036604|FG000|Phase A|Lost to Follow-up|6|||
145597330|NCT00541450|525036605|FG001|Phase A|Lost to Follow-up|4|||
145597331|NCT00541450|525036604|FG000|Phase A|Physician Decision|2|||
145597332|NCT00541450|525036605|FG001|Phase A|Physician Decision|0|||
145597333|NCT00541450|525036604|FG000|Phase A|Protocol Violation|2|||
145597334|NCT00541450|525036605|FG001|Phase A|Protocol Violation|3|||
145597335|NCT00541450|525036604|FG000|Phase A|Withdrawal by Subject|7|||
145597336|NCT00541450|525036605|FG001|Phase A|Withdrawal by Subject|7|||
145597337|NCT00541450|525036604|FG000|Phase B|Adverse Event|6|||
145597338|NCT00541450|525036605|FG001|Phase B|Adverse Event|6|||
145597339|NCT00541450|525036604|FG000|Phase B|Hyperglycemia|10|||
145597340|NCT00541450|525036605|FG001|Phase B|Hyperglycemia|9|||
145597341|NCT00541450|525036604|FG000|Phase B|Lost to Follow-up|6|||
145597342|NCT00541450|525036605|FG001|Phase B|Lost to Follow-up|4|||
145597343|NCT00541450|525036604|FG000|Phase B|Physician Decision|4|||
145597344|NCT00541450|525036605|FG001|Phase B|Physician Decision|2|||
145597345|NCT00541450|525036604|FG000|Phase B|Pregnancy|0|||
145597346|NCT00541450|525036605|FG001|Phase B|Pregnancy|1|||
145597347|NCT00541450|525036604|FG000|Phase B|Protocol Violation|3|||
145597348|NCT00541450|525036605|FG001|Phase B|Protocol Violation|3|||
145627078|NCT02616263|525147159|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
145627079|NCT02616263|525147158|FG000|6 Month to 1.5 Year|Death|1|||
145627080|NCT02616263|525147159|FG001|6 Month to 1.5 Year|Death|0|||
145627081|NCT02616263|525147158|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
145627082|NCT02616263|525147159|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
145627083|NCT02616263|525147158|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
145627084|NCT02616263|525147159|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
145597349|NCT00541450|525036604|FG000|Phase B|Withdrawal by Subject|8|||
145597350|NCT00541450|525036605|FG001|Phase B|Withdrawal by Subject|6|||
145597351|NCT00818753|525036606|FG000|Overall Study|Protocol Violation|1|||
145597352|NCT00818753|525036607|FG001|Overall Study|Protocol Violation|0|||
145597353|NCT00818753|525036608|FG002|Overall Study|Protocol Violation|0|||
145597354|NCT00818753|525036606|FG000|Overall Study|Other reason (not specified)|0|||
145597355|NCT00818753|525036607|FG001|Overall Study|Other reason (not specified)|0|||
145597356|NCT00818753|525036608|FG002|Overall Study|Other reason (not specified)|1|||
145597357|NCT00818753|525036606|FG000|Overall Study|Randomised and not treated|2|||
145597358|NCT00818753|525036607|FG001|Overall Study|Randomised and not treated|0|||
145597359|NCT00818753|525036608|FG002|Overall Study|Randomised and not treated|0|||
145597360|NCT01389973|525036609|FG000|Overall Study|Lost to Follow-up|1|||
145597361|NCT01389973|525036609|FG000|Overall Study|Trial Stopped by Sponsor|9|||
145597362|NCT01389973|525036609|FG000|Overall Study|Other|10|||
145597363|NCT00725296|525036610|FG000|Overall Study|Adverse Event|11|||
145597364|NCT00725296|525036610|FG000|Overall Study|Lack of Efficacy|7|||
145597365|NCT00725296|525036610|FG000|Overall Study|Withdrawal by Subject|3|||
145597366|NCT00725296|525036610|FG000|Overall Study|Non-Compliance|2|||
145597367|NCT00725296|525036610|FG000|Overall Study|Lost to Follow-up|1|||
145597368|NCT00725296|525036610|FG000|Overall Study|Other|38|||
145597369|NCT02693743|525036611|FG000|Overall Study|Physician Decision|1|||
145597370|NCT02693743|525036612|FG001|Overall Study|Physician Decision|0|||
145597371|NCT03360942|525036613|FG000|Overall Study|Device explanted|2|||
145597372|NCT03360942|525036613|FG000|Overall Study|Study closure|1|||
145597373|NCT03360942|525036613|FG000|Overall Study|Withdrawal by Subject|2|||
145597374|NCT02459574|525036619|FG000|Overall Study|Withdrawal by Subject|6|||
145597375|NCT02459574|525036620|FG001|Overall Study|Withdrawal by Subject|6|||
145597376|NCT02459574|525036621|FG002|Overall Study|Withdrawal by Subject|2|||
145597377|NCT02459574|525036619|FG000|Overall Study|Lost to Follow-up|1|||
145597378|NCT02459574|525036620|FG001|Overall Study|Lost to Follow-up|1|||
145597379|NCT02459574|525036621|FG002|Overall Study|Lost to Follow-up|0|||
145597380|NCT02459574|525036619|FG000|Overall Study|Death|0|||
145597381|NCT02459574|525036620|FG001|Overall Study|Death|1|||
145597382|NCT02459574|525036621|FG002|Overall Study|Death|0|||
145597383|NCT00251745|525036623|FG000|Overall Study|Adverse Event|7|||
145597384|NCT00251745|525036624|FG001|Overall Study|Adverse Event|9|||
145597385|NCT00251745|525036625|FG002|Overall Study|Adverse Event|11|||
145597386|NCT00251745|525036623|FG000|Overall Study|Lost to Follow-up|4|||
145597387|NCT00251745|525036624|FG001|Overall Study|Lost to Follow-up|2|||
145597388|NCT00251745|525036625|FG002|Overall Study|Lost to Follow-up|5|||
145597389|NCT00251745|525036623|FG000|Overall Study|Withdrawal by Subject|13|||
145597390|NCT00251745|525036624|FG001|Overall Study|Withdrawal by Subject|7|||
145597391|NCT00251745|525036625|FG002|Overall Study|Withdrawal by Subject|3|||
145597392|NCT00251745|525036623|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
145597393|NCT00251745|525036624|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
145597394|NCT00251745|525036625|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
145597395|NCT00251745|525036623|FG000|Overall Study|Lack of Efficacy|3|||
145597396|NCT00251745|525036624|FG001|Overall Study|Lack of Efficacy|0|||
145597397|NCT00251745|525036625|FG002|Overall Study|Lack of Efficacy|0|||
145597398|NCT00251745|525036623|FG000|Overall Study|Noncompliant|0|||
145597399|NCT00251745|525036624|FG001|Overall Study|Noncompliant|2|||
145597400|NCT00251745|525036625|FG002|Overall Study|Noncompliant|2|||
145597401|NCT00251745|525036623|FG000|Overall Study|Pregnancy|0|||
145597402|NCT00251745|525036624|FG001|Overall Study|Pregnancy|1|||
145597403|NCT00251745|525036625|FG002|Overall Study|Pregnancy|0|||
145597404|NCT00251745|525036623|FG000|Overall Study|Per Subject Request|0|||
145597405|NCT00251745|525036624|FG001|Overall Study|Per Subject Request|0|||
145597406|NCT00251745|525036625|FG002|Overall Study|Per Subject Request|1|||
145597407|NCT00251745|525036623|FG000|Overall Study|Per Investigator Request|1|||
145597408|NCT00251745|525036624|FG001|Overall Study|Per Investigator Request|0|||
145627085|NCT02616263|525147158|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
145627086|NCT02616263|525147159|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
145466323|NCT02124772|524560076|FG004|Overall Study|Lack of Efficacy|2|||
145466324|NCT02124772|524560077|FG005|Overall Study|Lack of Efficacy|3|||
145466325|NCT02124772|524560078|FG006|Overall Study|Lack of Efficacy|0|||
145466326|NCT02124772|524560079|FG007|Overall Study|Lack of Efficacy|2|||
145466327|NCT02124772|524560080|FG008|Overall Study|Lack of Efficacy|0|||
145466328|NCT02124772|524560081|FG009|Overall Study|Lack of Efficacy|1|||
145466329|NCT02124772|524560082|FG010|Overall Study|Lack of Efficacy|0|||
145466330|NCT02124772|524560083|FG011|Overall Study|Lack of Efficacy|0|||
145466331|NCT02124772|524560084|FG012|Overall Study|Lack of Efficacy|1|||
145466332|NCT02124772|524560072|FG000|Overall Study|Adverse Event|1|||
145466333|NCT02124772|524560073|FG001|Overall Study|Adverse Event|4|||
145466334|NCT02124772|524560074|FG002|Overall Study|Adverse Event|1|||
145466335|NCT02124772|524560075|FG003|Overall Study|Adverse Event|5|||
145597409|NCT00251745|525036625|FG002|Overall Study|Per Investigator Request|0|||
145597410|NCT04508699|525036630|FG000|Overall Study|Lack of Efficacy|2|||
145597411|NCT04508699|525036631|FG001|Overall Study|Lack of Efficacy|15|||
145597412|NCT04508699|525036630|FG000|Overall Study|Withdrawal by Subject|0|||
145597413|NCT04508699|525036631|FG001|Overall Study|Withdrawal by Subject|2|||
145597414|NCT04866017|525036632|FG000|Overall Study|Study Terminated by Sponsor|13|||
145597415|NCT04866017|525036633|FG001|Overall Study|Study Terminated by Sponsor|14|||
145597416|NCT04866017|525036634|FG002|Overall Study|Study Terminated by Sponsor|13|||
145597417|NCT04866017|525036632|FG000|Overall Study|Death|8|||
145627087|NCT00614744|525147162|FG000|Overall Study|Lost to Follow-up|5|||
145466336|NCT02124772|524560076|FG004|Overall Study|Adverse Event|2|||
145466337|NCT02124772|524560077|FG005|Overall Study|Adverse Event|1|||
145597418|NCT04866017|525036633|FG001|Overall Study|Death|4|||
145597419|NCT04866017|525036634|FG002|Overall Study|Death|8|||
145597420|NCT04866017|525036632|FG000|Overall Study|Withdrawal by Subject|1|||
145597421|NCT04866017|525036633|FG001|Overall Study|Withdrawal by Subject|0|||
145466338|NCT02124772|524560078|FG006|Overall Study|Adverse Event|1|||
145466339|NCT02124772|524560079|FG007|Overall Study|Adverse Event|5|||
145466340|NCT02124772|524560080|FG008|Overall Study|Adverse Event|0|||
145597422|NCT04866017|525036634|FG002|Overall Study|Withdrawal by Subject|1|||
145597423|NCT04866017|525036632|FG000|Overall Study|Physician Decision|0|||
145597424|NCT04866017|525036633|FG001|Overall Study|Physician Decision|1|||
145597425|NCT04866017|525036634|FG002|Overall Study|Physician Decision|0|||
145597426|NCT03355326|525036635|FG000|Overall Study|Protocol Violation|3|||
145597427|NCT03355326|525036636|FG001|Overall Study|Protocol Violation|3|||
145597428|NCT01111123|525038344|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
145597429|NCT01111123|525038345|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
145597430|NCT01111123|525038344|FG000|Maintenance Phase|Lost to Follow-up|0|||
145597431|NCT01111123|525038345|FG001|Maintenance Phase|Lost to Follow-up|2|||
145597432|NCT01203930|525038350|FG000|Overall Study|Disease Progression|0|||
145597433|NCT01203930|525038351|FG001|Overall Study|Disease Progression|4|||
145597434|NCT01203930|525038350|FG000|Overall Study|Death|3|||
145597435|NCT01203930|525038351|FG001|Overall Study|Death|1|||
145597436|NCT01203930|525038350|FG000|Overall Study|Withdrew Consent|1|||
145597437|NCT01203930|525038351|FG001|Overall Study|Withdrew Consent|10|||
145597438|NCT01203930|525038350|FG000|Overall Study|Investigator Request|0|||
145597439|NCT01203930|525038351|FG001|Overall Study|Investigator Request|8|||
145597440|NCT01203930|525038350|FG000|Overall Study|Study Terminated by Sponsor|0|||
145597441|NCT01203930|525038351|FG001|Overall Study|Study Terminated by Sponsor|12|||
145597442|NCT01203930|525038350|FG000|Overall Study|Poor tolerance of study drug|0|||
145597443|NCT01203930|525038351|FG001|Overall Study|Poor tolerance of study drug|1|||
145597444|NCT01203930|525038350|FG000|Overall Study|Adverse Event|17|||
145597445|NCT01203930|525038351|FG001|Overall Study|Adverse Event|5|||
145597446|NCT03014674|525038355|FG000|Overall Study|Withdrawal by Subject|1|||
145597447|NCT03014674|525038356|FG001|Overall Study|Withdrawal by Subject|0|||
145597448|NCT03014674|525038357|FG002|Overall Study|Withdrawal by Subject|0|||
145597449|NCT01332227|525038358|FG000|Overall Study|Adverse Event|4|||
145597450|NCT01332227|525038359|FG001|Overall Study|Adverse Event|1|||
145597451|NCT01332227|525038358|FG000|Overall Study|Withdrawal by Subject|5|||
145597452|NCT01332227|525038359|FG001|Overall Study|Withdrawal by Subject|1|||
145597453|NCT01332227|525038358|FG000|Overall Study|Lost to Follow-up|2|||
145597454|NCT01332227|525038359|FG001|Overall Study|Lost to Follow-up|0|||
145597455|NCT01332227|525038358|FG000|Overall Study|Lack of Efficacy|3|||
145597456|NCT01332227|525038359|FG001|Overall Study|Lack of Efficacy|1|||
145597457|NCT01332227|525038358|FG000|Overall Study|Poor compliance/noncompliance|1|||
145597458|NCT01332227|525038359|FG001|Overall Study|Poor compliance/noncompliance|1|||
145597459|NCT01332227|525038358|FG000|Overall Study|Patient moved from area|1|||
145597460|NCT01332227|525038359|FG001|Overall Study|Patient moved from area|0|||
145597461|NCT01332227|525038358|FG000|Overall Study|Patient began prohibited medication|0|||
145597462|NCT01332227|525038359|FG001|Overall Study|Patient began prohibited medication|1|||
145597463|NCT00514943|525038360|FG000|Stage 1|Progressive disease|4|||
145597464|NCT00514943|525038361|FG001|Stage 1|Progressive disease|8|||
145597465|NCT00514943|525038360|FG000|Stage 1|Other Adverse Event|16|||
145597466|NCT00514943|525038361|FG001|Stage 1|Other Adverse Event|6|||
145466341|NCT02124772|524560081|FG009|Overall Study|Adverse Event|3|||
145466342|NCT02124772|524560082|FG010|Overall Study|Adverse Event|1|||
145466343|NCT02124772|524560083|FG011|Overall Study|Adverse Event|3|||
145466344|NCT02124772|524560084|FG012|Overall Study|Adverse Event|1|||
145466345|NCT02124772|524560072|FG000|Overall Study|Withdrawal consent|0|||
145466346|NCT02124772|524560073|FG001|Overall Study|Withdrawal consent|1|||
145466347|NCT02124772|524560074|FG002|Overall Study|Withdrawal consent|1|||
145466348|NCT02124772|524560075|FG003|Overall Study|Withdrawal consent|1|||
145466349|NCT02124772|524560076|FG004|Overall Study|Withdrawal consent|0|||
145466350|NCT02124772|524560077|FG005|Overall Study|Withdrawal consent|1|||
145466351|NCT02124772|524560078|FG006|Overall Study|Withdrawal consent|1|||
145466352|NCT02124772|524560079|FG007|Overall Study|Withdrawal consent|0|||
145466353|NCT02124772|524560080|FG008|Overall Study|Withdrawal consent|0|||
145466354|NCT02124772|524560081|FG009|Overall Study|Withdrawal consent|1|||
145466355|NCT02124772|524560082|FG010|Overall Study|Withdrawal consent|0|||
145466356|NCT02124772|524560083|FG011|Overall Study|Withdrawal consent|1|||
145466357|NCT02124772|524560084|FG012|Overall Study|Withdrawal consent|0|||
145466358|NCT02124772|524560072|FG000|Overall Study|Investigator discretion|0|||
145466359|NCT02124772|524560073|FG001|Overall Study|Investigator discretion|2|||
145466360|NCT02124772|524560074|FG002|Overall Study|Investigator discretion|2|||
145597467|NCT00514943|525038360|FG000|Stage 1|Not treated|1|||
145627088|NCT00614744|525147163|FG001|Overall Study|Lost to Follow-up|4|||
145597468|NCT00514943|525038361|FG001|Stage 1|Not treated|2|||
145466361|NCT02124772|524560075|FG003|Overall Study|Investigator discretion|1|||
145466362|NCT02124772|524560076|FG004|Overall Study|Investigator discretion|1|||
145597469|NCT00514943|525038360|FG000|Stage 1|Patient refused to continue study meds|8|||
145597470|NCT00514943|525038361|FG001|Stage 1|Patient refused to continue study meds|3|||
145597471|NCT00514943|525038360|FG000|Stage 1|Other than stated above|1|||
145597472|NCT00514943|525038361|FG001|Stage 1|Other than stated above|7|||
145597473|NCT00514943|525038360|FG000|Stage 2|Progressive disease|27|||
145466363|NCT02124772|524560077|FG005|Overall Study|Investigator discretion|0|||
145466364|NCT02124772|524560078|FG006|Overall Study|Investigator discretion|1|||
145466365|NCT02124772|524560079|FG007|Overall Study|Investigator discretion|0|||
145466366|NCT02124772|524560080|FG008|Overall Study|Investigator discretion|0|||
145466367|NCT02124772|524560081|FG009|Overall Study|Investigator discretion|1|||
145466368|NCT02124772|524560082|FG010|Overall Study|Investigator discretion|0|||
145466369|NCT02124772|524560083|FG011|Overall Study|Investigator discretion|1|||
145466370|NCT02124772|524560084|FG012|Overall Study|Investigator discretion|0|||
145466371|NCT02124772|524560072|FG000|Overall Study|Progressive disease|0|||
145466372|NCT02124772|524560073|FG001|Overall Study|Progressive disease|0|||
145466373|NCT02124772|524560074|FG002|Overall Study|Progressive disease|0|||
145466374|NCT02124772|524560075|FG003|Overall Study|Progressive disease|0|||
145466375|NCT02124772|524560076|FG004|Overall Study|Progressive disease|0|||
145466376|NCT02124772|524560077|FG005|Overall Study|Progressive disease|0|||
145466377|NCT02124772|524560078|FG006|Overall Study|Progressive disease|1|||
145466378|NCT02124772|524560079|FG007|Overall Study|Progressive disease|1|||
145466379|NCT02124772|524560080|FG008|Overall Study|Progressive disease|0|||
145466380|NCT02124772|524560081|FG009|Overall Study|Progressive disease|0|||
145466381|NCT02124772|524560082|FG010|Overall Study|Progressive disease|0|||
145466382|NCT02124772|524560083|FG011|Overall Study|Progressive disease|0|||
145466383|NCT02124772|524560084|FG012|Overall Study|Progressive disease|0|||
145466384|NCT02124772|524560072|FG000|Overall Study|Other|0|||
145466385|NCT02124772|524560073|FG001|Overall Study|Other|7|||
145466386|NCT02124772|524560074|FG002|Overall Study|Other|2|||
145466387|NCT02124772|524560075|FG003|Overall Study|Other|5|||
145466388|NCT02124772|524560076|FG004|Overall Study|Other|4|||
145466389|NCT02124772|524560077|FG005|Overall Study|Other|3|||
145466390|NCT02124772|524560078|FG006|Overall Study|Other|4|||
145466391|NCT02124772|524560079|FG007|Overall Study|Other|1|||
145466392|NCT02124772|524560080|FG008|Overall Study|Other|1|||
145466393|NCT02124772|524560081|FG009|Overall Study|Other|1|||
145466394|NCT02124772|524560082|FG010|Overall Study|Other|1|||
145466395|NCT02124772|524560083|FG011|Overall Study|Other|1|||
145466396|NCT02124772|524560084|FG012|Overall Study|Other|0|||
145466397|NCT02827500|524560085|FG000|Overall Study|Death|7|||
145466398|NCT02827500|524560086|FG001|Overall Study|Death|3|||
145466399|NCT02827500|524560085|FG000|Overall Study|Lost to Follow-up|1|||
145466400|NCT02827500|524560086|FG001|Overall Study|Lost to Follow-up|1|||
145466401|NCT02827500|524560085|FG000|Overall Study|Withdrawal by Subject|3|||
145466402|NCT02827500|524560086|FG001|Overall Study|Withdrawal by Subject|1|||
145466403|NCT02827500|524560085|FG000|Overall Study|Missing primary endpoint data|3|||
145466404|NCT02827500|524560086|FG001|Overall Study|Missing primary endpoint data|1|||
145466405|NCT02827500|524560085|FG000|Overall Study|Other|5|||
145627089|NCT00614744|525147162|FG000|Overall Study|Incomplete for Behavior Issues|0|||
145627090|NCT00614744|525147163|FG001|Overall Study|Incomplete for Behavior Issues|2|||
145627091|NCT01446003|525147164|FG000|Period 1|Protocol Violation|2|||
145627092|NCT01446003|525147165|FG001|Period 1|Protocol Violation|0|||
145627093|NCT01446003|525147164|FG000|Period 2|Adverse Event|1|||
145627094|NCT01446003|525147165|FG001|Period 2|Adverse Event|0|||
145627095|NCT00490555|525147166|FG000|Overall Study|noncompliant with drug administration|0|||
145627096|NCT00490555|525147167|FG001|Overall Study|noncompliant with drug administration|0|||
145627097|NCT00490555|525147168|FG002|Overall Study|noncompliant with drug administration|2|||
145627098|NCT00490555|525147169|FG003|Overall Study|noncompliant with drug administration|0|||
145627099|NCT00603538|525147170|FG000|Overall Study|Adverse Event|0|||
145627100|NCT00603538|525147171|FG001|Overall Study|Adverse Event|4|||
145627101|NCT00603538|525147172|FG002|Overall Study|Adverse Event|2|||
145627102|NCT00603538|525147170|FG000|Overall Study|Objective progression or relapse|3|||
145627103|NCT00603538|525147171|FG001|Overall Study|Objective progression or relapse|0|||
145627104|NCT00603538|525147172|FG002|Overall Study|Objective progression or relapse|0|||
145627105|NCT04794179|525147173|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
145627106|NCT04794179|525147174|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
145627107|NCT01096056|525147175|FG000|Overall Study|Lost to Follow-up|0|||
145627108|NCT01096056|525147176|FG001|Overall Study|Lost to Follow-up|1|||
145627109|NCT01737268|525147179|FG000|Overall Study|Adverse Event|6|||
145466406|NCT02827500|524560086|FG001|Overall Study|Other|1|||
145466407|NCT03089944|524560089|FG000|Overall Study|Lost to Follow-up|8|||
145466408|NCT03089944|524560089|FG000|Overall Study|Withdrew Consent|2|||
145466409|NCT03089944|524560089|FG000|Overall Study|Adverse Event|1|||
145466410|NCT03089944|524560089|FG000|Overall Study|Other|1|||
145466411|NCT01636713|524560090|FG000|Overall Study|Adverse Event|16|||
145466412|NCT01636713|524560091|FG001|Overall Study|Adverse Event|16|||
145466413|NCT01636713|524560092|FG002|Overall Study|Adverse Event|7|||
145466414|NCT01636713|524560090|FG000|Overall Study|Lack of Efficacy|6|||
145627110|NCT01737268|525147179|FG000|Overall Study|Worsening of Target Disease|2|||
145466415|NCT01636713|524560091|FG001|Overall Study|Lack of Efficacy|6|||
145466416|NCT01636713|524560092|FG002|Overall Study|Lack of Efficacy|2|||
145627111|NCT01737268|525147179|FG000|Overall Study|In consideration of the patient's safety|1|||
145466417|NCT01636713|524560090|FG000|Overall Study|Protocol Violation|3|||
145466418|NCT01636713|524560091|FG001|Overall Study|Protocol Violation|0|||
145466419|NCT01636713|524560092|FG002|Overall Study|Protocol Violation|1|||
145466420|NCT01636713|524560090|FG000|Overall Study|Lost to Follow-up|0|||
145466421|NCT01636713|524560091|FG001|Overall Study|Lost to Follow-up|0|||
145466422|NCT01636713|524560092|FG002|Overall Study|Lost to Follow-up|1|||
145466423|NCT01636713|524560090|FG000|Overall Study|Withdrawal by Subject|5|||
145466424|NCT01636713|524560091|FG001|Overall Study|Withdrawal by Subject|4|||
145466425|NCT01636713|524560092|FG002|Overall Study|Withdrawal by Subject|8|||
145466426|NCT01636713|524560090|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
145466427|NCT01636713|524560091|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
145466428|NCT01636713|524560092|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
145466429|NCT03689244|524560093|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
145466430|NCT03689244|524560094|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
145466431|NCT03689244|524560095|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
145466432|NCT03689244|524560096|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
145466433|NCT03689244|524560093|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
145466434|NCT03689244|524560094|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
145466435|NCT03689244|524560095|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
145466436|NCT03689244|524560096|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
145466437|NCT03689244|524560093|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
145466438|NCT03689244|524560094|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
145466439|NCT03689244|524560095|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
145466440|NCT03689244|524560096|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
145466441|NCT03689244|524560093|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
145466442|NCT03689244|524560094|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
145466443|NCT03689244|524560095|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
145466444|NCT03689244|524560096|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
145466445|NCT03689244|524560093|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
145466446|NCT03689244|524560094|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
145466447|NCT03689244|524560095|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
145466448|NCT03689244|524560096|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
145466449|NCT03689244|524560093|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
145466450|NCT03689244|524560094|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
145466451|NCT03689244|524560095|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
145466452|NCT03689244|524560096|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
145466453|NCT03689244|524560093|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
145466454|NCT03689244|524560094|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
145466455|NCT03689244|524560095|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
145466456|NCT03689244|524560096|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
145466457|NCT03689244|524560093|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
145466458|NCT03689244|524560094|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
145466459|NCT03689244|524560095|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
145466460|NCT03689244|524560096|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
145466461|NCT02308488|524560099|FG000|Overall Study|Withdrawal by Subject|2|||
145466462|NCT01541917|524560100|FG000|Overall Study|Lost to Follow-up|2|||
145466463|NCT01541917|524560101|FG001|Overall Study|Lost to Follow-up|2|||
145466464|NCT01541917|524560100|FG000|Overall Study|Withdrawal by Subject|13|||
145466465|NCT01541917|524560101|FG001|Overall Study|Withdrawal by Subject|7|||
145466466|NCT01739803|524560102|FG000|Overall Study|Lost to Follow-up|9|||
145466467|NCT01739803|524560103|FG001|Overall Study|Lost to Follow-up|6|||
145466468|NCT03759041|524560113|FG000|Overall Study|Withdrawal by Subject|4|||
145466469|NCT03759041|524560114|FG001|Overall Study|Withdrawal by Subject|10|||
145466470|NCT03759041|524560115|FG002|Overall Study|Withdrawal by Subject|10|||
145466471|NCT03759041|524560113|FG000|Overall Study|Adverse Event|1|||
145466472|NCT03759041|524560114|FG001|Overall Study|Adverse Event|3|||
145466473|NCT03759041|524560115|FG002|Overall Study|Adverse Event|4|||
145466474|NCT03759041|524560113|FG000|Overall Study|Lack of Efficacy|0|||
145466475|NCT03759041|524560114|FG001|Overall Study|Lack of Efficacy|0|||
145466476|NCT03759041|524560115|FG002|Overall Study|Lack of Efficacy|1|||
145466477|NCT03759041|524560113|FG000|Overall Study|Study Terminated by Sponsor|15|||
145597474|NCT00514943|525038361|FG001|Stage 2|Progressive disease|24|||
145597475|NCT00514943|525038360|FG000|Stage 2|Other Adverse Event|3|||
145597476|NCT00514943|525038361|FG001|Stage 2|Other Adverse Event|10|||
145597477|NCT00514943|525038360|FG000|Stage 2|Patient refused to continue study meds|2|||
145597478|NCT00514943|525038361|FG001|Stage 2|Patient refused to continue study meds|0|||
145597479|NCT00514943|525038360|FG000|Stage 2|Other than stated above|0|||
145597480|NCT00514943|525038361|FG001|Stage 2|Other than stated above|2|||
145597481|NCT03751631|525038367|FG000|Overall Study|Withdrawal by Subject|0|||
145597482|NCT03751631|525038368|FG001|Overall Study|Withdrawal by Subject|0|||
145597483|NCT03751631|525038369|FG002|Overall Study|Withdrawal by Subject|1|||
145597484|NCT03751631|525038370|FG003|Overall Study|Withdrawal by Subject|1|||
145627112|NCT01190176|525147182|FG000|Overall Study|Withdrawal by Subject|1|||
145597485|NCT03751631|525038371|FG004|Overall Study|Withdrawal by Subject|0|||
145466478|NCT03759041|524560114|FG001|Overall Study|Study Terminated by Sponsor|16|||
145466479|NCT03759041|524560115|FG002|Overall Study|Study Terminated by Sponsor|10|||
145597486|NCT03751631|525038372|FG005|Overall Study|Withdrawal by Subject|0|||
145597487|NCT03382782|525038373|FG000|Cohort 1|Withdrawal by Subject|11|||
145597488|NCT03382782|525038374|FG001|Cohort 1|Withdrawal by Subject|5|||
145597489|NCT03382782|525038375|FG002|Cohort 1|Withdrawal by Subject|0|||
145597490|NCT03382782|525038373|FG000|Cohort 2|Withdrawal by Subject|1|||
145597491|NCT03382782|525038374|FG001|Cohort 2|Withdrawal by Subject|1|||
145597492|NCT03382782|525038375|FG002|Cohort 2|Withdrawal by Subject|0|||
145597493|NCT03382782|525038373|FG000|Cohort 3|Withdrawal by Subject|1|||
145597494|NCT03382782|525038374|FG001|Cohort 3|Withdrawal by Subject|2|||
145597495|NCT03382782|525038375|FG002|Cohort 3|Withdrawal by Subject|0|||
145597496|NCT01791725|525038376|FG000|Overall Study|Withdrawal by Subject|0|||
145597497|NCT01791725|525038377|FG001|Overall Study|Withdrawal by Subject|1|||
145597498|NCT01791725|525038378|FG002|Overall Study|Withdrawal by Subject|0|||
145597499|NCT02366910|525038379|FG000|Overall Study|Withdrawal by Subject|2|||
145597500|NCT02366910|525038379|FG000|Overall Study|Screen Failure|3|||
145597501|NCT03813238|525038380|FG000|Overall Study|Adverse Event|0|||
145597502|NCT03813238|525038381|FG001|Overall Study|Adverse Event|6|||
145597503|NCT03813238|525038380|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145597504|NCT03813238|525038381|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145597505|NCT03813238|525038380|FG000|Overall Study|Lost to Follow-up|0|||
145597506|NCT03813238|525038381|FG001|Overall Study|Lost to Follow-up|1|||
145597507|NCT03813238|525038380|FG000|Overall Study|Other than specified|1|||
145597508|NCT03813238|525038381|FG001|Overall Study|Other than specified|2|||
145597509|NCT00605293|525038382|FG000|Overall Study|Death|2|||
145597510|NCT00605293|525038383|FG001|Overall Study|Death|1|||
145597511|NCT00605293|525038382|FG000|Overall Study|Insufficient Therapeutic Response|2|||
145597512|NCT00605293|525038383|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145597513|NCT00605293|525038382|FG000|Overall Study|Adverse Event|1|||
145597514|NCT00605293|525038383|FG001|Overall Study|Adverse Event|0|||
145597515|NCT00605293|525038382|FG000|Overall Study|Holidays Dialysis Out|1|||
145597516|NCT00605293|525038383|FG001|Overall Study|Holidays Dialysis Out|0|||
145597517|NCT00605293|525038382|FG000|Overall Study|Blood Transfusion|7|||
145597518|NCT00605293|525038383|FG001|Overall Study|Blood Transfusion|1|||
145597519|NCT00605293|525038382|FG000|Overall Study|Renal Transplantation|3|||
145597520|NCT00605293|525038383|FG001|Overall Study|Renal Transplantation|1|||
145597521|NCT00605293|525038382|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
145597522|NCT00605293|525038383|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
145597523|NCT00605293|525038382|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
145597524|NCT00605293|525038383|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
145597525|NCT00605293|525038382|FG000|Overall Study|Principal Investigator Decision|0|||
145597526|NCT00605293|525038383|FG001|Overall Study|Principal Investigator Decision|1|||
145597527|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
145597528|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
145597529|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
145597530|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
145597531|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
145597532|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
145597533|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
145597534|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
145597535|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Other|18|||
145597536|NCT02565914|525038384|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
145597537|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
145597538|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Other|1|||
145597539|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
145597540|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
145597541|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
145597542|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
145597543|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
145597544|NCT02565914|525038384|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
145466480|NCT03759041|524560113|FG000|Overall Study|Other reason for discontinuation|0|||
145466481|NCT03759041|524560114|FG001|Overall Study|Other reason for discontinuation|2|||
145597545|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
145597546|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
145597547|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
145597548|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
145466482|NCT03759041|524560115|FG002|Overall Study|Other reason for discontinuation|1|||
145597549|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
145597550|NCT02565914|525038384|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
145597551|NCT01410474|525038388|FG000|Overall Study|Withdrawal by Subject|0|||
145597552|NCT01410474|525038389|FG001|Overall Study|Withdrawal by Subject|1|||
145466483|NCT03759041|524560113|FG000|Overall Study|Lost to Follow-up|7|||
145466484|NCT03759041|524560114|FG001|Overall Study|Lost to Follow-up|2|||
145466485|NCT03759041|524560115|FG002|Overall Study|Lost to Follow-up|2|||
145466486|NCT03759041|524560113|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
145466487|NCT03759041|524560114|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
145466488|NCT03759041|524560115|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
145466489|NCT00525824|524560121|FG000|Overall Study|Adverse Event|7|||
145466490|NCT00525824|524560122|FG001|Overall Study|Adverse Event|11|||
145466491|NCT00525824|524560123|FG002|Overall Study|Adverse Event|6|||
145466492|NCT00525824|524560124|FG003|Overall Study|Adverse Event|7|||
145466493|NCT00525824|524560121|FG000|Overall Study|Withdrawal by Subject|5|||
145466494|NCT00525824|524560122|FG001|Overall Study|Withdrawal by Subject|9|||
145466495|NCT00525824|524560123|FG002|Overall Study|Withdrawal by Subject|3|||
145466496|NCT00525824|524560124|FG003|Overall Study|Withdrawal by Subject|4|||
145466497|NCT00525824|524560121|FG000|Overall Study|Lost to Follow-up|4|||
145466498|NCT00525824|524560122|FG001|Overall Study|Lost to Follow-up|2|||
145466499|NCT00525824|524560123|FG002|Overall Study|Lost to Follow-up|4|||
145466500|NCT00525824|524560124|FG003|Overall Study|Lost to Follow-up|0|||
145466501|NCT00525824|524560121|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
145466502|NCT00525824|524560122|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
145466503|NCT00525824|524560123|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
145466504|NCT00525824|524560124|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
145466505|NCT00525824|524560121|FG000|Overall Study|Severe non-compliance|0|||
145466506|NCT00525824|524560122|FG001|Overall Study|Severe non-compliance|1|||
145466507|NCT00525824|524560123|FG002|Overall Study|Severe non-compliance|1|||
145466508|NCT00525824|524560124|FG003|Overall Study|Severe non-compliance|1|||
145466509|NCT00525824|524560121|FG000|Overall Study|Safety reasons|1|||
145466510|NCT00525824|524560122|FG001|Overall Study|Safety reasons|0|||
145466511|NCT00525824|524560123|FG002|Overall Study|Safety reasons|1|||
145466512|NCT00525824|524560124|FG003|Overall Study|Safety reasons|0|||
145466513|NCT00525824|524560121|FG000|Overall Study|Other|1|||
145466514|NCT00525824|524560122|FG001|Overall Study|Other|3|||
145466515|NCT00525824|524560123|FG002|Overall Study|Other|3|||
145466516|NCT00525824|524560124|FG003|Overall Study|Other|1|||
145466517|NCT01490294|524560129|FG000|Overall Study|Prematurely discontinuation|4|||
145466518|NCT01490294|524560130|FG001|Overall Study|Prematurely discontinuation|0|||
145466519|NCT01490294|524560131|FG002|Overall Study|Prematurely discontinuation|1|||
145466520|NCT01490294|524560132|FG003|Overall Study|Prematurely discontinuation|1|||
145466521|NCT01490294|524560129|FG000|Overall Study|Adverse Event|1|||
145466522|NCT01490294|524560130|FG001|Overall Study|Adverse Event|0|||
145466523|NCT01490294|524560131|FG002|Overall Study|Adverse Event|0|||
145466524|NCT01490294|524560132|FG003|Overall Study|Adverse Event|0|||
145466525|NCT01751776|524560135|FG000|Overall Study|Adverse Event|0|||
145466526|NCT01751776|524560136|FG001|Overall Study|Adverse Event|0|||
145466527|NCT01751776|524560137|FG002|Overall Study|Adverse Event|0|||
145466528|NCT01751776|524560138|FG003|Overall Study|Adverse Event|0|||
145466529|NCT01751776|524560139|FG004|Overall Study|Adverse Event|0|||
145466530|NCT01751776|524560140|FG005|Overall Study|Adverse Event|0|||
145466531|NCT01751776|524560141|FG006|Overall Study|Adverse Event|4|||
145466532|NCT01751776|524560142|FG007|Overall Study|Adverse Event|2|||
145466533|NCT01751776|524560135|FG000|Overall Study|Consent withdrawn|0|||
145466534|NCT01751776|524560136|FG001|Overall Study|Consent withdrawn|0|||
145466535|NCT01751776|524560137|FG002|Overall Study|Consent withdrawn|0|||
145466536|NCT01751776|524560138|FG003|Overall Study|Consent withdrawn|0|||
145466537|NCT01751776|524560139|FG004|Overall Study|Consent withdrawn|0|||
145466538|NCT01751776|524560140|FG005|Overall Study|Consent withdrawn|0|||
145466539|NCT01751776|524560141|FG006|Overall Study|Consent withdrawn|0|||
145466540|NCT01751776|524560142|FG007|Overall Study|Consent withdrawn|1|||
145466541|NCT01751776|524560135|FG000|Overall Study|Other reason not specified above|0|||
145627113|NCT01190176|525147182|FG000|Overall Study|Lost to Follow-up|1|||
145627114|NCT02189863|525147183|FG000|First 2 Weeks|Motion Sickness|4|||
145627115|NCT02189863|525147184|FG001|First 2 Weeks|Motion Sickness|2|||
145466542|NCT01751776|524560136|FG001|Overall Study|Other reason not specified above|0|||
145466543|NCT01751776|524560137|FG002|Overall Study|Other reason not specified above|0|||
145466544|NCT01751776|524560138|FG003|Overall Study|Other reason not specified above|0|||
145466545|NCT01751776|524560139|FG004|Overall Study|Other reason not specified above|0|||
145466546|NCT01751776|524560140|FG005|Overall Study|Other reason not specified above|0|||
145466547|NCT01751776|524560141|FG006|Overall Study|Other reason not specified above|0|||
145466548|NCT01751776|524560142|FG007|Overall Study|Other reason not specified above|1|||
145466549|NCT00160654|524560143|FG000|Overall Study|Adverse Event|14|||
145466550|NCT00160654|524560143|FG000|Overall Study|Lack of Efficacy|4|||
145466551|NCT00160654|524560143|FG000|Overall Study|Lost to Follow-up|2|||
145466552|NCT00160654|524560143|FG000|Overall Study|Intake of expired drug|7|||
145466553|NCT00160654|524560143|FG000|Overall Study|Psychological trauma|1|||
145466554|NCT00160654|524560143|FG000|Overall Study|Sponsor decision|1|||
145466555|NCT00160654|524560143|FG000|Overall Study|Patient met exclusion criteria|1|||
145466556|NCT00160654|524560143|FG000|Overall Study|Patient decision|1|||
145597553|NCT02428296|525038390|FG000|Overall Study|Adverse Event|7|||
145597554|NCT02428296|525038390|FG000|Overall Study|Withdrawal by Subject|2|||
145597555|NCT00828984|525038391|FG000|Overall Study|Adverse Event|2|||
145597556|NCT00828984|525038392|FG001|Overall Study|Adverse Event|3|||
145597557|NCT00828984|525038393|FG002|Overall Study|Adverse Event|0|||
145597558|NCT00828984|525038391|FG000|Overall Study|Lost to Follow-up|5|||
145597559|NCT00828984|525038392|FG001|Overall Study|Lost to Follow-up|3|||
145597560|NCT00828984|525038393|FG002|Overall Study|Lost to Follow-up|1|||
145597561|NCT00828984|525038391|FG000|Overall Study|Withdrawal by Subject|4|||
145597562|NCT00828984|525038392|FG001|Overall Study|Withdrawal by Subject|4|||
145597563|NCT00828984|525038393|FG002|Overall Study|Withdrawal by Subject|4|||
145597564|NCT00828984|525038391|FG000|Overall Study|Ineligable|1|||
145597565|NCT00828984|525038392|FG001|Overall Study|Ineligable|2|||
145597566|NCT00828984|525038393|FG002|Overall Study|Ineligable|0|||
145597567|NCT00828984|525038391|FG000|Overall Study|Medical Contraindication|0|||
145597568|NCT00828984|525038392|FG001|Overall Study|Medical Contraindication|1|||
145597569|NCT00828984|525038393|FG002|Overall Study|Medical Contraindication|0|||
145597570|NCT00828984|525038391|FG000|Overall Study|Noncompliant|1|||
145597571|NCT00828984|525038392|FG001|Overall Study|Noncompliant|2|||
145597572|NCT00828984|525038393|FG002|Overall Study|Noncompliant|3|||
145597573|NCT00828984|525038391|FG000|Overall Study|ConMed|1|||
145597574|NCT00828984|525038392|FG001|Overall Study|ConMed|1|||
145597575|NCT00828984|525038393|FG002|Overall Study|ConMed|1|||
145597576|NCT00831779|525038399|FG000|Overall Study|Lost to Follow-up|1|||
145597577|NCT00831779|525038400|FG001|Overall Study|Lost to Follow-up|0|||
145597578|NCT00831779|525038399|FG000|Overall Study|No longer met criteria|0|||
145597579|NCT00831779|525038400|FG001|Overall Study|No longer met criteria|1|||
145597580|NCT02219048|525038401|FG000|Overall Study|Adverse Event|2|||
145597581|NCT02219048|525038402|FG001|Overall Study|Adverse Event|5|||
145597582|NCT02219048|525038401|FG000|Overall Study|No longer meets eligibility criteria|1|||
145597583|NCT02219048|525038402|FG001|Overall Study|No longer meets eligibility criteria|0|||
145597584|NCT02219048|525038401|FG000|Overall Study|Study terminated by sponsor|16|||
145597585|NCT02219048|525038402|FG001|Overall Study|Study terminated by sponsor|15|||
145597586|NCT02219048|525038401|FG000|Overall Study|Withdrawal by Subject|2|||
145597587|NCT02219048|525038402|FG001|Overall Study|Withdrawal by Subject|0|||
145597588|NCT02219048|525038401|FG000|Overall Study|Other|0|||
145597589|NCT02219048|525038402|FG001|Overall Study|Other|1|||
145597590|NCT02054806|525038403|FG000|Overall Study|Sponsor Decision|31|||
145597591|NCT02054806|525038403|FG000|Overall Study|Withdrawal by Subject|43|||
145597592|NCT02054806|525038403|FG000|Overall Study|Protocol Violation|2|||
145597593|NCT02054806|525038403|FG000|Overall Study|Lost to Follow-up|10|||
145597594|NCT02054806|525038403|FG000|Overall Study|Death|391|||
145597595|NCT00952367|525038404|FG000|Overall Study|Withdrawal by Subject|2|||
145597596|NCT00952367|525038404|FG000|Overall Study|Noncoordination|1|||
145597597|NCT00952367|525038404|FG000|Overall Study|Protocol Violation|3|||
145597598|NCT02230956|525038405|FG000|Overall Study|Adverse Event|1|||
145597599|NCT02230956|525038406|FG001|Overall Study|Adverse Event|1|||
145597600|NCT02230956|525038407|FG002|Overall Study|Adverse Event|0|||
145597601|NCT02230956|525038405|FG000|Overall Study|Lack of Efficacy|1|||
145597602|NCT02230956|525038406|FG001|Overall Study|Lack of Efficacy|1|||
145597603|NCT02230956|525038407|FG002|Overall Study|Lack of Efficacy|1|||
145597604|NCT02230956|525038405|FG000|Overall Study|Lost to Follow-up|1|||
145597605|NCT02230956|525038406|FG001|Overall Study|Lost to Follow-up|1|||
145597606|NCT02230956|525038407|FG002|Overall Study|Lost to Follow-up|2|||
145597607|NCT02230956|525038405|FG000|Overall Study|Personal Reasons|2|||
145597608|NCT02230956|525038406|FG001|Overall Study|Personal Reasons|1|||
145597609|NCT02230956|525038407|FG002|Overall Study|Personal Reasons|1|||
145597610|NCT02230956|525038405|FG000|Overall Study|Protocol Violation|0|||
145597611|NCT02230956|525038406|FG001|Overall Study|Protocol Violation|1|||
145597612|NCT02230956|525038407|FG002|Overall Study|Protocol Violation|1|||
145597613|NCT02230956|525038405|FG000|Overall Study|Other Miscellaneous Reason|0|||
145597614|NCT02230956|525038406|FG001|Overall Study|Other Miscellaneous Reason|1|||
145597615|NCT02230956|525038407|FG002|Overall Study|Other Miscellaneous Reason|2|||
145597616|NCT00781391|525038408|FG000|Overall Study|never received study drug|24|||
145597617|NCT00781391|525038409|FG001|Overall Study|never received study drug|23|||
145597618|NCT00781391|525038410|FG002|Overall Study|never received study drug|32|||
145597619|NCT00781391|525038408|FG000|Overall Study|Protocol Violation|19|||
145597620|NCT00781391|525038409|FG001|Overall Study|Protocol Violation|17|||
145597621|NCT00781391|525038410|FG002|Overall Study|Protocol Violation|20|||
145597622|NCT00781391|525038408|FG000|Overall Study|Death|789|||
145597623|NCT00781391|525038409|FG001|Overall Study|Death|730|||
145597624|NCT00781391|525038410|FG002|Overall Study|Death|706|||
145597625|NCT00781391|525038408|FG000|Overall Study|Withdrawal by Subject|47|||
145597626|NCT00781391|525038409|FG001|Overall Study|Withdrawal by Subject|37|||
145597627|NCT00781391|525038410|FG002|Overall Study|Withdrawal by Subject|25|||
145597628|NCT00781391|525038408|FG000|Overall Study|Lost to Follow-up|0|||
145597629|NCT00781391|525038409|FG001|Overall Study|Lost to Follow-up|0|||
145597630|NCT00781391|525038410|FG002|Overall Study|Lost to Follow-up|1|||
145597631|NCT03575325|525038423|FG000|Overall Study|Death|1|||
145466557|NCT00160654|524560143|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
145466558|NCT00160654|524560143|FG000|Overall Study|Met exclusion criteria|1|||
145466559|NCT04938037|524561298|FG000|Overall Study|Lost to Follow-up|4|||
145466560|NCT04938037|524561299|FG001|Overall Study|Lost to Follow-up|3|||
145466561|NCT03323736|524561300|FG000|Overall Study|Screen Failure|14|||
145466562|NCT03323736|524561301|FG001|Overall Study|Screen Failure|9|||
145466563|NCT03323736|524561302|FG002|Overall Study|Screen Failure|1|||
145466564|NCT03323736|524561300|FG000|Overall Study|Withdrawal Before Treatment|3|||
145466565|NCT03323736|524561301|FG001|Overall Study|Withdrawal Before Treatment|1|||
145466566|NCT03323736|524561302|FG002|Overall Study|Withdrawal Before Treatment|1|||
145466567|NCT03323736|524561300|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
145466568|NCT03323736|524561301|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
145466569|NCT03323736|524561302|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
145466570|NCT01549873|524561304|FG000|Overall Study|Physician Decision|0|||
145466571|NCT01549873|524561305|FG001|Overall Study|Physician Decision|1|||
145466572|NCT00701805|524561306|FG000|Overall Study|Withdrawal by Subject|3|||
145597632|NCT04575051|525038424|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
145597633|NCT04575051|525038425|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
145597634|NCT04575051|525038426|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
145597635|NCT04575051|525038427|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
145597636|NCT04575051|525038428|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
145597637|NCT04575051|525038424|FG000|Time Period 1|Missing follow up|1|||
145597638|NCT04575051|525038425|FG001|Time Period 1|Missing follow up|3|||
145597639|NCT04575051|525038426|FG002|Time Period 1|Missing follow up|1|||
145597640|NCT04575051|525038427|FG003|Time Period 1|Missing follow up|3|||
145597641|NCT04575051|525038428|FG004|Time Period 1|Missing follow up|2|||
145597642|NCT04575051|525038424|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
145597643|NCT04575051|525038425|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
145597644|NCT04575051|525038426|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
145597645|NCT04575051|525038427|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
145597646|NCT04575051|525038428|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
145597647|NCT04575051|525038424|FG000|Time Period 2|Missing follow up|1|||
145597648|NCT04575051|525038425|FG001|Time Period 2|Missing follow up|8|||
145597649|NCT04575051|525038426|FG002|Time Period 2|Missing follow up|7|||
145597650|NCT04575051|525038427|FG003|Time Period 2|Missing follow up|0|||
145597651|NCT04575051|525038428|FG004|Time Period 2|Missing follow up|1|||
145597652|NCT04575051|525038424|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
145597653|NCT04575051|525038425|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
145597654|NCT04575051|525038426|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
145597655|NCT04575051|525038427|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
145597656|NCT04575051|525038428|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
145597657|NCT04575051|525038424|FG000|Time Period 3|Missing follow up|8|||
145597658|NCT04575051|525038425|FG001|Time Period 3|Missing follow up|6|||
145597659|NCT04575051|525038426|FG002|Time Period 3|Missing follow up|4|||
145597660|NCT04575051|525038427|FG003|Time Period 3|Missing follow up|3|||
145597661|NCT04575051|525038428|FG004|Time Period 3|Missing follow up|0|||
145597662|NCT04575051|525038424|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
145597663|NCT04575051|525038425|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
145597664|NCT04575051|525038426|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
145597665|NCT04575051|525038427|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
145597666|NCT04575051|525038428|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
145597667|NCT04575051|525038424|FG000|Time Period 4|Missing follow up|17|||
145597668|NCT04575051|525038425|FG001|Time Period 4|Missing follow up|3|||
145597669|NCT04575051|525038426|FG002|Time Period 4|Missing follow up|4|||
145597670|NCT04575051|525038427|FG003|Time Period 4|Missing follow up|2|||
145597671|NCT04575051|525038428|FG004|Time Period 4|Missing follow up|1|||
145597672|NCT04575051|525038424|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
145597673|NCT04575051|525038425|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
145597674|NCT04575051|525038426|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
145597675|NCT04575051|525038427|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
145597676|NCT04575051|525038428|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
145597677|NCT04575051|525038424|FG000|Time Period 5|Missing follow up|11|||
145597678|NCT04575051|525038425|FG001|Time Period 5|Missing follow up|8|||
145597679|NCT04575051|525038426|FG002|Time Period 5|Missing follow up|12|||
145597680|NCT04575051|525038427|FG003|Time Period 5|Missing follow up|3|||
145597681|NCT04575051|525038428|FG004|Time Period 5|Missing follow up|11|||
145597682|NCT03178266|525038430|FG000|Overall Study|Death|0|||
145597683|NCT03178266|525038431|FG001|Overall Study|Death|1|||
145466573|NCT00701805|524561307|FG001|Overall Study|Withdrawal by Subject|1|||
145466574|NCT00701805|524561308|FG002|Overall Study|Withdrawal by Subject|4|||
145466575|NCT00701805|524561309|FG003|Overall Study|Withdrawal by Subject|3|||
145466576|NCT00701805|524561306|FG000|Overall Study|Adverse Event|0|||
145466577|NCT00701805|524561307|FG001|Overall Study|Adverse Event|1|||
145466578|NCT00701805|524561308|FG002|Overall Study|Adverse Event|1|||
145466579|NCT00701805|524561309|FG003|Overall Study|Adverse Event|0|||
145466580|NCT00701805|524561306|FG000|Overall Study|Missed 7 consecutive doses|0|||
145466581|NCT00701805|524561307|FG001|Overall Study|Missed 7 consecutive doses|1|||
145466582|NCT00701805|524561308|FG002|Overall Study|Missed 7 consecutive doses|0|||
145466583|NCT00701805|524561309|FG003|Overall Study|Missed 7 consecutive doses|0|||
145466584|NCT00701805|524561306|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
145466585|NCT00701805|524561307|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
145466586|NCT00701805|524561308|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
145466587|NCT00701805|524561309|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
145466588|NCT00701805|524561306|FG000|Overall Study|Physician decision, change of therapy|0|||
145466589|NCT00701805|524561307|FG001|Overall Study|Physician decision, change of therapy|0|||
145466590|NCT00701805|524561308|FG002|Overall Study|Physician decision, change of therapy|0|||
145466591|NCT00701805|524561309|FG003|Overall Study|Physician decision, change of therapy|1|||
145466592|NCT00701805|524561306|FG000|Overall Study|Difficult to travel to dialysis site|0|||
145466593|NCT00701805|524561307|FG001|Overall Study|Difficult to travel to dialysis site|0|||
145466594|NCT00701805|524561308|FG002|Overall Study|Difficult to travel to dialysis site|1|||
145466595|NCT00701805|524561309|FG003|Overall Study|Difficult to travel to dialysis site|0|||
145466596|NCT00701805|524561306|FG000|Overall Study|Resumption criteria were not met|0|||
145466597|NCT00701805|524561307|FG001|Overall Study|Resumption criteria were not met|1|||
145466598|NCT00701805|524561308|FG002|Overall Study|Resumption criteria were not met|0|||
145466599|NCT00701805|524561309|FG003|Overall Study|Resumption criteria were not met|0|||
145466600|NCT02804750|524561324|FG000|Period 1|Adverse Event|0|||
145466601|NCT02804750|524561325|FG001|Period 1|Adverse Event|2|||
145466602|NCT02804750|524561324|FG000|Period 1|Withdrawal by Subject|0|||
145466603|NCT02804750|524561325|FG001|Period 1|Withdrawal by Subject|1|||
145466604|NCT02804750|524561324|FG000|Period 2|Adverse Event|1|||
145466605|NCT02804750|524561325|FG001|Period 2|Adverse Event|0|||
145466606|NCT02804750|524561324|FG000|Period 3|Adverse Event|0|||
145466607|NCT02804750|524561325|FG001|Period 3|Adverse Event|2|||
145466608|NCT02804750|524561324|FG000|Period 4|Adverse Event|0|||
145466609|NCT02804750|524561325|FG001|Period 4|Adverse Event|5|||
145466610|NCT00940485|524561333|FG000|Overall Study|HBeAb positive at Baseline|3|||
145466611|NCT00940485|524561334|FG001|Overall Study|HBeAb positive at Baseline|2|||
145466612|NCT00940485|524561333|FG000|Overall Study|Lost to Follow-up|2|||
145466613|NCT00940485|524561334|FG001|Overall Study|Lost to Follow-up|3|||
145466614|NCT00940485|524561333|FG000|Overall Study|Adverse Event|8|||
145466615|NCT00940485|524561334|FG001|Overall Study|Adverse Event|0|||
145466616|NCT00940485|524561333|FG000|Overall Study|Withdrawal by Subject|1|||
145466617|NCT00940485|524561334|FG001|Overall Study|Withdrawal by Subject|1|||
145466618|NCT00940485|524561333|FG000|Overall Study|Others|1|||
145466619|NCT00940485|524561334|FG001|Overall Study|Others|1|||
145466620|NCT03681678|524561337|FG000|Overall Study|Lost to Follow-up|20|||
145466621|NCT03106415|524561343|FG000|Phase 1|Withdrawal by Subject|1|||
145466622|NCT03106415|524561344|FG001|Phase 1|Withdrawal by Subject|0|||
145466623|NCT03106415|524561345|FG002|Phase 1|Withdrawal by Subject|0|||
145466624|NCT03106415|524561343|FG000|Phase 1|Adverse Event|1|||
145466625|NCT03106415|524561344|FG001|Phase 1|Adverse Event|1|||
145466626|NCT03106415|524561345|FG002|Phase 1|Adverse Event|0|||
145466627|NCT03106415|524561343|FG000|Phase 1|Protocol Violation|0|||
145466628|NCT03106415|524561344|FG001|Phase 1|Protocol Violation|1|||
145466629|NCT03106415|524561345|FG002|Phase 1|Protocol Violation|0|||
145466630|NCT01804582|524561346|FG000|Overall Study|Lost to Follow-up|47|||
145466631|NCT01804582|524561347|FG001|Overall Study|Lost to Follow-up|56|||
145466632|NCT01804582|524561346|FG000|Overall Study|Physician Decision|2|||
145466633|NCT01804582|524561347|FG001|Overall Study|Physician Decision|0|||
145466634|NCT00159913|524561350|FG000|Overall Study|Adverse Event|1|||
145466635|NCT00159913|524561351|FG001|Overall Study|Adverse Event|0|||
145466636|NCT00159913|524561352|FG002|Overall Study|Adverse Event|1|||
145466637|NCT00159913|524561353|FG003|Overall Study|Adverse Event|0|||
145466638|NCT00159913|524561350|FG000|Overall Study|Withdrawal by Subject|0|||
145466639|NCT00159913|524561351|FG001|Overall Study|Withdrawal by Subject|0|||
145466640|NCT00159913|524561352|FG002|Overall Study|Withdrawal by Subject|0|||
145466641|NCT00159913|524561353|FG003|Overall Study|Withdrawal by Subject|1|||
145466642|NCT00159913|524561350|FG000|Overall Study|Lost to Follow-up|0|||
145466643|NCT00159913|524561351|FG001|Overall Study|Lost to Follow-up|0|||
145466644|NCT00159913|524561352|FG002|Overall Study|Lost to Follow-up|0|||
145466645|NCT00159913|524561353|FG003|Overall Study|Lost to Follow-up|1|||
145466646|NCT00159913|524561350|FG000|Overall Study|Protocol Violation|1|||
145466647|NCT00159913|524561351|FG001|Overall Study|Protocol Violation|0|||
145466648|NCT00159913|524561352|FG002|Overall Study|Protocol Violation|1|||
145466649|NCT00159913|524561353|FG003|Overall Study|Protocol Violation|0|||
145466650|NCT00385723|524561354|FG000|Overall Study|Lost to Follow-up|1|||
145466651|NCT00385723|524561355|FG001|Overall Study|Lost to Follow-up|1|||
145466652|NCT00385723|524561356|FG002|Overall Study|Lost to Follow-up|0|||
145597684|NCT03178266|525038430|FG000|Overall Study|Disont. Early|0|||
145597685|NCT03178266|525038431|FG001|Overall Study|Disont. Early|1|||
145597686|NCT03178266|525038430|FG000|Overall Study|Withdrawal by Subject|0|||
145597687|NCT03178266|525038431|FG001|Overall Study|Withdrawal by Subject|2|||
145597688|NCT02363946|525038432|FG000|Overall Study|Lost to Follow-up|0|||
145597689|NCT02363946|525038433|FG001|Overall Study|Lost to Follow-up|0|||
145597690|NCT02363946|525038434|FG002|Overall Study|Lost to Follow-up|0|||
145597691|NCT02363946|525038435|FG003|Overall Study|Lost to Follow-up|0|||
145597692|NCT02363946|525038436|FG004|Overall Study|Lost to Follow-up|0|||
145597693|NCT02363946|525038437|FG005|Overall Study|Lost to Follow-up|0|||
145597694|NCT02363946|525038438|FG006|Overall Study|Lost to Follow-up|0|||
145597695|NCT02363946|525038439|FG007|Overall Study|Lost to Follow-up|1|||
145597696|NCT02363946|525038440|FG008|Overall Study|Lost to Follow-up|0|||
145597697|NCT02363946|525038441|FG009|Overall Study|Lost to Follow-up|0|||
145597698|NCT02363946|525038442|FG010|Overall Study|Lost to Follow-up|0|||
145597699|NCT02363946|525038443|FG011|Overall Study|Lost to Follow-up|0|||
145597700|NCT02363946|525038444|FG012|Overall Study|Lost to Follow-up|0|||
145597701|NCT01292239|525038445|FG000|Overall Study|Other|1|||
145597702|NCT01292239|525038446|FG001|Overall Study|Other|1|||
145597703|NCT01292239|525038445|FG000|Overall Study|Withdrawal by Subject|3|||
145597704|NCT01292239|525038446|FG001|Overall Study|Withdrawal by Subject|6|||
145597705|NCT00316082|525038452|FG000|Overall Study|Lack of Efficacy|2|||
145597706|NCT00316082|525038453|FG001|Overall Study|Lack of Efficacy|3|||
145597707|NCT00316082|525038454|FG002|Overall Study|Lack of Efficacy|3|||
145597708|NCT00316082|525038455|FG003|Overall Study|Lack of Efficacy|4|||
145597709|NCT00316082|525038456|FG004|Overall Study|Lack of Efficacy|6|||
145597710|NCT00316082|525038452|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
145597711|NCT00316082|525038453|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
145597712|NCT00316082|525038454|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
145597713|NCT00316082|525038455|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
145597714|NCT00316082|525038456|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
145597715|NCT00316082|525038452|FG000|Overall Study|Lost to Follow-up|7|||
145597716|NCT00316082|525038453|FG001|Overall Study|Lost to Follow-up|6|||
145597717|NCT00316082|525038454|FG002|Overall Study|Lost to Follow-up|7|||
145597718|NCT00316082|525038455|FG003|Overall Study|Lost to Follow-up|8|||
145597719|NCT00316082|525038456|FG004|Overall Study|Lost to Follow-up|6|||
145597720|NCT00316082|525038452|FG000|Overall Study|Poor/noncompliance|6|||
145597721|NCT00316082|525038453|FG001|Overall Study|Poor/noncompliance|1|||
145597722|NCT00316082|525038454|FG002|Overall Study|Poor/noncompliance|4|||
145597723|NCT00316082|525038455|FG003|Overall Study|Poor/noncompliance|1|||
145597724|NCT00316082|525038456|FG004|Overall Study|Poor/noncompliance|4|||
145597725|NCT00316082|525038452|FG000|Overall Study|Adverse Event|4|||
145597726|NCT00316082|525038453|FG001|Overall Study|Adverse Event|2|||
145597727|NCT00316082|525038454|FG002|Overall Study|Adverse Event|5|||
145597728|NCT00316082|525038455|FG003|Overall Study|Adverse Event|1|||
145597729|NCT00316082|525038456|FG004|Overall Study|Adverse Event|3|||
145597730|NCT00316082|525038452|FG000|Overall Study|Subject no longer meets study criteria|3|||
145597731|NCT00316082|525038453|FG001|Overall Study|Subject no longer meets study criteria|1|||
145597732|NCT00316082|525038454|FG002|Overall Study|Subject no longer meets study criteria|2|||
145597733|NCT00316082|525038455|FG003|Overall Study|Subject no longer meets study criteria|2|||
145597734|NCT00316082|525038456|FG004|Overall Study|Subject no longer meets study criteria|1|||
145597735|NCT00316082|525038452|FG000|Overall Study|Physician Decision|1|||
145597736|NCT00316082|525038453|FG001|Overall Study|Physician Decision|1|||
145597737|NCT00316082|525038454|FG002|Overall Study|Physician Decision|2|||
145597738|NCT00316082|525038455|FG003|Overall Study|Physician Decision|1|||
145597739|NCT00316082|525038456|FG004|Overall Study|Physician Decision|1|||
145597740|NCT00316082|525038452|FG000|Overall Study|Death|0|||
145597741|NCT00316082|525038453|FG001|Overall Study|Death|0|||
145597742|NCT00316082|525038454|FG002|Overall Study|Death|1|||
145597743|NCT00316082|525038455|FG003|Overall Study|Death|0|||
145597744|NCT00316082|525038456|FG004|Overall Study|Death|0|||
145597745|NCT00316082|525038452|FG000|Overall Study|Administrative reason by sponsor|0|||
145597746|NCT00316082|525038453|FG001|Overall Study|Administrative reason by sponsor|0|||
145597747|NCT00316082|525038454|FG002|Overall Study|Administrative reason by sponsor|1|||
145597748|NCT00316082|525038455|FG003|Overall Study|Administrative reason by sponsor|0|||
145597749|NCT00316082|525038456|FG004|Overall Study|Administrative reason by sponsor|0|||
145597750|NCT00528775|525038459|FG000|Overall Study|Other not specified|1|||
145597751|NCT01995461|525038460|FG000|Overall Study|Death|1|||
145597752|NCT01995461|525038460|FG000|Overall Study|Lost to Follow-up|2|||
145597753|NCT01995461|525038460|FG000|Overall Study|Withdrawal by Subject|2|||
145597754|NCT00540124|525038461|FG000|Overall Study|Adverse Event|0|||
145597755|NCT00540124|525038462|FG001|Overall Study|Adverse Event|2|||
145597756|NCT00540124|525038463|FG002|Overall Study|Adverse Event|1|||
145597757|NCT00540124|525038461|FG000|Overall Study|Entry Criteria Not Met|2|||
145597758|NCT00540124|525038462|FG001|Overall Study|Entry Criteria Not Met|0|||
145597759|NCT00540124|525038463|FG002|Overall Study|Entry Criteria Not Met|0|||
145597760|NCT00540124|525038461|FG000|Overall Study|Lack of Efficacy|1|||
145597761|NCT00540124|525038462|FG001|Overall Study|Lack of Efficacy|0|||
145597762|NCT00540124|525038463|FG002|Overall Study|Lack of Efficacy|0|||
145597763|NCT00540124|525038461|FG000|Overall Study|Withdrawal by Subject|1|||
145597764|NCT00540124|525038462|FG001|Overall Study|Withdrawal by Subject|1|||
145597765|NCT00540124|525038463|FG002|Overall Study|Withdrawal by Subject|0|||
145597766|NCT01777854|525038470|FG000|Overall Study|Physician Decision|3|||
145597767|NCT01777854|525038471|FG001|Overall Study|Physician Decision|3|||
145597768|NCT03311373|525038474|FG000|Overall Study|Adverse Event|1|||
145597769|NCT03311373|525038474|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
145597770|NCT03311373|525038474|FG000|Overall Study|Lost to Follow-up|1|||
145597771|NCT03311373|525038474|FG000|Overall Study|Physician Decision|1|||
145597772|NCT03311373|525038474|FG000|Overall Study|Withdrawal by Subject|3|||
145597773|NCT01830127|525038477|FG000|Overall Study|Adverse Event|1|||
145597774|NCT01830127|525038478|FG001|Overall Study|Adverse Event|6|||
145597775|NCT01830127|525038477|FG000|Overall Study|Lack of Efficacy|3|||
145597776|NCT01830127|525038478|FG001|Overall Study|Lack of Efficacy|0|||
145597777|NCT01830127|525038477|FG000|Overall Study|Withdrawal by Subject|1|||
145597778|NCT01830127|525038478|FG001|Overall Study|Withdrawal by Subject|1|||
145597779|NCT01830127|525038477|FG000|Overall Study|Other reason not defined above|0|||
145597780|NCT01830127|525038478|FG001|Overall Study|Other reason not defined above|2|||
145597781|NCT00374322|525038480|FG000|Overall Study|Lost to Follow-up|92|||
145597782|NCT00374322|525038481|FG001|Overall Study|Lost to Follow-up|90|||
145597783|NCT00374322|525038480|FG000|Overall Study|Protocol Violation|8|||
145597784|NCT00374322|525038481|FG001|Overall Study|Protocol Violation|3|||
145597785|NCT00374322|525038480|FG000|Overall Study|Withdrawal by Subject|235|||
145597786|NCT00374322|525038481|FG001|Overall Study|Withdrawal by Subject|167|||
145597787|NCT00374322|525038480|FG000|Overall Study|Sponsor Terminated Study|866|||
145597788|NCT00374322|525038481|FG001|Overall Study|Sponsor Terminated Study|990|||
145597789|NCT00374322|525038480|FG000|Overall Study|Physician Decision|36|||
145597790|NCT00374322|525038481|FG001|Overall Study|Physician Decision|32|||
145597791|NCT00374322|525038480|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
145597792|NCT00374322|525038481|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
145597793|NCT00374322|525038480|FG000|Overall Study|Sponsor Decision|2|||
145597794|NCT00374322|525038481|FG001|Overall Study|Sponsor Decision|3|||
145597795|NCT00374322|525038480|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
145597796|NCT00374322|525038481|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
145597797|NCT00374322|525038480|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
145597798|NCT00374322|525038481|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
145597799|NCT00374322|525038480|FG000|Overall Study|Severe Toxicity|1|||
145597800|NCT00374322|525038481|FG001|Overall Study|Severe Toxicity|0|||
145597801|NCT00374322|525038480|FG000|Overall Study|Site Closed|2|||
145597802|NCT00374322|525038481|FG001|Overall Study|Site Closed|2|||
145597803|NCT00374322|525038480|FG000|Overall Study|Participant Changed Physician|1|||
145597804|NCT00374322|525038481|FG001|Overall Study|Participant Changed Physician|0|||
145597805|NCT00374322|525038480|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
145597806|NCT00374322|525038481|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
145597807|NCT00374322|525038480|FG000|Overall Study|Noncompliance with Study Requirements|0|||
145597808|NCT00374322|525038481|FG001|Overall Study|Noncompliance with Study Requirements|1|||
145597809|NCT00374322|525038480|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
145597810|NCT00374322|525038481|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
145597811|NCT00374322|525038480|FG000|Overall Study|Did Not Receive Study Medication|8|||
145597812|NCT00374322|525038481|FG001|Overall Study|Did Not Receive Study Medication|6|||
145597813|NCT01297959|525038484|FG000|Overall Study|Adverse Event|0|||
145597814|NCT01297959|525038485|FG001|Overall Study|Adverse Event|1|||
145597815|NCT01297959|525038484|FG000|Overall Study|Protocol Violation|2|||
145597816|NCT01297959|525038485|FG001|Overall Study|Protocol Violation|1|||
145597817|NCT01297959|525038484|FG000|Overall Study|Withdrawal by Subject|5|||
145597818|NCT01297959|525038485|FG001|Overall Study|Withdrawal by Subject|4|||
145597819|NCT01297959|525038484|FG000|Overall Study|Physician Decision|0|||
145597820|NCT01297959|525038485|FG001|Overall Study|Physician Decision|1|||
145597821|NCT01297959|525038484|FG000|Overall Study|Unrelated medical illness / complication|0|||
145597822|NCT01297959|525038485|FG001|Overall Study|Unrelated medical illness / complication|2|||
145597823|NCT01297959|525038484|FG000|Overall Study|Other|13|||
145597824|NCT01297959|525038485|FG001|Overall Study|Other|7|||
145597825|NCT01667432|525038486|FG000|Overall Study|Premature Study Termination|26|||
145597826|NCT01667432|525038486|FG000|Overall Study|Failure to Return|10|||
145597827|NCT01667432|525038486|FG000|Overall Study|Moved to Another Center|3|||
145597828|NCT01667432|525038486|FG000|Overall Study|Lost to Follow-up|3|||
145597829|NCT01667432|525038486|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
145597830|NCT01667432|525038486|FG000|Overall Study|Insufficient Therapeutic Response|4|||
145597831|NCT01667432|525038486|FG000|Overall Study|Adverse Event|1|||
145597832|NCT01667432|525038486|FG000|Overall Study|Protocol Deviation|2|||
145597833|NCT01667432|525038486|FG000|Overall Study|Principal Investigator Decision|1|||
145597834|NCT01667432|525038486|FG000|Overall Study|Reason Not Specified|2|||
145597835|NCT01667432|525038486|FG000|Overall Study|Missing Information|4|||
145597836|NCT00671931|525038491|FG000|Overall Study|Physician Decision|1|||
145597837|NCT00671931|525038492|FG001|Overall Study|Physician Decision|0|||
145597838|NCT00671931|525038493|FG002|Overall Study|Physician Decision|0|||
145597839|NCT00671931|525038494|FG003|Overall Study|Physician Decision|2|||
145597840|NCT00671931|525038495|FG004|Overall Study|Physician Decision|1|||
145597841|NCT02048072|525038496|FG000|Overall Study|Adverse Event|3|||
145597842|NCT02048072|525038496|FG000|Overall Study|Lost to Follow-up|1|||
145597843|NCT01112579|525038497|FG000|Overall Study|Missed Visit|1|||
145597844|NCT01112579|525038498|FG001|Overall Study|Missed Visit|1|||
145597845|NCT01112579|525038497|FG000|Overall Study|Death|0|||
145597846|NCT01112579|525038498|FG001|Overall Study|Death|2|||
145597847|NCT01648270|525038499|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
145597848|NCT01553318|525039922|FG000|Overall Study|Protocol Violation|3|||
145597849|NCT01553318|525039923|FG001|Overall Study|Protocol Violation|2|||
145597850|NCT02178059|525039925|FG000|Washout|Physician Decision|1|||
145597851|NCT02178059|525039926|FG001|Washout|Physician Decision|0|||
145597852|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
145597853|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
145597854|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
145597855|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
145597856|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
145597857|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
145597858|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Death|1|||
145597859|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Death|0|||
145597860|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Adverse Event|1|||
145597861|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Adverse Event|0|||
145597862|NCT02586025|525039927|FG000|Neoadjuvant Treatment|Physician Decision|2|||
145597863|NCT02586025|525039928|FG001|Neoadjuvant Treatment|Physician Decision|1|||
145597864|NCT02586025|525039927|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
145597865|NCT02586025|525039928|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
145597866|NCT02586025|525039927|FG000|Adjuvant Treatment|Recurrent Disease|4|||
145466653|NCT00385723|524561354|FG000|Overall Study|Withdrawal by Subject|1|||
145466654|NCT00385723|524561355|FG001|Overall Study|Withdrawal by Subject|0|||
145466655|NCT00385723|524561356|FG002|Overall Study|Withdrawal by Subject|2|||
145466656|NCT03689712|524561358|FG000|Overall Study|Adverse Event|1|||
145466657|NCT03689712|524561359|FG001|Overall Study|Adverse Event|0|||
145466658|NCT03689712|524561358|FG000|Overall Study|Death|20|||
145466659|NCT03689712|524561359|FG001|Overall Study|Death|10|||
145466660|NCT03689712|524561358|FG000|Overall Study|Lost to Follow-up|6|||
145466661|NCT03689712|524561359|FG001|Overall Study|Lost to Follow-up|6|||
145466662|NCT03689712|524561358|FG000|Overall Study|Other|1|||
145466663|NCT03689712|524561359|FG001|Overall Study|Other|0|||
145466664|NCT03689712|524561358|FG000|Overall Study|Patient Non-Compliance|0|||
145466665|NCT03689712|524561359|FG001|Overall Study|Patient Non-Compliance|1|||
145466666|NCT03689712|524561358|FG000|Overall Study|Withdrawal by Subject|20|||
145466667|NCT03689712|524561359|FG001|Overall Study|Withdrawal by Subject|4|||
145466668|NCT03689712|524561358|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
145466669|NCT03689712|524561359|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
145466670|NCT03689712|524561358|FG000|Overall Study|Randomized but not Treated|13|||
145466671|NCT03689712|524561359|FG001|Overall Study|Randomized but not Treated|7|||
145466672|NCT03689712|524561358|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
145466673|NCT03689712|524561359|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
145466674|NCT00689793|524561360|FG000|Overall Study|Lost to Follow-up|4|||
145466675|NCT00689793|524561361|FG001|Overall Study|Lost to Follow-up|5|||
145466676|NCT00875056|524561364|FG000|Overall Study|Adverse Event|6|||
145466677|NCT00875056|524561365|FG001|Overall Study|Adverse Event|1|||
145466678|NCT00875056|524561366|FG002|Overall Study|Adverse Event|2|||
145466679|NCT00875056|524561364|FG000|Overall Study|Progressive Disease|14|||
145466680|NCT00875056|524561365|FG001|Overall Study|Progressive Disease|8|||
145466681|NCT00875056|524561366|FG002|Overall Study|Progressive Disease|3|||
145466682|NCT00875056|524561364|FG000|Overall Study|Withdrawal by Subject|3|||
145466683|NCT00875056|524561365|FG001|Overall Study|Withdrawal by Subject|0|||
145466684|NCT00875056|524561366|FG002|Overall Study|Withdrawal by Subject|1|||
145466685|NCT02573246|524561375|FG000|Overall Study|Lost to Follow-up|2|||
145597867|NCT02586025|525039928|FG001|Adjuvant Treatment|Recurrent Disease|5|||
145597868|NCT02586025|525039927|FG000|Adjuvant Treatment|Physician Decision|0|||
145466686|NCT02573246|524561376|FG001|Overall Study|Lost to Follow-up|0|||
145466687|NCT02573246|524561377|FG002|Overall Study|Lost to Follow-up|0|||
145466688|NCT02573246|524561378|FG003|Overall Study|Lost to Follow-up|0|||
145597869|NCT02586025|525039928|FG001|Adjuvant Treatment|Physician Decision|1|||
145597870|NCT02586025|525039927|FG000|Adjuvant Treatment|Pregnancy|1|||
145597871|NCT02586025|525039928|FG001|Adjuvant Treatment|Pregnancy|0|||
145597872|NCT02586025|525039927|FG000|Treatment-Free Follow-Up|Death|11|||
145597873|NCT02586025|525039928|FG001|Treatment-Free Follow-Up|Death|11|||
145466689|NCT02573246|524561379|FG004|Overall Study|Lost to Follow-up|1|||
145466690|NCT02573246|524561375|FG000|Overall Study|Withdrawal by Subject|0|||
145466691|NCT02573246|524561376|FG001|Overall Study|Withdrawal by Subject|0|||
145597874|NCT02586025|525039927|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
145466692|NCT02573246|524561377|FG002|Overall Study|Withdrawal by Subject|0|||
145466693|NCT02573246|524561378|FG003|Overall Study|Withdrawal by Subject|0|||
145466694|NCT02573246|524561379|FG004|Overall Study|Withdrawal by Subject|1|||
145466695|NCT02573246|524561375|FG000|Overall Study|Physician Decision|1|||
145466696|NCT02573246|524561376|FG001|Overall Study|Physician Decision|1|||
145466697|NCT02573246|524561377|FG002|Overall Study|Physician Decision|3|||
145466698|NCT02573246|524561378|FG003|Overall Study|Physician Decision|2|||
145466699|NCT02573246|524561379|FG004|Overall Study|Physician Decision|2|||
145466700|NCT01219933|524561380|FG000|Overall Study|Adverse Event|8|||
145466701|NCT01219933|524561380|FG000|Overall Study|No LDA reached|5|||
145466702|NCT01219933|524561380|FG000|Overall Study|No LDA maintained|7|||
145466703|NCT01219933|524561380|FG000|Overall Study|Lost to Follow-up|3|||
145466704|NCT01219933|524561380|FG000|Overall Study|GC free|1|||
145466705|NCT01219933|524561380|FG000|Overall Study|Withdrawal by Subject|5|||
145466706|NCT01219933|524561380|FG000|Overall Study|Protocol Violation|8|||
145466707|NCT01219933|524561380|FG000|Overall Study|Lack of Efficacy|1|||
145466708|NCT01902888|524561381|FG000|Overall Study|Study Terminated|3|||
145466709|NCT03149003|524561382|FG000|Overall Study|Randomized but not treated|0|||
145466710|NCT03149003|524561383|FG001|Overall Study|Randomized but not treated|1|||
145466711|NCT03149003|524561384|FG002|Overall Study|Randomized but not treated|18|||
145466712|NCT00685373|524561386|FG000|Overall Study|Adverse Event|3|||
145466713|NCT00685373|524561386|FG000|Overall Study|Withdrawal by Subject|5|||
145466714|NCT00685373|524561386|FG000|Overall Study|Lack of Efficacy|3|||
145466715|NCT00685373|524561386|FG000|Overall Study|Condition no longer requires study drug|1|||
145466716|NCT00685373|524561386|FG000|Overall Study|Lost to Follow-up|2|||
145466717|NCT00685373|524561386|FG000|Overall Study|Protocol Violation|1|||
145466718|NCT01814670|524561392|FG000|Overall Study|Protocol Violation|12|||
145466719|NCT00973102|524561393|FG000|Overall Study|Protocol Violation|1|||
145466720|NCT00973102|524561394|FG001|Overall Study|Protocol Violation|0|||
145466721|NCT00973102|524561393|FG000|Overall Study|Prisoner|0|||
145466722|NCT00973102|524561394|FG001|Overall Study|Prisoner|1|||
145466723|NCT04941807|524561397|FG000|Overall Study|Lost to Follow-up|1|||
145466724|NCT04941807|524561398|FG001|Overall Study|Lost to Follow-up|1|||
145466725|NCT01100567|524561399|FG000|Overall Study|Withdrawal by Subject|5|||
145466726|NCT01100567|524561400|FG001|Overall Study|Withdrawal by Subject|8|||
145466727|NCT01100567|524561399|FG000|Overall Study|Early Hospital Discharge|6|||
145466728|NCT01100567|524561400|FG001|Overall Study|Early Hospital Discharge|4|||
145466729|NCT01100567|524561399|FG000|Overall Study|Lost to Follow-up|1|||
145466730|NCT01100567|524561400|FG001|Overall Study|Lost to Follow-up|2|||
145466731|NCT01100567|524561399|FG000|Overall Study|Physician Decision|0|||
145466732|NCT01100567|524561400|FG001|Overall Study|Physician Decision|1|||
145466733|NCT01100567|524561399|FG000|Overall Study|Deemed ineligible after consent|0|||
145466734|NCT01100567|524561400|FG001|Overall Study|Deemed ineligible after consent|1|||
145466735|NCT01703065|524561401|FG000|Overall Study|Lack of Efficacy|1|||
145466736|NCT01703065|524561402|FG001|Overall Study|Lack of Efficacy|0|||
145466737|NCT01565564|524561408|FG000|Overall Study|Lost to Follow-up|5|||
145466738|NCT01565564|524561409|FG001|Overall Study|Lost to Follow-up|1|||
145466739|NCT02449018|524561410|FG000|Overall Study|Abnormal laboratory value|0|||
145466740|NCT02449018|524561411|FG001|Overall Study|Abnormal laboratory value|1|||
145466741|NCT02449018|524561410|FG000|Overall Study|Administrative problems|1|||
145466742|NCT02449018|524561411|FG001|Overall Study|Administrative problems|0|||
145466743|NCT02449018|524561410|FG000|Overall Study|Adverse Event|5|||
145466744|NCT02449018|524561411|FG001|Overall Study|Adverse Event|1|||
145466745|NCT02449018|524561410|FG000|Overall Study|Protocol deviation|4|||
145466746|NCT02449018|524561411|FG001|Overall Study|Protocol deviation|0|||
145466747|NCT02449018|524561410|FG000|Overall Study|Patient decision|2|||
145466748|NCT02449018|524561411|FG001|Overall Study|Patient decision|0|||
145466749|NCT00094107|524561412|FG000|Overall Study|Lack of Efficacy|23|||
145466750|NCT00094107|524561412|FG000|Overall Study|Death|5|||
145466751|NCT00094107|524561412|FG000|Overall Study|Adverse Event|3|||
145466752|NCT00094107|524561412|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
145466753|NCT02242981|524561436|FG000|Overall Study|Withdrawal by Subject|1|||
145466754|NCT03474081|524561437|FG000|Overall Study|Adverse Event|6|||
145466755|NCT03474081|524561438|FG001|Overall Study|Adverse Event|3|||
145466756|NCT03474081|524561437|FG000|Overall Study|Lost to Follow-up|2|||
145466757|NCT03474081|524561438|FG001|Overall Study|Lost to Follow-up|1|||
145466758|NCT03474081|524561437|FG000|Overall Study|Physician Decision|3|||
145466759|NCT03474081|524561438|FG001|Overall Study|Physician Decision|2|||
145466760|NCT03474081|524561437|FG000|Overall Study|Withdrawal by Subject|5|||
145466761|NCT03474081|524561438|FG001|Overall Study|Withdrawal by Subject|7|||
145466762|NCT03474081|524561437|FG000|Overall Study|Investigator site closed|1|||
145466763|NCT03474081|524561438|FG001|Overall Study|Investigator site closed|0|||
145466764|NCT02290938|524561444|FG000|Overall Study|Lost to Follow-up|14|||
145466765|NCT02290938|524561445|FG001|Overall Study|Lost to Follow-up|43|||
145466766|NCT00528996|524563070|FG000|Overall Study|Other reasons than listing|6|||
145466767|NCT00528996|524563071|FG001|Overall Study|Other reasons than listing|7|||
145466768|NCT00528996|524563072|FG002|Overall Study|Other reasons than listing|14|||
145466769|NCT00528996|524563073|FG003|Overall Study|Other reasons than listing|11|||
145466770|NCT00528996|524563074|FG004|Overall Study|Other reasons than listing|5|||
145466771|NCT00528996|524563070|FG000|Overall Study|Refused continue medication|16|||
145466772|NCT00528996|524563071|FG001|Overall Study|Refused continue medication|0|||
145466773|NCT00528996|524563072|FG002|Overall Study|Refused continue medication|3|||
145466774|NCT00528996|524563073|FG003|Overall Study|Refused continue medication|3|||
145466775|NCT00528996|524563074|FG004|Overall Study|Refused continue medication|6|||
145466776|NCT00528996|524563070|FG000|Overall Study|Lost to Follow-up|2|||
145466777|NCT00528996|524563071|FG001|Overall Study|Lost to Follow-up|0|||
145466778|NCT00528996|524563072|FG002|Overall Study|Lost to Follow-up|4|||
145597875|NCT02586025|525039928|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
145597876|NCT02586025|525039927|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
145597877|NCT02586025|525039928|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
145597878|NCT02586025|525039927|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
145597879|NCT02586025|525039928|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
145597880|NCT02586025|525039927|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
145597881|NCT02586025|525039928|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
145597882|NCT03255824|525039929|FG000|Overall Study|Under-sedation|2|||
145597883|NCT03255824|525039930|FG001|Overall Study|Under-sedation|1|||
145597884|NCT02001194|525039932|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
145597885|NCT02001194|525039933|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
145597886|NCT02001194|525039934|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
145597887|NCT02001194|525039935|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
145597888|NCT02001194|525039932|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
145597889|NCT02001194|525039933|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
145597890|NCT02001194|525039934|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
145597891|NCT02001194|525039935|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
145597892|NCT03040713|525039937|FG000|Overall Study|Positive amyloid scan|3|||
145597893|NCT02570126|525039944|FG000|Overall Study|Lost to Follow-up|2|||
145597894|NCT02570126|525039945|FG001|Overall Study|Lost to Follow-up|0|||
145597895|NCT02570126|525039944|FG000|Overall Study|Unable To Arrange Visit 3|1|||
145597896|NCT02570126|525039945|FG001|Overall Study|Unable To Arrange Visit 3|0|||
145597897|NCT02570126|525039944|FG000|Overall Study|Violation Of Procedures GSK|0|||
145597898|NCT02570126|525039945|FG001|Overall Study|Violation Of Procedures GSK|1|||
145597899|NCT02570126|525039944|FG000|Overall Study|Protocol Violation|0|||
145597900|NCT02570126|525039945|FG001|Overall Study|Protocol Violation|1|||
145597901|NCT02570126|525039944|FG000|Overall Study|Withdrawal by Subject|3|||
145597902|NCT02570126|525039945|FG001|Overall Study|Withdrawal by Subject|7|||
145597903|NCT02123108|525039946|FG000|Overall Study|Death|2|||
145597904|NCT02123108|525039947|FG001|Overall Study|Death|3|||
145597905|NCT00677235|525039948|FG000|Overall Study|Withdrawal by Subject|1|||
145597906|NCT00677235|525039949|FG001|Overall Study|Withdrawal by Subject|1|||
145597907|NCT00677235|525039948|FG000|Overall Study|Lost to Follow-up|2|||
145597908|NCT00677235|525039949|FG001|Overall Study|Lost to Follow-up|1|||
145597909|NCT00677235|525039948|FG000|Overall Study|Death|37|||
145597910|NCT00677235|525039949|FG001|Overall Study|Death|36|||
145597911|NCT00677235|525039948|FG000|Overall Study|Adverse Experience|1|||
145597912|NCT00677235|525039949|FG001|Overall Study|Adverse Experience|0|||
145597913|NCT01970982|525039953|FG000|Overall Study|Withdrawal by Subject|0|||
145597914|NCT01970982|525039954|FG001|Overall Study|Withdrawal by Subject|0|||
145597915|NCT01970982|525039955|FG002|Overall Study|Withdrawal by Subject|2|||
145597916|NCT00708916|525039956|FG000|Overall Study|Subject Noncompliance|2|||
145597917|NCT00708916|525039956|FG000|Overall Study|Adverse Event|2|||
145597918|NCT01984684|525039959|FG000|Overall Study|Lost to Follow-up|25|||
145597919|NCT01984684|525039960|FG001|Overall Study|Lost to Follow-up|24|||
145597920|NCT01984684|525039959|FG000|Overall Study|Adverse Event|8|||
145597921|NCT01984684|525039960|FG001|Overall Study|Adverse Event|12|||
145597922|NCT01984684|525039959|FG000|Overall Study|Withdrawal by Subject|9|||
145597923|NCT01984684|525039960|FG001|Overall Study|Withdrawal by Subject|9|||
145597924|NCT01984684|525039959|FG000|Overall Study|Lack of Efficacy|3|||
145597925|NCT01984684|525039960|FG001|Overall Study|Lack of Efficacy|6|||
145597926|NCT01984684|525039959|FG000|Overall Study|Physician Decision|4|||
145597927|NCT01984684|525039960|FG001|Overall Study|Physician Decision|2|||
145597928|NCT01984684|525039959|FG000|Overall Study|Protocol Violation|4|||
145597929|NCT01984684|525039960|FG001|Overall Study|Protocol Violation|2|||
145597930|NCT01984684|525039959|FG000|Overall Study|Death|0|||
145597931|NCT01984684|525039960|FG001|Overall Study|Death|1|||
145597932|NCT01984684|525039959|FG000|Overall Study|Noncompliance with study drug|2|||
145597933|NCT01984684|525039960|FG001|Overall Study|Noncompliance with study drug|1|||
145597934|NCT01984684|525039959|FG000|Overall Study|Subject incarcerated|1|||
145597935|NCT01984684|525039960|FG001|Overall Study|Subject incarcerated|0|||
145597936|NCT01984684|525039959|FG000|Overall Study|Study drug not available at site|1|||
145597937|NCT01984684|525039960|FG001|Overall Study|Study drug not available at site|1|||
145597938|NCT01984684|525039959|FG000|Overall Study|Subject had inadequate IV access|0|||
145597939|NCT01984684|525039960|FG001|Overall Study|Subject had inadequate IV access|1|||
145466779|NCT00528996|524563073|FG003|Overall Study|Lost to Follow-up|1|||
145597940|NCT03574597|525039964|FG000|Overall Study|Withdrawal by Subject|67|||
145597941|NCT03574597|525039965|FG001|Overall Study|Withdrawal by Subject|96|||
145597942|NCT03574597|525039964|FG000|Overall Study|Lost to Follow-up|192|||
145597943|NCT03574597|525039965|FG001|Overall Study|Lost to Follow-up|188|||
145597944|NCT02355743|525039966|FG000|Overall Study|Withdrawal by Subject|1|||
145597945|NCT02355743|525039966|FG000|Overall Study|Lost to Follow-up|1|||
145597946|NCT03492281|525039970|FG000|Overall Study|Withdrawal by Subject|21|||
145597947|NCT03492281|525039971|FG001|Overall Study|Withdrawal by Subject|14|||
145597948|NCT03492281|525039972|FG002|Overall Study|Withdrawal by Subject|13|||
145597949|NCT03492281|525039970|FG000|Overall Study|Lost to Follow-up|14|||
145597950|NCT03492281|525039971|FG001|Overall Study|Lost to Follow-up|15|||
145597951|NCT03492281|525039972|FG002|Overall Study|Lost to Follow-up|10|||
145597952|NCT03492281|525039970|FG000|Overall Study|Adverse Event|6|||
145597953|NCT03492281|525039971|FG001|Overall Study|Adverse Event|8|||
145597954|NCT03492281|525039972|FG002|Overall Study|Adverse Event|13|||
145597955|NCT03492281|525039970|FG000|Overall Study|Lack of Efficacy|3|||
145597956|NCT03492281|525039971|FG001|Overall Study|Lack of Efficacy|0|||
145597957|NCT03492281|525039972|FG002|Overall Study|Lack of Efficacy|1|||
145597958|NCT03492281|525039970|FG000|Overall Study|Physician Decision|1|||
145597959|NCT03492281|525039971|FG001|Overall Study|Physician Decision|0|||
145597960|NCT03492281|525039972|FG002|Overall Study|Physician Decision|3|||
145597961|NCT03492281|525039970|FG000|Overall Study|Protocol Violation|0|||
145597962|NCT03492281|525039971|FG001|Overall Study|Protocol Violation|2|||
145597963|NCT03492281|525039972|FG002|Overall Study|Protocol Violation|1|||
145597964|NCT03492281|525039970|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
145597965|NCT03492281|525039971|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
145597966|NCT03492281|525039972|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
145597967|NCT03492281|525039970|FG000|Overall Study|Death|0|||
145597968|NCT03492281|525039971|FG001|Overall Study|Death|0|||
145597969|NCT03492281|525039972|FG002|Overall Study|Death|1|||
145597970|NCT03492281|525039970|FG000|Overall Study|Captured as Other in Database|8|||
145597971|NCT03492281|525039971|FG001|Overall Study|Captured as Other in Database|6|||
145597972|NCT03492281|525039972|FG002|Overall Study|Captured as Other in Database|3|||
145597973|NCT03624504|525039973|FG000|Overall Study|Unsuccessful Implant|1|||
145597974|NCT02862457|525039974|FG000|Overall Study|Death|1|||
145597975|NCT02862457|525039975|FG001|Overall Study|Death|3|||
145597976|NCT02862457|525039976|FG002|Overall Study|Death|2|||
145597977|NCT02862457|525039977|FG003|Overall Study|Death|3|||
145597978|NCT02862457|525039978|FG004|Overall Study|Death|0|||
145597979|NCT02862457|525039979|FG005|Overall Study|Death|2|||
145597980|NCT02862457|525039980|FG006|Overall Study|Death|1|||
145597981|NCT02862457|525039974|FG000|Overall Study|Lost to Follow-up|1|||
145597982|NCT02862457|525039975|FG001|Overall Study|Lost to Follow-up|0|||
145597983|NCT02862457|525039976|FG002|Overall Study|Lost to Follow-up|0|||
145597984|NCT02862457|525039977|FG003|Overall Study|Lost to Follow-up|1|||
145597985|NCT02862457|525039978|FG004|Overall Study|Lost to Follow-up|0|||
145597986|NCT02862457|525039979|FG005|Overall Study|Lost to Follow-up|0|||
145597987|NCT02862457|525039980|FG006|Overall Study|Lost to Follow-up|0|||
145597988|NCT02862457|525039974|FG000|Overall Study|Withdrawal by Subject|0|||
145597989|NCT02862457|525039975|FG001|Overall Study|Withdrawal by Subject|0|||
145597990|NCT02862457|525039976|FG002|Overall Study|Withdrawal by Subject|1|||
145597991|NCT02862457|525039977|FG003|Overall Study|Withdrawal by Subject|0|||
145597992|NCT02862457|525039978|FG004|Overall Study|Withdrawal by Subject|0|||
145597993|NCT02862457|525039979|FG005|Overall Study|Withdrawal by Subject|1|||
145597994|NCT02862457|525039980|FG006|Overall Study|Withdrawal by Subject|0|||
145597995|NCT00951483|525039983|FG000|Overall Study|Physician Decision|4|||
145597996|NCT00951483|525039984|FG001|Overall Study|Physician Decision|0|||
145597997|NCT00951483|525039983|FG000|Overall Study|Withdrawal by Subject|15|||
145597998|NCT00951483|525039984|FG001|Overall Study|Withdrawal by Subject|0|||
145597999|NCT03565887|525039985|FG000|Overall Study|Adverse Event|1|||
145598000|NCT03565887|525039986|FG001|Overall Study|Adverse Event|0|||
145598001|NCT03565887|525039985|FG000|Overall Study|Withdrawal by Subject|0|||
145598002|NCT03565887|525039986|FG001|Overall Study|Withdrawal by Subject|2|||
145598003|NCT03364751|525039987|FG000|Overall Study|Withdrawal by Subject|1|||
145598004|NCT03364751|525039988|FG001|Overall Study|Withdrawal by Subject|0|||
145598005|NCT03364751|525039989|FG002|Overall Study|Withdrawal by Subject|0|||
145598006|NCT03364751|525039990|FG003|Overall Study|Withdrawal by Subject|0|||
145598007|NCT03364751|525039987|FG000|Overall Study|Lost to Follow-up|0|||
145598008|NCT03364751|525039988|FG001|Overall Study|Lost to Follow-up|1|||
145598009|NCT03364751|525039989|FG002|Overall Study|Lost to Follow-up|0|||
145598010|NCT03364751|525039990|FG003|Overall Study|Lost to Follow-up|0|||
145598011|NCT02975973|525039991|FG000|Overall Study|Adverse Event|1|||
145598012|NCT02975973|525039992|FG001|Overall Study|Adverse Event|1|||
145598013|NCT02975973|525039993|FG002|Overall Study|Adverse Event|1|||
145598014|NCT02975973|525039994|FG003|Overall Study|Adverse Event|0|||
145598015|NCT03804710|525039995|FG000|Overall Study|Adverse Event|0|||
145598016|NCT03804710|525039996|FG001|Overall Study|Adverse Event|3|||
145598017|NCT03804710|525039995|FG000|Overall Study|Withdrawal by Subject|2|||
145598018|NCT03804710|525039996|FG001|Overall Study|Withdrawal by Subject|1|||
145598019|NCT03804710|525039995|FG000|Overall Study|Other|0|||
145598020|NCT03804710|525039996|FG001|Overall Study|Other|1|||
145598021|NCT04542018|525039997|FG000|Overall Study|Withdrawal by Subject|0|||
145598022|NCT04542018|525039998|FG001|Overall Study|Withdrawal by Subject|0|||
145598023|NCT04542018|525039999|FG002|Overall Study|Withdrawal by Subject|4|||
145598024|NCT04542018|525039997|FG000|Overall Study|Protocol Violation|0|||
145598025|NCT04542018|525039998|FG001|Overall Study|Protocol Violation|0|||
145598026|NCT04542018|525039999|FG002|Overall Study|Protocol Violation|2|||
145598027|NCT03583554|525040000|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
145598028|NCT03583554|525040001|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
145598029|NCT03583554|525040002|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
145598030|NCT00689221|525040008|FG000|Overall Study|Ongoing at cut-off date|39|||
145598031|NCT00689221|525040009|FG001|Overall Study|Ongoing at cut-off date|36|||
145598032|NCT00765388|525040010|FG000|Period 1|Lack of Efficacy|1|||
145598033|NCT00765388|525040011|FG001|Period 1|Lack of Efficacy|2|||
145598034|NCT00765388|525040010|FG000|Period 1|Lost to Follow-up|0|||
145598035|NCT00765388|525040011|FG001|Period 1|Lost to Follow-up|1|||
145598036|NCT00765388|525040010|FG000|Period 1|Herpes Zoster|0|||
145598037|NCT00765388|525040011|FG001|Period 1|Herpes Zoster|1|||
145598038|NCT00765388|525040010|FG000|Period 1|Hip operation|0|||
145598039|NCT00765388|525040011|FG001|Period 1|Hip operation|1|||
145598040|NCT03923933|525040015|FG000|Overall Study|Lost to Follow-up|1|||
145598041|NCT03923933|525040016|FG001|Overall Study|Lost to Follow-up|0|||
145598042|NCT03923933|525040015|FG000|Overall Study|Withdrawal by Subject|0|||
145598043|NCT03923933|525040016|FG001|Overall Study|Withdrawal by Subject|1|||
145598044|NCT00419263|525040017|FG000|Overall Study|Lost to Follow-up|2|||
145598045|NCT00419263|525040018|FG001|Overall Study|Lost to Follow-up|1|||
145598046|NCT00419263|525040019|FG002|Overall Study|Lost to Follow-up|1|||
145598047|NCT00419263|525040017|FG000|Overall Study|Randomized in Error, Not Treated|1|||
145598048|NCT00419263|525040018|FG001|Overall Study|Randomized in Error, Not Treated|1|||
145598049|NCT00419263|525040019|FG002|Overall Study|Randomized in Error, Not Treated|0|||
145598050|NCT00419263|525040017|FG000|Overall Study|Adverse Event|0|||
145598051|NCT00419263|525040018|FG001|Overall Study|Adverse Event|0|||
145598052|NCT00419263|525040019|FG002|Overall Study|Adverse Event|1|||
145598053|NCT00419263|525040017|FG000|Overall Study|Withdrawal by Subject|0|||
145598054|NCT00419263|525040018|FG001|Overall Study|Withdrawal by Subject|0|||
145598055|NCT00419263|525040019|FG002|Overall Study|Withdrawal by Subject|1|||
145598056|NCT02342886|525040020|FG000|Overall Study|Treatment non-compliance|1|||
145598057|NCT02342886|525040021|FG001|Overall Study|Treatment non-compliance|0|||
145598058|NCT02342886|525040022|FG002|Overall Study|Treatment non-compliance|0|||
145598059|NCT02342886|525040023|FG003|Overall Study|Treatment non-compliance|1|||
145598060|NCT02342886|525040024|FG004|Overall Study|Treatment non-compliance|0|||
145598061|NCT02342886|525040020|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
145598062|NCT02342886|525040021|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
145598063|NCT02342886|525040022|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
145598064|NCT02342886|525040023|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
145598065|NCT02342886|525040024|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
145598066|NCT02342886|525040020|FG000|Overall Study|Adverse event/specific toxicity|4|||
145598067|NCT02342886|525040021|FG001|Overall Study|Adverse event/specific toxicity|3|||
145598068|NCT02342886|525040022|FG002|Overall Study|Adverse event/specific toxicity|11|||
145598069|NCT02342886|525040023|FG003|Overall Study|Adverse event/specific toxicity|2|||
145598070|NCT02342886|525040024|FG004|Overall Study|Adverse event/specific toxicity|1|||
145598071|NCT02342886|525040020|FG000|Overall Study|Lost to Follow-up|1|||
145598072|NCT02342886|525040021|FG001|Overall Study|Lost to Follow-up|0|||
145598073|NCT02342886|525040022|FG002|Overall Study|Lost to Follow-up|0|||
145598074|NCT02342886|525040023|FG003|Overall Study|Lost to Follow-up|0|||
145598075|NCT02342886|525040024|FG004|Overall Study|Lost to Follow-up|0|||
145598076|NCT02342886|525040020|FG000|Overall Study|Death|1|||
145598077|NCT02342886|525040021|FG001|Overall Study|Death|2|||
145598078|NCT02342886|525040022|FG002|Overall Study|Death|1|||
145598079|NCT02342886|525040023|FG003|Overall Study|Death|0|||
145598080|NCT02342886|525040024|FG004|Overall Study|Death|1|||
145598081|NCT02342886|525040020|FG000|Overall Study|Withdrawal by Subject|0|||
145598082|NCT02342886|525040021|FG001|Overall Study|Withdrawal by Subject|1|||
145627116|NCT03697460|525147185|FG000|Overall Study|Withdrawal by Subject|3|||
145627117|NCT03369951|525147186|FG000|Overall Study|Withdrawal by Subject|3|||
145627118|NCT03369951|525147186|FG000|Overall Study|Death|1|||
145466780|NCT00528996|524563074|FG004|Overall Study|Lost to Follow-up|3|||
145598083|NCT02342886|525040022|FG002|Overall Study|Withdrawal by Subject|0|||
145598084|NCT02342886|525040023|FG003|Overall Study|Withdrawal by Subject|1|||
145598085|NCT02342886|525040024|FG004|Overall Study|Withdrawal by Subject|0|||
145598086|NCT02342886|525040020|FG000|Overall Study|Investigator/sponsor decision|0|||
145598087|NCT02342886|525040021|FG001|Overall Study|Investigator/sponsor decision|2|||
145598088|NCT02342886|525040022|FG002|Overall Study|Investigator/sponsor decision|0|||
145598089|NCT02342886|525040023|FG003|Overall Study|Investigator/sponsor decision|3|||
145598090|NCT02342886|525040024|FG004|Overall Study|Investigator/sponsor decision|1|||
145598091|NCT02342886|525040020|FG000|Overall Study|Pregnancy|0|||
145598092|NCT02342886|525040021|FG001|Overall Study|Pregnancy|0|||
145627119|NCT03369951|525147186|FG000|Overall Study|Lost to Follow-up|1|||
145598093|NCT02342886|525040022|FG002|Overall Study|Pregnancy|2|||
145598094|NCT02342886|525040023|FG003|Overall Study|Pregnancy|0|||
145466781|NCT00528996|524563070|FG000|Overall Study|Protocol Violation|1|||
145466782|NCT00528996|524563071|FG001|Overall Study|Protocol Violation|2|||
145466783|NCT00528996|524563072|FG002|Overall Study|Protocol Violation|3|||
145466784|NCT00528996|524563073|FG003|Overall Study|Protocol Violation|3|||
145466785|NCT00528996|524563074|FG004|Overall Study|Protocol Violation|2|||
145466786|NCT00528996|524563070|FG000|Overall Study|Lack of Efficacy|7|||
145466787|NCT00528996|524563071|FG001|Overall Study|Lack of Efficacy|2|||
145466788|NCT00528996|524563072|FG002|Overall Study|Lack of Efficacy|1|||
145466789|NCT00528996|524563073|FG003|Overall Study|Lack of Efficacy|3|||
145466790|NCT00528996|524563074|FG004|Overall Study|Lack of Efficacy|3|||
145466791|NCT00528996|524563070|FG000|Overall Study|Adverse Event|32|||
145466792|NCT00528996|524563071|FG001|Overall Study|Adverse Event|13|||
145466793|NCT00528996|524563072|FG002|Overall Study|Adverse Event|18|||
145466794|NCT00528996|524563073|FG003|Overall Study|Adverse Event|29|||
145466795|NCT00528996|524563074|FG004|Overall Study|Adverse Event|18|||
145466796|NCT02831933|524563075|FG000|Overall Study|Physician Decision|11|||
145466797|NCT05065190|524563079|FG000|Overall Study|Other than listed|2|||
145466798|NCT05065190|524563080|FG001|Overall Study|Other than listed|12|||
145466799|NCT05065190|524563079|FG000|Overall Study|Lack of Efficacy|4|||
145466800|NCT05065190|524563080|FG001|Overall Study|Lack of Efficacy|0|||
145466801|NCT05065190|524563079|FG000|Overall Study|Adverse Event|1|||
145466802|NCT05065190|524563080|FG001|Overall Study|Adverse Event|10|||
145466803|NCT05160766|524563083|FG000|Overall Study|Adverse Event|0|||
145466804|NCT05160766|524563084|FG001|Overall Study|Adverse Event|1|||
145466805|NCT05160766|524563085|FG002|Overall Study|Adverse Event|0|||
145466806|NCT05160766|524563086|FG003|Overall Study|Adverse Event|0|||
145466807|NCT05160766|524563083|FG000|Overall Study|COVID-19 infection|0|||
145466808|NCT05160766|524563084|FG001|Overall Study|COVID-19 infection|1|||
145466809|NCT05160766|524563085|FG002|Overall Study|COVID-19 infection|0|||
145466810|NCT05160766|524563086|FG003|Overall Study|COVID-19 infection|0|||
145466811|NCT05160766|524563083|FG000|Overall Study|travel time|1|||
145466812|NCT05160766|524563084|FG001|Overall Study|travel time|0|||
145466813|NCT05160766|524563085|FG002|Overall Study|travel time|0|||
145466814|NCT05160766|524563086|FG003|Overall Study|travel time|1|||
145466815|NCT05160766|524563083|FG000|Overall Study|Withdrawal by Subject|3|||
145466816|NCT05160766|524563084|FG001|Overall Study|Withdrawal by Subject|5|||
145466817|NCT05160766|524563085|FG002|Overall Study|Withdrawal by Subject|4|||
145466818|NCT05160766|524563086|FG003|Overall Study|Withdrawal by Subject|2|||
145466819|NCT05160766|524563083|FG000|Overall Study|Death|0|||
145466820|NCT05160766|524563084|FG001|Overall Study|Death|0|||
145466821|NCT05160766|524563085|FG002|Overall Study|Death|2|||
145466822|NCT05160766|524563086|FG003|Overall Study|Death|5|||
145466823|NCT05160766|524563083|FG000|Overall Study|Lost to Follow-up|0|||
145466824|NCT05160766|524563084|FG001|Overall Study|Lost to Follow-up|0|||
145466825|NCT05160766|524563085|FG002|Overall Study|Lost to Follow-up|1|||
145466826|NCT05160766|524563086|FG003|Overall Study|Lost to Follow-up|2|||
145466827|NCT05160766|524563083|FG000|Overall Study|No show|0|||
145466828|NCT05160766|524563084|FG001|Overall Study|No show|0|||
145466829|NCT05160766|524563085|FG002|Overall Study|No show|1|||
145466830|NCT05160766|524563086|FG003|Overall Study|No show|1|||
145466831|NCT05160766|524563083|FG000|Overall Study|Physician Decision|0|||
145466832|NCT05160766|524563084|FG001|Overall Study|Physician Decision|0|||
145466833|NCT05160766|524563085|FG002|Overall Study|Physician Decision|0|||
145466834|NCT05160766|524563086|FG003|Overall Study|Physician Decision|1|||
145466835|NCT05160766|524563083|FG000|Overall Study|Protocol Violation|0|||
145466836|NCT05160766|524563084|FG001|Overall Study|Protocol Violation|0|||
145466837|NCT05160766|524563085|FG002|Overall Study|Protocol Violation|1|||
145466838|NCT05160766|524563086|FG003|Overall Study|Protocol Violation|0|||
145466839|NCT02654236|524563087|FG000|Overall Study|Withdrawal by Subject|0|||
145466840|NCT02654236|524563088|FG001|Overall Study|Withdrawal by Subject|0|||
145466841|NCT02654236|524563089|FG002|Overall Study|Withdrawal by Subject|2|||
145466842|NCT02943915|524563090|FG000|Overall Study|Withdrawal by Subject|2|||
145466843|NCT02943915|524563091|FG001|Overall Study|Withdrawal by Subject|1|||
145466844|NCT02943915|524563092|FG002|Overall Study|Withdrawal by Subject|0|||
145466845|NCT02943915|524563093|FG003|Overall Study|Withdrawal by Subject|0|||
145466846|NCT02943915|524563090|FG000|Overall Study|Lost to Follow-up|3|||
145466847|NCT02943915|524563091|FG001|Overall Study|Lost to Follow-up|1|||
145466848|NCT02943915|524563092|FG002|Overall Study|Lost to Follow-up|0|||
145466849|NCT02943915|524563093|FG003|Overall Study|Lost to Follow-up|0|||
145466850|NCT02943915|524563090|FG000|Overall Study|excluded|0|||
145466851|NCT02943915|524563091|FG001|Overall Study|excluded|1|||
145466852|NCT02943915|524563092|FG002|Overall Study|excluded|0|||
145466853|NCT02943915|524563093|FG003|Overall Study|excluded|0|||
145466854|NCT04692077|524563096|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
145466855|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
145466856|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
145466857|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
145466858|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
145466859|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
145466860|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
145598095|NCT02342886|525040024|FG004|Overall Study|Pregnancy|0|||
145598096|NCT02342886|525040020|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
145598097|NCT02342886|525040021|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
145598098|NCT02342886|525040022|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
145598099|NCT02342886|525040023|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
145598100|NCT02342886|525040024|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
145598101|NCT02342886|525040020|FG000|Overall Study|Protocol Violation|0|||
145598102|NCT02342886|525040021|FG001|Overall Study|Protocol Violation|0|||
145598103|NCT02342886|525040022|FG002|Overall Study|Protocol Violation|0|||
145598104|NCT02342886|525040023|FG003|Overall Study|Protocol Violation|2|||
145598105|NCT02342886|525040024|FG004|Overall Study|Protocol Violation|0|||
145598106|NCT01328080|525040025|FG000|Overall Study|Lost to Follow-up|5|||
145598107|NCT00862134|525040026|FG000|Overall Study|Death|1|||
145598108|NCT00862134|525040027|FG001|Overall Study|Death|0|||
145598109|NCT00862134|525040026|FG000|Overall Study|Physician Decision|0|||
145598110|NCT00862134|525040027|FG001|Overall Study|Physician Decision|1|||
145598111|NCT00862134|525040026|FG000|Overall Study|Withdrawal by Subject|1|||
145598112|NCT00862134|525040027|FG001|Overall Study|Withdrawal by Subject|2|||
145598113|NCT00862134|525040026|FG000|Overall Study|Sponsor terminated study|5|||
145598114|NCT00862134|525040027|FG001|Overall Study|Sponsor terminated study|7|||
145598115|NCT00862134|525040026|FG000|Overall Study|Adverse Event|2|||
145598116|NCT00862134|525040027|FG001|Overall Study|Adverse Event|2|||
145598117|NCT00862134|525040026|FG000|Overall Study|Withdrew prior to dosing|2|||
145598118|NCT00862134|525040027|FG001|Overall Study|Withdrew prior to dosing|0|||
145598119|NCT02191267|525040028|FG000|Overall Study|Withdrawal by Subject|1|||
145598120|NCT02191267|525040029|FG001|Overall Study|Withdrawal by Subject|0|||
145598121|NCT02191267|525040030|FG002|Overall Study|Withdrawal by Subject|0|||
145598122|NCT00765674|525040031|FG000|Overall Study|Adverse Event|7|||
145598123|NCT00765674|525040032|FG001|Overall Study|Adverse Event|2|||
145598124|NCT00765674|525040033|FG002|Overall Study|Adverse Event|8|||
145598125|NCT00765674|525040034|FG003|Overall Study|Adverse Event|11|||
145598126|NCT00765674|525040031|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
145598127|NCT00765674|525040032|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
145598128|NCT00765674|525040033|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
145598129|NCT00765674|525040034|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
145598130|NCT00765674|525040031|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
145598131|NCT00765674|525040032|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
145598132|NCT00765674|525040033|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
145598133|NCT00765674|525040034|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
145598134|NCT00765674|525040031|FG000|Overall Study|Lack of Efficacy|2|||
145598135|NCT00765674|525040032|FG001|Overall Study|Lack of Efficacy|3|||
145598136|NCT00765674|525040033|FG002|Overall Study|Lack of Efficacy|1|||
145598137|NCT00765674|525040034|FG003|Overall Study|Lack of Efficacy|2|||
145598138|NCT00765674|525040031|FG000|Overall Study|Protocol Violation|2|||
145598139|NCT00765674|525040032|FG001|Overall Study|Protocol Violation|0|||
145598140|NCT00765674|525040033|FG002|Overall Study|Protocol Violation|1|||
145598141|NCT00765674|525040034|FG003|Overall Study|Protocol Violation|0|||
145598142|NCT00765674|525040031|FG000|Overall Study|Withdrawal by Subject|5|||
145598143|NCT00765674|525040032|FG001|Overall Study|Withdrawal by Subject|7|||
145598144|NCT00765674|525040033|FG002|Overall Study|Withdrawal by Subject|3|||
145598145|NCT00765674|525040034|FG003|Overall Study|Withdrawal by Subject|8|||
145598146|NCT00765674|525040031|FG000|Overall Study|Lost to Follow-up|4|||
145598147|NCT00765674|525040032|FG001|Overall Study|Lost to Follow-up|6|||
145598148|NCT00765674|525040033|FG002|Overall Study|Lost to Follow-up|2|||
145598149|NCT00765674|525040034|FG003|Overall Study|Lost to Follow-up|1|||
145598150|NCT00765674|525040031|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
145598151|NCT00765674|525040032|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
145598152|NCT00765674|525040033|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
145598153|NCT00765674|525040034|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
145598154|NCT01813474|525040035|FG000|Overall Study|Withdrawal by Subject|0|||
145598155|NCT01813474|525040036|FG001|Overall Study|Withdrawal by Subject|0|||
145598156|NCT01813474|525040037|FG002|Overall Study|Withdrawal by Subject|1|||
145598157|NCT01813474|525040035|FG000|Overall Study|Adverse Event|1|||
145598158|NCT01813474|525040036|FG001|Overall Study|Adverse Event|1|||
145598159|NCT01813474|525040037|FG002|Overall Study|Adverse Event|0|||
145598160|NCT01813474|525040035|FG000|Overall Study|Lack of Efficacy|2|||
145598161|NCT01813474|525040036|FG001|Overall Study|Lack of Efficacy|6|||
145598162|NCT01813474|525040037|FG002|Overall Study|Lack of Efficacy|9|||
145598163|NCT01813474|525040035|FG000|Overall Study|Death|0|||
145598164|NCT01813474|525040036|FG001|Overall Study|Death|0|||
145598165|NCT01813474|525040037|FG002|Overall Study|Death|1|||
145598166|NCT03015402|525040038|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
145598167|NCT03015402|525040039|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
145598168|NCT03015402|525040038|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
145598169|NCT03015402|525040039|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
145598170|NCT00538590|525040047|FG000|Overall Study|Death|1|||
145598171|NCT00538590|525040048|FG001|Overall Study|Death|0|||
145598172|NCT00567190|525040049|FG000|Overall Study|Death|235|||
145598173|NCT00567190|525040050|FG001|Overall Study|Death|280|||
145598174|NCT00567190|525040049|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
145598175|NCT00567190|525040050|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
145598176|NCT00636610|525040051|FG000|Overall Study|Adverse Event|4|||
145598177|NCT00636610|525040052|FG001|Overall Study|Adverse Event|4|||
145598178|NCT00636610|525040051|FG000|Overall Study|Death|6|||
145598179|NCT00636610|525040052|FG001|Overall Study|Death|3|||
145598180|NCT00636610|525040051|FG000|Overall Study|Physician decision to withdraw patient|15|||
145598181|NCT00636610|525040052|FG001|Overall Study|Physician decision to withdraw patient|9|||
145598182|NCT00636610|525040051|FG000|Overall Study|Subject decision to withdraw|15|||
145598183|NCT00636610|525040052|FG001|Overall Study|Subject decision to withdraw|11|||
145598184|NCT00636610|525040051|FG000|Overall Study|Disease progression - radiographic|41|||
145598185|NCT00636610|525040052|FG001|Overall Study|Disease progression - radiographic|51|||
145598186|NCT00636610|525040051|FG000|Overall Study|Disease progression - clinical|8|||
145598187|NCT00636610|525040052|FG001|Overall Study|Disease progression - clinical|3|||
145598188|NCT00636610|525040051|FG000|Overall Study|Reason for discontinuation not available|3|||
145598189|NCT00636610|525040052|FG001|Overall Study|Reason for discontinuation not available|2|||
145598190|NCT00553696|525040057|FG000|Overall Study|Adverse Event|2|||
145598191|NCT00553696|525040058|FG001|Overall Study|Adverse Event|4|||
145598192|NCT00553696|525040059|FG002|Overall Study|Adverse Event|0|||
145598193|NCT00553696|525040060|FG003|Overall Study|Adverse Event|1|||
145598194|NCT00553696|525040057|FG000|Overall Study|Global deterioration of health status|0|||
145598195|NCT00553696|525040058|FG001|Overall Study|Global deterioration of health status|2|||
145598196|NCT00553696|525040059|FG002|Overall Study|Global deterioration of health status|0|||
145598197|NCT00553696|525040060|FG003|Overall Study|Global deterioration of health status|0|||
145598198|NCT00553696|525040057|FG000|Overall Study|Objective progression or relapse|2|||
145466861|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
145466862|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
145466863|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
145466864|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
145466865|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
145466866|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
145466867|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
145466868|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
145466869|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
145466870|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
145466871|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
145598199|NCT00553696|525040058|FG001|Overall Study|Objective progression or relapse|9|||
145598200|NCT00553696|525040059|FG002|Overall Study|Objective progression or relapse|6|||
145598201|NCT00553696|525040060|FG003|Overall Study|Objective progression or relapse|0|||
145598202|NCT00553696|525040057|FG000|Overall Study|Withdrawal by Subject|0|||
145598203|NCT00553696|525040058|FG001|Overall Study|Withdrawal by Subject|1|||
145598204|NCT00553696|525040059|FG002|Overall Study|Withdrawal by Subject|0|||
145598205|NCT00553696|525040060|FG003|Overall Study|Withdrawal by Subject|0|||
145598206|NCT02085252|525040061|FG000|Overall Study|Withdrawal of Consent|1|||
145598207|NCT02085252|525040062|FG001|Overall Study|Withdrawal of Consent|0|||
145598208|NCT02085252|525040061|FG000|Overall Study|Adverse Event|0|||
145598209|NCT02085252|525040062|FG001|Overall Study|Adverse Event|1|||
145598210|NCT02085252|525040061|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
145598211|NCT02085252|525040062|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
145598212|NCT02085252|525040061|FG000|Overall Study|Reason Not Specified|0|||
145598213|NCT02085252|525040062|FG001|Overall Study|Reason Not Specified|1|||
145598214|NCT02085252|525040061|FG000|Overall Study|Reason Unknown|0|||
145598215|NCT02085252|525040062|FG001|Overall Study|Reason Unknown|1|||
145598216|NCT00981084|525040063|FG000|Post Intervention (Data Analysis)|poor effort|1|||
145598217|NCT00981084|525040064|FG001|Post Intervention (Data Analysis)|poor effort|1|||
145598218|NCT00981084|525040063|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
145598219|NCT00981084|525040064|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
145598220|NCT00902694|525040065|FG000|Overall Study|Death|1|||
145598221|NCT00902694|525040066|FG001|Overall Study|Death|3|||
145598222|NCT00902694|525040065|FG000|Overall Study|Lost to Follow-up|1|||
145598223|NCT00902694|525040066|FG001|Overall Study|Lost to Follow-up|0|||
145598224|NCT00902694|525040065|FG000|Overall Study|Censored per protocol|3|||
145598225|NCT00902694|525040066|FG001|Overall Study|Censored per protocol|1|||
145598226|NCT00902694|525040065|FG000|Overall Study|Pregnancy|1|||
145598227|NCT00902694|525040066|FG001|Overall Study|Pregnancy|1|||
145598228|NCT00902694|525040065|FG000|Overall Study|Incarceration|1|||
145598229|NCT00902694|525040066|FG001|Overall Study|Incarceration|0|||
145598230|NCT04969263|525040067|FG000|Overall Study|Death|1|||
145598231|NCT04969263|525040067|FG000|Overall Study|Lost to Follow-up|2|||
145598232|NCT04969263|525040067|FG000|Overall Study|Withdrawal by Subject|5|||
145598233|NCT04969263|525040067|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
145598234|NCT03456700|525040068|FG000|Overall Study|Withdrawal by Subject|1|||
145598235|NCT04154787|525040069|FG000|Overall Study|Adverse Event|0|||
145598236|NCT04154787|525040070|FG001|Overall Study|Adverse Event|1|||
145598237|NCT04154787|525040071|FG002|Overall Study|Adverse Event|0|||
145598238|NCT04154787|525040069|FG000|Overall Study|Patient Requires Other Treatment|0|||
145598239|NCT04154787|525040070|FG001|Overall Study|Patient Requires Other Treatment|1|||
145598240|NCT04154787|525040071|FG002|Overall Study|Patient Requires Other Treatment|0|||
145598241|NCT04154787|525040069|FG000|Overall Study|Study Terminated By Sponsor|0|||
145598242|NCT04154787|525040070|FG001|Overall Study|Study Terminated By Sponsor|6|||
145598243|NCT04154787|525040071|FG002|Overall Study|Study Terminated By Sponsor|1|||
145598244|NCT04154787|525040069|FG000|Overall Study|Subject Decision|0|||
145598245|NCT04154787|525040070|FG001|Overall Study|Subject Decision|1|||
145598246|NCT04154787|525040071|FG002|Overall Study|Subject Decision|0|||
145598247|NCT04154787|525040069|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
145598248|NCT04154787|525040070|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
145598249|NCT04154787|525040071|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
145598250|NCT03053050|525040072|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
145598251|NCT03053050|525040073|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
145598252|NCT03053050|525040074|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
145598253|NCT03053050|525040075|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
145598254|NCT03053050|525040072|FG000|Randomized Phase|Withdrew Consent|16|||
145598255|NCT03053050|525040073|FG001|Randomized Phase|Withdrew Consent|8|||
145598256|NCT03053050|525040074|FG002|Randomized Phase|Withdrew Consent|9|||
145598257|NCT03053050|525040075|FG003|Randomized Phase|Withdrew Consent|0|||
145598258|NCT03053050|525040072|FG000|Randomized Phase|Investigator's Discretion|6|||
145598259|NCT03053050|525040073|FG001|Randomized Phase|Investigator's Discretion|6|||
145598260|NCT03053050|525040074|FG002|Randomized Phase|Investigator's Discretion|3|||
145598261|NCT03053050|525040075|FG003|Randomized Phase|Investigator's Discretion|0|||
145598262|NCT03053050|525040072|FG000|Randomized Phase|Lost to Follow-up|5|||
145598263|NCT03053050|525040073|FG001|Randomized Phase|Lost to Follow-up|1|||
145598264|NCT03053050|525040074|FG002|Randomized Phase|Lost to Follow-up|1|||
145598265|NCT03053050|525040075|FG003|Randomized Phase|Lost to Follow-up|0|||
145598266|NCT03053050|525040072|FG000|Randomized Phase|Adverse Event|0|||
145598267|NCT03053050|525040073|FG001|Randomized Phase|Adverse Event|1|||
145598268|NCT03053050|525040074|FG002|Randomized Phase|Adverse Event|0|||
145598269|NCT03053050|525040075|FG003|Randomized Phase|Adverse Event|0|||
145598270|NCT03053050|525040072|FG000|Randomized Phase|Randomized but Never Treated|2|||
145598271|NCT03053050|525040073|FG001|Randomized Phase|Randomized but Never Treated|2|||
145598272|NCT03053050|525040074|FG002|Randomized Phase|Randomized but Never Treated|2|||
145598273|NCT03053050|525040075|FG003|Randomized Phase|Randomized but Never Treated|0|||
145598274|NCT03053050|525040072|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
145598275|NCT03053050|525040073|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
145598276|NCT03053050|525040074|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
145598277|NCT03053050|525040075|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
145598278|NCT03053050|525040072|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
145598279|NCT03053050|525040073|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
145598280|NCT03053050|525040074|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
145598281|NCT03053050|525040075|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
145598282|NCT03053050|525040072|FG000|Open-label Phase|Withdrew Consent|0|||
145598283|NCT03053050|525040073|FG001|Open-label Phase|Withdrew Consent|0|||
145598284|NCT03053050|525040074|FG002|Open-label Phase|Withdrew Consent|0|||
145598285|NCT03053050|525040075|FG003|Open-label Phase|Withdrew Consent|6|||
145598286|NCT03053050|525040072|FG000|Open-label Phase|Investigator's Discretion|0|||
145598287|NCT03053050|525040073|FG001|Open-label Phase|Investigator's Discretion|0|||
145598288|NCT03053050|525040074|FG002|Open-label Phase|Investigator's Discretion|0|||
145598289|NCT03053050|525040075|FG003|Open-label Phase|Investigator's Discretion|4|||
145598290|NCT03703466|525040076|FG000|Overall Study|Death|2|||
145598291|NCT03703466|525040077|FG001|Overall Study|Death|1|||
145598292|NCT03703466|525040078|FG002|Overall Study|Death|0|||
145598293|NCT03703466|525040076|FG000|Overall Study|Withdrawal by Subject|0|||
145598294|NCT03703466|525040077|FG001|Overall Study|Withdrawal by Subject|3|||
145598295|NCT03703466|525040078|FG002|Overall Study|Withdrawal by Subject|0|||
145598296|NCT03703466|525040076|FG000|Overall Study|Completed < 3 Cycles|2|||
145598297|NCT03703466|525040077|FG001|Overall Study|Completed < 3 Cycles|2|||
145598298|NCT03703466|525040078|FG002|Overall Study|Completed < 3 Cycles|2|||
145598299|NCT02543658|525042160|FG000|Overall Study|Lack of Efficacy|0|||
145598300|NCT02543658|525042161|FG001|Overall Study|Lack of Efficacy|4|||
145598301|NCT00437645|525042168|FG000|Overall Study|Adverse Event|15|||
145598302|NCT00437645|525042169|FG001|Overall Study|Adverse Event|84|||
145598303|NCT00437645|525042168|FG000|Overall Study|Withdrawal by Subject|10|||
145598304|NCT00437645|525042169|FG001|Overall Study|Withdrawal by Subject|22|||
145598305|NCT00437645|525042168|FG000|Overall Study|Protocol Violation|3|||
145598306|NCT00437645|525042169|FG001|Overall Study|Protocol Violation|3|||
145598307|NCT00437645|525042168|FG000|Overall Study|Lost to Follow-up|2|||
145598308|NCT00437645|525042169|FG001|Overall Study|Lost to Follow-up|3|||
145598309|NCT00437645|525042168|FG000|Overall Study|Administrative problems|2|||
145598310|NCT00437645|525042169|FG001|Overall Study|Administrative problems|1|||
145598311|NCT00437645|525042168|FG000|Overall Study|Lack of Efficacy|2|||
145598312|NCT00437645|525042169|FG001|Overall Study|Lack of Efficacy|1|||
145598313|NCT00437645|525042168|FG000|Overall Study|Condition no longer requires study drug|1|||
145598314|NCT00437645|525042169|FG001|Overall Study|Condition no longer requires study drug|1|||
145598315|NCT03966053|525042170|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
145598316|NCT00175825|525042173|FG000|Overall Study|Adverse Event|3|||
145598317|NCT00175825|525042174|FG001|Overall Study|Adverse Event|2|||
145598318|NCT00175825|525042175|FG002|Overall Study|Adverse Event|1|||
145598319|NCT00175825|525042176|FG003|Overall Study|Adverse Event|1|||
145598320|NCT00175825|525042173|FG000|Overall Study|Lost to Follow-up|1|||
145598321|NCT00175825|525042174|FG001|Overall Study|Lost to Follow-up|2|||
145598322|NCT00175825|525042175|FG002|Overall Study|Lost to Follow-up|0|||
145598323|NCT00175825|525042176|FG003|Overall Study|Lost to Follow-up|0|||
145598324|NCT00175825|525042173|FG000|Overall Study|Withdrawal by Subject|1|||
145598325|NCT00175825|525042174|FG001|Overall Study|Withdrawal by Subject|0|||
145598326|NCT00175825|525042175|FG002|Overall Study|Withdrawal by Subject|0|||
145598327|NCT00175825|525042176|FG003|Overall Study|Withdrawal by Subject|0|||
145598328|NCT04586569|525042177|FG000|Overall Study|Withdrawal by Subject|0|||
145598329|NCT04586569|525042178|FG001|Overall Study|Withdrawal by Subject|2|||
145598330|NCT04586569|525042177|FG000|Overall Study|No longer eligible|2|||
145598331|NCT04586569|525042178|FG001|Overall Study|No longer eligible|3|||
145598332|NCT04586569|525042177|FG000|Overall Study|Physician Decision|1|||
145598333|NCT04586569|525042178|FG001|Overall Study|Physician Decision|0|||
145598334|NCT04098406|525042180|FG000|Overall Study|Adverse Event|2|||
145598335|NCT04098406|525042181|FG001|Overall Study|Adverse Event|1|||
145598336|NCT04098406|525042180|FG000|Overall Study|Withdrawal by Subject|1|||
145598337|NCT04098406|525042181|FG001|Overall Study|Withdrawal by Subject|0|||
145598338|NCT03597568|525042182|FG000|Overall Study|Withdrawal by Subject|1|||
145598339|NCT03597568|525042183|FG001|Overall Study|Withdrawal by Subject|1|||
145598340|NCT03597568|525042182|FG000|Overall Study|Unable to analyze vascular data|1|||
145598341|NCT03597568|525042183|FG001|Overall Study|Unable to analyze vascular data|1|||
145598342|NCT03548207|525042186|FG000|Overall Study|Death|10|||
145598343|NCT03548207|525042187|FG001|Overall Study|Death|23|||
145598344|NCT03548207|525042188|FG002|Overall Study|Death|3|||
145598345|NCT03548207|525042186|FG000|Overall Study|Lost to Follow-up|0|||
145598346|NCT03548207|525042187|FG001|Overall Study|Lost to Follow-up|2|||
145598347|NCT03548207|525042188|FG002|Overall Study|Lost to Follow-up|0|||
145598348|NCT03548207|525042186|FG000|Overall Study|Withdrawal by Subject|0|||
145598349|NCT03548207|525042187|FG001|Overall Study|Withdrawal by Subject|3|||
145598350|NCT03548207|525042188|FG002|Overall Study|Withdrawal by Subject|0|||
145598351|NCT03548207|525042186|FG000|Overall Study|Sponsor decision|19|||
145598352|NCT03548207|525042187|FG001|Overall Study|Sponsor decision|40|||
145598353|NCT03548207|525042188|FG002|Overall Study|Sponsor decision|6|||
145598354|NCT03548207|525042186|FG000|Overall Study|Randomized but not treated|6|||
145598355|NCT03548207|525042187|FG001|Overall Study|Randomized but not treated|10|||
145598356|NCT03548207|525042188|FG002|Overall Study|Randomized but not treated|4|||
145598357|NCT00999466|525042189|FG000|Main Part|Withdrawal by Subject|0|||
145598358|NCT00999466|525042190|FG001|Main Part|Withdrawal by Subject|0|||
145598359|NCT00999466|525042191|FG002|Main Part|Withdrawal by Subject|2|||
145598360|NCT00999466|525042189|FG000|Main Part|Adverse Event|0|||
145598361|NCT00999466|525042190|FG001|Main Part|Adverse Event|4|||
145598362|NCT00999466|525042191|FG002|Main Part|Adverse Event|2|||
145598363|NCT01357616|525042192|FG000|Overall Study|Adverse Event|1|||
145598364|NCT01357616|525042193|FG001|Overall Study|Adverse Event|1|||
145598365|NCT01357616|525042192|FG000|Overall Study|Lost to Follow-up|4|||
145627120|NCT03369951|525147186|FG000|Overall Study|Protocol Violation|1|||
145627121|NCT00725010|525147196|FG000|Overall Study|Toxicity|9|||
145627122|NCT00725010|525147196|FG000|Overall Study|Tumor Progression|7|||
145627123|NCT00725010|525147196|FG000|Overall Study|Withdrawal by Subject|2|||
145598366|NCT01357616|525042193|FG001|Overall Study|Lost to Follow-up|3|||
145598367|NCT01357616|525042192|FG000|Overall Study|Protocol Violation|0|||
145598368|NCT01357616|525042193|FG001|Overall Study|Protocol Violation|2|||
145627124|NCT00725010|525147196|FG000|Overall Study|Death|1|||
145466872|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
145598369|NCT01357616|525042192|FG000|Overall Study|Inadequate Control of IOP|1|||
145598370|NCT01357616|525042193|FG001|Overall Study|Inadequate Control of IOP|2|||
145598371|NCT01357616|525042192|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
145598372|NCT01357616|525042193|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
145598373|NCT01357616|525042192|FG000|Overall Study|Withdrawal by Subject|1|||
145598374|NCT01357616|525042193|FG001|Overall Study|Withdrawal by Subject|0|||
145598375|NCT03432364|525042195|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
145598376|NCT00522301|525042196|FG000|Overall Study|Withdrawal by Subject|1|||
145598377|NCT00522301|525042196|FG000|Overall Study|Adverse Event|5|||
145627125|NCT00725010|525147196|FG000|Overall Study|Lost to Follow-up|1|||
145627126|NCT00725010|525147196|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
145627127|NCT00725010|525147196|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
145627128|NCT00725010|525147196|FG000|Overall Study|No further documentation|1|||
145627129|NCT00725010|525147196|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
145627130|NCT03499600|525147197|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
145627131|NCT03499600|525147198|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
145627132|NCT02414828|525147199|FG000|Overall Study|Lost to Follow-up|0|||
145627133|NCT02414828|525147200|FG001|Overall Study|Lost to Follow-up|1|||
145627134|NCT02414828|525147201|FG002|Overall Study|Lost to Follow-up|1|||
145627135|NCT02414828|525147202|FG003|Overall Study|Lost to Follow-up|2|||
145627136|NCT00389519|525147206|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
145627137|NCT00389519|525147207|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
145627138|NCT00389519|525147208|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
145627139|NCT00389519|525147209|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
145627140|NCT00389519|525147206|FG000|Placebo Run-In|Withdrawal by Subject|19|||
145627141|NCT00389519|525147207|FG001|Placebo Run-In|Withdrawal by Subject|0|||
145627142|NCT00389519|525147208|FG002|Placebo Run-In|Withdrawal by Subject|0|||
145627143|NCT00389519|525147209|FG003|Placebo Run-In|Withdrawal by Subject|0|||
145627144|NCT00389519|525147206|FG000|Placebo Run-In|Reason not specified|40|||
145627145|NCT00389519|525147207|FG001|Placebo Run-In|Reason not specified|0|||
145627146|NCT00389519|525147208|FG002|Placebo Run-In|Reason not specified|0|||
145627147|NCT00389519|525147209|FG003|Placebo Run-In|Reason not specified|0|||
145627148|NCT00389519|525147206|FG000|Randomized|Did not receive study drug|2|||
145627149|NCT00389519|525147207|FG001|Randomized|Did not receive study drug|0|||
145627150|NCT00389519|525147208|FG002|Randomized|Did not receive study drug|0|||
145627151|NCT00389519|525147209|FG003|Randomized|Did not receive study drug|0|||
145627152|NCT00389519|525147206|FG000|Treated|Adverse Event|1|||
145627153|NCT00389519|525147207|FG001|Treated|Adverse Event|0|||
145627154|NCT00389519|525147208|FG002|Treated|Adverse Event|0|||
145627155|NCT00389519|525147209|FG003|Treated|Adverse Event|2|||
145627156|NCT00389519|525147206|FG000|Treated|Reason not specified|1|||
145627157|NCT00389519|525147207|FG001|Treated|Reason not specified|1|||
145627158|NCT00389519|525147208|FG002|Treated|Reason not specified|0|||
145627159|NCT00389519|525147209|FG003|Treated|Reason not specified|2|||
145627160|NCT01537133|525149130|FG000|Overall Study|Withdrawal by Subject|2|||
145627161|NCT01537133|525149131|FG001|Overall Study|Withdrawal by Subject|0|||
145627162|NCT01537133|525149132|FG002|Overall Study|Withdrawal by Subject|0|||
145627163|NCT01537133|525149133|FG003|Overall Study|Withdrawal by Subject|0|||
145627164|NCT01537133|525149130|FG000|Overall Study|Lost to Follow-up|1|||
145627165|NCT01537133|525149131|FG001|Overall Study|Lost to Follow-up|0|||
145627166|NCT01537133|525149132|FG002|Overall Study|Lost to Follow-up|0|||
145627167|NCT01537133|525149133|FG003|Overall Study|Lost to Follow-up|0|||
145627168|NCT00569946|525149134|FG000|Overall Study|Adverse Event|16|||
145627169|NCT00569946|525149134|FG000|Overall Study|Objective Progression or Relapse|42|||
145627170|NCT00569946|525149134|FG000|Overall Study|Global Deterioration of Health Status|1|||
145627171|NCT00531479|525149135|FG000|Overall Study|Death|68|||
145627172|NCT00531479|525149136|FG001|Overall Study|Death|71|||
145627173|NCT00531479|525149135|FG000|Overall Study|Lost to Follow-up|0|||
145627174|NCT00531479|525149136|FG001|Overall Study|Lost to Follow-up|2|||
145627175|NCT00531479|525149135|FG000|Overall Study|Other|0|||
145627176|NCT00531479|525149136|FG001|Overall Study|Other|1|||
145627177|NCT00531479|525149135|FG000|Overall Study|Withdrawal by Subject|6|||
145627178|NCT00531479|525149136|FG001|Overall Study|Withdrawal by Subject|6|||
145627179|NCT00531479|525149135|FG000|Overall Study|Did not receive treatment|2|||
145627180|NCT00531479|525149136|FG001|Overall Study|Did not receive treatment|3|||
145627181|NCT00797862|525149137|FG000|Overall Study|Adverse Event|86|||
145627182|NCT00797862|525149138|FG001|Overall Study|Adverse Event|44|||
145627183|NCT00797862|525149139|FG002|Overall Study|Adverse Event|58|||
145627184|NCT00797862|525149137|FG000|Overall Study|Abnormal Test Procedure Result|0|||
145627185|NCT00797862|525149138|FG001|Overall Study|Abnormal Test Procedure Result|1|||
145466873|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
145598378|NCT00337272|525042197|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
145598379|NCT00337272|525042198|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
145598380|NCT00337272|525042197|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
145598381|NCT00337272|525042198|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
145598382|NCT00337272|525042197|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
145598383|NCT00337272|525042198|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
145598384|NCT00337272|525042197|FG000|Treatment Period|Non-compliance|1|||
145598385|NCT00337272|525042198|FG001|Treatment Period|Non-compliance|1|||
145598386|NCT00337272|525042197|FG000|Treatment Period|Withdrawal by Subject|0|||
145598387|NCT00337272|525042198|FG001|Treatment Period|Withdrawal by Subject|1|||
145598388|NCT00337272|525042197|FG000|Withdrawal Period|Non-compliance|0|||
145627186|NCT00797862|525149139|FG002|Overall Study|Abnormal Test Procedure Result|1|||
145627187|NCT00797862|525149137|FG000|Overall Study|Lack of Efficacy|1|||
145627188|NCT00797862|525149138|FG001|Overall Study|Lack of Efficacy|7|||
145598389|NCT00337272|525042198|FG001|Withdrawal Period|Non-compliance|1|||
145598390|NCT01699022|525042204|FG000|Overall Study|Early discontinuation from the study|3|||
145598391|NCT02066402|525042205|FG000|Overall Study|Adverse Event|1|||
145598392|NCT02066402|525042206|FG001|Overall Study|Adverse Event|2|||
145598393|NCT02066402|525042205|FG000|Overall Study|Lost to Follow-up|11|||
145598394|NCT02066402|525042206|FG001|Overall Study|Lost to Follow-up|8|||
145598395|NCT02066402|525042205|FG000|Overall Study|Withdrawal by Subject|14|||
145598396|NCT02066402|525042206|FG001|Overall Study|Withdrawal by Subject|11|||
145598397|NCT02066402|525042205|FG000|Overall Study|Progressive disease-clinical progression|0|||
145598398|NCT02066402|525042206|FG001|Overall Study|Progressive disease-clinical progression|1|||
145598399|NCT02066402|525042205|FG000|Overall Study|Protocol driven decision point|0|||
145598400|NCT02066402|525042206|FG001|Overall Study|Protocol driven decision point|1|||
145598401|NCT00152464|525042207|FG000|Overall Study|Adverse Event|3|||
145598402|NCT00152464|525042208|FG001|Overall Study|Adverse Event|6|||
145598403|NCT00152464|525042207|FG000|Overall Study|Lost to Follow-up|8|||
145598404|NCT00152464|525042208|FG001|Overall Study|Lost to Follow-up|4|||
145598405|NCT00152464|525042207|FG000|Overall Study|Protocol Violation|3|||
145598406|NCT00152464|525042208|FG001|Overall Study|Protocol Violation|1|||
145598407|NCT00152464|525042207|FG000|Overall Study|Withdrawal by Subject|21|||
145598408|NCT00152464|525042208|FG001|Overall Study|Withdrawal by Subject|22|||
145598409|NCT00152464|525042207|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
145598410|NCT00152464|525042208|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
145598411|NCT00152464|525042207|FG000|Overall Study|Eczema deterioration|0|||
145598412|NCT00152464|525042208|FG001|Overall Study|Eczema deterioration|1|||
145598413|NCT00152464|525042207|FG000|Overall Study|Parent decision|1|||
145598414|NCT00152464|525042208|FG001|Overall Study|Parent decision|1|||
145598415|NCT00152464|525042207|FG000|Overall Study|Investigator decision|1|||
145598416|NCT00152464|525042208|FG001|Overall Study|Investigator decision|0|||
145598417|NCT00152464|525042207|FG000|Overall Study|Lack of Efficacy|1|||
145598418|NCT00152464|525042208|FG001|Overall Study|Lack of Efficacy|0|||
145598419|NCT00152464|525042207|FG000|Overall Study|Eczema poorly controlled|1|||
145598420|NCT00152464|525042208|FG001|Overall Study|Eczema poorly controlled|0|||
145598421|NCT00152464|525042207|FG000|Overall Study|Patient relocated|1|||
145598422|NCT00152464|525042208|FG001|Overall Study|Patient relocated|0|||
145598423|NCT04465357|525042210|FG000|Overall Study|Adverse Event|2|||
145598424|NCT04465357|525042210|FG000|Overall Study|Lack of Efficacy|1|||
145598425|NCT04465357|525042210|FG000|Overall Study|Lost to Follow-up|2|||
145598426|NCT04465357|525042210|FG000|Overall Study|Withdrawal by Subject|6|||
145598427|NCT04465357|525042210|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
145598428|NCT01754467|525042212|FG000|Overall Study|Lost to Follow-up|1|||
145598429|NCT01970462|525042213|FG000|Overall Study|Lost to Follow-up|0|||
145598430|NCT01970462|525042214|FG001|Overall Study|Lost to Follow-up|2|||
145598431|NCT00917579|525042215|FG000|Washout >= 2 Weeks|Adverse Event|1|||
145598432|NCT00917579|525042216|FG001|Washout >= 2 Weeks|Adverse Event|0|||
145598433|NCT00917579|525042215|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
145598434|NCT00917579|525042216|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
145598435|NCT00754338|525042217|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
145598436|NCT00754338|525042218|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
145598437|NCT00754338|525042219|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
145598438|NCT00754338|525042220|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
145598439|NCT00754338|525042217|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
145598440|NCT00754338|525042218|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
145598441|NCT00754338|525042219|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
145598442|NCT00754338|525042220|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
145598443|NCT04020341|525042223|FG000|Overall Study|Adverse Event|8|||
145598444|NCT04020341|525042224|FG001|Overall Study|Adverse Event|6|||
145598445|NCT04020341|525042223|FG000|Overall Study|Lost to Follow-up|8|||
145598446|NCT04020341|525042224|FG001|Overall Study|Lost to Follow-up|2|||
145598447|NCT04020341|525042223|FG000|Overall Study|Withdrawal by Subject|16|||
145598448|NCT04020341|525042224|FG001|Overall Study|Withdrawal by Subject|16|||
145598449|NCT04020341|525042223|FG000|Overall Study|Participant not able to swallow the tablet|1|||
145598450|NCT04020341|525042224|FG001|Overall Study|Participant not able to swallow the tablet|0|||
145598451|NCT04020341|525042223|FG000|Overall Study|Physician Decision|0|||
145598452|NCT04020341|525042224|FG001|Overall Study|Physician Decision|2|||
145598453|NCT04020341|525042223|FG000|Overall Study|Protocol Deviation|0|||
145598454|NCT04020341|525042224|FG001|Overall Study|Protocol Deviation|2|||
145598455|NCT05763628|525042225|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
145598456|NCT05763628|525042226|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
145598457|NCT05763628|525042225|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
145598458|NCT05763628|525042226|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
145598459|NCT05763628|525042225|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
145598460|NCT05763628|525042226|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
145598461|NCT04683926|525042234|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
145598462|NCT04683926|525042235|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
145598463|NCT04683926|525042236|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
145598464|NCT04683926|525042237|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
145598465|NCT04385368|525042239|FG000|Overall Study|Death|5|||
145598466|NCT04385368|525042240|FG001|Overall Study|Death|5|||
145598467|NCT04385368|525042239|FG000|Overall Study|Physician Decision|3|||
145598468|NCT04385368|525042240|FG001|Overall Study|Physician Decision|0|||
145598469|NCT04385368|525042239|FG000|Overall Study|Withdrawal by Subject|4|||
145598470|NCT04385368|525042240|FG001|Overall Study|Withdrawal by Subject|3|||
145598471|NCT00716092|525042243|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
145598472|NCT00716092|525042244|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
145598473|NCT00716092|525042245|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
145598474|NCT01132326|525042246|FG000|Overall Study|Lack of Efficacy|25|||
145598475|NCT01132326|525042246|FG000|Overall Study|Adverse Event|37|||
145598476|NCT01132326|525042246|FG000|Overall Study|Protocol Violation|1|||
145598477|NCT01132326|525042246|FG000|Overall Study|Lost to Follow-up|16|||
145598478|NCT01132326|525042246|FG000|Overall Study|Withdrawal by Subject|40|||
145598479|NCT01132326|525042246|FG000|Overall Study|Physician Decision|10|||
145598480|NCT01132326|525042246|FG000|Overall Study|Study Termination|80|||
145598481|NCT01132326|525042246|FG000|Overall Study|Declining Health|1|||
145598482|NCT01132326|525042246|FG000|Overall Study|Pregnancy|1|||
145598483|NCT01132326|525042246|FG000|Overall Study|Caregiver Withdrew Consent|1|||
145598484|NCT01132326|525042246|FG000|Overall Study|Death|5|||
145598485|NCT01132326|525042246|FG000|Overall Study|Subject Unable to Come To Visits|1|||
145598486|NCT01040260|525042247|FG000|Overall Study|Withdrawal by Subject|12|||
145598487|NCT01040260|525042248|FG001|Overall Study|Withdrawal by Subject|6|||
145598488|NCT01040260|525042247|FG000|Overall Study|Lost to Follow-up|3|||
145598489|NCT01040260|525042248|FG001|Overall Study|Lost to Follow-up|5|||
145598490|NCT01113502|525042251|FG000|Overall Study|Withdrawal by Subject|1|||
145598491|NCT01113502|525042252|FG001|Overall Study|Withdrawal by Subject|0|||
145598492|NCT01113502|525042253|FG002|Overall Study|Withdrawal by Subject|1|||
145598493|NCT01113502|525042254|FG003|Overall Study|Withdrawal by Subject|1|||
145598494|NCT01113502|525042255|FG004|Overall Study|Withdrawal by Subject|0|||
145598495|NCT01113502|525042251|FG000|Overall Study|Adverse Event|0|||
145598496|NCT01113502|525042252|FG001|Overall Study|Adverse Event|0|||
145598497|NCT01113502|525042253|FG002|Overall Study|Adverse Event|3|||
145598498|NCT01113502|525042254|FG003|Overall Study|Adverse Event|2|||
145598499|NCT01113502|525042255|FG004|Overall Study|Adverse Event|0|||
145598500|NCT01362439|525042258|FG000|Overall Study|Adverse Event|1|||
145598501|NCT01362439|525042258|FG000|Overall Study|Lack of Efficacy|3|||
145598502|NCT01362439|525042258|FG000|Overall Study|Lost to Follow-up|2|||
145598503|NCT01362439|525042258|FG000|Overall Study|Study medication non-compliant|1|||
145598504|NCT01362439|525042258|FG000|Overall Study|Participant who withdrew consent|8|||
145598505|NCT02835339|525042259|FG000|Overall Study|Did not receive allocated intervention|13|||
145598506|NCT02835339|525042260|FG001|Overall Study|Did not receive allocated intervention|16|||
145598507|NCT01077544|525042261|FG000|Overall Study|New Cancer Therapy|3|||
145598508|NCT01077544|525042262|FG001|Overall Study|New Cancer Therapy|3|||
145598509|NCT01077544|525042261|FG000|Overall Study|Adverse Event|0|||
145598510|NCT01077544|525042262|FG001|Overall Study|Adverse Event|1|||
145598511|NCT01077544|525042261|FG000|Overall Study|Disease Progression|0|||
145598512|NCT01077544|525042262|FG001|Overall Study|Disease Progression|1|||
145598513|NCT03923959|525042271|FG000|Overall Study|Death|16|||
145598514|NCT03923959|525042272|FG001|Overall Study|Death|12|||
145598515|NCT03923959|525042271|FG000|Overall Study|Lost to Follow-up|56|||
145598516|NCT03923959|525042272|FG001|Overall Study|Lost to Follow-up|56|||
145598517|NCT03923959|525042271|FG000|Overall Study|Withdrawal by Subject|1|||
145598518|NCT03923959|525042272|FG001|Overall Study|Withdrawal by Subject|1|||
145598519|NCT03923959|525042271|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
145598520|NCT03923959|525042272|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
145598521|NCT04918147|525042273|FG000|Overall Study|Disease flare as defined in protocol|0|||
145598522|NCT04918147|525042274|FG001|Overall Study|Disease flare as defined in protocol|2|||
145598523|NCT01812655|525042279|FG000|Overall Study|Protocol Violation|1|||
145598524|NCT01812655|525042280|FG001|Overall Study|Protocol Violation|1|||
145598525|NCT01812655|525042281|FG002|Overall Study|Protocol Violation|0|||
145598526|NCT01596582|525042283|FG000|Overall Study|Deemed ineligible after study visit|3|||
145598527|NCT01596582|525042284|FG001|Overall Study|Deemed ineligible after study visit|6|||
145598528|NCT01596582|525042283|FG000|Overall Study|Missing all outcome data|1|||
145598529|NCT01596582|525042284|FG001|Overall Study|Missing all outcome data|1|||
145466874|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
145598530|NCT01428076|525042285|FG000|Overall Study|Adverse Event|0|||
145598531|NCT01428076|525042286|FG001|Overall Study|Adverse Event|1|||
145466875|NCT05149313|524563097|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
145466876|NCT05149313|524563098|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
145466877|NCT05149313|524563099|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
145598532|NCT04435665|525042287|FG000|Overall Study|Lost to Follow-up|0|||
145598533|NCT04435665|525042288|FG001|Overall Study|Lost to Follow-up|0|||
145598534|NCT04435665|525042289|FG002|Overall Study|Lost to Follow-up|0|||
145598535|NCT04435665|525042290|FG003|Overall Study|Lost to Follow-up|1|||
145598536|NCT02216773|525042291|FG000|Overall Study|Disease progression|4|||
145598537|NCT02216773|525042292|FG001|Overall Study|Disease progression|2|||
145598538|NCT02216773|525042291|FG000|Overall Study|Insufficient FLRV|4|||
145598539|NCT02216773|525042292|FG001|Overall Study|Insufficient FLRV|0|||
145598540|NCT02216773|525042291|FG000|Overall Study|Abandoned|4|||
145598541|NCT02216773|525042292|FG001|Overall Study|Abandoned|3|||
145598542|NCT02124265|525042296|FG000|Overall Study|Adverse Event|1|||
145598543|NCT04510675|525042299|FG000|Overall Study|Withdrawal by Subject|5|||
145598544|NCT00810264|525042300|FG000|Overall Study|Lost to Follow-up|191|||
145598545|NCT00810264|525042300|FG000|Overall Study|Withdrawal by subject or physician|721|||
145598546|NCT00810264|525042300|FG000|Overall Study|Death|641|||
145598547|NCT01563536|525042301|FG000|Overall Study|Withdrawal by Subject|0|||
145598548|NCT01563536|525042302|FG001|Overall Study|Withdrawal by Subject|2|||
145598549|NCT01563536|525042301|FG000|Overall Study|Lost to Follow-up|1|||
145598550|NCT01563536|525042302|FG001|Overall Study|Lost to Follow-up|0|||
145598551|NCT00058123|525042314|FG000|Overall Study|Wrong histology|9|||
145598552|NCT00058123|525042314|FG000|Overall Study|Received >3 prior treatments|1|||
145598553|NCT01298999|525042315|FG000|Overall Study|Physician Decision|0|||
145598554|NCT01298999|525042316|FG001|Overall Study|Physician Decision|1|||
145598555|NCT01298999|525042315|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
145598556|NCT01298999|525042316|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
145598557|NCT02151266|525042317|FG000|Overall Study|Lost to Follow-up|1|||
145598558|NCT02151266|525042318|FG001|Overall Study|Lost to Follow-up|4|||
145598559|NCT02151266|525042319|FG002|Overall Study|Lost to Follow-up|1|||
145598560|NCT02151266|525042317|FG000|Overall Study|Did NOT receive intervention|3|||
145598561|NCT02151266|525042318|FG001|Overall Study|Did NOT receive intervention|6|||
145598562|NCT02151266|525042319|FG002|Overall Study|Did NOT receive intervention|2|||
145598563|NCT02151266|525042317|FG000|Overall Study|Not able to exercise|4|||
145598564|NCT02151266|525042318|FG001|Overall Study|Not able to exercise|5|||
145598565|NCT02151266|525042319|FG002|Overall Study|Not able to exercise|4|||
145598566|NCT04839965|525042321|FG000|Overall Study|Death|6|||
145598567|NCT04839965|525042322|FG001|Overall Study|Death|6|||
145598568|NCT04839965|525042321|FG000|Overall Study|Lost to Follow-up|1|||
145598569|NCT04839965|525042322|FG001|Overall Study|Lost to Follow-up|0|||
145598570|NCT02291679|525042323|FG000|Overall Study|Adverse Event|2|||
145598571|NCT02291679|525042324|FG001|Overall Study|Adverse Event|12|||
145598572|NCT02291679|525042325|FG002|Overall Study|Adverse Event|19|||
145598573|NCT02291679|525042323|FG000|Overall Study|Protocol Violation|5|||
145598574|NCT02291679|525042324|FG001|Overall Study|Protocol Violation|1|||
145598575|NCT02291679|525042325|FG002|Overall Study|Protocol Violation|7|||
145598576|NCT02291679|525042323|FG000|Overall Study|Withdrew Consent|18|||
145598577|NCT02291679|525042324|FG001|Overall Study|Withdrew Consent|10|||
145598578|NCT02291679|525042325|FG002|Overall Study|Withdrew Consent|15|||
145598579|NCT02291679|525042323|FG000|Overall Study|Lost to Follow-up|12|||
145598580|NCT02291679|525042324|FG001|Overall Study|Lost to Follow-up|10|||
145598581|NCT02291679|525042325|FG002|Overall Study|Lost to Follow-up|9|||
145598582|NCT02291679|525042323|FG000|Overall Study|Insufficient Therapeutic Response|5|||
145598583|NCT02291679|525042324|FG001|Overall Study|Insufficient Therapeutic Response|5|||
145598584|NCT02291679|525042325|FG002|Overall Study|Insufficient Therapeutic Response|7|||
145598585|NCT02291679|525042323|FG000|Overall Study|Other|2|||
145598586|NCT02291679|525042324|FG001|Overall Study|Other|4|||
145598587|NCT02291679|525042325|FG002|Overall Study|Other|2|||
145598588|NCT02276222|525042326|FG000|Overall Study|Adverse Event|62|||
145598589|NCT02276222|525042327|FG001|Overall Study|Adverse Event|11|||
145598590|NCT02276222|525042326|FG000|Overall Study|Death|3|||
145598591|NCT02276222|525042327|FG001|Overall Study|Death|4|||
145598592|NCT02276222|525042326|FG000|Overall Study|Lack of Efficacy|13|||
145598593|NCT02276222|525042327|FG001|Overall Study|Lack of Efficacy|3|||
145598594|NCT02276222|525042326|FG000|Overall Study|Protocol Violation|3|||
145598595|NCT02276222|525042327|FG001|Overall Study|Protocol Violation|2|||
145598596|NCT02276222|525042326|FG000|Overall Study|Withdrawal by Subject|79|||
145598597|NCT02276222|525042327|FG001|Overall Study|Withdrawal by Subject|33|||
145598598|NCT02276222|525042326|FG000|Overall Study|non compliance with study medication|6|||
145598599|NCT02276222|525042327|FG001|Overall Study|non compliance with study medication|2|||
145598600|NCT02276222|525042326|FG000|Overall Study|sponsor decision|0|||
145598601|NCT02276222|525042327|FG001|Overall Study|sponsor decision|3|||
145598602|NCT02276222|525042326|FG000|Overall Study|Lost to Follow-up|15|||
145598603|NCT02276222|525042327|FG001|Overall Study|Lost to Follow-up|5|||
145598604|NCT02276222|525042326|FG000|Overall Study|Physician Decision|2|||
145598605|NCT02276222|525042327|FG001|Overall Study|Physician Decision|1|||
145598606|NCT02276222|525042326|FG000|Overall Study|sheduling conflict|1|||
145598607|NCT02276222|525042327|FG001|Overall Study|sheduling conflict|0|||
145598608|NCT02276222|525042326|FG000|Overall Study|subject withdrew after randomization|1|||
145598609|NCT02276222|525042327|FG001|Overall Study|subject withdrew after randomization|0|||
145598610|NCT03320018|525044270|FG000|Treatment Period|Withdrawal by Subject|1|||
145598611|NCT03320018|525044271|FG001|Treatment Period|Withdrawal by Subject|0|||
145598612|NCT03320018|525044270|FG000|Day 90 Follow up|Death|0|||
145466878|NCT05149313|524563100|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
145466879|NCT05149313|524563097|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
145466880|NCT05149313|524563098|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
145466881|NCT05149313|524563099|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
145466882|NCT05149313|524563100|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
145466883|NCT05149313|524563097|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145466884|NCT05149313|524563098|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145466885|NCT05149313|524563099|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
145466886|NCT05149313|524563100|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
145466887|NCT05149313|524563097|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
145466888|NCT05149313|524563098|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
145466889|NCT05149313|524563099|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
145466890|NCT05149313|524563100|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
145466891|NCT05149313|524563097|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145466892|NCT05149313|524563098|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145466893|NCT05149313|524563099|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
145466894|NCT05149313|524563100|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145466895|NCT05149313|524563097|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
145466896|NCT05149313|524563098|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
145466897|NCT05149313|524563099|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
145466898|NCT05149313|524563100|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
145466899|NCT01867086|524563101|FG000|Overall Study|Disease Progression|1|||
145466900|NCT03826342|524563102|FG000|Overall Study|Withdrawal by Subject|8|||
145466901|NCT03826342|524563103|FG001|Overall Study|Withdrawal by Subject|1|||
145466902|NCT03826342|524563102|FG000|Overall Study|Lost to Follow-up|7|||
145466903|NCT03826342|524563103|FG001|Overall Study|Lost to Follow-up|7|||
145466904|NCT03826342|524563102|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
145466905|NCT03826342|524563103|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
145466906|NCT02046070|524563109|FG000|Overall Study|Progressive Disease|18|||
145466907|NCT02046070|524563110|FG001|Overall Study|Progressive Disease|11|||
145466908|NCT02046070|524563111|FG002|Overall Study|Progressive Disease|40|||
145466909|NCT02046070|524563109|FG000|Overall Study|Adverse Event|8|||
145466910|NCT02046070|524563110|FG001|Overall Study|Adverse Event|10|||
145466911|NCT02046070|524563111|FG002|Overall Study|Adverse Event|17|||
145466912|NCT02046070|524563109|FG000|Overall Study|Withdrawal by Subject|1|||
145466913|NCT02046070|524563110|FG001|Overall Study|Withdrawal by Subject|2|||
145466914|NCT02046070|524563111|FG002|Overall Study|Withdrawal by Subject|6|||
145466915|NCT02046070|524563109|FG000|Overall Study|Study Terminated by Sponsor|1|||
145466916|NCT02046070|524563110|FG001|Overall Study|Study Terminated by Sponsor|1|||
145466917|NCT02046070|524563111|FG002|Overall Study|Study Terminated by Sponsor|1|||
145466918|NCT02046070|524563109|FG000|Overall Study|Reason not Specified|4|||
145466919|NCT02046070|524563110|FG001|Overall Study|Reason not Specified|4|||
145466920|NCT02046070|524563111|FG002|Overall Study|Reason not Specified|6|||
145466921|NCT01818284|524563112|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
145466922|NCT01818284|524563113|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
145466923|NCT01818284|524563112|FG000|Overall Study|Death|0|||
145466924|NCT01818284|524563113|FG001|Overall Study|Death|2|||
145466925|NCT04030962|524563114|FG000|Stage 2|Adverse Event|0|||
145466926|NCT04030962|524563115|FG001|Stage 2|Adverse Event|0|||
145466927|NCT04030962|524563116|FG002|Stage 2|Adverse Event|0|||
145466928|NCT04030962|524563117|FG003|Stage 2|Adverse Event|0|||
145466929|NCT04030962|524563118|FG004|Stage 2|Adverse Event|0|||
145466930|NCT04030962|524563119|FG005|Stage 2|Adverse Event|0|||
145466931|NCT04030962|524563120|FG006|Stage 2|Adverse Event|0|||
145466932|NCT04030962|524563121|FG007|Stage 2|Adverse Event|0|||
145466933|NCT04030962|524563122|FG008|Stage 2|Adverse Event|1|||
145466934|NCT04030962|524563123|FG009|Stage 2|Adverse Event|0|||
145466935|NCT04030962|524563124|FG010|Stage 2|Adverse Event|1|||
145466936|NCT04030962|524563125|FG011|Stage 2|Adverse Event|1|||
145466937|NCT04030962|524563126|FG012|Stage 2|Adverse Event|1|||
145466938|NCT04030962|524563114|FG000|Stage 2|Withdrawal by Subject|0|||
145466939|NCT04030962|524563115|FG001|Stage 2|Withdrawal by Subject|0|||
145466940|NCT04030962|524563116|FG002|Stage 2|Withdrawal by Subject|0|||
145466941|NCT04030962|524563117|FG003|Stage 2|Withdrawal by Subject|0|||
145466942|NCT04030962|524563118|FG004|Stage 2|Withdrawal by Subject|0|||
145466943|NCT04030962|524563119|FG005|Stage 2|Withdrawal by Subject|0|||
145466944|NCT04030962|524563120|FG006|Stage 2|Withdrawal by Subject|0|||
145466945|NCT04030962|524563121|FG007|Stage 2|Withdrawal by Subject|0|||
145466946|NCT04030962|524563122|FG008|Stage 2|Withdrawal by Subject|1|||
145466947|NCT04030962|524563123|FG009|Stage 2|Withdrawal by Subject|0|||
145466948|NCT04030962|524563124|FG010|Stage 2|Withdrawal by Subject|0|||
145466949|NCT04030962|524563125|FG011|Stage 2|Withdrawal by Subject|2|||
145466950|NCT04030962|524563126|FG012|Stage 2|Withdrawal by Subject|1|||
145466951|NCT04030962|524563114|FG000|Stage 2|Lost to Follow-up|0|||
145466952|NCT04030962|524563115|FG001|Stage 2|Lost to Follow-up|0|||
145466953|NCT04030962|524563116|FG002|Stage 2|Lost to Follow-up|0|||
145466954|NCT04030962|524563117|FG003|Stage 2|Lost to Follow-up|0|||
145466955|NCT04030962|524563118|FG004|Stage 2|Lost to Follow-up|0|||
145466956|NCT04030962|524563119|FG005|Stage 2|Lost to Follow-up|0|||
145598613|NCT03320018|525044271|FG001|Day 90 Follow up|Death|1|||
145598614|NCT02691182|525044272|FG000|Overall Study|Withdrawal by Subject|4|||
145598615|NCT02691182|525044273|FG001|Overall Study|Withdrawal by Subject|7|||
145598616|NCT02691182|525044274|FG002|Overall Study|Withdrawal by Subject|6|||
145598617|NCT02691182|525044275|FG003|Overall Study|Withdrawal by Subject|8|||
145598618|NCT02691182|525044272|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
145598619|NCT02691182|525044273|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
145598620|NCT02691182|525044274|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
145598621|NCT02691182|525044275|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
145598622|NCT02691182|525044272|FG000|Overall Study|Lost to Follow-up|8|||
145598623|NCT02691182|525044273|FG001|Overall Study|Lost to Follow-up|33|||
145598624|NCT02691182|525044274|FG002|Overall Study|Lost to Follow-up|19|||
145598625|NCT02691182|525044275|FG003|Overall Study|Lost to Follow-up|22|||
145598626|NCT02691182|525044272|FG000|Overall Study|Adverse Event|3|||
145598627|NCT02691182|525044273|FG001|Overall Study|Adverse Event|10|||
145598628|NCT02691182|525044274|FG002|Overall Study|Adverse Event|10|||
145598629|NCT02691182|525044275|FG003|Overall Study|Adverse Event|11|||
145598630|NCT02691182|525044272|FG000|Overall Study|Physician Decision|3|||
145598631|NCT02691182|525044273|FG001|Overall Study|Physician Decision|7|||
145598632|NCT02691182|525044274|FG002|Overall Study|Physician Decision|14|||
145598633|NCT02691182|525044275|FG003|Overall Study|Physician Decision|8|||
145598634|NCT02691182|525044272|FG000|Overall Study|Lack of Efficacy|0|||
145598635|NCT02691182|525044273|FG001|Overall Study|Lack of Efficacy|0|||
145598636|NCT02691182|525044274|FG002|Overall Study|Lack of Efficacy|0|||
145598637|NCT02691182|525044275|FG003|Overall Study|Lack of Efficacy|4|||
145598638|NCT02691182|525044272|FG000|Overall Study|Protocol Violation|2|||
145598639|NCT02691182|525044273|FG001|Overall Study|Protocol Violation|6|||
145598640|NCT02691182|525044274|FG002|Overall Study|Protocol Violation|6|||
145598641|NCT02691182|525044275|FG003|Overall Study|Protocol Violation|8|||
145598642|NCT02691182|525044272|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
145598643|NCT02691182|525044273|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
145598644|NCT02691182|525044274|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
145598645|NCT02691182|525044275|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
145598646|NCT02691182|525044272|FG000|Overall Study|Missing|0|||
145598647|NCT02691182|525044273|FG001|Overall Study|Missing|5|||
145598648|NCT02691182|525044274|FG002|Overall Study|Missing|1|||
145598649|NCT02691182|525044275|FG003|Overall Study|Missing|5|||
145598650|NCT05906368|525044278|FG000|Overall Study|Withdrawal by Subject|1|||
145598651|NCT05906368|525044279|FG001|Overall Study|Withdrawal by Subject|1|||
145598652|NCT05906368|525044278|FG000|Overall Study|Ineligibility criteria identified|2|||
145598653|NCT05906368|525044279|FG001|Overall Study|Ineligibility criteria identified|0|||
145598654|NCT04493931|525044280|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
145598655|NCT04493931|525044281|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598656|NCT04493931|525044282|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598657|NCT04493931|525044283|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598658|NCT04493931|525044284|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598659|NCT04493931|525044285|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598660|NCT04493931|525044286|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
145598661|NCT04493931|525044280|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145598662|NCT04493931|525044281|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
145598663|NCT04493931|525044282|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145598664|NCT04493931|525044283|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145598665|NCT04493931|525044284|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145598666|NCT04493931|525044285|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145598667|NCT04493931|525044286|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
145466957|NCT04030962|524563120|FG006|Stage 2|Lost to Follow-up|0|||
145466958|NCT04030962|524563121|FG007|Stage 2|Lost to Follow-up|0|||
145598668|NCT04493931|525044280|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145598669|NCT04493931|525044281|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
145598670|NCT04493931|525044282|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145598671|NCT04493931|525044283|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145598672|NCT04493931|525044284|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145466959|NCT04030962|524563122|FG008|Stage 2|Lost to Follow-up|1|||
145466960|NCT04030962|524563123|FG009|Stage 2|Lost to Follow-up|0|||
145466961|NCT04030962|524563124|FG010|Stage 2|Lost to Follow-up|0|||
145466962|NCT04030962|524563125|FG011|Stage 2|Lost to Follow-up|0|||
145466963|NCT04030962|524563126|FG012|Stage 2|Lost to Follow-up|0|||
145466964|NCT04030962|524563114|FG000|Stage 2|Technical Problems|0|||
145598673|NCT04493931|525044285|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145598674|NCT04493931|525044286|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
145598675|NCT04493931|525044280|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598676|NCT04493931|525044281|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598677|NCT04493931|525044282|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
145598678|NCT04493931|525044283|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598679|NCT04493931|525044284|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598680|NCT04493931|525044285|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598681|NCT04493931|525044286|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
145598682|NCT03338894|525044287|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
145598683|NCT01127646|525044288|FG000|Overall Study|Entry Criteria Not Met|1|||
145598684|NCT01127646|525044289|FG001|Overall Study|Entry Criteria Not Met|0|||
145598685|NCT01127646|525044288|FG000|Overall Study|Protocol Violation|0|||
145598686|NCT01127646|525044289|FG001|Overall Study|Protocol Violation|1|||
145598687|NCT03466086|525044290|FG000|Period 1|Sponsor decision due to study timeline|1|||
145598688|NCT03466086|525044291|FG001|Period 1|Sponsor decision due to study timeline|0|||
145598689|NCT03466086|525044290|FG000|Period 1|Withdrawal by Subject|1|||
145598690|NCT03466086|525044291|FG001|Period 1|Withdrawal by Subject|0|||
145598691|NCT04721925|525044296|FG000|2-Month Assessment|Lost to Follow-up|5|||
145598692|NCT04721925|525044297|FG001|2-Month Assessment|Lost to Follow-up|3|||
145598693|NCT04721925|525044296|FG000|4-Month Assessment|Lost to Follow-up|3|||
145598694|NCT04721925|525044297|FG001|4-Month Assessment|Lost to Follow-up|6|||
145598695|NCT04570436|525044301|FG000|Overall Study|Adverse Event|0|||
145598696|NCT04570436|525044302|FG001|Overall Study|Adverse Event|0|||
145598697|NCT04570436|525044303|FG002|Overall Study|Adverse Event|1|||
145598698|NCT04570436|525044304|FG003|Overall Study|Adverse Event|0|||
145598699|NCT04570436|525044305|FG004|Overall Study|Adverse Event|0|||
145598700|NCT04570436|525044306|FG005|Overall Study|Adverse Event|0|||
145598701|NCT04570436|525044307|FG006|Overall Study|Adverse Event|0|||
145598702|NCT04570436|525044308|FG007|Overall Study|Adverse Event|0|||
145598703|NCT04570436|525044309|FG008|Overall Study|Adverse Event|0|||
145598704|NCT04570436|525044310|FG009|Overall Study|Adverse Event|0|||
145598705|NCT04570436|525044301|FG000|Overall Study|Physician Decision|1|||
145598706|NCT04570436|525044302|FG001|Overall Study|Physician Decision|0|||
145598707|NCT04570436|525044303|FG002|Overall Study|Physician Decision|0|||
145598708|NCT04570436|525044304|FG003|Overall Study|Physician Decision|0|||
145598709|NCT04570436|525044305|FG004|Overall Study|Physician Decision|0|||
145598710|NCT04570436|525044306|FG005|Overall Study|Physician Decision|0|||
145598711|NCT04570436|525044307|FG006|Overall Study|Physician Decision|0|||
145598712|NCT04570436|525044308|FG007|Overall Study|Physician Decision|0|||
145598713|NCT04570436|525044309|FG008|Overall Study|Physician Decision|0|||
145598714|NCT04570436|525044310|FG009|Overall Study|Physician Decision|0|||
145598715|NCT03002610|525044311|FG000|Overall Study|Withdrawal by Subject|6|||
145598716|NCT03002610|525044312|FG001|Overall Study|Withdrawal by Subject|25|||
145598717|NCT03002610|525044313|FG002|Overall Study|Withdrawal by Subject|13|||
145598718|NCT03802123|525044314|FG000|Overall Study|Withdrawal by Subject|3|||
145598719|NCT03802123|525044314|FG000|Overall Study|Physician Decision|1|||
145598720|NCT03802123|525044314|FG000|Overall Study|Subject moved to hospice care|1|||
145598721|NCT03802123|525044314|FG000|Overall Study|technician error|1|||
145598722|NCT03802123|525044314|FG000|Overall Study|Death|3|||
145598723|NCT00658567|525044315|FG000|Overall Study|Adverse Event|5|||
145598724|NCT00658567|525044316|FG001|Overall Study|Adverse Event|2|||
145598725|NCT00658567|525044317|FG002|Overall Study|Adverse Event|3|||
145598726|NCT00658567|525044315|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
145598727|NCT00658567|525044316|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
145598728|NCT00658567|525044317|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
145598729|NCT00658567|525044315|FG000|Overall Study|Physician Decision|0|||
145598730|NCT00658567|525044316|FG001|Overall Study|Physician Decision|1|||
145598731|NCT00658567|525044317|FG002|Overall Study|Physician Decision|0|||
145598732|NCT00658567|525044315|FG000|Overall Study|At Discretion of Sponsor|1|||
145598733|NCT00658567|525044316|FG001|Overall Study|At Discretion of Sponsor|1|||
145598734|NCT00658567|525044317|FG002|Overall Study|At Discretion of Sponsor|1|||
145598735|NCT04860518|525044318|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
145598736|NCT04860518|525044319|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
145598737|NCT04555096|525044323|FG000|Overall Study|Death|4|||
145598738|NCT04555096|525044324|FG001|Overall Study|Death|4|||
145598739|NCT04555096|525044323|FG000|Overall Study|Withdrawal by Subject|1|||
145598740|NCT04555096|525044324|FG001|Overall Study|Withdrawal by Subject|0|||
145598741|NCT04555096|525044323|FG000|Overall Study|Other|0|||
145598742|NCT04555096|525044324|FG001|Overall Study|Other|1|||
145598743|NCT03172702|525044327|FG000|Overall Study|Adverse Event|9|||
145598744|NCT03172702|525044327|FG000|Overall Study|Death|2|||
145598745|NCT03172702|525044327|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
145598746|NCT03172702|525044327|FG000|Overall Study|Withdrawal by Subject|5|||
145598747|NCT03172702|525044327|FG000|Overall Study|Other|2|||
145598748|NCT02954354|525044328|FG000|Overall Study|Adverse Event|2|||
145598749|NCT02954354|525044329|FG001|Overall Study|Adverse Event|2|||
145598750|NCT02954354|525044330|FG002|Overall Study|Adverse Event|4|||
145598751|NCT02954354|525044328|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
145598752|NCT02954354|525044329|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
145598753|NCT02954354|525044330|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
145598754|NCT02954354|525044328|FG000|Overall Study|Lack of Efficacy|0|||
145598755|NCT02954354|525044329|FG001|Overall Study|Lack of Efficacy|2|||
145598756|NCT02954354|525044330|FG002|Overall Study|Lack of Efficacy|0|||
145598757|NCT02954354|525044328|FG000|Overall Study|Withdrawal by Subject|17|||
145598758|NCT02954354|525044329|FG001|Overall Study|Withdrawal by Subject|9|||
145598759|NCT02954354|525044330|FG002|Overall Study|Withdrawal by Subject|11|||
145598760|NCT02954354|525044328|FG000|Overall Study|Lost to Follow-up|12|||
145598761|NCT02954354|525044329|FG001|Overall Study|Lost to Follow-up|5|||
145598762|NCT02954354|525044330|FG002|Overall Study|Lost to Follow-up|0|||
145598763|NCT02954354|525044328|FG000|Overall Study|Miscellaneous|2|||
145598764|NCT02954354|525044329|FG001|Overall Study|Miscellaneous|2|||
145598765|NCT02954354|525044330|FG002|Overall Study|Miscellaneous|1|||
145598766|NCT06134180|525044333|FG000|Overall Study|Lost to Follow-up|4|||
145598767|NCT04495179|525044338|FG000|Overall Study|Lost to Follow-up|0|||
145598768|NCT04495179|525044339|FG001|Overall Study|Lost to Follow-up|1|||
145598769|NCT04495179|525044338|FG000|Overall Study|Withdrawal by Subject|2|||
145598770|NCT04495179|525044339|FG001|Overall Study|Withdrawal by Subject|4|||
145598771|NCT04495179|525044338|FG000|Overall Study|Study terminated by sponsor|0|||
145598772|NCT04495179|525044339|FG001|Overall Study|Study terminated by sponsor|18|||
145598773|NCT04495179|525044338|FG000|Overall Study|Death|0|||
145598774|NCT04495179|525044339|FG001|Overall Study|Death|4|||
145598775|NCT04495179|525044338|FG000|Overall Study|Adverse Event|0|||
145598776|NCT04495179|525044339|FG001|Overall Study|Adverse Event|1|||
145598777|NCT00162370|525044340|FG000|Efficacy Population|Lost to Follow-up|51|||
145598778|NCT00569582|525044351|FG000|Overall Study|Withdrawal by Subject|5|||
145598779|NCT00569582|525044351|FG000|Overall Study|Death|2|||
145598780|NCT00569582|525044351|FG000|Overall Study|Adverse Event|7|||
145598781|NCT00569582|525044351|FG000|Overall Study|Subject was too ill to travel.|1|||
145598782|NCT00569582|525044351|FG000|Overall Study|Subject was non-compliant.|1|||
145598783|NCT04040751|525044352|FG000|Overall Study|Withdrawal by Subject|2|||
145598784|NCT04040751|525044353|FG001|Overall Study|Withdrawal by Subject|0|||
145598785|NCT04040751|525044354|FG002|Overall Study|Withdrawal by Subject|2|||
145598786|NCT04040751|525044355|FG003|Overall Study|Withdrawal by Subject|0|||
145598787|NCT04212091|525044358|FG000|Overall Study|Lost to Follow-up|0|||
145598788|NCT04212091|525044359|FG001|Overall Study|Lost to Follow-up|0|||
145598789|NCT04212091|525044360|FG002|Overall Study|Lost to Follow-up|0|||
145598790|NCT04212091|525044361|FG003|Overall Study|Lost to Follow-up|0|||
145598791|NCT04212091|525044362|FG004|Overall Study|Lost to Follow-up|1|||
145598792|NCT04212091|525044363|FG005|Overall Study|Lost to Follow-up|1|||
145598793|NCT04212091|525044358|FG000|Overall Study|Participant unable to adhere to visit|0|||
145598794|NCT04212091|525044359|FG001|Overall Study|Participant unable to adhere to visit|0|||
145598795|NCT04212091|525044360|FG002|Overall Study|Participant unable to adhere to visit|0|||
145598796|NCT04212091|525044361|FG003|Overall Study|Participant unable to adhere to visit|0|||
145598797|NCT04212091|525044362|FG004|Overall Study|Participant unable to adhere to visit|1|||
145598798|NCT04212091|525044363|FG005|Overall Study|Participant unable to adhere to visit|0|||
145598799|NCT02712905|525044364|FG000|Monotherapy|Death|2|||
145598800|NCT02712905|525044365|FG001|Monotherapy|Death|5|||
145598801|NCT02712905|525044366|FG002|Monotherapy|Death|0|||
145598802|NCT02712905|525044367|FG003|Monotherapy|Death|3|||
145598803|NCT02712905|525044368|FG004|Monotherapy|Death|15|||
145598804|NCT02712905|525044369|FG005|Monotherapy|Death|1|||
145598805|NCT02712905|525044370|FG006|Monotherapy|Death|3|||
145598806|NCT02712905|525044371|FG007|Monotherapy|Death|3|||
145598807|NCT02712905|525044372|FG008|Monotherapy|Death|0|||
145598808|NCT02712905|525044373|FG009|Monotherapy|Death|27|||
145598809|NCT02712905|525044374|FG010|Monotherapy|Death|2|||
145598810|NCT02712905|525044375|FG011|Monotherapy|Death|5|||
145598811|NCT02712905|525044376|FG012|Monotherapy|Death|0|||
145598812|NCT02712905|525044377|FG013|Monotherapy|Death|0|||
145598813|NCT02712905|525044378|FG014|Monotherapy|Death|0|||
145598814|NCT02712905|525044379|FG015|Monotherapy|Death|0|||
145598815|NCT02712905|525044380|FG016|Monotherapy|Death|0|||
145598816|NCT02712905|525044381|FG017|Monotherapy|Death|0|||
145598817|NCT02712905|525044364|FG000|Monotherapy|Lost to Follow-up|0|||
145598818|NCT02712905|525044365|FG001|Monotherapy|Lost to Follow-up|1|||
145598819|NCT02712905|525044366|FG002|Monotherapy|Lost to Follow-up|0|||
145598820|NCT02712905|525044367|FG003|Monotherapy|Lost to Follow-up|1|||
145598821|NCT02712905|525044368|FG004|Monotherapy|Lost to Follow-up|0|||
145598822|NCT02712905|525044369|FG005|Monotherapy|Lost to Follow-up|0|||
145598823|NCT02712905|525044370|FG006|Monotherapy|Lost to Follow-up|0|||
145598824|NCT02712905|525044371|FG007|Monotherapy|Lost to Follow-up|0|||
145598825|NCT02712905|525044372|FG008|Monotherapy|Lost to Follow-up|0|||
145598826|NCT02712905|525044373|FG009|Monotherapy|Lost to Follow-up|2|||
145598827|NCT02712905|525044374|FG010|Monotherapy|Lost to Follow-up|0|||
145598828|NCT02712905|525044375|FG011|Monotherapy|Lost to Follow-up|0|||
145466965|NCT04030962|524563115|FG001|Stage 2|Technical Problems|0|||
145466966|NCT04030962|524563116|FG002|Stage 2|Technical Problems|0|||
145466967|NCT04030962|524563117|FG003|Stage 2|Technical Problems|0|||
145466968|NCT04030962|524563118|FG004|Stage 2|Technical Problems|0|||
145466969|NCT04030962|524563119|FG005|Stage 2|Technical Problems|0|||
145466970|NCT04030962|524563120|FG006|Stage 2|Technical Problems|0|||
145466971|NCT04030962|524563121|FG007|Stage 2|Technical Problems|0|||
145466972|NCT04030962|524563122|FG008|Stage 2|Technical Problems|0|||
145466973|NCT04030962|524563123|FG009|Stage 2|Technical Problems|0|||
145466974|NCT04030962|524563124|FG010|Stage 2|Technical Problems|0|||
145466975|NCT04030962|524563125|FG011|Stage 2|Technical Problems|1|||
145466976|NCT04030962|524563126|FG012|Stage 2|Technical Problems|0|||
145466977|NCT04284813|524563129|FG000|Overall Study|Withdrawal by Subject|1|||
145466978|NCT03921554|524563130|FG000|Overall Study|Adverse Event|2|||
145466979|NCT03921554|524563130|FG000|Overall Study|Withdrawal by Subject|1|||
145466980|NCT03921554|524563130|FG000|Overall Study|Death|3|||
145466981|NCT00096018|524563139|FG000|Overall Study|Became Ineligible (not treated)|0|||
145466982|NCT00096018|524563140|FG001|Overall Study|Became Ineligible (not treated)|3|||
145466983|NCT00096018|524563139|FG000|Overall Study|Miscellaneous (not treated)|0|||
145466984|NCT00096018|524563140|FG001|Overall Study|Miscellaneous (not treated)|2|||
145466985|NCT00096018|524563139|FG000|Overall Study|Adverse Event|0|||
145466986|NCT00096018|524563140|FG001|Overall Study|Adverse Event|5|||
145466987|NCT00096018|524563139|FG000|Overall Study|Death|0|||
145466988|NCT00096018|524563140|FG001|Overall Study|Death|1|||
145466989|NCT00096018|524563139|FG000|Overall Study|Withdrawal by Subject|0|||
145466990|NCT00096018|524563140|FG001|Overall Study|Withdrawal by Subject|2|||
145466991|NCT00096018|524563139|FG000|Overall Study|Miscellaneous|2|||
145466992|NCT00096018|524563140|FG001|Overall Study|Miscellaneous|1|||
145466993|NCT00895661|524563151|FG000|Overall Study|Death|1|||
145466994|NCT00895661|524563151|FG000|Overall Study|reason unknown|2|||
145466995|NCT02006069|524563152|FG000|Overall Study|MPP other programming|239|||
145466996|NCT02006069|524563153|FG001|Overall Study|MPP other programming|0|||
145466997|NCT02006069|524563152|FG000|Overall Study|RV only pacing|0|||
145466998|NCT02006069|524563153|FG001|Overall Study|RV only pacing|3|||
145466999|NCT00791557|524563154|FG000|Overall Study|Adverse Event|1|||
145467000|NCT02066129|524563155|FG000|Overall Study|Lost to Follow-up|13|||
145467001|NCT02066129|524563156|FG001|Overall Study|Lost to Follow-up|12|||
145467002|NCT02066129|524563155|FG000|Overall Study|Withdrawal by Subject|7|||
145467003|NCT02066129|524563156|FG001|Overall Study|Withdrawal by Subject|10|||
145467004|NCT02066129|524563155|FG000|Overall Study|Lack of Efficacy|8|||
145467005|NCT02066129|524563156|FG001|Overall Study|Lack of Efficacy|10|||
145467006|NCT02066129|524563155|FG000|Overall Study|Physician Decision|1|||
145467007|NCT02066129|524563156|FG001|Overall Study|Physician Decision|1|||
145467008|NCT02322190|524563157|FG000|Overall Study|Death on study|1|||
145467009|NCT02322190|524563158|FG001|Overall Study|Death on study|0|||
145467010|NCT00357656|524563159|FG000|Overall Study|Other, No surgery performed|0|||
145467011|NCT00357656|524563160|FG001|Overall Study|Other, No surgery performed|3|||
145467012|NCT00316888|524563162|FG000|Overall Study|Adverse Event|4|||
145467013|NCT00316888|524563163|FG001|Overall Study|Adverse Event|5|||
145467014|NCT00316888|524563162|FG000|Overall Study|Withdrawal by Subject|2|||
145467015|NCT00316888|524563163|FG001|Overall Study|Withdrawal by Subject|2|||
145467016|NCT00316888|524563162|FG000|Overall Study|Not start protocol therapy|0|||
145467017|NCT00316888|524563163|FG001|Overall Study|Not start protocol therapy|1|||
145467018|NCT03553498|524563166|FG000|Overall Study|Missing primary outcome|1|||
145467019|NCT03553498|524563167|FG001|Overall Study|Missing primary outcome|2|||
145467020|NCT02713529|524563168|FG000|Overall Study|Withdrawal by Subject|3|||
145467021|NCT02713529|524563169|FG001|Overall Study|Withdrawal by Subject|1|||
145467022|NCT02713529|524563170|FG002|Overall Study|Withdrawal by Subject|4|||
145467023|NCT02713529|524563171|FG003|Overall Study|Withdrawal by Subject|2|||
145467024|NCT02713529|524563172|FG004|Overall Study|Withdrawal by Subject|0|||
145467025|NCT02713529|524563173|FG005|Overall Study|Withdrawal by Subject|1|||
145467026|NCT02713529|524563174|FG006|Overall Study|Withdrawal by Subject|1|||
145467027|NCT02713529|524563168|FG000|Overall Study|Lost to Follow-up|1|||
145467028|NCT02713529|524563169|FG001|Overall Study|Lost to Follow-up|0|||
145467029|NCT02713529|524563170|FG002|Overall Study|Lost to Follow-up|1|||
145467030|NCT02713529|524563171|FG003|Overall Study|Lost to Follow-up|0|||
145467031|NCT02713529|524563172|FG004|Overall Study|Lost to Follow-up|0|||
145467032|NCT02713529|524563173|FG005|Overall Study|Lost to Follow-up|0|||
145467033|NCT02713529|524563174|FG006|Overall Study|Lost to Follow-up|0|||
145467034|NCT02713529|524563168|FG000|Overall Study|Death|3|||
145467035|NCT02713529|524563169|FG001|Overall Study|Death|3|||
145467036|NCT02713529|524563170|FG002|Overall Study|Death|26|||
145467037|NCT02713529|524563171|FG003|Overall Study|Death|27|||
145467038|NCT02713529|524563172|FG004|Overall Study|Death|3|||
145467039|NCT02713529|524563173|FG005|Overall Study|Death|13|||
145467040|NCT02713529|524563174|FG006|Overall Study|Death|3|||
145467041|NCT03995355|524563177|FG000|Overall Study|Adverse Event|1|||
145467042|NCT03995355|524563178|FG001|Overall Study|Adverse Event|0|||
145467043|NCT03995355|524563177|FG000|Overall Study|Withdrawal by Subject|1|||
145467044|NCT03995355|524563178|FG001|Overall Study|Withdrawal by Subject|0|||
145598829|NCT02712905|525044376|FG012|Monotherapy|Lost to Follow-up|0|||
145598830|NCT02712905|525044377|FG013|Monotherapy|Lost to Follow-up|0|||
145598831|NCT02712905|525044378|FG014|Monotherapy|Lost to Follow-up|0|||
145598832|NCT02712905|525044379|FG015|Monotherapy|Lost to Follow-up|0|||
145598833|NCT02712905|525044380|FG016|Monotherapy|Lost to Follow-up|0|||
145598834|NCT02712905|525044381|FG017|Monotherapy|Lost to Follow-up|0|||
145598835|NCT02712905|525044364|FG000|Monotherapy|Physician Decision|1|||
145598836|NCT02712905|525044365|FG001|Monotherapy|Physician Decision|0|||
145598837|NCT02712905|525044366|FG002|Monotherapy|Physician Decision|0|||
145598838|NCT02712905|525044367|FG003|Monotherapy|Physician Decision|1|||
145598839|NCT02712905|525044368|FG004|Monotherapy|Physician Decision|0|||
145598840|NCT02712905|525044369|FG005|Monotherapy|Physician Decision|0|||
145598841|NCT02712905|525044370|FG006|Monotherapy|Physician Decision|0|||
145598842|NCT02712905|525044371|FG007|Monotherapy|Physician Decision|0|||
145598843|NCT02712905|525044372|FG008|Monotherapy|Physician Decision|0|||
145598844|NCT02712905|525044373|FG009|Monotherapy|Physician Decision|1|||
145598845|NCT02712905|525044374|FG010|Monotherapy|Physician Decision|0|||
145598846|NCT02712905|525044375|FG011|Monotherapy|Physician Decision|0|||
145598847|NCT02712905|525044376|FG012|Monotherapy|Physician Decision|0|||
145598848|NCT02712905|525044377|FG013|Monotherapy|Physician Decision|0|||
145598849|NCT02712905|525044378|FG014|Monotherapy|Physician Decision|0|||
145598850|NCT02712905|525044379|FG015|Monotherapy|Physician Decision|0|||
145598851|NCT02712905|525044380|FG016|Monotherapy|Physician Decision|0|||
145598852|NCT02712905|525044381|FG017|Monotherapy|Physician Decision|0|||
145598853|NCT02712905|525044364|FG000|Monotherapy|Study Terminated by Sponsor|0|||
145598854|NCT02712905|525044365|FG001|Monotherapy|Study Terminated by Sponsor|0|||
145598855|NCT02712905|525044366|FG002|Monotherapy|Study Terminated by Sponsor|0|||
145598856|NCT02712905|525044367|FG003|Monotherapy|Study Terminated by Sponsor|0|||
145598857|NCT02712905|525044368|FG004|Monotherapy|Study Terminated by Sponsor|1|||
145598858|NCT02712905|525044369|FG005|Monotherapy|Study Terminated by Sponsor|0|||
145598859|NCT02712905|525044370|FG006|Monotherapy|Study Terminated by Sponsor|0|||
145598860|NCT02712905|525044371|FG007|Monotherapy|Study Terminated by Sponsor|0|||
145598861|NCT02712905|525044372|FG008|Monotherapy|Study Terminated by Sponsor|0|||
145598862|NCT02712905|525044373|FG009|Monotherapy|Study Terminated by Sponsor|2|||
145598863|NCT02712905|525044374|FG010|Monotherapy|Study Terminated by Sponsor|0|||
145598864|NCT02712905|525044375|FG011|Monotherapy|Study Terminated by Sponsor|0|||
145598865|NCT02712905|525044376|FG012|Monotherapy|Study Terminated by Sponsor|0|||
145598866|NCT02712905|525044377|FG013|Monotherapy|Study Terminated by Sponsor|0|||
145598867|NCT02712905|525044378|FG014|Monotherapy|Study Terminated by Sponsor|0|||
145598868|NCT02712905|525044379|FG015|Monotherapy|Study Terminated by Sponsor|0|||
145598869|NCT02712905|525044380|FG016|Monotherapy|Study Terminated by Sponsor|0|||
145598870|NCT02712905|525044381|FG017|Monotherapy|Study Terminated by Sponsor|0|||
145598871|NCT02712905|525044364|FG000|Monotherapy|Withdrawal by Subject|0|||
145598872|NCT02712905|525044365|FG001|Monotherapy|Withdrawal by Subject|0|||
145598873|NCT02712905|525044366|FG002|Monotherapy|Withdrawal by Subject|1|||
145598874|NCT02712905|525044367|FG003|Monotherapy|Withdrawal by Subject|0|||
145598875|NCT02712905|525044368|FG004|Monotherapy|Withdrawal by Subject|2|||
145598876|NCT02712905|525044369|FG005|Monotherapy|Withdrawal by Subject|0|||
145598877|NCT02712905|525044370|FG006|Monotherapy|Withdrawal by Subject|0|||
145598878|NCT02712905|525044371|FG007|Monotherapy|Withdrawal by Subject|0|||
145598879|NCT02712905|525044372|FG008|Monotherapy|Withdrawal by Subject|0|||
145598880|NCT02712905|525044373|FG009|Monotherapy|Withdrawal by Subject|4|||
145598881|NCT02712905|525044374|FG010|Monotherapy|Withdrawal by Subject|1|||
145598882|NCT02712905|525044375|FG011|Monotherapy|Withdrawal by Subject|2|||
145598883|NCT02712905|525044376|FG012|Monotherapy|Withdrawal by Subject|0|||
145598884|NCT02712905|525044377|FG013|Monotherapy|Withdrawal by Subject|0|||
145598885|NCT02712905|525044378|FG014|Monotherapy|Withdrawal by Subject|0|||
145598886|NCT02712905|525044379|FG015|Monotherapy|Withdrawal by Subject|0|||
145598887|NCT02712905|525044380|FG016|Monotherapy|Withdrawal by Subject|0|||
145598888|NCT02712905|525044381|FG017|Monotherapy|Withdrawal by Subject|0|||
145598889|NCT02712905|525044364|FG000|Monotherapy|Started New Cancer Drug|0|||
145598890|NCT02712905|525044365|FG001|Monotherapy|Started New Cancer Drug|0|||
145598891|NCT02712905|525044366|FG002|Monotherapy|Started New Cancer Drug|0|||
145598892|NCT02712905|525044367|FG003|Monotherapy|Started New Cancer Drug|0|||
145598893|NCT02712905|525044368|FG004|Monotherapy|Started New Cancer Drug|0|||
145598894|NCT02712905|525044369|FG005|Monotherapy|Started New Cancer Drug|1|||
145598895|NCT02712905|525044370|FG006|Monotherapy|Started New Cancer Drug|0|||
145598896|NCT02712905|525044371|FG007|Monotherapy|Started New Cancer Drug|0|||
145598897|NCT02712905|525044372|FG008|Monotherapy|Started New Cancer Drug|0|||
145598898|NCT02712905|525044373|FG009|Monotherapy|Started New Cancer Drug|0|||
145598899|NCT02712905|525044374|FG010|Monotherapy|Started New Cancer Drug|0|||
145598900|NCT02712905|525044375|FG011|Monotherapy|Started New Cancer Drug|0|||
145598901|NCT02712905|525044376|FG012|Monotherapy|Started New Cancer Drug|0|||
145598902|NCT02712905|525044377|FG013|Monotherapy|Started New Cancer Drug|0|||
145598903|NCT02712905|525044378|FG014|Monotherapy|Started New Cancer Drug|0|||
145598904|NCT02712905|525044379|FG015|Monotherapy|Started New Cancer Drug|0|||
145598905|NCT02712905|525044380|FG016|Monotherapy|Started New Cancer Drug|0|||
145598906|NCT02712905|525044381|FG017|Monotherapy|Started New Cancer Drug|0|||
145467045|NCT03995355|524563177|FG000|Overall Study|Scheduling Issues|0|||
145467046|NCT03995355|524563178|FG001|Overall Study|Scheduling Issues|1|||
145467047|NCT02698371|524563183|FG000|All Participants Flow|Lost to Follow-up|3|||
145467048|NCT02698371|524563183|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
145467049|NCT02698371|524563183|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
145467050|NCT02698371|524563183|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
145467051|NCT02698371|524563183|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
145467052|NCT02698371|524563183|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
145467053|NCT02698371|524563183|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
145467054|NCT02525094|524563184|FG000|Overall Study|Lost to Follow-up|2|||
145467055|NCT02525094|524563185|FG001|Overall Study|Lost to Follow-up|1|||
145467056|NCT02525094|524563184|FG000|Overall Study|Withdrawal by Subject|5|||
145467057|NCT02525094|524563185|FG001|Overall Study|Withdrawal by Subject|6|||
145467058|NCT02525094|524563184|FG000|Overall Study|Not Treated|1|||
145467059|NCT02525094|524563185|FG001|Overall Study|Not Treated|1|||
145627189|NCT00797862|525149139|FG002|Overall Study|Lack of Efficacy|6|||
145627190|NCT00797862|525149137|FG000|Overall Study|No longer required study medication|1|||
145627191|NCT00797862|525149138|FG001|Overall Study|No longer required study medication|0|||
145627192|NCT00797862|525149139|FG002|Overall Study|No longer required study medication|0|||
145627193|NCT00797862|525149137|FG000|Overall Study|Withdrawal by Subject|14|||
145627194|NCT00797862|525149138|FG001|Overall Study|Withdrawal by Subject|7|||
145627195|NCT00797862|525149139|FG002|Overall Study|Withdrawal by Subject|7|||
145627196|NCT00797862|525149137|FG000|Overall Study|Lost to Follow-up|11|||
145627197|NCT00797862|525149138|FG001|Overall Study|Lost to Follow-up|0|||
145627198|NCT00797862|525149139|FG002|Overall Study|Lost to Follow-up|5|||
145627199|NCT00797862|525149137|FG000|Overall Study|Administrative Problem|4|||
145627200|NCT00797862|525149138|FG001|Overall Study|Administrative Problem|0|||
145627201|NCT00797862|525149139|FG002|Overall Study|Administrative Problem|0|||
145627202|NCT00797862|525149137|FG000|Overall Study|Protocol Violation|4|||
145627203|NCT00797862|525149138|FG001|Overall Study|Protocol Violation|6|||
145627204|NCT00797862|525149139|FG002|Overall Study|Protocol Violation|8|||
145627205|NCT00797862|525149137|FG000|Overall Study|Mis-randomized|3|||
145467060|NCT00969436|524563187|FG000|Overall Study|Protocol Violation|1|||
145598907|NCT02712905|525044364|FG000|Monotherapy|Adverse Event|0|||
145598908|NCT02712905|525044365|FG001|Monotherapy|Adverse Event|0|||
145598909|NCT02712905|525044366|FG002|Monotherapy|Adverse Event|0|||
145598910|NCT02712905|525044367|FG003|Monotherapy|Adverse Event|0|||
145598911|NCT02712905|525044368|FG004|Monotherapy|Adverse Event|0|||
145598912|NCT02712905|525044369|FG005|Monotherapy|Adverse Event|0|||
145598913|NCT02712905|525044370|FG006|Monotherapy|Adverse Event|0|||
145598914|NCT02712905|525044371|FG007|Monotherapy|Adverse Event|0|||
145598915|NCT02712905|525044372|FG008|Monotherapy|Adverse Event|1|||
145598916|NCT02712905|525044373|FG009|Monotherapy|Adverse Event|0|||
145598917|NCT02712905|525044374|FG010|Monotherapy|Adverse Event|0|||
145598918|NCT02712905|525044375|FG011|Monotherapy|Adverse Event|0|||
145598919|NCT02712905|525044376|FG012|Monotherapy|Adverse Event|0|||
145598920|NCT02712905|525044377|FG013|Monotherapy|Adverse Event|0|||
145598921|NCT02712905|525044378|FG014|Monotherapy|Adverse Event|0|||
145598922|NCT02712905|525044379|FG015|Monotherapy|Adverse Event|0|||
145598923|NCT02712905|525044380|FG016|Monotherapy|Adverse Event|0|||
145598924|NCT02712905|525044381|FG017|Monotherapy|Adverse Event|0|||
145598925|NCT02712905|525044364|FG000|Combination Therapy|Death|0|||
145598926|NCT02712905|525044365|FG001|Combination Therapy|Death|0|||
145598927|NCT02712905|525044366|FG002|Combination Therapy|Death|0|||
145598928|NCT02712905|525044367|FG003|Combination Therapy|Death|0|||
145598929|NCT02712905|525044368|FG004|Combination Therapy|Death|0|||
145598930|NCT02712905|525044369|FG005|Combination Therapy|Death|0|||
145598931|NCT02712905|525044370|FG006|Combination Therapy|Death|0|||
145598932|NCT02712905|525044371|FG007|Combination Therapy|Death|0|||
145598933|NCT02712905|525044372|FG008|Combination Therapy|Death|0|||
145598934|NCT02712905|525044373|FG009|Combination Therapy|Death|0|||
145598935|NCT02712905|525044374|FG010|Combination Therapy|Death|0|||
145598936|NCT02712905|525044375|FG011|Combination Therapy|Death|0|||
145598937|NCT02712905|525044376|FG012|Combination Therapy|Death|5|||
145467061|NCT00969436|524563188|FG001|Overall Study|Protocol Violation|3|||
145598938|NCT02712905|525044377|FG013|Combination Therapy|Death|6|||
145598939|NCT02712905|525044378|FG014|Combination Therapy|Death|1|||
145598940|NCT02712905|525044379|FG015|Combination Therapy|Death|3|||
145598941|NCT02712905|525044380|FG016|Combination Therapy|Death|1|||
145627206|NCT00797862|525149138|FG001|Overall Study|Mis-randomized|3|||
145627207|NCT00797862|525149139|FG002|Overall Study|Mis-randomized|1|||
145467062|NCT00969436|524563189|FG002|Overall Study|Protocol Violation|0|||
145467063|NCT00969436|524563187|FG000|Overall Study|Migrated/moved from study area|12|||
145467064|NCT00969436|524563188|FG001|Overall Study|Migrated/moved from study area|10|||
145598942|NCT02712905|525044381|FG017|Combination Therapy|Death|3|||
145598943|NCT02712905|525044364|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
145598944|NCT02712905|525044365|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
145598945|NCT02712905|525044366|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
145627208|NCT05074498|525149142|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
145627209|NCT05074498|525149143|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
145598946|NCT02712905|525044367|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
145598947|NCT02712905|525044368|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
145598948|NCT02712905|525044369|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
145598949|NCT02712905|525044370|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
145598950|NCT02712905|525044371|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
145598951|NCT02712905|525044372|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
145598952|NCT02712905|525044373|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
145598953|NCT02712905|525044374|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
145598954|NCT02712905|525044375|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
145598955|NCT02712905|525044376|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
145598956|NCT02712905|525044377|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
145598957|NCT02712905|525044378|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
145598958|NCT02712905|525044379|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
145598959|NCT02712905|525044380|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
145598960|NCT02712905|525044381|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
145598961|NCT02712905|525044364|FG000|Combination Therapy|Withdrawal by Subject|0|||
145598962|NCT02712905|525044365|FG001|Combination Therapy|Withdrawal by Subject|0|||
145598963|NCT02712905|525044366|FG002|Combination Therapy|Withdrawal by Subject|0|||
145598964|NCT02712905|525044367|FG003|Combination Therapy|Withdrawal by Subject|0|||
145598965|NCT02712905|525044368|FG004|Combination Therapy|Withdrawal by Subject|0|||
145598966|NCT02712905|525044369|FG005|Combination Therapy|Withdrawal by Subject|0|||
145598967|NCT02712905|525044370|FG006|Combination Therapy|Withdrawal by Subject|0|||
145598968|NCT02712905|525044371|FG007|Combination Therapy|Withdrawal by Subject|0|||
145598969|NCT02712905|525044372|FG008|Combination Therapy|Withdrawal by Subject|0|||
145598970|NCT02712905|525044373|FG009|Combination Therapy|Withdrawal by Subject|0|||
145598971|NCT02712905|525044374|FG010|Combination Therapy|Withdrawal by Subject|0|||
145598972|NCT02712905|525044375|FG011|Combination Therapy|Withdrawal by Subject|0|||
145598973|NCT02712905|525044376|FG012|Combination Therapy|Withdrawal by Subject|0|||
145598974|NCT02712905|525044377|FG013|Combination Therapy|Withdrawal by Subject|0|||
145598975|NCT02712905|525044378|FG014|Combination Therapy|Withdrawal by Subject|0|||
145598976|NCT02712905|525044379|FG015|Combination Therapy|Withdrawal by Subject|1|||
145598977|NCT02712905|525044380|FG016|Combination Therapy|Withdrawal by Subject|0|||
145598978|NCT02712905|525044381|FG017|Combination Therapy|Withdrawal by Subject|2|||
145598979|NCT02712905|525044364|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598980|NCT02712905|525044365|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598981|NCT02712905|525044366|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598982|NCT02712905|525044367|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598983|NCT02712905|525044368|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598984|NCT02712905|525044369|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598985|NCT02712905|525044370|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598986|NCT02712905|525044371|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598987|NCT02712905|525044372|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598988|NCT02712905|525044373|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598989|NCT02712905|525044374|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598990|NCT02712905|525044375|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598991|NCT02712905|525044376|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598992|NCT02712905|525044377|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598993|NCT02712905|525044378|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598994|NCT02712905|525044379|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
145598995|NCT02712905|525044380|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598996|NCT02712905|525044381|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
145598997|NCT03721965|525044382|FG000|Overall Study|Death|1|||
145598998|NCT03721965|525044382|FG000|Overall Study|Study Terminated by Sponsor|1|||
145598999|NCT02612311|525044383|FG000|Overall Study|Adverse Event|16|||
145599000|NCT02612311|525044384|FG001|Overall Study|Adverse Event|12|||
145599001|NCT02612311|525044385|FG002|Overall Study|Adverse Event|7|||
145599002|NCT02612311|525044386|FG003|Overall Study|Adverse Event|13|||
145599003|NCT02612311|525044383|FG000|Overall Study|Death|29|||
145599004|NCT02612311|525044384|FG001|Overall Study|Death|10|||
145599005|NCT02612311|525044385|FG002|Overall Study|Death|11|||
145599006|NCT02612311|525044386|FG003|Overall Study|Death|11|||
145599007|NCT02612311|525044383|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
145599008|NCT02612311|525044384|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
145599009|NCT02612311|525044385|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
145599010|NCT02612311|525044386|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
145599011|NCT02612311|525044383|FG000|Overall Study|Investigator's Decision|11|||
145599012|NCT02612311|525044384|FG001|Overall Study|Investigator's Decision|15|||
145599013|NCT02612311|525044385|FG002|Overall Study|Investigator's Decision|6|||
145599014|NCT02612311|525044386|FG003|Overall Study|Investigator's Decision|6|||
145599015|NCT02612311|525044383|FG000|Overall Study|Lack of Efficacy|0|||
145599016|NCT02612311|525044384|FG001|Overall Study|Lack of Efficacy|0|||
145599017|NCT02612311|525044385|FG002|Overall Study|Lack of Efficacy|1|||
145599018|NCT02612311|525044386|FG003|Overall Study|Lack of Efficacy|1|||
145599019|NCT02612311|525044383|FG000|Overall Study|Lost to Follow-up|2|||
145599020|NCT02612311|525044384|FG001|Overall Study|Lost to Follow-up|2|||
145599021|NCT02612311|525044385|FG002|Overall Study|Lost to Follow-up|1|||
145599022|NCT02612311|525044386|FG003|Overall Study|Lost to Follow-up|2|||
145599023|NCT02612311|525044383|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
145599024|NCT02612311|525044384|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
145599025|NCT02612311|525044385|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
145599026|NCT02612311|525044386|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
145599027|NCT02612311|525044383|FG000|Overall Study|Site Terminated by Sponsor|29|||
145599028|NCT02612311|525044384|FG001|Overall Study|Site Terminated by Sponsor|12|||
145599029|NCT02612311|525044385|FG002|Overall Study|Site Terminated by Sponsor|13|||
145599030|NCT02612311|525044386|FG003|Overall Study|Site Terminated by Sponsor|5|||
145599031|NCT02612311|525044383|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
145599032|NCT02612311|525044384|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
145599033|NCT02612311|525044385|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
145599034|NCT02612311|525044386|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
145599035|NCT02612311|525044383|FG000|Overall Study|Reason Not Specified|3|||
145599036|NCT02612311|525044384|FG001|Overall Study|Reason Not Specified|7|||
145599037|NCT02612311|525044385|FG002|Overall Study|Reason Not Specified|4|||
145599038|NCT02612311|525044386|FG003|Overall Study|Reason Not Specified|5|||
145599039|NCT02612311|525044383|FG000|Overall Study|Unknown/Missing|10|||
145599040|NCT02612311|525044384|FG001|Overall Study|Unknown/Missing|13|||
145599041|NCT02612311|525044385|FG002|Overall Study|Unknown/Missing|4|||
145599042|NCT02612311|525044386|FG003|Overall Study|Unknown/Missing|0|||
145599043|NCT02612311|525044383|FG000|Overall Study|Non-Compliance with Study|1|||
145599044|NCT02612311|525044384|FG001|Overall Study|Non-Compliance with Study|0|||
145599045|NCT02612311|525044385|FG002|Overall Study|Non-Compliance with Study|0|||
145599046|NCT02612311|525044386|FG003|Overall Study|Non-Compliance with Study|0|||
145599047|NCT04085328|525044387|FG000|Overall Study|Witihdrew Consent|16|||
145599048|NCT04085328|525044388|FG001|Overall Study|Witihdrew Consent|16|||
145599049|NCT04085328|525044387|FG000|Overall Study|Adverse Event|8|||
145599050|NCT04085328|525044388|FG001|Overall Study|Adverse Event|7|||
145599051|NCT04085328|525044387|FG000|Overall Study|Lost to Follow-up|7|||
145599052|NCT04085328|525044388|FG001|Overall Study|Lost to Follow-up|2|||
145599053|NCT04085328|525044387|FG000|Overall Study|Physician Decision|0|||
145599054|NCT04085328|525044388|FG001|Overall Study|Physician Decision|1|||
145599055|NCT04085328|525044387|FG000|Overall Study|Pregnancy|0|||
145599056|NCT04085328|525044388|FG001|Overall Study|Pregnancy|1|||
145599057|NCT04085328|525044387|FG000|Overall Study|Reasons Related to COVID-19|5|||
145599058|NCT04085328|525044388|FG001|Overall Study|Reasons Related to COVID-19|8|||
145599059|NCT04085328|525044387|FG000|Overall Study|Did not meet inclusion criteria|1|||
145599060|NCT04085328|525044388|FG001|Overall Study|Did not meet inclusion criteria|1|||
145599061|NCT04085328|525044387|FG000|Overall Study|Early termination|1|||
145599062|NCT04085328|525044388|FG001|Overall Study|Early termination|0|||
145599063|NCT02454101|525044389|FG000|Overall Study|Adverse Event|2|||
145599064|NCT02454101|525044390|FG001|Overall Study|Adverse Event|3|||
145599065|NCT02454101|525044389|FG000|Overall Study|Lost to Follow-up|3|||
145599066|NCT02454101|525044390|FG001|Overall Study|Lost to Follow-up|4|||
145599067|NCT00313820|525044398|FG000|Assigned to Treatment|Other|1|||
145599068|NCT00313820|525044399|FG001|Assigned to Treatment|Other|0|||
145599069|NCT00313820|525044398|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
145599070|NCT00313820|525044399|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
145599071|NCT00313820|525044398|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
145599072|NCT00313820|525044399|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
145599073|NCT00313820|525044398|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
145599074|NCT00313820|525044399|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
145599075|NCT00313820|525044398|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
145599076|NCT00313820|525044399|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
145599077|NCT00313820|525044398|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
145599078|NCT00313820|525044399|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
145599079|NCT00686881|525044400|FG000|Overall Study|Withdrawal by Subject|11|||
145599080|NCT00686881|525044401|FG001|Overall Study|Withdrawal by Subject|18|||
145599081|NCT00686881|525044400|FG000|Overall Study|Lost to Follow-up|0|||
145599082|NCT00686881|525044401|FG001|Overall Study|Lost to Follow-up|1|||
145599083|NCT00686881|525044400|FG000|Overall Study|Treatment-related adverse event|10|||
145599084|NCT00686881|525044401|FG001|Overall Study|Treatment-related adverse event|9|||
145467065|NCT00969436|524563189|FG002|Overall Study|Migrated/moved from study area|2|||
145467066|NCT00969436|524563187|FG000|Overall Study|Father - serious health problem|0|||
145467067|NCT00969436|524563188|FG001|Overall Study|Father - serious health problem|0|||
145467068|NCT00969436|524563189|FG002|Overall Study|Father - serious health problem|1|||
145467069|NCT00969436|524563187|FG000|Overall Study|Parents personal problem|0|||
145467070|NCT00969436|524563188|FG001|Overall Study|Parents personal problem|0|||
145467071|NCT00969436|524563189|FG002|Overall Study|Parents personal problem|1|||
145467072|NCT00969436|524563187|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
145467073|NCT00969436|524563188|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
145467074|NCT00969436|524563189|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
145467075|NCT00969436|524563187|FG000|Overall Study|Withdrawal by Subject|3|||
145467076|NCT00969436|524563188|FG001|Overall Study|Withdrawal by Subject|0|||
145467077|NCT00969436|524563189|FG002|Overall Study|Withdrawal by Subject|2|||
145467078|NCT00969436|524563187|FG000|Overall Study|Lost to Follow-up|8|||
145467079|NCT00969436|524563188|FG001|Overall Study|Lost to Follow-up|8|||
145467080|NCT00969436|524563189|FG002|Overall Study|Lost to Follow-up|5|||
145467081|NCT00831701|524563193|FG000|Overall Study|Withdrawal by Subject|2|||
145467082|NCT00831701|524563194|FG001|Overall Study|Withdrawal by Subject|0|||
145467083|NCT00831701|524563193|FG000|Overall Study|Stone expulsion before first medication|2|||
145467084|NCT00831701|524563194|FG001|Overall Study|Stone expulsion before first medication|2|||
145467085|NCT00831701|524563193|FG000|Overall Study|Lost to Follow-up|1|||
145467086|NCT00831701|524563194|FG001|Overall Study|Lost to Follow-up|3|||
145467087|NCT02117349|524563195|FG000|Overall Study|Withdrawal by Subject|1|||
145467088|NCT02117349|524563196|FG001|Overall Study|Withdrawal by Subject|0|||
145467089|NCT02117349|524563195|FG000|Overall Study|Lost to Follow-up|1|||
145467090|NCT02117349|524563196|FG001|Overall Study|Lost to Follow-up|1|||
145467091|NCT02117349|524563195|FG000|Overall Study|Death|1|||
145467092|NCT02117349|524563196|FG001|Overall Study|Death|0|||
145467093|NCT01440881|524563197|FG000|Overall Study|Death|0|||
145467094|NCT01440881|524563198|FG001|Overall Study|Death|1|||
145467095|NCT02535416|524563201|FG000|Overall Study|Family bereavement overseas|1|||
145467096|NCT02535416|524563202|FG001|Overall Study|Family bereavement overseas|0|||
145467097|NCT02535416|524563203|FG002|Overall Study|Family bereavement overseas|0|||
145467098|NCT02535416|524563204|FG003|Overall Study|Family bereavement overseas|0|||
145467099|NCT02535416|524563205|FG004|Overall Study|Family bereavement overseas|0|||
145467100|NCT02535416|524563206|FG005|Overall Study|Family bereavement overseas|0|||
145467101|NCT02535416|524563207|FG006|Overall Study|Family bereavement overseas|0|||
145467102|NCT02535416|524563208|FG007|Overall Study|Family bereavement overseas|0|||
145467103|NCT02535416|524563209|FG008|Overall Study|Family bereavement overseas|0|||
145467104|NCT01977690|524563210|FG000|Overall Study|Withdrawal by Subject|0|||
145467105|NCT01977690|524563211|FG001|Overall Study|Withdrawal by Subject|4|||
145467106|NCT02739321|524563214|FG000|Overall Study|Lack of Efficacy|1|||
145467107|NCT02739321|524563215|FG001|Overall Study|Lack of Efficacy|1|||
145467108|NCT02739321|524563214|FG000|Overall Study|Lost to Follow-up|1|||
145467109|NCT02739321|524563215|FG001|Overall Study|Lost to Follow-up|1|||
145467110|NCT02739321|524563214|FG000|Overall Study|Withdrawal by Subject|1|||
145467111|NCT02739321|524563215|FG001|Overall Study|Withdrawal by Subject|2|||
145467112|NCT02440789|524563218|FG000|Overall Study|Withdrawal by Subject|3|||
145467113|NCT02440789|524563218|FG000|Overall Study|Not willing to adhere to reqs|1|||
145467114|NCT03172130|524564439|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
145467115|NCT03172130|524564440|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
145467116|NCT01350115|524564444|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
145467117|NCT01350115|524564445|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
145467118|NCT01350115|524564444|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
145467119|NCT01350115|524564445|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
145467120|NCT01350115|524564444|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
145467121|NCT01350115|524564445|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
145467122|NCT02769962|524564452|FG000|Overall Study|Physician Decision|0|||
145467123|NCT02769962|524564453|FG001|Overall Study|Physician Decision|0|||
145599085|NCT00686881|525044400|FG000|Overall Study|Met discontinuation criteria|5|||
145599086|NCT00686881|525044401|FG001|Overall Study|Met discontinuation criteria|0|||
145599087|NCT00686881|525044400|FG000|Overall Study|Onset of malignant tumor|11|||
145599088|NCT00686881|525044401|FG001|Overall Study|Onset of malignant tumor|11|||
145599089|NCT00686881|525044400|FG000|Overall Study|Lack of Efficacy|4|||
145467124|NCT02769962|524564454|FG002|Overall Study|Physician Decision|0|||
145467125|NCT02769962|524564455|FG003|Overall Study|Physician Decision|0|||
145467126|NCT02769962|524564456|FG004|Overall Study|Physician Decision|0|||
145467127|NCT02769962|524564457|FG005|Overall Study|Physician Decision|1|||
145467128|NCT02769962|524564458|FG006|Overall Study|Physician Decision|0|||
145467129|NCT02769962|524564459|FG007|Overall Study|Physician Decision|1|||
145467130|NCT02769962|524564452|FG000|Overall Study|Refused further treatment|0|||
145467131|NCT02769962|524564453|FG001|Overall Study|Refused further treatment|0|||
145467132|NCT02769962|524564454|FG002|Overall Study|Refused further treatment|0|||
145467133|NCT02769962|524564455|FG003|Overall Study|Refused further treatment|0|||
145467134|NCT02769962|524564456|FG004|Overall Study|Refused further treatment|0|||
145467135|NCT02769962|524564457|FG005|Overall Study|Refused further treatment|1|||
145467136|NCT02769962|524564458|FG006|Overall Study|Refused further treatment|1|||
145467137|NCT02769962|524564459|FG007|Overall Study|Refused further treatment|0|||
145467138|NCT05565937|524564460|FG000|Overall Study|Adverse Event|0|||
145467139|NCT05565937|524564461|FG001|Overall Study|Adverse Event|1|||
145467140|NCT05565937|524564460|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
145467141|NCT05565937|524564461|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
145467142|NCT05565937|524564460|FG000|Overall Study|Lost to Follow-up|2|||
145467143|NCT05565937|524564461|FG001|Overall Study|Lost to Follow-up|0|||
145467144|NCT05565937|524564460|FG000|Overall Study|Pregnancy|0|||
145467145|NCT05565937|524564461|FG001|Overall Study|Pregnancy|2|||
145467146|NCT05565937|524564460|FG000|Overall Study|Anisometropia|0|||
145467147|NCT05565937|524564461|FG001|Overall Study|Anisometropia|1|||
145467148|NCT04544683|524564462|FG000|Overall Study|Lost to Follow-up|2|||
145467149|NCT04544683|524564462|FG000|Overall Study|Underwent cervical spine surgery|6|||
145467150|NCT00151372|524564463|FG000|Overall Study|Death|12|||
145467151|NCT00151372|524564464|FG001|Overall Study|Death|11|||
145467152|NCT00151372|524564463|FG000|Overall Study|Lost to Follow-up|5|||
145467153|NCT00151372|524564464|FG001|Overall Study|Lost to Follow-up|5|||
145467154|NCT00151372|524564463|FG000|Overall Study|Too sick medically to continue|5|||
145467155|NCT00151372|524564464|FG001|Overall Study|Too sick medically to continue|6|||
145467156|NCT00151372|524564463|FG000|Overall Study|Withdrawal by Subject|7|||
145467157|NCT00151372|524564464|FG001|Overall Study|Withdrawal by Subject|7|||
145467158|NCT02783170|524564467|FG000|Overall Study|Randomized but not Vaccinated|1|||
145467159|NCT02783170|524564468|FG001|Overall Study|Randomized but not Vaccinated|0|||
145467160|NCT00541346|524564469|FG000|Follow-up|Adverse Event|1|||
145467161|NCT02008773|524564472|FG000|Overall Study|Adverse Event|3|||
145467162|NCT02008773|524564473|FG001|Overall Study|Adverse Event|3|||
145467163|NCT02008773|524564474|FG002|Overall Study|Adverse Event|1|||
145467164|NCT02008773|524564475|FG003|Overall Study|Adverse Event|2|||
145467165|NCT02008773|524564472|FG000|Overall Study|Medication Non-compliance|2|||
145467166|NCT02008773|524564473|FG001|Overall Study|Medication Non-compliance|1|||
145467167|NCT02008773|524564474|FG002|Overall Study|Medication Non-compliance|3|||
145467168|NCT02008773|524564475|FG003|Overall Study|Medication Non-compliance|2|||
145467169|NCT02008773|524564472|FG000|Overall Study|Withdrawal by Subject|8|||
145467170|NCT02008773|524564473|FG001|Overall Study|Withdrawal by Subject|4|||
145467171|NCT02008773|524564474|FG002|Overall Study|Withdrawal by Subject|7|||
145467172|NCT02008773|524564475|FG003|Overall Study|Withdrawal by Subject|6|||
145467173|NCT02008773|524564472|FG000|Overall Study|Lost to Follow-up|0|||
145467174|NCT02008773|524564473|FG001|Overall Study|Lost to Follow-up|1|||
145467175|NCT02008773|524564474|FG002|Overall Study|Lost to Follow-up|3|||
145467176|NCT02008773|524564475|FG003|Overall Study|Lost to Follow-up|2|||
145467177|NCT04732949|524564476|FG000|Overall Study|Withdrawal by Subject|23|||
145467178|NCT04732949|524564477|FG001|Overall Study|Withdrawal by Subject|27|||
145467179|NCT04732949|524564476|FG000|Overall Study|Protocol Violation|0|||
145467180|NCT04732949|524564477|FG001|Overall Study|Protocol Violation|1|||
145467181|NCT04732949|524564476|FG000|Overall Study|Non-compliance|0|||
145467182|NCT04732949|524564477|FG001|Overall Study|Non-compliance|2|||
145467183|NCT04732949|524564476|FG000|Overall Study|Physician Decision|2|||
145467184|NCT04732949|524564477|FG001|Overall Study|Physician Decision|1|||
145467185|NCT04732949|524564476|FG000|Overall Study|Serious adverse event (Fatal)|16|||
145467186|NCT04732949|524564477|FG001|Overall Study|Serious adverse event (Fatal)|18|||
145467187|NCT04732949|524564476|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
145467188|NCT04732949|524564477|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
145467189|NCT04732949|524564476|FG000|Overall Study|Non-serious adverse event|1|||
145467190|NCT04732949|524564477|FG001|Overall Study|Non-serious adverse event|3|||
145467191|NCT04732949|524564476|FG000|Overall Study|Lost to Follow-up|26|||
145467192|NCT04732949|524564477|FG001|Overall Study|Lost to Follow-up|27|||
145467193|NCT04732949|524564476|FG000|Overall Study|Other|6|||
145467194|NCT04732949|524564477|FG001|Overall Study|Other|3|||
145599090|NCT00686881|525044401|FG001|Overall Study|Lack of Efficacy|3|||
145599091|NCT00686881|525044400|FG000|Overall Study|Physician Decision|1|||
145599092|NCT00686881|525044401|FG001|Overall Study|Physician Decision|0|||
145467195|NCT01806064|524564478|FG000|Overall Study|Randomized Not Enrolled|0|||
145467196|NCT01806064|524564479|FG001|Overall Study|Randomized Not Enrolled|0|||
145467197|NCT01806064|524564480|FG002|Overall Study|Randomized Not Enrolled|0|||
145599093|NCT00686881|525044400|FG000|Overall Study|Circumstances of site|1|||
145599094|NCT00686881|525044401|FG001|Overall Study|Circumstances of site|1|||
145599095|NCT00686881|525044400|FG000|Overall Study|Did not meet protocol eligibility|1|||
145467198|NCT01806064|524564481|FG003|Overall Study|Randomized Not Enrolled|1|||
145599096|NCT00686881|525044401|FG001|Overall Study|Did not meet protocol eligibility|0|||
145599097|NCT00686881|525044400|FG000|Overall Study|Irregular visits|1|||
145599098|NCT00686881|525044401|FG001|Overall Study|Irregular visits|0|||
145467199|NCT01806064|524564482|FG004|Overall Study|Randomized Not Enrolled|2|||
145467200|NCT01286077|524564485|FG000|Overall Study|Adverse Event|2|||
145467201|NCT01286077|524564486|FG001|Overall Study|Adverse Event|0|||
145467202|NCT01286077|524564485|FG000|Overall Study|Death|1|||
145599099|NCT00686881|525044400|FG000|Overall Study|Study discontinuation|35|||
145599100|NCT00686881|525044401|FG001|Overall Study|Study discontinuation|32|||
145599101|NCT00686881|525044400|FG000|Overall Study|Never received study drug|2|||
145599102|NCT00686881|525044401|FG001|Overall Study|Never received study drug|6|||
145599103|NCT02925676|525044403|FG000|Overall Study|Withdrawal by Subject|1|||
145599104|NCT03260868|525044407|FG000|Overall Study|Poor Compliance to Protocol|0|||
145599105|NCT03260868|525044408|FG001|Overall Study|Poor Compliance to Protocol|2|||
145599106|NCT03260868|525044407|FG000|Overall Study|Study Terminated By Sponsor|2|||
145599107|NCT03260868|525044408|FG001|Overall Study|Study Terminated By Sponsor|1|||
145599108|NCT03260868|525044407|FG000|Overall Study|Other than specified above|1|||
145599109|NCT03260868|525044408|FG001|Overall Study|Other than specified above|0|||
145599110|NCT01169675|525044411|FG000|Overall Study|Progressive disease|13|||
145599111|NCT01169675|525044412|FG001|Overall Study|Progressive disease|2|||
145599112|NCT01169675|525044413|FG002|Overall Study|Progressive disease|5|||
145599113|NCT01169675|525044414|FG003|Overall Study|Progressive disease|15|||
145599114|NCT01169675|525044415|FG004|Overall Study|Progressive disease|1|||
145599115|NCT01169675|525044411|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
145599116|NCT01169675|525044412|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145599117|NCT01169675|525044413|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145599118|NCT01169675|525044414|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145599119|NCT01169675|525044415|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145599120|NCT01169675|525044411|FG000|Overall Study|Adverse Event|5|||
145599121|NCT01169675|525044412|FG001|Overall Study|Adverse Event|1|||
145599122|NCT01169675|525044413|FG002|Overall Study|Adverse Event|2|||
145599123|NCT01169675|525044414|FG003|Overall Study|Adverse Event|0|||
145599124|NCT01169675|525044415|FG004|Overall Study|Adverse Event|0|||
145599125|NCT01169675|525044411|FG000|Overall Study|Withdrawal by Subject|1|||
145599126|NCT01169675|525044412|FG001|Overall Study|Withdrawal by Subject|0|||
145599127|NCT01169675|525044413|FG002|Overall Study|Withdrawal by Subject|0|||
145599128|NCT01169675|525044414|FG003|Overall Study|Withdrawal by Subject|1|||
145599129|NCT01169675|525044415|FG004|Overall Study|Withdrawal by Subject|2|||
145599130|NCT01169675|525044411|FG000|Overall Study|Other Reason Not Defined Above|0|||
145599131|NCT01169675|525044412|FG001|Overall Study|Other Reason Not Defined Above|0|||
145599132|NCT01169675|525044413|FG002|Overall Study|Other Reason Not Defined Above|0|||
145599133|NCT01169675|525044414|FG003|Overall Study|Other Reason Not Defined Above|1|||
145599134|NCT01169675|525044415|FG004|Overall Study|Other Reason Not Defined Above|1|||
145599135|NCT02816138|525044418|FG000|Overall Study|Adverse Event|1|||
145599136|NCT02355028|525044419|FG000|Overall Study|Adverse Event|2|||
145599137|NCT02355028|525044420|FG001|Overall Study|Adverse Event|0|||
145599138|NCT02355028|525044419|FG000|Overall Study|Withdrawal by Subject|1|||
145599139|NCT02355028|525044420|FG001|Overall Study|Withdrawal by Subject|1|||
145599140|NCT02355028|525044419|FG000|Overall Study|Deemed ineligible after randomization|8|||
145599141|NCT02355028|525044420|FG001|Overall Study|Deemed ineligible after randomization|4|||
145599142|NCT04102579|525044421|FG000|Overall Study|Withdrawal by Subject|3|||
145599143|NCT04102579|525044422|FG001|Overall Study|Withdrawal by Subject|4|||
145599144|NCT04102579|525044421|FG000|Overall Study|Lost to Follow-up|0|||
145599145|NCT04102579|525044422|FG001|Overall Study|Lost to Follow-up|1|||
145599146|NCT04102579|525044421|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
145599147|NCT04102579|525044422|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
145599148|NCT04102579|525044421|FG000|Overall Study|Other than Specified|1|||
145599149|NCT04102579|525044422|FG001|Overall Study|Other than Specified|0|||
145599150|NCT04102579|525044421|FG000|Overall Study|Not Dosed with Study Drug|0|||
145599151|NCT04102579|525044422|FG001|Overall Study|Not Dosed with Study Drug|1|||
145599152|NCT05899686|525044423|FG000|Overall Study|Protocol Violation|1|||
145599153|NCT02170025|525044424|FG000|Overall Study|Adverse Event|2|||
145599154|NCT02170025|525044425|FG001|Overall Study|Adverse Event|0|||
145599155|NCT00572195|525044426|FG000|Overall Study|Withdrawal by Subject|50|||
145599156|NCT00572195|525044426|FG000|Overall Study|Death|9|||
145599157|NCT00572195|525044426|FG000|Overall Study|Adverse Event|4|||
145599158|NCT00572195|525044426|FG000|Overall Study|Lost to Follow-up|5|||
145599159|NCT01525602|525044427|FG000|Overall Study|Adverse Event|1|||
145599160|NCT01525602|525044428|FG001|Overall Study|Adverse Event|0|||
145599161|NCT01525602|525044429|FG002|Overall Study|Adverse Event|1|||
145599162|NCT01525602|525044430|FG003|Overall Study|Adverse Event|1|||
145467203|NCT01286077|524564486|FG001|Overall Study|Death|0|||
145599163|NCT01525602|525044431|FG004|Overall Study|Adverse Event|3|||
145599164|NCT01525602|525044432|FG005|Overall Study|Adverse Event|3|||
145599165|NCT01525602|525044433|FG006|Overall Study|Adverse Event|0|||
145599166|NCT01525602|525044434|FG007|Overall Study|Adverse Event|1|||
145599167|NCT01525602|525044427|FG000|Overall Study|Disease progression|6|||
145599168|NCT01525602|525044428|FG001|Overall Study|Disease progression|3|||
145599169|NCT01525602|525044429|FG002|Overall Study|Disease progression|2|||
145599170|NCT01525602|525044430|FG003|Overall Study|Disease progression|5|||
145599171|NCT01525602|525044431|FG004|Overall Study|Disease progression|22|||
145599172|NCT01525602|525044432|FG005|Overall Study|Disease progression|2|||
145599173|NCT01525602|525044433|FG006|Overall Study|Disease progression|3|||
145599174|NCT01525602|525044434|FG007|Overall Study|Disease progression|3|||
145599175|NCT01525602|525044427|FG000|Overall Study|Clinical progression|2|||
145599176|NCT01525602|525044428|FG001|Overall Study|Clinical progression|0|||
145599177|NCT01525602|525044429|FG002|Overall Study|Clinical progression|0|||
145599178|NCT01525602|525044430|FG003|Overall Study|Clinical progression|0|||
145599179|NCT01525602|525044431|FG004|Overall Study|Clinical progression|0|||
145599180|NCT01525602|525044432|FG005|Overall Study|Clinical progression|0|||
145599181|NCT01525602|525044433|FG006|Overall Study|Clinical progression|1|||
145599182|NCT01525602|525044434|FG007|Overall Study|Clinical progression|1|||
145599183|NCT01525602|525044427|FG000|Overall Study|Non-compliance|0|||
145599184|NCT01525602|525044428|FG001|Overall Study|Non-compliance|0|||
145599185|NCT01525602|525044429|FG002|Overall Study|Non-compliance|0|||
145599186|NCT01525602|525044430|FG003|Overall Study|Non-compliance|0|||
145599187|NCT01525602|525044431|FG004|Overall Study|Non-compliance|1|||
145599188|NCT01525602|525044432|FG005|Overall Study|Non-compliance|0|||
145599189|NCT01525602|525044433|FG006|Overall Study|Non-compliance|0|||
145599190|NCT01525602|525044434|FG007|Overall Study|Non-compliance|0|||
145599191|NCT01525602|525044427|FG000|Overall Study|Withdrawal by Subject|0|||
145599192|NCT01525602|525044428|FG001|Overall Study|Withdrawal by Subject|0|||
145599193|NCT01525602|525044429|FG002|Overall Study|Withdrawal by Subject|0|||
145599194|NCT01525602|525044430|FG003|Overall Study|Withdrawal by Subject|0|||
145599195|NCT01525602|525044431|FG004|Overall Study|Withdrawal by Subject|3|||
145599196|NCT01525602|525044432|FG005|Overall Study|Withdrawal by Subject|1|||
145599197|NCT01525602|525044433|FG006|Overall Study|Withdrawal by Subject|0|||
145599198|NCT01525602|525044434|FG007|Overall Study|Withdrawal by Subject|1|||
145599199|NCT01525602|525044427|FG000|Overall Study|Physician Decision|0|||
145599200|NCT01525602|525044428|FG001|Overall Study|Physician Decision|0|||
145599201|NCT01525602|525044429|FG002|Overall Study|Physician Decision|0|||
145599202|NCT01525602|525044430|FG003|Overall Study|Physician Decision|0|||
145599203|NCT01525602|525044431|FG004|Overall Study|Physician Decision|3|||
145599204|NCT01525602|525044432|FG005|Overall Study|Physician Decision|0|||
145599205|NCT01525602|525044433|FG006|Overall Study|Physician Decision|1|||
145599206|NCT01525602|525044434|FG007|Overall Study|Physician Decision|0|||
145599207|NCT01525602|525044427|FG000|Overall Study|Death|0|||
145599208|NCT01525602|525044428|FG001|Overall Study|Death|0|||
145599209|NCT01525602|525044429|FG002|Overall Study|Death|0|||
145599210|NCT01525602|525044430|FG003|Overall Study|Death|0|||
145599211|NCT01525602|525044431|FG004|Overall Study|Death|1|||
145599212|NCT01525602|525044432|FG005|Overall Study|Death|1|||
145599213|NCT01525602|525044433|FG006|Overall Study|Death|0|||
145599214|NCT01525602|525044434|FG007|Overall Study|Death|0|||
145599215|NCT01525602|525044427|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599216|NCT01525602|525044428|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599217|NCT01525602|525044429|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599218|NCT01525602|525044430|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599219|NCT01525602|525044431|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599220|NCT01525602|525044432|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
145599221|NCT01525602|525044433|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
145599222|NCT01525602|525044434|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
145599223|NCT01024608|525044437|FG000|Overall Study|Adverse Event|1|||
145599224|NCT01024608|525044438|FG001|Overall Study|Adverse Event|0|||
145599225|NCT01024608|525044437|FG000|Overall Study|Withdrawal by Subject|1|||
145599226|NCT01024608|525044438|FG001|Overall Study|Withdrawal by Subject|0|||
145599227|NCT01024608|525044437|FG000|Overall Study|Lost to Follow-up|0|||
145599228|NCT01024608|525044438|FG001|Overall Study|Lost to Follow-up|1|||
145599229|NCT01024608|525044437|FG000|Overall Study|Protocol Violation|0|||
145627210|NCT05074498|525149144|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
145467204|NCT01286077|524564485|FG000|Overall Study|Protocol Violation|1|||
145467205|NCT01286077|524564486|FG001|Overall Study|Protocol Violation|1|||
145599230|NCT01024608|525044438|FG001|Overall Study|Protocol Violation|3|||
145599231|NCT01024608|525044437|FG000|Overall Study|Never received study treatment|2|||
145599232|NCT01024608|525044438|FG001|Overall Study|Never received study treatment|0|||
145599233|NCT01756352|525046107|FG000|Overall Study|moved away and lost to followup|1|||
145599234|NCT00415610|525046108|FG000|Overall Study|Death|3|||
145599235|NCT00415610|525046109|FG001|Overall Study|Death|2|||
145599236|NCT00415610|525046110|FG002|Overall Study|Death|5|||
145599237|NCT05131165|525046111|FG000|Overall Study|Death|1|||
145599238|NCT05131165|525046112|FG001|Overall Study|Death|1|||
145599239|NCT05131165|525046113|FG002|Overall Study|Death|0|||
145599240|NCT05131165|525046111|FG000|Overall Study|Lost to Follow-up|2|||
145467206|NCT01286077|524564485|FG000|Overall Study|Withdrawal by Subject|0|||
145599241|NCT05131165|525046112|FG001|Overall Study|Lost to Follow-up|2|||
145599242|NCT05131165|525046113|FG002|Overall Study|Lost to Follow-up|5|||
145467207|NCT01286077|524564486|FG001|Overall Study|Withdrawal by Subject|2|||
145599243|NCT05131165|525046111|FG000|Overall Study|Transferred out of clinic|1|||
145599244|NCT05131165|525046112|FG001|Overall Study|Transferred out of clinic|0|||
145599245|NCT05131165|525046113|FG002|Overall Study|Transferred out of clinic|3|||
145599246|NCT05131165|525046111|FG000|Overall Study|Dropped out|1|||
145599247|NCT05131165|525046112|FG001|Overall Study|Dropped out|2|||
145467208|NCT01286077|524564485|FG000|Overall Study|Intercurrent illness|1|||
145467209|NCT01286077|524564486|FG001|Overall Study|Intercurrent illness|0|||
145467210|NCT01286077|524564485|FG000|Overall Study|Non-compliance|1|||
145467211|NCT01286077|524564486|FG001|Overall Study|Non-compliance|0|||
145467212|NCT01286077|524564485|FG000|Overall Study|The subject starts with alternative MMY|0|||
145467213|NCT01286077|524564486|FG001|Overall Study|The subject starts with alternative MMY|3|||
145467214|NCT01286077|524564485|FG000|Overall Study|Patient's decision to stop treatment|3|||
145467215|NCT01286077|524564486|FG001|Overall Study|Patient's decision to stop treatment|0|||
145467216|NCT01286077|524564485|FG000|Overall Study|Progression of disease|0|||
145467217|NCT01286077|524564486|FG001|Overall Study|Progression of disease|1|||
145467218|NCT01286077|524564485|FG000|Overall Study|refill medication not received in time|1|||
145467219|NCT01286077|524564486|FG001|Overall Study|refill medication not received in time|0|||
145467220|NCT01282294|524564489|FG000|Overall Study|Lost to Follow-up|14|||
145467221|NCT01282294|524564489|FG000|Overall Study|Screening failure|1|||
145467222|NCT01282294|524564489|FG000|Overall Study|Adverse Event|1|||
145467223|NCT01282294|524564489|FG000|Overall Study|Patient non-compliance|2|||
145467224|NCT01282294|524564489|FG000|Overall Study|Physician Decision|1|||
145467225|NCT02408523|524564490|FG000|Overall Study|Adverse Event|4|||
145467226|NCT02408523|524564491|FG001|Overall Study|Adverse Event|10|||
145467227|NCT02408523|524564490|FG000|Overall Study|Lack of Efficacy|0|||
145467228|NCT02408523|524564491|FG001|Overall Study|Lack of Efficacy|1|||
145467229|NCT02408523|524564490|FG000|Overall Study|Protocol Violation|1|||
145467230|NCT02408523|524564491|FG001|Overall Study|Protocol Violation|2|||
145467231|NCT02408523|524564490|FG000|Overall Study|Lost to Follow-up|2|||
145467232|NCT02408523|524564491|FG001|Overall Study|Lost to Follow-up|3|||
145467233|NCT02408523|524564490|FG000|Overall Study|Withdrawal by Subject|3|||
145467234|NCT02408523|524564491|FG001|Overall Study|Withdrawal by Subject|1|||
145467235|NCT02408523|524564490|FG000|Overall Study|Sponsor request|1|||
145467236|NCT02408523|524564491|FG001|Overall Study|Sponsor request|0|||
145467237|NCT02408523|524564490|FG000|Overall Study|Did not satisfy extension conditions|0|||
145467238|NCT02408523|524564491|FG001|Overall Study|Did not satisfy extension conditions|1|||
145467239|NCT04256512|524564492|FG000|Overall Study|Withdrawal by Subject|1|||
145467240|NCT03199391|524564504|FG000|Overall Study|Death|1|||
145467241|NCT03199391|524564504|FG000|Overall Study|Lost to Follow-up|3|||
145467242|NCT03199391|524564504|FG000|Overall Study|Adverse Event|2|||
145467243|NCT03199391|524564504|FG000|Overall Study|Withdrawal by Subject|10|||
145467244|NCT02212678|524564515|FG000|Overall Study|Adverse Event|1|||
145467245|NCT02337634|524564516|FG000|Overall Study|Protocol Violation|3|||
145467246|NCT02337634|524564517|FG001|Overall Study|Protocol Violation|1|||
145467247|NCT02337634|524564516|FG000|Overall Study|Lost to Follow-up|1|||
145467248|NCT02337634|524564517|FG001|Overall Study|Lost to Follow-up|0|||
145467249|NCT04068610|524564518|FG000|Overall Study|Death|4|||
145467250|NCT04068610|524564519|FG001|Overall Study|Death|8|||
145467251|NCT04068610|524564520|FG002|Overall Study|Death|13|||
145467252|NCT04068610|524564518|FG000|Overall Study|Lost to Follow-up|0|||
145467253|NCT04068610|524564519|FG001|Overall Study|Lost to Follow-up|2|||
145467254|NCT04068610|524564520|FG002|Overall Study|Lost to Follow-up|0|||
145467255|NCT04068610|524564518|FG000|Overall Study|Withdrawal by Subject|0|||
145467256|NCT04068610|524564519|FG001|Overall Study|Withdrawal by Subject|4|||
145467257|NCT04068610|524564520|FG002|Overall Study|Withdrawal by Subject|2|||
145467258|NCT04068610|524564518|FG000|Overall Study|Other|3|||
145467259|NCT04068610|524564519|FG001|Overall Study|Other|12|||
145467260|NCT04068610|524564520|FG002|Overall Study|Other|11|||
145467261|NCT05601102|524564522|FG000|Overall Study|Death|1|||
145467262|NCT05601102|524564523|FG001|Overall Study|Death|2|||
145467263|NCT05601102|524564522|FG000|Overall Study|Withdrawal by Subject|1|||
145467264|NCT05601102|524564523|FG001|Overall Study|Withdrawal by Subject|1|||
145467265|NCT05601102|524564522|FG000|Overall Study|Lost to Follow-up|0|||
145467266|NCT05601102|524564523|FG001|Overall Study|Lost to Follow-up|2|||
145467267|NCT05288166|524564524|FG000|Overall Study|Adverse Event|1|||
145599248|NCT05131165|525046113|FG002|Overall Study|Dropped out|0|||
145599249|NCT04539821|525046117|FG000|Overall Study|Withdrawal by Subject|2|||
145599250|NCT04539821|525046117|FG000|Overall Study|continued care with their physician|20|||
145467268|NCT05288166|524564525|FG001|Overall Study|Adverse Event|0|||
145599251|NCT04539821|525046117|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
145599252|NCT02563002|525046120|FG000|Overall Study|Death|72|||
145599253|NCT02563002|525046121|FG001|Overall Study|Death|87|||
145599254|NCT02563002|525046120|FG000|Overall Study|Lost to Follow-up|5|||
145467269|NCT05288166|524564524|FG000|Overall Study|Lost to Follow-up|2|||
145467270|NCT05288166|524564525|FG001|Overall Study|Lost to Follow-up|0|||
145467271|NCT05288166|524564524|FG000|Overall Study|Physician Decision|0|||
145467272|NCT05288166|524564525|FG001|Overall Study|Physician Decision|2|||
145467273|NCT05288166|524564524|FG000|Overall Study|Screen Failure|1|||
145467274|NCT05288166|524564525|FG001|Overall Study|Screen Failure|1|||
145467275|NCT05288166|524564524|FG000|Overall Study|Withdrawal by Subject|4|||
145467276|NCT05288166|524564525|FG001|Overall Study|Withdrawal by Subject|2|||
145467277|NCT05288166|524564524|FG000|Overall Study|On Study Treatment|408|||
145467278|NCT05288166|524564525|FG001|Overall Study|On Study Treatment|418|||
145467279|NCT03007745|524564526|FG000|Overall Study|Sleep test negative for OSA|53|||
145467280|NCT03007745|524564527|FG001|Overall Study|Sleep test negative for OSA|49|||
145467281|NCT03007745|524564526|FG000|Overall Study|Physician Decision|6|||
145467282|NCT03007745|524564527|FG001|Overall Study|Physician Decision|9|||
145467283|NCT03007745|524564526|FG000|Overall Study|Withdrawal by Subject|38|||
145467284|NCT03007745|524564527|FG001|Overall Study|Withdrawal by Subject|16|||
145467285|NCT03007745|524564526|FG000|Overall Study|Lost to Follow-up|19|||
145467286|NCT03007745|524564527|FG001|Overall Study|Lost to Follow-up|25|||
145467287|NCT03007745|524564526|FG000|Overall Study|Unable to login to website|17|||
145467288|NCT03007745|524564527|FG001|Overall Study|Unable to login to website|4|||
145467289|NCT00431951|524564529|FG000|Overall Study|Inability to follow study procedures|1|||
145467290|NCT00431951|524564530|FG001|Overall Study|Inability to follow study procedures|0|||
145467291|NCT00431951|524564531|FG002|Overall Study|Inability to follow study procedures|1|||
145467292|NCT00431951|524564532|FG003|Overall Study|Inability to follow study procedures|2|||
145467293|NCT00431951|524564529|FG000|Overall Study|Lost to Follow-up|0|||
145467294|NCT00431951|524564530|FG001|Overall Study|Lost to Follow-up|1|||
145467295|NCT00431951|524564531|FG002|Overall Study|Lost to Follow-up|0|||
145467296|NCT00431951|524564532|FG003|Overall Study|Lost to Follow-up|0|||
145467297|NCT00431951|524564529|FG000|Overall Study|Withdrawal by Subject|0|||
145467298|NCT00431951|524564530|FG001|Overall Study|Withdrawal by Subject|1|||
145467299|NCT00431951|524564531|FG002|Overall Study|Withdrawal by Subject|0|||
145467300|NCT00431951|524564532|FG003|Overall Study|Withdrawal by Subject|0|||
145467301|NCT00431951|524564529|FG000|Overall Study|Adverse Event|0|||
145467302|NCT00431951|524564530|FG001|Overall Study|Adverse Event|0|||
145467303|NCT00431951|524564531|FG002|Overall Study|Adverse Event|1|||
145467304|NCT00431951|524564532|FG003|Overall Study|Adverse Event|0|||
145467305|NCT05824936|524564535|FG000|Overall Study|Lost to Follow-up|1|||
145467306|NCT00673881|524564536|FG000|Overall Study|Withdrawal by Subject|1|||
145467307|NCT03968159|524564537|FG000|Overall Study|Adverse Event|4|||
145467308|NCT03968159|524564538|FG001|Overall Study|Adverse Event|4|||
145467309|NCT03968159|524564537|FG000|Overall Study|Lost to Follow-up|1|||
145467310|NCT03968159|524564538|FG001|Overall Study|Lost to Follow-up|1|||
145467311|NCT03968159|524564537|FG000|Overall Study|Use of prohibited medication|0|||
145467312|NCT03968159|524564538|FG001|Overall Study|Use of prohibited medication|1|||
145467313|NCT03968159|524564537|FG000|Overall Study|Protocol Violation|2|||
145467314|NCT03968159|524564538|FG001|Overall Study|Protocol Violation|2|||
145467315|NCT03968159|524564537|FG000|Overall Study|Withdrawal by Subject|4|||
145467316|NCT03968159|524564538|FG001|Overall Study|Withdrawal by Subject|6|||
145467317|NCT03968159|524564537|FG000|Overall Study|Lack of Efficacy|0|||
145467318|NCT03968159|524564538|FG001|Overall Study|Lack of Efficacy|1|||
145467319|NCT03968159|524564537|FG000|Overall Study|Not further specified|2|||
145467320|NCT03968159|524564538|FG001|Overall Study|Not further specified|0|||
145467321|NCT01299571|524564543|FG000|Overall Study|Protocol Violation|107|||
145467322|NCT00413010|524564544|FG000|Overall Study|Adverse Event|8|||
145467323|NCT00413010|524564545|FG001|Overall Study|Adverse Event|4|||
145467324|NCT00413010|524564544|FG000|Overall Study|Laboratory abnormality|0|||
145467325|NCT00413010|524564545|FG001|Overall Study|Laboratory abnormality|2|||
145467326|NCT00413010|524564544|FG000|Overall Study|Lack of Efficacy|0|||
145467327|NCT00413010|524564545|FG001|Overall Study|Lack of Efficacy|3|||
145467328|NCT00413010|524564544|FG000|Overall Study|Lost to Follow-up|3|||
145467329|NCT00413010|524564545|FG001|Overall Study|Lost to Follow-up|0|||
145467330|NCT00413010|524564544|FG000|Overall Study|Withdrawal by Subject|7|||
145467331|NCT00413010|524564545|FG001|Overall Study|Withdrawal by Subject|2|||
145467332|NCT00413010|524564544|FG000|Overall Study|Due to termination of the study|54|||
145467333|NCT00413010|524564545|FG001|Overall Study|Due to termination of the study|52|||
145467334|NCT00708734|524564546|FG000|Overall Study|scheduling conflict|2|||
145467335|NCT00708734|524564546|FG000|Overall Study|moved|1|||
145467336|NCT00708734|524564546|FG000|Overall Study|leg injury|1|||
145467337|NCT00708734|524564546|FG000|Overall Study|knee replacement|1|||
145599255|NCT02563002|525046121|FG001|Overall Study|Lost to Follow-up|0|||
145599256|NCT02563002|525046120|FG000|Overall Study|Physician Decision|0|||
145599257|NCT02563002|525046121|FG001|Overall Study|Physician Decision|2|||
145599258|NCT02563002|525046120|FG000|Overall Study|Withdrawal by Subject|2|||
145467338|NCT00708734|524564546|FG000|Overall Study|vertigo|1|||
145467339|NCT00708734|524564546|FG000|Overall Study|leg fracture|1|||
145467340|NCT01533922|524564547|FG000|Overall Study|Adverse Event|5|||
145467341|NCT01533922|524564548|FG001|Overall Study|Adverse Event|8|||
145467342|NCT01533922|524564549|FG002|Overall Study|Adverse Event|6|||
145467343|NCT01533922|524564550|FG003|Overall Study|Adverse Event|3|||
145467344|NCT01533922|524564551|FG004|Overall Study|Adverse Event|4|||
145467345|NCT01533922|524564547|FG000|Overall Study|Lack of Efficacy|0|||
145467346|NCT01533922|524564548|FG001|Overall Study|Lack of Efficacy|0|||
145599259|NCT02563002|525046121|FG001|Overall Study|Withdrawal by Subject|10|||
145467347|NCT01533922|524564549|FG002|Overall Study|Lack of Efficacy|1|||
145467348|NCT01533922|524564550|FG003|Overall Study|Lack of Efficacy|0|||
145467349|NCT01533922|524564551|FG004|Overall Study|Lack of Efficacy|0|||
145467350|NCT01533922|524564547|FG000|Overall Study|Protocol Violation|0|||
145467351|NCT01533922|524564548|FG001|Overall Study|Protocol Violation|3|||
145599260|NCT02563002|525046120|FG000|Overall Study|Sponsor decision|74|||
145599261|NCT02563002|525046121|FG001|Overall Study|Sponsor decision|55|||
145467352|NCT01533922|524564549|FG002|Overall Study|Protocol Violation|0|||
145467353|NCT01533922|524564550|FG003|Overall Study|Protocol Violation|0|||
145467354|NCT01533922|524564551|FG004|Overall Study|Protocol Violation|1|||
145467355|NCT01533922|524564547|FG000|Overall Study|Withdrawal by Subject|3|||
145467356|NCT01533922|524564548|FG001|Overall Study|Withdrawal by Subject|1|||
145467357|NCT01533922|524564549|FG002|Overall Study|Withdrawal by Subject|2|||
145467358|NCT01533922|524564550|FG003|Overall Study|Withdrawal by Subject|2|||
145467359|NCT01533922|524564551|FG004|Overall Study|Withdrawal by Subject|1|||
145467360|NCT01533922|524564547|FG000|Overall Study|Other reason not defined above|2|||
145467361|NCT01533922|524564548|FG001|Overall Study|Other reason not defined above|0|||
145467362|NCT01533922|524564549|FG002|Overall Study|Other reason not defined above|1|||
145467363|NCT01533922|524564550|FG003|Overall Study|Other reason not defined above|0|||
145467364|NCT01533922|524564551|FG004|Overall Study|Other reason not defined above|0|||
145467365|NCT05432167|524564552|FG000|Overall Study|Adverse Event|0|||
145467366|NCT05432167|524564553|FG001|Overall Study|Adverse Event|2|||
145467367|NCT05432167|524564554|FG002|Overall Study|Adverse Event|1|||
145467368|NCT05432167|524564552|FG000|Overall Study|Lost to Follow-up|3|||
145467369|NCT05432167|524564553|FG001|Overall Study|Lost to Follow-up|3|||
145467370|NCT05432167|524564554|FG002|Overall Study|Lost to Follow-up|2|||
145467371|NCT05432167|524564552|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
145467372|NCT05432167|524564553|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
145467373|NCT05432167|524564554|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
145467374|NCT05432167|524564552|FG000|Overall Study|Physician Decision|1|||
145467375|NCT05432167|524564553|FG001|Overall Study|Physician Decision|0|||
145467376|NCT05432167|524564554|FG002|Overall Study|Physician Decision|0|||
145467377|NCT05432167|524564552|FG000|Overall Study|Withdrawal by Subject|7|||
145467378|NCT05432167|524564553|FG001|Overall Study|Withdrawal by Subject|4|||
145467379|NCT05432167|524564554|FG002|Overall Study|Withdrawal by Subject|11|||
145467380|NCT05432167|524564552|FG000|Overall Study|Other|0|||
145467381|NCT05432167|524564553|FG001|Overall Study|Other|0|||
145467382|NCT05432167|524564554|FG002|Overall Study|Other|1|||
145467383|NCT01267175|524564555|FG000|Overall Study|Withdrawal by Subject|1|||
145467384|NCT01267175|524564555|FG000|Overall Study|Lost to Follow-up|1|||
145467385|NCT02690649|524564558|FG000|Overall Study|Withdrawal by Subject|1|||
145467386|NCT02690649|524564559|FG001|Overall Study|Withdrawal by Subject|1|||
145467387|NCT02690649|524564558|FG000|Overall Study|Protocol Violation|0|||
145467388|NCT02690649|524564559|FG001|Overall Study|Protocol Violation|3|||
145467389|NCT02276547|524564560|FG000|Overall Study|Death|2|||
145467390|NCT02276547|524564560|FG000|Overall Study|Explant|2|||
145467391|NCT03757130|524564568|FG000|Overall Study|Lost to Follow-up|0|||
145467392|NCT03757130|524564569|FG001|Overall Study|Lost to Follow-up|0|||
145467393|NCT03757130|524564570|FG002|Overall Study|Lost to Follow-up|0|||
145467394|NCT03757130|524564571|FG003|Overall Study|Lost to Follow-up|1|||
145467395|NCT03757130|524564572|FG004|Overall Study|Lost to Follow-up|0|||
145467396|NCT03757130|524564573|FG005|Overall Study|Lost to Follow-up|0|||
145467397|NCT03757130|524564574|FG006|Overall Study|Lost to Follow-up|0|||
145467398|NCT03757130|524564575|FG007|Overall Study|Lost to Follow-up|1|||
145467399|NCT03757130|524564568|FG000|Overall Study|Withdrawal by Subject|0|||
145467400|NCT03757130|524564569|FG001|Overall Study|Withdrawal by Subject|0|||
145467401|NCT03757130|524564570|FG002|Overall Study|Withdrawal by Subject|0|||
145467402|NCT03757130|524564571|FG003|Overall Study|Withdrawal by Subject|0|||
145467403|NCT03757130|524564572|FG004|Overall Study|Withdrawal by Subject|0|||
145467404|NCT03757130|524564573|FG005|Overall Study|Withdrawal by Subject|0|||
145467405|NCT03757130|524564574|FG006|Overall Study|Withdrawal by Subject|1|||
145467406|NCT03757130|524564575|FG007|Overall Study|Withdrawal by Subject|0|||
145467407|NCT01439126|524564576|FG000|Overall Study|Adverse Event|2|||
145467408|NCT01439126|524564577|FG001|Overall Study|Adverse Event|0|||
145467409|NCT01439126|524564576|FG000|Overall Study|Withdrawal by Subject|5|||
145599262|NCT05453110|525046130|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
145599263|NCT05453110|525046131|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
145599264|NCT05453110|525046132|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
145599265|NCT00266825|525046139|FG000|Completed Follow-Up|Lost to Follow-up|14|||
145467410|NCT01439126|524564577|FG001|Overall Study|Withdrawal by Subject|21|||
145467411|NCT01439126|524564576|FG000|Overall Study|Protocol Violation|6|||
145467412|NCT01439126|524564577|FG001|Overall Study|Protocol Violation|4|||
145467413|NCT01439126|524564576|FG000|Overall Study|Lost to Follow-up|6|||
145467414|NCT01439126|524564577|FG001|Overall Study|Lost to Follow-up|3|||
145467415|NCT01439126|524564576|FG000|Overall Study|Other-Use of prohibited treatment|0|||
145467416|NCT01439126|524564577|FG001|Overall Study|Other-Use of prohibited treatment|2|||
145467417|NCT01439126|524564576|FG000|Overall Study|Other-Miscellaneous|12|||
145467418|NCT01439126|524564577|FG001|Overall Study|Other-Miscellaneous|12|||
145467419|NCT00687609|524564578|FG000|Overall Study|Physician Decision|1|||
145467420|NCT00687609|524564578|FG000|Overall Study|Withdrawal by Subject|2|||
145467421|NCT00780273|524564580|FG000|Overall Study|Death|1|||
145467422|NCT00780273|524564580|FG000|Overall Study|Lost to Follow-up|1|||
145467423|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
145467424|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
145467425|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
145467426|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
145467427|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
145467428|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
145467429|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
145467430|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
145467431|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
145467432|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
145467433|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
145467434|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
145467435|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
145467436|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
145467437|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
145467438|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
145467439|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
145467440|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
145467441|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
145467442|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
145467443|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
145467444|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
145467445|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
145467446|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
145467447|NCT01672866|524564582|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
145467448|NCT01672866|524564583|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
145467449|NCT01672866|524564584|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
145467450|NCT01672866|524564582|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
145467451|NCT01672866|524564583|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
145467452|NCT01672866|524564584|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
145467453|NCT01672866|524564582|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
145599266|NCT00266825|525046140|FG001|Completed Follow-Up|Lost to Follow-up|19|||
145599267|NCT00266825|525046139|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
145599268|NCT00266825|525046140|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
145599269|NCT00430248|525046141|FG000|Overall Study|Adverse Event|49|||
145599270|NCT00430248|525046142|FG001|Overall Study|Adverse Event|61|||
145599271|NCT00430248|525046143|FG002|Overall Study|Adverse Event|64|||
145599272|NCT00430248|525046141|FG000|Overall Study|Protocol Violation|10|||
145599273|NCT00430248|525046142|FG001|Overall Study|Protocol Violation|2|||
145599274|NCT00430248|525046143|FG002|Overall Study|Protocol Violation|4|||
145599275|NCT00430248|525046141|FG000|Overall Study|Personal Reasons|12|||
145599276|NCT00430248|525046142|FG001|Overall Study|Personal Reasons|24|||
145599277|NCT00430248|525046143|FG002|Overall Study|Personal Reasons|9|||
145599278|NCT00430248|525046141|FG000|Overall Study|Lost to Follow-up|28|||
145599279|NCT00430248|525046142|FG001|Overall Study|Lost to Follow-up|33|||
145599280|NCT00430248|525046143|FG002|Overall Study|Lost to Follow-up|28|||
145599281|NCT00430248|525046141|FG000|Overall Study|Therapeutic Failure|1|||
145599282|NCT00430248|525046142|FG001|Overall Study|Therapeutic Failure|1|||
145599283|NCT00430248|525046143|FG002|Overall Study|Therapeutic Failure|1|||
145599284|NCT00430248|525046141|FG000|Overall Study|Withdrawal by Subject|14|||
145599285|NCT00430248|525046142|FG001|Overall Study|Withdrawal by Subject|20|||
145599286|NCT00430248|525046143|FG002|Overall Study|Withdrawal by Subject|16|||
145599287|NCT00430248|525046141|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145599288|NCT00430248|525046142|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
145599289|NCT00430248|525046143|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145599290|NCT00430248|525046141|FG000|Overall Study|Gout Flare|3|||
145599291|NCT00430248|525046142|FG001|Overall Study|Gout Flare|7|||
145599292|NCT00430248|525046143|FG002|Overall Study|Gout Flare|2|||
145599293|NCT00430248|525046141|FG000|Overall Study|Reason Not Specified|8|||
145599294|NCT00430248|525046142|FG001|Overall Study|Reason Not Specified|8|||
145599295|NCT00430248|525046143|FG002|Overall Study|Reason Not Specified|11|||
145599296|NCT01274182|525046146|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
145599297|NCT01274182|525046147|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
145467454|NCT01672866|524564583|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
145467455|NCT01672866|524564584|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
145599298|NCT01274182|525046148|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
145599299|NCT01274182|525046146|FG000|Overall Study|Adverse Event|4|||
145599300|NCT01274182|525046147|FG001|Overall Study|Adverse Event|5|||
145599301|NCT01274182|525046148|FG002|Overall Study|Adverse Event|3|||
145599302|NCT01274182|525046146|FG000|Overall Study|Withdrawal by Subject|5|||
145599303|NCT01274182|525046147|FG001|Overall Study|Withdrawal by Subject|5|||
145599304|NCT01274182|525046148|FG002|Overall Study|Withdrawal by Subject|3|||
145599305|NCT01274182|525046146|FG000|Overall Study|Lost to Follow-up|2|||
145599306|NCT01274182|525046147|FG001|Overall Study|Lost to Follow-up|3|||
145599307|NCT01274182|525046148|FG002|Overall Study|Lost to Follow-up|1|||
145599308|NCT01274182|525046146|FG000|Overall Study|Protocol Violation|3|||
145599309|NCT01274182|525046147|FG001|Overall Study|Protocol Violation|2|||
145599310|NCT01274182|525046148|FG002|Overall Study|Protocol Violation|0|||
145599311|NCT01274182|525046146|FG000|Overall Study|Death|1|||
145599312|NCT01274182|525046147|FG001|Overall Study|Death|0|||
145599313|NCT01274182|525046148|FG002|Overall Study|Death|1|||
145599314|NCT01822587|525046149|FG000|Overall Study|Lost to Follow-up|7|||
145599315|NCT01822587|525046150|FG001|Overall Study|Lost to Follow-up|9|||
145599316|NCT01822587|525046151|FG002|Overall Study|Lost to Follow-up|12|||
145599317|NCT01822587|525046149|FG000|Overall Study|Physician Decision|9|||
145599318|NCT01822587|525046150|FG001|Overall Study|Physician Decision|6|||
145599319|NCT01822587|525046151|FG002|Overall Study|Physician Decision|6|||
145599320|NCT00691938|525046152|FG000|Overall Study|QTc prolongation|1|||
145599321|NCT00691938|525046153|FG001|Overall Study|QTc prolongation|0|||
145599322|NCT00691938|525046154|FG002|Overall Study|QTc prolongation|0|||
145599323|NCT00691938|525046155|FG003|Overall Study|QTc prolongation|0|||
145599324|NCT00691938|525046156|FG004|Overall Study|QTc prolongation|0|||
145599325|NCT00691938|525046157|FG005|Overall Study|QTc prolongation|0|||
145599326|NCT00691938|525046158|FG006|Overall Study|QTc prolongation|0|||
145599327|NCT00594854|525046161|FG000|Overall Study|Study terminated|7|||
145599328|NCT00594854|525046162|FG001|Overall Study|Study terminated|10|||
145599329|NCT03292146|525046165|FG000|Baseline to 12 months|Relocation|1|||
145599330|NCT03292146|525046166|FG001|Baseline to 12 months|Relocation|0|||
145599331|NCT03292146|525046165|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
145599332|NCT03292146|525046166|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
145599333|NCT03292146|525046165|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
145599334|NCT03292146|525046166|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
145599335|NCT03292146|525046165|FG000|12 months to 24 months|Planning pregnancy|2|||
145599336|NCT03292146|525046166|FG001|12 months to 24 months|Planning pregnancy|2|||
145599337|NCT03292146|525046165|FG000|12 months to 24 months|Personal reasons|1|||
145599338|NCT03292146|525046166|FG001|12 months to 24 months|Personal reasons|0|||
145599339|NCT03292146|525046165|FG000|12 months to 24 months|Lost to Follow-up|0|||
145599340|NCT03292146|525046166|FG001|12 months to 24 months|Lost to Follow-up|1|||
145599341|NCT03039023|525046167|FG000|Overall Study|Withdrawal by Subject|1|||
145599342|NCT03039023|525046168|FG001|Overall Study|Withdrawal by Subject|0|||
145599343|NCT03039023|525046169|FG002|Overall Study|Withdrawal by Subject|1|||
145599344|NCT03039023|525046170|FG003|Overall Study|Withdrawal by Subject|1|||
145599345|NCT03039023|525046171|FG004|Overall Study|Withdrawal by Subject|0|||
145599346|NCT03039023|525046167|FG000|Overall Study|Physician Decision|0|||
145599347|NCT03039023|525046168|FG001|Overall Study|Physician Decision|0|||
145599348|NCT03039023|525046169|FG002|Overall Study|Physician Decision|0|||
145599349|NCT03039023|525046170|FG003|Overall Study|Physician Decision|1|||
145599350|NCT03039023|525046171|FG004|Overall Study|Physician Decision|0|||
145599351|NCT03701399|525046174|FG000|Overall Study|Adverse Event|3|||
145599352|NCT03701399|525046175|FG001|Overall Study|Adverse Event|5|||
145599353|NCT03701399|525046174|FG000|Overall Study|Withdrawal by Subject|6|||
145599354|NCT03701399|525046175|FG001|Overall Study|Withdrawal by Subject|3|||
145599355|NCT03701399|525046174|FG000|Overall Study|Investigators decision|1|||
145599356|NCT03701399|525046175|FG001|Overall Study|Investigators decision|2|||
145599357|NCT03701399|525046174|FG000|Overall Study|Lost to Follow-up|1|||
145599358|NCT03701399|525046175|FG001|Overall Study|Lost to Follow-up|2|||
145599359|NCT03701399|525046174|FG000|Overall Study|Death|1|||
145599360|NCT03701399|525046175|FG001|Overall Study|Death|1|||
145599361|NCT03701399|525046174|FG000|Overall Study|Randomized but not treated|1|||
145599362|NCT03701399|525046175|FG001|Overall Study|Randomized but not treated|0|||
145599363|NCT00448448|525046176|FG000|Overall Study|Withdrawal by Subject|13|||
145599364|NCT00448448|525046177|FG001|Overall Study|Withdrawal by Subject|2|||
145599365|NCT00448448|525046176|FG000|Overall Study|On protocol when study ended|83|||
145599366|NCT00448448|525046177|FG001|Overall Study|On protocol when study ended|36|||
145599367|NCT00448448|525046176|FG000|Overall Study|Lost to Follow-up|2|||
145599368|NCT00448448|525046177|FG001|Overall Study|Lost to Follow-up|1|||
145599369|NCT00448448|525046176|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
145599370|NCT00448448|525046177|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
145599371|NCT00448448|525046176|FG000|Overall Study|Signed consent lost|0|||
145599372|NCT00448448|525046177|FG001|Overall Study|Signed consent lost|1|||
145599373|NCT04642898|525046178|FG000|Overall Study|Withdrawal by Subject|2|||
145599374|NCT04642898|525046179|FG001|Overall Study|Withdrawal by Subject|4|||
145599375|NCT04642898|525046180|FG002|Overall Study|Withdrawal by Subject|4|||
145599376|NCT04642898|525046181|FG003|Overall Study|Withdrawal by Subject|6|||
145599377|NCT04642898|525046182|FG004|Overall Study|Withdrawal by Subject|2|||
145599378|NCT04642898|525046183|FG005|Overall Study|Withdrawal by Subject|6|||
145599379|NCT04642898|525046178|FG000|Overall Study|Lost to Follow-up|0|||
145599380|NCT04642898|525046179|FG001|Overall Study|Lost to Follow-up|0|||
145599381|NCT04642898|525046180|FG002|Overall Study|Lost to Follow-up|0|||
145599382|NCT04642898|525046181|FG003|Overall Study|Lost to Follow-up|2|||
145599383|NCT04642898|525046182|FG004|Overall Study|Lost to Follow-up|0|||
145599384|NCT04642898|525046183|FG005|Overall Study|Lost to Follow-up|1|||
145599385|NCT04642898|525046178|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
145599386|NCT04642898|525046179|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
145599387|NCT04642898|525046180|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
145599388|NCT04642898|525046181|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
145599389|NCT04642898|525046182|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
145599390|NCT04642898|525046183|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
145599391|NCT04642898|525046178|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
145599392|NCT04642898|525046179|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
145599393|NCT04642898|525046180|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
145599394|NCT04642898|525046181|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
145599395|NCT04642898|525046182|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
145599396|NCT04642898|525046183|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
145599397|NCT04280562|525046184|FG000|Study|Adverse Event|2|||
145599398|NCT04280562|525046185|FG001|Study|Adverse Event|0|||
145599399|NCT04280562|525046184|FG000|Study|Lost to Follow-up|3|||
145599400|NCT04280562|525046185|FG001|Study|Lost to Follow-up|3|||
145599401|NCT01368965|525046189|FG000|Overall Study|Lost to Follow-up|12|||
145599402|NCT02618967|525046190|FG000|Overall Study|Lost to Follow-up|0|||
145599403|NCT02618967|525046191|FG001|Overall Study|Lost to Follow-up|0|||
145599404|NCT02618967|525046192|FG002|Overall Study|Lost to Follow-up|1|||
145599405|NCT02618967|525046193|FG003|Overall Study|Lost to Follow-up|0|||
145599406|NCT02618967|525046194|FG004|Overall Study|Lost to Follow-up|2|||
145599407|NCT02618967|525046195|FG005|Overall Study|Lost to Follow-up|0|||
145599408|NCT02618967|525046196|FG006|Overall Study|Lost to Follow-up|0|||
145599409|NCT02618967|525046197|FG007|Overall Study|Lost to Follow-up|0|||
145599410|NCT02618967|525046190|FG000|Overall Study|Withdrawal by Subject|1|||
145599411|NCT02618967|525046191|FG001|Overall Study|Withdrawal by Subject|0|||
145599412|NCT02618967|525046192|FG002|Overall Study|Withdrawal by Subject|0|||
145599413|NCT02618967|525046193|FG003|Overall Study|Withdrawal by Subject|0|||
145599414|NCT02618967|525046194|FG004|Overall Study|Withdrawal by Subject|0|||
145599415|NCT02618967|525046195|FG005|Overall Study|Withdrawal by Subject|0|||
145599416|NCT02618967|525046196|FG006|Overall Study|Withdrawal by Subject|0|||
145599417|NCT02618967|525046197|FG007|Overall Study|Withdrawal by Subject|0|||
145599418|NCT04559568|525046201|FG000|Overall Study|Physician Decision|0|||
145599419|NCT04559568|525046202|FG001|Overall Study|Physician Decision|0|||
145599420|NCT04559568|525046203|FG002|Overall Study|Physician Decision|0|||
145599421|NCT04559568|525046204|FG003|Overall Study|Physician Decision|0|||
145599422|NCT04559568|525046205|FG004|Overall Study|Physician Decision|0|||
145599423|NCT04559568|525046206|FG005|Overall Study|Physician Decision|0|||
145599424|NCT04559568|525046207|FG006|Overall Study|Physician Decision|0|||
145599425|NCT04559568|525046208|FG007|Overall Study|Physician Decision|0|||
145599426|NCT04559568|525046209|FG008|Overall Study|Physician Decision|0|||
145599427|NCT04559568|525046210|FG009|Overall Study|Physician Decision|1|||
145599428|NCT04559568|525046211|FG010|Overall Study|Physician Decision|0|||
145599429|NCT04559568|525046201|FG000|Overall Study|Withdrawal by Subject|0|||
145599430|NCT04559568|525046202|FG001|Overall Study|Withdrawal by Subject|0|||
145599431|NCT04559568|525046203|FG002|Overall Study|Withdrawal by Subject|0|||
145599432|NCT04559568|525046204|FG003|Overall Study|Withdrawal by Subject|0|||
145599433|NCT04559568|525046205|FG004|Overall Study|Withdrawal by Subject|0|||
145599434|NCT04559568|525046206|FG005|Overall Study|Withdrawal by Subject|0|||
145599435|NCT04559568|525046207|FG006|Overall Study|Withdrawal by Subject|0|||
145599436|NCT04559568|525046208|FG007|Overall Study|Withdrawal by Subject|0|||
145599437|NCT04559568|525046209|FG008|Overall Study|Withdrawal by Subject|0|||
145599438|NCT04559568|525046210|FG009|Overall Study|Withdrawal by Subject|0|||
145599439|NCT04559568|525046211|FG010|Overall Study|Withdrawal by Subject|1|||
145599440|NCT00045305|525046217|FG000|Overall Study|Lack of Efficacy|6|||
145599441|NCT00045305|525046217|FG000|Overall Study|Adverse Event|3|||
145599442|NCT00045305|525046217|FG000|Overall Study|Death|3|||
145599443|NCT00045305|525046217|FG000|Overall Study|site error|2|||
145599444|NCT04274894|525046218|FG000|Overall Study|Adverse Event|7|||
145599445|NCT04274894|525046218|FG000|Overall Study|Withdrew consent|5|||
145599446|NCT04274894|525046218|FG000|Overall Study|Lost to Follow-up|9|||
145599447|NCT04274894|525046218|FG000|Overall Study|COVID-19 infection|1|||
145599448|NCT04274894|525046218|FG000|Overall Study|Other, not specified|20|||
145599449|NCT01936857|525046219|FG000|Overall Study|Sent to prison or 06 center|11|||
145599450|NCT01936857|525046220|FG001|Overall Study|Sent to prison or 06 center|12|||
145599451|NCT01936857|525046219|FG000|Overall Study|Lost to Follow-up|10|||
145599452|NCT01936857|525046220|FG001|Overall Study|Lost to Follow-up|7|||
145599453|NCT01936857|525046219|FG000|Overall Study|Death|7|||
145599454|NCT01936857|525046220|FG001|Overall Study|Death|3|||
145599455|NCT01936857|525046219|FG000|Overall Study|Moved|2|||
145599456|NCT01936857|525046220|FG001|Overall Study|Moved|1|||
145599457|NCT01936857|525046219|FG000|Overall Study|Withdrawal by Subject|1|||
145599458|NCT01936857|525046220|FG001|Overall Study|Withdrawal by Subject|0|||
145599459|NCT01936857|525046219|FG000|Overall Study|Side effect of medication|1|||
145599460|NCT01936857|525046220|FG001|Overall Study|Side effect of medication|0|||
145599461|NCT01936857|525046219|FG000|Overall Study|Other|2|||
145599462|NCT01936857|525046220|FG001|Overall Study|Other|2|||
145599463|NCT02279043|525046221|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
145599464|NCT02279043|525046222|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
145599465|NCT02279043|525046223|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
145599466|NCT02279043|525046221|FG000|Overall Study|Lost to Follow-up|46|||
145599467|NCT02279043|525046222|FG001|Overall Study|Lost to Follow-up|88|||
145599468|NCT02279043|525046223|FG002|Overall Study|Lost to Follow-up|0|||
145599469|NCT01939548|525046224|FG000|Overall Study|Non compliance|0|||
145599470|NCT01939548|525046225|FG001|Overall Study|Non compliance|2|||
145599471|NCT01939548|525046226|FG002|Overall Study|Non compliance|0|||
145599472|NCT01939548|525046224|FG000|Overall Study|Study Terminated by Sponsor|17|||
145599473|NCT01939548|525046225|FG001|Overall Study|Study Terminated by Sponsor|19|||
145599474|NCT01939548|525046226|FG002|Overall Study|Study Terminated by Sponsor|12|||
145599475|NCT01939548|525046224|FG000|Overall Study|Insufficient Clinical Response|1|||
145599476|NCT01939548|525046225|FG001|Overall Study|Insufficient Clinical Response|0|||
145599477|NCT01939548|525046226|FG002|Overall Study|Insufficient Clinical Response|0|||
145599478|NCT01939548|525046224|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145599479|NCT01939548|525046225|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
145599480|NCT01939548|525046226|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
145599481|NCT01939548|525046224|FG000|Overall Study|Withdrawal by Subject|4|||
145599482|NCT01939548|525046225|FG001|Overall Study|Withdrawal by Subject|4|||
145599483|NCT01939548|525046226|FG002|Overall Study|Withdrawal by Subject|1|||
145599484|NCT01939548|525046224|FG000|Overall Study|Protocol Violation|7|||
145599485|NCT01939548|525046225|FG001|Overall Study|Protocol Violation|6|||
145599486|NCT01939548|525046226|FG002|Overall Study|Protocol Violation|5|||
145599487|NCT01939548|525046224|FG000|Overall Study|Lost to Follow-up|5|||
145599488|NCT01939548|525046225|FG001|Overall Study|Lost to Follow-up|5|||
145599489|NCT01939548|525046226|FG002|Overall Study|Lost to Follow-up|3|||
145599490|NCT01939548|525046224|FG000|Overall Study|Adverse Event|2|||
145599491|NCT01939548|525046225|FG001|Overall Study|Adverse Event|9|||
145599492|NCT01939548|525046226|FG002|Overall Study|Adverse Event|7|||
145599493|NCT01939548|525046224|FG000|Overall Study|Death|0|||
145599494|NCT01939548|525046225|FG001|Overall Study|Death|0|||
145599495|NCT01939548|525046226|FG002|Overall Study|Death|1|||
145599496|NCT01939548|525046224|FG000|Overall Study|Participant dropped|0|||
145599497|NCT01939548|525046225|FG001|Overall Study|Participant dropped|0|||
145599498|NCT01939548|525046226|FG002|Overall Study|Participant dropped|1|||
145599499|NCT01939548|525046224|FG000|Overall Study|Participant unwilling to continue|0|||
145599500|NCT01939548|525046225|FG001|Overall Study|Participant unwilling to continue|1|||
145599501|NCT01939548|525046226|FG002|Overall Study|Participant unwilling to continue|0|||
145599502|NCT01939548|525046224|FG000|Overall Study|Participant withdrew consent|0|||
145599503|NCT01939548|525046225|FG001|Overall Study|Participant withdrew consent|2|||
145599504|NCT01939548|525046226|FG002|Overall Study|Participant withdrew consent|0|||
145599505|NCT01939548|525046224|FG000|Overall Study|Did not complete follow-up|0|||
145599506|NCT01939548|525046225|FG001|Overall Study|Did not complete follow-up|1|||
145599507|NCT01939548|525046226|FG002|Overall Study|Did not complete follow-up|0|||
145599508|NCT00490282|525046227|FG000|Overall Study|Withdrawal by Subject|3|||
145599509|NCT01494584|525046233|FG000|Overall Study|Study Closed/Terminated|1|||
145599510|NCT01499082|525046234|FG000|Overall Study|Randomized but not Treated|0|||
145599511|NCT01499082|525046235|FG001|Overall Study|Randomized but not Treated|1|||
145599512|NCT01499082|525046234|FG000|Overall Study|Adverse Event|12|||
145599513|NCT01499082|525046235|FG001|Overall Study|Adverse Event|16|||
145599514|NCT01499082|525046234|FG000|Overall Study|Lack of Efficacy|1|||
145599515|NCT01499082|525046235|FG001|Overall Study|Lack of Efficacy|1|||
145599516|NCT01499082|525046234|FG000|Overall Study|Protocol Violation|6|||
145599517|NCT01499082|525046235|FG001|Overall Study|Protocol Violation|8|||
145599518|NCT01499082|525046234|FG000|Overall Study|Diverse Reasons|18|||
145599519|NCT01499082|525046235|FG001|Overall Study|Diverse Reasons|14|||
145599520|NCT01499082|525046234|FG000|Overall Study|Site Closure for Noncompliance|5|||
145599521|NCT01499082|525046235|FG001|Overall Study|Site Closure for Noncompliance|2|||
145599522|NCT01499082|525046234|FG000|Overall Study|Hypoglycemia|2|||
145599523|NCT01499082|525046235|FG001|Overall Study|Hypoglycemia|3|||
145599524|NCT01499082|525046234|FG000|Overall Study|Lost to Follow-up|1|||
145599525|NCT01499082|525046235|FG001|Overall Study|Lost to Follow-up|3|||
145599526|NCT05380947|525046241|FG000|Washout Period 1|Not attend visit|1|||
145599527|NCT05380947|525046242|FG001|Washout Period 1|Not attend visit|0|||
145599528|NCT05380947|525046243|FG002|Washout Period 1|Not attend visit|0|||
145599529|NCT05380947|525046244|FG003|Washout Period 1|Not attend visit|0|||
145599530|NCT05380947|525046241|FG000|Washout Period 2|Adverse Event|1|||
145599531|NCT05380947|525046242|FG001|Washout Period 2|Adverse Event|0|||
145599532|NCT05380947|525046243|FG002|Washout Period 2|Adverse Event|0|||
145599533|NCT05380947|525046244|FG003|Washout Period 2|Adverse Event|0|||
145467456|NCT01672866|524564582|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
145467457|NCT01672866|524564583|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
145467458|NCT01672866|524564584|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
145467459|NCT01672866|524564582|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
145467460|NCT01672866|524564583|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
145467461|NCT01672866|524564584|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
145467462|NCT01825941|524565954|FG000|Overall Study|Lost to Follow-up|4|||
145467463|NCT01825941|524565955|FG001|Overall Study|Lost to Follow-up|1|||
145467464|NCT02797184|524565960|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
145467465|NCT02797184|524565961|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
145599534|NCT05380947|525046241|FG000|Washout Period 3|Adverse Event|0|||
145599535|NCT05380947|525046242|FG001|Washout Period 3|Adverse Event|1|||
145599536|NCT05380947|525046243|FG002|Washout Period 3|Adverse Event|0|||
145599537|NCT05380947|525046244|FG003|Washout Period 3|Adverse Event|0|||
145467466|NCT01300351|524565964|FG000|Overall Study|Did not receive treatment|2|||
145467467|NCT01300351|524565965|FG001|Overall Study|Did not receive treatment|0|||
145467468|NCT01300351|524565964|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
145467469|NCT01300351|524565965|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
145467470|NCT01300351|524565964|FG000|Overall Study|Lost to Follow-up|0|||
145467471|NCT01300351|524565965|FG001|Overall Study|Lost to Follow-up|1|||
145467472|NCT01300351|524565964|FG000|Overall Study|Adverse Event|0|||
145467473|NCT01300351|524565965|FG001|Overall Study|Adverse Event|4|||
145467474|NCT01300351|524565964|FG000|Overall Study|Withdrawal by Subject|7|||
145467475|NCT01300351|524565965|FG001|Overall Study|Withdrawal by Subject|10|||
145467476|NCT02258529|524565969|FG000|Overall Study|Study Terminated by Sponsor|9|||
145467477|NCT02258529|524565969|FG000|Overall Study|Adverse Event|1|||
145467478|NCT00443781|524565970|FG000|Overall Study|Lost to Follow-up|10|||
145467479|NCT00443781|524565970|FG000|Overall Study|Physician Decision|2|||
145467480|NCT00443781|524565970|FG000|Overall Study|Protocol Violation|1|||
145467481|NCT00443781|524565970|FG000|Overall Study|Withdrawal by Subject|6|||
145467482|NCT00443781|524565970|FG000|Overall Study|Unable to comply with study follow up|2|||
145467483|NCT00443781|524565970|FG000|Overall Study|Investigator terminated participation|1|||
145467484|NCT00443781|524565970|FG000|Overall Study|Insurance not covered|2|||
145467485|NCT00443781|524565970|FG000|Overall Study|PD/FAD not done|1|||
145467486|NCT00430937|524565971|FG000|Overall Study|Adverse Event|3|||
145467487|NCT00430937|524565972|FG001|Overall Study|Adverse Event|8|||
145467488|NCT00430937|524565971|FG000|Overall Study|Death|0|||
145467489|NCT00430937|524565972|FG001|Overall Study|Death|1|||
145467490|NCT00430937|524565971|FG000|Overall Study|Lost to Follow-up|6|||
145467491|NCT00430937|524565972|FG001|Overall Study|Lost to Follow-up|6|||
145467492|NCT00430937|524565971|FG000|Overall Study|Withdrawal by Subject|5|||
145467493|NCT00430937|524565972|FG001|Overall Study|Withdrawal by Subject|2|||
145467494|NCT00430937|524565971|FG000|Overall Study|Protocol Violation|3|||
145467495|NCT00430937|524565972|FG001|Overall Study|Protocol Violation|2|||
145467496|NCT00430937|524565971|FG000|Overall Study|Lack of Efficacy|6|||
145467497|NCT00430937|524565972|FG001|Overall Study|Lack of Efficacy|5|||
145467498|NCT00430937|524565971|FG000|Overall Study|Inappropriate enrollment|2|||
145467499|NCT00430937|524565972|FG001|Overall Study|Inappropriate enrollment|1|||
145467500|NCT00430937|524565971|FG000|Overall Study|Administrative reasons|1|||
145467501|NCT00430937|524565972|FG001|Overall Study|Administrative reasons|0|||
145467502|NCT00430937|524565971|FG000|Overall Study|Protocol discontinuation criteria met|1|||
145467503|NCT00430937|524565972|FG001|Overall Study|Protocol discontinuation criteria met|2|||
145467504|NCT00430937|524565971|FG000|Overall Study|Unable to classify|0|||
145467505|NCT00430937|524565972|FG001|Overall Study|Unable to classify|1|||
145467506|NCT02634606|524565973|FG000|Overall Study|unable to obtain the drug at start|13|||
145467507|NCT00353873|524565977|FG000|Overall Study|Protocol Violation|1|||
145467508|NCT00353873|524565978|FG001|Overall Study|Protocol Violation|2|||
145467509|NCT00353873|524565977|FG000|Overall Study|Exacerbation|1|||
145467510|NCT00353873|524565978|FG001|Overall Study|Exacerbation|0|||
145467511|NCT00353873|524565977|FG000|Overall Study|Adverse Event|1|||
145467512|NCT00353873|524565978|FG001|Overall Study|Adverse Event|0|||
145467513|NCT00353873|524565977|FG000|Overall Study|Physician Decision|2|||
145467514|NCT00353873|524565978|FG001|Overall Study|Physician Decision|0|||
145467515|NCT00353873|524565977|FG000|Overall Study|Withdrawal by Subject|1|||
145599538|NCT05380947|525046241|FG000|Washout Period 3|Not attend visit|0|||
145599539|NCT05380947|525046242|FG001|Washout Period 3|Not attend visit|1|||
145467516|NCT00353873|524565978|FG001|Overall Study|Withdrawal by Subject|1|||
145467517|NCT03743064|524565979|FG000|Overall Study|Adverse Event|7|||
145599540|NCT05380947|525046243|FG002|Washout Period 3|Not attend visit|0|||
145467518|NCT03743064|524565980|FG001|Overall Study|Adverse Event|9|||
145467519|NCT03743064|524565979|FG000|Overall Study|Death|25|||
145467520|NCT03743064|524565980|FG001|Overall Study|Death|28|||
145467521|NCT03743064|524565979|FG000|Overall Study|Lost to Follow-up|3|||
145467522|NCT03743064|524565980|FG001|Overall Study|Lost to Follow-up|6|||
145467523|NCT03743064|524565979|FG000|Overall Study|Withdrawal by Subject|28|||
145467524|NCT03743064|524565980|FG001|Overall Study|Withdrawal by Subject|25|||
145599541|NCT05380947|525046244|FG003|Washout Period 3|Not attend visit|1|||
145599542|NCT01256567|525046246|FG000|Overall Study|Withdrawal by Subject|1|||
145599543|NCT02453685|525046259|FG000|Overall Study|Adverse Event|0|||
145599544|NCT02453685|525046260|FG001|Overall Study|Adverse Event|1|||
145599545|NCT02453685|525046259|FG000|Overall Study|Protocol Violation|7|||
145599546|NCT02453685|525046260|FG001|Overall Study|Protocol Violation|4|||
145599547|NCT02453685|525046259|FG000|Overall Study|Lost to Follow-up|0|||
145599548|NCT02453685|525046260|FG001|Overall Study|Lost to Follow-up|1|||
145599549|NCT02453685|525046259|FG000|Overall Study|Withdrawal by Subject|8|||
145599550|NCT02453685|525046260|FG001|Overall Study|Withdrawal by Subject|4|||
145599551|NCT02453685|525046259|FG000|Overall Study|Unclassified|4|||
145599552|NCT02453685|525046260|FG001|Overall Study|Unclassified|2|||
145599553|NCT00522626|525046265|FG000|Overall Study|Lost to Follow-up|7|||
145599554|NCT00803452|525046266|FG000|Overall Study|Adverse Event|0|||
145599555|NCT00803452|525046267|FG001|Overall Study|Adverse Event|2|||
145599556|NCT00803452|525046266|FG000|Overall Study|Lost to Follow-up|0|||
145599557|NCT00803452|525046267|FG001|Overall Study|Lost to Follow-up|3|||
145599558|NCT02412137|525046277|FG000|Overall Study|Withdrawal by Subject|2|||
145599559|NCT02412137|525046278|FG001|Overall Study|Withdrawal by Subject|0|||
145599560|NCT02412137|525046277|FG000|Overall Study|Lost to Follow-up|21|||
145599561|NCT02412137|525046278|FG001|Overall Study|Lost to Follow-up|14|||
145599562|NCT02412137|525046277|FG000|Overall Study|Physician Decision|28|||
145599563|NCT02412137|525046278|FG001|Overall Study|Physician Decision|9|||
145599564|NCT00608582|525046290|FG000|Overall Study|Lost to Follow-up|2|||
145599565|NCT00608582|525046291|FG001|Overall Study|Lost to Follow-up|0|||
145599566|NCT00608582|525046290|FG000|Overall Study|No Best Response in Phase 1 located|1|||
145599567|NCT00608582|525046291|FG001|Overall Study|No Best Response in Phase 1 located|1|||
145599568|NCT00608582|525046290|FG000|Overall Study|Illicit Drug Use|1|||
145599569|NCT00608582|525046291|FG001|Overall Study|Illicit Drug Use|0|||
145599570|NCT00608582|525046290|FG000|Overall Study|Early stage Design Change|0|||
145599571|NCT00608582|525046291|FG001|Overall Study|Early stage Design Change|3|||
145599572|NCT02532179|525048166|FG000|Overall Study|Lost to Follow-up|1|||
145599573|NCT02532179|525048166|FG000|Overall Study|Pregnancy|1|||
145599574|NCT02532179|525048166|FG000|Overall Study|Subject received depot steroid injection|1|||
145599575|NCT01337674|525048172|FG000|Treatment Period 1|Adverse Event|0|||
145599576|NCT01337674|525048173|FG001|Treatment Period 1|Adverse Event|1|||
145599577|NCT01337674|525048174|FG002|Treatment Period 1|Adverse Event|0|||
145599578|NCT01337674|525048175|FG003|Treatment Period 1|Adverse Event|0|||
145599579|NCT01337674|525048172|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
145599580|NCT01337674|525048173|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
145599581|NCT01337674|525048174|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
145599582|NCT01337674|525048175|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
145599583|NCT01337674|525048172|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145599584|NCT01337674|525048173|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145599585|NCT01337674|525048174|FG002|Treatment Period 2|Withdrawal by Subject|1|||
145599586|NCT01337674|525048175|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145599587|NCT03076970|525048176|FG000|Washout Period 2|Adverse Event|0|||
145599588|NCT03076970|525048177|FG001|Washout Period 2|Adverse Event|0|||
145599589|NCT03076970|525048178|FG002|Washout Period 2|Adverse Event|0|||
145599590|NCT03076970|525048179|FG003|Washout Period 2|Adverse Event|0|||
145599591|NCT03076970|525048180|FG004|Washout Period 2|Adverse Event|1|||
145599592|NCT03076970|525048181|FG005|Washout Period 2|Adverse Event|0|||
145599593|NCT03076970|525048176|FG000|Period 3|Withdrawal by Subject|0|||
145599594|NCT03076970|525048177|FG001|Period 3|Withdrawal by Subject|0|||
145599595|NCT03076970|525048178|FG002|Period 3|Withdrawal by Subject|0|||
145599596|NCT03076970|525048179|FG003|Period 3|Withdrawal by Subject|0|||
145599597|NCT03076970|525048180|FG004|Period 3|Withdrawal by Subject|0|||
145599598|NCT03076970|525048181|FG005|Period 3|Withdrawal by Subject|1|||
145599599|NCT03076970|525048176|FG000|Period 3|Failure to meet I/E criteria|0|||
145599600|NCT03076970|525048177|FG001|Period 3|Failure to meet I/E criteria|0|||
145599601|NCT03076970|525048178|FG002|Period 3|Failure to meet I/E criteria|0|||
145599602|NCT03076970|525048179|FG003|Period 3|Failure to meet I/E criteria|0|||
145599603|NCT03076970|525048180|FG004|Period 3|Failure to meet I/E criteria|1|||
145599604|NCT03076970|525048181|FG005|Period 3|Failure to meet I/E criteria|0|||
145599605|NCT00789815|525048182|FG000|Overall Study|Protocol Violation|6|||
145599606|NCT00789815|525048183|FG001|Overall Study|Protocol Violation|1|||
145599607|NCT00789815|525048182|FG000|Overall Study|Intubation due to massive bleeding|1|||
145599608|NCT00789815|525048183|FG001|Overall Study|Intubation due to massive bleeding|0|||
145599609|NCT00119405|525048184|FG000|Overall Study|Withdrawal by Subject|1|||
145599610|NCT04958785|525048188|FG000|Overall Study|Study Terminated by Sponsor|4|||
145599611|NCT04958785|525048189|FG001|Overall Study|Study Terminated by Sponsor|10|||
145599612|NCT04958785|525048190|FG002|Overall Study|Study Terminated by Sponsor|7|||
145599613|NCT04958785|525048191|FG003|Overall Study|Study Terminated by Sponsor|6|||
145599614|NCT04958785|525048192|FG004|Overall Study|Study Terminated by Sponsor|34|||
145599615|NCT04958785|525048188|FG000|Overall Study|Death|2|||
145599616|NCT04958785|525048189|FG001|Overall Study|Death|3|||
145599617|NCT04958785|525048190|FG002|Overall Study|Death|4|||
145599618|NCT04958785|525048191|FG003|Overall Study|Death|5|||
145599619|NCT04958785|525048192|FG004|Overall Study|Death|5|||
145599620|NCT04958785|525048188|FG000|Overall Study|Withdrew consent|2|||
145599621|NCT04958785|525048189|FG001|Overall Study|Withdrew consent|0|||
145599622|NCT04958785|525048190|FG002|Overall Study|Withdrew consent|3|||
145599623|NCT04958785|525048191|FG003|Overall Study|Withdrew consent|1|||
145599624|NCT04958785|525048192|FG004|Overall Study|Withdrew consent|0|||
145599625|NCT04958785|525048188|FG000|Overall Study|Investigator's discretion|0|||
145599626|NCT04958785|525048189|FG001|Overall Study|Investigator's discretion|1|||
145599627|NCT04958785|525048190|FG002|Overall Study|Investigator's discretion|0|||
145599628|NCT04958785|525048191|FG003|Overall Study|Investigator's discretion|1|||
145599629|NCT04958785|525048192|FG004|Overall Study|Investigator's discretion|2|||
145599630|NCT04958785|525048188|FG000|Overall Study|Adverse Event|0|||
145599631|NCT04958785|525048189|FG001|Overall Study|Adverse Event|0|||
145599632|NCT04958785|525048190|FG002|Overall Study|Adverse Event|0|||
145599633|NCT04958785|525048191|FG003|Overall Study|Adverse Event|0|||
145599634|NCT04958785|525048192|FG004|Overall Study|Adverse Event|1|||
145599635|NCT04958785|525048188|FG000|Overall Study|Lost to Follow-up|0|||
145599636|NCT04958785|525048189|FG001|Overall Study|Lost to Follow-up|0|||
145599637|NCT04958785|525048190|FG002|Overall Study|Lost to Follow-up|0|||
145599638|NCT04958785|525048191|FG003|Overall Study|Lost to Follow-up|0|||
145599639|NCT04958785|525048192|FG004|Overall Study|Lost to Follow-up|1|||
145599640|NCT01224925|525048193|FG000|Overall Study|Lost to Follow-up|3|||
145599641|NCT01224925|525048194|FG001|Overall Study|Lost to Follow-up|2|||
145599642|NCT00949884|525048197|FG000|Overall Study|Adverse Event|14|||
145599643|NCT00949884|525048198|FG001|Overall Study|Adverse Event|3|||
145599644|NCT00949884|525048199|FG002|Overall Study|Adverse Event|12|||
145599645|NCT00949884|525048197|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
145599646|NCT00949884|525048198|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
145599647|NCT00949884|525048199|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
145599648|NCT00949884|525048197|FG000|Overall Study|Lost to Follow-up|7|||
145599649|NCT00949884|525048198|FG001|Overall Study|Lost to Follow-up|5|||
145599650|NCT00949884|525048199|FG002|Overall Study|Lost to Follow-up|5|||
145599651|NCT00949884|525048197|FG000|Overall Study|Physician Decision|5|||
145599652|NCT00949884|525048198|FG001|Overall Study|Physician Decision|0|||
145599653|NCT00949884|525048199|FG002|Overall Study|Physician Decision|6|||
145599654|NCT00949884|525048197|FG000|Overall Study|Treatment non-compliance|5|||
145599655|NCT00949884|525048198|FG001|Overall Study|Treatment non-compliance|0|||
145599656|NCT00949884|525048199|FG002|Overall Study|Treatment non-compliance|8|||
145599657|NCT00949884|525048197|FG000|Overall Study|Withdrawal by Subject|13|||
145599658|NCT00949884|525048198|FG001|Overall Study|Withdrawal by Subject|4|||
145599659|NCT00949884|525048199|FG002|Overall Study|Withdrawal by Subject|16|||
145599660|NCT00949884|525048197|FG000|Overall Study|Lack of Efficacy|4|||
145599661|NCT00949884|525048198|FG001|Overall Study|Lack of Efficacy|2|||
145599662|NCT00949884|525048199|FG002|Overall Study|Lack of Efficacy|7|||
145599663|NCT00949884|525048197|FG000|Overall Study|Study terminated by sponsor|0|||
145599664|NCT00949884|525048198|FG001|Overall Study|Study terminated by sponsor|0|||
145599665|NCT00949884|525048199|FG002|Overall Study|Study terminated by sponsor|1|||
145599666|NCT00245102|525048200|FG000|Overall Study|Not Treated|1|||
145599667|NCT00245102|525048201|FG001|Overall Study|Not Treated|0|||
145599668|NCT00245102|525048202|FG002|Overall Study|Not Treated|1|||
145599669|NCT00245102|525048203|FG003|Overall Study|Not Treated|0|||
145599670|NCT00245102|525048204|FG004|Overall Study|Not Treated|0|||
145599671|NCT00245102|525048205|FG005|Overall Study|Not Treated|0|||
145599672|NCT00245102|525048200|FG000|Overall Study|Protocol Violation|1|||
145599673|NCT00245102|525048201|FG001|Overall Study|Protocol Violation|0|||
145599674|NCT00245102|525048202|FG002|Overall Study|Protocol Violation|0|||
145599675|NCT00245102|525048203|FG003|Overall Study|Protocol Violation|0|||
145599676|NCT00245102|525048204|FG004|Overall Study|Protocol Violation|0|||
145599677|NCT00245102|525048205|FG005|Overall Study|Protocol Violation|0|||
145599678|NCT00245102|525048200|FG000|Overall Study|Death|0|||
145599679|NCT00245102|525048201|FG001|Overall Study|Death|0|||
145599680|NCT00245102|525048202|FG002|Overall Study|Death|0|||
145599681|NCT00245102|525048203|FG003|Overall Study|Death|1|||
145599682|NCT00245102|525048204|FG004|Overall Study|Death|0|||
145599683|NCT00245102|525048205|FG005|Overall Study|Death|0|||
145599684|NCT00245102|525048200|FG000|Overall Study|Adverse Event|4|||
145599685|NCT00245102|525048201|FG001|Overall Study|Adverse Event|2|||
145599686|NCT00245102|525048202|FG002|Overall Study|Adverse Event|5|||
145599687|NCT00245102|525048203|FG003|Overall Study|Adverse Event|1|||
145599688|NCT00245102|525048204|FG004|Overall Study|Adverse Event|0|||
145599689|NCT00245102|525048205|FG005|Overall Study|Adverse Event|2|||
145599690|NCT00245102|525048200|FG000|Overall Study|Decline in performance|0|||
145599691|NCT00245102|525048201|FG001|Overall Study|Decline in performance|2|||
145599692|NCT00245102|525048202|FG002|Overall Study|Decline in performance|0|||
145599693|NCT00245102|525048203|FG003|Overall Study|Decline in performance|1|||
145599694|NCT00245102|525048204|FG004|Overall Study|Decline in performance|0|||
145599695|NCT00245102|525048205|FG005|Overall Study|Decline in performance|2|||
145599696|NCT00245102|525048200|FG000|Overall Study|Participant needed surgery|0|||
145599697|NCT00245102|525048201|FG001|Overall Study|Participant needed surgery|0|||
145599698|NCT00245102|525048202|FG002|Overall Study|Participant needed surgery|1|||
145599699|NCT00245102|525048203|FG003|Overall Study|Participant needed surgery|0|||
145599700|NCT00245102|525048204|FG004|Overall Study|Participant needed surgery|0|||
145599701|NCT00245102|525048205|FG005|Overall Study|Participant needed surgery|0|||
145599702|NCT00245102|525048200|FG000|Overall Study|Clinical progression|1|||
145599703|NCT00245102|525048201|FG001|Overall Study|Clinical progression|0|||
145599704|NCT00245102|525048202|FG002|Overall Study|Clinical progression|0|||
145599705|NCT00245102|525048203|FG003|Overall Study|Clinical progression|0|||
145599706|NCT00245102|525048204|FG004|Overall Study|Clinical progression|0|||
145599707|NCT00245102|525048205|FG005|Overall Study|Clinical progression|0|||
145599708|NCT02293395|525048212|FG000|Overall Study|Lost to Follow-up|1|||
145599709|NCT02293395|525048213|FG001|Overall Study|Lost to Follow-up|0|||
145599710|NCT02293395|525048212|FG000|Overall Study|Withdrawal by Subject|8|||
145599711|NCT02293395|525048213|FG001|Overall Study|Withdrawal by Subject|7|||
145599712|NCT00224770|525048219|FG000|Overall Study|Lost to Follow-up|4|||
145599713|NCT00224770|525048220|FG001|Overall Study|Lost to Follow-up|2|||
145599714|NCT00224770|525048221|FG002|Overall Study|Lost to Follow-up|0|||
145599715|NCT01106430|525048222|FG000|Overall Study|Adverse Event|8|||
145627211|NCT05074498|525149145|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
145627212|NCT05074498|525149146|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
145627213|NCT05074498|525149147|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
145627214|NCT05074498|525149142|FG000|Part 1 (Upto Day 104)|Other|1|||
145627215|NCT05074498|525149143|FG001|Part 1 (Upto Day 104)|Other|0|||
145627216|NCT05074498|525149144|FG002|Part 1 (Upto Day 104)|Other|0|||
145627217|NCT05074498|525149145|FG003|Part 1 (Upto Day 104)|Other|0|||
145627218|NCT05074498|525149146|FG004|Part 1 (Upto Day 104)|Other|0|||
145627219|NCT05074498|525149147|FG005|Part 1 (Upto Day 104)|Other|0|||
145627220|NCT05074498|525149142|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
145627221|NCT05074498|525149143|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
145627222|NCT05074498|525149144|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
145627223|NCT05074498|525149145|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
145627224|NCT05074498|525149146|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
145627225|NCT05074498|525149147|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
145627226|NCT05074498|525149142|FG000|Part 2 (Upto Day 104)|Death|0|||
145627227|NCT05074498|525149143|FG001|Part 2 (Upto Day 104)|Death|0|||
145627228|NCT05074498|525149144|FG002|Part 2 (Upto Day 104)|Death|0|||
145627229|NCT05074498|525149145|FG003|Part 2 (Upto Day 104)|Death|0|||
145627230|NCT05074498|525149146|FG004|Part 2 (Upto Day 104)|Death|1|||
145627231|NCT05074498|525149147|FG005|Part 2 (Upto Day 104)|Death|0|||
145627232|NCT05074498|525149142|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
145599716|NCT01106430|525048223|FG001|Overall Study|Adverse Event|10|||
145599717|NCT01106430|525048222|FG000|Overall Study|Lack of Efficacy|2|||
145599718|NCT01106430|525048223|FG001|Overall Study|Lack of Efficacy|13|||
145599719|NCT01106430|525048222|FG000|Overall Study|Lost to Follow-up|5|||
145599720|NCT01106430|525048223|FG001|Overall Study|Lost to Follow-up|1|||
145599721|NCT01106430|525048222|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
145599722|NCT01106430|525048223|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
145599723|NCT01106430|525048222|FG000|Overall Study|Moved Out Of State|0|||
145599724|NCT01106430|525048223|FG001|Overall Study|Moved Out Of State|1|||
145599725|NCT01106430|525048222|FG000|Overall Study|Refused To Take Medication|0|||
145599726|NCT01106430|525048223|FG001|Overall Study|Refused To Take Medication|1|||
145599727|NCT01106430|525048222|FG000|Overall Study|Noncompliance|0|||
145599728|NCT01106430|525048223|FG001|Overall Study|Noncompliance|1|||
145599729|NCT01106430|525048222|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
145599730|NCT01106430|525048223|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
145599731|NCT01106430|525048222|FG000|Overall Study|Previous Use Of Marijuana|1|||
145599732|NCT01106430|525048223|FG001|Overall Study|Previous Use Of Marijuana|0|||
145599733|NCT01106430|525048222|FG000|Overall Study|Protocol Violation|7|||
145599734|NCT01106430|525048223|FG001|Overall Study|Protocol Violation|2|||
145599735|NCT01106430|525048222|FG000|Overall Study|Withdrawal by Subject|8|||
145599736|NCT01106430|525048223|FG001|Overall Study|Withdrawal by Subject|4|||
145599737|NCT00662857|525048226|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
145627233|NCT05074498|525149143|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
145627234|NCT05074498|525149144|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
145599738|NCT00662857|525048227|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
145599739|NCT00662857|525048226|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
145599740|NCT00662857|525048227|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
145599741|NCT00662857|525048226|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
145627235|NCT05074498|525149145|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
145627236|NCT05074498|525149146|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
145627237|NCT05074498|525149147|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
145627238|NCT05074498|525149142|FG000|Part 2 (Upto Day 104)|Other|0|||
145599742|NCT00662857|525048227|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
145599743|NCT00989092|525048228|FG000|Overall Study|Physician Decision|9|||
145599744|NCT00989092|525048229|FG001|Overall Study|Physician Decision|6|||
145627239|NCT05074498|525149143|FG001|Part 2 (Upto Day 104)|Other|0|||
145627240|NCT05074498|525149144|FG002|Part 2 (Upto Day 104)|Other|0|||
145467525|NCT03743064|524565979|FG000|Overall Study|Physician Decision|2|||
145467526|NCT03743064|524565980|FG001|Overall Study|Physician Decision|4|||
145467527|NCT03743064|524565979|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
145467528|NCT03743064|524565980|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
145467529|NCT04094584|524565983|FG000|Overall Study|No interest in study|88|||
145467530|NCT04094584|524565983|FG000|Overall Study|Unwilling to undergo screening tests|36|||
145467531|NCT04094584|524565983|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
145467532|NCT04094584|524565983|FG000|Overall Study|Opioid use|7|||
145467533|NCT04094584|524565983|FG000|Overall Study|Need for major surgery in study period|4|||
145467534|NCT04094584|524565983|FG000|Overall Study|eligible but declined enrollment|4|||
145467535|NCT04094584|524565983|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
145467536|NCT04094584|524565983|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
145467537|NCT04094584|524565983|FG000|Overall Study|Lost to Follow-up|3|||
145467538|NCT04094584|524565983|FG000|Overall Study|Withdrawal by Subject|2|||
145467539|NCT00530920|524565984|FG000|Overall Study|Randomized but not treated|0|||
145467540|NCT00530920|524565985|FG001|Overall Study|Randomized but not treated|2|||
145467541|NCT00530920|524565986|FG002|Overall Study|Randomized but not treated|0|||
145467542|NCT00530920|524565984|FG000|Overall Study|Adverse Event|0|||
145467543|NCT00530920|524565985|FG001|Overall Study|Adverse Event|0|||
145467544|NCT00530920|524565986|FG002|Overall Study|Adverse Event|3|||
145467545|NCT00530920|524565984|FG000|Overall Study|Withdrawal by Subject|0|||
145467546|NCT00530920|524565985|FG001|Overall Study|Withdrawal by Subject|0|||
145467547|NCT00530920|524565986|FG002|Overall Study|Withdrawal by Subject|1|||
145467548|NCT02616393|524565992|FG000|Overall Study|Death|5|||
145467549|NCT02616393|524565993|FG001|Overall Study|Death|12|||
145467550|NCT02616393|524565994|FG002|Overall Study|Death|1|||
145467551|NCT02616393|524565992|FG000|Overall Study|Termination by Sponsor|4|||
145467552|NCT02616393|524565993|FG001|Overall Study|Termination by Sponsor|5|||
145467553|NCT02616393|524565994|FG002|Overall Study|Termination by Sponsor|2|||
145467554|NCT02616393|524565992|FG000|Overall Study|Other|3|||
145467555|NCT02616393|524565993|FG001|Overall Study|Other|0|||
145467556|NCT02616393|524565994|FG002|Overall Study|Other|0|||
145467557|NCT02616393|524565992|FG000|Overall Study|Withdrawal by Subject|1|||
145467558|NCT02616393|524565993|FG001|Overall Study|Withdrawal by Subject|1|||
145467559|NCT02616393|524565994|FG002|Overall Study|Withdrawal by Subject|0|||
145467560|NCT02616393|524565992|FG000|Overall Study|Lost to Follow-up|0|||
145467561|NCT02616393|524565993|FG001|Overall Study|Lost to Follow-up|2|||
145467562|NCT02616393|524565994|FG002|Overall Study|Lost to Follow-up|0|||
145467563|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
145467564|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
145467565|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
145467566|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
145467567|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
145467568|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
145467569|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
145467570|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
145467571|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
145467572|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
145467573|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
145467574|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
145467575|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
145467576|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
145467577|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
145467578|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
145467579|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
145467580|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
145467581|NCT01302054|524565995|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
145467582|NCT01302054|524565996|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
145467583|NCT01302054|524565997|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
145467584|NCT01302054|524565995|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
145467585|NCT01302054|524565996|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
145467586|NCT01302054|524565997|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
145467587|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
145467588|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
145467589|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
145467590|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
145467591|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
145599745|NCT00989092|525048228|FG000|Overall Study|Adverse Event|20|||
145599746|NCT00989092|525048229|FG001|Overall Study|Adverse Event|1|||
145599747|NCT00989092|525048228|FG000|Overall Study|Chemotherapy initiated|12|||
145627241|NCT05074498|525149145|FG003|Part 2 (Upto Day 104)|Other|0|||
145599748|NCT00989092|525048229|FG001|Overall Study|Chemotherapy initiated|4|||
145599749|NCT00989092|525048228|FG000|Overall Study|Withdrawal by Subject|17|||
145599750|NCT00989092|525048229|FG001|Overall Study|Withdrawal by Subject|9|||
145599751|NCT00989092|525048228|FG000|Overall Study|Death|14|||
145599752|NCT00989092|525048229|FG001|Overall Study|Death|2|||
145599753|NCT00989092|525048228|FG000|Overall Study|Ineligibility determined|3|||
145599754|NCT00989092|525048229|FG001|Overall Study|Ineligibility determined|3|||
145599755|NCT00989092|525048228|FG000|Overall Study|Lost to Follow-up|6|||
145599756|NCT00989092|525048229|FG001|Overall Study|Lost to Follow-up|2|||
145599757|NCT00989092|525048228|FG000|Overall Study|Other|3|||
145599758|NCT00989092|525048229|FG001|Overall Study|Other|1|||
145599759|NCT00989092|525048228|FG000|Overall Study|Protocol deviation|2|||
145599760|NCT00989092|525048229|FG001|Overall Study|Protocol deviation|0|||
145599761|NCT00989092|525048228|FG000|Overall Study|Erythropoietin therapy initiated|2|||
145599762|NCT00989092|525048229|FG001|Overall Study|Erythropoietin therapy initiated|0|||
145599763|NCT00989092|525048228|FG000|Overall Study|Did not receive study drug|2|||
145599764|NCT00989092|525048229|FG001|Overall Study|Did not receive study drug|0|||
145599765|NCT02832622|525048231|FG000|Overall Study|MPP not programmed|1259|||
145599766|NCT02832622|525048231|FG000|Overall Study|Withdrawal by Subject|123|||
145599767|NCT02832622|525048231|FG000|Overall Study|Death|119|||
145599768|NCT02832622|525048231|FG000|Overall Study|Unsuccessful CRT implant|93|||
145599769|NCT02832622|525048231|FG000|Overall Study|Lost to Follow-up|45|||
145599770|NCT02832622|525048231|FG000|Overall Study|Patient non-compliance|42|||
145599771|NCT02832622|525048231|FG000|Overall Study|Withdrawal by other reasons|25|||
145599772|NCT02832622|525048231|FG000|Overall Study|System explant|24|||
145599773|NCT02832622|525048231|FG000|Overall Study|Physician Decision|6|||
145599774|NCT02127372|525048232|FG000|Overall Study|Withdrawal by Subject|1|||
145599775|NCT02127372|525048233|FG001|Overall Study|Withdrawal by Subject|0|||
145599776|NCT03837509|525048234|FG000|Phase 1|Death|5|||
145599777|NCT03837509|525048235|FG001|Phase 1|Death|2|||
145599778|NCT03837509|525048236|FG002|Phase 1|Death|0|||
145599779|NCT03837509|525048237|FG003|Phase 1|Death|0|||
145599780|NCT03837509|525048238|FG004|Phase 1|Death|0|||
145599781|NCT03837509|525048234|FG000|Phase 2|Death|0|||
145599782|NCT03837509|525048235|FG001|Phase 2|Death|0|||
145599783|NCT03837509|525048236|FG002|Phase 2|Death|0|||
145599784|NCT03837509|525048237|FG003|Phase 2|Death|1|||
145627242|NCT05074498|525149146|FG004|Part 2 (Upto Day 104)|Other|1|||
145627243|NCT05074498|525149147|FG005|Part 2 (Upto Day 104)|Other|0|||
145627244|NCT01240356|525149148|FG000|Overall Study|Withdrawal by Subject|2|||
145627245|NCT01240356|525149149|FG001|Overall Study|Withdrawal by Subject|0|||
145627246|NCT01240356|525149148|FG000|Overall Study|MRI contraindication|1|||
145627247|NCT01240356|525149149|FG001|Overall Study|MRI contraindication|0|||
145627248|NCT01306331|525149150|FG000|Overall Study|Adverse Event|28|||
145599785|NCT03837509|525048238|FG004|Phase 2|Death|1|||
145599786|NCT02173548|525048239|FG000|Overall Study|Lost to Follow-up|0|||
145599787|NCT02173548|525048240|FG001|Overall Study|Lost to Follow-up|2|||
145599788|NCT02173548|525048239|FG000|Overall Study|Withdrawal by Subject|1|||
145599789|NCT02173548|525048240|FG001|Overall Study|Withdrawal by Subject|0|||
145599790|NCT03822117|525048243|FG000|Overall Study|Death|18|||
145599791|NCT03822117|525048244|FG001|Overall Study|Death|17|||
145599792|NCT03822117|525048245|FG002|Overall Study|Death|12|||
145599793|NCT03822117|525048246|FG003|Overall Study|Death|4|||
145627249|NCT01306331|525149151|FG001|Overall Study|Adverse Event|25|||
145627250|NCT01306331|525149150|FG000|Overall Study|Lost to Follow-up|321|||
145627251|NCT01306331|525149151|FG001|Overall Study|Lost to Follow-up|323|||
145599794|NCT03822117|525048243|FG000|Overall Study|Lost to Follow-up|1|||
145599795|NCT03822117|525048244|FG001|Overall Study|Lost to Follow-up|2|||
145599796|NCT03822117|525048245|FG002|Overall Study|Lost to Follow-up|3|||
145599797|NCT03822117|525048246|FG003|Overall Study|Lost to Follow-up|0|||
145627252|NCT01306331|525149150|FG000|Overall Study|Physician Decision|26|||
145599798|NCT03822117|525048243|FG000|Overall Study|Study Terminated by Sponsor|25|||
145599799|NCT03822117|525048244|FG001|Overall Study|Study Terminated by Sponsor|11|||
145599800|NCT03822117|525048245|FG002|Overall Study|Study Terminated by Sponsor|6|||
145599801|NCT03822117|525048246|FG003|Overall Study|Study Terminated by Sponsor|0|||
145599802|NCT03822117|525048243|FG000|Overall Study|Withdrawal by Subject|4|||
145599803|NCT03822117|525048244|FG001|Overall Study|Withdrawal by Subject|0|||
145599804|NCT03822117|525048245|FG002|Overall Study|Withdrawal by Subject|3|||
145599805|NCT03822117|525048246|FG003|Overall Study|Withdrawal by Subject|0|||
145627253|NCT01306331|525149151|FG001|Overall Study|Physician Decision|22|||
145467592|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
145467593|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145467594|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
145627254|NCT01306331|525149150|FG000|Overall Study|Pregnancy|136|||
145599806|NCT03822117|525048243|FG000|Overall Study|Disease Progression|1|||
145599807|NCT03822117|525048244|FG001|Overall Study|Disease Progression|2|||
145599808|NCT03822117|525048245|FG002|Overall Study|Disease Progression|1|||
145599809|NCT03822117|525048246|FG003|Overall Study|Disease Progression|0|||
145599810|NCT03822117|525048243|FG000|Overall Study|Never Returned to Hospital|0|||
145599811|NCT03822117|525048244|FG001|Overall Study|Never Returned to Hospital|0|||
145599812|NCT03822117|525048245|FG002|Overall Study|Never Returned to Hospital|1|||
145599813|NCT03822117|525048246|FG003|Overall Study|Never Returned to Hospital|0|||
145599814|NCT02799784|525048254|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
145599815|NCT02799784|525048255|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
145599816|NCT02799784|525048254|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
145599817|NCT02799784|525048255|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
145599818|NCT02799784|525048254|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
145599819|NCT02799784|525048255|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
145599820|NCT02799784|525048254|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
145599821|NCT02799784|525048255|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
145599822|NCT02799784|525048254|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
145599823|NCT02799784|525048255|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
145599824|NCT02799784|525048254|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
145599825|NCT02799784|525048255|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
145599826|NCT01804816|525048259|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
145599827|NCT01804816|525048259|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
145599828|NCT01050816|525048260|FG000|Overall Study|Lost to Follow-up|2|||
145599829|NCT01050816|525048260|FG000|Overall Study|patient's refusal|2|||
145599830|NCT03086330|525048261|FG000|Overall Study|Withdrawal by Subject|3|||
145599831|NCT03086330|525048262|FG001|Overall Study|Withdrawal by Subject|2|||
145599832|NCT03086330|525048261|FG000|Overall Study|Lost to Follow-up|1|||
145599833|NCT03086330|525048262|FG001|Overall Study|Lost to Follow-up|2|||
145599834|NCT01256411|525048265|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
145599835|NCT01256411|525048266|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
145599836|NCT01256411|525048267|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
145599837|NCT01256411|525048268|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
145599838|NCT01256411|525048269|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
145599839|NCT01256411|525048270|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
145599840|NCT01256411|525048265|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
145599841|NCT01256411|525048266|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
145599842|NCT01256411|525048267|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
145599843|NCT01256411|525048268|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
145599844|NCT01256411|525048269|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
145599845|NCT01256411|525048270|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
145599846|NCT01256411|525048265|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
145599847|NCT01256411|525048266|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
145599848|NCT01256411|525048267|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
145599849|NCT01256411|525048268|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
145599850|NCT01256411|525048269|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
145599851|NCT01256411|525048270|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
145599852|NCT01256411|525048265|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
145599853|NCT01256411|525048266|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
145599854|NCT01256411|525048267|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
145599855|NCT01256411|525048268|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
145599856|NCT01256411|525048269|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
145599857|NCT01256411|525048270|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
145599858|NCT01256411|525048265|FG000|Extension by Maximum Treatment|Adverse Event|4|||
145599859|NCT01256411|525048266|FG001|Extension by Maximum Treatment|Adverse Event|2|||
145599860|NCT01256411|525048267|FG002|Extension by Maximum Treatment|Adverse Event|1|||
145599861|NCT01256411|525048268|FG003|Extension by Maximum Treatment|Adverse Event|0|||
145599862|NCT01256411|525048269|FG004|Extension by Maximum Treatment|Adverse Event|0|||
145599863|NCT01256411|525048270|FG005|Extension by Maximum Treatment|Adverse Event|0|||
145599864|NCT01256411|525048265|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
145599865|NCT01256411|525048266|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
145599866|NCT01256411|525048267|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
145599867|NCT01256411|525048268|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
145599868|NCT01256411|525048269|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
145599869|NCT01256411|525048270|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
145599870|NCT01256411|525048265|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
145599871|NCT01256411|525048266|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
145599872|NCT01256411|525048267|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
145599873|NCT01256411|525048268|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
145599874|NCT01256411|525048269|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
145599875|NCT01256411|525048270|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
145599876|NCT01256411|525048265|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
145599877|NCT01256411|525048266|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
145627255|NCT01306331|525149151|FG001|Overall Study|Pregnancy|151|||
145627256|NCT01306331|525149150|FG000|Overall Study|Protocol Violation|154|||
145599878|NCT01256411|525048267|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
145599879|NCT01256411|525048268|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
145599880|NCT01256411|525048269|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
145599881|NCT01256411|525048270|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
145599882|NCT01256411|525048265|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
145599883|NCT01256411|525048266|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
145599884|NCT01256411|525048267|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
145599885|NCT01256411|525048268|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
145627257|NCT01306331|525149151|FG001|Overall Study|Protocol Violation|124|||
145599886|NCT01256411|525048269|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
145599887|NCT01256411|525048270|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
145599888|NCT01256411|525048265|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
145599889|NCT01256411|525048266|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
145599890|NCT01256411|525048267|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
145599891|NCT01256411|525048268|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
145599892|NCT01256411|525048269|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
145599893|NCT01256411|525048270|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
145599894|NCT01445652|525048271|FG000|Overall Study|Not comfortable in lenses|5|||
145599895|NCT01445652|525048272|FG001|Overall Study|Not comfortable in lenses|0|||
145599896|NCT01445652|525048271|FG000|Overall Study|Failed to attend scheduled visit|2|||
145599897|NCT01445652|525048272|FG001|Overall Study|Failed to attend scheduled visit|3|||
145599898|NCT01445652|525048271|FG000|Overall Study|Failed teach session|2|||
145599899|NCT01445652|525048272|FG001|Overall Study|Failed teach session|0|||
145599900|NCT01445652|525048271|FG000|Overall Study|Adverse Event|1|||
145599901|NCT01445652|525048272|FG001|Overall Study|Adverse Event|0|||
145599902|NCT00929162|525048273|FG000|Overall Study|Adverse Event|8|||
145599903|NCT00929162|525048274|FG001|Overall Study|Adverse Event|5|||
145599904|NCT00929162|525048273|FG000|Overall Study|Withdrawal by Subject|3|||
145599905|NCT00929162|525048274|FG001|Overall Study|Withdrawal by Subject|1|||
145599906|NCT00929162|525048273|FG000|Overall Study|Protocol Violation|32|||
145599907|NCT00929162|525048274|FG001|Overall Study|Protocol Violation|30|||
145599908|NCT00929162|525048273|FG000|Overall Study|Other termination reason|5|||
145599909|NCT00929162|525048274|FG001|Overall Study|Other termination reason|6|||
145599910|NCT00117676|525048277|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
145599911|NCT00117676|525048278|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
145599912|NCT00117676|525048277|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
145599913|NCT00117676|525048278|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
145599914|NCT00117676|525048277|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
145599915|NCT00117676|525048278|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
145599916|NCT00117676|525048277|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
145599917|NCT00117676|525048278|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
145599918|NCT00117676|525048277|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
145599919|NCT00117676|525048278|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
145599920|NCT00117676|525048277|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
145599921|NCT00117676|525048278|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
145599922|NCT00117676|525048277|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
145599923|NCT00117676|525048278|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
145599924|NCT00117676|525048277|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
145599925|NCT00117676|525048278|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
145599926|NCT00117676|525048277|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
145599927|NCT00117676|525048278|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
145599928|NCT00117676|525048277|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
145599929|NCT00117676|525048278|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
145599930|NCT00117676|525048277|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
145599931|NCT00117676|525048278|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
145599932|NCT00117676|525048277|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
145599933|NCT00117676|525048278|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
145599934|NCT00117676|525048277|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
145599935|NCT00117676|525048278|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
145599936|NCT00117676|525048277|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
145599937|NCT00117676|525048278|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
145599938|NCT00117676|525048277|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
145599939|NCT00117676|525048278|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
145599940|NCT00117676|525048277|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
145627258|NCT01306331|525149150|FG000|Overall Study|Withdrawal by Subject|163|||
145627259|NCT01306331|525149151|FG001|Overall Study|Withdrawal by Subject|152|||
145599941|NCT00117676|525048278|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
145599942|NCT00117676|525048277|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
145599943|NCT00117676|525048278|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
145599944|NCT00117676|525048277|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
145599945|NCT00117676|525048278|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
145599946|NCT00117676|525048277|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
145599947|NCT00117676|525048278|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
145599948|NCT00117676|525048277|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
145599949|NCT00117676|525048278|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
145599950|NCT00117676|525048277|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
145599951|NCT00117676|525048278|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
145599952|NCT00117676|525048277|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
145599953|NCT00117676|525048278|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
145599954|NCT00117676|525048277|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
145599955|NCT00117676|525048278|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
145599956|NCT00117676|525048277|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
145599957|NCT00117676|525048278|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
145599958|NCT00117676|525048277|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
145599959|NCT00117676|525048278|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
145599960|NCT00117676|525048277|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
145599961|NCT00117676|525048278|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
145599962|NCT00117676|525048277|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
145599963|NCT00117676|525048278|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
145599964|NCT00117676|525048277|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
145599965|NCT00117676|525048278|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
145599966|NCT00117676|525048277|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
145599967|NCT00117676|525048278|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
145599968|NCT00117676|525048277|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
145599969|NCT00117676|525048278|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
145599970|NCT00117676|525048277|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
145599971|NCT00117676|525048278|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
145599972|NCT00117676|525048277|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
145599973|NCT00117676|525048278|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
145599974|NCT00117676|525048277|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
145599975|NCT00117676|525048278|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
145599976|NCT00117676|525048277|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
145599977|NCT00117676|525048278|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
145599978|NCT00117676|525048277|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
145599979|NCT00117676|525048278|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
145599980|NCT00952822|525048279|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
145599981|NCT00952822|525048280|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
145599982|NCT00952822|525048281|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
145599983|NCT00952822|525048282|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
145599984|NCT00952822|525048279|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
145599985|NCT00952822|525048280|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
145599986|NCT00952822|525048281|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
145599987|NCT00952822|525048282|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
145599988|NCT01281644|525048285|FG000|Overall Study|Lost to Follow-up|3|||
145599989|NCT01281644|525048285|FG000|Overall Study|Withdrawal by Subject|2|||
145599990|NCT01755702|525048286|FG000|Wash Out Period I|Other Reason|3|||
145599991|NCT01755702|525048286|FG000|Washout Period II|Other Reason|5|||
145599992|NCT03440372|525048291|FG000|Treatment|Adverse Event|16|||
145599993|NCT03440372|525048292|FG001|Treatment|Adverse Event|8|||
145599994|NCT03440372|525048291|FG000|Treatment|Lack of Efficacy|4|||
145599995|NCT03440372|525048292|FG001|Treatment|Lack of Efficacy|2|||
145599996|NCT03440372|525048291|FG000|Treatment|Withdrawal by Subject|12|||
145599997|NCT03440372|525048292|FG001|Treatment|Withdrawal by Subject|8|||
145599998|NCT03440372|525048291|FG000|Treatment|Lost to Follow-up|1|||
145599999|NCT03440372|525048292|FG001|Treatment|Lost to Follow-up|0|||
145600000|NCT03440372|525048291|FG000|Treatment|Pregnancy|1|||
145600001|NCT03440372|525048292|FG001|Treatment|Pregnancy|0|||
145600002|NCT03440372|525048291|FG000|Treatment|Study Terminated by Sponsor|2|||
145600003|NCT03440372|525048292|FG001|Treatment|Study Terminated by Sponsor|1|||
145600004|NCT03440372|525048291|FG000|Treatment|Other Reason|2|||
145600005|NCT03440372|525048292|FG001|Treatment|Other Reason|3|||
145600006|NCT03945292|525048293|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
145600007|NCT03945292|525048294|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600008|NCT03945292|525048295|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
145600009|NCT03945292|525048296|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600010|NCT03945292|525048297|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600011|NCT03945292|525048298|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600012|NCT03945292|525048299|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600013|NCT03945292|525048300|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
145600014|NCT03945292|525048293|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600015|NCT03945292|525048294|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600016|NCT03945292|525048295|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
145600017|NCT03945292|525048296|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600018|NCT03945292|525048297|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600019|NCT03945292|525048298|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600020|NCT03945292|525048299|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600021|NCT03945292|525048300|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
145600022|NCT03945292|525048293|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600023|NCT03945292|525048294|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600024|NCT03945292|525048295|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600025|NCT03945292|525048296|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600026|NCT03945292|525048297|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600027|NCT03945292|525048298|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600028|NCT03945292|525048299|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
145600029|NCT03945292|525048300|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
145600030|NCT02684006|525048301|FG000|Overall Study|Other|18|||
145600031|NCT02684006|525048302|FG001|Overall Study|Other|6|||
145600032|NCT02684006|525048301|FG000|Overall Study|Protocol Violation|2|||
145600033|NCT02684006|525048302|FG001|Overall Study|Protocol Violation|1|||
145600034|NCT02684006|525048301|FG000|Overall Study|Non-compliance with study drug|1|||
145600035|NCT02684006|525048302|FG001|Overall Study|Non-compliance with study drug|1|||
145600036|NCT02684006|525048301|FG000|Overall Study|No longer met eligibility criteria|6|||
145600037|NCT02684006|525048302|FG001|Overall Study|No longer met eligibility criteria|2|||
145600038|NCT02684006|525048301|FG000|Overall Study|Lost to Follow-up|0|||
145600039|NCT02684006|525048302|FG001|Overall Study|Lost to Follow-up|1|||
145600040|NCT02684006|525048301|FG000|Overall Study|Death|25|||
145600041|NCT02684006|525048302|FG001|Overall Study|Death|22|||
145600042|NCT02684006|525048301|FG000|Overall Study|Global deterioration of health status|18|||
145600043|NCT02684006|525048302|FG001|Overall Study|Global deterioration of health status|20|||
145600044|NCT02684006|525048301|FG000|Overall Study|Physician Decision|15|||
145600045|NCT02684006|525048302|FG001|Overall Study|Physician Decision|8|||
145600046|NCT02684006|525048301|FG000|Overall Study|Adverse Event|86|||
145600047|NCT02684006|525048302|FG001|Overall Study|Adverse Event|65|||
145600048|NCT02684006|525048301|FG000|Overall Study|Withdrawal by Subject|29|||
145600049|NCT02684006|525048302|FG001|Overall Study|Withdrawal by Subject|43|||
145600050|NCT02684006|525048301|FG000|Overall Study|Progressive disease|236|||
145600051|NCT02684006|525048302|FG001|Overall Study|Progressive disease|266|||
145600052|NCT02684006|525048301|FG000|Overall Study|Participation terminated by sponsor|6|||
145600053|NCT02684006|525048302|FG001|Overall Study|Participation terminated by sponsor|9|||
145600054|NCT05103384|525048303|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
145600055|NCT05608499|525048304|FG000|Overall Study|Lack of Efficacy|1|||
145600056|NCT05608499|525048305|FG001|Overall Study|Lack of Efficacy|0|||
145600057|NCT05608499|525048304|FG000|Overall Study|Lost to Follow-up|0|||
145600058|NCT05608499|525048305|FG001|Overall Study|Lost to Follow-up|1|||
145600059|NCT00514735|525048306|FG000|Overall Study|Withdrawal by Subject|13|||
145600060|NCT00514735|525048307|FG001|Overall Study|Withdrawal by Subject|5|||
145600061|NCT00514735|525048306|FG000|Overall Study|Death|1|||
145600062|NCT00514735|525048307|FG001|Overall Study|Death|0|||
145600063|NCT00514735|525048306|FG000|Overall Study|Lost to Follow-up|0|||
145600064|NCT00514735|525048307|FG001|Overall Study|Lost to Follow-up|1|||
145600065|NCT02660827|525048310|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
145600066|NCT02660827|525048310|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
145600067|NCT02660827|525048310|FG000|From Study to End of Continued Access|Adverse Event|3|||
145600068|NCT02660827|525048310|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
145600069|NCT02660827|525048310|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
145600070|NCT02660827|525048310|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
145600071|NCT02660827|525048310|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
145600072|NCT02660827|525048310|FG000|Period 2: Continued Access Period|Adverse Event|3|||
145600073|NCT01422408|525048311|FG000|Overall Study|Adverse Event|1|||
145600074|NCT01422408|525048311|FG000|Overall Study|Withdrawal by Subject|3|||
145600075|NCT04672941|525048312|FG000|Overall Study|Investigator decision|1|||
145600076|NCT04672941|525048312|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
145600077|NCT04672941|525048312|FG000|Overall Study|COVID-19 related but no adverse event|1|||
145600078|NCT04672941|525048312|FG000|Overall Study|Adverse Event|2|||
145467595|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
145467596|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
145467597|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
145467598|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
145467599|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
145467600|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
145467601|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
145467602|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
145467603|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
145467604|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
145467605|NCT01302054|524565995|FG000|Double-Blind Treatment Phase|Other|0|||
145467606|NCT01302054|524565996|FG001|Double-Blind Treatment Phase|Other|4|||
145467607|NCT01302054|524565997|FG002|Double-Blind Treatment Phase|Other|9|||
145467608|NCT02713867|524565998|FG000|Randomization|Other Reason|2|||
145467609|NCT02713867|524565999|FG001|Randomization|Other Reason|1|||
145467610|NCT02713867|524565998|FG000|Randomization|Participant Withdrew consent|0|||
145467611|NCT02713867|524565999|FG001|Randomization|Participant Withdrew consent|2|||
145467612|NCT02713867|524565998|FG000|Treatment Period|Other Reasons|22|||
145467613|NCT02713867|524565999|FG001|Treatment Period|Other Reasons|28|||
145467614|NCT02713867|524565998|FG000|Treatment Period|Administrative reason by sponsor|21|||
145467615|NCT02713867|524565999|FG001|Treatment Period|Administrative reason by sponsor|16|||
145467616|NCT02713867|524565998|FG000|Treatment Period|No longer meets study criteria|2|||
145467617|NCT02713867|524565999|FG001|Treatment Period|No longer meets study criteria|1|||
145467618|NCT02713867|524565998|FG000|Treatment Period|Poor/Non Compliance|1|||
145467619|NCT02713867|524565999|FG001|Treatment Period|Poor/Non Compliance|0|||
145467620|NCT02713867|524565998|FG000|Treatment Period|Maximum Clinical Benefit|5|||
145467621|NCT02713867|524565999|FG001|Treatment Period|Maximum Clinical Benefit|6|||
145467622|NCT02713867|524565998|FG000|Treatment Period|Withdrew consent|3|||
145467623|NCT02713867|524565999|FG001|Treatment Period|Withdrew consent|6|||
145467624|NCT02713867|524565998|FG000|Treatment Period|Requested to Discontinue|8|||
145467625|NCT02713867|524565999|FG001|Treatment Period|Requested to Discontinue|8|||
145467626|NCT02713867|524565998|FG000|Treatment Period|AE unrelated to Study Drug|11|||
145467627|NCT02713867|524565999|FG001|Treatment Period|AE unrelated to Study Drug|10|||
145467628|NCT02713867|524565998|FG000|Treatment Period|Death|7|||
145467629|NCT02713867|524565999|FG001|Treatment Period|Death|3|||
145467630|NCT02713867|524565998|FG000|Treatment Period|Study Drug Toxicity|16|||
145467631|NCT02713867|524565999|FG001|Treatment Period|Study Drug Toxicity|19|||
145467632|NCT02713867|524565998|FG000|Treatment Period|Disease Progression|82|||
145467633|NCT02713867|524565999|FG001|Treatment Period|Disease Progression|83|||
145467634|NCT00857948|524566000|FG000|Overall Study|Withdrawal by Subject|2|||
145467635|NCT00857948|524566001|FG001|Overall Study|Withdrawal by Subject|0|||
145467636|NCT00857948|524566002|FG002|Overall Study|Withdrawal by Subject|0|||
145467637|NCT00857948|524566003|FG003|Overall Study|Withdrawal by Subject|0|||
145467638|NCT00857948|524566000|FG000|Overall Study|Protocol Violation|1|||
145467639|NCT00857948|524566001|FG001|Overall Study|Protocol Violation|0|||
145467640|NCT00857948|524566002|FG002|Overall Study|Protocol Violation|1|||
145467641|NCT00857948|524566003|FG003|Overall Study|Protocol Violation|0|||
145467642|NCT04135859|524566005|FG000|Overall Study|Withdrawal by Subject|1|||
145467643|NCT04135859|524566006|FG001|Overall Study|Withdrawal by Subject|0|||
145467644|NCT04135859|524566005|FG000|Overall Study|Withdrawal due to screening failure|1|||
145467645|NCT04135859|524566006|FG001|Overall Study|Withdrawal due to screening failure|2|||
145467646|NCT04135859|524566005|FG000|Overall Study|Did not complete stress test|3|||
145467647|NCT04135859|524566006|FG001|Overall Study|Did not complete stress test|3|||
145467648|NCT04135859|524566005|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
145467649|NCT04135859|524566006|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
145467650|NCT03242018|524566010|FG000|Overall Study|Adverse Event|7|||
145467651|NCT03242018|524566011|FG001|Overall Study|Adverse Event|7|||
145467652|NCT03242018|524566012|FG002|Overall Study|Adverse Event|6|||
145467653|NCT03242018|524566010|FG000|Overall Study|Lost to Follow-up|2|||
145467654|NCT03242018|524566011|FG001|Overall Study|Lost to Follow-up|2|||
145467655|NCT03242018|524566012|FG002|Overall Study|Lost to Follow-up|2|||
145467656|NCT03242018|524566010|FG000|Overall Study|At the Participant's Own Request|5|||
145467657|NCT03242018|524566011|FG001|Overall Study|At the Participant's Own Request|1|||
145467658|NCT03242018|524566012|FG002|Overall Study|At the Participant's Own Request|4|||
145467659|NCT03242018|524566010|FG000|Overall Study|Reason Not Specified|3|||
145467660|NCT03242018|524566011|FG001|Overall Study|Reason Not Specified|4|||
145467661|NCT03242018|524566012|FG002|Overall Study|Reason Not Specified|1|||
145467662|NCT03242018|524566010|FG000|Overall Study|Study Terminated by Sponsor|1|||
145467663|NCT03242018|524566011|FG001|Overall Study|Study Terminated by Sponsor|0|||
145467664|NCT03242018|524566012|FG002|Overall Study|Study Terminated by Sponsor|1|||
145467665|NCT02365285|524566013|FG000|Overall Study|Physician Decision|0|||
145467666|NCT02365285|524566014|FG001|Overall Study|Physician Decision|1|||
145467667|NCT02365285|524566015|FG002|Overall Study|Physician Decision|1|||
145467668|NCT02365285|524566016|FG003|Overall Study|Physician Decision|0|||
145627260|NCT01306331|525149150|FG000|Overall Study|Not sexually active|29|||
145627261|NCT01306331|525149151|FG001|Overall Study|Not sexually active|28|||
145627262|NCT01306331|525149150|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
145627263|NCT01306331|525149151|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
145627264|NCT01306331|525149150|FG000|Overall Study|Other|34|||
145627265|NCT01306331|525149151|FG001|Overall Study|Other|32|||
145627266|NCT04048135|525149157|FG000|Overall Study|Withdrawal by Subject|1|||
145627267|NCT04048135|525149158|FG001|Overall Study|Withdrawal by Subject|1|||
145627268|NCT04048135|525149159|FG002|Overall Study|Withdrawal by Subject|1|||
145627269|NCT04048135|525149160|FG003|Overall Study|Withdrawal by Subject|2|||
145627270|NCT04048135|525149161|FG004|Overall Study|Withdrawal by Subject|0|||
145627271|NCT04048135|525149162|FG005|Overall Study|Withdrawal by Subject|0|||
145627272|NCT04048135|525149163|FG006|Overall Study|Withdrawal by Subject|1|||
145627273|NCT04048135|525149164|FG007|Overall Study|Withdrawal by Subject|1|||
145627274|NCT04048135|525149157|FG000|Overall Study|Adverse Event|0|||
145627275|NCT04048135|525149158|FG001|Overall Study|Adverse Event|0|||
145627276|NCT04048135|525149159|FG002|Overall Study|Adverse Event|0|||
145627277|NCT04048135|525149160|FG003|Overall Study|Adverse Event|1|||
145627278|NCT04048135|525149161|FG004|Overall Study|Adverse Event|1|||
145627279|NCT04048135|525149162|FG005|Overall Study|Adverse Event|0|||
145627280|NCT04048135|525149163|FG006|Overall Study|Adverse Event|0|||
145627281|NCT04048135|525149164|FG007|Overall Study|Adverse Event|0|||
145627282|NCT04048135|525149157|FG000|Overall Study|Protocol Violation|0|||
145627283|NCT04048135|525149158|FG001|Overall Study|Protocol Violation|0|||
145627284|NCT04048135|525149159|FG002|Overall Study|Protocol Violation|0|||
145627285|NCT04048135|525149160|FG003|Overall Study|Protocol Violation|0|||
145627286|NCT04048135|525149161|FG004|Overall Study|Protocol Violation|0|||
145627287|NCT04048135|525149162|FG005|Overall Study|Protocol Violation|1|||
145627288|NCT04048135|525149163|FG006|Overall Study|Protocol Violation|0|||
145627289|NCT04048135|525149164|FG007|Overall Study|Protocol Violation|0|||
145627290|NCT00172185|525149165|FG000|Overall Study|Adverse Event|0|||
145627291|NCT00172185|525149166|FG001|Overall Study|Adverse Event|1|||
145627292|NCT00172185|525149167|FG002|Overall Study|Adverse Event|3|||
145627293|NCT00172185|525149168|FG003|Overall Study|Adverse Event|4|||
145627294|NCT00172185|525149165|FG000|Overall Study|Physician Decision|0|||
145627295|NCT00172185|525149166|FG001|Overall Study|Physician Decision|0|||
145627296|NCT00172185|525149167|FG002|Overall Study|Physician Decision|1|||
145627297|NCT00172185|525149168|FG003|Overall Study|Physician Decision|0|||
145627298|NCT00172185|525149165|FG000|Overall Study|SPONSOR Decision|0|||
145627299|NCT00172185|525149166|FG001|Overall Study|SPONSOR Decision|1|||
145627300|NCT00172185|525149167|FG002|Overall Study|SPONSOR Decision|0|||
145627301|NCT00172185|525149168|FG003|Overall Study|SPONSOR Decision|0|||
145627302|NCT00172185|525149165|FG000|Overall Study|Withdrawal by Subject|0|||
145627303|NCT00172185|525149166|FG001|Overall Study|Withdrawal by Subject|0|||
145627304|NCT00172185|525149167|FG002|Overall Study|Withdrawal by Subject|1|||
145627305|NCT00172185|525149168|FG003|Overall Study|Withdrawal by Subject|0|||
145627306|NCT01677936|525149169|FG000|Overall Study|Lost to Follow-up|4|||
145627307|NCT01677936|525149170|FG001|Overall Study|Lost to Follow-up|1|||
145627308|NCT01677936|525149169|FG000|Overall Study|Protocol Violation|3|||
145627309|NCT01677936|525149170|FG001|Overall Study|Protocol Violation|0|||
145627310|NCT01677936|525149169|FG000|Overall Study|Adverse Event|1|||
145627311|NCT01677936|525149170|FG001|Overall Study|Adverse Event|0|||
145627312|NCT01677936|525149169|FG000|Overall Study|Lost to Follow-up|1|||
145627313|NCT01677936|525149170|FG001|Overall Study|Lost to Follow-up|0|||
145627314|NCT01677936|525149169|FG000|Overall Study|Protocol Violation|0|||
145627315|NCT01677936|525149170|FG001|Overall Study|Protocol Violation|4|||
145627316|NCT03837028|525149173|FG000|Overall Study|Lost to Follow-up|4|||
145627317|NCT03837028|525149174|FG001|Overall Study|Lost to Follow-up|0|||
145627318|NCT03837028|525149175|FG002|Overall Study|Lost to Follow-up|2|||
145627319|NCT03837028|525149176|FG003|Overall Study|Lost to Follow-up|0|||
145627320|NCT03837028|525149173|FG000|Overall Study|Withdrawal by Subject|12|||
145627321|NCT03837028|525149174|FG001|Overall Study|Withdrawal by Subject|11|||
145627322|NCT03837028|525149175|FG002|Overall Study|Withdrawal by Subject|11|||
145627323|NCT03837028|525149176|FG003|Overall Study|Withdrawal by Subject|7|||
145627324|NCT00157014|525149177|FG000|Overall Study|Death|4|||
145627325|NCT00157014|525149178|FG001|Overall Study|Death|2|||
145627326|NCT00157014|525149179|FG002|Overall Study|Death|1|||
145627327|NCT00157014|525149180|FG003|Overall Study|Death|1|||
145627328|NCT00157014|525149177|FG000|Overall Study|Physician Decision|0|||
145627329|NCT00157014|525149178|FG001|Overall Study|Physician Decision|1|||
145627330|NCT00157014|525149179|FG002|Overall Study|Physician Decision|0|||
145627331|NCT00157014|525149180|FG003|Overall Study|Physician Decision|0|||
145627332|NCT00157014|525149177|FG000|Overall Study|Medications withdrawn on family request|0|||
145627333|NCT00157014|525149178|FG001|Overall Study|Medications withdrawn on family request|1|||
145627334|NCT00157014|525149179|FG002|Overall Study|Medications withdrawn on family request|0|||
145627335|NCT00157014|525149180|FG003|Overall Study|Medications withdrawn on family request|0|||
145627336|NCT00157014|525149177|FG000|Overall Study|Patient withdrawn by investigator|1|||
145627337|NCT00157014|525149178|FG001|Overall Study|Patient withdrawn by investigator|0|||
145627338|NCT00157014|525149179|FG002|Overall Study|Patient withdrawn by investigator|0|||
145627339|NCT00157014|525149180|FG003|Overall Study|Patient withdrawn by investigator|0|||
145627340|NCT00157014|525149177|FG000|Overall Study|Patient unable to return in nursing home|1|||
145627341|NCT00157014|525149178|FG001|Overall Study|Patient unable to return in nursing home|0|||
145627342|NCT00157014|525149179|FG002|Overall Study|Patient unable to return in nursing home|0|||
145627343|NCT00157014|525149180|FG003|Overall Study|Patient unable to return in nursing home|0|||
145627344|NCT00157014|525149177|FG000|Overall Study|Patient would not receive transplant|0|||
145627345|NCT00157014|525149178|FG001|Overall Study|Patient would not receive transplant|1|||
145627346|NCT00157014|525149179|FG002|Overall Study|Patient would not receive transplant|0|||
145627347|NCT00157014|525149180|FG003|Overall Study|Patient would not receive transplant|0|||
145627348|NCT00157014|525149177|FG000|Overall Study|Withdrawal by Subject|1|||
145627349|NCT00157014|525149178|FG001|Overall Study|Withdrawal by Subject|0|||
145627350|NCT00157014|525149179|FG002|Overall Study|Withdrawal by Subject|0|||
145627351|NCT00157014|525149180|FG003|Overall Study|Withdrawal by Subject|0|||
145627352|NCT01362491|525149181|FG000|Overall Study|Ineligible|1|||
145627353|NCT01362491|525149182|FG001|Overall Study|Ineligible|0|||
145627354|NCT01362491|525149183|FG002|Overall Study|Ineligible|0|||
145627355|NCT01257503|525149184|FG000|Overall Study|Lost to Follow-up|7|||
145627356|NCT01257503|525149185|FG001|Overall Study|Lost to Follow-up|10|||
145627357|NCT01257503|525149184|FG000|Overall Study|Over 5 years old at enrollment|0|||
145627358|NCT01257503|525149185|FG001|Overall Study|Over 5 years old at enrollment|1|||
145627359|NCT01257503|525149184|FG000|Overall Study|strep culture positive at enrollment|1|||
145627360|NCT01257503|525149185|FG001|Overall Study|strep culture positive at enrollment|0|||
145627361|NCT01168401|525149186|FG000|Overall Study|Lost to Follow-up|1|||
145627362|NCT01168401|525149187|FG001|Overall Study|Lost to Follow-up|1|||
145627363|NCT01168401|525149188|FG002|Overall Study|Lost to Follow-up|2|||
145627364|NCT01168401|525149189|FG003|Overall Study|Lost to Follow-up|1|||
145627365|NCT01168401|525149190|FG004|Overall Study|Lost to Follow-up|0|||
145627366|NCT01168401|525149191|FG005|Overall Study|Lost to Follow-up|0|||
145627367|NCT01168401|525149192|FG006|Overall Study|Lost to Follow-up|0|||
145627368|NCT01168401|525149193|FG007|Overall Study|Lost to Follow-up|0|||
145627369|NCT01168401|525149194|FG008|Overall Study|Lost to Follow-up|0|||
145627370|NCT01168401|525149195|FG009|Overall Study|Lost to Follow-up|0|||
145627371|NCT01168401|525149196|FG010|Overall Study|Lost to Follow-up|0|||
145627372|NCT01168401|525149186|FG000|Overall Study|Withdrawal by Subject|0|||
145627373|NCT01168401|525149187|FG001|Overall Study|Withdrawal by Subject|0|||
145627374|NCT01168401|525149188|FG002|Overall Study|Withdrawal by Subject|0|||
145627375|NCT01168401|525149189|FG003|Overall Study|Withdrawal by Subject|1|||
145627376|NCT01168401|525149190|FG004|Overall Study|Withdrawal by Subject|0|||
145627377|NCT01168401|525149191|FG005|Overall Study|Withdrawal by Subject|0|||
145627378|NCT01168401|525149192|FG006|Overall Study|Withdrawal by Subject|0|||
145627379|NCT01168401|525149193|FG007|Overall Study|Withdrawal by Subject|0|||
145627380|NCT01168401|525149194|FG008|Overall Study|Withdrawal by Subject|0|||
145627381|NCT01168401|525149195|FG009|Overall Study|Withdrawal by Subject|0|||
145627382|NCT01168401|525149196|FG010|Overall Study|Withdrawal by Subject|0|||
145627383|NCT00672256|525149197|FG000|Overall Study|PI dropped, bad data|44|||
145627384|NCT01801930|525149199|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
145627385|NCT01801930|525149200|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
145627386|NCT01801930|525149201|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
145627387|NCT01801930|525149202|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
145627388|NCT01801930|525149199|FG000|Overall Study|DLT occurs|0|||
145627389|NCT01801930|525149200|FG001|Overall Study|DLT occurs|1|||
145627390|NCT01801930|525149201|FG002|Overall Study|DLT occurs|0|||
145627391|NCT01801930|525149202|FG003|Overall Study|DLT occurs|0|||
145467669|NCT02365285|524566013|FG000|Overall Study|Adverse Event|0|||
145627392|NCT01720043|525149214|FG000|Overall Study|Withdrawal by Subject|1|||
145627393|NCT04381494|525149216|FG000|Overall Study|Early termination of trial|19|||
145627394|NCT04381494|525149216|FG000|Overall Study|Investigator's discretion|1|||
145627395|NCT04381494|525149216|FG000|Overall Study|Withdrawal by Subject|9|||
145627396|NCT04381494|525149216|FG000|Overall Study|NSCLC disease progression|4|||
145627397|NCT04381494|525149216|FG000|Overall Study|Device-Related Adverse Event|2|||
145467670|NCT02365285|524566014|FG001|Overall Study|Adverse Event|0|||
145467671|NCT02365285|524566015|FG002|Overall Study|Adverse Event|0|||
145467672|NCT02365285|524566016|FG003|Overall Study|Adverse Event|2|||
145627398|NCT03101592|525149221|FG000|Overall Study|participant files could not be located|111|||
145627399|NCT03101592|525149222|FG001|Overall Study|participant files could not be located|170|||
145627400|NCT03101592|525149223|FG002|Overall Study|participant files could not be located|118|||
145627401|NCT00631917|525149228|FG000|Overall Study|Adverse Event|34|||
145627402|NCT00631917|525149229|FG001|Overall Study|Adverse Event|45|||
145627403|NCT00631917|525149228|FG000|Overall Study|Abnormal laboratory value(s)|2|||
145627404|NCT00631917|525149229|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145627405|NCT00631917|525149228|FG000|Overall Study|Abnormal test procedure result(s)|3|||
145467673|NCT02635347|524566017|FG000|Overall Study|Failed screening|20|||
145467674|NCT02635347|524566018|FG001|Overall Study|Failed screening|7|||
145467675|NCT01617447|524566021|FG000|Overall Study|Adverse Event|0|||
145467676|NCT01617447|524566022|FG001|Overall Study|Adverse Event|1|||
145467677|NCT01617447|524566021|FG000|Overall Study|Physician Decision|0|||
145467678|NCT01617447|524566022|FG001|Overall Study|Physician Decision|2|||
145467679|NCT01283542|524566023|FG000|Main Phase|Acute or progressive vision loss|1|||
145467680|NCT01283542|524566023|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
145467681|NCT01283542|524566023|FG000|Main Phase|abnormal laboratory values|5|||
145467682|NCT01283542|524566023|FG000|Extension Phase|Physician Decision|1|||
145467683|NCT01283542|524566023|FG000|Extension Phase|Adverse Event|1|||
145467684|NCT01283542|524566023|FG000|Extension Phase|Administrative problems|1|||
145467685|NCT03443427|524566024|FG000|Overall Study|Adverse Event|2|||
145467686|NCT03443427|524566025|FG001|Overall Study|Adverse Event|3|||
145467687|NCT03443427|524566024|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
145467688|NCT03443427|524566025|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145467689|NCT03443427|524566024|FG000|Overall Study|Other|4|||
145467690|NCT03443427|524566025|FG001|Overall Study|Other|6|||
145467691|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
145467692|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
145467693|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
145467694|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
145467695|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
145467696|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
145467697|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
145467698|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
145467699|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
145467700|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
145467701|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
145467702|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
145467703|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
145467704|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
145467705|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
145467706|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
145467707|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
145467708|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
145467709|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
145467710|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
145467711|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
145467712|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
145467713|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
145467714|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
145467715|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
145467716|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
145467717|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
145467718|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
145467719|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
145467720|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
145467721|NCT00121641|524566026|FG000|24-week Short-term Treatment Period|Other Reason|1|||
145467722|NCT00121641|524566027|FG001|24-week Short-term Treatment Period|Other Reason|0|||
145467723|NCT00121641|524566028|FG002|24-week Short-term Treatment Period|Other Reason|0|||
145467724|NCT00121641|524566029|FG003|24-week Short-term Treatment Period|Other Reason|0|||
145467725|NCT00121641|524566030|FG004|24-week Short-term Treatment Period|Other Reason|0|||
145467726|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
145467727|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
145600079|NCT04672941|525048312|FG000|Overall Study|Lost to Follow-up|2|||
145600080|NCT02953938|525048313|FG000|Overall Study|Adverse Event|0|||
145600081|NCT02953938|525048314|FG001|Overall Study|Adverse Event|1|||
145600082|NCT02953938|525048313|FG000|Overall Study|Withdrawal by Subject|1|||
145600083|NCT02953938|525048314|FG001|Overall Study|Withdrawal by Subject|1|||
145600084|NCT03848403|525048316|FG000|Period 2 (Day 8)|Adverse Event|1|||
145600085|NCT03848403|525048317|FG001|Period 2 (Day 8)|Adverse Event|2|||
145600086|NCT03848403|525048318|FG002|Period 2 (Day 8)|Adverse Event|2|||
145600087|NCT03848403|525048316|FG000|Period 2 (Day 8)|Physician Decision|0|||
145600088|NCT03848403|525048317|FG001|Period 2 (Day 8)|Physician Decision|1|||
145600089|NCT03848403|525048318|FG002|Period 2 (Day 8)|Physician Decision|0|||
145600090|NCT03848403|525048316|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
145600091|NCT03848403|525048317|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
145600092|NCT03848403|525048318|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
145600093|NCT00168038|525048319|FG000|Overall Study|Adverse Event|1|||
145600094|NCT00168038|525048319|FG000|Overall Study|Therapy failure|1|||
145627406|NCT00631917|525149229|FG001|Overall Study|Abnormal test procedure result(s)|2|||
145627407|NCT00631917|525149228|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
145627408|NCT00631917|525149229|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
145627409|NCT00631917|525149228|FG000|Overall Study|No longer required study drug|0|||
145627410|NCT00631917|525149229|FG001|Overall Study|No longer required study drug|1|||
145627411|NCT00631917|525149228|FG000|Overall Study|Protocol deviation|6|||
145627412|NCT00631917|525149229|FG001|Overall Study|Protocol deviation|5|||
145627413|NCT00631917|525149228|FG000|Overall Study|Subject withdrew consent|25|||
145627414|NCT00631917|525149229|FG001|Overall Study|Subject withdrew consent|33|||
145627415|NCT00631917|525149228|FG000|Overall Study|Lost to Follow-up|7|||
145627416|NCT00631917|525149229|FG001|Overall Study|Lost to Follow-up|7|||
145627417|NCT00631917|525149228|FG000|Overall Study|Administrative problems|2|||
145627418|NCT00631917|525149229|FG001|Overall Study|Administrative problems|0|||
145627419|NCT00631917|525149228|FG000|Overall Study|Death|1|||
145627420|NCT00631917|525149229|FG001|Overall Study|Death|0|||
145627421|NCT01835899|525149236|FG000|Overall Study|Adverse Event|0|||
145627422|NCT01835899|525149237|FG001|Overall Study|Adverse Event|0|||
145627423|NCT01835899|525149238|FG002|Overall Study|Adverse Event|1|||
145627424|NCT01835899|525149236|FG000|Overall Study|Other than stated above|0|||
145627425|NCT01835899|525149237|FG001|Overall Study|Other than stated above|1|||
145627426|NCT01835899|525149238|FG002|Overall Study|Other than stated above|0|||
145627427|NCT05015478|525149241|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
145627428|NCT05015478|525149242|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
145627429|NCT05015478|525149243|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
145627430|NCT05015478|525149244|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
145627431|NCT04939428|525149245|FG000|Overall Study|Death|0|||
145627432|NCT04939428|525149246|FG001|Overall Study|Death|1|||
145627433|NCT04939428|525149247|FG002|Overall Study|Death|0|||
145627434|NCT04939428|525149245|FG000|Overall Study|Lost to Follow-up|0|||
145627435|NCT04939428|525149246|FG001|Overall Study|Lost to Follow-up|5|||
145627436|NCT04939428|525149247|FG002|Overall Study|Lost to Follow-up|0|||
145627437|NCT04939428|525149245|FG000|Overall Study|Physician Decision|1|||
145627438|NCT04939428|525149246|FG001|Overall Study|Physician Decision|0|||
145627439|NCT04939428|525149247|FG002|Overall Study|Physician Decision|0|||
145627440|NCT04939428|525149245|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145627441|NCT04939428|525149246|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145627442|NCT04939428|525149247|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145627443|NCT04939428|525149245|FG000|Overall Study|Withdrawal by Subject|10|||
145627444|NCT04939428|525149246|FG001|Overall Study|Withdrawal by Subject|11|||
145627445|NCT04939428|525149247|FG002|Overall Study|Withdrawal by Subject|0|||
145627446|NCT04939428|525149245|FG000|Overall Study|Unkown|6|||
145627447|NCT04939428|525149246|FG001|Overall Study|Unkown|3|||
145627448|NCT04939428|525149247|FG002|Overall Study|Unkown|0|||
145627449|NCT04939428|525149245|FG000|Overall Study|Discotinued per protocol|0|||
145627450|NCT04939428|525149246|FG001|Overall Study|Discotinued per protocol|0|||
145627451|NCT04939428|525149247|FG002|Overall Study|Discotinued per protocol|902|||
145627452|NCT04319094|525149250|FG000|Baseline|Lost to Follow-up|4|||
145627453|NCT04319094|525149251|FG001|Baseline|Lost to Follow-up|5|||
145627454|NCT04319094|525149250|FG000|Baseline|Protocol Violation|0|||
145627455|NCT04319094|525149251|FG001|Baseline|Protocol Violation|3|||
145627456|NCT04319094|525149250|FG000|Baseline|Withdrawal by Subject|2|||
145627457|NCT04319094|525149251|FG001|Baseline|Withdrawal by Subject|1|||
145627458|NCT04319094|525149250|FG000|Post-Intervention|Death|0|||
145627459|NCT04319094|525149251|FG001|Post-Intervention|Death|1|||
145627460|NCT04319094|525149250|FG000|Post-Intervention|Lost to Follow-up|4|||
145627461|NCT04319094|525149251|FG001|Post-Intervention|Lost to Follow-up|4|||
145627462|NCT04319094|525149250|FG000|Post-Intervention|Withdrawal by Subject|8|||
145627463|NCT04319094|525149251|FG001|Post-Intervention|Withdrawal by Subject|5|||
145627464|NCT04319094|525149250|FG000|Post-Intervention|Incomplete Data Collection|1|||
145627465|NCT04319094|525149251|FG001|Post-Intervention|Incomplete Data Collection|3|||
145627466|NCT04319094|525149250|FG000|3-month|Death|1|||
145627467|NCT04319094|525149251|FG001|3-month|Death|0|||
145627468|NCT04319094|525149250|FG000|3-month|Lost to Follow-up|2|||
145627469|NCT04319094|525149251|FG001|3-month|Lost to Follow-up|2|||
145627470|NCT04319094|525149250|FG000|3-month|Withdrawal by Subject|0|||
145627471|NCT04319094|525149251|FG001|3-month|Withdrawal by Subject|3|||
145627472|NCT04319094|525149250|FG000|3-month|Incomplete data collection|9|||
145627473|NCT04319094|525149251|FG001|3-month|Incomplete data collection|7|||
145627474|NCT04319094|525149250|FG000|6-month|Lost to Follow-up|1|||
145627475|NCT04319094|525149251|FG001|6-month|Lost to Follow-up|1|||
145627476|NCT04319094|525149250|FG000|6-month|Withdrawal by Subject|0|||
145627477|NCT04319094|525149251|FG001|6-month|Withdrawal by Subject|3|||
145627478|NCT04319094|525149250|FG000|6-month|Incomplete data collection|14|||
145627479|NCT04319094|525149251|FG001|6-month|Incomplete data collection|9|||
145627480|NCT04319094|525149250|FG000|9-month|Lost to Follow-up|8|||
145627481|NCT04319094|525149251|FG001|9-month|Lost to Follow-up|4|||
145627482|NCT04319094|525149250|FG000|9-month|Withdrawal by Subject|0|||
145627483|NCT04319094|525149251|FG001|9-month|Withdrawal by Subject|1|||
145627484|NCT04319094|525149250|FG000|9-month|Incomplete data collection|8|||
145627485|NCT04319094|525149251|FG001|9-month|Incomplete data collection|5|||
145627486|NCT04319094|525149250|FG000|12-month|Lost to Follow-up|11|||
145627487|NCT04319094|525149251|FG001|12-month|Lost to Follow-up|8|||
145627488|NCT00654238|525149252|FG000|Overall Study|Screen Failures|4|||
145627489|NCT00877851|525149253|FG000|Overall Study|Lost to Follow-up|5|||
145627490|NCT00877851|525149254|FG001|Overall Study|Lost to Follow-up|5|||
145627491|NCT00877851|525149253|FG000|Overall Study|computer problem|3|||
145627492|NCT00877851|525149254|FG001|Overall Study|computer problem|0|||
145627493|NCT00877851|525149253|FG000|Overall Study|no longer interested in participating|1|||
145627494|NCT00877851|525149254|FG001|Overall Study|no longer interested in participating|0|||
145627495|NCT03424239|525149255|FG000|Overall Study|Withdrawal by Subject|2|||
145627496|NCT00770211|525149256|FG000|Overall Study|Lost to Follow-up|1|||
145627497|NCT00770211|525149257|FG001|Overall Study|Lost to Follow-up|0|||
145627498|NCT00770211|525149256|FG000|Overall Study|Withdrawal by Subject|0|||
145627499|NCT00770211|525149257|FG001|Overall Study|Withdrawal by Subject|2|||
145627500|NCT00318656|525149259|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
145627501|NCT00318656|525149260|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
145627502|NCT00318656|525149259|FG000|Overall Study|Did not receive any treatment|0|||
145627503|NCT00318656|525149260|FG001|Overall Study|Did not receive any treatment|1|||
145627504|NCT03905135|525149261|FG000|Dose Escalation|Adverse Event|1|||
145627505|NCT03905135|525149262|FG001|Dose Escalation|Adverse Event|1|||
145627506|NCT03905135|525149261|FG000|Dose Escalation|Progressive disease|3|||
145627507|NCT03905135|525149262|FG001|Dose Escalation|Progressive disease|1|||
145627508|NCT03905135|525149261|FG000|Dose Escalation|Intercurrent illness|1|||
145627509|NCT03905135|525149262|FG001|Dose Escalation|Intercurrent illness|0|||
145627510|NCT01740557|525149263|FG000|Overall Study|Ineligible|1|||
145627511|NCT01740557|525149263|FG000|Overall Study|Screen failure|1|||
145627512|NCT02042443|525149266|FG000|Overall Study|Adverse Event|2|||
145627513|NCT02042443|525149267|FG001|Overall Study|Adverse Event|1|||
145627514|NCT02042443|525149266|FG000|Overall Study|Withdrawal by Subject|0|||
145627515|NCT02042443|525149267|FG001|Overall Study|Withdrawal by Subject|1|||
145627516|NCT02042443|525149266|FG000|Overall Study|Progression|21|||
145627517|NCT02042443|525149267|FG001|Overall Study|Progression|17|||
145627518|NCT02042443|525149266|FG000|Overall Study|not protocol specified|1|||
145627519|NCT02042443|525149267|FG001|Overall Study|not protocol specified|1|||
145627520|NCT02042443|525149266|FG000|Overall Study|Not eligible/not analyzable|3|||
145627521|NCT02042443|525149267|FG001|Overall Study|Not eligible/not analyzable|6|||
145467728|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
145467729|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
145467730|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
145467731|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
145467732|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
145467733|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
145467734|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
145467735|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
145467736|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
145467737|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
145467738|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
145467739|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
145467740|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
145467741|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
145467742|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
145467743|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
145467744|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
145467745|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
145467746|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
145467747|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
145467748|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
145467749|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
145467750|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
145467751|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
145467752|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
145467753|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
145627522|NCT01007149|525149270|FG000|Overall Study|Administrative problems|0|||
145627523|NCT01007149|525149271|FG001|Overall Study|Administrative problems|1|||
145627524|NCT02784704|525149272|FG000|Overall Study|Adverse Event|4|||
145627525|NCT02784704|525149273|FG001|Overall Study|Adverse Event|2|||
145627526|NCT02784704|525149272|FG000|Overall Study|Lost to Follow-up|6|||
145627527|NCT02784704|525149273|FG001|Overall Study|Lost to Follow-up|4|||
145627528|NCT02784704|525149272|FG000|Overall Study|Withdrawal by Subject|1|||
145627529|NCT02784704|525149273|FG001|Overall Study|Withdrawal by Subject|3|||
145627530|NCT02784704|525149272|FG000|Overall Study|Subject Non Compliance|2|||
145627531|NCT02784704|525149273|FG001|Overall Study|Subject Non Compliance|0|||
145627532|NCT01913340|525149274|FG000|Overall Study|Death|2|||
145627533|NCT01913340|525149275|FG001|Overall Study|Death|5|||
145627534|NCT01913340|525149274|FG000|Overall Study|Lost to Follow-up|1|||
145627535|NCT01913340|525149275|FG001|Overall Study|Lost to Follow-up|1|||
145627536|NCT05096884|525149277|FG000|Overall Study|Excluded based on negative tilt table test|4|||
145627537|NCT03568162|525149278|FG000|Overall Study|Adverse Event|0|||
145627538|NCT03568162|525149279|FG001|Overall Study|Adverse Event|1|||
145627539|NCT03568162|525149280|FG002|Overall Study|Adverse Event|2|||
145627540|NCT03568162|525149281|FG003|Overall Study|Adverse Event|0|||
145627541|NCT03568162|525149282|FG004|Overall Study|Adverse Event|0|||
145627542|NCT03568162|525149283|FG005|Overall Study|Adverse Event|1|||
145627543|NCT03568162|525149278|FG000|Overall Study|Death|0|||
145627544|NCT03568162|525149279|FG001|Overall Study|Death|0|||
145627545|NCT03568162|525149280|FG002|Overall Study|Death|0|||
145627546|NCT03568162|525149281|FG003|Overall Study|Death|0|||
145627547|NCT03568162|525149282|FG004|Overall Study|Death|1|||
145627548|NCT03568162|525149283|FG005|Overall Study|Death|0|||
145627549|NCT03568162|525149278|FG000|Overall Study|Lost to Follow-up|3|||
145627550|NCT03568162|525149279|FG001|Overall Study|Lost to Follow-up|2|||
145627551|NCT03568162|525149280|FG002|Overall Study|Lost to Follow-up|4|||
145627552|NCT03568162|525149281|FG003|Overall Study|Lost to Follow-up|2|||
145627553|NCT03568162|525149282|FG004|Overall Study|Lost to Follow-up|3|||
145627554|NCT03568162|525149283|FG005|Overall Study|Lost to Follow-up|2|||
145627555|NCT03568162|525149278|FG000|Overall Study|Physician Decision|0|||
145627556|NCT03568162|525149279|FG001|Overall Study|Physician Decision|1|||
145627557|NCT03568162|525149280|FG002|Overall Study|Physician Decision|1|||
145627558|NCT03568162|525149281|FG003|Overall Study|Physician Decision|0|||
145627559|NCT03568162|525149282|FG004|Overall Study|Physician Decision|1|||
145627560|NCT03568162|525149283|FG005|Overall Study|Physician Decision|0|||
145627561|NCT03568162|525149278|FG000|Overall Study|Pregnancy|0|||
145627562|NCT03568162|525149279|FG001|Overall Study|Pregnancy|0|||
145627563|NCT03568162|525149280|FG002|Overall Study|Pregnancy|0|||
145627564|NCT03568162|525149281|FG003|Overall Study|Pregnancy|1|||
145627565|NCT03568162|525149282|FG004|Overall Study|Pregnancy|0|||
145627566|NCT03568162|525149283|FG005|Overall Study|Pregnancy|0|||
145627567|NCT03568162|525149278|FG000|Overall Study|Protocol Violation|1|||
145627568|NCT03568162|525149279|FG001|Overall Study|Protocol Violation|0|||
145627569|NCT03568162|525149280|FG002|Overall Study|Protocol Violation|1|||
145627570|NCT03568162|525149281|FG003|Overall Study|Protocol Violation|1|||
145627571|NCT03568162|525149282|FG004|Overall Study|Protocol Violation|1|||
145627572|NCT03568162|525149283|FG005|Overall Study|Protocol Violation|1|||
145627573|NCT03568162|525149278|FG000|Overall Study|Withdrawal by Subject|15|||
145627574|NCT03568162|525149279|FG001|Overall Study|Withdrawal by Subject|15|||
145627575|NCT03568162|525149280|FG002|Overall Study|Withdrawal by Subject|26|||
145627576|NCT03568162|525149281|FG003|Overall Study|Withdrawal by Subject|22|||
145627577|NCT03568162|525149282|FG004|Overall Study|Withdrawal by Subject|6|||
145627578|NCT03568162|525149283|FG005|Overall Study|Withdrawal by Subject|9|||
145627579|NCT03568162|525149278|FG000|Overall Study|Others|3|||
145627580|NCT03568162|525149279|FG001|Overall Study|Others|4|||
145627581|NCT03568162|525149280|FG002|Overall Study|Others|1|||
145627582|NCT03568162|525149281|FG003|Overall Study|Others|4|||
145627583|NCT03568162|525149282|FG004|Overall Study|Others|2|||
145627584|NCT03568162|525149283|FG005|Overall Study|Others|1|||
145627585|NCT03781804|525149284|FG000|Overall Study|Adverse Event|2|||
145627586|NCT03781804|525149285|FG001|Overall Study|Adverse Event|2|||
145627587|NCT03781804|525149286|FG002|Overall Study|Adverse Event|3|||
145627588|NCT03781804|525149284|FG000|Overall Study|Lost to Follow-up|1|||
145627589|NCT03781804|525149285|FG001|Overall Study|Lost to Follow-up|1|||
145627590|NCT03781804|525149286|FG002|Overall Study|Lost to Follow-up|2|||
145627591|NCT03781804|525149284|FG000|Overall Study|Lack of Efficacy|4|||
145627592|NCT03781804|525149285|FG001|Overall Study|Lack of Efficacy|2|||
145627593|NCT03781804|525149286|FG002|Overall Study|Lack of Efficacy|9|||
145627594|NCT03781804|525149284|FG000|Overall Study|Protocol Violation|0|||
145467754|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
145627595|NCT03781804|525149285|FG001|Overall Study|Protocol Violation|0|||
145627596|NCT03781804|525149286|FG002|Overall Study|Protocol Violation|1|||
145627597|NCT03781804|525149284|FG000|Overall Study|Withdrawal by Subject|0|||
145627598|NCT03781804|525149285|FG001|Overall Study|Withdrawal by Subject|1|||
145627599|NCT03781804|525149286|FG002|Overall Study|Withdrawal by Subject|1|||
145627600|NCT03781804|525149284|FG000|Overall Study|Reason not provided|2|||
145627601|NCT03781804|525149285|FG001|Overall Study|Reason not provided|2|||
145627602|NCT03781804|525149286|FG002|Overall Study|Reason not provided|0|||
145627603|NCT00768066|525149287|FG000|Overall Study|Did not receive study product injection.|3|||
145627604|NCT00768066|525149288|FG001|Overall Study|Did not receive study product injection.|3|||
145627605|NCT00768066|525149289|FG002|Overall Study|Did not receive study product injection.|0|||
145627606|NCT04831775|525149290|FG000|Overall Study|Lost to Follow-up|11|||
145627607|NCT04831775|525149291|FG001|Overall Study|Lost to Follow-up|13|||
145627608|NCT00337818|525149292|FG000|Overall Study|Lost to Follow-up|289|||
145627609|NCT00337818|525149293|FG001|Overall Study|Lost to Follow-up|91|||
145627610|NCT00337818|525149294|FG002|Overall Study|Lost to Follow-up|107|||
145627611|NCT04678830|525149295|FG000|Overall Study|Lack of Efficacy|2|||
145627612|NCT04678830|525149296|FG001|Overall Study|Lack of Efficacy|0|||
145627613|NCT04678830|525149295|FG000|Overall Study|Withdrawal by Subject|0|||
145627614|NCT04678830|525149296|FG001|Overall Study|Withdrawal by Subject|1|||
145627615|NCT05550337|525149297|FG000|Overall Study|Lack of Efficacy|0|||
145627616|NCT05550337|525149298|FG001|Overall Study|Lack of Efficacy|0|||
145627617|NCT05550337|525149299|FG002|Overall Study|Lack of Efficacy|1|||
145627618|NCT05550337|525149297|FG000|Overall Study|Adverse Event|1|||
145627619|NCT05550337|525149298|FG001|Overall Study|Adverse Event|5|||
145627620|NCT05550337|525149299|FG002|Overall Study|Adverse Event|0|||
145627621|NCT05550337|525149297|FG000|Overall Study|Withdrawal by Subject|8|||
145627622|NCT05550337|525149298|FG001|Overall Study|Withdrawal by Subject|14|||
145627623|NCT05550337|525149299|FG002|Overall Study|Withdrawal by Subject|10|||
145627624|NCT05550337|525149297|FG000|Overall Study|Pregnancy|0|||
145627625|NCT05550337|525149298|FG001|Overall Study|Pregnancy|0|||
145627626|NCT05550337|525149299|FG002|Overall Study|Pregnancy|1|||
145627627|NCT05550337|525149297|FG000|Overall Study|Protocol Violation|1|||
145627628|NCT05550337|525149298|FG001|Overall Study|Protocol Violation|3|||
145627629|NCT05550337|525149299|FG002|Overall Study|Protocol Violation|4|||
145627630|NCT05550337|525149297|FG000|Overall Study|Physician Decision|2|||
145627631|NCT05550337|525149298|FG001|Overall Study|Physician Decision|1|||
145627632|NCT05550337|525149299|FG002|Overall Study|Physician Decision|1|||
145627633|NCT05550337|525149297|FG000|Overall Study|Lost to Follow-up|16|||
145627634|NCT05550337|525149298|FG001|Overall Study|Lost to Follow-up|11|||
145627635|NCT05550337|525149299|FG002|Overall Study|Lost to Follow-up|11|||
145627636|NCT03115346|525149302|FG000|Overall Study|Did not have AAA surgery|28|||
145627637|NCT03115346|525149303|FG001|Overall Study|Did not have AAA surgery|15|||
145627638|NCT03115346|525149302|FG000|Overall Study|Death|3|||
145627639|NCT03115346|525149303|FG001|Overall Study|Death|1|||
145627640|NCT03115346|525149302|FG000|Overall Study|Withdrawal by Subject|0|||
145627641|NCT03115346|525149303|FG001|Overall Study|Withdrawal by Subject|3|||
145627642|NCT03115346|525149302|FG000|Overall Study|Lost to Follow-up|0|||
145627643|NCT03115346|525149303|FG001|Overall Study|Lost to Follow-up|3|||
145627644|NCT01560949|525149304|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
145627645|NCT01560949|525149304|FG000|Surgery Phase|Physician Decision|3|||
145627646|NCT05025449|525151446|FG000|Overall Study|Withdrawal by Subject|1|||
145627647|NCT05025449|525151446|FG000|Overall Study|Patient emergently taken to operating room|1|||
145627648|NCT00762463|525151448|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
145627649|NCT00762463|525151449|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
145627650|NCT00762463|525151450|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
145627651|NCT00762463|525151451|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
145627652|NCT00762463|525151448|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
145627653|NCT00762463|525151449|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
145627654|NCT00762463|525151450|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
145627655|NCT00762463|525151451|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
145627656|NCT00762463|525151448|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
145627657|NCT00762463|525151449|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
145627658|NCT00762463|525151450|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
145627659|NCT00762463|525151451|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
145627660|NCT00762463|525151448|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
145627661|NCT00762463|525151449|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
145627662|NCT00762463|525151450|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
145627663|NCT00762463|525151451|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
145627664|NCT00762463|525151448|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
145627665|NCT00762463|525151449|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
145627666|NCT00762463|525151450|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
145627667|NCT00762463|525151451|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
145467755|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
145467756|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
145627668|NCT00762463|525151448|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
145627669|NCT00762463|525151449|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
145627670|NCT00762463|525151450|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
145627671|NCT00762463|525151451|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
145627672|NCT00762463|525151448|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
145627673|NCT00762463|525151449|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
145627674|NCT00762463|525151450|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
145627675|NCT00762463|525151451|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
145627676|NCT00762463|525151448|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
145600095|NCT04198805|525048322|FG000|Overall Study|Death|0|||
145600096|NCT04198805|525048323|FG001|Overall Study|Death|0|||
145600097|NCT04198805|525048324|FG002|Overall Study|Death|0|||
145600098|NCT04198805|525048325|FG003|Overall Study|Death|1|||
145600099|NCT04198805|525048322|FG000|Overall Study|Early Termination|8|||
145600100|NCT04198805|525048323|FG001|Overall Study|Early Termination|4|||
145600101|NCT04198805|525048324|FG002|Overall Study|Early Termination|6|||
145600102|NCT04198805|525048325|FG003|Overall Study|Early Termination|9|||
145600103|NCT03599349|525048328|FG000|Overall Study|Lost to Follow-up|1|||
145600104|NCT06213701|525048329|FG000|Overall Study|Withdrawal by Subject|2|||
145600105|NCT06213701|525048330|FG001|Overall Study|Withdrawal by Subject|1|||
145600106|NCT06213701|525048331|FG002|Overall Study|Withdrawal by Subject|0|||
145600107|NCT00453986|525048332|FG000|Overall Study|Lost to Follow-up|6|||
145600108|NCT00453986|525048333|FG001|Overall Study|Lost to Follow-up|5|||
145600109|NCT00453986|525048334|FG002|Overall Study|Lost to Follow-up|6|||
145600110|NCT00453986|525048335|FG003|Overall Study|Lost to Follow-up|2|||
145600111|NCT00453986|525048336|FG004|Overall Study|Lost to Follow-up|0|||
145600112|NCT01659151|525048337|FG000|Overall Study|Inadequate TIL growth|1|||
145600113|NCT04233372|525049827|FG000|Overall Study|Lost to Follow-up|104|||
145600114|NCT04233372|525049827|FG000|Overall Study|Adverse Event|8|||
145600115|NCT04233372|525049827|FG000|Overall Study|Withdrawal by Subject|2|||
145600116|NCT01090310|525049828|FG000|Core Study|Adverse Event|2|||
145600117|NCT01090310|525049829|FG001|Core Study|Adverse Event|2|||
145600118|NCT01090310|525049830|FG002|Core Study|Adverse Event|1|||
145600119|NCT01090310|525049831|FG003|Core Study|Adverse Event|1|||
145600120|NCT01090310|525049828|FG000|Core Study|Subject withdrew consent|0|||
145600121|NCT01090310|525049829|FG001|Core Study|Subject withdrew consent|3|||
145600122|NCT01090310|525049830|FG002|Core Study|Subject withdrew consent|1|||
145600123|NCT01090310|525049831|FG003|Core Study|Subject withdrew consent|1|||
145600124|NCT01090310|525049828|FG000|Core Study|Abnormal test procedure result|0|||
145600125|NCT01090310|525049829|FG001|Core Study|Abnormal test procedure result|0|||
145600126|NCT01090310|525049830|FG002|Core Study|Abnormal test procedure result|1|||
145600127|NCT01090310|525049831|FG003|Core Study|Abnormal test procedure result|0|||
145600128|NCT01090310|525049828|FG000|Core Study|Administrative reasons|5|||
145600129|NCT01090310|525049829|FG001|Core Study|Administrative reasons|6|||
145600130|NCT01090310|525049830|FG002|Core Study|Administrative reasons|4|||
145600131|NCT01090310|525049831|FG003|Core Study|Administrative reasons|4|||
145600132|NCT01090310|525049828|FG000|Core Study|Protocol deviation|1|||
145600133|NCT01090310|525049829|FG001|Core Study|Protocol deviation|0|||
145600134|NCT01090310|525049830|FG002|Core Study|Protocol deviation|0|||
145600135|NCT01090310|525049831|FG003|Core Study|Protocol deviation|1|||
145600136|NCT01090310|525049828|FG000|Extension Study|Aministrative problems|13|||
145600137|NCT01090310|525049829|FG001|Extension Study|Aministrative problems|15|||
145600138|NCT01090310|525049830|FG002|Extension Study|Aministrative problems|14|||
145600139|NCT01090310|525049831|FG003|Extension Study|Aministrative problems|18|||
145600140|NCT01090310|525049828|FG000|Extension Study|Adverse Event|0|||
145600141|NCT01090310|525049829|FG001|Extension Study|Adverse Event|0|||
145600142|NCT01090310|525049830|FG002|Extension Study|Adverse Event|0|||
145600143|NCT01090310|525049831|FG003|Extension Study|Adverse Event|1|||
145600144|NCT01090310|525049828|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
145600145|NCT01090310|525049829|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
145600146|NCT01090310|525049830|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
145600147|NCT01090310|525049831|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
145600148|NCT01090310|525049828|FG000|Extension Study|Subject withdrew consent|0|||
145600149|NCT01090310|525049829|FG001|Extension Study|Subject withdrew consent|1|||
145600150|NCT01090310|525049830|FG002|Extension Study|Subject withdrew consent|0|||
145600151|NCT01090310|525049831|FG003|Extension Study|Subject withdrew consent|0|||
145600152|NCT00695786|525049832|FG000|Overall Study|Adverse Event|0|||
145600153|NCT00695786|525049833|FG001|Overall Study|Adverse Event|3|||
145600154|NCT00695786|525049834|FG002|Overall Study|Adverse Event|4|||
145600155|NCT00695786|525049835|FG003|Overall Study|Adverse Event|2|||
145600156|NCT00695786|525049832|FG000|Overall Study|Lost to Follow-up|0|||
145600157|NCT00695786|525049833|FG001|Overall Study|Lost to Follow-up|5|||
145600158|NCT00695786|525049834|FG002|Overall Study|Lost to Follow-up|1|||
145600159|NCT00695786|525049835|FG003|Overall Study|Lost to Follow-up|1|||
145600160|NCT00695786|525049832|FG000|Overall Study|Withdrawal by Subject|0|||
145600161|NCT00695786|525049833|FG001|Overall Study|Withdrawal by Subject|4|||
145600162|NCT00695786|525049834|FG002|Overall Study|Withdrawal by Subject|3|||
145600163|NCT00695786|525049835|FG003|Overall Study|Withdrawal by Subject|1|||
145600164|NCT00695786|525049832|FG000|Overall Study|Deemed Ineligible|1|||
145600165|NCT00695786|525049833|FG001|Overall Study|Deemed Ineligible|0|||
145600166|NCT00695786|525049834|FG002|Overall Study|Deemed Ineligible|0|||
145627677|NCT00762463|525151449|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
145600167|NCT00695786|525049835|FG003|Overall Study|Deemed Ineligible|0|||
145600168|NCT00695786|525049832|FG000|Overall Study|Lack of Efficacy|0|||
145600169|NCT00695786|525049833|FG001|Overall Study|Lack of Efficacy|0|||
145600170|NCT00695786|525049834|FG002|Overall Study|Lack of Efficacy|0|||
145600171|NCT00695786|525049835|FG003|Overall Study|Lack of Efficacy|4|||
145600172|NCT01364922|525049841|FG000|Open-label (OL) Period|Adverse Event|7|||
145600173|NCT01364922|525049842|FG001|Open-label (OL) Period|Adverse Event|0|||
145600174|NCT01364922|525049843|FG002|Open-label (OL) Period|Adverse Event|0|||
145600175|NCT01364922|525049841|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
145600176|NCT01364922|525049842|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
145600177|NCT01364922|525049843|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
145600178|NCT01364922|525049841|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
145600179|NCT01364922|525049842|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
145600180|NCT01364922|525049843|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
145600181|NCT01364922|525049841|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
145600182|NCT01364922|525049842|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
145600183|NCT01364922|525049843|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
145600184|NCT01364922|525049841|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
145600185|NCT01364922|525049842|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
145600186|NCT01364922|525049843|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
145600187|NCT01364922|525049841|FG000|Open-label (OL) Period|Other, Unspecified|1|||
145600188|NCT01364922|525049842|FG001|Open-label (OL) Period|Other, Unspecified|0|||
145600189|NCT01364922|525049843|FG002|Open-label (OL) Period|Other, Unspecified|0|||
145600190|NCT01364922|525049841|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
145600191|NCT01364922|525049842|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
145600192|NCT01364922|525049843|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
145600193|NCT01364922|525049841|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
145600194|NCT01364922|525049842|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
145600195|NCT01364922|525049843|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
145600196|NCT01364922|525049841|FG000|Double-Blind (DB) Period|Adverse Event|0|||
145600197|NCT01364922|525049842|FG001|Double-Blind (DB) Period|Adverse Event|0|||
145600198|NCT01364922|525049843|FG002|Double-Blind (DB) Period|Adverse Event|1|||
145600199|NCT01364922|525049841|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
145600200|NCT01364922|525049842|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
145600201|NCT01364922|525049843|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
145600202|NCT04244396|525049846|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
145600203|NCT04244396|525049846|FG000|Overall Study|Withdrawal by Subject|2|||
145600204|NCT04244396|525049846|FG000|Overall Study|Study termination|37|||
145600205|NCT01787097|525049847|FG000|Overall Study|Withdrawal by Subject|1|||
145600206|NCT01787097|525049848|FG001|Overall Study|Withdrawal by Subject|0|||
145600207|NCT01787097|525049849|FG002|Overall Study|Withdrawal by Subject|0|||
145600208|NCT01787097|525049850|FG003|Overall Study|Withdrawal by Subject|0|||
145600209|NCT05178121|525049851|FG000|Overall Study|Other|4|||
145600210|NCT05178121|525049851|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
145600211|NCT01953003|525049852|FG000|Overall Study|Not treated|0|||
145600212|NCT01953003|525049853|FG001|Overall Study|Not treated|1|||
145600213|NCT01953003|525049852|FG000|Overall Study|Progressive disease|35|||
145600214|NCT01953003|525049853|FG001|Overall Study|Progressive disease|45|||
145600215|NCT01953003|525049852|FG000|Overall Study|Related Adverse events|7|||
145600216|NCT01953003|525049853|FG001|Overall Study|Related Adverse events|2|||
145600217|NCT01953003|525049852|FG000|Overall Study|Non-related adverse events|0|||
145600218|NCT01953003|525049853|FG001|Overall Study|Non-related adverse events|2|||
145600219|NCT01953003|525049852|FG000|Overall Study|Protocol Violation|0|||
145600220|NCT01953003|525049853|FG001|Overall Study|Protocol Violation|1|||
145600221|NCT01953003|525049852|FG000|Overall Study|Withdrawal by Subject|14|||
145600222|NCT01953003|525049853|FG001|Overall Study|Withdrawal by Subject|4|||
145600223|NCT03391765|525049859|FG000|Overall Study|Adverse Event|2|||
145600224|NCT03391765|525049860|FG001|Overall Study|Adverse Event|0|||
145600225|NCT03391765|525049861|FG002|Overall Study|Adverse Event|0|||
145600226|NCT03391765|525049862|FG003|Overall Study|Adverse Event|2|||
145600227|NCT03391765|525049859|FG000|Overall Study|Withdrew consent|5|||
145600228|NCT03391765|525049860|FG001|Overall Study|Withdrew consent|7|||
145600229|NCT03391765|525049861|FG002|Overall Study|Withdrew consent|2|||
145600230|NCT03391765|525049862|FG003|Overall Study|Withdrew consent|5|||
145600231|NCT03391765|525049859|FG000|Overall Study|Other, not specified|44|||
145600232|NCT03391765|525049860|FG001|Overall Study|Other, not specified|38|||
145600233|NCT03391765|525049861|FG002|Overall Study|Other, not specified|21|||
145600234|NCT03391765|525049862|FG003|Overall Study|Other, not specified|16|||
145600235|NCT00944658|525049863|FG000|Treatment 12 Weeks|Adverse Event|0|||
145600236|NCT00944658|525049864|FG001|Treatment 12 Weeks|Adverse Event|2|||
145600237|NCT00838682|525049870|FG000|Overall Study|Lost to Follow-up|21|||
145600238|NCT00838682|525049871|FG001|Overall Study|Lost to Follow-up|14|||
145600239|NCT00838682|525049870|FG000|Overall Study|detection of exclusion criteria|4|||
145600240|NCT00838682|525049871|FG001|Overall Study|detection of exclusion criteria|3|||
145600241|NCT00838682|525049870|FG000|Overall Study|Protocol Violation|0|||
145600242|NCT00838682|525049871|FG001|Overall Study|Protocol Violation|1|||
145600243|NCT00838682|525049870|FG000|Overall Study|Withdrawal by Subject|0|||
145600244|NCT00838682|525049871|FG001|Overall Study|Withdrawal by Subject|1|||
145600245|NCT02472652|525049877|FG000|Overall Study|Lost to Follow-up|1|||
145600246|NCT00998400|525049882|FG000|Overall Study|Lack of interest/motivation|1|||
145600247|NCT00998400|525049883|FG001|Overall Study|Lack of interest/motivation|2|||
145467757|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
145467758|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
145467759|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
145467760|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
145467761|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
145467762|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
145467763|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
145467764|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
145467765|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
145467766|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Death|0|||
145467767|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Death|0|||
145467768|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Death|0|||
145467769|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Death|1|||
145467770|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Death|0|||
145467771|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Missing|0|||
145467772|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Missing|0|||
145467773|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Missing|1|||
145467774|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Missing|0|||
145467775|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Missing|0|||
145467776|NCT00121641|524566026|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
145467777|NCT00121641|524566027|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
145467778|NCT00121641|524566028|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
145467779|NCT00121641|524566029|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
145467780|NCT00121641|524566030|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
145467781|NCT00249613|524566033|FG000|12 Month Follow-up|Death|1|||
145467782|NCT00249613|524566034|FG001|12 Month Follow-up|Death|1|||
145467783|NCT00249613|524566033|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
145467784|NCT00249613|524566034|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
145467785|NCT00249613|524566033|FG000|12 Month Follow-up|Lost to Follow-up|10|||
145467786|NCT00249613|524566034|FG001|12 Month Follow-up|Lost to Follow-up|8|||
145467787|NCT00806442|524566036|FG000|Overall Study|Lost to Follow-up|3|||
145467788|NCT00806442|524566037|FG001|Overall Study|Lost to Follow-up|2|||
145467789|NCT00806442|524566036|FG000|Overall Study|Withdrawal by Subject|1|||
145467790|NCT00806442|524566037|FG001|Overall Study|Withdrawal by Subject|5|||
145467791|NCT00619489|524566047|FG000|Overall Study|Adverse Event|0|||
145467792|NCT00619489|524566048|FG001|Overall Study|Adverse Event|7|||
145467793|NCT00619489|524566047|FG000|Overall Study|Withdrawal by Subject|1|||
145467794|NCT00619489|524566048|FG001|Overall Study|Withdrawal by Subject|1|||
145467795|NCT00619489|524566047|FG000|Overall Study|Lack of Efficacy|0|||
145467796|NCT00619489|524566048|FG001|Overall Study|Lack of Efficacy|11|||
145467797|NCT00619489|524566047|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
145467798|NCT00619489|524566048|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
145467799|NCT02356887|524566049|FG000|Overall Study|poor compliance|2|||
145467800|NCT02544373|524566053|FG000|Overall Study|Lost to Follow-up|5|||
145467801|NCT02544373|524566054|FG001|Overall Study|Lost to Follow-up|3|||
145467802|NCT02544373|524566053|FG000|Overall Study|Withdrawal by Subject|8|||
145467803|NCT02544373|524566054|FG001|Overall Study|Withdrawal by Subject|2|||
145467804|NCT02404649|524566055|FG000|Overall Study|Adverse Event|1|||
145467805|NCT02404649|524566056|FG001|Overall Study|Adverse Event|2|||
145467806|NCT00162266|524566060|FG000|Double-Blind Period|Adverse Event|5|||
145467807|NCT00162266|524566061|FG001|Double-Blind Period|Adverse Event|9|||
145467808|NCT00162266|524566062|FG002|Double-Blind Period|Adverse Event|11|||
145467809|NCT00162266|524566063|FG003|Double-Blind Period|Adverse Event|0|||
145467810|NCT00162266|524566060|FG000|Double-Blind Period|Death|0|||
145467811|NCT00162266|524566061|FG001|Double-Blind Period|Death|1|||
145467812|NCT00162266|524566062|FG002|Double-Blind Period|Death|0|||
145467813|NCT00162266|524566063|FG003|Double-Blind Period|Death|0|||
145467814|NCT00162266|524566060|FG000|Double-Blind Period|Lost to Follow-up|1|||
145467815|NCT00162266|524566061|FG001|Double-Blind Period|Lost to Follow-up|2|||
145467816|NCT00162266|524566062|FG002|Double-Blind Period|Lost to Follow-up|0|||
145467817|NCT00162266|524566063|FG003|Double-Blind Period|Lost to Follow-up|0|||
145467818|NCT00162266|524566060|FG000|Double-Blind Period|Other Reason|1|||
145467819|NCT00162266|524566061|FG001|Double-Blind Period|Other Reason|0|||
145600248|NCT00998400|525049882|FG000|Overall Study|Logistical problems|1|||
145600249|NCT00998400|525049883|FG001|Overall Study|Logistical problems|0|||
145600250|NCT03704584|525049884|FG000|Overall Study|Withdrawal by Subject|1|||
145600251|NCT03704584|525049885|FG001|Overall Study|Withdrawal by Subject|0|||
145600252|NCT03185832|525049886|FG000|Overall Study|Death|9|||
145467820|NCT00162266|524566062|FG002|Double-Blind Period|Other Reason|1|||
145467821|NCT00162266|524566063|FG003|Double-Blind Period|Other Reason|0|||
145467822|NCT00162266|524566060|FG000|Double-Blind Period|Lack of Efficacy|13|||
145467823|NCT00162266|524566061|FG001|Double-Blind Period|Lack of Efficacy|17|||
145467824|NCT00162266|524566062|FG002|Double-Blind Period|Lack of Efficacy|30|||
145467825|NCT00162266|524566063|FG003|Double-Blind Period|Lack of Efficacy|0|||
145600253|NCT03185832|525049887|FG001|Overall Study|Death|14|||
145600254|NCT03185832|525049888|FG002|Overall Study|Death|9|||
145600255|NCT03185832|525049889|FG003|Overall Study|Death|7|||
145600256|NCT03185832|525049886|FG000|Overall Study|Withdrawn - vital status available|0|||
145600257|NCT03185832|525049887|FG001|Overall Study|Withdrawn - vital status available|1|||
145600258|NCT03185832|525049888|FG002|Overall Study|Withdrawn - vital status available|1|||
145600259|NCT03185832|525049889|FG003|Overall Study|Withdrawn - vital status available|4|||
145600260|NCT01083641|525049891|FG000|Overall Study|Withdrawal by Subject|2|||
145600261|NCT03439189|525049892|FG000|Overall Study|Protocol Violation|19|||
145600262|NCT03439189|525049892|FG000|Overall Study|Lack of Efficacy|63|||
145600263|NCT03412812|525049893|FG000|Level 1|Death|3|||
145600264|NCT03412812|525049894|FG001|Level 1|Death|0|||
145600265|NCT03412812|525049893|FG000|Level 1|Adverse Event|0|||
145600266|NCT03412812|525049894|FG001|Level 1|Adverse Event|1|||
145600267|NCT01777321|525049895|FG000|Overall Study|Withdrawal by Subject|0|||
145600268|NCT01777321|525049896|FG001|Overall Study|Withdrawal by Subject|1|||
145600269|NCT03315143|525049902|FG000|Overall Study|Death|240|||
145600270|NCT03315143|525049903|FG001|Overall Study|Death|246|||
145600271|NCT03315143|525049902|FG000|Overall Study|Withdrawal by Subject|57|||
145600272|NCT03315143|525049903|FG001|Overall Study|Withdrawal by Subject|68|||
145600273|NCT03315143|525049902|FG000|Overall Study|Site Terminated by Sponsor|256|||
145600274|NCT03315143|525049903|FG001|Overall Study|Site Terminated by Sponsor|282|||
145600275|NCT03315143|525049902|FG000|Overall Study|Study Terminated by Sponsor|4723|||
145600276|NCT03315143|525049903|FG001|Overall Study|Study Terminated by Sponsor|4664|||
145600277|NCT03315143|525049902|FG000|Overall Study|Reason not Specified|16|||
145600278|NCT03315143|525049903|FG001|Overall Study|Reason not Specified|32|||
145600279|NCT02052310|525049904|FG000|Overall Study|Death|64|||
145600280|NCT02052310|525049905|FG001|Overall Study|Death|54|||
145600281|NCT02052310|525049904|FG000|Overall Study|Withdrawal by Subject|37|||
145600282|NCT02052310|525049905|FG001|Overall Study|Withdrawal by Subject|49|||
145600283|NCT02052310|525049904|FG000|Overall Study|Other than specified|32|||
145600284|NCT02052310|525049905|FG001|Overall Study|Other than specified|29|||
145600285|NCT02052310|525049904|FG000|Overall Study|Adverse Event|29|||
145600286|NCT02052310|525049905|FG001|Overall Study|Adverse Event|22|||
145600287|NCT02052310|525049904|FG000|Overall Study|Kidney Transplant|23|||
145600288|NCT02052310|525049905|FG001|Overall Study|Kidney Transplant|29|||
145600289|NCT02052310|525049904|FG000|Overall Study|Physician Decision|14|||
145600290|NCT02052310|525049905|FG001|Overall Study|Physician Decision|7|||
145600291|NCT02052310|525049904|FG000|Overall Study|Lack of Efficacy|6|||
145600292|NCT02052310|525049905|FG001|Overall Study|Lack of Efficacy|1|||
145600293|NCT02052310|525049904|FG000|Overall Study|Site Terminated by Sponsor|5|||
145600294|NCT02052310|525049905|FG001|Overall Study|Site Terminated by Sponsor|13|||
145600295|NCT02052310|525049904|FG000|Overall Study|Lost to Follow-up|4|||
145600296|NCT02052310|525049905|FG001|Overall Study|Lost to Follow-up|2|||
145600297|NCT02052310|525049904|FG000|Overall Study|Protocol Violation|1|||
145600298|NCT02052310|525049905|FG001|Overall Study|Protocol Violation|6|||
145600299|NCT04452877|525049906|FG000|Overall Study|Adverse Event|5|||
145600300|NCT04452877|525049906|FG000|Overall Study|Lost to Follow-up|1|||
145600301|NCT04452877|525049906|FG000|Overall Study|Physician Decision|4|||
145600302|NCT04452877|525049906|FG000|Overall Study|Progressive Disease|18|||
145600303|NCT04452877|525049906|FG000|Overall Study|Withdrawal by Subject|3|||
145600304|NCT01505387|525049907|FG000|Overall Study|Protocol Violation|1|||
145600305|NCT01505387|525049908|FG001|Overall Study|Protocol Violation|0|||
145600306|NCT01505387|525049907|FG000|Overall Study|Withdrawal by Subject|1|||
145600307|NCT01505387|525049908|FG001|Overall Study|Withdrawal by Subject|1|||
145600308|NCT00595504|525049909|FG000|Overall Study|Withdrawal by Subject|1|||
145600309|NCT00595504|525049910|FG001|Overall Study|Withdrawal by Subject|3|||
145600310|NCT00595504|525049909|FG000|Overall Study|Physician Decision|1|||
145600311|NCT00595504|525049910|FG001|Overall Study|Physician Decision|0|||
145600312|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
145600313|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
145600314|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
145600315|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
145600316|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
145600317|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
145600318|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
145600319|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
145600320|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
145600321|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
145600322|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
145600323|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
145600324|NCT00293267|525049911|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
145600325|NCT00293267|525049912|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
145600326|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
145600327|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
145600328|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
145627678|NCT00762463|525151450|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
145627679|NCT00762463|525151451|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
145627680|NCT04358549|525151452|FG000|Overall Study|Adverse Event|0|||
145627681|NCT04358549|525151453|FG001|Overall Study|Adverse Event|1|||
145627682|NCT04358549|525151452|FG000|Overall Study|Death|1|||
145627683|NCT04358549|525151453|FG001|Overall Study|Death|0|||
145627684|NCT04358549|525151452|FG000|Overall Study|Lost to Follow-up|2|||
145627685|NCT04358549|525151453|FG001|Overall Study|Lost to Follow-up|1|||
145627686|NCT04358549|525151452|FG000|Overall Study|Withdrawal by Subject|6|||
145627687|NCT04358549|525151453|FG001|Overall Study|Withdrawal by Subject|6|||
145627688|NCT04358549|525151452|FG000|Overall Study|Start remdesivir|1|||
145627689|NCT04358549|525151453|FG001|Overall Study|Start remdesivir|0|||
145627690|NCT04867902|525151457|FG000|Overall Study|Lost to Follow-up|1|||
145627691|NCT04867902|525151457|FG000|Overall Study|Withdrawal by Subject|2|||
145627692|NCT04867902|525151457|FG000|Overall Study|Protocol Violation|1|||
145627693|NCT05355116|525151458|FG000|Overall Study|Withdrawal by Subject|2|||
145627694|NCT02501629|525151459|FG000|Overall Study|Death|0|||
145627695|NCT02501629|525151460|FG001|Overall Study|Death|1|||
145627696|NCT02501629|525151459|FG000|Overall Study|Withdrawn from study by sponsor|1|||
145627697|NCT02501629|525151460|FG001|Overall Study|Withdrawn from study by sponsor|0|||
145627698|NCT02501629|525151459|FG000|Overall Study|Early termination by sponsor|1|||
145627699|NCT02501629|525151460|FG001|Overall Study|Early termination by sponsor|0|||
145627700|NCT02501629|525151459|FG000|Overall Study|Withdrawal by Subject|3|||
145627701|NCT02501629|525151460|FG001|Overall Study|Withdrawal by Subject|5|||
145627702|NCT02501629|525151459|FG000|Overall Study|Subject did not return to site|0|||
145627703|NCT02501629|525151460|FG001|Overall Study|Subject did not return to site|1|||
145627704|NCT00868231|525151463|FG000|Treatment Period 1|Adverse Event|0|||
145627705|NCT00868231|525151464|FG001|Treatment Period 1|Adverse Event|0|||
145627706|NCT00868231|525151465|FG002|Treatment Period 1|Adverse Event|0|||
145627707|NCT00868231|525151466|FG003|Treatment Period 1|Adverse Event|0|||
145627708|NCT00868231|525151467|FG004|Treatment Period 1|Adverse Event|1|||
145627709|NCT00868231|525151468|FG005|Treatment Period 1|Adverse Event|0|||
145627710|NCT00868231|525151463|FG000|Treatment Period 2|Adverse Event|1|||
145627711|NCT00868231|525151464|FG001|Treatment Period 2|Adverse Event|0|||
145627712|NCT00868231|525151465|FG002|Treatment Period 2|Adverse Event|0|||
145627713|NCT00868231|525151466|FG003|Treatment Period 2|Adverse Event|0|||
145627714|NCT00868231|525151467|FG004|Treatment Period 2|Adverse Event|0|||
145627715|NCT00868231|525151468|FG005|Treatment Period 2|Adverse Event|0|||
145627716|NCT00868231|525151463|FG000|Treatment Period 3|Adverse Event|0|||
145627717|NCT00868231|525151464|FG001|Treatment Period 3|Adverse Event|0|||
145627718|NCT00868231|525151465|FG002|Treatment Period 3|Adverse Event|1|||
145627719|NCT00868231|525151466|FG003|Treatment Period 3|Adverse Event|0|||
145627720|NCT00868231|525151467|FG004|Treatment Period 3|Adverse Event|0|||
145627721|NCT00868231|525151468|FG005|Treatment Period 3|Adverse Event|0|||
145627722|NCT03120676|525151469|FG000|Overall Study|Not treated|1|||
145627723|NCT01688973|525151470|FG000|Overall Study|Ineligible|2|||
145627724|NCT01688973|525151471|FG001|Overall Study|Ineligible|3|||
145627725|NCT01124162|525151472|FG000|First Intervention|Adverse Event|2|||
145627726|NCT01124162|525151473|FG001|First Intervention|Adverse Event|0|||
145627727|NCT01124162|525151472|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145627728|NCT01124162|525151473|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145627729|NCT01516892|525151477|FG000|Overall Study|Adverse Event|25|||
145627730|NCT01516892|525151477|FG000|Overall Study|Lack of Efficacy|35|||
145627731|NCT01516892|525151477|FG000|Overall Study|Pregnancy|5|||
145627732|NCT01516892|525151477|FG000|Overall Study|Lost to Follow-up|82|||
145627733|NCT01516892|525151477|FG000|Overall Study|Subject Withdrew Consent|92|||
145627734|NCT01516892|525151477|FG000|Overall Study|Protocol Violation|60|||
145627735|NCT01516892|525151477|FG000|Overall Study|Other Miscellaneous Reasons|43|||
145627736|NCT01516892|525151477|FG000|Overall Study|Missing|1|||
145467826|NCT00162266|524566060|FG000|Double-Blind Period|Withdrawal by Subject|5|||
145467827|NCT00162266|524566061|FG001|Double-Blind Period|Withdrawal by Subject|2|||
145467828|NCT00162266|524566062|FG002|Double-Blind Period|Withdrawal by Subject|6|||
145467829|NCT00162266|524566063|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145467830|NCT00162266|524566060|FG000|Open-Label Period|Death|0|||
145467831|NCT00162266|524566061|FG001|Open-Label Period|Death|0|||
145467832|NCT00162266|524566062|FG002|Open-Label Period|Death|0|||
145467833|NCT00162266|524566063|FG003|Open-Label Period|Death|7|||
145627737|NCT03613129|525151478|FG000|Pre-treatment Assessment|Protocol Violation|2|||
145627738|NCT03613129|525151479|FG001|Pre-treatment Assessment|Protocol Violation|0|||
145627739|NCT03613129|525151480|FG002|Pre-treatment Assessment|Protocol Violation|0|||
145627740|NCT03613129|525151481|FG003|Pre-treatment Assessment|Protocol Violation|0|||
145627741|NCT03613129|525151482|FG004|Pre-treatment Assessment|Protocol Violation|0|||
145627742|NCT03613129|525151478|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
145627743|NCT03613129|525151479|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
145627744|NCT03613129|525151480|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
145627745|NCT03613129|525151481|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
145627746|NCT03613129|525151482|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
145627747|NCT00938340|525151483|FG000|Overall Study|Withdrawal by Subject|3|||
145600329|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
145600330|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
145600331|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
145600332|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
145600333|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
145600334|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Death|3|||
145600335|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Death|0|||
145600336|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
145600337|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
145600338|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
145600339|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
145600340|NCT00293267|525049911|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
145600341|NCT00293267|525049912|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
145600342|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
145600343|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
145600344|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
145600345|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
145600346|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
145600347|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
145600348|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
145600349|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
145600350|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
145600351|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
145600352|NCT00293267|525049911|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
145600353|NCT00293267|525049912|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
145600354|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
145600355|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
145600356|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
145600357|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
145600358|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
145600359|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
145600360|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
145600361|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
145600362|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
145600363|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
145600364|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
145600365|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
145600366|NCT00293267|525049911|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
145600367|NCT00293267|525049912|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
145600368|NCT02340026|525049913|FG000|Treatment Phase|Withdrawal by Subject|2|||
145600369|NCT02340026|525049914|FG001|Treatment Phase|Withdrawal by Subject|2|||
145600370|NCT02340026|525049913|FG000|Follow-up Phase|Lost to Follow-up|1|||
145600371|NCT02340026|525049914|FG001|Follow-up Phase|Lost to Follow-up|0|||
145600372|NCT04393441|525049924|FG000|Overall Study|Adverse Event|0|||
145600373|NCT04393441|525049925|FG001|Overall Study|Adverse Event|3|||
145600374|NCT04393441|525049924|FG000|Overall Study|Withdrawal by Subject|5|||
145600375|NCT04393441|525049925|FG001|Overall Study|Withdrawal by Subject|7|||
145600376|NCT04393441|525049924|FG000|Overall Study|Lost to Follow-up|0|||
145600377|NCT04393441|525049925|FG001|Overall Study|Lost to Follow-up|2|||
145600378|NCT04393441|525049924|FG000|Overall Study|Protocol Deviation|2|||
145600379|NCT04393441|525049925|FG001|Overall Study|Protocol Deviation|1|||
145600380|NCT04393441|525049924|FG000|Overall Study|Reason not Specified|1|||
145600381|NCT04393441|525049925|FG001|Overall Study|Reason not Specified|1|||
145600382|NCT02782169|525049926|FG000|Overall Study|Lost to Follow-up|1|||
145600383|NCT02782169|525049927|FG001|Overall Study|Lost to Follow-up|2|||
145600384|NCT04003610|525049928|FG000|Overall Study|Lost to Follow-up|0|||
145600385|NCT04003610|525049929|FG001|Overall Study|Lost to Follow-up|1|||
145600386|NCT04003610|525049930|FG002|Overall Study|Lost to Follow-up|0|||
145600387|NCT04003610|525049928|FG000|Overall Study|Death|0|||
145600388|NCT04003610|525049929|FG001|Overall Study|Death|0|||
145600389|NCT04003610|525049930|FG002|Overall Study|Death|3|||
145600390|NCT04003610|525049928|FG000|Overall Study|Study Terminated by Sponsor|0|||
145600391|NCT04003610|525049929|FG001|Overall Study|Study Terminated by Sponsor|0|||
145600392|NCT04003610|525049930|FG002|Overall Study|Study Terminated by Sponsor|3|||
145600393|NCT00771810|525049931|FG000|Overall Study|Adverse Event|3|||
145600394|NCT00771810|525049932|FG001|Overall Study|Adverse Event|0|||
145600395|NCT00771810|525049933|FG002|Overall Study|Adverse Event|2|||
145600396|NCT00771810|525049931|FG000|Overall Study|Lost to Follow-up|0|||
145600397|NCT00771810|525049932|FG001|Overall Study|Lost to Follow-up|0|||
145627748|NCT00938340|525151483|FG000|Overall Study|Protocol Violation|1|||
145600398|NCT00771810|525049933|FG002|Overall Study|Lost to Follow-up|1|||
145600399|NCT00771810|525049931|FG000|Overall Study|Physician Decision|1|||
145600400|NCT00771810|525049932|FG001|Overall Study|Physician Decision|2|||
145600401|NCT00771810|525049933|FG002|Overall Study|Physician Decision|2|||
145600402|NCT00771810|525049931|FG000|Overall Study|Protocol Violation|0|||
145600403|NCT00771810|525049932|FG001|Overall Study|Protocol Violation|1|||
145600404|NCT00771810|525049933|FG002|Overall Study|Protocol Violation|1|||
145600405|NCT00771810|525049931|FG000|Overall Study|Withdrawal by Subject|1|||
145600406|NCT00771810|525049932|FG001|Overall Study|Withdrawal by Subject|2|||
145600407|NCT00771810|525049933|FG002|Overall Study|Withdrawal by Subject|0|||
145600408|NCT00771810|525049931|FG000|Overall Study|Other|0|||
145600409|NCT00771810|525049932|FG001|Overall Study|Other|0|||
145600410|NCT00771810|525049933|FG002|Overall Study|Other|1|||
145600411|NCT04751942|525049939|FG000|Overall Study|Lost to Follow-up|9|||
145600412|NCT04751942|525049940|FG001|Overall Study|Lost to Follow-up|6|||
145600413|NCT00724152|525049944|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
145600414|NCT00724152|525049945|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
145600415|NCT00724152|525049946|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
145600416|NCT00724152|525049944|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
145600417|NCT00724152|525049945|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
145600418|NCT00724152|525049946|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
145600419|NCT03266770|525049947|FG000|Overall Study|Physician Decision|3|||
145600420|NCT03266770|525049947|FG000|Overall Study|Insufficient study supplies|1|||
145600421|NCT03266770|525049947|FG000|Overall Study|Adverse Event|1|||
145600422|NCT02657031|525049951|FG000|Overall Study|Adverse Event|1|||
145600423|NCT02657031|525049952|FG001|Overall Study|Adverse Event|2|||
145600424|NCT03078816|525049953|FG000|Overall Study|Withdrawal by Subject|1|||
145600425|NCT02114151|525049954|FG000|Overall Study|Death|1|||
145600426|NCT02114151|525049954|FG000|Overall Study|Lost to Follow-up|1|||
145600427|NCT02114151|525049954|FG000|Overall Study|Withdrawal by Subject|5|||
145600428|NCT02638948|525049959|FG000|Overall Study|Withdrawal by Subject|4|||
145600429|NCT02638948|525049960|FG001|Overall Study|Withdrawal by Subject|5|||
145600430|NCT02638948|525049961|FG002|Overall Study|Withdrawal by Subject|3|||
145600431|NCT02638948|525049962|FG003|Overall Study|Withdrawal by Subject|1|||
145600432|NCT02638948|525049959|FG000|Overall Study|Administrative Reason by Sponsor|0|||
145600433|NCT02638948|525049960|FG001|Overall Study|Administrative Reason by Sponsor|1|||
145600434|NCT02638948|525049961|FG002|Overall Study|Administrative Reason by Sponsor|0|||
145600435|NCT02638948|525049962|FG003|Overall Study|Administrative Reason by Sponsor|4|||
145600436|NCT02638948|525049959|FG000|Overall Study|Adverse Event|0|||
145600437|NCT02638948|525049960|FG001|Overall Study|Adverse Event|0|||
145600438|NCT02638948|525049961|FG002|Overall Study|Adverse Event|1|||
145600439|NCT02638948|525049962|FG003|Overall Study|Adverse Event|1|||
145600440|NCT02638948|525049959|FG000|Overall Study|Lack of Efficacy|1|||
145600441|NCT02638948|525049960|FG001|Overall Study|Lack of Efficacy|1|||
145600442|NCT02638948|525049961|FG002|Overall Study|Lack of Efficacy|0|||
145600443|NCT02638948|525049962|FG003|Overall Study|Lack of Efficacy|0|||
145600444|NCT02638948|525049959|FG000|Overall Study|Lost to Follow-up|0|||
145600445|NCT02638948|525049960|FG001|Overall Study|Lost to Follow-up|0|||
145600446|NCT02638948|525049961|FG002|Overall Study|Lost to Follow-up|1|||
145600447|NCT02638948|525049962|FG003|Overall Study|Lost to Follow-up|1|||
145600448|NCT02638948|525049959|FG000|Overall Study|Poor/Non-Compliance|0|||
145600449|NCT02638948|525049960|FG001|Overall Study|Poor/Non-Compliance|2|||
145600450|NCT02638948|525049961|FG002|Overall Study|Poor/Non-Compliance|1|||
145600451|NCT02638948|525049962|FG003|Overall Study|Poor/Non-Compliance|0|||
145600452|NCT02638948|525049959|FG000|Overall Study|Participant no longer met study criteria|0|||
145600453|NCT02638948|525049960|FG001|Overall Study|Participant no longer met study criteria|1|||
145600454|NCT02638948|525049961|FG002|Overall Study|Participant no longer met study criteria|0|||
145600455|NCT02638948|525049962|FG003|Overall Study|Participant no longer met study criteria|0|||
145600456|NCT02638948|525049959|FG000|Overall Study|Other than specified above|4|||
145600457|NCT02638948|525049960|FG001|Overall Study|Other than specified above|1|||
145600458|NCT02638948|525049961|FG002|Overall Study|Other than specified above|1|||
145600459|NCT02638948|525049962|FG003|Overall Study|Other than specified above|1|||
145600460|NCT05007392|525049963|FG000|Overall Study|Randomized but not treated|1|||
145600461|NCT05007392|525049964|FG001|Overall Study|Randomized but not treated|2|||
145600462|NCT05007392|525049963|FG000|Overall Study|Other|5|||
145600463|NCT05007392|525049964|FG001|Overall Study|Other|4|||
145600464|NCT05007392|525049963|FG000|Overall Study|Lost to Follow-up|1|||
145600465|NCT05007392|525049964|FG001|Overall Study|Lost to Follow-up|2|||
145600466|NCT05007392|525049963|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
145600467|NCT05007392|525049964|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
145600468|NCT05007392|525049963|FG000|Overall Study|Use of prohibited concomitant drug|1|||
145600469|NCT05007392|525049964|FG001|Overall Study|Use of prohibited concomitant drug|1|||
145600470|NCT05007392|525049963|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
145600471|NCT05007392|525049964|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
145600472|NCT05007392|525049963|FG000|Overall Study|Adverse Event|10|||
145600473|NCT05007392|525049964|FG001|Overall Study|Adverse Event|6|||
145600474|NCT05007392|525049963|FG000|Overall Study|Participant choice|5|||
145600475|NCT05007392|525049964|FG001|Overall Study|Participant choice|10|||
145600476|NCT05007392|525049963|FG000|Overall Study|Withdrawal of consent|5|||
145600477|NCT05007392|525049964|FG001|Overall Study|Withdrawal of consent|4|||
145600478|NCT06223373|525049965|FG000|Overall Study|Lost to Follow-up|1|||
145600479|NCT06223373|525049966|FG001|Overall Study|Lost to Follow-up|2|||
145600480|NCT04981678|525049968|FG000|Overall Study|Lost to Follow-up|0|||
145600481|NCT04981678|525049969|FG001|Overall Study|Lost to Follow-up|1|||
145600482|NCT03421808|525049970|FG000|Overall Study|COVID related problems|2|||
145600483|NCT03421808|525049971|FG001|Overall Study|COVID related problems|0|||
145600484|NCT03421808|525049970|FG000|Overall Study|Withdrawal by Subject|1|||
145600485|NCT03421808|525049971|FG001|Overall Study|Withdrawal by Subject|0|||
145600486|NCT03421808|525049970|FG000|Overall Study|Protocol Violation|0|||
145600487|NCT03421808|525049971|FG001|Overall Study|Protocol Violation|1|||
145600488|NCT03764774|525049972|FG000|Overall Study|Withdrawal by Subject|0|||
145600489|NCT03764774|525049973|FG001|Overall Study|Withdrawal by Subject|0|||
145600490|NCT03764774|525049974|FG002|Overall Study|Withdrawal by Subject|0|||
145600491|NCT03764774|525049975|FG003|Overall Study|Withdrawal by Subject|0|||
145600492|NCT03764774|525049976|FG004|Overall Study|Withdrawal by Subject|0|||
145600493|NCT03764774|525049977|FG005|Overall Study|Withdrawal by Subject|0|||
145600494|NCT03764774|525049978|FG006|Overall Study|Withdrawal by Subject|0|||
145600495|NCT03764774|525049979|FG007|Overall Study|Withdrawal by Subject|0|||
145600496|NCT03764774|525049980|FG008|Overall Study|Withdrawal by Subject|0|||
145600497|NCT03764774|525049981|FG009|Overall Study|Withdrawal by Subject|0|||
145600498|NCT03764774|525049982|FG010|Overall Study|Withdrawal by Subject|1|||
145600499|NCT03764774|525049983|FG011|Overall Study|Withdrawal by Subject|0|||
145600500|NCT03764774|525049984|FG012|Overall Study|Withdrawal by Subject|0|||
145600501|NCT03764774|525049985|FG013|Overall Study|Withdrawal by Subject|0|||
145600502|NCT03764774|525049972|FG000|Overall Study|Adverse Event|0|||
145600503|NCT03764774|525049973|FG001|Overall Study|Adverse Event|0|||
145600504|NCT03764774|525049974|FG002|Overall Study|Adverse Event|0|||
145600505|NCT03764774|525049975|FG003|Overall Study|Adverse Event|0|||
145600506|NCT03764774|525049976|FG004|Overall Study|Adverse Event|0|||
145600507|NCT03764774|525049977|FG005|Overall Study|Adverse Event|0|||
145600508|NCT03764774|525049978|FG006|Overall Study|Adverse Event|0|||
145600509|NCT03764774|525049979|FG007|Overall Study|Adverse Event|0|||
145600510|NCT03764774|525049980|FG008|Overall Study|Adverse Event|0|||
145600511|NCT03764774|525049981|FG009|Overall Study|Adverse Event|0|||
145600512|NCT03764774|525049982|FG010|Overall Study|Adverse Event|0|||
145600513|NCT03764774|525049983|FG011|Overall Study|Adverse Event|0|||
145600514|NCT03764774|525049984|FG012|Overall Study|Adverse Event|2|||
145600515|NCT03764774|525049985|FG013|Overall Study|Adverse Event|0|||
145600516|NCT03764774|525049972|FG000|Overall Study|Lost to Follow-up|0|||
145600517|NCT03764774|525049973|FG001|Overall Study|Lost to Follow-up|0|||
145600518|NCT03764774|525049974|FG002|Overall Study|Lost to Follow-up|0|||
145600519|NCT03764774|525049975|FG003|Overall Study|Lost to Follow-up|0|||
145600520|NCT03764774|525049976|FG004|Overall Study|Lost to Follow-up|0|||
145600521|NCT03764774|525049977|FG005|Overall Study|Lost to Follow-up|0|||
145600522|NCT03764774|525049978|FG006|Overall Study|Lost to Follow-up|0|||
145600523|NCT03764774|525049979|FG007|Overall Study|Lost to Follow-up|0|||
145600524|NCT03764774|525049980|FG008|Overall Study|Lost to Follow-up|0|||
145600525|NCT03764774|525049981|FG009|Overall Study|Lost to Follow-up|0|||
145600526|NCT03764774|525049982|FG010|Overall Study|Lost to Follow-up|0|||
145600527|NCT03764774|525049983|FG011|Overall Study|Lost to Follow-up|0|||
145600528|NCT03764774|525049984|FG012|Overall Study|Lost to Follow-up|0|||
145600529|NCT03764774|525049985|FG013|Overall Study|Lost to Follow-up|1|||
145600530|NCT03764774|525049972|FG000|Overall Study|Physician Decision|0|||
145600531|NCT03764774|525049973|FG001|Overall Study|Physician Decision|0|||
145600532|NCT03764774|525049974|FG002|Overall Study|Physician Decision|0|||
145600533|NCT03764774|525049975|FG003|Overall Study|Physician Decision|0|||
145600534|NCT03764774|525049976|FG004|Overall Study|Physician Decision|0|||
145600535|NCT03764774|525049977|FG005|Overall Study|Physician Decision|0|||
145600536|NCT03764774|525049978|FG006|Overall Study|Physician Decision|0|||
145600537|NCT03764774|525049979|FG007|Overall Study|Physician Decision|0|||
145600538|NCT03764774|525049980|FG008|Overall Study|Physician Decision|0|||
145600539|NCT03764774|525049981|FG009|Overall Study|Physician Decision|4|||
145600540|NCT03764774|525049982|FG010|Overall Study|Physician Decision|1|||
145600541|NCT03764774|525049983|FG011|Overall Study|Physician Decision|4|||
145600542|NCT03764774|525049984|FG012|Overall Study|Physician Decision|9|||
145600543|NCT03764774|525049985|FG013|Overall Study|Physician Decision|0|||
145600544|NCT03764774|525049972|FG000|Overall Study|Study Termination|0|||
145600545|NCT03764774|525049973|FG001|Overall Study|Study Termination|0|||
145600546|NCT03764774|525049974|FG002|Overall Study|Study Termination|0|||
145600547|NCT03764774|525049975|FG003|Overall Study|Study Termination|0|||
145600548|NCT03764774|525049976|FG004|Overall Study|Study Termination|0|||
145600549|NCT03764774|525049977|FG005|Overall Study|Study Termination|0|||
145600550|NCT03764774|525049978|FG006|Overall Study|Study Termination|0|||
145600551|NCT03764774|525049979|FG007|Overall Study|Study Termination|0|||
145600552|NCT03764774|525049980|FG008|Overall Study|Study Termination|0|||
145467834|NCT00162266|524566060|FG000|Open-Label Period|Adverse Event|0|||
145467835|NCT00162266|524566061|FG001|Open-Label Period|Adverse Event|0|||
145467836|NCT00162266|524566062|FG002|Open-Label Period|Adverse Event|0|||
145600553|NCT03764774|525049981|FG009|Overall Study|Study Termination|1|||
145600554|NCT03764774|525049982|FG010|Overall Study|Study Termination|0|||
145600555|NCT03764774|525049983|FG011|Overall Study|Study Termination|0|||
145600556|NCT03764774|525049984|FG012|Overall Study|Study Termination|0|||
145600557|NCT03764774|525049985|FG013|Overall Study|Study Termination|2|||
145600558|NCT05809596|525049988|FG000|Overall Study|Death|16|||
145600559|NCT05809596|525049988|FG000|Overall Study|Withdrawal by Subject|4|||
145600560|NCT05809596|525049988|FG000|Overall Study|Physician Decision|1|||
145600561|NCT05809596|525049988|FG000|Overall Study|Missed Visit|2|||
145600562|NCT05809596|525049988|FG000|Overall Study|Other|3|||
145600563|NCT03770494|525049990|FG000|Overall Study|Lost to Follow-up|0|||
145600564|NCT03770494|525049991|FG001|Overall Study|Lost to Follow-up|0|||
145600565|NCT03770494|525049992|FG002|Overall Study|Lost to Follow-up|1|||
145600566|NCT03770494|525049993|FG003|Overall Study|Lost to Follow-up|1|||
145600567|NCT03770494|525049994|FG004|Overall Study|Lost to Follow-up|1|||
145600568|NCT03770494|525049995|FG005|Overall Study|Lost to Follow-up|0|||
145600569|NCT03770494|525049996|FG006|Overall Study|Lost to Follow-up|0|||
145600570|NCT03770494|525049997|FG007|Overall Study|Lost to Follow-up|0|||
145600571|NCT03770494|525049998|FG008|Overall Study|Lost to Follow-up|0|||
145600572|NCT03770494|525049999|FG009|Overall Study|Lost to Follow-up|0|||
145600573|NCT03770494|525050000|FG010|Overall Study|Lost to Follow-up|0|||
145600574|NCT03770494|525050001|FG011|Overall Study|Lost to Follow-up|0|||
145600575|NCT03770494|525050002|FG012|Overall Study|Lost to Follow-up|0|||
145600576|NCT03770494|525050003|FG013|Overall Study|Lost to Follow-up|0|||
145600577|NCT03770494|525049990|FG000|Overall Study|Study terminated by sponsor|1|||
145600578|NCT03770494|525049991|FG001|Overall Study|Study terminated by sponsor|2|||
145600579|NCT03770494|525049992|FG002|Overall Study|Study terminated by sponsor|1|||
145600580|NCT03770494|525049993|FG003|Overall Study|Study terminated by sponsor|1|||
145600581|NCT03770494|525049994|FG004|Overall Study|Study terminated by sponsor|1|||
145600582|NCT03770494|525049995|FG005|Overall Study|Study terminated by sponsor|2|||
145600583|NCT03770494|525049996|FG006|Overall Study|Study terminated by sponsor|1|||
145600584|NCT03770494|525049997|FG007|Overall Study|Study terminated by sponsor|2|||
145600585|NCT03770494|525049998|FG008|Overall Study|Study terminated by sponsor|1|||
145600586|NCT03770494|525049999|FG009|Overall Study|Study terminated by sponsor|2|||
145600587|NCT03770494|525050000|FG010|Overall Study|Study terminated by sponsor|1|||
145600588|NCT03770494|525050001|FG011|Overall Study|Study terminated by sponsor|2|||
145600589|NCT03770494|525050002|FG012|Overall Study|Study terminated by sponsor|0|||
145600590|NCT03770494|525050003|FG013|Overall Study|Study terminated by sponsor|0|||
145600591|NCT03770494|525049990|FG000|Overall Study|Withdrawal by Subject|1|||
145600592|NCT03770494|525049991|FG001|Overall Study|Withdrawal by Subject|1|||
145600593|NCT03770494|525049992|FG002|Overall Study|Withdrawal by Subject|0|||
145600594|NCT03770494|525049993|FG003|Overall Study|Withdrawal by Subject|0|||
145600595|NCT03770494|525049994|FG004|Overall Study|Withdrawal by Subject|2|||
145600596|NCT03770494|525049995|FG005|Overall Study|Withdrawal by Subject|2|||
145600597|NCT03770494|525049996|FG006|Overall Study|Withdrawal by Subject|2|||
145600598|NCT03770494|525049997|FG007|Overall Study|Withdrawal by Subject|0|||
145600599|NCT03770494|525049998|FG008|Overall Study|Withdrawal by Subject|2|||
145600600|NCT03770494|525049999|FG009|Overall Study|Withdrawal by Subject|3|||
145600601|NCT03770494|525050000|FG010|Overall Study|Withdrawal by Subject|1|||
145600602|NCT03770494|525050001|FG011|Overall Study|Withdrawal by Subject|0|||
145600603|NCT03770494|525050002|FG012|Overall Study|Withdrawal by Subject|0|||
145600604|NCT03770494|525050003|FG013|Overall Study|Withdrawal by Subject|0|||
145600605|NCT04922554|525050004|FG000|Overall Study|Adverse Event|4|||
145600606|NCT04922554|525050005|FG001|Overall Study|Adverse Event|0|||
145600607|NCT04922554|525050004|FG000|Overall Study|Withdrawal by Subject|1|||
145600608|NCT04922554|525050005|FG001|Overall Study|Withdrawal by Subject|0|||
145600609|NCT02240108|525051074|FG000|Overall Study|Other than specified|8|||
145600610|NCT02240108|525051075|FG001|Overall Study|Other than specified|6|||
145600611|NCT02240108|525051074|FG000|Overall Study|Adverse Event|1|||
145600612|NCT02240108|525051075|FG001|Overall Study|Adverse Event|9|||
145600613|NCT02240108|525051074|FG000|Overall Study|Pregnancy|1|||
145600614|NCT02240108|525051075|FG001|Overall Study|Pregnancy|0|||
145600615|NCT02240108|525051074|FG000|Overall Study|Withdrawal by Subject|4|||
145600616|NCT02240108|525051075|FG001|Overall Study|Withdrawal by Subject|9|||
145600617|NCT02240108|525051074|FG000|Overall Study|StudyTerminated by Sponsor|0|||
145600618|NCT02240108|525051075|FG001|Overall Study|StudyTerminated by Sponsor|1|||
145600619|NCT03928028|525051076|FG000|Overall Study|Physician Decision|9|||
145600620|NCT03928028|525051077|FG001|Overall Study|Physician Decision|6|||
145600621|NCT03928028|525051078|FG002|Overall Study|Physician Decision|3|||
145600622|NCT03928028|525051076|FG000|Overall Study|Withdrawal by Subject|12|||
145600623|NCT03928028|525051077|FG001|Overall Study|Withdrawal by Subject|3|||
145600624|NCT03928028|525051078|FG002|Overall Study|Withdrawal by Subject|3|||
145600625|NCT04525547|525051084|FG000|Overall Study|Not treated with Ofev|2|||
145600626|NCT04525547|525051084|FG000|Overall Study|Off-label use|2|||
145600627|NCT04525547|525051084|FG000|Overall Study|Lost to Follow-up|1|||
145600628|NCT00800202|525051085|FG000|Overall Study|Adverse Event|7|||
145600629|NCT00800202|525051086|FG001|Overall Study|Adverse Event|6|||
145600630|NCT00800202|525051085|FG000|Overall Study|Death|1|||
145600631|NCT00800202|525051086|FG001|Overall Study|Death|0|||
145600632|NCT00800202|525051085|FG000|Overall Study|Other|5|||
145600633|NCT00800202|525051086|FG001|Overall Study|Other|0|||
145600634|NCT00800202|525051085|FG000|Overall Study|Disease Progression|54|||
145600635|NCT00800202|525051086|FG001|Overall Study|Disease Progression|18|||
145600636|NCT02641392|525051092|FG000|Overall Study|Lost to Follow-up|0|||
145600637|NCT02641392|525051093|FG001|Overall Study|Lost to Follow-up|0|||
145600638|NCT02641392|525051094|FG002|Overall Study|Lost to Follow-up|2|||
145600639|NCT02641392|525051092|FG000|Overall Study|Withdrawal by Subject|0|||
145600640|NCT02641392|525051093|FG001|Overall Study|Withdrawal by Subject|0|||
145600641|NCT02641392|525051094|FG002|Overall Study|Withdrawal by Subject|17|||
145600642|NCT02641392|525051092|FG000|Overall Study|Adverse Event|0|||
145600643|NCT02641392|525051093|FG001|Overall Study|Adverse Event|1|||
145600644|NCT02641392|525051094|FG002|Overall Study|Adverse Event|25|||
145600645|NCT02641392|525051092|FG000|Overall Study|Study Terminated by Sponsor|4|||
145600646|NCT02641392|525051093|FG001|Overall Study|Study Terminated by Sponsor|12|||
145600647|NCT02641392|525051094|FG002|Overall Study|Study Terminated by Sponsor|144|||
145600648|NCT02641392|525051092|FG000|Overall Study|Lack of Efficacy|0|||
145600649|NCT02641392|525051093|FG001|Overall Study|Lack of Efficacy|0|||
145600650|NCT02641392|525051094|FG002|Overall Study|Lack of Efficacy|101|||
145600651|NCT02641392|525051092|FG000|Overall Study|Miscellaneous|0|||
145600652|NCT02641392|525051093|FG001|Overall Study|Miscellaneous|0|||
145600653|NCT02641392|525051094|FG002|Overall Study|Miscellaneous|3|||
145600654|NCT02641392|525051092|FG000|Overall Study|Death|0|||
145600655|NCT02641392|525051093|FG001|Overall Study|Death|0|||
145600656|NCT02641392|525051094|FG002|Overall Study|Death|1|||
145600657|NCT03518125|525051095|FG000|Overall Study|Lost to Follow-up|0|||
145600658|NCT03518125|525051096|FG001|Overall Study|Lost to Follow-up|2|||
145600659|NCT03518125|525051097|FG002|Overall Study|Lost to Follow-up|0|||
145600660|NCT03518125|525051098|FG003|Overall Study|Lost to Follow-up|0|||
145600661|NCT03518125|525051099|FG004|Overall Study|Lost to Follow-up|3|||
145600662|NCT03518125|525051100|FG005|Overall Study|Lost to Follow-up|5|||
145600663|NCT03518125|525051095|FG000|Overall Study|Physician Decision|0|||
145600664|NCT03518125|525051096|FG001|Overall Study|Physician Decision|1|||
145600665|NCT03518125|525051097|FG002|Overall Study|Physician Decision|0|||
145600666|NCT03518125|525051098|FG003|Overall Study|Physician Decision|0|||
145600667|NCT03518125|525051099|FG004|Overall Study|Physician Decision|0|||
145600668|NCT03518125|525051100|FG005|Overall Study|Physician Decision|0|||
145600669|NCT03518125|525051095|FG000|Overall Study|Withdrawal by Subject|1|||
145600670|NCT03518125|525051096|FG001|Overall Study|Withdrawal by Subject|1|||
145600671|NCT03518125|525051097|FG002|Overall Study|Withdrawal by Subject|0|||
145600672|NCT03518125|525051098|FG003|Overall Study|Withdrawal by Subject|1|||
145600673|NCT03518125|525051099|FG004|Overall Study|Withdrawal by Subject|1|||
145600674|NCT03518125|525051100|FG005|Overall Study|Withdrawal by Subject|3|||
145600675|NCT03518125|525051095|FG000|Overall Study|Missed Day 394 Visit|1|||
145600676|NCT03518125|525051096|FG001|Overall Study|Missed Day 394 Visit|0|||
145600677|NCT03518125|525051097|FG002|Overall Study|Missed Day 394 Visit|0|||
145600678|NCT03518125|525051098|FG003|Overall Study|Missed Day 394 Visit|0|||
145600679|NCT03518125|525051099|FG004|Overall Study|Missed Day 394 Visit|0|||
145600680|NCT03518125|525051100|FG005|Overall Study|Missed Day 394 Visit|0|||
145600681|NCT01301391|525051101|FG000|Overall Study|Death|13|||
145600682|NCT01301391|525051101|FG000|Overall Study|Lost to Follow-up|3|||
145600683|NCT01301391|525051101|FG000|Overall Study|Physician Decision|2|||
145600684|NCT01301391|525051101|FG000|Overall Study|Sponsor's decision|8|||
145600685|NCT01949870|525051102|FG000|Overall Study|Lack of Efficacy|2|||
145600686|NCT01949870|525051102|FG000|Overall Study|Adverse Event|1|||
145600687|NCT01949870|525051102|FG000|Overall Study|Study termination|1|||
145600688|NCT01949870|525051102|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
145600689|NCT02182973|525051103|FG000|Overall Study|Withdrawal by Subject|3|||
145600690|NCT02182973|525051104|FG001|Overall Study|Withdrawal by Subject|0|||
145600691|NCT01235546|525051105|FG000|Overall Study|Staff error, medication not administered|1|||
145600692|NCT01235546|525051106|FG001|Overall Study|Staff error, medication not administered|0|||
145600693|NCT01235546|525051105|FG000|Overall Study|Protocol Violation|1|||
145627749|NCT00938340|525151483|FG000|Overall Study|Adverse Event|1|||
145600694|NCT01235546|525051106|FG001|Overall Study|Protocol Violation|1|||
145600695|NCT01123382|525051107|FG000|Overall Study|Withdrawal by Subject|1|||
145600696|NCT01123382|525051108|FG001|Overall Study|Withdrawal by Subject|4|||
145600697|NCT01123382|525051107|FG000|Overall Study|Lost to Follow-up|1|||
145600698|NCT01123382|525051108|FG001|Overall Study|Lost to Follow-up|2|||
145600699|NCT02740049|525051109|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
145600700|NCT02274857|525051110|FG000|Overall Study|Adverse Event|1|||
145600701|NCT02274857|525051111|FG001|Overall Study|Adverse Event|0|||
145600702|NCT02274857|525051110|FG000|Overall Study|Death|1|||
145600703|NCT02274857|525051111|FG001|Overall Study|Death|2|||
145600704|NCT02274857|525051110|FG000|Overall Study|Lost to Follow-up|3|||
145600705|NCT02274857|525051111|FG001|Overall Study|Lost to Follow-up|0|||
145627750|NCT00711646|525151484|FG000|Overall Study|Adverse Event|6|||
145627751|NCT00711646|525151485|FG001|Overall Study|Adverse Event|1|||
145627752|NCT00711646|525151484|FG000|Overall Study|Withdrawal by Subject|4|||
145627753|NCT00711646|525151485|FG001|Overall Study|Withdrawal by Subject|0|||
145627754|NCT00711646|525151484|FG000|Overall Study|Protocol Violation|0|||
145627755|NCT00711646|525151485|FG001|Overall Study|Protocol Violation|1|||
145627756|NCT00711646|525151484|FG000|Overall Study|Lost to Follow-up|1|||
145627757|NCT00711646|525151485|FG001|Overall Study|Lost to Follow-up|0|||
145627758|NCT00711646|525151484|FG000|Overall Study|administrative decision|0|||
145627759|NCT00711646|525151485|FG001|Overall Study|administrative decision|1|||
145627760|NCT00711646|525151484|FG000|Overall Study|patient non-compliance|1|||
145627761|NCT00711646|525151485|FG001|Overall Study|patient non-compliance|0|||
145627762|NCT03441360|525151486|FG000|Overall Study|Radiological disease progression|5|||
145627763|NCT03441360|525151487|FG001|Overall Study|Radiological disease progression|6|||
145627764|NCT03441360|525151488|FG002|Overall Study|Radiological disease progression|4|||
145627765|NCT03441360|525151486|FG000|Overall Study|Clinical disease progression|2|||
145627766|NCT03441360|525151487|FG001|Overall Study|Clinical disease progression|2|||
145627767|NCT03441360|525151488|FG002|Overall Study|Clinical disease progression|0|||
145627768|NCT03441360|525151486|FG000|Overall Study|Adverse Event|1|||
145627769|NCT03441360|525151487|FG001|Overall Study|Adverse Event|0|||
145627770|NCT03441360|525151488|FG002|Overall Study|Adverse Event|1|||
145627771|NCT00269399|525151489|FG000|Overall Study|Lack of Efficacy|27|||
145627772|NCT00269399|525151490|FG001|Overall Study|Lack of Efficacy|10|||
145627773|NCT00269399|525151489|FG000|Overall Study|Adverse Event|10|||
145627774|NCT00269399|525151490|FG001|Overall Study|Adverse Event|4|||
145600706|NCT02274857|525051110|FG000|Overall Study|Physician Decision|2|||
145600707|NCT02274857|525051111|FG001|Overall Study|Physician Decision|0|||
145600708|NCT02274857|525051110|FG000|Overall Study|Trial screen failure|0|||
145600709|NCT02274857|525051111|FG001|Overall Study|Trial screen failure|2|||
145600710|NCT02274857|525051110|FG000|Overall Study|Withdrawal by Subject|11|||
145600711|NCT02274857|525051111|FG001|Overall Study|Withdrawal by Subject|2|||
145600712|NCT02274857|525051110|FG000|Overall Study|Other|2|||
145600713|NCT02274857|525051111|FG001|Overall Study|Other|0|||
145600714|NCT03338829|525051116|FG000|Overall Study|Lost to Follow-up|4|||
145600715|NCT03338829|525051117|FG001|Overall Study|Lost to Follow-up|2|||
145600716|NCT03338829|525051118|FG002|Overall Study|Lost to Follow-up|4|||
145600717|NCT03338829|525051116|FG000|Overall Study|Pregnancy loss|1|||
145600718|NCT03338829|525051117|FG001|Overall Study|Pregnancy loss|1|||
145600719|NCT03338829|525051118|FG002|Overall Study|Pregnancy loss|0|||
145600720|NCT03338829|525051116|FG000|Overall Study|Protocol Violation|0|||
145600721|NCT03338829|525051117|FG001|Overall Study|Protocol Violation|1|||
145600722|NCT03338829|525051118|FG002|Overall Study|Protocol Violation|0|||
145600723|NCT01218126|525051121|FG000|Overall Study|Adverse Event|8|||
145600724|NCT01218126|525051122|FG001|Overall Study|Adverse Event|10|||
145600725|NCT01218126|525051123|FG002|Overall Study|Adverse Event|12|||
145600726|NCT01218126|525051124|FG003|Overall Study|Adverse Event|16|||
145600727|NCT01218126|525051121|FG000|Overall Study|Lack of Efficacy|7|||
145600728|NCT01218126|525051122|FG001|Overall Study|Lack of Efficacy|2|||
145600729|NCT01218126|525051123|FG002|Overall Study|Lack of Efficacy|2|||
145600730|NCT01218126|525051124|FG003|Overall Study|Lack of Efficacy|6|||
145600731|NCT01218126|525051121|FG000|Overall Study|Protocol Violation|5|||
145600732|NCT01218126|525051122|FG001|Overall Study|Protocol Violation|2|||
145600733|NCT01218126|525051123|FG002|Overall Study|Protocol Violation|2|||
145600734|NCT01218126|525051124|FG003|Overall Study|Protocol Violation|3|||
145600735|NCT01218126|525051121|FG000|Overall Study|Protocol-defined stopping criteria|1|||
145600736|NCT01218126|525051122|FG001|Overall Study|Protocol-defined stopping criteria|1|||
145600737|NCT01218126|525051123|FG002|Overall Study|Protocol-defined stopping criteria|0|||
145627775|NCT00269399|525151489|FG000|Overall Study|Withdrawal by Subject|2|||
145627776|NCT00269399|525151490|FG001|Overall Study|Withdrawal by Subject|5|||
145627777|NCT00269399|525151489|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
145600738|NCT01218126|525051124|FG003|Overall Study|Protocol-defined stopping criteria|0|||
145600739|NCT01218126|525051121|FG000|Overall Study|Lost to Follow-up|0|||
145600740|NCT01218126|525051122|FG001|Overall Study|Lost to Follow-up|0|||
145627778|NCT00269399|525151490|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
145627779|NCT00269399|525151489|FG000|Overall Study|Other|0|||
145627780|NCT00269399|525151490|FG001|Overall Study|Other|4|||
145627781|NCT00269399|525151489|FG000|Overall Study|Development of exclusion criteria|0|||
145627782|NCT00269399|525151490|FG001|Overall Study|Development of exclusion criteria|1|||
145627783|NCT03396835|525151491|FG000|Overall Study|Withdrawn prior to completion|1|||
145627784|NCT03396835|525151491|FG000|Overall Study|Did not meet criteria for data analysis|1|||
145627785|NCT03439124|525151492|FG000|Overall Study|Adverse Event|2|||
145600741|NCT01218126|525051123|FG002|Overall Study|Lost to Follow-up|0|||
145600742|NCT01218126|525051124|FG003|Overall Study|Lost to Follow-up|2|||
145600743|NCT01218126|525051121|FG000|Overall Study|Physician Decision|1|||
145600744|NCT01218126|525051122|FG001|Overall Study|Physician Decision|2|||
145600745|NCT01218126|525051123|FG002|Overall Study|Physician Decision|4|||
145600746|NCT01218126|525051124|FG003|Overall Study|Physician Decision|2|||
145600747|NCT01218126|525051121|FG000|Overall Study|Withdrawal by Subject|2|||
145600748|NCT01218126|525051122|FG001|Overall Study|Withdrawal by Subject|5|||
145600749|NCT01218126|525051123|FG002|Overall Study|Withdrawal by Subject|4|||
145600750|NCT01218126|525051124|FG003|Overall Study|Withdrawal by Subject|6|||
145600751|NCT01860703|525051127|FG000|Overall Study|Adverse Event|1|||
145600752|NCT01860703|525051128|FG001|Overall Study|Adverse Event|4|||
145600753|NCT01860703|525051129|FG002|Overall Study|Adverse Event|0|||
145600754|NCT01860703|525051130|FG003|Overall Study|Adverse Event|2|||
145600755|NCT01860703|525051127|FG000|Overall Study|Withdrawal by Subject|0|||
145600756|NCT01860703|525051128|FG001|Overall Study|Withdrawal by Subject|1|||
145600757|NCT01860703|525051129|FG002|Overall Study|Withdrawal by Subject|0|||
145600758|NCT01860703|525051130|FG003|Overall Study|Withdrawal by Subject|0|||
145600759|NCT01860703|525051127|FG000|Overall Study|Personal reason|1|||
145600760|NCT01860703|525051128|FG001|Overall Study|Personal reason|0|||
145600761|NCT01860703|525051129|FG002|Overall Study|Personal reason|1|||
145600762|NCT01860703|525051130|FG003|Overall Study|Personal reason|0|||
145600763|NCT00696410|525051132|FG000|Overall Study|Lost to Follow-up|2|||
145600764|NCT00696410|525051133|FG001|Overall Study|Lost to Follow-up|0|||
145600765|NCT00696410|525051132|FG000|Overall Study|Withdrawal by Subject|8|||
145600766|NCT00696410|525051133|FG001|Overall Study|Withdrawal by Subject|0|||
145600767|NCT00696410|525051132|FG000|Overall Study|Physician Decision|3|||
145600768|NCT00696410|525051133|FG001|Overall Study|Physician Decision|0|||
145600769|NCT03184792|525051137|FG000|Overall Study|Pandemic|2|||
145600770|NCT03184792|525051138|FG001|Overall Study|Pandemic|2|||
145600771|NCT02134587|525051140|FG000|Overall Study|Did not completed all meetings|30|||
145600772|NCT00265889|525051141|FG000|Overall Study|Physician Decision|1|||
145600773|NCT00265889|525051141|FG000|Overall Study|Protocol Violation|1|||
145600774|NCT00265889|525051141|FG000|Overall Study|Insurance denied the request|3|||
145600775|NCT01515748|525051151|FG000|Overall Study|Withdrawal by Subject|32|||
145600776|NCT01515748|525051152|FG001|Overall Study|Withdrawal by Subject|41|||
145600777|NCT01515748|525051151|FG000|Overall Study|Lost to Follow-up|2|||
145600778|NCT01515748|525051152|FG001|Overall Study|Lost to Follow-up|4|||
145600779|NCT01515748|525051151|FG000|Overall Study|Other than specified above|5|||
145600780|NCT01515748|525051152|FG001|Overall Study|Other than specified above|10|||
145600781|NCT03221387|525051153|FG000|Overall Study|Lost to Follow-up|1|||
145600782|NCT03221387|525051153|FG000|Overall Study|Lung transplant|1|||
145600783|NCT02365519|525051154|FG000|Randomized and Treated|Adverse Event|0|||
145600784|NCT02365519|525051155|FG001|Randomized and Treated|Adverse Event|1|||
145600785|NCT02365519|525051156|FG002|Randomized and Treated|Adverse Event|0|||
145600786|NCT02365519|525051154|FG000|Randomized and Treated|Withdrawal by Subject|0|||
145600787|NCT02365519|525051155|FG001|Randomized and Treated|Withdrawal by Subject|1|||
145600788|NCT02365519|525051156|FG002|Randomized and Treated|Withdrawal by Subject|1|||
145600789|NCT01971723|525051157|FG000|Overall Study|Withdrawal by Subject|1|||
145600790|NCT01971723|525051158|FG001|Overall Study|Withdrawal by Subject|1|||
145600791|NCT01971723|525051157|FG000|Overall Study|Protocol Violation|1|||
145600792|NCT01971723|525051158|FG001|Overall Study|Protocol Violation|2|||
145600793|NCT03188055|525051162|FG000|Overall Study|Unavailable for training|0|||
145600794|NCT03188055|525051163|FG001|Overall Study|Unavailable for training|0|||
145600795|NCT03188055|525051164|FG002|Overall Study|Unavailable for training|19|||
145600796|NCT03188055|525051165|FG003|Overall Study|Unavailable for training|0|||
145600797|NCT03188055|525051166|FG004|Overall Study|Unavailable for training|0|||
145600798|NCT03188055|525051167|FG005|Overall Study|Unavailable for training|0|||
145600799|NCT03188055|525051162|FG000|Overall Study|Lost to Follow-up|0|||
145600800|NCT03188055|525051163|FG001|Overall Study|Lost to Follow-up|18|||
145600801|NCT03188055|525051164|FG002|Overall Study|Lost to Follow-up|0|||
145600802|NCT03188055|525051165|FG003|Overall Study|Lost to Follow-up|11|||
145600803|NCT03188055|525051166|FG004|Overall Study|Lost to Follow-up|0|||
145600804|NCT03188055|525051167|FG005|Overall Study|Lost to Follow-up|0|||
145600805|NCT03188055|525051162|FG000|Overall Study|Withdrawal by Subject|0|||
145600806|NCT03188055|525051163|FG001|Overall Study|Withdrawal by Subject|1|||
145600807|NCT03188055|525051164|FG002|Overall Study|Withdrawal by Subject|0|||
145600808|NCT03188055|525051165|FG003|Overall Study|Withdrawal by Subject|1|||
145600809|NCT03188055|525051166|FG004|Overall Study|Withdrawal by Subject|0|||
145600810|NCT03188055|525051167|FG005|Overall Study|Withdrawal by Subject|0|||
145600811|NCT03657277|525051168|FG000|Overall Study|Physician Decision|2|||
145600812|NCT03657277|525051168|FG000|Overall Study|Lost to Follow-up|1|||
145600813|NCT03657277|525051168|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
145600814|NCT02286089|525051171|FG000|Overall Study|Ongoing in Study|1|||
145600815|NCT02286089|525051172|FG001|Overall Study|Ongoing in Study|1|||
145600816|NCT02286089|525051173|FG002|Overall Study|Ongoing in Study|4|||
145600817|NCT02286089|525051174|FG003|Overall Study|Ongoing in Study|10|||
145600818|NCT02286089|525051171|FG000|Overall Study|Withdrawal by Subject|0|||
145600819|NCT02286089|525051172|FG001|Overall Study|Withdrawal by Subject|0|||
145627786|NCT03439124|525151493|FG001|Overall Study|Adverse Event|0|||
145600820|NCT02286089|525051173|FG002|Overall Study|Withdrawal by Subject|2|||
145600821|NCT02286089|525051174|FG003|Overall Study|Withdrawal by Subject|2|||
145600822|NCT00657618|525051175|FG000|Overall Study|Adverse Event|32|||
145600823|NCT00657618|525051175|FG000|Overall Study|Withdrawal by Subject|8|||
145467837|NCT00162266|524566063|FG003|Open-Label Period|Adverse Event|46|||
145467838|NCT00162266|524566060|FG000|Open-Label Period|Lack of Efficacy|0|||
145467839|NCT00162266|524566061|FG001|Open-Label Period|Lack of Efficacy|0|||
145467840|NCT00162266|524566062|FG002|Open-Label Period|Lack of Efficacy|0|||
145467841|NCT00162266|524566063|FG003|Open-Label Period|Lack of Efficacy|26|||
145467842|NCT00162266|524566060|FG000|Open-Label Period|Lost to Follow-up|0|||
145467843|NCT00162266|524566061|FG001|Open-Label Period|Lost to Follow-up|0|||
145467844|NCT00162266|524566062|FG002|Open-Label Period|Lost to Follow-up|0|||
145467845|NCT00162266|524566063|FG003|Open-Label Period|Lost to Follow-up|3|||
145467846|NCT00162266|524566060|FG000|Open-Label Period|Withdrawal by Subject|0|||
145600824|NCT00657618|525051175|FG000|Overall Study|negative for leishmaniasis|2|||
145600825|NCT00657618|525051175|FG000|Overall Study|didn't start due to schedule conflicts|1|||
145600826|NCT05774197|525051176|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
145600827|NCT05073133|525051178|FG000|Overall Study|Death|2|||
145600828|NCT05002218|525051179|FG000|Overall Study|Lost to Follow-up|5|||
145600829|NCT05002218|525051180|FG001|Overall Study|Lost to Follow-up|6|||
145600830|NCT04120233|525051181|FG000|Overall Study|Adverse Event|0|||
145600831|NCT04120233|525051182|FG001|Overall Study|Adverse Event|0|||
145600832|NCT04120233|525051183|FG002|Overall Study|Adverse Event|0|||
145600833|NCT04120233|525051184|FG003|Overall Study|Adverse Event|0|||
145600834|NCT04120233|525051185|FG004|Overall Study|Adverse Event|1|||
145600835|NCT04120233|525051186|FG005|Overall Study|Adverse Event|0|||
145600836|NCT01345630|525052550|FG000|Overall Study|Adverse Event|22|||
145600837|NCT01345630|525052551|FG001|Overall Study|Adverse Event|23|||
145600838|NCT01345630|525052550|FG000|Overall Study|Lost to Follow-up|17|||
145600839|NCT01345630|525052551|FG001|Overall Study|Lost to Follow-up|16|||
145600840|NCT01345630|525052550|FG000|Overall Study|Protocol Violation|4|||
145600841|NCT01345630|525052551|FG001|Overall Study|Protocol Violation|1|||
145600842|NCT01345630|525052550|FG000|Overall Study|Medication error without associated AE|0|||
145600843|NCT01345630|525052551|FG001|Overall Study|Medication error without associated AE|1|||
145600844|NCT01345630|525052550|FG000|Overall Study|Study terminated by sponsor|254|||
145600845|NCT01345630|525052551|FG001|Overall Study|Study terminated by sponsor|285|||
145600846|NCT01345630|525052550|FG000|Overall Study|Other reasons|6|||
145600847|NCT01345630|525052551|FG001|Overall Study|Other reasons|8|||
145600848|NCT01345630|525052550|FG000|Overall Study|Withdrawn due to pregnancy|1|||
145600849|NCT01345630|525052551|FG001|Overall Study|Withdrawn due to pregnancy|2|||
145600850|NCT01345630|525052550|FG000|Overall Study|No longer willing to participate|9|||
145600851|NCT01345630|525052551|FG001|Overall Study|No longer willing to participate|12|||
145600852|NCT01345630|525052550|FG000|Overall Study|Insufficient clinical response|48|||
145600853|NCT01345630|525052551|FG001|Overall Study|Insufficient clinical response|11|||
145600854|NCT00939484|525052552|FG000|Overall Study|Progression/Relapse|8|||
145600855|NCT00939484|525052553|FG001|Overall Study|Progression/Relapse|20|||
145600856|NCT00939484|525052554|FG002|Overall Study|Progression/Relapse|3|||
145600857|NCT03938454|525052555|FG000|Overall Study|Protocol Violation|1|||
145600858|NCT03938454|525052555|FG000|Overall Study|Withdrawal by Subject|2|||
145600859|NCT03938454|525052555|FG000|Overall Study|Lost to Follow-up|3|||
145600860|NCT03092375|525052562|FG000|Overall Study|Lack of Efficacy|0|||
145600861|NCT03092375|525052563|FG001|Overall Study|Lack of Efficacy|1|||
145600862|NCT03092375|525052564|FG002|Overall Study|Lack of Efficacy|1|||
145600863|NCT03092375|525052565|FG003|Overall Study|Lack of Efficacy|0|||
145600864|NCT00553501|525052566|FG000|Overall Study|Adverse Event|2|||
145600865|NCT00553501|525052566|FG000|Overall Study|Death|1|||
145600866|NCT00553501|525052566|FG000|Overall Study|Progression|1|||
145600867|NCT01464021|525052567|FG000|Overall Study|Withdrawal by Subject|13|||
145600868|NCT01464021|525052567|FG000|Overall Study|Lost to Follow-up|1|||
145600869|NCT01464021|525052567|FG000|Overall Study|Lack of Efficacy|1|||
145600870|NCT01464021|525052567|FG000|Overall Study|various|11|||
145600871|NCT00949715|525052568|FG000|Overall Study|Physician Decision|1|||
145600872|NCT00949715|525052569|FG001|Overall Study|Physician Decision|0|||
145600873|NCT00949715|525052568|FG000|Overall Study|Lost to Follow-up|1|||
145600874|NCT00949715|525052569|FG001|Overall Study|Lost to Follow-up|0|||
145600875|NCT00949715|525052568|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
145600876|NCT00949715|525052569|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
145600877|NCT00861614|525052571|FG000|Overall Study|Disease Progression|182|||
145600878|NCT00861614|525052572|FG001|Overall Study|Disease Progression|263|||
145600879|NCT00861614|525052571|FG000|Overall Study|Study Drug Toxicity|79|||
145600880|NCT00861614|525052572|FG001|Overall Study|Study Drug Toxicity|6|||
145600881|NCT00861614|525052571|FG000|Overall Study|Death|32|||
145600882|NCT00861614|525052572|FG001|Overall Study|Death|19|||
145600883|NCT00861614|525052571|FG000|Overall Study|Adverse Event|27|||
145600884|NCT00861614|525052572|FG001|Overall Study|Adverse Event|23|||
145600885|NCT00861614|525052571|FG000|Overall Study|Withdrawal by Subject|34|||
145600886|NCT00861614|525052572|FG001|Overall Study|Withdrawal by Subject|35|||
145600887|NCT00861614|525052571|FG000|Overall Study|Other|17|||
145600888|NCT00861614|525052572|FG001|Overall Study|Other|22|||
145600889|NCT01255592|525052573|FG000|Overall Study|Adverse Event|5|||
145600890|NCT01255592|525052574|FG001|Overall Study|Adverse Event|0|||
145627787|NCT03439124|525151492|FG000|Overall Study|Lost to Follow-up|1|||
145600891|NCT01255592|525052573|FG000|Overall Study|Withdrawal by Subject|1|||
145600892|NCT01255592|525052574|FG001|Overall Study|Withdrawal by Subject|0|||
145600893|NCT01255592|525052573|FG000|Overall Study|Other|0|||
145600894|NCT01255592|525052574|FG001|Overall Study|Other|1|||
145600895|NCT01289418|525052575|FG000|Day 8 Survey|email address invalid|283|||
145600896|NCT01289418|525052575|FG000|Day 8 Survey|participants did not complete the survey|1935|||
145600897|NCT01289418|525052575|FG000|Day 29 Survey|email address invalid|283|||
145600898|NCT01289418|525052575|FG000|Day 29 Survey|participants did not complete the survey|2185|||
145600899|NCT01352585|525052577|FG000|Overall Study|Adverse Event|2|||
145600900|NCT01352585|525052578|FG001|Overall Study|Adverse Event|1|||
145600901|NCT01352585|525052577|FG000|Overall Study|Lost to Follow-up|1|||
145600902|NCT01352585|525052578|FG001|Overall Study|Lost to Follow-up|0|||
145600903|NCT01352585|525052577|FG000|Overall Study|Other|5|||
145600904|NCT01352585|525052578|FG001|Overall Study|Other|2|||
145600905|NCT02243280|525052581|FG000|Treated|Adverse Event|1|||
145600906|NCT02243280|525052582|FG001|Treated|Adverse Event|0|||
145600907|NCT02243280|525052583|FG002|Treated|Adverse Event|0|||
145600908|NCT02243280|525052584|FG003|Treated|Adverse Event|0|||
145600909|NCT02243280|525052585|FG004|Treated|Adverse Event|0|||
145600910|NCT02243280|525052586|FG005|Treated|Adverse Event|0|||
145600911|NCT02243280|525052587|FG006|Treated|Adverse Event|0|||
145600912|NCT02243280|525052588|FG007|Treated|Adverse Event|0|||
145600913|NCT02243280|525052589|FG008|Treated|Adverse Event|0|||
145600914|NCT02243280|525052590|FG009|Treated|Adverse Event|0|||
145600915|NCT02243280|525052591|FG010|Treated|Adverse Event|1|||
145600916|NCT02243280|525052581|FG000|Treated|Lost to Follow-up|0|||
145600917|NCT02243280|525052582|FG001|Treated|Lost to Follow-up|0|||
145600918|NCT02243280|525052583|FG002|Treated|Lost to Follow-up|0|||
145600919|NCT02243280|525052584|FG003|Treated|Lost to Follow-up|0|||
145600920|NCT02243280|525052585|FG004|Treated|Lost to Follow-up|0|||
145600921|NCT02243280|525052586|FG005|Treated|Lost to Follow-up|0|||
145600922|NCT02243280|525052587|FG006|Treated|Lost to Follow-up|0|||
145600923|NCT02243280|525052588|FG007|Treated|Lost to Follow-up|0|||
145600924|NCT02243280|525052589|FG008|Treated|Lost to Follow-up|1|||
145600925|NCT02243280|525052590|FG009|Treated|Lost to Follow-up|0|||
145600926|NCT02243280|525052591|FG010|Treated|Lost to Follow-up|2|||
145600927|NCT01807156|525052602|FG000|Overall Study|Physician Decision|1|||
145600928|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
145600929|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
145600930|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
145600931|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
145600932|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
145600933|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
145600934|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
145600935|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
145600936|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
145600937|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
145600938|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
145600939|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
145600940|NCT01493687|525052609|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
145600941|NCT01493687|525052610|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
145600942|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
145600943|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
145600944|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
145600945|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
145600946|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
145600947|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
145600948|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
145600949|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
145600950|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
145600951|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
145600952|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
145600953|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
145600954|NCT01493687|525052609|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
145600955|NCT01493687|525052610|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
145600956|NCT01493687|525052609|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
145600957|NCT01493687|525052610|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
145600958|NCT02323646|525052614|FG000|Treatment Course 1|Adverse Event|1|||
145600959|NCT02323646|525052615|FG001|Treatment Course 1|Adverse Event|0|||
145600960|NCT02323646|525052616|FG002|Treatment Course 1|Adverse Event|1|||
145600961|NCT02323646|525052614|FG000|Treatment Course 1|Heavy Bleeding|1|||
145600962|NCT02323646|525052615|FG001|Treatment Course 1|Heavy Bleeding|1|||
145600963|NCT02323646|525052616|FG002|Treatment Course 1|Heavy Bleeding|0|||
145600964|NCT02323646|525052614|FG000|Treatment Course 1|Lost to Follow-up|1|||
145600965|NCT02323646|525052615|FG001|Treatment Course 1|Lost to Follow-up|0|||
145600966|NCT02323646|525052616|FG002|Treatment Course 1|Lost to Follow-up|2|||
145600967|NCT02323646|525052614|FG000|Treatment Course 1|Withdrawal by Subject|0|||
145600968|NCT02323646|525052615|FG001|Treatment Course 1|Withdrawal by Subject|2|||
145600969|NCT02323646|525052616|FG002|Treatment Course 1|Withdrawal by Subject|0|||
145600970|NCT02323646|525052614|FG000|Treatment Course 2|Adverse Event|1|||
145600971|NCT02323646|525052615|FG001|Treatment Course 2|Adverse Event|0|||
145600972|NCT02323646|525052616|FG002|Treatment Course 2|Adverse Event|1|||
145600973|NCT02323646|525052614|FG000|Treatment Course 2|Lost to Follow-up|0|||
145600974|NCT02323646|525052615|FG001|Treatment Course 2|Lost to Follow-up|0|||
145600975|NCT02323646|525052616|FG002|Treatment Course 2|Lost to Follow-up|1|||
145600976|NCT02323646|525052614|FG000|Treatment Course 2|Non-compliance|0|||
145600977|NCT02323646|525052615|FG001|Treatment Course 2|Non-compliance|1|||
145600978|NCT02323646|525052616|FG002|Treatment Course 2|Non-compliance|1|||
145600979|NCT00521144|525052617|FG000|Overall Study|Not Treated|0|||
145600980|NCT00521144|525052618|FG001|Overall Study|Not Treated|0|||
145600981|NCT00521144|525052619|FG002|Overall Study|Not Treated|0|||
145600982|NCT00521144|525052620|FG003|Overall Study|Not Treated|1|||
145600983|NCT00521144|525052621|FG004|Overall Study|Not Treated|0|||
145600984|NCT00521144|525052617|FG000|Overall Study|Adverse Event|0|||
145600985|NCT00521144|525052618|FG001|Overall Study|Adverse Event|1|||
145600986|NCT00521144|525052619|FG002|Overall Study|Adverse Event|0|||
145600987|NCT00521144|525052620|FG003|Overall Study|Adverse Event|0|||
145600988|NCT00521144|525052621|FG004|Overall Study|Adverse Event|1|||
145600989|NCT00521144|525052617|FG000|Overall Study|Progressive Disease|4|||
145600990|NCT00521144|525052618|FG001|Overall Study|Progressive Disease|2|||
145600991|NCT00521144|525052619|FG002|Overall Study|Progressive Disease|2|||
145600992|NCT00521144|525052620|FG003|Overall Study|Progressive Disease|0|||
145600993|NCT00521144|525052621|FG004|Overall Study|Progressive Disease|6|||
145600994|NCT01370525|525052622|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
145600995|NCT01370525|525052623|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
145600996|NCT01370525|525052622|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
145600997|NCT01370525|525052623|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145600998|NCT01370525|525052622|FG000|Overall Study|Adverse Event|0|||
145600999|NCT01370525|525052623|FG001|Overall Study|Adverse Event|1|||
145601000|NCT01370525|525052622|FG000|Overall Study|Protocol Violation|2|||
145601001|NCT01370525|525052623|FG001|Overall Study|Protocol Violation|1|||
145601002|NCT01370525|525052622|FG000|Overall Study|Lost to follow up|2|||
145601003|NCT01370525|525052623|FG001|Overall Study|Lost to follow up|6|||
145601004|NCT04791761|525052626|FG000|Overall Study|Lost to Follow-up|8|||
145601005|NCT04791761|525052627|FG001|Overall Study|Lost to Follow-up|6|||
145601006|NCT04791761|525052628|FG002|Overall Study|Lost to Follow-up|10|||
145601007|NCT04791761|525052626|FG000|Overall Study|Withdrawal by Subject|0|||
145601008|NCT04791761|525052627|FG001|Overall Study|Withdrawal by Subject|1|||
145601009|NCT04791761|525052628|FG002|Overall Study|Withdrawal by Subject|1|||
145601010|NCT04791761|525052626|FG000|Overall Study|Protocol Violation|0|||
145601011|NCT04791761|525052627|FG001|Overall Study|Protocol Violation|1|||
145601012|NCT04791761|525052628|FG002|Overall Study|Protocol Violation|1|||
145601013|NCT00180479|525052632|FG000|Overall Study|Death|4|||
145601014|NCT00180479|525052633|FG001|Overall Study|Death|2|||
145601015|NCT00180479|525052632|FG000|Overall Study|Lost to Follow-up|9|||
145601016|NCT00180479|525052633|FG001|Overall Study|Lost to Follow-up|7|||
145601017|NCT00180479|525052632|FG000|Overall Study|Withdrawal by Subject|3|||
145601018|NCT00180479|525052633|FG001|Overall Study|Withdrawal by Subject|3|||
145601019|NCT00180479|525052632|FG000|Overall Study|Informed consent not signed|0|||
145601020|NCT00180479|525052633|FG001|Overall Study|Informed consent not signed|1|||
145601021|NCT02459262|525052638|FG000|Overall Study|Withdrawal by Subject|0|||
145601022|NCT02459262|525052639|FG001|Overall Study|Withdrawal by Subject|0|||
145601023|NCT02459262|525052640|FG002|Overall Study|Withdrawal by Subject|0|||
145601024|NCT02459262|525052641|FG003|Overall Study|Withdrawal by Subject|0|||
145601025|NCT02459262|525052642|FG004|Overall Study|Withdrawal by Subject|0|||
145601026|NCT02459262|525052643|FG005|Overall Study|Withdrawal by Subject|0|||
145601027|NCT02459262|525052644|FG006|Overall Study|Withdrawal by Subject|0|||
145601028|NCT02459262|525052645|FG007|Overall Study|Withdrawal by Subject|0|||
145601029|NCT02459262|525052646|FG008|Overall Study|Withdrawal by Subject|0|||
145601030|NCT02459262|525052647|FG009|Overall Study|Withdrawal by Subject|1|||
145601031|NCT02459262|525052648|FG010|Overall Study|Withdrawal by Subject|0|||
145601032|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
145601033|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
145601034|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
145601035|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
145601036|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
145601037|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
145601038|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
145601039|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
145601040|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
145627788|NCT03439124|525151493|FG001|Overall Study|Lost to Follow-up|0|||
145467847|NCT00162266|524566061|FG001|Open-Label Period|Withdrawal by Subject|0|||
145467848|NCT00162266|524566062|FG002|Open-Label Period|Withdrawal by Subject|0|||
145467849|NCT00162266|524566063|FG003|Open-Label Period|Withdrawal by Subject|31|||
145467850|NCT00162266|524566060|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
145467851|NCT00162266|524566061|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
145467852|NCT00162266|524566062|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
145467853|NCT00162266|524566063|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
145467854|NCT00162266|524566060|FG000|Open-Label Period|Other Reasons|0|||
145467855|NCT00162266|524566061|FG001|Open-Label Period|Other Reasons|0|||
145467856|NCT00162266|524566062|FG002|Open-Label Period|Other Reasons|0|||
145467857|NCT00162266|524566063|FG003|Open-Label Period|Other Reasons|15|||
145467858|NCT04208087|524566064|FG000|Overall Study|Adverse Event|1|||
145467859|NCT04208087|524566065|FG001|Overall Study|Adverse Event|0|||
145467860|NCT04208087|524566066|FG002|Overall Study|Adverse Event|0|||
145467861|NCT04208087|524566067|FG003|Overall Study|Adverse Event|0|||
145467862|NCT04208087|524566068|FG004|Overall Study|Adverse Event|0|||
145467863|NCT04208087|524566064|FG000|Overall Study|Withdrawal by Subject|0|||
145467864|NCT04208087|524566065|FG001|Overall Study|Withdrawal by Subject|0|||
145467865|NCT04208087|524566066|FG002|Overall Study|Withdrawal by Subject|1|||
145467866|NCT04208087|524566067|FG003|Overall Study|Withdrawal by Subject|0|||
145467867|NCT04208087|524566068|FG004|Overall Study|Withdrawal by Subject|0|||
145467868|NCT04208087|524566064|FG000|Overall Study|Other|0|||
145467869|NCT04208087|524566065|FG001|Overall Study|Other|0|||
145467870|NCT04208087|524566066|FG002|Overall Study|Other|0|||
145467871|NCT04208087|524566067|FG003|Overall Study|Other|0|||
145467872|NCT04208087|524566068|FG004|Overall Study|Other|1|||
145467873|NCT01839656|524566069|FG000|Overall Study|Withdrawal by Subject|1|||
145467874|NCT01839656|524566070|FG001|Overall Study|Withdrawal by Subject|1|||
145467875|NCT01839656|524566069|FG000|Overall Study|Adverse event, serious fatal|1|||
145467876|NCT01839656|524566070|FG001|Overall Study|Adverse event, serious fatal|4|||
145467877|NCT01839656|524566069|FG000|Overall Study|Early study closure|0|||
145467878|NCT01839656|524566070|FG001|Overall Study|Early study closure|11|||
145467879|NCT01839656|524566069|FG000|Overall Study|Adverse Event|1|||
145467880|NCT01839656|524566070|FG001|Overall Study|Adverse Event|0|||
145467881|NCT02621073|524566071|FG000|Overall Study|Lost to Follow-up|0|||
145467882|NCT02621073|524566072|FG001|Overall Study|Lost to Follow-up|1|||
145467883|NCT02621073|524566071|FG000|Overall Study|Physician Decision|3|||
145467884|NCT02621073|524566072|FG001|Overall Study|Physician Decision|2|||
145467885|NCT01595581|524566073|FG000|Overall Study|Withdrawal by Subject|1|||
145467886|NCT01595581|524566074|FG001|Overall Study|Withdrawal by Subject|0|||
145467887|NCT02273960|524566087|FG000|Short Term Period|Lost to Follow-up|1|||
145467888|NCT02273960|524566088|FG001|Short Term Period|Lost to Follow-up|0|||
145467889|NCT02273960|524566089|FG002|Short Term Period|Lost to Follow-up|0|||
145467890|NCT02273960|524566090|FG003|Short Term Period|Lost to Follow-up|0|||
145467891|NCT02273960|524566087|FG000|Short Term Period|Lack of Efficacy|0|||
145467892|NCT02273960|524566088|FG001|Short Term Period|Lack of Efficacy|0|||
145467893|NCT02273960|524566089|FG002|Short Term Period|Lack of Efficacy|0|||
145467894|NCT02273960|524566090|FG003|Short Term Period|Lack of Efficacy|1|||
145467895|NCT02273960|524566087|FG000|Short Term Period|ST complete, not entering LTE|4|||
145467896|NCT02273960|524566088|FG001|Short Term Period|ST complete, not entering LTE|6|||
145467897|NCT02273960|524566089|FG002|Short Term Period|ST complete, not entering LTE|4|||
145467898|NCT02273960|524566090|FG003|Short Term Period|ST complete, not entering LTE|5|||
145467899|NCT02273960|524566087|FG000|Long Term Extension|Death|0|||
145467900|NCT02273960|524566088|FG001|Long Term Extension|Death|0|||
145467901|NCT02273960|524566089|FG002|Long Term Extension|Death|0|||
145467902|NCT02273960|524566090|FG003|Long Term Extension|Death|1|||
145467903|NCT01012323|524566091|FG000|Overall Study|Investigator Judgment|1|||
145467904|NCT00495755|524566092|FG000|Overall Study|Adverse Event|3|||
145467905|NCT01789606|524566093|FG000|Overall Study|Participant not Purchased the Product|0|||
145467906|NCT01789606|524566094|FG001|Overall Study|Participant not Purchased the Product|20|||
145467907|NCT01789606|524566093|FG000|Overall Study|Withdrawal by Subject|0|||
145467908|NCT01789606|524566094|FG001|Overall Study|Withdrawal by Subject|1|||
145467909|NCT01789606|524566093|FG000|Overall Study|Ineligible|6|||
145467910|NCT01789606|524566094|FG001|Overall Study|Ineligible|2|||
145467911|NCT01789606|524566093|FG000|Overall Study|Administrative Reasons|17|||
145467912|NCT01789606|524566094|FG001|Overall Study|Administrative Reasons|6|||
145467913|NCT01789606|524566093|FG000|Overall Study|No Study Medication Taken|0|||
145467914|NCT01789606|524566094|FG001|Overall Study|No Study Medication Taken|1|||
145467915|NCT01789606|524566093|FG000|Overall Study|Protocol Violation|0|||
145467916|NCT01789606|524566094|FG001|Overall Study|Protocol Violation|55|||
145467917|NCT01789606|524566093|FG000|Overall Study|Adverse Event|0|||
145467918|NCT01789606|524566094|FG001|Overall Study|Adverse Event|3|||
145467919|NCT01789606|524566093|FG000|Overall Study|Lost to Follow-up|0|||
145627789|NCT03439124|525151492|FG000|Overall Study|Other reasons|1|||
145467920|NCT01789606|524566094|FG001|Overall Study|Lost to Follow-up|14|||
145467921|NCT01789606|524566093|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
145467922|NCT01789606|524566094|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
145467923|NCT01105377|524566098|FG000|Overall Study|Withdrawal by Subject|0|||
145467924|NCT01105377|524566099|FG001|Overall Study|Withdrawal by Subject|1|||
145467925|NCT03495102|524567795|FG000|Overall Study|Adverse Event|5|||
145467926|NCT03495102|524567796|FG001|Overall Study|Adverse Event|7|||
145467927|NCT03495102|524567797|FG002|Overall Study|Adverse Event|10|||
145467928|NCT03495102|524567795|FG000|Overall Study|Death|3|||
145467929|NCT03495102|524567796|FG001|Overall Study|Death|4|||
145467930|NCT03495102|524567797|FG002|Overall Study|Death|4|||
145467931|NCT03495102|524567795|FG000|Overall Study|Lost to Follow-up|15|||
145467932|NCT03495102|524567796|FG001|Overall Study|Lost to Follow-up|16|||
145467933|NCT03495102|524567797|FG002|Overall Study|Lost to Follow-up|17|||
145467934|NCT03495102|524567795|FG000|Overall Study|Physician Decision|2|||
145467935|NCT03495102|524567796|FG001|Overall Study|Physician Decision|0|||
145601041|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
145601042|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
145601043|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
145601044|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
145601045|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
145601046|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
145601047|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
145601048|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
145601049|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
145601050|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
145601051|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
145601052|NCT00549757|525052655|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
145601053|NCT00549757|525052656|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
145601054|NCT00549757|525052655|FG000|Extension Period (in Average 9 Months)|Death|143|||
145601055|NCT00549757|525052656|FG001|Extension Period (in Average 9 Months)|Death|136|||
145601056|NCT00549757|525052655|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
145601057|NCT00549757|525052656|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
145601058|NCT00549757|525052655|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
145601059|NCT00549757|525052656|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
145601060|NCT00549757|525052655|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
145601061|NCT00549757|525052656|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
145601062|NCT01814748|525052659|FG000|Overall Study|Lost to Follow-up|1|||
145601063|NCT01814748|525052660|FG001|Overall Study|Lost to Follow-up|2|||
145601064|NCT01814748|525052659|FG000|Overall Study|Study site terminated by sponsor|1|||
145601065|NCT01814748|525052660|FG001|Overall Study|Study site terminated by sponsor|1|||
145601066|NCT01814748|525052659|FG000|Overall Study|Withdrawal by Subject|6|||
145601067|NCT01814748|525052660|FG001|Overall Study|Withdrawal by Subject|4|||
145601068|NCT00330174|525052662|FG000|Overall Study|Withdrawal by Subject|7|||
145601069|NCT00330174|525052663|FG001|Overall Study|Withdrawal by Subject|7|||
145601070|NCT00330174|525052662|FG000|Overall Study|Lost to Follow-up|4|||
145601071|NCT00330174|525052663|FG001|Overall Study|Lost to Follow-up|1|||
145601072|NCT00330174|525052662|FG000|Overall Study|Clinical deterioration|1|||
145601073|NCT00330174|525052663|FG001|Overall Study|Clinical deterioration|2|||
145601074|NCT00330174|525052662|FG000|Overall Study|Excessive missed visits|3|||
145601075|NCT00330174|525052663|FG001|Overall Study|Excessive missed visits|8|||
145601076|NCT00330174|525052662|FG000|Overall Study|Miscellaneous reasons|7|||
145601077|NCT00330174|525052663|FG001|Overall Study|Miscellaneous reasons|1|||
145601078|NCT02316769|525052666|FG000|Overall Study|Physician Decision|1|||
145601079|NCT02316769|525052667|FG001|Overall Study|Physician Decision|0|||
145601080|NCT02316769|525052666|FG000|Overall Study|Withdrawal by Subject|1|||
145601081|NCT02316769|525052667|FG001|Overall Study|Withdrawal by Subject|0|||
145601082|NCT02403180|525052668|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
145601083|NCT02403180|525052669|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
145601084|NCT02403180|525052668|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
145601085|NCT02403180|525052669|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
145601086|NCT00645164|525052673|FG000|Overall Study|Lost to Follow-up|2|||
145601087|NCT00645164|525052673|FG000|Overall Study|Withdrawal by Subject|4|||
145601088|NCT00645164|525052673|FG000|Overall Study|Protocol Violation|1|||
145601089|NCT00715429|525052676|FG000|Overall Study|Did not complete the study diary|0|||
145601090|NCT00715429|525052677|FG001|Overall Study|Did not complete the study diary|1|||
145601091|NCT04899245|525052681|FG000|Overall Study|Withdrawal by Subject|3|||
145601092|NCT04899245|525052682|FG001|Overall Study|Withdrawal by Subject|5|||
145601093|NCT04899245|525052683|FG002|Overall Study|Withdrawal by Subject|2|||
145601094|NCT04899245|525052681|FG000|Overall Study|No longer eligible - Left staff position|0|||
145601095|NCT04899245|525052682|FG001|Overall Study|No longer eligible - Left staff position|0|||
145601096|NCT04899245|525052683|FG002|Overall Study|No longer eligible - Left staff position|1|||
145467936|NCT03495102|524567797|FG002|Overall Study|Physician Decision|2|||
145467937|NCT03495102|524567795|FG000|Overall Study|Withdrawal by Subject|25|||
145467938|NCT03495102|524567796|FG001|Overall Study|Withdrawal by Subject|36|||
145627790|NCT03439124|525151493|FG001|Overall Study|Other reasons|0|||
145627791|NCT01451814|525151494|FG000|Overall Study|Withdrawal by Subject|1|||
145627792|NCT01451814|525151495|FG001|Overall Study|Withdrawal by Subject|1|||
145627793|NCT01451814|525151494|FG000|Overall Study|Lost to Follow-up|5|||
145627794|NCT01451814|525151495|FG001|Overall Study|Lost to Follow-up|4|||
145627795|NCT04353037|525151497|FG000|Overall Study|Lost to Follow-up|0|||
145627796|NCT04353037|525151498|FG001|Overall Study|Lost to Follow-up|1|||
145627797|NCT04353037|525151499|FG002|Overall Study|Lost to Follow-up|2|||
145627798|NCT04353037|525151500|FG003|Overall Study|Lost to Follow-up|3|||
145627799|NCT04353037|525151497|FG000|Overall Study|Withdrawal by Subject|0|||
145627800|NCT04353037|525151498|FG001|Overall Study|Withdrawal by Subject|2|||
145627801|NCT04353037|525151499|FG002|Overall Study|Withdrawal by Subject|3|||
145627802|NCT04353037|525151500|FG003|Overall Study|Withdrawal by Subject|5|||
145627803|NCT04353037|525151497|FG000|Overall Study|Adverse Event|0|||
145627804|NCT04353037|525151498|FG001|Overall Study|Adverse Event|0|||
145627805|NCT04353037|525151499|FG002|Overall Study|Adverse Event|2|||
145627806|NCT04353037|525151500|FG003|Overall Study|Adverse Event|0|||
145627807|NCT04353037|525151497|FG000|Overall Study|Exposure Change|0|||
145627808|NCT04353037|525151498|FG001|Overall Study|Exposure Change|0|||
145627809|NCT04353037|525151499|FG002|Overall Study|Exposure Change|0|||
145627810|NCT04353037|525151500|FG003|Overall Study|Exposure Change|2|||
145627811|NCT03710564|525151501|FG000|Overall Study|Study Terminated by Sponsor|104|||
145627812|NCT03710564|525151502|FG001|Overall Study|Study Terminated by Sponsor|55|||
145627813|NCT03710564|525151501|FG000|Overall Study|Withdrawal by Subject|57|||
145627814|NCT03710564|525151502|FG001|Overall Study|Withdrawal by Subject|25|||
145627815|NCT03710564|525151501|FG000|Overall Study|Death|10|||
145627816|NCT03710564|525151502|FG001|Overall Study|Death|4|||
145627817|NCT03710564|525151501|FG000|Overall Study|Lost to Follow-up|5|||
145627818|NCT03710564|525151502|FG001|Overall Study|Lost to Follow-up|4|||
145627819|NCT03710564|525151501|FG000|Overall Study|Protocol Violation|3|||
145627820|NCT03710564|525151502|FG001|Overall Study|Protocol Violation|2|||
145627821|NCT03710564|525151501|FG000|Overall Study|Adverse Event|3|||
145627822|NCT03710564|525151502|FG001|Overall Study|Adverse Event|0|||
145627823|NCT03710564|525151501|FG000|Overall Study|Physician Decision|2|||
145627824|NCT03710564|525151502|FG001|Overall Study|Physician Decision|3|||
145627825|NCT02993471|525151503|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
145627826|NCT02993471|525151503|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
145627827|NCT03006341|525151507|FG000|Overall Study|Not linked in the EMR|25069|||
145627828|NCT03006341|525151508|FG001|Overall Study|Not linked in the EMR|67505|||
145627829|NCT03006341|525151509|FG002|Overall Study|Not linked in the EMR|30993|||
145627830|NCT03006341|525151510|FG003|Overall Study|Not linked in the EMR|10685|||
145627831|NCT00742274|525151513|FG000|Overall Study|Death|1|||
145627832|NCT00742274|525151514|FG001|Overall Study|Death|0|||
145627833|NCT00742274|525151513|FG000|Overall Study|Withdrawal by Subject|1|||
145627834|NCT00742274|525151514|FG001|Overall Study|Withdrawal by Subject|2|||
145627835|NCT00742274|525151513|FG000|Overall Study|Removed for medical reasons|1|||
145627836|NCT00742274|525151514|FG001|Overall Study|Removed for medical reasons|1|||
145627837|NCT02365298|525151518|FG000|Period 2|incorrect Rx dispensed|1|||
145627838|NCT02365298|525151519|FG001|Period 2|incorrect Rx dispensed|0|||
145627839|NCT02365298|525151518|FG000|Period 2|Discontinued at request of Sponsor|1|||
145627840|NCT02365298|525151519|FG001|Period 2|Discontinued at request of Sponsor|0|||
145627841|NCT02365298|525151518|FG000|Period 2|Test Article longer available|0|||
145627842|NCT02365298|525151519|FG001|Period 2|Test Article longer available|1|||
145627843|NCT02365298|525151518|FG000|Period 2|Protocol Violation|0|||
145627844|NCT02365298|525151519|FG001|Period 2|Protocol Violation|1|||
145627845|NCT02974010|525151522|FG000|Overall Study|Lost to Follow-up|3|||
145627846|NCT02974010|525151523|FG001|Overall Study|Lost to Follow-up|1|||
145627847|NCT02974010|525151524|FG002|Overall Study|Lost to Follow-up|0|||
145627848|NCT02974010|525151525|FG003|Overall Study|Lost to Follow-up|0|||
145627849|NCT02974010|525151522|FG000|Overall Study|Withdrawal by Subject|2|||
145627850|NCT02974010|525151523|FG001|Overall Study|Withdrawal by Subject|1|||
145627851|NCT02974010|525151524|FG002|Overall Study|Withdrawal by Subject|0|||
145627852|NCT02974010|525151525|FG003|Overall Study|Withdrawal by Subject|0|||
145627853|NCT02974010|525151522|FG000|Overall Study|Adverse Event|0|||
145627854|NCT02974010|525151523|FG001|Overall Study|Adverse Event|1|||
145627855|NCT02974010|525151524|FG002|Overall Study|Adverse Event|0|||
145627856|NCT02974010|525151525|FG003|Overall Study|Adverse Event|0|||
145627857|NCT02974010|525151522|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
145627858|NCT02974010|525151523|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
145627859|NCT02974010|525151524|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
145627860|NCT02974010|525151525|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
145627861|NCT02974010|525151522|FG000|Overall Study|Lack of Efficacy|0|||
145627862|NCT02974010|525151523|FG001|Overall Study|Lack of Efficacy|0|||
145627863|NCT02974010|525151524|FG002|Overall Study|Lack of Efficacy|1|||
145627864|NCT02974010|525151525|FG003|Overall Study|Lack of Efficacy|0|||
145627865|NCT01941316|525151526|FG000|Overall Study|Adverse Event|0|||
145627866|NCT01941316|525151527|FG001|Overall Study|Adverse Event|1|||
145627867|NCT01941316|525151528|FG002|Overall Study|Adverse Event|0|||
145627868|NCT01941316|525151529|FG003|Overall Study|Adverse Event|7|||
145627869|NCT01941316|525151526|FG000|Overall Study|Progressive Disease|3|||
145627870|NCT01941316|525151527|FG001|Overall Study|Progressive Disease|6|||
145627871|NCT01941316|525151528|FG002|Overall Study|Progressive Disease|2|||
145627872|NCT01941316|525151529|FG003|Overall Study|Progressive Disease|29|||
145627873|NCT01941316|525151526|FG000|Overall Study|Withdrawal by Subject|0|||
145627874|NCT01941316|525151527|FG001|Overall Study|Withdrawal by Subject|2|||
145627875|NCT01941316|525151528|FG002|Overall Study|Withdrawal by Subject|1|||
145627876|NCT01941316|525151529|FG003|Overall Study|Withdrawal by Subject|8|||
145627877|NCT01941316|525151526|FG000|Overall Study|Death|0|||
145627878|NCT01941316|525151527|FG001|Overall Study|Death|0|||
145627879|NCT01941316|525151528|FG002|Overall Study|Death|0|||
145627880|NCT01941316|525151529|FG003|Overall Study|Death|3|||
145627881|NCT01941316|525151526|FG000|Overall Study|Physician Decision|0|||
145627882|NCT01941316|525151527|FG001|Overall Study|Physician Decision|0|||
145627883|NCT01941316|525151528|FG002|Overall Study|Physician Decision|0|||
145627884|NCT01941316|525151529|FG003|Overall Study|Physician Decision|3|||
145627885|NCT01941316|525151526|FG000|Overall Study|Protocol Violation|0|||
145627886|NCT01941316|525151527|FG001|Overall Study|Protocol Violation|0|||
145627887|NCT01941316|525151528|FG002|Overall Study|Protocol Violation|0|||
145627888|NCT01941316|525151529|FG003|Overall Study|Protocol Violation|3|||
145627889|NCT01941316|525151526|FG000|Overall Study|Intercurrent illness|0|||
145627890|NCT01941316|525151527|FG001|Overall Study|Intercurrent illness|0|||
145627891|NCT01941316|525151528|FG002|Overall Study|Intercurrent illness|0|||
145627892|NCT01941316|525151529|FG003|Overall Study|Intercurrent illness|1|||
145627893|NCT01941316|525151526|FG000|Overall Study|Other, not specified|0|||
145627894|NCT01941316|525151527|FG001|Overall Study|Other, not specified|0|||
145627895|NCT01941316|525151528|FG002|Overall Study|Other, not specified|0|||
145627896|NCT01941316|525151529|FG003|Overall Study|Other, not specified|1|||
145627897|NCT02775435|525151530|FG000|Overall Study|Adverse Event|32|||
145627898|NCT02775435|525151531|FG001|Overall Study|Adverse Event|27|||
145627899|NCT02775435|525151530|FG000|Overall Study|Lost to Follow-up|2|||
145627900|NCT02775435|525151531|FG001|Overall Study|Lost to Follow-up|2|||
145627901|NCT02775435|525151530|FG000|Overall Study|Sponsor decision|44|||
145627902|NCT02775435|525151531|FG001|Overall Study|Sponsor decision|19|||
145627903|NCT02775435|525151530|FG000|Overall Study|Withdrawal by Subject|4|||
145627904|NCT02775435|525151531|FG001|Overall Study|Withdrawal by Subject|9|||
145627905|NCT02775435|525151530|FG000|Overall Study|Death|196|||
145627906|NCT02775435|525151531|FG001|Overall Study|Death|224|||
145627907|NCT04555044|525151534|FG000|Overall Study|Adverse Event|0|||
145627908|NCT04555044|525151535|FG001|Overall Study|Adverse Event|1|||
145627909|NCT04088188|525151537|FG000|Overall Study|Withdrawal by Subject|2|||
145627910|NCT04088188|525151538|FG001|Overall Study|Withdrawal by Subject|0|||
145627911|NCT04088188|525151537|FG000|Overall Study|Adverse Event|2|||
145627912|NCT04088188|525151538|FG001|Overall Study|Adverse Event|0|||
145627913|NCT03124108|525151539|FG000|Overall Study|Adverse Event|0|||
145627914|NCT03124108|525151540|FG001|Overall Study|Adverse Event|1|||
145627915|NCT03124108|525151541|FG002|Overall Study|Adverse Event|0|||
145627916|NCT05650333|525151544|FG000|Treatment Period (7 Days)|Adverse Event|1|||
145627917|NCT01649427|525151545|FG000|Overall Study|Adverse Event|1|||
145627918|NCT01649427|525151546|FG001|Overall Study|Adverse Event|1|||
145627919|NCT01649427|525151545|FG000|Overall Study|Withdrawal by Subject|8|||
145627920|NCT01649427|525151546|FG001|Overall Study|Withdrawal by Subject|7|||
145627921|NCT01649427|525151545|FG000|Overall Study|Lost to Follow-up|0|||
145627922|NCT01649427|525151546|FG001|Overall Study|Lost to Follow-up|1|||
145627923|NCT01649427|525151545|FG000|Overall Study|Graft loss|0|||
145627924|NCT01649427|525151546|FG001|Overall Study|Graft loss|1|||
145627925|NCT01649427|525151545|FG000|Overall Study|Surgical problems during nephrectomy|2|||
145627926|NCT01649427|525151546|FG001|Overall Study|Surgical problems during nephrectomy|2|||
145627927|NCT03717194|525151547|FG000|Overall Study|Withdrawal by Subject|2|||
145627928|NCT03717194|525151548|FG001|Overall Study|Withdrawal by Subject|4|||
145627929|NCT03717194|525151547|FG000|Overall Study|Adverse Event|1|||
145627930|NCT03717194|525151548|FG001|Overall Study|Adverse Event|1|||
145627931|NCT03425539|525151553|FG000|Overall Study|Randomized but not treated|0|||
145627932|NCT03425539|525151554|FG001|Overall Study|Randomized but not treated|1|||
145627933|NCT03425539|525151553|FG000|Overall Study|Adverse Event|2|||
145627934|NCT03425539|525151554|FG001|Overall Study|Adverse Event|2|||
145627935|NCT03425539|525151553|FG000|Overall Study|Withdrawal by Subject|3|||
145627936|NCT03425539|525151554|FG001|Overall Study|Withdrawal by Subject|0|||
145627937|NCT03425539|525151553|FG000|Overall Study|Lost to Follow-up|0|||
145627938|NCT03425539|525151554|FG001|Overall Study|Lost to Follow-up|1|||
145627939|NCT00946192|525151555|FG000|Overall Study|Lost to Follow-up|6|||
145627940|NCT00946192|525151556|FG001|Overall Study|Lost to Follow-up|11|||
145627941|NCT00946192|525151557|FG002|Overall Study|Lost to Follow-up|9|||
145627942|NCT00946192|525151555|FG000|Overall Study|Withdrawal by Subject|10|||
145627943|NCT00946192|525151556|FG001|Overall Study|Withdrawal by Subject|7|||
145627944|NCT00946192|525151557|FG002|Overall Study|Withdrawal by Subject|3|||
145627945|NCT00946192|525151555|FG000|Overall Study|Did not start medication|2|||
145627946|NCT00946192|525151556|FG001|Overall Study|Did not start medication|0|||
145627947|NCT00946192|525151557|FG002|Overall Study|Did not start medication|0|||
145627948|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
145627949|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
145627950|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
145627951|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
145627952|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
145627953|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
145627954|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
145627955|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
145627956|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Death|1|||
145627957|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Death|0|||
145627958|NCT01080131|525151558|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
145627959|NCT01080131|525151559|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
145627960|NCT01080131|525151558|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
145627961|NCT01080131|525151559|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
145627962|NCT01080131|525151558|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
145627963|NCT01080131|525151559|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
145627964|NCT01080131|525151558|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
145627965|NCT01080131|525151559|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
145627966|NCT01080131|525151558|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
145627967|NCT01080131|525151559|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
145627968|NCT01080131|525151558|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
145627969|NCT01080131|525151559|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
145627970|NCT01080131|525151558|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
145627971|NCT01080131|525151559|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
145627972|NCT01080131|525151558|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
145627973|NCT01080131|525151559|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
145467939|NCT03495102|524567797|FG002|Overall Study|Withdrawal by Subject|18|||
145467940|NCT03495102|524567795|FG000|Overall Study|Protocol Violation|1|||
145601097|NCT04899245|525052681|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
145601098|NCT04899245|525052682|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
145601099|NCT04899245|525052683|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
145601100|NCT04899245|525052681|FG000|Overall Study|No longer eligible - Moved away from area|2|||
145601101|NCT04899245|525052682|FG001|Overall Study|No longer eligible - Moved away from area|2|||
145601102|NCT04899245|525052683|FG002|Overall Study|No longer eligible - Moved away from area|0|||
145601103|NCT01666808|525052685|FG000|Overall Study|Lost to Follow-up|9|||
145601104|NCT01666808|525052686|FG001|Overall Study|Lost to Follow-up|15|||
145601105|NCT01666808|525052685|FG000|Overall Study|Withdrawal by Subject|3|||
145601106|NCT01666808|525052686|FG001|Overall Study|Withdrawal by Subject|1|||
145601107|NCT01666808|525052685|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
145601108|NCT01666808|525052686|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
145601109|NCT03933826|525052687|FG000|Overall Study|Withdrawal by Subject|8|||
145601110|NCT03933826|525052688|FG001|Overall Study|Withdrawal by Subject|1|||
145601111|NCT03933826|525052687|FG000|Overall Study|Death|19|||
145601112|NCT03933826|525052688|FG001|Overall Study|Death|11|||
145601113|NCT03933826|525052687|FG000|Overall Study|Lost to Follow-up|41|||
145601114|NCT03933826|525052688|FG001|Overall Study|Lost to Follow-up|13|||
145601115|NCT02495025|525052695|FG000|Overall Study|Lost to Follow-up|21|||
145601116|NCT02495025|525052696|FG001|Overall Study|Lost to Follow-up|14|||
145601117|NCT02495025|525052695|FG000|Overall Study|Withdrawal by Subject|5|||
145601118|NCT02495025|525052696|FG001|Overall Study|Withdrawal by Subject|0|||
145601119|NCT03779906|525052697|FG000|Overall Study|Lost to Follow-up|7|||
145601120|NCT03779906|525052697|FG000|Overall Study|COVID pandemic|1|||
145601121|NCT02553460|525052698|FG000|Overall Study|Death|3|||
145601122|NCT02553460|525052698|FG000|Overall Study|Withdrawal by Subject|1|||
145601123|NCT02553460|525052698|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
145601124|NCT02553460|525052698|FG000|Overall Study|Relapse or Transplant|14|||
145601125|NCT02553460|525052698|FG000|Overall Study|No response to treatment|2|||
145601126|NCT02553460|525052698|FG000|Overall Study|CAR T cells|2|||
145601127|NCT01984697|525054193|FG000|Overall Study|Adverse Event|0|||
145601128|NCT01984697|525054194|FG001|Overall Study|Adverse Event|0|||
145601129|NCT01984697|525054195|FG002|Overall Study|Adverse Event|2|||
145601130|NCT01984697|525054196|FG003|Overall Study|Adverse Event|0|||
145601131|NCT01984697|525054197|FG004|Overall Study|Adverse Event|0|||
145601132|NCT01984697|525054193|FG000|Overall Study|Lost to Follow-up|14|||
145601133|NCT01984697|525054194|FG001|Overall Study|Lost to Follow-up|5|||
145601134|NCT01984697|525054195|FG002|Overall Study|Lost to Follow-up|10|||
145601135|NCT01984697|525054196|FG003|Overall Study|Lost to Follow-up|6|||
145627974|NCT02014558|525151560|FG000|Overall Study|Never Received Study Drug|0|||
145627975|NCT02014558|525151561|FG001|Overall Study|Never Received Study Drug|0|||
145627976|NCT02014558|525151562|FG002|Overall Study|Never Received Study Drug|0|||
145467941|NCT03495102|524567796|FG001|Overall Study|Protocol Violation|1|||
145467942|NCT03495102|524567797|FG002|Overall Study|Protocol Violation|0|||
145467943|NCT03495102|524567795|FG000|Overall Study|Site Closure|3|||
145467944|NCT03495102|524567796|FG001|Overall Study|Site Closure|1|||
145467945|NCT03495102|524567797|FG002|Overall Study|Site Closure|2|||
145467946|NCT03495102|524567795|FG000|Overall Study|Non-compliance|1|||
145467947|NCT03495102|524567796|FG001|Overall Study|Non-compliance|0|||
145467948|NCT03495102|524567797|FG002|Overall Study|Non-compliance|0|||
145467949|NCT03495102|524567795|FG000|Overall Study|Participant Duplicated at Another Site|0|||
145467950|NCT03495102|524567796|FG001|Overall Study|Participant Duplicated at Another Site|0|||
145467951|NCT03495102|524567797|FG002|Overall Study|Participant Duplicated at Another Site|1|||
145467952|NCT03495102|524567795|FG000|Overall Study|Primary Care Physician Recommendation|0|||
145467953|NCT03495102|524567796|FG001|Overall Study|Primary Care Physician Recommendation|1|||
145467954|NCT03495102|524567797|FG002|Overall Study|Primary Care Physician Recommendation|0|||
145467955|NCT03495102|524567795|FG000|Overall Study|Relocated to Another Country|0|||
145467956|NCT03495102|524567796|FG001|Overall Study|Relocated to Another Country|1|||
145601136|NCT01984697|525054197|FG004|Overall Study|Lost to Follow-up|21|||
145601137|NCT01984697|525054193|FG000|Overall Study|Physician Decision|3|||
145601138|NCT01984697|525054194|FG001|Overall Study|Physician Decision|0|||
145601139|NCT01984697|525054195|FG002|Overall Study|Physician Decision|0|||
145601140|NCT01984697|525054196|FG003|Overall Study|Physician Decision|1|||
145601141|NCT01984697|525054197|FG004|Overall Study|Physician Decision|0|||
145601142|NCT01984697|525054193|FG000|Overall Study|Protocol Violation|8|||
145601143|NCT01984697|525054194|FG001|Overall Study|Protocol Violation|5|||
145601144|NCT01984697|525054195|FG002|Overall Study|Protocol Violation|3|||
145601145|NCT01984697|525054196|FG003|Overall Study|Protocol Violation|2|||
145601146|NCT01984697|525054197|FG004|Overall Study|Protocol Violation|0|||
145601147|NCT01984697|525054193|FG000|Overall Study|Withdrawal by Subject|15|||
145601148|NCT01984697|525054194|FG001|Overall Study|Withdrawal by Subject|21|||
145601149|NCT01984697|525054195|FG002|Overall Study|Withdrawal by Subject|13|||
145601150|NCT01984697|525054196|FG003|Overall Study|Withdrawal by Subject|11|||
145601151|NCT01984697|525054197|FG004|Overall Study|Withdrawal by Subject|13|||
145601152|NCT01984697|525054193|FG000|Overall Study|Missed last follow-up visit|1|||
145601153|NCT01984697|525054194|FG001|Overall Study|Missed last follow-up visit|0|||
145601154|NCT01984697|525054195|FG002|Overall Study|Missed last follow-up visit|0|||
145601155|NCT01984697|525054196|FG003|Overall Study|Missed last follow-up visit|0|||
145601156|NCT01984697|525054197|FG004|Overall Study|Missed last follow-up visit|0|||
145601157|NCT01984697|525054193|FG000|Overall Study|Death|0|||
145601158|NCT01984697|525054194|FG001|Overall Study|Death|0|||
145601159|NCT01984697|525054195|FG002|Overall Study|Death|0|||
145601160|NCT01984697|525054196|FG003|Overall Study|Death|1|||
145601161|NCT01984697|525054197|FG004|Overall Study|Death|0|||
145601162|NCT01984697|525054193|FG000|Overall Study|Pregnancy|2|||
145601163|NCT01984697|525054194|FG001|Overall Study|Pregnancy|0|||
145601164|NCT01984697|525054195|FG002|Overall Study|Pregnancy|1|||
145601165|NCT01984697|525054196|FG003|Overall Study|Pregnancy|0|||
145601166|NCT01984697|525054197|FG004|Overall Study|Pregnancy|1|||
145601167|NCT04737109|525054199|FG000|Study Treatment|Disease Progression|5|||
145601168|NCT04737109|525054200|FG001|Study Treatment|Disease Progression|0|||
145601169|NCT04737109|525054201|FG002|Study Treatment|Disease Progression|0|||
145601170|NCT04737109|525054202|FG003|Study Treatment|Disease Progression|0|||
145601171|NCT04737109|525054199|FG000|Study Treatment|Death on study|1|||
145601172|NCT04737109|525054200|FG001|Study Treatment|Death on study|0|||
145601173|NCT04737109|525054201|FG002|Study Treatment|Death on study|0|||
145601174|NCT04737109|525054202|FG003|Study Treatment|Death on study|0|||
145601175|NCT01582789|525054204|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
145601176|NCT01582789|525054205|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
145601177|NCT02276066|525054206|FG000|Overall Study|Lost to Follow-up|21|||
145601178|NCT02276066|525054207|FG001|Overall Study|Lost to Follow-up|11|||
145601179|NCT05050578|525054208|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
145601180|NCT05050578|525054209|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
145601181|NCT05050578|525054208|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
145601182|NCT05050578|525054209|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
145601183|NCT05050578|525054208|FG000|Period 2, 30 Days|Protocol Violation|0|||
145601184|NCT05050578|525054209|FG001|Period 2, 30 Days|Protocol Violation|1|||
145601185|NCT03386032|525054211|FG000|Overall Study|Lack of Efficacy|6|||
145601186|NCT03386032|525054212|FG001|Overall Study|Lack of Efficacy|2|||
145601187|NCT03386032|525054213|FG002|Overall Study|Lack of Efficacy|0|||
145601188|NCT03386032|525054211|FG000|Overall Study|Adverse Event|2|||
145601189|NCT03386032|525054212|FG001|Overall Study|Adverse Event|2|||
145601190|NCT03386032|525054213|FG002|Overall Study|Adverse Event|0|||
145601191|NCT03386032|525054211|FG000|Overall Study|Withdrawal by Subject|1|||
145601192|NCT03386032|525054212|FG001|Overall Study|Withdrawal by Subject|0|||
145601193|NCT03386032|525054213|FG002|Overall Study|Withdrawal by Subject|0|||
145601194|NCT03386032|525054211|FG000|Overall Study|Lost to Follow-up|9|||
145601195|NCT03386032|525054212|FG001|Overall Study|Lost to Follow-up|3|||
145601196|NCT03386032|525054213|FG002|Overall Study|Lost to Follow-up|0|||
145601197|NCT02710292|525054218|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
145627977|NCT02014558|525151563|FG003|Overall Study|Never Received Study Drug|0|||
145627978|NCT02014558|525151564|FG004|Overall Study|Never Received Study Drug|1|||
145627979|NCT02014558|525151565|FG005|Overall Study|Never Received Study Drug|0|||
145627980|NCT02014558|525151566|FG006|Overall Study|Never Received Study Drug|1|||
145627981|NCT02014558|525151567|FG007|Overall Study|Never Received Study Drug|0|||
145627982|NCT02014558|525151568|FG008|Overall Study|Never Received Study Drug|2|||
145627983|NCT02014558|525151569|FG009|Overall Study|Never Received Study Drug|0|||
145627984|NCT02014558|525151570|FG010|Overall Study|Never Received Study Drug|2|||
145627985|NCT02014558|525151571|FG011|Overall Study|Never Received Study Drug|2|||
145627986|NCT02014558|525151572|FG012|Overall Study|Never Received Study Drug|0|||
145627987|NCT02014558|525151560|FG000|Overall Study|Adverse Event|0|||
145627988|NCT02014558|525151561|FG001|Overall Study|Adverse Event|0|||
145627989|NCT02014558|525151562|FG002|Overall Study|Adverse Event|0|||
145627990|NCT02014558|525151563|FG003|Overall Study|Adverse Event|0|||
145627991|NCT02014558|525151564|FG004|Overall Study|Adverse Event|1|||
145627992|NCT02014558|525151565|FG005|Overall Study|Adverse Event|0|||
145627993|NCT02014558|525151566|FG006|Overall Study|Adverse Event|0|||
145627994|NCT02014558|525151567|FG007|Overall Study|Adverse Event|0|||
145627995|NCT02014558|525151568|FG008|Overall Study|Adverse Event|2|||
145627996|NCT02014558|525151569|FG009|Overall Study|Adverse Event|2|||
145627997|NCT02014558|525151570|FG010|Overall Study|Adverse Event|5|||
145627998|NCT02014558|525151571|FG011|Overall Study|Adverse Event|21|||
145627999|NCT02014558|525151572|FG012|Overall Study|Adverse Event|3|||
145628000|NCT02014558|525151560|FG000|Overall Study|Death|1|||
145628001|NCT02014558|525151561|FG001|Overall Study|Death|0|||
145628002|NCT02014558|525151562|FG002|Overall Study|Death|0|||
145628003|NCT02014558|525151563|FG003|Overall Study|Death|0|||
145628004|NCT02014558|525151564|FG004|Overall Study|Death|0|||
145628005|NCT02014558|525151565|FG005|Overall Study|Death|0|||
145628006|NCT02014558|525151566|FG006|Overall Study|Death|1|||
145628007|NCT02014558|525151567|FG007|Overall Study|Death|1|||
145628008|NCT02014558|525151568|FG008|Overall Study|Death|2|||
145628009|NCT02014558|525151569|FG009|Overall Study|Death|5|||
145628010|NCT02014558|525151570|FG010|Overall Study|Death|5|||
145628011|NCT02014558|525151571|FG011|Overall Study|Death|19|||
145628012|NCT02014558|525151572|FG012|Overall Study|Death|2|||
145628013|NCT02014558|525151560|FG000|Overall Study|Lack of Efficacy|1|||
145628014|NCT02014558|525151561|FG001|Overall Study|Lack of Efficacy|2|||
145628015|NCT02014558|525151562|FG002|Overall Study|Lack of Efficacy|1|||
145628016|NCT02014558|525151563|FG003|Overall Study|Lack of Efficacy|1|||
145628017|NCT02014558|525151564|FG004|Overall Study|Lack of Efficacy|0|||
145628018|NCT02014558|525151565|FG005|Overall Study|Lack of Efficacy|0|||
145628019|NCT02014558|525151566|FG006|Overall Study|Lack of Efficacy|1|||
145628020|NCT02014558|525151567|FG007|Overall Study|Lack of Efficacy|3|||
145628021|NCT02014558|525151568|FG008|Overall Study|Lack of Efficacy|3|||
145628022|NCT02014558|525151569|FG009|Overall Study|Lack of Efficacy|3|||
145628023|NCT02014558|525151570|FG010|Overall Study|Lack of Efficacy|16|||
145628024|NCT02014558|525151571|FG011|Overall Study|Lack of Efficacy|8|||
145628025|NCT02014558|525151572|FG012|Overall Study|Lack of Efficacy|5|||
145628026|NCT02014558|525151560|FG000|Overall Study|Lost to Follow-up|0|||
145628027|NCT02014558|525151561|FG001|Overall Study|Lost to Follow-up|0|||
145628028|NCT02014558|525151562|FG002|Overall Study|Lost to Follow-up|0|||
145628029|NCT02014558|525151563|FG003|Overall Study|Lost to Follow-up|0|||
145628030|NCT02014558|525151564|FG004|Overall Study|Lost to Follow-up|0|||
145628031|NCT02014558|525151565|FG005|Overall Study|Lost to Follow-up|0|||
145628032|NCT02014558|525151566|FG006|Overall Study|Lost to Follow-up|0|||
145628033|NCT02014558|525151567|FG007|Overall Study|Lost to Follow-up|0|||
145628034|NCT02014558|525151568|FG008|Overall Study|Lost to Follow-up|0|||
145628035|NCT02014558|525151569|FG009|Overall Study|Lost to Follow-up|0|||
145628036|NCT02014558|525151570|FG010|Overall Study|Lost to Follow-up|1|||
145628037|NCT02014558|525151571|FG011|Overall Study|Lost to Follow-up|0|||
145628038|NCT02014558|525151572|FG012|Overall Study|Lost to Follow-up|0|||
145628039|NCT02014558|525151560|FG000|Overall Study|Progressive Disease|1|||
145628040|NCT02014558|525151561|FG001|Overall Study|Progressive Disease|0|||
145628041|NCT02014558|525151562|FG002|Overall Study|Progressive Disease|1|||
145628042|NCT02014558|525151563|FG003|Overall Study|Progressive Disease|1|||
145628043|NCT02014558|525151564|FG004|Overall Study|Progressive Disease|1|||
145628044|NCT02014558|525151565|FG005|Overall Study|Progressive Disease|2|||
145628045|NCT02014558|525151566|FG006|Overall Study|Progressive Disease|1|||
145628046|NCT02014558|525151567|FG007|Overall Study|Progressive Disease|6|||
145628047|NCT02014558|525151568|FG008|Overall Study|Progressive Disease|5|||
145628048|NCT02014558|525151569|FG009|Overall Study|Progressive Disease|6|||
145628049|NCT02014558|525151570|FG010|Overall Study|Progressive Disease|22|||
145628050|NCT02014558|525151571|FG011|Overall Study|Progressive Disease|31|||
145628051|NCT02014558|525151572|FG012|Overall Study|Progressive Disease|6|||
145628052|NCT02014558|525151560|FG000|Overall Study|Withdrawal by Subject|0|||
145628053|NCT02014558|525151561|FG001|Overall Study|Withdrawal by Subject|0|||
145628054|NCT02014558|525151562|FG002|Overall Study|Withdrawal by Subject|0|||
145628055|NCT02014558|525151563|FG003|Overall Study|Withdrawal by Subject|0|||
145628056|NCT02014558|525151564|FG004|Overall Study|Withdrawal by Subject|1|||
145628057|NCT02014558|525151565|FG005|Overall Study|Withdrawal by Subject|0|||
145467957|NCT03495102|524567797|FG002|Overall Study|Relocated to Another Country|0|||
145467958|NCT03495102|524567795|FG000|Overall Study|Participant was in Rehabilitation|1|||
145467959|NCT03495102|524567796|FG001|Overall Study|Participant was in Rehabilitation|0|||
145467960|NCT03495102|524567797|FG002|Overall Study|Participant was in Rehabilitation|0|||
145467961|NCT01161537|524567798|FG000|Part B|Withdrawal by Subject|2|||
145467962|NCT00358436|524567801|FG000|Overall Study|Adverse Event|29|||
145467963|NCT00358436|524567802|FG001|Overall Study|Adverse Event|13|||
145467964|NCT00358436|524567801|FG000|Overall Study|Lack of Efficacy|34|||
145467965|NCT00358436|524567802|FG001|Overall Study|Lack of Efficacy|36|||
145467966|NCT00358436|524567801|FG000|Overall Study|Lost to Follow-up|11|||
145467967|NCT00358436|524567802|FG001|Overall Study|Lost to Follow-up|6|||
145467968|NCT00358436|524567801|FG000|Overall Study|Protocol Violation|8|||
145467969|NCT00358436|524567802|FG001|Overall Study|Protocol Violation|3|||
145467970|NCT00358436|524567801|FG000|Overall Study|Withdrawal by Subject|40|||
145467971|NCT00358436|524567802|FG001|Overall Study|Withdrawal by Subject|17|||
145467972|NCT00358436|524567801|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
145467973|NCT00358436|524567802|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
145467974|NCT00358436|524567801|FG000|Overall Study|COPD exacerbation|22|||
145467975|NCT00358436|524567802|FG001|Overall Study|COPD exacerbation|10|||
145467976|NCT00358436|524567801|FG000|Overall Study|Other|6|||
145467977|NCT00358436|524567802|FG001|Overall Study|Other|1|||
145467978|NCT03938324|524567803|FG000|Overall Study|Lost to Follow-up|42|||
145467979|NCT03938324|524567804|FG001|Overall Study|Lost to Follow-up|21|||
145467980|NCT03938324|524567803|FG000|Overall Study|Withdrawal by Subject|6|||
145467981|NCT03938324|524567804|FG001|Overall Study|Withdrawal by Subject|1|||
145467982|NCT01073930|524567806|FG000|Overall Study|Withdrawal by Subject|3|||
145467983|NCT01073930|524567807|FG001|Overall Study|Withdrawal by Subject|2|||
145467984|NCT01073930|524567806|FG000|Overall Study|Lost to Follow-up|0|||
145467985|NCT01073930|524567807|FG001|Overall Study|Lost to Follow-up|1|||
145467986|NCT01073930|524567806|FG000|Overall Study|Adverse Event|0|||
145467987|NCT01073930|524567807|FG001|Overall Study|Adverse Event|1|||
145467988|NCT01073930|524567806|FG000|Overall Study|Noncompliance with study drug|0|||
145467989|NCT01073930|524567807|FG001|Overall Study|Noncompliance with study drug|1|||
145467990|NCT01073930|524567806|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
145467991|NCT01073930|524567807|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
145467992|NCT01266590|524567808|FG000|Overall Study|Adverse Event|3|||
145467993|NCT01266590|524567808|FG000|Overall Study|Lost to Follow-up|1|||
145467994|NCT01266590|524567808|FG000|Overall Study|Withdrawal by Subject|1|||
145467995|NCT01266590|524567808|FG000|Overall Study|Physician Decision|1|||
145467996|NCT00720343|524567809|FG000|Overall Study|Lost to Follow-up|1|||
145467997|NCT00720343|524567810|FG001|Overall Study|Lost to Follow-up|0|||
145467998|NCT00720343|524567809|FG000|Overall Study|Protocol Violation|0|||
145467999|NCT00720343|524567810|FG001|Overall Study|Protocol Violation|2|||
145468000|NCT03459365|524567811|FG000|Overall Study|Withdrawal by Subject|6|||
145468001|NCT03459365|524567811|FG000|Overall Study|Protocol Violation|8|||
145468002|NCT04037254|524567812|FG000|Overall Study|Protocol Violation|1|||
145468003|NCT04037254|524567813|FG001|Overall Study|Protocol Violation|0|||
145468004|NCT04037254|524567814|FG002|Overall Study|Protocol Violation|0|||
145468005|NCT04037254|524567815|FG003|Overall Study|Protocol Violation|0|||
145468006|NCT04037254|524567816|FG004|Overall Study|Protocol Violation|0|||
145468007|NCT04037254|524567812|FG000|Overall Study|Withdrawal by Subject|0|||
145468008|NCT04037254|524567813|FG001|Overall Study|Withdrawal by Subject|0|||
145468009|NCT04037254|524567814|FG002|Overall Study|Withdrawal by Subject|1|||
145468010|NCT04037254|524567815|FG003|Overall Study|Withdrawal by Subject|0|||
145468011|NCT04037254|524567816|FG004|Overall Study|Withdrawal by Subject|0|||
145468012|NCT04037254|524567812|FG000|Overall Study|Delayed or incomplete treatment|0|||
145628058|NCT02014558|525151566|FG006|Overall Study|Withdrawal by Subject|0|||
145628059|NCT02014558|525151567|FG007|Overall Study|Withdrawal by Subject|0|||
145628060|NCT02014558|525151568|FG008|Overall Study|Withdrawal by Subject|0|||
145628061|NCT02014558|525151569|FG009|Overall Study|Withdrawal by Subject|2|||
145628062|NCT02014558|525151570|FG010|Overall Study|Withdrawal by Subject|6|||
145468013|NCT04037254|524567813|FG001|Overall Study|Delayed or incomplete treatment|2|||
145468014|NCT04037254|524567814|FG002|Overall Study|Delayed or incomplete treatment|1|||
145468015|NCT04037254|524567815|FG003|Overall Study|Delayed or incomplete treatment|0|||
145468016|NCT04037254|524567816|FG004|Overall Study|Delayed or incomplete treatment|0|||
145468017|NCT03320330|524567817|FG000|Overall Study|Lack of Efficacy|5|||
145628063|NCT02014558|525151571|FG011|Overall Study|Withdrawal by Subject|10|||
145468018|NCT03320330|524567818|FG001|Overall Study|Lack of Efficacy|5|||
145468019|NCT03320330|524567819|FG002|Overall Study|Lack of Efficacy|14|||
145628064|NCT02014558|525151572|FG012|Overall Study|Withdrawal by Subject|0|||
145468020|NCT03320330|524567817|FG000|Overall Study|Physician Decision|1|||
145468021|NCT03320330|524567818|FG001|Overall Study|Physician Decision|0|||
145468022|NCT03320330|524567819|FG002|Overall Study|Physician Decision|0|||
145468023|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
145468024|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
145468025|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
145468026|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
145468027|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
145468028|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
145468029|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
145468030|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
145468031|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
145468032|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
145468033|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
145468034|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
145468035|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
145468036|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
145468037|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
145468038|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
145468039|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
145468040|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
145468041|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
145468042|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
145468043|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
145468044|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
145468045|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
145468046|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
145468047|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
145468048|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
145468049|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
145468050|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
145468051|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
145468052|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
145468053|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
145468054|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
145468055|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
145468056|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
145468057|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
145468058|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
145468059|NCT02198794|524567820|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
145468060|NCT02198794|524567821|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
145468061|NCT02198794|524567822|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
145468062|NCT02198794|524567823|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
145468063|NCT02198794|524567820|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
145468064|NCT02198794|524567821|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
145468065|NCT02198794|524567822|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
145468066|NCT02198794|524567823|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
145468067|NCT02198794|524567820|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
145468068|NCT02198794|524567821|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
145468069|NCT02198794|524567822|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
145468070|NCT02198794|524567823|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
145468071|NCT02198794|524567820|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
145468072|NCT02198794|524567821|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
145468073|NCT02198794|524567822|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
145468074|NCT02198794|524567823|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
145468075|NCT02198794|524567820|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
145468076|NCT02198794|524567821|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
145468077|NCT02198794|524567822|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
145468078|NCT02198794|524567823|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
145468079|NCT02198794|524567820|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
145468080|NCT02198794|524567821|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
145468081|NCT02198794|524567822|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
145468082|NCT02198794|524567823|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
145468083|NCT04435600|524567824|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468084|NCT04435600|524567825|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468085|NCT04435600|524567826|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
145468086|NCT04435600|524567827|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468087|NCT04435600|524567828|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468088|NCT04435600|524567829|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468089|NCT04435600|524567830|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468090|NCT04435600|524567831|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468091|NCT04435600|524567832|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468092|NCT04435600|524567833|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
145468093|NCT04435600|524567824|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468094|NCT04435600|524567825|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468095|NCT04435600|524567826|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468096|NCT04435600|524567827|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468097|NCT04435600|524567828|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468098|NCT04435600|524567829|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468099|NCT04435600|524567830|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468100|NCT04435600|524567831|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468101|NCT04435600|524567832|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
145468102|NCT04435600|524567833|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
145468103|NCT04435600|524567824|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468104|NCT04435600|524567825|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468105|NCT04435600|524567826|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468106|NCT04435600|524567827|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468107|NCT04435600|524567828|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468108|NCT04435600|524567829|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468109|NCT04435600|524567830|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468110|NCT04435600|524567831|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468111|NCT04435600|524567832|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
145468112|NCT04435600|524567833|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
145468113|NCT04435600|524567824|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468114|NCT04435600|524567825|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468115|NCT04435600|524567826|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468116|NCT04435600|524567827|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468117|NCT04435600|524567828|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468118|NCT04435600|524567829|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468119|NCT04435600|524567830|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468120|NCT04435600|524567831|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
145628065|NCT02014558|525151560|FG000|Overall Study|Miscellaneous|2|||
145628066|NCT02014558|525151561|FG001|Overall Study|Miscellaneous|1|||
145628067|NCT02014558|525151562|FG002|Overall Study|Miscellaneous|1|||
145628068|NCT02014558|525151563|FG003|Overall Study|Miscellaneous|1|||
145628069|NCT02014558|525151564|FG004|Overall Study|Miscellaneous|0|||
145628070|NCT02014558|525151565|FG005|Overall Study|Miscellaneous|1|||
145628071|NCT02014558|525151566|FG006|Overall Study|Miscellaneous|0|||
145628072|NCT02014558|525151567|FG007|Overall Study|Miscellaneous|1|||
145628073|NCT02014558|525151568|FG008|Overall Study|Miscellaneous|1|||
145628074|NCT02014558|525151569|FG009|Overall Study|Miscellaneous|3|||
145628075|NCT02014558|525151570|FG010|Overall Study|Miscellaneous|12|||
145628076|NCT02014558|525151571|FG011|Overall Study|Miscellaneous|11|||
145628077|NCT02014558|525151572|FG012|Overall Study|Miscellaneous|1|||
145628078|NCT00299702|525151575|FG000|Overall Study|Death|1|||
145628079|NCT00299702|525151576|FG001|Overall Study|Death|0|||
145628080|NCT00299702|525151575|FG000|Overall Study|Adverse Event|0|||
145628081|NCT00299702|525151576|FG001|Overall Study|Adverse Event|4|||
145628082|NCT00299702|525151575|FG000|Overall Study|Lost to Follow-up|18|||
145628083|NCT00299702|525151576|FG001|Overall Study|Lost to Follow-up|10|||
145628084|NCT00299702|525151575|FG000|Overall Study|Withdrawal by Subject|25|||
145628085|NCT00299702|525151576|FG001|Overall Study|Withdrawal by Subject|23|||
145628086|NCT00299702|525151575|FG000|Overall Study|Pregnancy|0|||
145628087|NCT00299702|525151576|FG001|Overall Study|Pregnancy|1|||
145628088|NCT00299702|525151575|FG000|Overall Study|Insufficient Response|4|||
145628089|NCT00299702|525151576|FG001|Overall Study|Insufficient Response|3|||
145628090|NCT00299702|525151575|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
145628091|NCT00299702|525151576|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
145628092|NCT00751036|525151577|FG000|Overall Study|Disease Progression|28|||
145628093|NCT00751036|525151578|FG001|Overall Study|Disease Progression|29|||
145628094|NCT00751036|525151577|FG000|Overall Study|Adverse Event|6|||
145628095|NCT00751036|525151578|FG001|Overall Study|Adverse Event|4|||
145628096|NCT00751036|525151577|FG000|Overall Study|Administrative Problems|3|||
145628097|NCT00751036|525151578|FG001|Overall Study|Administrative Problems|4|||
145628098|NCT00751036|525151577|FG000|Overall Study|Withdrawal by Subject|5|||
145628099|NCT00751036|525151578|FG001|Overall Study|Withdrawal by Subject|2|||
145468121|NCT04435600|524567832|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
145468122|NCT04435600|524567833|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
145468123|NCT02066415|524567835|FG000|Overall Study|Decision by Sponsor|5|||
145468124|NCT02066415|524567836|FG001|Overall Study|Decision by Sponsor|4|||
145628100|NCT00751036|525151577|FG000|Overall Study|Death|3|||
145628101|NCT00751036|525151578|FG001|Overall Study|Death|3|||
145628102|NCT00751036|525151577|FG000|Overall Study|Lost to Follow-up|0|||
145628103|NCT00751036|525151578|FG001|Overall Study|Lost to Follow-up|1|||
145628104|NCT00751036|525151577|FG000|Overall Study|Protocol Violation|1|||
145628105|NCT00751036|525151578|FG001|Overall Study|Protocol Violation|0|||
145628106|NCT00751036|525151577|FG000|Overall Study|Missing end of Treatment Page|2|||
145628107|NCT00751036|525151578|FG001|Overall Study|Missing end of Treatment Page|3|||
145468125|NCT02066415|524567837|FG002|Overall Study|Decision by Sponsor|2|||
145468126|NCT02066415|524567835|FG000|Overall Study|Withdrawal by Subject|9|||
145468127|NCT02066415|524567836|FG001|Overall Study|Withdrawal by Subject|1|||
145468128|NCT02066415|524567837|FG002|Overall Study|Withdrawal by Subject|4|||
145468129|NCT02066415|524567835|FG000|Overall Study|Lost to Follow-up|7|||
145468130|NCT02066415|524567836|FG001|Overall Study|Lost to Follow-up|2|||
145468131|NCT02066415|524567837|FG002|Overall Study|Lost to Follow-up|2|||
145468132|NCT02989805|524567838|FG000|Overall Study|invalid consent|6|||
145468133|NCT02989805|524567839|FG001|Overall Study|invalid consent|4|||
145468134|NCT00286221|524567840|FG000|Overall Study|Protocol Violation|2|||
145468135|NCT00286221|524567841|FG001|Overall Study|Protocol Violation|1|||
145468136|NCT00286221|524567842|FG002|Overall Study|Protocol Violation|6|||
145468137|NCT00286221|524567843|FG003|Overall Study|Protocol Violation|4|||
145468138|NCT00286221|524567840|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
145468139|NCT00286221|524567841|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
145468140|NCT00286221|524567842|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
145468141|NCT00286221|524567843|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
145468142|NCT00286221|524567840|FG000|Overall Study|Inability to trigger PCA|2|||
145468143|NCT00286221|524567841|FG001|Overall Study|Inability to trigger PCA|0|||
145468144|NCT00286221|524567842|FG002|Overall Study|Inability to trigger PCA|0|||
145468145|NCT00286221|524567843|FG003|Overall Study|Inability to trigger PCA|0|||
145468146|NCT00286221|524567840|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
145468147|NCT00286221|524567841|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
145468148|NCT00286221|524567842|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
145468149|NCT00286221|524567843|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
145468150|NCT02771626|524567847|FG000|Overall Study|Adverse Event|1|||
145468151|NCT02771626|524567848|FG001|Overall Study|Adverse Event|5|||
145468152|NCT02771626|524567849|FG002|Overall Study|Adverse Event|3|||
145468153|NCT02771626|524567850|FG003|Overall Study|Adverse Event|0|||
145468154|NCT02771626|524567851|FG004|Overall Study|Adverse Event|1|||
145468155|NCT02771626|524567852|FG005|Overall Study|Adverse Event|1|||
145468156|NCT02771626|524567847|FG000|Overall Study|Radiologic Disease Progression|6|||
145468157|NCT02771626|524567848|FG001|Overall Study|Radiologic Disease Progression|13|||
145468158|NCT02771626|524567849|FG002|Overall Study|Radiologic Disease Progression|10|||
145468159|NCT02771626|524567850|FG003|Overall Study|Radiologic Disease Progression|7|||
145468160|NCT02771626|524567851|FG004|Overall Study|Radiologic Disease Progression|28|||
145468161|NCT02771626|524567852|FG005|Overall Study|Radiologic Disease Progression|15|||
145468162|NCT02771626|524567847|FG000|Overall Study|Symptomatic Deterioration|0|||
145468163|NCT02771626|524567848|FG001|Overall Study|Symptomatic Deterioration|4|||
145468164|NCT02771626|524567849|FG002|Overall Study|Symptomatic Deterioration|2|||
145468165|NCT02771626|524567850|FG003|Overall Study|Symptomatic Deterioration|0|||
145468166|NCT02771626|524567851|FG004|Overall Study|Symptomatic Deterioration|5|||
145468167|NCT02771626|524567852|FG005|Overall Study|Symptomatic Deterioration|2|||
145468168|NCT02771626|524567847|FG000|Overall Study|Participant Request|0|||
145468169|NCT02771626|524567848|FG001|Overall Study|Participant Request|1|||
145468170|NCT02771626|524567849|FG002|Overall Study|Participant Request|0|||
145468171|NCT02771626|524567850|FG003|Overall Study|Participant Request|2|||
145468172|NCT02771626|524567851|FG004|Overall Study|Participant Request|0|||
145468173|NCT02771626|524567852|FG005|Overall Study|Participant Request|1|||
145468174|NCT02771626|524567847|FG000|Overall Study|Investigator Decision|0|||
145468175|NCT02771626|524567848|FG001|Overall Study|Investigator Decision|1|||
145468176|NCT02771626|524567849|FG002|Overall Study|Investigator Decision|0|||
145468177|NCT02771626|524567850|FG003|Overall Study|Investigator Decision|0|||
145468178|NCT02771626|524567851|FG004|Overall Study|Investigator Decision|1|||
145468179|NCT02771626|524567852|FG005|Overall Study|Investigator Decision|0|||
145468180|NCT02771626|524567847|FG000|Overall Study|Study Termination by Sponsor|0|||
145468181|NCT02771626|524567848|FG001|Overall Study|Study Termination by Sponsor|2|||
145468182|NCT02771626|524567849|FG002|Overall Study|Study Termination by Sponsor|1|||
145468183|NCT02771626|524567850|FG003|Overall Study|Study Termination by Sponsor|0|||
145468184|NCT02771626|524567851|FG004|Overall Study|Study Termination by Sponsor|1|||
145468185|NCT02771626|524567852|FG005|Overall Study|Study Termination by Sponsor|0|||
145468186|NCT02771626|524567847|FG000|Overall Study|Informed Consent Withdrawn|0|||
145468187|NCT02771626|524567848|FG001|Overall Study|Informed Consent Withdrawn|0|||
145468188|NCT02771626|524567849|FG002|Overall Study|Informed Consent Withdrawn|1|||
145468189|NCT02771626|524567850|FG003|Overall Study|Informed Consent Withdrawn|0|||
145468190|NCT02771626|524567851|FG004|Overall Study|Informed Consent Withdrawn|1|||
145468191|NCT02771626|524567852|FG005|Overall Study|Informed Consent Withdrawn|1|||
145468192|NCT02771626|524567847|FG000|Overall Study|Other, Not Specified|1|||
145468193|NCT02771626|524567848|FG001|Overall Study|Other, Not Specified|0|||
145601198|NCT02710292|525054219|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
145601199|NCT02710292|525054218|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
145601200|NCT02710292|525054219|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
145468194|NCT02771626|524567849|FG002|Overall Study|Other, Not Specified|0|||
145468195|NCT02771626|524567850|FG003|Overall Study|Other, Not Specified|0|||
145468196|NCT02771626|524567851|FG004|Overall Study|Other, Not Specified|0|||
145468197|NCT02771626|524567852|FG005|Overall Study|Other, Not Specified|1|||
145468198|NCT02648217|524567853|FG000|Overall Study|Adverse Event|0|||
145628108|NCT04580407|525151579|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
145628109|NCT00681811|525151584|FG000|Overall Study|Adverse Event|1|||
145628110|NCT00681811|525151585|FG001|Overall Study|Adverse Event|1|||
145628111|NCT00681811|525151584|FG000|Overall Study|Withdrawal by Subject|2|||
145628112|NCT00681811|525151585|FG001|Overall Study|Withdrawal by Subject|2|||
145628113|NCT00681811|525151584|FG000|Overall Study|Non-compliance|0|||
145628114|NCT00681811|525151585|FG001|Overall Study|Non-compliance|1|||
145628115|NCT02068885|525151586|FG000|Overall Study|Withdrew|3|||
145628116|NCT02068885|525151587|FG001|Overall Study|Withdrew|5|||
145628117|NCT02068885|525151588|FG002|Overall Study|Withdrew|8|||
145628118|NCT01562743|525151596|FG000|Overall Study|Adverse Event|29|||
145628119|NCT01562743|525151596|FG000|Overall Study|Lack of Efficacy|3|||
145628120|NCT01562743|525151596|FG000|Overall Study|Withdrawal by Subject|13|||
145628121|NCT01562743|525151596|FG000|Overall Study|Protocol Violation|1|||
145628122|NCT01562743|525151596|FG000|Overall Study|Discontinuation criteria|2|||
145628123|NCT01562743|525151596|FG000|Overall Study|Lost to Follow-up|2|||
145628124|NCT01562743|525151596|FG000|Overall Study|Physician Decision|2|||
145628125|NCT04155424|525151598|FG000|Overall Study|Other than specified|3|||
145628126|NCT04155424|525151598|FG000|Overall Study|Withdrawal by Subject|1|||
145468199|NCT02648217|524567854|FG001|Overall Study|Adverse Event|1|||
145468200|NCT02648217|524567853|FG000|Overall Study|Lost to Follow-up|1|||
145468201|NCT02648217|524567854|FG001|Overall Study|Lost to Follow-up|1|||
145468202|NCT02648217|524567853|FG000|Overall Study|Withdrawal by Subject|4|||
145468203|NCT02648217|524567854|FG001|Overall Study|Withdrawal by Subject|3|||
145468204|NCT02648217|524567853|FG000|Overall Study|Unclassified|5|||
145468205|NCT02648217|524567854|FG001|Overall Study|Unclassified|0|||
145468206|NCT02553538|524567855|FG000|Overall Study|Could Not Reach by Telephone|133|||
145468207|NCT02553538|524567856|FG001|Overall Study|Could Not Reach by Telephone|0|||
145468208|NCT02553538|524567855|FG000|Overall Study|Died or Left Network|54|||
145468209|NCT02553538|524567856|FG001|Overall Study|Died or Left Network|56|||
145468210|NCT00106691|524567857|FG000|Overall Study|Adverse Event|60|||
145468211|NCT00106691|524567858|FG001|Overall Study|Adverse Event|64|||
145468212|NCT00106691|524567857|FG000|Overall Study|Lost to Follow-up|23|||
145468213|NCT00106691|524567858|FG001|Overall Study|Lost to Follow-up|18|||
145468214|NCT00106691|524567857|FG000|Overall Study|Physician Decision|18|||
145468215|NCT00106691|524567858|FG001|Overall Study|Physician Decision|21|||
145468216|NCT00106691|524567857|FG000|Overall Study|Protocol Violation|13|||
145468217|NCT00106691|524567858|FG001|Overall Study|Protocol Violation|18|||
145468218|NCT00106691|524567857|FG000|Overall Study|Withdrawal by Subject|75|||
145468219|NCT00106691|524567858|FG001|Overall Study|Withdrawal by Subject|70|||
145468220|NCT00106691|524567857|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
145468221|NCT00106691|524567858|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
145468222|NCT00106691|524567857|FG000|Overall Study|QTc>480|3|||
145468223|NCT00106691|524567858|FG001|Overall Study|QTc>480|1|||
145468224|NCT00106691|524567857|FG000|Overall Study|mililtary deployment|2|||
145468225|NCT00106691|524567858|FG001|Overall Study|mililtary deployment|0|||
145468226|NCT00106691|524567857|FG000|Overall Study|Study Site Closing/PI Moved|1|||
145468227|NCT00106691|524567858|FG001|Overall Study|Study Site Closing/PI Moved|2|||
145468228|NCT00106691|524567857|FG000|Overall Study|Cardiologist recommendation|1|||
145468229|NCT00106691|524567858|FG001|Overall Study|Cardiologist recommendation|0|||
145628127|NCT04155424|525151598|FG000|Overall Study|Adverse Event|1|||
145628128|NCT04159506|525151599|FG000|Overall Study|Lost to Follow-up|2|||
145628129|NCT04159506|525151600|FG001|Overall Study|Lost to Follow-up|5|||
145628130|NCT02449044|525151601|FG000|Overall Study|Lost to Follow-up|2|||
145628131|NCT02449044|525151601|FG000|Overall Study|Withdrawal by Subject|13|||
145628132|NCT02449044|525151601|FG000|Overall Study|Adverse Event|30|||
145628133|NCT02449044|525151601|FG000|Overall Study|Met Withdrawal Criteria|7|||
145628134|NCT02449044|525151601|FG000|Overall Study|Physician Decision|9|||
145628135|NCT02449044|525151601|FG000|Overall Study|Sponsor Discontinued Trial|3|||
145628136|NCT00662909|525151603|FG000|Overall Study|Adverse Event|17|||
145628137|NCT00662909|525151604|FG001|Overall Study|Adverse Event|18|||
145628138|NCT00662909|525151605|FG002|Overall Study|Adverse Event|19|||
145468230|NCT00106691|524567857|FG000|Overall Study|Pt. moved to another state|1|||
145468231|NCT00106691|524567858|FG001|Overall Study|Pt. moved to another state|0|||
145468232|NCT00106691|524567857|FG000|Overall Study|Taking exclusionary avodart|1|||
145468233|NCT00106691|524567858|FG001|Overall Study|Taking exclusionary avodart|0|||
145468234|NCT00106691|524567857|FG000|Overall Study|Not able to discontinue plavix|0|||
145468235|NCT00106691|524567858|FG001|Overall Study|Not able to discontinue plavix|1|||
145468236|NCT01754194|524567859|FG000|Overall Study|Lost to Follow-up|39|||
145628139|NCT00662909|525151603|FG000|Overall Study|Lack of Efficacy|9|||
145628140|NCT00662909|525151604|FG001|Overall Study|Lack of Efficacy|1|||
145628141|NCT00662909|525151605|FG002|Overall Study|Lack of Efficacy|5|||
145628142|NCT00662909|525151603|FG000|Overall Study|Withdrawal by Subject|29|||
145628143|NCT00662909|525151604|FG001|Overall Study|Withdrawal by Subject|22|||
145628144|NCT00662909|525151605|FG002|Overall Study|Withdrawal by Subject|16|||
145628145|NCT00662909|525151603|FG000|Overall Study|Lost to Follow-up|2|||
145468237|NCT01754194|524567860|FG001|Overall Study|Lost to Follow-up|14|||
145468238|NCT01754194|524567859|FG000|Overall Study|Withdrawal by Subject|4|||
145468239|NCT01754194|524567860|FG001|Overall Study|Withdrawal by Subject|5|||
145468240|NCT01754194|524567859|FG000|Overall Study|Other|9|||
145468241|NCT01754194|524567860|FG001|Overall Study|Other|8|||
145468242|NCT00907296|524567861|FG000|Overall Study|Ineligibility Determined|1|||
145468243|NCT00907296|524567862|FG001|Overall Study|Ineligibility Determined|0|||
145468244|NCT00907296|524567863|FG002|Overall Study|Ineligibility Determined|0|||
145468245|NCT00907296|524567864|FG003|Overall Study|Ineligibility Determined|1|||
145468246|NCT00907296|524567865|FG004|Overall Study|Ineligibility Determined|0|||
145468247|NCT00907296|524567866|FG005|Overall Study|Ineligibility Determined|0|||
145468248|NCT00907296|524567867|FG006|Overall Study|Ineligibility Determined|0|||
145468249|NCT00907296|524567868|FG007|Overall Study|Ineligibility Determined|1|||
145468250|NCT00907296|524567869|FG008|Overall Study|Ineligibility Determined|0|||
145468251|NCT00907296|524567870|FG009|Overall Study|Ineligibility Determined|0|||
145468252|NCT00907296|524567861|FG000|Overall Study|Protocol Deviation|0|||
145468253|NCT00907296|524567862|FG001|Overall Study|Protocol Deviation|1|||
145468254|NCT00907296|524567863|FG002|Overall Study|Protocol Deviation|0|||
145468255|NCT00907296|524567864|FG003|Overall Study|Protocol Deviation|0|||
145468256|NCT00907296|524567865|FG004|Overall Study|Protocol Deviation|0|||
145468257|NCT00907296|524567866|FG005|Overall Study|Protocol Deviation|0|||
145468258|NCT00907296|524567867|FG006|Overall Study|Protocol Deviation|0|||
145468259|NCT00907296|524567868|FG007|Overall Study|Protocol Deviation|0|||
145468260|NCT00907296|524567869|FG008|Overall Study|Protocol Deviation|0|||
145468261|NCT00907296|524567870|FG009|Overall Study|Protocol Deviation|0|||
145468262|NCT00907296|524567861|FG000|Overall Study|Noncompliance|1|||
145468263|NCT00907296|524567862|FG001|Overall Study|Noncompliance|1|||
145468264|NCT00907296|524567863|FG002|Overall Study|Noncompliance|1|||
145468265|NCT00907296|524567864|FG003|Overall Study|Noncompliance|0|||
145468266|NCT00907296|524567865|FG004|Overall Study|Noncompliance|0|||
145468267|NCT00907296|524567866|FG005|Overall Study|Noncompliance|1|||
145468268|NCT00907296|524567867|FG006|Overall Study|Noncompliance|0|||
145468269|NCT00907296|524567868|FG007|Overall Study|Noncompliance|2|||
145468270|NCT00907296|524567869|FG008|Overall Study|Noncompliance|0|||
145468271|NCT00907296|524567870|FG009|Overall Study|Noncompliance|0|||
145468272|NCT00907296|524567861|FG000|Overall Study|Adverse Event|2|||
145468273|NCT00907296|524567862|FG001|Overall Study|Adverse Event|0|||
145468274|NCT00907296|524567863|FG002|Overall Study|Adverse Event|0|||
145468275|NCT00907296|524567864|FG003|Overall Study|Adverse Event|0|||
145468276|NCT00907296|524567865|FG004|Overall Study|Adverse Event|0|||
145468277|NCT00907296|524567866|FG005|Overall Study|Adverse Event|0|||
145468278|NCT00907296|524567867|FG006|Overall Study|Adverse Event|1|||
145468279|NCT00907296|524567868|FG007|Overall Study|Adverse Event|0|||
145468280|NCT00907296|524567869|FG008|Overall Study|Adverse Event|0|||
145468281|NCT00907296|524567870|FG009|Overall Study|Adverse Event|1|||
145468282|NCT00907296|524567861|FG000|Overall Study|Withdrawal by Subject|7|||
145468283|NCT00907296|524567862|FG001|Overall Study|Withdrawal by Subject|2|||
145468284|NCT00907296|524567863|FG002|Overall Study|Withdrawal by Subject|1|||
145468285|NCT00907296|524567864|FG003|Overall Study|Withdrawal by Subject|1|||
145468286|NCT00907296|524567865|FG004|Overall Study|Withdrawal by Subject|1|||
145468287|NCT00907296|524567866|FG005|Overall Study|Withdrawal by Subject|5|||
145468288|NCT00907296|524567867|FG006|Overall Study|Withdrawal by Subject|3|||
145468289|NCT00907296|524567868|FG007|Overall Study|Withdrawal by Subject|2|||
145468290|NCT00907296|524567869|FG008|Overall Study|Withdrawal by Subject|4|||
145468291|NCT00907296|524567870|FG009|Overall Study|Withdrawal by Subject|2|||
145468292|NCT00907296|524567861|FG000|Overall Study|Lost to Follow-up|9|||
145468293|NCT00907296|524567862|FG001|Overall Study|Lost to Follow-up|1|||
145468294|NCT00907296|524567863|FG002|Overall Study|Lost to Follow-up|0|||
145468295|NCT00907296|524567864|FG003|Overall Study|Lost to Follow-up|2|||
145468296|NCT00907296|524567865|FG004|Overall Study|Lost to Follow-up|0|||
145468297|NCT00907296|524567866|FG005|Overall Study|Lost to Follow-up|3|||
145468298|NCT00907296|524567867|FG006|Overall Study|Lost to Follow-up|2|||
145468299|NCT00907296|524567868|FG007|Overall Study|Lost to Follow-up|2|||
145468300|NCT00907296|524567869|FG008|Overall Study|Lost to Follow-up|0|||
145468301|NCT00907296|524567870|FG009|Overall Study|Lost to Follow-up|4|||
145468302|NCT02392403|524567871|FG000|Overall Study|Adverse Event|1|||
145468303|NCT02392403|524567871|FG000|Overall Study|Death|1|||
145468304|NCT02392403|524567871|FG000|Overall Study|Withdrawal by Subject|1|||
145468305|NCT02776033|524567872|FG000|Overall Study|Withdrawal by Subject|0|||
145468306|NCT02776033|524567873|FG001|Overall Study|Withdrawal by Subject|0|||
145468307|NCT02776033|524567874|FG002|Overall Study|Withdrawal by Subject|2|||
145468308|NCT02776033|524567872|FG000|Overall Study|Physician Decision|2|||
145468309|NCT02776033|524567873|FG001|Overall Study|Physician Decision|0|||
145468310|NCT02776033|524567874|FG002|Overall Study|Physician Decision|0|||
145468311|NCT02776033|524567872|FG000|Overall Study|Lost to Follow-up|1|||
145468312|NCT02776033|524567873|FG001|Overall Study|Lost to Follow-up|0|||
145468313|NCT02776033|524567874|FG002|Overall Study|Lost to Follow-up|0|||
145468314|NCT02776033|524567872|FG000|Overall Study|Adverse Event|1|||
145468315|NCT02776033|524567873|FG001|Overall Study|Adverse Event|2|||
145628146|NCT00662909|525151604|FG001|Overall Study|Lost to Follow-up|9|||
145628147|NCT00662909|525151605|FG002|Overall Study|Lost to Follow-up|3|||
145628148|NCT00662909|525151603|FG000|Overall Study|Protocol Violation|7|||
145628149|NCT00662909|525151604|FG001|Overall Study|Protocol Violation|4|||
145468316|NCT02776033|524567874|FG002|Overall Study|Adverse Event|0|||
145468317|NCT04047420|524567877|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
145468318|NCT04047420|524567877|FG000|Washout Period|Refused Participation|2|||
145468319|NCT03230292|524567878|FG000|Overall Study|Adverse Event|1|||
145468320|NCT03230292|524567878|FG000|Overall Study|Protocol Violation|1|||
145468321|NCT03230292|524567878|FG000|Overall Study|Lost to Follow-up|1|||
145468322|NCT03230292|524567878|FG000|Overall Study|Withdrawal by Subject|3|||
145468323|NCT01639755|524567879|FG000|Overall Study|Study Ongoing|15|||
145468324|NCT01639755|524567879|FG000|Overall Study|Patient had device explantation|4|||
145468325|NCT03629912|524567882|FG000|Overall Study|Lost to Follow-up|19|||
145468326|NCT03629912|524567883|FG001|Overall Study|Lost to Follow-up|7|||
145468327|NCT03629912|524567884|FG002|Overall Study|Lost to Follow-up|5|||
145468328|NCT03629912|524567885|FG003|Overall Study|Lost to Follow-up|1|||
145468329|NCT03629912|524567882|FG000|Overall Study|Withdrawal by Subject|6|||
145468330|NCT03629912|524567883|FG001|Overall Study|Withdrawal by Subject|0|||
145468331|NCT03629912|524567884|FG002|Overall Study|Withdrawal by Subject|1|||
145468332|NCT03629912|524567885|FG003|Overall Study|Withdrawal by Subject|2|||
145468333|NCT03629912|524567882|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
145468334|NCT03629912|524567883|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
145468335|NCT03629912|524567884|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
145468336|NCT03629912|524567885|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
145468337|NCT03629912|524567882|FG000|Overall Study|Death|1|||
145468338|NCT03629912|524567883|FG001|Overall Study|Death|0|||
145468339|NCT03629912|524567884|FG002|Overall Study|Death|0|||
145468340|NCT03629912|524567885|FG003|Overall Study|Death|0|||
145468341|NCT03262116|524567887|FG000|Overall Study|Physician Decision|0|||
145468342|NCT03262116|524567888|FG001|Overall Study|Physician Decision|2|||
145468343|NCT03262116|524567889|FG002|Overall Study|Physician Decision|1|||
145468344|NCT03262116|524567890|FG003|Overall Study|Physician Decision|1|||
145468345|NCT03262116|524567891|FG004|Overall Study|Physician Decision|1|||
145468346|NCT03262116|524567892|FG005|Overall Study|Physician Decision|2|||
145468347|NCT02608450|524567893|FG000|Overall Study|Lost to Follow-up|39|||
145468348|NCT02608450|524567894|FG001|Overall Study|Lost to Follow-up|32|||
145468349|NCT02608450|524567893|FG000|Overall Study|Withdrawal by Subject|21|||
145468350|NCT02608450|524567894|FG001|Overall Study|Withdrawal by Subject|15|||
145468351|NCT02608450|524567893|FG000|Overall Study|Adverse Event|3|||
145468352|NCT02608450|524567894|FG001|Overall Study|Adverse Event|6|||
145468353|NCT02608450|524567893|FG000|Overall Study|Withdrawal by parent|2|||
145468354|NCT02608450|524567894|FG001|Overall Study|Withdrawal by parent|3|||
145468355|NCT02608450|524567893|FG000|Overall Study|Lack of Efficacy|0|||
145468356|NCT02608450|524567894|FG001|Overall Study|Lack of Efficacy|3|||
145468357|NCT02608450|524567893|FG000|Overall Study|Noncompliance with study drug|0|||
145468358|NCT02608450|524567894|FG001|Overall Study|Noncompliance with study drug|2|||
145468359|NCT02608450|524567893|FG000|Overall Study|Physician Decision|0|||
145468360|NCT02608450|524567894|FG001|Overall Study|Physician Decision|1|||
145468361|NCT02608450|524567893|FG000|Overall Study|Pregnancy|0|||
145468362|NCT02608450|524567894|FG001|Overall Study|Pregnancy|1|||
145468363|NCT02608450|524567893|FG000|Overall Study|Progressive disease|1|||
145468364|NCT02608450|524567894|FG001|Overall Study|Progressive disease|0|||
145468365|NCT02608450|524567893|FG000|Overall Study|Multiple reasons|0|||
145468366|NCT02608450|524567894|FG001|Overall Study|Multiple reasons|2|||
145468367|NCT00635089|524567896|FG000|Overall Study|Adverse Event|7|||
145468368|NCT00635089|524567896|FG000|Overall Study|Lack of Efficacy|28|||
145468369|NCT00635089|524567896|FG000|Overall Study|Protocol Deviation|4|||
145468370|NCT00635089|524567896|FG000|Overall Study|Lost to Follow-up|8|||
145468371|NCT00635089|524567896|FG000|Overall Study|Other|31|||
145468372|NCT02636946|524567900|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
145468373|NCT02636946|524567901|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
145468374|NCT02636946|524567900|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
145468375|NCT02636946|524567901|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
145468376|NCT02636946|524567900|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
145468377|NCT02636946|524567901|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
145468378|NCT02636946|524567900|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
145468379|NCT02636946|524567901|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
145468380|NCT02636946|524567900|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
145628150|NCT00662909|525151605|FG002|Overall Study|Protocol Violation|5|||
145468381|NCT02636946|524567901|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
145468382|NCT02636946|524567900|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
145468383|NCT02636946|524567901|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
145468384|NCT05059977|524567902|FG000|Overall Study|Withdrawal by Subject|0|||
145468385|NCT05059977|524567903|FG001|Overall Study|Withdrawal by Subject|0|||
145628151|NCT00662909|525151603|FG000|Overall Study|Randomized- never received study drug|1|||
145468386|NCT05059977|524567904|FG002|Overall Study|Withdrawal by Subject|1|||
145468387|NCT04405245|524567905|FG000|Overall Study|Adverse Event|0|||
145468388|NCT04405245|524567906|FG001|Overall Study|Adverse Event|1|||
145468389|NCT04405245|524567907|FG002|Overall Study|Adverse Event|0|||
145468390|NCT00576472|524567910|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468391|NCT00576472|524567911|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468392|NCT00576472|524567912|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468393|NCT00576472|524567913|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
145468394|NCT00576472|524567914|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468395|NCT00576472|524567915|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468396|NCT00576472|524567916|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468397|NCT00576472|524567917|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468398|NCT00576472|524567918|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468399|NCT00576472|524567919|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468400|NCT00576472|524567920|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468401|NCT00576472|524567921|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468402|NCT00576472|524567922|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468403|NCT00576472|524567923|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468404|NCT00576472|524567924|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
145468405|NCT00576472|524567910|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
145468406|NCT00576472|524567911|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
145468407|NCT00576472|524567912|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
145468408|NCT00576472|524567913|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
145468409|NCT00576472|524567914|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
145468410|NCT00576472|524567915|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
145468411|NCT00576472|524567916|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
145468412|NCT00576472|524567917|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
145468413|NCT00576472|524567918|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
145468414|NCT00576472|524567919|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
145468415|NCT00576472|524567920|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
145468416|NCT00576472|524567921|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
145468417|NCT00576472|524567922|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
145468418|NCT00576472|524567923|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
145468419|NCT00576472|524567924|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
145468420|NCT00576472|524567910|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468421|NCT00576472|524567911|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468422|NCT00576472|524567912|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468423|NCT00576472|524567913|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
145468424|NCT00576472|524567914|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468425|NCT00576472|524567915|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468426|NCT00576472|524567916|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468427|NCT00576472|524567917|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468428|NCT00576472|524567918|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468429|NCT00576472|524567919|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468430|NCT00576472|524567920|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468431|NCT00576472|524567921|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468432|NCT00576472|524567922|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468433|NCT00576472|524567923|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468434|NCT00576472|524567924|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
145468435|NCT00576472|524567910|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
145468436|NCT00576472|524567911|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
145468437|NCT00576472|524567912|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
145468438|NCT00576472|524567913|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
145468439|NCT00576472|524567914|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
145468440|NCT00576472|524567915|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
145468441|NCT00576472|524567916|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
145468442|NCT00576472|524567917|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
145468443|NCT00576472|524567918|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
145468444|NCT00576472|524567919|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
145468445|NCT00576472|524567920|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
145601201|NCT03122119|525054220|FG000|Overall Study|Did not meet eligibility critria|1|||
145601202|NCT02364180|525054226|FG000|Overall Study|Screen Fail|1|||
145601203|NCT01783418|525054227|FG000|Overall Study|Withdrawal by Subject|1|||
145468446|NCT00576472|524567921|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
145468447|NCT00576472|524567922|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
145468448|NCT00576472|524567923|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
145601204|NCT01783418|525054228|FG001|Overall Study|Withdrawal by Subject|0|||
145468449|NCT00576472|524567924|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
145468450|NCT00576472|524567910|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468451|NCT00576472|524567911|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468452|NCT00576472|524567912|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468453|NCT00576472|524567913|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
145468454|NCT00576472|524567914|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468455|NCT00576472|524567915|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468456|NCT00576472|524567916|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468457|NCT00576472|524567917|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468458|NCT00576472|524567918|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468459|NCT00576472|524567919|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468460|NCT00576472|524567920|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468461|NCT00576472|524567921|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468462|NCT00576472|524567922|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468463|NCT00576472|524567923|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468464|NCT00576472|524567924|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
145468465|NCT00576472|524567910|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468466|NCT00576472|524567911|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468467|NCT00576472|524567912|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468468|NCT00576472|524567913|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468469|NCT00576472|524567914|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468470|NCT00576472|524567915|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468471|NCT00576472|524567916|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
145468472|NCT00576472|524567917|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468473|NCT00576472|524567918|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468474|NCT00576472|524567919|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468475|NCT00576472|524567920|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468476|NCT00576472|524567921|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468477|NCT00576472|524567922|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468478|NCT00576472|524567923|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468479|NCT00576472|524567924|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
145468480|NCT00576472|524567910|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
145468481|NCT00576472|524567911|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
145468482|NCT00576472|524567912|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
145468483|NCT00576472|524567913|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
145468484|NCT00576472|524567914|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
145468485|NCT00576472|524567915|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
145468486|NCT00576472|524567916|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
145468487|NCT00576472|524567917|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
145468488|NCT00576472|524567918|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
145468489|NCT00576472|524567919|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
145468490|NCT00576472|524567920|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
145468491|NCT00576472|524567921|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
145468492|NCT00576472|524567922|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
145468493|NCT00576472|524567923|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
145468494|NCT00576472|524567924|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
145468495|NCT00576472|524567910|FG000|MPH Cross Over Phase|Physician Decision|0|||
145468496|NCT00576472|524567911|FG001|MPH Cross Over Phase|Physician Decision|0|||
145468497|NCT00576472|524567912|FG002|MPH Cross Over Phase|Physician Decision|0|||
145468498|NCT00576472|524567913|FG003|MPH Cross Over Phase|Physician Decision|0|||
145468499|NCT00576472|524567914|FG004|MPH Cross Over Phase|Physician Decision|0|||
145468500|NCT00576472|524567915|FG005|MPH Cross Over Phase|Physician Decision|0|||
145468501|NCT00576472|524567916|FG006|MPH Cross Over Phase|Physician Decision|4|||
145468502|NCT00576472|524567917|FG007|MPH Cross Over Phase|Physician Decision|0|||
145468503|NCT00576472|524567918|FG008|MPH Cross Over Phase|Physician Decision|0|||
145468504|NCT00576472|524567919|FG009|MPH Cross Over Phase|Physician Decision|0|||
145468505|NCT00576472|524567920|FG010|MPH Cross Over Phase|Physician Decision|0|||
145468506|NCT00576472|524567921|FG011|MPH Cross Over Phase|Physician Decision|0|||
145468507|NCT00576472|524567922|FG012|MPH Cross Over Phase|Physician Decision|0|||
145468508|NCT00576472|524567923|FG013|MPH Cross Over Phase|Physician Decision|0|||
145468509|NCT00576472|524567924|FG014|MPH Cross Over Phase|Physician Decision|0|||
145468510|NCT00576472|524567910|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
145601205|NCT00089141|525054229|FG000|Overall Study|Termination of trial|18|||
145601206|NCT00089141|525054230|FG001|Overall Study|Termination of trial|24|||
145601207|NCT00508261|525054231|FG000|Overall Study|Other|0|||
145468511|NCT00576472|524567911|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468512|NCT00576472|524567912|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468513|NCT00576472|524567913|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468514|NCT00576472|524567914|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468515|NCT00576472|524567915|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468516|NCT00576472|524567916|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468517|NCT00576472|524567917|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
145601208|NCT00508261|525054232|FG001|Overall Study|Other|1|||
145601209|NCT00508261|525054233|FG002|Overall Study|Other|1|||
145601210|NCT00508261|525054234|FG003|Overall Study|Other|0|||
145468518|NCT00576472|524567918|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
145468519|NCT00576472|524567919|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468520|NCT00576472|524567920|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
145468521|NCT00576472|524567921|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
145468522|NCT00576472|524567922|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468523|NCT00576472|524567923|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468524|NCT00576472|524567924|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
145468525|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468526|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468527|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468528|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468529|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468530|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468531|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468532|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468533|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468534|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468535|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468536|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468537|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145628152|NCT00662909|525151604|FG001|Overall Study|Randomized- never received study drug|0|||
145628153|NCT00662909|525151605|FG002|Overall Study|Randomized- never received study drug|0|||
145628154|NCT00662909|525151603|FG000|Overall Study|Non-compliance with study procedures|3|||
145628155|NCT00662909|525151604|FG001|Overall Study|Non-compliance with study procedures|3|||
145628156|NCT00662909|525151605|FG002|Overall Study|Non-compliance with study procedures|2|||
145628157|NCT00662909|525151603|FG000|Overall Study|Physician Decision|1|||
145628158|NCT00662909|525151604|FG001|Overall Study|Physician Decision|1|||
145628159|NCT00662909|525151605|FG002|Overall Study|Physician Decision|2|||
145628160|NCT00662909|525151603|FG000|Overall Study|Eligibility criterion not met|0|||
145628161|NCT00662909|525151604|FG001|Overall Study|Eligibility criterion not met|1|||
145628162|NCT00662909|525151605|FG002|Overall Study|Eligibility criterion not met|1|||
145628163|NCT02738840|525153263|FG000|Overall Study|MRI Scan not Performed|5|||
145628164|NCT02738840|525153263|FG000|Overall Study|Lost to Follow-up|1|||
145628165|NCT02738840|525153263|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
145628166|NCT02738840|525153263|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
145628167|NCT05526911|525153266|FG000|Overall Study|Adverse Event|2|||
145628168|NCT00256308|525153267|FG000|Overall Study|Death|2|||
145628169|NCT00991276|525153276|FG000|First Intervention Period|Adverse Event|0|||
145628170|NCT00991276|525153277|FG001|First Intervention Period|Adverse Event|1|||
145628171|NCT00991276|525153278|FG002|First Intervention Period|Adverse Event|0|||
145628172|NCT00991276|525153279|FG003|First Intervention Period|Adverse Event|1|||
145628173|NCT00991276|525153280|FG004|First Intervention Period|Adverse Event|0|||
145628174|NCT00991276|525153281|FG005|First Intervention Period|Adverse Event|0|||
145628175|NCT00991276|525153276|FG000|First Intervention Period|Protocol Violation|0|||
145628176|NCT00991276|525153277|FG001|First Intervention Period|Protocol Violation|0|||
145628177|NCT00991276|525153278|FG002|First Intervention Period|Protocol Violation|0|||
145628178|NCT00991276|525153279|FG003|First Intervention Period|Protocol Violation|0|||
145628179|NCT00991276|525153280|FG004|First Intervention Period|Protocol Violation|2|||
145628180|NCT00991276|525153281|FG005|First Intervention Period|Protocol Violation|0|||
145628181|NCT00991276|525153276|FG000|First Intervention Period|Insufficient clinical response|0|||
145628182|NCT00991276|525153277|FG001|First Intervention Period|Insufficient clinical response|0|||
145628183|NCT00991276|525153278|FG002|First Intervention Period|Insufficient clinical response|0|||
145628184|NCT00991276|525153279|FG003|First Intervention Period|Insufficient clinical response|0|||
145628185|NCT00991276|525153280|FG004|First Intervention Period|Insufficient clinical response|1|||
145628186|NCT00991276|525153281|FG005|First Intervention Period|Insufficient clinical response|0|||
145628187|NCT00991276|525153276|FG000|First Intervention Period|Other|0|||
145628188|NCT00991276|525153277|FG001|First Intervention Period|Other|0|||
145628189|NCT00991276|525153278|FG002|First Intervention Period|Other|0|||
145628190|NCT00991276|525153279|FG003|First Intervention Period|Other|1|||
145628191|NCT00991276|525153280|FG004|First Intervention Period|Other|1|||
145628192|NCT00991276|525153281|FG005|First Intervention Period|Other|0|||
145628193|NCT00991276|525153276|FG000|First Intervention Period|Withdrawal by Subject|0|||
145628194|NCT00991276|525153277|FG001|First Intervention Period|Withdrawal by Subject|1|||
145628195|NCT00991276|525153278|FG002|First Intervention Period|Withdrawal by Subject|0|||
145628196|NCT00991276|525153279|FG003|First Intervention Period|Withdrawal by Subject|1|||
145468538|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
145628197|NCT00991276|525153280|FG004|First Intervention Period|Withdrawal by Subject|0|||
145628198|NCT00991276|525153281|FG005|First Intervention Period|Withdrawal by Subject|1|||
145628199|NCT00991276|525153276|FG000|First Intervention Period|Lost to Follow-up|0|||
145628200|NCT00991276|525153277|FG001|First Intervention Period|Lost to Follow-up|1|||
145468539|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
145468540|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
145468541|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
145468542|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
145468543|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
145468544|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
145468545|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
145468546|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
145468547|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
145468548|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
145468549|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
145468550|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
145468551|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
145468552|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
145468553|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
145468554|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
145468555|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
145468556|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
145468557|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
145468558|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
145468559|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
145468560|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
145468561|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
145468562|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
145468563|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
145468564|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
145468565|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
145468566|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
145468567|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
145468568|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
145468569|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
145468570|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Side effects|0|||
145468571|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Side effects|0|||
145468572|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Side effects|0|||
145468573|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Side effects|0|||
145468574|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Side effects|0|||
145468575|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Side effects|0|||
145468576|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Side effects|0|||
145468577|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Side effects|0|||
145468578|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Side effects|0|||
145468579|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Side effects|0|||
145468580|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Side effects|0|||
145468581|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Side effects|0|||
145468582|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Side effects|0|||
145468583|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Side effects|0|||
145468584|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Side effects|8|||
145468585|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468586|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468587|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468588|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468589|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468590|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468591|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468592|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468593|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468594|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468595|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468596|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468597|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468598|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
145468599|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
145468600|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
145468601|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
145468602|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
145468603|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
145468604|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
145468605|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
145468606|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
145468607|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
145468608|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
145468609|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
145468610|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
145468611|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
145468612|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
145468613|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
145468614|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
145468615|NCT00576472|524567910|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468616|NCT00576472|524567911|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468617|NCT00576472|524567912|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468618|NCT00576472|524567913|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468619|NCT00576472|524567914|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145628201|NCT00991276|525153278|FG002|First Intervention Period|Lost to Follow-up|0|||
145628202|NCT00991276|525153279|FG003|First Intervention Period|Lost to Follow-up|1|||
145628203|NCT00991276|525153280|FG004|First Intervention Period|Lost to Follow-up|0|||
145628204|NCT00991276|525153281|FG005|First Intervention Period|Lost to Follow-up|0|||
145628205|NCT00991276|525153276|FG000|Second Intervention Period|Adverse Event|0|||
145628206|NCT00991276|525153277|FG001|Second Intervention Period|Adverse Event|2|||
145628207|NCT00991276|525153278|FG002|Second Intervention Period|Adverse Event|0|||
145628208|NCT00991276|525153279|FG003|Second Intervention Period|Adverse Event|1|||
145628209|NCT00991276|525153280|FG004|Second Intervention Period|Adverse Event|1|||
145628210|NCT00991276|525153281|FG005|Second Intervention Period|Adverse Event|0|||
145628211|NCT00991276|525153276|FG000|Second Intervention Period|Protocol Violation|1|||
145628212|NCT00991276|525153277|FG001|Second Intervention Period|Protocol Violation|0|||
145628213|NCT00991276|525153278|FG002|Second Intervention Period|Protocol Violation|0|||
145628214|NCT00991276|525153279|FG003|Second Intervention Period|Protocol Violation|0|||
145628215|NCT00991276|525153280|FG004|Second Intervention Period|Protocol Violation|0|||
145628216|NCT00991276|525153281|FG005|Second Intervention Period|Protocol Violation|0|||
145628217|NCT00991276|525153276|FG000|Second Intervention Period|Other|0|||
145628218|NCT00991276|525153277|FG001|Second Intervention Period|Other|0|||
145628219|NCT00991276|525153278|FG002|Second Intervention Period|Other|0|||
145628220|NCT00991276|525153279|FG003|Second Intervention Period|Other|1|||
145628221|NCT00991276|525153280|FG004|Second Intervention Period|Other|0|||
145628222|NCT00991276|525153281|FG005|Second Intervention Period|Other|1|||
145628223|NCT00991276|525153276|FG000|Third Intervention Period|Protocol Violation|1|||
145628224|NCT00991276|525153277|FG001|Third Intervention Period|Protocol Violation|0|||
145628225|NCT00991276|525153278|FG002|Third Intervention Period|Protocol Violation|0|||
145628226|NCT00991276|525153279|FG003|Third Intervention Period|Protocol Violation|0|||
145628227|NCT00991276|525153280|FG004|Third Intervention Period|Protocol Violation|0|||
145628228|NCT00991276|525153281|FG005|Third Intervention Period|Protocol Violation|0|||
145628229|NCT00991276|525153276|FG000|Third Intervention Period|Other|0|||
145628230|NCT00991276|525153277|FG001|Third Intervention Period|Other|0|||
145628231|NCT00991276|525153278|FG002|Third Intervention Period|Other|0|||
145628232|NCT00991276|525153279|FG003|Third Intervention Period|Other|0|||
145628233|NCT00991276|525153280|FG004|Third Intervention Period|Other|0|||
145628234|NCT00991276|525153281|FG005|Third Intervention Period|Other|1|||
145628235|NCT00991276|525153276|FG000|Third Intervention Period|Adverse Event|0|||
145628236|NCT00991276|525153277|FG001|Third Intervention Period|Adverse Event|0|||
145628237|NCT00991276|525153278|FG002|Third Intervention Period|Adverse Event|1|||
145468620|NCT00576472|524567915|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468621|NCT00576472|524567916|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468622|NCT00576472|524567917|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468623|NCT00576472|524567918|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468624|NCT00576472|524567919|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468625|NCT00576472|524567920|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468626|NCT00576472|524567921|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468627|NCT00576472|524567922|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468628|NCT00576472|524567923|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
145468629|NCT00576472|524567924|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
145468630|NCT02576860|524567925|FG000|Overall Study|Adverse Event|6|||
145468631|NCT02576860|524567926|FG001|Overall Study|Adverse Event|6|||
145468632|NCT02576860|524567925|FG000|Overall Study|Lost to Follow-up|5|||
145468633|NCT02576860|524567926|FG001|Overall Study|Lost to Follow-up|7|||
145468634|NCT02576860|524567925|FG000|Overall Study|Physician Decision|0|||
145468635|NCT02576860|524567926|FG001|Overall Study|Physician Decision|1|||
145468636|NCT02576860|524567925|FG000|Overall Study|Protocol Violation|0|||
145628238|NCT00991276|525153279|FG003|Third Intervention Period|Adverse Event|0|||
145628239|NCT00991276|525153280|FG004|Third Intervention Period|Adverse Event|0|||
145628240|NCT00991276|525153281|FG005|Third Intervention Period|Adverse Event|0|||
145628241|NCT00991276|525153276|FG000|Third Intervention Period|Withdrawal by Subject|0|||
145628242|NCT00991276|525153277|FG001|Third Intervention Period|Withdrawal by Subject|0|||
145468637|NCT02576860|524567926|FG001|Overall Study|Protocol Violation|2|||
145468638|NCT02576860|524567925|FG000|Overall Study|Withdrawal by Subject|13|||
145468639|NCT02576860|524567926|FG001|Overall Study|Withdrawal by Subject|8|||
145468640|NCT02576860|524567925|FG000|Overall Study|Disallowed medication|1|||
145468641|NCT02576860|524567926|FG001|Overall Study|Disallowed medication|0|||
145468642|NCT00477269|524567927|FG000|Core Study|Adverse Event|6|||
145468643|NCT00477269|524567928|FG001|Core Study|Adverse Event|4|||
145468644|NCT00477269|524567929|FG002|Core Study|Adverse Event|0|||
145468645|NCT00477269|524567927|FG000|Core Study|Death|3|||
145468646|NCT00477269|524567928|FG001|Core Study|Death|3|||
145468647|NCT00477269|524567929|FG002|Core Study|Death|0|||
145468648|NCT00477269|524567927|FG000|Core Study|Withdrawn Consent|0|||
145468649|NCT00477269|524567928|FG001|Core Study|Withdrawn Consent|1|||
145468650|NCT00477269|524567929|FG002|Core Study|Withdrawn Consent|0|||
145468651|NCT00477269|524567927|FG000|Open Label Extension|Adverse Event|0|||
145468652|NCT00477269|524567928|FG001|Open Label Extension|Adverse Event|0|||
145468653|NCT00477269|524567929|FG002|Open Label Extension|Adverse Event|4|||
145468654|NCT00477269|524567927|FG000|Open Label Extension|Abnormal laboratory values|0|||
145468655|NCT00477269|524567928|FG001|Open Label Extension|Abnormal laboratory values|0|||
145468656|NCT00477269|524567929|FG002|Open Label Extension|Abnormal laboratory values|1|||
145468657|NCT00477269|524567927|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
145468658|NCT00477269|524567928|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
145468659|NCT00477269|524567929|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
145468660|NCT00477269|524567927|FG000|Open Label Extension|Adminiatrative problems|0|||
145468661|NCT00477269|524567928|FG001|Open Label Extension|Adminiatrative problems|0|||
145468662|NCT00477269|524567929|FG002|Open Label Extension|Adminiatrative problems|2|||
145468663|NCT00477269|524567927|FG000|Open Label Extension|Death|0|||
145468664|NCT00477269|524567928|FG001|Open Label Extension|Death|0|||
145468665|NCT00477269|524567929|FG002|Open Label Extension|Death|4|||
145468666|NCT03263780|524567936|FG000|Overall Study|Withdrawal by Subject|3|||
145468667|NCT03263780|524567936|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
145468668|NCT00424190|524567946|FG000|Overall Study|Withdrew consent|3|||
145468669|NCT00424190|524567947|FG001|Overall Study|Withdrew consent|4|||
145468670|NCT00424190|524567946|FG000|Overall Study|Death|3|||
145468671|NCT00424190|524567947|FG001|Overall Study|Death|0|||
145468672|NCT00424190|524567946|FG000|Overall Study|Noncompliance|1|||
145468673|NCT00424190|524567947|FG001|Overall Study|Noncompliance|2|||
145468674|NCT00424190|524567946|FG000|Overall Study|Request of sponsor or investigator|0|||
145468675|NCT00424190|524567947|FG001|Overall Study|Request of sponsor or investigator|2|||
145468676|NCT00424190|524567946|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
145468677|NCT00424190|524567947|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
145468678|NCT00424190|524567946|FG000|Overall Study|Other|15|||
145468679|NCT00424190|524567947|FG001|Overall Study|Other|21|||
145468680|NCT02241187|524567949|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
145468681|NCT00199888|524567950|FG000|Overall Study|Lost to Follow-up|1|||
145468682|NCT00330668|524567953|FG000|BID Dosing Period|Adverse Event|1|||
145468683|NCT00330668|524567953|FG000|BID Dosing Period|Lost to Follow-up|7|||
145468684|NCT00330668|524567953|FG000|BID Dosing Period|Non-Compliance|5|||
145468685|NCT00330668|524567953|FG000|BID Dosing Period|Withdrawal by Subject|19|||
145468686|NCT00330668|524567953|FG000|BID Dosing Period|Sponsor's decision|1|||
145468687|NCT00330668|524567953|FG000|BID Dosing Period|Other|3|||
145468688|NCT00330668|524567953|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
145468689|NCT00330668|524567953|FG000|QD Dosing Period|Other|1|||
145468690|NCT00330668|524567953|FG000|QD Dosing Period|Withdrawal by Subject|1|||
145468691|NCT00330668|524567953|FG000|QD Dosing Period|Lost to Follow-up|2|||
145468692|NCT02265796|524567954|FG000|Overall Study|Death|1|||
145468693|NCT02265796|524567955|FG001|Overall Study|Death|0|||
145468694|NCT02265796|524567954|FG000|Overall Study|started on excluded medication|1|||
145468695|NCT02265796|524567955|FG001|Overall Study|started on excluded medication|0|||
145468696|NCT02265796|524567954|FG000|Overall Study|Withdrawal by Subject|1|||
145468697|NCT02265796|524567955|FG001|Overall Study|Withdrawal by Subject|1|||
145468698|NCT00558272|524567956|FG000|Overall Study|Adverse Event|10|||
145468699|NCT00558272|524567957|FG001|Overall Study|Adverse Event|0|||
145468700|NCT00558272|524567956|FG000|Overall Study|Death|1|||
145468701|NCT00558272|524567957|FG001|Overall Study|Death|0|||
145468702|NCT00558272|524567956|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
145468703|NCT00558272|524567957|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
145468704|NCT00558272|524567956|FG000|Overall Study|AZ study team decision|0|||
145468705|NCT00558272|524567957|FG001|Overall Study|AZ study team decision|1|||
145468706|NCT00558272|524567956|FG000|Overall Study|Incorrectly enrolled|1|||
145468707|NCT00558272|524567957|FG001|Overall Study|Incorrectly enrolled|0|||
145468708|NCT00558272|524567956|FG000|Overall Study|Withdrawal by Subject|0|||
145468709|NCT00558272|524567957|FG001|Overall Study|Withdrawal by Subject|1|||
145468710|NCT00483002|524567958|FG000|Overall Study|Adverse Event|68|||
145468711|NCT00483002|524567958|FG000|Overall Study|Lack of Efficacy|555|||
145468712|NCT00483002|524567958|FG000|Overall Study|Lost to Follow-up|962|||
145468713|NCT00483002|524567958|FG000|Overall Study|Other|2|||
145468714|NCT00483002|524567958|FG000|Overall Study|Other|967|||
145468715|NCT02014584|524567959|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145468716|NCT02014584|524567960|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
145468717|NCT02014584|524567961|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145468718|NCT02014584|524567962|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145468719|NCT02014584|524567963|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145468720|NCT02014584|524567964|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145468721|NCT02014584|524567959|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
145468722|NCT02014584|524567960|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
145468723|NCT02014584|524567961|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145468724|NCT02014584|524567962|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145468725|NCT02014584|524567963|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145468726|NCT02014584|524567964|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145468727|NCT02014584|524567959|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
145468728|NCT02014584|524567960|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
145468729|NCT02014584|524567961|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
145468730|NCT02014584|524567962|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
145468731|NCT02014584|524567963|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
145601211|NCT00508261|525054231|FG000|Overall Study|Serious Adverse Event|0|||
145601212|NCT00508261|525054232|FG001|Overall Study|Serious Adverse Event|1|||
145601213|NCT00508261|525054233|FG002|Overall Study|Serious Adverse Event|0|||
145601214|NCT00508261|525054234|FG003|Overall Study|Serious Adverse Event|0|||
145601215|NCT00508261|525054231|FG000|Overall Study|Withdrawal by Subject|3|||
145601216|NCT00508261|525054232|FG001|Overall Study|Withdrawal by Subject|4|||
145601217|NCT00508261|525054233|FG002|Overall Study|Withdrawal by Subject|4|||
145601218|NCT00508261|525054234|FG003|Overall Study|Withdrawal by Subject|0|||
145601219|NCT00508261|525054231|FG000|Overall Study|Migrated/ moved from study area|0|||
145601220|NCT00508261|525054232|FG001|Overall Study|Migrated/ moved from study area|1|||
145601221|NCT00508261|525054233|FG002|Overall Study|Migrated/ moved from study area|0|||
145601222|NCT00508261|525054234|FG003|Overall Study|Migrated/ moved from study area|0|||
145601223|NCT00508261|525054231|FG000|Overall Study|Lost to Follow-up|0|||
145601224|NCT00508261|525054232|FG001|Overall Study|Lost to Follow-up|1|||
145601225|NCT00508261|525054233|FG002|Overall Study|Lost to Follow-up|1|||
145601226|NCT00508261|525054234|FG003|Overall Study|Lost to Follow-up|1|||
145601227|NCT01964326|525054235|FG000|Overall Study|Adverse Event|48|||
145601228|NCT01964326|525054235|FG000|Overall Study|Death|2|||
145601229|NCT01964326|525054235|FG000|Overall Study|Protocol Violation|4|||
145601230|NCT01964326|525054235|FG000|Overall Study|Lost to Follow-up|88|||
145601231|NCT01964326|525054235|FG000|Overall Study|Withdrawal by Subject|87|||
145601232|NCT01964326|525054235|FG000|Overall Study|Pregnancy|1|||
145601233|NCT01964326|525054235|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
145601234|NCT01964326|525054235|FG000|Overall Study|Physician Decision|55|||
145601235|NCT01964326|525054235|FG000|Overall Study|Investigator Discretion|1|||
145601236|NCT01964326|525054235|FG000|Overall Study|Other|9|||
145601237|NCT01964326|525054235|FG000|Overall Study|Did not meet eligibility criteria|1|||
145601238|NCT01197508|525054241|FG000|Overall Study|Withdrawal by Subject|8|||
145601239|NCT01197508|525054242|FG001|Overall Study|Withdrawal by Subject|7|||
145601240|NCT01197508|525054243|FG002|Overall Study|Withdrawal by Subject|15|||
145601241|NCT01197508|525054244|FG003|Overall Study|Withdrawal by Subject|4|||
145601242|NCT01197508|525054241|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
145601243|NCT01197508|525054242|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
145601244|NCT01197508|525054243|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
145601245|NCT01197508|525054244|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
145601246|NCT01197508|525054241|FG000|Overall Study|Adverse Event|10|||
145601247|NCT01197508|525054242|FG001|Overall Study|Adverse Event|13|||
145601248|NCT01197508|525054243|FG002|Overall Study|Adverse Event|23|||
145601249|NCT01197508|525054244|FG003|Overall Study|Adverse Event|3|||
145601250|NCT01197508|525054241|FG000|Overall Study|Severe non-compliance to protocol|0|||
145601251|NCT01197508|525054242|FG001|Overall Study|Severe non-compliance to protocol|3|||
145601252|NCT01197508|525054243|FG002|Overall Study|Severe non-compliance to protocol|1|||
145601253|NCT01197508|525054244|FG003|Overall Study|Severe non-compliance to protocol|3|||
145601254|NCT01197508|525054241|FG000|Overall Study|Condition under investigation worsened|1|||
145601255|NCT01197508|525054242|FG001|Overall Study|Condition under investigation worsened|1|||
145601256|NCT01197508|525054243|FG002|Overall Study|Condition under investigation worsened|1|||
145601257|NCT01197508|525054244|FG003|Overall Study|Condition under investigation worsened|1|||
145601258|NCT01197508|525054241|FG000|Overall Study|Lack of Efficacy|1|||
145601259|NCT01197508|525054242|FG001|Overall Study|Lack of Efficacy|2|||
145601260|NCT01197508|525054243|FG002|Overall Study|Lack of Efficacy|2|||
145468732|NCT02014584|524567964|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
145468733|NCT02014584|524567959|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
145468734|NCT02014584|524567960|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
145601261|NCT01197508|525054244|FG003|Overall Study|Lack of Efficacy|1|||
145601262|NCT01197508|525054241|FG000|Overall Study|Study-specific withdrawal criteria|0|||
145601263|NCT01197508|525054242|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145601264|NCT01197508|525054243|FG002|Overall Study|Study-specific withdrawal criteria|1|||
145601265|NCT01197508|525054244|FG003|Overall Study|Study-specific withdrawal criteria|2|||
145601266|NCT01197508|525054241|FG000|Overall Study|Lost to Follow-up|1|||
145468735|NCT02014584|524567961|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
145628243|NCT00991276|525153278|FG002|Third Intervention Period|Withdrawal by Subject|0|||
145628244|NCT00991276|525153279|FG003|Third Intervention Period|Withdrawal by Subject|1|||
145468736|NCT02014584|524567962|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
145468737|NCT02014584|524567963|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
145468738|NCT02014584|524567964|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
145468739|NCT02014584|524567959|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
145468740|NCT02014584|524567960|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
145468741|NCT02014584|524567961|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
145468742|NCT02014584|524567962|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
145468743|NCT02014584|524567963|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
145468744|NCT02014584|524567964|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
145468745|NCT03442296|524567965|FG000|3 Month Follow-up|Death|3|||
145468746|NCT03442296|524567966|FG001|3 Month Follow-up|Death|1|||
145468747|NCT03442296|524567965|FG000|3 Month Follow-up|Lost to Follow-up|1|||
145468748|NCT03442296|524567966|FG001|3 Month Follow-up|Lost to Follow-up|1|||
145468749|NCT03442296|524567965|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
145468750|NCT03442296|524567966|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
145468751|NCT03442296|524567965|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
145468752|NCT03442296|524567966|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
145468753|NCT03442296|524567965|FG000|12 Month Follow-up|Incomplete measurement|1|||
145468754|NCT03442296|524567966|FG001|12 Month Follow-up|Incomplete measurement|1|||
145468755|NCT03684694|524567967|FG000|Phase 1|Withdrawal by Subject|1|||
145468756|NCT03684694|524567968|FG001|Phase 1|Withdrawal by Subject|0|||
145468757|NCT03684694|524567969|FG002|Phase 1|Withdrawal by Subject|0|||
145468758|NCT03684694|524567970|FG003|Phase 1|Withdrawal by Subject|0|||
145468759|NCT03684694|524567971|FG004|Phase 1|Withdrawal by Subject|0|||
145468760|NCT03684694|524567972|FG005|Phase 1|Withdrawal by Subject|0|||
145468761|NCT03684694|524567967|FG000|Phase 1|Investigator/Sponsor Decision|12|||
145468762|NCT03684694|524567968|FG001|Phase 1|Investigator/Sponsor Decision|2|||
145468763|NCT03684694|524567969|FG002|Phase 1|Investigator/Sponsor Decision|1|||
145468764|NCT03684694|524567970|FG003|Phase 1|Investigator/Sponsor Decision|0|||
145468765|NCT03684694|524567971|FG004|Phase 1|Investigator/Sponsor Decision|0|||
145468766|NCT03684694|524567972|FG005|Phase 1|Investigator/Sponsor Decision|0|||
145468767|NCT03684694|524567967|FG000|Phase 1|Death|24|||
145468768|NCT03684694|524567968|FG001|Phase 1|Death|0|||
145468769|NCT03684694|524567969|FG002|Phase 1|Death|3|||
145468770|NCT03684694|524567970|FG003|Phase 1|Death|0|||
145468771|NCT03684694|524567971|FG004|Phase 1|Death|0|||
145468772|NCT03684694|524567972|FG005|Phase 1|Death|0|||
145468773|NCT03684694|524567967|FG000|Phase 1|Lost to Follow-up|0|||
145468774|NCT03684694|524567968|FG001|Phase 1|Lost to Follow-up|0|||
145468775|NCT03684694|524567969|FG002|Phase 1|Lost to Follow-up|1|||
145468776|NCT03684694|524567970|FG003|Phase 1|Lost to Follow-up|0|||
145468777|NCT03684694|524567971|FG004|Phase 1|Lost to Follow-up|0|||
145628245|NCT00991276|525153280|FG004|Third Intervention Period|Withdrawal by Subject|0|||
145628246|NCT00991276|525153281|FG005|Third Intervention Period|Withdrawal by Subject|0|||
145628247|NCT01268891|525153282|FG000|Overall Study|Adverse Event|3|||
145628248|NCT01268891|525153283|FG001|Overall Study|Adverse Event|7|||
145628249|NCT01268891|525153282|FG000|Overall Study|Lack of Efficacy|1|||
145628250|NCT01268891|525153283|FG001|Overall Study|Lack of Efficacy|0|||
145628251|NCT01268891|525153282|FG000|Overall Study|Withdrawal of Consent|3|||
145628252|NCT01268891|525153283|FG001|Overall Study|Withdrawal of Consent|1|||
145628253|NCT01268891|525153282|FG000|Overall Study|Administrative or other reason(s)|1|||
145628254|NCT01268891|525153283|FG001|Overall Study|Administrative or other reason(s)|0|||
145628255|NCT02534896|525153290|FG000|Overall Study|Adverse Event|2|||
145468778|NCT03684694|524567972|FG005|Phase 1|Lost to Follow-up|0|||
145468779|NCT03684694|524567967|FG000|Phase 1|Miscellaneous|0|||
145468780|NCT03684694|524567968|FG001|Phase 1|Miscellaneous|1|||
145468781|NCT03684694|524567969|FG002|Phase 1|Miscellaneous|0|||
145468782|NCT03684694|524567970|FG003|Phase 1|Miscellaneous|0|||
145628256|NCT02534896|525153291|FG001|Overall Study|Adverse Event|1|||
145628257|NCT02534896|525153292|FG002|Overall Study|Adverse Event|1|||
145628258|NCT02534896|525153290|FG000|Overall Study|Insufficient therapeutic response|2|||
145628259|NCT02534896|525153291|FG001|Overall Study|Insufficient therapeutic response|0|||
145468783|NCT03684694|524567971|FG004|Phase 1|Miscellaneous|0|||
145468784|NCT03684694|524567972|FG005|Phase 1|Miscellaneous|0|||
145468785|NCT03684694|524567967|FG000|Phase 2|Withdrawal by Subject|0|||
145468786|NCT03684694|524567968|FG001|Phase 2|Withdrawal by Subject|0|||
145628260|NCT02534896|525153292|FG002|Overall Study|Insufficient therapeutic response|0|||
145628261|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
145468787|NCT03684694|524567969|FG002|Phase 2|Withdrawal by Subject|0|||
145628262|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
145468788|NCT03684694|524567970|FG003|Phase 2|Withdrawal by Subject|0|||
145468789|NCT03684694|524567971|FG004|Phase 2|Withdrawal by Subject|0|||
145468790|NCT03684694|524567972|FG005|Phase 2|Withdrawal by Subject|1|||
145468791|NCT03684694|524567967|FG000|Phase 2|Investigator/Sponsor Decision|0|||
145468792|NCT03684694|524567968|FG001|Phase 2|Investigator/Sponsor Decision|0|||
145468793|NCT03684694|524567969|FG002|Phase 2|Investigator/Sponsor Decision|0|||
145468794|NCT03684694|524567970|FG003|Phase 2|Investigator/Sponsor Decision|17|||
145468795|NCT03684694|524567971|FG004|Phase 2|Investigator/Sponsor Decision|16|||
145468796|NCT03684694|524567972|FG005|Phase 2|Investigator/Sponsor Decision|6|||
145468797|NCT03684694|524567967|FG000|Phase 2|Death|0|||
145468798|NCT03684694|524567968|FG001|Phase 2|Death|0|||
145468799|NCT03684694|524567969|FG002|Phase 2|Death|0|||
145468800|NCT03684694|524567970|FG003|Phase 2|Death|28|||
145468801|NCT03684694|524567971|FG004|Phase 2|Death|14|||
145468802|NCT03684694|524567972|FG005|Phase 2|Death|3|||
145468803|NCT03684694|524567967|FG000|Phase 2|Lost to Follow-up|0|||
145468804|NCT03684694|524567968|FG001|Phase 2|Lost to Follow-up|0|||
145468805|NCT03684694|524567969|FG002|Phase 2|Lost to Follow-up|0|||
145468806|NCT03684694|524567970|FG003|Phase 2|Lost to Follow-up|1|||
145468807|NCT03684694|524567971|FG004|Phase 2|Lost to Follow-up|0|||
145468808|NCT03684694|524567972|FG005|Phase 2|Lost to Follow-up|0|||
145468809|NCT03684694|524567967|FG000|Phase 2|Miscellaneous|0|||
145468810|NCT03684694|524567968|FG001|Phase 2|Miscellaneous|0|||
145468811|NCT03684694|524567969|FG002|Phase 2|Miscellaneous|0|||
145468812|NCT03684694|524567970|FG003|Phase 2|Miscellaneous|3|||
145468813|NCT03684694|524567971|FG004|Phase 2|Miscellaneous|0|||
145468814|NCT03684694|524567972|FG005|Phase 2|Miscellaneous|0|||
145468815|NCT04327024|524569131|FG000|Overall Study|Death|1|||
145468816|NCT04327024|524569132|FG001|Overall Study|Death|2|||
145468817|NCT04327024|524569133|FG002|Overall Study|Death|1|||
145468818|NCT04327024|524569131|FG000|Overall Study|Non-compliance with study drug|0|||
145468819|NCT04327024|524569132|FG001|Overall Study|Non-compliance with study drug|1|||
145468820|NCT04327024|524569133|FG002|Overall Study|Non-compliance with study drug|0|||
145468821|NCT04327024|524569131|FG000|Overall Study|Withdrawal by Subject|1|||
145468822|NCT04327024|524569132|FG001|Overall Study|Withdrawal by Subject|1|||
145468823|NCT04327024|524569133|FG002|Overall Study|Withdrawal by Subject|2|||
145468824|NCT00837759|524569135|FG000|Overall Study|Protocol Violation|3|||
145468825|NCT00837759|524569135|FG000|Overall Study|Lost to Follow-up|1|||
145468826|NCT01022424|524569136|FG000|Overall Study|Adverse Event|1|||
145468827|NCT01022424|524569136|FG000|Overall Study|Physician Decision|1|||
145468828|NCT01022424|524569136|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
145468829|NCT01918332|524569138|FG000|Overall Study|Adverse Event|0|||
145468830|NCT01918332|524569139|FG001|Overall Study|Adverse Event|0|||
145468831|NCT01918332|524569140|FG002|Overall Study|Adverse Event|0|||
145468832|NCT01918332|524569141|FG003|Overall Study|Adverse Event|1|||
145468833|NCT01918332|524569138|FG000|Overall Study|Withdrawal by Subject|2|||
145468834|NCT01918332|524569139|FG001|Overall Study|Withdrawal by Subject|3|||
145468835|NCT01918332|524569140|FG002|Overall Study|Withdrawal by Subject|2|||
145468836|NCT01918332|524569141|FG003|Overall Study|Withdrawal by Subject|3|||
145468837|NCT01918332|524569138|FG000|Overall Study|Protocol Violation|6|||
145468838|NCT01918332|524569139|FG001|Overall Study|Protocol Violation|2|||
145468839|NCT01918332|524569140|FG002|Overall Study|Protocol Violation|6|||
145468840|NCT01918332|524569141|FG003|Overall Study|Protocol Violation|3|||
145468841|NCT01918332|524569138|FG000|Overall Study|lipid result by central lab did not meet|0|||
145468842|NCT01918332|524569139|FG001|Overall Study|lipid result by central lab did not meet|0|||
145468843|NCT01918332|524569140|FG002|Overall Study|lipid result by central lab did not meet|1|||
145468844|NCT01918332|524569141|FG003|Overall Study|lipid result by central lab did not meet|0|||
145468845|NCT05063539|524569142|FG000|Overall Study|Adverse Event|1|||
145468846|NCT05063539|524569143|FG001|Overall Study|Adverse Event|2|||
145468847|NCT05063539|524569144|FG002|Overall Study|Adverse Event|1|||
145468848|NCT05063539|524569142|FG000|Overall Study|Death|0|||
145468849|NCT05063539|524569143|FG001|Overall Study|Death|1|||
145468850|NCT05063539|524569144|FG002|Overall Study|Death|1|||
145468851|NCT05063539|524569142|FG000|Overall Study|Lost to Follow-up|0|||
145468852|NCT05063539|524569143|FG001|Overall Study|Lost to Follow-up|1|||
145468853|NCT05063539|524569144|FG002|Overall Study|Lost to Follow-up|0|||
145468854|NCT05063539|524569142|FG000|Overall Study|Physician Decision|4|||
145468855|NCT05063539|524569143|FG001|Overall Study|Physician Decision|3|||
145601267|NCT01197508|525054242|FG001|Overall Study|Lost to Follow-up|1|||
145601268|NCT01197508|525054243|FG002|Overall Study|Lost to Follow-up|2|||
145601269|NCT01197508|525054244|FG003|Overall Study|Lost to Follow-up|0|||
145468856|NCT05063539|524569144|FG002|Overall Study|Physician Decision|1|||
145468857|NCT05063539|524569142|FG000|Overall Study|Progressive Disease|0|||
145468858|NCT05063539|524569143|FG001|Overall Study|Progressive Disease|2|||
145468859|NCT05063539|524569144|FG002|Overall Study|Progressive Disease|0|||
145601270|NCT01197508|525054241|FG000|Overall Study|Other|2|||
145468860|NCT05063539|524569142|FG000|Overall Study|Withdrawal by Subject|17|||
145468861|NCT05063539|524569143|FG001|Overall Study|Withdrawal by Subject|26|||
145468862|NCT05063539|524569144|FG002|Overall Study|Withdrawal by Subject|14|||
145468863|NCT05063539|524569142|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
145468864|NCT05063539|524569143|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
145468865|NCT05063539|524569144|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
145468866|NCT05063539|524569142|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
145601271|NCT01197508|525054242|FG001|Overall Study|Other|3|||
145468867|NCT05063539|524569143|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
145468868|NCT05063539|524569144|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
145468869|NCT05063539|524569142|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
145468870|NCT05063539|524569143|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
145468871|NCT05063539|524569144|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
145468872|NCT05063539|524569142|FG000|Overall Study|Discontinued due to Common Close Design|0|||
145468873|NCT05063539|524569143|FG001|Overall Study|Discontinued due to Common Close Design|1|||
145468874|NCT05063539|524569144|FG002|Overall Study|Discontinued due to Common Close Design|0|||
145468875|NCT05063539|524569142|FG000|Overall Study|Participant not co-operative|0|||
145468876|NCT05063539|524569143|FG001|Overall Study|Participant not co-operative|1|||
145468877|NCT05063539|524569144|FG002|Overall Study|Participant not co-operative|0|||
145468878|NCT05063539|524569142|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
145468879|NCT05063539|524569143|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
145468880|NCT05063539|524569144|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
145468881|NCT05063539|524569142|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
145468882|NCT05063539|524569143|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
145468883|NCT05063539|524569144|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
145468884|NCT00527319|524569145|FG000|Overall Study|Withdrawal by Subject|5|||
145468885|NCT00527319|524569146|FG001|Overall Study|Withdrawal by Subject|0|||
145468886|NCT00527319|524569147|FG002|Overall Study|Withdrawal by Subject|1|||
145468887|NCT00527319|524569145|FG000|Overall Study|Lost to Follow-up|1|||
145468888|NCT00527319|524569146|FG001|Overall Study|Lost to Follow-up|0|||
145468889|NCT00527319|524569147|FG002|Overall Study|Lost to Follow-up|0|||
145468890|NCT00527319|524569145|FG000|Overall Study|Death|0|||
145468891|NCT00527319|524569146|FG001|Overall Study|Death|3|||
145468892|NCT00527319|524569147|FG002|Overall Study|Death|1|||
145468893|NCT00527319|524569145|FG000|Overall Study|Intercurrent Medical Illness|0|||
145468894|NCT00527319|524569146|FG001|Overall Study|Intercurrent Medical Illness|1|||
145468895|NCT00527319|524569147|FG002|Overall Study|Intercurrent Medical Illness|3|||
145468896|NCT00527319|524569145|FG000|Overall Study|Adverse Event|0|||
145468897|NCT00527319|524569146|FG001|Overall Study|Adverse Event|0|||
145468898|NCT00527319|524569147|FG002|Overall Study|Adverse Event|1|||
145468899|NCT03344172|524569151|FG000|Overall Study|Received <1 dose of treatment|1|||
145468900|NCT03344172|524569152|FG001|Overall Study|Received <1 dose of treatment|0|||
145468901|NCT00680368|524569153|FG000|Overall Study|not supervised, not eligible|15|||
145468902|NCT00483041|524569154|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
145468903|NCT00483041|524569155|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
145468904|NCT03779503|524569156|FG000|First Intervention|Adverse Event|0|||
145468905|NCT03779503|524569157|FG001|First Intervention|Adverse Event|1|||
145468906|NCT03779503|524569156|FG000|First Intervention|Withdrawal by Subject|1|||
145468907|NCT03779503|524569157|FG001|First Intervention|Withdrawal by Subject|0|||
145468908|NCT00864851|524569158|FG000|Overall Study|Withdrawal by Subject|0|||
145468909|NCT00864851|524569159|FG001|Overall Study|Withdrawal by Subject|1|||
145468910|NCT00864851|524569160|FG002|Overall Study|Withdrawal by Subject|0|||
145468911|NCT00864851|524569158|FG000|Overall Study|Physician Decision|1|||
145468912|NCT00864851|524569159|FG001|Overall Study|Physician Decision|0|||
145468913|NCT00864851|524569160|FG002|Overall Study|Physician Decision|0|||
145468914|NCT00864851|524569158|FG000|Overall Study|Death|1|||
145468915|NCT00864851|524569159|FG001|Overall Study|Death|0|||
145468916|NCT00864851|524569160|FG002|Overall Study|Death|0|||
145468917|NCT00864851|524569158|FG000|Overall Study|Patient uncooperative|1|||
145468918|NCT00864851|524569159|FG001|Overall Study|Patient uncooperative|0|||
145468919|NCT00864851|524569160|FG002|Overall Study|Patient uncooperative|0|||
145468920|NCT03242252|524569162|FG000|Overall Study|At the Participant's own Request|18|||
145468921|NCT03242252|524569163|FG001|Overall Study|At the Participant's own Request|10|||
145468922|NCT03242252|524569164|FG002|Overall Study|At the Participant's own Request|15|||
145468923|NCT03242252|524569162|FG000|Overall Study|Adverse Event|8|||
145468924|NCT03242252|524569163|FG001|Overall Study|Adverse Event|6|||
145468925|NCT03242252|524569164|FG002|Overall Study|Adverse Event|9|||
145468926|NCT03242252|524569162|FG000|Overall Study|Poor Compliance to Protocol|0|||
145468927|NCT03242252|524569163|FG001|Overall Study|Poor Compliance to Protocol|2|||
145468928|NCT03242252|524569164|FG002|Overall Study|Poor Compliance to Protocol|3|||
145468929|NCT03242252|524569162|FG000|Overall Study|Study Terminated by Sponsor|1|||
145468930|NCT03242252|524569163|FG001|Overall Study|Study Terminated by Sponsor|0|||
145468931|NCT03242252|524569164|FG002|Overall Study|Study Terminated by Sponsor|0|||
145468932|NCT03242252|524569162|FG000|Overall Study|Reason not Specified|4|||
145468933|NCT03242252|524569163|FG001|Overall Study|Reason not Specified|4|||
145468934|NCT03242252|524569164|FG002|Overall Study|Reason not Specified|1|||
145468935|NCT03242252|524569162|FG000|Overall Study|Lost to Follow-up|5|||
145468936|NCT03242252|524569163|FG001|Overall Study|Lost to Follow-up|1|||
145468937|NCT03242252|524569164|FG002|Overall Study|Lost to Follow-up|4|||
145468938|NCT01116427|524569165|FG000|Core Phase|Adverse Event|0|||
145468939|NCT01116427|524569166|FG001|Core Phase|Adverse Event|1|||
145468940|NCT01116427|524569165|FG000|Core Phase|Lost to Follow-up|1|||
145468941|NCT01116427|524569166|FG001|Core Phase|Lost to Follow-up|0|||
145468942|NCT01116427|524569165|FG000|Core Phase|Withdrawal by Subject|3|||
145468943|NCT01116427|524569166|FG001|Core Phase|Withdrawal by Subject|0|||
145468944|NCT01116427|524569165|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
145468945|NCT01116427|524569166|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
145468946|NCT01116427|524569165|FG000|Extension Phase|Adverse Event|1|||
145468947|NCT01116427|524569166|FG001|Extension Phase|Adverse Event|1|||
145468948|NCT01116427|524569165|FG000|Extension Phase|Lost to Follow-up|2|||
145468949|NCT01116427|524569166|FG001|Extension Phase|Lost to Follow-up|0|||
145468950|NCT01116427|524569165|FG000|Extension Phase|Withdrawal by Subject|5|||
145468951|NCT01116427|524569166|FG001|Extension Phase|Withdrawal by Subject|1|||
145468952|NCT01116427|524569165|FG000|Extension Phase|Not using appropriate birth control|1|||
145468953|NCT01116427|524569166|FG001|Extension Phase|Not using appropriate birth control|0|||
145468954|NCT02211313|524569167|FG000|Overall Study|Treatment Failure|5|||
145468955|NCT02211313|524569168|FG001|Overall Study|Treatment Failure|2|||
145468956|NCT02211313|524569167|FG000|Overall Study|No Follow up Questionnaires|1|||
145468957|NCT02211313|524569168|FG001|Overall Study|No Follow up Questionnaires|1|||
145468958|NCT02717130|524569169|FG000|Overall Study|Withdrawal by Subject|1|||
145468959|NCT02717130|524569169|FG000|Overall Study|Adverse Event|1|||
145468960|NCT02717130|524569169|FG000|Overall Study|Physician Decision|1|||
145468961|NCT02717130|524569169|FG000|Overall Study|Study Closure|4|||
145468962|NCT03344640|524569170|FG000|Overall Study|Adverse Event|1|||
145468963|NCT03344640|524569171|FG001|Overall Study|Adverse Event|0|||
145468964|NCT03344640|524569170|FG000|Overall Study|Physician Decision|1|||
145468965|NCT03344640|524569171|FG001|Overall Study|Physician Decision|1|||
145468966|NCT03344640|524569170|FG000|Overall Study|Withdrawal by Subject|1|||
145468967|NCT03344640|524569171|FG001|Overall Study|Withdrawal by Subject|2|||
145468968|NCT03344640|524569170|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
145468969|NCT03344640|524569171|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
145468970|NCT00657371|524569175|FG000|Overall Study|Poor bowel preparation|15|||
145468971|NCT00657371|524569175|FG000|Overall Study|Unable to intubate the cecum|5|||
145468972|NCT00657371|524569175|FG000|Overall Study|Protocol Violation|2|||
145468973|NCT00657371|524569175|FG000|Overall Study|Device- related reasons|13|||
145468974|NCT00657371|524569175|FG000|Overall Study|Pre-existing medical condition|4|||
145468975|NCT00652899|524569181|FG000|Overall Study|Death|1|||
145468976|NCT00652899|524569181|FG000|Overall Study|Treating physician decision|1|||
145468977|NCT01943552|524569182|FG000|Overall Study|Adverse Event|3|||
145468978|NCT01943552|524569183|FG001|Overall Study|Adverse Event|2|||
145468979|NCT01943552|524569182|FG000|Overall Study|Withdrawal by Subject|6|||
145468980|NCT01943552|524569183|FG001|Overall Study|Withdrawal by Subject|6|||
145468981|NCT01943552|524569182|FG000|Overall Study|Other Reasons|16|||
145468982|NCT01943552|524569183|FG001|Overall Study|Other Reasons|17|||
145468983|NCT01600053|524569184|FG000|Overall Study|Adverse Event|2|||
145468984|NCT01600053|524569184|FG000|Overall Study|trial will not meet the interim endpoint|9|||
145468985|NCT02715726|524569185|FG000|Overall Study|Adverse Event|2|||
145468986|NCT02715726|524569186|FG001|Overall Study|Adverse Event|6|||
145468987|NCT02715726|524569185|FG000|Overall Study|Protocol Violation|1|||
145468988|NCT02715726|524569186|FG001|Overall Study|Protocol Violation|0|||
145468989|NCT02715726|524569185|FG000|Overall Study|Death|2|||
145468990|NCT02715726|524569186|FG001|Overall Study|Death|1|||
145601272|NCT01197508|525054243|FG002|Overall Study|Other|2|||
145601273|NCT01197508|525054244|FG003|Overall Study|Other|2|||
145601274|NCT01119768|525054245|FG000|Treatment Period|Lack of Efficacy|18|||
145601275|NCT01119768|525054246|FG001|Treatment Period|Lack of Efficacy|25|||
145601276|NCT01662063|525054247|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
145601277|NCT01662063|525054248|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
145601278|NCT01662063|525054249|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
145601279|NCT01662063|525054247|FG000|Overall Study|Lack of Efficacy|1|||
145601280|NCT01662063|525054248|FG001|Overall Study|Lack of Efficacy|6|||
145601281|NCT01662063|525054249|FG002|Overall Study|Lack of Efficacy|0|||
145601282|NCT01662063|525054247|FG000|Overall Study|Lost to Follow-up|0|||
145601283|NCT01662063|525054248|FG001|Overall Study|Lost to Follow-up|4|||
145601284|NCT01662063|525054249|FG002|Overall Study|Lost to Follow-up|0|||
145601285|NCT01662063|525054247|FG000|Overall Study|Protocol Violation|1|||
145601286|NCT01662063|525054248|FG001|Overall Study|Protocol Violation|0|||
145601287|NCT01662063|525054249|FG002|Overall Study|Protocol Violation|0|||
145601288|NCT01662063|525054247|FG000|Overall Study|Withdrawal by Subject|2|||
145601289|NCT01662063|525054248|FG001|Overall Study|Withdrawal by Subject|4|||
145601290|NCT01662063|525054249|FG002|Overall Study|Withdrawal by Subject|1|||
145601291|NCT01662063|525054247|FG000|Overall Study|Physician Decision|0|||
145601292|NCT01662063|525054248|FG001|Overall Study|Physician Decision|2|||
145601293|NCT01662063|525054249|FG002|Overall Study|Physician Decision|0|||
145601294|NCT01662063|525054247|FG000|Overall Study|Other|0|||
145601295|NCT01662063|525054248|FG001|Overall Study|Other|1|||
145601296|NCT01662063|525054249|FG002|Overall Study|Other|0|||
145468991|NCT02715726|524569185|FG000|Overall Study|Participant moved|1|||
145468992|NCT02715726|524569186|FG001|Overall Study|Participant moved|3|||
145468993|NCT02715726|524569185|FG000|Overall Study|Other than specified above|11|||
145468994|NCT02715726|524569186|FG001|Overall Study|Other than specified above|15|||
145468995|NCT02715726|524569185|FG000|Overall Study|Randomized but not treated|1|||
145468996|NCT02715726|524569186|FG001|Overall Study|Randomized but not treated|2|||
145468997|NCT02445573|524569187|FG000|Overall Study|Withdrawal by Subject|1|||
145468998|NCT02445573|524569188|FG001|Overall Study|Withdrawal by Subject|1|||
145468999|NCT02445573|524569187|FG000|Overall Study|Lost to Follow-up|0|||
145469000|NCT02445573|524569188|FG001|Overall Study|Lost to Follow-up|1|||
145469001|NCT01565941|524569189|FG000|Overall Study|Withdrawn by parent/guardian|3|||
145469002|NCT01565941|524569190|FG001|Overall Study|Withdrawn by parent/guardian|2|||
145469003|NCT01565941|524569189|FG000|Overall Study|Randomized; did not receive intevention|8|||
145469004|NCT01565941|524569190|FG001|Overall Study|Randomized; did not receive intevention|2|||
145469005|NCT02855944|524569191|FG000|Period 1: Treatment|Ongoing|14|||
145469006|NCT02855944|524569192|FG001|Period 1: Treatment|Ongoing|0|||
145469007|NCT02855944|524569191|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
145469008|NCT02855944|524569192|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
145469009|NCT02855944|524569191|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
145469010|NCT02855944|524569192|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
145469011|NCT02391961|524569197|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
145469012|NCT02391961|524569198|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
145469013|NCT02391961|524569197|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
145469014|NCT02391961|524569198|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
145469015|NCT02391961|524569197|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145469016|NCT02391961|524569198|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
145469017|NCT02358044|524569199|FG000|Overall Study|Adverse Event|0|||
145469018|NCT02358044|524569200|FG001|Overall Study|Adverse Event|1|||
145469019|NCT02358044|524569199|FG000|Overall Study|Lost to Follow-up|2|||
145469020|NCT02358044|524569200|FG001|Overall Study|Lost to Follow-up|1|||
145469021|NCT02358044|524569199|FG000|Overall Study|Physician Decision|0|||
145469022|NCT02358044|524569200|FG001|Overall Study|Physician Decision|1|||
145469023|NCT02358044|524569199|FG000|Overall Study|Withdrawal by Subject|0|||
145469024|NCT02358044|524569200|FG001|Overall Study|Withdrawal by Subject|4|||
145469025|NCT01792518|524569203|FG000|Overall Study|Adverse Event|3|||
145469026|NCT01792518|524569204|FG001|Overall Study|Adverse Event|4|||
145469027|NCT01792518|524569203|FG000|Overall Study|Protocol Violation|0|||
145469028|NCT01792518|524569204|FG001|Overall Study|Protocol Violation|1|||
145469029|NCT01792518|524569203|FG000|Overall Study|Lost to Follow-up|3|||
145469030|NCT01792518|524569204|FG001|Overall Study|Lost to Follow-up|1|||
145469031|NCT01792518|524569203|FG000|Overall Study|Withdrawal by Subject|2|||
145469032|NCT01792518|524569204|FG001|Overall Study|Withdrawal by Subject|0|||
145469033|NCT01792518|524569203|FG000|Overall Study|Other Reason|0|||
145469034|NCT01792518|524569204|FG001|Overall Study|Other Reason|1|||
145469035|NCT00351273|524569210|FG000|Overall Study|Lost to Follow-up|1|||
145469036|NCT00351273|524569211|FG001|Overall Study|Lost to Follow-up|2|||
145469037|NCT00351273|524569212|FG002|Overall Study|Lost to Follow-up|5|||
145469038|NCT01378429|524569213|FG000|Overall Study|Noncompliance with study drug|1|||
145469039|NCT01378429|524569214|FG001|Overall Study|Noncompliance with study drug|0|||
145469040|NCT05219669|524569217|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
145469041|NCT05219669|524569218|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
145469042|NCT05219669|524569219|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
145469043|NCT05219669|524569220|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
145469044|NCT05219669|524569221|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
145469045|NCT05219669|524569222|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
145469046|NCT02920957|524569223|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
145469047|NCT02920957|524569224|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
145469048|NCT02920957|524569223|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
145469049|NCT02920957|524569224|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
145469050|NCT02920957|524569223|FG000|First Intervention : 1 Month|Adverse Event|1|||
145469051|NCT02920957|524569224|FG001|First Intervention : 1 Month|Adverse Event|0|||
145469052|NCT02920957|524569223|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
145469053|NCT02920957|524569224|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
145469054|NCT02745535|524569231|FG000|Overall Study|Death|1|||
145628263|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
145469055|NCT02745535|524569231|FG000|Overall Study|Adverse Event|3|||
145469056|NCT02745535|524569231|FG000|Overall Study|Lost to Follow-up|2|||
145469057|NCT01345682|524569235|FG000|Overall Study|Progressive disease per RECIST|226|||
145469058|NCT01345682|524569236|FG001|Overall Study|Progressive disease per RECIST|93|||
145469059|NCT01345682|524569235|FG000|Overall Study|Worsening of underlying cancer disease|23|||
145469060|NCT01345682|524569236|FG001|Overall Study|Worsening of underlying cancer disease|12|||
145469061|NCT01345682|524569235|FG000|Overall Study|Adverse Event|51|||
145469062|NCT01345682|524569236|FG001|Overall Study|Adverse Event|41|||
145469063|NCT01345682|524569235|FG000|Overall Study|Non-compliance with protocol|0|||
145469064|NCT01345682|524569236|FG001|Overall Study|Non-compliance with protocol|1|||
145469065|NCT01345682|524569235|FG000|Overall Study|Lost to Follow-up|0|||
145469066|NCT01345682|524569236|FG001|Overall Study|Lost to Follow-up|1|||
145469067|NCT01345682|524569235|FG000|Overall Study|Refused to continue trial medication|16|||
145469068|NCT01345682|524569236|FG001|Overall Study|Refused to continue trial medication|9|||
145469069|NCT01345682|524569235|FG000|Overall Study|Not treated|2|||
145469070|NCT01345682|524569236|FG001|Overall Study|Not treated|1|||
145469071|NCT01345682|524569235|FG000|Overall Study|Reason other than those specified above|4|||
145469072|NCT01345682|524569236|FG001|Overall Study|Reason other than those specified above|3|||
145469073|NCT01075984|524569237|FG000|Treatment Phase|Adverse Event|0|||
145469074|NCT01075984|524569238|FG001|Treatment Phase|Adverse Event|1|||
145469075|NCT01075984|524569239|FG002|Treatment Phase|Adverse Event|3|||
145469076|NCT01075984|524569240|FG003|Treatment Phase|Adverse Event|7|||
145469077|NCT01075984|524569241|FG004|Treatment Phase|Adverse Event|35|||
145469078|NCT01075984|524569237|FG000|Treatment Phase|Protocol Violation|0|||
145469079|NCT01075984|524569238|FG001|Treatment Phase|Protocol Violation|0|||
145469080|NCT01075984|524569239|FG002|Treatment Phase|Protocol Violation|1|||
145469081|NCT01075984|524569240|FG003|Treatment Phase|Protocol Violation|0|||
145469082|NCT01075984|524569241|FG004|Treatment Phase|Protocol Violation|3|||
145469083|NCT01075984|524569237|FG000|Treatment Phase|Withdrawal by Subject|0|||
145469084|NCT01075984|524569238|FG001|Treatment Phase|Withdrawal by Subject|0|||
145469085|NCT01075984|524569239|FG002|Treatment Phase|Withdrawal by Subject|2|||
145469086|NCT01075984|524569240|FG003|Treatment Phase|Withdrawal by Subject|0|||
145469087|NCT01075984|524569241|FG004|Treatment Phase|Withdrawal by Subject|15|||
145469088|NCT01075984|524569237|FG000|Treatment Phase|Treatment Failure|0|||
145469089|NCT01075984|524569238|FG001|Treatment Phase|Treatment Failure|0|||
145469090|NCT01075984|524569239|FG002|Treatment Phase|Treatment Failure|1|||
145469091|NCT01075984|524569240|FG003|Treatment Phase|Treatment Failure|0|||
145469092|NCT01075984|524569241|FG004|Treatment Phase|Treatment Failure|5|||
145469093|NCT01075984|524569237|FG000|Treatment Phase|Progression of disease|0|||
145469094|NCT01075984|524569238|FG001|Treatment Phase|Progression of disease|0|||
145469095|NCT01075984|524569239|FG002|Treatment Phase|Progression of disease|0|||
145469096|NCT01075984|524569240|FG003|Treatment Phase|Progression of disease|0|||
145469097|NCT01075984|524569241|FG004|Treatment Phase|Progression of disease|2|||
145469098|NCT01075984|524569237|FG000|Follow-up Phase|Protocol Violation|0|||
145469099|NCT01075984|524569238|FG001|Follow-up Phase|Protocol Violation|0|||
145469100|NCT01075984|524569239|FG002|Follow-up Phase|Protocol Violation|1|||
145469101|NCT01075984|524569240|FG003|Follow-up Phase|Protocol Violation|0|||
145469102|NCT01075984|524569241|FG004|Follow-up Phase|Protocol Violation|3|||
145469103|NCT01075984|524569237|FG000|Follow-up Phase|Adverse Event|0|||
145469104|NCT01075984|524569238|FG001|Follow-up Phase|Adverse Event|0|||
145469105|NCT01075984|524569239|FG002|Follow-up Phase|Adverse Event|0|||
145469106|NCT01075984|524569240|FG003|Follow-up Phase|Adverse Event|2|||
145469107|NCT01075984|524569241|FG004|Follow-up Phase|Adverse Event|27|||
145469108|NCT01075984|524569237|FG000|Follow-up Phase|Administrative|0|||
145469109|NCT01075984|524569238|FG001|Follow-up Phase|Administrative|0|||
145469110|NCT01075984|524569239|FG002|Follow-up Phase|Administrative|0|||
145469111|NCT01075984|524569240|FG003|Follow-up Phase|Administrative|0|||
145469112|NCT01075984|524569241|FG004|Follow-up Phase|Administrative|1|||
145469113|NCT01075984|524569237|FG000|Follow-up Phase|Withdrawal by Subject|0|||
145469114|NCT01075984|524569238|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145469115|NCT01075984|524569239|FG002|Follow-up Phase|Withdrawal by Subject|0|||
145469116|NCT01075984|524569240|FG003|Follow-up Phase|Withdrawal by Subject|0|||
145469117|NCT01075984|524569241|FG004|Follow-up Phase|Withdrawal by Subject|10|||
145469118|NCT01075984|524569237|FG000|Follow-up Phase|Progression of disease|0|||
145469119|NCT01075984|524569238|FG001|Follow-up Phase|Progression of disease|0|||
145469120|NCT01075984|524569239|FG002|Follow-up Phase|Progression of disease|0|||
145469121|NCT01075984|524569240|FG003|Follow-up Phase|Progression of disease|0|||
145469122|NCT01075984|524569241|FG004|Follow-up Phase|Progression of disease|2|||
145469123|NCT01075984|524569237|FG000|Follow-up Phase|Treatment failure|0|||
145469124|NCT01075984|524569238|FG001|Follow-up Phase|Treatment failure|0|||
145469125|NCT01075984|524569239|FG002|Follow-up Phase|Treatment failure|0|||
145469126|NCT01075984|524569240|FG003|Follow-up Phase|Treatment failure|0|||
145469127|NCT01075984|524569241|FG004|Follow-up Phase|Treatment failure|4|||
145469128|NCT05011513|524570970|FG000|Overall Study|Death|0|||
145469129|NCT05011513|524570971|FG001|Overall Study|Death|1|||
145469130|NCT05011513|524570970|FG000|Overall Study|Lost to Follow-up|4|||
145469131|NCT05011513|524570971|FG001|Overall Study|Lost to Follow-up|0|||
145469132|NCT05011513|524570970|FG000|Overall Study|Withdrawal by Subject|18|||
145469133|NCT05011513|524570971|FG001|Overall Study|Withdrawal by Subject|17|||
145601297|NCT01477853|525054256|FG000|Phase A|Adverse Event|1|||
145601298|NCT01477853|525054257|FG001|Phase A|Adverse Event|2|||
145469134|NCT05011513|524570970|FG000|Overall Study|Other|4|||
145469135|NCT05011513|524570971|FG001|Overall Study|Other|2|||
145469136|NCT03667690|524570972|FG000|Overall Study|Adverse Event|0|||
145469137|NCT03667690|524570973|FG001|Overall Study|Adverse Event|3|||
145469138|NCT03667690|524570972|FG000|Overall Study|Death|22|||
145469139|NCT03667690|524570973|FG001|Overall Study|Death|21|||
145469140|NCT03667690|524570972|FG000|Overall Study|Lost to Follow-up|4|||
145469141|NCT03667690|524570973|FG001|Overall Study|Lost to Follow-up|5|||
145469142|NCT03667690|524570972|FG000|Overall Study|Withdrawal by Subject|7|||
145469143|NCT03667690|524570973|FG001|Overall Study|Withdrawal by Subject|8|||
145469144|NCT03667690|524570972|FG000|Overall Study|Subject could not return for additional investigational product|1|||
145469145|NCT03667690|524570973|FG001|Overall Study|Subject could not return for additional investigational product|0|||
145469146|NCT03667690|524570972|FG000|Overall Study|Subject discharged to hospice care|2|||
145469147|NCT03667690|524570973|FG001|Overall Study|Subject discharged to hospice care|0|||
145469148|NCT03667690|524570972|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
145469149|NCT03667690|524570973|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
145469150|NCT03667690|524570972|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
145469151|NCT03667690|524570973|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
145469152|NCT03667690|524570972|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
145469153|NCT03667690|524570973|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
145469154|NCT03667690|524570972|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
145469155|NCT03667690|524570973|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
145469156|NCT03667690|524570972|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
145469157|NCT03667690|524570973|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
145469158|NCT01597635|524570982|FG000|Part A|Adverse Event|3|||
145469159|NCT01597635|524570983|FG001|Part A|Adverse Event|0|||
145469160|NCT01597635|524570984|FG002|Part A|Adverse Event|0|||
145469161|NCT01597635|524570982|FG000|Part B|Adverse Event|0|||
145469162|NCT01597635|524570983|FG001|Part B|Adverse Event|0|||
145469163|NCT01597635|524570984|FG002|Part B|Adverse Event|1|||
145469164|NCT01597635|524570982|FG000|Part B|Protocol Violation|0|||
145469165|NCT01597635|524570983|FG001|Part B|Protocol Violation|1|||
145469166|NCT01597635|524570984|FG002|Part B|Protocol Violation|0|||
145469167|NCT01597635|524570982|FG000|Part B|Protocol-defined stopping criteria|0|||
145469168|NCT01597635|524570983|FG001|Part B|Protocol-defined stopping criteria|4|||
145469169|NCT01597635|524570984|FG002|Part B|Protocol-defined stopping criteria|3|||
145469170|NCT01597635|524570982|FG000|Part B|Withdrawal by Subject|0|||
145469171|NCT01597635|524570983|FG001|Part B|Withdrawal by Subject|1|||
145469172|NCT01597635|524570984|FG002|Part B|Withdrawal by Subject|0|||
145469173|NCT00652951|524570985|FG000|Booster Phase|Adverse event, non-fatal|0|||
145469174|NCT00652951|524570986|FG001|Booster Phase|Adverse event, non-fatal|1|||
145469175|NCT00652951|524570987|FG002|Booster Phase|Adverse event, non-fatal|0|||
145469176|NCT00652951|524570985|FG000|Booster Phase|Other|1|||
145469177|NCT00652951|524570986|FG001|Booster Phase|Other|0|||
145469178|NCT00652951|524570987|FG002|Booster Phase|Other|0|||
145469179|NCT01192568|524570988|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
145469180|NCT01192568|524570989|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
145469181|NCT01192568|524570990|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
145469182|NCT01192568|524570991|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
145469183|NCT01192568|524570988|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
145469184|NCT01192568|524570989|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
145469185|NCT01192568|524570990|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
145469186|NCT01192568|524570991|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
145469187|NCT02593825|524570992|FG000|Intervention|Lost to Follow-up|10|||
145469188|NCT02593825|524570993|FG001|Intervention|Lost to Follow-up|12|||
145469189|NCT02100969|524570994|FG000|Overall Study|Did not pass screening phase|1|||
145469190|NCT06359080|524570995|FG000|Overall Study|Withdrawal by Subject|3|||
145469191|NCT00511134|524570996|FG000|Overall Study|Withdrawal by Subject|0|||
145469192|NCT00511134|524570997|FG001|Overall Study|Withdrawal by Subject|2|||
145469193|NCT01949090|524570998|FG000|Overall Study|Serious Adverse Event|0|||
145469194|NCT01949090|524570999|FG001|Overall Study|Serious Adverse Event|1|||
145469195|NCT01949090|524571000|FG002|Overall Study|Serious Adverse Event|2|||
145469196|NCT01949090|524571001|FG003|Overall Study|Serious Adverse Event|0|||
145469197|NCT01949090|524571002|FG004|Overall Study|Serious Adverse Event|1|||
145469198|NCT01949090|524570998|FG000|Overall Study|Withdrawal by Subject|2|||
145469199|NCT01949090|524570999|FG001|Overall Study|Withdrawal by Subject|0|||
145469200|NCT01949090|524571000|FG002|Overall Study|Withdrawal by Subject|0|||
145469201|NCT01949090|524571001|FG003|Overall Study|Withdrawal by Subject|0|||
145469202|NCT01949090|524571002|FG004|Overall Study|Withdrawal by Subject|1|||
145469203|NCT01949090|524570998|FG000|Overall Study|Protocol non-compliance|0|||
145469204|NCT01949090|524570999|FG001|Overall Study|Protocol non-compliance|0|||
145469205|NCT01949090|524571000|FG002|Overall Study|Protocol non-compliance|0|||
145469206|NCT01949090|524571001|FG003|Overall Study|Protocol non-compliance|0|||
145469207|NCT01949090|524571002|FG004|Overall Study|Protocol non-compliance|1|||
145469208|NCT01949090|524570998|FG000|Overall Study|Lost to Follow-up|2|||
145469209|NCT01949090|524570999|FG001|Overall Study|Lost to Follow-up|1|||
145469210|NCT01949090|524571000|FG002|Overall Study|Lost to Follow-up|0|||
145469211|NCT01949090|524571001|FG003|Overall Study|Lost to Follow-up|1|||
145469212|NCT01949090|524571002|FG004|Overall Study|Lost to Follow-up|1|||
145469213|NCT00599755|524571003|FG000|Overall Study|Adverse Event|11|||
145469214|NCT00599755|524571003|FG000|Overall Study|Withdrawal by Subject|2|||
145469215|NCT00599755|524571003|FG000|Overall Study|Progression of Disease|3|||
145469216|NCT00599755|524571003|FG000|Overall Study|Other Reason|2|||
145469217|NCT00599755|524571003|FG000|Overall Study|No data available|1|||
145469218|NCT01306656|524571004|FG000|Overall Study|Lost to Follow-up|1|||
145469219|NCT01306656|524571005|FG001|Overall Study|Lost to Follow-up|0|||
145469220|NCT00417963|524571009|FG000|Overall Study|Lost to Follow-up|3|||
145469221|NCT00417963|524571009|FG000|Overall Study|Withdrawal by Subject|18|||
145469222|NCT00417963|524571009|FG000|Overall Study|Death|17|||
145469223|NCT00417963|524571009|FG000|Overall Study|Study device could not be deployed|3|||
145469224|NCT00477152|524571012|FG000|Overall Study|Parent withdrew consent|2|||
145469225|NCT00477152|524571012|FG000|Overall Study|Adverse Event|1|||
145469226|NCT00448747|524571013|FG000|Overall Study|collapsed veins|1|||
145469227|NCT00448747|524571014|FG001|Overall Study|collapsed veins|0|||
145469228|NCT02905006|524571015|FG000|Overall Study|Adverse Event|1|||
145469229|NCT02905006|524571016|FG001|Overall Study|Adverse Event|1|||
145469230|NCT02905006|524571017|FG002|Overall Study|Adverse Event|1|||
145469231|NCT02905006|524571018|FG003|Overall Study|Adverse Event|1|||
145469232|NCT02905006|524571019|FG004|Overall Study|Adverse Event|0|||
145469233|NCT02905006|524571020|FG005|Overall Study|Adverse Event|1|||
145469234|NCT02905006|524571015|FG000|Overall Study|Lack of Efficacy|1|||
145469235|NCT02905006|524571016|FG001|Overall Study|Lack of Efficacy|0|||
145469236|NCT02905006|524571017|FG002|Overall Study|Lack of Efficacy|0|||
145469237|NCT02905006|524571018|FG003|Overall Study|Lack of Efficacy|0|||
145469238|NCT02905006|524571019|FG004|Overall Study|Lack of Efficacy|0|||
145469239|NCT02905006|524571020|FG005|Overall Study|Lack of Efficacy|0|||
145469240|NCT02905006|524571015|FG000|Overall Study|Protocol Violation|2|||
145469241|NCT02905006|524571016|FG001|Overall Study|Protocol Violation|0|||
145469242|NCT02905006|524571017|FG002|Overall Study|Protocol Violation|0|||
145469243|NCT02905006|524571018|FG003|Overall Study|Protocol Violation|0|||
145469244|NCT02905006|524571019|FG004|Overall Study|Protocol Violation|0|||
145469245|NCT02905006|524571020|FG005|Overall Study|Protocol Violation|0|||
145469246|NCT02905006|524571015|FG000|Overall Study|Lost to Follow-up|0|||
145469247|NCT02905006|524571016|FG001|Overall Study|Lost to Follow-up|0|||
145469248|NCT02905006|524571017|FG002|Overall Study|Lost to Follow-up|0|||
145469249|NCT02905006|524571018|FG003|Overall Study|Lost to Follow-up|1|||
145469250|NCT02905006|524571019|FG004|Overall Study|Lost to Follow-up|1|||
145469251|NCT02905006|524571020|FG005|Overall Study|Lost to Follow-up|0|||
145469252|NCT02905006|524571015|FG000|Overall Study|Withdrawal by Subject|0|||
145469253|NCT02905006|524571016|FG001|Overall Study|Withdrawal by Subject|0|||
145469254|NCT02905006|524571017|FG002|Overall Study|Withdrawal by Subject|1|||
145469255|NCT02905006|524571018|FG003|Overall Study|Withdrawal by Subject|1|||
145469256|NCT02905006|524571019|FG004|Overall Study|Withdrawal by Subject|0|||
145469257|NCT02905006|524571020|FG005|Overall Study|Withdrawal by Subject|1|||
145469258|NCT02905006|524571015|FG000|Overall Study|Screening exclusion criteria met|1|||
145469259|NCT02905006|524571016|FG001|Overall Study|Screening exclusion criteria met|0|||
145469260|NCT02905006|524571017|FG002|Overall Study|Screening exclusion criteria met|0|||
145469261|NCT02905006|524571018|FG003|Overall Study|Screening exclusion criteria met|0|||
145469262|NCT02905006|524571019|FG004|Overall Study|Screening exclusion criteria met|0|||
145469263|NCT02905006|524571020|FG005|Overall Study|Screening exclusion criteria met|0|||
145469264|NCT02905006|524571015|FG000|Overall Study|Lab withdrawal criterion met|0|||
145469265|NCT02905006|524571016|FG001|Overall Study|Lab withdrawal criterion met|1|||
145469266|NCT02905006|524571017|FG002|Overall Study|Lab withdrawal criterion met|2|||
145469267|NCT02905006|524571018|FG003|Overall Study|Lab withdrawal criterion met|2|||
145469268|NCT02905006|524571019|FG004|Overall Study|Lab withdrawal criterion met|2|||
145469269|NCT02905006|524571020|FG005|Overall Study|Lab withdrawal criterion met|1|||
145469270|NCT02905006|524571015|FG000|Overall Study|Positive for Tuberculosis|0|||
145469271|NCT02905006|524571016|FG001|Overall Study|Positive for Tuberculosis|1|||
145469272|NCT02905006|524571017|FG002|Overall Study|Positive for Tuberculosis|0|||
145601299|NCT01477853|525054258|FG002|Phase A|Adverse Event|2|||
145601300|NCT01477853|525054256|FG000|Phase A|Lost to Follow-up|4|||
145601301|NCT01477853|525054257|FG001|Phase A|Lost to Follow-up|3|||
145601302|NCT01477853|525054258|FG002|Phase A|Lost to Follow-up|2|||
145469273|NCT02905006|524571018|FG003|Overall Study|Positive for Tuberculosis|0|||
145469274|NCT02905006|524571019|FG004|Overall Study|Positive for Tuberculosis|0|||
145601303|NCT01477853|525054256|FG000|Phase A|Physician Decision|1|||
145469275|NCT02905006|524571020|FG005|Overall Study|Positive for Tuberculosis|0|||
145469276|NCT02905006|524571015|FG000|Overall Study|Subject positive for Hep B|0|||
145469277|NCT02905006|524571016|FG001|Overall Study|Subject positive for Hep B|0|||
145469278|NCT02905006|524571017|FG002|Overall Study|Subject positive for Hep B|1|||
145469279|NCT02905006|524571018|FG003|Overall Study|Subject positive for Hep B|0|||
145469280|NCT02905006|524571019|FG004|Overall Study|Subject positive for Hep B|0|||
145469281|NCT02905006|524571020|FG005|Overall Study|Subject positive for Hep B|0|||
145469282|NCT02905006|524571015|FG000|Overall Study|Patient moved abroad|0|||
145469283|NCT02905006|524571016|FG001|Overall Study|Patient moved abroad|0|||
145601304|NCT01477853|525054257|FG001|Phase A|Physician Decision|0|||
145469284|NCT02905006|524571017|FG002|Overall Study|Patient moved abroad|0|||
145469285|NCT02905006|524571018|FG003|Overall Study|Patient moved abroad|1|||
145469286|NCT02905006|524571019|FG004|Overall Study|Patient moved abroad|0|||
145469287|NCT02905006|524571020|FG005|Overall Study|Patient moved abroad|0|||
145469288|NCT02905006|524571015|FG000|Overall Study|Patient randomized by mistake|0|||
145469289|NCT02905006|524571016|FG001|Overall Study|Patient randomized by mistake|0|||
145469290|NCT02905006|524571017|FG002|Overall Study|Patient randomized by mistake|0|||
145469291|NCT02905006|524571018|FG003|Overall Study|Patient randomized by mistake|0|||
145469292|NCT02905006|524571019|FG004|Overall Study|Patient randomized by mistake|0|||
145469293|NCT02905006|524571020|FG005|Overall Study|Patient randomized by mistake|1|||
145469294|NCT02017522|524571021|FG000|Overall Study|Withdrawal by Subject|1|||
145469295|NCT05856227|524571022|FG000|Overall Study|Adverse Event|0|||
145469296|NCT05856227|524571023|FG001|Overall Study|Adverse Event|1|||
145469297|NCT05856227|524571022|FG000|Overall Study|Due to Investigator absence|1|||
145469298|NCT05856227|524571023|FG001|Overall Study|Due to Investigator absence|0|||
145469299|NCT05856227|524571022|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
145469300|NCT05856227|524571023|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
145469301|NCT01751139|524571024|FG000|Overall Study|Other|135|||
145469302|NCT01751139|524571024|FG000|Overall Study|Sponsor study termination|1609|||
145469303|NCT01751139|524571024|FG000|Overall Study|Lost to Follow-up|240|||
145469304|NCT01751139|524571024|FG000|Overall Study|Withdrawal by Subject|251|||
145469305|NCT01751139|524571024|FG000|Overall Study|Adverse Event|1|||
145469306|NCT01751139|524571024|FG000|Overall Study|Death|31|||
145469307|NCT04736628|524571025|FG000|Overall Study|Not treated|0|||
145469308|NCT04736628|524571026|FG001|Overall Study|Not treated|0|||
145469309|NCT04736628|524571027|FG002|Overall Study|Not treated|0|||
145469310|NCT04736628|524571028|FG003|Overall Study|Not treated|2|||
145469311|NCT04736628|524571025|FG000|Overall Study|Other reason than listed|1|||
145469312|NCT04736628|524571026|FG001|Overall Study|Other reason than listed|2|||
145469313|NCT04736628|524571027|FG002|Overall Study|Other reason than listed|2|||
145469314|NCT04736628|524571028|FG003|Overall Study|Other reason than listed|3|||
145469315|NCT04736628|524571025|FG000|Overall Study|Protocol deviation|0|||
145469316|NCT04736628|524571026|FG001|Overall Study|Protocol deviation|0|||
145469317|NCT04736628|524571027|FG002|Overall Study|Protocol deviation|0|||
145469318|NCT04736628|524571028|FG003|Overall Study|Protocol deviation|1|||
145469319|NCT04736628|524571025|FG000|Overall Study|Burden of study procedures|1|||
145469320|NCT04736628|524571026|FG001|Overall Study|Burden of study procedures|0|||
145469321|NCT04736628|524571027|FG002|Overall Study|Burden of study procedures|0|||
145469322|NCT04736628|524571028|FG003|Overall Study|Burden of study procedures|1|||
145469323|NCT04736628|524571025|FG000|Overall Study|Change of residence|0|||
145469324|NCT04736628|524571026|FG001|Overall Study|Change of residence|1|||
145469325|NCT04736628|524571027|FG002|Overall Study|Change of residence|0|||
145469326|NCT04736628|524571028|FG003|Overall Study|Change of residence|0|||
145469327|NCT04736628|524571025|FG000|Overall Study|Perceived lack of efficacy|1|||
145469328|NCT04736628|524571026|FG001|Overall Study|Perceived lack of efficacy|0|||
145469329|NCT04736628|524571027|FG002|Overall Study|Perceived lack of efficacy|0|||
145469330|NCT04736628|524571028|FG003|Overall Study|Perceived lack of efficacy|1|||
145469331|NCT04736628|524571025|FG000|Overall Study|Adverse Event|3|||
145469332|NCT04736628|524571026|FG001|Overall Study|Adverse Event|2|||
145469333|NCT04736628|524571027|FG002|Overall Study|Adverse Event|4|||
145469334|NCT04736628|524571028|FG003|Overall Study|Adverse Event|3|||
145469335|NCT02704689|524571029|FG000|Overall Study|Physician Decision|1|||
145469336|NCT02704689|524571029|FG000|Overall Study|Study device not implanted|2|||
145469337|NCT02428205|524571032|FG000|Overall Study|Lack of Efficacy|1|||
145469338|NCT02428205|524571033|FG001|Overall Study|Lack of Efficacy|0|||
145469339|NCT02428205|524571032|FG000|Overall Study|Lost to Follow-up|1|||
145469340|NCT02428205|524571033|FG001|Overall Study|Lost to Follow-up|1|||
145469341|NCT02428205|524571032|FG000|Overall Study|Worse behavior|0|||
145469342|NCT02428205|524571033|FG001|Overall Study|Worse behavior|1|||
145469343|NCT01646203|524571034|FG000|Overall Study|Adverse Event|2|||
145469344|NCT01646203|524571035|FG001|Overall Study|Adverse Event|0|||
145469345|NCT01646203|524571036|FG002|Overall Study|Adverse Event|1|||
145469346|NCT01646203|524571034|FG000|Overall Study|Withdrawal by Subject|0|||
145469347|NCT01646203|524571035|FG001|Overall Study|Withdrawal by Subject|1|||
145469348|NCT01646203|524571036|FG002|Overall Study|Withdrawal by Subject|0|||
145469349|NCT01646203|524571034|FG000|Overall Study|Physician's Decision|0|||
145469350|NCT01646203|524571035|FG001|Overall Study|Physician's Decision|1|||
145469351|NCT01646203|524571036|FG002|Overall Study|Physician's Decision|0|||
145469352|NCT01100528|524571037|FG000|Overall Study|Death|1|||
145469353|NCT01100528|524571037|FG000|Overall Study|Withdrawal by Subject|2|||
145469354|NCT00551291|524571040|FG000|Overall Study|Physician Decision|1|||
145469355|NCT01177969|524571041|FG000|Overall Study|Protocol Violation|2|||
145469356|NCT01177969|524571042|FG001|Overall Study|Protocol Violation|1|||
145469357|NCT01177969|524571041|FG000|Overall Study|Withdrawal by Subject|1|||
145469358|NCT01177969|524571042|FG001|Overall Study|Withdrawal by Subject|2|||
145469359|NCT01475162|524571046|FG000|Overall Study|Physician Decision|1|||
145469360|NCT01475162|524571046|FG000|Overall Study|Death|10|||
145469361|NCT01475162|524571046|FG000|Overall Study|Study closed for safety|3|||
145469362|NCT00490022|524571047|FG000|Overall Study|Adverse Event|0|||
145469363|NCT00490022|524571048|FG001|Overall Study|Adverse Event|2|||
145469364|NCT00490022|524571047|FG000|Overall Study|Withdrawal by Subject|1|||
145469365|NCT00490022|524571048|FG001|Overall Study|Withdrawal by Subject|0|||
145469366|NCT00490022|524571047|FG000|Overall Study|Subject failed to disclose concommitant|0|||
145469367|NCT00490022|524571048|FG001|Overall Study|Subject failed to disclose concommitant|1|||
145469368|NCT00903331|524571049|FG000|Overall Study|Death|4|||
145469369|NCT00903331|524571050|FG001|Overall Study|Death|8|||
145469370|NCT00903331|524571049|FG000|Overall Study|Withdrawal of consent|1|||
145469371|NCT00903331|524571050|FG001|Overall Study|Withdrawal of consent|8|||
145469372|NCT00903331|524571049|FG000|Overall Study|Lung transplant|0|||
145469373|NCT00903331|524571050|FG001|Overall Study|Lung transplant|2|||
145469374|NCT03426631|524571051|FG000|Overall Study|Lost to Follow-up|0|||
145469375|NCT03426631|524571052|FG001|Overall Study|Lost to Follow-up|1|||
145469376|NCT00654004|524571053|FG000|Overall Study|Lost to Follow-up|1|||
145469377|NCT00654004|524571054|FG001|Overall Study|Lost to Follow-up|0|||
145469378|NCT00444067|524571055|FG000|Overall Study|Lost to Follow-up|0|||
145469379|NCT00444067|524571056|FG001|Overall Study|Lost to Follow-up|1|||
145469380|NCT00710385|524571057|FG000|Overall Study|Did not qualify|1|||
145469381|NCT00710385|524571057|FG000|Overall Study|Withdrawal by Subject|1|||
145469382|NCT00710385|524571057|FG000|Overall Study|Undisclosed back pain|1|||
145469383|NCT00710385|524571057|FG000|Overall Study|Physician Decision|1|||
145469384|NCT00710385|524571057|FG000|Overall Study|Undisclosed excessive methadone use|1|||
145469385|NCT01455220|524571061|FG000|Overall Study|screen fail|30|||
145469386|NCT00267150|524571062|FG000|Overall Study|Adverse Event|1|||
145469387|NCT04881747|524571063|FG000|Period 2 Washout|Adverse Event|1|||
145469388|NCT04881747|524571064|FG001|Period 2 Washout|Adverse Event|0|||
145469389|NCT04881747|524571065|FG002|Period 2 Washout|Adverse Event|0|||
145469390|NCT04881747|524571066|FG003|Period 2 Washout|Adverse Event|0|||
145469391|NCT04881747|524571067|FG004|Period 2 Washout|Adverse Event|1|||
145469392|NCT04881747|524571068|FG005|Period 2 Washout|Adverse Event|0|||
145469393|NCT04881747|524571063|FG000|Period 2 Washout|Withdrawal by Subject|1|||
145469394|NCT04881747|524571064|FG001|Period 2 Washout|Withdrawal by Subject|0|||
145469395|NCT04881747|524571065|FG002|Period 2 Washout|Withdrawal by Subject|0|||
145469396|NCT04881747|524571066|FG003|Period 2 Washout|Withdrawal by Subject|1|||
145469397|NCT04881747|524571067|FG004|Period 2 Washout|Withdrawal by Subject|0|||
145469398|NCT04881747|524571068|FG005|Period 2 Washout|Withdrawal by Subject|0|||
145469399|NCT00521222|524571070|FG000|Overall Study|Lost to Follow-up|0|||
145469400|NCT00521222|524571071|FG001|Overall Study|Lost to Follow-up|0|||
145469401|NCT00521222|524571072|FG002|Overall Study|Lost to Follow-up|1|||
145469402|NCT00521222|524571073|FG003|Overall Study|Lost to Follow-up|1|||
145469403|NCT00521222|524571070|FG000|Overall Study|Withdrawal by Subject|0|||
145469404|NCT00521222|524571071|FG001|Overall Study|Withdrawal by Subject|0|||
145469405|NCT00521222|524571072|FG002|Overall Study|Withdrawal by Subject|2|||
145469406|NCT00521222|524571073|FG003|Overall Study|Withdrawal by Subject|0|||
145601305|NCT01477853|525054258|FG002|Phase A|Physician Decision|1|||
145601306|NCT01477853|525054256|FG000|Phase A|Study terminated by sponsor|37|||
145601307|NCT01477853|525054257|FG001|Phase A|Study terminated by sponsor|40|||
145601308|NCT01477853|525054258|FG002|Phase A|Study terminated by sponsor|39|||
145601309|NCT01477853|525054256|FG000|Phase B|Lost to Follow-up|0|||
145601310|NCT01477853|525054257|FG001|Phase B|Lost to Follow-up|1|||
145601311|NCT01477853|525054258|FG002|Phase B|Lost to Follow-up|0|||
145601312|NCT01477853|525054256|FG000|Phase B|Study terminated by sponsor|12|||
145601313|NCT01477853|525054257|FG001|Phase B|Study terminated by sponsor|10|||
145601314|NCT01477853|525054258|FG002|Phase B|Study terminated by sponsor|11|||
145601315|NCT00677352|525054264|FG000|Treatment Phase|Adverse Event|14|||
145601316|NCT00677352|525054265|FG001|Treatment Phase|Adverse Event|22|||
145601317|NCT00677352|525054264|FG000|Treatment Phase|Lack of Efficacy|2|||
145601318|NCT00677352|525054265|FG001|Treatment Phase|Lack of Efficacy|3|||
145601319|NCT00677352|525054264|FG000|Treatment Phase|Lost to Follow-up|0|||
145601320|NCT00677352|525054265|FG001|Treatment Phase|Lost to Follow-up|1|||
145601321|NCT00677352|525054264|FG000|Treatment Phase|Withdrawal by Subject|7|||
145601322|NCT00677352|525054265|FG001|Treatment Phase|Withdrawal by Subject|7|||
145601323|NCT00677352|525054264|FG000|Treatment Phase|Physician Decision|1|||
145601324|NCT00677352|525054265|FG001|Treatment Phase|Physician Decision|0|||
145601325|NCT00677352|525054264|FG000|Treatment Phase|Pregnancy|0|||
145601326|NCT00677352|525054265|FG001|Treatment Phase|Pregnancy|1|||
145601327|NCT00677352|525054264|FG000|Treatment Phase|Protocol Violation|1|||
145601328|NCT00677352|525054265|FG001|Treatment Phase|Protocol Violation|1|||
145601329|NCT00677352|525054264|FG000|Treatment Phase|Transference or work related matter|0|||
145469407|NCT00521222|524571070|FG000|Overall Study|Physician Decision|0|||
145469408|NCT00521222|524571071|FG001|Overall Study|Physician Decision|1|||
145469409|NCT00521222|524571072|FG002|Overall Study|Physician Decision|0|||
145469410|NCT00521222|524571073|FG003|Overall Study|Physician Decision|1|||
145469411|NCT02477553|524571075|FG000|Overall Study|Screening up-to-date|12|||
145469412|NCT02477553|524571076|FG001|Overall Study|Screening up-to-date|13|||
145469413|NCT02477553|524571075|FG000|Overall Study|No MD visit|1|||
145601330|NCT00677352|525054265|FG001|Treatment Phase|Transference or work related matter|5|||
145469414|NCT02477553|524571076|FG001|Overall Study|No MD visit|1|||
145469415|NCT02477553|524571075|FG000|Overall Study|Workup consistent w/CRC|1|||
145469416|NCT02477553|524571076|FG001|Overall Study|Workup consistent w/CRC|1|||
145469417|NCT02477553|524571075|FG000|Overall Study|Technical issues with intervention|2|||
145469418|NCT02477553|524571076|FG001|Overall Study|Technical issues with intervention|0|||
145469419|NCT02477553|524571075|FG000|Overall Study|Elevated risk for CRC|2|||
145469420|NCT02477553|524571076|FG001|Overall Study|Elevated risk for CRC|2|||
145469421|NCT02477553|524571075|FG000|Overall Study|MD advised against screening|1|||
145469422|NCT02477553|524571076|FG001|Overall Study|MD advised against screening|3|||
145469423|NCT02477553|524571075|FG000|Overall Study|patient deceased|1|||
145469424|NCT02477553|524571076|FG001|Overall Study|patient deceased|0|||
145469425|NCT00637572|524571077|FG000|Overall Study|Adverse Event|1|||
145469426|NCT00637572|524571078|FG001|Overall Study|Adverse Event|2|||
145469427|NCT00637572|524571077|FG000|Overall Study|Death|0|||
145469428|NCT00637572|524571078|FG001|Overall Study|Death|1|||
145469429|NCT00637572|524571077|FG000|Overall Study|Lost to Follow-up|0|||
145469430|NCT00637572|524571078|FG001|Overall Study|Lost to Follow-up|1|||
145469431|NCT00637572|524571077|FG000|Overall Study|Physician Decision|1|||
145469432|NCT00637572|524571078|FG001|Overall Study|Physician Decision|1|||
145469433|NCT00637572|524571077|FG000|Overall Study|Withdrawal by Subject|0|||
145469434|NCT00637572|524571078|FG001|Overall Study|Withdrawal by Subject|2|||
145469435|NCT00637572|524571077|FG000|Overall Study|Illicit Drug Use|1|||
145469436|NCT00637572|524571078|FG001|Overall Study|Illicit Drug Use|0|||
145469437|NCT03652675|524571080|FG000|Overall Study|Lost to Follow-up|4|||
145469438|NCT03652675|524571081|FG001|Overall Study|Lost to Follow-up|4|||
145469439|NCT01638559|524571082|FG000|Overall Study|Lost to Follow-up|1|||
145469440|NCT01638559|524571082|FG000|Overall Study|Withdrawal by Subject|1|||
145469441|NCT01638559|524571082|FG000|Overall Study|Subject declined to travel for biopsy|1|||
145469442|NCT00752726|524571086|FG000|Overall Study|Lost to Follow-up|2|||
145469443|NCT00752726|524571087|FG001|Overall Study|Lost to Follow-up|1|||
145469444|NCT00752726|524571086|FG000|Overall Study|Adverse Event|3|||
145469445|NCT00752726|524571087|FG001|Overall Study|Adverse Event|0|||
145469446|NCT00752726|524571086|FG000|Overall Study|Withdrawal by Subject|5|||
145469447|NCT00752726|524571087|FG001|Overall Study|Withdrawal by Subject|10|||
145469448|NCT00752726|524571086|FG000|Overall Study|Other Reason|1|||
145469449|NCT00752726|524571087|FG001|Overall Study|Other Reason|2|||
145469450|NCT01403116|524571088|FG000|Overall Study|Adverse Event|7|||
145469451|NCT01403116|524571089|FG001|Overall Study|Adverse Event|4|||
145469452|NCT01403116|524571088|FG000|Overall Study|Lost to Follow-up|7|||
145469453|NCT01403116|524571089|FG001|Overall Study|Lost to Follow-up|5|||
145469454|NCT01403116|524571088|FG000|Overall Study|Withdrawal by Subject|12|||
145469455|NCT01403116|524571089|FG001|Overall Study|Withdrawal by Subject|15|||
145469456|NCT01403116|524571088|FG000|Overall Study|Non-compliance of study drug|3|||
145469457|NCT01403116|524571089|FG001|Overall Study|Non-compliance of study drug|0|||
145469458|NCT01403116|524571088|FG000|Overall Study|Protocol Violation|0|||
145469459|NCT01403116|524571089|FG001|Overall Study|Protocol Violation|1|||
145469460|NCT01403116|524571088|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
145469461|NCT01403116|524571089|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
145469462|NCT01403116|524571088|FG000|Overall Study|Hct >54%|2|||
145469463|NCT01403116|524571089|FG001|Overall Study|Hct >54%|0|||
145469464|NCT01403116|524571088|FG000|Overall Study|unable to keep appointments|0|||
145469465|NCT01403116|524571089|FG001|Overall Study|unable to keep appointments|2|||
145469466|NCT01895309|524571090|FG000|Overall Study|Adverse Event|13|||
145469467|NCT01895309|524571091|FG001|Overall Study|Adverse Event|17|||
145469468|NCT01895309|524571090|FG000|Overall Study|Protocol Violation|1|||
145469469|NCT01895309|524571091|FG001|Overall Study|Protocol Violation|0|||
145469470|NCT01895309|524571090|FG000|Overall Study|Lack of Efficacy|1|||
145469471|NCT01895309|524571091|FG001|Overall Study|Lack of Efficacy|3|||
145469472|NCT01895309|524571090|FG000|Overall Study|Lost to Follow-up|1|||
145469473|NCT01895309|524571091|FG001|Overall Study|Lost to Follow-up|3|||
145469474|NCT01895309|524571090|FG000|Overall Study|Physician Decision|15|||
145469475|NCT01895309|524571091|FG001|Overall Study|Physician Decision|10|||
145469476|NCT01895309|524571090|FG000|Overall Study|Withdrawal by Subject|9|||
145469477|NCT01895309|524571091|FG001|Overall Study|Withdrawal by Subject|18|||
145469478|NCT00042666|524571092|FG000|Overall Study|Adverse Event|2|||
145469479|NCT00042666|524571092|FG000|Overall Study|Death|4|||
145628264|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
145469480|NCT00042666|524571092|FG000|Overall Study|Protocol Violation|1|||
145469481|NCT00042666|524571092|FG000|Overall Study|Participant/Physician Perception|1|||
145469482|NCT00042666|524571092|FG000|Overall Study|Progressive Disease|41|||
145469483|NCT00042666|524571092|FG000|Overall Study|Other|1|||
145469484|NCT00042666|524571092|FG000|Overall Study|Other|4|||
145469485|NCT04232215|524571093|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
145469486|NCT04232215|524571094|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145469487|NCT00447122|524571095|FG000|Overall Study|worsening medical condition -came off|0|||
145469488|NCT00447122|524571096|FG001|Overall Study|worsening medical condition -came off|1|||
145469489|NCT00447122|524571097|FG002|Overall Study|worsening medical condition -came off|0|||
145469490|NCT00447122|524571098|FG003|Overall Study|worsening medical condition -came off|0|||
145469491|NCT02409342|524571099|FG000|Overall Study|Death|211|||
145469492|NCT02409342|524571100|FG001|Overall Study|Death|201|||
145469493|NCT02409342|524571099|FG000|Overall Study|Withdrawal by Subject|24|||
145469494|NCT02409342|524571100|FG001|Overall Study|Withdrawal by Subject|17|||
145469495|NCT02409342|524571099|FG000|Overall Study|Study Terminated By Sponsor|48|||
145469496|NCT02409342|524571100|FG001|Overall Study|Study Terminated By Sponsor|59|||
145469497|NCT02409342|524571099|FG000|Overall Study|Lost to Follow-up|3|||
145469498|NCT02409342|524571100|FG001|Overall Study|Lost to Follow-up|5|||
145469499|NCT02409342|524571099|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
145469500|NCT02409342|524571100|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
145469501|NCT02409342|524571099|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
145469502|NCT02409342|524571100|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
145469503|NCT02409342|524571099|FG000|Overall Study|Sponsor Decision|1|||
145469504|NCT02409342|524571100|FG001|Overall Study|Sponsor Decision|0|||
145469505|NCT00279812|524571101|FG000|Overall Study|Protocol Violation|1|||
145469506|NCT00279812|524571102|FG001|Overall Study|Protocol Violation|1|||
145469507|NCT00279812|524571103|FG002|Overall Study|Protocol Violation|0|||
145469508|NCT00279812|524571104|FG003|Overall Study|Protocol Violation|0|||
145469509|NCT00279812|524571105|FG004|Overall Study|Protocol Violation|1|||
145469510|NCT00279812|524571106|FG005|Overall Study|Protocol Violation|0|||
145469511|NCT00279812|524571101|FG000|Overall Study|Withdrawal by Subject|0|||
145469512|NCT00279812|524571102|FG001|Overall Study|Withdrawal by Subject|4|||
145469513|NCT00279812|524571103|FG002|Overall Study|Withdrawal by Subject|2|||
145469514|NCT00279812|524571104|FG003|Overall Study|Withdrawal by Subject|0|||
145469515|NCT00279812|524571105|FG004|Overall Study|Withdrawal by Subject|0|||
145469516|NCT00279812|524571106|FG005|Overall Study|Withdrawal by Subject|0|||
145469517|NCT00279812|524571101|FG000|Overall Study|Adverse Event|0|||
145469518|NCT00279812|524571102|FG001|Overall Study|Adverse Event|1|||
145469519|NCT00279812|524571103|FG002|Overall Study|Adverse Event|1|||
145469520|NCT00279812|524571104|FG003|Overall Study|Adverse Event|0|||
145469521|NCT00279812|524571105|FG004|Overall Study|Adverse Event|2|||
145469522|NCT00279812|524571106|FG005|Overall Study|Adverse Event|1|||
145469523|NCT01274429|524571107|FG000|Overall Study|Study closed do to lack of funding|5|||
145469524|NCT01439373|524571113|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
145469525|NCT01439373|524571114|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
145469526|NCT01439373|524571113|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
145469527|NCT01439373|524571114|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
145469528|NCT04046250|524571117|FG000|Overall Study|Death|0|||
145469529|NCT04046250|524571118|FG001|Overall Study|Death|1|||
145469530|NCT04046250|524571117|FG000|Overall Study|Withdrawal by Subject|3|||
145469531|NCT04046250|524571118|FG001|Overall Study|Withdrawal by Subject|3|||
145469532|NCT04576897|524571125|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
145469533|NCT03834220|524571126|FG000|Overall Study|Adverse Event|1|||
145469534|NCT03834220|524571127|FG001|Overall Study|Adverse Event|0|||
145469535|NCT03834220|524571128|FG002|Overall Study|Adverse Event|0|||
145469536|NCT03834220|524571126|FG000|Overall Study|Death|8|||
145469537|NCT03834220|524571127|FG001|Overall Study|Death|1|||
145469538|NCT03834220|524571128|FG002|Overall Study|Death|17|||
145469539|NCT03834220|524571126|FG000|Overall Study|Reason not Specified|9|||
145469540|NCT03834220|524571127|FG001|Overall Study|Reason not Specified|0|||
145469541|NCT03834220|524571128|FG002|Overall Study|Reason not Specified|6|||
145469542|NCT03834220|524571126|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
145469543|NCT03834220|524571127|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
145469544|NCT03834220|524571128|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
145469545|NCT03834220|524571126|FG000|Overall Study|Withdrawal of Consent|2|||
145469546|NCT03834220|524571127|FG001|Overall Study|Withdrawal of Consent|2|||
145601331|NCT00677352|525054264|FG000|Treatment Phase|Not treated|0|||
145601332|NCT00677352|525054265|FG001|Treatment Phase|Not treated|2|||
145601333|NCT00677352|525054264|FG000|Tapering Phase|Adverse Event|1|||
145601334|NCT00677352|525054265|FG001|Tapering Phase|Adverse Event|5|||
145601335|NCT00677352|525054264|FG000|Tapering Phase|Withdrawal by Subject|5|||
145601336|NCT00677352|525054265|FG001|Tapering Phase|Withdrawal by Subject|3|||
145601337|NCT00677352|525054264|FG000|Tapering Phase|Pregnancy|0|||
145469547|NCT03834220|524571128|FG002|Overall Study|Withdrawal of Consent|2|||
145469548|NCT02593318|524571131|FG000|Overall Study|Withdrawal by Subject|1|||
145469549|NCT02593318|524571132|FG001|Overall Study|Withdrawal by Subject|1|||
145469550|NCT01174173|524571134|FG000|Overall Study|drug-drug interaction|1|||
145469551|NCT00527332|524571138|FG000|Overall Study|Protocol Violation|4|||
145469552|NCT00527332|524571139|FG001|Overall Study|Protocol Violation|8|||
145469553|NCT00527332|524571138|FG000|Overall Study|Withdrew consent|5|||
145469554|NCT00527332|524571139|FG001|Overall Study|Withdrew consent|1|||
145469555|NCT03268941|524573242|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469556|NCT03268941|524573243|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469557|NCT03268941|524573244|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469558|NCT03268941|524573245|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
145469559|NCT03268941|524573246|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469560|NCT03268941|524573247|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469561|NCT03268941|524573248|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
145469562|NCT03268941|524573242|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469563|NCT03268941|524573243|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469564|NCT03268941|524573244|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469565|NCT03268941|524573245|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
145469566|NCT03268941|524573246|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469567|NCT03268941|524573247|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469568|NCT03268941|524573248|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
145469569|NCT03268941|524573242|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
145469570|NCT03268941|524573243|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469571|NCT03268941|524573244|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469572|NCT03268941|524573245|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469573|NCT03268941|524573246|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469574|NCT03268941|524573247|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469575|NCT03268941|524573248|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
145469576|NCT03268941|524573242|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
145469577|NCT03268941|524573243|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
145469578|NCT03268941|524573244|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
145469579|NCT03268941|524573245|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
145469580|NCT03268941|524573246|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
145469581|NCT03268941|524573247|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
145469582|NCT03268941|524573248|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
145469583|NCT03268941|524573242|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469584|NCT03268941|524573243|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469585|NCT03268941|524573244|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469586|NCT03268941|524573245|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469587|NCT03268941|524573246|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469588|NCT03268941|524573247|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
145469589|NCT03268941|524573248|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
145469590|NCT01629953|524573249|FG000|Overall Study|Death|3|||
145469591|NCT01629953|524573250|FG001|Overall Study|Death|1|||
145469592|NCT01629953|524573249|FG000|Overall Study|Lost to Follow-up|10|||
145469593|NCT01629953|524573250|FG001|Overall Study|Lost to Follow-up|14|||
145469594|NCT00707954|524573251|FG000|Overall Study|Physician Decision|0|||
145469595|NCT00707954|524573252|FG001|Overall Study|Physician Decision|0|||
145469596|NCT00707954|524573253|FG002|Overall Study|Physician Decision|0|||
145469597|NCT00707954|524573254|FG003|Overall Study|Physician Decision|0|||
145469598|NCT00707954|524573255|FG004|Overall Study|Physician Decision|1|||
145469599|NCT00344500|524573256|FG000|Overall Study|Adverse Event|6|||
145469600|NCT00344500|524573257|FG001|Overall Study|Adverse Event|2|||
145469601|NCT00344500|524573258|FG002|Overall Study|Adverse Event|0|||
145469602|NCT00344500|524573256|FG000|Overall Study|Lost to Follow-up|5|||
145469603|NCT00344500|524573257|FG001|Overall Study|Lost to Follow-up|13|||
145601338|NCT00677352|525054265|FG001|Tapering Phase|Pregnancy|1|||
145601339|NCT00677352|525054264|FG000|Tapering Phase|Job transfer|0|||
145601340|NCT00677352|525054265|FG001|Tapering Phase|Job transfer|1|||
145601341|NCT04044456|525054268|FG000|Overall Study|Lost to Follow-up|4|||
145601342|NCT04044456|525054269|FG001|Overall Study|Lost to Follow-up|1|||
145601343|NCT04044456|525054268|FG000|Overall Study|Withdrawal by Subject|1|||
145601344|NCT04044456|525054269|FG001|Overall Study|Withdrawal by Subject|0|||
145601345|NCT01972529|525054270|FG000|Overall Study|Adverse Event|0|||
145601346|NCT01972529|525054271|FG001|Overall Study|Adverse Event|1|||
145601347|NCT01972529|525054272|FG002|Overall Study|Adverse Event|0|||
145601348|NCT01972529|525054273|FG003|Overall Study|Adverse Event|0|||
145601349|NCT01972529|525054270|FG000|Overall Study|Lost to Follow-up|1|||
145601350|NCT01972529|525054271|FG001|Overall Study|Lost to Follow-up|0|||
145601351|NCT01972529|525054272|FG002|Overall Study|Lost to Follow-up|0|||
145601352|NCT01972529|525054273|FG003|Overall Study|Lost to Follow-up|0|||
145601353|NCT01972529|525054270|FG000|Overall Study|Participant Choice|0|||
145601354|NCT01972529|525054271|FG001|Overall Study|Participant Choice|1|||
145601355|NCT01972529|525054272|FG002|Overall Study|Participant Choice|0|||
145601356|NCT01972529|525054273|FG003|Overall Study|Participant Choice|0|||
145601357|NCT01972529|525054270|FG000|Overall Study|Withdrawl of Consent|1|||
145601358|NCT01972529|525054271|FG001|Overall Study|Withdrawl of Consent|2|||
145601359|NCT01972529|525054272|FG002|Overall Study|Withdrawl of Consent|0|||
145469604|NCT00344500|524573258|FG002|Overall Study|Lost to Follow-up|1|||
145469605|NCT00344500|524573256|FG000|Overall Study|Withdrawal by Subject|7|||
145469606|NCT00344500|524573257|FG001|Overall Study|Withdrawal by Subject|10|||
145469607|NCT00344500|524573258|FG002|Overall Study|Withdrawal by Subject|0|||
145469608|NCT00344500|524573256|FG000|Overall Study|Protocol Violation|4|||
145601360|NCT01972529|525054273|FG003|Overall Study|Withdrawl of Consent|1|||
145601361|NCT01972529|525054270|FG000|Overall Study|Other|0|||
145601362|NCT01972529|525054271|FG001|Overall Study|Other|0|||
145601363|NCT01972529|525054272|FG002|Overall Study|Other|0|||
145469609|NCT00344500|524573257|FG001|Overall Study|Protocol Violation|7|||
145469610|NCT00344500|524573258|FG002|Overall Study|Protocol Violation|1|||
145469611|NCT00344500|524573256|FG000|Overall Study|Not Noted|1|||
145469612|NCT00344500|524573257|FG001|Overall Study|Not Noted|3|||
145469613|NCT00344500|524573258|FG002|Overall Study|Not Noted|0|||
145469614|NCT01023672|524573259|FG000|Overall Study|Worsening disease|2|||
145469615|NCT01023672|524573259|FG000|Overall Study|Death|1|||
145469616|NCT02504580|524573260|FG000|Overall Study|Other|1|||
145469617|NCT02504580|524573261|FG001|Overall Study|Other|0|||
145469618|NCT02504580|524573262|FG002|Overall Study|Other|0|||
145469619|NCT02504580|524573263|FG003|Overall Study|Other|2|||
145469620|NCT02504580|524573264|FG004|Overall Study|Other|1|||
145469621|NCT02504580|524573265|FG005|Overall Study|Other|1|||
145469622|NCT02504580|524573266|FG006|Overall Study|Other|1|||
145469623|NCT02504580|524573267|FG007|Overall Study|Other|2|||
145469624|NCT02504580|524573268|FG008|Overall Study|Other|0|||
145469625|NCT02504580|524573269|FG009|Overall Study|Other|0|||
145469626|NCT02504580|524573270|FG010|Overall Study|Other|0|||
145469627|NCT02504580|524573271|FG011|Overall Study|Other|2|||
145469628|NCT02504580|524573260|FG000|Overall Study|Subject refusal to continue|0|||
145469629|NCT02504580|524573261|FG001|Overall Study|Subject refusal to continue|1|||
145469630|NCT02504580|524573262|FG002|Overall Study|Subject refusal to continue|0|||
145469631|NCT02504580|524573263|FG003|Overall Study|Subject refusal to continue|0|||
145469632|NCT02504580|524573264|FG004|Overall Study|Subject refusal to continue|0|||
145469633|NCT02504580|524573265|FG005|Overall Study|Subject refusal to continue|0|||
145469634|NCT02504580|524573266|FG006|Overall Study|Subject refusal to continue|0|||
145469635|NCT02504580|524573267|FG007|Overall Study|Subject refusal to continue|0|||
145469636|NCT02504580|524573268|FG008|Overall Study|Subject refusal to continue|0|||
145469637|NCT02504580|524573269|FG009|Overall Study|Subject refusal to continue|0|||
145469638|NCT02504580|524573270|FG010|Overall Study|Subject refusal to continue|0|||
145469639|NCT02504580|524573271|FG011|Overall Study|Subject refusal to continue|0|||
145469640|NCT02252965|524573278|FG000|Overall Study|Adverse Event|9|||
145469641|NCT02252965|524573279|FG001|Overall Study|Adverse Event|14|||
145469642|NCT02252965|524573278|FG000|Overall Study|Lost to Follow-up|16|||
145469643|NCT02252965|524573279|FG001|Overall Study|Lost to Follow-up|8|||
145469644|NCT02252965|524573278|FG000|Overall Study|Protocol Violation|4|||
145469645|NCT02252965|524573279|FG001|Overall Study|Protocol Violation|5|||
145469646|NCT02252965|524573278|FG000|Overall Study|Lack of Efficacy|0|||
145469647|NCT02252965|524573279|FG001|Overall Study|Lack of Efficacy|2|||
145469648|NCT02252965|524573278|FG000|Overall Study|Withdrawal by Subject|7|||
145469649|NCT02252965|524573279|FG001|Overall Study|Withdrawal by Subject|9|||
145469650|NCT02252965|524573278|FG000|Overall Study|Other|4|||
145469651|NCT02252965|524573279|FG001|Overall Study|Other|5|||
145469652|NCT02615691|524573282|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
145469653|NCT02615691|524573282|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
145469654|NCT02615691|524573282|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
145469655|NCT02615691|524573282|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
145469656|NCT04279613|524573284|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
145469657|NCT04279613|524573285|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
145469658|NCT04279613|524573286|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
145469659|NCT04279613|524573287|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
145469660|NCT04279613|524573288|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
145469661|NCT04279613|524573284|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
145469662|NCT04279613|524573285|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
145469663|NCT04279613|524573286|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
145469664|NCT04279613|524573287|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
145469665|NCT04279613|524573288|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
145469666|NCT04279613|524573284|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
145469667|NCT04279613|524573285|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
145469668|NCT04279613|524573286|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
145469669|NCT04279613|524573287|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
145469670|NCT04279613|524573288|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
145469671|NCT04279613|524573284|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
145628265|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Adverse Event|198|||
145628266|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Adverse Event|0|||
145469672|NCT04279613|524573285|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
145469673|NCT04279613|524573286|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
145469674|NCT04279613|524573287|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
145469675|NCT04279613|524573288|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
145469676|NCT04279613|524573284|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
145469677|NCT04279613|524573285|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
145469678|NCT04279613|524573286|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
145469679|NCT04279613|524573287|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
145469680|NCT04279613|524573288|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
145469681|NCT04051827|524573289|FG000|Overall Study|Death|1|||
145469682|NCT04051827|524573289|FG000|Overall Study|Withdrawal by Subject|4|||
145469683|NCT04051827|524573289|FG000|Overall Study|Progressive disease|16|||
145469684|NCT04051827|524573289|FG000|Overall Study|Physician Decision|1|||
145469685|NCT04051827|524573289|FG000|Overall Study|Other|4|||
145469686|NCT02888743|524573290|FG000|Overall Study|Withdrawal by Subject|1|||
145469687|NCT02888743|524573291|FG001|Overall Study|Withdrawal by Subject|2|||
145469688|NCT02888743|524573292|FG002|Overall Study|Withdrawal by Subject|2|||
145469689|NCT02888743|524573293|FG003|Overall Study|Withdrawal by Subject|0|||
145469690|NCT02888743|524573294|FG004|Overall Study|Withdrawal by Subject|1|||
145469691|NCT02888743|524573290|FG000|Overall Study|Disease progression before treatment|2|||
145469692|NCT02888743|524573291|FG001|Overall Study|Disease progression before treatment|0|||
145469693|NCT02888743|524573292|FG002|Overall Study|Disease progression before treatment|2|||
145469694|NCT02888743|524573293|FG003|Overall Study|Disease progression before treatment|0|||
145469695|NCT02888743|524573294|FG004|Overall Study|Disease progression before treatment|0|||
145469696|NCT02888743|524573290|FG000|Overall Study|Patient ineligible|1|||
145469697|NCT02888743|524573291|FG001|Overall Study|Patient ineligible|2|||
145469698|NCT02888743|524573292|FG002|Overall Study|Patient ineligible|0|||
145469699|NCT02888743|524573293|FG003|Overall Study|Patient ineligible|0|||
145469700|NCT02888743|524573294|FG004|Overall Study|Patient ineligible|0|||
145469701|NCT01424566|524573295|FG000|Single-blind Treatment|Adverse Event|71|||
145469702|NCT01424566|524573296|FG001|Single-blind Treatment|Adverse Event|0|||
145469703|NCT01424566|524573297|FG002|Single-blind Treatment|Adverse Event|0|||
145469704|NCT01424566|524573295|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
145469705|NCT01424566|524573296|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
145469706|NCT01424566|524573297|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
145469707|NCT01424566|524573295|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
145469708|NCT01424566|524573296|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
145469709|NCT01424566|524573297|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
145469710|NCT01424566|524573295|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
145469711|NCT01424566|524573296|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
145469712|NCT01424566|524573297|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
145469713|NCT01424566|524573295|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
145469714|NCT01424566|524573296|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
145469715|NCT01424566|524573297|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
145469716|NCT01424566|524573295|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
145469717|NCT01424566|524573296|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
145469718|NCT01424566|524573297|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
145469719|NCT01424566|524573295|FG000|Double-blind Treatment|Adverse Event|0|||
145469720|NCT01424566|524573296|FG001|Double-blind Treatment|Adverse Event|21|||
145469721|NCT01424566|524573297|FG002|Double-blind Treatment|Adverse Event|13|||
145469722|NCT01424566|524573295|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
145469723|NCT01424566|524573296|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
145469724|NCT01424566|524573297|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
145469725|NCT01424566|524573295|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
145469726|NCT01424566|524573296|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
145469727|NCT01424566|524573297|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
145469728|NCT01424566|524573295|FG000|Double-blind Treatment|Lack of Efficacy|0|||
145469729|NCT01424566|524573296|FG001|Double-blind Treatment|Lack of Efficacy|1|||
145469730|NCT01424566|524573297|FG002|Double-blind Treatment|Lack of Efficacy|1|||
145469731|NCT01659255|524573301|FG000|Overall Study|Adverse Event|0|||
145469732|NCT01659255|524573302|FG001|Overall Study|Adverse Event|0|||
145469733|NCT01659255|524573303|FG002|Overall Study|Adverse Event|0|||
145469734|NCT01659255|524573304|FG003|Overall Study|Adverse Event|0|||
145469735|NCT01659255|524573305|FG004|Overall Study|Adverse Event|0|||
145469736|NCT01659255|524573306|FG005|Overall Study|Adverse Event|1|||
145469737|NCT01659255|524573307|FG006|Overall Study|Adverse Event|1|||
145469738|NCT01659255|524573308|FG007|Overall Study|Adverse Event|0|||
145469739|NCT01659255|524573309|FG008|Overall Study|Adverse Event|0|||
145469740|NCT01659255|524573310|FG009|Overall Study|Adverse Event|1|||
145469741|NCT01659255|524573311|FG010|Overall Study|Adverse Event|0|||
145469742|NCT01659255|524573312|FG011|Overall Study|Adverse Event|1|||
145469743|NCT01659255|524573313|FG012|Overall Study|Adverse Event|0|||
145469744|NCT01659255|524573314|FG013|Overall Study|Adverse Event|2|||
145469745|NCT01659255|524573315|FG014|Overall Study|Adverse Event|0|||
145469746|NCT01659255|524573316|FG015|Overall Study|Adverse Event|1|||
145469747|NCT01659255|524573317|FG016|Overall Study|Adverse Event|0|||
145469748|NCT01659255|524573301|FG000|Overall Study|Death|0|||
145469749|NCT01659255|524573302|FG001|Overall Study|Death|1|||
145469750|NCT01659255|524573303|FG002|Overall Study|Death|0|||
145469751|NCT01659255|524573304|FG003|Overall Study|Death|0|||
145469752|NCT01659255|524573305|FG004|Overall Study|Death|0|||
145469753|NCT01659255|524573306|FG005|Overall Study|Death|0|||
145469754|NCT01659255|524573307|FG006|Overall Study|Death|0|||
145469755|NCT01659255|524573308|FG007|Overall Study|Death|1|||
145469756|NCT01659255|524573309|FG008|Overall Study|Death|1|||
145469757|NCT01659255|524573310|FG009|Overall Study|Death|0|||
145469758|NCT01659255|524573311|FG010|Overall Study|Death|0|||
145469759|NCT01659255|524573312|FG011|Overall Study|Death|0|||
145469760|NCT01659255|524573313|FG012|Overall Study|Death|1|||
145469761|NCT01659255|524573314|FG013|Overall Study|Death|1|||
145469762|NCT01659255|524573315|FG014|Overall Study|Death|2|||
145469763|NCT01659255|524573316|FG015|Overall Study|Death|1|||
145469764|NCT01659255|524573317|FG016|Overall Study|Death|0|||
145469765|NCT01659255|524573301|FG000|Overall Study|Progressive Disease|2|||
145469766|NCT01659255|524573302|FG001|Overall Study|Progressive Disease|0|||
145469767|NCT01659255|524573303|FG002|Overall Study|Progressive Disease|0|||
145469768|NCT01659255|524573304|FG003|Overall Study|Progressive Disease|0|||
145469769|NCT01659255|524573305|FG004|Overall Study|Progressive Disease|0|||
145469770|NCT01659255|524573306|FG005|Overall Study|Progressive Disease|0|||
145469771|NCT01659255|524573307|FG006|Overall Study|Progressive Disease|0|||
145469772|NCT01659255|524573308|FG007|Overall Study|Progressive Disease|1|||
145469773|NCT01659255|524573309|FG008|Overall Study|Progressive Disease|0|||
145469774|NCT01659255|524573310|FG009|Overall Study|Progressive Disease|2|||
145469775|NCT01659255|524573311|FG010|Overall Study|Progressive Disease|2|||
145469776|NCT01659255|524573312|FG011|Overall Study|Progressive Disease|3|||
145469777|NCT01659255|524573313|FG012|Overall Study|Progressive Disease|5|||
145469778|NCT01659255|524573314|FG013|Overall Study|Progressive Disease|13|||
145469779|NCT01659255|524573315|FG014|Overall Study|Progressive Disease|6|||
145469780|NCT01659255|524573316|FG015|Overall Study|Progressive Disease|2|||
145469781|NCT01659255|524573317|FG016|Overall Study|Progressive Disease|3|||
145469782|NCT01659255|524573301|FG000|Overall Study|Withdrew Consent|0|||
145469783|NCT01659255|524573302|FG001|Overall Study|Withdrew Consent|0|||
145469784|NCT01659255|524573303|FG002|Overall Study|Withdrew Consent|0|||
145469785|NCT01659255|524573304|FG003|Overall Study|Withdrew Consent|0|||
145469786|NCT01659255|524573305|FG004|Overall Study|Withdrew Consent|0|||
145469787|NCT01659255|524573306|FG005|Overall Study|Withdrew Consent|0|||
145469788|NCT01659255|524573307|FG006|Overall Study|Withdrew Consent|0|||
145469789|NCT01659255|524573308|FG007|Overall Study|Withdrew Consent|0|||
145469790|NCT01659255|524573309|FG008|Overall Study|Withdrew Consent|0|||
145469791|NCT01659255|524573310|FG009|Overall Study|Withdrew Consent|0|||
145469792|NCT01659255|524573311|FG010|Overall Study|Withdrew Consent|1|||
145469793|NCT01659255|524573312|FG011|Overall Study|Withdrew Consent|0|||
145469794|NCT01659255|524573313|FG012|Overall Study|Withdrew Consent|0|||
145469795|NCT01659255|524573314|FG013|Overall Study|Withdrew Consent|1|||
145469796|NCT01659255|524573315|FG014|Overall Study|Withdrew Consent|0|||
145469797|NCT01659255|524573316|FG015|Overall Study|Withdrew Consent|0|||
145469798|NCT01659255|524573317|FG016|Overall Study|Withdrew Consent|0|||
145469799|NCT01659255|524573301|FG000|Overall Study|Investigator Decision|0|||
145469800|NCT01659255|524573302|FG001|Overall Study|Investigator Decision|0|||
145469801|NCT01659255|524573303|FG002|Overall Study|Investigator Decision|0|||
145469802|NCT01659255|524573304|FG003|Overall Study|Investigator Decision|0|||
145469803|NCT01659255|524573305|FG004|Overall Study|Investigator Decision|0|||
145469804|NCT01659255|524573306|FG005|Overall Study|Investigator Decision|0|||
145469805|NCT01659255|524573307|FG006|Overall Study|Investigator Decision|0|||
145469806|NCT01659255|524573308|FG007|Overall Study|Investigator Decision|0|||
145469807|NCT01659255|524573309|FG008|Overall Study|Investigator Decision|0|||
145469808|NCT01659255|524573310|FG009|Overall Study|Investigator Decision|0|||
145469809|NCT01659255|524573311|FG010|Overall Study|Investigator Decision|0|||
145469810|NCT01659255|524573312|FG011|Overall Study|Investigator Decision|0|||
145469811|NCT01659255|524573313|FG012|Overall Study|Investigator Decision|1|||
145469812|NCT01659255|524573314|FG013|Overall Study|Investigator Decision|1|||
145469813|NCT01659255|524573315|FG014|Overall Study|Investigator Decision|0|||
145469814|NCT01659255|524573316|FG015|Overall Study|Investigator Decision|0|||
145469815|NCT01659255|524573317|FG016|Overall Study|Investigator Decision|0|||
145469816|NCT01659255|524573301|FG000|Overall Study|Sponsor's Decision|0|||
145469817|NCT01659255|524573302|FG001|Overall Study|Sponsor's Decision|0|||
145469818|NCT01659255|524573303|FG002|Overall Study|Sponsor's Decision|0|||
145469819|NCT01659255|524573304|FG003|Overall Study|Sponsor's Decision|0|||
145469820|NCT01659255|524573305|FG004|Overall Study|Sponsor's Decision|0|||
145469821|NCT01659255|524573306|FG005|Overall Study|Sponsor's Decision|0|||
145469822|NCT01659255|524573307|FG006|Overall Study|Sponsor's Decision|1|||
145469823|NCT01659255|524573308|FG007|Overall Study|Sponsor's Decision|0|||
145469824|NCT01659255|524573309|FG008|Overall Study|Sponsor's Decision|0|||
145469825|NCT01659255|524573310|FG009|Overall Study|Sponsor's Decision|0|||
145469826|NCT01659255|524573311|FG010|Overall Study|Sponsor's Decision|0|||
145469827|NCT01659255|524573312|FG011|Overall Study|Sponsor's Decision|0|||
145469828|NCT01659255|524573313|FG012|Overall Study|Sponsor's Decision|0|||
145469829|NCT01659255|524573314|FG013|Overall Study|Sponsor's Decision|0|||
145469830|NCT01659255|524573315|FG014|Overall Study|Sponsor's Decision|0|||
145469831|NCT01659255|524573316|FG015|Overall Study|Sponsor's Decision|0|||
145469832|NCT01659255|524573317|FG016|Overall Study|Sponsor's Decision|0|||
145469833|NCT01659255|524573301|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145601364|NCT01972529|525054273|FG003|Overall Study|Other|2|||
145601365|NCT01972529|525054270|FG000|Overall Study|Not treated|0|||
145601366|NCT01972529|525054271|FG001|Overall Study|Not treated|1|||
145601367|NCT01972529|525054272|FG002|Overall Study|Not treated|2|||
145601368|NCT01972529|525054273|FG003|Overall Study|Not treated|1|||
145601369|NCT01201811|525054274|FG000|Overall Study|Adverse Event|6|||
145469834|NCT01659255|524573302|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469835|NCT01659255|524573303|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469836|NCT01659255|524573304|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469837|NCT01659255|524573305|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469838|NCT01659255|524573306|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469839|NCT01659255|524573307|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469840|NCT01659255|524573308|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469841|NCT01659255|524573309|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469842|NCT01659255|524573310|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469843|NCT01659255|524573311|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469844|NCT01659255|524573312|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469845|NCT01659255|524573313|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469846|NCT01659255|524573314|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469847|NCT01659255|524573315|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469848|NCT01659255|524573316|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
145469849|NCT01659255|524573317|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
145469850|NCT01659255|524573301|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
145469851|NCT01659255|524573302|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
145469852|NCT01659255|524573303|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
145469853|NCT01659255|524573304|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
145469854|NCT01659255|524573305|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
145469855|NCT01659255|524573306|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
145469856|NCT01659255|524573307|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
145469857|NCT01659255|524573308|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
145469858|NCT01659255|524573309|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
145469859|NCT01659255|524573310|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
145469860|NCT01659255|524573311|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
145469861|NCT01659255|524573312|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
145469862|NCT01659255|524573313|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
145469863|NCT01659255|524573314|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
145469864|NCT01659255|524573315|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
145469865|NCT01659255|524573316|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
145469866|NCT01659255|524573317|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
145469867|NCT01079936|524573320|FG000|Phase I: MTD|First Remission Status|2|||
145469868|NCT01079936|524573321|FG001|Phase I: MTD|First Remission Status|0|||
145469869|NCT01079936|524573322|FG002|Phase I: MTD|First Remission Status|0|||
145469870|NCT01079936|524573323|FG003|Phase I: MTD|First Remission Status|0|||
145469871|NCT01079936|524573324|FG004|Phase I: MTD|First Remission Status|0|||
145469872|NCT01079936|524573320|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
145469873|NCT01079936|524573321|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
145469874|NCT01079936|524573322|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
145469875|NCT01079936|524573323|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
145469876|NCT01079936|524573324|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
145469877|NCT01079936|524573320|FG000|Phase II|Adverse Event|0|||
145469878|NCT01079936|524573321|FG001|Phase II|Adverse Event|0|||
145469879|NCT01079936|524573322|FG002|Phase II|Adverse Event|1|||
145469880|NCT01079936|524573323|FG003|Phase II|Adverse Event|0|||
145469881|NCT01079936|524573324|FG004|Phase II|Adverse Event|0|||
145469882|NCT01079936|524573320|FG000|Phase II|Insurance Issue|0|||
145469883|NCT01079936|524573321|FG001|Phase II|Insurance Issue|0|||
145469884|NCT01079936|524573322|FG002|Phase II|Insurance Issue|0|||
145469885|NCT01079936|524573323|FG003|Phase II|Insurance Issue|0|||
145469886|NCT01079936|524573324|FG004|Phase II|Insurance Issue|1|||
145469887|NCT02335424|524573325|FG000|Overall Study|Withdrawal by Subject|19|||
145469888|NCT02335424|524573325|FG000|Overall Study|Adverse Event|25|||
145469889|NCT02335424|524573325|FG000|Overall Study|Death|273|||
145469890|NCT02335424|524573325|FG000|Overall Study|Lost to Follow-up|3|||
145469891|NCT02335424|524573325|FG000|Overall Study|Physician Decision|13|||
145469892|NCT02335424|524573325|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
145469893|NCT02335424|524573325|FG000|Overall Study|Protocol Violation|1|||
145469894|NCT02335424|524573325|FG000|Overall Study|Screen failure|1|||
145469895|NCT02712424|524573326|FG000|Overall Study|Lost to Follow-up|34|||
145469896|NCT02712424|524573327|FG001|Overall Study|Lost to Follow-up|32|||
145469897|NCT02809053|524573328|FG000|Overall Study|Death|0|||
145469898|NCT02809053|524573329|FG001|Overall Study|Death|1|||
145469899|NCT02809053|524573328|FG000|Overall Study|Lost to Follow-up|3|||
145469900|NCT02809053|524573329|FG001|Overall Study|Lost to Follow-up|1|||
145469901|NCT02809053|524573328|FG000|Overall Study|Withdrawal by Subject|2|||
145469902|NCT02809053|524573329|FG001|Overall Study|Withdrawal by Subject|3|||
145469903|NCT02809053|524573328|FG000|Overall Study|Disease Progression|2|||
145469904|NCT02809053|524573329|FG001|Overall Study|Disease Progression|1|||
145469905|NCT01504204|524573332|FG000|Overall Study|Lost to Follow-up|1|||
145469906|NCT01504204|524573333|FG001|Overall Study|Lost to Follow-up|1|||
145469907|NCT02723175|524573334|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
145469908|NCT02723175|524573335|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
145469909|NCT02723175|524573334|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
145469910|NCT02723175|524573335|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
145469911|NCT02049138|524573336|FG000|Overall Study|Adverse Event|46|||
145469912|NCT02049138|524573337|FG001|Overall Study|Adverse Event|25|||
145469913|NCT02049138|524573338|FG002|Overall Study|Adverse Event|1|||
145469914|NCT02049138|524573336|FG000|Overall Study|Withdrawal by Subject|57|||
145469915|NCT02049138|524573337|FG001|Overall Study|Withdrawal by Subject|21|||
145469916|NCT02049138|524573338|FG002|Overall Study|Withdrawal by Subject|5|||
145469917|NCT02049138|524573336|FG000|Overall Study|Lost to Follow-up|18|||
145469918|NCT02049138|524573337|FG001|Overall Study|Lost to Follow-up|5|||
145469919|NCT02049138|524573338|FG002|Overall Study|Lost to Follow-up|1|||
145469920|NCT02049138|524573336|FG000|Overall Study|Lack of Efficacy|10|||
145469921|NCT02049138|524573337|FG001|Overall Study|Lack of Efficacy|26|||
145469922|NCT02049138|524573338|FG002|Overall Study|Lack of Efficacy|1|||
145469923|NCT02049138|524573336|FG000|Overall Study|Non-Compliance|15|||
145469924|NCT02049138|524573337|FG001|Overall Study|Non-Compliance|6|||
145469925|NCT02049138|524573338|FG002|Overall Study|Non-Compliance|0|||
145469926|NCT02049138|524573336|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
145469927|NCT02049138|524573337|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
145469928|NCT02049138|524573338|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
145469929|NCT02049138|524573336|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
145469930|NCT02049138|524573337|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
145469931|NCT02049138|524573338|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
145469932|NCT02049138|524573336|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
145469933|NCT02049138|524573337|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
145469934|NCT02049138|524573338|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
145469935|NCT02049138|524573336|FG000|Overall Study|Other|15|||
145469936|NCT02049138|524573337|FG001|Overall Study|Other|13|||
145469937|NCT02049138|524573338|FG002|Overall Study|Other|0|||
145469938|NCT02049138|524573336|FG000|Overall Study|Missing|0|||
145469939|NCT02049138|524573337|FG001|Overall Study|Missing|1|||
145469940|NCT02049138|524573338|FG002|Overall Study|Missing|0|||
145469941|NCT04109976|524573339|FG000|Overall Study|Withdrawal by Subject|1|||
145469942|NCT04109976|524573340|FG001|Overall Study|Withdrawal by Subject|0|||
145469943|NCT00491608|524573341|FG000|Overall Study|Death|2|||
145469944|NCT00491608|524573341|FG000|Overall Study|Withdrawal by Subject|1|||
145469945|NCT00257660|524573342|FG000|Overall Study|Lack of Efficacy|5|||
145469946|NCT00257660|524573343|FG001|Overall Study|Lack of Efficacy|23|||
145469947|NCT00257660|524573342|FG000|Overall Study|Withdrawal by Subject|2|||
145469948|NCT00257660|524573343|FG001|Overall Study|Withdrawal by Subject|0|||
145469949|NCT00257660|524573342|FG000|Overall Study|Lost to Follow-up|1|||
145469950|NCT00257660|524573343|FG001|Overall Study|Lost to Follow-up|0|||
145469951|NCT00257660|524573342|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
145469952|NCT00257660|524573343|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
145469953|NCT00257660|524573342|FG000|Overall Study|No longer wanted to do blood draws|1|||
145469954|NCT00257660|524573343|FG001|Overall Study|No longer wanted to do blood draws|0|||
145469955|NCT01264770|524573354|FG000|Overall Study|Not reported|0|||
145469956|NCT01264770|524573355|FG001|Overall Study|Not reported|0|||
145469957|NCT01264770|524573356|FG002|Overall Study|Not reported|1|||
145469958|NCT01264770|524573357|FG003|Overall Study|Not reported|0|||
145469959|NCT01264770|524573358|FG004|Overall Study|Not reported|0|||
145469960|NCT01264770|524573359|FG005|Overall Study|Not reported|0|||
145469961|NCT01264770|524573354|FG000|Overall Study|e.g., change in circumstances|8|||
145469962|NCT01264770|524573355|FG001|Overall Study|e.g., change in circumstances|3|||
145469963|NCT01264770|524573356|FG002|Overall Study|e.g., change in circumstances|3|||
145469964|NCT01264770|524573357|FG003|Overall Study|e.g., change in circumstances|3|||
145469965|NCT01264770|524573358|FG004|Overall Study|e.g., change in circumstances|4|||
145469966|NCT01264770|524573359|FG005|Overall Study|e.g., change in circumstances|4|||
145469967|NCT01264770|524573354|FG000|Overall Study|Severe non-compliance to protocol|0|||
145469968|NCT01264770|524573355|FG001|Overall Study|Severe non-compliance to protocol|0|||
145469969|NCT01264770|524573356|FG002|Overall Study|Severe non-compliance to protocol|1|||
145469970|NCT01264770|524573357|FG003|Overall Study|Severe non-compliance to protocol|1|||
145469971|NCT01264770|524573358|FG004|Overall Study|Severe non-compliance to protocol|0|||
145469972|NCT01264770|524573359|FG005|Overall Study|Severe non-compliance to protocol|0|||
145469973|NCT01264770|524573354|FG000|Overall Study|Lack of therapeutic response|1|||
145469974|NCT01264770|524573355|FG001|Overall Study|Lack of therapeutic response|0|||
145469975|NCT01264770|524573356|FG002|Overall Study|Lack of therapeutic response|2|||
145469976|NCT01264770|524573357|FG003|Overall Study|Lack of therapeutic response|1|||
145469977|NCT01264770|524573358|FG004|Overall Study|Lack of therapeutic response|1|||
145469978|NCT01264770|524573359|FG005|Overall Study|Lack of therapeutic response|0|||
145469979|NCT01264770|524573354|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
145469980|NCT01264770|524573355|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
145469981|NCT01264770|524573356|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
145469982|NCT01264770|524573357|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
145469983|NCT01264770|524573358|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
145469984|NCT01264770|524573359|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
145469985|NCT01264770|524573354|FG000|Overall Study|Lost to Follow-up|0|||
145469986|NCT01264770|524573355|FG001|Overall Study|Lost to Follow-up|0|||
145469987|NCT01264770|524573356|FG002|Overall Study|Lost to Follow-up|1|||
145469988|NCT01264770|524573357|FG003|Overall Study|Lost to Follow-up|1|||
145469989|NCT01264770|524573358|FG004|Overall Study|Lost to Follow-up|0|||
145469990|NCT01264770|524573359|FG005|Overall Study|Lost to Follow-up|0|||
145469991|NCT01264770|524573354|FG000|Overall Study|Adverse Event|7|||
145469992|NCT01264770|524573355|FG001|Overall Study|Adverse Event|7|||
145469993|NCT01264770|524573356|FG002|Overall Study|Adverse Event|8|||
145469994|NCT01264770|524573357|FG003|Overall Study|Adverse Event|0|||
145469995|NCT01264770|524573358|FG004|Overall Study|Adverse Event|2|||
145469996|NCT01264770|524573359|FG005|Overall Study|Adverse Event|1|||
145469997|NCT02528357|524573360|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145469998|NCT02528357|524573361|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
145469999|NCT02528357|524573362|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470000|NCT02528357|524573363|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470001|NCT02528357|524573364|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470002|NCT02528357|524573365|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470003|NCT02528357|524573366|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470004|NCT02528357|524573367|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470005|NCT02528357|524573368|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470006|NCT02528357|524573369|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470007|NCT02528357|524573370|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470008|NCT02528357|524573371|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470009|NCT02528357|524573372|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470010|NCT02528357|524573373|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470011|NCT02528357|524573374|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470012|NCT02528357|524573375|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470013|NCT02528357|524573376|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470014|NCT02528357|524573377|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470015|NCT02528357|524573378|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
145470016|NCT02528357|524573360|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470017|NCT02528357|524573361|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470018|NCT02528357|524573362|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470019|NCT02528357|524573363|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
145470020|NCT02528357|524573364|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470021|NCT02528357|524573365|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
145470022|NCT02528357|524573366|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470023|NCT02528357|524573367|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
145470024|NCT02528357|524573368|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470025|NCT02528357|524573369|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470026|NCT02528357|524573370|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470027|NCT02528357|524573371|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470028|NCT02528357|524573372|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470029|NCT02528357|524573373|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470030|NCT02528357|524573374|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470031|NCT02528357|524573375|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470032|NCT02528357|524573376|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470033|NCT02528357|524573377|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470034|NCT02528357|524573378|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
145470035|NCT02528357|524573360|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470036|NCT02528357|524573361|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470037|NCT02528357|524573362|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
145470038|NCT02528357|524573363|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470039|NCT02528357|524573364|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
145470040|NCT02528357|524573365|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470041|NCT02528357|524573366|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
145601370|NCT01201811|525054274|FG000|Overall Study|Disease progression|3|||
145601371|NCT01201811|525054274|FG000|Overall Study|Withdrawal by Subject|3|||
145601372|NCT01201811|525054274|FG000|Overall Study|Death|4|||
145601373|NCT01201811|525054274|FG000|Overall Study|Treatment Failure|2|||
145601374|NCT01201811|525054274|FG000|Overall Study|Physician Decision|1|||
145628267|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Adverse Event|0|||
145628268|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Adverse Event|0|||
145628269|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Death|62|||
145628270|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Death|0|||
145628271|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Death|0|||
145628272|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Death|0|||
145628273|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
145628274|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
145628275|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
145628276|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
145628277|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Complicating disease|13|||
145628278|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Complicating disease|0|||
145628279|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Complicating disease|0|||
145628280|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Complicating disease|0|||
145628281|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
145628282|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
145628283|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
145628284|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
145628285|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
145628286|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
145628287|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
145628288|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
145628289|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Non-compliance|4|||
145628290|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Non-compliance|0|||
145628291|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Non-compliance|0|||
145628292|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Non-compliance|0|||
145628293|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Pain|4|||
145628294|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Pain|0|||
145628295|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Pain|0|||
145628296|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Pain|0|||
145628297|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
145628298|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
145628299|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
145628300|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
145628301|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Hospice care|1|||
145628302|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Hospice care|0|||
145628303|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Hospice care|0|||
145628304|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Hospice care|0|||
145628305|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Physician Decision|1|||
145628306|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Physician Decision|0|||
145628307|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Physician Decision|0|||
145628308|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Physician Decision|0|||
145628309|NCT01107626|525153295|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
145628310|NCT01107626|525153296|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
145628311|NCT01107626|525153297|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
145628312|NCT01107626|525153298|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
145628313|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
145628314|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
145628315|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
145628316|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
145628317|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
145628318|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
145628319|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
145628320|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
145628321|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Death|0|||
145628322|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Death|8|||
145628323|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Death|2|||
145628324|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Death|13|||
145628325|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
145628326|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
145628327|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
145628328|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
145628329|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
145628330|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
145628331|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
145628332|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
145628333|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
145628334|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
145628335|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
145628336|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
145628337|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
145470042|NCT02528357|524573367|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
145470043|NCT02528357|524573368|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470044|NCT02528357|524573369|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470045|NCT02528357|524573370|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470046|NCT02528357|524573371|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470047|NCT02528357|524573372|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470048|NCT02528357|524573373|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470049|NCT02528357|524573374|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470050|NCT02528357|524573375|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470051|NCT02528357|524573376|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470052|NCT02528357|524573377|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470053|NCT02528357|524573378|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
145470054|NCT02528357|524573360|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470055|NCT02528357|524573361|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470056|NCT02528357|524573362|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470057|NCT02528357|524573363|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470058|NCT02528357|524573364|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470059|NCT02528357|524573365|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470060|NCT02528357|524573366|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470061|NCT02528357|524573367|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470062|NCT02528357|524573368|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470063|NCT02528357|524573369|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470064|NCT02528357|524573370|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470065|NCT02528357|524573371|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470066|NCT02528357|524573372|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470067|NCT02528357|524573373|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470068|NCT02528357|524573374|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470069|NCT02528357|524573375|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470070|NCT02528357|524573376|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470071|NCT02528357|524573377|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470072|NCT02528357|524573378|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470073|NCT02528357|524573360|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470074|NCT02528357|524573361|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470075|NCT02528357|524573362|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470076|NCT02528357|524573363|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470077|NCT02528357|524573364|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470078|NCT02528357|524573365|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470079|NCT02528357|524573366|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470080|NCT02528357|524573367|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470081|NCT02528357|524573368|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470082|NCT02528357|524573369|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470083|NCT02528357|524573370|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470084|NCT02528357|524573371|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470085|NCT02528357|524573372|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470086|NCT02528357|524573373|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
145470087|NCT02528357|524573374|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
145470088|NCT02528357|524573375|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470089|NCT02528357|524573376|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470090|NCT02528357|524573377|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470091|NCT02528357|524573378|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
145470092|NCT02528357|524573360|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470093|NCT02528357|524573361|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470094|NCT02528357|524573362|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470095|NCT02528357|524573363|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470096|NCT02528357|524573364|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470097|NCT02528357|524573365|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470098|NCT02528357|524573366|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145628338|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
145628339|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
145628340|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
145628341|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
145628342|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
145628343|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
145628344|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
145628345|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
145628346|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
145628347|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
145628348|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
145628349|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
145628350|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
145628351|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
145628352|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
145628353|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
145628354|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
145628355|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
145628356|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
145628357|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
145628358|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
145628359|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
145628360|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
145628361|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
145628362|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
145628363|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
145628364|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
145628365|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Pain|0|||
145628366|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Pain|0|||
145628367|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Pain|0|||
145628368|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Pain|1|||
145628369|NCT01107626|525153295|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
145628370|NCT01107626|525153296|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
145628371|NCT01107626|525153297|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
145628372|NCT01107626|525153298|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
145628373|NCT04310579|525153306|FG000|Overall Study|Adverse Event|0|||
145628374|NCT04310579|525153307|FG001|Overall Study|Adverse Event|0|||
145470099|NCT02528357|524573367|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470100|NCT02528357|524573368|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470101|NCT02528357|524573369|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470102|NCT02528357|524573370|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470103|NCT02528357|524573371|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470104|NCT02528357|524573372|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470105|NCT02528357|524573373|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
145470106|NCT02528357|524573374|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470107|NCT02528357|524573375|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470108|NCT02528357|524573376|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470109|NCT02528357|524573377|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470110|NCT02528357|524573378|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
145470111|NCT02528357|524573360|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470112|NCT02528357|524573361|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470113|NCT02528357|524573362|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470114|NCT02528357|524573363|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470115|NCT02528357|524573364|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470116|NCT02528357|524573365|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470117|NCT02528357|524573366|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470118|NCT02528357|524573367|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470119|NCT02528357|524573368|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470120|NCT02528357|524573369|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470121|NCT02528357|524573370|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
145470122|NCT02528357|524573371|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470123|NCT02528357|524573372|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
145470124|NCT02528357|524573373|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
145470125|NCT02528357|524573374|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
145628375|NCT04310579|525153308|FG002|Overall Study|Adverse Event|0|||
145470126|NCT02528357|524573375|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470127|NCT02528357|524573376|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470128|NCT02528357|524573377|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470129|NCT02528357|524573378|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
145470130|NCT02528357|524573360|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470131|NCT02528357|524573361|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470132|NCT02528357|524573362|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470133|NCT02528357|524573363|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470134|NCT02528357|524573364|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470135|NCT02528357|524573365|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470136|NCT02528357|524573366|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470137|NCT02528357|524573367|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470138|NCT02528357|524573368|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470139|NCT02528357|524573369|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470140|NCT02528357|524573370|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470141|NCT02528357|524573371|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
145470142|NCT02528357|524573372|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
145470143|NCT02528357|524573373|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470144|NCT02528357|524573374|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470145|NCT02528357|524573375|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470146|NCT02528357|524573376|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470147|NCT02528357|524573377|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470148|NCT02528357|524573378|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470149|NCT02528357|524573360|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470150|NCT02528357|524573361|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470151|NCT02528357|524573362|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470152|NCT02528357|524573363|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470153|NCT02528357|524573364|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470154|NCT02528357|524573365|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470155|NCT02528357|524573366|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470156|NCT02528357|524573367|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470157|NCT02528357|524573368|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470158|NCT02528357|524573369|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470159|NCT02528357|524573370|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470160|NCT02528357|524573371|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470161|NCT02528357|524573372|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470162|NCT02528357|524573373|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470163|NCT02528357|524573374|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470164|NCT02528357|524573375|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470165|NCT02528357|524573376|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
145470166|NCT02528357|524573377|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470167|NCT02528357|524573378|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
145470168|NCT02528357|524573360|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470169|NCT02528357|524573361|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470170|NCT02528357|524573362|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470171|NCT02528357|524573363|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470172|NCT02528357|524573364|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470173|NCT02528357|524573365|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470174|NCT02528357|524573366|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470175|NCT02528357|524573367|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470176|NCT02528357|524573368|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145601375|NCT01820559|525054275|FG000|Overall Study|Adverse Event|4|||
145601376|NCT01820559|525054276|FG001|Overall Study|Adverse Event|6|||
145601377|NCT01820559|525054277|FG002|Overall Study|Adverse Event|13|||
145601378|NCT01820559|525054275|FG000|Overall Study|Withdrawal by Subject|1|||
145601379|NCT01820559|525054276|FG001|Overall Study|Withdrawal by Subject|2|||
145470177|NCT02528357|524573369|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470178|NCT02528357|524573370|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470179|NCT02528357|524573371|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470180|NCT02528357|524573372|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470181|NCT02528357|524573373|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470182|NCT02528357|524573374|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470183|NCT02528357|524573375|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
145470184|NCT02528357|524573376|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
145470185|NCT02528357|524573377|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
145470186|NCT02528357|524573378|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
145470187|NCT03869333|524573385|FG000|Overall Study|Lost to Follow-up|1|||
145470188|NCT03869333|524573386|FG001|Overall Study|Lost to Follow-up|0|||
145470189|NCT03869333|524573387|FG002|Overall Study|Lost to Follow-up|0|||
145470190|NCT03869333|524573388|FG003|Overall Study|Lost to Follow-up|0|||
145470191|NCT03869333|524573385|FG000|Overall Study|Pregnancy|1|||
145470192|NCT03869333|524573386|FG001|Overall Study|Pregnancy|0|||
145470193|NCT03869333|524573387|FG002|Overall Study|Pregnancy|0|||
145470194|NCT03869333|524573388|FG003|Overall Study|Pregnancy|0|||
145470195|NCT03869333|524573385|FG000|Overall Study|Physician Decision|0|||
145470196|NCT03869333|524573386|FG001|Overall Study|Physician Decision|1|||
145470197|NCT03869333|524573387|FG002|Overall Study|Physician Decision|0|||
145470198|NCT03869333|524573388|FG003|Overall Study|Physician Decision|0|||
145470199|NCT01927055|524573389|FG000|Open-label|Adverse Event|6|||
145470200|NCT01927055|524573390|FG001|Open-label|Adverse Event|0|||
145470201|NCT01927055|524573391|FG002|Open-label|Adverse Event|0|||
145470202|NCT01927055|524573389|FG000|Open-label|Withdrawal by Subject|1|||
145470203|NCT01927055|524573390|FG001|Open-label|Withdrawal by Subject|0|||
145470204|NCT01927055|524573391|FG002|Open-label|Withdrawal by Subject|0|||
145470205|NCT01927055|524573389|FG000|Open-label|Study Stopped|4|||
145470206|NCT01927055|524573390|FG001|Open-label|Study Stopped|0|||
145470207|NCT01927055|524573391|FG002|Open-label|Study Stopped|0|||
145470208|NCT01927055|524573389|FG000|Open-label|Supine Hypertension|4|||
145470209|NCT01927055|524573390|FG001|Open-label|Supine Hypertension|0|||
145470210|NCT01927055|524573391|FG002|Open-label|Supine Hypertension|0|||
145470211|NCT01927055|524573389|FG000|Open-label|Difficulty attending study visits|1|||
145470212|NCT01927055|524573390|FG001|Open-label|Difficulty attending study visits|0|||
145470213|NCT01927055|524573391|FG002|Open-label|Difficulty attending study visits|0|||
145470214|NCT01927055|524573389|FG000|Double-Blind|Adverse Event|0|||
145470215|NCT01927055|524573390|FG001|Double-Blind|Adverse Event|1|||
145470216|NCT01927055|524573391|FG002|Double-Blind|Adverse Event|1|||
145470217|NCT01927055|524573389|FG000|Double-Blind|Protocol Violation|0|||
145470218|NCT01927055|524573390|FG001|Double-Blind|Protocol Violation|0|||
145470219|NCT01927055|524573391|FG002|Double-Blind|Protocol Violation|1|||
145470220|NCT01927055|524573389|FG000|Double-Blind|Withdrawal by Subject|0|||
145470221|NCT01927055|524573390|FG001|Double-Blind|Withdrawal by Subject|2|||
145470222|NCT01927055|524573391|FG002|Double-Blind|Withdrawal by Subject|3|||
145470223|NCT01927055|524573389|FG000|Double-Blind|Study Stopped|0|||
145470224|NCT01927055|524573390|FG001|Double-Blind|Study Stopped|7|||
145470225|NCT01927055|524573391|FG002|Double-Blind|Study Stopped|7|||
145470226|NCT01927055|524573389|FG000|Double-Blind|Supine Hypertension|0|||
145470227|NCT01927055|524573390|FG001|Double-Blind|Supine Hypertension|0|||
145470228|NCT01927055|524573391|FG002|Double-Blind|Supine Hypertension|1|||
145470229|NCT01927055|524573389|FG000|Double-Blind|Extended Vacation|0|||
145470230|NCT01927055|524573390|FG001|Double-Blind|Extended Vacation|1|||
145470231|NCT01927055|524573391|FG002|Double-Blind|Extended Vacation|0|||
145470232|NCT02598128|524573392|FG000|Period A: Days -7 to -1|Adverse Event|1|||
145470233|NCT02598128|524573393|FG001|Period A: Days -7 to -1|Adverse Event|0|||
145470234|NCT02598128|524573394|FG002|Period A: Days -7 to -1|Adverse Event|0|||
145470235|NCT02598128|524573395|FG003|Period A: Days -7 to -1|Adverse Event|0|||
145470236|NCT01459913|524573396|FG000|Overall Study|Adverse Event|0|||
145470237|NCT01459913|524573397|FG001|Overall Study|Adverse Event|0|||
145628376|NCT04310579|525153309|FG003|Overall Study|Adverse Event|0|||
145470238|NCT01459913|524573398|FG002|Overall Study|Adverse Event|0|||
145470239|NCT01459913|524573399|FG003|Overall Study|Adverse Event|3|||
145470240|NCT01459913|524573396|FG000|Overall Study|Withdrawal by Subject|4|||
145470241|NCT01459913|524573397|FG001|Overall Study|Withdrawal by Subject|0|||
145470242|NCT01459913|524573398|FG002|Overall Study|Withdrawal by Subject|0|||
145470243|NCT01459913|524573399|FG003|Overall Study|Withdrawal by Subject|5|||
145470244|NCT01459913|524573396|FG000|Overall Study|Lost to Follow-up|7|||
145470245|NCT01459913|524573397|FG001|Overall Study|Lost to Follow-up|4|||
145470246|NCT01459913|524573398|FG002|Overall Study|Lost to Follow-up|1|||
145470247|NCT01459913|524573399|FG003|Overall Study|Lost to Follow-up|8|||
145470248|NCT01459913|524573396|FG000|Overall Study|Death|0|||
145470249|NCT01459913|524573397|FG001|Overall Study|Death|0|||
145470250|NCT01459913|524573398|FG002|Overall Study|Death|0|||
145470251|NCT01459913|524573399|FG003|Overall Study|Death|1|||
145470252|NCT01459913|524573396|FG000|Overall Study|Non- Compliance|0|||
145470253|NCT01459913|524573397|FG001|Overall Study|Non- Compliance|0|||
145470254|NCT01459913|524573398|FG002|Overall Study|Non- Compliance|0|||
145470255|NCT01459913|524573399|FG003|Overall Study|Non- Compliance|3|||
145470256|NCT01459913|524573396|FG000|Overall Study|Physician Decision|0|||
145470257|NCT01459913|524573397|FG001|Overall Study|Physician Decision|1|||
145470258|NCT01459913|524573398|FG002|Overall Study|Physician Decision|0|||
145470259|NCT01459913|524573399|FG003|Overall Study|Physician Decision|0|||
145470260|NCT01459913|524573396|FG000|Overall Study|Study Terminated by Sponsor|30|||
145470261|NCT01459913|524573397|FG001|Overall Study|Study Terminated by Sponsor|15|||
145470262|NCT01459913|524573398|FG002|Overall Study|Study Terminated by Sponsor|9|||
145470263|NCT01459913|524573399|FG003|Overall Study|Study Terminated by Sponsor|11|||
145470264|NCT01459913|524573396|FG000|Overall Study|Other|0|||
145470265|NCT01459913|524573397|FG001|Overall Study|Other|0|||
145470266|NCT01459913|524573398|FG002|Overall Study|Other|3|||
145470267|NCT01459913|524573399|FG003|Overall Study|Other|1|||
145470268|NCT01459913|524573396|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
145470269|NCT01459913|524573397|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
145470270|NCT01459913|524573398|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
145470271|NCT01459913|524573399|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
145470272|NCT03134183|524573402|FG000|Overall Study|Withdrawal by Subject|1|||
145470273|NCT03134183|524573403|FG001|Overall Study|Withdrawal by Subject|1|||
145470274|NCT02299076|524573404|FG000|Overall Study|Fraudulent Entries|20|||
145470275|NCT02299076|524573405|FG001|Overall Study|Fraudulent Entries|14|||
145470276|NCT00499746|524573411|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
145470277|NCT00499746|524573411|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
145470278|NCT00499746|524573411|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
145470279|NCT00499746|524573411|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
145470280|NCT01969721|524573412|FG000|Overall Study|Adverse Event|3|||
145470281|NCT01969721|524573413|FG001|Overall Study|Adverse Event|8|||
145470282|NCT01969721|524573414|FG002|Overall Study|Adverse Event|3|||
145470283|NCT01969721|524573415|FG003|Overall Study|Adverse Event|2|||
145470284|NCT01969721|524573412|FG000|Overall Study|Lack of Efficacy|0|||
145470285|NCT01969721|524573413|FG001|Overall Study|Lack of Efficacy|0|||
145470286|NCT01969721|524573414|FG002|Overall Study|Lack of Efficacy|1|||
145470287|NCT01969721|524573415|FG003|Overall Study|Lack of Efficacy|0|||
145470288|NCT01969721|524573412|FG000|Overall Study|Non compliant with protocol|1|||
145470289|NCT01969721|524573413|FG001|Overall Study|Non compliant with protocol|1|||
145470290|NCT01969721|524573414|FG002|Overall Study|Non compliant with protocol|0|||
145470291|NCT01969721|524573415|FG003|Overall Study|Non compliant with protocol|2|||
145470292|NCT01969721|524573412|FG000|Overall Study|Other not defined above|0|||
145470293|NCT01969721|524573413|FG001|Overall Study|Other not defined above|2|||
145470294|NCT01969721|524573414|FG002|Overall Study|Other not defined above|0|||
145470295|NCT01969721|524573415|FG003|Overall Study|Other not defined above|0|||
145470296|NCT01969721|524573412|FG000|Overall Study|Discontinued during washout periods.|0|||
145470297|NCT01969721|524573413|FG001|Overall Study|Discontinued during washout periods.|1|||
145470298|NCT01969721|524573414|FG002|Overall Study|Discontinued during washout periods.|1|||
145470299|NCT01969721|524573415|FG003|Overall Study|Discontinued during washout periods.|2|||
145470300|NCT02383433|524573416|FG000|Overall Study|Disease progression|2|||
145470301|NCT04023682|524573417|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
145470302|NCT01291277|524573418|FG000|Overall Study|Death|2|||
145470303|NCT01291277|524573419|FG001|Overall Study|Death|2|||
145470304|NCT01291277|524573418|FG000|Overall Study|Lost to Follow-up|3|||
145470305|NCT01291277|524573419|FG001|Overall Study|Lost to Follow-up|1|||
145470306|NCT00849108|524573420|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
145470307|NCT00849108|524573421|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
145470308|NCT00849108|524573420|FG000|Cohort 2 Efficacy|Adverse Event|0|||
145470309|NCT00849108|524573421|FG001|Cohort 2 Efficacy|Adverse Event|1|||
145470310|NCT00849108|524573420|FG000|Cohort 2 Efficacy|Other|0|||
145470311|NCT00849108|524573421|FG001|Cohort 2 Efficacy|Other|9|||
145470312|NCT02963701|524573422|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
145470313|NCT02963701|524573423|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
145470314|NCT03480009|524573424|FG000|Overall Study|Lost to Follow-up|4|||
145470315|NCT03480009|524573425|FG001|Overall Study|Lost to Follow-up|5|||
145470316|NCT03480009|524573426|FG002|Overall Study|Lost to Follow-up|4|||
145470317|NCT03480009|524573427|FG003|Overall Study|Lost to Follow-up|0|||
145470318|NCT00896649|524573430|FG000|Overall Study|Physician Decision|1|||
145470319|NCT00896649|524573430|FG000|Overall Study|Pregnancy|1|||
145470320|NCT00896649|524573430|FG000|Overall Study|missing documentation|1|||
145470321|NCT00896649|524573430|FG000|Overall Study|technical difficulties|2|||
145470322|NCT01563172|524573433|FG000|Overall Study|Adverse Event|5|||
145470323|NCT01563172|524573433|FG000|Overall Study|Lost to Follow-up|2|||
145470324|NCT01563172|524573433|FG000|Overall Study|Other (Protocol deviation)|5|||
145470325|NCT01563172|524573433|FG000|Overall Study|Other (Not specified)|1|||
145470326|NCT01555125|524573438|FG000|Induction Period|Lost to Follow-up|0|||
145470327|NCT01555125|524573439|FG001|Induction Period|Lost to Follow-up|2|||
145470328|NCT01555125|524573440|FG002|Induction Period|Lost to Follow-up|0|||
145470329|NCT01555125|524573441|FG003|Induction Period|Lost to Follow-up|0|||
145470330|NCT01555125|524573442|FG004|Induction Period|Lost to Follow-up|0|||
145470331|NCT01555125|524573438|FG000|Induction Period|Adverse Event|0|||
145470332|NCT01555125|524573439|FG001|Induction Period|Adverse Event|1|||
145470333|NCT01555125|524573440|FG002|Induction Period|Adverse Event|0|||
145470334|NCT01555125|524573441|FG003|Induction Period|Adverse Event|0|||
145470335|NCT01555125|524573442|FG004|Induction Period|Adverse Event|1|||
145470336|NCT01555125|524573438|FG000|Induction Period|Subject / guardian decision|0|||
145470337|NCT01555125|524573439|FG001|Induction Period|Subject / guardian decision|0|||
145470338|NCT01555125|524573440|FG002|Induction Period|Subject / guardian decision|0|||
145470339|NCT01555125|524573441|FG003|Induction Period|Subject / guardian decision|0|||
145470340|NCT01555125|524573442|FG004|Induction Period|Subject / guardian decision|2|||
145470341|NCT01555125|524573438|FG000|Induction Period|Death|1|||
145470342|NCT01555125|524573439|FG001|Induction Period|Death|0|||
145470343|NCT01555125|524573440|FG002|Induction Period|Death|0|||
145470344|NCT01555125|524573441|FG003|Induction Period|Death|0|||
145470345|NCT01555125|524573442|FG004|Induction Period|Death|0|||
145470346|NCT01555125|524573438|FG000|Maintenance Period|Adverse Event|1|||
145470347|NCT01555125|524573439|FG001|Maintenance Period|Adverse Event|1|||
145470348|NCT01555125|524573440|FG002|Maintenance Period|Adverse Event|0|||
145470349|NCT01555125|524573441|FG003|Maintenance Period|Adverse Event|0|||
145470350|NCT01555125|524573442|FG004|Maintenance Period|Adverse Event|0|||
145470351|NCT01555125|524573438|FG000|Maintenance Period|Subject / guardian decision|1|||
145470352|NCT01555125|524573439|FG001|Maintenance Period|Subject / guardian decision|2|||
145470353|NCT01555125|524573440|FG002|Maintenance Period|Subject / guardian decision|0|||
145470354|NCT01555125|524573441|FG003|Maintenance Period|Subject / guardian decision|0|||
145470355|NCT01555125|524573442|FG004|Maintenance Period|Subject / guardian decision|0|||
145470356|NCT01555125|524573438|FG000|Maintenance Period|Lost to Follow-up|2|||
145470357|NCT01555125|524573439|FG001|Maintenance Period|Lost to Follow-up|0|||
145470358|NCT01555125|524573440|FG002|Maintenance Period|Lost to Follow-up|0|||
145470359|NCT01555125|524573441|FG003|Maintenance Period|Lost to Follow-up|1|||
145470360|NCT01555125|524573442|FG004|Maintenance Period|Lost to Follow-up|0|||
145470361|NCT01555125|524573438|FG000|Maintenance Period|Lack of Efficacy|6|||
145470362|NCT01555125|524573439|FG001|Maintenance Period|Lack of Efficacy|1|||
145470363|NCT01555125|524573440|FG002|Maintenance Period|Lack of Efficacy|3|||
145470364|NCT01555125|524573441|FG003|Maintenance Period|Lack of Efficacy|0|||
145470365|NCT01555125|524573442|FG004|Maintenance Period|Lack of Efficacy|0|||
145470366|NCT01555125|524573438|FG000|Maintenance Period|Physician Decision|0|||
145470367|NCT01555125|524573439|FG001|Maintenance Period|Physician Decision|0|||
145470368|NCT01555125|524573440|FG002|Maintenance Period|Physician Decision|1|||
145470369|NCT01555125|524573441|FG003|Maintenance Period|Physician Decision|0|||
145470370|NCT01555125|524573442|FG004|Maintenance Period|Physician Decision|0|||
145470371|NCT01555125|524573438|FG000|Maintenance Period|Death|0|||
145470372|NCT01555125|524573439|FG001|Maintenance Period|Death|0|||
145470373|NCT01555125|524573440|FG002|Maintenance Period|Death|0|||
145470374|NCT01555125|524573441|FG003|Maintenance Period|Death|1|||
145470375|NCT01555125|524573442|FG004|Maintenance Period|Death|0|||
145470376|NCT01555125|524573438|FG000|Extension|Adverse Event|1|||
145470377|NCT01555125|524573439|FG001|Extension|Adverse Event|2|||
145470378|NCT01555125|524573440|FG002|Extension|Adverse Event|1|||
145470379|NCT01555125|524573441|FG003|Extension|Adverse Event|1|||
145470380|NCT01555125|524573442|FG004|Extension|Adverse Event|0|||
145470381|NCT01555125|524573438|FG000|Extension|Protocol deviation|1|||
145470382|NCT01555125|524573439|FG001|Extension|Protocol deviation|0|||
145470383|NCT01555125|524573440|FG002|Extension|Protocol deviation|0|||
145470384|NCT01555125|524573441|FG003|Extension|Protocol deviation|0|||
145470385|NCT01555125|524573442|FG004|Extension|Protocol deviation|0|||
145470386|NCT01555125|524573438|FG000|Extension|Lack of Efficacy|7|||
145470387|NCT01555125|524573439|FG001|Extension|Lack of Efficacy|6|||
145470388|NCT01555125|524573440|FG002|Extension|Lack of Efficacy|3|||
145470389|NCT01555125|524573441|FG003|Extension|Lack of Efficacy|0|||
145470390|NCT01555125|524573442|FG004|Extension|Lack of Efficacy|0|||
145470391|NCT01555125|524573438|FG000|Extension|Lost to Follow-up|2|||
145470392|NCT01555125|524573439|FG001|Extension|Lost to Follow-up|1|||
145470393|NCT01555125|524573440|FG002|Extension|Lost to Follow-up|2|||
145470394|NCT01555125|524573441|FG003|Extension|Lost to Follow-up|0|||
145470395|NCT01555125|524573442|FG004|Extension|Lost to Follow-up|0|||
145470396|NCT01555125|524573438|FG000|Extension|Study terminated by sponsor|32|||
145470397|NCT01555125|524573439|FG001|Extension|Study terminated by sponsor|33|||
145470398|NCT01555125|524573440|FG002|Extension|Study terminated by sponsor|16|||
145470399|NCT01555125|524573441|FG003|Extension|Study terminated by sponsor|20|||
145470400|NCT01555125|524573442|FG004|Extension|Study terminated by sponsor|0|||
145470401|NCT01555125|524573438|FG000|Extension|Subject/guardian decision|1|||
145470402|NCT01555125|524573439|FG001|Extension|Subject/guardian decision|9|||
145470403|NCT01555125|524573440|FG002|Extension|Subject/guardian decision|1|||
145628377|NCT04310579|525153310|FG004|Overall Study|Adverse Event|0|||
145470404|NCT01555125|524573441|FG003|Extension|Subject/guardian decision|0|||
145470405|NCT01555125|524573442|FG004|Extension|Subject/guardian decision|0|||
145470406|NCT01555125|524573438|FG000|Extension|Technical Problems|1|||
145470407|NCT01555125|524573439|FG001|Extension|Technical Problems|0|||
145470408|NCT01555125|524573440|FG002|Extension|Technical Problems|0|||
145470409|NCT01555125|524573441|FG003|Extension|Technical Problems|1|||
145470410|NCT01555125|524573442|FG004|Extension|Technical Problems|0|||
145470411|NCT01555125|524573438|FG000|Follow-Up Period|Lost to Follow-up|1|||
145470412|NCT01555125|524573439|FG001|Follow-Up Period|Lost to Follow-up|0|||
145470413|NCT01555125|524573440|FG002|Follow-Up Period|Lost to Follow-up|0|||
145470414|NCT01555125|524573441|FG003|Follow-Up Period|Lost to Follow-up|0|||
145470415|NCT01555125|524573442|FG004|Follow-Up Period|Lost to Follow-up|0|||
145470416|NCT01555125|524573438|FG000|Follow-Up Period|Subject / guardian decision|3|||
145470417|NCT01555125|524573439|FG001|Follow-Up Period|Subject / guardian decision|1|||
145470418|NCT01555125|524573440|FG002|Follow-Up Period|Subject / guardian decision|1|||
145470419|NCT01555125|524573441|FG003|Follow-Up Period|Subject / guardian decision|1|||
145470420|NCT01555125|524573442|FG004|Follow-Up Period|Subject / guardian decision|0|||
145470421|NCT02651220|524573443|FG000|Overall Study|Adverse Event|1|||
145470422|NCT02651220|524573444|FG001|Overall Study|Adverse Event|5|||
145470423|NCT02651220|524573445|FG002|Overall Study|Adverse Event|1|||
145470424|NCT02651220|524573443|FG000|Overall Study|Lost to Follow-up|8|||
145470425|NCT02651220|524573444|FG001|Overall Study|Lost to Follow-up|14|||
145470426|NCT02651220|524573445|FG002|Overall Study|Lost to Follow-up|14|||
145470427|NCT02651220|524573443|FG000|Overall Study|Non-Compliance with Study Drug|4|||
145470428|NCT02651220|524573444|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145470429|NCT02651220|524573445|FG002|Overall Study|Non-Compliance with Study Drug|1|||
145470430|NCT02651220|524573443|FG000|Overall Study|Pregnancy|1|||
145470431|NCT02651220|524573444|FG001|Overall Study|Pregnancy|0|||
145470432|NCT02651220|524573445|FG002|Overall Study|Pregnancy|1|||
145470433|NCT02651220|524573443|FG000|Overall Study|Protocol Violation|0|||
145470434|NCT02651220|524573444|FG001|Overall Study|Protocol Violation|0|||
145470435|NCT02651220|524573445|FG002|Overall Study|Protocol Violation|1|||
145470436|NCT02651220|524573443|FG000|Overall Study|Withdrawal by Subject|5|||
145470437|NCT02651220|524573444|FG001|Overall Study|Withdrawal by Subject|6|||
145470438|NCT02651220|524573445|FG002|Overall Study|Withdrawal by Subject|8|||
145470439|NCT02651220|524573443|FG000|Overall Study|Miscellaneous|4|||
145470440|NCT02651220|524573444|FG001|Overall Study|Miscellaneous|1|||
145470441|NCT02651220|524573445|FG002|Overall Study|Miscellaneous|2|||
145470442|NCT02651220|524573443|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145470443|NCT02651220|524573444|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145470444|NCT02651220|524573445|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
145470445|NCT04268745|524573446|FG000|Overall Study|Lost to Follow-up|2|||
145470446|NCT04268745|524573447|FG001|Overall Study|Lost to Follow-up|3|||
145470447|NCT04268745|524573446|FG000|Overall Study|Withdrawal by Subject|4|||
145470448|NCT04268745|524573447|FG001|Overall Study|Withdrawal by Subject|2|||
145470449|NCT04268745|524573446|FG000|Overall Study|Death in the family|1|||
145470450|NCT04268745|524573447|FG001|Overall Study|Death in the family|0|||
145470451|NCT05327361|524573459|FG000|Overall Study|Lost to Follow-up|4|||
145470452|NCT01216683|524575426|FG000|Induction|Never started treatment|0|||
145470453|NCT01216683|524575427|FG001|Induction|Never started treatment|6|||
145470454|NCT01216683|524575428|FG002|Induction|Never started treatment|3|||
145470455|NCT01216683|524575426|FG000|Induction|Lack of Efficacy|4|||
145470456|NCT01216683|524575427|FG001|Induction|Lack of Efficacy|3|||
145470457|NCT01216683|524575428|FG002|Induction|Lack of Efficacy|7|||
145470458|NCT01216683|524575426|FG000|Induction|Adverse Event|0|||
145470459|NCT01216683|524575427|FG001|Induction|Adverse Event|5|||
145470460|NCT01216683|524575428|FG002|Induction|Adverse Event|5|||
145470461|NCT01216683|524575426|FG000|Induction|Death|0|||
145470462|NCT01216683|524575427|FG001|Induction|Death|0|||
145470463|NCT01216683|524575428|FG002|Induction|Death|2|||
145470464|NCT01216683|524575426|FG000|Induction|Withdrawal by Subject|0|||
145470465|NCT01216683|524575427|FG001|Induction|Withdrawal by Subject|4|||
145628378|NCT04310579|525153311|FG005|Overall Study|Adverse Event|0|||
145628379|NCT04310579|525153312|FG006|Overall Study|Adverse Event|2|||
145628380|NCT04310579|525153313|FG007|Overall Study|Adverse Event|0|||
145628381|NCT04310579|525153314|FG008|Overall Study|Adverse Event|1|||
145470466|NCT01216683|524575428|FG002|Induction|Withdrawal by Subject|2|||
145470467|NCT01216683|524575426|FG000|Induction|Other disease|0|||
145470468|NCT01216683|524575427|FG001|Induction|Other disease|1|||
145470469|NCT01216683|524575428|FG002|Induction|Other disease|2|||
145470470|NCT01216683|524575426|FG000|Continuation|Lack of Efficacy|3|||
145470471|NCT01216683|524575427|FG001|Continuation|Lack of Efficacy|2|||
145470472|NCT01216683|524575428|FG002|Continuation|Lack of Efficacy|7|||
145470473|NCT01216683|524575426|FG000|Continuation|Adverse Event|5|||
145470474|NCT01216683|524575427|FG001|Continuation|Adverse Event|3|||
145470475|NCT01216683|524575428|FG002|Continuation|Adverse Event|16|||
145470476|NCT01216683|524575426|FG000|Continuation|Death|1|||
145470477|NCT01216683|524575427|FG001|Continuation|Death|0|||
145470478|NCT01216683|524575428|FG002|Continuation|Death|2|||
145628382|NCT04310579|525153315|FG009|Overall Study|Adverse Event|1|||
145470479|NCT01216683|524575426|FG000|Continuation|Withdrawal by Subject|4|||
145470480|NCT01216683|524575427|FG001|Continuation|Withdrawal by Subject|5|||
145470481|NCT01216683|524575428|FG002|Continuation|Withdrawal by Subject|9|||
145470482|NCT01216683|524575426|FG000|Continuation|Other diseases|0|||
145470483|NCT01216683|524575427|FG001|Continuation|Other diseases|2|||
145470484|NCT01216683|524575428|FG002|Continuation|Other diseases|1|||
145470485|NCT01216683|524575426|FG000|Continuation|Physician Decision|1|||
145470486|NCT01216683|524575427|FG001|Continuation|Physician Decision|0|||
145470487|NCT01216683|524575428|FG002|Continuation|Physician Decision|1|||
145470488|NCT01216683|524575426|FG000|Continuation|Non-compliance|1|||
145470489|NCT01216683|524575427|FG001|Continuation|Non-compliance|0|||
145470490|NCT01216683|524575428|FG002|Continuation|Non-compliance|1|||
145470491|NCT01216683|524575426|FG000|Continuation|Insurance change|0|||
145470492|NCT01216683|524575427|FG001|Continuation|Insurance change|1|||
145470493|NCT01216683|524575428|FG002|Continuation|Insurance change|0|||
145470494|NCT01216683|524575426|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
145470495|NCT01216683|524575427|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
145470496|NCT01216683|524575428|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
145470497|NCT01216683|524575426|FG000|Continuation|Not reported|0|||
145470498|NCT01216683|524575427|FG001|Continuation|Not reported|0|||
145470499|NCT01216683|524575428|FG002|Continuation|Not reported|1|||
145470500|NCT01216683|524575426|FG000|Continuation|Never started treatment|0|||
145470501|NCT01216683|524575427|FG001|Continuation|Never started treatment|1|||
145470502|NCT01216683|524575428|FG002|Continuation|Never started treatment|5|||
145470503|NCT02720692|524575429|FG000|Overall Study|Withdrawal by Subject|3|||
145470504|NCT02720692|524575430|FG001|Overall Study|Withdrawal by Subject|0|||
145470505|NCT02720692|524575429|FG000|Overall Study|Physician Decision|1|||
145470506|NCT02720692|524575430|FG001|Overall Study|Physician Decision|0|||
145470507|NCT02720692|524575429|FG000|Overall Study|Lost to Follow-up|8|||
145470508|NCT02720692|524575430|FG001|Overall Study|Lost to Follow-up|3|||
145470509|NCT02720692|524575429|FG000|Overall Study|Subject unable to return for visit|1|||
145470510|NCT02720692|524575430|FG001|Overall Study|Subject unable to return for visit|0|||
145470511|NCT02503501|524575431|FG000|Overall Study|Physician Decision|1|||
145470512|NCT02503501|524575432|FG001|Overall Study|Physician Decision|0|||
145470513|NCT02503501|524575431|FG000|Overall Study|Protocol Violation|0|||
145470514|NCT02503501|524575432|FG001|Overall Study|Protocol Violation|1|||
145470515|NCT02503501|524575431|FG000|Overall Study|Withdrawal by Subject|0|||
145470516|NCT02503501|524575432|FG001|Overall Study|Withdrawal by Subject|2|||
145470517|NCT03878758|524575433|FG000|Overall Study|Withdrawal by Subject|1|||
145470518|NCT03878758|524575433|FG000|Overall Study|Protocol defined|2|||
145470519|NCT03878758|524575433|FG000|Overall Study|Improper consent documentation|1|||
145470520|NCT00765063|524575434|FG000|Overall Study|Lack of Efficacy|5|||
145470521|NCT00765063|524575434|FG000|Overall Study|Withdrawal by Subject|1|||
145470522|NCT00765063|524575434|FG000|Overall Study|Other|16|||
145470523|NCT00765063|524575434|FG000|Overall Study|Protocol Violation|6|||
145470524|NCT00765063|524575434|FG000|Overall Study|Adverse Event|4|||
145470525|NCT03614325|524575435|FG000|Overall Study|Withdrawal by Subject|0|||
145470526|NCT03614325|524575436|FG001|Overall Study|Withdrawal by Subject|2|||
145470527|NCT03614325|524575435|FG000|Overall Study|Surgery Cancelled|2|||
145470528|NCT03614325|524575436|FG001|Overall Study|Surgery Cancelled|1|||
145470529|NCT03614325|524575435|FG000|Overall Study|Lost to Follow-up|2|||
145470530|NCT03614325|524575436|FG001|Overall Study|Lost to Follow-up|1|||
145470531|NCT03614325|524575435|FG000|Overall Study|Surgery never scheduled|1|||
145470532|NCT03614325|524575436|FG001|Overall Study|Surgery never scheduled|0|||
145470533|NCT00321464|524575437|FG000|Overall Study|Death|169|||
145470534|NCT00321464|524575438|FG001|Overall Study|Death|174|||
145470535|NCT00321464|524575437|FG000|Overall Study|Disease progression|124|||
145470536|NCT00321464|524575438|FG001|Overall Study|Disease progression|124|||
145470537|NCT00321464|524575437|FG000|Overall Study|Withdrawal by Subject|117|||
145601380|NCT01820559|525054277|FG002|Overall Study|Withdrawal by Subject|5|||
145601381|NCT01820559|525054275|FG000|Overall Study|Protocol Violation|2|||
145601382|NCT01820559|525054276|FG001|Overall Study|Protocol Violation|1|||
145601383|NCT01820559|525054277|FG002|Overall Study|Protocol Violation|3|||
145601384|NCT01820559|525054275|FG000|Overall Study|Subject's non-compliance|1|||
145470538|NCT00321464|524575438|FG001|Overall Study|Withdrawal by Subject|118|||
145470539|NCT00321464|524575437|FG000|Overall Study|Participant request|57|||
145470540|NCT00321464|524575438|FG001|Overall Study|Participant request|61|||
145470541|NCT00321464|524575437|FG000|Overall Study|Adverse Event|43|||
145470542|NCT00321464|524575438|FG001|Overall Study|Adverse Event|28|||
145470543|NCT00321464|524575437|FG000|Overall Study|Physician Decision|15|||
145470544|NCT00321464|524575438|FG001|Overall Study|Physician Decision|14|||
145470545|NCT00321464|524575437|FG000|Overall Study|Noncompliance|4|||
145470546|NCT00321464|524575438|FG001|Overall Study|Noncompliance|10|||
145470547|NCT00321464|524575437|FG000|Overall Study|Lost to Follow-up|7|||
145470548|NCT00321464|524575438|FG001|Overall Study|Lost to Follow-up|8|||
145470549|NCT00321464|524575437|FG000|Overall Study|Protocol deviation|0|||
145470550|NCT00321464|524575438|FG001|Overall Study|Protocol deviation|2|||
145601385|NCT01820559|525054276|FG001|Overall Study|Subject's non-compliance|0|||
145470551|NCT00321464|524575437|FG000|Overall Study|Ineligibility determined|2|||
145470552|NCT00321464|524575438|FG001|Overall Study|Ineligibility determined|1|||
145470553|NCT00321464|524575437|FG000|Overall Study|Other|21|||
145470554|NCT00321464|524575438|FG001|Overall Study|Other|18|||
145470555|NCT02081599|524575439|FG000|Period 1：Double-blind Period|Adverse Event|3|||
145470556|NCT02081599|524575440|FG001|Period 1：Double-blind Period|Adverse Event|0|||
145470557|NCT02081599|524575439|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
145470558|NCT02081599|524575440|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
145470559|NCT02081599|524575439|FG000|Period 1：Double-blind Period|Physician Decision|1|||
145470560|NCT02081599|524575440|FG001|Period 1：Double-blind Period|Physician Decision|0|||
145470561|NCT02081599|524575439|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
145470562|NCT02081599|524575440|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
145470563|NCT02081599|524575439|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
145470564|NCT02081599|524575440|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
145470565|NCT02081599|524575439|FG000|Period 1：Double-blind Period|stopping criteria|1|||
145470566|NCT02081599|524575440|FG001|Period 1：Double-blind Period|stopping criteria|0|||
145470567|NCT02081599|524575439|FG000|Period 2：Open-label Period|Adverse Event|1|||
145470568|NCT02081599|524575440|FG001|Period 2：Open-label Period|Adverse Event|0|||
145470569|NCT02081599|524575439|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
145470570|NCT02081599|524575440|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
145470571|NCT02081599|524575439|FG000|Period 2：Open-label Period|Physician Decision|1|||
145470572|NCT02081599|524575440|FG001|Period 2：Open-label Period|Physician Decision|0|||
145470573|NCT02081599|524575439|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
145470574|NCT02081599|524575440|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
145470575|NCT00306527|524575446|FG000|Overall Study|Lost to Follow-up|3|||
145470576|NCT00306527|524575447|FG001|Overall Study|Lost to Follow-up|4|||
145470577|NCT00306527|524575448|FG002|Overall Study|Lost to Follow-up|3|||
145470578|NCT00306527|524575449|FG003|Overall Study|Lost to Follow-up|0|||
145470579|NCT00306527|524575446|FG000|Overall Study|Withdrawal by Subject|2|||
145470580|NCT00306527|524575447|FG001|Overall Study|Withdrawal by Subject|3|||
145470581|NCT00306527|524575448|FG002|Overall Study|Withdrawal by Subject|0|||
145470582|NCT00306527|524575449|FG003|Overall Study|Withdrawal by Subject|3|||
145470583|NCT00306527|524575446|FG000|Overall Study|Adverse Event|0|||
145470584|NCT00306527|524575447|FG001|Overall Study|Adverse Event|0|||
145470585|NCT00306527|524575448|FG002|Overall Study|Adverse Event|1|||
145470586|NCT00306527|524575449|FG003|Overall Study|Adverse Event|1|||
145470587|NCT00306527|524575446|FG000|Overall Study|Death|1|||
145470588|NCT00306527|524575447|FG001|Overall Study|Death|0|||
145470589|NCT00306527|524575448|FG002|Overall Study|Death|1|||
145470590|NCT00306527|524575449|FG003|Overall Study|Death|2|||
145470591|NCT00785980|524575450|FG000|7 Day Washout Period|Protocol Violation|3|||
145470592|NCT00528801|524575451|FG000|Overall Study|Withdrawal by Subject|1|||
145470593|NCT00528801|524575452|FG001|Overall Study|Withdrawal by Subject|1|||
145470594|NCT00528801|524575451|FG000|Overall Study|Protocol Violation|11|||
145470595|NCT00528801|524575452|FG001|Overall Study|Protocol Violation|5|||
145470596|NCT00528801|524575451|FG000|Overall Study|Lost to Follow-up|15|||
145470597|NCT00528801|524575452|FG001|Overall Study|Lost to Follow-up|4|||
145470598|NCT00528801|524575451|FG000|Overall Study|Administrative Reasons|0|||
145470599|NCT00528801|524575452|FG001|Overall Study|Administrative Reasons|1|||
145470600|NCT02207491|524575453|FG000|Overall Study|Adverse Event|20|||
145470601|NCT02207491|524575454|FG001|Overall Study|Adverse Event|4|||
145470602|NCT02207491|524575453|FG000|Overall Study|Withdrawal by Subject|3|||
145470603|NCT02207491|524575454|FG001|Overall Study|Withdrawal by Subject|2|||
145470604|NCT02207491|524575453|FG000|Overall Study|Non-compliant|0|||
145470605|NCT02207491|524575454|FG001|Overall Study|Non-compliant|1|||
145470606|NCT02207491|524575453|FG000|Overall Study|Lost to Follow-up|0|||
145470607|NCT02207491|524575454|FG001|Overall Study|Lost to Follow-up|1|||
145470608|NCT02207491|524575453|FG000|Overall Study|Lack of Efficacy|3|||
145470609|NCT02207491|524575454|FG001|Overall Study|Lack of Efficacy|0|||
145470610|NCT02207491|524575453|FG000|Overall Study|Physician Decision|2|||
145470611|NCT02207491|524575454|FG001|Overall Study|Physician Decision|0|||
145470612|NCT02207491|524575453|FG000|Overall Study|Protocol Violation|3|||
145470613|NCT02207491|524575454|FG001|Overall Study|Protocol Violation|5|||
145470614|NCT04201093|524575456|FG000|Overall Study|Adverse Event|6|||
145470615|NCT04201093|524575457|FG001|Overall Study|Adverse Event|29|||
145470616|NCT04201093|524575458|FG002|Overall Study|Adverse Event|35|||
145470617|NCT04201093|524575456|FG000|Overall Study|Death|2|||
145470618|NCT04201093|524575457|FG001|Overall Study|Death|1|||
145470619|NCT04201093|524575458|FG002|Overall Study|Death|0|||
145470620|NCT04201093|524575456|FG000|Overall Study|Lack of Efficacy|5|||
145470621|NCT04201093|524575457|FG001|Overall Study|Lack of Efficacy|1|||
145470622|NCT04201093|524575458|FG002|Overall Study|Lack of Efficacy|2|||
145470623|NCT04201093|524575456|FG000|Overall Study|Lost to Follow-up|0|||
145470624|NCT04201093|524575457|FG001|Overall Study|Lost to Follow-up|0|||
145470625|NCT04201093|524575458|FG002|Overall Study|Lost to Follow-up|1|||
145470626|NCT04201093|524575456|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
145601386|NCT01820559|525054277|FG002|Overall Study|Subject's non-compliance|2|||
145470627|NCT04201093|524575457|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
145470628|NCT04201093|524575458|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
145470629|NCT04201093|524575456|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
145470630|NCT04201093|524575457|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
145470631|NCT04201093|524575458|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
145470632|NCT04201093|524575456|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
145470633|NCT04201093|524575457|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
145470634|NCT04201093|524575458|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
145470635|NCT04201093|524575456|FG000|Overall Study|Physician Decision|1|||
145470636|NCT04201093|524575457|FG001|Overall Study|Physician Decision|0|||
145470637|NCT04201093|524575458|FG002|Overall Study|Physician Decision|0|||
145470638|NCT04201093|524575456|FG000|Overall Study|Protocol Deviation|1|||
145470639|NCT04201093|524575457|FG001|Overall Study|Protocol Deviation|0|||
145470640|NCT04201093|524575458|FG002|Overall Study|Protocol Deviation|0|||
145470641|NCT04201093|524575456|FG000|Overall Study|Site Terminated by Sponsor|5|||
145470642|NCT04201093|524575457|FG001|Overall Study|Site Terminated by Sponsor|3|||
145470643|NCT04201093|524575458|FG002|Overall Study|Site Terminated by Sponsor|1|||
145470644|NCT04201093|524575456|FG000|Overall Study|Withdrawal by Subject|7|||
145470645|NCT04201093|524575457|FG001|Overall Study|Withdrawal by Subject|8|||
145470646|NCT04201093|524575458|FG002|Overall Study|Withdrawal by Subject|15|||
145470647|NCT04201093|524575456|FG000|Overall Study|Other|0|||
145470648|NCT04201093|524575457|FG001|Overall Study|Other|1|||
145470649|NCT04201093|524575458|FG002|Overall Study|Other|2|||
145470650|NCT00881504|524575459|FG000|Overall Study|Withdrawal by Subject|1|||
145470651|NCT00007020|524575460|FG000|Overall Study|Death|16|||
145470652|NCT00007020|524575460|FG000|Overall Study|Lost to Follow-up|13|||
145470653|NCT00007020|524575460|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
145470654|NCT00007020|524575460|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
145470655|NCT00007020|524575460|FG000|Overall Study|Pt cared for by outside physician|4|||
145470656|NCT00007020|524575460|FG000|Overall Study|No evidence of treatment|6|||
145470657|NCT01276223|524575461|FG000|Overall Study|Adverse Event|7|||
145470658|NCT01276223|524575462|FG001|Overall Study|Adverse Event|4|||
145470659|NCT01276223|524575463|FG002|Overall Study|Adverse Event|1|||
145470660|NCT01276223|524575461|FG000|Overall Study|Lost to Follow-up|0|||
145470661|NCT01276223|524575462|FG001|Overall Study|Lost to Follow-up|0|||
145470662|NCT01276223|524575463|FG002|Overall Study|Lost to Follow-up|1|||
145470663|NCT01276223|524575461|FG000|Overall Study|Other|0|||
145470664|NCT01276223|524575462|FG001|Overall Study|Other|0|||
145470665|NCT01276223|524575463|FG002|Overall Study|Other|1|||
145470666|NCT01276223|524575461|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
145470667|NCT01276223|524575462|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
145470668|NCT01276223|524575463|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
145470669|NCT01276223|524575461|FG000|Overall Study|Protocol Violation|1|||
145470670|NCT01276223|524575462|FG001|Overall Study|Protocol Violation|0|||
145470671|NCT01276223|524575463|FG002|Overall Study|Protocol Violation|0|||
145470672|NCT02478164|524575464|FG000|Overall Study|Lack of Efficacy|13|||
145470673|NCT02478164|524575464|FG000|Overall Study|Adverse Event|1|||
145470674|NCT02478164|524575464|FG000|Overall Study|Withdrawal by Subject|1|||
145470675|NCT00802893|524575465|FG000|Overall Study|study terminated|3|||
145470676|NCT00320424|524575466|FG000|Overall Study|Adverse Event|3|||
145470677|NCT00320424|524575466|FG000|Overall Study|Other|3|||
145470678|NCT00231413|524575475|FG000|Overall Study|Non-serious AE|0|||
145470679|NCT00231413|524575476|FG001|Overall Study|Non-serious AE|0|||
145601387|NCT01820559|525054275|FG000|Overall Study|Lost to Follow-up|3|||
145601388|NCT01820559|525054276|FG001|Overall Study|Lost to Follow-up|2|||
145601389|NCT01820559|525054277|FG002|Overall Study|Lost to Follow-up|2|||
145601390|NCT01820559|525054275|FG000|Overall Study|At sponsor request|0|||
145601391|NCT01820559|525054276|FG001|Overall Study|At sponsor request|0|||
145601392|NCT01820559|525054277|FG002|Overall Study|At sponsor request|1|||
145470680|NCT00231413|524575477|FG002|Overall Study|Non-serious AE|1|||
145470681|NCT00231413|524575478|FG003|Overall Study|Non-serious AE|0|||
145470682|NCT00231413|524575479|FG004|Overall Study|Non-serious AE|0|||
145470683|NCT00231413|524575480|FG005|Overall Study|Non-serious AE|0|||
145470684|NCT00231413|524575481|FG006|Overall Study|Non-serious AE|1|||
145470685|NCT00231413|524575475|FG000|Overall Study|Withdrawal by Subject|3|||
145470686|NCT00231413|524575476|FG001|Overall Study|Withdrawal by Subject|1|||
145601393|NCT01820559|525054275|FG000|Overall Study|Lack of Efficacy|3|||
145470687|NCT00231413|524575477|FG002|Overall Study|Withdrawal by Subject|4|||
145470688|NCT00231413|524575478|FG003|Overall Study|Withdrawal by Subject|2|||
145470689|NCT00231413|524575479|FG004|Overall Study|Withdrawal by Subject|2|||
145470690|NCT00231413|524575480|FG005|Overall Study|Withdrawal by Subject|0|||
145470691|NCT00231413|524575481|FG006|Overall Study|Withdrawal by Subject|3|||
145470692|NCT00231413|524575475|FG000|Overall Study|Migrated/moved from study area|0|||
145470693|NCT00231413|524575476|FG001|Overall Study|Migrated/moved from study area|0|||
145470694|NCT00231413|524575477|FG002|Overall Study|Migrated/moved from study area|1|||
145470695|NCT00231413|524575478|FG003|Overall Study|Migrated/moved from study area|0|||
145601394|NCT01820559|525054276|FG001|Overall Study|Lack of Efficacy|2|||
145470696|NCT00231413|524575479|FG004|Overall Study|Migrated/moved from study area|0|||
145470697|NCT00231413|524575480|FG005|Overall Study|Migrated/moved from study area|1|||
145470698|NCT00231413|524575481|FG006|Overall Study|Migrated/moved from study area|0|||
145470699|NCT00231413|524575475|FG000|Overall Study|Lost to Follow-up|4|||
145470700|NCT00231413|524575476|FG001|Overall Study|Lost to Follow-up|4|||
145470701|NCT00231413|524575477|FG002|Overall Study|Lost to Follow-up|1|||
145470702|NCT00231413|524575478|FG003|Overall Study|Lost to Follow-up|1|||
145470703|NCT00231413|524575479|FG004|Overall Study|Lost to Follow-up|1|||
145470704|NCT00231413|524575480|FG005|Overall Study|Lost to Follow-up|4|||
145470705|NCT00231413|524575481|FG006|Overall Study|Lost to Follow-up|0|||
145470706|NCT00231413|524575475|FG000|Overall Study|Pregnancy|1|||
145470707|NCT00231413|524575476|FG001|Overall Study|Pregnancy|0|||
145470708|NCT00231413|524575477|FG002|Overall Study|Pregnancy|0|||
145470709|NCT00231413|524575478|FG003|Overall Study|Pregnancy|0|||
145470710|NCT00231413|524575479|FG004|Overall Study|Pregnancy|0|||
145470711|NCT00231413|524575480|FG005|Overall Study|Pregnancy|0|||
145470712|NCT00231413|524575481|FG006|Overall Study|Pregnancy|0|||
145470713|NCT03316950|524575482|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
145470714|NCT03316950|524575483|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
145470715|NCT03316950|524575484|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
145470716|NCT03316950|524575485|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
145470717|NCT03316950|524575482|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
145470718|NCT03316950|524575483|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
145470719|NCT03316950|524575484|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
145470720|NCT03316950|524575485|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
145470721|NCT03316950|524575482|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
145470722|NCT03316950|524575483|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
145470723|NCT03316950|524575484|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
145470724|NCT03316950|524575485|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
145470725|NCT02565810|524575486|FG000|Overall Study|Withdrawal by Subject|1|||
145470726|NCT05086510|524575489|FG000|Overall Study|Lost to Follow-up|0|||
145470727|NCT05086510|524575490|FG001|Overall Study|Lost to Follow-up|2|||
145470728|NCT05086510|524575489|FG000|Overall Study|Death|0|||
145470729|NCT05086510|524575490|FG001|Overall Study|Death|2|||
145470730|NCT00413374|524575491|FG000|Overall Study|Ineligible due to screening criteria.|3|||
145470731|NCT00413374|524575492|FG001|Overall Study|Ineligible due to screening criteria.|0|||
145470732|NCT00413374|524575491|FG000|Overall Study|Adverse Event|1|||
145470733|NCT00413374|524575492|FG001|Overall Study|Adverse Event|0|||
145470734|NCT00413374|524575491|FG000|Overall Study|Lost to Follow-up|1|||
145470735|NCT00413374|524575492|FG001|Overall Study|Lost to Follow-up|0|||
145470736|NCT00413374|524575491|FG000|Overall Study|Surgery|1|||
145470737|NCT00413374|524575492|FG001|Overall Study|Surgery|0|||
145470738|NCT00552760|524575493|FG000|Overall Study|Adverse Event|3|||
145470739|NCT00552760|524575494|FG001|Overall Study|Adverse Event|5|||
145470740|NCT00552760|524575493|FG000|Overall Study|Relapsed- Depressed Event|10|||
145470741|NCT00552760|524575494|FG001|Overall Study|Relapsed- Depressed Event|16|||
145470742|NCT00552760|524575493|FG000|Overall Study|Relapse- Manic Event|3|||
145470743|NCT00552760|524575494|FG001|Overall Study|Relapse- Manic Event|3|||
145470744|NCT00552760|524575493|FG000|Overall Study|Relapsed- Mixed Event|3|||
145470745|NCT00552760|524575494|FG001|Overall Study|Relapsed- Mixed Event|5|||
145470746|NCT00552760|524575493|FG000|Overall Study|Protocol Violation|0|||
145470747|NCT00552760|524575494|FG001|Overall Study|Protocol Violation|1|||
145470748|NCT00552760|524575493|FG000|Overall Study|Lost to Follow-up|1|||
145470749|NCT00552760|524575494|FG001|Overall Study|Lost to Follow-up|1|||
145470750|NCT00552760|524575493|FG000|Overall Study|Non-compliance|1|||
145470751|NCT00552760|524575494|FG001|Overall Study|Non-compliance|1|||
145470752|NCT00552760|524575493|FG000|Overall Study|Medical Condition|1|||
145470753|NCT00552760|524575494|FG001|Overall Study|Medical Condition|1|||
145470754|NCT00552760|524575493|FG000|Overall Study|Withdrawal by Subject|3|||
145470755|NCT00552760|524575494|FG001|Overall Study|Withdrawal by Subject|0|||
145628383|NCT04310579|525153316|FG010|Overall Study|Adverse Event|0|||
145628384|NCT04310579|525153306|FG000|Overall Study|Withdrawal by Subject|0|||
145628385|NCT04310579|525153307|FG001|Overall Study|Withdrawal by Subject|0|||
145470756|NCT00552760|524575493|FG000|Overall Study|Medication Change|1|||
145470757|NCT00552760|524575494|FG001|Overall Study|Medication Change|0|||
145470758|NCT03022981|524575495|FG000|Overall Study|Adverse Event|0|||
145470759|NCT03022981|524575496|FG001|Overall Study|Adverse Event|1|||
145470760|NCT03022981|524575497|FG002|Overall Study|Adverse Event|0|||
145470761|NCT03022981|524575495|FG000|Overall Study|Investigator's Discretion|0|||
145470762|NCT03022981|524575496|FG001|Overall Study|Investigator's Discretion|1|||
145470763|NCT03022981|524575497|FG002|Overall Study|Investigator's Discretion|2|||
145470764|NCT03022981|524575495|FG000|Overall Study|Lost to Follow-up|6|||
145628386|NCT04310579|525153308|FG002|Overall Study|Withdrawal by Subject|0|||
145470765|NCT03022981|524575496|FG001|Overall Study|Lost to Follow-up|2|||
145470766|NCT03022981|524575497|FG002|Overall Study|Lost to Follow-up|1|||
145470767|NCT03022981|524575495|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145470768|NCT03022981|524575496|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145470769|NCT03022981|524575497|FG002|Overall Study|Non-Compliance With Study Drug|2|||
145470770|NCT03022981|524575495|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
145470771|NCT03022981|524575496|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
145470772|NCT03022981|524575497|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
145470773|NCT03615066|524575499|FG000|Main Study|Withdrew Consent|0|||
145470774|NCT03615066|524575500|FG001|Main Study|Withdrew Consent|1|||
145470775|NCT03615066|524575501|FG002|Main Study|Withdrew Consent|1|||
145470776|NCT03615066|524575499|FG000|Main Study|Lost to Follow-up|0|||
145470777|NCT03615066|524575500|FG001|Main Study|Lost to Follow-up|0|||
145470778|NCT03615066|524575501|FG002|Main Study|Lost to Follow-up|1|||
145470779|NCT03615066|524575499|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
145470780|NCT03615066|524575500|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
145470781|NCT03615066|524575501|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
145470782|NCT03615066|524575499|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
145470783|NCT03615066|524575500|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
145470784|NCT03615066|524575501|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
145470785|NCT03615066|524575499|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
145470786|NCT03615066|524575500|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
145470787|NCT03615066|524575501|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
145470788|NCT00924404|524575502|FG000|Overall Study|Lost to Follow-up|6|||
145470789|NCT00924404|524575503|FG001|Overall Study|Lost to Follow-up|4|||
145470790|NCT02437084|524575504|FG000|Overall Study|Withdrawal by Subject|2|||
145470791|NCT02437084|524575504|FG000|Overall Study|Physician Decision|1|||
145470792|NCT03691779|524575507|FG000|Part B (24 Weeks)|Adverse Event|0|||
145470793|NCT03691779|524575508|FG001|Part B (24 Weeks)|Adverse Event|1|||
145470794|NCT03691779|524575507|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
145470795|NCT03691779|524575508|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
145470796|NCT01561963|524575509|FG000|Overall Study|Adverse Event|1|||
145470797|NCT01064687|524575511|FG000|Overall Study|Adverse Event|9|||
145470798|NCT01064687|524575512|FG001|Overall Study|Adverse Event|4|||
145470799|NCT01064687|524575513|FG002|Overall Study|Adverse Event|10|||
145470800|NCT01064687|524575514|FG003|Overall Study|Adverse Event|3|||
145470801|NCT01064687|524575511|FG000|Overall Study|Death|1|||
145470802|NCT01064687|524575512|FG001|Overall Study|Death|1|||
145470803|NCT01064687|524575513|FG002|Overall Study|Death|0|||
145470804|NCT01064687|524575514|FG003|Overall Study|Death|0|||
145470805|NCT01064687|524575511|FG000|Overall Study|Entry Criteria Not Met|3|||
145470806|NCT01064687|524575512|FG001|Overall Study|Entry Criteria Not Met|0|||
145470807|NCT01064687|524575513|FG002|Overall Study|Entry Criteria Not Met|0|||
145470808|NCT01064687|524575514|FG003|Overall Study|Entry Criteria Not Met|0|||
145470809|NCT01064687|524575511|FG000|Overall Study|Lack of Efficacy|1|||
145470810|NCT01064687|524575512|FG001|Overall Study|Lack of Efficacy|0|||
145470811|NCT01064687|524575513|FG002|Overall Study|Lack of Efficacy|2|||
145470812|NCT01064687|524575514|FG003|Overall Study|Lack of Efficacy|3|||
145470813|NCT01064687|524575511|FG000|Overall Study|Lost to Follow-up|7|||
145470814|NCT01064687|524575512|FG001|Overall Study|Lost to Follow-up|10|||
145470815|NCT01064687|524575513|FG002|Overall Study|Lost to Follow-up|13|||
145470816|NCT01064687|524575514|FG003|Overall Study|Lost to Follow-up|5|||
145470817|NCT01064687|524575511|FG000|Overall Study|Physician Decision|2|||
145470818|NCT01064687|524575512|FG001|Overall Study|Physician Decision|2|||
145470819|NCT01064687|524575513|FG002|Overall Study|Physician Decision|0|||
145470820|NCT01064687|524575514|FG003|Overall Study|Physician Decision|0|||
145470821|NCT01064687|524575511|FG000|Overall Study|Protocol Violation|1|||
145470822|NCT01064687|524575512|FG001|Overall Study|Protocol Violation|1|||
145628387|NCT04310579|525153309|FG003|Overall Study|Withdrawal by Subject|0|||
145628388|NCT04310579|525153310|FG004|Overall Study|Withdrawal by Subject|0|||
145628389|NCT04310579|525153311|FG005|Overall Study|Withdrawal by Subject|1|||
145628390|NCT04310579|525153312|FG006|Overall Study|Withdrawal by Subject|0|||
145628391|NCT04310579|525153313|FG007|Overall Study|Withdrawal by Subject|0|||
145470823|NCT01064687|524575513|FG002|Overall Study|Protocol Violation|0|||
145628392|NCT04310579|525153314|FG008|Overall Study|Withdrawal by Subject|0|||
145470824|NCT01064687|524575514|FG003|Overall Study|Protocol Violation|1|||
145470825|NCT01064687|524575511|FG000|Overall Study|Sponsor Decision|0|||
145470826|NCT01064687|524575512|FG001|Overall Study|Sponsor Decision|0|||
145470827|NCT01064687|524575513|FG002|Overall Study|Sponsor Decision|3|||
145470828|NCT01064687|524575514|FG003|Overall Study|Sponsor Decision|0|||
145470829|NCT01064687|524575511|FG000|Overall Study|Withdrawal by Subject|9|||
145470830|NCT01064687|524575512|FG001|Overall Study|Withdrawal by Subject|7|||
145470831|NCT01064687|524575513|FG002|Overall Study|Withdrawal by Subject|12|||
145470832|NCT01064687|524575514|FG003|Overall Study|Withdrawal by Subject|5|||
145470833|NCT01064687|524575511|FG000|Overall Study|Treatment Noncompliance|1|||
145470834|NCT01064687|524575512|FG001|Overall Study|Treatment Noncompliance|1|||
145628393|NCT04310579|525153315|FG009|Overall Study|Withdrawal by Subject|0|||
145470835|NCT01064687|524575513|FG002|Overall Study|Treatment Noncompliance|1|||
145470836|NCT01064687|524575514|FG003|Overall Study|Treatment Noncompliance|0|||
145470837|NCT00845065|524575517|FG000|Overall Study|Adverse Event|3|||
145470838|NCT00845065|524575518|FG001|Overall Study|Adverse Event|23|||
145470839|NCT00845065|524575517|FG000|Overall Study|Lack of Efficacy|43|||
145470840|NCT00845065|524575518|FG001|Overall Study|Lack of Efficacy|21|||
145470841|NCT00845065|524575517|FG000|Overall Study|Non-Medical Reasons|1|||
145470842|NCT00845065|524575518|FG001|Overall Study|Non-Medical Reasons|11|||
145470843|NCT01198509|524575519|FG000|Overall Study|Withdrawal by Subject|1|||
145470844|NCT01198509|524575520|FG001|Overall Study|Withdrawal by Subject|0|||
145470845|NCT01198509|524575521|FG002|Overall Study|Withdrawal by Subject|0|||
145470846|NCT01198509|524575522|FG003|Overall Study|Withdrawal by Subject|0|||
145470847|NCT01198509|524575523|FG004|Overall Study|Withdrawal by Subject|0|||
145470848|NCT01198509|524575524|FG005|Overall Study|Withdrawal by Subject|0|||
145470849|NCT02228096|524575528|FG000|Overall Study|Study terminated by Sponsor|24|||
145470850|NCT02228096|524575528|FG000|Overall Study|Lack of Efficacy|18|||
145470851|NCT02228096|524575528|FG000|Overall Study|Death|12|||
145470852|NCT02228096|524575528|FG000|Overall Study|Physician Decision|3|||
145470853|NCT02228096|524575528|FG000|Overall Study|Subject/guardian decision|2|||
145470854|NCT02228096|524575528|FG000|Overall Study|New therapy for study indication|1|||
145470855|NCT02228096|524575528|FG000|Overall Study|Enrolled, not infused|11|||
145470856|NCT04311463|524575533|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
145470857|NCT04311463|524575534|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
145470858|NCT04311463|524575533|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
145470859|NCT04311463|524575534|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
145470860|NCT04311463|524575533|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
145470861|NCT04311463|524575534|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
145470862|NCT00952614|524575535|FG000|Overall Study|Death|3|||
145470863|NCT00952614|524575535|FG000|Overall Study|Lost to Follow-up|3|||
145470864|NCT00952614|524575535|FG000|Overall Study|other reason|1|||
145470865|NCT03180307|524575547|FG000|Overall Study|Lost to Follow-up|2|||
145470866|NCT03180307|524575548|FG001|Overall Study|Lost to Follow-up|0|||
145470867|NCT03180307|524575547|FG000|Overall Study|Death|1|||
145470868|NCT03180307|524575548|FG001|Overall Study|Death|0|||
145470869|NCT03180307|524575547|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
145470870|NCT03180307|524575548|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
145470871|NCT02986854|524575550|FG000|Overall Study|Withdrawal by Subject|0|||
145470872|NCT02986854|524575551|FG001|Overall Study|Withdrawal by Subject|1|||
145470873|NCT02986854|524575552|FG002|Overall Study|Withdrawal by Subject|1|||
145470874|NCT02986854|524575550|FG000|Overall Study|Lost to Follow-up|3|||
145470875|NCT02986854|524575551|FG001|Overall Study|Lost to Follow-up|11|||
145470876|NCT02986854|524575552|FG002|Overall Study|Lost to Follow-up|2|||
145470877|NCT00718770|524575553|FG000|Overall Study|Adverse Event|1|||
145470878|NCT00718770|524575553|FG000|Overall Study|Lack of Efficacy|1|||
145470879|NCT00718770|524575553|FG000|Overall Study|Lack of Efficacy|1|||
145470880|NCT00718770|524575553|FG000|Overall Study|Adverse Event|1|||
145470881|NCT00718770|524575553|FG000|Overall Study|Lack of Efficacy|1|||
145470882|NCT00718770|524575553|FG000|Overall Study|Adverse Event|1|||
145470883|NCT00718770|524575553|FG000|Overall Study|Lack of Efficacy|1|||
145470884|NCT00718770|524575553|FG000|Overall Study|Adverse Event|1|||
145470885|NCT00772109|524575557|FG000|Overall Study|Serious adverse event|1|||
145470886|NCT00772109|524575558|FG001|Overall Study|Serious adverse event|0|||
145470887|NCT00772109|524575559|FG002|Overall Study|Serious adverse event|1|||
145470888|NCT00772109|524575560|FG003|Overall Study|Serious adverse event|0|||
145470889|NCT00772109|524575557|FG000|Overall Study|Protocol Violation|5|||
145628394|NCT04310579|525153316|FG010|Overall Study|Withdrawal by Subject|0|||
145470890|NCT00772109|524575558|FG001|Overall Study|Protocol Violation|8|||
145470891|NCT00772109|524575559|FG002|Overall Study|Protocol Violation|7|||
145470892|NCT00772109|524575560|FG003|Overall Study|Protocol Violation|6|||
145470893|NCT00772109|524575557|FG000|Overall Study|Lost to Follow-up|7|||
145470894|NCT00772109|524575558|FG001|Overall Study|Lost to Follow-up|3|||
145470895|NCT00772109|524575559|FG002|Overall Study|Lost to Follow-up|5|||
145470896|NCT00772109|524575560|FG003|Overall Study|Lost to Follow-up|9|||
145470897|NCT00772109|524575557|FG000|Overall Study|Withdrawal by Subject|8|||
145470898|NCT00772109|524575558|FG001|Overall Study|Withdrawal by Subject|8|||
145470899|NCT00772109|524575559|FG002|Overall Study|Withdrawal by Subject|6|||
145470900|NCT00772109|524575560|FG003|Overall Study|Withdrawal by Subject|16|||
145470901|NCT01624090|524575561|FG000|Overall Study|DLT, taken off therapy|0|||
145470902|NCT01624090|524575562|FG001|Overall Study|DLT, taken off therapy|1|||
145470903|NCT01624090|524575563|FG002|Overall Study|DLT, taken off therapy|0|||
145628395|NCT04310579|525153306|FG000|Overall Study|Positive COVID-19 test|0|||
145470904|NCT01624090|524575564|FG003|Overall Study|DLT, taken off therapy|0|||
145470905|NCT01624090|524575561|FG000|Overall Study|Withdrew prior to treatment|0|||
145470906|NCT01624090|524575562|FG001|Overall Study|Withdrew prior to treatment|1|||
145470907|NCT01624090|524575563|FG002|Overall Study|Withdrew prior to treatment|0|||
145470908|NCT01624090|524575564|FG003|Overall Study|Withdrew prior to treatment|0|||
145470909|NCT01624090|524575561|FG000|Overall Study|Died on study|0|||
145470910|NCT01624090|524575562|FG001|Overall Study|Died on study|0|||
145470911|NCT01624090|524575563|FG002|Overall Study|Died on study|2|||
145470912|NCT01624090|524575564|FG003|Overall Study|Died on study|0|||
145470913|NCT01624090|524575561|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
145470914|NCT01624090|524575562|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
145470915|NCT01624090|524575563|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
145470916|NCT01624090|524575564|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
145470917|NCT01624090|524575561|FG000|Overall Study|Dose escalated|0|||
145470918|NCT01624090|524575562|FG001|Overall Study|Dose escalated|0|||
145470919|NCT01624090|524575563|FG002|Overall Study|Dose escalated|3|||
145470920|NCT01624090|524575564|FG003|Overall Study|Dose escalated|0|||
145470921|NCT02039856|524575565|FG000|Overall Study|Death|5|||
145470922|NCT02039856|524575566|FG001|Overall Study|Death|3|||
145470923|NCT02039856|524575565|FG000|Overall Study|Partial survey completion|61|||
145470924|NCT02039856|524575566|FG001|Overall Study|Partial survey completion|26|||
145470925|NCT02039856|524575565|FG000|Overall Study|Lost to Follow-up|388|||
145470926|NCT02039856|524575566|FG001|Overall Study|Lost to Follow-up|206|||
145470927|NCT02039856|524575565|FG000|Overall Study|Withdrawal by Subject|1573|||
145470928|NCT02039856|524575566|FG001|Overall Study|Withdrawal by Subject|618|||
145470929|NCT02540291|524575567|FG000|Overall Study|Death|7|||
145470930|NCT02540291|524575568|FG001|Overall Study|Death|7|||
145470931|NCT02540291|524575569|FG002|Overall Study|Death|5|||
145470932|NCT02540291|524575570|FG003|Overall Study|Death|7|||
145470933|NCT02540291|524575567|FG000|Overall Study|Lost to Follow-up|0|||
145470934|NCT02540291|524575568|FG001|Overall Study|Lost to Follow-up|0|||
145470935|NCT02540291|524575569|FG002|Overall Study|Lost to Follow-up|1|||
145470936|NCT02540291|524575570|FG003|Overall Study|Lost to Follow-up|0|||
145470937|NCT02540291|524575567|FG000|Overall Study|Withdrawal Of Consent|0|||
145470938|NCT02540291|524575568|FG001|Overall Study|Withdrawal Of Consent|1|||
145470939|NCT02540291|524575569|FG002|Overall Study|Withdrawal Of Consent|0|||
145470940|NCT02540291|524575570|FG003|Overall Study|Withdrawal Of Consent|0|||
145470941|NCT02540291|524575567|FG000|Overall Study|Study Terminated By Sponsor|1|||
145470942|NCT02540291|524575568|FG001|Overall Study|Study Terminated By Sponsor|0|||
145470943|NCT02540291|524575569|FG002|Overall Study|Study Terminated By Sponsor|0|||
145470944|NCT02540291|524575570|FG003|Overall Study|Study Terminated By Sponsor|0|||
145470945|NCT02540291|524575567|FG000|Overall Study|Other|0|||
145470946|NCT02540291|524575568|FG001|Overall Study|Other|0|||
145470947|NCT02540291|524575569|FG002|Overall Study|Other|1|||
145470948|NCT02540291|524575570|FG003|Overall Study|Other|0|||
145470949|NCT02666105|524575580|FG000|Overall Study|Death|1|||
145470950|NCT01740401|524577857|FG000|Overall Study|Progression of disease|6|||
145470951|NCT01740401|524577857|FG000|Overall Study|Adverse Event|2|||
145470952|NCT01740401|524577857|FG000|Overall Study|Did not reach primary endpoint|2|||
145470953|NCT02806960|524577858|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
145470954|NCT02806960|524577859|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
145628396|NCT04310579|525153307|FG001|Overall Study|Positive COVID-19 test|0|||
145628397|NCT04310579|525153308|FG002|Overall Study|Positive COVID-19 test|0|||
145628398|NCT04310579|525153309|FG003|Overall Study|Positive COVID-19 test|0|||
145628399|NCT04310579|525153310|FG004|Overall Study|Positive COVID-19 test|0|||
145628400|NCT04310579|525153311|FG005|Overall Study|Positive COVID-19 test|0|||
145628401|NCT04310579|525153312|FG006|Overall Study|Positive COVID-19 test|0|||
145628402|NCT04310579|525153313|FG007|Overall Study|Positive COVID-19 test|0|||
145628403|NCT04310579|525153314|FG008|Overall Study|Positive COVID-19 test|0|||
145628404|NCT04310579|525153315|FG009|Overall Study|Positive COVID-19 test|0|||
145628405|NCT04310579|525153316|FG010|Overall Study|Positive COVID-19 test|1|||
145628406|NCT03467724|525153317|FG000|Overall Study|Lost to Follow-up|5|||
145628407|NCT03467724|525153317|FG000|Overall Study|Withdrawal by Subject|1|||
145628408|NCT03467724|525153317|FG000|Overall Study|Protocol Violation|1|||
145628409|NCT03467724|525153317|FG000|Overall Study|Adverse Event|1|||
145628410|NCT02236559|525153321|FG000|Overall Study|Met Exclusion|3|||
145628411|NCT02236559|525153322|FG001|Overall Study|Met Exclusion|6|||
145628412|NCT02236559|525153321|FG000|Overall Study|Did not Meet Inclusion|3|||
145628413|NCT02236559|525153322|FG001|Overall Study|Did not Meet Inclusion|3|||
145628414|NCT02236559|525153321|FG000|Overall Study|Subject Did Not Consent|4|||
145470955|NCT02806960|524577860|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
145470956|NCT02806960|524577861|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
145470957|NCT01769196|524577862|FG000|Overall Study|Adverse Event|24|||
145470958|NCT01769196|524577863|FG001|Overall Study|Adverse Event|20|||
145470959|NCT01769196|524577862|FG000|Overall Study|Death|21|||
145470960|NCT01769196|524577863|FG001|Overall Study|Death|26|||
145628415|NCT02236559|525153322|FG001|Overall Study|Subject Did Not Consent|2|||
145470961|NCT01769196|524577862|FG000|Overall Study|Investigator Discretion|7|||
145470962|NCT01769196|524577863|FG001|Overall Study|Investigator Discretion|3|||
145470963|NCT01769196|524577862|FG000|Overall Study|Lack of Efficacy|3|||
145470964|NCT01769196|524577863|FG001|Overall Study|Lack of Efficacy|2|||
145628416|NCT02236559|525153321|FG000|Overall Study|Physician Decision|1|||
145628417|NCT02236559|525153322|FG001|Overall Study|Physician Decision|1|||
145470965|NCT01769196|524577862|FG000|Overall Study|Progressive disease|11|||
145470966|NCT01769196|524577863|FG001|Overall Study|Progressive disease|6|||
145470967|NCT01769196|524577862|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
145470968|NCT01769196|524577863|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
145470969|NCT01769196|524577862|FG000|Overall Study|Protocol Violation|0|||
145470970|NCT01769196|524577863|FG001|Overall Study|Protocol Violation|3|||
145470971|NCT01769196|524577862|FG000|Overall Study|Study terminated by sponsor|160|||
145470972|NCT01769196|524577863|FG001|Overall Study|Study terminated by sponsor|161|||
145470973|NCT01769196|524577862|FG000|Overall Study|Participant never dosed with study drug|1|||
145470974|NCT01769196|524577863|FG001|Overall Study|Participant never dosed with study drug|0|||
145470975|NCT01769196|524577862|FG000|Overall Study|Withdrew consent|36|||
145470976|NCT01769196|524577863|FG001|Overall Study|Withdrew consent|40|||
145470977|NCT01673620|524577864|FG000|Overall Study|Adverse Event|1|||
145470978|NCT01673620|524577865|FG001|Overall Study|Adverse Event|0|||
145470979|NCT01206582|524577866|FG000|Overall Study|Withdrew prior to study|1|||
145470980|NCT01206582|524577867|FG001|Overall Study|Withdrew prior to study|0|||
145470981|NCT01206582|524577866|FG000|Overall Study|Discontinued intervention before week 8|1|||
145470982|NCT01206582|524577867|FG001|Overall Study|Discontinued intervention before week 8|2|||
145470983|NCT02522325|524577868|FG000|Overall Study|Adverse Event|0|||
145470984|NCT02522325|524577869|FG001|Overall Study|Adverse Event|1|||
145470985|NCT00387725|524577872|FG000|Overall Study|Adverse Event|0|||
145470986|NCT00387725|524577873|FG001|Overall Study|Adverse Event|0|||
145470987|NCT00387725|524577874|FG002|Overall Study|Adverse Event|0|||
145470988|NCT00387725|524577875|FG003|Overall Study|Adverse Event|1|||
145470989|NCT00387725|524577872|FG000|Overall Study|Protocol Violation|0|||
145470990|NCT00387725|524577873|FG001|Overall Study|Protocol Violation|1|||
145470991|NCT00387725|524577874|FG002|Overall Study|Protocol Violation|0|||
145470992|NCT00387725|524577875|FG003|Overall Study|Protocol Violation|0|||
145470993|NCT00387725|524577872|FG000|Overall Study|Withdrawal by Subject|1|||
145470994|NCT00387725|524577873|FG001|Overall Study|Withdrawal by Subject|0|||
145470995|NCT00387725|524577874|FG002|Overall Study|Withdrawal by Subject|1|||
145470996|NCT00387725|524577875|FG003|Overall Study|Withdrawal by Subject|0|||
145470997|NCT00387725|524577872|FG000|Overall Study|Parent/legal guardian request|0|||
145470998|NCT00387725|524577873|FG001|Overall Study|Parent/legal guardian request|0|||
145470999|NCT00387725|524577874|FG002|Overall Study|Parent/legal guardian request|1|||
145471000|NCT00387725|524577875|FG003|Overall Study|Parent/legal guardian request|1|||
145471001|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
145471002|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
145471003|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
145471004|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
145471005|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
145471006|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
145471007|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
145471008|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
145471009|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
145471010|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
145471011|NCT02429791|524577876|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
145471012|NCT02429791|524577877|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
145471013|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
145471014|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
145471015|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
145471016|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
145471017|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
145471018|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
145471019|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
145471020|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
145471021|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
145471022|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
145471023|NCT02429791|524577876|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
145471024|NCT02429791|524577877|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
145471025|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
145471026|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
145471027|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
145601395|NCT01820559|525054277|FG002|Overall Study|Lack of Efficacy|3|||
145471028|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
145471029|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
145471030|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
145471031|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
145471032|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
145471033|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
145471034|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
145601396|NCT02277990|525054278|FG000|Overall Study|Death|170|||
145471035|NCT02429791|524577876|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
145471036|NCT02429791|524577877|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
145471037|NCT05011058|524577878|FG000|Overall Study|Sponsor Decision|2|||
145471038|NCT05011058|524577879|FG001|Overall Study|Sponsor Decision|0|||
145471039|NCT05011058|524577880|FG002|Overall Study|Sponsor Decision|14|||
145471040|NCT05011058|524577881|FG003|Overall Study|Sponsor Decision|0|||
145471041|NCT05011058|524577882|FG004|Overall Study|Sponsor Decision|0|||
145471042|NCT05011058|524577883|FG005|Overall Study|Sponsor Decision|1|||
145471043|NCT05011058|524577884|FG006|Overall Study|Sponsor Decision|0|||
145471044|NCT05011058|524577885|FG007|Overall Study|Sponsor Decision|5|||
145471045|NCT02596230|524577886|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
145471046|NCT02596230|524577887|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
145471047|NCT02596230|524577888|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
145471048|NCT02596230|524577889|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
145471049|NCT02596230|524577890|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
145471050|NCT02596230|524577886|FG000|Objective 2, One Year|Lost to Follow-up|0|||
145471051|NCT02596230|524577887|FG001|Objective 2, One Year|Lost to Follow-up|41|||
145471052|NCT02596230|524577888|FG002|Objective 2, One Year|Lost to Follow-up|41|||
145471053|NCT02596230|524577889|FG003|Objective 2, One Year|Lost to Follow-up|32|||
145471054|NCT02596230|524577890|FG004|Objective 2, One Year|Lost to Follow-up|46|||
145471055|NCT02596230|524577886|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
145471056|NCT02596230|524577887|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
145471057|NCT02596230|524577888|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
145471058|NCT02596230|524577889|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
145471059|NCT02596230|524577890|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
145471060|NCT02596230|524577886|FG000|Objective 2, One Year|Adverse drug reaction|0|||
145471061|NCT02596230|524577887|FG001|Objective 2, One Year|Adverse drug reaction|1|||
145471062|NCT02596230|524577888|FG002|Objective 2, One Year|Adverse drug reaction|0|||
145471063|NCT02596230|524577889|FG003|Objective 2, One Year|Adverse drug reaction|0|||
145471064|NCT02596230|524577890|FG004|Objective 2, One Year|Adverse drug reaction|0|||
145471065|NCT02596230|524577886|FG000|Objective 2, One Year|Death|0|||
145471066|NCT02596230|524577887|FG001|Objective 2, One Year|Death|12|||
145471067|NCT02596230|524577888|FG002|Objective 2, One Year|Death|41|||
145471068|NCT02596230|524577889|FG003|Objective 2, One Year|Death|21|||
145471069|NCT02596230|524577890|FG004|Objective 2, One Year|Death|30|||
145471070|NCT02596230|524577886|FG000|Objective 2, One Year|Other|0|||
145471071|NCT02596230|524577887|FG001|Objective 2, One Year|Other|3|||
145471072|NCT02596230|524577888|FG002|Objective 2, One Year|Other|2|||
145471073|NCT02596230|524577889|FG003|Objective 2, One Year|Other|0|||
145471074|NCT02596230|524577890|FG004|Objective 2, One Year|Other|0|||
145471075|NCT01571232|524577891|FG000|Overall Study|Lost to Follow-up|0|||
145471076|NCT01571232|524577892|FG001|Overall Study|Lost to Follow-up|1|||
145471077|NCT01571232|524577891|FG000|Overall Study|Withdrawal by Subject|1|||
145471078|NCT01571232|524577892|FG001|Overall Study|Withdrawal by Subject|0|||
145471079|NCT01272869|524577893|FG000|Period 2 (14 Days)|Adverse Event|1|||
145471080|NCT01272869|524577894|FG001|Period 2 (14 Days)|Adverse Event|0|||
145471081|NCT00771615|524577895|FG000|Overall Study|Withdrawal by Subject|0|||
145471082|NCT00771615|524577896|FG001|Overall Study|Withdrawal by Subject|1|||
145471083|NCT00771615|524577897|FG002|Overall Study|Withdrawal by Subject|0|||
145471084|NCT00771615|524577898|FG003|Overall Study|Withdrawal by Subject|0|||
145471085|NCT00771615|524577899|FG004|Overall Study|Withdrawal by Subject|0|||
145471086|NCT00771615|524577900|FG005|Overall Study|Withdrawal by Subject|0|||
145471087|NCT00771615|524577901|FG006|Overall Study|Withdrawal by Subject|0|||
145471088|NCT00771615|524577902|FG007|Overall Study|Withdrawal by Subject|1|||
145471089|NCT00771615|524577903|FG008|Overall Study|Withdrawal by Subject|0|||
145471090|NCT00771615|524577895|FG000|Overall Study|Lost to Follow-up|1|||
145471091|NCT00771615|524577896|FG001|Overall Study|Lost to Follow-up|1|||
145471092|NCT00771615|524577897|FG002|Overall Study|Lost to Follow-up|1|||
145471093|NCT00771615|524577898|FG003|Overall Study|Lost to Follow-up|1|||
145471094|NCT00771615|524577899|FG004|Overall Study|Lost to Follow-up|0|||
145471095|NCT00771615|524577900|FG005|Overall Study|Lost to Follow-up|1|||
145471096|NCT00771615|524577901|FG006|Overall Study|Lost to Follow-up|1|||
145471097|NCT00771615|524577902|FG007|Overall Study|Lost to Follow-up|0|||
145471098|NCT00771615|524577903|FG008|Overall Study|Lost to Follow-up|0|||
145471099|NCT02455076|524577904|FG000|Inpatient|Withdrawal by Subject|1|||
145471100|NCT02455076|524577905|FG001|Inpatient|Withdrawal by Subject|0|||
145471101|NCT02455076|524577906|FG002|Inpatient|Withdrawal by Subject|0|||
145471102|NCT02455076|524577907|FG003|Inpatient|Withdrawal by Subject|0|||
145471103|NCT02455076|524577908|FG004|Inpatient|Withdrawal by Subject|0|||
145471104|NCT02455076|524577904|FG000|Inpatient|Discharged <24 h after admission|0|||
145471105|NCT02455076|524577905|FG001|Inpatient|Discharged <24 h after admission|1|||
145471106|NCT02455076|524577906|FG002|Inpatient|Discharged <24 h after admission|0|||
145471107|NCT02455076|524577907|FG003|Inpatient|Discharged <24 h after admission|0|||
145471108|NCT02455076|524577908|FG004|Inpatient|Discharged <24 h after admission|0|||
145471109|NCT02455076|524577904|FG000|Inpatient|Adverse Event|3|||
145471110|NCT02455076|524577905|FG001|Inpatient|Adverse Event|0|||
145471111|NCT02455076|524577906|FG002|Inpatient|Adverse Event|0|||
145471112|NCT02455076|524577907|FG003|Inpatient|Adverse Event|0|||
145471113|NCT02455076|524577908|FG004|Inpatient|Adverse Event|0|||
145471114|NCT02455076|524577904|FG000|Outpatient|Adverse Event|0|||
145471115|NCT02455076|524577905|FG001|Outpatient|Adverse Event|0|||
145471116|NCT02455076|524577906|FG002|Outpatient|Adverse Event|0|||
145471117|NCT02455076|524577907|FG003|Outpatient|Adverse Event|5|||
145471118|NCT02455076|524577908|FG004|Outpatient|Adverse Event|0|||
145471119|NCT02455076|524577904|FG000|Outpatient|Lost to Follow-up|0|||
145471120|NCT02455076|524577905|FG001|Outpatient|Lost to Follow-up|0|||
145471121|NCT02455076|524577906|FG002|Outpatient|Lost to Follow-up|0|||
145471122|NCT02455076|524577907|FG003|Outpatient|Lost to Follow-up|1|||
145471123|NCT02455076|524577908|FG004|Outpatient|Lost to Follow-up|12|||
145471124|NCT00859937|524577909|FG000|Overall Study|Protocol Violation|1|||
145471125|NCT00859937|524577910|FG001|Overall Study|Protocol Violation|0|||
145471126|NCT03908476|524577911|FG000|Overall Study|Death|3|||
145471127|NCT03908476|524577912|FG001|Overall Study|Death|0|||
145471128|NCT03908476|524577911|FG000|Overall Study|Lost to Follow-up|3|||
145471129|NCT03908476|524577912|FG001|Overall Study|Lost to Follow-up|1|||
145471130|NCT03908476|524577911|FG000|Overall Study|Withdrawal by Subject|7|||
145471131|NCT03908476|524577912|FG001|Overall Study|Withdrawal by Subject|1|||
145471132|NCT03908476|524577911|FG000|Overall Study|Physician Decision|2|||
145471133|NCT03908476|524577912|FG001|Overall Study|Physician Decision|0|||
145471134|NCT03908476|524577911|FG000|Overall Study|System Explanted and not Replaced|4|||
145471135|NCT03908476|524577912|FG001|Overall Study|System Explanted and not Replaced|0|||
145471136|NCT03908476|524577911|FG000|Overall Study|Intrathecal Pump|1|||
145471137|NCT03908476|524577912|FG001|Overall Study|Intrathecal Pump|0|||
145471138|NCT03908476|524577911|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
145471139|NCT03908476|524577912|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
145471140|NCT05194267|524577913|FG000|Overall Study|Withdrawal by Subject|2|||
145471141|NCT02868229|524577914|FG000|Overall Study|Adverse Event|1|||
145471142|NCT02868229|524577915|FG001|Overall Study|Adverse Event|0|||
145471143|NCT02868229|524577916|FG002|Overall Study|Adverse Event|0|||
145471144|NCT02868229|524577917|FG003|Overall Study|Adverse Event|1|||
145471145|NCT02868229|524577914|FG000|Overall Study|Death|0|||
145471146|NCT02868229|524577915|FG001|Overall Study|Death|0|||
145471147|NCT02868229|524577916|FG002|Overall Study|Death|1|||
145471148|NCT02868229|524577917|FG003|Overall Study|Death|1|||
145471149|NCT02868229|524577914|FG000|Overall Study|Missed dose|0|||
145471150|NCT02868229|524577915|FG001|Overall Study|Missed dose|0|||
145471151|NCT02868229|524577916|FG002|Overall Study|Missed dose|0|||
145471152|NCT02868229|524577917|FG003|Overall Study|Missed dose|3|||
145471153|NCT02540668|524577920|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
145471154|NCT02540668|524577921|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
145471155|NCT03270891|524577922|FG000|Overall Study|Lost to Follow-up|3|||
145471156|NCT03270891|524577923|FG001|Overall Study|Lost to Follow-up|6|||
145471157|NCT03270891|524577924|FG002|Overall Study|Lost to Follow-up|0|||
145471158|NCT03270891|524577922|FG000|Overall Study|Withdrawal by Subject|1|||
145471159|NCT03270891|524577923|FG001|Overall Study|Withdrawal by Subject|0|||
145471160|NCT03270891|524577924|FG002|Overall Study|Withdrawal by Subject|0|||
145471161|NCT03270891|524577922|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
145471162|NCT03270891|524577923|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
145471163|NCT03270891|524577924|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
145471164|NCT05779007|524577925|FG000|Overall Study|not meeting eligibility criteria|3517|||
145628418|NCT02236559|525153321|FG000|Overall Study|Withdrawal by Subject|1|||
145628419|NCT02236559|525153322|FG001|Overall Study|Withdrawal by Subject|0|||
145628420|NCT02049866|525153323|FG000|Overall Study|Withdrawal by Subject|1|||
145471165|NCT05779007|524577926|FG001|Overall Study|not meeting eligibility criteria|2009|||
145471166|NCT05147662|524577929|FG000|Overall Study|Withdrawal by parent/guardian|3|||
145471167|NCT05147662|524577929|FG000|Overall Study|Assigned to treatment but never treated|1|||
145471168|NCT04676867|524577932|FG000|Overall Study|Screen failure|0|||
145471169|NCT04676867|524577933|FG001|Overall Study|Screen failure|0|||
145471170|NCT04676867|524577934|FG002|Overall Study|Screen failure|6|||
145471171|NCT04676867|524577935|FG003|Overall Study|Screen failure|2|||
145471172|NCT04676867|524577932|FG000|Overall Study|Death|0|||
145471173|NCT04676867|524577933|FG001|Overall Study|Death|0|||
145471174|NCT04676867|524577934|FG002|Overall Study|Death|1|||
145471175|NCT04676867|524577935|FG003|Overall Study|Death|0|||
145471176|NCT04676867|524577932|FG000|Overall Study|Withdrawal by Subject|2|||
145471177|NCT04676867|524577933|FG001|Overall Study|Withdrawal by Subject|2|||
145471178|NCT04676867|524577934|FG002|Overall Study|Withdrawal by Subject|4|||
145471179|NCT04676867|524577935|FG003|Overall Study|Withdrawal by Subject|4|||
145471180|NCT04676867|524577932|FG000|Overall Study|Lost to Follow-up|1|||
145471181|NCT04676867|524577933|FG001|Overall Study|Lost to Follow-up|0|||
145471182|NCT04676867|524577934|FG002|Overall Study|Lost to Follow-up|0|||
145471183|NCT04676867|524577935|FG003|Overall Study|Lost to Follow-up|0|||
145471184|NCT00549770|524577936|FG000|Overall Study|Protocol deviation|1|||
145471185|NCT00549770|524577937|FG001|Overall Study|Protocol deviation|1|||
145471186|NCT00549770|524577938|FG002|Overall Study|Protocol deviation|1|||
145471187|NCT00549770|524577939|FG003|Overall Study|Protocol deviation|2|||
145471188|NCT00549770|524577940|FG004|Overall Study|Protocol deviation|2|||
145471189|NCT00549770|524577941|FG005|Overall Study|Protocol deviation|2|||
145471190|NCT00549770|524577942|FG006|Overall Study|Protocol deviation|1|||
145471191|NCT00549770|524577943|FG007|Overall Study|Protocol deviation|2|||
145471192|NCT00549770|524577936|FG000|Overall Study|Administrative problems|0|||
145471193|NCT00549770|524577937|FG001|Overall Study|Administrative problems|1|||
145471194|NCT00549770|524577938|FG002|Overall Study|Administrative problems|0|||
145471195|NCT00549770|524577939|FG003|Overall Study|Administrative problems|0|||
145471196|NCT00549770|524577940|FG004|Overall Study|Administrative problems|0|||
145471197|NCT00549770|524577941|FG005|Overall Study|Administrative problems|0|||
145471198|NCT00549770|524577942|FG006|Overall Study|Administrative problems|0|||
145471199|NCT00549770|524577943|FG007|Overall Study|Administrative problems|1|||
145471200|NCT00549770|524577936|FG000|Overall Study|Lost to Follow-up|0|||
145471201|NCT00549770|524577937|FG001|Overall Study|Lost to Follow-up|0|||
145471202|NCT00549770|524577938|FG002|Overall Study|Lost to Follow-up|2|||
145471203|NCT00549770|524577939|FG003|Overall Study|Lost to Follow-up|2|||
145471204|NCT00549770|524577940|FG004|Overall Study|Lost to Follow-up|3|||
145471205|NCT00549770|524577941|FG005|Overall Study|Lost to Follow-up|2|||
145471206|NCT00549770|524577942|FG006|Overall Study|Lost to Follow-up|0|||
145471207|NCT00549770|524577943|FG007|Overall Study|Lost to Follow-up|0|||
145471208|NCT00549770|524577936|FG000|Overall Study|Withdrawal by Subject|4|||
145471209|NCT00549770|524577937|FG001|Overall Study|Withdrawal by Subject|6|||
145471210|NCT00549770|524577938|FG002|Overall Study|Withdrawal by Subject|4|||
145471211|NCT00549770|524577939|FG003|Overall Study|Withdrawal by Subject|5|||
145471212|NCT00549770|524577940|FG004|Overall Study|Withdrawal by Subject|6|||
145628421|NCT01117480|525153324|FG000|Overall Study|Protocol Violation|8|||
145628422|NCT01117480|525153324|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
145628423|NCT03721016|525153325|FG000|Overall Study|Adverse Event|0|||
145628424|NCT03721016|525153326|FG001|Overall Study|Adverse Event|1|||
145628425|NCT03721016|525153327|FG002|Overall Study|Adverse Event|1|||
145628426|NCT03721016|525153325|FG000|Overall Study|Withdrawal by Subject|8|||
145628427|NCT03721016|525153326|FG001|Overall Study|Withdrawal by Subject|16|||
145628428|NCT03721016|525153327|FG002|Overall Study|Withdrawal by Subject|13|||
145628429|NCT03721016|525153325|FG000|Overall Study|Lost to Follow-up|4|||
145628430|NCT03721016|525153326|FG001|Overall Study|Lost to Follow-up|6|||
145628431|NCT03721016|525153327|FG002|Overall Study|Lost to Follow-up|5|||
145628432|NCT03721016|525153325|FG000|Overall Study|Physician Decision|0|||
145628433|NCT03721016|525153326|FG001|Overall Study|Physician Decision|1|||
145628434|NCT03721016|525153327|FG002|Overall Study|Physician Decision|2|||
145628435|NCT03721016|525153325|FG000|Overall Study|Protocol Violation|0|||
145628436|NCT03721016|525153326|FG001|Overall Study|Protocol Violation|1|||
145628437|NCT03721016|525153327|FG002|Overall Study|Protocol Violation|0|||
145628438|NCT03721016|525153325|FG000|Overall Study|Site terminated by sponsor|3|||
145628439|NCT03721016|525153326|FG001|Overall Study|Site terminated by sponsor|7|||
145628440|NCT03721016|525153327|FG002|Overall Study|Site terminated by sponsor|6|||
145628441|NCT03721016|525153325|FG000|Overall Study|Subject exited early due to COVID-19|1|||
145628442|NCT03721016|525153326|FG001|Overall Study|Subject exited early due to COVID-19|0|||
145628443|NCT03721016|525153327|FG002|Overall Study|Subject exited early due to COVID-19|0|||
145628444|NCT02232178|525153331|FG000|Overall Study|Lost to Follow-up|0|||
145628445|NCT02232178|525153332|FG001|Overall Study|Lost to Follow-up|1|||
145628446|NCT02232178|525153333|FG002|Overall Study|Lost to Follow-up|0|||
145628447|NCT02232178|525153331|FG000|Overall Study|ineligibility|0|||
145628448|NCT02232178|525153332|FG001|Overall Study|ineligibility|0|||
145628449|NCT02232178|525153333|FG002|Overall Study|ineligibility|1|||
145628450|NCT02232178|525153331|FG000|Overall Study|surgical complication|1|||
145628451|NCT02232178|525153332|FG001|Overall Study|surgical complication|0|||
145628452|NCT02232178|525153333|FG002|Overall Study|surgical complication|0|||
145628453|NCT00817635|525153334|FG000|Overall Study|Adverse Event|1|||
145628454|NCT00817635|525153335|FG001|Overall Study|Adverse Event|0|||
145628455|NCT00817635|525153336|FG002|Overall Study|Adverse Event|0|||
145628456|NCT00817635|525153337|FG003|Overall Study|Adverse Event|1|||
145628457|NCT00817635|525153338|FG004|Overall Study|Adverse Event|1|||
145628458|NCT00817635|525153334|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
145471213|NCT00549770|524577941|FG005|Overall Study|Withdrawal by Subject|6|||
145471214|NCT00549770|524577942|FG006|Overall Study|Withdrawal by Subject|4|||
145471215|NCT00549770|524577943|FG007|Overall Study|Withdrawal by Subject|9|||
145628459|NCT00817635|525153335|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
145471216|NCT00549770|524577936|FG000|Overall Study|Lack of Efficacy|1|||
145471217|NCT00549770|524577937|FG001|Overall Study|Lack of Efficacy|0|||
145471218|NCT00549770|524577938|FG002|Overall Study|Lack of Efficacy|2|||
145471219|NCT00549770|524577939|FG003|Overall Study|Lack of Efficacy|3|||
145628460|NCT00817635|525153336|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
145628461|NCT00817635|525153337|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
145628462|NCT00817635|525153338|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
145471220|NCT00549770|524577940|FG004|Overall Study|Lack of Efficacy|5|||
145471221|NCT00549770|524577941|FG005|Overall Study|Lack of Efficacy|1|||
145471222|NCT00549770|524577942|FG006|Overall Study|Lack of Efficacy|3|||
145471223|NCT00549770|524577943|FG007|Overall Study|Lack of Efficacy|8|||
145471224|NCT00549770|524577936|FG000|Overall Study|Abnormal test procedure results|0|||
145471225|NCT00549770|524577937|FG001|Overall Study|Abnormal test procedure results|0|||
145471226|NCT00549770|524577938|FG002|Overall Study|Abnormal test procedure results|0|||
145471227|NCT00549770|524577939|FG003|Overall Study|Abnormal test procedure results|2|||
145471228|NCT00549770|524577940|FG004|Overall Study|Abnormal test procedure results|0|||
145471229|NCT00549770|524577941|FG005|Overall Study|Abnormal test procedure results|1|||
145471230|NCT00549770|524577942|FG006|Overall Study|Abnormal test procedure results|1|||
145471231|NCT00549770|524577943|FG007|Overall Study|Abnormal test procedure results|1|||
145471232|NCT00549770|524577936|FG000|Overall Study|Abnormal laboratory values|0|||
145471233|NCT00549770|524577937|FG001|Overall Study|Abnormal laboratory values|0|||
145471234|NCT00549770|524577938|FG002|Overall Study|Abnormal laboratory values|0|||
145471235|NCT00549770|524577939|FG003|Overall Study|Abnormal laboratory values|0|||
145471236|NCT00549770|524577940|FG004|Overall Study|Abnormal laboratory values|0|||
145471237|NCT00549770|524577941|FG005|Overall Study|Abnormal laboratory values|1|||
145471238|NCT00549770|524577942|FG006|Overall Study|Abnormal laboratory values|0|||
145471239|NCT00549770|524577943|FG007|Overall Study|Abnormal laboratory values|0|||
145471240|NCT00549770|524577936|FG000|Overall Study|Adverse Event|1|||
145471241|NCT00549770|524577937|FG001|Overall Study|Adverse Event|3|||
145471242|NCT00549770|524577938|FG002|Overall Study|Adverse Event|1|||
145471243|NCT00549770|524577939|FG003|Overall Study|Adverse Event|2|||
145471244|NCT00549770|524577940|FG004|Overall Study|Adverse Event|1|||
145471245|NCT00549770|524577941|FG005|Overall Study|Adverse Event|0|||
145471246|NCT00549770|524577942|FG006|Overall Study|Adverse Event|5|||
145471247|NCT00549770|524577943|FG007|Overall Study|Adverse Event|4|||
145471248|NCT02294734|524577944|FG000|Overall Study|Adverse Event|5|||
145471249|NCT02294734|524577945|FG001|Overall Study|Adverse Event|5|||
145471250|NCT02294734|524577944|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
145471251|NCT02294734|524577945|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
145471252|NCT02294734|524577944|FG000|Overall Study|Lost to Follow-up|2|||
145471253|NCT02294734|524577945|FG001|Overall Study|Lost to Follow-up|0|||
145471254|NCT02294734|524577944|FG000|Overall Study|Physician Decision|2|||
145471255|NCT02294734|524577945|FG001|Overall Study|Physician Decision|1|||
145471256|NCT02294734|524577944|FG000|Overall Study|Withdrawal by Subject|4|||
145471257|NCT02294734|524577945|FG001|Overall Study|Withdrawal by Subject|2|||
145471258|NCT00548717|524577946|FG000|Overall Study|Death|5|||
145471259|NCT00548717|524577947|FG001|Overall Study|Death|2|||
145471260|NCT00548717|524577946|FG000|Overall Study|Relapse|3|||
145471261|NCT00548717|524577947|FG001|Overall Study|Relapse|0|||
145471262|NCT00548717|524577946|FG000|Overall Study|Alternative treatment for GVHD|1|||
145471263|NCT00548717|524577947|FG001|Overall Study|Alternative treatment for GVHD|0|||
145471264|NCT00908037|524577953|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471265|NCT00908037|524577954|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471266|NCT00908037|524577955|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471267|NCT00908037|524577956|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471268|NCT00908037|524577957|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
145471269|NCT00908037|524577958|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471270|NCT00908037|524577959|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
145471271|NCT00908037|524577960|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471272|NCT00908037|524577961|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
145471273|NCT00908037|524577962|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471274|NCT00908037|524577963|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471275|NCT00908037|524577964|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
145471276|NCT00908037|524577953|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471277|NCT00908037|524577954|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471278|NCT00908037|524577955|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471279|NCT00908037|524577956|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471280|NCT00908037|524577957|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
145471281|NCT00908037|524577958|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471282|NCT00908037|524577959|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145601397|NCT02277990|525054279|FG001|Overall Study|Death|188|||
145601398|NCT02277990|525054278|FG000|Overall Study|Withdrawal by Subject|64|||
145601399|NCT02277990|525054279|FG001|Overall Study|Withdrawal by Subject|53|||
145601400|NCT02277990|525054278|FG000|Overall Study|Physician Decision|40|||
145601401|NCT02277990|525054279|FG001|Overall Study|Physician Decision|34|||
145601402|NCT02277990|525054278|FG000|Overall Study|Lost to Follow-up|66|||
145601403|NCT02277990|525054279|FG001|Overall Study|Lost to Follow-up|69|||
145601404|NCT02277990|525054278|FG000|Overall Study|Had other reason|26|||
145601405|NCT02277990|525054279|FG001|Overall Study|Had other reason|32|||
145601406|NCT03351738|525054280|FG000|Overall Study|Withdrawal by Subject|0|||
145601407|NCT03351738|525054281|FG001|Overall Study|Withdrawal by Subject|1|||
145471283|NCT00908037|524577960|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471284|NCT00908037|524577961|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
145471285|NCT00908037|524577962|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471286|NCT00908037|524577963|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471287|NCT00908037|524577964|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
145471288|NCT00908037|524577953|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471289|NCT00908037|524577954|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471290|NCT00908037|524577955|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471291|NCT00908037|524577956|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
145471292|NCT00908037|524577957|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471293|NCT00908037|524577958|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471294|NCT00908037|524577959|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
145471295|NCT00908037|524577960|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471296|NCT00908037|524577961|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471297|NCT00908037|524577962|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471298|NCT00908037|524577963|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471299|NCT00908037|524577964|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
145471300|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471301|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471302|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471303|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471304|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471305|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471306|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471307|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471308|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471309|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471310|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
145471311|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
145471312|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471313|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471314|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471315|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471316|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471317|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471318|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471319|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471320|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471321|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
145471322|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
145471323|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
145471324|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471325|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471326|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471327|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471328|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471329|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471330|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471331|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471332|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471333|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
145471334|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471335|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
145471336|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471337|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145601408|NCT03351738|525054282|FG002|Overall Study|Withdrawal by Subject|0|||
145471338|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471339|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471340|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471341|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471342|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471343|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471344|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471345|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471346|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
145471347|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
145471348|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471349|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471350|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471351|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471352|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471353|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471354|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471355|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471356|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471357|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
145471358|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471359|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
145471360|NCT00908037|524577953|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471361|NCT00908037|524577954|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471362|NCT00908037|524577955|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471363|NCT00908037|524577956|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471364|NCT00908037|524577957|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471365|NCT00908037|524577958|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471366|NCT00908037|524577959|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471367|NCT00908037|524577960|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471368|NCT00908037|524577961|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471369|NCT00908037|524577962|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471370|NCT00908037|524577963|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
145471371|NCT00908037|524577964|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
145471372|NCT00025155|524577965|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
145471373|NCT00025155|524577965|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
145471374|NCT00109577|524577968|FG000|Overall Study|Withdrawal by Subject|3|||
145471375|NCT00109577|524577969|FG001|Overall Study|Withdrawal by Subject|3|||
145471376|NCT02613169|524577970|FG000|Overall Study|Withdrawal by Subject|4|||
145471377|NCT02613169|524577971|FG001|Overall Study|Withdrawal by Subject|1|||
145471378|NCT02613169|524577970|FG000|Overall Study|Lost to Follow-up|0|||
145471379|NCT02613169|524577971|FG001|Overall Study|Lost to Follow-up|5|||
145471380|NCT02613169|524577970|FG000|Overall Study|HIV|0|||
145471381|NCT02613169|524577971|FG001|Overall Study|HIV|2|||
145471382|NCT02613169|524577970|FG000|Overall Study|No TB infection endpoint|14|||
145471383|NCT02613169|524577971|FG001|Overall Study|No TB infection endpoint|9|||
145601409|NCT03351738|525054283|FG003|Overall Study|Withdrawal by Subject|1|||
145601410|NCT03351738|525054284|FG004|Overall Study|Withdrawal by Subject|0|||
145601411|NCT03351738|525054285|FG005|Overall Study|Withdrawal by Subject|0|||
145601412|NCT03641313|525054296|FG000|Overall Study|Death|1|||
145601413|NCT03641313|525054296|FG000|Overall Study|Withdrawal by Subject|2|||
145601414|NCT03641313|525054296|FG000|Overall Study|Declining health|1|||
145601415|NCT03641313|525054296|FG000|Overall Study|Adverse Event|1|||
145601416|NCT03033225|525054297|FG000|Overall Study|Withdrawal by Subject|5|||
145601417|NCT00946296|525054298|FG000|Overall Study|Physician Decision|3|||
145601418|NCT00946296|525054299|FG001|Overall Study|Physician Decision|0|||
145601419|NCT03434678|525054300|FG000|Overall Study|Withdrawal by Subject|13|||
145601420|NCT03434678|525054301|FG001|Overall Study|Withdrawal by Subject|13|||
145601421|NCT03434678|525054300|FG000|Overall Study|Found to be ineligible post randomization|2|||
145601422|NCT03434678|525054301|FG001|Overall Study|Found to be ineligible post randomization|1|||
145601423|NCT06060457|525054304|FG000|Overall Study|Adverse Event|1|||
145601424|NCT06060457|525054305|FG001|Overall Study|Adverse Event|1|||
145601425|NCT06060457|525054304|FG000|Overall Study|Death|2|||
145601426|NCT06060457|525054305|FG001|Overall Study|Death|2|||
145601427|NCT06060457|525054304|FG000|Overall Study|Lost to Follow-up|17|||
145601428|NCT06060457|525054305|FG001|Overall Study|Lost to Follow-up|19|||
145601429|NCT06060457|525054304|FG000|Overall Study|Physician Decision|0|||
145601430|NCT06060457|525054305|FG001|Overall Study|Physician Decision|1|||
145601431|NCT06060457|525054304|FG000|Overall Study|Protocol Violation|1|||
145601432|NCT06060457|525054305|FG001|Overall Study|Protocol Violation|1|||
145601433|NCT06060457|525054304|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
145601434|NCT06060457|525054305|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
145601435|NCT06060457|525054304|FG000|Overall Study|Withdrawal by Subject|12|||
145628463|NCT00817635|525153334|FG000|Overall Study|Withdrawal by Subject|2|||
145601436|NCT06060457|525054305|FG001|Overall Study|Withdrawal by Subject|15|||
145471384|NCT00343382|524577972|FG000|Overall Study|Adverse Event|2|||
145471385|NCT00343382|524577973|FG001|Overall Study|Adverse Event|10|||
145471386|NCT00343382|524577974|FG002|Overall Study|Adverse Event|7|||
145628464|NCT00817635|525153335|FG001|Overall Study|Withdrawal by Subject|1|||
145628465|NCT00817635|525153336|FG002|Overall Study|Withdrawal by Subject|0|||
145628466|NCT00817635|525153337|FG003|Overall Study|Withdrawal by Subject|1|||
145628467|NCT00817635|525153338|FG004|Overall Study|Withdrawal by Subject|2|||
145628468|NCT00817635|525153334|FG000|Overall Study|Lost to Follow-up|0|||
145628469|NCT00817635|525153335|FG001|Overall Study|Lost to Follow-up|1|||
145628470|NCT00817635|525153336|FG002|Overall Study|Lost to Follow-up|0|||
145628471|NCT00817635|525153337|FG003|Overall Study|Lost to Follow-up|1|||
145628472|NCT00817635|525153338|FG004|Overall Study|Lost to Follow-up|0|||
145628473|NCT00817635|525153334|FG000|Overall Study|Administrative Problems|0|||
145628474|NCT00817635|525153335|FG001|Overall Study|Administrative Problems|0|||
145628475|NCT00817635|525153336|FG002|Overall Study|Administrative Problems|0|||
145628476|NCT00817635|525153337|FG003|Overall Study|Administrative Problems|0|||
145628477|NCT00817635|525153338|FG004|Overall Study|Administrative Problems|1|||
145628478|NCT00817635|525153334|FG000|Overall Study|Protocol Violation|5|||
145628479|NCT00817635|525153335|FG001|Overall Study|Protocol Violation|1|||
145628480|NCT00817635|525153336|FG002|Overall Study|Protocol Violation|3|||
145628481|NCT00817635|525153337|FG003|Overall Study|Protocol Violation|2|||
145628482|NCT00817635|525153338|FG004|Overall Study|Protocol Violation|3|||
145628483|NCT01167426|525153339|FG000|Overall Study|Lost to Follow-up|6|||
145628484|NCT01167426|525153339|FG000|Overall Study|Protocol Violation|1|||
145628485|NCT01167426|525153339|FG000|Overall Study|Withdrawal by Subject|2|||
145628486|NCT01167426|525153339|FG000|Overall Study|Sponsor Decision|1|||
145628487|NCT04176458|525153341|FG000|Overall Study|Covid 19|4|||
145628488|NCT01670019|525153347|FG000|Overall Study|Adverse Event|3|||
145628489|NCT01670019|525153348|FG001|Overall Study|Adverse Event|0|||
145628490|NCT01670019|525153347|FG000|Overall Study|Withdrawal by Subject|6|||
145628491|NCT01670019|525153348|FG001|Overall Study|Withdrawal by Subject|0|||
145628492|NCT03601507|525153349|FG000|Overall Study|Adverse Event|1|||
145628493|NCT02107014|525153353|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
145628494|NCT03761784|525153354|FG000|Overall Study|Adverse Event|4|||
145628495|NCT03761784|525153355|FG001|Overall Study|Adverse Event|0|||
145628496|NCT03761784|525153354|FG000|Overall Study|Lost to Follow-up|10|||
145628497|NCT03761784|525153355|FG001|Overall Study|Lost to Follow-up|7|||
145628498|NCT03761784|525153354|FG000|Overall Study|Pregnancy|1|||
145628499|NCT03761784|525153355|FG001|Overall Study|Pregnancy|0|||
145628500|NCT03761784|525153354|FG000|Overall Study|Protocol Violation|2|||
145628501|NCT03761784|525153355|FG001|Overall Study|Protocol Violation|0|||
145628502|NCT03761784|525153354|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
145628503|NCT03761784|525153355|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
145628504|NCT03761784|525153354|FG000|Overall Study|Withdrawal by Subject|9|||
145628505|NCT03761784|525153355|FG001|Overall Study|Withdrawal by Subject|4|||
145628506|NCT03761784|525153354|FG000|Overall Study|Physician Decision|1|||
145628507|NCT03761784|525153355|FG001|Overall Study|Physician Decision|0|||
145628508|NCT03761784|525153354|FG000|Overall Study|Other Than Specified|1|||
145628509|NCT03761784|525153355|FG001|Overall Study|Other Than Specified|0|||
145628510|NCT03852433|525153359|FG000|Overall Study|Withdrawal of consent|5|||
145628511|NCT03852433|525153360|FG001|Overall Study|Withdrawal of consent|8|||
145628512|NCT03852433|525153361|FG002|Overall Study|Withdrawal of consent|1|||
145628513|NCT03852433|525153362|FG003|Overall Study|Withdrawal of consent|1|||
145628514|NCT03852433|525153359|FG000|Overall Study|Adverse Event|1|||
145628515|NCT03852433|525153360|FG001|Overall Study|Adverse Event|1|||
145628516|NCT03852433|525153361|FG002|Overall Study|Adverse Event|1|||
145628517|NCT03852433|525153362|FG003|Overall Study|Adverse Event|1|||
145628518|NCT03852433|525153359|FG000|Overall Study|Lost to Follow-up|0|||
145628519|NCT03852433|525153360|FG001|Overall Study|Lost to Follow-up|1|||
145628520|NCT03852433|525153361|FG002|Overall Study|Lost to Follow-up|0|||
145628521|NCT03852433|525153362|FG003|Overall Study|Lost to Follow-up|1|||
145628522|NCT03852433|525153359|FG000|Overall Study|Pregnancy|0|||
145628523|NCT03852433|525153360|FG001|Overall Study|Pregnancy|1|||
145628524|NCT03852433|525153361|FG002|Overall Study|Pregnancy|1|||
145628525|NCT03852433|525153362|FG003|Overall Study|Pregnancy|0|||
145628526|NCT03852433|525153359|FG000|Overall Study|Protocol Violation|0|||
145628527|NCT03852433|525153360|FG001|Overall Study|Protocol Violation|0|||
145628528|NCT03852433|525153361|FG002|Overall Study|Protocol Violation|1|||
145628529|NCT03852433|525153362|FG003|Overall Study|Protocol Violation|1|||
145628530|NCT03852433|525153359|FG000|Overall Study|Death|0|||
145628531|NCT03852433|525153360|FG001|Overall Study|Death|0|||
145628532|NCT03852433|525153361|FG002|Overall Study|Death|1|||
145628533|NCT03852433|525153362|FG003|Overall Study|Death|0|||
145628534|NCT03852433|525153359|FG000|Overall Study|Lack of Efficacy|0|||
145628535|NCT03852433|525153360|FG001|Overall Study|Lack of Efficacy|1|||
145628536|NCT03852433|525153361|FG002|Overall Study|Lack of Efficacy|0|||
145628537|NCT03852433|525153362|FG003|Overall Study|Lack of Efficacy|0|||
145628538|NCT03852433|525153359|FG000|Overall Study|Non-compliance with study drug|0|||
145628539|NCT03852433|525153360|FG001|Overall Study|Non-compliance with study drug|0|||
145471387|NCT00343382|524577972|FG000|Overall Study|Withdrawal by Subject|1|||
145471388|NCT00343382|524577973|FG001|Overall Study|Withdrawal by Subject|2|||
145471389|NCT00343382|524577974|FG002|Overall Study|Withdrawal by Subject|6|||
145471390|NCT00343382|524577972|FG000|Overall Study|Other Reason Not Specified|1|||
145471391|NCT00343382|524577973|FG001|Overall Study|Other Reason Not Specified|2|||
145471392|NCT00343382|524577974|FG002|Overall Study|Other Reason Not Specified|4|||
145471393|NCT01571453|524577976|FG000|Overall Study|Adverse Event|14|||
145471394|NCT01571453|524577977|FG001|Overall Study|Adverse Event|32|||
145471395|NCT01571453|524577976|FG000|Overall Study|Lack of Efficacy|8|||
145471396|NCT01571453|524577977|FG001|Overall Study|Lack of Efficacy|3|||
145471397|NCT01571453|524577976|FG000|Overall Study|Non-compliance|2|||
145471398|NCT01571453|524577977|FG001|Overall Study|Non-compliance|4|||
145471399|NCT01571453|524577976|FG000|Overall Study|Protocol Violation|1|||
145471400|NCT01571453|524577977|FG001|Overall Study|Protocol Violation|5|||
145471401|NCT01571453|524577976|FG000|Overall Study|Withdrawal of consent|5|||
145471402|NCT01571453|524577977|FG001|Overall Study|Withdrawal of consent|13|||
145471403|NCT01571453|524577976|FG000|Overall Study|Lost to Follow-up|4|||
145471404|NCT01571453|524577977|FG001|Overall Study|Lost to Follow-up|2|||
145471405|NCT01571453|524577976|FG000|Overall Study|Administrative or other reason(s)|4|||
145471406|NCT01571453|524577977|FG001|Overall Study|Administrative or other reason(s)|3|||
145471407|NCT00129961|524577979|FG000|Overall Study|Adverse Event|1|||
145471408|NCT00129961|524577980|FG001|Overall Study|Adverse Event|0|||
145471409|NCT00129961|524577979|FG000|Overall Study|Death|1|||
145471410|NCT00129961|524577980|FG001|Overall Study|Death|1|||
145471411|NCT00129961|524577979|FG000|Overall Study|Withdrawal by Sponsor|14|||
145471412|NCT00129961|524577980|FG001|Overall Study|Withdrawal by Sponsor|20|||
145471413|NCT00129961|524577979|FG000|Overall Study|Physician Decision|1|||
145471414|NCT00129961|524577980|FG001|Overall Study|Physician Decision|0|||
145471415|NCT00129961|524577979|FG000|Overall Study|Withdrawal by Subject|2|||
145471416|NCT00129961|524577980|FG001|Overall Study|Withdrawal by Subject|1|||
145471417|NCT00129961|524577979|FG000|Overall Study|Missing Record|0|||
145471418|NCT00129961|524577980|FG001|Overall Study|Missing Record|1|||
145471419|NCT01985360|524577981|FG000|Overall Study|Withdrawal by Subject|4|||
145471420|NCT01985360|524577982|FG001|Overall Study|Withdrawal by Subject|0|||
145471421|NCT01985360|524577981|FG000|Overall Study|Lost to Follow-up|5|||
145471422|NCT01985360|524577982|FG001|Overall Study|Lost to Follow-up|3|||
145471423|NCT00084487|524577983|FG000|Overall Study|Death|1|||
145471424|NCT04598269|524577988|FG000|Overall Study|Adverse Event|0|||
145471425|NCT04598269|524577989|FG001|Overall Study|Adverse Event|3|||
145471426|NCT04598269|524577988|FG000|Overall Study|Withdrawal by Subject|1|||
145471427|NCT04598269|524577989|FG001|Overall Study|Withdrawal by Subject|4|||
145471428|NCT04598269|524577988|FG000|Overall Study|Lost to Follow-up|1|||
145471429|NCT04598269|524577989|FG001|Overall Study|Lost to Follow-up|0|||
145471430|NCT04598269|524577988|FG000|Overall Study|Not Treated|2|||
145471431|NCT04598269|524577989|FG001|Overall Study|Not Treated|0|||
145471432|NCT02966015|524577990|FG000|Inclusion Visit|did not answer questionnaire|8|||
145471433|NCT02966015|524577991|FG001|Inclusion Visit|did not answer questionnaire|3|||
145471434|NCT03040986|524577994|FG000|Overall Study|Hospice|1|||
145471435|NCT03040986|524577995|FG001|Overall Study|Hospice|0|||
145471436|NCT03040986|524577994|FG000|Overall Study|Adverse Event|2|||
145471437|NCT03040986|524577995|FG001|Overall Study|Adverse Event|1|||
145471438|NCT03040986|524577994|FG000|Overall Study|Disease progression on study|3|||
145471439|NCT03040986|524577995|FG001|Overall Study|Disease progression on study|1|||
145471440|NCT01183468|524577996|FG000|Overall Study|Lost to Follow-up|2|||
145471441|NCT01183468|524577997|FG001|Overall Study|Lost to Follow-up|1|||
145471442|NCT01183468|524577998|FG002|Overall Study|Lost to Follow-up|0|||
145471443|NCT01183468|524577999|FG003|Overall Study|Lost to Follow-up|0|||
145471444|NCT01183468|524577996|FG000|Overall Study|Physician Decision|1|||
145471445|NCT01183468|524577997|FG001|Overall Study|Physician Decision|0|||
145471446|NCT01183468|524577998|FG002|Overall Study|Physician Decision|0|||
145471447|NCT01183468|524577999|FG003|Overall Study|Physician Decision|0|||
145471448|NCT01183468|524577996|FG000|Overall Study|Withdrawal by Subject|0|||
145471449|NCT01183468|524577997|FG001|Overall Study|Withdrawal by Subject|1|||
145471450|NCT01183468|524577998|FG002|Overall Study|Withdrawal by Subject|0|||
145471451|NCT01183468|524577999|FG003|Overall Study|Withdrawal by Subject|0|||
145471452|NCT00454649|524578005|FG000|Overall Study|Lack of Efficacy|2|||
145471453|NCT00454649|524578006|FG001|Overall Study|Lack of Efficacy|2|||
145471454|NCT00454649|524578007|FG002|Overall Study|Lack of Efficacy|10|||
145471455|NCT00454649|524578008|FG003|Overall Study|Lack of Efficacy|3|||
145471456|NCT00454649|524578009|FG004|Overall Study|Lack of Efficacy|0|||
145471457|NCT00454649|524578010|FG005|Overall Study|Lack of Efficacy|4|||
145471458|NCT00454649|524578011|FG006|Overall Study|Lack of Efficacy|5|||
145471459|NCT00454649|524578012|FG007|Overall Study|Lack of Efficacy|13|||
145471460|NCT00454649|524578013|FG008|Overall Study|Lack of Efficacy|10|||
145471461|NCT00454649|524578014|FG009|Overall Study|Lack of Efficacy|2|||
145471462|NCT00454649|524578005|FG000|Overall Study|Adverse Event|0|||
145471463|NCT00454649|524578006|FG001|Overall Study|Adverse Event|1|||
145471464|NCT00454649|524578007|FG002|Overall Study|Adverse Event|3|||
145471465|NCT00454649|524578008|FG003|Overall Study|Adverse Event|0|||
145471466|NCT00454649|524578009|FG004|Overall Study|Adverse Event|1|||
145471467|NCT00454649|524578010|FG005|Overall Study|Adverse Event|2|||
145471468|NCT00454649|524578011|FG006|Overall Study|Adverse Event|3|||
145471469|NCT00454649|524578012|FG007|Overall Study|Adverse Event|4|||
145471470|NCT00454649|524578013|FG008|Overall Study|Adverse Event|6|||
145471471|NCT00454649|524578014|FG009|Overall Study|Adverse Event|2|||
145471472|NCT00454649|524578005|FG000|Overall Study|Lost to Follow-up|0|||
145471473|NCT00454649|524578006|FG001|Overall Study|Lost to Follow-up|0|||
145471474|NCT00454649|524578007|FG002|Overall Study|Lost to Follow-up|1|||
145471475|NCT00454649|524578008|FG003|Overall Study|Lost to Follow-up|0|||
145471476|NCT00454649|524578009|FG004|Overall Study|Lost to Follow-up|0|||
145471477|NCT00454649|524578010|FG005|Overall Study|Lost to Follow-up|0|||
145471478|NCT00454649|524578011|FG006|Overall Study|Lost to Follow-up|1|||
145471479|NCT00454649|524578012|FG007|Overall Study|Lost to Follow-up|0|||
145471480|NCT00454649|524578013|FG008|Overall Study|Lost to Follow-up|0|||
145471481|NCT00454649|524578014|FG009|Overall Study|Lost to Follow-up|0|||
145471482|NCT00454649|524578005|FG000|Overall Study|Other|1|||
145471483|NCT00454649|524578006|FG001|Overall Study|Other|1|||
145471484|NCT00454649|524578007|FG002|Overall Study|Other|5|||
145471485|NCT00454649|524578008|FG003|Overall Study|Other|3|||
145471486|NCT00454649|524578009|FG004|Overall Study|Other|0|||
145471487|NCT00454649|524578010|FG005|Overall Study|Other|0|||
145471488|NCT00454649|524578011|FG006|Overall Study|Other|0|||
145471489|NCT00454649|524578012|FG007|Overall Study|Other|0|||
145471490|NCT00454649|524578013|FG008|Overall Study|Other|3|||
145471491|NCT00454649|524578014|FG009|Overall Study|Other|1|||
145471492|NCT00454649|524578005|FG000|Overall Study|Withdrawal by Subject|0|||
145471493|NCT00454649|524578006|FG001|Overall Study|Withdrawal by Subject|0|||
145471494|NCT00454649|524578007|FG002|Overall Study|Withdrawal by Subject|0|||
145471495|NCT00454649|524578008|FG003|Overall Study|Withdrawal by Subject|0|||
145471496|NCT00454649|524578009|FG004|Overall Study|Withdrawal by Subject|0|||
145471497|NCT00454649|524578010|FG005|Overall Study|Withdrawal by Subject|1|||
145471498|NCT00454649|524578011|FG006|Overall Study|Withdrawal by Subject|0|||
145471499|NCT00454649|524578012|FG007|Overall Study|Withdrawal by Subject|2|||
145471500|NCT00454649|524578013|FG008|Overall Study|Withdrawal by Subject|1|||
145471501|NCT00454649|524578014|FG009|Overall Study|Withdrawal by Subject|0|||
145471502|NCT00695864|524578018|FG000|Placebo|Withdrawal by Subject|1|||
145471503|NCT00695864|524578018|FG000|Placebo|Physician Decision|4|||
145471504|NCT01879072|524578019|FG000|Overall Study|Withdrawal by Subject|121|||
145471505|NCT01879072|524578019|FG000|Overall Study|Not Transplanted|30|||
145471506|NCT00626405|524578027|FG000|Overall Study|Deemed Ineligible|1|||
145471507|NCT00626405|524578028|FG001|Overall Study|Deemed Ineligible|0|||
145471508|NCT00626405|524578027|FG000|Overall Study|Withdrawal by Subject|0|||
145471509|NCT00626405|524578028|FG001|Overall Study|Withdrawal by Subject|1|||
145471510|NCT01264419|524578032|FG000|Overall Study|Lost to Follow-up|3|||
145471511|NCT01041287|524579636|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
145471512|NCT01041287|524579637|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
145471513|NCT01041287|524579636|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
145471514|NCT01041287|524579637|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
145471515|NCT00126776|524579643|FG000|Overall Study|follow up complete on all patients|0|||
145471516|NCT00126776|524579644|FG001|Overall Study|follow up complete on all patients|0|||
145471517|NCT00527982|524579657|FG000|Overall Study|Physician Decision|1|||
145628540|NCT03852433|525153361|FG002|Overall Study|Non-compliance with study drug|0|||
145628541|NCT03852433|525153362|FG003|Overall Study|Non-compliance with study drug|1|||
145628542|NCT03852433|525153359|FG000|Overall Study|Physician Decision|1|||
145628543|NCT03852433|525153360|FG001|Overall Study|Physician Decision|0|||
145628544|NCT03852433|525153361|FG002|Overall Study|Physician Decision|0|||
145471518|NCT00527982|524579658|FG001|Overall Study|Physician Decision|0|||
145471519|NCT01939366|524579659|FG000|Overall Study|Adverse Event|8|||
145471520|NCT01939366|524579660|FG001|Overall Study|Adverse Event|17|||
145471521|NCT01939366|524579661|FG002|Overall Study|Adverse Event|30|||
145471522|NCT01939366|524579662|FG003|Overall Study|Adverse Event|8|||
145471523|NCT01939366|524579663|FG004|Overall Study|Adverse Event|5|||
145628545|NCT03852433|525153362|FG003|Overall Study|Physician Decision|0|||
145628546|NCT03852433|525153359|FG000|Overall Study|Randomized but never treated|1|||
145471524|NCT01939366|524579659|FG000|Overall Study|Lack of Efficacy|2|||
145471525|NCT01939366|524579660|FG001|Overall Study|Lack of Efficacy|1|||
145471526|NCT01939366|524579661|FG002|Overall Study|Lack of Efficacy|1|||
145471527|NCT01939366|524579662|FG003|Overall Study|Lack of Efficacy|1|||
145471528|NCT01939366|524579663|FG004|Overall Study|Lack of Efficacy|3|||
145628547|NCT03852433|525153360|FG001|Overall Study|Randomized but never treated|0|||
145471529|NCT01939366|524579659|FG000|Overall Study|Lost to Follow-up|1|||
145471530|NCT01939366|524579660|FG001|Overall Study|Lost to Follow-up|1|||
145471531|NCT01939366|524579661|FG002|Overall Study|Lost to Follow-up|0|||
145471532|NCT01939366|524579662|FG003|Overall Study|Lost to Follow-up|0|||
145471533|NCT01939366|524579663|FG004|Overall Study|Lost to Follow-up|0|||
145471534|NCT01939366|524579659|FG000|Overall Study|Withdrawal by Subject|1|||
145471535|NCT01939366|524579660|FG001|Overall Study|Withdrawal by Subject|0|||
145628548|NCT03852433|525153361|FG002|Overall Study|Randomized but never treated|0|||
145471536|NCT01939366|524579661|FG002|Overall Study|Withdrawal by Subject|2|||
145471537|NCT01939366|524579662|FG003|Overall Study|Withdrawal by Subject|2|||
145471538|NCT01939366|524579663|FG004|Overall Study|Withdrawal by Subject|3|||
145471539|NCT01939366|524579659|FG000|Overall Study|Inclusion criteria not met|0|||
145471540|NCT01939366|524579660|FG001|Overall Study|Inclusion criteria not met|1|||
145471541|NCT01939366|524579661|FG002|Overall Study|Inclusion criteria not met|1|||
145471542|NCT01939366|524579662|FG003|Overall Study|Inclusion criteria not met|0|||
145471543|NCT01939366|524579663|FG004|Overall Study|Inclusion criteria not met|1|||
145471544|NCT01939366|524579659|FG000|Overall Study|Other|0|||
145471545|NCT01939366|524579660|FG001|Overall Study|Other|0|||
145471546|NCT01939366|524579661|FG002|Overall Study|Other|2|||
145471547|NCT01939366|524579662|FG003|Overall Study|Other|2|||
145471548|NCT01939366|524579663|FG004|Overall Study|Other|1|||
145471549|NCT01939366|524579659|FG000|Overall Study|Protocol Violation|0|||
145471550|NCT01939366|524579660|FG001|Overall Study|Protocol Violation|0|||
145471551|NCT01939366|524579661|FG002|Overall Study|Protocol Violation|0|||
145471552|NCT01939366|524579662|FG003|Overall Study|Protocol Violation|1|||
145471553|NCT01939366|524579663|FG004|Overall Study|Protocol Violation|0|||
145471554|NCT01939366|524579659|FG000|Overall Study|Sponsor decision|0|||
145471555|NCT01939366|524579660|FG001|Overall Study|Sponsor decision|0|||
145471556|NCT01939366|524579661|FG002|Overall Study|Sponsor decision|0|||
145471557|NCT01939366|524579662|FG003|Overall Study|Sponsor decision|0|||
145471558|NCT01939366|524579663|FG004|Overall Study|Sponsor decision|2|||
145471559|NCT01939366|524579659|FG000|Overall Study|GCP non-compliance at site|2|||
145471560|NCT01939366|524579660|FG001|Overall Study|GCP non-compliance at site|3|||
145471561|NCT01939366|524579661|FG002|Overall Study|GCP non-compliance at site|2|||
145471562|NCT01939366|524579662|FG003|Overall Study|GCP non-compliance at site|3|||
145471563|NCT01939366|524579663|FG004|Overall Study|GCP non-compliance at site|3|||
145471564|NCT04680975|524579668|FG000|Overall Study|Adverse Event|3|||
145471565|NCT04680975|524579668|FG000|Overall Study|Death|1|||
145471566|NCT04680975|524579668|FG000|Overall Study|Progressive Disease|1|||
145471567|NCT04680975|524579668|FG000|Overall Study|Withdrawal by Subject|1|||
145471568|NCT03909152|524579669|FG000|Overall Study|Adverse Event|14|||
145471569|NCT03909152|524579670|FG001|Overall Study|Adverse Event|5|||
145471570|NCT03909152|524579671|FG002|Overall Study|Adverse Event|1|||
145471571|NCT03909152|524579672|FG003|Overall Study|Adverse Event|14|||
145471572|NCT04099511|524579675|FG000|Overall Study|Lost to Follow-up|2|||
145471573|NCT04099511|524579676|FG001|Overall Study|Lost to Follow-up|2|||
145471574|NCT04099511|524579675|FG000|Overall Study|Withdrawal by Subject|8|||
145471575|NCT04099511|524579676|FG001|Overall Study|Withdrawal by Subject|4|||
145471576|NCT01240200|524579678|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
145471577|NCT01240200|524579679|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
145471578|NCT02708485|524579680|FG000|Overall Study|Withdrawal by Subject|3|||
145471579|NCT02708485|524579681|FG001|Overall Study|Withdrawal by Subject|2|||
145471580|NCT03157583|524579686|FG000|Overall Study|Other (did not meet study criteria)|1|||
145471581|NCT01581619|524579692|FG000|Overall Study|Withdrawal by Subject|1|||
145471582|NCT01581619|524579692|FG000|Overall Study|Lost to Follow-up|1|||
145471583|NCT00290498|524579693|FG000|Overall Study|Death|2|||
145471584|NCT00290498|524579694|FG001|Overall Study|Death|0|||
145471585|NCT00290498|524579693|FG000|Overall Study|Physician Decision|1|||
145471586|NCT00290498|524579694|FG001|Overall Study|Physician Decision|0|||
145471587|NCT00290498|524579693|FG000|Overall Study|Withdrawal by Subject|1|||
145471588|NCT00290498|524579694|FG001|Overall Study|Withdrawal by Subject|0|||
145471589|NCT00290498|524579693|FG000|Overall Study|Ineligible|3|||
145471590|NCT00290498|524579694|FG001|Overall Study|Ineligible|0|||
145471591|NCT00290498|524579693|FG000|Overall Study|Non-Compliance|1|||
145471592|NCT00290498|524579694|FG001|Overall Study|Non-Compliance|0|||
145471593|NCT04268173|524579697|FG000|Overall Study|Lost to Follow-up|75|||
145471594|NCT04268173|524579698|FG001|Overall Study|Lost to Follow-up|108|||
145471595|NCT00869401|524579699|FG000|Overall Study|Withdrawal by Subject|0|||
145471596|NCT00869401|524579700|FG001|Overall Study|Withdrawal by Subject|0|||
145471597|NCT00869401|524579701|FG002|Overall Study|Withdrawal by Subject|0|||
145471598|NCT00869401|524579702|FG003|Overall Study|Withdrawal by Subject|5|||
145471599|NCT00869401|524579703|FG004|Overall Study|Withdrawal by Subject|3|||
145471600|NCT01147900|524579704|FG000|At Year 10|Lost to Follow-up|0|||
145471601|NCT01147900|524579705|FG001|At Year 10|Lost to Follow-up|1|||
145471602|NCT01147900|524579706|FG002|At Year 10|Lost to Follow-up|0|||
145471603|NCT00975143|524579707|FG000|Overall Study|Adverse Event|19|||
145471604|NCT00975143|524579708|FG001|Overall Study|Adverse Event|15|||
145471605|NCT00975143|524579707|FG000|Overall Study|Withdrawal by Subject|15|||
145471606|NCT00975143|524579708|FG001|Overall Study|Withdrawal by Subject|15|||
145471607|NCT00975143|524579707|FG000|Overall Study|Lost to Follow-up|20|||
145471608|NCT00975143|524579708|FG001|Overall Study|Lost to Follow-up|16|||
145471609|NCT00975143|524579707|FG000|Overall Study|Non-compliance|5|||
145471610|NCT00975143|524579708|FG001|Overall Study|Non-compliance|8|||
145471611|NCT00975143|524579707|FG000|Overall Study|Physician Decision|1|||
145471612|NCT00975143|524579708|FG001|Overall Study|Physician Decision|2|||
145471613|NCT00975143|524579707|FG000|Overall Study|Details not available|10|||
145471614|NCT00975143|524579708|FG001|Overall Study|Details not available|4|||
145471615|NCT01375608|524579709|FG000|Overall Study|Withdrawal by Subject|2|||
145471616|NCT00581360|524579710|FG000|Overall Study|Withdrawal by Subject|1|||
145471617|NCT03129360|524579711|FG000|Overall Study|Did not meet entry criteria|0|||
145471618|NCT03129360|524579712|FG001|Overall Study|Did not meet entry criteria|2|||
145471619|NCT03129360|524579713|FG002|Overall Study|Did not meet entry criteria|1|||
145471620|NCT03129360|524579711|FG000|Overall Study|Excluded due to motion in scanner|1|||
145471621|NCT03129360|524579712|FG001|Overall Study|Excluded due to motion in scanner|0|||
145471622|NCT03129360|524579713|FG002|Overall Study|Excluded due to motion in scanner|0|||
145471623|NCT00545103|524579714|FG000|Overall Study|Lack of Efficacy|48|||
145471624|NCT00545103|524579715|FG001|Overall Study|Lack of Efficacy|45|||
145471625|NCT00545103|524579716|FG002|Overall Study|Lack of Efficacy|31|||
145471626|NCT00545103|524579717|FG003|Overall Study|Lack of Efficacy|27|||
145471627|NCT00545103|524579714|FG000|Overall Study|Withdrawal by Subject|6|||
145471628|NCT00545103|524579715|FG001|Overall Study|Withdrawal by Subject|10|||
145471629|NCT00545103|524579716|FG002|Overall Study|Withdrawal by Subject|18|||
145471630|NCT00545103|524579717|FG003|Overall Study|Withdrawal by Subject|22|||
145471631|NCT00545103|524579714|FG000|Overall Study|Adverse Event|11|||
145471632|NCT00545103|524579715|FG001|Overall Study|Adverse Event|12|||
145471633|NCT00545103|524579716|FG002|Overall Study|Adverse Event|17|||
145601437|NCT06060457|525054304|FG000|Overall Study|Other Than Specified|2|||
145601438|NCT06060457|525054305|FG001|Overall Study|Other Than Specified|1|||
145601439|NCT01533493|525054306|FG000|Overall Study|Adverse Event|2|||
145601440|NCT01533493|525054307|FG001|Overall Study|Adverse Event|1|||
145601441|NCT01533493|525054306|FG000|Overall Study|Withdrawal by Subject|1|||
145601442|NCT01533493|525054307|FG001|Overall Study|Withdrawal by Subject|2|||
145601443|NCT01533493|525054306|FG000|Overall Study|Lost to Follow-up|2|||
145601444|NCT01533493|525054307|FG001|Overall Study|Lost to Follow-up|0|||
145601445|NCT00386022|525054317|FG000|Plus Estrogen|Lost to Follow-up|2|||
145601446|NCT00386022|525054318|FG001|Plus Estrogen|Lost to Follow-up|0|||
145601447|NCT00386022|525054317|FG000|Plus Estrogen|Adverse Event|0|||
145601448|NCT00386022|525054318|FG001|Plus Estrogen|Adverse Event|1|||
145601449|NCT01648348|525054328|FG000|Overall Study|Cancel|1|||
145601450|NCT01648348|525054329|FG001|Overall Study|Cancel|0|||
145601451|NCT01648348|525054330|FG002|Overall Study|Cancel|0|||
145601452|NCT01648348|525054331|FG003|Overall Study|Cancel|0|||
145601453|NCT01648348|525054332|FG004|Overall Study|Cancel|3|||
145601454|NCT01648348|525054333|FG005|Overall Study|Cancel|6|||
145601455|NCT01648348|525054328|FG000|Overall Study|Replaced for MTD analysis|1|||
145601456|NCT01648348|525054329|FG001|Overall Study|Replaced for MTD analysis|0|||
145601457|NCT01648348|525054330|FG002|Overall Study|Replaced for MTD analysis|1|||
145601458|NCT01648348|525054331|FG003|Overall Study|Replaced for MTD analysis|0|||
145601459|NCT01648348|525054332|FG004|Overall Study|Replaced for MTD analysis|0|||
145601460|NCT01648348|525054333|FG005|Overall Study|Replaced for MTD analysis|0|||
145601461|NCT02778100|525054337|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
145601462|NCT02778100|525054338|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
145601463|NCT03419364|525054343|FG000|Overall Study|Delivery due to maternal condition|2|||
145601464|NCT03419364|525054344|FG001|Overall Study|Delivery due to maternal condition|0|||
145601465|NCT03419364|525054345|FG002|Overall Study|Delivery due to maternal condition|0|||
145601466|NCT00552084|525054346|FG000|Overall Study|Adverse Event|2|||
145601467|NCT00552084|525054347|FG001|Overall Study|Adverse Event|3|||
145601468|NCT00552084|525054346|FG000|Overall Study|Withdrawal by Subject|4|||
145601469|NCT00552084|525054347|FG001|Overall Study|Withdrawal by Subject|5|||
145601470|NCT00552084|525054346|FG000|Overall Study|Protocol Violation|1|||
145601471|NCT00552084|525054347|FG001|Overall Study|Protocol Violation|0|||
145601472|NCT00552084|525054346|FG000|Overall Study|change in anti-arrythmic drug|1|||
145601473|NCT00552084|525054347|FG001|Overall Study|change in anti-arrythmic drug|1|||
145601474|NCT01338025|525054348|FG000|Overall Study|Unexpected closure of study|10|||
145601475|NCT01338025|525054349|FG001|Overall Study|Unexpected closure of study|9|||
145601476|NCT01338025|525054348|FG000|Overall Study|Withdrawal by Subject|0|||
145601477|NCT01338025|525054349|FG001|Overall Study|Withdrawal by Subject|2|||
145601478|NCT01338025|525054348|FG000|Overall Study|Found ineligible after starting|1|||
145601479|NCT01338025|525054349|FG001|Overall Study|Found ineligible after starting|0|||
145601480|NCT03017079|525054350|FG000|Overall Study|Physician Decision|1|||
145601481|NCT03017079|525054351|FG001|Overall Study|Physician Decision|1|||
145601482|NCT03017079|525054350|FG000|Overall Study|Death|3|||
145601483|NCT03017079|525054351|FG001|Overall Study|Death|2|||
145601484|NCT03017079|525054350|FG000|Overall Study|Lack of Efficacy|2|||
145601485|NCT03017079|525054351|FG001|Overall Study|Lack of Efficacy|2|||
145601486|NCT03017079|525054350|FG000|Overall Study|Protocol Violation|0|||
145601487|NCT03017079|525054351|FG001|Overall Study|Protocol Violation|1|||
145601488|NCT04349280|525054354|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
145601489|NCT04349280|525054355|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
145601490|NCT04349280|525054354|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
145601491|NCT04349280|525054355|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
145471634|NCT00545103|524579717|FG003|Overall Study|Adverse Event|10|||
145471635|NCT00545103|524579714|FG000|Overall Study|Lost to Follow-up|4|||
145601492|NCT04349280|525054354|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
145628549|NCT03852433|525153362|FG003|Overall Study|Randomized but never treated|0|||
145628550|NCT01981850|525153363|FG000|Main Phase Stage 1|Death|2|||
145628551|NCT01981850|525153364|FG001|Main Phase Stage 1|Death|0|||
145628552|NCT01981850|525153365|FG002|Main Phase Stage 1|Death|0|||
145628553|NCT01981850|525153366|FG003|Main Phase Stage 1|Death|0|||
145628554|NCT01981850|525153367|FG004|Main Phase Stage 1|Death|0|||
145628555|NCT01981850|525153368|FG005|Main Phase Stage 1|Death|0|||
145628556|NCT01981850|525153369|FG006|Main Phase Stage 1|Death|0|||
145628557|NCT01981850|525153370|FG007|Main Phase Stage 1|Death|0|||
145628558|NCT01981850|525153371|FG008|Main Phase Stage 1|Death|0|||
145628559|NCT01981850|525153372|FG009|Main Phase Stage 1|Death|0|||
145628560|NCT01981850|525153363|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
145628561|NCT01981850|525153364|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628562|NCT01981850|525153365|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628563|NCT01981850|525153366|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628564|NCT01981850|525153367|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628565|NCT01981850|525153368|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628566|NCT01981850|525153369|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628567|NCT01981850|525153370|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628568|NCT01981850|525153371|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628569|NCT01981850|525153372|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
145628570|NCT01981850|525153363|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
145628571|NCT01981850|525153364|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
145628572|NCT01981850|525153365|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
145628573|NCT01981850|525153366|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
145628574|NCT01981850|525153367|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
145628575|NCT01981850|525153368|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
145471636|NCT00545103|524579715|FG001|Overall Study|Lost to Follow-up|6|||
145471637|NCT00545103|524579716|FG002|Overall Study|Lost to Follow-up|3|||
145471638|NCT00545103|524579717|FG003|Overall Study|Lost to Follow-up|4|||
145471639|NCT00545103|524579714|FG000|Overall Study|Protocol Violation|1|||
145471640|NCT00545103|524579715|FG001|Overall Study|Protocol Violation|2|||
145471641|NCT00545103|524579716|FG002|Overall Study|Protocol Violation|3|||
145471642|NCT00545103|524579717|FG003|Overall Study|Protocol Violation|0|||
145471643|NCT00545103|524579714|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
145471644|NCT00545103|524579715|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
145471645|NCT00545103|524579716|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
145471646|NCT00545103|524579717|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
145471647|NCT00545103|524579714|FG000|Overall Study|Difficult to open package|0|||
145471648|NCT00545103|524579715|FG001|Overall Study|Difficult to open package|0|||
145471649|NCT00545103|524579716|FG002|Overall Study|Difficult to open package|0|||
145471650|NCT00545103|524579717|FG003|Overall Study|Difficult to open package|1|||
145471651|NCT00545103|524579714|FG000|Overall Study|Investigational product not taken|1|||
145471652|NCT00545103|524579715|FG001|Overall Study|Investigational product not taken|0|||
145471653|NCT00545103|524579716|FG002|Overall Study|Investigational product not taken|0|||
145471654|NCT00545103|524579717|FG003|Overall Study|Investigational product not taken|1|||
145471655|NCT00545103|524579714|FG000|Overall Study|Wish to start a family|0|||
145471656|NCT00545103|524579715|FG001|Overall Study|Wish to start a family|0|||
145471657|NCT00545103|524579716|FG002|Overall Study|Wish to start a family|0|||
145471658|NCT00545103|524579717|FG003|Overall Study|Wish to start a family|1|||
145471659|NCT00545103|524579714|FG000|Overall Study|Diverticulitis crisis|0|||
145471660|NCT00545103|524579715|FG001|Overall Study|Diverticulitis crisis|0|||
145471661|NCT00545103|524579716|FG002|Overall Study|Diverticulitis crisis|0|||
145471662|NCT00545103|524579717|FG003|Overall Study|Diverticulitis crisis|1|||
145471663|NCT00545103|524579714|FG000|Overall Study|Personal reasons|1|||
145471664|NCT00545103|524579715|FG001|Overall Study|Personal reasons|0|||
145471665|NCT00545103|524579716|FG002|Overall Study|Personal reasons|0|||
145471666|NCT00545103|524579717|FG003|Overall Study|Personal reasons|0|||
145471667|NCT00545103|524579714|FG000|Overall Study|Subject's decision|1|||
145628576|NCT01981850|525153369|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
145471668|NCT00545103|524579715|FG001|Overall Study|Subject's decision|0|||
145628577|NCT01981850|525153370|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
145628578|NCT01981850|525153371|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
145471669|NCT00545103|524579716|FG002|Overall Study|Subject's decision|0|||
145471670|NCT00545103|524579717|FG003|Overall Study|Subject's decision|0|||
145471671|NCT00545103|524579714|FG000|Overall Study|Noncompliance|0|||
145471672|NCT00545103|524579715|FG001|Overall Study|Noncompliance|1|||
145628579|NCT01981850|525153372|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
145628580|NCT01981850|525153363|FG000|Main Phase Stage 1|Various reasons|0|||
145628581|NCT01981850|525153364|FG001|Main Phase Stage 1|Various reasons|0|||
145628582|NCT01981850|525153365|FG002|Main Phase Stage 1|Various reasons|2|||
145628583|NCT01981850|525153366|FG003|Main Phase Stage 1|Various reasons|0|||
145471673|NCT00545103|524579716|FG002|Overall Study|Noncompliance|0|||
145471674|NCT00545103|524579717|FG003|Overall Study|Noncompliance|0|||
145471675|NCT00545103|524579714|FG000|Overall Study|Investigator decision|0|||
145471676|NCT00545103|524579715|FG001|Overall Study|Investigator decision|0|||
145471677|NCT00545103|524579716|FG002|Overall Study|Investigator decision|1|||
145471678|NCT00545103|524579717|FG003|Overall Study|Investigator decision|0|||
145471679|NCT00545103|524579714|FG000|Overall Study|Subject moved|0|||
145471680|NCT00545103|524579715|FG001|Overall Study|Subject moved|1|||
145471681|NCT00545103|524579716|FG002|Overall Study|Subject moved|0|||
145471682|NCT00545103|524579717|FG003|Overall Study|Subject moved|0|||
145471683|NCT00545103|524579714|FG000|Overall Study|Use of prohibited medication|0|||
145471684|NCT00545103|524579715|FG001|Overall Study|Use of prohibited medication|0|||
145471685|NCT00545103|524579716|FG002|Overall Study|Use of prohibited medication|1|||
145471686|NCT00545103|524579717|FG003|Overall Study|Use of prohibited medication|0|||
145471687|NCT00545103|524579714|FG000|Overall Study|Does not want to take study drug anymore|1|||
145471688|NCT00545103|524579715|FG001|Overall Study|Does not want to take study drug anymore|0|||
145471689|NCT00545103|524579716|FG002|Overall Study|Does not want to take study drug anymore|1|||
145471690|NCT00545103|524579717|FG003|Overall Study|Does not want to take study drug anymore|0|||
145471691|NCT00545103|524579714|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
145471692|NCT00545103|524579715|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
145471693|NCT00545103|524579716|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
145471694|NCT00545103|524579717|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
145471695|NCT00545103|524579714|FG000|Overall Study|Death|0|||
145471696|NCT00545103|524579715|FG001|Overall Study|Death|1|||
145471697|NCT00545103|524579716|FG002|Overall Study|Death|0|||
145471698|NCT00545103|524579717|FG003|Overall Study|Death|0|||
145471699|NCT01353911|524579718|FG000|Overall Study|Lost to Follow-up|2|||
145471700|NCT01353911|524579719|FG001|Overall Study|Lost to Follow-up|6|||
145471701|NCT01353911|524579720|FG002|Overall Study|Lost to Follow-up|4|||
145471702|NCT01353911|524579721|FG003|Overall Study|Lost to Follow-up|0|||
145471703|NCT01353911|524579722|FG004|Overall Study|Lost to Follow-up|4|||
145471704|NCT01353911|524579723|FG005|Overall Study|Lost to Follow-up|4|||
145471705|NCT01353911|524579724|FG006|Overall Study|Lost to Follow-up|3|||
145471706|NCT01353911|524579725|FG007|Overall Study|Lost to Follow-up|6|||
145471707|NCT01353911|524579718|FG000|Overall Study|Withdrawal by Subject|2|||
145471708|NCT01353911|524579719|FG001|Overall Study|Withdrawal by Subject|3|||
145471709|NCT01353911|524579720|FG002|Overall Study|Withdrawal by Subject|4|||
145471710|NCT01353911|524579721|FG003|Overall Study|Withdrawal by Subject|2|||
145471711|NCT01353911|524579722|FG004|Overall Study|Withdrawal by Subject|2|||
145471712|NCT01353911|524579723|FG005|Overall Study|Withdrawal by Subject|3|||
145471713|NCT01353911|524579724|FG006|Overall Study|Withdrawal by Subject|3|||
145471714|NCT01353911|524579725|FG007|Overall Study|Withdrawal by Subject|9|||
145471715|NCT01353911|524579718|FG000|Overall Study|Status Not Recorded|4|||
145471716|NCT01353911|524579719|FG001|Overall Study|Status Not Recorded|0|||
145471717|NCT01353911|524579720|FG002|Overall Study|Status Not Recorded|1|||
145471718|NCT01353911|524579721|FG003|Overall Study|Status Not Recorded|0|||
145471719|NCT01353911|524579722|FG004|Overall Study|Status Not Recorded|0|||
145471720|NCT01353911|524579723|FG005|Overall Study|Status Not Recorded|0|||
145471721|NCT01353911|524579724|FG006|Overall Study|Status Not Recorded|0|||
145471722|NCT01353911|524579725|FG007|Overall Study|Status Not Recorded|0|||
145471723|NCT00082381|524579726|FG000|Overall Study|Adverse Event|27|||
145471724|NCT00082381|524579727|FG001|Overall Study|Adverse Event|2|||
145471725|NCT00082381|524579726|FG000|Overall Study|Lost to Follow-up|5|||
145471726|NCT00082381|524579727|FG001|Overall Study|Lost to Follow-up|7|||
145471727|NCT00082381|524579726|FG000|Overall Study|Patient Decision|8|||
145471728|NCT00082381|524579727|FG001|Overall Study|Patient Decision|4|||
145471729|NCT00082381|524579726|FG000|Overall Study|Physician Decision|1|||
145471730|NCT00082381|524579727|FG001|Overall Study|Physician Decision|2|||
145471731|NCT00082381|524579726|FG000|Overall Study|Protocol Violation|10|||
145471732|NCT00082381|524579727|FG001|Overall Study|Protocol Violation|11|||
145471733|NCT00082381|524579726|FG000|Overall Study|Loss of Glucose Control|4|||
145471734|NCT00082381|524579727|FG001|Overall Study|Loss of Glucose Control|0|||
145471735|NCT02925741|524579730|FG000|Overall Study|Withdrawal by Subject|11|||
145471736|NCT02925741|524579731|FG001|Overall Study|Withdrawal by Subject|0|||
145471737|NCT00494507|524579734|FG000|Double-Blind Phase|Adverse Event|2|||
145471738|NCT00494507|524579735|FG001|Double-Blind Phase|Adverse Event|0|||
145471739|NCT00494507|524579736|FG002|Double-Blind Phase|Adverse Event|1|||
145471740|NCT00494507|524579737|FG003|Double-Blind Phase|Adverse Event|0|||
145471741|NCT00494507|524579734|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
145471742|NCT00494507|524579735|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
145471743|NCT00494507|524579736|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
145471744|NCT00494507|524579737|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
145601493|NCT04349280|525054355|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
145601494|NCT00526630|525056201|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
145601495|NCT00526630|525056202|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
145471745|NCT00494507|524579734|FG000|Double-Blind Phase|Subject Non-compliance|0|||
145471746|NCT00494507|524579735|FG001|Double-Blind Phase|Subject Non-compliance|0|||
145471747|NCT00494507|524579736|FG002|Double-Blind Phase|Subject Non-compliance|1|||
145471748|NCT00494507|524579737|FG003|Double-Blind Phase|Subject Non-compliance|0|||
145471749|NCT00494507|524579734|FG000|Double-Blind Phase|Negative DNA test|0|||
145471750|NCT00494507|524579735|FG001|Double-Blind Phase|Negative DNA test|0|||
145471751|NCT00494507|524579736|FG002|Double-Blind Phase|Negative DNA test|0|||
145471752|NCT00494507|524579737|FG003|Double-Blind Phase|Negative DNA test|1|||
145471753|NCT00494507|524579734|FG000|Open-Label Phase|Adverse Event|0|||
145471754|NCT00494507|524579735|FG001|Open-Label Phase|Adverse Event|1|||
145471755|NCT00494507|524579736|FG002|Open-Label Phase|Adverse Event|5|||
145471756|NCT00494507|524579737|FG003|Open-Label Phase|Adverse Event|3|||
145471757|NCT00494507|524579734|FG000|Open-Label Phase|Worsening Disease|0|||
145471758|NCT00494507|524579735|FG001|Open-Label Phase|Worsening Disease|0|||
145471759|NCT00494507|524579736|FG002|Open-Label Phase|Worsening Disease|0|||
145471760|NCT00494507|524579737|FG003|Open-Label Phase|Worsening Disease|2|||
145471761|NCT00295932|524579738|FG000|Overall Study|Not Treated|0|||
145471762|NCT00295932|524579739|FG001|Overall Study|Not Treated|0|||
145471763|NCT00295932|524579740|FG002|Overall Study|Not Treated|0|||
145471764|NCT00295932|524579741|FG003|Overall Study|Not Treated|0|||
145471765|NCT00295932|524579742|FG004|Overall Study|Not Treated|0|||
145471766|NCT00295932|524579743|FG005|Overall Study|Not Treated|0|||
145471767|NCT00295932|524579744|FG006|Overall Study|Not Treated|0|||
145471768|NCT00295932|524579745|FG007|Overall Study|Not Treated|0|||
145471769|NCT00295932|524579746|FG008|Overall Study|Not Treated|0|||
145471770|NCT00295932|524579747|FG009|Overall Study|Not Treated|0|||
145471771|NCT00295932|524579748|FG010|Overall Study|Not Treated|1|||
145471772|NCT00587847|524579749|FG000|Overall Study|Lack of Efficacy|5|||
145471773|NCT00587847|524579749|FG000|Overall Study|Adverse Event|2|||
145471774|NCT04032080|524579750|FG000|Overall Study|Death|6|||
145471775|NCT03729245|524579754|FG000|Overall Study|Lost to Follow-up|5|||
145471776|NCT03729245|524579755|FG001|Overall Study|Lost to Follow-up|6|||
145471777|NCT03729245|524579754|FG000|Overall Study|Withdrawal by Subject|16|||
145471778|NCT03729245|524579755|FG001|Overall Study|Withdrawal by Subject|19|||
145471779|NCT03729245|524579754|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
145471780|NCT03729245|524579755|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
145471781|NCT00884832|524579756|FG000|Overall Study|Withdrawal by Subject|0|||
145471782|NCT00884832|524579757|FG001|Overall Study|Withdrawal by Subject|1|||
145471783|NCT02096263|524579758|FG000|Overall Study|Adverse Event|1|||
145471784|NCT02096263|524579759|FG001|Overall Study|Adverse Event|0|||
145471785|NCT02096263|524579760|FG002|Overall Study|Adverse Event|1|||
145471786|NCT02096263|524579758|FG000|Overall Study|Lost to Follow-up|14|||
145471787|NCT02096263|524579759|FG001|Overall Study|Lost to Follow-up|18|||
145471788|NCT02096263|524579760|FG002|Overall Study|Lost to Follow-up|15|||
145471789|NCT02096263|524579758|FG000|Overall Study|Other|7|||
145471790|NCT02096263|524579759|FG001|Overall Study|Other|9|||
145471791|NCT02096263|524579760|FG002|Overall Study|Other|6|||
145471792|NCT02096263|524579758|FG000|Overall Study|Sponsor study termination|0|||
145471793|NCT02096263|524579759|FG001|Overall Study|Sponsor study termination|0|||
145471794|NCT02096263|524579760|FG002|Overall Study|Sponsor study termination|1|||
145471795|NCT02096263|524579758|FG000|Overall Study|Protocol Violation|7|||
145471796|NCT02096263|524579759|FG001|Overall Study|Protocol Violation|2|||
145471797|NCT02096263|524579760|FG002|Overall Study|Protocol Violation|8|||
145471798|NCT02096263|524579758|FG000|Overall Study|Withdrawal by Subject|5|||
145471799|NCT02096263|524579759|FG001|Overall Study|Withdrawal by Subject|7|||
145471800|NCT02096263|524579760|FG002|Overall Study|Withdrawal by Subject|8|||
145471801|NCT02337725|524579761|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
145471802|NCT02337725|524579762|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
145471803|NCT02337725|524579761|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
145471804|NCT02337725|524579762|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
145471805|NCT02337725|524579761|FG000|Overall Study|Major Protocol Deviation|0|||
145471806|NCT02337725|524579762|FG001|Overall Study|Major Protocol Deviation|1|||
145471807|NCT02337725|524579761|FG000|Overall Study|Voluntary Withdrawal|14|||
145471808|NCT02337725|524579762|FG001|Overall Study|Voluntary Withdrawal|3|||
145471809|NCT02337725|524579761|FG000|Overall Study|Lack of Efficacy|4|||
145471810|NCT02337725|524579762|FG001|Overall Study|Lack of Efficacy|0|||
145471811|NCT03322423|524579763|FG000|Period 1|Subject no longer eligible|0|||
145471812|NCT03322423|524579764|FG001|Period 1|Subject no longer eligible|1|||
145601496|NCT00526630|525056201|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
145471813|NCT03322423|524579763|FG000|Period 1|Withdrawal by Subject|0|||
145471814|NCT03322423|524579764|FG001|Period 1|Withdrawal by Subject|1|||
145471815|NCT03322423|524579763|FG000|Period 1|Incorrect Lens Dispensed|1|||
145471816|NCT03322423|524579764|FG001|Period 1|Incorrect Lens Dispensed|0|||
145471817|NCT03322423|524579763|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
145471818|NCT03322423|524579764|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
145471819|NCT03322423|524579763|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
145471820|NCT03322423|524579764|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
145471821|NCT03322423|524579763|FG000|Period 2|Protocol Violation|1|||
145471822|NCT03322423|524579764|FG001|Period 2|Protocol Violation|0|||
145471823|NCT03322423|524579763|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
145471824|NCT03322423|524579764|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
145471825|NCT04891107|524579766|FG000|Overall Study|Physician Decision|1|||
145471826|NCT04891107|524579766|FG000|Overall Study|Withdrawal by Subject|1|||
145471827|NCT04891107|524579766|FG000|Overall Study|Screen failure after consent|1|||
145471828|NCT00500760|524579773|FG000|Overall Study|Death|32|||
145471829|NCT00500760|524579774|FG001|Overall Study|Death|15|||
145471830|NCT00500760|524579773|FG000|Overall Study|Withdrawal by Subject|5|||
145471831|NCT00500760|524579774|FG001|Overall Study|Withdrawal by Subject|7|||
145471832|NCT00500760|524579773|FG000|Overall Study|Administrative decision|2|||
145471833|NCT00500760|524579774|FG001|Overall Study|Administrative decision|0|||
145471834|NCT00500760|524579773|FG000|Overall Study|Lost to Follow-up|3|||
145471835|NCT00500760|524579774|FG001|Overall Study|Lost to Follow-up|0|||
145471836|NCT00500760|524579773|FG000|Overall Study|Other|1|||
145471837|NCT00500760|524579774|FG001|Overall Study|Other|2|||
145471838|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
145471839|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
145471840|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
145471841|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
145471842|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
145471843|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
145471844|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
145471845|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
145471846|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
145471847|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
145471848|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
145471849|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
145471850|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
145471851|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
145471852|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471853|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
145471854|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
145471855|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471856|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471857|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471858|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471859|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
145471860|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471861|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
145471862|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
145471863|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
145471864|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
145471865|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
145471866|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471867|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471868|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471869|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471870|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
145471871|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
145471872|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
145471873|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
145471874|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471875|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
145471876|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
145471877|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471878|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471879|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471880|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471881|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
145471882|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471883|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471884|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
145471885|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471886|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471887|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
145628584|NCT01981850|525153367|FG004|Main Phase Stage 1|Various reasons|0|||
145628585|NCT01981850|525153368|FG005|Main Phase Stage 1|Various reasons|0|||
145471888|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471889|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471890|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471891|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471892|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
145471893|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
145471894|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471895|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471896|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471897|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471898|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471899|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471900|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471901|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471902|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471903|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
145471904|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471905|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471906|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
145471907|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471908|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471909|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471910|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471911|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471912|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471913|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471914|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
145471915|NCT02914561|524579775|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
145471916|NCT02914561|524579776|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471917|NCT02914561|524579777|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
145471918|NCT02914561|524579778|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
145471919|NCT02914561|524579779|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
145471920|NCT02914561|524579780|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
145471921|NCT02914561|524579781|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471922|NCT02914561|524579782|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471923|NCT02914561|524579783|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471924|NCT02914561|524579784|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471925|NCT02914561|524579785|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
145471926|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471927|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471928|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471929|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471930|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471931|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
145471932|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
145471933|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
145471934|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
145471935|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
145471936|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
145471937|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471938|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471939|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471940|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471941|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471942|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
145471943|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
145471944|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
145471945|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
145471946|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
145471947|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
145471948|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145471949|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145471950|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145471951|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145471952|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145471953|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
145601497|NCT00526630|525056202|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
145601498|NCT05168579|525056203|FG000|Overall Study|Lack of Consent|1|||
145601499|NCT05168579|525056204|FG001|Overall Study|Lack of Consent|0|||
145471954|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
145471955|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
145471956|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
145471957|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
145471958|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
145471959|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471960|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471961|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471962|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471963|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471964|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471965|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
145471966|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471967|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
145471968|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
145471969|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
145471970|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471971|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471972|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471973|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471974|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471975|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471976|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
145471977|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
145471978|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
145471979|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
145471980|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
145471981|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471982|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471983|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471984|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471985|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471986|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471987|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
145471988|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471989|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
145471990|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471991|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
145471992|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471993|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471994|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471995|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471996|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471997|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471998|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145471999|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145472000|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
145472001|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145472002|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
145472003|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472004|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472005|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472006|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472007|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472008|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472009|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
145472010|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472011|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472012|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472013|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
145472014|NCT02914561|524579775|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472015|NCT02914561|524579776|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472016|NCT02914561|524579777|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472017|NCT02914561|524579778|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145601500|NCT05168579|525056203|FG000|Overall Study|Conflicts with time|2|||
145472018|NCT02914561|524579779|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472019|NCT02914561|524579780|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472020|NCT02914561|524579781|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472021|NCT02914561|524579782|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
145472022|NCT02914561|524579783|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
145472023|NCT02914561|524579784|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
145472024|NCT02914561|524579785|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
145472025|NCT01300455|524579786|FG000|Washout|Withdrawal by Subject|1|||
145472026|NCT01300455|524579787|FG001|Washout|Withdrawal by Subject|0|||
145472027|NCT03332160|524579788|FG000|Overall Study|Withdrawal by Subject|1|||
145472028|NCT03332160|524579789|FG001|Overall Study|Withdrawal by Subject|1|||
145472029|NCT03332160|524579788|FG000|Overall Study|Adverse Event|0|||
145472030|NCT03332160|524579789|FG001|Overall Study|Adverse Event|1|||
145472031|NCT03332160|524579788|FG000|Overall Study|Developed Exclusion Criteria|0|||
145472032|NCT03332160|524579789|FG001|Overall Study|Developed Exclusion Criteria|1|||
145472033|NCT03332160|524579788|FG000|Overall Study|Non-adherence to treatment|0|||
145472034|NCT03332160|524579789|FG001|Overall Study|Non-adherence to treatment|2|||
145472035|NCT01270256|524579795|FG000|Overall Study|Withdrawal by Subject|1|||
145472036|NCT01270256|524579796|FG001|Overall Study|Withdrawal by Subject|0|||
145472037|NCT02879578|524579797|FG000|Overall Study|Adverse Event|1|||
145472038|NCT02879578|524579798|FG001|Overall Study|Adverse Event|2|||
145472039|NCT02879578|524579799|FG002|Overall Study|Adverse Event|14|||
145472040|NCT02879578|524579797|FG000|Overall Study|Protocol Violation|0|||
145472041|NCT02879578|524579798|FG001|Overall Study|Protocol Violation|1|||
145472042|NCT02879578|524579799|FG002|Overall Study|Protocol Violation|1|||
145472043|NCT02879578|524579797|FG000|Overall Study|Withdrawal by Subject|8|||
145472044|NCT02879578|524579798|FG001|Overall Study|Withdrawal by Subject|6|||
145472045|NCT02879578|524579799|FG002|Overall Study|Withdrawal by Subject|9|||
145472046|NCT02879578|524579797|FG000|Overall Study|Lost to Follow-up|1|||
145472047|NCT02879578|524579798|FG001|Overall Study|Lost to Follow-up|0|||
145472048|NCT02879578|524579799|FG002|Overall Study|Lost to Follow-up|4|||
145472049|NCT02879578|524579797|FG000|Overall Study|Physician Decision|0|||
145472050|NCT02879578|524579798|FG001|Overall Study|Physician Decision|0|||
145472051|NCT02879578|524579799|FG002|Overall Study|Physician Decision|4|||
145472052|NCT02177838|524579802|FG000|Overall Study|Withdrawal by Subject|1|||
145472053|NCT02177838|524579802|FG000|Overall Study|Physician Decision|1|||
145472054|NCT02177838|524579802|FG000|Overall Study|Death|1|||
145472055|NCT03517566|524579803|FG000|Overall Study|Adverse Event|5|||
145472056|NCT03517566|524579804|FG001|Overall Study|Adverse Event|2|||
145472057|NCT03517566|524579805|FG002|Overall Study|Adverse Event|2|||
145472058|NCT03517566|524579806|FG003|Overall Study|Adverse Event|8|||
145472059|NCT03517566|524579807|FG004|Overall Study|Adverse Event|7|||
145472060|NCT03517566|524579803|FG000|Overall Study|Lack of Efficacy|3|||
145472061|NCT03517566|524579804|FG001|Overall Study|Lack of Efficacy|2|||
145472062|NCT03517566|524579805|FG002|Overall Study|Lack of Efficacy|1|||
145472063|NCT03517566|524579806|FG003|Overall Study|Lack of Efficacy|1|||
145472064|NCT03517566|524579807|FG004|Overall Study|Lack of Efficacy|4|||
145472065|NCT03517566|524579803|FG000|Overall Study|Lost to Follow-up|3|||
145472066|NCT03517566|524579804|FG001|Overall Study|Lost to Follow-up|1|||
145472067|NCT03517566|524579805|FG002|Overall Study|Lost to Follow-up|1|||
145472068|NCT03517566|524579806|FG003|Overall Study|Lost to Follow-up|1|||
145472069|NCT03517566|524579807|FG004|Overall Study|Lost to Follow-up|0|||
145472070|NCT03517566|524579803|FG000|Overall Study|Physician Decision|1|||
145472071|NCT03517566|524579804|FG001|Overall Study|Physician Decision|1|||
145472072|NCT03517566|524579805|FG002|Overall Study|Physician Decision|0|||
145472073|NCT03517566|524579806|FG003|Overall Study|Physician Decision|1|||
145472074|NCT03517566|524579807|FG004|Overall Study|Physician Decision|0|||
145472075|NCT03517566|524579803|FG000|Overall Study|Pregnancy|0|||
145472076|NCT03517566|524579804|FG001|Overall Study|Pregnancy|1|||
145472077|NCT03517566|524579805|FG002|Overall Study|Pregnancy|0|||
145472078|NCT03517566|524579806|FG003|Overall Study|Pregnancy|0|||
145472079|NCT03517566|524579807|FG004|Overall Study|Pregnancy|0|||
145472080|NCT03517566|524579803|FG000|Overall Study|Protocol Deviation|0|||
145472081|NCT03517566|524579804|FG001|Overall Study|Protocol Deviation|1|||
145472082|NCT03517566|524579805|FG002|Overall Study|Protocol Deviation|0|||
145601501|NCT05168579|525056204|FG001|Overall Study|Conflicts with time|0|||
145601502|NCT05168579|525056203|FG000|Overall Study|Time slots were full|3|||
145472083|NCT03517566|524579806|FG003|Overall Study|Protocol Deviation|1|||
145472084|NCT03517566|524579807|FG004|Overall Study|Protocol Deviation|1|||
145472085|NCT03517566|524579803|FG000|Overall Study|Study terminated by Sponsor|11|||
145472086|NCT03517566|524579804|FG001|Overall Study|Study terminated by Sponsor|5|||
145472087|NCT03517566|524579805|FG002|Overall Study|Study terminated by Sponsor|6|||
145472088|NCT03517566|524579806|FG003|Overall Study|Study terminated by Sponsor|14|||
145472089|NCT03517566|524579807|FG004|Overall Study|Study terminated by Sponsor|12|||
145472090|NCT03517566|524579803|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
145472091|NCT03517566|524579804|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
145472092|NCT03517566|524579805|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
145472093|NCT03517566|524579806|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
145472094|NCT03517566|524579807|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
145472095|NCT00737633|524579808|FG000|Overall Study|Study terminated by sponsor|44|||
145472096|NCT00737633|524579809|FG001|Overall Study|Study terminated by sponsor|55|||
145472097|NCT00737633|524579808|FG000|Overall Study|Lost to Follow-up|0|||
145472098|NCT00737633|524579809|FG001|Overall Study|Lost to Follow-up|1|||
145472099|NCT00737633|524579808|FG000|Overall Study|protocol non-compliance|0|||
145472100|NCT00737633|524579809|FG001|Overall Study|protocol non-compliance|1|||
145472101|NCT00377364|524579810|FG000|Overall Study|Lost to Follow-up|1|||
145472102|NCT00377364|524579811|FG001|Overall Study|Lost to Follow-up|0|||
145472103|NCT00377364|524579810|FG000|Overall Study|Withdrawal by Subject|1|||
145472104|NCT00377364|524579811|FG001|Overall Study|Withdrawal by Subject|0|||
145472105|NCT02925728|524579812|FG000|Overall Study|Death|3|||
145472106|NCT02925728|524579813|FG001|Overall Study|Death|5|||
145472107|NCT02925728|524579812|FG000|Overall Study|Physician Decision|1|||
145472108|NCT02925728|524579813|FG001|Overall Study|Physician Decision|0|||
145472109|NCT02925728|524579812|FG000|Overall Study|Withdrawal by Subject|1|||
145472110|NCT02925728|524579813|FG001|Overall Study|Withdrawal by Subject|0|||
145472111|NCT05098509|524579814|FG000|Overall Study|Withdrawal by Subject|0|||
145472112|NCT05098509|524579815|FG001|Overall Study|Withdrawal by Subject|0|||
145472113|NCT05098509|524579816|FG002|Overall Study|Withdrawal by Subject|1|||
145472114|NCT05098509|524579817|FG003|Overall Study|Withdrawal by Subject|0|||
145472115|NCT05098509|524579814|FG000|Overall Study|Early study termination|1|||
145472116|NCT05098509|524579815|FG001|Overall Study|Early study termination|1|||
145472117|NCT05098509|524579816|FG002|Overall Study|Early study termination|1|||
145472118|NCT05098509|524579817|FG003|Overall Study|Early study termination|0|||
145472119|NCT03101085|524579818|FG000|Overall Study|Lost to Follow-up|0|||
145472120|NCT03101085|524579819|FG001|Overall Study|Lost to Follow-up|1|||
145472121|NCT01972789|524579822|FG000|Overall Study|Adverse Event|11|||
145472122|NCT01972789|524579823|FG001|Overall Study|Adverse Event|4|||
145472123|NCT01972789|524579822|FG000|Overall Study|Subject withdrew consent|14|||
145472124|NCT01972789|524579823|FG001|Overall Study|Subject withdrew consent|12|||
145472125|NCT01972789|524579822|FG000|Overall Study|Lost to Follow-up|4|||
145472126|NCT01972789|524579823|FG001|Overall Study|Lost to Follow-up|7|||
145472127|NCT01972789|524579822|FG000|Overall Study|Death|7|||
145472128|NCT01972789|524579823|FG001|Overall Study|Death|5|||
145472129|NCT01972789|524579822|FG000|Overall Study|Protocol deviation|1|||
145472130|NCT01972789|524579823|FG001|Overall Study|Protocol deviation|0|||
145472131|NCT01972789|524579822|FG000|Overall Study|Physician Decision|3|||
145472132|NCT01972789|524579823|FG001|Overall Study|Physician Decision|2|||
145472133|NCT00086411|524579826|FG000|Overall Study|Lost to Follow-up|11|||
145472134|NCT00086411|524579827|FG001|Overall Study|Lost to Follow-up|11|||
145472135|NCT00086411|524579828|FG002|Overall Study|Lost to Follow-up|13|||
145472136|NCT00086411|524579829|FG003|Overall Study|Lost to Follow-up|12|||
145472137|NCT01078168|524579832|FG000|Overall Study|Physician Decision|0|||
145472138|NCT01078168|524579833|FG001|Overall Study|Physician Decision|1|||
145472139|NCT02100475|524581624|FG000|Overall Study|Unclassified|1|||
145472140|NCT02100475|524581625|FG001|Overall Study|Unclassified|2|||
145472141|NCT02100475|524581624|FG000|Overall Study|Withdrawal criteria|1|||
145472142|NCT02100475|524581625|FG001|Overall Study|Withdrawal criteria|0|||
145472143|NCT02315560|524581629|FG000|Overall Study|noncompliance by subjects|3|||
145472144|NCT01209078|524581630|FG000|Overall Study|Adverse Event|5|||
145472145|NCT01209078|524581631|FG001|Overall Study|Adverse Event|0|||
145472146|NCT01209078|524581630|FG000|Overall Study|Lost to Follow-up|4|||
145472147|NCT01209078|524581631|FG001|Overall Study|Lost to Follow-up|0|||
145472148|NCT01209078|524581630|FG000|Overall Study|Physician Decision|5|||
145472149|NCT01209078|524581631|FG001|Overall Study|Physician Decision|2|||
145472150|NCT01209078|524581630|FG000|Overall Study|Withdrawal by Subject|2|||
145472151|NCT01209078|524581631|FG001|Overall Study|Withdrawal by Subject|1|||
145472152|NCT00924508|524581632|FG000|Overall Study|Withdrawal by Subject|3|||
145472153|NCT03464019|524581633|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
145472154|NCT03464019|524581634|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
145472155|NCT03464019|524581635|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
145472156|NCT03464019|524581633|FG000|NODE-301 Part 1|Ablation|0|||
145472157|NCT03464019|524581634|FG001|NODE-301 Part 1|Ablation|0|||
145472158|NCT03464019|524581635|FG002|NODE-301 Part 1|Ablation|16|||
145472159|NCT03464019|524581633|FG000|NODE-301 Part 1|Test Dose Failure|0|||
145472160|NCT03464019|524581634|FG001|NODE-301 Part 1|Test Dose Failure|0|||
145472161|NCT03464019|524581635|FG002|NODE-301 Part 1|Test Dose Failure|8|||
145472162|NCT03464019|524581633|FG000|NODE-301 Part 1|Adverse Event|0|||
145472163|NCT03464019|524581634|FG001|NODE-301 Part 1|Adverse Event|0|||
145472164|NCT03464019|524581635|FG002|NODE-301 Part 1|Adverse Event|5|||
145472165|NCT03464019|524581633|FG000|NODE-301 Part 1|Physician Decision|0|||
145472166|NCT03464019|524581634|FG001|NODE-301 Part 1|Physician Decision|0|||
145472167|NCT03464019|524581635|FG002|NODE-301 Part 1|Physician Decision|4|||
145472168|NCT03464019|524581633|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
145472169|NCT03464019|524581634|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
145472170|NCT03464019|524581635|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
145472171|NCT03464019|524581633|FG000|NODE-301 Part 1|Protocol Violation|0|||
145472172|NCT03464019|524581634|FG001|NODE-301 Part 1|Protocol Violation|0|||
145472173|NCT03464019|524581635|FG002|NODE-301 Part 1|Protocol Violation|2|||
145472174|NCT03464019|524581633|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
145472175|NCT03464019|524581634|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
145472176|NCT03464019|524581635|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
145472177|NCT03464019|524581633|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
145472178|NCT03464019|524581634|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
145472179|NCT03464019|524581635|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
145472180|NCT03464019|524581633|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
145472181|NCT03464019|524581634|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
145472182|NCT03464019|524581635|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
145472183|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
145472184|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
145472185|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
145472186|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
145472187|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
145472188|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
145472189|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
145472190|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
145472191|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
145472192|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
145472193|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
145472194|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
145472195|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
145472196|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
145472197|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
145472198|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
145472199|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
145472200|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
145472201|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
145472202|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
145472203|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
145472204|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
145472205|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
145472206|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
145472207|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
145472208|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
145472209|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
145472210|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
145472211|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
145472212|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
145472213|NCT03464019|524581633|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
145472214|NCT03464019|524581634|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
145472215|NCT03464019|524581635|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
145472216|NCT00767806|524581636|FG000|Overall Study|Adverse Event|30|||
145472217|NCT00767806|524581637|FG001|Overall Study|Adverse Event|11|||
145472218|NCT00767806|524581636|FG000|Overall Study|Withdrawal by Subject|8|||
145472219|NCT00767806|524581637|FG001|Overall Study|Withdrawal by Subject|13|||
145472220|NCT00767806|524581636|FG000|Overall Study|Protocol Violation|6|||
145472221|NCT00767806|524581637|FG001|Overall Study|Protocol Violation|5|||
145472222|NCT00767806|524581636|FG000|Overall Study|Lack of Efficacy|1|||
145628586|NCT01981850|525153369|FG006|Main Phase Stage 1|Various reasons|0|||
145628587|NCT01981850|525153370|FG007|Main Phase Stage 1|Various reasons|0|||
145472223|NCT00767806|524581637|FG001|Overall Study|Lack of Efficacy|9|||
145472224|NCT00767806|524581636|FG000|Overall Study|Physician Decision|4|||
145472225|NCT00767806|524581637|FG001|Overall Study|Physician Decision|3|||
145472226|NCT00767806|524581636|FG000|Overall Study|Lost to Follow-up|1|||
145472227|NCT00767806|524581637|FG001|Overall Study|Lost to Follow-up|4|||
145472228|NCT00767806|524581636|FG000|Overall Study|Entry Criteria Not Met|1|||
145472229|NCT00767806|524581637|FG001|Overall Study|Entry Criteria Not Met|1|||
145472230|NCT00767806|524581636|FG000|Overall Study|Sponsor Decision|0|||
145472231|NCT00767806|524581637|FG001|Overall Study|Sponsor Decision|1|||
145628588|NCT01981850|525153371|FG008|Main Phase Stage 1|Various reasons|0|||
145628589|NCT01981850|525153372|FG009|Main Phase Stage 1|Various reasons|0|||
145472232|NCT00704288|524581638|FG000|Overall Treatment Period|Adverse Event|11|||
145472233|NCT00704288|524581639|FG001|Overall Treatment Period|Adverse Event|8|||
145472234|NCT00704288|524581640|FG002|Overall Treatment Period|Adverse Event|22|||
145472235|NCT00704288|524581638|FG000|Overall Treatment Period|Death|0|||
145472236|NCT00704288|524581639|FG001|Overall Treatment Period|Death|0|||
145472237|NCT00704288|524581640|FG002|Overall Treatment Period|Death|1|||
145472238|NCT00704288|524581638|FG000|Overall Treatment Period|Physician Decision|0|||
145472239|NCT00704288|524581639|FG001|Overall Treatment Period|Physician Decision|2|||
145472240|NCT00704288|524581640|FG002|Overall Treatment Period|Physician Decision|0|||
145472241|NCT00704288|524581638|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
145472242|NCT00704288|524581639|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
145472243|NCT00704288|524581640|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
145472244|NCT00704288|524581638|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
145472245|NCT00704288|524581639|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
145472246|NCT00704288|524581640|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
145472247|NCT00704288|524581638|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
145472248|NCT00704288|524581639|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
145472249|NCT00704288|524581640|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
145472250|NCT00704288|524581638|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
145472251|NCT00704288|524581639|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
145472252|NCT00704288|524581640|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
145472253|NCT00704288|524581638|FG000|Overall Treatment Period|Roll-over to another study|1|||
145472254|NCT00704288|524581639|FG001|Overall Treatment Period|Roll-over to another study|0|||
145472255|NCT00704288|524581640|FG002|Overall Treatment Period|Roll-over to another study|4|||
145472256|NCT00704288|524581638|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
145472257|NCT00704288|524581639|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
145472258|NCT00704288|524581640|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
145472259|NCT00704288|524581638|FG000|Extended Post Treatment Follow Up Period|Death|41|||
145472260|NCT00704288|524581639|FG001|Extended Post Treatment Follow Up Period|Death|50|||
145472261|NCT00704288|524581640|FG002|Extended Post Treatment Follow Up Period|Death|93|||
145472262|NCT00704288|524581638|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
145472263|NCT00704288|524581639|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
145472264|NCT00704288|524581640|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
145472265|NCT00704288|524581638|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
145472266|NCT00704288|524581639|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
145472267|NCT00704288|524581640|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
145472268|NCT00704288|524581638|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
145472269|NCT00704288|524581639|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
145472270|NCT00704288|524581640|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
145601503|NCT05168579|525056204|FG001|Overall Study|Time slots were full|0|||
145601504|NCT05168579|525056203|FG000|Overall Study|Lost to Follow-up|0|||
145601505|NCT05168579|525056204|FG001|Overall Study|Lost to Follow-up|15|||
145601506|NCT00840801|525056205|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
145601507|NCT00840801|525056206|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
145601508|NCT00840801|525056207|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
145601509|NCT00840801|525056205|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
145601510|NCT00840801|525056206|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
145601511|NCT00840801|525056207|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
145601512|NCT00840801|525056205|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
145601513|NCT00840801|525056206|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
145601514|NCT00840801|525056207|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
145601515|NCT00840801|525056205|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
145601516|NCT00840801|525056206|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
145601517|NCT00840801|525056207|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
145601518|NCT01242748|525056208|FG000|Overall Study|Adverse Event|10|||
145601519|NCT01242748|525056209|FG001|Overall Study|Adverse Event|5|||
145601520|NCT01242748|525056208|FG000|Overall Study|Lost to Follow-up|6|||
145601521|NCT01242748|525056209|FG001|Overall Study|Lost to Follow-up|2|||
145601522|NCT01242748|525056208|FG000|Overall Study|Physician Decision|3|||
145601523|NCT01242748|525056209|FG001|Overall Study|Physician Decision|2|||
145601524|NCT01242748|525056208|FG000|Overall Study|Protocol Violation|1|||
145601525|NCT01242748|525056209|FG001|Overall Study|Protocol Violation|0|||
145601526|NCT01242748|525056208|FG000|Overall Study|Withdrawal by Subject|10|||
145601527|NCT01242748|525056209|FG001|Overall Study|Withdrawal by Subject|2|||
145601528|NCT01242748|525056208|FG000|Overall Study|Miscellaneous reasons|8|||
145601529|NCT01242748|525056209|FG001|Overall Study|Miscellaneous reasons|3|||
145601530|NCT00335452|525056210|FG000|Overall Study|Death|156|||
145601531|NCT00335452|525056211|FG001|Overall Study|Death|144|||
145601532|NCT00335452|525056212|FG002|Overall Study|Death|158|||
145601533|NCT00335452|525056213|FG003|Overall Study|Death|129|||
145601534|NCT00335452|525056210|FG000|Overall Study|Lost to Follow-up|2|||
145601535|NCT00335452|525056211|FG001|Overall Study|Lost to Follow-up|3|||
145601536|NCT00335452|525056212|FG002|Overall Study|Lost to Follow-up|1|||
145601537|NCT00335452|525056213|FG003|Overall Study|Lost to Follow-up|2|||
145601538|NCT02736825|525056214|FG000|Overall Study|Lost to Follow-up|10|||
145472271|NCT01055314|524581641|FG000|Overall Study|Adverse Event|7|||
145472272|NCT01055314|524581642|FG001|Overall Study|Adverse Event|4|||
145472273|NCT01055314|524581641|FG000|Overall Study|Death|2|||
145472274|NCT01055314|524581642|FG001|Overall Study|Death|1|||
145472275|NCT01055314|524581641|FG000|Overall Study|Lack of Efficacy|11|||
145472276|NCT01055314|524581642|FG001|Overall Study|Lack of Efficacy|19|||
145472277|NCT01055314|524581641|FG000|Overall Study|Physician Decision|10|||
145472278|NCT01055314|524581642|FG001|Overall Study|Physician Decision|5|||
145472279|NCT01055314|524581641|FG000|Overall Study|Withdrawal by Subject|1|||
145472280|NCT01055314|524581642|FG001|Overall Study|Withdrawal by Subject|0|||
145472281|NCT01055314|524581641|FG000|Overall Study|Ineligible|3|||
145472282|NCT01055314|524581642|FG001|Overall Study|Ineligible|5|||
145472283|NCT01055314|524581641|FG000|Overall Study|Refusal of further protocol therapy|10|||
145472284|NCT01055314|524581642|FG001|Overall Study|Refusal of further protocol therapy|4|||
145472285|NCT01055314|524581641|FG000|Overall Study|No treatment|1|||
145472286|NCT01055314|524581642|FG001|Overall Study|No treatment|0|||
145472287|NCT04512976|524581643|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
145472288|NCT04512976|524581644|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
145472289|NCT04512976|524581645|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
145472290|NCT04512976|524581646|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
145472291|NCT04512976|524581647|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
145472292|NCT04512976|524581648|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
145472293|NCT02702414|524581649|FG000|Overall Study|Death|96|||
145472294|NCT02702414|524581650|FG001|Overall Study|Death|42|||
145472295|NCT02702414|524581649|FG000|Overall Study|Lost to Follow-up|0|||
145601539|NCT02736825|525056215|FG001|Overall Study|Lost to Follow-up|11|||
145601540|NCT02736825|525056214|FG000|Overall Study|Early Termination|0|||
145601541|NCT02736825|525056215|FG001|Overall Study|Early Termination|1|||
145601542|NCT00790452|525056217|FG000|Overall Study|Drug supply issue|1|||
145601543|NCT00790452|525056218|FG001|Overall Study|Drug supply issue|0|||
145601544|NCT02940574|525056219|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
145601545|NCT02940574|525056220|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
145601546|NCT02940574|525056219|FG000|1-year Follow-up|Lost to Follow-up|3|||
145601547|NCT02940574|525056220|FG001|1-year Follow-up|Lost to Follow-up|4|||
145601548|NCT01750879|525056223|FG000|Overall Study|Adverse Event|8|||
145601549|NCT01750879|525056224|FG001|Overall Study|Adverse Event|0|||
145601550|NCT01750879|525056223|FG000|Overall Study|Lack of Efficacy|1|||
145601551|NCT01750879|525056224|FG001|Overall Study|Lack of Efficacy|0|||
145601552|NCT01750879|525056223|FG000|Overall Study|Withdrawal by Subject|1|||
145601553|NCT01750879|525056224|FG001|Overall Study|Withdrawal by Subject|0|||
145601554|NCT01750879|525056223|FG000|Overall Study|Did not complete per protocol|0|||
145601555|NCT01750879|525056224|FG001|Overall Study|Did not complete per protocol|3|||
145601556|NCT04810221|525056225|FG000|Overall Study|Physician Decision|3|||
145601557|NCT03642938|525056226|FG000|Overall Study|Withdrawal by Subject|0|||
145601558|NCT03642938|525056227|FG001|Overall Study|Withdrawal by Subject|0|||
145601559|NCT03642938|525056228|FG002|Overall Study|Withdrawal by Subject|0|||
145601560|NCT03642938|525056229|FG003|Overall Study|Withdrawal by Subject|1|||
145601561|NCT00105235|525056230|FG000|Overall Study|Death|4|||
145601562|NCT00105235|525056230|FG000|Overall Study|Physician Decision|1|||
145601563|NCT00105235|525056230|FG000|Overall Study|Withdrawal by Subject|2|||
145601564|NCT02347657|525056231|FG000|Overall Study|Physician Decision|0|||
145601565|NCT02347657|525056232|FG001|Overall Study|Physician Decision|1|||
145601566|NCT02347657|525056231|FG000|Overall Study|Adverse Event|8|||
145601567|NCT02347657|525056232|FG001|Overall Study|Adverse Event|4|||
145601568|NCT02347657|525056231|FG000|Overall Study|Withdrawal by Subject|6|||
145601569|NCT02347657|525056232|FG001|Overall Study|Withdrawal by Subject|7|||
145601570|NCT02347657|525056231|FG000|Overall Study|Randomized but not treated|1|||
145601571|NCT02347657|525056232|FG001|Overall Study|Randomized but not treated|0|||
145601572|NCT02347657|525056231|FG000|Overall Study|Other|3|||
145601573|NCT02347657|525056232|FG001|Overall Study|Other|3|||
145601574|NCT02093663|525056237|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
145601575|NCT02093663|525056238|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
145601576|NCT02093663|525056239|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
145601577|NCT02093663|525056240|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
145601578|NCT02093663|525056241|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
145601579|NCT02093663|525056237|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
145601580|NCT02093663|525056238|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601581|NCT02093663|525056239|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601582|NCT02093663|525056240|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145472296|NCT02702414|524581650|FG001|Overall Study|Lost to Follow-up|1|||
145472297|NCT02702414|524581649|FG000|Overall Study|Withdrawal by Subject|0|||
145472298|NCT02702414|524581650|FG001|Overall Study|Withdrawal by Subject|1|||
145472299|NCT02702414|524581649|FG000|Overall Study|Protocol Violation|1|||
145601583|NCT02093663|525056241|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145628590|NCT01981850|525153363|FG000|Main Phase Stage 2|Adverse Event|0|||
145472300|NCT02702414|524581650|FG001|Overall Study|Protocol Violation|0|||
145472301|NCT02702414|524581649|FG000|Overall Study|Sponsor Decision|8|||
145472302|NCT02702414|524581650|FG001|Overall Study|Sponsor Decision|7|||
145472303|NCT04541628|524581651|FG000|Overall Study|Study Terminated|1|||
145472304|NCT04541628|524581652|FG001|Overall Study|Study Terminated|1|||
145472305|NCT04541628|524581653|FG002|Overall Study|Study Terminated|1|||
145472306|NCT01192412|524581658|FG000|Overall Study|Lost to Follow-up|2|||
145472307|NCT01192412|524581659|FG001|Overall Study|Lost to Follow-up|1|||
145472308|NCT01192412|524581658|FG000|Overall Study|Withdrawal by Subject|2|||
145472309|NCT01192412|524581659|FG001|Overall Study|Withdrawal by Subject|1|||
145472310|NCT00151476|524581660|FG000|FAP Identified Subjects|Protocol Violation|0|||
145472311|NCT00151476|524581661|FG001|FAP Identified Subjects|Protocol Violation|1|||
145472312|NCT00151476|524581660|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
145472313|NCT00151476|524581661|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
145472314|NCT00151476|524581660|FG000|FAP Analyzed Subjects|Other study participation|0|||
145472315|NCT00151476|524581661|FG001|FAP Analyzed Subjects|Other study participation|1|||
145472316|NCT03446456|524581662|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
145472317|NCT03446456|524581663|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
145472318|NCT03446456|524581662|FG000|Overall Study|Lost to Follow-up|1|||
145472319|NCT03446456|524581663|FG001|Overall Study|Lost to Follow-up|3|||
145472320|NCT03446456|524581662|FG000|Overall Study|Participant failed the toxicology test|1|||
145472321|NCT03446456|524581663|FG001|Overall Study|Participant failed the toxicology test|0|||
145472322|NCT03446456|524581662|FG000|Overall Study|Break down of the experimental equipment|1|||
145472323|NCT03446456|524581663|FG001|Overall Study|Break down of the experimental equipment|0|||
145472324|NCT06151288|524581669|FG000|Overall Study|Lost to Follow-up|4|||
145472325|NCT06151288|524581670|FG001|Overall Study|Lost to Follow-up|2|||
145472326|NCT06151288|524581671|FG002|Overall Study|Lost to Follow-up|4|||
145472327|NCT06151288|524581672|FG003|Overall Study|Lost to Follow-up|3|||
145472328|NCT06151288|524581669|FG000|Overall Study|Withdrawal by Subject|4|||
145472329|NCT06151288|524581670|FG001|Overall Study|Withdrawal by Subject|5|||
145472330|NCT06151288|524581671|FG002|Overall Study|Withdrawal by Subject|1|||
145472331|NCT06151288|524581672|FG003|Overall Study|Withdrawal by Subject|1|||
145472332|NCT04369950|524581673|FG000|Overall Study|Protocol Violation|2|||
145472333|NCT04369950|524581674|FG001|Overall Study|Protocol Violation|2|||
145472334|NCT00989963|524581675|FG000|Overall Study|Adverse Event|1|||
145472335|NCT00989963|524581676|FG001|Overall Study|Adverse Event|1|||
145472336|NCT00989963|524581677|FG002|Overall Study|Adverse Event|1|||
145472337|NCT01529034|524581686|FG000|Overall Study|Discontinued prior to study treatment|14|||
145472338|NCT01529034|524581686|FG000|Overall Study|Site closure|62|||
145472339|NCT01529034|524581686|FG000|Overall Study|Study termination|29|||
145472340|NCT01529034|524581686|FG000|Overall Study|Withdrawal by Subject|25|||
145472341|NCT01529034|524581686|FG000|Overall Study|No treated SCs within protocol window|13|||
145472342|NCT01529034|524581686|FG000|Overall Study|Noncompliance|8|||
145472343|NCT01529034|524581686|FG000|Overall Study|Caregiver no longer available|7|||
145472344|NCT01529034|524581686|FG000|Overall Study|Adverse Event|4|||
145472345|NCT01529034|524581686|FG000|Overall Study|Protocol Violation|4|||
145472346|NCT01529034|524581686|FG000|Overall Study|Lack of Efficacy|4|||
145472347|NCT01529034|524581686|FG000|Overall Study|Investigator no longer available|2|||
145472348|NCT01529034|524581686|FG000|Overall Study|Study drug not available|2|||
145472349|NCT04588389|524581687|FG000|Overall Study|Issues with anesthesia during surgery|2|||
145472350|NCT04588389|524581688|FG001|Overall Study|Issues with anesthesia during surgery|0|||
145472351|NCT04588389|524581689|FG002|Overall Study|Issues with anesthesia during surgery|0|||
145472352|NCT02649894|524581692|FG000|Overall Study|Adverse Event|1|||
145472353|NCT02649894|524581693|FG001|Overall Study|Adverse Event|0|||
145472354|NCT02649894|524581692|FG000|Overall Study|Physician Decision|0|||
145472355|NCT02649894|524581693|FG001|Overall Study|Physician Decision|1|||
145472356|NCT02649894|524581692|FG000|Overall Study|Withdrawal by Subject|5|||
145472357|NCT02649894|524581693|FG001|Overall Study|Withdrawal by Subject|2|||
145472358|NCT02649894|524581692|FG000|Overall Study|Lost to Follow-up|2|||
145472359|NCT02649894|524581693|FG001|Overall Study|Lost to Follow-up|1|||
145472360|NCT02649894|524581692|FG000|Overall Study|Death|30|||
145472361|NCT02649894|524581693|FG001|Overall Study|Death|7|||
145472362|NCT02649894|524581692|FG000|Overall Study|Other, not specified|6|||
145472363|NCT02649894|524581693|FG001|Overall Study|Other, not specified|0|||
145472364|NCT00719680|524581694|FG000|Overall Study|Adverse Event|1|||
145472365|NCT00719680|524581694|FG000|Overall Study|Lost to Follow-up|1|||
145472366|NCT00719680|524581694|FG000|Overall Study|Withdrawal by Subject|3|||
145472367|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
145472368|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
145472369|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
145472370|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
145601584|NCT02093663|525056237|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
145601585|NCT02093663|525056238|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
145472371|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
145472372|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
145472373|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Death|1|||
145472374|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Death|4|||
145472375|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
145472376|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
145472377|NCT00658814|524581695|FG000|Remission Induction Chemotherapy|Not eligible|1|||
145472378|NCT00658814|524581696|FG001|Remission Induction Chemotherapy|Not eligible|2|||
145472379|NCT00658814|524581695|FG000|Consolidation Therapy|Not protocol specified|0|||
145472380|NCT00658814|524581696|FG001|Consolidation Therapy|Not protocol specified|1|||
145472381|NCT00658814|524581695|FG000|Consolidation Therapy|Not eligible|2|||
145472382|NCT00658814|524581696|FG001|Consolidation Therapy|Not eligible|2|||
145472383|NCT00658814|524581695|FG000|Maintenance Therapy|Adverse Event|1|||
145472384|NCT00658814|524581696|FG001|Maintenance Therapy|Adverse Event|1|||
145472385|NCT00658814|524581695|FG000|Maintenance Therapy|Not protocol specified|1|||
145472386|NCT00658814|524581696|FG001|Maintenance Therapy|Not protocol specified|0|||
145472387|NCT00658814|524581695|FG000|Maintenance Therapy|Not eligible|1|||
145472388|NCT00658814|524581696|FG001|Maintenance Therapy|Not eligible|0|||
145472389|NCT02911142|524581697|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
145472390|NCT02911142|524581697|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
145472391|NCT02911142|524581697|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
145472392|NCT02911142|524581697|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
145472393|NCT03194438|524581700|FG000|Overall Study|Withdrawal by Subject|2|||
145472394|NCT01554514|524581701|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
145472395|NCT01554514|524581701|FG000|Overall Study|Physician Decision|1|||
145472396|NCT01423916|524581702|FG000|Overall Study|Adverse Event|5|||
145472397|NCT01423916|524581703|FG001|Overall Study|Adverse Event|9|||
145472398|NCT01423916|524581704|FG002|Overall Study|Adverse Event|2|||
145472399|NCT01423916|524581702|FG000|Overall Study|Met Withdrawal Criteria|1|||
145472400|NCT01423916|524581703|FG001|Overall Study|Met Withdrawal Criteria|1|||
145472401|NCT01423916|524581704|FG002|Overall Study|Met Withdrawal Criteria|1|||
145472402|NCT01423916|524581702|FG000|Overall Study|Physician Decision|1|||
145472403|NCT01423916|524581703|FG001|Overall Study|Physician Decision|0|||
145472404|NCT01423916|524581704|FG002|Overall Study|Physician Decision|1|||
145472405|NCT01423916|524581702|FG000|Overall Study|Withdrawal by Subject|3|||
145472406|NCT01423916|524581703|FG001|Overall Study|Withdrawal by Subject|10|||
145472407|NCT01423916|524581704|FG002|Overall Study|Withdrawal by Subject|3|||
145472408|NCT01423916|524581702|FG000|Overall Study|Protocol Deviation|1|||
145472409|NCT01423916|524581703|FG001|Overall Study|Protocol Deviation|0|||
145472410|NCT01423916|524581704|FG002|Overall Study|Protocol Deviation|0|||
145472411|NCT00847015|524581709|FG000|Overall Study|Withdrawal by Subject|1|||
145472412|NCT00847015|524581709|FG000|Overall Study|declined any surgery|1|||
145472413|NCT00847015|524581709|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
145472414|NCT01141478|524581710|FG000|Overall Study|Withdrawal by Subject|1|||
145472415|NCT01141478|524581711|FG001|Overall Study|Withdrawal by Subject|1|||
145472416|NCT02250664|524581712|FG000|Overall Study|Lost to Follow-up|18|||
145472417|NCT02250664|524581713|FG001|Overall Study|Lost to Follow-up|28|||
145472418|NCT02250664|524581714|FG002|Overall Study|Lost to Follow-up|33|||
145472419|NCT02250664|524581712|FG000|Overall Study|Personal Reasons|7|||
145472420|NCT02250664|524581713|FG001|Overall Study|Personal Reasons|8|||
145472421|NCT02250664|524581714|FG002|Overall Study|Personal Reasons|14|||
145472422|NCT02250664|524581712|FG000|Overall Study|Adverse Event|6|||
145472423|NCT02250664|524581713|FG001|Overall Study|Adverse Event|3|||
145472424|NCT02250664|524581714|FG002|Overall Study|Adverse Event|8|||
145472425|NCT02250664|524581712|FG000|Overall Study|Incarcerated|2|||
145472426|NCT02250664|524581713|FG001|Overall Study|Incarcerated|1|||
145472427|NCT02250664|524581714|FG002|Overall Study|Incarcerated|2|||
145472428|NCT02250664|524581712|FG000|Overall Study|Withdrawal by Subject|0|||
145472429|NCT02250664|524581713|FG001|Overall Study|Withdrawal by Subject|1|||
145472430|NCT02250664|524581714|FG002|Overall Study|Withdrawal by Subject|2|||
145472431|NCT02250664|524581712|FG000|Overall Study|Death|0|||
145472432|NCT02250664|524581713|FG001|Overall Study|Death|1|||
145472433|NCT02250664|524581714|FG002|Overall Study|Death|1|||
145472434|NCT02250664|524581712|FG000|Overall Study|Physician Decision|1|||
145472435|NCT02250664|524581713|FG001|Overall Study|Physician Decision|3|||
145472436|NCT02250664|524581714|FG002|Overall Study|Physician Decision|1|||
145472437|NCT02250664|524581712|FG000|Overall Study|Protocol Violation|1|||
145472438|NCT02250664|524581713|FG001|Overall Study|Protocol Violation|0|||
145472439|NCT02250664|524581714|FG002|Overall Study|Protocol Violation|1|||
145472440|NCT02250664|524581712|FG000|Overall Study|Reason unknown|1|||
145472441|NCT02250664|524581713|FG001|Overall Study|Reason unknown|0|||
145472442|NCT02250664|524581714|FG002|Overall Study|Reason unknown|0|||
145472443|NCT03847909|524581715|FG000|Overall Study|Withdrawal by Subject|1|||
145601586|NCT02093663|525056239|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
145472444|NCT03847909|524581716|FG001|Overall Study|Withdrawal by Subject|1|||
145628591|NCT01981850|525153364|FG001|Main Phase Stage 2|Adverse Event|0|||
145472445|NCT01953913|524581722|FG000|Overall Study|Disease Progression|349|||
145472446|NCT01953913|524581722|FG000|Overall Study|Worsening of underlying cancer|22|||
145472447|NCT01953913|524581722|FG000|Overall Study|Adverse Event|20|||
145472448|NCT01953913|524581722|FG000|Overall Study|Protocol Violation|6|||
145472449|NCT01953913|524581722|FG000|Overall Study|Lost to Follow-up|4|||
145472450|NCT01953913|524581722|FG000|Overall Study|Withdrawal by Subject|32|||
145472451|NCT01953913|524581722|FG000|Overall Study|Other than listed|108|||
145472452|NCT01953913|524581722|FG000|Overall Study|Not Treated|1|||
145472453|NCT05026853|524581723|FG000|Overall Study|Cancelled appointment|1|||
145472454|NCT05026853|524581724|FG001|Overall Study|Cancelled appointment|0|||
145472455|NCT05026853|524581723|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
145472456|NCT05026853|524581724|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
145472457|NCT05026853|524581723|FG000|Overall Study|Did not complete 12-week survey|16|||
145472458|NCT05026853|524581724|FG001|Overall Study|Did not complete 12-week survey|16|||
145472459|NCT03836677|524581725|FG000|Period 1|Adverse Event|0|||
145472460|NCT03836677|524581726|FG001|Period 1|Adverse Event|1|||
145472461|NCT03836677|524581725|FG000|Period 2|Severe non-compliance to protocol|1|||
145472462|NCT03836677|524581726|FG001|Period 2|Severe non-compliance to protocol|0|||
145472463|NCT01732913|524581727|FG000|Overall Study|Study Terminated by Sponsor|105|||
145472464|NCT01732913|524581728|FG001|Overall Study|Study Terminated by Sponsor|55|||
145472465|NCT01732913|524581727|FG000|Overall Study|Withdrawal by Subject|27|||
145472466|NCT01732913|524581728|FG001|Overall Study|Withdrawal by Subject|4|||
145472467|NCT01732913|524581727|FG000|Overall Study|Physician Decision|14|||
145472468|NCT01732913|524581728|FG001|Overall Study|Physician Decision|7|||
145472469|NCT01732913|524581727|FG000|Overall Study|Other|7|||
145472470|NCT01732913|524581728|FG001|Overall Study|Other|1|||
145472471|NCT01732913|524581727|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
145472472|NCT01732913|524581728|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
145472473|NCT02895945|524581729|FG000|Overall Study|Physician Decision|2|||
145472474|NCT02895945|524581730|FG001|Overall Study|Physician Decision|1|||
145472475|NCT03233438|524581733|FG000|Overall Study|Lost to Follow-up|4|||
145472476|NCT03233438|524581734|FG001|Overall Study|Lost to Follow-up|9|||
145472477|NCT03233438|524581733|FG000|Overall Study|Withdrawal by Subject|2|||
145472478|NCT03233438|524581734|FG001|Overall Study|Withdrawal by Subject|1|||
145472479|NCT03233438|524581733|FG000|Overall Study|No recording of dalbavancin|0|||
145472480|NCT03233438|524581734|FG001|Overall Study|No recording of dalbavancin|1|||
145472481|NCT02345330|524581735|FG000|Overall Study|Death|1|||
145472482|NCT02345330|524581735|FG000|Overall Study|Progressive Disease|2|||
145472483|NCT03831945|524581736|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
145472484|NCT03831945|524581737|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
145472485|NCT03831945|524581736|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
145472486|NCT03831945|524581737|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
145472487|NCT03831945|524581736|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
145472488|NCT03831945|524581737|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
145472489|NCT03178669|524581738|FG000|Overall Study|Adverse Event|4|||
145472490|NCT03178669|524581739|FG001|Overall Study|Adverse Event|1|||
145472491|NCT03178669|524581740|FG002|Overall Study|Adverse Event|4|||
145472492|NCT03178669|524581741|FG003|Overall Study|Adverse Event|2|||
145472493|NCT03178669|524581742|FG004|Overall Study|Adverse Event|2|||
145628592|NCT01981850|525153365|FG002|Main Phase Stage 2|Adverse Event|0|||
145628593|NCT01981850|525153366|FG003|Main Phase Stage 2|Adverse Event|0|||
145628594|NCT01981850|525153367|FG004|Main Phase Stage 2|Adverse Event|6|||
145628595|NCT01981850|525153368|FG005|Main Phase Stage 2|Adverse Event|5|||
145628596|NCT01981850|525153369|FG006|Main Phase Stage 2|Adverse Event|7|||
145628597|NCT01981850|525153370|FG007|Main Phase Stage 2|Adverse Event|0|||
145628598|NCT01981850|525153371|FG008|Main Phase Stage 2|Adverse Event|0|||
145628599|NCT01981850|525153372|FG009|Main Phase Stage 2|Adverse Event|0|||
145472494|NCT03178669|524581738|FG000|Overall Study|Lack of Efficacy|0|||
145472495|NCT03178669|524581739|FG001|Overall Study|Lack of Efficacy|0|||
145472496|NCT03178669|524581740|FG002|Overall Study|Lack of Efficacy|2|||
145472497|NCT03178669|524581741|FG003|Overall Study|Lack of Efficacy|0|||
145472498|NCT03178669|524581742|FG004|Overall Study|Lack of Efficacy|1|||
145472499|NCT03178669|524581738|FG000|Overall Study|Physician Decision|0|||
145472500|NCT03178669|524581739|FG001|Overall Study|Physician Decision|0|||
145472501|NCT03178669|524581740|FG002|Overall Study|Physician Decision|0|||
145472502|NCT03178669|524581741|FG003|Overall Study|Physician Decision|0|||
145472503|NCT03178669|524581742|FG004|Overall Study|Physician Decision|1|||
145472504|NCT03178669|524581738|FG000|Overall Study|Withdrawal by Subject|1|||
145472505|NCT03178669|524581739|FG001|Overall Study|Withdrawal by Subject|0|||
145472506|NCT03178669|524581740|FG002|Overall Study|Withdrawal by Subject|1|||
145472507|NCT03178669|524581741|FG003|Overall Study|Withdrawal by Subject|1|||
145628600|NCT01981850|525153363|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628601|NCT01981850|525153364|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628602|NCT01981850|525153365|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145472508|NCT03178669|524581742|FG004|Overall Study|Withdrawal by Subject|0|||
145472509|NCT03178669|524581738|FG000|Overall Study|Lost to Follow-up|0|||
145472510|NCT03178669|524581739|FG001|Overall Study|Lost to Follow-up|0|||
145472511|NCT03178669|524581740|FG002|Overall Study|Lost to Follow-up|0|||
145472512|NCT03178669|524581741|FG003|Overall Study|Lost to Follow-up|1|||
145472513|NCT03178669|524581742|FG004|Overall Study|Lost to Follow-up|0|||
145472514|NCT01600092|524581743|FG000|Overall Study|Adverse Event|2|||
145472515|NCT01600092|524581744|FG001|Overall Study|Adverse Event|0|||
145472516|NCT01600092|524581743|FG000|Overall Study|Lost to Follow-up|4|||
145472517|NCT01600092|524581744|FG001|Overall Study|Lost to Follow-up|6|||
145472518|NCT01600092|524581743|FG000|Overall Study|Withdrawal by parent/guardian|8|||
145472519|NCT01600092|524581744|FG001|Overall Study|Withdrawal by parent/guardian|6|||
145472520|NCT01600092|524581743|FG000|Overall Study|Physician Decision|1|||
145472521|NCT01600092|524581744|FG001|Overall Study|Physician Decision|1|||
145472522|NCT01600092|524581743|FG000|Overall Study|Randomized but not vaccinated|3|||
145472523|NCT01600092|524581744|FG001|Overall Study|Randomized but not vaccinated|3|||
145472524|NCT02976103|524581746|FG000|Overall Study|Withdrawal by Subject|1|||
145601587|NCT02093663|525056240|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
145601588|NCT02093663|525056241|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
145601589|NCT02093663|525056237|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
145601590|NCT02093663|525056238|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
145601591|NCT02093663|525056239|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
145601592|NCT02093663|525056240|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
145601593|NCT02093663|525056241|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
145601594|NCT02093663|525056237|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601595|NCT02093663|525056238|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601596|NCT02093663|525056239|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
145601597|NCT02093663|525056240|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601598|NCT02093663|525056241|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
145601599|NCT02093663|525056237|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
145601600|NCT02093663|525056238|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
145601601|NCT02093663|525056239|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
145601602|NCT02093663|525056240|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
145601603|NCT02093663|525056241|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
145601604|NCT02093663|525056237|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
145601605|NCT02093663|525056238|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
145601606|NCT02093663|525056239|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
145601607|NCT02093663|525056240|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
145601608|NCT02093663|525056241|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
145601609|NCT02093663|525056237|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
145601610|NCT02093663|525056238|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
145601611|NCT02093663|525056239|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
145601612|NCT02093663|525056240|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
145601613|NCT02093663|525056241|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
145601614|NCT02093663|525056237|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
145601615|NCT02093663|525056238|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
145601616|NCT02093663|525056239|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
145601617|NCT02093663|525056240|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
145601618|NCT02093663|525056241|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
145601619|NCT00508404|525056242|FG000|Overall Study|Ongoing at Data Cut-off|12|||
145601620|NCT00508404|525056242|FG000|Overall Study|Adverse Event|2|||
145601621|NCT00508404|525056242|FG000|Overall Study|Death|16|||
145601622|NCT00508404|525056242|FG000|Overall Study|Physician Decision|2|||
145601623|NCT00508404|525056242|FG000|Overall Study|Withdrawal by Subject|3|||
145601624|NCT00508404|525056242|FG000|Overall Study|Protocol-specified Criteria|2|||
145601625|NCT00508404|525056242|FG000|Overall Study|Lost to Follow-up|2|||
145601626|NCT00508404|525056242|FG000|Overall Study|Other - Not Specified|3|||
145601627|NCT01424930|525056243|FG000|Overall Study|Adverse Event|0|||
145601628|NCT01424930|525056244|FG001|Overall Study|Adverse Event|1|||
145601629|NCT01424930|525056243|FG000|Overall Study|Death|1|||
145601630|NCT01424930|525056244|FG001|Overall Study|Death|0|||
145601631|NCT01424930|525056243|FG000|Overall Study|Progressive Disease|3|||
145601632|NCT01424930|525056244|FG001|Overall Study|Progressive Disease|6|||
145601633|NCT01424930|525056243|FG000|Overall Study|Screen Failure|0|||
145601634|NCT01424930|525056244|FG001|Overall Study|Screen Failure|1|||
145601635|NCT01424930|525056243|FG000|Overall Study|Reason not specified|0|||
145601636|NCT01424930|525056244|FG001|Overall Study|Reason not specified|6|||
145472525|NCT02976103|524581747|FG001|Overall Study|Withdrawal by Subject|0|||
145472526|NCT02976103|524581746|FG000|Overall Study|Lost to Follow-up|12|||
145472527|NCT02976103|524581747|FG001|Overall Study|Lost to Follow-up|8|||
145472528|NCT00565136|524581748|FG000|Overall Study|Lost to Follow-up|1|||
145472529|NCT00565136|524581748|FG000|Overall Study|Withdrawal by Subject|1|||
145472530|NCT00565136|524581748|FG000|Overall Study|Protocol Violation|1|||
145472531|NCT00694304|524581757|FG000|Overall Study|Adverse Event|42|||
145472532|NCT00694304|524581757|FG000|Overall Study|Lack of Efficacy|35|||
145472533|NCT00694304|524581757|FG000|Overall Study|Non-compliance With Study Product|16|||
145472534|NCT00694304|524581757|FG000|Overall Study|Protocol Violation|6|||
145472535|NCT00694304|524581757|FG000|Overall Study|Withdrawal of Consent|61|||
145472536|NCT00694304|524581757|FG000|Overall Study|Lost to Follow-up|15|||
145472537|NCT00694304|524581757|FG000|Overall Study|Administrative or Other Reasons|32|||
145472538|NCT02438813|524581758|FG000|Overall Study|Patient Decision|59|||
145472539|NCT02438813|524581758|FG000|Overall Study|Patient Lost to Follow-Up|137|||
145472540|NCT02438813|524581758|FG000|Overall Study|Study Ended by Sponsor|80|||
145472541|NCT02438813|524581758|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
145472542|NCT00576576|524581761|FG000|Overall Study|Lost to Follow-up|6|||
145472543|NCT00576576|524581761|FG000|Overall Study|Protocol Violation|1|||
145472544|NCT03135210|524581762|FG000|Overall Study|Death|0|||
145472545|NCT03135210|524581763|FG001|Overall Study|Death|1|||
145472546|NCT01805037|524581769|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
145472547|NCT01805037|524581770|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
145472548|NCT01805037|524581769|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
145472549|NCT01805037|524581770|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
145472550|NCT01805037|524581769|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
145472551|NCT01805037|524581770|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
145472552|NCT01805037|524581769|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
145472553|NCT01805037|524581770|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
145472554|NCT01805037|524581769|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
145472555|NCT01805037|524581770|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
145472556|NCT01805037|524581769|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
145472557|NCT01805037|524581770|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
145472558|NCT01805037|524581769|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
145472559|NCT01805037|524581770|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
145472560|NCT01805037|524581769|FG000|Follow Up (up to 3 Years)|Death|0|||
145472561|NCT01805037|524581770|FG001|Follow Up (up to 3 Years)|Death|2|||
145472562|NCT01805037|524581769|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
145472563|NCT01805037|524581770|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
145472564|NCT01805037|524581769|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
145472565|NCT01805037|524581770|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
145472566|NCT04566692|524581771|FG000|Overall Study|Adverse Event|2|||
145472567|NCT04566692|524581772|FG001|Overall Study|Adverse Event|0|||
145472568|NCT04566692|524581771|FG000|Overall Study|Withdrawal by Subject|1|||
145472569|NCT04566692|524581772|FG001|Overall Study|Withdrawal by Subject|1|||
145472570|NCT00671437|524581773|FG000|Overall Study|Progressive disease before C1 week 8|8|||
145472571|NCT00671437|524581773|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
145472572|NCT00671437|524581773|FG000|Overall Study|Adverse Event|3|||
145472573|NCT00671437|524581773|FG000|Overall Study|Ineligible post-hoc|1|||
145472574|NCT03109184|524583468|FG000|Overall Study|Lost to Follow-up|6|||
145472575|NCT03109184|524583469|FG001|Overall Study|Lost to Follow-up|6|||
145472576|NCT03109184|524583468|FG000|Overall Study|Withdrawal by Subject|1|||
145472577|NCT03109184|524583469|FG001|Overall Study|Withdrawal by Subject|1|||
145472578|NCT00602420|524583470|FG000|Overall Study|Death|1|||
145472579|NCT00602420|524583471|FG001|Overall Study|Death|4|||
145472580|NCT00602420|524583470|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
145472581|NCT00602420|524583471|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
145472582|NCT00602420|524583470|FG000|Overall Study|Withdrawal by Subject|18|||
145472583|NCT00602420|524583471|FG001|Overall Study|Withdrawal by Subject|17|||
145472584|NCT00602420|524583470|FG000|Overall Study|Adverse Event|1|||
145472585|NCT00602420|524583471|FG001|Overall Study|Adverse Event|0|||
145472586|NCT00649428|524583480|FG000|Overall Study|Adverse Event|2|||
145472587|NCT00649428|524583481|FG001|Overall Study|Adverse Event|2|||
145472588|NCT00649428|524583480|FG000|Overall Study|Withdrawal by Subject|6|||
145472589|NCT00649428|524583481|FG001|Overall Study|Withdrawal by Subject|6|||
145472590|NCT00649428|524583480|FG000|Overall Study|Lost to Follow-up|1|||
145472591|NCT00649428|524583481|FG001|Overall Study|Lost to Follow-up|3|||
145472592|NCT00649428|524583480|FG000|Overall Study|Insufficient manufacturing yield|5|||
145472593|NCT00649428|524583481|FG001|Overall Study|Insufficient manufacturing yield|1|||
145601637|NCT01078155|525056249|FG000|Overall Study|Adverse Event|7|||
145601638|NCT01078155|525056249|FG000|Overall Study|Lack of Efficacy|16|||
145472594|NCT00649428|524583480|FG000|Overall Study|Protocol Violation|6|||
145472595|NCT00649428|524583481|FG001|Overall Study|Protocol Violation|2|||
145472596|NCT00649428|524583480|FG000|Overall Study|Physician Decision|0|||
145472597|NCT00649428|524583481|FG001|Overall Study|Physician Decision|1|||
145472598|NCT04599465|524583482|FG000|Overall Study|Physician Decision|1|||
145472599|NCT04599465|524583482|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
145472600|NCT00495625|524583485|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
145472601|NCT02702180|524583487|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
145472602|NCT02702180|524583488|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145601639|NCT01078155|525056249|FG000|Overall Study|Participant's Decision|6|||
145472603|NCT02702180|524583489|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145472604|NCT02702180|524583487|FG000|Double-blind Treatment Period|Adverse Event|0|||
145472605|NCT02702180|524583488|FG001|Double-blind Treatment Period|Adverse Event|0|||
145472606|NCT02702180|524583489|FG002|Double-blind Treatment Period|Adverse Event|1|||
145472607|NCT02702180|524583487|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145472608|NCT02702180|524583488|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145472609|NCT02702180|524583489|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
145472610|NCT02702180|524583487|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145472611|NCT02702180|524583488|FG001|Double-blind Treatment Period|Protocol Violation|0|||
145472612|NCT02702180|524583489|FG002|Double-blind Treatment Period|Protocol Violation|2|||
145472613|NCT02702180|524583487|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
145472614|NCT02702180|524583488|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
145472615|NCT02702180|524583489|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
145472616|NCT02702180|524583487|FG000|Open-label Treatment Period|Withdrawn in error|0|||
145472617|NCT02702180|524583488|FG001|Open-label Treatment Period|Withdrawn in error|0|||
145472618|NCT02702180|524583489|FG002|Open-label Treatment Period|Withdrawn in error|1|||
145472619|NCT00372697|524583490|FG000|Overall Study|Protocol Violation|1|||
145472620|NCT00372697|524583491|FG001|Overall Study|Protocol Violation|1|||
145472621|NCT01815840|524583492|FG000|Overall Study|Missing|1|||
145472622|NCT01815840|524583493|FG001|Overall Study|Missing|0|||
145472623|NCT01815840|524583492|FG000|Overall Study|Withdrew Consent|31|||
145472624|NCT01815840|524583493|FG001|Overall Study|Withdrew Consent|30|||
145472625|NCT01815840|524583492|FG000|Overall Study|Administrative/Other|1|||
145472626|NCT01815840|524583493|FG001|Overall Study|Administrative/Other|3|||
145472627|NCT01815840|524583492|FG000|Overall Study|Adverse Event|10|||
145472628|NCT01815840|524583493|FG001|Overall Study|Adverse Event|16|||
145472629|NCT01815840|524583492|FG000|Overall Study|Death|2|||
145472630|NCT01815840|524583493|FG001|Overall Study|Death|2|||
145472631|NCT01815840|524583492|FG000|Overall Study|Disease progression|3|||
145472632|NCT01815840|524583493|FG001|Overall Study|Disease progression|2|||
145472633|NCT01815840|524583492|FG000|Overall Study|Investigators Decision|2|||
145472634|NCT01815840|524583493|FG001|Overall Study|Investigators Decision|3|||
145472635|NCT01815840|524583492|FG000|Overall Study|Lost to Follow-up|3|||
145472636|NCT01815840|524583493|FG001|Overall Study|Lost to Follow-up|6|||
145472637|NCT01815840|524583492|FG000|Overall Study|Refused Treatment|5|||
145472638|NCT01815840|524583493|FG001|Overall Study|Refused Treatment|1|||
145472639|NCT01815840|524583492|FG000|Overall Study|Sponsor Termination Treatment|1|||
145472640|NCT01815840|524583493|FG001|Overall Study|Sponsor Termination Treatment|0|||
145472641|NCT03221842|524583494|FG000|Period 1 (Open-label)|Adverse Event|4|||
145472642|NCT03221842|524583495|FG001|Period 1 (Open-label)|Adverse Event|0|||
145472643|NCT03221842|524583494|FG000|Period 1 (Open-label)|Physician Decision|2|||
145472644|NCT03221842|524583495|FG001|Period 1 (Open-label)|Physician Decision|0|||
145472645|NCT03221842|524583494|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
145472646|NCT03221842|524583495|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
145472647|NCT03221842|524583494|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
145472648|NCT03221842|524583495|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
145472649|NCT03221842|524583494|FG000|Period 1 (Open-label)|Other|2|||
145472650|NCT03221842|524583495|FG001|Period 1 (Open-label)|Other|0|||
145472651|NCT03221842|524583494|FG000|Period 2 (Randomized, Blinded)|Death|0|||
145472652|NCT03221842|524583495|FG001|Period 2 (Randomized, Blinded)|Death|1|||
145472653|NCT03221842|524583494|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
145472654|NCT03221842|524583495|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
145472655|NCT00568126|524583497|FG000|Overall Study|Adverse Event|3|||
145472656|NCT00568126|524583498|FG001|Overall Study|Adverse Event|0|||
145472657|NCT00568126|524583497|FG000|Overall Study|Withdrawal by Subject|2|||
145472658|NCT00568126|524583498|FG001|Overall Study|Withdrawal by Subject|3|||
145472659|NCT00568126|524583497|FG000|Overall Study|Lost to Follow-up|4|||
145472660|NCT00568126|524583498|FG001|Overall Study|Lost to Follow-up|3|||
145472661|NCT00568126|524583497|FG000|Overall Study|Lack of Efficacy|0|||
145472662|NCT00568126|524583498|FG001|Overall Study|Lack of Efficacy|1|||
145472663|NCT00568126|524583497|FG000|Overall Study|Physician Decision|2|||
145472664|NCT00568126|524583498|FG001|Overall Study|Physician Decision|2|||
145472665|NCT04395690|524583499|FG000|Overall Study|Lost to Follow-up|1|||
145472666|NCT04395690|524583500|FG001|Overall Study|Lost to Follow-up|1|||
145472667|NCT00753454|524583501|FG000|Overall Study|Adverse Event|4|||
145472668|NCT00753454|524583501|FG000|Overall Study|Lack of Efficacy|1|||
145472669|NCT00753454|524583501|FG000|Overall Study|Lost to Follow-up|3|||
145472670|NCT00753454|524583501|FG000|Overall Study|Withdrawal by Subject|5|||
145472671|NCT00753454|524583501|FG000|Overall Study|Investigator Decision|1|||
145601640|NCT01078155|525056249|FG000|Overall Study|Lost to Follow-up|15|||
145601641|NCT03286751|525056250|FG000|Washout Period 1|Withdrawal by Subject|0|||
145472672|NCT05249569|524583502|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
145472673|NCT03927144|524583503|FG000|Core Phase|Adverse Event|9|||
145472674|NCT03927144|524583504|FG001|Core Phase|Adverse Event|5|||
145472675|NCT03927144|524583503|FG000|Core Phase|Lost to Follow-up|3|||
145472676|NCT03927144|524583504|FG001|Core Phase|Lost to Follow-up|2|||
145628603|NCT01981850|525153366|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628604|NCT01981850|525153367|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
145628605|NCT01981850|525153368|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
145628606|NCT01981850|525153369|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
145628607|NCT01981850|525153370|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628608|NCT01981850|525153371|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628609|NCT01981850|525153372|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
145628610|NCT01981850|525153363|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
145628611|NCT01981850|525153364|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
145628612|NCT01981850|525153365|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
145628613|NCT01981850|525153366|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
145628614|NCT01981850|525153367|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
145628615|NCT01981850|525153368|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
145628616|NCT01981850|525153369|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
145628617|NCT01981850|525153370|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
145628618|NCT01981850|525153371|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
145628619|NCT01981850|525153372|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
145628620|NCT01981850|525153363|FG000|Main Phase Stage 2|Various reasons|0|||
145628621|NCT01981850|525153364|FG001|Main Phase Stage 2|Various reasons|0|||
145628622|NCT01981850|525153365|FG002|Main Phase Stage 2|Various reasons|0|||
145628623|NCT01981850|525153366|FG003|Main Phase Stage 2|Various reasons|0|||
145628624|NCT01981850|525153367|FG004|Main Phase Stage 2|Various reasons|2|||
145628625|NCT01981850|525153368|FG005|Main Phase Stage 2|Various reasons|0|||
145628626|NCT01981850|525153369|FG006|Main Phase Stage 2|Various reasons|1|||
145628627|NCT01981850|525153370|FG007|Main Phase Stage 2|Various reasons|0|||
145628628|NCT01981850|525153371|FG008|Main Phase Stage 2|Various reasons|0|||
145628629|NCT01981850|525153372|FG009|Main Phase Stage 2|Various reasons|0|||
145628630|NCT01981850|525153363|FG000|Main Phase Stage 2|Progressive Disease|0|||
145628631|NCT01981850|525153364|FG001|Main Phase Stage 2|Progressive Disease|0|||
145628632|NCT01981850|525153365|FG002|Main Phase Stage 2|Progressive Disease|0|||
145628633|NCT01981850|525153366|FG003|Main Phase Stage 2|Progressive Disease|0|||
145628634|NCT01981850|525153367|FG004|Main Phase Stage 2|Progressive Disease|0|||
145628635|NCT01981850|525153368|FG005|Main Phase Stage 2|Progressive Disease|6|||
145628636|NCT01981850|525153369|FG006|Main Phase Stage 2|Progressive Disease|6|||
145628637|NCT01981850|525153370|FG007|Main Phase Stage 2|Progressive Disease|0|||
145628638|NCT01981850|525153371|FG008|Main Phase Stage 2|Progressive Disease|0|||
145628639|NCT01981850|525153372|FG009|Main Phase Stage 2|Progressive Disease|0|||
145628640|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Adverse Event|0|||
145628641|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Adverse Event|0|||
145628642|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Adverse Event|0|||
145628643|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Adverse Event|0|||
145628644|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Adverse Event|0|||
145628645|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Adverse Event|0|||
145628646|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Adverse Event|0|||
145628647|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Adverse Event|2|||
145628648|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Adverse Event|1|||
145628649|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Adverse Event|8|||
145628650|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628651|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628652|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628653|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628654|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628655|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628656|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
145628657|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
145628658|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
145628659|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
145628660|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Various reasons|0|||
145628661|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Various reasons|0|||
145628662|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Various reasons|0|||
145628663|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Various reasons|0|||
145628664|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Various reasons|0|||
145628665|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Various reasons|0|||
145628666|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Various reasons|0|||
145628667|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Various reasons|3|||
145628668|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Various reasons|1|||
145628669|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Various reasons|3|||
145628670|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
145628671|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
145628672|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
145628673|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
145628674|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
145628675|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
145472677|NCT03927144|524583503|FG000|Core Phase|New Therapy for Study Indication|0|||
145472678|NCT03927144|524583504|FG001|Core Phase|New Therapy for Study Indication|1|||
145472679|NCT03927144|524583503|FG000|Core Phase|No Longer Clinically Benefiting|4|||
145472680|NCT03927144|524583504|FG001|Core Phase|No Longer Clinically Benefiting|4|||
145472681|NCT03927144|524583503|FG000|Core Phase|Physician Decision|2|||
145472682|NCT03927144|524583504|FG001|Core Phase|Physician Decision|8|||
145472683|NCT03927144|524583503|FG000|Core Phase|Protocol Violation|2|||
145472684|NCT03927144|524583504|FG001|Core Phase|Protocol Violation|2|||
145472685|NCT03927144|524583503|FG000|Core Phase|Withdrawal by Subject|16|||
145472686|NCT03927144|524583504|FG001|Core Phase|Withdrawal by Subject|40|||
145472687|NCT03927144|524583503|FG000|Extension Phase|Adverse Event|2|||
145472688|NCT03927144|524583504|FG001|Extension Phase|Adverse Event|1|||
145472689|NCT03927144|524583503|FG000|Extension Phase|No longer clinically benefiting|4|||
145472690|NCT03927144|524583504|FG001|Extension Phase|No longer clinically benefiting|5|||
145472691|NCT03927144|524583503|FG000|Extension Phase|Pregnancy|1|||
145472692|NCT03927144|524583504|FG001|Extension Phase|Pregnancy|0|||
145472693|NCT03927144|524583503|FG000|Extension Phase|Protocol Violation|0|||
145472694|NCT03927144|524583504|FG001|Extension Phase|Protocol Violation|1|||
145472695|NCT03927144|524583503|FG000|Extension Phase|Withdrawal by Subject|8|||
145472696|NCT03927144|524583504|FG001|Extension Phase|Withdrawal by Subject|3|||
145472697|NCT02271945|524583507|FG000|Overall Study|Death|3|||
145472698|NCT02271945|524583508|FG001|Overall Study|Death|3|||
145472699|NCT02271945|524583507|FG000|Overall Study|Withdrawal by Subject|1|||
145472700|NCT02271945|524583508|FG001|Overall Study|Withdrawal by Subject|1|||
145472701|NCT02271945|524583507|FG000|Overall Study|Other|1|||
145472702|NCT02271945|524583508|FG001|Overall Study|Other|1|||
145472703|NCT01452919|524583509|FG000|Open-Label Treatment|Adverse Event|5|||
145472704|NCT01452919|524583510|FG001|Open-Label Treatment|Adverse Event|0|||
145472705|NCT01452919|524583511|FG002|Open-Label Treatment|Adverse Event|0|||
145472706|NCT01452919|524583509|FG000|Open-Label Treatment|Lost to Follow-up|4|||
145472707|NCT01452919|524583510|FG001|Open-Label Treatment|Lost to Follow-up|0|||
145472708|NCT01452919|524583511|FG002|Open-Label Treatment|Lost to Follow-up|0|||
145472709|NCT01452919|524583509|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
145472710|NCT01452919|524583510|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
145472711|NCT01452919|524583511|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
145472712|NCT01452919|524583509|FG000|Open-Label Treatment|Protocol Violation|4|||
145472713|NCT01452919|524583510|FG001|Open-Label Treatment|Protocol Violation|0|||
145472714|NCT01452919|524583511|FG002|Open-Label Treatment|Protocol Violation|0|||
145472715|NCT01452919|524583509|FG000|Open-Label Treatment|Sponsor Decision|1|||
145472716|NCT01452919|524583510|FG001|Open-Label Treatment|Sponsor Decision|0|||
145472717|NCT01452919|524583511|FG002|Open-Label Treatment|Sponsor Decision|0|||
145472718|NCT01452919|524583509|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
145472719|NCT01452919|524583510|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
145472720|NCT01452919|524583511|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
145472721|NCT01452919|524583509|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
145472722|NCT01452919|524583510|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
145472723|NCT01452919|524583511|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
145472724|NCT01452919|524583509|FG000|Randomization Treatment|Adverse Event|0|||
145472725|NCT01452919|524583510|FG001|Randomization Treatment|Adverse Event|0|||
145472726|NCT01452919|524583511|FG002|Randomization Treatment|Adverse Event|2|||
145472727|NCT01452919|524583509|FG000|Randomization Treatment|Sponsor Decision|0|||
145472728|NCT01452919|524583510|FG001|Randomization Treatment|Sponsor Decision|1|||
145472729|NCT01452919|524583511|FG002|Randomization Treatment|Sponsor Decision|0|||
145472730|NCT01452919|524583509|FG000|Randomization Treatment|Withdrawal by Subject|0|||
145472731|NCT01452919|524583510|FG001|Randomization Treatment|Withdrawal by Subject|1|||
145472732|NCT01452919|524583511|FG002|Randomization Treatment|Withdrawal by Subject|0|||
145472733|NCT01452919|524583509|FG000|Randomization Treatment|Subject is moving or has moved|0|||
145472734|NCT01452919|524583510|FG001|Randomization Treatment|Subject is moving or has moved|1|||
145472735|NCT01452919|524583511|FG002|Randomization Treatment|Subject is moving or has moved|0|||
145472736|NCT00615030|524583513|FG000|Period I|Administrative problem|0|||
145472737|NCT00615030|524583514|FG001|Period I|Administrative problem|0|||
145472738|NCT00615030|524583515|FG002|Period I|Administrative problem|0|||
145472739|NCT00615030|524583516|FG003|Period I|Administrative problem|0|||
145472740|NCT00615030|524583517|FG004|Period I|Administrative problem|1|||
145472741|NCT00615030|524583518|FG005|Period I|Administrative problem|0|||
145472742|NCT00615030|524583519|FG006|Period I|Administrative problem|0|||
145472743|NCT00615030|524583520|FG007|Period I|Administrative problem|0|||
145472744|NCT00615030|524583521|FG008|Period I|Administrative problem|0|||
145472745|NCT00615030|524583522|FG009|Period I|Administrative problem|0|||
145472746|NCT00615030|524583523|FG010|Period I|Administrative problem|0|||
145472747|NCT00615030|524583524|FG011|Period I|Administrative problem|0|||
145472748|NCT00615030|524583513|FG000|Period I|Protocol deviation|1|||
145601642|NCT03286751|525056251|FG001|Washout Period 1|Withdrawal by Subject|0|||
145601643|NCT03286751|525056252|FG002|Washout Period 1|Withdrawal by Subject|0|||
145601644|NCT03286751|525056253|FG003|Washout Period 1|Withdrawal by Subject|0|||
145601645|NCT03286751|525056254|FG004|Washout Period 1|Withdrawal by Subject|1|||
145472749|NCT00615030|524583514|FG001|Period I|Protocol deviation|0|||
145472750|NCT00615030|524583515|FG002|Period I|Protocol deviation|0|||
145472751|NCT00615030|524583516|FG003|Period I|Protocol deviation|0|||
145472752|NCT00615030|524583517|FG004|Period I|Protocol deviation|0|||
145472753|NCT00615030|524583518|FG005|Period I|Protocol deviation|0|||
145472754|NCT00615030|524583519|FG006|Period I|Protocol deviation|0|||
145472755|NCT00615030|524583520|FG007|Period I|Protocol deviation|0|||
145472756|NCT00615030|524583521|FG008|Period I|Protocol deviation|0|||
145472757|NCT00615030|524583522|FG009|Period I|Protocol deviation|0|||
145628676|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
145628677|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
145628678|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
145628679|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
145628680|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628681|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628682|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628683|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628684|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628685|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628686|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628687|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628688|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
145628689|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
145628690|NCT01981850|525153363|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628691|NCT01981850|525153364|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628692|NCT01981850|525153365|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628693|NCT01981850|525153366|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628694|NCT01981850|525153367|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628695|NCT01981850|525153368|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628696|NCT01981850|525153369|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628697|NCT01981850|525153370|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628698|NCT01981850|525153371|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
145628699|NCT01981850|525153372|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
145628700|NCT02524288|525153373|FG000|Overall Study|Adverse Event|115|||
145628701|NCT02524288|525153373|FG000|Overall Study|Lost to Follow-up|216|||
145628702|NCT02524288|525153373|FG000|Overall Study|Non-Compliance With Protocol|32|||
145628703|NCT02524288|525153373|FG000|Overall Study|Non-Compliance With Study Drug|14|||
145628704|NCT02524288|525153373|FG000|Overall Study|Pregnancy Wish|6|||
145628705|NCT02524288|525153373|FG000|Overall Study|Protocol Violation|6|||
145628706|NCT02524288|525153373|FG000|Overall Study|Screen Failure|2|||
145628707|NCT02524288|525153373|FG000|Overall Study|Site Discontinued Study Participation|1|||
145628708|NCT02524288|525153373|FG000|Overall Study|Study Terminated By Sponsor|1417|||
145628709|NCT02524288|525153373|FG000|Overall Study|Subject Moved|32|||
145628710|NCT02524288|525153373|FG000|Overall Study|Withdrawal by Subject|76|||
145628711|NCT02524288|525153373|FG000|Overall Study|Pregnancy|22|||
145628712|NCT02524288|525153373|FG000|Overall Study|Physician Decision|2|||
145628713|NCT00517933|525153375|FG000|Period 1|Death|2|||
145628714|NCT00517933|525153376|FG001|Period 1|Death|1|||
145628715|NCT00517933|525153375|FG000|Period 1|Adverse Event|4|||
145628716|NCT00517933|525153376|FG001|Period 1|Adverse Event|4|||
145628717|NCT00517933|525153375|FG000|Period 1|Lost to Follow-up|2|||
145628718|NCT00517933|525153376|FG001|Period 1|Lost to Follow-up|0|||
145628719|NCT00517933|525153375|FG000|Period 1|Underwent lung transplant|0|||
145628720|NCT00517933|525153376|FG001|Period 1|Underwent lung transplant|1|||
145628721|NCT00517933|525153375|FG000|Period 2|Death|2|||
145628722|NCT00517933|525153376|FG001|Period 2|Death|4|||
145628723|NCT00517933|525153375|FG000|Period 2|Adverse Event|2|||
145628724|NCT00517933|525153376|FG001|Period 2|Adverse Event|4|||
145628725|NCT00517933|525153375|FG000|Period 2|Physician Decision|1|||
145628726|NCT00517933|525153376|FG001|Period 2|Physician Decision|0|||
145628727|NCT00517933|525153375|FG000|Period 2|Withdrawal by Subject|1|||
145628728|NCT00517933|525153376|FG001|Period 2|Withdrawal by Subject|3|||
145472758|NCT00615030|524583523|FG010|Period I|Protocol deviation|0|||
145628729|NCT00517933|525153375|FG000|Period 2|Underwent lung transplant|0|||
145628730|NCT00517933|525153376|FG001|Period 2|Underwent lung transplant|2|||
145628731|NCT01836458|525153380|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
145628732|NCT01836458|525153381|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145628733|NCT01836458|525153382|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
145628734|NCT01836458|525153383|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
145628735|NCT00561574|525153384|FG000|Overall Study|Adverse Event|21|||
145628736|NCT00561574|525153385|FG001|Overall Study|Adverse Event|24|||
145628737|NCT00561574|525153384|FG000|Overall Study|Lack of Efficacy|11|||
145628738|NCT00561574|525153385|FG001|Overall Study|Lack of Efficacy|21|||
145628739|NCT00561574|525153384|FG000|Overall Study|Withdrawal by Subject|4|||
145628740|NCT00561574|525153385|FG001|Overall Study|Withdrawal by Subject|4|||
145472759|NCT00615030|524583524|FG011|Period I|Protocol deviation|0|||
145472760|NCT00615030|524583513|FG000|Period I|Subject withdrew consent|0|||
145472761|NCT00615030|524583514|FG001|Period I|Subject withdrew consent|0|||
145472762|NCT00615030|524583515|FG002|Period I|Subject withdrew consent|0|||
145472763|NCT00615030|524583516|FG003|Period I|Subject withdrew consent|0|||
145472764|NCT00615030|524583517|FG004|Period I|Subject withdrew consent|0|||
145472765|NCT00615030|524583518|FG005|Period I|Subject withdrew consent|0|||
145472766|NCT00615030|524583519|FG006|Period I|Subject withdrew consent|0|||
145472767|NCT00615030|524583520|FG007|Period I|Subject withdrew consent|0|||
145472768|NCT00615030|524583521|FG008|Period I|Subject withdrew consent|1|||
145472769|NCT00615030|524583522|FG009|Period I|Subject withdrew consent|0|||
145472770|NCT00615030|524583523|FG010|Period I|Subject withdrew consent|1|||
145472771|NCT00615030|524583524|FG011|Period I|Subject withdrew consent|1|||
145472772|NCT00615030|524583513|FG000|Period I|Abnormal laboratory value(s)|0|||
145472773|NCT00615030|524583514|FG001|Period I|Abnormal laboratory value(s)|0|||
145472774|NCT00615030|524583515|FG002|Period I|Abnormal laboratory value(s)|0|||
145472775|NCT00615030|524583516|FG003|Period I|Abnormal laboratory value(s)|0|||
145472776|NCT00615030|524583517|FG004|Period I|Abnormal laboratory value(s)|0|||
145472777|NCT00615030|524583518|FG005|Period I|Abnormal laboratory value(s)|1|||
145472778|NCT00615030|524583519|FG006|Period I|Abnormal laboratory value(s)|0|||
145472779|NCT00615030|524583520|FG007|Period I|Abnormal laboratory value(s)|0|||
145472780|NCT00615030|524583521|FG008|Period I|Abnormal laboratory value(s)|0|||
145472781|NCT00615030|524583522|FG009|Period I|Abnormal laboratory value(s)|0|||
145472782|NCT00615030|524583523|FG010|Period I|Abnormal laboratory value(s)|0|||
145472783|NCT00615030|524583524|FG011|Period I|Abnormal laboratory value(s)|0|||
145472784|NCT00615030|524583513|FG000|Period II|Adverse Event|0|||
145472785|NCT00615030|524583514|FG001|Period II|Adverse Event|0|||
145472786|NCT00615030|524583515|FG002|Period II|Adverse Event|1|||
145472787|NCT00615030|524583516|FG003|Period II|Adverse Event|0|||
145472788|NCT00615030|524583517|FG004|Period II|Adverse Event|0|||
145472789|NCT00615030|524583518|FG005|Period II|Adverse Event|0|||
145472790|NCT00615030|524583519|FG006|Period II|Adverse Event|0|||
145472791|NCT00615030|524583520|FG007|Period II|Adverse Event|0|||
145472792|NCT00615030|524583521|FG008|Period II|Adverse Event|1|||
145472793|NCT00615030|524583522|FG009|Period II|Adverse Event|0|||
145472794|NCT00615030|524583523|FG010|Period II|Adverse Event|0|||
145472795|NCT00615030|524583524|FG011|Period II|Adverse Event|0|||
145472796|NCT00615030|524583513|FG000|Period II|Subject withdrew consent|0|||
145472797|NCT00615030|524583514|FG001|Period II|Subject withdrew consent|0|||
145472798|NCT00615030|524583515|FG002|Period II|Subject withdrew consent|0|||
145472799|NCT00615030|524583516|FG003|Period II|Subject withdrew consent|1|||
145472800|NCT00615030|524583517|FG004|Period II|Subject withdrew consent|0|||
145472801|NCT00615030|524583518|FG005|Period II|Subject withdrew consent|0|||
145472802|NCT00615030|524583519|FG006|Period II|Subject withdrew consent|1|||
145472803|NCT00615030|524583520|FG007|Period II|Subject withdrew consent|0|||
145472804|NCT00615030|524583521|FG008|Period II|Subject withdrew consent|0|||
145472805|NCT00615030|524583522|FG009|Period II|Subject withdrew consent|0|||
145472806|NCT00615030|524583523|FG010|Period II|Subject withdrew consent|0|||
145472807|NCT00615030|524583524|FG011|Period II|Subject withdrew consent|0|||
145472808|NCT00615030|524583513|FG000|Period III|Administrative problems|1|||
145472809|NCT00615030|524583514|FG001|Period III|Administrative problems|0|||
145472810|NCT00615030|524583515|FG002|Period III|Administrative problems|0|||
145472811|NCT00615030|524583516|FG003|Period III|Administrative problems|1|||
145472812|NCT00615030|524583517|FG004|Period III|Administrative problems|0|||
145472813|NCT00615030|524583518|FG005|Period III|Administrative problems|0|||
145472814|NCT00615030|524583519|FG006|Period III|Administrative problems|0|||
145472815|NCT00615030|524583520|FG007|Period III|Administrative problems|0|||
145472816|NCT00615030|524583521|FG008|Period III|Administrative problems|0|||
145472817|NCT00615030|524583522|FG009|Period III|Administrative problems|0|||
145472818|NCT00615030|524583523|FG010|Period III|Administrative problems|0|||
145472819|NCT00615030|524583524|FG011|Period III|Administrative problems|0|||
145472820|NCT01359943|524583525|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
145472821|NCT01359943|524583526|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
145472822|NCT01359943|524583527|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
145472823|NCT01359943|524583525|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
145472824|NCT01359943|524583526|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
145628741|NCT00561574|525153384|FG000|Overall Study|Reason Unrelated to Trial|6|||
145628742|NCT00561574|525153385|FG001|Overall Study|Reason Unrelated to Trial|2|||
145628743|NCT00561574|525153384|FG000|Overall Study|Lost to Follow-up|1|||
145628744|NCT00561574|525153385|FG001|Overall Study|Lost to Follow-up|0|||
145628745|NCT00561574|525153384|FG000|Overall Study|Other|5|||
145628746|NCT00561574|525153385|FG001|Overall Study|Other|7|||
145628747|NCT00445692|525153386|FG000|Overall Study|Adverse Event|11|||
145472825|NCT01359943|524583527|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
145472826|NCT01359943|524583525|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
145472827|NCT01359943|524583526|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
145472828|NCT01359943|524583527|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
145472829|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
145628748|NCT00445692|525153386|FG000|Overall Study|Lack of Efficacy|5|||
145472830|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
145472831|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
145472832|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
145472833|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
145472834|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
145472835|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
145472836|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
145472837|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
145472838|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
145472839|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
145472840|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
145472841|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
145472842|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
145472843|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
145472844|NCT01359943|524583525|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
145472845|NCT01359943|524583526|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
145472846|NCT01359943|524583527|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
145472847|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
145472848|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
145472849|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
145472850|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
145472851|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
145472852|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
145472853|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
145472854|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
145472855|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
145472856|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
145472857|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
145472858|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
145472859|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
145472860|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
145472861|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
145472862|NCT01359943|524583525|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
145472863|NCT01359943|524583526|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
145472864|NCT01359943|524583527|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
145472865|NCT00308074|524583532|FG000|Overall Study|Withdrawal by Subject|1|||
145472866|NCT03002311|524583533|FG000|Overall Study|Lost to Follow-up|13|||
145472867|NCT03002311|524583534|FG001|Overall Study|Lost to Follow-up|26|||
145472868|NCT03002311|524583533|FG000|Overall Study|Referral provider called to schedule app|3|||
145472869|NCT03002311|524583534|FG001|Overall Study|Referral provider called to schedule app|3|||
145472870|NCT03002311|524583533|FG000|Overall Study|Physician Decision|3|||
145601646|NCT03286751|525056255|FG005|Washout Period 1|Withdrawal by Subject|0|||
145601647|NCT03286751|525056250|FG000|Washout Period 2|Personal Reasons|0|||
145601648|NCT03286751|525056251|FG001|Washout Period 2|Personal Reasons|1|||
145601649|NCT03286751|525056252|FG002|Washout Period 2|Personal Reasons|0|||
145601650|NCT03286751|525056253|FG003|Washout Period 2|Personal Reasons|0|||
145601651|NCT03286751|525056254|FG004|Washout Period 2|Personal Reasons|0|||
145601652|NCT03286751|525056255|FG005|Washout Period 2|Personal Reasons|0|||
145601653|NCT03286751|525056250|FG000|Washout Period 5|Adverse Event|0|||
145601654|NCT03286751|525056251|FG001|Washout Period 5|Adverse Event|0|||
145601655|NCT03286751|525056252|FG002|Washout Period 5|Adverse Event|0|||
145601656|NCT03286751|525056253|FG003|Washout Period 5|Adverse Event|0|||
145601657|NCT03286751|525056254|FG004|Washout Period 5|Adverse Event|1|||
145601658|NCT03286751|525056255|FG005|Washout Period 5|Adverse Event|0|||
145601659|NCT01059643|525056256|FG000|Overall Study|Adverse Event|3|||
145601660|NCT01059643|525056256|FG000|Overall Study|Withdrawal by Subject|2|||
145601661|NCT01059643|525056256|FG000|Overall Study|Physician Decision|1|||
145601662|NCT01621880|525056257|FG000|Overall Study|Adverse Event|5|||
145601663|NCT01621880|525056258|FG001|Overall Study|Adverse Event|1|||
145601664|NCT01621880|525056257|FG000|Overall Study|Withdrawal by Subject|5|||
145601665|NCT01621880|525056258|FG001|Overall Study|Withdrawal by Subject|4|||
145601666|NCT00106184|525056266|FG000|Overall Study|Withdrawal by Subject|3|||
145601667|NCT00106184|525056267|FG001|Overall Study|Withdrawal by Subject|2|||
145601668|NCT02313909|525056271|FG000|Overall Study|Consent withdrawn by participant|33|||
145601669|NCT02313909|525056272|FG001|Overall Study|Consent withdrawn by participant|33|||
145601670|NCT02313909|525056271|FG000|Overall Study|Lost to Follow-up|24|||
145601671|NCT02313909|525056272|FG001|Overall Study|Lost to Follow-up|17|||
145601672|NCT00643123|525056278|FG000|Overall Study|Lost to Follow-up|4|||
145601673|NCT00643123|525056279|FG001|Overall Study|Lost to Follow-up|0|||
145601674|NCT00643123|525056278|FG000|Overall Study|Withdrawal by Subject|1|||
145601675|NCT00643123|525056279|FG001|Overall Study|Withdrawal by Subject|1|||
145601676|NCT02309112|525056280|FG000|Overall Study|Withdrawal by Subject|1|||
145472871|NCT03002311|524583534|FG001|Overall Study|Physician Decision|1|||
145472872|NCT03722524|524583538|FG000|Overall Study|Protocol Violation|86|||
145472873|NCT03722524|524583538|FG000|Overall Study|Adverse Event|7|||
145472874|NCT03722524|524583538|FG000|Overall Study|Lost to Follow-up|1|||
145472875|NCT03722524|524583538|FG000|Overall Study|Reason is not stated|1|||
145472876|NCT03722524|524583538|FG000|Overall Study|Physician Decision|1|||
145472877|NCT03722524|524583538|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
145472878|NCT01716104|524583539|FG000|Overall Study|Do not meet inclusion criteria|6|||
145472879|NCT01716104|524583540|FG001|Overall Study|Do not meet inclusion criteria|7|||
145472880|NCT03429543|524583543|FG000|Overall Study|Adverse Event|1|||
145472881|NCT03429543|524583544|FG001|Overall Study|Adverse Event|1|||
145472882|NCT03429543|524583545|FG002|Overall Study|Adverse Event|0|||
145472883|NCT03429543|524583546|FG003|Overall Study|Adverse Event|0|||
145472884|NCT03429543|524583547|FG004|Overall Study|Adverse Event|0|||
145472885|NCT03429543|524583548|FG005|Overall Study|Adverse Event|2|||
145472886|NCT03429543|524583549|FG006|Overall Study|Adverse Event|0|||
145472887|NCT03429543|524583543|FG000|Overall Study|Lost to Follow-up|1|||
145472888|NCT03429543|524583544|FG001|Overall Study|Lost to Follow-up|0|||
145472889|NCT03429543|524583545|FG002|Overall Study|Lost to Follow-up|0|||
145472890|NCT03429543|524583546|FG003|Overall Study|Lost to Follow-up|0|||
145472891|NCT03429543|524583547|FG004|Overall Study|Lost to Follow-up|1|||
145472892|NCT03429543|524583548|FG005|Overall Study|Lost to Follow-up|0|||
145472893|NCT03429543|524583549|FG006|Overall Study|Lost to Follow-up|0|||
145472894|NCT03429543|524583543|FG000|Overall Study|Withdrawal by Subject|5|||
145472895|NCT03429543|524583544|FG001|Overall Study|Withdrawal by Subject|0|||
145472896|NCT03429543|524583545|FG002|Overall Study|Withdrawal by Subject|1|||
145472897|NCT03429543|524583546|FG003|Overall Study|Withdrawal by Subject|2|||
145472898|NCT03429543|524583547|FG004|Overall Study|Withdrawal by Subject|6|||
145472899|NCT03429543|524583548|FG005|Overall Study|Withdrawal by Subject|3|||
145472900|NCT03429543|524583549|FG006|Overall Study|Withdrawal by Subject|1|||
145472901|NCT03429543|524583543|FG000|Overall Study|Other reason than listed|0|||
145472902|NCT03429543|524583544|FG001|Overall Study|Other reason than listed|1|||
145472903|NCT03429543|524583545|FG002|Overall Study|Other reason than listed|0|||
145472904|NCT03429543|524583546|FG003|Overall Study|Other reason than listed|0|||
145472905|NCT03429543|524583547|FG004|Overall Study|Other reason than listed|4|||
145472906|NCT03429543|524583548|FG005|Overall Study|Other reason than listed|4|||
145472907|NCT03429543|524583549|FG006|Overall Study|Other reason than listed|0|||
145472908|NCT03429543|524583543|FG000|Overall Study|Not treated|0|||
145472909|NCT03429543|524583544|FG001|Overall Study|Not treated|0|||
145472910|NCT03429543|524583545|FG002|Overall Study|Not treated|0|||
145472911|NCT03429543|524583546|FG003|Overall Study|Not treated|0|||
145472912|NCT03429543|524583547|FG004|Overall Study|Not treated|1|||
145472913|NCT03429543|524583548|FG005|Overall Study|Not treated|0|||
145472914|NCT03429543|524583549|FG006|Overall Study|Not treated|0|||
145472915|NCT01818492|524583550|FG000|Overall Study|Adverse Event|2|||
145472916|NCT01818492|524583550|FG000|Overall Study|Death|3|||
145472917|NCT01818492|524583550|FG000|Overall Study|Withdrawal by Subject|1|||
145472918|NCT01818492|524583550|FG000|Overall Study|Additional therapy when not allowed PP|4|||
145472919|NCT00454181|524583554|FG000|Overall Study|Adverse Event|1|||
145472920|NCT00454181|524583555|FG001|Overall Study|Adverse Event|1|||
145472921|NCT00454181|524583554|FG000|Overall Study|Lost to Follow-up|11|||
145472922|NCT00454181|524583555|FG001|Overall Study|Lost to Follow-up|1|||
145472923|NCT00454181|524583554|FG000|Overall Study|Protocol Violation|1|||
145472924|NCT00454181|524583555|FG001|Overall Study|Protocol Violation|1|||
145472925|NCT00454181|524583554|FG000|Overall Study|Withdrawal by Subject|2|||
145472926|NCT00454181|524583555|FG001|Overall Study|Withdrawal by Subject|0|||
145472927|NCT00079677|524583559|FG000|Overall Study|Adverse Event|5|||
145472928|NCT00079677|524583560|FG001|Overall Study|Adverse Event|6|||
145472929|NCT00079677|524583559|FG000|Overall Study|Lack of Efficacy|1|||
145472930|NCT00079677|524583560|FG001|Overall Study|Lack of Efficacy|0|||
145472931|NCT00079677|524583559|FG000|Overall Study|Lost to Follow-up|2|||
145472932|NCT00079677|524583560|FG001|Overall Study|Lost to Follow-up|2|||
145472933|NCT00079677|524583559|FG000|Overall Study|Physician Decision|3|||
145472934|NCT00079677|524583560|FG001|Overall Study|Physician Decision|0|||
145472935|NCT00079677|524583559|FG000|Overall Study|Protocol Violation|2|||
145472936|NCT00079677|524583560|FG001|Overall Study|Protocol Violation|3|||
145472937|NCT00079677|524583559|FG000|Overall Study|Withdrawal by Subject|5|||
145472938|NCT00079677|524583560|FG001|Overall Study|Withdrawal by Subject|3|||
145472939|NCT00079677|524583559|FG000|Overall Study|Miscellaneous|2|||
145472940|NCT00079677|524583560|FG001|Overall Study|Miscellaneous|0|||
145472941|NCT00989781|524583563|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
145601677|NCT02309112|525056281|FG001|Overall Study|Withdrawal by Subject|0|||
145472942|NCT00989781|524583564|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
145472943|NCT00409344|524583565|FG000|Overall Study|no enrollment|0|||
145472944|NCT00409344|524583566|FG001|Overall Study|no enrollment|0|||
145472945|NCT05096312|524583567|FG000|Overall Study|Lost to Follow-up|2|||
145472946|NCT05096312|524583568|FG001|Overall Study|Lost to Follow-up|4|||
145472947|NCT05096312|524583567|FG000|Overall Study|Adverse Event|1|||
145472948|NCT05096312|524583568|FG001|Overall Study|Adverse Event|0|||
145472949|NCT03927404|524583569|FG000|Overall Study|Withdrawal by Subject|1|||
145472950|NCT01229449|524583572|FG000|Overall Study|Withdrawal by Subject|0|||
145472951|NCT01229449|524583573|FG001|Overall Study|Withdrawal by Subject|3|||
145472952|NCT01229449|524583574|FG002|Overall Study|Withdrawal by Subject|0|||
145472953|NCT01229449|524583575|FG003|Overall Study|Withdrawal by Subject|1|||
145472954|NCT01229449|524583576|FG004|Overall Study|Withdrawal by Subject|1|||
145472955|NCT01229449|524583572|FG000|Overall Study|Lost to Follow-up|1|||
145472956|NCT01229449|524583573|FG001|Overall Study|Lost to Follow-up|1|||
145472957|NCT01229449|524583574|FG002|Overall Study|Lost to Follow-up|1|||
145472958|NCT01229449|524583575|FG003|Overall Study|Lost to Follow-up|0|||
145472959|NCT01229449|524583576|FG004|Overall Study|Lost to Follow-up|0|||
145472960|NCT01229449|524583572|FG000|Overall Study|Physician Decision|0|||
145472961|NCT01229449|524583573|FG001|Overall Study|Physician Decision|0|||
145472962|NCT01229449|524583574|FG002|Overall Study|Physician Decision|1|||
145472963|NCT01229449|524583575|FG003|Overall Study|Physician Decision|0|||
145472964|NCT01229449|524583576|FG004|Overall Study|Physician Decision|0|||
145472965|NCT03203291|524583577|FG000|Overall Study|Withdrawal by Subject|1|||
145472966|NCT04033068|524583578|FG000|Overall Study|Withdrawal by Subject|0|||
145472967|NCT04033068|524583579|FG001|Overall Study|Withdrawal by Subject|0|||
145472968|NCT04033068|524583580|FG002|Overall Study|Withdrawal by Subject|1|||
145472969|NCT04033068|524583581|FG003|Overall Study|Withdrawal by Subject|0|||
145472970|NCT04033068|524583578|FG000|Overall Study|Lost to Follow-up|0|||
145472971|NCT04033068|524583579|FG001|Overall Study|Lost to Follow-up|1|||
145472972|NCT04033068|524583580|FG002|Overall Study|Lost to Follow-up|0|||
145472973|NCT04033068|524583581|FG003|Overall Study|Lost to Follow-up|0|||
145472974|NCT04033068|524583578|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
145472975|NCT04033068|524583579|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
145472976|NCT04033068|524583580|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
145472977|NCT04033068|524583581|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
145472978|NCT02540265|524583583|FG000|Overall Study|Lost to Follow-up|0|||
145472979|NCT02540265|524583584|FG001|Overall Study|Lost to Follow-up|0|||
145472980|NCT02540265|524583585|FG002|Overall Study|Lost to Follow-up|1|||
145472981|NCT03157037|524583586|FG000|Overall Study|Death|1|||
145472982|NCT02102399|524583587|FG000|Overall Study|Withdrawal by Subject|6|||
145472983|NCT02102399|524583588|FG001|Overall Study|Withdrawal by Subject|4|||
145472984|NCT04349033|524583589|FG000|Overall Study|Lost to Follow-up|3|||
145472985|NCT04349033|524583590|FG001|Overall Study|Lost to Follow-up|1|||
145472986|NCT04349033|524583591|FG002|Overall Study|Lost to Follow-up|1|||
145472987|NCT00324233|524583592|FG000|First Period|unable to insert catheter|1|||
145472988|NCT00324233|524583593|FG001|First Period|unable to insert catheter|0|||
145472989|NCT00324233|524583592|FG000|Second Period|unable to insert catheter|1|||
145472990|NCT00324233|524583593|FG001|Second Period|unable to insert catheter|1|||
145472991|NCT00324233|524583592|FG000|Second Period|Protocol Violation|4|||
145472992|NCT00324233|524583593|FG001|Second Period|Protocol Violation|6|||
145472993|NCT01704456|524583598|FG000|Overall Study|Lost to Follow-up|8|||
145472994|NCT01704456|524583599|FG001|Overall Study|Lost to Follow-up|14|||
145472995|NCT00498355|524583600|FG000|Overall Study|Lost to Follow-up|1|||
145472996|NCT00410605|524583601|FG000|Overall Study|Adverse Event|12|||
145472997|NCT00410605|524583601|FG000|Overall Study|Physician Decision|3|||
145472998|NCT00410605|524583601|FG000|Overall Study|Withdrawal by Subject|5|||
145472999|NCT00410605|524583601|FG000|Overall Study|Started Non-Protocol Therapy|3|||
145473000|NCT00410605|524583601|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
145473001|NCT00410605|524583601|FG000|Overall Study|Transferred to another Institution|1|||
145473002|NCT04583956|524583602|FG000|Overall Study|Death|9|||
145473003|NCT04583956|524583603|FG001|Overall Study|Death|11|||
145473004|NCT04583956|524583602|FG000|Overall Study|Lost to Follow-up|7|||
145473005|NCT04583956|524583603|FG001|Overall Study|Lost to Follow-up|9|||
145473006|NCT04583956|524583602|FG000|Overall Study|Protocol Violation|2|||
145473007|NCT04583956|524583603|FG001|Overall Study|Protocol Violation|0|||
145473008|NCT04583956|524583602|FG000|Overall Study|Withdrawal by Subject|0|||
145473009|NCT04583956|524583603|FG001|Overall Study|Withdrawal by Subject|2|||
145473010|NCT04583956|524583602|FG000|Overall Study|Randomized but not dosed|2|||
145473011|NCT04583956|524583603|FG001|Overall Study|Randomized but not dosed|3|||
145473012|NCT04583956|524583602|FG000|Overall Study|Withdrawal of consent before product administration|1|||
145473013|NCT04583956|524583603|FG001|Overall Study|Withdrawal of consent before product administration|0|||
145473014|NCT01887353|524583614|FG000|Overall Study|Study stopped early|4|||
145473015|NCT01887353|524583615|FG001|Overall Study|Study stopped early|3|||
145473016|NCT04407234|524583617|FG000|Overall Study|Adverse Event|3|||
145473017|NCT04407234|524583618|FG001|Overall Study|Adverse Event|3|||
145473018|NCT03908970|524583619|FG000|Overall Study|Adverse Event|7|||
145473019|NCT03908970|524583620|FG001|Overall Study|Adverse Event|21|||
145473020|NCT03908970|524583619|FG000|Overall Study|Physician Decision|1|||
145473021|NCT03908970|524583620|FG001|Overall Study|Physician Decision|4|||
145473022|NCT03908970|524583619|FG000|Overall Study|Withdrawal by Subject|9|||
145473023|NCT03908970|524583620|FG001|Overall Study|Withdrawal by Subject|22|||
145473024|NCT00605345|524583622|FG000|Overall Study|Withdrawal by Subject|1|||
145473025|NCT00605345|524583623|FG001|Overall Study|Withdrawal by Subject|0|||
145473026|NCT00605345|524583622|FG000|Overall Study|Adverse Event|0|||
145473027|NCT00605345|524583623|FG001|Overall Study|Adverse Event|1|||
145473028|NCT00605345|524583622|FG000|Overall Study|Protocol Violation|0|||
145473029|NCT00605345|524583623|FG001|Overall Study|Protocol Violation|2|||
145473030|NCT00761527|524583626|FG000|Overall Study|Adverse Event|3|||
145473031|NCT00761527|524583626|FG000|Overall Study|Poor Compliance|8|||
145473032|NCT00761527|524583626|FG000|Overall Study|Lost to Follow-up|9|||
145473033|NCT00761527|524583626|FG000|Overall Study|Unknown reason|2|||
145473034|NCT00965575|524585407|FG000|Overall Study|subject unwillingness to swallow study c|1|||
145473035|NCT00965575|524585408|FG001|Overall Study|subject unwillingness to swallow study c|0|||
145473036|NCT02814175|524585411|FG000|Part 1|Adverse Event|2|||
145473037|NCT02814175|524585412|FG001|Part 1|Adverse Event|3|||
145473038|NCT02814175|524585413|FG002|Part 1|Adverse Event|0|||
145473039|NCT02814175|524585414|FG003|Part 1|Adverse Event|0|||
145473040|NCT02814175|524585415|FG004|Part 1|Adverse Event|0|||
145473041|NCT02814175|524585416|FG005|Part 1|Adverse Event|0|||
145473042|NCT02814175|524585411|FG000|Part 1|Withdrawal Consent|8|||
145473043|NCT02814175|524585412|FG001|Part 1|Withdrawal Consent|1|||
145473044|NCT02814175|524585413|FG002|Part 1|Withdrawal Consent|0|||
145473045|NCT02814175|524585414|FG003|Part 1|Withdrawal Consent|0|||
145473046|NCT02814175|524585415|FG004|Part 1|Withdrawal Consent|0|||
145473047|NCT02814175|524585416|FG005|Part 1|Withdrawal Consent|0|||
145473048|NCT02814175|524585411|FG000|Part 1|Lost to Follow-up|1|||
145473049|NCT02814175|524585412|FG001|Part 1|Lost to Follow-up|0|||
145473050|NCT02814175|524585413|FG002|Part 1|Lost to Follow-up|0|||
145473051|NCT02814175|524585414|FG003|Part 1|Lost to Follow-up|0|||
145473052|NCT02814175|524585415|FG004|Part 1|Lost to Follow-up|0|||
145473053|NCT02814175|524585416|FG005|Part 1|Lost to Follow-up|0|||
145473054|NCT02814175|524585411|FG000|Part 1|Lack of Efficacy|1|||
145473055|NCT02814175|524585412|FG001|Part 1|Lack of Efficacy|2|||
145473056|NCT02814175|524585413|FG002|Part 1|Lack of Efficacy|0|||
145473057|NCT02814175|524585414|FG003|Part 1|Lack of Efficacy|0|||
145473058|NCT02814175|524585415|FG004|Part 1|Lack of Efficacy|0|||
145473059|NCT02814175|524585416|FG005|Part 1|Lack of Efficacy|0|||
145473060|NCT02814175|524585411|FG000|Part 2|Adverse Event|0|||
145473061|NCT02814175|524585412|FG001|Part 2|Adverse Event|0|||
145473062|NCT02814175|524585413|FG002|Part 2|Adverse Event|0|||
145473063|NCT02814175|524585414|FG003|Part 2|Adverse Event|1|||
145473064|NCT02814175|524585415|FG004|Part 2|Adverse Event|1|||
145473065|NCT02814175|524585416|FG005|Part 2|Adverse Event|2|||
145473066|NCT02814175|524585411|FG000|Part 2|Withdrawal Consent|0|||
145473067|NCT02814175|524585412|FG001|Part 2|Withdrawal Consent|0|||
145473068|NCT02814175|524585413|FG002|Part 2|Withdrawal Consent|0|||
145473069|NCT02814175|524585414|FG003|Part 2|Withdrawal Consent|2|||
145473070|NCT02814175|524585415|FG004|Part 2|Withdrawal Consent|1|||
145473071|NCT02814175|524585416|FG005|Part 2|Withdrawal Consent|1|||
145473072|NCT02814175|524585411|FG000|Part 2|Lost to Follow-up|0|||
145473073|NCT02814175|524585412|FG001|Part 2|Lost to Follow-up|0|||
145473074|NCT02814175|524585413|FG002|Part 2|Lost to Follow-up|0|||
145473075|NCT02814175|524585414|FG003|Part 2|Lost to Follow-up|1|||
145473076|NCT02814175|524585415|FG004|Part 2|Lost to Follow-up|0|||
145473077|NCT02814175|524585416|FG005|Part 2|Lost to Follow-up|0|||
145473078|NCT02814175|524585411|FG000|Part 2|Lack of Efficacy|0|||
145473079|NCT02814175|524585412|FG001|Part 2|Lack of Efficacy|0|||
145473080|NCT02814175|524585413|FG002|Part 2|Lack of Efficacy|0|||
145473081|NCT02814175|524585414|FG003|Part 2|Lack of Efficacy|0|||
145473082|NCT02814175|524585415|FG004|Part 2|Lack of Efficacy|0|||
145473083|NCT02814175|524585416|FG005|Part 2|Lack of Efficacy|3|||
145601678|NCT02309112|525056282|FG002|Overall Study|Withdrawal by Subject|1|||
145601679|NCT02309112|525056280|FG000|Overall Study|Lost to Follow-up|0|||
145601680|NCT02309112|525056281|FG001|Overall Study|Lost to Follow-up|1|||
145601681|NCT02309112|525056282|FG002|Overall Study|Lost to Follow-up|0|||
145601682|NCT02133872|525056283|FG000|Overall Study|Withdrawal by Subject|5|||
145601683|NCT02133872|525056284|FG001|Overall Study|Withdrawal by Subject|3|||
145601684|NCT02133872|525056285|FG002|Overall Study|Withdrawal by Subject|0|||
145601685|NCT02923739|525056286|FG000|Overall Study|Withdrawal by Subject|2|||
145601686|NCT02923739|525056287|FG001|Overall Study|Withdrawal by Subject|0|||
145473084|NCT01912339|524585417|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
145473085|NCT01912339|524585418|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
145473086|NCT01912339|524585419|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
145473087|NCT01912339|524585417|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
145473088|NCT01912339|524585418|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
145473089|NCT01912339|524585419|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
145473090|NCT01912339|524585417|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
145473091|NCT01912339|524585418|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
145473092|NCT01912339|524585419|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
145473093|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
145473094|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
145473095|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
145473096|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
145473097|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
145473098|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
145473099|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
145473100|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
145473101|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
145473102|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
145473103|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
145473104|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
145473105|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
145473106|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
145473107|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
145473108|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
145473109|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
145473110|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
145473111|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
145473112|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
145473113|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
145473114|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
145473115|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
145473116|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
145473117|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
145473118|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
145473119|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
145473120|NCT01912339|524585417|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
145473121|NCT01912339|524585418|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
145473122|NCT01912339|524585419|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
145473123|NCT01754493|524585420|FG000|Overall Study|Adverse Event|1|||
145473124|NCT01754493|524585420|FG000|Overall Study|Lost to Follow-up|3|||
145473125|NCT01754493|524585420|FG000|Overall Study|Withdrawal by Subject|1|||
145473126|NCT01754493|524585420|FG000|Overall Study|Moved out of town|1|||
145473127|NCT01754493|524585420|FG000|Overall Study|Scheduling conflict|1|||
145473128|NCT02489942|524585421|FG000|Overall Study|Request by patient|602|||
145473129|NCT02489942|524585421|FG000|Overall Study|Improvement/remission|157|||
145473130|NCT02489942|524585421|FG000|Overall Study|No change/Progressive disease|263|||
145473131|NCT02489942|524585421|FG000|Overall Study|Adverse Event|522|||
145473132|NCT02489942|524585421|FG000|Overall Study|Other personal reasons|1218|||
145473133|NCT02489942|524585421|FG000|Overall Study|Lost to Follow-up|456|||
145473134|NCT02489942|524585421|FG000|Overall Study|Not continuously investigated|7|||
145473135|NCT02489942|524585421|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
145473136|NCT02489942|524585421|FG000|Overall Study|Multiple registration|1|||
145473137|NCT02489942|524585421|FG000|Overall Study|No patient visit after entry|100|||
145473138|NCT02489942|524585421|FG000|Overall Study|No treatment with Jardiance|2|||
145473139|NCT02489942|524585421|FG000|Overall Study|Patient received Jardiance before registration|1|||
145473140|NCT02489942|524585421|FG000|Overall Study|No CRF collected|86|||
145473141|NCT01272635|524585422|FG000|Overall Study|Lost to Follow-up|31|||
145473142|NCT01272635|524585423|FG001|Overall Study|Lost to Follow-up|20|||
145473143|NCT01272635|524585424|FG002|Overall Study|Lost to Follow-up|31|||
145473144|NCT01272635|524585425|FG003|Overall Study|Lost to Follow-up|23|||
145473145|NCT01543776|524585428|FG000|Overall Study|Withdrawal by Subject|2|||
145473146|NCT01543776|524585429|FG001|Overall Study|Withdrawal by Subject|2|||
145473147|NCT03626545|524585433|FG000|Overall Study|Progressive disease|3|||
145473148|NCT03626545|524585434|FG001|Overall Study|Progressive disease|82|||
145473149|NCT03626545|524585435|FG002|Overall Study|Progressive disease|85|||
145473150|NCT03626545|524585433|FG000|Overall Study|Adverse Event|3|||
145473151|NCT03626545|524585434|FG001|Overall Study|Adverse Event|13|||
145473152|NCT03626545|524585435|FG002|Overall Study|Adverse Event|10|||
145628749|NCT00430677|525153390|FG000|Short-term Period|Death|1|||
145628750|NCT00430677|525153391|FG001|Short-term Period|Death|1|||
145628751|NCT00430677|525153392|FG002|Short-term Period|Death|5|||
145473153|NCT03626545|524585433|FG000|Overall Study|Physician Decision|1|||
145628752|NCT00430677|525153390|FG000|Short-term Period|Adverse Event|15|||
145628753|NCT00430677|525153391|FG001|Short-term Period|Adverse Event|13|||
145473154|NCT03626545|524585434|FG001|Overall Study|Physician Decision|18|||
145473155|NCT03626545|524585435|FG002|Overall Study|Physician Decision|14|||
145628754|NCT00430677|525153392|FG002|Short-term Period|Adverse Event|9|||
145628755|NCT00430677|525153390|FG000|Short-term Period|Lack of Efficacy|5|||
145473156|NCT03626545|524585433|FG000|Overall Study|Subject Decision|0|||
145473157|NCT03626545|524585434|FG001|Overall Study|Subject Decision|5|||
145473158|NCT03626545|524585435|FG002|Overall Study|Subject Decision|5|||
145473159|NCT03626545|524585433|FG000|Overall Study|Death|1|||
145473160|NCT03626545|524585434|FG001|Overall Study|Death|1|||
145473161|NCT03626545|524585435|FG002|Overall Study|Death|1|||
145473162|NCT03626545|524585433|FG000|Overall Study|Protocol Deviation|0|||
145628756|NCT00430677|525153391|FG001|Short-term Period|Lack of Efficacy|6|||
145473163|NCT03626545|524585434|FG001|Overall Study|Protocol Deviation|1|||
145473164|NCT03626545|524585435|FG002|Overall Study|Protocol Deviation|1|||
145473165|NCT03626545|524585433|FG000|Overall Study|Guardian Decision|0|||
145473166|NCT03626545|524585434|FG001|Overall Study|Guardian Decision|0|||
145473167|NCT03626545|524585435|FG002|Overall Study|Guardian Decision|1|||
145473168|NCT00679172|524585436|FG000|Overall Study|Non-compliance|1|||
145473169|NCT00679172|524585437|FG001|Overall Study|Non-compliance|1|||
145473170|NCT00679172|524585438|FG002|Overall Study|Non-compliance|0|||
145473171|NCT00679172|524585439|FG003|Overall Study|Non-compliance|1|||
145473172|NCT00679172|524585440|FG004|Overall Study|Non-compliance|0|||
145473173|NCT00679172|524585436|FG000|Overall Study|Other not specified|0|||
145473174|NCT00679172|524585437|FG001|Overall Study|Other not specified|0|||
145473175|NCT00679172|524585438|FG002|Overall Study|Other not specified|1|||
145473176|NCT00679172|524585439|FG003|Overall Study|Other not specified|0|||
145473177|NCT00679172|524585440|FG004|Overall Study|Other not specified|0|||
145473178|NCT03387020|524585443|FG000|Overall Study|Adverse Event|0|||
145473179|NCT03387020|524585444|FG001|Overall Study|Adverse Event|2|||
145473180|NCT03387020|524585445|FG002|Overall Study|Adverse Event|0|||
145473181|NCT03387020|524585443|FG000|Overall Study|Withdrawal by Subject|2|||
145473182|NCT03387020|524585444|FG001|Overall Study|Withdrawal by Subject|0|||
145473183|NCT03387020|524585445|FG002|Overall Study|Withdrawal by Subject|0|||
145473184|NCT00434642|524585446|FG000|Blinded Treatment Phase|Adverse Event|12|||
145473185|NCT00434642|524585447|FG001|Blinded Treatment Phase|Adverse Event|58|||
145473186|NCT00434642|524585446|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
145473187|NCT00434642|524585447|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
145473188|NCT00434642|524585446|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
145473189|NCT00434642|524585447|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
145473190|NCT00434642|524585446|FG000|Blinded Treatment Phase|Physician Decision|19|||
145473191|NCT00434642|524585447|FG001|Blinded Treatment Phase|Physician Decision|27|||
145628757|NCT00430677|525153392|FG002|Short-term Period|Lack of Efficacy|4|||
145628758|NCT00430677|525153390|FG000|Short-term Period|Withdrawal by Subject|1|||
145628759|NCT00430677|525153391|FG001|Short-term Period|Withdrawal by Subject|1|||
145628760|NCT00430677|525153392|FG002|Short-term Period|Withdrawal by Subject|2|||
145628761|NCT00430677|525153390|FG000|Short-term Period|Participant no longer met study criteria|1|||
145628762|NCT00430677|525153391|FG001|Short-term Period|Participant no longer met study criteria|1|||
145628763|NCT00430677|525153392|FG002|Short-term Period|Participant no longer met study criteria|2|||
145628764|NCT00430677|525153390|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
145628765|NCT00430677|525153391|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
145628766|NCT00430677|525153392|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
145628767|NCT00430677|525153390|FG000|Short-term Period|Pregnancy|0|||
145628768|NCT00430677|525153391|FG001|Short-term Period|Pregnancy|2|||
145628769|NCT00430677|525153392|FG002|Short-term Period|Pregnancy|0|||
145628770|NCT00430677|525153390|FG000|Long-term Extension Period|Death|1|||
145628771|NCT00430677|525153391|FG001|Long-term Extension Period|Death|0|||
145628772|NCT00430677|525153392|FG002|Long-term Extension Period|Death|0|||
145628773|NCT00430677|525153390|FG000|Long-term Extension Period|Adverse Event|3|||
145628774|NCT00430677|525153391|FG001|Long-term Extension Period|Adverse Event|2|||
145628775|NCT00430677|525153392|FG002|Long-term Extension Period|Adverse Event|5|||
145628776|NCT00430677|525153390|FG000|Long-term Extension Period|Lack of Efficacy|5|||
145628777|NCT00430677|525153391|FG001|Long-term Extension Period|Lack of Efficacy|3|||
145628778|NCT00430677|525153392|FG002|Long-term Extension Period|Lack of Efficacy|8|||
145628779|NCT00430677|525153390|FG000|Long-term Extension Period|Lost to Follow-up|1|||
145628780|NCT00430677|525153391|FG001|Long-term Extension Period|Lost to Follow-up|1|||
145628781|NCT00430677|525153392|FG002|Long-term Extension Period|Lost to Follow-up|1|||
145628782|NCT00430677|525153390|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
145628783|NCT00430677|525153391|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
145628784|NCT00430677|525153392|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
145628785|NCT00430677|525153390|FG000|Long-term Extension Period|Pregnancy|1|||
145628786|NCT00430677|525153391|FG001|Long-term Extension Period|Pregnancy|1|||
145628787|NCT00430677|525153392|FG002|Long-term Extension Period|Pregnancy|0|||
145628788|NCT00430677|525153390|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
145473192|NCT00434642|524585446|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
145473193|NCT00434642|524585447|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
145473194|NCT00434642|524585446|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
145473195|NCT00434642|524585447|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
145628789|NCT00430677|525153391|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
145473196|NCT00434642|524585446|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
145628790|NCT00430677|525153392|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
145628791|NCT00430677|525153390|FG000|Long-term Extension Period|Other|2|||
145628792|NCT00430677|525153391|FG001|Long-term Extension Period|Other|1|||
145628793|NCT00430677|525153392|FG002|Long-term Extension Period|Other|1|||
145473197|NCT00434642|524585447|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
145473198|NCT00434642|524585446|FG000|Open-label Treatment Phase|Adverse Event|0|||
145473199|NCT00434642|524585447|FG001|Open-label Treatment Phase|Adverse Event|5|||
145473200|NCT00434642|524585446|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
145473201|NCT00434642|524585447|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
145473202|NCT02241343|524585450|FG000|Overall Study|Adverse Event|1|||
145473203|NCT02421588|524585451|FG000|Overall Study|Non-treatment-related AE|8|||
145473204|NCT02421588|524585452|FG001|Overall Study|Non-treatment-related AE|8|||
145473205|NCT02421588|524585451|FG000|Overall Study|Progressive disease|152|||
145473206|NCT02421588|524585452|FG001|Overall Study|Progressive disease|135|||
145473207|NCT02421588|524585451|FG000|Overall Study|Death|11|||
145473208|NCT02421588|524585452|FG001|Overall Study|Death|3|||
145473209|NCT02421588|524585451|FG000|Overall Study|Physician Decision|8|||
145473210|NCT02421588|524585452|FG001|Overall Study|Physician Decision|17|||
145473211|NCT02421588|524585451|FG000|Overall Study|Other reason not specified|3|||
145473212|NCT02421588|524585452|FG001|Overall Study|Other reason not specified|1|||
145473213|NCT02421588|524585451|FG000|Overall Study|Symptomatic deterioration|13|||
145473214|NCT02421588|524585452|FG001|Overall Study|Symptomatic deterioration|19|||
145473215|NCT02421588|524585451|FG000|Overall Study|Treatment-related AE|10|||
145473216|NCT02421588|524585452|FG001|Overall Study|Treatment-related AE|14|||
145473217|NCT02421588|524585451|FG000|Overall Study|Withdrawal by Subject|14|||
145473218|NCT02421588|524585452|FG001|Overall Study|Withdrawal by Subject|16|||
145473219|NCT02421588|524585451|FG000|Overall Study|Not treated|2|||
145473220|NCT02421588|524585452|FG001|Overall Study|Not treated|8|||
145473221|NCT04071158|524585459|FG000|Overall Study|Lost to Follow-up|1|||
145473222|NCT04071158|524585460|FG001|Overall Study|Lost to Follow-up|2|||
145473223|NCT04071158|524585461|FG002|Overall Study|Lost to Follow-up|3|||
145473224|NCT04071158|524585462|FG003|Overall Study|Lost to Follow-up|3|||
145473225|NCT04071158|524585463|FG004|Overall Study|Lost to Follow-up|5|||
145473226|NCT04071158|524585459|FG000|Overall Study|Randomized but not treated|2|||
145473227|NCT04071158|524585460|FG001|Overall Study|Randomized but not treated|2|||
145473228|NCT04071158|524585461|FG002|Overall Study|Randomized but not treated|0|||
145473229|NCT04071158|524585462|FG003|Overall Study|Randomized but not treated|0|||
145473230|NCT04071158|524585463|FG004|Overall Study|Randomized but not treated|0|||
145473231|NCT01178099|524585464|FG000|Overall Study|Physician Decision|0|||
145473232|NCT01178099|524585465|FG001|Overall Study|Physician Decision|1|||
145473233|NCT02473367|524585466|FG000|Wait 1|Withdrawal by Subject|1|||
145473234|NCT02473367|524585466|FG000|Period 4|Lost to Follow-up|1|||
145473235|NCT04816721|524585467|FG000|Overall Study|Withdrawal by Subject|0|||
145473236|NCT04816721|524585468|FG001|Overall Study|Withdrawal by Subject|2|||
145473237|NCT04816721|524585469|FG002|Overall Study|Withdrawal by Subject|0|||
145473238|NCT04816721|524585470|FG003|Overall Study|Withdrawal by Subject|1|||
145473239|NCT04816721|524585471|FG004|Overall Study|Withdrawal by Subject|1|||
145473240|NCT04816721|524585472|FG005|Overall Study|Withdrawal by Subject|0|||
145473241|NCT04816721|524585473|FG006|Overall Study|Withdrawal by Subject|0|||
145473242|NCT04816721|524585474|FG007|Overall Study|Withdrawal by Subject|0|||
145473243|NCT04816721|524585467|FG000|Overall Study|Miscellaneous|0|||
145473244|NCT04816721|524585468|FG001|Overall Study|Miscellaneous|0|||
145473245|NCT04816721|524585469|FG002|Overall Study|Miscellaneous|0|||
145473246|NCT04816721|524585470|FG003|Overall Study|Miscellaneous|0|||
145473247|NCT04816721|524585471|FG004|Overall Study|Miscellaneous|0|||
145473248|NCT04816721|524585472|FG005|Overall Study|Miscellaneous|1|||
145473249|NCT04816721|524585473|FG006|Overall Study|Miscellaneous|0|||
145473250|NCT04816721|524585474|FG007|Overall Study|Miscellaneous|0|||
145473251|NCT04816721|524585467|FG000|Overall Study|Lost to Follow-up|0|||
145473252|NCT04816721|524585468|FG001|Overall Study|Lost to Follow-up|0|||
145473253|NCT04816721|524585469|FG002|Overall Study|Lost to Follow-up|0|||
145628794|NCT00430677|525153390|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
145628795|NCT00430677|525153391|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
145628796|NCT00430677|525153392|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
145628797|NCT02040844|525153395|FG000|Overall Study|Adverse Event|0|||
145628798|NCT02040844|525153396|FG001|Overall Study|Adverse Event|0|||
145628799|NCT02040844|525153397|FG002|Overall Study|Adverse Event|1|||
145628800|NCT02040844|525153395|FG000|Overall Study|Withdrawal by Subject|16|||
145473254|NCT04816721|524585470|FG003|Overall Study|Lost to Follow-up|1|||
145473255|NCT04816721|524585471|FG004|Overall Study|Lost to Follow-up|0|||
145473256|NCT04816721|524585472|FG005|Overall Study|Lost to Follow-up|0|||
145628801|NCT02040844|525153396|FG001|Overall Study|Withdrawal by Subject|22|||
145473257|NCT04816721|524585473|FG006|Overall Study|Lost to Follow-up|0|||
145473258|NCT04816721|524585474|FG007|Overall Study|Lost to Follow-up|0|||
145473259|NCT01286740|524585476|FG000|Overall Study|Enrolled but not treated|1|||
145473260|NCT01286740|524585476|FG000|Overall Study|Protocol Violation|1|||
145473261|NCT03266172|524585477|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
145473262|NCT03266172|524585478|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
145473263|NCT03266172|524585479|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
145473264|NCT03266172|524585477|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
145473265|NCT03266172|524585478|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
145473266|NCT03266172|524585479|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
145473267|NCT03266172|524585477|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
145628802|NCT02040844|525153397|FG002|Overall Study|Withdrawal by Subject|25|||
145628803|NCT02040844|525153395|FG000|Overall Study|Lost to Follow-up|12|||
145628804|NCT02040844|525153396|FG001|Overall Study|Lost to Follow-up|9|||
145628805|NCT02040844|525153397|FG002|Overall Study|Lost to Follow-up|13|||
145628806|NCT02040844|525153395|FG000|Overall Study|Missing|13|||
145628807|NCT02040844|525153396|FG001|Overall Study|Missing|3|||
145628808|NCT02040844|525153397|FG002|Overall Study|Missing|2|||
145628809|NCT02040844|525153395|FG000|Overall Study|Non-specified|8|||
145628810|NCT02040844|525153396|FG001|Overall Study|Non-specified|2|||
145628811|NCT02040844|525153397|FG002|Overall Study|Non-specified|5|||
145628812|NCT02040844|525153395|FG000|Overall Study|Concomitant medication|1|||
145628813|NCT02040844|525153396|FG001|Overall Study|Concomitant medication|3|||
145628814|NCT02040844|525153397|FG002|Overall Study|Concomitant medication|1|||
145628815|NCT00828919|525153398|FG000|Overall Study|Death|0|||
145628816|NCT00828919|525153399|FG001|Overall Study|Death|1|||
145628817|NCT00828919|525153400|FG002|Overall Study|Death|2|||
145628818|NCT00828919|525153401|FG003|Overall Study|Death|0|||
145628819|NCT00828919|525153402|FG004|Overall Study|Death|0|||
145628820|NCT00828919|525153398|FG000|Overall Study|Adverse Event|2|||
145628821|NCT00828919|525153399|FG001|Overall Study|Adverse Event|2|||
145628822|NCT00828919|525153400|FG002|Overall Study|Adverse Event|2|||
145628823|NCT00828919|525153401|FG003|Overall Study|Adverse Event|1|||
145628824|NCT00828919|525153402|FG004|Overall Study|Adverse Event|3|||
145628825|NCT00828919|525153398|FG000|Overall Study|Objective progression or relapse|4|||
145628826|NCT00828919|525153399|FG001|Overall Study|Objective progression or relapse|4|||
145628827|NCT00828919|525153400|FG002|Overall Study|Objective progression or relapse|11|||
145628828|NCT00828919|525153401|FG003|Overall Study|Objective progression or relapse|0|||
145628829|NCT00828919|525153402|FG004|Overall Study|Objective progression or relapse|5|||
145628830|NCT00828919|525153398|FG000|Overall Study|No longer willing to participate in study|0|||
145628831|NCT00828919|525153399|FG001|Overall Study|No longer willing to participate in study|0|||
145628832|NCT00828919|525153400|FG002|Overall Study|No longer willing to participate in study|2|||
145628833|NCT00828919|525153401|FG003|Overall Study|No longer willing to participate in study|0|||
145628834|NCT00828919|525153402|FG004|Overall Study|No longer willing to participate in study|0|||
145628835|NCT00828919|525153398|FG000|Overall Study|Insufficient Clinical Response|0|||
145628836|NCT00828919|525153399|FG001|Overall Study|Insufficient Clinical Response|1|||
145628837|NCT00828919|525153400|FG002|Overall Study|Insufficient Clinical Response|2|||
145628838|NCT00828919|525153401|FG003|Overall Study|Insufficient Clinical Response|0|||
145628839|NCT00828919|525153402|FG004|Overall Study|Insufficient Clinical Response|0|||
145628840|NCT00828919|525153398|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
145628841|NCT00828919|525153399|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
145628842|NCT00828919|525153400|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
145628843|NCT00828919|525153401|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
145628844|NCT00828919|525153402|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
145628845|NCT00828919|525153398|FG000|Overall Study|Other|1|||
145628846|NCT00828919|525153399|FG001|Overall Study|Other|0|||
145628847|NCT00828919|525153400|FG002|Overall Study|Other|1|||
145628848|NCT00828919|525153401|FG003|Overall Study|Other|1|||
145628849|NCT00828919|525153402|FG004|Overall Study|Other|0|||
145628850|NCT00828919|525153398|FG000|Overall Study|Lost to Follow-up|0|||
145628851|NCT00828919|525153399|FG001|Overall Study|Lost to Follow-up|1|||
145628852|NCT00828919|525153400|FG002|Overall Study|Lost to Follow-up|0|||
145628853|NCT00828919|525153401|FG003|Overall Study|Lost to Follow-up|0|||
145628854|NCT00828919|525153402|FG004|Overall Study|Lost to Follow-up|0|||
145628855|NCT05567159|525153403|FG000|Overall Study|Adverse Event|4|||
145628856|NCT05567159|525153403|FG000|Overall Study|Physician Decision|3|||
145628857|NCT05567159|525153403|FG000|Overall Study|Protocol deviation|1|||
145628858|NCT02501811|525153405|FG000|Overall Study|Death|1|||
145628859|NCT02501811|525153406|FG001|Overall Study|Death|3|||
145628860|NCT02501811|525153407|FG002|Overall Study|Death|2|||
145628861|NCT02501811|525153408|FG003|Overall Study|Death|3|||
145628862|NCT02501811|525153405|FG000|Overall Study|Withdrawal by Subject|3|||
145628863|NCT02501811|525153406|FG001|Overall Study|Withdrawal by Subject|3|||
145628864|NCT02501811|525153407|FG002|Overall Study|Withdrawal by Subject|2|||
145628865|NCT02501811|525153408|FG003|Overall Study|Withdrawal by Subject|3|||
145628866|NCT02501811|525153405|FG000|Overall Study|Lost to Follow-up|0|||
145473268|NCT03266172|524585478|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
145628867|NCT02501811|525153406|FG001|Overall Study|Lost to Follow-up|0|||
145628868|NCT02501811|525153407|FG002|Overall Study|Lost to Follow-up|2|||
145628869|NCT02501811|525153408|FG003|Overall Study|Lost to Follow-up|1|||
145628870|NCT01311648|525155605|FG000|Main Study|Protocol Violation|0|||
145628871|NCT01311648|525155606|FG001|Main Study|Protocol Violation|1|||
145628872|NCT01311648|525155605|FG000|Main Study|Adverse Event|0|||
145628873|NCT01311648|525155606|FG001|Main Study|Adverse Event|1|||
145628874|NCT01311648|525155605|FG000|Main Study|Inhibitor management|0|||
145628875|NCT01311648|525155606|FG001|Main Study|Inhibitor management|17|||
145628876|NCT01311648|525155605|FG000|Main Study|Withdrawal by Subject|0|||
145473269|NCT03266172|524585479|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
145473270|NCT03266172|524585477|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
145473271|NCT03266172|524585478|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
145473272|NCT03266172|524585479|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
145473273|NCT03266172|524585477|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
145473274|NCT03266172|524585478|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
145473275|NCT03266172|524585479|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
145473276|NCT03266172|524585477|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
145473277|NCT03266172|524585478|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
145473278|NCT03266172|524585479|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
145473279|NCT04856904|524585481|FG000|Overall Study|Physician Decision|1|||
145473280|NCT04856904|524585482|FG001|Overall Study|Physician Decision|1|||
145473281|NCT04856904|524585481|FG000|Overall Study|Withdrawal by Subject|13|||
145473282|NCT04856904|524585482|FG001|Overall Study|Withdrawal by Subject|13|||
145473283|NCT04856904|524585481|FG000|Overall Study|Adverse Event|1|||
145473284|NCT04856904|524585482|FG001|Overall Study|Adverse Event|1|||
145473285|NCT04856904|524585481|FG000|Overall Study|Non-compliance with study drug|1|||
145473286|NCT04856904|524585482|FG001|Overall Study|Non-compliance with study drug|1|||
145473287|NCT04856904|524585481|FG000|Overall Study|Lost to Follow-up|4|||
145473288|NCT04856904|524585482|FG001|Overall Study|Lost to Follow-up|4|||
145473289|NCT04856904|524585481|FG000|Overall Study|Withdrawal by Subject|1|||
145473290|NCT04856904|524585482|FG001|Overall Study|Withdrawal by Subject|1|||
145473291|NCT04856904|524585481|FG000|Overall Study|Protocol Violation|1|||
145628877|NCT01311648|525155606|FG001|Main Study|Withdrawal by Subject|2|||
145628878|NCT01311648|525155605|FG000|Extension Study|Physician Decision|0|||
145628879|NCT01311648|525155606|FG001|Extension Study|Physician Decision|1|||
145628880|NCT01311648|525155605|FG000|Extension Study|ITI therapy with marketed product|0|||
145628881|NCT01311648|525155606|FG001|Extension Study|ITI therapy with marketed product|1|||
145628882|NCT01311648|525155605|FG000|Extension Study|Incorrect visit planning|0|||
145628883|NCT01311648|525155606|FG001|Extension Study|Incorrect visit planning|1|||
145628884|NCT01311648|525155605|FG000|Extension Study|Family's decision|0|||
145628885|NCT01311648|525155606|FG001|Extension Study|Family's decision|1|||
145628886|NCT01311648|525155605|FG000|Extension Study|Failure of ITI therapy|0|||
145628887|NCT01311648|525155606|FG001|Extension Study|Failure of ITI therapy|3|||
145628888|NCT01311648|525155605|FG000|Extension Study|Long travel|0|||
145628889|NCT01311648|525155606|FG001|Extension Study|Long travel|1|||
145628890|NCT01311648|525155605|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
145628891|NCT01311648|525155606|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
145628892|NCT01311648|525155605|FG000|Extension Study|Withdrawal by Subject|0|||
145628893|NCT01311648|525155606|FG001|Extension Study|Withdrawal by Subject|1|||
145628894|NCT01311648|525155605|FG000|Extension Study|Inhibitor management|0|||
145628895|NCT01311648|525155606|FG001|Extension Study|Inhibitor management|2|||
145628896|NCT02131324|525155611|FG000|Overall Study|Withdrawal by Subject|1|||
145628897|NCT02131324|525155612|FG001|Overall Study|Withdrawal by Subject|2|||
145628898|NCT02131324|525155611|FG000|Overall Study|Lost to Follow-up|1|||
145628899|NCT02131324|525155612|FG001|Overall Study|Lost to Follow-up|1|||
145628900|NCT00891618|525155613|FG000|Overall Study|Withdrawal by Subject|1|||
145628901|NCT00920686|525155614|FG000|Overall Study|Lost to Follow-up|2|||
145628902|NCT00920686|525155615|FG001|Overall Study|Lost to Follow-up|3|||
145628903|NCT00920686|525155616|FG002|Overall Study|Lost to Follow-up|1|||
145628904|NCT00920686|525155614|FG000|Overall Study|Study drug dosing criteria not met|17|||
145628905|NCT00920686|525155615|FG001|Overall Study|Study drug dosing criteria not met|19|||
145628906|NCT00920686|525155616|FG002|Overall Study|Study drug dosing criteria not met|12|||
145628907|NCT00003656|525155617|FG000|Overall Study|Adverse Event|0|||
145628908|NCT00003656|525155618|FG001|Overall Study|Adverse Event|1|||
145628909|NCT00763282|525155619|FG000|Overall Study|Withdrawal by Subject|6|||
145628910|NCT00763282|525155620|FG001|Overall Study|Withdrawal by Subject|5|||
145628911|NCT00763282|525155619|FG000|Overall Study|Death|4|||
145628912|NCT00763282|525155620|FG001|Overall Study|Death|3|||
145628913|NCT00763282|525155619|FG000|Overall Study|Lost to Follow-up|22|||
145628914|NCT00763282|525155620|FG001|Overall Study|Lost to Follow-up|26|||
145628915|NCT02219490|525155621|FG000|Overall Study|Adverse Event|24|||
145628916|NCT02219490|525155621|FG000|Overall Study|Withdrew consent|96|||
145628917|NCT02219490|525155621|FG000|Overall Study|Lost to Follow-up|126|||
145628918|NCT02219490|525155621|FG000|Overall Study|COVID-19 infection|2|||
145628919|NCT02219490|525155621|FG000|Overall Study|COVID-19 logistical restrictions|33|||
145628920|NCT02219490|525155621|FG000|Overall Study|Other, not specified|57|||
145628921|NCT00335556|525155622|FG000|Overall Study|Death|0|||
145473292|NCT04856904|524585482|FG001|Overall Study|Protocol Violation|1|||
145473293|NCT00902174|524585483|FG000|Overall Study|Adverse Event|27|||
145473294|NCT00902174|524585484|FG001|Overall Study|Adverse Event|7|||
145473295|NCT00902174|524585483|FG000|Overall Study|Lack of Efficacy|1|||
145473296|NCT00902174|524585484|FG001|Overall Study|Lack of Efficacy|5|||
145628922|NCT00335556|525155623|FG001|Overall Study|Death|5|||
145628923|NCT00335556|525155624|FG002|Overall Study|Death|0|||
145628924|NCT00335556|525155625|FG003|Overall Study|Death|0|||
145628925|NCT00335556|525155626|FG004|Overall Study|Death|1|||
145628926|NCT00335556|525155627|FG005|Overall Study|Death|0|||
145628927|NCT00335556|525155622|FG000|Overall Study|Lack of Efficacy|0|||
145628928|NCT00335556|525155623|FG001|Overall Study|Lack of Efficacy|19|||
145628929|NCT00335556|525155624|FG002|Overall Study|Lack of Efficacy|3|||
145628930|NCT00335556|525155625|FG003|Overall Study|Lack of Efficacy|3|||
145628931|NCT00335556|525155626|FG004|Overall Study|Lack of Efficacy|0|||
145628932|NCT00335556|525155627|FG005|Overall Study|Lack of Efficacy|1|||
145628933|NCT00335556|525155622|FG000|Overall Study|Physician Decision|0|||
145628934|NCT00335556|525155623|FG001|Overall Study|Physician Decision|6|||
145628935|NCT00335556|525155624|FG002|Overall Study|Physician Decision|2|||
145628936|NCT00335556|525155625|FG003|Overall Study|Physician Decision|1|||
145628937|NCT00335556|525155626|FG004|Overall Study|Physician Decision|0|||
145628938|NCT00335556|525155627|FG005|Overall Study|Physician Decision|0|||
145628939|NCT00335556|525155622|FG000|Overall Study|Ineligible|2|||
145628940|NCT00335556|525155623|FG001|Overall Study|Ineligible|0|||
145628941|NCT00335556|525155624|FG002|Overall Study|Ineligible|0|||
145628942|NCT00335556|525155625|FG003|Overall Study|Ineligible|0|||
145628943|NCT00335556|525155626|FG004|Overall Study|Ineligible|0|||
145628944|NCT00335556|525155627|FG005|Overall Study|Ineligible|0|||
145628945|NCT00335556|525155622|FG000|Overall Study|Refusal of further protocol therapy|0|||
145628946|NCT00335556|525155623|FG001|Overall Study|Refusal of further protocol therapy|4|||
145628947|NCT00335556|525155624|FG002|Overall Study|Refusal of further protocol therapy|0|||
145628948|NCT00335556|525155625|FG003|Overall Study|Refusal of further protocol therapy|1|||
145628949|NCT00335556|525155626|FG004|Overall Study|Refusal of further protocol therapy|0|||
145628950|NCT00335556|525155627|FG005|Overall Study|Refusal of further protocol therapy|0|||
145628951|NCT03441984|525155628|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628952|NCT03441984|525155629|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628953|NCT03441984|525155630|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
145628954|NCT03441984|525155631|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628955|NCT03441984|525155632|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628956|NCT03441984|525155633|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628957|NCT03441984|525155634|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628958|NCT03441984|525155635|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628959|NCT03441984|525155636|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628960|NCT03441984|525155637|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628961|NCT03441984|525155638|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628962|NCT03441984|525155639|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
145628963|NCT02595398|525155646|FG000|Overall Study|Non-compliance|1|||
145628964|NCT02595398|525155647|FG001|Overall Study|Non-compliance|0|||
145628965|NCT02595398|525155646|FG000|Overall Study|Withdrawal by Subject|2|||
145628966|NCT02595398|525155647|FG001|Overall Study|Withdrawal by Subject|1|||
145628967|NCT02595398|525155646|FG000|Overall Study|Lost to Follow-up|1|||
145628968|NCT02595398|525155647|FG001|Overall Study|Lost to Follow-up|0|||
145628969|NCT01664104|525155648|FG000|Overall Study|Adverse Event|6|||
145628970|NCT01664104|525155648|FG000|Overall Study|Lack of Efficacy|2|||
145628971|NCT01664104|525155648|FG000|Overall Study|Withdrawal by Subject|1|||
145628972|NCT01664104|525155648|FG000|Overall Study|Lost to Follow-up|4|||
145628973|NCT01664104|525155648|FG000|Overall Study|Other|1|||
145628974|NCT01664104|525155648|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
145628975|NCT00586339|525155649|FG000|Overall Study|Withdrawal by Subject|1|||
145628976|NCT00586339|525155650|FG001|Overall Study|Withdrawal by Subject|3|||
145628977|NCT00586339|525155651|FG002|Overall Study|Withdrawal by Subject|1|||
145628978|NCT00586339|525155649|FG000|Overall Study|Migrated/moved from study area|3|||
145628979|NCT00586339|525155650|FG001|Overall Study|Migrated/moved from study area|2|||
145628980|NCT00586339|525155651|FG002|Overall Study|Migrated/moved from study area|4|||
145628981|NCT00586339|525155649|FG000|Overall Study|Lost to Follow-up|3|||
145628982|NCT00586339|525155650|FG001|Overall Study|Lost to Follow-up|2|||
145628983|NCT00586339|525155651|FG002|Overall Study|Lost to Follow-up|1|||
145628984|NCT03168438|525155660|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
145628985|NCT03168438|525155661|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
145628986|NCT03235349|525155662|FG000|Overall Study|Adverse Event|1|||
145628987|NCT03235349|525155662|FG000|Overall Study|Other|1|||
145628988|NCT04523181|525155663|FG000|Overall Study|Withdrawal by Subject|4|||
145628989|NCT04523181|525155664|FG001|Overall Study|Withdrawal by Subject|5|||
145628990|NCT04523181|525155663|FG000|Overall Study|Lost to Follow-up|2|||
145628991|NCT04523181|525155664|FG001|Overall Study|Lost to Follow-up|3|||
145628992|NCT04523181|525155663|FG000|Overall Study|Physician Decision|1|||
145628993|NCT04523181|525155664|FG001|Overall Study|Physician Decision|0|||
145628994|NCT04523181|525155663|FG000|Overall Study|Transferred to external facility.|1|||
145628995|NCT04523181|525155664|FG001|Overall Study|Transferred to external facility.|1|||
145628996|NCT02138916|525155669|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
145628997|NCT02138916|525155670|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
145473297|NCT00902174|524585483|FG000|Overall Study|Death|2|||
145601687|NCT02923739|525056288|FG002|Overall Study|Withdrawal by Subject|0|||
145601688|NCT02923739|525056289|FG003|Overall Study|Withdrawal by Subject|0|||
145601689|NCT02923739|525056286|FG000|Overall Study|Failed Screening|3|||
145601690|NCT02923739|525056287|FG001|Overall Study|Failed Screening|0|||
145601691|NCT02923739|525056288|FG002|Overall Study|Failed Screening|0|||
145601692|NCT02923739|525056289|FG003|Overall Study|Failed Screening|0|||
145601693|NCT02857426|525056294|FG000|Overall Study|Disease progression|34|||
145601694|NCT02857426|525056295|FG001|Overall Study|Disease progression|13|||
145601695|NCT02857426|525056294|FG000|Overall Study|Study drug toxicity|4|||
145601696|NCT02857426|525056295|FG001|Overall Study|Study drug toxicity|1|||
145601697|NCT02857426|525056294|FG000|Overall Study|Death|1|||
145601698|NCT02857426|525056295|FG001|Overall Study|Death|0|||
145601699|NCT02857426|525056294|FG000|Overall Study|Adverse event unrelated to study drug|6|||
145601700|NCT02857426|525056295|FG001|Overall Study|Adverse event unrelated to study drug|2|||
145601701|NCT02857426|525056294|FG000|Overall Study|Participant withdrew consent|1|||
145601702|NCT02857426|525056295|FG001|Overall Study|Participant withdrew consent|1|||
145601703|NCT02857426|525056294|FG000|Overall Study|Maximum clinical benefit|1|||
145601704|NCT02857426|525056295|FG001|Overall Study|Maximum clinical benefit|0|||
145601705|NCT02857426|525056294|FG000|Overall Study|Completed treatment|0|||
145601706|NCT02857426|525056295|FG001|Overall Study|Completed treatment|2|||
145601707|NCT02831257|525056299|FG000|Overall Study|Lack of Efficacy|3|||
145601708|NCT02831257|525056299|FG000|Overall Study|Adverse Event|2|||
145601709|NCT02831257|525056299|FG000|Overall Study|Physician Decision|1|||
145601710|NCT02831257|525056299|FG000|Overall Study|Withdrawal by Subject|6|||
145601711|NCT00611858|525056300|FG000|Overall Study|Adverse Event|2|||
145601712|NCT00611858|525056300|FG000|Overall Study|Withdrawal by Subject|2|||
145601713|NCT00166296|525056302|FG000|Overall Study|Withdrawal by Subject|1|||
145601714|NCT00166296|525056303|FG001|Overall Study|Withdrawal by Subject|3|||
145601715|NCT00166296|525056302|FG000|Overall Study|Adverse Event|2|||
145601716|NCT00166296|525056303|FG001|Overall Study|Adverse Event|4|||
145601717|NCT00166296|525056302|FG000|Overall Study|Lost to Follow-up|4|||
145601718|NCT00166296|525056303|FG001|Overall Study|Lost to Follow-up|2|||
145601719|NCT04035200|525056309|FG000|Overall Study|Lost to Follow-up|0|||
145601720|NCT04035200|525056310|FG001|Overall Study|Lost to Follow-up|1|||
145601721|NCT04035200|525056311|FG002|Overall Study|Lost to Follow-up|0|||
145601722|NCT04035200|525056309|FG000|Overall Study|Withdrawal by Subject|1|||
145601723|NCT04035200|525056310|FG001|Overall Study|Withdrawal by Subject|4|||
145601724|NCT04035200|525056311|FG002|Overall Study|Withdrawal by Subject|4|||
145601725|NCT04035200|525056309|FG000|Overall Study|COVID-19|1|||
145601726|NCT04035200|525056310|FG001|Overall Study|COVID-19|0|||
145601727|NCT04035200|525056311|FG002|Overall Study|COVID-19|0|||
145601728|NCT04035200|525056309|FG000|Overall Study|Early Termination|0|||
145601729|NCT04035200|525056310|FG001|Overall Study|Early Termination|1|||
145601730|NCT04035200|525056311|FG002|Overall Study|Early Termination|0|||
145601731|NCT04035200|525056309|FG000|Overall Study|Non-compliance|0|||
145601732|NCT04035200|525056310|FG001|Overall Study|Non-compliance|1|||
145601733|NCT04035200|525056311|FG002|Overall Study|Non-compliance|0|||
145601734|NCT05479604|525056312|FG000|Overall Study|Lost to Follow-up|1|||
145601735|NCT05479604|525056313|FG001|Overall Study|Lost to Follow-up|5|||
145601736|NCT02061202|525056314|FG000|Overall Study|Lost to Follow-up|1|||
145601737|NCT02061202|525056315|FG001|Overall Study|Lost to Follow-up|1|||
145601738|NCT05163522|525056318|FG000|Overall Study|Withdrawal by Subject|0|||
145601739|NCT05163522|525056319|FG001|Overall Study|Withdrawal by Subject|0|||
145601740|NCT05163522|525056320|FG002|Overall Study|Withdrawal by Subject|1|||
145601741|NCT05163522|525056321|FG003|Overall Study|Withdrawal by Subject|0|||
145601742|NCT05163522|525056322|FG004|Overall Study|Withdrawal by Subject|0|||
145601743|NCT05163522|525056323|FG005|Overall Study|Withdrawal by Subject|0|||
145601744|NCT05163522|525056324|FG006|Overall Study|Withdrawal by Subject|0|||
145601745|NCT05163522|525056325|FG007|Overall Study|Withdrawal by Subject|0|||
145601746|NCT05163522|525056326|FG008|Overall Study|Withdrawal by Subject|0|||
145601747|NCT05163522|525056327|FG009|Overall Study|Withdrawal by Subject|0|||
145601748|NCT05163522|525056328|FG010|Overall Study|Withdrawal by Subject|0|||
145601749|NCT02753595|525056337|FG000|Overall Study|Sponsor termination|2|||
145601750|NCT02753595|525056338|FG001|Overall Study|Sponsor termination|2|||
145601751|NCT01570868|525056339|FG000|Overall Study|Adverse Event|8|||
145601752|NCT01570868|525056340|FG001|Overall Study|Adverse Event|1|||
145601753|NCT01570868|525056339|FG000|Overall Study|FDA Recommendation|23|||
145601754|NCT01570868|525056340|FG001|Overall Study|FDA Recommendation|3|||
145601755|NCT01570868|525056339|FG000|Overall Study|Physician Decision|10|||
145601756|NCT01570868|525056340|FG001|Overall Study|Physician Decision|4|||
145601757|NCT01570868|525056339|FG000|Overall Study|Lost to Follow-up|1|||
145601758|NCT01570868|525056340|FG001|Overall Study|Lost to Follow-up|0|||
145601759|NCT01570868|525056339|FG000|Overall Study|Withdrawal by Subject|1|||
145601760|NCT01570868|525056340|FG001|Overall Study|Withdrawal by Subject|0|||
145601761|NCT02515279|525056346|FG000|Overall Study|Adverse Event|7|||
145601762|NCT02515279|525056346|FG000|Overall Study|Lack of Efficacy|31|||
145601763|NCT02515279|525056346|FG000|Overall Study|Lost to Follow-up|9|||
145601764|NCT02515279|525056346|FG000|Overall Study|Withdrawal by Subject|18|||
145473298|NCT00902174|524585484|FG001|Overall Study|Death|2|||
145473299|NCT00902174|524585483|FG000|Overall Study|Withdrawal by Subject|2|||
145473300|NCT00902174|524585484|FG001|Overall Study|Withdrawal by Subject|1|||
145473301|NCT00902174|524585483|FG000|Overall Study|Abnormal labs|1|||
145473302|NCT00902174|524585484|FG001|Overall Study|Abnormal labs|1|||
145473303|NCT00902174|524585483|FG000|Overall Study|Protocol Violation|1|||
145473304|NCT00902174|524585484|FG001|Overall Study|Protocol Violation|1|||
145473305|NCT00902174|524585483|FG000|Overall Study|Administration problem|0|||
145473306|NCT00902174|524585484|FG001|Overall Study|Administration problem|1|||
145473307|NCT01641822|524585485|FG000|Run-in Phase|Noncompliance with study drug|1|||
145473308|NCT01641822|524585486|FG001|Run-in Phase|Noncompliance with study drug|0|||
145473309|NCT01641822|524585487|FG002|Run-in Phase|Noncompliance with study drug|0|||
145473310|NCT01641822|524585485|FG000|Run-in Phase|Adverse Event|3|||
145473311|NCT01641822|524585486|FG001|Run-in Phase|Adverse Event|0|||
145473312|NCT01641822|524585487|FG002|Run-in Phase|Adverse Event|0|||
145473313|NCT01641822|524585485|FG000|Run-in Phase|Withdrew consent|1|||
145473314|NCT01641822|524585486|FG001|Run-in Phase|Withdrew consent|0|||
145473315|NCT01641822|524585487|FG002|Run-in Phase|Withdrew consent|0|||
145473316|NCT01641822|524585485|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
145473317|NCT01641822|524585486|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
145473318|NCT01641822|524585487|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
145473319|NCT01641822|524585485|FG000|Comparative Phase|Noncompliance with study drug|0|||
145473320|NCT01641822|524585486|FG001|Comparative Phase|Noncompliance with study drug|1|||
145628998|NCT02138916|525155671|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
145628999|NCT02138916|525155669|FG000|Overall Study|Death|14|||
145629000|NCT02138916|525155670|FG001|Overall Study|Death|11|||
145629001|NCT02138916|525155671|FG002|Overall Study|Death|12|||
145629002|NCT02138916|525155669|FG000|Overall Study|Withdrawal by Subject|27|||
145629003|NCT02138916|525155670|FG001|Overall Study|Withdrawal by Subject|31|||
145629004|NCT02138916|525155671|FG002|Overall Study|Withdrawal by Subject|32|||
145629005|NCT02138916|525155669|FG000|Overall Study|Study specific withdrawal criteria|0|||
145629006|NCT02138916|525155670|FG001|Overall Study|Study specific withdrawal criteria|0|||
145629007|NCT02138916|525155671|FG002|Overall Study|Study specific withdrawal criteria|1|||
145629008|NCT02138916|525155669|FG000|Overall Study|incorrect enrolment|1|||
145629009|NCT02138916|525155670|FG001|Overall Study|incorrect enrolment|1|||
145629010|NCT02138916|525155671|FG002|Overall Study|incorrect enrolment|0|||
145629011|NCT02138916|525155669|FG000|Overall Study|Severe non-compliance|1|||
145629012|NCT02138916|525155670|FG001|Overall Study|Severe non-compliance|2|||
145629013|NCT02138916|525155671|FG002|Overall Study|Severe non-compliance|1|||
145629014|NCT02138916|525155669|FG000|Overall Study|Lost to Follow-up|4|||
145629015|NCT02138916|525155670|FG001|Overall Study|Lost to Follow-up|2|||
145629016|NCT02138916|525155671|FG002|Overall Study|Lost to Follow-up|3|||
145629017|NCT02138916|525155669|FG000|Overall Study|Adverse Event|4|||
145629018|NCT02138916|525155670|FG001|Overall Study|Adverse Event|4|||
145629019|NCT02138916|525155671|FG002|Overall Study|Adverse Event|3|||
145629020|NCT01348087|525155672|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
145629021|NCT01348087|525155672|FG000|Overall Study|Administrative problems|79|||
145629022|NCT01348087|525155672|FG000|Overall Study|protocol deviation|1|||
145629023|NCT01348087|525155672|FG000|Overall Study|Lost to Follow-up|1|||
145629024|NCT01348087|525155672|FG000|Overall Study|Subject withdrew consent|7|||
145629025|NCT01348087|525155672|FG000|Overall Study|Adverse Event|25|||
145629026|NCT00117988|525155676|FG000|Overall Study|Death|3|||
145629027|NCT00117988|525155676|FG000|Overall Study|Adverse Event|1|||
145629028|NCT02482233|525155683|FG000|Overall Study|Lost to Follow-up|1|||
145629029|NCT02482233|525155684|FG001|Overall Study|Lost to Follow-up|1|||
145629030|NCT04888585|525155685|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
145629031|NCT04888585|525155686|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
145629032|NCT04888585|525155687|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
145629033|NCT04888585|525155688|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
145629034|NCT04888585|525155689|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
145629035|NCT04888585|525155690|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145629036|NCT04888585|525155691|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145473321|NCT01641822|524585487|FG002|Comparative Phase|Noncompliance with study drug|0|||
145473322|NCT01641822|524585485|FG000|Comparative Phase|Investigator's discretion|0|||
145473323|NCT01641822|524585486|FG001|Comparative Phase|Investigator's discretion|0|||
145473324|NCT01641822|524585487|FG002|Comparative Phase|Investigator's discretion|1|||
145473325|NCT01641822|524585485|FG000|Comparative Phase|Pregnancy|0|||
145473326|NCT01641822|524585486|FG001|Comparative Phase|Pregnancy|0|||
145473327|NCT01641822|524585487|FG002|Comparative Phase|Pregnancy|1|||
145473328|NCT01641822|524585485|FG000|Comparative Phase|Adverse event, serious fatal|0|||
145629037|NCT04888585|525155692|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145629038|NCT04888585|525155693|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145629039|NCT04888585|525155694|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145629040|NCT04888585|525155695|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
145629041|NCT04888585|525155685|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629042|NCT04888585|525155686|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
145629043|NCT04888585|525155687|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
145629044|NCT04888585|525155688|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
145629045|NCT04888585|525155689|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
145629046|NCT04888585|525155690|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629047|NCT04888585|525155691|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629048|NCT04888585|525155692|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629049|NCT04888585|525155693|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629050|NCT04888585|525155694|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629051|NCT04888585|525155695|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
145629052|NCT04888585|525155685|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629053|NCT04888585|525155686|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629054|NCT04888585|525155687|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
145629055|NCT04888585|525155688|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629056|NCT04888585|525155689|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
145629057|NCT04888585|525155690|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629058|NCT04888585|525155691|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629059|NCT04888585|525155692|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629060|NCT04888585|525155693|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629061|NCT04888585|525155694|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629062|NCT04888585|525155695|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
145629063|NCT04888585|525155685|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629064|NCT04888585|525155686|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629065|NCT04888585|525155687|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629066|NCT04888585|525155688|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629067|NCT04888585|525155689|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629068|NCT04888585|525155690|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629069|NCT04888585|525155691|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629070|NCT04888585|525155692|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
145629071|NCT04888585|525155693|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629072|NCT04888585|525155694|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
145629073|NCT04888585|525155695|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
145629074|NCT04888585|525155685|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
145629075|NCT04888585|525155686|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
145629076|NCT04888585|525155687|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
145629077|NCT04888585|525155688|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
145629078|NCT04888585|525155689|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
145629079|NCT04888585|525155690|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
145629080|NCT04888585|525155691|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
145629081|NCT04888585|525155692|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
145629082|NCT04888585|525155693|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
145629083|NCT04888585|525155694|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
145629084|NCT04888585|525155695|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
145629085|NCT04888585|525155685|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
145629086|NCT04888585|525155686|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
145629087|NCT04888585|525155687|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
145629088|NCT04888585|525155688|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
145629089|NCT04888585|525155689|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
145629090|NCT04888585|525155690|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
145629091|NCT04888585|525155691|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
145629092|NCT04888585|525155692|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
145629093|NCT04888585|525155693|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
145629094|NCT04888585|525155694|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
145629095|NCT04888585|525155695|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
145629096|NCT04888585|525155685|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
145629097|NCT04888585|525155686|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
145629098|NCT04888585|525155687|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
145629099|NCT04888585|525155688|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
145629100|NCT04888585|525155689|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
145629101|NCT04888585|525155690|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
145629102|NCT04888585|525155691|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
145629103|NCT04888585|525155692|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
145629104|NCT04888585|525155693|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
145629105|NCT04888585|525155694|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
145629106|NCT04888585|525155695|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
145629107|NCT04888585|525155685|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629108|NCT04888585|525155686|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629109|NCT04888585|525155687|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629110|NCT04888585|525155688|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629111|NCT04888585|525155689|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629112|NCT04888585|525155690|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629113|NCT04888585|525155691|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
145629114|NCT04888585|525155692|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
145629115|NCT04888585|525155693|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
145629116|NCT04888585|525155694|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
145629117|NCT04888585|525155695|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
145629118|NCT04927975|525155696|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
145629119|NCT04927975|525155697|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
145629120|NCT04927975|525155698|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
145629121|NCT04927975|525155699|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
145629122|NCT04927975|525155700|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
145629123|NCT04927975|525155701|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
145629124|NCT04927975|525155696|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
145629125|NCT04927975|525155697|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
145629126|NCT04927975|525155698|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
145629127|NCT04927975|525155699|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
145629128|NCT04927975|525155700|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
145629129|NCT04927975|525155701|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
145629130|NCT04927975|525155696|FG000|Period 1 (Baseline-Week 24)|Death|0|||
145629131|NCT04927975|525155697|FG001|Period 1 (Baseline-Week 24)|Death|0|||
145629132|NCT04927975|525155698|FG002|Period 1 (Baseline-Week 24)|Death|0|||
145629133|NCT04927975|525155699|FG003|Period 1 (Baseline-Week 24)|Death|0|||
145629134|NCT04927975|525155700|FG004|Period 1 (Baseline-Week 24)|Death|0|||
145629135|NCT04927975|525155701|FG005|Period 1 (Baseline-Week 24)|Death|1|||
145629136|NCT04927975|525155696|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
145629137|NCT04927975|525155697|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
145629138|NCT04927975|525155698|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
145629139|NCT04927975|525155699|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
145629140|NCT04927975|525155700|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
145629141|NCT04927975|525155701|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
145629142|NCT04927975|525155696|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
145629143|NCT04927975|525155697|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
145629144|NCT04927975|525155698|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
145629145|NCT04927975|525155699|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
145629146|NCT04927975|525155700|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
145629147|NCT04927975|525155701|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
145629148|NCT03822351|525155702|FG000|Overall Study|Death|27|||
145629149|NCT03822351|525155703|FG001|Overall Study|Death|23|||
145629150|NCT03822351|525155704|FG002|Overall Study|Death|24|||
145629151|NCT03822351|525155702|FG000|Overall Study|Lost to Follow-up|6|||
145629152|NCT03822351|525155703|FG001|Overall Study|Lost to Follow-up|2|||
145629153|NCT03822351|525155704|FG002|Overall Study|Lost to Follow-up|1|||
145629154|NCT03822351|525155702|FG000|Overall Study|Withdrawal by Subject|10|||
145629155|NCT03822351|525155703|FG001|Overall Study|Withdrawal by Subject|4|||
145629156|NCT03822351|525155704|FG002|Overall Study|Withdrawal by Subject|6|||
145629157|NCT03822351|525155702|FG000|Overall Study|Progressive Disease|2|||
145629158|NCT03822351|525155703|FG001|Overall Study|Progressive Disease|1|||
145629159|NCT03822351|525155704|FG002|Overall Study|Progressive Disease|0|||
145629160|NCT03822351|525155702|FG000|Overall Study|Not Treated|1|||
145629161|NCT03822351|525155703|FG001|Overall Study|Not Treated|1|||
145629162|NCT03822351|525155704|FG002|Overall Study|Not Treated|1|||
145629163|NCT03563053|525155713|FG000|Overall Study|Withdrawal by Subject|17|||
145473329|NCT01641822|524585486|FG001|Comparative Phase|Adverse event, serious fatal|1|||
145473330|NCT01641822|524585487|FG002|Comparative Phase|Adverse event, serious fatal|0|||
145629164|NCT03563053|525155713|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
145629165|NCT03563053|525155713|FG000|Overall Study|Adverse Event|3|||
145473331|NCT01641822|524585485|FG000|Comparative Phase|Withdrew consent|0|||
145473332|NCT01641822|524585486|FG001|Comparative Phase|Withdrew consent|3|||
145629166|NCT03563053|525155713|FG000|Overall Study|Physician Decision|1|||
145629167|NCT03563053|525155713|FG000|Overall Study|study terminated by sponsor|71|||
145629168|NCT02081391|525155714|FG000|12-hour Treatment|Withdrawal by Subject|3|||
145629169|NCT02081391|525155715|FG001|12-hour Treatment|Withdrawal by Subject|2|||
145629170|NCT02081391|525155716|FG002|12-hour Treatment|Withdrawal by Subject|0|||
145629171|NCT02081391|525155717|FG003|12-hour Treatment|Withdrawal by Subject|0|||
145629172|NCT02081391|525155714|FG000|12-hour Treatment|Physician Decision|4|||
145629173|NCT02081391|525155715|FG001|12-hour Treatment|Physician Decision|1|||
145473333|NCT01641822|524585487|FG002|Comparative Phase|Withdrew consent|7|||
145473334|NCT01641822|524585485|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
145473335|NCT01641822|524585486|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
145473336|NCT01641822|524585487|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
145473337|NCT00454584|524585488|FG000|Controlled Period|Adverse Event|5|||
145473338|NCT00454584|524585489|FG001|Controlled Period|Adverse Event|2|||
145473339|NCT00454584|524585490|FG002|Controlled Period|Adverse Event|1|||
145473340|NCT00454584|524585491|FG003|Controlled Period|Adverse Event|0|||
145473341|NCT00454584|524585492|FG004|Controlled Period|Adverse Event|0|||
145473342|NCT00454584|524585493|FG005|Controlled Period|Adverse Event|0|||
145473343|NCT00454584|524585488|FG000|Controlled Period|Lost to Follow-up|1|||
145473344|NCT00454584|524585489|FG001|Controlled Period|Lost to Follow-up|2|||
145473345|NCT00454584|524585490|FG002|Controlled Period|Lost to Follow-up|2|||
145473346|NCT00454584|524585491|FG003|Controlled Period|Lost to Follow-up|0|||
145473347|NCT00454584|524585492|FG004|Controlled Period|Lost to Follow-up|0|||
145473348|NCT00454584|524585493|FG005|Controlled Period|Lost to Follow-up|0|||
145473349|NCT00454584|524585488|FG000|Controlled Period|Other|5|||
145473350|NCT00454584|524585489|FG001|Controlled Period|Other|4|||
145473351|NCT00454584|524585490|FG002|Controlled Period|Other|2|||
145473352|NCT00454584|524585491|FG003|Controlled Period|Other|0|||
145473353|NCT00454584|524585492|FG004|Controlled Period|Other|0|||
145473354|NCT00454584|524585493|FG005|Controlled Period|Other|0|||
145473355|NCT00454584|524585488|FG000|After Controlled Period|Adverse Event|0|||
145473356|NCT00454584|524585489|FG001|After Controlled Period|Adverse Event|0|||
145473357|NCT00454584|524585490|FG002|After Controlled Period|Adverse Event|0|||
145473358|NCT00454584|524585491|FG003|After Controlled Period|Adverse Event|9|||
145473359|NCT00454584|524585492|FG004|After Controlled Period|Adverse Event|3|||
145473360|NCT00454584|524585493|FG005|After Controlled Period|Adverse Event|9|||
145473361|NCT00454584|524585488|FG000|After Controlled Period|Lack of Efficacy|0|||
145473362|NCT00454584|524585489|FG001|After Controlled Period|Lack of Efficacy|0|||
145473363|NCT00454584|524585490|FG002|After Controlled Period|Lack of Efficacy|0|||
145473364|NCT00454584|524585491|FG003|After Controlled Period|Lack of Efficacy|1|||
145473365|NCT00454584|524585492|FG004|After Controlled Period|Lack of Efficacy|0|||
145473366|NCT00454584|524585493|FG005|After Controlled Period|Lack of Efficacy|0|||
145473367|NCT00454584|524585488|FG000|After Controlled Period|Lost to Follow-up|0|||
145473368|NCT00454584|524585489|FG001|After Controlled Period|Lost to Follow-up|0|||
145473369|NCT00454584|524585490|FG002|After Controlled Period|Lost to Follow-up|0|||
145473370|NCT00454584|524585491|FG003|After Controlled Period|Lost to Follow-up|2|||
145473371|NCT00454584|524585492|FG004|After Controlled Period|Lost to Follow-up|4|||
145473372|NCT00454584|524585493|FG005|After Controlled Period|Lost to Follow-up|6|||
145473373|NCT00454584|524585488|FG000|After Controlled Period|Other|0|||
145473374|NCT00454584|524585489|FG001|After Controlled Period|Other|0|||
145473375|NCT00454584|524585490|FG002|After Controlled Period|Other|0|||
145473376|NCT00454584|524585491|FG003|After Controlled Period|Other|1|||
145473377|NCT00454584|524585492|FG004|After Controlled Period|Other|0|||
145473378|NCT00454584|524585493|FG005|After Controlled Period|Other|0|||
145473379|NCT00454584|524585488|FG000|After Controlled Period|Other|0|||
145473380|NCT00454584|524585489|FG001|After Controlled Period|Other|0|||
145473381|NCT00454584|524585490|FG002|After Controlled Period|Other|0|||
145473382|NCT00454584|524585491|FG003|After Controlled Period|Other|13|||
145473383|NCT00454584|524585492|FG004|After Controlled Period|Other|5|||
145473384|NCT00454584|524585493|FG005|After Controlled Period|Other|17|||
145473385|NCT02421601|524585494|FG000|Overall Study|Adverse Event|4|||
145473386|NCT02421601|524585494|FG000|Overall Study|Lack of Efficacy|5|||
145473387|NCT02421601|524585494|FG000|Overall Study|Physician Decision|1|||
145473388|NCT02421601|524585494|FG000|Overall Study|Withdrawal by Subject|31|||
145473389|NCT02421601|524585494|FG000|Overall Study|Others|41|||
145473390|NCT00470418|524585499|FG000|Overall Study|Withdrawal by Subject|1|||
145473391|NCT00470418|524585500|FG001|Overall Study|Withdrawal by Subject|0|||
145473392|NCT00599638|524585501|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
145473393|NCT00599638|524585502|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
145473394|NCT00599638|524585503|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
145473395|NCT00599638|524585504|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
145473396|NCT00599638|524585501|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
145473397|NCT00599638|524585502|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
145473398|NCT00599638|524585503|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
145473399|NCT00599638|524585504|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
145473400|NCT00599638|524585501|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
145473401|NCT00599638|524585502|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
145473402|NCT00599638|524585503|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
145473403|NCT00599638|524585504|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
145473404|NCT00599638|524585501|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
145473405|NCT00599638|524585502|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
145473406|NCT00599638|524585503|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
145473407|NCT00599638|524585504|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
145473408|NCT00599638|524585501|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
145629174|NCT02081391|525155716|FG002|12-hour Treatment|Physician Decision|0|||
145629175|NCT02081391|525155717|FG003|12-hour Treatment|Physician Decision|0|||
145629176|NCT02081391|525155714|FG000|12-hour Treatment|Lack of Efficacy|3|||
145629177|NCT02081391|525155715|FG001|12-hour Treatment|Lack of Efficacy|0|||
145629178|NCT02081391|525155716|FG002|12-hour Treatment|Lack of Efficacy|0|||
145629179|NCT02081391|525155717|FG003|12-hour Treatment|Lack of Efficacy|0|||
145629180|NCT02081391|525155714|FG000|12-hour Treatment|Adverse Event|4|||
145629181|NCT02081391|525155715|FG001|12-hour Treatment|Adverse Event|2|||
145629182|NCT02081391|525155716|FG002|12-hour Treatment|Adverse Event|0|||
145629183|NCT02081391|525155717|FG003|12-hour Treatment|Adverse Event|0|||
145629184|NCT02081391|525155714|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
145629185|NCT02081391|525155715|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
145629186|NCT02081391|525155716|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
145629187|NCT02081391|525155717|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
145629188|NCT02081391|525155714|FG000|12-hour Treatment|Further reasons|2|||
145629189|NCT02081391|525155715|FG001|12-hour Treatment|Further reasons|1|||
145629190|NCT02081391|525155716|FG002|12-hour Treatment|Further reasons|0|||
145629191|NCT02081391|525155717|FG003|12-hour Treatment|Further reasons|0|||
145629192|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
145629193|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
145629194|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
145629195|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
145629196|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
145629197|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
145629198|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
145629199|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
145629200|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
145629201|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
145629202|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
145629203|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
145629204|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
145629205|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
145629206|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
145629207|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
145629208|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
145629209|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
145629210|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
145629211|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
145629212|NCT02081391|525155714|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
145629213|NCT02081391|525155715|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
145629214|NCT02081391|525155716|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
145629215|NCT02081391|525155717|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
145629216|NCT01458275|525155718|FG000|Overall Study|Adverse Event|3|||
145629217|NCT01458275|525155719|FG001|Overall Study|Adverse Event|4|||
145629218|NCT01458275|525155720|FG002|Overall Study|Adverse Event|1|||
145629219|NCT01458275|525155718|FG000|Overall Study|Lost to Follow-up|3|||
145629220|NCT01458275|525155719|FG001|Overall Study|Lost to Follow-up|2|||
145629221|NCT01458275|525155720|FG002|Overall Study|Lost to Follow-up|5|||
145629222|NCT01458275|525155718|FG000|Overall Study|Protocol Violation|5|||
145629223|NCT01458275|525155719|FG001|Overall Study|Protocol Violation|5|||
145629224|NCT01458275|525155720|FG002|Overall Study|Protocol Violation|2|||
145629225|NCT01458275|525155718|FG000|Overall Study|Withdrawal by Subject|3|||
145629226|NCT01458275|525155719|FG001|Overall Study|Withdrawal by Subject|2|||
145629227|NCT01458275|525155720|FG002|Overall Study|Withdrawal by Subject|1|||
145629228|NCT00813488|525155721|FG000|Titration Period 1|Adverse Event|6|||
145629229|NCT00813488|525155722|FG001|Titration Period 1|Adverse Event|1|||
145629230|NCT00813488|525155721|FG000|Titration Period 1|Lack of Efficacy|9|||
145629231|NCT00813488|525155722|FG001|Titration Period 1|Lack of Efficacy|7|||
145629232|NCT00813488|525155721|FG000|Titration Period 1|Withdrawal by Subject|2|||
145629233|NCT00813488|525155722|FG001|Titration Period 1|Withdrawal by Subject|2|||
145629234|NCT00813488|525155721|FG000|Titration Period 1|Protocol Violation|4|||
145629235|NCT00813488|525155722|FG001|Titration Period 1|Protocol Violation|3|||
145629236|NCT00813488|525155721|FG000|Titration Period 1|Non-compliance to study medication|4|||
145629237|NCT00813488|525155722|FG001|Titration Period 1|Non-compliance to study medication|1|||
145629238|NCT00813488|525155721|FG000|Titration Period 1|Non-compliance to study procedures|2|||
145629239|NCT00813488|525155722|FG001|Titration Period 1|Non-compliance to study procedures|2|||
145629240|NCT00813488|525155721|FG000|Titration Period 1|Technical Difficulties|0|||
145473409|NCT00599638|524585502|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
145473410|NCT00599638|524585503|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
145473411|NCT00599638|524585504|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
145629241|NCT00813488|525155722|FG001|Titration Period 1|Technical Difficulties|1|||
145629242|NCT00813488|525155721|FG000|Titration Period 2|Adverse Event|2|||
145629243|NCT00813488|525155722|FG001|Titration Period 2|Adverse Event|3|||
145629244|NCT00813488|525155721|FG000|Titration Period 2|Lack of Efficacy|8|||
145629245|NCT00813488|525155722|FG001|Titration Period 2|Lack of Efficacy|4|||
145629246|NCT00813488|525155721|FG000|Titration Period 2|Protocol Violation|3|||
145629247|NCT00813488|525155722|FG001|Titration Period 2|Protocol Violation|2|||
145629248|NCT00813488|525155721|FG000|Titration Period 2|Lost to Follow-up|1|||
145629249|NCT00813488|525155722|FG001|Titration Period 2|Lost to Follow-up|0|||
145629250|NCT00813488|525155721|FG000|Titration Period 2|Non-compliance with study procedures|2|||
145629251|NCT00813488|525155722|FG001|Titration Period 2|Non-compliance with study procedures|1|||
145629252|NCT00813488|525155721|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
145629253|NCT00813488|525155722|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
145629254|NCT00813488|525155721|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
145629255|NCT00813488|525155722|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
145629256|NCT00813488|525155721|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
145629257|NCT00813488|525155722|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
145629258|NCT00813488|525155721|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
145629259|NCT00813488|525155722|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
145629260|NCT00813488|525155721|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
145629261|NCT00813488|525155722|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
145629262|NCT00813488|525155721|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
145629263|NCT00813488|525155722|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
145629264|NCT00813488|525155721|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
145629265|NCT00813488|525155722|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
145629266|NCT00813488|525155721|FG000|Double-blind Treatment Period 2|Other|1|||
145629267|NCT00813488|525155722|FG001|Double-blind Treatment Period 2|Other|0|||
145629268|NCT00813488|525155721|FG000|Open-label Extension|Adverse Event|1|||
145629269|NCT00813488|525155722|FG001|Open-label Extension|Adverse Event|2|||
145629270|NCT00813488|525155721|FG000|Open-label Extension|Lack of Efficacy|3|||
145629271|NCT00813488|525155722|FG001|Open-label Extension|Lack of Efficacy|0|||
145629272|NCT00813488|525155721|FG000|Open-label Extension|Withdrawal by Subject|0|||
145629273|NCT00813488|525155722|FG001|Open-label Extension|Withdrawal by Subject|2|||
145629274|NCT00813488|525155721|FG000|Open-label Extension|Protocol Violation|1|||
145629275|NCT00813488|525155722|FG001|Open-label Extension|Protocol Violation|2|||
145629276|NCT00813488|525155721|FG000|Open-label Extension|Non-compliance study medication|4|||
145629277|NCT00813488|525155722|FG001|Open-label Extension|Non-compliance study medication|0|||
145629278|NCT00813488|525155721|FG000|Open-label Extension|Non-compliance study procedures|2|||
145629279|NCT00813488|525155722|FG001|Open-label Extension|Non-compliance study procedures|1|||
145629280|NCT00813488|525155721|FG000|Open-label Extension|Other|1|||
145629281|NCT00813488|525155722|FG001|Open-label Extension|Other|0|||
145629282|NCT02926937|525155723|FG000|Overall Study|Adverse Event|0|||
145629283|NCT02926937|525155724|FG001|Overall Study|Adverse Event|1|||
145629284|NCT02926937|525155725|FG002|Overall Study|Adverse Event|1|||
145629285|NCT02926937|525155723|FG000|Overall Study|Poor Compliance to Protocol|1|||
145629286|NCT02926937|525155724|FG001|Overall Study|Poor Compliance to Protocol|0|||
145629287|NCT02926937|525155725|FG002|Overall Study|Poor Compliance to Protocol|0|||
145629288|NCT02926937|525155723|FG000|Overall Study|Lost to Follow-up|4|||
145629289|NCT02926937|525155724|FG001|Overall Study|Lost to Follow-up|5|||
145629290|NCT02926937|525155725|FG002|Overall Study|Lost to Follow-up|0|||
145629291|NCT02926937|525155723|FG000|Overall Study|At the Participant's own Request|11|||
145629292|NCT02926937|525155724|FG001|Overall Study|At the Participant's own Request|5|||
145629293|NCT02926937|525155725|FG002|Overall Study|At the Participant's own Request|8|||
145629294|NCT02926937|525155723|FG000|Overall Study|Reason not Specified|3|||
145629295|NCT02926937|525155724|FG001|Overall Study|Reason not Specified|4|||
145473412|NCT00599638|524585501|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
145473413|NCT00599638|524585502|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
145473414|NCT00599638|524585503|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
145473415|NCT00599638|524585504|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
145473416|NCT00599638|524585501|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
145473417|NCT00599638|524585502|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
145473418|NCT00599638|524585503|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
145473419|NCT00599638|524585504|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
145473420|NCT00599638|524585501|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
145473421|NCT00599638|524585502|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
145473422|NCT00599638|524585503|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
145629296|NCT02926937|525155725|FG002|Overall Study|Reason not Specified|2|||
145629297|NCT01559090|525155726|FG000|Stage I|Withdrawal by Subject|2|||
145629298|NCT01559090|525155727|FG001|Stage I|Withdrawal by Subject|2|||
145629299|NCT01559090|525155728|FG002|Stage I|Withdrawal by Subject|3|||
145629300|NCT01559090|525155726|FG000|Stage II|Withdrawal by Subject|1|||
145629301|NCT01559090|525155727|FG001|Stage II|Withdrawal by Subject|0|||
145629302|NCT01559090|525155728|FG002|Stage II|Withdrawal by Subject|0|||
145629303|NCT03677375|525155730|FG000|Overall Study|Incomplete procedure|8|||
145473423|NCT00599638|524585504|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
145473424|NCT00599638|524585501|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
145473425|NCT00599638|524585502|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
145473426|NCT00599638|524585503|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
145473427|NCT00599638|524585504|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
145473428|NCT03006887|524585505|FG000|Overall Study|Adverse Event|1|||
145473429|NCT00462748|524585506|FG000|Overall Study|Adverse Event|7|||
145473430|NCT00462748|524585507|FG001|Overall Study|Adverse Event|5|||
145473431|NCT00462748|524585508|FG002|Overall Study|Adverse Event|9|||
145473432|NCT00462748|524585506|FG000|Overall Study|Protocol Violation|0|||
145629304|NCT03677375|525155730|FG000|Overall Study|Adverse Event|3|||
145629305|NCT03677375|525155730|FG000|Overall Study|Physician Decision|1|||
145629306|NCT03971357|525155733|FG000|Overall Study|Lack of Efficacy|0|||
145629307|NCT03971357|525155734|FG001|Overall Study|Lack of Efficacy|1|||
145629308|NCT01729871|525155735|FG000|Overall Study|Adverse Event|7|||
145629309|NCT01729871|525155736|FG001|Overall Study|Adverse Event|7|||
145629310|NCT01729871|525155735|FG000|Overall Study|Death|0|||
145629311|NCT01729871|525155736|FG001|Overall Study|Death|1|||
145629312|NCT01729871|525155735|FG000|Overall Study|Lack of Efficacy|0|||
145629313|NCT01729871|525155736|FG001|Overall Study|Lack of Efficacy|1|||
145629314|NCT01729871|525155735|FG000|Overall Study|Physician Decision|0|||
145629315|NCT01729871|525155736|FG001|Overall Study|Physician Decision|2|||
145629316|NCT01729871|525155735|FG000|Overall Study|Protocol Violation|1|||
145629317|NCT01729871|525155736|FG001|Overall Study|Protocol Violation|0|||
145629318|NCT01729871|525155735|FG000|Overall Study|Withdrawal by Subject|0|||
145629319|NCT01729871|525155736|FG001|Overall Study|Withdrawal by Subject|3|||
145629320|NCT01729871|525155735|FG000|Overall Study|Other|4|||
145629321|NCT01729871|525155736|FG001|Overall Study|Other|9|||
145629322|NCT01143077|525155737|FG000|Overall Study|Lack of Efficacy|0|||
145629323|NCT01143077|525155738|FG001|Overall Study|Lack of Efficacy|2|||
145629324|NCT01143077|525155739|FG002|Overall Study|Lack of Efficacy|1|||
145629325|NCT01143077|525155737|FG000|Overall Study|Adverse Event|5|||
145629326|NCT01143077|525155738|FG001|Overall Study|Adverse Event|6|||
145629327|NCT01143077|525155739|FG002|Overall Study|Adverse Event|5|||
145629328|NCT01143077|525155737|FG000|Overall Study|Lost to Follow-up|2|||
145629329|NCT01143077|525155738|FG001|Overall Study|Lost to Follow-up|3|||
145629330|NCT01143077|525155739|FG002|Overall Study|Lost to Follow-up|4|||
145629331|NCT01143077|525155737|FG000|Overall Study|Protocol Violation|2|||
145629332|NCT01143077|525155738|FG001|Overall Study|Protocol Violation|0|||
145629333|NCT01143077|525155739|FG002|Overall Study|Protocol Violation|0|||
145629334|NCT01143077|525155737|FG000|Overall Study|Withdrawal by Subject|4|||
145629335|NCT01143077|525155738|FG001|Overall Study|Withdrawal by Subject|3|||
145629336|NCT01143077|525155739|FG002|Overall Study|Withdrawal by Subject|3|||
145629337|NCT01143077|525155737|FG000|Overall Study|Non-compliance with study drug|0|||
145629338|NCT01143077|525155738|FG001|Overall Study|Non-compliance with study drug|1|||
145629339|NCT01143077|525155739|FG002|Overall Study|Non-compliance with study drug|1|||
145629340|NCT01143077|525155737|FG000|Overall Study|Administrative|1|||
145629341|NCT01143077|525155738|FG001|Overall Study|Administrative|0|||
145629342|NCT01143077|525155739|FG002|Overall Study|Administrative|0|||
145629343|NCT01143077|525155737|FG000|Overall Study|Principal Investigator Decision|2|||
145629344|NCT01143077|525155738|FG001|Overall Study|Principal Investigator Decision|0|||
145629345|NCT01143077|525155739|FG002|Overall Study|Principal Investigator Decision|1|||
145629346|NCT00630864|525155740|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
145629347|NCT00630864|525155740|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
145629348|NCT00124982|525155741|FG000|Short-term Period|Death|1|||
145629349|NCT00124982|525155742|FG001|Short-term Period|Death|1|||
145629350|NCT00124982|525155743|FG002|Short-term Period|Death|0|||
145629351|NCT00124982|525155741|FG000|Short-term Period|Adverse Event|17|||
145629352|NCT00124982|525155742|FG001|Short-term Period|Adverse Event|22|||
145629353|NCT00124982|525155743|FG002|Short-term Period|Adverse Event|0|||
145473433|NCT00462748|524585507|FG001|Overall Study|Protocol Violation|2|||
145473434|NCT00462748|524585508|FG002|Overall Study|Protocol Violation|1|||
145473435|NCT00462748|524585506|FG000|Overall Study|Withdrew consent|3|||
145473436|NCT00462748|524585507|FG001|Overall Study|Withdrew consent|3|||
145629354|NCT00124982|525155741|FG000|Short-term Period|Lack of Efficacy|32|||
145629355|NCT00124982|525155742|FG001|Short-term Period|Lack of Efficacy|73|||
145473437|NCT00462748|524585508|FG002|Overall Study|Withdrew consent|0|||
145473438|NCT00462748|524585506|FG000|Overall Study|Lost to Follow-up|1|||
145473439|NCT00462748|524585507|FG001|Overall Study|Lost to Follow-up|1|||
145629356|NCT00124982|525155743|FG002|Short-term Period|Lack of Efficacy|0|||
145629357|NCT00124982|525155741|FG000|Short-term Period|Lost to Follow-up|8|||
145629358|NCT00124982|525155742|FG001|Short-term Period|Lost to Follow-up|5|||
145629359|NCT00124982|525155743|FG002|Short-term Period|Lost to Follow-up|0|||
145629360|NCT00124982|525155741|FG000|Short-term Period|Withdrawal of Consent|7|||
145629361|NCT00124982|525155742|FG001|Short-term Period|Withdrawal of Consent|9|||
145629362|NCT00124982|525155743|FG002|Short-term Period|Withdrawal of Consent|0|||
145629363|NCT00124982|525155741|FG000|Short-term Period|Poor/Non-compliance|3|||
145629364|NCT00124982|525155742|FG001|Short-term Period|Poor/Non-compliance|1|||
145629365|NCT00124982|525155743|FG002|Short-term Period|Poor/Non-compliance|0|||
145629366|NCT00124982|525155741|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
145629367|NCT00124982|525155742|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
145629368|NCT00124982|525155743|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
145629369|NCT00124982|525155741|FG000|Short-term Period|Participant Decision|1|||
145629370|NCT00124982|525155742|FG001|Short-term Period|Participant Decision|0|||
145629371|NCT00124982|525155743|FG002|Short-term Period|Participant Decision|0|||
145629372|NCT00124982|525155741|FG000|Short-term Period|Participant Chose Own Doctor|0|||
145629373|NCT00124982|525155742|FG001|Short-term Period|Participant Chose Own Doctor|1|||
145629374|NCT00124982|525155743|FG002|Short-term Period|Participant Chose Own Doctor|0|||
145629375|NCT00124982|525155741|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
145629376|NCT00124982|525155742|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
145629377|NCT00124982|525155743|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
145629378|NCT00124982|525155741|FG000|Short-term Period|Participant Had Lymphopenia|1|||
145629379|NCT00124982|525155742|FG001|Short-term Period|Participant Had Lymphopenia|0|||
145629380|NCT00124982|525155743|FG002|Short-term Period|Participant Had Lymphopenia|0|||
145629381|NCT00124982|525155741|FG000|Long-term Period|Death|0|||
145629382|NCT00124982|525155742|FG001|Long-term Period|Death|0|||
145629383|NCT00124982|525155743|FG002|Long-term Period|Death|1|||
145629384|NCT00124982|525155741|FG000|Long-term Period|Adverse Event|0|||
145629385|NCT00124982|525155742|FG001|Long-term Period|Adverse Event|0|||
145629386|NCT00124982|525155743|FG002|Long-term Period|Adverse Event|17|||
145629387|NCT00124982|525155741|FG000|Long-term Period|Lack of Efficacy|0|||
145629388|NCT00124982|525155742|FG001|Long-term Period|Lack of Efficacy|0|||
145629389|NCT00124982|525155743|FG002|Long-term Period|Lack of Efficacy|46|||
145629390|NCT00124982|525155741|FG000|Long-term Period|Lost to Follow-up|0|||
145629391|NCT00124982|525155742|FG001|Long-term Period|Lost to Follow-up|0|||
145629392|NCT00124982|525155743|FG002|Long-term Period|Lost to Follow-up|4|||
145629393|NCT00124982|525155741|FG000|Long-term Period|Withdrawal by Subject|0|||
145629394|NCT00124982|525155742|FG001|Long-term Period|Withdrawal by Subject|0|||
145629395|NCT00124982|525155743|FG002|Long-term Period|Withdrawal by Subject|16|||
145629396|NCT00124982|525155741|FG000|Long-term Period|Pregnancy|0|||
145629397|NCT00124982|525155742|FG001|Long-term Period|Pregnancy|0|||
145629398|NCT00124982|525155743|FG002|Long-term Period|Pregnancy|1|||
145629399|NCT00124982|525155741|FG000|Long-term Period|Poor/Non-compliance|0|||
145629400|NCT00124982|525155742|FG001|Long-term Period|Poor/Non-compliance|0|||
145629401|NCT00124982|525155743|FG002|Long-term Period|Poor/Non-compliance|2|||
145629402|NCT00124982|525155741|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
145629403|NCT00124982|525155742|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
145629404|NCT00124982|525155743|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
145629405|NCT00124982|525155741|FG000|Long-term Period|Neurologist Recommendation|0|||
145629406|NCT00124982|525155742|FG001|Long-term Period|Neurologist Recommendation|0|||
145629407|NCT00124982|525155743|FG002|Long-term Period|Neurologist Recommendation|1|||
145629408|NCT01555762|525155744|FG000|Overall Study|No information on Bevacizumab intake|11|||
145629409|NCT01555762|525155744|FG000|Overall Study|Missing start date of infusion|8|||
145629410|NCT01555762|525155744|FG000|Overall Study|75 years old or more ticked No|1|||
145629411|NCT01555762|525155744|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
145629412|NCT01555762|525155744|FG000|Overall Study|Death linked to progression of disease|165|||
145629413|NCT01555762|525155744|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
145629414|NCT01555762|525155744|FG000|Overall Study|Investigator's decision|10|||
145629415|NCT01555762|525155744|FG000|Overall Study|Participant not wishing to continue|5|||
145629416|NCT01555762|525155744|FG000|Overall Study|Missing data|1|||
145629417|NCT01555762|525155744|FG000|Overall Study|Death linked to an adverse event|14|||
145629418|NCT00819910|525155745|FG000|Overall Study|Adverse Event|0|||
145629419|NCT00819910|525155746|FG001|Overall Study|Adverse Event|0|||
145629420|NCT00819910|525155747|FG002|Overall Study|Adverse Event|2|||
145629421|NCT00819910|525155748|FG003|Overall Study|Adverse Event|1|||
145629422|NCT00819910|525155745|FG000|Overall Study|Withdrawal by Subject|1|||
145629423|NCT00819910|525155746|FG001|Overall Study|Withdrawal by Subject|1|||
145629424|NCT00819910|525155747|FG002|Overall Study|Withdrawal by Subject|1|||
145629425|NCT00819910|525155748|FG003|Overall Study|Withdrawal by Subject|0|||
145629426|NCT00819910|525155745|FG000|Overall Study|Lost to Follow-up|1|||
145629427|NCT00819910|525155746|FG001|Overall Study|Lost to Follow-up|0|||
145629428|NCT00819910|525155747|FG002|Overall Study|Lost to Follow-up|0|||
145629429|NCT00819910|525155748|FG003|Overall Study|Lost to Follow-up|0|||
145629430|NCT00836810|525155749|FG000|Overall Study|New diagnosis|1|||
145629431|NCT00836810|525155750|FG001|Overall Study|New diagnosis|0|||
145629432|NCT00871429|525155751|FG000|Overall Study|Lost to Follow-up|6|||
145629433|NCT00871429|525155751|FG000|Overall Study|Withdrawal by Subject|17|||
145629434|NCT00871429|525155751|FG000|Overall Study|Questionnaire not completed|1|||
145629435|NCT03102242|525155752|FG000|Overall Study|Adverse Event|2|||
145629436|NCT01137292|525155753|FG000|Overall Study|Death|30|||
145629437|NCT01137292|525155753|FG000|Overall Study|Adverse Event|3|||
145629438|NCT01137292|525155753|FG000|Overall Study|Lack of Efficacy|13|||
145629439|NCT01137292|525155753|FG000|Overall Study|Lost to Follow-up|1|||
145629440|NCT01137292|525155753|FG000|Overall Study|Other|7|||
145629441|NCT01311713|525155754|FG000|Overall Study|Death|0|||
145629442|NCT01311713|525155755|FG001|Overall Study|Death|0|||
145629443|NCT01311713|525155756|FG002|Overall Study|Death|1|||
145629444|NCT01311713|525155757|FG003|Overall Study|Death|1|||
145629445|NCT01311713|525155758|FG004|Overall Study|Death|0|||
145629446|NCT01311713|525155759|FG005|Overall Study|Death|1|||
145629447|NCT01311713|525155760|FG006|Overall Study|Death|0|||
145629448|NCT01311713|525155754|FG000|Overall Study|Adverse Event|0|||
145629449|NCT01311713|525155755|FG001|Overall Study|Adverse Event|1|||
145629450|NCT01311713|525155756|FG002|Overall Study|Adverse Event|0|||
145629451|NCT01311713|525155757|FG003|Overall Study|Adverse Event|2|||
145629452|NCT01311713|525155758|FG004|Overall Study|Adverse Event|0|||
145629453|NCT01311713|525155759|FG005|Overall Study|Adverse Event|0|||
145629454|NCT01311713|525155760|FG006|Overall Study|Adverse Event|2|||
145629455|NCT01311713|525155754|FG000|Overall Study|Withdrawal by Subject|0|||
145629456|NCT01311713|525155755|FG001|Overall Study|Withdrawal by Subject|1|||
145629457|NCT01311713|525155756|FG002|Overall Study|Withdrawal by Subject|1|||
145629458|NCT01311713|525155757|FG003|Overall Study|Withdrawal by Subject|0|||
145629459|NCT01311713|525155758|FG004|Overall Study|Withdrawal by Subject|0|||
145629460|NCT01311713|525155759|FG005|Overall Study|Withdrawal by Subject|1|||
145629461|NCT01311713|525155760|FG006|Overall Study|Withdrawal by Subject|2|||
145629462|NCT01311713|525155754|FG000|Overall Study|Disease progression|3|||
145629463|NCT01311713|525155755|FG001|Overall Study|Disease progression|4|||
145629464|NCT01311713|525155756|FG002|Overall Study|Disease progression|3|||
145629465|NCT01311713|525155757|FG003|Overall Study|Disease progression|2|||
145629466|NCT01311713|525155758|FG004|Overall Study|Disease progression|4|||
145629467|NCT01311713|525155759|FG005|Overall Study|Disease progression|4|||
145629468|NCT01311713|525155760|FG006|Overall Study|Disease progression|5|||
145629469|NCT01311713|525155754|FG000|Overall Study|Lost to Follow-up|0|||
145629470|NCT01311713|525155755|FG001|Overall Study|Lost to Follow-up|0|||
145629471|NCT01311713|525155756|FG002|Overall Study|Lost to Follow-up|1|||
145629472|NCT01311713|525155757|FG003|Overall Study|Lost to Follow-up|0|||
145629473|NCT01311713|525155758|FG004|Overall Study|Lost to Follow-up|0|||
145629474|NCT01311713|525155759|FG005|Overall Study|Lost to Follow-up|0|||
145629475|NCT01311713|525155760|FG006|Overall Study|Lost to Follow-up|0|||
145629476|NCT01311713|525155754|FG000|Overall Study|Stopped taking study medication|0|||
145629477|NCT01311713|525155755|FG001|Overall Study|Stopped taking study medication|0|||
145629478|NCT01311713|525155756|FG002|Overall Study|Stopped taking study medication|0|||
145629479|NCT01311713|525155757|FG003|Overall Study|Stopped taking study medication|1|||
145629480|NCT01311713|525155758|FG004|Overall Study|Stopped taking study medication|1|||
145629481|NCT01311713|525155759|FG005|Overall Study|Stopped taking study medication|0|||
145629482|NCT01311713|525155760|FG006|Overall Study|Stopped taking study medication|0|||
145629483|NCT01311713|525155754|FG000|Overall Study|Enrolled but not treated|0|||
145629484|NCT01311713|525155755|FG001|Overall Study|Enrolled but not treated|0|||
145629485|NCT01311713|525155756|FG002|Overall Study|Enrolled but not treated|1|||
145629486|NCT01311713|525155757|FG003|Overall Study|Enrolled but not treated|0|||
145629487|NCT01311713|525155758|FG004|Overall Study|Enrolled but not treated|0|||
145629488|NCT01311713|525155759|FG005|Overall Study|Enrolled but not treated|0|||
145629489|NCT01311713|525155760|FG006|Overall Study|Enrolled but not treated|0|||
145629490|NCT01311713|525155754|FG000|Overall Study|Other than specified|0|||
145629491|NCT01311713|525155755|FG001|Overall Study|Other than specified|1|||
145629492|NCT01311713|525155756|FG002|Overall Study|Other than specified|2|||
145629493|NCT01311713|525155757|FG003|Overall Study|Other than specified|0|||
145629494|NCT01311713|525155758|FG004|Overall Study|Other than specified|0|||
145629495|NCT01311713|525155759|FG005|Overall Study|Other than specified|0|||
145629496|NCT01311713|525155760|FG006|Overall Study|Other than specified|0|||
145629497|NCT01772719|525155767|FG000|Overall Study|Withdrawal by Subject|3|||
145629498|NCT01772719|525155767|FG000|Overall Study|Adverse Event|2|||
145629499|NCT01772719|525155767|FG000|Overall Study|Protocol Violation|1|||
145629500|NCT01772719|525155767|FG000|Overall Study|Lost to Follow-up|1|||
145629501|NCT00477412|525155768|FG000|Overall Study|Death|0|||
145629502|NCT00477412|525155769|FG001|Overall Study|Death|0|||
145629503|NCT00477412|525155770|FG002|Overall Study|Death|0|||
145629504|NCT00477412|525155771|FG003|Overall Study|Death|4|||
145629505|NCT00477412|525155768|FG000|Overall Study|Lost to Follow-up|0|||
145629506|NCT00477412|525155769|FG001|Overall Study|Lost to Follow-up|0|||
145629507|NCT00477412|525155770|FG002|Overall Study|Lost to Follow-up|0|||
145629508|NCT00477412|525155771|FG003|Overall Study|Lost to Follow-up|1|||
145629509|NCT00477412|525155768|FG000|Overall Study|Withdrawal by Subject|0|||
145629510|NCT00477412|525155769|FG001|Overall Study|Withdrawal by Subject|0|||
145629511|NCT00477412|525155770|FG002|Overall Study|Withdrawal by Subject|0|||
145629512|NCT00477412|525155771|FG003|Overall Study|Withdrawal by Subject|2|||
145629513|NCT00477412|525155768|FG000|Overall Study|Second Malignancy|0|||
145629514|NCT00477412|525155769|FG001|Overall Study|Second Malignancy|0|||
145629515|NCT00477412|525155770|FG002|Overall Study|Second Malignancy|0|||
145629516|NCT00477412|525155771|FG003|Overall Study|Second Malignancy|1|||
145629517|NCT00477412|525155768|FG000|Overall Study|Adverse Event|1|||
145629518|NCT00477412|525155769|FG001|Overall Study|Adverse Event|0|||
145629519|NCT00477412|525155770|FG002|Overall Study|Adverse Event|1|||
145629520|NCT00477412|525155771|FG003|Overall Study|Adverse Event|0|||
145629521|NCT02931396|525155772|FG000|Overall Study|Lost to Follow-up|3|||
145629522|NCT02931396|525155773|FG001|Overall Study|Lost to Follow-up|0|||
145629523|NCT02931396|525155772|FG000|Overall Study|Withdrawal by Subject|2|||
145629524|NCT02931396|525155773|FG001|Overall Study|Withdrawal by Subject|0|||
145629525|NCT05460663|525155774|FG000|Overall Study|Withdrawal by Subject|2|||
145629526|NCT05460663|525155775|FG001|Overall Study|Withdrawal by Subject|5|||
145629527|NCT04057196|525157559|FG000|Overall Study|Withdrawal by Subject|3|||
145629528|NCT04057196|525157559|FG000|Overall Study|Death|3|||
145629529|NCT02466516|525157561|FG000|Overall Study|Adverse Event|1|||
145629530|NCT02466516|525157562|FG001|Overall Study|Adverse Event|1|||
145629531|NCT02466516|525157563|FG002|Overall Study|Adverse Event|0|||
145629532|NCT02466516|525157564|FG003|Overall Study|Adverse Event|0|||
145629533|NCT02466516|525157565|FG004|Overall Study|Adverse Event|0|||
145629534|NCT02466516|525157561|FG000|Overall Study|Withdrew Consent|1|||
145629535|NCT02466516|525157562|FG001|Overall Study|Withdrew Consent|0|||
145629536|NCT02466516|525157563|FG002|Overall Study|Withdrew Consent|0|||
145629537|NCT02466516|525157564|FG003|Overall Study|Withdrew Consent|0|||
145629538|NCT02466516|525157565|FG004|Overall Study|Withdrew Consent|0|||
145629539|NCT02466516|525157561|FG000|Overall Study|Lost to Follow-up|2|||
145629540|NCT02466516|525157562|FG001|Overall Study|Lost to Follow-up|0|||
145629541|NCT02466516|525157563|FG002|Overall Study|Lost to Follow-up|1|||
145629542|NCT02466516|525157564|FG003|Overall Study|Lost to Follow-up|0|||
145629543|NCT02466516|525157565|FG004|Overall Study|Lost to Follow-up|0|||
145629544|NCT03895034|525157566|FG000|Overall Study|Lost to Follow-up|2|||
145629545|NCT03712930|525157567|FG000|Overall Study|Death|7|||
145629546|NCT03712930|525157567|FG000|Overall Study|Physician Decision|1|||
145629547|NCT03712930|525157567|FG000|Overall Study|Study Terminated by Sponsor|3|||
145629548|NCT03712930|525157567|FG000|Overall Study|Progressive Disease|2|||
145629549|NCT01118377|525157572|FG000|Overall Study|Did Not Receive Study Medication|1|||
145629550|NCT01118377|525157572|FG000|Overall Study|Death|38|||
145629551|NCT01118377|525157572|FG000|Overall Study|Failure to Return|3|||
145629552|NCT00646451|525157573|FG000|Overall Study|Adverse Event|3|||
145629553|NCT00646451|525157574|FG001|Overall Study|Adverse Event|0|||
145629554|NCT00646451|525157573|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
145629555|NCT00646451|525157574|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
145629556|NCT03181958|525157575|FG000|Overall Study|Lost to Follow-up|17|||
145629557|NCT03181958|525157576|FG001|Overall Study|Lost to Follow-up|21|||
145629558|NCT03181958|525157577|FG002|Overall Study|Lost to Follow-up|15|||
145629559|NCT00109967|525157582|FG000|Overall Study|Cancel Prior to Treatment|2|||
145629560|NCT00109967|525157583|FG001|Overall Study|Cancel Prior to Treatment|0|||
145629561|NCT00109967|525157582|FG000|Overall Study|Adverse Event|12|||
145629562|NCT00109967|525157583|FG001|Overall Study|Adverse Event|1|||
145629563|NCT00109967|525157582|FG000|Overall Study|Withdrawal by Subject|5|||
145629564|NCT00109967|525157583|FG001|Overall Study|Withdrawal by Subject|0|||
145629565|NCT00109967|525157582|FG000|Overall Study|Physician Decision|1|||
145629566|NCT00109967|525157583|FG001|Overall Study|Physician Decision|3|||
145629567|NCT00109967|525157582|FG000|Overall Study|Death|0|||
145629568|NCT00109967|525157583|FG001|Overall Study|Death|2|||
145629569|NCT01977612|525157586|FG000|Overall Study|Lost to Follow-up|1|||
145629570|NCT01977612|525157587|FG001|Overall Study|Lost to Follow-up|1|||
145629571|NCT02715258|525157588|FG000|Overall Study|Withdrawal by Subject|6|||
145629572|NCT02715258|525157589|FG001|Overall Study|Withdrawal by Subject|1|||
145629573|NCT02715258|525157588|FG000|Overall Study|Lost to Follow-up|7|||
145629574|NCT02715258|525157589|FG001|Overall Study|Lost to Follow-up|1|||
145629575|NCT02715258|525157588|FG000|Overall Study|Terminated by Sponsor|0|||
145629576|NCT02715258|525157589|FG001|Overall Study|Terminated by Sponsor|1|||
145629577|NCT02715258|525157588|FG000|Overall Study|Death|0|||
145629578|NCT02715258|525157589|FG001|Overall Study|Death|1|||
145629579|NCT02715258|525157588|FG000|Overall Study|Subject non-compliant|1|||
145629580|NCT02715258|525157589|FG001|Overall Study|Subject non-compliant|1|||
145629581|NCT02715258|525157588|FG000|Overall Study|GCP violation|2|||
145473440|NCT00462748|524585508|FG002|Overall Study|Lost to Follow-up|1|||
145473441|NCT00462748|524585506|FG000|Overall Study|Discontinued after 41 days Rx|1|||
145629582|NCT02715258|525157589|FG001|Overall Study|GCP violation|1|||
145629583|NCT02955069|525157591|FG000|Overall Study|Adverse Event|7|||
145629584|NCT02955069|525157592|FG001|Overall Study|Adverse Event|2|||
145629585|NCT02955069|525157591|FG000|Overall Study|Death|7|||
145629586|NCT02955069|525157592|FG001|Overall Study|Death|3|||
145473442|NCT00462748|524585507|FG001|Overall Study|Discontinued after 41 days Rx|0|||
145473443|NCT00462748|524585508|FG002|Overall Study|Discontinued after 41 days Rx|0|||
145473444|NCT01729208|524585509|FG000|Baseline|Physician Decision|5|||
145629587|NCT02955069|525157591|FG000|Overall Study|Physician Decision|10|||
145629588|NCT02955069|525157592|FG001|Overall Study|Physician Decision|2|||
145629589|NCT02955069|525157591|FG000|Overall Study|Progressive disease|64|||
145629590|NCT02955069|525157592|FG001|Overall Study|Progressive disease|13|||
145629591|NCT02955069|525157591|FG000|Overall Study|Study terminated by sponsor|4|||
145629592|NCT02955069|525157592|FG001|Overall Study|Study terminated by sponsor|0|||
145629593|NCT02955069|525157591|FG000|Overall Study|Subject/Guardian decision|3|||
145629594|NCT02955069|525157592|FG001|Overall Study|Subject/Guardian decision|1|||
145629595|NCT00943605|525157593|FG000|Overall Study|Study termination|30|||
145629596|NCT00943605|525157594|FG001|Overall Study|Study termination|30|||
145629597|NCT04148937|525157595|FG000|Overall Study|Withdrawal by Subject|0|||
145629598|NCT04148937|525157596|FG001|Overall Study|Withdrawal by Subject|0|||
145629599|NCT04148937|525157597|FG002|Overall Study|Withdrawal by Subject|0|||
145629600|NCT04148937|525157598|FG003|Overall Study|Withdrawal by Subject|1|||
145629601|NCT04148937|525157599|FG004|Overall Study|Withdrawal by Subject|0|||
145629602|NCT04148937|525157600|FG005|Overall Study|Withdrawal by Subject|1|||
145629603|NCT04148937|525157601|FG006|Overall Study|Withdrawal by Subject|1|||
145629604|NCT04148937|525157602|FG007|Overall Study|Withdrawal by Subject|0|||
145629605|NCT04148937|525157595|FG000|Overall Study|Lost to Follow-up|0|||
145629606|NCT04148937|525157596|FG001|Overall Study|Lost to Follow-up|0|||
145629607|NCT04148937|525157597|FG002|Overall Study|Lost to Follow-up|1|||
145629608|NCT04148937|525157598|FG003|Overall Study|Lost to Follow-up|0|||
145629609|NCT04148937|525157599|FG004|Overall Study|Lost to Follow-up|0|||
145629610|NCT04148937|525157600|FG005|Overall Study|Lost to Follow-up|2|||
145629611|NCT04148937|525157601|FG006|Overall Study|Lost to Follow-up|0|||
145629612|NCT04148937|525157602|FG007|Overall Study|Lost to Follow-up|0|||
145629613|NCT01149681|525157603|FG000|Overall Study|Withdrawal by Subject|7|||
145629614|NCT01149681|525157603|FG000|Overall Study|Progressive disease|1|||
145629615|NCT01149681|525157603|FG000|Overall Study|Physician Decision|2|||
145629616|NCT01149681|525157603|FG000|Overall Study|adverse events nonrelated study drug|2|||
145629617|NCT03107611|525157605|FG000|Overall Study|Adverse Event|1|||
145629618|NCT03107611|525157606|FG001|Overall Study|Adverse Event|0|||
145629619|NCT03107611|525157607|FG002|Overall Study|Adverse Event|2|||
145629620|NCT03107611|525157605|FG000|Overall Study|Lost to Follow-up|3|||
145629621|NCT03107611|525157606|FG001|Overall Study|Lost to Follow-up|3|||
145629622|NCT03107611|525157607|FG002|Overall Study|Lost to Follow-up|3|||
145629623|NCT03107611|525157605|FG000|Overall Study|Protocol Violation|0|||
145629624|NCT03107611|525157606|FG001|Overall Study|Protocol Violation|0|||
145629625|NCT03107611|525157607|FG002|Overall Study|Protocol Violation|1|||
145629626|NCT03107611|525157605|FG000|Overall Study|Withdrawal by Subject|1|||
145629627|NCT03107611|525157606|FG001|Overall Study|Withdrawal by Subject|0|||
145629628|NCT03107611|525157607|FG002|Overall Study|Withdrawal by Subject|1|||
145629629|NCT03107611|525157605|FG000|Overall Study|Worsening signs/symptoms|2|||
145629630|NCT03107611|525157606|FG001|Overall Study|Worsening signs/symptoms|1|||
145629631|NCT03107611|525157607|FG002|Overall Study|Worsening signs/symptoms|2|||
145629632|NCT01908634|525157612|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
145629633|NCT01908634|525157612|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
145629634|NCT01570751|525157613|FG000|Period A (16 Weeks)|Protocol Violation|1|||
145629635|NCT01570751|525157614|FG001|Period A (16 Weeks)|Protocol Violation|1|||
145629636|NCT01570751|525157613|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
145629637|NCT01570751|525157614|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
145629638|NCT01570751|525157613|FG000|Period A (16 Weeks)|Unclassified|2|||
145629639|NCT01570751|525157614|FG001|Period A (16 Weeks)|Unclassified|3|||
145629640|NCT01570751|525157613|FG000|Period B (16 Weeks)|Adverse Event|1|||
145629641|NCT01570751|525157614|FG001|Period B (16 Weeks)|Adverse Event|0|||
145629642|NCT01570751|525157613|FG000|Period B (16 Weeks)|Protocol Violation|0|||
145629643|NCT01570751|525157614|FG001|Period B (16 Weeks)|Protocol Violation|1|||
145629644|NCT01876511|525157615|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
145629645|NCT01876511|525157616|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
145629646|NCT01876511|525157617|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
145629647|NCT01876511|525157615|FG000|Overall Study|Death (unrelated)|3|||
145629648|NCT01876511|525157616|FG001|Overall Study|Death (unrelated)|0|||
145629649|NCT01876511|525157617|FG002|Overall Study|Death (unrelated)|2|||
145629650|NCT01876511|525157615|FG000|Overall Study|Drug-related Toxicity|5|||
145629651|NCT01876511|525157616|FG001|Overall Study|Drug-related Toxicity|1|||
145629652|NCT01876511|525157617|FG002|Overall Study|Drug-related Toxicity|6|||
145629653|NCT01876511|525157615|FG000|Overall Study|Patient Decision|3|||
145473445|NCT01729208|524585510|FG001|Baseline|Physician Decision|4|||
145629654|NCT01876511|525157616|FG001|Overall Study|Patient Decision|0|||
145629655|NCT01876511|525157617|FG002|Overall Study|Patient Decision|6|||
145629656|NCT01876511|525157615|FG000|Overall Study|Physician Decision|1|||
145629657|NCT01876511|525157616|FG001|Overall Study|Physician Decision|0|||
145629658|NCT01876511|525157617|FG002|Overall Study|Physician Decision|1|||
145629659|NCT02145182|525157622|FG000|Overall Study|Adverse Event|4|||
145629660|NCT02145182|525157623|FG001|Overall Study|Adverse Event|1|||
145629661|NCT02145182|525157622|FG000|Overall Study|Death|7|||
145629662|NCT02145182|525157623|FG001|Overall Study|Death|7|||
145629663|NCT02145182|525157622|FG000|Overall Study|Lost to Follow-up|2|||
145629664|NCT02145182|525157623|FG001|Overall Study|Lost to Follow-up|2|||
145629665|NCT02145182|525157622|FG000|Overall Study|Pre-transplant Withdrawal|0|||
145629666|NCT02145182|525157623|FG001|Overall Study|Pre-transplant Withdrawal|2|||
145629667|NCT02145182|525157622|FG000|Overall Study|Withdrawal by Subject|5|||
145473446|NCT01729208|524585509|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
145473447|NCT01729208|524585510|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
145601765|NCT02515279|525056346|FG000|Overall Study|End-of-treatment visit not attended|17|||
145601766|NCT02515279|525056346|FG000|Overall Study|Other|22|||
145601767|NCT01800968|525056347|FG000|Overall Study|Death|23|||
145601768|NCT01800968|525056348|FG001|Overall Study|Death|16|||
145601769|NCT01800968|525056347|FG000|Overall Study|Lost to Follow-up|5|||
145601770|NCT01800968|525056348|FG001|Overall Study|Lost to Follow-up|7|||
145601771|NCT01800968|525056347|FG000|Overall Study|Withdrawal by Subject|7|||
145601772|NCT01800968|525056348|FG001|Overall Study|Withdrawal by Subject|9|||
145601773|NCT01800968|525056347|FG000|Overall Study|Physician Decision|1|||
145601774|NCT01800968|525056348|FG001|Overall Study|Physician Decision|0|||
145601775|NCT00701038|525056355|FG000|Overall Study|study amended pilot group of patients|4|||
145601776|NCT00701038|525056356|FG001|Overall Study|study amended pilot group of patients|4|||
145601777|NCT03371940|525056362|FG000|Overall Study|Withdrawal by Subject|8|||
145601778|NCT03371940|525056363|FG001|Overall Study|Withdrawal by Subject|1|||
145601779|NCT03371940|525056364|FG002|Overall Study|Withdrawal by Subject|3|||
145601780|NCT03371940|525056365|FG003|Overall Study|Withdrawal by Subject|4|||
145601781|NCT05099926|525056368|FG000|Overall Study|Lost to Follow-up|1|||
145601782|NCT00504426|525056371|FG000|Overall Study|Adverse Event|0|||
145601783|NCT00504426|525056372|FG001|Overall Study|Adverse Event|0|||
145601784|NCT00504426|525056373|FG002|Overall Study|Adverse Event|2|||
145601785|NCT00504426|525056374|FG003|Overall Study|Adverse Event|0|||
145601786|NCT00504426|525056371|FG000|Overall Study|Protocol Violation|1|||
145601787|NCT00504426|525056372|FG001|Overall Study|Protocol Violation|1|||
145601788|NCT00504426|525056373|FG002|Overall Study|Protocol Violation|2|||
145601789|NCT00504426|525056374|FG003|Overall Study|Protocol Violation|0|||
145601790|NCT00504426|525056371|FG000|Overall Study|Withdrawal by Subject|2|||
145601791|NCT00504426|525056372|FG001|Overall Study|Withdrawal by Subject|0|||
145601792|NCT00504426|525056373|FG002|Overall Study|Withdrawal by Subject|0|||
145601793|NCT00504426|525056374|FG003|Overall Study|Withdrawal by Subject|0|||
145601794|NCT00031486|525056380|FG000|Overall Study|Adverse Event|1|||
145601795|NCT00031486|525056381|FG001|Overall Study|Adverse Event|0|||
145601796|NCT00031486|525056380|FG000|Overall Study|Lost to Follow-up|0|||
145601797|NCT00031486|525056381|FG001|Overall Study|Lost to Follow-up|1|||
145601798|NCT00031486|525056380|FG000|Overall Study|Withdrawal by Subject|3|||
145601799|NCT00031486|525056381|FG001|Overall Study|Withdrawal by Subject|2|||
145601800|NCT00031486|525056380|FG000|Overall Study|Death|0|||
145601801|NCT00031486|525056381|FG001|Overall Study|Death|3|||
145601802|NCT00031486|525056380|FG000|Overall Study|Non-compliant|0|||
145601803|NCT00031486|525056381|FG001|Overall Study|Non-compliant|4|||
145601804|NCT00031486|525056380|FG000|Overall Study|Did not meet eligibility requirement|2|||
145601805|NCT00031486|525056381|FG001|Overall Study|Did not meet eligibility requirement|1|||
145601806|NCT00031486|525056380|FG000|Overall Study|Other|1|||
145601807|NCT00031486|525056381|FG001|Overall Study|Other|1|||
145601808|NCT03685591|525056382|FG000|Overall Study|Global Deterioration of Health Status|0|||
145601809|NCT03685591|525056383|FG001|Overall Study|Global Deterioration of Health Status|0|||
145601810|NCT03685591|525056384|FG002|Overall Study|Global Deterioration of Health Status|0|||
145601811|NCT03685591|525056385|FG003|Overall Study|Global Deterioration of Health Status|1|||
145601812|NCT03685591|525056386|FG004|Overall Study|Global Deterioration of Health Status|2|||
145601813|NCT03685591|525056387|FG005|Overall Study|Global Deterioration of Health Status|4|||
145601814|NCT03685591|525056388|FG006|Overall Study|Global Deterioration of Health Status|1|||
145601815|NCT03685591|525056389|FG007|Overall Study|Global Deterioration of Health Status|1|||
145601816|NCT03685591|525056390|FG008|Overall Study|Global Deterioration of Health Status|0|||
145601817|NCT03685591|525056382|FG000|Overall Study|Progressive Disease|1|||
145601818|NCT03685591|525056383|FG001|Overall Study|Progressive Disease|1|||
145601819|NCT03685591|525056384|FG002|Overall Study|Progressive Disease|0|||
145601820|NCT03685591|525056385|FG003|Overall Study|Progressive Disease|3|||
145601821|NCT03685591|525056386|FG004|Overall Study|Progressive Disease|5|||
145601822|NCT03685591|525056387|FG005|Overall Study|Progressive Disease|4|||
145601823|NCT03685591|525056388|FG006|Overall Study|Progressive Disease|3|||
145601824|NCT03685591|525056389|FG007|Overall Study|Progressive Disease|2|||
145601825|NCT03685591|525056390|FG008|Overall Study|Progressive Disease|1|||
145601826|NCT03685591|525056382|FG000|Overall Study|Other|0|||
145601827|NCT03685591|525056383|FG001|Overall Study|Other|0|||
145601828|NCT03685591|525056384|FG002|Overall Study|Other|1|||
145601829|NCT03685591|525056385|FG003|Overall Study|Other|0|||
145601830|NCT03685591|525056386|FG004|Overall Study|Other|2|||
145601831|NCT03685591|525056387|FG005|Overall Study|Other|3|||
145601832|NCT03685591|525056388|FG006|Overall Study|Other|0|||
145601833|NCT03685591|525056389|FG007|Overall Study|Other|0|||
145601834|NCT03685591|525056390|FG008|Overall Study|Other|0|||
145601835|NCT03685591|525056382|FG000|Overall Study|Withdrawal by Subject|0|||
145601836|NCT03685591|525056383|FG001|Overall Study|Withdrawal by Subject|0|||
145601837|NCT03685591|525056384|FG002|Overall Study|Withdrawal by Subject|0|||
145601838|NCT03685591|525056385|FG003|Overall Study|Withdrawal by Subject|0|||
145601839|NCT03685591|525056386|FG004|Overall Study|Withdrawal by Subject|3|||
145601840|NCT03685591|525056387|FG005|Overall Study|Withdrawal by Subject|2|||
145601841|NCT03685591|525056388|FG006|Overall Study|Withdrawal by Subject|0|||
145629668|NCT02145182|525157623|FG001|Overall Study|Withdrawal by Subject|4|||
145629669|NCT01196988|525157625|FG000|Overall Study|Adverse Event|1|||
145629670|NCT01196988|525157626|FG001|Overall Study|Adverse Event|2|||
145629671|NCT01196988|525157627|FG002|Overall Study|Adverse Event|0|||
145629672|NCT01196988|525157628|FG003|Overall Study|Adverse Event|0|||
145629673|NCT01196988|525157625|FG000|Overall Study|Withdrawal by Subject|5|||
145629674|NCT01196988|525157626|FG001|Overall Study|Withdrawal by Subject|1|||
145629675|NCT01196988|525157627|FG002|Overall Study|Withdrawal by Subject|4|||
145629676|NCT01196988|525157628|FG003|Overall Study|Withdrawal by Subject|0|||
145629677|NCT01196988|525157625|FG000|Overall Study|Lost to Follow-up|16|||
145629678|NCT01196988|525157626|FG001|Overall Study|Lost to Follow-up|29|||
145629679|NCT01196988|525157627|FG002|Overall Study|Lost to Follow-up|21|||
145629680|NCT01196988|525157628|FG003|Overall Study|Lost to Follow-up|1|||
145629681|NCT01196988|525157625|FG000|Overall Study|Other|2|||
145629682|NCT01196988|525157626|FG001|Overall Study|Other|0|||
145629683|NCT01196988|525157627|FG002|Overall Study|Other|0|||
145629684|NCT01196988|525157628|FG003|Overall Study|Other|0|||
145629685|NCT05419557|525157629|FG000|Overall Study|Lost to Follow-up|11|||
145629686|NCT05419557|525157630|FG001|Overall Study|Lost to Follow-up|4|||
145629687|NCT00588666|525157631|FG000|Overall Study|Adverse Event|4|||
145629688|NCT01233050|525157632|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
145629689|NCT01233050|525157633|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
145629690|NCT03999554|525157636|FG000|Overall Study|Lost to Follow-up|4|||
145629691|NCT03999554|525157637|FG001|Overall Study|Lost to Follow-up|5|||
145629692|NCT03999554|525157638|FG002|Overall Study|Lost to Follow-up|4|||
145629693|NCT03999554|525157639|FG003|Overall Study|Lost to Follow-up|5|||
145629694|NCT03999554|525157640|FG004|Overall Study|Lost to Follow-up|8|||
145629695|NCT03999554|525157636|FG000|Overall Study|Protocol Violation|0|||
145629696|NCT03999554|525157637|FG001|Overall Study|Protocol Violation|0|||
145629697|NCT03999554|525157638|FG002|Overall Study|Protocol Violation|5|||
145629698|NCT03999554|525157639|FG003|Overall Study|Protocol Violation|0|||
145629699|NCT03999554|525157640|FG004|Overall Study|Protocol Violation|0|||
145629700|NCT03999554|525157636|FG000|Overall Study|Pregnancy|0|||
145629701|NCT03999554|525157637|FG001|Overall Study|Pregnancy|0|||
145629702|NCT03999554|525157638|FG002|Overall Study|Pregnancy|1|||
145629703|NCT03999554|525157639|FG003|Overall Study|Pregnancy|0|||
145629704|NCT03999554|525157640|FG004|Overall Study|Pregnancy|0|||
145629705|NCT03999554|525157636|FG000|Overall Study|Withdrawal by Subject|2|||
145629706|NCT03999554|525157637|FG001|Overall Study|Withdrawal by Subject|2|||
145629707|NCT03999554|525157638|FG002|Overall Study|Withdrawal by Subject|2|||
145629708|NCT03999554|525157639|FG003|Overall Study|Withdrawal by Subject|1|||
145629709|NCT03999554|525157640|FG004|Overall Study|Withdrawal by Subject|1|||
145629710|NCT03999554|525157636|FG000|Overall Study|failure to comply with protocol requirements|0|||
145629711|NCT03999554|525157637|FG001|Overall Study|failure to comply with protocol requirements|0|||
145629712|NCT03999554|525157638|FG002|Overall Study|failure to comply with protocol requirements|0|||
145629713|NCT03999554|525157639|FG003|Overall Study|failure to comply with protocol requirements|1|||
145629714|NCT03999554|525157640|FG004|Overall Study|failure to comply with protocol requirements|0|||
145629715|NCT04582877|525157641|FG000|Overall Study|Did not use device measurement|5|||
145629716|NCT04582877|525157641|FG000|Overall Study|No fractional flow reserve test results|2|||
145629717|NCT04582877|525157641|FG000|Overall Study|Protocol Violation|1|||
145629718|NCT04304534|525157642|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
145629719|NCT04304534|525157643|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
145629720|NCT04304534|525157644|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
145629721|NCT04304534|525157645|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
145629722|NCT04304534|525157642|FG000|Overall Study|Non-Compliance with study drug|0|||
145629723|NCT04304534|525157643|FG001|Overall Study|Non-Compliance with study drug|1|||
145629724|NCT04304534|525157644|FG002|Overall Study|Non-Compliance with study drug|1|||
145629725|NCT04304534|525157645|FG003|Overall Study|Non-Compliance with study drug|1|||
145629726|NCT04304534|525157642|FG000|Overall Study|Lost to Follow-up|0|||
145473448|NCT01729208|524585509|FG000|12 Months Follow-up|Lost to Follow-up|3|||
145473449|NCT01729208|524585510|FG001|12 Months Follow-up|Lost to Follow-up|3|||
145473450|NCT01729208|524585509|FG000|24 Months Follow-up|Lost to Follow-up|3|||
145473451|NCT01729208|524585510|FG001|24 Months Follow-up|Lost to Follow-up|0|||
145473452|NCT01729208|524585509|FG000|36 Months Follow-up|Physician Decision|1|||
145473453|NCT01729208|524585510|FG001|36 Months Follow-up|Physician Decision|0|||
145629727|NCT04304534|525157643|FG001|Overall Study|Lost to Follow-up|1|||
145629728|NCT04304534|525157644|FG002|Overall Study|Lost to Follow-up|2|||
145629729|NCT04304534|525157645|FG003|Overall Study|Lost to Follow-up|3|||
145629730|NCT04304534|525157642|FG000|Overall Study|Unspecific|4|||
145629731|NCT04304534|525157643|FG001|Overall Study|Unspecific|2|||
145629732|NCT04304534|525157644|FG002|Overall Study|Unspecific|2|||
145629733|NCT04304534|525157645|FG003|Overall Study|Unspecific|2|||
145629734|NCT04304534|525157642|FG000|Overall Study|Technical Problems|2|||
145629735|NCT04304534|525157643|FG001|Overall Study|Technical Problems|2|||
145629736|NCT04304534|525157644|FG002|Overall Study|Technical Problems|3|||
145629737|NCT04304534|525157645|FG003|Overall Study|Technical Problems|4|||
145473454|NCT01729208|524585509|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
145629738|NCT04304534|525157642|FG000|Overall Study|Death|7|||
145629739|NCT04304534|525157643|FG001|Overall Study|Death|2|||
145629740|NCT04304534|525157644|FG002|Overall Study|Death|4|||
145629741|NCT04304534|525157645|FG003|Overall Study|Death|3|||
145629742|NCT04304534|525157642|FG000|Overall Study|Withdrawal by Subject|7|||
145629743|NCT04304534|525157643|FG001|Overall Study|Withdrawal by Subject|2|||
145629744|NCT04304534|525157644|FG002|Overall Study|Withdrawal by Subject|7|||
145629745|NCT04304534|525157645|FG003|Overall Study|Withdrawal by Subject|4|||
145629746|NCT04304534|525157642|FG000|Overall Study|Physician Decision|4|||
145629747|NCT04304534|525157643|FG001|Overall Study|Physician Decision|9|||
145629748|NCT04304534|525157644|FG002|Overall Study|Physician Decision|9|||
145629749|NCT04304534|525157645|FG003|Overall Study|Physician Decision|5|||
145629750|NCT04304534|525157642|FG000|Overall Study|Subject Decision|34|||
145629751|NCT04304534|525157643|FG001|Overall Study|Subject Decision|25|||
145629752|NCT04304534|525157644|FG002|Overall Study|Subject Decision|25|||
145629753|NCT04304534|525157645|FG003|Overall Study|Subject Decision|26|||
145629754|NCT04304534|525157642|FG000|Overall Study|Adverse Event|35|||
145629755|NCT04304534|525157643|FG001|Overall Study|Adverse Event|40|||
145629756|NCT04304534|525157644|FG002|Overall Study|Adverse Event|39|||
145629757|NCT04304534|525157645|FG003|Overall Study|Adverse Event|44|||
145629758|NCT00464672|525157646|FG000|Overall Study|withdrawal of consent|0|||
145629759|NCT00464672|525157647|FG001|Overall Study|withdrawal of consent|0|||
145629760|NCT00464672|525157648|FG002|Overall Study|withdrawal of consent|0|||
145629761|NCT00464672|525157649|FG003|Overall Study|withdrawal of consent|1|||
145629762|NCT00464672|525157650|FG004|Overall Study|withdrawal of consent|9|||
145629763|NCT00464672|525157651|FG005|Overall Study|withdrawal of consent|4|||
145629764|NCT00464672|525157646|FG000|Overall Study|Lost to Follow-up|25|||
145629765|NCT00464672|525157647|FG001|Overall Study|Lost to Follow-up|10|||
145629766|NCT00464672|525157648|FG002|Overall Study|Lost to Follow-up|0|||
145629767|NCT00464672|525157649|FG003|Overall Study|Lost to Follow-up|0|||
145629768|NCT00464672|525157650|FG004|Overall Study|Lost to Follow-up|1|||
145629769|NCT00464672|525157651|FG005|Overall Study|Lost to Follow-up|0|||
145629770|NCT02299635|525157652|FG000|Overall Study|Adverse Event|2|||
145629771|NCT02299635|525157652|FG000|Overall Study|Death|1|||
145629772|NCT02299635|525157652|FG000|Overall Study|Global deterioration of health status|1|||
145629773|NCT02299635|525157652|FG000|Overall Study|Objective progression or relapse|10|||
145473455|NCT01729208|524585510|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
145473456|NCT02428413|524585511|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
145473457|NCT02428413|524585512|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
145473458|NCT02428413|524585511|FG000|Overall Study|Protocol Violation|1|||
145473459|NCT02428413|524585512|FG001|Overall Study|Protocol Violation|2|||
145473460|NCT02428413|524585511|FG000|Overall Study|Case Cancelled|2|||
145473461|NCT02428413|524585512|FG001|Overall Study|Case Cancelled|0|||
145473462|NCT02428413|524585511|FG000|Overall Study|Missed Cases|1|||
145473463|NCT02428413|524585512|FG001|Overall Study|Missed Cases|2|||
145473464|NCT02428413|524585511|FG000|Overall Study|Nurse Refusal|1|||
145473465|NCT02428413|524585512|FG001|Overall Study|Nurse Refusal|0|||
145473466|NCT01438177|524585515|FG000|Overall Study|Withdrawal by Subject|1|||
145473467|NCT01438177|524585515|FG000|Overall Study|Initiation of new therapy|1|||
145473468|NCT02772978|524585516|FG000|Overall Study|Withdrawal by Subject|1|||
145473469|NCT02772978|524585517|FG001|Overall Study|Withdrawal by Subject|1|||
145473470|NCT01026220|524585518|FG000|Induction|Death|1|||
145473471|NCT01026220|524585519|FG001|Induction|Death|0|||
145473472|NCT01026220|524585520|FG002|Induction|Death|0|||
145473473|NCT01026220|524585518|FG000|Induction|Lack of Efficacy|2|||
145473474|NCT01026220|524585519|FG001|Induction|Lack of Efficacy|0|||
145473475|NCT01026220|524585520|FG002|Induction|Lack of Efficacy|0|||
145473476|NCT01026220|524585518|FG000|Induction|Physician Decision|12|||
145473477|NCT01026220|524585519|FG001|Induction|Physician Decision|0|||
145473478|NCT01026220|524585520|FG002|Induction|Physician Decision|0|||
145473479|NCT01026220|524585518|FG000|Induction|Withdrawal by Subject|9|||
145473480|NCT01026220|524585519|FG001|Induction|Withdrawal by Subject|0|||
145473481|NCT01026220|524585520|FG002|Induction|Withdrawal by Subject|0|||
145473482|NCT01026220|524585518|FG000|Induction|Ineligible|1|||
145473483|NCT01026220|524585519|FG001|Induction|Ineligible|0|||
145473484|NCT01026220|524585520|FG002|Induction|Ineligible|0|||
145629774|NCT02299635|525157652|FG000|Overall Study|Withdrawal by Subject|2|||
145629775|NCT02299635|525157652|FG000|Overall Study|Other|3|||
145629776|NCT00601640|525157653|FG000|Overall Study|Withdrawal by Subject|3|||
145473485|NCT01026220|524585518|FG000|Consolidation Maintenance|Death|0|||
145473486|NCT01026220|524585519|FG001|Consolidation Maintenance|Death|1|||
145473487|NCT01026220|524585520|FG002|Consolidation Maintenance|Death|0|||
145629777|NCT00601640|525157654|FG001|Overall Study|Withdrawal by Subject|0|||
145473488|NCT01026220|524585518|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
145473489|NCT01026220|524585519|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
145473490|NCT01026220|524585520|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
145473491|NCT01026220|524585518|FG000|Consolidation Maintenance|Physician Decision|0|||
145473492|NCT01026220|524585519|FG001|Consolidation Maintenance|Physician Decision|2|||
145473493|NCT01026220|524585520|FG002|Consolidation Maintenance|Physician Decision|7|||
145473494|NCT01026220|524585518|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
145473495|NCT01026220|524585519|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
145473496|NCT01026220|524585520|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
145473497|NCT00727558|524585526|FG000|Overall Study|Lens issue|0|||
145473498|NCT00727558|524585527|FG001|Overall Study|Lens issue|1|||
145473499|NCT00727558|524585526|FG000|Overall Study|Adverse Event|0|||
145473500|NCT00727558|524585527|FG001|Overall Study|Adverse Event|1|||
145473501|NCT00727558|524585526|FG000|Overall Study|Subject unable to return for follow-up|1|||
145473502|NCT00727558|524585527|FG001|Overall Study|Subject unable to return for follow-up|1|||
145473503|NCT00727558|524585526|FG000|Overall Study|Lost to Follow-up|1|||
145473504|NCT00727558|524585527|FG001|Overall Study|Lost to Follow-up|0|||
145473505|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
145473506|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
145473507|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
145473508|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
145473509|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
145473510|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
145473511|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
145473512|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
145473513|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Death|0|||
145473514|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Death|1|||
145473515|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
145473516|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
145473517|NCT03281304|524585538|FG000|Treatment Phase (up to 42 Months)|Other|0|||
145473518|NCT03281304|524585539|FG001|Treatment Phase (up to 42 Months)|Other|2|||
145473519|NCT03281304|524585538|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
145473520|NCT03281304|524585539|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
145473521|NCT01114438|524585540|FG000|Overall Study|Adverse Event|10|||
145473522|NCT01114438|524585540|FG000|Overall Study|concomitant medication|1|||
145473523|NCT01114438|524585540|FG000|Overall Study|Physician Decision|1|||
145473524|NCT01114438|524585540|FG000|Overall Study|Withdrawal by Subject|2|||
145473525|NCT00428844|524585543|FG000|Completed Study Drug Treatment|Adverse Event|2|||
145473526|NCT00428844|524585544|FG001|Completed Study Drug Treatment|Adverse Event|4|||
145473527|NCT00428844|524585545|FG002|Completed Study Drug Treatment|Adverse Event|4|||
145473528|NCT00428844|524585543|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
145629778|NCT00601640|525157655|FG002|Overall Study|Withdrawal by Subject|7|||
145629779|NCT00601640|525157653|FG000|Overall Study|Death|1|||
145629780|NCT00601640|525157654|FG001|Overall Study|Death|0|||
145629781|NCT00601640|525157655|FG002|Overall Study|Death|0|||
145629782|NCT00601640|525157653|FG000|Overall Study|Adverse Event|0|||
145629783|NCT00601640|525157654|FG001|Overall Study|Adverse Event|4|||
145629784|NCT00601640|525157655|FG002|Overall Study|Adverse Event|2|||
145629785|NCT00601640|525157653|FG000|Overall Study|intercurrent illness|1|||
145629786|NCT00601640|525157654|FG001|Overall Study|intercurrent illness|0|||
145629787|NCT00601640|525157655|FG002|Overall Study|intercurrent illness|0|||
145629788|NCT00601640|525157653|FG000|Overall Study|change in eligibility status|0|||
145629789|NCT00601640|525157654|FG001|Overall Study|change in eligibility status|1|||
145629790|NCT00601640|525157655|FG002|Overall Study|change in eligibility status|1|||
145629791|NCT00015457|525157659|FG000|First Intervention|Adverse Event|0|||
145629792|NCT00015457|525157660|FG001|First Intervention|Adverse Event|2|||
145629793|NCT00015457|525157659|FG000|First Intervention|Lack of Efficacy|0|||
145629794|NCT00015457|525157660|FG001|First Intervention|Lack of Efficacy|1|||
145629795|NCT00015457|525157659|FG000|Second Intervention|Withdrawal by Subject|1|||
145629796|NCT00015457|525157660|FG001|Second Intervention|Withdrawal by Subject|0|||
145629797|NCT03736785|525157667|FG000|Overall Study|Adverse Event|1|||
145629798|NCT03736785|525157668|FG001|Overall Study|Adverse Event|1|||
145629799|NCT03736785|525157669|FG002|Overall Study|Adverse Event|1|||
145629800|NCT03736785|525157667|FG000|Overall Study|Death|1|||
145629801|NCT03736785|525157668|FG001|Overall Study|Death|0|||
145629802|NCT03736785|525157669|FG002|Overall Study|Death|1|||
145629803|NCT03736785|525157667|FG000|Overall Study|Lost to Follow-up|0|||
145473529|NCT00428844|524585544|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
145473530|NCT00428844|524585545|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
145473531|NCT00428844|524585543|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
145473532|NCT00428844|524585544|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
145473533|NCT00428844|524585545|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
145473534|NCT00428844|524585543|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
145629804|NCT03736785|525157668|FG001|Overall Study|Lost to Follow-up|2|||
145473535|NCT00428844|524585544|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
145473536|NCT00428844|524585545|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
145629805|NCT03736785|525157669|FG002|Overall Study|Lost to Follow-up|3|||
145629806|NCT03736785|525157667|FG000|Overall Study|Non compliance with study drug|1|||
145629807|NCT03736785|525157668|FG001|Overall Study|Non compliance with study drug|1|||
145629808|NCT03736785|525157669|FG002|Overall Study|Non compliance with study drug|0|||
145473537|NCT00428844|524585543|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
145473538|NCT00428844|524585544|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
145473539|NCT00428844|524585545|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
145473540|NCT00428844|524585543|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
145473541|NCT00428844|524585544|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
145473542|NCT00428844|524585545|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
145473543|NCT00428844|524585543|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
145473544|NCT00428844|524585544|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
145473545|NCT00428844|524585545|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
145473546|NCT00428844|524585543|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
145473547|NCT00428844|524585544|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
145473548|NCT00428844|524585545|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
145473549|NCT00428844|524585543|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
145473550|NCT00428844|524585544|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
145473551|NCT00428844|524585545|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
145473552|NCT00488826|524585546|FG000|Overall Study|Withdrawal by Subject|40|||
145473553|NCT00488826|524585547|FG001|Overall Study|Withdrawal by Subject|35|||
145473554|NCT00488826|524585548|FG002|Overall Study|Withdrawal by Subject|19|||
145473555|NCT00488826|524585546|FG000|Overall Study|Protocol Violation|0|||
145473556|NCT00488826|524585547|FG001|Overall Study|Protocol Violation|0|||
145473557|NCT00488826|524585548|FG002|Overall Study|Protocol Violation|2|||
145473558|NCT00488826|524585546|FG000|Overall Study|Adverse Event|9|||
145473559|NCT00488826|524585547|FG001|Overall Study|Adverse Event|15|||
145473560|NCT00488826|524585548|FG002|Overall Study|Adverse Event|4|||
145473561|NCT00488826|524585546|FG000|Overall Study|Lost to Follow-up|5|||
145473562|NCT00488826|524585547|FG001|Overall Study|Lost to Follow-up|1|||
145473563|NCT00488826|524585548|FG002|Overall Study|Lost to Follow-up|0|||
145473564|NCT00488826|524585546|FG000|Overall Study|Protocol Deviations|2|||
145473565|NCT00488826|524585547|FG001|Overall Study|Protocol Deviations|1|||
145473566|NCT00488826|524585548|FG002|Overall Study|Protocol Deviations|1|||
145473567|NCT04667104|524585556|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
145473568|NCT04667104|524585557|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
145473569|NCT04667104|524585558|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
145473570|NCT03208088|524585559|FG000|Period 2|Withdrawal by Subject|0|||
145473571|NCT03208088|524585560|FG001|Period 2|Withdrawal by Subject|0|||
145473572|NCT03208088|524585561|FG002|Period 2|Withdrawal by Subject|0|||
145473573|NCT03208088|524585562|FG003|Period 2|Withdrawal by Subject|0|||
145473574|NCT03208088|524585563|FG004|Period 2|Withdrawal by Subject|0|||
145473575|NCT03208088|524585564|FG005|Period 2|Withdrawal by Subject|0|||
145473576|NCT03208088|524585565|FG006|Period 2|Withdrawal by Subject|0|||
145473577|NCT03208088|524585566|FG007|Period 2|Withdrawal by Subject|0|||
145473578|NCT03208088|524585567|FG008|Period 2|Withdrawal by Subject|1|||
145473579|NCT03208088|524585568|FG009|Period 2|Withdrawal by Subject|0|||
145473580|NCT03208088|524585559|FG000|Period 3|Unsatisfactory Test Article|0|||
145473581|NCT03208088|524585560|FG001|Period 3|Unsatisfactory Test Article|0|||
145473582|NCT03208088|524585561|FG002|Period 3|Unsatisfactory Test Article|0|||
145473583|NCT03208088|524585562|FG003|Period 3|Unsatisfactory Test Article|1|||
145473584|NCT03208088|524585563|FG004|Period 3|Unsatisfactory Test Article|0|||
145473585|NCT03208088|524585564|FG005|Period 3|Unsatisfactory Test Article|0|||
145473586|NCT03208088|524585565|FG006|Period 3|Unsatisfactory Test Article|0|||
145473587|NCT03208088|524585566|FG007|Period 3|Unsatisfactory Test Article|0|||
145473588|NCT03208088|524585567|FG008|Period 3|Unsatisfactory Test Article|0|||
145473589|NCT03208088|524585568|FG009|Period 3|Unsatisfactory Test Article|0|||
145473590|NCT03208088|524585559|FG000|Period 4|Unsatisfactory Test Article|0|||
145473591|NCT03208088|524585560|FG001|Period 4|Unsatisfactory Test Article|0|||
145473592|NCT03208088|524585561|FG002|Period 4|Unsatisfactory Test Article|0|||
145473593|NCT03208088|524585562|FG003|Period 4|Unsatisfactory Test Article|1|||
145473594|NCT03208088|524585563|FG004|Period 4|Unsatisfactory Test Article|0|||
145473595|NCT03208088|524585564|FG005|Period 4|Unsatisfactory Test Article|0|||
145473596|NCT03208088|524585565|FG006|Period 4|Unsatisfactory Test Article|0|||
145473597|NCT03208088|524585566|FG007|Period 4|Unsatisfactory Test Article|0|||
145473598|NCT03208088|524585567|FG008|Period 4|Unsatisfactory Test Article|0|||
145473599|NCT03208088|524585568|FG009|Period 4|Unsatisfactory Test Article|0|||
145473600|NCT02577016|524585571|FG000|Overall Study|Adverse Event|2|||
145473601|NCT02577016|524585572|FG001|Overall Study|Adverse Event|1|||
145473602|NCT02577016|524585571|FG000|Overall Study|Physician Decision|0|||
145473603|NCT02577016|524585572|FG001|Overall Study|Physician Decision|1|||
145473604|NCT02126839|524585573|FG000|Overall Study|Adverse Event|0|||
145473605|NCT02126839|524585574|FG001|Overall Study|Adverse Event|1|||
145473606|NCT02126839|524585573|FG000|Overall Study|Withdrawal by Subject|1|||
145473607|NCT02126839|524585574|FG001|Overall Study|Withdrawal by Subject|0|||
145473608|NCT02126839|524585573|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145473609|NCT02126839|524585574|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145473610|NCT02126839|524585573|FG000|Overall Study|Protocol Violation|2|||
145473611|NCT02126839|524585574|FG001|Overall Study|Protocol Violation|3|||
145473612|NCT02126839|524585573|FG000|Overall Study|Sponsor request|0|||
145473613|NCT02126839|524585574|FG001|Overall Study|Sponsor request|1|||
145473614|NCT02126839|524585573|FG000|Overall Study|Lost to Follow-up|1|||
145473615|NCT02126839|524585574|FG001|Overall Study|Lost to Follow-up|4|||
145473616|NCT02126839|524585573|FG000|Overall Study|Other|5|||
145473617|NCT02126839|524585574|FG001|Overall Study|Other|5|||
145473618|NCT00422383|524585575|FG000|Overall Study|Adverse Event|5|||
145473619|NCT00422383|524585576|FG001|Overall Study|Adverse Event|3|||
145473620|NCT00422383|524585577|FG002|Overall Study|Adverse Event|1|||
145473621|NCT00422383|524585578|FG003|Overall Study|Adverse Event|1|||
145473622|NCT00422383|524585579|FG004|Overall Study|Adverse Event|0|||
145473623|NCT00422383|524585575|FG000|Overall Study|Lack of Efficacy|4|||
145473624|NCT00422383|524585576|FG001|Overall Study|Lack of Efficacy|4|||
145473625|NCT00422383|524585577|FG002|Overall Study|Lack of Efficacy|2|||
145473626|NCT00422383|524585578|FG003|Overall Study|Lack of Efficacy|1|||
145473627|NCT00422383|524585579|FG004|Overall Study|Lack of Efficacy|1|||
145473628|NCT00422383|524585575|FG000|Overall Study|Lost to Follow-up|0|||
145473629|NCT00422383|524585576|FG001|Overall Study|Lost to Follow-up|1|||
145473630|NCT00422383|524585577|FG002|Overall Study|Lost to Follow-up|0|||
145473631|NCT00422383|524585578|FG003|Overall Study|Lost to Follow-up|0|||
145473632|NCT00422383|524585579|FG004|Overall Study|Lost to Follow-up|1|||
145473633|NCT00422383|524585575|FG000|Overall Study|Protocol Violation|1|||
145473634|NCT00422383|524585576|FG001|Overall Study|Protocol Violation|1|||
145473635|NCT00422383|524585577|FG002|Overall Study|Protocol Violation|1|||
145473636|NCT00422383|524585578|FG003|Overall Study|Protocol Violation|0|||
145473637|NCT00422383|524585579|FG004|Overall Study|Protocol Violation|0|||
145473638|NCT00422383|524585575|FG000|Overall Study|Withdrawal by Subject|5|||
145473639|NCT00422383|524585576|FG001|Overall Study|Withdrawal by Subject|5|||
145473640|NCT00422383|524585577|FG002|Overall Study|Withdrawal by Subject|0|||
145473641|NCT00422383|524585578|FG003|Overall Study|Withdrawal by Subject|0|||
145473642|NCT00422383|524585579|FG004|Overall Study|Withdrawal by Subject|1|||
145473643|NCT00566254|524585580|FG000|Overall Study|Adverse Event|3|||
145473644|NCT00566254|524585581|FG001|Overall Study|Adverse Event|1|||
145473645|NCT00566254|524585580|FG000|Overall Study|Protocol Violation|1|||
145473646|NCT00566254|524585581|FG001|Overall Study|Protocol Violation|3|||
145473647|NCT00566254|524585580|FG000|Overall Study|Withdrawal by Subject|1|||
145473648|NCT00566254|524585581|FG001|Overall Study|Withdrawal by Subject|2|||
145473649|NCT00566254|524585580|FG000|Overall Study|Lack of Efficacy|5|||
145473650|NCT00566254|524585581|FG001|Overall Study|Lack of Efficacy|6|||
145473651|NCT00566254|524585580|FG000|Overall Study|Other|0|||
145473652|NCT00566254|524585581|FG001|Overall Study|Other|2|||
145473653|NCT00411632|524585582|FG000|Overall Study|Death|1|||
145473654|NCT01108523|524585583|FG000|Overall Study|Protocol Violation|4|||
145473655|NCT02008227|524587511|FG000|Overall Study|Lost to Follow-up|7|||
145473656|NCT02008227|524587512|FG001|Overall Study|Lost to Follow-up|9|||
145473657|NCT02008227|524587511|FG000|Overall Study|Death|494|||
145473658|NCT02008227|524587512|FG001|Overall Study|Death|485|||
145473659|NCT02008227|524587511|FG000|Overall Study|Withdrawal by Subject|67|||
145473660|NCT02008227|524587512|FG001|Overall Study|Withdrawal by Subject|36|||
145473661|NCT02008227|524587511|FG000|Overall Study|Study Terminated By Sponsor|44|||
145473662|NCT02008227|524587512|FG001|Overall Study|Study Terminated By Sponsor|83|||
145473663|NCT00742417|524587513|FG000|Randomized|Withdrawal by legal representative|0|||
145473664|NCT00742417|524587514|FG001|Randomized|Withdrawal by legal representative|1|||
145473665|NCT00742417|524587513|FG000|Randomized|Withdrawal by Subject|1|||
145473666|NCT00742417|524587514|FG001|Randomized|Withdrawal by Subject|0|||
145473667|NCT00742417|524587513|FG000|Randomized|Physician Decision|1|||
145473668|NCT00742417|524587514|FG001|Randomized|Physician Decision|0|||
145473669|NCT00742417|524587513|FG000|Intensive Period|Withdrawal by Subject|1|||
145629809|NCT03736785|525157667|FG000|Overall Study|Physician Decision|0|||
145629810|NCT03736785|525157668|FG001|Overall Study|Physician Decision|1|||
145629811|NCT03736785|525157669|FG002|Overall Study|Physician Decision|1|||
145473670|NCT00742417|524587514|FG001|Intensive Period|Withdrawal by Subject|1|||
145629812|NCT03736785|525157667|FG000|Overall Study|Protocol Violation|1|||
145473671|NCT00742417|524587513|FG000|Intensive Period|Adverse Event|2|||
145473672|NCT00742417|524587514|FG001|Intensive Period|Adverse Event|0|||
145473673|NCT04566601|524587517|FG000|Overall Study|Other than listed|13|||
145473674|NCT04566601|524587518|FG001|Overall Study|Other than listed|4|||
145473675|NCT04566601|524587519|FG002|Overall Study|Other than listed|2|||
145473676|NCT04566601|524587520|FG003|Overall Study|Other than listed|1|||
145473677|NCT04566601|524587521|FG004|Overall Study|Other than listed|4|||
145473678|NCT04566601|524587517|FG000|Overall Study|Protocol deviation|3|||
145473679|NCT04566601|524587518|FG001|Overall Study|Protocol deviation|0|||
145629813|NCT03736785|525157668|FG001|Overall Study|Protocol Violation|4|||
145473680|NCT04566601|524587519|FG002|Overall Study|Protocol deviation|1|||
145473681|NCT04566601|524587520|FG003|Overall Study|Protocol deviation|1|||
145473682|NCT04566601|524587521|FG004|Overall Study|Protocol deviation|1|||
145473683|NCT04566601|524587517|FG000|Overall Study|Technical problems|0|||
145473684|NCT04566601|524587518|FG001|Overall Study|Technical problems|0|||
145473685|NCT04566601|524587519|FG002|Overall Study|Technical problems|1|||
145473686|NCT04566601|524587520|FG003|Overall Study|Technical problems|0|||
145473687|NCT04566601|524587521|FG004|Overall Study|Technical problems|0|||
145473688|NCT04566601|524587517|FG000|Overall Study|No reason available|3|||
145473689|NCT04566601|524587518|FG001|Overall Study|No reason available|2|||
145473690|NCT04566601|524587519|FG002|Overall Study|No reason available|7|||
145473691|NCT04566601|524587520|FG003|Overall Study|No reason available|1|||
145473692|NCT04566601|524587521|FG004|Overall Study|No reason available|5|||
145473693|NCT04566601|524587517|FG000|Overall Study|Burden of study procedures|3|||
145473694|NCT04566601|524587518|FG001|Overall Study|Burden of study procedures|0|||
145473695|NCT04566601|524587519|FG002|Overall Study|Burden of study procedures|0|||
145473696|NCT04566601|524587520|FG003|Overall Study|Burden of study procedures|3|||
145473697|NCT04566601|524587521|FG004|Overall Study|Burden of study procedures|1|||
145473698|NCT04566601|524587517|FG000|Overall Study|Change of residence|2|||
145473699|NCT04566601|524587518|FG001|Overall Study|Change of residence|2|||
145473700|NCT04566601|524587519|FG002|Overall Study|Change of residence|0|||
145473701|NCT04566601|524587520|FG003|Overall Study|Change of residence|1|||
145473702|NCT04566601|524587521|FG004|Overall Study|Change of residence|2|||
145473703|NCT04566601|524587517|FG000|Overall Study|Perceived lack of efficacy|2|||
145473704|NCT04566601|524587518|FG001|Overall Study|Perceived lack of efficacy|0|||
145629814|NCT03736785|525157669|FG002|Overall Study|Protocol Violation|3|||
145629815|NCT03736785|525157667|FG000|Overall Study|Sponsor Decision|1|||
145473705|NCT04566601|524587519|FG002|Overall Study|Perceived lack of efficacy|1|||
145473706|NCT04566601|524587520|FG003|Overall Study|Perceived lack of efficacy|1|||
145473707|NCT04566601|524587521|FG004|Overall Study|Perceived lack of efficacy|2|||
145473708|NCT04566601|524587517|FG000|Overall Study|Adverse Event|7|||
145473709|NCT04566601|524587518|FG001|Overall Study|Adverse Event|4|||
145473710|NCT04566601|524587519|FG002|Overall Study|Adverse Event|6|||
145473711|NCT04566601|524587520|FG003|Overall Study|Adverse Event|5|||
145473712|NCT04566601|524587521|FG004|Overall Study|Adverse Event|12|||
145473713|NCT03047031|524587523|FG000|Overall Study|Other than listed|1|||
145473714|NCT03047031|524587524|FG001|Overall Study|Other than listed|0|||
145473715|NCT03047031|524587525|FG002|Overall Study|Other than listed|0|||
145473716|NCT03047031|524587523|FG000|Overall Study|Lost to Follow-up|4|||
145473717|NCT03047031|524587524|FG001|Overall Study|Lost to Follow-up|0|||
145473718|NCT03047031|524587525|FG002|Overall Study|Lost to Follow-up|0|||
145473719|NCT03047031|524587523|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
145473720|NCT03047031|524587524|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
145473721|NCT03047031|524587525|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
145473722|NCT03047031|524587523|FG000|Overall Study|Adverse Event|1|||
145473723|NCT03047031|524587524|FG001|Overall Study|Adverse Event|0|||
145473724|NCT03047031|524587525|FG002|Overall Study|Adverse Event|0|||
145473725|NCT03047031|524587523|FG000|Overall Study|Withdrawal by Subject|2|||
145473726|NCT03047031|524587524|FG001|Overall Study|Withdrawal by Subject|0|||
145473727|NCT03047031|524587525|FG002|Overall Study|Withdrawal by Subject|0|||
145473728|NCT03047031|524587523|FG000|Overall Study|Change to other medication|2|||
145473729|NCT03047031|524587524|FG001|Overall Study|Change to other medication|0|||
145473730|NCT03047031|524587525|FG002|Overall Study|Change to other medication|0|||
145473731|NCT03047031|524587523|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
145473732|NCT03047031|524587524|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
145473733|NCT03047031|524587525|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
145473734|NCT01450098|524587526|FG000|Period 3|Protocol Violation|0|||
145473735|NCT01450098|524587527|FG001|Period 3|Protocol Violation|1|||
145473736|NCT01450098|524587526|FG000|Period 3|Withdrawal by Subject|0|||
145473737|NCT01450098|524587527|FG001|Period 3|Withdrawal by Subject|2|||
145473738|NCT03229109|524587529|FG000|Overall Study|Withdrawal by Subject|0|||
145473739|NCT03229109|524587530|FG001|Overall Study|Withdrawal by Subject|0|||
145473740|NCT03229109|524587531|FG002|Overall Study|Withdrawal by Subject|0|||
145473741|NCT03229109|524587532|FG003|Overall Study|Withdrawal by Subject|1|||
145473742|NCT04207749|524587533|FG000|Overall Study|Lost to Follow-up|0|||
145473743|NCT04207749|524587534|FG001|Overall Study|Lost to Follow-up|2|||
145473744|NCT04207749|524587533|FG000|Overall Study|Protocol Violation|0|||
145473745|NCT04207749|524587534|FG001|Overall Study|Protocol Violation|1|||
145473746|NCT04207749|524587533|FG000|Overall Study|Withdrawal by Subject|3|||
145473747|NCT04207749|524587534|FG001|Overall Study|Withdrawal by Subject|0|||
145473748|NCT04207749|524587533|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
145473749|NCT04207749|524587534|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
145473750|NCT01971008|524587537|FG000|Overall Study|Protocol Violation|2|||
145473751|NCT01971008|524587538|FG001|Overall Study|Protocol Violation|1|||
145473752|NCT03416127|524587539|FG000|Overall Study|Withdrawal by Subject|0|||
145473753|NCT03416127|524587540|FG001|Overall Study|Withdrawal by Subject|1|||
145473754|NCT03416127|524587541|FG002|Overall Study|Withdrawal by Subject|1|||
145473755|NCT03775512|524587542|FG000|Overall Study|Death|1|||
145629816|NCT03736785|525157668|FG001|Overall Study|Sponsor Decision|0|||
145473756|NCT03775512|524587543|FG001|Overall Study|Death|1|||
145473757|NCT03775512|524587542|FG000|Overall Study|Withdrawal by Subject|7|||
145473758|NCT03775512|524587543|FG001|Overall Study|Withdrawal by Subject|4|||
145473759|NCT03775512|524587542|FG000|Overall Study|Lost to Follow-up|5|||
145473760|NCT03775512|524587543|FG001|Overall Study|Lost to Follow-up|5|||
145473761|NCT03775512|524587542|FG000|Overall Study|Excluded before Catheter insertion|14|||
145473762|NCT03775512|524587543|FG001|Overall Study|Excluded before Catheter insertion|5|||
145473763|NCT03775512|524587542|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
145473764|NCT03775512|524587543|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
145473765|NCT03775512|524587542|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
145473766|NCT03775512|524587543|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
145473767|NCT00567359|524587544|FG000|Overall Study|Withdrawal by Subject|1|||
145473768|NCT02397057|524587545|FG000|Overall Study|Withdrawal by Subject|6|||
145473769|NCT02397057|524587546|FG001|Overall Study|Withdrawal by Subject|7|||
145473770|NCT02397057|524587545|FG000|Overall Study|Lost to Follow-up|4|||
145473771|NCT02397057|524587546|FG001|Overall Study|Lost to Follow-up|3|||
145473772|NCT02397057|524587545|FG000|Overall Study|Death|1|||
145473773|NCT02397057|524587546|FG001|Overall Study|Death|0|||
145473774|NCT02397057|524587545|FG000|Overall Study|Adverse Event|0|||
145473775|NCT02397057|524587546|FG001|Overall Study|Adverse Event|1|||
145473776|NCT02397057|524587545|FG000|Overall Study|Physician Decision|0|||
145473777|NCT02397057|524587546|FG001|Overall Study|Physician Decision|1|||
145473778|NCT02397057|524587545|FG000|Overall Study|Subject did not receive study drug|0|||
145473779|NCT02397057|524587546|FG001|Overall Study|Subject did not receive study drug|1|||
145473780|NCT00793325|524587547|FG000|Overall Study|Protocol Violation|18|||
145473781|NCT00793325|524587547|FG000|Overall Study|Lost to Follow-up|1|||
145473782|NCT01329939|524587552|FG000|Overall Study|Lost to Follow-up|3|||
145473783|NCT01329939|524587553|FG001|Overall Study|Lost to Follow-up|0|||
145473784|NCT01329939|524587554|FG002|Overall Study|Lost to Follow-up|1|||
145473785|NCT01329939|524587555|FG003|Overall Study|Lost to Follow-up|2|||
145473786|NCT01329939|524587552|FG000|Overall Study|Withdrawal by Subject|0|||
145473787|NCT01329939|524587553|FG001|Overall Study|Withdrawal by Subject|1|||
145473788|NCT01329939|524587554|FG002|Overall Study|Withdrawal by Subject|0|||
145473789|NCT01329939|524587555|FG003|Overall Study|Withdrawal by Subject|0|||
145473790|NCT01329939|524587552|FG000|Overall Study|Adverse Event|0|||
145473791|NCT01329939|524587553|FG001|Overall Study|Adverse Event|0|||
145473792|NCT01329939|524587554|FG002|Overall Study|Adverse Event|0|||
145473793|NCT01329939|524587555|FG003|Overall Study|Adverse Event|3|||
145473794|NCT02678923|524587571|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
145473795|NCT02678923|524587572|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
145473796|NCT02678923|524587571|FG000|Overall Study|Withdrawal by Subject|3|||
145473797|NCT02678923|524587572|FG001|Overall Study|Withdrawal by Subject|2|||
145473798|NCT02678923|524587571|FG000|Overall Study|Lost to Follow-up|1|||
145473799|NCT02678923|524587572|FG001|Overall Study|Lost to Follow-up|0|||
145473800|NCT02678923|524587571|FG000|Overall Study|Did Not Return for Study Visits|1|||
145473801|NCT02678923|524587572|FG001|Overall Study|Did Not Return for Study Visits|0|||
145473802|NCT00455143|524587573|FG000|Overall Study|Physician Decision|1|||
145473803|NCT00455143|524587573|FG000|Overall Study|Withdrawal by Subject|1|||
145473804|NCT00455143|524587573|FG000|Overall Study|Staff was not avail to follow patient|2|||
145473805|NCT00455143|524587573|FG000|Overall Study|No longer met Inclusion Criteria|1|||
145473806|NCT00455143|524587573|FG000|Overall Study|Surgical time, staff not available|1|||
145473807|NCT05222555|524587576|FG000|Overall Study|Ongoing|2|||
145473808|NCT05222555|524587577|FG001|Overall Study|Ongoing|18|||
145473809|NCT05222555|524587576|FG000|Overall Study|Adverse Event|1|||
145473810|NCT05222555|524587577|FG001|Overall Study|Adverse Event|1|||
145473811|NCT05222555|524587576|FG000|Overall Study|Death|0|||
145473812|NCT05222555|524587577|FG001|Overall Study|Death|6|||
145473813|NCT05222555|524587576|FG000|Overall Study|Withdrawal by Subject|0|||
145473814|NCT05222555|524587577|FG001|Overall Study|Withdrawal by Subject|11|||
145473815|NCT00300365|524587578|FG000|Overall Study|Lost to Follow-up|1|||
145473816|NCT00300365|524587579|FG001|Overall Study|Lost to Follow-up|0|||
145473817|NCT00300365|524587578|FG000|Overall Study|Physician Decision|2|||
145473818|NCT00300365|524587579|FG001|Overall Study|Physician Decision|0|||
145473819|NCT00300365|524587578|FG000|Overall Study|Withdrawal by Subject|1|||
145473820|NCT00300365|524587579|FG001|Overall Study|Withdrawal by Subject|0|||
145473821|NCT00300365|524587578|FG000|Overall Study|Adverse Event|0|||
145473822|NCT00300365|524587579|FG001|Overall Study|Adverse Event|2|||
145473823|NCT01374178|524587582|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
145473824|NCT01374178|524587583|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
145473825|NCT01374178|524587582|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
145473826|NCT01374178|524587583|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
145473827|NCT01422824|524587584|FG000|Overall Study|Case record form not evaluated|1|||
145473828|NCT01422824|524587584|FG000|Overall Study|Lost to Follow-up|37|||
145473829|NCT02760810|524587585|FG000|Overall Study|Protocol Violation|1|||
145473830|NCT00117793|524587586|FG000|Overall Study|Withdrawal by Subject|12|||
145473831|NCT01753401|524587587|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
145473832|NCT01753401|524587588|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
145473833|NCT01753401|524587589|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
145473834|NCT01753401|524587590|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
145629817|NCT03736785|525157669|FG002|Overall Study|Sponsor Decision|0|||
145473835|NCT01753401|524587587|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
145473836|NCT01753401|524587588|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
145473837|NCT01753401|524587589|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
145473838|NCT01753401|524587590|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
145473839|NCT01753401|524587587|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
145473840|NCT01753401|524587588|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
145473841|NCT01753401|524587589|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
145473842|NCT01753401|524587590|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
145473843|NCT01753401|524587587|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
145473844|NCT01753401|524587588|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
145473845|NCT01753401|524587589|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
145473846|NCT01753401|524587590|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
145473847|NCT01753401|524587587|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
145473848|NCT01753401|524587588|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
145473849|NCT01753401|524587589|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
145473850|NCT01753401|524587590|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
145473851|NCT01753401|524587587|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
145473852|NCT01753401|524587588|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
145473853|NCT01753401|524587589|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
145473854|NCT01753401|524587590|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
145473855|NCT01753401|524587587|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
145473856|NCT01753401|524587588|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
145473857|NCT01753401|524587589|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
145473858|NCT01753401|524587590|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
145473859|NCT02453555|524587597|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
145473860|NCT02453555|524587598|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
145473861|NCT02453555|524587599|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
145473862|NCT02453555|524587600|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
145473863|NCT02453555|524587601|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
145473864|NCT02453555|524587602|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
145473865|NCT02453555|524587597|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
145473866|NCT02453555|524587598|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
145473867|NCT02453555|524587599|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
145473868|NCT02453555|524587600|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
145473869|NCT02453555|524587601|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
145473870|NCT02453555|524587602|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
145473871|NCT02453555|524587597|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
145473872|NCT02453555|524587598|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
145473873|NCT02453555|524587599|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145473874|NCT02453555|524587600|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145473875|NCT02453555|524587601|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145473876|NCT02453555|524587602|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
145473877|NCT02453555|524587597|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
145473878|NCT02453555|524587598|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
145473879|NCT02453555|524587599|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
145473880|NCT02453555|524587600|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
145473881|NCT02453555|524587601|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
145473882|NCT02453555|524587602|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
145473883|NCT02453555|524587597|FG000|Extension Period|Adverse Event|0|||
145473884|NCT02453555|524587598|FG001|Extension Period|Adverse Event|0|||
145473885|NCT02453555|524587599|FG002|Extension Period|Adverse Event|1|||
145473886|NCT02453555|524587600|FG003|Extension Period|Adverse Event|2|||
145473887|NCT02453555|524587601|FG004|Extension Period|Adverse Event|1|||
145473888|NCT02453555|524587602|FG005|Extension Period|Adverse Event|1|||
145473889|NCT02453555|524587597|FG000|Extension Period|Protocol Violation|0|||
145473890|NCT02453555|524587598|FG001|Extension Period|Protocol Violation|0|||
145473891|NCT02453555|524587599|FG002|Extension Period|Protocol Violation|1|||
145473892|NCT02453555|524587600|FG003|Extension Period|Protocol Violation|0|||
145473893|NCT02453555|524587601|FG004|Extension Period|Protocol Violation|0|||
145473894|NCT02453555|524587602|FG005|Extension Period|Protocol Violation|0|||
145473895|NCT02453555|524587597|FG000|Extension Period|Withdrawal by Subject|0|||
145473896|NCT02453555|524587598|FG001|Extension Period|Withdrawal by Subject|0|||
145473897|NCT02453555|524587599|FG002|Extension Period|Withdrawal by Subject|1|||
145473898|NCT02453555|524587600|FG003|Extension Period|Withdrawal by Subject|0|||
145473899|NCT02453555|524587601|FG004|Extension Period|Withdrawal by Subject|0|||
145473900|NCT02453555|524587602|FG005|Extension Period|Withdrawal by Subject|0|||
145473901|NCT03689855|524587607|FG000|Overall Study|Adverse Event|3|||
145473902|NCT03689855|524587607|FG000|Overall Study|Withdrawal by Subject|1|||
145473903|NCT02479139|524587608|FG000|Overall Study|Lost to Follow-up|2|||
145473904|NCT02479139|524587609|FG001|Overall Study|Lost to Follow-up|4|||
145473905|NCT02479139|524587610|FG002|Overall Study|Lost to Follow-up|4|||
145473906|NCT02479139|524587611|FG003|Overall Study|Lost to Follow-up|2|||
145473907|NCT02479139|524587612|FG004|Overall Study|Lost to Follow-up|3|||
145473908|NCT02479139|524587613|FG005|Overall Study|Lost to Follow-up|5|||
145473909|NCT02479139|524587608|FG000|Overall Study|Withdrew Consent|5|||
145473910|NCT02479139|524587609|FG001|Overall Study|Withdrew Consent|6|||
145473911|NCT02479139|524587610|FG002|Overall Study|Withdrew Consent|1|||
145473912|NCT02479139|524587611|FG003|Overall Study|Withdrew Consent|4|||
145473913|NCT02479139|524587612|FG004|Overall Study|Withdrew Consent|1|||
145473914|NCT02479139|524587613|FG005|Overall Study|Withdrew Consent|1|||
145473915|NCT02479139|524587608|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
145473916|NCT02479139|524587609|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
145473917|NCT02479139|524587610|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
145629818|NCT03736785|525157667|FG000|Overall Study|Unknown/Missing data|3|||
145629819|NCT03736785|525157668|FG001|Overall Study|Unknown/Missing data|2|||
145629820|NCT03736785|525157669|FG002|Overall Study|Unknown/Missing data|1|||
145629821|NCT03736785|525157667|FG000|Overall Study|Withdrawal by Subject|9|||
145629822|NCT03736785|525157668|FG001|Overall Study|Withdrawal by Subject|6|||
145629823|NCT03736785|525157669|FG002|Overall Study|Withdrawal by Subject|4|||
145629824|NCT00320489|525157672|FG000|Overall Study|Adverse Event|26|||
145629825|NCT00320489|525157673|FG001|Overall Study|Adverse Event|25|||
145629826|NCT00320489|525157672|FG000|Overall Study|Clinical Relapse|26|||
145629827|NCT00320489|525157673|FG001|Overall Study|Clinical Relapse|20|||
145473918|NCT02479139|524587611|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
145473919|NCT02479139|524587612|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
145473920|NCT02479139|524587613|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
145629828|NCT00320489|525157672|FG000|Overall Study|Death|0|||
145629829|NCT00320489|525157673|FG001|Overall Study|Death|2|||
145629830|NCT00320489|525157672|FG000|Overall Study|Entry Criteria Exclusion|2|||
145629831|NCT00320489|525157673|FG001|Overall Study|Entry Criteria Exclusion|4|||
145629832|NCT00320489|525157672|FG000|Overall Study|Lack of Efficacy|16|||
145629833|NCT00320489|525157673|FG001|Overall Study|Lack of Efficacy|7|||
145629834|NCT00320489|525157672|FG000|Overall Study|Lost to Follow-up|21|||
145629835|NCT00320489|525157673|FG001|Overall Study|Lost to Follow-up|22|||
145629836|NCT00320489|525157672|FG000|Overall Study|Physician Decision|8|||
145629837|NCT00320489|525157673|FG001|Overall Study|Physician Decision|8|||
145629838|NCT00320489|525157672|FG000|Overall Study|Protocol Violation|4|||
145629839|NCT00320489|525157673|FG001|Overall Study|Protocol Violation|4|||
145629840|NCT00320489|525157672|FG000|Overall Study|Sponsor Decision|3|||
145629841|NCT00320489|525157673|FG001|Overall Study|Sponsor Decision|3|||
145629842|NCT00320489|525157672|FG000|Overall Study|Withdrawal by Subject|39|||
145629843|NCT00320489|525157673|FG001|Overall Study|Withdrawal by Subject|41|||
145629844|NCT01190150|525157680|FG000|First Treatment|Withdrawal by Subject|1|||
145629845|NCT01190150|525157681|FG001|First Treatment|Withdrawal by Subject|0|||
145629846|NCT01190150|525157680|FG000|Washout|Withdrawal by Subject|0|||
145473921|NCT02479139|524587608|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145473922|NCT02479139|524587609|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145473923|NCT02479139|524587610|FG002|Overall Study|Other Miscellaneous Reasons|1|||
145473924|NCT02479139|524587611|FG003|Overall Study|Other Miscellaneous Reasons|1|||
145473925|NCT02479139|524587612|FG004|Overall Study|Other Miscellaneous Reasons|1|||
145473926|NCT02479139|524587613|FG005|Overall Study|Other Miscellaneous Reasons|0|||
145473927|NCT00885482|524587614|FG000|Overall Study|Pregnancy|1|||
145473928|NCT00885482|524587614|FG000|Overall Study|Lack of Efficacy|1|||
145473929|NCT00885482|524587614|FG000|Overall Study|Death|1|||
145473930|NCT00885482|524587614|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
145473931|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
145473932|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
145473933|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
145473934|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
145473935|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
145473936|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
145473937|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
145473938|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
145473939|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
145473940|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
145473941|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
145473942|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
145473943|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
145629847|NCT01190150|525157681|FG001|Washout|Withdrawal by Subject|1|||
145629848|NCT01190150|525157680|FG000|Washout|Difficulty in adherence|0|||
145629849|NCT01190150|525157681|FG001|Washout|Difficulty in adherence|1|||
145629850|NCT00746330|525157682|FG000|Period 1|Abnormal test procedure result|0|||
145629851|NCT00746330|525157683|FG001|Period 1|Abnormal test procedure result|0|||
145629852|NCT00746330|525157684|FG002|Period 1|Abnormal test procedure result|1|||
145473944|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
145473945|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
145473946|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
145473947|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
145473948|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
145473949|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
145473950|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
145473951|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
145473952|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
145473953|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
145473954|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
145473955|NCT01532869|524587615|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
145473956|NCT01532869|524587616|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
145473957|NCT01532869|524587615|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
145473958|NCT01532869|524587616|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
145473959|NCT01532869|524587615|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
145473960|NCT01532869|524587616|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
145473961|NCT01532869|524587615|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
145473962|NCT01532869|524587616|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
145473963|NCT01532869|524587615|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
145473964|NCT01532869|524587616|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
145473965|NCT01009086|524587617|FG000|Overall Study|Lack of Efficacy|16|||
145473966|NCT01009086|524587618|FG001|Overall Study|Lack of Efficacy|15|||
145473967|NCT01009086|524587619|FG002|Overall Study|Lack of Efficacy|9|||
145473968|NCT01009086|524587617|FG000|Overall Study|Lost to Follow-up|4|||
145473969|NCT01009086|524587618|FG001|Overall Study|Lost to Follow-up|5|||
145473970|NCT01009086|524587619|FG002|Overall Study|Lost to Follow-up|3|||
145473971|NCT01009086|524587617|FG000|Overall Study|Adverse Event|12|||
145473972|NCT01009086|524587618|FG001|Overall Study|Adverse Event|11|||
145473973|NCT01009086|524587619|FG002|Overall Study|Adverse Event|8|||
145473974|NCT01009086|524587617|FG000|Overall Study|Withdrawal by Subject|9|||
145473975|NCT01009086|524587618|FG001|Overall Study|Withdrawal by Subject|11|||
145473976|NCT01009086|524587619|FG002|Overall Study|Withdrawal by Subject|13|||
145473977|NCT01009086|524587617|FG000|Overall Study|Other|3|||
145473978|NCT01009086|524587618|FG001|Overall Study|Other|5|||
145473979|NCT01009086|524587619|FG002|Overall Study|Other|1|||
145473980|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
145473981|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
145473982|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
145473983|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
145473984|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
145473985|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
145473986|NCT01389323|524587620|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
145473987|NCT01389323|524587620|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
145473988|NCT01389323|524587620|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
145473989|NCT01389323|524587620|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
145473990|NCT01389323|524587620|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
145473991|NCT01147848|524587624|FG000|Run-in Period|Screen Failure|623|||
145473992|NCT01147848|524587625|FG001|Run-in Period|Screen Failure|0|||
145473993|NCT01147848|524587626|FG002|Run-in Period|Screen Failure|0|||
145473994|NCT01147848|524587624|FG000|Run-in Period|Run-in Failure|135|||
145473995|NCT01147848|524587625|FG001|Run-in Period|Run-in Failure|0|||
145473996|NCT01147848|524587626|FG002|Run-in Period|Run-in Failure|0|||
145473997|NCT01147848|524587624|FG000|Randomized Phase|Adverse Event|0|||
145473998|NCT01147848|524587625|FG001|Randomized Phase|Adverse Event|6|||
145473999|NCT01147848|524587626|FG002|Randomized Phase|Adverse Event|8|||
145474000|NCT01147848|524587624|FG000|Randomized Phase|Lack of Efficacy|0|||
145474001|NCT01147848|524587625|FG001|Randomized Phase|Lack of Efficacy|20|||
145601842|NCT03685591|525056389|FG007|Overall Study|Withdrawal by Subject|0|||
145601843|NCT03685591|525056390|FG008|Overall Study|Withdrawal by Subject|1|||
145601844|NCT03685591|525056382|FG000|Overall Study|Adverse Event|0|||
145601845|NCT03685591|525056383|FG001|Overall Study|Adverse Event|0|||
145601846|NCT03685591|525056384|FG002|Overall Study|Adverse Event|0|||
145601847|NCT03685591|525056385|FG003|Overall Study|Adverse Event|1|||
145601848|NCT03685591|525056386|FG004|Overall Study|Adverse Event|1|||
145629853|NCT00746330|525157685|FG003|Period 1|Abnormal test procedure result|0|||
145474002|NCT01147848|524587626|FG002|Randomized Phase|Lack of Efficacy|11|||
145474003|NCT01147848|524587624|FG000|Randomized Phase|Protocol Violation|0|||
145474004|NCT01147848|524587625|FG001|Randomized Phase|Protocol Violation|7|||
145474005|NCT01147848|524587626|FG002|Randomized Phase|Protocol Violation|10|||
145601849|NCT03685591|525056387|FG005|Overall Study|Adverse Event|4|||
145601850|NCT03685591|525056388|FG006|Overall Study|Adverse Event|0|||
145474006|NCT01147848|524587624|FG000|Randomized Phase|Lost to Follow-up|0|||
145474007|NCT01147848|524587625|FG001|Randomized Phase|Lost to Follow-up|5|||
145474008|NCT01147848|524587626|FG002|Randomized Phase|Lost to Follow-up|7|||
145474009|NCT01147848|524587624|FG000|Randomized Phase|Physician Decision|0|||
145474010|NCT01147848|524587625|FG001|Randomized Phase|Physician Decision|0|||
145474011|NCT01147848|524587626|FG002|Randomized Phase|Physician Decision|1|||
145474012|NCT01147848|524587624|FG000|Randomized Phase|Withdrawal by Subject|0|||
145474013|NCT01147848|524587625|FG001|Randomized Phase|Withdrawal by Subject|7|||
145474014|NCT01147848|524587626|FG002|Randomized Phase|Withdrawal by Subject|9|||
145474015|NCT03596450|524587639|FG000|Overall Study|Death|9|||
145474016|NCT03596450|524587640|FG001|Overall Study|Death|9|||
145474017|NCT03596450|524587639|FG000|Overall Study|Protocol Violation|18|||
145474018|NCT03596450|524587640|FG001|Overall Study|Protocol Violation|26|||
145474019|NCT03596450|524587639|FG000|Overall Study|Lost to Follow-up|50|||
145474020|NCT03596450|524587640|FG001|Overall Study|Lost to Follow-up|56|||
145474021|NCT03596450|524587639|FG000|Overall Study|Adverse Event|14|||
145474022|NCT03596450|524587640|FG001|Overall Study|Adverse Event|7|||
145474023|NCT03596450|524587639|FG000|Overall Study|Withdrawal by Subject|38|||
145474024|NCT03596450|524587640|FG001|Overall Study|Withdrawal by Subject|36|||
145474025|NCT03596450|524587639|FG000|Overall Study|Accidentally Randomized|2|||
145474026|NCT03596450|524587640|FG001|Overall Study|Accidentally Randomized|0|||
145474027|NCT03596450|524587639|FG000|Overall Study|Other reasons|48|||
145474028|NCT03596450|524587640|FG001|Overall Study|Other reasons|53|||
145474029|NCT03596450|524587639|FG000|Overall Study|Pregnancy|2|||
145474030|NCT03596450|524587640|FG001|Overall Study|Pregnancy|0|||
145474031|NCT04058886|524587641|FG000|Overall Study|Withdrawal by Subject|4|||
145474032|NCT04058886|524587641|FG000|Overall Study|Inadequate deafness interpreter service|1|||
145474033|NCT01069705|524587642|FG000|Overall Study|Adverse Event|1|||
145474034|NCT01069705|524587642|FG000|Overall Study|Withdrawal by Subject|2|||
145474035|NCT03624127|524587643|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
145474036|NCT03624127|524587644|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
145474037|NCT03624127|524587645|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
145474038|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
145474039|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
145474040|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
145474041|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Death|0|||
145474042|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Death|1|||
145474043|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Death|0|||
145474044|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
145474045|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
145474046|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
145474047|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
145474048|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
145474049|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
145474050|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
145474051|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
145474052|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
145474053|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
145474054|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
145474055|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
145474056|NCT03624127|524587643|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
145474057|NCT03624127|524587644|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
145474058|NCT03624127|524587645|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
145474059|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
145474060|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
145474061|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
145474062|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
145474063|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
145601851|NCT03685591|525056389|FG007|Overall Study|Adverse Event|1|||
145601852|NCT03685591|525056390|FG008|Overall Study|Adverse Event|1|||
145601853|NCT01685138|525056393|FG000|Overall Study|Lost to Follow-up|1|||
145601854|NCT01685138|525056393|FG000|Overall Study|Protocol Violation|1|||
145601855|NCT01685138|525056393|FG000|Overall Study|No longer requires treatment|1|||
145601856|NCT01685138|525056393|FG000|Overall Study|Subject/guardian decision|2|||
145601857|NCT01685138|525056393|FG000|Overall Study|Physician Decision|6|||
145601858|NCT01685138|525056393|FG000|Overall Study|Death|10|||
145601859|NCT01685138|525056393|FG000|Overall Study|Adverse Event|18|||
145601860|NCT01685138|525056393|FG000|Overall Study|Progressive disease|53|||
145601861|NCT02068495|525056394|FG000|Overall Study|Case Report Forms Uncollected|60|||
145601862|NCT02068495|525056394|FG000|Overall Study|Protocol Deviation|49|||
145601863|NCT00689026|525056395|FG000|Overall Study|Withdrawal by Subject|13|||
145601864|NCT00689026|525056396|FG001|Overall Study|Withdrawal by Subject|6|||
145601865|NCT03988166|525056397|FG000|Overall Study|Lost to Follow-up|2|||
145601866|NCT03988166|525056397|FG000|Overall Study|Death|1|||
145474064|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
145474065|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
145474066|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
145474067|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
145474068|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
145474069|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
145474070|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
145474071|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
145474072|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
145474073|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
145474074|NCT03624127|524587643|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
145474075|NCT03624127|524587644|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
145474076|NCT03624127|524587645|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
145474077|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
145474078|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
145474079|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
145474080|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
145474081|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
145474082|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
145474083|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
145474084|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
145474085|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
145474086|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
145474087|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
145474088|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
145474089|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
145474090|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
145474091|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
145474092|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
145474093|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
145474094|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
145474095|NCT03624127|524587643|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
145474096|NCT03624127|524587644|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
145474097|NCT03624127|524587645|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
145474098|NCT00915551|524587646|FG000|Overall Study|Withdrawal by Subject|0|||
145474099|NCT00915551|524587647|FG001|Overall Study|Withdrawal by Subject|1|||
145474100|NCT04390841|524587648|FG000|Overall Study|Withdrawal by Subject|2|||
145474101|NCT02999633|524587649|FG000|Overall Study|Adverse Event|2|||
145474102|NCT02999633|524587649|FG000|Overall Study|Progressive disease|12|||
145474103|NCT01545050|524587650|FG000|Overall Study|Lack of Efficacy|0|||
145474104|NCT01545050|524587651|FG001|Overall Study|Lack of Efficacy|0|||
145474105|NCT01545050|524587652|FG002|Overall Study|Lack of Efficacy|0|||
145474106|NCT01545050|524587653|FG003|Overall Study|Lack of Efficacy|3|||
145474107|NCT01545050|524587654|FG004|Overall Study|Lack of Efficacy|2|||
145474108|NCT01545050|524587650|FG000|Overall Study|Adverse Event|1|||
145474109|NCT01545050|524587651|FG001|Overall Study|Adverse Event|1|||
145474110|NCT01545050|524587652|FG002|Overall Study|Adverse Event|2|||
145474111|NCT01545050|524587653|FG003|Overall Study|Adverse Event|2|||
145474112|NCT01545050|524587654|FG004|Overall Study|Adverse Event|0|||
145474113|NCT01545050|524587650|FG000|Overall Study|Discontinued study treatment|1|||
145474114|NCT01545050|524587651|FG001|Overall Study|Discontinued study treatment|0|||
145474115|NCT01545050|524587652|FG002|Overall Study|Discontinued study treatment|0|||
145474116|NCT01545050|524587653|FG003|Overall Study|Discontinued study treatment|0|||
145474117|NCT01545050|524587654|FG004|Overall Study|Discontinued study treatment|0|||
145474118|NCT01545050|524587650|FG000|Overall Study|Withdrawal by Subject|1|||
145474119|NCT01545050|524587651|FG001|Overall Study|Withdrawal by Subject|0|||
145474120|NCT01545050|524587652|FG002|Overall Study|Withdrawal by Subject|0|||
145474121|NCT01545050|524587653|FG003|Overall Study|Withdrawal by Subject|2|||
145474122|NCT01545050|524587654|FG004|Overall Study|Withdrawal by Subject|1|||
145474123|NCT01545050|524587650|FG000|Overall Study|Participant no longer meets study criteria|0|||
145474124|NCT01545050|524587651|FG001|Overall Study|Participant no longer meets study criteria|2|||
145474125|NCT01545050|524587652|FG002|Overall Study|Participant no longer meets study criteria|0|||
145474126|NCT01545050|524587653|FG003|Overall Study|Participant no longer meets study criteria|0|||
145474127|NCT01545050|524587654|FG004|Overall Study|Participant no longer meets study criteria|1|||
145474128|NCT01545050|524587650|FG000|Overall Study|Administrative reason by sponsor|4|||
145474129|NCT01545050|524587651|FG001|Overall Study|Administrative reason by sponsor|2|||
145474130|NCT01545050|524587652|FG002|Overall Study|Administrative reason by sponsor|3|||
145474131|NCT01545050|524587653|FG003|Overall Study|Administrative reason by sponsor|5|||
145474132|NCT01545050|524587654|FG004|Overall Study|Administrative reason by sponsor|5|||
145474133|NCT03262441|524587655|FG000|Overall Study|Withdrawal by Subject|1|||
145474134|NCT02607228|524587656|FG000|Overall Study|Progressive Disease|4|||
145474135|NCT02607228|524587657|FG001|Overall Study|Progressive Disease|3|||
145474136|NCT02607228|524587658|FG002|Overall Study|Progressive Disease|1|||
145474137|NCT02607228|524587659|FG003|Overall Study|Progressive Disease|5|||
145474138|NCT02607228|524587660|FG004|Overall Study|Progressive Disease|4|||
145629854|NCT01467700|525157686|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
145629855|NCT01467700|525157687|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
145629856|NCT01467700|525157688|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
145629857|NCT01467700|525157689|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
145629858|NCT01467700|525157686|FG000|Overall Study|Major Protocol Deviation|3|||
145629859|NCT01467700|525157687|FG001|Overall Study|Major Protocol Deviation|3|||
145629860|NCT01467700|525157688|FG002|Overall Study|Major Protocol Deviation|2|||
145629861|NCT01467700|525157689|FG003|Overall Study|Major Protocol Deviation|3|||
145629862|NCT01467700|525157686|FG000|Overall Study|Lost to Follow-up|6|||
145629863|NCT01467700|525157687|FG001|Overall Study|Lost to Follow-up|5|||
145629864|NCT01467700|525157688|FG002|Overall Study|Lost to Follow-up|2|||
145629865|NCT01467700|525157689|FG003|Overall Study|Lost to Follow-up|3|||
145474139|NCT02607228|524587661|FG005|Overall Study|Progressive Disease|3|||
145474140|NCT02607228|524587662|FG006|Overall Study|Progressive Disease|1|||
145474141|NCT02607228|524587656|FG000|Overall Study|Adverse Event|1|||
145629866|NCT01467700|525157686|FG000|Overall Study|Voluntary Withdrawal|5|||
145629867|NCT01467700|525157687|FG001|Overall Study|Voluntary Withdrawal|7|||
145629868|NCT01467700|525157688|FG002|Overall Study|Voluntary Withdrawal|6|||
145629869|NCT01467700|525157689|FG003|Overall Study|Voluntary Withdrawal|2|||
145474142|NCT02607228|524587657|FG001|Overall Study|Adverse Event|0|||
145474143|NCT02607228|524587658|FG002|Overall Study|Adverse Event|1|||
145629870|NCT01467700|525157686|FG000|Overall Study|Study Termination|6|||
145629871|NCT01467700|525157687|FG001|Overall Study|Study Termination|5|||
145629872|NCT01467700|525157688|FG002|Overall Study|Study Termination|10|||
145629873|NCT01467700|525157689|FG003|Overall Study|Study Termination|7|||
145629874|NCT01467700|525157686|FG000|Overall Study|Pregnancy|0|||
145629875|NCT01467700|525157687|FG001|Overall Study|Pregnancy|1|||
145629876|NCT01467700|525157688|FG002|Overall Study|Pregnancy|1|||
145629877|NCT01467700|525157689|FG003|Overall Study|Pregnancy|0|||
145629878|NCT01467700|525157686|FG000|Overall Study|Lack of Efficacy|2|||
145629879|NCT01467700|525157687|FG001|Overall Study|Lack of Efficacy|0|||
145629880|NCT01467700|525157688|FG002|Overall Study|Lack of Efficacy|2|||
145629881|NCT01467700|525157689|FG003|Overall Study|Lack of Efficacy|1|||
145629882|NCT01467700|525157686|FG000|Overall Study|Reason not Specified|1|||
145629883|NCT01467700|525157687|FG001|Overall Study|Reason not Specified|3|||
145629884|NCT01467700|525157688|FG002|Overall Study|Reason not Specified|2|||
145629885|NCT01467700|525157689|FG003|Overall Study|Reason not Specified|8|||
145629886|NCT03523962|525157690|FG000|Closed Fractures|Death|86|||
145629887|NCT03523962|525157691|FG001|Closed Fractures|Death|71|||
145629888|NCT03523962|525157692|FG002|Closed Fractures|Death|0|||
145629889|NCT03523962|525157693|FG003|Closed Fractures|Death|0|||
145629890|NCT03523962|525157690|FG000|Closed Fractures|Lost to Follow-up|62|||
145629891|NCT03523962|525157691|FG001|Closed Fractures|Lost to Follow-up|36|||
145474144|NCT02607228|524587659|FG003|Overall Study|Adverse Event|0|||
145474145|NCT02607228|524587660|FG004|Overall Study|Adverse Event|1|||
145474146|NCT02607228|524587661|FG005|Overall Study|Adverse Event|1|||
145474147|NCT02607228|524587662|FG006|Overall Study|Adverse Event|1|||
145474148|NCT02607228|524587656|FG000|Overall Study|Investigator's Discretion|0|||
145474149|NCT02607228|524587657|FG001|Overall Study|Investigator's Discretion|0|||
145474150|NCT02607228|524587658|FG002|Overall Study|Investigator's Discretion|1|||
145474151|NCT02607228|524587659|FG003|Overall Study|Investigator's Discretion|0|||
145474152|NCT02607228|524587660|FG004|Overall Study|Investigator's Discretion|0|||
145474153|NCT02607228|524587661|FG005|Overall Study|Investigator's Discretion|1|||
145474154|NCT02607228|524587662|FG006|Overall Study|Investigator's Discretion|0|||
145474155|NCT02607228|524587656|FG000|Overall Study|Withdrew Consent|0|||
145474156|NCT02607228|524587657|FG001|Overall Study|Withdrew Consent|1|||
145474157|NCT02607228|524587658|FG002|Overall Study|Withdrew Consent|0|||
145474158|NCT02607228|524587659|FG003|Overall Study|Withdrew Consent|0|||
145474159|NCT02607228|524587660|FG004|Overall Study|Withdrew Consent|0|||
145474160|NCT02607228|524587661|FG005|Overall Study|Withdrew Consent|1|||
145474161|NCT02607228|524587662|FG006|Overall Study|Withdrew Consent|0|||
145474162|NCT02607228|524587656|FG000|Overall Study|Study Terminated by Sponsor|0|||
145474163|NCT02607228|524587657|FG001|Overall Study|Study Terminated by Sponsor|0|||
145474164|NCT02607228|524587658|FG002|Overall Study|Study Terminated by Sponsor|0|||
145629892|NCT03523962|525157692|FG002|Closed Fractures|Lost to Follow-up|0|||
145474165|NCT02607228|524587659|FG003|Overall Study|Study Terminated by Sponsor|1|||
145474166|NCT02607228|524587660|FG004|Overall Study|Study Terminated by Sponsor|0|||
145474167|NCT02607228|524587661|FG005|Overall Study|Study Terminated by Sponsor|0|||
145629893|NCT03523962|525157693|FG003|Closed Fractures|Lost to Follow-up|0|||
145629894|NCT03523962|525157690|FG000|Closed Fractures|Withdrawal by Subject|19|||
145629895|NCT03523962|525157691|FG001|Closed Fractures|Withdrawal by Subject|29|||
145629896|NCT03523962|525157692|FG002|Closed Fractures|Withdrawal by Subject|0|||
145629897|NCT03523962|525157693|FG003|Closed Fractures|Withdrawal by Subject|0|||
145629898|NCT03523962|525157690|FG000|Closed Fractures|Incarceration|1|||
145474168|NCT02607228|524587662|FG006|Overall Study|Study Terminated by Sponsor|0|||
145474169|NCT03235089|524587663|FG000|Overall Study|Lost to Follow-up|1|||
145474170|NCT03235089|524587664|FG001|Overall Study|Lost to Follow-up|1|||
145474171|NCT03235089|524587663|FG000|Overall Study|Physician Decision|2|||
145474172|NCT03235089|524587664|FG001|Overall Study|Physician Decision|2|||
145474173|NCT00559988|524587673|FG000|Overall Study|Death|147|||
145474174|NCT00559988|524587674|FG001|Overall Study|Death|140|||
145474175|NCT00559988|524587673|FG000|Overall Study|Withdrawal by Subject|152|||
145474176|NCT00559988|524587674|FG001|Overall Study|Withdrawal by Subject|139|||
145474177|NCT00559988|524587673|FG000|Overall Study|Lost to Follow-up|42|||
145474178|NCT00559988|524587674|FG001|Overall Study|Lost to Follow-up|56|||
145474179|NCT00559988|524587673|FG000|Overall Study|ICD device explanted|10|||
145474180|NCT00559988|524587674|FG001|Overall Study|ICD device explanted|17|||
145474181|NCT01196416|524587675|FG000|Overall Study|Withdrawal by Subject|2|||
145474182|NCT00788710|524587676|FG000|Overall Study|Adverse Event|1|||
145474183|NCT00788710|524587677|FG001|Overall Study|Adverse Event|3|||
145474184|NCT00788710|524587678|FG002|Overall Study|Adverse Event|4|||
145474185|NCT00788710|524587676|FG000|Overall Study|Lack of Efficacy|0|||
145474186|NCT00788710|524587677|FG001|Overall Study|Lack of Efficacy|0|||
145474187|NCT00788710|524587678|FG002|Overall Study|Lack of Efficacy|1|||
145474188|NCT00788710|524587676|FG000|Overall Study|Lost to Follow-up|0|||
145474189|NCT00788710|524587677|FG001|Overall Study|Lost to Follow-up|1|||
145474190|NCT00788710|524587678|FG002|Overall Study|Lost to Follow-up|0|||
145474191|NCT00788710|524587676|FG000|Overall Study|Physician Decision|2|||
145474192|NCT00788710|524587677|FG001|Overall Study|Physician Decision|1|||
145474193|NCT00788710|524587678|FG002|Overall Study|Physician Decision|0|||
145474194|NCT00788710|524587676|FG000|Overall Study|Protocol Violation|0|||
145474195|NCT00788710|524587677|FG001|Overall Study|Protocol Violation|1|||
145474196|NCT00788710|524587678|FG002|Overall Study|Protocol Violation|1|||
145474197|NCT00788710|524587676|FG000|Overall Study|Withdrawal by Subject|2|||
145474198|NCT00788710|524587677|FG001|Overall Study|Withdrawal by Subject|2|||
145474199|NCT00788710|524587678|FG002|Overall Study|Withdrawal by Subject|0|||
145474200|NCT01717326|524587681|FG000|Overall Study|Death|0|||
145474201|NCT01717326|524587682|FG001|Overall Study|Death|0|||
145474202|NCT01717326|524587683|FG002|Overall Study|Death|0|||
145474203|NCT01717326|524587684|FG003|Overall Study|Death|0|||
145474204|NCT01717326|524587685|FG004|Overall Study|Death|0|||
145474205|NCT01717326|524587686|FG005|Overall Study|Death|0|||
145474206|NCT01717326|524587687|FG006|Overall Study|Death|0|||
145474207|NCT01717326|524587688|FG007|Overall Study|Death|0|||
145474208|NCT01717326|524587689|FG008|Overall Study|Death|0|||
145474209|NCT01717326|524587690|FG009|Overall Study|Death|0|||
145474210|NCT01717326|524587691|FG010|Overall Study|Death|1|||
145474211|NCT01717326|524587692|FG011|Overall Study|Death|0|||
145474212|NCT01717326|524587693|FG012|Overall Study|Death|0|||
145474213|NCT01717326|524587694|FG013|Overall Study|Death|0|||
145474214|NCT01717326|524587695|FG014|Overall Study|Death|0|||
145474215|NCT01717326|524587696|FG015|Overall Study|Death|0|||
145474216|NCT01717326|524587697|FG016|Overall Study|Death|0|||
145474217|NCT01717326|524587698|FG017|Overall Study|Death|0|||
145474218|NCT01717326|524587699|FG018|Overall Study|Death|0|||
145474219|NCT01717326|524587700|FG019|Overall Study|Death|0|||
145474220|NCT01717326|524587681|FG000|Overall Study|Lost to Follow-up|3|||
145474221|NCT01717326|524587682|FG001|Overall Study|Lost to Follow-up|0|||
145474222|NCT01717326|524587683|FG002|Overall Study|Lost to Follow-up|0|||
145474223|NCT01717326|524587684|FG003|Overall Study|Lost to Follow-up|2|||
145474224|NCT01717326|524587685|FG004|Overall Study|Lost to Follow-up|1|||
145474225|NCT01717326|524587686|FG005|Overall Study|Lost to Follow-up|0|||
145474226|NCT01717326|524587687|FG006|Overall Study|Lost to Follow-up|1|||
145474227|NCT01717326|524587688|FG007|Overall Study|Lost to Follow-up|0|||
145474228|NCT01717326|524587689|FG008|Overall Study|Lost to Follow-up|0|||
145474229|NCT01717326|524587690|FG009|Overall Study|Lost to Follow-up|0|||
145474230|NCT01717326|524587691|FG010|Overall Study|Lost to Follow-up|1|||
145474231|NCT01717326|524587692|FG011|Overall Study|Lost to Follow-up|0|||
145474232|NCT01717326|524587693|FG012|Overall Study|Lost to Follow-up|0|||
145474233|NCT01717326|524587694|FG013|Overall Study|Lost to Follow-up|0|||
145474234|NCT01717326|524587695|FG014|Overall Study|Lost to Follow-up|0|||
145474235|NCT01717326|524587696|FG015|Overall Study|Lost to Follow-up|2|||
145474236|NCT01717326|524587697|FG016|Overall Study|Lost to Follow-up|1|||
145474237|NCT01717326|524587698|FG017|Overall Study|Lost to Follow-up|0|||
145474238|NCT01717326|524587699|FG018|Overall Study|Lost to Follow-up|2|||
145474239|NCT01717326|524587700|FG019|Overall Study|Lost to Follow-up|3|||
145474240|NCT01717326|524587681|FG000|Overall Study|Physician Decision|0|||
145474241|NCT01717326|524587682|FG001|Overall Study|Physician Decision|0|||
145474242|NCT01717326|524587683|FG002|Overall Study|Physician Decision|0|||
145474243|NCT01717326|524587684|FG003|Overall Study|Physician Decision|0|||
145629899|NCT03523962|525157691|FG001|Closed Fractures|Incarceration|4|||
145629900|NCT03523962|525157692|FG002|Closed Fractures|Incarceration|0|||
145629901|NCT03523962|525157693|FG003|Closed Fractures|Incarceration|0|||
145474244|NCT01717326|524587685|FG004|Overall Study|Physician Decision|0|||
145474245|NCT01717326|524587686|FG005|Overall Study|Physician Decision|0|||
145474246|NCT01717326|524587687|FG006|Overall Study|Physician Decision|0|||
145474247|NCT01717326|524587688|FG007|Overall Study|Physician Decision|0|||
145474248|NCT01717326|524587689|FG008|Overall Study|Physician Decision|0|||
145474249|NCT01717326|524587690|FG009|Overall Study|Physician Decision|1|||
145474250|NCT01717326|524587691|FG010|Overall Study|Physician Decision|0|||
145474251|NCT01717326|524587692|FG011|Overall Study|Physician Decision|0|||
145474252|NCT01717326|524587693|FG012|Overall Study|Physician Decision|0|||
145474253|NCT01717326|524587694|FG013|Overall Study|Physician Decision|0|||
145474254|NCT01717326|524587695|FG014|Overall Study|Physician Decision|0|||
145474255|NCT01717326|524587696|FG015|Overall Study|Physician Decision|0|||
145474256|NCT01717326|524587697|FG016|Overall Study|Physician Decision|0|||
145474257|NCT01717326|524587698|FG017|Overall Study|Physician Decision|0|||
145474258|NCT01717326|524587699|FG018|Overall Study|Physician Decision|0|||
145474259|NCT01717326|524587700|FG019|Overall Study|Physician Decision|0|||
145474260|NCT01717326|524587681|FG000|Overall Study|Protocol Violation|0|||
145474261|NCT01717326|524587682|FG001|Overall Study|Protocol Violation|0|||
145474262|NCT01717326|524587683|FG002|Overall Study|Protocol Violation|0|||
145474263|NCT01717326|524587684|FG003|Overall Study|Protocol Violation|0|||
145474264|NCT01717326|524587685|FG004|Overall Study|Protocol Violation|1|||
145474265|NCT01717326|524587686|FG005|Overall Study|Protocol Violation|0|||
145474266|NCT01717326|524587687|FG006|Overall Study|Protocol Violation|0|||
145474267|NCT01717326|524587688|FG007|Overall Study|Protocol Violation|0|||
145474268|NCT01717326|524587689|FG008|Overall Study|Protocol Violation|0|||
145474269|NCT01717326|524587690|FG009|Overall Study|Protocol Violation|0|||
145474270|NCT01717326|524587691|FG010|Overall Study|Protocol Violation|0|||
145474271|NCT01717326|524587692|FG011|Overall Study|Protocol Violation|0|||
145474272|NCT01717326|524587693|FG012|Overall Study|Protocol Violation|0|||
145474273|NCT01717326|524587694|FG013|Overall Study|Protocol Violation|0|||
145474274|NCT01717326|524587695|FG014|Overall Study|Protocol Violation|0|||
145474275|NCT01717326|524587696|FG015|Overall Study|Protocol Violation|0|||
145474276|NCT01717326|524587697|FG016|Overall Study|Protocol Violation|0|||
145474277|NCT01717326|524587698|FG017|Overall Study|Protocol Violation|0|||
145474278|NCT01717326|524587699|FG018|Overall Study|Protocol Violation|0|||
145474279|NCT01717326|524587700|FG019|Overall Study|Protocol Violation|0|||
145474280|NCT01717326|524587681|FG000|Overall Study|Withdrawal by Subject|0|||
145474281|NCT01717326|524587682|FG001|Overall Study|Withdrawal by Subject|1|||
145474282|NCT01717326|524587683|FG002|Overall Study|Withdrawal by Subject|0|||
145474283|NCT01717326|524587684|FG003|Overall Study|Withdrawal by Subject|0|||
145474284|NCT01717326|524587685|FG004|Overall Study|Withdrawal by Subject|0|||
145474285|NCT01717326|524587686|FG005|Overall Study|Withdrawal by Subject|0|||
145474286|NCT01717326|524587687|FG006|Overall Study|Withdrawal by Subject|0|||
145474287|NCT01717326|524587688|FG007|Overall Study|Withdrawal by Subject|0|||
145474288|NCT01717326|524587689|FG008|Overall Study|Withdrawal by Subject|0|||
145474289|NCT01717326|524587690|FG009|Overall Study|Withdrawal by Subject|1|||
145474290|NCT01717326|524587691|FG010|Overall Study|Withdrawal by Subject|0|||
145474291|NCT01717326|524587692|FG011|Overall Study|Withdrawal by Subject|0|||
145474292|NCT01717326|524587693|FG012|Overall Study|Withdrawal by Subject|1|||
145474293|NCT01717326|524587694|FG013|Overall Study|Withdrawal by Subject|0|||
145474294|NCT01717326|524587695|FG014|Overall Study|Withdrawal by Subject|0|||
145474295|NCT01717326|524587696|FG015|Overall Study|Withdrawal by Subject|1|||
145474296|NCT01717326|524587697|FG016|Overall Study|Withdrawal by Subject|0|||
145474297|NCT01717326|524587698|FG017|Overall Study|Withdrawal by Subject|0|||
145474298|NCT01717326|524587699|FG018|Overall Study|Withdrawal by Subject|2|||
145474299|NCT01717326|524587700|FG019|Overall Study|Withdrawal by Subject|3|||
145474300|NCT01123707|524587701|FG000|Overall Study|Lost to Follow-up|3|||
145474301|NCT01123707|524587702|FG001|Overall Study|Lost to Follow-up|1|||
145474302|NCT01123707|524587703|FG002|Overall Study|Lost to Follow-up|3|||
145474303|NCT01123707|524587704|FG003|Overall Study|Lost to Follow-up|2|||
145474304|NCT01123707|524587701|FG000|Overall Study|Adverse Event|5|||
145474305|NCT01123707|524587702|FG001|Overall Study|Adverse Event|7|||
145474306|NCT01123707|524587703|FG002|Overall Study|Adverse Event|5|||
145474307|NCT01123707|524587704|FG003|Overall Study|Adverse Event|3|||
145474308|NCT01123707|524587701|FG000|Overall Study|Sponsor Discontinued Study|30|||
145474309|NCT01123707|524587702|FG001|Overall Study|Sponsor Discontinued Study|24|||
145474310|NCT01123707|524587703|FG002|Overall Study|Sponsor Discontinued Study|25|||
145474311|NCT01123707|524587704|FG003|Overall Study|Sponsor Discontinued Study|40|||
145474312|NCT01123707|524587701|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
145474313|NCT01123707|524587702|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
145629902|NCT03523962|525157690|FG000|Open Fractures|Death|0|||
145629903|NCT03523962|525157691|FG001|Open Fractures|Death|0|||
145474314|NCT01123707|524587703|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
145474315|NCT01123707|524587704|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
145474316|NCT01123707|524587701|FG000|Overall Study|Investigator Withdrew Participant|0|||
145474317|NCT01123707|524587702|FG001|Overall Study|Investigator Withdrew Participant|1|||
145474318|NCT01123707|524587703|FG002|Overall Study|Investigator Withdrew Participant|1|||
145474319|NCT01123707|524587704|FG003|Overall Study|Investigator Withdrew Participant|1|||
145474320|NCT01123707|524587701|FG000|Overall Study|Subject Withdrew Consent|4|||
145629904|NCT03523962|525157692|FG002|Open Fractures|Death|11|||
145474321|NCT01123707|524587702|FG001|Overall Study|Subject Withdrew Consent|5|||
145474322|NCT01123707|524587703|FG002|Overall Study|Subject Withdrew Consent|1|||
145474323|NCT01123707|524587704|FG003|Overall Study|Subject Withdrew Consent|2|||
145474324|NCT01123707|524587701|FG000|Overall Study|Lack of Efficacy|1|||
145474325|NCT01123707|524587702|FG001|Overall Study|Lack of Efficacy|2|||
145474326|NCT01123707|524587703|FG002|Overall Study|Lack of Efficacy|1|||
145474327|NCT01123707|524587704|FG003|Overall Study|Lack of Efficacy|0|||
145474328|NCT01123707|524587701|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
145474329|NCT01123707|524587702|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
145474330|NCT01123707|524587703|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
145474331|NCT01123707|524587704|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
145474332|NCT03210961|524590000|FG000|Overall Study|Adverse Event|0|||
145474333|NCT03210961|524590001|FG001|Overall Study|Adverse Event|0|||
145474334|NCT03210961|524590002|FG002|Overall Study|Adverse Event|0|||
145474335|NCT03210961|524590003|FG003|Overall Study|Adverse Event|0|||
145474336|NCT03210961|524590004|FG004|Overall Study|Adverse Event|0|||
145474337|NCT03210961|524590005|FG005|Overall Study|Adverse Event|0|||
145474338|NCT03210961|524590006|FG006|Overall Study|Adverse Event|0|||
145474339|NCT03210961|524590007|FG007|Overall Study|Adverse Event|0|||
145474340|NCT03210961|524590008|FG008|Overall Study|Adverse Event|0|||
145474341|NCT03210961|524590009|FG009|Overall Study|Adverse Event|0|||
145474342|NCT03210961|524590010|FG010|Overall Study|Adverse Event|0|||
145474343|NCT03210961|524590011|FG011|Overall Study|Adverse Event|0|||
145474344|NCT03210961|524590012|FG012|Overall Study|Adverse Event|0|||
145474345|NCT03210961|524590013|FG013|Overall Study|Adverse Event|1|||
145474346|NCT03210961|524590014|FG014|Overall Study|Adverse Event|0|||
145474347|NCT03210961|524590000|FG000|Overall Study|Lost to Follow-up|0|||
145474348|NCT03210961|524590001|FG001|Overall Study|Lost to Follow-up|0|||
145474349|NCT03210961|524590002|FG002|Overall Study|Lost to Follow-up|0|||
145474350|NCT03210961|524590003|FG003|Overall Study|Lost to Follow-up|0|||
145474351|NCT03210961|524590004|FG004|Overall Study|Lost to Follow-up|0|||
145474352|NCT03210961|524590005|FG005|Overall Study|Lost to Follow-up|0|||
145474353|NCT03210961|524590006|FG006|Overall Study|Lost to Follow-up|0|||
145474354|NCT03210961|524590007|FG007|Overall Study|Lost to Follow-up|0|||
145474355|NCT03210961|524590008|FG008|Overall Study|Lost to Follow-up|0|||
145629905|NCT03523962|525157693|FG003|Open Fractures|Death|6|||
145629906|NCT03523962|525157690|FG000|Open Fractures|Lost to Follow-up|0|||
145629907|NCT03523962|525157691|FG001|Open Fractures|Lost to Follow-up|0|||
145629908|NCT03523962|525157692|FG002|Open Fractures|Lost to Follow-up|15|||
145629909|NCT03523962|525157693|FG003|Open Fractures|Lost to Follow-up|8|||
145629910|NCT03523962|525157690|FG000|Open Fractures|Withdrawal by Subject|0|||
145629911|NCT03523962|525157691|FG001|Open Fractures|Withdrawal by Subject|0|||
145629912|NCT03523962|525157692|FG002|Open Fractures|Withdrawal by Subject|6|||
145629913|NCT03523962|525157693|FG003|Open Fractures|Withdrawal by Subject|2|||
145629914|NCT03523962|525157690|FG000|Open Fractures|Incarceration|0|||
145629915|NCT03523962|525157691|FG001|Open Fractures|Incarceration|0|||
145629916|NCT03523962|525157692|FG002|Open Fractures|Incarceration|1|||
145629917|NCT03523962|525157693|FG003|Open Fractures|Incarceration|0|||
145629918|NCT01081145|525157696|FG000|Open-Label Phase|Lack of Efficacy|56|||
145629919|NCT01081145|525157697|FG001|Open-Label Phase|Lack of Efficacy|0|||
145629920|NCT01081145|525157696|FG000|Open-Label Phase|Response criteria not met|46|||
145629921|NCT01081145|525157697|FG001|Open-Label Phase|Response criteria not met|0|||
145629922|NCT01081145|525157696|FG000|Open-Label Phase|Adverse Event|42|||
145629923|NCT01081145|525157697|FG001|Open-Label Phase|Adverse Event|0|||
145629924|NCT01081145|525157696|FG000|Open-Label Phase|Withdrawal by Subject|41|||
145629925|NCT01081145|525157697|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145629926|NCT01081145|525157696|FG000|Open-Label Phase|Other|12|||
145629927|NCT01081145|525157697|FG001|Open-Label Phase|Other|0|||
145629928|NCT01081145|525157696|FG000|Open-Label Phase|Lost to Follow-up|11|||
145474356|NCT03210961|524590009|FG009|Overall Study|Lost to Follow-up|0|||
145474357|NCT03210961|524590010|FG010|Overall Study|Lost to Follow-up|0|||
145474358|NCT03210961|524590011|FG011|Overall Study|Lost to Follow-up|0|||
145474359|NCT03210961|524590012|FG012|Overall Study|Lost to Follow-up|0|||
145474360|NCT03210961|524590013|FG013|Overall Study|Lost to Follow-up|0|||
145474361|NCT03210961|524590014|FG014|Overall Study|Lost to Follow-up|1|||
145474362|NCT03210961|524590000|FG000|Overall Study|Withdrawal by Subject|0|||
145474363|NCT03210961|524590001|FG001|Overall Study|Withdrawal by Subject|0|||
145629929|NCT01081145|525157697|FG001|Open-Label Phase|Lost to Follow-up|0|||
145474364|NCT03210961|524590002|FG002|Overall Study|Withdrawal by Subject|0|||
145629930|NCT01081145|525157696|FG000|Open-Label Phase|Protocol Violation|4|||
145629931|NCT01081145|525157697|FG001|Open-Label Phase|Protocol Violation|0|||
145629932|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
145474365|NCT03210961|524590003|FG003|Overall Study|Withdrawal by Subject|0|||
145474366|NCT03210961|524590004|FG004|Overall Study|Withdrawal by Subject|0|||
145474367|NCT03210961|524590005|FG005|Overall Study|Withdrawal by Subject|0|||
145629933|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
145629934|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
145629935|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
145474368|NCT03210961|524590006|FG006|Overall Study|Withdrawal by Subject|0|||
145474369|NCT03210961|524590007|FG007|Overall Study|Withdrawal by Subject|0|||
145474370|NCT03210961|524590008|FG008|Overall Study|Withdrawal by Subject|0|||
145474371|NCT03210961|524590009|FG009|Overall Study|Withdrawal by Subject|0|||
145474372|NCT03210961|524590010|FG010|Overall Study|Withdrawal by Subject|0|||
145474373|NCT03210961|524590011|FG011|Overall Study|Withdrawal by Subject|0|||
145474374|NCT03210961|524590012|FG012|Overall Study|Withdrawal by Subject|0|||
145474375|NCT03210961|524590013|FG013|Overall Study|Withdrawal by Subject|0|||
145629936|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
145629937|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
145629938|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
145629939|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
145629940|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
145629941|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
145629942|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
145629943|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
145629944|NCT01081145|525157696|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
145629945|NCT01081145|525157697|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
145629946|NCT00121199|525157698|FG000|Overall Study|Adverse Event|11|||
145629947|NCT00121199|525157698|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
145629948|NCT00121199|525157698|FG000|Overall Study|Progression/Relapse|1|||
145474376|NCT03210961|524590014|FG014|Overall Study|Withdrawal by Subject|1|||
145474377|NCT03210961|524590000|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474378|NCT03210961|524590001|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474379|NCT03210961|524590002|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474380|NCT03210961|524590003|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474381|NCT03210961|524590004|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474382|NCT03210961|524590005|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474383|NCT03210961|524590006|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474384|NCT03210961|524590007|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474385|NCT03210961|524590008|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474386|NCT03210961|524590009|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474387|NCT03210961|524590010|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474388|NCT03210961|524590011|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474389|NCT03210961|524590012|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474390|NCT03210961|524590013|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
145474391|NCT03210961|524590014|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
145474392|NCT03210961|524590000|FG000|Overall Study|Other|0|||
145474393|NCT03210961|524590001|FG001|Overall Study|Other|0|||
145474394|NCT03210961|524590002|FG002|Overall Study|Other|0|||
145474395|NCT03210961|524590003|FG003|Overall Study|Other|1|||
145474396|NCT03210961|524590004|FG004|Overall Study|Other|0|||
145474397|NCT03210961|524590005|FG005|Overall Study|Other|0|||
145474398|NCT03210961|524590006|FG006|Overall Study|Other|1|||
145474399|NCT03210961|524590007|FG007|Overall Study|Other|0|||
145474400|NCT03210961|524590008|FG008|Overall Study|Other|0|||
145474401|NCT03210961|524590009|FG009|Overall Study|Other|0|||
145474402|NCT03210961|524590010|FG010|Overall Study|Other|1|||
145474403|NCT03210961|524590011|FG011|Overall Study|Other|0|||
145474404|NCT03210961|524590012|FG012|Overall Study|Other|2|||
145474405|NCT03210961|524590013|FG013|Overall Study|Other|2|||
145474406|NCT03210961|524590014|FG014|Overall Study|Other|0|||
145474407|NCT02467582|524590015|FG000|Allocation|Withdrawal by Subject|1|||
145474408|NCT02467582|524590016|FG001|Allocation|Withdrawal by Subject|0|||
145474409|NCT02467582|524590015|FG000|Follow-up|Death|5|||
145474410|NCT02467582|524590016|FG001|Follow-up|Death|4|||
145474411|NCT02467582|524590015|FG000|Follow-up|Lost to Follow-up|6|||
145474412|NCT02467582|524590016|FG001|Follow-up|Lost to Follow-up|5|||
145474413|NCT00703924|524590017|FG000|Overall Study|Withdrawal by Subject|1|||
145474414|NCT00703924|524590018|FG001|Overall Study|Withdrawal by Subject|1|||
145474415|NCT01031979|524590021|FG000|Overall Study|Lost to Follow-up|5|||
145474416|NCT01031979|524590022|FG001|Overall Study|Lost to Follow-up|4|||
145474417|NCT03592368|524590024|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
145474418|NCT03592368|524590025|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
145474419|NCT03592368|524590026|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
145474420|NCT03592368|524590027|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
145474421|NCT03592368|524590024|FG000|Overall Study|Adverse Event|0|||
145629949|NCT00121199|525157698|FG000|Overall Study|Death|3|||
145629950|NCT00121199|525157698|FG000|Overall Study|Other - Not Protocol Specified|3|||
145474422|NCT03592368|524590025|FG001|Overall Study|Adverse Event|0|||
145474423|NCT03592368|524590026|FG002|Overall Study|Adverse Event|0|||
145474424|NCT03592368|524590027|FG003|Overall Study|Adverse Event|1|||
145474425|NCT03592368|524590024|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
145474426|NCT03592368|524590025|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
145629951|NCT00121199|525157698|FG000|Overall Study|Ineligible|9|||
145629952|NCT01018511|525157704|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
145629953|NCT01018511|525157705|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
145629954|NCT01018511|525157706|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
145629955|NCT01018511|525157707|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
145629956|NCT01018511|525157704|FG000|Overall Study|Adverse Event|5|||
145629957|NCT01018511|525157705|FG001|Overall Study|Adverse Event|9|||
145629958|NCT01018511|525157706|FG002|Overall Study|Adverse Event|13|||
145629959|NCT01018511|525157707|FG003|Overall Study|Adverse Event|10|||
145629960|NCT01018511|525157704|FG000|Overall Study|Lack of Efficacy|4|||
145474427|NCT03592368|524590026|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
145474428|NCT03592368|524590027|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
145474429|NCT03831100|524590028|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
145474430|NCT03831100|524590029|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
145474431|NCT03354273|524590037|FG000|Overall Study|Adverse Event|5|||
145474432|NCT03354273|524590037|FG000|Overall Study|Screen Failure|21|||
145474433|NCT03354273|524590037|FG000|Overall Study|Withdrawal by Subject|34|||
145474434|NCT03354273|524590037|FG000|Overall Study|Technical Problems|30|||
145474435|NCT03354273|524590037|FG000|Overall Study|Lost to Follow-up|4|||
145474436|NCT03354273|524590037|FG000|Overall Study|Investigator Decision|3|||
145474437|NCT03354273|524590037|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
145474438|NCT03354273|524590037|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
145474439|NCT03354273|524590037|FG000|Overall Study|COVID-19 Restrictions|9|||
145474440|NCT03354273|524590037|FG000|Overall Study|Other|5|||
145474441|NCT00705367|524590040|FG000|Long-term Extension Period|Adverse Event|2|||
145474442|NCT00705367|524590041|FG001|Long-term Extension Period|Adverse Event|0|||
145474443|NCT00705367|524590040|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
145474444|NCT00705367|524590041|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
145474445|NCT00705367|524590040|FG000|Long-term Extension Period|Lack of Efficacy|1|||
145474446|NCT00705367|524590041|FG001|Long-term Extension Period|Lack of Efficacy|0|||
145474447|NCT00705367|524590040|FG000|Long-term Extension Period|No longer met study criteria|1|||
145474448|NCT00705367|524590041|FG001|Long-term Extension Period|No longer met study criteria|0|||
145474449|NCT00705367|524590040|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
145474450|NCT00705367|524590041|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
145474451|NCT01959139|524590045|FG000|Phase II|Disease progression|0|||
145474452|NCT01959139|524590046|FG001|Phase II|Disease progression|0|||
145474453|NCT01959139|524590047|FG002|Phase II|Disease progression|26|||
145474454|NCT01959139|524590048|FG003|Phase II|Disease progression|34|||
145474455|NCT01959139|524590045|FG000|Phase II|Adverse Event|0|||
145474456|NCT01959139|524590046|FG001|Phase II|Adverse Event|0|||
145474457|NCT01959139|524590047|FG002|Phase II|Adverse Event|10|||
145474458|NCT01959139|524590048|FG003|Phase II|Adverse Event|11|||
145474459|NCT01959139|524590045|FG000|Phase II|Patient Refusal|0|||
145474460|NCT01959139|524590046|FG001|Phase II|Patient Refusal|0|||
145474461|NCT01959139|524590047|FG002|Phase II|Patient Refusal|5|||
145474462|NCT01959139|524590048|FG003|Phase II|Patient Refusal|4|||
145474463|NCT01959139|524590045|FG000|Phase II|Death|0|||
145474464|NCT01959139|524590046|FG001|Phase II|Death|0|||
145474465|NCT01959139|524590047|FG002|Phase II|Death|3|||
145474466|NCT01959139|524590048|FG003|Phase II|Death|1|||
145474467|NCT01959139|524590045|FG000|Phase II|Other/Unknown|0|||
145474468|NCT01959139|524590046|FG001|Phase II|Other/Unknown|0|||
145474469|NCT01959139|524590047|FG002|Phase II|Other/Unknown|8|||
145474470|NCT01959139|524590048|FG003|Phase II|Other/Unknown|5|||
145474471|NCT01959139|524590045|FG000|Phase II|On treatment|0|||
145474472|NCT01959139|524590046|FG001|Phase II|On treatment|0|||
145474473|NCT01959139|524590047|FG002|Phase II|On treatment|4|||
145474474|NCT01959139|524590048|FG003|Phase II|On treatment|0|||
145474475|NCT03679624|524590049|FG000|Overall Study|Adverse Event|1|||
145474476|NCT03679624|524590050|FG001|Overall Study|Adverse Event|0|||
145474477|NCT02629822|524590051|FG000|Base Study|Lost to Follow-up|2|||
145474478|NCT02629822|524590051|FG000|Base Study|Non-Compliance With Study Drug|1|||
145474479|NCT02629822|524590051|FG000|Extension Study|Adverse Event|1|||
145474480|NCT02629822|524590051|FG000|Extension Study|Lost to Follow-up|1|||
145474481|NCT00741013|524590052|FG000|Overall Study|Adverse Event|1|||
145474482|NCT00741013|524590053|FG001|Overall Study|Adverse Event|0|||
145474483|NCT00741013|524590054|FG002|Overall Study|Adverse Event|0|||
145474484|NCT00741013|524590052|FG000|Overall Study|Withdrawal by Subject|0|||
145629961|NCT01018511|525157705|FG001|Overall Study|Lack of Efficacy|1|||
145629962|NCT01018511|525157706|FG002|Overall Study|Lack of Efficacy|1|||
145629963|NCT01018511|525157707|FG003|Overall Study|Lack of Efficacy|2|||
145629964|NCT01018511|525157704|FG000|Overall Study|Withdrawal by Subject|6|||
145474485|NCT00741013|524590053|FG001|Overall Study|Withdrawal by Subject|0|||
145474486|NCT00741013|524590054|FG002|Overall Study|Withdrawal by Subject|1|||
145474487|NCT00741013|524590052|FG000|Overall Study|Discovered failed screen after enrolled|0|||
145474488|NCT00741013|524590053|FG001|Overall Study|Discovered failed screen after enrolled|2|||
145474489|NCT00741013|524590054|FG002|Overall Study|Discovered failed screen after enrolled|0|||
145474490|NCT00082407|524590055|FG000|Overall Study|Adverse Event|20|||
145474491|NCT00082407|524590056|FG001|Overall Study|Adverse Event|0|||
145474492|NCT00082407|524590055|FG000|Overall Study|Protocol Violation|14|||
145474493|NCT00082407|524590056|FG001|Overall Study|Protocol Violation|12|||
145474494|NCT00082407|524590055|FG000|Overall Study|Patient Decision|13|||
145474495|NCT00082407|524590056|FG001|Overall Study|Patient Decision|6|||
145474496|NCT00082407|524590055|FG000|Overall Study|Physician Decision|5|||
145474497|NCT00082407|524590056|FG001|Overall Study|Physician Decision|3|||
145474498|NCT00082407|524590055|FG000|Overall Study|Loss of Glucose Control|2|||
145474499|NCT00082407|524590056|FG001|Overall Study|Loss of Glucose Control|2|||
145474500|NCT00082407|524590055|FG000|Overall Study|Death|2|||
145474501|NCT00082407|524590056|FG001|Overall Study|Death|1|||
145474502|NCT00082407|524590055|FG000|Overall Study|Lost to Follow-up|0|||
145474503|NCT00082407|524590056|FG001|Overall Study|Lost to Follow-up|3|||
145474504|NCT00858208|524590057|FG000|Overall Study|Adverse Event|3|||
145474505|NCT00858208|524590057|FG000|Overall Study|Lost to Follow-up|26|||
145474506|NCT00858208|524590057|FG000|Overall Study|Participant refused|40|||
145474507|NCT00858208|524590057|FG000|Overall Study|Other|10|||
145474508|NCT02352753|524590058|FG000|6-Month Dosing Period|Decision by sponsor|2|||
145474509|NCT02352753|524590058|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
145474510|NCT02352753|524590058|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
145474511|NCT02352753|524590058|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
145474512|NCT02352753|524590058|FG000|3-Month Dosing Period|Decision by sponsor|14|||
145474513|NCT02352753|524590058|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
145474514|NCT00539305|524590059|FG000|Overall Study|Adverse Event|1|||
145474515|NCT00539305|524590060|FG001|Overall Study|Adverse Event|0|||
145474516|NCT00539305|524590059|FG000|Overall Study|Substance Use|0|||
145474517|NCT00539305|524590060|FG001|Overall Study|Substance Use|1|||
145474518|NCT00539305|524590059|FG000|Overall Study|Withdrawal by Subject|0|||
145474519|NCT00539305|524590060|FG001|Overall Study|Withdrawal by Subject|1|||
145474520|NCT01393639|524590064|FG000|Overall Study|Protocol Violation|0|||
145474521|NCT01393639|524590065|FG001|Overall Study|Protocol Violation|0|||
145474522|NCT01393639|524590066|FG002|Overall Study|Protocol Violation|0|||
145474523|NCT01393639|524590067|FG003|Overall Study|Protocol Violation|1|||
145474524|NCT01393639|524590068|FG004|Overall Study|Protocol Violation|0|||
145474525|NCT01393639|524590069|FG005|Overall Study|Protocol Violation|0|||
145474526|NCT01393639|524590070|FG006|Overall Study|Protocol Violation|0|||
145474527|NCT01393639|524590064|FG000|Overall Study|Other|0|||
145474528|NCT01393639|524590065|FG001|Overall Study|Other|2|||
145474529|NCT01393639|524590066|FG002|Overall Study|Other|0|||
145474530|NCT01393639|524590067|FG003|Overall Study|Other|2|||
145474531|NCT01393639|524590068|FG004|Overall Study|Other|1|||
145474532|NCT01393639|524590069|FG005|Overall Study|Other|0|||
145474533|NCT01393639|524590070|FG006|Overall Study|Other|1|||
145474534|NCT01393639|524590064|FG000|Overall Study|Withdrawal by Subject|1|||
145474535|NCT01393639|524590065|FG001|Overall Study|Withdrawal by Subject|1|||
145474536|NCT01393639|524590066|FG002|Overall Study|Withdrawal by Subject|0|||
145474537|NCT01393639|524590067|FG003|Overall Study|Withdrawal by Subject|0|||
145474538|NCT01393639|524590068|FG004|Overall Study|Withdrawal by Subject|0|||
145474539|NCT01393639|524590069|FG005|Overall Study|Withdrawal by Subject|0|||
145474540|NCT01393639|524590070|FG006|Overall Study|Withdrawal by Subject|1|||
145474541|NCT01393639|524590064|FG000|Overall Study|Medication error without associated AE|0|||
145474542|NCT01393639|524590065|FG001|Overall Study|Medication error without associated AE|0|||
145474543|NCT01393639|524590066|FG002|Overall Study|Medication error without associated AE|0|||
145474544|NCT01393639|524590067|FG003|Overall Study|Medication error without associated AE|0|||
145474545|NCT01393639|524590068|FG004|Overall Study|Medication error without associated AE|0|||
145474546|NCT01393639|524590069|FG005|Overall Study|Medication error without associated AE|0|||
145474547|NCT01393639|524590070|FG006|Overall Study|Medication error without associated AE|1|||
145474548|NCT01393639|524590064|FG000|Overall Study|Lost to Follow-up|0|||
145474549|NCT01393639|524590065|FG001|Overall Study|Lost to Follow-up|1|||
145474550|NCT01393639|524590066|FG002|Overall Study|Lost to Follow-up|0|||
145474551|NCT01393639|524590067|FG003|Overall Study|Lost to Follow-up|0|||
145474552|NCT01393639|524590068|FG004|Overall Study|Lost to Follow-up|0|||
145474553|NCT01393639|524590069|FG005|Overall Study|Lost to Follow-up|0|||
145474554|NCT01393639|524590070|FG006|Overall Study|Lost to Follow-up|1|||
145474555|NCT01393639|524590064|FG000|Overall Study|Lack of Efficacy|0|||
145474556|NCT01393639|524590065|FG001|Overall Study|Lack of Efficacy|0|||
145474557|NCT01393639|524590066|FG002|Overall Study|Lack of Efficacy|0|||
145474558|NCT01393639|524590067|FG003|Overall Study|Lack of Efficacy|0|||
145474559|NCT01393639|524590068|FG004|Overall Study|Lack of Efficacy|0|||
145474560|NCT01393639|524590069|FG005|Overall Study|Lack of Efficacy|0|||
145474561|NCT01393639|524590070|FG006|Overall Study|Lack of Efficacy|1|||
145474562|NCT01393639|524590064|FG000|Overall Study|Adverse Event|2|||
145474563|NCT01393639|524590065|FG001|Overall Study|Adverse Event|3|||
145474564|NCT01393639|524590066|FG002|Overall Study|Adverse Event|1|||
145474565|NCT01393639|524590067|FG003|Overall Study|Adverse Event|2|||
145474566|NCT01393639|524590068|FG004|Overall Study|Adverse Event|0|||
145474567|NCT01393639|524590069|FG005|Overall Study|Adverse Event|2|||
145474568|NCT01393639|524590070|FG006|Overall Study|Adverse Event|3|||
145474569|NCT01440816|524590071|FG000|Overall Study|Disease Progression|0|||
145629965|NCT01018511|525157705|FG001|Overall Study|Withdrawal by Subject|5|||
145629966|NCT01018511|525157706|FG002|Overall Study|Withdrawal by Subject|11|||
145629967|NCT01018511|525157707|FG003|Overall Study|Withdrawal by Subject|9|||
145629968|NCT01018511|525157704|FG000|Overall Study|Lost to Follow-up|0|||
145629969|NCT01018511|525157705|FG001|Overall Study|Lost to Follow-up|0|||
145474570|NCT01440816|524590072|FG001|Overall Study|Disease Progression|9|||
145474571|NCT01440816|524590071|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
145474572|NCT01440816|524590072|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
145474573|NCT02942485|524590075|FG000|Overall Study|Lost to Follow-up|1|||
145474574|NCT02942485|524590076|FG001|Overall Study|Lost to Follow-up|0|||
145474575|NCT02516592|524590079|FG000|Overall Study|Patient withdrew consent|5|||
145474576|NCT02516592|524590080|FG001|Overall Study|Patient withdrew consent|2|||
145474577|NCT02516592|524590079|FG000|Overall Study|Protocol deviation|4|||
145474578|NCT02516592|524590080|FG001|Overall Study|Protocol deviation|4|||
145474579|NCT02516592|524590079|FG000|Overall Study|Lost to Follow-up|2|||
145474580|NCT02516592|524590080|FG001|Overall Study|Lost to Follow-up|3|||
145474581|NCT02516592|524590079|FG000|Overall Study|Patient/guardian decision|2|||
145474582|NCT02516592|524590080|FG001|Overall Study|Patient/guardian decision|1|||
145474583|NCT02516592|524590079|FG000|Overall Study|Adverse Event|1|||
145474584|NCT02516592|524590080|FG001|Overall Study|Adverse Event|2|||
145629970|NCT01018511|525157706|FG002|Overall Study|Lost to Follow-up|1|||
145629971|NCT01018511|525157707|FG003|Overall Study|Lost to Follow-up|0|||
145629972|NCT01018511|525157704|FG000|Overall Study|Protocol Violation|5|||
145629973|NCT01018511|525157705|FG001|Overall Study|Protocol Violation|8|||
145629974|NCT01018511|525157706|FG002|Overall Study|Protocol Violation|7|||
145629975|NCT01018511|525157707|FG003|Overall Study|Protocol Violation|9|||
145629976|NCT01018511|525157704|FG000|Overall Study|Miscellaneous|0|||
145629977|NCT01018511|525157705|FG001|Overall Study|Miscellaneous|2|||
145629978|NCT01018511|525157706|FG002|Overall Study|Miscellaneous|0|||
145629979|NCT01018511|525157707|FG003|Overall Study|Miscellaneous|0|||
145629980|NCT04305912|525157708|FG000|First Intervention|COVID-19 Suspension|2|||
145629981|NCT04305912|525157709|FG001|First Intervention|COVID-19 Suspension|0|||
145629982|NCT04305912|525157708|FG000|First Intervention|Withdrawal by Subject|0|||
145629983|NCT04305912|525157709|FG001|First Intervention|Withdrawal by Subject|1|||
145629984|NCT04305912|525157708|FG000|Second Intervention|Adverse Event|0|||
145629985|NCT04305912|525157709|FG001|Second Intervention|Adverse Event|1|||
145629986|NCT01333514|525157711|FG000|Overall Study|Withdrawal by Subject|1|||
145629987|NCT01333514|525157712|FG001|Overall Study|Withdrawal by Subject|0|||
145629988|NCT05273801|525157717|FG000|Overall Study|Physician Decision|1|||
145629989|NCT01645111|525158986|FG000|Overall Study|Did not require Clevidipine|15|||
145629990|NCT03068468|525158987|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
145629991|NCT03068468|525158988|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
145629992|NCT03068468|525158989|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
145629993|NCT03068468|525158990|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
145629994|NCT03068468|525158987|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
145629995|NCT03068468|525158988|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
145629996|NCT03068468|525158989|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
145629997|NCT03068468|525158990|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
145629998|NCT03068468|525158987|FG000|Placebo-Controlled Period|Adverse Event|16|||
145629999|NCT03068468|525158988|FG001|Placebo-Controlled Period|Adverse Event|21|||
145630000|NCT03068468|525158989|FG002|Placebo-Controlled Period|Adverse Event|0|||
145630001|NCT03068468|525158990|FG003|Placebo-Controlled Period|Adverse Event|0|||
145630002|NCT03068468|525158987|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
145630003|NCT03068468|525158988|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
145630004|NCT03068468|525158989|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
145630005|NCT03068468|525158990|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
145630006|NCT03068468|525158987|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
145630007|NCT03068468|525158988|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
145630008|NCT03068468|525158989|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145630009|NCT03068468|525158990|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145474585|NCT02516592|524590079|FG000|Overall Study|Abnormal test procedure result|1|||
145474586|NCT02516592|524590080|FG001|Overall Study|Abnormal test procedure result|0|||
145474587|NCT02516592|524590079|FG000|Overall Study|Death|1|||
145474588|NCT02516592|524590080|FG001|Overall Study|Death|1|||
145474589|NCT01110382|524590082|FG000|Overall Study|Withdrawal by Subject|0|||
145474590|NCT01110382|524590083|FG001|Overall Study|Withdrawal by Subject|1|||
145630010|NCT03068468|525158987|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
145630011|NCT03068468|525158988|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
145630012|NCT03068468|525158989|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
145630013|NCT03068468|525158990|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
145474591|NCT01110382|524590082|FG000|Overall Study|Protocol Violation|0|||
145474592|NCT01110382|524590083|FG001|Overall Study|Protocol Violation|1|||
145630014|NCT03068468|525158987|FG000|Placebo-Controlled Period|Death|0|||
145630015|NCT03068468|525158988|FG001|Placebo-Controlled Period|Death|1|||
145630016|NCT03068468|525158989|FG002|Placebo-Controlled Period|Death|0|||
145630017|NCT03068468|525158990|FG003|Placebo-Controlled Period|Death|0|||
145630018|NCT03068468|525158987|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
145630019|NCT03068468|525158988|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
145630020|NCT03068468|525158989|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
145630021|NCT03068468|525158990|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
145630022|NCT03068468|525158987|FG000|Open-Label Extension Period|Adverse Event|0|||
145630023|NCT03068468|525158988|FG001|Open-Label Extension Period|Adverse Event|0|||
145630024|NCT03068468|525158989|FG002|Open-Label Extension Period|Adverse Event|13|||
145630025|NCT03068468|525158990|FG003|Open-Label Extension Period|Adverse Event|17|||
145630026|NCT03068468|525158987|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
145630027|NCT03068468|525158988|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
145630028|NCT03068468|525158989|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
145474593|NCT00098306|524590084|FG000|Double Blind|Randomized, not treated|9|||
145474594|NCT00098306|524590085|FG001|Double Blind|Randomized, not treated|5|||
145630029|NCT03068468|525158990|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
145630030|NCT03068468|525158987|FG000|Open-Label Extension Period|Death|0|||
145630031|NCT03068468|525158988|FG001|Open-Label Extension Period|Death|0|||
145474595|NCT00098306|524590086|FG002|Double Blind|Randomized, not treated|2|||
145474596|NCT00098306|524590087|FG003|Double Blind|Randomized, not treated|0|||
145474597|NCT00098306|524590088|FG004|Double Blind|Randomized, not treated|0|||
145474598|NCT00098306|524590089|FG005|Double Blind|Randomized, not treated|0|||
145630032|NCT03068468|525158989|FG002|Open-Label Extension Period|Death|0|||
145630033|NCT03068468|525158990|FG003|Open-Label Extension Period|Death|1|||
145630034|NCT03068468|525158987|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
145630035|NCT03068468|525158988|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
145630036|NCT03068468|525158989|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
145630037|NCT03068468|525158990|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
145630038|NCT03068468|525158987|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
145630039|NCT03068468|525158988|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
145630040|NCT03068468|525158989|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
145630041|NCT03068468|525158990|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
145630042|NCT03068468|525158987|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
145630043|NCT03068468|525158988|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
145630044|NCT03068468|525158989|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
145630045|NCT03068468|525158990|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
145630046|NCT03068468|525158987|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
145630047|NCT03068468|525158988|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
145630048|NCT03068468|525158989|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
145630049|NCT03068468|525158990|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
145630050|NCT03068468|525158987|FG000|Open-Label Extension Period|Reason not Specified|0|||
145474599|NCT00098306|524590090|FG006|Double Blind|Randomized, not treated|0|||
145474600|NCT00098306|524590084|FG000|Double Blind|Ongoing at cut-off date|151|||
145474601|NCT00098306|524590085|FG001|Double Blind|Ongoing at cut-off date|166|||
145474602|NCT00098306|524590086|FG002|Double Blind|Ongoing at cut-off date|72|||
145474603|NCT00098306|524590087|FG003|Double Blind|Ongoing at cut-off date|0|||
145474604|NCT00098306|524590088|FG004|Double Blind|Ongoing at cut-off date|0|||
145474605|NCT00098306|524590089|FG005|Double Blind|Ongoing at cut-off date|0|||
145474606|NCT00098306|524590090|FG006|Double Blind|Ongoing at cut-off date|0|||
145474607|NCT00098306|524590084|FG000|Double Blind|Adverse Event|11|||
145474608|NCT00098306|524590085|FG001|Double Blind|Adverse Event|10|||
145474609|NCT00098306|524590086|FG002|Double Blind|Adverse Event|6|||
145474610|NCT00098306|524590087|FG003|Double Blind|Adverse Event|0|||
145474611|NCT00098306|524590088|FG004|Double Blind|Adverse Event|0|||
145474612|NCT00098306|524590089|FG005|Double Blind|Adverse Event|0|||
145474613|NCT00098306|524590090|FG006|Double Blind|Adverse Event|0|||
145474614|NCT00098306|524590084|FG000|Double Blind|Lack of Efficacy|43|||
145474615|NCT00098306|524590085|FG001|Double Blind|Lack of Efficacy|34|||
145474616|NCT00098306|524590086|FG002|Double Blind|Lack of Efficacy|17|||
145474617|NCT00098306|524590087|FG003|Double Blind|Lack of Efficacy|0|||
145630051|NCT03068468|525158988|FG001|Open-Label Extension Period|Reason not Specified|0|||
145630052|NCT03068468|525158989|FG002|Open-Label Extension Period|Reason not Specified|1|||
145630053|NCT03068468|525158990|FG003|Open-Label Extension Period|Reason not Specified|4|||
145474618|NCT00098306|524590088|FG004|Double Blind|Lack of Efficacy|0|||
145474619|NCT00098306|524590089|FG005|Double Blind|Lack of Efficacy|0|||
145474620|NCT00098306|524590090|FG006|Double Blind|Lack of Efficacy|0|||
145630054|NCT00739102|525158991|FG000|Overall Study|Death|5|||
145630055|NCT00739102|525158991|FG000|Overall Study|Withdrawal by Subject|10|||
145474621|NCT00098306|524590084|FG000|Double Blind|Death|1|||
145474622|NCT00098306|524590085|FG001|Double Blind|Death|4|||
145474623|NCT00098306|524590086|FG002|Double Blind|Death|1|||
145474624|NCT00098306|524590087|FG003|Double Blind|Death|0|||
145474625|NCT00098306|524590088|FG004|Double Blind|Death|0|||
145474626|NCT00098306|524590089|FG005|Double Blind|Death|0|||
145474627|NCT00098306|524590090|FG006|Double Blind|Death|0|||
145474628|NCT00098306|524590084|FG000|Double Blind|Participant defaulted|19|||
145474629|NCT00098306|524590085|FG001|Double Blind|Participant defaulted|18|||
145474630|NCT00098306|524590086|FG002|Double Blind|Participant defaulted|11|||
145474631|NCT00098306|524590087|FG003|Double Blind|Participant defaulted|0|||
145474632|NCT00098306|524590088|FG004|Double Blind|Participant defaulted|0|||
145474633|NCT00098306|524590089|FG005|Double Blind|Participant defaulted|0|||
145474634|NCT00098306|524590090|FG006|Double Blind|Participant defaulted|0|||
145474635|NCT00098306|524590084|FG000|Double Blind|Un-specified|7|||
145474636|NCT00098306|524590085|FG001|Double Blind|Un-specified|3|||
145474637|NCT00098306|524590086|FG002|Double Blind|Un-specified|11|||
145474638|NCT00098306|524590087|FG003|Double Blind|Un-specified|0|||
145474639|NCT00098306|524590088|FG004|Double Blind|Un-specified|0|||
145474640|NCT00098306|524590089|FG005|Double Blind|Un-specified|0|||
145474641|NCT00098306|524590090|FG006|Double Blind|Un-specified|0|||
145474642|NCT00098306|524590084|FG000|Open Label|Lack of Efficacy|0|||
145474643|NCT00098306|524590085|FG001|Open Label|Lack of Efficacy|0|||
145474644|NCT00098306|524590086|FG002|Open Label|Lack of Efficacy|0|||
145474645|NCT00098306|524590087|FG003|Open Label|Lack of Efficacy|13|||
145474646|NCT00098306|524590088|FG004|Open Label|Lack of Efficacy|0|||
145474647|NCT00098306|524590089|FG005|Open Label|Lack of Efficacy|0|||
145474648|NCT00098306|524590090|FG006|Open Label|Lack of Efficacy|0|||
145474649|NCT00098306|524590084|FG000|Open Label|Adverse Event|0|||
145474650|NCT00098306|524590085|FG001|Open Label|Adverse Event|0|||
145474651|NCT00098306|524590086|FG002|Open Label|Adverse Event|0|||
145474652|NCT00098306|524590087|FG003|Open Label|Adverse Event|2|||
145474653|NCT00098306|524590088|FG004|Open Label|Adverse Event|0|||
145474654|NCT00098306|524590089|FG005|Open Label|Adverse Event|0|||
145474655|NCT00098306|524590090|FG006|Open Label|Adverse Event|0|||
145474656|NCT00098306|524590084|FG000|Open Label|Death|0|||
145474657|NCT00098306|524590085|FG001|Open Label|Death|0|||
145474658|NCT00098306|524590086|FG002|Open Label|Death|0|||
145474659|NCT00098306|524590087|FG003|Open Label|Death|4|||
145474660|NCT00098306|524590088|FG004|Open Label|Death|0|||
145474661|NCT00098306|524590089|FG005|Open Label|Death|0|||
145474662|NCT00098306|524590090|FG006|Open Label|Death|0|||
145474663|NCT00098306|524590084|FG000|Open Label|Participant defaulted|0|||
145474664|NCT00098306|524590085|FG001|Open Label|Participant defaulted|0|||
145474665|NCT00098306|524590086|FG002|Open Label|Participant defaulted|0|||
145474666|NCT00098306|524590087|FG003|Open Label|Participant defaulted|24|||
145474667|NCT00098306|524590088|FG004|Open Label|Participant defaulted|0|||
145474668|NCT00098306|524590089|FG005|Open Label|Participant defaulted|0|||
145474669|NCT00098306|524590090|FG006|Open Label|Participant defaulted|0|||
145474670|NCT00098306|524590084|FG000|Open Label|Un-specified|0|||
145474671|NCT00098306|524590085|FG001|Open Label|Un-specified|0|||
145474672|NCT00098306|524590086|FG002|Open Label|Un-specified|0|||
145474673|NCT00098306|524590087|FG003|Open Label|Un-specified|15|||
145474674|NCT00098306|524590088|FG004|Open Label|Un-specified|0|||
145474675|NCT00098306|524590089|FG005|Open Label|Un-specified|0|||
145474676|NCT00098306|524590090|FG006|Open Label|Un-specified|0|||
145474677|NCT00098306|524590084|FG000|Open Label|Ongoing at cut-off date|0|||
145474678|NCT00098306|524590085|FG001|Open Label|Ongoing at cut-off date|0|||
145474679|NCT00098306|524590086|FG002|Open Label|Ongoing at cut-off date|0|||
145474680|NCT00098306|524590087|FG003|Open Label|Ongoing at cut-off date|269|||
145474681|NCT00098306|524590088|FG004|Open Label|Ongoing at cut-off date|62|||
145474682|NCT00098306|524590089|FG005|Open Label|Ongoing at cut-off date|0|||
145474683|NCT00098306|524590090|FG006|Open Label|Ongoing at cut-off date|0|||
145474684|NCT00098306|524590084|FG000|Observational Phase|Death|0|||
145474685|NCT00098306|524590085|FG001|Observational Phase|Death|0|||
145474686|NCT00098306|524590086|FG002|Observational Phase|Death|0|||
145474687|NCT00098306|524590087|FG003|Observational Phase|Death|0|||
145474688|NCT00098306|524590088|FG004|Observational Phase|Death|0|||
145474689|NCT00098306|524590089|FG005|Observational Phase|Death|5|||
145474690|NCT00098306|524590090|FG006|Observational Phase|Death|4|||
145474691|NCT00098306|524590084|FG000|Observational Phase|Participant defaulted|0|||
145474692|NCT00098306|524590085|FG001|Observational Phase|Participant defaulted|0|||
145474693|NCT00098306|524590086|FG002|Observational Phase|Participant defaulted|0|||
145474694|NCT00098306|524590087|FG003|Observational Phase|Participant defaulted|0|||
145474695|NCT00098306|524590088|FG004|Observational Phase|Participant defaulted|0|||
145474696|NCT00098306|524590089|FG005|Observational Phase|Participant defaulted|34|||
145474697|NCT00098306|524590090|FG006|Observational Phase|Participant defaulted|18|||
145474698|NCT00098306|524590084|FG000|Observational Phase|Un-specified|0|||
145474699|NCT00098306|524590085|FG001|Observational Phase|Un-specified|0|||
145474700|NCT00098306|524590086|FG002|Observational Phase|Un-specified|0|||
145474701|NCT00098306|524590087|FG003|Observational Phase|Un-specified|0|||
145474702|NCT00098306|524590088|FG004|Observational Phase|Un-specified|0|||
145474703|NCT00098306|524590089|FG005|Observational Phase|Un-specified|7|||
145474704|NCT00098306|524590090|FG006|Observational Phase|Un-specified|4|||
145474705|NCT01966445|524590091|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
145474706|NCT01966445|524590092|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
145630056|NCT01062126|525158993|FG000|Overall Study|Death|209|||
145474707|NCT01966445|524590093|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
145474708|NCT01966445|524590094|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
145474709|NCT01966445|524590095|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
145474710|NCT01966445|524590096|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
145474711|NCT01966445|524590097|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
145474712|NCT01966445|524590091|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
145474713|NCT01966445|524590092|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
145474714|NCT01966445|524590093|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
145474715|NCT01966445|524590094|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
145474716|NCT01966445|524590095|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
145474717|NCT01966445|524590096|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
145474718|NCT01966445|524590097|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
145474719|NCT01966445|524590091|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
145474720|NCT01966445|524590092|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
145474721|NCT01966445|524590093|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
145474722|NCT01966445|524590094|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
145474723|NCT01966445|524590095|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
145474724|NCT01966445|524590096|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
145474725|NCT01966445|524590097|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
145474726|NCT01966445|524590091|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474727|NCT01966445|524590092|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474728|NCT01966445|524590093|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474729|NCT01966445|524590094|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474730|NCT01966445|524590095|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474731|NCT01966445|524590096|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
145474732|NCT01966445|524590097|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
145474733|NCT01966445|524590091|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474734|NCT01966445|524590092|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474735|NCT01966445|524590093|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474736|NCT01966445|524590094|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474737|NCT01966445|524590095|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474738|NCT01966445|524590096|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
145474739|NCT01966445|524590097|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
145474740|NCT00077649|524590100|FG000|Overall Study|Adverse Event|5|||
145474741|NCT00077649|524590101|FG001|Overall Study|Adverse Event|1|||
145474742|NCT00077649|524590102|FG002|Overall Study|Adverse Event|7|||
145474743|NCT00077649|524590103|FG003|Overall Study|Adverse Event|9|||
145474744|NCT00077649|524590100|FG000|Overall Study|Lack of Efficacy|5|||
145474745|NCT00077649|524590101|FG001|Overall Study|Lack of Efficacy|3|||
145474746|NCT00077649|524590102|FG002|Overall Study|Lack of Efficacy|3|||
145474747|NCT00077649|524590103|FG003|Overall Study|Lack of Efficacy|2|||
145474748|NCT00077649|524590100|FG000|Overall Study|Withdrawal by Subject|0|||
145474749|NCT00077649|524590101|FG001|Overall Study|Withdrawal by Subject|1|||
145474750|NCT00077649|524590102|FG002|Overall Study|Withdrawal by Subject|1|||
145474751|NCT00077649|524590103|FG003|Overall Study|Withdrawal by Subject|2|||
145474752|NCT00077649|524590100|FG000|Overall Study|Lost to Follow-up|2|||
145474753|NCT00077649|524590101|FG001|Overall Study|Lost to Follow-up|2|||
145474754|NCT00077649|524590102|FG002|Overall Study|Lost to Follow-up|3|||
145630057|NCT01062126|525158993|FG000|Overall Study|All Withdrawals|324|||
145630058|NCT01510912|525158994|FG000|Overall Study|Adverse Event|99|||
145630059|NCT01510912|525158994|FG000|Overall Study|Lack of Efficacy|12|||
145630060|NCT01510912|525158994|FG000|Overall Study|Non-compliance with trial drug|23|||
145630061|NCT01510912|525158994|FG000|Overall Study|Withdrawal by Subject|49|||
145630062|NCT01510912|525158994|FG000|Overall Study|Physician Decision|1|||
145630063|NCT01510912|525158994|FG000|Overall Study|Protocol Violation|27|||
145474755|NCT00077649|524590103|FG003|Overall Study|Lost to Follow-up|2|||
145474756|NCT00077649|524590100|FG000|Overall Study|Abnormality of Laboratory Test|1|||
145474757|NCT00077649|524590101|FG001|Overall Study|Abnormality of Laboratory Test|2|||
145474758|NCT00077649|524590102|FG002|Overall Study|Abnormality of Laboratory Test|1|||
145474759|NCT00077649|524590103|FG003|Overall Study|Abnormality of Laboratory Test|2|||
145474760|NCT00077649|524590100|FG000|Overall Study|Randomized but never dosed|1|||
145474761|NCT00077649|524590101|FG001|Overall Study|Randomized but never dosed|0|||
145474762|NCT00077649|524590102|FG002|Overall Study|Randomized but never dosed|0|||
145630064|NCT01510912|525158994|FG000|Overall Study|Lost to Follow-up|26|||
145630065|NCT01510912|525158994|FG000|Overall Study|Other, including joint replacement|5|||
145474763|NCT00077649|524590103|FG003|Overall Study|Randomized but never dosed|0|||
145474764|NCT03688100|524590104|FG000|Overall Study|Lost to Follow-up|21|||
145474765|NCT03688100|524590105|FG001|Overall Study|Lost to Follow-up|15|||
145474766|NCT03688100|524590106|FG002|Overall Study|Lost to Follow-up|15|||
145630066|NCT03784963|525158995|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
145474767|NCT03688100|524590107|FG003|Overall Study|Lost to Follow-up|18|||
145474768|NCT03688100|524590104|FG000|Overall Study|Withdrawal by Subject|19|||
145474769|NCT03688100|524590105|FG001|Overall Study|Withdrawal by Subject|16|||
145474770|NCT03688100|524590106|FG002|Overall Study|Withdrawal by Subject|0|||
145474771|NCT03688100|524590107|FG003|Overall Study|Withdrawal by Subject|0|||
145474772|NCT03688100|524590104|FG000|Overall Study|Death|36|||
145474773|NCT03688100|524590105|FG001|Overall Study|Death|27|||
145474774|NCT03688100|524590106|FG002|Overall Study|Death|0|||
145474775|NCT03688100|524590107|FG003|Overall Study|Death|0|||
145474776|NCT02409719|524590113|FG000|Overall Study|Lost to Follow-up|3|||
145474777|NCT02409719|524590114|FG001|Overall Study|Lost to Follow-up|3|||
145474778|NCT00764673|524590115|FG000|Overall Study|Death|1|||
145474779|NCT00764673|524590115|FG000|Overall Study|Lost to Follow-up|3|||
145474780|NCT00764673|524590115|FG000|Overall Study|Withdrawal by Subject|6|||
145474781|NCT00764673|524590115|FG000|Overall Study|Revision of Device|2|||
145474782|NCT01727336|524590116|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
145474783|NCT01727336|524590117|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
145474784|NCT01727336|524590118|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
145474785|NCT01727336|524590119|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
145474786|NCT01727336|524590120|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
145474787|NCT01727336|524590121|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
145474788|NCT01727336|524590116|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
145474789|NCT01727336|524590117|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
145474790|NCT01727336|524590118|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
145630067|NCT03784963|525158996|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
145630068|NCT03784963|525158997|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
145630069|NCT03784963|525158998|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
145630070|NCT00349908|525158999|FG000|Overall Study|Withdrawal by Subject|0|||
145630071|NCT00349908|525159000|FG001|Overall Study|Withdrawal by Subject|4|||
145630072|NCT01249092|525159003|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
145630073|NCT01249092|525159003|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
145630074|NCT00151996|525159006|FG000|Overall Study|Adverse Event|3|||
145630075|NCT00151996|525159007|FG001|Overall Study|Adverse Event|2|||
145630076|NCT00151996|525159006|FG000|Overall Study|Withdrawal by Subject|1|||
145630077|NCT00151996|525159007|FG001|Overall Study|Withdrawal by Subject|1|||
145630078|NCT00151996|525159006|FG000|Overall Study|Protocol Violation|1|||
145630079|NCT00151996|525159007|FG001|Overall Study|Protocol Violation|2|||
145630080|NCT00151996|525159006|FG000|Overall Study|Sponsor's decision|0|||
145630081|NCT00151996|525159007|FG001|Overall Study|Sponsor's decision|2|||
145630082|NCT01720446|525159010|FG000|Overall Study|Lost to Follow-up|12|||
145630083|NCT01720446|525159011|FG001|Overall Study|Lost to Follow-up|6|||
145630084|NCT01720446|525159012|FG002|Overall Study|Lost to Follow-up|16|||
145630085|NCT01720446|525159013|FG003|Overall Study|Lost to Follow-up|16|||
145630086|NCT01720446|525159010|FG000|Overall Study|Withdrawal by Subject|2|||
145630087|NCT01720446|525159011|FG001|Overall Study|Withdrawal by Subject|5|||
145630088|NCT01720446|525159012|FG002|Overall Study|Withdrawal by Subject|4|||
145630089|NCT01720446|525159013|FG003|Overall Study|Withdrawal by Subject|4|||
145630090|NCT01020838|525159014|FG000|Overall Study|Death|90|||
145630091|NCT01020838|525159014|FG000|Overall Study|Adverse Event|1|||
145630092|NCT01020838|525159014|FG000|Overall Study|Withdrawal by Subject|9|||
145630093|NCT01020838|525159014|FG000|Overall Study|Lost to Follow-up|6|||
145630094|NCT01020838|525159014|FG000|Overall Study|Most common: Study ended by sponsor|77|||
145630095|NCT00930813|525159015|FG000|Overall Study|Death|4|||
145630096|NCT00930813|525159016|FG001|Overall Study|Death|5|||
145630097|NCT00930813|525159015|FG000|Overall Study|Withdrawal by Subject|2|||
145630098|NCT00930813|525159016|FG001|Overall Study|Withdrawal by Subject|5|||
145630099|NCT00930813|525159015|FG000|Overall Study|Lost to Follow-up|2|||
145630100|NCT00930813|525159016|FG001|Overall Study|Lost to Follow-up|4|||
145630101|NCT01072357|525159017|FG000|Overall Study|Lost to Follow-up|0|||
145630102|NCT01072357|525159018|FG001|Overall Study|Lost to Follow-up|1|||
145630103|NCT01048788|525159019|FG000|Overall Study|Adverse Event|5|||
145630104|NCT01048788|525159020|FG001|Overall Study|Adverse Event|1|||
145630105|NCT01048788|525159021|FG002|Overall Study|Adverse Event|1|||
145630106|NCT01048788|525159019|FG000|Overall Study|Lack of Efficacy|0|||
145630107|NCT01048788|525159020|FG001|Overall Study|Lack of Efficacy|0|||
145630108|NCT01048788|525159021|FG002|Overall Study|Lack of Efficacy|1|||
145630109|NCT01048788|525159019|FG000|Overall Study|Withdrawal by Subject|0|||
145630110|NCT01048788|525159020|FG001|Overall Study|Withdrawal by Subject|1|||
145474791|NCT01727336|524590119|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
145474792|NCT01727336|524590120|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
145474793|NCT01727336|524590121|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
145474794|NCT01727336|524590116|FG000|Part 2 Blinded|Death|0|||
145474795|NCT01727336|524590117|FG001|Part 2 Blinded|Death|0|||
145474796|NCT01727336|524590118|FG002|Part 2 Blinded|Death|0|||
145474797|NCT01727336|524590119|FG003|Part 2 Blinded|Death|0|||
145630111|NCT01048788|525159021|FG002|Overall Study|Withdrawal by Subject|0|||
145630112|NCT01131494|525159022|FG000|Overall Study|Withdrawal by Subject|2|||
145630113|NCT02759731|525159023|FG000|Overall Study|Did not complete treatment.|8|||
145630114|NCT01674569|525159024|FG000|Overall Study|Adverse Event|0|||
145630115|NCT01674569|525159025|FG001|Overall Study|Adverse Event|2|||
145630116|NCT01674569|525159026|FG002|Overall Study|Adverse Event|0|||
145630117|NCT01674569|525159027|FG003|Overall Study|Adverse Event|1|||
145630118|NCT01674569|525159028|FG004|Overall Study|Adverse Event|2|||
145630119|NCT01674569|525159029|FG005|Overall Study|Adverse Event|2|||
145630120|NCT01674569|525159024|FG000|Overall Study|Protocol Violation|0|||
145630121|NCT01674569|525159025|FG001|Overall Study|Protocol Violation|1|||
145630122|NCT01674569|525159026|FG002|Overall Study|Protocol Violation|1|||
145630123|NCT01674569|525159027|FG003|Overall Study|Protocol Violation|0|||
145630124|NCT01674569|525159028|FG004|Overall Study|Protocol Violation|0|||
145630125|NCT01674569|525159029|FG005|Overall Study|Protocol Violation|0|||
145630126|NCT01674569|525159024|FG000|Overall Study|Withdrawal by Subject|0|||
145630127|NCT01674569|525159025|FG001|Overall Study|Withdrawal by Subject|0|||
145630128|NCT01674569|525159026|FG002|Overall Study|Withdrawal by Subject|1|||
145630129|NCT01674569|525159027|FG003|Overall Study|Withdrawal by Subject|0|||
145630130|NCT01674569|525159028|FG004|Overall Study|Withdrawal by Subject|0|||
145630131|NCT01674569|525159029|FG005|Overall Study|Withdrawal by Subject|0|||
145630132|NCT01599325|525159030|FG000|Primary Parent Phase|Adverse Event|5|||
145630133|NCT01599325|525159030|FG000|Primary Parent Phase|Disease Progression|7|||
145630134|NCT01599325|525159030|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
145630135|NCT01599325|525159030|FG000|Primary Parent Phase|Death|13|||
145630136|NCT01599325|525159030|FG000|Primary Parent Phase|Protocol Violation|1|||
145630137|NCT01599325|525159030|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
145630138|NCT01599325|525159030|FG000|Primary Parent Phase|Other|2|||
145630139|NCT01599325|525159030|FG000|Extension Phase|Study Closure|1|||
145630140|NCT01599325|525159030|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
145630141|NCT01599325|525159030|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
145630142|NCT01599325|525159030|FG000|Extension Phase|Disease Progression|1|||
145630143|NCT01599325|525159030|FG000|Extension Phase|Withdrawal by Subject|8|||
145630144|NCT01878890|525159031|FG000|Overall Study|Protocol Violation|0|||
145630145|NCT01878890|525159032|FG001|Overall Study|Protocol Violation|1|||
145630146|NCT01878890|525159033|FG002|Overall Study|Protocol Violation|0|||
145630147|NCT01878890|525159034|FG003|Overall Study|Protocol Violation|0|||
145630148|NCT01710514|525159040|FG000|Overall Study|Adverse Event|6|||
145630149|NCT01710514|525159041|FG001|Overall Study|Adverse Event|7|||
145630150|NCT01710514|525159040|FG000|Overall Study|Withdrawal by Subject|1|||
145630151|NCT01710514|525159041|FG001|Overall Study|Withdrawal by Subject|0|||
145630152|NCT03404843|525159042|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
145630153|NCT03404843|525159043|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
145630154|NCT00567164|525159044|FG000|Overall Study|Withdrawal by Subject|171|||
145630155|NCT00567164|525159045|FG001|Overall Study|Withdrawal by Subject|21|||
145630156|NCT00567164|525159046|FG002|Overall Study|Withdrawal by Subject|17|||
145630157|NCT00567164|525159044|FG000|Overall Study|Protocol Violation|23|||
145630158|NCT00567164|525159045|FG001|Overall Study|Protocol Violation|4|||
145630159|NCT00567164|525159046|FG002|Overall Study|Protocol Violation|2|||
145630160|NCT00567164|525159044|FG000|Overall Study|Adverse Event|92|||
145630161|NCT00567164|525159045|FG001|Overall Study|Adverse Event|13|||
145630162|NCT00567164|525159046|FG002|Overall Study|Adverse Event|9|||
145630163|NCT00567164|525159044|FG000|Overall Study|Death|0|||
145630164|NCT00567164|525159045|FG001|Overall Study|Death|0|||
145630165|NCT00567164|525159046|FG002|Overall Study|Death|1|||
145630166|NCT00567164|525159044|FG000|Overall Study|Lost to Follow-up|202|||
145630167|NCT00567164|525159045|FG001|Overall Study|Lost to Follow-up|23|||
145630168|NCT00567164|525159046|FG002|Overall Study|Lost to Follow-up|21|||
145630169|NCT00567164|525159044|FG000|Overall Study|Pregnancy|20|||
145630170|NCT00567164|525159045|FG001|Overall Study|Pregnancy|4|||
145630171|NCT00567164|525159046|FG002|Overall Study|Pregnancy|6|||
145630172|NCT00567164|525159044|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
145630173|NCT00567164|525159045|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
145630174|NCT00567164|525159046|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
145630175|NCT00567164|525159044|FG000|Overall Study|Missing|1|||
145630176|NCT00567164|525159045|FG001|Overall Study|Missing|0|||
145630177|NCT00567164|525159046|FG002|Overall Study|Missing|0|||
145630178|NCT04044664|525159047|FG000|Stage 1|Adverse Event|3|||
145630179|NCT04044664|525159048|FG001|Stage 1|Adverse Event|3|||
145630180|NCT04044664|525159049|FG002|Stage 1|Adverse Event|1|||
145630181|NCT04044664|525159047|FG000|Stage 1|Lost to Follow-up|3|||
145630182|NCT04044664|525159048|FG001|Stage 1|Lost to Follow-up|2|||
145630183|NCT04044664|525159049|FG002|Stage 1|Lost to Follow-up|2|||
145630184|NCT04044664|525159047|FG000|Stage 1|Withdrawal by Subject|9|||
145630185|NCT04044664|525159048|FG001|Stage 1|Withdrawal by Subject|1|||
145630186|NCT04044664|525159049|FG002|Stage 1|Withdrawal by Subject|0|||
145630187|NCT04044664|525159047|FG000|Stage 1|noncompliance, personal reason|2|||
145630188|NCT04044664|525159048|FG001|Stage 1|noncompliance, personal reason|0|||
145474798|NCT01727336|524590120|FG004|Part 2 Blinded|Death|20|||
145630189|NCT04044664|525159049|FG002|Stage 1|noncompliance, personal reason|0|||
145630190|NCT04044664|525159047|FG000|Stage 1|randomization error|0|||
145630191|NCT04044664|525159048|FG001|Stage 1|randomization error|1|||
145630192|NCT04044664|525159049|FG002|Stage 1|randomization error|0|||
145630193|NCT04044664|525159047|FG000|Stage 2|Adverse Event|2|||
145630194|NCT04044664|525159048|FG001|Stage 2|Adverse Event|0|||
145630195|NCT04044664|525159049|FG002|Stage 2|Adverse Event|0|||
145630196|NCT04044664|525159047|FG000|Stage 2|Lost to Follow-up|3|||
145630197|NCT04044664|525159048|FG001|Stage 2|Lost to Follow-up|2|||
145630198|NCT04044664|525159049|FG002|Stage 2|Lost to Follow-up|1|||
145630199|NCT04044664|525159047|FG000|Stage 2|Withdrawal by Subject|3|||
145630200|NCT04044664|525159048|FG001|Stage 2|Withdrawal by Subject|0|||
145630201|NCT04044664|525159049|FG002|Stage 2|Withdrawal by Subject|0|||
145630202|NCT04044664|525159047|FG000|Stage 2|protocol deviation|1|||
145630203|NCT04044664|525159048|FG001|Stage 2|protocol deviation|0|||
145630204|NCT04044664|525159049|FG002|Stage 2|protocol deviation|0|||
145630205|NCT01744691|525159056|FG000|Overall Study|Progressive Disease|18|||
145630206|NCT01744691|525159056|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
145630207|NCT01744691|525159056|FG000|Overall Study|Withdrawal of consent for treatment|3|||
145630208|NCT01744691|525159056|FG000|Overall Study|Physician Decision|4|||
145630209|NCT02701361|525159058|FG000|Overall Study|Lost to Follow-up|5|||
145630210|NCT02701361|525159059|FG001|Overall Study|Lost to Follow-up|2|||
145630211|NCT02701361|525159060|FG002|Overall Study|Lost to Follow-up|1|||
145630212|NCT02701361|525159058|FG000|Overall Study|Withdrawal by Subject|4|||
145630213|NCT02701361|525159059|FG001|Overall Study|Withdrawal by Subject|0|||
145630214|NCT02701361|525159060|FG002|Overall Study|Withdrawal by Subject|0|||
145630215|NCT02701361|525159058|FG000|Overall Study|timed out in rehab center|0|||
145630216|NCT02701361|525159059|FG001|Overall Study|timed out in rehab center|1|||
145630217|NCT02701361|525159060|FG002|Overall Study|timed out in rehab center|0|||
145630218|NCT02701361|525159058|FG000|Overall Study|incarceration|0|||
145630219|NCT02701361|525159059|FG001|Overall Study|incarceration|0|||
145630220|NCT02701361|525159060|FG002|Overall Study|incarceration|1|||
145630221|NCT04588480|525159061|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
145630222|NCT04588480|525159062|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
145630223|NCT04588480|525159063|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
145630224|NCT04588480|525159061|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
145630225|NCT04588480|525159062|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
145630226|NCT04588480|525159063|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
145630227|NCT02750709|525159066|FG000|Treatment Period 1|Adverse Event|0|||
145630228|NCT02750709|525159067|FG001|Treatment Period 1|Adverse Event|0|||
145630229|NCT02750709|525159068|FG002|Treatment Period 1|Adverse Event|0|||
145630230|NCT02750709|525159069|FG003|Treatment Period 1|Adverse Event|0|||
145630231|NCT02750709|525159070|FG004|Treatment Period 1|Adverse Event|0|||
145630232|NCT02750709|525159071|FG005|Treatment Period 1|Adverse Event|1|||
145474799|NCT01727336|524590121|FG005|Part 2 Blinded|Death|16|||
145474800|NCT01727336|524590116|FG000|Part 2 Blinded|Lack of Efficacy|0|||
145630233|NCT03256344|525159072|FG000|Overall Study|Death|6|||
145630234|NCT03256344|525159073|FG001|Overall Study|Death|22|||
145630235|NCT03256344|525159072|FG000|Overall Study|Withdrawal by Subject|3|||
145630236|NCT03256344|525159073|FG001|Overall Study|Withdrawal by Subject|3|||
145630237|NCT03256344|525159072|FG000|Overall Study|Sponsor Decision|1|||
145630238|NCT03256344|525159073|FG001|Overall Study|Sponsor Decision|0|||
145630239|NCT00580801|525159083|FG000|Overall Study|Physician Decision|1|||
145630240|NCT00580801|525159084|FG001|Overall Study|Physician Decision|0|||
145630241|NCT00580801|525159085|FG002|Overall Study|Physician Decision|0|||
145630242|NCT00580801|525159083|FG000|Overall Study|Adverse Event|2|||
145630243|NCT00580801|525159084|FG001|Overall Study|Adverse Event|0|||
145630244|NCT00580801|525159085|FG002|Overall Study|Adverse Event|0|||
145630245|NCT00580801|525159083|FG000|Overall Study|Lost to Follow-up|2|||
145630246|NCT00580801|525159084|FG001|Overall Study|Lost to Follow-up|0|||
145630247|NCT00580801|525159085|FG002|Overall Study|Lost to Follow-up|0|||
145630248|NCT00580801|525159083|FG000|Overall Study|Reached a virologic endpoint|0|||
145630249|NCT00580801|525159084|FG001|Overall Study|Reached a virologic endpoint|1|||
145630250|NCT00580801|525159085|FG002|Overall Study|Reached a virologic endpoint|2|||
145630251|NCT00580801|525159083|FG000|Overall Study|Participant non-compliant|0|||
145630252|NCT00580801|525159084|FG001|Overall Study|Participant non-compliant|0|||
145630253|NCT00580801|525159085|FG002|Overall Study|Participant non-compliant|1|||
145630254|NCT00580801|525159083|FG000|Overall Study|Travel|1|||
145630255|NCT00580801|525159084|FG001|Overall Study|Travel|0|||
145474801|NCT01727336|524590117|FG001|Part 2 Blinded|Lack of Efficacy|0|||
145630256|NCT00580801|525159085|FG002|Overall Study|Travel|0|||
145630257|NCT00843193|525159086|FG000|Overall Study|Adverse Event|2|||
145630258|NCT00843193|525159087|FG001|Overall Study|Adverse Event|4|||
145474802|NCT01727336|524590118|FG002|Part 2 Blinded|Lack of Efficacy|0|||
145630259|NCT00843193|525159086|FG000|Overall Study|Lack of Efficacy|1|||
145630260|NCT00843193|525159087|FG001|Overall Study|Lack of Efficacy|1|||
145630261|NCT00843193|525159086|FG000|Overall Study|Protocol Violation|1|||
145630262|NCT00843193|525159087|FG001|Overall Study|Protocol Violation|2|||
145630263|NCT00843193|525159086|FG000|Overall Study|Lost to Follow-up|1|||
145630264|NCT00843193|525159087|FG001|Overall Study|Lost to Follow-up|0|||
145630265|NCT00843193|525159086|FG000|Overall Study|Physician Decision|0|||
145630266|NCT00843193|525159087|FG001|Overall Study|Physician Decision|1|||
145630267|NCT00843193|525159086|FG000|Overall Study|Withdrawal by Subject|3|||
145630268|NCT00843193|525159087|FG001|Overall Study|Withdrawal by Subject|3|||
145630269|NCT00542386|525159088|FG000|Overall Study|Adverse Event|1|||
145630270|NCT00542386|525159089|FG001|Overall Study|Adverse Event|7|||
145630271|NCT00542386|525159090|FG002|Overall Study|Adverse Event|7|||
145630272|NCT00542386|525159091|FG003|Overall Study|Adverse Event|8|||
145630273|NCT00542386|525159092|FG004|Overall Study|Adverse Event|13|||
145630274|NCT00542386|525159093|FG005|Overall Study|Adverse Event|4|||
145630275|NCT00542386|525159088|FG000|Overall Study|Death|0|||
145630276|NCT00542386|525159089|FG001|Overall Study|Death|0|||
145630277|NCT00542386|525159090|FG002|Overall Study|Death|1|||
145630278|NCT00542386|525159091|FG003|Overall Study|Death|2|||
145630279|NCT00542386|525159092|FG004|Overall Study|Death|1|||
145630280|NCT00542386|525159093|FG005|Overall Study|Death|2|||
145630281|NCT00542386|525159088|FG000|Overall Study|Lack of Efficacy|32|||
145630282|NCT00542386|525159089|FG001|Overall Study|Lack of Efficacy|12|||
145630283|NCT00542386|525159090|FG002|Overall Study|Lack of Efficacy|10|||
145630284|NCT00542386|525159091|FG003|Overall Study|Lack of Efficacy|13|||
145630285|NCT00542386|525159092|FG004|Overall Study|Lack of Efficacy|7|||
145630286|NCT00542386|525159093|FG005|Overall Study|Lack of Efficacy|31|||
145630287|NCT00542386|525159088|FG000|Overall Study|Physician Decision|1|||
145630288|NCT00542386|525159089|FG001|Overall Study|Physician Decision|0|||
145630289|NCT00542386|525159090|FG002|Overall Study|Physician Decision|0|||
145630290|NCT00542386|525159091|FG003|Overall Study|Physician Decision|1|||
145630291|NCT00542386|525159092|FG004|Overall Study|Physician Decision|0|||
145630292|NCT00542386|525159093|FG005|Overall Study|Physician Decision|0|||
145630293|NCT00542386|525159088|FG000|Overall Study|Protocol Violation|0|||
145630294|NCT00542386|525159089|FG001|Overall Study|Protocol Violation|0|||
145630295|NCT00542386|525159090|FG002|Overall Study|Protocol Violation|1|||
145630296|NCT00542386|525159091|FG003|Overall Study|Protocol Violation|0|||
145630297|NCT00542386|525159092|FG004|Overall Study|Protocol Violation|0|||
145630298|NCT00542386|525159093|FG005|Overall Study|Protocol Violation|4|||
145630299|NCT00542386|525159088|FG000|Overall Study|Withdrawal by Subject|5|||
145630300|NCT00542386|525159089|FG001|Overall Study|Withdrawal by Subject|8|||
145630301|NCT00542386|525159090|FG002|Overall Study|Withdrawal by Subject|10|||
145630302|NCT00542386|525159091|FG003|Overall Study|Withdrawal by Subject|11|||
145630303|NCT00542386|525159092|FG004|Overall Study|Withdrawal by Subject|15|||
145630304|NCT00542386|525159093|FG005|Overall Study|Withdrawal by Subject|7|||
145630305|NCT00542386|525159088|FG000|Overall Study|Other Reasons|4|||
145630306|NCT00542386|525159089|FG001|Overall Study|Other Reasons|1|||
145630307|NCT00542386|525159090|FG002|Overall Study|Other Reasons|4|||
145630308|NCT00542386|525159091|FG003|Overall Study|Other Reasons|3|||
145630309|NCT00542386|525159092|FG004|Overall Study|Other Reasons|4|||
145630310|NCT00542386|525159093|FG005|Overall Study|Other Reasons|2|||
145630311|NCT00880906|525159095|FG000|Overall Study|Lost to Follow-up|0|||
145630312|NCT00880906|525159096|FG001|Overall Study|Lost to Follow-up|1|||
145630313|NCT00880906|525159095|FG000|Overall Study|Did not meet criteria following patholog|12|||
145630314|NCT00880906|525159096|FG001|Overall Study|Did not meet criteria following patholog|6|||
145630315|NCT00544440|525159097|FG000|Overall Study|Other|1|||
145630316|NCT00544440|525159097|FG000|Overall Study|Adverse Event|1|||
145630317|NCT00544440|525159097|FG000|Overall Study|Withdrawal by Subject|2|||
145630318|NCT00544440|525159097|FG000|Overall Study|Subject Non-compliance|1|||
145630319|NCT00544440|525159097|FG000|Overall Study|Progressive Disease|47|||
145630320|NCT00544440|525159097|FG000|Overall Study|Other|5|||
145630321|NCT03586167|525159098|FG000|Overall Study|Other|1|||
145630322|NCT03586167|525159099|FG001|Overall Study|Other|0|||
145630323|NCT02512042|525159100|FG000|Overall Study|Adverse Event|0|||
145630324|NCT02512042|525159101|FG001|Overall Study|Adverse Event|4|||
145630325|NCT02512042|525159100|FG000|Overall Study|Withdrawal by Subject|6|||
145630326|NCT02512042|525159101|FG001|Overall Study|Withdrawal by Subject|6|||
145630327|NCT02512042|525159100|FG000|Overall Study|Non-compliance with study drug|1|||
145630328|NCT02512042|525159101|FG001|Overall Study|Non-compliance with study drug|2|||
145630329|NCT02512042|525159100|FG000|Overall Study|Lost to Follow-up|5|||
145630330|NCT02512042|525159101|FG001|Overall Study|Lost to Follow-up|2|||
145630331|NCT02512042|525159100|FG000|Overall Study|Other|11|||
145630332|NCT02512042|525159101|FG001|Overall Study|Other|11|||
145630333|NCT04109118|525159106|FG000|Overall Study|Lost to Follow-up|3|||
145630334|NCT03394027|525159107|FG000|Overall Study|Ineligible|3|||
145630335|NCT03394027|525159108|FG001|Overall Study|Ineligible|1|||
145630336|NCT03394027|525159109|FG002|Overall Study|Ineligible|3|||
145630337|NCT03394027|525159107|FG000|Overall Study|Participant declined to participate before treatment started|0|||
145630338|NCT03394027|525159108|FG001|Overall Study|Participant declined to participate before treatment started|0|||
145630339|NCT03394027|525159109|FG002|Overall Study|Participant declined to participate before treatment started|1|||
145630340|NCT01268566|525159119|FG000|Overall Study|Lost to Follow-up|1|||
145630341|NCT01268566|525159119|FG000|Overall Study|Withdrawal by Subject|12|||
145630342|NCT01268566|525159119|FG000|Overall Study|Death|30|||
145630343|NCT04257058|525161067|FG000|Overall Study|Lost to Follow-up|31|||
145630344|NCT03227757|525161068|FG000|Overall Study|Death|25|||
145630345|NCT03227757|525161068|FG000|Overall Study|Withdrawal|10|||
145630346|NCT03227757|525161068|FG000|Overall Study|Missed visits|1|||
145630347|NCT03227757|525161068|FG000|Overall Study|Lost to Follow-up|2|||
145630348|NCT01144468|525161070|FG000|Overall Study|Lost to Follow-up|4|||
145630349|NCT01144468|525161071|FG001|Overall Study|Lost to Follow-up|7|||
145630350|NCT01144468|525161070|FG000|Overall Study|Adverse Event|3|||
145630351|NCT01144468|525161071|FG001|Overall Study|Adverse Event|2|||
145630352|NCT01144468|525161070|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
145630353|NCT01144468|525161071|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
145630354|NCT02960659|525161072|FG000|Overall Study|Withdrawal by Subject|1|||
145630355|NCT02960659|525161073|FG001|Overall Study|Withdrawal by Subject|0|||
145630356|NCT02960659|525161072|FG000|Overall Study|Poor compliance|0|||
145630357|NCT02960659|525161073|FG001|Overall Study|Poor compliance|1|||
145630358|NCT04199728|525161077|FG000|Overall Study|Adverse Event|1|||
145630359|NCT04199728|525161078|FG001|Overall Study|Adverse Event|0|||
145630360|NCT04199728|525161077|FG000|Overall Study|Withdrawal by Subject|8|||
145630361|NCT04199728|525161078|FG001|Overall Study|Withdrawal by Subject|3|||
145630362|NCT04199728|525161077|FG000|Overall Study|Screen fail after consent|0|||
145630363|NCT04199728|525161078|FG001|Overall Study|Screen fail after consent|1|||
145630364|NCT04199728|525161077|FG000|Overall Study|Early withdraw criteria met|0|||
145630365|NCT04199728|525161078|FG001|Overall Study|Early withdraw criteria met|1|||
145630366|NCT04199728|525161077|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
145630367|NCT04199728|525161078|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
145630368|NCT01331824|525161083|FG000|Overall Study|Adverse Event|2|||
145630369|NCT01331824|525161083|FG000|Overall Study|Death|1|||
145630370|NCT01331824|525161083|FG000|Overall Study|Disease Progression|9|||
145630371|NCT01331824|525161083|FG000|Overall Study|Withdrawal by Subject|1|||
145630372|NCT03179787|525161087|FG000|Overall Study|Lost to Follow-up|15|||
145630373|NCT03179787|525161087|FG000|Overall Study|Case report failures|2|||
145630374|NCT03179787|525161087|FG000|Overall Study|Treatment not administered|1|||
145630375|NCT02030028|525161088|FG000|Overall Study|Withdrawal by Subject|4|||
145630376|NCT02030028|525161088|FG000|Overall Study|lack of transportation|1|||
145630377|NCT00661778|525161089|FG000|Overall Study|Disease Progression|23|||
145630378|NCT00661778|525161089|FG000|Overall Study|Adverse Event|18|||
145630379|NCT00661778|525161089|FG000|Overall Study|Reason not Specified|6|||
145630380|NCT00661778|525161089|FG000|Overall Study|Protocol Violation|2|||
145630381|NCT00661778|525161089|FG000|Overall Study|Withdrawal of Consent|1|||
145630382|NCT01090024|525161094|FG000|Period 1|Met exclusion criteria|0|||
145630383|NCT01090024|525161095|FG001|Period 1|Met exclusion criteria|0|||
145630384|NCT01090024|525161096|FG002|Period 1|Met exclusion criteria|0|||
145630385|NCT01090024|525161097|FG003|Period 1|Met exclusion criteria|0|||
145630386|NCT01090024|525161098|FG004|Period 1|Met exclusion criteria|0|||
145630387|NCT01090024|525161099|FG005|Period 1|Met exclusion criteria|0|||
145630388|NCT01090024|525161100|FG006|Period 1|Met exclusion criteria|0|||
145630389|NCT01090024|525161101|FG007|Period 1|Met exclusion criteria|0|||
145630390|NCT01090024|525161102|FG008|Period 1|Met exclusion criteria|0|||
145630391|NCT01090024|525161103|FG009|Period 1|Met exclusion criteria|0|||
145630392|NCT01090024|525161104|FG010|Period 1|Met exclusion criteria|0|||
145630393|NCT01090024|525161105|FG011|Period 1|Met exclusion criteria|0|||
145630394|NCT01090024|525161106|FG012|Period 1|Met exclusion criteria|0|||
145630395|NCT01090024|525161107|FG013|Period 1|Met exclusion criteria|0|||
145630396|NCT01090024|525161108|FG014|Period 1|Met exclusion criteria|1|||
145630397|NCT01090024|525161109|FG015|Period 1|Met exclusion criteria|0|||
145630398|NCT01090024|525161110|FG016|Period 1|Met exclusion criteria|0|||
145630399|NCT01090024|525161111|FG017|Period 1|Met exclusion criteria|0|||
145630400|NCT01090024|525161094|FG000|Period 1|Adverse Event|0|||
145630401|NCT01090024|525161095|FG001|Period 1|Adverse Event|0|||
145630402|NCT01090024|525161096|FG002|Period 1|Adverse Event|0|||
145630403|NCT01090024|525161097|FG003|Period 1|Adverse Event|0|||
145630404|NCT01090024|525161098|FG004|Period 1|Adverse Event|0|||
145630405|NCT01090024|525161099|FG005|Period 1|Adverse Event|0|||
145630406|NCT01090024|525161100|FG006|Period 1|Adverse Event|0|||
145630407|NCT01090024|525161101|FG007|Period 1|Adverse Event|0|||
145630408|NCT01090024|525161102|FG008|Period 1|Adverse Event|0|||
145630409|NCT01090024|525161103|FG009|Period 1|Adverse Event|1|||
145630410|NCT01090024|525161104|FG010|Period 1|Adverse Event|0|||
145630411|NCT01090024|525161105|FG011|Period 1|Adverse Event|1|||
145630412|NCT01090024|525161106|FG012|Period 1|Adverse Event|0|||
145630413|NCT01090024|525161107|FG013|Period 1|Adverse Event|0|||
145630414|NCT01090024|525161108|FG014|Period 1|Adverse Event|0|||
145630415|NCT01090024|525161109|FG015|Period 1|Adverse Event|0|||
145630416|NCT01090024|525161110|FG016|Period 1|Adverse Event|0|||
145630417|NCT01090024|525161111|FG017|Period 1|Adverse Event|1|||
145630418|NCT01090024|525161094|FG000|Period 1|Withdrawal by Subject|0|||
145630419|NCT01090024|525161095|FG001|Period 1|Withdrawal by Subject|0|||
145630420|NCT01090024|525161096|FG002|Period 1|Withdrawal by Subject|0|||
145630421|NCT01090024|525161097|FG003|Period 1|Withdrawal by Subject|1|||
145630422|NCT01090024|525161098|FG004|Period 1|Withdrawal by Subject|0|||
145630423|NCT01090024|525161099|FG005|Period 1|Withdrawal by Subject|0|||
145630424|NCT01090024|525161100|FG006|Period 1|Withdrawal by Subject|0|||
145630425|NCT01090024|525161101|FG007|Period 1|Withdrawal by Subject|0|||
145630426|NCT01090024|525161102|FG008|Period 1|Withdrawal by Subject|0|||
145630427|NCT01090024|525161103|FG009|Period 1|Withdrawal by Subject|0|||
145630428|NCT01090024|525161104|FG010|Period 1|Withdrawal by Subject|0|||
145630429|NCT01090024|525161105|FG011|Period 1|Withdrawal by Subject|0|||
145630430|NCT01090024|525161106|FG012|Period 1|Withdrawal by Subject|0|||
145630431|NCT01090024|525161107|FG013|Period 1|Withdrawal by Subject|0|||
145630432|NCT01090024|525161108|FG014|Period 1|Withdrawal by Subject|0|||
145630433|NCT01090024|525161109|FG015|Period 1|Withdrawal by Subject|0|||
145630434|NCT01090024|525161110|FG016|Period 1|Withdrawal by Subject|0|||
145630435|NCT01090024|525161111|FG017|Period 1|Withdrawal by Subject|0|||
145630436|NCT01090024|525161094|FG000|Period 1|Lost to Follow-up|0|||
145630437|NCT01090024|525161095|FG001|Period 1|Lost to Follow-up|1|||
145630438|NCT01090024|525161096|FG002|Period 1|Lost to Follow-up|0|||
145630439|NCT01090024|525161097|FG003|Period 1|Lost to Follow-up|0|||
145630440|NCT01090024|525161098|FG004|Period 1|Lost to Follow-up|0|||
145630441|NCT01090024|525161099|FG005|Period 1|Lost to Follow-up|0|||
145630442|NCT01090024|525161100|FG006|Period 1|Lost to Follow-up|0|||
145630443|NCT01090024|525161101|FG007|Period 1|Lost to Follow-up|0|||
145630444|NCT01090024|525161102|FG008|Period 1|Lost to Follow-up|0|||
145630445|NCT01090024|525161103|FG009|Period 1|Lost to Follow-up|0|||
145630446|NCT01090024|525161104|FG010|Period 1|Lost to Follow-up|0|||
145630447|NCT01090024|525161105|FG011|Period 1|Lost to Follow-up|0|||
145630448|NCT01090024|525161106|FG012|Period 1|Lost to Follow-up|0|||
145630449|NCT01090024|525161107|FG013|Period 1|Lost to Follow-up|0|||
145630450|NCT01090024|525161108|FG014|Period 1|Lost to Follow-up|0|||
145630451|NCT01090024|525161109|FG015|Period 1|Lost to Follow-up|0|||
145630452|NCT01090024|525161110|FG016|Period 1|Lost to Follow-up|0|||
145630453|NCT01090024|525161111|FG017|Period 1|Lost to Follow-up|0|||
145630454|NCT01090024|525161094|FG000|Period 2|Lost to Follow-up|0|||
145630455|NCT01090024|525161095|FG001|Period 2|Lost to Follow-up|0|||
145630456|NCT01090024|525161096|FG002|Period 2|Lost to Follow-up|0|||
145630457|NCT01090024|525161097|FG003|Period 2|Lost to Follow-up|1|||
145630458|NCT01090024|525161098|FG004|Period 2|Lost to Follow-up|0|||
145630459|NCT01090024|525161099|FG005|Period 2|Lost to Follow-up|0|||
145630460|NCT01090024|525161100|FG006|Period 2|Lost to Follow-up|0|||
145630461|NCT01090024|525161101|FG007|Period 2|Lost to Follow-up|0|||
145630462|NCT01090024|525161102|FG008|Period 2|Lost to Follow-up|0|||
145630463|NCT01090024|525161103|FG009|Period 2|Lost to Follow-up|0|||
145630464|NCT01090024|525161104|FG010|Period 2|Lost to Follow-up|0|||
145630465|NCT01090024|525161105|FG011|Period 2|Lost to Follow-up|0|||
145630466|NCT01090024|525161106|FG012|Period 2|Lost to Follow-up|0|||
145630467|NCT01090024|525161107|FG013|Period 2|Lost to Follow-up|0|||
145630468|NCT01090024|525161108|FG014|Period 2|Lost to Follow-up|0|||
145630469|NCT01090024|525161109|FG015|Period 2|Lost to Follow-up|0|||
145630470|NCT01090024|525161110|FG016|Period 2|Lost to Follow-up|0|||
145630471|NCT01090024|525161111|FG017|Period 2|Lost to Follow-up|0|||
145630472|NCT01090024|525161094|FG000|Period 2|Adverse Event|1|||
145630473|NCT01090024|525161095|FG001|Period 2|Adverse Event|0|||
145630474|NCT01090024|525161096|FG002|Period 2|Adverse Event|0|||
145630475|NCT01090024|525161097|FG003|Period 2|Adverse Event|0|||
145630476|NCT01090024|525161098|FG004|Period 2|Adverse Event|0|||
145630477|NCT01090024|525161099|FG005|Period 2|Adverse Event|0|||
145630478|NCT01090024|525161100|FG006|Period 2|Adverse Event|0|||
145630479|NCT01090024|525161101|FG007|Period 2|Adverse Event|0|||
145630480|NCT01090024|525161102|FG008|Period 2|Adverse Event|0|||
145630481|NCT01090024|525161103|FG009|Period 2|Adverse Event|0|||
145630482|NCT01090024|525161104|FG010|Period 2|Adverse Event|0|||
145630483|NCT01090024|525161105|FG011|Period 2|Adverse Event|0|||
145630484|NCT01090024|525161106|FG012|Period 2|Adverse Event|0|||
145630485|NCT01090024|525161107|FG013|Period 2|Adverse Event|0|||
145630486|NCT01090024|525161108|FG014|Period 2|Adverse Event|0|||
145630487|NCT01090024|525161109|FG015|Period 2|Adverse Event|0|||
145630488|NCT01090024|525161110|FG016|Period 2|Adverse Event|0|||
145630489|NCT01090024|525161111|FG017|Period 2|Adverse Event|0|||
145630490|NCT01090024|525161094|FG000|Period 3|Withdrawal by Subject|0|||
145630491|NCT01090024|525161095|FG001|Period 3|Withdrawal by Subject|0|||
145630492|NCT01090024|525161096|FG002|Period 3|Withdrawal by Subject|0|||
145630493|NCT01090024|525161097|FG003|Period 3|Withdrawal by Subject|0|||
145630494|NCT01090024|525161098|FG004|Period 3|Withdrawal by Subject|0|||
145630495|NCT01090024|525161099|FG005|Period 3|Withdrawal by Subject|0|||
145630496|NCT01090024|525161100|FG006|Period 3|Withdrawal by Subject|0|||
145630497|NCT01090024|525161101|FG007|Period 3|Withdrawal by Subject|0|||
145630498|NCT01090024|525161102|FG008|Period 3|Withdrawal by Subject|0|||
145630499|NCT01090024|525161103|FG009|Period 3|Withdrawal by Subject|0|||
145630500|NCT01090024|525161104|FG010|Period 3|Withdrawal by Subject|0|||
145630501|NCT01090024|525161105|FG011|Period 3|Withdrawal by Subject|0|||
145630502|NCT01090024|525161106|FG012|Period 3|Withdrawal by Subject|0|||
145630503|NCT01090024|525161107|FG013|Period 3|Withdrawal by Subject|0|||
145630504|NCT01090024|525161108|FG014|Period 3|Withdrawal by Subject|0|||
145630505|NCT01090024|525161109|FG015|Period 3|Withdrawal by Subject|1|||
145630506|NCT01090024|525161110|FG016|Period 3|Withdrawal by Subject|0|||
145630507|NCT01090024|525161111|FG017|Period 3|Withdrawal by Subject|0|||
145630508|NCT01090024|525161094|FG000|Period 3|Protocol Violation|0|||
145630509|NCT01090024|525161095|FG001|Period 3|Protocol Violation|0|||
145630510|NCT01090024|525161096|FG002|Period 3|Protocol Violation|0|||
145630511|NCT01090024|525161097|FG003|Period 3|Protocol Violation|0|||
145630512|NCT01090024|525161098|FG004|Period 3|Protocol Violation|0|||
145630513|NCT01090024|525161099|FG005|Period 3|Protocol Violation|0|||
145630514|NCT01090024|525161100|FG006|Period 3|Protocol Violation|0|||
145630515|NCT01090024|525161101|FG007|Period 3|Protocol Violation|0|||
145630516|NCT01090024|525161102|FG008|Period 3|Protocol Violation|1|||
145630517|NCT01090024|525161103|FG009|Period 3|Protocol Violation|0|||
145630518|NCT01090024|525161104|FG010|Period 3|Protocol Violation|0|||
145630519|NCT01090024|525161105|FG011|Period 3|Protocol Violation|0|||
145630520|NCT01090024|525161106|FG012|Period 3|Protocol Violation|0|||
145630521|NCT01090024|525161107|FG013|Period 3|Protocol Violation|0|||
145630522|NCT01090024|525161108|FG014|Period 3|Protocol Violation|0|||
145630523|NCT01090024|525161109|FG015|Period 3|Protocol Violation|0|||
145630524|NCT01090024|525161110|FG016|Period 3|Protocol Violation|0|||
145630525|NCT01090024|525161111|FG017|Period 3|Protocol Violation|0|||
145630526|NCT01090024|525161094|FG000|Period 3|Adverse Event|0|||
145630527|NCT01090024|525161095|FG001|Period 3|Adverse Event|0|||
145630528|NCT01090024|525161096|FG002|Period 3|Adverse Event|0|||
145630529|NCT01090024|525161097|FG003|Period 3|Adverse Event|0|||
145630530|NCT01090024|525161098|FG004|Period 3|Adverse Event|0|||
145630531|NCT01090024|525161099|FG005|Period 3|Adverse Event|1|||
145630532|NCT01090024|525161100|FG006|Period 3|Adverse Event|0|||
145630533|NCT01090024|525161101|FG007|Period 3|Adverse Event|0|||
145630534|NCT01090024|525161102|FG008|Period 3|Adverse Event|0|||
145630535|NCT01090024|525161103|FG009|Period 3|Adverse Event|0|||
145630536|NCT01090024|525161104|FG010|Period 3|Adverse Event|0|||
145630537|NCT01090024|525161105|FG011|Period 3|Adverse Event|0|||
145630538|NCT01090024|525161106|FG012|Period 3|Adverse Event|0|||
145630539|NCT01090024|525161107|FG013|Period 3|Adverse Event|0|||
145630540|NCT01090024|525161108|FG014|Period 3|Adverse Event|0|||
145630541|NCT01090024|525161109|FG015|Period 3|Adverse Event|0|||
145630542|NCT01090024|525161110|FG016|Period 3|Adverse Event|0|||
145630543|NCT01090024|525161111|FG017|Period 3|Adverse Event|0|||
145630544|NCT00149630|525161114|FG000|Overall Study|Incarceration|2|||
145630545|NCT00149630|525161115|FG001|Overall Study|Incarceration|0|||
145630546|NCT00149630|525161114|FG000|Overall Study|Treatment Programs|4|||
145630547|NCT00149630|525161115|FG001|Overall Study|Treatment Programs|5|||
145630548|NCT00149630|525161114|FG000|Overall Study|Adverse Event|2|||
145630549|NCT00149630|525161115|FG001|Overall Study|Adverse Event|0|||
145630550|NCT00567879|525161119|FG000|Overall Study|Adverse Event|2|||
145630551|NCT00567879|525161120|FG001|Overall Study|Adverse Event|0|||
145630552|NCT00567879|525161121|FG002|Overall Study|Adverse Event|1|||
145630553|NCT00567879|525161122|FG003|Overall Study|Adverse Event|0|||
145630554|NCT00567879|525161123|FG004|Overall Study|Adverse Event|1|||
145630555|NCT00567879|525161124|FG005|Overall Study|Adverse Event|0|||
145630556|NCT00567879|525161119|FG000|Overall Study|Abnormal test procedure(s)|0|||
145630557|NCT00567879|525161120|FG001|Overall Study|Abnormal test procedure(s)|0|||
145630558|NCT00567879|525161121|FG002|Overall Study|Abnormal test procedure(s)|1|||
145630559|NCT00567879|525161122|FG003|Overall Study|Abnormal test procedure(s)|0|||
145630560|NCT00567879|525161123|FG004|Overall Study|Abnormal test procedure(s)|0|||
145630561|NCT00567879|525161124|FG005|Overall Study|Abnormal test procedure(s)|0|||
145630562|NCT00567879|525161119|FG000|Overall Study|Withdrawal by Subject|0|||
145630563|NCT00567879|525161120|FG001|Overall Study|Withdrawal by Subject|0|||
145630564|NCT00567879|525161121|FG002|Overall Study|Withdrawal by Subject|3|||
145630565|NCT00567879|525161122|FG003|Overall Study|Withdrawal by Subject|1|||
145630566|NCT00567879|525161123|FG004|Overall Study|Withdrawal by Subject|0|||
145630567|NCT00567879|525161124|FG005|Overall Study|Withdrawal by Subject|0|||
145630568|NCT00567879|525161119|FG000|Overall Study|New cancer therapy|0|||
145630569|NCT00567879|525161120|FG001|Overall Study|New cancer therapy|0|||
145630570|NCT00567879|525161121|FG002|Overall Study|New cancer therapy|1|||
145630571|NCT00567879|525161122|FG003|Overall Study|New cancer therapy|0|||
145630572|NCT00567879|525161123|FG004|Overall Study|New cancer therapy|0|||
145630573|NCT00567879|525161124|FG005|Overall Study|New cancer therapy|0|||
145630574|NCT00567879|525161119|FG000|Overall Study|Disease progression|5|||
145630575|NCT00567879|525161120|FG001|Overall Study|Disease progression|7|||
145630576|NCT00567879|525161121|FG002|Overall Study|Disease progression|15|||
145630577|NCT00567879|525161122|FG003|Overall Study|Disease progression|5|||
145630578|NCT00567879|525161123|FG004|Overall Study|Disease progression|11|||
145630579|NCT00567879|525161124|FG005|Overall Study|Disease progression|3|||
145630580|NCT01259102|525161129|FG000|Overall Study|Adverse Event|1|||
145630581|NCT01259102|525161130|FG001|Overall Study|Adverse Event|0|||
145630582|NCT01259102|525161131|FG002|Overall Study|Adverse Event|1|||
145630583|NCT01259102|525161132|FG003|Overall Study|Adverse Event|1|||
145630584|NCT01259102|525161133|FG004|Overall Study|Adverse Event|0|||
145630585|NCT01259102|525161129|FG000|Overall Study|Other|0|||
145630586|NCT01259102|525161130|FG001|Overall Study|Other|0|||
145630587|NCT01259102|525161131|FG002|Overall Study|Other|1|||
145630588|NCT01259102|525161132|FG003|Overall Study|Other|1|||
145630589|NCT01259102|525161133|FG004|Overall Study|Other|1|||
145630590|NCT00918957|525161134|FG000|Overall Study|Adverse Event|2|||
145630591|NCT00918957|525161135|FG001|Overall Study|Adverse Event|0|||
145630592|NCT00918957|525161134|FG000|Overall Study|Withdrawal by Subject|1|||
145630593|NCT00918957|525161135|FG001|Overall Study|Withdrawal by Subject|0|||
145630594|NCT04464421|525161136|FG000|Overall Study|Lost to Follow-up|2|||
145630595|NCT04464421|525161137|FG001|Overall Study|Lost to Follow-up|2|||
145630596|NCT01956669|525161138|FG000|Overall Study|Disease Progression|12|||
145630597|NCT01956669|525161139|FG001|Overall Study|Disease Progression|7|||
145630598|NCT01956669|525161140|FG002|Overall Study|Disease Progression|7|||
145630599|NCT01956669|525161141|FG003|Overall Study|Disease Progression|8|||
145630600|NCT01956669|525161142|FG004|Overall Study|Disease Progression|4|||
145630601|NCT01956669|525161143|FG005|Overall Study|Disease Progression|3|||
145630602|NCT01956669|525161144|FG006|Overall Study|Disease Progression|5|||
145630603|NCT01956669|525161138|FG000|Overall Study|Adverse Event|0|||
145630604|NCT01956669|525161139|FG001|Overall Study|Adverse Event|2|||
145630605|NCT01956669|525161140|FG002|Overall Study|Adverse Event|2|||
145630606|NCT01956669|525161141|FG003|Overall Study|Adverse Event|1|||
145630607|NCT01956669|525161142|FG004|Overall Study|Adverse Event|0|||
145630608|NCT01956669|525161143|FG005|Overall Study|Adverse Event|0|||
145630609|NCT01956669|525161144|FG006|Overall Study|Adverse Event|0|||
145630610|NCT01956669|525161138|FG000|Overall Study|Physician Decision|0|||
145630611|NCT01956669|525161139|FG001|Overall Study|Physician Decision|2|||
145630612|NCT01956669|525161140|FG002|Overall Study|Physician Decision|0|||
145630613|NCT01956669|525161141|FG003|Overall Study|Physician Decision|0|||
145630614|NCT01956669|525161142|FG004|Overall Study|Physician Decision|0|||
145630615|NCT01956669|525161143|FG005|Overall Study|Physician Decision|1|||
145630616|NCT01956669|525161144|FG006|Overall Study|Physician Decision|0|||
145630617|NCT01956669|525161138|FG000|Overall Study|Withdrawal by Subject|0|||
145630618|NCT01956669|525161139|FG001|Overall Study|Withdrawal by Subject|0|||
145630619|NCT01956669|525161140|FG002|Overall Study|Withdrawal by Subject|1|||
145630620|NCT01956669|525161141|FG003|Overall Study|Withdrawal by Subject|1|||
145630621|NCT01956669|525161142|FG004|Overall Study|Withdrawal by Subject|0|||
145630622|NCT01956669|525161143|FG005|Overall Study|Withdrawal by Subject|0|||
145630623|NCT01956669|525161144|FG006|Overall Study|Withdrawal by Subject|1|||
145630624|NCT00558363|525161146|FG000|Overall Study|Physician Decision|18|||
145630625|NCT00558363|525161147|FG001|Overall Study|Physician Decision|4|||
145630626|NCT00558363|525161146|FG000|Overall Study|Withdrawal by Subject|11|||
145630627|NCT00558363|525161147|FG001|Overall Study|Withdrawal by Subject|4|||
145630628|NCT00558363|525161146|FG000|Overall Study|Adverse Event|5|||
145630629|NCT00558363|525161147|FG001|Overall Study|Adverse Event|5|||
145630630|NCT00558363|525161146|FG000|Overall Study|Lack of Efficacy|2|||
145630631|NCT00558363|525161147|FG001|Overall Study|Lack of Efficacy|2|||
145630632|NCT00558363|525161146|FG000|Overall Study|Protocol Violation|2|||
145630633|NCT00558363|525161147|FG001|Overall Study|Protocol Violation|1|||
145630634|NCT00558363|525161146|FG000|Overall Study|Lost to Follow-up|0|||
145630635|NCT00558363|525161147|FG001|Overall Study|Lost to Follow-up|1|||
145630636|NCT00558363|525161146|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
145630637|NCT00558363|525161147|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
145630638|NCT00558363|525161146|FG000|Overall Study|Randomized in Error|1|||
145630639|NCT00558363|525161147|FG001|Overall Study|Randomized in Error|2|||
145630640|NCT00558363|525161146|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
145630641|NCT00558363|525161147|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
145630642|NCT04012853|525161148|FG000|Overall Study|Withdrawal by Subject|1|||
145630643|NCT04012853|525161149|FG001|Overall Study|Withdrawal by Subject|1|||
145630644|NCT04012853|525161148|FG000|Overall Study|Protocol Violation|1|||
145630645|NCT04012853|525161149|FG001|Overall Study|Protocol Violation|0|||
145630646|NCT04012853|525161148|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
145630647|NCT04012853|525161149|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
145630648|NCT03055767|525161150|FG000|Open-Label Period|Lost to Follow-up|0|||
145630649|NCT03055767|525161151|FG001|Open-Label Period|Lost to Follow-up|0|||
145630650|NCT03055767|525161152|FG002|Open-Label Period|Lost to Follow-up|2|||
145630651|NCT03055767|525161153|FG003|Open-Label Period|Lost to Follow-up|0|||
145630652|NCT03055767|525161150|FG000|Open-Label Period|Withdrawal by Subject|0|||
145630653|NCT03055767|525161151|FG001|Open-Label Period|Withdrawal by Subject|0|||
145630654|NCT03055767|525161152|FG002|Open-Label Period|Withdrawal by Subject|0|||
145630655|NCT03055767|525161153|FG003|Open-Label Period|Withdrawal by Subject|1|||
145630656|NCT01466881|525161154|FG000|Overall Study|Ineligible|5|||
145630657|NCT01466881|525161154|FG000|Overall Study|Adverse Event|6|||
145630658|NCT01466881|525161154|FG000|Overall Study|Progression/relapse|20|||
145630659|NCT01466881|525161154|FG000|Overall Study|Death|4|||
145630660|NCT01466881|525161154|FG000|Overall Study|Other reason not protocol specified|5|||
145630661|NCT01101165|525161155|FG000|Period 1|Adverse Event|1|||
145630662|NCT01101165|525161156|FG001|Period 1|Adverse Event|2|||
145630663|NCT01101165|525161155|FG000|Period 1|Withdrawal by Subject|0|||
145630664|NCT01101165|525161156|FG001|Period 1|Withdrawal by Subject|2|||
145630665|NCT01101165|525161155|FG000|Period 1|Positive Drug Screen|0|||
145630666|NCT01101165|525161156|FG001|Period 1|Positive Drug Screen|1|||
145630667|NCT01101165|525161155|FG000|Period 1|Lost to Follow-up|1|||
145630668|NCT01101165|525161156|FG001|Period 1|Lost to Follow-up|0|||
145630669|NCT01101165|525161155|FG000|Period 2|Withdrawal by Subject|3|||
145630670|NCT01101165|525161156|FG001|Period 2|Withdrawal by Subject|1|||
145630671|NCT01101165|525161155|FG000|Period 2|Adverse Event|1|||
145630672|NCT01101165|525161156|FG001|Period 2|Adverse Event|0|||
145630673|NCT00927823|525161160|FG000|Continuous Dosing Period|Death|0|||
145630674|NCT00927823|525161161|FG001|Continuous Dosing Period|Death|0|||
145630675|NCT00927823|525161162|FG002|Continuous Dosing Period|Death|6|||
145630676|NCT00927823|525161163|FG003|Continuous Dosing Period|Death|0|||
145630677|NCT00927823|525161160|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
145630678|NCT00927823|525161161|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
145630679|NCT00927823|525161162|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
145630680|NCT00927823|525161163|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
145630681|NCT00927823|525161160|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
145630682|NCT00927823|525161161|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
145630683|NCT00927823|525161162|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
145630684|NCT00927823|525161163|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
145630685|NCT00927823|525161160|FG000|Continuous Dosing Period|Other|1|||
145630686|NCT00927823|525161161|FG001|Continuous Dosing Period|Other|2|||
145630687|NCT00927823|525161162|FG002|Continuous Dosing Period|Other|9|||
145630688|NCT00927823|525161163|FG003|Continuous Dosing Period|Other|3|||
145630689|NCT02317705|525161169|FG000|Overall Study|Withdrawal by Subject|3|||
145630690|NCT02317705|525161169|FG000|Overall Study|Physician Decision|1|||
145630691|NCT02317705|525161169|FG000|Overall Study|Drug not usable|1|||
145630692|NCT02430532|525161178|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
145630693|NCT02430532|525161179|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
145630694|NCT02430532|525161178|FG000|Overall Study|Consent Withdrawn|0|||
145630695|NCT02430532|525161179|FG001|Overall Study|Consent Withdrawn|2|||
145630696|NCT02430532|525161178|FG000|Overall Study|Adverse Event|0|||
145630697|NCT02430532|525161179|FG001|Overall Study|Adverse Event|1|||
145630698|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Other|4|||
145630699|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Other|0|||
145630700|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
145630701|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
145630702|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
145630703|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
145630704|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
145630705|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
145630706|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
145630707|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
145630708|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
145630709|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
145630710|NCT00853827|525161180|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
145630711|NCT00853827|525161181|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
145630712|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
145630713|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
145630714|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
145630715|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
145630716|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
145630717|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
145630718|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
145630719|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
145630720|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
145630721|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
145630722|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
145630723|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
145630724|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
145630725|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
145630726|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
145630727|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
145630728|NCT00853827|525161180|FG000|Double Blind Period (103 Weeks)|Death|1|||
145474803|NCT01727336|524590119|FG003|Part 2 Blinded|Lack of Efficacy|0|||
145630729|NCT00853827|525161181|FG001|Double Blind Period (103 Weeks)|Death|6|||
145630730|NCT00290732|525161183|FG000|Overall Study|Inability to instill drug intraductally.|0|||
145630731|NCT00290732|525161184|FG001|Overall Study|Inability to instill drug intraductally.|1|||
145630732|NCT00290732|525161185|FG002|Overall Study|Inability to instill drug intraductally.|1|||
145630733|NCT00290732|525161186|FG003|Overall Study|Inability to instill drug intraductally.|0|||
145630734|NCT00290732|525161187|FG004|Overall Study|Inability to instill drug intraductally.|0|||
145630735|NCT00502593|525161188|FG000|Overall Study|Withdrawn unspecified reason|1|||
145474804|NCT01727336|524590120|FG004|Part 2 Blinded|Lack of Efficacy|42|||
145630736|NCT00502593|525161189|FG001|Overall Study|Withdrawn unspecified reason|1|||
145630737|NCT00502593|525161190|FG002|Overall Study|Withdrawn unspecified reason|3|||
145630738|NCT00502593|525161191|FG003|Overall Study|Withdrawn unspecified reason|1|||
145630739|NCT00502593|525161192|FG004|Overall Study|Withdrawn unspecified reason|2|||
145630740|NCT00502593|525161193|FG005|Overall Study|Withdrawn unspecified reason|0|||
145630741|NCT00502593|525161194|FG006|Overall Study|Withdrawn unspecified reason|2|||
145630742|NCT00502593|525161195|FG007|Overall Study|Withdrawn unspecified reason|0|||
145630743|NCT00502593|525161196|FG008|Overall Study|Withdrawn unspecified reason|0|||
145630744|NCT00502593|525161197|FG009|Overall Study|Withdrawn unspecified reason|0|||
145630745|NCT00502593|525161198|FG010|Overall Study|Withdrawn unspecified reason|0|||
145630746|NCT00502593|525161199|FG011|Overall Study|Withdrawn unspecified reason|0|||
145630747|NCT00502593|525161188|FG000|Overall Study|Withdrawal by Subject|0|||
145630748|NCT00502593|525161189|FG001|Overall Study|Withdrawal by Subject|0|||
145630749|NCT00502593|525161190|FG002|Overall Study|Withdrawal by Subject|6|||
145630750|NCT00502593|525161191|FG003|Overall Study|Withdrawal by Subject|2|||
145630751|NCT00502593|525161192|FG004|Overall Study|Withdrawal by Subject|2|||
145630752|NCT00502593|525161193|FG005|Overall Study|Withdrawal by Subject|0|||
145630753|NCT00502593|525161194|FG006|Overall Study|Withdrawal by Subject|3|||
145630754|NCT00502593|525161195|FG007|Overall Study|Withdrawal by Subject|0|||
145630755|NCT00502593|525161196|FG008|Overall Study|Withdrawal by Subject|3|||
145630756|NCT00502593|525161197|FG009|Overall Study|Withdrawal by Subject|0|||
145630757|NCT00502593|525161198|FG010|Overall Study|Withdrawal by Subject|1|||
145630758|NCT00502593|525161199|FG011|Overall Study|Withdrawal by Subject|0|||
145630759|NCT00502593|525161188|FG000|Overall Study|Lost to Follow-up|2|||
145630760|NCT00502593|525161189|FG001|Overall Study|Lost to Follow-up|1|||
145630761|NCT00502593|525161190|FG002|Overall Study|Lost to Follow-up|1|||
145630762|NCT00502593|525161191|FG003|Overall Study|Lost to Follow-up|1|||
145630763|NCT00502593|525161192|FG004|Overall Study|Lost to Follow-up|0|||
145630764|NCT00502593|525161193|FG005|Overall Study|Lost to Follow-up|0|||
145630765|NCT00502593|525161194|FG006|Overall Study|Lost to Follow-up|0|||
145630766|NCT00502593|525161195|FG007|Overall Study|Lost to Follow-up|0|||
145630767|NCT00502593|525161196|FG008|Overall Study|Lost to Follow-up|3|||
145630768|NCT00502593|525161197|FG009|Overall Study|Lost to Follow-up|0|||
145630769|NCT00502593|525161198|FG010|Overall Study|Lost to Follow-up|1|||
145630770|NCT00502593|525161199|FG011|Overall Study|Lost to Follow-up|0|||
145630771|NCT01460342|525161202|FG000|Overall Study|Adverse Event|5|||
145630772|NCT01460342|525161203|FG001|Overall Study|Adverse Event|4|||
145630773|NCT01460342|525161202|FG000|Overall Study|Lost to Follow-up|1|||
145630774|NCT01460342|525161203|FG001|Overall Study|Lost to Follow-up|2|||
145630775|NCT01460342|525161202|FG000|Overall Study|Protocol Violation|0|||
145630776|NCT01460342|525161203|FG001|Overall Study|Protocol Violation|1|||
145630777|NCT01460342|525161202|FG000|Overall Study|Withdrawal by Subject|3|||
145630778|NCT01460342|525161203|FG001|Overall Study|Withdrawal by Subject|4|||
145630779|NCT01460342|525161202|FG000|Overall Study|Physician Decision|1|||
145630780|NCT01460342|525161203|FG001|Overall Study|Physician Decision|3|||
145630781|NCT01460342|525161202|FG000|Overall Study|Lack of Efficacy|1|||
145630782|NCT01460342|525161203|FG001|Overall Study|Lack of Efficacy|0|||
145630783|NCT00591838|525161204|FG000|Overall Study|Withdrawal by Subject|0|||
145630784|NCT00591838|525161205|FG001|Overall Study|Withdrawal by Subject|0|||
145630785|NCT00591838|525161206|FG002|Overall Study|Withdrawal by Subject|0|||
145630786|NCT00591838|525161207|FG003|Overall Study|Withdrawal by Subject|1|||
145630787|NCT00591838|525161208|FG004|Overall Study|Withdrawal by Subject|0|||
145630788|NCT02982213|525161210|FG000|Overall Study|Did not complete follow up questionnaire|5|||
145630789|NCT02982213|525161211|FG001|Overall Study|Did not complete follow up questionnaire|1|||
145630790|NCT01549652|525161212|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
145630791|NCT01549652|525161213|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
145630792|NCT01549652|525161214|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
145630793|NCT01549652|525161215|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
145630794|NCT01549652|525161212|FG000|Overall Study|Study Drug Titration Failure|5|||
145630795|NCT01549652|525161213|FG001|Overall Study|Study Drug Titration Failure|6|||
145630796|NCT01549652|525161214|FG002|Overall Study|Study Drug Titration Failure|0|||
145630797|NCT01549652|525161215|FG003|Overall Study|Study Drug Titration Failure|0|||
145630798|NCT01549652|525161212|FG000|Overall Study|Withdrawal Effect|0|||
145630799|NCT01549652|525161213|FG001|Overall Study|Withdrawal Effect|2|||
145630800|NCT01549652|525161214|FG002|Overall Study|Withdrawal Effect|0|||
145630801|NCT01549652|525161215|FG003|Overall Study|Withdrawal Effect|0|||
145630802|NCT01549652|525161212|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
145630803|NCT01549652|525161213|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
145630804|NCT01549652|525161214|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
145630805|NCT01549652|525161215|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
145630806|NCT01549652|525161212|FG000|Overall Study|Problem with Infusion|1|||
145630807|NCT01549652|525161213|FG001|Overall Study|Problem with Infusion|0|||
145630808|NCT01549652|525161214|FG002|Overall Study|Problem with Infusion|0|||
145630809|NCT01549652|525161215|FG003|Overall Study|Problem with Infusion|0|||
145630810|NCT01549652|525161212|FG000|Overall Study|Titration Non-Compliance|1|||
145630811|NCT01549652|525161213|FG001|Overall Study|Titration Non-Compliance|3|||
145630812|NCT01549652|525161214|FG002|Overall Study|Titration Non-Compliance|4|||
145630813|NCT01549652|525161215|FG003|Overall Study|Titration Non-Compliance|5|||
145630814|NCT01549652|525161212|FG000|Overall Study|Titration Side Effects|0|||
145630815|NCT01549652|525161213|FG001|Overall Study|Titration Side Effects|0|||
145630816|NCT01549652|525161214|FG002|Overall Study|Titration Side Effects|6|||
145630817|NCT01549652|525161215|FG003|Overall Study|Titration Side Effects|3|||
145630818|NCT01549652|525161212|FG000|Overall Study|Withdrawal by Subject|0|||
145630819|NCT01549652|525161213|FG001|Overall Study|Withdrawal by Subject|0|||
145630820|NCT01549652|525161214|FG002|Overall Study|Withdrawal by Subject|5|||
145630821|NCT01549652|525161215|FG003|Overall Study|Withdrawal by Subject|3|||
145630822|NCT04163458|525161220|FG000|Overall Study|Protocol Deviation|7|||
145630823|NCT04163458|525161221|FG001|Overall Study|Protocol Deviation|13|||
145630824|NCT04163458|525161220|FG000|Overall Study|Adverse Event|5|||
145630825|NCT04163458|525161221|FG001|Overall Study|Adverse Event|8|||
145630826|NCT04163458|525161220|FG000|Overall Study|Due to COVID-19 pandemic|4|||
145630827|NCT04163458|525161221|FG001|Overall Study|Due to COVID-19 pandemic|2|||
145630828|NCT04163458|525161220|FG000|Overall Study|Participant withdrew consent|2|||
145630829|NCT04163458|525161221|FG001|Overall Study|Participant withdrew consent|3|||
145630830|NCT04163458|525161220|FG000|Overall Study|Randomization failure|2|||
145630831|NCT04163458|525161221|FG001|Overall Study|Randomization failure|2|||
145630832|NCT04163458|525161220|FG000|Overall Study|Other|4|||
145630833|NCT04163458|525161221|FG001|Overall Study|Other|2|||
145630834|NCT03247543|525161222|FG000|Overall Study|Adverse Event|3|||
145630835|NCT03247543|525161223|FG001|Overall Study|Adverse Event|6|||
145630836|NCT03247543|525161224|FG002|Overall Study|Adverse Event|4|||
145630837|NCT03247543|525161222|FG000|Overall Study|Lost to Follow-up|10|||
145630838|NCT03247543|525161223|FG001|Overall Study|Lost to Follow-up|7|||
145630839|NCT03247543|525161224|FG002|Overall Study|Lost to Follow-up|8|||
145630840|NCT03247543|525161222|FG000|Overall Study|Consent withdrawn by caregiver|2|||
145630841|NCT03247543|525161223|FG001|Overall Study|Consent withdrawn by caregiver|2|||
145630842|NCT03247543|525161224|FG002|Overall Study|Consent withdrawn by caregiver|9|||
145630843|NCT03247543|525161222|FG000|Overall Study|Withdrawal by Subject|0|||
145630844|NCT03247543|525161223|FG001|Overall Study|Withdrawal by Subject|0|||
145630845|NCT03247543|525161224|FG002|Overall Study|Withdrawal by Subject|1|||
145630846|NCT03247543|525161222|FG000|Overall Study|Failure to Follow study procedures|1|||
145630847|NCT03247543|525161223|FG001|Overall Study|Failure to Follow study procedures|3|||
145630848|NCT03247543|525161224|FG002|Overall Study|Failure to Follow study procedures|1|||
145630849|NCT03247543|525161222|FG000|Overall Study|Lack of Efficacy|1|||
145630850|NCT03247543|525161223|FG001|Overall Study|Lack of Efficacy|0|||
145630851|NCT03247543|525161224|FG002|Overall Study|Lack of Efficacy|0|||
145630852|NCT03247543|525161222|FG000|Overall Study|Non-compliance with study visits|0|||
145630853|NCT03247543|525161223|FG001|Overall Study|Non-compliance with study visits|1|||
145630854|NCT03247543|525161224|FG002|Overall Study|Non-compliance with study visits|0|||
145630855|NCT02059980|525161228|FG000|Overall Study|Lost to Follow-up|2|||
145630856|NCT02059980|525161229|FG001|Overall Study|Lost to Follow-up|1|||
145630857|NCT01104415|525161230|FG000|Core Phase|Consent withdrawn by subjects|1|||
145630858|NCT01104415|525161231|FG001|Core Phase|Consent withdrawn by subjects|0|||
145630859|NCT01104415|525161230|FG000|Extension Period|Progressive disease|0|||
145630860|NCT01104415|525161231|FG001|Extension Period|Progressive disease|4|||
145630861|NCT01104415|525161230|FG000|Extension Period|Death|0|||
145630862|NCT01104415|525161231|FG001|Extension Period|Death|1|||
145630863|NCT01104415|525161230|FG000|Extension Period|Physician Decision|0|||
145630864|NCT01104415|525161231|FG001|Extension Period|Physician Decision|1|||
145630865|NCT01104415|525161230|FG000|Extension Period|Transition to Study LX1606.302|0|||
145630866|NCT01104415|525161231|FG001|Extension Period|Transition to Study LX1606.302|4|||
145630867|NCT01104415|525161230|FG000|Extension Period|Heart surgery/feeling miserable|0|||
145630868|NCT01104415|525161231|FG001|Extension Period|Heart surgery/feeling miserable|1|||
145630869|NCT05196737|525161232|FG000|Non-intervention Week|Lost to Follow-up|2|||
145630870|NCT05196737|525161232|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
145630871|NCT03722446|525161233|FG000|Overall Study|Protocol Violation|15|||
145630872|NCT03722446|525161234|FG001|Overall Study|Protocol Violation|2|||
145630873|NCT02908464|525161239|FG000|Overall Study|Withdrawal by Subject|2|||
145630874|NCT02908464|525161240|FG001|Overall Study|Withdrawal by Subject|1|||
145630875|NCT02908464|525161239|FG000|Overall Study|Found ineligible after randomization|0|||
145630876|NCT02908464|525161240|FG001|Overall Study|Found ineligible after randomization|2|||
145630877|NCT02163915|525161241|FG000|Overall Study|Withdrawal by Subject|2|||
145630878|NCT02163915|525161242|FG001|Overall Study|Withdrawal by Subject|0|||
145630879|NCT02163915|525161243|FG002|Overall Study|Withdrawal by Subject|2|||
145630880|NCT02163915|525161244|FG003|Overall Study|Withdrawal by Subject|2|||
145630881|NCT02163915|525161245|FG004|Overall Study|Withdrawal by Subject|2|||
145630882|NCT02163915|525161241|FG000|Overall Study|Study termination|1|||
145630883|NCT02163915|525161242|FG001|Overall Study|Study termination|0|||
145630884|NCT02163915|525161243|FG002|Overall Study|Study termination|0|||
145630885|NCT02163915|525161244|FG003|Overall Study|Study termination|0|||
145630886|NCT02163915|525161245|FG004|Overall Study|Study termination|2|||
145630887|NCT02163915|525161241|FG000|Overall Study|Physician Decision|0|||
145630888|NCT02163915|525161242|FG001|Overall Study|Physician Decision|0|||
145630889|NCT02163915|525161243|FG002|Overall Study|Physician Decision|0|||
145630890|NCT02163915|525161244|FG003|Overall Study|Physician Decision|1|||
145630891|NCT02163915|525161245|FG004|Overall Study|Physician Decision|0|||
145630892|NCT00777556|525162667|FG000|Overall Study|Inappropriate self-selection|34|||
145630893|NCT00777556|525162667|FG000|Overall Study|Dispensed but did not use product|12|||
145630894|NCT00777556|525162667|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
145630895|NCT05298111|525162669|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
145630896|NCT05298111|525162670|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
145630897|NCT02380742|525162673|FG000|Overall Study|Withdrawal by Subject|1|||
145630898|NCT02380742|525162674|FG001|Overall Study|Withdrawal by Subject|0|||
145630899|NCT01729819|525162676|FG000|Overall Study|Adverse Event|2|||
145630900|NCT01729819|525162677|FG001|Overall Study|Adverse Event|4|||
145630901|NCT01729819|525162676|FG000|Overall Study|Lack of Efficacy|1|||
145630902|NCT01729819|525162677|FG001|Overall Study|Lack of Efficacy|0|||
145630903|NCT01729819|525162676|FG000|Overall Study|Lost to Follow-up|2|||
145630904|NCT01729819|525162677|FG001|Overall Study|Lost to Follow-up|0|||
145630905|NCT01729819|525162676|FG000|Overall Study|Other reason|1|||
145630906|NCT01729819|525162677|FG001|Overall Study|Other reason|0|||
145630907|NCT01729819|525162676|FG000|Overall Study|Protocol Violation|0|||
145630908|NCT01729819|525162677|FG001|Overall Study|Protocol Violation|1|||
145630909|NCT01729819|525162676|FG000|Overall Study|Withdrawal by Subject|0|||
145630910|NCT01729819|525162677|FG001|Overall Study|Withdrawal by Subject|2|||
145630911|NCT02987543|525162680|FG000|Overall Study|Ongoing study at data cut off|49|||
145630912|NCT02987543|525162681|FG001|Overall Study|Ongoing study at data cut off|21|||
145630913|NCT02987543|525162682|FG002|Overall Study|Ongoing study at data cut off|19|||
145630914|NCT02987543|525162683|FG003|Overall Study|Ongoing study at data cut off|12|||
145630915|NCT02987543|525162680|FG000|Overall Study|Death|88|||
145630916|NCT02987543|525162681|FG001|Overall Study|Death|54|||
145630917|NCT02987543|525162682|FG002|Overall Study|Death|67|||
145630918|NCT02987543|525162683|FG003|Overall Study|Death|28|||
145630919|NCT02987543|525162680|FG000|Overall Study|Lost to Follow-up|3|||
145630920|NCT02987543|525162681|FG001|Overall Study|Lost to Follow-up|0|||
145630921|NCT02987543|525162682|FG002|Overall Study|Lost to Follow-up|1|||
145630922|NCT02987543|525162683|FG003|Overall Study|Lost to Follow-up|0|||
145630923|NCT02987543|525162680|FG000|Overall Study|Screen failure|0|||
145630924|NCT02987543|525162681|FG001|Overall Study|Screen failure|0|||
145630925|NCT02987543|525162682|FG002|Overall Study|Screen failure|0|||
145630926|NCT02987543|525162683|FG003|Overall Study|Screen failure|1|||
145630927|NCT02987543|525162680|FG000|Overall Study|Withdrawal by Subject|21|||
145630928|NCT02987543|525162681|FG001|Overall Study|Withdrawal by Subject|7|||
145630929|NCT02987543|525162682|FG002|Overall Study|Withdrawal by Subject|7|||
145630930|NCT02987543|525162683|FG003|Overall Study|Withdrawal by Subject|6|||
145630931|NCT02987543|525162680|FG000|Overall Study|Study terminated by sponsor|1|||
145630932|NCT02987543|525162681|FG001|Overall Study|Study terminated by sponsor|0|||
145630933|NCT02987543|525162682|FG002|Overall Study|Study terminated by sponsor|0|||
145630934|NCT02987543|525162683|FG003|Overall Study|Study terminated by sponsor|0|||
145630935|NCT02987543|525162680|FG000|Overall Study|Investigator decision|0|||
145630936|NCT02987543|525162681|FG001|Overall Study|Investigator decision|1|||
145630937|NCT02987543|525162682|FG002|Overall Study|Investigator decision|0|||
145630938|NCT02987543|525162683|FG003|Overall Study|Investigator decision|0|||
145630939|NCT02987543|525162680|FG000|Overall Study|Disease progression|0|||
145630940|NCT02987543|525162681|FG001|Overall Study|Disease progression|0|||
145630941|NCT02987543|525162682|FG002|Overall Study|Disease progression|0|||
145630942|NCT02987543|525162683|FG003|Overall Study|Disease progression|1|||
145630943|NCT02001623|525162684|FG000|Overall Study|Disease Progression|2|||
145630944|NCT02001623|525162685|FG001|Overall Study|Disease Progression|2|||
145630945|NCT02001623|525162686|FG002|Overall Study|Disease Progression|3|||
145630946|NCT02001623|525162687|FG003|Overall Study|Disease Progression|2|||
145630947|NCT02001623|525162688|FG004|Overall Study|Disease Progression|3|||
145630948|NCT02001623|525162689|FG005|Overall Study|Disease Progression|2|||
145630949|NCT02001623|525162690|FG006|Overall Study|Disease Progression|3|||
145630950|NCT02001623|525162691|FG007|Overall Study|Disease Progression|3|||
145630951|NCT02001623|525162692|FG008|Overall Study|Disease Progression|7|||
145474805|NCT01727336|524590121|FG005|Part 2 Blinded|Lack of Efficacy|44|||
145474806|NCT01727336|524590116|FG000|Part 2 Blinded|Lost to Follow-up|0|||
145630952|NCT02001623|525162693|FG009|Overall Study|Disease Progression|40|||
145630953|NCT02001623|525162694|FG010|Overall Study|Disease Progression|5|||
145630954|NCT02001623|525162695|FG011|Overall Study|Disease Progression|9|||
145630955|NCT02001623|525162696|FG012|Overall Study|Disease Progression|9|||
145630956|NCT02001623|525162697|FG013|Overall Study|Disease Progression|20|||
145630957|NCT02001623|525162698|FG014|Overall Study|Disease Progression|9|||
145630958|NCT02001623|525162684|FG000|Overall Study|Physician Decision|0|||
145630959|NCT02001623|525162685|FG001|Overall Study|Physician Decision|0|||
145630960|NCT02001623|525162686|FG002|Overall Study|Physician Decision|0|||
145630961|NCT02001623|525162687|FG003|Overall Study|Physician Decision|0|||
145630962|NCT02001623|525162688|FG004|Overall Study|Physician Decision|0|||
145630963|NCT02001623|525162689|FG005|Overall Study|Physician Decision|0|||
145630964|NCT02001623|525162690|FG006|Overall Study|Physician Decision|0|||
145630965|NCT02001623|525162691|FG007|Overall Study|Physician Decision|0|||
145630966|NCT02001623|525162692|FG008|Overall Study|Physician Decision|3|||
145630967|NCT02001623|525162693|FG009|Overall Study|Physician Decision|2|||
145630968|NCT02001623|525162694|FG010|Overall Study|Physician Decision|3|||
145630969|NCT02001623|525162695|FG011|Overall Study|Physician Decision|3|||
145630970|NCT02001623|525162696|FG012|Overall Study|Physician Decision|1|||
145630971|NCT02001623|525162697|FG013|Overall Study|Physician Decision|2|||
145630972|NCT02001623|525162698|FG014|Overall Study|Physician Decision|1|||
145630973|NCT02001623|525162684|FG000|Overall Study|Death|0|||
145630974|NCT02001623|525162685|FG001|Overall Study|Death|1|||
145630975|NCT02001623|525162686|FG002|Overall Study|Death|0|||
145630976|NCT02001623|525162687|FG003|Overall Study|Death|0|||
145630977|NCT02001623|525162688|FG004|Overall Study|Death|0|||
145630978|NCT02001623|525162689|FG005|Overall Study|Death|0|||
145630979|NCT02001623|525162690|FG006|Overall Study|Death|0|||
145630980|NCT02001623|525162691|FG007|Overall Study|Death|0|||
145630981|NCT02001623|525162692|FG008|Overall Study|Death|0|||
145630982|NCT02001623|525162693|FG009|Overall Study|Death|0|||
145630983|NCT02001623|525162694|FG010|Overall Study|Death|0|||
145630984|NCT02001623|525162695|FG011|Overall Study|Death|0|||
145630985|NCT02001623|525162696|FG012|Overall Study|Death|0|||
145630986|NCT02001623|525162697|FG013|Overall Study|Death|0|||
145630987|NCT02001623|525162698|FG014|Overall Study|Death|0|||
145630988|NCT02001623|525162684|FG000|Overall Study|Adverse Event|0|||
145630989|NCT02001623|525162685|FG001|Overall Study|Adverse Event|0|||
145630990|NCT02001623|525162686|FG002|Overall Study|Adverse Event|0|||
145630991|NCT02001623|525162687|FG003|Overall Study|Adverse Event|0|||
145630992|NCT02001623|525162688|FG004|Overall Study|Adverse Event|0|||
145630993|NCT02001623|525162689|FG005|Overall Study|Adverse Event|1|||
145630994|NCT02001623|525162690|FG006|Overall Study|Adverse Event|0|||
145630995|NCT02001623|525162691|FG007|Overall Study|Adverse Event|3|||
145630996|NCT02001623|525162692|FG008|Overall Study|Adverse Event|4|||
145630997|NCT02001623|525162693|FG009|Overall Study|Adverse Event|6|||
145630998|NCT02001623|525162694|FG010|Overall Study|Adverse Event|4|||
145630999|NCT02001623|525162695|FG011|Overall Study|Adverse Event|0|||
145631000|NCT02001623|525162696|FG012|Overall Study|Adverse Event|3|||
145631001|NCT02001623|525162697|FG013|Overall Study|Adverse Event|5|||
145631002|NCT02001623|525162698|FG014|Overall Study|Adverse Event|6|||
145474807|NCT01727336|524590117|FG001|Part 2 Blinded|Lost to Follow-up|0|||
145474808|NCT01727336|524590118|FG002|Part 2 Blinded|Lost to Follow-up|0|||
145474809|NCT01727336|524590119|FG003|Part 2 Blinded|Lost to Follow-up|0|||
145474810|NCT01727336|524590120|FG004|Part 2 Blinded|Lost to Follow-up|0|||
145474811|NCT01727336|524590121|FG005|Part 2 Blinded|Lost to Follow-up|1|||
145474812|NCT01727336|524590116|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
145631003|NCT02001623|525162684|FG000|Overall Study|Other - Miscellaneous|0|||
145631004|NCT02001623|525162685|FG001|Overall Study|Other - Miscellaneous|0|||
145631005|NCT02001623|525162686|FG002|Overall Study|Other - Miscellaneous|0|||
145631006|NCT02001623|525162687|FG003|Overall Study|Other - Miscellaneous|0|||
145631007|NCT02001623|525162688|FG004|Overall Study|Other - Miscellaneous|0|||
145631008|NCT02001623|525162689|FG005|Overall Study|Other - Miscellaneous|0|||
145631009|NCT02001623|525162690|FG006|Overall Study|Other - Miscellaneous|0|||
145631010|NCT02001623|525162691|FG007|Overall Study|Other - Miscellaneous|0|||
145631011|NCT02001623|525162692|FG008|Overall Study|Other - Miscellaneous|0|||
145631012|NCT02001623|525162693|FG009|Overall Study|Other - Miscellaneous|1|||
145631013|NCT02001623|525162694|FG010|Overall Study|Other - Miscellaneous|0|||
145631014|NCT02001623|525162695|FG011|Overall Study|Other - Miscellaneous|0|||
145631015|NCT02001623|525162696|FG012|Overall Study|Other - Miscellaneous|0|||
145631016|NCT02001623|525162697|FG013|Overall Study|Other - Miscellaneous|1|||
145631017|NCT02001623|525162698|FG014|Overall Study|Other - Miscellaneous|0|||
145631018|NCT02001623|525162684|FG000|Overall Study|Withdrawal by Subject|1|||
145474813|NCT01727336|524590117|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
145631019|NCT02001623|525162685|FG001|Overall Study|Withdrawal by Subject|0|||
145631020|NCT02001623|525162686|FG002|Overall Study|Withdrawal by Subject|0|||
145631021|NCT02001623|525162687|FG003|Overall Study|Withdrawal by Subject|0|||
145631022|NCT02001623|525162688|FG004|Overall Study|Withdrawal by Subject|0|||
145631023|NCT02001623|525162689|FG005|Overall Study|Withdrawal by Subject|0|||
145631024|NCT02001623|525162690|FG006|Overall Study|Withdrawal by Subject|0|||
145631025|NCT02001623|525162691|FG007|Overall Study|Withdrawal by Subject|0|||
145631026|NCT02001623|525162692|FG008|Overall Study|Withdrawal by Subject|1|||
145631027|NCT02001623|525162693|FG009|Overall Study|Withdrawal by Subject|3|||
145631028|NCT02001623|525162694|FG010|Overall Study|Withdrawal by Subject|2|||
145631029|NCT02001623|525162695|FG011|Overall Study|Withdrawal by Subject|2|||
145631030|NCT02001623|525162696|FG012|Overall Study|Withdrawal by Subject|1|||
145631031|NCT02001623|525162697|FG013|Overall Study|Withdrawal by Subject|5|||
145631032|NCT02001623|525162698|FG014|Overall Study|Withdrawal by Subject|2|||
145474814|NCT01727336|524590118|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
145631033|NCT02001623|525162684|FG000|Overall Study|Lost to Follow-up|0|||
145631034|NCT02001623|525162685|FG001|Overall Study|Lost to Follow-up|0|||
145631035|NCT02001623|525162686|FG002|Overall Study|Lost to Follow-up|0|||
145631036|NCT02001623|525162687|FG003|Overall Study|Lost to Follow-up|0|||
145474815|NCT01727336|524590119|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
145474816|NCT01727336|524590120|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
145474817|NCT01727336|524590121|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
145474818|NCT01727336|524590116|FG000|Part 2 Blinded|use of prohibited medications|0|||
145474819|NCT01727336|524590117|FG001|Part 2 Blinded|use of prohibited medications|0|||
145474820|NCT01727336|524590118|FG002|Part 2 Blinded|use of prohibited medications|0|||
145474821|NCT01727336|524590119|FG003|Part 2 Blinded|use of prohibited medications|0|||
145474822|NCT01727336|524590120|FG004|Part 2 Blinded|use of prohibited medications|1|||
145474823|NCT01727336|524590121|FG005|Part 2 Blinded|use of prohibited medications|3|||
145474824|NCT00619099|524590124|FG000|Overall Study|Progressive Disease|7|||
145474825|NCT00619099|524590125|FG001|Overall Study|Progressive Disease|5|||
145474826|NCT00619099|524590124|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
145474827|NCT00619099|524590125|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
145474828|NCT00619099|524590124|FG000|Overall Study|Adverse Event|4|||
145474829|NCT00619099|524590125|FG001|Overall Study|Adverse Event|3|||
145474830|NCT00619099|524590124|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
145474831|NCT00619099|524590125|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
145474832|NCT00619099|524590124|FG000|Overall Study|Withdrawal by Subject|10|||
145474833|NCT00619099|524590125|FG001|Overall Study|Withdrawal by Subject|2|||
145474834|NCT00619099|524590124|FG000|Overall Study|Physician Decision|9|||
145474835|NCT00619099|524590125|FG001|Overall Study|Physician Decision|6|||
145474836|NCT00084656|524590126|FG000|Overall Study|Other reasons|0|||
145474837|NCT00084656|524590127|FG001|Overall Study|Other reasons|12|||
145474838|NCT00084656|524590128|FG002|Overall Study|Other reasons|11|||
145474839|NCT00084656|524590126|FG000|Overall Study|Withdrawal by Subject|15|||
145474840|NCT00084656|524590127|FG001|Overall Study|Withdrawal by Subject|4|||
145474841|NCT00084656|524590128|FG002|Overall Study|Withdrawal by Subject|4|||
145474842|NCT00084656|524590126|FG000|Overall Study|Disease relapse|0|||
145474843|NCT00084656|524590127|FG001|Overall Study|Disease relapse|9|||
145631037|NCT02001623|525162688|FG004|Overall Study|Lost to Follow-up|0|||
145631038|NCT02001623|525162689|FG005|Overall Study|Lost to Follow-up|0|||
145631039|NCT02001623|525162690|FG006|Overall Study|Lost to Follow-up|0|||
145631040|NCT02001623|525162691|FG007|Overall Study|Lost to Follow-up|0|||
145631041|NCT02001623|525162692|FG008|Overall Study|Lost to Follow-up|0|||
145631042|NCT02001623|525162693|FG009|Overall Study|Lost to Follow-up|1|||
145631043|NCT02001623|525162694|FG010|Overall Study|Lost to Follow-up|0|||
145631044|NCT02001623|525162695|FG011|Overall Study|Lost to Follow-up|0|||
145631045|NCT02001623|525162696|FG012|Overall Study|Lost to Follow-up|0|||
145631046|NCT02001623|525162697|FG013|Overall Study|Lost to Follow-up|0|||
145631047|NCT02001623|525162698|FG014|Overall Study|Lost to Follow-up|0|||
145631048|NCT02001623|525162684|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
145631049|NCT02001623|525162685|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
145631050|NCT02001623|525162686|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
145631051|NCT02001623|525162687|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
145631052|NCT02001623|525162688|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
145631053|NCT02001623|525162689|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
145631054|NCT02001623|525162690|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
145631055|NCT02001623|525162691|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
145631056|NCT02001623|525162692|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
145631057|NCT02001623|525162693|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
145631058|NCT02001623|525162694|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
145631059|NCT02001623|525162695|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
145631060|NCT02001623|525162696|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
145631061|NCT02001623|525162697|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
145631062|NCT02001623|525162698|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
145631063|NCT02001623|525162684|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
145631064|NCT02001623|525162685|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
145631065|NCT02001623|525162686|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
145631066|NCT02001623|525162687|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
145474844|NCT00084656|524590128|FG002|Overall Study|Disease relapse|10|||
145474845|NCT00084656|524590126|FG000|Overall Study|Disease progression|9|||
145474846|NCT00084656|524590127|FG001|Overall Study|Disease progression|0|||
145631067|NCT02001623|525162688|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
145631068|NCT02001623|525162689|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
145631069|NCT02001623|525162690|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
145474847|NCT00084656|524590128|FG002|Overall Study|Disease progression|0|||
145474848|NCT00084656|524590126|FG000|Overall Study|Lost to Follow-up|1|||
145474849|NCT00084656|524590127|FG001|Overall Study|Lost to Follow-up|0|||
145474850|NCT00084656|524590128|FG002|Overall Study|Lost to Follow-up|1|||
145631070|NCT02001623|525162691|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
145631071|NCT02001623|525162692|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
145631072|NCT02001623|525162693|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
145474851|NCT00778895|524590129|FG000|Active Phase|Adverse Event|3|||
145631073|NCT02001623|525162694|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
145631074|NCT02001623|525162695|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
145631075|NCT02001623|525162696|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
145631076|NCT02001623|525162697|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
145631077|NCT02001623|525162698|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
145631078|NCT01063036|525162703|FG000|Participants Treated With Study Drug|Adverse Event|1|||
145631079|NCT01063036|525162703|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
145631080|NCT01063036|525162703|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
145631081|NCT01063036|525162703|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
145631082|NCT01063036|525162703|FG000|Participants Treated With Study Drug|Pregnancy|1|||
145631083|NCT01063036|525162703|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
145631084|NCT01063036|525162703|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
145631085|NCT01063036|525162703|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
145631086|NCT05790408|525162704|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
145631087|NCT01064817|525162705|FG000|Study Completion|Physician Decision|1|||
145631088|NCT01064817|525162706|FG001|Study Completion|Physician Decision|0|||
145631089|NCT01064817|525162705|FG000|Study Completion|Withdrawal by Subject|1|||
145631090|NCT01064817|525162706|FG001|Study Completion|Withdrawal by Subject|0|||
145631091|NCT02274493|525162707|FG000|Overall Study|Withdrawal by Subject|1|||
145631092|NCT03102710|525162708|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
145631093|NCT03102710|525162709|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
145631094|NCT03102710|525162710|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
145631095|NCT03102710|525162708|FG000|Overall Study|Technical issues during final MRI scan|0|||
145631096|NCT03102710|525162709|FG001|Overall Study|Technical issues during final MRI scan|1|||
145631097|NCT03102710|525162710|FG002|Overall Study|Technical issues during final MRI scan|0|||
145631098|NCT03102710|525162708|FG000|Overall Study|Nausea during MRI scan|0|||
145631099|NCT03102710|525162709|FG001|Overall Study|Nausea during MRI scan|1|||
145631100|NCT03102710|525162710|FG002|Overall Study|Nausea during MRI scan|0|||
145631101|NCT03102710|525162708|FG000|Overall Study|Subject unable to attend final session|0|||
145631102|NCT03102710|525162709|FG001|Overall Study|Subject unable to attend final session|1|||
145631103|NCT03102710|525162710|FG002|Overall Study|Subject unable to attend final session|0|||
145631104|NCT01313182|525162711|FG000|Overall Study|Protocol Violation|66|||
145631105|NCT01313182|525162712|FG001|Overall Study|Protocol Violation|92|||
145631106|NCT01695317|525162713|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
145631107|NCT01695317|525162714|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
145631108|NCT01695317|525162713|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
145631109|NCT01695317|525162714|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
145631110|NCT00606580|525162718|FG000|Overall Study|Lost to Follow-up|1|||
145631111|NCT00606580|525162719|FG001|Overall Study|Lost to Follow-up|1|||
145631112|NCT00606580|525162720|FG002|Overall Study|Lost to Follow-up|4|||
145631113|NCT00606580|525162718|FG000|Overall Study|Clinical failures|1|||
145631114|NCT00606580|525162719|FG001|Overall Study|Clinical failures|0|||
145631115|NCT00606580|525162720|FG002|Overall Study|Clinical failures|12|||
145631116|NCT00606580|525162718|FG000|Overall Study|Withdrawal by investigator|0|||
145631117|NCT00606580|525162719|FG001|Overall Study|Withdrawal by investigator|1|||
145631118|NCT00606580|525162720|FG002|Overall Study|Withdrawal by investigator|6|||
145631119|NCT00606580|525162718|FG000|Overall Study|Withdrawal by Subject|0|||
145631120|NCT00606580|525162719|FG001|Overall Study|Withdrawal by Subject|1|||
145631121|NCT00606580|525162720|FG002|Overall Study|Withdrawal by Subject|0|||
145631122|NCT04580303|525162721|FG000|Overall Study|Adverse Event|0|||
145631123|NCT04580303|525162722|FG001|Overall Study|Adverse Event|1|||
145631124|NCT04580303|525162723|FG002|Overall Study|Adverse Event|0|||
145631125|NCT04580303|525162724|FG003|Overall Study|Adverse Event|0|||
145631126|NCT04580303|525162721|FG000|Overall Study|Withdrawal by Subject|0|||
145631127|NCT04580303|525162722|FG001|Overall Study|Withdrawal by Subject|0|||
145631128|NCT04580303|525162723|FG002|Overall Study|Withdrawal by Subject|1|||
145631129|NCT04580303|525162724|FG003|Overall Study|Withdrawal by Subject|0|||
145631130|NCT01456936|525162725|FG000|Overall Study|Other reason|41|||
145631131|NCT01456936|525162726|FG001|Overall Study|Other reason|30|||
145631132|NCT01456936|525162727|FG002|Overall Study|Other reason|36|||
145631133|NCT01456936|525162728|FG003|Overall Study|Other reason|33|||
145631134|NCT01456936|525162725|FG000|Overall Study|No longer meets eligibility criteria|4|||
145631135|NCT01456936|525162726|FG001|Overall Study|No longer meets eligibility criteria|8|||
145631136|NCT01456936|525162727|FG002|Overall Study|No longer meets eligibility criteria|6|||
145631137|NCT01456936|525162728|FG003|Overall Study|No longer meets eligibility criteria|5|||
145631138|NCT01456936|525162725|FG000|Overall Study|Protocol Violation|4|||
145631139|NCT01456936|525162726|FG001|Overall Study|Protocol Violation|2|||
145631140|NCT01456936|525162727|FG002|Overall Study|Protocol Violation|5|||
145631141|NCT01456936|525162728|FG003|Overall Study|Protocol Violation|5|||
145631142|NCT01456936|525162725|FG000|Overall Study|Pregnancy|1|||
145631143|NCT01456936|525162726|FG001|Overall Study|Pregnancy|0|||
145631144|NCT01456936|525162727|FG002|Overall Study|Pregnancy|0|||
145631145|NCT01456936|525162728|FG003|Overall Study|Pregnancy|1|||
145631146|NCT01456936|525162725|FG000|Overall Study|Insufficient clinical response|4|||
145631147|NCT01456936|525162726|FG001|Overall Study|Insufficient clinical response|4|||
145631148|NCT01456936|525162727|FG002|Overall Study|Insufficient clinical response|14|||
145631149|NCT01456936|525162728|FG003|Overall Study|Insufficient clinical response|13|||
145631150|NCT01456936|525162725|FG000|Overall Study|No longer willing to participate|195|||
145631151|NCT01456936|525162726|FG001|Overall Study|No longer willing to participate|218|||
145631152|NCT01456936|525162727|FG002|Overall Study|No longer willing to participate|224|||
145631153|NCT01456936|525162728|FG003|Overall Study|No longer willing to participate|248|||
145631154|NCT01456936|525162725|FG000|Overall Study|Lost to Follow-up|135|||
145631155|NCT01456936|525162726|FG001|Overall Study|Lost to Follow-up|126|||
145631156|NCT01456936|525162727|FG002|Overall Study|Lost to Follow-up|144|||
145631157|NCT01456936|525162728|FG003|Overall Study|Lost to Follow-up|127|||
145631158|NCT01456936|525162725|FG000|Overall Study|Medication error|0|||
145631159|NCT01456936|525162726|FG001|Overall Study|Medication error|1|||
145631160|NCT01456936|525162727|FG002|Overall Study|Medication error|0|||
145631161|NCT01456936|525162728|FG003|Overall Study|Medication error|1|||
145631162|NCT01456936|525162725|FG000|Overall Study|Adverse event (study drug)|25|||
145631163|NCT01456936|525162726|FG001|Overall Study|Adverse event (study drug)|21|||
145631164|NCT01456936|525162727|FG002|Overall Study|Adverse event (study drug)|26|||
145631165|NCT01456936|525162728|FG003|Overall Study|Adverse event (study drug)|17|||
145631166|NCT01456936|525162725|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
145631167|NCT01456936|525162726|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
145631168|NCT01456936|525162727|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
145631169|NCT01456936|525162728|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
145631170|NCT01456936|525162725|FG000|Overall Study|Death|0|||
145631171|NCT01456936|525162726|FG001|Overall Study|Death|3|||
145631172|NCT01456936|525162727|FG002|Overall Study|Death|1|||
145631173|NCT01456936|525162728|FG003|Overall Study|Death|3|||
145631174|NCT01456936|525162725|FG000|Overall Study|Randomized but not treated|21|||
145631175|NCT01456936|525162726|FG001|Overall Study|Randomized but not treated|28|||
145631176|NCT01456936|525162727|FG002|Overall Study|Randomized but not treated|16|||
145631177|NCT01456936|525162728|FG003|Overall Study|Randomized but not treated|21|||
145631178|NCT03095508|525162729|FG000|Overall Study|Adverse Event|0|||
145631179|NCT03095508|525162730|FG001|Overall Study|Adverse Event|1|||
145631180|NCT00001575|525162738|FG000|Overall Study|Screening failures-Ph I portion|22|||
145631181|NCT00001575|525162738|FG000|Overall Study|Withdrawn/deaths|23|||
145631182|NCT00831792|525162739|FG000|Overall Study|Not Eligible|3|||
145631183|NCT00831792|525162739|FG000|Overall Study|Adverse Event|1|||
145631184|NCT00831792|525162739|FG000|Overall Study|Death|1|||
145631185|NCT00831792|525162739|FG000|Overall Study|Lack of Efficacy|1|||
145631186|NCT01178762|525162740|FG000|Overall Study|Lost to Follow-up|15|||
145631187|NCT01651949|525162741|FG000|Overall Study|Unknown status|4|||
145631188|NCT01651949|525162742|FG001|Overall Study|Unknown status|4|||
145631189|NCT01651949|525162743|FG002|Overall Study|Unknown status|0|||
145631190|NCT01651949|525162741|FG000|Overall Study|Lost to Follow-up|30|||
145631191|NCT01651949|525162742|FG001|Overall Study|Lost to Follow-up|56|||
145631192|NCT01651949|525162743|FG002|Overall Study|Lost to Follow-up|20|||
145631193|NCT01651949|525162741|FG000|Overall Study|Protocol Violation|0|||
145631194|NCT01651949|525162742|FG001|Overall Study|Protocol Violation|2|||
145631195|NCT01651949|525162743|FG002|Overall Study|Protocol Violation|1|||
145631196|NCT01651949|525162741|FG000|Overall Study|Physician Decision|0|||
145631197|NCT01651949|525162742|FG001|Overall Study|Physician Decision|2|||
145631198|NCT01651949|525162743|FG002|Overall Study|Physician Decision|0|||
145631199|NCT01651949|525162741|FG000|Overall Study|Adverse Event|0|||
145631200|NCT01651949|525162742|FG001|Overall Study|Adverse Event|2|||
145631201|NCT01651949|525162743|FG002|Overall Study|Adverse Event|1|||
145631202|NCT01651949|525162741|FG000|Overall Study|Screen failure|2|||
145631203|NCT01651949|525162742|FG001|Overall Study|Screen failure|2|||
145631204|NCT01651949|525162743|FG002|Overall Study|Screen failure|0|||
145631205|NCT01651949|525162741|FG000|Overall Study|Withdrawal by Subject|17|||
145631206|NCT01651949|525162742|FG001|Overall Study|Withdrawal by Subject|18|||
145631207|NCT01651949|525162743|FG002|Overall Study|Withdrawal by Subject|9|||
145631208|NCT01191086|525162744|FG000|Overall Study|Adverse Event|20|||
145631209|NCT01191086|525162744|FG000|Overall Study|Lack of Efficacy|10|||
145631210|NCT01191086|525162744|FG000|Overall Study|Lost to Follow-up|4|||
145631211|NCT01191086|525162744|FG000|Overall Study|Physician Decision|2|||
145631212|NCT01191086|525162744|FG000|Overall Study|Withdrawal by Subject|24|||
145631213|NCT01191086|525162744|FG000|Overall Study|Discontinuation criterion met|1|||
145631214|NCT01191086|525162744|FG000|Overall Study|Other|1|||
145631215|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
145631216|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
145631217|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
145631218|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
145631219|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
145631220|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
145631221|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
145631222|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
145631223|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
145631224|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
145631225|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
145631226|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
145631227|NCT02057718|525162747|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
145631228|NCT02057718|525162748|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
145631229|NCT02057718|525162747|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
145631230|NCT02057718|525162748|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
145631231|NCT02057718|525162747|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
145631232|NCT02057718|525162748|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
145631233|NCT02057718|525162747|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
145631234|NCT02057718|525162748|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
145631235|NCT02057718|525162747|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
145631236|NCT02057718|525162748|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
145631237|NCT00906035|525162753|FG000|Overall Study|Withdrawal by Subject|2|||
145631238|NCT00906035|525162754|FG001|Overall Study|Withdrawal by Subject|3|||
145631239|NCT00906035|525162755|FG002|Overall Study|Withdrawal by Subject|0|||
145631240|NCT00835380|525162756|FG000|Overall Study|Withdrawal by Subject|2|||
145631241|NCT01582945|525162757|FG000|Overall Study|Intolerable side-effects|1|||
145631242|NCT01582945|525162757|FG000|Overall Study|Scheduling conflicts|1|||
145631243|NCT04858425|525162760|FG000|Overall Study|Adverse Event|2|||
145631244|NCT04858425|525162761|FG001|Overall Study|Adverse Event|2|||
145631245|NCT04858425|525162760|FG000|Overall Study|Withdrawal by Subject|3|||
145631246|NCT04858425|525162761|FG001|Overall Study|Withdrawal by Subject|1|||
145631247|NCT04858425|525162760|FG000|Overall Study|Lost to Follow-up|4|||
145631248|NCT04858425|525162761|FG001|Overall Study|Lost to Follow-up|2|||
145631249|NCT04858425|525162760|FG000|Overall Study|Lost to Follow-up|1|||
145631250|NCT04858425|525162761|FG001|Overall Study|Lost to Follow-up|0|||
145631251|NCT04536077|525162763|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
145631252|NCT04536077|525162764|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
145631253|NCT04536077|525162763|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
145631254|NCT04536077|525162764|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
145631255|NCT04550039|525162769|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
145631256|NCT04550039|525162770|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
145631257|NCT04550039|525162769|FG000|Overall Study|patient self-withdrew from study|0|||
145631258|NCT04550039|525162770|FG001|Overall Study|patient self-withdrew from study|1|||
145631259|NCT01155869|525162776|FG000|Overall Study|Lost to Follow-up|3|||
145631260|NCT01155869|525162777|FG001|Overall Study|Lost to Follow-up|1|||
145631261|NCT02824432|525162779|FG000|Overall Study|Major Protocol Deviation|1|||
145631262|NCT02824432|525162780|FG001|Overall Study|Major Protocol Deviation|0|||
145631263|NCT05824351|525162783|FG000|Overall Study|Adverse Event|6|||
145631264|NCT00828945|525162784|FG000|Overall Study|Death|4|||
145631265|NCT00828945|525162784|FG000|Overall Study|Participant was missing|1|||
145631266|NCT00828945|525162784|FG000|Overall Study|Other|36|||
145631267|NCT02698241|525162787|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
145631268|NCT02698241|525162787|FG000|Overall Study|Screening not met|7|||
145631269|NCT02698241|525162787|FG000|Overall Study|Withdrawal by Subject|7|||
145631270|NCT02698241|525162787|FG000|Overall Study|Physician Decision|2|||
145631271|NCT02698241|525162787|FG000|Overall Study|Subject underwent system modification|2|||
145631272|NCT02698241|525162787|FG000|Overall Study|Lost to Follow-up|3|||
145631273|NCT02698241|525162787|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
145631274|NCT02698241|525162787|FG000|Overall Study|geographic and licensing issue|1|||
145631275|NCT02698241|525162787|FG000|Overall Study|Death|2|||
145631276|NCT01543685|525162788|FG000|Overall Study|Lack of Efficacy|1|||
145631277|NCT01543685|525162789|FG001|Overall Study|Lack of Efficacy|2|||
145631278|NCT01543685|525162790|FG002|Overall Study|Lack of Efficacy|2|||
145631279|NCT01543685|525162791|FG003|Overall Study|Lack of Efficacy|0|||
145631280|NCT01543685|525162792|FG004|Overall Study|Lack of Efficacy|2|||
145631281|NCT01543685|525162788|FG000|Overall Study|Adverse Event|2|||
145631282|NCT01543685|525162789|FG001|Overall Study|Adverse Event|1|||
145631283|NCT01543685|525162790|FG002|Overall Study|Adverse Event|0|||
145631284|NCT01543685|525162791|FG003|Overall Study|Adverse Event|0|||
145631285|NCT01543685|525162792|FG004|Overall Study|Adverse Event|2|||
145631286|NCT00708097|525162795|FG000|Period 1|Protocol Violation|0|||
145631287|NCT00708097|525162796|FG001|Period 1|Protocol Violation|1|||
145631288|NCT00708097|525162797|FG002|Period 1|Protocol Violation|0|||
145631289|NCT00708097|525162798|FG003|Period 1|Protocol Violation|2|||
145631290|NCT00708097|525162799|FG004|Period 1|Protocol Violation|0|||
145631291|NCT00708097|525162795|FG000|Period 1|Other Reason|0|||
145631292|NCT00708097|525162796|FG001|Period 1|Other Reason|0|||
145474852|NCT00778895|524590130|FG001|Active Phase|Adverse Event|1|||
145631293|NCT00708097|525162797|FG002|Period 1|Other Reason|0|||
145631294|NCT00708097|525162798|FG003|Period 1|Other Reason|0|||
145631295|NCT00708097|525162799|FG004|Period 1|Other Reason|1|||
145631296|NCT00708097|525162795|FG000|Period 2|Protocol Violation|0|||
145631297|NCT00708097|525162796|FG001|Period 2|Protocol Violation|1|||
145631298|NCT00708097|525162797|FG002|Period 2|Protocol Violation|1|||
145631299|NCT00708097|525162798|FG003|Period 2|Protocol Violation|1|||
145631300|NCT00708097|525162799|FG004|Period 2|Protocol Violation|0|||
145631301|NCT00603447|525162800|FG000|Overall Study|Adverse Event|0|||
145631302|NCT00603447|525162801|FG001|Overall Study|Adverse Event|1|||
145631303|NCT00603447|525162802|FG002|Overall Study|Adverse Event|1|||
145631304|NCT00603447|525162803|FG003|Overall Study|Adverse Event|2|||
145631305|NCT00603447|525162804|FG004|Overall Study|Adverse Event|1|||
145631306|NCT00603447|525162805|FG005|Overall Study|Adverse Event|2|||
145631307|NCT00603447|525162806|FG006|Overall Study|Adverse Event|10|||
145631308|NCT00603447|525162800|FG000|Overall Study|Other|0|||
145631309|NCT00603447|525162801|FG001|Overall Study|Other|0|||
145631310|NCT00603447|525162802|FG002|Overall Study|Other|1|||
145631311|NCT00603447|525162803|FG003|Overall Study|Other|0|||
145631312|NCT00603447|525162804|FG004|Overall Study|Other|3|||
145631313|NCT00603447|525162805|FG005|Overall Study|Other|0|||
145631314|NCT00603447|525162806|FG006|Overall Study|Other|13|||
145631315|NCT00603447|525162800|FG000|Overall Study|Withdrew Consent|0|||
145631316|NCT00603447|525162801|FG001|Overall Study|Withdrew Consent|2|||
145631317|NCT00603447|525162802|FG002|Overall Study|Withdrew Consent|0|||
145631318|NCT00603447|525162803|FG003|Overall Study|Withdrew Consent|0|||
145631319|NCT00603447|525162804|FG004|Overall Study|Withdrew Consent|1|||
145631320|NCT00603447|525162805|FG005|Overall Study|Withdrew Consent|0|||
145631321|NCT00603447|525162806|FG006|Overall Study|Withdrew Consent|1|||
145631322|NCT01838200|525162807|FG000|Overall Study|Adverse Event|0|||
145631323|NCT01838200|525162808|FG001|Overall Study|Adverse Event|2|||
145631324|NCT01838200|525162807|FG000|Overall Study|Progressive disease|3|||
145631325|NCT01838200|525162808|FG001|Overall Study|Progressive disease|0|||
145631326|NCT01875250|525164469|FG000|Overall Study|Adverse Event|2|||
145631327|NCT01875250|525164470|FG001|Overall Study|Adverse Event|0|||
145631328|NCT00482729|525164473|FG000|Overall Study|Adverse Event|29|||
145631329|NCT00482729|525164474|FG001|Overall Study|Adverse Event|33|||
145631330|NCT00482729|525164473|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
145631331|NCT00482729|525164474|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
145631332|NCT00482729|525164473|FG000|Overall Study|Hyperglycemia Criteria|7|||
145631333|NCT00482729|525164474|FG001|Overall Study|Hyperglycemia Criteria|5|||
145631334|NCT00482729|525164473|FG000|Overall Study|Lack of Efficacy|4|||
145631335|NCT00482729|525164474|FG001|Overall Study|Lack of Efficacy|16|||
145631336|NCT00482729|525164473|FG000|Overall Study|Lost to Follow-up|86|||
145631337|NCT00482729|525164474|FG001|Overall Study|Lost to Follow-up|66|||
145631338|NCT00482729|525164473|FG000|Overall Study|Physician Decision|10|||
145631339|NCT00482729|525164474|FG001|Overall Study|Physician Decision|7|||
145631340|NCT00482729|525164473|FG000|Overall Study|Pregnancy|4|||
145631341|NCT00482729|525164474|FG001|Overall Study|Pregnancy|2|||
145631342|NCT00482729|525164473|FG000|Overall Study|Protocol Violation|10|||
145631343|NCT00482729|525164474|FG001|Overall Study|Protocol Violation|18|||
145631344|NCT00482729|525164473|FG000|Overall Study|Withdrawal by Subject|67|||
145631345|NCT00482729|525164474|FG001|Overall Study|Withdrawal by Subject|69|||
145631346|NCT03140176|525164475|FG000|Overall Study|Reason missing|23|||
145631347|NCT03140176|525164475|FG000|Overall Study|Death|33|||
145631348|NCT03140176|525164475|FG000|Overall Study|Disease progression|1|||
145631349|NCT03140176|525164475|FG000|Overall Study|Physician Decision|1|||
145631350|NCT03140176|525164475|FG000|Overall Study|Withdrawal by Subject|1|||
145631351|NCT03140176|525164475|FG000|Overall Study|Lost to Follow-up|15|||
145631352|NCT01091454|525164478|FG000|Overall Study|Ineligible|1|||
145631353|NCT00470626|525164479|FG000|Overall Study|Lost to Follow-up|10|||
145631354|NCT00470626|525164479|FG000|Overall Study|Withdrawal by Subject|7|||
145631355|NCT02689349|525164480|FG000|Overall Study|Not implanted|4|||
145631356|NCT02689349|525164481|FG001|Overall Study|Not implanted|0|||
145631357|NCT02689349|525164480|FG000|Overall Study|Withdrawal by Subject|9|||
145631358|NCT02689349|525164481|FG001|Overall Study|Withdrawal by Subject|0|||
145631359|NCT03518112|525164482|FG000|Overall Study|Withdrawal by Subject|1|||
145631360|NCT02930343|525164483|FG000|Overall Study|Lost to Follow-up|9|||
145631361|NCT02930343|525164484|FG001|Overall Study|Lost to Follow-up|7|||
145631362|NCT00377455|525164487|FG000|Overall Study|Withdrawal by Subject|1|||
145631363|NCT02814643|525164488|FG000|Overall Study|Lost to Follow-up|0|||
145631364|NCT02814643|525164489|FG001|Overall Study|Lost to Follow-up|1|||
145631365|NCT02814643|525164488|FG000|Overall Study|Withdrawal by Subject|1|||
145631366|NCT02814643|525164489|FG001|Overall Study|Withdrawal by Subject|2|||
145631367|NCT02263508|525164491|FG000|Overall Study|Withdrawal by Subject|1|||
145631368|NCT02263508|525164492|FG001|Overall Study|Withdrawal by Subject|23|||
145631369|NCT02263508|525164493|FG002|Overall Study|Withdrawal by Subject|17|||
145631370|NCT02263508|525164491|FG000|Overall Study|Sponsor Decision|12|||
145631371|NCT02263508|525164492|FG001|Overall Study|Sponsor Decision|165|||
145631372|NCT02263508|525164493|FG002|Overall Study|Sponsor Decision|182|||
145631373|NCT02263508|525164491|FG000|Overall Study|Lost to Follow-up|2|||
145631374|NCT02263508|525164492|FG001|Overall Study|Lost to Follow-up|7|||
145631375|NCT02263508|525164493|FG002|Overall Study|Lost to Follow-up|7|||
145631376|NCT02263508|525164491|FG000|Overall Study|Death|6|||
145631377|NCT02263508|525164492|FG001|Overall Study|Death|151|||
145631378|NCT02263508|525164493|FG002|Overall Study|Death|140|||
145631379|NCT01280591|525164494|FG000|Overall Study|Withdrawal by Subject|0|||
145631380|NCT01280591|525164495|FG001|Overall Study|Withdrawal by Subject|0|||
145631381|NCT01280591|525164496|FG002|Overall Study|Withdrawal by Subject|0|||
145631382|NCT01280591|525164497|FG003|Overall Study|Withdrawal by Subject|2|||
145631383|NCT01280591|525164494|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
145631384|NCT01280591|525164495|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
145631385|NCT01280591|525164496|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
145631386|NCT01280591|525164497|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
145631387|NCT01883492|525164501|FG000|Overall Study|Lost to Follow-up|3|||
145631388|NCT01883492|525164502|FG001|Overall Study|Lost to Follow-up|4|||
145631389|NCT01883492|525164501|FG000|Overall Study|Surgery on contra-lateral hip|0|||
145631390|NCT01883492|525164502|FG001|Overall Study|Surgery on contra-lateral hip|1|||
145631391|NCT01883492|525164501|FG000|Overall Study|Poor X-ray quality|7|||
145631392|NCT01883492|525164502|FG001|Overall Study|Poor X-ray quality|4|||
145631393|NCT01883492|525164501|FG000|Overall Study|Withdrawal by Subject|1|||
145631394|NCT01883492|525164502|FG001|Overall Study|Withdrawal by Subject|0|||
145631395|NCT01883492|525164501|FG000|Overall Study|inappropriate implant used|1|||
145631396|NCT01883492|525164502|FG001|Overall Study|inappropriate implant used|1|||
145631397|NCT01883492|525164501|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
145631398|NCT01883492|525164502|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
145631399|NCT03265210|525164503|FG000|Overall Study|Withdrawal by Subject|7|||
145631400|NCT03265210|525164504|FG001|Overall Study|Withdrawal by Subject|9|||
145631401|NCT03265210|525164503|FG000|Overall Study|Lost to Follow-up|2|||
145631402|NCT03265210|525164504|FG001|Overall Study|Lost to Follow-up|0|||
145631403|NCT03265210|525164503|FG000|Overall Study|Physician Decision|2|||
145631404|NCT03265210|525164504|FG001|Overall Study|Physician Decision|0|||
145631405|NCT03265210|525164503|FG000|Overall Study|Adverse Event|1|||
145631406|NCT03265210|525164504|FG001|Overall Study|Adverse Event|0|||
145631407|NCT03357341|525164507|FG000|Overall Study|Withdrawal by Subject|3|||
145631408|NCT03357341|525164508|FG001|Overall Study|Withdrawal by Subject|6|||
145631409|NCT03357341|525164507|FG000|Overall Study|Lost to Follow-up|4|||
145631410|NCT03357341|525164508|FG001|Overall Study|Lost to Follow-up|5|||
145631411|NCT03357341|525164507|FG000|Overall Study|Death|0|||
145631412|NCT03357341|525164508|FG001|Overall Study|Death|1|||
145631413|NCT00686517|525164509|FG000|Treatment|Serious Adverse Event|1|||
145631414|NCT00686517|525164510|FG001|Treatment|Serious Adverse Event|2|||
145631415|NCT00686517|525164511|FG002|Treatment|Serious Adverse Event|1|||
145631416|NCT00686517|525164509|FG000|Treatment|Adverse Event|2|||
145631417|NCT00686517|525164510|FG001|Treatment|Adverse Event|0|||
145631418|NCT00686517|525164511|FG002|Treatment|Adverse Event|0|||
145631419|NCT00686517|525164509|FG000|Treatment|Poor Protocol Compliance|1|||
145631420|NCT00686517|525164510|FG001|Treatment|Poor Protocol Compliance|0|||
145631421|NCT00686517|525164511|FG002|Treatment|Poor Protocol Compliance|0|||
145631422|NCT00686517|525164509|FG000|Treatment|Protocol Violation|2|||
145631423|NCT00686517|525164510|FG001|Treatment|Protocol Violation|1|||
145631424|NCT00686517|525164511|FG002|Treatment|Protocol Violation|0|||
145631425|NCT01803646|525164514|FG000|Overall Study|Protocol Violation|1|||
145631426|NCT01803646|525164515|FG001|Overall Study|Protocol Violation|0|||
145631427|NCT01803646|525164514|FG000|Overall Study|Adverse Event|1|||
145631428|NCT01803646|525164515|FG001|Overall Study|Adverse Event|1|||
145631429|NCT01803646|525164514|FG000|Overall Study|Withdrawal by Subject|9|||
145631430|NCT01803646|525164515|FG001|Overall Study|Withdrawal by Subject|6|||
145631431|NCT01803646|525164514|FG000|Overall Study|Randomization error|1|||
145631432|NCT01803646|525164515|FG001|Overall Study|Randomization error|2|||
145631433|NCT01803646|525164514|FG000|Overall Study|Lost to Follow-up|5|||
145631434|NCT01803646|525164515|FG001|Overall Study|Lost to Follow-up|1|||
145631435|NCT01693614|525164517|FG000|Overall Study|Adverse Event|7|||
145631436|NCT01693614|525164518|FG001|Overall Study|Adverse Event|11|||
145631437|NCT01693614|525164519|FG002|Overall Study|Adverse Event|5|||
145631438|NCT01693614|525164517|FG000|Overall Study|Disease progression|11|||
145631439|NCT01693614|525164518|FG001|Overall Study|Disease progression|8|||
145631440|NCT01693614|525164519|FG002|Overall Study|Disease progression|7|||
145631441|NCT01693614|525164517|FG000|Overall Study|Protocol Violation|5|||
145631442|NCT01693614|525164518|FG001|Overall Study|Protocol Violation|2|||
145631443|NCT01693614|525164519|FG002|Overall Study|Protocol Violation|1|||
145631444|NCT01693614|525164517|FG000|Overall Study|Death|1|||
145631445|NCT01693614|525164518|FG001|Overall Study|Death|0|||
145631446|NCT01693614|525164519|FG002|Overall Study|Death|0|||
145631447|NCT01693614|525164517|FG000|Overall Study|Physician Decision|1|||
145631448|NCT01693614|525164518|FG001|Overall Study|Physician Decision|1|||
145631449|NCT01693614|525164519|FG002|Overall Study|Physician Decision|4|||
145631450|NCT01693614|525164517|FG000|Overall Study|Withdrawal by subject/guardian|0|||
145631451|NCT01693614|525164518|FG001|Overall Study|Withdrawal by subject/guardian|0|||
145631452|NCT01693614|525164519|FG002|Overall Study|Withdrawal by subject/guardian|2|||
145631453|NCT01693614|525164517|FG000|Overall Study|Withdrawal by Subject|1|||
145631454|NCT01693614|525164518|FG001|Overall Study|Withdrawal by Subject|0|||
145631455|NCT01693614|525164519|FG002|Overall Study|Withdrawal by Subject|5|||
145631456|NCT00420316|525164522|FG000|Overall Study|Withdrawal by Subject|0|||
145631457|NCT00420316|525164523|FG001|Overall Study|Withdrawal by Subject|1|||
145631458|NCT00420316|525164522|FG000|Overall Study|Lost to Follow-up|12|||
145631459|NCT00420316|525164523|FG001|Overall Study|Lost to Follow-up|8|||
145631460|NCT02281318|525164524|FG000|Overall Study|Adverse Event|2|||
145631461|NCT02281318|525164525|FG001|Overall Study|Adverse Event|2|||
145631462|NCT02281318|525164524|FG000|Overall Study|Lack of Efficacy|2|||
145631463|NCT02281318|525164525|FG001|Overall Study|Lack of Efficacy|0|||
145631464|NCT02281318|525164524|FG000|Overall Study|Lost to Follow-up|2|||
145631465|NCT02281318|525164525|FG001|Overall Study|Lost to Follow-up|1|||
145631466|NCT02281318|525164524|FG000|Overall Study|Physician Decision|2|||
145631467|NCT02281318|525164525|FG001|Overall Study|Physician Decision|0|||
145631468|NCT02281318|525164524|FG000|Overall Study|Withdrawal by Subject|6|||
145631469|NCT02281318|525164525|FG001|Overall Study|Withdrawal by Subject|2|||
145631470|NCT02614560|525164526|FG000|Overall Study|Death|6|||
145631471|NCT02614560|525164527|FG001|Overall Study|Death|2|||
145631472|NCT01368406|525164528|FG000|Overall Study|Lost to Follow-up|8|||
145631473|NCT01368406|525164529|FG001|Overall Study|Lost to Follow-up|4|||
145631474|NCT01368406|525164528|FG000|Overall Study|Withdrawal by Subject|8|||
145631475|NCT01368406|525164529|FG001|Overall Study|Withdrawal by Subject|4|||
145631476|NCT01368406|525164528|FG000|Overall Study|relapse of the disease|3|||
145631477|NCT01368406|525164529|FG001|Overall Study|relapse of the disease|2|||
145631478|NCT01368406|525164528|FG000|Overall Study|started working|2|||
145631479|NCT01368406|525164529|FG001|Overall Study|started working|3|||
145631480|NCT00957229|525164532|FG000|Study Start|Adverse Event|0|||
145631481|NCT00957229|525164533|FG001|Study Start|Adverse Event|3|||
145631482|NCT00957229|525164532|FG000|Study Start|Disease Progression|1|||
145631483|NCT00957229|525164533|FG001|Study Start|Disease Progression|0|||
145631484|NCT00957229|525164532|FG000|Reallocated to or Continued Vismodegib|Death|1|||
145631485|NCT00957229|525164533|FG001|Reallocated to or Continued Vismodegib|Death|1|||
145631486|NCT00957229|525164532|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
145631487|NCT00957229|525164533|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
145631488|NCT01833065|525164534|FG000|Overall Study|Adverse Event|6|||
145631489|NCT01833065|525164535|FG001|Overall Study|Adverse Event|1|||
145631490|NCT01833065|525164536|FG002|Overall Study|Adverse Event|0|||
145631491|NCT01833065|525164537|FG003|Overall Study|Adverse Event|2|||
145631492|NCT01833065|525164538|FG004|Overall Study|Adverse Event|3|||
145631493|NCT01833065|525164534|FG000|Overall Study|Protocol Violation|1|||
145631494|NCT01833065|525164535|FG001|Overall Study|Protocol Violation|0|||
145631495|NCT01833065|525164536|FG002|Overall Study|Protocol Violation|0|||
145631496|NCT01833065|525164537|FG003|Overall Study|Protocol Violation|0|||
145631497|NCT01833065|525164538|FG004|Overall Study|Protocol Violation|2|||
145631498|NCT01833065|525164534|FG000|Overall Study|Lost to Follow-up|1|||
145631499|NCT01833065|525164535|FG001|Overall Study|Lost to Follow-up|0|||
145631500|NCT01833065|525164536|FG002|Overall Study|Lost to Follow-up|0|||
145631501|NCT01833065|525164537|FG003|Overall Study|Lost to Follow-up|0|||
145631502|NCT01833065|525164538|FG004|Overall Study|Lost to Follow-up|3|||
145631503|NCT01833065|525164534|FG000|Overall Study|Withdrawal by Subject|6|||
145631504|NCT01833065|525164535|FG001|Overall Study|Withdrawal by Subject|2|||
145631505|NCT01833065|525164536|FG002|Overall Study|Withdrawal by Subject|4|||
145631506|NCT01833065|525164537|FG003|Overall Study|Withdrawal by Subject|3|||
145631507|NCT01833065|525164538|FG004|Overall Study|Withdrawal by Subject|11|||
145631508|NCT01833065|525164534|FG000|Overall Study|Subject's substantial non-compliance|0|||
145631509|NCT01833065|525164535|FG001|Overall Study|Subject's substantial non-compliance|1|||
145631510|NCT01833065|525164536|FG002|Overall Study|Subject's substantial non-compliance|0|||
145631511|NCT01833065|525164537|FG003|Overall Study|Subject's substantial non-compliance|0|||
145631512|NCT01833065|525164538|FG004|Overall Study|Subject's substantial non-compliance|0|||
145631513|NCT01833065|525164534|FG000|Overall Study|Trial terminated by sponsor|8|||
145631514|NCT01833065|525164535|FG001|Overall Study|Trial terminated by sponsor|8|||
145631515|NCT01833065|525164536|FG002|Overall Study|Trial terminated by sponsor|7|||
145631516|NCT01833065|525164537|FG003|Overall Study|Trial terminated by sponsor|3|||
145631517|NCT01833065|525164538|FG004|Overall Study|Trial terminated by sponsor|13|||
145631518|NCT01833065|525164534|FG000|Overall Study|Others|2|||
145631519|NCT01833065|525164535|FG001|Overall Study|Others|1|||
145631520|NCT01833065|525164536|FG002|Overall Study|Others|1|||
145631521|NCT01833065|525164537|FG003|Overall Study|Others|1|||
145631522|NCT01833065|525164538|FG004|Overall Study|Others|4|||
145631523|NCT00828672|525164539|FG000|Study Treatment|Lost to Follow-up|1|||
145631524|NCT00828672|525164540|FG001|Study Treatment|Lost to Follow-up|0|||
145631525|NCT00828672|525164539|FG000|Study Treatment|Adverse Event|0|||
145631526|NCT00828672|525164540|FG001|Study Treatment|Adverse Event|1|||
145631527|NCT00828672|525164539|FG000|Study Treatment|Complete response, no surgery|1|||
145631528|NCT00828672|525164540|FG001|Study Treatment|Complete response, no surgery|1|||
145631529|NCT00828672|525164539|FG000|Post-surgery (<30 Days)|No central review materials|0|||
145631530|NCT00828672|525164540|FG001|Post-surgery (<30 Days)|No central review materials|1|||
145631531|NCT00543725|525164541|FG000|Overall Study|Adverse Event|18|||
145631532|NCT00543725|525164542|FG001|Overall Study|Adverse Event|27|||
145631533|NCT00543725|525164541|FG000|Overall Study|Sponsor's Decision|0|||
145631534|NCT00543725|525164542|FG001|Overall Study|Sponsor's Decision|1|||
145631535|NCT00543725|525164541|FG000|Overall Study|Subject Non-Compliant|4|||
145631536|NCT00543725|525164542|FG001|Overall Study|Subject Non-Compliant|4|||
145631537|NCT00543725|525164541|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
145631538|NCT00543725|525164542|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
145631539|NCT00543725|525164541|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
145631540|NCT00543725|525164542|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
145631541|NCT00543725|525164541|FG000|Overall Study|Protocol Violation|0|||
145631542|NCT00543725|525164542|FG001|Overall Study|Protocol Violation|1|||
145631543|NCT00543725|525164541|FG000|Overall Study|Withdrawal by Subject|4|||
145631544|NCT00543725|525164542|FG001|Overall Study|Withdrawal by Subject|13|||
145631545|NCT00543725|525164541|FG000|Overall Study|Lost to Follow-up|15|||
145631546|NCT00543725|525164542|FG001|Overall Study|Lost to Follow-up|11|||
145631547|NCT00543725|525164541|FG000|Overall Study|Other|3|||
145631548|NCT00543725|525164542|FG001|Overall Study|Other|3|||
145631549|NCT00906698|525164543|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
145631550|NCT00906698|525164544|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
145631551|NCT00906698|525164545|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
145631552|NCT00906698|525164546|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
145631553|NCT00906698|525164547|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
145631554|NCT00906698|525164548|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
145631555|NCT00906698|525164543|FG000|Overall Study|Adverse Event|0|||
145631556|NCT00906698|525164544|FG001|Overall Study|Adverse Event|0|||
145631557|NCT00906698|525164545|FG002|Overall Study|Adverse Event|2|||
145631558|NCT00906698|525164546|FG003|Overall Study|Adverse Event|0|||
145631559|NCT00906698|525164547|FG004|Overall Study|Adverse Event|4|||
145631560|NCT00906698|525164548|FG005|Overall Study|Adverse Event|1|||
145631561|NCT00906698|525164543|FG000|Overall Study|Disease progression|3|||
145631562|NCT00906698|525164544|FG001|Overall Study|Disease progression|12|||
145631563|NCT00906698|525164545|FG002|Overall Study|Disease progression|4|||
145631564|NCT00906698|525164546|FG003|Overall Study|Disease progression|4|||
145631565|NCT00906698|525164547|FG004|Overall Study|Disease progression|12|||
145631566|NCT00906698|525164548|FG005|Overall Study|Disease progression|4|||
145631567|NCT00906698|525164543|FG000|Overall Study|Withdrawal by Subject|0|||
145631568|NCT00906698|525164544|FG001|Overall Study|Withdrawal by Subject|0|||
145631569|NCT00906698|525164545|FG002|Overall Study|Withdrawal by Subject|0|||
145631570|NCT00906698|525164546|FG003|Overall Study|Withdrawal by Subject|0|||
145631571|NCT00906698|525164547|FG004|Overall Study|Withdrawal by Subject|1|||
145631572|NCT00906698|525164548|FG005|Overall Study|Withdrawal by Subject|0|||
145631573|NCT00906698|525164543|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
145631574|NCT00906698|525164544|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
145631575|NCT00906698|525164545|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
145631576|NCT00906698|525164546|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
145631577|NCT00906698|525164547|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
145631578|NCT00906698|525164548|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
145631579|NCT01250002|525164549|FG000|Overall Study|Change to open surgical procedure|4|||
145631580|NCT01250002|525164550|FG001|Overall Study|Change to open surgical procedure|3|||
145631581|NCT03383887|525164553|FG000|Overall Study|Lost to Follow-up|0|||
145631582|NCT03383887|525164554|FG001|Overall Study|Lost to Follow-up|1|||
145631583|NCT00975806|525164562|FG000|Overall Study|Adverse Event|2|||
145631584|NCT00975806|525164563|FG001|Overall Study|Adverse Event|1|||
145631585|NCT00975806|525164564|FG002|Overall Study|Adverse Event|2|||
145631586|NCT00975806|525164562|FG000|Overall Study|Disease Progression|1|||
145631587|NCT00975806|525164563|FG001|Overall Study|Disease Progression|5|||
145631588|NCT00975806|525164564|FG002|Overall Study|Disease Progression|1|||
145631589|NCT00975806|525164562|FG000|Overall Study|Withdrawal by Subject|1|||
145631590|NCT00975806|525164563|FG001|Overall Study|Withdrawal by Subject|0|||
145631591|NCT00975806|525164564|FG002|Overall Study|Withdrawal by Subject|0|||
145631592|NCT00975806|525164562|FG000|Overall Study|Death|0|||
145631593|NCT00975806|525164563|FG001|Overall Study|Death|1|||
145631594|NCT00975806|525164564|FG002|Overall Study|Death|0|||
145631595|NCT00975806|525164562|FG000|Overall Study|Physician decision and disease related|1|||
145631596|NCT00975806|525164563|FG001|Overall Study|Physician decision and disease related|0|||
145631597|NCT00975806|525164564|FG002|Overall Study|Physician decision and disease related|1|||
145631598|NCT01242085|525164565|FG000|Overall Study|Withdrawal by Subject|4|||
145631599|NCT01242085|525164566|FG001|Overall Study|Withdrawal by Subject|2|||
145631600|NCT01242085|525164567|FG002|Overall Study|Withdrawal by Subject|0|||
145631601|NCT01242085|525164565|FG000|Overall Study|medically unable to have surgery|4|||
145631602|NCT01242085|525164566|FG001|Overall Study|medically unable to have surgery|5|||
145631603|NCT01242085|525164567|FG002|Overall Study|medically unable to have surgery|0|||
145631604|NCT02377362|525164568|FG000|Part A Second Treatment|Protocol Violation|0|||
145631605|NCT02377362|525164569|FG001|Part A Second Treatment|Protocol Violation|0|||
145631606|NCT02377362|525164570|FG002|Part A Second Treatment|Protocol Violation|0|||
145631607|NCT02377362|525164571|FG003|Part A Second Treatment|Protocol Violation|0|||
145631608|NCT02377362|525164572|FG004|Part A Second Treatment|Protocol Violation|1|||
145631609|NCT02377362|525164573|FG005|Part A Second Treatment|Protocol Violation|0|||
145631610|NCT02377362|525164574|FG006|Part A Second Treatment|Protocol Violation|0|||
145631611|NCT02377362|525164575|FG007|Part A Second Treatment|Protocol Violation|0|||
145631612|NCT02377362|525164576|FG008|Part A Second Treatment|Protocol Violation|0|||
145631613|NCT02377362|525164577|FG009|Part A Second Treatment|Protocol Violation|0|||
145631614|NCT02377362|525164578|FG010|Part A Second Treatment|Protocol Violation|0|||
145631615|NCT02377362|525164579|FG011|Part A Second Treatment|Protocol Violation|0|||
145631616|NCT02377362|525164580|FG012|Part A Second Treatment|Protocol Violation|0|||
145631617|NCT02377362|525164568|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631618|NCT02377362|525164569|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631619|NCT02377362|525164570|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631620|NCT02377362|525164571|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
145631621|NCT02377362|525164572|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
145631622|NCT02377362|525164573|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
145631623|NCT02377362|525164574|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631624|NCT02377362|525164575|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631625|NCT02377362|525164576|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631626|NCT02377362|525164577|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631627|NCT02377362|525164578|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631628|NCT02377362|525164579|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631629|NCT02377362|525164580|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
145631630|NCT02377362|525164568|FG000|Part B Overall|Protocol Violation|0|||
145631631|NCT02377362|525164569|FG001|Part B Overall|Protocol Violation|0|||
145631632|NCT02377362|525164570|FG002|Part B Overall|Protocol Violation|0|||
145631633|NCT02377362|525164571|FG003|Part B Overall|Protocol Violation|0|||
145631634|NCT02377362|525164572|FG004|Part B Overall|Protocol Violation|0|||
145631635|NCT02377362|525164573|FG005|Part B Overall|Protocol Violation|0|||
145631636|NCT02377362|525164574|FG006|Part B Overall|Protocol Violation|0|||
145631637|NCT02377362|525164575|FG007|Part B Overall|Protocol Violation|0|||
145631638|NCT02377362|525164576|FG008|Part B Overall|Protocol Violation|0|||
145631639|NCT02377362|525164577|FG009|Part B Overall|Protocol Violation|1|||
145631640|NCT02377362|525164578|FG010|Part B Overall|Protocol Violation|0|||
145631641|NCT02377362|525164579|FG011|Part B Overall|Protocol Violation|0|||
145631642|NCT02377362|525164580|FG012|Part B Overall|Protocol Violation|0|||
145631643|NCT02377362|525164568|FG000|Part B Overall|Adverse Event|0|||
145631644|NCT02377362|525164569|FG001|Part B Overall|Adverse Event|0|||
145631645|NCT02377362|525164570|FG002|Part B Overall|Adverse Event|0|||
145631646|NCT02377362|525164571|FG003|Part B Overall|Adverse Event|0|||
145631647|NCT02377362|525164572|FG004|Part B Overall|Adverse Event|0|||
145631648|NCT02377362|525164573|FG005|Part B Overall|Adverse Event|0|||
145631649|NCT02377362|525164574|FG006|Part B Overall|Adverse Event|1|||
145631650|NCT02377362|525164575|FG007|Part B Overall|Adverse Event|1|||
145631651|NCT02377362|525164576|FG008|Part B Overall|Adverse Event|0|||
145631652|NCT02377362|525164577|FG009|Part B Overall|Adverse Event|0|||
145631653|NCT02377362|525164578|FG010|Part B Overall|Adverse Event|0|||
145631654|NCT02377362|525164579|FG011|Part B Overall|Adverse Event|0|||
145631655|NCT02377362|525164580|FG012|Part B Overall|Adverse Event|0|||
145631656|NCT02377362|525164568|FG000|Part B Overall|Withdrawal by Subject|0|||
145631657|NCT02377362|525164569|FG001|Part B Overall|Withdrawal by Subject|0|||
145631658|NCT02377362|525164570|FG002|Part B Overall|Withdrawal by Subject|0|||
145631659|NCT02377362|525164571|FG003|Part B Overall|Withdrawal by Subject|0|||
145631660|NCT02377362|525164572|FG004|Part B Overall|Withdrawal by Subject|0|||
145631661|NCT02377362|525164573|FG005|Part B Overall|Withdrawal by Subject|0|||
145631662|NCT02377362|525164574|FG006|Part B Overall|Withdrawal by Subject|1|||
145631663|NCT02377362|525164575|FG007|Part B Overall|Withdrawal by Subject|0|||
145631664|NCT02377362|525164576|FG008|Part B Overall|Withdrawal by Subject|0|||
145631665|NCT02377362|525164577|FG009|Part B Overall|Withdrawal by Subject|0|||
145631666|NCT02377362|525164578|FG010|Part B Overall|Withdrawal by Subject|0|||
145631667|NCT02377362|525164579|FG011|Part B Overall|Withdrawal by Subject|1|||
145631668|NCT02377362|525164580|FG012|Part B Overall|Withdrawal by Subject|0|||
145631669|NCT02322216|525164583|FG000|Overall Study|Adverse Event|1|||
145631670|NCT02322216|525164584|FG001|Overall Study|Adverse Event|0|||
145631671|NCT02322216|525164583|FG000|Overall Study|Withdrawal by Subject|1|||
145631672|NCT02322216|525164584|FG001|Overall Study|Withdrawal by Subject|4|||
145631673|NCT01806714|525164586|FG000|Overall Study|No functioning phone number|200|||
145631674|NCT01806714|525164587|FG001|Overall Study|No functioning phone number|170|||
145631675|NCT00678795|525164588|FG000|Overall Study|Adverse Event|7|||
145631676|NCT00678795|525164589|FG001|Overall Study|Adverse Event|3|||
145631677|NCT00678795|525164588|FG000|Overall Study|Withdrawal by Subject|3|||
145631678|NCT00678795|525164589|FG001|Overall Study|Withdrawal by Subject|0|||
145631679|NCT00678795|525164588|FG000|Overall Study|Protocol Violation|0|||
145631680|NCT00678795|525164589|FG001|Overall Study|Protocol Violation|1|||
145631681|NCT00678795|525164588|FG000|Overall Study|Lost to Follow-up|0|||
145631682|NCT00678795|525164589|FG001|Overall Study|Lost to Follow-up|1|||
145631683|NCT00678795|525164588|FG000|Overall Study|Lack of Efficacy|1|||
145631684|NCT00678795|525164589|FG001|Overall Study|Lack of Efficacy|1|||
145631685|NCT00608907|525164591|FG000|Overall Study|Adverse Event|6|||
145631686|NCT00608907|525164592|FG001|Overall Study|Adverse Event|0|||
145631687|NCT00608907|525164593|FG002|Overall Study|Adverse Event|1|||
145631688|NCT00608907|525164591|FG000|Overall Study|Death|1|||
145631689|NCT00608907|525164592|FG001|Overall Study|Death|0|||
145631690|NCT00608907|525164593|FG002|Overall Study|Death|0|||
145631691|NCT00608907|525164591|FG000|Overall Study|Withdrawal by Subject|4|||
145631692|NCT00608907|525164592|FG001|Overall Study|Withdrawal by Subject|0|||
145631693|NCT00608907|525164593|FG002|Overall Study|Withdrawal by Subject|0|||
145631694|NCT00608907|525164591|FG000|Overall Study|Progressive Disease|1|||
145631695|NCT00608907|525164592|FG001|Overall Study|Progressive Disease|0|||
145631696|NCT00608907|525164593|FG002|Overall Study|Progressive Disease|0|||
145631697|NCT03058991|525164594|FG000|Overall Study|Lost to Follow-up|17|||
145631698|NCT03058991|525164595|FG001|Overall Study|Lost to Follow-up|12|||
145631699|NCT03058991|525164596|FG002|Overall Study|Lost to Follow-up|12|||
145631700|NCT03058991|525164594|FG000|Overall Study|Withdrawal by Subject|1|||
145631701|NCT03058991|525164595|FG001|Overall Study|Withdrawal by Subject|0|||
145631702|NCT03058991|525164596|FG002|Overall Study|Withdrawal by Subject|0|||
145631703|NCT01689519|525164597|FG000|Intent to Treat|Death|157|||
145631704|NCT01689519|525164598|FG001|Intent to Treat|Death|167|||
145631705|NCT01689519|525164597|FG000|Intent to Treat|Lost to Follow-up|4|||
145631706|NCT01689519|525164598|FG001|Intent to Treat|Lost to Follow-up|8|||
145631707|NCT01689519|525164597|FG000|Intent to Treat|Other|2|||
145631708|NCT01689519|525164598|FG001|Intent to Treat|Other|4|||
145631709|NCT01689519|525164597|FG000|Intent to Treat|Physician Decision|4|||
145631710|NCT01689519|525164598|FG001|Intent to Treat|Physician Decision|1|||
145631711|NCT01689519|525164597|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
145631712|NCT01689519|525164598|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
145631713|NCT01689519|525164597|FG000|Intent to Treat|Withdrawal by Subject|21|||
145631714|NCT01689519|525164598|FG001|Intent to Treat|Withdrawal by Subject|20|||
145631715|NCT01689519|525164597|FG000|Safety Population|Death|158|||
145631716|NCT01689519|525164598|FG001|Safety Population|Death|165|||
145631717|NCT01689519|525164597|FG000|Safety Population|Lost to Follow-up|4|||
145631718|NCT01689519|525164598|FG001|Safety Population|Lost to Follow-up|8|||
145631719|NCT01689519|525164597|FG000|Safety Population|Other|2|||
145631720|NCT01689519|525164598|FG001|Safety Population|Other|4|||
145631721|NCT01689519|525164597|FG000|Safety Population|Physician Decision|4|||
145631722|NCT01689519|525164598|FG001|Safety Population|Physician Decision|1|||
145631723|NCT01689519|525164597|FG000|Safety Population|Study Terminated By Sponsor|60|||
145631724|NCT01689519|525164598|FG001|Safety Population|Study Terminated By Sponsor|47|||
145631725|NCT01689519|525164597|FG000|Safety Population|Withdrawal by Subject|20|||
145631726|NCT01689519|525164598|FG001|Safety Population|Withdrawal by Subject|20|||
145631727|NCT00559949|525164603|FG000|Overall Study|Progressive Disease during cycle 1|1|||
145631728|NCT00559949|525164603|FG000|Overall Study|Adverse Event|1|||
145631729|NCT00559949|525164603|FG000|Overall Study|Withdrawal by Subject|4|||
145631730|NCT00559949|525164603|FG000|Overall Study|No disease evaluation per protocol|1|||
145631731|NCT04173572|525164608|FG000|Overall Study|Withdrawal by Subject|1|||
145631732|NCT04173572|525164609|FG001|Overall Study|Withdrawal by Subject|5|||
145631733|NCT04173572|525164608|FG000|Overall Study|Lost to Follow-up|3|||
145631734|NCT04173572|525164609|FG001|Overall Study|Lost to Follow-up|1|||
145631735|NCT01253226|525164611|FG000|Overall Study|Adverse Event|0|||
145631736|NCT01253226|525164612|FG001|Overall Study|Adverse Event|0|||
145631737|NCT01253226|525164613|FG002|Overall Study|Adverse Event|1|||
145631738|NCT01253226|525164614|FG003|Overall Study|Adverse Event|0|||
145631739|NCT01253226|525164615|FG004|Overall Study|Adverse Event|0|||
145631740|NCT01253226|525164611|FG000|Overall Study|Death|0|||
145631741|NCT01253226|525164612|FG001|Overall Study|Death|1|||
145631742|NCT01253226|525164613|FG002|Overall Study|Death|0|||
145631743|NCT01253226|525164614|FG003|Overall Study|Death|0|||
145631744|NCT01253226|525164615|FG004|Overall Study|Death|0|||
145631745|NCT01253226|525164611|FG000|Overall Study|Physician Decision|0|||
145631746|NCT01253226|525164612|FG001|Overall Study|Physician Decision|0|||
145631747|NCT01253226|525164613|FG002|Overall Study|Physician Decision|0|||
145631748|NCT01253226|525164614|FG003|Overall Study|Physician Decision|0|||
145631749|NCT01253226|525164615|FG004|Overall Study|Physician Decision|2|||
145631750|NCT01253226|525164611|FG000|Overall Study|Withdrawal by Subject|0|||
145631751|NCT01253226|525164612|FG001|Overall Study|Withdrawal by Subject|0|||
145631752|NCT01253226|525164613|FG002|Overall Study|Withdrawal by Subject|0|||
145631753|NCT01253226|525164614|FG003|Overall Study|Withdrawal by Subject|1|||
145631754|NCT01253226|525164615|FG004|Overall Study|Withdrawal by Subject|0|||
145631755|NCT00988637|525164616|FG000|Overall Study|Lost to Follow-up|2|||
145631756|NCT00988637|525164617|FG001|Overall Study|Lost to Follow-up|1|||
145631757|NCT00988637|525164616|FG000|Overall Study|Withdrawal by Subject|1|||
145631758|NCT00988637|525164617|FG001|Overall Study|Withdrawal by Subject|1|||
145631759|NCT00988637|525164616|FG000|Overall Study|non-compliance with study drug|0|||
145631760|NCT00988637|525164617|FG001|Overall Study|non-compliance with study drug|1|||
145631761|NCT01726023|525164619|FG000|Overall Study|Death|1|||
145631762|NCT01726023|525164620|FG001|Overall Study|Death|1|||
145631763|NCT01726023|525164619|FG000|Overall Study|Lost to Follow-up|5|||
145631764|NCT01726023|525164620|FG001|Overall Study|Lost to Follow-up|10|||
145631765|NCT01726023|525164619|FG000|Overall Study|Other Eligibility criteria|7|||
145631766|NCT01726023|525164620|FG001|Overall Study|Other Eligibility criteria|7|||
145631767|NCT01726023|525164619|FG000|Overall Study|Withdrawal by Subject|16|||
145631768|NCT01726023|525164620|FG001|Overall Study|Withdrawal by Subject|8|||
145631769|NCT03643211|525164624|FG000|Overall Study|Contract violation/deficiency|12|||
145631770|NCT03643211|525164624|FG000|Overall Study|Invalid registration|3|||
145631771|NCT03643211|525164624|FG000|Overall Study|No treatment information|2|||
145631772|NCT03643211|525164624|FG000|Overall Study|No adverse event information - No revisit|4|||
145631773|NCT02685033|525164625|FG000|Overall Study|Withdrawal of Consent|0|||
145631774|NCT02685033|525164626|FG001|Overall Study|Withdrawal of Consent|1|||
145631775|NCT02685033|525164625|FG000|Overall Study|Lost to Follow-up|2|||
145631776|NCT02685033|525164626|FG001|Overall Study|Lost to Follow-up|1|||
145631777|NCT02685033|525164625|FG000|Overall Study|Adverse Event|1|||
145631778|NCT02685033|525164626|FG001|Overall Study|Adverse Event|0|||
145631779|NCT03425643|525164629|FG000|Overall Study|Withdrawal by Subject|10|||
145631780|NCT03425643|525164630|FG001|Overall Study|Withdrawal by Subject|12|||
145631781|NCT03425643|525164629|FG000|Overall Study|Lost to Follow-up|2|||
145631782|NCT03425643|525164630|FG001|Overall Study|Lost to Follow-up|0|||
145631783|NCT03425643|525164629|FG000|Overall Study|Death|109|||
145631784|NCT03425643|525164630|FG001|Overall Study|Death|141|||
145631785|NCT03425643|525164629|FG000|Overall Study|Ongoing in study|276|||
145631786|NCT03425643|525164630|FG001|Overall Study|Ongoing in study|247|||
145631787|NCT03141788|525164631|FG000|Overall Study|Lost to Follow-up|1|||
145631788|NCT03141788|525164631|FG000|Overall Study|Protocol Violation|3|||
145631789|NCT03141788|525164631|FG000|Overall Study|Withdrawal by Subject|4|||
145631790|NCT04133363|525164632|FG000|Overall Study|Lost to Follow-up|2|||
145631791|NCT04133363|525164633|FG001|Overall Study|Lost to Follow-up|1|||
145631792|NCT04133363|525164634|FG002|Overall Study|Lost to Follow-up|4|||
145631793|NCT00486759|525165983|FG000|Treatment|Adverse event/intercurrent illness|86|||
145631794|NCT00486759|525165984|FG001|Treatment|Adverse event/intercurrent illness|39|||
145631795|NCT00486759|525165983|FG000|Treatment|Insufficient therapeutic response|37|||
145631796|NCT00486759|525165984|FG001|Treatment|Insufficient therapeutic response|39|||
145631797|NCT00486759|525165983|FG000|Treatment|Death|17|||
145631798|NCT00486759|525165984|FG001|Treatment|Death|10|||
145631799|NCT00486759|525165983|FG000|Treatment|Withdrew consent|15|||
145631800|NCT00486759|525165984|FG001|Treatment|Withdrew consent|12|||
145631801|NCT00486759|525165983|FG000|Treatment|Administrative/reason not specified|17|||
145631802|NCT00486759|525165984|FG001|Treatment|Administrative/reason not specified|21|||
145631803|NCT00486759|525165983|FG000|Treatment|Refused treatment|10|||
145631804|NCT00486759|525165984|FG001|Treatment|Refused treatment|7|||
145631805|NCT00486759|525165983|FG000|Treatment|Violation of selection criteria at entry|3|||
145631806|NCT00486759|525165984|FG001|Treatment|Violation of selection criteria at entry|3|||
145631807|NCT00486759|525165983|FG000|Treatment|Other protocol violation|1|||
145631808|NCT00486759|525165984|FG001|Treatment|Other protocol violation|5|||
145631809|NCT00486759|525165983|FG000|Treatment|Failure to return|1|||
145631810|NCT00486759|525165984|FG001|Treatment|Failure to return|1|||
145631811|NCT00486759|525165983|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
145631812|NCT00486759|525165984|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
145631813|NCT00486759|525165983|FG000|Safety Follow-up|Death|40|||
145631814|NCT00486759|525165984|FG001|Safety Follow-up|Death|29|||
145631815|NCT00486759|525165983|FG000|Safety Follow-up|Withdrew consent|32|||
145631816|NCT00486759|525165984|FG001|Safety Follow-up|Withdrew consent|23|||
145631817|NCT00486759|525165983|FG000|Safety Follow-up|Failure to return|9|||
145631818|NCT00486759|525165984|FG001|Safety Follow-up|Failure to return|6|||
145631819|NCT00486759|525165983|FG000|Safety Follow-up|Administrative/not specified|8|||
145474853|NCT00778895|524590131|FG002|Active Phase|Adverse Event|0|||
145474854|NCT00778895|524590129|FG000|Active Phase|Withdrawal by Subject|1|||
145631820|NCT00486759|525165984|FG001|Safety Follow-up|Administrative/not specified|6|||
145631821|NCT00486759|525165983|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
145631822|NCT00486759|525165984|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
145631823|NCT00486759|525165983|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
145631824|NCT00486759|525165984|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
145631825|NCT01025843|525165985|FG000|Washout 4|Withdrawal by Subject|0|||
145631826|NCT01025843|525165986|FG001|Washout 4|Withdrawal by Subject|0|||
145474855|NCT00778895|524590130|FG001|Active Phase|Withdrawal by Subject|4|||
145631827|NCT01025843|525165987|FG002|Washout 4|Withdrawal by Subject|1|||
145631828|NCT01025843|525165988|FG003|Washout 4|Withdrawal by Subject|1|||
145631829|NCT01025843|525165989|FG004|Washout 4|Withdrawal by Subject|0|||
145631830|NCT01025843|525165990|FG005|Washout 4|Withdrawal by Subject|0|||
145631831|NCT01025843|525165991|FG006|Washout 4|Withdrawal by Subject|0|||
145631832|NCT01025843|525165992|FG007|Washout 4|Withdrawal by Subject|0|||
145474856|NCT00778895|524590131|FG002|Active Phase|Withdrawal by Subject|0|||
145474857|NCT00778895|524590129|FG000|Active Phase|Lost to Follow-up|1|||
145474858|NCT00778895|524590130|FG001|Active Phase|Lost to Follow-up|1|||
145474859|NCT00778895|524590131|FG002|Active Phase|Lost to Follow-up|0|||
145474860|NCT00778895|524590129|FG000|Active Phase|Other|2|||
145474861|NCT00778895|524590130|FG001|Active Phase|Other|0|||
145474862|NCT00778895|524590131|FG002|Active Phase|Other|0|||
145474863|NCT00778895|524590129|FG000|ESFU Phase|Adverse Event|2|||
145474864|NCT00778895|524590130|FG001|ESFU Phase|Adverse Event|1|||
145474865|NCT00778895|524590131|FG002|ESFU Phase|Adverse Event|0|||
145474866|NCT00778895|524590129|FG000|ESFU Phase|Withdrawal by Subject|1|||
145474867|NCT00778895|524590130|FG001|ESFU Phase|Withdrawal by Subject|4|||
145474868|NCT00778895|524590131|FG002|ESFU Phase|Withdrawal by Subject|0|||
145474869|NCT00778895|524590129|FG000|ESFU Phase|Lost to Follow-up|6|||
145474870|NCT00778895|524590130|FG001|ESFU Phase|Lost to Follow-up|7|||
145474871|NCT00778895|524590131|FG002|ESFU Phase|Lost to Follow-up|2|||
145474872|NCT00778895|524590129|FG000|ESFU Phase|Other|2|||
145474873|NCT00778895|524590130|FG001|ESFU Phase|Other|0|||
145474874|NCT00778895|524590131|FG002|ESFU Phase|Other|0|||
145474875|NCT01424228|524590136|FG000|Overall Study|Withdrawal by Subject|27|||
145474876|NCT01424228|524590137|FG001|Overall Study|Withdrawal by Subject|11|||
145474877|NCT01424228|524590136|FG000|Overall Study|Adverse Event|10|||
145474878|NCT01424228|524590137|FG001|Overall Study|Adverse Event|14|||
145474879|NCT01424228|524590136|FG000|Overall Study|Sponsor's decision|9|||
145474880|NCT01424228|524590137|FG001|Overall Study|Sponsor's decision|12|||
145474881|NCT01424228|524590136|FG000|Overall Study|Lack of Efficacy|5|||
145631833|NCT01025843|525165993|FG008|Washout 4|Withdrawal by Subject|0|||
145631834|NCT01025843|525165994|FG009|Washout 4|Withdrawal by Subject|0|||
145631835|NCT03646669|525165999|FG000|Overall Study|Withdrawal by Subject|5|||
145631836|NCT03646669|525166000|FG001|Overall Study|Withdrawal by Subject|0|||
145631837|NCT00309452|525166001|FG000|Overall Study|Withdrawal by Subject|3|||
145631838|NCT00309452|525166002|FG001|Overall Study|Withdrawal by Subject|0|||
145631839|NCT01281813|525166005|FG000|Overall Study|Adverse Event|0|||
145631840|NCT01281813|525166006|FG001|Overall Study|Adverse Event|0|||
145631841|NCT01281813|525166007|FG002|Overall Study|Adverse Event|10|||
145631842|NCT01281813|525166005|FG000|Overall Study|Lost to Follow-up|0|||
145631843|NCT01281813|525166006|FG001|Overall Study|Lost to Follow-up|0|||
145631844|NCT01281813|525166007|FG002|Overall Study|Lost to Follow-up|31|||
145631845|NCT01281813|525166005|FG000|Overall Study|Withdrawal by Subject|0|||
145631846|NCT01281813|525166006|FG001|Overall Study|Withdrawal by Subject|0|||
145631847|NCT01281813|525166007|FG002|Overall Study|Withdrawal by Subject|13|||
145631848|NCT01281813|525166005|FG000|Overall Study|Subject Non-Compliant|0|||
145631849|NCT01281813|525166006|FG001|Overall Study|Subject Non-Compliant|0|||
145631850|NCT01281813|525166007|FG002|Overall Study|Subject Non-Compliant|6|||
145631851|NCT01281813|525166005|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
145631852|NCT01281813|525166006|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
145631853|NCT01281813|525166007|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
145631854|NCT01281813|525166005|FG000|Overall Study|Sponsor's Decision|4|||
145631855|NCT01281813|525166006|FG001|Overall Study|Sponsor's Decision|3|||
145631856|NCT01281813|525166007|FG002|Overall Study|Sponsor's Decision|7|||
145631857|NCT01281813|525166005|FG000|Overall Study|Switched to Commercially Available Medication|0|||
145631858|NCT01281813|525166006|FG001|Overall Study|Switched to Commercially Available Medication|0|||
145631859|NCT01281813|525166007|FG002|Overall Study|Switched to Commercially Available Medication|26|||
145631860|NCT01281813|525166005|FG000|Overall Study|Other|0|||
145631861|NCT01281813|525166006|FG001|Overall Study|Other|1|||
145631862|NCT01281813|525166007|FG002|Overall Study|Other|39|||
145631863|NCT05257798|525166008|FG000|Follow-up Phase|Lost to Follow-up|1|||
145631864|NCT05257798|525166009|FG001|Follow-up Phase|Lost to Follow-up|0|||
145631865|NCT00703911|525166012|FG000|Overall Study|Death|1|||
145631866|NCT00703911|525166012|FG000|Overall Study|Physician Decision|6|||
145631867|NCT00703911|525166012|FG000|Overall Study|Lost to Follow-up|1|||
145631868|NCT00703911|525166012|FG000|Overall Study|Withdrawal by Subject|2|||
145631869|NCT02082158|525166013|FG000|Overall Study|Withdrawal by Subject|0|||
145631870|NCT02082158|525166014|FG001|Overall Study|Withdrawal by Subject|0|||
145631871|NCT02082158|525166015|FG002|Overall Study|Withdrawal by Subject|0|||
145631872|NCT02082158|525166016|FG003|Overall Study|Withdrawal by Subject|0|||
145631873|NCT02082158|525166017|FG004|Overall Study|Withdrawal by Subject|1|||
145631874|NCT02082158|525166018|FG005|Overall Study|Withdrawal by Subject|0|||
145474882|NCT01424228|524590137|FG001|Overall Study|Lack of Efficacy|7|||
145474883|NCT01424228|524590136|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
145474884|NCT01424228|524590137|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
145474885|NCT01424228|524590136|FG000|Overall Study|Non-compliance|2|||
145631875|NCT02082158|525166013|FG000|Overall Study|Failed Fit-testing|8|||
145631876|NCT02082158|525166014|FG001|Overall Study|Failed Fit-testing|8|||
145631877|NCT02082158|525166015|FG002|Overall Study|Failed Fit-testing|14|||
145474886|NCT01424228|524590137|FG001|Overall Study|Non-compliance|0|||
145474887|NCT01424228|524590136|FG000|Overall Study|Worsening of symptoms|1|||
145474888|NCT01424228|524590137|FG001|Overall Study|Worsening of symptoms|0|||
145631878|NCT02082158|525166016|FG003|Overall Study|Failed Fit-testing|4|||
145474889|NCT01424228|524590136|FG000|Overall Study|Unplanned journey|0|||
145474890|NCT01424228|524590137|FG001|Overall Study|Unplanned journey|1|||
145474891|NCT00590577|524590141|FG000|Overall Study|Lack of Efficacy|31|||
145474892|NCT00590577|524590142|FG001|Overall Study|Lack of Efficacy|28|||
145474893|NCT00590577|524590143|FG002|Overall Study|Lack of Efficacy|23|||
145474894|NCT00590577|524590144|FG003|Overall Study|Lack of Efficacy|45|||
145474895|NCT00590577|524590141|FG000|Overall Study|Withdrawal by Subject|23|||
145474896|NCT00590577|524590142|FG001|Overall Study|Withdrawal by Subject|28|||
145474897|NCT00590577|524590143|FG002|Overall Study|Withdrawal by Subject|30|||
145474898|NCT00590577|524590144|FG003|Overall Study|Withdrawal by Subject|26|||
145474899|NCT00590577|524590141|FG000|Overall Study|Adverse Event|10|||
145474900|NCT00590577|524590142|FG001|Overall Study|Adverse Event|10|||
145474901|NCT00590577|524590143|FG002|Overall Study|Adverse Event|13|||
145474902|NCT00590577|524590144|FG003|Overall Study|Adverse Event|11|||
145474903|NCT00590577|524590141|FG000|Overall Study|Lost to Follow-up|12|||
145474904|NCT00590577|524590142|FG001|Overall Study|Lost to Follow-up|6|||
145474905|NCT00590577|524590143|FG002|Overall Study|Lost to Follow-up|6|||
145474906|NCT00590577|524590144|FG003|Overall Study|Lost to Follow-up|9|||
145474907|NCT00590577|524590141|FG000|Overall Study|Pregnancy|0|||
145474908|NCT00590577|524590142|FG001|Overall Study|Pregnancy|1|||
145474909|NCT00590577|524590143|FG002|Overall Study|Pregnancy|0|||
145474910|NCT00590577|524590144|FG003|Overall Study|Pregnancy|0|||
145474911|NCT00590577|524590141|FG000|Overall Study|Various reasons|1|||
145474912|NCT00590577|524590142|FG001|Overall Study|Various reasons|3|||
145474913|NCT00590577|524590143|FG002|Overall Study|Various reasons|1|||
145474914|NCT00590577|524590144|FG003|Overall Study|Various reasons|2|||
145474915|NCT01300260|524590145|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
145474916|NCT01300260|524590146|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
145474917|NCT01300260|524590145|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
145474918|NCT01300260|524590146|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
145474919|NCT01300260|524590145|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
145474920|NCT01300260|524590146|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
145474921|NCT00235716|524590158|FG000|Overall Study|Death|26|||
145474922|NCT00235716|524590159|FG001|Overall Study|Death|39|||
145474923|NCT00235716|524590160|FG002|Overall Study|Death|32|||
145474924|NCT00235716|524590161|FG003|Overall Study|Death|31|||
145474925|NCT00235716|524590158|FG000|Overall Study|Withdrawal by Subject|23|||
145474926|NCT00235716|524590159|FG001|Overall Study|Withdrawal by Subject|19|||
145474927|NCT00235716|524590160|FG002|Overall Study|Withdrawal by Subject|17|||
145474928|NCT00235716|524590161|FG003|Overall Study|Withdrawal by Subject|18|||
145474929|NCT00235716|524590158|FG000|Overall Study|Lost to Follow-up|12|||
145474930|NCT00235716|524590159|FG001|Overall Study|Lost to Follow-up|7|||
145474931|NCT00235716|524590160|FG002|Overall Study|Lost to Follow-up|14|||
145474932|NCT00235716|524590161|FG003|Overall Study|Lost to Follow-up|10|||
145474933|NCT00235716|524590158|FG000|Overall Study|Adverse Event|1|||
145474934|NCT00235716|524590159|FG001|Overall Study|Adverse Event|1|||
145474935|NCT00235716|524590160|FG002|Overall Study|Adverse Event|1|||
145474936|NCT00235716|524590161|FG003|Overall Study|Adverse Event|0|||
145474937|NCT00235716|524590158|FG000|Overall Study|Physician Decision|0|||
145631879|NCT02082158|525166017|FG004|Overall Study|Failed Fit-testing|3|||
145631880|NCT02082158|525166018|FG005|Overall Study|Failed Fit-testing|7|||
145631881|NCT00549848|525166019|FG000|Overall Study|Death|1|||
145631882|NCT00549848|525166020|FG001|Overall Study|Death|4|||
145631883|NCT00549848|525166021|FG002|Overall Study|Death|13|||
145631884|NCT00549848|525166019|FG000|Overall Study|Physician Decision|0|||
145631885|NCT00549848|525166020|FG001|Overall Study|Physician Decision|0|||
145631886|NCT00549848|525166021|FG002|Overall Study|Physician Decision|4|||
145631887|NCT00549848|525166019|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
145631888|NCT00549848|525166020|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
145631889|NCT00549848|525166021|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
145631890|NCT00549848|525166019|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
145631891|NCT00549848|525166020|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
145631892|NCT00549848|525166021|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
145631893|NCT00549848|525166019|FG000|Overall Study|Participant/Family Withdraw|2|||
145474938|NCT00235716|524590159|FG001|Overall Study|Physician Decision|1|||
145474939|NCT00235716|524590160|FG002|Overall Study|Physician Decision|1|||
145474940|NCT00235716|524590161|FG003|Overall Study|Physician Decision|3|||
145474941|NCT03238924|524590162|FG000|Overall Study|Withdrawal by Subject|2|||
145474942|NCT03238924|524590163|FG001|Overall Study|Withdrawal by Subject|2|||
145474943|NCT03576716|524590167|FG000|Overall Study|Withdrawal by Subject|0|||
145474944|NCT03576716|524590168|FG001|Overall Study|Withdrawal by Subject|1|||
145474945|NCT01455194|524590169|FG000|Overall Study|Screen Failure|20|||
145474946|NCT01455194|524590170|FG001|Overall Study|Screen Failure|0|||
145474947|NCT01455194|524590171|FG002|Overall Study|Screen Failure|0|||
145474948|NCT01455194|524590172|FG003|Overall Study|Screen Failure|0|||
145474949|NCT01455194|524590169|FG000|Overall Study|Randomisation Failure|90|||
145631894|NCT00549848|525166020|FG001|Overall Study|Participant/Family Withdraw|3|||
145631895|NCT00549848|525166021|FG002|Overall Study|Participant/Family Withdraw|5|||
145474950|NCT01455194|524590170|FG001|Overall Study|Randomisation Failure|0|||
145474951|NCT01455194|524590171|FG002|Overall Study|Randomisation Failure|0|||
145474952|NCT01455194|524590172|FG003|Overall Study|Randomisation Failure|0|||
145474953|NCT01455194|524590169|FG000|Overall Study|Deterioration in asthma|12|||
145474954|NCT01455194|524590170|FG001|Overall Study|Deterioration in asthma|6|||
145474955|NCT01455194|524590171|FG002|Overall Study|Deterioration in asthma|14|||
145474956|NCT01455194|524590172|FG003|Overall Study|Deterioration in asthma|9|||
145474957|NCT01455194|524590169|FG000|Overall Study|Adverse Event|1|||
145474958|NCT01455194|524590170|FG001|Overall Study|Adverse Event|1|||
145474959|NCT01455194|524590171|FG002|Overall Study|Adverse Event|1|||
145474960|NCT01455194|524590172|FG003|Overall Study|Adverse Event|3|||
145474961|NCT01455194|524590169|FG000|Overall Study|Withdrawal by Subject|21|||
145474962|NCT01455194|524590170|FG001|Overall Study|Withdrawal by Subject|16|||
145474963|NCT01455194|524590171|FG002|Overall Study|Withdrawal by Subject|12|||
145474964|NCT01455194|524590172|FG003|Overall Study|Withdrawal by Subject|9|||
145474965|NCT01455194|524590169|FG000|Overall Study|Lost to Follow-up|2|||
145474966|NCT01455194|524590170|FG001|Overall Study|Lost to Follow-up|0|||
145474967|NCT01455194|524590171|FG002|Overall Study|Lost to Follow-up|1|||
145474968|NCT01455194|524590172|FG003|Overall Study|Lost to Follow-up|1|||
145474969|NCT01455194|524590169|FG000|Overall Study|Pregnancy|0|||
145474970|NCT01455194|524590170|FG001|Overall Study|Pregnancy|1|||
145474971|NCT01455194|524590171|FG002|Overall Study|Pregnancy|1|||
145474972|NCT01455194|524590172|FG003|Overall Study|Pregnancy|0|||
145474973|NCT01455194|524590169|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
145474974|NCT01455194|524590170|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
145474975|NCT01455194|524590171|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
145474976|NCT01455194|524590172|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
145474977|NCT01455194|524590169|FG000|Overall Study|Miscellaneous|4|||
145474978|NCT01455194|524590170|FG001|Overall Study|Miscellaneous|5|||
145474979|NCT01455194|524590171|FG002|Overall Study|Miscellaneous|1|||
145474980|NCT01455194|524590172|FG003|Overall Study|Miscellaneous|4|||
145474981|NCT02891382|524590173|FG000|Overall Study|Lost to Follow-up|3|||
145474982|NCT02891382|524590174|FG001|Overall Study|Lost to Follow-up|4|||
145474983|NCT02891382|524590175|FG002|Overall Study|Lost to Follow-up|5|||
145474984|NCT02891382|524590176|FG003|Overall Study|Lost to Follow-up|3|||
145474985|NCT02891382|524590177|FG004|Overall Study|Lost to Follow-up|4|||
145474986|NCT02516228|524590178|FG000|Overall Study|Lost to Follow-up|1|||
145474987|NCT02516228|524590178|FG000|Overall Study|Withdrawal by Subject|1|||
145474988|NCT02516228|524590178|FG000|Overall Study|Physician Decision|1|||
145474989|NCT03916484|524590179|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145474990|NCT03916484|524590180|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
145474991|NCT03916484|524590181|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145474992|NCT03916484|524590182|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
145474993|NCT03916484|524590179|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
145474994|NCT03916484|524590180|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
145474995|NCT03916484|524590181|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
145474996|NCT03916484|524590182|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
145474997|NCT01990859|524590183|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
145474998|NCT01990859|524590183|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
145474999|NCT02262754|524590184|FG000|Overall Study|Adverse Event|3|||
145475000|NCT02262754|524590185|FG001|Overall Study|Adverse Event|4|||
145475001|NCT02262754|524590186|FG002|Overall Study|Adverse Event|0|||
145475002|NCT02262754|524590184|FG000|Overall Study|Lack of Efficacy|2|||
145475003|NCT02262754|524590185|FG001|Overall Study|Lack of Efficacy|0|||
145475004|NCT02262754|524590186|FG002|Overall Study|Lack of Efficacy|1|||
145475005|NCT02262754|524590184|FG000|Overall Study|Lost to Follow-up|0|||
145475006|NCT02262754|524590185|FG001|Overall Study|Lost to Follow-up|0|||
145475007|NCT02262754|524590186|FG002|Overall Study|Lost to Follow-up|1|||
145475008|NCT02262754|524590184|FG000|Overall Study|No longer meets eligibility criteria|0|||
145631896|NCT00549848|525166019|FG000|Overall Study|Second Malignancy|1|||
145631897|NCT00549848|525166020|FG001|Overall Study|Second Malignancy|0|||
145631898|NCT00549848|525166021|FG002|Overall Study|Second Malignancy|0|||
145631899|NCT00549848|525166019|FG000|Overall Study|Transplant|3|||
145631900|NCT00549848|525166020|FG001|Overall Study|Transplant|3|||
145631901|NCT00549848|525166021|FG002|Overall Study|Transplant|18|||
145475009|NCT02262754|524590185|FG001|Overall Study|No longer meets eligibility criteria|1|||
145475010|NCT02262754|524590186|FG002|Overall Study|No longer meets eligibility criteria|0|||
145475011|NCT02262754|524590184|FG000|Overall Study|Study terminated by sponsor|5|||
145475012|NCT02262754|524590185|FG001|Overall Study|Study terminated by sponsor|4|||
145475013|NCT02262754|524590186|FG002|Overall Study|Study terminated by sponsor|4|||
145475014|NCT02262754|524590184|FG000|Overall Study|Protocol Violation|1|||
145475015|NCT02262754|524590185|FG001|Overall Study|Protocol Violation|0|||
145475016|NCT02262754|524590186|FG002|Overall Study|Protocol Violation|0|||
145475017|NCT02262754|524590184|FG000|Overall Study|Withdrawal by Subject|1|||
145475018|NCT02262754|524590185|FG001|Overall Study|Withdrawal by Subject|0|||
145631902|NCT00549848|525166019|FG000|Overall Study|Unacceptable Toxicity|1|||
145475019|NCT02262754|524590186|FG002|Overall Study|Withdrawal by Subject|1|||
145475020|NCT02262754|524590184|FG000|Overall Study|Other|4|||
145475021|NCT02262754|524590185|FG001|Overall Study|Other|0|||
145475022|NCT02262754|524590186|FG002|Overall Study|Other|2|||
145475023|NCT04079114|524590189|FG000|Overall Study|Study prematuely terminated.|166|||
145475024|NCT02292706|524590190|FG000|Overall Study|Lost to Follow-up|20|||
145475025|NCT02292706|524590191|FG001|Overall Study|Lost to Follow-up|44|||
145475026|NCT02292706|524590192|FG002|Overall Study|Lost to Follow-up|24|||
145475027|NCT02292706|524590193|FG003|Overall Study|Lost to Follow-up|61|||
145475028|NCT02292706|524590194|FG004|Overall Study|Lost to Follow-up|21|||
145475029|NCT02292706|524590195|FG005|Overall Study|Lost to Follow-up|52|||
145475030|NCT02292706|524590196|FG006|Overall Study|Lost to Follow-up|25|||
145475031|NCT02292706|524590197|FG007|Overall Study|Lost to Follow-up|0|||
145475032|NCT02292706|524590190|FG000|Overall Study|Withdrew consent|15|||
145475033|NCT02292706|524590191|FG001|Overall Study|Withdrew consent|56|||
145475034|NCT02292706|524590192|FG002|Overall Study|Withdrew consent|43|||
145475035|NCT02292706|524590193|FG003|Overall Study|Withdrew consent|36|||
145475036|NCT02292706|524590194|FG004|Overall Study|Withdrew consent|13|||
145475037|NCT02292706|524590195|FG005|Overall Study|Withdrew consent|51|||
145475038|NCT02292706|524590196|FG006|Overall Study|Withdrew consent|20|||
145475039|NCT02292706|524590197|FG007|Overall Study|Withdrew consent|0|||
145475040|NCT02292706|524590190|FG000|Overall Study|Death|3|||
145475041|NCT02292706|524590191|FG001|Overall Study|Death|11|||
145475042|NCT02292706|524590192|FG002|Overall Study|Death|16|||
145475043|NCT02292706|524590193|FG003|Overall Study|Death|22|||
145475044|NCT02292706|524590194|FG004|Overall Study|Death|8|||
145475045|NCT02292706|524590195|FG005|Overall Study|Death|17|||
145475046|NCT02292706|524590196|FG006|Overall Study|Death|3|||
145475047|NCT02292706|524590197|FG007|Overall Study|Death|0|||
145475048|NCT02292706|524590190|FG000|Overall Study|Study terminated by sponsor|0|||
145475049|NCT02292706|524590191|FG001|Overall Study|Study terminated by sponsor|9|||
145475050|NCT02292706|524590192|FG002|Overall Study|Study terminated by sponsor|4|||
145475051|NCT02292706|524590193|FG003|Overall Study|Study terminated by sponsor|21|||
145475052|NCT02292706|524590194|FG004|Overall Study|Study terminated by sponsor|11|||
145475053|NCT02292706|524590195|FG005|Overall Study|Study terminated by sponsor|13|||
145475054|NCT02292706|524590196|FG006|Overall Study|Study terminated by sponsor|3|||
145475055|NCT02292706|524590197|FG007|Overall Study|Study terminated by sponsor|0|||
145475056|NCT02292706|524590190|FG000|Overall Study|Investigator's discretion|4|||
145475057|NCT02292706|524590191|FG001|Overall Study|Investigator's discretion|9|||
145475058|NCT02292706|524590192|FG002|Overall Study|Investigator's discretion|7|||
145475059|NCT02292706|524590193|FG003|Overall Study|Investigator's discretion|11|||
145475060|NCT02292706|524590194|FG004|Overall Study|Investigator's discretion|4|||
145475061|NCT02292706|524590195|FG005|Overall Study|Investigator's discretion|10|||
145475062|NCT02292706|524590196|FG006|Overall Study|Investigator's discretion|1|||
145475063|NCT02292706|524590197|FG007|Overall Study|Investigator's discretion|0|||
145475064|NCT02292706|524590190|FG000|Overall Study|Liver transplant|1|||
145475065|NCT02292706|524590191|FG001|Overall Study|Liver transplant|1|||
145475066|NCT02292706|524590192|FG002|Overall Study|Liver transplant|11|||
145475067|NCT02292706|524590193|FG003|Overall Study|Liver transplant|16|||
145475068|NCT02292706|524590194|FG004|Overall Study|Liver transplant|5|||
145475069|NCT02292706|524590195|FG005|Overall Study|Liver transplant|6|||
145475070|NCT02292706|524590196|FG006|Overall Study|Liver transplant|5|||
145475071|NCT02292706|524590197|FG007|Overall Study|Liver transplant|0|||
145475072|NCT02292706|524590190|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
145475073|NCT02292706|524590191|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
145475074|NCT02292706|524590192|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
145475075|NCT02292706|524590193|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
145475076|NCT02292706|524590194|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
145475077|NCT02292706|524590195|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
145475078|NCT02292706|524590196|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
145475079|NCT02292706|524590197|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
145475080|NCT02292706|524590190|FG000|Overall Study|Subject terminated by sponsor|1|||
145475081|NCT02292706|524590191|FG001|Overall Study|Subject terminated by sponsor|0|||
145475082|NCT02292706|524590192|FG002|Overall Study|Subject terminated by sponsor|0|||
145631903|NCT00549848|525166020|FG001|Overall Study|Unacceptable Toxicity|6|||
145631904|NCT00549848|525166021|FG002|Overall Study|Unacceptable Toxicity|6|||
145631905|NCT05193318|525166028|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
145631906|NCT05193318|525166028|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
145631907|NCT02846415|525166029|FG000|Overall Study|Lost to Follow-up|2|||
145631908|NCT02846415|525166030|FG001|Overall Study|Lost to Follow-up|0|||
145475083|NCT02292706|524590193|FG003|Overall Study|Subject terminated by sponsor|2|||
145475084|NCT02292706|524590194|FG004|Overall Study|Subject terminated by sponsor|1|||
145475085|NCT02292706|524590195|FG005|Overall Study|Subject terminated by sponsor|0|||
145475086|NCT02292706|524590196|FG006|Overall Study|Subject terminated by sponsor|0|||
145475087|NCT02292706|524590197|FG007|Overall Study|Subject terminated by sponsor|0|||
145475088|NCT02292706|524590190|FG000|Overall Study|Missing|0|||
145475089|NCT02292706|524590191|FG001|Overall Study|Missing|0|||
145475090|NCT02292706|524590192|FG002|Overall Study|Missing|1|||
145475091|NCT02292706|524590193|FG003|Overall Study|Missing|1|||
145475092|NCT02292706|524590194|FG004|Overall Study|Missing|0|||
145475093|NCT02292706|524590195|FG005|Overall Study|Missing|1|||
145475094|NCT02292706|524590196|FG006|Overall Study|Missing|0|||
145475095|NCT02292706|524590197|FG007|Overall Study|Missing|0|||
145475096|NCT02292706|524590190|FG000|Overall Study|Virologic relapse or reinfection|1|||
145475097|NCT02292706|524590191|FG001|Overall Study|Virologic relapse or reinfection|0|||
145475098|NCT02292706|524590192|FG002|Overall Study|Virologic relapse or reinfection|0|||
145475099|NCT02292706|524590193|FG003|Overall Study|Virologic relapse or reinfection|1|||
145475100|NCT02292706|524590194|FG004|Overall Study|Virologic relapse or reinfection|0|||
145475101|NCT02292706|524590195|FG005|Overall Study|Virologic relapse or reinfection|1|||
145475102|NCT02292706|524590196|FG006|Overall Study|Virologic relapse or reinfection|0|||
145475103|NCT02292706|524590197|FG007|Overall Study|Virologic relapse or reinfection|0|||
145475104|NCT02725866|524590200|FG000|Overall Study|Failure to return|6|||
145475105|NCT02725866|524590200|FG000|Overall Study|Withdrew consent|3|||
145475106|NCT02725866|524590200|FG000|Overall Study|Insufficient virological response|1|||
145475107|NCT02725866|524590200|FG000|Overall Study|Other, not specified|4|||
145475108|NCT01990612|524590201|FG000|Overall Study|Lost to Follow-up|2|||
145475109|NCT01990612|524590202|FG001|Overall Study|Lost to Follow-up|1|||
145475110|NCT01990612|524590201|FG000|Overall Study|Withdrawal by Subject|5|||
145475111|NCT01990612|524590202|FG001|Overall Study|Withdrawal by Subject|2|||
145475112|NCT02188849|524590205|FG000|Overall Study|Lost to Follow-up|3|||
145475113|NCT02188849|524590206|FG001|Overall Study|Lost to Follow-up|8|||
145475114|NCT00687531|524590210|FG000|Overall Study|Did not meet protocol eligibility|104|||
145475115|NCT00687531|524590210|FG000|Overall Study|Adverse Event|5|||
145475116|NCT00687531|524590210|FG000|Overall Study|Lost to Follow-up|26|||
145475117|NCT02353728|524590211|FG000|Overall Study|Subject non-compliance|1|||
145475118|NCT02301624|524590212|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
145475119|NCT02301624|524590213|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
145475120|NCT02301624|524590212|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
145475121|NCT02301624|524590213|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
145475122|NCT02301624|524590212|FG000|Open-label Maintenance Phase|Adverse Event|2|||
145475123|NCT02301624|524590213|FG001|Open-label Maintenance Phase|Adverse Event|5|||
145475124|NCT02301624|524590212|FG000|Open-label Maintenance Phase|Physician Decision|3|||
145475125|NCT02301624|524590213|FG001|Open-label Maintenance Phase|Physician Decision|3|||
145475126|NCT02301624|524590212|FG000|Open-label Maintenance Phase|Death|2|||
145475127|NCT02301624|524590213|FG001|Open-label Maintenance Phase|Death|1|||
145475128|NCT02301624|524590212|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
145475129|NCT02301624|524590213|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
145475130|NCT00895310|524590214|FG000|Overall Study|Withdrawal by Subject|1|||
145475131|NCT00659230|524590215|FG000|Overall Study|Lost to Follow-up|2|||
145475132|NCT00659230|524590216|FG001|Overall Study|Lost to Follow-up|5|||
145475133|NCT00659230|524590215|FG000|Overall Study|Lost source documentation|5|||
145475134|NCT00659230|524590216|FG001|Overall Study|Lost source documentation|4|||
145475135|NCT00659230|524590215|FG000|Overall Study|Did not return post-randomization|2|||
145475136|NCT00659230|524590216|FG001|Overall Study|Did not return post-randomization|3|||
145475137|NCT00547521|524590217|FG000|Short Term Study (4 Months)|Adverse Event|1|||
145475138|NCT00547521|524590218|FG001|Short Term Study (4 Months)|Adverse Event|0|||
145475139|NCT00547521|524590217|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
145475140|NCT00547521|524590218|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
145475141|NCT00547521|524590217|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
145475142|NCT00547521|524590218|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
145475143|NCT00547521|524590217|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
145475144|NCT00547521|524590218|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
145475145|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
145475146|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
145475147|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
145475148|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
145475149|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
145475150|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
145475151|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
145475152|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
145475153|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Other|0|||
145475154|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Other|2|||
145475155|NCT00547521|524590217|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
145475156|NCT00547521|524590218|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
145475157|NCT05066165|524592081|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
145475158|NCT05066165|524592082|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
145475159|NCT05066165|524592081|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
145475160|NCT05066165|524592082|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
145475161|NCT02454478|524592086|FG000|Overall Study|Incomplete DLT Evaluation|1|||
145475162|NCT03521141|524592096|FG000|Overall Study|Death|1|||
145475163|NCT03521141|524592097|FG001|Overall Study|Death|0|||
145475164|NCT03521141|524592098|FG002|Overall Study|Death|1|||
145475165|NCT00655629|524592106|FG000|Overall Study|Adverse Event|4|||
145475166|NCT00655629|524592107|FG001|Overall Study|Adverse Event|1|||
145475167|NCT00655629|524592106|FG000|Overall Study|Lack of Efficacy|2|||
145475168|NCT00655629|524592107|FG001|Overall Study|Lack of Efficacy|12|||
145475169|NCT00655629|524592106|FG000|Overall Study|Lost to Follow-up|4|||
145475170|NCT00655629|524592107|FG001|Overall Study|Lost to Follow-up|3|||
145475171|NCT00655629|524592106|FG000|Overall Study|Protocol Violation|5|||
145475172|NCT00655629|524592107|FG001|Overall Study|Protocol Violation|3|||
145475173|NCT00655629|524592106|FG000|Overall Study|consent withdrawn|6|||
145475174|NCT00655629|524592107|FG001|Overall Study|consent withdrawn|4|||
145475175|NCT01610336|524592108|FG000|Overall Study|Progressive Disease|4|||
145475176|NCT01610336|524592109|FG001|Overall Study|Progressive Disease|6|||
145475177|NCT01610336|524592110|FG002|Overall Study|Progressive Disease|6|||
145475178|NCT01610336|524592111|FG003|Overall Study|Progressive Disease|5|||
145475179|NCT01610336|524592112|FG004|Overall Study|Progressive Disease|3|||
145475180|NCT01610336|524592113|FG005|Overall Study|Progressive Disease|10|||
145475181|NCT01610336|524592114|FG006|Overall Study|Progressive Disease|1|||
145475182|NCT01610336|524592115|FG007|Overall Study|Progressive Disease|6|||
145475183|NCT01610336|524592116|FG008|Overall Study|Progressive Disease|6|||
145475184|NCT01610336|524592117|FG009|Overall Study|Progressive Disease|40|||
145475185|NCT01610336|524592118|FG010|Overall Study|Progressive Disease|36|||
145475186|NCT01610336|524592108|FG000|Overall Study|Adverse Event|0|||
145475187|NCT01610336|524592109|FG001|Overall Study|Adverse Event|0|||
145475188|NCT01610336|524592110|FG002|Overall Study|Adverse Event|0|||
145475189|NCT01610336|524592111|FG003|Overall Study|Adverse Event|1|||
145475190|NCT01610336|524592112|FG004|Overall Study|Adverse Event|1|||
145475191|NCT01610336|524592113|FG005|Overall Study|Adverse Event|1|||
145475192|NCT01610336|524592114|FG006|Overall Study|Adverse Event|0|||
145475193|NCT01610336|524592115|FG007|Overall Study|Adverse Event|0|||
145475194|NCT01610336|524592116|FG008|Overall Study|Adverse Event|2|||
145475195|NCT01610336|524592117|FG009|Overall Study|Adverse Event|8|||
145475196|NCT01610336|524592118|FG010|Overall Study|Adverse Event|6|||
145475197|NCT01610336|524592108|FG000|Overall Study|Subject/Guardian decision|1|||
145475198|NCT01610336|524592109|FG001|Overall Study|Subject/Guardian decision|1|||
145475199|NCT01610336|524592110|FG002|Overall Study|Subject/Guardian decision|0|||
145475200|NCT01610336|524592111|FG003|Overall Study|Subject/Guardian decision|1|||
145475201|NCT01610336|524592112|FG004|Overall Study|Subject/Guardian decision|0|||
145475202|NCT01610336|524592113|FG005|Overall Study|Subject/Guardian decision|0|||
145475203|NCT01610336|524592114|FG006|Overall Study|Subject/Guardian decision|0|||
145475204|NCT01610336|524592115|FG007|Overall Study|Subject/Guardian decision|1|||
145475205|NCT01610336|524592116|FG008|Overall Study|Subject/Guardian decision|0|||
145475206|NCT01610336|524592117|FG009|Overall Study|Subject/Guardian decision|2|||
145475207|NCT01610336|524592118|FG010|Overall Study|Subject/Guardian decision|2|||
145475208|NCT01610336|524592108|FG000|Overall Study|Death|0|||
145475209|NCT01610336|524592109|FG001|Overall Study|Death|0|||
145475210|NCT01610336|524592110|FG002|Overall Study|Death|0|||
145475211|NCT01610336|524592111|FG003|Overall Study|Death|0|||
145475212|NCT01610336|524592112|FG004|Overall Study|Death|0|||
145475213|NCT01610336|524592113|FG005|Overall Study|Death|1|||
145475214|NCT01610336|524592114|FG006|Overall Study|Death|3|||
145475215|NCT01610336|524592115|FG007|Overall Study|Death|0|||
145475216|NCT01610336|524592116|FG008|Overall Study|Death|0|||
145475217|NCT01610336|524592117|FG009|Overall Study|Death|1|||
145475218|NCT01610336|524592118|FG010|Overall Study|Death|2|||
145631909|NCT02846415|525166029|FG000|Overall Study|Withdrawal by Subject|1|||
145631910|NCT02846415|525166030|FG001|Overall Study|Withdrawal by Subject|1|||
145631911|NCT04889664|525166034|FG000|Screen|Lost to Follow-up|1|||
145631912|NCT04889664|525166034|FG000|Screen|Failed to meet screening criteria|1|||
145475219|NCT01610336|524592108|FG000|Overall Study|Non-Compliance with study treatment|0|||
145475220|NCT01610336|524592109|FG001|Overall Study|Non-Compliance with study treatment|0|||
145475221|NCT01610336|524592110|FG002|Overall Study|Non-Compliance with study treatment|0|||
145475222|NCT01610336|524592111|FG003|Overall Study|Non-Compliance with study treatment|0|||
145475223|NCT01610336|524592112|FG004|Overall Study|Non-Compliance with study treatment|0|||
145475224|NCT01610336|524592113|FG005|Overall Study|Non-Compliance with study treatment|0|||
145475225|NCT01610336|524592114|FG006|Overall Study|Non-Compliance with study treatment|0|||
145475226|NCT01610336|524592115|FG007|Overall Study|Non-Compliance with study treatment|0|||
145475227|NCT01610336|524592116|FG008|Overall Study|Non-Compliance with study treatment|0|||
145475228|NCT01610336|524592117|FG009|Overall Study|Non-Compliance with study treatment|1|||
145631913|NCT04889664|525166034|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
145475229|NCT01610336|524592118|FG010|Overall Study|Non-Compliance with study treatment|0|||
145475230|NCT01610336|524592108|FG000|Overall Study|Physician Decision|0|||
145475231|NCT01610336|524592109|FG001|Overall Study|Physician Decision|0|||
145475232|NCT01610336|524592110|FG002|Overall Study|Physician Decision|0|||
145475233|NCT01610336|524592111|FG003|Overall Study|Physician Decision|0|||
145475234|NCT01610336|524592112|FG004|Overall Study|Physician Decision|0|||
145475235|NCT01610336|524592113|FG005|Overall Study|Physician Decision|0|||
145475236|NCT01610336|524592114|FG006|Overall Study|Physician Decision|1|||
145475237|NCT01610336|524592115|FG007|Overall Study|Physician Decision|0|||
145475238|NCT01610336|524592116|FG008|Overall Study|Physician Decision|0|||
145475239|NCT01610336|524592117|FG009|Overall Study|Physician Decision|0|||
145475240|NCT01610336|524592118|FG010|Overall Study|Physician Decision|0|||
145475241|NCT01610336|524592108|FG000|Overall Study|Protocol Deviation|0|||
145475242|NCT01610336|524592109|FG001|Overall Study|Protocol Deviation|0|||
145475243|NCT01610336|524592110|FG002|Overall Study|Protocol Deviation|0|||
145475244|NCT01610336|524592111|FG003|Overall Study|Protocol Deviation|0|||
145475245|NCT01610336|524592112|FG004|Overall Study|Protocol Deviation|0|||
145475246|NCT01610336|524592113|FG005|Overall Study|Protocol Deviation|0|||
145475247|NCT01610336|524592114|FG006|Overall Study|Protocol Deviation|0|||
145475248|NCT01610336|524592115|FG007|Overall Study|Protocol Deviation|0|||
145475249|NCT01610336|524592116|FG008|Overall Study|Protocol Deviation|0|||
145475250|NCT01610336|524592117|FG009|Overall Study|Protocol Deviation|1|||
145475251|NCT01610336|524592118|FG010|Overall Study|Protocol Deviation|0|||
145475252|NCT01610336|524592108|FG000|Overall Study|Transfer to another trial|0|||
145475253|NCT01610336|524592109|FG001|Overall Study|Transfer to another trial|0|||
145475254|NCT01610336|524592110|FG002|Overall Study|Transfer to another trial|0|||
145475255|NCT01610336|524592111|FG003|Overall Study|Transfer to another trial|0|||
145475256|NCT01610336|524592112|FG004|Overall Study|Transfer to another trial|0|||
145475257|NCT01610336|524592113|FG005|Overall Study|Transfer to another trial|0|||
145475258|NCT01610336|524592114|FG006|Overall Study|Transfer to another trial|0|||
145475259|NCT01610336|524592115|FG007|Overall Study|Transfer to another trial|0|||
145475260|NCT01610336|524592116|FG008|Overall Study|Transfer to another trial|0|||
145475261|NCT01610336|524592117|FG009|Overall Study|Transfer to another trial|0|||
145475262|NCT01610336|524592118|FG010|Overall Study|Transfer to another trial|1|||
145475263|NCT00193180|524592123|FG000|Overall Study|Lack of Efficacy|1|||
145475264|NCT00193180|524592123|FG000|Overall Study|Adverse Event|8|||
145475265|NCT00193180|524592123|FG000|Overall Study|Protocol Violation|1|||
145475266|NCT01832155|524592124|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
145475267|NCT01832155|524592125|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
145475268|NCT01832155|524592124|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
145475269|NCT01832155|524592125|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
145475270|NCT01369641|524592126|FG000|Overall Study|Withdrawal by Subject|1|||
145475271|NCT00842543|524592127|FG000|Overall Study|Withdrawal by Subject|2|||
145475272|NCT00842543|524592128|FG001|Overall Study|Withdrawal by Subject|0|||
145475273|NCT00842543|524592129|FG002|Overall Study|Withdrawal by Subject|3|||
145475274|NCT00842543|524592130|FG003|Overall Study|Withdrawal by Subject|4|||
145475275|NCT01483183|524592135|FG000|Overall Study|Physician Decision|0|||
145475276|NCT01483183|524592136|FG001|Overall Study|Physician Decision|0|||
145475277|NCT01483183|524592137|FG002|Overall Study|Physician Decision|0|||
145475278|NCT01483183|524592138|FG003|Overall Study|Physician Decision|0|||
145475279|NCT01483183|524592139|FG004|Overall Study|Physician Decision|0|||
145475280|NCT01483183|524592140|FG005|Overall Study|Physician Decision|0|||
145475281|NCT01483183|524592141|FG006|Overall Study|Physician Decision|2|||
145475282|NCT01483183|524592142|FG007|Overall Study|Physician Decision|0|||
145475283|NCT01483183|524592143|FG008|Overall Study|Physician Decision|0|||
145475284|NCT01483183|524592144|FG009|Overall Study|Physician Decision|0|||
145475285|NCT01483183|524592135|FG000|Overall Study|Withdrawal by Subject|0|||
145475286|NCT01483183|524592136|FG001|Overall Study|Withdrawal by Subject|0|||
145475287|NCT01483183|524592137|FG002|Overall Study|Withdrawal by Subject|0|||
145475288|NCT01483183|524592138|FG003|Overall Study|Withdrawal by Subject|0|||
145475289|NCT01483183|524592139|FG004|Overall Study|Withdrawal by Subject|0|||
145475290|NCT01483183|524592140|FG005|Overall Study|Withdrawal by Subject|0|||
145475291|NCT01483183|524592141|FG006|Overall Study|Withdrawal by Subject|0|||
145475292|NCT01483183|524592142|FG007|Overall Study|Withdrawal by Subject|0|||
145475293|NCT01483183|524592143|FG008|Overall Study|Withdrawal by Subject|0|||
145475294|NCT01483183|524592144|FG009|Overall Study|Withdrawal by Subject|1|||
145475295|NCT00239928|524592145|FG000|Overall Study|Lack of Efficacy|1|||
145475296|NCT00239928|524592145|FG000|Overall Study|Adverse Event|4|||
145475297|NCT00239928|524592145|FG000|Overall Study|Not need to continue study|3|||
145631914|NCT02155829|525166039|FG000|Overall Study|Adverse Event|1|||
145631915|NCT02155829|525166040|FG001|Overall Study|Adverse Event|0|||
145631916|NCT02155829|525166039|FG000|Overall Study|Withdrawal by Subject|3|||
145631917|NCT02155829|525166040|FG001|Overall Study|Withdrawal by Subject|3|||
145475298|NCT00239928|524592145|FG000|Overall Study|Withdrawal by Subject|2|||
145475299|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475300|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475301|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
145475302|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
145475303|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
145475304|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475305|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
145475306|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
145631918|NCT02155829|525166039|FG000|Overall Study|Protocol Violation|2|||
145631919|NCT02155829|525166040|FG001|Overall Study|Protocol Violation|0|||
145475307|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
145475308|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475309|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475310|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475311|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
145475312|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
145475313|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
145475314|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
145475315|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
145475316|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
145475317|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
145475318|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
145475319|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
145475320|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
145475321|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
145475322|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
145475323|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
145475324|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
145475325|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475326|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
145475327|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
145475328|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475329|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475330|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
145475331|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
145475332|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475333|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475334|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475335|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475336|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475337|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
145475338|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475339|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
145475340|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
145475341|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475342|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475343|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475344|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
145475345|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475346|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
145475347|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475348|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475349|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475350|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
145475351|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475352|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475353|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475354|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
145475355|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475356|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475357|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145631920|NCT04107805|525166041|FG000|Overall Study|Adverse Event|0|||
145631921|NCT04107805|525166042|FG001|Overall Study|Adverse Event|0|||
145631922|NCT04107805|525166043|FG002|Overall Study|Adverse Event|0|||
145631923|NCT04107805|525166044|FG003|Overall Study|Adverse Event|1|||
145631924|NCT04107805|525166045|FG004|Overall Study|Adverse Event|0|||
145631925|NCT04107805|525166046|FG005|Overall Study|Adverse Event|1|||
145631926|NCT04107805|525166047|FG006|Overall Study|Adverse Event|0|||
145631927|NCT04107805|525166048|FG007|Overall Study|Adverse Event|0|||
145631928|NCT04107805|525166049|FG008|Overall Study|Adverse Event|1|||
145631929|NCT01120275|525166055|FG000|Overall Study|Adverse Event|3|||
145631930|NCT01120275|525166055|FG000|Overall Study|Progression|27|||
145631931|NCT01120275|525166055|FG000|Overall Study|Ineligible|3|||
145631932|NCT01120275|525166055|FG000|Overall Study|Withdrawal by Subject|1|||
145631933|NCT01120275|525166055|FG000|Overall Study|Refusal|1|||
145631934|NCT01120275|525166055|FG000|Overall Study|Not specific|1|||
145631935|NCT00771849|525166056|FG000|Overall Study|Lost to Follow-up|1|||
145475358|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
145475359|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475360|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475361|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475362|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475363|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
145475364|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475365|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475366|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475367|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
145475368|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475369|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475370|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
145475371|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475372|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475373|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475374|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475375|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475376|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
145475377|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475378|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
145475379|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475380|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475381|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475382|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475383|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475384|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475385|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475386|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475387|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475388|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475389|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
145475390|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
145475391|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475392|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475393|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475394|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475395|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475396|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475397|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475398|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475399|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475400|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475401|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475402|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
145475403|NCT03100058|524592147|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475404|NCT03100058|524592148|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475405|NCT03100058|524592149|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475406|NCT03100058|524592150|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475407|NCT03100058|524592151|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475408|NCT03100058|524592152|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475409|NCT03100058|524592153|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
145475410|NCT03100058|524592154|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475411|NCT03100058|524592155|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475412|NCT03100058|524592156|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475413|NCT03100058|524592157|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475414|NCT03100058|524592158|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475415|NCT03100058|524592159|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
145475416|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145631936|NCT00771849|525166057|FG001|Overall Study|Lost to Follow-up|2|||
145631937|NCT00771849|525166056|FG000|Overall Study|Withdrawal by Subject|1|||
145631938|NCT00771849|525166057|FG001|Overall Study|Withdrawal by Subject|1|||
145631939|NCT00771849|525166056|FG000|Overall Study|Not vaccinated|0|||
145631940|NCT00771849|525166057|FG001|Overall Study|Not vaccinated|1|||
145475417|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475418|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475419|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145631941|NCT02736799|525166061|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
145631942|NCT02736799|525166062|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
145631943|NCT02736799|525166063|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
145475420|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475421|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475422|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475423|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475424|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475425|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
145475426|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
145475427|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
145475428|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
145475429|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475430|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475431|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475432|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475433|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475434|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475435|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475436|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475437|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475438|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475439|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
145475440|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
145475441|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
145475442|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475443|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475444|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475445|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475446|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475447|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475448|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475449|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475450|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475451|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
145475452|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
145475453|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
145475454|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
145475455|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475456|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475457|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475458|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475459|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475460|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475461|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475462|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475463|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475464|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475465|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
145475466|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475467|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
145475468|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475469|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475470|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475471|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475472|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475473|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475474|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475475|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475476|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475477|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475478|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145475479|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
145631944|NCT02736799|525166064|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
145631945|NCT00197015|525166065|FG000|Overall Study|Adverse Event|3|||
145475480|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
145475481|NCT03100058|524592147|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475482|NCT03100058|524592148|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145631946|NCT00197015|525166066|FG001|Overall Study|Adverse Event|0|||
145631947|NCT00197015|525166067|FG002|Overall Study|Adverse Event|1|||
145475483|NCT03100058|524592149|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475484|NCT03100058|524592150|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475485|NCT03100058|524592151|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475486|NCT03100058|524592152|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475487|NCT03100058|524592153|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475488|NCT03100058|524592154|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475489|NCT03100058|524592155|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475490|NCT03100058|524592156|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
145475491|NCT03100058|524592157|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475492|NCT03100058|524592158|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475493|NCT03100058|524592159|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
145475494|NCT02718716|524592161|FG000|Overall Study|Lack of Efficacy|1|||
145475495|NCT02718716|524592162|FG001|Overall Study|Lack of Efficacy|0|||
145475496|NCT02718716|524592163|FG002|Overall Study|Lack of Efficacy|0|||
145475497|NCT02718716|524592164|FG003|Overall Study|Lack of Efficacy|0|||
145475498|NCT02718716|524592165|FG004|Overall Study|Lack of Efficacy|0|||
145475499|NCT03194646|524592172|FG000|Overall Study|Adverse Event|24|||
145475500|NCT03194646|524592173|FG001|Overall Study|Adverse Event|25|||
145475501|NCT03194646|524592174|FG002|Overall Study|Adverse Event|14|||
145475502|NCT03194646|524592175|FG003|Overall Study|Adverse Event|17|||
145475503|NCT03194646|524592172|FG000|Overall Study|Lack of Efficacy|4|||
145475504|NCT03194646|524592173|FG001|Overall Study|Lack of Efficacy|2|||
145475505|NCT03194646|524592174|FG002|Overall Study|Lack of Efficacy|2|||
145475506|NCT03194646|524592175|FG003|Overall Study|Lack of Efficacy|12|||
145475507|NCT03194646|524592172|FG000|Overall Study|Lost to Follow-up|30|||
145475508|NCT03194646|524592173|FG001|Overall Study|Lost to Follow-up|22|||
145475509|NCT03194646|524592174|FG002|Overall Study|Lost to Follow-up|12|||
145475510|NCT03194646|524592175|FG003|Overall Study|Lost to Follow-up|35|||
145475511|NCT03194646|524592172|FG000|Overall Study|Non-compliance with study drug|4|||
145475512|NCT03194646|524592173|FG001|Overall Study|Non-compliance with study drug|0|||
145475513|NCT03194646|524592174|FG002|Overall Study|Non-compliance with study drug|1|||
145475514|NCT03194646|524592175|FG003|Overall Study|Non-compliance with study drug|1|||
145475515|NCT03194646|524592172|FG000|Overall Study|Other|89|||
145475516|NCT03194646|524592173|FG001|Overall Study|Other|68|||
145475517|NCT03194646|524592174|FG002|Overall Study|Other|34|||
145475518|NCT03194646|524592175|FG003|Overall Study|Other|31|||
145475519|NCT03194646|524592172|FG000|Overall Study|Physician Decision|7|||
145475520|NCT03194646|524592173|FG001|Overall Study|Physician Decision|9|||
145475521|NCT03194646|524592174|FG002|Overall Study|Physician Decision|5|||
145475522|NCT03194646|524592175|FG003|Overall Study|Physician Decision|4|||
145475523|NCT03194646|524592172|FG000|Overall Study|Pregnancy|4|||
145475524|NCT03194646|524592173|FG001|Overall Study|Pregnancy|5|||
145475525|NCT03194646|524592174|FG002|Overall Study|Pregnancy|1|||
145475526|NCT03194646|524592175|FG003|Overall Study|Pregnancy|2|||
145475527|NCT03194646|524592172|FG000|Overall Study|Protocol Violation|4|||
145475528|NCT03194646|524592173|FG001|Overall Study|Protocol Violation|2|||
145475529|NCT03194646|524592174|FG002|Overall Study|Protocol Violation|1|||
145475530|NCT03194646|524592175|FG003|Overall Study|Protocol Violation|1|||
145475531|NCT03194646|524592172|FG000|Overall Study|Site terminated by sponsor|0|||
145475532|NCT03194646|524592173|FG001|Overall Study|Site terminated by sponsor|0|||
145475533|NCT03194646|524592174|FG002|Overall Study|Site terminated by sponsor|2|||
145475534|NCT03194646|524592175|FG003|Overall Study|Site terminated by sponsor|0|||
145475535|NCT03194646|524592172|FG000|Overall Study|Study terminated by sponsor|62|||
145475536|NCT03194646|524592173|FG001|Overall Study|Study terminated by sponsor|61|||
145475537|NCT03194646|524592174|FG002|Overall Study|Study terminated by sponsor|30|||
145475538|NCT03194646|524592175|FG003|Overall Study|Study terminated by sponsor|34|||
145475539|NCT03194646|524592172|FG000|Overall Study|Withdrawal by Subject|75|||
145475540|NCT03194646|524592173|FG001|Overall Study|Withdrawal by Subject|74|||
145475541|NCT03194646|524592174|FG002|Overall Study|Withdrawal by Subject|36|||
145475542|NCT03194646|524592175|FG003|Overall Study|Withdrawal by Subject|131|||
145475543|NCT03194646|524592172|FG000|Overall Study|Missing|1|||
145475544|NCT03194646|524592173|FG001|Overall Study|Missing|0|||
145475545|NCT03194646|524592174|FG002|Overall Study|Missing|1|||
145475546|NCT03194646|524592175|FG003|Overall Study|Missing|12|||
145475547|NCT04869358|524592176|FG000|Overall Study|Wish to have children.|1|||
145475548|NCT04869358|524592177|FG001|Overall Study|Wish to have children.|0|||
145475549|NCT04869358|524592178|FG002|Overall Study|Wish to have children.|0|||
145475550|NCT04869358|524592179|FG003|Overall Study|Wish to have children.|0|||
145475551|NCT02141360|524592180|FG000|Overall Study|Withdrawal by Subject|6|||
145475552|NCT02141360|524592181|FG001|Overall Study|Withdrawal by Subject|0|||
145475553|NCT02141360|524592182|FG002|Overall Study|Withdrawal by Subject|0|||
145475554|NCT02141360|524592180|FG000|Overall Study|Study Terminated before Visit|1|||
145475555|NCT02141360|524592181|FG001|Overall Study|Study Terminated before Visit|0|||
145475556|NCT02141360|524592182|FG002|Overall Study|Study Terminated before Visit|0|||
145475557|NCT04302545|524592185|FG000|Overall Study|Lost to Follow-up|3|||
145475558|NCT04302545|524592186|FG001|Overall Study|Lost to Follow-up|4|||
145475559|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
145475560|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
145475561|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
145475562|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
145475563|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Death|2|||
145475564|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Death|2|||
145475565|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Death|0|||
145475566|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Death|0|||
145475567|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
145475568|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
145475569|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
145475570|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
145475571|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
145475572|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
145475573|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
145475574|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
145475575|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
145475576|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
145475577|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
145475578|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
145475579|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
145475580|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
145475581|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
145475582|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
145475583|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
145475584|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
145475585|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
145475586|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
145475587|NCT03068754|524592187|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
145475588|NCT03068754|524592188|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
145475589|NCT03068754|524592189|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
145475590|NCT03068754|524592190|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
145475591|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
145475592|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
145475593|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
145475594|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
145475595|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Death|0|||
145475596|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Death|0|||
145475597|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Death|0|||
145475598|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Death|1|||
145475599|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
145475600|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
145475601|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
145475602|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
145631948|NCT00197015|525166065|FG000|Overall Study|Protocol Violation|0|||
145631949|NCT00197015|525166066|FG001|Overall Study|Protocol Violation|3|||
145631950|NCT00197015|525166067|FG002|Overall Study|Protocol Violation|3|||
145631951|NCT00197015|525166065|FG000|Overall Study|Withdrawal by Subject|17|||
145631952|NCT00197015|525166066|FG001|Overall Study|Withdrawal by Subject|37|||
145631953|NCT00197015|525166067|FG002|Overall Study|Withdrawal by Subject|34|||
145631954|NCT00197015|525166065|FG000|Overall Study|Lost to Follow-up|28|||
145475603|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
145631955|NCT00197015|525166066|FG001|Overall Study|Lost to Follow-up|46|||
145631956|NCT00197015|525166067|FG002|Overall Study|Lost to Follow-up|37|||
145631957|NCT00197015|525166065|FG000|Overall Study|Other|2|||
145631958|NCT00197015|525166066|FG001|Overall Study|Other|3|||
145631959|NCT00197015|525166067|FG002|Overall Study|Other|2|||
145631960|NCT04511650|525166070|FG000|Overall Study|Lost to Follow-up|1|||
145631961|NCT04511650|525166071|FG001|Overall Study|Lost to Follow-up|0|||
145631962|NCT04511650|525166072|FG002|Overall Study|Lost to Follow-up|0|||
145631963|NCT04511650|525166070|FG000|Overall Study|Withdrawal by Subject|1|||
145631964|NCT04511650|525166071|FG001|Overall Study|Withdrawal by Subject|0|||
145475604|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
145631965|NCT04511650|525166072|FG002|Overall Study|Withdrawal by Subject|0|||
145631966|NCT04511650|525166070|FG000|Overall Study|reason not provided|0|||
145631967|NCT04511650|525166071|FG001|Overall Study|reason not provided|0|||
145631968|NCT04511650|525166072|FG002|Overall Study|reason not provided|1|||
145631969|NCT04511650|525166070|FG000|Overall Study|Death|1|||
145631970|NCT04511650|525166071|FG001|Overall Study|Death|1|||
145631971|NCT04511650|525166072|FG002|Overall Study|Death|1|||
145631972|NCT01972152|525166075|FG000|First Treatment Visit|Lost to Follow-up|0|||
145631973|NCT01972152|525166076|FG001|First Treatment Visit|Lost to Follow-up|1|||
145631974|NCT01972152|525166077|FG002|First Treatment Visit|Lost to Follow-up|0|||
145631975|NCT01972152|525166078|FG003|First Treatment Visit|Lost to Follow-up|0|||
145631976|NCT01972152|525166079|FG004|First Treatment Visit|Lost to Follow-up|0|||
145631977|NCT01972152|525166080|FG005|First Treatment Visit|Lost to Follow-up|0|||
145631978|NCT01972152|525166075|FG000|Second Treatment Visit|Protocol Violation|0|||
145631979|NCT01972152|525166076|FG001|Second Treatment Visit|Protocol Violation|1|||
145631980|NCT01972152|525166077|FG002|Second Treatment Visit|Protocol Violation|0|||
145631981|NCT01972152|525166078|FG003|Second Treatment Visit|Protocol Violation|0|||
145631982|NCT01972152|525166079|FG004|Second Treatment Visit|Protocol Violation|0|||
145631983|NCT01972152|525166080|FG005|Second Treatment Visit|Protocol Violation|0|||
145631984|NCT02596035|525166081|FG000|Overall Study|Disease Progression|64|||
145631985|NCT02596035|525166082|FG001|Overall Study|Disease Progression|32|||
145631986|NCT02596035|525166083|FG002|Overall Study|Disease Progression|1|||
145631987|NCT02596035|525166081|FG000|Overall Study|study drug toxicity|12|||
145631988|NCT02596035|525166082|FG001|Overall Study|study drug toxicity|3|||
145631989|NCT02596035|525166083|FG002|Overall Study|study drug toxicity|0|||
145631990|NCT02596035|525166081|FG000|Overall Study|AE unrelated to study drug|5|||
145631991|NCT02596035|525166082|FG001|Overall Study|AE unrelated to study drug|2|||
145631992|NCT02596035|525166083|FG002|Overall Study|AE unrelated to study drug|0|||
145631993|NCT02596035|525166081|FG000|Overall Study|participant request to discontinue study treatment|2|||
145631994|NCT02596035|525166082|FG001|Overall Study|participant request to discontinue study treatment|0|||
145631995|NCT02596035|525166083|FG002|Overall Study|participant request to discontinue study treatment|0|||
145631996|NCT02596035|525166081|FG000|Overall Study|participant withdrew consent|2|||
145475605|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
145475606|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
145475607|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
145475608|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
145475609|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
145475610|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
145475611|NCT03068754|524592187|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
145475612|NCT03068754|524592188|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
145475613|NCT03068754|524592189|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
145475614|NCT03068754|524592190|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
145475615|NCT00129467|524592191|FG000|Received Intervention|Death|1|||
145475616|NCT00129467|524592192|FG001|Received Intervention|Death|1|||
145475617|NCT00129467|524592191|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
145631997|NCT02596035|525166082|FG001|Overall Study|participant withdrew consent|2|||
145631998|NCT02596035|525166083|FG002|Overall Study|participant withdrew consent|0|||
145631999|NCT02596035|525166081|FG000|Overall Study|Poor/Non Comlpiance|0|||
145632000|NCT02596035|525166082|FG001|Overall Study|Poor/Non Comlpiance|1|||
145632001|NCT02596035|525166083|FG002|Overall Study|Poor/Non Comlpiance|0|||
145632002|NCT02596035|525166081|FG000|Overall Study|participant no longer meets study criteria|1|||
145632003|NCT02596035|525166082|FG001|Overall Study|participant no longer meets study criteria|0|||
145632004|NCT02596035|525166083|FG002|Overall Study|participant no longer meets study criteria|0|||
145632005|NCT02596035|525166081|FG000|Overall Study|other reasons|11|||
145632006|NCT02596035|525166082|FG001|Overall Study|other reasons|4|||
145632007|NCT02596035|525166083|FG002|Overall Study|other reasons|0|||
145632008|NCT03593070|525166084|FG000|Overall Study|administrative withdrawal|1|||
145632009|NCT03593070|525166085|FG001|Overall Study|administrative withdrawal|1|||
145632010|NCT03310983|525166086|FG000|Overall Study|Lost to Follow-up|15|||
145632011|NCT03310983|525166087|FG001|Overall Study|Lost to Follow-up|17|||
145632012|NCT01656304|525166088|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
145632013|NCT00881335|525166089|FG000|Overall Study|Lost to Follow-up|3|||
145632014|NCT00881335|525166090|FG001|Overall Study|Lost to Follow-up|2|||
145475618|NCT00129467|524592192|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
145475619|NCT00129467|524592191|FG000|Received Intervention|Delirium|2|||
145475620|NCT00129467|524592192|FG001|Received Intervention|Delirium|0|||
145475621|NCT00129467|524592191|FG000|Received Intervention|Withdrawal by Subject|1|||
145475622|NCT00129467|524592192|FG001|Received Intervention|Withdrawal by Subject|0|||
145475623|NCT00129467|524592191|FG000|Received Intervention|Nausea|1|||
145632015|NCT00554801|525166091|FG000|Overall Study|left area before completion|5|||
145632016|NCT00554801|525166092|FG001|Overall Study|left area before completion|0|||
145632017|NCT00554801|525166091|FG000|Overall Study|Withdrawal by Subject|14|||
145632018|NCT00554801|525166092|FG001|Overall Study|Withdrawal by Subject|0|||
145632019|NCT02104765|525166095|FG000|Overall Study|Lost to Follow-up|0|||
145632020|NCT02104765|525166096|FG001|Overall Study|Lost to Follow-up|0|||
145632021|NCT02104765|525166097|FG002|Overall Study|Lost to Follow-up|1|||
145632022|NCT02104765|525166098|FG003|Overall Study|Lost to Follow-up|0|||
145632023|NCT02104765|525166099|FG004|Overall Study|Lost to Follow-up|0|||
145632024|NCT02104765|525166100|FG005|Overall Study|Lost to Follow-up|0|||
145475624|NCT00129467|524592192|FG001|Received Intervention|Nausea|0|||
145632025|NCT02104765|525166101|FG006|Overall Study|Lost to Follow-up|0|||
145632026|NCT02104765|525166095|FG000|Overall Study|Withdrawal by Subject|0|||
145632027|NCT02104765|525166096|FG001|Overall Study|Withdrawal by Subject|0|||
145632028|NCT02104765|525166097|FG002|Overall Study|Withdrawal by Subject|0|||
145632029|NCT02104765|525166098|FG003|Overall Study|Withdrawal by Subject|1|||
145632030|NCT02104765|525166099|FG004|Overall Study|Withdrawal by Subject|1|||
145632031|NCT02104765|525166100|FG005|Overall Study|Withdrawal by Subject|0|||
145475625|NCT00129467|524592191|FG000|Received Intervention|Intolerance to citalopram|0|||
145475626|NCT00129467|524592192|FG001|Received Intervention|Intolerance to citalopram|1|||
145475627|NCT00129467|524592191|FG000|Received Intervention|Dizzyness, fatigue|0|||
145475628|NCT00129467|524592192|FG001|Received Intervention|Dizzyness, fatigue|1|||
145475629|NCT00129467|524592191|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
145475630|NCT00129467|524592192|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
145475631|NCT00129467|524592191|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
145475632|NCT00129467|524592192|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
145475633|NCT01331291|524592193|FG000|Overall Study|Lack of Efficacy|2|||
145475634|NCT01331291|524592194|FG001|Overall Study|Lack of Efficacy|8|||
145475635|NCT01331291|524592193|FG000|Overall Study|Death|0|||
145632032|NCT02104765|525166101|FG006|Overall Study|Withdrawal by Subject|1|||
145632033|NCT00462943|525166102|FG000|Overall Study|Failure to achieve a response|5|||
145632034|NCT00462943|525166103|FG001|Overall Study|Failure to achieve a response|5|||
145632035|NCT00462943|525166104|FG002|Overall Study|Failure to achieve a response|1|||
145632036|NCT00462943|525166102|FG000|Overall Study|Adverse Event|6|||
145632037|NCT00462943|525166103|FG001|Overall Study|Adverse Event|4|||
145632038|NCT00462943|525166104|FG002|Overall Study|Adverse Event|1|||
145632039|NCT00462943|525166102|FG000|Overall Study|Protocol Violation|1|||
145632040|NCT00462943|525166103|FG001|Overall Study|Protocol Violation|0|||
145632041|NCT00462943|525166104|FG002|Overall Study|Protocol Violation|0|||
145632042|NCT00462943|525166102|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
145632043|NCT00462943|525166103|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
145632044|NCT00462943|525166104|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
145632045|NCT00462943|525166102|FG000|Overall Study|Disease Progression|15|||
145632046|NCT00462943|525166103|FG001|Overall Study|Disease Progression|15|||
145632047|NCT00462943|525166104|FG002|Overall Study|Disease Progression|9|||
145632048|NCT00462943|525166102|FG000|Overall Study|Death|5|||
145632049|NCT00462943|525166103|FG001|Overall Study|Death|2|||
145632050|NCT00462943|525166104|FG002|Overall Study|Death|7|||
145632051|NCT00462943|525166102|FG000|Overall Study|Stem Cell Transplant|1|||
145632052|NCT00462943|525166103|FG001|Overall Study|Stem Cell Transplant|1|||
145632053|NCT00462943|525166104|FG002|Overall Study|Stem Cell Transplant|0|||
145632054|NCT00462943|525166102|FG000|Overall Study|Bone Marrow Transplant|1|||
145632055|NCT00462943|525166103|FG001|Overall Study|Bone Marrow Transplant|0|||
145632056|NCT00462943|525166104|FG002|Overall Study|Bone Marrow Transplant|0|||
145632057|NCT00462943|525166102|FG000|Overall Study|Required Lymphocyte Infusion|1|||
145632058|NCT00462943|525166103|FG001|Overall Study|Required Lymphocyte Infusion|0|||
145632059|NCT00462943|525166104|FG002|Overall Study|Required Lymphocyte Infusion|0|||
145632060|NCT00462943|525166102|FG000|Overall Study|Transplant - not specified|1|||
145632061|NCT00462943|525166103|FG001|Overall Study|Transplant - not specified|0|||
145632062|NCT00462943|525166104|FG002|Overall Study|Transplant - not specified|1|||
145632063|NCT00462943|525166102|FG000|Overall Study|Physician Decision|1|||
145632064|NCT00462943|525166103|FG001|Overall Study|Physician Decision|0|||
145632065|NCT00462943|525166104|FG002|Overall Study|Physician Decision|0|||
145632066|NCT00462943|525166102|FG000|Overall Study|Withdrawal by Subject|0|||
145632067|NCT00462943|525166103|FG001|Overall Study|Withdrawal by Subject|1|||
145632068|NCT00462943|525166104|FG002|Overall Study|Withdrawal by Subject|0|||
145632069|NCT01697319|525166105|FG000|Primary Phase|Withdrawal by Subject|1|||
145632070|NCT01697319|525166105|FG000|Extension Phase|Terminated by Sponsor|15|||
145632071|NCT00604721|525166110|FG000|Overall Study|Physician Decision|1|||
145632072|NCT00604721|525166110|FG000|Overall Study|Withdrawal by Subject|1|||
145632073|NCT01838551|525166114|FG000|Overall Study|Adverse Event|16|||
145632074|NCT01838551|525166114|FG000|Overall Study|Death|1|||
145632075|NCT01838551|525166114|FG000|Overall Study|Lack of Efficacy|10|||
145632076|NCT01838551|525166114|FG000|Overall Study|Physician Decision|4|||
145632077|NCT01838551|525166114|FG000|Overall Study|Withdrawal by Subject|10|||
145475636|NCT01331291|524592194|FG001|Overall Study|Death|1|||
145632078|NCT01838551|525166114|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
145632079|NCT00906282|525166115|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
145632080|NCT00906282|525166115|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
145632081|NCT00906282|525166115|FG000|Preoperative Chemotherapy|Progressive disease|6|||
145632082|NCT00906282|525166115|FG000|Preoperative Chemotherapy|Toxicity|1|||
145632083|NCT00038103|525166118|FG000|Overall Study|Adverse Event|5|||
145632084|NCT00038103|525166119|FG001|Overall Study|Adverse Event|6|||
145632085|NCT00038103|525166118|FG000|Overall Study|Lack of Efficacy|48|||
145632086|NCT00038103|525166119|FG001|Overall Study|Lack of Efficacy|41|||
145632087|NCT00038103|525166118|FG000|Overall Study|Withdrawal by Subject|0|||
145475637|NCT03550404|524592195|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
145475638|NCT03550404|524592196|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
145475639|NCT03550404|524592197|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
145475640|NCT03550404|524592195|FG000|Phase 2|Vacated position|1|||
145475641|NCT03550404|524592196|FG001|Phase 2|Vacated position|0|||
145475642|NCT03550404|524592197|FG002|Phase 2|Vacated position|0|||
145475643|NCT00932165|524592198|FG000|Overall Study|Lost to Follow-up|1|||
145475644|NCT02690714|524592199|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
145475645|NCT02690714|524592199|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
145475646|NCT00293020|524592200|FG000|Overall Study|Withdrawal by Subject|34|||
145475647|NCT00293020|524592200|FG000|Overall Study|Adverse Event|30|||
145475648|NCT00293020|524592200|FG000|Overall Study|Death|32|||
145475649|NCT00293020|524592200|FG000|Overall Study|Lack of Efficacy|12|||
145475650|NCT00293020|524592200|FG000|Overall Study|Lost to Follow-up|4|||
145475651|NCT00293020|524592200|FG000|Overall Study|Protocol Violation|6|||
145475652|NCT00293020|524592200|FG000|Overall Study|Physician Decision|21|||
145475653|NCT00293020|524592200|FG000|Overall Study|Other Reason|22|||
145475654|NCT00293020|524592200|FG000|Overall Study|No dose taken|1|||
145475655|NCT00666965|524592201|FG000|Overall Study|Adverse Event|0|||
145475656|NCT00666965|524592202|FG001|Overall Study|Adverse Event|2|||
145475657|NCT00666965|524592203|FG002|Overall Study|Adverse Event|1|||
145475658|NCT00666965|524592204|FG003|Overall Study|Adverse Event|9|||
145475659|NCT00666965|524592201|FG000|Overall Study|Lack of Efficacy|1|||
145475660|NCT00666965|524592202|FG001|Overall Study|Lack of Efficacy|1|||
145475661|NCT00666965|524592203|FG002|Overall Study|Lack of Efficacy|0|||
145475662|NCT00666965|524592204|FG003|Overall Study|Lack of Efficacy|0|||
145475663|NCT00666965|524592201|FG000|Overall Study|Protocol Violation|0|||
145475664|NCT00666965|524592202|FG001|Overall Study|Protocol Violation|0|||
145475665|NCT00666965|524592203|FG002|Overall Study|Protocol Violation|0|||
145475666|NCT00666965|524592204|FG003|Overall Study|Protocol Violation|2|||
145475667|NCT00666965|524592201|FG000|Overall Study|Discontinuation criteria|2|||
145475668|NCT00666965|524592202|FG001|Overall Study|Discontinuation criteria|1|||
145475669|NCT00666965|524592203|FG002|Overall Study|Discontinuation criteria|1|||
145475670|NCT00666965|524592204|FG003|Overall Study|Discontinuation criteria|2|||
145475671|NCT00666965|524592201|FG000|Overall Study|Withdrawal by Subject|0|||
145475672|NCT00666965|524592202|FG001|Overall Study|Withdrawal by Subject|0|||
145475673|NCT00666965|524592203|FG002|Overall Study|Withdrawal by Subject|0|||
145475674|NCT00666965|524592204|FG003|Overall Study|Withdrawal by Subject|2|||
145475675|NCT02249182|524592205|FG000|Treatment Phase|Lost to Follow-up|4|||
145475676|NCT02249182|524592206|FG001|Treatment Phase|Lost to Follow-up|0|||
145475677|NCT02249182|524592207|FG002|Treatment Phase|Lost to Follow-up|0|||
145475678|NCT02249182|524592208|FG003|Treatment Phase|Lost to Follow-up|0|||
145475679|NCT02249182|524592209|FG004|Treatment Phase|Lost to Follow-up|0|||
145475680|NCT00504894|524592216|FG000|Overall Study|fMRI technical problems|1|||
145475681|NCT00504894|524592217|FG001|Overall Study|fMRI technical problems|1|||
145475682|NCT00504894|524592218|FG002|Overall Study|fMRI technical problems|0|||
145475683|NCT00504894|524592216|FG000|Overall Study|Withdrawal by Subject|0|||
145475684|NCT00504894|524592217|FG001|Overall Study|Withdrawal by Subject|1|||
145475685|NCT00504894|524592218|FG002|Overall Study|Withdrawal by Subject|0|||
145475686|NCT00504894|524592216|FG000|Overall Study|Infusion technical problems|0|||
145475687|NCT00504894|524592217|FG001|Overall Study|Infusion technical problems|1|||
145475688|NCT00504894|524592218|FG002|Overall Study|Infusion technical problems|0|||
145475689|NCT00504894|524592216|FG000|Overall Study|poor subject data|2|||
145475690|NCT00504894|524592217|FG001|Overall Study|poor subject data|0|||
145475691|NCT00504894|524592218|FG002|Overall Study|poor subject data|0|||
145475692|NCT05090852|524592219|FG000|Overall Study|Physician Decision|5|||
145475693|NCT00148941|524592220|FG000|Overall Study|Lost to Follow-up|17|||
145475694|NCT00148941|524592221|FG001|Overall Study|Lost to Follow-up|24|||
145475695|NCT00148941|524592222|FG002|Overall Study|Lost to Follow-up|18|||
145475696|NCT00148941|524592223|FG003|Overall Study|Lost to Follow-up|22|||
145475697|NCT00148941|524592220|FG000|Overall Study|Withdrawal by Subject|1|||
145475698|NCT00148941|524592221|FG001|Overall Study|Withdrawal by Subject|0|||
145475699|NCT00148941|524592222|FG002|Overall Study|Withdrawal by Subject|1|||
145475700|NCT00148941|524592223|FG003|Overall Study|Withdrawal by Subject|0|||
145475701|NCT00148941|524592220|FG000|Overall Study|Other|0|||
145475702|NCT00148941|524592221|FG001|Overall Study|Other|0|||
145475703|NCT00148941|524592222|FG002|Overall Study|Other|1|||
145475704|NCT00148941|524592223|FG003|Overall Study|Other|2|||
145475705|NCT03244826|524592224|FG000|Overall Study|Withdrawal by Subject|2|||
145475706|NCT03244826|524592225|FG001|Overall Study|Withdrawal by Subject|0|||
145475707|NCT03244826|524592224|FG000|Overall Study|Transplant delayed or withdrawn|12|||
145475708|NCT03244826|524592225|FG001|Overall Study|Transplant delayed or withdrawn|10|||
145475709|NCT02673684|524592228|FG000|Overall Study|Study not completed d/t loss of funding|9|||
145475710|NCT02673684|524592229|FG001|Overall Study|Study not completed d/t loss of funding|8|||
145475711|NCT00360568|524592230|FG000|Overall Study|Adverse Event|1|||
145475712|NCT00360568|524592231|FG001|Overall Study|Adverse Event|2|||
145475713|NCT00360568|524592230|FG000|Overall Study|Lack of Efficacy|1|||
145475714|NCT00360568|524592231|FG001|Overall Study|Lack of Efficacy|0|||
145475715|NCT00360568|524592230|FG000|Overall Study|Withdrawal by Subject|0|||
145475716|NCT00360568|524592231|FG001|Overall Study|Withdrawal by Subject|3|||
145475717|NCT01008449|524592232|FG000|Overall Study|Lost to Follow-up|29|||
145475718|NCT01008449|524592233|FG001|Overall Study|Lost to Follow-up|19|||
145475719|NCT01220180|524592234|FG000|Overall Study|Lost to Follow-up|76|||
145475720|NCT01220180|524592234|FG000|Overall Study|Other|72|||
145475721|NCT01220180|524592234|FG000|Overall Study|Adverse Event|35|||
145475722|NCT01220180|524592234|FG000|Overall Study|Lack of Efficacy|22|||
145475723|NCT01220180|524592234|FG000|Overall Study|Death|1|||
145475724|NCT01220180|524592234|FG000|Overall Study|Randomized but not treated|1|||
145475725|NCT01067469|524592235|FG000|Overall Study|Withdrawal by Subject|0|||
145475726|NCT01067469|524592236|FG001|Overall Study|Withdrawal by Subject|1|||
145475727|NCT01067469|524592235|FG000|Overall Study|Disease Progression|0|||
145475728|NCT01067469|524592236|FG001|Overall Study|Disease Progression|1|||
145475729|NCT01534195|524592239|FG000|Overall Study|Withdrawal by Subject|1|||
145475730|NCT01534195|524592240|FG001|Overall Study|Withdrawal by Subject|1|||
145475731|NCT00629798|524592245|FG000|Overall Study|Not Treated|4|||
145475732|NCT02554981|524592246|FG000|Overall Study|Adverse Event|1|||
145475733|NCT02554981|524592246|FG000|Overall Study|Administrative Reasons|1|||
145475734|NCT02554981|524592246|FG000|Overall Study|Other Miscellaneous Reasons|3|||
145475735|NCT01959243|524592253|FG000|Overall Study|Investigator Decision|3|||
145475736|NCT01959243|524592254|FG001|Overall Study|Investigator Decision|0|||
145475737|NCT01959243|524592253|FG000|Overall Study|Adverse Event|5|||
145475738|NCT01959243|524592254|FG001|Overall Study|Adverse Event|2|||
145475739|NCT01959243|524592253|FG000|Overall Study|Administrative reasons|2|||
145475740|NCT01959243|524592254|FG001|Overall Study|Administrative reasons|1|||
145475741|NCT01959243|524592253|FG000|Overall Study|Lost to Follow-up|3|||
145475742|NCT01959243|524592254|FG001|Overall Study|Lost to Follow-up|1|||
145475743|NCT00812565|524592257|FG000|Overall Study|Did Not Receive Study Medication|1|||
145475744|NCT00812565|524592258|FG001|Overall Study|Did Not Receive Study Medication|1|||
145475745|NCT00812565|524592259|FG002|Overall Study|Did Not Receive Study Medication|0|||
145475746|NCT00812565|524592260|FG003|Overall Study|Did Not Receive Study Medication|0|||
145475747|NCT00812565|524592261|FG004|Overall Study|Did Not Receive Study Medication|0|||
145475748|NCT00812565|524592262|FG005|Overall Study|Did Not Receive Study Medication|0|||
145475749|NCT00812565|524592263|FG006|Overall Study|Did Not Receive Study Medication|0|||
145475750|NCT00812565|524592264|FG007|Overall Study|Did Not Receive Study Medication|0|||
145475751|NCT00812565|524592257|FG000|Overall Study|Adverse Event|0|||
145475752|NCT00812565|524592258|FG001|Overall Study|Adverse Event|0|||
145475753|NCT00812565|524592259|FG002|Overall Study|Adverse Event|0|||
145475754|NCT00812565|524592260|FG003|Overall Study|Adverse Event|2|||
145475755|NCT00812565|524592261|FG004|Overall Study|Adverse Event|0|||
145475756|NCT00812565|524592262|FG005|Overall Study|Adverse Event|0|||
145475757|NCT00812565|524592263|FG006|Overall Study|Adverse Event|0|||
145475758|NCT00812565|524592264|FG007|Overall Study|Adverse Event|1|||
145632088|NCT00038103|525166119|FG001|Overall Study|Withdrawal by Subject|3|||
145475759|NCT00812565|524592257|FG000|Overall Study|Did Not Come to Study Visit|1|||
145475760|NCT00812565|524592258|FG001|Overall Study|Did Not Come to Study Visit|0|||
145475761|NCT00812565|524592259|FG002|Overall Study|Did Not Come to Study Visit|0|||
145475762|NCT00812565|524592260|FG003|Overall Study|Did Not Come to Study Visit|0|||
145475763|NCT00812565|524592261|FG004|Overall Study|Did Not Come to Study Visit|0|||
145475764|NCT00812565|524592262|FG005|Overall Study|Did Not Come to Study Visit|0|||
145475765|NCT00812565|524592263|FG006|Overall Study|Did Not Come to Study Visit|0|||
145475766|NCT00812565|524592264|FG007|Overall Study|Did Not Come to Study Visit|0|||
145632089|NCT00038103|525166118|FG000|Overall Study|Lost to Follow-up|0|||
145632090|NCT00038103|525166119|FG001|Overall Study|Lost to Follow-up|3|||
145632091|NCT00038103|525166118|FG000|Overall Study|Protocol Violation|0|||
145475767|NCT00812565|524592257|FG000|Overall Study|Withdrawal of Consent|1|||
145475768|NCT00812565|524592258|FG001|Overall Study|Withdrawal of Consent|0|||
145475769|NCT00812565|524592259|FG002|Overall Study|Withdrawal of Consent|0|||
145475770|NCT00812565|524592260|FG003|Overall Study|Withdrawal of Consent|0|||
145475771|NCT00812565|524592261|FG004|Overall Study|Withdrawal of Consent|1|||
145475772|NCT00812565|524592262|FG005|Overall Study|Withdrawal of Consent|0|||
145632092|NCT00038103|525166119|FG001|Overall Study|Protocol Violation|2|||
145475773|NCT00812565|524592263|FG006|Overall Study|Withdrawal of Consent|0|||
145475774|NCT00812565|524592264|FG007|Overall Study|Withdrawal of Consent|0|||
145475775|NCT00812565|524592257|FG000|Overall Study|Reason Not Specified|0|||
145475776|NCT00812565|524592258|FG001|Overall Study|Reason Not Specified|0|||
145475777|NCT00812565|524592259|FG002|Overall Study|Reason Not Specified|0|||
145475778|NCT00812565|524592260|FG003|Overall Study|Reason Not Specified|0|||
145475779|NCT00812565|524592261|FG004|Overall Study|Reason Not Specified|0|||
145475780|NCT00812565|524592262|FG005|Overall Study|Reason Not Specified|1|||
145632093|NCT00038103|525166118|FG000|Overall Study|Sponsor Decision|0|||
145475781|NCT00812565|524592263|FG006|Overall Study|Reason Not Specified|0|||
145475782|NCT00812565|524592264|FG007|Overall Study|Reason Not Specified|0|||
145475783|NCT01345669|524592265|FG000|Overall Study|Primary tumour recurrence|53|||
145632094|NCT00038103|525166119|FG001|Overall Study|Sponsor Decision|1|||
145475784|NCT01345669|524592266|FG001|Overall Study|Primary tumour recurrence|32|||
145475785|NCT01345669|524592265|FG000|Overall Study|Second primary tumour|4|||
145475786|NCT01345669|524592266|FG001|Overall Study|Second primary tumour|3|||
145475787|NCT01345669|524592265|FG000|Overall Study|Adverse Event|63|||
145475788|NCT01345669|524592266|FG001|Overall Study|Adverse Event|9|||
145475789|NCT01345669|524592265|FG000|Overall Study|Protocol Violation|3|||
145475790|NCT01345669|524592266|FG001|Overall Study|Protocol Violation|1|||
145475791|NCT01345669|524592265|FG000|Overall Study|Lost to Follow-up|1|||
145475792|NCT01345669|524592266|FG001|Overall Study|Lost to Follow-up|1|||
145475793|NCT01345669|524592265|FG000|Overall Study|Withdrawal by Subject|52|||
145475794|NCT01345669|524592266|FG001|Overall Study|Withdrawal by Subject|13|||
145475795|NCT01345669|524592265|FG000|Overall Study|Other Reasons|111|||
145475796|NCT01345669|524592266|FG001|Overall Study|Other Reasons|60|||
145475797|NCT01793883|524592267|FG000|Overall Study|Withdrawal by Subject|3|||
145475798|NCT01793883|524592268|FG001|Overall Study|Withdrawal by Subject|7|||
145475799|NCT01793883|524592269|FG002|Overall Study|Withdrawal by Subject|3|||
145475800|NCT01793883|524592267|FG000|Overall Study|Subject noncompliance|0|||
145475801|NCT01793883|524592268|FG001|Overall Study|Subject noncompliance|1|||
145475802|NCT01793883|524592269|FG002|Overall Study|Subject noncompliance|1|||
145475803|NCT01793883|524592267|FG000|Overall Study|Lost to Follow-up|5|||
145475804|NCT01793883|524592268|FG001|Overall Study|Lost to Follow-up|1|||
145475805|NCT01793883|524592269|FG002|Overall Study|Lost to Follow-up|3|||
145475806|NCT01793883|524592267|FG000|Overall Study|Randomized in error|1|||
145475807|NCT01793883|524592268|FG001|Overall Study|Randomized in error|0|||
145475808|NCT01793883|524592269|FG002|Overall Study|Randomized in error|0|||
145475809|NCT01793883|524592267|FG000|Overall Study|Unable to complete spriometry|1|||
145475810|NCT01793883|524592268|FG001|Overall Study|Unable to complete spriometry|0|||
145475811|NCT01793883|524592269|FG002|Overall Study|Unable to complete spriometry|0|||
145475812|NCT01793883|524592267|FG000|Overall Study|Unable to complete measurements|1|||
145475813|NCT01793883|524592268|FG001|Overall Study|Unable to complete measurements|0|||
145475814|NCT01793883|524592269|FG002|Overall Study|Unable to complete measurements|0|||
145475815|NCT01793883|524592267|FG000|Overall Study|Met exclusion criteria|1|||
145475816|NCT01793883|524592268|FG001|Overall Study|Met exclusion criteria|0|||
145475817|NCT01793883|524592269|FG002|Overall Study|Met exclusion criteria|0|||
145475818|NCT01793883|524592267|FG000|Overall Study|Dosing error|0|||
145475819|NCT01793883|524592268|FG001|Overall Study|Dosing error|1|||
145475820|NCT01793883|524592269|FG002|Overall Study|Dosing error|0|||
145475821|NCT01793883|524592267|FG000|Overall Study|Respiratory distress during spirometry|0|||
145475822|NCT01793883|524592268|FG001|Overall Study|Respiratory distress during spirometry|0|||
145475823|NCT01793883|524592269|FG002|Overall Study|Respiratory distress during spirometry|1|||
145475824|NCT02478255|524592271|FG000|Overall Study|Physician Decision|6|||
145475825|NCT02478255|524592272|FG001|Overall Study|Physician Decision|0|||
145475826|NCT02478255|524592271|FG000|Overall Study|Withdrawal by Subject|2|||
145475827|NCT02478255|524592272|FG001|Overall Study|Withdrawal by Subject|0|||
145475828|NCT01431963|524592273|FG000|Overall Study|Adverse Event|18|||
145475829|NCT01431963|524592273|FG000|Overall Study|Lack of Efficacy|7|||
145475830|NCT01431963|524592273|FG000|Overall Study|Protocol Violation|1|||
145475831|NCT01431963|524592273|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
145475832|NCT01431963|524592273|FG000|Overall Study|Physician Decision|4|||
145475833|NCT01431963|524592273|FG000|Overall Study|Withdrawal by Subject|3|||
145475834|NCT01487265|524594242|FG000|Overall Study|Adverse Event|8|||
145475835|NCT01487265|524594242|FG000|Overall Study|Withdrawal by Subject|5|||
145475836|NCT01487265|524594242|FG000|Overall Study|Disease Progression|21|||
145475837|NCT01487265|524594242|FG000|Overall Study|Death|2|||
145475838|NCT01487265|524594242|FG000|Overall Study|Still on Treatment|1|||
145475839|NCT01618695|524594243|FG000|Core Phase|Adverse Event|4|||
145475840|NCT01618695|524594244|FG001|Core Phase|Adverse Event|5|||
145475841|NCT01618695|524594245|FG002|Core Phase|Adverse Event|15|||
145475842|NCT01618695|524594246|FG003|Core Phase|Adverse Event|20|||
145475843|NCT01618695|524594243|FG000|Core Phase|Lost to Follow-up|0|||
145632095|NCT00038103|525166118|FG000|Overall Study|Randomized/never treated|2|||
145632096|NCT00038103|525166119|FG001|Overall Study|Randomized/never treated|0|||
145632097|NCT02465359|525166127|FG000|Overall Study|Lack of Efficacy|1|||
145632098|NCT02465359|525166127|FG000|Overall Study|Withdrawal by Subject|1|||
145632099|NCT02465359|525166127|FG000|Overall Study|Adverse Event|1|||
145632100|NCT01278862|525166128|FG000|Overall Study|Lost to Follow-up|1|||
145632101|NCT01278862|525166129|FG001|Overall Study|Lost to Follow-up|1|||
145475844|NCT01618695|524594244|FG001|Core Phase|Lost to Follow-up|0|||
145475845|NCT01618695|524594245|FG002|Core Phase|Lost to Follow-up|1|||
145475846|NCT01618695|524594246|FG003|Core Phase|Lost to Follow-up|0|||
145475847|NCT01618695|524594243|FG000|Core Phase|Withdrawal by Subject|16|||
145475848|NCT01618695|524594244|FG001|Core Phase|Withdrawal by Subject|11|||
145632102|NCT02952261|525166130|FG000|Overall Study|Withdrawal by Subject|4|||
145632103|NCT02952261|525166131|FG001|Overall Study|Withdrawal by Subject|5|||
145475849|NCT01618695|524594245|FG002|Core Phase|Withdrawal by Subject|9|||
145475850|NCT01618695|524594246|FG003|Core Phase|Withdrawal by Subject|13|||
145475851|NCT01618695|524594243|FG000|Core Phase|Pregnancy|2|||
145475852|NCT01618695|524594244|FG001|Core Phase|Pregnancy|0|||
145475853|NCT01618695|524594245|FG002|Core Phase|Pregnancy|0|||
145475854|NCT01618695|524594246|FG003|Core Phase|Pregnancy|0|||
145475855|NCT01618695|524594243|FG000|Core Phase|Lack of Efficacy|1|||
145475856|NCT01618695|524594244|FG001|Core Phase|Lack of Efficacy|2|||
145475857|NCT01618695|524594245|FG002|Core Phase|Lack of Efficacy|1|||
145475858|NCT01618695|524594246|FG003|Core Phase|Lack of Efficacy|1|||
145475859|NCT01618695|524594243|FG000|Core Phase|Other than specified|1|||
145475860|NCT01618695|524594244|FG001|Core Phase|Other than specified|2|||
145475861|NCT01618695|524594245|FG002|Core Phase|Other than specified|2|||
145475862|NCT01618695|524594246|FG003|Core Phase|Other than specified|2|||
145475863|NCT01618695|524594243|FG000|Core Phase|Not treated|1|||
145475864|NCT01618695|524594244|FG001|Core Phase|Not treated|0|||
145475865|NCT01618695|524594245|FG002|Core Phase|Not treated|2|||
145475866|NCT01618695|524594246|FG003|Core Phase|Not treated|0|||
145475867|NCT01618695|524594243|FG000|Extension Phase|Lack of Efficacy|17|||
145475868|NCT01618695|524594244|FG001|Extension Phase|Lack of Efficacy|33|||
145475869|NCT01618695|524594245|FG002|Extension Phase|Lack of Efficacy|26|||
145475870|NCT01618695|524594246|FG003|Extension Phase|Lack of Efficacy|24|||
145475871|NCT01618695|524594243|FG000|Extension Phase|Pregnancy|2|||
145475872|NCT01618695|524594244|FG001|Extension Phase|Pregnancy|0|||
145475873|NCT01618695|524594245|FG002|Extension Phase|Pregnancy|1|||
145475874|NCT01618695|524594246|FG003|Extension Phase|Pregnancy|1|||
145475875|NCT01618695|524594243|FG000|Extension Phase|Withdrawal by Subject|43|||
145475876|NCT01618695|524594244|FG001|Extension Phase|Withdrawal by Subject|48|||
145475877|NCT01618695|524594245|FG002|Extension Phase|Withdrawal by Subject|42|||
145475878|NCT01618695|524594246|FG003|Extension Phase|Withdrawal by Subject|33|||
145475879|NCT01618695|524594243|FG000|Extension Phase|Adverse Event|18|||
145475880|NCT01618695|524594244|FG001|Extension Phase|Adverse Event|16|||
145475881|NCT01618695|524594245|FG002|Extension Phase|Adverse Event|9|||
145475882|NCT01618695|524594246|FG003|Extension Phase|Adverse Event|20|||
145475883|NCT01618695|524594243|FG000|Extension Phase|Lost to Follow-up|2|||
145475884|NCT01618695|524594244|FG001|Extension Phase|Lost to Follow-up|1|||
145475885|NCT01618695|524594245|FG002|Extension Phase|Lost to Follow-up|1|||
145475886|NCT01618695|524594246|FG003|Extension Phase|Lost to Follow-up|1|||
145475887|NCT01618695|524594243|FG000|Extension Phase|Other than specified|13|||
145475888|NCT01618695|524594244|FG001|Extension Phase|Other than specified|18|||
145475889|NCT01618695|524594245|FG002|Extension Phase|Other than specified|13|||
145475890|NCT01618695|524594246|FG003|Extension Phase|Other than specified|18|||
145475891|NCT02291419|524594247|FG000|Overall Study|Early study termination|1|||
145475892|NCT02291419|524594248|FG001|Overall Study|Early study termination|5|||
145475893|NCT01732770|524594253|FG000|Overall Study|Lost to Follow-up|2|||
145475894|NCT01732770|524594254|FG001|Overall Study|Lost to Follow-up|3|||
145475895|NCT01732770|524594253|FG000|Overall Study|Withdrawal by Subject|5|||
145475896|NCT01732770|524594254|FG001|Overall Study|Withdrawal by Subject|3|||
145475897|NCT01732770|524594253|FG000|Overall Study|Decision by Sponsor|2|||
145475898|NCT01732770|524594254|FG001|Overall Study|Decision by Sponsor|2|||
145475899|NCT01732770|524594253|FG000|Overall Study|Death|1|||
145475900|NCT01732770|524594254|FG001|Overall Study|Death|0|||
145475901|NCT01959841|524594255|FG000|Overall Study|Adverse Event|1|||
145475902|NCT01959841|524594256|FG001|Overall Study|Adverse Event|3|||
145475903|NCT01959841|524594257|FG002|Overall Study|Adverse Event|2|||
145475904|NCT01959841|524594255|FG000|Overall Study|Lack of Efficacy|5|||
145475905|NCT01959841|524594256|FG001|Overall Study|Lack of Efficacy|0|||
145475906|NCT01959841|524594257|FG002|Overall Study|Lack of Efficacy|0|||
145475907|NCT01959841|524594255|FG000|Overall Study|Lost to Follow-up|1|||
145475908|NCT01959841|524594256|FG001|Overall Study|Lost to Follow-up|1|||
145475909|NCT01959841|524594257|FG002|Overall Study|Lost to Follow-up|0|||
145475910|NCT01959841|524594255|FG000|Overall Study|Physician Decision|0|||
145475911|NCT01959841|524594256|FG001|Overall Study|Physician Decision|2|||
145475912|NCT01959841|524594257|FG002|Overall Study|Physician Decision|3|||
145475913|NCT01959841|524594255|FG000|Overall Study|Protocol Violation|16|||
145475914|NCT01959841|524594256|FG001|Overall Study|Protocol Violation|23|||
145475915|NCT01959841|524594257|FG002|Overall Study|Protocol Violation|16|||
145475916|NCT01959841|524594255|FG000|Overall Study|Withdrawal by Subject|7|||
145475917|NCT01959841|524594256|FG001|Overall Study|Withdrawal by Subject|7|||
145475918|NCT01959841|524594257|FG002|Overall Study|Withdrawal by Subject|5|||
145475919|NCT01959841|524594255|FG000|Overall Study|Clinical laboratory value|2|||
145475920|NCT01959841|524594256|FG001|Overall Study|Clinical laboratory value|6|||
145475921|NCT01959841|524594257|FG002|Overall Study|Clinical laboratory value|6|||
145475922|NCT01959841|524594255|FG000|Overall Study|Platelet count below on day1 or 4|11|||
145475923|NCT01959841|524594256|FG001|Overall Study|Platelet count below on day1 or 4|15|||
145475924|NCT01959841|524594257|FG002|Overall Study|Platelet count below on day1 or 4|11|||
145475925|NCT00780416|524594259|FG000|Overall Study|Physician Decision|3|||
145475926|NCT00780416|524594260|FG001|Overall Study|Physician Decision|3|||
145475927|NCT00780416|524594259|FG000|Overall Study|Protocol Violation|1|||
145475928|NCT00780416|524594260|FG001|Overall Study|Protocol Violation|0|||
145475929|NCT00780416|524594259|FG000|Overall Study|Withdrawal by Subject|8|||
145475930|NCT00780416|524594260|FG001|Overall Study|Withdrawal by Subject|6|||
145475931|NCT00666224|524594263|FG000|Double-Blind|Adverse Event|15|||
145475932|NCT00666224|524594264|FG001|Double-Blind|Adverse Event|5|||
145475933|NCT00666224|524594263|FG000|Double-Blind|Lost to Follow-up|2|||
145475934|NCT00666224|524594264|FG001|Double-Blind|Lost to Follow-up|2|||
145475935|NCT00666224|524594263|FG000|Double-Blind|Withdrawal by Subject|18|||
145475936|NCT00666224|524594264|FG001|Double-Blind|Withdrawal by Subject|14|||
145475937|NCT00666224|524594263|FG000|Double-Blind|Physician Decision|0|||
145475938|NCT00666224|524594264|FG001|Double-Blind|Physician Decision|3|||
145475939|NCT00666224|524594263|FG000|Double-Blind|Sponsor decision|1|||
145475940|NCT00666224|524594264|FG001|Double-Blind|Sponsor decision|0|||
145475941|NCT00666224|524594263|FG000|Double-Blind|Pregnancy|3|||
145475942|NCT00666224|524594264|FG001|Double-Blind|Pregnancy|2|||
145475943|NCT00666224|524594263|FG000|Double-Blind|Noncompliance|1|||
145475944|NCT00666224|524594264|FG001|Double-Blind|Noncompliance|0|||
145475945|NCT00666224|524594263|FG000|Double-Blind|Death|1|||
145475946|NCT00666224|524594264|FG001|Double-Blind|Death|0|||
145475947|NCT00666224|524594263|FG000|Double-Blind|Undefined/Unknown|4|||
145475948|NCT00666224|524594264|FG001|Double-Blind|Undefined/Unknown|1|||
145475949|NCT00666224|524594263|FG000|Open-Label|Adverse Event|8|||
145475950|NCT00666224|524594264|FG001|Open-Label|Adverse Event|43|||
145475951|NCT00666224|524594263|FG000|Open-Label|Lost to Follow-up|4|||
145475952|NCT00666224|524594264|FG001|Open-Label|Lost to Follow-up|5|||
145475953|NCT00666224|524594263|FG000|Open-Label|Withdrawal by Subject|12|||
145475954|NCT00666224|524594264|FG001|Open-Label|Withdrawal by Subject|25|||
145475955|NCT00666224|524594263|FG000|Open-Label|Physician Decision|7|||
145475956|NCT00666224|524594264|FG001|Open-Label|Physician Decision|5|||
145475957|NCT00666224|524594263|FG000|Open-Label|Pregnancy|1|||
145632104|NCT02952261|525166130|FG000|Overall Study|Protocol Violation|1|||
145632105|NCT02952261|525166131|FG001|Overall Study|Protocol Violation|0|||
145632106|NCT00798265|525166132|FG000|Overall Study|Lost to Follow-up|1|||
145632107|NCT00798265|525166133|FG001|Overall Study|Lost to Follow-up|10|||
145475958|NCT00666224|524594264|FG001|Open-Label|Pregnancy|5|||
145475959|NCT00666224|524594263|FG000|Open-Label|Noncompliance|2|||
145475960|NCT00666224|524594264|FG001|Open-Label|Noncompliance|1|||
145475961|NCT00666224|524594263|FG000|Open-Label|Undefined/Unknown|1|||
145475962|NCT00666224|524594264|FG001|Open-Label|Undefined/Unknown|1|||
145475963|NCT03828617|524594276|FG000|Overall Study|Lost to Follow-up|22|||
145475964|NCT03828617|524594277|FG001|Overall Study|Lost to Follow-up|12|||
145475965|NCT03828617|524594278|FG002|Overall Study|Lost to Follow-up|23|||
145475966|NCT03828617|524594279|FG003|Overall Study|Lost to Follow-up|7|||
145475967|NCT03828617|524594276|FG000|Overall Study|No longer met eligibility criteria|0|||
145475968|NCT03828617|524594277|FG001|Overall Study|No longer met eligibility criteria|1|||
145475969|NCT03828617|524594278|FG002|Overall Study|No longer met eligibility criteria|1|||
145475970|NCT03828617|524594279|FG003|Overall Study|No longer met eligibility criteria|3|||
145475971|NCT03828617|524594276|FG000|Overall Study|Protocol Violation|0|||
145475972|NCT03828617|524594277|FG001|Overall Study|Protocol Violation|2|||
145632108|NCT00798265|525166132|FG000|Overall Study|Study closing|7|||
145475973|NCT03828617|524594278|FG002|Overall Study|Protocol Violation|0|||
145475974|NCT03828617|524594279|FG003|Overall Study|Protocol Violation|0|||
145475975|NCT03828617|524594276|FG000|Overall Study|Withdrawal by Subject|2|||
145475976|NCT03828617|524594277|FG001|Overall Study|Withdrawal by Subject|0|||
145475977|NCT03828617|524594278|FG002|Overall Study|Withdrawal by Subject|2|||
145475978|NCT03828617|524594279|FG003|Overall Study|Withdrawal by Subject|0|||
145475979|NCT01271725|524594280|FG000|Part A|Progressive disease according to RECIST|8|||
145475980|NCT01271725|524594281|FG001|Part A|Progressive disease according to RECIST|0|||
145475981|NCT01271725|524594280|FG000|Part A|Clinical signs/symptoms of progression|2|||
145475982|NCT01271725|524594281|FG001|Part A|Clinical signs/symptoms of progression|0|||
145475983|NCT01271725|524594280|FG000|Part A|Other Adverse Event|8|||
145632109|NCT00798265|525166133|FG001|Overall Study|Study closing|6|||
145632110|NCT00798265|525166132|FG000|Overall Study|Withdrawal by Subject|0|||
145632111|NCT00798265|525166133|FG001|Overall Study|Withdrawal by Subject|1|||
145475984|NCT01271725|524594281|FG001|Part A|Other Adverse Event|0|||
145475985|NCT01271725|524594280|FG000|Part A|Lost to Follow-up|1|||
145475986|NCT01271725|524594281|FG001|Part A|Lost to Follow-up|0|||
145475987|NCT01271725|524594280|FG000|Part A|Withdrawal by Subject|12|||
145632112|NCT00798265|525166132|FG000|Overall Study|Screen failure|0|||
145632113|NCT00798265|525166133|FG001|Overall Study|Screen failure|1|||
145475988|NCT01271725|524594281|FG001|Part A|Withdrawal by Subject|0|||
145475989|NCT01271725|524594280|FG000|Part A|Other than specified|3|||
145475990|NCT01271725|524594281|FG001|Part A|Other than specified|0|||
145475991|NCT01271725|524594280|FG000|Part A|Protocol Violation|1|||
145475992|NCT01271725|524594281|FG001|Part A|Protocol Violation|0|||
145475993|NCT01271725|524594280|FG000|Part B|Other than specified|0|||
145475994|NCT01271725|524594281|FG001|Part B|Other than specified|2|||
145475995|NCT01271725|524594280|FG000|Part B|Clinical signs/symptoms of progression|0|||
145475996|NCT01271725|524594281|FG001|Part B|Clinical signs/symptoms of progression|2|||
145475997|NCT01271725|524594280|FG000|Part B|Other Adverse Event|0|||
145475998|NCT01271725|524594281|FG001|Part B|Other Adverse Event|1|||
145632114|NCT01546155|525167666|FG000|Overall Study|could not tolerate long scan duration|3|||
145475999|NCT01271725|524594280|FG000|Part B|Protocol Violation|0|||
145476000|NCT01271725|524594281|FG001|Part B|Protocol Violation|1|||
145632115|NCT01185522|525167671|FG000|Overall Study|Lack of Efficacy|28|||
145476001|NCT01271725|524594280|FG000|Part B|Withdrawal by Subject|0|||
145476002|NCT01271725|524594281|FG001|Part B|Withdrawal by Subject|6|||
145476003|NCT02950480|524594284|FG000|Overall Study|Withdrawal by Subject|1|||
145476004|NCT02950480|524594285|FG001|Overall Study|Withdrawal by Subject|0|||
145476005|NCT01363661|524594292|FG000|Overall Study|Adverse Event|9|||
145476006|NCT01363661|524594293|FG001|Overall Study|Adverse Event|2|||
145476007|NCT01363661|524594292|FG000|Overall Study|Withdrawal by Subject|1|||
145476008|NCT01363661|524594293|FG001|Overall Study|Withdrawal by Subject|1|||
145476009|NCT01363661|524594292|FG000|Overall Study|Protocol Violation|1|||
145476010|NCT01363661|524594293|FG001|Overall Study|Protocol Violation|0|||
145476011|NCT01363661|524594292|FG000|Overall Study|Lost to Follow-up|3|||
145476012|NCT01363661|524594293|FG001|Overall Study|Lost to Follow-up|1|||
145476013|NCT03149055|524594298|FG000|Overall Study|Not treated|4|||
145476014|NCT01378325|524594299|FG000|Overall Study|Protocol Violation|0|||
145476015|NCT01378325|524594300|FG001|Overall Study|Protocol Violation|1|||
145476016|NCT01559675|524594301|FG000|Overall Study|Protocol Violation|1|||
145476017|NCT01559675|524594302|FG001|Overall Study|Protocol Violation|2|||
145476018|NCT01559675|524594301|FG000|Overall Study|2nd operation on same patient excluded|14|||
145476019|NCT01559675|524594302|FG001|Overall Study|2nd operation on same patient excluded|12|||
145476020|NCT01279616|524594303|FG000|Overall Study|donor could not be located|5|||
145476021|NCT01279616|524594303|FG000|Overall Study|no signs of sickle cell disease|2|||
145476022|NCT02462720|524594304|FG000|Part 2|Withdrawal by Subject|1|||
145476023|NCT02462720|524594305|FG001|Part 2|Withdrawal by Subject|0|||
145476024|NCT02462720|524594304|FG000|Part 2|Protocol Violation|0|||
145476025|NCT02462720|524594305|FG001|Part 2|Protocol Violation|1|||
145476026|NCT00413036|524594306|FG000|Overall Study|Adverse Event|44|||
145476027|NCT00413036|524594306|FG000|Overall Study|Lack of Efficacy|129|||
145476028|NCT00413036|524594306|FG000|Overall Study|Withdrawal by Subject|7|||
145476029|NCT00413036|524594306|FG000|Overall Study|Death|9|||
145476030|NCT00413036|524594306|FG000|Overall Study|Other|26|||
145476031|NCT00413036|524594306|FG000|Overall Study|Missing|2|||
145476032|NCT00183625|524594311|FG000|Overall Study|Withdrawal by Subject|18|||
145476033|NCT00183625|524594312|FG001|Overall Study|Withdrawal by Subject|18|||
145476034|NCT00183625|524594313|FG002|Overall Study|Withdrawal by Subject|19|||
145476035|NCT00183625|524594314|FG003|Overall Study|Withdrawal by Subject|14|||
145476036|NCT01894022|524594324|FG000|Overall Study|Death|1|||
145476037|NCT01894022|524594325|FG001|Overall Study|Death|0|||
145476038|NCT01894022|524594324|FG000|Overall Study|Adverse Event, non-fatal|1|||
145476039|NCT01894022|524594325|FG001|Overall Study|Adverse Event, non-fatal|0|||
145476040|NCT01894022|524594324|FG000|Overall Study|Study Closed/terminated|7|||
145476041|NCT01894022|524594325|FG001|Overall Study|Study Closed/terminated|10|||
145476042|NCT04496453|524594327|FG000|Overall Study|Lost to Follow-up|6|||
145476043|NCT01361178|524594328|FG000|Overall Study|Death|13|||
145476044|NCT01361178|524594329|FG001|Overall Study|Death|0|||
145476045|NCT05392803|524594332|FG000|Overall Study|Lost to Follow-up|0|||
145476046|NCT05392803|524594333|FG001|Overall Study|Lost to Follow-up|2|||
145476047|NCT04356040|524594336|FG000|Overall Study|Death|2|||
145476048|NCT04356040|524594337|FG001|Overall Study|Death|0|||
145476049|NCT04356040|524594336|FG000|Overall Study|Lost to Follow-up|1|||
145476050|NCT04356040|524594337|FG001|Overall Study|Lost to Follow-up|0|||
145476051|NCT04356040|524594336|FG000|Overall Study|Physician Decision|0|||
145476052|NCT04356040|524594337|FG001|Overall Study|Physician Decision|1|||
145476053|NCT04356040|524594336|FG000|Overall Study|Withdrawal by Subject|13|||
145476054|NCT04356040|524594337|FG001|Overall Study|Withdrawal by Subject|1|||
145476055|NCT04356040|524594336|FG000|Overall Study|Enrollment Pause|10|||
145476056|NCT04356040|524594337|FG001|Overall Study|Enrollment Pause|0|||
145476057|NCT04356040|524594336|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
145476058|NCT04356040|524594337|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
145476059|NCT04356040|524594336|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
145476060|NCT04356040|524594337|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
145476061|NCT04356040|524594336|FG000|Overall Study|PI left institution|3|||
145632116|NCT01185522|525167671|FG000|Overall Study|Lost to Follow-up|19|||
145632117|NCT01185522|525167671|FG000|Overall Study|Withdrawal by Subject|10|||
145632118|NCT01185522|525167671|FG000|Overall Study|Poor tolerance|39|||
145476062|NCT04356040|524594337|FG001|Overall Study|PI left institution|0|||
145476063|NCT01092663|524594338|FG000|Overall Study|Withdrawal by Subject|3|||
145476064|NCT01092663|524594339|FG001|Overall Study|Withdrawal by Subject|2|||
145476065|NCT01092663|524594338|FG000|Overall Study|Glucose >300mg/dL|1|||
145476066|NCT01092663|524594339|FG001|Overall Study|Glucose >300mg/dL|0|||
145476067|NCT01092663|524594338|FG000|Overall Study|High fasting triglyceride|2|||
145476068|NCT01092663|524594339|FG001|Overall Study|High fasting triglyceride|0|||
145476069|NCT01092663|524594338|FG000|Overall Study|Adverse Event|1|||
145476070|NCT01092663|524594339|FG001|Overall Study|Adverse Event|1|||
145476071|NCT01092663|524594338|FG000|Overall Study|Protocol Violation|0|||
145476072|NCT01092663|524594339|FG001|Overall Study|Protocol Violation|1|||
145476073|NCT02828020|524594340|FG000|Treatment Period|Adverse Event|3|||
145476074|NCT02828020|524594341|FG001|Treatment Period|Adverse Event|1|||
145476075|NCT02828020|524594342|FG002|Treatment Period|Adverse Event|1|||
145476076|NCT02828020|524594340|FG000|Treatment Period|Withdrawal of Consent|10|||
145476077|NCT02828020|524594341|FG001|Treatment Period|Withdrawal of Consent|14|||
145476078|NCT02828020|524594342|FG002|Treatment Period|Withdrawal of Consent|9|||
145476079|NCT02828020|524594340|FG000|Treatment Period|Lost to Follow-up|21|||
145476080|NCT02828020|524594341|FG001|Treatment Period|Lost to Follow-up|24|||
145476081|NCT02828020|524594342|FG002|Treatment Period|Lost to Follow-up|18|||
145476082|NCT02828020|524594340|FG000|Treatment Period|Lack of Qualifying Event|44|||
145476083|NCT02828020|524594341|FG001|Treatment Period|Lack of Qualifying Event|53|||
145476084|NCT02828020|524594342|FG002|Treatment Period|Lack of Qualifying Event|43|||
145476085|NCT02828020|524594340|FG000|Treatment Period|Pregnancy|0|||
145476086|NCT02828020|524594341|FG001|Treatment Period|Pregnancy|2|||
145476087|NCT02828020|524594342|FG002|Treatment Period|Pregnancy|0|||
145476088|NCT02828020|524594340|FG000|Treatment Period|Protocol Violation|2|||
145476089|NCT02828020|524594341|FG001|Treatment Period|Protocol Violation|4|||
145476090|NCT02828020|524594342|FG002|Treatment Period|Protocol Violation|7|||
145476091|NCT02828020|524594340|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
145476092|NCT02828020|524594341|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
145476093|NCT02828020|524594342|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
145476094|NCT02828020|524594340|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
145476095|NCT02828020|524594341|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
145476096|NCT02828020|524594342|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
145632119|NCT01185522|525167671|FG000|Overall Study|Other reasons|12|||
145632120|NCT00954707|525167672|FG000|Overall Study|Death|34|||
145632121|NCT00954707|525167672|FG000|Overall Study|Withdrawal by Subject|100|||
145632122|NCT00954707|525167672|FG000|Overall Study|Lost to Follow-up|33|||
145632123|NCT01649791|525167673|FG000|Overall Study|Disease Progression|2|||
145632124|NCT01649791|525167673|FG000|Overall Study|Adverse Event|1|||
145632125|NCT00771667|525167674|FG000|Induction Phase|Adverse Event|5|||
145632126|NCT00771667|525167675|FG001|Induction Phase|Adverse Event|2|||
145632127|NCT00771667|525167676|FG002|Induction Phase|Adverse Event|4|||
145632128|NCT00771667|525167677|FG003|Induction Phase|Adverse Event|1|||
145632129|NCT00771667|525167678|FG004|Induction Phase|Adverse Event|0|||
145632130|NCT00771667|525167679|FG005|Induction Phase|Adverse Event|0|||
145632131|NCT00771667|525167680|FG006|Induction Phase|Adverse Event|0|||
145632132|NCT00771667|525167681|FG007|Induction Phase|Adverse Event|0|||
145632133|NCT00771667|525167682|FG008|Induction Phase|Adverse Event|0|||
145632134|NCT00771667|525167683|FG009|Induction Phase|Adverse Event|0|||
145632135|NCT00771667|525167674|FG000|Induction Phase|Lack of Efficacy|9|||
145632136|NCT00771667|525167675|FG001|Induction Phase|Lack of Efficacy|2|||
145632137|NCT00771667|525167676|FG002|Induction Phase|Lack of Efficacy|4|||
145632138|NCT00771667|525167677|FG003|Induction Phase|Lack of Efficacy|3|||
145476097|NCT02828020|524594340|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
145476098|NCT02828020|524594341|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
145476099|NCT02828020|524594342|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
145476100|NCT02828020|524594340|FG000|Safety Follow-up Period|Protocol Violation|0|||
145476101|NCT02828020|524594341|FG001|Safety Follow-up Period|Protocol Violation|2|||
145476102|NCT02828020|524594342|FG002|Safety Follow-up Period|Protocol Violation|1|||
145476103|NCT02828020|524594340|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
145476104|NCT02828020|524594341|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
145476105|NCT02828020|524594342|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
145476106|NCT03688620|524594343|FG000|Overall Study|Other|0|||
145632139|NCT00771667|525167678|FG004|Induction Phase|Lack of Efficacy|0|||
145632140|NCT00771667|525167679|FG005|Induction Phase|Lack of Efficacy|0|||
145476107|NCT03688620|524594344|FG001|Overall Study|Other|0|||
145476108|NCT03688620|524594345|FG002|Overall Study|Other|1|||
145476109|NCT03688620|524594343|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
145476110|NCT03688620|524594344|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
145476111|NCT03688620|524594345|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
145632141|NCT00771667|525167680|FG006|Induction Phase|Lack of Efficacy|0|||
145632142|NCT00771667|525167681|FG007|Induction Phase|Lack of Efficacy|0|||
145632143|NCT00771667|525167682|FG008|Induction Phase|Lack of Efficacy|0|||
145632144|NCT00771667|525167683|FG009|Induction Phase|Lack of Efficacy|0|||
145632145|NCT00771667|525167674|FG000|Induction Phase|Lost to Follow-up|1|||
145632146|NCT00771667|525167675|FG001|Induction Phase|Lost to Follow-up|0|||
145632147|NCT00771667|525167676|FG002|Induction Phase|Lost to Follow-up|1|||
145632148|NCT00771667|525167677|FG003|Induction Phase|Lost to Follow-up|0|||
145632149|NCT00771667|525167678|FG004|Induction Phase|Lost to Follow-up|0|||
145476112|NCT03688620|524594343|FG000|Overall Study|Lost to Follow-up|16|||
145476113|NCT03688620|524594344|FG001|Overall Study|Lost to Follow-up|0|||
145476114|NCT03688620|524594345|FG002|Overall Study|Lost to Follow-up|1|||
145476115|NCT03688620|524594343|FG000|Overall Study|Withdrawal by Subject|0|||
145476116|NCT03688620|524594344|FG001|Overall Study|Withdrawal by Subject|0|||
145632150|NCT00771667|525167679|FG005|Induction Phase|Lost to Follow-up|0|||
145632151|NCT00771667|525167680|FG006|Induction Phase|Lost to Follow-up|0|||
145632152|NCT00771667|525167681|FG007|Induction Phase|Lost to Follow-up|0|||
145632153|NCT00771667|525167682|FG008|Induction Phase|Lost to Follow-up|0|||
145632154|NCT00771667|525167683|FG009|Induction Phase|Lost to Follow-up|0|||
145476117|NCT03688620|524594345|FG002|Overall Study|Withdrawal by Subject|6|||
145476118|NCT01008904|524594346|FG000|Overall Study|Lost to Follow-up|1|||
145476119|NCT01008904|524594346|FG000|Overall Study|Adverse Event|2|||
145476120|NCT01008904|524594346|FG000|Overall Study|unexpected unrelated surgery|1|||
145476121|NCT01364389|524594355|FG000|Overall Study|Withdrawal by Subject|0|||
145476122|NCT01364389|524594356|FG001|Overall Study|Withdrawal by Subject|1|||
145476123|NCT01364389|524594357|FG002|Overall Study|Withdrawal by Subject|0|||
145476124|NCT01364389|524594355|FG000|Overall Study|Protocol deviation|0|||
145476125|NCT01364389|524594356|FG001|Overall Study|Protocol deviation|0|||
145476126|NCT01364389|524594357|FG002|Overall Study|Protocol deviation|1|||
145476127|NCT01364389|524594355|FG000|Overall Study|Administrative problems|1|||
145476128|NCT01364389|524594356|FG001|Overall Study|Administrative problems|0|||
145476129|NCT01364389|524594357|FG002|Overall Study|Administrative problems|0|||
145476130|NCT01364389|524594355|FG000|Overall Study|Adverse Event|1|||
145476131|NCT01364389|524594356|FG001|Overall Study|Adverse Event|0|||
145476132|NCT01364389|524594357|FG002|Overall Study|Adverse Event|0|||
145476133|NCT01630889|524594360|FG000|Overall Study|Death|2|||
145476134|NCT01630889|524594360|FG000|Overall Study|Withdrawal by Subject|1|||
145476135|NCT01630889|524594360|FG000|Overall Study|Other than Specified|2|||
145476136|NCT01630889|524594360|FG000|Overall Study|Lost to Follow-up|4|||
145476137|NCT01630889|524594360|FG000|Overall Study|Other|1|||
145476138|NCT02974842|524594361|FG000|Overall Study|Withdrawal by Subject|4|||
145476139|NCT02974842|524594361|FG000|Overall Study|Screen failures|4|||
145476140|NCT01068158|524594367|FG000|Overall Study|Withdrawal by Subject|1|||
145476141|NCT01068158|524594368|FG001|Overall Study|Withdrawal by Subject|2|||
145476142|NCT01068158|524594367|FG000|Overall Study|Lost to Follow-up|7|||
145476143|NCT01068158|524594368|FG001|Overall Study|Lost to Follow-up|0|||
145476144|NCT01068158|524594367|FG000|Overall Study|Protocol Violation|0|||
145476145|NCT01068158|524594368|FG001|Overall Study|Protocol Violation|2|||
145476146|NCT01368081|524594375|FG000|Overall Study|Adverse Event|4|||
145476147|NCT01368081|524594376|FG001|Overall Study|Adverse Event|4|||
145476148|NCT01368081|524594377|FG002|Overall Study|Adverse Event|3|||
145476149|NCT01368081|524594378|FG003|Overall Study|Adverse Event|2|||
145476150|NCT01368081|524594379|FG004|Overall Study|Adverse Event|2|||
145476151|NCT01368081|524594380|FG005|Overall Study|Adverse Event|5|||
145476152|NCT01368081|524594381|FG006|Overall Study|Adverse Event|6|||
145476153|NCT01368081|524594382|FG007|Overall Study|Adverse Event|2|||
145476154|NCT01368081|524594383|FG008|Overall Study|Adverse Event|3|||
145476155|NCT01368081|524594384|FG009|Overall Study|Adverse Event|5|||
145476156|NCT01368081|524594385|FG010|Overall Study|Adverse Event|6|||
145476157|NCT01368081|524594386|FG011|Overall Study|Adverse Event|1|||
145476158|NCT01368081|524594387|FG012|Overall Study|Adverse Event|3|||
145476159|NCT01368081|524594375|FG000|Overall Study|Lack of Efficacy|0|||
145476160|NCT01368081|524594376|FG001|Overall Study|Lack of Efficacy|1|||
145476161|NCT01368081|524594377|FG002|Overall Study|Lack of Efficacy|0|||
145476162|NCT01368081|524594378|FG003|Overall Study|Lack of Efficacy|1|||
145476163|NCT01368081|524594379|FG004|Overall Study|Lack of Efficacy|0|||
145476164|NCT01368081|524594380|FG005|Overall Study|Lack of Efficacy|0|||
145632155|NCT00771667|525167674|FG000|Induction Phase|Other|4|||
145632156|NCT00771667|525167675|FG001|Induction Phase|Other|6|||
145632157|NCT00771667|525167676|FG002|Induction Phase|Other|3|||
145632158|NCT00771667|525167677|FG003|Induction Phase|Other|4|||
145632159|NCT00771667|525167678|FG004|Induction Phase|Other|0|||
145632160|NCT00771667|525167679|FG005|Induction Phase|Other|0|||
145632161|NCT00771667|525167680|FG006|Induction Phase|Other|0|||
145632162|NCT00771667|525167681|FG007|Induction Phase|Other|0|||
145632163|NCT00771667|525167682|FG008|Induction Phase|Other|0|||
145476165|NCT01368081|524594381|FG006|Overall Study|Lack of Efficacy|0|||
145476166|NCT01368081|524594382|FG007|Overall Study|Lack of Efficacy|2|||
145476167|NCT01368081|524594383|FG008|Overall Study|Lack of Efficacy|0|||
145476168|NCT01368081|524594384|FG009|Overall Study|Lack of Efficacy|0|||
145476169|NCT01368081|524594385|FG010|Overall Study|Lack of Efficacy|0|||
145476170|NCT01368081|524594386|FG011|Overall Study|Lack of Efficacy|0|||
145476171|NCT01368081|524594387|FG012|Overall Study|Lack of Efficacy|0|||
145476172|NCT01368081|524594375|FG000|Overall Study|Protocol Violation|0|||
145476173|NCT01368081|524594376|FG001|Overall Study|Protocol Violation|0|||
145476174|NCT01368081|524594377|FG002|Overall Study|Protocol Violation|0|||
145476175|NCT01368081|524594378|FG003|Overall Study|Protocol Violation|0|||
145476176|NCT01368081|524594379|FG004|Overall Study|Protocol Violation|0|||
145476177|NCT01368081|524594380|FG005|Overall Study|Protocol Violation|1|||
145476178|NCT01368081|524594381|FG006|Overall Study|Protocol Violation|0|||
145476179|NCT01368081|524594382|FG007|Overall Study|Protocol Violation|1|||
145476180|NCT01368081|524594383|FG008|Overall Study|Protocol Violation|0|||
145476181|NCT01368081|524594384|FG009|Overall Study|Protocol Violation|0|||
145476182|NCT01368081|524594385|FG010|Overall Study|Protocol Violation|0|||
145476183|NCT01368081|524594386|FG011|Overall Study|Protocol Violation|0|||
145476184|NCT01368081|524594387|FG012|Overall Study|Protocol Violation|0|||
145476185|NCT01368081|524594375|FG000|Overall Study|Lost to Follow-up|0|||
145476186|NCT01368081|524594376|FG001|Overall Study|Lost to Follow-up|0|||
145632164|NCT00771667|525167683|FG009|Induction Phase|Other|0|||
145632165|NCT00771667|525167674|FG000|Maintenance Phase|Adverse Event|0|||
145632166|NCT00771667|525167675|FG001|Maintenance Phase|Adverse Event|0|||
145632167|NCT00771667|525167676|FG002|Maintenance Phase|Adverse Event|0|||
145632168|NCT00771667|525167677|FG003|Maintenance Phase|Adverse Event|0|||
145632169|NCT00771667|525167678|FG004|Maintenance Phase|Adverse Event|1|||
145632170|NCT00771667|525167679|FG005|Maintenance Phase|Adverse Event|3|||
145632171|NCT00771667|525167680|FG006|Maintenance Phase|Adverse Event|5|||
145632172|NCT00771667|525167681|FG007|Maintenance Phase|Adverse Event|1|||
145632173|NCT00771667|525167682|FG008|Maintenance Phase|Adverse Event|8|||
145632174|NCT00771667|525167683|FG009|Maintenance Phase|Adverse Event|7|||
145632175|NCT00771667|525167674|FG000|Maintenance Phase|Lack of Efficacy|0|||
145632176|NCT00771667|525167675|FG001|Maintenance Phase|Lack of Efficacy|0|||
145632177|NCT00771667|525167676|FG002|Maintenance Phase|Lack of Efficacy|0|||
145632178|NCT00771667|525167677|FG003|Maintenance Phase|Lack of Efficacy|0|||
145632179|NCT00771667|525167678|FG004|Maintenance Phase|Lack of Efficacy|1|||
145632180|NCT00771667|525167679|FG005|Maintenance Phase|Lack of Efficacy|3|||
145632181|NCT00771667|525167680|FG006|Maintenance Phase|Lack of Efficacy|3|||
145632182|NCT00771667|525167681|FG007|Maintenance Phase|Lack of Efficacy|2|||
145632183|NCT00771667|525167682|FG008|Maintenance Phase|Lack of Efficacy|11|||
145632184|NCT00771667|525167683|FG009|Maintenance Phase|Lack of Efficacy|7|||
145632185|NCT00771667|525167674|FG000|Maintenance Phase|Other|0|||
145632186|NCT00771667|525167675|FG001|Maintenance Phase|Other|0|||
145632187|NCT00771667|525167676|FG002|Maintenance Phase|Other|0|||
145632188|NCT00771667|525167677|FG003|Maintenance Phase|Other|0|||
145632189|NCT00771667|525167678|FG004|Maintenance Phase|Other|0|||
145632190|NCT00771667|525167679|FG005|Maintenance Phase|Other|1|||
145632191|NCT00771667|525167680|FG006|Maintenance Phase|Other|2|||
145632192|NCT00771667|525167681|FG007|Maintenance Phase|Other|2|||
145632193|NCT00771667|525167682|FG008|Maintenance Phase|Other|3|||
145632194|NCT00771667|525167683|FG009|Maintenance Phase|Other|3|||
145632195|NCT01897233|525167684|FG000|Part B (24 Weeks)|Adverse Event|1|||
145632196|NCT01897233|525167684|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
145632197|NCT01897233|525167684|FG000|Part B (24 Weeks)|Physician Decision|1|||
145476187|NCT01368081|524594377|FG002|Overall Study|Lost to Follow-up|0|||
145476188|NCT01368081|524594378|FG003|Overall Study|Lost to Follow-up|0|||
145476189|NCT01368081|524594379|FG004|Overall Study|Lost to Follow-up|0|||
145476190|NCT01368081|524594380|FG005|Overall Study|Lost to Follow-up|0|||
145476191|NCT01368081|524594381|FG006|Overall Study|Lost to Follow-up|0|||
145476192|NCT01368081|524594382|FG007|Overall Study|Lost to Follow-up|0|||
145476193|NCT01368081|524594383|FG008|Overall Study|Lost to Follow-up|0|||
145476194|NCT01368081|524594384|FG009|Overall Study|Lost to Follow-up|0|||
145476195|NCT01368081|524594385|FG010|Overall Study|Lost to Follow-up|0|||
145476196|NCT01368081|524594386|FG011|Overall Study|Lost to Follow-up|0|||
145476197|NCT01368081|524594387|FG012|Overall Study|Lost to Follow-up|1|||
145476198|NCT01368081|524594375|FG000|Overall Study|Withdrawal by Subject|4|||
145476199|NCT01368081|524594376|FG001|Overall Study|Withdrawal by Subject|4|||
145476200|NCT01368081|524594377|FG002|Overall Study|Withdrawal by Subject|1|||
145476201|NCT01368081|524594378|FG003|Overall Study|Withdrawal by Subject|1|||
145476202|NCT01368081|524594379|FG004|Overall Study|Withdrawal by Subject|0|||
145476203|NCT01368081|524594380|FG005|Overall Study|Withdrawal by Subject|3|||
145476204|NCT01368081|524594381|FG006|Overall Study|Withdrawal by Subject|4|||
145476205|NCT01368081|524594382|FG007|Overall Study|Withdrawal by Subject|2|||
145476206|NCT01368081|524594383|FG008|Overall Study|Withdrawal by Subject|5|||
145476207|NCT01368081|524594384|FG009|Overall Study|Withdrawal by Subject|4|||
145476208|NCT01368081|524594385|FG010|Overall Study|Withdrawal by Subject|3|||
145476209|NCT01368081|524594386|FG011|Overall Study|Withdrawal by Subject|2|||
145476210|NCT01368081|524594387|FG012|Overall Study|Withdrawal by Subject|0|||
145476211|NCT01368081|524594375|FG000|Overall Study|Other reason not defined above|2|||
145476212|NCT01368081|524594376|FG001|Overall Study|Other reason not defined above|0|||
145476213|NCT01368081|524594377|FG002|Overall Study|Other reason not defined above|0|||
145632198|NCT00628862|525167685|FG000|Overall Study|Adverse Event|6|||
145476214|NCT01368081|524594378|FG003|Overall Study|Other reason not defined above|1|||
145476215|NCT01368081|524594379|FG004|Overall Study|Other reason not defined above|0|||
145476216|NCT01368081|524594380|FG005|Overall Study|Other reason not defined above|1|||
145476217|NCT01368081|524594381|FG006|Overall Study|Other reason not defined above|2|||
145632199|NCT00628862|525167686|FG001|Overall Study|Adverse Event|8|||
145632200|NCT00628862|525167687|FG002|Overall Study|Adverse Event|10|||
145632201|NCT00628862|525167685|FG000|Overall Study|Withdrawal by Subject|4|||
145632202|NCT00628862|525167686|FG001|Overall Study|Withdrawal by Subject|6|||
145476218|NCT01368081|524594382|FG007|Overall Study|Other reason not defined above|0|||
145476219|NCT01368081|524594383|FG008|Overall Study|Other reason not defined above|0|||
145476220|NCT01368081|524594384|FG009|Overall Study|Other reason not defined above|1|||
145476221|NCT01368081|524594385|FG010|Overall Study|Other reason not defined above|0|||
145476222|NCT01368081|524594386|FG011|Overall Study|Other reason not defined above|0|||
145476223|NCT01368081|524594387|FG012|Overall Study|Other reason not defined above|3|||
145632203|NCT00628862|525167687|FG002|Overall Study|Withdrawal by Subject|11|||
145632204|NCT00628862|525167685|FG000|Overall Study|Lost to Follow-up|0|||
145632205|NCT00628862|525167686|FG001|Overall Study|Lost to Follow-up|2|||
145632206|NCT00628862|525167687|FG002|Overall Study|Lost to Follow-up|1|||
145476224|NCT00238238|524594393|FG000|Overall Study|Withdrawal by Subject|0|||
145476225|NCT00238238|524594394|FG001|Overall Study|Withdrawal by Subject|3|||
145476226|NCT00238238|524594395|FG002|Overall Study|Withdrawal by Subject|0|||
145476227|NCT02277119|524594398|FG000|Overall Study|Lack of Efficacy|1|||
145476228|NCT02277119|524594399|FG001|Overall Study|Lack of Efficacy|1|||
145476229|NCT02277119|524594400|FG002|Overall Study|Lack of Efficacy|1|||
145476230|NCT02277119|524594398|FG000|Overall Study|Protocol Violation|2|||
145476231|NCT02277119|524594399|FG001|Overall Study|Protocol Violation|3|||
145476232|NCT02277119|524594400|FG002|Overall Study|Protocol Violation|7|||
145476233|NCT01730586|524594406|FG000|Overall Study|Progressive Disease|2|||
145476234|NCT01730586|524594406|FG000|Overall Study|Inadequate Trial|8|||
145476235|NCT01730586|524594406|FG000|Overall Study|Adverse Event|2|||
145476236|NCT01730586|524594406|FG000|Overall Study|Hospice|1|||
145476237|NCT01370265|524596115|FG000|First Intervention|Adverse Event|1|||
145476238|NCT01370265|524596116|FG001|First Intervention|Adverse Event|1|||
145476239|NCT03343626|524596117|FG000|Overall Study|Lost to Follow-up|4|||
145476240|NCT03343626|524596118|FG001|Overall Study|Lost to Follow-up|3|||
145476241|NCT03343626|524596119|FG002|Overall Study|Lost to Follow-up|2|||
145476242|NCT03343626|524596120|FG003|Overall Study|Lost to Follow-up|5|||
145476243|NCT03343626|524596121|FG004|Overall Study|Lost to Follow-up|4|||
145476244|NCT03343626|524596122|FG005|Overall Study|Lost to Follow-up|4|||
145476245|NCT03343626|524596123|FG006|Overall Study|Lost to Follow-up|4|||
145476246|NCT03343626|524596124|FG007|Overall Study|Lost to Follow-up|7|||
145476247|NCT03343626|524596117|FG000|Overall Study|Withdrawal of Consent|2|||
145476248|NCT03343626|524596118|FG001|Overall Study|Withdrawal of Consent|1|||
145476249|NCT03343626|524596119|FG002|Overall Study|Withdrawal of Consent|0|||
145476250|NCT03343626|524596120|FG003|Overall Study|Withdrawal of Consent|3|||
145632207|NCT00628862|525167685|FG000|Overall Study|Protocol Violation|1|||
145632208|NCT00628862|525167686|FG001|Overall Study|Protocol Violation|0|||
145632209|NCT00628862|525167687|FG002|Overall Study|Protocol Violation|0|||
145632210|NCT00628862|525167685|FG000|Overall Study|COPD Exacerbation|0|||
145632211|NCT00628862|525167686|FG001|Overall Study|COPD Exacerbation|1|||
145632212|NCT00628862|525167687|FG002|Overall Study|COPD Exacerbation|0|||
145632213|NCT04033432|525167708|FG000|Overall Study|Progressive Disease|8|||
145632214|NCT04033432|525167708|FG000|Overall Study|Adverse Event|4|||
145632215|NCT04033432|525167708|FG000|Overall Study|Death|1|||
145632216|NCT00738699|525167714|FG000|Overall Study|Withdrawal by Subject|5|||
145632217|NCT00738699|525167715|FG001|Overall Study|Withdrawal by Subject|0|||
145632218|NCT00738699|525167714|FG000|Overall Study|Lost to Follow-up|1|||
145632219|NCT00738699|525167715|FG001|Overall Study|Lost to Follow-up|0|||
145476251|NCT03343626|524596121|FG004|Overall Study|Withdrawal of Consent|3|||
145476252|NCT03343626|524596122|FG005|Overall Study|Withdrawal of Consent|1|||
145476253|NCT03343626|524596123|FG006|Overall Study|Withdrawal of Consent|1|||
145476254|NCT03343626|524596124|FG007|Overall Study|Withdrawal of Consent|2|||
145476255|NCT03343626|524596117|FG000|Overall Study|Reason not Specified|0|||
145476256|NCT03343626|524596118|FG001|Overall Study|Reason not Specified|1|||
145476257|NCT03343626|524596119|FG002|Overall Study|Reason not Specified|0|||
145476258|NCT03343626|524596120|FG003|Overall Study|Reason not Specified|0|||
145476259|NCT03343626|524596121|FG004|Overall Study|Reason not Specified|0|||
145476260|NCT03343626|524596122|FG005|Overall Study|Reason not Specified|0|||
145476261|NCT03343626|524596123|FG006|Overall Study|Reason not Specified|0|||
145476262|NCT03343626|524596124|FG007|Overall Study|Reason not Specified|1|||
145476263|NCT03343626|524596117|FG000|Overall Study|Data Entry Error|0|||
145476264|NCT03343626|524596118|FG001|Overall Study|Data Entry Error|0|||
145476265|NCT03343626|524596119|FG002|Overall Study|Data Entry Error|0|||
145476266|NCT03343626|524596120|FG003|Overall Study|Data Entry Error|0|||
145476267|NCT03343626|524596121|FG004|Overall Study|Data Entry Error|0|||
145476268|NCT03343626|524596122|FG005|Overall Study|Data Entry Error|0|||
145632220|NCT00738699|525167714|FG000|Overall Study|Death|144|||
145476269|NCT03343626|524596123|FG006|Overall Study|Data Entry Error|0|||
145476270|NCT03343626|524596124|FG007|Overall Study|Data Entry Error|1|||
145632221|NCT00738699|525167715|FG001|Overall Study|Death|68|||
145632222|NCT00738699|525167714|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
145632223|NCT00738699|525167715|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
145632224|NCT00738699|525167714|FG000|Overall Study|Other|2|||
145476271|NCT02611817|524596125|FG000|Open-label Induction Phase|Reason not Specified|9|||
145476272|NCT02611817|524596126|FG001|Open-label Induction Phase|Reason not Specified|0|||
145476273|NCT02611817|524596127|FG002|Open-label Induction Phase|Reason not Specified|0|||
145476274|NCT02611817|524596125|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
145476275|NCT02611817|524596126|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
145632225|NCT00738699|525167715|FG001|Overall Study|Other|0|||
145632226|NCT00868192|525167717|FG000|Overall Study|Ineligible|4|||
145476276|NCT02611817|524596127|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
145476277|NCT02611817|524596125|FG000|Open-label Induction Phase|Pregnancy|1|||
145476278|NCT02611817|524596126|FG001|Open-label Induction Phase|Pregnancy|0|||
145476279|NCT02611817|524596127|FG002|Open-label Induction Phase|Pregnancy|0|||
145476280|NCT02611817|524596125|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
145476281|NCT02611817|524596126|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
145476282|NCT02611817|524596127|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
145476283|NCT02611817|524596125|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
145476284|NCT02611817|524596126|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
145476285|NCT02611817|524596127|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
145476286|NCT02611817|524596125|FG000|Open-label Induction Phase|Protocol Violation|5|||
145476287|NCT02611817|524596126|FG001|Open-label Induction Phase|Protocol Violation|0|||
145476288|NCT02611817|524596127|FG002|Open-label Induction Phase|Protocol Violation|0|||
145476289|NCT02611817|524596125|FG000|Open-label Induction Phase|Adverse Event|16|||
145476290|NCT02611817|524596126|FG001|Open-label Induction Phase|Adverse Event|0|||
145476291|NCT02611817|524596127|FG002|Open-label Induction Phase|Adverse Event|0|||
145476292|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
145476293|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
145476294|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
145476295|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
145476296|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
145476297|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
145476298|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
145476299|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
145476300|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
145476301|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
145476302|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
145476303|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
145476304|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
145476305|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
145476306|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
145476307|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
145476308|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
145476309|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
145476310|NCT02611817|524596125|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
145476311|NCT02611817|524596126|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
145476312|NCT02611817|524596127|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
145476313|NCT03077919|524596128|FG000|Overall Study|Lost to Follow-up|4|||
145476314|NCT03077919|524596129|FG001|Overall Study|Lost to Follow-up|1|||
145476315|NCT03738618|524596130|FG000|Overall Study|Protocol deviation|23|||
145476316|NCT03738618|524596131|FG001|Overall Study|Protocol deviation|0|||
145476317|NCT03738618|524596130|FG000|Overall Study|Adverse Event|4|||
145476318|NCT03738618|524596131|FG001|Overall Study|Adverse Event|0|||
145476319|NCT03738618|524596130|FG000|Overall Study|Lost to Follow-up|2|||
145476320|NCT03738618|524596131|FG001|Overall Study|Lost to Follow-up|0|||
145476321|NCT03738618|524596130|FG000|Overall Study|Randomization failure|1|||
145476322|NCT03738618|524596131|FG001|Overall Study|Randomization failure|0|||
145476323|NCT03738618|524596130|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
145476324|NCT03738618|524596131|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
145476325|NCT03738618|524596130|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
145476326|NCT03738618|524596131|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
145476327|NCT00826618|524596132|FG000|Overall Study|Withdrawal by Subject|1|||
145476328|NCT03499314|524596135|FG000|Overall Study|Time Commitment|1|||
145476329|NCT03499314|524596136|FG001|Overall Study|Time Commitment|2|||
145476330|NCT03499314|524596135|FG000|Overall Study|Medical issue unrelated to research study|1|||
145476331|NCT03499314|524596136|FG001|Overall Study|Medical issue unrelated to research study|1|||
145476332|NCT00872599|524596137|FG000|Second Washout Period|Adverse Event|1|||
145476333|NCT00872599|524596138|FG001|Second Washout Period|Adverse Event|1|||
145476334|NCT04794270|524596139|FG000|Period 1|Non Compliance|1|||
145476335|NCT04794270|524596140|FG001|Period 1|Non Compliance|0|||
145476336|NCT04794270|524596139|FG000|Period 1|Adverse Event|1|||
145476337|NCT04794270|524596140|FG001|Period 1|Adverse Event|0|||
145476338|NCT04794270|524596139|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
145476339|NCT04794270|524596140|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
145476340|NCT02510001|524596143|FG000|Overall Study|Early disease progression|0|||
145476341|NCT02510001|524596144|FG001|Overall Study|Early disease progression|0|||
145476342|NCT02510001|524596145|FG002|Overall Study|Early disease progression|0|||
145476343|NCT02510001|524596146|FG003|Overall Study|Early disease progression|1|||
145476344|NCT02510001|524596147|FG004|Overall Study|Early disease progression|1|||
145476345|NCT02510001|524596148|FG005|Overall Study|Early disease progression|1|||
145476346|NCT02510001|524596149|FG006|Overall Study|Early disease progression|0|||
145476347|NCT02510001|524596150|FG007|Overall Study|Early disease progression|0|||
145476348|NCT02510001|524596143|FG000|Overall Study|Adverse Event|0|||
145476349|NCT02510001|524596144|FG001|Overall Study|Adverse Event|0|||
145476350|NCT02510001|524596145|FG002|Overall Study|Adverse Event|0|||
145476351|NCT02510001|524596146|FG003|Overall Study|Adverse Event|1|||
145476352|NCT02510001|524596147|FG004|Overall Study|Adverse Event|2|||
145476353|NCT02510001|524596148|FG005|Overall Study|Adverse Event|1|||
145476354|NCT02510001|524596149|FG006|Overall Study|Adverse Event|2|||
145476355|NCT02510001|524596150|FG007|Overall Study|Adverse Event|5|||
145476356|NCT02510001|524596143|FG000|Overall Study|Physician Decision|0|||
145476357|NCT02510001|524596144|FG001|Overall Study|Physician Decision|0|||
145476358|NCT02510001|524596145|FG002|Overall Study|Physician Decision|0|||
145476359|NCT02510001|524596146|FG003|Overall Study|Physician Decision|0|||
145476360|NCT02510001|524596147|FG004|Overall Study|Physician Decision|1|||
145476361|NCT02510001|524596148|FG005|Overall Study|Physician Decision|0|||
145476362|NCT02510001|524596149|FG006|Overall Study|Physician Decision|0|||
145476363|NCT02510001|524596150|FG007|Overall Study|Physician Decision|0|||
145476364|NCT02510001|524596143|FG000|Overall Study|Withdrawal by Subject|0|||
145476365|NCT02510001|524596144|FG001|Overall Study|Withdrawal by Subject|0|||
145476366|NCT02510001|524596145|FG002|Overall Study|Withdrawal by Subject|0|||
145476367|NCT02510001|524596146|FG003|Overall Study|Withdrawal by Subject|0|||
145476368|NCT02510001|524596147|FG004|Overall Study|Withdrawal by Subject|0|||
145476369|NCT02510001|524596148|FG005|Overall Study|Withdrawal by Subject|0|||
145476370|NCT02510001|524596149|FG006|Overall Study|Withdrawal by Subject|0|||
145476371|NCT02510001|524596150|FG007|Overall Study|Withdrawal by Subject|2|||
145476372|NCT01835223|524596164|FG000|Overall Study|Adverse Event|1|||
145476373|NCT01835223|524596165|FG001|Overall Study|Adverse Event|0|||
145476374|NCT01835223|524596164|FG000|Overall Study|Withdrawal by Subject|2|||
145476375|NCT01835223|524596165|FG001|Overall Study|Withdrawal by Subject|0|||
145476376|NCT01835223|524596164|FG000|Overall Study|Disease progression|2|||
145476377|NCT01835223|524596165|FG001|Overall Study|Disease progression|1|||
145476378|NCT01835223|524596164|FG000|Overall Study|Became Inelligible|4|||
145476379|NCT01835223|524596165|FG001|Overall Study|Became Inelligible|0|||
145476380|NCT00303485|524596166|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
145476381|NCT00303485|524596167|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
145476382|NCT00303485|524596166|FG000|Overall Study|Failure to return|0|||
145476383|NCT00303485|524596167|FG001|Overall Study|Failure to return|1|||
145476384|NCT00303485|524596166|FG000|Overall Study|Withdrawal by Subject|1|||
145476385|NCT00303485|524596167|FG001|Overall Study|Withdrawal by Subject|0|||
145476386|NCT01504841|524596168|FG000|Overall Study|Withdrawal by Subject|1|||
145476387|NCT01504841|524596169|FG001|Overall Study|Withdrawal by Subject|1|||
145476388|NCT01504841|524596170|FG002|Overall Study|Withdrawal by Subject|0|||
145476389|NCT01496469|524596178|FG000|Overall Study|Adverse Event|1|||
145476390|NCT01496469|524596179|FG001|Overall Study|Adverse Event|0|||
145476391|NCT01496469|524596178|FG000|Overall Study|Protocol Violation|2|||
145476392|NCT01496469|524596179|FG001|Overall Study|Protocol Violation|0|||
145476393|NCT01496469|524596178|FG000|Overall Study|Lost to Follow-up|1|||
145476394|NCT01496469|524596179|FG001|Overall Study|Lost to Follow-up|1|||
145476395|NCT01496469|524596178|FG000|Overall Study|Withdrawal by Subject|4|||
145476396|NCT01496469|524596179|FG001|Overall Study|Withdrawal by Subject|4|||
145476397|NCT01496469|524596178|FG000|Overall Study|BP exceeds protocol limits|1|||
145476398|NCT01496469|524596179|FG001|Overall Study|BP exceeds protocol limits|2|||
145476399|NCT01496469|524596178|FG000|Overall Study|Other|1|||
145476400|NCT01496469|524596179|FG001|Overall Study|Other|1|||
145476401|NCT00630344|524596181|FG000|Overall Study|Adverse Event|5|||
145476402|NCT00630344|524596181|FG000|Overall Study|Progressive Disease|19|||
145476403|NCT00630344|524596181|FG000|Overall Study|Physician Decision|9|||
145476404|NCT00630344|524596181|FG000|Overall Study|Withdrawal by Subject|1|||
145476405|NCT00630344|524596181|FG000|Overall Study|Intercurrent Illness|1|||
145476406|NCT00630344|524596181|FG000|Overall Study|Other|1|||
145476407|NCT01357551|524596182|FG000|Overall Study|Withdrawal by Subject|6|||
145476408|NCT01357551|524596183|FG001|Overall Study|Withdrawal by Subject|4|||
145476409|NCT01357551|524596182|FG000|Overall Study|Death|0|||
145476410|NCT01357551|524596183|FG001|Overall Study|Death|1|||
145476411|NCT01357551|524596182|FG000|Overall Study|Lost to Follow-up|16|||
145476412|NCT01357551|524596183|FG001|Overall Study|Lost to Follow-up|6|||
145476413|NCT00891228|524596186|FG000|Overall Study|Adverse Event|0|||
145476414|NCT00891228|524596187|FG001|Overall Study|Adverse Event|2|||
145476415|NCT00891228|524596188|FG002|Overall Study|Adverse Event|3|||
145476416|NCT00891228|524596186|FG000|Overall Study|Withdrawal by Subject|2|||
145632227|NCT02174562|525167718|FG000|Overall Study|Withdrawal by Subject|7|||
145476417|NCT00891228|524596187|FG001|Overall Study|Withdrawal by Subject|4|||
145476418|NCT00891228|524596188|FG002|Overall Study|Withdrawal by Subject|5|||
145476419|NCT00891228|524596186|FG000|Overall Study|Protocol Violation|3|||
145476420|NCT00891228|524596187|FG001|Overall Study|Protocol Violation|1|||
145476421|NCT00891228|524596188|FG002|Overall Study|Protocol Violation|2|||
145476422|NCT00891228|524596186|FG000|Overall Study|Physician Decision|2|||
145476423|NCT00891228|524596187|FG001|Overall Study|Physician Decision|1|||
145476424|NCT00891228|524596188|FG002|Overall Study|Physician Decision|0|||
145476425|NCT00891228|524596186|FG000|Overall Study|Lost to Follow-up|4|||
145476426|NCT00891228|524596187|FG001|Overall Study|Lost to Follow-up|4|||
145476427|NCT00891228|524596188|FG002|Overall Study|Lost to Follow-up|5|||
145476428|NCT00891228|524596186|FG000|Overall Study|Pregnancy|0|||
145476429|NCT00891228|524596187|FG001|Overall Study|Pregnancy|1|||
145476430|NCT00891228|524596188|FG002|Overall Study|Pregnancy|0|||
145476431|NCT01726582|524596195|FG000|Overall Study|Physician Decision|99|||
145476432|NCT01726582|524596195|FG000|Overall Study|Death|85|||
145476433|NCT01235234|524596196|FG000|Overall Study|Adverse Event|2|||
145476434|NCT01235234|524596197|FG001|Overall Study|Adverse Event|2|||
145476435|NCT01235234|524596198|FG002|Overall Study|Adverse Event|1|||
145476436|NCT03704688|524596203|FG000|Overall Study|Adverse Event|0|||
145476437|NCT03704688|524596204|FG001|Overall Study|Adverse Event|0|||
145476438|NCT03704688|524596205|FG002|Overall Study|Adverse Event|0|||
145476439|NCT03704688|524596206|FG003|Overall Study|Adverse Event|4|||
145476440|NCT03704688|524596207|FG004|Overall Study|Adverse Event|1|||
145476441|NCT03704688|524596208|FG005|Overall Study|Adverse Event|0|||
145476442|NCT03704688|524596203|FG000|Overall Study|Disease Progression|0|||
145476443|NCT03704688|524596204|FG001|Overall Study|Disease Progression|0|||
145476444|NCT03704688|524596205|FG002|Overall Study|Disease Progression|0|||
145476445|NCT03704688|524596206|FG003|Overall Study|Disease Progression|3|||
145476446|NCT03704688|524596207|FG004|Overall Study|Disease Progression|1|||
145476447|NCT03704688|524596208|FG005|Overall Study|Disease Progression|0|||
145476448|NCT03704688|524596203|FG000|Overall Study|Death|0|||
145476449|NCT03704688|524596204|FG001|Overall Study|Death|0|||
145476450|NCT03704688|524596205|FG002|Overall Study|Death|0|||
145476451|NCT03704688|524596206|FG003|Overall Study|Death|0|||
145476452|NCT03704688|524596207|FG004|Overall Study|Death|3|||
145476453|NCT03704688|524596208|FG005|Overall Study|Death|0|||
145476454|NCT03671304|524596213|FG000|Overall Study|study terminated|7|||
145476455|NCT00596830|524596214|FG000|Overall Study|Death|258|||
145476456|NCT00596830|524596215|FG001|Overall Study|Death|247|||
145476457|NCT00596830|524596214|FG000|Overall Study|Lost to Follow-up|7|||
145476458|NCT00596830|524596215|FG001|Overall Study|Lost to Follow-up|11|||
145476459|NCT00596830|524596214|FG000|Overall Study|Withdrawal by Subject|22|||
145476460|NCT00596830|524596215|FG001|Overall Study|Withdrawal by Subject|12|||
145476461|NCT00596830|524596214|FG000|Overall Study|Study terminated by sponsor|51|||
145476462|NCT00596830|524596215|FG001|Overall Study|Study terminated by sponsor|62|||
145476463|NCT00596830|524596214|FG000|Overall Study|Follow-up was discontinued|1|||
145476464|NCT00596830|524596215|FG001|Overall Study|Follow-up was discontinued|0|||
145476465|NCT00596830|524596214|FG000|Overall Study|Randomized but not treated|3|||
145476466|NCT00596830|524596215|FG001|Overall Study|Randomized but not treated|7|||
145476467|NCT00887926|524596216|FG000|Overall Study|Withdrawal by Subject|0|||
145476468|NCT00887926|524596217|FG001|Overall Study|Withdrawal by Subject|1|||
145476469|NCT00887926|524596218|FG002|Overall Study|Withdrawal by Subject|0|||
145476470|NCT00887926|524596219|FG003|Overall Study|Withdrawal by Subject|0|||
145476471|NCT02097030|524596220|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
145476472|NCT02097030|524596221|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
145476473|NCT02097030|524596220|FG000|First Intervention (3 Days)|Visual Acuity|0|||
145476474|NCT02097030|524596221|FG001|First Intervention (3 Days)|Visual Acuity|1|||
145476475|NCT00774800|524596222|FG000|Intervention 4|Withdrawal by Subject|1|||
145476476|NCT01973998|524596227|FG000|Overall Study|Death|2|||
145476477|NCT01973998|524596228|FG001|Overall Study|Death|2|||
145476478|NCT00646399|524596229|FG000|Overall Study|Death|63|||
145476479|NCT00646399|524596230|FG001|Overall Study|Death|53|||
145476480|NCT00646399|524596229|FG000|Overall Study|Withdrawal by Subject|9|||
145476481|NCT00646399|524596230|FG001|Overall Study|Withdrawal by Subject|10|||
145476482|NCT00646399|524596229|FG000|Overall Study|Other Reason|11|||
145476483|NCT00646399|524596230|FG001|Overall Study|Other Reason|11|||
145476484|NCT02540993|524596236|FG000|Overall Study|Lost to Follow-up|5|||
145476485|NCT02540993|524596237|FG001|Overall Study|Lost to Follow-up|3|||
145476486|NCT02540993|524596236|FG000|Overall Study|Withdrawal by Subject|4|||
145476487|NCT02540993|524596237|FG001|Overall Study|Withdrawal by Subject|6|||
145476488|NCT02540993|524596236|FG000|Overall Study|GCP violations|33|||
145476489|NCT02540993|524596237|FG001|Overall Study|GCP violations|27|||
145476490|NCT00820222|524596238|FG000|Overall Study|Lost to Follow-up|10|||
145476491|NCT00820222|524596239|FG001|Overall Study|Lost to Follow-up|9|||
145476492|NCT00820222|524596238|FG000|Overall Study|Withdrawal by Subject|19|||
145476493|NCT00820222|524596239|FG001|Overall Study|Withdrawal by Subject|21|||
145476494|NCT00820222|524596238|FG000|Overall Study|Physician Decision|93|||
145476495|NCT00820222|524596239|FG001|Overall Study|Physician Decision|88|||
145476496|NCT00820222|524596238|FG000|Overall Study|Sponsor Terminated Study|43|||
145476497|NCT00820222|524596239|FG001|Overall Study|Sponsor Terminated Study|65|||
145476498|NCT00820222|524596238|FG000|Overall Study|Unkown|11|||
145476499|NCT00820222|524596239|FG001|Overall Study|Unkown|7|||
145476500|NCT00844558|524596240|FG000|Overall Study|Withdrawal by Subject|9|||
145476501|NCT00844558|524596241|FG001|Overall Study|Withdrawal by Subject|2|||
145476502|NCT00844558|524596240|FG000|Overall Study|Death|1|||
145476503|NCT00844558|524596241|FG001|Overall Study|Death|0|||
145476504|NCT00844558|524596240|FG000|Overall Study|Protocol Violation|1|||
145476505|NCT00844558|524596241|FG001|Overall Study|Protocol Violation|1|||
145476506|NCT00844558|524596240|FG000|Overall Study|Lost to Follow-up|0|||
145476507|NCT00844558|524596241|FG001|Overall Study|Lost to Follow-up|1|||
145476508|NCT00844558|524596240|FG000|Overall Study|Physician Decision|1|||
145476509|NCT00844558|524596241|FG001|Overall Study|Physician Decision|0|||
145476510|NCT00588094|524596242|FG000|Overall Study|Adverse Event|3|||
145476511|NCT00588094|524596242|FG000|Overall Study|Progression of Disease|2|||
145476512|NCT01336023|524596243|FG000|Week 0 to Week 26|Adverse Event|8|||
145476513|NCT01336023|524596244|FG001|Week 0 to Week 26|Adverse Event|10|||
145476514|NCT01336023|524596245|FG002|Week 0 to Week 26|Adverse Event|24|||
145476515|NCT01336023|524596243|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
145476516|NCT01336023|524596244|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
145476517|NCT01336023|524596245|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
145476518|NCT01336023|524596243|FG000|Week 0 to Week 26|Protocol Violation|1|||
145476519|NCT01336023|524596244|FG001|Week 0 to Week 26|Protocol Violation|2|||
145632228|NCT02174562|525167719|FG001|Overall Study|Withdrawal by Subject|2|||
145632229|NCT02174562|525167718|FG000|Overall Study|Death|2|||
145632230|NCT02174562|525167719|FG001|Overall Study|Death|0|||
145632231|NCT02174562|525167718|FG000|Overall Study|Lost to Follow-up|0|||
145632232|NCT02174562|525167719|FG001|Overall Study|Lost to Follow-up|3|||
145632233|NCT00798096|525167721|FG000|Overall Study|Ongoing|2|||
145632234|NCT03670602|525167722|FG000|Overall Study|Lost to Follow-up|1|||
145632235|NCT03670602|525167723|FG001|Overall Study|Lost to Follow-up|0|||
145476520|NCT01336023|524596245|FG002|Week 0 to Week 26|Protocol Violation|0|||
145476521|NCT01336023|524596243|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
145476522|NCT01336023|524596244|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
145476523|NCT01336023|524596245|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
145476524|NCT01336023|524596243|FG000|Week 0 to Week 26|Unclassified|5|||
145476525|NCT01336023|524596244|FG001|Week 0 to Week 26|Unclassified|16|||
145476526|NCT01336023|524596245|FG002|Week 0 to Week 26|Unclassified|9|||
145476527|NCT01336023|524596243|FG000|Week 27 to 52|Adverse Event|1|||
145476528|NCT01336023|524596244|FG001|Week 27 to 52|Adverse Event|5|||
145476529|NCT01336023|524596245|FG002|Week 27 to 52|Adverse Event|2|||
145476530|NCT01336023|524596243|FG000|Week 27 to 52|Protocol Violation|0|||
145476531|NCT01336023|524596244|FG001|Week 27 to 52|Protocol Violation|2|||
145476532|NCT01336023|524596245|FG002|Week 27 to 52|Protocol Violation|1|||
145476533|NCT01336023|524596243|FG000|Week 27 to 52|Withdrawal Criteria|14|||
145476534|NCT01336023|524596244|FG001|Week 27 to 52|Withdrawal Criteria|19|||
145476535|NCT01336023|524596245|FG002|Week 27 to 52|Withdrawal Criteria|16|||
145476536|NCT01336023|524596243|FG000|Week 27 to 52|Unclassified|13|||
145476537|NCT01336023|524596244|FG001|Week 27 to 52|Unclassified|18|||
145476538|NCT01336023|524596245|FG002|Week 27 to 52|Unclassified|9|||
145476539|NCT04294147|524596250|FG000|Overall Study|Protocol Violation|2|||
145476540|NCT04294147|524596251|FG001|Overall Study|Protocol Violation|0|||
145476541|NCT02332291|524596252|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
145476542|NCT02332291|524596253|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
145476543|NCT02332291|524596252|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
145476544|NCT02332291|524596253|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
145476545|NCT02332291|524596252|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
145476546|NCT02332291|524596253|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
145476547|NCT02332291|524596252|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
145476548|NCT02332291|524596253|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
145476549|NCT02332291|524596252|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
145476550|NCT02332291|524596253|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
145476551|NCT02332291|524596252|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
145476552|NCT02332291|524596253|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
145476553|NCT00465647|524596258|FG000|Overall Study|Administrative|2|||
145476554|NCT00465647|524596259|FG001|Overall Study|Administrative|2|||
145476555|NCT00465647|524596260|FG002|Overall Study|Administrative|3|||
145476556|NCT00465647|524596261|FG003|Overall Study|Administrative|2|||
145476557|NCT00465647|524596258|FG000|Overall Study|Adverse Event|2|||
145476558|NCT00465647|524596259|FG001|Overall Study|Adverse Event|0|||
145476559|NCT00465647|524596260|FG002|Overall Study|Adverse Event|3|||
145476560|NCT00465647|524596261|FG003|Overall Study|Adverse Event|2|||
145476561|NCT00465647|524596258|FG000|Overall Study|Withdrawal by Subject|1|||
145476562|NCT00465647|524596259|FG001|Overall Study|Withdrawal by Subject|2|||
145476563|NCT00465647|524596260|FG002|Overall Study|Withdrawal by Subject|2|||
145476564|NCT00465647|524596261|FG003|Overall Study|Withdrawal by Subject|7|||
145476565|NCT00465647|524596258|FG000|Overall Study|"The other reasons included loss of IV"|8|||
145476566|NCT00465647|524596259|FG001|Overall Study|"The other reasons included loss of IV"|4|||
145476567|NCT00465647|524596260|FG002|Overall Study|"The other reasons included loss of IV"|3|||
145476568|NCT00465647|524596261|FG003|Overall Study|"The other reasons included loss of IV"|2|||
145476569|NCT03916081|524596264|FG000|Overall Study|Adverse Event|1|||
145476570|NCT03916081|524596265|FG001|Overall Study|Adverse Event|0|||
145476571|NCT03916081|524596266|FG002|Overall Study|Adverse Event|0|||
145476572|NCT03916081|524596264|FG000|Overall Study|Physician Decision|0|||
145632236|NCT03670602|525167722|FG000|Overall Study|Withdrawal by Subject|0|||
145476573|NCT03916081|524596265|FG001|Overall Study|Physician Decision|0|||
145476574|NCT03916081|524596266|FG002|Overall Study|Physician Decision|1|||
145476575|NCT03916081|524596264|FG000|Overall Study|Lost to Follow-up|0|||
145476576|NCT03916081|524596265|FG001|Overall Study|Lost to Follow-up|1|||
145476577|NCT03916081|524596266|FG002|Overall Study|Lost to Follow-up|0|||
145476578|NCT03916081|524596264|FG000|Overall Study|Withdrawal by Subject|3|||
145476579|NCT03916081|524596265|FG001|Overall Study|Withdrawal by Subject|0|||
145476580|NCT03916081|524596266|FG002|Overall Study|Withdrawal by Subject|1|||
145476581|NCT03916081|524596264|FG000|Overall Study|Worsening of AD|0|||
145476582|NCT03916081|524596265|FG001|Overall Study|Worsening of AD|0|||
145476583|NCT03916081|524596266|FG002|Overall Study|Worsening of AD|1|||
145476584|NCT01240135|524596267|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
145476585|NCT01240135|524596268|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
145476586|NCT01240135|524596267|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
145476587|NCT01240135|524596268|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
145476588|NCT00699335|524596269|FG000|Overall Study|Combination of multiple reasons|176|||
145476589|NCT00699335|524596269|FG000|Overall Study|Missing data|52|||
145476590|NCT00416455|524596276|FG000|Overall Study|PET / CT not done|3|||
145476591|NCT00416455|524596277|FG001|Overall Study|PET / CT not done|5|||
145476592|NCT00416455|524596276|FG000|Overall Study|PET / CT poor quality|2|||
145476593|NCT00416455|524596277|FG001|Overall Study|PET / CT poor quality|1|||
145476594|NCT00416455|524596276|FG000|Overall Study|Inadequate pathology|11|||
145476595|NCT00416455|524596277|FG001|Overall Study|Inadequate pathology|2|||
145476596|NCT02456857|524596278|FG000|Overall Study|Disease Progression|4|||
145476597|NCT00781859|524596279|FG000|Overall Study|Adverse Event|2|||
145476598|NCT00781859|524596280|FG001|Overall Study|Adverse Event|2|||
145476599|NCT00781859|524596279|FG000|Overall Study|Withdrawal by Subject|8|||
145476600|NCT00781859|524596280|FG001|Overall Study|Withdrawal by Subject|4|||
145476601|NCT00781859|524596279|FG000|Overall Study|Lost to Follow-up|6|||
145476602|NCT00781859|524596280|FG001|Overall Study|Lost to Follow-up|3|||
145476603|NCT00781859|524596279|FG000|Overall Study|Death|3|||
145476604|NCT00781859|524596280|FG001|Overall Study|Death|0|||
145476605|NCT01983774|524596284|FG000|Overall Study|Lung Transplant|0|||
145476606|NCT01983774|524596285|FG001|Overall Study|Lung Transplant|1|||
145476607|NCT01983774|524596284|FG000|Overall Study|Lost to Follow-up|1|||
145476608|NCT01983774|524596285|FG001|Overall Study|Lost to Follow-up|0|||
145476609|NCT01339897|524596286|FG000|Overall Study|Adverse Event|1|||
145476610|NCT01339897|524596287|FG001|Overall Study|Adverse Event|0|||
145476611|NCT01339897|524596288|FG002|Overall Study|Adverse Event|0|||
145476612|NCT01339897|524596289|FG003|Overall Study|Adverse Event|1|||
145476613|NCT03043651|524596293|FG000|Overall Study|Death|1|||
145476614|NCT03043651|524596293|FG000|Overall Study|Progressive Disease|2|||
145476615|NCT03043651|524596293|FG000|Overall Study|Adverse Event|2|||
145476616|NCT03043651|524596293|FG000|Overall Study|Withdrawal by Subject|4|||
145476617|NCT03043651|524596293|FG000|Overall Study|Study Terminated by Sponsor|39|||
145476618|NCT02980133|524596294|FG000|Overall Study|Other than specified|1|||
145476619|NCT02980133|524596295|FG001|Overall Study|Other than specified|1|||
145476620|NCT02980133|524596296|FG002|Overall Study|Other than specified|2|||
145476621|NCT02980133|524596297|FG003|Overall Study|Other than specified|2|||
145476622|NCT02980133|524596294|FG000|Overall Study|Lost to Follow-up|0|||
145476623|NCT02980133|524596295|FG001|Overall Study|Lost to Follow-up|0|||
145476624|NCT02980133|524596296|FG002|Overall Study|Lost to Follow-up|1|||
145476625|NCT02980133|524596297|FG003|Overall Study|Lost to Follow-up|3|||
145476626|NCT02980133|524596294|FG000|Overall Study|Protocol Violation|0|||
145476627|NCT02980133|524596295|FG001|Overall Study|Protocol Violation|1|||
145476628|NCT02980133|524596296|FG002|Overall Study|Protocol Violation|0|||
145632237|NCT03670602|525167723|FG001|Overall Study|Withdrawal by Subject|3|||
145632238|NCT03201809|525167724|FG000|Overall Study|Lost to Follow-up|2|||
145632239|NCT03201809|525167725|FG001|Overall Study|Lost to Follow-up|0|||
145476629|NCT02980133|524596297|FG003|Overall Study|Protocol Violation|0|||
145476630|NCT02980133|524596294|FG000|Overall Study|Withdrawal by parent/guardian|6|||
145476631|NCT02980133|524596295|FG001|Overall Study|Withdrawal by parent/guardian|3|||
145476632|NCT02980133|524596296|FG002|Overall Study|Withdrawal by parent/guardian|3|||
145476633|NCT02980133|524596297|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145476634|NCT02980133|524596294|FG000|Overall Study|Withdrawal by Subject|0|||
145476635|NCT02980133|524596295|FG001|Overall Study|Withdrawal by Subject|0|||
145476636|NCT02980133|524596296|FG002|Overall Study|Withdrawal by Subject|1|||
145476637|NCT02980133|524596297|FG003|Overall Study|Withdrawal by Subject|0|||
145476638|NCT02596945|524596298|FG000|Overall Study|No documentation of study drug dosing|3|||
145632240|NCT00957658|525167726|FG000|Overall Study|Death|1|||
145476639|NCT02596945|524596298|FG000|Overall Study|Other|32|||
145632241|NCT00957658|525167726|FG000|Overall Study|Lost to Follow-up|4|||
145476640|NCT02596945|524596298|FG000|Overall Study|Change to hemodialysis|15|||
145476641|NCT02596945|524596298|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
145476642|NCT02596945|524596298|FG000|Overall Study|Withdrawal by Subject|1|||
145476643|NCT02596945|524596298|FG000|Overall Study|Missing|1|||
145476644|NCT01007838|524596299|FG000|Overall Study|Withdrawal by Subject|1|||
145476645|NCT01007838|524596300|FG001|Overall Study|Withdrawal by Subject|0|||
145476646|NCT01007838|524596301|FG002|Overall Study|Withdrawal by Subject|0|||
145476647|NCT01007838|524596302|FG003|Overall Study|Withdrawal by Subject|0|||
145476648|NCT01007838|524596299|FG000|Overall Study|Physician Decision|1|||
145476649|NCT01007838|524596300|FG001|Overall Study|Physician Decision|0|||
145476650|NCT01007838|524596301|FG002|Overall Study|Physician Decision|0|||
145476651|NCT01007838|524596302|FG003|Overall Study|Physician Decision|0|||
145632242|NCT00957658|525167726|FG000|Overall Study|Withdrawal by Subject|12|||
145476652|NCT01007838|524596299|FG000|Overall Study|Started home haemodialysis|1|||
145476653|NCT01007838|524596300|FG001|Overall Study|Started home haemodialysis|0|||
145476654|NCT01007838|524596301|FG002|Overall Study|Started home haemodialysis|0|||
145476655|NCT01007838|524596302|FG003|Overall Study|Started home haemodialysis|0|||
145476656|NCT04699461|524596304|FG000|Overall Study|Withdrawal by Subject|1|||
145476657|NCT04699461|524596305|FG001|Overall Study|Withdrawal by Subject|0|||
145476658|NCT04699461|524596304|FG000|Overall Study|Study termination by sponsor|2|||
145476659|NCT04699461|524596305|FG001|Overall Study|Study termination by sponsor|1|||
145476660|NCT04699461|524596304|FG000|Overall Study|Death|1|||
145632243|NCT00957658|525167726|FG000|Overall Study|Revision|1|||
145632244|NCT00957658|525167726|FG000|Overall Study|Incomplete 2 yr data|28|||
145632245|NCT00957658|525167726|FG000|Overall Study|Site termination|10|||
145632246|NCT00957658|525167726|FG000|Overall Study|unwilling/unable to return|2|||
145632247|NCT00957658|525167726|FG000|Overall Study|surgery cancelled|2|||
145632248|NCT00957658|525167726|FG000|Overall Study|Protocol Violation|5|||
145632249|NCT00246012|525167727|FG000|Overall Study|Adverse Event|0|||
145632250|NCT00246012|525167728|FG001|Overall Study|Adverse Event|0|||
145632251|NCT00246012|525167729|FG002|Overall Study|Adverse Event|0|||
145632252|NCT00246012|525167730|FG003|Overall Study|Adverse Event|0|||
145632253|NCT00246012|525167731|FG004|Overall Study|Adverse Event|0|||
145632254|NCT00246012|525167732|FG005|Overall Study|Adverse Event|1|||
145632255|NCT00246012|525167733|FG006|Overall Study|Adverse Event|0|||
145632256|NCT00246012|525167734|FG007|Overall Study|Adverse Event|0|||
145632257|NCT00246012|525167735|FG008|Overall Study|Adverse Event|2|||
145632258|NCT00246012|525167727|FG000|Overall Study|Withdrawal by Subject|0|||
145632259|NCT00246012|525167728|FG001|Overall Study|Withdrawal by Subject|0|||
145632260|NCT00246012|525167729|FG002|Overall Study|Withdrawal by Subject|0|||
145632261|NCT00246012|525167730|FG003|Overall Study|Withdrawal by Subject|0|||
145632262|NCT00246012|525167731|FG004|Overall Study|Withdrawal by Subject|0|||
145632263|NCT00246012|525167732|FG005|Overall Study|Withdrawal by Subject|1|||
145632264|NCT00246012|525167733|FG006|Overall Study|Withdrawal by Subject|0|||
145632265|NCT00246012|525167734|FG007|Overall Study|Withdrawal by Subject|0|||
145632266|NCT00246012|525167735|FG008|Overall Study|Withdrawal by Subject|0|||
145632267|NCT00246012|525167727|FG000|Overall Study|Disease progression|3|||
145632268|NCT00246012|525167728|FG001|Overall Study|Disease progression|1|||
145632269|NCT00246012|525167729|FG002|Overall Study|Disease progression|2|||
145632270|NCT00246012|525167730|FG003|Overall Study|Disease progression|3|||
145632271|NCT00246012|525167731|FG004|Overall Study|Disease progression|3|||
145632272|NCT00246012|525167732|FG005|Overall Study|Disease progression|25|||
145632273|NCT00246012|525167733|FG006|Overall Study|Disease progression|30|||
145632274|NCT00246012|525167734|FG007|Overall Study|Disease progression|27|||
145632275|NCT00246012|525167735|FG008|Overall Study|Disease progression|26|||
145632276|NCT00246012|525167727|FG000|Overall Study|Other|0|||
145632277|NCT00246012|525167728|FG001|Overall Study|Other|0|||
145632278|NCT00246012|525167729|FG002|Overall Study|Other|0|||
145632279|NCT00246012|525167730|FG003|Overall Study|Other|0|||
145632280|NCT00246012|525167731|FG004|Overall Study|Other|0|||
145632281|NCT00246012|525167732|FG005|Overall Study|Other|0|||
145632282|NCT00246012|525167733|FG006|Overall Study|Other|0|||
145632283|NCT00246012|525167734|FG007|Overall Study|Other|1|||
145632284|NCT00246012|525167735|FG008|Overall Study|Other|0|||
145632285|NCT00246012|525167727|FG000|Overall Study|Randomly assigned but not treated|0|||
145632286|NCT00246012|525167728|FG001|Overall Study|Randomly assigned but not treated|0|||
145632287|NCT00246012|525167729|FG002|Overall Study|Randomly assigned but not treated|0|||
145632288|NCT00246012|525167730|FG003|Overall Study|Randomly assigned but not treated|0|||
145632289|NCT00246012|525167731|FG004|Overall Study|Randomly assigned but not treated|0|||
145632290|NCT00246012|525167732|FG005|Overall Study|Randomly assigned but not treated|1|||
145632291|NCT00246012|525167733|FG006|Overall Study|Randomly assigned but not treated|1|||
145632292|NCT00246012|525167734|FG007|Overall Study|Randomly assigned but not treated|0|||
145632293|NCT00246012|525167735|FG008|Overall Study|Randomly assigned but not treated|0|||
145632294|NCT02469064|525167738|FG000|Overall Study|Request not to receive intervention.|1|||
145476661|NCT04699461|524596305|FG001|Overall Study|Death|0|||
145632295|NCT02469064|525167739|FG001|Overall Study|Request not to receive intervention.|3|||
145632296|NCT00404079|525167740|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
145632297|NCT00404079|525167741|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
145632298|NCT02046616|525167744|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
145632299|NCT02046616|525167744|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
145632300|NCT02046616|525167744|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
145632301|NCT02046616|525167744|FG000|24-Week Treatment Period|Physician Decision|3|||
145632302|NCT02046616|525167744|FG000|24-Week Treatment Period|Other|1|||
145632303|NCT02046616|525167744|FG000|8-Week FU Period|Lost to Follow-up|1|||
145476662|NCT04699461|524596304|FG000|Overall Study|Radiographic progression|0|||
145476663|NCT04699461|524596305|FG001|Overall Study|Radiographic progression|1|||
145476664|NCT03068767|524596306|FG000|Overall Study|Lost to Follow-up|7|||
145632304|NCT01156116|525167745|FG000|Overall Study|Withdrawal by Subject|3|||
145632305|NCT01156116|525167746|FG001|Overall Study|Withdrawal by Subject|1|||
145632306|NCT01156116|525167745|FG000|Overall Study|CPAP intolerance|2|||
145632307|NCT01156116|525167746|FG001|Overall Study|CPAP intolerance|0|||
145632308|NCT01591616|525167748|FG000|Overall Study|Withdrawal by Subject|1|||
145632309|NCT01959412|525167749|FG000|Overall Study|Protocol deviation|1|||
145632310|NCT01959412|525167750|FG001|Overall Study|Protocol deviation|1|||
145632311|NCT01959412|525167751|FG002|Overall Study|Protocol deviation|0|||
145632312|NCT01959412|525167752|FG003|Overall Study|Protocol deviation|1|||
145632313|NCT01959412|525167753|FG004|Overall Study|Protocol deviation|3|||
145632314|NCT01959412|525167754|FG005|Overall Study|Protocol deviation|0|||
145632315|NCT01959412|525167749|FG000|Overall Study|Adverse Event|0|||
145632316|NCT01959412|525167750|FG001|Overall Study|Adverse Event|0|||
145632317|NCT01959412|525167751|FG002|Overall Study|Adverse Event|0|||
145632318|NCT01959412|525167752|FG003|Overall Study|Adverse Event|1|||
145632319|NCT01959412|525167753|FG004|Overall Study|Adverse Event|0|||
145632320|NCT01959412|525167754|FG005|Overall Study|Adverse Event|0|||
145632321|NCT01186848|525167755|FG000|Overall Study|Lost to Follow-up|4|||
145632322|NCT01186848|525167755|FG000|Overall Study|Withdrawal by Subject|2|||
145632323|NCT01186848|525167755|FG000|Overall Study|Adverse Event|2|||
145632324|NCT00158054|525167757|FG000|Overall Study|Refused to continue|3|||
145632325|NCT00158054|525167758|FG001|Overall Study|Refused to continue|0|||
145632326|NCT00158054|525167757|FG000|Overall Study|Unavailable for follow up|7|||
145632327|NCT00158054|525167758|FG001|Overall Study|Unavailable for follow up|3|||
145632328|NCT00509769|525167764|FG000|Overall Study|Progressive disease|77|||
145632329|NCT00509769|525167764|FG000|Overall Study|Adverse Event|4|||
145632330|NCT00509769|525167764|FG000|Overall Study|Patient's decision|1|||
145632331|NCT00509769|525167764|FG000|Overall Study|Physician Decision|8|||
145632332|NCT00509769|525167764|FG000|Overall Study|Use of prohibited therapies during study|1|||
145632333|NCT04567888|525167765|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
145632334|NCT04567888|525167766|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
145632335|NCT04567888|525167765|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
145632336|NCT04567888|525167766|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
145632337|NCT04567888|525167765|FG000|Overall Study|Reported Unusual Birth Year|2|||
145632338|NCT04567888|525167766|FG001|Overall Study|Reported Unusual Birth Year|3|||
145632339|NCT04567888|525167765|FG000|Overall Study|Duplicate Responses|0|||
145632340|NCT04567888|525167766|FG001|Overall Study|Duplicate Responses|1|||
145632341|NCT00414648|525167767|FG000|Overall Study|Adverse Event|5|||
145632342|NCT00414648|525167768|FG001|Overall Study|Adverse Event|5|||
145632343|NCT00414648|525167767|FG000|Overall Study|Death|0|||
145632344|NCT00414648|525167768|FG001|Overall Study|Death|1|||
145632345|NCT00414648|525167767|FG000|Overall Study|Lack of Efficacy|0|||
145632346|NCT00414648|525167768|FG001|Overall Study|Lack of Efficacy|2|||
145632347|NCT00414648|525167767|FG000|Overall Study|Withdrawal by Subject|0|||
145632348|NCT00414648|525167768|FG001|Overall Study|Withdrawal by Subject|1|||
145632349|NCT01194258|525167769|FG000|Titration Period|Withdrawal by Subject|6|||
145632350|NCT01194258|525167770|FG001|Titration Period|Withdrawal by Subject|0|||
145632351|NCT01194258|525167771|FG002|Titration Period|Withdrawal by Subject|0|||
145632352|NCT01194258|525167772|FG003|Titration Period|Withdrawal by Subject|0|||
145632353|NCT01194258|525167773|FG004|Titration Period|Withdrawal by Subject|0|||
145632354|NCT01194258|525167769|FG000|Titration Period|Lost to Follow-up|2|||
145632355|NCT01194258|525167770|FG001|Titration Period|Lost to Follow-up|0|||
145632356|NCT01194258|525167771|FG002|Titration Period|Lost to Follow-up|0|||
145632357|NCT01194258|525167772|FG003|Titration Period|Lost to Follow-up|0|||
145632358|NCT01194258|525167773|FG004|Titration Period|Lost to Follow-up|0|||
145476665|NCT03068767|524596307|FG001|Overall Study|Lost to Follow-up|3|||
145632359|NCT01194258|525167769|FG000|Titration Period|Titration failure|3|||
145632360|NCT01194258|525167770|FG001|Titration Period|Titration failure|0|||
145632361|NCT01194258|525167771|FG002|Titration Period|Titration failure|0|||
145632362|NCT01194258|525167772|FG003|Titration Period|Titration failure|0|||
145632363|NCT01194258|525167773|FG004|Titration Period|Titration failure|0|||
145632364|NCT01194258|525167769|FG000|Period 1 (12 Weeks)|Death|0|||
145632365|NCT01194258|525167770|FG001|Period 1 (12 Weeks)|Death|0|||
145632366|NCT01194258|525167771|FG002|Period 1 (12 Weeks)|Death|0|||
145632367|NCT01194258|525167772|FG003|Period 1 (12 Weeks)|Death|0|||
145632368|NCT01194258|525167773|FG004|Period 1 (12 Weeks)|Death|1|||
145632369|NCT01194258|525167769|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145632370|NCT01194258|525167770|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145632371|NCT01194258|525167771|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145632372|NCT01194258|525167772|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
145632373|NCT01194258|525167773|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
145632374|NCT01194258|525167769|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
145632375|NCT01194258|525167770|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
145632376|NCT01194258|525167771|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
145632377|NCT01194258|525167772|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
145632378|NCT01194258|525167773|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
145632379|NCT01194258|525167769|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145632380|NCT01194258|525167770|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145632381|NCT01194258|525167771|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
145632382|NCT01194258|525167772|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145632383|NCT01194258|525167773|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
145632384|NCT00619645|525167774|FG000|Overall Study|Adverse Event|1|||
145632385|NCT01490580|525167776|FG000|Overall Study|Parents withdrew consent|0|||
145632386|NCT01490580|525167777|FG001|Overall Study|Parents withdrew consent|2|||
145632387|NCT02026258|525167780|FG000|Randomized|Did not start treatment|2|||
145632388|NCT02026258|525167781|FG001|Randomized|Did not start treatment|1|||
145632389|NCT02026258|525167780|FG000|Randomized|Change in treatment plan|1|||
145632390|NCT02026258|525167781|FG001|Randomized|Change in treatment plan|0|||
145632391|NCT02026258|525167780|FG000|Randomized|Presence of periodontal disease|1|||
145632392|NCT02026258|525167781|FG001|Randomized|Presence of periodontal disease|1|||
145632393|NCT02026258|525167780|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
145632394|NCT02026258|525167781|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
145632395|NCT02026258|525167780|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
145632396|NCT02026258|525167781|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
145632397|NCT00383188|525167782|FG000|Overall Study|Adverse Event|4|||
145632398|NCT00383188|525167783|FG001|Overall Study|Adverse Event|7|||
145632399|NCT00383188|525167784|FG002|Overall Study|Adverse Event|9|||
145632400|NCT00383188|525167785|FG003|Overall Study|Adverse Event|8|||
145632401|NCT00383188|525167786|FG004|Overall Study|Adverse Event|8|||
145632402|NCT00383188|525167782|FG000|Overall Study|Lack of Efficacy|9|||
145632403|NCT00383188|525167783|FG001|Overall Study|Lack of Efficacy|3|||
145632404|NCT00383188|525167784|FG002|Overall Study|Lack of Efficacy|3|||
145632405|NCT00383188|525167785|FG003|Overall Study|Lack of Efficacy|2|||
145632406|NCT00383188|525167786|FG004|Overall Study|Lack of Efficacy|6|||
145632407|NCT00383188|525167782|FG000|Overall Study|Other|3|||
145632408|NCT00383188|525167783|FG001|Overall Study|Other|1|||
145632409|NCT00383188|525167784|FG002|Overall Study|Other|0|||
145632410|NCT00383188|525167785|FG003|Overall Study|Other|2|||
145632411|NCT00383188|525167786|FG004|Overall Study|Other|6|||
145632412|NCT00383188|525167782|FG000|Overall Study|No longer willing to participate|1|||
145632413|NCT00383188|525167783|FG001|Overall Study|No longer willing to participate|0|||
145632414|NCT00383188|525167784|FG002|Overall Study|No longer willing to participate|1|||
145632415|NCT00383188|525167785|FG003|Overall Study|No longer willing to participate|0|||
145632416|NCT00383188|525167786|FG004|Overall Study|No longer willing to participate|2|||
145632417|NCT00383188|525167782|FG000|Overall Study|Lost to Follow-up|0|||
145632418|NCT00383188|525167783|FG001|Overall Study|Lost to Follow-up|0|||
145632419|NCT00383188|525167784|FG002|Overall Study|Lost to Follow-up|0|||
145632420|NCT00383188|525167785|FG003|Overall Study|Lost to Follow-up|0|||
145632421|NCT00383188|525167786|FG004|Overall Study|Lost to Follow-up|1|||
145632422|NCT02873754|525167787|FG000|Overall Study|Lost to Follow-up|5|||
145632423|NCT02873754|525167787|FG000|Overall Study|Couldn't complete study procedures|1|||
145632424|NCT00597519|525167788|FG000|Overall Study|Death|1|||
145632425|NCT04246762|525167789|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
145632426|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
145632427|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
145632428|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
145632429|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
145632430|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
145632431|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
145632432|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
145632433|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
145632434|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
145632435|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
145632436|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
145632437|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
145632438|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Death|7|||
145632439|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Death|4|||
145632440|NCT00410124|525167790|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
145632441|NCT00410124|525167791|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
145632442|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
145632443|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
145632444|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
145632445|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
145632446|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
145632447|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
145632448|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
145632449|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
145632450|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
145632451|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
145632452|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
145632453|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
145632454|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
145632455|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
145632456|NCT00410124|525167790|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
145632457|NCT00410124|525167791|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
145632458|NCT03098030|525167794|FG000|Overall Study|Death|10|||
145632459|NCT03098030|525167795|FG001|Overall Study|Death|156|||
145632460|NCT03098030|525167796|FG002|Overall Study|Death|156|||
145632461|NCT03098030|525167797|FG003|Overall Study|Death|82|||
145632462|NCT03098030|525167794|FG000|Overall Study|Withdrawal by Subject|0|||
145632463|NCT03098030|525167795|FG001|Overall Study|Withdrawal by Subject|7|||
145632464|NCT03098030|525167796|FG002|Overall Study|Withdrawal by Subject|8|||
145632465|NCT03098030|525167797|FG003|Overall Study|Withdrawal by Subject|2|||
145632466|NCT03098030|525167794|FG000|Overall Study|Lost to Follow-up|0|||
145632467|NCT03098030|525167795|FG001|Overall Study|Lost to Follow-up|0|||
145632468|NCT03098030|525167796|FG002|Overall Study|Lost to Follow-up|2|||
145632469|NCT03098030|525167797|FG003|Overall Study|Lost to Follow-up|1|||
145632470|NCT03612804|525167798|FG000|Overall Study|Death|0|||
145632471|NCT03612804|525167799|FG001|Overall Study|Death|7|||
145632472|NCT03612804|525167800|FG002|Overall Study|Death|0|||
145632473|NCT03612804|525167801|FG003|Overall Study|Death|8|||
145632474|NCT03612804|525167798|FG000|Overall Study|Medication copay coverage issues|0|||
145632475|NCT03612804|525167799|FG001|Overall Study|Medication copay coverage issues|0|||
145632476|NCT03612804|525167800|FG002|Overall Study|Medication copay coverage issues|0|||
145632477|NCT03612804|525167801|FG003|Overall Study|Medication copay coverage issues|17|||
145632478|NCT03612804|525167798|FG000|Overall Study|Not current smoker at time of screening|0|||
145632479|NCT03612804|525167799|FG001|Overall Study|Not current smoker at time of screening|1|||
145632480|NCT03612804|525167800|FG002|Overall Study|Not current smoker at time of screening|0|||
145632481|NCT03612804|525167801|FG003|Overall Study|Not current smoker at time of screening|3|||
145632482|NCT03612804|525167798|FG000|Overall Study|Non-veteran status|0|||
145632483|NCT03612804|525167799|FG001|Overall Study|Non-veteran status|1|||
145632484|NCT03612804|525167800|FG002|Overall Study|Non-veteran status|0|||
145632485|NCT03612804|525167801|FG003|Overall Study|Non-veteran status|0|||
145632486|NCT03612804|525167798|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
145632487|NCT03612804|525167799|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
145632488|NCT03612804|525167800|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
145632489|NCT03612804|525167801|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
145632490|NCT03612804|525167798|FG000|Overall Study|Provider retired from VA|0|||
145632491|NCT03612804|525167799|FG001|Overall Study|Provider retired from VA|0|||
145632492|NCT03612804|525167800|FG002|Overall Study|Provider retired from VA|2|||
145632493|NCT03612804|525167801|FG003|Overall Study|Provider retired from VA|0|||
145632494|NCT03612804|525167798|FG000|Overall Study|Withdrawal by Subject|0|||
145632495|NCT03612804|525167799|FG001|Overall Study|Withdrawal by Subject|0|||
145632496|NCT03612804|525167800|FG002|Overall Study|Withdrawal by Subject|7|||
145632497|NCT03612804|525167801|FG003|Overall Study|Withdrawal by Subject|0|||
145632498|NCT03612804|525167798|FG000|Overall Study|Provider involved with study activities|1|||
145632499|NCT03612804|525167799|FG001|Overall Study|Provider involved with study activities|0|||
145632500|NCT03612804|525167800|FG002|Overall Study|Provider involved with study activities|0|||
145632501|NCT03612804|525167801|FG003|Overall Study|Provider involved with study activities|0|||
145632502|NCT04391309|525167802|FG000|Overall Study|Death|1|||
145632503|NCT04391309|525167803|FG001|Overall Study|Death|1|||
145632504|NCT04391309|525167802|FG000|Overall Study|Lost to Follow-up|3|||
145632505|NCT04391309|525167803|FG001|Overall Study|Lost to Follow-up|2|||
145632506|NCT04391309|525167802|FG000|Overall Study|Withdrawal by Subject|2|||
145632507|NCT04391309|525167803|FG001|Overall Study|Withdrawal by Subject|2|||
145632508|NCT03396913|525167804|FG000|Overall Study|Lost to Follow-up|0|||
145632509|NCT03396913|525167805|FG001|Overall Study|Lost to Follow-up|6|||
145632510|NCT05826431|525167807|FG000|Overall Study|Withdrawal by Subject|1|||
145632511|NCT02357784|525167808|FG000|Overall Study|Withdrawal by Subject|1|||
145632512|NCT01751724|525167809|FG000|Overall Study|extubated bef.start assigned treatment|1|||
145632513|NCT01751724|525167810|FG001|Overall Study|extubated bef.start assigned treatment|0|||
145632514|NCT01751724|525167809|FG000|Overall Study|withdrawn by parent|0|||
145632515|NCT01751724|525167810|FG001|Overall Study|withdrawn by parent|2|||
145632516|NCT03354390|525167811|FG000|Level 1|Death|2|||
145632517|NCT03354390|525167812|FG001|Level 1|Death|0|||
145632518|NCT03354390|525167813|FG002|Level 1|Death|0|||
145632519|NCT03354390|525167814|FG003|Level 1|Death|0|||
145632520|NCT03354390|525167811|FG000|Level 1|Physician Decision|1|||
145632521|NCT03354390|525167812|FG001|Level 1|Physician Decision|0|||
145632522|NCT03354390|525167813|FG002|Level 1|Physician Decision|0|||
145632523|NCT03354390|525167814|FG003|Level 1|Physician Decision|0|||
145632524|NCT03354390|525167811|FG000|Level 2|Physician Decision|0|||
145632525|NCT03354390|525167812|FG001|Level 2|Physician Decision|2|||
145632526|NCT03354390|525167813|FG002|Level 2|Physician Decision|0|||
145632527|NCT03354390|525167814|FG003|Level 2|Physician Decision|0|||
145632528|NCT03354390|525167811|FG000|Level 2|Lack of Efficacy|0|||
145632529|NCT03354390|525167812|FG001|Level 2|Lack of Efficacy|1|||
145632530|NCT03354390|525167813|FG002|Level 2|Lack of Efficacy|0|||
145632531|NCT03354390|525167814|FG003|Level 2|Lack of Efficacy|0|||
145632532|NCT03354390|525167811|FG000|Level 2|Lost to Follow-up|0|||
145632533|NCT03354390|525167812|FG001|Level 2|Lost to Follow-up|1|||
145632534|NCT03354390|525167813|FG002|Level 2|Lost to Follow-up|0|||
145632535|NCT03354390|525167814|FG003|Level 2|Lost to Follow-up|0|||
145632536|NCT03354390|525167811|FG000|Level 3|Death|0|||
145632537|NCT03354390|525167812|FG001|Level 3|Death|0|||
145632538|NCT03354390|525167813|FG002|Level 3|Death|1|||
145632539|NCT03354390|525167814|FG003|Level 3|Death|0|||
145632540|NCT03354390|525167811|FG000|Level 3|Physician Decision|0|||
145632541|NCT03354390|525167812|FG001|Level 3|Physician Decision|0|||
145632542|NCT03354390|525167813|FG002|Level 3|Physician Decision|2|||
145632543|NCT03354390|525167814|FG003|Level 3|Physician Decision|0|||
145632544|NCT03354390|525167811|FG000|Level 4|Death|0|||
145632545|NCT03354390|525167812|FG001|Level 4|Death|0|||
145632546|NCT03354390|525167813|FG002|Level 4|Death|0|||
145632547|NCT03354390|525167814|FG003|Level 4|Death|3|||
145632548|NCT00864682|525169089|FG000|Overall Study|Protocol Violation|2|||
145632549|NCT00864682|525169090|FG001|Overall Study|Protocol Violation|1|||
145632550|NCT00864682|525169091|FG002|Overall Study|Protocol Violation|2|||
145632551|NCT01585038|525169092|FG000|Overall Study|Adverse Event|2|||
145632552|NCT01585038|525169093|FG001|Overall Study|Adverse Event|2|||
145632553|NCT01833832|525169099|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
145632554|NCT04842604|525169100|FG000|Overall Study|Death|1|||
145632555|NCT04842604|525169101|FG001|Overall Study|Death|0|||
145632556|NCT04842604|525169100|FG000|Overall Study|Other|4|||
145632557|NCT04842604|525169101|FG001|Overall Study|Other|4|||
145632558|NCT04842604|525169100|FG000|Overall Study|Randomized but not treated|1|||
145632559|NCT04842604|525169101|FG001|Overall Study|Randomized but not treated|0|||
145632560|NCT00344019|525169103|FG000|Overall Study|did not meet final inclusion criteria|0|||
145632561|NCT00344019|525169104|FG001|Overall Study|did not meet final inclusion criteria|0|||
145632562|NCT00344019|525169105|FG002|Overall Study|did not meet final inclusion criteria|74|||
145632563|NCT02503202|525169106|FG000|Base Study: Up to Month 6|Death|1|||
145632564|NCT02503202|525169107|FG001|Base Study: Up to Month 6|Death|1|||
145632565|NCT02503202|525169108|FG002|Base Study: Up to Month 6|Death|0|||
145632566|NCT02503202|525169109|FG003|Base Study: Up to Month 6|Death|0|||
145632567|NCT02503202|525169110|FG004|Base Study: Up to Month 6|Death|0|||
145632568|NCT02503202|525169106|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
145632569|NCT02503202|525169107|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
145632570|NCT02503202|525169108|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
145632571|NCT02503202|525169109|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
145632572|NCT02503202|525169110|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
145632573|NCT02503202|525169106|FG000|Base Study: Up to Month 6|Physician Decision|0|||
145632574|NCT02503202|525169107|FG001|Base Study: Up to Month 6|Physician Decision|0|||
145632575|NCT02503202|525169108|FG002|Base Study: Up to Month 6|Physician Decision|0|||
145632576|NCT02503202|525169109|FG003|Base Study: Up to Month 6|Physician Decision|0|||
145632577|NCT02503202|525169110|FG004|Base Study: Up to Month 6|Physician Decision|1|||
145632578|NCT02503202|525169106|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
145632579|NCT02503202|525169107|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
145632580|NCT02503202|525169108|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
145632581|NCT02503202|525169109|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
145632582|NCT02503202|525169110|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
145632583|NCT02503202|525169106|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
145632584|NCT02503202|525169107|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
145632585|NCT02503202|525169108|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
145632586|NCT02503202|525169109|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
145632587|NCT02503202|525169110|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
145632588|NCT02503202|525169106|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
145632589|NCT02503202|525169107|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
145632590|NCT02503202|525169108|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
145632591|NCT02503202|525169109|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
145632592|NCT02503202|525169110|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
145632593|NCT02503202|525169106|FG000|Extension: Month 6 to 24|Death|1|||
145632594|NCT02503202|525169107|FG001|Extension: Month 6 to 24|Death|0|||
145632595|NCT02503202|525169108|FG002|Extension: Month 6 to 24|Death|0|||
145632596|NCT02503202|525169109|FG003|Extension: Month 6 to 24|Death|0|||
145632597|NCT02503202|525169110|FG004|Extension: Month 6 to 24|Death|0|||
145632598|NCT02503202|525169106|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
145632599|NCT02503202|525169107|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
145632600|NCT02503202|525169108|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
145632601|NCT02503202|525169109|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
145632602|NCT02503202|525169110|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
145632603|NCT02503202|525169106|FG000|Extension: Month 6 to 24|Physician Decision|1|||
145632604|NCT02503202|525169107|FG001|Extension: Month 6 to 24|Physician Decision|0|||
145632605|NCT02503202|525169108|FG002|Extension: Month 6 to 24|Physician Decision|1|||
145632606|NCT02503202|525169109|FG003|Extension: Month 6 to 24|Physician Decision|3|||
145632607|NCT02503202|525169110|FG004|Extension: Month 6 to 24|Physician Decision|0|||
145632608|NCT02503202|525169106|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
145632609|NCT02503202|525169107|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
145632610|NCT02503202|525169108|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
145632611|NCT02503202|525169109|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
145632612|NCT02503202|525169110|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
145476666|NCT03068767|524596306|FG000|Overall Study|Protocol Violation|3|||
145632613|NCT00130637|525169113|FG000|Overall Study|Adverse Event|2|||
145632614|NCT00130637|525169113|FG000|Overall Study|Withdrawal by Subject|1|||
145632615|NCT01191788|525169114|FG000|Overall Study|Lost to Follow-up|21|||
145632616|NCT01191788|525169115|FG001|Overall Study|Lost to Follow-up|22|||
145632617|NCT00217672|525169119|FG000|Allocation|Ineligible|2|||
145632618|NCT00217672|525169120|FG001|Allocation|Ineligible|0|||
145632619|NCT00217672|525169119|FG000|Treatment|disease progression|33|||
145632620|NCT00217672|525169120|FG001|Treatment|disease progression|4|||
145632621|NCT00217672|525169119|FG000|Treatment|Adverse Event|18|||
145632622|NCT00217672|525169120|FG001|Treatment|Adverse Event|2|||
145632623|NCT00217672|525169119|FG000|Treatment|reqd treatment not permitted by protocol|6|||
145632624|NCT00217672|525169120|FG001|Treatment|reqd treatment not permitted by protocol|0|||
145632625|NCT00217672|525169119|FG000|Treatment|Physician Decision|6|||
145632626|NCT00217672|525169120|FG001|Treatment|Physician Decision|0|||
145632627|NCT00217672|525169119|FG000|Treatment|insurance issues|1|||
145632628|NCT00217672|525169120|FG001|Treatment|insurance issues|1|||
145632629|NCT00217672|525169119|FG000|Treatment|Death|2|||
145632630|NCT00217672|525169120|FG001|Treatment|Death|0|||
145632631|NCT00217672|525169119|FG000|Treatment|secondary malignancy|1|||
145632632|NCT00217672|525169120|FG001|Treatment|secondary malignancy|0|||
145632633|NCT00217672|525169119|FG000|Follow-up|Withdrawal by Subject|4|||
145632634|NCT00217672|525169120|FG001|Follow-up|Withdrawal by Subject|0|||
145632635|NCT00217672|525169119|FG000|Follow-up|Lost to Follow-up|1|||
145632636|NCT00217672|525169120|FG001|Follow-up|Lost to Follow-up|0|||
145632637|NCT00436644|525169131|FG000|Overall Study|Adverse Event|2|||
145632638|NCT00436644|525169131|FG000|Overall Study|Death|1|||
145632639|NCT04364269|525169132|FG000|Overall Study|Adverse Event|1|||
145632640|NCT04364269|525169133|FG001|Overall Study|Adverse Event|0|||
145632641|NCT04364269|525169134|FG002|Overall Study|Adverse Event|0|||
145632642|NCT04364269|525169132|FG000|Overall Study|Withdrawal by Subject|0|||
145632643|NCT04364269|525169133|FG001|Overall Study|Withdrawal by Subject|1|||
145632644|NCT04364269|525169134|FG002|Overall Study|Withdrawal by Subject|0|||
145632645|NCT00878722|525169135|FG000|Overall Study|Progressive disease|3|||
145632646|NCT00878722|525169136|FG001|Overall Study|Progressive disease|3|||
145632647|NCT00878722|525169137|FG002|Overall Study|Progressive disease|3|||
145632648|NCT00878722|525169138|FG003|Overall Study|Progressive disease|7|||
145632649|NCT00878722|525169139|FG004|Overall Study|Progressive disease|7|||
145632650|NCT00878722|525169140|FG005|Overall Study|Progressive disease|1|||
145632651|NCT00878722|525169141|FG006|Overall Study|Progressive disease|4|||
145632652|NCT00878722|525169142|FG007|Overall Study|Progressive disease|3|||
145632653|NCT00878722|525169135|FG000|Overall Study|Death|0|||
145632654|NCT00878722|525169136|FG001|Overall Study|Death|0|||
145632655|NCT00878722|525169137|FG002|Overall Study|Death|0|||
145632656|NCT00878722|525169138|FG003|Overall Study|Death|1|||
145632657|NCT00878722|525169139|FG004|Overall Study|Death|0|||
145632658|NCT00878722|525169140|FG005|Overall Study|Death|1|||
145632659|NCT00878722|525169141|FG006|Overall Study|Death|0|||
145632660|NCT00878722|525169142|FG007|Overall Study|Death|2|||
145632661|NCT00878722|525169135|FG000|Overall Study|Adverse Event|0|||
145632662|NCT00878722|525169136|FG001|Overall Study|Adverse Event|0|||
145632663|NCT00878722|525169137|FG002|Overall Study|Adverse Event|0|||
145632664|NCT00878722|525169138|FG003|Overall Study|Adverse Event|0|||
145632665|NCT00878722|525169139|FG004|Overall Study|Adverse Event|0|||
145632666|NCT00878722|525169140|FG005|Overall Study|Adverse Event|0|||
145632667|NCT00878722|525169141|FG006|Overall Study|Adverse Event|2|||
145632668|NCT00878722|525169142|FG007|Overall Study|Adverse Event|0|||
145632669|NCT00878722|525169135|FG000|Overall Study|Withdrawal by Subject|0|||
145632670|NCT00878722|525169136|FG001|Overall Study|Withdrawal by Subject|0|||
145476667|NCT03068767|524596307|FG001|Overall Study|Protocol Violation|0|||
145476668|NCT00061633|524596308|FG000|Overall Study|Adverse Event|1|||
145632671|NCT00878722|525169137|FG002|Overall Study|Withdrawal by Subject|0|||
145476669|NCT00061633|524596309|FG001|Overall Study|Adverse Event|2|||
145476670|NCT00061633|524596308|FG000|Overall Study|Withdrawal by Subject|2|||
145476671|NCT00061633|524596309|FG001|Overall Study|Withdrawal by Subject|2|||
145632672|NCT00878722|525169138|FG003|Overall Study|Withdrawal by Subject|0|||
145632673|NCT00878722|525169139|FG004|Overall Study|Withdrawal by Subject|0|||
145632674|NCT00878722|525169140|FG005|Overall Study|Withdrawal by Subject|0|||
145632675|NCT00878722|525169141|FG006|Overall Study|Withdrawal by Subject|0|||
145632676|NCT00878722|525169142|FG007|Overall Study|Withdrawal by Subject|2|||
145632677|NCT00878722|525169135|FG000|Overall Study|Relapse|0|||
145632678|NCT00878722|525169136|FG001|Overall Study|Relapse|0|||
145632679|NCT00878722|525169137|FG002|Overall Study|Relapse|0|||
145632680|NCT00878722|525169138|FG003|Overall Study|Relapse|1|||
145632681|NCT00878722|525169139|FG004|Overall Study|Relapse|0|||
145632682|NCT00878722|525169140|FG005|Overall Study|Relapse|0|||
145632683|NCT00878722|525169141|FG006|Overall Study|Relapse|0|||
145632684|NCT00878722|525169142|FG007|Overall Study|Relapse|0|||
145632685|NCT00972504|525169143|FG000|Overall Study|Adverse Event|2|||
145632686|NCT00972504|525169143|FG000|Overall Study|Investigator discretion|1|||
145632687|NCT02878330|525169144|FG000|Overall Study|Death|3|||
145632688|NCT02878330|525169145|FG001|Overall Study|Death|2|||
145632689|NCT02878330|525169144|FG000|Overall Study|Lost to Follow-up|11|||
145632690|NCT02878330|525169145|FG001|Overall Study|Lost to Follow-up|26|||
145632691|NCT02878330|525169144|FG000|Overall Study|Withdrawal by Subject|11|||
145632692|NCT02878330|525169145|FG001|Overall Study|Withdrawal by Subject|21|||
145632693|NCT02878330|525169144|FG000|Overall Study|Other|4|||
145632694|NCT02878330|525169145|FG001|Overall Study|Other|7|||
145632695|NCT00082810|525169150|FG000|Overall Study|Adverse Event|3|||
145632696|NCT00082810|525169150|FG000|Overall Study|Progressive disease|24|||
145632697|NCT00082810|525169150|FG000|Overall Study|Withdrawal by Subject|4|||
145632698|NCT01321606|525169156|FG000|Overall Study|Lost to Follow-up|0|||
145632699|NCT01321606|525169157|FG001|Overall Study|Lost to Follow-up|0|||
145632700|NCT01321606|525169158|FG002|Overall Study|Lost to Follow-up|0|||
145632701|NCT01321606|525169159|FG003|Overall Study|Lost to Follow-up|1|||
145632702|NCT02341625|525169167|FG000|Overall Study|Disease Progression|2|||
145632703|NCT02341625|525169168|FG001|Overall Study|Disease Progression|2|||
145632704|NCT02341625|525169169|FG002|Overall Study|Disease Progression|3|||
145632705|NCT02341625|525169170|FG003|Overall Study|Disease Progression|6|||
145632706|NCT02341625|525169171|FG004|Overall Study|Disease Progression|7|||
145632707|NCT02341625|525169172|FG005|Overall Study|Disease Progression|7|||
145632708|NCT02341625|525169173|FG006|Overall Study|Disease Progression|28|||
145632709|NCT02341625|525169174|FG007|Overall Study|Disease Progression|5|||
145632710|NCT02341625|525169175|FG008|Overall Study|Disease Progression|4|||
145632711|NCT02341625|525169176|FG009|Overall Study|Disease Progression|19|||
145632712|NCT02341625|525169167|FG000|Overall Study|Study Drug Toxicity|0|||
145632713|NCT02341625|525169168|FG001|Overall Study|Study Drug Toxicity|0|||
145632714|NCT02341625|525169169|FG002|Overall Study|Study Drug Toxicity|0|||
145632715|NCT02341625|525169170|FG003|Overall Study|Study Drug Toxicity|1|||
145632716|NCT02341625|525169171|FG004|Overall Study|Study Drug Toxicity|0|||
145632717|NCT02341625|525169172|FG005|Overall Study|Study Drug Toxicity|3|||
145632718|NCT02341625|525169173|FG006|Overall Study|Study Drug Toxicity|10|||
145632719|NCT02341625|525169174|FG007|Overall Study|Study Drug Toxicity|0|||
145632720|NCT02341625|525169175|FG008|Overall Study|Study Drug Toxicity|0|||
145632721|NCT02341625|525169176|FG009|Overall Study|Study Drug Toxicity|3|||
145632722|NCT02341625|525169167|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632723|NCT02341625|525169168|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632724|NCT02341625|525169169|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632725|NCT02341625|525169170|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632726|NCT02341625|525169171|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632727|NCT02341625|525169172|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632728|NCT02341625|525169173|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
145632729|NCT02341625|525169174|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
145632730|NCT02341625|525169175|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
145632731|NCT02341625|525169176|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
145632732|NCT02341625|525169167|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632733|NCT02341625|525169168|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632734|NCT02341625|525169169|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632735|NCT02341625|525169170|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632736|NCT02341625|525169171|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632737|NCT02341625|525169172|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632738|NCT02341625|525169173|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
145632739|NCT02341625|525169174|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
145632740|NCT02341625|525169175|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632741|NCT02341625|525169176|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
145632742|NCT02341625|525169167|FG000|Overall Study|Participant Withdrew Consent|0|||
145632743|NCT02341625|525169168|FG001|Overall Study|Participant Withdrew Consent|0|||
145632744|NCT02341625|525169169|FG002|Overall Study|Participant Withdrew Consent|0|||
145632745|NCT02341625|525169170|FG003|Overall Study|Participant Withdrew Consent|1|||
145632746|NCT02341625|525169171|FG004|Overall Study|Participant Withdrew Consent|0|||
145632747|NCT02341625|525169172|FG005|Overall Study|Participant Withdrew Consent|0|||
145632748|NCT02341625|525169173|FG006|Overall Study|Participant Withdrew Consent|0|||
145632749|NCT02341625|525169174|FG007|Overall Study|Participant Withdrew Consent|0|||
145632750|NCT02341625|525169175|FG008|Overall Study|Participant Withdrew Consent|0|||
145476672|NCT00061633|524596308|FG000|Overall Study|Lost to Follow-up|1|||
145632751|NCT02341625|525169176|FG009|Overall Study|Participant Withdrew Consent|0|||
145632752|NCT02341625|525169167|FG000|Overall Study|Completed Treatment as per Protocol|0|||
145632753|NCT02341625|525169168|FG001|Overall Study|Completed Treatment as per Protocol|0|||
145476673|NCT00061633|524596309|FG001|Overall Study|Lost to Follow-up|4|||
145632754|NCT02341625|525169169|FG002|Overall Study|Completed Treatment as per Protocol|0|||
145632755|NCT02341625|525169170|FG003|Overall Study|Completed Treatment as per Protocol|0|||
145632756|NCT02341625|525169171|FG004|Overall Study|Completed Treatment as per Protocol|0|||
145632757|NCT02341625|525169172|FG005|Overall Study|Completed Treatment as per Protocol|0|||
145632758|NCT02341625|525169173|FG006|Overall Study|Completed Treatment as per Protocol|0|||
145632759|NCT02341625|525169174|FG007|Overall Study|Completed Treatment as per Protocol|0|||
145632760|NCT02341625|525169175|FG008|Overall Study|Completed Treatment as per Protocol|0|||
145632761|NCT02341625|525169176|FG009|Overall Study|Completed Treatment as per Protocol|1|||
145632762|NCT02341625|525169167|FG000|Overall Study|Other Reasons|0|||
145632763|NCT02341625|525169168|FG001|Overall Study|Other Reasons|0|||
145632764|NCT02341625|525169169|FG002|Overall Study|Other Reasons|0|||
145632765|NCT02341625|525169170|FG003|Overall Study|Other Reasons|0|||
145632766|NCT02341625|525169171|FG004|Overall Study|Other Reasons|1|||
145632767|NCT02341625|525169172|FG005|Overall Study|Other Reasons|0|||
145632768|NCT02341625|525169173|FG006|Overall Study|Other Reasons|5|||
145632769|NCT02341625|525169174|FG007|Overall Study|Other Reasons|0|||
145632770|NCT02341625|525169175|FG008|Overall Study|Other Reasons|0|||
145632771|NCT02341625|525169176|FG009|Overall Study|Other Reasons|2|||
145632772|NCT02341625|525169167|FG000|Overall Study|Not Reported|0|||
145632773|NCT02341625|525169168|FG001|Overall Study|Not Reported|0|||
145632774|NCT02341625|525169169|FG002|Overall Study|Not Reported|0|||
145632775|NCT02341625|525169170|FG003|Overall Study|Not Reported|0|||
145632776|NCT02341625|525169171|FG004|Overall Study|Not Reported|0|||
145632777|NCT02341625|525169172|FG005|Overall Study|Not Reported|0|||
145632778|NCT02341625|525169173|FG006|Overall Study|Not Reported|0|||
145632779|NCT02341625|525169174|FG007|Overall Study|Not Reported|0|||
145632780|NCT02341625|525169175|FG008|Overall Study|Not Reported|0|||
145632781|NCT02341625|525169176|FG009|Overall Study|Not Reported|3|||
145632782|NCT01839877|525169179|FG000|Overall Study|Protocol Violation|1|||
145476674|NCT00061633|524596308|FG000|Overall Study|Other|1|||
145476675|NCT00061633|524596309|FG001|Overall Study|Other|1|||
145476676|NCT00061633|524596308|FG000|Overall Study|Never received study treatment|0|||
145476677|NCT00061633|524596309|FG001|Overall Study|Never received study treatment|2|||
145476678|NCT00291018|524597861|FG000|Overall Study|Not Consented or Declined PAS|12|||
145476679|NCT00291018|524597862|FG001|Overall Study|Not Consented or Declined PAS|15|||
145476680|NCT00291018|524597863|FG002|Overall Study|Not Consented or Declined PAS|15|||
145476681|NCT00291018|524597861|FG000|Overall Study|Death|3|||
145632783|NCT03368001|525169182|FG000|Allocation|Lost to Pretest|16|||
145632784|NCT03368001|525169183|FG001|Allocation|Lost to Pretest|25|||
145632785|NCT03368001|525169182|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
145632786|NCT03368001|525169183|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
145632787|NCT03368001|525169182|FG000|Posttest|Lost to Posttest|7|||
145632788|NCT03368001|525169183|FG001|Posttest|Lost to Posttest|11|||
145632789|NCT03368001|525169182|FG000|Posttest|Discontinued Intervention|6|||
145632790|NCT03368001|525169183|FG001|Posttest|Discontinued Intervention|19|||
145632791|NCT03368001|525169182|FG000|Follow-up|Lost to Follow-up|6|||
145632792|NCT03368001|525169183|FG001|Follow-up|Lost to Follow-up|3|||
145632793|NCT05484726|525169184|FG000|Overall Study|Protocol Violation|3|||
145632794|NCT05484726|525169185|FG001|Overall Study|Protocol Violation|3|||
145632795|NCT05484726|525169184|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
145632796|NCT05484726|525169185|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
145632797|NCT05484726|525169184|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
145632798|NCT05484726|525169185|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
145632799|NCT05484726|525169184|FG000|Overall Study|continued need of mechanical ventilation|2|||
145632800|NCT05484726|525169185|FG001|Overall Study|continued need of mechanical ventilation|3|||
145632801|NCT05484726|525169184|FG000|Overall Study|Withdrawal by Subject|2|||
145632802|NCT05484726|525169185|FG001|Overall Study|Withdrawal by Subject|3|||
145632803|NCT05484726|525169184|FG000|Overall Study|IVH (G III & IV)|2|||
145632804|NCT05484726|525169185|FG001|Overall Study|IVH (G III & IV)|1|||
145632805|NCT05484726|525169184|FG000|Overall Study|NEC (stage II & III)|2|||
145632806|NCT05484726|525169185|FG001|Overall Study|NEC (stage II & III)|3|||
145632807|NCT02781584|525169186|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
145632808|NCT02781584|525169187|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
145632809|NCT02781584|525169188|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
145632810|NCT02781584|525169189|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
145632811|NCT02781584|525169190|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
145632812|NCT02781584|525169191|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
145632813|NCT02781584|525169192|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
145632814|NCT02781584|525169193|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
145632815|NCT02781584|525169194|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
145632816|NCT02781584|525169195|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
145632817|NCT02781584|525169196|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
145632818|NCT02781584|525169197|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
145632819|NCT02781584|525169198|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
145632820|NCT02781584|525169186|FG000|Pre-treatment Phase|Adverse Event|0|||
145632821|NCT02781584|525169187|FG001|Pre-treatment Phase|Adverse Event|0|||
145632822|NCT02781584|525169188|FG002|Pre-treatment Phase|Adverse Event|0|||
145632823|NCT02781584|525169189|FG003|Pre-treatment Phase|Adverse Event|0|||
145632824|NCT02781584|525169190|FG004|Pre-treatment Phase|Adverse Event|0|||
145632825|NCT02781584|525169191|FG005|Pre-treatment Phase|Adverse Event|0|||
145632826|NCT02781584|525169192|FG006|Pre-treatment Phase|Adverse Event|0|||
145632827|NCT02781584|525169193|FG007|Pre-treatment Phase|Adverse Event|0|||
145632828|NCT02781584|525169194|FG008|Pre-treatment Phase|Adverse Event|0|||
145632829|NCT02781584|525169195|FG009|Pre-treatment Phase|Adverse Event|0|||
145632830|NCT02781584|525169196|FG010|Pre-treatment Phase|Adverse Event|0|||
145632831|NCT02781584|525169197|FG011|Pre-treatment Phase|Adverse Event|1|||
145632832|NCT02781584|525169198|FG012|Pre-treatment Phase|Adverse Event|0|||
145632833|NCT02781584|525169186|FG000|Treatment Phase|Withdrew Consent|0|||
145632834|NCT02781584|525169187|FG001|Treatment Phase|Withdrew Consent|0|||
145632835|NCT02781584|525169188|FG002|Treatment Phase|Withdrew Consent|0|||
145632836|NCT02781584|525169189|FG003|Treatment Phase|Withdrew Consent|0|||
145632837|NCT02781584|525169190|FG004|Treatment Phase|Withdrew Consent|0|||
145632838|NCT02781584|525169191|FG005|Treatment Phase|Withdrew Consent|1|||
145632839|NCT02781584|525169192|FG006|Treatment Phase|Withdrew Consent|0|||
145632840|NCT02781584|525169193|FG007|Treatment Phase|Withdrew Consent|0|||
145632841|NCT02781584|525169194|FG008|Treatment Phase|Withdrew Consent|0|||
145632842|NCT02781584|525169195|FG009|Treatment Phase|Withdrew Consent|0|||
145632843|NCT02781584|525169196|FG010|Treatment Phase|Withdrew Consent|1|||
145632844|NCT02781584|525169197|FG011|Treatment Phase|Withdrew Consent|2|||
145632845|NCT02781584|525169198|FG012|Treatment Phase|Withdrew Consent|0|||
145632846|NCT02781584|525169186|FG000|Treatment Phase|Adverse Event|0|||
145632847|NCT02781584|525169187|FG001|Treatment Phase|Adverse Event|0|||
145632848|NCT02781584|525169188|FG002|Treatment Phase|Adverse Event|0|||
145632849|NCT02781584|525169189|FG003|Treatment Phase|Adverse Event|0|||
145632850|NCT02781584|525169190|FG004|Treatment Phase|Adverse Event|0|||
145632851|NCT02781584|525169191|FG005|Treatment Phase|Adverse Event|0|||
145632852|NCT02781584|525169192|FG006|Treatment Phase|Adverse Event|0|||
145632853|NCT02781584|525169193|FG007|Treatment Phase|Adverse Event|1|||
145632854|NCT02781584|525169194|FG008|Treatment Phase|Adverse Event|0|||
145632855|NCT02781584|525169195|FG009|Treatment Phase|Adverse Event|0|||
145632856|NCT02781584|525169196|FG010|Treatment Phase|Adverse Event|0|||
145632857|NCT02781584|525169197|FG011|Treatment Phase|Adverse Event|0|||
145632858|NCT02781584|525169198|FG012|Treatment Phase|Adverse Event|0|||
145632859|NCT04771273|525169201|FG000|Dose Escalation Period|Not treated with trial medication|0|||
145632860|NCT04771273|525169202|FG001|Dose Escalation Period|Not treated with trial medication|1|||
145632861|NCT04771273|525169203|FG002|Dose Escalation Period|Not treated with trial medication|1|||
145632862|NCT04771273|525169204|FG003|Dose Escalation Period|Not treated with trial medication|0|||
145632863|NCT04771273|525169201|FG000|Dose Escalation Period|Other reasons than listed|2|||
145632864|NCT04771273|525169202|FG001|Dose Escalation Period|Other reasons than listed|0|||
145632865|NCT04771273|525169203|FG002|Dose Escalation Period|Other reasons than listed|2|||
145632866|NCT04771273|525169204|FG003|Dose Escalation Period|Other reasons than listed|1|||
145632867|NCT04771273|525169201|FG000|Dose Escalation Period|Protocol Violation|0|||
145632868|NCT04771273|525169202|FG001|Dose Escalation Period|Protocol Violation|0|||
145632869|NCT04771273|525169203|FG002|Dose Escalation Period|Protocol Violation|3|||
145632870|NCT04771273|525169204|FG003|Dose Escalation Period|Protocol Violation|1|||
145632871|NCT04771273|525169201|FG000|Dose Escalation Period|Burden of study procedures|1|||
145632872|NCT04771273|525169202|FG001|Dose Escalation Period|Burden of study procedures|0|||
145632873|NCT04771273|525169203|FG002|Dose Escalation Period|Burden of study procedures|0|||
145632874|NCT04771273|525169204|FG003|Dose Escalation Period|Burden of study procedures|0|||
145632875|NCT04771273|525169201|FG000|Dose Escalation Period|Change of residence|0|||
145632876|NCT04771273|525169202|FG001|Dose Escalation Period|Change of residence|0|||
145632877|NCT04771273|525169203|FG002|Dose Escalation Period|Change of residence|0|||
145632878|NCT04771273|525169204|FG003|Dose Escalation Period|Change of residence|1|||
145632879|NCT04771273|525169201|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
145632880|NCT04771273|525169202|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
145632881|NCT04771273|525169203|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
145632882|NCT04771273|525169204|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
145632883|NCT04771273|525169201|FG000|Dose Escalation Period|Adverse Event|8|||
145632884|NCT04771273|525169202|FG001|Dose Escalation Period|Adverse Event|9|||
145632885|NCT04771273|525169203|FG002|Dose Escalation Period|Adverse Event|12|||
145632886|NCT04771273|525169204|FG003|Dose Escalation Period|Adverse Event|2|||
145632887|NCT04771273|525169201|FG000|Maintenance Period|Other than listed|4|||
145476682|NCT00291018|524597862|FG001|Overall Study|Death|3|||
145632888|NCT04771273|525169202|FG001|Maintenance Period|Other than listed|2|||
145632889|NCT04771273|525169203|FG002|Maintenance Period|Other than listed|0|||
145632890|NCT04771273|525169204|FG003|Maintenance Period|Other than listed|3|||
145632891|NCT04771273|525169201|FG000|Maintenance Period|Burden of study procedures|1|||
145476683|NCT00291018|524597863|FG002|Overall Study|Death|4|||
145632892|NCT04771273|525169202|FG001|Maintenance Period|Burden of study procedures|0|||
145632893|NCT04771273|525169203|FG002|Maintenance Period|Burden of study procedures|0|||
145476684|NCT00291018|524597861|FG000|Overall Study|Withdrawal by Subject|2|||
145632894|NCT04771273|525169204|FG003|Maintenance Period|Burden of study procedures|0|||
145632895|NCT04771273|525169201|FG000|Maintenance Period|Change of residence|0|||
145632896|NCT04771273|525169202|FG001|Maintenance Period|Change of residence|1|||
145632897|NCT04771273|525169203|FG002|Maintenance Period|Change of residence|3|||
145632898|NCT04771273|525169204|FG003|Maintenance Period|Change of residence|0|||
145632899|NCT04771273|525169201|FG000|Maintenance Period|Perceived lack of efficacy|0|||
145632900|NCT04771273|525169202|FG001|Maintenance Period|Perceived lack of efficacy|0|||
145632901|NCT04771273|525169203|FG002|Maintenance Period|Perceived lack of efficacy|0|||
145632902|NCT04771273|525169204|FG003|Maintenance Period|Perceived lack of efficacy|1|||
145632903|NCT04771273|525169201|FG000|Maintenance Period|Adverse Event|4|||
145632904|NCT04771273|525169202|FG001|Maintenance Period|Adverse Event|5|||
145632905|NCT04771273|525169203|FG002|Maintenance Period|Adverse Event|5|||
145632906|NCT04771273|525169204|FG003|Maintenance Period|Adverse Event|0|||
145632907|NCT04436120|525169208|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
145632908|NCT04436120|525169209|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
145632909|NCT04436120|525169210|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
145632910|NCT04436120|525169211|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
145632911|NCT04436120|525169212|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
145632912|NCT04436120|525169213|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
145632913|NCT04436120|525169214|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
145632914|NCT04222959|525169218|FG000|Overall Study|Lost to Follow-up|76|||
145632915|NCT04222959|525169219|FG001|Overall Study|Lost to Follow-up|28|||
145632916|NCT04776213|525169226|FG000|Overall Study|Other|1|||
145632917|NCT04776213|525169226|FG000|Overall Study|Withdrawal by Subject|7|||
145632918|NCT04776213|525169226|FG000|Overall Study|Protocol Violation|1|||
145632919|NCT04776213|525169226|FG000|Overall Study|Lost to Follow-up|2|||
145632920|NCT02289560|525169227|FG000|Overall Study|Lost to Follow-up|6|||
145632921|NCT02289560|525169227|FG000|Overall Study|Alternative Treatment|4|||
145632922|NCT02289560|525169227|FG000|Overall Study|Inadequate Treatment|2|||
145632923|NCT02289560|525169227|FG000|Overall Study|Withdrawal by Subject|23|||
145632924|NCT02540213|525169228|FG000|Overall Study|Death/adverse event|18|||
145632925|NCT02540213|525169228|FG000|Overall Study|Administrative reasons|3|||
145632926|NCT02540213|525169228|FG000|Overall Study|Kidney transplant|3|||
145632927|NCT02540213|525169228|FG000|Overall Study|Lack of Efficacy|6|||
145632928|NCT02540213|525169228|FG000|Overall Study|Consent withdrawn|7|||
145632929|NCT02540213|525169228|FG000|Overall Study|Enrolled but not treated|2|||
145632930|NCT01981356|525169236|FG000|Overall Study|Lost to Follow-up|4|||
145632931|NCT01981356|525169237|FG001|Overall Study|Lost to Follow-up|1|||
145632932|NCT01981356|525169236|FG000|Overall Study|Withdrawal by Subject|1|||
145632933|NCT01981356|525169237|FG001|Overall Study|Withdrawal by Subject|1|||
145632934|NCT01981356|525169236|FG000|Overall Study|Protocol Violation|2|||
145632935|NCT01981356|525169237|FG001|Overall Study|Protocol Violation|0|||
145632936|NCT03395353|525169238|FG000|Overall Study|Adverse Event|20|||
145632937|NCT03395353|525169238|FG000|Overall Study|Protocol Violation|1|||
145632938|NCT03395353|525169238|FG000|Overall Study|Lack of Efficacy|3|||
145632939|NCT03395353|525169238|FG000|Overall Study|Withdrawal by Subject|24|||
145632940|NCT03395353|525169238|FG000|Overall Study|Discontinued visit|1|||
145632941|NCT03395353|525169238|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
145632942|NCT03395353|525169238|FG000|Overall Study|Physician Decision|4|||
145632943|NCT03395353|525169238|FG000|Overall Study|Early termination of overall study|33|||
145632944|NCT02013037|525169240|FG000|Overall Study|Death|6|||
145632945|NCT02013037|525169240|FG000|Overall Study|Withdrawal by Subject|1|||
145632946|NCT02013037|525169240|FG000|Overall Study|Awaiting Transplantation|7|||
145632947|NCT02013037|525169240|FG000|Overall Study|Transplanted without DSA|2|||
145632948|NCT00726596|525170658|FG000|Overall Study|Adverse Event|2|||
145632949|NCT00726596|525170659|FG001|Overall Study|Adverse Event|1|||
145632950|NCT00726596|525170658|FG000|Overall Study|Withdrawal by Subject|3|||
145632951|NCT00726596|525170659|FG001|Overall Study|Withdrawal by Subject|3|||
145632952|NCT02962674|525170662|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
145632953|NCT00364286|525170663|FG000|Overall Study|Withdrawal by Subject|1|||
145632954|NCT00364286|525170663|FG000|Overall Study|Adverse Event|2|||
145632955|NCT00357396|525170666|FG000|Overall Study|Adverse Event|1|||
145632956|NCT00357396|525170667|FG001|Overall Study|Adverse Event|0|||
145476685|NCT00291018|524597862|FG001|Overall Study|Withdrawal by Subject|8|||
145632957|NCT02488980|525170669|FG000|Overall Study|Protocol Violation|2|||
145632958|NCT02488980|525170670|FG001|Overall Study|Protocol Violation|2|||
145632959|NCT02488980|525170671|FG002|Overall Study|Protocol Violation|2|||
145632960|NCT01227278|525170672|FG000|Overall Study|Withdrawal by Subject|4|||
145632961|NCT01227278|525170673|FG001|Overall Study|Withdrawal by Subject|4|||
145632962|NCT01227278|525170672|FG000|Overall Study|Death|0|||
145632963|NCT01227278|525170673|FG001|Overall Study|Death|2|||
145632964|NCT01227278|525170672|FG000|Overall Study|Other|1|||
145632965|NCT01227278|525170673|FG001|Overall Study|Other|2|||
145632966|NCT03546907|525170674|FG000|Overall Study|Lack of Efficacy|1|||
145632967|NCT03546907|525170675|FG001|Overall Study|Lack of Efficacy|1|||
145632968|NCT03546907|525170674|FG000|Overall Study|Withdrawal by Subject|8|||
145632969|NCT03546907|525170675|FG001|Overall Study|Withdrawal by Subject|9|||
145632970|NCT03546907|525170674|FG000|Overall Study|Adverse events (AEs)|7|||
145632971|NCT03546907|525170675|FG001|Overall Study|Adverse events (AEs)|10|||
145632972|NCT03546907|525170674|FG000|Overall Study|Other-unspecified|1|||
145632973|NCT03546907|525170675|FG001|Overall Study|Other-unspecified|1|||
145632974|NCT03720210|525170676|FG000|Overall Study|Lost to Follow-up|1|||
145632975|NCT00753012|525170682|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
145632976|NCT00753012|525170683|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
145632977|NCT00753012|525170682|FG000|Overall Study|Adverse Event|2|||
145632978|NCT00753012|525170683|FG001|Overall Study|Adverse Event|0|||
145632979|NCT00753012|525170682|FG000|Overall Study|Withdrawal by Subject|0|||
145632980|NCT00753012|525170683|FG001|Overall Study|Withdrawal by Subject|1|||
145632981|NCT00753012|525170682|FG000|Overall Study|Lost to Follow-up|4|||
145632982|NCT00753012|525170683|FG001|Overall Study|Lost to Follow-up|0|||
145632983|NCT00753012|525170682|FG000|Overall Study|Confounded endpoint data|1|||
145632984|NCT00753012|525170683|FG001|Overall Study|Confounded endpoint data|0|||
145632985|NCT01027286|525170684|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
145632986|NCT01027286|525170685|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
145632987|NCT01027286|525170684|FG000|Overall Study|Lost to Follow-up|0|||
145632988|NCT01027286|525170685|FG001|Overall Study|Lost to Follow-up|1|||
145632989|NCT00545844|525170686|FG000|Overall Study|Lost to Follow-up|9|||
145632990|NCT00545844|525170686|FG000|Overall Study|Protocol Violation|1|||
145632991|NCT00545844|525170686|FG000|Overall Study|Withdrawal by Subject|2|||
145632992|NCT01565928|525170698|FG000|Overall Study|Adverse Event|3|||
145632993|NCT01565928|525170698|FG000|Overall Study|Other|3|||
145632994|NCT01565928|525170698|FG000|Overall Study|Progressive Disease|13|||
145632995|NCT01565928|525170698|FG000|Overall Study|Withdrawal by Subject|1|||
145632996|NCT01565928|525170698|FG000|Overall Study|Death|2|||
145632997|NCT01713530|525170706|FG000|Overall Study|Adverse Event|0|||
145632998|NCT01713530|525170707|FG001|Overall Study|Adverse Event|5|||
145632999|NCT01713530|525170706|FG000|Overall Study|Withdrawal criteria|21|||
145633000|NCT01713530|525170707|FG001|Overall Study|Withdrawal criteria|12|||
145633001|NCT01713530|525170706|FG000|Overall Study|Unclassified|4|||
145633002|NCT01713530|525170707|FG001|Overall Study|Unclassified|2|||
145633003|NCT03525119|525170708|FG000|Overall Study|Adverse Event|0|||
145633004|NCT03525119|525170709|FG001|Overall Study|Adverse Event|1|||
145633005|NCT03525119|525170710|FG002|Overall Study|Adverse Event|0|||
145633006|NCT03525119|525170708|FG000|Overall Study|Lost to Follow-up|32|||
145633007|NCT03525119|525170709|FG001|Overall Study|Lost to Follow-up|33|||
145633008|NCT03525119|525170710|FG002|Overall Study|Lost to Follow-up|37|||
145633009|NCT03525119|525170708|FG000|Overall Study|Withdrawal by Subject|5|||
145633010|NCT03525119|525170709|FG001|Overall Study|Withdrawal by Subject|4|||
145633011|NCT03525119|525170710|FG002|Overall Study|Withdrawal by Subject|2|||
145633012|NCT03525119|525170708|FG000|Overall Study|Reason not Specified|2|||
145633013|NCT03525119|525170709|FG001|Overall Study|Reason not Specified|1|||
145633014|NCT03525119|525170710|FG002|Overall Study|Reason not Specified|2|||
145633015|NCT03525119|525170708|FG000|Overall Study|Randomized but not Vaccinated|1|||
145633016|NCT03525119|525170709|FG001|Overall Study|Randomized but not Vaccinated|0|||
145633017|NCT03525119|525170710|FG002|Overall Study|Randomized but not Vaccinated|2|||
145633018|NCT04379713|525170715|FG000|Overall Study|Adverse Event|2|||
145633019|NCT04379713|525170716|FG001|Overall Study|Adverse Event|0|||
145633020|NCT04379713|525170715|FG000|Overall Study|Physician Decision|2|||
145633021|NCT04379713|525170716|FG001|Overall Study|Physician Decision|1|||
145633022|NCT04379713|525170715|FG000|Overall Study|Protocol Violation|11|||
145633023|NCT04379713|525170716|FG001|Overall Study|Protocol Violation|6|||
145633024|NCT04379713|525170715|FG000|Overall Study|No longer met eligibility criteria|14|||
145633025|NCT04379713|525170716|FG001|Overall Study|No longer met eligibility criteria|11|||
145633026|NCT04379713|525170715|FG000|Overall Study|Withdrawal by parent/guardian|36|||
145633027|NCT04379713|525170716|FG001|Overall Study|Withdrawal by parent/guardian|15|||
145633028|NCT04379713|525170715|FG000|Overall Study|Lost to Follow-up|31|||
145633029|NCT04379713|525170716|FG001|Overall Study|Lost to Follow-up|21|||
145633030|NCT03808883|525170717|FG000|Overall Study|Withdrawal by Subject|2|||
145633031|NCT03808883|525170718|FG001|Overall Study|Withdrawal by Subject|0|||
145633032|NCT03808883|525170717|FG000|Overall Study|Did not complete pre test or post test survey|4|||
145633033|NCT03808883|525170718|FG001|Overall Study|Did not complete pre test or post test survey|3|||
145633034|NCT02371746|525170727|FG000|Overall Study|Consent withdrawn|0|||
145633035|NCT02371746|525170728|FG001|Overall Study|Consent withdrawn|0|||
145633036|NCT02371746|525170729|FG002|Overall Study|Consent withdrawn|0|||
145633037|NCT02371746|525170730|FG003|Overall Study|Consent withdrawn|0|||
145633038|NCT02371746|525170731|FG004|Overall Study|Consent withdrawn|0|||
145633039|NCT02371746|525170732|FG005|Overall Study|Consent withdrawn|0|||
145633040|NCT02371746|525170733|FG006|Overall Study|Consent withdrawn|1|||
145633041|NCT02613364|525170734|FG000|Overall Study|Other|19|||
145633042|NCT02613364|525170735|FG001|Overall Study|Other|29|||
145633043|NCT02613364|525170736|FG002|Overall Study|Other|17|||
145633044|NCT02613364|525170734|FG000|Overall Study|Too time consuming|21|||
145633045|NCT02613364|525170735|FG001|Overall Study|Too time consuming|26|||
145633046|NCT02613364|525170736|FG002|Overall Study|Too time consuming|26|||
145633047|NCT02613364|525170734|FG000|Overall Study|Withdrawal by Subject|13|||
145633048|NCT02613364|525170735|FG001|Overall Study|Withdrawal by Subject|18|||
145633049|NCT02613364|525170736|FG002|Overall Study|Withdrawal by Subject|17|||
145633050|NCT02613364|525170734|FG000|Overall Study|Medical|12|||
145633051|NCT02613364|525170735|FG001|Overall Study|Medical|13|||
145633052|NCT02613364|525170736|FG002|Overall Study|Medical|9|||
145633053|NCT02613364|525170734|FG000|Overall Study|Disliked Study Procedure|1|||
145633054|NCT02613364|525170735|FG001|Overall Study|Disliked Study Procedure|1|||
145633055|NCT02613364|525170736|FG002|Overall Study|Disliked Study Procedure|4|||
145633056|NCT02613364|525170734|FG000|Overall Study|Disliked Intervention|0|||
145633057|NCT02613364|525170735|FG001|Overall Study|Disliked Intervention|3|||
145476686|NCT00291018|524597863|FG002|Overall Study|Withdrawal by Subject|1|||
145476687|NCT00291018|524597861|FG000|Overall Study|Failures|5|||
145476688|NCT00291018|524597862|FG001|Overall Study|Failures|12|||
145476689|NCT00291018|524597863|FG002|Overall Study|Failures|5|||
145476690|NCT00291018|524597861|FG000|Overall Study|Lost to Follow-up|3|||
145476691|NCT00291018|524597862|FG001|Overall Study|Lost to Follow-up|4|||
145476692|NCT00291018|524597863|FG002|Overall Study|Lost to Follow-up|18|||
145476693|NCT05362058|524597865|FG000|Treatment Period|Adverse Event|3|||
145476694|NCT05362058|524597866|FG001|Treatment Period|Adverse Event|3|||
145476695|NCT05362058|524597865|FG000|Treatment Period|Assigned treatment by mistake|3|||
145476696|NCT05362058|524597866|FG001|Treatment Period|Assigned treatment by mistake|4|||
145476697|NCT05362058|524597865|FG000|Treatment Period|Death|1|||
145476698|NCT05362058|524597866|FG001|Treatment Period|Death|1|||
145476699|NCT05362058|524597865|FG000|Treatment Period|Lost to Follow-up|6|||
145476700|NCT05362058|524597866|FG001|Treatment Period|Lost to Follow-up|3|||
145476701|NCT05362058|524597865|FG000|Treatment Period|Non-compliance with study drug|0|||
145476702|NCT05362058|524597866|FG001|Treatment Period|Non-compliance with study drug|1|||
145476703|NCT05362058|524597865|FG000|Treatment Period|Physician Decision|1|||
145476704|NCT05362058|524597866|FG001|Treatment Period|Physician Decision|0|||
145476705|NCT05362058|524597865|FG000|Treatment Period|Protocol deviation|1|||
145476706|NCT05362058|524597866|FG001|Treatment Period|Protocol deviation|0|||
145476707|NCT05362058|524597865|FG000|Treatment Period|Withdrawal by Subject|10|||
145476708|NCT05362058|524597866|FG001|Treatment Period|Withdrawal by Subject|11|||
145476709|NCT05362058|524597865|FG000|Follow-Up Period|Death|1|||
145476710|NCT05362058|524597866|FG001|Follow-Up Period|Death|0|||
145476711|NCT05362058|524597865|FG000|Follow-Up Period|Lost to Follow-up|2|||
145476712|NCT05362058|524597866|FG001|Follow-Up Period|Lost to Follow-up|1|||
145476713|NCT05362058|524597865|FG000|Follow-Up Period|Protocol deviation|1|||
145476714|NCT05362058|524597866|FG001|Follow-Up Period|Protocol deviation|1|||
145476715|NCT05362058|524597865|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145476716|NCT05362058|524597866|FG001|Follow-Up Period|Withdrawal by Subject|3|||
145476717|NCT02688985|524597869|FG000|Overall Study|Adverse Event|1|||
145476718|NCT02688985|524597870|FG001|Overall Study|Adverse Event|2|||
145476719|NCT02688985|524597871|FG002|Overall Study|Adverse Event|2|||
145476720|NCT02688985|524597872|FG003|Overall Study|Adverse Event|0|||
145476721|NCT02688985|524597873|FG004|Overall Study|Adverse Event|0|||
145476722|NCT02688985|524597869|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
145476723|NCT02688985|524597870|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
145476724|NCT02688985|524597871|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
145476725|NCT02688985|524597872|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
145476726|NCT02688985|524597873|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
145476727|NCT02688985|524597869|FG000|Overall Study|Death|0|||
145476728|NCT02688985|524597870|FG001|Overall Study|Death|0|||
145476729|NCT02688985|524597871|FG002|Overall Study|Death|0|||
145476730|NCT02688985|524597872|FG003|Overall Study|Death|0|||
145476731|NCT02688985|524597873|FG004|Overall Study|Death|1|||
145476732|NCT02688985|524597869|FG000|Overall Study|Lack of Efficacy|0|||
145476733|NCT02688985|524597870|FG001|Overall Study|Lack of Efficacy|0|||
145476734|NCT02688985|524597871|FG002|Overall Study|Lack of Efficacy|0|||
145476735|NCT02688985|524597872|FG003|Overall Study|Lack of Efficacy|0|||
145476736|NCT02688985|524597873|FG004|Overall Study|Lack of Efficacy|1|||
145476737|NCT02688985|524597869|FG000|Overall Study|Lost to Follow-up|2|||
145476738|NCT02688985|524597870|FG001|Overall Study|Lost to Follow-up|0|||
145476739|NCT02688985|524597871|FG002|Overall Study|Lost to Follow-up|1|||
145476740|NCT02688985|524597872|FG003|Overall Study|Lost to Follow-up|1|||
145633058|NCT02613364|525170736|FG002|Overall Study|Disliked Intervention|3|||
145476741|NCT02688985|524597873|FG004|Overall Study|Lost to Follow-up|1|||
145476742|NCT02688985|524597869|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145476743|NCT02688985|524597870|FG001|Overall Study|Non-Compliance With Study Drug|3|||
145476744|NCT02688985|524597871|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145476745|NCT02688985|524597872|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145476746|NCT02688985|524597873|FG004|Overall Study|Non-Compliance With Study Drug|1|||
145476747|NCT02688985|524597869|FG000|Overall Study|Other|3|||
145476748|NCT02688985|524597870|FG001|Overall Study|Other|4|||
145476749|NCT02688985|524597871|FG002|Overall Study|Other|1|||
145476750|NCT02688985|524597872|FG003|Overall Study|Other|0|||
145633059|NCT01909336|525170737|FG000|Overall Study|Lost to Follow-up|4|||
145476751|NCT02688985|524597873|FG004|Overall Study|Other|0|||
145476752|NCT02688985|524597869|FG000|Overall Study|Physician Decision|2|||
145476753|NCT02688985|524597870|FG001|Overall Study|Physician Decision|2|||
145476754|NCT02688985|524597871|FG002|Overall Study|Physician Decision|0|||
145476755|NCT02688985|524597872|FG003|Overall Study|Physician Decision|0|||
145476756|NCT02688985|524597873|FG004|Overall Study|Physician Decision|1|||
145476757|NCT02688985|524597869|FG000|Overall Study|Pregnancy|0|||
145476758|NCT02688985|524597870|FG001|Overall Study|Pregnancy|0|||
145476759|NCT02688985|524597871|FG002|Overall Study|Pregnancy|2|||
145476760|NCT02688985|524597872|FG003|Overall Study|Pregnancy|1|||
145476761|NCT02688985|524597873|FG004|Overall Study|Pregnancy|0|||
145476762|NCT02688985|524597869|FG000|Overall Study|Study Terminated By Sponsor|0|||
145476763|NCT02688985|524597870|FG001|Overall Study|Study Terminated By Sponsor|0|||
145476764|NCT02688985|524597871|FG002|Overall Study|Study Terminated By Sponsor|0|||
145476765|NCT02688985|524597872|FG003|Overall Study|Study Terminated By Sponsor|1|||
145476766|NCT02688985|524597873|FG004|Overall Study|Study Terminated By Sponsor|0|||
145476767|NCT02688985|524597869|FG000|Overall Study|Withdrawal by Subject|2|||
145476768|NCT02688985|524597870|FG001|Overall Study|Withdrawal by Subject|8|||
145476769|NCT02688985|524597871|FG002|Overall Study|Withdrawal by Subject|7|||
145476770|NCT02688985|524597872|FG003|Overall Study|Withdrawal by Subject|1|||
145476771|NCT02688985|524597873|FG004|Overall Study|Withdrawal by Subject|4|||
145476772|NCT01964963|524597876|FG000|Overall Study|Case Report Forms Uncollected|888|||
145476773|NCT01964963|524597876|FG000|Overall Study|Protocol Deviation|50|||
145476774|NCT01964963|524597876|FG000|Overall Study|Data Reliability was not Assured|5|||
145476775|NCT00930553|524597877|FG000|Overall Study|Adverse Event|1|||
145476776|NCT00930553|524597877|FG000|Overall Study|Lack of Efficacy|7|||
145476777|NCT00930553|524597877|FG000|Overall Study|Physician Decision|39|||
145476778|NCT00930553|524597877|FG000|Overall Study|Protocol Violation|1|||
145476779|NCT00930553|524597877|FG000|Overall Study|Pregnancy|1|||
145476780|NCT00930553|524597877|FG000|Overall Study|Withdrawal by Subject|88|||
145476781|NCT00930553|524597877|FG000|Overall Study|Lost to Follow-up|25|||
145476782|NCT00930553|524597877|FG000|Overall Study|Death|9|||
145476783|NCT00930553|524597877|FG000|Overall Study|Study terminated by sponsor|24|||
145476784|NCT00930553|524597877|FG000|Overall Study|Other than specified above|28|||
145476785|NCT02630472|524597878|FG000|Overall Study|Physician Decision|10|||
145476786|NCT02630472|524597879|FG001|Overall Study|Physician Decision|0|||
145476787|NCT00787189|524597880|FG000|Overall Study|Lost to Follow-up|2|||
145476788|NCT00787189|524597881|FG001|Overall Study|Lost to Follow-up|2|||
145476789|NCT03250182|524597882|FG000|Overall Study|Withdrawal by Subject|1|||
145476790|NCT01858740|524597883|FG000|Overall Study|Death|4|||
145476791|NCT01068769|524597884|FG000|Overall Study|Ineligible|1|||
145476792|NCT02524158|524597885|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
145476793|NCT02524158|524597886|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
145476794|NCT02524158|524597885|FG000|12-weeks Assessment|Lost to Follow-up|18|||
145476795|NCT02524158|524597886|FG001|12-weeks Assessment|Lost to Follow-up|12|||
145476796|NCT02524158|524597885|FG000|6-month Assessment|Withdrawal by Subject|1|||
145476797|NCT02524158|524597886|FG001|6-month Assessment|Withdrawal by Subject|1|||
145476798|NCT02524158|524597885|FG000|6-month Assessment|Lost to Follow-up|21|||
145476799|NCT02524158|524597886|FG001|6-month Assessment|Lost to Follow-up|20|||
145476800|NCT00773747|524597893|FG000|Overall Study|Lack of Efficacy|112|||
145476801|NCT00773747|524597894|FG001|Overall Study|Lack of Efficacy|144|||
145476802|NCT00773747|524597893|FG000|Overall Study|Physician Decision|26|||
145476803|NCT00773747|524597894|FG001|Overall Study|Physician Decision|18|||
145476804|NCT00773747|524597893|FG000|Overall Study|Lost to Follow-up|0|||
145476805|NCT00773747|524597894|FG001|Overall Study|Lost to Follow-up|1|||
145476806|NCT00773747|524597893|FG000|Overall Study|Protocol Violation|2|||
145476807|NCT00773747|524597894|FG001|Overall Study|Protocol Violation|2|||
145476808|NCT00773747|524597893|FG000|Overall Study|Withdrawal by Subject|89|||
145476809|NCT00773747|524597894|FG001|Overall Study|Withdrawal by Subject|61|||
145476810|NCT00773747|524597893|FG000|Overall Study|Adverse Event|61|||
145476811|NCT00773747|524597894|FG001|Overall Study|Adverse Event|62|||
145476812|NCT00773747|524597893|FG000|Overall Study|Death|5|||
145476813|NCT00773747|524597894|FG001|Overall Study|Death|8|||
145476814|NCT00773747|524597893|FG000|Overall Study|Not Treated|2|||
145476815|NCT00773747|524597894|FG001|Overall Study|Not Treated|0|||
145476816|NCT02202538|524597900|FG000|Overall Study|Withdrawal by Subject|5|||
145476817|NCT02202538|524597900|FG000|Overall Study|Did not meet all inclusion criteria|2|||
145476818|NCT02202538|524597900|FG000|Overall Study|Investigator Decision|1|||
145476819|NCT01457846|524597902|FG000|Overall Study|Death before treatment|1|||
145476820|NCT01457846|524597903|FG001|Overall Study|Death before treatment|2|||
145476821|NCT01457846|524597902|FG000|Overall Study|Did not receive treatment|0|||
145476822|NCT01457846|524597903|FG001|Overall Study|Did not receive treatment|1|||
145476823|NCT01457846|524597902|FG000|Overall Study|Death|27|||
145476824|NCT01457846|524597903|FG001|Overall Study|Death|16|||
145476825|NCT01457846|524597902|FG000|Overall Study|Unclassified reason for not completed|11|||
145476826|NCT01457846|524597903|FG001|Overall Study|Unclassified reason for not completed|10|||
145476827|NCT01457846|524597902|FG000|Overall Study|Withdrawal by Subject|1|||
145476828|NCT01457846|524597903|FG001|Overall Study|Withdrawal by Subject|1|||
145476829|NCT01457846|524597902|FG000|Overall Study|Lost to Follow-up|1|||
145476830|NCT01457846|524597903|FG001|Overall Study|Lost to Follow-up|0|||
145476831|NCT01846741|524597904|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
145476832|NCT01853878|524597905|FG000|Overall Study|Recurrence|2|||
145476833|NCT01853878|524597906|FG001|Overall Study|Recurrence|0|||
145476834|NCT01853878|524597905|FG000|Overall Study|Adverse Event|2|||
145476835|NCT01853878|524597906|FG001|Overall Study|Adverse Event|0|||
145476836|NCT01853878|524597905|FG000|Overall Study|Withdrawal by Subject|3|||
145476837|NCT01853878|524597906|FG001|Overall Study|Withdrawal by Subject|1|||
145476838|NCT01853878|524597905|FG000|Overall Study|Migrated/moved from the study area|1|||
145476839|NCT01853878|524597906|FG001|Overall Study|Migrated/moved from the study area|0|||
145476840|NCT01853878|524597905|FG000|Overall Study|Other|55|||
145476841|NCT01853878|524597906|FG001|Overall Study|Other|43|||
145476842|NCT02161757|524597907|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
145476843|NCT02161757|524597908|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
145476844|NCT02161757|524597909|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
145476845|NCT02161757|524597907|FG000|Treatment Through Study Completion|Adverse Event|1|||
145476846|NCT02161757|524597908|FG001|Treatment Through Study Completion|Adverse Event|1|||
145476847|NCT02161757|524597909|FG002|Treatment Through Study Completion|Adverse Event|0|||
145476848|NCT02161757|524597907|FG000|Treatment Through Study Completion|Protocol Violation|0|||
145476849|NCT02161757|524597908|FG001|Treatment Through Study Completion|Protocol Violation|1|||
145476850|NCT02161757|524597909|FG002|Treatment Through Study Completion|Protocol Violation|2|||
145476851|NCT02161757|524597907|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
145476852|NCT02161757|524597908|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
145476853|NCT02161757|524597909|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
145476854|NCT02161757|524597907|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
145476855|NCT02161757|524597908|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
145476856|NCT02161757|524597909|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
145476857|NCT02161757|524597907|FG000|Treatment Through Study Completion|Other|20|||
145476858|NCT02161757|524597908|FG001|Treatment Through Study Completion|Other|19|||
145476859|NCT02161757|524597909|FG002|Treatment Through Study Completion|Other|12|||
145476860|NCT02161757|524597907|FG000|Treatment Through Study Completion|Death|2|||
145476861|NCT02161757|524597908|FG001|Treatment Through Study Completion|Death|1|||
145476862|NCT02161757|524597909|FG002|Treatment Through Study Completion|Death|1|||
145476863|NCT03997825|524597910|FG000|Overall Study|Death|3|||
145476864|NCT03997825|524597910|FG000|Overall Study|Lost to Follow-up|10|||
145476865|NCT03997825|524597910|FG000|Overall Study|Withdrawal by Subject|3|||
145476866|NCT03997825|524597910|FG000|Overall Study|Refused participation|1|||
145476867|NCT00391625|524597911|FG000|Month 14|Withdrawal by Subject|1|||
145476868|NCT00391625|524597911|FG000|Month 50|Physician Decision|1|||
145476869|NCT00383162|524597912|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
145476870|NCT00383162|524597913|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
145476871|NCT00383162|524597912|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
145476872|NCT00383162|524597913|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
145476873|NCT00383162|524597912|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
145476874|NCT00383162|524597913|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
145476875|NCT00383162|524597912|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
145476876|NCT00383162|524597913|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
145476877|NCT00383162|524597912|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
145476878|NCT00383162|524597913|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
145476879|NCT00383162|524597912|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
145476880|NCT00383162|524597913|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
145476881|NCT00383162|524597912|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
145476882|NCT00383162|524597913|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
145476883|NCT00383162|524597912|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
145476884|NCT00383162|524597913|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
145476885|NCT00383162|524597912|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
145476886|NCT00383162|524597913|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
145476887|NCT01153698|524597914|FG000|Overall Study|Adverse Event|12|||
145476888|NCT01153698|524597914|FG000|Overall Study|Lost to Follow-up|4|||
145476889|NCT01153698|524597914|FG000|Overall Study|Withdrawal by Subject|2|||
145476890|NCT01153698|524597914|FG000|Overall Study|Switch to other anticoagulants|4|||
145476891|NCT01153698|524597914|FG000|Overall Study|Other|2|||
145476892|NCT01153698|524597914|FG000|Overall Study|Not treated with Pradaxa|5|||
145476893|NCT01371305|524597918|FG000|Overall Study|Adverse Event|0|||
145476894|NCT01371305|524597919|FG001|Overall Study|Adverse Event|0|||
145476895|NCT01371305|524597920|FG002|Overall Study|Adverse Event|0|||
145476896|NCT01371305|524597921|FG003|Overall Study|Adverse Event|2|||
145476897|NCT01371305|524597922|FG004|Overall Study|Adverse Event|1|||
145476898|NCT01371305|524597923|FG005|Overall Study|Adverse Event|0|||
145476899|NCT01371305|524597918|FG000|Overall Study|Study terminated by sponsor|0|||
145476900|NCT01371305|524597919|FG001|Overall Study|Study terminated by sponsor|0|||
145476901|NCT01371305|524597920|FG002|Overall Study|Study terminated by sponsor|0|||
145476902|NCT01371305|524597921|FG003|Overall Study|Study terminated by sponsor|0|||
145476903|NCT01371305|524597922|FG004|Overall Study|Study terminated by sponsor|3|||
145476904|NCT01371305|524597923|FG005|Overall Study|Study terminated by sponsor|1|||
145476905|NCT01371305|524597918|FG000|Overall Study|Subject request|0|||
145476906|NCT01371305|524597919|FG001|Overall Study|Subject request|0|||
145476907|NCT01371305|524597920|FG002|Overall Study|Subject request|0|||
145476908|NCT01371305|524597921|FG003|Overall Study|Subject request|0|||
145476909|NCT01371305|524597922|FG004|Overall Study|Subject request|0|||
145476910|NCT01371305|524597923|FG005|Overall Study|Subject request|1|||
145476911|NCT02220712|524597924|FG000|Overall Study|Adverse Event|1|||
145476912|NCT02220712|524597924|FG000|Overall Study|Withdrawal by Subject|2|||
145476913|NCT02220712|524597924|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
145476914|NCT00760838|524597928|FG000|Overall Study|Adverse Event|1|||
145476915|NCT00760838|524597929|FG001|Overall Study|Adverse Event|1|||
145476916|NCT00760838|524597928|FG000|Overall Study|Lack of Efficacy|1|||
145476917|NCT00760838|524597929|FG001|Overall Study|Lack of Efficacy|0|||
145476918|NCT00760838|524597928|FG000|Overall Study|Lost to Follow-up|2|||
145476919|NCT00760838|524597929|FG001|Overall Study|Lost to Follow-up|0|||
145476920|NCT00760838|524597928|FG000|Overall Study|Withdrawal by Subject|1|||
145476921|NCT00760838|524597929|FG001|Overall Study|Withdrawal by Subject|1|||
145476922|NCT02726022|524597930|FG000|Overall Study|Adverse Event|14|||
145476923|NCT02726022|524597930|FG000|Overall Study|Treatment Failure|8|||
145476924|NCT02726022|524597930|FG000|Overall Study|Poor Compliance|13|||
145476925|NCT02726022|524597930|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
145476926|NCT01817959|524597931|FG000|Overall Study|Graft loss|1|||
145476927|NCT01817959|524597932|FG001|Overall Study|Graft loss|1|||
145476928|NCT01817959|524597931|FG000|Overall Study|forbidden medication|1|||
145476929|NCT01817959|524597932|FG001|Overall Study|forbidden medication|1|||
145476930|NCT01817959|524597931|FG000|Overall Study|Adverse Event|1|||
145476931|NCT01817959|524597932|FG001|Overall Study|Adverse Event|0|||
145476932|NCT01817959|524597931|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
145476933|NCT01817959|524597932|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
145476934|NCT01183065|524597938|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
145476935|NCT03657095|524597940|FG000|Overall Study|Withdrawal by Subject|1|||
145476936|NCT03657095|524597941|FG001|Overall Study|Withdrawal by Subject|1|||
145476937|NCT03657095|524597940|FG000|Overall Study|Adverse Event|0|||
145476938|NCT03657095|524597941|FG001|Overall Study|Adverse Event|3|||
145476939|NCT03657095|524597940|FG000|Overall Study|Study Terminated by Sponsor|58|||
145476940|NCT03657095|524597941|FG001|Overall Study|Study Terminated by Sponsor|49|||
145476941|NCT00348309|524597944|FG000|Overall Study|Adverse Event|56|||
145476942|NCT00348309|524597945|FG001|Overall Study|Adverse Event|28|||
145476943|NCT00348309|524597946|FG002|Overall Study|Adverse Event|63|||
145476944|NCT00348309|524597944|FG000|Overall Study|Lost to Follow-up|6|||
145476945|NCT00348309|524597945|FG001|Overall Study|Lost to Follow-up|7|||
145476946|NCT00348309|524597946|FG002|Overall Study|Lost to Follow-up|4|||
145476947|NCT00348309|524597944|FG000|Overall Study|Protocol Violation|7|||
145476948|NCT00348309|524597945|FG001|Overall Study|Protocol Violation|12|||
145476949|NCT00348309|524597946|FG002|Overall Study|Protocol Violation|7|||
145476950|NCT00348309|524597944|FG000|Overall Study|Withdrawal by Subject|33|||
145476951|NCT00348309|524597945|FG001|Overall Study|Withdrawal by Subject|37|||
145476952|NCT00348309|524597946|FG002|Overall Study|Withdrawal by Subject|40|||
145476953|NCT00348309|524597944|FG000|Overall Study|Non-compliance|8|||
145476954|NCT00348309|524597945|FG001|Overall Study|Non-compliance|6|||
145476955|NCT00348309|524597946|FG002|Overall Study|Non-compliance|8|||
145476956|NCT00348309|524597944|FG000|Overall Study|Death of caregiver|1|||
145476957|NCT00348309|524597945|FG001|Overall Study|Death of caregiver|0|||
145476958|NCT00348309|524597946|FG002|Overall Study|Death of caregiver|1|||
145476959|NCT00348309|524597944|FG000|Overall Study|Lack of insight, dementia|1|||
145476960|NCT00348309|524597945|FG001|Overall Study|Lack of insight, dementia|0|||
145476961|NCT00348309|524597946|FG002|Overall Study|Lack of insight, dementia|0|||
145476962|NCT00348309|524597944|FG000|Overall Study|Wrong bottle allocated|1|||
145476963|NCT00348309|524597945|FG001|Overall Study|Wrong bottle allocated|0|||
145476964|NCT00348309|524597946|FG002|Overall Study|Wrong bottle allocated|0|||
145476965|NCT00348309|524597944|FG000|Overall Study|Caregiver sick|1|||
145476966|NCT00348309|524597945|FG001|Overall Study|Caregiver sick|0|||
145476967|NCT00348309|524597946|FG002|Overall Study|Caregiver sick|0|||
145476968|NCT00348309|524597944|FG000|Overall Study|Use of prohibited medication|5|||
145476969|NCT00348309|524597945|FG001|Overall Study|Use of prohibited medication|2|||
145476970|NCT00348309|524597946|FG002|Overall Study|Use of prohibited medication|2|||
145476971|NCT00348309|524597944|FG000|Overall Study|Caregiver withdrawal|3|||
145476972|NCT00348309|524597945|FG001|Overall Study|Caregiver withdrawal|0|||
145476973|NCT00348309|524597946|FG002|Overall Study|Caregiver withdrawal|7|||
145476974|NCT00348309|524597944|FG000|Overall Study|Unable to complete ET visit|1|||
145633060|NCT01909336|525170738|FG001|Overall Study|Lost to Follow-up|2|||
145476975|NCT00348309|524597945|FG001|Overall Study|Unable to complete ET visit|0|||
145633061|NCT01909336|525170739|FG002|Overall Study|Lost to Follow-up|2|||
145476976|NCT00348309|524597946|FG002|Overall Study|Unable to complete ET visit|0|||
145476977|NCT00348309|524597944|FG000|Overall Study|PI closing medical practice|1|||
145476978|NCT00348309|524597945|FG001|Overall Study|PI closing medical practice|0|||
145476979|NCT00348309|524597946|FG002|Overall Study|PI closing medical practice|0|||
145476980|NCT00348309|524597944|FG000|Overall Study|Principal investigator's decision|1|||
145476981|NCT00348309|524597945|FG001|Overall Study|Principal investigator's decision|0|||
145476982|NCT00348309|524597946|FG002|Overall Study|Principal investigator's decision|0|||
145476983|NCT00348309|524597944|FG000|Overall Study|No disponibility of medication|1|||
145476984|NCT00348309|524597945|FG001|Overall Study|No disponibility of medication|0|||
145476985|NCT00348309|524597946|FG002|Overall Study|No disponibility of medication|0|||
145476986|NCT00348309|524597944|FG000|Overall Study|Worsened neurodegenerative disease|1|||
145476987|NCT00348309|524597945|FG001|Overall Study|Worsened neurodegenerative disease|0|||
145476988|NCT00348309|524597946|FG002|Overall Study|Worsened neurodegenerative disease|0|||
145476989|NCT00348309|524597944|FG000|Overall Study|Cognitive and behaviour worsening|2|||
145476990|NCT00348309|524597945|FG001|Overall Study|Cognitive and behaviour worsening|0|||
145476991|NCT00348309|524597946|FG002|Overall Study|Cognitive and behaviour worsening|0|||
145476992|NCT00348309|524597944|FG000|Overall Study|Worsening of alzheimer|1|||
145476993|NCT00348309|524597945|FG001|Overall Study|Worsening of alzheimer|0|||
145476994|NCT00348309|524597946|FG002|Overall Study|Worsening of alzheimer|1|||
145476995|NCT00348309|524597944|FG000|Overall Study|Did not appear in time for Visit 3|1|||
145476996|NCT00348309|524597945|FG001|Overall Study|Did not appear in time for Visit 3|0|||
145476997|NCT00348309|524597946|FG002|Overall Study|Did not appear in time for Visit 3|0|||
145476998|NCT00348309|524597944|FG000|Overall Study|Participant died|2|||
145476999|NCT00348309|524597945|FG001|Overall Study|Participant died|1|||
145477000|NCT00348309|524597946|FG002|Overall Study|Participant died|1|||
145477001|NCT00348309|524597944|FG000|Overall Study|Decision of sponsor|1|||
145477002|NCT00348309|524597945|FG001|Overall Study|Decision of sponsor|0|||
145477003|NCT00348309|524597946|FG002|Overall Study|Decision of sponsor|0|||
145477004|NCT00348309|524597944|FG000|Overall Study|Ineffectiveness of treatment|0|||
145477005|NCT00348309|524597945|FG001|Overall Study|Ineffectiveness of treatment|1|||
145477006|NCT00348309|524597946|FG002|Overall Study|Ineffectiveness of treatment|0|||
145477007|NCT00348309|524597944|FG000|Overall Study|A foul of exclusion criteria|0|||
145477008|NCT00348309|524597945|FG001|Overall Study|A foul of exclusion criteria|1|||
145477009|NCT00348309|524597946|FG002|Overall Study|A foul of exclusion criteria|0|||
145477010|NCT00348309|524597944|FG000|Overall Study|Participant was hospitalized|0|||
145477011|NCT00348309|524597945|FG001|Overall Study|Participant was hospitalized|1|||
145477012|NCT00348309|524597946|FG002|Overall Study|Participant was hospitalized|0|||
145477013|NCT00348309|524597944|FG000|Overall Study|Sponsor refuseal|0|||
145477014|NCT00348309|524597945|FG001|Overall Study|Sponsor refuseal|1|||
145477015|NCT00348309|524597946|FG002|Overall Study|Sponsor refuseal|1|||
145477016|NCT00348309|524597944|FG000|Overall Study|Forgot often medication|0|||
145477017|NCT00348309|524597945|FG001|Overall Study|Forgot often medication|1|||
145477018|NCT00348309|524597946|FG002|Overall Study|Forgot often medication|0|||
145477019|NCT00348309|524597944|FG000|Overall Study|Medical Monitor decision|0|||
145477020|NCT00348309|524597945|FG001|Overall Study|Medical Monitor decision|0|||
145477021|NCT00348309|524597946|FG002|Overall Study|Medical Monitor decision|1|||
145477022|NCT00348309|524597944|FG000|Overall Study|Increased dose of Aricept|0|||
145477023|NCT00348309|524597945|FG001|Overall Study|Increased dose of Aricept|0|||
145477024|NCT00348309|524597946|FG002|Overall Study|Increased dose of Aricept|1|||
145477025|NCT00348309|524597944|FG000|Overall Study|Site closure|0|||
145477026|NCT00348309|524597945|FG001|Overall Study|Site closure|0|||
145477027|NCT00348309|524597946|FG002|Overall Study|Site closure|1|||
145477028|NCT00348309|524597944|FG000|Overall Study|Adverse event not attended|0|||
145477029|NCT00348309|524597945|FG001|Overall Study|Adverse event not attended|0|||
145477030|NCT00348309|524597946|FG002|Overall Study|Adverse event not attended|1|||
145477031|NCT00348309|524597944|FG000|Overall Study|ECG abnormal|0|||
145477032|NCT00348309|524597945|FG001|Overall Study|ECG abnormal|0|||
145477033|NCT00348309|524597946|FG002|Overall Study|ECG abnormal|2|||
145477034|NCT00348309|524597944|FG000|Overall Study|Cardiologist recommendations|0|||
145477035|NCT00348309|524597945|FG001|Overall Study|Cardiologist recommendations|0|||
145477036|NCT00348309|524597946|FG002|Overall Study|Cardiologist recommendations|1|||
145477037|NCT00348309|524597944|FG000|Overall Study|HCV career|0|||
145477038|NCT00348309|524597945|FG001|Overall Study|HCV career|0|||
145477039|NCT00348309|524597946|FG002|Overall Study|HCV career|1|||
145477040|NCT00622388|524597947|FG000|Overall Study|Disease Progression|47|||
145477041|NCT00622388|524597947|FG000|Overall Study|Adverse Event|6|||
145477042|NCT00622388|524597947|FG000|Overall Study|Protocol Violation|3|||
145477043|NCT00622388|524597947|FG000|Overall Study|Participant Refusal|1|||
145477044|NCT00622388|524597947|FG000|Overall Study|Death|3|||
145477045|NCT00622388|524597947|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
145477046|NCT00622388|524597947|FG000|Overall Study|Took Prohibited Medication|2|||
145477047|NCT00622388|524597947|FG000|Overall Study|Withdrew Consent|1|||
145477048|NCT00622388|524597947|FG000|Overall Study|Insurance Expired|1|||
145477049|NCT01743040|524597948|FG000|Overall Study|Death|1|||
145477050|NCT01743040|524597948|FG000|Overall Study|Lost to Follow-up|66|||
145633062|NCT01909336|525170737|FG000|Overall Study|Physician Decision|0|||
145633063|NCT01909336|525170738|FG001|Overall Study|Physician Decision|1|||
145477051|NCT01743040|524597948|FG000|Overall Study|Physician Decision|40|||
145477052|NCT01743040|524597948|FG000|Overall Study|Protocol Violation|1|||
145477053|NCT01743040|524597948|FG000|Overall Study|Withdrawal by Subject|121|||
145477054|NCT01894243|524597949|FG000|Overall Study|Adverse Event|0|||
145477055|NCT01894243|524597950|FG001|Overall Study|Adverse Event|1|||
145477056|NCT01894243|524597951|FG002|Overall Study|Adverse Event|2|||
145477057|NCT01894243|524597949|FG000|Overall Study|Death|0|||
145477058|NCT01894243|524597950|FG001|Overall Study|Death|0|||
145477059|NCT01894243|524597951|FG002|Overall Study|Death|3|||
145477060|NCT01894243|524597949|FG000|Overall Study|Lack of Efficacy|3|||
145477061|NCT01894243|524597950|FG001|Overall Study|Lack of Efficacy|3|||
145477062|NCT01894243|524597951|FG002|Overall Study|Lack of Efficacy|1|||
145477063|NCT01894243|524597949|FG000|Overall Study|Condition under investigation worsened|8|||
145477064|NCT01894243|524597950|FG001|Overall Study|Condition under investigation worsened|6|||
145477065|NCT01894243|524597951|FG002|Overall Study|Condition under investigation worsened|2|||
145477066|NCT01894243|524597949|FG000|Overall Study|Subject decision|1|||
145477067|NCT01894243|524597950|FG001|Overall Study|Subject decision|0|||
145477068|NCT01894243|524597951|FG002|Overall Study|Subject decision|0|||
145477069|NCT01894243|524597949|FG000|Overall Study|Other|1|||
145477070|NCT01894243|524597950|FG001|Overall Study|Other|0|||
145477071|NCT01894243|524597951|FG002|Overall Study|Other|0|||
145477072|NCT00828750|524597952|FG000|Overall Study|Lack of Efficacy|3|||
145477073|NCT00828750|524597952|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
145477074|NCT04006392|524597953|FG000|Overall Study|Lost to Follow-up|0|||
145477075|NCT04006392|524597954|FG001|Overall Study|Lost to Follow-up|1|||
145477076|NCT01299116|524597955|FG000|Overall Study|Lost to Follow-up|65|||
145477077|NCT01299116|524597956|FG001|Overall Study|Lost to Follow-up|9|||
145477078|NCT01299116|524597957|FG002|Overall Study|Lost to Follow-up|11|||
145477079|NCT01620944|524597958|FG000|Overall Study|Early termination of Study|2|||
145477080|NCT01620944|524597959|FG001|Overall Study|Early termination of Study|1|||
145477081|NCT04378114|524597960|FG000|Overall Study|Withdrawal by Subject|5|||
145477082|NCT00830180|524597961|FG000|Overall Study|Adverse Event|6|||
145477083|NCT00830180|524597961|FG000|Overall Study|Death|11|||
145477084|NCT00830180|524597961|FG000|Overall Study|Insufficient clinical response|1|||
145477085|NCT00830180|524597961|FG000|Overall Study|Withdrawal by Subject|5|||
145477086|NCT00830180|524597961|FG000|Overall Study|Progressive disease|2|||
145477087|NCT00830180|524597961|FG000|Overall Study|Other - Unspecified|1|||
145477088|NCT01832532|524597962|FG000|Overall Study|Withdrawal by Subject|5|||
145477089|NCT01832532|524597963|FG001|Overall Study|Withdrawal by Subject|2|||
145477090|NCT00392990|524597964|FG000|Treatment on Study|Adverse Event|3|||
145477091|NCT00392990|524597965|FG001|Treatment on Study|Adverse Event|1|||
145477092|NCT00392990|524597964|FG000|Follow up for 2 Years|Death|4|||
145477093|NCT00392990|524597965|FG001|Follow up for 2 Years|Death|0|||
145477094|NCT00991406|524597969|FG000|Overall Study|One participant did not respond to FES.|1|||
145477095|NCT03824587|524597970|FG000|Run-in Period|Screen Failure|0|||
145477096|NCT03824587|524597971|FG001|Run-in Period|Screen Failure|275|||
145477097|NCT03824587|524597970|FG000|Treatment Period|Adverse Event|4|||
145477098|NCT03824587|524597971|FG001|Treatment Period|Adverse Event|1|||
145477099|NCT03824587|524597970|FG000|Treatment Period|Withdrawal by Subject|0|||
145477100|NCT03824587|524597971|FG001|Treatment Period|Withdrawal by Subject|1|||
145477101|NCT03824587|524597970|FG000|Treatment Period|Kidney Transplant|1|||
145477102|NCT03824587|524597971|FG001|Treatment Period|Kidney Transplant|1|||
145477103|NCT00986362|524597972|FG000|Overall Study|Death|2|||
145477104|NCT00986362|524597973|FG001|Overall Study|Death|0|||
145477105|NCT00986362|524597972|FG000|Overall Study|Lost to Follow-up|0|||
145477106|NCT00986362|524597973|FG001|Overall Study|Lost to Follow-up|1|||
145477107|NCT01300572|524597974|FG000|Overall Study|HAMA + post dosimetry|1|||
145477108|NCT03597061|524597975|FG000|Overall Study|Lost to Follow-up|1|||
145477109|NCT03597061|524597976|FG001|Overall Study|Lost to Follow-up|0|||
145477110|NCT03597061|524597975|FG000|Overall Study|Protocol Violation|0|||
145477111|NCT03597061|524597976|FG001|Overall Study|Protocol Violation|1|||
145477112|NCT02160145|524597977|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
145477113|NCT02160145|524597978|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
145477114|NCT02160145|524597979|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
145477115|NCT02160145|524597977|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
145477116|NCT02160145|524597978|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
145477117|NCT02160145|524597979|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
145477118|NCT02160145|524597977|FG000|Randomized Double-blind Period|Subject decision|0|||
145477119|NCT02160145|524597978|FG001|Randomized Double-blind Period|Subject decision|21|||
145477120|NCT02160145|524597979|FG002|Randomized Double-blind Period|Subject decision|20|||
145477121|NCT02160145|524597977|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
145477122|NCT02160145|524597978|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
145477123|NCT02160145|524597979|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
145477124|NCT02160145|524597977|FG000|Randomized Double-blind Period|Physician Decision|0|||
145477125|NCT02160145|524597978|FG001|Randomized Double-blind Period|Physician Decision|7|||
145477126|NCT02160145|524597979|FG002|Randomized Double-blind Period|Physician Decision|5|||
145477127|NCT02006979|524597980|FG000|Overall Study|Withdrawal by Subject|1|||
145477128|NCT02006979|524597981|FG001|Overall Study|Withdrawal by Subject|1|||
145477129|NCT02006979|524597980|FG000|Overall Study|Protocol Violation|0|||
145477130|NCT02006979|524597981|FG001|Overall Study|Protocol Violation|1|||
145477131|NCT00375518|524597982|FG000|Overall Study|Withdrawal by Subject|2|||
145477132|NCT00375518|524597983|FG001|Overall Study|Withdrawal by Subject|10|||
145477133|NCT00375518|524597982|FG000|Overall Study|Patient Not Treated|6|||
145477134|NCT00375518|524597983|FG001|Overall Study|Patient Not Treated|6|||
145477135|NCT00375518|524597982|FG000|Overall Study|Death|0|||
145477136|NCT00375518|524597983|FG001|Overall Study|Death|1|||
145477137|NCT03170193|524597984|FG000|Overall Study|Withdrawal by Subject|0|||
145477138|NCT03170193|524597985|FG001|Overall Study|Withdrawal by Subject|0|||
145477139|NCT03170193|524597986|FG002|Overall Study|Withdrawal by Subject|0|||
145477140|NCT03170193|524597987|FG003|Overall Study|Withdrawal by Subject|1|||
145477141|NCT03170193|524597988|FG004|Overall Study|Withdrawal by Subject|0|||
145477142|NCT03170193|524597989|FG005|Overall Study|Withdrawal by Subject|0|||
145477143|NCT03170193|524597990|FG006|Overall Study|Withdrawal by Subject|0|||
145477144|NCT03170193|524597984|FG000|Overall Study|Lost to Follow-up|1|||
145477145|NCT03170193|524597985|FG001|Overall Study|Lost to Follow-up|1|||
145477146|NCT03170193|524597986|FG002|Overall Study|Lost to Follow-up|0|||
145477147|NCT03170193|524597987|FG003|Overall Study|Lost to Follow-up|0|||
145477148|NCT03170193|524597988|FG004|Overall Study|Lost to Follow-up|0|||
145477149|NCT03170193|524597989|FG005|Overall Study|Lost to Follow-up|0|||
145477150|NCT03170193|524597990|FG006|Overall Study|Lost to Follow-up|0|||
145477151|NCT03052816|524597995|FG000|Overall Study|Withdrawal by Subject|1|||
145477152|NCT03052816|524597996|FG001|Overall Study|Withdrawal by Subject|0|||
145477153|NCT03052816|524597995|FG000|Overall Study|Desired opioids|2|||
145477154|NCT03052816|524597996|FG001|Overall Study|Desired opioids|0|||
145477155|NCT03755661|524597997|FG000|Overall Study|Lost to Follow-up|1|||
145477156|NCT03755661|524597998|FG001|Overall Study|Lost to Follow-up|0|||
145477157|NCT00931606|524600930|FG000|Overall Study|Death|1|||
145477158|NCT00931606|524600931|FG001|Overall Study|Death|3|||
145477159|NCT00931606|524600932|FG002|Overall Study|Death|2|||
145477160|NCT00931606|524600933|FG003|Overall Study|Death|0|||
145477161|NCT00931606|524600930|FG000|Overall Study|Lost to Follow-up|0|||
145477162|NCT00931606|524600931|FG001|Overall Study|Lost to Follow-up|1|||
145477163|NCT00931606|524600932|FG002|Overall Study|Lost to Follow-up|0|||
145477164|NCT00931606|524600933|FG003|Overall Study|Lost to Follow-up|0|||
145477165|NCT00931606|524600930|FG000|Overall Study|Physician Decision|0|||
145477166|NCT00931606|524600931|FG001|Overall Study|Physician Decision|0|||
145477167|NCT00931606|524600932|FG002|Overall Study|Physician Decision|3|||
145477168|NCT00931606|524600933|FG003|Overall Study|Physician Decision|0|||
145477169|NCT00931606|524600930|FG000|Overall Study|Sponsor Decision|1|||
145477170|NCT00931606|524600931|FG001|Overall Study|Sponsor Decision|4|||
145477171|NCT00931606|524600932|FG002|Overall Study|Sponsor Decision|0|||
145477172|NCT00931606|524600933|FG003|Overall Study|Sponsor Decision|2|||
145477173|NCT00931606|524600930|FG000|Overall Study|Withdrawal by Subject|3|||
145477174|NCT00931606|524600931|FG001|Overall Study|Withdrawal by Subject|1|||
145477175|NCT00931606|524600932|FG002|Overall Study|Withdrawal by Subject|1|||
145477176|NCT00931606|524600933|FG003|Overall Study|Withdrawal by Subject|1|||
145477177|NCT00871338|524600938|FG000|Prior to Booster|Withdrawal by Subject|1|||
145477178|NCT00871338|524600939|FG001|Prior to Booster|Withdrawal by Subject|3|||
145477179|NCT00871338|524600938|FG000|Prior to Booster|Lost to Follow-up|1|||
145477180|NCT00871338|524600939|FG001|Prior to Booster|Lost to Follow-up|0|||
145477181|NCT02391363|524600940|FG000|Overall Study|Lost to Follow-up|5|||
145477182|NCT02391363|524600941|FG001|Overall Study|Lost to Follow-up|5|||
145477183|NCT02391363|524600940|FG000|Overall Study|Withdrawal by Subject|6|||
145477184|NCT02391363|524600941|FG001|Overall Study|Withdrawal by Subject|3|||
145477185|NCT00799266|524600944|FG000|Overall Study|Adverse Event|0|||
145477186|NCT00799266|524600945|FG001|Overall Study|Adverse Event|1|||
145477187|NCT00799266|524600944|FG000|Overall Study|Subject withdrew consent|3|||
145477188|NCT00799266|524600945|FG001|Overall Study|Subject withdrew consent|0|||
145477189|NCT01016600|524600946|FG000|Overall Study|Did not start treatment|1|||
145633064|NCT01909336|525170739|FG002|Overall Study|Physician Decision|1|||
145477190|NCT01016600|524600947|FG001|Overall Study|Did not start treatment|0|||
145477191|NCT01016600|524600948|FG002|Overall Study|Did not start treatment|0|||
145477192|NCT01016600|524600949|FG003|Overall Study|Did not start treatment|0|||
145477193|NCT01702025|524600953|FG000|Overall Study|Equipment failure|1|||
145477194|NCT01702025|524600954|FG001|Overall Study|Equipment failure|0|||
145477195|NCT01702025|524600955|FG002|Overall Study|Equipment failure|0|||
145477196|NCT01702025|524600956|FG003|Overall Study|Equipment failure|0|||
145477197|NCT01702025|524600953|FG000|Overall Study|Adverse Event|1|||
145477198|NCT01702025|524600954|FG001|Overall Study|Adverse Event|1|||
145477199|NCT01702025|524600955|FG002|Overall Study|Adverse Event|1|||
145477200|NCT01702025|524600956|FG003|Overall Study|Adverse Event|0|||
145477201|NCT00265317|524600959|FG000|Lead-In|Objective progression or relapse|6|||
145477202|NCT00265317|524600960|FG001|Lead-In|Objective progression or relapse|11|||
145477203|NCT00265317|524600961|FG002|Lead-In|Objective progression or relapse|0|||
145477204|NCT00265317|524600962|FG003|Lead-In|Objective progression or relapse|0|||
145477205|NCT00265317|524600959|FG000|Lead-In|Adverse Event|2|||
145477206|NCT00265317|524600960|FG001|Lead-In|Adverse Event|1|||
145477207|NCT00265317|524600961|FG002|Lead-In|Adverse Event|0|||
145477208|NCT00265317|524600962|FG003|Lead-In|Adverse Event|0|||
145477209|NCT00265317|524600959|FG000|Lead-In|Death|3|||
145477210|NCT00265317|524600960|FG001|Lead-In|Death|5|||
145477211|NCT00265317|524600961|FG002|Lead-In|Death|0|||
145477212|NCT00265317|524600962|FG003|Lead-In|Death|0|||
145477213|NCT00265317|524600959|FG000|Lead-In|Withdrawal/other than adverse event|1|||
145477214|NCT00265317|524600960|FG001|Lead-In|Withdrawal/other than adverse event|0|||
145477215|NCT00265317|524600961|FG002|Lead-In|Withdrawal/other than adverse event|0|||
145477216|NCT00265317|524600962|FG003|Lead-In|Withdrawal/other than adverse event|0|||
145477217|NCT00265317|524600959|FG000|Phase 2|Objective progression or relapse|0|||
145477218|NCT00265317|524600960|FG001|Phase 2|Objective progression or relapse|0|||
145477219|NCT00265317|524600961|FG002|Phase 2|Objective progression or relapse|37|||
145477220|NCT00265317|524600962|FG003|Phase 2|Objective progression or relapse|38|||
145477221|NCT00265317|524600959|FG000|Phase 2|Global deterioration of health status|0|||
145477222|NCT00265317|524600960|FG001|Phase 2|Global deterioration of health status|0|||
145477223|NCT00265317|524600961|FG002|Phase 2|Global deterioration of health status|3|||
145477224|NCT00265317|524600962|FG003|Phase 2|Global deterioration of health status|0|||
145477225|NCT00265317|524600959|FG000|Phase 2|Adverse Event|0|||
145477226|NCT00265317|524600960|FG001|Phase 2|Adverse Event|0|||
145477227|NCT00265317|524600961|FG002|Phase 2|Adverse Event|7|||
145477228|NCT00265317|524600962|FG003|Phase 2|Adverse Event|5|||
145477229|NCT00265317|524600959|FG000|Phase 2|Death|0|||
145477230|NCT00265317|524600960|FG001|Phase 2|Death|0|||
145477231|NCT00265317|524600961|FG002|Phase 2|Death|12|||
145477232|NCT00265317|524600962|FG003|Phase 2|Death|15|||
145477233|NCT00265317|524600959|FG000|Phase 2|Protocol Violation|0|||
145477234|NCT00265317|524600960|FG001|Phase 2|Protocol Violation|0|||
145477235|NCT00265317|524600961|FG002|Phase 2|Protocol Violation|1|||
145477236|NCT00265317|524600962|FG003|Phase 2|Protocol Violation|4|||
145477237|NCT00265317|524600959|FG000|Phase 2|Lost to Follow-up|0|||
145477238|NCT00265317|524600960|FG001|Phase 2|Lost to Follow-up|0|||
145477239|NCT00265317|524600961|FG002|Phase 2|Lost to Follow-up|0|||
145477240|NCT00265317|524600962|FG003|Phase 2|Lost to Follow-up|1|||
145477241|NCT00265317|524600959|FG000|Phase 2|Withdrawal/other than adverse event|0|||
145477242|NCT00265317|524600960|FG001|Phase 2|Withdrawal/other than adverse event|0|||
145477243|NCT00265317|524600961|FG002|Phase 2|Withdrawal/other than adverse event|2|||
145477244|NCT00265317|524600962|FG003|Phase 2|Withdrawal/other than adverse event|1|||
145477245|NCT00265317|524600959|FG000|Phase 2|Study terminated by sponsor|0|||
145477246|NCT00265317|524600960|FG001|Phase 2|Study terminated by sponsor|0|||
145477247|NCT00265317|524600961|FG002|Phase 2|Study terminated by sponsor|1|||
145477248|NCT00265317|524600962|FG003|Phase 2|Study terminated by sponsor|0|||
145477249|NCT00265317|524600959|FG000|Phase 2|Other|0|||
145477250|NCT00265317|524600960|FG001|Phase 2|Other|0|||
145477251|NCT00265317|524600961|FG002|Phase 2|Other|1|||
145477252|NCT00265317|524600962|FG003|Phase 2|Other|1|||
145477253|NCT00801229|524600963|FG000|Signed Consent|Withdrawal by Subject|2|||
145477254|NCT00801229|524600964|FG001|Signed Consent|Withdrawal by Subject|2|||
145477255|NCT00801229|524600963|FG000|Signed Consent|Found Ineligible|1|||
145477256|NCT00801229|524600964|FG001|Signed Consent|Found Ineligible|1|||
145477257|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
145477258|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
145477259|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
145477260|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
145477261|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
145477262|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
145477263|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
145477264|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
145477265|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
145477266|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
145477267|NCT00801229|524600963|FG000|Received Study Drug/Placebo|Adverse Event|1|||
145477268|NCT00801229|524600964|FG001|Received Study Drug/Placebo|Adverse Event|1|||
145477269|NCT00732875|524600965|FG000|Overall Study|Adverse Event|16|||
145477270|NCT00732875|524600965|FG000|Overall Study|Withdrawal by Subject|6|||
145477271|NCT00732875|524600965|FG000|Overall Study|Lack of Efficacy|13|||
145477272|NCT03826186|524600968|FG000|Overall Study|Protocol Violation|2|||
145477273|NCT03826186|524600969|FG001|Overall Study|Protocol Violation|0|||
145477274|NCT03826186|524600968|FG000|Overall Study|Withdrawal by Subject|1|||
145477275|NCT03826186|524600969|FG001|Overall Study|Withdrawal by Subject|0|||
145477276|NCT02300259|524600970|FG000|Period 1|Adverse Event|0|||
145477277|NCT02300259|524600971|FG001|Period 1|Adverse Event|0|||
145477278|NCT02300259|524600972|FG002|Period 1|Adverse Event|1|||
145477279|NCT02300259|524600970|FG000|Period 1|Withdrawal by Subject|0|||
145477280|NCT02300259|524600971|FG001|Period 1|Withdrawal by Subject|0|||
145477281|NCT02300259|524600972|FG002|Period 1|Withdrawal by Subject|1|||
145477282|NCT02300259|524600970|FG000|Period 2|Adverse Event|1|||
145477283|NCT02300259|524600971|FG001|Period 2|Adverse Event|0|||
145477284|NCT02300259|524600972|FG002|Period 2|Adverse Event|0|||
145477285|NCT02300259|524600970|FG000|Period 2|Withdrawal by Subject|0|||
145477286|NCT02300259|524600971|FG001|Period 2|Withdrawal by Subject|0|||
145477287|NCT02300259|524600972|FG002|Period 2|Withdrawal by Subject|1|||
145477288|NCT02737475|524600973|FG000|Overall Study|Other reasons|0|||
145477289|NCT02737475|524600974|FG001|Overall Study|Other reasons|0|||
145477290|NCT02737475|524600975|FG002|Overall Study|Other reasons|0|||
145477291|NCT02737475|524600976|FG003|Overall Study|Other reasons|0|||
145477292|NCT02737475|524600977|FG004|Overall Study|Other reasons|1|||
145477293|NCT02737475|524600978|FG005|Overall Study|Other reasons|1|||
145477294|NCT02737475|524600979|FG006|Overall Study|Other reasons|0|||
145477295|NCT02737475|524600980|FG007|Overall Study|Other reasons|0|||
145477296|NCT02737475|524600981|FG008|Overall Study|Other reasons|1|||
145477297|NCT02737475|524600982|FG009|Overall Study|Other reasons|0|||
145477298|NCT02737475|524600983|FG010|Overall Study|Other reasons|1|||
145477299|NCT02737475|524600984|FG011|Overall Study|Other reasons|0|||
145477300|NCT02737475|524600985|FG012|Overall Study|Other reasons|0|||
145477301|NCT02737475|524600986|FG013|Overall Study|Other reasons|0|||
145477302|NCT02737475|524600987|FG014|Overall Study|Other reasons|0|||
145477303|NCT02737475|524600988|FG015|Overall Study|Other reasons|0|||
145477304|NCT02737475|524600989|FG016|Overall Study|Other reasons|0|||
145477305|NCT02737475|524600990|FG017|Overall Study|Other reasons|0|||
145477306|NCT02737475|524600991|FG018|Overall Study|Other reasons|0|||
145477307|NCT02737475|524600992|FG019|Overall Study|Other reasons|0|||
145477308|NCT02737475|524600993|FG020|Overall Study|Other reasons|0|||
145477309|NCT02737475|524600994|FG021|Overall Study|Other reasons|1|||
145477310|NCT02737475|524600995|FG022|Overall Study|Other reasons|0|||
145477311|NCT02737475|524600996|FG023|Overall Study|Other reasons|1|||
145477312|NCT02737475|524600997|FG024|Overall Study|Other reasons|1|||
145477313|NCT02737475|524600998|FG025|Overall Study|Other reasons|1|||
145477314|NCT02737475|524600999|FG026|Overall Study|Other reasons|0|||
145477315|NCT02737475|524600973|FG000|Overall Study|Death|1|||
145477316|NCT02737475|524600974|FG001|Overall Study|Death|0|||
145477317|NCT02737475|524600975|FG002|Overall Study|Death|0|||
145477318|NCT02737475|524600976|FG003|Overall Study|Death|1|||
145477319|NCT02737475|524600977|FG004|Overall Study|Death|0|||
145477320|NCT02737475|524600978|FG005|Overall Study|Death|0|||
145477321|NCT02737475|524600979|FG006|Overall Study|Death|0|||
145477322|NCT02737475|524600980|FG007|Overall Study|Death|2|||
145477323|NCT02737475|524600981|FG008|Overall Study|Death|0|||
145477324|NCT02737475|524600982|FG009|Overall Study|Death|0|||
145477325|NCT02737475|524600983|FG010|Overall Study|Death|0|||
145477326|NCT02737475|524600984|FG011|Overall Study|Death|4|||
145477327|NCT02737475|524600985|FG012|Overall Study|Death|2|||
145477328|NCT02737475|524600986|FG013|Overall Study|Death|2|||
145477329|NCT02737475|524600987|FG014|Overall Study|Death|0|||
145477330|NCT02737475|524600988|FG015|Overall Study|Death|2|||
145477331|NCT02737475|524600989|FG016|Overall Study|Death|2|||
145477332|NCT02737475|524600990|FG017|Overall Study|Death|2|||
145477333|NCT02737475|524600991|FG018|Overall Study|Death|1|||
145477334|NCT02737475|524600992|FG019|Overall Study|Death|0|||
145477335|NCT02737475|524600993|FG020|Overall Study|Death|0|||
145477336|NCT02737475|524600994|FG021|Overall Study|Death|0|||
145477337|NCT02737475|524600995|FG022|Overall Study|Death|0|||
145477338|NCT02737475|524600996|FG023|Overall Study|Death|0|||
145477339|NCT02737475|524600997|FG024|Overall Study|Death|0|||
145477340|NCT02737475|524600998|FG025|Overall Study|Death|0|||
145477341|NCT02737475|524600999|FG026|Overall Study|Death|0|||
145477342|NCT02737475|524600973|FG000|Overall Study|Participant withdrew consent|0|||
145477343|NCT02737475|524600974|FG001|Overall Study|Participant withdrew consent|0|||
145477344|NCT02737475|524600975|FG002|Overall Study|Participant withdrew consent|0|||
145477345|NCT02737475|524600976|FG003|Overall Study|Participant withdrew consent|0|||
145477346|NCT02737475|524600977|FG004|Overall Study|Participant withdrew consent|0|||
145477347|NCT02737475|524600978|FG005|Overall Study|Participant withdrew consent|2|||
145477348|NCT02737475|524600979|FG006|Overall Study|Participant withdrew consent|0|||
145477349|NCT02737475|524600980|FG007|Overall Study|Participant withdrew consent|0|||
145633065|NCT01235949|525170740|FG000|Primary Phase|Migrated/moved from study area|1|||
145477350|NCT02737475|524600981|FG008|Overall Study|Participant withdrew consent|0|||
145477351|NCT02737475|524600982|FG009|Overall Study|Participant withdrew consent|0|||
145477352|NCT02737475|524600983|FG010|Overall Study|Participant withdrew consent|0|||
145477353|NCT02737475|524600984|FG011|Overall Study|Participant withdrew consent|0|||
145633066|NCT01235949|525170741|FG001|Primary Phase|Migrated/moved from study area|1|||
145633067|NCT01235949|525170742|FG002|Primary Phase|Migrated/moved from study area|0|||
145477354|NCT02737475|524600985|FG012|Overall Study|Participant withdrew consent|0|||
145477355|NCT02737475|524600986|FG013|Overall Study|Participant withdrew consent|0|||
145477356|NCT02737475|524600987|FG014|Overall Study|Participant withdrew consent|1|||
145477357|NCT02737475|524600988|FG015|Overall Study|Participant withdrew consent|0|||
145477358|NCT02737475|524600989|FG016|Overall Study|Participant withdrew consent|0|||
145477359|NCT02737475|524600990|FG017|Overall Study|Participant withdrew consent|2|||
145477360|NCT02737475|524600991|FG018|Overall Study|Participant withdrew consent|1|||
145477361|NCT02737475|524600992|FG019|Overall Study|Participant withdrew consent|0|||
145477362|NCT02737475|524600993|FG020|Overall Study|Participant withdrew consent|2|||
145477363|NCT02737475|524600994|FG021|Overall Study|Participant withdrew consent|0|||
145477364|NCT02737475|524600995|FG022|Overall Study|Participant withdrew consent|0|||
145477365|NCT02737475|524600996|FG023|Overall Study|Participant withdrew consent|0|||
145477366|NCT02737475|524600997|FG024|Overall Study|Participant withdrew consent|0|||
145477367|NCT02737475|524600998|FG025|Overall Study|Participant withdrew consent|0|||
145477368|NCT02737475|524600999|FG026|Overall Study|Participant withdrew consent|0|||
145477369|NCT02737475|524600973|FG000|Overall Study|Lost to Follow-up|0|||
145477370|NCT02737475|524600974|FG001|Overall Study|Lost to Follow-up|0|||
145477371|NCT02737475|524600975|FG002|Overall Study|Lost to Follow-up|0|||
145477372|NCT02737475|524600976|FG003|Overall Study|Lost to Follow-up|0|||
145477373|NCT02737475|524600977|FG004|Overall Study|Lost to Follow-up|0|||
145477374|NCT02737475|524600978|FG005|Overall Study|Lost to Follow-up|0|||
145477375|NCT02737475|524600979|FG006|Overall Study|Lost to Follow-up|0|||
145477376|NCT02737475|524600980|FG007|Overall Study|Lost to Follow-up|0|||
145477377|NCT02737475|524600981|FG008|Overall Study|Lost to Follow-up|0|||
145477378|NCT02737475|524600982|FG009|Overall Study|Lost to Follow-up|0|||
145477379|NCT02737475|524600983|FG010|Overall Study|Lost to Follow-up|0|||
145477380|NCT02737475|524600984|FG011|Overall Study|Lost to Follow-up|0|||
145477381|NCT02737475|524600985|FG012|Overall Study|Lost to Follow-up|0|||
145477382|NCT02737475|524600986|FG013|Overall Study|Lost to Follow-up|0|||
145477383|NCT02737475|524600987|FG014|Overall Study|Lost to Follow-up|0|||
145477384|NCT02737475|524600988|FG015|Overall Study|Lost to Follow-up|1|||
145477385|NCT02737475|524600989|FG016|Overall Study|Lost to Follow-up|0|||
145477386|NCT02737475|524600990|FG017|Overall Study|Lost to Follow-up|0|||
145477387|NCT02737475|524600991|FG018|Overall Study|Lost to Follow-up|0|||
145477388|NCT02737475|524600992|FG019|Overall Study|Lost to Follow-up|0|||
145477389|NCT02737475|524600993|FG020|Overall Study|Lost to Follow-up|0|||
145477390|NCT02737475|524600994|FG021|Overall Study|Lost to Follow-up|0|||
145477391|NCT02737475|524600995|FG022|Overall Study|Lost to Follow-up|0|||
145477392|NCT02737475|524600996|FG023|Overall Study|Lost to Follow-up|0|||
145477393|NCT02737475|524600997|FG024|Overall Study|Lost to Follow-up|0|||
145477394|NCT02737475|524600998|FG025|Overall Study|Lost to Follow-up|0|||
145477395|NCT02737475|524600999|FG026|Overall Study|Lost to Follow-up|0|||
145477396|NCT02737475|524600973|FG000|Overall Study|Disease Progression|0|||
145477397|NCT02737475|524600974|FG001|Overall Study|Disease Progression|0|||
145477398|NCT02737475|524600975|FG002|Overall Study|Disease Progression|0|||
145477399|NCT02737475|524600976|FG003|Overall Study|Disease Progression|0|||
145477400|NCT02737475|524600977|FG004|Overall Study|Disease Progression|0|||
145477401|NCT02737475|524600978|FG005|Overall Study|Disease Progression|0|||
145477402|NCT02737475|524600979|FG006|Overall Study|Disease Progression|0|||
145477403|NCT02737475|524600980|FG007|Overall Study|Disease Progression|0|||
145477404|NCT02737475|524600981|FG008|Overall Study|Disease Progression|0|||
145477405|NCT02737475|524600982|FG009|Overall Study|Disease Progression|0|||
145477406|NCT02737475|524600983|FG010|Overall Study|Disease Progression|0|||
145477407|NCT02737475|524600984|FG011|Overall Study|Disease Progression|0|||
145477408|NCT02737475|524600985|FG012|Overall Study|Disease Progression|0|||
145477409|NCT02737475|524600986|FG013|Overall Study|Disease Progression|0|||
145477410|NCT02737475|524600987|FG014|Overall Study|Disease Progression|0|||
145477411|NCT02737475|524600988|FG015|Overall Study|Disease Progression|0|||
145477412|NCT02737475|524600989|FG016|Overall Study|Disease Progression|0|||
145477413|NCT02737475|524600990|FG017|Overall Study|Disease Progression|0|||
145477414|NCT02737475|524600991|FG018|Overall Study|Disease Progression|0|||
145477415|NCT02737475|524600992|FG019|Overall Study|Disease Progression|0|||
145477416|NCT02737475|524600993|FG020|Overall Study|Disease Progression|0|||
145477417|NCT02737475|524600994|FG021|Overall Study|Disease Progression|0|||
145477418|NCT02737475|524600995|FG022|Overall Study|Disease Progression|0|||
145477419|NCT02737475|524600996|FG023|Overall Study|Disease Progression|0|||
145477420|NCT02737475|524600997|FG024|Overall Study|Disease Progression|0|||
145477421|NCT02737475|524600998|FG025|Overall Study|Disease Progression|0|||
145477422|NCT02737475|524600999|FG026|Overall Study|Disease Progression|1|||
145477423|NCT04440813|524601004|FG000|Overall Study|Lost to Follow-up|5|||
145477424|NCT04440813|524601005|FG001|Overall Study|Lost to Follow-up|5|||
145477425|NCT02255461|524601006|FG000|Overall Study|Adverse Event|0|||
145477426|NCT02255461|524601007|FG001|Overall Study|Adverse Event|1|||
145477427|NCT02255461|524601008|FG002|Overall Study|Adverse Event|0|||
145477428|NCT02255461|524601009|FG003|Overall Study|Adverse Event|0|||
145477429|NCT02255461|524601010|FG004|Overall Study|Adverse Event|1|||
145477430|NCT02255461|524601006|FG000|Overall Study|Withdrawal by Subject|0|||
145477431|NCT02255461|524601007|FG001|Overall Study|Withdrawal by Subject|0|||
145477432|NCT02255461|524601008|FG002|Overall Study|Withdrawal by Subject|1|||
145477433|NCT02255461|524601009|FG003|Overall Study|Withdrawal by Subject|0|||
145477434|NCT02255461|524601010|FG004|Overall Study|Withdrawal by Subject|1|||
145477435|NCT02255461|524601006|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
145477436|NCT02255461|524601007|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
145477437|NCT02255461|524601008|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
145477438|NCT02255461|524601009|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
145477439|NCT02255461|524601010|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
145477440|NCT02219334|524601011|FG000|Overall Study|Withdrawal by Subject|1|||
145477441|NCT02219334|524601012|FG001|Overall Study|Withdrawal by Subject|0|||
145477442|NCT02219334|524601011|FG000|Overall Study|Protocol Violation|7|||
145477443|NCT02219334|524601012|FG001|Overall Study|Protocol Violation|3|||
145477444|NCT00711971|524601013|FG000|Overall Study|Lost to Follow-up|3|||
145477445|NCT00711971|524601014|FG001|Overall Study|Lost to Follow-up|4|||
145477446|NCT00711971|524601015|FG002|Overall Study|Lost to Follow-up|1|||
145477447|NCT04774926|524601019|FG000|Overall Study|Adverse Event|15|||
145477448|NCT04774926|524601019|FG000|Overall Study|Lost to Follow-up|3|||
145477449|NCT04774926|524601019|FG000|Overall Study|Physician Decision|6|||
145477450|NCT04774926|524601019|FG000|Overall Study|Withdrawal by Subject|3|||
145477451|NCT04774926|524601019|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
145477452|NCT00847886|524601022|FG000|Overall Study|Adverse Event|0|||
145477453|NCT00847886|524601023|FG001|Overall Study|Adverse Event|1|||
145477454|NCT03386487|524601025|FG000|Overall Study|Lost to Follow-up|5|||
145477455|NCT03386487|524601026|FG001|Overall Study|Lost to Follow-up|6|||
145477456|NCT03386487|524601025|FG000|Overall Study|Withdrawal by Subject|11|||
145477457|NCT03386487|524601026|FG001|Overall Study|Withdrawal by Subject|7|||
145477458|NCT03386487|524601025|FG000|Overall Study|Physician Decision|11|||
145477459|NCT03386487|524601026|FG001|Overall Study|Physician Decision|8|||
145477460|NCT04207060|524601029|FG000|Overall Study|Lost to Follow-up|2|||
145477461|NCT04207060|524601030|FG001|Overall Study|Lost to Follow-up|0|||
145477462|NCT01067144|524601031|FG000|Treatment|Did not receive allocated intervention|4|||
145477463|NCT01067144|524601032|FG001|Treatment|Did not receive allocated intervention|7|||
145477464|NCT01067144|524601031|FG000|Follow-up|Lost to Follow-up|22|||
145477465|NCT01067144|524601032|FG001|Follow-up|Lost to Follow-up|12|||
145477466|NCT01067144|524601031|FG000|Follow-up|Censored owing to second surgery|19|||
145477467|NCT01067144|524601032|FG001|Follow-up|Censored owing to second surgery|28|||
145477468|NCT01067144|524601031|FG000|Follow-up|Withdrawal by Subject|18|||
145477469|NCT01067144|524601032|FG001|Follow-up|Withdrawal by Subject|14|||
145477470|NCT01067144|524601031|FG000|Follow-up|Surgery cancelled|0|||
145477471|NCT01067144|524601032|FG001|Follow-up|Surgery cancelled|1|||
145477472|NCT01067144|524601031|FG000|Follow-up|Death|0|||
145477473|NCT01067144|524601032|FG001|Follow-up|Death|1|||
145477474|NCT01835158|524601035|FG000|Overall Study|Withdrawal by Subject|1|||
145477475|NCT01835158|524601036|FG001|Overall Study|Withdrawal by Subject|6|||
145477476|NCT00296140|524601037|FG000|Overall Study|Lost to Follow-up|1|||
145477477|NCT00296140|524601038|FG001|Overall Study|Lost to Follow-up|0|||
145477478|NCT00296140|524601037|FG000|Overall Study|Withdrawal by Subject|1|||
145477479|NCT00296140|524601038|FG001|Overall Study|Withdrawal by Subject|0|||
145477480|NCT00296140|524601037|FG000|Overall Study|Discharge to Nursing Home|1|||
145477481|NCT00296140|524601038|FG001|Overall Study|Discharge to Nursing Home|0|||
145477482|NCT01856582|524601039|FG000|Overall Study|Died prior to Boost infusion|1|||
145477483|NCT00880191|524601040|FG000|Overall Study|Refused further treatment|4|||
145477484|NCT00880191|524601041|FG001|Overall Study|Refused further treatment|1|||
145477485|NCT00880191|524601040|FG000|Overall Study|Adverse Event|8|||
145477486|NCT00880191|524601041|FG001|Overall Study|Adverse Event|6|||
145477487|NCT00880191|524601040|FG000|Overall Study|Hospitalization/efficacy|1|||
145477488|NCT00880191|524601041|FG001|Overall Study|Hospitalization/efficacy|1|||
145477489|NCT01919801|524601044|FG000|Overall Study|Withdrawal by Subject|1|||
145477490|NCT01919801|524601045|FG001|Overall Study|Withdrawal by Subject|0|||
145477491|NCT01919801|524601044|FG000|Overall Study|Physician Decision|0|||
145477492|NCT01919801|524601045|FG001|Overall Study|Physician Decision|1|||
145477493|NCT01919801|524601044|FG000|Overall Study|Lost to Follow-up|0|||
145477494|NCT01919801|524601045|FG001|Overall Study|Lost to Follow-up|1|||
145477495|NCT01919801|524601044|FG000|Overall Study|Other|0|||
145477496|NCT01919801|524601045|FG001|Overall Study|Other|1|||
145477497|NCT01843062|524601046|FG000|Overall Study|Protocol Violation|1|||
145477498|NCT01843062|524601047|FG001|Overall Study|Protocol Violation|0|||
145477499|NCT01843062|524601046|FG000|Overall Study|New treatment following progression|2|||
145477500|NCT01843062|524601047|FG001|Overall Study|New treatment following progression|0|||
145477501|NCT01843062|524601046|FG000|Overall Study|Pregnancy|1|||
145477502|NCT01843062|524601047|FG001|Overall Study|Pregnancy|0|||
145633068|NCT01235949|525170743|FG003|Primary Phase|Migrated/moved from study area|0|||
145633069|NCT01235949|525170744|FG004|Primary Phase|Migrated/moved from study area|1|||
145633070|NCT01235949|525170745|FG005|Primary Phase|Migrated/moved from study area|2|||
145633071|NCT01235949|525170746|FG006|Primary Phase|Migrated/moved from study area|0|||
145477503|NCT01843062|524601046|FG000|Overall Study|Adverse Event|2|||
145477504|NCT01843062|524601047|FG001|Overall Study|Adverse Event|0|||
145477505|NCT01843062|524601046|FG000|Overall Study|Incorrect randomisation|1|||
145477506|NCT01843062|524601047|FG001|Overall Study|Incorrect randomisation|0|||
145477507|NCT01843062|524601046|FG000|Overall Study|Withdrawal by Subject|12|||
145477508|NCT01843062|524601047|FG001|Overall Study|Withdrawal by Subject|3|||
145477509|NCT01843062|524601046|FG000|Overall Study|Death|1|||
145477510|NCT01843062|524601047|FG001|Overall Study|Death|2|||
145477511|NCT01843062|524601046|FG000|Overall Study|Lost to Follow-up|2|||
145477512|NCT01843062|524601047|FG001|Overall Study|Lost to Follow-up|4|||
145477513|NCT01677858|524601048|FG000|Overall Study|Adverse Event|0|||
145477514|NCT01677858|524601049|FG001|Overall Study|Adverse Event|0|||
145477515|NCT01677858|524601050|FG002|Overall Study|Adverse Event|2|||
145477516|NCT01677858|524601051|FG003|Overall Study|Adverse Event|3|||
145477517|NCT01677858|524601052|FG004|Overall Study|Adverse Event|13|||
145477518|NCT01677858|524601048|FG000|Overall Study|Death|0|||
145477519|NCT01677858|524601049|FG001|Overall Study|Death|0|||
145477520|NCT01677858|524601050|FG002|Overall Study|Death|0|||
145477521|NCT01677858|524601051|FG003|Overall Study|Death|0|||
145477522|NCT01677858|524601052|FG004|Overall Study|Death|1|||
145477523|NCT01677858|524601048|FG000|Overall Study|Physician Decision|1|||
145477524|NCT01677858|524601049|FG001|Overall Study|Physician Decision|0|||
145477525|NCT01677858|524601050|FG002|Overall Study|Physician Decision|2|||
145477526|NCT01677858|524601051|FG003|Overall Study|Physician Decision|0|||
145477527|NCT01677858|524601052|FG004|Overall Study|Physician Decision|12|||
145477528|NCT01677858|524601048|FG000|Overall Study|Progressive Disease|2|||
145477529|NCT01677858|524601049|FG001|Overall Study|Progressive Disease|1|||
145477530|NCT01677858|524601050|FG002|Overall Study|Progressive Disease|9|||
145477531|NCT01677858|524601051|FG003|Overall Study|Progressive Disease|3|||
145477532|NCT01677858|524601052|FG004|Overall Study|Progressive Disease|43|||
145477533|NCT01677858|524601048|FG000|Overall Study|Withdrawal by Subject|0|||
145477534|NCT01677858|524601049|FG001|Overall Study|Withdrawal by Subject|1|||
145477535|NCT01677858|524601050|FG002|Overall Study|Withdrawal by Subject|1|||
145477536|NCT01677858|524601051|FG003|Overall Study|Withdrawal by Subject|0|||
145477537|NCT01677858|524601052|FG004|Overall Study|Withdrawal by Subject|15|||
145477538|NCT01677858|524601048|FG000|Overall Study|Lost to Follow-up|0|||
145477539|NCT01677858|524601049|FG001|Overall Study|Lost to Follow-up|0|||
145477540|NCT01677858|524601050|FG002|Overall Study|Lost to Follow-up|0|||
145477541|NCT01677858|524601051|FG003|Overall Study|Lost to Follow-up|0|||
145477542|NCT01677858|524601052|FG004|Overall Study|Lost to Follow-up|1|||
145477543|NCT01331109|524601053|FG000|Overall Study|Adverse Event|6|||
145477544|NCT01331109|524601053|FG000|Overall Study|Lack of Efficacy|2|||
145477545|NCT01331109|524601053|FG000|Overall Study|Protocol Violation|3|||
145477546|NCT01331109|524601053|FG000|Overall Study|Withdrawal by Subject|7|||
145477547|NCT01331109|524601053|FG000|Overall Study|Lost to Follow-up|1|||
145477548|NCT01331109|524601053|FG000|Overall Study|Study Terminated by Sponsor|38|||
145477549|NCT00988091|524601057|FG000|Double-blind Period|Withdrawal by Subject|15|||
145477550|NCT00988091|524601058|FG001|Double-blind Period|Withdrawal by Subject|13|||
145477551|NCT00988091|524601057|FG000|Double-blind Period|Lost to Follow-up|12|||
145477552|NCT00988091|524601058|FG001|Double-blind Period|Lost to Follow-up|14|||
145477553|NCT00988091|524601057|FG000|Double-blind Period|Other|8|||
145477554|NCT00988091|524601058|FG001|Double-blind Period|Other|8|||
145477555|NCT00988091|524601057|FG000|Double-blind Period|Adverse Event|6|||
145477556|NCT00988091|524601058|FG001|Double-blind Period|Adverse Event|9|||
145477557|NCT00988091|524601057|FG000|Double-blind Period|Use of exclusionary medication|2|||
145477558|NCT00988091|524601058|FG001|Double-blind Period|Use of exclusionary medication|3|||
145477559|NCT00988091|524601057|FG000|Open-label Period|Adverse Event|4|||
145477560|NCT00988091|524601058|FG001|Open-label Period|Adverse Event|7|||
145477561|NCT00988091|524601057|FG000|Open-label Period|Use of exclusionary medication|1|||
145477562|NCT00988091|524601058|FG001|Open-label Period|Use of exclusionary medication|1|||
145477563|NCT00988091|524601057|FG000|Open-label Period|Protocol Violation|1|||
145477564|NCT00988091|524601058|FG001|Open-label Period|Protocol Violation|1|||
145477565|NCT00988091|524601057|FG000|Open-label Period|Withdrawal by Subject|10|||
145477566|NCT00988091|524601058|FG001|Open-label Period|Withdrawal by Subject|16|||
145477567|NCT00988091|524601057|FG000|Open-label Period|Lost to Follow-up|3|||
145477568|NCT00988091|524601058|FG001|Open-label Period|Lost to Follow-up|5|||
145477569|NCT00988091|524601057|FG000|Open-label Period|Other|2|||
145477570|NCT00988091|524601058|FG001|Open-label Period|Other|3|||
145477571|NCT02669212|524601061|FG000|Overall Study|Lost to Follow-up|1|||
145477572|NCT02669212|524601062|FG001|Overall Study|Lost to Follow-up|0|||
145477573|NCT02669212|524601061|FG000|Overall Study|Medical Condition|3|||
145477574|NCT02669212|524601062|FG001|Overall Study|Medical Condition|4|||
145477575|NCT02669212|524601061|FG000|Overall Study|Withdrawal by Subject|0|||
145477576|NCT02669212|524601062|FG001|Overall Study|Withdrawal by Subject|2|||
145477577|NCT02669212|524601061|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
145477578|NCT02669212|524601062|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
145477579|NCT03549104|524601063|FG000|Overall Study|Withdrawal by Subject|5|||
145477580|NCT03549104|524601064|FG001|Overall Study|Withdrawal by Subject|2|||
145477581|NCT03549104|524601063|FG000|Overall Study|Covid shelter in place|1|||
145477582|NCT03549104|524601064|FG001|Overall Study|Covid shelter in place|2|||
145477583|NCT03078855|524601068|FG000|Overall Study|Lack of Efficacy|62|||
145477584|NCT03078855|524601069|FG001|Overall Study|Lack of Efficacy|31|||
145477585|NCT03078855|524601068|FG000|Overall Study|Death|1|||
145477586|NCT03078855|524601069|FG001|Overall Study|Death|0|||
145477587|NCT03078855|524601068|FG000|Overall Study|Withdrawal by Subject|12|||
145477588|NCT03078855|524601069|FG001|Overall Study|Withdrawal by Subject|6|||
145477589|NCT03078855|524601068|FG000|Overall Study|Physician Decision|3|||
145477590|NCT03078855|524601069|FG001|Overall Study|Physician Decision|2|||
145477591|NCT03078855|524601068|FG000|Overall Study|Second Malignancy|4|||
145477592|NCT03078855|524601069|FG001|Overall Study|Second Malignancy|0|||
145477593|NCT03078855|524601068|FG000|Overall Study|Ineligible|2|||
145477594|NCT03078855|524601069|FG001|Overall Study|Ineligible|0|||
145477595|NCT03078855|524601068|FG000|Overall Study|Withdrew before day 1 treatment|2|||
145477596|NCT03078855|524601069|FG001|Overall Study|Withdrew before day 1 treatment|1|||
145477597|NCT00391027|524601070|FG000|Overall Study|Adverse Event|8|||
145477598|NCT00391027|524601071|FG001|Overall Study|Adverse Event|8|||
145477599|NCT00391027|524601070|FG000|Overall Study|Lack of Efficacy|3|||
145477600|NCT00391027|524601071|FG001|Overall Study|Lack of Efficacy|0|||
145477601|NCT00391027|524601070|FG000|Overall Study|Withdrawal by Subject|10|||
145477602|NCT00391027|524601071|FG001|Overall Study|Withdrawal by Subject|1|||
145477603|NCT00391027|524601070|FG000|Overall Study|Other|4|||
145477604|NCT00391027|524601071|FG001|Overall Study|Other|3|||
145477605|NCT02951429|524601079|FG000|Overall Study|Adverse Event|3|||
145477606|NCT02951429|524601080|FG001|Overall Study|Adverse Event|7|||
145477607|NCT02951429|524601079|FG000|Overall Study|Death|28|||
145477608|NCT02951429|524601080|FG001|Overall Study|Death|36|||
145477609|NCT02951429|524601079|FG000|Overall Study|Lack of Efficacy|0|||
145477610|NCT02951429|524601080|FG001|Overall Study|Lack of Efficacy|1|||
145477611|NCT02951429|524601079|FG000|Overall Study|Lost to Follow-up|0|||
145477612|NCT02951429|524601080|FG001|Overall Study|Lost to Follow-up|1|||
145477613|NCT02951429|524601079|FG000|Overall Study|Lung Transplantation|9|||
145477614|NCT02951429|524601080|FG001|Overall Study|Lung Transplantation|6|||
145477615|NCT02951429|524601079|FG000|Overall Study|Other|1|||
145477616|NCT02951429|524601080|FG001|Overall Study|Other|3|||
145477617|NCT02951429|524601079|FG000|Overall Study|Progressive Disease|1|||
145477618|NCT02951429|524601080|FG001|Overall Study|Progressive Disease|1|||
145477619|NCT02951429|524601079|FG000|Overall Study|Withdrawal by Subject|7|||
145477620|NCT02951429|524601080|FG001|Overall Study|Withdrawal by Subject|11|||
145477621|NCT02951429|524601079|FG000|Overall Study|Participant ongoing in the study|23|||
145477622|NCT02951429|524601080|FG001|Overall Study|Participant ongoing in the study|17|||
145477623|NCT01620528|524601081|FG000|Treatment Period|Did Not Receive Study Drug|0|||
145477624|NCT01620528|524601082|FG001|Treatment Period|Did Not Receive Study Drug|0|||
145477625|NCT01620528|524601083|FG002|Treatment Period|Did Not Receive Study Drug|1|||
145477626|NCT01620528|524601081|FG000|Treatment Period|Withdrawal by Subject|35|||
145477627|NCT01620528|524601082|FG001|Treatment Period|Withdrawal by Subject|21|||
145477628|NCT01620528|524601083|FG002|Treatment Period|Withdrawal by Subject|16|||
145477629|NCT01620528|524601081|FG000|Treatment Period|Adverse Event|17|||
145477630|NCT01620528|524601082|FG001|Treatment Period|Adverse Event|13|||
145477631|NCT01620528|524601083|FG002|Treatment Period|Adverse Event|21|||
145477632|NCT01620528|524601081|FG000|Treatment Period|Lost to Follow-up|16|||
145477633|NCT01620528|524601082|FG001|Treatment Period|Lost to Follow-up|8|||
145477634|NCT01620528|524601083|FG002|Treatment Period|Lost to Follow-up|14|||
145477635|NCT01620528|524601081|FG000|Treatment Period|Other|9|||
145477636|NCT01620528|524601082|FG001|Treatment Period|Other|5|||
145477637|NCT01620528|524601083|FG002|Treatment Period|Other|7|||
145477638|NCT01620528|524601081|FG000|Treatment Period|Subject Noncompliant|11|||
145477639|NCT01620528|524601082|FG001|Treatment Period|Subject Noncompliant|2|||
145477640|NCT01620528|524601083|FG002|Treatment Period|Subject Noncompliant|2|||
145477641|NCT01620528|524601081|FG000|Treatment Period|Pregnancy|7|||
145477642|NCT01620528|524601082|FG001|Treatment Period|Pregnancy|2|||
145477643|NCT01620528|524601083|FG002|Treatment Period|Pregnancy|2|||
145477644|NCT01620528|524601081|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
145477645|NCT01620528|524601082|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
145477646|NCT01620528|524601083|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
145477647|NCT01620528|524601081|FG000|Treatment Period|Exclusionary Medication Received|0|||
145477648|NCT01620528|524601082|FG001|Treatment Period|Exclusionary Medication Received|1|||
145477649|NCT01620528|524601083|FG002|Treatment Period|Exclusionary Medication Received|0|||
145477650|NCT01620528|524601081|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
145477651|NCT01620528|524601082|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
145477652|NCT01620528|524601083|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
145477653|NCT01620528|524601081|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
145477654|NCT01620528|524601082|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145477655|NCT01620528|524601083|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
145477656|NCT01620528|524601081|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
145477657|NCT01620528|524601082|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
145633072|NCT01235949|525170747|FG007|Primary Phase|Migrated/moved from study area|0|||
145477658|NCT01620528|524601083|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
145477659|NCT01620528|524601081|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
145477660|NCT01620528|524601082|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
145477661|NCT01620528|524601083|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
145477662|NCT01620528|524601081|FG000|Post-Treatment Follow-Up Period|Other|6|||
145477663|NCT01620528|524601082|FG001|Post-Treatment Follow-Up Period|Other|4|||
145477664|NCT01620528|524601083|FG002|Post-Treatment Follow-Up Period|Other|2|||
145477665|NCT03664765|524601086|FG000|Overall Study|Withdrawal by Subject|4|||
145477666|NCT03664765|524601087|FG001|Overall Study|Withdrawal by Subject|1|||
145477667|NCT03664765|524601086|FG000|Overall Study|Lost to Follow-up|0|||
145477668|NCT03664765|524601087|FG001|Overall Study|Lost to Follow-up|1|||
145477669|NCT00767819|524601088|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
145477670|NCT00767819|524601089|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
145477671|NCT00767819|524601090|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
145477672|NCT00767819|524601088|FG000|Overall Study|Withdrawal by Subject|1|||
145477673|NCT00767819|524601089|FG001|Overall Study|Withdrawal by Subject|1|||
145477674|NCT00767819|524601090|FG002|Overall Study|Withdrawal by Subject|0|||
145477675|NCT00767819|524601088|FG000|Overall Study|Administrative problems|0|||
145477676|NCT00767819|524601089|FG001|Overall Study|Administrative problems|1|||
145477677|NCT00767819|524601090|FG002|Overall Study|Administrative problems|0|||
145477678|NCT00767819|524601088|FG000|Overall Study|Death|2|||
145477679|NCT00767819|524601089|FG001|Overall Study|Death|3|||
145477680|NCT00767819|524601090|FG002|Overall Study|Death|0|||
145477681|NCT00767819|524601088|FG000|Overall Study|Adverse Event|2|||
145477682|NCT00767819|524601089|FG001|Overall Study|Adverse Event|0|||
145477683|NCT00767819|524601090|FG002|Overall Study|Adverse Event|0|||
145477684|NCT00767819|524601088|FG000|Overall Study|Abnormal lab values|1|||
145477685|NCT00767819|524601089|FG001|Overall Study|Abnormal lab values|0|||
145477686|NCT00767819|524601090|FG002|Overall Study|Abnormal lab values|0|||
145477687|NCT00767819|524601088|FG000|Overall Study|Lost to Follow-up|1|||
145477688|NCT00767819|524601089|FG001|Overall Study|Lost to Follow-up|0|||
145477689|NCT00767819|524601090|FG002|Overall Study|Lost to Follow-up|0|||
145477690|NCT04038567|524601092|FG000|Overall Study|Lost to Follow-up|6|||
145477691|NCT04038567|524601093|FG001|Overall Study|Lost to Follow-up|4|||
145477692|NCT04038567|524601094|FG002|Overall Study|Lost to Follow-up|5|||
145477693|NCT04038567|524601095|FG003|Overall Study|Lost to Follow-up|4|||
145477694|NCT04038567|524601096|FG004|Overall Study|Lost to Follow-up|6|||
145477695|NCT04038567|524601097|FG005|Overall Study|Lost to Follow-up|4|||
145477696|NCT04038567|524601098|FG006|Overall Study|Lost to Follow-up|4|||
145477697|NCT04038567|524601099|FG007|Overall Study|Lost to Follow-up|1|||
145477698|NCT04038567|524601092|FG000|Overall Study|Withdrawal by Subject|2|||
145477699|NCT04038567|524601093|FG001|Overall Study|Withdrawal by Subject|1|||
145477700|NCT04038567|524601094|FG002|Overall Study|Withdrawal by Subject|1|||
145477701|NCT04038567|524601095|FG003|Overall Study|Withdrawal by Subject|1|||
145477702|NCT04038567|524601096|FG004|Overall Study|Withdrawal by Subject|4|||
145477703|NCT04038567|524601097|FG005|Overall Study|Withdrawal by Subject|1|||
145477704|NCT04038567|524601098|FG006|Overall Study|Withdrawal by Subject|1|||
145477705|NCT04038567|524601099|FG007|Overall Study|Withdrawal by Subject|1|||
145477706|NCT04038567|524601092|FG000|Overall Study|missed survey window|1|||
145477707|NCT04038567|524601093|FG001|Overall Study|missed survey window|2|||
145477708|NCT04038567|524601094|FG002|Overall Study|missed survey window|0|||
145477709|NCT04038567|524601095|FG003|Overall Study|missed survey window|0|||
145477710|NCT04038567|524601096|FG004|Overall Study|missed survey window|1|||
145477711|NCT04038567|524601097|FG005|Overall Study|missed survey window|1|||
145477712|NCT04038567|524601098|FG006|Overall Study|missed survey window|2|||
145477713|NCT04038567|524601099|FG007|Overall Study|missed survey window|2|||
145477714|NCT04038567|524601092|FG000|Overall Study|technical issues|0|||
145477715|NCT04038567|524601093|FG001|Overall Study|technical issues|0|||
145477716|NCT04038567|524601094|FG002|Overall Study|technical issues|0|||
145477717|NCT04038567|524601095|FG003|Overall Study|technical issues|0|||
145477718|NCT04038567|524601096|FG004|Overall Study|technical issues|0|||
145477719|NCT04038567|524601097|FG005|Overall Study|technical issues|0|||
145477720|NCT04038567|524601098|FG006|Overall Study|technical issues|1|||
145477721|NCT04038567|524601099|FG007|Overall Study|technical issues|0|||
145477722|NCT04038567|524601092|FG000|Overall Study|Medical issues (i.e., illness)|0|||
145477723|NCT04038567|524601093|FG001|Overall Study|Medical issues (i.e., illness)|1|||
145477724|NCT04038567|524601094|FG002|Overall Study|Medical issues (i.e., illness)|2|||
145477725|NCT04038567|524601095|FG003|Overall Study|Medical issues (i.e., illness)|1|||
145477726|NCT04038567|524601096|FG004|Overall Study|Medical issues (i.e., illness)|1|||
145477727|NCT04038567|524601097|FG005|Overall Study|Medical issues (i.e., illness)|1|||
145477728|NCT04038567|524601098|FG006|Overall Study|Medical issues (i.e., illness)|0|||
145477729|NCT04038567|524601099|FG007|Overall Study|Medical issues (i.e., illness)|0|||
145477730|NCT04038567|524601092|FG000|Overall Study|Death|0|||
145477731|NCT04038567|524601093|FG001|Overall Study|Death|0|||
145477732|NCT04038567|524601094|FG002|Overall Study|Death|0|||
145477733|NCT04038567|524601095|FG003|Overall Study|Death|1|||
145477734|NCT04038567|524601096|FG004|Overall Study|Death|1|||
145477735|NCT04038567|524601097|FG005|Overall Study|Death|0|||
145477736|NCT04038567|524601098|FG006|Overall Study|Death|0|||
145477737|NCT04038567|524601099|FG007|Overall Study|Death|1|||
145633073|NCT01235949|525170748|FG008|Primary Phase|Migrated/moved from study area|0|||
145633074|NCT01235949|525170749|FG009|Primary Phase|Migrated/moved from study area|0|||
145477738|NCT01628965|524601104|FG000|Overall Study|Adverse Event|30|||
145477739|NCT01628965|524601104|FG000|Overall Study|Lack of Efficacy|7|||
145633075|NCT01235949|525170750|FG010|Primary Phase|Migrated/moved from study area|0|||
145477740|NCT01628965|524601104|FG000|Overall Study|Withdrawal by Subject|3|||
145477741|NCT01628965|524601104|FG000|Overall Study|Lost to Follow-up|1|||
145477742|NCT01628965|524601104|FG000|Overall Study|Discontinuation criteria|8|||
145477743|NCT04356352|524601107|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
145477744|NCT04356352|524601108|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
145477745|NCT04356352|524601109|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
145477746|NCT04356352|524601107|FG000|Overall Study|Protocol Violation|0|||
145477747|NCT04356352|524601108|FG001|Overall Study|Protocol Violation|3|||
145477748|NCT04356352|524601109|FG002|Overall Study|Protocol Violation|1|||
145477749|NCT01138501|524601110|FG000|Overall Study|Protocol Violation|2|||
145477750|NCT01138501|524601110|FG000|Overall Study|Withdrawal by Subject|3|||
145477751|NCT00825812|524601112|FG000|Overall Study|Never entered follow up|0|||
145477752|NCT00825812|524601113|FG001|Overall Study|Never entered follow up|0|||
145477753|NCT00825812|524601114|FG002|Overall Study|Never entered follow up|0|||
145477754|NCT00825812|524601115|FG003|Overall Study|Never entered follow up|1|||
145477755|NCT00825812|524601112|FG000|Overall Study|Adverse Event|0|||
145477756|NCT00825812|524601113|FG001|Overall Study|Adverse Event|0|||
145477757|NCT00825812|524601114|FG002|Overall Study|Adverse Event|0|||
145477758|NCT00825812|524601115|FG003|Overall Study|Adverse Event|1|||
145477759|NCT00825812|524601112|FG000|Overall Study|Subject withdrew consent|0|||
145477760|NCT00825812|524601113|FG001|Overall Study|Subject withdrew consent|0|||
145477761|NCT00825812|524601114|FG002|Overall Study|Subject withdrew consent|3|||
145477762|NCT00825812|524601115|FG003|Overall Study|Subject withdrew consent|2|||
145477763|NCT00825812|524601112|FG000|Overall Study|Non-compliance with protocol|0|||
145477764|NCT00825812|524601113|FG001|Overall Study|Non-compliance with protocol|0|||
145477765|NCT00825812|524601114|FG002|Overall Study|Non-compliance with protocol|0|||
145477766|NCT00825812|524601115|FG003|Overall Study|Non-compliance with protocol|1|||
145477767|NCT00825812|524601112|FG000|Overall Study|Administrative|0|||
145477768|NCT00825812|524601113|FG001|Overall Study|Administrative|1|||
145477769|NCT00825812|524601114|FG002|Overall Study|Administrative|3|||
145477770|NCT00825812|524601115|FG003|Overall Study|Administrative|5|||
145477771|NCT00895453|524601116|FG000|Overall Study|Lost to Follow-up|25|||
145477772|NCT00895453|524601117|FG001|Overall Study|Lost to Follow-up|25|||
145477773|NCT00895453|524601118|FG002|Overall Study|Lost to Follow-up|23|||
145477774|NCT01736618|524601121|FG000|Overall Study|Death|294|||
145477775|NCT01736618|524601121|FG000|Overall Study|Lost to Follow-up|193|||
145477776|NCT01736618|524601121|FG000|Overall Study|Withdrawal by Subject|54|||
145477777|NCT01736618|524601121|FG000|Overall Study|Subject unable to be followed at study location|223|||
145477778|NCT01736618|524601121|FG000|Overall Study|Physician Decision|33|||
145477779|NCT01736618|524601121|FG000|Overall Study|Transplant or removal of target organ|19|||
145477780|NCT01736618|524601121|FG000|Overall Study|Change in indication or condition|78|||
145477781|NCT01736618|524601121|FG000|Overall Study|Study device explant|103|||
145477782|NCT01736618|524601121|FG000|Overall Study|Unable to complete implant|2|||
145477783|NCT04167137|524601122|FG000|Overall Study|Disease progression|1|||
145477784|NCT04167137|524601123|FG001|Overall Study|Disease progression|1|||
145477785|NCT04167137|524601124|FG002|Overall Study|Disease progression|3|||
145477786|NCT04167137|524601125|FG003|Overall Study|Disease progression|3|||
145477787|NCT04167137|524601126|FG004|Overall Study|Disease progression|2|||
145477788|NCT04167137|524601127|FG005|Overall Study|Disease progression|3|||
145477789|NCT04167137|524601128|FG006|Overall Study|Disease progression|2|||
145477790|NCT04167137|524601129|FG007|Overall Study|Disease progression|2|||
145633076|NCT01235949|525170751|FG011|Primary Phase|Migrated/moved from study area|0|||
145477791|NCT04167137|524601122|FG000|Overall Study|Withdrawal by Subject|1|||
145477792|NCT04167137|524601123|FG001|Overall Study|Withdrawal by Subject|0|||
145477793|NCT04167137|524601124|FG002|Overall Study|Withdrawal by Subject|0|||
145477794|NCT04167137|524601125|FG003|Overall Study|Withdrawal by Subject|1|||
145477795|NCT04167137|524601126|FG004|Overall Study|Withdrawal by Subject|0|||
145477796|NCT04167137|524601127|FG005|Overall Study|Withdrawal by Subject|2|||
145477797|NCT04167137|524601128|FG006|Overall Study|Withdrawal by Subject|1|||
145477798|NCT04167137|524601129|FG007|Overall Study|Withdrawal by Subject|0|||
145477799|NCT04167137|524601122|FG000|Overall Study|Adverse Event|0|||
145477800|NCT04167137|524601123|FG001|Overall Study|Adverse Event|0|||
145477801|NCT04167137|524601124|FG002|Overall Study|Adverse Event|0|||
145477802|NCT04167137|524601125|FG003|Overall Study|Adverse Event|0|||
145477803|NCT04167137|524601126|FG004|Overall Study|Adverse Event|0|||
145477804|NCT04167137|524601127|FG005|Overall Study|Adverse Event|1|||
145477805|NCT04167137|524601128|FG006|Overall Study|Adverse Event|0|||
145477806|NCT04167137|524601129|FG007|Overall Study|Adverse Event|1|||
145633077|NCT01235949|525170752|FG012|Primary Phase|Migrated/moved from study area|0|||
145477807|NCT04167137|524601122|FG000|Overall Study|Physician Decision|0|||
145477808|NCT04167137|524601123|FG001|Overall Study|Physician Decision|0|||
145477809|NCT04167137|524601124|FG002|Overall Study|Physician Decision|0|||
145477810|NCT04167137|524601125|FG003|Overall Study|Physician Decision|1|||
145477811|NCT04167137|524601126|FG004|Overall Study|Physician Decision|0|||
145477812|NCT04167137|524601127|FG005|Overall Study|Physician Decision|0|||
145477813|NCT04167137|524601128|FG006|Overall Study|Physician Decision|1|||
145477814|NCT04167137|524601129|FG007|Overall Study|Physician Decision|0|||
145477815|NCT04167137|524601122|FG000|Overall Study|Death|0|||
145477816|NCT04167137|524601123|FG001|Overall Study|Death|1|||
145477817|NCT04167137|524601124|FG002|Overall Study|Death|0|||
145477818|NCT04167137|524601125|FG003|Overall Study|Death|0|||
145477819|NCT04167137|524601126|FG004|Overall Study|Death|0|||
145477820|NCT04167137|524601127|FG005|Overall Study|Death|0|||
145477821|NCT04167137|524601128|FG006|Overall Study|Death|0|||
145477822|NCT04167137|524601129|FG007|Overall Study|Death|0|||
145477823|NCT04167137|524601122|FG000|Overall Study|Study terminated by Sponsor|0|||
145477824|NCT04167137|524601123|FG001|Overall Study|Study terminated by Sponsor|0|||
145477825|NCT04167137|524601124|FG002|Overall Study|Study terminated by Sponsor|0|||
145477826|NCT04167137|524601125|FG003|Overall Study|Study terminated by Sponsor|0|||
145477827|NCT04167137|524601126|FG004|Overall Study|Study terminated by Sponsor|0|||
145477828|NCT04167137|524601127|FG005|Overall Study|Study terminated by Sponsor|0|||
145477829|NCT04167137|524601128|FG006|Overall Study|Study terminated by Sponsor|0|||
145477830|NCT04167137|524601129|FG007|Overall Study|Study terminated by Sponsor|1|||
145477831|NCT00400569|524601133|FG000|Overall Study|Death|1|||
145477832|NCT03848949|524601137|FG000|Overall Study|Lost to Follow-up|5|||
145477833|NCT03848949|524601138|FG001|Overall Study|Lost to Follow-up|7|||
145477834|NCT01865448|524603625|FG000|Overall Study|Adverse Event|1|||
145477835|NCT01865448|524603626|FG001|Overall Study|Adverse Event|1|||
145477836|NCT01865448|524603625|FG000|Overall Study|Pregnancy|0|||
145477837|NCT01865448|524603626|FG001|Overall Study|Pregnancy|1|||
145477838|NCT01865448|524603625|FG000|Overall Study|dropout unrelated to study|1|||
145477839|NCT01865448|524603626|FG001|Overall Study|dropout unrelated to study|1|||
145477840|NCT05128578|524603630|FG000|Overall Study|Withdrawal by Subject|9|||
145477841|NCT05128578|524603630|FG000|Overall Study|Lost to Follow-up|5|||
145477842|NCT02679755|524603631|FG000|Overall Study|Death|0|||
145477843|NCT02679755|524603632|FG001|Overall Study|Death|3|||
145477844|NCT02679755|524603631|FG000|Overall Study|Global deterioration of health status|1|||
145477845|NCT02679755|524603632|FG001|Overall Study|Global deterioration of health status|8|||
145477846|NCT02679755|524603631|FG000|Overall Study|Lost to Follow-up|1|||
145477847|NCT02679755|524603632|FG001|Overall Study|Lost to Follow-up|0|||
145477848|NCT02679755|524603631|FG000|Overall Study|Objective progression or relapse|24|||
145477849|NCT02679755|524603632|FG001|Overall Study|Objective progression or relapse|83|||
145477850|NCT02679755|524603631|FG000|Overall Study|Not defined|0|||
145477851|NCT02679755|524603632|FG001|Overall Study|Not defined|2|||
145477852|NCT02679755|524603631|FG000|Overall Study|Withdrawal by participant|6|||
145477853|NCT02679755|524603632|FG001|Overall Study|Withdrawal by participant|3|||
145477854|NCT02679755|524603631|FG000|Overall Study|Adverse Event|1|||
145477855|NCT02679755|524603632|FG001|Overall Study|Adverse Event|4|||
145477856|NCT02679755|524603631|FG000|Overall Study|Adverse events not related to study drug|1|||
145477857|NCT02679755|524603632|FG001|Overall Study|Adverse events not related to study drug|2|||
145477858|NCT01061359|524603633|FG000|Overall Study|Death|32|||
145477859|NCT01061359|524603633|FG000|Overall Study|Lost to Follow-up|1072|||
145477860|NCT01061359|524603633|FG000|Overall Study|Relapse|187|||
145477861|NCT01061359|524603633|FG000|Overall Study|Secondary neoplasm|11|||
145477862|NCT02610777|524603636|FG000|Overall Study|Lost to Follow-up|1|||
145477863|NCT02610777|524603637|FG001|Overall Study|Lost to Follow-up|0|||
145477864|NCT02610777|524603636|FG000|Overall Study|Site Terminated by Sponsor|9|||
145477865|NCT02610777|524603637|FG001|Overall Study|Site Terminated by Sponsor|8|||
145477866|NCT02610777|524603636|FG000|Overall Study|Withdrawal by Subject|2|||
145477867|NCT02610777|524603637|FG001|Overall Study|Withdrawal by Subject|2|||
145477868|NCT02610777|524603636|FG000|Overall Study|Reason not Specified|0|||
145477869|NCT02610777|524603637|FG001|Overall Study|Reason not Specified|1|||
145477870|NCT02610777|524603636|FG000|Overall Study|Death|50|||
145477871|NCT02610777|524603637|FG001|Overall Study|Death|47|||
145477872|NCT00660179|524603638|FG000|Overall Study|Death|44|||
145477873|NCT00660179|524603639|FG001|Overall Study|Death|47|||
145477874|NCT00660179|524603640|FG002|Overall Study|Death|34|||
145477875|NCT00660179|524603638|FG000|Overall Study|Withdrawal of consent|4|||
145477876|NCT00660179|524603639|FG001|Overall Study|Withdrawal of consent|6|||
145477877|NCT00660179|524603640|FG002|Overall Study|Withdrawal of consent|4|||
145477878|NCT00660179|524603638|FG000|Overall Study|Lost to Follow-up|7|||
145477879|NCT00660179|524603639|FG001|Overall Study|Lost to Follow-up|5|||
145477880|NCT00660179|524603640|FG002|Overall Study|Lost to Follow-up|2|||
145477881|NCT00660179|524603638|FG000|Overall Study|Administrative reason|0|||
145477882|NCT00660179|524603639|FG001|Overall Study|Administrative reason|0|||
145633078|NCT01235949|525170753|FG013|Primary Phase|Migrated/moved from study area|0|||
145477883|NCT00660179|524603640|FG002|Overall Study|Administrative reason|1|||
145633079|NCT01235949|525170754|FG014|Primary Phase|Migrated/moved from study area|0|||
145477884|NCT00660179|524603638|FG000|Overall Study|Incorrect randomization|1|||
145477885|NCT00660179|524603639|FG001|Overall Study|Incorrect randomization|0|||
145477886|NCT00660179|524603640|FG002|Overall Study|Incorrect randomization|0|||
145477887|NCT04171219|524603645|FG000|Overall Study|Adverse Event|1|||
145477888|NCT04171219|524603646|FG001|Overall Study|Adverse Event|0|||
145477889|NCT04171219|524603645|FG000|Overall Study|Death|0|||
145477890|NCT04171219|524603646|FG001|Overall Study|Death|1|||
145477891|NCT04171219|524603645|FG000|Overall Study|Lack of Efficacy|9|||
145477892|NCT04171219|524603646|FG001|Overall Study|Lack of Efficacy|13|||
145477893|NCT04171219|524603645|FG000|Overall Study|Withdrawal by Subject|1|||
145477894|NCT04171219|524603646|FG001|Overall Study|Withdrawal by Subject|2|||
145477895|NCT04171219|524603645|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
145477896|NCT04171219|524603646|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
145477897|NCT04171219|524603645|FG000|Overall Study|Clinical PD/Patient choice|1|||
145477898|NCT04171219|524603646|FG001|Overall Study|Clinical PD/Patient choice|0|||
145477899|NCT04171219|524603645|FG000|Overall Study|Toxicity/ Patient choice|1|||
145477900|NCT04171219|524603646|FG001|Overall Study|Toxicity/ Patient choice|0|||
145477901|NCT02974257|524603649|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
145477902|NCT02974257|524603650|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
145477903|NCT02974257|524603649|FG000|Overall Study|Clinical indication for thiamine|1|||
145477904|NCT02974257|524603650|FG001|Overall Study|Clinical indication for thiamine|0|||
145477905|NCT02974257|524603649|FG000|Overall Study|Already on thiamine|1|||
145477906|NCT02974257|524603650|FG001|Overall Study|Already on thiamine|0|||
145477907|NCT02974257|524603649|FG000|Overall Study|Extubated prior to study drug|0|||
145477908|NCT02974257|524603650|FG001|Overall Study|Extubated prior to study drug|1|||
145477909|NCT02974257|524603649|FG000|Overall Study|Death|0|||
145477910|NCT02974257|524603650|FG001|Overall Study|Death|1|||
145477911|NCT00398567|524603653|FG000|Overall Study|Disease Progression|3|||
145477912|NCT00398567|524603654|FG001|Overall Study|Disease Progression|4|||
145477913|NCT00398567|524603655|FG002|Overall Study|Disease Progression|27|||
145477914|NCT00398567|524603653|FG000|Overall Study|Withdrawal by Subject|1|||
145477915|NCT00398567|524603654|FG001|Overall Study|Withdrawal by Subject|0|||
145477916|NCT00398567|524603655|FG002|Overall Study|Withdrawal by Subject|4|||
145477917|NCT00398567|524603653|FG000|Overall Study|Adverse Event|0|||
145477918|NCT00398567|524603654|FG001|Overall Study|Adverse Event|0|||
145477919|NCT00398567|524603655|FG002|Overall Study|Adverse Event|2|||
145477920|NCT00398567|524603653|FG000|Overall Study|Protocol Violation|0|||
145477921|NCT00398567|524603654|FG001|Overall Study|Protocol Violation|0|||
145477922|NCT00398567|524603655|FG002|Overall Study|Protocol Violation|1|||
145477923|NCT04878211|524603662|FG000|Overall Study|Lost to Follow-up|0|||
145477924|NCT04878211|524603663|FG001|Overall Study|Lost to Follow-up|0|||
145477925|NCT04878211|524603664|FG002|Overall Study|Lost to Follow-up|0|||
145477926|NCT04878211|524603665|FG003|Overall Study|Lost to Follow-up|1|||
145477927|NCT04878211|524603666|FG004|Overall Study|Lost to Follow-up|0|||
145477928|NCT04878211|524603667|FG005|Overall Study|Lost to Follow-up|1|||
145477929|NCT04878211|524603662|FG000|Overall Study|Protocol deviation|1|||
145477930|NCT04878211|524603663|FG001|Overall Study|Protocol deviation|0|||
145477931|NCT04878211|524603664|FG002|Overall Study|Protocol deviation|0|||
145477932|NCT04878211|524603665|FG003|Overall Study|Protocol deviation|0|||
145477933|NCT04878211|524603666|FG004|Overall Study|Protocol deviation|0|||
145477934|NCT04878211|524603667|FG005|Overall Study|Protocol deviation|0|||
145477935|NCT04878211|524603662|FG000|Overall Study|Study terminated by sponsor|0|||
145477936|NCT04878211|524603663|FG001|Overall Study|Study terminated by sponsor|0|||
145477937|NCT04878211|524603664|FG002|Overall Study|Study terminated by sponsor|0|||
145477938|NCT04878211|524603665|FG003|Overall Study|Study terminated by sponsor|0|||
145477939|NCT04878211|524603666|FG004|Overall Study|Study terminated by sponsor|9|||
145477940|NCT04878211|524603667|FG005|Overall Study|Study terminated by sponsor|4|||
145477941|NCT04878211|524603662|FG000|Overall Study|Subject decision|0|||
145477942|NCT04878211|524603663|FG001|Overall Study|Subject decision|0|||
145477943|NCT04878211|524603664|FG002|Overall Study|Subject decision|0|||
145477944|NCT04878211|524603665|FG003|Overall Study|Subject decision|0|||
145477945|NCT04878211|524603666|FG004|Overall Study|Subject decision|1|||
145477946|NCT04878211|524603667|FG005|Overall Study|Subject decision|0|||
145477947|NCT01687101|524603674|FG000|Overall Study|Lost to Follow-up|7|||
145477948|NCT05274269|524603675|FG000|Overall Study|Adverse Event|0|||
145477949|NCT05274269|524603676|FG001|Overall Study|Adverse Event|3|||
145477950|NCT05274269|524603675|FG000|Overall Study|Death|0|||
145477951|NCT05274269|524603676|FG001|Overall Study|Death|1|||
145477952|NCT05274269|524603675|FG000|Overall Study|Other|0|||
145477953|NCT05274269|524603676|FG001|Overall Study|Other|2|||
145477954|NCT05274269|524603675|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
145477955|NCT05274269|524603676|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
145477956|NCT02206035|524603677|FG000|Overall Study|Physician Decision|10|||
145477957|NCT02206035|524603678|FG001|Overall Study|Physician Decision|0|||
145477958|NCT02206035|524603679|FG002|Overall Study|Physician Decision|175|||
145477959|NCT02936843|524603680|FG000|Overall Study|Lost to Follow-up|3|||
145477960|NCT02936843|524603681|FG001|Overall Study|Lost to Follow-up|1|||
145477961|NCT02936843|524603680|FG000|Overall Study|Withdrawal by Subject|1|||
145477962|NCT02936843|524603681|FG001|Overall Study|Withdrawal by Subject|1|||
145477963|NCT03668613|524603682|FG000|Overall Study|Adverse Event|1|||
145477964|NCT03668613|524603683|FG001|Overall Study|Adverse Event|2|||
145477965|NCT03668613|524603682|FG000|Overall Study|Lack of Efficacy|5|||
145477966|NCT03668613|524603683|FG001|Overall Study|Lack of Efficacy|1|||
145477967|NCT03668613|524603682|FG000|Overall Study|Pregnancy|0|||
145477968|NCT03668613|524603683|FG001|Overall Study|Pregnancy|2|||
145477969|NCT03668613|524603682|FG000|Overall Study|Protocol Violation|1|||
145477970|NCT03668613|524603683|FG001|Overall Study|Protocol Violation|0|||
145477971|NCT03668613|524603682|FG000|Overall Study|Physician Decision|1|||
145477972|NCT03668613|524603683|FG001|Overall Study|Physician Decision|0|||
145477973|NCT03668613|524603682|FG000|Overall Study|Withdrawal by Subject|2|||
145477974|NCT03668613|524603683|FG001|Overall Study|Withdrawal by Subject|1|||
145477975|NCT03668613|524603682|FG000|Overall Study|Guardian decision|1|||
145477976|NCT03668613|524603683|FG001|Overall Study|Guardian decision|0|||
145477977|NCT00709618|524603686|FG000|Overall Study|Withdrawal by Subject|4|||
145477978|NCT00709618|524603686|FG000|Overall Study|Lost to Follow-up|1|||
145477979|NCT00709618|524603686|FG000|Overall Study|Study Closed/Terminated|25|||
145477980|NCT04042909|524603687|FG000|Overall Study|Withdrawal by Subject|1|||
145477981|NCT04042909|524603688|FG001|Overall Study|Withdrawal by Subject|0|||
145477982|NCT04042909|524603689|FG002|Overall Study|Withdrawal by Subject|0|||
145477983|NCT04042909|524603687|FG000|Overall Study|duplicate cases|2|||
145477984|NCT04042909|524603688|FG001|Overall Study|duplicate cases|0|||
145477985|NCT04042909|524603689|FG002|Overall Study|duplicate cases|0|||
145477986|NCT04042909|524603687|FG000|Overall Study|technical problem|0|||
145477987|NCT04042909|524603688|FG001|Overall Study|technical problem|1|||
145477988|NCT04042909|524603689|FG002|Overall Study|technical problem|0|||
145477989|NCT00894361|524603692|FG000|Overall Study|deaths and less than 2 years followup|24|||
145477990|NCT00894361|524603693|FG001|Overall Study|deaths and less than 2 years followup|64|||
145477991|NCT00286494|524603698|FG000|Overall Study|Hyperglycemic rescue|12|||
145477992|NCT00286494|524603699|FG001|Overall Study|Hyperglycemic rescue|19|||
145477993|NCT00286494|524603700|FG002|Overall Study|Hyperglycemic rescue|18|||
145477994|NCT00286494|524603698|FG000|Overall Study|Withdrawal by Subject|2|||
145477995|NCT00286494|524603699|FG001|Overall Study|Withdrawal by Subject|10|||
145477996|NCT00286494|524603700|FG002|Overall Study|Withdrawal by Subject|9|||
145477997|NCT00286494|524603698|FG000|Overall Study|Adverse Event|3|||
145477998|NCT00286494|524603699|FG001|Overall Study|Adverse Event|8|||
145477999|NCT00286494|524603700|FG002|Overall Study|Adverse Event|6|||
145478000|NCT00286494|524603698|FG000|Overall Study|Physician Decision|5|||
145478001|NCT00286494|524603699|FG001|Overall Study|Physician Decision|5|||
145478002|NCT00286494|524603700|FG002|Overall Study|Physician Decision|1|||
145478003|NCT00286494|524603698|FG000|Overall Study|Lost to Follow-up|3|||
145478004|NCT00286494|524603699|FG001|Overall Study|Lost to Follow-up|1|||
145478005|NCT00286494|524603700|FG002|Overall Study|Lost to Follow-up|3|||
145478006|NCT00286494|524603698|FG000|Overall Study|Protocol Violation|1|||
145478007|NCT00286494|524603699|FG001|Overall Study|Protocol Violation|1|||
145478008|NCT00286494|524603700|FG002|Overall Study|Protocol Violation|2|||
145478009|NCT04776317|524603701|FG000|Overall Study|Physician Decision|0|||
145478010|NCT04776317|524603702|FG001|Overall Study|Physician Decision|1|||
145478011|NCT04776317|524603703|FG002|Overall Study|Physician Decision|0|||
145478012|NCT04776317|524603704|FG003|Overall Study|Physician Decision|0|||
145478013|NCT04776317|524603705|FG004|Overall Study|Physician Decision|0|||
145478014|NCT04776317|524603706|FG005|Overall Study|Physician Decision|0|||
145478015|NCT04776317|524603707|FG006|Overall Study|Physician Decision|0|||
145478016|NCT04776317|524603708|FG007|Overall Study|Physician Decision|0|||
145478017|NCT04776317|524603709|FG008|Overall Study|Physician Decision|0|||
145478018|NCT04776317|524603710|FG009|Overall Study|Physician Decision|0|||
145478019|NCT04776317|524603711|FG010|Overall Study|Physician Decision|0|||
145478020|NCT04776317|524603712|FG011|Overall Study|Physician Decision|0|||
145478021|NCT04776317|524603713|FG012|Overall Study|Physician Decision|0|||
145478022|NCT04776317|524603714|FG013|Overall Study|Physician Decision|0|||
145478023|NCT04776317|524603715|FG014|Overall Study|Physician Decision|0|||
145478024|NCT04776317|524603701|FG000|Overall Study|Protocol Violation|0|||
145478025|NCT04776317|524603702|FG001|Overall Study|Protocol Violation|0|||
145478026|NCT04776317|524603703|FG002|Overall Study|Protocol Violation|1|||
145478027|NCT04776317|524603704|FG003|Overall Study|Protocol Violation|0|||
145478028|NCT04776317|524603705|FG004|Overall Study|Protocol Violation|0|||
145478029|NCT04776317|524603706|FG005|Overall Study|Protocol Violation|0|||
145478030|NCT04776317|524603707|FG006|Overall Study|Protocol Violation|0|||
145478031|NCT04776317|524603708|FG007|Overall Study|Protocol Violation|0|||
145478032|NCT04776317|524603709|FG008|Overall Study|Protocol Violation|0|||
145478033|NCT04776317|524603710|FG009|Overall Study|Protocol Violation|0|||
145478034|NCT04776317|524603711|FG010|Overall Study|Protocol Violation|0|||
145478035|NCT04776317|524603712|FG011|Overall Study|Protocol Violation|0|||
145478036|NCT04776317|524603713|FG012|Overall Study|Protocol Violation|0|||
145478037|NCT04776317|524603714|FG013|Overall Study|Protocol Violation|0|||
145478038|NCT04776317|524603715|FG014|Overall Study|Protocol Violation|0|||
145478039|NCT04776317|524603701|FG000|Overall Study|Withdrawal by Subject|0|||
145478040|NCT04776317|524603702|FG001|Overall Study|Withdrawal by Subject|0|||
145478041|NCT04776317|524603703|FG002|Overall Study|Withdrawal by Subject|0|||
145633080|NCT01235949|525170755|FG015|Primary Phase|Migrated/moved from study area|0|||
145478042|NCT04776317|524603704|FG003|Overall Study|Withdrawal by Subject|0|||
145478043|NCT04776317|524603705|FG004|Overall Study|Withdrawal by Subject|1|||
145478044|NCT04776317|524603706|FG005|Overall Study|Withdrawal by Subject|0|||
145478045|NCT04776317|524603707|FG006|Overall Study|Withdrawal by Subject|0|||
145478046|NCT04776317|524603708|FG007|Overall Study|Withdrawal by Subject|0|||
145478047|NCT04776317|524603709|FG008|Overall Study|Withdrawal by Subject|0|||
145478048|NCT04776317|524603710|FG009|Overall Study|Withdrawal by Subject|0|||
145478049|NCT04776317|524603711|FG010|Overall Study|Withdrawal by Subject|0|||
145478050|NCT04776317|524603712|FG011|Overall Study|Withdrawal by Subject|0|||
145478051|NCT04776317|524603713|FG012|Overall Study|Withdrawal by Subject|0|||
145478052|NCT04776317|524603714|FG013|Overall Study|Withdrawal by Subject|0|||
145478053|NCT04776317|524603715|FG014|Overall Study|Withdrawal by Subject|0|||
145478054|NCT05438576|524603716|FG000|Overall Study|Death|1|||
145478055|NCT05438576|524603717|FG001|Overall Study|Death|1|||
145478056|NCT05438576|524603716|FG000|Overall Study|Withdrawal by Subject|4|||
145478057|NCT05438576|524603717|FG001|Overall Study|Withdrawal by Subject|2|||
145478058|NCT05438576|524603716|FG000|Overall Study|Not Eligible|2|||
145478059|NCT05438576|524603717|FG001|Overall Study|Not Eligible|1|||
145478060|NCT05438576|524603716|FG000|Overall Study|Did not complete baseline testing|22|||
145478061|NCT05438576|524603717|FG001|Overall Study|Did not complete baseline testing|4|||
145478062|NCT01415401|524603720|FG000|Overall Study|Adverse Event|5|||
145478063|NCT01415401|524603720|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
145478064|NCT01415401|524603720|FG000|Overall Study|Terminated by Sponsor|1|||
145478065|NCT00994422|524603721|FG000|Overall Study|Lost to Follow-up|7|||
145478066|NCT00994422|524603722|FG001|Overall Study|Lost to Follow-up|1|||
145478067|NCT03422536|524603723|FG000|Randomized|Physician Decision|1|||
145478068|NCT03422536|524603724|FG001|Randomized|Physician Decision|1|||
145478069|NCT03422536|524603723|FG000|Allocation - Received Intervention|Disease progression|19|||
145478070|NCT03422536|524603724|FG001|Allocation - Received Intervention|Disease progression|25|||
145478071|NCT03422536|524603723|FG000|Allocation - Received Intervention|Death|1|||
145478072|NCT03422536|524603724|FG001|Allocation - Received Intervention|Death|3|||
145478073|NCT03422536|524603723|FG000|Allocation - Received Intervention|Adverse Event|1|||
145478074|NCT03422536|524603724|FG001|Allocation - Received Intervention|Adverse Event|0|||
145478075|NCT03422536|524603723|FG000|Allocation - Received Intervention|Physician Decision|1|||
145478076|NCT03422536|524603724|FG001|Allocation - Received Intervention|Physician Decision|1|||
145478077|NCT03422536|524603723|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
145478078|NCT03422536|524603724|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
145478079|NCT03422536|524603723|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
145478080|NCT03422536|524603724|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
145478081|NCT00532298|524603725|FG000|Overall Study|Adverse Event|1|||
145478082|NCT00532298|524603726|FG001|Overall Study|Adverse Event|0|||
145478083|NCT00532298|524603727|FG002|Overall Study|Adverse Event|0|||
145478084|NCT00532298|524603728|FG003|Overall Study|Adverse Event|0|||
145478085|NCT00532298|524603729|FG004|Overall Study|Adverse Event|1|||
145478086|NCT00532298|524603730|FG005|Overall Study|Adverse Event|1|||
145478087|NCT00532298|524603725|FG000|Overall Study|Lost to Follow-up|1|||
145478088|NCT00532298|524603726|FG001|Overall Study|Lost to Follow-up|1|||
145478089|NCT00532298|524603727|FG002|Overall Study|Lost to Follow-up|1|||
145478090|NCT00532298|524603728|FG003|Overall Study|Lost to Follow-up|0|||
145478091|NCT00532298|524603729|FG004|Overall Study|Lost to Follow-up|0|||
145478092|NCT00532298|524603730|FG005|Overall Study|Lost to Follow-up|1|||
145478093|NCT00479856|524603731|FG000|Overall Study|Adverse Event|1|||
145478094|NCT00479856|524603731|FG000|Overall Study|Withdrawal by Subject|1|||
145478095|NCT00479856|524603731|FG000|Overall Study|Physician Decision|1|||
145478096|NCT04164732|524603738|FG000|Treatment run-in Period|Adverse Event|4|||
145478097|NCT04164732|524603739|FG001|Treatment run-in Period|Adverse Event|0|||
145478098|NCT04164732|524603740|FG002|Treatment run-in Period|Adverse Event|0|||
145478099|NCT04164732|524603738|FG000|Treatment run-in Period|Physician Decision|1|||
145478100|NCT04164732|524603739|FG001|Treatment run-in Period|Physician Decision|0|||
145478101|NCT04164732|524603740|FG002|Treatment run-in Period|Physician Decision|0|||
145478102|NCT04164732|524603738|FG000|Treatment run-in Period|Screen Failure|1|||
145478103|NCT04164732|524603739|FG001|Treatment run-in Period|Screen Failure|0|||
145478104|NCT04164732|524603740|FG002|Treatment run-in Period|Screen Failure|0|||
145478105|NCT04164732|524603738|FG000|Randomized Treatment Period|Adverse Event|0|||
145478106|NCT04164732|524603739|FG001|Randomized Treatment Period|Adverse Event|1|||
145478107|NCT04164732|524603740|FG002|Randomized Treatment Period|Adverse Event|0|||
145478108|NCT04164732|524603738|FG000|Randomized Treatment Period|Protocol Deviation|0|||
145478109|NCT04164732|524603739|FG001|Randomized Treatment Period|Protocol Deviation|1|||
145478110|NCT04164732|524603740|FG002|Randomized Treatment Period|Protocol Deviation|1|||
145478111|NCT04164732|524603738|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
145478112|NCT04164732|524603739|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
145478113|NCT04164732|524603740|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
145478114|NCT00661622|524603741|FG000|Overall Study|Protocol Violation|1|||
145478115|NCT00661622|524603742|FG001|Overall Study|Protocol Violation|0|||
145478116|NCT04765202|524603749|FG000|Overall Study|Lost to Follow-up|1|||
145478117|NCT04765202|524603750|FG001|Overall Study|Lost to Follow-up|1|||
145478118|NCT04765202|524603751|FG002|Overall Study|Lost to Follow-up|2|||
145478119|NCT04765202|524603752|FG003|Overall Study|Lost to Follow-up|2|||
145478120|NCT04765202|524603749|FG000|Overall Study|Physician Decision|0|||
145478121|NCT04765202|524603750|FG001|Overall Study|Physician Decision|0|||
145478122|NCT04765202|524603751|FG002|Overall Study|Physician Decision|1|||
145478123|NCT04765202|524603752|FG003|Overall Study|Physician Decision|1|||
145478124|NCT04929249|524603753|FG000|Overall Study|Adverse Event|2|||
145478125|NCT04929249|524603754|FG001|Overall Study|Adverse Event|1|||
145478126|NCT04929249|524603753|FG000|Overall Study|Death|2|||
145478127|NCT04929249|524603754|FG001|Overall Study|Death|1|||
145478128|NCT04929249|524603753|FG000|Overall Study|Lost to Follow-up|3|||
145478129|NCT04929249|524603754|FG001|Overall Study|Lost to Follow-up|11|||
145478130|NCT04929249|524603753|FG000|Overall Study|Technical problems|0|||
145478131|NCT04929249|524603754|FG001|Overall Study|Technical problems|1|||
145478132|NCT04929249|524603753|FG000|Overall Study|Subject decision|6|||
145478133|NCT04929249|524603754|FG001|Overall Study|Subject decision|8|||
145478134|NCT04929249|524603753|FG000|Overall Study|Withdrew consent|0|||
145478135|NCT04929249|524603754|FG001|Overall Study|Withdrew consent|8|||
145478136|NCT00395850|524603764|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
145478137|NCT00395850|524603765|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
145478138|NCT00395850|524603766|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
145478139|NCT00395850|524603767|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
145478140|NCT00395850|524603764|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
145478141|NCT00395850|524603765|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
145478142|NCT00395850|524603766|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
145478143|NCT00395850|524603767|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
145478144|NCT00395850|524603764|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
145478145|NCT00395850|524603765|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
145478146|NCT00395850|524603766|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
145478147|NCT00395850|524603767|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
145478148|NCT00395850|524603764|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
145478149|NCT00395850|524603765|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
145478150|NCT00395850|524603766|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
145478151|NCT00395850|524603767|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
145478152|NCT00395850|524603764|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
145478153|NCT00395850|524603765|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
145478154|NCT00395850|524603766|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
145478155|NCT00395850|524603767|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
145478156|NCT00395850|524603764|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
145478157|NCT00395850|524603765|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
145478158|NCT00395850|524603766|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
145478159|NCT00395850|524603767|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
145478160|NCT00395850|524603764|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
145478161|NCT00395850|524603765|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
145478162|NCT00395850|524603766|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
145478163|NCT00395850|524603767|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
145478164|NCT01844778|524603772|FG000|Overall Study|Protocol deviation|0|||
145478165|NCT01844778|524603773|FG001|Overall Study|Protocol deviation|1|||
145478166|NCT01844778|524603774|FG002|Overall Study|Protocol deviation|2|||
145478167|NCT01844778|524603772|FG000|Overall Study|Withdrawal by Subject|2|||
145478168|NCT01844778|524603773|FG001|Overall Study|Withdrawal by Subject|0|||
145478169|NCT01844778|524603774|FG002|Overall Study|Withdrawal by Subject|0|||
145478170|NCT01844778|524603772|FG000|Overall Study|Adverse Event|0|||
145478171|NCT01844778|524603773|FG001|Overall Study|Adverse Event|2|||
145478172|NCT01844778|524603774|FG002|Overall Study|Adverse Event|2|||
145478173|NCT01620762|524603776|FG000|Overall Study|Protocol Violation|1|||
145478174|NCT01620762|524603777|FG001|Overall Study|Protocol Violation|1|||
145478175|NCT01620762|524603778|FG002|Overall Study|Protocol Violation|1|||
145478176|NCT01620762|524603776|FG000|Overall Study|Adverse Event|9|||
145478177|NCT01620762|524603777|FG001|Overall Study|Adverse Event|5|||
145478178|NCT01620762|524603778|FG002|Overall Study|Adverse Event|2|||
145478179|NCT01620762|524603776|FG000|Overall Study|Withdrawal by Subject|23|||
145478180|NCT01620762|524603777|FG001|Overall Study|Withdrawal by Subject|26|||
145478181|NCT01620762|524603778|FG002|Overall Study|Withdrawal by Subject|27|||
145478182|NCT01620762|524603776|FG000|Overall Study|Lost to Follow-up|11|||
145478183|NCT01620762|524603777|FG001|Overall Study|Lost to Follow-up|17|||
145478184|NCT01620762|524603778|FG002|Overall Study|Lost to Follow-up|10|||
145478185|NCT01620762|524603776|FG000|Overall Study|Protocol deviation|1|||
145478186|NCT01620762|524603777|FG001|Overall Study|Protocol deviation|1|||
145478187|NCT01620762|524603778|FG002|Overall Study|Protocol deviation|6|||
145478188|NCT01620762|524603776|FG000|Overall Study|Subject deterioration|0|||
145478189|NCT01620762|524603777|FG001|Overall Study|Subject deterioration|1|||
145478190|NCT01620762|524603778|FG002|Overall Study|Subject deterioration|1|||
145478191|NCT01620762|524603776|FG000|Overall Study|Non-specified|3|||
145478192|NCT01620762|524603777|FG001|Overall Study|Non-specified|6|||
145478193|NCT01620762|524603778|FG002|Overall Study|Non-specified|5|||
145633081|NCT01235949|525170756|FG016|Primary Phase|Migrated/moved from study area|0|||
145478194|NCT01620762|524603776|FG000|Overall Study|Use of prohibted therapies|0|||
145478195|NCT01620762|524603777|FG001|Overall Study|Use of prohibted therapies|1|||
145478196|NCT01620762|524603778|FG002|Overall Study|Use of prohibted therapies|1|||
145478197|NCT00705146|524603783|FG000|Overall Study|Lost to Follow-up|1|||
145478198|NCT00705146|524603784|FG001|Overall Study|Lost to Follow-up|1|||
145478199|NCT00095173|524603785|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
145478200|NCT00095173|524603786|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
145478201|NCT00095173|524603787|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
145478202|NCT00095173|524603788|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
145478203|NCT00095173|524603789|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
145478204|NCT00095173|524603790|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
145478205|NCT00095173|524603785|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
145478206|NCT00095173|524603786|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
145478207|NCT00095173|524603787|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
145478208|NCT00095173|524603788|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
145478209|NCT00095173|524603789|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
145478210|NCT00095173|524603790|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
145478211|NCT00095173|524603785|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
145478212|NCT00095173|524603786|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
145478213|NCT00095173|524603787|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
145478214|NCT00095173|524603788|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
145478215|NCT00095173|524603789|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
145478216|NCT00095173|524603790|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
145478217|NCT00095173|524603785|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
145478218|NCT00095173|524603786|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
145478219|NCT00095173|524603787|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
145478220|NCT00095173|524603788|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
145478221|NCT00095173|524603789|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
145478222|NCT00095173|524603790|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
145478223|NCT00095173|524603785|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
145478224|NCT00095173|524603786|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
145478225|NCT00095173|524603787|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
145478226|NCT00095173|524603788|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
145478227|NCT00095173|524603789|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
145478228|NCT00095173|524603790|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
145478229|NCT00095173|524603785|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
145478230|NCT00095173|524603786|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
145478231|NCT00095173|524603787|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
145478232|NCT00095173|524603788|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
145478233|NCT00095173|524603789|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
145478234|NCT00095173|524603790|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
145478235|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Death|0|||
145478236|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Death|0|||
145478237|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Death|0|||
145478238|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Death|0|||
145478239|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Death|0|||
145478240|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Death|1|||
145478241|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
145478242|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
145478243|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
145478244|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
145478245|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
145478246|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
145478247|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
145478248|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
145478249|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
145478250|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
145478251|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
145478252|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
145478253|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
145478254|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
145478255|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
145478256|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
145478257|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
145478258|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
145478259|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
145478260|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
145478261|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
145478262|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
145478263|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
145478264|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
145478265|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
145478266|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
145478267|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
145478268|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
145478269|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
145478270|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
145478271|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
145478272|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
145478273|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
145478274|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
145478275|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
145478276|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
145478277|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
145478278|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
145478279|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
145478280|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
145478281|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
145478282|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
145478283|NCT00095173|524603785|FG000|Open-Label Extension Phase (Period C)|Other|0|||
145478284|NCT00095173|524603786|FG001|Open-Label Extension Phase (Period C)|Other|0|||
145478285|NCT00095173|524603787|FG002|Open-Label Extension Phase (Period C)|Other|0|||
145478286|NCT00095173|524603788|FG003|Open-Label Extension Phase (Period C)|Other|4|||
145478287|NCT00095173|524603789|FG004|Open-Label Extension Phase (Period C)|Other|6|||
145478288|NCT00095173|524603790|FG005|Open-Label Extension Phase (Period C)|Other|8|||
145478289|NCT00330681|524603799|FG000|Overall Study|Adverse Event|3|||
145478290|NCT00330681|524603800|FG001|Overall Study|Adverse Event|6|||
145478291|NCT00330681|524603799|FG000|Overall Study|Protocol Violation|0|||
145478292|NCT00330681|524603800|FG001|Overall Study|Protocol Violation|1|||
145478293|NCT00330681|524603799|FG000|Overall Study|Withdrawal by Subject|5|||
145478294|NCT00330681|524603800|FG001|Overall Study|Withdrawal by Subject|5|||
145478295|NCT00330681|524603799|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
145478296|NCT00330681|524603800|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
145478297|NCT00847197|524603801|FG000|Overall Study|Adverse Event|21|||
145478298|NCT00847197|524603802|FG001|Overall Study|Adverse Event|3|||
145478299|NCT00847197|524603801|FG000|Overall Study|Protocol Violation|0|||
145478300|NCT00847197|524603802|FG001|Overall Study|Protocol Violation|1|||
145478301|NCT00847197|524603801|FG000|Overall Study|Withdrawal by Subject|3|||
145478302|NCT00847197|524603802|FG001|Overall Study|Withdrawal by Subject|1|||
145478303|NCT01748825|524603804|FG000|Dose Escalation|Refused further treatment|2|||
145478304|NCT01748825|524603805|FG001|Dose Escalation|Refused further treatment|2|||
145478305|NCT01748825|524603806|FG002|Dose Escalation|Refused further treatment|0|||
145478306|NCT01748825|524603807|FG003|Dose Escalation|Refused further treatment|0|||
145478307|NCT01748825|524603808|FG004|Dose Escalation|Refused further treatment|1|||
145478308|NCT01748825|524603809|FG005|Dose Escalation|Refused further treatment|2|||
145478309|NCT01748825|524603810|FG006|Dose Escalation|Refused further treatment|0|||
145478310|NCT01748825|524603811|FG007|Dose Escalation|Refused further treatment|0|||
145478311|NCT01748825|524603812|FG008|Dose Escalation|Refused further treatment|0|||
145478312|NCT01748825|524603813|FG009|Dose Escalation|Refused further treatment|0|||
145478313|NCT01748825|524603804|FG000|Dose Escalation|Switched to alternative treatment|0|||
145478314|NCT01748825|524603805|FG001|Dose Escalation|Switched to alternative treatment|0|||
145478315|NCT01748825|524603806|FG002|Dose Escalation|Switched to alternative treatment|0|||
145478316|NCT01748825|524603807|FG003|Dose Escalation|Switched to alternative treatment|1|||
145478317|NCT01748825|524603808|FG004|Dose Escalation|Switched to alternative treatment|0|||
145478318|NCT01748825|524603809|FG005|Dose Escalation|Switched to alternative treatment|0|||
145478319|NCT01748825|524603810|FG006|Dose Escalation|Switched to alternative treatment|0|||
145478320|NCT01748825|524603811|FG007|Dose Escalation|Switched to alternative treatment|0|||
145478321|NCT01748825|524603812|FG008|Dose Escalation|Switched to alternative treatment|0|||
145478322|NCT01748825|524603813|FG009|Dose Escalation|Switched to alternative treatment|0|||
145478323|NCT01748825|524603804|FG000|Dose Escalation|Adverse Event|0|||
145478324|NCT01748825|524603805|FG001|Dose Escalation|Adverse Event|0|||
145478325|NCT01748825|524603806|FG002|Dose Escalation|Adverse Event|0|||
145478326|NCT01748825|524603807|FG003|Dose Escalation|Adverse Event|0|||
145478327|NCT01748825|524603808|FG004|Dose Escalation|Adverse Event|0|||
145633082|NCT01235949|525170757|FG017|Primary Phase|Migrated/moved from study area|0|||
145478328|NCT01748825|524603809|FG005|Dose Escalation|Adverse Event|0|||
145478329|NCT01748825|524603810|FG006|Dose Escalation|Adverse Event|1|||
145478330|NCT01748825|524603811|FG007|Dose Escalation|Adverse Event|0|||
145478331|NCT01748825|524603812|FG008|Dose Escalation|Adverse Event|0|||
145478332|NCT01748825|524603813|FG009|Dose Escalation|Adverse Event|0|||
145478333|NCT01748825|524603804|FG000|Dose Expansion|Refused further treatment|0|||
145478334|NCT01748825|524603805|FG001|Dose Expansion|Refused further treatment|0|||
145478335|NCT01748825|524603806|FG002|Dose Expansion|Refused further treatment|0|||
145478336|NCT01748825|524603807|FG003|Dose Expansion|Refused further treatment|0|||
145478337|NCT01748825|524603808|FG004|Dose Expansion|Refused further treatment|0|||
145478338|NCT01748825|524603809|FG005|Dose Expansion|Refused further treatment|0|||
145478339|NCT01748825|524603810|FG006|Dose Expansion|Refused further treatment|0|||
145478340|NCT01748825|524603811|FG007|Dose Expansion|Refused further treatment|0|||
145478341|NCT01748825|524603812|FG008|Dose Expansion|Refused further treatment|1|||
145478342|NCT01748825|524603813|FG009|Dose Expansion|Refused further treatment|1|||
145478343|NCT01748825|524603804|FG000|Dose Expansion|Switched to alternative treatment|0|||
145478344|NCT01748825|524603805|FG001|Dose Expansion|Switched to alternative treatment|0|||
145478345|NCT01748825|524603806|FG002|Dose Expansion|Switched to alternative treatment|0|||
145478346|NCT01748825|524603807|FG003|Dose Expansion|Switched to alternative treatment|0|||
145478347|NCT01748825|524603808|FG004|Dose Expansion|Switched to alternative treatment|0|||
145478348|NCT01748825|524603809|FG005|Dose Expansion|Switched to alternative treatment|0|||
145478349|NCT01748825|524603810|FG006|Dose Expansion|Switched to alternative treatment|0|||
145478350|NCT01748825|524603811|FG007|Dose Expansion|Switched to alternative treatment|0|||
145478351|NCT01748825|524603812|FG008|Dose Expansion|Switched to alternative treatment|0|||
145478352|NCT01748825|524603813|FG009|Dose Expansion|Switched to alternative treatment|1|||
145478353|NCT01748825|524603804|FG000|Dose Expansion|Adverse Event|0|||
145478354|NCT01748825|524603805|FG001|Dose Expansion|Adverse Event|0|||
145478355|NCT01748825|524603806|FG002|Dose Expansion|Adverse Event|0|||
145478356|NCT01748825|524603807|FG003|Dose Expansion|Adverse Event|0|||
145478357|NCT01748825|524603808|FG004|Dose Expansion|Adverse Event|0|||
145478358|NCT01748825|524603809|FG005|Dose Expansion|Adverse Event|0|||
145478359|NCT01748825|524603810|FG006|Dose Expansion|Adverse Event|0|||
145478360|NCT01748825|524603811|FG007|Dose Expansion|Adverse Event|0|||
145478361|NCT01748825|524603812|FG008|Dose Expansion|Adverse Event|0|||
145478362|NCT01748825|524603813|FG009|Dose Expansion|Adverse Event|3|||
145478363|NCT01748825|524603804|FG000|Dose Expansion|Physician Decision|0|||
145478364|NCT01748825|524603805|FG001|Dose Expansion|Physician Decision|0|||
145478365|NCT01748825|524603806|FG002|Dose Expansion|Physician Decision|0|||
145478366|NCT01748825|524603807|FG003|Dose Expansion|Physician Decision|0|||
145478367|NCT01748825|524603808|FG004|Dose Expansion|Physician Decision|0|||
145478368|NCT01748825|524603809|FG005|Dose Expansion|Physician Decision|0|||
145478369|NCT01748825|524603810|FG006|Dose Expansion|Physician Decision|0|||
145478370|NCT01748825|524603811|FG007|Dose Expansion|Physician Decision|0|||
145478371|NCT01748825|524603812|FG008|Dose Expansion|Physician Decision|1|||
145478372|NCT01748825|524603813|FG009|Dose Expansion|Physician Decision|0|||
145478373|NCT02461745|524603814|FG000|Overall Study|Lack of Efficacy|9|||
145478374|NCT02461745|524603815|FG001|Overall Study|Lack of Efficacy|1|||
145478375|NCT02461745|524603814|FG000|Overall Study|Lost to Follow-up|2|||
145478376|NCT02461745|524603815|FG001|Overall Study|Lost to Follow-up|2|||
145478377|NCT02461745|524603814|FG000|Overall Study|Withdrawal by Subject|3|||
145478378|NCT02461745|524603815|FG001|Overall Study|Withdrawal by Subject|1|||
145478379|NCT02921087|524603816|FG000|Overall Study|Withdrawal by Subject|0|||
145478380|NCT02921087|524603817|FG001|Overall Study|Withdrawal by Subject|1|||
145478381|NCT00211887|524603818|FG000|Overall Study|Adverse Event|8|||
145478382|NCT00211887|524603819|FG001|Overall Study|Adverse Event|4|||
145478383|NCT00211887|524603820|FG002|Overall Study|Adverse Event|6|||
145478384|NCT00211887|524603818|FG000|Overall Study|Death|1|||
145478385|NCT00211887|524603819|FG001|Overall Study|Death|1|||
145478386|NCT00211887|524603820|FG002|Overall Study|Death|1|||
145478387|NCT00211887|524603818|FG000|Overall Study|Lost to Follow-up|28|||
145478388|NCT00211887|524603819|FG001|Overall Study|Lost to Follow-up|13|||
145478389|NCT00211887|524603820|FG002|Overall Study|Lost to Follow-up|9|||
145478390|NCT00211887|524603818|FG000|Overall Study|Non-medical reason|31|||
145478391|NCT00211887|524603819|FG001|Overall Study|Non-medical reason|14|||
145478392|NCT00211887|524603820|FG002|Overall Study|Non-medical reason|8|||
145633083|NCT01235949|525170740|FG000|Primary Phase|Adverse Event|0|||
145478393|NCT00211887|524603818|FG000|Overall Study|Other medical reason|15|||
145478394|NCT00211887|524603819|FG001|Overall Study|Other medical reason|11|||
145478395|NCT00211887|524603820|FG002|Overall Study|Other medical reason|7|||
145478396|NCT00211887|524603818|FG000|Overall Study|Side effects|19|||
145478397|NCT00211887|524603819|FG001|Overall Study|Side effects|13|||
145478398|NCT00211887|524603820|FG002|Overall Study|Side effects|5|||
145633084|NCT01235949|525170741|FG001|Primary Phase|Adverse Event|0|||
145478399|NCT00619307|524603822|FG000|Overall Study|Adverse Event|0|||
145478400|NCT00619307|524603823|FG001|Overall Study|Adverse Event|1|||
145478401|NCT00619307|524603822|FG000|Overall Study|Lost to Follow-up|0|||
145478402|NCT00619307|524603823|FG001|Overall Study|Lost to Follow-up|1|||
145478403|NCT00619307|524603822|FG000|Overall Study|Protocol Violation|3|||
145478404|NCT00619307|524603823|FG001|Overall Study|Protocol Violation|0|||
145478405|NCT00619307|524603822|FG000|Overall Study|Withdrew consent|1|||
145478406|NCT00619307|524603823|FG001|Overall Study|Withdrew consent|0|||
145478407|NCT00619307|524603822|FG000|Overall Study|Severe migraine|0|||
145478408|NCT00619307|524603823|FG001|Overall Study|Severe migraine|1|||
145478409|NCT00619307|524603822|FG000|Overall Study|MS attack plus steroids|0|||
145478410|NCT00619307|524603823|FG001|Overall Study|MS attack plus steroids|1|||
145478411|NCT02475278|524605493|FG000|Overall Study|Lost to Follow-up|1|||
145478412|NCT02475278|524605493|FG000|Overall Study|Reason Not Specified|1|||
145478413|NCT01946152|524605494|FG000|Overall Study|Adverse Event|1|||
145478414|NCT01946152|524605495|FG001|Overall Study|Adverse Event|0|||
145478415|NCT01946152|524605496|FG002|Overall Study|Adverse Event|0|||
145478416|NCT01946152|524605497|FG003|Overall Study|Adverse Event|0|||
145478417|NCT01946152|524605494|FG000|Overall Study|Withdrawal by Subject|0|||
145478418|NCT01946152|524605495|FG001|Overall Study|Withdrawal by Subject|2|||
145478419|NCT01946152|524605496|FG002|Overall Study|Withdrawal by Subject|0|||
145478420|NCT01946152|524605497|FG003|Overall Study|Withdrawal by Subject|0|||
145478421|NCT01946152|524605494|FG000|Overall Study|Progression|0|||
145478422|NCT01946152|524605495|FG001|Overall Study|Progression|1|||
145478423|NCT01946152|524605496|FG002|Overall Study|Progression|4|||
145478424|NCT01946152|524605497|FG003|Overall Study|Progression|7|||
145478425|NCT01946152|524605494|FG000|Overall Study|Physician Decision|0|||
145478426|NCT01946152|524605495|FG001|Overall Study|Physician Decision|0|||
145478427|NCT01946152|524605496|FG002|Overall Study|Physician Decision|1|||
145478428|NCT01946152|524605497|FG003|Overall Study|Physician Decision|0|||
145478429|NCT01946152|524605494|FG000|Overall Study|Second malignancy|0|||
145478430|NCT01946152|524605495|FG001|Overall Study|Second malignancy|0|||
145478431|NCT01946152|524605496|FG002|Overall Study|Second malignancy|1|||
145478432|NCT01946152|524605497|FG003|Overall Study|Second malignancy|0|||
145478433|NCT01946152|524605494|FG000|Overall Study|Adverse Event|0|||
145478434|NCT01946152|524605495|FG001|Overall Study|Adverse Event|0|||
145478435|NCT01946152|524605496|FG002|Overall Study|Adverse Event|0|||
145478436|NCT01946152|524605497|FG003|Overall Study|Adverse Event|1|||
145478437|NCT03712787|524605498|FG000|Overall Study|Adverse Event|2|||
145478438|NCT03712787|524605499|FG001|Overall Study|Adverse Event|3|||
145478439|NCT03712787|524605500|FG002|Overall Study|Adverse Event|0|||
145478440|NCT03712787|524605501|FG003|Overall Study|Adverse Event|4|||
145478441|NCT03712787|524605498|FG000|Overall Study|Withdrawal by Subject|4|||
145478442|NCT03712787|524605499|FG001|Overall Study|Withdrawal by Subject|14|||
145478443|NCT03712787|524605500|FG002|Overall Study|Withdrawal by Subject|12|||
145478444|NCT03712787|524605501|FG003|Overall Study|Withdrawal by Subject|8|||
145478445|NCT03712787|524605498|FG000|Overall Study|Lost to Follow-up|1|||
145478446|NCT03712787|524605499|FG001|Overall Study|Lost to Follow-up|1|||
145478447|NCT03712787|524605500|FG002|Overall Study|Lost to Follow-up|2|||
145478448|NCT03712787|524605501|FG003|Overall Study|Lost to Follow-up|1|||
145478449|NCT03712787|524605498|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
145478450|NCT03712787|524605499|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
145478451|NCT03712787|524605500|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
145478452|NCT03712787|524605501|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
145478453|NCT03712787|524605498|FG000|Overall Study|COVID-19 Infection|0|||
145478454|NCT03712787|524605499|FG001|Overall Study|COVID-19 Infection|1|||
145478455|NCT03712787|524605500|FG002|Overall Study|COVID-19 Infection|0|||
145478456|NCT03712787|524605501|FG003|Overall Study|COVID-19 Infection|0|||
145478457|NCT03712787|524605498|FG000|Overall Study|Other, Not Specified|79|||
145478458|NCT03712787|524605499|FG001|Overall Study|Other, Not Specified|77|||
145478459|NCT03712787|524605500|FG002|Overall Study|Other, Not Specified|74|||
145478460|NCT03712787|524605501|FG003|Overall Study|Other, Not Specified|78|||
145478461|NCT05111249|524605502|FG000|Overall Study|Lost to Follow-up|0|||
145478462|NCT05111249|524605503|FG001|Overall Study|Lost to Follow-up|2|||
145478463|NCT05111249|524605502|FG000|Overall Study|Physician Decision|0|||
145478464|NCT05111249|524605503|FG001|Overall Study|Physician Decision|1|||
145478465|NCT05111249|524605502|FG000|Overall Study|Participant decision|1|||
145478466|NCT05111249|524605503|FG001|Overall Study|Participant decision|5|||
145478467|NCT03688074|524605506|FG000|Overall Study|Adverse Event|0|||
145478468|NCT03688074|524605507|FG001|Overall Study|Adverse Event|1|||
145478469|NCT03688074|524605506|FG000|Overall Study|Other|1|||
145478470|NCT03688074|524605507|FG001|Overall Study|Other|0|||
145478471|NCT03056339|524605508|FG000|Overall Study|Failed Requirements|0|||
145478472|NCT03056339|524605509|FG001|Overall Study|Failed Requirements|2|||
145478473|NCT03056339|524605510|FG002|Overall Study|Failed Requirements|7|||
145478474|NCT03056339|524605511|FG003|Overall Study|Failed Requirements|1|||
145478475|NCT01363908|524605514|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
145478476|NCT01363908|524605515|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
145478477|NCT01363908|524605514|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
145478478|NCT01363908|524605515|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
145478479|NCT01363908|524605514|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
145478480|NCT01363908|524605515|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
145478481|NCT01363908|524605514|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
145478482|NCT01363908|524605515|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
145478483|NCT00536471|524605516|FG000|Overall Study|Lost to Follow-up|48|||
145478484|NCT00536471|524605517|FG001|Overall Study|Lost to Follow-up|23|||
145478485|NCT00536471|524605518|FG002|Overall Study|Lost to Follow-up|48|||
145478486|NCT00536471|524605519|FG003|Overall Study|Lost to Follow-up|22|||
145478487|NCT00536471|524605516|FG000|Overall Study|Adverse Event|32|||
145478488|NCT00536471|524605517|FG001|Overall Study|Adverse Event|16|||
145478489|NCT00536471|524605518|FG002|Overall Study|Adverse Event|28|||
145478490|NCT00536471|524605519|FG003|Overall Study|Adverse Event|13|||
145478491|NCT00536471|524605516|FG000|Overall Study|Withdrawal by Subject|40|||
145478492|NCT00536471|524605517|FG001|Overall Study|Withdrawal by Subject|24|||
145478493|NCT00536471|524605518|FG002|Overall Study|Withdrawal by Subject|43|||
145478494|NCT00536471|524605519|FG003|Overall Study|Withdrawal by Subject|21|||
145478495|NCT00536471|524605516|FG000|Overall Study|Lack of Efficacy|17|||
145478496|NCT00536471|524605517|FG001|Overall Study|Lack of Efficacy|18|||
145478497|NCT00536471|524605518|FG002|Overall Study|Lack of Efficacy|11|||
145478498|NCT00536471|524605519|FG003|Overall Study|Lack of Efficacy|9|||
145478499|NCT00536471|524605516|FG000|Overall Study|Protocol Violation|8|||
145478500|NCT00536471|524605517|FG001|Overall Study|Protocol Violation|1|||
145478501|NCT00536471|524605518|FG002|Overall Study|Protocol Violation|2|||
145478502|NCT00536471|524605519|FG003|Overall Study|Protocol Violation|3|||
145478503|NCT00536471|524605516|FG000|Overall Study|Physician Decision|11|||
145478504|NCT00536471|524605517|FG001|Overall Study|Physician Decision|1|||
145478505|NCT00536471|524605518|FG002|Overall Study|Physician Decision|3|||
145478506|NCT00536471|524605519|FG003|Overall Study|Physician Decision|2|||
145478507|NCT00536471|524605516|FG000|Overall Study|Death|0|||
145478508|NCT00536471|524605517|FG001|Overall Study|Death|0|||
145478509|NCT00536471|524605518|FG002|Overall Study|Death|1|||
145478510|NCT00536471|524605519|FG003|Overall Study|Death|2|||
145478511|NCT00536471|524605516|FG000|Overall Study|Sponsor Decision|0|||
145478512|NCT00536471|524605517|FG001|Overall Study|Sponsor Decision|1|||
145478513|NCT00536471|524605518|FG002|Overall Study|Sponsor Decision|3|||
145478514|NCT00536471|524605519|FG003|Overall Study|Sponsor Decision|2|||
145478515|NCT04273893|524605522|FG000|Overall Study|Withdrawal by Subject|0|||
145478516|NCT04273893|524605523|FG001|Overall Study|Withdrawal by Subject|2|||
145478517|NCT04273893|524605522|FG000|Overall Study|Treatment of Disease Progression|0|||
145478518|NCT04273893|524605523|FG001|Overall Study|Treatment of Disease Progression|2|||
145478519|NCT04273893|524605522|FG000|Overall Study|Death|1|||
145478520|NCT04273893|524605523|FG001|Overall Study|Death|2|||
145478521|NCT04273893|524605522|FG000|Overall Study|Lost to Follow-up|0|||
145478522|NCT04273893|524605523|FG001|Overall Study|Lost to Follow-up|2|||
145478523|NCT04273893|524605522|FG000|Overall Study|Physician Decision|1|||
145478524|NCT04273893|524605523|FG001|Overall Study|Physician Decision|0|||
145478525|NCT02783599|524605528|FG000|Overall Study|Progressive disease|23|||
145478526|NCT02783599|524605528|FG000|Overall Study|Surgical Resection|10|||
145478527|NCT02783599|524605528|FG000|Overall Study|Adverse Event|4|||
145478528|NCT02783599|524605528|FG000|Overall Study|Physician Decision|2|||
145478529|NCT02783599|524605528|FG000|Overall Study|Death|1|||
145478530|NCT00856544|524605535|FG000|Overall Study|Randomized but not treated|3|||
145478531|NCT00856544|524605536|FG001|Overall Study|Randomized but not treated|0|||
145478532|NCT00856544|524605537|FG002|Overall Study|Randomized but not treated|0|||
145478533|NCT00856544|524605538|FG003|Overall Study|Randomized but not treated|0|||
145478534|NCT00856544|524605535|FG000|Overall Study|Death|0|||
145478535|NCT00856544|524605536|FG001|Overall Study|Death|2|||
145478536|NCT00856544|524605537|FG002|Overall Study|Death|0|||
145478537|NCT00856544|524605538|FG003|Overall Study|Death|0|||
145478538|NCT00856544|524605535|FG000|Overall Study|Adverse Event|20|||
145478539|NCT00856544|524605536|FG001|Overall Study|Adverse Event|29|||
145478540|NCT00856544|524605537|FG002|Overall Study|Adverse Event|2|||
145478541|NCT00856544|524605538|FG003|Overall Study|Adverse Event|3|||
145478542|NCT00856544|524605535|FG000|Overall Study|Lack of Efficacy|16|||
145478543|NCT00856544|524605536|FG001|Overall Study|Lack of Efficacy|12|||
145478544|NCT00856544|524605537|FG002|Overall Study|Lack of Efficacy|3|||
145478545|NCT00856544|524605538|FG003|Overall Study|Lack of Efficacy|3|||
145478546|NCT00856544|524605535|FG000|Overall Study|Other|9|||
145478547|NCT00856544|524605536|FG001|Overall Study|Other|16|||
145478548|NCT00856544|524605537|FG002|Overall Study|Other|1|||
145478549|NCT00856544|524605538|FG003|Overall Study|Other|6|||
145478550|NCT00856544|524605535|FG000|Overall Study|Lost to Follow-up|1|||
145478551|NCT00856544|524605536|FG001|Overall Study|Lost to Follow-up|2|||
145478552|NCT00856544|524605537|FG002|Overall Study|Lost to Follow-up|2|||
145478553|NCT00856544|524605538|FG003|Overall Study|Lost to Follow-up|0|||
145478554|NCT00856544|524605535|FG000|Overall Study|Withdrawal by Subject|8|||
145478555|NCT00856544|524605536|FG001|Overall Study|Withdrawal by Subject|5|||
145478556|NCT00856544|524605537|FG002|Overall Study|Withdrawal by Subject|0|||
145478557|NCT00856544|524605538|FG003|Overall Study|Withdrawal by Subject|1|||
145633085|NCT01235949|525170742|FG002|Primary Phase|Adverse Event|0|||
145478558|NCT01564732|524605539|FG000|Overall Study|Early termination by the study sponsor|6|||
145478559|NCT01564732|524605540|FG001|Overall Study|Early termination by the study sponsor|5|||
145478560|NCT01036321|524605543|FG000|Overall Study|Ineligible after randomization|0|||
145478561|NCT01036321|524605544|FG001|Overall Study|Ineligible after randomization|1|||
145478562|NCT01036321|524605543|FG000|Overall Study|Withdrawal by Subject|3|||
145478563|NCT01036321|524605544|FG001|Overall Study|Withdrawal by Subject|2|||
145478564|NCT01036321|524605543|FG000|Overall Study|Adverse Event|2|||
145478565|NCT01036321|524605544|FG001|Overall Study|Adverse Event|1|||
145478566|NCT00381693|524605547|FG000|Overall Study|Death|1|||
145478567|NCT00381693|524605547|FG000|Overall Study|Adverse Event|4|||
145478568|NCT00381693|524605547|FG000|Overall Study|Patient Choice|1|||
145478569|NCT00381693|524605547|FG000|Overall Study|Progression|2|||
145478570|NCT02003534|524605554|FG000|Overall Study|Lost to Follow-up|47|||
145478571|NCT03920254|524605555|FG000|Overall Study|Adverse Event|1|||
145478572|NCT03920254|524605556|FG001|Overall Study|Adverse Event|0|||
145478573|NCT03920254|524605557|FG002|Overall Study|Adverse Event|0|||
145478574|NCT03920254|524605555|FG000|Overall Study|Physician Decision|0|||
145478575|NCT03920254|524605556|FG001|Overall Study|Physician Decision|1|||
145478576|NCT03920254|524605557|FG002|Overall Study|Physician Decision|2|||
145478577|NCT03920254|524605555|FG000|Overall Study|Study Terminated By Sponsor|12|||
145478578|NCT03920254|524605556|FG001|Overall Study|Study Terminated By Sponsor|17|||
145478579|NCT03920254|524605557|FG002|Overall Study|Study Terminated By Sponsor|12|||
145478580|NCT03920254|524605555|FG000|Overall Study|Withdrawal by Subject|0|||
145478581|NCT03920254|524605556|FG001|Overall Study|Withdrawal by Subject|0|||
145478582|NCT03920254|524605557|FG002|Overall Study|Withdrawal by Subject|1|||
145478583|NCT03040674|524605558|FG000|Overall Study|Lost to Follow-up|225|||
145478584|NCT03040674|524605558|FG000|Overall Study|Death|23|||
145478585|NCT05173012|524605559|FG000|Overall Study|Adverse Event|2|||
145478586|NCT05173012|524605560|FG001|Overall Study|Adverse Event|3|||
145633086|NCT01235949|525170743|FG003|Primary Phase|Adverse Event|1|||
145633087|NCT01235949|525170744|FG004|Primary Phase|Adverse Event|0|||
145633088|NCT01235949|525170745|FG005|Primary Phase|Adverse Event|0|||
145633089|NCT01235949|525170746|FG006|Primary Phase|Adverse Event|0|||
145633090|NCT01235949|525170747|FG007|Primary Phase|Adverse Event|0|||
145633091|NCT01235949|525170748|FG008|Primary Phase|Adverse Event|0|||
145478587|NCT05173012|524605561|FG002|Overall Study|Adverse Event|4|||
145478588|NCT05173012|524605562|FG003|Overall Study|Adverse Event|13|||
145478589|NCT05173012|524605563|FG004|Overall Study|Adverse Event|0|||
145478590|NCT05173012|524605564|FG005|Overall Study|Adverse Event|0|||
145478591|NCT05173012|524605565|FG006|Overall Study|Adverse Event|2|||
145478592|NCT05173012|524605566|FG007|Overall Study|Adverse Event|4|||
145478593|NCT05173012|524605559|FG000|Overall Study|Lost to Follow-up|0|||
145478594|NCT05173012|524605560|FG001|Overall Study|Lost to Follow-up|0|||
145478595|NCT05173012|524605561|FG002|Overall Study|Lost to Follow-up|0|||
145478596|NCT05173012|524605562|FG003|Overall Study|Lost to Follow-up|1|||
145478597|NCT05173012|524605563|FG004|Overall Study|Lost to Follow-up|0|||
145478598|NCT05173012|524605564|FG005|Overall Study|Lost to Follow-up|0|||
145478599|NCT05173012|524605565|FG006|Overall Study|Lost to Follow-up|0|||
145478600|NCT05173012|524605566|FG007|Overall Study|Lost to Follow-up|0|||
145478601|NCT05173012|524605559|FG000|Overall Study|Withdrawal by Subject|1|||
145478602|NCT05173012|524605560|FG001|Overall Study|Withdrawal by Subject|0|||
145478603|NCT05173012|524605561|FG002|Overall Study|Withdrawal by Subject|1|||
145478604|NCT05173012|524605562|FG003|Overall Study|Withdrawal by Subject|3|||
145478605|NCT05173012|524605563|FG004|Overall Study|Withdrawal by Subject|1|||
145478606|NCT05173012|524605564|FG005|Overall Study|Withdrawal by Subject|0|||
145478607|NCT05173012|524605565|FG006|Overall Study|Withdrawal by Subject|1|||
145478608|NCT05173012|524605566|FG007|Overall Study|Withdrawal by Subject|0|||
145478609|NCT05173012|524605559|FG000|Overall Study|Protocol Deviation|0|||
145478610|NCT05173012|524605560|FG001|Overall Study|Protocol Deviation|0|||
145478611|NCT05173012|524605561|FG002|Overall Study|Protocol Deviation|0|||
145478612|NCT05173012|524605562|FG003|Overall Study|Protocol Deviation|1|||
145478613|NCT05173012|524605563|FG004|Overall Study|Protocol Deviation|0|||
145478614|NCT05173012|524605564|FG005|Overall Study|Protocol Deviation|0|||
145478615|NCT05173012|524605565|FG006|Overall Study|Protocol Deviation|0|||
145478616|NCT05173012|524605566|FG007|Overall Study|Protocol Deviation|0|||
145478617|NCT05173012|524605559|FG000|Overall Study|Other|0|||
145478618|NCT05173012|524605560|FG001|Overall Study|Other|0|||
145478619|NCT05173012|524605561|FG002|Overall Study|Other|0|||
145478620|NCT05173012|524605562|FG003|Overall Study|Other|2|||
145478621|NCT05173012|524605563|FG004|Overall Study|Other|0|||
145478622|NCT05173012|524605564|FG005|Overall Study|Other|0|||
145478623|NCT05173012|524605565|FG006|Overall Study|Other|0|||
145478624|NCT05173012|524605566|FG007|Overall Study|Other|0|||
145478625|NCT00517361|524605567|FG000|Overall Study|Death|6|||
145478626|NCT00517361|524605567|FG000|Overall Study|The study was terminated|5|||
145478627|NCT03517228|524605571|FG000|Overall Study|Withdrawal by Subject|2|||
145478628|NCT03517228|524605571|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
145478629|NCT03517228|524605571|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
145478630|NCT03517228|524605571|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
145478631|NCT03517228|524605571|FG000|Overall Study|Canceled due to device being updated|1|||
145478632|NCT03517228|524605571|FG000|Overall Study|No V Cares in stock|1|||
145478633|NCT03517228|524605571|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
145478634|NCT03781414|524605576|FG000|Overall Study|Study terminated by sponsor|39|||
145478635|NCT03781414|524605577|FG001|Overall Study|Study terminated by sponsor|34|||
145478636|NCT03781414|524605578|FG002|Overall Study|Study terminated by sponsor|25|||
145478637|NCT03781414|524605576|FG000|Overall Study|Adverse Event|3|||
145478638|NCT03781414|524605577|FG001|Overall Study|Adverse Event|6|||
145478639|NCT03781414|524605578|FG002|Overall Study|Adverse Event|3|||
145478640|NCT03781414|524605576|FG000|Overall Study|Physician Decision|2|||
145478641|NCT03781414|524605577|FG001|Overall Study|Physician Decision|0|||
145478642|NCT03781414|524605578|FG002|Overall Study|Physician Decision|1|||
145478643|NCT03781414|524605576|FG000|Overall Study|Withdrawal by Subject|2|||
145478644|NCT03781414|524605577|FG001|Overall Study|Withdrawal by Subject|3|||
145478645|NCT03781414|524605578|FG002|Overall Study|Withdrawal by Subject|3|||
145478646|NCT03781414|524605576|FG000|Overall Study|Death|1|||
145478647|NCT03781414|524605577|FG001|Overall Study|Death|4|||
145478648|NCT03781414|524605578|FG002|Overall Study|Death|0|||
145478649|NCT03781414|524605576|FG000|Overall Study|Lost to Follow-up|1|||
145478650|NCT03781414|524605577|FG001|Overall Study|Lost to Follow-up|1|||
145478651|NCT03781414|524605578|FG002|Overall Study|Lost to Follow-up|0|||
145478652|NCT02881762|524605581|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
145478653|NCT02881762|524605582|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
145478654|NCT04124705|524605587|FG000|Titration Period|Adverse Event|9|||
145478655|NCT04124705|524605588|FG001|Titration Period|Adverse Event|5|||
145478656|NCT04124705|524605587|FG000|Titration Period|Withdrawal by Subject|6|||
145478657|NCT04124705|524605588|FG001|Titration Period|Withdrawal by Subject|3|||
145478658|NCT04124705|524605587|FG000|Titration Period|Lost to Follow-up|0|||
145478659|NCT04124705|524605588|FG001|Titration Period|Lost to Follow-up|1|||
145478660|NCT04124705|524605587|FG000|Titration Period|Death|1|||
145478661|NCT04124705|524605588|FG001|Titration Period|Death|1|||
145478662|NCT04124705|524605587|FG000|Titration Period|Lack of Efficacy|2|||
145478663|NCT04124705|524605588|FG001|Titration Period|Lack of Efficacy|0|||
145478664|NCT04124705|524605587|FG000|Titration Period|Physician Decision|2|||
145478665|NCT04124705|524605588|FG001|Titration Period|Physician Decision|0|||
145478666|NCT04124705|524605587|FG000|Titration Period|Non-compliance with Study Drug|2|||
145478667|NCT04124705|524605588|FG001|Titration Period|Non-compliance with Study Drug|0|||
145478668|NCT04124705|524605587|FG000|Titration Period|Other|4|||
145478669|NCT04124705|524605588|FG001|Titration Period|Other|9|||
145478670|NCT04124705|524605587|FG000|Stabilization Period|Adverse Event|4|||
145478671|NCT04124705|524605588|FG001|Stabilization Period|Adverse Event|2|||
145478672|NCT04124705|524605587|FG000|Stabilization Period|Withdrawal by Subject|1|||
145478673|NCT04124705|524605588|FG001|Stabilization Period|Withdrawal by Subject|1|||
145478674|NCT04124705|524605587|FG000|Stabilization Period|Lost to Follow-up|0|||
145478675|NCT04124705|524605588|FG001|Stabilization Period|Lost to Follow-up|1|||
145478676|NCT04124705|524605587|FG000|Stabilization Period|Lack of Efficacy|4|||
145478677|NCT04124705|524605588|FG001|Stabilization Period|Lack of Efficacy|2|||
145478678|NCT04124705|524605587|FG000|Stabilization Period|Protocol Deviation|0|||
145478679|NCT04124705|524605588|FG001|Stabilization Period|Protocol Deviation|2|||
145478680|NCT04124705|524605587|FG000|Stabilization Period|Other|2|||
145478681|NCT04124705|524605588|FG001|Stabilization Period|Other|2|||
145478682|NCT05232864|524605589|FG000|Overall Study|Adverse Event|0|||
145478683|NCT05232864|524605590|FG001|Overall Study|Adverse Event|1|||
145478684|NCT05232864|524605589|FG000|Overall Study|Study terminated by sponsor|16|||
145478685|NCT05232864|524605590|FG001|Overall Study|Study terminated by sponsor|14|||
145478686|NCT02023996|524605591|FG000|Overall Study|Protocol Violation|6|||
145478687|NCT01636986|524605592|FG000|Overall Study|Withdrawal by Subject|0|||
145478688|NCT01636986|524605593|FG001|Overall Study|Withdrawal by Subject|1|||
145478689|NCT01636986|524605592|FG000|Overall Study|Corneal Staining|0|||
145478690|NCT01636986|524605593|FG001|Overall Study|Corneal Staining|1|||
145478691|NCT01496846|524605596|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
145478692|NCT01496846|524605597|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
145478693|NCT01496846|524605598|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
145478694|NCT01496846|524605599|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
145478695|NCT01496846|524605600|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
145478696|NCT01496846|524605601|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
145478697|NCT01772576|524605602|FG000|Overall Study|Death|15|||
145478698|NCT01772576|524605602|FG000|Overall Study|Protocol Violation|1|||
145478699|NCT01772576|524605602|FG000|Overall Study|Lost to Follow-up|3|||
145478700|NCT01772576|524605602|FG000|Overall Study|Study device not used|3|||
145478701|NCT01772576|524605602|FG000|Overall Study|Adverse Event|6|||
145478702|NCT01772576|524605602|FG000|Overall Study|Withdrawal by Subject|6|||
145478703|NCT00923845|524605603|FG000|Induction Therapy|Poor performance status|0|||
145478704|NCT00923845|524605604|FG001|Induction Therapy|Poor performance status|2|||
145478705|NCT00379912|524605606|FG000|Overall Study|Lack of Efficacy|1|||
145478706|NCT00379912|524605607|FG001|Overall Study|Lack of Efficacy|0|||
145478707|NCT02578186|524605608|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
145478708|NCT02578186|524605609|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
145478709|NCT02578186|524605608|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
145478710|NCT02578186|524605609|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
145478711|NCT02873338|524605610|FG000|Overall Study|Adverse Event|0|||
145478712|NCT02873338|524605611|FG001|Overall Study|Adverse Event|2|||
145478713|NCT02873338|524605612|FG002|Overall Study|Adverse Event|1|||
145478714|NCT02873338|524605610|FG000|Overall Study|Death|2|||
145478715|NCT02873338|524605611|FG001|Overall Study|Death|1|||
145478716|NCT02873338|524605612|FG002|Overall Study|Death|1|||
145478717|NCT02873338|524605610|FG000|Overall Study|Withdrawal by Subject|2|||
145478718|NCT02873338|524605611|FG001|Overall Study|Withdrawal by Subject|1|||
145478719|NCT02873338|524605612|FG002|Overall Study|Withdrawal by Subject|3|||
145478720|NCT02873338|524605610|FG000|Overall Study|Lack of Efficacy|0|||
145478721|NCT02873338|524605611|FG001|Overall Study|Lack of Efficacy|2|||
145478722|NCT02873338|524605612|FG002|Overall Study|Lack of Efficacy|0|||
145478723|NCT02873338|524605610|FG000|Overall Study|Other or Missing|14|||
145478724|NCT02873338|524605611|FG001|Overall Study|Other or Missing|15|||
145478725|NCT02873338|524605612|FG002|Overall Study|Other or Missing|13|||
145478726|NCT00852241|524605613|FG000|Overall Study|Physician Decision|18|||
145478727|NCT00118430|524605616|FG000|Overall Study|Withdrawal by Subject|6|||
145478728|NCT00118430|524605617|FG001|Overall Study|Withdrawal by Subject|2|||
145478729|NCT00118430|524605618|FG002|Overall Study|Withdrawal by Subject|0|||
145478730|NCT00118430|524605616|FG000|Overall Study|Lost to Follow-up|15|||
145478731|NCT00118430|524605617|FG001|Overall Study|Lost to Follow-up|22|||
145478732|NCT00118430|524605618|FG002|Overall Study|Lost to Follow-up|28|||
145478733|NCT02147288|524605619|FG000|Overall Study|post-operative hematoma|1|||
145478734|NCT02147288|524605620|FG001|Overall Study|post-operative hematoma|1|||
145478735|NCT02147288|524605621|FG002|Overall Study|post-operative hematoma|0|||
145478736|NCT02147288|524605622|FG003|Overall Study|post-operative hematoma|0|||
145478737|NCT02147288|524605623|FG004|Overall Study|post-operative hematoma|0|||
145478738|NCT02147288|524605624|FG005|Overall Study|post-operative hematoma|0|||
145478739|NCT02147288|524605625|FG006|Overall Study|post-operative hematoma|0|||
145478740|NCT02147288|524605626|FG007|Overall Study|post-operative hematoma|0|||
145478741|NCT02147288|524605627|FG008|Overall Study|post-operative hematoma|0|||
145478742|NCT02147288|524605628|FG009|Overall Study|post-operative hematoma|0|||
145478743|NCT02147288|524605619|FG000|Overall Study|complications from concurrent hernia rep|0|||
145478744|NCT02147288|524605620|FG001|Overall Study|complications from concurrent hernia rep|1|||
145478745|NCT02147288|524605621|FG002|Overall Study|complications from concurrent hernia rep|0|||
145478746|NCT02147288|524605622|FG003|Overall Study|complications from concurrent hernia rep|0|||
145478747|NCT02147288|524605623|FG004|Overall Study|complications from concurrent hernia rep|0|||
145478748|NCT02147288|524605624|FG005|Overall Study|complications from concurrent hernia rep|0|||
145478749|NCT02147288|524605625|FG006|Overall Study|complications from concurrent hernia rep|0|||
145478750|NCT02147288|524605626|FG007|Overall Study|complications from concurrent hernia rep|0|||
145478751|NCT02147288|524605627|FG008|Overall Study|complications from concurrent hernia rep|0|||
145478752|NCT02147288|524605628|FG009|Overall Study|complications from concurrent hernia rep|0|||
145478753|NCT02069392|524605631|FG000|Overall Study|Withdrawal by Subject|4|||
145478754|NCT02069392|524605632|FG001|Overall Study|Withdrawal by Subject|2|||
145478755|NCT00269633|524605633|FG000|Overall Study|Withdrawal by Subject|1|||
145478756|NCT00269633|524605634|FG001|Overall Study|Withdrawal by Subject|0|||
145478757|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Adverse Event|33|||
145478758|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
145478759|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
145478760|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
145478761|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Physician Decision|6|||
145478762|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
145478763|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
145478764|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
145478765|NCT00965419|524605635|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
145478766|NCT00965419|524605635|FG000|Follow-up Phase|Adverse Event|9|||
145478767|NCT00965419|524605635|FG000|Follow-up Phase|Protocol Violation|4|||
145478768|NCT00965419|524605635|FG000|Follow-up Phase|Withdrawal by Subject|8|||
145478769|NCT00965419|524605635|FG000|Follow-up Phase|Physician Decision|4|||
145478770|NCT00965419|524605635|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
145478771|NCT00965419|524605635|FG000|Follow-up Phase|Lack of Efficacy|28|||
145478772|NCT04412707|524605636|FG000|Cycle 1|Death|0|||
145478773|NCT04412707|524605637|FG001|Cycle 1|Death|3|||
145478774|NCT04412707|524605636|FG000|Cycle 1|Disease progression|1|||
145478775|NCT04412707|524605637|FG001|Cycle 1|Disease progression|2|||
145478776|NCT04412707|524605636|FG000|Cycle 2|Death|0|||
145478777|NCT04412707|524605637|FG001|Cycle 2|Death|1|||
145478778|NCT04412707|524605636|FG000|Cycle 2|Disease progression|3|||
145478779|NCT04412707|524605637|FG001|Cycle 2|Disease progression|0|||
145478780|NCT04412707|524605636|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
145478781|NCT04412707|524605637|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
145478782|NCT04412707|524605636|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
145478783|NCT04412707|524605637|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
145478784|NCT04412707|524605636|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
145478785|NCT04412707|524605637|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
145478786|NCT04412707|524605636|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
145478787|NCT04412707|524605637|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
145478788|NCT02927938|524605638|FG000|Overall Study|Death|0|||
145478789|NCT02927938|524605639|FG001|Overall Study|Death|1|||
145478790|NCT02927938|524605640|FG002|Overall Study|Death|0|||
145478791|NCT02927938|524605641|FG003|Overall Study|Death|4|||
145478792|NCT02927938|524605638|FG000|Overall Study|Early Study Termination|1|||
145478793|NCT02927938|524605639|FG001|Overall Study|Early Study Termination|5|||
145478794|NCT02927938|524605640|FG002|Overall Study|Early Study Termination|4|||
145478795|NCT02927938|524605641|FG003|Overall Study|Early Study Termination|3|||
145478796|NCT01504412|524607242|FG000|Overall Study|Adverse Event|1|||
145478797|NCT01504412|524607243|FG001|Overall Study|Adverse Event|8|||
145478798|NCT01504412|524607244|FG002|Overall Study|Adverse Event|1|||
145478799|NCT01504412|524607245|FG003|Overall Study|Adverse Event|7|||
145478800|NCT01504412|524607246|FG004|Overall Study|Adverse Event|10|||
145478801|NCT01504412|524607242|FG000|Overall Study|Withdrawal by Subject|2|||
145478802|NCT01504412|524607243|FG001|Overall Study|Withdrawal by Subject|1|||
145478803|NCT01504412|524607244|FG002|Overall Study|Withdrawal by Subject|1|||
145478804|NCT01504412|524607245|FG003|Overall Study|Withdrawal by Subject|5|||
145478805|NCT01504412|524607246|FG004|Overall Study|Withdrawal by Subject|1|||
145478806|NCT01504412|524607242|FG000|Overall Study|Other|2|||
145478807|NCT01504412|524607243|FG001|Overall Study|Other|1|||
145478808|NCT01504412|524607244|FG002|Overall Study|Other|1|||
145478809|NCT01504412|524607245|FG003|Overall Study|Other|6|||
145478810|NCT01504412|524607246|FG004|Overall Study|Other|1|||
145478811|NCT01504412|524607242|FG000|Overall Study|Lost to Follow-up|0|||
145478812|NCT01504412|524607243|FG001|Overall Study|Lost to Follow-up|2|||
145478813|NCT01504412|524607244|FG002|Overall Study|Lost to Follow-up|0|||
145478814|NCT01504412|524607245|FG003|Overall Study|Lost to Follow-up|0|||
145478815|NCT01504412|524607246|FG004|Overall Study|Lost to Follow-up|0|||
145478816|NCT01504412|524607242|FG000|Overall Study|Lack of Efficacy|0|||
145478817|NCT01504412|524607243|FG001|Overall Study|Lack of Efficacy|0|||
145478818|NCT01504412|524607244|FG002|Overall Study|Lack of Efficacy|1|||
145478819|NCT01504412|524607245|FG003|Overall Study|Lack of Efficacy|0|||
145478820|NCT01504412|524607246|FG004|Overall Study|Lack of Efficacy|1|||
145478821|NCT01504412|524607242|FG000|Overall Study|Death|0|||
145478822|NCT01504412|524607243|FG001|Overall Study|Death|0|||
145478823|NCT01504412|524607244|FG002|Overall Study|Death|0|||
145478824|NCT01504412|524607245|FG003|Overall Study|Death|1|||
145478825|NCT01504412|524607246|FG004|Overall Study|Death|0|||
145478826|NCT02644343|524607247|FG000|Overall Study|Withdrawal by Subject|1|||
145478827|NCT03437577|524607248|FG000|Pre-Randomization|Withdrawal by Subject|0|||
145478828|NCT03437577|524607249|FG001|Pre-Randomization|Withdrawal by Subject|0|||
145478829|NCT03437577|524607250|FG002|Pre-Randomization|Withdrawal by Subject|10|||
145478830|NCT03437577|524607248|FG000|Post-Randomization|Physician Decision|0|||
145478831|NCT03437577|524607249|FG001|Post-Randomization|Physician Decision|2|||
145478832|NCT03437577|524607250|FG002|Post-Randomization|Physician Decision|0|||
145478833|NCT02598297|524607258|FG000|Overall Study|Study terminated by Sponsor|21|||
145478834|NCT02598297|524607259|FG001|Overall Study|Study terminated by Sponsor|23|||
145478835|NCT02598297|524607258|FG000|Overall Study|Adverse Event|1|||
145478836|NCT02598297|524607259|FG001|Overall Study|Adverse Event|1|||
145478837|NCT02598297|524607258|FG000|Overall Study|Physician Decision|1|||
145478838|NCT02598297|524607259|FG001|Overall Study|Physician Decision|0|||
145478839|NCT02598297|524607258|FG000|Overall Study|Subject/guardian decision|1|||
145478840|NCT02598297|524607259|FG001|Overall Study|Subject/guardian decision|0|||
145478841|NCT02598297|524607258|FG000|Overall Study|Followed for survival|1|||
145478842|NCT02598297|524607259|FG001|Overall Study|Followed for survival|0|||
145478843|NCT01934010|524607266|FG000|Overall Study|Adverse Event|1|||
145478844|NCT01934010|524607267|FG001|Overall Study|Adverse Event|1|||
145478845|NCT01934010|524607268|FG002|Overall Study|Adverse Event|0|||
145478846|NCT01934010|524607266|FG000|Overall Study|Withdrawal by Subject|15|||
145478847|NCT01934010|524607267|FG001|Overall Study|Withdrawal by Subject|6|||
145478848|NCT01934010|524607268|FG002|Overall Study|Withdrawal by Subject|2|||
145478849|NCT01934010|524607266|FG000|Overall Study|Lost to Follow-up|7|||
145478850|NCT01934010|524607267|FG001|Overall Study|Lost to Follow-up|4|||
145478851|NCT01934010|524607268|FG002|Overall Study|Lost to Follow-up|0|||
145478852|NCT01393821|524607269|FG000|Overall Study|Cancel|1|||
145478853|NCT01393821|524607270|FG001|Overall Study|Cancel|1|||
145478854|NCT01393821|524607269|FG000|Overall Study|not evaluable for primary endpoint|4|||
145478855|NCT01393821|524607270|FG001|Overall Study|not evaluable for primary endpoint|2|||
145478856|NCT00377858|524607281|FG000|Overall Study|Withdrawal by Subject|12|||
145478857|NCT00377858|524607282|FG001|Overall Study|Withdrawal by Subject|11|||
145478858|NCT00377858|524607281|FG000|Overall Study|Lost to Follow-up|6|||
145478859|NCT00377858|524607282|FG001|Overall Study|Lost to Follow-up|1|||
145478860|NCT00377858|524607281|FG000|Overall Study|Physician Decision|5|||
145478861|NCT00377858|524607282|FG001|Overall Study|Physician Decision|5|||
145478862|NCT00377858|524607281|FG000|Overall Study|Protocol Violation|3|||
145478863|NCT00377858|524607282|FG001|Overall Study|Protocol Violation|4|||
145478864|NCT00377858|524607281|FG000|Overall Study|Adverse Event|2|||
145478865|NCT00377858|524607282|FG001|Overall Study|Adverse Event|1|||
145478866|NCT00377858|524607281|FG000|Overall Study|Entry Criteria Not Met|2|||
145478867|NCT00377858|524607282|FG001|Overall Study|Entry Criteria Not Met|0|||
145478868|NCT00377858|524607281|FG000|Overall Study|Sponsor Decision|1|||
145478869|NCT00377858|524607282|FG001|Overall Study|Sponsor Decision|2|||
145478870|NCT00377858|524607281|FG000|Overall Study|Death|0|||
145478871|NCT00377858|524607282|FG001|Overall Study|Death|3|||
145478872|NCT03534141|524607283|FG000|Overall Study|Enrolled in other clinical trial|1|||
145478873|NCT03534141|524607284|FG001|Overall Study|Enrolled in other clinical trial|0|||
145478874|NCT03534141|524607283|FG000|Overall Study|Liver transplant aborted after randomization|0|||
145478875|NCT03534141|524607284|FG001|Overall Study|Liver transplant aborted after randomization|2|||
145478876|NCT03534141|524607283|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
145478877|NCT03534141|524607284|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
145478878|NCT04303572|524607285|FG000|Overall Study|Study closed due to poor enrollment|1|||
145478879|NCT06312592|524607286|FG000|Overall Study|Lost to Follow-up|29|||
145478880|NCT06312592|524607287|FG001|Overall Study|Lost to Follow-up|13|||
145478881|NCT03785405|524607290|FG000|Overall Study|Adverse Event|16|||
145478882|NCT03785405|524607291|FG001|Overall Study|Adverse Event|1|||
145478883|NCT03785405|524607290|FG000|Overall Study|Death|6|||
145478884|NCT03785405|524607291|FG001|Overall Study|Death|4|||
145478885|NCT03785405|524607290|FG000|Overall Study|Guardian decision|4|||
145478886|NCT03785405|524607291|FG001|Overall Study|Guardian decision|1|||
145478887|NCT03785405|524607290|FG000|Overall Study|Lost to Follow-up|1|||
145478888|NCT03785405|524607291|FG001|Overall Study|Lost to Follow-up|0|||
145478889|NCT03785405|524607290|FG000|Overall Study|Physician Decision|8|||
145478890|NCT03785405|524607291|FG001|Overall Study|Physician Decision|5|||
145478891|NCT03785405|524607290|FG000|Overall Study|Participant decision|2|||
145478892|NCT03785405|524607291|FG001|Overall Study|Participant decision|0|||
145478893|NCT03785405|524607290|FG000|Overall Study|Other|1|||
145478894|NCT03785405|524607291|FG001|Overall Study|Other|0|||
145478895|NCT03785405|524607290|FG000|Overall Study|No treatment was received|0|||
145478896|NCT03785405|524607291|FG001|Overall Study|No treatment was received|1|||
145478897|NCT01948063|524607292|FG000|Overall Study|Boston MCI halted research protocol|0|||
145478898|NCT01948063|524607293|FG001|Overall Study|Boston MCI halted research protocol|1|||
145478899|NCT01948063|524607292|FG000|Overall Study|Discovered an enrollment in other study|0|||
145478900|NCT01948063|524607293|FG001|Overall Study|Discovered an enrollment in other study|1|||
145478901|NCT01948063|524607292|FG000|Overall Study|Blood samples were accidentally thawed|1|||
145478902|NCT01948063|524607293|FG001|Overall Study|Blood samples were accidentally thawed|0|||
145478903|NCT04752358|524607298|FG000|Overall Study|Death|2|||
145478904|NCT04752358|524607299|FG001|Overall Study|Death|1|||
145478905|NCT00719355|524607300|FG000|Overall Study|Death|0|||
145478906|NCT00719355|524607301|FG001|Overall Study|Death|1|||
145478907|NCT00719355|524607300|FG000|Overall Study|Medical|14|||
145478908|NCT00719355|524607301|FG001|Overall Study|Medical|5|||
145478909|NCT00719355|524607300|FG000|Overall Study|Compliance|4|||
145478910|NCT00719355|524607301|FG001|Overall Study|Compliance|6|||
145478911|NCT00719355|524607300|FG000|Overall Study|Moved|0|||
145478912|NCT00719355|524607301|FG001|Overall Study|Moved|1|||
145478913|NCT01824355|524607302|FG000|Overall Study|Adverse Event|2|||
145478914|NCT01824355|524607302|FG000|Overall Study|unevaluable reference method results per|1|||
145478915|NCT00836186|524607306|FG000|Overall Study|Blood could not be drawn|1|||
145478916|NCT02123823|524607312|FG000|Overall Study|Lack of Efficacy|0|||
145478917|NCT02123823|524607313|FG001|Overall Study|Lack of Efficacy|2|||
145478918|NCT02123823|524607314|FG002|Overall Study|Lack of Efficacy|8|||
145478919|NCT02123823|524607315|FG003|Overall Study|Lack of Efficacy|10|||
145478920|NCT02123823|524607312|FG000|Overall Study|Progressive disease|3|||
145478921|NCT02123823|524607313|FG001|Overall Study|Progressive disease|19|||
145478922|NCT02123823|524607314|FG002|Overall Study|Progressive disease|52|||
145478923|NCT02123823|524607315|FG003|Overall Study|Progressive disease|53|||
145478924|NCT02123823|524607312|FG000|Overall Study|Withdrawal by Subject|0|||
145478925|NCT02123823|524607313|FG001|Overall Study|Withdrawal by Subject|0|||
145478926|NCT02123823|524607314|FG002|Overall Study|Withdrawal by Subject|7|||
145478927|NCT02123823|524607315|FG003|Overall Study|Withdrawal by Subject|2|||
145478928|NCT02123823|524607312|FG000|Overall Study|Adverse Event|0|||
145478929|NCT02123823|524607313|FG001|Overall Study|Adverse Event|0|||
145478930|NCT02123823|524607314|FG002|Overall Study|Adverse Event|3|||
145478931|NCT02123823|524607315|FG003|Overall Study|Adverse Event|5|||
145478932|NCT02106403|524607317|FG000|Follow-Up Visit 3|Other Reason|0|||
145478933|NCT02106403|524607318|FG001|Follow-Up Visit 3|Other Reason|0|||
145478934|NCT02106403|524607319|FG002|Follow-Up Visit 3|Other Reason|0|||
145478935|NCT02106403|524607320|FG003|Follow-Up Visit 3|Other Reason|0|||
145478936|NCT02106403|524607321|FG004|Follow-Up Visit 3|Other Reason|0|||
145478937|NCT02106403|524607322|FG005|Follow-Up Visit 3|Other Reason|1|||
145478938|NCT01128946|524607324|FG000|Period I|Protocol Violation|0|||
145478939|NCT01128946|524607325|FG001|Period I|Protocol Violation|1|||
145478940|NCT01128946|524607326|FG002|Period I|Protocol Violation|0|||
145478941|NCT01128946|524607327|FG003|Period I|Protocol Violation|0|||
145478942|NCT01128946|524607324|FG000|Period I|Withdrawal by Subject|0|||
145478943|NCT01128946|524607325|FG001|Period I|Withdrawal by Subject|0|||
145478944|NCT01128946|524607326|FG002|Period I|Withdrawal by Subject|1|||
145478945|NCT01128946|524607327|FG003|Period I|Withdrawal by Subject|1|||
145478946|NCT01128946|524607324|FG000|Period II|Protocol Violation|0|||
145478947|NCT01128946|524607325|FG001|Period II|Protocol Violation|1|||
145478948|NCT01128946|524607326|FG002|Period II|Protocol Violation|0|||
145478949|NCT01128946|524607327|FG003|Period II|Protocol Violation|0|||
145478950|NCT01128946|524607324|FG000|Period II|Withdrawal by Subject|0|||
145478951|NCT01128946|524607325|FG001|Period II|Withdrawal by Subject|0|||
145478952|NCT01128946|524607326|FG002|Period II|Withdrawal by Subject|0|||
145478953|NCT01128946|524607327|FG003|Period II|Withdrawal by Subject|1|||
145478954|NCT01128946|524607324|FG000|Period III|Protocol Violation|1|||
145478955|NCT01128946|524607325|FG001|Period III|Protocol Violation|0|||
145478956|NCT01128946|524607326|FG002|Period III|Protocol Violation|0|||
145478957|NCT01128946|524607327|FG003|Period III|Protocol Violation|0|||
145478958|NCT04698993|524607328|FG000|Overall Study|PCR results not accessible|2|||
145478959|NCT04698993|524607329|FG001|Overall Study|PCR results not accessible|7|||
145478960|NCT04698993|524607328|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
145478961|NCT04698993|524607329|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
145478962|NCT00145574|524607330|FG000|Double Blind|Adverse Event|0|||
145478963|NCT00145574|524607331|FG001|Double Blind|Adverse Event|3|||
145478964|NCT00145574|524607332|FG002|Double Blind|Adverse Event|1|||
145478965|NCT00145574|524607330|FG000|Double Blind|Withdrawal by Subject|1|||
145478966|NCT00145574|524607331|FG001|Double Blind|Withdrawal by Subject|1|||
145478967|NCT00145574|524607332|FG002|Double Blind|Withdrawal by Subject|1|||
145478968|NCT00145574|524607330|FG000|Double Blind|required restricted medicine|0|||
145478969|NCT00145574|524607331|FG001|Double Blind|required restricted medicine|1|||
145478970|NCT00145574|524607332|FG002|Double Blind|required restricted medicine|0|||
145478971|NCT00145574|524607330|FG000|Open Label Long-term Extension|Adverse Event|0|||
145478972|NCT00145574|524607331|FG001|Open Label Long-term Extension|Adverse Event|0|||
145478973|NCT00145574|524607332|FG002|Open Label Long-term Extension|Adverse Event|5|||
145478974|NCT00145574|524607330|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
145478975|NCT00145574|524607331|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
145478976|NCT00145574|524607332|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
145478977|NCT00145574|524607330|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
145478978|NCT00145574|524607331|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
145478979|NCT00145574|524607332|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
145478980|NCT00145574|524607330|FG000|Open Label Long-term Extension|required restricted medicine|0|||
145478981|NCT00145574|524607331|FG001|Open Label Long-term Extension|required restricted medicine|0|||
145478982|NCT00145574|524607332|FG002|Open Label Long-term Extension|required restricted medicine|1|||
145478983|NCT00621140|524607333|FG000|Overall Study|Adverse Event|4|||
145478984|NCT00621140|524607334|FG001|Overall Study|Adverse Event|5|||
145478985|NCT00621140|524607333|FG000|Overall Study|Lost to Follow-up|1|||
145478986|NCT00621140|524607334|FG001|Overall Study|Lost to Follow-up|2|||
145478987|NCT00621140|524607333|FG000|Overall Study|Withdrawal by Subject|4|||
145478988|NCT00621140|524607334|FG001|Overall Study|Withdrawal by Subject|6|||
145478989|NCT00621140|524607333|FG000|Overall Study|Other incl. lack of efficacy|6|||
145478990|NCT00621140|524607334|FG001|Overall Study|Other incl. lack of efficacy|5|||
145478991|NCT00527904|524607335|FG000|Overall Study|Adverse Event|45|||
145478992|NCT00527904|524607335|FG000|Overall Study|Withdrawal by Subject|21|||
145478993|NCT00527904|524607335|FG000|Overall Study|Lost to Follow-up|8|||
145478994|NCT00527904|524607335|FG000|Overall Study|misc|22|||
145478995|NCT02669121|524607337|FG000|Overall Study|Adverse Event|4|||
145478996|NCT02669121|524607338|FG001|Overall Study|Adverse Event|5|||
145478997|NCT02669121|524607337|FG000|Overall Study|Lost to Follow-up|15|||
145478998|NCT02669121|524607338|FG001|Overall Study|Lost to Follow-up|27|||
145478999|NCT02669121|524607337|FG000|Overall Study|Withdrawal by Subject|132|||
145479000|NCT02669121|524607338|FG001|Overall Study|Withdrawal by Subject|140|||
145479001|NCT02669121|524607337|FG000|Overall Study|Pregnancy|0|||
145479002|NCT02669121|524607338|FG001|Overall Study|Pregnancy|1|||
145479003|NCT02669121|524607337|FG000|Overall Study|Discharged from US Military Active Service|117|||
145479004|NCT02669121|524607338|FG001|Overall Study|Discharged from US Military Active Service|91|||
145479005|NCT02669121|524607337|FG000|Overall Study|Reason not Specified|22|||
145479006|NCT02669121|524607338|FG001|Overall Study|Reason not Specified|18|||
145479007|NCT04384523|524607339|FG000|Overall Study|Lost to Follow-up|0|||
145479008|NCT04384523|524607340|FG001|Overall Study|Lost to Follow-up|0|||
145479009|NCT04384523|524607341|FG002|Overall Study|Lost to Follow-up|0|||
145479010|NCT04384523|524607342|FG003|Overall Study|Lost to Follow-up|0|||
145479011|NCT04384523|524607343|FG004|Overall Study|Lost to Follow-up|0|||
145479012|NCT04384523|524607344|FG005|Overall Study|Lost to Follow-up|1|||
145479013|NCT04384523|524607339|FG000|Overall Study|Protocol Violation|0|||
145479014|NCT04384523|524607340|FG001|Overall Study|Protocol Violation|1|||
145479015|NCT04384523|524607341|FG002|Overall Study|Protocol Violation|0|||
145479016|NCT04384523|524607342|FG003|Overall Study|Protocol Violation|0|||
145479017|NCT04384523|524607343|FG004|Overall Study|Protocol Violation|0|||
145479018|NCT04384523|524607344|FG005|Overall Study|Protocol Violation|0|||
145479019|NCT04384523|524607339|FG000|Overall Study|Withdrawal by Subject|1|||
145479020|NCT04384523|524607340|FG001|Overall Study|Withdrawal by Subject|0|||
145479021|NCT04384523|524607341|FG002|Overall Study|Withdrawal by Subject|0|||
145479022|NCT04384523|524607342|FG003|Overall Study|Withdrawal by Subject|0|||
145479023|NCT04384523|524607343|FG004|Overall Study|Withdrawal by Subject|0|||
145479024|NCT04384523|524607344|FG005|Overall Study|Withdrawal by Subject|0|||
145479025|NCT03216746|524607345|FG000|Overall Study|Lost to Follow-up|6|||
145479026|NCT03216746|524607346|FG001|Overall Study|Lost to Follow-up|8|||
145479027|NCT03216746|524607347|FG002|Overall Study|Lost to Follow-up|5|||
145479028|NCT03216746|524607348|FG003|Overall Study|Lost to Follow-up|6|||
145479029|NCT00635882|524607349|FG000|Overall Study|Protocol Violation|1|||
145479030|NCT00635882|524607350|FG001|Overall Study|Protocol Violation|0|||
145479031|NCT00635882|524607351|FG002|Overall Study|Protocol Violation|0|||
145479032|NCT00635882|524607352|FG003|Overall Study|Protocol Violation|0|||
145479033|NCT00635882|524607353|FG004|Overall Study|Protocol Violation|0|||
145479034|NCT00635882|524607354|FG005|Overall Study|Protocol Violation|0|||
145479035|NCT02687581|524607355|FG000|Overall Study|Withdrawal by Subject|1|||
145479036|NCT02687581|524607356|FG001|Overall Study|Withdrawal by Subject|0|||
145479037|NCT02687581|524607357|FG002|Overall Study|Withdrawal by Subject|0|||
145479038|NCT02687581|524607358|FG003|Overall Study|Withdrawal by Subject|1|||
145479039|NCT02687581|524607355|FG000|Overall Study|Lost to Follow-up|2|||
145479040|NCT02687581|524607356|FG001|Overall Study|Lost to Follow-up|2|||
145479041|NCT02687581|524607357|FG002|Overall Study|Lost to Follow-up|0|||
145479042|NCT02687581|524607358|FG003|Overall Study|Lost to Follow-up|0|||
145479043|NCT02687581|524607355|FG000|Overall Study|the device is too small for the patient.|1|||
145479044|NCT02687581|524607356|FG001|Overall Study|the device is too small for the patient.|0|||
145479045|NCT02687581|524607357|FG002|Overall Study|the device is too small for the patient.|0|||
145479046|NCT02687581|524607358|FG003|Overall Study|the device is too small for the patient.|0|||
145479047|NCT00835341|524607359|FG000|Overall Study|Lost to Follow-up|3|||
145479048|NCT00835341|524607360|FG001|Overall Study|Lost to Follow-up|12|||
145479049|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
145479050|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
145479051|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
145479052|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479053|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479054|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479055|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479056|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479057|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
145479058|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Physician Decision|1|||
145479059|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Physician Decision|2|||
145479060|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Physician Decision|0|||
145479061|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Physician Decision|0|||
145479062|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Physician Decision|0|||
145479063|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Physician Decision|0|||
145479064|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Physician Decision|0|||
145479065|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Physician Decision|0|||
145479066|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Physician Decision|0|||
145479067|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
145479068|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
145479069|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
145479070|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
145479071|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
145479072|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
145479073|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
145479074|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
145479075|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
145479076|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
145479077|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479078|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479079|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479080|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479081|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479082|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479083|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479084|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
145479085|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
145479086|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
145479087|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479088|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479089|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479090|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479091|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479092|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145633092|NCT01235949|525170749|FG009|Primary Phase|Adverse Event|0|||
145479093|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
145479094|NCT04405076|524607362|FG000|Part A (Blinded Phase)|Other than Specified|0|||
145479095|NCT04405076|524607363|FG001|Part A (Blinded Phase)|Other than Specified|0|||
145479096|NCT04405076|524607364|FG002|Part A (Blinded Phase)|Other than Specified|3|||
145479097|NCT04405076|524607365|FG003|Part A (Blinded Phase)|Other than Specified|0|||
145479098|NCT04405076|524607366|FG004|Part A (Blinded Phase)|Other than Specified|0|||
145479099|NCT04405076|524607367|FG005|Part A (Blinded Phase)|Other than Specified|0|||
145479100|NCT04405076|524607368|FG006|Part A (Blinded Phase)|Other than Specified|0|||
145479101|NCT04405076|524607369|FG007|Part A (Blinded Phase)|Other than Specified|0|||
145479102|NCT04405076|524607370|FG008|Part A (Blinded Phase)|Other than Specified|0|||
145479103|NCT04405076|524607362|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479104|NCT04405076|524607363|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479105|NCT04405076|524607364|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479106|NCT04405076|524607365|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
145479107|NCT04405076|524607366|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
145479108|NCT04405076|524607367|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
145479109|NCT04405076|524607368|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479110|NCT04405076|524607369|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479111|NCT04405076|524607370|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
145479112|NCT04405076|524607362|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479113|NCT04405076|524607363|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479114|NCT04405076|524607364|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479115|NCT04405076|524607365|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479116|NCT04405076|524607366|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
145479117|NCT04405076|524607367|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479118|NCT04405076|524607368|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479119|NCT04405076|524607369|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479120|NCT04405076|524607370|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
145479121|NCT04405076|524607362|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479122|NCT04405076|524607363|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479123|NCT04405076|524607364|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479124|NCT04405076|524607365|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
145479125|NCT04405076|524607366|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
145479126|NCT04405076|524607367|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
145479127|NCT04405076|524607368|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479128|NCT04405076|524607369|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479129|NCT04405076|524607370|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
145479130|NCT04405076|524607362|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479131|NCT04405076|524607363|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479132|NCT04405076|524607364|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479133|NCT04405076|524607365|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479134|NCT04405076|524607366|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479135|NCT04405076|524607367|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479136|NCT04405076|524607368|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
145479137|NCT04405076|524607369|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
145479138|NCT04405076|524607370|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
145479139|NCT04405076|524607362|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479140|NCT04405076|524607363|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479141|NCT04405076|524607364|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479142|NCT04405076|524607365|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479143|NCT04405076|524607366|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479144|NCT04405076|524607367|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479145|NCT04405076|524607368|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
145479146|NCT04405076|524607369|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479147|NCT04405076|524607370|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
145479148|NCT04310566|524607371|FG000|Period 1|Study Termination due to COVID-19|15|||
145479149|NCT04310566|524607372|FG001|Period 1|Study Termination due to COVID-19|17|||
145479150|NCT04310566|524607371|FG000|Period 1|Protocol Violation|0|||
145479151|NCT04310566|524607372|FG001|Period 1|Protocol Violation|1|||
145479152|NCT04310566|524607371|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
145479153|NCT04310566|524607372|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
145479154|NCT04310566|524607371|FG000|Period 1|Lost to Follow-up|1|||
145479155|NCT04310566|524607372|FG001|Period 1|Lost to Follow-up|0|||
145479156|NCT04310566|524607371|FG000|Period 1|Withdrawal by Subject|0|||
145479157|NCT04310566|524607372|FG001|Period 1|Withdrawal by Subject|1|||
145479158|NCT04310566|524607371|FG000|Period 2|Study Termination|7|||
145479159|NCT04310566|524607372|FG001|Period 2|Study Termination|5|||
145479160|NCT00384332|524607382|FG000|Overall Study|Lost to Follow-up|4|||
145479161|NCT00384332|524607383|FG001|Overall Study|Lost to Follow-up|0|||
145479162|NCT02560012|524607384|FG000|Overall Study|Study Terminated|2|||
145479163|NCT02218008|524607387|FG000|Stage 1 (S1)|Adverse Event|6|||
145479164|NCT02218008|524607388|FG001|Stage 1 (S1)|Adverse Event|5|||
145479165|NCT02218008|524607389|FG002|Stage 1 (S1)|Adverse Event|11|||
145479166|NCT02218008|524607390|FG003|Stage 1 (S1)|Adverse Event|0|||
145479167|NCT02218008|524607391|FG004|Stage 1 (S1)|Adverse Event|0|||
145479168|NCT02218008|524607392|FG005|Stage 1 (S1)|Adverse Event|0|||
145479169|NCT02218008|524607387|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
145479170|NCT02218008|524607388|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
145479171|NCT02218008|524607389|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
145479172|NCT02218008|524607390|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
145479173|NCT02218008|524607391|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
145479174|NCT02218008|524607392|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
145479175|NCT02218008|524607387|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
145479176|NCT02218008|524607388|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
145479177|NCT02218008|524607389|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
145479178|NCT02218008|524607390|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
145479179|NCT02218008|524607391|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
145479180|NCT02218008|524607392|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
145479181|NCT02218008|524607387|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
145479182|NCT02218008|524607388|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
145479183|NCT02218008|524607389|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
145479184|NCT02218008|524607390|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
145479185|NCT02218008|524607391|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
145479186|NCT02218008|524607392|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
145479187|NCT02218008|524607387|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
145479188|NCT02218008|524607388|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
145479189|NCT02218008|524607389|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
145479190|NCT02218008|524607390|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
145479191|NCT02218008|524607391|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
145479192|NCT02218008|524607392|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
145479193|NCT02218008|524607387|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
145479194|NCT02218008|524607388|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
145479195|NCT02218008|524607389|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
145479196|NCT02218008|524607390|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
145479197|NCT02218008|524607391|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
145479198|NCT02218008|524607392|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
145479199|NCT02218008|524607387|FG000|Stage 1 (S1)|Pregnancy|0|||
145479200|NCT02218008|524607388|FG001|Stage 1 (S1)|Pregnancy|0|||
145479201|NCT02218008|524607389|FG002|Stage 1 (S1)|Pregnancy|1|||
145479202|NCT02218008|524607390|FG003|Stage 1 (S1)|Pregnancy|0|||
145479203|NCT02218008|524607391|FG004|Stage 1 (S1)|Pregnancy|0|||
145479204|NCT02218008|524607392|FG005|Stage 1 (S1)|Pregnancy|0|||
145479205|NCT02218008|524607387|FG000|Stage 1 (S1)|Protocol Violation|0|||
145479206|NCT02218008|524607388|FG001|Stage 1 (S1)|Protocol Violation|0|||
145479207|NCT02218008|524607389|FG002|Stage 1 (S1)|Protocol Violation|1|||
145479208|NCT02218008|524607390|FG003|Stage 1 (S1)|Protocol Violation|0|||
145479209|NCT02218008|524607391|FG004|Stage 1 (S1)|Protocol Violation|0|||
145479210|NCT02218008|524607392|FG005|Stage 1 (S1)|Protocol Violation|0|||
145479211|NCT02218008|524607387|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
145479212|NCT02218008|524607388|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
145479213|NCT02218008|524607389|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
145479214|NCT02218008|524607390|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
145479215|NCT02218008|524607391|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
145479216|NCT02218008|524607392|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
145479217|NCT02218008|524607387|FG000|Stage 2 (S2)|Adverse Event|0|||
145479218|NCT02218008|524607388|FG001|Stage 2 (S2)|Adverse Event|0|||
145479219|NCT02218008|524607389|FG002|Stage 2 (S2)|Adverse Event|0|||
145479220|NCT02218008|524607390|FG003|Stage 2 (S2)|Adverse Event|2|||
145479221|NCT02218008|524607391|FG004|Stage 2 (S2)|Adverse Event|3|||
145479222|NCT02218008|524607392|FG005|Stage 2 (S2)|Adverse Event|3|||
145479223|NCT02218008|524607387|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
145479224|NCT02218008|524607388|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
145479225|NCT02218008|524607389|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
145479226|NCT02218008|524607390|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
145479227|NCT02218008|524607391|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
145479228|NCT02218008|524607392|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
145479229|NCT02218008|524607387|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
145479230|NCT02218008|524607388|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
145479231|NCT02218008|524607389|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
145479232|NCT02218008|524607390|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
145479233|NCT02218008|524607391|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
145479234|NCT02218008|524607392|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
145479235|NCT02218008|524607387|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
145479236|NCT02218008|524607388|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
145479237|NCT02218008|524607389|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
145479238|NCT02218008|524607390|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
145479239|NCT02218008|524607391|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
145479240|NCT02218008|524607392|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
145479241|NCT02218008|524607387|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
145479242|NCT02218008|524607388|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
145479243|NCT02218008|524607389|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
145479244|NCT02218008|524607390|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
145479245|NCT02218008|524607391|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
145479246|NCT02218008|524607392|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
145479247|NCT02038075|524607393|FG000|Overall Study|Withdrawal by Subject|3|||
145479248|NCT02038075|524607394|FG001|Overall Study|Withdrawal by Subject|0|||
145479249|NCT01278797|524607395|FG000|Period 1|Adverse Event|0|||
145479250|NCT01278797|524607396|FG001|Period 1|Adverse Event|1|||
145479251|NCT01278797|524607395|FG000|Period 1|Protocol Violation|1|||
145479252|NCT01278797|524607396|FG001|Period 1|Protocol Violation|0|||
145479253|NCT04000581|524607397|FG000|Overall Study|Withdrawal by Subject|0|||
145479254|NCT04000581|524607398|FG001|Overall Study|Withdrawal by Subject|1|||
145479255|NCT03477838|524607402|FG000|Overall Study|Lost to Follow-up|14|||
145479256|NCT02519595|524607404|FG000|Overall Study|Protocol Violation|8|||
145479257|NCT02519595|524607405|FG001|Overall Study|Protocol Violation|22|||
145479258|NCT02519595|524607406|FG002|Overall Study|Protocol Violation|16|||
145479259|NCT00850538|524607407|FG000|Overall Study|unable/unwilling to complete MRI|13|||
145479260|NCT00850538|524607407|FG000|Overall Study|specimen missed due to scheduling error|14|||
145479261|NCT00850538|524607407|FG000|Overall Study|specimen unusable|7|||
145479262|NCT00850538|524607407|FG000|Overall Study|Withdrawal by Subject|3|||
145479263|NCT00850538|524607407|FG000|Overall Study|radiology error|2|||
145479264|NCT00850538|524607407|FG000|Overall Study|Protocol Violation|2|||
145479265|NCT03188510|524607415|FG000|Overall Study|Inappropriate behavior with site staff|0|||
145479266|NCT03188510|524607416|FG001|Overall Study|Inappropriate behavior with site staff|1|||
145479267|NCT03188510|524607417|FG002|Overall Study|Inappropriate behavior with site staff|0|||
145479268|NCT01088399|524607419|FG000|Overall Study|Adverse Event|211|||
145479269|NCT01088399|524607420|FG001|Overall Study|Adverse Event|16|||
145479270|NCT01088399|524607421|FG002|Overall Study|Adverse Event|0|||
145479271|NCT01088399|524607419|FG000|Overall Study|Death|204|||
145479272|NCT01088399|524607420|FG001|Overall Study|Death|45|||
145479273|NCT01088399|524607421|FG002|Overall Study|Death|0|||
145479274|NCT01088399|524607419|FG000|Overall Study|Lack of Efficacy|298|||
145479275|NCT01088399|524607420|FG001|Overall Study|Lack of Efficacy|7|||
145479276|NCT01088399|524607421|FG002|Overall Study|Lack of Efficacy|5|||
145479277|NCT01088399|524607419|FG000|Overall Study|Lost to Follow-up|1070|||
145479278|NCT01088399|524607420|FG001|Overall Study|Lost to Follow-up|278|||
145479279|NCT01088399|524607421|FG002|Overall Study|Lost to Follow-up|58|||
145479280|NCT01088399|524607419|FG000|Overall Study|Physician Decision|531|||
145479281|NCT01088399|524607420|FG001|Overall Study|Physician Decision|88|||
145479282|NCT01088399|524607421|FG002|Overall Study|Physician Decision|16|||
145479283|NCT01088399|524607419|FG000|Overall Study|Withdrawal by Subject|544|||
145479284|NCT01088399|524607420|FG001|Overall Study|Withdrawal by Subject|195|||
145479285|NCT01088399|524607421|FG002|Overall Study|Withdrawal by Subject|33|||
145479286|NCT01088399|524607419|FG000|Overall Study|Change to or start of somatropin therapy|234|||
145479287|NCT01088399|524607420|FG001|Overall Study|Change to or start of somatropin therapy|17|||
145479288|NCT01088399|524607421|FG002|Overall Study|Change to or start of somatropin therapy|12|||
145479289|NCT01088399|524607419|FG000|Overall Study|Sponsor decision|1573|||
145479290|NCT01088399|524607420|FG001|Overall Study|Sponsor decision|298|||
145479291|NCT01088399|524607421|FG002|Overall Study|Sponsor decision|7|||
145479292|NCT01088399|524607419|FG000|Overall Study|Protocol Violation|10|||
145479293|NCT01088399|524607420|FG001|Overall Study|Protocol Violation|1|||
145479294|NCT01088399|524607421|FG002|Overall Study|Protocol Violation|0|||
145479295|NCT01088399|524607419|FG000|Overall Study|Enrollment criteria not met|48|||
145479296|NCT01088399|524607420|FG001|Overall Study|Enrollment criteria not met|119|||
145479297|NCT01088399|524607421|FG002|Overall Study|Enrollment criteria not met|70|||
145479298|NCT01088399|524607419|FG000|Overall Study|Study summary visit not completed|2398|||
145479299|NCT01088399|524607420|FG001|Overall Study|Study summary visit not completed|283|||
145479300|NCT01088399|524607421|FG002|Overall Study|Study summary visit not completed|80|||
145479301|NCT00620113|524607425|FG000|Overall Study|Adverse Event|3|||
145479302|NCT00620113|524607426|FG001|Overall Study|Adverse Event|2|||
145479303|NCT00620113|524607427|FG002|Overall Study|Adverse Event|2|||
145479304|NCT00620113|524607428|FG003|Overall Study|Adverse Event|1|||
145479305|NCT00620113|524607425|FG000|Overall Study|Lack of Efficacy|2|||
145479306|NCT00620113|524607426|FG001|Overall Study|Lack of Efficacy|3|||
145479307|NCT00620113|524607427|FG002|Overall Study|Lack of Efficacy|0|||
145479308|NCT00620113|524607428|FG003|Overall Study|Lack of Efficacy|2|||
145479309|NCT00620113|524607425|FG000|Overall Study|Physician Decision|1|||
145479310|NCT00620113|524607426|FG001|Overall Study|Physician Decision|0|||
145479311|NCT00620113|524607427|FG002|Overall Study|Physician Decision|0|||
145479312|NCT00620113|524607428|FG003|Overall Study|Physician Decision|2|||
145479313|NCT00620113|524607425|FG000|Overall Study|Protocol Violation|2|||
145479314|NCT00620113|524607426|FG001|Overall Study|Protocol Violation|1|||
145479315|NCT00620113|524607427|FG002|Overall Study|Protocol Violation|0|||
145479316|NCT00620113|524607428|FG003|Overall Study|Protocol Violation|0|||
145479317|NCT00620113|524607425|FG000|Overall Study|Withdrawal by Subject|5|||
145479318|NCT00620113|524607426|FG001|Overall Study|Withdrawal by Subject|1|||
145479319|NCT00620113|524607427|FG002|Overall Study|Withdrawal by Subject|3|||
145479320|NCT00620113|524607428|FG003|Overall Study|Withdrawal by Subject|5|||
145479321|NCT02476006|524607454|FG000|Overall Study|Death|4|||
145479322|NCT02476006|524607454|FG000|Overall Study|Lack of treatment efficacy|2|||
145479323|NCT02476006|524607454|FG000|Overall Study|Pregnancy|1|||
145479324|NCT02476006|524607454|FG000|Overall Study|Participant did not wish to continue|39|||
145479325|NCT02476006|524607454|FG000|Overall Study|Adverse Event|41|||
145479326|NCT02476006|524607454|FG000|Overall Study|Poor compliance to study protocol|3|||
145479327|NCT02476006|524607454|FG000|Overall Study|Sponsor decision|6|||
145479328|NCT02476006|524607454|FG000|Overall Study|Lost to Follow-up|5|||
145479329|NCT02476006|524607454|FG000|Overall Study|Physician Decision|5|||
145479330|NCT02476006|524607454|FG000|Overall Study|Study ended treatment not available|4|||
145479331|NCT02476006|524607454|FG000|Overall Study|Switched to commercial drug|4|||
145479332|NCT02476006|524607454|FG000|Overall Study|Excluded from study|1|||
145479333|NCT02476006|524607454|FG000|Overall Study|Protocol Violation|1|||
145479334|NCT02476006|524607454|FG000|Overall Study|Enrolled but not treated|4|||
145479335|NCT01698814|524609180|FG000|Overall Study|Adverse Event|0|||
145479336|NCT01698814|524609181|FG001|Overall Study|Adverse Event|2|||
145479337|NCT01698814|524609180|FG000|Overall Study|Lost to Follow-up|0|||
145479338|NCT01698814|524609181|FG001|Overall Study|Lost to Follow-up|1|||
145479339|NCT01698814|524609180|FG000|Overall Study|Pregnancy|1|||
145479340|NCT01698814|524609181|FG001|Overall Study|Pregnancy|0|||
145479341|NCT01698814|524609180|FG000|Overall Study|Randomized in error|1|||
145479342|NCT01698814|524609181|FG001|Overall Study|Randomized in error|0|||
145479343|NCT00368641|524609182|FG000|Overall Study|Adverse Event|2|||
145479344|NCT00368641|524609183|FG001|Overall Study|Adverse Event|1|||
145479345|NCT00368641|524609182|FG000|Overall Study|Death|1|||
145479346|NCT00368641|524609183|FG001|Overall Study|Death|0|||
145479347|NCT00368641|524609182|FG000|Overall Study|Withdrawal by Subject|1|||
145479348|NCT00368641|524609183|FG001|Overall Study|Withdrawal by Subject|0|||
145479349|NCT00368641|524609182|FG000|Overall Study|Sponsor decision to terminate study|2|||
145479350|NCT00368641|524609183|FG001|Overall Study|Sponsor decision to terminate study|5|||
145479351|NCT04809285|524609190|FG000|Phase 1|Lost to Follow-up|6|||
145479352|NCT04809285|524609190|FG000|Phase 1|Protocol Violation|2|||
145479353|NCT04809285|524609190|FG000|Phase 1|Physician Decision|3|||
145479354|NCT04809285|524609190|FG000|Phase 1|Withdrawal by Subject|29|||
145479355|NCT04809285|524609190|FG000|Phase 2|Protocol Violation|3|||
145479356|NCT04809285|524609190|FG000|Phase 2|Withdrawal by Subject|4|||
145479357|NCT02837029|524609191|FG000|Screening|Failed to meet screening requirements.|7|||
145479358|NCT02837029|524609192|FG001|Screening|Failed to meet screening requirements.|3|||
145479359|NCT02837029|524609193|FG002|Screening|Failed to meet screening requirements.|0|||
145479360|NCT02837029|524609191|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
145479361|NCT02837029|524609192|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
145479362|NCT02837029|524609193|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
145479363|NCT02837029|524609191|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
145479364|NCT02837029|524609192|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
145479365|NCT02837029|524609193|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
145479366|NCT02837029|524609191|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
145479367|NCT02837029|524609192|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
145479368|NCT02837029|524609193|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
145479369|NCT02837029|524609191|FG000|Cycle 2 and Beyond|Adverse Event|1|||
145479370|NCT02837029|524609192|FG001|Cycle 2 and Beyond|Adverse Event|0|||
145479371|NCT02837029|524609193|FG002|Cycle 2 and Beyond|Adverse Event|0|||
145479372|NCT02837029|524609191|FG000|2 Year Follow-up|Death|6|||
145479373|NCT02837029|524609192|FG001|2 Year Follow-up|Death|7|||
145479374|NCT02837029|524609193|FG002|2 Year Follow-up|Death|0|||
145479375|NCT02034877|524609194|FG000|Overall Study|Lost to Follow-up|0|||
145479376|NCT02034877|524609195|FG001|Overall Study|Lost to Follow-up|3|||
145479377|NCT02034877|524609194|FG000|Overall Study|No Longer Willing to Participate|0|||
145479378|NCT02034877|524609195|FG001|Overall Study|No Longer Willing to Participate|3|||
145479379|NCT00394706|524609196|FG000|Overall Study|Withdrawal by Subject|2|||
145479380|NCT00394706|524609197|FG001|Overall Study|Withdrawal by Subject|0|||
145479381|NCT00394706|524609198|FG002|Overall Study|Withdrawal by Subject|1|||
145479382|NCT00394706|524609199|FG003|Overall Study|Withdrawal by Subject|0|||
145479383|NCT00394706|524609200|FG004|Overall Study|Withdrawal by Subject|0|||
145479384|NCT00394706|524609201|FG005|Overall Study|Withdrawal by Subject|2|||
145479385|NCT00394706|524609202|FG006|Overall Study|Withdrawal by Subject|1|||
145479386|NCT00394706|524609203|FG007|Overall Study|Withdrawal by Subject|0|||
145479387|NCT00394706|524609196|FG000|Overall Study|Lost to Follow-up|2|||
145479388|NCT00394706|524609197|FG001|Overall Study|Lost to Follow-up|2|||
145479389|NCT00394706|524609198|FG002|Overall Study|Lost to Follow-up|8|||
145479390|NCT00394706|524609199|FG003|Overall Study|Lost to Follow-up|1|||
145479391|NCT00394706|524609200|FG004|Overall Study|Lost to Follow-up|2|||
145479392|NCT00394706|524609201|FG005|Overall Study|Lost to Follow-up|5|||
145479393|NCT00394706|524609202|FG006|Overall Study|Lost to Follow-up|2|||
145479394|NCT00394706|524609203|FG007|Overall Study|Lost to Follow-up|0|||
145479395|NCT00887549|524609206|FG000|Induction Therapy|Adverse Event|8|||
145479396|NCT00887549|524609206|FG000|Induction Therapy|Physician Decision|1|||
145479397|NCT00887549|524609206|FG000|Induction Therapy|Progressive Disease|13|||
145479398|NCT00887549|524609206|FG000|Induction Therapy|Death due to Study Disease|4|||
145479399|NCT00887549|524609206|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
145479400|NCT00887549|524609206|FG000|Maintenance Therapy|Adverse Event|16|||
145479401|NCT00887549|524609206|FG000|Maintenance Therapy|Physician Decision|1|||
145479402|NCT00887549|524609206|FG000|Maintenance Therapy|Progressive Disease|25|||
145479403|NCT00887549|524609206|FG000|Maintenance Therapy|Death due to adverse event|1|||
145479404|NCT00100789|524609207|FG000|Overall Study|Adverse Event|10|||
145479405|NCT00100789|524609207|FG000|Overall Study|Withdrawal by Subject|1|||
145479406|NCT00100789|524609207|FG000|Overall Study|Progression/relapse|42|||
145479407|NCT00100789|524609207|FG000|Overall Study|Death|2|||
145479408|NCT00100789|524609207|FG000|Overall Study|Not protocol specified|5|||
145479409|NCT00100789|524609207|FG000|Overall Study|Ineligible|3|||
145479410|NCT00100789|524609207|FG000|Overall Study|Never received treatment|1|||
145479411|NCT02506192|524609210|FG000|Overall Study|Withdrawal by Subject|1|||
145479412|NCT02506192|524609211|FG001|Overall Study|Withdrawal by Subject|1|||
145479413|NCT01685697|524609212|FG000|Overall Study|Protocol Violation|3|||
145479414|NCT01685697|524609213|FG001|Overall Study|Protocol Violation|3|||
145479415|NCT02703324|524609214|FG000|Period Two|Withdrawal by Subject|0|||
145479416|NCT02703324|524609215|FG001|Period Two|Withdrawal by Subject|0|||
145479417|NCT02703324|524609216|FG002|Period Two|Withdrawal by Subject|1|||
145479418|NCT02703324|524609217|FG003|Period Two|Withdrawal by Subject|0|||
145479419|NCT02703324|524609218|FG004|Period Two|Withdrawal by Subject|0|||
145479420|NCT02703324|524609219|FG005|Period Two|Withdrawal by Subject|0|||
145479421|NCT06136897|524609220|FG000|Overall Study|Ineligible|3|||
145479422|NCT06136897|524609220|FG000|Overall Study|Mutation status not confirmed|7|||
145479423|NCT06136897|524609220|FG000|Overall Study|Adverse Event|2|||
145479424|NCT06136897|524609220|FG000|Overall Study|Death|1|||
145479425|NCT06136897|524609220|FG000|Overall Study|Disease progression|18|||
145479426|NCT06136897|524609220|FG000|Overall Study|Other complicating disease|1|||
145479427|NCT06136897|524609220|FG000|Overall Study|Withdrawal by Subject|1|||
145479428|NCT06136897|524609220|FG000|Overall Study|Still on treatment|1|||
145479429|NCT06136897|524609220|FG000|Overall Study|Lost to Follow-up|1|||
145479430|NCT03705559|524609221|FG000|Overall Study|COVID Shut down|1|||
145479431|NCT01858766|524609222|FG000|Overall Study|Randomized but Never Treated|0|||
145479432|NCT01858766|524609223|FG001|Overall Study|Randomized but Never Treated|0|||
145479433|NCT01858766|524609224|FG002|Overall Study|Randomized but Never Treated|0|||
145479434|NCT01858766|524609225|FG003|Overall Study|Randomized but Never Treated|0|||
145479435|NCT01858766|524609226|FG004|Overall Study|Randomized but Never Treated|0|||
145479436|NCT01858766|524609227|FG005|Overall Study|Randomized but Never Treated|1|||
145479437|NCT01858766|524609228|FG006|Overall Study|Randomized but Never Treated|0|||
145479438|NCT01858766|524609229|FG007|Overall Study|Randomized but Never Treated|0|||
145479439|NCT01858766|524609230|FG008|Overall Study|Randomized but Never Treated|0|||
145479440|NCT01858766|524609231|FG009|Overall Study|Randomized but Never Treated|0|||
145479441|NCT01858766|524609232|FG010|Overall Study|Randomized but Never Treated|0|||
145479442|NCT01858766|524609233|FG011|Overall Study|Randomized but Never Treated|0|||
145479443|NCT01858766|524609234|FG012|Overall Study|Randomized but Never Treated|0|||
145479444|NCT01858766|524609235|FG013|Overall Study|Randomized but Never Treated|0|||
145479445|NCT01858766|524609236|FG014|Overall Study|Randomized but Never Treated|0|||
145479446|NCT01858766|524609237|FG015|Overall Study|Randomized but Never Treated|0|||
145479447|NCT01858766|524609238|FG016|Overall Study|Randomized but Never Treated|0|||
145479448|NCT01858766|524609239|FG017|Overall Study|Randomized but Never Treated|1|||
145479449|NCT01858766|524609240|FG018|Overall Study|Randomized but Never Treated|0|||
145479450|NCT01858766|524609222|FG000|Overall Study|Death|0|||
145479451|NCT01858766|524609223|FG001|Overall Study|Death|0|||
145479452|NCT01858766|524609224|FG002|Overall Study|Death|1|||
145479453|NCT01858766|524609225|FG003|Overall Study|Death|0|||
145479454|NCT01858766|524609226|FG004|Overall Study|Death|0|||
145479455|NCT01858766|524609227|FG005|Overall Study|Death|0|||
145479456|NCT01858766|524609228|FG006|Overall Study|Death|0|||
145479457|NCT01858766|524609229|FG007|Overall Study|Death|0|||
145479458|NCT01858766|524609230|FG008|Overall Study|Death|0|||
145479459|NCT01858766|524609231|FG009|Overall Study|Death|0|||
145479460|NCT01858766|524609232|FG010|Overall Study|Death|0|||
145479461|NCT01858766|524609233|FG011|Overall Study|Death|0|||
145479462|NCT01858766|524609234|FG012|Overall Study|Death|0|||
145479463|NCT01858766|524609235|FG013|Overall Study|Death|0|||
145479464|NCT01858766|524609236|FG014|Overall Study|Death|0|||
145479465|NCT01858766|524609237|FG015|Overall Study|Death|0|||
145479466|NCT01858766|524609238|FG016|Overall Study|Death|0|||
145479467|NCT01858766|524609239|FG017|Overall Study|Death|0|||
145479468|NCT01858766|524609240|FG018|Overall Study|Death|0|||
145479469|NCT01858766|524609222|FG000|Overall Study|Lack of Efficacy|1|||
145479470|NCT01858766|524609223|FG001|Overall Study|Lack of Efficacy|0|||
145479471|NCT01858766|524609224|FG002|Overall Study|Lack of Efficacy|0|||
145479472|NCT01858766|524609225|FG003|Overall Study|Lack of Efficacy|0|||
145479473|NCT01858766|524609226|FG004|Overall Study|Lack of Efficacy|1|||
145479474|NCT01858766|524609227|FG005|Overall Study|Lack of Efficacy|2|||
145479475|NCT01858766|524609228|FG006|Overall Study|Lack of Efficacy|0|||
145479476|NCT01858766|524609229|FG007|Overall Study|Lack of Efficacy|0|||
145479477|NCT01858766|524609230|FG008|Overall Study|Lack of Efficacy|0|||
145479478|NCT01858766|524609231|FG009|Overall Study|Lack of Efficacy|0|||
145479479|NCT01858766|524609232|FG010|Overall Study|Lack of Efficacy|0|||
145479480|NCT01858766|524609233|FG011|Overall Study|Lack of Efficacy|3|||
145479481|NCT01858766|524609234|FG012|Overall Study|Lack of Efficacy|5|||
145479482|NCT01858766|524609235|FG013|Overall Study|Lack of Efficacy|3|||
145479483|NCT01858766|524609236|FG014|Overall Study|Lack of Efficacy|5|||
145479484|NCT01858766|524609237|FG015|Overall Study|Lack of Efficacy|5|||
145479485|NCT01858766|524609238|FG016|Overall Study|Lack of Efficacy|2|||
145479486|NCT01858766|524609239|FG017|Overall Study|Lack of Efficacy|3|||
145479487|NCT01858766|524609240|FG018|Overall Study|Lack of Efficacy|3|||
145479488|NCT01858766|524609222|FG000|Overall Study|Lost to Follow-up|0|||
145479489|NCT01858766|524609223|FG001|Overall Study|Lost to Follow-up|0|||
145479490|NCT01858766|524609224|FG002|Overall Study|Lost to Follow-up|0|||
145479491|NCT01858766|524609225|FG003|Overall Study|Lost to Follow-up|0|||
145479492|NCT01858766|524609226|FG004|Overall Study|Lost to Follow-up|0|||
145479493|NCT01858766|524609227|FG005|Overall Study|Lost to Follow-up|1|||
145479494|NCT01858766|524609228|FG006|Overall Study|Lost to Follow-up|0|||
145479495|NCT01858766|524609229|FG007|Overall Study|Lost to Follow-up|2|||
145479496|NCT01858766|524609230|FG008|Overall Study|Lost to Follow-up|0|||
145479497|NCT01858766|524609231|FG009|Overall Study|Lost to Follow-up|0|||
145479498|NCT01858766|524609232|FG010|Overall Study|Lost to Follow-up|0|||
145479499|NCT01858766|524609233|FG011|Overall Study|Lost to Follow-up|1|||
145479500|NCT01858766|524609234|FG012|Overall Study|Lost to Follow-up|0|||
145479501|NCT01858766|524609235|FG013|Overall Study|Lost to Follow-up|0|||
145479502|NCT01858766|524609236|FG014|Overall Study|Lost to Follow-up|3|||
145479503|NCT01858766|524609237|FG015|Overall Study|Lost to Follow-up|1|||
145479504|NCT01858766|524609238|FG016|Overall Study|Lost to Follow-up|1|||
145479505|NCT01858766|524609239|FG017|Overall Study|Lost to Follow-up|0|||
145479506|NCT01858766|524609240|FG018|Overall Study|Lost to Follow-up|1|||
145479507|NCT01858766|524609222|FG000|Overall Study|Withdrew Consent|0|||
145479508|NCT01858766|524609223|FG001|Overall Study|Withdrew Consent|0|||
145479509|NCT01858766|524609224|FG002|Overall Study|Withdrew Consent|0|||
145479510|NCT01858766|524609225|FG003|Overall Study|Withdrew Consent|0|||
145479511|NCT01858766|524609226|FG004|Overall Study|Withdrew Consent|0|||
145479512|NCT01858766|524609227|FG005|Overall Study|Withdrew Consent|0|||
145479513|NCT01858766|524609228|FG006|Overall Study|Withdrew Consent|0|||
145479514|NCT01858766|524609229|FG007|Overall Study|Withdrew Consent|0|||
145479515|NCT01858766|524609230|FG008|Overall Study|Withdrew Consent|0|||
145479516|NCT01858766|524609231|FG009|Overall Study|Withdrew Consent|0|||
145479517|NCT01858766|524609232|FG010|Overall Study|Withdrew Consent|0|||
145479518|NCT01858766|524609233|FG011|Overall Study|Withdrew Consent|1|||
145479519|NCT01858766|524609234|FG012|Overall Study|Withdrew Consent|0|||
145479520|NCT01858766|524609235|FG013|Overall Study|Withdrew Consent|0|||
145479521|NCT01858766|524609236|FG014|Overall Study|Withdrew Consent|0|||
145479522|NCT01858766|524609237|FG015|Overall Study|Withdrew Consent|0|||
145479523|NCT01858766|524609238|FG016|Overall Study|Withdrew Consent|0|||
145479524|NCT01858766|524609239|FG017|Overall Study|Withdrew Consent|0|||
145479525|NCT01858766|524609240|FG018|Overall Study|Withdrew Consent|0|||
145479526|NCT00245037|524609241|FG000|Overall Study|Death|17|||
145479527|NCT00203424|524609247|FG000|Treatment Period|Withdrawal by Subject|4|||
145479528|NCT00203424|524609247|FG000|Treatment Period|Adverse Event|5|||
145479529|NCT00203424|524609247|FG000|Treatment Period|progressive disease|2|||
145479530|NCT00203424|524609247|FG000|Follow-up Period|Withdrawal by Subject|1|||
145479531|NCT00203424|524609247|FG000|Follow-up Period|progressive disease|4|||
145479532|NCT00203424|524609247|FG000|Follow-up Period|Lost to Follow-up|1|||
145479533|NCT00475709|524609248|FG000|Overall Study|Did not meet eligibility criteria|8|||
145479534|NCT00475709|524609248|FG000|Overall Study|Death|41|||
145479535|NCT00475709|524609248|FG000|Overall Study|Device Explant|6|||
145479536|NCT00475709|524609248|FG000|Overall Study|Lost to Follow-up|21|||
145479537|NCT00555672|524609249|FG000|Overall Study|Death|0|||
145479538|NCT00555672|524609250|FG001|Overall Study|Death|2|||
145479539|NCT00555672|524609249|FG000|Overall Study|Adverse Event|8|||
145479540|NCT00555672|524609250|FG001|Overall Study|Adverse Event|2|||
145479541|NCT00555672|524609249|FG000|Overall Study|Objective progression or relapse|11|||
145479542|NCT00555672|524609250|FG001|Overall Study|Objective progression or relapse|5|||
145479543|NCT00555672|524609249|FG000|Overall Study|Other|3|||
145479544|NCT00555672|524609250|FG001|Overall Study|Other|1|||
145479545|NCT00555672|524609249|FG000|Overall Study|Participant refused|2|||
145479546|NCT00555672|524609250|FG001|Overall Study|Participant refused|0|||
145479547|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
145479548|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145479549|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145479550|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145479551|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145479552|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
145479553|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
145479554|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145479555|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145479556|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145479557|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145479558|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
145479559|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
145479560|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145479561|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145479562|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145479563|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145479564|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
145479565|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
145479566|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
145479567|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
145479568|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
145479569|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
145479570|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
145479571|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
145479572|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
145479573|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
145479574|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
145479575|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
145479576|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
145479577|NCT01053988|524609251|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
145479578|NCT01053988|524609252|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145479579|NCT01053988|524609253|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145479580|NCT01053988|524609254|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145479581|NCT01053988|524609255|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145479582|NCT01053988|524609256|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
145479583|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
145479584|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
145479585|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
145479586|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
145479587|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
145479588|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
145479589|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145479590|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
145479591|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
145479592|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
145479593|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
145479594|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
145479595|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
145479596|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
145479597|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
145479598|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
145479599|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
145479600|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
145479601|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
145479602|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
145479603|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
145479604|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
145479605|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
145479606|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
145479607|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
145479608|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
145479609|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
145633093|NCT01235949|525170750|FG010|Primary Phase|Adverse Event|0|||
145633094|NCT01235949|525170751|FG011|Primary Phase|Adverse Event|0|||
145479610|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
145479611|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
145479612|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
145479613|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145479614|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
145479615|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
145479616|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
145479617|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
145479618|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
145479619|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
145479620|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
145479621|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
145479622|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
145479623|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
145479624|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
145479625|NCT01053988|524609251|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
145479626|NCT01053988|524609252|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
145479627|NCT01053988|524609253|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
145479628|NCT01053988|524609254|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
145479629|NCT01053988|524609255|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
145479630|NCT01053988|524609256|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
145479631|NCT01922271|524609257|FG000|WASHOUT Period|Withdrawal by Subject|1|||
145479632|NCT01922271|524609258|FG001|WASHOUT Period|Withdrawal by Subject|0|||
145479633|NCT03245398|524609269|FG000|Overall Study|Travelled to another island|1|||
145479634|NCT03245398|524609270|FG001|Overall Study|Travelled to another island|0|||
145479635|NCT04531241|524609271|FG000|Period 1|Withdrawal by Subject|2|||
145479636|NCT04531241|524609272|FG001|Period 1|Withdrawal by Subject|0|||
145479637|NCT04531241|524609271|FG000|Period 1|Dispesed incorrect lens power|1|||
145479638|NCT04531241|524609272|FG001|Period 1|Dispesed incorrect lens power|0|||
145479639|NCT04531241|524609271|FG000|Period 1|Protocol Violation|1|||
145479640|NCT04531241|524609272|FG001|Period 1|Protocol Violation|0|||
145479641|NCT04531241|524609271|FG000|Period 1|No longer eligible|0|||
145479642|NCT04531241|524609272|FG001|Period 1|No longer eligible|1|||
145479643|NCT04531241|524609271|FG000|Period 1|Lens Discomfort|0|||
145479644|NCT04531241|524609272|FG001|Period 1|Lens Discomfort|1|||
145479645|NCT04531241|524609271|FG000|Period 2|Covid-19 Related|1|||
145479646|NCT04531241|524609272|FG001|Period 2|Covid-19 Related|1|||
145479647|NCT03724890|524609273|FG000|Overall Study|Death|2|||
145479648|NCT03724890|524609274|FG001|Overall Study|Death|6|||
145479649|NCT03724890|524609275|FG002|Overall Study|Death|3|||
145479650|NCT03724890|524609276|FG003|Overall Study|Death|5|||
145479651|NCT03724890|524609277|FG004|Overall Study|Death|2|||
145479652|NCT03724890|524609278|FG005|Overall Study|Death|0|||
145479653|NCT03724890|524609279|FG006|Overall Study|Death|2|||
145479654|NCT03724890|524609280|FG007|Overall Study|Death|3|||
145479655|NCT03724890|524609281|FG008|Overall Study|Death|4|||
145479656|NCT03724890|524609282|FG009|Overall Study|Death|2|||
145479657|NCT03724890|524609283|FG010|Overall Study|Death|2|||
145479658|NCT03724890|524609273|FG000|Overall Study|Lost to Follow-up|0|||
145479659|NCT03724890|524609274|FG001|Overall Study|Lost to Follow-up|3|||
145479660|NCT03724890|524609275|FG002|Overall Study|Lost to Follow-up|0|||
145479661|NCT03724890|524609276|FG003|Overall Study|Lost to Follow-up|1|||
145479662|NCT03724890|524609277|FG004|Overall Study|Lost to Follow-up|2|||
145479663|NCT03724890|524609278|FG005|Overall Study|Lost to Follow-up|2|||
145479664|NCT03724890|524609279|FG006|Overall Study|Lost to Follow-up|1|||
145479665|NCT03724890|524609280|FG007|Overall Study|Lost to Follow-up|0|||
145479666|NCT03724890|524609281|FG008|Overall Study|Lost to Follow-up|2|||
145479667|NCT03724890|524609282|FG009|Overall Study|Lost to Follow-up|0|||
145479668|NCT03724890|524609283|FG010|Overall Study|Lost to Follow-up|0|||
145479669|NCT03724890|524609273|FG000|Overall Study|Withdrawal by Subject|1|||
145479670|NCT03724890|524609274|FG001|Overall Study|Withdrawal by Subject|2|||
145479671|NCT03724890|524609275|FG002|Overall Study|Withdrawal by Subject|1|||
145479672|NCT03724890|524609276|FG003|Overall Study|Withdrawal by Subject|0|||
145479673|NCT03724890|524609277|FG004|Overall Study|Withdrawal by Subject|0|||
145479674|NCT03724890|524609278|FG005|Overall Study|Withdrawal by Subject|1|||
145479675|NCT03724890|524609279|FG006|Overall Study|Withdrawal by Subject|0|||
145479676|NCT03724890|524609280|FG007|Overall Study|Withdrawal by Subject|0|||
145479677|NCT03724890|524609281|FG008|Overall Study|Withdrawal by Subject|2|||
145479678|NCT03724890|524609282|FG009|Overall Study|Withdrawal by Subject|2|||
145479679|NCT03724890|524609283|FG010|Overall Study|Withdrawal by Subject|1|||
145479680|NCT03724890|524609273|FG000|Overall Study|Other|1|||
145479681|NCT03724890|524609274|FG001|Overall Study|Other|0|||
145479682|NCT03724890|524609275|FG002|Overall Study|Other|0|||
145479683|NCT03724890|524609276|FG003|Overall Study|Other|0|||
145479684|NCT03724890|524609277|FG004|Overall Study|Other|0|||
145479685|NCT03724890|524609278|FG005|Overall Study|Other|0|||
145479686|NCT03724890|524609279|FG006|Overall Study|Other|0|||
145479687|NCT03724890|524609280|FG007|Overall Study|Other|1|||
145479688|NCT03724890|524609281|FG008|Overall Study|Other|1|||
145479689|NCT03724890|524609282|FG009|Overall Study|Other|0|||
145479690|NCT03724890|524609283|FG010|Overall Study|Other|2|||
145479691|NCT04427072|524609285|FG000|Randomized Treatment Phase|Progressive disease|9|||
145479692|NCT04427072|524609286|FG001|Randomized Treatment Phase|Progressive disease|4|||
145479693|NCT04427072|524609285|FG000|Randomized Treatment Phase|Adverse Event|3|||
145479694|NCT04427072|524609286|FG001|Randomized Treatment Phase|Adverse Event|1|||
145479695|NCT04427072|524609285|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
145479696|NCT04427072|524609286|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
145479697|NCT04427072|524609285|FG000|Randomized Treatment Phase|Death|0|||
145479698|NCT04427072|524609286|FG001|Randomized Treatment Phase|Death|1|||
145479699|NCT04427072|524609285|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
145479700|NCT04427072|524609286|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
145479701|NCT04427072|524609285|FG000|Extension Treatment Phase|Progressive disease|0|||
145479702|NCT04427072|524609286|FG001|Extension Treatment Phase|Progressive disease|5|||
145479703|NCT03400176|524609290|FG000|Dose Escalation|Progressive disease|1|||
145479704|NCT03400176|524609291|FG001|Dose Escalation|Progressive disease|1|||
145479705|NCT03400176|524609292|FG002|Dose Escalation|Progressive disease|0|||
145479706|NCT03400176|524609293|FG003|Dose Escalation|Progressive disease|0|||
145479707|NCT03400176|524609294|FG004|Dose Escalation|Progressive disease|1|||
145479708|NCT03400176|524609290|FG000|Dose Escalation|Patient decision|0|||
145479709|NCT03400176|524609291|FG001|Dose Escalation|Patient decision|0|||
145479710|NCT03400176|524609292|FG002|Dose Escalation|Patient decision|0|||
145479711|NCT03400176|524609293|FG003|Dose Escalation|Patient decision|0|||
145479712|NCT03400176|524609294|FG004|Dose Escalation|Patient decision|1|||
145479713|NCT03400176|524609290|FG000|Dose Expansion|Patient decision|0|||
145479714|NCT03400176|524609291|FG001|Dose Expansion|Patient decision|0|||
145479715|NCT03400176|524609292|FG002|Dose Expansion|Patient decision|0|||
145479716|NCT03400176|524609293|FG003|Dose Expansion|Patient decision|1|||
145479717|NCT03400176|524609294|FG004|Dose Expansion|Patient decision|0|||
145479718|NCT03400176|524609290|FG000|Dose Expansion|Adverse Event|0|||
145479719|NCT03400176|524609291|FG001|Dose Expansion|Adverse Event|0|||
145479720|NCT03400176|524609292|FG002|Dose Expansion|Adverse Event|0|||
145479721|NCT03400176|524609293|FG003|Dose Expansion|Adverse Event|1|||
145479722|NCT03400176|524609294|FG004|Dose Expansion|Adverse Event|0|||
145479723|NCT03400176|524609290|FG000|Dose Expansion|Physician Decision|0|||
145479724|NCT03400176|524609291|FG001|Dose Expansion|Physician Decision|0|||
145479725|NCT03400176|524609292|FG002|Dose Expansion|Physician Decision|0|||
145479726|NCT03400176|524609293|FG003|Dose Expansion|Physician Decision|1|||
145479727|NCT03400176|524609294|FG004|Dose Expansion|Physician Decision|0|||
145479728|NCT03400176|524609290|FG000|Dose Expansion|Progressive disease|0|||
145479729|NCT03400176|524609291|FG001|Dose Expansion|Progressive disease|0|||
145479730|NCT03400176|524609292|FG002|Dose Expansion|Progressive disease|1|||
145479731|NCT03400176|524609293|FG003|Dose Expansion|Progressive disease|1|||
145479732|NCT03400176|524609294|FG004|Dose Expansion|Progressive disease|0|||
145479733|NCT02104947|524609299|FG000|Overall Study|Withdrawal by Subject|10|||
145479734|NCT02104947|524609300|FG001|Overall Study|Withdrawal by Subject|3|||
145479735|NCT02104947|524609299|FG000|Overall Study|Lost to Follow-up|4|||
145479736|NCT02104947|524609300|FG001|Overall Study|Lost to Follow-up|4|||
145479737|NCT02104947|524609299|FG000|Overall Study|Protocol Violation|6|||
145479738|NCT02104947|524609300|FG001|Overall Study|Protocol Violation|8|||
145479739|NCT02104947|524609299|FG000|Overall Study|Adverse Event|57|||
145479740|NCT02104947|524609300|FG001|Overall Study|Adverse Event|38|||
145479741|NCT02104947|524609299|FG000|Overall Study|Other than stated above|2|||
145479742|NCT02104947|524609300|FG001|Overall Study|Other than stated above|3|||
145479743|NCT01090063|524609311|FG000|Screen|Screen Failed|4|||
145479744|NCT01090063|524609311|FG000|Treatment|Withdrawal by Subject|4|||
145479745|NCT00206440|524609324|FG000|Overall Study|Protocol Violation|1|||
145479746|NCT00206440|524609325|FG001|Overall Study|Protocol Violation|2|||
145479747|NCT00206440|524609324|FG000|Overall Study|Adverse Event|4|||
145479748|NCT00206440|524609325|FG001|Overall Study|Adverse Event|2|||
145479749|NCT01371734|524609326|FG000|Overall Study|Other|2|||
145479750|NCT01371734|524609327|FG001|Overall Study|Other|1|||
145479751|NCT01371734|524609328|FG002|Overall Study|Other|2|||
145479752|NCT01371734|524609326|FG000|Overall Study|Withdrawal by Subject|3|||
145479753|NCT01371734|524609327|FG001|Overall Study|Withdrawal by Subject|4|||
145479754|NCT01371734|524609328|FG002|Overall Study|Withdrawal by Subject|9|||
145479755|NCT01371734|524609326|FG000|Overall Study|Lost to Follow-up|5|||
145479756|NCT01371734|524609327|FG001|Overall Study|Lost to Follow-up|3|||
145479757|NCT01371734|524609328|FG002|Overall Study|Lost to Follow-up|1|||
145479758|NCT01371734|524609326|FG000|Overall Study|Protocol Violation|3|||
145479759|NCT01371734|524609327|FG001|Overall Study|Protocol Violation|1|||
145479760|NCT01371734|524609328|FG002|Overall Study|Protocol Violation|2|||
145479761|NCT01371734|524609326|FG000|Overall Study|Adverse Event|8|||
145479762|NCT01371734|524609327|FG001|Overall Study|Adverse Event|8|||
145479763|NCT01371734|524609328|FG002|Overall Study|Adverse Event|3|||
145479764|NCT01371734|524609326|FG000|Overall Study|Lack of Efficacy|2|||
145479765|NCT01371734|524609327|FG001|Overall Study|Lack of Efficacy|2|||
145479766|NCT01371734|524609328|FG002|Overall Study|Lack of Efficacy|0|||
145479767|NCT00958165|524609329|FG000|Overall Study|Lost to Follow-up|5|||
145479768|NCT00958165|524609329|FG000|Overall Study|Not eligible|9|||
145479769|NCT01298765|524609330|FG000|Titration Period|Adverse Event|26|||
145479770|NCT01298765|524609330|FG000|Titration Period|Death|1|||
145479771|NCT01298765|524609330|FG000|Titration Period|Lack of Efficacy|21|||
145479772|NCT01298765|524609330|FG000|Titration Period|Lost to Follow-up|9|||
145479773|NCT01298765|524609330|FG000|Titration Period|Physician Decision|1|||
145479774|NCT01298765|524609330|FG000|Titration Period|Withdrawal by Subject|10|||
145479775|NCT01298765|524609330|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
145479776|NCT01298765|524609330|FG000|Long-Term Treatment Period|Adverse Event|19|||
145479777|NCT01298765|524609330|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
145479778|NCT01298765|524609330|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
145479779|NCT01298765|524609330|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
145479780|NCT01298765|524609330|FG000|Long-Term Treatment Period|Physician Decision|1|||
145479781|NCT01298765|524609330|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
145479782|NCT03565237|524609331|FG000|Overall Study|Non-compliance of Investigational Product|1|||
145479783|NCT03565237|524609331|FG000|Overall Study|Physician Decision|1|||
145479784|NCT01140061|524609337|FG000|Part I|Adverse Event|1|||
145479785|NCT01140061|524609338|FG001|Part I|Adverse Event|0|||
145479786|NCT01140061|524609339|FG002|Part I|Adverse Event|0|||
145479787|NCT01140061|524609340|FG003|Part I|Adverse Event|0|||
145479788|NCT01140061|524609341|FG004|Part I|Adverse Event|0|||
145479789|NCT01140061|524609342|FG005|Part I|Adverse Event|0|||
145479790|NCT01140061|524609343|FG006|Part I|Adverse Event|0|||
145479791|NCT01140061|524609344|FG007|Part I|Adverse Event|0|||
145479792|NCT01140061|524609345|FG008|Part I|Adverse Event|0|||
145479793|NCT01140061|524609346|FG009|Part I|Adverse Event|0|||
145479794|NCT01140061|524609337|FG000|Extension|Laboratory Adverse Event|0|||
145479795|NCT01140061|524609338|FG001|Extension|Laboratory Adverse Event|0|||
145479796|NCT01140061|524609339|FG002|Extension|Laboratory Adverse Event|0|||
145479797|NCT01140061|524609340|FG003|Extension|Laboratory Adverse Event|0|||
145479798|NCT01140061|524609341|FG004|Extension|Laboratory Adverse Event|0|||
145479799|NCT01140061|524609342|FG005|Extension|Laboratory Adverse Event|0|||
145479800|NCT01140061|524609343|FG006|Extension|Laboratory Adverse Event|0|||
145479801|NCT01140061|524609344|FG007|Extension|Laboratory Adverse Event|0|||
145479802|NCT01140061|524609345|FG008|Extension|Laboratory Adverse Event|0|||
145479803|NCT01140061|524609346|FG009|Extension|Laboratory Adverse Event|1|||
145479804|NCT00428389|524609348|FG000|Core Phase|Adverse Event|6|||
145479805|NCT00428389|524609349|FG001|Core Phase|Adverse Event|4|||
145479806|NCT00428389|524609348|FG000|Core Phase|Lack of Efficacy|2|||
145479807|NCT00428389|524609349|FG001|Core Phase|Lack of Efficacy|0|||
145479808|NCT00428389|524609348|FG000|Core Phase|Abnormal test procedure result(s)|0|||
145479809|NCT00428389|524609349|FG001|Core Phase|Abnormal test procedure result(s)|1|||
145479810|NCT00428389|524609348|FG000|Core Phase|Withdrawal by Subject|3|||
145479811|NCT00428389|524609349|FG001|Core Phase|Withdrawal by Subject|4|||
145479812|NCT00428389|524609348|FG000|Core Phase|Protocol deviation|0|||
145479813|NCT00428389|524609349|FG001|Core Phase|Protocol deviation|2|||
145479814|NCT00428389|524609348|FG000|Extension Phase|Adverse Event|17|||
145479815|NCT00428389|524609349|FG001|Extension Phase|Adverse Event|11|||
145479816|NCT00428389|524609348|FG000|Extension Phase|Lack of Efficacy|4|||
145479817|NCT00428389|524609349|FG001|Extension Phase|Lack of Efficacy|3|||
145479818|NCT00428389|524609348|FG000|Extension Phase|Withdrawal by Subject|6|||
145479819|NCT00428389|524609349|FG001|Extension Phase|Withdrawal by Subject|6|||
145479820|NCT00428389|524609348|FG000|Extension Phase|Lost to Follow-up|0|||
145479821|NCT00428389|524609349|FG001|Extension Phase|Lost to Follow-up|3|||
145479822|NCT00428389|524609348|FG000|Extension Phase|Death|1|||
145479823|NCT00428389|524609349|FG001|Extension Phase|Death|0|||
145479824|NCT00428389|524609348|FG000|Extension Phase|Protocol Violation|3|||
145479825|NCT00428389|524609349|FG001|Extension Phase|Protocol Violation|2|||
145479826|NCT00428389|524609348|FG000|Extension Phase|Administrative problems|1|||
145479827|NCT00428389|524609349|FG001|Extension Phase|Administrative problems|1|||
145479828|NCT00766051|524609350|FG000|Overall Study|Withdrawal by Subject|2|||
145633095|NCT01235949|525170752|FG012|Primary Phase|Adverse Event|0|||
145633096|NCT01235949|525170753|FG013|Primary Phase|Adverse Event|0|||
145633097|NCT01235949|525170754|FG014|Primary Phase|Adverse Event|0|||
145633098|NCT01235949|525170755|FG015|Primary Phase|Adverse Event|0|||
145479829|NCT00766051|524609351|FG001|Overall Study|Withdrawal by Subject|0|||
145479830|NCT01711645|524609352|FG000|Overall Study|Withdrawal by Subject|8|||
145479831|NCT01711645|524609352|FG000|Overall Study|Lost to Follow-up|6|||
145479832|NCT01711645|524609352|FG000|Overall Study|Physician Decision|5|||
145479833|NCT00408434|524609353|FG000|Overall Study|Adverse Event|0|||
145479834|NCT00408434|524609354|FG001|Overall Study|Adverse Event|0|||
145479835|NCT00408434|524609355|FG002|Overall Study|Adverse Event|1|||
145479836|NCT00408434|524609356|FG003|Overall Study|Adverse Event|0|||
145479837|NCT00408434|524609357|FG004|Overall Study|Adverse Event|0|||
145633099|NCT01235949|525170756|FG016|Primary Phase|Adverse Event|0|||
145479838|NCT00408434|524609358|FG005|Overall Study|Adverse Event|0|||
145479839|NCT00408434|524609359|FG006|Overall Study|Adverse Event|0|||
145479840|NCT00408434|524609353|FG000|Overall Study|Progressive disease|6|||
145479841|NCT00408434|524609354|FG001|Overall Study|Progressive disease|3|||
145479842|NCT00408434|524609355|FG002|Overall Study|Progressive disease|4|||
145479843|NCT00408434|524609356|FG003|Overall Study|Progressive disease|3|||
145479844|NCT00408434|524609357|FG004|Overall Study|Progressive disease|3|||
145479845|NCT00408434|524609358|FG005|Overall Study|Progressive disease|1|||
145479846|NCT00408434|524609359|FG006|Overall Study|Progressive disease|4|||
145479847|NCT00408434|524609353|FG000|Overall Study|Other|0|||
145479848|NCT00408434|524609354|FG001|Overall Study|Other|0|||
145479849|NCT00408434|524609355|FG002|Overall Study|Other|1|||
145479850|NCT00408434|524609356|FG003|Overall Study|Other|0|||
145479851|NCT00408434|524609357|FG004|Overall Study|Other|2|||
145479852|NCT00408434|524609358|FG005|Overall Study|Other|1|||
145479853|NCT00408434|524609359|FG006|Overall Study|Other|0|||
145479854|NCT00408434|524609353|FG000|Overall Study|Terminated by Investigator|0|||
145479855|NCT00408434|524609354|FG001|Overall Study|Terminated by Investigator|0|||
145479856|NCT00408434|524609355|FG002|Overall Study|Terminated by Investigator|0|||
145479857|NCT00408434|524609356|FG003|Overall Study|Terminated by Investigator|0|||
145479858|NCT00408434|524609357|FG004|Overall Study|Terminated by Investigator|1|||
145479859|NCT00408434|524609358|FG005|Overall Study|Terminated by Investigator|1|||
145479860|NCT00408434|524609359|FG006|Overall Study|Terminated by Investigator|0|||
145479861|NCT00588354|524609360|FG000|Baseline to 2 Weeks|Adverse Event|1|||
145479862|NCT00588354|524609361|FG001|Baseline to 2 Weeks|Adverse Event|0|||
145479863|NCT00588354|524609360|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
145479864|NCT00588354|524609361|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
145479865|NCT00588354|524609360|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
145479866|NCT00588354|524609361|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
145479867|NCT04230213|524609362|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
145479868|NCT04230213|524609363|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
145479869|NCT04230213|524609364|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
145479870|NCT04230213|524609362|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
145479871|NCT04230213|524609363|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
145479872|NCT04230213|524609364|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
145479873|NCT04230213|524609362|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
145479874|NCT04230213|524609363|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
145479875|NCT04230213|524609364|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
145479876|NCT04230213|524609362|FG000|TP2: Week 10 to Week 16|Other|0|||
145479877|NCT04230213|524609363|FG001|TP2: Week 10 to Week 16|Other|2|||
145479878|NCT04230213|524609364|FG002|TP2: Week 10 to Week 16|Other|1|||
145479879|NCT04230213|524609362|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
145479880|NCT04230213|524609363|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
145479881|NCT04230213|524609364|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
145479882|NCT04230213|524609362|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
145479883|NCT04230213|524609363|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
145479884|NCT04230213|524609364|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
145479885|NCT04230213|524609362|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
145479886|NCT04230213|524609363|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
145479887|NCT04230213|524609364|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
145479888|NCT04230213|524609362|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
145479889|NCT04230213|524609363|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
145479890|NCT04230213|524609364|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
145479891|NCT04230213|524609362|FG000|TP3: Week 16 to Week 22|Other|0|||
145479892|NCT04230213|524609363|FG001|TP3: Week 16 to Week 22|Other|1|||
145479893|NCT04230213|524609364|FG002|TP3: Week 16 to Week 22|Other|3|||
145479894|NCT04230213|524609362|FG000|TP4: Week 22 to Week 32|Other|0|||
145479895|NCT04230213|524609363|FG001|TP4: Week 22 to Week 32|Other|5|||
145479896|NCT04230213|524609364|FG002|TP4: Week 22 to Week 32|Other|5|||
145479897|NCT04230213|524609362|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
145479898|NCT04230213|524609363|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
145479899|NCT04230213|524609364|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
145479900|NCT04230213|524609362|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
145479901|NCT04230213|524609363|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
145479902|NCT04230213|524609364|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
145479903|NCT04230213|524609362|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
145479904|NCT04230213|524609363|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
145479905|NCT04230213|524609364|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
145479906|NCT04230213|524609362|FG000|Follow up: Week 32 to Week 36|Other|0|||
145479907|NCT04230213|524609363|FG001|Follow up: Week 32 to Week 36|Other|1|||
145479908|NCT04230213|524609364|FG002|Follow up: Week 32 to Week 36|Other|1|||
145479909|NCT03058692|524611022|FG000|Overall Study|Lost to Follow-up|2|||
145479910|NCT03058692|524611023|FG001|Overall Study|Lost to Follow-up|1|||
145479911|NCT03058692|524611022|FG000|Overall Study|Withdrawal by Subject|1|||
145479912|NCT03058692|524611023|FG001|Overall Study|Withdrawal by Subject|1|||
145479913|NCT00806988|524611024|FG000|Overall Study|Death|15|||
145479914|NCT00806988|524611025|FG001|Overall Study|Death|16|||
145479915|NCT00806988|524611024|FG000|Overall Study|Withdrawal by Subject|8|||
145479916|NCT00806988|524611025|FG001|Overall Study|Withdrawal by Subject|8|||
145479917|NCT00806988|524611024|FG000|Overall Study|Lost to Follow-up|4|||
145479918|NCT00806988|524611025|FG001|Overall Study|Lost to Follow-up|19|||
145479919|NCT04775953|524611027|FG000|Overall Study|Lost to Follow-up|6|||
145479920|NCT04775953|524611028|FG001|Overall Study|Lost to Follow-up|11|||
145479921|NCT04775953|524611027|FG000|Overall Study|Death|5|||
145479922|NCT04775953|524611028|FG001|Overall Study|Death|4|||
145479923|NCT04775953|524611027|FG000|Overall Study|Withdrawal by Subject|3|||
145479924|NCT04775953|524611028|FG001|Overall Study|Withdrawal by Subject|3|||
145479925|NCT04775953|524611027|FG000|Overall Study|Protocol Violation|2|||
145479926|NCT04775953|524611028|FG001|Overall Study|Protocol Violation|0|||
145479927|NCT04775953|524611027|FG000|Overall Study|Participant non-compliance|0|||
145479928|NCT04775953|524611028|FG001|Overall Study|Participant non-compliance|1|||
145479929|NCT00855959|524611029|FG000|Overall Study|Adverse Event|2|||
145479930|NCT00855959|524611029|FG000|Overall Study|Lost to Follow-up|2|||
145479931|NCT00855959|524611029|FG000|Overall Study|Withdrawal by Subject|3|||
145479932|NCT00855959|524611029|FG000|Overall Study|Pregnancy|1|||
145479933|NCT00855959|524611029|FG000|Overall Study|Incorrect enrolment|1|||
145479934|NCT02813889|524611030|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
145479935|NCT02813889|524611031|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
145479936|NCT04014062|524611037|FG000|Period I: Dosing|Medical Grounds|4|||
145479937|NCT04014062|524611038|FG001|Period I: Dosing|Medical Grounds|5|||
145479938|NCT04014062|524611037|FG000|Period I: Dosing|Withdrawal by Subject|3|||
145479939|NCT04014062|524611038|FG001|Period I: Dosing|Withdrawal by Subject|1|||
145479940|NCT03038126|524611039|FG000|Overall Study|Death|1|||
145479941|NCT03038126|524611040|FG001|Overall Study|Death|1|||
145479942|NCT03038126|524611039|FG000|Overall Study|Withdrawal by Subject|5|||
145479943|NCT03038126|524611040|FG001|Overall Study|Withdrawal by Subject|0|||
145479944|NCT03038126|524611039|FG000|Overall Study|Lost to Follow-up|0|||
145479945|NCT03038126|524611040|FG001|Overall Study|Lost to Follow-up|1|||
145479946|NCT03038126|524611039|FG000|Overall Study|Long Term Hospitalization|2|||
145479947|NCT03038126|524611040|FG001|Overall Study|Long Term Hospitalization|0|||
145479948|NCT03038126|524611039|FG000|Overall Study|Too Ill to Participate|1|||
145479949|NCT03038126|524611040|FG001|Overall Study|Too Ill to Participate|2|||
145479950|NCT02451917|524611041|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
145479951|NCT02451917|524611042|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
145479952|NCT02451917|524611041|FG000|First Intervention (24 Weeks)|Death|0|||
145479953|NCT02451917|524611042|FG001|First Intervention (24 Weeks)|Death|1|||
145479954|NCT02451917|524611041|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
145479955|NCT02451917|524611042|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
145479956|NCT01724866|524611043|FG000|Overall Study|Adverse Event|0|||
145479957|NCT01724866|524611044|FG001|Overall Study|Adverse Event|0|||
145479958|NCT01724866|524611045|FG002|Overall Study|Adverse Event|1|||
145479959|NCT01724866|524611046|FG003|Overall Study|Adverse Event|1|||
145479960|NCT01724866|524611043|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
145479961|NCT01724866|524611044|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
145479962|NCT01724866|524611045|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
145479963|NCT01724866|524611046|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
145479964|NCT01724866|524611043|FG000|Overall Study|Investigator's Discretion|0|||
145479965|NCT01724866|524611044|FG001|Overall Study|Investigator's Discretion|1|||
145479966|NCT01724866|524611045|FG002|Overall Study|Investigator's Discretion|1|||
145479967|NCT01724866|524611046|FG003|Overall Study|Investigator's Discretion|0|||
145479968|NCT01724866|524611043|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
145479969|NCT01724866|524611044|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
145479970|NCT01724866|524611045|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
145479971|NCT01724866|524611046|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
145479972|NCT01724866|524611043|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
145479973|NCT01724866|524611044|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
145479974|NCT01724866|524611045|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
145479975|NCT01724866|524611046|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
145479976|NCT00411671|524611049|FG000|Overall Study|Adverse Event|15|||
145479977|NCT00411671|524611049|FG000|Overall Study|Death|2|||
145479978|NCT00411671|524611049|FG000|Overall Study|Lost to Follow-up|3|||
145479979|NCT01424501|524611050|FG000|Overall Study|Withdrawal by Subject|1|||
145633100|NCT01235949|525170757|FG017|Primary Phase|Adverse Event|0|||
145633101|NCT01235949|525170740|FG000|Primary Phase|Withdrawal by Subject|3|||
145633102|NCT01235949|525170741|FG001|Primary Phase|Withdrawal by Subject|2|||
145633103|NCT01235949|525170742|FG002|Primary Phase|Withdrawal by Subject|2|||
145479980|NCT01424501|524611051|FG001|Overall Study|Withdrawal by Subject|0|||
145479981|NCT01424501|524611052|FG002|Overall Study|Withdrawal by Subject|1|||
145479982|NCT01424501|524611053|FG003|Overall Study|Withdrawal by Subject|0|||
145479983|NCT01424501|524611054|FG004|Overall Study|Withdrawal by Subject|0|||
145479984|NCT01424501|524611055|FG005|Overall Study|Withdrawal by Subject|0|||
145479985|NCT01424501|524611050|FG000|Overall Study|Lost to Follow-up|0|||
145479986|NCT01424501|524611051|FG001|Overall Study|Lost to Follow-up|1|||
145479987|NCT01424501|524611052|FG002|Overall Study|Lost to Follow-up|1|||
145479988|NCT01424501|524611053|FG003|Overall Study|Lost to Follow-up|0|||
145479989|NCT01424501|524611054|FG004|Overall Study|Lost to Follow-up|0|||
145479990|NCT01424501|524611055|FG005|Overall Study|Lost to Follow-up|0|||
145479991|NCT01980095|524611056|FG000|Overall Study|Lost to Follow-up|6|||
145479992|NCT01980095|524611057|FG001|Overall Study|Lost to Follow-up|7|||
145479993|NCT01980095|524611056|FG000|Overall Study|Withdrawal by Subject|2|||
145479994|NCT01980095|524611057|FG001|Overall Study|Withdrawal by Subject|3|||
145479995|NCT01980095|524611056|FG000|Overall Study|Poor compliance|5|||
145479996|NCT01980095|524611057|FG001|Overall Study|Poor compliance|0|||
145479997|NCT01980095|524611056|FG000|Overall Study|Safety issue|0|||
145479998|NCT01980095|524611057|FG001|Overall Study|Safety issue|1|||
145479999|NCT01980095|524611056|FG000|Overall Study|Study drug discontinued|1|||
145480000|NCT01980095|524611057|FG001|Overall Study|Study drug discontinued|0|||
145480001|NCT01980095|524611056|FG000|Overall Study|Randomized by mistake|1|||
145480002|NCT01980095|524611057|FG001|Overall Study|Randomized by mistake|0|||
145480003|NCT04737278|524611058|FG000|Overall Study|Lost to Follow-up|1|||
145480004|NCT04737278|524611059|FG001|Overall Study|Lost to Follow-up|1|||
145480005|NCT04737278|524611058|FG000|Overall Study|Withdrawal by Subject|1|||
145480006|NCT04737278|524611059|FG001|Overall Study|Withdrawal by Subject|0|||
145480007|NCT04737278|524611058|FG000|Overall Study|Protocol Violation|1|||
145480008|NCT04737278|524611059|FG001|Overall Study|Protocol Violation|1|||
145480009|NCT04737278|524611058|FG000|Overall Study|failure to complete questionnaire|1|||
145480010|NCT04737278|524611059|FG001|Overall Study|failure to complete questionnaire|1|||
145480011|NCT00546000|524611064|FG000|Overall Study|Adverse Event|1|||
145480012|NCT00546000|524611064|FG000|Overall Study|Lost to Follow-up|1|||
145480013|NCT00546000|524611064|FG000|Overall Study|Baseline HPA Axis Supression|2|||
145480014|NCT01362608|524611071|FG000|Overall Study|Protocol Violation|0|||
145480015|NCT01362608|524611072|FG001|Overall Study|Protocol Violation|1|||
145480016|NCT01362608|524611071|FG000|Overall Study|Lost to Follow-up|3|||
145480017|NCT01362608|524611072|FG001|Overall Study|Lost to Follow-up|1|||
145480018|NCT01362608|524611071|FG000|Overall Study|Withdrawal by Subject|1|||
145480019|NCT01362608|524611072|FG001|Overall Study|Withdrawal by Subject|2|||
145480020|NCT01362608|524611071|FG000|Overall Study|Lack of Efficacy|0|||
145480021|NCT01362608|524611072|FG001|Overall Study|Lack of Efficacy|2|||
145480022|NCT01362608|524611071|FG000|Overall Study|Adverse Event|0|||
145480023|NCT01362608|524611072|FG001|Overall Study|Adverse Event|2|||
145480024|NCT01128244|524611078|FG000|Overall Study|Adverse Event|1|||
145480025|NCT01128244|524611078|FG000|Overall Study|Scheduling conflict|2|||
145480026|NCT04506502|524611082|FG000|Overall Study|Withdrawal by Subject|1|||
145480027|NCT04506502|524611082|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
145480028|NCT01449006|524611083|FG000|Overall Study|Lost to Follow-up|1|||
145480029|NCT01449006|524611084|FG001|Overall Study|Lost to Follow-up|0|||
145480030|NCT01449006|524611083|FG000|Overall Study|Withdrawal by Subject|1|||
145480031|NCT01449006|524611084|FG001|Overall Study|Withdrawal by Subject|0|||
145480032|NCT01449006|524611083|FG000|Overall Study|Protocol Violation|1|||
145480033|NCT01449006|524611084|FG001|Overall Study|Protocol Violation|0|||
145480034|NCT03526146|524611085|FG000|Overall Study|Lost to Follow-up|5|||
145480035|NCT03526146|524611085|FG000|Overall Study|Withdrawal by Subject|6|||
145480036|NCT03526146|524611085|FG000|Overall Study|class canceled due to COVID-19|4|||
145480037|NCT04112303|524611095|FG000|Overall Study|Death|1|||
145480038|NCT03472950|524611096|FG000|Overall Study|Lost to Follow-up|0|||
145480039|NCT03472950|524611097|FG001|Overall Study|Lost to Follow-up|1|||
145480040|NCT03472950|524611096|FG000|Overall Study|Adverse Event|0|||
145480041|NCT03472950|524611097|FG001|Overall Study|Adverse Event|3|||
145480042|NCT00195091|524611100|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
145480043|NCT01979952|524611110|FG000|Overall Study|Adverse Event|4|||
145480044|NCT01979952|524611111|FG001|Overall Study|Adverse Event|5|||
145480045|NCT01979952|524611110|FG000|Overall Study|Protocol Violation|1|||
145480046|NCT01979952|524611111|FG001|Overall Study|Protocol Violation|0|||
145480047|NCT01979952|524611110|FG000|Overall Study|Withdrawal by Subject|2|||
145480048|NCT01979952|524611111|FG001|Overall Study|Withdrawal by Subject|1|||
145480049|NCT01979952|524611110|FG000|Overall Study|Other than specified above|1|||
145480050|NCT01979952|524611111|FG001|Overall Study|Other than specified above|0|||
145480051|NCT03364738|524611112|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
145480052|NCT03364738|524611112|FG000|Overall Study|Withdrawal by Subject|1|||
145480053|NCT03364738|524611112|FG000|Overall Study|Adverse Event|1|||
145480054|NCT04079816|524611113|FG000|Overall Study|Request of Subject|2|||
145633104|NCT01235949|525170743|FG003|Primary Phase|Withdrawal by Subject|0|||
145480055|NCT04079816|524611113|FG000|Overall Study|Unable to draw samples|1|||
145480056|NCT02576795|524611114|FG000|Overall Study|Lost to Follow-up|0|||
145480057|NCT02576795|524611115|FG001|Overall Study|Lost to Follow-up|0|||
145480058|NCT02576795|524611116|FG002|Overall Study|Lost to Follow-up|1|||
145480059|NCT02576795|524611117|FG003|Overall Study|Lost to Follow-up|0|||
145480060|NCT01702246|524611118|FG000|Overall Study|Lost to Follow-up|2|||
145480061|NCT01702246|524611118|FG000|Overall Study|Withdrawal by Subject|2|||
145480062|NCT01702246|524611118|FG000|Overall Study|Physician Decision|1|||
145480063|NCT01635855|524611129|FG000|Overall Study|Withdrawal by Subject|4|||
145480064|NCT02708355|524611133|FG000|Overall Study|Adverse Event|1|||
145480065|NCT02708355|524611134|FG001|Overall Study|Adverse Event|0|||
145480066|NCT02708355|524611135|FG002|Overall Study|Adverse Event|0|||
145480067|NCT01320202|524611136|FG000|Overall Study|Adverse Event|5|||
145480068|NCT01320202|524611137|FG001|Overall Study|Adverse Event|5|||
145480069|NCT01320202|524611136|FG000|Overall Study|Death|5|||
145480070|NCT01320202|524611137|FG001|Overall Study|Death|3|||
145480071|NCT01320202|524611136|FG000|Overall Study|Lost to Follow-up|1|||
145480072|NCT01320202|524611137|FG001|Overall Study|Lost to Follow-up|0|||
145480073|NCT01320202|524611136|FG000|Overall Study|Physician Decision|3|||
145480074|NCT01320202|524611137|FG001|Overall Study|Physician Decision|1|||
145480075|NCT01320202|524611136|FG000|Overall Study|Protocol Violation|2|||
145480076|NCT01320202|524611137|FG001|Overall Study|Protocol Violation|1|||
145480077|NCT01320202|524611136|FG000|Overall Study|Withdrawal by Subject|10|||
145480078|NCT01320202|524611137|FG001|Overall Study|Withdrawal by Subject|3|||
145480079|NCT01320202|524611136|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
145480080|NCT01320202|524611137|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
145480081|NCT01320202|524611136|FG000|Overall Study|kidney transplant|1|||
145480082|NCT01320202|524611137|FG001|Overall Study|kidney transplant|2|||
145480083|NCT01320202|524611136|FG000|Overall Study|blood transfusion|1|||
145480084|NCT01320202|524611137|FG001|Overall Study|blood transfusion|7|||
145480085|NCT01320202|524611136|FG000|Overall Study|moved/changed dialysis|5|||
145480086|NCT01320202|524611137|FG001|Overall Study|moved/changed dialysis|2|||
145480087|NCT01320202|524611136|FG000|Overall Study|sponsor request|2|||
145480088|NCT01320202|524611137|FG001|Overall Study|sponsor request|0|||
145480089|NCT01320202|524611136|FG000|Overall Study|ineligible|3|||
145480090|NCT01320202|524611137|FG001|Overall Study|ineligible|0|||
145480091|NCT01320202|524611136|FG000|Overall Study|regained renal function|1|||
145480092|NCT01320202|524611137|FG001|Overall Study|regained renal function|0|||
145480093|NCT04090242|524611138|FG000|Overall Study|Withdrawal by Subject|1|||
145480094|NCT04090242|524611139|FG001|Overall Study|Withdrawal by Subject|0|||
145480095|NCT02305238|524611140|FG000|Overall Study|Death|2|||
145480096|NCT02305238|524611141|FG001|Overall Study|Death|1|||
145480097|NCT02305238|524611142|FG002|Overall Study|Death|0|||
145480098|NCT02305238|524611140|FG000|Overall Study|Progressive disease|4|||
145480099|NCT02305238|524611141|FG001|Overall Study|Progressive disease|4|||
145480100|NCT02305238|524611142|FG002|Overall Study|Progressive disease|0|||
145480101|NCT02305238|524611140|FG000|Overall Study|Logistical difficulties|1|||
145480102|NCT02305238|524611141|FG001|Overall Study|Logistical difficulties|3|||
145480103|NCT02305238|524611142|FG002|Overall Study|Logistical difficulties|0|||
145480104|NCT02305238|524611140|FG000|Overall Study|Protocol Violation|0|||
145480105|NCT02305238|524611141|FG001|Overall Study|Protocol Violation|3|||
145480106|NCT02305238|524611142|FG002|Overall Study|Protocol Violation|0|||
145480107|NCT02305238|524611140|FG000|Overall Study|Physician Decision|2|||
145480108|NCT02305238|524611141|FG001|Overall Study|Physician Decision|1|||
145480109|NCT02305238|524611142|FG002|Overall Study|Physician Decision|0|||
145480110|NCT02305238|524611140|FG000|Overall Study|Adverse Event|4|||
145480111|NCT02305238|524611141|FG001|Overall Study|Adverse Event|2|||
145480112|NCT02305238|524611142|FG002|Overall Study|Adverse Event|0|||
145480113|NCT02305238|524611140|FG000|Overall Study|Withdrawal by Subject|3|||
145480114|NCT02305238|524611141|FG001|Overall Study|Withdrawal by Subject|4|||
145480115|NCT02305238|524611142|FG002|Overall Study|Withdrawal by Subject|0|||
145480116|NCT02305238|524611140|FG000|Overall Study|Randomized failure|0|||
145480117|NCT02305238|524611141|FG001|Overall Study|Randomized failure|0|||
145480118|NCT02305238|524611142|FG002|Overall Study|Randomized failure|8|||
145480119|NCT02305238|524611140|FG000|Overall Study|Required procedure failed|0|||
145480120|NCT02305238|524611141|FG001|Overall Study|Required procedure failed|1|||
145480121|NCT02305238|524611142|FG002|Overall Study|Required procedure failed|0|||
145480122|NCT01019369|524611143|FG000|Overall Study|Lost to Follow-up|10|||
145480123|NCT01019369|524611144|FG001|Overall Study|Lost to Follow-up|6|||
145480124|NCT01019369|524611143|FG000|Overall Study|Withdrawal by Subject|0|||
145480125|NCT01019369|524611144|FG001|Overall Study|Withdrawal by Subject|1|||
145480126|NCT02513472|524611145|FG000|Overall Study|Radiological Disease Progression|45|||
145480127|NCT02513472|524611146|FG001|Overall Study|Radiological Disease Progression|57|||
145480128|NCT02513472|524611145|FG000|Overall Study|Clinical Disease Progression|5|||
145633105|NCT01235949|525170744|FG004|Primary Phase|Withdrawal by Subject|0|||
145633106|NCT01235949|525170745|FG005|Primary Phase|Withdrawal by Subject|3|||
145480129|NCT02513472|524611146|FG001|Overall Study|Clinical Disease Progression|13|||
145480130|NCT02513472|524611145|FG000|Overall Study|Adverse Event|8|||
145480131|NCT02513472|524611146|FG001|Overall Study|Adverse Event|11|||
145480132|NCT02513472|524611145|FG000|Overall Study|Withdrawal by Subject|0|||
145480133|NCT02513472|524611146|FG001|Overall Study|Withdrawal by Subject|4|||
145480134|NCT02513472|524611145|FG000|Overall Study|Subject Choice|2|||
145480135|NCT02513472|524611146|FG001|Overall Study|Subject Choice|7|||
145480136|NCT02513472|524611145|FG000|Overall Study|Treatment Completed as per Protocol|3|||
145480137|NCT02513472|524611146|FG001|Overall Study|Treatment Completed as per Protocol|3|||
145480138|NCT02513472|524611145|FG000|Overall Study|Other|3|||
145480139|NCT02513472|524611146|FG001|Overall Study|Other|6|||
145480140|NCT00604695|524611147|FG000|Overall Study|Did not receive first bolus.|0|||
145480141|NCT00604695|524611148|FG001|Overall Study|Did not receive first bolus.|4|||
145480142|NCT03214406|524611149|FG000|Overall Study|did not meet enrollment criteria|9|||
145480143|NCT03214406|524611150|FG001|Overall Study|did not meet enrollment criteria|13|||
145480144|NCT03214406|524611149|FG000|Overall Study|Withdrawal by Subject|1|||
145480145|NCT03214406|524611150|FG001|Overall Study|Withdrawal by Subject|0|||
145480146|NCT03214406|524611149|FG000|Overall Study|Lost to Follow-up|0|||
145480147|NCT03214406|524611150|FG001|Overall Study|Lost to Follow-up|2|||
145480148|NCT01098305|524611156|FG000|Overall Study|Lost to Follow-up|31|||
145480149|NCT01098305|524611157|FG001|Overall Study|Lost to Follow-up|33|||
145480150|NCT04565951|524611161|FG000|Overall Study|Lost to Follow-up|66|||
145480151|NCT04565951|524611162|FG001|Overall Study|Lost to Follow-up|38|||
145480152|NCT04565951|524611161|FG000|Overall Study|Withdrawal by Subject|14|||
145480153|NCT04565951|524611162|FG001|Overall Study|Withdrawal by Subject|7|||
145480154|NCT04565951|524611161|FG000|Overall Study|Death|0|||
145480155|NCT04565951|524611162|FG001|Overall Study|Death|1|||
145480156|NCT00615017|524613074|FG000|Overall Study|Adverse Event|0|||
145480157|NCT00615017|524613075|FG001|Overall Study|Adverse Event|1|||
145480158|NCT00615017|524613076|FG002|Overall Study|Adverse Event|2|||
145480159|NCT00615017|524613077|FG003|Overall Study|Adverse Event|0|||
145480160|NCT00615017|524613078|FG004|Overall Study|Adverse Event|0|||
145480161|NCT00615017|524613079|FG005|Overall Study|Adverse Event|1|||
145480162|NCT00615017|524613074|FG000|Overall Study|Death|0|||
145480163|NCT00615017|524613075|FG001|Overall Study|Death|0|||
145480164|NCT00615017|524613076|FG002|Overall Study|Death|2|||
145480165|NCT00615017|524613077|FG003|Overall Study|Death|0|||
145480166|NCT00615017|524613078|FG004|Overall Study|Death|1|||
145480167|NCT00615017|524613079|FG005|Overall Study|Death|1|||
145480168|NCT00615017|524613074|FG000|Overall Study|Sepsis resolved|0|||
145480169|NCT00615017|524613075|FG001|Overall Study|Sepsis resolved|0|||
145480170|NCT00615017|524613076|FG002|Overall Study|Sepsis resolved|1|||
145480171|NCT00615017|524613077|FG003|Overall Study|Sepsis resolved|0|||
145480172|NCT00615017|524613078|FG004|Overall Study|Sepsis resolved|0|||
145480173|NCT00615017|524613079|FG005|Overall Study|Sepsis resolved|0|||
145480174|NCT00615017|524613074|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
145480175|NCT00615017|524613075|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
145480176|NCT00615017|524613076|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
145480177|NCT00615017|524613077|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
145480178|NCT00615017|524613078|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
145480179|NCT00615017|524613079|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
145480180|NCT00615017|524613074|FG000|Overall Study|Physician discontinued drug|0|||
145480181|NCT00615017|524613075|FG001|Overall Study|Physician discontinued drug|0|||
145480182|NCT00615017|524613076|FG002|Overall Study|Physician discontinued drug|0|||
145480183|NCT00615017|524613077|FG003|Overall Study|Physician discontinued drug|0|||
145480184|NCT00615017|524613078|FG004|Overall Study|Physician discontinued drug|0|||
145480185|NCT00615017|524613079|FG005|Overall Study|Physician discontinued drug|1|||
145480186|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
145480187|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
145480188|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
145480189|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
145480190|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
145480191|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
145480192|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
145480193|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
145480194|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
145480195|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
145480196|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
145480197|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
145480198|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
145480199|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
145480200|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
145480201|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
145480202|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
145480203|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
145480204|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
145480205|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
145480206|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
145480207|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
145480208|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
145480209|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
145480210|NCT03777059|524613080|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
145480211|NCT03777059|524613081|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
145480212|NCT03777059|524613082|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
145480213|NCT03777059|524613083|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
145480214|NCT03777059|524613080|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
145480215|NCT03777059|524613081|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
145480216|NCT03777059|524613082|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
145480217|NCT03777059|524613083|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
145480218|NCT03777059|524613080|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
145480219|NCT03777059|524613081|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
145480220|NCT03777059|524613082|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
145480221|NCT03777059|524613083|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
145480222|NCT03777059|524613080|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
145480223|NCT03777059|524613081|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
145480224|NCT03777059|524613082|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
145480225|NCT03777059|524613083|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
145480226|NCT03777059|524613080|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
145480227|NCT03777059|524613081|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
145480228|NCT03777059|524613082|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
145480229|NCT03777059|524613083|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
145480230|NCT03350815|524613086|FG000|Period 1|Adverse Event|10|||
145480231|NCT03350815|524613087|FG001|Period 1|Adverse Event|0|||
145480232|NCT03350815|524613088|FG002|Period 1|Adverse Event|0|||
145480233|NCT03350815|524613089|FG003|Period 1|Adverse Event|0|||
145480234|NCT03350815|524613086|FG000|Period 1|Technical problems|1|||
145480235|NCT03350815|524613087|FG001|Period 1|Technical problems|0|||
145480236|NCT03350815|524613088|FG002|Period 1|Technical problems|0|||
145480237|NCT03350815|524613089|FG003|Period 1|Technical problems|0|||
145480238|NCT03350815|524613086|FG000|Period 1|Lost to Follow-up|3|||
145480239|NCT03350815|524613087|FG001|Period 1|Lost to Follow-up|0|||
145480240|NCT03350815|524613088|FG002|Period 1|Lost to Follow-up|0|||
145480241|NCT03350815|524613089|FG003|Period 1|Lost to Follow-up|0|||
145480242|NCT03350815|524613086|FG000|Period 1|Physician Decision|1|||
145480243|NCT03350815|524613087|FG001|Period 1|Physician Decision|0|||
145480244|NCT03350815|524613088|FG002|Period 1|Physician Decision|0|||
145480245|NCT03350815|524613089|FG003|Period 1|Physician Decision|0|||
145480246|NCT03350815|524613086|FG000|Period 1|Withdrawal by Subject|8|||
145480247|NCT03350815|524613087|FG001|Period 1|Withdrawal by Subject|0|||
145480248|NCT03350815|524613088|FG002|Period 1|Withdrawal by Subject|0|||
145480249|NCT03350815|524613089|FG003|Period 1|Withdrawal by Subject|0|||
145480250|NCT03350815|524613086|FG000|Period 1|Lack of Efficacy|15|||
145480251|NCT03350815|524613087|FG001|Period 1|Lack of Efficacy|0|||
145480252|NCT03350815|524613088|FG002|Period 1|Lack of Efficacy|0|||
145480253|NCT03350815|524613089|FG003|Period 1|Lack of Efficacy|0|||
145480254|NCT03350815|524613086|FG000|Period 1|Non-compliance with study treatment|2|||
145480255|NCT03350815|524613087|FG001|Period 1|Non-compliance with study treatment|0|||
145480256|NCT03350815|524613088|FG002|Period 1|Non-compliance with study treatment|0|||
145480257|NCT03350815|524613089|FG003|Period 1|Non-compliance with study treatment|0|||
145480258|NCT03350815|524613086|FG000|Period 1|Protocol Violation|3|||
145480259|NCT03350815|524613087|FG001|Period 1|Protocol Violation|0|||
145480260|NCT03350815|524613088|FG002|Period 1|Protocol Violation|0|||
145480261|NCT03350815|524613089|FG003|Period 1|Protocol Violation|0|||
145480262|NCT03350815|524613086|FG000|Period 2|Adverse Event|0|||
145480263|NCT03350815|524613087|FG001|Period 2|Adverse Event|3|||
145480264|NCT03350815|524613088|FG002|Period 2|Adverse Event|5|||
145480265|NCT03350815|524613089|FG003|Period 2|Adverse Event|0|||
145480266|NCT03350815|524613086|FG000|Period 2|Technical problem|0|||
145480267|NCT03350815|524613087|FG001|Period 2|Technical problem|1|||
145480268|NCT03350815|524613088|FG002|Period 2|Technical problem|0|||
145480269|NCT03350815|524613089|FG003|Period 2|Technical problem|0|||
145480270|NCT03350815|524613086|FG000|Period 2|Lost to Follow-up|0|||
145480271|NCT03350815|524613087|FG001|Period 2|Lost to Follow-up|3|||
145480272|NCT03350815|524613088|FG002|Period 2|Lost to Follow-up|3|||
145480273|NCT03350815|524613089|FG003|Period 2|Lost to Follow-up|0|||
145480274|NCT03350815|524613086|FG000|Period 2|Physician Decision|0|||
145480275|NCT03350815|524613087|FG001|Period 2|Physician Decision|0|||
145480276|NCT03350815|524613088|FG002|Period 2|Physician Decision|1|||
145480277|NCT03350815|524613089|FG003|Period 2|Physician Decision|0|||
145480278|NCT03350815|524613086|FG000|Period 2|Withdrawal by Subject|0|||
145480279|NCT03350815|524613087|FG001|Period 2|Withdrawal by Subject|3|||
145480280|NCT03350815|524613088|FG002|Period 2|Withdrawal by Subject|4|||
145633107|NCT01235949|525170746|FG006|Primary Phase|Withdrawal by Subject|0|||
145480281|NCT03350815|524613089|FG003|Period 2|Withdrawal by Subject|0|||
145480282|NCT03350815|524613086|FG000|Period 2|Lack of Efficacy|0|||
145480283|NCT03350815|524613087|FG001|Period 2|Lack of Efficacy|6|||
145480284|NCT03350815|524613088|FG002|Period 2|Lack of Efficacy|2|||
145480285|NCT03350815|524613089|FG003|Period 2|Lack of Efficacy|0|||
145480286|NCT03350815|524613086|FG000|Period 2|Protocol Violation|0|||
145480287|NCT03350815|524613087|FG001|Period 2|Protocol Violation|0|||
145480288|NCT03350815|524613088|FG002|Period 2|Protocol Violation|1|||
145480289|NCT03350815|524613089|FG003|Period 2|Protocol Violation|0|||
145480290|NCT03350815|524613086|FG000|Period 2|New therapy for study indication|0|||
145480291|NCT03350815|524613087|FG001|Period 2|New therapy for study indication|0|||
145480292|NCT03350815|524613088|FG002|Period 2|New therapy for study indication|1|||
145480293|NCT03350815|524613089|FG003|Period 2|New therapy for study indication|0|||
145480294|NCT02517541|524613094|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
145480295|NCT02517541|524613094|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
145480296|NCT02517541|524613094|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
145480297|NCT02517541|524613094|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
145480298|NCT02517541|524613094|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
145480299|NCT02517541|524613094|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
145480300|NCT00699608|524613095|FG000|First Intervention|Withdrawal by Subject|0|||
145480301|NCT00699608|524613096|FG001|First Intervention|Withdrawal by Subject|0|||
145480302|NCT00699608|524613097|FG002|First Intervention|Withdrawal by Subject|1|||
145480303|NCT00699608|524613098|FG003|First Intervention|Withdrawal by Subject|0|||
145480304|NCT00699608|524613099|FG004|First Intervention|Withdrawal by Subject|0|||
145480305|NCT00699608|524613100|FG005|First Intervention|Withdrawal by Subject|0|||
145480306|NCT00699608|524613095|FG000|First Intervention|Protocol Violation|0|||
145480307|NCT00699608|524613096|FG001|First Intervention|Protocol Violation|0|||
145480308|NCT00699608|524613097|FG002|First Intervention|Protocol Violation|0|||
145480309|NCT00699608|524613098|FG003|First Intervention|Protocol Violation|0|||
145480310|NCT00699608|524613099|FG004|First Intervention|Protocol Violation|1|||
145480311|NCT00699608|524613100|FG005|First Intervention|Protocol Violation|0|||
145480312|NCT00699608|524613095|FG000|Second Intervention|Adverse Event|0|||
145480313|NCT00699608|524613096|FG001|Second Intervention|Adverse Event|0|||
145480314|NCT00699608|524613097|FG002|Second Intervention|Adverse Event|1|||
145480315|NCT00699608|524613098|FG003|Second Intervention|Adverse Event|0|||
145480316|NCT00699608|524613099|FG004|Second Intervention|Adverse Event|0|||
145480317|NCT00699608|524613100|FG005|Second Intervention|Adverse Event|0|||
145480318|NCT00699608|524613095|FG000|Second Intervention|Withdrawal by Subject|0|||
145480319|NCT00699608|524613096|FG001|Second Intervention|Withdrawal by Subject|0|||
145480320|NCT00699608|524613097|FG002|Second Intervention|Withdrawal by Subject|0|||
145480321|NCT00699608|524613098|FG003|Second Intervention|Withdrawal by Subject|1|||
145480322|NCT00699608|524613099|FG004|Second Intervention|Withdrawal by Subject|0|||
145480323|NCT00699608|524613100|FG005|Second Intervention|Withdrawal by Subject|0|||
145480324|NCT01136408|524613101|FG000|Overall Study|Adverse Event|4|||
145480325|NCT01136408|524613102|FG001|Overall Study|Adverse Event|8|||
145480326|NCT01136408|524613103|FG002|Overall Study|Adverse Event|4|||
145480327|NCT01136408|524613101|FG000|Overall Study|Protocol Violation|1|||
145480328|NCT01136408|524613102|FG001|Overall Study|Protocol Violation|1|||
145480329|NCT01136408|524613103|FG002|Overall Study|Protocol Violation|1|||
145480330|NCT02828436|524613104|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
145480331|NCT02828436|524613105|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
145480332|NCT02828436|524613104|FG000|Period 1|Lost to Follow-up|0|||
145480333|NCT02828436|524613105|FG001|Period 1|Lost to Follow-up|1|||
145480334|NCT02828436|524613104|FG000|Period 2|Withdrawal by Subject|4|||
145480335|NCT02828436|524613105|FG001|Period 2|Withdrawal by Subject|0|||
145480336|NCT02828436|524613104|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
145480337|NCT02828436|524613105|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
145480338|NCT02828436|524613104|FG000|Period 2|Lost to Follow-up|1|||
145480339|NCT02828436|524613105|FG001|Period 2|Lost to Follow-up|0|||
145480340|NCT03078556|524613108|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
145480341|NCT03078556|524613109|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
145480342|NCT03078556|524613110|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
145480343|NCT03078556|524613111|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
145480344|NCT03078556|524613108|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
145480345|NCT03078556|524613109|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
145480346|NCT03078556|524613110|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
145480347|NCT03078556|524613111|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
145480348|NCT03078556|524613108|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
145480349|NCT03078556|524613109|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
145480350|NCT03078556|524613110|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
145480351|NCT03078556|524613111|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
145480352|NCT03078556|524613108|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
145480353|NCT03078556|524613109|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
145480354|NCT03078556|524613110|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
145480355|NCT03078556|524613111|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
145480356|NCT04421482|524613113|FG000|Overall Study|Physician Decision|1|||
145480357|NCT03010319|524613114|FG000|Overall Study|Adverse Event|15|||
145480358|NCT03010319|524613115|FG001|Overall Study|Adverse Event|9|||
145480359|NCT03010319|524613114|FG000|Overall Study|Withdrawal by Subject|1|||
145480360|NCT03010319|524613115|FG001|Overall Study|Withdrawal by Subject|6|||
145480361|NCT03010319|524613114|FG000|Overall Study|Physician Decision|2|||
145480362|NCT03010319|524613115|FG001|Overall Study|Physician Decision|4|||
145480363|NCT03010319|524613114|FG000|Overall Study|Sponsor requested withdrawal|2|||
145480364|NCT03010319|524613115|FG001|Overall Study|Sponsor requested withdrawal|2|||
145480365|NCT03010319|524613114|FG000|Overall Study|Death|1|||
145480366|NCT03010319|524613115|FG001|Overall Study|Death|0|||
145480367|NCT03010319|524613114|FG000|Overall Study|Lost to Follow-up|0|||
145480368|NCT03010319|524613115|FG001|Overall Study|Lost to Follow-up|1|||
145480369|NCT03010319|524613114|FG000|Overall Study|Other Reason|5|||
145480370|NCT03010319|524613115|FG001|Overall Study|Other Reason|7|||
145480371|NCT02128724|524613116|FG000|Overall Study|Death|1|||
145480372|NCT02128724|524613117|FG001|Overall Study|Death|0|||
145480373|NCT02128724|524613118|FG002|Overall Study|Death|0|||
145480374|NCT02128724|524613119|FG003|Overall Study|Death|0|||
145480375|NCT02128724|524613116|FG000|Overall Study|Adverse Event|0|||
145480376|NCT02128724|524613117|FG001|Overall Study|Adverse Event|1|||
145480377|NCT02128724|524613118|FG002|Overall Study|Adverse Event|0|||
145480378|NCT02128724|524613119|FG003|Overall Study|Adverse Event|0|||
145480379|NCT02128724|524613116|FG000|Overall Study|Physician Decision|0|||
145480380|NCT02128724|524613117|FG001|Overall Study|Physician Decision|0|||
145480381|NCT02128724|524613118|FG002|Overall Study|Physician Decision|0|||
145480382|NCT02128724|524613119|FG003|Overall Study|Physician Decision|2|||
145480383|NCT02128724|524613116|FG000|Overall Study|Withdrawal by Subject|0|||
145480384|NCT02128724|524613117|FG001|Overall Study|Withdrawal by Subject|0|||
145480385|NCT02128724|524613118|FG002|Overall Study|Withdrawal by Subject|0|||
145480386|NCT02128724|524613119|FG003|Overall Study|Withdrawal by Subject|1|||
145480387|NCT01442714|524613120|FG000|Overall Study|Death|11|||
145480388|NCT01442714|524613120|FG000|Overall Study|Withdrawal by Subject|1|||
145480389|NCT04306510|524613121|FG000|Overall Study|Voluntarily withdrawal|1|||
145480390|NCT04306510|524613121|FG000|Overall Study|Enrolled but Not Treated|1|||
145480391|NCT04720417|524613122|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
145480392|NCT03329092|524613123|FG000|Overall Study|Other|2|||
145480393|NCT03329092|524613124|FG001|Overall Study|Other|2|||
145480394|NCT03329092|524613123|FG000|Overall Study|Withdrawal by Subject|16|||
145480395|NCT03329092|524613124|FG001|Overall Study|Withdrawal by Subject|3|||
145480396|NCT03329092|524613123|FG000|Overall Study|Physician Decision|1|||
145480397|NCT03329092|524613124|FG001|Overall Study|Physician Decision|0|||
145480398|NCT03329092|524613123|FG000|Overall Study|Death|17|||
145480399|NCT03329092|524613124|FG001|Overall Study|Death|11|||
145480400|NCT03329092|524613123|FG000|Overall Study|Adverse Event|3|||
145480401|NCT03329092|524613124|FG001|Overall Study|Adverse Event|1|||
145480402|NCT03329092|524613123|FG000|Overall Study|Lost to Follow-up|1|||
145480403|NCT03329092|524613124|FG001|Overall Study|Lost to Follow-up|1|||
145480404|NCT02751580|524613125|FG000|Overall Study|Lost to Follow-up|4|||
145480405|NCT02751580|524613125|FG000|Overall Study|Death|2|||
145480406|NCT02588261|524613126|FG000|Overall Study|Study Terminated by Sponsor|157|||
145480407|NCT02588261|524613127|FG001|Overall Study|Study Terminated by Sponsor|142|||
145480408|NCT02588261|524613126|FG000|Overall Study|Protocol Deviation|1|||
145480409|NCT02588261|524613127|FG001|Overall Study|Protocol Deviation|0|||
145480410|NCT02588261|524613126|FG000|Overall Study|Death|1|||
145480411|NCT02588261|524613127|FG001|Overall Study|Death|2|||
145480412|NCT02588261|524613126|FG000|Overall Study|Withdrawal by Subject|12|||
145480413|NCT02588261|524613127|FG001|Overall Study|Withdrawal by Subject|8|||
145480414|NCT02588261|524613126|FG000|Overall Study|Noncompliance with Study Drug|0|||
145480415|NCT02588261|524613127|FG001|Overall Study|Noncompliance with Study Drug|1|||
145480416|NCT02588261|524613126|FG000|Overall Study|Miscellaneous|5|||
145480417|NCT02588261|524613127|FG001|Overall Study|Miscellaneous|4|||
145480418|NCT02588261|524613126|FG000|Overall Study|Progressive Disease|61|||
145480419|NCT02588261|524613127|FG001|Overall Study|Progressive Disease|82|||
145480420|NCT02588261|524613126|FG000|Overall Study|Adverse Event|29|||
145480421|NCT02588261|524613127|FG001|Overall Study|Adverse Event|24|||
145480422|NCT02588261|524613126|FG000|Overall Study|Lost to Follow-up|1|||
145480423|NCT02588261|524613127|FG001|Overall Study|Lost to Follow-up|0|||
145480424|NCT01746368|524613132|FG000|Overall Study|Lost to Follow-up|2|||
145480425|NCT01746368|524613133|FG001|Overall Study|Lost to Follow-up|0|||
145480426|NCT01746368|524613132|FG000|Overall Study|Withdrawal by Subject|0|||
145480427|NCT01746368|524613133|FG001|Overall Study|Withdrawal by Subject|1|||
145480428|NCT05636852|524613134|FG000|Overall Study|Withdrawal by Subject|1|||
145480429|NCT05636852|524613134|FG000|Overall Study|Other than specified|1|||
145480430|NCT01076036|524613137|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
145480431|NCT02221674|524613138|FG000|Overall Study|Lost to Follow-up|1|||
145480432|NCT02221674|524613139|FG001|Overall Study|Lost to Follow-up|0|||
145480433|NCT02221674|524613140|FG002|Overall Study|Lost to Follow-up|0|||
145480434|NCT05292131|524613141|FG000|Overall Study|Lost to Follow-up|1|||
145480435|NCT05292131|524613142|FG001|Overall Study|Lost to Follow-up|1|||
145480436|NCT05292131|524613141|FG000|Overall Study|Withdrawal by Subject|0|||
145480437|NCT05292131|524613142|FG001|Overall Study|Withdrawal by Subject|1|||
145480438|NCT02557542|524613144|FG000|Overall Study|Poor recruitment|3|||
145480439|NCT02557542|524613145|FG001|Overall Study|Poor recruitment|0|||
145480440|NCT04390880|524613146|FG000|Overall Study|Withdrawal by Subject|1|||
145480441|NCT05715242|524613147|FG000|Overall Study|Lost to Follow-up|0|||
145480442|NCT05715242|524613148|FG001|Overall Study|Lost to Follow-up|0|||
145480443|NCT05715242|524613149|FG002|Overall Study|Lost to Follow-up|1|||
145480444|NCT05715242|524613150|FG003|Overall Study|Lost to Follow-up|0|||
145480445|NCT05715242|524613151|FG004|Overall Study|Lost to Follow-up|0|||
145480446|NCT05715242|524613152|FG005|Overall Study|Lost to Follow-up|1|||
145480447|NCT05715242|524613153|FG006|Overall Study|Lost to Follow-up|0|||
145480448|NCT05715242|524613154|FG007|Overall Study|Lost to Follow-up|0|||
145480449|NCT05715242|524613155|FG008|Overall Study|Lost to Follow-up|0|||
145480450|NCT05715242|524613156|FG009|Overall Study|Lost to Follow-up|0|||
145480451|NCT05715242|524613157|FG010|Overall Study|Lost to Follow-up|0|||
145480452|NCT05715242|524613158|FG011|Overall Study|Lost to Follow-up|0|||
145480453|NCT05715242|524613159|FG012|Overall Study|Lost to Follow-up|0|||
145480454|NCT05715242|524613160|FG013|Overall Study|Lost to Follow-up|0|||
145480455|NCT05715242|524613161|FG014|Overall Study|Lost to Follow-up|0|||
145480456|NCT05715242|524613162|FG015|Overall Study|Lost to Follow-up|0|||
145480457|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
145480458|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
145480459|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
145633108|NCT01235949|525170747|FG007|Primary Phase|Withdrawal by Subject|0|||
145633109|NCT01235949|525170748|FG008|Primary Phase|Withdrawal by Subject|0|||
145633110|NCT01235949|525170749|FG009|Primary Phase|Withdrawal by Subject|0|||
145633111|NCT01235949|525170750|FG010|Primary Phase|Withdrawal by Subject|0|||
145633112|NCT01235949|525170751|FG011|Primary Phase|Withdrawal by Subject|0|||
145633113|NCT01235949|525170752|FG012|Primary Phase|Withdrawal by Subject|0|||
145633114|NCT01235949|525170753|FG013|Primary Phase|Withdrawal by Subject|0|||
145633115|NCT01235949|525170754|FG014|Primary Phase|Withdrawal by Subject|0|||
145633116|NCT01235949|525170755|FG015|Primary Phase|Withdrawal by Subject|0|||
145633117|NCT01235949|525170756|FG016|Primary Phase|Withdrawal by Subject|0|||
145633118|NCT01235949|525170757|FG017|Primary Phase|Withdrawal by Subject|0|||
145633119|NCT01235949|525170740|FG000|Primary Phase|Lost to Follow-up|0|||
145633120|NCT01235949|525170741|FG001|Primary Phase|Lost to Follow-up|0|||
145633121|NCT01235949|525170742|FG002|Primary Phase|Lost to Follow-up|1|||
145633122|NCT01235949|525170743|FG003|Primary Phase|Lost to Follow-up|1|||
145633123|NCT01235949|525170744|FG004|Primary Phase|Lost to Follow-up|0|||
145633124|NCT01235949|525170745|FG005|Primary Phase|Lost to Follow-up|2|||
145633125|NCT01235949|525170746|FG006|Primary Phase|Lost to Follow-up|0|||
145633126|NCT01235949|525170747|FG007|Primary Phase|Lost to Follow-up|0|||
145480460|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Death|0|||
145480461|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Death|2|||
145480462|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Death|0|||
145480463|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
145480464|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
145480465|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
145480466|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
145480467|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
145480468|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
145480469|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
145480470|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
145480471|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
145480472|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
145480473|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
145480474|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
145480475|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
145480476|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
145480477|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
145480478|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Recovery|1|||
145480479|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Recovery|0|||
145480480|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Recovery|1|||
145633127|NCT01235949|525170748|FG008|Primary Phase|Lost to Follow-up|0|||
145633128|NCT01235949|525170749|FG009|Primary Phase|Lost to Follow-up|0|||
145633129|NCT01235949|525170750|FG010|Primary Phase|Lost to Follow-up|0|||
145633130|NCT01235949|525170751|FG011|Primary Phase|Lost to Follow-up|0|||
145480481|NCT00195663|524613165|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
145480482|NCT00195663|524613166|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
145480483|NCT00195663|524613167|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
145480484|NCT00195663|524613165|FG000|Open-Label Extension Period|Adverse Event|21|||
145480485|NCT00195663|524613166|FG001|Open-Label Extension Period|Adverse Event|32|||
145601867|NCT04992546|525056399|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
145601868|NCT04992546|525056399|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
145601869|NCT04992546|525056399|FG000|Open-Label Treatment Period|Adverse Event|3|||
145601870|NCT04992546|525056399|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
145601871|NCT00500903|525056401|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
145601872|NCT00500903|525056402|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
145601873|NCT00500903|525056403|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
145601874|NCT00500903|525056401|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
145601875|NCT00500903|525056402|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
145601876|NCT00500903|525056403|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
145601877|NCT00500903|525056401|FG000|Overall Study|Progressive Disease|41|||
145601878|NCT00500903|525056402|FG001|Overall Study|Progressive Disease|2|||
145601879|NCT00500903|525056403|FG002|Overall Study|Progressive Disease|15|||
145601880|NCT00500903|525056401|FG000|Overall Study|Patient Declined Further Treatment|0|||
145601881|NCT00500903|525056402|FG001|Overall Study|Patient Declined Further Treatment|0|||
145601882|NCT00500903|525056403|FG002|Overall Study|Patient Declined Further Treatment|3|||
145601883|NCT00500903|525056401|FG000|Overall Study|Symptomatic Deterioration|2|||
145601884|NCT00500903|525056402|FG001|Overall Study|Symptomatic Deterioration|0|||
145601885|NCT00500903|525056403|FG002|Overall Study|Symptomatic Deterioration|0|||
145601886|NCT00500903|525056401|FG000|Overall Study|Reason Not Specified|10|||
145601887|NCT00500903|525056402|FG001|Overall Study|Reason Not Specified|0|||
145601888|NCT00500903|525056403|FG002|Overall Study|Reason Not Specified|2|||
145601889|NCT00717860|525056404|FG000|Overall Study|Clinical adverse experience|5|||
145601890|NCT00717860|525056405|FG001|Overall Study|Clinical adverse experience|9|||
145601891|NCT00717860|525056404|FG000|Overall Study|Laboratory adverse experience|2|||
145601892|NCT00717860|525056405|FG001|Overall Study|Laboratory adverse experience|2|||
145601893|NCT00717860|525056404|FG000|Overall Study|Lack of Efficacy|7|||
145601894|NCT00717860|525056405|FG001|Overall Study|Lack of Efficacy|13|||
145601895|NCT00717860|525056404|FG000|Overall Study|Discontinued for other reason|6|||
145601896|NCT00717860|525056405|FG001|Overall Study|Discontinued for other reason|1|||
145601897|NCT00717860|525056404|FG000|Overall Study|Withdrew consent|7|||
145601898|NCT00717860|525056405|FG001|Overall Study|Withdrew consent|3|||
145601899|NCT04058353|525056406|FG000|Overall Study|Adverse Event|2|||
145601900|NCT04058353|525056407|FG001|Overall Study|Adverse Event|1|||
145601901|NCT04058353|525056406|FG000|Overall Study|Physician Decision|1|||
145601902|NCT04058353|525056407|FG001|Overall Study|Physician Decision|0|||
145601903|NCT04058353|525056406|FG000|Overall Study|Other|1|||
145601904|NCT04058353|525056407|FG001|Overall Study|Other|0|||
145601905|NCT02901626|525058162|FG000|Overall Study|Lost to Follow-up|1|||
145601906|NCT02901626|525058163|FG001|Overall Study|Lost to Follow-up|1|||
145601907|NCT04082884|525058164|FG000|Overall Study|Withdrawal by Subject|1|||
145601908|NCT04857034|525058166|FG000|Placebo-Controlled Period|Request to discontinue|2|||
145601909|NCT04857034|525058167|FG001|Placebo-Controlled Period|Request to discontinue|2|||
145601910|NCT04857034|525058168|FG002|Placebo-Controlled Period|Request to discontinue|0|||
145601911|NCT04857034|525058169|FG003|Placebo-Controlled Period|Request to discontinue|0|||
145601912|NCT04857034|525058170|FG004|Placebo-Controlled Period|Request to discontinue|0|||
145601913|NCT04857034|525058166|FG000|Placebo-Controlled Period|withdrew consent|1|||
145601914|NCT04857034|525058167|FG001|Placebo-Controlled Period|withdrew consent|1|||
145601915|NCT04857034|525058168|FG002|Placebo-Controlled Period|withdrew consent|2|||
145601916|NCT04857034|525058169|FG003|Placebo-Controlled Period|withdrew consent|0|||
145601917|NCT04857034|525058170|FG004|Placebo-Controlled Period|withdrew consent|0|||
145601918|NCT04857034|525058166|FG000|Placebo-Controlled Period|Pregnancy|1|||
145601919|NCT04857034|525058167|FG001|Placebo-Controlled Period|Pregnancy|1|||
145601920|NCT04857034|525058168|FG002|Placebo-Controlled Period|Pregnancy|0|||
145601921|NCT04857034|525058169|FG003|Placebo-Controlled Period|Pregnancy|0|||
145601922|NCT04857034|525058170|FG004|Placebo-Controlled Period|Pregnancy|0|||
145601923|NCT04857034|525058166|FG000|Placebo-Controlled Period|Ongoing study period|0|||
145601924|NCT04857034|525058167|FG001|Placebo-Controlled Period|Ongoing study period|1|||
145601925|NCT04857034|525058168|FG002|Placebo-Controlled Period|Ongoing study period|0|||
145601926|NCT04857034|525058169|FG003|Placebo-Controlled Period|Ongoing study period|0|||
145601927|NCT04857034|525058170|FG004|Placebo-Controlled Period|Ongoing study period|0|||
145601928|NCT04857034|525058166|FG000|Active Treatment Period|Lack of Efficacy|1|||
145601929|NCT04857034|525058167|FG001|Active Treatment Period|Lack of Efficacy|0|||
145601930|NCT04857034|525058168|FG002|Active Treatment Period|Lack of Efficacy|0|||
145601931|NCT04857034|525058169|FG003|Active Treatment Period|Lack of Efficacy|0|||
145601932|NCT04857034|525058170|FG004|Active Treatment Period|Lack of Efficacy|0|||
145601933|NCT04857034|525058166|FG000|Active Treatment Period|request to discontinue|0|||
145601934|NCT04857034|525058167|FG001|Active Treatment Period|request to discontinue|1|||
145601935|NCT04857034|525058168|FG002|Active Treatment Period|request to discontinue|0|||
145601936|NCT04857034|525058169|FG003|Active Treatment Period|request to discontinue|1|||
145601937|NCT04857034|525058170|FG004|Active Treatment Period|request to discontinue|0|||
145601938|NCT04857034|525058166|FG000|Active Treatment Period|administrative reason by sponsor|1|||
145601939|NCT04857034|525058167|FG001|Active Treatment Period|administrative reason by sponsor|5|||
145601940|NCT04857034|525058168|FG002|Active Treatment Period|administrative reason by sponsor|0|||
145601941|NCT04857034|525058169|FG003|Active Treatment Period|administrative reason by sponsor|2|||
145601942|NCT04857034|525058170|FG004|Active Treatment Period|administrative reason by sponsor|2|||
145601943|NCT04857034|525058166|FG000|Active Treatment Period|other reasons|1|||
145601944|NCT04857034|525058167|FG001|Active Treatment Period|other reasons|1|||
145601945|NCT04857034|525058168|FG002|Active Treatment Period|other reasons|0|||
145601946|NCT04857034|525058169|FG003|Active Treatment Period|other reasons|0|||
145601947|NCT04857034|525058170|FG004|Active Treatment Period|other reasons|1|||
145601948|NCT04857034|525058166|FG000|Active Treatment Period|Ongoing Study Period|2|||
145601949|NCT04857034|525058167|FG001|Active Treatment Period|Ongoing Study Period|4|||
145601950|NCT04857034|525058168|FG002|Active Treatment Period|Ongoing Study Period|0|||
145601951|NCT04857034|525058169|FG003|Active Treatment Period|Ongoing Study Period|1|||
145601952|NCT04857034|525058170|FG004|Active Treatment Period|Ongoing Study Period|0|||
145601953|NCT00387894|525058171|FG000|Overall Study|Withdrawal by Subject|1|||
145601954|NCT00659490|525058172|FG000|Overall Study|Lost to Follow-up|2|||
145601955|NCT00659490|525058173|FG001|Overall Study|Lost to Follow-up|0|||
145601956|NCT00659490|525058174|FG002|Overall Study|Lost to Follow-up|1|||
145601957|NCT05674890|525058175|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
145601958|NCT05674890|525058176|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
145601959|NCT05674890|525058175|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
145601960|NCT05674890|525058176|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
145601961|NCT05674890|525058175|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
145601962|NCT05674890|525058176|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
145601963|NCT00827541|525058177|FG000|Overall Study|Exitus|1|||
145601964|NCT00827541|525058178|FG001|Overall Study|Exitus|8|||
145601965|NCT00827541|525058177|FG000|Overall Study|Other|1|||
145601966|NCT00827541|525058178|FG001|Overall Study|Other|3|||
145601967|NCT00827541|525058177|FG000|Overall Study|Pathogen not susceptible|1|||
145601968|NCT00827541|525058178|FG001|Overall Study|Pathogen not susceptible|0|||
145601969|NCT00827541|525058177|FG000|Overall Study|Lack of effectiveness|1|||
145601970|NCT00827541|525058178|FG001|Overall Study|Lack of effectiveness|0|||
145601971|NCT01649232|525058179|FG000|Overall Study|Physician Decision|2|||
145601972|NCT01649232|525058180|FG001|Overall Study|Physician Decision|0|||
145601973|NCT02421666|525058181|FG000|6-month Follow-up|Lost to Follow-up|8|||
145601974|NCT02421666|525058182|FG001|6-month Follow-up|Lost to Follow-up|7|||
145601975|NCT02421666|525058181|FG000|6-month Follow-up|Withdrawal by Subject|5|||
145601976|NCT02421666|525058182|FG001|6-month Follow-up|Withdrawal by Subject|6|||
145601977|NCT02421666|525058181|FG000|12-month Follow-up|Lost to Follow-up|5|||
145601978|NCT02421666|525058182|FG001|12-month Follow-up|Lost to Follow-up|5|||
145601979|NCT02421666|525058181|FG000|12-month Follow-up|Withdrawal by Subject|6|||
145601980|NCT02421666|525058182|FG001|12-month Follow-up|Withdrawal by Subject|11|||
145601981|NCT01896869|525058196|FG000|Overall Study|Withdrawal by Subject|0|||
145601982|NCT01896869|525058197|FG001|Overall Study|Withdrawal by Subject|6|||
145601983|NCT01896869|525058196|FG000|Overall Study|Lost to Follow-up|1|||
145601984|NCT01896869|525058197|FG001|Overall Study|Lost to Follow-up|0|||
145601985|NCT00118716|525058202|FG000|Overall Study|Adverse Event|2|||
145601986|NCT00118716|525058203|FG001|Overall Study|Adverse Event|7|||
145601987|NCT00118716|525058202|FG000|Overall Study|Protocol Violation|5|||
145601988|NCT00118716|525058203|FG001|Overall Study|Protocol Violation|4|||
145601989|NCT00118716|525058202|FG000|Overall Study|Withdrawal by Subject|0|||
145601990|NCT00118716|525058203|FG001|Overall Study|Withdrawal by Subject|1|||
145601991|NCT00118716|525058202|FG000|Overall Study|Exacerbation|2|||
145601992|NCT00118716|525058203|FG001|Overall Study|Exacerbation|2|||
145601993|NCT00118716|525058202|FG000|Overall Study|Discontinued by sponsor|1|||
145601994|NCT00118716|525058203|FG001|Overall Study|Discontinued by sponsor|1|||
145601995|NCT00118716|525058202|FG000|Overall Study|Non-compliance|1|||
145601996|NCT00118716|525058203|FG001|Overall Study|Non-compliance|3|||
145601997|NCT00118716|525058202|FG000|Overall Study|misrandomized|1|||
145601998|NCT00118716|525058203|FG001|Overall Study|misrandomized|1|||
145601999|NCT00118716|525058202|FG000|Overall Study|Expired drug use|1|||
145602000|NCT00118716|525058203|FG001|Overall Study|Expired drug use|2|||
145602001|NCT00118716|525058202|FG000|Overall Study|Investigator discretion|0|||
145602002|NCT00118716|525058203|FG001|Overall Study|Investigator discretion|1|||
145602003|NCT00855062|525058205|FG000|Step1|Early Study Closure|5|||
145602004|NCT00855062|525058206|FG001|Step1|Early Study Closure|7|||
145602005|NCT00855062|525058205|FG000|Step1|Adverse Event|1|||
145602006|NCT00855062|525058206|FG001|Step1|Adverse Event|1|||
145602007|NCT00855062|525058205|FG000|Step1|Protocol Violation|1|||
145602008|NCT00855062|525058206|FG001|Step1|Protocol Violation|0|||
145602009|NCT00855062|525058205|FG000|Step1|Pregnancy|1|||
145602010|NCT00855062|525058206|FG001|Step1|Pregnancy|0|||
145602011|NCT00855062|525058205|FG000|Step1|Withdrawal by Subject|2|||
145602012|NCT00855062|525058206|FG001|Step1|Withdrawal by Subject|3|||
145602013|NCT00855062|525058205|FG000|Step2|Early Study Closure|6|||
145602014|NCT00855062|525058206|FG001|Step2|Early Study Closure|2|||
145480486|NCT00195663|524613167|FG002|Open-Label Extension Period|Adverse Event|36|||
145480487|NCT00195663|524613165|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
145480488|NCT00195663|524613166|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
145480489|NCT00195663|524613167|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
145480490|NCT00195663|524613165|FG000|Open-Label Extension Period|Recovery|0|||
145480491|NCT00195663|524613166|FG001|Open-Label Extension Period|Recovery|2|||
145480492|NCT00195663|524613167|FG002|Open-Label Extension Period|Recovery|2|||
145480493|NCT00195663|524613165|FG000|Open-Label Extension Period|Protocol Violation|3|||
145602015|NCT00855062|525058205|FG000|Step2|Adverse Event|0|||
145602016|NCT00855062|525058206|FG001|Step2|Adverse Event|3|||
145602017|NCT00855062|525058205|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
145602018|NCT00855062|525058206|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
145602019|NCT01376323|525058209|FG000|Overall Study|Adverse Event|1|||
145602020|NCT01376323|525058210|FG001|Overall Study|Adverse Event|0|||
145602021|NCT01376323|525058211|FG002|Overall Study|Adverse Event|0|||
145602022|NCT01376323|525058212|FG003|Overall Study|Adverse Event|2|||
145602023|NCT01376323|525058213|FG004|Overall Study|Adverse Event|0|||
145602024|NCT01376323|525058209|FG000|Overall Study|Lost to Follow-up|0|||
145602025|NCT01376323|525058210|FG001|Overall Study|Lost to Follow-up|0|||
145602026|NCT01376323|525058211|FG002|Overall Study|Lost to Follow-up|0|||
145602027|NCT01376323|525058212|FG003|Overall Study|Lost to Follow-up|2|||
145602028|NCT01376323|525058213|FG004|Overall Study|Lost to Follow-up|0|||
145602029|NCT01376323|525058209|FG000|Overall Study|Physician Decision|1|||
145602030|NCT01376323|525058210|FG001|Overall Study|Physician Decision|0|||
145602031|NCT01376323|525058211|FG002|Overall Study|Physician Decision|2|||
145602032|NCT01376323|525058212|FG003|Overall Study|Physician Decision|1|||
145602033|NCT01376323|525058213|FG004|Overall Study|Physician Decision|1|||
145602034|NCT01376323|525058209|FG000|Overall Study|Withdrawal by Subject|0|||
145602035|NCT01376323|525058210|FG001|Overall Study|Withdrawal by Subject|1|||
145602036|NCT01376323|525058211|FG002|Overall Study|Withdrawal by Subject|1|||
145602037|NCT01376323|525058212|FG003|Overall Study|Withdrawal by Subject|0|||
145602038|NCT01376323|525058213|FG004|Overall Study|Withdrawal by Subject|0|||
145602039|NCT02436811|525058214|FG000|Overall Study|Lost to Follow-up|2|||
145602040|NCT02436811|525058215|FG001|Overall Study|Lost to Follow-up|9|||
145602041|NCT02436811|525058216|FG002|Overall Study|Lost to Follow-up|7|||
145602042|NCT03595332|525058217|FG000|Overall Study|Lost to Follow-up|16|||
145602043|NCT03595332|525058218|FG001|Overall Study|Lost to Follow-up|22|||
145602044|NCT03595332|525058217|FG000|Overall Study|Unable to retrieve ID from school|0|||
145602045|NCT03595332|525058218|FG001|Overall Study|Unable to retrieve ID from school|2|||
145602046|NCT04209725|525058219|FG000|Overall Study|Adverse Event|1|||
145602047|NCT02657317|525058220|FG000|Overall Study|Withdrawal by Subject|2|||
145602048|NCT02657317|525058221|FG001|Overall Study|Withdrawal by Subject|0|||
145602049|NCT02657317|525058220|FG000|Overall Study|Lost to Follow-up|3|||
145602050|NCT02657317|525058221|FG001|Overall Study|Lost to Follow-up|3|||
145602051|NCT01089374|525058222|FG000|Overall Study|Lost to Follow-up|3|||
145602052|NCT01089374|525058223|FG001|Overall Study|Lost to Follow-up|0|||
145602053|NCT01089374|525058222|FG000|Overall Study|Withdrawal by Subject|1|||
145602054|NCT01089374|525058223|FG001|Overall Study|Withdrawal by Subject|0|||
145602055|NCT01089374|525058222|FG000|Overall Study|Study closed early - low accrual|6|||
145602056|NCT01089374|525058223|FG001|Overall Study|Study closed early - low accrual|0|||
145602057|NCT03494166|525058224|FG000|Overall Study|Death|0|||
145602058|NCT03494166|525058225|FG001|Overall Study|Death|0|||
145602059|NCT03494166|525058226|FG002|Overall Study|Death|0|||
145602060|NCT03494166|525058227|FG003|Overall Study|Death|1|||
145602061|NCT03494166|525058228|FG004|Overall Study|Death|3|||
145602062|NCT03494166|525058229|FG005|Overall Study|Death|0|||
145602063|NCT03494166|525058224|FG000|Overall Study|Lost to Follow-up|2|||
145602064|NCT03494166|525058225|FG001|Overall Study|Lost to Follow-up|2|||
145602065|NCT03494166|525058226|FG002|Overall Study|Lost to Follow-up|2|||
145602066|NCT03494166|525058227|FG003|Overall Study|Lost to Follow-up|2|||
145602067|NCT03494166|525058228|FG004|Overall Study|Lost to Follow-up|14|||
145602068|NCT03494166|525058229|FG005|Overall Study|Lost to Follow-up|0|||
145602069|NCT03494166|525058224|FG000|Overall Study|Withdrawal by Subject|10|||
145480494|NCT00195663|524613166|FG001|Open-Label Extension Period|Protocol Violation|4|||
145480495|NCT00195663|524613167|FG002|Open-Label Extension Period|Protocol Violation|4|||
145602070|NCT03494166|525058225|FG001|Overall Study|Withdrawal by Subject|7|||
145602071|NCT03494166|525058226|FG002|Overall Study|Withdrawal by Subject|0|||
145602072|NCT03494166|525058227|FG003|Overall Study|Withdrawal by Subject|5|||
145602073|NCT03494166|525058228|FG004|Overall Study|Withdrawal by Subject|3|||
145602074|NCT03494166|525058229|FG005|Overall Study|Withdrawal by Subject|17|||
145602075|NCT03494166|525058224|FG000|Overall Study|Screen failure|1|||
145602076|NCT03494166|525058225|FG001|Overall Study|Screen failure|0|||
145602077|NCT03494166|525058226|FG002|Overall Study|Screen failure|0|||
145602078|NCT03494166|525058227|FG003|Overall Study|Screen failure|0|||
145602079|NCT03494166|525058228|FG004|Overall Study|Screen failure|1|||
145602080|NCT03494166|525058229|FG005|Overall Study|Screen failure|0|||
145602081|NCT02634788|525058231|FG000|Overall Study|Adverse Event|0|||
145602082|NCT02634788|525058232|FG001|Overall Study|Adverse Event|8|||
145480496|NCT00195663|524613165|FG000|Open-Label Extension Period|Death|2|||
145480497|NCT00195663|524613166|FG001|Open-Label Extension Period|Death|2|||
145480498|NCT00195663|524613167|FG002|Open-Label Extension Period|Death|2|||
145480499|NCT00195663|524613165|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
145480500|NCT00195663|524613166|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
145480501|NCT00195663|524613167|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
145480502|NCT00195663|524613165|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
145480503|NCT00195663|524613166|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
145480504|NCT00195663|524613167|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
145480505|NCT00195663|524613165|FG000|Open-Label Extension Period|Administrative reasons|11|||
145480506|NCT00195663|524613166|FG001|Open-Label Extension Period|Administrative reasons|11|||
145480507|NCT00195663|524613167|FG002|Open-Label Extension Period|Administrative reasons|13|||
145480508|NCT00429169|524613168|FG000|Overall Study|Lost to Follow-up|0|||
145480509|NCT00429169|524613169|FG001|Overall Study|Lost to Follow-up|1|||
145480510|NCT00429169|524613168|FG000|Overall Study|Ineligibility discovered after entry|2|||
145633131|NCT01235949|525170752|FG012|Primary Phase|Lost to Follow-up|0|||
145633132|NCT01235949|525170753|FG013|Primary Phase|Lost to Follow-up|0|||
145633133|NCT01235949|525170754|FG014|Primary Phase|Lost to Follow-up|0|||
145633134|NCT01235949|525170755|FG015|Primary Phase|Lost to Follow-up|0|||
145633135|NCT01235949|525170756|FG016|Primary Phase|Lost to Follow-up|0|||
145633136|NCT01235949|525170757|FG017|Primary Phase|Lost to Follow-up|0|||
145633137|NCT01235949|525170740|FG000|Booster Phase|Migrated/moved from study area|0|||
145633138|NCT01235949|525170741|FG001|Booster Phase|Migrated/moved from study area|0|||
145633139|NCT01235949|525170742|FG002|Booster Phase|Migrated/moved from study area|0|||
145633140|NCT01235949|525170743|FG003|Booster Phase|Migrated/moved from study area|0|||
145633141|NCT01235949|525170744|FG004|Booster Phase|Migrated/moved from study area|0|||
145633142|NCT01235949|525170745|FG005|Booster Phase|Migrated/moved from study area|0|||
145633143|NCT01235949|525170746|FG006|Booster Phase|Migrated/moved from study area|0|||
145633144|NCT01235949|525170747|FG007|Booster Phase|Migrated/moved from study area|0|||
145633145|NCT01235949|525170748|FG008|Booster Phase|Migrated/moved from study area|0|||
145633146|NCT01235949|525170749|FG009|Booster Phase|Migrated/moved from study area|0|||
145633147|NCT01235949|525170750|FG010|Booster Phase|Migrated/moved from study area|0|||
145633148|NCT01235949|525170751|FG011|Booster Phase|Migrated/moved from study area|1|||
145633149|NCT01235949|525170752|FG012|Booster Phase|Migrated/moved from study area|1|||
145633150|NCT01235949|525170753|FG013|Booster Phase|Migrated/moved from study area|0|||
145633151|NCT01235949|525170754|FG014|Booster Phase|Migrated/moved from study area|0|||
145633152|NCT01235949|525170755|FG015|Booster Phase|Migrated/moved from study area|0|||
145633153|NCT01235949|525170756|FG016|Booster Phase|Migrated/moved from study area|0|||
145633154|NCT01235949|525170757|FG017|Booster Phase|Migrated/moved from study area|1|||
145633155|NCT01235949|525170740|FG000|Booster Phase|Adverse Event|0|||
145633156|NCT01235949|525170741|FG001|Booster Phase|Adverse Event|0|||
145633157|NCT01235949|525170742|FG002|Booster Phase|Adverse Event|0|||
145633158|NCT01235949|525170743|FG003|Booster Phase|Adverse Event|0|||
145633159|NCT01235949|525170744|FG004|Booster Phase|Adverse Event|0|||
145633160|NCT01235949|525170745|FG005|Booster Phase|Adverse Event|0|||
145633161|NCT01235949|525170746|FG006|Booster Phase|Adverse Event|0|||
145633162|NCT01235949|525170747|FG007|Booster Phase|Adverse Event|0|||
145633163|NCT01235949|525170748|FG008|Booster Phase|Adverse Event|0|||
145633164|NCT01235949|525170749|FG009|Booster Phase|Adverse Event|0|||
145633165|NCT01235949|525170750|FG010|Booster Phase|Adverse Event|0|||
145633166|NCT01235949|525170751|FG011|Booster Phase|Adverse Event|0|||
145633167|NCT01235949|525170752|FG012|Booster Phase|Adverse Event|0|||
145633168|NCT01235949|525170753|FG013|Booster Phase|Adverse Event|0|||
145633169|NCT01235949|525170754|FG014|Booster Phase|Adverse Event|0|||
145633170|NCT01235949|525170755|FG015|Booster Phase|Adverse Event|1|||
145633171|NCT01235949|525170756|FG016|Booster Phase|Adverse Event|0|||
145480511|NCT00429169|524613169|FG001|Overall Study|Ineligibility discovered after entry|1|||
145480512|NCT01746173|524613174|FG000|Overall Study|Disease Progression|2|||
145480513|NCT00172042|524613178|FG000|Overall Study|Adverse Event|27|||
145633172|NCT01235949|525170757|FG017|Booster Phase|Adverse Event|0|||
145633173|NCT01235949|525170740|FG000|Booster Phase|Withdrawal by Subject|0|||
145633174|NCT01235949|525170741|FG001|Booster Phase|Withdrawal by Subject|0|||
145633175|NCT01235949|525170742|FG002|Booster Phase|Withdrawal by Subject|0|||
145633176|NCT01235949|525170743|FG003|Booster Phase|Withdrawal by Subject|0|||
145633177|NCT01235949|525170744|FG004|Booster Phase|Withdrawal by Subject|0|||
145633178|NCT01235949|525170745|FG005|Booster Phase|Withdrawal by Subject|0|||
145633179|NCT01235949|525170746|FG006|Booster Phase|Withdrawal by Subject|0|||
145480514|NCT00172042|524613179|FG001|Overall Study|Adverse Event|13|||
145633180|NCT01235949|525170747|FG007|Booster Phase|Withdrawal by Subject|1|||
145633181|NCT01235949|525170748|FG008|Booster Phase|Withdrawal by Subject|1|||
145633182|NCT01235949|525170749|FG009|Booster Phase|Withdrawal by Subject|0|||
145633183|NCT01235949|525170750|FG010|Booster Phase|Withdrawal by Subject|1|||
145633184|NCT01235949|525170751|FG011|Booster Phase|Withdrawal by Subject|1|||
145633185|NCT01235949|525170752|FG012|Booster Phase|Withdrawal by Subject|2|||
145633186|NCT01235949|525170753|FG013|Booster Phase|Withdrawal by Subject|0|||
145633187|NCT01235949|525170754|FG014|Booster Phase|Withdrawal by Subject|2|||
145633188|NCT01235949|525170755|FG015|Booster Phase|Withdrawal by Subject|0|||
145633189|NCT01235949|525170756|FG016|Booster Phase|Withdrawal by Subject|0|||
145633190|NCT01235949|525170757|FG017|Booster Phase|Withdrawal by Subject|0|||
145633191|NCT01235949|525170740|FG000|Booster Phase|Lost to Follow-up|0|||
145633192|NCT01235949|525170741|FG001|Booster Phase|Lost to Follow-up|0|||
145633193|NCT01235949|525170742|FG002|Booster Phase|Lost to Follow-up|0|||
145633194|NCT01235949|525170743|FG003|Booster Phase|Lost to Follow-up|0|||
145633195|NCT01235949|525170744|FG004|Booster Phase|Lost to Follow-up|0|||
145633196|NCT01235949|525170745|FG005|Booster Phase|Lost to Follow-up|0|||
145633197|NCT01235949|525170746|FG006|Booster Phase|Lost to Follow-up|0|||
145633198|NCT01235949|525170747|FG007|Booster Phase|Lost to Follow-up|0|||
145633199|NCT01235949|525170748|FG008|Booster Phase|Lost to Follow-up|1|||
145633200|NCT01235949|525170749|FG009|Booster Phase|Lost to Follow-up|1|||
145633201|NCT01235949|525170750|FG010|Booster Phase|Lost to Follow-up|1|||
145633202|NCT01235949|525170751|FG011|Booster Phase|Lost to Follow-up|1|||
145633203|NCT01235949|525170752|FG012|Booster Phase|Lost to Follow-up|0|||
145633204|NCT01235949|525170753|FG013|Booster Phase|Lost to Follow-up|0|||
145633205|NCT01235949|525170754|FG014|Booster Phase|Lost to Follow-up|0|||
145633206|NCT01235949|525170755|FG015|Booster Phase|Lost to Follow-up|0|||
145633207|NCT01235949|525170756|FG016|Booster Phase|Lost to Follow-up|0|||
145633208|NCT01235949|525170757|FG017|Booster Phase|Lost to Follow-up|1|||
145633209|NCT00754936|525170758|FG000|Overall Study|Lost to Follow-up|3|||
145633210|NCT00754936|525170758|FG000|Overall Study|Physician Decision|1|||
145633211|NCT00754936|525170758|FG000|Overall Study|Withdrawal by Subject|2|||
145633212|NCT00754936|525170758|FG000|Overall Study|Side Effects|3|||
145633213|NCT00754936|525170758|FG000|Overall Study|Inter-current medical events|3|||
145633214|NCT00371566|525170763|FG000|Treatment Phase|Withdrawal by Subject|0|||
145633215|NCT00371566|525170764|FG001|Treatment Phase|Withdrawal by Subject|1|||
145633216|NCT00371566|525170763|FG000|Treatment Phase|Adverse Event|0|||
145633217|NCT00371566|525170764|FG001|Treatment Phase|Adverse Event|1|||
145633218|NCT00371566|525170763|FG000|Treatment Phase|Protocol Violation|0|||
145633219|NCT00371566|525170764|FG001|Treatment Phase|Protocol Violation|1|||
145633220|NCT00371566|525170763|FG000|Chemoradiation Phase|Physician Decision|2|||
145633221|NCT00371566|525170764|FG001|Chemoradiation Phase|Physician Decision|0|||
145633222|NCT00371566|525170763|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
145633223|NCT00371566|525170764|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
145633224|NCT00371566|525170763|FG000|Chemoradiation Phase|Non compliant|0|||
145633225|NCT00371566|525170764|FG001|Chemoradiation Phase|Non compliant|1|||
145633226|NCT00371566|525170763|FG000|Chemoradiation Phase|Progressive Disease|1|||
145633227|NCT00371566|525170764|FG001|Chemoradiation Phase|Progressive Disease|1|||
145633228|NCT00371566|525170763|FG000|Chemoradiation Phase|Death|2|||
145633229|NCT00371566|525170764|FG001|Chemoradiation Phase|Death|0|||
145633230|NCT00371566|525170763|FG000|Follow Up Phase|Death|0|||
145633231|NCT00371566|525170764|FG001|Follow Up Phase|Death|5|||
145633232|NCT00371566|525170763|FG000|Follow Up Phase|Disease progression|1|||
145633233|NCT00371566|525170764|FG001|Follow Up Phase|Disease progression|0|||
145633234|NCT00371566|525170763|FG000|Follow Up Phase|Withdrawal by Subject|0|||
145633235|NCT00371566|525170764|FG001|Follow Up Phase|Withdrawal by Subject|1|||
145633236|NCT00371566|525170763|FG000|Follow Up Phase|Physician Decision|1|||
145633237|NCT00371566|525170764|FG001|Follow Up Phase|Physician Decision|1|||
145633238|NCT00371566|525170763|FG000|Follow Up Phase|Lost to Follow-up|1|||
145633239|NCT00371566|525170764|FG001|Follow Up Phase|Lost to Follow-up|0|||
145633240|NCT00177216|525170765|FG000|Overall Study|Withdrawal by Subject|6|||
145633241|NCT00177216|525170766|FG001|Overall Study|Withdrawal by Subject|3|||
145633242|NCT00177216|525170767|FG002|Overall Study|Withdrawal by Subject|1|||
145633243|NCT01093534|525170768|FG000|Overall Study|Adverse Event|2|||
145633244|NCT01093534|525170769|FG001|Overall Study|Adverse Event|5|||
145633245|NCT01093534|525170770|FG002|Overall Study|Adverse Event|2|||
145633246|NCT01093534|525170768|FG000|Overall Study|Lack of Efficacy|2|||
145633247|NCT01093534|525170769|FG001|Overall Study|Lack of Efficacy|1|||
145633248|NCT01093534|525170770|FG002|Overall Study|Lack of Efficacy|1|||
145633249|NCT01093534|525170768|FG000|Overall Study|Withdrawal by Subject|5|||
145633250|NCT01093534|525170769|FG001|Overall Study|Withdrawal by Subject|7|||
145633251|NCT01093534|525170770|FG002|Overall Study|Withdrawal by Subject|2|||
145633252|NCT01093534|525170768|FG000|Overall Study|Other|1|||
145633253|NCT01093534|525170769|FG001|Overall Study|Other|3|||
145633254|NCT01093534|525170770|FG002|Overall Study|Other|4|||
145633255|NCT00811057|525170771|FG000|Overall Study|Protocol Violation|5|||
145633256|NCT00811057|525170772|FG001|Overall Study|Protocol Violation|10|||
145633257|NCT00811057|525170773|FG002|Overall Study|Protocol Violation|10|||
145633258|NCT00768651|525170774|FG000|Overall Study|Withdrawal by Subject|1|||
145633259|NCT00995709|525170779|FG000|Overall Study|Adverse Event|4|||
145633260|NCT00995709|525170780|FG001|Overall Study|Adverse Event|2|||
145633261|NCT00995709|525170781|FG002|Overall Study|Adverse Event|0|||
145633262|NCT00995709|525170779|FG000|Overall Study|Lack of Efficacy|0|||
145633263|NCT00995709|525170780|FG001|Overall Study|Lack of Efficacy|1|||
145633264|NCT00995709|525170781|FG002|Overall Study|Lack of Efficacy|4|||
145633265|NCT00995709|525170779|FG000|Overall Study|Withdrawal by Subject|0|||
145633266|NCT00995709|525170780|FG001|Overall Study|Withdrawal by Subject|4|||
145633267|NCT00995709|525170781|FG002|Overall Study|Withdrawal by Subject|1|||
145633268|NCT00995709|525170779|FG000|Overall Study|Lost to Follow-up|1|||
145633269|NCT00995709|525170780|FG001|Overall Study|Lost to Follow-up|0|||
145633270|NCT00995709|525170781|FG002|Overall Study|Lost to Follow-up|0|||
145633271|NCT00995709|525170779|FG000|Overall Study|Death|0|||
145633272|NCT00995709|525170780|FG001|Overall Study|Death|1|||
145633273|NCT00995709|525170781|FG002|Overall Study|Death|0|||
145633274|NCT00995709|525170779|FG000|Overall Study|Protocol Violation|2|||
145633275|NCT00995709|525170780|FG001|Overall Study|Protocol Violation|1|||
145633276|NCT00995709|525170781|FG002|Overall Study|Protocol Violation|0|||
145633277|NCT03008915|525170784|FG000|Treatment 1|Withdrawal by Subject|0|||
145633278|NCT03008915|525170785|FG001|Treatment 1|Withdrawal by Subject|1|||
145633279|NCT00712166|525170786|FG000|Overall Study|Noncompliance|0|||
145633280|NCT00712166|525170787|FG001|Overall Study|Noncompliance|1|||
145633281|NCT01773122|525170788|FG000|Overall Study|Due to amended age eligibility criteria|3|||
145633282|NCT01773122|525170789|FG001|Overall Study|Due to amended age eligibility criteria|1|||
145633283|NCT01773122|525170790|FG002|Overall Study|Due to amended age eligibility criteria|0|||
145633284|NCT01773122|525170791|FG003|Overall Study|Due to amended age eligibility criteria|1|||
145633285|NCT01264718|525170792|FG000|Overall Study|Lost to Follow-up|3|||
145633286|NCT01264718|525170793|FG001|Overall Study|Lost to Follow-up|2|||
145633287|NCT01264718|525170792|FG000|Overall Study|Withdrawal by Subject|9|||
145633288|NCT01264718|525170793|FG001|Overall Study|Withdrawal by Subject|15|||
145633289|NCT01264718|525170792|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
145633290|NCT01264718|525170793|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
145633291|NCT01769391|525170794|FG000|Overall Study|Death|10|||
145633292|NCT01769391|525170795|FG001|Overall Study|Death|1|||
145633293|NCT01769391|525170794|FG000|Overall Study|Adverse Event|0|||
145633294|NCT01769391|525170795|FG001|Overall Study|Adverse Event|3|||
145633295|NCT01769391|525170794|FG000|Overall Study|Progressive Disease|1|||
145633296|NCT01769391|525170795|FG001|Overall Study|Progressive Disease|2|||
145633297|NCT01769391|525170794|FG000|Overall Study|Withdrawal by Subject|4|||
145633298|NCT01769391|525170795|FG001|Overall Study|Withdrawal by Subject|3|||
145633299|NCT01769391|525170794|FG000|Overall Study|Investigator Decision|2|||
145633300|NCT01769391|525170795|FG001|Overall Study|Investigator Decision|0|||
145633301|NCT03121950|525170801|FG000|Overall Study|Withdrawal by Subject|11|||
145633302|NCT03121950|525170802|FG001|Overall Study|Withdrawal by Subject|2|||
145633303|NCT05233085|525170805|FG000|Overall Study|Adverse Event|1|||
145633304|NCT05233085|525170806|FG001|Overall Study|Adverse Event|0|||
145633305|NCT05233085|525170807|FG002|Overall Study|Adverse Event|0|||
145633306|NCT05233085|525170808|FG003|Overall Study|Adverse Event|0|||
145633307|NCT05052983|525170809|FG000|Overall Study|Lack of Efficacy|3|||
145633308|NCT05052983|525170810|FG001|Overall Study|Lack of Efficacy|12|||
145633309|NCT05052983|525170809|FG000|Overall Study|Adverse Event|1|||
145633310|NCT05052983|525170810|FG001|Overall Study|Adverse Event|0|||
145633311|NCT01066923|525170811|FG000|Overall Study|Withdrawal by Subject|3|||
145633312|NCT01066923|525170812|FG001|Overall Study|Withdrawal by Subject|3|||
145633313|NCT01066923|525170813|FG002|Overall Study|Withdrawal by Subject|8|||
145633314|NCT01066923|525170814|FG003|Overall Study|Withdrawal by Subject|8|||
145633315|NCT01070888|525172655|FG000|First Intervention (14 Days)|Adverse Event|0|||
145633316|NCT01070888|525172656|FG001|First Intervention (14 Days)|Adverse Event|1|||
145633317|NCT01070888|525172655|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
145633318|NCT01070888|525172656|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
145633319|NCT01070888|525172655|FG000|Washout (14 Days)|Physician Decision|1|||
145633320|NCT01070888|525172656|FG001|Washout (14 Days)|Physician Decision|0|||
145633321|NCT02577523|525172657|FG000|Overall Study|Adverse Event|1|||
145633322|NCT02577523|525172658|FG001|Overall Study|Adverse Event|1|||
145633323|NCT02577523|525172657|FG000|Overall Study|Lack of Efficacy|1|||
145633324|NCT02577523|525172658|FG001|Overall Study|Lack of Efficacy|1|||
145480515|NCT00172042|524613178|FG000|Overall Study|Abnormal laboratory value(s)|5|||
145480516|NCT00172042|524613179|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145633325|NCT02577523|525172657|FG000|Overall Study|Withdrawal by Subject|1|||
145633326|NCT02577523|525172658|FG001|Overall Study|Withdrawal by Subject|0|||
145633327|NCT02631148|525172659|FG000|Overall Study|8 were ineligible|8|||
145633328|NCT02631148|525172660|FG001|Overall Study|8 were ineligible|0|||
145633329|NCT02631148|525172659|FG000|Overall Study|Withdrawal by Subject|1|||
145633330|NCT02631148|525172660|FG001|Overall Study|Withdrawal by Subject|0|||
145633331|NCT02631148|525172659|FG000|Overall Study|PAH not available to study participant|1|||
145633332|NCT02631148|525172660|FG001|Overall Study|PAH not available to study participant|0|||
145633333|NCT00028769|525172661|FG000|Overall Study|Adverse Event|2|||
145633334|NCT00028769|525172661|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
145633335|NCT00028769|525172661|FG000|Overall Study|Progression or Death|31|||
145480517|NCT00172042|524613178|FG000|Overall Study|Abnormal test procedure(s)|0|||
145633336|NCT00028769|525172661|FG000|Overall Study|Other - Not Protocol Specified|1|||
145633337|NCT00028769|525172661|FG000|Overall Study|Ineligible|5|||
145633338|NCT00028769|525172661|FG000|Overall Study|Not Analyzable|1|||
145633339|NCT00487578|525172662|FG000|Overall Study|Adverse Event|1|||
145633340|NCT00487578|525172663|FG001|Overall Study|Adverse Event|2|||
145633341|NCT00487578|525172662|FG000|Overall Study|Lack of Efficacy|0|||
145633342|NCT00487578|525172663|FG001|Overall Study|Lack of Efficacy|1|||
145633343|NCT00487578|525172662|FG000|Overall Study|Lost to Follow-up|0|||
145633344|NCT00487578|525172663|FG001|Overall Study|Lost to Follow-up|1|||
145633345|NCT02525796|525172664|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
145633346|NCT02525796|525172665|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
145633347|NCT02525796|525172666|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
145633348|NCT02525796|525172664|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
145633349|NCT02525796|525172665|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
145633350|NCT02525796|525172666|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
145633351|NCT02525796|525172664|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
145633352|NCT02525796|525172665|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
145633353|NCT02525796|525172666|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
145633354|NCT02525796|525172664|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
145633355|NCT02525796|525172665|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
145633356|NCT02525796|525172666|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
145633357|NCT02525796|525172664|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
145633358|NCT02525796|525172665|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
145633359|NCT02525796|525172666|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
145633360|NCT00150176|525172667|FG000|Overall Study|Adverse Event|16|||
145633361|NCT00150176|525172668|FG001|Overall Study|Adverse Event|53|||
145633362|NCT00150176|525172667|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
145633363|NCT00150176|525172668|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
145633364|NCT00150176|525172667|FG000|Overall Study|Withdrawal by Subject|19|||
145633365|NCT00150176|525172668|FG001|Overall Study|Withdrawal by Subject|12|||
145633366|NCT00150176|525172667|FG000|Overall Study|Lost to Follow-up|3|||
145633367|NCT00150176|525172668|FG001|Overall Study|Lost to Follow-up|3|||
145633368|NCT00150176|525172667|FG000|Overall Study|OTHER|11|||
145633369|NCT00150176|525172668|FG001|Overall Study|OTHER|13|||
145633370|NCT02385669|525172672|FG000|Overall Study|Adverse Event|2|||
145633371|NCT00970307|525172673|FG000|Overall Study|Serious Adverse Event|1|||
145633372|NCT00970307|525172674|FG001|Overall Study|Serious Adverse Event|0|||
145633373|NCT00970307|525172675|FG002|Overall Study|Serious Adverse Event|0|||
145633374|NCT00970307|525172673|FG000|Overall Study|Withdrawal by Subject|2|||
145633375|NCT00970307|525172674|FG001|Overall Study|Withdrawal by Subject|3|||
145633376|NCT00970307|525172675|FG002|Overall Study|Withdrawal by Subject|2|||
145633377|NCT02810080|525172676|FG000|Overall Study|Adverse Event|3|||
145633378|NCT02810080|525172677|FG001|Overall Study|Adverse Event|0|||
145633379|NCT02810080|525172676|FG000|Overall Study|Death|0|||
145633380|NCT02810080|525172677|FG001|Overall Study|Death|2|||
145633381|NCT02810080|525172676|FG000|Overall Study|Physician Decision|4|||
145633382|NCT02810080|525172677|FG001|Overall Study|Physician Decision|0|||
145633383|NCT02810080|525172676|FG000|Overall Study|Withdrawal by Subject|0|||
145633384|NCT02810080|525172677|FG001|Overall Study|Withdrawal by Subject|2|||
145633385|NCT01458210|525172680|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
145633386|NCT01458210|525172680|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
145633387|NCT01458210|525172680|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
145633388|NCT01458210|525172680|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
145633389|NCT02224924|525172681|FG000|Overall Study|Withdrawal by Subject|7|||
145633390|NCT02224924|525172682|FG001|Overall Study|Withdrawal by Subject|6|||
145633391|NCT02224924|525172681|FG000|Overall Study|Biopsy cancelled|20|||
145480518|NCT00172042|524613179|FG001|Overall Study|Abnormal test procedure(s)|3|||
145480519|NCT00172042|524613178|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
145480520|NCT00172042|524613179|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
145633392|NCT02224924|525172682|FG001|Overall Study|Biopsy cancelled|14|||
145633393|NCT02224924|525172681|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
145633394|NCT02224924|525172682|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
145633395|NCT02224924|525172681|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
145633396|NCT02224924|525172682|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
145633397|NCT05174013|525172683|FG000|Overall Study|Lost to Follow-up|0|||
145633398|NCT05174013|525172684|FG001|Overall Study|Lost to Follow-up|0|||
145633399|NCT05174013|525172685|FG002|Overall Study|Lost to Follow-up|0|||
145633400|NCT05174013|525172686|FG003|Overall Study|Lost to Follow-up|1|||
145633401|NCT05174013|525172687|FG004|Overall Study|Lost to Follow-up|0|||
145633402|NCT05174013|525172688|FG005|Overall Study|Lost to Follow-up|0|||
145633403|NCT05174013|525172683|FG000|Overall Study|Withdrawal by Subject|0|||
145633404|NCT05174013|525172684|FG001|Overall Study|Withdrawal by Subject|0|||
145633405|NCT05174013|525172685|FG002|Overall Study|Withdrawal by Subject|1|||
145633406|NCT05174013|525172686|FG003|Overall Study|Withdrawal by Subject|0|||
145633407|NCT05174013|525172687|FG004|Overall Study|Withdrawal by Subject|0|||
145633408|NCT05174013|525172688|FG005|Overall Study|Withdrawal by Subject|0|||
145633409|NCT02034916|525172689|FG000|Overall Study|Death|39|||
145633410|NCT02034916|525172690|FG001|Overall Study|Death|28|||
145633411|NCT02034916|525172689|FG000|Overall Study|Withdrawal by Subject|2|||
145633412|NCT02034916|525172690|FG001|Overall Study|Withdrawal by Subject|1|||
145633413|NCT02034916|525172689|FG000|Overall Study|Lost to Follow-up|4|||
145633414|NCT02034916|525172690|FG001|Overall Study|Lost to Follow-up|1|||
145633415|NCT02034916|525172689|FG000|Overall Study|Study terminated by sponsor|4|||
145633416|NCT02034916|525172690|FG001|Overall Study|Study terminated by sponsor|5|||
145633417|NCT01616654|525172691|FG000|Overall Study|Lack of Efficacy|1|||
145633418|NCT01616654|525172692|FG001|Overall Study|Lack of Efficacy|0|||
145633419|NCT01616654|525172693|FG002|Overall Study|Lack of Efficacy|0|||
145633420|NCT01616654|525172694|FG003|Overall Study|Lack of Efficacy|0|||
145633421|NCT01616654|525172695|FG004|Overall Study|Lack of Efficacy|1|||
145633422|NCT01616654|525172691|FG000|Overall Study|Adverse Event|0|||
145633423|NCT01616654|525172692|FG001|Overall Study|Adverse Event|1|||
145633424|NCT01616654|525172693|FG002|Overall Study|Adverse Event|2|||
145633425|NCT01616654|525172694|FG003|Overall Study|Adverse Event|1|||
145633426|NCT01616654|525172695|FG004|Overall Study|Adverse Event|0|||
145633427|NCT01616654|525172691|FG000|Overall Study|Withdrawal by Subject|2|||
145633428|NCT01616654|525172692|FG001|Overall Study|Withdrawal by Subject|2|||
145633429|NCT01616654|525172693|FG002|Overall Study|Withdrawal by Subject|3|||
145633430|NCT01616654|525172694|FG003|Overall Study|Withdrawal by Subject|1|||
145633431|NCT01616654|525172695|FG004|Overall Study|Withdrawal by Subject|5|||
145633432|NCT01616654|525172691|FG000|Overall Study|Protocol Violation|0|||
145633433|NCT01616654|525172692|FG001|Overall Study|Protocol Violation|5|||
145633434|NCT01616654|525172693|FG002|Overall Study|Protocol Violation|2|||
145633435|NCT01616654|525172694|FG003|Overall Study|Protocol Violation|4|||
145633436|NCT01616654|525172695|FG004|Overall Study|Protocol Violation|4|||
145633437|NCT01616654|525172691|FG000|Overall Study|Lost to Follow-up|1|||
145633438|NCT01616654|525172692|FG001|Overall Study|Lost to Follow-up|0|||
145633439|NCT01616654|525172693|FG002|Overall Study|Lost to Follow-up|3|||
145633440|NCT01616654|525172694|FG003|Overall Study|Lost to Follow-up|2|||
145633441|NCT01616654|525172695|FG004|Overall Study|Lost to Follow-up|1|||
145633442|NCT01616654|525172691|FG000|Overall Study|Pregnancy|1|||
145633443|NCT01616654|525172692|FG001|Overall Study|Pregnancy|0|||
145633444|NCT01616654|525172693|FG002|Overall Study|Pregnancy|0|||
145633445|NCT01616654|525172694|FG003|Overall Study|Pregnancy|0|||
145633446|NCT01616654|525172695|FG004|Overall Study|Pregnancy|1|||
145633447|NCT00094809|525172699|FG000|Overall Study|Protocol deviation|2|||
145633448|NCT00094809|525172700|FG001|Overall Study|Protocol deviation|2|||
145633449|NCT00094809|525172699|FG000|Overall Study|Noncompliance|1|||
145633450|NCT00094809|525172700|FG001|Overall Study|Noncompliance|0|||
145633451|NCT00094809|525172699|FG000|Overall Study|Adverse Event|3|||
145633452|NCT00094809|525172700|FG001|Overall Study|Adverse Event|1|||
145633453|NCT00094809|525172699|FG000|Overall Study|Withdrawal by Subject|8|||
145633454|NCT00094809|525172700|FG001|Overall Study|Withdrawal by Subject|9|||
145633455|NCT00094809|525172699|FG000|Overall Study|Disease progression|3|||
145633456|NCT00094809|525172700|FG001|Overall Study|Disease progression|3|||
145633457|NCT00094809|525172699|FG000|Overall Study|Physician Decision|3|||
145633458|NCT00094809|525172700|FG001|Overall Study|Physician Decision|5|||
145633459|NCT00094809|525172699|FG000|Overall Study|Lost to Follow-up|6|||
145633460|NCT00094809|525172700|FG001|Overall Study|Lost to Follow-up|6|||
145633461|NCT00094809|525172699|FG000|Overall Study|Death|19|||
145633462|NCT00094809|525172700|FG001|Overall Study|Death|25|||
145633463|NCT00094809|525172699|FG000|Overall Study|Protocol-specified criteria|1|||
145633464|NCT00094809|525172700|FG001|Overall Study|Protocol-specified criteria|1|||
145633465|NCT00094809|525172699|FG000|Overall Study|Other|2|||
145633466|NCT00094809|525172700|FG001|Overall Study|Other|4|||
145633467|NCT00094809|525172699|FG000|Overall Study|Informed consent signed after treatment|1|||
145633468|NCT00094809|525172700|FG001|Overall Study|Informed consent signed after treatment|0|||
145633469|NCT00094809|525172699|FG000|Overall Study|Study drug not received|2|||
145633470|NCT00094809|525172700|FG001|Overall Study|Study drug not received|8|||
145633471|NCT00094809|525172699|FG000|Overall Study|Other|1|||
145633472|NCT00094809|525172700|FG001|Overall Study|Other|1|||
145633473|NCT01329328|525172701|FG000|Overall Study|Withdrawal by Subject|2|||
145633474|NCT01329328|525172702|FG001|Overall Study|Withdrawal by Subject|4|||
145633475|NCT01329328|525172703|FG002|Overall Study|Withdrawal by Subject|3|||
145633476|NCT02393716|525172704|FG000|Overall Study|Death|29|||
145633477|NCT02393716|525172704|FG000|Overall Study|Withdrawal by Subject|8|||
145633478|NCT02393716|525172704|FG000|Overall Study|Device Explanted|8|||
145633479|NCT02393716|525172704|FG000|Overall Study|Missed visit|16|||
145633480|NCT01119950|525172706|FG000|Overall Study|Adverse Event|25|||
145633481|NCT01119950|525172706|FG000|Overall Study|Withdrawal by Subject|9|||
145633482|NCT01119950|525172706|FG000|Overall Study|Protocol Violation|5|||
145633483|NCT01119950|525172706|FG000|Overall Study|Lost to Follow-up|4|||
145633484|NCT01119950|525172706|FG000|Overall Study|Administrative|2|||
145633485|NCT01119950|525172706|FG000|Overall Study|Abnormal lab value|1|||
145633486|NCT01119950|525172706|FG000|Overall Study|Death|1|||
145633487|NCT00758602|525172711|FG000|Overall Study|Adverse Event|11|||
145633488|NCT00758602|525172712|FG001|Overall Study|Adverse Event|10|||
145633489|NCT00758602|525172711|FG000|Overall Study|Lost to Follow-up|4|||
145633490|NCT00758602|525172712|FG001|Overall Study|Lost to Follow-up|3|||
145633491|NCT00758602|525172711|FG000|Overall Study|Withdrawal by Subject|1|||
145633492|NCT00758602|525172712|FG001|Overall Study|Withdrawal by Subject|3|||
145633493|NCT00758602|525172711|FG000|Overall Study|Protocol Violation|0|||
145633494|NCT00758602|525172712|FG001|Overall Study|Protocol Violation|2|||
145633495|NCT00758602|525172711|FG000|Overall Study|Death|0|||
145633496|NCT00758602|525172712|FG001|Overall Study|Death|1|||
145633497|NCT00758602|525172711|FG000|Overall Study|Reason not specified|3|||
145633498|NCT00758602|525172712|FG001|Overall Study|Reason not specified|3|||
145633499|NCT03939819|525172713|FG000|Overall Study|Death|2|||
145633500|NCT03939819|525172714|FG001|Overall Study|Death|0|||
145633501|NCT05046132|525172715|FG000|Overall Study|Adverse Event|4|||
145633502|NCT05046132|525172716|FG001|Overall Study|Adverse Event|0|||
145633503|NCT05046132|525172717|FG002|Overall Study|Adverse Event|0|||
145633504|NCT05046132|525172715|FG000|Overall Study|Withdrawal by Subject|3|||
145633505|NCT05046132|525172716|FG001|Overall Study|Withdrawal by Subject|0|||
145633506|NCT05046132|525172717|FG002|Overall Study|Withdrawal by Subject|0|||
145633507|NCT05046132|525172715|FG000|Overall Study|Positive Covid19 Result.|0|||
145633508|NCT05046132|525172716|FG001|Overall Study|Positive Covid19 Result.|1|||
145633509|NCT05046132|525172717|FG002|Overall Study|Positive Covid19 Result.|0|||
145633510|NCT02148133|525172722|FG000|Overall Study|Investigator discretion|1|||
145633511|NCT02148133|525172722|FG000|Overall Study|Lack of Efficacy|1|||
145633512|NCT02148133|525172722|FG000|Overall Study|Protocol deviation|1|||
145633513|NCT02148133|525172722|FG000|Overall Study|Protocol-defined stopping criteria|2|||
145633514|NCT00855465|525172724|FG000|Treatment Period|Adverse Event|4|||
145633515|NCT00855465|525172725|FG001|Treatment Period|Adverse Event|2|||
145633516|NCT00855465|525172724|FG000|Treatment Period|Death|2|||
145633517|NCT00855465|525172725|FG001|Treatment Period|Death|2|||
145633518|NCT00855465|525172724|FG000|Treatment Period|Lack of Efficacy|2|||
145633519|NCT00855465|525172725|FG001|Treatment Period|Lack of Efficacy|1|||
145633520|NCT00855465|525172724|FG000|Treatment Period|Non-compliance|1|||
145633521|NCT00855465|525172725|FG001|Treatment Period|Non-compliance|0|||
145633522|NCT00855465|525172724|FG000|Treatment Period|Protocol Violation|2|||
145633523|NCT00855465|525172725|FG001|Treatment Period|Protocol Violation|0|||
145633524|NCT00855465|525172724|FG000|Treatment Period|Withdrawal by Subject|2|||
145633525|NCT00855465|525172725|FG001|Treatment Period|Withdrawal by Subject|0|||
145633526|NCT00855465|525172724|FG000|Treatment Period|Not treated|1|||
145633527|NCT00855465|525172725|FG001|Treatment Period|Not treated|0|||
145633528|NCT00855465|525172724|FG000|Follow-up Period (FUP)|Adverse Event|0|||
145633529|NCT00855465|525172725|FG001|Follow-up Period (FUP)|Adverse Event|1|||
145633530|NCT00855465|525172724|FG000|Follow-up Period (FUP)|Death|0|||
145633531|NCT00855465|525172725|FG001|Follow-up Period (FUP)|Death|1|||
145633532|NCT00855465|525172724|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
145633533|NCT00855465|525172725|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
145633534|NCT00855465|525172724|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
145633535|NCT00855465|525172725|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
145633536|NCT00855465|525172724|FG000|Follow-up Period (FUP)|Missing|1|||
145633537|NCT00855465|525172725|FG001|Follow-up Period (FUP)|Missing|0|||
145633538|NCT00079183|525172728|FG000|Overall Study|Withdrawal by Subject|4|||
145633539|NCT00079183|525172728|FG000|Overall Study|Study medication non-compliance|2|||
145633540|NCT00079183|525172728|FG000|Overall Study|Specimen collection non-compliance|1|||
145633541|NCT01157182|525172729|FG000|Washout of 28 Days|Adverse Event|2|||
145633542|NCT01157182|525172730|FG001|Washout of 28 Days|Adverse Event|0|||
145633543|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
145633544|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
145633545|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
145633546|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
145633547|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
145480521|NCT00172042|524613178|FG000|Overall Study|Patient no longer requires study drug|10|||
145480522|NCT00172042|524613179|FG001|Overall Study|Patient no longer requires study drug|8|||
145480523|NCT00172042|524613178|FG000|Overall Study|Protocol Violation|8|||
145633548|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
145633549|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
145633550|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
145633551|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
145633552|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
145633553|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
145633554|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
145633555|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
145633556|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
145633557|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
145633558|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
145633559|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
145633560|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
145633561|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
145633562|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
145602083|NCT02634788|525058233|FG002|Overall Study|Adverse Event|3|||
145602084|NCT02634788|525058234|FG003|Overall Study|Adverse Event|1|||
145602085|NCT02634788|525058231|FG000|Overall Study|Lack of Efficacy|4|||
145602086|NCT02634788|525058232|FG001|Overall Study|Lack of Efficacy|0|||
145602087|NCT02634788|525058233|FG002|Overall Study|Lack of Efficacy|1|||
145602088|NCT02634788|525058234|FG003|Overall Study|Lack of Efficacy|4|||
145602089|NCT02634788|525058231|FG000|Overall Study|Lost to Follow-up|0|||
145602090|NCT02634788|525058232|FG001|Overall Study|Lost to Follow-up|1|||
145602091|NCT02634788|525058233|FG002|Overall Study|Lost to Follow-up|0|||
145602092|NCT02634788|525058234|FG003|Overall Study|Lost to Follow-up|0|||
145602093|NCT02634788|525058231|FG000|Overall Study|Withdrawal by Subject|0|||
145602094|NCT02634788|525058232|FG001|Overall Study|Withdrawal by Subject|1|||
145602095|NCT02634788|525058233|FG002|Overall Study|Withdrawal by Subject|1|||
145602096|NCT02634788|525058234|FG003|Overall Study|Withdrawal by Subject|0|||
145602097|NCT00758459|525058235|FG000|Overall Study|Adverse Event|3|||
145602098|NCT00758459|525058236|FG001|Overall Study|Adverse Event|2|||
145602099|NCT00758459|525058235|FG000|Overall Study|Protocol Violation|0|||
145602100|NCT00758459|525058236|FG001|Overall Study|Protocol Violation|1|||
145602101|NCT00758459|525058235|FG000|Overall Study|Withdrawal by Subject|0|||
145602102|NCT00758459|525058236|FG001|Overall Study|Withdrawal by Subject|1|||
145602103|NCT01780935|525058238|FG000|Overall Study|Admin problems due to early termination|321|||
145602104|NCT01780935|525058239|FG001|Overall Study|Admin problems due to early termination|309|||
145602105|NCT01780935|525058238|FG000|Overall Study|Adverse Event|2|||
145602106|NCT01780935|525058239|FG001|Overall Study|Adverse Event|4|||
145602107|NCT01780935|525058238|FG000|Overall Study|Death|1|||
145602108|NCT01780935|525058239|FG001|Overall Study|Death|6|||
145602109|NCT01780935|525058238|FG000|Overall Study|Lost to Follow-up|2|||
145602110|NCT01780935|525058239|FG001|Overall Study|Lost to Follow-up|6|||
145602111|NCT01780935|525058238|FG000|Overall Study|Physician Decision|1|||
145602112|NCT01780935|525058239|FG001|Overall Study|Physician Decision|1|||
145602113|NCT01780935|525058238|FG000|Overall Study|Protocol deviation|0|||
145602114|NCT01780935|525058239|FG001|Overall Study|Protocol deviation|1|||
145602115|NCT01780935|525058238|FG000|Overall Study|Patient withdrew consent|8|||
145602116|NCT01780935|525058239|FG001|Overall Study|Patient withdrew consent|9|||
145602117|NCT00855595|525058240|FG000|Overall Study|Withdrawal by Subject|1|||
145602118|NCT00855595|525058241|FG001|Overall Study|Withdrawal by Subject|2|||
145602119|NCT00855595|525058240|FG000|Overall Study|Lost to Follow-up|3|||
145602120|NCT00855595|525058241|FG001|Overall Study|Lost to Follow-up|3|||
145602121|NCT00855595|525058240|FG000|Overall Study|Adverse Event|1|||
145602122|NCT00855595|525058241|FG001|Overall Study|Adverse Event|1|||
145602123|NCT00855595|525058240|FG000|Overall Study|patient moved out of state|1|||
145602124|NCT00855595|525058241|FG001|Overall Study|patient moved out of state|0|||
145602125|NCT00855595|525058240|FG000|Overall Study|patient left country|0|||
145602126|NCT00855595|525058241|FG001|Overall Study|patient left country|1|||
145602127|NCT01844284|525058242|FG000|Overall Study|Lost to Follow-up|12|||
145602128|NCT01844284|525058243|FG001|Overall Study|Lost to Follow-up|7|||
145602129|NCT02755597|525058245|FG000|Overall Study|Withdrew consent|27|||
145602130|NCT02755597|525058246|FG001|Overall Study|Withdrew consent|11|||
145602131|NCT02755597|525058245|FG000|Overall Study|Lost to Follow-up|1|||
145602132|NCT02755597|525058246|FG001|Overall Study|Lost to Follow-up|0|||
145602133|NCT02755597|525058245|FG000|Overall Study|Death|78|||
145602134|NCT02755597|525058246|FG001|Overall Study|Death|36|||
145602135|NCT02755597|525058245|FG000|Overall Study|Study terminated by Sponsor|67|||
145602136|NCT02755597|525058246|FG001|Overall Study|Study terminated by Sponsor|47|||
145602137|NCT02755597|525058245|FG000|Overall Study|Other, not specified|20|||
145602138|NCT02755597|525058246|FG001|Overall Study|Other, not specified|3|||
145602139|NCT02755597|525058245|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
145480524|NCT00172042|524613179|FG001|Overall Study|Protocol Violation|7|||
145480525|NCT00172042|524613178|FG000|Overall Study|Withdrawal by Subject|37|||
145480526|NCT00172042|524613179|FG001|Overall Study|Withdrawal by Subject|25|||
145480527|NCT00172042|524613178|FG000|Overall Study|Lost to Follow-up|3|||
145480528|NCT00172042|524613179|FG001|Overall Study|Lost to Follow-up|5|||
145480529|NCT00172042|524613178|FG000|Overall Study|Administrative problems|13|||
145480530|NCT00172042|524613179|FG001|Overall Study|Administrative problems|10|||
145480531|NCT00172042|524613178|FG000|Overall Study|Death|42|||
145480532|NCT00172042|524613179|FG001|Overall Study|Death|42|||
145602140|NCT02755597|525058246|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
145602141|NCT03138733|525058247|FG000|Overall Study|Death|17|||
145602142|NCT03138733|525058248|FG001|Overall Study|Death|18|||
145602143|NCT03138733|525058247|FG000|Overall Study|Withdrawal by Subject|11|||
145480533|NCT01771250|524613180|FG000|Period 1|Met exclusion criteria|1|||
145480534|NCT01771250|524613181|FG001|Period 1|Met exclusion criteria|0|||
145480535|NCT01180296|524613182|FG000|Overall Study|Protocol Violation|1|||
145480536|NCT01180296|524613183|FG001|Overall Study|Protocol Violation|2|||
145602144|NCT03138733|525058248|FG001|Overall Study|Withdrawal by Subject|6|||
145602145|NCT03138733|525058247|FG000|Overall Study|Lost to Follow-up|3|||
145602146|NCT03138733|525058248|FG001|Overall Study|Lost to Follow-up|2|||
145602147|NCT03138733|525058247|FG000|Overall Study|Adverse Event|1|||
145602148|NCT03138733|525058248|FG001|Overall Study|Adverse Event|0|||
145633563|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
145633564|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
145633565|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
145633566|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
145633567|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
145633568|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
145633569|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
145633570|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
145633571|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
145633572|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
145633573|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
145633574|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
145633575|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
145633576|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633577|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
145633578|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
145633579|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
145633580|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633581|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633582|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633583|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633584|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633585|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633586|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
145633587|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633588|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633589|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633590|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633591|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
145633592|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633593|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633594|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633595|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633596|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633597|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
145633598|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
145633599|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633600|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633601|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633602|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633603|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633604|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633605|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633606|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633607|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633608|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
145633609|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
145633610|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
145480537|NCT00483938|524613184|FG000|Overall Study|Protocol Violation|0|||
145633611|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
145633612|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
145633613|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
145633614|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
145633615|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
145633616|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
145633617|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
145633618|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
145633619|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
145633620|NCT02914522|525172731|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633621|NCT02914522|525172732|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
145633622|NCT02914522|525172733|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633623|NCT02914522|525172734|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633624|NCT02914522|525172735|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
145633625|NCT02914522|525172736|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
145633626|NCT02914522|525172737|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633627|NCT02914522|525172738|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633628|NCT02914522|525172739|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145480538|NCT00483938|524613185|FG001|Overall Study|Protocol Violation|0|||
145480539|NCT00483938|524613186|FG002|Overall Study|Protocol Violation|0|||
145480540|NCT00483938|524613187|FG003|Overall Study|Protocol Violation|0|||
145480541|NCT00483938|524613188|FG004|Overall Study|Protocol Violation|0|||
145602149|NCT03138733|525058247|FG000|Overall Study|Protocol Violation|1|||
145602150|NCT03138733|525058248|FG001|Overall Study|Protocol Violation|3|||
145602151|NCT03138733|525058247|FG000|Overall Study|Administrative or logistical reason|1|||
145602152|NCT03138733|525058248|FG001|Overall Study|Administrative or logistical reason|0|||
145602153|NCT03138733|525058247|FG000|Overall Study|The patient was transferred to another hospital|1|||
145602154|NCT03138733|525058248|FG001|Overall Study|The patient was transferred to another hospital|0|||
145602155|NCT05614089|525058257|FG000|Overall Study|Pregnancy|5|||
145602156|NCT05614089|525058258|FG001|Overall Study|Pregnancy|2|||
145602157|NCT05614089|525058257|FG000|Overall Study|Lost to Follow-up|5|||
145602158|NCT05614089|525058258|FG001|Overall Study|Lost to Follow-up|1|||
145602159|NCT05614089|525058257|FG000|Overall Study|Death|0|||
145602160|NCT05614089|525058258|FG001|Overall Study|Death|1|||
145602161|NCT05614089|525058257|FG000|Overall Study|Adverse Event|1|||
145602162|NCT05614089|525058258|FG001|Overall Study|Adverse Event|0|||
145602163|NCT02521285|525058260|FG000|Overall Study|Lost to Follow-up|1|||
145602164|NCT02521285|525058261|FG001|Overall Study|Lost to Follow-up|1|||
145602165|NCT02521285|525058260|FG000|Overall Study|Withdrawal by Subject|1|||
145602166|NCT02521285|525058261|FG001|Overall Study|Withdrawal by Subject|1|||
145602167|NCT02521285|525058260|FG000|Overall Study|Adverse Event|0|||
145602168|NCT02521285|525058261|FG001|Overall Study|Adverse Event|1|||
145602169|NCT05701995|525058262|FG000|Pre-Treatment|Randomization Error|1|||
145602170|NCT05701995|525058263|FG001|Pre-Treatment|Randomization Error|1|||
145602171|NCT05701995|525058262|FG000|Treatment|Withdrawal by Subject|8|||
145602172|NCT05701995|525058263|FG001|Treatment|Withdrawal by Subject|4|||
145602173|NCT05701995|525058262|FG000|Treatment|Lost to Follow-up|2|||
145602174|NCT05701995|525058263|FG001|Treatment|Lost to Follow-up|3|||
145602175|NCT05701995|525058262|FG000|Treatment|Adverse Event|3|||
145602176|NCT05701995|525058263|FG001|Treatment|Adverse Event|1|||
145602177|NCT05701995|525058262|FG000|Treatment|Other Reason|1|||
145602178|NCT05701995|525058263|FG001|Treatment|Other Reason|1|||
145602179|NCT05701995|525058262|FG000|Treatment|Death|1|||
145602180|NCT05701995|525058263|FG001|Treatment|Death|0|||
145602181|NCT05701995|525058262|FG000|Treatment|Physician Decision|0|||
145602182|NCT05701995|525058263|FG001|Treatment|Physician Decision|1|||
145602183|NCT03937219|525058264|FG000|Overall Study|Death|223|||
145602184|NCT03937219|525058265|FG001|Overall Study|Death|211|||
145602185|NCT03937219|525058264|FG000|Overall Study|Withdrawal by Subject|17|||
145602186|NCT03937219|525058265|FG001|Overall Study|Withdrawal by Subject|25|||
145602187|NCT03937219|525058264|FG000|Overall Study|Lost to Follow-up|3|||
145602188|NCT03937219|525058265|FG001|Overall Study|Lost to Follow-up|4|||
145602189|NCT03185481|525058266|FG000|Overall Study|Adverse Event|1|||
145602190|NCT03185481|525058266|FG000|Overall Study|Study Terminated by Sponsor|4|||
145602191|NCT02220894|525058267|FG000|Overall Study|Adverse Event|127|||
145602192|NCT02220894|525058268|FG001|Overall Study|Adverse Event|74|||
145602193|NCT02220894|525058267|FG000|Overall Study|Death|418|||
145602194|NCT02220894|525058268|FG001|Overall Study|Death|508|||
145602195|NCT02220894|525058267|FG000|Overall Study|Lost to Follow-up|0|||
145480542|NCT00483938|524613189|FG005|Overall Study|Protocol Violation|0|||
145480543|NCT00483938|524613190|FG006|Overall Study|Protocol Violation|3|||
145480544|NCT00483938|524613184|FG000|Overall Study|Withdrawal by Subject|1|||
145480545|NCT00483938|524613185|FG001|Overall Study|Withdrawal by Subject|6|||
145480546|NCT00483938|524613186|FG002|Overall Study|Withdrawal by Subject|0|||
145480547|NCT00483938|524613187|FG003|Overall Study|Withdrawal by Subject|0|||
145480548|NCT00483938|524613188|FG004|Overall Study|Withdrawal by Subject|1|||
145480549|NCT00483938|524613189|FG005|Overall Study|Withdrawal by Subject|3|||
145480550|NCT00483938|524613190|FG006|Overall Study|Withdrawal by Subject|2|||
145480551|NCT00483938|524613184|FG000|Overall Study|Lost to Follow-up|1|||
145480552|NCT00483938|524613185|FG001|Overall Study|Lost to Follow-up|2|||
145480553|NCT00483938|524613186|FG002|Overall Study|Lost to Follow-up|0|||
145480554|NCT00483938|524613187|FG003|Overall Study|Lost to Follow-up|2|||
145480555|NCT00483938|524613188|FG004|Overall Study|Lost to Follow-up|1|||
145480556|NCT00483938|524613189|FG005|Overall Study|Lost to Follow-up|1|||
145480557|NCT00483938|524613190|FG006|Overall Study|Lost to Follow-up|3|||
145480558|NCT00483938|524613184|FG000|Overall Study|Death|0|||
145480559|NCT00483938|524613185|FG001|Overall Study|Death|2|||
145602196|NCT02220894|525058268|FG001|Overall Study|Lost to Follow-up|4|||
145602197|NCT02220894|525058267|FG000|Overall Study|Site Terminated by Sponsor|2|||
145602198|NCT02220894|525058268|FG001|Overall Study|Site Terminated by Sponsor|0|||
145602199|NCT02220894|525058267|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
145602200|NCT02220894|525058268|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
145602201|NCT02220894|525058267|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145602202|NCT02220894|525058268|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145602203|NCT02220894|525058267|FG000|Overall Study|Withdrawal by Subject|10|||
145602204|NCT02220894|525058268|FG001|Overall Study|Withdrawal by Subject|9|||
145602205|NCT02703922|525058271|FG000|Overall Study|Death|5|||
145602206|NCT02703922|525058272|FG001|Overall Study|Death|8|||
145602207|NCT02703922|525058271|FG000|Overall Study|Lost to Follow-up|10|||
145633629|NCT02914522|525172740|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633630|NCT02914522|525172741|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
145633631|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633632|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633633|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633634|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633635|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633636|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
145633637|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
145633638|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
145633639|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
145633640|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
145633641|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
145633642|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633643|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633644|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633645|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633646|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633647|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
145633648|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
145633649|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
145633650|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
145633651|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
145633652|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
145633653|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633654|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633655|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633656|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633657|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633658|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633659|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
145633660|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
145633661|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
145633662|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
145633663|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
145633664|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633665|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633666|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633667|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633668|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633669|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
145633670|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
145633671|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
145633672|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
145633673|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
145633674|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
145633675|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
145633676|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
145633677|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
145633678|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
145633679|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
145633680|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
145633681|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
145633682|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
145633683|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
145633684|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
145633685|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
145633686|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633687|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633688|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633689|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633690|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633691|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633692|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633693|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
145480560|NCT00483938|524613186|FG002|Overall Study|Death|0|||
145480561|NCT00483938|524613187|FG003|Overall Study|Death|0|||
145633694|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
145633695|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633696|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
145633697|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633698|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633699|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633700|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633701|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633702|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633703|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633704|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633705|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
145633706|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
145633707|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
145633708|NCT02914522|525172731|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633709|NCT02914522|525172732|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633710|NCT02914522|525172733|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633711|NCT02914522|525172734|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633712|NCT02914522|525172735|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633713|NCT02914522|525172736|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633714|NCT02914522|525172737|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633715|NCT02914522|525172738|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633716|NCT02914522|525172739|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633717|NCT02914522|525172740|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
145633718|NCT02914522|525172741|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
145633719|NCT01161498|525172744|FG000|Overall Study|Disease Progression|0|||
145633720|NCT01161498|525172745|FG001|Overall Study|Disease Progression|1|||
145633721|NCT02807493|525172746|FG000|Overall Study|Adverse Event|5|||
145633722|NCT02807493|525172747|FG001|Overall Study|Adverse Event|2|||
145633723|NCT02807493|525172746|FG000|Overall Study|Lost to Follow-up|6|||
145633724|NCT02807493|525172747|FG001|Overall Study|Lost to Follow-up|0|||
145633725|NCT02807493|525172746|FG000|Overall Study|Physician Decision|4|||
145633726|NCT02807493|525172747|FG001|Overall Study|Physician Decision|1|||
145633727|NCT02807493|525172746|FG000|Overall Study|Protocol Violation|7|||
145633728|NCT02807493|525172747|FG001|Overall Study|Protocol Violation|0|||
145633729|NCT02807493|525172746|FG000|Overall Study|Withdrawal by Subject|17|||
145633730|NCT02807493|525172747|FG001|Overall Study|Withdrawal by Subject|10|||
145633731|NCT02807493|525172746|FG000|Overall Study|Other withdrawal|17|||
145633732|NCT02807493|525172747|FG001|Overall Study|Other withdrawal|0|||
145633733|NCT02807493|525172746|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
145633734|NCT02807493|525172747|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
145633735|NCT01227707|525172748|FG000|Overall Study|Adverse Event|10|||
145633736|NCT01227707|525172748|FG000|Overall Study|Progression of disease|3|||
145633737|NCT01227707|525172748|FG000|Overall Study|Withdrawal by Subject|1|||
145633738|NCT01227707|525172748|FG000|Overall Study|Patient non-compliance|3|||
145633739|NCT01227707|525172748|FG000|Overall Study|Medical decision|6|||
145633740|NCT01227707|525172748|FG000|Overall Study|Death|1|||
145633741|NCT03386929|525172753|FG000|Overall Study|Death|0|||
145633742|NCT03386929|525172754|FG001|Overall Study|Death|0|||
145633743|NCT03386929|525172755|FG002|Overall Study|Death|1|||
145633744|NCT03386929|525172753|FG000|Overall Study|Withdrawal by Subject|0|||
145633745|NCT03386929|525172754|FG001|Overall Study|Withdrawal by Subject|1|||
145633746|NCT03386929|525172755|FG002|Overall Study|Withdrawal by Subject|0|||
145633747|NCT03386929|525172753|FG000|Overall Study|Physician Decision|0|||
145633748|NCT03386929|525172754|FG001|Overall Study|Physician Decision|0|||
145633749|NCT03386929|525172755|FG002|Overall Study|Physician Decision|1|||
145633750|NCT03386929|525172753|FG000|Overall Study|Progression|4|||
145633751|NCT03386929|525172754|FG001|Overall Study|Progression|4|||
145633752|NCT03386929|525172755|FG002|Overall Study|Progression|0|||
145633753|NCT03386929|525172753|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
145633754|NCT03386929|525172754|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
145633755|NCT03386929|525172755|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
145633756|NCT03386929|525172753|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
145633757|NCT03386929|525172754|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
145633758|NCT03386929|525172755|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
145633759|NCT01144182|525172756|FG000|Overall Study|Death|5|||
145633760|NCT01144182|525172757|FG001|Overall Study|Death|6|||
145633761|NCT01144182|525172756|FG000|Overall Study|Withdrawal by Subject|3|||
145633762|NCT01144182|525172757|FG001|Overall Study|Withdrawal by Subject|6|||
145633763|NCT01144182|525172756|FG000|Overall Study|Lost to Follow-up|9|||
145633764|NCT01144182|525172757|FG001|Overall Study|Lost to Follow-up|9|||
145633765|NCT02351180|525172764|FG000|Overall Study|Withdrawal by Subject|1|||
145633766|NCT02351180|525172765|FG001|Overall Study|Withdrawal by Subject|0|||
145633767|NCT00208767|525172766|FG000|Overall Study|Adverse Event|9|||
145633768|NCT00208767|525172767|FG001|Overall Study|Adverse Event|1|||
145633769|NCT00208767|525172766|FG000|Overall Study|Withdrawal by Subject|14|||
145633770|NCT00208767|525172767|FG001|Overall Study|Withdrawal by Subject|3|||
145633771|NCT00208767|525172766|FG000|Overall Study|Death|1|||
145633772|NCT00208767|525172767|FG001|Overall Study|Death|0|||
145633773|NCT00208767|525172766|FG000|Overall Study|Lost to Follow-up|3|||
145633774|NCT00208767|525172767|FG001|Overall Study|Lost to Follow-up|3|||
145633775|NCT02317016|525172768|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
145633776|NCT02317016|525172768|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
145633777|NCT02317016|525172768|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
145633778|NCT02317016|525172768|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
145633779|NCT02317016|525172768|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
145633780|NCT02317016|525172768|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
145633781|NCT02317016|525172768|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
145633782|NCT00536380|525172769|FG000|Overall Study|Adverse Event|0|||
145633783|NCT00536380|525172770|FG001|Overall Study|Adverse Event|2|||
145633784|NCT00536380|525172771|FG002|Overall Study|Adverse Event|2|||
145633785|NCT00536380|525172769|FG000|Overall Study|Lost to Follow-up|0|||
145633786|NCT00536380|525172770|FG001|Overall Study|Lost to Follow-up|0|||
145633787|NCT00536380|525172771|FG002|Overall Study|Lost to Follow-up|1|||
145633788|NCT00536380|525172769|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
145633789|NCT00536380|525172770|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
145633790|NCT00536380|525172771|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
145633791|NCT00536380|525172769|FG000|Overall Study|Withdrawal related to study drug|7|||
145633792|NCT00536380|525172770|FG001|Overall Study|Withdrawal related to study drug|5|||
145633793|NCT00536380|525172771|FG002|Overall Study|Withdrawal related to study drug|2|||
145633794|NCT00536380|525172769|FG000|Overall Study|Noncompliance with protocol|3|||
145633795|NCT00536380|525172770|FG001|Overall Study|Noncompliance with protocol|2|||
145633796|NCT00536380|525172771|FG002|Overall Study|Noncompliance with protocol|2|||
145633797|NCT00536380|525172769|FG000|Overall Study|Did not meet protocol eligibility|0|||
145633798|NCT00536380|525172770|FG001|Overall Study|Did not meet protocol eligibility|0|||
145633799|NCT00536380|525172771|FG002|Overall Study|Did not meet protocol eligibility|1|||
145633800|NCT00536380|525172769|FG000|Overall Study|Administrative|0|||
145633801|NCT00536380|525172770|FG001|Overall Study|Administrative|0|||
145633802|NCT00536380|525172771|FG002|Overall Study|Administrative|1|||
145633803|NCT03545984|525172772|FG000|Overall Study|CSF cases not present during rotation|11|||
145633804|NCT03545984|525172773|FG001|Overall Study|CSF cases not present during rotation|9|||
145633805|NCT03418324|525172774|FG000|Overall Study|Death|0|||
145633806|NCT03418324|525172775|FG001|Overall Study|Death|1|||
145633807|NCT03418324|525172774|FG000|Overall Study|Physician Decision|1|||
145633808|NCT03418324|525172775|FG001|Overall Study|Physician Decision|1|||
145633809|NCT00290706|525172779|FG000|Overall Study|Withdrawal by Subject|2|||
145633810|NCT00290706|525172780|FG001|Overall Study|Withdrawal by Subject|0|||
145633811|NCT00290706|525172781|FG002|Overall Study|Withdrawal by Subject|0|||
145633812|NCT00290706|525172782|FG003|Overall Study|Withdrawal by Subject|0|||
145633813|NCT00290706|525172779|FG000|Overall Study|Progressive Disease|3|||
145633814|NCT00290706|525172780|FG001|Overall Study|Progressive Disease|5|||
145633815|NCT00290706|525172781|FG002|Overall Study|Progressive Disease|4|||
145633816|NCT00290706|525172782|FG003|Overall Study|Progressive Disease|10|||
145633817|NCT00290706|525172779|FG000|Overall Study|Adverse Event|0|||
145633818|NCT00290706|525172780|FG001|Overall Study|Adverse Event|1|||
145633819|NCT00290706|525172781|FG002|Overall Study|Adverse Event|2|||
145633820|NCT00290706|525172782|FG003|Overall Study|Adverse Event|0|||
145633821|NCT00290706|525172779|FG000|Overall Study|Receive auto transplant or radiation|0|||
145633822|NCT00290706|525172780|FG001|Overall Study|Receive auto transplant or radiation|0|||
145633823|NCT00290706|525172781|FG002|Overall Study|Receive auto transplant or radiation|0|||
145633824|NCT00290706|525172782|FG003|Overall Study|Receive auto transplant or radiation|1|||
145633825|NCT00290706|525172779|FG000|Overall Study|Physician Decision|0|||
145633826|NCT00290706|525172780|FG001|Overall Study|Physician Decision|0|||
145633827|NCT00290706|525172781|FG002|Overall Study|Physician Decision|0|||
145633828|NCT00290706|525172782|FG003|Overall Study|Physician Decision|1|||
145633829|NCT01768676|525172783|FG000|Overall Study|Adverse Event|3|||
145633830|NCT01768676|525172784|FG001|Overall Study|Adverse Event|3|||
145633831|NCT01768676|525172783|FG000|Overall Study|Lost to Follow-up|13|||
145633832|NCT01768676|525172784|FG001|Overall Study|Lost to Follow-up|16|||
145633833|NCT01768676|525172783|FG000|Overall Study|Protocol Violation|1|||
145633834|NCT01768676|525172784|FG001|Overall Study|Protocol Violation|1|||
145633835|NCT01768676|525172783|FG000|Overall Study|Physician Decision|4|||
145633836|NCT01768676|525172784|FG001|Overall Study|Physician Decision|1|||
145633837|NCT01768676|525172783|FG000|Overall Study|Withdrawal by Subject|3|||
145633838|NCT01768676|525172784|FG001|Overall Study|Withdrawal by Subject|10|||
145633839|NCT03183518|525172788|FG000|Overall Study|Other (Not specified)|2|||
145633840|NCT03183518|525172788|FG000|Overall Study|Other (Withdrawal of consent)|1|||
145633841|NCT04248829|525172789|FG000|Overall Study|Disease progression|44|||
145633842|NCT04248829|525172790|FG001|Overall Study|Disease progression|109|||
145633843|NCT04248829|525172789|FG000|Overall Study|Adverse Event|19|||
145633844|NCT04248829|525172790|FG001|Overall Study|Adverse Event|18|||
145633845|NCT04248829|525172789|FG000|Overall Study|Withdrawal by Subject|11|||
145633846|NCT04248829|525172790|FG001|Overall Study|Withdrawal by Subject|2|||
145633847|NCT04248829|525172789|FG000|Overall Study|Lost to Follow-up|0|||
145633848|NCT04248829|525172790|FG001|Overall Study|Lost to Follow-up|1|||
145633849|NCT04248829|525172789|FG000|Overall Study|Death|12|||
145633850|NCT04248829|525172790|FG001|Overall Study|Death|14|||
145633851|NCT04248829|525172789|FG000|Overall Study|Physician Decision|2|||
145633852|NCT04248829|525172790|FG001|Overall Study|Physician Decision|4|||
145633853|NCT04248829|525172789|FG000|Overall Study|Any reason not specifically recorded|0|||
145633854|NCT04248829|525172790|FG001|Overall Study|Any reason not specifically recorded|2|||
145633855|NCT02132702|525172791|FG000|Overall Study|Protocol Violation|2|||
145633856|NCT02132702|525172791|FG000|Overall Study|Adverse Event|3|||
145633857|NCT02132702|525172791|FG000|Overall Study|Withdrawal by Subject|3|||
145633858|NCT01867580|525172793|FG000|Overall Study|Withdrawal by Subject|2|||
145633859|NCT01867580|525172794|FG001|Overall Study|Withdrawal by Subject|3|||
145633860|NCT01867580|525172793|FG000|Overall Study|Physician Decision|17|||
145633861|NCT01867580|525172794|FG001|Overall Study|Physician Decision|12|||
145633862|NCT01867580|525172793|FG000|Overall Study|Lost to Follow-up|3|||
145633863|NCT01867580|525172794|FG001|Overall Study|Lost to Follow-up|5|||
145633864|NCT01867580|525172793|FG000|Overall Study|Sponsor terminated study|1|||
145633865|NCT01867580|525172794|FG001|Overall Study|Sponsor terminated study|0|||
145633866|NCT01867580|525172793|FG000|Overall Study|Missed follow-up assessment|2|||
145633867|NCT01867580|525172794|FG001|Overall Study|Missed follow-up assessment|1|||
145633868|NCT01867580|525172793|FG000|Overall Study|Interruption to therapy|3|||
145633869|NCT01867580|525172794|FG001|Overall Study|Interruption to therapy|0|||
145480562|NCT00483938|524613188|FG004|Overall Study|Death|0|||
145480563|NCT00483938|524613189|FG005|Overall Study|Death|0|||
145480564|NCT00483938|524613190|FG006|Overall Study|Death|0|||
145480565|NCT00483938|524613184|FG000|Overall Study|Other|3|||
145480566|NCT00483938|524613185|FG001|Overall Study|Other|9|||
145480567|NCT00483938|524613186|FG002|Overall Study|Other|0|||
145480568|NCT00483938|524613187|FG003|Overall Study|Other|4|||
145480569|NCT00483938|524613188|FG004|Overall Study|Other|0|||
145480570|NCT00483938|524613189|FG005|Overall Study|Other|4|||
145480571|NCT00483938|524613190|FG006|Overall Study|Other|32|||
145480572|NCT00106353|524613193|FG000|Part 1|Disease progression|3|||
145480573|NCT00106353|524613194|FG001|Part 1|Disease progression|4|||
145480574|NCT00106353|524613195|FG002|Part 1|Disease progression|1|||
145480575|NCT00106353|524613196|FG003|Part 1|Disease progression|3|||
145480576|NCT00106353|524613197|FG004|Part 1|Disease progression|0|||
145480577|NCT00106353|524613198|FG005|Part 1|Disease progression|0|||
145480578|NCT00106353|524613199|FG006|Part 1|Disease progression|0|||
145480579|NCT00106353|524613193|FG000|Part 1|Withdrawal by Subject|0|||
145480580|NCT00106353|524613194|FG001|Part 1|Withdrawal by Subject|0|||
145480581|NCT00106353|524613195|FG002|Part 1|Withdrawal by Subject|1|||
145480582|NCT00106353|524613196|FG003|Part 1|Withdrawal by Subject|2|||
145480583|NCT00106353|524613197|FG004|Part 1|Withdrawal by Subject|0|||
145480584|NCT00106353|524613198|FG005|Part 1|Withdrawal by Subject|0|||
145480585|NCT00106353|524613199|FG006|Part 1|Withdrawal by Subject|0|||
145480586|NCT00106353|524613193|FG000|Part 1|Symptomatic deterioration|0|||
145480587|NCT00106353|524613194|FG001|Part 1|Symptomatic deterioration|0|||
145480588|NCT00106353|524613195|FG002|Part 1|Symptomatic deterioration|1|||
145480589|NCT00106353|524613196|FG003|Part 1|Symptomatic deterioration|0|||
145480590|NCT00106353|524613197|FG004|Part 1|Symptomatic deterioration|0|||
145480591|NCT00106353|524613198|FG005|Part 1|Symptomatic deterioration|0|||
145633870|NCT01867580|525172793|FG000|Overall Study|Osteomyelitis|0|||
145633871|NCT01867580|525172794|FG001|Overall Study|Osteomyelitis|1|||
145633872|NCT01867580|525172793|FG000|Overall Study|Continuation of therapy|0|||
145633873|NCT01867580|525172794|FG001|Overall Study|Continuation of therapy|1|||
145633874|NCT01867580|525172793|FG000|Overall Study|Wound recurrence|0|||
145480592|NCT00106353|524613199|FG006|Part 1|Symptomatic deterioration|0|||
145480593|NCT00106353|524613193|FG000|Part 1|Entered follow-up phase|1|||
145480594|NCT00106353|524613194|FG001|Part 1|Entered follow-up phase|1|||
145633875|NCT01867580|525172794|FG001|Overall Study|Wound recurrence|1|||
145633876|NCT01304147|525172795|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
145633877|NCT01304147|525172796|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
145633878|NCT01244828|525172797|FG000|Overall Study|Adverse Event|37|||
145633879|NCT01244828|525172797|FG000|Overall Study|Withdrawal by Subject|31|||
145633880|NCT01244828|525172797|FG000|Overall Study|Lack of Efficacy|7|||
145480595|NCT00106353|524613195|FG002|Part 1|Entered follow-up phase|0|||
145480596|NCT00106353|524613196|FG003|Part 1|Entered follow-up phase|1|||
145480597|NCT00106353|524613197|FG004|Part 1|Entered follow-up phase|0|||
145480598|NCT00106353|524613198|FG005|Part 1|Entered follow-up phase|0|||
145480599|NCT00106353|524613199|FG006|Part 1|Entered follow-up phase|0|||
145480600|NCT00106353|524613193|FG000|Part 1|Adverse Event|0|||
145480601|NCT00106353|524613194|FG001|Part 1|Adverse Event|0|||
145480602|NCT00106353|524613195|FG002|Part 1|Adverse Event|0|||
145480603|NCT00106353|524613196|FG003|Part 1|Adverse Event|1|||
145480604|NCT00106353|524613197|FG004|Part 1|Adverse Event|0|||
145480605|NCT00106353|524613198|FG005|Part 1|Adverse Event|0|||
145480606|NCT00106353|524613199|FG006|Part 1|Adverse Event|0|||
145480607|NCT00106353|524613193|FG000|Part 2|Disease progression|0|||
145480608|NCT00106353|524613194|FG001|Part 2|Disease progression|0|||
145480609|NCT00106353|524613195|FG002|Part 2|Disease progression|0|||
145480610|NCT00106353|524613196|FG003|Part 2|Disease progression|0|||
145480611|NCT00106353|524613197|FG004|Part 2|Disease progression|8|||
145480612|NCT00106353|524613198|FG005|Part 2|Disease progression|14|||
145480613|NCT00106353|524613199|FG006|Part 2|Disease progression|13|||
145480614|NCT00106353|524613193|FG000|Part 2|Death|0|||
145480615|NCT00106353|524613194|FG001|Part 2|Death|0|||
145480616|NCT00106353|524613195|FG002|Part 2|Death|0|||
145480617|NCT00106353|524613196|FG003|Part 2|Death|0|||
145480618|NCT00106353|524613197|FG004|Part 2|Death|3|||
145480619|NCT00106353|524613198|FG005|Part 2|Death|0|||
145480620|NCT00106353|524613199|FG006|Part 2|Death|1|||
145480621|NCT00106353|524613193|FG000|Part 2|Symptomatic deterioration|0|||
145480622|NCT00106353|524613194|FG001|Part 2|Symptomatic deterioration|0|||
145480623|NCT00106353|524613195|FG002|Part 2|Symptomatic deterioration|0|||
145480624|NCT00106353|524613196|FG003|Part 2|Symptomatic deterioration|0|||
145480625|NCT00106353|524613197|FG004|Part 2|Symptomatic deterioration|3|||
145480626|NCT00106353|524613198|FG005|Part 2|Symptomatic deterioration|0|||
145480627|NCT00106353|524613199|FG006|Part 2|Symptomatic deterioration|0|||
145480628|NCT00106353|524613193|FG000|Part 2|Adverse Event|0|||
145480629|NCT00106353|524613194|FG001|Part 2|Adverse Event|0|||
145480630|NCT00106353|524613195|FG002|Part 2|Adverse Event|0|||
145480631|NCT00106353|524613196|FG003|Part 2|Adverse Event|0|||
145480632|NCT00106353|524613197|FG004|Part 2|Adverse Event|0|||
145480633|NCT00106353|524613198|FG005|Part 2|Adverse Event|2|||
145480634|NCT00106353|524613199|FG006|Part 2|Adverse Event|1|||
145480635|NCT00106353|524613193|FG000|Part 2|Other|0|||
145480636|NCT00106353|524613194|FG001|Part 2|Other|0|||
145480637|NCT00106353|524613195|FG002|Part 2|Other|0|||
145602208|NCT02703922|525058272|FG001|Overall Study|Lost to Follow-up|10|||
145602209|NCT02390531|525058276|FG000|Overall Study|Death|0|||
145602210|NCT02390531|525058277|FG001|Overall Study|Death|2|||
145602211|NCT02390531|525058278|FG002|Overall Study|Death|0|||
145602212|NCT02390531|525058279|FG003|Overall Study|Death|1|||
145602213|NCT02390531|525058280|FG004|Overall Study|Death|0|||
145602214|NCT02390531|525058281|FG005|Overall Study|Death|0|||
145602215|NCT02390531|525058282|FG006|Overall Study|Death|0|||
145602216|NCT02390531|525058283|FG007|Overall Study|Death|1|||
145602217|NCT02390531|525058276|FG000|Overall Study|Protocol Violation|0|||
145602218|NCT02390531|525058277|FG001|Overall Study|Protocol Violation|0|||
145602219|NCT02390531|525058278|FG002|Overall Study|Protocol Violation|0|||
145602220|NCT02390531|525058279|FG003|Overall Study|Protocol Violation|0|||
145602221|NCT02390531|525058280|FG004|Overall Study|Protocol Violation|1|||
145602222|NCT02390531|525058281|FG005|Overall Study|Protocol Violation|0|||
145602223|NCT02390531|525058282|FG006|Overall Study|Protocol Violation|2|||
145602224|NCT02390531|525058283|FG007|Overall Study|Protocol Violation|0|||
145602225|NCT02618616|525058284|FG000|Overall Study|Lack of Efficacy|4|||
145602226|NCT02618616|525058285|FG001|Overall Study|Lack of Efficacy|0|||
145480638|NCT00106353|524613196|FG003|Part 2|Other|0|||
145480639|NCT00106353|524613197|FG004|Part 2|Other|1|||
145480640|NCT00106353|524613198|FG005|Part 2|Other|1|||
145480641|NCT00106353|524613199|FG006|Part 2|Other|1|||
145480642|NCT00106353|524613193|FG000|Part 2|Withdrawal by Subject|0|||
145480643|NCT00106353|524613194|FG001|Part 2|Withdrawal by Subject|0|||
145480644|NCT00106353|524613195|FG002|Part 2|Withdrawal by Subject|0|||
145480645|NCT00106353|524613196|FG003|Part 2|Withdrawal by Subject|0|||
145480646|NCT00106353|524613197|FG004|Part 2|Withdrawal by Subject|1|||
145480647|NCT00106353|524613198|FG005|Part 2|Withdrawal by Subject|0|||
145480648|NCT00106353|524613199|FG006|Part 2|Withdrawal by Subject|0|||
145480649|NCT00106353|524613193|FG000|Part 2|Physician Decision|0|||
145480650|NCT00106353|524613194|FG001|Part 2|Physician Decision|0|||
145480651|NCT00106353|524613195|FG002|Part 2|Physician Decision|0|||
145480652|NCT00106353|524613196|FG003|Part 2|Physician Decision|0|||
145480653|NCT00106353|524613197|FG004|Part 2|Physician Decision|0|||
145480654|NCT00106353|524613198|FG005|Part 2|Physician Decision|1|||
145480655|NCT00106353|524613199|FG006|Part 2|Physician Decision|0|||
145480656|NCT01371552|524613200|FG000|Part 1, First 3 Days|Inconvenience|0|||
145480657|NCT01371552|524613201|FG001|Part 1, First 3 Days|Inconvenience|0|||
145602227|NCT02618616|525058284|FG000|Overall Study|Pregnancy|0|||
145602228|NCT02618616|525058285|FG001|Overall Study|Pregnancy|1|||
145602229|NCT02618616|525058284|FG000|Overall Study|Adverse Event|8|||
145602230|NCT02618616|525058285|FG001|Overall Study|Adverse Event|0|||
145602231|NCT02618616|525058284|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
145602232|NCT02618616|525058285|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
145480658|NCT01371552|524613202|FG002|Part 1, First 3 Days|Inconvenience|1|||
145480659|NCT01371552|524613203|FG003|Part 1, First 3 Days|Inconvenience|0|||
145480660|NCT01371552|524613204|FG004|Part 1, First 3 Days|Inconvenience|0|||
145480661|NCT01371552|524613205|FG005|Part 1, First 3 Days|Inconvenience|0|||
145480662|NCT03364309|524613206|FG000|Induction Period|Adverse Event|4|||
145480663|NCT03364309|524613207|FG001|Induction Period|Adverse Event|0|||
145480664|NCT03364309|524613208|FG002|Induction Period|Adverse Event|1|||
145480665|NCT03364309|524613209|FG003|Induction Period|Adverse Event|0|||
145480666|NCT03364309|524613210|FG004|Induction Period|Adverse Event|0|||
145602233|NCT02618616|525058284|FG000|Overall Study|Consent withdrawn by subject|8|||
145602234|NCT02618616|525058285|FG001|Overall Study|Consent withdrawn by subject|5|||
145602235|NCT02618616|525058284|FG000|Overall Study|Lost to Follow-up|0|||
145602236|NCT02618616|525058285|FG001|Overall Study|Lost to Follow-up|1|||
145602237|NCT01951638|525058286|FG000|Treatment Period|Protocol Violation|0|||
145602238|NCT01951638|525058287|FG001|Treatment Period|Protocol Violation|0|||
145602239|NCT01951638|525058288|FG002|Treatment Period|Protocol Violation|0|||
145602240|NCT01951638|525058289|FG003|Treatment Period|Protocol Violation|2|||
145602241|NCT01951638|525058290|FG004|Treatment Period|Protocol Violation|0|||
145602242|NCT01951638|525058286|FG000|Treatment Period|Protocol-driven decision point|1|||
145602243|NCT01951638|525058287|FG001|Treatment Period|Protocol-driven decision point|3|||
145602244|NCT01951638|525058288|FG002|Treatment Period|Protocol-driven decision point|0|||
145602245|NCT01951638|525058289|FG003|Treatment Period|Protocol-driven decision point|0|||
145602246|NCT01951638|525058290|FG004|Treatment Period|Protocol-driven decision point|0|||
145602247|NCT01951638|525058286|FG000|Treatment Period|Logistical difficulties|0|||
145602248|NCT01951638|525058287|FG001|Treatment Period|Logistical difficulties|1|||
145602249|NCT01951638|525058288|FG002|Treatment Period|Logistical difficulties|1|||
145602250|NCT01951638|525058289|FG003|Treatment Period|Logistical difficulties|0|||
145602251|NCT01951638|525058290|FG004|Treatment Period|Logistical difficulties|0|||
145602252|NCT01951638|525058286|FG000|Treatment Period|Withdrawal by Subject|9|||
145602253|NCT01951638|525058287|FG001|Treatment Period|Withdrawal by Subject|6|||
145602254|NCT01951638|525058288|FG002|Treatment Period|Withdrawal by Subject|4|||
145602255|NCT01951638|525058289|FG003|Treatment Period|Withdrawal by Subject|5|||
145602256|NCT01951638|525058290|FG004|Treatment Period|Withdrawal by Subject|4|||
145602257|NCT01951638|525058286|FG000|Treatment Period|Death|0|||
145602258|NCT01951638|525058287|FG001|Treatment Period|Death|0|||
145602259|NCT01951638|525058288|FG002|Treatment Period|Death|0|||
145602260|NCT01951638|525058289|FG003|Treatment Period|Death|3|||
145602261|NCT01951638|525058290|FG004|Treatment Period|Death|1|||
145602262|NCT01951638|525058286|FG000|Treatment Period|Adverse Event|3|||
145602263|NCT01951638|525058287|FG001|Treatment Period|Adverse Event|4|||
145602264|NCT01951638|525058288|FG002|Treatment Period|Adverse Event|8|||
145602265|NCT01951638|525058289|FG003|Treatment Period|Adverse Event|6|||
145602266|NCT01951638|525058290|FG004|Treatment Period|Adverse Event|5|||
145602267|NCT01951638|525058286|FG000|Follow-up Period|Protocol Violation|0|||
145602268|NCT01951638|525058287|FG001|Follow-up Period|Protocol Violation|0|||
145602269|NCT01951638|525058288|FG002|Follow-up Period|Protocol Violation|0|||
145602270|NCT01951638|525058289|FG003|Follow-up Period|Protocol Violation|1|||
145602271|NCT01951638|525058290|FG004|Follow-up Period|Protocol Violation|0|||
145602272|NCT01951638|525058286|FG000|Follow-up Period|Logistical difficulties|0|||
145602273|NCT01951638|525058287|FG001|Follow-up Period|Logistical difficulties|2|||
145602274|NCT01951638|525058288|FG002|Follow-up Period|Logistical difficulties|0|||
145602275|NCT01951638|525058289|FG003|Follow-up Period|Logistical difficulties|0|||
145602276|NCT01951638|525058290|FG004|Follow-up Period|Logistical difficulties|1|||
145602277|NCT01951638|525058286|FG000|Follow-up Period|Withdrawal by Subject|1|||
145602278|NCT01951638|525058287|FG001|Follow-up Period|Withdrawal by Subject|5|||
145602279|NCT01951638|525058288|FG002|Follow-up Period|Withdrawal by Subject|2|||
145602280|NCT01951638|525058289|FG003|Follow-up Period|Withdrawal by Subject|1|||
145602281|NCT01951638|525058290|FG004|Follow-up Period|Withdrawal by Subject|2|||
145602282|NCT01951638|525058286|FG000|Follow-up Period|Lost to Follow-up|0|||
145602283|NCT01951638|525058287|FG001|Follow-up Period|Lost to Follow-up|1|||
145602284|NCT01951638|525058288|FG002|Follow-up Period|Lost to Follow-up|0|||
145602285|NCT01951638|525058289|FG003|Follow-up Period|Lost to Follow-up|1|||
145602286|NCT01951638|525058290|FG004|Follow-up Period|Lost to Follow-up|0|||
145602287|NCT01951638|525058286|FG000|Follow-up Period|Death|1|||
145480667|NCT03364309|524613211|FG005|Induction Period|Adverse Event|0|||
145480668|NCT03364309|524613212|FG006|Induction Period|Adverse Event|0|||
145480669|NCT03364309|524613213|FG007|Induction Period|Adverse Event|0|||
145602288|NCT01951638|525058287|FG001|Follow-up Period|Death|0|||
145602289|NCT01951638|525058288|FG002|Follow-up Period|Death|1|||
145602290|NCT01951638|525058289|FG003|Follow-up Period|Death|4|||
145602291|NCT01951638|525058290|FG004|Follow-up Period|Death|1|||
145602292|NCT01951638|525058286|FG000|Follow-up Period|Adverse Event|0|||
145602293|NCT01951638|525058287|FG001|Follow-up Period|Adverse Event|1|||
145602294|NCT01951638|525058288|FG002|Follow-up Period|Adverse Event|2|||
145602295|NCT01951638|525058289|FG003|Follow-up Period|Adverse Event|1|||
145602296|NCT01951638|525058290|FG004|Follow-up Period|Adverse Event|1|||
145602297|NCT04225988|525058293|FG000|Overall Study|Withdrawal by Subject|2|||
145602298|NCT04225988|525058294|FG001|Overall Study|Withdrawal by Subject|0|||
145480670|NCT03364309|524613214|FG008|Induction Period|Adverse Event|0|||
145480671|NCT03364309|524613215|FG009|Induction Period|Adverse Event|0|||
145480672|NCT03364309|524613216|FG010|Induction Period|Adverse Event|0|||
145480673|NCT03364309|524613217|FG011|Induction Period|Adverse Event|0|||
145480674|NCT03364309|524613218|FG012|Induction Period|Adverse Event|0|||
145602299|NCT02044848|525060011|FG000|Overall Study|Administrative Problems|2|||
145602300|NCT02044848|525060012|FG001|Overall Study|Administrative Problems|3|||
145602301|NCT00045708|525060013|FG000|Phase 1|early progressive disease|0|||
145602302|NCT00045708|525060014|FG001|Phase 1|early progressive disease|1|||
145602303|NCT00045708|525060015|FG002|Phase 1|early progressive disease|0|||
145602304|NCT03183388|525060017|FG000|Overall Study|Lost to Follow-up|3|||
145602305|NCT03183388|525060018|FG001|Overall Study|Lost to Follow-up|5|||
145602306|NCT03183388|525060017|FG000|Overall Study|Physician Decision|1|||
145602307|NCT03183388|525060018|FG001|Overall Study|Physician Decision|4|||
145602308|NCT03183388|525060017|FG000|Overall Study|Withdrawal by Subject|4|||
145602309|NCT03183388|525060018|FG001|Overall Study|Withdrawal by Subject|1|||
145602310|NCT03183388|525060017|FG000|Overall Study|Moved|1|||
145602311|NCT03183388|525060018|FG001|Overall Study|Moved|0|||
145602312|NCT03183388|525060017|FG000|Overall Study|Met Exclusion Criteria|2|||
145602313|NCT03183388|525060018|FG001|Overall Study|Met Exclusion Criteria|2|||
145602314|NCT03183388|525060017|FG000|Overall Study|COVID Pandemic Related|2|||
145602315|NCT03183388|525060018|FG001|Overall Study|COVID Pandemic Related|4|||
145602316|NCT01493960|525060021|FG000|Overall Study|Adverse Event|0|||
145602317|NCT01493960|525060022|FG001|Overall Study|Adverse Event|1|||
145602318|NCT01493960|525060021|FG000|Overall Study|Lack of Efficacy|15|||
145602319|NCT01493960|525060022|FG001|Overall Study|Lack of Efficacy|9|||
145602320|NCT01493960|525060021|FG000|Overall Study|Protocol Violation|3|||
145602321|NCT01493960|525060022|FG001|Overall Study|Protocol Violation|0|||
145602322|NCT01493960|525060021|FG000|Overall Study|Withdrawal by Subject|10|||
145602323|NCT01493960|525060022|FG001|Overall Study|Withdrawal by Subject|4|||
145602324|NCT01493960|525060021|FG000|Overall Study|Non-specified|4|||
145602325|NCT01493960|525060022|FG001|Overall Study|Non-specified|4|||
145602326|NCT01679236|525060027|FG000|Overall Study|Lost to Follow-up|15|||
145602327|NCT01679236|525060028|FG001|Overall Study|Lost to Follow-up|15|||
145602328|NCT03935217|525060030|FG000|Overall Study|Adverse Event|1|||
145602329|NCT03935217|525060031|FG001|Overall Study|Adverse Event|0|||
145602330|NCT03935217|525060030|FG000|Overall Study|Lost to Follow-up|0|||
145602331|NCT03935217|525060031|FG001|Overall Study|Lost to Follow-up|1|||
145602332|NCT03935217|525060030|FG000|Overall Study|Withdrawal by Subject|0|||
145602333|NCT03935217|525060031|FG001|Overall Study|Withdrawal by Subject|2|||
145602334|NCT00847405|525060032|FG000|First Intervention|Adverse Event|0|||
145602335|NCT00847405|525060033|FG001|First Intervention|Adverse Event|1|||
145602336|NCT00847405|525060032|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
145602337|NCT00847405|525060033|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
145602338|NCT01728792|525060034|FG000|Overall Study|Withdrawal of Consent|1|||
145602339|NCT01728792|525060035|FG001|Overall Study|Withdrawal of Consent|1|||
145602340|NCT01728792|525060036|FG002|Overall Study|Withdrawal of Consent|0|||
145602341|NCT01728792|525060037|FG003|Overall Study|Withdrawal of Consent|1|||
145602342|NCT01728792|525060038|FG004|Overall Study|Withdrawal of Consent|0|||
145602343|NCT01728792|525060034|FG000|Overall Study|Lost to Follow-up|2|||
145602344|NCT01728792|525060035|FG001|Overall Study|Lost to Follow-up|1|||
145602345|NCT01728792|525060036|FG002|Overall Study|Lost to Follow-up|4|||
145602346|NCT01728792|525060037|FG003|Overall Study|Lost to Follow-up|2|||
145602347|NCT01728792|525060038|FG004|Overall Study|Lost to Follow-up|0|||
145602348|NCT03559218|525060039|FG000|Overall Study|Withdrawal by Subject|1|||
145602349|NCT03559218|525060040|FG001|Overall Study|Withdrawal by Subject|0|||
145602350|NCT04277455|525060041|FG000|Overall Study|Lost to Follow-up|1|||
145602351|NCT00514683|525060043|FG000|Overall Study|Not treated|2|||
145602352|NCT00514683|525060044|FG001|Overall Study|Not treated|1|||
145602353|NCT00514683|525060045|FG002|Overall Study|Not treated|0|||
145602354|NCT00514683|525060046|FG003|Overall Study|Not treated|0|||
145602355|NCT00514683|525060047|FG004|Overall Study|Not treated|1|||
145602356|NCT00514683|525060043|FG000|Overall Study|Adverse Event|21|||
145602357|NCT00514683|525060044|FG001|Overall Study|Adverse Event|20|||
145602358|NCT00514683|525060045|FG002|Overall Study|Adverse Event|15|||
145602359|NCT00514683|525060046|FG003|Overall Study|Adverse Event|13|||
145602360|NCT00514683|525060047|FG004|Overall Study|Adverse Event|27|||
145602361|NCT00514683|525060043|FG000|Overall Study|Protocol Violation|1|||
145480675|NCT03364309|524613219|FG013|Induction Period|Adverse Event|0|||
145480676|NCT03364309|524613220|FG014|Induction Period|Adverse Event|0|||
145602362|NCT00514683|525060044|FG001|Overall Study|Protocol Violation|1|||
145602363|NCT00514683|525060045|FG002|Overall Study|Protocol Violation|0|||
145602364|NCT00514683|525060046|FG003|Overall Study|Protocol Violation|1|||
145602365|NCT00514683|525060047|FG004|Overall Study|Protocol Violation|0|||
145602366|NCT00514683|525060043|FG000|Overall Study|Withdrawal by Subject|2|||
145602367|NCT00514683|525060044|FG001|Overall Study|Withdrawal by Subject|2|||
145602368|NCT00514683|525060045|FG002|Overall Study|Withdrawal by Subject|1|||
145602369|NCT00514683|525060046|FG003|Overall Study|Withdrawal by Subject|0|||
145602370|NCT00514683|525060047|FG004|Overall Study|Withdrawal by Subject|4|||
145602371|NCT00514683|525060043|FG000|Overall Study|Reason other than listed above|0|||
145633881|NCT01244828|525172797|FG000|Overall Study|Lost to Follow-up|2|||
145633882|NCT01244828|525172797|FG000|Overall Study|Other reason (not specified)|1|||
145633883|NCT02812966|525172800|FG000|Overall Study|Death|1|||
145633884|NCT02812966|525172801|FG001|Overall Study|Death|0|||
145633885|NCT05147233|525174776|FG000|Overall Study|Adverse Event|0|||
145633886|NCT05147233|525174777|FG001|Overall Study|Adverse Event|1|||
145633887|NCT05147233|525174776|FG000|Overall Study|Lost to Follow-up|1|||
145633888|NCT05147233|525174777|FG001|Overall Study|Lost to Follow-up|1|||
145633889|NCT05147233|525174776|FG000|Overall Study|Protocol Violation|0|||
145633890|NCT05147233|525174777|FG001|Overall Study|Protocol Violation|1|||
145633891|NCT05147233|525174776|FG000|Overall Study|Withdrawal by Subject|2|||
145633892|NCT05147233|525174777|FG001|Overall Study|Withdrawal by Subject|1|||
145633893|NCT00589667|525174786|FG000|Overall Study|Adverse Event|2|||
145633894|NCT00589667|525174786|FG000|Overall Study|Withdrawal by Subject|1|||
145633895|NCT03538041|525174789|FG000|12-Week Treatment Period|Adverse Event|1|||
145633896|NCT03538041|525174790|FG001|12-Week Treatment Period|Adverse Event|1|||
145633897|NCT03538041|525174789|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
145633898|NCT03538041|525174790|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
145633899|NCT03538041|525174789|FG000|Treatment Extension Period|Adverse Event|4|||
145633900|NCT03538041|525174790|FG001|Treatment Extension Period|Adverse Event|1|||
145633901|NCT03538041|525174789|FG000|Treatment Extension Period|Physician Decision|1|||
145633902|NCT03538041|525174790|FG001|Treatment Extension Period|Physician Decision|1|||
145633903|NCT03538041|525174789|FG000|Treatment Extension Period|Lack of Efficacy|1|||
145633904|NCT03538041|525174790|FG001|Treatment Extension Period|Lack of Efficacy|4|||
145633905|NCT03538041|525174789|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
145633906|NCT03538041|525174790|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
145633907|NCT03538041|525174789|FG000|Treatment Extension Period|Death|0|||
145633908|NCT03538041|525174790|FG001|Treatment Extension Period|Death|1|||
145633909|NCT00726999|525174798|FG000|Overall Study|Physician Decision|0|||
145633910|NCT00726999|525174799|FG001|Overall Study|Physician Decision|1|||
145633911|NCT00726999|525174798|FG000|Overall Study|Withdrawal by Subject|2|||
145633912|NCT00726999|525174799|FG001|Overall Study|Withdrawal by Subject|0|||
145633913|NCT00726999|525174798|FG000|Overall Study|Protocol Violation|1|||
145633914|NCT00726999|525174799|FG001|Overall Study|Protocol Violation|0|||
145633915|NCT00955825|525174800|FG000|Overall Study|Adverse Event|15|||
145633916|NCT00955825|525174801|FG001|Overall Study|Adverse Event|2|||
145633917|NCT00955825|525174800|FG000|Overall Study|Withdrawal by Subject|4|||
145633918|NCT00955825|525174801|FG001|Overall Study|Withdrawal by Subject|6|||
145633919|NCT00955825|525174800|FG000|Overall Study|Any other reason not above-mentioned|7|||
145633920|NCT00955825|525174801|FG001|Overall Study|Any other reason not above-mentioned|9|||
145633921|NCT01198275|525174802|FG000|Overall Study|Adverse Event|2|||
145633922|NCT01198275|525174803|FG001|Overall Study|Adverse Event|3|||
145633923|NCT01198275|525174802|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
145633924|NCT01198275|525174803|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
145633925|NCT00393848|525174807|FG000|Overall Study|Surgical schedule|0|||
145633926|NCT00393848|525174808|FG001|Overall Study|Surgical schedule|0|||
145633927|NCT00393848|525174809|FG002|Overall Study|Surgical schedule|0|||
145633928|NCT00393848|525174810|FG003|Overall Study|Surgical schedule|1|||
145633929|NCT00393848|525174807|FG000|Overall Study|Personal reasons|0|||
145633930|NCT00393848|525174808|FG001|Overall Study|Personal reasons|0|||
145633931|NCT00393848|525174809|FG002|Overall Study|Personal reasons|2|||
145633932|NCT00393848|525174810|FG003|Overall Study|Personal reasons|0|||
145633933|NCT02192606|525174811|FG000|Overall Study|surgery type was changed|1|||
145633934|NCT02192606|525174812|FG001|Overall Study|surgery type was changed|1|||
145633935|NCT02192606|525174811|FG000|Overall Study|Physician Decision|1|||
145633936|NCT02192606|525174812|FG001|Overall Study|Physician Decision|2|||
145633937|NCT02192606|525174811|FG000|Overall Study|3D equipment rep unable to join|0|||
145633938|NCT02192606|525174812|FG001|Overall Study|3D equipment rep unable to join|1|||
145633939|NCT00964366|525174817|FG000|Overall Study|Did not qualify at Day 1|1|||
145633940|NCT00964366|525174818|FG001|Overall Study|Did not qualify at Day 1|0|||
145633941|NCT00964366|525174817|FG000|Overall Study|Withdrawal by Subject|0|||
145633942|NCT00964366|525174818|FG001|Overall Study|Withdrawal by Subject|1|||
145633943|NCT01370694|525174819|FG000|Overall Study|Switched to rituximab|4|||
145633944|NCT01370694|525174819|FG000|Overall Study|Progressive disease|2|||
145633945|NCT02957539|525174820|FG000|Baseline to Week 16|Lost to Follow-up|8|||
145633946|NCT02957539|525174821|FG001|Baseline to Week 16|Lost to Follow-up|10|||
145633947|NCT02957539|525174822|FG002|Baseline to Week 16|Lost to Follow-up|16|||
145633948|NCT02957539|525174820|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
145633949|NCT02957539|525174821|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
145633950|NCT02957539|525174822|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
145633951|NCT02957539|525174820|FG000|Week 16 to 32|Withdrawal by Subject|3|||
145633952|NCT02957539|525174821|FG001|Week 16 to 32|Withdrawal by Subject|3|||
145633953|NCT02957539|525174822|FG002|Week 16 to 32|Withdrawal by Subject|1|||
145633954|NCT02957539|525174820|FG000|Week 16 to 32|Lost to Follow-up|8|||
145633955|NCT02957539|525174821|FG001|Week 16 to 32|Lost to Follow-up|7|||
145633956|NCT02957539|525174822|FG002|Week 16 to 32|Lost to Follow-up|5|||
145633957|NCT02957539|525174820|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
145633958|NCT02957539|525174821|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
145633959|NCT02957539|525174822|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
145633960|NCT02957539|525174820|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
145633961|NCT02957539|525174821|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
145633962|NCT02957539|525174822|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
145633963|NCT00139737|525174823|FG000|Overall Study|Withdrawal by Subject|190|||
145633964|NCT00139737|525174823|FG000|Overall Study|Adverse Event|58|||
145633965|NCT00139737|525174823|FG000|Overall Study|Lack of Efficacy|40|||
145633966|NCT00139737|525174823|FG000|Overall Study|Lost to Follow-up|8|||
145633967|NCT00139737|525174823|FG000|Overall Study|Death|3|||
145633968|NCT00139737|525174823|FG000|Overall Study|Laboratory Abnormality|2|||
145633969|NCT00139737|525174823|FG000|Overall Study|Protocol Violation|18|||
145633970|NCT00139737|525174823|FG000|Overall Study|Withdrew During Screening Phase|8|||
145633971|NCT00139737|525174823|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
145633972|NCT00139737|525174823|FG000|Overall Study|Screened, Not Treated|13|||
145633973|NCT03743246|525174825|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
145633974|NCT03743246|525174826|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
145633975|NCT03743246|525174827|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
145633976|NCT03743246|525174828|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
145633977|NCT03743246|525174825|FG000|Pre-Treatment Period|Death|0|||
145633978|NCT03743246|525174826|FG001|Pre-Treatment Period|Death|1|||
145633979|NCT03743246|525174827|FG002|Pre-Treatment Period|Death|0|||
145633980|NCT03743246|525174828|FG003|Pre-Treatment Period|Death|1|||
145480677|NCT03364309|524613221|FG015|Induction Period|Adverse Event|0|||
145480678|NCT03364309|524613222|FG016|Induction Period|Adverse Event|0|||
145480679|NCT03364309|524613223|FG017|Induction Period|Adverse Event|0|||
145633981|NCT03743246|525174825|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
145633982|NCT03743246|525174826|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
145633983|NCT03743246|525174827|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
145633984|NCT03743246|525174828|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
145633985|NCT03743246|525174825|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
145633986|NCT03743246|525174826|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
145633987|NCT03743246|525174827|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
145633988|NCT03743246|525174828|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
145633989|NCT03743246|525174825|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
145633990|NCT03743246|525174826|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
145633991|NCT03743246|525174827|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
145633992|NCT03743246|525174828|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
145633993|NCT03743246|525174825|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
145633994|NCT03743246|525174826|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
145633995|NCT03743246|525174827|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
145633996|NCT03743246|525174828|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
145633997|NCT03743246|525174825|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
145633998|NCT03743246|525174826|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
145633999|NCT03743246|525174827|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
145634000|NCT03743246|525174828|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
145634001|NCT03743246|525174825|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
145634002|NCT03743246|525174826|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
145634003|NCT03743246|525174827|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
145634004|NCT03743246|525174828|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
145634005|NCT03743246|525174825|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
145634006|NCT03743246|525174826|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
145634007|NCT03743246|525174827|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
145634008|NCT03743246|525174828|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
145634009|NCT00530842|525174829|FG000|Overall Study|Adverse Event|10|||
145480680|NCT03364309|524613224|FG018|Induction Period|Adverse Event|0|||
145480681|NCT03364309|524613206|FG000|Induction Period|Withdrawal by Subject|1|||
145480682|NCT03364309|524613207|FG001|Induction Period|Withdrawal by Subject|3|||
145634010|NCT00530842|525174830|FG001|Overall Study|Adverse Event|6|||
145634011|NCT00530842|525174829|FG000|Overall Study|Lack of Efficacy|2|||
145634012|NCT00530842|525174830|FG001|Overall Study|Lack of Efficacy|1|||
145634013|NCT00530842|525174829|FG000|Overall Study|Lost to Follow-up|0|||
145634014|NCT00530842|525174830|FG001|Overall Study|Lost to Follow-up|4|||
145634015|NCT00530842|525174829|FG000|Overall Study|Protocol Violation|3|||
145634016|NCT00530842|525174830|FG001|Overall Study|Protocol Violation|2|||
145634017|NCT00530842|525174829|FG000|Overall Study|Withdrawal by Subject|4|||
145634018|NCT00530842|525174830|FG001|Overall Study|Withdrawal by Subject|5|||
145634019|NCT00530842|525174829|FG000|Overall Study|Individual different reasons|4|||
145634020|NCT00530842|525174830|FG001|Overall Study|Individual different reasons|3|||
145634021|NCT00530842|525174829|FG000|Period 1|Adverse Event|7|||
145634022|NCT00530842|525174830|FG001|Period 1|Adverse Event|3|||
145634023|NCT00530842|525174829|FG000|Period 1|Lack of Efficacy|1|||
145634024|NCT00530842|525174830|FG001|Period 1|Lack of Efficacy|1|||
145634025|NCT00530842|525174829|FG000|Period 1|Protocol Violation|2|||
145634026|NCT00530842|525174830|FG001|Period 1|Protocol Violation|1|||
145634027|NCT00530842|525174829|FG000|Period 1|Withdrawal by Subject|2|||
145634028|NCT00530842|525174830|FG001|Period 1|Withdrawal by Subject|3|||
145634029|NCT00530842|525174829|FG000|Period 1|Individual different reasons|2|||
145634030|NCT00530842|525174830|FG001|Period 1|Individual different reasons|3|||
145634031|NCT00530842|525174829|FG000|Period 2|Adverse Event|3|||
145634032|NCT00530842|525174830|FG001|Period 2|Adverse Event|3|||
145634033|NCT00530842|525174829|FG000|Period 2|Lack of Efficacy|1|||
145634034|NCT00530842|525174830|FG001|Period 2|Lack of Efficacy|0|||
145634035|NCT00530842|525174829|FG000|Period 2|Lost to Follow-up|0|||
145634036|NCT00530842|525174830|FG001|Period 2|Lost to Follow-up|4|||
145634037|NCT00530842|525174829|FG000|Period 2|Protocol Violation|1|||
145634038|NCT00530842|525174830|FG001|Period 2|Protocol Violation|0|||
145634039|NCT00530842|525174829|FG000|Period 2|Withdrawal by Subject|1|||
145634040|NCT00530842|525174830|FG001|Period 2|Withdrawal by Subject|2|||
145634041|NCT00530842|525174829|FG000|Period 2|Individual different reasons|2|||
145634042|NCT00530842|525174830|FG001|Period 2|Individual different reasons|0|||
145634043|NCT00880048|525174835|FG000|Overall Study|Adverse Event|2|||
145634044|NCT00880048|525174836|FG001|Overall Study|Adverse Event|3|||
145634045|NCT00880048|525174837|FG002|Overall Study|Adverse Event|5|||
145634046|NCT00880048|525174835|FG000|Overall Study|Lack of Efficacy|1|||
145634047|NCT00880048|525174836|FG001|Overall Study|Lack of Efficacy|2|||
145634048|NCT00880048|525174837|FG002|Overall Study|Lack of Efficacy|2|||
145634049|NCT00880048|525174835|FG000|Overall Study|Protocol Violation|4|||
145634050|NCT00880048|525174836|FG001|Overall Study|Protocol Violation|6|||
145634051|NCT00880048|525174837|FG002|Overall Study|Protocol Violation|5|||
145634052|NCT00880048|525174835|FG000|Overall Study|Lost to Follow-up|6|||
145634053|NCT00880048|525174836|FG001|Overall Study|Lost to Follow-up|6|||
145634054|NCT00880048|525174837|FG002|Overall Study|Lost to Follow-up|5|||
145634055|NCT00880048|525174835|FG000|Overall Study|Physician Decision|1|||
145634056|NCT00880048|525174836|FG001|Overall Study|Physician Decision|1|||
145634057|NCT00880048|525174837|FG002|Overall Study|Physician Decision|7|||
145634058|NCT00880048|525174835|FG000|Overall Study|Withdrawal by Subject|5|||
145634059|NCT00880048|525174836|FG001|Overall Study|Withdrawal by Subject|8|||
145634060|NCT00880048|525174837|FG002|Overall Study|Withdrawal by Subject|5|||
145634061|NCT00880048|525174835|FG000|Overall Study|Study closed/terminated|9|||
145634062|NCT00880048|525174836|FG001|Overall Study|Study closed/terminated|7|||
145634063|NCT00880048|525174837|FG002|Overall Study|Study closed/terminated|6|||
145634064|NCT01069341|525174838|FG000|Overall Study|Lost to Follow-up|1|||
145634065|NCT02950558|525174842|FG000|Overall Study|Lost to Follow-up|2|||
145634066|NCT02950558|525174843|FG001|Overall Study|Lost to Follow-up|0|||
145634067|NCT01184508|525174844|FG000|Overall Study|Adverse Event|4|||
145634068|NCT01184508|525174845|FG001|Overall Study|Adverse Event|6|||
145634069|NCT01184508|525174844|FG000|Overall Study|Lack of Efficacy|1|||
145634070|NCT01184508|525174845|FG001|Overall Study|Lack of Efficacy|1|||
145634071|NCT01184508|525174844|FG000|Overall Study|Lost to Follow-up|1|||
145634072|NCT01184508|525174845|FG001|Overall Study|Lost to Follow-up|1|||
145634073|NCT01184508|525174844|FG000|Overall Study|Physician Decision|1|||
145634074|NCT01184508|525174845|FG001|Overall Study|Physician Decision|0|||
145634075|NCT01184508|525174844|FG000|Overall Study|Protocol Violation|3|||
145634076|NCT01184508|525174845|FG001|Overall Study|Protocol Violation|1|||
145480683|NCT03364309|524613208|FG002|Induction Period|Withdrawal by Subject|0|||
145480684|NCT03364309|524613209|FG003|Induction Period|Withdrawal by Subject|0|||
145480685|NCT03364309|524613210|FG004|Induction Period|Withdrawal by Subject|0|||
145480686|NCT03364309|524613211|FG005|Induction Period|Withdrawal by Subject|0|||
145480687|NCT03364309|524613212|FG006|Induction Period|Withdrawal by Subject|0|||
145634077|NCT01184508|525174844|FG000|Overall Study|Sponsor Decision|5|||
145634078|NCT01184508|525174845|FG001|Overall Study|Sponsor Decision|2|||
145634079|NCT01184508|525174844|FG000|Overall Study|Withdrawal by Subject|1|||
145634080|NCT01184508|525174845|FG001|Overall Study|Withdrawal by Subject|3|||
145634081|NCT01184508|525174844|FG000|Overall Study|Randomized, Not Treated|0|||
145634082|NCT01184508|525174845|FG001|Overall Study|Randomized, Not Treated|1|||
145634083|NCT00319436|525174851|FG000|Overall Study|Withdrawal by Subject|6|||
145634084|NCT00319436|525174852|FG001|Overall Study|Withdrawal by Subject|7|||
145634085|NCT01493778|525174858|FG000|Overall Study|Withdrawal by Subject|8|||
145634086|NCT04210180|525174859|FG000|Overall Study|Withdrawal by Subject|2|||
145634087|NCT00823979|525174872|FG000|Overall Study|Lack of Efficacy|13|||
145634088|NCT00823979|525174873|FG001|Overall Study|Lack of Efficacy|16|||
145634089|NCT00823979|525174874|FG002|Overall Study|Lack of Efficacy|9|||
145634090|NCT00823979|525174872|FG000|Overall Study|Lost to Follow-up|2|||
145634091|NCT00823979|525174873|FG001|Overall Study|Lost to Follow-up|1|||
145634092|NCT00823979|525174874|FG002|Overall Study|Lost to Follow-up|0|||
145634093|NCT00823979|525174872|FG000|Overall Study|Withdrawal by Subject|2|||
145634094|NCT00823979|525174873|FG001|Overall Study|Withdrawal by Subject|3|||
145634095|NCT00823979|525174874|FG002|Overall Study|Withdrawal by Subject|2|||
145634096|NCT00823979|525174872|FG000|Overall Study|Protocol Violation|1|||
145634097|NCT00823979|525174873|FG001|Overall Study|Protocol Violation|1|||
145634098|NCT00823979|525174874|FG002|Overall Study|Protocol Violation|0|||
145634099|NCT00823979|525174872|FG000|Overall Study|Pregnancy|0|||
145634100|NCT00823979|525174873|FG001|Overall Study|Pregnancy|1|||
145634101|NCT00823979|525174874|FG002|Overall Study|Pregnancy|0|||
145634102|NCT00823979|525174872|FG000|Overall Study|Adverse Event|0|||
145634103|NCT00823979|525174873|FG001|Overall Study|Adverse Event|2|||
145634104|NCT00823979|525174874|FG002|Overall Study|Adverse Event|4|||
145634105|NCT00823979|525174872|FG000|Overall Study|Other|2|||
145634106|NCT00823979|525174873|FG001|Overall Study|Other|0|||
145634107|NCT00823979|525174874|FG002|Overall Study|Other|1|||
145634108|NCT00823979|525174872|FG000|Overall Study|Randomized but not Treated|4|||
145634109|NCT00823979|525174873|FG001|Overall Study|Randomized but not Treated|3|||
145634110|NCT00823979|525174874|FG002|Overall Study|Randomized but not Treated|1|||
145634111|NCT00823979|525174872|FG000|Overall Study|Study Terminated by Sponsor|5|||
145634112|NCT00823979|525174873|FG001|Overall Study|Study Terminated by Sponsor|5|||
145634113|NCT00823979|525174874|FG002|Overall Study|Study Terminated by Sponsor|7|||
145634114|NCT03523091|525174875|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
145634115|NCT03523091|525174876|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
145634116|NCT03523091|525174875|FG000|Overall Study|Withdrawal by Subject|0|||
145634117|NCT03523091|525174876|FG001|Overall Study|Withdrawal by Subject|3|||
145634118|NCT03523091|525174875|FG000|Overall Study|Increase Botox dose|0|||
145634119|NCT03523091|525174876|FG001|Overall Study|Increase Botox dose|1|||
145634120|NCT00741988|525174877|FG000|Overall Study|Adverse Event|2|||
145634121|NCT00741988|525174878|FG001|Overall Study|Adverse Event|4|||
145634122|NCT00741988|525174877|FG000|Overall Study|Lack of Efficacy|2|||
145634123|NCT00741988|525174878|FG001|Overall Study|Lack of Efficacy|0|||
145634124|NCT02685488|525174885|FG000|Overall Study|Withdrawal by Subject|0|||
145634125|NCT02685488|525174886|FG001|Overall Study|Withdrawal by Subject|1|||
145634126|NCT05019729|525174887|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
145634127|NCT05019729|525174888|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
145634128|NCT05019729|525174889|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
145634129|NCT05019729|525174890|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
145634130|NCT05019729|525174891|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
145634131|NCT05019729|525174892|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
145634132|NCT03538054|525174893|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
145634133|NCT03538054|525174893|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
145480688|NCT03364309|524613213|FG007|Induction Period|Withdrawal by Subject|0|||
145480689|NCT03364309|524613214|FG008|Induction Period|Withdrawal by Subject|0|||
145480690|NCT03364309|524613215|FG009|Induction Period|Withdrawal by Subject|0|||
145480691|NCT03364309|524613216|FG010|Induction Period|Withdrawal by Subject|0|||
145480692|NCT03364309|524613217|FG011|Induction Period|Withdrawal by Subject|0|||
145480693|NCT03364309|524613218|FG012|Induction Period|Withdrawal by Subject|0|||
145480694|NCT03364309|524613219|FG013|Induction Period|Withdrawal by Subject|0|||
145480695|NCT03364309|524613220|FG014|Induction Period|Withdrawal by Subject|0|||
145480696|NCT03364309|524613221|FG015|Induction Period|Withdrawal by Subject|0|||
145480697|NCT03364309|524613222|FG016|Induction Period|Withdrawal by Subject|0|||
145480698|NCT03364309|524613223|FG017|Induction Period|Withdrawal by Subject|0|||
145480699|NCT03364309|524613224|FG018|Induction Period|Withdrawal by Subject|0|||
145480700|NCT03364309|524613206|FG000|Induction Period|Lost to Follow-up|1|||
145480701|NCT03364309|524613207|FG001|Induction Period|Lost to Follow-up|0|||
145480702|NCT03364309|524613208|FG002|Induction Period|Lost to Follow-up|0|||
145480703|NCT03364309|524613209|FG003|Induction Period|Lost to Follow-up|0|||
145480704|NCT03364309|524613210|FG004|Induction Period|Lost to Follow-up|0|||
145480705|NCT03364309|524613211|FG005|Induction Period|Lost to Follow-up|0|||
145480706|NCT03364309|524613212|FG006|Induction Period|Lost to Follow-up|0|||
145480707|NCT03364309|524613213|FG007|Induction Period|Lost to Follow-up|0|||
145480708|NCT03364309|524613214|FG008|Induction Period|Lost to Follow-up|0|||
145480709|NCT03364309|524613215|FG009|Induction Period|Lost to Follow-up|0|||
145634134|NCT03538054|525174893|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
145634135|NCT03254394|525174896|FG000|Overall Study|Withdrawal by Subject|0|||
145634136|NCT03254394|525174897|FG001|Overall Study|Withdrawal by Subject|2|||
145634137|NCT00387465|525174904|FG000|Overall Study|Withdrawal by Subject|0|||
145634138|NCT00387465|525174905|FG001|Overall Study|Withdrawal by Subject|1|||
145634139|NCT00387465|525174906|FG002|Overall Study|Withdrawal by Subject|0|||
145634140|NCT00605033|525174908|FG000|Overall Study|Adverse Event|2|||
145634141|NCT00605033|525174909|FG001|Overall Study|Adverse Event|2|||
145634142|NCT00605033|525174908|FG000|Overall Study|Lost to Follow-up|1|||
145480710|NCT03364309|524613216|FG010|Induction Period|Lost to Follow-up|0|||
145480711|NCT03364309|524613217|FG011|Induction Period|Lost to Follow-up|0|||
145634143|NCT00605033|525174909|FG001|Overall Study|Lost to Follow-up|1|||
145634144|NCT00605033|525174908|FG000|Overall Study|Withdrawal by Subject|3|||
145634145|NCT00605033|525174909|FG001|Overall Study|Withdrawal by Subject|4|||
145634146|NCT00605033|525174908|FG000|Overall Study|Protocol Violation|1|||
145634147|NCT00605033|525174909|FG001|Overall Study|Protocol Violation|1|||
145480712|NCT03364309|524613218|FG012|Induction Period|Lost to Follow-up|0|||
145480713|NCT03364309|524613219|FG013|Induction Period|Lost to Follow-up|0|||
145480714|NCT03364309|524613220|FG014|Induction Period|Lost to Follow-up|0|||
145634148|NCT01196429|525174910|FG000|Overall Study|Ineligible - inadequate pathology|1|||
145634149|NCT01196429|525174911|FG001|Overall Study|Ineligible - inadequate pathology|0|||
145634150|NCT01196429|525174910|FG000|Overall Study|Ineligible - wrong cell type|1|||
145634151|NCT01196429|525174911|FG001|Overall Study|Ineligible - wrong cell type|0|||
145634152|NCT01196429|525174910|FG000|Overall Study|Refused - Never Treated|1|||
145634153|NCT01196429|525174911|FG001|Overall Study|Refused - Never Treated|0|||
145634154|NCT03768206|525174912|FG000|Overall Study|Lost to Follow-up|2|||
145634155|NCT03768206|525174913|FG001|Overall Study|Lost to Follow-up|1|||
145634156|NCT03768206|525174912|FG000|Overall Study|Withdrawal by Subject|0|||
145634157|NCT03768206|525174913|FG001|Overall Study|Withdrawal by Subject|1|||
145634158|NCT02754479|525174914|FG000|Overall Study|Lost to Follow-up|1|||
145634159|NCT02299336|525174917|FG000|Overall Study|Withdrawal by Subject|11|||
145634160|NCT02299336|525174917|FG000|Overall Study|Adverse Event|1|||
145634161|NCT02299336|525174917|FG000|Overall Study|Death|1|||
145634162|NCT02299336|525174917|FG000|Overall Study|Lost to Follow-up|1|||
145634163|NCT02106442|525174921|FG000|Overall Study|Case Report Forms Uncollected|7|||
145634164|NCT02106442|525174921|FG000|Overall Study|Protocol Deviation|30|||
145634165|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
145634166|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
145634167|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
145634168|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634169|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634170|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634171|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634172|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634173|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
145634174|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
145634175|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
145634176|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
145634177|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634178|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634179|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634180|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634181|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634182|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
145634183|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
145634184|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
145634185|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
145634186|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634187|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634188|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634189|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634190|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634191|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
145634192|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
145634193|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634194|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
145634195|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634196|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634197|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634198|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634199|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634200|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
145634201|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
145634202|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
145634203|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
145634204|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145480715|NCT03364309|524613221|FG015|Induction Period|Lost to Follow-up|0|||
145480716|NCT03364309|524613222|FG016|Induction Period|Lost to Follow-up|0|||
145480717|NCT03364309|524613223|FG017|Induction Period|Lost to Follow-up|0|||
145634205|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145634206|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145634207|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145634208|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145480718|NCT03364309|524613224|FG018|Induction Period|Lost to Follow-up|0|||
145480719|NCT03364309|524613206|FG000|Induction Period|Physician Decision|0|||
145480720|NCT03364309|524613207|FG001|Induction Period|Physician Decision|1|||
145480721|NCT03364309|524613208|FG002|Induction Period|Physician Decision|0|||
145480722|NCT03364309|524613209|FG003|Induction Period|Physician Decision|0|||
145480723|NCT03364309|524613210|FG004|Induction Period|Physician Decision|0|||
145480724|NCT03364309|524613211|FG005|Induction Period|Physician Decision|0|||
145480725|NCT03364309|524613212|FG006|Induction Period|Physician Decision|0|||
145480726|NCT03364309|524613213|FG007|Induction Period|Physician Decision|0|||
145480727|NCT03364309|524613214|FG008|Induction Period|Physician Decision|0|||
145480728|NCT03364309|524613215|FG009|Induction Period|Physician Decision|0|||
145480729|NCT03364309|524613216|FG010|Induction Period|Physician Decision|0|||
145480730|NCT03364309|524613217|FG011|Induction Period|Physician Decision|0|||
145480731|NCT03364309|524613218|FG012|Induction Period|Physician Decision|0|||
145480732|NCT03364309|524613219|FG013|Induction Period|Physician Decision|0|||
145480733|NCT03364309|524613220|FG014|Induction Period|Physician Decision|0|||
145480734|NCT03364309|524613221|FG015|Induction Period|Physician Decision|0|||
145480735|NCT03364309|524613222|FG016|Induction Period|Physician Decision|0|||
145480736|NCT03364309|524613223|FG017|Induction Period|Physician Decision|0|||
145480737|NCT03364309|524613224|FG018|Induction Period|Physician Decision|0|||
145480738|NCT03364309|524613206|FG000|Maintenance Period|Withdrawal by Subject|0|||
145480739|NCT03364309|524613207|FG001|Maintenance Period|Withdrawal by Subject|0|||
145480740|NCT03364309|524613208|FG002|Maintenance Period|Withdrawal by Subject|0|||
145480741|NCT03364309|524613209|FG003|Maintenance Period|Withdrawal by Subject|1|||
145480742|NCT03364309|524613210|FG004|Maintenance Period|Withdrawal by Subject|3|||
145480743|NCT03364309|524613211|FG005|Maintenance Period|Withdrawal by Subject|1|||
145480744|NCT03364309|524613212|FG006|Maintenance Period|Withdrawal by Subject|3|||
145480745|NCT03364309|524613213|FG007|Maintenance Period|Withdrawal by Subject|0|||
145480746|NCT03364309|524613214|FG008|Maintenance Period|Withdrawal by Subject|1|||
145480747|NCT03364309|524613215|FG009|Maintenance Period|Withdrawal by Subject|1|||
145480748|NCT03364309|524613216|FG010|Maintenance Period|Withdrawal by Subject|2|||
145480749|NCT03364309|524613217|FG011|Maintenance Period|Withdrawal by Subject|0|||
145480750|NCT03364309|524613218|FG012|Maintenance Period|Withdrawal by Subject|0|||
145480751|NCT03364309|524613219|FG013|Maintenance Period|Withdrawal by Subject|0|||
145480752|NCT03364309|524613220|FG014|Maintenance Period|Withdrawal by Subject|0|||
145480753|NCT03364309|524613221|FG015|Maintenance Period|Withdrawal by Subject|0|||
145480754|NCT03364309|524613222|FG016|Maintenance Period|Withdrawal by Subject|0|||
145480755|NCT03364309|524613223|FG017|Maintenance Period|Withdrawal by Subject|0|||
145480756|NCT03364309|524613224|FG018|Maintenance Period|Withdrawal by Subject|0|||
145480757|NCT03364309|524613206|FG000|Maintenance Period|Adverse Event|0|||
145480758|NCT03364309|524613207|FG001|Maintenance Period|Adverse Event|0|||
145634209|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
145634210|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634211|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
145634212|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
145634213|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634214|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634215|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634216|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634217|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634218|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
145634219|NCT01212757|525174925|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
145634220|NCT01212757|525174926|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
145634221|NCT01212757|525174927|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634222|NCT01212757|525174928|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634223|NCT01212757|525174929|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634224|NCT01212757|525174930|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634225|NCT01212757|525174931|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634226|NCT01212757|525174932|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634227|NCT01212757|525174933|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
145634228|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
145634229|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
145634230|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
145634231|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
145634232|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
145634233|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
145480759|NCT03364309|524613208|FG002|Maintenance Period|Adverse Event|0|||
145480760|NCT03364309|524613209|FG003|Maintenance Period|Adverse Event|0|||
145480761|NCT03364309|524613210|FG004|Maintenance Period|Adverse Event|2|||
145480762|NCT03364309|524613211|FG005|Maintenance Period|Adverse Event|0|||
145480763|NCT03364309|524613212|FG006|Maintenance Period|Adverse Event|3|||
145480764|NCT03364309|524613213|FG007|Maintenance Period|Adverse Event|0|||
145634234|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
145634235|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
145634236|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
145634237|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
145634238|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
145634239|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
145634240|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
145634241|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
145634242|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
145634243|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
145634244|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
145634245|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
145634246|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634247|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634248|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
145634249|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634250|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634251|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634252|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634253|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634254|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
145634255|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145634256|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
145634257|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
145634258|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
145634259|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
145634260|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
145634261|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145634262|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145634263|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
145634264|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634265|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
145634266|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634267|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634268|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
145634269|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634270|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634271|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634272|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
145634273|NCT01212757|525174925|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634274|NCT01212757|525174926|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
145634275|NCT01212757|525174927|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
145634276|NCT01212757|525174928|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634277|NCT01212757|525174929|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634278|NCT01212757|525174930|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634279|NCT01212757|525174931|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634280|NCT01212757|525174932|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634281|NCT01212757|525174933|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
145634282|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634283|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634284|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634285|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634286|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634287|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634288|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634289|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
145634290|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
145634291|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
145634292|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
145634293|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
145634294|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
145634295|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
145634296|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
145634297|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
145634298|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
145480765|NCT03364309|524613214|FG008|Maintenance Period|Adverse Event|1|||
145480766|NCT03364309|524613215|FG009|Maintenance Period|Adverse Event|0|||
145480767|NCT03364309|524613216|FG010|Maintenance Period|Adverse Event|2|||
145602372|NCT00514683|525060044|FG001|Overall Study|Reason other than listed above|1|||
145602373|NCT00514683|525060045|FG002|Overall Study|Reason other than listed above|2|||
145602374|NCT00514683|525060046|FG003|Overall Study|Reason other than listed above|0|||
145602375|NCT00514683|525060047|FG004|Overall Study|Reason other than listed above|1|||
145602376|NCT01564368|525060054|FG000|Overall Study|Ineligible|18|||
145602377|NCT01564368|525060054|FG000|Overall Study|Not Randomized in Parent study|116|||
145602378|NCT01564368|525060054|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
145602379|NCT01564368|525060054|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
145602380|NCT01802437|525060058|FG000|Overall Study|Lost to Follow-up|1|||
145602381|NCT01802437|525060059|FG001|Overall Study|Lost to Follow-up|0|||
145602382|NCT01802437|525060058|FG000|Overall Study|Withdrawal by Subject|3|||
145602383|NCT01802437|525060059|FG001|Overall Study|Withdrawal by Subject|4|||
145602384|NCT02228967|525060060|FG000|Overall Study|Lost to Follow-up|146|||
145602385|NCT02228967|525060061|FG001|Overall Study|Lost to Follow-up|142|||
145602386|NCT02228967|525060060|FG000|Overall Study|Withdrawal by Subject|13|||
145602387|NCT02228967|525060061|FG001|Overall Study|Withdrawal by Subject|18|||
145602388|NCT00520975|525060062|FG000|Overall Study|Disease progression|31|||
145602389|NCT00520975|525060063|FG001|Overall Study|Disease progression|23|||
145602390|NCT00520975|525060062|FG000|Overall Study|Adverse Event|7|||
145602391|NCT00520975|525060063|FG001|Overall Study|Adverse Event|10|||
145602392|NCT00520975|525060062|FG000|Overall Study|Death|0|||
145602393|NCT00520975|525060063|FG001|Overall Study|Death|2|||
145602394|NCT00520975|525060062|FG000|Overall Study|Withdrawal by Subject|3|||
145602395|NCT00520975|525060063|FG001|Overall Study|Withdrawal by Subject|5|||
145602396|NCT00520975|525060062|FG000|Overall Study|Other therapy|2|||
145602397|NCT00520975|525060063|FG001|Overall Study|Other therapy|4|||
145602398|NCT00520975|525060062|FG000|Overall Study|Other reasons|4|||
145602399|NCT00520975|525060063|FG001|Overall Study|Other reasons|2|||
145602400|NCT00520975|525060062|FG000|Overall Study|Not start protocol therapy|1|||
145602401|NCT00520975|525060063|FG001|Overall Study|Not start protocol therapy|2|||
145602402|NCT04998604|525060064|FG000|Overall Study|Adverse Event|3|||
145602403|NCT04998604|525060065|FG001|Overall Study|Adverse Event|2|||
145602404|NCT04998604|525060064|FG000|Overall Study|Withdrawal by Subject|2|||
145602405|NCT04998604|525060065|FG001|Overall Study|Withdrawal by Subject|4|||
145602406|NCT04998604|525060064|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
145602407|NCT04998604|525060065|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
145602408|NCT00642902|525060066|FG000|Overall Study|Adverse Event|0|||
145602409|NCT00642902|525060067|FG001|Overall Study|Adverse Event|1|||
145602410|NCT00642902|525060068|FG002|Overall Study|Adverse Event|3|||
145602411|NCT00642902|525060069|FG003|Overall Study|Adverse Event|1|||
145602412|NCT00642902|525060066|FG000|Overall Study|Lost to Follow-up|1|||
145602413|NCT00642902|525060067|FG001|Overall Study|Lost to Follow-up|1|||
145602414|NCT00642902|525060068|FG002|Overall Study|Lost to Follow-up|0|||
145602415|NCT00642902|525060069|FG003|Overall Study|Lost to Follow-up|0|||
145602416|NCT00642902|525060066|FG000|Overall Study|Lack of Efficacy|0|||
145602417|NCT00642902|525060067|FG001|Overall Study|Lack of Efficacy|3|||
145602418|NCT00642902|525060068|FG002|Overall Study|Lack of Efficacy|3|||
145602419|NCT00642902|525060069|FG003|Overall Study|Lack of Efficacy|0|||
145602420|NCT00642902|525060066|FG000|Overall Study|Death|1|||
145602421|NCT00642902|525060067|FG001|Overall Study|Death|0|||
145602422|NCT00642902|525060068|FG002|Overall Study|Death|0|||
145602423|NCT00642902|525060069|FG003|Overall Study|Death|0|||
145602424|NCT00642902|525060066|FG000|Overall Study|Premature termination of clinical trial|37|||
145602425|NCT00642902|525060067|FG001|Overall Study|Premature termination of clinical trial|32|||
145602426|NCT00642902|525060068|FG002|Overall Study|Premature termination of clinical trial|35|||
145602427|NCT00642902|525060069|FG003|Overall Study|Premature termination of clinical trial|35|||
145602428|NCT00642902|525060066|FG000|Overall Study|Randomized, but not treated|0|||
145602429|NCT00642902|525060067|FG001|Overall Study|Randomized, but not treated|0|||
145602430|NCT00642902|525060068|FG002|Overall Study|Randomized, but not treated|1|||
145602431|NCT00642902|525060069|FG003|Overall Study|Randomized, but not treated|0|||
145602432|NCT00642902|525060066|FG000|Overall Study|Other|1|||
145602433|NCT00642902|525060067|FG001|Overall Study|Other|5|||
145602434|NCT00642902|525060068|FG002|Overall Study|Other|1|||
145602435|NCT00642902|525060069|FG003|Overall Study|Other|4|||
145602436|NCT00429663|525060070|FG000|Overall Study|Lost to Follow-up|24|||
145602437|NCT00429663|525060071|FG001|Overall Study|Lost to Follow-up|31|||
145602438|NCT00429663|525060070|FG000|Overall Study|Physician Decision|6|||
145602439|NCT00429663|525060071|FG001|Overall Study|Physician Decision|3|||
145602440|NCT00429663|525060070|FG000|Overall Study|Withdrawal by Subject|2|||
145602441|NCT00429663|525060071|FG001|Overall Study|Withdrawal by Subject|5|||
145602442|NCT00429663|525060070|FG000|Overall Study|Death|4|||
145602443|NCT00429663|525060071|FG001|Overall Study|Death|0|||
145602444|NCT03953898|525060077|FG000|Overall Study|Lack of Efficacy|8|||
145602445|NCT03953898|525060077|FG000|Overall Study|Death|3|||
145602446|NCT03953898|525060077|FG000|Overall Study|Withdrawal by Subject|2|||
145480768|NCT03364309|524613217|FG011|Maintenance Period|Adverse Event|0|||
145480769|NCT03364309|524613218|FG012|Maintenance Period|Adverse Event|0|||
145602447|NCT03953898|525060077|FG000|Overall Study|Adverse Event|1|||
145602448|NCT03261271|525060078|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
145602449|NCT03261271|525060079|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
145602450|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
145602451|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
145602452|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
145602453|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
145602454|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
145602455|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
145602456|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
145602457|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
145602458|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
145602459|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
145602460|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
145602461|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
145602462|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
145602463|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
145602464|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
145602465|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
145602466|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
145602467|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145602468|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145602469|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
145602470|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Death|2|||
145602471|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Death|2|||
145602472|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Death|0|||
145602473|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Death|0|||
145602474|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Death|0|||
145602475|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
145602476|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
145602477|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
145602478|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
145602479|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
145602480|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
145602481|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
145602482|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
145602483|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
145602484|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
145602485|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
145602486|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
145602487|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
145602488|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
145602489|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
145602490|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
145602491|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
145602492|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
145602493|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
145602494|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
145602495|NCT03420781|525060080|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
145602496|NCT03420781|525060081|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
145602497|NCT03420781|525060082|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
145602498|NCT03420781|525060083|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
145602499|NCT03420781|525060084|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
145602500|NCT03420781|525060080|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
145602501|NCT03420781|525060081|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
145602502|NCT03420781|525060082|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
145602503|NCT03420781|525060083|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
145602504|NCT03420781|525060084|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
145602505|NCT03420781|525060080|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
145602506|NCT03420781|525060081|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
145602507|NCT03420781|525060082|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
145602508|NCT03420781|525060083|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
145602509|NCT03420781|525060084|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
145602510|NCT03420781|525060080|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
145602511|NCT03420781|525060081|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
145602512|NCT03420781|525060082|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
145634299|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
145634300|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634301|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
145634302|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
145634303|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634304|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634305|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634306|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634307|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
145634308|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
145634309|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145634310|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
145634311|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
145634312|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145634313|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145634314|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145634315|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
145634316|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
145634317|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
145634318|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634319|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634320|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
145634321|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634322|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634323|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634324|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634325|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634326|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
145634327|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634328|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
145634329|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
145634330|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634331|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634332|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634333|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634334|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
145634335|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
145634336|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
145634337|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
145634338|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
145634339|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
145634340|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
145634341|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
145634342|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
145634343|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
145634344|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
145634345|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634346|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634347|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
145634348|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634349|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634350|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634351|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634352|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634353|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
145634354|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145634355|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
145634356|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
145634357|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145634358|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145634359|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145634360|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
145634361|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
145634362|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
145634363|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634364|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634365|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145480770|NCT03364309|524613219|FG013|Maintenance Period|Adverse Event|0|||
145480771|NCT03364309|524613220|FG014|Maintenance Period|Adverse Event|0|||
145480772|NCT03364309|524613221|FG015|Maintenance Period|Adverse Event|0|||
145480773|NCT03364309|524613222|FG016|Maintenance Period|Adverse Event|0|||
145480774|NCT03364309|524613223|FG017|Maintenance Period|Adverse Event|0|||
145480775|NCT03364309|524613224|FG018|Maintenance Period|Adverse Event|0|||
145602513|NCT03420781|525060083|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
145602514|NCT03420781|525060084|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
145602515|NCT00246337|525060085|FG000|Overall Study|Lost to Follow-up|3|||
145602516|NCT00246337|525060086|FG001|Overall Study|Lost to Follow-up|0|||
145602517|NCT00246337|525060087|FG002|Overall Study|Lost to Follow-up|0|||
145602518|NCT00246337|525060088|FG003|Overall Study|Lost to Follow-up|0|||
145602519|NCT00246337|525060089|FG004|Overall Study|Lost to Follow-up|2|||
145602520|NCT00246337|525060090|FG005|Overall Study|Lost to Follow-up|2|||
145602521|NCT00246337|525060091|FG006|Overall Study|Lost to Follow-up|1|||
145602522|NCT00246337|525060092|FG007|Overall Study|Lost to Follow-up|2|||
145602523|NCT00246337|525060093|FG008|Overall Study|Lost to Follow-up|0|||
145602524|NCT00246337|525060085|FG000|Overall Study|Protocol Violation|1|||
145602525|NCT00246337|525060086|FG001|Overall Study|Protocol Violation|0|||
145602526|NCT00246337|525060087|FG002|Overall Study|Protocol Violation|0|||
145602527|NCT00246337|525060088|FG003|Overall Study|Protocol Violation|0|||
145602528|NCT00246337|525060089|FG004|Overall Study|Protocol Violation|1|||
145602529|NCT00246337|525060090|FG005|Overall Study|Protocol Violation|0|||
145602530|NCT00246337|525060091|FG006|Overall Study|Protocol Violation|1|||
145602531|NCT00246337|525060092|FG007|Overall Study|Protocol Violation|1|||
145602532|NCT00246337|525060093|FG008|Overall Study|Protocol Violation|0|||
145602533|NCT00246337|525060085|FG000|Overall Study|Withdrawal by Subject|2|||
145602534|NCT00246337|525060086|FG001|Overall Study|Withdrawal by Subject|0|||
145602535|NCT00246337|525060087|FG002|Overall Study|Withdrawal by Subject|0|||
145602536|NCT00246337|525060088|FG003|Overall Study|Withdrawal by Subject|0|||
145602537|NCT00246337|525060089|FG004|Overall Study|Withdrawal by Subject|0|||
145602538|NCT00246337|525060090|FG005|Overall Study|Withdrawal by Subject|0|||
145602539|NCT00246337|525060091|FG006|Overall Study|Withdrawal by Subject|1|||
145602540|NCT00246337|525060092|FG007|Overall Study|Withdrawal by Subject|1|||
145602541|NCT00246337|525060093|FG008|Overall Study|Withdrawal by Subject|0|||
145602542|NCT00246337|525060085|FG000|Overall Study|Lack of Qualifying Event|8|||
145602543|NCT00246337|525060086|FG001|Overall Study|Lack of Qualifying Event|2|||
145602544|NCT00246337|525060087|FG002|Overall Study|Lack of Qualifying Event|1|||
145602545|NCT00246337|525060088|FG003|Overall Study|Lack of Qualifying Event|1|||
145602546|NCT00246337|525060089|FG004|Overall Study|Lack of Qualifying Event|1|||
145602547|NCT00246337|525060090|FG005|Overall Study|Lack of Qualifying Event|3|||
145602548|NCT00246337|525060091|FG006|Overall Study|Lack of Qualifying Event|3|||
145602549|NCT00246337|525060092|FG007|Overall Study|Lack of Qualifying Event|2|||
145602550|NCT00246337|525060093|FG008|Overall Study|Lack of Qualifying Event|5|||
145602551|NCT00246337|525060085|FG000|Overall Study|Site Terminated|10|||
145602552|NCT00246337|525060086|FG001|Overall Study|Site Terminated|0|||
145602553|NCT00246337|525060087|FG002|Overall Study|Site Terminated|0|||
145602554|NCT00246337|525060088|FG003|Overall Study|Site Terminated|0|||
145602555|NCT00246337|525060089|FG004|Overall Study|Site Terminated|0|||
145602556|NCT00246337|525060090|FG005|Overall Study|Site Terminated|7|||
145602557|NCT00246337|525060091|FG006|Overall Study|Site Terminated|1|||
145602558|NCT00246337|525060092|FG007|Overall Study|Site Terminated|6|||
145602559|NCT00246337|525060093|FG008|Overall Study|Site Terminated|2|||
145602560|NCT00246337|525060085|FG000|Overall Study|Abnormal baseline lab values|7|||
145602561|NCT00246337|525060086|FG001|Overall Study|Abnormal baseline lab values|0|||
145602562|NCT00246337|525060087|FG002|Overall Study|Abnormal baseline lab values|2|||
145602563|NCT00246337|525060088|FG003|Overall Study|Abnormal baseline lab values|0|||
145602564|NCT00246337|525060089|FG004|Overall Study|Abnormal baseline lab values|0|||
145602565|NCT00246337|525060090|FG005|Overall Study|Abnormal baseline lab values|2|||
145602566|NCT00246337|525060091|FG006|Overall Study|Abnormal baseline lab values|2|||
145602567|NCT00246337|525060092|FG007|Overall Study|Abnormal baseline lab values|0|||
145602568|NCT00246337|525060093|FG008|Overall Study|Abnormal baseline lab values|4|||
145480776|NCT03364309|524613206|FG000|Maintenance Period|Relapsed|0|||
145602569|NCT00246337|525060085|FG000|Overall Study|Overwhelmed|0|||
145602570|NCT00246337|525060086|FG001|Overall Study|Overwhelmed|0|||
145602571|NCT00246337|525060087|FG002|Overall Study|Overwhelmed|0|||
145602572|NCT00246337|525060088|FG003|Overall Study|Overwhelmed|0|||
145602573|NCT00246337|525060089|FG004|Overall Study|Overwhelmed|0|||
145602574|NCT00246337|525060090|FG005|Overall Study|Overwhelmed|1|||
145602575|NCT00246337|525060091|FG006|Overall Study|Overwhelmed|0|||
145602576|NCT00246337|525060092|FG007|Overall Study|Overwhelmed|0|||
145602577|NCT00246337|525060093|FG008|Overall Study|Overwhelmed|0|||
145602578|NCT00246337|525060085|FG000|Overall Study|Protocol Violator|1|||
145602579|NCT00246337|525060086|FG001|Overall Study|Protocol Violator|0|||
145602580|NCT00246337|525060087|FG002|Overall Study|Protocol Violator|0|||
145602581|NCT00246337|525060088|FG003|Overall Study|Protocol Violator|0|||
145480777|NCT03364309|524613207|FG001|Maintenance Period|Relapsed|0|||
145480778|NCT03364309|524613208|FG002|Maintenance Period|Relapsed|0|||
145480779|NCT03364309|524613209|FG003|Maintenance Period|Relapsed|43|||
145480780|NCT03364309|524613210|FG004|Maintenance Period|Relapsed|7|||
145480781|NCT03364309|524613211|FG005|Maintenance Period|Relapsed|45|||
145480782|NCT03364309|524613212|FG006|Maintenance Period|Relapsed|10|||
145480783|NCT03364309|524613213|FG007|Maintenance Period|Relapsed|2|||
145480784|NCT03364309|524613214|FG008|Maintenance Period|Relapsed|0|||
145480785|NCT03364309|524613215|FG009|Maintenance Period|Relapsed|0|||
145602582|NCT00246337|525060089|FG004|Overall Study|Protocol Violator|0|||
145602583|NCT00246337|525060090|FG005|Overall Study|Protocol Violator|0|||
145602584|NCT00246337|525060091|FG006|Overall Study|Protocol Violator|0|||
145602585|NCT00246337|525060092|FG007|Overall Study|Protocol Violator|0|||
145602586|NCT00246337|525060093|FG008|Overall Study|Protocol Violator|0|||
145602587|NCT00246337|525060085|FG000|Overall Study|Reported as completing trial in error|0|||
145602588|NCT00246337|525060086|FG001|Overall Study|Reported as completing trial in error|0|||
145602589|NCT00246337|525060087|FG002|Overall Study|Reported as completing trial in error|0|||
145602590|NCT00246337|525060088|FG003|Overall Study|Reported as completing trial in error|0|||
145602591|NCT00246337|525060089|FG004|Overall Study|Reported as completing trial in error|0|||
145602592|NCT00246337|525060090|FG005|Overall Study|Reported as completing trial in error|0|||
145602593|NCT00246337|525060091|FG006|Overall Study|Reported as completing trial in error|0|||
145602594|NCT00246337|525060092|FG007|Overall Study|Reported as completing trial in error|1|||
145602595|NCT00246337|525060093|FG008|Overall Study|Reported as completing trial in error|0|||
145602596|NCT01226511|525060096|FG000|Acute Treatment Period|Adverse Event|7|||
145602597|NCT01226511|525060097|FG001|Acute Treatment Period|Adverse Event|6|||
145602598|NCT01226511|525060096|FG000|Acute Treatment Period|Lack of Efficacy|2|||
145602599|NCT01226511|525060097|FG001|Acute Treatment Period|Lack of Efficacy|1|||
145602600|NCT01226511|525060096|FG000|Acute Treatment Period|Lost to Follow-up|3|||
145602601|NCT01226511|525060097|FG001|Acute Treatment Period|Lost to Follow-up|6|||
145602602|NCT01226511|525060096|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
145602603|NCT01226511|525060097|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
145602604|NCT01226511|525060096|FG000|Acute Treatment Period|Protocol Violation|5|||
145602605|NCT01226511|525060097|FG001|Acute Treatment Period|Protocol Violation|5|||
145602606|NCT01226511|525060096|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
145602607|NCT01226511|525060097|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
145602608|NCT01226511|525060096|FG000|Extension Treatment Period|Adverse Event|8|||
145602609|NCT01226511|525060097|FG001|Extension Treatment Period|Adverse Event|8|||
145602610|NCT01226511|525060096|FG000|Extension Treatment Period|Lack of Efficacy|3|||
145602611|NCT01226511|525060097|FG001|Extension Treatment Period|Lack of Efficacy|2|||
145602612|NCT01226511|525060096|FG000|Extension Treatment Period|Lost to Follow-up|4|||
145602613|NCT01226511|525060097|FG001|Extension Treatment Period|Lost to Follow-up|3|||
145602614|NCT01226511|525060096|FG000|Extension Treatment Period|Protocol Violation|2|||
145602615|NCT01226511|525060097|FG001|Extension Treatment Period|Protocol Violation|2|||
145602616|NCT01226511|525060096|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
145602617|NCT01226511|525060097|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
145602618|NCT01226511|525060096|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
145602619|NCT01226511|525060097|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
145602620|NCT01226511|525060096|FG000|Extension Treatment Period|Sponsor Decision|1|||
145602621|NCT01226511|525060097|FG001|Extension Treatment Period|Sponsor Decision|1|||
145602622|NCT01226511|525060096|FG000|Taper Period|Adverse Event|1|||
145602623|NCT01226511|525060097|FG001|Taper Period|Adverse Event|0|||
145602624|NCT01226511|525060096|FG000|Taper Period|Lost to Follow-up|2|||
145602625|NCT01226511|525060097|FG001|Taper Period|Lost to Follow-up|2|||
145602626|NCT01226511|525060096|FG000|Taper Period|Protocol Violation|1|||
145602627|NCT01226511|525060097|FG001|Taper Period|Protocol Violation|0|||
145602628|NCT01226511|525060096|FG000|Taper Period|Parent/Caregiver Decision|1|||
145602629|NCT01226511|525060097|FG001|Taper Period|Parent/Caregiver Decision|1|||
145602630|NCT05267600|525060098|FG000|Overall Study|Adverse Event|1|||
145602631|NCT05267600|525060099|FG001|Overall Study|Adverse Event|4|||
145602632|NCT05267600|525060098|FG000|Overall Study|Death|1|||
145602633|NCT05267600|525060099|FG001|Overall Study|Death|2|||
145602634|NCT05267600|525060098|FG000|Overall Study|Lack of Efficacy|1|||
145602635|NCT05267600|525060099|FG001|Overall Study|Lack of Efficacy|2|||
145602636|NCT05267600|525060098|FG000|Overall Study|Lost to Follow-up|3|||
145602637|NCT05267600|525060099|FG001|Overall Study|Lost to Follow-up|0|||
145602638|NCT05267600|525060098|FG000|Overall Study|Physician Decision|4|||
145602639|NCT05267600|525060099|FG001|Overall Study|Physician Decision|0|||
145602640|NCT05267600|525060098|FG000|Overall Study|Treatment Unblinded|0|||
145602641|NCT05267600|525060099|FG001|Overall Study|Treatment Unblinded|1|||
145480786|NCT03364309|524613216|FG010|Maintenance Period|Relapsed|0|||
145602642|NCT05267600|525060098|FG000|Overall Study|Withdrawal by Subject|5|||
145602643|NCT05267600|525060099|FG001|Overall Study|Withdrawal by Subject|4|||
145602644|NCT04067401|525060100|FG000|Overall Study|Withdrawal by Subject|7|||
145602645|NCT04067401|525060101|FG001|Overall Study|Withdrawal by Subject|0|||
145602646|NCT04067401|525060100|FG000|Overall Study|no data provided|1|||
145602647|NCT04067401|525060101|FG001|Overall Study|no data provided|0|||
145480787|NCT03364309|524613217|FG011|Maintenance Period|Relapsed|0|||
145480788|NCT03364309|524613218|FG012|Maintenance Period|Relapsed|0|||
145480789|NCT03364309|524613219|FG013|Maintenance Period|Relapsed|0|||
145480790|NCT03364309|524613220|FG014|Maintenance Period|Relapsed|0|||
145480791|NCT03364309|524613221|FG015|Maintenance Period|Relapsed|0|||
145480792|NCT03364309|524613222|FG016|Maintenance Period|Relapsed|0|||
145480793|NCT03364309|524613223|FG017|Maintenance Period|Relapsed|0|||
145480794|NCT03364309|524613224|FG018|Maintenance Period|Relapsed|0|||
145480795|NCT03364309|524613206|FG000|Maintenance Period|Lack of Efficacy|0|||
145480796|NCT03364309|524613207|FG001|Maintenance Period|Lack of Efficacy|0|||
145480797|NCT03364309|524613208|FG002|Maintenance Period|Lack of Efficacy|0|||
145480798|NCT03364309|524613209|FG003|Maintenance Period|Lack of Efficacy|0|||
145480799|NCT03364309|524613210|FG004|Maintenance Period|Lack of Efficacy|0|||
145480800|NCT03364309|524613211|FG005|Maintenance Period|Lack of Efficacy|0|||
145480801|NCT03364309|524613212|FG006|Maintenance Period|Lack of Efficacy|0|||
145480802|NCT03364309|524613213|FG007|Maintenance Period|Lack of Efficacy|0|||
145480803|NCT03364309|524613214|FG008|Maintenance Period|Lack of Efficacy|1|||
145480804|NCT03364309|524613215|FG009|Maintenance Period|Lack of Efficacy|3|||
145480805|NCT03364309|524613216|FG010|Maintenance Period|Lack of Efficacy|2|||
145480806|NCT03364309|524613217|FG011|Maintenance Period|Lack of Efficacy|0|||
145480807|NCT03364309|524613218|FG012|Maintenance Period|Lack of Efficacy|0|||
145480808|NCT03364309|524613219|FG013|Maintenance Period|Lack of Efficacy|0|||
145480809|NCT03364309|524613220|FG014|Maintenance Period|Lack of Efficacy|0|||
145480810|NCT03364309|524613221|FG015|Maintenance Period|Lack of Efficacy|0|||
145480811|NCT03364309|524613222|FG016|Maintenance Period|Lack of Efficacy|0|||
145480812|NCT03364309|524613223|FG017|Maintenance Period|Lack of Efficacy|0|||
145634366|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634367|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634368|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634369|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634370|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
145634371|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
145634372|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634373|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
145634374|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634375|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634376|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634377|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634378|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634379|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634380|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
145634381|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634382|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634383|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
145634384|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634385|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634386|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634387|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634388|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
145634389|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
145634390|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634391|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
145634392|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634393|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634394|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634395|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634396|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634397|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
145634398|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
145634399|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
145634400|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
145634401|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
145634402|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
145634403|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
145634404|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
145480813|NCT03364309|524613224|FG018|Maintenance Period|Lack of Efficacy|0|||
145480814|NCT03364309|524613206|FG000|Maintenance Period|Death|0|||
145634405|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
145634406|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
145634407|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
145634408|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
145480815|NCT03364309|524613207|FG001|Maintenance Period|Death|0|||
145480816|NCT03364309|524613208|FG002|Maintenance Period|Death|0|||
145634409|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
145634410|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
145634411|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
145634412|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
145634413|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
145634414|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
145634415|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
145634416|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
145634417|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145634418|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
145634419|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
145634420|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145634421|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145634422|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145634423|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
145634424|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
145634425|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
145634426|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
145634427|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
145634428|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
145634429|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
145634430|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
145634431|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
145634432|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
145634433|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
145634434|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
145634435|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634436|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634437|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634438|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634439|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634440|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634441|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634442|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
145634443|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
145634444|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145634445|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
145634446|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
145634447|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145634448|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145634449|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145634450|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
145634451|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
145634452|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
145634453|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634454|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
145634455|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
145634456|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634457|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634458|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634459|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634460|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
145634461|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
145634462|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
145634463|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
145634464|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
145634465|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
145634466|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
145480817|NCT03364309|524613209|FG003|Maintenance Period|Death|0|||
145480818|NCT03364309|524613210|FG004|Maintenance Period|Death|0|||
145634467|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
145634468|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
145634469|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
145634470|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
145634471|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634472|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
145634473|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145480819|NCT03364309|524613211|FG005|Maintenance Period|Death|0|||
145480820|NCT03364309|524613212|FG006|Maintenance Period|Death|0|||
145480821|NCT03364309|524613213|FG007|Maintenance Period|Death|0|||
145634474|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634475|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634476|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634477|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634478|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634479|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
145634480|NCT01212757|525174925|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634481|NCT01212757|525174926|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
145634482|NCT01212757|525174927|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
145634483|NCT01212757|525174928|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634484|NCT01212757|525174929|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634485|NCT01212757|525174930|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634486|NCT01212757|525174931|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634487|NCT01212757|525174932|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634488|NCT01212757|525174933|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
145634489|NCT00573833|525174934|FG000|Overall Study|Not Treated|2|||
145634490|NCT04493242|525174935|FG000|Overall Study|Death|10|||
145634491|NCT04493242|525174936|FG001|Overall Study|Death|14|||
145634492|NCT04493242|525174937|FG002|Overall Study|Death|16|||
145634493|NCT04493242|525174935|FG000|Overall Study|Lost to Follow-up|1|||
145634494|NCT04493242|525174936|FG001|Overall Study|Lost to Follow-up|1|||
145634495|NCT04493242|525174937|FG002|Overall Study|Lost to Follow-up|0|||
145634496|NCT04493242|525174935|FG000|Overall Study|Withdrawal by Subject|1|||
145634497|NCT04493242|525174936|FG001|Overall Study|Withdrawal by Subject|0|||
145634498|NCT04493242|525174937|FG002|Overall Study|Withdrawal by Subject|0|||
145634499|NCT04493242|525174935|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
145634500|NCT04493242|525174936|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
145634501|NCT04493242|525174937|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
145634502|NCT04493242|525174935|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
145634503|NCT04493242|525174936|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
145634504|NCT04493242|525174937|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
145634505|NCT00849147|525174938|FG000|Overall Study|Withdrawal by Subject|1|||
145634506|NCT00849147|525174938|FG000|Overall Study|Protocol Violation|2|||
145634507|NCT00849147|525174938|FG000|Overall Study|Disease Relapse/Progression|2|||
145634508|NCT01049503|525177843|FG000|Overall Study|Lost to Follow-up|11|||
145634509|NCT01049503|525177844|FG001|Overall Study|Lost to Follow-up|12|||
145634510|NCT01049503|525177845|FG002|Overall Study|Lost to Follow-up|24|||
145634511|NCT01049503|525177846|FG003|Overall Study|Lost to Follow-up|26|||
145634512|NCT01049503|525177847|FG004|Overall Study|Lost to Follow-up|27|||
145634513|NCT01049503|525177848|FG005|Overall Study|Lost to Follow-up|8|||
145634514|NCT02974634|525177849|FG000|Overall Study|Advanced disease|12|||
145634515|NCT02974634|525177850|FG001|Overall Study|Advanced disease|3|||
145634516|NCT02974634|525177849|FG000|Overall Study|Noncompliance|3|||
145634517|NCT02974634|525177850|FG001|Overall Study|Noncompliance|7|||
145634518|NCT02974634|525177849|FG000|Overall Study|intervention technology related issues|5|||
145634519|NCT02974634|525177850|FG001|Overall Study|intervention technology related issues|0|||
145634520|NCT02974634|525177849|FG000|Overall Study|Death|8|||
145634521|NCT02974634|525177850|FG001|Overall Study|Death|11|||
145634522|NCT02496702|525177853|FG000|Overall Study|Lost to Follow-up|8|||
145634523|NCT02496702|525177854|FG001|Overall Study|Lost to Follow-up|6|||
145634524|NCT02496702|525177853|FG000|Overall Study|Only partially tested|0|||
145634525|NCT02496702|525177854|FG001|Overall Study|Only partially tested|2|||
145634526|NCT01499134|525177855|FG000|Overall Study|Withdrawal by Subject|0|||
145634527|NCT01499134|525177856|FG001|Overall Study|Withdrawal by Subject|1|||
145634528|NCT01400776|525177857|FG000|Overall Study|Adverse Event|7|||
145634529|NCT01400776|525177858|FG001|Overall Study|Adverse Event|2|||
145634530|NCT01400776|525177859|FG002|Overall Study|Adverse Event|9|||
145634531|NCT01400776|525177860|FG003|Overall Study|Adverse Event|2|||
145634532|NCT01400776|525177857|FG000|Overall Study|Lost to Follow-up|1|||
145634533|NCT01400776|525177858|FG001|Overall Study|Lost to Follow-up|0|||
145634534|NCT01400776|525177859|FG002|Overall Study|Lost to Follow-up|4|||
145634535|NCT01400776|525177860|FG003|Overall Study|Lost to Follow-up|1|||
145634536|NCT01400776|525177857|FG000|Overall Study|Withdrew Consent|4|||
145634537|NCT01400776|525177858|FG001|Overall Study|Withdrew Consent|2|||
145634538|NCT01400776|525177859|FG002|Overall Study|Withdrew Consent|6|||
145634539|NCT01400776|525177860|FG003|Overall Study|Withdrew Consent|1|||
145634540|NCT01400776|525177857|FG000|Overall Study|Protocol Deviation|6|||
145634541|NCT01400776|525177858|FG001|Overall Study|Protocol Deviation|1|||
145634542|NCT01400776|525177859|FG002|Overall Study|Protocol Deviation|5|||
145634543|NCT01400776|525177860|FG003|Overall Study|Protocol Deviation|2|||
145634544|NCT01400776|525177857|FG000|Overall Study|Reason not Specified|3|||
145634545|NCT01400776|525177858|FG001|Overall Study|Reason not Specified|0|||
145634546|NCT01400776|525177859|FG002|Overall Study|Reason not Specified|4|||
145634547|NCT01400776|525177860|FG003|Overall Study|Reason not Specified|3|||
145634548|NCT00391846|525177861|FG000|Overall Study|Adverse Event|4|||
145634549|NCT00391846|525177862|FG001|Overall Study|Adverse Event|1|||
145634550|NCT00391846|525177861|FG000|Overall Study|Did not meet the required elig. crit|2|||
145634551|NCT00391846|525177862|FG001|Overall Study|Did not meet the required elig. crit|2|||
145634552|NCT00391846|525177861|FG000|Overall Study|Withdrawal by Subject|2|||
145634553|NCT00391846|525177862|FG001|Overall Study|Withdrawal by Subject|3|||
145634554|NCT00391846|525177861|FG000|Overall Study|Developed study specific DC criteria|0|||
145634555|NCT00391846|525177862|FG001|Overall Study|Developed study specific DC criteria|1|||
145634556|NCT04035668|525177864|FG000|Overall Study|Adverse Event|3|||
145634557|NCT04035668|525177865|FG001|Overall Study|Adverse Event|4|||
145634558|NCT04035668|525177866|FG002|Overall Study|Adverse Event|2|||
145634559|NCT04035668|525177864|FG000|Overall Study|Lost to Follow-up|0|||
145634560|NCT04035668|525177865|FG001|Overall Study|Lost to Follow-up|1|||
145634561|NCT04035668|525177866|FG002|Overall Study|Lost to Follow-up|0|||
145634562|NCT04035668|525177864|FG000|Overall Study|Physician Decision|2|||
145634563|NCT04035668|525177865|FG001|Overall Study|Physician Decision|1|||
145634564|NCT04035668|525177866|FG002|Overall Study|Physician Decision|1|||
145634565|NCT04035668|525177864|FG000|Overall Study|Subject Decision|2|||
145634566|NCT04035668|525177865|FG001|Overall Study|Subject Decision|2|||
145634567|NCT04035668|525177866|FG002|Overall Study|Subject Decision|0|||
145634568|NCT01376089|525177867|FG000|Overall Study|Patient received no contrast media|3|||
145634569|NCT01376089|525177868|FG001|Overall Study|Patient received no contrast media|4|||
145634570|NCT00419094|525177871|FG000|Overall Study|Adverse Event|3|||
145634571|NCT00419094|525177872|FG001|Overall Study|Adverse Event|7|||
145634572|NCT00419094|525177871|FG000|Overall Study|Lack of Efficacy|1|||
145634573|NCT00419094|525177872|FG001|Overall Study|Lack of Efficacy|0|||
145634574|NCT00419094|525177871|FG000|Overall Study|Lost to Follow-up|0|||
145634575|NCT00419094|525177872|FG001|Overall Study|Lost to Follow-up|2|||
145634576|NCT00419094|525177871|FG000|Overall Study|Protocol Violation|1|||
145634577|NCT00419094|525177872|FG001|Overall Study|Protocol Violation|14|||
145634578|NCT00419094|525177871|FG000|Overall Study|Withdrawal of consent|1|||
145634579|NCT00419094|525177872|FG001|Overall Study|Withdrawal of consent|5|||
145634580|NCT00419094|525177871|FG000|Overall Study|Other: Error determining exit criteria|1|||
145634581|NCT00419094|525177872|FG001|Overall Study|Other: Error determining exit criteria|0|||
145634582|NCT00419094|525177871|FG000|Overall Study|Other: Patient non-compliant|0|||
145634583|NCT00419094|525177872|FG001|Overall Study|Other: Patient non-compliant|1|||
145634584|NCT00419094|525177871|FG000|Overall Study|Other: No contact for extended period|0|||
145634585|NCT00419094|525177872|FG001|Overall Study|Other: No contact for extended period|1|||
145634586|NCT01811706|525177873|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
145634587|NCT01811706|525177874|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
145634588|NCT03020745|525177875|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634589|NCT03020745|525177876|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634590|NCT03020745|525177877|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634591|NCT03020745|525177878|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634592|NCT03020745|525177879|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634593|NCT03020745|525177880|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634594|NCT03020745|525177881|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634595|NCT03020745|525177882|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634596|NCT03020745|525177883|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
145634597|NCT03020745|525177884|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
145634598|NCT03020745|525177875|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634599|NCT03020745|525177876|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634600|NCT03020745|525177877|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634601|NCT03020745|525177878|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634602|NCT03020745|525177879|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634603|NCT03020745|525177880|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634604|NCT03020745|525177881|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634605|NCT03020745|525177882|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
145634606|NCT03020745|525177883|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634607|NCT03020745|525177884|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
145634608|NCT03020745|525177875|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634609|NCT03020745|525177876|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634610|NCT03020745|525177877|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634611|NCT03020745|525177878|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634612|NCT03020745|525177879|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634613|NCT03020745|525177880|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
145634614|NCT03020745|525177881|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634615|NCT03020745|525177882|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634616|NCT03020745|525177883|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
145634617|NCT03020745|525177884|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
145634618|NCT03020745|525177875|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634619|NCT03020745|525177876|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634620|NCT03020745|525177877|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634621|NCT03020745|525177878|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634622|NCT03020745|525177879|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634623|NCT03020745|525177880|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634624|NCT03020745|525177881|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634625|NCT03020745|525177882|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634626|NCT03020745|525177883|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
145634627|NCT03020745|525177884|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
145634628|NCT02057692|525177889|FG000|Overall Study|Adverse Event|1|||
145634629|NCT02057692|525177890|FG001|Overall Study|Adverse Event|0|||
145634630|NCT02057692|525177891|FG002|Overall Study|Adverse Event|0|||
145634631|NCT02057692|525177892|FG003|Overall Study|Adverse Event|0|||
145634632|NCT02057692|525177889|FG000|Overall Study|Lost to Follow-up|0|||
145634633|NCT02057692|525177890|FG001|Overall Study|Lost to Follow-up|0|||
145634634|NCT02057692|525177891|FG002|Overall Study|Lost to Follow-up|0|||
145634635|NCT02057692|525177892|FG003|Overall Study|Lost to Follow-up|1|||
145634636|NCT03923491|525177893|FG000|Overall Study|Lost to Follow-up|5|||
145634637|NCT03923491|525177894|FG001|Overall Study|Lost to Follow-up|8|||
145634638|NCT03923491|525177893|FG000|Overall Study|Withdrawal by Subject|4|||
145634639|NCT03923491|525177894|FG001|Overall Study|Withdrawal by Subject|6|||
145634640|NCT03823300|525177901|FG000|Overall Study|Withdrawal by Subject|16|||
145634641|NCT03823300|525177902|FG001|Overall Study|Withdrawal by Subject|22|||
145634642|NCT03823300|525177901|FG000|Overall Study|Death|10|||
145634643|NCT03823300|525177902|FG001|Overall Study|Death|14|||
145634644|NCT03823300|525177901|FG000|Overall Study|Adverse Event|3|||
145634645|NCT03823300|525177902|FG001|Overall Study|Adverse Event|5|||
145634646|NCT03823300|525177901|FG000|Overall Study|Physician Decision|1|||
145634647|NCT03823300|525177902|FG001|Overall Study|Physician Decision|7|||
145634648|NCT03823300|525177901|FG000|Overall Study|Lost to Follow-up|1|||
145634649|NCT03823300|525177902|FG001|Overall Study|Lost to Follow-up|3|||
145634650|NCT03823300|525177901|FG000|Overall Study|Protocol Violation|1|||
145634651|NCT03823300|525177902|FG001|Overall Study|Protocol Violation|1|||
145634652|NCT03823300|525177901|FG000|Overall Study|Lack of Efficacy|1|||
145634653|NCT03823300|525177902|FG001|Overall Study|Lack of Efficacy|1|||
145634654|NCT03823300|525177901|FG000|Overall Study|Not Eligible|0|||
145634655|NCT03823300|525177902|FG001|Overall Study|Not Eligible|1|||
145634656|NCT03823300|525177901|FG000|Overall Study|Other|1|||
145634657|NCT03823300|525177902|FG001|Overall Study|Other|0|||
145634658|NCT00943735|525177903|FG000|Overall Study|Adverse Event|12|||
145634659|NCT00943735|525177903|FG000|Overall Study|Withdrawal by Subject|8|||
145634660|NCT00943735|525177903|FG000|Overall Study|Death|1|||
145634661|NCT00943735|525177903|FG000|Overall Study|Other|8|||
145634662|NCT00943735|525177903|FG000|Overall Study|Other|3|||
145634663|NCT00486330|525177904|FG000|Overall Study|Adverse Event|2|||
145634664|NCT01924767|525177905|FG000|Overall Study|Adverse Event|1|||
145634665|NCT01924767|525177906|FG001|Overall Study|Adverse Event|0|||
145634666|NCT01924767|525177907|FG002|Overall Study|Adverse Event|1|||
145634667|NCT01924767|525177908|FG003|Overall Study|Adverse Event|0|||
145634668|NCT01924767|525177909|FG004|Overall Study|Adverse Event|0|||
145634669|NCT01193153|525177910|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
145634670|NCT01193153|525177911|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
145634671|NCT01193153|525177910|FG000|Open-label Lead in Period|Pregnancy|1|||
145634672|NCT01193153|525177911|FG001|Open-label Lead in Period|Pregnancy|0|||
145634673|NCT01193153|525177910|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
145634674|NCT01193153|525177911|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
145634675|NCT01193153|525177910|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
145634676|NCT01193153|525177911|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
145634677|NCT01193153|525177910|FG000|Open-label Lead in Period|Other|14|||
145634678|NCT01193153|525177911|FG001|Open-label Lead in Period|Other|0|||
145634679|NCT01193153|525177910|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
145634680|NCT01193153|525177911|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
145634681|NCT01193153|525177910|FG000|Open-label Lead in Period|Adverse Event|41|||
145634682|NCT01193153|525177911|FG001|Open-label Lead in Period|Adverse Event|0|||
145634683|NCT01193153|525177910|FG000|Open-label Lead in Period|Death|1|||
145634684|NCT01193153|525177911|FG001|Open-label Lead in Period|Death|0|||
145634685|NCT01193153|525177910|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
145634686|NCT01193153|525177911|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
145634687|NCT01193153|525177910|FG000|Open-label Stabilization Period|Adverse Event|9|||
145634688|NCT01193153|525177911|FG001|Open-label Stabilization Period|Adverse Event|0|||
145634689|NCT01193153|525177910|FG000|Open-label Stabilization Period|Death|2|||
145634690|NCT01193153|525177911|FG001|Open-label Stabilization Period|Death|0|||
145634691|NCT01193153|525177910|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
145634692|NCT01193153|525177911|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
145634693|NCT01193153|525177910|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
145634694|NCT01193153|525177911|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
145634695|NCT01193153|525177910|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
145602648|NCT05292534|525060104|FG000|Overall Study|Protocol Violation|3|||
145602649|NCT05292534|525060105|FG001|Overall Study|Protocol Violation|4|||
145602650|NCT05292534|525060104|FG000|Overall Study|Withdrawal by Subject|0|||
145602651|NCT05292534|525060105|FG001|Overall Study|Withdrawal by Subject|1|||
145602652|NCT01538472|525060106|FG000|Overall Study|Disease Progression|3|||
145602653|NCT01538472|525060106|FG000|Overall Study|Death|1|||
145602654|NCT00948974|525060107|FG000|Overall Study|Lost to Follow-up|23|||
145602655|NCT00948974|525060108|FG001|Overall Study|Lost to Follow-up|20|||
145602656|NCT00238433|525060110|FG000|Overall Study|Screen failure|1|||
145602657|NCT00238433|525060110|FG000|Overall Study|Lost to Follow-up|1|||
145602658|NCT00238433|525060110|FG000|Overall Study|Death|1|||
145602659|NCT01591382|525060111|FG000|Overall Study|Discharged Prior to Study Completion|2|||
145602660|NCT01591382|525060112|FG001|Overall Study|Discharged Prior to Study Completion|1|||
145602661|NCT01591382|525060111|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
145602662|NCT01591382|525060112|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
145602663|NCT00409682|525060113|FG000|Open-label Induction Period|Adverse Event|1|||
145602664|NCT00409682|525060114|FG001|Open-label Induction Period|Adverse Event|0|||
145602665|NCT00409682|525060115|FG002|Open-label Induction Period|Adverse Event|0|||
145602666|NCT00409682|525060113|FG000|Open-label Induction Period|Lack of Efficacy|1|||
145602667|NCT00409682|525060114|FG001|Open-label Induction Period|Lack of Efficacy|0|||
145602668|NCT00409682|525060115|FG002|Open-label Induction Period|Lack of Efficacy|0|||
145602669|NCT00409682|525060113|FG000|Open-label Induction Period|Protocol Violation|1|||
145602670|NCT00409682|525060114|FG001|Open-label Induction Period|Protocol Violation|0|||
145602671|NCT00409682|525060115|FG002|Open-label Induction Period|Protocol Violation|0|||
145602672|NCT00409682|525060113|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
145602673|NCT00409682|525060114|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
145602674|NCT00409682|525060115|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
145602675|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
145602676|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
145602677|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
145602678|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
145602679|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
145602680|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
145602681|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
145602682|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
145602683|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
145602684|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
145602685|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
145602686|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
145602687|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
145602688|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
145602689|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
145602690|NCT00409682|525060113|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
145602691|NCT00409682|525060114|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
145602692|NCT00409682|525060115|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
145602693|NCT04710927|525060119|FG000|Overall Study|Lost to Follow-up|7|||
145602694|NCT04710927|525060120|FG001|Overall Study|Lost to Follow-up|6|||
145602695|NCT04710927|525060121|FG002|Overall Study|Lost to Follow-up|5|||
145602696|NCT00454571|525060125|FG000|Overall Study|Adverse Event|2|||
145602697|NCT00454571|525060126|FG001|Overall Study|Adverse Event|0|||
145602698|NCT00454571|525060125|FG000|Overall Study|Physician Decision|0|||
145602699|NCT00454571|525060126|FG001|Overall Study|Physician Decision|1|||
145602700|NCT00454571|525060125|FG000|Overall Study|Protocol Violation|1|||
145602701|NCT00454571|525060126|FG001|Overall Study|Protocol Violation|0|||
145602702|NCT00454571|525060125|FG000|Overall Study|Withdrawal by Subject|10|||
145602703|NCT00454571|525060126|FG001|Overall Study|Withdrawal by Subject|5|||
145602704|NCT04681729|525060127|FG000|Overall Study|Lack of Efficacy|2|||
145602705|NCT04681729|525060128|FG001|Overall Study|Lack of Efficacy|2|||
145602706|NCT04681729|525060127|FG000|Overall Study|Withdrawal by Subject|8|||
145602707|NCT04681729|525060128|FG001|Overall Study|Withdrawal by Subject|9|||
145602708|NCT02227875|525060129|FG000|Overall Study|Protocol Violation|10|||
145602709|NCT02227875|525060130|FG001|Overall Study|Protocol Violation|7|||
145602710|NCT02227875|525060129|FG000|Overall Study|Other|1|||
145602711|NCT02227875|525060130|FG001|Overall Study|Other|3|||
145602712|NCT02227875|525060129|FG000|Overall Study|Physician Decision|1|||
145602713|NCT02227875|525060130|FG001|Overall Study|Physician Decision|0|||
145602714|NCT02227875|525060129|FG000|Overall Study|Adverse Event|3|||
145602715|NCT02227875|525060130|FG001|Overall Study|Adverse Event|0|||
145602716|NCT02227875|525060129|FG000|Overall Study|Withdrawal by Subject|12|||
145602717|NCT02227875|525060130|FG001|Overall Study|Withdrawal by Subject|13|||
145602718|NCT02227875|525060129|FG000|Overall Study|Lost to Follow-up|10|||
145602719|NCT02227875|525060130|FG001|Overall Study|Lost to Follow-up|10|||
145602720|NCT02856113|525060133|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
145602721|NCT02856113|525060134|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
145602722|NCT02856113|525060133|FG000|Overall Study|Significant Protocol Deviation|1|||
145602723|NCT02856113|525060134|FG001|Overall Study|Significant Protocol Deviation|0|||
145602724|NCT02856113|525060133|FG000|Overall Study|Lost to Follow-up|3|||
145602725|NCT02856113|525060134|FG001|Overall Study|Lost to Follow-up|5|||
145602726|NCT02856113|525060133|FG000|Overall Study|Voluntary Withdrawal|3|||
145602727|NCT02856113|525060134|FG001|Overall Study|Voluntary Withdrawal|5|||
145602728|NCT02856113|525060133|FG000|Overall Study|Pregnancy|0|||
145602729|NCT02856113|525060134|FG001|Overall Study|Pregnancy|1|||
145602730|NCT02856113|525060133|FG000|Overall Study|Principal Investigator Discretion|2|||
145602731|NCT02856113|525060134|FG001|Overall Study|Principal Investigator Discretion|1|||
145602732|NCT02856113|525060133|FG000|Overall Study|Randomized but not Treated|1|||
145602733|NCT02856113|525060134|FG001|Overall Study|Randomized but not Treated|0|||
145602734|NCT02856113|525060133|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
145602735|NCT02856113|525060134|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
145602736|NCT01960725|525060135|FG000|Overall Study|Lost to Follow-up|4|||
145602737|NCT01960725|525060136|FG001|Overall Study|Lost to Follow-up|3|||
145602738|NCT01960725|525060135|FG000|Overall Study|Withdrawal by Subject|1|||
145602739|NCT01960725|525060136|FG001|Overall Study|Withdrawal by Subject|0|||
145602740|NCT01960725|525060135|FG000|Overall Study|unable to obtain blood sample|1|||
145602741|NCT01960725|525060136|FG001|Overall Study|unable to obtain blood sample|2|||
145602742|NCT02110901|525060137|FG000|Overall Study|Death|6|||
145602743|NCT02110901|525060138|FG001|Overall Study|Death|3|||
145602744|NCT02110901|525060137|FG000|Overall Study|Lost to Follow-up|12|||
145602745|NCT02110901|525060138|FG001|Overall Study|Lost to Follow-up|8|||
145602746|NCT02110901|525060137|FG000|Overall Study|Withdrawal by Subject|7|||
145602747|NCT02110901|525060138|FG001|Overall Study|Withdrawal by Subject|3|||
145602748|NCT02110901|525060137|FG000|Overall Study|received a kidney transplant|5|||
145602749|NCT02110901|525060138|FG001|Overall Study|received a kidney transplant|0|||
145602750|NCT01058304|525060141|FG000|Overall Study|Withdrawal by Subject|8|||
145602751|NCT01058304|525060142|FG001|Overall Study|Withdrawal by Subject|5|||
145602752|NCT01058304|525060141|FG000|Overall Study|Lost to Follow-up|13|||
145602753|NCT01058304|525060142|FG001|Overall Study|Lost to Follow-up|16|||
145602754|NCT01058304|525060141|FG000|Overall Study|Developed exclusion criterion|6|||
145602755|NCT01058304|525060142|FG001|Overall Study|Developed exclusion criterion|12|||
145602756|NCT02496767|525060143|FG000|Open-label Lead-in Phase|Adverse Event|176|||
145602757|NCT02496767|525060144|FG001|Open-label Lead-in Phase|Adverse Event|0|||
145602758|NCT02496767|525060145|FG002|Open-label Lead-in Phase|Adverse Event|0|||
145602759|NCT02496767|525060146|FG003|Open-label Lead-in Phase|Adverse Event|0|||
145602760|NCT02496767|525060147|FG004|Open-label Lead-in Phase|Adverse Event|0|||
145602761|NCT02496767|525060148|FG005|Open-label Lead-in Phase|Adverse Event|0|||
145602762|NCT02496767|525060149|FG006|Open-label Lead-in Phase|Adverse Event|0|||
145602763|NCT02496767|525060150|FG007|Open-label Lead-in Phase|Adverse Event|0|||
145602764|NCT02496767|525060143|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
145602765|NCT02496767|525060144|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
145602766|NCT02496767|525060145|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
145602767|NCT02496767|525060146|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
145602768|NCT02496767|525060147|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
145602769|NCT02496767|525060148|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
145602770|NCT02496767|525060149|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
145602771|NCT02496767|525060150|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
145602772|NCT02496767|525060143|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
145602773|NCT02496767|525060144|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602774|NCT02496767|525060145|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602775|NCT02496767|525060146|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602776|NCT02496767|525060147|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602777|NCT02496767|525060148|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602778|NCT02496767|525060149|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602779|NCT02496767|525060150|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
145602780|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
145602781|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
145602782|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
145602783|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
145602784|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
145602785|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
145602786|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
145602787|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
145634696|NCT01193153|525177911|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
145602788|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
145602789|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
145602790|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
145602791|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
145634697|NCT01193153|525177910|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
145634698|NCT01193153|525177911|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
145634699|NCT01193153|525177910|FG000|Open-label Stabilization Period|Other|8|||
145634700|NCT01193153|525177911|FG001|Open-label Stabilization Period|Other|0|||
145634701|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Other|2|||
145634702|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Other|3|||
145634703|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
145634704|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
145634705|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Death|2|||
145634706|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Death|0|||
145634707|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
145634708|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
145634709|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
145634710|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
145634711|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
145634712|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
145634713|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
145634714|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
145634715|NCT01193153|525177910|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
145634716|NCT01193153|525177911|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
145634717|NCT01648140|525177912|FG000|Overall Study|Physician Decision|1|||
145634718|NCT01648140|525177913|FG001|Overall Study|Physician Decision|0|||
145634719|NCT01648140|525177914|FG002|Overall Study|Physician Decision|0|||
145634720|NCT01648140|525177915|FG003|Overall Study|Physician Decision|0|||
145634721|NCT01648140|525177912|FG000|Overall Study|Lack of Efficacy|4|||
145634722|NCT01648140|525177913|FG001|Overall Study|Lack of Efficacy|7|||
145634723|NCT01648140|525177914|FG002|Overall Study|Lack of Efficacy|1|||
145634724|NCT01648140|525177915|FG003|Overall Study|Lack of Efficacy|0|||
145634725|NCT01648140|525177912|FG000|Overall Study|Adverse Event|3|||
145634726|NCT01648140|525177913|FG001|Overall Study|Adverse Event|1|||
145634727|NCT01648140|525177914|FG002|Overall Study|Adverse Event|2|||
145634728|NCT01648140|525177915|FG003|Overall Study|Adverse Event|0|||
145634729|NCT01648140|525177912|FG000|Overall Study|Withdrawal by Subject|2|||
145634730|NCT01648140|525177913|FG001|Overall Study|Withdrawal by Subject|3|||
145634731|NCT01648140|525177914|FG002|Overall Study|Withdrawal by Subject|3|||
145634732|NCT01648140|525177915|FG003|Overall Study|Withdrawal by Subject|2|||
145634733|NCT01648140|525177912|FG000|Overall Study|Lost to Follow-up|2|||
145634734|NCT01648140|525177913|FG001|Overall Study|Lost to Follow-up|1|||
145634735|NCT01648140|525177914|FG002|Overall Study|Lost to Follow-up|2|||
145634736|NCT01648140|525177915|FG003|Overall Study|Lost to Follow-up|0|||
145634737|NCT03781336|525177920|FG000|Overall Study|Withdrawal by Subject|2|||
145634738|NCT03781336|525177921|FG001|Overall Study|Withdrawal by Subject|2|||
145634739|NCT02534350|525177924|FG000|Overall Study|Randomized But Not Treated|1|||
145634740|NCT02534350|525177925|FG001|Overall Study|Randomized But Not Treated|0|||
145634741|NCT02534350|525177924|FG000|Overall Study|Protocol Violation|1|||
145634742|NCT02534350|525177925|FG001|Overall Study|Protocol Violation|0|||
145634743|NCT02534350|525177924|FG000|Overall Study|Withdrew Consent|2|||
145634744|NCT02534350|525177925|FG001|Overall Study|Withdrew Consent|0|||
145634745|NCT00790790|525177938|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
145634746|NCT00790790|525177939|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
145634747|NCT00790790|525177940|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
145634748|NCT00790790|525177938|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
145634749|NCT00790790|525177939|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
145634750|NCT00790790|525177940|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
145634751|NCT00790790|525177938|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
145634752|NCT00790790|525177939|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
145634753|NCT00790790|525177940|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
145634754|NCT00790790|525177938|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
145634755|NCT00790790|525177939|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
145634756|NCT00790790|525177940|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
145634757|NCT00790790|525177938|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
145480822|NCT03364309|524613214|FG008|Maintenance Period|Death|1|||
145480823|NCT03364309|524613215|FG009|Maintenance Period|Death|0|||
145480824|NCT03364309|524613216|FG010|Maintenance Period|Death|0|||
145480825|NCT03364309|524613217|FG011|Maintenance Period|Death|0|||
145480826|NCT03364309|524613218|FG012|Maintenance Period|Death|0|||
145634758|NCT00790790|525177939|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
145634759|NCT00790790|525177940|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
145634760|NCT02808338|525177941|FG000|Screening|Screen Failure|10|||
145634761|NCT02808338|525177941|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
145634762|NCT02808338|525177941|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
145634763|NCT02194933|525177942|FG000|Overall Study|Lost to Follow-up|1|||
145480827|NCT03364309|524613219|FG013|Maintenance Period|Death|0|||
145634764|NCT02194933|525177943|FG001|Overall Study|Lost to Follow-up|2|||
145634765|NCT02194933|525177942|FG000|Overall Study|Participant met withdrawal criteria|1|||
145634766|NCT02194933|525177943|FG001|Overall Study|Participant met withdrawal criteria|3|||
145634767|NCT02194933|525177942|FG000|Overall Study|Withdrawal by Subject|0|||
145634768|NCT02194933|525177943|FG001|Overall Study|Withdrawal by Subject|2|||
145634769|NCT02194933|525177942|FG000|Overall Study|Lack of Efficacy|1|||
145634770|NCT02194933|525177943|FG001|Overall Study|Lack of Efficacy|2|||
145634771|NCT02000817|525177946|FG000|Overall Study|Withdrawal by Subject|2|||
145634772|NCT02000817|525177947|FG001|Overall Study|Withdrawal by Subject|0|||
145634773|NCT02000817|525177948|FG002|Overall Study|Withdrawal by Subject|0|||
145634774|NCT02000817|525177949|FG003|Overall Study|Withdrawal by Subject|0|||
145634775|NCT02000817|525177946|FG000|Overall Study|Adverse Event|0|||
145634776|NCT02000817|525177947|FG001|Overall Study|Adverse Event|1|||
145634777|NCT02000817|525177948|FG002|Overall Study|Adverse Event|0|||
145634778|NCT02000817|525177949|FG003|Overall Study|Adverse Event|0|||
145634779|NCT02000817|525177946|FG000|Overall Study|Lost to Follow-up|0|||
145634780|NCT02000817|525177947|FG001|Overall Study|Lost to Follow-up|0|||
145634781|NCT02000817|525177948|FG002|Overall Study|Lost to Follow-up|1|||
145634782|NCT02000817|525177949|FG003|Overall Study|Lost to Follow-up|0|||
145634783|NCT00756730|525177950|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
145634784|NCT00756730|525177951|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
145634785|NCT00756730|525177950|FG000|Overall Study|persistent low-level viremmia|0|||
145634786|NCT00756730|525177951|FG001|Overall Study|persistent low-level viremmia|1|||
145634787|NCT03383146|525177955|FG000|Overall Study|Screen Failure|1|||
145634788|NCT03383146|525177956|FG001|Overall Study|Screen Failure|0|||
145634789|NCT03383146|525177955|FG000|Overall Study|Adverse Event|6|||
145634790|NCT03383146|525177956|FG001|Overall Study|Adverse Event|18|||
145634791|NCT03383146|525177955|FG000|Overall Study|Lack of Efficacy|0|||
145634792|NCT03383146|525177956|FG001|Overall Study|Lack of Efficacy|3|||
145634793|NCT03383146|525177955|FG000|Overall Study|Withdrawal by Subject|20|||
145634794|NCT03383146|525177956|FG001|Overall Study|Withdrawal by Subject|36|||
145634795|NCT03383146|525177955|FG000|Overall Study|Lost to Follow-up|5|||
145634796|NCT03383146|525177956|FG001|Overall Study|Lost to Follow-up|15|||
145634797|NCT03383146|525177955|FG000|Overall Study|Death|0|||
145634798|NCT03383146|525177956|FG001|Overall Study|Death|2|||
145634799|NCT03383146|525177955|FG000|Overall Study|Physician Decision|0|||
145634800|NCT03383146|525177956|FG001|Overall Study|Physician Decision|1|||
145634801|NCT03383146|525177955|FG000|Overall Study|Protocol Deviation|1|||
145634802|NCT03383146|525177956|FG001|Overall Study|Protocol Deviation|8|||
145634803|NCT03383146|525177955|FG000|Overall Study|Study Terminated by the Sponsor|48|||
145634804|NCT03383146|525177956|FG001|Overall Study|Study Terminated by the Sponsor|95|||
145634805|NCT03383146|525177955|FG000|Overall Study|Reason not Specified|4|||
145634806|NCT03383146|525177956|FG001|Overall Study|Reason not Specified|6|||
145634807|NCT00639002|525177957|FG000|Overall Study|Death|1|||
145634808|NCT00639002|525177957|FG000|Overall Study|Adverse Event|1|||
145634809|NCT00639002|525177957|FG000|Overall Study|Protocol Violation|1|||
145634810|NCT00639002|525177957|FG000|Overall Study|Disease progression|3|||
145634811|NCT00639002|525177957|FG000|Overall Study|Physician Decision|6|||
145634812|NCT00639002|525177957|FG000|Overall Study|Lack of Efficacy|1|||
145634813|NCT05382104|525177958|FG000|Period 2 (2 Days)|Adverse Event|0|||
145634814|NCT05382104|525177959|FG001|Period 2 (2 Days)|Adverse Event|1|||
145634815|NCT05382104|525177960|FG002|Period 2 (2 Days)|Adverse Event|0|||
145634816|NCT05382104|525177961|FG003|Period 2 (2 Days)|Adverse Event|0|||
145634817|NCT05382104|525177962|FG004|Period 2 (2 Days)|Adverse Event|0|||
145634818|NCT05382104|525177963|FG005|Period 2 (2 Days)|Adverse Event|0|||
145634819|NCT01317420|525177969|FG000|Overall Study|Progressive disease according to RECIST|2|||
145634820|NCT01317420|525177970|FG001|Overall Study|Progressive disease according to RECIST|3|||
145634821|NCT01317420|525177971|FG002|Overall Study|Progressive disease according to RECIST|3|||
145634822|NCT01317420|525177972|FG003|Overall Study|Progressive disease according to RECIST|3|||
145634823|NCT01317420|525177973|FG004|Overall Study|Progressive disease according to RECIST|3|||
145634824|NCT01317420|525177974|FG005|Overall Study|Progressive disease according to RECIST|3|||
145634825|NCT01317420|525177975|FG006|Overall Study|Progressive disease according to RECIST|3|||
145634826|NCT01317420|525177976|FG007|Overall Study|Progressive disease according to RECIST|3|||
145634827|NCT01317420|525177977|FG008|Overall Study|Progressive disease according to RECIST|3|||
145634828|NCT01317420|525177978|FG009|Overall Study|Progressive disease according to RECIST|2|||
145634829|NCT01317420|525177979|FG010|Overall Study|Progressive disease according to RECIST|3|||
145634830|NCT01317420|525177980|FG011|Overall Study|Progressive disease according to RECIST|11|||
145634831|NCT01317420|525177981|FG012|Overall Study|Progressive disease according to RECIST|16|||
145634832|NCT01317420|525177969|FG000|Overall Study|Other adverse event|1|||
145634833|NCT01317420|525177970|FG001|Overall Study|Other adverse event|0|||
145634834|NCT01317420|525177971|FG002|Overall Study|Other adverse event|0|||
145634835|NCT01317420|525177972|FG003|Overall Study|Other adverse event|0|||
145634836|NCT01317420|525177973|FG004|Overall Study|Other adverse event|0|||
145634837|NCT01317420|525177974|FG005|Overall Study|Other adverse event|0|||
145634838|NCT01317420|525177975|FG006|Overall Study|Other adverse event|0|||
145634839|NCT01317420|525177976|FG007|Overall Study|Other adverse event|0|||
145634840|NCT01317420|525177977|FG008|Overall Study|Other adverse event|0|||
145634841|NCT01317420|525177978|FG009|Overall Study|Other adverse event|0|||
145634842|NCT01317420|525177979|FG010|Overall Study|Other adverse event|0|||
145634843|NCT01317420|525177980|FG011|Overall Study|Other adverse event|0|||
145634844|NCT01317420|525177981|FG012|Overall Study|Other adverse event|2|||
145634845|NCT01317420|525177969|FG000|Overall Study|Non-compliant with protocol|0|||
145634846|NCT01317420|525177970|FG001|Overall Study|Non-compliant with protocol|0|||
145634847|NCT01317420|525177971|FG002|Overall Study|Non-compliant with protocol|0|||
145634848|NCT01317420|525177972|FG003|Overall Study|Non-compliant with protocol|0|||
145634849|NCT01317420|525177973|FG004|Overall Study|Non-compliant with protocol|0|||
145634850|NCT01317420|525177974|FG005|Overall Study|Non-compliant with protocol|0|||
145634851|NCT01317420|525177975|FG006|Overall Study|Non-compliant with protocol|0|||
145634852|NCT01317420|525177976|FG007|Overall Study|Non-compliant with protocol|0|||
145634853|NCT01317420|525177977|FG008|Overall Study|Non-compliant with protocol|0|||
145634854|NCT01317420|525177978|FG009|Overall Study|Non-compliant with protocol|0|||
145634855|NCT01317420|525177979|FG010|Overall Study|Non-compliant with protocol|0|||
145634856|NCT01317420|525177980|FG011|Overall Study|Non-compliant with protocol|0|||
145634857|NCT01317420|525177981|FG012|Overall Study|Non-compliant with protocol|1|||
145634858|NCT01317420|525177969|FG000|Overall Study|Refused to cont. taking trial medication|0|||
145634859|NCT01317420|525177970|FG001|Overall Study|Refused to cont. taking trial medication|0|||
145634860|NCT01317420|525177971|FG002|Overall Study|Refused to cont. taking trial medication|0|||
145634861|NCT01317420|525177972|FG003|Overall Study|Refused to cont. taking trial medication|0|||
145634862|NCT01317420|525177973|FG004|Overall Study|Refused to cont. taking trial medication|0|||
145634863|NCT01317420|525177974|FG005|Overall Study|Refused to cont. taking trial medication|0|||
145634864|NCT01317420|525177975|FG006|Overall Study|Refused to cont. taking trial medication|0|||
145634865|NCT01317420|525177976|FG007|Overall Study|Refused to cont. taking trial medication|0|||
145634866|NCT01317420|525177977|FG008|Overall Study|Refused to cont. taking trial medication|0|||
145634867|NCT01317420|525177978|FG009|Overall Study|Refused to cont. taking trial medication|0|||
145634868|NCT01317420|525177979|FG010|Overall Study|Refused to cont. taking trial medication|0|||
145634869|NCT01317420|525177980|FG011|Overall Study|Refused to cont. taking trial medication|0|||
145634870|NCT01317420|525177981|FG012|Overall Study|Refused to cont. taking trial medication|1|||
145480828|NCT03364309|524613220|FG014|Maintenance Period|Death|0|||
145480829|NCT03364309|524613221|FG015|Maintenance Period|Death|0|||
145480830|NCT03364309|524613222|FG016|Maintenance Period|Death|0|||
145480831|NCT03364309|524613223|FG017|Maintenance Period|Death|0|||
145480832|NCT03364309|524613224|FG018|Maintenance Period|Death|0|||
145480833|NCT03364309|524613206|FG000|Maintenance Period|Lost to Follow-up|0|||
145480834|NCT03364309|524613207|FG001|Maintenance Period|Lost to Follow-up|0|||
145480835|NCT03364309|524613208|FG002|Maintenance Period|Lost to Follow-up|0|||
145634871|NCT01317420|525177969|FG000|Overall Study|Reason other than those specified|0|||
145634872|NCT01317420|525177970|FG001|Overall Study|Reason other than those specified|0|||
145634873|NCT01317420|525177971|FG002|Overall Study|Reason other than those specified|0|||
145634874|NCT01317420|525177972|FG003|Overall Study|Reason other than those specified|0|||
145634875|NCT01317420|525177973|FG004|Overall Study|Reason other than those specified|0|||
145634876|NCT01317420|525177974|FG005|Overall Study|Reason other than those specified|0|||
145634877|NCT01317420|525177975|FG006|Overall Study|Reason other than those specified|0|||
145634878|NCT01317420|525177976|FG007|Overall Study|Reason other than those specified|0|||
145634879|NCT01317420|525177977|FG008|Overall Study|Reason other than those specified|0|||
145634880|NCT01317420|525177978|FG009|Overall Study|Reason other than those specified|1|||
145634881|NCT01317420|525177979|FG010|Overall Study|Reason other than those specified|0|||
145634882|NCT01317420|525177980|FG011|Overall Study|Reason other than those specified|0|||
145634883|NCT01317420|525177981|FG012|Overall Study|Reason other than those specified|0|||
145634884|NCT05686421|525177982|FG000|Overall Study|Screen failure|22|||
145634885|NCT05686421|525177983|FG001|Overall Study|Screen failure|0|||
145634886|NCT05686421|525177984|FG002|Overall Study|Screen failure|0|||
145634887|NCT05686421|525177985|FG003|Overall Study|Screen failure|0|||
145634888|NCT05082025|525177986|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
145480836|NCT03364309|524613209|FG003|Maintenance Period|Lost to Follow-up|0|||
145480837|NCT03364309|524613210|FG004|Maintenance Period|Lost to Follow-up|0|||
145480838|NCT03364309|524613211|FG005|Maintenance Period|Lost to Follow-up|0|||
145480839|NCT03364309|524613212|FG006|Maintenance Period|Lost to Follow-up|0|||
145480840|NCT03364309|524613213|FG007|Maintenance Period|Lost to Follow-up|0|||
145634889|NCT00857649|525177987|FG000|Overall Study|Adverse Event|15|||
145480841|NCT03364309|524613214|FG008|Maintenance Period|Lost to Follow-up|1|||
145634890|NCT00857649|525177988|FG001|Overall Study|Adverse Event|10|||
145634891|NCT00857649|525177987|FG000|Overall Study|Non-compliance|1|||
145634892|NCT00857649|525177988|FG001|Overall Study|Non-compliance|1|||
145634893|NCT00857649|525177987|FG000|Overall Study|Protocol Violation|2|||
145634894|NCT00857649|525177988|FG001|Overall Study|Protocol Violation|2|||
145634895|NCT00857649|525177987|FG000|Overall Study|Withdrawal of Consent|10|||
145634896|NCT00857649|525177988|FG001|Overall Study|Withdrawal of Consent|7|||
145480842|NCT03364309|524613215|FG009|Maintenance Period|Lost to Follow-up|0|||
145480843|NCT03364309|524613216|FG010|Maintenance Period|Lost to Follow-up|0|||
145480844|NCT03364309|524613217|FG011|Maintenance Period|Lost to Follow-up|0|||
145634897|NCT00857649|525177987|FG000|Overall Study|Nursing Home Placement|2|||
145634898|NCT00857649|525177988|FG001|Overall Study|Nursing Home Placement|9|||
145634899|NCT00857649|525177987|FG000|Overall Study|Other Reasons|1|||
145634900|NCT00857649|525177988|FG001|Overall Study|Other Reasons|3|||
145634901|NCT05190419|525177989|FG000|Overall Study|Lack of Efficacy|8|||
145634902|NCT05190419|525177990|FG001|Overall Study|Lack of Efficacy|0|||
145634903|NCT05190419|525177991|FG002|Overall Study|Lack of Efficacy|1|||
145634904|NCT05190419|525177992|FG003|Overall Study|Lack of Efficacy|0|||
145634905|NCT05190419|525177989|FG000|Overall Study|Withdrawal by Subject|7|||
145634906|NCT05190419|525177990|FG001|Overall Study|Withdrawal by Subject|1|||
145634907|NCT05190419|525177991|FG002|Overall Study|Withdrawal by Subject|2|||
145634908|NCT05190419|525177992|FG003|Overall Study|Withdrawal by Subject|2|||
145634909|NCT05190419|525177989|FG000|Overall Study|Adverse Event|2|||
145634910|NCT05190419|525177990|FG001|Overall Study|Adverse Event|10|||
145634911|NCT05190419|525177991|FG002|Overall Study|Adverse Event|11|||
145634912|NCT05190419|525177992|FG003|Overall Study|Adverse Event|21|||
145634913|NCT05190419|525177989|FG000|Overall Study|Lost to Follow-up|1|||
145634914|NCT05190419|525177990|FG001|Overall Study|Lost to Follow-up|2|||
145634915|NCT05190419|525177991|FG002|Overall Study|Lost to Follow-up|3|||
145634916|NCT05190419|525177992|FG003|Overall Study|Lost to Follow-up|1|||
145634917|NCT05190419|525177989|FG000|Overall Study|Other|1|||
145634918|NCT05190419|525177990|FG001|Overall Study|Other|1|||
145634919|NCT05190419|525177991|FG002|Overall Study|Other|0|||
145634920|NCT05190419|525177992|FG003|Overall Study|Other|3|||
145634921|NCT00367055|525177995|FG000|Overall Study|Adverse Event|6|||
145634922|NCT00367055|525177996|FG001|Overall Study|Adverse Event|3|||
145634923|NCT00367055|525177995|FG000|Overall Study|Patient's Willing|3|||
145634924|NCT00367055|525177996|FG001|Overall Study|Patient's Willing|2|||
145634925|NCT00367055|525177995|FG000|Overall Study|Lack of Efficacy|1|||
145634926|NCT00367055|525177996|FG001|Overall Study|Lack of Efficacy|2|||
145634927|NCT00367055|525177995|FG000|Overall Study|Lost to Follow-up|1|||
145634928|NCT00367055|525177996|FG001|Overall Study|Lost to Follow-up|1|||
145634929|NCT00367055|525177995|FG000|Overall Study|Protocol Violation|0|||
145634930|NCT00367055|525177996|FG001|Overall Study|Protocol Violation|1|||
145634931|NCT00367055|525177995|FG000|Overall Study|Stopping Criterion Met|0|||
145634932|NCT00367055|525177996|FG001|Overall Study|Stopping Criterion Met|1|||
145634933|NCT00367055|525177995|FG000|Overall Study|Participant Living too Far from Hospital|0|||
145634934|NCT00367055|525177996|FG001|Overall Study|Participant Living too Far from Hospital|1|||
145634935|NCT03210402|525177997|FG000|Overall Study|Withdrawal by Subject|0|||
145634936|NCT03210402|525177998|FG001|Overall Study|Withdrawal by Subject|1|||
145634937|NCT02517307|525178013|FG000|Overall Study|Withdrawal by Subject|1|||
145634938|NCT02517307|525178014|FG001|Overall Study|Withdrawal by Subject|0|||
145634939|NCT02517307|525178015|FG002|Overall Study|Withdrawal by Subject|1|||
145634940|NCT02517307|525178016|FG003|Overall Study|Withdrawal by Subject|0|||
145634941|NCT02517307|525178013|FG000|Overall Study|Protocol Violation|0|||
145634942|NCT02517307|525178014|FG001|Overall Study|Protocol Violation|0|||
145634943|NCT02517307|525178015|FG002|Overall Study|Protocol Violation|1|||
145634944|NCT02517307|525178016|FG003|Overall Study|Protocol Violation|1|||
145634945|NCT03586544|525178017|FG000|First Intervention|Adverse Event|0|||
145634946|NCT03586544|525178018|FG001|First Intervention|Adverse Event|1|||
145634947|NCT03586544|525178017|FG000|Second Intervention|Withdrawal by Subject|0|||
145634948|NCT03586544|525178018|FG001|Second Intervention|Withdrawal by Subject|1|||
145634949|NCT03863834|525178022|FG000|Overall Study|Lost to Follow-up|3|||
145634950|NCT02770248|525178024|FG000|Overall Study|Adverse Event|0|||
145634951|NCT02770248|525178025|FG001|Overall Study|Adverse Event|1|||
145634952|NCT02770248|525178024|FG000|Overall Study|Randomized in error, prior to treatment|0|||
145634953|NCT02770248|525178025|FG001|Overall Study|Randomized in error, prior to treatment|1|||
145634954|NCT01837641|525178026|FG000|Overall Study|Sponsor decision|1|||
145634955|NCT01837641|525178027|FG001|Overall Study|Sponsor decision|0|||
145634956|NCT01837641|525178028|FG002|Overall Study|Sponsor decision|0|||
145634957|NCT01837641|525178029|FG003|Overall Study|Sponsor decision|0|||
145634958|NCT01837641|525178030|FG004|Overall Study|Sponsor decision|0|||
145480845|NCT03364309|524613218|FG012|Maintenance Period|Lost to Follow-up|0|||
145480846|NCT03364309|524613219|FG013|Maintenance Period|Lost to Follow-up|0|||
145634959|NCT01837641|525178031|FG005|Overall Study|Sponsor decision|1|||
145480847|NCT03364309|524613220|FG014|Maintenance Period|Lost to Follow-up|0|||
145634960|NCT01837641|525178032|FG006|Overall Study|Sponsor decision|0|||
145634961|NCT01837641|525178033|FG007|Overall Study|Sponsor decision|0|||
145634962|NCT01837641|525178026|FG000|Overall Study|Adverse Event|0|||
145634963|NCT01837641|525178027|FG001|Overall Study|Adverse Event|0|||
145634964|NCT01837641|525178028|FG002|Overall Study|Adverse Event|0|||
145634965|NCT01837641|525178029|FG003|Overall Study|Adverse Event|0|||
145634966|NCT01837641|525178030|FG004|Overall Study|Adverse Event|0|||
145634967|NCT01837641|525178031|FG005|Overall Study|Adverse Event|1|||
145634968|NCT01837641|525178032|FG006|Overall Study|Adverse Event|0|||
145634969|NCT01837641|525178033|FG007|Overall Study|Adverse Event|0|||
145634970|NCT01837641|525178026|FG000|Overall Study|Withdrawal by Subject|0|||
145634971|NCT01837641|525178027|FG001|Overall Study|Withdrawal by Subject|0|||
145634972|NCT01837641|525178028|FG002|Overall Study|Withdrawal by Subject|0|||
145634973|NCT01837641|525178029|FG003|Overall Study|Withdrawal by Subject|0|||
145634974|NCT01837641|525178030|FG004|Overall Study|Withdrawal by Subject|1|||
145634975|NCT01837641|525178031|FG005|Overall Study|Withdrawal by Subject|0|||
145634976|NCT01837641|525178032|FG006|Overall Study|Withdrawal by Subject|1|||
145634977|NCT01837641|525178033|FG007|Overall Study|Withdrawal by Subject|0|||
145634978|NCT01579916|525178034|FG000|Overall Study|Lost to Follow-up|6|||
145634979|NCT01579916|525178035|FG001|Overall Study|Lost to Follow-up|1|||
145634980|NCT01579916|525178034|FG000|Overall Study|Withdrawal by Subject|1|||
145634981|NCT01579916|525178035|FG001|Overall Study|Withdrawal by Subject|1|||
145634982|NCT01579916|525178034|FG000|Overall Study|Death|1|||
145634983|NCT01579916|525178035|FG001|Overall Study|Death|0|||
145634984|NCT03264456|525178036|FG000|Overall Study|Withdrawal by Subject|3|||
145634985|NCT03264456|525178036|FG000|Overall Study|Lost to Follow-up|1|||
145634986|NCT01123083|525178039|FG000|Overall Study|Investigator recommendation|1|||
145634987|NCT01123083|525178040|FG001|Overall Study|Investigator recommendation|1|||
145634988|NCT01123083|525178039|FG000|Overall Study|Administrative reasons|0|||
145634989|NCT01123083|525178040|FG001|Overall Study|Administrative reasons|4|||
145634990|NCT01123083|525178039|FG000|Overall Study|Lost to Follow-up|2|||
145634991|NCT01123083|525178040|FG001|Overall Study|Lost to Follow-up|6|||
145634992|NCT01123083|525178039|FG000|Overall Study|Adverse Event|1|||
145634993|NCT01123083|525178040|FG001|Overall Study|Adverse Event|0|||
145634994|NCT01123083|525178039|FG000|Overall Study|Withdrew for another reason not covered|0|||
145634995|NCT01123083|525178040|FG001|Overall Study|Withdrew for another reason not covered|1|||
145634996|NCT01123083|525178039|FG000|Overall Study|Participant/legal representative request|7|||
145634997|NCT01123083|525178040|FG001|Overall Study|Participant/legal representative request|3|||
145634998|NCT02486588|525178043|FG000|Overall Study|Randomized in error- ineligible|738|||
145634999|NCT02486588|525178044|FG001|Overall Study|Randomized in error- ineligible|750|||
145635000|NCT02486588|525178045|FG002|Overall Study|Randomized in error- ineligible|755|||
145635001|NCT02486588|525178046|FG003|Overall Study|Randomized in error- ineligible|738|||
145635002|NCT02486588|525178047|FG004|Overall Study|Randomized in error- ineligible|746|||
145635003|NCT02486588|525178048|FG005|Overall Study|Randomized in error- ineligible|746|||
145635004|NCT02551055|525178051|FG000|Overall Study|Death|2|||
145635005|NCT02551055|525178052|FG001|Overall Study|Death|4|||
145635006|NCT02551055|525178053|FG002|Overall Study|Death|2|||
145635007|NCT02551055|525178054|FG003|Overall Study|Death|2|||
145635008|NCT02551055|525178055|FG004|Overall Study|Death|2|||
145635009|NCT02551055|525178056|FG005|Overall Study|Death|1|||
145635010|NCT02551055|525178057|FG006|Overall Study|Death|2|||
145635011|NCT02551055|525178058|FG007|Overall Study|Death|0|||
145635012|NCT02551055|525178051|FG000|Overall Study|Study Terminated by Sponsor|1|||
145635013|NCT02551055|525178052|FG001|Overall Study|Study Terminated by Sponsor|1|||
145635014|NCT02551055|525178053|FG002|Overall Study|Study Terminated by Sponsor|0|||
145635015|NCT02551055|525178054|FG003|Overall Study|Study Terminated by Sponsor|2|||
145635016|NCT02551055|525178055|FG004|Overall Study|Study Terminated by Sponsor|2|||
145635017|NCT02551055|525178056|FG005|Overall Study|Study Terminated by Sponsor|0|||
145635018|NCT02551055|525178057|FG006|Overall Study|Study Terminated by Sponsor|0|||
145635019|NCT02551055|525178058|FG007|Overall Study|Study Terminated by Sponsor|0|||
145635020|NCT02551055|525178051|FG000|Overall Study|Withdrawal by Subject|1|||
145635021|NCT02551055|525178052|FG001|Overall Study|Withdrawal by Subject|1|||
145635022|NCT02551055|525178053|FG002|Overall Study|Withdrawal by Subject|0|||
145635023|NCT02551055|525178054|FG003|Overall Study|Withdrawal by Subject|1|||
145635024|NCT02551055|525178055|FG004|Overall Study|Withdrawal by Subject|2|||
145635025|NCT02551055|525178056|FG005|Overall Study|Withdrawal by Subject|0|||
145635026|NCT02551055|525178057|FG006|Overall Study|Withdrawal by Subject|0|||
145635027|NCT02551055|525178058|FG007|Overall Study|Withdrawal by Subject|0|||
145635028|NCT02551055|525178051|FG000|Overall Study|Reason not specified|0|||
145635029|NCT02551055|525178052|FG001|Overall Study|Reason not specified|0|||
145635030|NCT02551055|525178053|FG002|Overall Study|Reason not specified|0|||
145635031|NCT02551055|525178054|FG003|Overall Study|Reason not specified|0|||
145635032|NCT02551055|525178055|FG004|Overall Study|Reason not specified|1|||
145635033|NCT02551055|525178056|FG005|Overall Study|Reason not specified|0|||
145635034|NCT02551055|525178057|FG006|Overall Study|Reason not specified|1|||
145635035|NCT02551055|525178058|FG007|Overall Study|Reason not specified|0|||
145635036|NCT00430300|525178059|FG000|Overall Study|Adverse Event|0|||
145635037|NCT00430300|525178060|FG001|Overall Study|Adverse Event|2|||
145635038|NCT00430300|525178061|FG002|Overall Study|Adverse Event|1|||
145635039|NCT00430300|525178062|FG003|Overall Study|Adverse Event|1|||
145635040|NCT00430300|525178059|FG000|Overall Study|Withdrawal by Subject|1|||
145635041|NCT00430300|525178060|FG001|Overall Study|Withdrawal by Subject|0|||
145635042|NCT00430300|525178061|FG002|Overall Study|Withdrawal by Subject|5|||
145635043|NCT00430300|525178062|FG003|Overall Study|Withdrawal by Subject|0|||
145635044|NCT00430300|525178059|FG000|Overall Study|Laboratory abnormality|1|||
145635045|NCT00430300|525178060|FG001|Overall Study|Laboratory abnormality|0|||
145635046|NCT00430300|525178061|FG002|Overall Study|Laboratory abnormality|0|||
145635047|NCT00430300|525178062|FG003|Overall Study|Laboratory abnormality|0|||
145635048|NCT00430300|525178059|FG000|Overall Study|Other|0|||
145635049|NCT00430300|525178060|FG001|Overall Study|Other|0|||
145635050|NCT00430300|525178061|FG002|Overall Study|Other|0|||
145635051|NCT00430300|525178062|FG003|Overall Study|Other|1|||
145635052|NCT02041104|525178065|FG000|Overall Study|Lost to Follow-up|1|||
145635053|NCT02041104|525178066|FG001|Overall Study|Lost to Follow-up|4|||
145635054|NCT02041104|525178065|FG000|Overall Study|discomfort during OGTT|0|||
145635055|NCT02041104|525178066|FG001|Overall Study|discomfort during OGTT|3|||
145635056|NCT00546871|525178069|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
145635057|NCT00546871|525178070|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
145635058|NCT00546871|525178069|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
145635059|NCT00546871|525178070|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
145635060|NCT00546871|525178069|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
145635061|NCT00546871|525178070|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
145635062|NCT00546871|525178069|FG000|Study Extension Period|Protocol Violation|1|||
145635063|NCT00546871|525178070|FG001|Study Extension Period|Protocol Violation|0|||
145635064|NCT00546871|525178069|FG000|Study Extension Period|Withdrawal by Subject|0|||
145635065|NCT00546871|525178070|FG001|Study Extension Period|Withdrawal by Subject|1|||
145635066|NCT01713946|525178071|FG000|Overall Study|Death|0|||
145635067|NCT01713946|525178072|FG001|Overall Study|Death|2|||
145635068|NCT01713946|525178073|FG002|Overall Study|Death|2|||
145635069|NCT01713946|525178071|FG000|Overall Study|Adverse Event|19|||
145635070|NCT01713946|525178072|FG001|Overall Study|Adverse Event|14|||
145635071|NCT01713946|525178073|FG002|Overall Study|Adverse Event|13|||
145480848|NCT03364309|524613221|FG015|Maintenance Period|Lost to Follow-up|0|||
145480849|NCT03364309|524613222|FG016|Maintenance Period|Lost to Follow-up|0|||
145480850|NCT03364309|524613223|FG017|Maintenance Period|Lost to Follow-up|0|||
145480851|NCT03364309|524613224|FG018|Maintenance Period|Lost to Follow-up|0|||
145480852|NCT03364309|524613206|FG000|Maintenance Period|Miscellaneous|0|||
145480853|NCT03364309|524613207|FG001|Maintenance Period|Miscellaneous|0|||
145480854|NCT03364309|524613208|FG002|Maintenance Period|Miscellaneous|0|||
145480855|NCT03364309|524613209|FG003|Maintenance Period|Miscellaneous|0|||
145602792|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
145602793|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
145602794|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
145602795|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
145602796|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
145602797|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
145602798|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
145602799|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
145602800|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
145602801|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
145602802|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
145602803|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
145602804|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
145602805|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
145602806|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
145602807|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
145602808|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
145602809|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
145602810|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
145602811|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
145602812|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145602813|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
145602814|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
145602815|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
145602816|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
145602817|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145602818|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145602819|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
145602820|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602821|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
145602822|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
145602823|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602824|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602825|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602826|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602827|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
145602828|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145602829|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
145635072|NCT01713946|525178071|FG000|Overall Study|Withdrawal by Subject|12|||
145635073|NCT01713946|525178072|FG001|Overall Study|Withdrawal by Subject|12|||
145602830|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145602831|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
145602832|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
145602833|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145602834|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145602835|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
145602836|NCT02496767|525060143|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602837|NCT02496767|525060144|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
145602838|NCT02496767|525060145|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602839|NCT02496767|525060146|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602840|NCT02496767|525060147|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602841|NCT02496767|525060148|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602842|NCT02496767|525060149|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602843|NCT02496767|525060150|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
145602844|NCT02496767|525060143|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602845|NCT02496767|525060144|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602846|NCT02496767|525060145|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602847|NCT02496767|525060146|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602848|NCT02496767|525060147|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602849|NCT02496767|525060148|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
145602850|NCT02496767|525060149|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
145602851|NCT02496767|525060150|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
145602852|NCT02496767|525060143|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
145602853|NCT02496767|525060144|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
145602854|NCT02496767|525060145|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
145602855|NCT02496767|525060146|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
145602856|NCT02496767|525060147|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
145602857|NCT02496767|525060148|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
145602858|NCT02496767|525060149|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
145602859|NCT02496767|525060150|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
145602860|NCT02496767|525060143|FG000|Double-blind, Withdrawal Phase|Death|0|||
145602861|NCT02496767|525060144|FG001|Double-blind, Withdrawal Phase|Death|0|||
145602862|NCT02496767|525060145|FG002|Double-blind, Withdrawal Phase|Death|0|||
145602863|NCT02496767|525060146|FG003|Double-blind, Withdrawal Phase|Death|0|||
145602864|NCT02496767|525060147|FG004|Double-blind, Withdrawal Phase|Death|0|||
145602865|NCT02496767|525060148|FG005|Double-blind, Withdrawal Phase|Death|0|||
145602866|NCT02496767|525060149|FG006|Double-blind, Withdrawal Phase|Death|1|||
145602867|NCT02496767|525060150|FG007|Double-blind, Withdrawal Phase|Death|2|||
145602868|NCT02496767|525060143|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
145602869|NCT02496767|525060144|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
145602870|NCT02496767|525060145|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
145602871|NCT02496767|525060146|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
145602872|NCT02496767|525060147|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
145602873|NCT02496767|525060148|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
145602874|NCT02496767|525060149|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
145602875|NCT02496767|525060150|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
145602876|NCT02889133|525060151|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
145602877|NCT02889133|525060152|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
145602878|NCT02889133|525060151|FG000|Completed Primary Outcome|Manufacturing error|3|||
145602879|NCT02889133|525060152|FG001|Completed Primary Outcome|Manufacturing error|8|||
145602880|NCT02889133|525060151|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
145602881|NCT02889133|525060152|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
145602882|NCT02889133|525060151|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
145602883|NCT02889133|525060152|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
145602884|NCT02889133|525060151|FG000|Completed Primary Outcome|Protocol Violation|1|||
145602885|NCT02889133|525060152|FG001|Completed Primary Outcome|Protocol Violation|0|||
145602886|NCT02889133|525060151|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
145602887|NCT02889133|525060152|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
145602888|NCT02889133|525060151|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
145602889|NCT02889133|525060152|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
145602890|NCT02889133|525060151|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
145602891|NCT02889133|525060152|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
145602892|NCT02889133|525060151|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
145602893|NCT02889133|525060152|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
145602894|NCT02889133|525060151|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
145602895|NCT02889133|525060152|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
145602896|NCT02597036|525060153|FG000|Overall Study|Progressive Disease|0|||
145602897|NCT02597036|525060154|FG001|Overall Study|Progressive Disease|0|||
145602898|NCT02597036|525060155|FG002|Overall Study|Progressive Disease|0|||
145602899|NCT02597036|525060156|FG003|Overall Study|Progressive Disease|0|||
145602900|NCT02597036|525060157|FG004|Overall Study|Progressive Disease|1|||
145602901|NCT02597036|525060158|FG005|Overall Study|Progressive Disease|1|||
145602902|NCT02597036|525060159|FG006|Overall Study|Progressive Disease|1|||
145602903|NCT02597036|525060160|FG007|Overall Study|Progressive Disease|0|||
145602904|NCT02597036|525060161|FG008|Overall Study|Progressive Disease|0|||
145602905|NCT02597036|525060162|FG009|Overall Study|Progressive Disease|0|||
145602906|NCT02597036|525060163|FG010|Overall Study|Progressive Disease|0|||
145602907|NCT02597036|525060164|FG011|Overall Study|Progressive Disease|0|||
145602908|NCT02597036|525060153|FG000|Overall Study|Adverse Event|0|||
145602909|NCT02597036|525060154|FG001|Overall Study|Adverse Event|0|||
145602910|NCT02597036|525060155|FG002|Overall Study|Adverse Event|0|||
145602911|NCT02597036|525060156|FG003|Overall Study|Adverse Event|0|||
145602912|NCT02597036|525060157|FG004|Overall Study|Adverse Event|0|||
145602913|NCT02597036|525060158|FG005|Overall Study|Adverse Event|0|||
145602914|NCT02597036|525060159|FG006|Overall Study|Adverse Event|0|||
145602915|NCT02597036|525060160|FG007|Overall Study|Adverse Event|1|||
145602916|NCT02597036|525060161|FG008|Overall Study|Adverse Event|0|||
145602917|NCT02597036|525060162|FG009|Overall Study|Adverse Event|0|||
145602918|NCT02597036|525060163|FG010|Overall Study|Adverse Event|0|||
145602919|NCT02597036|525060164|FG011|Overall Study|Adverse Event|1|||
145602920|NCT02597036|525060153|FG000|Overall Study|Death|0|||
145602921|NCT02597036|525060154|FG001|Overall Study|Death|0|||
145602922|NCT02597036|525060155|FG002|Overall Study|Death|0|||
145602923|NCT02597036|525060156|FG003|Overall Study|Death|0|||
145602924|NCT02597036|525060157|FG004|Overall Study|Death|0|||
145602925|NCT02597036|525060158|FG005|Overall Study|Death|0|||
145602926|NCT02597036|525060159|FG006|Overall Study|Death|0|||
145602927|NCT02597036|525060160|FG007|Overall Study|Death|0|||
145602928|NCT02597036|525060161|FG008|Overall Study|Death|0|||
145602929|NCT02597036|525060162|FG009|Overall Study|Death|1|||
145602930|NCT02597036|525060163|FG010|Overall Study|Death|1|||
145602931|NCT02597036|525060164|FG011|Overall Study|Death|0|||
145602932|NCT02597036|525060153|FG000|Overall Study|Lost to Follow-up|0|||
145602933|NCT02597036|525060154|FG001|Overall Study|Lost to Follow-up|0|||
145602934|NCT02597036|525060155|FG002|Overall Study|Lost to Follow-up|0|||
145602935|NCT02597036|525060156|FG003|Overall Study|Lost to Follow-up|0|||
145602936|NCT02597036|525060157|FG004|Overall Study|Lost to Follow-up|0|||
145602937|NCT02597036|525060158|FG005|Overall Study|Lost to Follow-up|0|||
145602938|NCT02597036|525060159|FG006|Overall Study|Lost to Follow-up|0|||
145602939|NCT02597036|525060160|FG007|Overall Study|Lost to Follow-up|0|||
145602940|NCT02597036|525060161|FG008|Overall Study|Lost to Follow-up|0|||
145602941|NCT02597036|525060162|FG009|Overall Study|Lost to Follow-up|0|||
145602942|NCT02597036|525060163|FG010|Overall Study|Lost to Follow-up|1|||
145602943|NCT02597036|525060164|FG011|Overall Study|Lost to Follow-up|0|||
145602944|NCT02597036|525060153|FG000|Overall Study|Withdrawal by Subject|0|||
145602945|NCT02597036|525060154|FG001|Overall Study|Withdrawal by Subject|0|||
145602946|NCT02597036|525060155|FG002|Overall Study|Withdrawal by Subject|0|||
145602947|NCT02597036|525060156|FG003|Overall Study|Withdrawal by Subject|0|||
145602948|NCT02597036|525060157|FG004|Overall Study|Withdrawal by Subject|0|||
145602949|NCT02597036|525060158|FG005|Overall Study|Withdrawal by Subject|0|||
145602950|NCT02597036|525060159|FG006|Overall Study|Withdrawal by Subject|0|||
145602951|NCT02597036|525060160|FG007|Overall Study|Withdrawal by Subject|0|||
145602952|NCT02597036|525060161|FG008|Overall Study|Withdrawal by Subject|0|||
145602953|NCT02597036|525060162|FG009|Overall Study|Withdrawal by Subject|0|||
145602954|NCT02597036|525060163|FG010|Overall Study|Withdrawal by Subject|0|||
145602955|NCT02597036|525060164|FG011|Overall Study|Withdrawal by Subject|1|||
145602956|NCT06351371|525060167|FG000|Overall Study|Mutation Status Not Confirmed|9|||
145602957|NCT06351371|525060167|FG000|Overall Study|Ineligible|1|||
145602958|NCT06351371|525060167|FG000|Overall Study|Adverse Event|4|||
145602959|NCT06351371|525060167|FG000|Overall Study|Death|1|||
145602960|NCT06351371|525060167|FG000|Overall Study|Disease progression|14|||
145602961|NCT06351371|525060167|FG000|Overall Study|Withdrawal by Subject|3|||
145602962|NCT06351371|525060167|FG000|Overall Study|Physician Decision|3|||
145602963|NCT04359784|525060169|FG000|Overall Study|Death|2|||
145602964|NCT03217747|525060177|FG000|Overall Study|Adverse Event|0|||
145602965|NCT03217747|525060178|FG001|Overall Study|Adverse Event|1|||
145602966|NCT03217747|525060179|FG002|Overall Study|Adverse Event|0|||
145602967|NCT03217747|525060180|FG003|Overall Study|Adverse Event|0|||
145635074|NCT01713946|525178073|FG002|Overall Study|Withdrawal by Subject|8|||
145480856|NCT03364309|524613210|FG004|Maintenance Period|Miscellaneous|0|||
145602968|NCT03217747|525060181|FG004|Overall Study|Adverse Event|0|||
145602969|NCT03217747|525060182|FG005|Overall Study|Adverse Event|0|||
145602970|NCT03217747|525060183|FG006|Overall Study|Adverse Event|0|||
145602971|NCT03217747|525060184|FG007|Overall Study|Adverse Event|0|||
145602972|NCT03217747|525060185|FG008|Overall Study|Adverse Event|0|||
145602973|NCT03217747|525060186|FG009|Overall Study|Adverse Event|0|||
145602974|NCT03217747|525060187|FG010|Overall Study|Adverse Event|0|||
145602975|NCT03217747|525060188|FG011|Overall Study|Adverse Event|0|||
145602976|NCT03217747|525060189|FG012|Overall Study|Adverse Event|1|||
145635075|NCT01713946|525178071|FG000|Overall Study|Lack of Efficacy|8|||
145635076|NCT01713946|525178072|FG001|Overall Study|Lack of Efficacy|8|||
145635077|NCT01713946|525178073|FG002|Overall Study|Lack of Efficacy|14|||
145635078|NCT01713946|525178071|FG000|Overall Study|Protocol Violation|2|||
145635079|NCT01713946|525178072|FG001|Overall Study|Protocol Violation|4|||
145635080|NCT01713946|525178073|FG002|Overall Study|Protocol Violation|1|||
145635081|NCT01713946|525178071|FG000|Overall Study|Lost to Follow-up|0|||
145602977|NCT03217747|525060190|FG013|Overall Study|Adverse Event|1|||
145602978|NCT03217747|525060177|FG000|Overall Study|Death|0|||
145602979|NCT03217747|525060178|FG001|Overall Study|Death|0|||
145602980|NCT03217747|525060179|FG002|Overall Study|Death|0|||
145602981|NCT03217747|525060180|FG003|Overall Study|Death|0|||
145602982|NCT03217747|525060181|FG004|Overall Study|Death|0|||
145602983|NCT03217747|525060182|FG005|Overall Study|Death|0|||
145602984|NCT03217747|525060183|FG006|Overall Study|Death|0|||
145602985|NCT03217747|525060184|FG007|Overall Study|Death|0|||
145602986|NCT03217747|525060185|FG008|Overall Study|Death|1|||
145602987|NCT03217747|525060186|FG009|Overall Study|Death|0|||
145602988|NCT03217747|525060187|FG010|Overall Study|Death|0|||
145602989|NCT03217747|525060188|FG011|Overall Study|Death|0|||
145602990|NCT03217747|525060189|FG012|Overall Study|Death|0|||
145602991|NCT03217747|525060190|FG013|Overall Study|Death|0|||
145602992|NCT03217747|525060177|FG000|Overall Study|Lack of Efficacy|12|||
145602993|NCT03217747|525060178|FG001|Overall Study|Lack of Efficacy|6|||
145602994|NCT03217747|525060179|FG002|Overall Study|Lack of Efficacy|15|||
145602995|NCT03217747|525060180|FG003|Overall Study|Lack of Efficacy|11|||
145602996|NCT03217747|525060181|FG004|Overall Study|Lack of Efficacy|3|||
145602997|NCT03217747|525060182|FG005|Overall Study|Lack of Efficacy|14|||
145602998|NCT03217747|525060183|FG006|Overall Study|Lack of Efficacy|10|||
145602999|NCT03217747|525060184|FG007|Overall Study|Lack of Efficacy|4|||
145603000|NCT03217747|525060185|FG008|Overall Study|Lack of Efficacy|2|||
145603001|NCT03217747|525060186|FG009|Overall Study|Lack of Efficacy|7|||
145603002|NCT03217747|525060187|FG010|Overall Study|Lack of Efficacy|3|||
145603003|NCT03217747|525060188|FG011|Overall Study|Lack of Efficacy|1|||
145603004|NCT03217747|525060189|FG012|Overall Study|Lack of Efficacy|3|||
145603005|NCT03217747|525060190|FG013|Overall Study|Lack of Efficacy|1|||
145603006|NCT03217747|525060177|FG000|Overall Study|Withdrawal by Subject|2|||
145603007|NCT03217747|525060178|FG001|Overall Study|Withdrawal by Subject|1|||
145603008|NCT03217747|525060179|FG002|Overall Study|Withdrawal by Subject|1|||
145603009|NCT03217747|525060180|FG003|Overall Study|Withdrawal by Subject|1|||
145603010|NCT03217747|525060181|FG004|Overall Study|Withdrawal by Subject|1|||
145603011|NCT03217747|525060182|FG005|Overall Study|Withdrawal by Subject|2|||
145603012|NCT03217747|525060183|FG006|Overall Study|Withdrawal by Subject|1|||
145603013|NCT03217747|525060184|FG007|Overall Study|Withdrawal by Subject|0|||
145603014|NCT03217747|525060185|FG008|Overall Study|Withdrawal by Subject|0|||
145603015|NCT03217747|525060186|FG009|Overall Study|Withdrawal by Subject|0|||
145603016|NCT03217747|525060187|FG010|Overall Study|Withdrawal by Subject|0|||
145603017|NCT03217747|525060188|FG011|Overall Study|Withdrawal by Subject|1|||
145603018|NCT03217747|525060189|FG012|Overall Study|Withdrawal by Subject|0|||
145603019|NCT03217747|525060190|FG013|Overall Study|Withdrawal by Subject|1|||
145603020|NCT03217747|525060177|FG000|Overall Study|Toxicity and progression|1|||
145603021|NCT03217747|525060178|FG001|Overall Study|Toxicity and progression|0|||
145603022|NCT03217747|525060179|FG002|Overall Study|Toxicity and progression|0|||
145603023|NCT03217747|525060180|FG003|Overall Study|Toxicity and progression|0|||
145603024|NCT03217747|525060181|FG004|Overall Study|Toxicity and progression|0|||
145603025|NCT03217747|525060182|FG005|Overall Study|Toxicity and progression|0|||
145603026|NCT03217747|525060183|FG006|Overall Study|Toxicity and progression|0|||
145603027|NCT03217747|525060184|FG007|Overall Study|Toxicity and progression|0|||
145603028|NCT03217747|525060185|FG008|Overall Study|Toxicity and progression|0|||
145603029|NCT03217747|525060186|FG009|Overall Study|Toxicity and progression|0|||
145603030|NCT03217747|525060187|FG010|Overall Study|Toxicity and progression|0|||
145603031|NCT03217747|525060188|FG011|Overall Study|Toxicity and progression|0|||
145603032|NCT03217747|525060189|FG012|Overall Study|Toxicity and progression|0|||
145603033|NCT03217747|525060190|FG013|Overall Study|Toxicity and progression|0|||
145603034|NCT03217747|525060177|FG000|Overall Study|Removal of sole target lesion|1|||
145603035|NCT03217747|525060178|FG001|Overall Study|Removal of sole target lesion|0|||
145603036|NCT03217747|525060179|FG002|Overall Study|Removal of sole target lesion|0|||
145603037|NCT03217747|525060180|FG003|Overall Study|Removal of sole target lesion|0|||
145603038|NCT03217747|525060181|FG004|Overall Study|Removal of sole target lesion|0|||
145603039|NCT03217747|525060182|FG005|Overall Study|Removal of sole target lesion|0|||
145603040|NCT03217747|525060183|FG006|Overall Study|Removal of sole target lesion|0|||
145603041|NCT03217747|525060184|FG007|Overall Study|Removal of sole target lesion|0|||
145603042|NCT03217747|525060185|FG008|Overall Study|Removal of sole target lesion|0|||
145603043|NCT03217747|525060186|FG009|Overall Study|Removal of sole target lesion|0|||
145603044|NCT03217747|525060187|FG010|Overall Study|Removal of sole target lesion|0|||
145603045|NCT03217747|525060188|FG011|Overall Study|Removal of sole target lesion|0|||
145603046|NCT03217747|525060189|FG012|Overall Study|Removal of sole target lesion|0|||
145635082|NCT01713946|525178072|FG001|Overall Study|Lost to Follow-up|0|||
145635083|NCT01713946|525178073|FG002|Overall Study|Lost to Follow-up|1|||
145635084|NCT01713946|525178071|FG000|Overall Study|Administrative problems|1|||
145635085|NCT01713946|525178072|FG001|Overall Study|Administrative problems|0|||
145635086|NCT01713946|525178073|FG002|Overall Study|Administrative problems|0|||
145635087|NCT01713946|525178071|FG000|Overall Study|Did not continue in Ext|0|||
145635088|NCT01713946|525178072|FG001|Overall Study|Did not continue in Ext|3|||
145635089|NCT01713946|525178073|FG002|Overall Study|Did not continue in Ext|0|||
145635090|NCT01713946|525178071|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
145635091|NCT01713946|525178072|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
145635092|NCT01713946|525178073|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
145635093|NCT01713946|525178071|FG000|Overall Study|Patients never switched to everolimus|0|||
145635094|NCT01713946|525178072|FG001|Overall Study|Patients never switched to everolimus|0|||
145635095|NCT01713946|525178073|FG002|Overall Study|Patients never switched to everolimus|5|||
145635096|NCT04517864|525180074|FG000|Placebo-Controlled Phase|Adverse Event|1|||
145635097|NCT04517864|525180075|FG001|Placebo-Controlled Phase|Adverse Event|0|||
145635098|NCT04517864|525180076|FG002|Placebo-Controlled Phase|Adverse Event|0|||
145635099|NCT04517864|525180074|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
145635100|NCT04517864|525180075|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
145635101|NCT04517864|525180076|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
145635102|NCT04517864|525180074|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
145635103|NCT04517864|525180075|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
145635104|NCT04517864|525180076|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
145635105|NCT04517864|525180074|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
145635106|NCT04517864|525180075|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
145635107|NCT04517864|525180076|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
145635108|NCT04517864|525180074|FG000|Active Therapy Extension Phase|Adverse Event|1|||
145635109|NCT04517864|525180075|FG001|Active Therapy Extension Phase|Adverse Event|0|||
145635110|NCT04517864|525180076|FG002|Active Therapy Extension Phase|Adverse Event|0|||
145635111|NCT04517864|525180074|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
145635112|NCT04517864|525180075|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
145635113|NCT04517864|525180076|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
145635114|NCT04517864|525180074|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
145635115|NCT04517864|525180075|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
145635116|NCT04517864|525180076|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
145635117|NCT04517864|525180074|FG000|Active Therapy Extension Phase|Physician Decision|1|||
145635118|NCT04517864|525180075|FG001|Active Therapy Extension Phase|Physician Decision|0|||
145635119|NCT04517864|525180076|FG002|Active Therapy Extension Phase|Physician Decision|0|||
145635120|NCT04517864|525180074|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
145635121|NCT04517864|525180075|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
145635122|NCT04517864|525180076|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
145635123|NCT04517864|525180074|FG000|Extension Phase|Adverse Event|0|||
145635124|NCT04517864|525180075|FG001|Extension Phase|Adverse Event|0|||
145635125|NCT04517864|525180076|FG002|Extension Phase|Adverse Event|1|||
145635126|NCT04517864|525180074|FG000|Extension Phase|Lack of Efficacy|0|||
145635127|NCT04517864|525180075|FG001|Extension Phase|Lack of Efficacy|0|||
145635128|NCT04517864|525180076|FG002|Extension Phase|Lack of Efficacy|2|||
145635129|NCT04517864|525180074|FG000|Extension Phase|Study Terminated By Sponsor|0|||
145635130|NCT04517864|525180075|FG001|Extension Phase|Study Terminated By Sponsor|0|||
145635131|NCT04517864|525180076|FG002|Extension Phase|Study Terminated By Sponsor|32|||
145635132|NCT04517864|525180074|FG000|Extension Phase|Withdrawal by Subject|0|||
145635133|NCT04517864|525180075|FG001|Extension Phase|Withdrawal by Subject|0|||
145635134|NCT04517864|525180076|FG002|Extension Phase|Withdrawal by Subject|3|||
145635135|NCT04517864|525180074|FG000|Extension Phase|Approved Drug Available for Indication|0|||
145635136|NCT04517864|525180075|FG001|Extension Phase|Approved Drug Available for Indication|0|||
145635137|NCT04517864|525180076|FG002|Extension Phase|Approved Drug Available for Indication|7|||
145635138|NCT04722003|525180077|FG000|Overall Study|Lost to Follow-up|2|||
145635139|NCT04722003|525180078|FG001|Overall Study|Lost to Follow-up|0|||
145635140|NCT04722003|525180077|FG000|Overall Study|Physician Decision|1|||
145635141|NCT04722003|525180078|FG001|Overall Study|Physician Decision|0|||
145635142|NCT03351075|525180079|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
145635143|NCT03351075|525180080|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
145635144|NCT03351075|525180079|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
145635145|NCT03351075|525180080|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
145635146|NCT03351075|525180079|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
145635147|NCT03351075|525180080|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
145635148|NCT03351075|525180079|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
145635149|NCT03351075|525180080|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
145635150|NCT03175172|525180081|FG000|Overall Study|Death|3|||
145635151|NCT03175172|525180081|FG000|Overall Study|Withdrawal by Subject|3|||
145635152|NCT03175172|525180081|FG000|Overall Study|Lost to Follow-up|1|||
145635153|NCT03175172|525180081|FG000|Overall Study|Study Terminated by Sponsor|3|||
145635154|NCT03169244|525180082|FG000|Overall Study|Lost to Follow-up|1|||
145480857|NCT03364309|524613211|FG005|Maintenance Period|Miscellaneous|0|||
145480858|NCT03364309|524613212|FG006|Maintenance Period|Miscellaneous|0|||
145480859|NCT03364309|524613213|FG007|Maintenance Period|Miscellaneous|0|||
145480860|NCT03364309|524613214|FG008|Maintenance Period|Miscellaneous|1|||
145480861|NCT03364309|524613215|FG009|Maintenance Period|Miscellaneous|0|||
145480862|NCT03364309|524613216|FG010|Maintenance Period|Miscellaneous|0|||
145480863|NCT03364309|524613217|FG011|Maintenance Period|Miscellaneous|0|||
145480864|NCT03364309|524613218|FG012|Maintenance Period|Miscellaneous|0|||
145480865|NCT03364309|524613219|FG013|Maintenance Period|Miscellaneous|0|||
145480866|NCT03364309|524613220|FG014|Maintenance Period|Miscellaneous|0|||
145480867|NCT03364309|524613221|FG015|Maintenance Period|Miscellaneous|0|||
145480868|NCT03364309|524613222|FG016|Maintenance Period|Miscellaneous|0|||
145480869|NCT03364309|524613223|FG017|Maintenance Period|Miscellaneous|0|||
145480870|NCT03364309|524613224|FG018|Maintenance Period|Miscellaneous|0|||
145480871|NCT03364309|524613206|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480872|NCT03364309|524613207|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480873|NCT03364309|524613208|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480874|NCT03364309|524613209|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480875|NCT03364309|524613210|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145603047|NCT03217747|525060190|FG013|Overall Study|Removal of sole target lesion|0|||
145603048|NCT03217747|525060177|FG000|Overall Study|Stroke|0|||
145603049|NCT03217747|525060178|FG001|Overall Study|Stroke|0|||
145603050|NCT03217747|525060179|FG002|Overall Study|Stroke|0|||
145603051|NCT03217747|525060180|FG003|Overall Study|Stroke|0|||
145603052|NCT03217747|525060181|FG004|Overall Study|Stroke|0|||
145603053|NCT03217747|525060182|FG005|Overall Study|Stroke|1|||
145603054|NCT03217747|525060183|FG006|Overall Study|Stroke|0|||
145603055|NCT03217747|525060184|FG007|Overall Study|Stroke|0|||
145603056|NCT03217747|525060185|FG008|Overall Study|Stroke|0|||
145603057|NCT03217747|525060186|FG009|Overall Study|Stroke|0|||
145603058|NCT03217747|525060187|FG010|Overall Study|Stroke|0|||
145603059|NCT03217747|525060188|FG011|Overall Study|Stroke|1|||
145603060|NCT03217747|525060189|FG012|Overall Study|Stroke|0|||
145603061|NCT03217747|525060190|FG013|Overall Study|Stroke|0|||
145603062|NCT03996291|525060191|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
145603063|NCT03996291|525060192|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
145603064|NCT03996291|525060193|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
145603065|NCT03996291|525060194|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
145603066|NCT03996291|525060195|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
145603067|NCT03996291|525060196|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
145603068|NCT03996291|525060197|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
145603069|NCT03996291|525060198|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
145603070|NCT03996291|525060191|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603071|NCT03996291|525060192|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603072|NCT03996291|525060193|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603073|NCT03996291|525060194|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603074|NCT03996291|525060195|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603075|NCT03996291|525060196|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
145603076|NCT03996291|525060197|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
145603077|NCT03996291|525060198|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
145603078|NCT03996291|525060191|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603079|NCT03996291|525060192|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603080|NCT03996291|525060193|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603081|NCT03996291|525060194|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603082|NCT03996291|525060195|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
145603083|NCT03996291|525060196|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603084|NCT03996291|525060197|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
145603085|NCT03996291|525060198|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
145603086|NCT03996291|525060191|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
145603087|NCT03996291|525060192|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
145603088|NCT03996291|525060193|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
145603089|NCT03996291|525060194|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
145603090|NCT03996291|525060195|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
145603091|NCT03996291|525060196|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
145603092|NCT03996291|525060197|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
145603093|NCT03996291|525060198|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
145603094|NCT03996291|525060191|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145480876|NCT03364309|524613211|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480877|NCT03364309|524613212|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480878|NCT03364309|524613213|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145603095|NCT03996291|525060192|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145635155|NCT03169244|525180083|FG001|Overall Study|Lost to Follow-up|2|||
145635156|NCT03169244|525180082|FG000|Overall Study|Adverse Event|1|||
145635157|NCT03169244|525180083|FG001|Overall Study|Adverse Event|0|||
145635158|NCT03169244|525180082|FG000|Overall Study|Withdrawal by Subject|2|||
145635159|NCT03169244|525180083|FG001|Overall Study|Withdrawal by Subject|2|||
145635160|NCT03169244|525180082|FG000|Overall Study|Physician Decision|1|||
145635161|NCT03169244|525180083|FG001|Overall Study|Physician Decision|0|||
145635162|NCT04860258|525180084|FG000|Overall Study|Withdrawal by Subject|0|||
145635163|NCT04860258|525180085|FG001|Overall Study|Withdrawal by Subject|0|||
145635164|NCT04860258|525180086|FG002|Overall Study|Withdrawal by Subject|4|||
145635165|NCT04860258|525180087|FG003|Overall Study|Withdrawal by Subject|1|||
145635166|NCT04860258|525180088|FG004|Overall Study|Withdrawal by Subject|4|||
145635167|NCT04860258|525180089|FG005|Overall Study|Withdrawal by Subject|1|||
145635168|NCT04860258|525180090|FG006|Overall Study|Withdrawal by Subject|0|||
145635169|NCT02937831|525180091|FG000|Overall Study|Protocol Violation|4|||
145635170|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
145635171|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
145635172|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
145635173|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
145635174|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
145635175|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
145635176|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
145635177|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
145635178|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
145635179|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
145635180|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
145635181|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
145635182|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
145635183|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
145635184|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
145635185|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
145635186|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
145635187|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
145635188|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
145635189|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
145635190|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
145635191|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
145635192|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
145635193|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
145635194|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
145635195|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
145635196|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
145635197|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
145635198|NCT00241644|525180093|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
145635199|NCT00241644|525180094|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
145635200|NCT00241644|525180095|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
145635201|NCT00241644|525180096|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
145635202|NCT00241644|525180093|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
145635203|NCT00241644|525180094|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
145635204|NCT00241644|525180095|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
145635205|NCT00241644|525180096|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
145635206|NCT00241644|525180093|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
145480879|NCT03364309|524613214|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480880|NCT03364309|524613215|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480881|NCT03364309|524613216|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480882|NCT03364309|524613217|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480883|NCT03364309|524613218|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480884|NCT03364309|524613219|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
145480885|NCT03364309|524613220|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
145480886|NCT03364309|524613221|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
145480887|NCT03364309|524613222|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480888|NCT03364309|524613223|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480889|NCT03364309|524613224|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
145480890|NCT03364309|524613206|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480891|NCT03364309|524613207|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480892|NCT03364309|524613208|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480893|NCT03364309|524613209|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480894|NCT03364309|524613210|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480895|NCT03364309|524613211|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480896|NCT03364309|524613212|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
145635207|NCT00241644|525180094|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
145635208|NCT00241644|525180095|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
145635209|NCT00241644|525180096|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
145635210|NCT00241644|525180093|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
145635211|NCT00241644|525180094|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
145635212|NCT00241644|525180095|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
145635213|NCT00241644|525180096|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
145635214|NCT00241644|525180093|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
145635215|NCT00241644|525180094|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
145635216|NCT00241644|525180095|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
145635217|NCT00241644|525180096|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
145635218|NCT00241644|525180093|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
145635219|NCT00241644|525180094|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
145635220|NCT00241644|525180095|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
145635221|NCT00241644|525180096|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
145635222|NCT03804918|525180097|FG000|Overall Study|Participant did not use the app|1|||
145635223|NCT00813904|525180098|FG000|Overall Study|Death|1|||
145635224|NCT01087762|525180099|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
145635225|NCT01087762|525180100|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
145635226|NCT01087762|525180101|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
145635227|NCT01087762|525180102|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
145635228|NCT01087762|525180103|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
145635229|NCT01087762|525180099|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
145635230|NCT01087762|525180100|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
145635231|NCT01087762|525180101|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
145635232|NCT01087762|525180102|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
145635233|NCT01087762|525180103|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
145635234|NCT01087762|525180099|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
145635235|NCT01087762|525180100|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
145635236|NCT01087762|525180101|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
145635237|NCT01087762|525180102|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
145635238|NCT01087762|525180103|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
145635239|NCT01087762|525180099|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
145635240|NCT01087762|525180100|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
145635241|NCT01087762|525180101|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
145635242|NCT01087762|525180102|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
145635243|NCT01087762|525180103|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
145635244|NCT01087762|525180099|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
145635245|NCT01087762|525180100|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
145635246|NCT01087762|525180101|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
145635247|NCT01087762|525180102|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
145635248|NCT01087762|525180103|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
145635249|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
145635250|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
145635251|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
145635252|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
145635253|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
145635254|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
145635255|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
145635256|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
145635257|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
145635258|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
145635259|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
145635260|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
145635261|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
145635262|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
145635263|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
145635264|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
145635265|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
145635266|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
145635267|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
145635268|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
145635269|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
145635270|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
145480897|NCT03364309|524613213|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480898|NCT03364309|524613214|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480899|NCT03364309|524613215|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
145635271|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
145635272|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
145635273|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
145635274|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
145635275|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
145635276|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
145635277|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
145635278|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
145635279|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
145635280|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
145635281|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
145635282|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
145635283|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
145635284|NCT01087762|525180099|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
145635285|NCT01087762|525180100|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
145635286|NCT01087762|525180101|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
145635287|NCT01087762|525180102|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
145635288|NCT01087762|525180103|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
145635289|NCT01405924|525180104|FG000|Overall Study|Protocol Violation|8|||
145635290|NCT01405924|525180104|FG000|Overall Study|Missing/Incomplete Data|2|||
145635291|NCT02506257|525180105|FG000|Overall Study|Adverse Event|0|||
145635292|NCT02506257|525180106|FG001|Overall Study|Adverse Event|2|||
145635293|NCT02506257|525180107|FG002|Overall Study|Adverse Event|3|||
145635294|NCT02506257|525180108|FG003|Overall Study|Adverse Event|0|||
145635295|NCT02506257|525180105|FG000|Overall Study|Protocol Violation|0|||
145635296|NCT02506257|525180106|FG001|Overall Study|Protocol Violation|0|||
145635297|NCT02506257|525180107|FG002|Overall Study|Protocol Violation|1|||
145635298|NCT02506257|525180108|FG003|Overall Study|Protocol Violation|0|||
145635299|NCT01563354|525180111|FG000|Core Phase|Adverse Event|5|||
145603096|NCT03996291|525060193|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145603097|NCT03996291|525060194|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145603098|NCT03996291|525060195|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
145603099|NCT03996291|525060196|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145603100|NCT03996291|525060197|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145603101|NCT03996291|525060198|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
145603102|NCT03248375|525060199|FG000|Overall Study|Lost to Follow-up|5|||
145603103|NCT00766675|525061377|FG000|Overall Study|Adverse Event|16|||
145603104|NCT00766675|525061377|FG000|Overall Study|Lost to Follow-up|2|||
145603105|NCT00766675|525061377|FG000|Overall Study|Withdrawal by Subject|11|||
145603106|NCT00766675|525061377|FG000|Overall Study|Protocol Violation|8|||
145603107|NCT00766675|525061377|FG000|Overall Study|Participant took prohibited medication|1|||
145603108|NCT00766675|525061377|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
145603109|NCT00766675|525061377|FG000|Overall Study|Insufficient therapy|1|||
145603110|NCT03308825|525061378|FG000|Overall Study|Lost to Follow-up|2|||
145603111|NCT03308825|525061379|FG001|Overall Study|Lost to Follow-up|2|||
145603112|NCT03308825|525061380|FG002|Overall Study|Lost to Follow-up|1|||
145603113|NCT03308825|525061381|FG003|Overall Study|Lost to Follow-up|0|||
145603114|NCT03308825|525061378|FG000|Overall Study|Protocol Violation|0|||
145603115|NCT03308825|525061379|FG001|Overall Study|Protocol Violation|2|||
145603116|NCT03308825|525061380|FG002|Overall Study|Protocol Violation|0|||
145603117|NCT03308825|525061381|FG003|Overall Study|Protocol Violation|0|||
145603118|NCT00685945|525061383|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
145603119|NCT00284141|525061384|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
145603120|NCT00284141|525061384|FG000|Overall Study|Adverse Event|19|||
145603121|NCT00284141|525061384|FG000|Overall Study|Participant's request|9|||
145603122|NCT00284141|525061384|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
145603123|NCT00284141|525061384|FG000|Overall Study|Clinical deterioration / death|2|||
145603124|NCT00284141|525061384|FG000|Overall Study|General decline|1|||
145603125|NCT00284141|525061384|FG000|Overall Study|Pneumonia|1|||
145603126|NCT00284141|525061384|FG000|Overall Study|Did not take study medication|2|||
145603127|NCT00284141|525061384|FG000|Overall Study|Ongoing treatment|2|||
145603128|NCT01160484|525061398|FG000|Overall Study|Lack of Efficacy|9|||
145603129|NCT01160484|525061398|FG000|Overall Study|Adverse Event|6|||
145603130|NCT01160484|525061398|FG000|Overall Study|Withdrawal by Subject|2|||
145603131|NCT01160484|525061398|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
145603132|NCT00803101|525061399|FG000|Overall Study|Death / Serious Adverse Event|4|||
145603133|NCT00803101|525061400|FG001|Overall Study|Death / Serious Adverse Event|6|||
145635300|NCT01563354|525180112|FG001|Core Phase|Adverse Event|15|||
145635301|NCT01563354|525180113|FG002|Core Phase|Adverse Event|13|||
145635302|NCT01563354|525180111|FG000|Core Phase|Withdrawal by Subject|1|||
145603134|NCT00803101|525061399|FG000|Overall Study|Withdrawal by Subject|6|||
145603135|NCT00803101|525061400|FG001|Overall Study|Withdrawal by Subject|4|||
145603136|NCT00803101|525061399|FG000|Overall Study|Lost to Follow-up|2|||
145603137|NCT00803101|525061400|FG001|Overall Study|Lost to Follow-up|2|||
145603138|NCT00803101|525061399|FG000|Overall Study|Protocol Violation|1|||
145603139|NCT00803101|525061400|FG001|Overall Study|Protocol Violation|7|||
145603140|NCT00803101|525061399|FG000|Overall Study|Surgery finished outside protocol window|1|||
145603141|NCT00803101|525061400|FG001|Overall Study|Surgery finished outside protocol window|1|||
145603142|NCT00803101|525061399|FG000|Overall Study|Patient died outside SAE report period|1|||
145603143|NCT00803101|525061400|FG001|Overall Study|Patient died outside SAE report period|0|||
145603144|NCT00803101|525061399|FG000|Overall Study|Patient did not attend scheduled visit|2|||
145603145|NCT00803101|525061400|FG001|Overall Study|Patient did not attend scheduled visit|1|||
145603146|NCT00803101|525061399|FG000|Overall Study|Patient did not have surgery|1|||
145603147|NCT00803101|525061400|FG001|Overall Study|Patient did not have surgery|1|||
145603148|NCT01782742|525061401|FG000|Double-blind Treatment Phase|Adverse Event|1|||
145603149|NCT01782742|525061402|FG001|Double-blind Treatment Phase|Adverse Event|0|||
145603150|NCT01679301|525061403|FG000|Screening Period|screen failure|3|||
145603151|NCT01679301|525061404|FG001|Screening Period|screen failure|0|||
145603152|NCT01679301|525061405|FG002|Screening Period|screen failure|0|||
145603153|NCT01181726|525061406|FG000|First Intervention|Adverse Event|1|||
145603154|NCT01181726|525061407|FG001|First Intervention|Adverse Event|0|||
145603155|NCT03633929|525061408|FG000|Overall Study|Lost to Follow-up|1|||
145603156|NCT03633929|525061408|FG000|Overall Study|Did not login to software. Did not participate|3|||
145603157|NCT01722162|525061409|FG000|Overall Study|Withdrawal by Subject|1|||
145603158|NCT01722162|525061410|FG001|Overall Study|Withdrawal by Subject|1|||
145603159|NCT01722162|525061409|FG000|Overall Study|Found ineligible|1|||
145603160|NCT01722162|525061410|FG001|Overall Study|Found ineligible|0|||
145603161|NCT01722162|525061409|FG000|Overall Study|Unrelated to study adverse event|2|||
145603162|NCT01722162|525061410|FG001|Overall Study|Unrelated to study adverse event|2|||
145603163|NCT01722162|525061409|FG000|Overall Study|Adverse Event|1|||
145603164|NCT01722162|525061410|FG001|Overall Study|Adverse Event|1|||
145603165|NCT01722162|525061409|FG000|Overall Study|Insurance denial post enrollment|0|||
145603166|NCT01722162|525061410|FG001|Overall Study|Insurance denial post enrollment|1|||
145603167|NCT01722162|525061409|FG000|Overall Study|Noncompliance|0|||
145603168|NCT01722162|525061410|FG001|Overall Study|Noncompliance|1|||
145603169|NCT02487810|525061412|FG000|Overall Study|Withdrawal by Subject|1|||
145603170|NCT02487810|525061413|FG001|Overall Study|Withdrawal by Subject|0|||
145603171|NCT01889186|525061414|FG000|Overall Study|Adverse event- not related to progression|18|||
145603172|NCT01889186|525061415|FG001|Overall Study|Adverse event- not related to progression|5|||
145603173|NCT01889186|525061414|FG000|Overall Study|Adverse event- related to progression|7|||
145603174|NCT01889186|525061415|FG001|Overall Study|Adverse event- related to progression|2|||
145603175|NCT01889186|525061414|FG000|Overall Study|COVID-19 logistical restrictions|1|||
145603176|NCT01889186|525061415|FG001|Overall Study|COVID-19 logistical restrictions|0|||
145603177|NCT01889186|525061414|FG000|Overall Study|Investigator request|1|||
145603178|NCT01889186|525061415|FG001|Overall Study|Investigator request|1|||
145603179|NCT01889186|525061414|FG000|Overall Study|Progressive disease- Richter's|12|||
145603180|NCT01889186|525061415|FG001|Overall Study|Progressive disease- Richter's|7|||
145603181|NCT01889186|525061414|FG000|Overall Study|Progressive disease per protocol|46|||
145603182|NCT01889186|525061415|FG001|Overall Study|Progressive disease per protocol|17|||
145603183|NCT01889186|525061414|FG000|Overall Study|Stem cell transplant|2|||
145603184|NCT01889186|525061415|FG001|Overall Study|Stem cell transplant|1|||
145603185|NCT01889186|525061414|FG000|Overall Study|Withdrew consent|2|||
145603186|NCT01889186|525061415|FG001|Overall Study|Withdrew consent|3|||
145603187|NCT01889186|525061414|FG000|Overall Study|Other, not specified|18|||
145603188|NCT01889186|525061415|FG001|Overall Study|Other, not specified|15|||
145603189|NCT00077064|525061418|FG000|Overall Study|Adverse Event|0|||
145603190|NCT00077064|525061419|FG001|Overall Study|Adverse Event|4|||
145603191|NCT00077064|525061418|FG000|Overall Study|Patient refusal|0|||
145603192|NCT00077064|525061419|FG001|Overall Study|Patient refusal|2|||
145603193|NCT01281202|525061433|FG000|Overall Study|Adverse Event|2|||
145603194|NCT01281202|525061434|FG001|Overall Study|Adverse Event|0|||
145603195|NCT01281202|525061433|FG000|Overall Study|Withdrawal by Subject|2|||
145603196|NCT01281202|525061434|FG001|Overall Study|Withdrawal by Subject|2|||
145603197|NCT01281202|525061433|FG000|Overall Study|Protocol Violation|11|||
145603198|NCT01281202|525061434|FG001|Overall Study|Protocol Violation|10|||
145603199|NCT01281202|525061433|FG000|Overall Study|Administrative|2|||
145603200|NCT01281202|525061434|FG001|Overall Study|Administrative|8|||
145603201|NCT01281202|525061433|FG000|Overall Study|Lost to Follow-up|11|||
145603202|NCT01281202|525061434|FG001|Overall Study|Lost to Follow-up|13|||
145603203|NCT01281202|525061433|FG000|Overall Study|Incarceration|0|||
145603204|NCT01281202|525061434|FG001|Overall Study|Incarceration|3|||
145603205|NCT04711603|525061435|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
145603206|NCT04711603|525061436|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
145603207|NCT04711603|525061437|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
145635303|NCT01563354|525180112|FG001|Core Phase|Withdrawal by Subject|0|||
145603208|NCT04711603|525061438|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
145635304|NCT01563354|525180113|FG002|Core Phase|Withdrawal by Subject|3|||
145603209|NCT04711603|525061435|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
145603210|NCT04711603|525061436|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
145603211|NCT04711603|525061437|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
145603212|NCT04711603|525061438|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
145603213|NCT04711603|525061435|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
145603214|NCT04711603|525061436|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
145603215|NCT04711603|525061437|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
145603216|NCT04711603|525061438|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
145603217|NCT04711603|525061435|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
145603218|NCT04711603|525061436|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
145603219|NCT04711603|525061437|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
145603220|NCT04711603|525061438|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
145603221|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
145603222|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
145603223|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
145603224|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
145603225|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
145603226|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
145603227|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
145603228|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
145603229|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
145603230|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
145603231|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
145603232|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
145603233|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
145603234|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
145603235|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
145603236|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
145603237|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
145603238|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
145603239|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
145603240|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
145603241|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
145603242|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
145603243|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
145603244|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
145603245|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
145603246|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
145603247|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
145603248|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
145603249|NCT04711603|525061435|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
145603250|NCT04711603|525061436|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
145603251|NCT04711603|525061437|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
145603252|NCT04711603|525061438|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
145603253|NCT04252742|525061441|FG000|Overall Study|Decision by sponsor|0|||
145603254|NCT04252742|525061442|FG001|Overall Study|Decision by sponsor|2|||
145603255|NCT04252742|525061441|FG000|Overall Study|Withdrawal by Subject|15|||
145603256|NCT04252742|525061442|FG001|Overall Study|Withdrawal by Subject|9|||
145603257|NCT04252742|525061441|FG000|Overall Study|Lost to Follow-up|0|||
145603258|NCT04252742|525061442|FG001|Overall Study|Lost to Follow-up|1|||
145603259|NCT04179032|525061443|FG000|Part B (Up to Week 52)|Adverse Event|1|||
145603260|NCT04179032|525061443|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
145603261|NCT04179032|525061443|FG000|Access Extension Phase|Ongoing|11|||
145603262|NCT04098250|525061445|FG000|Overall Study|Withdrawal by Subject|1|||
145603263|NCT04098250|525061446|FG001|Overall Study|Withdrawal by Subject|0|||
145603264|NCT04098250|525061445|FG000|Overall Study|Lost to Follow-up|0|||
145603265|NCT04098250|525061446|FG001|Overall Study|Lost to Follow-up|1|||
145603266|NCT00394355|525061447|FG000|Overall Study|Adverse Event|10|||
145603267|NCT00394355|525061448|FG001|Overall Study|Adverse Event|6|||
145603268|NCT00394355|525061449|FG002|Overall Study|Adverse Event|7|||
145603269|NCT00394355|525061450|FG003|Overall Study|Adverse Event|8|||
145603270|NCT00394355|525061447|FG000|Overall Study|Did not meet protocol eligibility|1|||
145603271|NCT00394355|525061448|FG001|Overall Study|Did not meet protocol eligibility|5|||
145603272|NCT00394355|525061449|FG002|Overall Study|Did not meet protocol eligibility|4|||
145635305|NCT01563354|525180111|FG000|Core Phase|Lost to Follow-up|1|||
145635306|NCT01563354|525180112|FG001|Core Phase|Lost to Follow-up|0|||
145635307|NCT01563354|525180113|FG002|Core Phase|Lost to Follow-up|0|||
145635308|NCT01563354|525180111|FG000|Core Phase|Death|1|||
145635309|NCT01563354|525180112|FG001|Core Phase|Death|5|||
145635310|NCT01563354|525180113|FG002|Core Phase|Death|2|||
145635311|NCT01563354|525180111|FG000|Core Phase|Diseasse progression|18|||
145635312|NCT01563354|525180112|FG001|Core Phase|Diseasse progression|7|||
145635313|NCT01563354|525180113|FG002|Core Phase|Diseasse progression|8|||
145635314|NCT01563354|525180111|FG000|Core Phase|Protocol deviation|2|||
145635315|NCT01563354|525180112|FG001|Core Phase|Protocol deviation|0|||
145635316|NCT01563354|525180113|FG002|Core Phase|Protocol deviation|0|||
145635317|NCT01563354|525180111|FG000|Core Phase|PI decision - did not enter extension|0|||
145635318|NCT01563354|525180112|FG001|Core Phase|PI decision - did not enter extension|1|||
145635319|NCT01563354|525180113|FG002|Core Phase|PI decision - did not enter extension|0|||
145635320|NCT01563354|525180111|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
145635321|NCT01563354|525180112|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
145635322|NCT01563354|525180113|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
145635323|NCT01563354|525180111|FG000|Extension Phase|Adverse Event|0|||
145635324|NCT01563354|525180112|FG001|Extension Phase|Adverse Event|3|||
145635325|NCT01563354|525180113|FG002|Extension Phase|Adverse Event|2|||
145635326|NCT01563354|525180111|FG000|Extension Phase|Withdrawal by Subject|0|||
145635327|NCT01563354|525180112|FG001|Extension Phase|Withdrawal by Subject|1|||
145635328|NCT01563354|525180113|FG002|Extension Phase|Withdrawal by Subject|0|||
145635329|NCT01563354|525180111|FG000|Extension Phase|Administration problems|3|||
145635330|NCT01563354|525180112|FG001|Extension Phase|Administration problems|2|||
145635331|NCT01563354|525180113|FG002|Extension Phase|Administration problems|3|||
145635332|NCT01563354|525180111|FG000|Extension Phase|Disease progression|9|||
145635333|NCT01563354|525180112|FG001|Extension Phase|Disease progression|8|||
145635334|NCT01563354|525180113|FG002|Extension Phase|Disease progression|10|||
145635335|NCT01988233|525180117|FG000|Overall Study|Lost to Follow-up|64|||
145635336|NCT01988233|525180118|FG001|Overall Study|Lost to Follow-up|51|||
145480900|NCT03364309|524613216|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
145603273|NCT00394355|525061450|FG003|Overall Study|Did not meet protocol eligibility|2|||
145603274|NCT00394355|525061447|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
145603275|NCT00394355|525061448|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
145603276|NCT00394355|525061449|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
145603277|NCT00394355|525061450|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
145603278|NCT00394355|525061447|FG000|Overall Study|Subject withdrawal - related to drug|1|||
145603279|NCT00394355|525061448|FG001|Overall Study|Subject withdrawal - related to drug|0|||
145603280|NCT00394355|525061449|FG002|Overall Study|Subject withdrawal - related to drug|0|||
145603281|NCT00394355|525061450|FG003|Overall Study|Subject withdrawal - related to drug|0|||
145603282|NCT00394355|525061447|FG000|Overall Study|Lost to Follow-up|7|||
145603283|NCT00394355|525061448|FG001|Overall Study|Lost to Follow-up|5|||
145603284|NCT00394355|525061449|FG002|Overall Study|Lost to Follow-up|4|||
145603285|NCT00394355|525061450|FG003|Overall Study|Lost to Follow-up|3|||
145603286|NCT00394355|525061447|FG000|Overall Study|Noncompliance with protocol|4|||
145603287|NCT00394355|525061448|FG001|Overall Study|Noncompliance with protocol|3|||
145603288|NCT00394355|525061449|FG002|Overall Study|Noncompliance with protocol|10|||
145603289|NCT00394355|525061450|FG003|Overall Study|Noncompliance with protocol|8|||
145603290|NCT00394355|525061447|FG000|Overall Study|Administrative|0|||
145603291|NCT00394355|525061448|FG001|Overall Study|Administrative|1|||
145603292|NCT00394355|525061449|FG002|Overall Study|Administrative|1|||
145603293|NCT00394355|525061450|FG003|Overall Study|Administrative|1|||
145603294|NCT00394355|525061447|FG000|Overall Study|Lack of Efficacy|0|||
145603295|NCT00394355|525061448|FG001|Overall Study|Lack of Efficacy|0|||
145603296|NCT00394355|525061449|FG002|Overall Study|Lack of Efficacy|2|||
145603297|NCT00394355|525061450|FG003|Overall Study|Lack of Efficacy|3|||
145603298|NCT00698646|525061454|FG000|Overall Study|Adverse Event|8|||
145480901|NCT03364309|524613217|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480902|NCT03364309|524613218|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480903|NCT03364309|524613219|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480904|NCT03364309|524613220|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
145480905|NCT03364309|524613221|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480906|NCT03364309|524613222|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480907|NCT03364309|524613223|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480908|NCT03364309|524613224|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
145480909|NCT03364309|524613206|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
145603299|NCT00698646|525061455|FG001|Overall Study|Adverse Event|7|||
145603300|NCT00698646|525061456|FG002|Overall Study|Adverse Event|8|||
145603301|NCT00698646|525061454|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
145603302|NCT00698646|525061455|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
145635337|NCT03621761|525180123|FG000|Overall Study|Lost to Follow-up|1|||
145635338|NCT03621761|525180124|FG001|Overall Study|Lost to Follow-up|1|||
145635339|NCT03621761|525180125|FG002|Overall Study|Lost to Follow-up|2|||
145635340|NCT03621761|525180123|FG000|Overall Study|Withdrawal by Subject|2|||
145635341|NCT03621761|525180124|FG001|Overall Study|Withdrawal by Subject|1|||
145480910|NCT03364309|524613207|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
145480911|NCT03364309|524613208|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
145480912|NCT03364309|524613209|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
145480913|NCT03364309|524613210|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
145603303|NCT00698646|525061456|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
145603304|NCT00698646|525061454|FG000|Overall Study|Protocol Deviation|6|||
145603305|NCT00698646|525061455|FG001|Overall Study|Protocol Deviation|2|||
145603306|NCT00698646|525061456|FG002|Overall Study|Protocol Deviation|3|||
145603307|NCT00698646|525061454|FG000|Overall Study|Withdrawal by Subject|10|||
145603308|NCT00698646|525061455|FG001|Overall Study|Withdrawal by Subject|11|||
145603309|NCT00698646|525061456|FG002|Overall Study|Withdrawal by Subject|8|||
145603310|NCT00698646|525061454|FG000|Overall Study|Lost to Follow-up|0|||
145603311|NCT00698646|525061455|FG001|Overall Study|Lost to Follow-up|0|||
145603312|NCT00698646|525061456|FG002|Overall Study|Lost to Follow-up|2|||
145603313|NCT00698646|525061454|FG000|Overall Study|Administrative problems|1|||
145603314|NCT00698646|525061455|FG001|Overall Study|Administrative problems|0|||
145603315|NCT00698646|525061456|FG002|Overall Study|Administrative problems|1|||
145603316|NCT00511875|525061459|FG000|Overall Study|Lost to Follow-up|4|||
145603317|NCT00511875|525061460|FG001|Overall Study|Lost to Follow-up|0|||
145603318|NCT00511875|525061459|FG000|Overall Study|Missing variables|1|||
145603319|NCT00511875|525061460|FG001|Overall Study|Missing variables|0|||
145603320|NCT02686034|525061463|FG000|Run-In Period 1|Eligibility|12|||
145603321|NCT02686034|525061464|FG001|Run-In Period 1|Eligibility|10|||
145603322|NCT02686034|525061463|FG000|Run-In Period 1|Withdrawal by Subject|4|||
145603323|NCT02686034|525061464|FG001|Run-In Period 1|Withdrawal by Subject|3|||
145603324|NCT02686034|525061463|FG000|Run-In Period 1|Lost to Follow-up|4|||
145603325|NCT02686034|525061464|FG001|Run-In Period 1|Lost to Follow-up|4|||
145603326|NCT02686034|525061463|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
145603327|NCT02686034|525061464|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
145603328|NCT02686034|525061463|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
145603329|NCT02686034|525061464|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
145603330|NCT02686034|525061463|FG000|Randomized Controlled Period 2|Adverse Event|0|||
145603331|NCT02686034|525061464|FG001|Randomized Controlled Period 2|Adverse Event|2|||
145603332|NCT02686034|525061463|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
145603333|NCT02686034|525061464|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
145603334|NCT02686034|525061463|FG000|Open Label Period 3|Lost to Follow-up|0|||
145603335|NCT02686034|525061464|FG001|Open Label Period 3|Lost to Follow-up|1|||
145603336|NCT00459342|525061465|FG000|Overall Study|Not eligible|1|||
145603337|NCT00542880|525061466|FG000|Period 1|Eligibility criteria not fulfilled|2|||
145603338|NCT00542880|525061467|FG001|Period 1|Eligibility criteria not fulfilled|6|||
145603339|NCT00542880|525061466|FG000|Period 1|Adverse Event|2|||
145603340|NCT00542880|525061467|FG001|Period 1|Adverse Event|2|||
145603341|NCT00542880|525061466|FG000|Period 1|Development of study-specific criteria|1|||
145603342|NCT00542880|525061467|FG001|Period 1|Development of study-specific criteria|2|||
145603343|NCT00542880|525061466|FG000|Period 1|Withdrawal by Subject|1|||
145603344|NCT00542880|525061467|FG001|Period 1|Withdrawal by Subject|1|||
145603345|NCT00542880|525061466|FG000|Period 1|Protocol Violation|0|||
145603346|NCT00542880|525061467|FG001|Period 1|Protocol Violation|1|||
145603347|NCT00542880|525061466|FG000|Period 2|Adverse Event|5|||
145603348|NCT00542880|525061467|FG001|Period 2|Adverse Event|7|||
145603349|NCT00542880|525061466|FG000|Period 2|Eligibility not fulfilled|0|||
145603350|NCT00542880|525061467|FG001|Period 2|Eligibility not fulfilled|1|||
145603351|NCT00542880|525061466|FG000|Period 2|Discontinuation criteria|2|||
145603352|NCT00542880|525061467|FG001|Period 2|Discontinuation criteria|0|||
145603353|NCT00542880|525061466|FG000|Period 2|Severe non-compliance|0|||
145603354|NCT00542880|525061467|FG001|Period 2|Severe non-compliance|1|||
145603355|NCT00542880|525061466|FG000|Period 2|Other|0|||
145603356|NCT00542880|525061467|FG001|Period 2|Other|1|||
145603357|NCT00542880|525061466|FG000|Period 3|Adverse Event|0|||
145603358|NCT00542880|525061467|FG001|Period 3|Adverse Event|2|||
145603359|NCT00696384|525061468|FG000|Open Label Phase|Adverse Event|27|||
145603360|NCT00696384|525061469|FG001|Open Label Phase|Adverse Event|0|||
145603361|NCT00696384|525061470|FG002|Open Label Phase|Adverse Event|0|||
145603362|NCT00696384|525061468|FG000|Open Label Phase|Protocol Violation|18|||
145603363|NCT00696384|525061469|FG001|Open Label Phase|Protocol Violation|0|||
145603364|NCT00696384|525061470|FG002|Open Label Phase|Protocol Violation|0|||
145603365|NCT00696384|525061468|FG000|Open Label Phase|Lost to Follow-up|24|||
145603366|NCT00696384|525061469|FG001|Open Label Phase|Lost to Follow-up|0|||
145603367|NCT00696384|525061470|FG002|Open Label Phase|Lost to Follow-up|0|||
145603368|NCT00696384|525061468|FG000|Open Label Phase|Withdrawal by Subject|37|||
145603369|NCT00696384|525061469|FG001|Open Label Phase|Withdrawal by Subject|0|||
145603370|NCT00696384|525061470|FG002|Open Label Phase|Withdrawal by Subject|0|||
145603371|NCT00696384|525061468|FG000|Open Label Phase|Other|6|||
145603372|NCT00696384|525061469|FG001|Open Label Phase|Other|0|||
145603373|NCT00696384|525061470|FG002|Open Label Phase|Other|0|||
145603374|NCT00696384|525061468|FG000|Open Label Phase|Lack of Efficacy|3|||
145603375|NCT00696384|525061469|FG001|Open Label Phase|Lack of Efficacy|0|||
145635342|NCT03621761|525180125|FG002|Overall Study|Withdrawal by Subject|1|||
145635343|NCT03621761|525180123|FG000|Overall Study|Became Ineligible|0|||
145635344|NCT03621761|525180124|FG001|Overall Study|Became Ineligible|2|||
145635345|NCT03621761|525180125|FG002|Overall Study|Became Ineligible|0|||
145635346|NCT01050569|525180126|FG000|Overall Study|Lost to Follow-up|20|||
145635347|NCT01050569|525180127|FG001|Overall Study|Lost to Follow-up|14|||
145635348|NCT01050569|525180128|FG002|Overall Study|Lost to Follow-up|16|||
145635349|NCT01050569|525180126|FG000|Overall Study|Withdrawal by Subject|9|||
145635350|NCT01050569|525180127|FG001|Overall Study|Withdrawal by Subject|3|||
145635351|NCT01050569|525180128|FG002|Overall Study|Withdrawal by Subject|11|||
145635352|NCT01050569|525180126|FG000|Overall Study|Lack of Efficacy|5|||
145635353|NCT01050569|525180127|FG001|Overall Study|Lack of Efficacy|4|||
145635354|NCT01050569|525180128|FG002|Overall Study|Lack of Efficacy|3|||
145635355|NCT01050569|525180126|FG000|Overall Study|Adverse Event|1|||
145635356|NCT01050569|525180127|FG001|Overall Study|Adverse Event|0|||
145635357|NCT01050569|525180128|FG002|Overall Study|Adverse Event|0|||
145635358|NCT01050569|525180126|FG000|Overall Study|Physician Decision|3|||
145635359|NCT01050569|525180127|FG001|Overall Study|Physician Decision|3|||
145635360|NCT01050569|525180128|FG002|Overall Study|Physician Decision|3|||
145635361|NCT03987451|525180131|FG000|Overall Study|Lost to Follow-up|1|||
145635362|NCT03987451|525180132|FG001|Overall Study|Lost to Follow-up|0|||
145635363|NCT03987451|525180131|FG000|Overall Study|Withdrawal by Subject|1|||
145635364|NCT03987451|525180132|FG001|Overall Study|Withdrawal by Subject|1|||
145635365|NCT02441036|525180133|FG000|Overall Study|No tissue resected|0|||
145635366|NCT02441036|525180134|FG001|Overall Study|No tissue resected|1|||
145635367|NCT02441036|525180135|FG002|Overall Study|No tissue resected|0|||
145635368|NCT02441036|525180136|FG003|Overall Study|No tissue resected|1|||
145635369|NCT02441036|525180137|FG004|Overall Study|No tissue resected|0|||
145635370|NCT01183780|525180138|FG000|Overall Study|Withdrawal by Subject|25|||
145635371|NCT01183780|525180139|FG001|Overall Study|Withdrawal by Subject|14|||
145635372|NCT01183780|525180138|FG000|Overall Study|Lost to Follow-up|6|||
145635373|NCT01183780|525180139|FG001|Overall Study|Lost to Follow-up|11|||
145635374|NCT00770965|525180142|FG000|Safety Set|Withdrawal by Subject|0|||
145635375|NCT00770965|525180143|FG001|Safety Set|Withdrawal by Subject|0|||
145635376|NCT00770965|525180144|FG002|Safety Set|Withdrawal by Subject|0|||
145635377|NCT00770965|525180145|FG003|Safety Set|Withdrawal by Subject|1|||
145635378|NCT00770965|525180142|FG000|Safety Set|Protocol deviation|0|||
145635379|NCT00770965|525180143|FG001|Safety Set|Protocol deviation|0|||
145635380|NCT00770965|525180144|FG002|Safety Set|Protocol deviation|1|||
145635381|NCT00770965|525180145|FG003|Safety Set|Protocol deviation|0|||
145635382|NCT00770965|525180142|FG000|Excluded Set|Administrative problems|14|||
145635383|NCT00770965|525180143|FG001|Excluded Set|Administrative problems|12|||
145635384|NCT00770965|525180144|FG002|Excluded Set|Administrative problems|12|||
145635385|NCT00770965|525180145|FG003|Excluded Set|Administrative problems|10|||
145635386|NCT00770965|525180142|FG000|Excluded Set|Withdrawal by Subject|1|||
145635387|NCT00770965|525180143|FG001|Excluded Set|Withdrawal by Subject|1|||
145635388|NCT00770965|525180144|FG002|Excluded Set|Withdrawal by Subject|2|||
145635389|NCT00770965|525180145|FG003|Excluded Set|Withdrawal by Subject|3|||
145635390|NCT00612586|525180146|FG000|Overall Study|Adverse Event|6|||
145635391|NCT00612586|525180147|FG001|Overall Study|Adverse Event|2|||
145635392|NCT00612586|525180146|FG000|Overall Study|Death|1|||
145635393|NCT00612586|525180147|FG001|Overall Study|Death|0|||
145635394|NCT00612586|525180146|FG000|Overall Study|Entry Criteria Not Met|0|||
145635395|NCT00612586|525180147|FG001|Overall Study|Entry Criteria Not Met|2|||
145635396|NCT00612586|525180146|FG000|Overall Study|Withdrawal by Subject|7|||
145635397|NCT00612586|525180147|FG001|Overall Study|Withdrawal by Subject|9|||
145635398|NCT00612586|525180146|FG000|Overall Study|Physician Decision|1|||
145635399|NCT00612586|525180147|FG001|Overall Study|Physician Decision|2|||
145635400|NCT00612586|525180146|FG000|Overall Study|Sponsor Decision|1|||
145635401|NCT00612586|525180147|FG001|Overall Study|Sponsor Decision|1|||
145635402|NCT00612586|525180146|FG000|Overall Study|Progressive Disease|26|||
145635403|NCT00612586|525180147|FG001|Overall Study|Progressive Disease|24|||
145635404|NCT00612586|525180146|FG000|Overall Study|Randomized and Not Treated|1|||
145635405|NCT00612586|525180147|FG001|Overall Study|Randomized and Not Treated|1|||
145635406|NCT01505881|525180148|FG000|Overall Study|Adverse Event|0|||
145635407|NCT01505881|525180149|FG001|Overall Study|Adverse Event|1|||
145635408|NCT01505881|525180148|FG000|Overall Study|Lost to Follow-up|2|||
145635409|NCT01505881|525180149|FG001|Overall Study|Lost to Follow-up|0|||
145635410|NCT01505881|525180148|FG000|Overall Study|Withdrawal by Subject|2|||
145635411|NCT01505881|525180149|FG001|Overall Study|Withdrawal by Subject|0|||
145635412|NCT01194154|525180150|FG000|Overall Study|Adverse Event|12|||
145635413|NCT01194154|525180151|FG001|Overall Study|Adverse Event|7|||
145635414|NCT01194154|525180150|FG000|Overall Study|Lost to Follow-up|2|||
145635415|NCT01194154|525180151|FG001|Overall Study|Lost to Follow-up|3|||
145635416|NCT01194154|525180150|FG000|Overall Study|Protocol Violation|0|||
145635417|NCT01194154|525180151|FG001|Overall Study|Protocol Violation|1|||
145635418|NCT01194154|525180150|FG000|Overall Study|Withdrawal by Subject|5|||
145635419|NCT01194154|525180151|FG001|Overall Study|Withdrawal by Subject|6|||
145635420|NCT01194154|525180150|FG000|Overall Study|Blood pressure increase|5|||
145603376|NCT00696384|525061470|FG002|Open Label Phase|Lack of Efficacy|0|||
145603377|NCT00696384|525061468|FG000|Open Label Phase|Physician Decision|4|||
145603378|NCT00696384|525061469|FG001|Open Label Phase|Physician Decision|0|||
145603379|NCT00696384|525061470|FG002|Open Label Phase|Physician Decision|0|||
145603380|NCT00696384|525061468|FG000|Double Blind Phase|Adverse Event|0|||
145603381|NCT00696384|525061469|FG001|Double Blind Phase|Adverse Event|2|||
145603382|NCT00696384|525061470|FG002|Double Blind Phase|Adverse Event|2|||
145603383|NCT00696384|525061468|FG000|Double Blind Phase|Lost to Follow-up|0|||
145603384|NCT00696384|525061469|FG001|Double Blind Phase|Lost to Follow-up|2|||
145603385|NCT00696384|525061470|FG002|Double Blind Phase|Lost to Follow-up|1|||
145603386|NCT00696384|525061468|FG000|Double Blind Phase|Withdrawal by Subject|0|||
145603387|NCT00696384|525061469|FG001|Double Blind Phase|Withdrawal by Subject|4|||
145603388|NCT00696384|525061470|FG002|Double Blind Phase|Withdrawal by Subject|3|||
145603389|NCT00696384|525061468|FG000|Double Blind Phase|Lack of Efficacy|0|||
145603390|NCT00696384|525061469|FG001|Double Blind Phase|Lack of Efficacy|1|||
145603391|NCT00696384|525061470|FG002|Double Blind Phase|Lack of Efficacy|0|||
145603392|NCT00696384|525061468|FG000|Double Blind Phase|Physician Decision|0|||
145603393|NCT00696384|525061469|FG001|Double Blind Phase|Physician Decision|2|||
145603394|NCT00696384|525061470|FG002|Double Blind Phase|Physician Decision|0|||
145603395|NCT01678131|525061471|FG000|Overall Study|Adverse Event|0|||
145603396|NCT01678131|525061472|FG001|Overall Study|Adverse Event|1|||
145603397|NCT01678131|525061473|FG002|Overall Study|Adverse Event|0|||
145603398|NCT01678131|525061471|FG000|Overall Study|Withdrawal by Subject|0|||
145603399|NCT01678131|525061472|FG001|Overall Study|Withdrawal by Subject|0|||
145603400|NCT01678131|525061473|FG002|Overall Study|Withdrawal by Subject|2|||
145603401|NCT00558064|525061475|FG000|Overall Study|Adverse Event|3|||
145603402|NCT00558064|525061476|FG001|Overall Study|Adverse Event|2|||
145603403|NCT00558064|525061475|FG000|Overall Study|Lack of Efficacy|0|||
145603404|NCT00558064|525061476|FG001|Overall Study|Lack of Efficacy|1|||
145603405|NCT00558064|525061475|FG000|Overall Study|Protocol Violation|1|||
145603406|NCT00558064|525061476|FG001|Overall Study|Protocol Violation|0|||
145603407|NCT00558064|525061475|FG000|Overall Study|Lost to Follow-up|0|||
145603408|NCT00558064|525061476|FG001|Overall Study|Lost to Follow-up|1|||
145603409|NCT00558064|525061475|FG000|Overall Study|Withdrawal by Subject|0|||
145603410|NCT00558064|525061476|FG001|Overall Study|Withdrawal by Subject|1|||
145603411|NCT00558064|525061475|FG000|Overall Study|No visit within allowance period|1|||
145603412|NCT00558064|525061476|FG001|Overall Study|No visit within allowance period|0|||
145603413|NCT02027402|525061477|FG000|Overall Study|Withdrawal by Subject|4|||
145603414|NCT02027402|525061478|FG001|Overall Study|Withdrawal by Subject|1|||
145603415|NCT00941798|525061481|FG000|Overall Study|Withdrawal by Subject|72|||
145603416|NCT00941798|525061482|FG001|Overall Study|Withdrawal by Subject|74|||
145603417|NCT00941798|525061481|FG000|Overall Study|Adverse Event|43|||
145603418|NCT00941798|525061482|FG001|Overall Study|Adverse Event|23|||
145603419|NCT00941798|525061481|FG000|Overall Study|Lost to Follow-up|29|||
145603420|NCT00941798|525061482|FG001|Overall Study|Lost to Follow-up|23|||
145603421|NCT00941798|525061481|FG000|Overall Study|Protocol Violation|17|||
145603422|NCT00941798|525061482|FG001|Overall Study|Protocol Violation|20|||
145603423|NCT00941798|525061481|FG000|Overall Study|Administrative problems|13|||
145603424|NCT00941798|525061482|FG001|Overall Study|Administrative problems|23|||
145603425|NCT00941798|525061481|FG000|Overall Study|Lack of Efficacy|10|||
145603426|NCT00941798|525061482|FG001|Overall Study|Lack of Efficacy|17|||
145603427|NCT00941798|525061481|FG000|Overall Study|Patient's inability to use device|6|||
145603428|NCT00941798|525061482|FG001|Overall Study|Patient's inability to use device|1|||
145603429|NCT00941798|525061481|FG000|Overall Study|Abnormal test procedure results|3|||
145603430|NCT00941798|525061482|FG001|Overall Study|Abnormal test procedure results|1|||
145603431|NCT00941798|525061481|FG000|Overall Study|Abnormal laboratory values|1|||
145603432|NCT00941798|525061482|FG001|Overall Study|Abnormal laboratory values|2|||
145603433|NCT00941798|525061481|FG000|Overall Study|Death|0|||
145603434|NCT00941798|525061482|FG001|Overall Study|Death|1|||
145603435|NCT04179721|525061485|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
145603436|NCT04179721|525061486|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
145603437|NCT04179721|525061485|FG000|Overall Study|Lost to Follow-up|0|||
145603438|NCT04179721|525061486|FG001|Overall Study|Lost to Follow-up|1|||
145603439|NCT01489189|525061487|FG000|Overall Study|Withdrawal by Subject|20|||
145603440|NCT01489189|525061488|FG001|Overall Study|Withdrawal by Subject|23|||
145603441|NCT01489189|525061487|FG000|Overall Study|Death|10|||
145603442|NCT01489189|525061488|FG001|Overall Study|Death|8|||
145603443|NCT01489189|525061487|FG000|Overall Study|Missed Visit|1|||
145603444|NCT01489189|525061488|FG001|Overall Study|Missed Visit|4|||
145603445|NCT00112580|525061489|FG000|Overall Study|Adverse Event|1|||
145603446|NCT00112580|525061490|FG001|Overall Study|Adverse Event|2|||
145603447|NCT00112580|525061489|FG000|Overall Study|Disease progression|5|||
145603448|NCT00112580|525061490|FG001|Overall Study|Disease progression|16|||
145603449|NCT00112580|525061489|FG000|Overall Study|Participant withdrew consent|2|||
145603450|NCT00112580|525061490|FG001|Overall Study|Participant withdrew consent|1|||
145603451|NCT05597722|525061493|FG000|Overall Study|Study was terminated|6|||
145603452|NCT05597722|525061494|FG001|Overall Study|Study was terminated|1|||
145635421|NCT01194154|525180151|FG001|Overall Study|Blood pressure increase|3|||
145635422|NCT01194154|525180150|FG000|Overall Study|Hemoglobin decrease|0|||
145635423|NCT01194154|525180151|FG001|Overall Study|Hemoglobin decrease|1|||
145635424|NCT01194154|525180150|FG000|Overall Study|Hemoglobin increase|12|||
145635425|NCT01194154|525180151|FG001|Overall Study|Hemoglobin increase|3|||
145635426|NCT01194154|525180150|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
145635427|NCT01194154|525180151|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
145635428|NCT01194154|525180150|FG000|Overall Study|Treatment with prohibited medication|4|||
145635429|NCT01194154|525180151|FG001|Overall Study|Treatment with prohibited medication|5|||
145635430|NCT01194154|525180150|FG000|Overall Study|Other|4|||
145635431|NCT01194154|525180151|FG001|Overall Study|Other|0|||
145635432|NCT01194154|525180150|FG000|Overall Study|Did not receive study medication|2|||
145635433|NCT01194154|525180151|FG001|Overall Study|Did not receive study medication|4|||
145635434|NCT01901276|525180152|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
145635435|NCT01901276|525180153|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
145635436|NCT01596504|525180154|FG000|Overall Study|Participant's Private Reason|0|||
145635437|NCT01596504|525180155|FG001|Overall Study|Participant's Private Reason|1|||
145635438|NCT01596504|525180156|FG002|Overall Study|Participant's Private Reason|0|||
145635439|NCT01596504|525180154|FG000|Overall Study|Adverse Event|1|||
145635440|NCT01596504|525180155|FG001|Overall Study|Adverse Event|2|||
145635441|NCT01596504|525180156|FG002|Overall Study|Adverse Event|1|||
145635442|NCT01596504|525180154|FG000|Overall Study|Withdrawal by Subject|1|||
145635443|NCT01596504|525180155|FG001|Overall Study|Withdrawal by Subject|0|||
145635444|NCT01596504|525180156|FG002|Overall Study|Withdrawal by Subject|0|||
145635445|NCT00395018|525180157|FG000|On-Treatment|Death|4|||
145635446|NCT00395018|525180157|FG000|On-Treatment|Other Reason|2|||
145635447|NCT00395018|525180157|FG000|On-Treatment|Poor/non-compliance|2|||
145635448|NCT00395018|525180157|FG000|On-Treatment|Subject no longer meets study criteria|2|||
145635449|NCT00395018|525180157|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
145635450|NCT00395018|525180157|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
145635451|NCT00395018|525180157|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
145635452|NCT02314117|525180158|FG000|Overall Study|Lost to Follow-up|9|||
145635453|NCT02314117|525180159|FG001|Overall Study|Lost to Follow-up|14|||
145635454|NCT02314117|525180158|FG000|Overall Study|Withdrawal by Subject|3|||
145635455|NCT02314117|525180159|FG001|Overall Study|Withdrawal by Subject|2|||
145635456|NCT00949975|525180160|FG000|Overall Study|Voluntary discontinuation|6|||
145635457|NCT00949975|525180161|FG001|Overall Study|Voluntary discontinuation|5|||
145635458|NCT00949975|525180162|FG002|Overall Study|Voluntary discontinuation|3|||
145635459|NCT00949975|525180163|FG003|Overall Study|Voluntary discontinuation|6|||
145635460|NCT00949975|525180160|FG000|Overall Study|Adverse Event|11|||
145635461|NCT00949975|525180161|FG001|Overall Study|Adverse Event|11|||
145635462|NCT00949975|525180162|FG002|Overall Study|Adverse Event|10|||
145635463|NCT00949975|525180163|FG003|Overall Study|Adverse Event|10|||
145635464|NCT00949975|525180160|FG000|Overall Study|Safety reason|0|||
145635465|NCT00949975|525180161|FG001|Overall Study|Safety reason|1|||
145635466|NCT00949975|525180162|FG002|Overall Study|Safety reason|0|||
145635467|NCT00949975|525180163|FG003|Overall Study|Safety reason|0|||
145635468|NCT00949975|525180160|FG000|Overall Study|Study-specific criteria|0|||
145635469|NCT00949975|525180161|FG001|Overall Study|Study-specific criteria|1|||
145635470|NCT00949975|525180162|FG002|Overall Study|Study-specific criteria|1|||
145635471|NCT00949975|525180163|FG003|Overall Study|Study-specific criteria|0|||
145635472|NCT00949975|525180160|FG000|Overall Study|Incorrect enrolment|5|||
145635473|NCT00949975|525180161|FG001|Overall Study|Incorrect enrolment|10|||
145635474|NCT00949975|525180162|FG002|Overall Study|Incorrect enrolment|4|||
145635475|NCT00949975|525180163|FG003|Overall Study|Incorrect enrolment|7|||
145635476|NCT00949975|525180160|FG000|Overall Study|Severe non-compliance|3|||
145635477|NCT00949975|525180161|FG001|Overall Study|Severe non-compliance|1|||
145635478|NCT00949975|525180162|FG002|Overall Study|Severe non-compliance|0|||
145635479|NCT00949975|525180163|FG003|Overall Study|Severe non-compliance|2|||
145635480|NCT00949975|525180160|FG000|Overall Study|Lost to Follow-up|1|||
145635481|NCT00949975|525180161|FG001|Overall Study|Lost to Follow-up|0|||
145635482|NCT00949975|525180162|FG002|Overall Study|Lost to Follow-up|1|||
145635483|NCT00949975|525180163|FG003|Overall Study|Lost to Follow-up|3|||
145635484|NCT00949975|525180160|FG000|Overall Study|Other|1|||
145635485|NCT00949975|525180161|FG001|Overall Study|Other|0|||
145635486|NCT00949975|525180162|FG002|Overall Study|Other|0|||
145635487|NCT00949975|525180163|FG003|Overall Study|Other|0|||
145635488|NCT04347954|525180164|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
145635489|NCT04347954|525180165|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
145635490|NCT04347954|525180166|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
145635491|NCT04347954|525180164|FG000|Overall Study|Lost to Follow-up|0|||
145635492|NCT04347954|525180165|FG001|Overall Study|Lost to Follow-up|1|||
145635493|NCT04347954|525180166|FG002|Overall Study|Lost to Follow-up|0|||
145635494|NCT03257813|525180170|FG000|Overall Study|Protocol Violation|6|||
145635495|NCT03257813|525180171|FG001|Overall Study|Protocol Violation|3|||
145635496|NCT03478696|525180172|FG000|Overall Study|Adverse Event|1|||
145635497|NCT03478696|525180173|FG001|Overall Study|Adverse Event|5|||
145635498|NCT03478696|525180172|FG000|Overall Study|Lost to Follow-up|1|||
145635499|NCT03478696|525180173|FG001|Overall Study|Lost to Follow-up|0|||
145635500|NCT03478696|525180172|FG000|Overall Study|Physician Decision|6|||
145635501|NCT03478696|525180173|FG001|Overall Study|Physician Decision|3|||
145635502|NCT03478696|525180172|FG000|Overall Study|Withdrawal by Subject|9|||
145635503|NCT03478696|525180173|FG001|Overall Study|Withdrawal by Subject|4|||
145635504|NCT03615924|525180174|FG000|Overall Study|Withdrawal by Subject|2|||
145635505|NCT03615924|525180175|FG001|Overall Study|Withdrawal by Subject|5|||
145635506|NCT03615924|525180174|FG000|Overall Study|Death|3|||
145635507|NCT03615924|525180175|FG001|Overall Study|Death|1|||
145635508|NCT03615924|525180174|FG000|Overall Study|Lost to Follow-up|1|||
145635509|NCT03615924|525180175|FG001|Overall Study|Lost to Follow-up|0|||
145635510|NCT03615924|525180174|FG000|Overall Study|Randomized in error|1|||
145635511|NCT03615924|525180175|FG001|Overall Study|Randomized in error|0|||
145635512|NCT03615924|525180174|FG000|Overall Study|Study termination by Sponsor|94|||
145635513|NCT03615924|525180175|FG001|Overall Study|Study termination by Sponsor|86|||
145635514|NCT00716144|525180176|FG000|Overall Study|Withdrawal by Subject|4|||
145635515|NCT00716144|525180177|FG001|Overall Study|Withdrawal by Subject|2|||
145635516|NCT00716144|525180178|FG002|Overall Study|Withdrawal by Subject|6|||
145635517|NCT00716144|525180179|FG003|Overall Study|Withdrawal by Subject|6|||
145635518|NCT00716144|525180176|FG000|Overall Study|Lost to Follow-up|2|||
145635519|NCT00716144|525180177|FG001|Overall Study|Lost to Follow-up|2|||
145635520|NCT00716144|525180178|FG002|Overall Study|Lost to Follow-up|1|||
145635521|NCT00716144|525180179|FG003|Overall Study|Lost to Follow-up|2|||
145635522|NCT00716144|525180176|FG000|Overall Study|Adverse Event|0|||
145635523|NCT00716144|525180177|FG001|Overall Study|Adverse Event|0|||
145635524|NCT00716144|525180178|FG002|Overall Study|Adverse Event|0|||
145635525|NCT00716144|525180179|FG003|Overall Study|Adverse Event|2|||
145635526|NCT00716144|525180176|FG000|Overall Study|Non-compliance|1|||
145635527|NCT00716144|525180177|FG001|Overall Study|Non-compliance|0|||
145635528|NCT00716144|525180178|FG002|Overall Study|Non-compliance|0|||
145635529|NCT00716144|525180179|FG003|Overall Study|Non-compliance|0|||
145635530|NCT00716144|525180176|FG000|Overall Study|Protocol Violation|2|||
145635531|NCT00716144|525180177|FG001|Overall Study|Protocol Violation|0|||
145635532|NCT00716144|525180178|FG002|Overall Study|Protocol Violation|1|||
145635533|NCT00716144|525180179|FG003|Overall Study|Protocol Violation|0|||
145635534|NCT00716144|525180176|FG000|Overall Study|Physician Decision|0|||
145635535|NCT00716144|525180177|FG001|Overall Study|Physician Decision|1|||
145635536|NCT00716144|525180178|FG002|Overall Study|Physician Decision|2|||
145635537|NCT00716144|525180179|FG003|Overall Study|Physician Decision|2|||
145635538|NCT00716144|525180176|FG000|Overall Study|Intercurrent illness|0|||
145635539|NCT00716144|525180177|FG001|Overall Study|Intercurrent illness|0|||
145635540|NCT00716144|525180178|FG002|Overall Study|Intercurrent illness|1|||
145635541|NCT00716144|525180179|FG003|Overall Study|Intercurrent illness|0|||
145635542|NCT00716144|525180176|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
145635543|NCT00716144|525180177|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
145635544|NCT00716144|525180178|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
145635545|NCT00716144|525180179|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
145635546|NCT00716144|525180176|FG000|Overall Study|Adverse event: left foot pain|0|||
145635547|NCT00716144|525180177|FG001|Overall Study|Adverse event: left foot pain|1|||
145635548|NCT00716144|525180178|FG002|Overall Study|Adverse event: left foot pain|0|||
145635549|NCT00716144|525180179|FG003|Overall Study|Adverse event: left foot pain|0|||
145635550|NCT00716144|525180176|FG000|Overall Study|Clinical Depression|0|||
145635551|NCT00716144|525180177|FG001|Overall Study|Clinical Depression|1|||
145635552|NCT00716144|525180178|FG002|Overall Study|Clinical Depression|0|||
145635553|NCT00716144|525180179|FG003|Overall Study|Clinical Depression|0|||
145635554|NCT00909363|525180180|FG000|Overall Study|Withdrawal by Subject|1|||
145635555|NCT00909363|525180181|FG001|Overall Study|Withdrawal by Subject|0|||
145635556|NCT00909363|525180182|FG002|Overall Study|Withdrawal by Subject|0|||
145635557|NCT00909363|525180180|FG000|Overall Study|Lack of Efficacy|1|||
145635558|NCT00909363|525180181|FG001|Overall Study|Lack of Efficacy|0|||
145635559|NCT00909363|525180182|FG002|Overall Study|Lack of Efficacy|0|||
145635560|NCT02954848|525180192|FG000|Overall Study|Randomized but Not Treated|0|||
145480914|NCT03364309|524613211|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
145480915|NCT03364309|524613212|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
145635561|NCT02954848|525180193|FG001|Overall Study|Randomized but Not Treated|1|||
145635562|NCT02954848|525180192|FG000|Overall Study|Adverse Event|2|||
145635563|NCT02954848|525180193|FG001|Overall Study|Adverse Event|3|||
145635564|NCT02954848|525180192|FG000|Overall Study|Withdrawal by Participant|0|||
145635565|NCT02954848|525180193|FG001|Overall Study|Withdrawal by Participant|1|||
145635566|NCT01802632|525180194|FG000|Overall Study|Death|28|||
145635567|NCT01802632|525180195|FG001|Overall Study|Death|1|||
145635568|NCT01802632|525180196|FG002|Overall Study|Death|38|||
145635569|NCT01802632|525180197|FG003|Overall Study|Death|0|||
145635570|NCT01802632|525180198|FG004|Overall Study|Death|2|||
145635571|NCT01802632|525180199|FG005|Overall Study|Death|0|||
145635572|NCT01802632|525180194|FG000|Overall Study|Withdrawal by Subject|4|||
145635573|NCT01802632|525180195|FG001|Overall Study|Withdrawal by Subject|2|||
145635574|NCT01802632|525180196|FG002|Overall Study|Withdrawal by Subject|7|||
145635575|NCT01802632|525180197|FG003|Overall Study|Withdrawal by Subject|3|||
145635576|NCT01802632|525180198|FG004|Overall Study|Withdrawal by Subject|0|||
145635577|NCT01802632|525180199|FG005|Overall Study|Withdrawal by Subject|1|||
145635578|NCT01802632|525180194|FG000|Overall Study|Objective Disease Progression|1|||
145635579|NCT01802632|525180195|FG001|Overall Study|Objective Disease Progression|12|||
145635580|NCT01802632|525180196|FG002|Overall Study|Objective Disease Progression|104|||
145635581|NCT01802632|525180197|FG003|Overall Study|Objective Disease Progression|6|||
145635582|NCT01802632|525180198|FG004|Overall Study|Objective Disease Progression|4|||
145635583|NCT01802632|525180199|FG005|Overall Study|Objective Disease Progression|4|||
145635584|NCT01802632|525180194|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
145635585|NCT01802632|525180195|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
145635586|NCT01802632|525180196|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
145635587|NCT01802632|525180197|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
145635588|NCT01802632|525180198|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
145635589|NCT01802632|525180199|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
145635590|NCT01802632|525180194|FG000|Overall Study|Other (not specified)|0|||
145635591|NCT01802632|525180195|FG001|Overall Study|Other (not specified)|0|||
145635592|NCT01802632|525180196|FG002|Overall Study|Other (not specified)|7|||
145635593|NCT01802632|525180197|FG003|Overall Study|Other (not specified)|1|||
145635594|NCT01802632|525180198|FG004|Overall Study|Other (not specified)|0|||
145635595|NCT01802632|525180199|FG005|Overall Study|Other (not specified)|1|||
145635596|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
145635597|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
145635598|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
145635599|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
145635600|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
145635601|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
145635602|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
145635603|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
145635604|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
145635605|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
145635606|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
145635607|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
145635608|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
145635609|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
145635610|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
145603453|NCT00404495|525061495|FG000|Overall Study|Death|37|||
145603454|NCT00404495|525061496|FG001|Overall Study|Death|11|||
145603455|NCT00404495|525061495|FG000|Overall Study|Lost to Follow-up|5|||
145603456|NCT00404495|525061496|FG001|Overall Study|Lost to Follow-up|0|||
145603457|NCT00404495|525061495|FG000|Overall Study|Other|1|||
145603458|NCT00404495|525061496|FG001|Overall Study|Other|0|||
145603459|NCT00404495|525061495|FG000|Overall Study|Withdrawal by Subject|1|||
145603460|NCT00404495|525061496|FG001|Overall Study|Withdrawal by Subject|0|||
145603461|NCT01529008|525063081|FG000|Bone Marrow Harvesting|Physician Decision|1|||
145603462|NCT01529008|525063082|FG001|Bone Marrow Harvesting|Physician Decision|1|||
145603463|NCT01529008|525063081|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
145603464|NCT01529008|525063082|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
145603465|NCT01529008|525063081|FG000|Treatment|Adverse Event|6|||
145603466|NCT01529008|525063082|FG001|Treatment|Adverse Event|0|||
145603467|NCT01529008|525063081|FG000|Treatment|Other|3|||
145603468|NCT01529008|525063082|FG001|Treatment|Other|1|||
145603469|NCT01529008|525063081|FG000|Efficacy Analysis|Protocol Violation|2|||
145603470|NCT01529008|525063082|FG001|Efficacy Analysis|Protocol Violation|0|||
145603471|NCT01529008|525063081|FG000|Efficacy Analysis|Physician Decision|0|||
145603472|NCT01529008|525063082|FG001|Efficacy Analysis|Physician Decision|1|||
145603473|NCT01529008|525063081|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
145603474|NCT01529008|525063082|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
145603475|NCT00332332|525063083|FG000|Overall Study|Adverse Event|13|||
145603476|NCT00332332|525063083|FG000|Overall Study|Death|1|||
145603477|NCT00332332|525063083|FG000|Overall Study|Withdrawal by Subject|8|||
145603478|NCT00332332|525063083|FG000|Overall Study|Physician Decision|1|||
145603479|NCT00332332|525063083|FG000|Overall Study|Lost to Follow-up|3|||
145603480|NCT00332332|525063083|FG000|Overall Study|Protocol deviation|4|||
145603481|NCT00332332|525063083|FG000|Overall Study|Noncompliance|2|||
145603482|NCT00332332|525063083|FG000|Overall Study|Disease progression|2|||
145603483|NCT00332332|525063083|FG000|Overall Study|Other|18|||
145635611|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635612|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635613|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
145635614|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635615|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635616|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635617|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635618|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635619|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635620|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635621|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
145635622|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
145635623|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
145635624|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
145635625|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
145635626|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
145635627|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
145635628|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
145635629|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
145635630|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
145635631|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
145635632|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
145635633|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
145635634|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
145635635|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635636|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
145635637|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
145635638|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635639|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
145635640|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635641|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635642|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635643|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635644|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635645|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635646|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635647|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
145635648|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
145635649|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
145635650|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
145635651|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
145635652|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
145635653|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635654|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635655|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635656|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
145635657|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635658|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635659|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635660|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
145635661|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
145635662|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635663|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635664|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635665|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635666|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
145635667|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
145635668|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
145635669|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635670|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635671|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635672|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635673|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
145635674|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
145635675|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
145635676|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
145480916|NCT03364309|524613213|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
145480917|NCT03364309|524613214|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
145480918|NCT03364309|524613215|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
145480919|NCT03364309|524613216|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
145480920|NCT03364309|524613217|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
145635677|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
145635678|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
145635679|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
145635680|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
145635681|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
145635682|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
145635683|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
145635684|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
145635685|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
145635686|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
145635687|NCT04707313|525180201|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635688|NCT04707313|525180202|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635689|NCT04707313|525180203|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
145635690|NCT04707313|525180204|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635691|NCT04707313|525180205|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635692|NCT04707313|525180206|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635693|NCT04707313|525180207|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635694|NCT04707313|525180208|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
145635695|NCT04707313|525180209|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635696|NCT04707313|525180210|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635697|NCT04707313|525180211|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635698|NCT04707313|525180212|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635699|NCT04707313|525180213|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
145635700|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635701|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635702|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635703|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635704|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635705|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635706|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635707|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635708|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635709|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
145635710|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
145635711|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
145635712|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
145635713|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635714|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635715|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635716|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635717|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635718|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635719|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635720|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635721|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635722|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
145635723|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
145635724|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
145635725|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
145635726|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635727|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635728|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635729|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635730|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635731|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635732|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635733|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635734|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
145635735|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
145635736|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
145635737|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
145635738|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
145635739|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635740|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635741|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635742|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635743|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635744|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635745|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635746|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635747|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635748|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635749|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
145635750|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
145635751|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
145635752|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635753|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635754|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635755|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635756|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635757|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635758|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635759|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635760|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635761|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
145635762|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
145635763|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635764|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
145635765|NCT04707313|525180201|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635766|NCT04707313|525180202|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635767|NCT04707313|525180203|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635768|NCT04707313|525180204|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635769|NCT04707313|525180205|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635770|NCT04707313|525180206|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635771|NCT04707313|525180207|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635772|NCT04707313|525180208|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635773|NCT04707313|525180209|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
145635774|NCT04707313|525180210|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
145635775|NCT04707313|525180211|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
145635776|NCT04707313|525180212|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
145635777|NCT04707313|525180213|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
145635778|NCT02020616|525180218|FG000|Overall Study|Adverse Event|0|||
145635779|NCT02020616|525180219|FG001|Overall Study|Adverse Event|0|||
145635780|NCT02020616|525180220|FG002|Overall Study|Adverse Event|0|||
145635781|NCT02020616|525180221|FG003|Overall Study|Adverse Event|0|||
145635782|NCT02020616|525180222|FG004|Overall Study|Adverse Event|0|||
145635783|NCT02020616|525180223|FG005|Overall Study|Adverse Event|1|||
145635784|NCT02020616|525180224|FG006|Overall Study|Adverse Event|1|||
145635785|NCT02020616|525180218|FG000|Overall Study|Physician Decision|0|||
145635786|NCT02020616|525180219|FG001|Overall Study|Physician Decision|0|||
145635787|NCT02020616|525180220|FG002|Overall Study|Physician Decision|0|||
145635788|NCT02020616|525180221|FG003|Overall Study|Physician Decision|0|||
145635789|NCT02020616|525180222|FG004|Overall Study|Physician Decision|0|||
145635790|NCT02020616|525180223|FG005|Overall Study|Physician Decision|1|||
145635791|NCT02020616|525180224|FG006|Overall Study|Physician Decision|2|||
145635792|NCT02020616|525180218|FG000|Overall Study|Withdrawal by Subject|0|||
145635793|NCT02020616|525180219|FG001|Overall Study|Withdrawal by Subject|0|||
145635794|NCT02020616|525180220|FG002|Overall Study|Withdrawal by Subject|1|||
145635795|NCT02020616|525180221|FG003|Overall Study|Withdrawal by Subject|0|||
145635796|NCT02020616|525180222|FG004|Overall Study|Withdrawal by Subject|0|||
145635797|NCT02020616|525180223|FG005|Overall Study|Withdrawal by Subject|1|||
145635798|NCT02020616|525180224|FG006|Overall Study|Withdrawal by Subject|1|||
145635799|NCT02020616|525180218|FG000|Overall Study|Lost to Follow-up|0|||
145635800|NCT02020616|525180219|FG001|Overall Study|Lost to Follow-up|1|||
145635801|NCT02020616|525180220|FG002|Overall Study|Lost to Follow-up|0|||
145635802|NCT02020616|525180221|FG003|Overall Study|Lost to Follow-up|1|||
145635803|NCT02020616|525180222|FG004|Overall Study|Lost to Follow-up|1|||
145635804|NCT02020616|525180223|FG005|Overall Study|Lost to Follow-up|1|||
145635805|NCT02020616|525180224|FG006|Overall Study|Lost to Follow-up|0|||
145635806|NCT02020616|525180218|FG000|Overall Study|Early Termination Criteria Met|0|||
145635807|NCT02020616|525180219|FG001|Overall Study|Early Termination Criteria Met|0|||
145635808|NCT02020616|525180220|FG002|Overall Study|Early Termination Criteria Met|1|||
145635809|NCT02020616|525180221|FG003|Overall Study|Early Termination Criteria Met|0|||
145635810|NCT02020616|525180222|FG004|Overall Study|Early Termination Criteria Met|0|||
145635811|NCT02020616|525180223|FG005|Overall Study|Early Termination Criteria Met|1|||
145635812|NCT02020616|525180224|FG006|Overall Study|Early Termination Criteria Met|0|||
145635813|NCT02020616|525180218|FG000|Overall Study|Randomized in Error|0|||
145635814|NCT02020616|525180219|FG001|Overall Study|Randomized in Error|0|||
145635815|NCT02020616|525180220|FG002|Overall Study|Randomized in Error|0|||
145635816|NCT02020616|525180221|FG003|Overall Study|Randomized in Error|1|||
145635817|NCT02020616|525180222|FG004|Overall Study|Randomized in Error|0|||
145635818|NCT02020616|525180223|FG005|Overall Study|Randomized in Error|0|||
145635819|NCT02020616|525180224|FG006|Overall Study|Randomized in Error|0|||
145635820|NCT02020616|525180218|FG000|Overall Study|Lack of Efficacy|0|||
145635821|NCT02020616|525180219|FG001|Overall Study|Lack of Efficacy|0|||
145635822|NCT02020616|525180220|FG002|Overall Study|Lack of Efficacy|0|||
145635823|NCT02020616|525180221|FG003|Overall Study|Lack of Efficacy|0|||
145635824|NCT02020616|525180222|FG004|Overall Study|Lack of Efficacy|1|||
145635825|NCT02020616|525180223|FG005|Overall Study|Lack of Efficacy|0|||
145635826|NCT02020616|525180224|FG006|Overall Study|Lack of Efficacy|0|||
145635827|NCT03070483|525180230|FG000|Overall Study|Lost to Follow-up|2|||
145635828|NCT02031471|525180231|FG000|24 Week Treatment Period|Adverse Event|6|||
145635829|NCT02031471|525180231|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
145635830|NCT02031471|525180231|FG000|24 Week Treatment Period|Protocol Violation|1|||
145635831|NCT02031471|525180231|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
145635832|NCT02031471|525180231|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
145635833|NCT02031471|525180231|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
145635834|NCT02031471|525180231|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
145635835|NCT00361283|525180235|FG000|Overall Study|Lost to Follow-up|27|||
145635836|NCT00961636|525180236|FG000|Overall Study|Adverse Event|35|||
145635837|NCT00961636|525180237|FG001|Overall Study|Adverse Event|54|||
145635838|NCT00961636|525180238|FG002|Overall Study|Adverse Event|13|||
145635839|NCT00961636|525180236|FG000|Overall Study|Flushing Symptoms|29|||
145635840|NCT00961636|525180237|FG001|Overall Study|Flushing Symptoms|46|||
145635841|NCT00961636|525180238|FG002|Overall Study|Flushing Symptoms|3|||
145635842|NCT00961636|525180236|FG000|Overall Study|Lost to Follow-up|2|||
145635843|NCT00961636|525180237|FG001|Overall Study|Lost to Follow-up|3|||
145635844|NCT00961636|525180238|FG002|Overall Study|Lost to Follow-up|1|||
145635845|NCT00961636|525180236|FG000|Overall Study|Physician Decision|3|||
145635846|NCT00961636|525180237|FG001|Overall Study|Physician Decision|1|||
145635847|NCT00961636|525180238|FG002|Overall Study|Physician Decision|1|||
145635848|NCT00961636|525180236|FG000|Overall Study|Protocol Violation|9|||
145635849|NCT00961636|525180237|FG001|Overall Study|Protocol Violation|5|||
145635850|NCT00961636|525180238|FG002|Overall Study|Protocol Violation|1|||
145635851|NCT00961636|525180236|FG000|Overall Study|Withdrawal by Subject|29|||
145635852|NCT00961636|525180237|FG001|Overall Study|Withdrawal by Subject|22|||
145635853|NCT00961636|525180238|FG002|Overall Study|Withdrawal by Subject|13|||
145635854|NCT01063517|525180239|FG000|Overall Study|Consent withdrawal|1|||
145635855|NCT01063517|525180240|FG001|Overall Study|Consent withdrawal|0|||
145635856|NCT01063517|525180239|FG000|Overall Study|Study reached data cut-off|19|||
145635857|NCT01063517|525180240|FG001|Overall Study|Study reached data cut-off|7|||
145635858|NCT01063517|525180239|FG000|Overall Study|Lost to Follow-up|4|||
145635859|NCT01063517|525180240|FG001|Overall Study|Lost to Follow-up|3|||
145635860|NCT01063517|525180239|FG000|Overall Study|Withdrawal by Subject|1|||
145635861|NCT01063517|525180240|FG001|Overall Study|Withdrawal by Subject|2|||
145635862|NCT01063517|525180239|FG000|Overall Study|Death|33|||
145635863|NCT01063517|525180240|FG001|Overall Study|Death|48|||
145655523|NCT02985957|525257253|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655524|NCT02985957|525257254|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655525|NCT02985957|525257255|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655526|NCT02985957|525257256|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655527|NCT02985957|525257257|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
145655528|NCT02985957|525257258|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655529|NCT02985957|525257259|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
145655530|NCT02985957|525257253|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
145655531|NCT02985957|525257254|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
145655532|NCT02985957|525257255|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
145655533|NCT02985957|525257256|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
145655534|NCT02985957|525257257|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
145655535|NCT02985957|525257258|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
145655536|NCT02985957|525257259|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
145655537|NCT02985957|525257253|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655538|NCT02985957|525257254|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655539|NCT02985957|525257255|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655540|NCT02985957|525257256|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655541|NCT02985957|525257257|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655542|NCT02985957|525257258|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
145655543|NCT02985957|525257259|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
145655544|NCT02985957|525257253|FG000|Treatment Period|Death|0|||
145655545|NCT02985957|525257254|FG001|Treatment Period|Death|0|||
145655546|NCT02985957|525257255|FG002|Treatment Period|Death|0|||
145655547|NCT02985957|525257256|FG003|Treatment Period|Death|0|||
145655548|NCT02985957|525257257|FG004|Treatment Period|Death|1|||
145655549|NCT02985957|525257258|FG005|Treatment Period|Death|0|||
145655550|NCT02985957|525257259|FG006|Treatment Period|Death|0|||
145655551|NCT02985957|525257253|FG000|Treatment Period|Participant withdrew consent|0|||
145480921|NCT03364309|524613218|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
145635864|NCT05328297|525181904|FG000|Overall Study|Adverse Event|5|||
145635865|NCT05328297|525181905|FG001|Overall Study|Adverse Event|7|||
145635866|NCT05328297|525181904|FG000|Overall Study|Withdrawal by Subject|4|||
145635867|NCT05328297|525181905|FG001|Overall Study|Withdrawal by Subject|3|||
145635868|NCT05328297|525181904|FG000|Overall Study|Lack of Efficacy|1|||
145635869|NCT05328297|525181905|FG001|Overall Study|Lack of Efficacy|0|||
145635870|NCT05328297|525181904|FG000|Overall Study|Lost to Follow-up|1|||
145635871|NCT05328297|525181905|FG001|Overall Study|Lost to Follow-up|0|||
145635872|NCT05328297|525181904|FG000|Overall Study|Protocol Violation|1|||
145635873|NCT05328297|525181905|FG001|Overall Study|Protocol Violation|0|||
145635874|NCT05328297|525181904|FG000|Overall Study|Randomized but not treated|1|||
145635875|NCT05328297|525181905|FG001|Overall Study|Randomized but not treated|1|||
145635876|NCT04513522|525181906|FG000|Overall Study|Other reasons|1|||
145635877|NCT04513522|525181906|FG000|Overall Study|Adverse event unrelated to study drug|9|||
145635878|NCT04513522|525181906|FG000|Overall Study|Study drug toxicity|14|||
145635879|NCT04513522|525181906|FG000|Overall Study|Disease progression|39|||
145635880|NCT04513522|525181906|FG000|Overall Study|Participants withdrew consent|2|||
145635881|NCT05219253|525181918|FG000|Overall Study|Withdrawal by Subject|1|||
145635882|NCT05219253|525181919|FG001|Overall Study|Withdrawal by Subject|2|||
145635883|NCT03086369|525181920|FG000|Overall Study|Lost to Follow-up|1|||
145635884|NCT03086369|525181921|FG001|Overall Study|Lost to Follow-up|0|||
145635885|NCT03086369|525181922|FG002|Overall Study|Lost to Follow-up|0|||
145635886|NCT03086369|525181923|FG003|Overall Study|Lost to Follow-up|2|||
145635887|NCT03086369|525181924|FG004|Overall Study|Lost to Follow-up|1|||
145635888|NCT03086369|525181920|FG000|Overall Study|Physician Decision|0|||
145635889|NCT03086369|525181921|FG001|Overall Study|Physician Decision|0|||
145635890|NCT03086369|525181922|FG002|Overall Study|Physician Decision|0|||
145635891|NCT03086369|525181923|FG003|Overall Study|Physician Decision|1|||
145635892|NCT03086369|525181924|FG004|Overall Study|Physician Decision|2|||
145635893|NCT03086369|525181920|FG000|Overall Study|Withdrawal by Subject|0|||
145635894|NCT03086369|525181921|FG001|Overall Study|Withdrawal by Subject|0|||
145635895|NCT03086369|525181922|FG002|Overall Study|Withdrawal by Subject|0|||
145635896|NCT03086369|525181923|FG003|Overall Study|Withdrawal by Subject|5|||
145635897|NCT03086369|525181924|FG004|Overall Study|Withdrawal by Subject|3|||
145635898|NCT03086369|525181920|FG000|Overall Study|Progressive Disease|0|||
145635899|NCT03086369|525181921|FG001|Overall Study|Progressive Disease|0|||
145635900|NCT03086369|525181922|FG002|Overall Study|Progressive Disease|0|||
145635901|NCT03086369|525181923|FG003|Overall Study|Progressive Disease|1|||
145635902|NCT03086369|525181924|FG004|Overall Study|Progressive Disease|1|||
145635903|NCT04668339|525181925|FG000|Overall Study|Physician Decision|1|||
145635904|NCT04668339|525181926|FG001|Overall Study|Physician Decision|0|||
145635905|NCT04668339|525181927|FG002|Overall Study|Physician Decision|1|||
145635906|NCT04668339|525181928|FG003|Overall Study|Physician Decision|1|||
145635907|NCT04668339|525181925|FG000|Overall Study|Lost to Follow-up|14|||
145635908|NCT04668339|525181926|FG001|Overall Study|Lost to Follow-up|12|||
145635909|NCT04668339|525181927|FG002|Overall Study|Lost to Follow-up|8|||
145635910|NCT04668339|525181928|FG003|Overall Study|Lost to Follow-up|5|||
145635911|NCT04668339|525181925|FG000|Overall Study|Adverse Event|0|||
145635912|NCT04668339|525181926|FG001|Overall Study|Adverse Event|0|||
145635913|NCT04668339|525181927|FG002|Overall Study|Adverse Event|1|||
145635914|NCT04668339|525181928|FG003|Overall Study|Adverse Event|0|||
145635915|NCT04668339|525181925|FG000|Overall Study|Other than specified|3|||
145635916|NCT04668339|525181926|FG001|Overall Study|Other than specified|0|||
145635917|NCT04668339|525181927|FG002|Overall Study|Other than specified|1|||
145635918|NCT04668339|525181928|FG003|Overall Study|Other than specified|0|||
145635919|NCT04668339|525181925|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
145635920|NCT04668339|525181926|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
145635921|NCT04668339|525181927|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
145635922|NCT04668339|525181928|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
145635923|NCT04668339|525181925|FG000|Overall Study|Vaccine not Administered|0|||
145635924|NCT04668339|525181926|FG001|Overall Study|Vaccine not Administered|0|||
145635925|NCT04668339|525181927|FG002|Overall Study|Vaccine not Administered|1|||
145635926|NCT04668339|525181928|FG003|Overall Study|Vaccine not Administered|0|||
145635927|NCT04668339|525181925|FG000|Overall Study|Protocol Violation|18|||
145635928|NCT04668339|525181926|FG001|Overall Study|Protocol Violation|23|||
145635929|NCT04668339|525181927|FG002|Overall Study|Protocol Violation|12|||
145635930|NCT04668339|525181928|FG003|Overall Study|Protocol Violation|20|||
145635931|NCT04668339|525181925|FG000|Overall Study|Withdrawal by Subject|45|||
145635932|NCT04668339|525181926|FG001|Overall Study|Withdrawal by Subject|46|||
145635933|NCT04668339|525181927|FG002|Overall Study|Withdrawal by Subject|46|||
145635934|NCT04668339|525181928|FG003|Overall Study|Withdrawal by Subject|27|||
145635935|NCT04668339|525181925|FG000|Overall Study|Study Terminated by Sponsor|59|||
145635936|NCT04668339|525181926|FG001|Overall Study|Study Terminated by Sponsor|59|||
145635937|NCT04668339|525181927|FG002|Overall Study|Study Terminated by Sponsor|71|||
145635938|NCT04668339|525181928|FG003|Overall Study|Study Terminated by Sponsor|1|||
145635939|NCT00178399|525181932|FG000|Overall Study|Physician Decision|4|||
145635940|NCT00178399|525181932|FG000|Overall Study|Withdrawal by Subject|8|||
145480922|NCT03364309|524613219|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
145480923|NCT03364309|524613220|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
145603484|NCT00332332|525063083|FG000|Overall Study|Did not receive study treatment|16|||
145603485|NCT01382602|525063084|FG000|Overall Study|Protocol Violation|0|||
145603486|NCT01382602|525063085|FG001|Overall Study|Protocol Violation|3|||
145603487|NCT01382602|525063084|FG000|Overall Study|Withdrawal by Subject|0|||
145603488|NCT01382602|525063085|FG001|Overall Study|Withdrawal by Subject|1|||
145603489|NCT02790073|525063088|FG000|Overall Study|Death|1|||
145603490|NCT02790073|525063088|FG000|Overall Study|Withdrawal from HD|1|||
145603491|NCT02790073|525063088|FG000|Overall Study|Withdrawal by Subject|1|||
145603492|NCT04170686|525063089|FG000|Screening|Physician Decision|12|||
145603493|NCT04170686|525063090|FG001|Screening|Physician Decision|13|||
145603494|NCT04170686|525063089|FG000|Randomization and Treatment|Lost to Follow-up|26|||
145603495|NCT04170686|525063090|FG001|Randomization and Treatment|Lost to Follow-up|15|||
145603496|NCT03328143|525063091|FG000|Overall Study|Declined|3|||
145603497|NCT03328143|525063091|FG000|Overall Study|Required increased sedation|4|||
145603498|NCT03328143|525063091|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
145603499|NCT03328143|525063091|FG000|Overall Study|Surgery cancelled|1|||
145603500|NCT02259517|525063092|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
145603501|NCT02259517|525063093|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
145603502|NCT02259517|525063094|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
145603503|NCT02259517|525063092|FG000|Overall Study|Withdrawal by Subject|0|||
145603504|NCT02259517|525063093|FG001|Overall Study|Withdrawal by Subject|0|||
145603505|NCT02259517|525063094|FG002|Overall Study|Withdrawal by Subject|3|||
145603506|NCT04770753|525063095|FG000|Overall Study|Randomized, never treated|1|||
145603507|NCT04770753|525063096|FG001|Overall Study|Randomized, never treated|1|||
145603508|NCT04770753|525063095|FG000|Overall Study|Withdrawal by Subject|3|||
145603509|NCT04770753|525063096|FG001|Overall Study|Withdrawal by Subject|1|||
145603510|NCT04770753|525063095|FG000|Overall Study|Adverse Event|2|||
145603511|NCT04770753|525063096|FG001|Overall Study|Adverse Event|0|||
145603512|NCT04770753|525063095|FG000|Overall Study|Pregnancy|1|||
145603513|NCT04770753|525063096|FG001|Overall Study|Pregnancy|0|||
145603514|NCT04770753|525063095|FG000|Overall Study|Other un-specified|1|||
145603515|NCT04770753|525063096|FG001|Overall Study|Other un-specified|0|||
145603516|NCT02305381|525063097|FG000|Overall Study|Unclassified|5|||
145603517|NCT02305381|525063098|FG001|Overall Study|Unclassified|5|||
145603518|NCT02305381|525063099|FG002|Overall Study|Unclassified|7|||
145603519|NCT02882282|525063100|FG000|Overall Study|Adverse Event|1|||
145603520|NCT02882282|525063101|FG001|Overall Study|Adverse Event|0|||
145603521|NCT04425902|525063104|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
145603522|NCT01191840|525063105|FG000|Overall Study|withdrew consent|2|||
145603523|NCT01191840|525063106|FG001|Overall Study|withdrew consent|1|||
145603524|NCT01191840|525063105|FG000|Overall Study|Subject discontinued treatment|1|||
145603525|NCT01191840|525063106|FG001|Overall Study|Subject discontinued treatment|2|||
145603526|NCT01191840|525063105|FG000|Overall Study|Lost to Follow-up|4|||
145603527|NCT01191840|525063106|FG001|Overall Study|Lost to Follow-up|6|||
145603528|NCT01191840|525063105|FG000|Overall Study|Non Staph Infection|4|||
145603529|NCT01191840|525063106|FG001|Overall Study|Non Staph Infection|3|||
145603530|NCT01191840|525063105|FG000|Overall Study|ineligible at enrollment|1|||
145603531|NCT01191840|525063106|FG001|Overall Study|ineligible at enrollment|0|||
145603532|NCT01191840|525063105|FG000|Overall Study|IRB approval lapse|0|||
145603533|NCT01191840|525063106|FG001|Overall Study|IRB approval lapse|2|||
145603534|NCT01191840|525063105|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
145603535|NCT01191840|525063106|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
145603536|NCT01191840|525063105|FG000|Overall Study|Withdrawal by Subject|2|||
145603537|NCT01191840|525063106|FG001|Overall Study|Withdrawal by Subject|0|||
145603538|NCT04669600|525063107|FG000|Overall Study|Withdrawal by Subject|1|||
145603539|NCT04669600|525063107|FG000|Overall Study|Other|6|||
145603540|NCT00710606|525063110|FG000|Overall Study|Adverse Event|0|||
145603541|NCT00710606|525063111|FG001|Overall Study|Adverse Event|2|||
145603542|NCT02487498|525063116|FG000|Period: Period 1|Adverse Event|2|||
145603543|NCT02487498|525063117|FG001|Period: Period 1|Adverse Event|4|||
145603544|NCT02487498|525063116|FG000|Period: Period 1|Subject/guardian decision|2|||
145603545|NCT02487498|525063117|FG001|Period: Period 1|Subject/guardian decision|4|||
145603546|NCT02487498|525063116|FG000|Period: Period 1|Lost to Follow-up|0|||
145603547|NCT02487498|525063117|FG001|Period: Period 1|Lost to Follow-up|2|||
145603548|NCT02487498|525063116|FG000|Period: Period 1|Lack of Efficacy|1|||
145603549|NCT02487498|525063117|FG001|Period: Period 1|Lack of Efficacy|0|||
145603550|NCT02487498|525063116|FG000|Period: Period 1|Physician Decision|0|||
145603551|NCT02487498|525063117|FG001|Period: Period 1|Physician Decision|1|||
145603552|NCT02487498|525063116|FG000|Period: Period 1|Protocol deviation|1|||
145603553|NCT02487498|525063117|FG001|Period: Period 1|Protocol deviation|0|||
145603554|NCT02487498|525063116|FG000|Period: Washout|Subject/guardian decision|0|||
145603555|NCT02487498|525063117|FG001|Period: Washout|Subject/guardian decision|5|||
145603556|NCT02487498|525063116|FG000|Period: Washout|Lack of Efficacy|1|||
145603557|NCT02487498|525063117|FG001|Period: Washout|Lack of Efficacy|1|||
145603558|NCT02487498|525063116|FG000|Period: Washout|Physician Decision|1|||
145480924|NCT03364309|524613221|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
145480925|NCT03364309|524613222|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
145480926|NCT03364309|524613223|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
145480927|NCT03364309|524613224|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
145635941|NCT00178399|525181932|FG000|Overall Study|Lost to Follow-up|1|||
145635942|NCT01134562|525181937|FG000|Overall Study|Adverse Event|0|||
145635943|NCT01134562|525181938|FG001|Overall Study|Adverse Event|1|||
145635944|NCT01134562|525181939|FG002|Overall Study|Adverse Event|0|||
145635945|NCT01134562|525181940|FG003|Overall Study|Adverse Event|0|||
145635946|NCT01134562|525181941|FG004|Overall Study|Adverse Event|0|||
145635947|NCT00768664|525181942|FG000|Overall Study|Death|57|||
145635948|NCT00768664|525181942|FG000|Overall Study|Lost to Follow-up|2|||
145635949|NCT00768664|525181942|FG000|Overall Study|Other|9|||
145635950|NCT00768664|525181942|FG000|Overall Study|Participant refused|1|||
145635951|NCT00708032|525181945|FG000|Overall Study|Adverse Event|0|||
145635952|NCT00708032|525181946|FG001|Overall Study|Adverse Event|2|||
145635953|NCT00708032|525181945|FG000|Overall Study|Lost to Follow-up|1|||
145635954|NCT00708032|525181946|FG001|Overall Study|Lost to Follow-up|2|||
145635955|NCT00708032|525181945|FG000|Overall Study|Pregnancy|0|||
145635956|NCT00708032|525181946|FG001|Overall Study|Pregnancy|1|||
145635957|NCT00708032|525181945|FG000|Overall Study|Poor vision|0|||
145635958|NCT00708032|525181946|FG001|Overall Study|Poor vision|6|||
145635959|NCT00708032|525181945|FG000|Overall Study|Visit out of range at month 12|4|||
145635960|NCT00708032|525181946|FG001|Overall Study|Visit out of range at month 12|1|||
145635961|NCT00708032|525181945|FG000|Overall Study|Did not meet protocol criteria|1|||
145635962|NCT00708032|525181946|FG001|Overall Study|Did not meet protocol criteria|2|||
145635963|NCT00708032|525181945|FG000|Overall Study|Protocol Violation|4|||
145635964|NCT00708032|525181946|FG001|Overall Study|Protocol Violation|1|||
145635965|NCT00708032|525181945|FG000|Overall Study|Withdrawal by Subject|0|||
145635966|NCT00708032|525181946|FG001|Overall Study|Withdrawal by Subject|1|||
145635967|NCT02320123|525181950|FG000|Overall Study|Lost to Follow-up|4|||
145635968|NCT02320123|525181951|FG001|Overall Study|Lost to Follow-up|6|||
145635969|NCT02320123|525181950|FG000|Overall Study|Death|6|||
145635970|NCT02320123|525181951|FG001|Overall Study|Death|5|||
145635971|NCT00941655|525181958|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
145635972|NCT00941655|525181959|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
145635973|NCT00941655|525181958|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
145635974|NCT00941655|525181959|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
145635975|NCT00941655|525181958|FG000|Overall Study|progressed while on chemo|0|||
145635976|NCT00941655|525181959|FG001|Overall Study|progressed while on chemo|2|||
145635977|NCT00941655|525181958|FG000|Overall Study|refused further treatment|0|||
145635978|NCT00941655|525181959|FG001|Overall Study|refused further treatment|1|||
145635979|NCT00941655|525181958|FG000|Overall Study|withdrew consent|0|||
145635980|NCT00941655|525181959|FG001|Overall Study|withdrew consent|1|||
145635981|NCT00941655|525181958|FG000|Overall Study|non-compliant|0|||
145635982|NCT00941655|525181959|FG001|Overall Study|non-compliant|1|||
145635983|NCT02477670|525181965|FG000|Stage 1|Adverse Event|2|||
145635984|NCT02477670|525181966|FG001|Stage 1|Adverse Event|7|||
145635985|NCT02477670|525181967|FG002|Stage 1|Adverse Event|0|||
145635986|NCT02477670|525181968|FG003|Stage 1|Adverse Event|0|||
145635987|NCT02477670|525181969|FG004|Stage 1|Adverse Event|0|||
145635988|NCT02477670|525181970|FG005|Stage 1|Adverse Event|0|||
145635989|NCT02477670|525181971|FG006|Stage 1|Adverse Event|0|||
145635990|NCT02477670|525181965|FG000|Stage 1|Lost to Follow-up|0|||
145635991|NCT02477670|525181966|FG001|Stage 1|Lost to Follow-up|2|||
145635992|NCT02477670|525181967|FG002|Stage 1|Lost to Follow-up|0|||
145480928|NCT03364309|524613206|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145635993|NCT02477670|525181968|FG003|Stage 1|Lost to Follow-up|0|||
145635994|NCT02477670|525181969|FG004|Stage 1|Lost to Follow-up|0|||
145635995|NCT02477670|525181970|FG005|Stage 1|Lost to Follow-up|0|||
145635996|NCT02477670|525181971|FG006|Stage 1|Lost to Follow-up|0|||
145635997|NCT02477670|525181965|FG000|Stage 1|Withdrawal by Subject|1|||
145635998|NCT02477670|525181966|FG001|Stage 1|Withdrawal by Subject|2|||
145635999|NCT02477670|525181967|FG002|Stage 1|Withdrawal by Subject|0|||
145636000|NCT02477670|525181968|FG003|Stage 1|Withdrawal by Subject|0|||
145636001|NCT02477670|525181969|FG004|Stage 1|Withdrawal by Subject|0|||
145636002|NCT02477670|525181970|FG005|Stage 1|Withdrawal by Subject|0|||
145636003|NCT02477670|525181971|FG006|Stage 1|Withdrawal by Subject|0|||
145636004|NCT02477670|525181965|FG000|Stage 1|Non-compliance with Study Drug|1|||
145636005|NCT02477670|525181966|FG001|Stage 1|Non-compliance with Study Drug|2|||
145636006|NCT02477670|525181967|FG002|Stage 1|Non-compliance with Study Drug|0|||
145636007|NCT02477670|525181968|FG003|Stage 1|Non-compliance with Study Drug|0|||
145636008|NCT02477670|525181969|FG004|Stage 1|Non-compliance with Study Drug|0|||
145636009|NCT02477670|525181970|FG005|Stage 1|Non-compliance with Study Drug|0|||
145636010|NCT02477670|525181971|FG006|Stage 1|Non-compliance with Study Drug|0|||
145636011|NCT02477670|525181965|FG000|Stage 2|Adverse Event|0|||
145636012|NCT02477670|525181966|FG001|Stage 2|Adverse Event|0|||
145636013|NCT02477670|525181967|FG002|Stage 2|Adverse Event|1|||
145636014|NCT02477670|525181968|FG003|Stage 2|Adverse Event|0|||
145636015|NCT02477670|525181969|FG004|Stage 2|Adverse Event|0|||
145636016|NCT02477670|525181970|FG005|Stage 2|Adverse Event|0|||
145636017|NCT02477670|525181971|FG006|Stage 2|Adverse Event|0|||
145636018|NCT02477670|525181965|FG000|Stage 2|Antipsychotic Medication Changed|0|||
145636019|NCT02477670|525181966|FG001|Stage 2|Antipsychotic Medication Changed|0|||
145636020|NCT02477670|525181967|FG002|Stage 2|Antipsychotic Medication Changed|1|||
145636021|NCT02477670|525181968|FG003|Stage 2|Antipsychotic Medication Changed|0|||
145636022|NCT02477670|525181969|FG004|Stage 2|Antipsychotic Medication Changed|0|||
145636023|NCT02477670|525181970|FG005|Stage 2|Antipsychotic Medication Changed|0|||
145636024|NCT02477670|525181971|FG006|Stage 2|Antipsychotic Medication Changed|0|||
145636025|NCT02477670|525181965|FG000|Stage 2|Withdrawal by Subject|0|||
145636026|NCT02477670|525181966|FG001|Stage 2|Withdrawal by Subject|0|||
145636027|NCT02477670|525181967|FG002|Stage 2|Withdrawal by Subject|0|||
145636028|NCT02477670|525181968|FG003|Stage 2|Withdrawal by Subject|1|||
145636029|NCT02477670|525181969|FG004|Stage 2|Withdrawal by Subject|0|||
145636030|NCT02477670|525181970|FG005|Stage 2|Withdrawal by Subject|0|||
145636031|NCT02477670|525181971|FG006|Stage 2|Withdrawal by Subject|0|||
145636032|NCT00004124|525181973|FG000|Overall Study|Received no protocol therapy|12|||
145636033|NCT00004124|525181974|FG001|Overall Study|Received no protocol therapy|20|||
145636034|NCT00446550|525181975|FG000|Overall Study|Adverse Event|1|||
145636035|NCT00446550|525181976|FG001|Overall Study|Adverse Event|0|||
145636036|NCT01759264|525181977|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
145636037|NCT01759264|525181977|FG000|Overall Study|Adverse Event|1|||
145636038|NCT01759264|525181977|FG000|Overall Study|Other|2|||
145636039|NCT01759264|525181977|FG000|Overall Study|Lost to Follow-up|2|||
145636040|NCT01759264|525181977|FG000|Overall Study|Withdrawal by Subject|3|||
145636041|NCT01759264|525181977|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
145636042|NCT02027558|525181982|FG000|Overall Study|Death|0|||
145636043|NCT02027558|525181983|FG001|Overall Study|Death|1|||
145636044|NCT02027558|525181982|FG000|Overall Study|Withdrawal by Subject|2|||
145636045|NCT02027558|525181983|FG001|Overall Study|Withdrawal by Subject|0|||
145636046|NCT02027558|525181982|FG000|Overall Study|Lost to Follow-up|4|||
145636047|NCT02027558|525181983|FG001|Overall Study|Lost to Follow-up|1|||
145636048|NCT02027558|525181982|FG000|Overall Study|Refused assessment|3|||
145636049|NCT02027558|525181983|FG001|Overall Study|Refused assessment|0|||
145636050|NCT00114244|525181988|FG000|Overall Study|Adverse Event|2|||
145636051|NCT00114244|525181989|FG001|Overall Study|Adverse Event|5|||
145636052|NCT00114244|525181988|FG000|Overall Study|Withdrawal by Subject|0|||
145636053|NCT00114244|525181989|FG001|Overall Study|Withdrawal by Subject|2|||
145636054|NCT00516386|525181990|FG000|Overall Study|not interested in the study|4|||
145636055|NCT00516386|525181990|FG000|Overall Study|Lost to Follow-up|2|||
145636056|NCT02698891|525181991|FG000|Overall Study|Withdrawal by Subject|2|||
145636057|NCT02698891|525181991|FG000|Overall Study|deemed ineligible|1|||
145636058|NCT02698891|525181991|FG000|Overall Study|Adverse Event|9|||
145636059|NCT02383472|525181992|FG000|Overall Study|Withdrawal by Subject|1|||
145636060|NCT02383472|525181993|FG001|Overall Study|Withdrawal by Subject|1|||
145636061|NCT01111526|525181994|FG000|Overall Study|GVHD Disease Progression|0|||
145636062|NCT01111526|525181995|FG001|Overall Study|GVHD Disease Progression|1|||
145636063|NCT01111526|525181996|FG002|Overall Study|GVHD Disease Progression|2|||
145636064|NCT02013830|525181997|FG000|Overall Study|Adverse Event|3|||
145636065|NCT02013830|525181997|FG000|Overall Study|Death|1|||
145636066|NCT02013830|525181997|FG000|Overall Study|Insufficient therapeutic response|25|||
145480929|NCT03364309|524613207|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480930|NCT03364309|524613208|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145636067|NCT02013830|525181997|FG000|Overall Study|Refused treatment|1|||
145636068|NCT04424641|525182000|FG000|Overall Study|Death|1|||
145636069|NCT04424641|525182001|FG001|Overall Study|Death|2|||
145636070|NCT04424641|525182002|FG002|Overall Study|Death|3|||
145480931|NCT03364309|524613209|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145636071|NCT04424641|525182003|FG003|Overall Study|Death|0|||
145636072|NCT04424641|525182004|FG004|Overall Study|Death|3|||
145636073|NCT04424641|525182005|FG005|Overall Study|Death|0|||
145636074|NCT04424641|525182006|FG006|Overall Study|Death|1|||
145636075|NCT04424641|525182007|FG007|Overall Study|Death|2|||
145636076|NCT04424641|525182000|FG000|Overall Study|Sponsor decision|0|||
145636077|NCT04424641|525182001|FG001|Overall Study|Sponsor decision|2|||
145636078|NCT04424641|525182002|FG002|Overall Study|Sponsor decision|3|||
145636079|NCT04424641|525182003|FG003|Overall Study|Sponsor decision|7|||
145636080|NCT04424641|525182004|FG004|Overall Study|Sponsor decision|2|||
145636081|NCT04424641|525182005|FG005|Overall Study|Sponsor decision|2|||
145636082|NCT04424641|525182006|FG006|Overall Study|Sponsor decision|3|||
145636083|NCT04424641|525182007|FG007|Overall Study|Sponsor decision|4|||
145636084|NCT04424641|525182000|FG000|Overall Study|Withdrawal by Subject|0|||
145636085|NCT04424641|525182001|FG001|Overall Study|Withdrawal by Subject|0|||
145636086|NCT04424641|525182002|FG002|Overall Study|Withdrawal by Subject|0|||
145636087|NCT04424641|525182003|FG003|Overall Study|Withdrawal by Subject|0|||
145636088|NCT04424641|525182004|FG004|Overall Study|Withdrawal by Subject|1|||
145636089|NCT04424641|525182005|FG005|Overall Study|Withdrawal by Subject|0|||
145636090|NCT04424641|525182006|FG006|Overall Study|Withdrawal by Subject|0|||
145636091|NCT04424641|525182007|FG007|Overall Study|Withdrawal by Subject|0|||
145636092|NCT04424641|525182000|FG000|Overall Study|Other|0|||
145636093|NCT04424641|525182001|FG001|Overall Study|Other|0|||
145636094|NCT04424641|525182002|FG002|Overall Study|Other|1|||
145636095|NCT04424641|525182003|FG003|Overall Study|Other|0|||
145636096|NCT04424641|525182004|FG004|Overall Study|Other|0|||
145636097|NCT04424641|525182005|FG005|Overall Study|Other|0|||
145636098|NCT04424641|525182006|FG006|Overall Study|Other|0|||
145636099|NCT04424641|525182007|FG007|Overall Study|Other|0|||
145636100|NCT02694978|525182014|FG000|Overall Study|Adverse Event|10|||
145636101|NCT02694978|525182015|FG001|Overall Study|Adverse Event|9|||
145636102|NCT02694978|525182014|FG000|Overall Study|Withdrawal by Subject|22|||
145636103|NCT02694978|525182015|FG001|Overall Study|Withdrawal by Subject|19|||
145636104|NCT02694978|525182014|FG000|Overall Study|Lost to Follow-up|14|||
145636105|NCT02694978|525182015|FG001|Overall Study|Lost to Follow-up|17|||
145636106|NCT02694978|525182014|FG000|Overall Study|Death|4|||
145636107|NCT02694978|525182015|FG001|Overall Study|Death|1|||
145636108|NCT02694978|525182014|FG000|Overall Study|Other-Decision of Participant|6|||
145636109|NCT02694978|525182015|FG001|Overall Study|Other-Decision of Participant|1|||
145636110|NCT02694978|525182014|FG000|Overall Study|Other-Investigator's decision|1|||
145636111|NCT02694978|525182015|FG001|Overall Study|Other-Investigator's decision|0|||
145636112|NCT02694978|525182014|FG000|Overall Study|Other-Unable to be reached|0|||
145636113|NCT02694978|525182015|FG001|Overall Study|Other-Unable to be reached|1|||
145636114|NCT02694978|525182014|FG000|Overall Study|Other-Protocol noncompliant|2|||
145636115|NCT02694978|525182015|FG001|Overall Study|Other-Protocol noncompliant|1|||
145636116|NCT02694978|525182014|FG000|Overall Study|Other-Personal reasons|3|||
145636117|NCT02694978|525182015|FG001|Overall Study|Other-Personal reasons|3|||
145636118|NCT02694978|525182014|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
145636119|NCT02694978|525182015|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
145636120|NCT01613716|525182016|FG000|Overall Study|screen failures|3|||
145636121|NCT01613716|525182016|FG000|Overall Study|Lost to Follow-up|4|||
145636122|NCT01171625|525182018|FG000|Overall Study|On-Protocol|67|||
145636123|NCT01171625|525182018|FG000|Overall Study|Death|38|||
145636124|NCT01171625|525182018|FG000|Overall Study|Withdrawal by Subject|31|||
145636125|NCT01171625|525182018|FG000|Overall Study|Explanted|10|||
145636126|NCT01171625|525182018|FG000|Overall Study|Lost to Follow-up|5|||
145636127|NCT01171625|525182018|FG000|Overall Study|Patient received valve-in-valve|3|||
145636128|NCT01171625|525182018|FG000|Overall Study|Other|1|||
145636129|NCT01171625|525182018|FG000|Overall Study|Consented but did not receive device|25|||
145636130|NCT03262935|525182019|FG000|Overall Study|Withdrawal by Subject|6|||
145636131|NCT03262935|525182020|FG001|Overall Study|Withdrawal by Subject|7|||
145636132|NCT03262935|525182019|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
145636133|NCT03262935|525182020|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
145636134|NCT03262935|525182019|FG000|Overall Study|Death|181|||
145636135|NCT03262935|525182020|FG001|Overall Study|Death|94|||
145636136|NCT03262935|525182019|FG000|Overall Study|Lost to Follow-up|9|||
145636137|NCT03262935|525182020|FG001|Overall Study|Lost to Follow-up|4|||
145636138|NCT03262935|525182019|FG000|Overall Study|Other reason|5|||
145636139|NCT03262935|525182020|FG001|Overall Study|Other reason|0|||
145636140|NCT03557008|525182021|FG000|Overall Study|Withdrawal by Subject|2|||
145636141|NCT03557008|525182022|FG001|Overall Study|Withdrawal by Subject|2|||
145636142|NCT03557008|525182021|FG000|Overall Study|Early termination from study|3|||
145636143|NCT03557008|525182022|FG001|Overall Study|Early termination from study|1|||
145636144|NCT00743444|525182025|FG000|First Intervention|Catheter placement problems|0|||
145636145|NCT00743444|525182026|FG001|First Intervention|Catheter placement problems|1|||
145636146|NCT00743444|525182025|FG000|Washout Period|Adverse Event|0|||
145636147|NCT00743444|525182026|FG001|Washout Period|Adverse Event|1|||
145636148|NCT02567656|525182029|FG000|Overall Study|Premature discontinuation due to PD|1|||
145636149|NCT02567656|525182030|FG001|Overall Study|Premature discontinuation due to PD|1|||
145636150|NCT02567656|525182031|FG002|Overall Study|Premature discontinuation due to PD|2|||
145636151|NCT02567656|525182032|FG003|Overall Study|Premature discontinuation due to PD|0|||
145636152|NCT02567656|525182033|FG004|Overall Study|Premature discontinuation due to PD|0|||
145636153|NCT02567656|525182034|FG005|Overall Study|Premature discontinuation due to PD|0|||
145636154|NCT03287622|525182035|FG000|Overall Study|Withdrawal by Subject|1|||
145636155|NCT03287622|525182036|FG001|Overall Study|Withdrawal by Subject|0|||
145636156|NCT03287622|525182035|FG000|Overall Study|Lost to Follow-up|27|||
145636157|NCT03287622|525182036|FG001|Overall Study|Lost to Follow-up|15|||
145636158|NCT03287622|525182035|FG000|Overall Study|No prescripion after surgery|28|||
145636159|NCT03287622|525182036|FG001|Overall Study|No prescripion after surgery|31|||
145636160|NCT03287622|525182035|FG000|Overall Study|prolonged Length of stay|2|||
145636161|NCT03287622|525182036|FG001|Overall Study|prolonged Length of stay|0|||
145636162|NCT03287622|525182035|FG000|Overall Study|surgery related|0|||
145636163|NCT03287622|525182036|FG001|Overall Study|surgery related|2|||
145636164|NCT03622580|525182039|FG000|Overall Study|Death|16|||
145636165|NCT03622580|525182040|FG001|Overall Study|Death|21|||
145636166|NCT03622580|525182041|FG002|Overall Study|Death|13|||
145636167|NCT03622580|525182039|FG000|Overall Study|Adverse Event|6|||
145636168|NCT03622580|525182040|FG001|Overall Study|Adverse Event|6|||
145636169|NCT03622580|525182041|FG002|Overall Study|Adverse Event|5|||
145636170|NCT03622580|525182039|FG000|Overall Study|Withdrawal by Subject|12|||
145636171|NCT03622580|525182040|FG001|Overall Study|Withdrawal by Subject|7|||
145636172|NCT03622580|525182041|FG002|Overall Study|Withdrawal by Subject|19|||
145636173|NCT03622580|525182039|FG000|Overall Study|Lost to Follow-up|12|||
145636174|NCT03622580|525182040|FG001|Overall Study|Lost to Follow-up|9|||
145636175|NCT03622580|525182041|FG002|Overall Study|Lost to Follow-up|9|||
145636176|NCT03622580|525182039|FG000|Overall Study|Protocol Violation|1|||
145636177|NCT03622580|525182040|FG001|Overall Study|Protocol Violation|0|||
145636178|NCT03622580|525182041|FG002|Overall Study|Protocol Violation|1|||
145636179|NCT03622580|525182039|FG000|Overall Study|Physician Decision|3|||
145636180|NCT03622580|525182040|FG001|Overall Study|Physician Decision|0|||
145636181|NCT03622580|525182041|FG002|Overall Study|Physician Decision|1|||
145636182|NCT03622580|525182039|FG000|Overall Study|Pregnancy|0|||
145636183|NCT03622580|525182040|FG001|Overall Study|Pregnancy|1|||
145636184|NCT03622580|525182041|FG002|Overall Study|Pregnancy|0|||
145636185|NCT03622580|525182039|FG000|Overall Study|Lack of Efficacy|0|||
145636186|NCT03622580|525182040|FG001|Overall Study|Lack of Efficacy|0|||
145636187|NCT03622580|525182041|FG002|Overall Study|Lack of Efficacy|1|||
145636188|NCT03622580|525182039|FG000|Overall Study|Other|2|||
145636189|NCT03622580|525182040|FG001|Overall Study|Other|0|||
145636190|NCT03622580|525182041|FG002|Overall Study|Other|3|||
145636191|NCT01930045|525182044|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
145636192|NCT01930045|525182045|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
145636193|NCT01930045|525182046|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
145636194|NCT01930045|525182047|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
145636195|NCT01930045|525182048|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
145636196|NCT01930045|525182049|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
145636197|NCT01930045|525182044|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
145636198|NCT01930045|525182045|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
145636199|NCT01930045|525182046|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
145636200|NCT01930045|525182047|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
145636201|NCT01930045|525182048|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
145636202|NCT01930045|525182049|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
145636203|NCT04439799|525182055|FG000|Overall Study|Lost to Follow-up|6|||
145636204|NCT04439799|525182056|FG001|Overall Study|Lost to Follow-up|6|||
145636205|NCT04439799|525182055|FG000|Overall Study|Withdrawal by Subject|2|||
145636206|NCT04439799|525182056|FG001|Overall Study|Withdrawal by Subject|6|||
145636207|NCT04439799|525182055|FG000|Overall Study|Adverse Event|2|||
145636208|NCT04439799|525182056|FG001|Overall Study|Adverse Event|5|||
145636209|NCT02459899|525182057|FG000|Overall Study|Adverse Event|1|||
145636210|NCT02459899|525182058|FG001|Overall Study|Adverse Event|1|||
145636211|NCT02459899|525182059|FG002|Overall Study|Adverse Event|0|||
145636212|NCT02459899|525182060|FG003|Overall Study|Adverse Event|0|||
145636213|NCT02459899|525182057|FG000|Overall Study|Lost to Follow-up|1|||
145636214|NCT02459899|525182058|FG001|Overall Study|Lost to Follow-up|2|||
145636215|NCT02459899|525182059|FG002|Overall Study|Lost to Follow-up|0|||
145636216|NCT02459899|525182060|FG003|Overall Study|Lost to Follow-up|1|||
145636217|NCT02459899|525182057|FG000|Overall Study|Non-compliance with the treatment|0|||
145636218|NCT02459899|525182058|FG001|Overall Study|Non-compliance with the treatment|0|||
145636219|NCT02459899|525182059|FG002|Overall Study|Non-compliance with the treatment|0|||
145636220|NCT02459899|525182060|FG003|Overall Study|Non-compliance with the treatment|1|||
145636221|NCT02459899|525182057|FG000|Overall Study|Withdrawal by Subject|1|||
145636222|NCT02459899|525182058|FG001|Overall Study|Withdrawal by Subject|3|||
145636223|NCT02459899|525182059|FG002|Overall Study|Withdrawal by Subject|0|||
145636224|NCT02459899|525182060|FG003|Overall Study|Withdrawal by Subject|0|||
145636225|NCT00940992|525182063|FG000|Overall Study|Adverse Event|2|||
145636226|NCT00940992|525182064|FG001|Overall Study|Adverse Event|0|||
145636227|NCT00940992|525182065|FG002|Overall Study|Adverse Event|1|||
145636228|NCT00940992|525182063|FG000|Overall Study|subject request|2|||
145636229|NCT00940992|525182064|FG001|Overall Study|subject request|1|||
145636230|NCT00940992|525182065|FG002|Overall Study|subject request|0|||
145636231|NCT00940992|525182063|FG000|Overall Study|Lost to Follow-up|0|||
145636232|NCT00940992|525182064|FG001|Overall Study|Lost to Follow-up|1|||
145636233|NCT00940992|525182065|FG002|Overall Study|Lost to Follow-up|1|||
145636234|NCT00630786|525182066|FG000|Overall Study|Physician Decision|0|||
145636235|NCT00630786|525182067|FG001|Overall Study|Physician Decision|0|||
145636236|NCT00630786|525182068|FG002|Overall Study|Physician Decision|1|||
145636237|NCT00630786|525182066|FG000|Overall Study|Withdrawal by Subject|0|||
145636238|NCT00630786|525182067|FG001|Overall Study|Withdrawal by Subject|1|||
145636239|NCT00630786|525182068|FG002|Overall Study|Withdrawal by Subject|1|||
145636240|NCT00630786|525182066|FG000|Overall Study|Lost to Follow-up|0|||
145636241|NCT00630786|525182067|FG001|Overall Study|Lost to Follow-up|1|||
145636242|NCT00630786|525182068|FG002|Overall Study|Lost to Follow-up|0|||
145636243|NCT00630786|525182066|FG000|Overall Study|Other|1|||
145636244|NCT00630786|525182067|FG001|Overall Study|Other|0|||
145636245|NCT00630786|525182068|FG002|Overall Study|Other|0|||
145636246|NCT00688519|525182074|FG000|Overall Study|Adverse Event|2|||
145636247|NCT00688519|525182075|FG001|Overall Study|Adverse Event|3|||
145636248|NCT00688519|525182074|FG000|Overall Study|Lost to Follow-up|3|||
145636249|NCT00688519|525182075|FG001|Overall Study|Lost to Follow-up|3|||
145636250|NCT00688519|525182074|FG000|Overall Study|Lack of Efficacy|3|||
145636251|NCT00688519|525182075|FG001|Overall Study|Lack of Efficacy|1|||
145636252|NCT00688519|525182074|FG000|Overall Study|Withdrawal by Subject|7|||
145636253|NCT00688519|525182075|FG001|Overall Study|Withdrawal by Subject|6|||
145636254|NCT00688519|525182074|FG000|Overall Study|Prohibited medication|1|||
145636255|NCT00688519|525182075|FG001|Overall Study|Prohibited medication|0|||
145636256|NCT00688519|525182074|FG000|Overall Study|Non-compliance|0|||
145636257|NCT00688519|525182075|FG001|Overall Study|Non-compliance|1|||
145636258|NCT00688519|525182074|FG000|Overall Study|Subject moved out of state|1|||
145636259|NCT00688519|525182075|FG001|Overall Study|Subject moved out of state|0|||
145636260|NCT00688519|525182074|FG000|Overall Study|Investigator decision|1|||
145636261|NCT00688519|525182075|FG001|Overall Study|Investigator decision|0|||
145636262|NCT00688519|525182074|FG000|Overall Study|Subject moved out of area|1|||
145636263|NCT00688519|525182075|FG001|Overall Study|Subject moved out of area|0|||
145636264|NCT00688519|525182074|FG000|Overall Study|Pregnancy|0|||
145636265|NCT00688519|525182075|FG001|Overall Study|Pregnancy|1|||
145636266|NCT03544515|525183832|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
145636267|NCT03544515|525183833|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
145636268|NCT03544515|525183832|FG000|Overall Study|Lost to Follow-up|2|||
145636269|NCT03544515|525183833|FG001|Overall Study|Lost to Follow-up|0|||
145636270|NCT03622593|525183834|FG000|Overall Study|Withdrawal by Subject|11|||
145636271|NCT03622593|525183835|FG001|Overall Study|Withdrawal by Subject|9|||
145636272|NCT03622593|525183836|FG002|Overall Study|Withdrawal by Subject|13|||
145636273|NCT03622593|525183834|FG000|Overall Study|Death|12|||
145636274|NCT03622593|525183835|FG001|Overall Study|Death|9|||
145636275|NCT03622593|525183836|FG002|Overall Study|Death|10|||
145636276|NCT03622593|525183834|FG000|Overall Study|Lost to Follow-up|11|||
145636277|NCT03622593|525183835|FG001|Overall Study|Lost to Follow-up|5|||
145636278|NCT03622593|525183836|FG002|Overall Study|Lost to Follow-up|8|||
145636279|NCT03622593|525183834|FG000|Overall Study|Adverse Event|4|||
145636280|NCT03622593|525183835|FG001|Overall Study|Adverse Event|5|||
145636281|NCT03622593|525183836|FG002|Overall Study|Adverse Event|6|||
145636282|NCT03622593|525183834|FG000|Overall Study|Physician Decision|2|||
145636283|NCT03622593|525183835|FG001|Overall Study|Physician Decision|1|||
145636284|NCT03622593|525183836|FG002|Overall Study|Physician Decision|6|||
145636285|NCT03622593|525183834|FG000|Overall Study|Other|2|||
145636286|NCT03622593|525183835|FG001|Overall Study|Other|2|||
145636287|NCT03622593|525183836|FG002|Overall Study|Other|3|||
145636288|NCT03622593|525183834|FG000|Overall Study|Protocol Violation|0|||
145636289|NCT03622593|525183835|FG001|Overall Study|Protocol Violation|0|||
145636290|NCT03622593|525183836|FG002|Overall Study|Protocol Violation|1|||
145636291|NCT03622593|525183834|FG000|Overall Study|Pregnancy|0|||
145636292|NCT03622593|525183835|FG001|Overall Study|Pregnancy|0|||
145636293|NCT03622593|525183836|FG002|Overall Study|Pregnancy|1|||
145636294|NCT00423098|525183837|FG000|Overall Study|Adverse Event|1|||
145636295|NCT00423098|525183838|FG001|Overall Study|Adverse Event|2|||
145636296|NCT00423098|525183837|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145636297|NCT00423098|525183838|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145636298|NCT00423098|525183837|FG000|Overall Study|Administrative problems|0|||
145636299|NCT00423098|525183838|FG001|Overall Study|Administrative problems|1|||
145636300|NCT00423098|525183837|FG000|Overall Study|Death|2|||
145636301|NCT00423098|525183838|FG001|Overall Study|Death|0|||
145636302|NCT02983617|525183839|FG000|Overall Study|Adverse Event|0|||
145636303|NCT02983617|525183840|FG001|Overall Study|Adverse Event|7|||
145636304|NCT02983617|525183839|FG000|Overall Study|Death|0|||
145636305|NCT02983617|525183840|FG001|Overall Study|Death|1|||
145636306|NCT02983617|525183839|FG000|Overall Study|Investigator's Discretion|0|||
145636307|NCT02983617|525183840|FG001|Overall Study|Investigator's Discretion|1|||
145636308|NCT00711958|525183841|FG000|Overall Study|Withdrawal by Subject|6|||
145636309|NCT00711958|525183842|FG001|Overall Study|Withdrawal by Subject|8|||
145636310|NCT00711958|525183841|FG000|Overall Study|Lack of Efficacy|3|||
145636311|NCT00711958|525183842|FG001|Overall Study|Lack of Efficacy|1|||
145636312|NCT00711958|525183841|FG000|Overall Study|Clinical deterioration|1|||
145636313|NCT00711958|525183842|FG001|Overall Study|Clinical deterioration|0|||
145636314|NCT00711958|525183841|FG000|Overall Study|Adverse Event|9|||
145636315|NCT00711958|525183842|FG001|Overall Study|Adverse Event|7|||
145636316|NCT00711958|525183841|FG000|Overall Study|Protocol Violation|1|||
145636317|NCT00711958|525183842|FG001|Overall Study|Protocol Violation|0|||
145636318|NCT00711958|525183841|FG000|Overall Study|Lost to Follow-up|2|||
145636319|NCT00711958|525183842|FG001|Overall Study|Lost to Follow-up|2|||
145636320|NCT00711958|525183841|FG000|Overall Study|Death|10|||
145636321|NCT00711958|525183842|FG001|Overall Study|Death|5|||
145636322|NCT00711958|525183841|FG000|Overall Study|Progression of disease|1|||
145636323|NCT00711958|525183842|FG001|Overall Study|Progression of disease|0|||
145636324|NCT02296424|525183846|FG000|Part 1|New therapy for study indication|0|||
145636325|NCT02296424|525183847|FG001|Part 1|New therapy for study indication|1|||
145636326|NCT02296424|525183848|FG002|Part 1|New therapy for study indication|0|||
145636327|NCT02296424|525183849|FG003|Part 1|New therapy for study indication|0|||
145636328|NCT02296424|525183846|FG000|Part 1|Protocol Violation|0|||
145636329|NCT02296424|525183847|FG001|Part 1|Protocol Violation|1|||
145636330|NCT02296424|525183848|FG002|Part 1|Protocol Violation|0|||
145636331|NCT02296424|525183849|FG003|Part 1|Protocol Violation|0|||
145636332|NCT02296424|525183846|FG000|Part 1|Withdrawal by Subject|0|||
145636333|NCT02296424|525183847|FG001|Part 1|Withdrawal by Subject|2|||
145636334|NCT02296424|525183848|FG002|Part 1|Withdrawal by Subject|0|||
145636335|NCT02296424|525183849|FG003|Part 1|Withdrawal by Subject|0|||
145636336|NCT02296424|525183846|FG000|Part 1|Study terminated by sponsor|0|||
145636337|NCT02296424|525183847|FG001|Part 1|Study terminated by sponsor|1|||
145636338|NCT02296424|525183848|FG002|Part 1|Study terminated by sponsor|0|||
145636339|NCT02296424|525183849|FG003|Part 1|Study terminated by sponsor|0|||
145636340|NCT02296424|525183846|FG000|Part 1|Adverse Event|2|||
145636341|NCT02296424|525183847|FG001|Part 1|Adverse Event|11|||
145636342|NCT02296424|525183848|FG002|Part 1|Adverse Event|0|||
145636343|NCT02296424|525183849|FG003|Part 1|Adverse Event|0|||
145636344|NCT02296424|525183846|FG000|Part 1|Lack of Efficacy|5|||
145636345|NCT02296424|525183847|FG001|Part 1|Lack of Efficacy|17|||
145636346|NCT02296424|525183848|FG002|Part 1|Lack of Efficacy|0|||
145636347|NCT02296424|525183849|FG003|Part 1|Lack of Efficacy|0|||
145636348|NCT02296424|525183846|FG000|Part 1|16 directly started part II|16|||
145636349|NCT02296424|525183847|FG001|Part 1|16 directly started part II|0|||
145636350|NCT02296424|525183848|FG002|Part 1|16 directly started part II|0|||
145636351|NCT02296424|525183849|FG003|Part 1|16 directly started part II|0|||
145636352|NCT02296424|525183846|FG000|Part 2|Lack of Efficacy|0|||
145636353|NCT02296424|525183847|FG001|Part 2|Lack of Efficacy|0|||
145636354|NCT02296424|525183848|FG002|Part 2|Lack of Efficacy|1|||
145636355|NCT02296424|525183849|FG003|Part 2|Lack of Efficacy|0|||
145636356|NCT02296424|525183846|FG000|Part 2|Adverse Event|0|||
145636357|NCT02296424|525183847|FG001|Part 2|Adverse Event|0|||
145636358|NCT02296424|525183848|FG002|Part 2|Adverse Event|1|||
145636359|NCT02296424|525183849|FG003|Part 2|Adverse Event|0|||
145636360|NCT02296424|525183846|FG000|Part 2|Lost to Follow-up|0|||
145636361|NCT02296424|525183847|FG001|Part 2|Lost to Follow-up|0|||
145636362|NCT02296424|525183848|FG002|Part 2|Lost to Follow-up|1|||
145636363|NCT02296424|525183849|FG003|Part 2|Lost to Follow-up|0|||
145636364|NCT00186186|525183850|FG000|Overall Study|Lack of Efficacy|3|||
145636365|NCT00186186|525183850|FG000|Overall Study|Withdrawal by Subject|3|||
145636366|NCT00186186|525183850|FG000|Overall Study|Not reported as to reason|2|||
145636367|NCT00807144|525183851|FG000|Overall Study|Lost to Follow-up|0|||
145636368|NCT00807144|525183852|FG001|Overall Study|Lost to Follow-up|1|||
145636369|NCT00071799|525183856|FG000|Overall Study|Adverse Event|19|||
145636370|NCT00071799|525183857|FG001|Overall Study|Adverse Event|10|||
145636371|NCT00071799|525183856|FG000|Overall Study|Protocol Violation|1|||
145636372|NCT00071799|525183857|FG001|Overall Study|Protocol Violation|7|||
145636373|NCT00071799|525183856|FG000|Overall Study|Lost to Follow-up|1|||
145636374|NCT00071799|525183857|FG001|Overall Study|Lost to Follow-up|1|||
145636375|NCT00071799|525183856|FG000|Overall Study|Withdrawal by Subject|15|||
145636376|NCT00071799|525183857|FG001|Overall Study|Withdrawal by Subject|37|||
145636377|NCT00071799|525183856|FG000|Overall Study|Physician Decision|0|||
145636378|NCT00071799|525183857|FG001|Overall Study|Physician Decision|2|||
145636379|NCT00071799|525183856|FG000|Overall Study|Lack of Efficacy|11|||
145636380|NCT00071799|525183857|FG001|Overall Study|Lack of Efficacy|18|||
145636381|NCT00071799|525183856|FG000|Overall Study|Disease Progression|23|||
145636382|NCT00071799|525183857|FG001|Overall Study|Disease Progression|20|||
145636383|NCT00071799|525183856|FG000|Overall Study|Different Central+Local Pathology Review|0|||
145636384|NCT00071799|525183857|FG001|Overall Study|Different Central+Local Pathology Review|1|||
145636385|NCT00071799|525183856|FG000|Overall Study|Not Documented|0|||
145636386|NCT00071799|525183857|FG001|Overall Study|Not Documented|2|||
145636387|NCT00814346|525183858|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
145636388|NCT00814346|525183859|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
145636389|NCT00814346|525183858|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
145636390|NCT00814346|525183859|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
145636391|NCT00814346|525183858|FG000|Open Phase (17 Months)|Adverse Event|5|||
145636392|NCT00814346|525183859|FG001|Open Phase (17 Months)|Adverse Event|0|||
145636393|NCT00814346|525183858|FG000|Open Phase (17 Months)|Consent|2|||
145636394|NCT00814346|525183859|FG001|Open Phase (17 Months)|Consent|0|||
145636395|NCT00814346|525183858|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
145480932|NCT03364309|524613210|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145636396|NCT00814346|525183859|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
145636397|NCT00814346|525183858|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
145480933|NCT03364309|524613211|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145636398|NCT00814346|525183859|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
145636399|NCT05136443|525183861|FG000|Overall Study|Lost to Follow-up|2|||
145636400|NCT05136443|525183861|FG000|Overall Study|Adverse Event|2|||
145636401|NCT03959241|525183872|FG000|Overall Study|Withdrawal by Subject|7|||
145636402|NCT03959241|525183873|FG001|Overall Study|Withdrawal by Subject|8|||
145636403|NCT03959241|525183872|FG000|Overall Study|Lost to Follow-up|1|||
145636404|NCT03959241|525183873|FG001|Overall Study|Lost to Follow-up|0|||
145636405|NCT03959241|525183872|FG000|Overall Study|Move to Hospice Care|1|||
145480934|NCT03364309|524613212|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480935|NCT03364309|524613213|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480936|NCT03364309|524613214|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480937|NCT03364309|524613215|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480938|NCT03364309|524613216|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480939|NCT03364309|524613217|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480940|NCT03364309|524613218|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480941|NCT03364309|524613219|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480942|NCT03364309|524613220|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145636406|NCT03959241|525183873|FG001|Overall Study|Move to Hospice Care|0|||
145636407|NCT03959241|525183872|FG000|Overall Study|Screen Failure|1|||
145636408|NCT03959241|525183873|FG001|Overall Study|Screen Failure|0|||
145636409|NCT03959241|525183872|FG000|Overall Study|Disease Relapse|0|||
145636410|NCT03959241|525183873|FG001|Overall Study|Disease Relapse|1|||
145636411|NCT03959241|525183872|FG000|Overall Study|Off Study|1|||
145636412|NCT03959241|525183873|FG001|Overall Study|Off Study|0|||
145636413|NCT03192046|525183874|FG000|Overall Study|Withdrawal by Subject|1|||
145636414|NCT03192046|525183875|FG001|Overall Study|Withdrawal by Subject|1|||
145636415|NCT00762606|525183876|FG000|Overall Study|Lost to Follow-up|18|||
145636416|NCT00762606|525183877|FG001|Overall Study|Lost to Follow-up|13|||
145636417|NCT00842257|525183880|FG000|Overall Study|Adverse Event|1|||
145636418|NCT01147341|525183881|FG000|Double Blind Period|Lack of Efficacy|1|||
145636419|NCT01147341|525183882|FG001|Double Blind Period|Lack of Efficacy|1|||
145636420|NCT01147341|525183881|FG000|Double Blind Period|Withdrawal by Subject|0|||
145636421|NCT01147341|525183882|FG001|Double Blind Period|Withdrawal by Subject|1|||
145636422|NCT01147341|525183881|FG000|Open Label Period|Lack of Efficacy|3|||
145636423|NCT01147341|525183882|FG001|Open Label Period|Lack of Efficacy|0|||
145636424|NCT01147341|525183881|FG000|Open Label Period|Subject moved|1|||
145636425|NCT01147341|525183882|FG001|Open Label Period|Subject moved|0|||
145636426|NCT05641311|525183890|FG000|Dosing Period 1|Adverse Event|1|||
145636427|NCT05641311|525183891|FG001|Dosing Period 1|Adverse Event|0|||
145636428|NCT02969863|525183899|FG000|Overall Study|Physician Decision|1|||
145636429|NCT02969863|525183900|FG001|Overall Study|Physician Decision|0|||
145636430|NCT02969863|525183901|FG002|Overall Study|Physician Decision|0|||
145636431|NCT02969863|525183902|FG003|Overall Study|Physician Decision|0|||
145636432|NCT02969863|525183903|FG004|Overall Study|Physician Decision|0|||
145480943|NCT03364309|524613221|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
145480944|NCT03364309|524613222|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
145636433|NCT02969863|525183904|FG005|Overall Study|Physician Decision|0|||
145636434|NCT02705586|525183912|FG000|Overall Study|Health Issues|2|||
145636435|NCT02705586|525183912|FG000|Overall Study|Transportation Difficulties|5|||
145636436|NCT02705586|525183912|FG000|Overall Study|Vacation/Planned Absence|1|||
145636437|NCT02045836|525183916|FG000|Overall Study|Adverse Event|4|||
145636438|NCT02045836|525183917|FG001|Overall Study|Adverse Event|4|||
145636439|NCT02045836|525183916|FG000|Overall Study|Withdrawal by Subject|1|||
145636440|NCT02045836|525183917|FG001|Overall Study|Withdrawal by Subject|1|||
145636441|NCT02045836|525183916|FG000|Overall Study|Lost to Follow-up|4|||
145636442|NCT02045836|525183917|FG001|Overall Study|Lost to Follow-up|7|||
145636443|NCT02045836|525183916|FG000|Overall Study|Migrated from study area|0|||
145636444|NCT02045836|525183917|FG001|Overall Study|Migrated from study area|2|||
145636445|NCT03920215|525183919|FG000|Overall Study|Lost to Follow-up|1|||
145636446|NCT03920215|525183920|FG001|Overall Study|Lost to Follow-up|2|||
145636447|NCT03920215|525183921|FG002|Overall Study|Lost to Follow-up|0|||
145636448|NCT03920215|525183922|FG003|Overall Study|Lost to Follow-up|0|||
145636449|NCT03920215|525183919|FG000|Overall Study|Death|0|||
145636450|NCT03920215|525183920|FG001|Overall Study|Death|0|||
145636451|NCT03920215|525183921|FG002|Overall Study|Death|0|||
145636452|NCT03920215|525183922|FG003|Overall Study|Death|1|||
145636453|NCT02798835|525183923|FG000|Overall Study|Protocol Violation|0|||
145636454|NCT02798835|525183924|FG001|Overall Study|Protocol Violation|0|||
145636455|NCT02798835|525183925|FG002|Overall Study|Protocol Violation|3|||
145636456|NCT03024606|525183930|FG000|Overall Study|Withdrawal by Subject|9|||
145636457|NCT03024606|525183931|FG001|Overall Study|Withdrawal by Subject|10|||
145636458|NCT02547922|525183938|FG000|Overall Study|Withdrawal by Subject|9|||
145636459|NCT02547922|525183939|FG001|Overall Study|Withdrawal by Subject|6|||
145636460|NCT02547922|525183940|FG002|Overall Study|Withdrawal by Subject|10|||
145636461|NCT02547922|525183938|FG000|Overall Study|Adverse Event|3|||
145636462|NCT02547922|525183939|FG001|Overall Study|Adverse Event|1|||
145636463|NCT02547922|525183940|FG002|Overall Study|Adverse Event|2|||
145636464|NCT02547922|525183938|FG000|Overall Study|Lost to Follow-up|1|||
145636465|NCT02547922|525183939|FG001|Overall Study|Lost to Follow-up|0|||
145636466|NCT02547922|525183940|FG002|Overall Study|Lost to Follow-up|0|||
145636467|NCT02547922|525183938|FG000|Overall Study|Lack of Efficacy|5|||
145636468|NCT02547922|525183939|FG001|Overall Study|Lack of Efficacy|7|||
145636469|NCT02547922|525183940|FG002|Overall Study|Lack of Efficacy|4|||
145636470|NCT02547922|525183938|FG000|Overall Study|Death|1|||
145636471|NCT02547922|525183939|FG001|Overall Study|Death|0|||
145636472|NCT02547922|525183940|FG002|Overall Study|Death|0|||
145636473|NCT02547922|525183938|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
145636474|NCT02547922|525183939|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
145636475|NCT02547922|525183940|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
145636476|NCT02547922|525183938|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
145636477|NCT02547922|525183939|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
145636478|NCT02547922|525183940|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
145636479|NCT02547922|525183938|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
145636480|NCT02547922|525183939|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
145636481|NCT02547922|525183940|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
145636482|NCT02547922|525183938|FG000|Overall Study|Physician Decision|2|||
145480945|NCT03364309|524613223|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
145480946|NCT03364309|524613224|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
145480947|NCT03364309|524613206|FG000|Post-Treatment Followup Period|Adverse Event|0|||
145480948|NCT03364309|524613207|FG001|Post-Treatment Followup Period|Adverse Event|0|||
145480949|NCT03364309|524613208|FG002|Post-Treatment Followup Period|Adverse Event|0|||
145480950|NCT03364309|524613209|FG003|Post-Treatment Followup Period|Adverse Event|0|||
145480951|NCT03364309|524613210|FG004|Post-Treatment Followup Period|Adverse Event|0|||
145480952|NCT03364309|524613211|FG005|Post-Treatment Followup Period|Adverse Event|0|||
145480953|NCT03364309|524613212|FG006|Post-Treatment Followup Period|Adverse Event|0|||
145480954|NCT03364309|524613213|FG007|Post-Treatment Followup Period|Adverse Event|0|||
145480955|NCT03364309|524613214|FG008|Post-Treatment Followup Period|Adverse Event|0|||
145480956|NCT03364309|524613215|FG009|Post-Treatment Followup Period|Adverse Event|0|||
145480957|NCT03364309|524613216|FG010|Post-Treatment Followup Period|Adverse Event|0|||
145480958|NCT03364309|524613217|FG011|Post-Treatment Followup Period|Adverse Event|0|||
145480959|NCT03364309|524613218|FG012|Post-Treatment Followup Period|Adverse Event|0|||
145480960|NCT03364309|524613219|FG013|Post-Treatment Followup Period|Adverse Event|0|||
145480961|NCT03364309|524613220|FG014|Post-Treatment Followup Period|Adverse Event|0|||
145480962|NCT03364309|524613221|FG015|Post-Treatment Followup Period|Adverse Event|0|||
145480963|NCT03364309|524613222|FG016|Post-Treatment Followup Period|Adverse Event|2|||
145480964|NCT03364309|524613223|FG017|Post-Treatment Followup Period|Adverse Event|6|||
145480965|NCT03364309|524613224|FG018|Post-Treatment Followup Period|Adverse Event|1|||
145480966|NCT03364309|524613206|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480967|NCT03364309|524613207|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480968|NCT03364309|524613208|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480969|NCT03364309|524613209|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480970|NCT03364309|524613210|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480971|NCT03364309|524613211|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480972|NCT03364309|524613212|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480973|NCT03364309|524613213|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480974|NCT03364309|524613214|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480975|NCT03364309|524613215|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480976|NCT03364309|524613216|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480977|NCT03364309|524613217|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480978|NCT03364309|524613218|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480979|NCT03364309|524613219|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480980|NCT03364309|524613220|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480981|NCT03364309|524613221|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480982|NCT03364309|524613222|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480983|NCT03364309|524613223|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
145480984|NCT03364309|524613224|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
145480985|NCT03364309|524613206|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
145480986|NCT03364309|524613207|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
145480987|NCT03364309|524613208|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
145480988|NCT03364309|524613209|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
145480989|NCT03364309|524613210|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
145480990|NCT03364309|524613211|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
145480991|NCT03364309|524613212|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
145636483|NCT02547922|525183939|FG001|Overall Study|Physician Decision|1|||
145636484|NCT02547922|525183940|FG002|Overall Study|Physician Decision|2|||
145636485|NCT02547922|525183938|FG000|Overall Study|Patients did not receive IP|1|||
145636486|NCT02547922|525183939|FG001|Overall Study|Patients did not receive IP|1|||
145636487|NCT02547922|525183940|FG002|Overall Study|Patients did not receive IP|0|||
145480992|NCT03364309|524613213|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
145480993|NCT03364309|524613214|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
145480994|NCT03364309|524613215|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
145480995|NCT03364309|524613216|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
145480996|NCT03364309|524613217|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
145480997|NCT03364309|524613218|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
145636488|NCT00102063|525183945|FG000|Overall Study|Lack of Efficacy|5|||
145636489|NCT00102063|525183946|FG001|Overall Study|Lack of Efficacy|1|||
145636490|NCT00102063|525183947|FG002|Overall Study|Lack of Efficacy|1|||
145636491|NCT00102063|525183945|FG000|Overall Study|Adverse Event|7|||
145636492|NCT00102063|525183946|FG001|Overall Study|Adverse Event|4|||
145636493|NCT00102063|525183947|FG002|Overall Study|Adverse Event|2|||
145636494|NCT00102063|525183945|FG000|Overall Study|Withdrawal by Subject|4|||
145636495|NCT00102063|525183946|FG001|Overall Study|Withdrawal by Subject|12|||
145636496|NCT00102063|525183947|FG002|Overall Study|Withdrawal by Subject|5|||
145636497|NCT00102063|525183945|FG000|Overall Study|Lost to Follow-up|0|||
145636498|NCT00102063|525183946|FG001|Overall Study|Lost to Follow-up|0|||
145636499|NCT00102063|525183947|FG002|Overall Study|Lost to Follow-up|1|||
145636500|NCT00102063|525183945|FG000|Overall Study|Protocol Violation|0|||
145636501|NCT00102063|525183946|FG001|Overall Study|Protocol Violation|1|||
145636502|NCT00102063|525183947|FG002|Overall Study|Protocol Violation|1|||
145636503|NCT02739035|525183951|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
145636504|NCT02739035|525183952|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
145636505|NCT02739035|525183951|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
145636506|NCT02739035|525183952|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
145636507|NCT02739035|525183951|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
145636508|NCT02739035|525183952|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
145636509|NCT02739035|525183951|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
145636510|NCT02739035|525183952|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
145636511|NCT00539292|525183958|FG000|Overall Study|Physician Decision|1|||
145636512|NCT00539292|525183959|FG001|Overall Study|Physician Decision|0|||
145636513|NCT00324038|525183960|FG000|Overall Study|Adverse Event|38|||
145636514|NCT00324038|525183961|FG001|Overall Study|Adverse Event|23|||
145636515|NCT00324038|525183960|FG000|Overall Study|Lack of Efficacy|5|||
145636516|NCT00324038|525183961|FG001|Overall Study|Lack of Efficacy|13|||
145636517|NCT00324038|525183960|FG000|Overall Study|Lost to Follow-up|0|||
145636518|NCT00324038|525183961|FG001|Overall Study|Lost to Follow-up|2|||
145636519|NCT00324038|525183960|FG000|Overall Study|Other|6|||
145636520|NCT00324038|525183961|FG001|Overall Study|Other|13|||
145636521|NCT01585558|525183962|FG000|Overall Study|Withdrawal by Subject|4|||
145636522|NCT01585558|525183963|FG001|Overall Study|Withdrawal by Subject|5|||
145636523|NCT01585558|525183964|FG002|Overall Study|Withdrawal by Subject|8|||
145636524|NCT01585558|525183962|FG000|Overall Study|Lost to Follow-up|2|||
145636525|NCT01585558|525183963|FG001|Overall Study|Lost to Follow-up|0|||
145636526|NCT01585558|525183964|FG002|Overall Study|Lost to Follow-up|3|||
145636527|NCT01585558|525183962|FG000|Overall Study|Adverse Event|3|||
145636528|NCT01585558|525183963|FG001|Overall Study|Adverse Event|4|||
145636529|NCT01585558|525183964|FG002|Overall Study|Adverse Event|1|||
145636530|NCT01585558|525183962|FG000|Overall Study|Protocol Violation|4|||
145636531|NCT01585558|525183963|FG001|Overall Study|Protocol Violation|3|||
145636532|NCT01585558|525183964|FG002|Overall Study|Protocol Violation|2|||
145636533|NCT01585558|525183962|FG000|Overall Study|Lack of Efficacy|0|||
145636534|NCT01585558|525183963|FG001|Overall Study|Lack of Efficacy|0|||
145636535|NCT01585558|525183964|FG002|Overall Study|Lack of Efficacy|1|||
145636536|NCT00997386|525183965|FG000|Overall Study|Death|7|||
145636537|NCT00617201|525183968|FG000|Overall Study|Lost to Follow-up|9|||
145636538|NCT00617201|525183969|FG001|Overall Study|Lost to Follow-up|13|||
145636539|NCT01350804|525183970|FG000|Core Study|Withdrawal by Subject|11|||
145636540|NCT01350804|525183971|FG001|Core Study|Withdrawal by Subject|17|||
145480998|NCT03364309|524613219|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
145480999|NCT03364309|524613220|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
145481000|NCT03364309|524613221|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
145481001|NCT03364309|524613222|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
145481002|NCT03364309|524613223|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
145481003|NCT03364309|524613224|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
145481004|NCT02328027|524613225|FG000|Overall Study|Withdrawal by Subject|0|||
145481005|NCT02328027|524613226|FG001|Overall Study|Withdrawal by Subject|1|||
145481006|NCT02465203|524613227|FG000|Overall Study|Protocol Violation|1|||
145481007|NCT02465203|524613228|FG001|Overall Study|Protocol Violation|1|||
145636541|NCT01350804|525183972|FG002|Core Study|Withdrawal by Subject|16|||
145636542|NCT01350804|525183973|FG003|Core Study|Withdrawal by Subject|7|||
145636543|NCT01350804|525183970|FG000|Core Study|Study terminated by Sponsor|0|||
145636544|NCT01350804|525183971|FG001|Core Study|Study terminated by Sponsor|0|||
145636545|NCT01350804|525183972|FG002|Core Study|Study terminated by Sponsor|0|||
145636546|NCT01350804|525183973|FG003|Core Study|Study terminated by Sponsor|2|||
145636547|NCT01350804|525183970|FG000|Core Study|Protocol deviation|1|||
145636548|NCT01350804|525183971|FG001|Core Study|Protocol deviation|0|||
145636549|NCT01350804|525183972|FG002|Core Study|Protocol deviation|1|||
145481008|NCT02465203|524613229|FG002|Overall Study|Protocol Violation|1|||
145481009|NCT02465203|524613227|FG000|Overall Study|Study terminated by sponsor|50|||
145636550|NCT01350804|525183973|FG003|Core Study|Protocol deviation|0|||
145636551|NCT01350804|525183970|FG000|Core Study|Physician Decision|1|||
145636552|NCT01350804|525183971|FG001|Core Study|Physician Decision|0|||
145481010|NCT02465203|524613228|FG001|Overall Study|Study terminated by sponsor|34|||
145636553|NCT01350804|525183972|FG002|Core Study|Physician Decision|1|||
145636554|NCT01350804|525183973|FG003|Core Study|Physician Decision|3|||
145636555|NCT01350804|525183970|FG000|Core Study|Lost to Follow-up|3|||
145481011|NCT02465203|524613229|FG002|Overall Study|Study terminated by sponsor|11|||
145481012|NCT02465203|524613227|FG000|Overall Study|New therapy for study indication|4|||
145481013|NCT02465203|524613228|FG001|Overall Study|New therapy for study indication|0|||
145481014|NCT02465203|524613229|FG002|Overall Study|New therapy for study indication|0|||
145481015|NCT02465203|524613227|FG000|Overall Study|Patient/guardian decision|1|||
145603559|NCT02487498|525063117|FG001|Period: Washout|Physician Decision|0|||
145603560|NCT02487498|525063116|FG000|Period: Washout|Non-compliance with study treatment|0|||
145603561|NCT02487498|525063117|FG001|Period: Washout|Non-compliance with study treatment|1|||
145603562|NCT02487498|525063116|FG000|Period: Period 2|Adverse Event|2|||
145603563|NCT02487498|525063117|FG001|Period: Period 2|Adverse Event|2|||
145603564|NCT02487498|525063116|FG000|Period: Period 2|Subject/guardian decision|2|||
145603565|NCT02487498|525063117|FG001|Period: Period 2|Subject/guardian decision|1|||
145603566|NCT02487498|525063116|FG000|Period: Period 2|Lost to Follow-up|1|||
145603567|NCT02487498|525063117|FG001|Period: Period 2|Lost to Follow-up|1|||
145603568|NCT02487498|525063116|FG000|Period: Period 2|Death|0|||
145603569|NCT02487498|525063117|FG001|Period: Period 2|Death|1|||
145603570|NCT02487498|525063116|FG000|Period: Period 2|Physician Decision|1|||
145603571|NCT02487498|525063117|FG001|Period: Period 2|Physician Decision|0|||
145603572|NCT00676130|525063118|FG000|Overall Study|Lost to Follow-up|0|||
145603573|NCT00676130|525063119|FG001|Overall Study|Lost to Follow-up|1|||
145603574|NCT00676130|525063118|FG000|Overall Study|Found ineligible|3|||
145603575|NCT00676130|525063119|FG001|Overall Study|Found ineligible|2|||
145603576|NCT00676130|525063118|FG000|Overall Study|Withdrawal by Subject|0|||
145603577|NCT00676130|525063119|FG001|Overall Study|Withdrawal by Subject|1|||
145603578|NCT00331344|525063126|FG000|Phase I|Adverse Event|0|||
145603579|NCT00331344|525063127|FG001|Phase I|Adverse Event|0|||
145603580|NCT00331344|525063128|FG002|Phase I|Adverse Event|0|||
145603581|NCT00331344|525063129|FG003|Phase I|Adverse Event|1|||
145603582|NCT00331344|525063130|FG004|Phase I|Adverse Event|2|||
145603583|NCT00331344|525063131|FG005|Phase I|Adverse Event|2|||
145603584|NCT00331344|525063132|FG006|Phase I|Adverse Event|0|||
145603585|NCT00331344|525063133|FG007|Phase I|Adverse Event|1|||
145603586|NCT00331344|525063134|FG008|Phase I|Adverse Event|0|||
145603587|NCT00331344|525063126|FG000|Phase II|Death|0|||
145603588|NCT00331344|525063127|FG001|Phase II|Death|0|||
145603589|NCT00331344|525063128|FG002|Phase II|Death|0|||
145603590|NCT00331344|525063129|FG003|Phase II|Death|0|||
145603591|NCT00331344|525063130|FG004|Phase II|Death|0|||
145603592|NCT00331344|525063131|FG005|Phase II|Death|0|||
145603593|NCT00331344|525063132|FG006|Phase II|Death|0|||
145603594|NCT00331344|525063133|FG007|Phase II|Death|0|||
145603595|NCT00331344|525063134|FG008|Phase II|Death|4|||
145603596|NCT01373931|525063140|FG000|Lead-in Period|Adverse Event|2|||
145603597|NCT01373931|525063141|FG001|Lead-in Period|Adverse Event|0|||
145603598|NCT01373931|525063140|FG000|Period 1|Adverse Event|2|||
145603599|NCT01373931|525063141|FG001|Period 1|Adverse Event|0|||
145603600|NCT01373931|525063140|FG000|Period 1|Withdrawal by Subject|0|||
145603601|NCT01373931|525063141|FG001|Period 1|Withdrawal by Subject|2|||
145603602|NCT04538144|525063142|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
145603603|NCT04538144|525063143|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
145603604|NCT04538144|525063144|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
145603605|NCT04538144|525063145|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
145603606|NCT01682213|525063153|FG000|Overall Study|Withdrawal by Subject|2|||
145603607|NCT01995539|525063154|FG000|Overall Study|Screening Failure|1|||
145603608|NCT01995539|525063154|FG000|Overall Study|Withdrawal by Investigator|15|||
145603609|NCT01995539|525063154|FG000|Overall Study|Withdrawal by Subject|11|||
145603610|NCT01995539|525063154|FG000|Overall Study|Lost to Follow-up|5|||
145603611|NCT01995539|525063154|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
145603612|NCT01264380|525063155|FG000|Period C|Disease Progression|0|||
145603613|NCT01264380|525063156|FG001|Period C|Disease Progression|0|||
145603614|NCT01264380|525063157|FG002|Period C|Disease Progression|4|||
145603615|NCT01264380|525063155|FG000|Period C|Death|0|||
145603616|NCT01264380|525063156|FG001|Period C|Death|0|||
145603617|NCT01264380|525063157|FG002|Period C|Death|2|||
145603618|NCT01264380|525063155|FG000|Period C|Follow-up for survival status|0|||
145603619|NCT01264380|525063156|FG001|Period C|Follow-up for survival status|0|||
145603620|NCT01264380|525063157|FG002|Period C|Follow-up for survival status|6|||
145603621|NCT01264380|525063155|FG000|Period C|Withdrawal by Subject|0|||
145603622|NCT01264380|525063156|FG001|Period C|Withdrawal by Subject|0|||
145603623|NCT01264380|525063157|FG002|Period C|Withdrawal by Subject|1|||
145603624|NCT01264380|525063155|FG000|Period C|Adverse Event|0|||
145603625|NCT01264380|525063156|FG001|Period C|Adverse Event|0|||
145603626|NCT01264380|525063157|FG002|Period C|Adverse Event|1|||
145603627|NCT01147822|525063158|FG000|Overall Study|Lost to Follow-up|14|||
145603628|NCT01147822|525063159|FG001|Overall Study|Lost to Follow-up|6|||
145603629|NCT01147822|525063158|FG000|Overall Study|Withdrawal by Subject|10|||
145603630|NCT01147822|525063159|FG001|Overall Study|Withdrawal by Subject|16|||
145603631|NCT01147822|525063158|FG000|Overall Study|Physician Decision|9|||
145603632|NCT01147822|525063159|FG001|Overall Study|Physician Decision|8|||
145603633|NCT01147822|525063158|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
145481016|NCT02465203|524613228|FG001|Overall Study|Patient/guardian decision|1|||
145481017|NCT02465203|524613229|FG002|Overall Study|Patient/guardian decision|1|||
145481018|NCT02508428|524613236|FG000|Overall Study|Death|32|||
145481019|NCT02508428|524613237|FG001|Overall Study|Death|33|||
145481020|NCT02508428|524613236|FG000|Overall Study|Liner revised|3|||
145481021|NCT02508428|524613237|FG001|Overall Study|Liner revised|19|||
145481022|NCT02508428|524613236|FG000|Overall Study|Incomplete follow-up|17|||
145481023|NCT02508428|524613237|FG001|Overall Study|Incomplete follow-up|15|||
145603634|NCT01147822|525063159|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
145603635|NCT01147822|525063158|FG000|Overall Study|Protocol Violation|1|||
145603636|NCT01147822|525063159|FG001|Overall Study|Protocol Violation|1|||
145603637|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
145603638|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
145603639|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
145603640|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
145603641|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
145603642|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
145603643|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
145603644|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
145603645|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
145603646|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
145603647|NCT00261495|525063163|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
145603648|NCT00261495|525063164|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
145603649|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
145603650|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
145603651|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
145603652|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
145603653|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
145603654|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
145603655|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
145603656|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
145603657|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
145603658|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
145603659|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
145603660|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
145603661|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
145603662|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
145603663|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
145603664|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
145603665|NCT00261495|525063163|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
145603666|NCT00261495|525063164|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
145603667|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
145603668|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
145603669|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
145603670|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
145603671|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
145603672|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
145603673|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
145603674|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
145603675|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
145603676|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
145603677|NCT00261495|525063163|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
145603678|NCT00261495|525063164|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
145603679|NCT03474107|525063165|FG000|Overall Study|Adverse Event|42|||
145603680|NCT03474107|525063166|FG001|Overall Study|Adverse Event|46|||
145603681|NCT03474107|525063165|FG000|Overall Study|Death|2|||
145603682|NCT03474107|525063166|FG001|Overall Study|Death|2|||
145603683|NCT03474107|525063165|FG000|Overall Study|Lost to Follow-up|0|||
145603684|NCT03474107|525063166|FG001|Overall Study|Lost to Follow-up|1|||
145603685|NCT03474107|525063165|FG000|Overall Study|Progressive Disease|177|||
145603686|NCT03474107|525063166|FG001|Overall Study|Progressive Disease|180|||
145603687|NCT03474107|525063165|FG000|Overall Study|Protocol Violation|1|||
145603688|NCT03474107|525063166|FG001|Overall Study|Protocol Violation|1|||
145603689|NCT03474107|525063165|FG000|Overall Study|Withdrawal by Subject|15|||
145603690|NCT03474107|525063166|FG001|Overall Study|Withdrawal by Subject|27|||
145603691|NCT03474107|525063165|FG000|Overall Study|Physician Decision|7|||
145603692|NCT03474107|525063166|FG001|Overall Study|Physician Decision|22|||
145603693|NCT03474107|525063165|FG000|Overall Study|Miscellaneous|1|||
145603694|NCT03474107|525063166|FG001|Overall Study|Miscellaneous|6|||
145636556|NCT01350804|525183971|FG001|Core Study|Lost to Follow-up|0|||
145481024|NCT04371666|524613239|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
145481025|NCT04371666|524613240|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
145636557|NCT01350804|525183972|FG002|Core Study|Lost to Follow-up|2|||
145636558|NCT01350804|525183973|FG003|Core Study|Lost to Follow-up|1|||
145636559|NCT01350804|525183970|FG000|Core Study|Lack of Efficacy|16|||
145636560|NCT01350804|525183971|FG001|Core Study|Lack of Efficacy|19|||
145636561|NCT01350804|525183972|FG002|Core Study|Lack of Efficacy|18|||
145636562|NCT01350804|525183973|FG003|Core Study|Lack of Efficacy|5|||
145636563|NCT01350804|525183970|FG000|Core Study|Death|1|||
145636564|NCT01350804|525183971|FG001|Core Study|Death|1|||
145636565|NCT01350804|525183972|FG002|Core Study|Death|1|||
145636566|NCT01350804|525183973|FG003|Core Study|Death|0|||
145636567|NCT01350804|525183970|FG000|Core Study|Adverse Event|8|||
145636568|NCT01350804|525183971|FG001|Core Study|Adverse Event|10|||
145636569|NCT01350804|525183972|FG002|Core Study|Adverse Event|8|||
145636570|NCT01350804|525183973|FG003|Core Study|Adverse Event|8|||
145636571|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
145636572|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
145636573|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
145636574|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
145636575|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
145636576|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
145636577|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
145636578|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
145636579|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
145636580|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
145636581|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
145636582|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
145636583|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
145636584|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
145636585|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
145636586|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
145636587|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
145636588|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
145636589|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
145636590|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
145636591|NCT01350804|525183970|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
145636592|NCT01350804|525183971|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
145636593|NCT01350804|525183972|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
145636594|NCT01350804|525183973|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
145636595|NCT03284957|525186019|FG000|Overall Study|Adverse Event|0|||
145636596|NCT03284957|525186020|FG001|Overall Study|Adverse Event|0|||
145636597|NCT03284957|525186021|FG002|Overall Study|Adverse Event|0|||
145636598|NCT03284957|525186022|FG003|Overall Study|Adverse Event|0|||
145636599|NCT03284957|525186023|FG004|Overall Study|Adverse Event|0|||
145636600|NCT03284957|525186024|FG005|Overall Study|Adverse Event|1|||
145636601|NCT03284957|525186025|FG006|Overall Study|Adverse Event|1|||
145636602|NCT03284957|525186026|FG007|Overall Study|Adverse Event|1|||
145636603|NCT03284957|525186027|FG008|Overall Study|Adverse Event|0|||
145636604|NCT03284957|525186028|FG009|Overall Study|Adverse Event|4|||
145636605|NCT03284957|525186029|FG010|Overall Study|Adverse Event|1|||
145636606|NCT03284957|525186030|FG011|Overall Study|Adverse Event|1|||
145636607|NCT03284957|525186031|FG012|Overall Study|Adverse Event|0|||
145636608|NCT03284957|525186032|FG013|Overall Study|Adverse Event|0|||
145636609|NCT03284957|525186033|FG014|Overall Study|Adverse Event|0|||
145636610|NCT03284957|525186034|FG015|Overall Study|Adverse Event|0|||
145636611|NCT03284957|525186019|FG000|Overall Study|Progressive Disease|3|||
145636612|NCT03284957|525186020|FG001|Overall Study|Progressive Disease|3|||
145636613|NCT03284957|525186021|FG002|Overall Study|Progressive Disease|4|||
145636614|NCT03284957|525186022|FG003|Overall Study|Progressive Disease|3|||
145636615|NCT03284957|525186023|FG004|Overall Study|Progressive Disease|3|||
145636616|NCT03284957|525186024|FG005|Overall Study|Progressive Disease|5|||
145636617|NCT03284957|525186025|FG006|Overall Study|Progressive Disease|45|||
145636618|NCT03284957|525186026|FG007|Overall Study|Progressive Disease|8|||
145636619|NCT03284957|525186027|FG008|Overall Study|Progressive Disease|5|||
145636620|NCT03284957|525186028|FG009|Overall Study|Progressive Disease|18|||
145636621|NCT03284957|525186029|FG010|Overall Study|Progressive Disease|7|||
145636622|NCT03284957|525186030|FG011|Overall Study|Progressive Disease|2|||
145636623|NCT03284957|525186031|FG012|Overall Study|Progressive Disease|3|||
145636624|NCT03284957|525186032|FG013|Overall Study|Progressive Disease|1|||
145636625|NCT03284957|525186033|FG014|Overall Study|Progressive Disease|1|||
145636626|NCT03284957|525186034|FG015|Overall Study|Progressive Disease|2|||
145636627|NCT03284957|525186019|FG000|Overall Study|Withdrawal by Subject|0|||
145636628|NCT03284957|525186020|FG001|Overall Study|Withdrawal by Subject|0|||
145636629|NCT03284957|525186021|FG002|Overall Study|Withdrawal by Subject|0|||
145636630|NCT03284957|525186022|FG003|Overall Study|Withdrawal by Subject|0|||
145636631|NCT03284957|525186023|FG004|Overall Study|Withdrawal by Subject|0|||
145636632|NCT03284957|525186024|FG005|Overall Study|Withdrawal by Subject|0|||
145481026|NCT04371666|524613239|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
145481027|NCT04371666|524613240|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
145481028|NCT04371666|524613239|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
145481029|NCT04371666|524613240|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
145481030|NCT04371666|524613239|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
145481031|NCT04371666|524613240|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
145603695|NCT01932697|525063167|FG000|Overall Study|Received a different amount of tx|1|||
145603696|NCT01932697|525063168|FG001|Overall Study|Received a different amount of tx|0|||
145603697|NCT01932697|525063167|FG000|Overall Study|Ineligible|1|||
145603698|NCT01932697|525063168|FG001|Overall Study|Ineligible|0|||
145603699|NCT01330316|525063169|FG000|Overall Study|Adverse Event|2|||
145603700|NCT01330316|525063170|FG001|Overall Study|Adverse Event|2|||
145603701|NCT01330316|525063169|FG000|Overall Study|Lack of Efficacy|0|||
145603702|NCT01330316|525063170|FG001|Overall Study|Lack of Efficacy|10|||
145603703|NCT01330316|525063169|FG000|Overall Study|Lost to Follow-up|0|||
145603704|NCT01330316|525063170|FG001|Overall Study|Lost to Follow-up|1|||
145603705|NCT01330316|525063169|FG000|Overall Study|Withdrawal by Subject|0|||
145603706|NCT01330316|525063170|FG001|Overall Study|Withdrawal by Subject|1|||
145603707|NCT01330316|525063169|FG000|Overall Study|other than above|0|||
145603708|NCT01330316|525063170|FG001|Overall Study|other than above|1|||
145603709|NCT02696564|525063174|FG000|Overall Study|Death|1|||
145603710|NCT02696564|525063175|FG001|Overall Study|Death|2|||
145603711|NCT02696564|525063174|FG000|Overall Study|Withdrawal by Subject|3|||
145603712|NCT02696564|525063175|FG001|Overall Study|Withdrawal by Subject|2|||
145603713|NCT02696564|525063174|FG000|Overall Study|Lost to Follow-up|3|||
145603714|NCT02696564|525063175|FG001|Overall Study|Lost to Follow-up|3|||
145603715|NCT02696564|525063174|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
145603716|NCT02696564|525063175|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
145603717|NCT02696564|525063174|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
145603718|NCT02696564|525063175|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
145603719|NCT02696564|525063174|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
145603720|NCT02696564|525063175|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
145603721|NCT02696564|525063174|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
145603722|NCT02696564|525063175|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
145603723|NCT02696564|525063174|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
145603724|NCT02696564|525063175|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
145603725|NCT01337986|525063176|FG000|Overall Study|Adverse Event|2|||
145603726|NCT01337986|525063177|FG001|Overall Study|Adverse Event|2|||
145603727|NCT01337986|525063176|FG000|Overall Study|Lost to Follow-up|1|||
145603728|NCT01337986|525063177|FG001|Overall Study|Lost to Follow-up|0|||
145603729|NCT01337986|525063176|FG000|Overall Study|Protocol Violation|0|||
145603730|NCT01337986|525063177|FG001|Overall Study|Protocol Violation|3|||
145603731|NCT01520402|525063179|FG000|Overall Study|Withdrawal by Subject|2|||
145603732|NCT01520402|525063179|FG000|Overall Study|Physician Decision|3|||
145603733|NCT02798211|525063180|FG000|Period 1|Adverse Event|1|||
145603734|NCT02798211|525063181|FG001|Period 1|Adverse Event|1|||
145603735|NCT02798211|525063182|FG002|Period 1|Adverse Event|0|||
145603736|NCT02798211|525063183|FG003|Period 1|Adverse Event|0|||
145603737|NCT02798211|525063184|FG004|Period 1|Adverse Event|0|||
145603738|NCT02798211|525063185|FG005|Period 1|Adverse Event|0|||
145603739|NCT02798211|525063180|FG000|Period 1|Lost to Follow-up|2|||
145603740|NCT02798211|525063181|FG001|Period 1|Lost to Follow-up|1|||
145603741|NCT02798211|525063182|FG002|Period 1|Lost to Follow-up|0|||
145603742|NCT02798211|525063183|FG003|Period 1|Lost to Follow-up|0|||
145603743|NCT02798211|525063184|FG004|Period 1|Lost to Follow-up|0|||
145603744|NCT02798211|525063185|FG005|Period 1|Lost to Follow-up|0|||
145603745|NCT02798211|525063180|FG000|Period 1|Protocol Violation|0|||
145603746|NCT02798211|525063181|FG001|Period 1|Protocol Violation|0|||
145603747|NCT02798211|525063182|FG002|Period 1|Protocol Violation|2|||
145603748|NCT02798211|525063183|FG003|Period 1|Protocol Violation|0|||
145603749|NCT02798211|525063184|FG004|Period 1|Protocol Violation|0|||
145603750|NCT02798211|525063185|FG005|Period 1|Protocol Violation|0|||
145603751|NCT02798211|525063180|FG000|Period 1|Withdrawal by Subject|1|||
145603752|NCT02798211|525063181|FG001|Period 1|Withdrawal by Subject|1|||
145603753|NCT02798211|525063182|FG002|Period 1|Withdrawal by Subject|0|||
145603754|NCT02798211|525063183|FG003|Period 1|Withdrawal by Subject|0|||
145603755|NCT02798211|525063184|FG004|Period 1|Withdrawal by Subject|0|||
145603756|NCT02798211|525063185|FG005|Period 1|Withdrawal by Subject|0|||
145636633|NCT03284957|525186025|FG006|Overall Study|Withdrawal by Subject|0|||
145603757|NCT02798211|525063180|FG000|Period 1|Death|0|||
145636634|NCT03284957|525186026|FG007|Overall Study|Withdrawal by Subject|0|||
145603758|NCT02798211|525063181|FG001|Period 1|Death|0|||
145603759|NCT02798211|525063182|FG002|Period 1|Death|1|||
145603760|NCT02798211|525063183|FG003|Period 1|Death|0|||
145603761|NCT02798211|525063184|FG004|Period 1|Death|0|||
145481032|NCT04371666|524613239|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
145481033|NCT04371666|524613240|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
145481034|NCT04371666|524613239|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
145603762|NCT02798211|525063185|FG005|Period 1|Death|0|||
145603763|NCT02798211|525063180|FG000|Period 1|Withdrawal of Informed Consent|2|||
145603764|NCT02798211|525063181|FG001|Period 1|Withdrawal of Informed Consent|7|||
145603765|NCT02798211|525063182|FG002|Period 1|Withdrawal of Informed Consent|3|||
145603766|NCT02798211|525063183|FG003|Period 1|Withdrawal of Informed Consent|0|||
145603767|NCT02798211|525063184|FG004|Period 1|Withdrawal of Informed Consent|0|||
145603768|NCT02798211|525063185|FG005|Period 1|Withdrawal of Informed Consent|0|||
145603769|NCT02798211|525063180|FG000|Period 2|Withdrawal by Subject|2|||
145603770|NCT02798211|525063181|FG001|Period 2|Withdrawal by Subject|0|||
145603771|NCT02798211|525063182|FG002|Period 2|Withdrawal by Subject|0|||
145603772|NCT02798211|525063183|FG003|Period 2|Withdrawal by Subject|0|||
145603773|NCT02798211|525063184|FG004|Period 2|Withdrawal by Subject|2|||
145603774|NCT02798211|525063185|FG005|Period 2|Withdrawal by Subject|2|||
145603775|NCT02798211|525063180|FG000|Period 2|Adverse Event|5|||
145603776|NCT02798211|525063181|FG001|Period 2|Adverse Event|0|||
145603777|NCT02798211|525063182|FG002|Period 2|Adverse Event|0|||
145603778|NCT02798211|525063183|FG003|Period 2|Adverse Event|0|||
145603779|NCT02798211|525063184|FG004|Period 2|Adverse Event|1|||
145603780|NCT02798211|525063185|FG005|Period 2|Adverse Event|0|||
145603781|NCT02798211|525063180|FG000|Period 2|Lack of Efficacy|1|||
145603782|NCT02798211|525063181|FG001|Period 2|Lack of Efficacy|0|||
145603783|NCT02798211|525063182|FG002|Period 2|Lack of Efficacy|0|||
145603784|NCT02798211|525063183|FG003|Period 2|Lack of Efficacy|1|||
145603785|NCT02798211|525063184|FG004|Period 2|Lack of Efficacy|0|||
145603786|NCT02798211|525063185|FG005|Period 2|Lack of Efficacy|1|||
145603787|NCT02798211|525063180|FG000|Period 2|Lost to Follow-up|3|||
145603788|NCT02798211|525063181|FG001|Period 2|Lost to Follow-up|0|||
145603789|NCT02798211|525063182|FG002|Period 2|Lost to Follow-up|0|||
145603790|NCT02798211|525063183|FG003|Period 2|Lost to Follow-up|0|||
145603791|NCT02798211|525063184|FG004|Period 2|Lost to Follow-up|2|||
145603792|NCT02798211|525063185|FG005|Period 2|Lost to Follow-up|0|||
145603793|NCT02798211|525063180|FG000|Period 2|Physician Decision|1|||
145603794|NCT02798211|525063181|FG001|Period 2|Physician Decision|0|||
145603795|NCT02798211|525063182|FG002|Period 2|Physician Decision|0|||
145603796|NCT02798211|525063183|FG003|Period 2|Physician Decision|1|||
145603797|NCT02798211|525063184|FG004|Period 2|Physician Decision|1|||
145603798|NCT02798211|525063185|FG005|Period 2|Physician Decision|0|||
145603799|NCT02798211|525063180|FG000|Period 2|Pregnancy|0|||
145603800|NCT02798211|525063181|FG001|Period 2|Pregnancy|0|||
145603801|NCT02798211|525063182|FG002|Period 2|Pregnancy|0|||
145603802|NCT02798211|525063183|FG003|Period 2|Pregnancy|2|||
145603803|NCT02798211|525063184|FG004|Period 2|Pregnancy|0|||
145603804|NCT02798211|525063185|FG005|Period 2|Pregnancy|0|||
145603805|NCT02798211|525063180|FG000|Period 2|Technical problems|1|||
145603806|NCT02798211|525063181|FG001|Period 2|Technical problems|0|||
145603807|NCT02798211|525063182|FG002|Period 2|Technical problems|0|||
145603808|NCT02798211|525063183|FG003|Period 2|Technical problems|1|||
145603809|NCT02798211|525063184|FG004|Period 2|Technical problems|0|||
145603810|NCT02798211|525063185|FG005|Period 2|Technical problems|0|||
145603811|NCT02798211|525063180|FG000|Period 2|Withdrawal of Informed Consent|1|||
145603812|NCT02798211|525063181|FG001|Period 2|Withdrawal of Informed Consent|0|||
145603813|NCT02798211|525063182|FG002|Period 2|Withdrawal of Informed Consent|0|||
145603814|NCT02798211|525063183|FG003|Period 2|Withdrawal of Informed Consent|2|||
145603815|NCT02798211|525063184|FG004|Period 2|Withdrawal of Informed Consent|2|||
145603816|NCT02798211|525063185|FG005|Period 2|Withdrawal of Informed Consent|3|||
145603817|NCT03815019|525063187|FG000|Overall Study|Withdrawal by Subject|6|||
145603818|NCT03815019|525063188|FG001|Overall Study|Withdrawal by Subject|8|||
145603819|NCT05398796|525063189|FG000|Overall Study|Participant moved from the area|0|||
145603820|NCT05398796|525063190|FG001|Overall Study|Participant moved from the area|1|||
145603821|NCT05398796|525063191|FG002|Overall Study|Participant moved from the area|0|||
145603822|NCT05398796|525063192|FG003|Overall Study|Participant moved from the area|0|||
145603823|NCT04270747|525063194|FG000|Through Week 16|Adverse Event|1|||
145603824|NCT04270747|525063195|FG001|Through Week 16|Adverse Event|2|||
145603825|NCT04270747|525063196|FG002|Through Week 16|Adverse Event|0|||
145603826|NCT04270747|525063194|FG000|Through Week 16|Death|0|||
145603827|NCT04270747|525063195|FG001|Through Week 16|Death|2|||
145603828|NCT04270747|525063196|FG002|Through Week 16|Death|0|||
145603829|NCT04270747|525063194|FG000|Through Week 16|Consent Withdrawn|3|||
145603830|NCT04270747|525063195|FG001|Through Week 16|Consent Withdrawn|3|||
145603831|NCT04270747|525063196|FG002|Through Week 16|Consent Withdrawn|0|||
145603832|NCT04270747|525063194|FG000|Through Week 16|Physician Decision|1|||
145603833|NCT04270747|525063195|FG001|Through Week 16|Physician Decision|1|||
145603834|NCT04270747|525063196|FG002|Through Week 16|Physician Decision|0|||
145603835|NCT04270747|525063194|FG000|Through Week 16|Lost to Follow-up|2|||
145481035|NCT04371666|524613240|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
145481036|NCT00534976|524613247|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
145603836|NCT04270747|525063195|FG001|Through Week 16|Lost to Follow-up|0|||
145603837|NCT04270747|525063196|FG002|Through Week 16|Lost to Follow-up|0|||
145603838|NCT04270747|525063194|FG000|Through Week 16|Protocol Violation|1|||
145603839|NCT04270747|525063195|FG001|Through Week 16|Protocol Violation|2|||
145603840|NCT04270747|525063196|FG002|Through Week 16|Protocol Violation|0|||
145603841|NCT04270747|525063194|FG000|Through Week 16|Protocol Specified Criteria|6|||
145603842|NCT04270747|525063195|FG001|Through Week 16|Protocol Specified Criteria|7|||
145603843|NCT04270747|525063196|FG002|Through Week 16|Protocol Specified Criteria|0|||
145603844|NCT04270747|525063194|FG000|Through Week 16|Miscellaneous|1|||
145603845|NCT04270747|525063195|FG001|Through Week 16|Miscellaneous|1|||
145603846|NCT04270747|525063196|FG002|Through Week 16|Miscellaneous|0|||
145603847|NCT04270747|525063194|FG000|Post Week 16|Adverse Event|7|||
145603848|NCT04270747|525063195|FG001|Post Week 16|Adverse Event|5|||
145603849|NCT04270747|525063196|FG002|Post Week 16|Adverse Event|1|||
145603850|NCT04270747|525063194|FG000|Post Week 16|Death|2|||
145603851|NCT04270747|525063195|FG001|Post Week 16|Death|0|||
145603852|NCT04270747|525063196|FG002|Post Week 16|Death|2|||
145603853|NCT04270747|525063194|FG000|Post Week 16|Consent Withdrawn|4|||
145603854|NCT04270747|525063195|FG001|Post Week 16|Consent Withdrawn|3|||
145603855|NCT04270747|525063196|FG002|Post Week 16|Consent Withdrawn|6|||
145603856|NCT04270747|525063194|FG000|Post Week 16|Physician Decision|3|||
145603857|NCT04270747|525063195|FG001|Post Week 16|Physician Decision|1|||
145603858|NCT04270747|525063196|FG002|Post Week 16|Physician Decision|1|||
145603859|NCT04270747|525063194|FG000|Post Week 16|Lost to Follow-up|2|||
145603860|NCT04270747|525063195|FG001|Post Week 16|Lost to Follow-up|1|||
145603861|NCT04270747|525063196|FG002|Post Week 16|Lost to Follow-up|0|||
145603862|NCT04270747|525063194|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
145603863|NCT04270747|525063195|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
145603864|NCT04270747|525063196|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
145603865|NCT04270747|525063194|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
145603866|NCT04270747|525063195|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
145603867|NCT04270747|525063196|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
145603868|NCT04270747|525063194|FG000|Post Week 16|Miscellaneous|1|||
145603869|NCT04270747|525063195|FG001|Post Week 16|Miscellaneous|0|||
145603870|NCT04270747|525063196|FG002|Post Week 16|Miscellaneous|1|||
145603871|NCT05960097|525063197|FG000|Overall Study|Lost to Follow-up|3|||
145603872|NCT05960097|525063198|FG001|Overall Study|Lost to Follow-up|1|||
145603873|NCT05960097|525063199|FG002|Overall Study|Lost to Follow-up|1|||
145603874|NCT05960097|525063200|FG003|Overall Study|Lost to Follow-up|2|||
145603875|NCT05960097|525063201|FG004|Overall Study|Lost to Follow-up|1|||
145603876|NCT05960097|525063202|FG005|Overall Study|Lost to Follow-up|1|||
145603877|NCT05960097|525063203|FG006|Overall Study|Lost to Follow-up|2|||
145603878|NCT05960097|525063204|FG007|Overall Study|Lost to Follow-up|3|||
145603879|NCT05960097|525063197|FG000|Overall Study|Physician Decision|0|||
145603880|NCT05960097|525063198|FG001|Overall Study|Physician Decision|0|||
145603881|NCT05960097|525063199|FG002|Overall Study|Physician Decision|0|||
145603882|NCT05960097|525063200|FG003|Overall Study|Physician Decision|0|||
145603883|NCT05960097|525063201|FG004|Overall Study|Physician Decision|0|||
145603884|NCT05960097|525063202|FG005|Overall Study|Physician Decision|0|||
145603885|NCT05960097|525063203|FG006|Overall Study|Physician Decision|1|||
145603886|NCT05960097|525063204|FG007|Overall Study|Physician Decision|0|||
145603887|NCT05960097|525063197|FG000|Overall Study|Withdrawal by Subject|1|||
145603888|NCT05960097|525063198|FG001|Overall Study|Withdrawal by Subject|0|||
145603889|NCT05960097|525063199|FG002|Overall Study|Withdrawal by Subject|0|||
145603890|NCT05960097|525063200|FG003|Overall Study|Withdrawal by Subject|1|||
145603891|NCT05960097|525063201|FG004|Overall Study|Withdrawal by Subject|1|||
145603892|NCT05960097|525063202|FG005|Overall Study|Withdrawal by Subject|0|||
145603893|NCT05960097|525063203|FG006|Overall Study|Withdrawal by Subject|0|||
145603894|NCT05960097|525063204|FG007|Overall Study|Withdrawal by Subject|0|||
145603895|NCT05960097|525063197|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603896|NCT05960097|525063198|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603897|NCT05960097|525063199|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
145603898|NCT05960097|525063200|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603899|NCT05960097|525063201|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603900|NCT05960097|525063202|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603901|NCT05960097|525063203|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603902|NCT05960097|525063204|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
145603903|NCT05805657|525063207|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
145603904|NCT05805657|525063208|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
145603905|NCT03904043|525063211|FG000|Overall Study|Adverse Event|1|||
145603906|NCT03904043|525063212|FG001|Overall Study|Adverse Event|1|||
145603907|NCT03904043|525063211|FG000|Overall Study|Withdrawal by Subject|1|||
145481037|NCT00534976|524613248|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
145481038|NCT00534976|524613247|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
145481039|NCT00534976|524613248|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
145481040|NCT00534976|524613247|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
145481041|NCT00534976|524613248|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
145481042|NCT00861471|524613249|FG000|Overall Study|Withdrawal by Subject|1|||
145481043|NCT00861471|524613249|FG000|Overall Study|Adverse Event|2|||
145481044|NCT00861471|524613249|FG000|Overall Study|Lack of Efficacy|3|||
145481045|NCT00861471|524613249|FG000|Overall Study|treatment for lumbar laminectomy|1|||
145481046|NCT00861471|524613249|FG000|Overall Study|Physician Decision|2|||
145481047|NCT02092025|524613250|FG000|Overall Study|Case Report Forms Uncollected|44|||
145481048|NCT02092025|524613250|FG000|Overall Study|Protocol Deviation|24|||
145481049|NCT00264537|524613251|FG000|Overall Study|Death|0|||
145481050|NCT00264537|524613252|FG001|Overall Study|Death|3|||
145481051|NCT00264537|524613253|FG002|Overall Study|Death|3|||
145481052|NCT00264537|524613254|FG003|Overall Study|Death|2|||
145481053|NCT00264537|524613251|FG000|Overall Study|Lost to Follow-up|3|||
145481054|NCT00264537|524613252|FG001|Overall Study|Lost to Follow-up|4|||
145481055|NCT00264537|524613253|FG002|Overall Study|Lost to Follow-up|7|||
145481056|NCT00264537|524613254|FG003|Overall Study|Lost to Follow-up|6|||
145481057|NCT00264537|524613251|FG000|Overall Study|Adverse Event|21|||
145481058|NCT00264537|524613252|FG001|Overall Study|Adverse Event|32|||
145481059|NCT00264537|524613253|FG002|Overall Study|Adverse Event|24|||
145481060|NCT00264537|524613254|FG003|Overall Study|Adverse Event|34|||
145481061|NCT00264537|524613251|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145481062|NCT00264537|524613252|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
145481063|NCT00264537|524613253|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
145481064|NCT00264537|524613254|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
145481065|NCT00264537|524613251|FG000|Overall Study|Other|21|||
145481066|NCT00264537|524613252|FG001|Overall Study|Other|11|||
145481067|NCT00264537|524613253|FG002|Overall Study|Other|10|||
145481068|NCT00264537|524613254|FG003|Overall Study|Other|11|||
145603908|NCT03904043|525063212|FG001|Overall Study|Withdrawal by Subject|0|||
145603909|NCT03904043|525063211|FG000|Overall Study|Non-compliance|1|||
145603910|NCT03904043|525063212|FG001|Overall Study|Non-compliance|0|||
145603911|NCT03904043|525063211|FG000|Overall Study|Did not start treatment|1|||
145603912|NCT03904043|525063212|FG001|Overall Study|Did not start treatment|0|||
145603913|NCT05619003|525063213|FG000|Overall Study|Adverse Event|1|||
145603914|NCT03538951|525063214|FG000|Overall Study|Withdrawal by Subject|1|||
145603915|NCT03538951|525063215|FG001|Overall Study|Withdrawal by Subject|2|||
145603916|NCT00856167|525063221|FG000|Period 1|Withdrawal by Subject|1|||
145603917|NCT00856167|525063222|FG001|Period 1|Withdrawal by Subject|4|||
145603918|NCT00856167|525063223|FG002|Period 1|Withdrawal by Subject|0|||
145603919|NCT00856167|525063224|FG003|Period 1|Withdrawal by Subject|0|||
145603920|NCT00856167|525063221|FG000|Period 1|Lost to Follow-up|2|||
145603921|NCT00856167|525063222|FG001|Period 1|Lost to Follow-up|1|||
145603922|NCT00856167|525063223|FG002|Period 1|Lost to Follow-up|0|||
145603923|NCT00856167|525063224|FG003|Period 1|Lost to Follow-up|0|||
145603924|NCT00856167|525063221|FG000|Period 2|Lost to Follow-up|0|||
145603925|NCT00856167|525063222|FG001|Period 2|Lost to Follow-up|0|||
145603926|NCT00856167|525063223|FG002|Period 2|Lost to Follow-up|3|||
145603927|NCT00856167|525063224|FG003|Period 2|Lost to Follow-up|1|||
145603928|NCT00856167|525063221|FG000|Period 2|Withdrawal by Subject|0|||
145603929|NCT00856167|525063222|FG001|Period 2|Withdrawal by Subject|0|||
145603930|NCT00856167|525063223|FG002|Period 2|Withdrawal by Subject|2|||
145603931|NCT00856167|525063224|FG003|Period 2|Withdrawal by Subject|4|||
145603932|NCT01392300|525064614|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
145603933|NCT01392300|525064615|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
145603934|NCT01392300|525064616|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
145603935|NCT01392300|525064614|FG000|Main Period (MP)|Withdrawal by Subject|5|||
145603936|NCT01392300|525064615|FG001|Main Period (MP)|Withdrawal by Subject|1|||
145603937|NCT01392300|525064616|FG002|Main Period (MP)|Withdrawal by Subject|0|||
145603938|NCT01392300|525064614|FG000|Main Period (MP)|Lost to Follow-up|3|||
145603939|NCT01392300|525064615|FG001|Main Period (MP)|Lost to Follow-up|3|||
145603940|NCT01392300|525064616|FG002|Main Period (MP)|Lost to Follow-up|0|||
145481069|NCT00264537|524613251|FG000|Overall Study|Not treated|0|||
145481070|NCT00264537|524613252|FG001|Overall Study|Not treated|2|||
145481071|NCT00264537|524613253|FG002|Overall Study|Not treated|1|||
145481072|NCT00264537|524613254|FG003|Overall Study|Not treated|0|||
145481073|NCT02123576|524613255|FG000|Overall Study|Adverse Event|1|||
145481074|NCT02123576|524613256|FG001|Overall Study|Adverse Event|0|||
145603941|NCT01392300|525064614|FG000|Main Period (MP)|Non-compliance|1|||
145603942|NCT01392300|525064615|FG001|Main Period (MP)|Non-compliance|0|||
145603943|NCT01392300|525064616|FG002|Main Period (MP)|Non-compliance|0|||
145603944|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
145603945|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
145603946|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
145636635|NCT03284957|525186027|FG008|Overall Study|Withdrawal by Subject|0|||
145636636|NCT03284957|525186028|FG009|Overall Study|Withdrawal by Subject|2|||
145636637|NCT03284957|525186029|FG010|Overall Study|Withdrawal by Subject|0|||
145636638|NCT03284957|525186030|FG011|Overall Study|Withdrawal by Subject|0|||
145636639|NCT03284957|525186031|FG012|Overall Study|Withdrawal by Subject|0|||
145636640|NCT03284957|525186032|FG013|Overall Study|Withdrawal by Subject|0|||
145636641|NCT03284957|525186033|FG014|Overall Study|Withdrawal by Subject|0|||
145636642|NCT03284957|525186034|FG015|Overall Study|Withdrawal by Subject|0|||
145636643|NCT03284957|525186019|FG000|Overall Study|Other|0|||
145636644|NCT03284957|525186020|FG001|Overall Study|Other|0|||
145636645|NCT03284957|525186021|FG002|Overall Study|Other|0|||
145636646|NCT03284957|525186022|FG003|Overall Study|Other|0|||
145636647|NCT03284957|525186023|FG004|Overall Study|Other|0|||
145636648|NCT03284957|525186024|FG005|Overall Study|Other|0|||
145636649|NCT03284957|525186025|FG006|Overall Study|Other|3|||
145636650|NCT03284957|525186026|FG007|Overall Study|Other|0|||
145636651|NCT03284957|525186027|FG008|Overall Study|Other|1|||
145636652|NCT03284957|525186028|FG009|Overall Study|Other|6|||
145636653|NCT03284957|525186029|FG010|Overall Study|Other|0|||
145636654|NCT03284957|525186030|FG011|Overall Study|Other|0|||
145636655|NCT03284957|525186031|FG012|Overall Study|Other|0|||
145636656|NCT03284957|525186032|FG013|Overall Study|Other|0|||
145636657|NCT03284957|525186033|FG014|Overall Study|Other|2|||
145636658|NCT03284957|525186034|FG015|Overall Study|Other|0|||
145636659|NCT01393119|525186037|FG000|Overall Study|Adverse Event|1|||
145636660|NCT01393119|525186038|FG001|Overall Study|Adverse Event|1|||
145636661|NCT01393119|525186039|FG002|Overall Study|Adverse Event|0|||
145636662|NCT01393119|525186040|FG003|Overall Study|Adverse Event|1|||
145636663|NCT01393119|525186037|FG000|Overall Study|Withdrawal by Subject|0|||
145636664|NCT01393119|525186038|FG001|Overall Study|Withdrawal by Subject|1|||
145636665|NCT01393119|525186039|FG002|Overall Study|Withdrawal by Subject|1|||
145636666|NCT01393119|525186040|FG003|Overall Study|Withdrawal by Subject|0|||
145636667|NCT01393119|525186037|FG000|Overall Study|Lack of Efficacy|1|||
145636668|NCT01393119|525186038|FG001|Overall Study|Lack of Efficacy|0|||
145636669|NCT01393119|525186039|FG002|Overall Study|Lack of Efficacy|2|||
145636670|NCT01393119|525186040|FG003|Overall Study|Lack of Efficacy|1|||
145636671|NCT01393119|525186037|FG000|Overall Study|Protocol Violation|0|||
145636672|NCT01393119|525186038|FG001|Overall Study|Protocol Violation|0|||
145636673|NCT01393119|525186039|FG002|Overall Study|Protocol Violation|1|||
145636674|NCT01393119|525186040|FG003|Overall Study|Protocol Violation|0|||
145636675|NCT01393119|525186037|FG000|Overall Study|Death|0|||
145636676|NCT01393119|525186038|FG001|Overall Study|Death|0|||
145636677|NCT01393119|525186039|FG002|Overall Study|Death|0|||
145636678|NCT01393119|525186040|FG003|Overall Study|Death|1|||
145636679|NCT01393119|525186037|FG000|Overall Study|Randomized but Not treated|1|||
145636680|NCT01393119|525186038|FG001|Overall Study|Randomized but Not treated|0|||
145636681|NCT01393119|525186039|FG002|Overall Study|Randomized but Not treated|1|||
145636682|NCT01393119|525186040|FG003|Overall Study|Randomized but Not treated|1|||
145636683|NCT01393119|525186037|FG000|Overall Study|Sponsor Termination of Study|11|||
145636684|NCT01393119|525186038|FG001|Overall Study|Sponsor Termination of Study|12|||
145636685|NCT01393119|525186039|FG002|Overall Study|Sponsor Termination of Study|9|||
145636686|NCT01393119|525186040|FG003|Overall Study|Sponsor Termination of Study|12|||
145636687|NCT01266265|525186041|FG000|Overall Study|Death|95|||
145636688|NCT01266265|525186042|FG001|Overall Study|Death|73|||
145636689|NCT01266265|525186041|FG000|Overall Study|Lost to Follow-up|23|||
145636690|NCT01266265|525186042|FG001|Overall Study|Lost to Follow-up|28|||
145636691|NCT01266265|525186041|FG000|Overall Study|Withdrawal by Subject|13|||
145636692|NCT01266265|525186042|FG001|Overall Study|Withdrawal by Subject|11|||
145636693|NCT01266265|525186041|FG000|Overall Study|Respiratory-related adverse event|2|||
145636694|NCT01266265|525186042|FG001|Overall Study|Respiratory-related adverse event|1|||
145636695|NCT01266265|525186041|FG000|Overall Study|Transferred care to another provider|22|||
145636696|NCT01266265|525186042|FG001|Overall Study|Transferred care to another provider|28|||
145636697|NCT01266265|525186041|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
145636698|NCT01266265|525186042|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
145636699|NCT01266265|525186041|FG000|Overall Study|Enrolled in another clinical study|15|||
145636700|NCT01266265|525186042|FG001|Overall Study|Enrolled in another clinical study|26|||
145636701|NCT01266265|525186041|FG000|Overall Study|Non-compliance|8|||
145636702|NCT01266265|525186042|FG001|Overall Study|Non-compliance|5|||
145636703|NCT01266265|525186041|FG000|Overall Study|Lung transplant|6|||
145636704|NCT01266265|525186042|FG001|Overall Study|Lung transplant|5|||
145636705|NCT01266265|525186041|FG000|Overall Study|Site closed early|4|||
145636706|NCT01266265|525186042|FG001|Overall Study|Site closed early|3|||
145636707|NCT01266265|525186041|FG000|Overall Study|Clinical worsening|1|||
145636708|NCT01266265|525186042|FG001|Overall Study|Clinical worsening|1|||
145636709|NCT01580293|525186043|FG000|Part A_Main Trial|Adverse Event|0|||
145636710|NCT01580293|525186044|FG001|Part A_Main Trial|Adverse Event|2|||
145636711|NCT01580293|525186045|FG002|Part A_Main Trial|Adverse Event|0|||
145636712|NCT01580293|525186043|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
145636713|NCT01580293|525186044|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
145481075|NCT00934128|524613257|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
145481076|NCT00934128|524613258|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
145481077|NCT00934128|524613257|FG000|First Intervention (2 Hours)|Adverse Event|4|||
145481078|NCT00934128|524613258|FG001|First Intervention (2 Hours)|Adverse Event|1|||
145481079|NCT00934128|524613257|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
145481080|NCT00934128|524613258|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
145481081|NCT00934128|524613257|FG000|Washout Period (1 Hour)|Patient preference|1|||
145481082|NCT00934128|524613258|FG001|Washout Period (1 Hour)|Patient preference|3|||
145481083|NCT00934128|524613257|FG000|Washout Period (1 Hour)|Pain|1|||
145481084|NCT00934128|524613258|FG001|Washout Period (1 Hour)|Pain|0|||
145481085|NCT00934128|524613257|FG000|Washout Period (1 Hour)|Too tired|1|||
145481086|NCT00934128|524613258|FG001|Washout Period (1 Hour)|Too tired|0|||
145481087|NCT00934128|524613257|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
145603947|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
145603948|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
145603949|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
145603950|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
145603951|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
145603952|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
145603953|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Death|0|||
145603954|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Death|0|||
145603955|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Death|4|||
145603956|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
145603957|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
145603958|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
145603959|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
145603960|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
145603961|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
145603962|NCT01392300|525064614|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
145603963|NCT01392300|525064615|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
145603964|NCT01392300|525064616|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
145603965|NCT05056870|525064621|FG000|Period 1|Site COVID-19 Related|3|||
145603966|NCT05056870|525064622|FG001|Period 1|Site COVID-19 Related|3|||
145603967|NCT05056870|525064621|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
145603968|NCT05056870|525064622|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
145603969|NCT05056870|525064621|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
145603970|NCT05056870|525064622|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
145603971|NCT05056870|525064621|FG000|Period 2|COVID-19 Related|1|||
145603972|NCT05056870|525064622|FG001|Period 2|COVID-19 Related|0|||
145603973|NCT05056870|525064621|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
145603974|NCT05056870|525064622|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
145603975|NCT00742079|525064623|FG000|Overall Study|Lost to Follow-up|0|||
145603976|NCT00742079|525064624|FG001|Overall Study|Lost to Follow-up|1|||
145603977|NCT03124199|525064627|FG000|Overall Study|Lost to Follow-up|4|||
145603978|NCT03086018|525064628|FG000|Final Testing for End of Trial|Adverse Event|1|||
145603979|NCT03086018|525064628|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
145603980|NCT01782872|525064629|FG000|Overall Study|Protocol Violation|0|||
145603981|NCT01782872|525064630|FG001|Overall Study|Protocol Violation|0|||
145603982|NCT01782872|525064631|FG002|Overall Study|Protocol Violation|0|||
145603983|NCT01782872|525064632|FG003|Overall Study|Protocol Violation|1|||
145603984|NCT01782872|525064629|FG000|Overall Study|Withdrawal by Subject|0|||
145603985|NCT01782872|525064630|FG001|Overall Study|Withdrawal by Subject|1|||
145603986|NCT01782872|525064631|FG002|Overall Study|Withdrawal by Subject|0|||
145603987|NCT01782872|525064632|FG003|Overall Study|Withdrawal by Subject|0|||
145603988|NCT01892345|525064633|FG000|Overall Study|Adverse Event|0|||
145603989|NCT01892345|525064634|FG001|Overall Study|Adverse Event|2|||
145603990|NCT01892345|525064633|FG000|Overall Study|Death|1|||
145603991|NCT01892345|525064634|FG001|Overall Study|Death|0|||
145603992|NCT01892345|525064633|FG000|Overall Study|Lost to Follow-up|3|||
145603993|NCT01892345|525064634|FG001|Overall Study|Lost to Follow-up|0|||
145603994|NCT01892345|525064633|FG000|Overall Study|Withdrawal by Subject|12|||
145603995|NCT01892345|525064634|FG001|Overall Study|Withdrawal by Subject|1|||
145603996|NCT03505476|525064635|FG000|Overall Study|Physician Decision|18|||
145603997|NCT03505476|525064635|FG000|Overall Study|Device Malfunctioned|101|||
145603998|NCT03505476|525064635|FG000|Overall Study|Data Corrupt|6|||
145603999|NCT03505476|525064635|FG000|Overall Study|Device application insufficiant|3|||
145604000|NCT04026165|525064636|FG000|Run-in Placebo Period|Enrollment Error|13|||
145604001|NCT04026165|525064637|FG001|Run-in Placebo Period|Enrollment Error|0|||
145604002|NCT04026165|525064638|FG002|Run-in Placebo Period|Enrollment Error|0|||
145604003|NCT04026165|525064639|FG003|Run-in Placebo Period|Enrollment Error|0|||
145604004|NCT04026165|525064636|FG000|Run-in Placebo Period|Run-in Failure|4|||
145604005|NCT04026165|525064637|FG001|Run-in Placebo Period|Run-in Failure|0|||
145604006|NCT04026165|525064638|FG002|Run-in Placebo Period|Run-in Failure|0|||
145604007|NCT04026165|525064639|FG003|Run-in Placebo Period|Run-in Failure|0|||
145604008|NCT04026165|525064636|FG000|Run-in Placebo Period|Protocol Violation|2|||
145604009|NCT04026165|525064637|FG001|Run-in Placebo Period|Protocol Violation|0|||
145604010|NCT04026165|525064638|FG002|Run-in Placebo Period|Protocol Violation|0|||
145604011|NCT04026165|525064639|FG003|Run-in Placebo Period|Protocol Violation|0|||
145604012|NCT04026165|525064636|FG000|Run-in Placebo Period|Withdrew Consent|2|||
145604013|NCT04026165|525064637|FG001|Run-in Placebo Period|Withdrew Consent|0|||
145604014|NCT04026165|525064638|FG002|Run-in Placebo Period|Withdrew Consent|0|||
145604015|NCT04026165|525064639|FG003|Run-in Placebo Period|Withdrew Consent|0|||
145604016|NCT04026165|525064636|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
145604017|NCT04026165|525064637|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
145604018|NCT04026165|525064638|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
145604019|NCT04026165|525064639|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
145604020|NCT04026165|525064636|FG000|Run-in SEL Period|Run-in Failure|0|||
145604021|NCT04026165|525064637|FG001|Run-in SEL Period|Run-in Failure|26|||
145604022|NCT04026165|525064638|FG002|Run-in SEL Period|Run-in Failure|0|||
145604023|NCT04026165|525064639|FG003|Run-in SEL Period|Run-in Failure|0|||
145604024|NCT04026165|525064636|FG000|Run-in SEL Period|Withdrew Consent|0|||
145604025|NCT04026165|525064637|FG001|Run-in SEL Period|Withdrew Consent|10|||
145604026|NCT04026165|525064638|FG002|Run-in SEL Period|Withdrew Consent|0|||
145604027|NCT04026165|525064639|FG003|Run-in SEL Period|Withdrew Consent|0|||
145604028|NCT04026165|525064636|FG000|Run-in SEL Period|Enrollment Error|0|||
145604029|NCT04026165|525064637|FG001|Run-in SEL Period|Enrollment Error|4|||
145604030|NCT04026165|525064638|FG002|Run-in SEL Period|Enrollment Error|0|||
145604031|NCT04026165|525064639|FG003|Run-in SEL Period|Enrollment Error|0|||
145604032|NCT04026165|525064636|FG000|Run-in SEL Period|Protocol Violation|0|||
145604033|NCT04026165|525064637|FG001|Run-in SEL Period|Protocol Violation|3|||
145604034|NCT04026165|525064638|FG002|Run-in SEL Period|Protocol Violation|0|||
145604035|NCT04026165|525064639|FG003|Run-in SEL Period|Protocol Violation|0|||
145604036|NCT04026165|525064636|FG000|Run-in SEL Period|Investigator's Discretion|0|||
145604037|NCT04026165|525064637|FG001|Run-in SEL Period|Investigator's Discretion|2|||
145604038|NCT04026165|525064638|FG002|Run-in SEL Period|Investigator's Discretion|0|||
145604039|NCT04026165|525064639|FG003|Run-in SEL Period|Investigator's Discretion|0|||
145604040|NCT04026165|525064636|FG000|Run-in SEL Period|Death|0|||
145604041|NCT04026165|525064637|FG001|Run-in SEL Period|Death|1|||
145604042|NCT04026165|525064638|FG002|Run-in SEL Period|Death|0|||
145604043|NCT04026165|525064639|FG003|Run-in SEL Period|Death|0|||
145604044|NCT04026165|525064636|FG000|Randomized Period|Withdrew Consent|0|||
145604045|NCT04026165|525064637|FG001|Randomized Period|Withdrew Consent|0|||
145604046|NCT04026165|525064638|FG002|Randomized Period|Withdrew Consent|5|||
145604047|NCT04026165|525064639|FG003|Randomized Period|Withdrew Consent|8|||
145604048|NCT04026165|525064636|FG000|Randomized Period|Death|0|||
145604049|NCT04026165|525064637|FG001|Randomized Period|Death|0|||
145604050|NCT04026165|525064638|FG002|Randomized Period|Death|5|||
145604051|NCT04026165|525064639|FG003|Randomized Period|Death|7|||
145604052|NCT04026165|525064636|FG000|Randomized Period|Investigator's Discretion|0|||
145604053|NCT04026165|525064637|FG001|Randomized Period|Investigator's Discretion|0|||
145604054|NCT04026165|525064638|FG002|Randomized Period|Investigator's Discretion|2|||
145604055|NCT04026165|525064639|FG003|Randomized Period|Investigator's Discretion|2|||
145604056|NCT04026165|525064636|FG000|Randomized Period|Lost to Follow-up|0|||
145604057|NCT04026165|525064637|FG001|Randomized Period|Lost to Follow-up|0|||
145604058|NCT04026165|525064638|FG002|Randomized Period|Lost to Follow-up|2|||
145604059|NCT04026165|525064639|FG003|Randomized Period|Lost to Follow-up|2|||
145604060|NCT01059630|525064640|FG000|Overall Study|Death|100|||
145604061|NCT01059630|525064641|FG001|Overall Study|Death|84|||
145604062|NCT01059630|525064640|FG000|Overall Study|Lost to Follow-up|4|||
145604063|NCT01059630|525064641|FG001|Overall Study|Lost to Follow-up|1|||
145604064|NCT01059630|525064640|FG000|Overall Study|Physician Decision|2|||
145604065|NCT01059630|525064641|FG001|Overall Study|Physician Decision|4|||
145604066|NCT01059630|525064640|FG000|Overall Study|Withdrawal by Subject|21|||
145604067|NCT01059630|525064641|FG001|Overall Study|Withdrawal by Subject|14|||
145604068|NCT03170375|525064642|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
145604069|NCT03170375|525064643|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
145604070|NCT03170375|525064644|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
145604071|NCT03170375|525064642|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
145604072|NCT03170375|525064643|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
145604073|NCT03170375|525064644|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
145604074|NCT00441701|525064645|FG000|Overall Study|Adverse Event|3|||
145604075|NCT00441701|525064646|FG001|Overall Study|Adverse Event|2|||
145604076|NCT00441701|525064647|FG002|Overall Study|Adverse Event|1|||
145604077|NCT00441701|525064648|FG003|Overall Study|Adverse Event|0|||
145636714|NCT01580293|525186045|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
145636715|NCT01580293|525186043|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
145604078|NCT00441701|525064649|FG004|Overall Study|Adverse Event|2|||
145604079|NCT00441701|525064650|FG005|Overall Study|Adverse Event|2|||
145604080|NCT00441701|525064651|FG006|Overall Study|Adverse Event|0|||
145481088|NCT00934128|524613258|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
145481089|NCT00934128|524613257|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
145481090|NCT00934128|524613258|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
145481091|NCT03228212|524613259|FG000|Period 1|Adverse Event|1|||
145481092|NCT03228212|524613260|FG001|Period 1|Adverse Event|0|||
145481093|NCT03228212|524613259|FG000|Period 1|no longer meets eligibility criteria|0|||
145481094|NCT03228212|524613260|FG001|Period 1|no longer meets eligibility criteria|1|||
145481095|NCT03228212|524613259|FG000|Period 2|Lost to Follow-up|1|||
145481096|NCT03228212|524613260|FG001|Period 2|Lost to Follow-up|0|||
145481097|NCT02834247|524613261|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
145481098|NCT02834247|524613262|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
145481099|NCT02834247|524613263|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
145481100|NCT02834247|524613264|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
145481101|NCT02834247|524613261|FG000|Dose Escalation Phase|Death|5|||
145481102|NCT02834247|524613262|FG001|Dose Escalation Phase|Death|6|||
145481103|NCT02834247|524613263|FG002|Dose Escalation Phase|Death|5|||
145481104|NCT02834247|524613264|FG003|Dose Escalation Phase|Death|0|||
145481105|NCT02834247|524613261|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
145481106|NCT02834247|524613262|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
145481107|NCT02834247|524613263|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
145481108|NCT02834247|524613264|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
145481109|NCT02834247|524613261|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
145481110|NCT02834247|524613262|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
145481111|NCT02834247|524613263|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
145481112|NCT02834247|524613264|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
145481113|NCT02834247|524613261|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
145481114|NCT02834247|524613262|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
145481115|NCT02834247|524613263|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
145481116|NCT02834247|524613264|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
145481117|NCT02834247|524613261|FG000|Dose Expansion Phase|Death|0|||
145481118|NCT02834247|524613262|FG001|Dose Expansion Phase|Death|0|||
145481119|NCT02834247|524613263|FG002|Dose Expansion Phase|Death|0|||
145481120|NCT02834247|524613264|FG003|Dose Expansion Phase|Death|8|||
145604081|NCT00441701|525064652|FG007|Overall Study|Adverse Event|0|||
145636716|NCT01580293|525186044|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
145604082|NCT00441701|525064653|FG008|Overall Study|Adverse Event|0|||
145604083|NCT00441701|525064654|FG009|Overall Study|Adverse Event|0|||
145604084|NCT00441701|525064645|FG000|Overall Study|Lack of Efficacy|2|||
145604085|NCT00441701|525064646|FG001|Overall Study|Lack of Efficacy|0|||
145604086|NCT00441701|525064647|FG002|Overall Study|Lack of Efficacy|2|||
145604087|NCT00441701|525064648|FG003|Overall Study|Lack of Efficacy|2|||
145604088|NCT00441701|525064649|FG004|Overall Study|Lack of Efficacy|0|||
145604089|NCT00441701|525064650|FG005|Overall Study|Lack of Efficacy|1|||
145604090|NCT00441701|525064651|FG006|Overall Study|Lack of Efficacy|0|||
145604091|NCT00441701|525064652|FG007|Overall Study|Lack of Efficacy|0|||
145604092|NCT00441701|525064653|FG008|Overall Study|Lack of Efficacy|0|||
145604093|NCT00441701|525064654|FG009|Overall Study|Lack of Efficacy|0|||
145604094|NCT00441701|525064645|FG000|Overall Study|Withdrawal by Subject|0|||
145604095|NCT00441701|525064646|FG001|Overall Study|Withdrawal by Subject|2|||
145604096|NCT00441701|525064647|FG002|Overall Study|Withdrawal by Subject|1|||
145604097|NCT00441701|525064648|FG003|Overall Study|Withdrawal by Subject|1|||
145604098|NCT00441701|525064649|FG004|Overall Study|Withdrawal by Subject|0|||
145604099|NCT00441701|525064650|FG005|Overall Study|Withdrawal by Subject|0|||
145604100|NCT00441701|525064651|FG006|Overall Study|Withdrawal by Subject|0|||
145604101|NCT00441701|525064652|FG007|Overall Study|Withdrawal by Subject|0|||
145604102|NCT00441701|525064653|FG008|Overall Study|Withdrawal by Subject|0|||
145604103|NCT00441701|525064654|FG009|Overall Study|Withdrawal by Subject|0|||
145604104|NCT00621543|525064658|FG000|Overall Study|Lost to Follow-up|23|||
145604105|NCT01287611|525064663|FG000|Overall Study|Lost to Follow-up|29|||
145604106|NCT01287611|525064664|FG001|Overall Study|Lost to Follow-up|16|||
145604107|NCT01287611|525064663|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
145604108|NCT01287611|525064664|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
145604109|NCT00763958|525064665|FG000|Overall Study|did not meet final criteria|4|||
145604110|NCT00763958|525064666|FG001|Overall Study|did not meet final criteria|4|||
145636717|NCT01580293|525186045|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
145636718|NCT01580293|525186043|FG000|Part A_Extension|Adverse Event|0|||
145636719|NCT01580293|525186044|FG001|Part A_Extension|Adverse Event|2|||
145636720|NCT01580293|525186045|FG002|Part A_Extension|Adverse Event|0|||
145636721|NCT01580293|525186043|FG000|Part A_Extension|Withdrawal by Subject|0|||
145636722|NCT01580293|525186044|FG001|Part A_Extension|Withdrawal by Subject|3|||
145636723|NCT01580293|525186045|FG002|Part A_Extension|Withdrawal by Subject|0|||
145636724|NCT01580293|525186043|FG000|Part A_Extension|Lost to Follow-up|0|||
145481121|NCT02834247|524613261|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
145604111|NCT00763958|525064665|FG000|Overall Study|Lost to Follow-up|10|||
145604112|NCT00763958|525064666|FG001|Overall Study|Lost to Follow-up|2|||
145604113|NCT00763958|525064665|FG000|Overall Study|Believed they were receiving placebo|0|||
145636725|NCT01580293|525186044|FG001|Part A_Extension|Lost to Follow-up|1|||
145636726|NCT01580293|525186045|FG002|Part A_Extension|Lost to Follow-up|0|||
145636727|NCT01580293|525186043|FG000|Part A_Extension|Other Reason|0|||
145636728|NCT01580293|525186044|FG001|Part A_Extension|Other Reason|1|||
145636729|NCT01580293|525186045|FG002|Part A_Extension|Other Reason|0|||
145636730|NCT01580293|525186043|FG000|Part A_Extension|Completed Japan only|0|||
145636731|NCT01580293|525186044|FG001|Part A_Extension|Completed Japan only|5|||
145636732|NCT01580293|525186045|FG002|Part A_Extension|Completed Japan only|0|||
145636733|NCT01580293|525186043|FG000|Part B|Withdrawal by Subject|0|||
145636734|NCT01580293|525186044|FG001|Part B|Withdrawal by Subject|0|||
145636735|NCT01580293|525186045|FG002|Part B|Withdrawal by Subject|1|||
145636736|NCT01580293|525186043|FG000|Part B|Other reason|0|||
145636737|NCT01580293|525186044|FG001|Part B|Other reason|0|||
145636738|NCT01580293|525186045|FG002|Part B|Other reason|1|||
145636739|NCT02544152|525186046|FG000|Overall Study|Adverse Event|0|||
145636740|NCT02544152|525186047|FG001|Overall Study|Adverse Event|4|||
145636741|NCT02544152|525186046|FG000|Overall Study|Withdrawal by Subject|0|||
145636742|NCT02544152|525186047|FG001|Overall Study|Withdrawal by Subject|3|||
145636743|NCT02544152|525186046|FG000|Overall Study|Other|1|||
145636744|NCT02544152|525186047|FG001|Overall Study|Other|0|||
145636745|NCT04480827|525186049|FG000|Overall Study|Adverse Event|0|||
145636746|NCT04480827|525186050|FG001|Overall Study|Adverse Event|0|||
145636747|NCT04480827|525186051|FG002|Overall Study|Adverse Event|0|||
145636748|NCT04480827|525186052|FG003|Overall Study|Adverse Event|0|||
145636749|NCT04480827|525186053|FG004|Overall Study|Adverse Event|0|||
145636750|NCT04480827|525186054|FG005|Overall Study|Adverse Event|1|||
145636751|NCT04480827|525186055|FG006|Overall Study|Adverse Event|0|||
145636752|NCT04218110|525186059|FG000|Overall Study|Withdrawal by Subject|0|||
145636753|NCT04218110|525186060|FG001|Overall Study|Withdrawal by Subject|0|||
145636754|NCT04218110|525186061|FG002|Overall Study|Withdrawal by Subject|0|||
145636755|NCT04218110|525186062|FG003|Overall Study|Withdrawal by Subject|1|||
145636756|NCT00002842|525186063|FG000|Overall Study|ineligible for surgical resection|27|||
145636757|NCT02015546|525186064|FG000|Overall Study|Withdrawal by Subject|1|||
145636758|NCT02015546|525186065|FG001|Overall Study|Withdrawal by Subject|1|||
145636759|NCT02015546|525186066|FG002|Overall Study|Withdrawal by Subject|1|||
145636760|NCT02015546|525186064|FG000|Overall Study|Screem Failure|2|||
145636761|NCT02015546|525186065|FG001|Overall Study|Screem Failure|1|||
145636762|NCT02015546|525186066|FG002|Overall Study|Screem Failure|3|||
145636763|NCT05855655|525186067|FG000|Overall Study|Withdrawal by Subject|0|||
145636764|NCT05855655|525186068|FG001|Overall Study|Withdrawal by Subject|1|||
145636765|NCT05855655|525186067|FG000|Overall Study|Lost to Follow-up|4|||
145636766|NCT05855655|525186068|FG001|Overall Study|Lost to Follow-up|0|||
145636767|NCT01337635|525186069|FG000|Overall Study|Lost to Follow-up|0|||
145636768|NCT01337635|525186070|FG001|Overall Study|Lost to Follow-up|1|||
145636769|NCT01113931|525186071|FG000|Overall Study|Adverse Event|2|||
145636770|NCT01113931|525186072|FG001|Overall Study|Adverse Event|2|||
145636771|NCT01113931|525186071|FG000|Overall Study|Physician Decision|0|||
145636772|NCT01113931|525186072|FG001|Overall Study|Physician Decision|2|||
145636773|NCT01113931|525186071|FG000|Overall Study|Lost to Follow-up|12|||
145636774|NCT01113931|525186072|FG001|Overall Study|Lost to Follow-up|9|||
145636775|NCT01113931|525186071|FG000|Overall Study|Various|2|||
145636776|NCT01113931|525186072|FG001|Overall Study|Various|4|||
145636777|NCT01113931|525186071|FG000|Overall Study|Withdrawal by Subject|3|||
145636778|NCT01113931|525186072|FG001|Overall Study|Withdrawal by Subject|0|||
145636779|NCT01307267|525186075|FG000|Overall Study|Death|4|||
145636780|NCT01307267|525186076|FG001|Overall Study|Death|3|||
145636781|NCT01307267|525186077|FG002|Overall Study|Death|5|||
145636782|NCT01307267|525186078|FG003|Overall Study|Death|3|||
145636783|NCT01307267|525186079|FG004|Overall Study|Death|1|||
145636784|NCT01307267|525186080|FG005|Overall Study|Death|26|||
145636785|NCT01307267|525186081|FG006|Overall Study|Death|2|||
145636786|NCT01307267|525186082|FG007|Overall Study|Death|2|||
145636787|NCT01307267|525186083|FG008|Overall Study|Death|21|||
145636788|NCT01307267|525186084|FG009|Overall Study|Death|2|||
145636789|NCT01307267|525186085|FG010|Overall Study|Death|3|||
145636790|NCT01307267|525186086|FG011|Overall Study|Death|9|||
145636791|NCT01307267|525186087|FG012|Overall Study|Death|0|||
145636792|NCT01307267|525186088|FG013|Overall Study|Death|0|||
145636793|NCT01307267|525186089|FG014|Overall Study|Death|0|||
145636794|NCT01307267|525186090|FG015|Overall Study|Death|0|||
145636795|NCT01307267|525186091|FG016|Overall Study|Death|1|||
145636796|NCT01307267|525186092|FG017|Overall Study|Death|1|||
145636797|NCT01307267|525186093|FG018|Overall Study|Death|2|||
145636798|NCT01307267|525186094|FG019|Overall Study|Death|8|||
145636799|NCT01307267|525186095|FG020|Overall Study|Death|1|||
145636800|NCT01307267|525186096|FG021|Overall Study|Death|2|||
145636801|NCT01307267|525186097|FG022|Overall Study|Death|2|||
145636802|NCT01307267|525186075|FG000|Overall Study|Lost to Follow-up|0|||
145636803|NCT01307267|525186076|FG001|Overall Study|Lost to Follow-up|0|||
145636804|NCT01307267|525186077|FG002|Overall Study|Lost to Follow-up|0|||
145636805|NCT01307267|525186078|FG003|Overall Study|Lost to Follow-up|0|||
145636806|NCT01307267|525186079|FG004|Overall Study|Lost to Follow-up|0|||
145636807|NCT01307267|525186080|FG005|Overall Study|Lost to Follow-up|7|||
145636808|NCT01307267|525186081|FG006|Overall Study|Lost to Follow-up|0|||
145636809|NCT01307267|525186082|FG007|Overall Study|Lost to Follow-up|0|||
145636810|NCT01307267|525186083|FG008|Overall Study|Lost to Follow-up|1|||
145636811|NCT01307267|525186084|FG009|Overall Study|Lost to Follow-up|2|||
145636812|NCT01307267|525186085|FG010|Overall Study|Lost to Follow-up|1|||
145481122|NCT02834247|524613262|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
145481123|NCT02834247|524613263|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
145481124|NCT02834247|524613264|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
145481125|NCT02834247|524613261|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
145481126|NCT02834247|524613262|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
145481127|NCT02834247|524613263|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
145481128|NCT02834247|524613264|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
145481129|NCT01807299|524613265|FG000|Overall Study|Protocol Violation|3|||
145481130|NCT01807299|524613266|FG001|Overall Study|Protocol Violation|1|||
145481131|NCT01807299|524613267|FG002|Overall Study|Protocol Violation|0|||
145481132|NCT01807299|524613268|FG003|Overall Study|Protocol Violation|2|||
145481133|NCT03314987|524614687|FG000|Overall Study|Lost to Follow-up|13|||
145481134|NCT03314987|524614688|FG001|Overall Study|Lost to Follow-up|13|||
145481135|NCT03574779|524614689|FG000|Overall Study|Screening failure|13|||
145481136|NCT03574779|524614690|FG001|Overall Study|Screening failure|83|||
145481137|NCT04829916|524614691|FG000|Overall Study|Withdrawal by Subject|1|||
145481138|NCT04829916|524614692|FG001|Overall Study|Withdrawal by Subject|0|||
145481139|NCT02287467|524614694|FG000|Overall Study|Protocol Violation|12|||
145481140|NCT02287467|524614695|FG001|Overall Study|Protocol Violation|9|||
145481141|NCT03781778|524614696|FG000|Overall Study|Withdrawal by Subject|2|||
145481142|NCT03781778|524614697|FG001|Overall Study|Withdrawal by Subject|2|||
145481143|NCT04343755|524614705|FG000|Overall Study|Death|11|||
145481144|NCT04343755|524614705|FG000|Overall Study|Screen Failure|1|||
145481145|NCT03755882|524614706|FG000|Period 1|Protocol Violation|1|||
145481146|NCT03755882|524614707|FG001|Period 1|Protocol Violation|0|||
145481147|NCT03755882|524614706|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
145481148|NCT03755882|524614707|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
145636813|NCT01307267|525186086|FG011|Overall Study|Lost to Follow-up|0|||
145481149|NCT02292446|524614708|FG000|Overall Study|Adverse Event|12|||
145481150|NCT02292446|524614708|FG000|Overall Study|Death|1|||
145481151|NCT02292446|524614708|FG000|Overall Study|Disease progression|2|||
145481152|NCT02292446|524614708|FG000|Overall Study|Subject/guardian decision|2|||
145481153|NCT02292446|524614708|FG000|Overall Study|Withdrawal by Subject|3|||
145481154|NCT02652156|524614710|FG000|Overall Study|Physician Decision|1|||
145481155|NCT02652156|524614711|FG001|Overall Study|Physician Decision|0|||
145481156|NCT02652156|524614712|FG002|Overall Study|Physician Decision|0|||
145481157|NCT00496080|524614716|FG000|Overall Study|Lost to Follow-up|9|||
145481158|NCT00496080|524614716|FG000|Overall Study|Surgical re-intervention|7|||
145481159|NCT00496080|524614716|FG000|Overall Study|Withdrawal by Subject|5|||
145481160|NCT00496080|524614716|FG000|Overall Study|Physician Decision|6|||
145481161|NCT00570310|524614717|FG000|Overall Study|Adverse Event|1|||
145481162|NCT00570310|524614718|FG001|Overall Study|Adverse Event|2|||
145481163|NCT00570310|524614717|FG000|Overall Study|Lack of Efficacy|1|||
145481164|NCT00570310|524614718|FG001|Overall Study|Lack of Efficacy|4|||
145481165|NCT00479336|524614721|FG000|Overall Study|Adverse Event|1|||
145481166|NCT00479336|524614722|FG001|Overall Study|Adverse Event|1|||
145481167|NCT00479336|524614723|FG002|Overall Study|Adverse Event|1|||
145481168|NCT00479336|524614724|FG003|Overall Study|Adverse Event|3|||
145481169|NCT00479336|524614721|FG000|Overall Study|Lack of Efficacy|1|||
145481170|NCT00479336|524614722|FG001|Overall Study|Lack of Efficacy|0|||
145481171|NCT00479336|524614723|FG002|Overall Study|Lack of Efficacy|0|||
145481172|NCT00479336|524614724|FG003|Overall Study|Lack of Efficacy|0|||
145481173|NCT00479336|524614721|FG000|Overall Study|Protocol Violation|0|||
145481174|NCT00479336|524614722|FG001|Overall Study|Protocol Violation|1|||
145481175|NCT00479336|524614723|FG002|Overall Study|Protocol Violation|0|||
145481176|NCT00479336|524614724|FG003|Overall Study|Protocol Violation|0|||
145481177|NCT00479336|524614721|FG000|Overall Study|Withdrawal by Subject|1|||
145481178|NCT00479336|524614722|FG001|Overall Study|Withdrawal by Subject|2|||
145481179|NCT00479336|524614723|FG002|Overall Study|Withdrawal by Subject|0|||
145481180|NCT00479336|524614724|FG003|Overall Study|Withdrawal by Subject|0|||
145481181|NCT00479336|524614721|FG000|Overall Study|Physician Decision|0|||
145481182|NCT00479336|524614722|FG001|Overall Study|Physician Decision|1|||
145481183|NCT00479336|524614723|FG002|Overall Study|Physician Decision|0|||
145481184|NCT00479336|524614724|FG003|Overall Study|Physician Decision|2|||
145481185|NCT00479336|524614721|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
145481186|NCT00479336|524614722|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
145481187|NCT00479336|524614723|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
145636814|NCT01307267|525186087|FG012|Overall Study|Lost to Follow-up|0|||
145481188|NCT00479336|524614724|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
145481189|NCT03329846|524614725|FG000|Overall Study|Disease progression|4|||
145481190|NCT03329846|524614726|FG001|Overall Study|Disease progression|6|||
145636815|NCT01307267|525186088|FG013|Overall Study|Lost to Follow-up|0|||
145481191|NCT03329846|524614725|FG000|Overall Study|Study drug toxicity|1|||
145481192|NCT03329846|524614726|FG001|Overall Study|Study drug toxicity|0|||
145481193|NCT03329846|524614725|FG000|Overall Study|Participant request to discontinue treatment|0|||
145481194|NCT03329846|524614726|FG001|Overall Study|Participant request to discontinue treatment|1|||
145481195|NCT03329846|524614725|FG000|Overall Study|Participant withdrew consent|1|||
145481196|NCT03329846|524614726|FG001|Overall Study|Participant withdrew consent|0|||
145481197|NCT03329846|524614725|FG000|Overall Study|Other reasons|2|||
145481198|NCT03329846|524614726|FG001|Overall Study|Other reasons|2|||
145481199|NCT00108862|524614727|FG000|Overall Study|Death|31|||
145481200|NCT00108862|524614728|FG001|Overall Study|Death|37|||
145481201|NCT00108862|524614727|FG000|Overall Study|Withdrawal by Subject|10|||
145481202|NCT00108862|524614728|FG001|Overall Study|Withdrawal by Subject|6|||
145481203|NCT00108862|524614727|FG000|Overall Study|Lost to Follow-up|27|||
145481204|NCT00108862|524614728|FG001|Overall Study|Lost to Follow-up|19|||
145481205|NCT03066193|524614729|FG000|Overall Study|Withdrawal by Subject|1|||
145481206|NCT02021643|524614730|FG000|Overall Study|Enrolled but Never Treated|1|||
145481207|NCT02021643|524614731|FG001|Overall Study|Enrolled but Never Treated|0|||
145481208|NCT02021643|524614732|FG002|Overall Study|Enrolled but Never Treated|0|||
145604114|NCT00763958|525064666|FG001|Overall Study|Believed they were receiving placebo|5|||
145604115|NCT02192970|525064667|FG000|Overall Study|Lost to Follow-up|6|||
145604116|NCT02192970|525064668|FG001|Overall Study|Lost to Follow-up|0|||
145604117|NCT03299686|525064670|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
145604118|NCT03299686|525064671|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
145604119|NCT03299686|525064670|FG000|Treatment Epoch|Physician Decision|1|||
145604120|NCT03299686|525064671|FG001|Treatment Epoch|Physician Decision|0|||
145604121|NCT03299686|525064670|FG000|Treatment Epoch|Adverse Event|8|||
145604122|NCT03299686|525064671|FG001|Treatment Epoch|Adverse Event|4|||
145604123|NCT03299686|525064670|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
145604124|NCT03299686|525064671|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
145604125|NCT02709005|525064672|FG000|Overall Study|Lost to Follow-up|1|||
145604126|NCT02709005|525064673|FG001|Overall Study|Lost to Follow-up|1|||
145604127|NCT02709005|525064672|FG000|Overall Study|Withdrawal by Subject|3|||
145604128|NCT02709005|525064673|FG001|Overall Study|Withdrawal by Subject|0|||
145604129|NCT00499863|525064679|FG000|Overall Study|Lack of Efficacy|21|||
145604130|NCT00499863|525064680|FG001|Overall Study|Lack of Efficacy|27|||
145604131|NCT00499863|525064679|FG000|Overall Study|Protocol Violation|12|||
145604132|NCT00499863|525064680|FG001|Overall Study|Protocol Violation|7|||
145604133|NCT00499863|525064679|FG000|Overall Study|Withdrawal by Subject|6|||
145604134|NCT00499863|525064680|FG001|Overall Study|Withdrawal by Subject|4|||
145604135|NCT00499863|525064679|FG000|Overall Study|Adverse Event|8|||
145604136|NCT00499863|525064680|FG001|Overall Study|Adverse Event|2|||
145604137|NCT00499863|525064679|FG000|Overall Study|Sponsor decision|2|||
145604138|NCT00499863|525064680|FG001|Overall Study|Sponsor decision|2|||
145604139|NCT00499863|525064679|FG000|Overall Study|Lost to Follow-up|1|||
145604140|NCT00499863|525064680|FG001|Overall Study|Lost to Follow-up|1|||
145604141|NCT00691132|525064681|FG000|Overall Study|Adverse Event|2|||
145604142|NCT00691132|525064682|FG001|Overall Study|Adverse Event|3|||
145604143|NCT00691132|525064681|FG000|Overall Study|Withdrawal by Subject|10|||
145604144|NCT00691132|525064682|FG001|Overall Study|Withdrawal by Subject|10|||
145604145|NCT00860067|525064685|FG000|Overall Study|Lost to Follow-up|46|||
145604146|NCT00860067|525064686|FG001|Overall Study|Lost to Follow-up|9|||
145604147|NCT00860067|525064687|FG002|Overall Study|Lost to Follow-up|9|||
145604148|NCT00860067|525064685|FG000|Overall Study|Withdrawal by Subject|4|||
145604149|NCT00860067|525064686|FG001|Overall Study|Withdrawal by Subject|0|||
145604150|NCT00860067|525064687|FG002|Overall Study|Withdrawal by Subject|0|||
145604151|NCT00860067|525064685|FG000|Overall Study|Pregnancy|1|||
145604152|NCT00860067|525064686|FG001|Overall Study|Pregnancy|0|||
145604153|NCT00860067|525064687|FG002|Overall Study|Pregnancy|0|||
145604154|NCT01282801|525064688|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
145604155|NCT01282801|525064689|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
145604156|NCT01060553|525064690|FG000|Overall Study|Lost to Follow-up|3|||
145604157|NCT01060553|525064691|FG001|Overall Study|Lost to Follow-up|5|||
145604158|NCT01060553|525064690|FG000|Overall Study|Withdrawal by Subject|5|||
145604159|NCT01060553|525064691|FG001|Overall Study|Withdrawal by Subject|5|||
145604160|NCT01060553|525064690|FG000|Overall Study|Lack of Efficacy|1|||
145604161|NCT01060553|525064691|FG001|Overall Study|Lack of Efficacy|0|||
145604162|NCT01498822|525064693|FG000|Overall Study|Protocol Violation|8|||
145604163|NCT01498822|525064694|FG001|Overall Study|Protocol Violation|4|||
145604164|NCT01498822|525064693|FG000|Overall Study|Other Reason|5|||
145604165|NCT01498822|525064694|FG001|Overall Study|Other Reason|2|||
145481209|NCT02021643|524614733|FG003|Overall Study|Enrolled but Never Treated|0|||
145481210|NCT02021643|524614730|FG000|Overall Study|Adverse Event|0|||
145481211|NCT02021643|524614731|FG001|Overall Study|Adverse Event|1|||
145481212|NCT02021643|524614732|FG002|Overall Study|Adverse Event|0|||
145481213|NCT02021643|524614733|FG003|Overall Study|Adverse Event|0|||
145604166|NCT01498822|525064693|FG000|Overall Study|Lack of Efficacy|7|||
145604167|NCT01498822|525064694|FG001|Overall Study|Lack of Efficacy|2|||
145604168|NCT01498822|525064693|FG000|Overall Study|AE, non-serious non-fatal|8|||
145636816|NCT01307267|525186089|FG014|Overall Study|Lost to Follow-up|0|||
145636817|NCT01307267|525186090|FG015|Overall Study|Lost to Follow-up|0|||
145636818|NCT01307267|525186091|FG016|Overall Study|Lost to Follow-up|0|||
145636819|NCT01307267|525186092|FG017|Overall Study|Lost to Follow-up|0|||
145636820|NCT01307267|525186093|FG018|Overall Study|Lost to Follow-up|0|||
145636821|NCT01307267|525186094|FG019|Overall Study|Lost to Follow-up|2|||
145636822|NCT01307267|525186095|FG020|Overall Study|Lost to Follow-up|0|||
145636823|NCT01307267|525186096|FG021|Overall Study|Lost to Follow-up|0|||
145636824|NCT01307267|525186097|FG022|Overall Study|Lost to Follow-up|0|||
145636825|NCT01307267|525186075|FG000|Overall Study|Withdrawal by Subject|0|||
145636826|NCT01307267|525186076|FG001|Overall Study|Withdrawal by Subject|0|||
145636827|NCT01307267|525186077|FG002|Overall Study|Withdrawal by Subject|0|||
145636828|NCT01307267|525186078|FG003|Overall Study|Withdrawal by Subject|0|||
145636829|NCT01307267|525186079|FG004|Overall Study|Withdrawal by Subject|0|||
145636830|NCT01307267|525186080|FG005|Overall Study|Withdrawal by Subject|1|||
145636831|NCT01307267|525186081|FG006|Overall Study|Withdrawal by Subject|0|||
145636832|NCT01307267|525186082|FG007|Overall Study|Withdrawal by Subject|1|||
145636833|NCT01307267|525186083|FG008|Overall Study|Withdrawal by Subject|5|||
145636834|NCT01307267|525186084|FG009|Overall Study|Withdrawal by Subject|1|||
145636835|NCT01307267|525186085|FG010|Overall Study|Withdrawal by Subject|1|||
145636836|NCT01307267|525186086|FG011|Overall Study|Withdrawal by Subject|1|||
145636837|NCT01307267|525186087|FG012|Overall Study|Withdrawal by Subject|0|||
145636838|NCT01307267|525186088|FG013|Overall Study|Withdrawal by Subject|0|||
145636839|NCT01307267|525186089|FG014|Overall Study|Withdrawal by Subject|0|||
145636840|NCT01307267|525186090|FG015|Overall Study|Withdrawal by Subject|0|||
145636841|NCT01307267|525186091|FG016|Overall Study|Withdrawal by Subject|0|||
145636842|NCT01307267|525186092|FG017|Overall Study|Withdrawal by Subject|0|||
145636843|NCT01307267|525186093|FG018|Overall Study|Withdrawal by Subject|0|||
145636844|NCT01307267|525186094|FG019|Overall Study|Withdrawal by Subject|3|||
145636845|NCT01307267|525186095|FG020|Overall Study|Withdrawal by Subject|0|||
145636846|NCT01307267|525186096|FG021|Overall Study|Withdrawal by Subject|0|||
145636847|NCT01307267|525186097|FG022|Overall Study|Withdrawal by Subject|0|||
145636848|NCT01307267|525186075|FG000|Overall Study|Other|0|||
145636849|NCT01307267|525186076|FG001|Overall Study|Other|0|||
145636850|NCT01307267|525186077|FG002|Overall Study|Other|0|||
145636851|NCT01307267|525186078|FG003|Overall Study|Other|0|||
145636852|NCT01307267|525186079|FG004|Overall Study|Other|0|||
145636853|NCT01307267|525186080|FG005|Overall Study|Other|7|||
145636854|NCT01307267|525186081|FG006|Overall Study|Other|0|||
145636855|NCT01307267|525186082|FG007|Overall Study|Other|1|||
145636856|NCT01307267|525186083|FG008|Overall Study|Other|3|||
145636857|NCT01307267|525186084|FG009|Overall Study|Other|0|||
145636858|NCT01307267|525186085|FG010|Overall Study|Other|1|||
145636859|NCT01307267|525186086|FG011|Overall Study|Other|1|||
145636860|NCT01307267|525186087|FG012|Overall Study|Other|1|||
145636861|NCT01307267|525186088|FG013|Overall Study|Other|0|||
145636862|NCT01307267|525186089|FG014|Overall Study|Other|2|||
145636863|NCT01307267|525186090|FG015|Overall Study|Other|1|||
145636864|NCT01307267|525186091|FG016|Overall Study|Other|0|||
145636865|NCT01307267|525186092|FG017|Overall Study|Other|0|||
145636866|NCT01307267|525186093|FG018|Overall Study|Other|0|||
145636867|NCT01307267|525186094|FG019|Overall Study|Other|19|||
145636868|NCT01307267|525186095|FG020|Overall Study|Other|2|||
145636869|NCT01307267|525186096|FG021|Overall Study|Other|3|||
145636870|NCT01307267|525186097|FG022|Overall Study|Other|2|||
145636871|NCT04956575|525186101|FG000|Overall Study|Death|1|||
145636872|NCT04956575|525186102|FG001|Overall Study|Death|0|||
145636873|NCT04956575|525186103|FG002|Overall Study|Death|0|||
145636874|NCT04956575|525186104|FG003|Overall Study|Death|0|||
145636875|NCT04956575|525186105|FG004|Overall Study|Death|0|||
145636876|NCT04956575|525186106|FG005|Overall Study|Death|0|||
145481214|NCT02021643|524614730|FG000|Overall Study|Death|0|||
145481215|NCT02021643|524614731|FG001|Overall Study|Death|1|||
145636877|NCT04956575|525186107|FG006|Overall Study|Death|0|||
145636878|NCT04956575|525186108|FG007|Overall Study|Death|1|||
145636879|NCT04956575|525186109|FG008|Overall Study|Death|0|||
145636880|NCT04956575|525186110|FG009|Overall Study|Death|1|||
145636881|NCT04956575|525186111|FG010|Overall Study|Death|0|||
145636882|NCT04956575|525186112|FG011|Overall Study|Death|0|||
145636883|NCT04956575|525186101|FG000|Overall Study|Lost to Follow-up|3|||
145636884|NCT04956575|525186102|FG001|Overall Study|Lost to Follow-up|4|||
145636885|NCT04956575|525186103|FG002|Overall Study|Lost to Follow-up|2|||
145636886|NCT04956575|525186104|FG003|Overall Study|Lost to Follow-up|3|||
145636887|NCT04956575|525186105|FG004|Overall Study|Lost to Follow-up|1|||
145636888|NCT04956575|525186106|FG005|Overall Study|Lost to Follow-up|10|||
145636889|NCT04956575|525186107|FG006|Overall Study|Lost to Follow-up|11|||
145636890|NCT04956575|525186108|FG007|Overall Study|Lost to Follow-up|7|||
145636891|NCT04956575|525186109|FG008|Overall Study|Lost to Follow-up|4|||
145636892|NCT04956575|525186110|FG009|Overall Study|Lost to Follow-up|2|||
145636893|NCT04956575|525186111|FG010|Overall Study|Lost to Follow-up|3|||
145636894|NCT04956575|525186112|FG011|Overall Study|Lost to Follow-up|8|||
145636895|NCT04956575|525186101|FG000|Overall Study|Withdrawal by Subject|1|||
145636896|NCT04956575|525186102|FG001|Overall Study|Withdrawal by Subject|2|||
145636897|NCT04956575|525186103|FG002|Overall Study|Withdrawal by Subject|1|||
145636898|NCT04956575|525186104|FG003|Overall Study|Withdrawal by Subject|4|||
145636899|NCT04956575|525186105|FG004|Overall Study|Withdrawal by Subject|2|||
145636900|NCT04956575|525186106|FG005|Overall Study|Withdrawal by Subject|8|||
145636901|NCT04956575|525186107|FG006|Overall Study|Withdrawal by Subject|5|||
145636902|NCT04956575|525186108|FG007|Overall Study|Withdrawal by Subject|1|||
145636903|NCT04956575|525186109|FG008|Overall Study|Withdrawal by Subject|1|||
145636904|NCT04956575|525186110|FG009|Overall Study|Withdrawal by Subject|0|||
145636905|NCT04956575|525186111|FG010|Overall Study|Withdrawal by Subject|3|||
145636906|NCT04956575|525186112|FG011|Overall Study|Withdrawal by Subject|1|||
145636907|NCT03593876|525186113|FG000|Overall Study|Withdrawal by Subject|1|||
145636908|NCT03593876|525186113|FG000|Overall Study|Discharged home before intervention completion|2|||
145636909|NCT00854906|525186116|FG000|Overall Study|One person had no ocular history|1|||
145636910|NCT04527549|525186120|FG000|Overall Study|Withdrawal by Subject|1|||
145636911|NCT04527549|525186121|FG001|Overall Study|Withdrawal by Subject|1|||
145636912|NCT05764161|525186124|FG000|12-week DBVC Period|Lack of Efficacy|2|||
145636913|NCT05764161|525186125|FG001|12-week DBVC Period|Lack of Efficacy|1|||
145636914|NCT05764161|525186124|FG000|12-week DBVC Period|Lost to Follow-up|0|||
145636915|NCT05764161|525186125|FG001|12-week DBVC Period|Lost to Follow-up|2|||
145636916|NCT05764161|525186124|FG000|12-week DBVC Period|Protocol Violation|2|||
145636917|NCT05764161|525186125|FG001|12-week DBVC Period|Protocol Violation|4|||
145636918|NCT05764161|525186124|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
145636919|NCT05764161|525186125|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
145636920|NCT05764161|525186124|FG000|40-week OLE Period|Lack of Efficacy|0|||
145636921|NCT05764161|525186125|FG001|40-week OLE Period|Lack of Efficacy|1|||
145636922|NCT05764161|525186124|FG000|40-week OLE Period|Lost to Follow-up|1|||
145636923|NCT05764161|525186125|FG001|40-week OLE Period|Lost to Follow-up|4|||
145636924|NCT05764161|525186124|FG000|40-week OLE Period|Withdrawal by Subject|2|||
145636925|NCT05764161|525186125|FG001|40-week OLE Period|Withdrawal by Subject|7|||
145636926|NCT05764161|525186124|FG000|40-week OLE Period|Extended Travel|0|||
145636927|NCT05764161|525186125|FG001|40-week OLE Period|Extended Travel|1|||
145636928|NCT05764161|525186124|FG000|40-week OLE Period|Ongoing|66|||
145636929|NCT05764161|525186125|FG001|40-week OLE Period|Ongoing|59|||
145636930|NCT03718767|525186126|FG000|Overall Study|Declined to participate (before treatment started)|0|||
145636931|NCT03718767|525186127|FG001|Overall Study|Declined to participate (before treatment started)|0|||
145636932|NCT03718767|525186128|FG002|Overall Study|Declined to participate (before treatment started)|7|||
145636933|NCT03718767|525186126|FG000|Overall Study|Ineligible|0|||
145636934|NCT03718767|525186127|FG001|Overall Study|Ineligible|0|||
145636935|NCT03718767|525186128|FG002|Overall Study|Ineligible|17|||
145636936|NCT00831415|525186129|FG000|Overall Study|Adverse Event|14|||
145636937|NCT00831415|525186129|FG000|Overall Study|Failed to return|3|||
145636938|NCT00831415|525186129|FG000|Overall Study|Physician Decision|6|||
145636939|NCT00831415|525186129|FG000|Overall Study|Lost to Follow-up|9|||
145636940|NCT00831415|525186129|FG000|Overall Study|Protocol Violation|3|||
145636941|NCT00831415|525186129|FG000|Overall Study|Withdrawal by Subject|35|||
145636942|NCT00831415|525186129|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
145636943|NCT00831415|525186129|FG000|Overall Study|Death|1|||
145636944|NCT01290224|525186130|FG000|Overall Study|Adverse Event|1|||
145636945|NCT01290224|525186130|FG000|Overall Study|Refused Further Treatment|4|||
145636946|NCT03861767|525186131|FG000|Overall Study|Withdrawal by Subject|2|||
145636947|NCT03861767|525186132|FG001|Overall Study|Withdrawal by Subject|1|||
145636948|NCT03861767|525186133|FG002|Overall Study|Withdrawal by Subject|0|||
145636949|NCT03861767|525186134|FG003|Overall Study|Withdrawal by Subject|5|||
145636950|NCT03861767|525186135|FG004|Overall Study|Withdrawal by Subject|2|||
145636951|NCT03861767|525186136|FG005|Overall Study|Withdrawal by Subject|1|||
145636952|NCT03861767|525186137|FG006|Overall Study|Withdrawal by Subject|3|||
145636953|NCT03861767|525186138|FG007|Overall Study|Withdrawal by Subject|1|||
145636954|NCT03861767|525186139|FG008|Overall Study|Withdrawal by Subject|0|||
145636955|NCT03861767|525186140|FG009|Overall Study|Withdrawal by Subject|5|||
145636956|NCT00346333|525186141|FG000|Overall Study|Death|1|||
145481216|NCT02021643|524614732|FG002|Overall Study|Death|0|||
145636957|NCT00346333|525186142|FG001|Overall Study|Death|0|||
145481217|NCT02021643|524614733|FG003|Overall Study|Death|0|||
145636958|NCT00346333|525186141|FG000|Overall Study|unwilling or unable to continue|4|||
145636959|NCT00346333|525186142|FG001|Overall Study|unwilling or unable to continue|8|||
145636960|NCT03184558|525186143|FG000|Overall Study|Withdrawal by Subject|2|||
145636961|NCT03184558|525186143|FG000|Overall Study|Death|16|||
145636962|NCT03184558|525186143|FG000|Overall Study|Lost to Follow-up|2|||
145636963|NCT03184558|525186143|FG000|Overall Study|Other|9|||
145636964|NCT05299606|525186144|FG000|Overall Study|Death|1|||
145636965|NCT03460756|525186145|FG000|Overall Study|Adverse Event|0|||
145636966|NCT03460756|525186146|FG001|Overall Study|Adverse Event|0|||
145636967|NCT03460756|525186147|FG002|Overall Study|Adverse Event|0|||
145636968|NCT03460756|525186148|FG003|Overall Study|Adverse Event|1|||
145636969|NCT03460756|525186145|FG000|Overall Study|Lack of Efficacy|0|||
145481218|NCT02021643|524614730|FG000|Overall Study|Investigator's Discretion|1|||
145636970|NCT03460756|525186146|FG001|Overall Study|Lack of Efficacy|0|||
145636971|NCT03460756|525186147|FG002|Overall Study|Lack of Efficacy|0|||
145636972|NCT03460756|525186148|FG003|Overall Study|Lack of Efficacy|2|||
145636973|NCT03460756|525186145|FG000|Overall Study|Lost to Follow-up|0|||
145636974|NCT03460756|525186146|FG001|Overall Study|Lost to Follow-up|1|||
145636975|NCT03460756|525186147|FG002|Overall Study|Lost to Follow-up|2|||
145636976|NCT03460756|525186148|FG003|Overall Study|Lost to Follow-up|1|||
145636977|NCT03460756|525186145|FG000|Overall Study|Pregnancy|0|||
145636978|NCT03460756|525186146|FG001|Overall Study|Pregnancy|0|||
145636979|NCT03460756|525186147|FG002|Overall Study|Pregnancy|0|||
145636980|NCT03460756|525186148|FG003|Overall Study|Pregnancy|1|||
145636981|NCT03460756|525186145|FG000|Overall Study|Protocol Violation|0|||
145636982|NCT03460756|525186146|FG001|Overall Study|Protocol Violation|0|||
145636983|NCT03460756|525186147|FG002|Overall Study|Protocol Violation|0|||
145636984|NCT03460756|525186148|FG003|Overall Study|Protocol Violation|1|||
145636985|NCT03460756|525186145|FG000|Overall Study|Withdrawal by Subject|0|||
145636986|NCT03460756|525186146|FG001|Overall Study|Withdrawal by Subject|4|||
145636987|NCT03460756|525186147|FG002|Overall Study|Withdrawal by Subject|7|||
145636988|NCT03460756|525186148|FG003|Overall Study|Withdrawal by Subject|3|||
145636989|NCT00922207|525186155|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
145636990|NCT00922207|525186156|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
145636991|NCT00922207|525186157|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
145636992|NCT00922207|525186155|FG000|Overall Study|Insufficient Therapeutic Response|0|||
145636993|NCT00922207|525186156|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145636994|NCT00922207|525186157|FG002|Overall Study|Insufficient Therapeutic Response|1|||
145636995|NCT00922207|525186155|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
145636996|NCT00922207|525186156|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
145636997|NCT00922207|525186157|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
145636998|NCT00922207|525186155|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
145636999|NCT00922207|525186156|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
145637000|NCT00922207|525186157|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
145637001|NCT00922207|525186155|FG000|Overall Study|Withdrew Consent|2|||
145637002|NCT00922207|525186156|FG001|Overall Study|Withdrew Consent|5|||
145637003|NCT00922207|525186157|FG002|Overall Study|Withdrew Consent|2|||
145637004|NCT00922207|525186155|FG000|Overall Study|Abnormality of Laboratory Test|0|||
145637005|NCT00922207|525186156|FG001|Overall Study|Abnormality of Laboratory Test|1|||
145637006|NCT00922207|525186157|FG002|Overall Study|Abnormality of Laboratory Test|1|||
145637007|NCT03299816|525186158|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
145637008|NCT03299816|525186159|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
145637009|NCT03299816|525186158|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
145637010|NCT03299816|525186159|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
145637011|NCT03299816|525186158|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
145637012|NCT03299816|525186159|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
145637013|NCT00367991|525186160|FG000|Overall Study|Withdrawal by Subject|1|||
145637014|NCT00367991|525186161|FG001|Overall Study|Withdrawal by Subject|1|||
145637015|NCT00367991|525186160|FG000|Overall Study|Adverse Event|1|||
145637016|NCT00367991|525186161|FG001|Overall Study|Adverse Event|1|||
145637017|NCT03515304|525186165|FG000|Overall Study|Lost to Follow-up|0|||
145637018|NCT03515304|525186166|FG001|Overall Study|Lost to Follow-up|3|||
145637019|NCT03946670|525186171|FG000|Overall Study|Progressive Disease|34|||
145637020|NCT03946670|525186172|FG001|Overall Study|Progressive Disease|27|||
145637021|NCT03946670|525186171|FG000|Overall Study|Adverse Event|7|||
145637022|NCT03946670|525186172|FG001|Overall Study|Adverse Event|10|||
145637023|NCT03946670|525186171|FG000|Overall Study|Physician Decision|6|||
145637024|NCT03946670|525186172|FG001|Overall Study|Physician Decision|5|||
145637025|NCT03946670|525186171|FG000|Overall Study|Death|5|||
145637026|NCT03946670|525186172|FG001|Overall Study|Death|8|||
145637027|NCT03946670|525186171|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
145637028|NCT03946670|525186172|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
145637029|NCT03946670|525186171|FG000|Overall Study|Subject Decision|4|||
145637030|NCT03946670|525186172|FG001|Overall Study|Subject Decision|5|||
145481219|NCT02021643|524614731|FG001|Overall Study|Investigator's Discretion|0|||
145481220|NCT02021643|524614732|FG002|Overall Study|Investigator's Discretion|0|||
145481221|NCT02021643|524614733|FG003|Overall Study|Investigator's Discretion|0|||
145637031|NCT03946670|525186171|FG000|Overall Study|Study Terminated By Sponsor|2|||
145637032|NCT03946670|525186172|FG001|Overall Study|Study Terminated By Sponsor|0|||
145637033|NCT03946670|525186171|FG000|Overall Study|New Therapy For Study Indication|1|||
145637034|NCT03946670|525186172|FG001|Overall Study|New Therapy For Study Indication|0|||
145481222|NCT02021643|524614730|FG000|Overall Study|Lack of Efficacy|7|||
145637035|NCT03946670|525186171|FG000|Overall Study|Not Treated|1|||
145637036|NCT03946670|525186172|FG001|Overall Study|Not Treated|1|||
145637037|NCT01286272|525186681|FG000|Overall Study|Ineligible after beginning treatment|1|||
145637038|NCT01286272|525186682|FG001|Overall Study|Ineligible after beginning treatment|3|||
145637039|NCT04001829|525186683|FG000|Overall Study|Never start protocol therapy|5|||
145637040|NCT04001829|525186684|FG001|Overall Study|Never start protocol therapy|5|||
145637041|NCT04001829|525186683|FG000|Overall Study|Adverse Event|11|||
145637042|NCT04001829|525186684|FG001|Overall Study|Adverse Event|7|||
145637043|NCT04001829|525186683|FG000|Overall Study|Alternative therapy|1|||
145637044|NCT04001829|525186684|FG001|Overall Study|Alternative therapy|2|||
145637045|NCT04001829|525186683|FG000|Overall Study|Disease progression/relapse|2|||
145637046|NCT04001829|525186684|FG001|Overall Study|Disease progression/relapse|1|||
145637047|NCT04001829|525186683|FG000|Overall Study|Other complicating disease|1|||
145637048|NCT04001829|525186684|FG001|Overall Study|Other complicating disease|0|||
145637049|NCT04001829|525186683|FG000|Overall Study|Withdrawal by Subject|1|||
145637050|NCT04001829|525186684|FG001|Overall Study|Withdrawal by Subject|4|||
145637051|NCT04001829|525186683|FG000|Overall Study|Ineligible|2|||
145637052|NCT04001829|525186684|FG001|Overall Study|Ineligible|2|||
145637053|NCT04001829|525186683|FG000|Overall Study|Reason missing due to delinquent data|1|||
145637054|NCT04001829|525186684|FG001|Overall Study|Reason missing due to delinquent data|0|||
145637055|NCT05011396|525186685|FG000|Overall Study|Lost to Follow-up|3|||
145637056|NCT05011396|525186686|FG001|Overall Study|Lost to Follow-up|1|||
145637057|NCT05011396|525186685|FG000|Overall Study|Withdrawal by Subject|0|||
145637058|NCT05011396|525186686|FG001|Overall Study|Withdrawal by Subject|1|||
145637059|NCT05011396|525186685|FG000|Overall Study|Positive Drug Screen|0|||
145637060|NCT05011396|525186686|FG001|Overall Study|Positive Drug Screen|1|||
145637061|NCT03253848|525186687|FG000|Overall Study|Adverse Event|7|||
145637062|NCT03253848|525186687|FG000|Overall Study|Death|5|||
145637063|NCT03253848|525186687|FG000|Overall Study|initiation of other treatments|3|||
145637064|NCT03253848|525186687|FG000|Overall Study|Other complicating disease|1|||
145637065|NCT03253848|525186687|FG000|Overall Study|Withdrawal by Subject|1|||
145637066|NCT03253848|525186687|FG000|Overall Study|Declining health|1|||
145637067|NCT05694065|525186689|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
145637068|NCT05694065|525186689|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
145637069|NCT05694065|525186689|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
145637070|NCT04221438|525186693|FG000|Overall Study|Adverse Event|1|||
145637071|NCT04221438|525186693|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
145637072|NCT00588770|525186696|FG000|Overall Study|Disease progression|85|||
145637073|NCT00588770|525186697|FG001|Overall Study|Disease progression|68|||
145637074|NCT00588770|525186696|FG000|Overall Study|Adverse Event|29|||
145637075|NCT00588770|525186697|FG001|Overall Study|Adverse Event|58|||
145637076|NCT00588770|525186696|FG000|Overall Study|Death|13|||
145637077|NCT00588770|525186697|FG001|Overall Study|Death|22|||
145637078|NCT00588770|525186696|FG000|Overall Study|Withdrawal by Subject|15|||
145637079|NCT00588770|525186697|FG001|Overall Study|Withdrawal by Subject|25|||
145637080|NCT00588770|525186696|FG000|Overall Study|Alternative therapy|2|||
145637081|NCT00588770|525186697|FG001|Overall Study|Alternative therapy|4|||
145637082|NCT00588770|525186696|FG000|Overall Study|Other complicating disease|3|||
145637083|NCT00588770|525186697|FG001|Overall Study|Other complicating disease|2|||
145637084|NCT00588770|525186696|FG000|Overall Study|Not start protocol therapy|0|||
145637085|NCT00588770|525186697|FG001|Overall Study|Not start protocol therapy|9|||
145637086|NCT00588770|525186696|FG000|Overall Study|Lack of Efficacy|8|||
145637087|NCT00588770|525186697|FG001|Overall Study|Lack of Efficacy|10|||
145637088|NCT00588770|525186696|FG000|Overall Study|Physician discretion|2|||
145637089|NCT00588770|525186697|FG001|Overall Study|Physician discretion|0|||
145637090|NCT00588770|525186696|FG000|Overall Study|Patient non-compliance|2|||
145637091|NCT00588770|525186697|FG001|Overall Study|Patient non-compliance|2|||
145637092|NCT00843882|525186698|FG000|Step 1|Lack of Efficacy|14|||
145637093|NCT00843882|525186699|FG001|Step 1|Lack of Efficacy|10|||
145637094|NCT00843882|525186700|FG002|Step 1|Lack of Efficacy|21|||
145637095|NCT00843882|525186698|FG000|Step 1|Adverse Event|8|||
145637096|NCT00843882|525186699|FG001|Step 1|Adverse Event|17|||
145637097|NCT00843882|525186700|FG002|Step 1|Adverse Event|20|||
145637098|NCT00843882|525186698|FG000|Step 1|Death|1|||
145637099|NCT00843882|525186699|FG001|Step 1|Death|2|||
145481223|NCT02021643|524614731|FG001|Overall Study|Lack of Efficacy|6|||
145481224|NCT02021643|524614732|FG002|Overall Study|Lack of Efficacy|0|||
145481225|NCT02021643|524614733|FG003|Overall Study|Lack of Efficacy|12|||
145637100|NCT00843882|525186700|FG002|Step 1|Death|4|||
145637101|NCT00843882|525186698|FG000|Step 1|Withdrawal by Subject|6|||
145637102|NCT00843882|525186699|FG001|Step 1|Withdrawal by Subject|12|||
145637103|NCT00843882|525186700|FG002|Step 1|Withdrawal by Subject|9|||
145637104|NCT00843882|525186698|FG000|Step 1|Physician Decision|0|||
145637105|NCT00843882|525186699|FG001|Step 1|Physician Decision|5|||
145637106|NCT00843882|525186700|FG002|Step 1|Physician Decision|1|||
145637107|NCT00843882|525186698|FG000|Step 1|Patient and physician's decision|0|||
145637108|NCT00843882|525186699|FG001|Step 1|Patient and physician's decision|0|||
145637109|NCT00843882|525186700|FG002|Step 1|Patient and physician's decision|1|||
145481226|NCT02021643|524614730|FG000|Overall Study|Lost to Follow-up|0|||
145637110|NCT00843882|525186698|FG000|Step 1|Other complicating disease|1|||
145637111|NCT00843882|525186699|FG001|Step 1|Other complicating disease|3|||
145637112|NCT00843882|525186700|FG002|Step 1|Other complicating disease|4|||
145637113|NCT00843882|525186698|FG000|Step 1|Alternative therapy|0|||
145637114|NCT00843882|525186699|FG001|Step 1|Alternative therapy|1|||
145637115|NCT00843882|525186700|FG002|Step 1|Alternative therapy|1|||
145637116|NCT00843882|525186698|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
145637117|NCT00843882|525186699|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
145637118|NCT00843882|525186700|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
145637119|NCT00843882|525186698|FG000|Step 1|Off treatment reason unknown|0|||
145637120|NCT00843882|525186699|FG001|Step 1|Off treatment reason unknown|1|||
145637121|NCT00843882|525186700|FG002|Step 1|Off treatment reason unknown|4|||
145637122|NCT00843882|525186698|FG000|Step 1|Never started treatment|2|||
145637123|NCT00843882|525186699|FG001|Step 1|Never started treatment|0|||
145637124|NCT00843882|525186700|FG002|Step 1|Never started treatment|0|||
145637125|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
145637126|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
145637127|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
145637128|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
145637129|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
145637130|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
145637131|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
145637132|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
145637133|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
145637134|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
145637135|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
145637136|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
145637137|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
145637138|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
145637139|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
145637140|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
145637141|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
145637142|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
145637143|NCT00843882|525186698|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
145637144|NCT00843882|525186699|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
145637145|NCT00843882|525186700|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
145637146|NCT04795752|525186701|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
145637147|NCT04795752|525186702|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
145637148|NCT04795752|525186701|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
145637149|NCT04795752|525186702|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
145637150|NCT04795752|525186701|FG000|Primary Endpoint Phase|Physician Decision|2|||
145637151|NCT04795752|525186702|FG001|Primary Endpoint Phase|Physician Decision|0|||
145637152|NCT04795752|525186701|FG000|Primary Endpoint Phase|Other|4|||
145637153|NCT04795752|525186702|FG001|Primary Endpoint Phase|Other|1|||
145637154|NCT04795752|525186701|FG000|Primary Endpoint Phase|Protocol Violation|1|||
145637155|NCT04795752|525186702|FG001|Primary Endpoint Phase|Protocol Violation|0|||
145637156|NCT04795752|525186701|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
145637157|NCT04795752|525186702|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
145637158|NCT04795752|525186701|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
145637159|NCT04795752|525186702|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
145637160|NCT04795752|525186701|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
145637161|NCT04795752|525186702|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
145637162|NCT04795752|525186701|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
145637163|NCT04795752|525186702|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
145637164|NCT04795752|525186701|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
145637165|NCT04795752|525186702|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
145637166|NCT00792948|525186703|FG000|Overall Study|Adverse Event|6|||
145637167|NCT00792948|525186703|FG000|Overall Study|Death|4|||
145637168|NCT00792948|525186703|FG000|Overall Study|Withdrawal by Subject|3|||
145637169|NCT00792948|525186703|FG000|Overall Study|Ineligible|2|||
145637170|NCT00792948|525186703|FG000|Overall Study|Insurance denial - not treated|1|||
145637171|NCT00792948|525186703|FG000|Overall Study|Physician Decision|11|||
145637172|NCT00792948|525186703|FG000|Overall Study|Protocol Violation|1|||
145637173|NCT06129045|525186704|FG000|Overall Study|Lost to Follow-up|1|||
145481227|NCT02021643|524614731|FG001|Overall Study|Lost to Follow-up|1|||
145481228|NCT02021643|524614732|FG002|Overall Study|Lost to Follow-up|0|||
145481229|NCT02021643|524614733|FG003|Overall Study|Lost to Follow-up|0|||
145481230|NCT02021643|524614730|FG000|Overall Study|Withdrew Consent|0|||
145637174|NCT06129045|525186705|FG001|Overall Study|Lost to Follow-up|1|||
145637175|NCT06129045|525186706|FG002|Overall Study|Lost to Follow-up|4|||
145637176|NCT01582269|525186709|FG000|Overall Study|Withdrawal by Subject|1|||
145481231|NCT02021643|524614731|FG001|Overall Study|Withdrew Consent|1|||
145637177|NCT01582269|525186710|FG001|Overall Study|Withdrawal by Subject|0|||
145637178|NCT01582269|525186711|FG002|Overall Study|Withdrawal by Subject|0|||
145637179|NCT06218251|525186712|FG000|Overall Study|Lost to Follow-up|4|||
145637180|NCT05076266|525186713|FG000|Overall Study|Survey not complete - Participant refusal|2|||
145481232|NCT02021643|524614732|FG002|Overall Study|Withdrew Consent|0|||
145637181|NCT05076266|525186714|FG001|Overall Study|Survey not complete - Participant refusal|0|||
145637182|NCT05797155|525186715|FG000|Overall Study|Lost to Follow-up|33|||
145637183|NCT05797155|525186716|FG001|Overall Study|Lost to Follow-up|12|||
145637184|NCT00026312|525186717|FG000|Overall Study|Adverse Event|0|||
145637185|NCT00026312|525186718|FG001|Overall Study|Adverse Event|32|||
145637186|NCT00026312|525186717|FG000|Overall Study|Death|1|||
145637187|NCT00026312|525186718|FG001|Overall Study|Death|7|||
145637188|NCT00026312|525186717|FG000|Overall Study|Lack of Efficacy|19|||
145637189|NCT00026312|525186718|FG001|Overall Study|Lack of Efficacy|114|||
145637190|NCT00026312|525186717|FG000|Overall Study|Lost to Follow-up|0|||
145637191|NCT00026312|525186718|FG001|Overall Study|Lost to Follow-up|5|||
145637192|NCT00026312|525186717|FG000|Overall Study|Physician Decision|1|||
145637193|NCT00026312|525186718|FG001|Overall Study|Physician Decision|37|||
145637194|NCT00026312|525186717|FG000|Overall Study|Protocol Violation|0|||
145637195|NCT00026312|525186718|FG001|Overall Study|Protocol Violation|3|||
145637196|NCT00026312|525186717|FG000|Overall Study|Withdrawal by Subject|1|||
145637197|NCT00026312|525186718|FG001|Overall Study|Withdrawal by Subject|6|||
145637198|NCT00026312|525186717|FG000|Overall Study|Ineligible|4|||
145637199|NCT00026312|525186718|FG001|Overall Study|Ineligible|5|||
145637200|NCT00026312|525186717|FG000|Overall Study|Entry onto another COG study|0|||
145637201|NCT00026312|525186718|FG001|Overall Study|Entry onto another COG study|1|||
145637202|NCT00026312|525186717|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
145637203|NCT00026312|525186718|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
145637204|NCT02445391|525186719|FG000|Overall Study|No active protocol treatment|3|||
145637205|NCT02445391|525186720|FG001|Overall Study|No active protocol treatment|0|||
145637206|NCT02445391|525186721|FG002|Overall Study|No active protocol treatment|0|||
145637207|NCT02445391|525186719|FG000|Overall Study|Adverse Event|0|||
145637208|NCT02445391|525186720|FG001|Overall Study|Adverse Event|21|||
145637209|NCT02445391|525186721|FG002|Overall Study|Adverse Event|12|||
145637210|NCT02445391|525186719|FG000|Overall Study|Alternative therapy|0|||
145637211|NCT02445391|525186720|FG001|Overall Study|Alternative therapy|0|||
145637212|NCT02445391|525186721|FG002|Overall Study|Alternative therapy|1|||
145637213|NCT02445391|525186719|FG000|Overall Study|Disease progression|0|||
145637214|NCT02445391|525186720|FG001|Overall Study|Disease progression|7|||
145637215|NCT02445391|525186721|FG002|Overall Study|Disease progression|22|||
145637216|NCT02445391|525186719|FG000|Overall Study|Complicating disease|0|||
145637217|NCT02445391|525186720|FG001|Overall Study|Complicating disease|2|||
145637218|NCT02445391|525186721|FG002|Overall Study|Complicating disease|1|||
145637219|NCT02445391|525186719|FG000|Overall Study|Withdrawal by Subject|0|||
145637220|NCT02445391|525186720|FG001|Overall Study|Withdrawal by Subject|4|||
145637221|NCT02445391|525186721|FG002|Overall Study|Withdrawal by Subject|9|||
145637222|NCT02445391|525186719|FG000|Overall Study|Financial issue|0|||
145637223|NCT02445391|525186720|FG001|Overall Study|Financial issue|0|||
145637224|NCT02445391|525186721|FG002|Overall Study|Financial issue|2|||
145637225|NCT02445391|525186719|FG000|Overall Study|Still on treatment|0|||
145637226|NCT02445391|525186720|FG001|Overall Study|Still on treatment|7|||
145637227|NCT02445391|525186721|FG002|Overall Study|Still on treatment|16|||
145637228|NCT02445391|525186719|FG000|Overall Study|Not start protocol therapy|0|||
145637229|NCT02445391|525186720|FG001|Overall Study|Not start protocol therapy|12|||
145637230|NCT02445391|525186721|FG002|Overall Study|Not start protocol therapy|9|||
145637231|NCT00465816|525187246|FG000|Overall Study|Lost to Follow-up|0|||
145637232|NCT00465816|525187247|FG001|Overall Study|Lost to Follow-up|0|||
145637233|NCT00465816|525187248|FG002|Overall Study|Lost to Follow-up|2|||
145637234|NCT00799396|525187249|FG000|Clopidogrel Treatment|Adverse Event|6|||
145637235|NCT00799396|525187249|FG000|Clopidogrel Treatment|Physician Decision|5|||
145637236|NCT00799396|525187249|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
145637237|NCT00799396|525187249|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
145637238|NCT00799396|525187249|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
145637239|NCT01867216|525187250|FG000|Overall Study|Withdrawal by Subject|2|||
145637240|NCT01867216|525187251|FG001|Overall Study|Withdrawal by Subject|0|||
145637241|NCT01867216|525187252|FG002|Overall Study|Withdrawal by Subject|0|||
145637242|NCT01867216|525187253|FG003|Overall Study|Withdrawal by Subject|0|||
145637243|NCT01867216|525187254|FG004|Overall Study|Withdrawal by Subject|1|||
145637244|NCT01867216|525187255|FG005|Overall Study|Withdrawal by Subject|0|||
145637245|NCT01867216|525187256|FG006|Overall Study|Withdrawal by Subject|1|||
145637246|NCT01867216|525187250|FG000|Overall Study|Physician Decision|1|||
145637247|NCT01867216|525187251|FG001|Overall Study|Physician Decision|0|||
145637248|NCT01867216|525187252|FG002|Overall Study|Physician Decision|0|||
145637249|NCT01867216|525187253|FG003|Overall Study|Physician Decision|0|||
145637250|NCT01867216|525187254|FG004|Overall Study|Physician Decision|0|||
145637251|NCT01867216|525187255|FG005|Overall Study|Physician Decision|0|||
145637252|NCT01867216|525187256|FG006|Overall Study|Physician Decision|0|||
145637253|NCT01867216|525187250|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
145637254|NCT01867216|525187251|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637255|NCT01867216|525187252|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637256|NCT01867216|525187253|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637257|NCT01867216|525187254|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637258|NCT01867216|525187255|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637259|NCT01867216|525187256|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
145637260|NCT01145885|525187266|FG000|Overall Study|Progressive Disease|7|||
145637261|NCT02425111|525187267|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
145637262|NCT02425111|525187267|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
145637263|NCT02425111|525187267|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
145637264|NCT02425111|525187267|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
145481233|NCT02021643|524614733|FG003|Overall Study|Withdrew Consent|0|||
145481234|NCT01345188|524614736|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
145481235|NCT01345188|524614736|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
145481236|NCT00577824|524614737|FG000|Overall Study|Adverse Event|6|||
145481237|NCT00577824|524614738|FG001|Overall Study|Adverse Event|18|||
145481238|NCT00577824|524614739|FG002|Overall Study|Adverse Event|1|||
145481239|NCT00577824|524614737|FG000|Overall Study|Patient decision|0|||
145481240|NCT00577824|524614738|FG001|Overall Study|Patient decision|1|||
145481241|NCT00577824|524614739|FG002|Overall Study|Patient decision|1|||
145481242|NCT00577824|524614737|FG000|Overall Study|Protocol Violation|1|||
145481243|NCT00577824|524614738|FG001|Overall Study|Protocol Violation|1|||
145481244|NCT00577824|524614739|FG002|Overall Study|Protocol Violation|0|||
145481245|NCT01518374|524614740|FG000|Overall Study|Withdrawal by Subject|2|||
145637265|NCT02425111|525187267|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
145637266|NCT02425111|525187267|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
145637267|NCT03482011|525187268|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
145637268|NCT03482011|525187269|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
145637269|NCT03482011|525187270|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
145637270|NCT03482011|525187271|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
145637271|NCT03482011|525187272|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
145637272|NCT03482011|525187273|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
145637273|NCT03482011|525187274|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
145637274|NCT03482011|525187275|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
145637275|NCT03482011|525187268|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
145637276|NCT03482011|525187269|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
145637277|NCT03482011|525187270|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637278|NCT03482011|525187271|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637279|NCT03482011|525187272|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637280|NCT03482011|525187273|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637281|NCT03482011|525187274|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637282|NCT03482011|525187275|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
145637283|NCT03482011|525187268|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145637284|NCT03482011|525187269|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
145637285|NCT03482011|525187270|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145637286|NCT03482011|525187271|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145481246|NCT01518374|524614740|FG000|Overall Study|Protocol Violation|3|||
145481247|NCT01518374|524614740|FG000|Overall Study|Lost to Follow-up|2|||
145481248|NCT04607837|524614746|FG000|Overall Study|Adverse Event|8|||
145481249|NCT04607837|524614747|FG001|Overall Study|Adverse Event|2|||
145481250|NCT04607837|524614746|FG000|Overall Study|Withdrawal by Subject|8|||
145481251|NCT04607837|524614747|FG001|Overall Study|Withdrawal by Subject|7|||
145481252|NCT04607837|524614746|FG000|Overall Study|Physician Decision|2|||
145481253|NCT04607837|524614747|FG001|Overall Study|Physician Decision|0|||
145481254|NCT04607837|524614746|FG000|Overall Study|Lack of Efficacy|2|||
145481255|NCT04607837|524614747|FG001|Overall Study|Lack of Efficacy|0|||
145481256|NCT04607837|524614746|FG000|Overall Study|Participant terminated by sponsor|1|||
145481257|NCT04607837|524614747|FG001|Overall Study|Participant terminated by sponsor|0|||
145481258|NCT04607837|524614746|FG000|Overall Study|Disease worsening|36|||
145481259|NCT04607837|524614747|FG001|Overall Study|Disease worsening|36|||
145481260|NCT04607837|524614746|FG000|Overall Study|Other|1|||
145481261|NCT04607837|524614747|FG001|Overall Study|Other|0|||
145481262|NCT02362464|524614748|FG000|Overall Study|Switched to alternative therapy|1|||
145481263|NCT02362464|524614748|FG000|Overall Study|Refused further treatment|1|||
145481264|NCT02362464|524614748|FG000|Overall Study|Physician Decision|4|||
145481265|NCT00465452|524614749|FG000|Overall Study|Adverse Event|1|||
145481266|NCT05870865|524614786|FG000|Randomized|Did not receive study treatment|2|||
145481267|NCT05870865|524614787|FG001|Randomized|Did not receive study treatment|4|||
145481268|NCT05870865|524614788|FG002|Randomized|Did not receive study treatment|4|||
145481269|NCT05870865|524614789|FG003|Randomized|Did not receive study treatment|3|||
145481270|NCT05870865|524614786|FG000|Treatment Period|Adverse Event|1|||
145481271|NCT05870865|524614787|FG001|Treatment Period|Adverse Event|1|||
145481272|NCT05870865|524614788|FG002|Treatment Period|Adverse Event|1|||
145481273|NCT05870865|524614789|FG003|Treatment Period|Adverse Event|1|||
145481274|NCT05870865|524614786|FG000|Treatment Period|Lost to Follow-up|0|||
145637287|NCT03482011|525187272|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145637288|NCT03482011|525187273|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145637289|NCT03482011|525187274|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145481275|NCT05870865|524614787|FG001|Treatment Period|Lost to Follow-up|1|||
145481276|NCT05870865|524614788|FG002|Treatment Period|Lost to Follow-up|2|||
145481277|NCT05870865|524614789|FG003|Treatment Period|Lost to Follow-up|0|||
145481278|NCT05870865|524614786|FG000|Treatment Period|Protocol Violation|0|||
145481279|NCT05870865|524614787|FG001|Treatment Period|Protocol Violation|0|||
145481280|NCT05870865|524614788|FG002|Treatment Period|Protocol Violation|0|||
145481281|NCT05870865|524614789|FG003|Treatment Period|Protocol Violation|1|||
145481282|NCT05870865|524614786|FG000|Treatment Period|Withdrawal by Subject|0|||
145481283|NCT05870865|524614787|FG001|Treatment Period|Withdrawal by Subject|1|||
145481284|NCT05870865|524614788|FG002|Treatment Period|Withdrawal by Subject|1|||
145481285|NCT05870865|524614789|FG003|Treatment Period|Withdrawal by Subject|1|||
145481286|NCT01380834|524614790|FG000|Overall Study|Physician Decision|1|||
145481287|NCT01380834|524614791|FG001|Overall Study|Physician Decision|0|||
145481288|NCT03182907|524614794|FG000|Overall Study|Death|3|||
145481289|NCT03182907|524614795|FG001|Overall Study|Death|0|||
145481290|NCT03182907|524614794|FG000|Overall Study|Protocol Violation|4|||
145637290|NCT03482011|525187275|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
145637291|NCT03482011|525187268|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
145637292|NCT03482011|525187269|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
145637293|NCT03482011|525187270|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
145637294|NCT03482011|525187271|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
145637295|NCT03482011|525187272|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
145637296|NCT03482011|525187273|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
145637297|NCT03482011|525187274|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
145637298|NCT03482011|525187275|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
145637299|NCT03482011|525187268|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
145637300|NCT03482011|525187269|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
145637301|NCT03482011|525187270|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637302|NCT03482011|525187271|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637303|NCT03482011|525187272|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637304|NCT03482011|525187273|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637305|NCT03482011|525187274|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637306|NCT03482011|525187275|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
145637307|NCT03482011|525187268|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
145637308|NCT03482011|525187269|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
145637309|NCT03482011|525187270|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
145637310|NCT03482011|525187271|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
145637311|NCT03482011|525187272|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
145637312|NCT03482011|525187273|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
145637313|NCT03482011|525187274|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
145637314|NCT03482011|525187275|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
145637315|NCT03482011|525187268|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
145637316|NCT03482011|525187269|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
145637317|NCT03482011|525187270|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
145637318|NCT03482011|525187271|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
145637319|NCT03482011|525187272|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
145637320|NCT03482011|525187273|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
145637321|NCT03482011|525187274|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
145637322|NCT03482011|525187275|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
145637323|NCT03482011|525187268|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145637324|NCT03482011|525187269|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145637325|NCT03482011|525187270|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145637326|NCT03482011|525187271|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145637327|NCT03482011|525187272|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
145637328|NCT03482011|525187273|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145481291|NCT03182907|524614795|FG001|Overall Study|Protocol Violation|0|||
145481292|NCT03182907|524614794|FG000|Overall Study|Lost to Follow-up|1|||
145481293|NCT03182907|524614795|FG001|Overall Study|Lost to Follow-up|0|||
145481294|NCT03182907|524614794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145481295|NCT03182907|524614795|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145481296|NCT02058563|524614799|FG000|Overall Study|Lost to Follow-up|26|||
145481297|NCT02058563|524614800|FG001|Overall Study|Lost to Follow-up|22|||
145481298|NCT02058563|524614799|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
145637329|NCT03482011|525187274|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
145637330|NCT03482011|525187275|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
145637331|NCT03482011|525187268|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
145637332|NCT03482011|525187269|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
145637333|NCT03482011|525187270|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
145637334|NCT03482011|525187271|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
145481299|NCT02058563|524614800|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
145481300|NCT02058563|524614799|FG000|Overall Study|Consent Withdrawal|1|||
145481301|NCT02058563|524614800|FG001|Overall Study|Consent Withdrawal|1|||
145481302|NCT02058563|524614799|FG000|Overall Study|Other (patient incarcerated)|0|||
145481303|NCT02058563|524614800|FG001|Overall Study|Other (patient incarcerated)|1|||
145481304|NCT00166439|524614801|FG000|Overall Study|Ineligible|5|||
145481305|NCT04039217|524614804|FG000|Overall Study|Lost to Follow-up|1|||
145481306|NCT00167310|524614805|FG000|Overall Study|Protocol Violation|5|||
145481307|NCT00167310|524614806|FG001|Overall Study|Protocol Violation|3|||
145481308|NCT00167310|524614805|FG000|Overall Study|Withdrawal by Subject|3|||
145481309|NCT00167310|524614806|FG001|Overall Study|Withdrawal by Subject|7|||
145481310|NCT00615992|524614807|FG000|Overall Study|Protocol Violation|67|||
145481311|NCT03319212|524614808|FG000|Overall Study|Discontinued as moving out of local area|0|||
145481312|NCT03319212|524614809|FG001|Overall Study|Discontinued as moving out of local area|1|||
145481313|NCT03319212|524614808|FG000|Overall Study|Adverse Event|2|||
145481314|NCT03319212|524614809|FG001|Overall Study|Adverse Event|2|||
145481315|NCT03319212|524614808|FG000|Overall Study|Withdrawal by Subject|0|||
145481316|NCT03319212|524614809|FG001|Overall Study|Withdrawal by Subject|1|||
145481317|NCT03319212|524614808|FG000|Overall Study|Lost to Follow-up|0|||
145481318|NCT03319212|524614809|FG001|Overall Study|Lost to Follow-up|1|||
145481319|NCT03319212|524614808|FG000|Overall Study|Physician Decision|1|||
145481320|NCT03319212|524614809|FG001|Overall Study|Physician Decision|0|||
145481321|NCT01811186|524614811|FG000|Overall Study|Adverse Event|54|||
145481322|NCT01811186|524614812|FG001|Overall Study|Adverse Event|38|||
145481323|NCT01811186|524614811|FG000|Overall Study|Protocol Violation|5|||
145481324|NCT01811186|524614812|FG001|Overall Study|Protocol Violation|6|||
145481325|NCT01811186|524614811|FG000|Overall Study|Withdrawal by Subject|5|||
145481326|NCT01811186|524614812|FG001|Overall Study|Withdrawal by Subject|10|||
145481327|NCT01811186|524614811|FG000|Overall Study|Lack of Efficacy|3|||
145481328|NCT01811186|524614812|FG001|Overall Study|Lack of Efficacy|6|||
145481329|NCT01811186|524614811|FG000|Overall Study|Lost to Follow-up|4|||
145481330|NCT01811186|524614812|FG001|Overall Study|Lost to Follow-up|2|||
145481331|NCT04072887|524614817|FG000|Overall Study|Withdrawal by Subject|3|||
145481332|NCT04072887|524614818|FG001|Overall Study|Withdrawal by Subject|8|||
145481333|NCT04072887|524614819|FG002|Overall Study|Withdrawal by Subject|1|||
145481334|NCT04072887|524614820|FG003|Overall Study|Withdrawal by Subject|3|||
145481335|NCT04072887|524614821|FG004|Overall Study|Withdrawal by Subject|3|||
145481336|NCT04072887|524614822|FG005|Overall Study|Withdrawal by Subject|13|||
145481337|NCT04072887|524614817|FG000|Overall Study|Adverse Event|2|||
145481338|NCT04072887|524614818|FG001|Overall Study|Adverse Event|4|||
145481339|NCT04072887|524614819|FG002|Overall Study|Adverse Event|1|||
145481340|NCT04072887|524614820|FG003|Overall Study|Adverse Event|4|||
145481341|NCT04072887|524614821|FG004|Overall Study|Adverse Event|0|||
145481342|NCT04072887|524614822|FG005|Overall Study|Adverse Event|1|||
145481343|NCT04072887|524614817|FG000|Overall Study|Physician Decision|2|||
145481344|NCT04072887|524614818|FG001|Overall Study|Physician Decision|0|||
145481345|NCT04072887|524614819|FG002|Overall Study|Physician Decision|0|||
145481346|NCT04072887|524614820|FG003|Overall Study|Physician Decision|0|||
145481347|NCT04072887|524614821|FG004|Overall Study|Physician Decision|0|||
145481348|NCT04072887|524614822|FG005|Overall Study|Physician Decision|1|||
145481349|NCT04072887|524614817|FG000|Overall Study|Lost to Follow-up|1|||
145481350|NCT04072887|524614818|FG001|Overall Study|Lost to Follow-up|3|||
145481351|NCT04072887|524614819|FG002|Overall Study|Lost to Follow-up|0|||
145481352|NCT04072887|524614820|FG003|Overall Study|Lost to Follow-up|0|||
145481353|NCT04072887|524614821|FG004|Overall Study|Lost to Follow-up|0|||
145637335|NCT03482011|525187272|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
145637336|NCT03482011|525187273|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
145637337|NCT03482011|525187274|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
145637338|NCT03482011|525187275|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
145637339|NCT03482011|525187268|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145637340|NCT03482011|525187269|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145637341|NCT03482011|525187270|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
145637342|NCT03482011|525187271|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
145637343|NCT03482011|525187272|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
145637344|NCT03482011|525187273|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
145637345|NCT03482011|525187274|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
145637346|NCT03482011|525187275|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
145637347|NCT03482011|525187268|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145481354|NCT04072887|524614822|FG005|Overall Study|Lost to Follow-up|0|||
145481355|NCT04072887|524614817|FG000|Overall Study|Death|0|||
145481356|NCT04072887|524614818|FG001|Overall Study|Death|2|||
145481357|NCT04072887|524614819|FG002|Overall Study|Death|0|||
145481358|NCT04072887|524614820|FG003|Overall Study|Death|2|||
145481359|NCT04072887|524614821|FG004|Overall Study|Death|3|||
145481360|NCT04072887|524614822|FG005|Overall Study|Death|0|||
145481361|NCT03193736|524614823|FG000|Overall Study|Death|2|||
145481362|NCT03193736|524614823|FG000|Overall Study|Withdrawal by Subject|1|||
145481363|NCT03193736|524614823|FG000|Overall Study|Lost to Follow-up|1|||
145481364|NCT03193736|524614823|FG000|Overall Study|implant not received|1|||
145481365|NCT00856297|524614824|FG000|Overall Study|Unable to classify|2|||
145481366|NCT00856297|524614825|FG001|Overall Study|Unable to classify|0|||
145481367|NCT00856297|524614826|FG002|Overall Study|Unable to classify|0|||
145481368|NCT00856297|524614827|FG003|Overall Study|Unable to classify|0|||
145481369|NCT00856297|524614828|FG004|Overall Study|Unable to classify|0|||
145481370|NCT03369236|524614829|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
145481371|NCT03369236|524614830|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
145481372|NCT03369236|524614829|FG000|Open-label Extension Period|Lack of Efficacy|2|||
145481373|NCT03369236|524614830|FG001|Open-label Extension Period|Lack of Efficacy|1|||
145481374|NCT03369236|524614829|FG000|Open-label Extension Period|Adverse Event|0|||
145481375|NCT03369236|524614830|FG001|Open-label Extension Period|Adverse Event|1|||
145481376|NCT03369236|524614829|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
145481377|NCT03369236|524614830|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
145481378|NCT00423449|524614831|FG000|Overall Study|Clinical Adverse Event|1|||
145604169|NCT01498822|525064694|FG001|Overall Study|AE, non-serious non-fatal|17|||
145604170|NCT01498822|525064693|FG000|Overall Study|SAE, non-fatal|2|||
145604171|NCT01498822|525064694|FG001|Overall Study|SAE, non-fatal|2|||
145604172|NCT01498822|525064693|FG000|Overall Study|Adverse Event, serious fatal|1|||
145604173|NCT01498822|525064694|FG001|Overall Study|Adverse Event, serious fatal|1|||
145604174|NCT01498822|525064693|FG000|Overall Study|Withdrawal by Subject|15|||
145604175|NCT01498822|525064694|FG001|Overall Study|Withdrawal by Subject|25|||
145604176|NCT01498822|525064693|FG000|Overall Study|Lost to Follow-up|8|||
145604177|NCT01498822|525064694|FG001|Overall Study|Lost to Follow-up|3|||
145604178|NCT04707196|525064695|FG000|Overall Study|Withdrawal by Subject|9|||
145604179|NCT04707196|525064696|FG001|Overall Study|Withdrawal by Subject|6|||
145604180|NCT04707196|525064695|FG000|Overall Study|Lost to Follow-up|1|||
145604181|NCT04707196|525064696|FG001|Overall Study|Lost to Follow-up|0|||
145604182|NCT04707196|525064695|FG000|Overall Study|Protocol Violation|4|||
145604183|NCT04707196|525064696|FG001|Overall Study|Protocol Violation|1|||
145604184|NCT04707196|525064695|FG000|Overall Study|Adverse Event|2|||
145604185|NCT04707196|525064696|FG001|Overall Study|Adverse Event|2|||
145604186|NCT04707196|525064695|FG000|Overall Study|Death|3|||
145604187|NCT04707196|525064696|FG001|Overall Study|Death|1|||
145604188|NCT04707196|525064695|FG000|Overall Study|Non-compliance with study drug|1|||
145604189|NCT04707196|525064696|FG001|Overall Study|Non-compliance with study drug|0|||
145604190|NCT04707196|525064695|FG000|Overall Study|Progressive disease|9|||
145604191|NCT04707196|525064696|FG001|Overall Study|Progressive disease|10|||
145604192|NCT01862796|525064697|FG000|Overall Study|Prohibited medications|0|||
145604193|NCT01862796|525064698|FG001|Overall Study|Prohibited medications|0|||
145604194|NCT01862796|525064699|FG002|Overall Study|Prohibited medications|1|||
145604195|NCT04404478|525064700|FG000|Overall Study|Withdrawal by Subject|1|||
145604196|NCT04404478|525064701|FG001|Overall Study|Withdrawal by Subject|3|||
145604197|NCT03333928|525064702|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
145604198|NCT03333928|525064703|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
145604199|NCT03333928|525064704|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
145604200|NCT03333928|525064702|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
145604201|NCT03333928|525064703|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
145604202|NCT03333928|525064704|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
145604203|NCT03333928|525064702|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
145604204|NCT03333928|525064703|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
145604205|NCT03333928|525064704|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
145604206|NCT03333928|525064702|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
145604207|NCT03333928|525064703|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
145604208|NCT03333928|525064704|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
145604209|NCT03333928|525064702|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
145604210|NCT03333928|525064703|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
145604211|NCT03333928|525064704|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
145604212|NCT03333928|525064702|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
145604213|NCT03333928|525064703|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
145604214|NCT03333928|525064704|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
145604215|NCT03333928|525064702|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
145604216|NCT03333928|525064703|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
145604217|NCT03333928|525064704|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
145604218|NCT03333928|525064702|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
145604219|NCT03333928|525064703|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
145604220|NCT03333928|525064704|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
145604221|NCT01375205|525064705|FG000|Overall Study|Lost to Follow-up|15|||
145604222|NCT01375205|525064706|FG001|Overall Study|Lost to Follow-up|12|||
145604223|NCT01375205|525064705|FG000|Overall Study|Withdrawal by Subject|6|||
145604224|NCT01375205|525064706|FG001|Overall Study|Withdrawal by Subject|1|||
145481379|NCT00423449|524614832|FG001|Overall Study|Clinical Adverse Event|0|||
145481380|NCT00423449|524614833|FG002|Overall Study|Clinical Adverse Event|1|||
145637348|NCT03482011|525187269|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145637349|NCT03482011|525187270|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145637350|NCT03482011|525187271|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
145637351|NCT03482011|525187272|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
145637352|NCT03482011|525187273|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
145637353|NCT03482011|525187274|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
145637354|NCT03482011|525187275|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
145637355|NCT03482011|525187268|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637356|NCT03482011|525187269|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637357|NCT03482011|525187270|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637358|NCT03482011|525187271|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637359|NCT03482011|525187272|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637360|NCT03482011|525187273|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
145637361|NCT03482011|525187274|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
145637362|NCT03482011|525187275|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
145637363|NCT03482011|525187268|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
145637364|NCT03482011|525187269|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
145637365|NCT03482011|525187270|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
145637366|NCT03482011|525187271|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
145637367|NCT03482011|525187272|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
145637368|NCT03482011|525187273|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
145637369|NCT03482011|525187274|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
145637370|NCT03482011|525187275|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
145637371|NCT03482011|525187268|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637372|NCT03482011|525187269|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637373|NCT03482011|525187270|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637374|NCT03482011|525187271|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637375|NCT03482011|525187272|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637376|NCT03482011|525187273|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637377|NCT03482011|525187274|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
145637378|NCT03482011|525187275|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
145637379|NCT03482011|525187268|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637380|NCT03482011|525187269|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637381|NCT03482011|525187270|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637382|NCT03482011|525187271|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637383|NCT03482011|525187272|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637384|NCT03482011|525187273|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637385|NCT03482011|525187274|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145637386|NCT03482011|525187275|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
145637387|NCT00468052|525187276|FG000|Overall Study|Protocol Violation|7|||
145637388|NCT00468052|525187277|FG001|Overall Study|Protocol Violation|8|||
145637389|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
145637390|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
145637391|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
145637392|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
145637393|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
145637394|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
145637395|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
145637396|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
145637397|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
145637398|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
145637399|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
145637400|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
145637401|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
145637402|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
145637403|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
145637404|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
145637405|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
145637406|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
145637407|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
145637408|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
145637409|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
145637410|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
145637411|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
145481381|NCT00423449|524614834|FG003|Overall Study|Clinical Adverse Event|8|||
145637412|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
145637413|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
145637414|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
145637415|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
145637416|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
145637417|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
145637418|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
145637419|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
145637420|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
145637421|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
145637422|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
145637423|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
145637424|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
145637425|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
145637426|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
145637427|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
145637428|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
145637429|NCT02709655|525187278|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
145637430|NCT02709655|525187279|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
145637431|NCT02709655|525187280|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
145637432|NCT02709655|525187281|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
145637433|NCT02709655|525187282|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
145637434|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
145637435|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
145637436|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
145637437|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
145637438|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
145637439|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
145637440|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
145637441|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
145637442|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
145637443|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
145637444|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
145637445|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
145637446|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
145637447|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
145637448|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
145637449|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
145637450|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
145637451|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
145637452|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
145637453|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
145637454|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
145637455|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
145637456|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
145637457|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
145637458|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
145637459|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
145637460|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
145637461|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
145637462|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
145637463|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
145637464|NCT02709655|525187278|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
145637465|NCT02709655|525187279|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
145637466|NCT02709655|525187280|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
145637467|NCT02709655|525187281|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
145637468|NCT02709655|525187282|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
145637469|NCT00256243|525187283|FG000|Overall Study|Lost to Follow-up|2|||
145637470|NCT00256243|525187283|FG000|Overall Study|Death|7|||
145637471|NCT00256243|525187283|FG000|Overall Study|Not treated|1|||
145637472|NCT02248480|525187284|FG000|Overall Study|Lack of Efficacy|4|||
145637473|NCT02248480|525187285|FG001|Overall Study|Lack of Efficacy|6|||
145637474|NCT02248480|525187284|FG000|Overall Study|Adverse Event|11|||
145637475|NCT02248480|525187285|FG001|Overall Study|Adverse Event|2|||
145637476|NCT02248480|525187284|FG000|Overall Study|Withdrawal by Subject|2|||
145637477|NCT02248480|525187285|FG001|Overall Study|Withdrawal by Subject|4|||
145637478|NCT02248480|525187284|FG000|Overall Study|Entry Criteria Not Met|0|||
145637479|NCT02248480|525187285|FG001|Overall Study|Entry Criteria Not Met|1|||
145637480|NCT02248480|525187284|FG000|Overall Study|Other:Physician Decision|0|||
145637481|NCT02248480|525187285|FG001|Overall Study|Other:Physician Decision|1|||
145637482|NCT03516942|525187286|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
145637483|NCT03516942|525187286|FG000|Registration through baseline survey com|Death|8|||
145637484|NCT03516942|525187286|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
145637485|NCT03516942|525187286|FG000|T0: Baseline|LOST|13|||
145481382|NCT00423449|524614835|FG004|Overall Study|Clinical Adverse Event|2|||
145481383|NCT00423449|524614831|FG000|Overall Study|Death|1|||
145481384|NCT00423449|524614832|FG001|Overall Study|Death|0|||
145481385|NCT00423449|524614833|FG002|Overall Study|Death|2|||
145481386|NCT00423449|524614834|FG003|Overall Study|Death|1|||
145481387|NCT00423449|524614835|FG004|Overall Study|Death|1|||
145481388|NCT00423449|524614831|FG000|Overall Study|Progressive Disease|1|||
145481389|NCT00423449|524614832|FG001|Overall Study|Progressive Disease|3|||
145481390|NCT00423449|524614833|FG002|Overall Study|Progressive Disease|8|||
145481391|NCT00423449|524614834|FG003|Overall Study|Progressive Disease|11|||
145481392|NCT00423449|524614835|FG004|Overall Study|Progressive Disease|4|||
145481393|NCT00423449|524614831|FG000|Overall Study|Laboratory Adverse Event|0|||
145481394|NCT00423449|524614832|FG001|Overall Study|Laboratory Adverse Event|1|||
145481395|NCT00423449|524614833|FG002|Overall Study|Laboratory Adverse Event|2|||
145481396|NCT00423449|524614834|FG003|Overall Study|Laboratory Adverse Event|0|||
145481397|NCT00423449|524614835|FG004|Overall Study|Laboratory Adverse Event|0|||
145481398|NCT00423449|524614831|FG000|Overall Study|Other|0|||
145481399|NCT00423449|524614832|FG001|Overall Study|Other|0|||
145481400|NCT00423449|524614833|FG002|Overall Study|Other|0|||
145481401|NCT00423449|524614834|FG003|Overall Study|Other|1|||
145481402|NCT00423449|524614835|FG004|Overall Study|Other|0|||
145481403|NCT00423449|524614831|FG000|Overall Study|Protocol Violation|0|||
145481404|NCT00423449|524614832|FG001|Overall Study|Protocol Violation|0|||
145481405|NCT00423449|524614833|FG002|Overall Study|Protocol Violation|2|||
145481406|NCT00423449|524614834|FG003|Overall Study|Protocol Violation|1|||
145481407|NCT00423449|524614835|FG004|Overall Study|Protocol Violation|0|||
145481408|NCT01153724|524614836|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145481409|NCT01153724|524614836|FG000|Treatment Period 2|Adverse Event|1|||
145481410|NCT01153724|524614836|FG000|Treatment Period 2|Other reason not defined above|1|||
145481411|NCT02697435|524614841|FG000|Overall Study|Withdrawal by Subject|1|||
145481412|NCT02697435|524614842|FG001|Overall Study|Withdrawal by Subject|0|||
145481413|NCT02697435|524614841|FG000|Overall Study|Physician Decision|0|||
145481414|NCT02697435|524614842|FG001|Overall Study|Physician Decision|4|||
145481415|NCT00367835|524614843|FG000|Overall Study|Adverse Event|14|||
145481416|NCT00367835|524614844|FG001|Overall Study|Adverse Event|1|||
145481417|NCT00367835|524614843|FG000|Overall Study|Protocol Violation|1|||
145481418|NCT00367835|524614844|FG001|Overall Study|Protocol Violation|7|||
145481419|NCT00367835|524614843|FG000|Overall Study|Withdrawal by Subject|7|||
145481420|NCT00367835|524614844|FG001|Overall Study|Withdrawal by Subject|6|||
145481421|NCT00367835|524614843|FG000|Overall Study|Lost to Follow-up|1|||
145481422|NCT00367835|524614844|FG001|Overall Study|Lost to Follow-up|4|||
145481423|NCT00367835|524614843|FG000|Overall Study|Lack of Efficacy|3|||
145481424|NCT00367835|524614844|FG001|Overall Study|Lack of Efficacy|12|||
145481425|NCT00367835|524614843|FG000|Overall Study|Subject in juvenile detention center|1|||
145481426|NCT00367835|524614844|FG001|Overall Study|Subject in juvenile detention center|0|||
145481427|NCT00367835|524614843|FG000|Overall Study|refused blood collection|1|||
145481428|NCT00367835|524614844|FG001|Overall Study|refused blood collection|0|||
145481429|NCT00367835|524614843|FG000|Overall Study|Did not respond to calls|1|||
145481430|NCT00367835|524614844|FG001|Overall Study|Did not respond to calls|0|||
145481431|NCT00367835|524614843|FG000|Overall Study|History of lead poisoning|0|||
145481432|NCT00367835|524614844|FG001|Overall Study|History of lead poisoning|1|||
145481433|NCT00445770|524614849|FG000|Overall Study|Adverse Event|9|||
145481434|NCT00445770|524614850|FG001|Overall Study|Adverse Event|15|||
145481435|NCT00445770|524614851|FG002|Overall Study|Adverse Event|19|||
145481436|NCT00445770|524614849|FG000|Overall Study|Lack of Efficacy|38|||
145481437|NCT00445770|524614850|FG001|Overall Study|Lack of Efficacy|13|||
145481438|NCT00445770|524614851|FG002|Overall Study|Lack of Efficacy|6|||
145481439|NCT00445770|524614849|FG000|Overall Study|Lost to Follow-up|0|||
145481440|NCT00445770|524614850|FG001|Overall Study|Lost to Follow-up|2|||
145481441|NCT00445770|524614851|FG002|Overall Study|Lost to Follow-up|0|||
145481442|NCT00445770|524614849|FG000|Overall Study|Other|6|||
145481443|NCT00445770|524614850|FG001|Overall Study|Other|5|||
145481444|NCT00445770|524614851|FG002|Overall Study|Other|6|||
145481445|NCT00811174|524614853|FG000|Overall Study|Protocol Violation|2|||
145481446|NCT00811174|524614853|FG000|Overall Study|Sponsors Decision|1|||
145481447|NCT00999544|524616383|FG000|Overall Study|Withdrawal by Subject|1|||
145481448|NCT01392547|524616384|FG000|Overall Study|Adverse Event|2|||
145481449|NCT01392547|524616384|FG000|Overall Study|Non-compliance|2|||
145481450|NCT01392547|524616384|FG000|Overall Study|Withdrawal criteria|3|||
145481451|NCT01392547|524616384|FG000|Overall Study|Unclassified|1|||
145481452|NCT02936635|524616385|FG000|Overall Study|Adverse Event|43|||
145481453|NCT02936635|524616386|FG001|Overall Study|Adverse Event|25|||
145481454|NCT02936635|524616385|FG000|Overall Study|Progressive Disease|10|||
145481455|NCT02936635|524616386|FG001|Overall Study|Progressive Disease|18|||
145481456|NCT02936635|524616385|FG000|Overall Study|Sponsor Discretion|10|||
145481457|NCT02936635|524616386|FG001|Overall Study|Sponsor Discretion|16|||
145481458|NCT02936635|524616385|FG000|Overall Study|Death|9|||
145481459|NCT02936635|524616386|FG001|Overall Study|Death|15|||
145481460|NCT02936635|524616385|FG000|Overall Study|Withdrawal by Subject|8|||
145481461|NCT02936635|524616386|FG001|Overall Study|Withdrawal by Subject|15|||
145637486|NCT03516942|525187286|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
145637487|NCT03516942|525187286|FG000|T1: 3 Months Survey|Death|10|||
145637488|NCT03516942|525187286|FG000|T1: 3 Months Survey|Lost|163|||
145637489|NCT03516942|525187286|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
145637490|NCT03516942|525187286|FG000|T2: 6 Month Survey|Death|14|||
145637491|NCT03516942|525187286|FG000|T2: 6 Month Survey|Lost|180|||
145637492|NCT03516942|525187286|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
145637493|NCT03516942|525187286|FG000|T3: 12 Month Survey|Death|19|||
145637494|NCT03516942|525187286|FG000|T3: 12 Month Survey|Lost|209|||
145637495|NCT03215927|525188504|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
145637496|NCT03215927|525188505|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
145637497|NCT03215927|525188504|FG000|Open Label Extension|Adverse Event|1|||
145637498|NCT03215927|525188505|FG001|Open Label Extension|Adverse Event|0|||
145637499|NCT03215927|525188504|FG000|Open Label Extension|Lack of Efficacy|1|||
145637500|NCT03215927|525188505|FG001|Open Label Extension|Lack of Efficacy|0|||
145637501|NCT03215927|525188504|FG000|Open Label Extension|Death|0|||
145637502|NCT03215927|525188505|FG001|Open Label Extension|Death|1|||
145637503|NCT01426269|525188508|FG000|Period 1: 12 Weeks|Adverse Event|5|||
145637504|NCT01426269|525188509|FG001|Period 1: 12 Weeks|Adverse Event|0|||
145637505|NCT01426269|525188510|FG002|Period 1: 12 Weeks|Adverse Event|0|||
145637506|NCT01426269|525188508|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
145637507|NCT01426269|525188509|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
145637508|NCT01426269|525188510|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
145637509|NCT01426269|525188508|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
145637510|NCT01426269|525188509|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
145637511|NCT01426269|525188510|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
145637512|NCT01426269|525188508|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
145637513|NCT01426269|525188509|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
145637514|NCT01426269|525188510|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
145637515|NCT01426269|525188508|FG000|Period 1: 12 Weeks|Pregnancy|1|||
145637516|NCT01426269|525188509|FG001|Period 1: 12 Weeks|Pregnancy|0|||
145637517|NCT01426269|525188510|FG002|Period 1: 12 Weeks|Pregnancy|0|||
145637518|NCT01426269|525188508|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
145637519|NCT01426269|525188509|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
145637520|NCT01426269|525188510|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
145637521|NCT01426269|525188508|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
145637522|NCT01426269|525188509|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
145637523|NCT01426269|525188510|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
145637524|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Adverse Event|0|||
145637525|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Adverse Event|1|||
145637526|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Adverse Event|2|||
145637527|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
145637528|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
145637529|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
145637530|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
145637531|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
145637532|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
145637533|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
145637534|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
145637535|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
145637536|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Site closed|0|||
145637537|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Site closed|6|||
145637538|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Site closed|5|||
145637539|NCT01426269|525188508|FG000|Period 2: 40 Weeks|Relapsed|0|||
145637540|NCT01426269|525188509|FG001|Period 2: 40 Weeks|Relapsed|9|||
145637541|NCT01426269|525188510|FG002|Period 2: 40 Weeks|Relapsed|18|||
145637542|NCT00818454|525188511|FG000|Treatment Period 1|Adverse Event|0|||
145637543|NCT00818454|525188512|FG001|Treatment Period 1|Adverse Event|1|||
145637544|NCT00818454|525188513|FG002|Treatment Period 1|Adverse Event|0|||
145637545|NCT00818454|525188514|FG003|Treatment Period 1|Adverse Event|0|||
145637546|NCT00818454|525188511|FG000|Treatment Period 1|Other|3|||
145637547|NCT00818454|525188512|FG001|Treatment Period 1|Other|0|||
145637548|NCT00818454|525188513|FG002|Treatment Period 1|Other|0|||
145637549|NCT00818454|525188514|FG003|Treatment Period 1|Other|0|||
145637550|NCT00818454|525188511|FG000|Washout Period of 1 Week|Adverse Event|1|||
145637551|NCT00818454|525188512|FG001|Washout Period of 1 Week|Adverse Event|1|||
145637552|NCT00818454|525188513|FG002|Washout Period of 1 Week|Adverse Event|0|||
145637553|NCT00818454|525188514|FG003|Washout Period of 1 Week|Adverse Event|0|||
145637554|NCT00818454|525188511|FG000|Washout Period of 1 Week|Protocol Violation|2|||
145637555|NCT00818454|525188512|FG001|Washout Period of 1 Week|Protocol Violation|0|||
145637556|NCT00818454|525188513|FG002|Washout Period of 1 Week|Protocol Violation|0|||
145637557|NCT00818454|525188514|FG003|Washout Period of 1 Week|Protocol Violation|0|||
145637558|NCT00818454|525188511|FG000|Washout Period of 1 Week|Other|1|||
145637559|NCT00818454|525188512|FG001|Washout Period of 1 Week|Other|2|||
145637560|NCT00818454|525188513|FG002|Washout Period of 1 Week|Other|0|||
145637561|NCT00818454|525188514|FG003|Washout Period of 1 Week|Other|0|||
145637562|NCT00818454|525188511|FG000|Treatment Period 2|Other|2|||
145481462|NCT02936635|524616385|FG000|Overall Study|Physician Decision|2|||
145481463|NCT02936635|524616386|FG001|Overall Study|Physician Decision|9|||
145481464|NCT02936635|524616385|FG000|Overall Study|Lost to Follow-up|1|||
145481465|NCT02936635|524616386|FG001|Overall Study|Lost to Follow-up|2|||
145481466|NCT02936635|524616385|FG000|Overall Study|Protocol Violation|1|||
145481467|NCT02936635|524616386|FG001|Overall Study|Protocol Violation|0|||
145481468|NCT02936635|524616385|FG000|Overall Study|Lack of effect/Entry into other study|31|||
145481469|NCT02936635|524616386|FG001|Overall Study|Lack of effect/Entry into other study|65|||
145481470|NCT02407223|524616387|FG000|Overall Study|Adverse Event|1|||
145481471|NCT02407223|524616388|FG001|Overall Study|Adverse Event|0|||
145481472|NCT02407223|524616389|FG002|Overall Study|Adverse Event|1|||
145481473|NCT02407223|524616387|FG000|Overall Study|Lack of Efficacy|6|||
145481474|NCT02407223|524616388|FG001|Overall Study|Lack of Efficacy|6|||
145481475|NCT02407223|524616389|FG002|Overall Study|Lack of Efficacy|4|||
145481476|NCT02407223|524616387|FG000|Overall Study|Lost to Follow-up|1|||
145481477|NCT02407223|524616388|FG001|Overall Study|Lost to Follow-up|0|||
145481478|NCT02407223|524616389|FG002|Overall Study|Lost to Follow-up|2|||
145481479|NCT02407223|524616387|FG000|Overall Study|Withdrawal by Subject|2|||
145481480|NCT02407223|524616388|FG001|Overall Study|Withdrawal by Subject|4|||
145481481|NCT02407223|524616389|FG002|Overall Study|Withdrawal by Subject|4|||
145481482|NCT02407223|524616387|FG000|Overall Study|Study Terminated by Sponsor|77|||
145481483|NCT02407223|524616388|FG001|Overall Study|Study Terminated by Sponsor|80|||
145481484|NCT02407223|524616389|FG002|Overall Study|Study Terminated by Sponsor|86|||
145637563|NCT00818454|525188512|FG001|Treatment Period 2|Other|1|||
145637564|NCT00818454|525188513|FG002|Treatment Period 2|Other|0|||
145637565|NCT00818454|525188514|FG003|Treatment Period 2|Other|0|||
145637566|NCT00818454|525188511|FG000|Treatment Period 3|Adverse Event|0|||
145637567|NCT00818454|525188512|FG001|Treatment Period 3|Adverse Event|0|||
145637568|NCT00818454|525188513|FG002|Treatment Period 3|Adverse Event|0|||
145637569|NCT00818454|525188514|FG003|Treatment Period 3|Adverse Event|1|||
145637570|NCT01765543|525188522|FG000|Overall Study|Death|1|||
145637571|NCT01765543|525188522|FG000|Overall Study|Withdrawal by Subject|2|||
145637572|NCT03454529|525188523|FG000|Overall Study|Did not receive treatment|6|||
145637573|NCT03454529|525188523|FG000|Overall Study|Received < 80% doses|1|||
145637574|NCT00507689|525188524|FG000|Pre-Randomization Period|Adverse Event|1|||
145637575|NCT00507689|525188525|FG001|Pre-Randomization Period|Adverse Event|0|||
145637576|NCT00507689|525188524|FG000|Pre-Randomization Period|Physician Decision|1|||
145637577|NCT00507689|525188525|FG001|Pre-Randomization Period|Physician Decision|0|||
145637578|NCT00507689|525188524|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
145637579|NCT00507689|525188525|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
145637580|NCT00507689|525188524|FG000|Randomized Period|Adverse Event|1|||
145637581|NCT00507689|525188525|FG001|Randomized Period|Adverse Event|1|||
145637582|NCT00507689|525188524|FG000|Randomized Period|Withdrawal by Subject|0|||
145637583|NCT00507689|525188525|FG001|Randomized Period|Withdrawal by Subject|1|||
145637584|NCT00424762|525188528|FG000|Overall Study|Withdrawal by Subject|18|||
145637585|NCT00424762|525188529|FG001|Overall Study|Withdrawal by Subject|19|||
145637586|NCT00424762|525188528|FG000|Overall Study|Lost to Follow-up|2|||
145637587|NCT00424762|525188529|FG001|Overall Study|Lost to Follow-up|3|||
145637588|NCT00723450|525188530|FG000|Open-Label Phase|Adverse Event|26|||
145637589|NCT00723450|525188531|FG001|Open-Label Phase|Adverse Event|0|||
145637590|NCT00723450|525188532|FG002|Open-Label Phase|Adverse Event|0|||
145637591|NCT00723450|525188530|FG000|Open-Label Phase|Lack of Efficacy|18|||
145637592|NCT00723450|525188531|FG001|Open-Label Phase|Lack of Efficacy|0|||
145637593|NCT00723450|525188532|FG002|Open-Label Phase|Lack of Efficacy|0|||
145637594|NCT00723450|525188530|FG000|Open-Label Phase|Protocol Violation|35|||
145637595|NCT00723450|525188531|FG001|Open-Label Phase|Protocol Violation|0|||
145637596|NCT00723450|525188532|FG002|Open-Label Phase|Protocol Violation|0|||
145637597|NCT00723450|525188530|FG000|Open-Label Phase|Lost to Follow-up|7|||
145637598|NCT00723450|525188531|FG001|Open-Label Phase|Lost to Follow-up|0|||
145637599|NCT00723450|525188532|FG002|Open-Label Phase|Lost to Follow-up|0|||
145637600|NCT00723450|525188530|FG000|Open-Label Phase|Physician Decision|2|||
145637601|NCT00723450|525188531|FG001|Open-Label Phase|Physician Decision|0|||
145637602|NCT00723450|525188532|FG002|Open-Label Phase|Physician Decision|0|||
145637603|NCT00723450|525188530|FG000|Open-Label Phase|Withdrawal by Subject|37|||
145637604|NCT00723450|525188531|FG001|Open-Label Phase|Withdrawal by Subject|0|||
145637605|NCT00723450|525188532|FG002|Open-Label Phase|Withdrawal by Subject|0|||
145637606|NCT00723450|525188530|FG000|Randomized Phase|Adverse Event|0|||
145637607|NCT00723450|525188531|FG001|Randomized Phase|Adverse Event|26|||
145637608|NCT00723450|525188532|FG002|Randomized Phase|Adverse Event|17|||
145637609|NCT00723450|525188530|FG000|Randomized Phase|Lack of Efficacy|0|||
145481485|NCT02407223|524616387|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
145481486|NCT02407223|524616388|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
145481487|NCT02407223|524616389|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
145481488|NCT02407223|524616387|FG000|Overall Study|Other|29|||
145637610|NCT00723450|525188531|FG001|Randomized Phase|Lack of Efficacy|11|||
145637611|NCT00723450|525188532|FG002|Randomized Phase|Lack of Efficacy|11|||
145637612|NCT00723450|525188530|FG000|Randomized Phase|Protocol Violation|0|||
145481489|NCT02407223|524616388|FG001|Overall Study|Other|27|||
145481490|NCT02407223|524616389|FG002|Overall Study|Other|25|||
145481491|NCT00447226|524616390|FG000|12-Week Open-label Phase|Adverse Event|0|||
145481492|NCT00447226|524616391|FG001|12-Week Open-label Phase|Adverse Event|3|||
145637613|NCT00723450|525188531|FG001|Randomized Phase|Protocol Violation|9|||
145637614|NCT00723450|525188532|FG002|Randomized Phase|Protocol Violation|13|||
145637615|NCT00723450|525188530|FG000|Randomized Phase|Lost to Follow-up|0|||
145637616|NCT00723450|525188531|FG001|Randomized Phase|Lost to Follow-up|2|||
145637617|NCT00723450|525188532|FG002|Randomized Phase|Lost to Follow-up|3|||
145637618|NCT00723450|525188530|FG000|Randomized Phase|Physician Decision|0|||
145637619|NCT00723450|525188531|FG001|Randomized Phase|Physician Decision|3|||
145637620|NCT00723450|525188532|FG002|Randomized Phase|Physician Decision|1|||
145637621|NCT00723450|525188530|FG000|Randomized Phase|Withdrawal by Subject|0|||
145637622|NCT00723450|525188531|FG001|Randomized Phase|Withdrawal by Subject|14|||
145637623|NCT00723450|525188532|FG002|Randomized Phase|Withdrawal by Subject|22|||
145637624|NCT01135511|525188533|FG000|Overall Study|Adverse Event|0|||
145637625|NCT01135511|525188534|FG001|Overall Study|Adverse Event|1|||
145637626|NCT01135511|525188535|FG002|Overall Study|Adverse Event|2|||
145637627|NCT01135511|525188536|FG003|Overall Study|Adverse Event|0|||
145637628|NCT01135511|525188537|FG004|Overall Study|Adverse Event|0|||
145637629|NCT01135511|525188538|FG005|Overall Study|Adverse Event|1|||
145637630|NCT01135511|525188539|FG006|Overall Study|Adverse Event|0|||
145637631|NCT01135511|525188540|FG007|Overall Study|Adverse Event|1|||
145637632|NCT01135511|525188541|FG008|Overall Study|Adverse Event|0|||
145637633|NCT01135511|525188533|FG000|Overall Study|Lack of Efficacy|0|||
145637634|NCT01135511|525188534|FG001|Overall Study|Lack of Efficacy|1|||
145637635|NCT01135511|525188535|FG002|Overall Study|Lack of Efficacy|1|||
145637636|NCT01135511|525188536|FG003|Overall Study|Lack of Efficacy|2|||
145637637|NCT01135511|525188537|FG004|Overall Study|Lack of Efficacy|0|||
145637638|NCT01135511|525188538|FG005|Overall Study|Lack of Efficacy|0|||
145637639|NCT01135511|525188539|FG006|Overall Study|Lack of Efficacy|0|||
145637640|NCT01135511|525188540|FG007|Overall Study|Lack of Efficacy|0|||
145637641|NCT01135511|525188541|FG008|Overall Study|Lack of Efficacy|0|||
145637642|NCT01135511|525188533|FG000|Overall Study|Protocol Violation|0|||
145637643|NCT01135511|525188534|FG001|Overall Study|Protocol Violation|0|||
145637644|NCT01135511|525188535|FG002|Overall Study|Protocol Violation|3|||
145637645|NCT01135511|525188536|FG003|Overall Study|Protocol Violation|0|||
145637646|NCT01135511|525188537|FG004|Overall Study|Protocol Violation|0|||
145637647|NCT01135511|525188538|FG005|Overall Study|Protocol Violation|0|||
145637648|NCT01135511|525188539|FG006|Overall Study|Protocol Violation|0|||
145637649|NCT01135511|525188540|FG007|Overall Study|Protocol Violation|0|||
145637650|NCT01135511|525188541|FG008|Overall Study|Protocol Violation|0|||
145637651|NCT01135511|525188533|FG000|Overall Study|Pregnancy|0|||
145637652|NCT01135511|525188534|FG001|Overall Study|Pregnancy|0|||
145637653|NCT01135511|525188535|FG002|Overall Study|Pregnancy|0|||
145637654|NCT01135511|525188536|FG003|Overall Study|Pregnancy|1|||
145637655|NCT01135511|525188537|FG004|Overall Study|Pregnancy|0|||
145637656|NCT01135511|525188538|FG005|Overall Study|Pregnancy|0|||
145637657|NCT01135511|525188539|FG006|Overall Study|Pregnancy|0|||
145637658|NCT01135511|525188540|FG007|Overall Study|Pregnancy|0|||
145637659|NCT01135511|525188541|FG008|Overall Study|Pregnancy|0|||
145637660|NCT01135511|525188533|FG000|Overall Study|could not visit the clinic|0|||
145637661|NCT01135511|525188534|FG001|Overall Study|could not visit the clinic|1|||
145637662|NCT01135511|525188535|FG002|Overall Study|could not visit the clinic|2|||
145637663|NCT01135511|525188536|FG003|Overall Study|could not visit the clinic|0|||
145637664|NCT01135511|525188537|FG004|Overall Study|could not visit the clinic|0|||
145637665|NCT01135511|525188538|FG005|Overall Study|could not visit the clinic|0|||
145637666|NCT01135511|525188539|FG006|Overall Study|could not visit the clinic|0|||
145637667|NCT01135511|525188540|FG007|Overall Study|could not visit the clinic|0|||
145637668|NCT01135511|525188541|FG008|Overall Study|could not visit the clinic|0|||
145637669|NCT01135511|525188533|FG000|Overall Study|noncompliance with study drug taken|0|||
145637670|NCT01135511|525188534|FG001|Overall Study|noncompliance with study drug taken|0|||
145637671|NCT01135511|525188535|FG002|Overall Study|noncompliance with study drug taken|0|||
145637672|NCT01135511|525188536|FG003|Overall Study|noncompliance with study drug taken|0|||
145637673|NCT01135511|525188537|FG004|Overall Study|noncompliance with study drug taken|1|||
145481493|NCT00447226|524616390|FG000|12-Week Open-label Phase|Protocol Violation|0|||
145481494|NCT00447226|524616391|FG001|12-Week Open-label Phase|Protocol Violation|1|||
145637674|NCT01135511|525188538|FG005|Overall Study|noncompliance with study drug taken|0|||
145481495|NCT00447226|524616390|FG000|12-Week Open-label Phase|Disease Progression|0|||
145481496|NCT00447226|524616391|FG001|12-Week Open-label Phase|Disease Progression|20|||
145481497|NCT00447226|524616390|FG000|12-Week Open-label Phase|Physician Decision|0|||
145637675|NCT01135511|525188539|FG006|Overall Study|noncompliance with study drug taken|0|||
145637676|NCT01135511|525188540|FG007|Overall Study|noncompliance with study drug taken|0|||
145637677|NCT01135511|525188541|FG008|Overall Study|noncompliance with study drug taken|0|||
145637678|NCT01135511|525188533|FG000|Overall Study|Withdrawal by Subject|0|||
145637679|NCT01135511|525188534|FG001|Overall Study|Withdrawal by Subject|0|||
145637680|NCT01135511|525188535|FG002|Overall Study|Withdrawal by Subject|0|||
145637681|NCT01135511|525188536|FG003|Overall Study|Withdrawal by Subject|0|||
145637682|NCT01135511|525188537|FG004|Overall Study|Withdrawal by Subject|0|||
145637683|NCT01135511|525188538|FG005|Overall Study|Withdrawal by Subject|0|||
145637684|NCT01135511|525188539|FG006|Overall Study|Withdrawal by Subject|1|||
145637685|NCT01135511|525188540|FG007|Overall Study|Withdrawal by Subject|0|||
145637686|NCT01135511|525188541|FG008|Overall Study|Withdrawal by Subject|1|||
145637687|NCT02880241|525188542|FG000|Overall Study|Lack of Efficacy|1|||
145637688|NCT02880241|525188543|FG001|Overall Study|Lack of Efficacy|0|||
145637689|NCT02880241|525188544|FG002|Overall Study|Lack of Efficacy|0|||
145637690|NCT02880241|525188545|FG003|Overall Study|Lack of Efficacy|0|||
145637691|NCT02880241|525188546|FG004|Overall Study|Lack of Efficacy|0|||
145637692|NCT02880241|525188547|FG005|Overall Study|Lack of Efficacy|0|||
145481498|NCT00447226|524616391|FG001|12-Week Open-label Phase|Physician Decision|1|||
145481499|NCT00447226|524616390|FG000|Double-blind Phase|Disease Progression|4|||
145481500|NCT00447226|524616391|FG001|Double-blind Phase|Disease Progression|3|||
145481501|NCT00584012|524616399|FG000|Overall Study|Withdrawal by Subject|1|||
145481502|NCT04404556|524616400|FG000|Intervention|Withdrawal by Subject|15|||
145481503|NCT04404556|524616401|FG001|Intervention|Withdrawal by Subject|3|||
145481504|NCT04404556|524616400|FG000|Intervention|Did not complete all intervention sessions|2|||
145481505|NCT04404556|524616401|FG001|Intervention|Did not complete all intervention sessions|1|||
145481506|NCT04404556|524616400|FG000|Post-Intervention|Missing Data|1|||
145481507|NCT04404556|524616401|FG001|Post-Intervention|Missing Data|2|||
145481508|NCT04404556|524616400|FG000|Follow-up 1|Withdrawal by Subject|5|||
145481509|NCT04404556|524616401|FG001|Follow-up 1|Withdrawal by Subject|1|||
145481510|NCT04404556|524616400|FG000|Follow-up 1|Missing Data|4|||
145481511|NCT04404556|524616401|FG001|Follow-up 1|Missing Data|7|||
145481512|NCT04404556|524616400|FG000|Follow-up 2|Withdrawal by Subject|1|||
145481513|NCT04404556|524616401|FG001|Follow-up 2|Withdrawal by Subject|1|||
145481514|NCT04404556|524616400|FG000|Follow-up 2|Missing Data|6|||
145481515|NCT04404556|524616401|FG001|Follow-up 2|Missing Data|5|||
145481516|NCT00681629|524616402|FG000|Overall Study|Study termination|4|||
145481517|NCT00681629|524616403|FG001|Overall Study|Study termination|2|||
145481518|NCT00681629|524616402|FG000|Overall Study|Adverse Event|1|||
145481519|NCT00681629|524616403|FG001|Overall Study|Adverse Event|0|||
145637693|NCT00057837|525188548|FG000|Overall Study|Progression/relapse|12|||
145637694|NCT00057837|525188549|FG001|Overall Study|Progression/relapse|14|||
145637695|NCT00057837|525188548|FG000|Overall Study|Adverse Event|2|||
145637696|NCT00057837|525188549|FG001|Overall Study|Adverse Event|12|||
145637697|NCT00057837|525188548|FG000|Overall Study|Death|5|||
145637698|NCT00057837|525188549|FG001|Overall Study|Death|4|||
145637699|NCT00057837|525188548|FG000|Overall Study|Withdrawal by Subject|5|||
145637700|NCT00057837|525188549|FG001|Overall Study|Withdrawal by Subject|3|||
145637701|NCT00057837|525188548|FG000|Overall Study|Alternative therapy|0|||
145637702|NCT00057837|525188549|FG001|Overall Study|Alternative therapy|1|||
145637703|NCT00057837|525188548|FG000|Overall Study|Other complicating disease|2|||
145637704|NCT00057837|525188549|FG001|Overall Study|Other complicating disease|1|||
145637705|NCT00057837|525188548|FG000|Overall Study|Physician Decision|1|||
145637706|NCT00057837|525188549|FG001|Overall Study|Physician Decision|0|||
145637707|NCT00057837|525188548|FG000|Overall Study|Ineligible|3|||
145637708|NCT00057837|525188549|FG001|Overall Study|Ineligible|3|||
145637709|NCT00057837|525188548|FG000|Overall Study|Never started treatment|1|||
145637710|NCT00057837|525188549|FG001|Overall Study|Never started treatment|1|||
145637711|NCT02537522|525188550|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
145637712|NCT02537522|525188551|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
145637713|NCT02537522|525188552|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
145637714|NCT02537522|525188553|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
145637715|NCT02537522|525188550|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
145637716|NCT02537522|525188551|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
145637717|NCT02537522|525188552|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
145481520|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
145481521|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145481522|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145481523|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145637718|NCT02537522|525188553|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
145481524|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145637719|NCT02537522|525188550|FG000|Phase I - Contralateral|incorrect randomization|0|||
145637720|NCT02537522|525188551|FG001|Phase I - Contralateral|incorrect randomization|1|||
145637721|NCT02537522|525188552|FG002|Phase I - Contralateral|incorrect randomization|0|||
145637722|NCT02537522|525188553|FG003|Phase I - Contralateral|incorrect randomization|0|||
145637723|NCT02537522|525188550|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
145481525|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
145481526|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145481527|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145481528|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145481529|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145481530|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
145481531|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145481532|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145481533|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145481534|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145481535|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
145481536|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145481537|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145481538|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145481539|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145481540|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
145481541|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145481542|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145481543|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145481544|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145481545|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
145481546|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145481547|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145481548|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145481549|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145481550|NCT01173601|524616404|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
145481551|NCT01173601|524616405|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145481552|NCT01173601|524616406|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145481553|NCT01173601|524616407|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145481554|NCT01173601|524616408|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145481555|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
145481556|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
145481557|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
145481558|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
145481559|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
145481560|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
145481561|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
145481562|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
145481563|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
145481564|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
145481565|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
145481566|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
145481567|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
145481568|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
145481569|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
145481570|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145481571|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
145481572|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145481573|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
145481574|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
145481575|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
145481576|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
145481577|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145481578|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
145481579|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145481580|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
145481581|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
145481582|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
145481583|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
145481584|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
145604225|NCT05687032|525064707|FG000|Treatment Phase|Adverse Event|13|||
145604226|NCT05687032|525064707|FG000|Treatment Phase|Death|1|||
145604227|NCT05687032|525064707|FG000|Treatment Phase|Physician Decision|3|||
145604228|NCT05687032|525064707|FG000|Treatment Phase|Progressive disease|9|||
145604229|NCT05687032|525064707|FG000|Treatment Phase|Withdrawal by Subject|5|||
145604230|NCT05687032|525064707|FG000|Follow-Up Phase|Death|16|||
145604231|NCT05687032|525064707|FG000|Follow-Up Phase|Ongoing|26|||
145604232|NCT01148862|525064708|FG000|Second Intervention|Withdrawal by Subject|0|||
145604233|NCT01148862|525064709|FG001|Second Intervention|Withdrawal by Subject|2|||
145604234|NCT03056534|525064712|FG000|Overall Study|Participant withdrew consent|8|||
145604235|NCT03056534|525064712|FG000|Overall Study|Participant not able to return|6|||
145604236|NCT03056534|525064712|FG000|Overall Study|Lost to Follow-up|37|||
145481585|NCT01173601|524616404|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145481586|NCT01173601|524616405|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145481587|NCT01173601|524616406|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145481588|NCT01173601|524616407|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
145481589|NCT01173601|524616408|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
145481590|NCT05258149|524616409|FG000|Period 1|Protocol Deviation|1|||
145481591|NCT05258149|524616410|FG001|Period 1|Protocol Deviation|0|||
145481592|NCT05258149|524616409|FG000|Period 1|Adverse Event|0|||
145481593|NCT05258149|524616410|FG001|Period 1|Adverse Event|1|||
145481594|NCT05258149|524616409|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
145481595|NCT05258149|524616410|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
145481596|NCT05258149|524616409|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
145481597|NCT05258149|524616410|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
145481598|NCT05258149|524616409|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
145481599|NCT05258149|524616410|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
145481600|NCT04426318|524616417|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
145481601|NCT04426318|524616418|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
145481602|NCT01290757|524616423|FG000|Overall Study|Adverse Event|1|||
145481603|NCT01290757|524616424|FG001|Overall Study|Adverse Event|0|||
145481604|NCT01290757|524616423|FG000|Overall Study|Protocol Violation|1|||
145481605|NCT01290757|524616424|FG001|Overall Study|Protocol Violation|1|||
145481606|NCT01290757|524616423|FG000|Overall Study|Other|0|||
145481607|NCT01290757|524616424|FG001|Overall Study|Other|1|||
145481608|NCT01397461|524616427|FG000|Overall Study|Withdrawal by Subject|2|||
145481609|NCT01397461|524616428|FG001|Overall Study|Withdrawal by Subject|1|||
145481610|NCT01397461|524616429|FG002|Overall Study|Withdrawal by Subject|0|||
145481611|NCT01397461|524616427|FG000|Overall Study|Lost to Follow-up|0|||
145481612|NCT01397461|524616428|FG001|Overall Study|Lost to Follow-up|2|||
145481613|NCT01397461|524616429|FG002|Overall Study|Lost to Follow-up|1|||
145481614|NCT01397461|524616427|FG000|Overall Study|Lack of Efficacy|0|||
145481615|NCT01397461|524616428|FG001|Overall Study|Lack of Efficacy|3|||
145481616|NCT01397461|524616429|FG002|Overall Study|Lack of Efficacy|0|||
145481617|NCT01397461|524616427|FG000|Overall Study|Not treated|0|||
145481618|NCT01397461|524616428|FG001|Overall Study|Not treated|0|||
145481619|NCT01397461|524616429|FG002|Overall Study|Not treated|1|||
145481620|NCT05729568|524616430|FG000|Overall Study|Still on Study|52|||
145481621|NCT05729568|524616431|FG001|Overall Study|Still on Study|26|||
145604237|NCT03056534|525064712|FG000|Overall Study|Investigator judgment|1|||
145604238|NCT03056534|525064712|FG000|Overall Study|Death|4|||
145604239|NCT03056534|525064712|FG000|Overall Study|Adverse Event|1|||
145604240|NCT03056534|525064712|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
145604241|NCT02675465|525064713|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
145604242|NCT02675465|525064714|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
145604243|NCT02675465|525064715|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
145604244|NCT02675465|525064716|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
145604245|NCT02675465|525064717|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
145604246|NCT02675465|525064718|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
145604247|NCT02675465|525064713|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
145604248|NCT02675465|525064714|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
145604249|NCT02675465|525064715|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
145604250|NCT02675465|525064716|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
145604251|NCT02675465|525064717|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
145604252|NCT02675465|525064718|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
145604253|NCT02675465|525064713|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
145604254|NCT02675465|525064714|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
145604255|NCT02675465|525064715|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
145604256|NCT02675465|525064716|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
145604257|NCT02675465|525064717|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
145604258|NCT02675465|525064718|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
145604259|NCT02675465|525064713|FG000|Stage 4: Long Term Extension|Death|0|||
145604260|NCT02675465|525064714|FG001|Stage 4: Long Term Extension|Death|0|||
145604261|NCT02675465|525064715|FG002|Stage 4: Long Term Extension|Death|0|||
145604262|NCT02675465|525064716|FG003|Stage 4: Long Term Extension|Death|1|||
145604263|NCT02675465|525064717|FG004|Stage 4: Long Term Extension|Death|0|||
145604264|NCT02675465|525064718|FG005|Stage 4: Long Term Extension|Death|0|||
145604265|NCT05031078|525064719|FG000|Overall Study|Withdrawal by Subject|0|||
145481622|NCT05729568|524616430|FG000|Overall Study|Randomized but Never Treated|3|||
145481623|NCT05729568|524616431|FG001|Overall Study|Randomized but Never Treated|0|||
145481624|NCT05729568|524616430|FG000|Overall Study|Adverse Event|0|||
145481625|NCT05729568|524616431|FG001|Overall Study|Adverse Event|1|||
145481626|NCT05729568|524616430|FG000|Overall Study|Investigator's Discretion|1|||
145481627|NCT05729568|524616431|FG001|Overall Study|Investigator's Discretion|0|||
145481628|NCT04181762|524616432|FG000|Overall Study|Adverse Event|1|||
145481629|NCT04181762|524616433|FG001|Overall Study|Adverse Event|3|||
145481630|NCT04181762|524616432|FG000|Overall Study|Lost to Follow-up|1|||
145481631|NCT04181762|524616433|FG001|Overall Study|Lost to Follow-up|1|||
145481632|NCT04181762|524616432|FG000|Overall Study|Physician Decision|1|||
145637724|NCT02537522|525188551|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
145637725|NCT02537522|525188552|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
145637726|NCT02537522|525188553|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
145637727|NCT02537522|525188550|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
145637728|NCT02537522|525188551|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
145637729|NCT02537522|525188552|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
145637730|NCT02537522|525188553|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
145637731|NCT02570711|525188557|FG000|Overall Study|Death|1|||
145637732|NCT02570711|525188558|FG001|Overall Study|Death|0|||
145637733|NCT02570711|525188557|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
145637734|NCT02570711|525188558|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
145637735|NCT05001945|525188559|FG000|Overall Study|Adverse Event|0|||
145637736|NCT05001945|525188560|FG001|Overall Study|Adverse Event|0|||
145637737|NCT05001945|525188561|FG002|Overall Study|Adverse Event|0|||
145637738|NCT05001945|525188562|FG003|Overall Study|Adverse Event|1|||
145637739|NCT05001945|525188563|FG004|Overall Study|Adverse Event|0|||
145637740|NCT05001945|525188564|FG005|Overall Study|Adverse Event|0|||
145637741|NCT05001945|525188565|FG006|Overall Study|Adverse Event|0|||
145637742|NCT05001945|525188566|FG007|Overall Study|Adverse Event|0|||
145637743|NCT05001945|525188559|FG000|Overall Study|Lost to Follow-up|0|||
145637744|NCT05001945|525188560|FG001|Overall Study|Lost to Follow-up|1|||
145637745|NCT05001945|525188561|FG002|Overall Study|Lost to Follow-up|1|||
145637746|NCT05001945|525188562|FG003|Overall Study|Lost to Follow-up|2|||
145637747|NCT05001945|525188563|FG004|Overall Study|Lost to Follow-up|0|||
145637748|NCT05001945|525188564|FG005|Overall Study|Lost to Follow-up|1|||
145637749|NCT05001945|525188565|FG006|Overall Study|Lost to Follow-up|0|||
145637750|NCT05001945|525188566|FG007|Overall Study|Lost to Follow-up|0|||
145637751|NCT05001945|525188559|FG000|Overall Study|Protocol Violation|1|||
145637752|NCT05001945|525188560|FG001|Overall Study|Protocol Violation|0|||
145637753|NCT05001945|525188561|FG002|Overall Study|Protocol Violation|1|||
145637754|NCT05001945|525188562|FG003|Overall Study|Protocol Violation|1|||
145637755|NCT05001945|525188563|FG004|Overall Study|Protocol Violation|0|||
145637756|NCT05001945|525188564|FG005|Overall Study|Protocol Violation|1|||
145637757|NCT05001945|525188565|FG006|Overall Study|Protocol Violation|0|||
145637758|NCT05001945|525188566|FG007|Overall Study|Protocol Violation|0|||
145637759|NCT05001945|525188559|FG000|Overall Study|Withdrawal by Subject|0|||
145637760|NCT05001945|525188560|FG001|Overall Study|Withdrawal by Subject|0|||
145637761|NCT05001945|525188561|FG002|Overall Study|Withdrawal by Subject|0|||
145637762|NCT05001945|525188562|FG003|Overall Study|Withdrawal by Subject|1|||
145637763|NCT05001945|525188563|FG004|Overall Study|Withdrawal by Subject|1|||
145637764|NCT05001945|525188564|FG005|Overall Study|Withdrawal by Subject|1|||
145637765|NCT05001945|525188565|FG006|Overall Study|Withdrawal by Subject|0|||
145637766|NCT05001945|525188566|FG007|Overall Study|Withdrawal by Subject|1|||
145637767|NCT05001945|525188559|FG000|Overall Study|Not specified by Investigator|0|||
145637768|NCT05001945|525188560|FG001|Overall Study|Not specified by Investigator|3|||
145637769|NCT05001945|525188561|FG002|Overall Study|Not specified by Investigator|0|||
145637770|NCT05001945|525188562|FG003|Overall Study|Not specified by Investigator|0|||
145637771|NCT05001945|525188563|FG004|Overall Study|Not specified by Investigator|1|||
145637772|NCT05001945|525188564|FG005|Overall Study|Not specified by Investigator|0|||
145637773|NCT05001945|525188565|FG006|Overall Study|Not specified by Investigator|0|||
145637774|NCT05001945|525188566|FG007|Overall Study|Not specified by Investigator|0|||
145637775|NCT00585533|525188567|FG000|Overall Study|objective or symptomatic progression|9|||
145637776|NCT00545077|525188568|FG000|Overall Study|Treatment not received|5|||
145637777|NCT00545077|525188569|FG001|Overall Study|Treatment not received|1|||
145637778|NCT00545077|525188568|FG000|Overall Study|Disease Progression|131|||
145637779|NCT00545077|525188569|FG001|Overall Study|Disease Progression|98|||
145637780|NCT00545077|525188568|FG000|Overall Study|Withdrawal by Subject|3|||
145637781|NCT00545077|525188569|FG001|Overall Study|Withdrawal by Subject|14|||
145637782|NCT00545077|525188568|FG000|Overall Study|Physician Decision|6|||
145481633|NCT04181762|524616433|FG001|Overall Study|Physician Decision|3|||
145481634|NCT04181762|524616432|FG000|Overall Study|Pregnancy|0|||
145481635|NCT04181762|524616433|FG001|Overall Study|Pregnancy|1|||
145481636|NCT04181762|524616432|FG000|Overall Study|Lack of Efficacy|2|||
145637783|NCT00545077|525188569|FG001|Overall Study|Physician Decision|3|||
145637784|NCT00545077|525188568|FG000|Overall Study|Lost to Follow-up|2|||
145637785|NCT00545077|525188569|FG001|Overall Study|Lost to Follow-up|0|||
145637786|NCT00545077|525188568|FG000|Overall Study|Protocol Violation|1|||
145637787|NCT00545077|525188569|FG001|Overall Study|Protocol Violation|0|||
145637788|NCT00545077|525188568|FG000|Overall Study|Adverse Event|0|||
145637789|NCT00545077|525188569|FG001|Overall Study|Adverse Event|31|||
145481637|NCT04181762|524616433|FG001|Overall Study|Lack of Efficacy|2|||
145637790|NCT00545077|525188568|FG000|Overall Study|Death|0|||
145481638|NCT04181762|524616432|FG000|Overall Study|Study terminated by sponsor|95|||
145637791|NCT00545077|525188569|FG001|Overall Study|Death|8|||
145481639|NCT04181762|524616433|FG001|Overall Study|Study terminated by sponsor|97|||
145481640|NCT04181762|524616432|FG000|Overall Study|Subject decision|11|||
145481641|NCT04181762|524616433|FG001|Overall Study|Subject decision|4|||
145481642|NCT04181762|524616432|FG000|Overall Study|Death|1|||
145481643|NCT04181762|524616433|FG001|Overall Study|Death|1|||
145481644|NCT04181762|524616432|FG000|Overall Study|Protocol deviation|1|||
145481645|NCT04181762|524616433|FG001|Overall Study|Protocol deviation|0|||
145481646|NCT04181762|524616432|FG000|Overall Study|Withdrawal of informed consent|1|||
145481647|NCT04181762|524616433|FG001|Overall Study|Withdrawal of informed consent|3|||
145481648|NCT06041919|524616434|FG000|Overall Study|Lost to Follow-up|1|||
145481649|NCT06041919|524616435|FG001|Overall Study|Lost to Follow-up|0|||
145481650|NCT06041919|524616436|FG002|Overall Study|Lost to Follow-up|0|||
145481651|NCT06041919|524616437|FG003|Overall Study|Lost to Follow-up|0|||
145481652|NCT06041919|524616438|FG004|Overall Study|Lost to Follow-up|0|||
145481653|NCT06041919|524616434|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
145637792|NCT03260140|525188570|FG000|Overall Study|Death|4|||
145637793|NCT03260140|525188571|FG001|Overall Study|Death|1|||
145637794|NCT03260140|525188570|FG000|Overall Study|Withdrawal by Subject|1|||
145637795|NCT03260140|525188571|FG001|Overall Study|Withdrawal by Subject|4|||
145637796|NCT05283395|525188574|FG000|Overall Study|Adverse Event|4|||
145481654|NCT06041919|524616435|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
145481655|NCT06041919|524616436|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
145481656|NCT06041919|524616437|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
145481657|NCT06041919|524616438|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
145481658|NCT04526145|524616439|FG000|Overall Study|Withdrawal by Subject|5|||
145481659|NCT01514201|524616452|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
145481660|NCT01514201|524616453|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481661|NCT01514201|524616454|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481662|NCT01514201|524616455|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481663|NCT01514201|524616452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
145481664|NCT01514201|524616453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
145637797|NCT05283395|525188575|FG001|Overall Study|Adverse Event|4|||
145637798|NCT05283395|525188576|FG002|Overall Study|Adverse Event|0|||
145637799|NCT05283395|525188574|FG000|Overall Study|Patient Lost to Follow-Up|0|||
145637800|NCT05283395|525188575|FG001|Overall Study|Patient Lost to Follow-Up|0|||
145637801|NCT05283395|525188576|FG002|Overall Study|Patient Lost to Follow-Up|1|||
145637802|NCT05283395|525188574|FG000|Overall Study|Patient Withdrawal|2|||
145637803|NCT05283395|525188575|FG001|Overall Study|Patient Withdrawal|4|||
145637804|NCT05283395|525188576|FG002|Overall Study|Patient Withdrawal|2|||
145637805|NCT05283395|525188574|FG000|Overall Study|Investigator Decision|1|||
145637806|NCT05283395|525188575|FG001|Overall Study|Investigator Decision|0|||
145637807|NCT05283395|525188576|FG002|Overall Study|Investigator Decision|1|||
145637808|NCT05283395|525188574|FG000|Overall Study|Enrolled in error|0|||
145637809|NCT05283395|525188575|FG001|Overall Study|Enrolled in error|0|||
145637810|NCT05283395|525188576|FG002|Overall Study|Enrolled in error|1|||
145637811|NCT01063972|525188577|FG000|Overall Study|Death|12|||
145637812|NCT01063972|525188578|FG001|Overall Study|Death|11|||
145637813|NCT01063972|525188577|FG000|Overall Study|Incarcerated|2|||
145637814|NCT01063972|525188578|FG001|Overall Study|Incarcerated|1|||
145637815|NCT00712335|525188579|FG000|Overall Study|Withdrawal by Subject|0|||
145637816|NCT00712335|525188580|FG001|Overall Study|Withdrawal by Subject|7|||
145637817|NCT00712335|525188581|FG002|Overall Study|Withdrawal by Subject|2|||
145637818|NCT00712335|525188582|FG003|Overall Study|Withdrawal by Subject|3|||
145637819|NCT00712335|525188583|FG004|Overall Study|Withdrawal by Subject|0|||
145637820|NCT00712335|525188579|FG000|Overall Study|Lost to Follow-up|2|||
145637821|NCT00712335|525188580|FG001|Overall Study|Lost to Follow-up|5|||
145637822|NCT00712335|525188581|FG002|Overall Study|Lost to Follow-up|0|||
145637823|NCT00712335|525188582|FG003|Overall Study|Lost to Follow-up|1|||
145637824|NCT00712335|525188583|FG004|Overall Study|Lost to Follow-up|0|||
145637825|NCT00712335|525188579|FG000|Overall Study|Protocol Violation|1|||
145637826|NCT00712335|525188580|FG001|Overall Study|Protocol Violation|2|||
145637827|NCT00712335|525188581|FG002|Overall Study|Protocol Violation|1|||
145637828|NCT00712335|525188582|FG003|Overall Study|Protocol Violation|0|||
145481665|NCT01514201|524616454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
145481666|NCT01514201|524616455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
145481667|NCT01514201|524616452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
145481668|NCT01514201|524616453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
145637829|NCT00712335|525188583|FG004|Overall Study|Protocol Violation|0|||
145637830|NCT00712335|525188579|FG000|Overall Study|Lack of Efficacy|0|||
145637831|NCT00712335|525188580|FG001|Overall Study|Lack of Efficacy|0|||
145637832|NCT00712335|525188581|FG002|Overall Study|Lack of Efficacy|1|||
145637833|NCT00712335|525188582|FG003|Overall Study|Lack of Efficacy|1|||
145637834|NCT00712335|525188583|FG004|Overall Study|Lack of Efficacy|0|||
145637835|NCT00712335|525188579|FG000|Overall Study|Other Reason|0|||
145637836|NCT00712335|525188580|FG001|Overall Study|Other Reason|3|||
145637837|NCT00712335|525188581|FG002|Overall Study|Other Reason|1|||
145481669|NCT01514201|524616454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
145481670|NCT01514201|524616455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
145481671|NCT01514201|524616452|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
145481672|NCT01514201|524616453|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
145481673|NCT01514201|524616454|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
145481674|NCT01514201|524616455|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
145481675|NCT01514201|524616452|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
145481676|NCT01514201|524616453|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
145481677|NCT01514201|524616454|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
145481678|NCT01514201|524616455|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
145481679|NCT01514201|524616452|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
145481680|NCT01514201|524616453|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
145481681|NCT01514201|524616454|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
145481682|NCT01514201|524616455|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
145481683|NCT01514201|524616452|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
145481684|NCT01514201|524616453|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
145481685|NCT01514201|524616454|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
145481686|NCT01514201|524616455|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
145481687|NCT01514201|524616452|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481688|NCT01514201|524616453|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481689|NCT01514201|524616454|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
145481690|NCT01514201|524616455|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
145481691|NCT01514201|524616452|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
145481692|NCT01514201|524616453|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
145481693|NCT01514201|524616454|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
145481694|NCT01514201|524616455|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
145481695|NCT01514201|524616452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
145481696|NCT01514201|524616453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
145481697|NCT01514201|524616454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
145481698|NCT01514201|524616455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
145481699|NCT01514201|524616452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
145481700|NCT01514201|524616453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
145481701|NCT01514201|524616454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
145481702|NCT01514201|524616455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
145481703|NCT01514201|524616452|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
145481704|NCT01514201|524616453|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
145481705|NCT01514201|524616454|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
145481706|NCT01514201|524616455|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
145481707|NCT05888181|524616457|FG000|Overall Study|Lost to Follow-up|1|||
145481708|NCT05888181|524616458|FG001|Overall Study|Lost to Follow-up|1|||
145481709|NCT05888181|524616459|FG002|Overall Study|Lost to Follow-up|0|||
145481710|NCT00637416|524616461|FG000|Overall Study|Lost to Follow-up|1|||
145481711|NCT00637416|524616462|FG001|Overall Study|Lost to Follow-up|1|||
145481712|NCT00637416|524616461|FG000|Overall Study|Unable to take study drug|0|||
145481713|NCT00637416|524616462|FG001|Overall Study|Unable to take study drug|1|||
145481714|NCT02534909|524616473|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
145481715|NCT01625000|524616474|FG000|Overall Study|Physician Decision|15|||
145481716|NCT01625000|524616475|FG001|Overall Study|Physician Decision|7|||
145604266|NCT05031078|525064720|FG001|Overall Study|Withdrawal by Subject|1|||
145604267|NCT05031078|525064721|FG002|Overall Study|Withdrawal by Subject|0|||
145604268|NCT01784068|525064722|FG000|NTCS Phase|Adverse Event|5|||
145604269|NCT01784068|525064723|FG001|NTCS Phase|Adverse Event|0|||
145604270|NCT01784068|525064722|FG000|NTCS Phase|Physician Decision|2|||
145604271|NCT01784068|525064723|FG001|NTCS Phase|Physician Decision|0|||
145604272|NCT01784068|525064722|FG000|NTCS Phase|Patient/guardian decision|3|||
145604273|NCT01784068|525064723|FG001|NTCS Phase|Patient/guardian decision|0|||
145604274|NCT01784068|525064722|FG000|NTCS Phase|Death|2|||
145604275|NCT01784068|525064723|FG001|NTCS Phase|Death|0|||
145604276|NCT01784068|525064722|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
145604277|NCT01784068|525064723|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
145604278|NCT01784068|525064722|FG000|TFR Phase|Physician Decision|0|||
145604279|NCT01784068|525064723|FG001|TFR Phase|Physician Decision|1|||
145604280|NCT01784068|525064722|FG000|TFR Phase|Patient/guardian decision|0|||
145604281|NCT01784068|525064723|FG001|TFR Phase|Patient/guardian decision|3|||
145604282|NCT01784068|525064722|FG000|TFR Phase|Death|0|||
145604283|NCT01784068|525064723|FG001|TFR Phase|Death|1|||
145604284|NCT01784068|525064722|FG000|TFR Phase|Lack of Efficacy|0|||
145481717|NCT01625000|524616476|FG002|Overall Study|Physician Decision|7|||
145481718|NCT01625000|524616477|FG003|Overall Study|Physician Decision|2|||
145481719|NCT01625000|524616478|FG004|Overall Study|Physician Decision|15|||
145481720|NCT01625000|524616474|FG000|Overall Study|Protocol Violation|3|||
145481721|NCT01625000|524616475|FG001|Overall Study|Protocol Violation|10|||
145481722|NCT01625000|524616476|FG002|Overall Study|Protocol Violation|4|||
145481723|NCT01625000|524616477|FG003|Overall Study|Protocol Violation|1|||
145481724|NCT01625000|524616478|FG004|Overall Study|Protocol Violation|2|||
145481725|NCT01625000|524616474|FG000|Overall Study|Withdrawal by Subject|19|||
145481726|NCT01625000|524616475|FG001|Overall Study|Withdrawal by Subject|16|||
145481727|NCT01625000|524616476|FG002|Overall Study|Withdrawal by Subject|11|||
145481728|NCT01625000|524616477|FG003|Overall Study|Withdrawal by Subject|9|||
145481729|NCT01625000|524616478|FG004|Overall Study|Withdrawal by Subject|17|||
145481730|NCT01625000|524616474|FG000|Overall Study|Adverse Event (including Death)|15|||
145481731|NCT01625000|524616475|FG001|Overall Study|Adverse Event (including Death)|19|||
145481732|NCT01625000|524616476|FG002|Overall Study|Adverse Event (including Death)|11|||
145481733|NCT01625000|524616477|FG003|Overall Study|Adverse Event (including Death)|7|||
145481734|NCT01625000|524616478|FG004|Overall Study|Adverse Event (including Death)|21|||
145481735|NCT00566852|524616479|FG000|Overall Study|Protocol Violation|22|||
145481736|NCT00566852|524616480|FG001|Overall Study|Protocol Violation|24|||
145481737|NCT00566852|524616479|FG000|Overall Study|Death|95|||
145481738|NCT00566852|524616480|FG001|Overall Study|Death|78|||
145481739|NCT00566852|524616479|FG000|Overall Study|Withdrawal by Subject|30|||
145481740|NCT00566852|524616480|FG001|Overall Study|Withdrawal by Subject|25|||
145481741|NCT00566852|524616479|FG000|Overall Study|Patient refusal|37|||
145481742|NCT00566852|524616480|FG001|Overall Study|Patient refusal|37|||
145481743|NCT00566852|524616479|FG000|Overall Study|Not tested due to disability|6|||
145481744|NCT00566852|524616480|FG001|Overall Study|Not tested due to disability|12|||
145481745|NCT00566852|524616479|FG000|Overall Study|Missing reason not specified|1|||
145481746|NCT00566852|524616480|FG001|Overall Study|Missing reason not specified|2|||
145481747|NCT00566852|524616479|FG000|Overall Study|Missing reason not reported|16|||
145481748|NCT00566852|524616480|FG001|Overall Study|Missing reason not reported|20|||
145481749|NCT01147055|524616481|FG000|First Intervention Period|Lost to Follow-up|1|||
145481750|NCT01147055|524616482|FG001|First Intervention Period|Lost to Follow-up|0|||
145481751|NCT00132808|524616483|FG000|Stratum I|Adverse Event|2|||
145481752|NCT00132808|524616484|FG001|Stratum I|Adverse Event|1|||
145481753|NCT00132808|524616485|FG002|Stratum I|Adverse Event|0|||
145481754|NCT00132808|524616483|FG000|Stratum I|Lost to Follow-up|3|||
145481755|NCT00132808|524616484|FG001|Stratum I|Lost to Follow-up|4|||
145481756|NCT00132808|524616485|FG002|Stratum I|Lost to Follow-up|1|||
145481757|NCT00132808|524616483|FG000|Stratum I|Withdrawal by Subject|4|||
145481758|NCT00132808|524616484|FG001|Stratum I|Withdrawal by Subject|7|||
145481759|NCT00132808|524616485|FG002|Stratum I|Withdrawal by Subject|3|||
145481760|NCT00132808|524616483|FG000|Stratum I|Abnormal test procedure result (s)|0|||
145481761|NCT00132808|524616484|FG001|Stratum I|Abnormal test procedure result (s)|0|||
145481762|NCT00132808|524616485|FG002|Stratum I|Abnormal test procedure result (s)|1|||
145481763|NCT00132808|524616483|FG000|Stratum II|Adverse Event|1|||
145481764|NCT00132808|524616484|FG001|Stratum II|Adverse Event|2|||
145481765|NCT00132808|524616485|FG002|Stratum II|Adverse Event|1|||
145481766|NCT00132808|524616483|FG000|Stratum II|Death|1|||
145481767|NCT00132808|524616484|FG001|Stratum II|Death|0|||
145481768|NCT00132808|524616485|FG002|Stratum II|Death|0|||
145481769|NCT00132808|524616483|FG000|Stratum II|Lost to Follow-up|2|||
145481770|NCT00132808|524616484|FG001|Stratum II|Lost to Follow-up|2|||
145481771|NCT00132808|524616485|FG002|Stratum II|Lost to Follow-up|1|||
145481772|NCT00132808|524616483|FG000|Stratum II|Protocol Violation|0|||
145481773|NCT00132808|524616484|FG001|Stratum II|Protocol Violation|2|||
145481774|NCT00132808|524616485|FG002|Stratum II|Protocol Violation|1|||
145481775|NCT00132808|524616483|FG000|Stratum II|Withdrawal by Subject|4|||
145481776|NCT00132808|524616484|FG001|Stratum II|Withdrawal by Subject|9|||
145481777|NCT00132808|524616485|FG002|Stratum II|Withdrawal by Subject|6|||
145481778|NCT04137731|524616488|FG000|Overall Study|Surgery Cancellation|1|||
145481779|NCT04137731|524616489|FG001|Overall Study|Surgery Cancellation|2|||
145481780|NCT04137731|524616488|FG000|Overall Study|Withdrawal by Subject|2|||
145481781|NCT04137731|524616489|FG001|Overall Study|Withdrawal by Subject|0|||
145481782|NCT04137731|524616488|FG000|Overall Study|Protocol Violation|0|||
145481783|NCT04137731|524616489|FG001|Overall Study|Protocol Violation|1|||
145604285|NCT01784068|525064723|FG001|TFR Phase|Lack of Efficacy|88|||
145481784|NCT00362648|524616490|FG000|Overall Study|Adverse Event|12|||
145481785|NCT00362648|524616491|FG001|Overall Study|Adverse Event|21|||
145481786|NCT00362648|524616492|FG002|Overall Study|Adverse Event|1|||
145481787|NCT00362648|524616493|FG003|Overall Study|Adverse Event|0|||
145481788|NCT00362648|524616490|FG000|Overall Study|Lost to Follow-up|62|||
145481789|NCT00362648|524616491|FG001|Overall Study|Lost to Follow-up|69|||
145481790|NCT00362648|524616492|FG002|Overall Study|Lost to Follow-up|4|||
145481791|NCT00362648|524616493|FG003|Overall Study|Lost to Follow-up|3|||
145481792|NCT00362648|524616490|FG000|Overall Study|Protocol Violation|4|||
145481793|NCT00362648|524616491|FG001|Overall Study|Protocol Violation|2|||
145481794|NCT00362648|524616492|FG002|Overall Study|Protocol Violation|2|||
145481795|NCT00362648|524616493|FG003|Overall Study|Protocol Violation|2|||
145481796|NCT00362648|524616490|FG000|Overall Study|Withdrawal by Subject|48|||
145481797|NCT00362648|524616491|FG001|Overall Study|Withdrawal by Subject|42|||
145481798|NCT00362648|524616492|FG002|Overall Study|Withdrawal by Subject|2|||
145481799|NCT00362648|524616493|FG003|Overall Study|Withdrawal by Subject|6|||
145481800|NCT02204072|524616494|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
145481801|NCT02204072|524616495|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
145481802|NCT02204072|524616496|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
145481803|NCT02204072|524616497|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
145481804|NCT02204072|524616498|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
145481805|NCT02204072|524616494|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
145481806|NCT02204072|524616495|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
145481807|NCT02204072|524616496|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
145481808|NCT02204072|524616497|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
145481809|NCT02204072|524616498|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
145481810|NCT02204072|524616494|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
145481811|NCT02204072|524616495|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
145481812|NCT02204072|524616496|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
145481813|NCT02204072|524616497|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
145481814|NCT02204072|524616498|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
145481815|NCT02204072|524616494|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
145481816|NCT02204072|524616495|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
145481817|NCT02204072|524616496|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
145481818|NCT02204072|524616497|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
145481819|NCT02204072|524616498|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
145481820|NCT03983304|524616499|FG000|Overall Study|Withdrawal by Subject|5|||
145481821|NCT03983304|524616499|FG000|Overall Study|Lost to Follow-up|2|||
145481822|NCT01587040|524616505|FG000|Overall Study|Protocol Violation|0|||
145481823|NCT01587040|524616506|FG001|Overall Study|Protocol Violation|0|||
145481824|NCT01587040|524616507|FG002|Overall Study|Protocol Violation|1|||
145481825|NCT01587040|524616508|FG003|Overall Study|Protocol Violation|0|||
145481826|NCT01587040|524616505|FG000|Overall Study|Adverse Event|0|||
145481827|NCT01587040|524616506|FG001|Overall Study|Adverse Event|1|||
145481828|NCT01587040|524616507|FG002|Overall Study|Adverse Event|10|||
145481829|NCT01587040|524616508|FG003|Overall Study|Adverse Event|0|||
145481830|NCT01587040|524616505|FG000|Overall Study|Disease progression|12|||
145481831|NCT01587040|524616506|FG001|Overall Study|Disease progression|1|||
145481832|NCT01587040|524616507|FG002|Overall Study|Disease progression|15|||
145481833|NCT01587040|524616508|FG003|Overall Study|Disease progression|3|||
145481834|NCT01587040|524616505|FG000|Overall Study|Other than specified|5|||
145481835|NCT01587040|524616506|FG001|Overall Study|Other than specified|1|||
145481836|NCT01587040|524616507|FG002|Overall Study|Other than specified|11|||
145481837|NCT01587040|524616508|FG003|Overall Study|Other than specified|1|||
145481838|NCT04300309|524616511|FG000|Overall Study|Lost to Follow-up|1|||
145481839|NCT04300309|524616512|FG001|Overall Study|Lost to Follow-up|0|||
145481840|NCT04346654|524616514|FG000|Overall Study|Adverse Event|2|||
145481841|NCT04346654|524616515|FG001|Overall Study|Adverse Event|0|||
145481842|NCT04346654|524616514|FG000|Overall Study|Non-response|1|||
145481843|NCT04346654|524616515|FG001|Overall Study|Non-response|1|||
145481844|NCT04346654|524616514|FG000|Overall Study|Withdrawal by Subject|2|||
145481845|NCT04346654|524616515|FG001|Overall Study|Withdrawal by Subject|0|||
145481846|NCT04346654|524616514|FG000|Overall Study|Lost to Follow-up|0|||
145481847|NCT04346654|524616515|FG001|Overall Study|Lost to Follow-up|1|||
145481848|NCT04346654|524616514|FG000|Overall Study|Pregnancy|0|||
145481849|NCT04346654|524616515|FG001|Overall Study|Pregnancy|1|||
145481850|NCT04209205|524616518|FG000|Overall Study|Adverse Event|2|||
145481851|NCT04209205|524616519|FG001|Overall Study|Adverse Event|3|||
145481852|NCT04209205|524616518|FG000|Overall Study|Lost to Follow-up|3|||
145481853|NCT04209205|524616519|FG001|Overall Study|Lost to Follow-up|1|||
145481854|NCT04209205|524616518|FG000|Overall Study|Physician Decision|1|||
145481855|NCT04209205|524616519|FG001|Overall Study|Physician Decision|1|||
145481856|NCT04209205|524616518|FG000|Overall Study|Subject decision|10|||
145481857|NCT04209205|524616519|FG001|Overall Study|Subject decision|10|||
145481858|NCT04209205|524616518|FG000|Overall Study|Progressive disease|1|||
145604286|NCT03759834|525064724|FG000|Overall Study|Withdrawal by Subject|1|||
145604287|NCT00633464|525064733|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
145481859|NCT04209205|524616519|FG001|Overall Study|Progressive disease|0|||
145481860|NCT04209205|524616518|FG000|Overall Study|Protocol deviation|0|||
145481861|NCT04209205|524616519|FG001|Overall Study|Protocol deviation|1|||
145481862|NCT04209205|524616518|FG000|Overall Study|New therapy for study indication|1|||
145481863|NCT04209205|524616519|FG001|Overall Study|New therapy for study indication|0|||
145481864|NCT04209205|524616518|FG000|Overall Study|Adverse event - placebo not switched|0|||
145481865|NCT04209205|524616519|FG001|Overall Study|Adverse event - placebo not switched|1|||
145481866|NCT04209205|524616518|FG000|Overall Study|Subject decision - placebo not switched|0|||
145604288|NCT00633464|525064734|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
145481867|NCT04209205|524616519|FG001|Overall Study|Subject decision - placebo not switched|5|||
145481868|NCT04209205|524616518|FG000|Overall Study|Death - placebo not switched|0|||
145481869|NCT04209205|524616519|FG001|Overall Study|Death - placebo not switched|1|||
145481870|NCT03828019|524616524|FG000|Overall Study|Withdrawal by Subject|3|||
145481871|NCT03828019|524616525|FG001|Overall Study|Withdrawal by Subject|8|||
145481872|NCT03828019|524616524|FG000|Overall Study|Lost to Follow-up|1|||
145481873|NCT03828019|524616525|FG001|Overall Study|Lost to Follow-up|6|||
145481874|NCT03828019|524616524|FG000|Overall Study|Incarcerated|1|||
145481875|NCT03828019|524616525|FG001|Overall Study|Incarcerated|0|||
145481876|NCT03828019|524616524|FG000|Overall Study|Adverse Event|0|||
145481877|NCT03828019|524616525|FG001|Overall Study|Adverse Event|1|||
145481878|NCT00048347|524616526|FG000|Overall Study|Screen failure|2|||
145481879|NCT02343406|524616527|FG000|Overall Study|Progressive disease|72|||
145481880|NCT02343406|524616528|FG001|Overall Study|Progressive disease|70|||
145481881|NCT02343406|524616529|FG002|Overall Study|Progressive disease|43|||
145481882|NCT02343406|524616530|FG003|Overall Study|Progressive disease|15|||
145481883|NCT02343406|524616531|FG004|Overall Study|Progressive disease|5|||
145481884|NCT02343406|524616527|FG000|Overall Study|Adverse Event|6|||
145481885|NCT02343406|524616528|FG001|Overall Study|Adverse Event|8|||
145481886|NCT02343406|524616529|FG002|Overall Study|Adverse Event|6|||
145481887|NCT02343406|524616530|FG003|Overall Study|Adverse Event|3|||
145481888|NCT02343406|524616531|FG004|Overall Study|Adverse Event|0|||
145481889|NCT02343406|524616527|FG000|Overall Study|Withdrawal by Subject|6|||
145481890|NCT02343406|524616528|FG001|Overall Study|Withdrawal by Subject|4|||
145481891|NCT02343406|524616529|FG002|Overall Study|Withdrawal by Subject|8|||
145481892|NCT02343406|524616530|FG003|Overall Study|Withdrawal by Subject|3|||
145481893|NCT02343406|524616531|FG004|Overall Study|Withdrawal by Subject|0|||
145481894|NCT02343406|524616527|FG000|Overall Study|Death|2|||
145481895|NCT02343406|524616528|FG001|Overall Study|Death|1|||
145481896|NCT02343406|524616529|FG002|Overall Study|Death|0|||
145481897|NCT02343406|524616530|FG003|Overall Study|Death|0|||
145481898|NCT02343406|524616531|FG004|Overall Study|Death|0|||
145481899|NCT02343406|524616527|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
145481900|NCT02343406|524616528|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
145481901|NCT02343406|524616529|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
145481902|NCT02343406|524616530|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
145481903|NCT02343406|524616531|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
145481904|NCT02343406|524616527|FG000|Overall Study|Other primary malignancy|0|||
145481905|NCT02343406|524616528|FG001|Overall Study|Other primary malignancy|1|||
145481906|NCT02343406|524616529|FG002|Overall Study|Other primary malignancy|0|||
145481907|NCT02343406|524616530|FG003|Overall Study|Other primary malignancy|0|||
145481908|NCT02343406|524616531|FG004|Overall Study|Other primary malignancy|0|||
145481909|NCT02343406|524616527|FG000|Overall Study|Other, not specified|2|||
145481910|NCT02343406|524616528|FG001|Overall Study|Other, not specified|1|||
145481911|NCT02343406|524616529|FG002|Overall Study|Other, not specified|1|||
145481912|NCT02343406|524616530|FG003|Overall Study|Other, not specified|4|||
145481913|NCT02343406|524616531|FG004|Overall Study|Other, not specified|0|||
145481914|NCT00858637|524616532|FG000|Active Comparison Phase|Adverse Event|14|||
145481915|NCT00858637|524616533|FG001|Active Comparison Phase|Adverse Event|0|||
145481916|NCT00858637|524616534|FG002|Active Comparison Phase|Adverse Event|0|||
145481917|NCT00858637|524616535|FG003|Active Comparison Phase|Adverse Event|9|||
145481918|NCT00858637|524616536|FG004|Active Comparison Phase|Adverse Event|0|||
145481919|NCT00858637|524616537|FG005|Active Comparison Phase|Adverse Event|0|||
145481920|NCT00858637|524616532|FG000|Active Comparison Phase|Death|1|||
145481921|NCT00858637|524616533|FG001|Active Comparison Phase|Death|0|||
145481922|NCT00858637|524616534|FG002|Active Comparison Phase|Death|0|||
145481923|NCT00858637|524616535|FG003|Active Comparison Phase|Death|1|||
145481924|NCT00858637|524616536|FG004|Active Comparison Phase|Death|0|||
145481925|NCT00858637|524616537|FG005|Active Comparison Phase|Death|0|||
145481926|NCT00858637|524616532|FG000|Active Comparison Phase|Physician Decision|1|||
145481927|NCT00858637|524616533|FG001|Active Comparison Phase|Physician Decision|0|||
145481928|NCT00858637|524616534|FG002|Active Comparison Phase|Physician Decision|0|||
145481929|NCT00858637|524616535|FG003|Active Comparison Phase|Physician Decision|1|||
145481930|NCT00858637|524616536|FG004|Active Comparison Phase|Physician Decision|0|||
145481931|NCT00858637|524616537|FG005|Active Comparison Phase|Physician Decision|0|||
145481932|NCT00858637|524616532|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
145481933|NCT00858637|524616533|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
145481934|NCT00858637|524616534|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
145481935|NCT00858637|524616535|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
145481936|NCT00858637|524616536|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
145481937|NCT00858637|524616537|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
145481938|NCT00858637|524616532|FG000|Active Comparison Phase|Other Reasons|1|||
145481939|NCT00858637|524616533|FG001|Active Comparison Phase|Other Reasons|0|||
145481940|NCT00858637|524616534|FG002|Active Comparison Phase|Other Reasons|0|||
145481941|NCT00858637|524616535|FG003|Active Comparison Phase|Other Reasons|1|||
145481942|NCT00858637|524616536|FG004|Active Comparison Phase|Other Reasons|0|||
145481943|NCT00858637|524616537|FG005|Active Comparison Phase|Other Reasons|0|||
145481944|NCT00858637|524616532|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
145481945|NCT00858637|524616533|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
145481946|NCT00858637|524616534|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
145481947|NCT00858637|524616535|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
145481948|NCT00858637|524616536|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
145481949|NCT00858637|524616537|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
145481950|NCT00858637|524616532|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
145481951|NCT00858637|524616533|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
145481952|NCT00858637|524616534|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
145481953|NCT00858637|524616535|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
145481954|NCT00858637|524616536|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
145481955|NCT00858637|524616537|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
145481956|NCT04677504|524616538|FG000|Overall Study|Death|51|||
145481957|NCT04677504|524616539|FG001|Overall Study|Death|49|||
145481958|NCT04677504|524616538|FG000|Overall Study|Progressive Disease|1|||
145481959|NCT04677504|524616539|FG001|Overall Study|Progressive Disease|0|||
145481960|NCT04677504|524616538|FG000|Overall Study|Symptomatic Deterioration|1|||
145481961|NCT04677504|524616539|FG001|Overall Study|Symptomatic Deterioration|0|||
145481962|NCT04677504|524616538|FG000|Overall Study|Withdrawal by Subject|2|||
145481963|NCT04677504|524616539|FG001|Overall Study|Withdrawal by Subject|5|||
145481964|NCT04677504|524616538|FG000|Overall Study|Study Terminated By Sponsor|28|||
145481965|NCT04677504|524616539|FG001|Overall Study|Study Terminated By Sponsor|24|||
145481966|NCT04677504|524616538|FG000|Overall Study|Adverse Event|0|||
145481967|NCT04677504|524616539|FG001|Overall Study|Adverse Event|1|||
145481968|NCT03508609|524616540|FG000|Overall Study|Withdrawal by Subject|1|||
145481969|NCT03304873|524616541|FG000|Overall Study|Lost to Follow-up|1|||
145481970|NCT03304873|524616542|FG001|Overall Study|Lost to Follow-up|8|||
145481971|NCT01546688|524616543|FG000|Overall Study|Adverse Event|0|||
145481972|NCT01546688|524616544|FG001|Overall Study|Adverse Event|4|||
145481973|NCT01546688|524616543|FG000|Overall Study|Withdrawal by Subject|2|||
145481974|NCT01546688|524616544|FG001|Overall Study|Withdrawal by Subject|1|||
145481975|NCT01546688|524616543|FG000|Overall Study|Lack of Efficacy|1|||
145481976|NCT01546688|524616544|FG001|Overall Study|Lack of Efficacy|0|||
145481977|NCT00782483|524616548|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
145481978|NCT01868477|524616549|FG000|Overall Study|Adverse Event|2|||
145481979|NCT01868477|524616550|FG001|Overall Study|Adverse Event|4|||
145481980|NCT01868477|524616549|FG000|Overall Study|Disease progression|1|||
145481981|NCT01868477|524616550|FG001|Overall Study|Disease progression|1|||
145481982|NCT01868477|524616549|FG000|Overall Study|Withdrawal by Subject|1|||
145481983|NCT01868477|524616550|FG001|Overall Study|Withdrawal by Subject|0|||
145481984|NCT01052077|524616552|FG000|Phase A|Lost to Follow-up|22|||
145481985|NCT01052077|524616553|FG001|Phase A|Lost to Follow-up|0|||
145481986|NCT01052077|524616554|FG002|Phase A|Lost to Follow-up|0|||
145481987|NCT01052077|524616555|FG003|Phase A|Lost to Follow-up|0|||
145481988|NCT01052077|524616552|FG000|Phase A|Adverse Event|32|||
145481989|NCT01052077|524616553|FG001|Phase A|Adverse Event|0|||
145481990|NCT01052077|524616554|FG002|Phase A|Adverse Event|0|||
145481991|NCT01052077|524616555|FG003|Phase A|Adverse Event|0|||
145481992|NCT01052077|524616552|FG000|Phase A|Met Withdrawal Criteria|26|||
145481993|NCT01052077|524616553|FG001|Phase A|Met Withdrawal Criteria|0|||
145481994|NCT01052077|524616554|FG002|Phase A|Met Withdrawal Criteria|0|||
145481995|NCT01052077|524616555|FG003|Phase A|Met Withdrawal Criteria|0|||
145481996|NCT01052077|524616552|FG000|Phase A|Physician Decision|10|||
145481997|NCT01052077|524616553|FG001|Phase A|Physician Decision|0|||
145481998|NCT01052077|524616554|FG002|Phase A|Physician Decision|0|||
145481999|NCT01052077|524616555|FG003|Phase A|Physician Decision|0|||
145482000|NCT01052077|524616552|FG000|Phase A|Withdrawal by Subject|29|||
145482001|NCT01052077|524616553|FG001|Phase A|Withdrawal by Subject|0|||
145482002|NCT01052077|524616554|FG002|Phase A|Withdrawal by Subject|0|||
145482003|NCT01052077|524616555|FG003|Phase A|Withdrawal by Subject|0|||
145482004|NCT01052077|524616552|FG000|Phase A|Protocol Deviation|27|||
145482005|NCT01052077|524616553|FG001|Phase A|Protocol Deviation|0|||
145482006|NCT01052077|524616554|FG002|Phase A|Protocol Deviation|0|||
145482007|NCT01052077|524616555|FG003|Phase A|Protocol Deviation|0|||
145482008|NCT01052077|524616552|FG000|Phase B|Lost to Follow-up|0|||
145482009|NCT01052077|524616553|FG001|Phase B|Lost to Follow-up|2|||
145482010|NCT01052077|524616554|FG002|Phase B|Lost to Follow-up|3|||
145482011|NCT01052077|524616555|FG003|Phase B|Lost to Follow-up|0|||
145482012|NCT01052077|524616552|FG000|Phase B|Adverse Event|0|||
145482013|NCT01052077|524616553|FG001|Phase B|Adverse Event|9|||
145604289|NCT00633464|525064733|FG000|Overall Study|Never Treated (Randomized in error)|0|||
145482014|NCT01052077|524616554|FG002|Phase B|Adverse Event|2|||
145482015|NCT01052077|524616555|FG003|Phase B|Adverse Event|0|||
145482016|NCT01052077|524616552|FG000|Phase B|Met Withdrawal Criteria|0|||
145482017|NCT01052077|524616553|FG001|Phase B|Met Withdrawal Criteria|2|||
145482018|NCT01052077|524616554|FG002|Phase B|Met Withdrawal Criteria|1|||
145482019|NCT01052077|524616555|FG003|Phase B|Met Withdrawal Criteria|0|||
145482020|NCT01052077|524616552|FG000|Phase B|Physician Decision|0|||
145482021|NCT01052077|524616553|FG001|Phase B|Physician Decision|1|||
145482022|NCT01052077|524616554|FG002|Phase B|Physician Decision|1|||
145482023|NCT01052077|524616555|FG003|Phase B|Physician Decision|0|||
145482024|NCT01052077|524616552|FG000|Phase B|Withdrawal by Subject|0|||
145482025|NCT01052077|524616553|FG001|Phase B|Withdrawal by Subject|0|||
145482026|NCT01052077|524616554|FG002|Phase B|Withdrawal by Subject|5|||
145482027|NCT01052077|524616555|FG003|Phase B|Withdrawal by Subject|0|||
145482028|NCT01052077|524616552|FG000|Phase B|Protocol Deviation|0|||
145482029|NCT01052077|524616553|FG001|Phase B|Protocol Deviation|3|||
145482030|NCT01052077|524616554|FG002|Phase B|Protocol Deviation|4|||
145482031|NCT01052077|524616555|FG003|Phase B|Protocol Deviation|0|||
145482032|NCT01052077|524616552|FG000|Phase B|Lack of Efficacy|0|||
145482033|NCT01052077|524616553|FG001|Phase B|Lack of Efficacy|1|||
145482034|NCT01052077|524616554|FG002|Phase B|Lack of Efficacy|0|||
145482035|NCT01052077|524616555|FG003|Phase B|Lack of Efficacy|0|||
145482036|NCT01052077|524616552|FG000|Phase A+|Lost to Follow-up|0|||
145482037|NCT01052077|524616553|FG001|Phase A+|Lost to Follow-up|0|||
145482038|NCT01052077|524616554|FG002|Phase A+|Lost to Follow-up|0|||
145482039|NCT01052077|524616555|FG003|Phase A+|Lost to Follow-up|8|||
145482040|NCT01052077|524616552|FG000|Phase A+|Adverse Event|0|||
145482041|NCT01052077|524616553|FG001|Phase A+|Adverse Event|0|||
145482042|NCT01052077|524616554|FG002|Phase A+|Adverse Event|0|||
145482043|NCT01052077|524616555|FG003|Phase A+|Adverse Event|4|||
145482044|NCT01052077|524616552|FG000|Phase A+|Met Withdrawal Criteria|0|||
145482045|NCT01052077|524616553|FG001|Phase A+|Met Withdrawal Criteria|0|||
145482046|NCT01052077|524616554|FG002|Phase A+|Met Withdrawal Criteria|0|||
145482047|NCT01052077|524616555|FG003|Phase A+|Met Withdrawal Criteria|2|||
145482048|NCT01052077|524616552|FG000|Phase A+|Withdrawal by Subject|0|||
145482049|NCT01052077|524616553|FG001|Phase A+|Withdrawal by Subject|0|||
145482050|NCT01052077|524616554|FG002|Phase A+|Withdrawal by Subject|0|||
145482051|NCT01052077|524616555|FG003|Phase A+|Withdrawal by Subject|7|||
145482052|NCT00042991|524616556|FG000|Overall Study|Adverse Event|1|||
145482053|NCT00042991|524616557|FG001|Overall Study|Adverse Event|4|||
145482054|NCT00042991|524616558|FG002|Overall Study|Adverse Event|2|||
145482055|NCT00042991|524616559|FG003|Overall Study|Adverse Event|0|||
145482056|NCT00042991|524616560|FG004|Overall Study|Adverse Event|0|||
145482057|NCT00042991|524616561|FG005|Overall Study|Adverse Event|1|||
145482058|NCT00042991|524616562|FG006|Overall Study|Adverse Event|0|||
145482059|NCT00042991|524616556|FG000|Overall Study|Withdrawal by Subject|0|||
145482060|NCT00042991|524616557|FG001|Overall Study|Withdrawal by Subject|7|||
145482061|NCT00042991|524616558|FG002|Overall Study|Withdrawal by Subject|2|||
145482062|NCT00042991|524616559|FG003|Overall Study|Withdrawal by Subject|0|||
145482063|NCT00042991|524616560|FG004|Overall Study|Withdrawal by Subject|1|||
145482064|NCT00042991|524616561|FG005|Overall Study|Withdrawal by Subject|0|||
145482065|NCT00042991|524616562|FG006|Overall Study|Withdrawal by Subject|0|||
145482066|NCT00042991|524616556|FG000|Overall Study|Disease Progression|5|||
145482067|NCT00042991|524616557|FG001|Overall Study|Disease Progression|29|||
145482068|NCT00042991|524616558|FG002|Overall Study|Disease Progression|2|||
145482069|NCT00042991|524616559|FG003|Overall Study|Disease Progression|2|||
145482070|NCT00042991|524616560|FG004|Overall Study|Disease Progression|1|||
145482071|NCT00042991|524616561|FG005|Overall Study|Disease Progression|4|||
145482072|NCT00042991|524616562|FG006|Overall Study|Disease Progression|2|||
145482073|NCT00042991|524616556|FG000|Overall Study|Alternative Therapy|0|||
145482074|NCT00042991|524616557|FG001|Overall Study|Alternative Therapy|0|||
145482075|NCT00042991|524616558|FG002|Overall Study|Alternative Therapy|0|||
145482076|NCT00042991|524616559|FG003|Overall Study|Alternative Therapy|0|||
145482077|NCT00042991|524616560|FG004|Overall Study|Alternative Therapy|1|||
145482078|NCT00042991|524616561|FG005|Overall Study|Alternative Therapy|0|||
145482079|NCT00042991|524616562|FG006|Overall Study|Alternative Therapy|0|||
145482080|NCT01445080|524616563|FG000|Overall Study|Adverse Event|5|||
145482081|NCT01445080|524616564|FG001|Overall Study|Adverse Event|3|||
145482082|NCT01445080|524616565|FG002|Overall Study|Adverse Event|11|||
145482083|NCT01445080|524616566|FG003|Overall Study|Adverse Event|6|||
145482084|NCT01445080|524616567|FG004|Overall Study|Adverse Event|2|||
145482085|NCT01445080|524616568|FG005|Overall Study|Adverse Event|3|||
145482086|NCT01445080|524616569|FG006|Overall Study|Adverse Event|0|||
145482087|NCT01445080|524616570|FG007|Overall Study|Adverse Event|3|||
145482088|NCT01445080|524616571|FG008|Overall Study|Adverse Event|10|||
145482089|NCT01445080|524616563|FG000|Overall Study|Physician Decision|0|||
145482090|NCT01445080|524616564|FG001|Overall Study|Physician Decision|0|||
145637838|NCT00712335|525188582|FG003|Overall Study|Other Reason|0|||
145482091|NCT01445080|524616565|FG002|Overall Study|Physician Decision|1|||
145482092|NCT01445080|524616566|FG003|Overall Study|Physician Decision|0|||
145482093|NCT01445080|524616567|FG004|Overall Study|Physician Decision|0|||
145482094|NCT01445080|524616568|FG005|Overall Study|Physician Decision|3|||
145482095|NCT01445080|524616569|FG006|Overall Study|Physician Decision|2|||
145482096|NCT01445080|524616570|FG007|Overall Study|Physician Decision|2|||
145482097|NCT01445080|524616571|FG008|Overall Study|Physician Decision|0|||
145482098|NCT01445080|524616563|FG000|Overall Study|Withdrawal by Subject|1|||
145482099|NCT01445080|524616564|FG001|Overall Study|Withdrawal by Subject|0|||
145482100|NCT01445080|524616565|FG002|Overall Study|Withdrawal by Subject|0|||
145482101|NCT01445080|524616566|FG003|Overall Study|Withdrawal by Subject|1|||
145482102|NCT01445080|524616567|FG004|Overall Study|Withdrawal by Subject|0|||
145482103|NCT01445080|524616568|FG005|Overall Study|Withdrawal by Subject|0|||
145482104|NCT01445080|524616569|FG006|Overall Study|Withdrawal by Subject|0|||
145482105|NCT01445080|524616570|FG007|Overall Study|Withdrawal by Subject|0|||
145482106|NCT01445080|524616571|FG008|Overall Study|Withdrawal by Subject|2|||
145482107|NCT01445080|524616563|FG000|Overall Study|Ineligible/Inevaluable|1|||
145482108|NCT01445080|524616564|FG001|Overall Study|Ineligible/Inevaluable|2|||
145482109|NCT01445080|524616565|FG002|Overall Study|Ineligible/Inevaluable|0|||
145482110|NCT01445080|524616566|FG003|Overall Study|Ineligible/Inevaluable|1|||
145482111|NCT01445080|524616567|FG004|Overall Study|Ineligible/Inevaluable|2|||
145482112|NCT01445080|524616568|FG005|Overall Study|Ineligible/Inevaluable|3|||
145482113|NCT01445080|524616569|FG006|Overall Study|Ineligible/Inevaluable|0|||
145482114|NCT01445080|524616570|FG007|Overall Study|Ineligible/Inevaluable|0|||
145482115|NCT01445080|524616571|FG008|Overall Study|Ineligible/Inevaluable|6|||
145482116|NCT01574651|524616572|FG000|Overall Study|Lost to Follow-up|2|||
145482117|NCT01574651|524616573|FG001|Overall Study|Lost to Follow-up|4|||
145482118|NCT01574651|524616572|FG000|Overall Study|Administrative problems|0|||
145482119|NCT01574651|524616573|FG001|Overall Study|Administrative problems|1|||
145482120|NCT01574651|524616572|FG000|Overall Study|Death|3|||
145482121|NCT01574651|524616573|FG001|Overall Study|Death|3|||
145482122|NCT01574651|524616572|FG000|Overall Study|Patient's inability to use the device|0|||
145482123|NCT01574651|524616573|FG001|Overall Study|Patient's inability to use the device|1|||
145482124|NCT01574651|524616572|FG000|Overall Study|Adverse Event|36|||
145482125|NCT01574651|524616573|FG001|Overall Study|Adverse Event|27|||
145482126|NCT01574651|524616572|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145482127|NCT01574651|524616573|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145482128|NCT01574651|524616572|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145482129|NCT01574651|524616573|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145482130|NCT01574651|524616572|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
145482131|NCT01574651|524616573|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145482132|NCT01574651|524616572|FG000|Overall Study|Protocol Violation|3|||
145482133|NCT01574651|524616573|FG001|Overall Study|Protocol Violation|5|||
145482134|NCT01574651|524616572|FG000|Overall Study|Withdrawal by Subject|9|||
145482135|NCT01574651|524616573|FG001|Overall Study|Withdrawal by Subject|10|||
145482136|NCT03857542|524616574|FG000|Overall Study|Adverse Event|1|||
145482137|NCT03857542|524616575|FG001|Overall Study|Adverse Event|3|||
145482138|NCT03857542|524616574|FG000|Overall Study|Withdrawal by Subject|2|||
145482139|NCT03857542|524616575|FG001|Overall Study|Withdrawal by Subject|1|||
145482140|NCT03857542|524616574|FG000|Overall Study|Lost to Follow-up|2|||
145482141|NCT03857542|524616575|FG001|Overall Study|Lost to Follow-up|1|||
145482142|NCT03857542|524616574|FG000|Overall Study|Reason not Specified|1|||
145482143|NCT03857542|524616575|FG001|Overall Study|Reason not Specified|0|||
145482144|NCT00763386|524618277|FG000|Overall Study|Adverse Event|43|||
145482145|NCT00763386|524618278|FG001|Overall Study|Adverse Event|33|||
145482146|NCT00763386|524618277|FG000|Overall Study|Death|1|||
145482147|NCT00763386|524618278|FG001|Overall Study|Death|2|||
145482148|NCT00763386|524618277|FG000|Overall Study|Lost to Follow-up|3|||
145482149|NCT00763386|524618278|FG001|Overall Study|Lost to Follow-up|3|||
145482150|NCT00763386|524618277|FG000|Overall Study|Withdrawal by Subject|0|||
145482151|NCT00763386|524618278|FG001|Overall Study|Withdrawal by Subject|1|||
145482152|NCT00763386|524618277|FG000|Overall Study|CRF missing|0|||
145482153|NCT00763386|524618278|FG001|Overall Study|CRF missing|1|||
145482154|NCT00763386|524618277|FG000|Overall Study|Study Prosthesis Removed|1|||
145482155|NCT00763386|524618278|FG001|Overall Study|Study Prosthesis Removed|0|||
145482156|NCT00502671|524618279|FG000|Overall Study|Disease Progression|13|||
145482157|NCT00502671|524618279|FG000|Overall Study|Personal Reasons|22|||
145482158|NCT00502671|524618279|FG000|Overall Study|Lost to Follow-up|7|||
145482159|NCT00502671|524618279|FG000|Overall Study|Protocol Violation|16|||
145604290|NCT00633464|525064734|FG001|Overall Study|Never Treated (Randomized in error)|1|||
145604291|NCT02612064|525064735|FG000|Overall Study|Withdrawal by Subject|1|||
145604292|NCT02612064|525064736|FG001|Overall Study|Withdrawal by Subject|1|||
145604293|NCT02612064|525064735|FG000|Overall Study|Other|0|||
145604294|NCT02612064|525064736|FG001|Overall Study|Other|2|||
145604295|NCT03764072|525064741|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
145604296|NCT03764072|525064742|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
145604297|NCT03764072|525064743|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
145604298|NCT03764072|525064744|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
145482160|NCT00502671|524618279|FG000|Overall Study|Adverse Event|19|||
145482161|NCT01402817|524618280|FG000|Overall Study|Withdrawal by Subject|3|||
145482162|NCT01402817|524618280|FG000|Overall Study|Study Suspended by FDA|8|||
145482163|NCT02274792|524618282|FG000|Overall Study|Withdrawal by Subject|13|||
145482164|NCT02274792|524618282|FG000|Overall Study|Lost to Follow-up|8|||
145482165|NCT02274792|524618282|FG000|Overall Study|Protocol Specified Criteria|2|||
145482166|NCT02274792|524618282|FG000|Overall Study|Sponsor Decision|2|||
145482167|NCT01510158|524618283|FG000|Overall Study|Adverse Event|7|||
145482168|NCT01510158|524618284|FG001|Overall Study|Adverse Event|8|||
145482169|NCT01510158|524618285|FG002|Overall Study|Adverse Event|5|||
145482170|NCT01510158|524618283|FG000|Overall Study|Gout flare|1|||
145482171|NCT01510158|524618284|FG001|Overall Study|Gout flare|0|||
145482172|NCT01510158|524618285|FG002|Overall Study|Gout flare|0|||
145482173|NCT01510158|524618283|FG000|Overall Study|Protocol Violation|17|||
145482174|NCT01510158|524618284|FG001|Overall Study|Protocol Violation|16|||
145482175|NCT01510158|524618285|FG002|Overall Study|Protocol Violation|24|||
145482176|NCT01510158|524618283|FG000|Overall Study|Sponsor terminated study.|2|||
145482177|NCT01510158|524618284|FG001|Overall Study|Sponsor terminated study.|0|||
145482178|NCT01510158|524618285|FG002|Overall Study|Sponsor terminated study.|2|||
145482179|NCT01510158|524618283|FG000|Overall Study|Lost to Follow-up|13|||
145482180|NCT01510158|524618284|FG001|Overall Study|Lost to Follow-up|16|||
145482181|NCT01510158|524618285|FG002|Overall Study|Lost to Follow-up|9|||
145482182|NCT01510158|524618283|FG000|Overall Study|Withdrawal by Subject|10|||
145482183|NCT01510158|524618284|FG001|Overall Study|Withdrawal by Subject|13|||
145482184|NCT01510158|524618285|FG002|Overall Study|Withdrawal by Subject|10|||
145482185|NCT01510158|524618283|FG000|Overall Study|Death|1|||
145482186|NCT01510158|524618284|FG001|Overall Study|Death|0|||
145482187|NCT01510158|524618285|FG002|Overall Study|Death|0|||
145482188|NCT00832416|524618286|FG000|Overall Study|Lack of Efficacy|17|||
145482189|NCT00832416|524618287|FG001|Overall Study|Lack of Efficacy|15|||
145482190|NCT00832416|524618288|FG002|Overall Study|Lack of Efficacy|13|||
145482191|NCT00832416|524618289|FG003|Overall Study|Lack of Efficacy|52|||
145482192|NCT00832416|524618286|FG000|Overall Study|Withdrawal by Subject|5|||
145482193|NCT00832416|524618287|FG001|Overall Study|Withdrawal by Subject|7|||
145482194|NCT00832416|524618288|FG002|Overall Study|Withdrawal by Subject|2|||
145482195|NCT00832416|524618289|FG003|Overall Study|Withdrawal by Subject|10|||
145482196|NCT00832416|524618286|FG000|Overall Study|Physician Decision|2|||
145482197|NCT00832416|524618287|FG001|Overall Study|Physician Decision|12|||
145482198|NCT00832416|524618288|FG002|Overall Study|Physician Decision|5|||
145482199|NCT00832416|524618289|FG003|Overall Study|Physician Decision|10|||
145482200|NCT00832416|524618286|FG000|Overall Study|Administrative|0|||
145482201|NCT00832416|524618287|FG001|Overall Study|Administrative|0|||
145482202|NCT00832416|524618288|FG002|Overall Study|Administrative|0|||
145482203|NCT00832416|524618289|FG003|Overall Study|Administrative|1|||
145482204|NCT00832416|524618286|FG000|Overall Study|Adverse Event|21|||
145482205|NCT00832416|524618287|FG001|Overall Study|Adverse Event|19|||
145482206|NCT00832416|524618288|FG002|Overall Study|Adverse Event|41|||
145482207|NCT00832416|524618289|FG003|Overall Study|Adverse Event|10|||
145482208|NCT00832416|524618286|FG000|Overall Study|Death|1|||
145482209|NCT00832416|524618287|FG001|Overall Study|Death|0|||
145482210|NCT00832416|524618288|FG002|Overall Study|Death|0|||
145482211|NCT00832416|524618289|FG003|Overall Study|Death|0|||
145482212|NCT02114606|524618290|FG000|Overall Study|Unable to swallow Cytosponge|6|||
145482213|NCT05786508|524618300|FG000|Overall Study|Withdrawal by Subject|2|||
145482214|NCT05786508|524618301|FG001|Overall Study|Withdrawal by Subject|0|||
145482215|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Technical problems|0|||
145482216|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Technical problems|0|||
145482217|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Technical problems|0|||
145482218|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Technical problems|1|||
145482219|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
145482220|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
145482221|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
145482222|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
145482223|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
145482224|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
145482225|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
145482226|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
145482227|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
145482228|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
145482229|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
145482230|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
145482231|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Death|0|||
145482232|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Death|3|||
145604299|NCT03764072|525064745|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
145604300|NCT03764072|525064746|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
145604301|NCT03764072|525064741|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
145604302|NCT03764072|525064742|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
145604303|NCT03764072|525064743|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
145482233|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Death|1|||
145482234|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Death|0|||
145482235|NCT02152761|524618304|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
145482236|NCT02152761|524618305|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
145482237|NCT02152761|524618306|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
145482238|NCT02152761|524618307|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
145482239|NCT02152761|524618304|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
145482240|NCT02152761|524618305|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
145482241|NCT02152761|524618306|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
145637839|NCT00712335|525188583|FG004|Overall Study|Other Reason|0|||
145482242|NCT02152761|524618307|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
145482243|NCT02152761|524618304|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
145482244|NCT02152761|524618305|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
145482245|NCT02152761|524618306|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
145482246|NCT02152761|524618307|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
145482247|NCT02152761|524618304|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
145482248|NCT02152761|524618305|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
145482249|NCT02152761|524618306|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
145482250|NCT02152761|524618307|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
145482251|NCT02152761|524618304|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
145482252|NCT02152761|524618305|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
145482253|NCT02152761|524618306|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
145482254|NCT02152761|524618307|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
145482255|NCT01957202|524618308|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482256|NCT01957202|524618309|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
145482257|NCT01957202|524618310|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482258|NCT01957202|524618311|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482259|NCT01957202|524618312|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482260|NCT01957202|524618313|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482261|NCT01957202|524618314|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482262|NCT01957202|524618315|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482263|NCT01957202|524618316|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482264|NCT01957202|524618317|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482265|NCT01957202|524618318|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482266|NCT01957202|524618319|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482267|NCT01957202|524618320|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482268|NCT01957202|524618321|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482269|NCT01957202|524618322|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482270|NCT01957202|524618323|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482271|NCT01957202|524618324|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
145482272|NCT01957202|524618325|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
145482273|NCT01957202|524618308|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482274|NCT01957202|524618309|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482275|NCT01957202|524618310|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482276|NCT01957202|524618311|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482277|NCT01957202|524618312|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482278|NCT01957202|524618313|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482279|NCT01957202|524618314|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482280|NCT01957202|524618315|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482281|NCT01957202|524618316|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482282|NCT01957202|524618317|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482283|NCT01957202|524618318|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482284|NCT01957202|524618319|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482285|NCT01957202|524618320|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482286|NCT01957202|524618321|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482287|NCT01957202|524618322|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482288|NCT01957202|524618323|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482289|NCT01957202|524618324|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
145482290|NCT01957202|524618325|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
145482291|NCT01456169|524618326|FG000|Overall Study|Adverse Event|1|||
145482292|NCT01456169|524618327|FG001|Overall Study|Adverse Event|2|||
145482293|NCT01456169|524618328|FG002|Overall Study|Adverse Event|7|||
145482294|NCT01456169|524618326|FG000|Overall Study|Major Protocol Deviation|3|||
145482295|NCT01456169|524618327|FG001|Overall Study|Major Protocol Deviation|2|||
145482296|NCT01456169|524618328|FG002|Overall Study|Major Protocol Deviation|3|||
145604304|NCT03764072|525064744|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
145604305|NCT03764072|525064745|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
145604306|NCT03764072|525064746|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
145604307|NCT03764072|525064741|FG000|Overall Study|Lost to Follow-up|0|||
145604308|NCT03764072|525064742|FG001|Overall Study|Lost to Follow-up|0|||
145604309|NCT03764072|525064743|FG002|Overall Study|Lost to Follow-up|0|||
145604310|NCT03764072|525064744|FG003|Overall Study|Lost to Follow-up|0|||
145637840|NCT03401112|525188584|FG000|Overall Study|Adverse Event|1|||
145482297|NCT01456169|524618326|FG000|Overall Study|Voluntary Withdrawal|3|||
145482298|NCT01456169|524618327|FG001|Overall Study|Voluntary Withdrawal|0|||
145482299|NCT01456169|524618328|FG002|Overall Study|Voluntary Withdrawal|2|||
145482300|NCT01456169|524618326|FG000|Overall Study|Lack of Efficacy|2|||
145482301|NCT01456169|524618327|FG001|Overall Study|Lack of Efficacy|0|||
145604311|NCT03764072|525064745|FG004|Overall Study|Lost to Follow-up|1|||
145482302|NCT01456169|524618328|FG002|Overall Study|Lack of Efficacy|0|||
145482303|NCT01456169|524618326|FG000|Overall Study|Other|1|||
145482304|NCT01456169|524618327|FG001|Overall Study|Other|1|||
145482305|NCT01456169|524618328|FG002|Overall Study|Other|0|||
145482306|NCT01797263|524618332|FG000|Overall Study|Withdrawal by Subject|21|||
145482307|NCT01797263|524618333|FG001|Overall Study|Withdrawal by Subject|25|||
145482308|NCT01797263|524618332|FG000|Overall Study|Death|1|||
145482309|NCT01797263|524618333|FG001|Overall Study|Death|0|||
145482310|NCT01797263|524618332|FG000|Overall Study|Lost to Follow-up|15|||
145482311|NCT01797263|524618333|FG001|Overall Study|Lost to Follow-up|15|||
145482312|NCT02342223|524618334|FG000|Overall Study|Lost to Follow-up|1|||
145482313|NCT04098809|524618337|FG000|Overall Study|Withdrawal by Subject|1|||
145482314|NCT04098809|524618338|FG001|Overall Study|Withdrawal by Subject|3|||
145482315|NCT04098809|524618337|FG000|Overall Study|Physician Decision|2|||
145482316|NCT04098809|524618338|FG001|Overall Study|Physician Decision|1|||
145482317|NCT01200368|524618339|FG000|Infant Series|Adverse Event|2|||
145482318|NCT01200368|524618340|FG001|Infant Series|Adverse Event|2|||
145482319|NCT01200368|524618341|FG002|Infant Series|Adverse Event|3|||
145482320|NCT01200368|524618339|FG000|Infant Series|Withdrawal by Subject|0|||
145482321|NCT01200368|524618340|FG001|Infant Series|Withdrawal by Subject|2|||
145482322|NCT01200368|524618341|FG002|Infant Series|Withdrawal by Subject|2|||
145482323|NCT01200368|524618339|FG000|Infant Series|Did not meet entrance criteria|0|||
145482324|NCT01200368|524618340|FG001|Infant Series|Did not meet entrance criteria|1|||
145482325|NCT01200368|524618341|FG002|Infant Series|Did not meet entrance criteria|0|||
145482326|NCT01200368|524618339|FG000|Infant Series|Randomized, not vaccinated|0|||
145482327|NCT01200368|524618340|FG001|Infant Series|Randomized, not vaccinated|1|||
145482328|NCT01200368|524618341|FG002|Infant Series|Randomized, not vaccinated|1|||
145482329|NCT01200368|524618339|FG000|Infant Series|Other|1|||
145482330|NCT01200368|524618340|FG001|Infant Series|Other|0|||
145482331|NCT01200368|524618341|FG002|Infant Series|Other|0|||
145482332|NCT01200368|524618339|FG000|After Infant Series|Adverse Event|6|||
145482333|NCT01200368|524618340|FG001|After Infant Series|Adverse Event|6|||
145482334|NCT01200368|524618341|FG002|After Infant Series|Adverse Event|3|||
145482335|NCT01200368|524618339|FG000|After Infant Series|Withdrawal by Subject|10|||
145482336|NCT01200368|524618340|FG001|After Infant Series|Withdrawal by Subject|8|||
145482337|NCT01200368|524618341|FG002|After Infant Series|Withdrawal by Subject|4|||
145482338|NCT01200368|524618339|FG000|After Infant Series|Lost to Follow-up|1|||
145482339|NCT01200368|524618340|FG001|After Infant Series|Lost to Follow-up|0|||
145482340|NCT01200368|524618341|FG002|After Infant Series|Lost to Follow-up|0|||
145482341|NCT01200368|524618339|FG000|After Infant Series|Other|1|||
145482342|NCT01200368|524618340|FG001|After Infant Series|Other|2|||
145482343|NCT01200368|524618341|FG002|After Infant Series|Other|2|||
145482344|NCT01200368|524618339|FG000|Toddler Dose|Adverse Event|0|||
145482345|NCT01200368|524618340|FG001|Toddler Dose|Adverse Event|3|||
145482346|NCT01200368|524618341|FG002|Toddler Dose|Adverse Event|1|||
145482347|NCT02741596|524618342|FG000|Overall Study|Adverse Event|1|||
145482348|NCT02741596|524618343|FG001|Overall Study|Adverse Event|5|||
145482349|NCT02741596|524618342|FG000|Overall Study|Lost to Follow-up|1|||
145482350|NCT02741596|524618343|FG001|Overall Study|Lost to Follow-up|1|||
145482351|NCT02741596|524618342|FG000|Overall Study|Physician Decision|2|||
145482352|NCT02741596|524618343|FG001|Overall Study|Physician Decision|1|||
145482353|NCT02741596|524618342|FG000|Overall Study|Pregnancy|3|||
145482354|NCT02741596|524618343|FG001|Overall Study|Pregnancy|1|||
145482355|NCT02741596|524618342|FG000|Overall Study|Other (Unspecified)|0|||
145482356|NCT02741596|524618343|FG001|Overall Study|Other (Unspecified)|3|||
145482357|NCT02741596|524618342|FG000|Overall Study|Subject withdrawn-Other|17|||
145482358|NCT02741596|524618343|FG001|Overall Study|Subject withdrawn-Other|4|||
145482359|NCT02741596|524618342|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
145482360|NCT02741596|524618343|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
145482361|NCT04854551|524618346|FG000|Overall Study|Withdrawal by Subject|1|||
145482362|NCT04854551|524618347|FG001|Overall Study|Withdrawal by Subject|1|||
145482363|NCT02859246|524618348|FG000|Overall Study|Screen fails|3|||
145482364|NCT02859246|524618348|FG000|Overall Study|Adverse Event|1|||
145637841|NCT03401112|525188585|FG001|Overall Study|Adverse Event|2|||
145482365|NCT02859246|524618348|FG000|Overall Study|Withdrawal by Subject|1|||
145482366|NCT05280717|524618349|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
145482367|NCT05280717|524618350|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
145482368|NCT05280717|524618351|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
145482369|NCT05280717|524618352|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
145482370|NCT05280717|524618353|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
145482371|NCT05280717|524618354|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
145482372|NCT05280717|524618355|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
145482373|NCT05280717|524618349|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
145482374|NCT05280717|524618350|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482375|NCT05280717|524618351|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482376|NCT05280717|524618352|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482377|NCT05280717|524618353|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482378|NCT05280717|524618354|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482379|NCT05280717|524618355|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
145482380|NCT05280717|524618349|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482381|NCT05280717|524618350|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
145482382|NCT05280717|524618351|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482383|NCT05280717|524618352|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482384|NCT05280717|524618353|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482385|NCT05280717|524618354|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482386|NCT05280717|524618355|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
145482387|NCT05280717|524618349|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482388|NCT05280717|524618350|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482389|NCT05280717|524618351|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
145482390|NCT05280717|524618352|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482391|NCT05280717|524618353|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482392|NCT05280717|524618354|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482393|NCT05280717|524618355|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
145482394|NCT05280717|524618349|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482395|NCT05280717|524618350|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482396|NCT05280717|524618351|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482397|NCT05280717|524618352|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482398|NCT05280717|524618353|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482399|NCT05280717|524618354|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
145482400|NCT05280717|524618355|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
145482401|NCT05280717|524618349|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145482402|NCT05280717|524618350|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145637842|NCT03401112|525188586|FG002|Overall Study|Adverse Event|3|||
145637843|NCT03401112|525188587|FG003|Overall Study|Adverse Event|2|||
145637844|NCT03401112|525188588|FG004|Overall Study|Adverse Event|0|||
145637845|NCT03401112|525188584|FG000|Overall Study|Lost to Follow-up|1|||
145637846|NCT03401112|525188585|FG001|Overall Study|Lost to Follow-up|0|||
145637847|NCT03401112|525188586|FG002|Overall Study|Lost to Follow-up|0|||
145637848|NCT03401112|525188587|FG003|Overall Study|Lost to Follow-up|0|||
145482403|NCT05280717|524618351|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145482404|NCT05280717|524618352|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145482405|NCT05280717|524618353|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145482406|NCT05280717|524618354|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
145482407|NCT05280717|524618355|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
145482408|NCT00080301|524618356|FG000|Overall Study|Randomized but Never Treated|5|||
145482409|NCT00080301|524618357|FG001|Overall Study|Randomized but Never Treated|10|||
145482410|NCT00080301|524618356|FG000|Overall Study|Still on Treatment as of CSR date|0|||
145482411|NCT00080301|524618357|FG001|Overall Study|Still on Treatment as of CSR date|1|||
145482412|NCT00181766|524618358|FG000|Overall Study|Lost to Follow-up|6|||
145482413|NCT00181766|524618358|FG000|Overall Study|Adverse Event|4|||
145482414|NCT00181766|524618358|FG000|Overall Study|non-compliance|2|||
145482415|NCT00687804|524618359|FG000|Core Study|Adverse Event|5|||
145482416|NCT00687804|524618360|FG001|Core Study|Adverse Event|3|||
145482417|NCT00687804|524618361|FG002|Core Study|Adverse Event|3|||
145482418|NCT00687804|524618359|FG000|Core Study|Abnormal laboratory value(s)|1|||
145482419|NCT00687804|524618360|FG001|Core Study|Abnormal laboratory value(s)|0|||
145482420|NCT00687804|524618361|FG002|Core Study|Abnormal laboratory value(s)|0|||
145482421|NCT00687804|524618359|FG000|Core Study|Lack of Efficacy|1|||
145482422|NCT00687804|524618360|FG001|Core Study|Lack of Efficacy|1|||
145482423|NCT00687804|524618361|FG002|Core Study|Lack of Efficacy|1|||
145482424|NCT00687804|524618359|FG000|Core Study|Withdrawal by Subject|4|||
145482425|NCT00687804|524618360|FG001|Core Study|Withdrawal by Subject|7|||
145482426|NCT00687804|524618361|FG002|Core Study|Withdrawal by Subject|7|||
145482427|NCT00687804|524618359|FG000|Core Study|Lost to Follow-up|0|||
145482428|NCT00687804|524618360|FG001|Core Study|Lost to Follow-up|1|||
145482429|NCT00687804|524618361|FG002|Core Study|Lost to Follow-up|0|||
145482430|NCT00687804|524618359|FG000|Core Study|Death|2|||
145482431|NCT00687804|524618360|FG001|Core Study|Death|2|||
145482432|NCT00687804|524618361|FG002|Core Study|Death|2|||
145482433|NCT00687804|524618359|FG000|Core Study|Protocol Violation|1|||
145482434|NCT00687804|524618360|FG001|Core Study|Protocol Violation|1|||
145637849|NCT03401112|525188588|FG004|Overall Study|Lost to Follow-up|0|||
145637850|NCT03401112|525188584|FG000|Overall Study|Noncompliance|1|||
145637851|NCT03401112|525188585|FG001|Overall Study|Noncompliance|2|||
145482435|NCT00687804|524618361|FG002|Core Study|Protocol Violation|0|||
145482436|NCT00687804|524618359|FG000|Open-Label Extension Study|Adverse Event|2|||
145482437|NCT00687804|524618360|FG001|Open-Label Extension Study|Adverse Event|2|||
145482438|NCT00687804|524618361|FG002|Open-Label Extension Study|Adverse Event|2|||
145482439|NCT00687804|524618359|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
145482440|NCT00687804|524618360|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
145482441|NCT00687804|524618361|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
145482442|NCT00687804|524618359|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
145637852|NCT03401112|525188586|FG002|Overall Study|Noncompliance|3|||
145637853|NCT03401112|525188587|FG003|Overall Study|Noncompliance|0|||
145637854|NCT03401112|525188588|FG004|Overall Study|Noncompliance|0|||
145637855|NCT03401112|525188584|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
145637856|NCT03401112|525188585|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
145637857|NCT03401112|525188586|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
145637858|NCT03401112|525188587|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
145637859|NCT03401112|525188588|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
145637860|NCT03401112|525188584|FG000|Overall Study|Withdrawal by Subject|0|||
145637861|NCT03401112|525188585|FG001|Overall Study|Withdrawal by Subject|3|||
145637862|NCT03401112|525188586|FG002|Overall Study|Withdrawal by Subject|2|||
145637863|NCT03401112|525188587|FG003|Overall Study|Withdrawal by Subject|1|||
145637864|NCT03401112|525188588|FG004|Overall Study|Withdrawal by Subject|0|||
145637865|NCT03401112|525188584|FG000|Overall Study|Physician Decision|0|||
145637866|NCT03401112|525188585|FG001|Overall Study|Physician Decision|0|||
145482443|NCT00687804|524618360|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
145482444|NCT00687804|524618361|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
145482445|NCT00687804|524618359|FG000|Open-Label Extension Study|Administrative problems|1|||
145482446|NCT00687804|524618360|FG001|Open-Label Extension Study|Administrative problems|1|||
145482447|NCT00687804|524618361|FG002|Open-Label Extension Study|Administrative problems|0|||
145482448|NCT00687804|524618359|FG000|Open-Label Extension Study|Death|2|||
145482449|NCT00687804|524618360|FG001|Open-Label Extension Study|Death|3|||
145482450|NCT00687804|524618361|FG002|Open-Label Extension Study|Death|3|||
145482451|NCT00413218|524618362|FG000|Overall Study|Randomized but didn't receive study drug|2|||
145482452|NCT00413218|524618363|FG001|Overall Study|Randomized but didn't receive study drug|8|||
145482453|NCT00413218|524618362|FG000|Overall Study|Death|57|||
145482454|NCT00413218|524618363|FG001|Overall Study|Death|56|||
145482455|NCT00413218|524618362|FG000|Overall Study|Lost to Follow-up|14|||
145482456|NCT00413218|524618363|FG001|Overall Study|Lost to Follow-up|17|||
145482457|NCT00413218|524618362|FG000|Overall Study|Admin|20|||
145482458|NCT00413218|524618363|FG001|Overall Study|Admin|14|||
145482459|NCT00413218|524618362|FG000|Overall Study|Missing|1|||
145482460|NCT00413218|524618363|FG001|Overall Study|Missing|0|||
145482461|NCT00413218|524618362|FG000|Overall Study|Withdrawal by Subject|9|||
145482462|NCT00413218|524618363|FG001|Overall Study|Withdrawal by Subject|1|||
145482463|NCT04034004|524618365|FG000|Overall Study|Withdrawal by Subject|1|||
145482464|NCT04034004|524618366|FG001|Overall Study|Withdrawal by Subject|2|||
145482465|NCT04034004|524618367|FG002|Overall Study|Withdrawal by Subject|2|||
145482466|NCT04034004|524618368|FG003|Overall Study|Withdrawal by Subject|3|||
145482467|NCT04034004|524618365|FG000|Overall Study|could not find vein to administer IV|2|||
145482468|NCT04034004|524618366|FG001|Overall Study|could not find vein to administer IV|1|||
145482469|NCT04034004|524618367|FG002|Overall Study|could not find vein to administer IV|0|||
145482470|NCT04034004|524618368|FG003|Overall Study|could not find vein to administer IV|0|||
145604312|NCT03764072|525064746|FG005|Overall Study|Lost to Follow-up|0|||
145604313|NCT00982930|525064747|FG000|Overall Study|Adverse Event|1|||
145604314|NCT00982930|525064747|FG000|Overall Study|Withdrawal by Subject|1|||
145604315|NCT00982930|525064747|FG000|Overall Study|Administrative Problems|2|||
145604316|NCT05559866|525064748|FG000|Overall Study|Withdrawal by Subject|1|||
145604317|NCT05559866|525064749|FG001|Overall Study|Withdrawal by Subject|0|||
145604318|NCT07018999|525064753|FG000|Overall Study|Protocol Violation|0|||
145604319|NCT07018999|525064754|FG001|Overall Study|Protocol Violation|1|||
145604320|NCT07018999|525064753|FG000|Overall Study|Incomplete data entry|4|||
145604321|NCT07018999|525064754|FG001|Overall Study|Incomplete data entry|7|||
145604322|NCT03444376|525064755|FG000|Part A|Disease relapse or Progression|1|||
145604323|NCT03444376|525064755|FG000|Part A|Withdrawal by Subject|2|||
145604324|NCT03444376|525064755|FG000|Part A|Adverse Event|1|||
145604325|NCT03444376|525064755|FG000|Part B|Disease relapse or Progression|18|||
145604326|NCT03444376|525064755|FG000|Part B|Withdrawal by Subject|2|||
145604327|NCT03444376|525064755|FG000|Part B|Adverse Event|2|||
145604328|NCT03444376|525064755|FG000|Part B|Physician Decision|1|||
145604329|NCT03444376|525064755|FG000|Part C|Disease relapse or Progression|43|||
145604330|NCT03444376|525064755|FG000|Part C|Withdrawal by Subject|5|||
145604331|NCT03444376|525064755|FG000|Part C|Adverse Event|2|||
145604332|NCT03444376|525064755|FG000|Part C|Physician Decision|2|||
145604333|NCT03444376|525064755|FG000|Part C|Death|1|||
145604334|NCT06027619|525064756|FG000|Overall Study|Adverse Event|0|||
145482471|NCT04034004|524618365|FG000|Overall Study|nurse accidentally unblinded subject|0|||
145604335|NCT06027619|525064757|FG001|Overall Study|Adverse Event|0|||
145482472|NCT04034004|524618366|FG001|Overall Study|nurse accidentally unblinded subject|0|||
145482473|NCT04034004|524618367|FG002|Overall Study|nurse accidentally unblinded subject|0|||
145482474|NCT04034004|524618368|FG003|Overall Study|nurse accidentally unblinded subject|1|||
145482475|NCT04317040|524618369|FG000|Overall Study|Lost to Follow-up|2|||
145482476|NCT04317040|524618370|FG001|Overall Study|Lost to Follow-up|0|||
145482477|NCT04317040|524618369|FG000|Overall Study|Death|16|||
145482478|NCT04317040|524618370|FG001|Overall Study|Death|18|||
145482479|NCT04317040|524618369|FG000|Overall Study|Withdrawal by Subject|0|||
145482480|NCT04317040|524618370|FG001|Overall Study|Withdrawal by Subject|1|||
145482481|NCT04317040|524618369|FG000|Overall Study|Incomplete assessments|0|||
145482482|NCT04317040|524618370|FG001|Overall Study|Incomplete assessments|1|||
145482483|NCT03672292|524618371|FG000|Overall Study|Adverse Event|3|||
145482484|NCT03672292|524618372|FG001|Overall Study|Adverse Event|1|||
145482485|NCT03672292|524618371|FG000|Overall Study|Physician Decision|0|||
145482486|NCT03672292|524618372|FG001|Overall Study|Physician Decision|1|||
145482487|NCT03672292|524618371|FG000|Overall Study|Withdrawal by Subject|1|||
145482488|NCT03672292|524618372|FG001|Overall Study|Withdrawal by Subject|2|||
145482489|NCT00799903|524618373|FG000|Overall Study|Investigator Site Closed|25|||
145482490|NCT00799903|524618374|FG001|Overall Study|Investigator Site Closed|23|||
145482491|NCT00799903|524618373|FG000|Overall Study|Withdrawal by Subject|179|||
145482492|NCT00799903|524618374|FG001|Overall Study|Withdrawal by Subject|175|||
145482493|NCT00799903|524618373|FG000|Overall Study|Lost to Follow-up|69|||
145482494|NCT00799903|524618374|FG001|Overall Study|Lost to Follow-up|80|||
145482495|NCT02518971|524618375|FG000|Overall Study|Lost to Follow-up|0|||
145482496|NCT02518971|524618376|FG001|Overall Study|Lost to Follow-up|1|||
145482497|NCT02518971|524618375|FG000|Overall Study|Physician Decision|6|||
145482498|NCT02518971|524618376|FG001|Overall Study|Physician Decision|6|||
145482499|NCT02518971|524618375|FG000|Overall Study|Protocol Violation|6|||
145482500|NCT02518971|524618376|FG001|Overall Study|Protocol Violation|4|||
145482501|NCT02518971|524618375|FG000|Overall Study|Withdrawal by Subject|4|||
145482502|NCT02518971|524618376|FG001|Overall Study|Withdrawal by Subject|5|||
145482503|NCT02518971|524618375|FG000|Overall Study|Side effects|1|||
145482504|NCT02518971|524618376|FG001|Overall Study|Side effects|0|||
145482505|NCT02518971|524618375|FG000|Overall Study|medication lost in mail|0|||
145482506|NCT02518971|524618376|FG001|Overall Study|medication lost in mail|1|||
145482507|NCT02518971|524618375|FG000|Overall Study|eligibility criteria no longer met|6|||
145482508|NCT02518971|524618376|FG001|Overall Study|eligibility criteria no longer met|3|||
145482509|NCT03088917|524618377|FG000|Overall Study|In care/cured elsewhere|15|||
145482510|NCT03088917|524618377|FG000|Overall Study|Refuse re-evaluation|13|||
145482511|NCT03088917|524618377|FG000|Overall Study|Contact not established|13|||
145482512|NCT03088917|524618377|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
145482513|NCT03088917|524618377|FG000|Overall Study|Moved outside study region|50|||
145482514|NCT00757237|524618378|FG000|Overall Study|Lost to Follow-up|0|||
145482515|NCT00757237|524618379|FG001|Overall Study|Lost to Follow-up|1|||
145482516|NCT00757237|524618378|FG000|Overall Study|Protocol Violation|0|||
145482517|NCT00757237|524618379|FG001|Overall Study|Protocol Violation|2|||
145482518|NCT00757237|524618378|FG000|Overall Study|Physician Decision|2|||
145482519|NCT00757237|524618379|FG001|Overall Study|Physician Decision|3|||
145482520|NCT00757237|524618378|FG000|Overall Study|Withdrawal by Subject|8|||
145482521|NCT00757237|524618379|FG001|Overall Study|Withdrawal by Subject|12|||
145482522|NCT00757237|524618378|FG000|Overall Study|Safety or Tolerability|3|||
145482523|NCT00757237|524618379|FG001|Overall Study|Safety or Tolerability|5|||
145482524|NCT00757237|524618378|FG000|Overall Study|Other|0|||
145482525|NCT00757237|524618379|FG001|Overall Study|Other|2|||
145482526|NCT05150990|524618386|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
145482527|NCT05150990|524618387|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
145482528|NCT05150990|524618386|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
145482529|NCT05150990|524618387|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
145482530|NCT05150990|524618386|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
145482531|NCT05150990|524618387|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
145482532|NCT05150990|524618386|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
145482533|NCT05150990|524618387|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
145482534|NCT05150990|524618386|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
145482535|NCT05150990|524618387|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
145482536|NCT05150990|524618386|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
145604336|NCT06027619|525064758|FG002|Overall Study|Adverse Event|1|||
145604337|NCT00755222|525066516|FG000|Overall Study|Withdrawal by Subject|4|||
145604338|NCT00755222|525066517|FG001|Overall Study|Withdrawal by Subject|2|||
145604339|NCT00755222|525066516|FG000|Overall Study|Adverse Event|2|||
145604340|NCT00755222|525066517|FG001|Overall Study|Adverse Event|0|||
145604341|NCT00755222|525066516|FG000|Overall Study|Protocol Violation|2|||
145604342|NCT00755222|525066517|FG001|Overall Study|Protocol Violation|0|||
145482537|NCT05150990|524618387|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
145482538|NCT05150990|524618386|FG000|Overall Study|Death (unrelated to the intervention)|1|||
145482539|NCT05150990|524618387|FG001|Overall Study|Death (unrelated to the intervention)|2|||
145482540|NCT00779025|524618388|FG000|Overall Study|Withdrawal by Subject|1|||
145482541|NCT02735343|524618411|FG000|Overall Study|screen fail|0|||
145482542|NCT02735343|524618412|FG001|Overall Study|screen fail|2|||
145482543|NCT02715609|524618422|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
145482544|NCT02715609|524618423|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
145482545|NCT02715609|524618424|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
145482546|NCT02715609|524618422|FG000|Overall Study|Withdrawal by Subject|0|||
145482547|NCT02715609|524618423|FG001|Overall Study|Withdrawal by Subject|0|||
145482548|NCT02715609|524618424|FG002|Overall Study|Withdrawal by Subject|1|||
145482549|NCT00310817|524618425|FG000|Overall Study|AE or Death|3|||
145482550|NCT00310817|524618426|FG001|Overall Study|AE or Death|1|||
145482551|NCT00310817|524618427|FG002|Overall Study|AE or Death|0|||
145482552|NCT00310817|524618428|FG003|Overall Study|AE or Death|0|||
145482553|NCT00310817|524618425|FG000|Overall Study|Withdrawal by Subject|1|||
145482554|NCT00310817|524618426|FG001|Overall Study|Withdrawal by Subject|4|||
145482555|NCT00310817|524618427|FG002|Overall Study|Withdrawal by Subject|6|||
145482556|NCT00310817|524618428|FG003|Overall Study|Withdrawal by Subject|7|||
145482557|NCT00310817|524618425|FG000|Overall Study|Lost to Follow-up|2|||
145482558|NCT00310817|524618426|FG001|Overall Study|Lost to Follow-up|1|||
145482559|NCT00310817|524618427|FG002|Overall Study|Lost to Follow-up|0|||
145482560|NCT00310817|524618428|FG003|Overall Study|Lost to Follow-up|0|||
145482561|NCT00310817|524618425|FG000|Overall Study|Inappropriate Enrollment|1|||
145482562|NCT00310817|524618426|FG001|Overall Study|Inappropriate Enrollment|0|||
145482563|NCT00310817|524618427|FG002|Overall Study|Inappropriate Enrollment|1|||
145482564|NCT00310817|524618428|FG003|Overall Study|Inappropriate Enrollment|0|||
145482565|NCT00310817|524618425|FG000|Overall Study|Protocol Violation|1|||
145482566|NCT00310817|524618426|FG001|Overall Study|Protocol Violation|1|||
145482567|NCT00310817|524618427|FG002|Overall Study|Protocol Violation|1|||
145482568|NCT00310817|524618428|FG003|Overall Study|Protocol Violation|1|||
145482569|NCT00310817|524618425|FG000|Overall Study|Unable to classify|3|||
145482570|NCT00310817|524618426|FG001|Overall Study|Unable to classify|1|||
145482571|NCT00310817|524618427|FG002|Overall Study|Unable to classify|0|||
145482572|NCT00310817|524618428|FG003|Overall Study|Unable to classify|0|||
145482573|NCT02915978|524618429|FG000|Overall Study|Adverse Event|2|||
145482574|NCT02915978|524618430|FG001|Overall Study|Adverse Event|1|||
145482575|NCT02915978|524618431|FG002|Overall Study|Adverse Event|0|||
145482576|NCT04522141|524618433|FG000|Overall Study|Withdrawal by Subject|1|||
145482577|NCT04522141|524618434|FG001|Overall Study|Withdrawal by Subject|0|||
145482578|NCT03052049|524618435|FG000|Overall Study|Withdrawal by Subject|2|||
145482579|NCT00999518|524618436|FG000|Overall Study|Adverse Event|1|||
145482580|NCT00999518|524618437|FG001|Overall Study|Adverse Event|6|||
145482581|NCT00999518|524618438|FG002|Overall Study|Adverse Event|3|||
145482582|NCT00999518|524618439|FG003|Overall Study|Adverse Event|1|||
145482583|NCT00999518|524618440|FG004|Overall Study|Adverse Event|2|||
145482584|NCT00999518|524618436|FG000|Overall Study|Lack of Efficacy|2|||
145482585|NCT00999518|524618437|FG001|Overall Study|Lack of Efficacy|0|||
145482586|NCT00999518|524618438|FG002|Overall Study|Lack of Efficacy|0|||
145482587|NCT00999518|524618439|FG003|Overall Study|Lack of Efficacy|2|||
145482588|NCT00999518|524618440|FG004|Overall Study|Lack of Efficacy|2|||
145482589|NCT00999518|524618436|FG000|Overall Study|Lost to Follow-up|0|||
145482590|NCT00999518|524618437|FG001|Overall Study|Lost to Follow-up|0|||
145482591|NCT00999518|524618438|FG002|Overall Study|Lost to Follow-up|0|||
145482592|NCT00999518|524618439|FG003|Overall Study|Lost to Follow-up|4|||
145482593|NCT00999518|524618440|FG004|Overall Study|Lost to Follow-up|1|||
145482594|NCT00999518|524618436|FG000|Overall Study|Did not meet entrance criteria|0|||
145482595|NCT00999518|524618437|FG001|Overall Study|Did not meet entrance criteria|0|||
145482596|NCT00999518|524618438|FG002|Overall Study|Did not meet entrance criteria|0|||
145482597|NCT00999518|524618439|FG003|Overall Study|Did not meet entrance criteria|0|||
145482598|NCT00999518|524618440|FG004|Overall Study|Did not meet entrance criteria|1|||
145482599|NCT00999518|524618436|FG000|Overall Study|Study terminated by sponsor|10|||
145482600|NCT00999518|524618437|FG001|Overall Study|Study terminated by sponsor|6|||
145482601|NCT00999518|524618438|FG002|Overall Study|Study terminated by sponsor|5|||
145482602|NCT00999518|524618439|FG003|Overall Study|Study terminated by sponsor|5|||
145482603|NCT00999518|524618440|FG004|Overall Study|Study terminated by sponsor|9|||
145482604|NCT00999518|524618436|FG000|Overall Study|Pregnancy|0|||
145482605|NCT00999518|524618437|FG001|Overall Study|Pregnancy|0|||
145482606|NCT00999518|524618438|FG002|Overall Study|Pregnancy|1|||
145482607|NCT00999518|524618439|FG003|Overall Study|Pregnancy|0|||
145482608|NCT00999518|524618440|FG004|Overall Study|Pregnancy|0|||
145482609|NCT00999518|524618436|FG000|Overall Study|Protocol Violation|0|||
145482610|NCT00999518|524618437|FG001|Overall Study|Protocol Violation|1|||
145482611|NCT00999518|524618438|FG002|Overall Study|Protocol Violation|0|||
145482612|NCT00999518|524618439|FG003|Overall Study|Protocol Violation|0|||
145482613|NCT00999518|524618440|FG004|Overall Study|Protocol Violation|2|||
145482614|NCT00999518|524618436|FG000|Overall Study|Withdrawal by Subject|5|||
145482615|NCT00999518|524618437|FG001|Overall Study|Withdrawal by Subject|4|||
145482616|NCT00999518|524618438|FG002|Overall Study|Withdrawal by Subject|10|||
145482617|NCT00999518|524618439|FG003|Overall Study|Withdrawal by Subject|6|||
145482618|NCT00999518|524618440|FG004|Overall Study|Withdrawal by Subject|1|||
145482619|NCT00999518|524618436|FG000|Overall Study|Other|5|||
145482620|NCT00999518|524618437|FG001|Overall Study|Other|7|||
145482621|NCT00999518|524618438|FG002|Overall Study|Other|1|||
145482622|NCT00999518|524618439|FG003|Overall Study|Other|4|||
145482623|NCT00999518|524618440|FG004|Overall Study|Other|5|||
145482624|NCT00999518|524618436|FG000|Overall Study|Randomized but not Treated|1|||
145482625|NCT00999518|524618437|FG001|Overall Study|Randomized but not Treated|1|||
145482626|NCT00999518|524618438|FG002|Overall Study|Randomized but not Treated|2|||
145482627|NCT00999518|524618439|FG003|Overall Study|Randomized but not Treated|0|||
145482628|NCT00999518|524618440|FG004|Overall Study|Randomized but not Treated|1|||
145482629|NCT00250276|524618444|FG000|Overall Study|Serious Adverse Event|0|||
145482630|NCT00250276|524618445|FG001|Overall Study|Serious Adverse Event|0|||
145482631|NCT00250276|524618446|FG002|Overall Study|Serious Adverse Event|1|||
145482632|NCT00250276|524618447|FG003|Overall Study|Serious Adverse Event|0|||
145482633|NCT00250276|524618444|FG000|Overall Study|Non-serious Adverse Event|2|||
145482634|NCT00250276|524618445|FG001|Overall Study|Non-serious Adverse Event|0|||
145482635|NCT00250276|524618446|FG002|Overall Study|Non-serious Adverse Event|0|||
145482636|NCT00250276|524618447|FG003|Overall Study|Non-serious Adverse Event|2|||
145482637|NCT00250276|524618444|FG000|Overall Study|Protocol Violation|0|||
145482638|NCT00250276|524618445|FG001|Overall Study|Protocol Violation|1|||
145482639|NCT00250276|524618446|FG002|Overall Study|Protocol Violation|0|||
145482640|NCT00250276|524618447|FG003|Overall Study|Protocol Violation|0|||
145482641|NCT00250276|524618444|FG000|Overall Study|Withdrawal by Subject|1|||
145482642|NCT00250276|524618445|FG001|Overall Study|Withdrawal by Subject|2|||
145482643|NCT00250276|524618446|FG002|Overall Study|Withdrawal by Subject|3|||
145482644|NCT00250276|524618447|FG003|Overall Study|Withdrawal by Subject|2|||
145482645|NCT00250276|524618444|FG000|Overall Study|Migrated/moved from study area|3|||
145482646|NCT00250276|524618445|FG001|Overall Study|Migrated/moved from study area|0|||
145482647|NCT00250276|524618446|FG002|Overall Study|Migrated/moved from study area|2|||
145482648|NCT00250276|524618447|FG003|Overall Study|Migrated/moved from study area|7|||
145482649|NCT00250276|524618444|FG000|Overall Study|Lost to Follow-up|11|||
145482650|NCT00250276|524618445|FG001|Overall Study|Lost to Follow-up|18|||
145482651|NCT00250276|524618446|FG002|Overall Study|Lost to Follow-up|13|||
145482652|NCT00250276|524618447|FG003|Overall Study|Lost to Follow-up|8|||
145482653|NCT03543137|524618448|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
145482654|NCT03543137|524618449|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
145482655|NCT03543137|524618448|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
145482656|NCT03543137|524618449|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
145482657|NCT03543137|524618448|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
145482658|NCT03543137|524618449|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
145482659|NCT01594931|524620563|FG000|Overall Study|Adverse Event|3|||
145482660|NCT01594931|524620564|FG001|Overall Study|Adverse Event|1|||
145482661|NCT01594931|524620565|FG002|Overall Study|Adverse Event|1|||
145482662|NCT01594931|524620563|FG000|Overall Study|Withdrawal by Subject|2|||
145482663|NCT01594931|524620564|FG001|Overall Study|Withdrawal by Subject|1|||
145482664|NCT01594931|524620565|FG002|Overall Study|Withdrawal by Subject|1|||
145482665|NCT01594931|524620563|FG000|Overall Study|Lack of Efficacy|7|||
145482666|NCT01594931|524620564|FG001|Overall Study|Lack of Efficacy|2|||
145482667|NCT01594931|524620565|FG002|Overall Study|Lack of Efficacy|2|||
145482668|NCT01594931|524620563|FG000|Overall Study|Lost to Follow-up|4|||
145482669|NCT01594931|524620564|FG001|Overall Study|Lost to Follow-up|3|||
145482670|NCT01594931|524620565|FG002|Overall Study|Lost to Follow-up|3|||
145482671|NCT01594931|524620563|FG000|Overall Study|Protocol Violation|2|||
145482672|NCT01594931|524620564|FG001|Overall Study|Protocol Violation|1|||
145482673|NCT01594931|524620565|FG002|Overall Study|Protocol Violation|0|||
145482674|NCT01594931|524620563|FG000|Overall Study|No defiined|11|||
145482675|NCT01594931|524620564|FG001|Overall Study|No defiined|4|||
145482676|NCT01594931|524620565|FG002|Overall Study|No defiined|7|||
145482677|NCT04864639|524620566|FG000|Overall Study|Death|1|||
145482678|NCT04864639|524620566|FG000|Overall Study|Lost to Follow-up|1|||
145482679|NCT01478971|524620570|FG000|Standard of Care Period|Adverse Event|1|||
145482680|NCT01478971|524620570|FG000|Standard of Care Period|Withdrawal by Subject|3|||
145482681|NCT01478971|524620570|FG000|Standard of Care Period|Death|8|||
145482682|NCT01478971|524620570|FG000|Standard of Care Period|Lost to Follow-up|9|||
145482683|NCT01478971|524620570|FG000|Standard of Care Period|Other|4|||
145482684|NCT01478971|524620570|FG000|Peginesatide Treatment Period|Adverse Event|1|||
145482685|NCT01478971|524620570|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
145482686|NCT01478971|524620570|FG000|Peginesatide Treatment Period|Death|4|||
145482687|NCT01478971|524620570|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
145482688|NCT01478971|524620570|FG000|Peginesatide Treatment Period|Other|4|||
145482689|NCT01525615|524620571|FG000|Overall Study|Adverse Event|11|||
145482690|NCT01525615|524620572|FG001|Overall Study|Adverse Event|7|||
145482691|NCT01525615|524620573|FG002|Overall Study|Adverse Event|5|||
145482692|NCT01525615|524620571|FG000|Overall Study|Lost to Follow-up|1|||
145482693|NCT01525615|524620572|FG001|Overall Study|Lost to Follow-up|0|||
145482694|NCT01525615|524620573|FG002|Overall Study|Lost to Follow-up|0|||
145482695|NCT01525615|524620571|FG000|Overall Study|Withdrawal by Subject|1|||
145482696|NCT01525615|524620572|FG001|Overall Study|Withdrawal by Subject|0|||
145482697|NCT01525615|524620573|FG002|Overall Study|Withdrawal by Subject|0|||
145482698|NCT01525615|524620571|FG000|Overall Study|Other reason not described above|1|||
145482699|NCT01525615|524620572|FG001|Overall Study|Other reason not described above|0|||
145482700|NCT01525615|524620573|FG002|Overall Study|Other reason not described above|1|||
145482701|NCT04050618|524620574|FG000|First Intervention|Withdrawal by Subject|2|||
145482702|NCT04050618|524620575|FG001|First Intervention|Withdrawal by Subject|0|||
145482703|NCT04050618|524620574|FG000|Second Intervention|Withdrawal by Subject|1|||
145482704|NCT04050618|524620575|FG001|Second Intervention|Withdrawal by Subject|0|||
145482705|NCT02451943|524620584|FG000|Overall Study|Withdrawal by Subject|13|||
145482706|NCT02451943|524620585|FG001|Overall Study|Withdrawal by Subject|16|||
145482707|NCT02451943|524620584|FG000|Overall Study|Lost to Follow-up|3|||
145482708|NCT02451943|524620585|FG001|Overall Study|Lost to Follow-up|4|||
145482709|NCT02451943|524620584|FG000|Overall Study|Sponsor Decision|0|||
145482710|NCT02451943|524620585|FG001|Overall Study|Sponsor Decision|4|||
145482711|NCT01101035|524620586|FG000|Overall Study|Adverse Event|191|||
145482712|NCT01101035|524620587|FG001|Overall Study|Adverse Event|172|||
145482713|NCT01101035|524620586|FG000|Overall Study|Major Protocol Deviation|52|||
145482714|NCT01101035|524620587|FG001|Overall Study|Major Protocol Deviation|46|||
145482715|NCT01101035|524620586|FG000|Overall Study|Lost to Follow-up|226|||
145482716|NCT01101035|524620587|FG001|Overall Study|Lost to Follow-up|223|||
145482717|NCT01101035|524620586|FG000|Overall Study|Voluntary Withdrawal|595|||
145482718|NCT01101035|524620587|FG001|Overall Study|Voluntary Withdrawal|587|||
145482719|NCT01101035|524620586|FG000|Overall Study|Reason not Specified|333|||
145482720|NCT01101035|524620587|FG001|Overall Study|Reason not Specified|363|||
145482721|NCT02871635|524620588|FG000|Overall Study|Primary lack of efficacy|4|||
145482722|NCT02871635|524620589|FG001|Overall Study|Primary lack of efficacy|4|||
145482723|NCT02871635|524620588|FG000|Overall Study|Protocol Violation|3|||
145482724|NCT02871635|524620589|FG001|Overall Study|Protocol Violation|1|||
145482725|NCT02871635|524620588|FG000|Overall Study|Lost to Follow-up|1|||
145482726|NCT02871635|524620589|FG001|Overall Study|Lost to Follow-up|2|||
145482727|NCT02871635|524620588|FG000|Overall Study|Pregnancy|0|||
145482728|NCT02871635|524620589|FG001|Overall Study|Pregnancy|2|||
145482729|NCT02871635|524620588|FG000|Overall Study|Physician Decision|1|||
145482730|NCT02871635|524620589|FG001|Overall Study|Physician Decision|1|||
145482731|NCT02871635|524620588|FG000|Overall Study|Withdrawal by Subject|3|||
145482732|NCT02871635|524620589|FG001|Overall Study|Withdrawal by Subject|4|||
145482733|NCT02871635|524620588|FG000|Overall Study|Adverse Event|4|||
145482734|NCT02871635|524620589|FG001|Overall Study|Adverse Event|4|||
145482735|NCT02871635|524620588|FG000|Overall Study|Secondary lack of efficacy|2|||
145482736|NCT02871635|524620589|FG001|Overall Study|Secondary lack of efficacy|1|||
145482737|NCT00412893|524620594|FG000|Overall Study|Adverse Event|31|||
145482738|NCT00412893|524620595|FG001|Overall Study|Adverse Event|53|||
145482739|NCT00412893|524620594|FG000|Overall Study|Death|17|||
145482740|NCT00412893|524620595|FG001|Overall Study|Death|21|||
145482741|NCT00412893|524620594|FG000|Overall Study|Insufficient Therapeutic Response|39|||
145482742|NCT00412893|524620595|FG001|Overall Study|Insufficient Therapeutic Response|23|||
145482743|NCT00412893|524620594|FG000|Overall Study|Lost to Follow-up|2|||
145482744|NCT00412893|524620595|FG001|Overall Study|Lost to Follow-up|1|||
145482745|NCT00412893|524620594|FG000|Overall Study|Violation of Selection at Entry|17|||
145482746|NCT00412893|524620595|FG001|Overall Study|Violation of Selection at Entry|10|||
145482747|NCT00412893|524620594|FG000|Overall Study|Other Protocol Violation|10|||
145482748|NCT00412893|524620595|FG001|Overall Study|Other Protocol Violation|6|||
145482749|NCT00412893|524620594|FG000|Overall Study|Did Not Cooperate|12|||
145482750|NCT00412893|524620595|FG001|Overall Study|Did Not Cooperate|9|||
145482751|NCT00412893|524620594|FG000|Overall Study|Administrative Reason|12|||
145482752|NCT00412893|524620595|FG001|Overall Study|Administrative Reason|15|||
145482753|NCT00412893|524620594|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
145482754|NCT00412893|524620595|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
145482755|NCT00217425|524620596|FG000|Overall Study|Never started treatment|2|||
145265297|NCT02389621|523819267|FG000|Posttreatment Period|Other - Miscellaneous|2|||
145482756|NCT00217425|524620596|FG000|Overall Study|Patient ineligible|5|||
145482757|NCT00217425|524620596|FG000|Overall Study|Lack of Efficacy|13|||
145482758|NCT00217425|524620596|FG000|Overall Study|Adverse Event|8|||
145482759|NCT00217425|524620596|FG000|Overall Study|Withdrawal by Subject|4|||
145482760|NCT00217425|524620596|FG000|Overall Study|Other complicating disease|1|||
145482761|NCT00217425|524620596|FG000|Overall Study|Other|4|||
145482762|NCT03951077|524620597|FG000|Overall Study|Adverse Event|1|||
145482763|NCT03951077|524620598|FG001|Overall Study|Adverse Event|0|||
145482764|NCT03951077|524620599|FG002|Overall Study|Adverse Event|0|||
145482765|NCT03951077|524620600|FG003|Overall Study|Adverse Event|0|||
145482766|NCT03951077|524620601|FG004|Overall Study|Adverse Event|0|||
145482767|NCT03951077|524620602|FG005|Overall Study|Adverse Event|0|||
145482768|NCT03951077|524620597|FG000|Overall Study|Withdrawal by Subject|3|||
145482769|NCT03951077|524620598|FG001|Overall Study|Withdrawal by Subject|3|||
145482770|NCT03951077|524620599|FG002|Overall Study|Withdrawal by Subject|0|||
145482771|NCT03951077|524620600|FG003|Overall Study|Withdrawal by Subject|3|||
145482772|NCT03951077|524620601|FG004|Overall Study|Withdrawal by Subject|3|||
145482773|NCT03951077|524620602|FG005|Overall Study|Withdrawal by Subject|2|||
145482774|NCT03951077|524620597|FG000|Overall Study|Lost to Follow-up|1|||
145482775|NCT03951077|524620598|FG001|Overall Study|Lost to Follow-up|1|||
145482776|NCT03951077|524620599|FG002|Overall Study|Lost to Follow-up|2|||
145482777|NCT03951077|524620600|FG003|Overall Study|Lost to Follow-up|3|||
145482778|NCT03951077|524620601|FG004|Overall Study|Lost to Follow-up|2|||
145482779|NCT03951077|524620602|FG005|Overall Study|Lost to Follow-up|3|||
145482780|NCT03951077|524620597|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
145482781|NCT03951077|524620598|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
145482782|NCT03951077|524620599|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
145482783|NCT03951077|524620600|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
145482784|NCT03951077|524620601|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
145482785|NCT03951077|524620602|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
145482786|NCT03951077|524620597|FG000|Overall Study|Other, Not Specified|12|||
145482787|NCT03951077|524620598|FG001|Overall Study|Other, Not Specified|10|||
145482788|NCT03951077|524620599|FG002|Overall Study|Other, Not Specified|10|||
145482789|NCT03951077|524620600|FG003|Overall Study|Other, Not Specified|5|||
145482790|NCT03951077|524620601|FG004|Overall Study|Other, Not Specified|9|||
145482791|NCT03951077|524620602|FG005|Overall Study|Other, Not Specified|6|||
145482792|NCT03951077|524620597|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
145482793|NCT03951077|524620598|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
145482794|NCT03951077|524620599|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
145482795|NCT03951077|524620600|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
145482796|NCT03951077|524620601|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
145482797|NCT03951077|524620602|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
145482798|NCT01473732|524620604|FG000|Overall Study|Adverse Event|1|||
145482799|NCT01473732|524620605|FG001|Overall Study|Adverse Event|0|||
145482800|NCT01473732|524620604|FG000|Overall Study|Death|1|||
145482801|NCT01473732|524620605|FG001|Overall Study|Death|0|||
145482802|NCT01395901|524620606|FG000|Overall Study|Lost to Follow-up|4|||
145482803|NCT01395901|524620607|FG001|Overall Study|Lost to Follow-up|0|||
145482804|NCT01395901|524620606|FG000|Overall Study|Randomized but not received study drug|5|||
145482805|NCT01395901|524620607|FG001|Overall Study|Randomized but not received study drug|4|||
145482806|NCT01395901|524620606|FG000|Overall Study|Adverse Event|0|||
145482807|NCT01395901|524620607|FG001|Overall Study|Adverse Event|1|||
145482808|NCT01395901|524620606|FG000|Overall Study|Withdrawal of consent|1|||
145482809|NCT01395901|524620607|FG001|Overall Study|Withdrawal of consent|0|||
145482810|NCT03579940|524620611|FG000|Period 2|Withdrawal by Subject|0|||
145482811|NCT03579940|524620612|FG001|Period 2|Withdrawal by Subject|0|||
145482812|NCT03579940|524620613|FG002|Period 2|Withdrawal by Subject|1|||
145482813|NCT03579940|524620614|FG003|Period 2|Withdrawal by Subject|0|||
145482814|NCT03579940|524620615|FG004|Period 2|Withdrawal by Subject|0|||
145482815|NCT03579940|524620616|FG005|Period 2|Withdrawal by Subject|0|||
145482816|NCT03579940|524620617|FG006|Period 2|Withdrawal by Subject|0|||
145482817|NCT03579940|524620618|FG007|Period 2|Withdrawal by Subject|0|||
145482818|NCT03579940|524620619|FG008|Period 2|Withdrawal by Subject|0|||
145482819|NCT03579940|524620620|FG009|Period 2|Withdrawal by Subject|0|||
145482820|NCT03579940|524620621|FG010|Period 2|Withdrawal by Subject|0|||
145482821|NCT01217944|524620622|FG000|Overall Study|Protocol Violation|1|||
145482822|NCT01217944|524620623|FG001|Overall Study|Protocol Violation|1|||
145482823|NCT01217944|524620624|FG002|Overall Study|Protocol Violation|0|||
145482824|NCT01217944|524620622|FG000|Overall Study|Lost to Follow-up|3|||
145482825|NCT01217944|524620623|FG001|Overall Study|Lost to Follow-up|1|||
145482826|NCT01217944|524620624|FG002|Overall Study|Lost to Follow-up|0|||
145482827|NCT01217944|524620622|FG000|Overall Study|Withdrawal by Subject|1|||
145482828|NCT01217944|524620623|FG001|Overall Study|Withdrawal by Subject|2|||
145482829|NCT01217944|524620624|FG002|Overall Study|Withdrawal by Subject|0|||
145482830|NCT01217944|524620622|FG000|Overall Study|Lack of Efficacy|1|||
145482831|NCT01217944|524620623|FG001|Overall Study|Lack of Efficacy|0|||
145265298|NCT02389621|523819268|FG001|Posttreatment Period|Other - Miscellaneous|0|||
145482832|NCT01217944|524620624|FG002|Overall Study|Lack of Efficacy|0|||
145482833|NCT00671034|524620625|FG000|Overall Study|Adverse Event|5|||
145482834|NCT00671034|524620626|FG001|Overall Study|Adverse Event|7|||
145482835|NCT00671034|524620627|FG002|Overall Study|Adverse Event|1|||
145482836|NCT00671034|524620625|FG000|Overall Study|Death|3|||
145482837|NCT00671034|524620626|FG001|Overall Study|Death|2|||
145482838|NCT00671034|524620627|FG002|Overall Study|Death|1|||
145482839|NCT00671034|524620625|FG000|Overall Study|Physician Decision|12|||
145482840|NCT00671034|524620626|FG001|Overall Study|Physician Decision|4|||
145482841|NCT00671034|524620627|FG002|Overall Study|Physician Decision|5|||
145482842|NCT00671034|524620625|FG000|Overall Study|VHR ALL feature|8|||
145482843|NCT00671034|524620626|FG001|Overall Study|VHR ALL feature|3|||
145482844|NCT00671034|524620627|FG002|Overall Study|VHR ALL feature|5|||
145637867|NCT03401112|525188586|FG002|Overall Study|Physician Decision|0|||
145482845|NCT00671034|524620625|FG000|Overall Study|Refusal|5|||
145482846|NCT00671034|524620626|FG001|Overall Study|Refusal|3|||
145482847|NCT00671034|524620627|FG002|Overall Study|Refusal|5|||
145482848|NCT00671034|524620625|FG000|Overall Study|includes Alternative therapy, etc.|6|||
145482849|NCT00671034|524620626|FG001|Overall Study|includes Alternative therapy, etc.|1|||
145482850|NCT00671034|524620627|FG002|Overall Study|includes Alternative therapy, etc.|7|||
145482851|NCT00853151|524620628|FG000|Overall Study|Adverse Event|1|||
145482852|NCT00853151|524620629|FG001|Overall Study|Adverse Event|4|||
145482853|NCT00853151|524620630|FG002|Overall Study|Adverse Event|2|||
145482854|NCT00853151|524620631|FG003|Overall Study|Adverse Event|0|||
145482855|NCT00853151|524620628|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
145482856|NCT00853151|524620629|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145482857|NCT00853151|524620630|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145482858|NCT00853151|524620631|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145482859|NCT00853151|524620628|FG000|Overall Study|Lost to Follow-up|2|||
145482860|NCT00853151|524620629|FG001|Overall Study|Lost to Follow-up|0|||
145482861|NCT00853151|524620630|FG002|Overall Study|Lost to Follow-up|3|||
145482862|NCT00853151|524620631|FG003|Overall Study|Lost to Follow-up|0|||
145482863|NCT00853151|524620628|FG000|Overall Study|Death|1|||
145482864|NCT00853151|524620629|FG001|Overall Study|Death|0|||
145482865|NCT00853151|524620630|FG002|Overall Study|Death|0|||
145482866|NCT00853151|524620631|FG003|Overall Study|Death|1|||
145482867|NCT00853151|524620628|FG000|Overall Study|Protocol Violation|0|||
145482868|NCT00853151|524620629|FG001|Overall Study|Protocol Violation|0|||
145482869|NCT00853151|524620630|FG002|Overall Study|Protocol Violation|0|||
145482870|NCT00853151|524620631|FG003|Overall Study|Protocol Violation|1|||
145482871|NCT00853151|524620628|FG000|Overall Study|Withdrawal by Subject|5|||
145482872|NCT00853151|524620629|FG001|Overall Study|Withdrawal by Subject|4|||
145482873|NCT00853151|524620630|FG002|Overall Study|Withdrawal by Subject|2|||
145482874|NCT00853151|524620631|FG003|Overall Study|Withdrawal by Subject|1|||
145482875|NCT00853151|524620628|FG000|Overall Study|Physician Decision|0|||
145482876|NCT00853151|524620629|FG001|Overall Study|Physician Decision|2|||
145482877|NCT00853151|524620630|FG002|Overall Study|Physician Decision|1|||
145482878|NCT00853151|524620631|FG003|Overall Study|Physician Decision|0|||
145482879|NCT00853151|524620628|FG000|Overall Study|Sponsor Decision|0|||
145482880|NCT00853151|524620629|FG001|Overall Study|Sponsor Decision|3|||
145482881|NCT00853151|524620630|FG002|Overall Study|Sponsor Decision|0|||
145482882|NCT00853151|524620631|FG003|Overall Study|Sponsor Decision|0|||
145482883|NCT00713544|524620632|FG000|Overall Study|Adverse Event|5|||
145482884|NCT00713544|524620633|FG001|Overall Study|Adverse Event|3|||
145482885|NCT00713544|524620634|FG002|Overall Study|Adverse Event|7|||
145482886|NCT00713544|524620635|FG003|Overall Study|Adverse Event|7|||
145482887|NCT00713544|524620636|FG004|Overall Study|Adverse Event|3|||
145482888|NCT00713544|524620637|FG005|Overall Study|Adverse Event|5|||
145482889|NCT00713544|524620632|FG000|Overall Study|Withdrawal by Subject|2|||
145482890|NCT00713544|524620633|FG001|Overall Study|Withdrawal by Subject|0|||
145482891|NCT00713544|524620634|FG002|Overall Study|Withdrawal by Subject|3|||
145482892|NCT00713544|524620635|FG003|Overall Study|Withdrawal by Subject|2|||
145482893|NCT00713544|524620636|FG004|Overall Study|Withdrawal by Subject|3|||
145637868|NCT03401112|525188587|FG003|Overall Study|Physician Decision|2|||
145637869|NCT03401112|525188588|FG004|Overall Study|Physician Decision|0|||
145637870|NCT03401112|525188584|FG000|Overall Study|Study was Terminated by Sponsor|0|||
145637871|NCT03401112|525188585|FG001|Overall Study|Study was Terminated by Sponsor|0|||
145637872|NCT03401112|525188586|FG002|Overall Study|Study was Terminated by Sponsor|0|||
145637873|NCT03401112|525188587|FG003|Overall Study|Study was Terminated by Sponsor|1|||
145637874|NCT03401112|525188588|FG004|Overall Study|Study was Terminated by Sponsor|0|||
145637875|NCT03401112|525188584|FG000|Overall Study|Day 1 Assessment not Done|1|||
145637876|NCT03401112|525188585|FG001|Overall Study|Day 1 Assessment not Done|0|||
145637877|NCT03401112|525188586|FG002|Overall Study|Day 1 Assessment not Done|0|||
145637878|NCT03401112|525188587|FG003|Overall Study|Day 1 Assessment not Done|0|||
145637879|NCT03401112|525188588|FG004|Overall Study|Day 1 Assessment not Done|0|||
145637880|NCT03401112|525188584|FG000|Overall Study|Not Dosed|0|||
145637881|NCT03401112|525188585|FG001|Overall Study|Not Dosed|0|||
145637882|NCT03401112|525188586|FG002|Overall Study|Not Dosed|1|||
145482894|NCT00713544|524620637|FG005|Overall Study|Withdrawal by Subject|1|||
145482895|NCT00713544|524620632|FG000|Overall Study|Protocol Violation|0|||
145482896|NCT00713544|524620633|FG001|Overall Study|Protocol Violation|0|||
145482897|NCT00713544|524620634|FG002|Overall Study|Protocol Violation|0|||
145482898|NCT00713544|524620635|FG003|Overall Study|Protocol Violation|0|||
145482899|NCT00713544|524620636|FG004|Overall Study|Protocol Violation|0|||
145637883|NCT03401112|525188587|FG003|Overall Study|Not Dosed|0|||
145637884|NCT03401112|525188588|FG004|Overall Study|Not Dosed|0|||
145482900|NCT00713544|524620637|FG005|Overall Study|Protocol Violation|1|||
145482901|NCT00713544|524620632|FG000|Overall Study|Physician Decision|0|||
145482902|NCT00713544|524620633|FG001|Overall Study|Physician Decision|0|||
145482903|NCT00713544|524620634|FG002|Overall Study|Physician Decision|0|||
145482904|NCT00713544|524620635|FG003|Overall Study|Physician Decision|0|||
145482905|NCT00713544|524620636|FG004|Overall Study|Physician Decision|0|||
145637885|NCT03401112|525188584|FG000|Overall Study|Missed Clinical Visit|0|||
145637886|NCT03401112|525188585|FG001|Overall Study|Missed Clinical Visit|0|||
145482906|NCT00713544|524620637|FG005|Overall Study|Physician Decision|2|||
145482907|NCT00713544|524620632|FG000|Overall Study|Lack of Efficacy|0|||
145482908|NCT00713544|524620633|FG001|Overall Study|Lack of Efficacy|1|||
145482909|NCT00713544|524620634|FG002|Overall Study|Lack of Efficacy|0|||
145482910|NCT00713544|524620635|FG003|Overall Study|Lack of Efficacy|1|||
145482911|NCT00713544|524620636|FG004|Overall Study|Lack of Efficacy|1|||
145482912|NCT00713544|524620637|FG005|Overall Study|Lack of Efficacy|0|||
145482913|NCT00713544|524620632|FG000|Overall Study|Lost to Follow-up|0|||
145482914|NCT00713544|524620633|FG001|Overall Study|Lost to Follow-up|0|||
145482915|NCT00713544|524620634|FG002|Overall Study|Lost to Follow-up|1|||
145482916|NCT00713544|524620635|FG003|Overall Study|Lost to Follow-up|0|||
145482917|NCT00713544|524620636|FG004|Overall Study|Lost to Follow-up|0|||
145482918|NCT00713544|524620637|FG005|Overall Study|Lost to Follow-up|0|||
145482919|NCT00713544|524620632|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
145482920|NCT00713544|524620633|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
145482921|NCT00713544|524620634|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
145482922|NCT00713544|524620635|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
145482923|NCT00713544|524620636|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
145482924|NCT00713544|524620637|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
145637887|NCT03401112|525188586|FG002|Overall Study|Missed Clinical Visit|1|||
145637888|NCT03401112|525188587|FG003|Overall Study|Missed Clinical Visit|0|||
145637889|NCT03401112|525188588|FG004|Overall Study|Missed Clinical Visit|0|||
145637890|NCT03401112|525188584|FG000|Overall Study|Missed Doses|0|||
145637891|NCT03401112|525188585|FG001|Overall Study|Missed Doses|0|||
145637892|NCT03401112|525188586|FG002|Overall Study|Missed Doses|1|||
145637893|NCT03401112|525188587|FG003|Overall Study|Missed Doses|0|||
145637894|NCT03401112|525188588|FG004|Overall Study|Missed Doses|0|||
145637895|NCT01264679|525188589|FG000|Overall Study|Participation in Another Clinical Trial|1|||
145637896|NCT01264679|525188589|FG000|Overall Study|Physician Decision|1|||
145637897|NCT01264679|525188589|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
145637898|NCT01264679|525188589|FG000|Overall Study|Withdrawal by Subject|1|||
145637899|NCT03475316|525188590|FG000|6 Month Intervention|Adverse Event|2|||
145637900|NCT03475316|525188591|FG001|6 Month Intervention|Adverse Event|1|||
145637901|NCT03475316|525188590|FG000|6 Month Intervention|Withdrawal by Subject|2|||
145637902|NCT03475316|525188591|FG001|6 Month Intervention|Withdrawal by Subject|0|||
145637903|NCT03475316|525188590|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
145637904|NCT03475316|525188591|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
145637905|NCT03475316|525188590|FG000|9 Months|Study stopped due to COVID pandemic|3|||
145637906|NCT03475316|525188591|FG001|9 Months|Study stopped due to COVID pandemic|4|||
145637907|NCT00424645|525188592|FG000|Overall Study|Death|1|||
145637908|NCT00424645|525188593|FG001|Overall Study|Death|0|||
145637909|NCT01179334|525188594|FG000|Treatment Period|Adverse Event|1|||
145482925|NCT00713544|524620632|FG000|Overall Study|Incorrect enrollment|0|||
145482926|NCT00713544|524620633|FG001|Overall Study|Incorrect enrollment|1|||
145482927|NCT00713544|524620634|FG002|Overall Study|Incorrect enrollment|0|||
145482928|NCT00713544|524620635|FG003|Overall Study|Incorrect enrollment|0|||
145482929|NCT00713544|524620636|FG004|Overall Study|Incorrect enrollment|0|||
145482930|NCT00713544|524620637|FG005|Overall Study|Incorrect enrollment|0|||
145482931|NCT00713544|524620632|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
145482932|NCT00713544|524620633|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
145482933|NCT00713544|524620634|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
145482934|NCT00713544|524620635|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
145482935|NCT00713544|524620636|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
145482936|NCT00713544|524620637|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
145482937|NCT02471014|524620640|FG000|Overall Study|Lost to Follow-up|2|||
145482938|NCT02471014|524620641|FG001|Overall Study|Lost to Follow-up|2|||
145482939|NCT02380287|524620642|FG000|Overall Study|Adverse Event|0|||
145482940|NCT02380287|524620643|FG001|Overall Study|Adverse Event|0|||
145482941|NCT02380287|524620644|FG002|Overall Study|Adverse Event|1|||
145482942|NCT02380287|524620645|FG003|Overall Study|Adverse Event|0|||
145482943|NCT02380287|524620646|FG004|Overall Study|Adverse Event|0|||
145482944|NCT02380287|524620647|FG005|Overall Study|Adverse Event|0|||
145482945|NCT02380287|524620648|FG006|Overall Study|Adverse Event|0|||
145482946|NCT02380287|524620649|FG007|Overall Study|Adverse Event|0|||
145637910|NCT01179334|525188595|FG001|Treatment Period|Adverse Event|0|||
145482947|NCT01751984|524620650|FG000|Overall Study|Adverse Event|5|||
145482948|NCT01751984|524620651|FG001|Overall Study|Adverse Event|3|||
145482949|NCT01751984|524620650|FG000|Overall Study|Withdrawal by Subject|0|||
145637911|NCT01179334|525188594|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
145482950|NCT01751984|524620651|FG001|Overall Study|Withdrawal by Subject|1|||
145482951|NCT01751984|524620650|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
145482952|NCT01751984|524620651|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
145482953|NCT04473963|524620652|FG000|Overall Study|Withdrawal by Subject|1|||
145637912|NCT01179334|525188595|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
145637913|NCT01179334|525188594|FG000|Long-term Extension (LTE) Period|Death|3|||
145637914|NCT01179334|525188595|FG001|Long-term Extension (LTE) Period|Death|0|||
145637915|NCT01179334|525188594|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
145637916|NCT01179334|525188595|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
145637917|NCT04177394|525188596|FG000|Overall Study|Death|16|||
145637918|NCT04177394|525188596|FG000|Overall Study|Withdrawal by Subject|19|||
145637919|NCT04177394|525188596|FG000|Overall Study|Missed visits|61|||
145637920|NCT04177394|525188596|FG000|Overall Study|Expected Visits|15|||
145637921|NCT00258895|525188597|FG000|Overall Study|Lost to Follow-up|3|||
145482954|NCT04473963|524620653|FG001|Overall Study|Withdrawal by Subject|1|||
145482955|NCT04473963|524620654|FG002|Overall Study|Withdrawal by Subject|0|||
145482956|NCT04473963|524620652|FG000|Overall Study|Not inducible in AF|0|||
145482957|NCT04473963|524620653|FG001|Overall Study|Not inducible in AF|0|||
145482958|NCT04473963|524620654|FG002|Overall Study|Not inducible in AF|2|||
145482959|NCT01641601|524620655|FG000|Overall Study|Study discontinued.|3|||
145482960|NCT01641601|524620656|FG001|Overall Study|Study discontinued.|5|||
145482961|NCT00587158|524620657|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
145482962|NCT00587158|524620658|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
145482963|NCT00587158|524620657|FG000|Overall Study|Physician Decision|0|||
145482964|NCT00587158|524620658|FG001|Overall Study|Physician Decision|1|||
145482965|NCT00587158|524620657|FG000|Overall Study|Lost to Follow-up|1|||
145482966|NCT00587158|524620658|FG001|Overall Study|Lost to Follow-up|2|||
145482967|NCT00587158|524620657|FG000|Overall Study|Death|0|||
145482968|NCT00587158|524620658|FG001|Overall Study|Death|1|||
145482969|NCT00587158|524620657|FG000|Overall Study|Subject did not want to take study med|0|||
145482970|NCT00587158|524620658|FG001|Overall Study|Subject did not want to take study med|1|||
145482971|NCT01196026|524620659|FG000|Overall Study|Withdrawal by Subject|1|||
145482972|NCT01196026|524620660|FG001|Overall Study|Withdrawal by Subject|4|||
145482973|NCT01196026|524620661|FG002|Overall Study|Withdrawal by Subject|0|||
145482974|NCT01196026|524620662|FG003|Overall Study|Withdrawal by Subject|0|||
145482975|NCT01196026|524620663|FG004|Overall Study|Withdrawal by Subject|0|||
145482976|NCT01196026|524620664|FG005|Overall Study|Withdrawal by Subject|0|||
145482977|NCT01196026|524620659|FG000|Overall Study|Lost to Follow-up|0|||
145482978|NCT01196026|524620660|FG001|Overall Study|Lost to Follow-up|3|||
145482979|NCT01196026|524620661|FG002|Overall Study|Lost to Follow-up|0|||
145482980|NCT01196026|524620662|FG003|Overall Study|Lost to Follow-up|0|||
145482981|NCT01196026|524620663|FG004|Overall Study|Lost to Follow-up|1|||
145482982|NCT01196026|524620664|FG005|Overall Study|Lost to Follow-up|0|||
145482983|NCT01196026|524620659|FG000|Overall Study|Other|0|||
145482984|NCT01196026|524620660|FG001|Overall Study|Other|1|||
145482985|NCT01196026|524620661|FG002|Overall Study|Other|0|||
145482986|NCT01196026|524620662|FG003|Overall Study|Other|0|||
145482987|NCT01196026|524620663|FG004|Overall Study|Other|0|||
145482988|NCT01196026|524620664|FG005|Overall Study|Other|0|||
145482989|NCT01221350|524620668|FG000|Overall Study|Discontinued intervention (GERD)|1|||
145482990|NCT01221350|524620669|FG001|Overall Study|Discontinued intervention (GERD)|0|||
145482991|NCT01221350|524620668|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
145482992|NCT01221350|524620669|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
145637922|NCT00258895|525188598|FG001|Overall Study|Lost to Follow-up|1|||
145637923|NCT00258895|525188597|FG000|Overall Study|Protocol Violation|6|||
145637924|NCT00258895|525188598|FG001|Overall Study|Protocol Violation|2|||
145637925|NCT00258895|525188597|FG000|Overall Study|Withdrawal by Subject|1|||
145482993|NCT01221350|524620668|FG000|Overall Study|Withdrawal by Subject|4|||
145482994|NCT01221350|524620669|FG001|Overall Study|Withdrawal by Subject|2|||
145482995|NCT05236257|524620672|FG000|Overall Study|Ongoing with study treatment|29|||
145482996|NCT05236257|524620673|FG001|Overall Study|Ongoing with study treatment|1|||
145482997|NCT05236257|524620672|FG000|Overall Study|Discontinued study treatment|22|||
145482998|NCT05236257|524620673|FG001|Overall Study|Discontinued study treatment|41|||
145482999|NCT04752332|524620674|FG000|Overall Study|Adverse Event|3|||
145637926|NCT00258895|525188598|FG001|Overall Study|Withdrawal by Subject|0|||
145637927|NCT00547118|525188601|FG000|Overall Study|Did not qualify prior to starting drug|1|||
145637928|NCT00547118|525188602|FG001|Overall Study|Did not qualify prior to starting drug|1|||
145637929|NCT00547118|525188601|FG000|Overall Study|Study suspended|7|||
145637930|NCT00547118|525188602|FG001|Overall Study|Study suspended|8|||
145637931|NCT01595321|525188603|FG000|Overall Study|Adverse Event|1|||
145483000|NCT04752332|524620675|FG001|Overall Study|Adverse Event|1|||
145483001|NCT04752332|524620674|FG000|Overall Study|Disease Relapse|1|||
145483002|NCT04752332|524620675|FG001|Overall Study|Disease Relapse|0|||
145483003|NCT04752332|524620674|FG000|Overall Study|Non-compliance With Study Drug|2|||
145483004|NCT04752332|524620675|FG001|Overall Study|Non-compliance With Study Drug|0|||
145483005|NCT04752332|524620674|FG000|Overall Study|Physician Decision|2|||
145483006|NCT04752332|524620675|FG001|Overall Study|Physician Decision|1|||
145483007|NCT04752332|524620674|FG000|Overall Study|Protocol Violation|1|||
145483008|NCT04752332|524620675|FG001|Overall Study|Protocol Violation|1|||
145483009|NCT04752332|524620674|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
145483010|NCT04752332|524620675|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
145483011|NCT04752332|524620674|FG000|Overall Study|Study Terminated by Sponsor|10|||
145483012|NCT04752332|524620675|FG001|Overall Study|Study Terminated by Sponsor|48|||
145483013|NCT04752332|524620674|FG000|Overall Study|Withdrawal by Subject|11|||
145483014|NCT04752332|524620675|FG001|Overall Study|Withdrawal by Subject|3|||
145483015|NCT00924443|524620678|FG000|Overall Study|Physician Decision|2|||
145637932|NCT01595321|525188604|FG001|Overall Study|Adverse Event|1|||
145637933|NCT01595321|525188605|FG002|Overall Study|Adverse Event|1|||
145637934|NCT01595321|525188603|FG000|Overall Study|Lack of Efficacy|0|||
145637935|NCT01595321|525188604|FG001|Overall Study|Lack of Efficacy|0|||
145637936|NCT01595321|525188605|FG002|Overall Study|Lack of Efficacy|4|||
145637937|NCT00834834|525188606|FG000|Overall Study|Withdrawal by Subject|4|||
145637938|NCT00834834|525188607|FG001|Overall Study|Withdrawal by Subject|3|||
145637939|NCT00373529|525188608|FG000|Overall Study|Physician Decision|19|||
145637940|NCT00373529|525188608|FG000|Overall Study|Withdrawal by Subject|7|||
145637941|NCT00373529|525188608|FG000|Overall Study|Adverse Event|7|||
145637942|NCT00373529|525188608|FG000|Overall Study|Treatment failure|36|||
145637943|NCT00373529|525188608|FG000|Overall Study|Disease recurrence|10|||
145637944|NCT00373529|525188608|FG000|Overall Study|Death|16|||
145637945|NCT00373529|525188608|FG000|Overall Study|Need for treatment prohibited by study|1|||
145637946|NCT00373529|525188608|FG000|Overall Study|Other|8|||
145637947|NCT00373529|525188608|FG000|Overall Study|Failed independent confirmation of AML|3|||
145637948|NCT00373529|525188608|FG000|Overall Study|Consent violation|1|||
145637949|NCT00442117|525188609|FG000|Overall Study|Adverse Event|3|||
145637950|NCT00442117|525188610|FG001|Overall Study|Adverse Event|2|||
145637951|NCT00442117|525188609|FG000|Overall Study|Lack of Efficacy|2|||
145637952|NCT00442117|525188610|FG001|Overall Study|Lack of Efficacy|6|||
145637953|NCT00442117|525188609|FG000|Overall Study|Lost to Follow-up|1|||
145637954|NCT00442117|525188610|FG001|Overall Study|Lost to Follow-up|2|||
145637955|NCT00442117|525188609|FG000|Overall Study|Withdrawal by Subject|2|||
145637956|NCT00442117|525188610|FG001|Overall Study|Withdrawal by Subject|2|||
145637957|NCT00442117|525188609|FG000|Overall Study|Major Deviation|25|||
145637958|NCT00442117|525188610|FG001|Overall Study|Major Deviation|20|||
145637959|NCT00442117|525188609|FG000|Overall Study|Non compliance with protocol|3|||
145637960|NCT00442117|525188610|FG001|Overall Study|Non compliance with protocol|5|||
145637961|NCT00442117|525188609|FG000|Overall Study|Met Withdrawal Criteria|2|||
145637962|NCT00442117|525188610|FG001|Overall Study|Met Withdrawal Criteria|1|||
145637963|NCT04009577|525188611|FG000|Core Study|Adverse Event|1|||
145637964|NCT04009577|525188612|FG001|Core Study|Adverse Event|0|||
145637965|NCT04009577|525188613|FG002|Core Study|Adverse Event|2|||
145637966|NCT04009577|525188614|FG003|Core Study|Adverse Event|4|||
145637967|NCT04009577|525188611|FG000|Core Study|Withdrawal by Subject|0|||
145637968|NCT04009577|525188612|FG001|Core Study|Withdrawal by Subject|0|||
145637969|NCT04009577|525188613|FG002|Core Study|Withdrawal by Subject|2|||
145637970|NCT04009577|525188614|FG003|Core Study|Withdrawal by Subject|0|||
145637971|NCT04009577|525188611|FG000|Core Study|Other|0|||
145637972|NCT04009577|525188612|FG001|Core Study|Other|0|||
145637973|NCT04009577|525188613|FG002|Core Study|Other|0|||
145637974|NCT04009577|525188614|FG003|Core Study|Other|1|||
145637975|NCT04009577|525188611|FG000|Extension Phase|Adverse Event|0|||
145637976|NCT04009577|525188612|FG001|Extension Phase|Adverse Event|0|||
145637977|NCT04009577|525188613|FG002|Extension Phase|Adverse Event|0|||
145637978|NCT04009577|525188614|FG003|Extension Phase|Adverse Event|1|||
145637979|NCT04009577|525188611|FG000|Extension Phase|Inadequate therapeutic effect|0|||
145637980|NCT04009577|525188612|FG001|Extension Phase|Inadequate therapeutic effect|0|||
145637981|NCT04009577|525188613|FG002|Extension Phase|Inadequate therapeutic effect|1|||
145637982|NCT04009577|525188614|FG003|Extension Phase|Inadequate therapeutic effect|0|||
145637983|NCT04009577|525188611|FG000|Extension Phase|Withdrawal by Subject|0|||
145637984|NCT04009577|525188612|FG001|Extension Phase|Withdrawal by Subject|0|||
145637985|NCT04009577|525188613|FG002|Extension Phase|Withdrawal by Subject|1|||
145637986|NCT04009577|525188614|FG003|Extension Phase|Withdrawal by Subject|0|||
145637987|NCT04009577|525188611|FG000|Extension Phase|Not Treated|0|||
145637988|NCT04009577|525188612|FG001|Extension Phase|Not Treated|0|||
145637989|NCT04009577|525188613|FG002|Extension Phase|Not Treated|2|||
145483016|NCT00924443|524620678|FG000|Overall Study|Protocol Violation|1|||
145637990|NCT04009577|525188614|FG003|Extension Phase|Not Treated|0|||
145637991|NCT00305695|525188620|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
145637992|NCT00305695|525188621|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
145637993|NCT00305695|525188620|FG000|Overall Study|Did not have baseline scan|1|||
145637994|NCT00305695|525188621|FG001|Overall Study|Did not have baseline scan|1|||
145637995|NCT00841035|525188623|FG000|Phase 1 Overall Study|Physician Decision|13|||
145637996|NCT02994654|525188634|FG000|Overall Study|Lost to Follow-up|1|||
145637997|NCT01810263|525188643|FG000|Overall Study|Lost to Follow-up|8|||
145483017|NCT00548145|524620682|FG000|Overall Study|Death|0|||
145483018|NCT00548145|524620683|FG001|Overall Study|Death|1|||
145637998|NCT01810263|525188644|FG001|Overall Study|Lost to Follow-up|7|||
145637999|NCT01390402|525188645|FG000|Overall Study|Death|1|||
145638000|NCT01390402|525188645|FG000|Overall Study|Disease Progression|4|||
145483019|NCT00548145|524620682|FG000|Overall Study|Withdrawal by Subject|0|||
145638001|NCT01353963|525188646|FG000|Overall Study|Adverse Event|2|||
145638002|NCT01121549|525188647|FG000|Overall Study|Adverse Event|10|||
145638003|NCT01121549|525188647|FG000|Overall Study|Lack of Efficacy|11|||
145483020|NCT00548145|524620683|FG001|Overall Study|Withdrawal by Subject|2|||
145483021|NCT00548145|524620682|FG000|Overall Study|Physician Decision|1|||
145483022|NCT00548145|524620683|FG001|Overall Study|Physician Decision|1|||
145483023|NCT00874848|524620684|FG000|Overall Study|Adverse Event|13|||
145483024|NCT00874848|524620685|FG001|Overall Study|Adverse Event|2|||
145483025|NCT00874848|524620684|FG000|Overall Study|Progressive neoplastic disease|38|||
145483026|NCT00874848|524620685|FG001|Overall Study|Progressive neoplastic disease|18|||
145638004|NCT01121549|525188647|FG000|Overall Study|Lost to Follow-up|12|||
145638005|NCT01121549|525188647|FG000|Overall Study|Did not meet entrance criteria|9|||
145638006|NCT01121549|525188647|FG000|Overall Study|Study terminated by sponsor|197|||
145638007|NCT01121549|525188647|FG000|Overall Study|Pregnancy|1|||
145638008|NCT01121549|525188647|FG000|Overall Study|Protocol Violation|33|||
145638009|NCT01121549|525188647|FG000|Overall Study|Withdrawal by Subject|16|||
145638010|NCT01121549|525188647|FG000|Overall Study|Other|58|||
145638011|NCT04789408|525188648|FG000|Overall Study|Death|4|||
145638012|NCT04789408|525188649|FG001|Overall Study|Death|3|||
145638013|NCT04789408|525188650|FG002|Overall Study|Death|6|||
145638014|NCT04789408|525188648|FG000|Overall Study|Did not meet eligibility criteria|1|||
145638015|NCT04789408|525188649|FG001|Overall Study|Did not meet eligibility criteria|0|||
145638016|NCT04789408|525188650|FG002|Overall Study|Did not meet eligibility criteria|0|||
145483027|NCT00874848|524620684|FG000|Overall Study|Withdrawal by Subject|7|||
145483028|NCT00874848|524620685|FG001|Overall Study|Withdrawal by Subject|4|||
145483029|NCT00874848|524620684|FG000|Overall Study|Noncompliance|1|||
145483030|NCT00874848|524620685|FG001|Overall Study|Noncompliance|1|||
145483031|NCT00874848|524620684|FG000|Overall Study|Failure to comply with protocol|0|||
145483032|NCT00874848|524620685|FG001|Overall Study|Failure to comply with protocol|1|||
145483033|NCT00874848|524620684|FG000|Overall Study|Physician Decision|0|||
145483034|NCT00874848|524620685|FG001|Overall Study|Physician Decision|2|||
145483035|NCT02451124|524620690|FG000|Overall Study|Withdrawal by Subject|1|||
145638017|NCT04789408|525188648|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
145638018|NCT04789408|525188649|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
145638019|NCT04789408|525188650|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
145638020|NCT03779048|525189742|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
145638021|NCT03779048|525189743|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
145638022|NCT03779048|525189744|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
145638023|NCT03779048|525189742|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
145638024|NCT03779048|525189743|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
145638025|NCT03779048|525189744|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
145638026|NCT03779048|525189742|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
145638027|NCT03779048|525189743|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
145638028|NCT03779048|525189744|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
145638029|NCT03762668|525189746|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
145638030|NCT03762668|525189747|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
145638031|NCT00686855|525189751|FG000|Overall Study|Lost to Follow-up|1|||
145638032|NCT00686855|525189752|FG001|Overall Study|Lost to Follow-up|0|||
145638033|NCT00686855|525189751|FG000|Overall Study|Progressive GVHD|0|||
145638034|NCT00686855|525189752|FG001|Overall Study|Progressive GVHD|1|||
145638035|NCT02731755|525189753|FG000|First Intervention|Withdrawal by Subject|0|||
145638036|NCT02731755|525189754|FG001|First Intervention|Withdrawal by Subject|2|||
145638037|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
145638038|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
145638039|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
145638040|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
145638041|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
145638042|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
145638043|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
145638044|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
145638045|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
145638046|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
145638047|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
145638048|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
145483036|NCT03301350|524620691|FG000|Overall Study|Withdrawal by Subject|4|||
145638049|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
145638050|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
145638051|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
145638052|NCT00516321|525189755|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
145483037|NCT03301350|524620691|FG000|Overall Study|Adverse Event|1|||
145638053|NCT00516321|525189756|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
145483038|NCT03301350|524620691|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
145483039|NCT03301350|524620691|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
145483040|NCT03301350|524620691|FG000|Overall Study|no detail provided|1|||
145483041|NCT01248949|524620692|FG000|Overall Study|Lost to Follow-up|2|||
145483042|NCT01248949|524620693|FG001|Overall Study|Lost to Follow-up|2|||
145483043|NCT01248949|524620694|FG002|Overall Study|Lost to Follow-up|2|||
145483044|NCT01248949|524620695|FG003|Overall Study|Lost to Follow-up|1|||
145483045|NCT01248949|524620696|FG004|Overall Study|Lost to Follow-up|0|||
145483046|NCT01248949|524620692|FG000|Overall Study|Withdrawal by Subject|5|||
145483047|NCT01248949|524620693|FG001|Overall Study|Withdrawal by Subject|3|||
145483048|NCT01248949|524620694|FG002|Overall Study|Withdrawal by Subject|11|||
145483049|NCT01248949|524620695|FG003|Overall Study|Withdrawal by Subject|3|||
145483050|NCT01248949|524620696|FG004|Overall Study|Withdrawal by Subject|1|||
145483051|NCT01248949|524620692|FG000|Overall Study|Death|22|||
145483052|NCT01248949|524620693|FG001|Overall Study|Death|7|||
145483053|NCT01248949|524620694|FG002|Overall Study|Death|21|||
145483054|NCT01248949|524620695|FG003|Overall Study|Death|6|||
145483055|NCT01248949|524620696|FG004|Overall Study|Death|2|||
145483056|NCT01248949|524620692|FG000|Overall Study|Alternative Therapy|1|||
145483057|NCT01248949|524620693|FG001|Overall Study|Alternative Therapy|0|||
145483058|NCT01248949|524620694|FG002|Overall Study|Alternative Therapy|0|||
145483059|NCT01248949|524620695|FG003|Overall Study|Alternative Therapy|0|||
145483060|NCT01248949|524620696|FG004|Overall Study|Alternative Therapy|0|||
145483061|NCT01248949|524620692|FG000|Overall Study|Alternative Therapy.|1|||
145483062|NCT01248949|524620693|FG001|Overall Study|Alternative Therapy.|0|||
145483063|NCT01248949|524620694|FG002|Overall Study|Alternative Therapy.|0|||
145483064|NCT01248949|524620695|FG003|Overall Study|Alternative Therapy.|0|||
145483065|NCT01248949|524620696|FG004|Overall Study|Alternative Therapy.|0|||
145483066|NCT01248949|524620692|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
145483067|NCT01248949|524620693|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
145483068|NCT01248949|524620694|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
145483069|NCT01248949|524620695|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
145483070|NCT01248949|524620696|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
145483071|NCT01248949|524620692|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
145483072|NCT01248949|524620693|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
145483073|NCT01248949|524620694|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
145483074|NCT01248949|524620695|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
145483075|NCT01248949|524620696|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
145483076|NCT01248949|524620692|FG000|Overall Study|Participant Went To Hospice|0|||
145483077|NCT01248949|524620693|FG001|Overall Study|Participant Went To Hospice|0|||
145483078|NCT01248949|524620694|FG002|Overall Study|Participant Went To Hospice|1|||
145483079|NCT01248949|524620695|FG003|Overall Study|Participant Went To Hospice|0|||
145483080|NCT01248949|524620696|FG004|Overall Study|Participant Went To Hospice|0|||
145483081|NCT01248949|524620692|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
145483082|NCT01248949|524620693|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
145483083|NCT01248949|524620694|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
145483084|NCT01248949|524620695|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
145483085|NCT01248949|524620696|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
145483086|NCT01248949|524620692|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
145483087|NCT01248949|524620693|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
145604343|NCT02243202|525066518|FG000|Overall Study|Adverse Event|5|||
145604344|NCT02243202|525066519|FG001|Overall Study|Adverse Event|6|||
145604345|NCT02243202|525066520|FG002|Overall Study|Adverse Event|10|||
145604346|NCT02243202|525066521|FG003|Overall Study|Adverse Event|4|||
145604347|NCT02243202|525066518|FG000|Overall Study|Lost to Follow-up|9|||
145604348|NCT02243202|525066519|FG001|Overall Study|Lost to Follow-up|9|||
145604349|NCT02243202|525066520|FG002|Overall Study|Lost to Follow-up|14|||
145604350|NCT02243202|525066521|FG003|Overall Study|Lost to Follow-up|11|||
145604351|NCT02243202|525066518|FG000|Overall Study|Protocol Violation|3|||
145604352|NCT02243202|525066519|FG001|Overall Study|Protocol Violation|1|||
145604353|NCT02243202|525066520|FG002|Overall Study|Protocol Violation|2|||
145604354|NCT02243202|525066521|FG003|Overall Study|Protocol Violation|1|||
145604355|NCT02243202|525066518|FG000|Overall Study|Withdrawal by Subject|7|||
145604356|NCT02243202|525066519|FG001|Overall Study|Withdrawal by Subject|6|||
145483088|NCT01248949|524620694|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
145483089|NCT01248949|524620695|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
145483090|NCT01248949|524620696|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
145483091|NCT01248949|524620692|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
145604357|NCT02243202|525066520|FG002|Overall Study|Withdrawal by Subject|4|||
145604358|NCT02243202|525066521|FG003|Overall Study|Withdrawal by Subject|4|||
145604359|NCT02243202|525066518|FG000|Overall Study|Other|1|||
145604360|NCT02243202|525066519|FG001|Overall Study|Other|3|||
145604361|NCT02243202|525066520|FG002|Overall Study|Other|1|||
145604362|NCT02243202|525066521|FG003|Overall Study|Other|2|||
145638054|NCT00516321|525189757|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
145483092|NCT01248949|524620693|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
145483093|NCT01248949|524620694|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
145483094|NCT01248949|524620695|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
145483095|NCT01248949|524620696|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
145483096|NCT01248949|524620692|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
145483097|NCT01248949|524620693|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
145483098|NCT01248949|524620694|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
145483099|NCT01248949|524620695|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
145483100|NCT01248949|524620696|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
145483101|NCT00286429|524620697|FG000|Overall Study|Adverse Event|4|||
145483102|NCT00286429|524620698|FG001|Overall Study|Adverse Event|1|||
145483103|NCT00286429|524620699|FG002|Overall Study|Adverse Event|6|||
145483104|NCT00286429|524620697|FG000|Overall Study|Lack of Efficacy|52|||
145483105|NCT00286429|524620698|FG001|Overall Study|Lack of Efficacy|27|||
145483106|NCT00286429|524620699|FG002|Overall Study|Lack of Efficacy|25|||
145483107|NCT00286429|524620697|FG000|Overall Study|Lost to Follow-up|2|||
145483108|NCT00286429|524620698|FG001|Overall Study|Lost to Follow-up|4|||
145483109|NCT00286429|524620699|FG002|Overall Study|Lost to Follow-up|3|||
145483110|NCT00286429|524620697|FG000|Overall Study|Physician Decision|10|||
145483111|NCT00286429|524620698|FG001|Overall Study|Physician Decision|7|||
145483112|NCT00286429|524620699|FG002|Overall Study|Physician Decision|7|||
145483113|NCT00286429|524620697|FG000|Overall Study|Protocol Violation|3|||
145483114|NCT00286429|524620698|FG001|Overall Study|Protocol Violation|5|||
145483115|NCT00286429|524620699|FG002|Overall Study|Protocol Violation|4|||
145483116|NCT00286429|524620697|FG000|Overall Study|Withdrawal by Subject|3|||
145483117|NCT00286429|524620698|FG001|Overall Study|Withdrawal by Subject|2|||
145483118|NCT00286429|524620699|FG002|Overall Study|Withdrawal by Subject|6|||
145483119|NCT00286429|524620697|FG000|Overall Study|Administrative Error|1|||
145483120|NCT00286429|524620698|FG001|Overall Study|Administrative Error|1|||
145483121|NCT00286429|524620699|FG002|Overall Study|Administrative Error|1|||
145483122|NCT00286429|524620697|FG000|Overall Study|Administrative Decision|0|||
145483123|NCT00286429|524620698|FG001|Overall Study|Administrative Decision|1|||
145483124|NCT00286429|524620699|FG002|Overall Study|Administrative Decision|0|||
145483125|NCT01746225|524620702|FG000|Overall Study|Death|1|||
145483126|NCT01746225|524620703|FG001|Overall Study|Death|0|||
145483127|NCT01746225|524620704|FG002|Overall Study|Death|1|||
145483128|NCT01746225|524620702|FG000|Overall Study|Withdrawal by Subject|5|||
145483129|NCT01746225|524620703|FG001|Overall Study|Withdrawal by Subject|15|||
145483130|NCT01746225|524620704|FG002|Overall Study|Withdrawal by Subject|19|||
145483131|NCT01746225|524620702|FG000|Overall Study|Physician Decision|14|||
145483132|NCT01746225|524620703|FG001|Overall Study|Physician Decision|11|||
145483133|NCT01746225|524620704|FG002|Overall Study|Physician Decision|3|||
145483134|NCT01746225|524620702|FG000|Overall Study|Adverse Event|15|||
145483135|NCT01746225|524620703|FG001|Overall Study|Adverse Event|12|||
145483136|NCT01746225|524620704|FG002|Overall Study|Adverse Event|17|||
145483137|NCT01746225|524620702|FG000|Overall Study|Continuing Treatment|5|||
145483138|NCT01746225|524620703|FG001|Overall Study|Continuing Treatment|8|||
145483139|NCT01746225|524620704|FG002|Overall Study|Continuing Treatment|3|||
145483140|NCT03245775|524620707|FG000|Overall Study|Lost to Follow-up|25|||
145483141|NCT03245775|524620708|FG001|Overall Study|Lost to Follow-up|26|||
145483142|NCT03245775|524620709|FG002|Overall Study|Lost to Follow-up|16|||
145483143|NCT03245775|524620710|FG003|Overall Study|Lost to Follow-up|16|||
145483144|NCT02713828|524620713|FG000|Overall Study|Death|2|||
145483145|NCT02713828|524620714|FG001|Overall Study|Death|0|||
145483146|NCT02713828|524620713|FG000|Overall Study|Withdrawal by Subject|1|||
145483147|NCT02713828|524620714|FG001|Overall Study|Withdrawal by Subject|0|||
145483148|NCT02713828|524620713|FG000|Overall Study|study terminated but patient allowed to|2|||
145483149|NCT02713828|524620714|FG001|Overall Study|study terminated but patient allowed to|0|||
145483150|NCT03302247|524620715|FG000|Overall Study|the study has closed prematurely|2|||
145483151|NCT03302247|524620715|FG000|Overall Study|Death|1|||
145483152|NCT03197376|524620716|FG000|Primary and Booster Phase|Adverse Event|0|||
145483153|NCT03197376|524620717|FG001|Primary and Booster Phase|Adverse Event|0|||
145483154|NCT03197376|524620718|FG002|Primary and Booster Phase|Adverse Event|0|||
145483155|NCT03197376|524620719|FG003|Primary and Booster Phase|Adverse Event|1|||
145483156|NCT03197376|524620716|FG000|Primary and Booster Phase|Death|1|||
145483157|NCT03197376|524620717|FG001|Primary and Booster Phase|Death|0|||
145483158|NCT03197376|524620718|FG002|Primary and Booster Phase|Death|0|||
145483159|NCT03197376|524620719|FG003|Primary and Booster Phase|Death|2|||
145483160|NCT03197376|524620716|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
145483161|NCT03197376|524620717|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
145483162|NCT03197376|524620718|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
145483163|NCT03197376|524620719|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
145483164|NCT03197376|524620716|FG000|Primary and Booster Phase|Physician Decision|1|||
145483165|NCT03197376|524620717|FG001|Primary and Booster Phase|Physician Decision|0|||
145483166|NCT03197376|524620718|FG002|Primary and Booster Phase|Physician Decision|1|||
145483167|NCT03197376|524620719|FG003|Primary and Booster Phase|Physician Decision|3|||
145483168|NCT03197376|524620716|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
145483169|NCT03197376|524620717|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
145483170|NCT03197376|524620718|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
145483171|NCT03197376|524620719|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
145483172|NCT03197376|524620716|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
145483173|NCT03197376|524620717|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
145483174|NCT03197376|524620718|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
145483175|NCT03197376|524620719|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
145483176|NCT03197376|524620716|FG000|Primary and Booster Phase|Not vaccine related|1|||
145483177|NCT03197376|524620717|FG001|Primary and Booster Phase|Not vaccine related|2|||
145483178|NCT03197376|524620718|FG002|Primary and Booster Phase|Not vaccine related|0|||
145483179|NCT03197376|524620719|FG003|Primary and Booster Phase|Not vaccine related|6|||
145483180|NCT03197376|524620716|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
145483181|NCT03197376|524620717|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
145483182|NCT03197376|524620718|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
145483183|NCT03197376|524620719|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
145483184|NCT03197376|524620716|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
145483185|NCT03197376|524620717|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
145483186|NCT03197376|524620718|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
145483187|NCT03197376|524620719|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
145483188|NCT03197376|524620716|FG000|Immune Persistence Phase|Not vaccine related|1|||
145483189|NCT03197376|524620717|FG001|Immune Persistence Phase|Not vaccine related|0|||
145483190|NCT03197376|524620718|FG002|Immune Persistence Phase|Not vaccine related|1|||
145483191|NCT03197376|524620719|FG003|Immune Persistence Phase|Not vaccine related|1|||
145483192|NCT01123395|524620721|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
145483193|NCT01123395|524620722|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
145483194|NCT03691571|524620723|FG000|Overall Study|Withdrawal by Subject|9|||
145483195|NCT03691571|524620724|FG001|Overall Study|Withdrawal by Subject|2|||
145483196|NCT03887221|524620726|FG000|Overall Study|Protocol Violation|1|||
145483197|NCT03887221|524620727|FG001|Overall Study|Protocol Violation|0|||
145483198|NCT02487030|524620728|FG000|Overall Study|Lack of Efficacy|2|||
145483199|NCT02487030|524620729|FG001|Overall Study|Lack of Efficacy|4|||
145483200|NCT02487030|524620730|FG002|Overall Study|Lack of Efficacy|1|||
145483201|NCT02487030|524620731|FG003|Overall Study|Lack of Efficacy|0|||
145483202|NCT02487030|524620732|FG004|Overall Study|Lack of Efficacy|1|||
145483203|NCT02487030|524620733|FG005|Overall Study|Lack of Efficacy|0|||
145483204|NCT02487030|524620734|FG006|Overall Study|Lack of Efficacy|0|||
145483205|NCT02487030|524620728|FG000|Overall Study|Lost to Follow-up|0|||
145483206|NCT02487030|524620729|FG001|Overall Study|Lost to Follow-up|0|||
145483207|NCT02487030|524620730|FG002|Overall Study|Lost to Follow-up|1|||
145483208|NCT02487030|524620731|FG003|Overall Study|Lost to Follow-up|1|||
145483209|NCT02487030|524620732|FG004|Overall Study|Lost to Follow-up|0|||
145483210|NCT02487030|524620733|FG005|Overall Study|Lost to Follow-up|1|||
145483211|NCT02487030|524620734|FG006|Overall Study|Lost to Follow-up|0|||
145483212|NCT02487030|524620728|FG000|Overall Study|Adverse Event|0|||
145483213|NCT02487030|524620729|FG001|Overall Study|Adverse Event|0|||
145483214|NCT02487030|524620730|FG002|Overall Study|Adverse Event|0|||
145483215|NCT02487030|524620731|FG003|Overall Study|Adverse Event|1|||
145483216|NCT02487030|524620732|FG004|Overall Study|Adverse Event|0|||
145483217|NCT02487030|524620733|FG005|Overall Study|Adverse Event|0|||
145483218|NCT02487030|524620734|FG006|Overall Study|Adverse Event|0|||
145483219|NCT02487030|524620728|FG000|Overall Study|Death|0|||
145604363|NCT02243202|525066518|FG000|Overall Study|Randomized but not received treatment|0|||
145604364|NCT02243202|525066519|FG001|Overall Study|Randomized but not received treatment|0|||
145604365|NCT02243202|525066520|FG002|Overall Study|Randomized but not received treatment|0|||
145604366|NCT02243202|525066521|FG003|Overall Study|Randomized but not received treatment|1|||
145604367|NCT04382924|525066522|FG000|Overall Study|Death|2|||
145483220|NCT02487030|524620729|FG001|Overall Study|Death|0|||
145483221|NCT02487030|524620730|FG002|Overall Study|Death|0|||
145483222|NCT02487030|524620731|FG003|Overall Study|Death|0|||
145483223|NCT02487030|524620732|FG004|Overall Study|Death|1|||
145483224|NCT02487030|524620733|FG005|Overall Study|Death|0|||
145483225|NCT02487030|524620734|FG006|Overall Study|Death|0|||
145483226|NCT00947115|524620735|FG000|Overall Study|Missed reporting interval|3|||
145483227|NCT00947115|524620736|FG001|Overall Study|Missed reporting interval|4|||
145483228|NCT00947115|524620737|FG002|Overall Study|Missed reporting interval|2|||
145483229|NCT00947115|524620735|FG000|Overall Study|Physician Decision|0|||
145483230|NCT00947115|524620736|FG001|Overall Study|Physician Decision|2|||
145483231|NCT00947115|524620737|FG002|Overall Study|Physician Decision|0|||
145483232|NCT00947115|524620735|FG000|Overall Study|Death|0|||
145483233|NCT00947115|524620736|FG001|Overall Study|Death|1|||
145483234|NCT00947115|524620737|FG002|Overall Study|Death|1|||
145483235|NCT00947115|524620735|FG000|Overall Study|Migrated from study area|2|||
145483236|NCT00947115|524620736|FG001|Overall Study|Migrated from study area|0|||
145604368|NCT04382924|525066523|FG001|Overall Study|Death|5|||
145604369|NCT04382924|525066524|FG002|Overall Study|Death|4|||
145483237|NCT00947115|524620737|FG002|Overall Study|Migrated from study area|0|||
145483238|NCT00947115|524620735|FG000|Overall Study|Withdrawal by Subject|1|||
145483239|NCT00947115|524620736|FG001|Overall Study|Withdrawal by Subject|3|||
145483240|NCT00947115|524620737|FG002|Overall Study|Withdrawal by Subject|4|||
145483241|NCT00947115|524620735|FG000|Overall Study|Lost to Follow-up|11|||
145483242|NCT00947115|524620736|FG001|Overall Study|Lost to Follow-up|12|||
145483243|NCT00947115|524620737|FG002|Overall Study|Lost to Follow-up|8|||
145483244|NCT03937713|524622274|FG000|Overall Study|Withdrawal by Subject|3|||
145483245|NCT03937713|524622275|FG001|Overall Study|Withdrawal by Subject|6|||
145483246|NCT03937713|524622274|FG000|Overall Study|Lost to Follow-up|1|||
145483247|NCT03937713|524622275|FG001|Overall Study|Lost to Follow-up|0|||
145483248|NCT00922623|524622281|FG000|Overall Study|Other|4|||
145483249|NCT00922623|524622281|FG000|Overall Study|Lost to Follow-up|1|||
145483250|NCT02420379|524622282|FG000|Overall Study|Withdrawal by Subject|0|||
145483251|NCT02420379|524622283|FG001|Overall Study|Withdrawal by Subject|3|||
145483252|NCT02420379|524622282|FG000|Overall Study|Unable to complete due to schooling|0|||
145483253|NCT02420379|524622283|FG001|Overall Study|Unable to complete due to schooling|1|||
145483254|NCT02420379|524622282|FG000|Overall Study|Transitioned to commercial drug|1|||
145483255|NCT02420379|524622283|FG001|Overall Study|Transitioned to commercial drug|0|||
145483256|NCT00086047|524622284|FG000|Overall Study|Lost to Follow-up|7|||
145483257|NCT00086047|524622285|FG001|Overall Study|Lost to Follow-up|6|||
145483258|NCT00086047|524622284|FG000|Overall Study|Physician Decision|0|||
145483259|NCT00086047|524622285|FG001|Overall Study|Physician Decision|1|||
145483260|NCT00269919|524622288|FG000|Overall Study|Other|26|||
145483261|NCT00269919|524622288|FG000|Overall Study|Started but not treated|1|||
145483262|NCT00950846|524622291|FG000|Overall Study|Death|6|||
145483263|NCT00950846|524622291|FG000|Overall Study|Lost to Follow-up|3|||
145483264|NCT00950846|524622291|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
145483265|NCT02178995|524622294|FG000|Double Blind|Adverse Event|0|||
145483266|NCT02178995|524622295|FG001|Double Blind|Adverse Event|0|||
145483267|NCT02178995|524622296|FG002|Double Blind|Adverse Event|0|||
145483268|NCT02178995|524622297|FG003|Double Blind|Adverse Event|0|||
145483269|NCT02178995|524622298|FG004|Double Blind|Adverse Event|0|||
145483270|NCT02178995|524622299|FG005|Double Blind|Adverse Event|1|||
145483271|NCT02178995|524622300|FG006|Double Blind|Adverse Event|0|||
145483272|NCT02178995|524622301|FG007|Double Blind|Adverse Event|1|||
145483273|NCT02178995|524622302|FG008|Double Blind|Adverse Event|1|||
145483274|NCT02178995|524622294|FG000|Double Blind|Lost to Follow-up|0|||
145483275|NCT02178995|524622295|FG001|Double Blind|Lost to Follow-up|1|||
145483276|NCT02178995|524622296|FG002|Double Blind|Lost to Follow-up|0|||
145483277|NCT02178995|524622297|FG003|Double Blind|Lost to Follow-up|0|||
145483278|NCT02178995|524622298|FG004|Double Blind|Lost to Follow-up|0|||
145483279|NCT02178995|524622299|FG005|Double Blind|Lost to Follow-up|0|||
145483280|NCT02178995|524622300|FG006|Double Blind|Lost to Follow-up|0|||
145483281|NCT02178995|524622301|FG007|Double Blind|Lost to Follow-up|1|||
145483282|NCT02178995|524622302|FG008|Double Blind|Lost to Follow-up|0|||
145483283|NCT02178995|524622294|FG000|Open Label|Adverse Event|2|||
145483284|NCT02178995|524622295|FG001|Open Label|Adverse Event|0|||
145483285|NCT02178995|524622296|FG002|Open Label|Adverse Event|0|||
145483286|NCT02178995|524622297|FG003|Open Label|Adverse Event|0|||
145483287|NCT02178995|524622298|FG004|Open Label|Adverse Event|0|||
145483288|NCT02178995|524622299|FG005|Open Label|Adverse Event|0|||
145483289|NCT02178995|524622300|FG006|Open Label|Adverse Event|0|||
145483290|NCT02178995|524622301|FG007|Open Label|Adverse Event|0|||
145483291|NCT02178995|524622302|FG008|Open Label|Adverse Event|0|||
145483292|NCT00981461|524622303|FG000|Overall Study|Lost to Follow-up|5|||
145483293|NCT00981461|524622304|FG001|Overall Study|Lost to Follow-up|2|||
145483294|NCT03361293|524622307|FG000|Overall Study|Lost to Follow-up|0|||
145483295|NCT03361293|524622308|FG001|Overall Study|Lost to Follow-up|2|||
145483296|NCT03361293|524622307|FG000|Overall Study|Withdrawal by Subject|1|||
145638055|NCT00516321|525189755|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
145483297|NCT03361293|524622308|FG001|Overall Study|Withdrawal by Subject|3|||
145483298|NCT00483405|524622309|FG000|Overall Study|Adverse Event|8|||
145483299|NCT00483405|524622309|FG000|Overall Study|Lack of Efficacy|14|||
145483300|NCT00483405|524622309|FG000|Overall Study|Death|3|||
145483301|NCT00483405|524622309|FG000|Overall Study|Withdrawal by Subject|2|||
145483302|NCT00483405|524622309|FG000|Overall Study|Other complicating disease|1|||
145483303|NCT00571038|524622310|FG000|Overall Study|Lost to Follow-up|1|||
145483304|NCT00571038|524622311|FG001|Overall Study|Lost to Follow-up|4|||
145483305|NCT00571038|524622310|FG000|Overall Study|Death|7|||
145483306|NCT00571038|524622311|FG001|Overall Study|Death|5|||
145483307|NCT00571038|524622310|FG000|Overall Study|Withdrawal by Subject|1|||
145483308|NCT00571038|524622311|FG001|Overall Study|Withdrawal by Subject|3|||
145638056|NCT00516321|525189756|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
145483309|NCT00571038|524622310|FG000|Overall Study|Moved out of state|2|||
145483310|NCT00571038|524622311|FG001|Overall Study|Moved out of state|2|||
145483311|NCT01426958|524622312|FG000|Overall Study|Adverse Event|2|||
145483312|NCT02073682|524622320|FG000|Overall Study|Low Creatinine Clearance|1|||
145483313|NCT02073682|524622321|FG001|Overall Study|Low Creatinine Clearance|2|||
145483314|NCT02073682|524622320|FG000|Overall Study|Death|86|||
145483315|NCT02073682|524622321|FG001|Overall Study|Death|100|||
145483316|NCT02073682|524622320|FG000|Overall Study|Cancer Cured|10|||
145483317|NCT02073682|524622321|FG001|Overall Study|Cancer Cured|15|||
145483318|NCT02073682|524622320|FG000|Overall Study|ID: Patient Noncompliance|1|||
145483319|NCT02073682|524622321|FG001|Overall Study|ID: Patient Noncompliance|2|||
145483320|NCT02073682|524622320|FG000|Overall Study|ID: Palliative Treatment Only|10|||
145483321|NCT02073682|524622321|FG001|Overall Study|ID: Palliative Treatment Only|7|||
145483322|NCT02073682|524622320|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
145483323|NCT02073682|524622321|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
145483324|NCT02073682|524622320|FG000|Overall Study|Platelet Count <50,000/mL|1|||
145483325|NCT02073682|524622321|FG001|Overall Study|Platelet Count <50,000/mL|2|||
145483326|NCT02073682|524622320|FG000|Overall Study|Surgery/Medical Procedure|3|||
145483327|NCT02073682|524622321|FG001|Overall Study|Surgery/Medical Procedure|1|||
145483328|NCT02073682|524622320|FG000|Overall Study|Withdrawal by Subject|6|||
145483329|NCT02073682|524622321|FG001|Overall Study|Withdrawal by Subject|8|||
145483330|NCT02073682|524622320|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
145483331|NCT02073682|524622321|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
145483332|NCT02073682|524622320|FG000|Overall Study|Cancer Progression|53|||
145483333|NCT02073682|524622321|FG001|Overall Study|Cancer Progression|33|||
145483334|NCT02073682|524622320|FG000|Overall Study|Protocol Violation|1|||
145483335|NCT02073682|524622321|FG001|Overall Study|Protocol Violation|0|||
145483336|NCT02073682|524622320|FG000|Overall Study|Adverse Event|79|||
145483337|NCT02073682|524622321|FG001|Overall Study|Adverse Event|62|||
145483338|NCT02073682|524622320|FG000|Overall Study|No reason provided|11|||
145483339|NCT02073682|524622321|FG001|Overall Study|No reason provided|9|||
145483340|NCT02073682|524622320|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
145483341|NCT02073682|524622321|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
145483342|NCT02073682|524622320|FG000|Overall Study|Lost to Follow-up|1|||
145483343|NCT02073682|524622321|FG001|Overall Study|Lost to Follow-up|1|||
145483344|NCT02073682|524622320|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
145483345|NCT02073682|524622321|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
145483346|NCT04390243|524622322|FG000|Overall Study|Death|1|||
145483347|NCT04390243|524622322|FG000|Overall Study|Disease Progression|4|||
145483348|NCT04390243|524622322|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
145483349|NCT01687296|524622332|FG000|Overall Study|Lack of Efficacy|1|||
145483350|NCT01687296|524622333|FG001|Overall Study|Lack of Efficacy|1|||
145483351|NCT01687296|524622332|FG000|Overall Study|Protocol Violation|0|||
145483352|NCT01687296|524622333|FG001|Overall Study|Protocol Violation|1|||
145483353|NCT01687296|524622332|FG000|Overall Study|Withdrawal by Subject|6|||
145483354|NCT01687296|524622333|FG001|Overall Study|Withdrawal by Subject|3|||
145483355|NCT02336230|524622335|FG000|Overall Study|Adverse Event|1|||
145483356|NCT02336230|524622335|FG000|Overall Study|Withdrawal of consent|1|||
145483357|NCT02336230|524622335|FG000|Overall Study|Death|9|||
145483358|NCT02336230|524622335|FG000|Overall Study|Dose not received due to shipping delay|1|||
145483359|NCT02336230|524622335|FG000|Overall Study|Discontinuation of MSC infusion|1|||
145483360|NCT02524171|524622336|FG000|6-month Follow-up|Lost to Follow-up|53|||
145483361|NCT02524171|524622337|FG001|6-month Follow-up|Lost to Follow-up|45|||
145483362|NCT02524171|524622336|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
145483363|NCT02524171|524622337|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
145483364|NCT00216671|524622338|FG000|Overall Study|Adverse Event|4|||
145483365|NCT00216671|524622339|FG001|Overall Study|Adverse Event|9|||
145483366|NCT00216671|524622338|FG000|Overall Study|Pregnancy|0|||
145483367|NCT00216671|524622339|FG001|Overall Study|Pregnancy|1|||
145483368|NCT00216671|524622338|FG000|Overall Study|Withdrawal by Subject|4|||
145483369|NCT00216671|524622339|FG001|Overall Study|Withdrawal by Subject|2|||
145483370|NCT00216671|524622338|FG000|Overall Study|Refused Injections|3|||
145483371|NCT00216671|524622339|FG001|Overall Study|Refused Injections|13|||
145483372|NCT00216671|524622338|FG000|Overall Study|No Need to Continue Medication|1|||
145483373|NCT00216671|524622339|FG001|Overall Study|No Need to Continue Medication|1|||
145483374|NCT00216671|524622338|FG000|Overall Study|Insufficient Response|9|||
145483375|NCT00216671|524622339|FG001|Overall Study|Insufficient Response|4|||
145483376|NCT00216671|524622338|FG000|Overall Study|Lost to Follow-up|3|||
145483377|NCT00216671|524622339|FG001|Overall Study|Lost to Follow-up|5|||
145483378|NCT00216671|524622338|FG000|Overall Study|Non compliant|2|||
145483379|NCT00216671|524622339|FG001|Overall Study|Non compliant|2|||
145483380|NCT00216671|524622338|FG000|Overall Study|Ineligible|0|||
145483381|NCT00216671|524622339|FG001|Overall Study|Ineligible|2|||
145483382|NCT00216671|524622338|FG000|Overall Study|Physician Decision|1|||
145483383|NCT00216671|524622339|FG001|Overall Study|Physician Decision|1|||
145483384|NCT00216671|524622338|FG000|Overall Study|Protocol Violation|3|||
145483385|NCT00216671|524622339|FG001|Overall Study|Protocol Violation|5|||
145483386|NCT00216671|524622338|FG000|Overall Study|Relapse|1|||
145483387|NCT00216671|524622339|FG001|Overall Study|Relapse|0|||
145483388|NCT00216671|524622338|FG000|Overall Study|Investigator Illness|0|||
145483389|NCT00216671|524622339|FG001|Overall Study|Investigator Illness|1|||
145483390|NCT00216671|524622338|FG000|Overall Study|Patient Moved|0|||
145483391|NCT00216671|524622339|FG001|Overall Study|Patient Moved|1|||
145604370|NCT04382924|525066522|FG000|Overall Study|Protocol Violation|0|||
145483392|NCT00216671|524622338|FG000|Overall Study|Ineligible, no efficacy data|2|||
145483393|NCT00216671|524622339|FG001|Overall Study|Ineligible, no efficacy data|2|||
145483394|NCT00216671|524622338|FG000|Overall Study|Insufficient Response Adverse Event|2|||
145483395|NCT00216671|524622339|FG001|Overall Study|Insufficient Response Adverse Event|1|||
145483396|NCT01843023|524622340|FG000|Overall Study|Death|1|||
145483397|NCT01843023|524622341|FG001|Overall Study|Death|0|||
145483398|NCT01843023|524622340|FG000|Overall Study|Lost to Follow-up|24|||
145483399|NCT01843023|524622341|FG001|Overall Study|Lost to Follow-up|29|||
145483400|NCT01843023|524622340|FG000|Overall Study|Withdrawal by Subject|8|||
145483401|NCT01843023|524622341|FG001|Overall Study|Withdrawal by Subject|6|||
145483402|NCT00466921|524622342|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
145483403|NCT00466921|524622342|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
145483404|NCT00466921|524622342|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
145483405|NCT00466921|524622342|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
145483406|NCT00466921|524622342|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
145483407|NCT00466921|524622342|FG000|Follow up for a Minimum of 1 Year|Death|6|||
145483408|NCT03305770|524622343|FG000|Overall Study|Physician Decision - prior to dispense|0|||
145483409|NCT03305770|524622344|FG001|Overall Study|Physician Decision - prior to dispense|1|||
145483410|NCT03305770|524622343|FG000|Overall Study|Subject moved|1|||
145483411|NCT03305770|524622344|FG001|Overall Study|Subject moved|0|||
145483412|NCT03539601|524622345|FG000|Overall Study|Withdraw by parent/guardian|1|||
145483413|NCT03539601|524622346|FG001|Overall Study|Withdraw by parent/guardian|0|||
145483414|NCT03539601|524622347|FG002|Overall Study|Withdraw by parent/guardian|1|||
145483415|NCT03539601|524622348|FG003|Overall Study|Withdraw by parent/guardian|0|||
145483416|NCT03539601|524622345|FG000|Overall Study|Adverse Event|0|||
145483417|NCT03539601|524622346|FG001|Overall Study|Adverse Event|2|||
145483418|NCT03539601|524622347|FG002|Overall Study|Adverse Event|0|||
145483419|NCT03539601|524622348|FG003|Overall Study|Adverse Event|0|||
145483420|NCT03539601|524622345|FG000|Overall Study|Lost to Follow-up|2|||
145483421|NCT03539601|524622346|FG001|Overall Study|Lost to Follow-up|4|||
145483422|NCT03539601|524622347|FG002|Overall Study|Lost to Follow-up|5|||
145483423|NCT03539601|524622348|FG003|Overall Study|Lost to Follow-up|0|||
145483424|NCT03539601|524622345|FG000|Overall Study|Withdrawal by Subject|2|||
145483425|NCT03539601|524622346|FG001|Overall Study|Withdrawal by Subject|0|||
145483426|NCT03539601|524622347|FG002|Overall Study|Withdrawal by Subject|0|||
145483427|NCT03539601|524622348|FG003|Overall Study|Withdrawal by Subject|1|||
145483428|NCT03539601|524622345|FG000|Overall Study|Randomized but not treated|1|||
145483429|NCT03539601|524622346|FG001|Overall Study|Randomized but not treated|1|||
145483430|NCT03539601|524622347|FG002|Overall Study|Randomized but not treated|0|||
145483431|NCT03539601|524622348|FG003|Overall Study|Randomized but not treated|0|||
145483432|NCT00226811|524622352|FG000|Overall Study|Death|8|||
145483433|NCT00226811|524622352|FG000|Overall Study|Adverse Event|11|||
145483434|NCT00226811|524622352|FG000|Overall Study|Lack of Efficacy|55|||
145483435|NCT00226811|524622352|FG000|Overall Study|Withdrawal by Subject|2|||
145483436|NCT02741635|524622355|FG000|Overall Study|Withdrawal by Subject|1|||
145483437|NCT01427933|524622359|FG000|Overall Study|Withdrawal by Subject|5|||
145483438|NCT01427933|524622360|FG001|Overall Study|Withdrawal by Subject|8|||
145483439|NCT01427933|524622359|FG000|Overall Study|Lost to Follow-up|1|||
145483440|NCT01427933|524622360|FG001|Overall Study|Lost to Follow-up|5|||
145483441|NCT01427933|524622359|FG000|Overall Study|Other|1|||
145483442|NCT01427933|524622360|FG001|Overall Study|Other|0|||
145483443|NCT01427933|524622359|FG000|Overall Study|Investigator's Decision|1|||
145483444|NCT01427933|524622360|FG001|Overall Study|Investigator's Decision|0|||
145483445|NCT01633541|524622361|FG000|Overall Study|Death|1|||
145483446|NCT01633541|524622362|FG001|Overall Study|Death|0|||
145483447|NCT03472326|524622365|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
145483448|NCT03472326|524622366|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
145483449|NCT03472326|524622367|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
145483450|NCT03472326|524622368|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
145483451|NCT03472326|524622365|FG000|Part 2: Combination Therapy|Pregnancy|0|||
145483452|NCT03472326|524622366|FG001|Part 2: Combination Therapy|Pregnancy|0|||
145483453|NCT03472326|524622367|FG002|Part 2: Combination Therapy|Pregnancy|0|||
145483454|NCT03472326|524622368|FG003|Part 2: Combination Therapy|Pregnancy|1|||
145483455|NCT01010971|524622369|FG000|Overall Study|Adverse Event|2|||
145483456|NCT01010971|524622370|FG001|Overall Study|Adverse Event|4|||
145483457|NCT01010971|524622371|FG002|Overall Study|Adverse Event|3|||
145483458|NCT01010971|524622369|FG000|Overall Study|Withdrawal by Subject|0|||
145483459|NCT01010971|524622370|FG001|Overall Study|Withdrawal by Subject|2|||
145483460|NCT01010971|524622371|FG002|Overall Study|Withdrawal by Subject|5|||
145483461|NCT01010971|524622369|FG000|Overall Study|Lost to Follow-up|0|||
145483462|NCT01010971|524622370|FG001|Overall Study|Lost to Follow-up|2|||
145483463|NCT01010971|524622371|FG002|Overall Study|Lost to Follow-up|3|||
145483464|NCT01010971|524622369|FG000|Overall Study|Other|1|||
145483465|NCT01010971|524622370|FG001|Overall Study|Other|0|||
145483466|NCT01010971|524622371|FG002|Overall Study|Other|2|||
145483467|NCT05447663|524622372|FG000|Overall Study|Study terminated by Sponsor|5|||
145483468|NCT05447663|524622372|FG000|Overall Study|Death|2|||
145483469|NCT05447663|524622372|FG000|Overall Study|Withdrawal by Subject|1|||
145483470|NCT04669301|524622375|FG000|Overall Study|Lost to Follow-up|0|||
145483471|NCT04669301|524622376|FG001|Overall Study|Lost to Follow-up|1|||
145483472|NCT04669301|524622377|FG002|Overall Study|Lost to Follow-up|0|||
145483473|NCT04669301|524622375|FG000|Overall Study|Withdrawal by Subject|3|||
145483474|NCT04669301|524622376|FG001|Overall Study|Withdrawal by Subject|2|||
145483475|NCT04669301|524622377|FG002|Overall Study|Withdrawal by Subject|0|||
145483476|NCT02978833|524622380|FG000|Overall Study|Study terminated|1|||
145483477|NCT02978833|524622381|FG001|Overall Study|Study terminated|1|||
145483478|NCT00186901|524622383|FG000|Overall Study|Pregnancy|6|||
145483479|NCT00186901|524622384|FG001|Overall Study|Pregnancy|3|||
145483480|NCT00186901|524622385|FG002|Overall Study|Pregnancy|0|||
145483481|NCT00186901|524622383|FG000|Overall Study|Lost to Follow-up|6|||
145483482|NCT00186901|524622384|FG001|Overall Study|Lost to Follow-up|3|||
145483483|NCT00186901|524622385|FG002|Overall Study|Lost to Follow-up|0|||
145483484|NCT00186901|524622383|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
145483485|NCT00186901|524622384|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
145483486|NCT00186901|524622385|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
145483487|NCT00186901|524622383|FG000|Overall Study|ALL relapse or second malignancy|1|||
145483488|NCT00186901|524622384|FG001|Overall Study|ALL relapse or second malignancy|2|||
145483489|NCT00186901|524622385|FG002|Overall Study|ALL relapse or second malignancy|0|||
145483490|NCT00186901|524622383|FG000|Overall Study|Withdrawal by Subject|4|||
145483491|NCT00186901|524622384|FG001|Overall Study|Withdrawal by Subject|5|||
145483492|NCT00186901|524622385|FG002|Overall Study|Withdrawal by Subject|0|||
145483493|NCT00186901|524622383|FG000|Overall Study|Open label|3|||
145483494|NCT00186901|524622384|FG001|Overall Study|Open label|2|||
145483495|NCT00186901|524622385|FG002|Overall Study|Open label|0|||
145483496|NCT00186901|524622383|FG000|Overall Study|Limited adherence to study requirements|20|||
145483497|NCT00186901|524622384|FG001|Overall Study|Limited adherence to study requirements|23|||
145483498|NCT00186901|524622385|FG002|Overall Study|Limited adherence to study requirements|0|||
145483499|NCT00186901|524622383|FG000|Overall Study|Bone Mineral Density > 0|0|||
145483500|NCT00186901|524622384|FG001|Overall Study|Bone Mineral Density > 0|0|||
145483501|NCT00186901|524622385|FG002|Overall Study|Bone Mineral Density > 0|149|||
145483502|NCT00555217|524622386|FG000|Overall Study|Withdrawal by Subject|35|||
145483503|NCT00555217|524622387|FG001|Overall Study|Withdrawal by Subject|31|||
145483504|NCT00555217|524622386|FG000|Overall Study|Lost to Follow-up|19|||
145483505|NCT00555217|524622387|FG001|Overall Study|Lost to Follow-up|20|||
145483506|NCT00555217|524622386|FG000|Overall Study|close out sites|21|||
145483507|NCT00555217|524622387|FG001|Overall Study|close out sites|17|||
145483508|NCT02363959|524622392|FG000|Overall Study|Medical instability|1|||
145483509|NCT02363959|524622393|FG001|Overall Study|Medical instability|0|||
145483510|NCT02663622|524622394|FG000|Overall Study|Death|3|||
145483511|NCT02663622|524622395|FG001|Overall Study|Death|1|||
145483512|NCT02663622|524622396|FG002|Overall Study|Death|1|||
145483513|NCT02663622|524622397|FG003|Overall Study|Death|8|||
145483514|NCT02663622|524622394|FG000|Overall Study|Protocol Violation|0|||
145483515|NCT02663622|524622395|FG001|Overall Study|Protocol Violation|0|||
145483516|NCT02663622|524622396|FG002|Overall Study|Protocol Violation|0|||
145483517|NCT02663622|524622397|FG003|Overall Study|Protocol Violation|1|||
145483518|NCT04618744|524622400|FG000|Overall Study|Adverse Event|0|||
145483519|NCT04618744|524622401|FG001|Overall Study|Adverse Event|1|||
145483520|NCT04618744|524622400|FG000|Overall Study|Withdrawal by Subject|0|||
145483521|NCT04618744|524622401|FG001|Overall Study|Withdrawal by Subject|1|||
145483522|NCT00930930|524622402|FG000|Overall Study|Death|1|||
145483523|NCT00930930|524622403|FG001|Overall Study|Death|0|||
145483524|NCT00930930|524622402|FG000|Overall Study|Physician Decision|1|||
145483525|NCT00930930|524622403|FG001|Overall Study|Physician Decision|0|||
145483526|NCT00930930|524622402|FG000|Overall Study|Adverse Event|13|||
145483527|NCT00930930|524622403|FG001|Overall Study|Adverse Event|3|||
145483528|NCT00930930|524622402|FG000|Overall Study|Withdrawal by Subject|3|||
145483529|NCT00930930|524622403|FG001|Overall Study|Withdrawal by Subject|1|||
145483530|NCT00930930|524622402|FG000|Overall Study|Disease progression|2|||
145483531|NCT00930930|524622403|FG001|Overall Study|Disease progression|3|||
145638057|NCT00516321|525189757|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
145483532|NCT00930930|524622402|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
145483533|NCT00930930|524622403|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
145483534|NCT00930930|524622402|FG000|Overall Study|patients not compliant|1|||
145483535|NCT00930930|524622403|FG001|Overall Study|patients not compliant|1|||
145483536|NCT00900029|524622404|FG000|Overall Study|Lost to Follow-up|0|||
145483537|NCT00900029|524622405|FG001|Overall Study|Lost to Follow-up|2|||
145483538|NCT00900029|524622406|FG002|Overall Study|Lost to Follow-up|1|||
145483539|NCT00900029|524622407|FG003|Overall Study|Lost to Follow-up|4|||
145483540|NCT00900029|524622408|FG004|Overall Study|Lost to Follow-up|4|||
145483541|NCT00900029|524622404|FG000|Overall Study|Withdrawal by Subject|2|||
145483542|NCT00900029|524622405|FG001|Overall Study|Withdrawal by Subject|2|||
145483543|NCT00900029|524622406|FG002|Overall Study|Withdrawal by Subject|1|||
145483544|NCT00900029|524622407|FG003|Overall Study|Withdrawal by Subject|1|||
145483545|NCT00900029|524622408|FG004|Overall Study|Withdrawal by Subject|1|||
145483546|NCT00900029|524622404|FG000|Overall Study|Adverse Event|0|||
145483547|NCT00900029|524622405|FG001|Overall Study|Adverse Event|0|||
145483548|NCT00900029|524622406|FG002|Overall Study|Adverse Event|1|||
145483549|NCT00900029|524622407|FG003|Overall Study|Adverse Event|1|||
145483550|NCT00900029|524622408|FG004|Overall Study|Adverse Event|1|||
145483551|NCT00900029|524622404|FG000|Overall Study|Death|1|||
145483552|NCT00900029|524622405|FG001|Overall Study|Death|0|||
145483553|NCT00900029|524622406|FG002|Overall Study|Death|0|||
145483554|NCT00900029|524622407|FG003|Overall Study|Death|1|||
145483555|NCT00900029|524622408|FG004|Overall Study|Death|0|||
145483556|NCT02709330|524622409|FG000|Overall Study|Death|5|||
145483557|NCT02709330|524622410|FG001|Overall Study|Death|0|||
145483558|NCT02709330|524622409|FG000|Overall Study|Lost to Follow-up|2|||
145483559|NCT02709330|524622410|FG001|Overall Study|Lost to Follow-up|0|||
145483560|NCT02709330|524622409|FG000|Overall Study|Physician Decision|2|||
145483561|NCT02709330|524622410|FG001|Overall Study|Physician Decision|0|||
145483562|NCT02709330|524622409|FG000|Overall Study|Withdrawal by Subject|4|||
145483563|NCT02709330|524622410|FG001|Overall Study|Withdrawal by Subject|0|||
145483564|NCT00511238|524622413|FG000|Overall Study|Adverse Event|13|||
145483565|NCT00511238|524622414|FG001|Overall Study|Adverse Event|33|||
145483566|NCT00511238|524622413|FG000|Overall Study|Withdrawal by Subject|2|||
145483567|NCT00511238|524622414|FG001|Overall Study|Withdrawal by Subject|22|||
145483568|NCT00511238|524622413|FG000|Overall Study|Progressive Disease|23|||
145604371|NCT04382924|525066523|FG001|Overall Study|Protocol Violation|1|||
145604372|NCT04382924|525066524|FG002|Overall Study|Protocol Violation|1|||
145604373|NCT04382924|525066522|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
145604374|NCT04382924|525066523|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
145604375|NCT04382924|525066524|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
145604376|NCT04382924|525066522|FG000|Overall Study|Withdrawal by Subject|6|||
145604377|NCT04382924|525066523|FG001|Overall Study|Withdrawal by Subject|3|||
145604378|NCT04382924|525066524|FG002|Overall Study|Withdrawal by Subject|6|||
145604379|NCT04207840|525066528|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
145604380|NCT04207840|525066529|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
145604381|NCT04207840|525066530|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
145604382|NCT04207840|525066528|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
145604383|NCT04207840|525066529|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
145604384|NCT04207840|525066530|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
145604385|NCT02173054|525066531|FG000|Overall Study|lack of compliance|1|||
145604386|NCT02173054|525066532|FG001|Overall Study|lack of compliance|0|||
145604387|NCT02173054|525066533|FG002|Overall Study|lack of compliance|0|||
145604388|NCT02173054|525066531|FG000|Overall Study|Withdrawal by Subject|0|||
145604389|NCT02173054|525066532|FG001|Overall Study|Withdrawal by Subject|0|||
145604390|NCT02173054|525066533|FG002|Overall Study|Withdrawal by Subject|1|||
145604391|NCT01114204|525066534|FG000|Overall Study|Adverse Event|3|||
145604392|NCT01114204|525066535|FG001|Overall Study|Adverse Event|2|||
145604393|NCT01114204|525066534|FG000|Overall Study|Lost to Follow-up|1|||
145604394|NCT01114204|525066535|FG001|Overall Study|Lost to Follow-up|0|||
145604395|NCT01114204|525066534|FG000|Overall Study|Withdrawal by Subject|10|||
145604396|NCT01114204|525066535|FG001|Overall Study|Withdrawal by Subject|6|||
145604397|NCT01114204|525066534|FG000|Overall Study|Death|1|||
145604398|NCT01114204|525066535|FG001|Overall Study|Death|0|||
145604399|NCT01114204|525066534|FG000|Overall Study|Other-Personal reasons|2|||
145604400|NCT01114204|525066535|FG001|Overall Study|Other-Personal reasons|0|||
145604401|NCT01114204|525066534|FG000|Overall Study|Other-Medical monitor request|1|||
145604402|NCT01114204|525066535|FG001|Overall Study|Other-Medical monitor request|0|||
145604403|NCT01114204|525066534|FG000|Overall Study|Other-Participant request|2|||
145604404|NCT01114204|525066535|FG001|Overall Study|Other-Participant request|0|||
145604405|NCT01114204|525066534|FG000|Overall Study|Other-Protocol Violation|1|||
145604406|NCT01114204|525066535|FG001|Overall Study|Other-Protocol Violation|0|||
145604407|NCT00991341|525066543|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
145604408|NCT00991341|525066544|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
145604409|NCT00991341|525066543|FG000|Overall Study|Death|3|||
145483569|NCT00511238|524622414|FG001|Overall Study|Progressive Disease|157|||
145483570|NCT00511238|524622413|FG000|Overall Study|various reasons|4|||
145604410|NCT00991341|525066544|FG001|Overall Study|Death|0|||
145604411|NCT00991341|525066543|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
145604412|NCT00991341|525066544|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
145604413|NCT00991341|525066543|FG000|Overall Study|Physician Decision|1|||
145604414|NCT00991341|525066544|FG001|Overall Study|Physician Decision|2|||
145604415|NCT00991341|525066543|FG000|Overall Study|Withdrawal by Subject|3|||
145604416|NCT00991341|525066544|FG001|Overall Study|Withdrawal by Subject|4|||
145604417|NCT03010462|525066559|FG000|Overall Study|Withdrawal by Subject|3|||
145604418|NCT03010462|525066560|FG001|Overall Study|Withdrawal by Subject|1|||
145604419|NCT02799472|525066563|FG000|Overall Study|Withdrawal by Subject|2|||
145483571|NCT00511238|524622414|FG001|Overall Study|various reasons|14|||
145483572|NCT02587819|524622415|FG000|Overall Study|Adverse Event|1|||
145483573|NCT02587819|524622415|FG000|Overall Study|Lost to Follow-up|1|||
145638058|NCT00516321|525189755|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
145638059|NCT00516321|525189756|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
145638060|NCT00516321|525189757|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
145638061|NCT00516321|525189755|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
145638062|NCT00516321|525189756|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
145638063|NCT00516321|525189757|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
145638064|NCT00516321|525189755|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
145638065|NCT00516321|525189756|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
145638066|NCT00516321|525189757|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
145638067|NCT00516321|525189755|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
145638068|NCT00516321|525189756|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
145638069|NCT00516321|525189757|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
145638070|NCT02139046|525189758|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
145638071|NCT02139046|525189759|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
145638072|NCT02139046|525189760|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
145638073|NCT02139046|525189761|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
145638074|NCT02139046|525189762|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
145638075|NCT02139046|525189758|FG000|Overall Study|Major Protocol Deviation|9|||
145638076|NCT02139046|525189759|FG001|Overall Study|Major Protocol Deviation|10|||
145638077|NCT02139046|525189760|FG002|Overall Study|Major Protocol Deviation|16|||
145638078|NCT02139046|525189761|FG003|Overall Study|Major Protocol Deviation|12|||
145638079|NCT02139046|525189762|FG004|Overall Study|Major Protocol Deviation|6|||
145638080|NCT02139046|525189758|FG000|Overall Study|Lost to Follow-up|13|||
145638081|NCT02139046|525189759|FG001|Overall Study|Lost to Follow-up|16|||
145638082|NCT02139046|525189760|FG002|Overall Study|Lost to Follow-up|16|||
145638083|NCT02139046|525189761|FG003|Overall Study|Lost to Follow-up|18|||
145638084|NCT02139046|525189762|FG004|Overall Study|Lost to Follow-up|13|||
145638085|NCT02139046|525189758|FG000|Overall Study|Voluntary Withdrawal|20|||
145638086|NCT02139046|525189759|FG001|Overall Study|Voluntary Withdrawal|8|||
145638087|NCT02139046|525189760|FG002|Overall Study|Voluntary Withdrawal|10|||
145638088|NCT02139046|525189761|FG003|Overall Study|Voluntary Withdrawal|15|||
145638089|NCT02139046|525189762|FG004|Overall Study|Voluntary Withdrawal|16|||
145638090|NCT02139046|525189758|FG000|Overall Study|Lack of Efficacy|0|||
145638091|NCT02139046|525189759|FG001|Overall Study|Lack of Efficacy|1|||
145638092|NCT02139046|525189760|FG002|Overall Study|Lack of Efficacy|2|||
145638093|NCT02139046|525189761|FG003|Overall Study|Lack of Efficacy|1|||
145638094|NCT02139046|525189762|FG004|Overall Study|Lack of Efficacy|2|||
145638095|NCT02139046|525189758|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
145638096|NCT02139046|525189759|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
145638097|NCT02139046|525189760|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
145638098|NCT02139046|525189761|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
145638099|NCT02139046|525189762|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
145638100|NCT02139046|525189758|FG000|Overall Study|Other Miscellaneous Reasons|10|||
145638101|NCT02139046|525189759|FG001|Overall Study|Other Miscellaneous Reasons|9|||
145638102|NCT02139046|525189760|FG002|Overall Study|Other Miscellaneous Reasons|4|||
145638103|NCT02139046|525189761|FG003|Overall Study|Other Miscellaneous Reasons|9|||
145638104|NCT02139046|525189762|FG004|Overall Study|Other Miscellaneous Reasons|12|||
145638105|NCT05876949|525189768|FG000|Overall Study|Withdrawal by Subject|1|||
145638106|NCT05876949|525189769|FG001|Overall Study|Withdrawal by Subject|3|||
145638107|NCT05876949|525189768|FG000|Overall Study|Physician Decision|0|||
145638108|NCT05876949|525189769|FG001|Overall Study|Physician Decision|2|||
145638109|NCT05876949|525189768|FG000|Overall Study|Death|0|||
145638110|NCT05876949|525189769|FG001|Overall Study|Death|1|||
145638111|NCT02613871|525189776|FG000|Overall Study|Death|2|||
145638112|NCT02613871|525189776|FG000|Overall Study|Withdrew Consent|1|||
145638113|NCT01786564|525189777|FG000|Overall Study|Lost to Follow-up|47|||
145638114|NCT01786564|525189777|FG000|Overall Study|Ineligible|17|||
145638115|NCT00494442|525189778|FG000|Overall Study|Death|1|||
145638116|NCT00494442|525189779|FG001|Overall Study|Death|1|||
145638117|NCT00494442|525189778|FG000|Overall Study|Lack of Efficacy|16|||
145638118|NCT00494442|525189779|FG001|Overall Study|Lack of Efficacy|10|||
145638119|NCT00494442|525189778|FG000|Overall Study|Adverse Event|0|||
145638120|NCT00494442|525189779|FG001|Overall Study|Adverse Event|2|||
145638121|NCT00494442|525189778|FG000|Overall Study|Physician Decision|0|||
145638122|NCT00494442|525189779|FG001|Overall Study|Physician Decision|1|||
145638123|NCT00494442|525189778|FG000|Overall Study|Non-compliance|0|||
145638124|NCT00494442|525189779|FG001|Overall Study|Non-compliance|1|||
145638125|NCT00494442|525189778|FG000|Overall Study|Intercurrent illness|0|||
145638126|NCT00494442|525189779|FG001|Overall Study|Intercurrent illness|1|||
145638127|NCT01241292|525189782|FG000|Overall Study|Administrative Reason by Sponsor|1|||
145638128|NCT01241292|525189783|FG001|Overall Study|Administrative Reason by Sponsor|0|||
145638129|NCT01241292|525189782|FG000|Overall Study|Disease Progression|2|||
145638130|NCT01241292|525189783|FG001|Overall Study|Disease Progression|0|||
145638131|NCT01241292|525189782|FG000|Overall Study|Study Drug Toxicity|0|||
145638132|NCT01241292|525189783|FG001|Overall Study|Study Drug Toxicity|1|||
145638133|NCT01241292|525189782|FG000|Overall Study|Participant Discontinued Treatment|0|||
145638134|NCT01241292|525189783|FG001|Overall Study|Participant Discontinued Treatment|2|||
145638135|NCT03034915|525189786|FG000|Overall Study|Adverse Event|29|||
145638136|NCT03034915|525189787|FG001|Overall Study|Adverse Event|32|||
145638137|NCT03034915|525189788|FG002|Overall Study|Adverse Event|22|||
145638138|NCT03034915|525189786|FG000|Overall Study|Lost to Follow-up|5|||
145638139|NCT03034915|525189787|FG001|Overall Study|Lost to Follow-up|13|||
145638140|NCT03034915|525189788|FG002|Overall Study|Lost to Follow-up|3|||
145638141|NCT03034915|525189786|FG000|Overall Study|Withdrawal by Subject|29|||
145638142|NCT03034915|525189787|FG001|Overall Study|Withdrawal by Subject|46|||
145638143|NCT03034915|525189788|FG002|Overall Study|Withdrawal by Subject|41|||
145638144|NCT03034915|525189786|FG000|Overall Study|Protocol Deviation|2|||
145638145|NCT03034915|525189787|FG001|Overall Study|Protocol Deviation|14|||
145638146|NCT03034915|525189788|FG002|Overall Study|Protocol Deviation|7|||
145638147|NCT03034915|525189786|FG000|Overall Study|Lack of Efficacy|8|||
145638148|NCT03034915|525189787|FG001|Overall Study|Lack of Efficacy|16|||
145638149|NCT03034915|525189788|FG002|Overall Study|Lack of Efficacy|18|||
145638150|NCT03034915|525189786|FG000|Overall Study|Site closed|2|||
145638151|NCT03034915|525189787|FG001|Overall Study|Site closed|2|||
145638152|NCT03034915|525189788|FG002|Overall Study|Site closed|4|||
145638153|NCT03034915|525189786|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
145638154|NCT03034915|525189787|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
145638155|NCT03034915|525189788|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
145638156|NCT03034915|525189786|FG000|Overall Study|Physician Decision|1|||
145638157|NCT03034915|525189787|FG001|Overall Study|Physician Decision|5|||
145638158|NCT03034915|525189788|FG002|Overall Study|Physician Decision|2|||
145638159|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
145638160|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
145638161|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
145638162|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
145638163|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
145638164|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
145638165|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
145638166|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
145638167|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
145638168|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
145638169|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
145638170|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
145638171|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
145638172|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
145638173|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
145638174|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
145638175|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
145638176|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
145638177|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
145638178|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
145638179|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
145638180|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
145638181|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
145638182|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
145638183|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
145638184|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
145638185|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
145638186|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
145638187|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
145638188|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
145638189|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
145638190|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
145638191|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
145638192|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
145638193|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
145638194|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
145638195|NCT03593213|525189789|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
145638196|NCT03593213|525189790|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
145638197|NCT03593213|525189791|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
145638198|NCT03593213|525189792|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
145638199|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
145483574|NCT00859547|524624097|FG000|Overall Study|Lost to Follow-up|1|||
145483575|NCT00859547|524624097|FG000|Overall Study|Parent withdrew consent|1|||
145604420|NCT02799472|525066564|FG001|Overall Study|Withdrawal by Subject|4|||
145604421|NCT02799472|525066563|FG000|Overall Study|Lack of Efficacy|2|||
145604422|NCT02799472|525066564|FG001|Overall Study|Lack of Efficacy|0|||
145604423|NCT02799472|525066563|FG000|Overall Study|Lost to Follow-up|0|||
145604424|NCT02799472|525066564|FG001|Overall Study|Lost to Follow-up|1|||
145604425|NCT02287584|525066565|FG000|the Double-blind Phase|Adverse Event|17|||
145604426|NCT02287584|525066566|FG001|the Double-blind Phase|Adverse Event|17|||
145604427|NCT02287584|525066567|FG002|the Double-blind Phase|Adverse Event|12|||
145604428|NCT02287584|525066568|FG003|the Double-blind Phase|Adverse Event|0|||
145604429|NCT02287584|525066569|FG004|the Double-blind Phase|Adverse Event|0|||
145604430|NCT02287584|525066570|FG005|the Double-blind Phase|Adverse Event|0|||
145604431|NCT02287584|525066565|FG000|the Double-blind Phase|Lack of Efficacy|18|||
145604432|NCT02287584|525066566|FG001|the Double-blind Phase|Lack of Efficacy|8|||
145604433|NCT02287584|525066567|FG002|the Double-blind Phase|Lack of Efficacy|8|||
145604434|NCT02287584|525066568|FG003|the Double-blind Phase|Lack of Efficacy|0|||
145604435|NCT02287584|525066569|FG004|the Double-blind Phase|Lack of Efficacy|0|||
145604436|NCT02287584|525066570|FG005|the Double-blind Phase|Lack of Efficacy|0|||
145604437|NCT02287584|525066565|FG000|the Double-blind Phase|Lost to Follow-up|0|||
145604438|NCT02287584|525066566|FG001|the Double-blind Phase|Lost to Follow-up|1|||
145604439|NCT02287584|525066567|FG002|the Double-blind Phase|Lost to Follow-up|1|||
145604440|NCT02287584|525066568|FG003|the Double-blind Phase|Lost to Follow-up|0|||
145604441|NCT02287584|525066569|FG004|the Double-blind Phase|Lost to Follow-up|0|||
145604442|NCT02287584|525066570|FG005|the Double-blind Phase|Lost to Follow-up|0|||
145604443|NCT02287584|525066565|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
145604444|NCT02287584|525066566|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
145604445|NCT02287584|525066567|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
145604446|NCT02287584|525066568|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
145604447|NCT02287584|525066569|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
145604448|NCT02287584|525066570|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
145604449|NCT02287584|525066565|FG000|the Double-blind Phase|Pregnancy|0|||
145604450|NCT02287584|525066566|FG001|the Double-blind Phase|Pregnancy|1|||
145604451|NCT02287584|525066567|FG002|the Double-blind Phase|Pregnancy|0|||
145604452|NCT02287584|525066568|FG003|the Double-blind Phase|Pregnancy|0|||
145604453|NCT02287584|525066569|FG004|the Double-blind Phase|Pregnancy|0|||
145604454|NCT02287584|525066570|FG005|the Double-blind Phase|Pregnancy|0|||
145604455|NCT02287584|525066565|FG000|the Double-blind Phase|Protocol Violation|0|||
145604456|NCT02287584|525066566|FG001|the Double-blind Phase|Protocol Violation|3|||
145604457|NCT02287584|525066567|FG002|the Double-blind Phase|Protocol Violation|0|||
145604458|NCT02287584|525066568|FG003|the Double-blind Phase|Protocol Violation|0|||
145604459|NCT02287584|525066569|FG004|the Double-blind Phase|Protocol Violation|0|||
145604460|NCT02287584|525066570|FG005|the Double-blind Phase|Protocol Violation|0|||
145604461|NCT02287584|525066565|FG000|the Double-blind Phase|other reasons|0|||
145604462|NCT02287584|525066566|FG001|the Double-blind Phase|other reasons|0|||
145604463|NCT02287584|525066567|FG002|the Double-blind Phase|other reasons|1|||
145604464|NCT02287584|525066568|FG003|the Double-blind Phase|other reasons|0|||
145604465|NCT02287584|525066569|FG004|the Double-blind Phase|other reasons|0|||
145604466|NCT02287584|525066570|FG005|the Double-blind Phase|other reasons|0|||
145604467|NCT02287584|525066565|FG000|the Open-label Phase|Did not receive drug|0|||
145604468|NCT02287584|525066566|FG001|the Open-label Phase|Did not receive drug|0|||
145604469|NCT02287584|525066567|FG002|the Open-label Phase|Did not receive drug|0|||
145604470|NCT02287584|525066568|FG003|the Open-label Phase|Did not receive drug|7|||
145604471|NCT02287584|525066569|FG004|the Open-label Phase|Did not receive drug|6|||
145604472|NCT02287584|525066570|FG005|the Open-label Phase|Did not receive drug|4|||
145604473|NCT02287584|525066565|FG000|the Open-label Phase|Adverse Event|0|||
145604474|NCT02287584|525066566|FG001|the Open-label Phase|Adverse Event|0|||
145604475|NCT02287584|525066567|FG002|the Open-label Phase|Adverse Event|0|||
145604476|NCT02287584|525066568|FG003|the Open-label Phase|Adverse Event|15|||
145604477|NCT02287584|525066569|FG004|the Open-label Phase|Adverse Event|12|||
145604478|NCT02287584|525066570|FG005|the Open-label Phase|Adverse Event|16|||
145604479|NCT02287584|525066565|FG000|the Open-label Phase|Lack of Efficacy|0|||
145604480|NCT02287584|525066566|FG001|the Open-label Phase|Lack of Efficacy|0|||
145604481|NCT02287584|525066567|FG002|the Open-label Phase|Lack of Efficacy|0|||
145483576|NCT01410890|524624099|FG000|Overall Study|Withdrawal by Subject|0|||
145483577|NCT01410890|524624100|FG001|Overall Study|Withdrawal by Subject|1|||
145604482|NCT02287584|525066568|FG003|the Open-label Phase|Lack of Efficacy|8|||
145604483|NCT02287584|525066569|FG004|the Open-label Phase|Lack of Efficacy|3|||
145604484|NCT02287584|525066570|FG005|the Open-label Phase|Lack of Efficacy|7|||
145604485|NCT02287584|525066565|FG000|the Open-label Phase|Lost to Follow-up|0|||
145604486|NCT02287584|525066566|FG001|the Open-label Phase|Lost to Follow-up|0|||
145604487|NCT02287584|525066567|FG002|the Open-label Phase|Lost to Follow-up|0|||
145604488|NCT02287584|525066568|FG003|the Open-label Phase|Lost to Follow-up|4|||
145604489|NCT02287584|525066569|FG004|the Open-label Phase|Lost to Follow-up|1|||
145483578|NCT00786799|524624109|FG000|Overall Study|Lost to Follow-up|1|||
145483579|NCT00786799|524624110|FG001|Overall Study|Lost to Follow-up|1|||
145483580|NCT01799226|524624111|FG000|Overall Study|Withdrawal by Subject|1|||
145483581|NCT01799226|524624112|FG001|Overall Study|Withdrawal by Subject|0|||
145604490|NCT02287584|525066570|FG005|the Open-label Phase|Lost to Follow-up|2|||
145604491|NCT02287584|525066565|FG000|the Open-label Phase|Withdrawal by Subject|0|||
145604492|NCT02287584|525066566|FG001|the Open-label Phase|Withdrawal by Subject|0|||
145604493|NCT02287584|525066567|FG002|the Open-label Phase|Withdrawal by Subject|0|||
145604494|NCT02287584|525066568|FG003|the Open-label Phase|Withdrawal by Subject|18|||
145604495|NCT02287584|525066569|FG004|the Open-label Phase|Withdrawal by Subject|29|||
145604496|NCT02287584|525066570|FG005|the Open-label Phase|Withdrawal by Subject|21|||
145604497|NCT02287584|525066565|FG000|the Open-label Phase|non-compliance|0|||
145604498|NCT02287584|525066566|FG001|the Open-label Phase|non-compliance|0|||
145604499|NCT02287584|525066567|FG002|the Open-label Phase|non-compliance|0|||
145604500|NCT02287584|525066568|FG003|the Open-label Phase|non-compliance|2|||
145604501|NCT02287584|525066569|FG004|the Open-label Phase|non-compliance|5|||
145604502|NCT02287584|525066570|FG005|the Open-label Phase|non-compliance|1|||
145604503|NCT02287584|525066565|FG000|the Open-label Phase|other reasons|0|||
145604504|NCT02287584|525066566|FG001|the Open-label Phase|other reasons|0|||
145604505|NCT02287584|525066567|FG002|the Open-label Phase|other reasons|0|||
145604506|NCT02287584|525066568|FG003|the Open-label Phase|other reasons|3|||
145604507|NCT02287584|525066569|FG004|the Open-label Phase|other reasons|6|||
145604508|NCT02287584|525066570|FG005|the Open-label Phase|other reasons|6|||
145604509|NCT01492686|525066573|FG000|Double-blind Phase|Adverse Event|0|||
145604510|NCT01492686|525066574|FG001|Double-blind Phase|Adverse Event|2|||
145604511|NCT01492686|525066573|FG000|Double-blind Phase|Physician Decision|0|||
145604512|NCT01492686|525066574|FG001|Double-blind Phase|Physician Decision|1|||
145604513|NCT01492686|525066573|FG000|Double-blind Phase|Withdrawal by Subject|0|||
145604514|NCT01492686|525066574|FG001|Double-blind Phase|Withdrawal by Subject|2|||
145604515|NCT01492686|525066573|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
145604516|NCT01492686|525066574|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
145604517|NCT01492686|525066573|FG000|Open-label Phase|Adverse Event|1|||
145604518|NCT01492686|525066574|FG001|Open-label Phase|Adverse Event|2|||
145604519|NCT01492686|525066573|FG000|Open-label Phase|Physician Decision|1|||
145604520|NCT01492686|525066574|FG001|Open-label Phase|Physician Decision|0|||
145604521|NCT01492686|525066573|FG000|Open-label Phase|Withdrawal by Subject|6|||
145604522|NCT01492686|525066574|FG001|Open-label Phase|Withdrawal by Subject|7|||
145604523|NCT01492686|525066573|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
145604524|NCT01492686|525066574|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
145604525|NCT02748694|525066576|FG000|Overall Study|Voluntary Withdrawal|0|||
145604526|NCT02748694|525066577|FG001|Overall Study|Voluntary Withdrawal|0|||
145604527|NCT02748694|525066578|FG002|Overall Study|Voluntary Withdrawal|0|||
145604528|NCT02748694|525066579|FG003|Overall Study|Voluntary Withdrawal|0|||
145604529|NCT02748694|525066580|FG004|Overall Study|Voluntary Withdrawal|0|||
145604530|NCT02748694|525066581|FG005|Overall Study|Voluntary Withdrawal|0|||
145604531|NCT02748694|525066582|FG006|Overall Study|Voluntary Withdrawal|0|||
145604532|NCT02748694|525066583|FG007|Overall Study|Voluntary Withdrawal|0|||
145604533|NCT02748694|525066584|FG008|Overall Study|Voluntary Withdrawal|0|||
145604534|NCT02748694|525066585|FG009|Overall Study|Voluntary Withdrawal|0|||
145604535|NCT02748694|525066586|FG010|Overall Study|Voluntary Withdrawal|0|||
145604536|NCT02748694|525066587|FG011|Overall Study|Voluntary Withdrawal|0|||
145604537|NCT02748694|525066588|FG012|Overall Study|Voluntary Withdrawal|0|||
145604538|NCT02748694|525066589|FG013|Overall Study|Voluntary Withdrawal|0|||
145604539|NCT02748694|525066590|FG014|Overall Study|Voluntary Withdrawal|2|||
145604540|NCT00659984|525066593|FG000|Overall Study|Adverse Event|1|||
145604541|NCT02007434|525066594|FG000|Overall Study|Lost to Follow-up|0|||
145604542|NCT02007434|525066595|FG001|Overall Study|Lost to Follow-up|1|||
145604543|NCT02007434|525066596|FG002|Overall Study|Lost to Follow-up|0|||
145604544|NCT02007434|525066597|FG003|Overall Study|Lost to Follow-up|0|||
145604545|NCT02007434|525066598|FG004|Overall Study|Lost to Follow-up|0|||
145604546|NCT02007434|525066599|FG005|Overall Study|Lost to Follow-up|0|||
145604547|NCT02007434|525066600|FG006|Overall Study|Lost to Follow-up|0|||
145604548|NCT02007434|525066601|FG007|Overall Study|Lost to Follow-up|0|||
145604549|NCT02007434|525066594|FG000|Overall Study|Non-compliance|1|||
145604550|NCT02007434|525066595|FG001|Overall Study|Non-compliance|0|||
145483582|NCT01799226|524624111|FG000|Overall Study|Disqualified at Day 14|1|||
145604551|NCT02007434|525066596|FG002|Overall Study|Non-compliance|1|||
145604552|NCT02007434|525066597|FG003|Overall Study|Non-compliance|0|||
145604553|NCT02007434|525066598|FG004|Overall Study|Non-compliance|0|||
145604554|NCT02007434|525066599|FG005|Overall Study|Non-compliance|0|||
145604555|NCT02007434|525066600|FG006|Overall Study|Non-compliance|0|||
145604556|NCT02007434|525066601|FG007|Overall Study|Non-compliance|0|||
145604557|NCT04074590|525066604|FG000|Overall Study|Adverse Event|1|||
145483583|NCT01799226|524624112|FG001|Overall Study|Disqualified at Day 14|0|||
145604558|NCT04074590|525066605|FG001|Overall Study|Adverse Event|0|||
145604559|NCT04074590|525066604|FG000|Overall Study|Physician Decision|1|||
145604560|NCT04074590|525066605|FG001|Overall Study|Physician Decision|0|||
145604561|NCT04074590|525066604|FG000|Overall Study|Withdrawal by Subject|2|||
145638200|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
145483584|NCT02631551|524624113|FG000|Overall Study|Adverse Event|1|||
145483585|NCT02631551|524624114|FG001|Overall Study|Adverse Event|2|||
145483586|NCT02631551|524624115|FG002|Overall Study|Adverse Event|4|||
145638201|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
145638202|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
145638203|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
145638204|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
145638205|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
145638206|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
145638207|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
145638208|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
145638209|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
145638210|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
145638211|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
145638212|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
145638213|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
145638214|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
145638215|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
145638216|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
145638217|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
145638218|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
145638219|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
145638220|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
145638221|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
145638222|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
145638223|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
145638224|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
145638225|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
145638226|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
145638227|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
145638228|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
145638229|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
145638230|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
145638231|NCT03593213|525189789|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
145638232|NCT03593213|525189790|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
145638233|NCT03593213|525189791|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
145638234|NCT03593213|525189792|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
145638235|NCT01831791|525189793|FG000|Overall Study|Withdrawal by Subject|10|||
145638236|NCT00494780|525189794|FG000|Overall Study|Adverse Event|1|||
145638237|NCT00494780|525189795|FG001|Overall Study|Adverse Event|0|||
145638238|NCT00494780|525189794|FG000|Overall Study|Withdrew before Dosed|0|||
145638239|NCT00494780|525189795|FG001|Overall Study|Withdrew before Dosed|1|||
145638240|NCT00494780|525189794|FG000|Overall Study|Progression of Study Disease|7|||
145638241|NCT00494780|525189795|FG001|Overall Study|Progression of Study Disease|8|||
145638242|NCT00494780|525189794|FG000|Overall Study|New Treatment|2|||
145638243|NCT00494780|525189795|FG001|Overall Study|New Treatment|2|||
145638244|NCT00494780|525189794|FG000|Overall Study|Non-compliance|1|||
145638245|NCT00494780|525189795|FG001|Overall Study|Non-compliance|0|||
145638246|NCT00494780|525189794|FG000|Overall Study|Residual Tumour Mass|0|||
145638247|NCT00494780|525189795|FG001|Overall Study|Residual Tumour Mass|1|||
145638248|NCT00494780|525189794|FG000|Overall Study|Insurance Issues|0|||
145638249|NCT00494780|525189795|FG001|Overall Study|Insurance Issues|1|||
145483587|NCT02631551|524624116|FG003|Overall Study|Adverse Event|0|||
145483588|NCT02631551|524624113|FG000|Overall Study|Lack of Efficacy|0|||
145483589|NCT02631551|524624114|FG001|Overall Study|Lack of Efficacy|0|||
145483590|NCT02631551|524624115|FG002|Overall Study|Lack of Efficacy|1|||
145483591|NCT02631551|524624116|FG003|Overall Study|Lack of Efficacy|0|||
145483592|NCT02631551|524624113|FG000|Overall Study|Lost to Follow-up|1|||
145483593|NCT02631551|524624114|FG001|Overall Study|Lost to Follow-up|2|||
145483594|NCT02631551|524624115|FG002|Overall Study|Lost to Follow-up|0|||
145483595|NCT02631551|524624116|FG003|Overall Study|Lost to Follow-up|3|||
145483596|NCT02631551|524624113|FG000|Overall Study|Withdrawal by Subject|2|||
145638250|NCT01190007|525189796|FG000|Overall Study|Withdrawal by Subject|4|||
145638251|NCT01190007|525189796|FG000|Overall Study|Adverse Event|8|||
145638252|NCT01190007|525189796|FG000|Overall Study|Difficulty of visit for complications|1|||
145483597|NCT02631551|524624114|FG001|Overall Study|Withdrawal by Subject|2|||
145483598|NCT02631551|524624115|FG002|Overall Study|Withdrawal by Subject|0|||
145638253|NCT01190007|525189796|FG000|Overall Study|Participant was arrested|1|||
145638254|NCT01254019|525189797|FG000|Overall Study|Adverse Event|0|||
145638255|NCT01254019|525189798|FG001|Overall Study|Adverse Event|2|||
145638256|NCT01254019|525189797|FG000|Overall Study|Protocol Violation|1|||
145638257|NCT01254019|525189798|FG001|Overall Study|Protocol Violation|0|||
145638258|NCT01254019|525189797|FG000|Overall Study|Withdrawal by Subject|0|||
145638259|NCT01254019|525189798|FG001|Overall Study|Withdrawal by Subject|2|||
145638260|NCT03061474|525189799|FG000|Overall Study|Adverse Event|2|||
145638261|NCT03061474|525189800|FG001|Overall Study|Adverse Event|0|||
145638262|NCT03061474|525189799|FG000|Overall Study|Safety Risk|0|||
145638263|NCT03061474|525189800|FG001|Overall Study|Safety Risk|1|||
145638264|NCT03061474|525189799|FG000|Overall Study|Participant unwilling or unable to participate|0|||
145638265|NCT03061474|525189800|FG001|Overall Study|Participant unwilling or unable to participate|2|||
145638266|NCT03061474|525189799|FG000|Overall Study|Lost to Follow-up|0|||
145638267|NCT03061474|525189800|FG001|Overall Study|Lost to Follow-up|1|||
145638268|NCT00845832|525189803|FG000|Treatment Period|Adverse Event|0|||
145638269|NCT00845832|525189804|FG001|Treatment Period|Adverse Event|2|||
145638270|NCT00845832|525189805|FG002|Treatment Period|Adverse Event|0|||
145638271|NCT00845832|525189803|FG000|Treatment Period|Protocol Violation|1|||
145638272|NCT00845832|525189804|FG001|Treatment Period|Protocol Violation|1|||
145638273|NCT00845832|525189805|FG002|Treatment Period|Protocol Violation|0|||
145638274|NCT00845832|525189803|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
145638275|NCT00845832|525189804|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
145638276|NCT00845832|525189805|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
145638277|NCT00845832|525189803|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
145638278|NCT00845832|525189804|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
145638279|NCT00845832|525189805|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
145638280|NCT01391130|525189806|FG000|Overall Study|Withdrawal by Subject|3|||
145638281|NCT01391130|525189807|FG001|Overall Study|Withdrawal by Subject|2|||
145638282|NCT01391130|525189806|FG000|Overall Study|Physician Decision|2|||
145638283|NCT01391130|525189807|FG001|Overall Study|Physician Decision|3|||
145638284|NCT01391130|525189806|FG000|Overall Study|Did not Receive Drug|1|||
145638285|NCT01391130|525189807|FG001|Overall Study|Did not Receive Drug|1|||
145638286|NCT00189202|525189808|FG000|Overall Study|Physician Decision|5|||
145638287|NCT00668863|525189809|FG000|Overall Study|Objective Progression or Relapse|42|||
145638288|NCT00668863|525189809|FG000|Overall Study|Adverse Event|13|||
145638289|NCT00668863|525189809|FG000|Overall Study|Study Terminated by Sponsor|8|||
145483599|NCT02631551|524624116|FG003|Overall Study|Withdrawal by Subject|5|||
145638290|NCT00668863|525189809|FG000|Overall Study|Global Deterioration of Health Status|4|||
145638291|NCT00668863|525189809|FG000|Overall Study|Withdrawal by Subject|1|||
145638292|NCT00668863|525189809|FG000|Overall Study|Surgery|1|||
145638293|NCT00668863|525189809|FG000|Overall Study|Subject's work scheduling problem|1|||
145638294|NCT00668863|525189809|FG000|Overall Study|Physician Decision|1|||
145638295|NCT00869323|525189814|FG000|Maintenance Therapy|concurrent illness|1|||
145638296|NCT01068743|525189817|FG000|Period 3|Adverse Event|0|||
145638297|NCT01068743|525189818|FG001|Period 3|Adverse Event|1|||
145638298|NCT01068743|525189819|FG002|Period 3|Adverse Event|0|||
145638299|NCT01068743|525189820|FG003|Period 3|Adverse Event|0|||
145638300|NCT00638963|525189821|FG000|Overall Study|Withdrawal by Subject|1|||
145638301|NCT00638963|525189822|FG001|Overall Study|Withdrawal by Subject|0|||
145483600|NCT02631551|524624113|FG000|Overall Study|Protocol deviation|3|||
145483601|NCT02631551|524624114|FG001|Overall Study|Protocol deviation|6|||
145483602|NCT02631551|524624115|FG002|Overall Study|Protocol deviation|3|||
145483603|NCT02631551|524624116|FG003|Overall Study|Protocol deviation|0|||
145483604|NCT02631551|524624113|FG000|Overall Study|Non-compliance with study procedures|0|||
145483605|NCT02631551|524624114|FG001|Overall Study|Non-compliance with study procedures|0|||
145483606|NCT02631551|524624115|FG002|Overall Study|Non-compliance with study procedures|1|||
145483607|NCT02631551|524624116|FG003|Overall Study|Non-compliance with study procedures|1|||
145483608|NCT02631551|524624113|FG000|Overall Study|Non-compliance with study drug|1|||
145483609|NCT02631551|524624114|FG001|Overall Study|Non-compliance with study drug|0|||
145483610|NCT02631551|524624115|FG002|Overall Study|Non-compliance with study drug|0|||
145483611|NCT02631551|524624116|FG003|Overall Study|Non-compliance with study drug|0|||
145483612|NCT02631551|524624113|FG000|Overall Study|Other, specific reasons not collected|5|||
145483613|NCT02631551|524624114|FG001|Overall Study|Other, specific reasons not collected|7|||
145638302|NCT00463788|525189826|FG000|Overall Study|Progressive Disease|86|||
145638303|NCT00463788|525189827|FG001|Overall Study|Progressive Disease|42|||
145638304|NCT00463788|525189826|FG000|Overall Study|Adverse Event|6|||
145638305|NCT00463788|525189827|FG001|Overall Study|Adverse Event|2|||
145638306|NCT00463788|525189826|FG000|Overall Study|Withdrawal by Subject|6|||
145638307|NCT00463788|525189827|FG001|Overall Study|Withdrawal by Subject|2|||
145638308|NCT00463788|525189826|FG000|Overall Study|Death|4|||
145638309|NCT00463788|525189827|FG001|Overall Study|Death|3|||
145638310|NCT00463788|525189826|FG000|Overall Study|Symptomatic Deterioration|2|||
145638311|NCT00463788|525189827|FG001|Overall Study|Symptomatic Deterioration|3|||
145638312|NCT00463788|525189826|FG000|Overall Study|Lost to Follow-up|1|||
145638313|NCT00463788|525189827|FG001|Overall Study|Lost to Follow-up|0|||
145638314|NCT00463788|525189826|FG000|Overall Study|Protocol Violation|0|||
145638315|NCT00463788|525189827|FG001|Overall Study|Protocol Violation|1|||
145638316|NCT00463788|525189826|FG000|Overall Study|Other|3|||
145638317|NCT00463788|525189827|FG001|Overall Study|Other|0|||
145638318|NCT00463788|525189826|FG000|Overall Study|Randomized but not treated|1|||
145638319|NCT00463788|525189827|FG001|Overall Study|Randomized but not treated|1|||
145638320|NCT00360698|525189828|FG000|Run-In|Physician Decision|0|||
145638321|NCT00360698|525189829|FG001|Run-In|Physician Decision|1|||
145638322|NCT00360698|525189828|FG000|Run-In|Withdrawal by Subject|0|||
145638323|NCT00360698|525189829|FG001|Run-In|Withdrawal by Subject|2|||
145638324|NCT00360698|525189828|FG000|Run-In|Non compliance with treatment procedure|0|||
145638325|NCT00360698|525189829|FG001|Run-In|Non compliance with treatment procedure|1|||
145638326|NCT00360698|525189828|FG000|Run-In|Sponsor request|0|||
145638327|NCT00360698|525189829|FG001|Run-In|Sponsor request|2|||
145638328|NCT00360698|525189828|FG000|Run-In|Patient did not meet inclusion criteria|0|||
145638329|NCT00360698|525189829|FG001|Run-In|Patient did not meet inclusion criteria|1|||
145638330|NCT00360698|525189828|FG000|Run-In|Patient personal reasons|0|||
145638331|NCT00360698|525189829|FG001|Run-In|Patient personal reasons|2|||
145638332|NCT00360698|525189828|FG000|Run-In|Need of insulin with meals|0|||
145638333|NCT00360698|525189829|FG001|Run-In|Need of insulin with meals|1|||
145638334|NCT00360698|525189828|FG000|Treatment Period|Non compliance with treatment procedure|1|||
145638335|NCT00360698|525189829|FG001|Treatment Period|Non compliance with treatment procedure|0|||
145638336|NCT00360698|525189828|FG000|Treatment Period|Early termination by error|0|||
145638337|NCT00360698|525189829|FG001|Treatment Period|Early termination by error|1|||
145638338|NCT01692938|525189837|FG000|Overall Study|Protocol Deviation|1|||
145638339|NCT01692938|525189838|FG001|Overall Study|Protocol Deviation|1|||
145638340|NCT01692938|525189837|FG000|Overall Study|Study completed prior to site completion|3|||
145638341|NCT01692938|525189838|FG001|Overall Study|Study completed prior to site completion|3|||
145638342|NCT02755116|525189839|FG000|Overall Study|surgery converted to open, pt admitted|3|||
145638343|NCT02755116|525189840|FG001|Overall Study|surgery converted to open, pt admitted|1|||
145638344|NCT02423291|525189841|FG000|Overall Study|Lack of Efficacy|14|||
145638345|NCT02423291|525189841|FG000|Overall Study|Adverse Event|1|||
145638346|NCT04975308|525189846|FG000|Overall Study|Withdrawal by Subject|6|||
145638347|NCT04975308|525189847|FG001|Overall Study|Withdrawal by Subject|16|||
145638348|NCT04975308|525189848|FG002|Overall Study|Withdrawal by Subject|6|||
145638349|NCT04975308|525189846|FG000|Overall Study|Physician Decision|0|||
145638350|NCT04975308|525189847|FG001|Overall Study|Physician Decision|3|||
145638351|NCT04975308|525189848|FG002|Overall Study|Physician Decision|1|||
145638352|NCT04975308|525189846|FG000|Overall Study|Adverse Event|10|||
145638353|NCT04975308|525189847|FG001|Overall Study|Adverse Event|1|||
145638354|NCT04975308|525189848|FG002|Overall Study|Adverse Event|12|||
145638355|NCT04975308|525189846|FG000|Overall Study|On study treatment (Ongoing)|65|||
145638356|NCT04975308|525189847|FG001|Overall Study|On study treatment (Ongoing)|43|||
145638357|NCT04975308|525189848|FG002|Overall Study|On study treatment (Ongoing)|75|||
145638358|NCT04975308|525189846|FG000|Overall Study|Protocol Deviation|4|||
145638359|NCT04975308|525189847|FG001|Overall Study|Protocol Deviation|3|||
145483614|NCT02631551|524624115|FG002|Overall Study|Other, specific reasons not collected|2|||
145483615|NCT02631551|524624116|FG003|Overall Study|Other, specific reasons not collected|2|||
145483616|NCT00991939|524624119|FG000|Overall Study|Lost to Follow-up|0|||
145483617|NCT00991939|524624120|FG001|Overall Study|Lost to Follow-up|1|||
145483618|NCT00991939|524624119|FG000|Overall Study|Withdrawal by Subject|1|||
145483619|NCT00991939|524624120|FG001|Overall Study|Withdrawal by Subject|0|||
145483620|NCT00991939|524624119|FG000|Overall Study|Entire study terminated|4|||
145483621|NCT00991939|524624120|FG001|Overall Study|Entire study terminated|1|||
145638360|NCT04975308|525189848|FG002|Overall Study|Protocol Deviation|2|||
145638361|NCT00658996|525189849|FG000|First Intervention|Positive slit lamp finding|1|||
145638362|NCT00658996|525189850|FG001|First Intervention|Positive slit lamp finding|0|||
145638363|NCT00658996|525189849|FG000|First Intervention|Lack of lenses|0|||
145638364|NCT00658996|525189850|FG001|First Intervention|Lack of lenses|1|||
145638365|NCT00658996|525189849|FG000|Crossover Period|Physician Decision|1|||
145638366|NCT00658996|525189850|FG001|Crossover Period|Physician Decision|0|||
145483622|NCT00714415|524624121|FG000|Overall Study|Lack of Efficacy|1|||
145483623|NCT00714415|524624122|FG001|Overall Study|Lack of Efficacy|0|||
145483624|NCT00714415|524624121|FG000|Overall Study|Death|1|||
145483625|NCT00714415|524624122|FG001|Overall Study|Death|0|||
145638367|NCT00658996|525189849|FG000|Crossover Period|Ineligible|1|||
145638368|NCT00658996|525189850|FG001|Crossover Period|Ineligible|1|||
145638369|NCT00658996|525189849|FG000|Second Intervention|Developed a stye on upper lid|1|||
145638370|NCT00658996|525189850|FG001|Second Intervention|Developed a stye on upper lid|0|||
145638371|NCT00658996|525189849|FG000|Second Intervention|Positive slit lamp finding|0|||
145638372|NCT00658996|525189850|FG001|Second Intervention|Positive slit lamp finding|1|||
145638373|NCT01170026|525191038|FG000|Overall Study|Lost to Follow-up|4|||
145483626|NCT01461707|524624125|FG000|Overall Study|Withdrawal by Subject|1|||
145483627|NCT01461707|524624126|FG001|Overall Study|Withdrawal by Subject|0|||
145638374|NCT01170026|525191039|FG001|Overall Study|Lost to Follow-up|2|||
145638375|NCT03785782|525191051|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
145483628|NCT01450761|524624127|FG000|Randomization|Subject no longer meets study criteria|1|||
145483629|NCT01450761|524624128|FG001|Randomization|Subject no longer meets study criteria|2|||
145483630|NCT01450761|524624127|FG000|Randomization|Withdrawal by Subject|2|||
145483631|NCT01450761|524624128|FG001|Randomization|Withdrawal by Subject|0|||
145483632|NCT01450761|524624127|FG000|Randomization|Disease progression|0|||
145483633|NCT01450761|524624128|FG001|Randomization|Disease progression|2|||
145483634|NCT01450761|524624127|FG000|Randomization|Adverse Event unrelated to study drug|1|||
145483635|NCT01450761|524624128|FG001|Randomization|Adverse Event unrelated to study drug|0|||
145604562|NCT04074590|525066605|FG001|Overall Study|Withdrawal by Subject|0|||
145604563|NCT03745222|525066618|FG000|Overall Study|Withdrawal by Subject|0|||
145604564|NCT03745222|525066619|FG001|Overall Study|Withdrawal by Subject|1|||
145604565|NCT03745222|525066620|FG002|Overall Study|Withdrawal by Subject|0|||
145604566|NCT00792103|525066621|FG000|Overall Study|Enrolled, not treated|15|||
145604567|NCT00792103|525066621|FG000|Overall Study|Lost to Follow-up|17|||
145604568|NCT00792103|525066621|FG000|Overall Study|Adverse Event|25|||
145604569|NCT00792103|525066621|FG000|Overall Study|Withdrawal by Subject|52|||
145604570|NCT00792103|525066621|FG000|Overall Study|Protocol Violation|10|||
145604571|NCT00792103|525066621|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
145604572|NCT02535364|525066622|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
145604573|NCT02535364|525066622|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
145604574|NCT02535364|525066622|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
145604575|NCT02535364|525066622|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
145604576|NCT02535364|525066622|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
145604577|NCT02535364|525066622|FG000|Part B Screening|Death|2|||
145604578|NCT02535364|525066622|FG000|Part B Screening|Physician Decision|1|||
145604579|NCT02535364|525066622|FG000|Part B Screening|Withdrawal by Subject|1|||
145604580|NCT02535364|525066622|FG000|Part B Screening|Adverse Event|1|||
145604581|NCT02535364|525066622|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
145604582|NCT02535364|525066622|FG000|Study Treatment|Death|1|||
145604583|NCT02535364|525066622|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
145604584|NCT02535364|525066622|FG000|12-Month Follow-up Period|Disease progression|22|||
145604585|NCT02535364|525066622|FG000|12-Month Follow-up Period|Death|5|||
145604586|NCT02535364|525066622|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
145604587|NCT02535364|525066622|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
145604588|NCT02535364|525066622|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
145604589|NCT00571701|525066623|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
145604590|NCT00571701|525066624|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
145604591|NCT00571701|525066623|FG000|First Intervention 12 Months|Death|1|||
145604592|NCT00571701|525066624|FG001|First Intervention 12 Months|Death|0|||
145604593|NCT00571701|525066623|FG000|Second Intervention 12 Months|Adverse Event|0|||
145604594|NCT00571701|525066624|FG001|Second Intervention 12 Months|Adverse Event|1|||
145604595|NCT00571701|525066623|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
145604596|NCT00571701|525066624|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
145604597|NCT04766086|525066626|FG000|Overall Study|Lost to Follow-up|3|||
145604598|NCT04766086|525066627|FG001|Overall Study|Lost to Follow-up|5|||
145604599|NCT04766086|525066628|FG002|Overall Study|Lost to Follow-up|3|||
145604600|NCT04766086|525066626|FG000|Overall Study|Withdrawal by Subject|1|||
145604601|NCT04766086|525066627|FG001|Overall Study|Withdrawal by Subject|1|||
145604602|NCT04766086|525066628|FG002|Overall Study|Withdrawal by Subject|2|||
145604603|NCT04766086|525066626|FG000|Overall Study|Other|0|||
145604604|NCT04766086|525066627|FG001|Overall Study|Other|0|||
145604605|NCT04766086|525066628|FG002|Overall Study|Other|1|||
145604606|NCT03541044|525066629|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
145604607|NCT03541044|525066630|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
145604608|NCT03541044|525066629|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
145604609|NCT03541044|525066630|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
145604610|NCT01462162|525066631|FG000|Overall Study|Adverse Event|5|||
145604611|NCT01462162|525066631|FG000|Overall Study|Lack of Efficacy|4|||
145604612|NCT01462162|525066631|FG000|Overall Study|Abnormal laboratory parameters|1|||
145604613|NCT01462162|525066631|FG000|Overall Study|Other|2|||
145604614|NCT01674621|525066642|FG000|Overall Study|Adverse Event|3|||
145604615|NCT01674621|525066643|FG001|Overall Study|Adverse Event|2|||
145604616|NCT01674621|525066644|FG002|Overall Study|Adverse Event|5|||
145604617|NCT01674621|525066645|FG003|Overall Study|Adverse Event|5|||
145604618|NCT01674621|525066646|FG004|Overall Study|Adverse Event|1|||
145604619|NCT01674621|525066642|FG000|Overall Study|Inability to Complete Study Procedures|0|||
145604620|NCT01674621|525066643|FG001|Overall Study|Inability to Complete Study Procedures|0|||
145604621|NCT01674621|525066644|FG002|Overall Study|Inability to Complete Study Procedures|0|||
145604622|NCT01674621|525066645|FG003|Overall Study|Inability to Complete Study Procedures|0|||
145604623|NCT01674621|525066646|FG004|Overall Study|Inability to Complete Study Procedures|2|||
145604624|NCT01674621|525066642|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
145483636|NCT01450761|524624127|FG000|Randomization|Other|0|||
145638376|NCT03785782|525191052|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
145638377|NCT03785782|525191051|FG000|Overall Study|Withdrawal by Subject|1|||
145638378|NCT03785782|525191052|FG001|Overall Study|Withdrawal by Subject|1|||
145483637|NCT01450761|524624128|FG001|Randomization|Other|1|||
145483638|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Disease progression|33|||
145483639|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Disease progression|32|||
145483640|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
145483641|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
145483642|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
145483643|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
145483644|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
145483645|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
145483646|NCT01450761|524624127|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
145638379|NCT03785782|525191051|FG000|Overall Study|insufficient image quality.|3|||
145638380|NCT03785782|525191052|FG001|Overall Study|insufficient image quality.|0|||
145638381|NCT03889925|525191053|FG000|Overall Study|Lost to Follow-up|11|||
145638382|NCT03889925|525191054|FG001|Overall Study|Lost to Follow-up|10|||
145638383|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
145638384|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
145638385|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
145638386|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
145638387|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
145638388|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
145638389|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
145638390|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
145638391|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
145638392|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
145638393|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
145638394|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
145638395|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
145638396|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
145638397|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
145638398|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
145638399|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
145638400|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
145638401|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
145638402|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
145638403|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
145638404|NCT00304031|525191055|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
145638405|NCT00304031|525191056|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
145638406|NCT00304031|525191057|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
145638407|NCT00304031|525191055|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
145638408|NCT00304031|525191056|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
145638409|NCT00304031|525191057|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
145638410|NCT00493649|525191058|FG000|Overall Study|Adverse Event|44|||
145638411|NCT00493649|525191058|FG000|Overall Study|Patient Request|21|||
145638412|NCT00493649|525191058|FG000|Overall Study|Investigator Request|2|||
145638413|NCT00493649|525191058|FG000|Overall Study|Disease Progression|1|||
145638414|NCT00493649|525191058|FG000|Overall Study|Lost to Follow-up|1|||
145638415|NCT00493649|525191058|FG000|Overall Study|Other|13|||
145638416|NCT01662336|525191071|FG000|Overall Study|Adverse Event|1|||
145638417|NCT01662336|525191071|FG000|Overall Study|No longer on LPV/r|30|||
145638418|NCT01662336|525191071|FG000|Overall Study|Other|29|||
145638419|NCT01662336|525191071|FG000|Overall Study|Withdrawal by Subject|6|||
145638420|NCT02189252|525191072|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
145638421|NCT02189252|525191073|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
145638422|NCT02189252|525191074|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
145638423|NCT02189252|525191075|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
145638424|NCT02189252|525191072|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
145638425|NCT02189252|525191073|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
145638426|NCT02189252|525191074|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
145638427|NCT02189252|525191075|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
145638428|NCT00566735|525191076|FG000|Overall Study|Withdrawal by Subject|0|||
145483647|NCT01450761|524624128|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
145638429|NCT00566735|525191077|FG001|Overall Study|Withdrawal by Subject|1|||
145638430|NCT00566735|525191076|FG000|Overall Study|Refused neuropsychological testing|2|||
145638431|NCT00566735|525191077|FG001|Overall Study|Refused neuropsychological testing|5|||
145638432|NCT00566735|525191076|FG000|Overall Study|Switched into a manic episode|0|||
145638433|NCT00566735|525191077|FG001|Overall Study|Switched into a manic episode|1|||
145638434|NCT04603924|525191078|FG000|Overall Study|Not Dosed|2|||
145638435|NCT04603924|525191079|FG001|Overall Study|Not Dosed|1|||
145638436|NCT04603924|525191078|FG000|Overall Study|Withdrawal by Subject|6|||
145638437|NCT04603924|525191079|FG001|Overall Study|Withdrawal by Subject|6|||
145638438|NCT04603924|525191078|FG000|Overall Study|Adverse Event|2|||
145638439|NCT04603924|525191079|FG001|Overall Study|Adverse Event|2|||
145638440|NCT01460446|525191088|FG000|Overall Study|Non-compliance|2|||
145638441|NCT01460446|525191089|FG001|Overall Study|Non-compliance|9|||
145638442|NCT01460446|525191088|FG000|Overall Study|Consent Withdrawn|0|||
145638443|NCT01460446|525191089|FG001|Overall Study|Consent Withdrawn|4|||
145483648|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Death|3|||
145483649|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Death|3|||
145483650|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Other|2|||
145483651|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Other|2|||
145483652|NCT01450761|524624127|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
145483653|NCT01450761|524624128|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
145638444|NCT01460446|525191088|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
145638445|NCT01460446|525191089|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
145638446|NCT01460446|525191088|FG000|Overall Study|Surgery/Illness|1|||
145638447|NCT01460446|525191089|FG001|Overall Study|Surgery/Illness|1|||
145638448|NCT01460446|525191088|FG000|Overall Study|Pregnancy|1|||
145638449|NCT01460446|525191089|FG001|Overall Study|Pregnancy|0|||
145638450|NCT01460446|525191088|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
145638451|NCT01460446|525191089|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
145638452|NCT01582100|525191095|FG000|Overall Study|Adverse Event|1|||
145638453|NCT01582100|525191095|FG000|Overall Study|Withdrawal by Subject|1|||
145638454|NCT01040689|525191096|FG000|Overall Study|Adverse Event|0|||
145638455|NCT01040689|525191097|FG001|Overall Study|Adverse Event|0|||
145483654|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
145483655|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
145483656|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
145483657|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
145483658|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
145483659|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
145638456|NCT01040689|525191098|FG002|Overall Study|Adverse Event|2|||
145638457|NCT01040689|525191099|FG003|Overall Study|Adverse Event|4|||
145638458|NCT01040689|525191096|FG000|Overall Study|Lack of Efficacy|0|||
145638459|NCT01040689|525191097|FG001|Overall Study|Lack of Efficacy|0|||
145483660|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
145483661|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
145483662|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
145483663|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
145638460|NCT01040689|525191098|FG002|Overall Study|Lack of Efficacy|1|||
145638461|NCT01040689|525191099|FG003|Overall Study|Lack of Efficacy|0|||
145638462|NCT01040689|525191096|FG000|Overall Study|Lost to Follow-up|1|||
145638463|NCT01040689|525191097|FG001|Overall Study|Lost to Follow-up|0|||
145638464|NCT01040689|525191098|FG002|Overall Study|Lost to Follow-up|0|||
145638465|NCT01040689|525191099|FG003|Overall Study|Lost to Follow-up|0|||
145638466|NCT01040689|525191096|FG000|Overall Study|Withdrawal by Subject|2|||
145638467|NCT01040689|525191097|FG001|Overall Study|Withdrawal by Subject|1|||
145638468|NCT01040689|525191098|FG002|Overall Study|Withdrawal by Subject|1|||
145638469|NCT01040689|525191099|FG003|Overall Study|Withdrawal by Subject|0|||
145638470|NCT01040689|525191096|FG000|Overall Study|Other reasons not listed above|0|||
145638471|NCT01040689|525191097|FG001|Overall Study|Other reasons not listed above|1|||
145638472|NCT01040689|525191098|FG002|Overall Study|Other reasons not listed above|0|||
145638473|NCT01040689|525191099|FG003|Overall Study|Other reasons not listed above|0|||
145638474|NCT01185561|525191100|FG000|Overall Study|Lost to Follow-up|0|||
145483664|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Death|5|||
145483665|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Death|6|||
145483666|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
145638475|NCT01185561|525191101|FG001|Overall Study|Lost to Follow-up|4|||
145638476|NCT01185561|525191100|FG000|Overall Study|Withdrawal by Subject|2|||
145638477|NCT01185561|525191101|FG001|Overall Study|Withdrawal by Subject|8|||
145638478|NCT01078116|525191102|FG000|Overall Study|Lost to Follow-up|17|||
145638479|NCT01078116|525191102|FG000|Overall Study|Adverse Event|5|||
145638480|NCT01078116|525191102|FG000|Overall Study|Withdrawal by Subject|8|||
145638481|NCT01078116|525191102|FG000|Overall Study|Lack of effectiveness|15|||
145638482|NCT01078116|525191102|FG000|Overall Study|Case report form not completed|3|||
145638483|NCT02616900|525191103|FG000|Overall Study|Lack of Efficacy|7|||
145638484|NCT02616900|525191103|FG000|Overall Study|Lost to Follow-up|2|||
145638485|NCT02616900|525191103|FG000|Overall Study|Protocol Violation|5|||
145638486|NCT02616900|525191103|FG000|Overall Study|Withdrawal by Subject|3|||
145638487|NCT02616900|525191103|FG000|Overall Study|Incomplete data|6|||
145638488|NCT02242487|525191104|FG000|Overall Study|Adverse Event|13|||
145638489|NCT02242487|525191105|FG001|Overall Study|Adverse Event|15|||
145483667|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
145483668|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
145483669|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
145483670|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
145483671|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
145604625|NCT01674621|525066643|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
145604626|NCT01674621|525066644|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
145604627|NCT01674621|525066645|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
145604628|NCT01674621|525066646|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
145604629|NCT01674621|525066642|FG000|Overall Study|Withdrawal by Subject|2|||
145604630|NCT01674621|525066643|FG001|Overall Study|Withdrawal by Subject|5|||
145604631|NCT01674621|525066644|FG002|Overall Study|Withdrawal by Subject|2|||
145604632|NCT01674621|525066645|FG003|Overall Study|Withdrawal by Subject|0|||
145604633|NCT01674621|525066646|FG004|Overall Study|Withdrawal by Subject|1|||
145604634|NCT01674621|525066642|FG000|Overall Study|Other than specified|0|||
145604635|NCT01674621|525066643|FG001|Overall Study|Other than specified|1|||
145604636|NCT01674621|525066644|FG002|Overall Study|Other than specified|0|||
145604637|NCT01674621|525066645|FG003|Overall Study|Other than specified|0|||
145604638|NCT01674621|525066646|FG004|Overall Study|Other than specified|2|||
145604639|NCT00728962|525066650|FG000|Implant Placement Surgery|Adverse Event|8|||
145604640|NCT00728962|525066650|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
145604641|NCT00728962|525066650|FG000|Implant Placement Surgery|Protocol Violation|1|||
145604642|NCT00728962|525066650|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
145604643|NCT00728962|525066650|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
145604644|NCT04954586|525066651|FG000|Overall Study|Withdrawal by Subject|5|||
145604645|NCT02063828|525066652|FG000|Overall Study|Withdrawal by Subject|4|||
145604646|NCT02063828|525066653|FG001|Overall Study|Withdrawal by Subject|6|||
145604647|NCT02063828|525066654|FG002|Overall Study|Withdrawal by Subject|3|||
145604648|NCT02063828|525066652|FG000|Overall Study|Death|0|||
145604649|NCT02063828|525066653|FG001|Overall Study|Death|0|||
145604650|NCT02063828|525066654|FG002|Overall Study|Death|1|||
145604651|NCT00532155|525066655|FG000|Overall Study|Adverse Event|66|||
145604652|NCT00532155|525066656|FG001|Overall Study|Adverse Event|123|||
145604653|NCT00532155|525066655|FG000|Overall Study|Lack of Efficacy|332|||
145604654|NCT00532155|525066656|FG001|Overall Study|Lack of Efficacy|255|||
145604655|NCT00532155|525066655|FG000|Overall Study|Protocol Violation|1|||
145604656|NCT00532155|525066656|FG001|Overall Study|Protocol Violation|3|||
145604657|NCT00532155|525066655|FG000|Overall Study|Lost to Follow-up|2|||
145604658|NCT00532155|525066656|FG001|Overall Study|Lost to Follow-up|0|||
145604659|NCT00532155|525066655|FG000|Overall Study|Physician Decision|16|||
145604660|NCT00532155|525066656|FG001|Overall Study|Physician Decision|15|||
145604661|NCT00532155|525066655|FG000|Overall Study|Withdrawal by Subject|23|||
145604662|NCT00532155|525066656|FG001|Overall Study|Withdrawal by Subject|44|||
145604663|NCT00532155|525066655|FG000|Overall Study|Consent withdrawn|5|||
145604664|NCT00532155|525066656|FG001|Overall Study|Consent withdrawn|7|||
145604665|NCT00532155|525066655|FG000|Overall Study|Moved|1|||
145604666|NCT00532155|525066656|FG001|Overall Study|Moved|0|||
145604667|NCT00532155|525066655|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
145604668|NCT00532155|525066656|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
145604669|NCT00532155|525066655|FG000|Overall Study|Occurence of a second cancer|0|||
145604670|NCT00532155|525066656|FG001|Overall Study|Occurence of a second cancer|1|||
145604671|NCT00532155|525066655|FG000|Overall Study|Occurence of a secondary cancer|0|||
145604672|NCT00532155|525066656|FG001|Overall Study|Occurence of a secondary cancer|1|||
145604673|NCT00532155|525066655|FG000|Overall Study|Promotor ended study|1|||
145604674|NCT00532155|525066656|FG001|Overall Study|Promotor ended study|0|||
145604675|NCT00532155|525066655|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
145604676|NCT00532155|525066656|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
145604677|NCT00532155|525066655|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
145604678|NCT00532155|525066656|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
145604679|NCT00532155|525066655|FG000|Overall Study|Study stopped|1|||
145604680|NCT00532155|525066656|FG001|Overall Study|Study stopped|0|||
145604681|NCT00532155|525066655|FG000|Overall Study|Study terminated by sponsor|1|||
145604682|NCT00532155|525066656|FG001|Overall Study|Study terminated by sponsor|0|||
145604683|NCT00532155|525066655|FG000|Overall Study|Study termination stop further treatment|4|||
145604684|NCT00532155|525066656|FG001|Overall Study|Study termination stop further treatment|0|||
145604685|NCT00532155|525066655|FG000|Overall Study|Did not receive study medication|2|||
145604686|NCT00532155|525066656|FG001|Overall Study|Did not receive study medication|6|||
145604687|NCT03483038|525066657|FG000|Overall Study|Subjects still in follow-up|18|||
145604688|NCT02134925|525066658|FG000|Overall Study|Withdrawal by Subject|1|||
145604689|NCT02134925|525066659|FG001|Overall Study|Withdrawal by Subject|0|||
145604690|NCT02134925|525066658|FG000|Overall Study|Cancel|1|||
145604691|NCT02134925|525066659|FG001|Overall Study|Cancel|6|||
145604692|NCT04987762|525066660|FG000|Overall Study|Study was Terminated by Sponsor|103|||
145604693|NCT01064297|525066661|FG000|Overall Study|Lost to Follow-up|791|||
145638490|NCT02242487|525191104|FG000|Overall Study|Lack of Efficacy|4|||
145638491|NCT02242487|525191105|FG001|Overall Study|Lack of Efficacy|6|||
145638492|NCT02242487|525191104|FG000|Overall Study|Protocol Violation|2|||
145638493|NCT02242487|525191105|FG001|Overall Study|Protocol Violation|0|||
145638494|NCT02242487|525191104|FG000|Overall Study|Lost to Follow-up|2|||
145638495|NCT02242487|525191105|FG001|Overall Study|Lost to Follow-up|1|||
145638496|NCT02242487|525191104|FG000|Overall Study|Other - Miscellaneous|4|||
145638497|NCT02242487|525191105|FG001|Overall Study|Other - Miscellaneous|6|||
145638498|NCT02242487|525191104|FG000|Overall Study|Withdrawal by Subject|37|||
145638499|NCT02242487|525191105|FG001|Overall Study|Withdrawal by Subject|19|||
145638500|NCT02755805|525191106|FG000|Overall Study|Lost to Follow-up|1|||
145638501|NCT02755805|525191107|FG001|Overall Study|Lost to Follow-up|2|||
145638502|NCT02755805|525191106|FG000|Overall Study|Refused assessments|1|||
145638503|NCT02755805|525191107|FG001|Overall Study|Refused assessments|0|||
145638504|NCT02755805|525191106|FG000|Overall Study|Withdrawal by Subject|0|||
145638505|NCT02755805|525191107|FG001|Overall Study|Withdrawal by Subject|2|||
145638506|NCT02252042|525191110|FG000|Overall Study|Adverse Event|9|||
145638507|NCT02252042|525191111|FG001|Overall Study|Adverse Event|6|||
145638508|NCT02252042|525191110|FG000|Overall Study|Death|209|||
145638509|NCT02252042|525191111|FG001|Overall Study|Death|217|||
145638510|NCT02252042|525191110|FG000|Overall Study|Physician Decision|0|||
145638511|NCT02252042|525191111|FG001|Overall Study|Physician Decision|2|||
145638512|NCT02252042|525191110|FG000|Overall Study|Transferred to Extension Study|7|||
145638513|NCT02252042|525191111|FG001|Overall Study|Transferred to Extension Study|1|||
145638514|NCT02252042|525191110|FG000|Overall Study|Did Not Continue on Extension Study|7|||
145638515|NCT02252042|525191111|FG001|Overall Study|Did Not Continue on Extension Study|2|||
145638516|NCT02252042|525191110|FG000|Overall Study|Withdrawal by Subject|15|||
145638517|NCT02252042|525191111|FG001|Overall Study|Withdrawal by Subject|20|||
145638518|NCT02593149|525191112|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
145638519|NCT02593149|525191113|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
145638520|NCT02593149|525191112|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
145638521|NCT02593149|525191113|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
145638522|NCT00979992|525191114|FG000|Overall Study|Ineligible - inadequate pathology|1|||
145638523|NCT00979992|525191114|FG000|Overall Study|Ineligible - wrong cell type|2|||
145638524|NCT00979992|525191114|FG000|Overall Study|Refused - Never Treated|2|||
145638525|NCT03691428|525191117|FG000|Overall Study|Withdrawal by Subject|6|||
145638526|NCT03691428|525191118|FG001|Overall Study|Withdrawal by Subject|8|||
145638527|NCT01460290|525191119|FG000|Overall Study|Adverse Event|3|||
145638528|NCT01460290|525191119|FG000|Overall Study|Elevated liver function|1|||
145638529|NCT02527148|525191120|FG000|Overall Study|Did not receive study intervention|1|||
145638530|NCT02527148|525191121|FG001|Overall Study|Did not receive study intervention|0|||
145638531|NCT02448446|525191130|FG000|Overall Study|Withdrawal by Subject|1|||
145638532|NCT02448446|525191131|FG001|Overall Study|Withdrawal by Subject|0|||
145483672|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
145483673|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
145483674|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
145483675|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
145483676|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
145483677|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
145483678|NCT01450761|524624127|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
145483679|NCT01450761|524624128|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
145483680|NCT03801174|524624150|FG000|Overall Study|Withdrawal by Subject|14|||
145483681|NCT03801174|524624151|FG001|Overall Study|Withdrawal by Subject|15|||
145483682|NCT03801174|524624150|FG000|Overall Study|Death|1|||
145483683|NCT03801174|524624151|FG001|Overall Study|Death|0|||
145483684|NCT03801174|524624150|FG000|Overall Study|Pregnancy|2|||
145483685|NCT03801174|524624151|FG001|Overall Study|Pregnancy|2|||
145483686|NCT03801174|524624150|FG000|Overall Study|Lost to Follow-up|19|||
145483687|NCT03801174|524624151|FG001|Overall Study|Lost to Follow-up|10|||
145483688|NCT03801174|524624150|FG000|Overall Study|Other|4|||
145483689|NCT03801174|524624151|FG001|Overall Study|Other|3|||
145483690|NCT03801174|524624150|FG000|Overall Study|Lack of Efficacy|4|||
145638533|NCT01254188|525191132|FG000|Overall Study|Disease Progression|6|||
145483691|NCT03801174|524624151|FG001|Overall Study|Lack of Efficacy|0|||
145483692|NCT03801174|524624150|FG000|Overall Study|Unwilling to complete activities|5|||
145483693|NCT03801174|524624151|FG001|Overall Study|Unwilling to complete activities|6|||
145483694|NCT03801174|524624150|FG000|Overall Study|Moved out of area|3|||
145638534|NCT01254188|525191132|FG000|Overall Study|Protocol Violation|6|||
145638535|NCT01254188|525191132|FG000|Overall Study|Pregnancy|2|||
145638536|NCT01254188|525191132|FG000|Overall Study|Death|4|||
145638537|NCT01254188|525191132|FG000|Overall Study|Lost to Follow-up|5|||
145638538|NCT01254188|525191132|FG000|Overall Study|Withdrawal by Subject|7|||
145638539|NCT01254188|525191132|FG000|Overall Study|Adverse Event|43|||
145638540|NCT01254188|525191132|FG000|Overall Study|per investigator discretion|20|||
145638541|NCT02202499|525191137|FG000|Overall Study|Cancer diagnosis|0|||
145638542|NCT02202499|525191138|FG001|Overall Study|Cancer diagnosis|0|||
145483695|NCT03801174|524624151|FG001|Overall Study|Moved out of area|0|||
145483696|NCT00855816|524624152|FG000|Overall Study|Withdrawal by Subject|22|||
145604694|NCT01064297|525066662|FG001|Overall Study|Lost to Follow-up|48|||
145604695|NCT01064297|525066663|FG002|Overall Study|Lost to Follow-up|133|||
145604696|NCT04027348|525066666|FG000|Overall Study|Adverse Event|2|||
145604697|NCT02158884|525066667|FG000|Baseline Assessment|Missed performance assessment|3|||
145604698|NCT02158884|525066667|FG000|Baseline Assessment|Missed SMFA|1|||
145604699|NCT02158884|525066667|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
145604700|NCT02158884|525066667|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
145604701|NCT02158884|525066667|FG000|6 Month Assessment|Missed SMFA|20|||
145604702|NCT02158884|525066667|FG000|12 Month Assessment|Missed SMFA|17|||
145604703|NCT02036645|525066668|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604704|NCT02036645|525066669|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604705|NCT02036645|525066670|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604706|NCT02036645|525066671|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604707|NCT02036645|525066672|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604708|NCT02036645|525066673|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604709|NCT02036645|525066674|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
145604710|NCT02036645|525066675|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604711|NCT02036645|525066676|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604712|NCT02036645|525066677|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604713|NCT02036645|525066678|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604714|NCT02036645|525066679|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
145604715|NCT02036645|525066668|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604716|NCT02036645|525066669|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604717|NCT02036645|525066670|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604718|NCT02036645|525066671|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
145604719|NCT02036645|525066672|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604720|NCT02036645|525066673|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604721|NCT02036645|525066674|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604722|NCT02036645|525066675|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604723|NCT02036645|525066676|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604724|NCT02036645|525066677|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604725|NCT02036645|525066678|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604726|NCT02036645|525066679|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
145604727|NCT00316173|525066684|FG000|Run-in Phase|Adverse Event|1|||
145604728|NCT00316173|525066685|FG001|Run-in Phase|Adverse Event|0|||
145604729|NCT00316173|525066684|FG000|Run-in Phase|Protocol Violation|1|||
145604730|NCT00316173|525066685|FG001|Run-in Phase|Protocol Violation|0|||
145604731|NCT00316173|525066684|FG000|Run-in Phase|Study Follow-up Stopped|5|||
145604732|NCT00316173|525066685|FG001|Run-in Phase|Study Follow-up Stopped|0|||
145604733|NCT00316173|525066684|FG000|Treatment Phase|Adverse Event|0|||
145604734|NCT00316173|525066685|FG001|Treatment Phase|Adverse Event|1|||
145604735|NCT00316173|525066684|FG000|Treatment Phase|Lack of Efficacy|0|||
145604736|NCT00316173|525066685|FG001|Treatment Phase|Lack of Efficacy|3|||
145604737|NCT00316173|525066684|FG000|Treatment Phase|Lost to Follow-up|0|||
145604738|NCT00316173|525066685|FG001|Treatment Phase|Lost to Follow-up|3|||
145604739|NCT00316173|525066684|FG000|Treatment Phase|Withdrawal by Subject|0|||
145604740|NCT00316173|525066685|FG001|Treatment Phase|Withdrawal by Subject|1|||
145604741|NCT00316173|525066684|FG000|Treatment Phase|Study Follow-up Stopped|0|||
145604742|NCT00316173|525066685|FG001|Treatment Phase|Study Follow-up Stopped|34|||
145604743|NCT04108000|525066694|FG000|Overall Study|Death of patient|1|||
145604744|NCT04108000|525066695|FG001|Overall Study|Death of patient|0|||
145604745|NCT04108000|525066696|FG002|Overall Study|Death of patient|1|||
145604746|NCT04108000|525066697|FG003|Overall Study|Death of patient|0|||
145604747|NCT04108000|525066694|FG000|Overall Study|Withdrawal by Subject|2|||
145604748|NCT04108000|525066695|FG001|Overall Study|Withdrawal by Subject|2|||
145604749|NCT04108000|525066696|FG002|Overall Study|Withdrawal by Subject|0|||
145604750|NCT04108000|525066697|FG003|Overall Study|Withdrawal by Subject|0|||
145604751|NCT04108000|525066694|FG000|Overall Study|Death of surrogate partner|0|||
145604752|NCT04108000|525066695|FG001|Overall Study|Death of surrogate partner|1|||
145604753|NCT04108000|525066696|FG002|Overall Study|Death of surrogate partner|0|||
145604754|NCT04108000|525066697|FG003|Overall Study|Death of surrogate partner|1|||
145604755|NCT03750006|525066698|FG000|Overall Study|Withdrawal by Subject|8|||
145604756|NCT03750006|525066698|FG000|Overall Study|COVID PANDEMIC|11|||
145604757|NCT01108458|525068840|FG000|Overall Study|Withdrawal by Subject|1|||
145604758|NCT05044325|525068846|FG000|Part A:Treatment Period 1|Adverse Event|0|||
145604759|NCT05044325|525068847|FG001|Part A:Treatment Period 1|Adverse Event|0|||
145604760|NCT05044325|525068848|FG002|Part A:Treatment Period 1|Adverse Event|0|||
145483697|NCT00855816|524624153|FG001|Overall Study|Withdrawal by Subject|15|||
145604761|NCT05044325|525068849|FG003|Part A:Treatment Period 1|Adverse Event|0|||
145604762|NCT05044325|525068850|FG004|Part A:Treatment Period 1|Adverse Event|0|||
145604763|NCT05044325|525068851|FG005|Part A:Treatment Period 1|Adverse Event|1|||
145604764|NCT05044325|525068852|FG006|Part A:Treatment Period 1|Adverse Event|0|||
145483698|NCT00855816|524624152|FG000|Overall Study|Lost to Follow-up|3|||
145483699|NCT00855816|524624153|FG001|Overall Study|Lost to Follow-up|5|||
145483700|NCT00855816|524624152|FG000|Overall Study|Death|1|||
145483701|NCT00855816|524624153|FG001|Overall Study|Death|0|||
145483702|NCT00855816|524624152|FG000|Overall Study|Became ineligible|0|||
145483703|NCT00855816|524624153|FG001|Overall Study|Became ineligible|1|||
145483704|NCT01965704|524624157|FG000|Overall Study|Withdrawal by Subject|2|||
145483705|NCT01965704|524624158|FG001|Overall Study|Withdrawal by Subject|2|||
145483706|NCT01965704|524624159|FG002|Overall Study|Withdrawal by Subject|1|||
145483707|NCT01965704|524624160|FG003|Overall Study|Withdrawal by Subject|1|||
145483708|NCT01965704|524624157|FG000|Overall Study|Delivered at home|1|||
145483709|NCT01965704|524624158|FG001|Overall Study|Delivered at home|1|||
145483710|NCT01965704|524624159|FG002|Overall Study|Delivered at home|0|||
145483711|NCT01965704|524624160|FG003|Overall Study|Delivered at home|0|||
145483712|NCT01965704|524624157|FG000|Overall Study|Experienced complications|0|||
145483713|NCT01965704|524624158|FG001|Overall Study|Experienced complications|0|||
145483714|NCT01965704|524624159|FG002|Overall Study|Experienced complications|2|||
145483715|NCT01965704|524624160|FG003|Overall Study|Experienced complications|2|||
145483716|NCT01965704|524624157|FG000|Overall Study|Adverse Event|0|||
145483717|NCT01965704|524624158|FG001|Overall Study|Adverse Event|0|||
145483718|NCT01965704|524624159|FG002|Overall Study|Adverse Event|1|||
145483719|NCT01965704|524624160|FG003|Overall Study|Adverse Event|1|||
145604765|NCT05044325|525068853|FG007|Part A:Treatment Period 1|Adverse Event|1|||
145604766|NCT05044325|525068854|FG008|Part A:Treatment Period 1|Adverse Event|0|||
145604767|NCT05044325|525068855|FG009|Part A:Treatment Period 1|Adverse Event|0|||
145604768|NCT05044325|525068846|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604769|NCT05044325|525068847|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604770|NCT05044325|525068848|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604771|NCT05044325|525068849|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
145604772|NCT05044325|525068850|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
145604773|NCT05044325|525068851|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
145604774|NCT05044325|525068852|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604775|NCT05044325|525068853|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604776|NCT05044325|525068854|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604777|NCT05044325|525068855|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
145604778|NCT05044325|525068846|FG000|Part A:Treatment Period 1|Physician Decision|0|||
145604779|NCT05044325|525068847|FG001|Part A:Treatment Period 1|Physician Decision|0|||
145604780|NCT05044325|525068848|FG002|Part A:Treatment Period 1|Physician Decision|0|||
145604781|NCT05044325|525068849|FG003|Part A:Treatment Period 1|Physician Decision|0|||
145604782|NCT05044325|525068850|FG004|Part A:Treatment Period 1|Physician Decision|0|||
145604783|NCT05044325|525068851|FG005|Part A:Treatment Period 1|Physician Decision|0|||
145604784|NCT05044325|525068852|FG006|Part A:Treatment Period 1|Physician Decision|1|||
145604785|NCT05044325|525068853|FG007|Part A:Treatment Period 1|Physician Decision|0|||
145604786|NCT05044325|525068854|FG008|Part A:Treatment Period 1|Physician Decision|0|||
145604787|NCT05044325|525068855|FG009|Part A:Treatment Period 1|Physician Decision|0|||
145604788|NCT05044325|525068846|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604789|NCT05044325|525068847|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604790|NCT05044325|525068848|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
145604791|NCT05044325|525068849|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604792|NCT05044325|525068850|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604793|NCT05044325|525068851|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604794|NCT05044325|525068852|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604795|NCT05044325|525068853|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604796|NCT05044325|525068854|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604797|NCT05044325|525068855|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
145604798|NCT05044325|525068846|FG000|Part A:Treatment Period 2|Adverse Event|0|||
145604799|NCT05044325|525068847|FG001|Part A:Treatment Period 2|Adverse Event|1|||
145604800|NCT05044325|525068848|FG002|Part A:Treatment Period 2|Adverse Event|0|||
145604801|NCT05044325|525068849|FG003|Part A:Treatment Period 2|Adverse Event|0|||
145604802|NCT05044325|525068850|FG004|Part A:Treatment Period 2|Adverse Event|1|||
145604803|NCT05044325|525068851|FG005|Part A:Treatment Period 2|Adverse Event|1|||
145604804|NCT05044325|525068852|FG006|Part A:Treatment Period 2|Adverse Event|0|||
145604805|NCT05044325|525068853|FG007|Part A:Treatment Period 2|Adverse Event|0|||
145604806|NCT05044325|525068854|FG008|Part A:Treatment Period 2|Adverse Event|0|||
145604807|NCT05044325|525068855|FG009|Part A:Treatment Period 2|Adverse Event|0|||
145604808|NCT05044325|525068846|FG000|Part A:Treatment Period 2|Physician Decision|0|||
145604809|NCT05044325|525068847|FG001|Part A:Treatment Period 2|Physician Decision|0|||
145483720|NCT01965704|524624157|FG000|Overall Study|Did not meet inclusion criteria|0|||
145483721|NCT01965704|524624158|FG001|Overall Study|Did not meet inclusion criteria|0|||
145483722|NCT01965704|524624159|FG002|Overall Study|Did not meet inclusion criteria|1|||
145483723|NCT01965704|524624160|FG003|Overall Study|Did not meet inclusion criteria|1|||
145483724|NCT00337207|524624168|FG000|Overall Study|Withdrawal by Subject|3|||
145483725|NCT01521507|524624169|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
145483726|NCT01521507|524624170|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
145483727|NCT01521507|524624169|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
145483728|NCT01521507|524624170|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
145483729|NCT01521507|524624169|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
145483730|NCT01521507|524624170|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
145483731|NCT01521507|524624169|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
145483732|NCT01521507|524624170|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
145483733|NCT01521507|524624169|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
145483734|NCT01521507|524624170|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
145483735|NCT01521507|524624169|FG000|Stage 2: Observational Design|Physician Decision|1|||
145483736|NCT01521507|524624170|FG001|Stage 2: Observational Design|Physician Decision|0|||
145483737|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
145483738|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
145483739|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
145483740|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
145483741|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
145483742|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
145483743|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
145483744|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
145483745|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
145483746|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
145483747|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
145483748|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
145483749|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
145483750|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
145483751|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
145483752|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
145483753|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
145483754|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
145483755|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
145638543|NCT02202499|525191139|FG002|Overall Study|Cancer diagnosis|1|||
145638544|NCT02202499|525191137|FG000|Overall Study|Moved from area|0|||
145638545|NCT02202499|525191138|FG001|Overall Study|Moved from area|0|||
145638546|NCT02202499|525191139|FG002|Overall Study|Moved from area|1|||
145638547|NCT02202499|525191137|FG000|Overall Study|Declined before randomization|1|||
145638548|NCT02202499|525191138|FG001|Overall Study|Declined before randomization|0|||
145638549|NCT02202499|525191139|FG002|Overall Study|Declined before randomization|0|||
145638550|NCT02202499|525191137|FG000|Overall Study|Auto accident|1|||
145638551|NCT02202499|525191138|FG001|Overall Study|Auto accident|0|||
145638552|NCT02202499|525191139|FG002|Overall Study|Auto accident|0|||
145638553|NCT02957136|525191142|FG000|Overall Study|Withdrawal by Subject|2|||
145638554|NCT02957136|525191143|FG001|Overall Study|Withdrawal by Subject|1|||
145638555|NCT02200770|525191145|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
145638556|NCT02200770|525191146|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
145638557|NCT02200770|525191145|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
145638558|NCT02200770|525191146|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
145638559|NCT02200770|525191145|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
145638560|NCT02200770|525191146|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
145638561|NCT02200770|525191145|FG000|Randomized-controlled Period (RCP)|Other|1|||
145638562|NCT02200770|525191146|FG001|Randomized-controlled Period (RCP)|Other|2|||
145638563|NCT02200770|525191145|FG000|Open-label Period (OLP)|Adverse Event|1|||
145638564|NCT02200770|525191146|FG001|Open-label Period (OLP)|Adverse Event|2|||
145638565|NCT02200770|525191145|FG000|Open-label Period (OLP)|Death|1|||
145638566|NCT02200770|525191146|FG001|Open-label Period (OLP)|Death|2|||
145638567|NCT02200770|525191145|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
145638568|NCT02200770|525191146|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
145638569|NCT02200770|525191145|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
145638570|NCT02200770|525191146|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
145638571|NCT02200770|525191145|FG000|Open-label Period (OLP)|Other|6|||
145638572|NCT02200770|525191146|FG001|Open-label Period (OLP)|Other|15|||
145638573|NCT02555215|525191151|FG000|Overall Study|Other|1|||
145483756|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
145638574|NCT02555215|525191151|FG000|Overall Study|Investigator Decision|2|||
145638575|NCT02538107|525191156|FG000|Overall Study|Did not receive any Mircera dose|11|||
145638576|NCT02538107|525191156|FG000|Overall Study|Missing|5|||
145638577|NCT02538107|525191156|FG000|Overall Study|Necessity of dialysis|20|||
145638578|NCT02538107|525191156|FG000|Overall Study|Administration of other ESA|11|||
145638579|NCT02538107|525191156|FG000|Overall Study|No further treatment necessary|18|||
145638580|NCT02538107|525191156|FG000|Overall Study|Withdrawal by Subject|17|||
145638581|NCT02538107|525191156|FG000|Overall Study|Death|4|||
145638582|NCT02538107|525191156|FG000|Overall Study|Administrative reason|5|||
145638583|NCT02538107|525191156|FG000|Overall Study|Adverse Event|4|||
145638584|NCT02538107|525191156|FG000|Overall Study|Surgery|1|||
145638585|NCT02538107|525191156|FG000|Overall Study|Other|7|||
145638586|NCT02538107|525191156|FG000|Overall Study|Not recorded|7|||
145638587|NCT00468910|525191157|FG000|Overall Study|Lost to Follow-up|2|||
145638588|NCT00468910|525191158|FG001|Overall Study|Lost to Follow-up|1|||
145638589|NCT00468910|525191157|FG000|Overall Study|Withdrawal by Subject|2|||
145638590|NCT00468910|525191158|FG001|Overall Study|Withdrawal by Subject|1|||
145638591|NCT00468910|525191157|FG000|Overall Study|Medical Contraindication|0|||
145638592|NCT00468910|525191158|FG001|Overall Study|Medical Contraindication|1|||
145638593|NCT01909778|525191159|FG000|Overall Study|failed screening|1|||
145638594|NCT00919763|525191160|FG000|Overall Study|Adverse Event|7|||
145638595|NCT00919763|525191161|FG001|Overall Study|Adverse Event|1|||
145638596|NCT00919763|525191160|FG000|Overall Study|Lost to Follow-up|1|||
145638597|NCT00919763|525191161|FG001|Overall Study|Lost to Follow-up|0|||
145638598|NCT00919763|525191160|FG000|Overall Study|Protocol Violation|1|||
145638599|NCT00919763|525191161|FG001|Overall Study|Protocol Violation|1|||
145638600|NCT00919763|525191160|FG000|Overall Study|Withdrawal by Subject|3|||
145638601|NCT00919763|525191161|FG001|Overall Study|Withdrawal by Subject|1|||
145638602|NCT00919763|525191160|FG000|Overall Study|Non-compliance|0|||
145638603|NCT00919763|525191161|FG001|Overall Study|Non-compliance|1|||
145638604|NCT02471755|525191162|FG000|Overall Study|Withdrawal by Subject|1|||
145638605|NCT02471755|525191163|FG001|Overall Study|Withdrawal by Subject|0|||
145638606|NCT02471755|525191162|FG000|Overall Study|Lost to Follow-up|0|||
145638607|NCT02471755|525191163|FG001|Overall Study|Lost to Follow-up|1|||
145638608|NCT04740164|525191165|FG000|Overall Study|Lack of Efficacy|4|||
145638609|NCT04740164|525191166|FG001|Overall Study|Lack of Efficacy|0|||
145638610|NCT04740164|525191165|FG000|Overall Study|Physician Decision|3|||
145638611|NCT04740164|525191166|FG001|Overall Study|Physician Decision|3|||
145638612|NCT05323734|525191170|FG000|Overall Study|Adverse Event|5|||
145638613|NCT05323734|525191171|FG001|Overall Study|Adverse Event|2|||
145638614|NCT05323734|525191170|FG000|Overall Study|Physician Decision|1|||
145638615|NCT05323734|525191171|FG001|Overall Study|Physician Decision|0|||
145638616|NCT05323734|525191170|FG000|Overall Study|Lack of Efficacy|1|||
145638617|NCT05323734|525191171|FG001|Overall Study|Lack of Efficacy|2|||
145638618|NCT05323734|525191170|FG000|Overall Study|Withdrawal by Subject|2|||
145638619|NCT05323734|525191171|FG001|Overall Study|Withdrawal by Subject|0|||
145638620|NCT05323734|525191170|FG000|Overall Study|Participant Withdrawn Due|0|||
145638621|NCT05323734|525191171|FG001|Overall Study|Participant Withdrawn Due|1|||
145638622|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
145638623|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
145638624|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
145638625|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638626|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638627|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638628|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638629|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638630|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638631|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638632|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638633|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
145638634|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
145638635|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
145638636|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
145638637|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
145638638|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
145638639|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
145638640|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
145638641|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
145638642|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
145638643|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
145638644|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
145638645|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
145638646|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
145638647|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638648|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638649|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638650|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638651|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638652|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638653|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638654|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638655|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638656|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638657|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
145638658|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638659|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638660|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
145638661|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638662|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638663|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638664|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638665|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638666|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638667|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638668|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638669|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
145638670|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
145638671|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
145638672|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
145638673|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
145638674|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638675|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638676|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638677|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638678|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638679|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638680|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145483757|NCT03573323|524624171|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
145483758|NCT03573323|524624172|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
145483759|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
145483760|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
145483761|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
145483762|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
145483763|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
145483764|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
145483765|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
145483766|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
145638681|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
145638682|NCT05061693|525191172|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
145638683|NCT05061693|525191173|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
145638684|NCT05061693|525191174|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
145638685|NCT05061693|525191175|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
145638686|NCT05061693|525191176|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638687|NCT05061693|525191177|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638688|NCT05061693|525191178|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638689|NCT05061693|525191179|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638690|NCT05061693|525191180|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145483767|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
145483768|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
145483769|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
145483770|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
145483771|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
145483772|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
145483773|NCT03573323|524624171|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
145483774|NCT03573323|524624172|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
145483775|NCT03188432|524624173|FG000|Overall Study|Death|3|||
145483776|NCT03188432|524624173|FG000|Overall Study|Withdrawal by Subject|15|||
145483777|NCT03188432|524624173|FG000|Overall Study|Did not complete protocol treatment|9|||
145483778|NCT03386721|524624178|FG000|Overall Study|Death|12|||
145483779|NCT03386721|524624179|FG001|Overall Study|Death|21|||
145483780|NCT03386721|524624180|FG002|Overall Study|Death|2|||
145483781|NCT03386721|524624181|FG003|Overall Study|Death|5|||
145483782|NCT03386721|524624182|FG004|Overall Study|Death|1|||
145483783|NCT03386721|524624183|FG005|Overall Study|Death|12|||
145483784|NCT03386721|524624184|FG006|Overall Study|Death|1|||
145638691|NCT05061693|525191181|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145483785|NCT03386721|524624185|FG007|Overall Study|Death|1|||
145483786|NCT03386721|524624186|FG008|Overall Study|Death|12|||
145483787|NCT03386721|524624187|FG009|Overall Study|Death|20|||
145483788|NCT03386721|524624188|FG010|Overall Study|Death|21|||
145483789|NCT03386721|524624189|FG011|Overall Study|Death|21|||
145483790|NCT03386721|524624190|FG012|Overall Study|Death|14|||
145483791|NCT03386721|524624191|FG013|Overall Study|Death|2|||
145483792|NCT03386721|524624192|FG014|Overall Study|Death|1|||
145483793|NCT03386721|524624178|FG000|Overall Study|Lost to Follow-up|1|||
145483794|NCT03386721|524624179|FG001|Overall Study|Lost to Follow-up|3|||
145483795|NCT03386721|524624180|FG002|Overall Study|Lost to Follow-up|0|||
145483796|NCT03386721|524624181|FG003|Overall Study|Lost to Follow-up|0|||
145483797|NCT03386721|524624182|FG004|Overall Study|Lost to Follow-up|0|||
145483798|NCT03386721|524624183|FG005|Overall Study|Lost to Follow-up|2|||
145483799|NCT03386721|524624184|FG006|Overall Study|Lost to Follow-up|1|||
145483800|NCT03386721|524624185|FG007|Overall Study|Lost to Follow-up|0|||
145483801|NCT03386721|524624186|FG008|Overall Study|Lost to Follow-up|1|||
145483802|NCT03386721|524624187|FG009|Overall Study|Lost to Follow-up|2|||
145483803|NCT03386721|524624188|FG010|Overall Study|Lost to Follow-up|1|||
145483804|NCT03386721|524624189|FG011|Overall Study|Lost to Follow-up|0|||
145483805|NCT03386721|524624190|FG012|Overall Study|Lost to Follow-up|0|||
145483806|NCT03386721|524624191|FG013|Overall Study|Lost to Follow-up|0|||
145483807|NCT03386721|524624192|FG014|Overall Study|Lost to Follow-up|0|||
145483808|NCT03386721|524624178|FG000|Overall Study|Reason not specified|3|||
145483809|NCT03386721|524624179|FG001|Overall Study|Reason not specified|0|||
145483810|NCT03386721|524624180|FG002|Overall Study|Reason not specified|0|||
145483811|NCT03386721|524624181|FG003|Overall Study|Reason not specified|0|||
145483812|NCT03386721|524624182|FG004|Overall Study|Reason not specified|0|||
145638692|NCT05061693|525191182|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638693|NCT05061693|525191183|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
145638694|NCT05061693|525191172|FG000|24-week Extension Period|Adverse Event|0|||
145638695|NCT05061693|525191173|FG001|24-week Extension Period|Adverse Event|0|||
145638696|NCT05061693|525191174|FG002|24-week Extension Period|Adverse Event|0|||
145638697|NCT05061693|525191175|FG003|24-week Extension Period|Adverse Event|0|||
145638698|NCT05061693|525191176|FG004|24-week Extension Period|Adverse Event|0|||
145483813|NCT03386721|524624183|FG005|Overall Study|Reason not specified|3|||
145483814|NCT03386721|524624184|FG006|Overall Study|Reason not specified|1|||
145483815|NCT03386721|524624185|FG007|Overall Study|Reason not specified|0|||
145483816|NCT03386721|524624186|FG008|Overall Study|Reason not specified|0|||
145483817|NCT03386721|524624187|FG009|Overall Study|Reason not specified|1|||
145483818|NCT03386721|524624188|FG010|Overall Study|Reason not specified|2|||
145483819|NCT03386721|524624189|FG011|Overall Study|Reason not specified|6|||
145483820|NCT03386721|524624190|FG012|Overall Study|Reason not specified|1|||
145483821|NCT03386721|524624191|FG013|Overall Study|Reason not specified|0|||
145483822|NCT03386721|524624192|FG014|Overall Study|Reason not specified|0|||
145483823|NCT03386721|524624178|FG000|Overall Study|Progressive Disease|0|||
145483824|NCT03386721|524624179|FG001|Overall Study|Progressive Disease|0|||
145483825|NCT03386721|524624180|FG002|Overall Study|Progressive Disease|1|||
145483826|NCT03386721|524624181|FG003|Overall Study|Progressive Disease|0|||
145483827|NCT03386721|524624182|FG004|Overall Study|Progressive Disease|0|||
145483828|NCT03386721|524624183|FG005|Overall Study|Progressive Disease|1|||
145483829|NCT03386721|524624184|FG006|Overall Study|Progressive Disease|0|||
145483830|NCT03386721|524624185|FG007|Overall Study|Progressive Disease|0|||
145483831|NCT03386721|524624186|FG008|Overall Study|Progressive Disease|2|||
145483832|NCT03386721|524624187|FG009|Overall Study|Progressive Disease|1|||
145483833|NCT03386721|524624188|FG010|Overall Study|Progressive Disease|1|||
145483834|NCT03386721|524624189|FG011|Overall Study|Progressive Disease|0|||
145483835|NCT03386721|524624190|FG012|Overall Study|Progressive Disease|1|||
145483836|NCT03386721|524624191|FG013|Overall Study|Progressive Disease|0|||
145483837|NCT03386721|524624192|FG014|Overall Study|Progressive Disease|0|||
145483838|NCT03386721|524624178|FG000|Overall Study|Site Terminated by Sponsor|5|||
145483839|NCT03386721|524624179|FG001|Overall Study|Site Terminated by Sponsor|5|||
145483840|NCT03386721|524624180|FG002|Overall Study|Site Terminated by Sponsor|0|||
145483841|NCT03386721|524624181|FG003|Overall Study|Site Terminated by Sponsor|0|||
145483842|NCT03386721|524624182|FG004|Overall Study|Site Terminated by Sponsor|1|||
145483843|NCT03386721|524624183|FG005|Overall Study|Site Terminated by Sponsor|3|||
145483844|NCT03386721|524624184|FG006|Overall Study|Site Terminated by Sponsor|0|||
145483845|NCT03386721|524624185|FG007|Overall Study|Site Terminated by Sponsor|1|||
145483846|NCT03386721|524624186|FG008|Overall Study|Site Terminated by Sponsor|4|||
145483847|NCT03386721|524624187|FG009|Overall Study|Site Terminated by Sponsor|5|||
145483848|NCT03386721|524624188|FG010|Overall Study|Site Terminated by Sponsor|3|||
145483849|NCT03386721|524624189|FG011|Overall Study|Site Terminated by Sponsor|11|||
145483850|NCT03386721|524624190|FG012|Overall Study|Site Terminated by Sponsor|6|||
145483851|NCT03386721|524624191|FG013|Overall Study|Site Terminated by Sponsor|0|||
145483852|NCT03386721|524624192|FG014|Overall Study|Site Terminated by Sponsor|0|||
145483853|NCT03386721|524624178|FG000|Overall Study|Symptomatic Deterioration|0|||
145483854|NCT03386721|524624179|FG001|Overall Study|Symptomatic Deterioration|0|||
145483855|NCT03386721|524624180|FG002|Overall Study|Symptomatic Deterioration|0|||
145483856|NCT03386721|524624181|FG003|Overall Study|Symptomatic Deterioration|0|||
145483857|NCT03386721|524624182|FG004|Overall Study|Symptomatic Deterioration|0|||
145483858|NCT03386721|524624183|FG005|Overall Study|Symptomatic Deterioration|0|||
145483859|NCT03386721|524624184|FG006|Overall Study|Symptomatic Deterioration|0|||
145483860|NCT03386721|524624185|FG007|Overall Study|Symptomatic Deterioration|0|||
145483861|NCT03386721|524624186|FG008|Overall Study|Symptomatic Deterioration|1|||
145483862|NCT03386721|524624187|FG009|Overall Study|Symptomatic Deterioration|0|||
145483863|NCT03386721|524624188|FG010|Overall Study|Symptomatic Deterioration|0|||
145483864|NCT03386721|524624189|FG011|Overall Study|Symptomatic Deterioration|1|||
145483865|NCT03386721|524624190|FG012|Overall Study|Symptomatic Deterioration|0|||
145483866|NCT03386721|524624191|FG013|Overall Study|Symptomatic Deterioration|0|||
145483867|NCT03386721|524624192|FG014|Overall Study|Symptomatic Deterioration|0|||
145483868|NCT03386721|524624178|FG000|Overall Study|Withdrawal by Subject|1|||
145483869|NCT03386721|524624179|FG001|Overall Study|Withdrawal by Subject|2|||
145483870|NCT03386721|524624180|FG002|Overall Study|Withdrawal by Subject|0|||
145483871|NCT03386721|524624181|FG003|Overall Study|Withdrawal by Subject|0|||
145483872|NCT03386721|524624182|FG004|Overall Study|Withdrawal by Subject|0|||
145483873|NCT03386721|524624183|FG005|Overall Study|Withdrawal by Subject|0|||
145483874|NCT03386721|524624184|FG006|Overall Study|Withdrawal by Subject|0|||
145638699|NCT05061693|525191177|FG005|24-week Extension Period|Adverse Event|0|||
145638700|NCT05061693|525191178|FG006|24-week Extension Period|Adverse Event|0|||
145638701|NCT05061693|525191179|FG007|24-week Extension Period|Adverse Event|2|||
145638702|NCT05061693|525191180|FG008|24-week Extension Period|Adverse Event|2|||
145638703|NCT05061693|525191181|FG009|24-week Extension Period|Adverse Event|0|||
145638704|NCT05061693|525191182|FG010|24-week Extension Period|Adverse Event|1|||
145638705|NCT05061693|525191183|FG011|24-week Extension Period|Adverse Event|3|||
145638706|NCT05061693|525191172|FG000|24-week Extension Period|Lack of Efficacy|0|||
145638707|NCT05061693|525191173|FG001|24-week Extension Period|Lack of Efficacy|0|||
145638708|NCT05061693|525191174|FG002|24-week Extension Period|Lack of Efficacy|0|||
145638709|NCT05061693|525191175|FG003|24-week Extension Period|Lack of Efficacy|0|||
145638710|NCT05061693|525191176|FG004|24-week Extension Period|Lack of Efficacy|0|||
145638711|NCT05061693|525191177|FG005|24-week Extension Period|Lack of Efficacy|0|||
145638712|NCT05061693|525191178|FG006|24-week Extension Period|Lack of Efficacy|0|||
145638713|NCT05061693|525191179|FG007|24-week Extension Period|Lack of Efficacy|0|||
145638714|NCT05061693|525191180|FG008|24-week Extension Period|Lack of Efficacy|0|||
145638715|NCT05061693|525191181|FG009|24-week Extension Period|Lack of Efficacy|0|||
145638716|NCT05061693|525191182|FG010|24-week Extension Period|Lack of Efficacy|2|||
145638717|NCT05061693|525191183|FG011|24-week Extension Period|Lack of Efficacy|0|||
145638718|NCT05061693|525191172|FG000|24-week Extension Period|Lost to Follow-up|0|||
145638719|NCT05061693|525191173|FG001|24-week Extension Period|Lost to Follow-up|0|||
145638720|NCT05061693|525191174|FG002|24-week Extension Period|Lost to Follow-up|0|||
145638721|NCT05061693|525191175|FG003|24-week Extension Period|Lost to Follow-up|0|||
145638722|NCT05061693|525191176|FG004|24-week Extension Period|Lost to Follow-up|0|||
145638723|NCT05061693|525191177|FG005|24-week Extension Period|Lost to Follow-up|0|||
145638724|NCT05061693|525191178|FG006|24-week Extension Period|Lost to Follow-up|1|||
145638725|NCT05061693|525191179|FG007|24-week Extension Period|Lost to Follow-up|0|||
145638726|NCT05061693|525191180|FG008|24-week Extension Period|Lost to Follow-up|1|||
145638727|NCT05061693|525191181|FG009|24-week Extension Period|Lost to Follow-up|1|||
145638728|NCT05061693|525191182|FG010|24-week Extension Period|Lost to Follow-up|0|||
145638729|NCT05061693|525191183|FG011|24-week Extension Period|Lost to Follow-up|0|||
145638730|NCT05061693|525191172|FG000|24-week Extension Period|Withdrawal by Subject|0|||
145638731|NCT05061693|525191173|FG001|24-week Extension Period|Withdrawal by Subject|0|||
145638732|NCT05061693|525191174|FG002|24-week Extension Period|Withdrawal by Subject|0|||
145638733|NCT05061693|525191175|FG003|24-week Extension Period|Withdrawal by Subject|0|||
145638734|NCT05061693|525191176|FG004|24-week Extension Period|Withdrawal by Subject|0|||
145638735|NCT05061693|525191177|FG005|24-week Extension Period|Withdrawal by Subject|0|||
145638736|NCT05061693|525191178|FG006|24-week Extension Period|Withdrawal by Subject|0|||
145483875|NCT03386721|524624185|FG007|Overall Study|Withdrawal by Subject|0|||
145483876|NCT03386721|524624186|FG008|Overall Study|Withdrawal by Subject|2|||
145638737|NCT05061693|525191179|FG007|24-week Extension Period|Withdrawal by Subject|0|||
145638738|NCT05061693|525191180|FG008|24-week Extension Period|Withdrawal by Subject|1|||
145638739|NCT05061693|525191181|FG009|24-week Extension Period|Withdrawal by Subject|2|||
145638740|NCT05061693|525191182|FG010|24-week Extension Period|Withdrawal by Subject|2|||
145638741|NCT05061693|525191183|FG011|24-week Extension Period|Withdrawal by Subject|1|||
145638742|NCT05061693|525191172|FG000|24-week Extension Period|Sponsor Decision|0|||
145638743|NCT05061693|525191173|FG001|24-week Extension Period|Sponsor Decision|0|||
145638744|NCT05061693|525191174|FG002|24-week Extension Period|Sponsor Decision|0|||
145638745|NCT05061693|525191175|FG003|24-week Extension Period|Sponsor Decision|0|||
145638746|NCT05061693|525191176|FG004|24-week Extension Period|Sponsor Decision|0|||
145638747|NCT05061693|525191177|FG005|24-week Extension Period|Sponsor Decision|0|||
145638748|NCT05061693|525191178|FG006|24-week Extension Period|Sponsor Decision|0|||
145483877|NCT03386721|524624187|FG009|Overall Study|Withdrawal by Subject|1|||
145483878|NCT03386721|524624188|FG010|Overall Study|Withdrawal by Subject|3|||
145638749|NCT05061693|525191179|FG007|24-week Extension Period|Sponsor Decision|1|||
145638750|NCT05061693|525191180|FG008|24-week Extension Period|Sponsor Decision|0|||
145638751|NCT05061693|525191181|FG009|24-week Extension Period|Sponsor Decision|0|||
145638752|NCT05061693|525191182|FG010|24-week Extension Period|Sponsor Decision|0|||
145483879|NCT03386721|524624189|FG011|Overall Study|Withdrawal by Subject|2|||
145483880|NCT03386721|524624190|FG012|Overall Study|Withdrawal by Subject|3|||
145483881|NCT03386721|524624191|FG013|Overall Study|Withdrawal by Subject|0|||
145483882|NCT03386721|524624192|FG014|Overall Study|Withdrawal by Subject|0|||
145483883|NCT00700713|524624194|FG000|Overall Study|Protocol Violation|1|||
145483884|NCT00700713|524624195|FG001|Overall Study|Protocol Violation|0|||
145483885|NCT00700713|524624196|FG002|Overall Study|Protocol Violation|1|||
145483886|NCT00700713|524624194|FG000|Overall Study|Withdrawal by Subject|0|||
145483887|NCT00700713|524624195|FG001|Overall Study|Withdrawal by Subject|0|||
145483888|NCT00700713|524624196|FG002|Overall Study|Withdrawal by Subject|1|||
145638753|NCT05061693|525191183|FG011|24-week Extension Period|Sponsor Decision|0|||
145638754|NCT05061693|525191172|FG000|24-week Extension Period|Site Closure|0|||
145638755|NCT05061693|525191173|FG001|24-week Extension Period|Site Closure|0|||
145638756|NCT05061693|525191174|FG002|24-week Extension Period|Site Closure|0|||
145638757|NCT05061693|525191175|FG003|24-week Extension Period|Site Closure|0|||
145638758|NCT05061693|525191176|FG004|24-week Extension Period|Site Closure|0|||
145638759|NCT05061693|525191177|FG005|24-week Extension Period|Site Closure|0|||
145638760|NCT05061693|525191178|FG006|24-week Extension Period|Site Closure|0|||
145638761|NCT05061693|525191179|FG007|24-week Extension Period|Site Closure|0|||
145638762|NCT05061693|525191180|FG008|24-week Extension Period|Site Closure|1|||
145638763|NCT05061693|525191181|FG009|24-week Extension Period|Site Closure|0|||
145638764|NCT05061693|525191182|FG010|24-week Extension Period|Site Closure|0|||
145638765|NCT05061693|525191183|FG011|24-week Extension Period|Site Closure|1|||
145638766|NCT01152190|525191184|FG000|Overall Study|Adverse Event|2|||
145638767|NCT01152190|525191185|FG001|Overall Study|Adverse Event|4|||
145638768|NCT01152190|525191184|FG000|Overall Study|Death|1|||
145638769|NCT01152190|525191185|FG001|Overall Study|Death|0|||
145638770|NCT01152190|525191184|FG000|Overall Study|Protocol Violation|1|||
145638771|NCT01152190|525191185|FG001|Overall Study|Protocol Violation|1|||
145638772|NCT01152190|525191184|FG000|Overall Study|Withdrawal by Subject|1|||
145638773|NCT01152190|525191185|FG001|Overall Study|Withdrawal by Subject|3|||
145638774|NCT00439569|525192381|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
145638775|NCT00439569|525192381|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
145638776|NCT00439569|525192381|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
145638777|NCT01124734|525192382|FG000|Overall Study|Disease progression|13|||
145638778|NCT01124734|525192382|FG000|Overall Study|Adverse Event|1|||
145638779|NCT01124734|525192382|FG000|Overall Study|Withdrawal by Subject|1|||
145638780|NCT01124734|525192382|FG000|Overall Study|Elected for alternative treatment|2|||
145638781|NCT01510717|525192383|FG000|Overall Study|Adverse Event|1|||
145638782|NCT01510717|525192384|FG001|Overall Study|Adverse Event|2|||
145638783|NCT01510717|525192383|FG000|Overall Study|Death|1|||
145638784|NCT01510717|525192384|FG001|Overall Study|Death|0|||
145638785|NCT01510717|525192383|FG000|Overall Study|Lost to Follow-up|0|||
145638786|NCT01510717|525192384|FG001|Overall Study|Lost to Follow-up|1|||
145638787|NCT01510717|525192383|FG000|Overall Study|Withdrawal by Subject|0|||
145638788|NCT01510717|525192384|FG001|Overall Study|Withdrawal by Subject|2|||
145638789|NCT00529789|525192387|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
145638790|NCT00529789|525192387|FG000|Study Period II/III|Adverse Event|3|||
145638791|NCT00529789|525192387|FG000|Study Period II/III|Lack of Efficacy|2|||
145638792|NCT00529789|525192387|FG000|Study Period II/III|Withdrawal by Subject|1|||
145638793|NCT00529789|525192387|FG000|Study Period II/III|Protocol Violation|3|||
145638794|NCT00529789|525192387|FG000|Study Period II/III|Physician Decision|3|||
145638795|NCT00529789|525192387|FG000|Study Period II/III|Lost to Follow-up|3|||
145638796|NCT00529789|525192387|FG000|Study Period IV|Parent/Caregiver Decision|1|||
145638797|NCT00529789|525192387|FG000|Study Period IV|Adverse Event|1|||
145638798|NCT00529789|525192387|FG000|Study Period IV|Lack of Efficacy|1|||
145638799|NCT00529789|525192387|FG000|Study Period IV|Lost to Follow-up|3|||
145638800|NCT01595061|525192388|FG000|Overall Study|Never Treated|3|||
145483889|NCT01100320|524624197|FG000|Period 1|Withdrawal by Subject|2|||
145483890|NCT01100320|524624198|FG001|Period 1|Withdrawal by Subject|4|||
145483891|NCT01100320|524624197|FG000|Period 1|Positive Drug Screen|1|||
145483892|NCT01100320|524624198|FG001|Period 1|Positive Drug Screen|1|||
145483893|NCT01100320|524624197|FG000|Period 1|Adverse Event|2|||
145638801|NCT01595061|525192388|FG000|Overall Study|Inadequate Pathology|1|||
145638802|NCT03194958|525192389|FG000|Overall Study|Death|0|||
145638803|NCT03194958|525192390|FG001|Overall Study|Death|1|||
145638804|NCT03194958|525192391|FG002|Overall Study|Death|1|||
145638805|NCT03194958|525192392|FG003|Overall Study|Death|1|||
145638806|NCT03194958|525192389|FG000|Overall Study|Withdrawal by Subject|24|||
145638807|NCT03194958|525192390|FG001|Overall Study|Withdrawal by Subject|27|||
145638808|NCT03194958|525192391|FG002|Overall Study|Withdrawal by Subject|7|||
145638809|NCT03194958|525192392|FG003|Overall Study|Withdrawal by Subject|22|||
145638810|NCT03194958|525192389|FG000|Overall Study|Lost to Follow-up|168|||
145638811|NCT03194958|525192390|FG001|Overall Study|Lost to Follow-up|196|||
145638812|NCT03194958|525192391|FG002|Overall Study|Lost to Follow-up|174|||
145638813|NCT03194958|525192392|FG003|Overall Study|Lost to Follow-up|186|||
145638814|NCT00959946|525192397|FG000|Overall Study|Adverse Event|0|||
145638815|NCT00959946|525192398|FG001|Overall Study|Adverse Event|0|||
145638816|NCT00959946|525192399|FG002|Overall Study|Adverse Event|2|||
145638817|NCT00959946|525192400|FG003|Overall Study|Adverse Event|1|||
145638818|NCT00959946|525192401|FG004|Overall Study|Adverse Event|0|||
145638819|NCT00959946|525192402|FG005|Overall Study|Adverse Event|1|||
145638820|NCT00959946|525192403|FG006|Overall Study|Adverse Event|0|||
145638821|NCT00959946|525192404|FG007|Overall Study|Adverse Event|0|||
145638822|NCT00959946|525192397|FG000|Overall Study|Death|0|||
145638823|NCT00959946|525192398|FG001|Overall Study|Death|0|||
145638824|NCT00959946|525192399|FG002|Overall Study|Death|0|||
145638825|NCT00959946|525192400|FG003|Overall Study|Death|0|||
145638826|NCT00959946|525192401|FG004|Overall Study|Death|0|||
145638827|NCT00959946|525192402|FG005|Overall Study|Death|1|||
145638828|NCT00959946|525192403|FG006|Overall Study|Death|0|||
145638829|NCT00959946|525192404|FG007|Overall Study|Death|0|||
145638830|NCT00959946|525192397|FG000|Overall Study|Disease Progression|2|||
145638831|NCT00959946|525192398|FG001|Overall Study|Disease Progression|4|||
145638832|NCT00959946|525192399|FG002|Overall Study|Disease Progression|2|||
145638833|NCT00959946|525192400|FG003|Overall Study|Disease Progression|4|||
145638834|NCT00959946|525192401|FG004|Overall Study|Disease Progression|4|||
145638835|NCT00959946|525192402|FG005|Overall Study|Disease Progression|6|||
145638836|NCT00959946|525192403|FG006|Overall Study|Disease Progression|2|||
145638837|NCT00959946|525192404|FG007|Overall Study|Disease Progression|2|||
145638838|NCT00959946|525192397|FG000|Overall Study|Withdrawal by Subject|0|||
145638839|NCT00959946|525192398|FG001|Overall Study|Withdrawal by Subject|0|||
145638840|NCT00959946|525192399|FG002|Overall Study|Withdrawal by Subject|0|||
145638841|NCT00959946|525192400|FG003|Overall Study|Withdrawal by Subject|0|||
145638842|NCT00959946|525192401|FG004|Overall Study|Withdrawal by Subject|0|||
145638843|NCT00959946|525192402|FG005|Overall Study|Withdrawal by Subject|1|||
145638844|NCT00959946|525192403|FG006|Overall Study|Withdrawal by Subject|0|||
145638845|NCT00959946|525192404|FG007|Overall Study|Withdrawal by Subject|0|||
145638846|NCT00356265|525192405|FG000|Overall Study|Withdrawal by Subject|0|||
145638847|NCT00356265|525192406|FG001|Overall Study|Withdrawal by Subject|0|||
145638848|NCT00356265|525192407|FG002|Overall Study|Withdrawal by Subject|1|||
145638849|NCT01837966|525192411|FG000|Overall Study|Withdrawal by Subject|2|||
145638850|NCT01837966|525192412|FG001|Overall Study|Withdrawal by Subject|1|||
145638851|NCT01202955|525192413|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
145638852|NCT01202955|525192414|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
145638853|NCT00159783|525192420|FG000|Overall Study|Adverse Event|5|||
145638854|NCT00159783|525192421|FG001|Overall Study|Adverse Event|7|||
145638855|NCT00159783|525192422|FG002|Overall Study|Adverse Event|9|||
145638856|NCT00159783|525192420|FG000|Overall Study|Lack of Efficacy|1|||
145638857|NCT00159783|525192421|FG001|Overall Study|Lack of Efficacy|2|||
145638858|NCT00159783|525192422|FG002|Overall Study|Lack of Efficacy|3|||
145638859|NCT00159783|525192420|FG000|Overall Study|Withdrawal by Subject|7|||
145638860|NCT00159783|525192421|FG001|Overall Study|Withdrawal by Subject|11|||
145638861|NCT00159783|525192422|FG002|Overall Study|Withdrawal by Subject|12|||
145638862|NCT00159783|525192420|FG000|Overall Study|Lost to Follow-up|6|||
145638863|NCT00159783|525192421|FG001|Overall Study|Lost to Follow-up|5|||
145638864|NCT00159783|525192422|FG002|Overall Study|Lost to Follow-up|11|||
145638865|NCT00159783|525192420|FG000|Overall Study|Other|0|||
145638866|NCT00159783|525192421|FG001|Overall Study|Other|2|||
145638867|NCT00159783|525192422|FG002|Overall Study|Other|4|||
145638868|NCT02928224|525192423|FG000|Overall Study|Lost to Follow-up|1|||
145638869|NCT02928224|525192424|FG001|Overall Study|Lost to Follow-up|1|||
145638870|NCT02928224|525192425|FG002|Overall Study|Lost to Follow-up|3|||
145638871|NCT02928224|525192426|FG003|Overall Study|Lost to Follow-up|0|||
145638872|NCT02928224|525192423|FG000|Overall Study|Death|30|||
145638873|NCT02928224|525192424|FG001|Overall Study|Death|209|||
145638874|NCT02928224|525192425|FG002|Overall Study|Death|193|||
145638875|NCT02928224|525192426|FG003|Overall Study|Death|198|||
145638876|NCT02928224|525192423|FG000|Overall Study|Withdrawal by Subject|0|||
145638877|NCT02928224|525192424|FG001|Overall Study|Withdrawal by Subject|3|||
145638878|NCT02928224|525192425|FG002|Overall Study|Withdrawal by Subject|7|||
145638879|NCT02928224|525192426|FG003|Overall Study|Withdrawal by Subject|20|||
145638880|NCT02928224|525192423|FG000|Overall Study|Study participation terminated by sponsor|3|||
145638881|NCT02928224|525192424|FG001|Overall Study|Study participation terminated by sponsor|8|||
145638882|NCT02928224|525192425|FG002|Overall Study|Study participation terminated by sponsor|12|||
145638883|NCT02928224|525192426|FG003|Overall Study|Study participation terminated by sponsor|3|||
145638884|NCT02928224|525192423|FG000|Overall Study|Other|3|||
145638885|NCT02928224|525192424|FG001|Overall Study|Other|3|||
145638886|NCT02928224|525192425|FG002|Overall Study|Other|5|||
145638887|NCT02928224|525192426|FG003|Overall Study|Other|0|||
145638888|NCT01278394|525192429|FG000|Overall Study|Lost to Follow-up|1|||
145638889|NCT01236560|525192430|FG000|Overall Study|Adverse Event|0|||
145638890|NCT01236560|525192431|FG001|Overall Study|Adverse Event|2|||
145638891|NCT01236560|525192432|FG002|Overall Study|Adverse Event|1|||
145638892|NCT01236560|525192433|FG003|Overall Study|Adverse Event|3|||
145638893|NCT01236560|525192434|FG004|Overall Study|Adverse Event|0|||
145638894|NCT01236560|525192435|FG005|Overall Study|Adverse Event|0|||
145638895|NCT01236560|525192430|FG000|Overall Study|Death|0|||
145638896|NCT01236560|525192431|FG001|Overall Study|Death|1|||
145638897|NCT01236560|525192432|FG002|Overall Study|Death|0|||
145638898|NCT01236560|525192433|FG003|Overall Study|Death|1|||
145638899|NCT01236560|525192434|FG004|Overall Study|Death|0|||
145638900|NCT01236560|525192435|FG005|Overall Study|Death|0|||
145638901|NCT01236560|525192430|FG000|Overall Study|Lost to Follow-up|0|||
145638902|NCT01236560|525192431|FG001|Overall Study|Lost to Follow-up|1|||
145638903|NCT01236560|525192432|FG002|Overall Study|Lost to Follow-up|1|||
145638904|NCT01236560|525192433|FG003|Overall Study|Lost to Follow-up|0|||
145638905|NCT01236560|525192434|FG004|Overall Study|Lost to Follow-up|0|||
145638906|NCT01236560|525192435|FG005|Overall Study|Lost to Follow-up|0|||
145638907|NCT01236560|525192430|FG000|Overall Study|Physician Decision|0|||
145638908|NCT01236560|525192431|FG001|Overall Study|Physician Decision|1|||
145638909|NCT01236560|525192432|FG002|Overall Study|Physician Decision|8|||
145638910|NCT01236560|525192433|FG003|Overall Study|Physician Decision|0|||
145638911|NCT01236560|525192434|FG004|Overall Study|Physician Decision|0|||
145638912|NCT01236560|525192435|FG005|Overall Study|Physician Decision|0|||
145638913|NCT01236560|525192430|FG000|Overall Study|Withdrawal by Subject|0|||
145638914|NCT01236560|525192431|FG001|Overall Study|Withdrawal by Subject|0|||
145638915|NCT01236560|525192432|FG002|Overall Study|Withdrawal by Subject|1|||
145638916|NCT01236560|525192433|FG003|Overall Study|Withdrawal by Subject|2|||
145638917|NCT01236560|525192434|FG004|Overall Study|Withdrawal by Subject|0|||
145638918|NCT01236560|525192435|FG005|Overall Study|Withdrawal by Subject|0|||
145638919|NCT01236560|525192430|FG000|Overall Study|Progressive disease|5|||
145638920|NCT01236560|525192431|FG001|Overall Study|Progressive disease|19|||
145638921|NCT01236560|525192432|FG002|Overall Study|Progressive disease|9|||
145638922|NCT01236560|525192433|FG003|Overall Study|Progressive disease|16|||
145638923|NCT01236560|525192434|FG004|Overall Study|Progressive disease|0|||
145638924|NCT01236560|525192435|FG005|Overall Study|Progressive disease|0|||
145638925|NCT02115139|525192436|FG000|Overall Study|Protocol Violation|1|||
145638926|NCT02115139|525192436|FG000|Overall Study|treatment discontinuation|6|||
145638927|NCT01943916|525192437|FG000|Overall Study|Technically invalid images|10|||
145638928|NCT01943916|525192437|FG000|Overall Study|Enrollment Failure|23|||
145638929|NCT01943916|525192437|FG000|Overall Study|Pilot Phase exclusion|100|||
145638930|NCT01943916|525192437|FG000|Overall Study|Quality Assurance Reader Fail|130|||
145638931|NCT01943916|525192437|FG000|Overall Study|Technical Failure|39|||
145638932|NCT01943916|525192437|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
145638933|NCT01943916|525192437|FG000|Overall Study|No Truth Panel Review|38|||
145638934|NCT01943916|525192437|FG000|Overall Study|Protocol Deviation|1|||
145638935|NCT01576484|525192438|FG000|Overall Study|Adverse Event|1|||
145638936|NCT01576484|525192439|FG001|Overall Study|Adverse Event|1|||
145638937|NCT01576484|525192438|FG000|Overall Study|Protocol Violation|0|||
145638938|NCT01576484|525192439|FG001|Overall Study|Protocol Violation|2|||
145638939|NCT01576484|525192438|FG000|Overall Study|Sponsor Decision|2|||
145638940|NCT01576484|525192439|FG001|Overall Study|Sponsor Decision|8|||
145638941|NCT01576484|525192438|FG000|Overall Study|Withdrawal by Subject|0|||
145638942|NCT01576484|525192439|FG001|Overall Study|Withdrawal by Subject|3|||
145638943|NCT01576484|525192438|FG000|Overall Study|Other|2|||
145638944|NCT01576484|525192439|FG001|Overall Study|Other|5|||
145638945|NCT03823911|525192443|FG000|Overall Study|Lost to Follow-up|1|||
145638946|NCT03823911|525192444|FG001|Overall Study|Lost to Follow-up|5|||
145638947|NCT03823911|525192445|FG002|Overall Study|Lost to Follow-up|2|||
145638948|NCT03823911|525192443|FG000|Overall Study|Did not meet eligibility criteria|13|||
145638949|NCT03823911|525192444|FG001|Overall Study|Did not meet eligibility criteria|7|||
145638950|NCT03823911|525192445|FG002|Overall Study|Did not meet eligibility criteria|4|||
145638951|NCT03823911|525192443|FG000|Overall Study|Death|0|||
145638952|NCT03823911|525192444|FG001|Overall Study|Death|1|||
145638953|NCT03823911|525192445|FG002|Overall Study|Death|0|||
145638954|NCT00433199|525192454|FG000|Double-Blind Period|Adverse Event|0|||
145483894|NCT01100320|524624198|FG001|Period 1|Adverse Event|2|||
145483895|NCT01100320|524624197|FG000|Period 2|Withdrawal by Subject|1|||
145638955|NCT00433199|525192455|FG001|Double-Blind Period|Adverse Event|25|||
145638956|NCT00433199|525192454|FG000|Double-Blind Period|Lack of Efficacy|0|||
145638957|NCT00433199|525192455|FG001|Double-Blind Period|Lack of Efficacy|2|||
145638958|NCT00433199|525192454|FG000|Double-Blind Period|Lost to Follow-up|2|||
145638959|NCT00433199|525192455|FG001|Double-Blind Period|Lost to Follow-up|5|||
145638960|NCT00433199|525192454|FG000|Double-Blind Period|Withdrawal by Subject|8|||
145638961|NCT00433199|525192455|FG001|Double-Blind Period|Withdrawal by Subject|19|||
145638962|NCT00433199|525192454|FG000|Double-Blind Period|Protocol Violation|1|||
145638963|NCT00433199|525192455|FG001|Double-Blind Period|Protocol Violation|10|||
145638964|NCT00433199|525192454|FG000|Double-Blind Period|Administrative|1|||
145483896|NCT01100320|524624198|FG001|Period 2|Withdrawal by Subject|1|||
145638965|NCT00433199|525192455|FG001|Double-Blind Period|Administrative|5|||
145638966|NCT00433199|525192454|FG000|Open-Label Period|Adverse Event|0|||
145638967|NCT00433199|525192455|FG001|Open-Label Period|Adverse Event|19|||
145638968|NCT00433199|525192454|FG000|Open-Label Period|Lack of Efficacy|0|||
145483897|NCT00550953|524624199|FG000|Overall Study|Adverse Event|4|||
145483898|NCT00550953|524624200|FG001|Overall Study|Adverse Event|3|||
145483899|NCT00550953|524624199|FG000|Overall Study|Not able to visit the site|2|||
145483900|NCT00550953|524624200|FG001|Overall Study|Not able to visit the site|3|||
145483901|NCT03797586|524624201|FG000|Overall Study|Lost to Follow-up|3|||
145483902|NCT03797586|524624202|FG001|Overall Study|Lost to Follow-up|6|||
145483903|NCT03797586|524624201|FG000|Overall Study|Death|1|||
145483904|NCT03797586|524624202|FG001|Overall Study|Death|1|||
145483905|NCT03797586|524624201|FG000|Overall Study|Adverse Event|0|||
145483906|NCT03797586|524624202|FG001|Overall Study|Adverse Event|2|||
145483907|NCT04980612|524624203|FG000|Overall Study|Withdrawal by Subject|7|||
145483908|NCT04980612|524624204|FG001|Overall Study|Withdrawal by Subject|5|||
145483909|NCT01502228|524624207|FG000|Overall Study|Death|1|||
145483910|NCT05730387|524624208|FG000|Overall Study|Stillbirth|0|||
145483911|NCT05730387|524624209|FG001|Overall Study|Stillbirth|262|||
145483912|NCT05730387|524624208|FG000|Overall Study|Died during or after delivery|2|||
145483913|NCT05730387|524624209|FG001|Overall Study|Died during or after delivery|85|||
145483914|NCT05730387|524624208|FG000|Overall Study|Died after being admitted|0|||
145483915|NCT05730387|524624209|FG001|Overall Study|Died after being admitted|44|||
145483916|NCT05730387|524624208|FG000|Overall Study|Lost to Follow-up|69|||
145483917|NCT05730387|524624209|FG001|Overall Study|Lost to Follow-up|77|||
145483918|NCT02728089|524624210|FG000|Overall Study|Physician Decision|2|||
145483919|NCT02728089|524624210|FG000|Overall Study|Withdrawal by Subject|1|||
145483920|NCT01219985|524624211|FG000|Overall Study|Physician Decision|20|||
145483921|NCT00596752|524624212|FG000|Overall Study|Other Reason|44|||
145483922|NCT00596752|524624213|FG001|Overall Study|Other Reason|49|||
145483923|NCT00596752|524624212|FG000|Overall Study|Adverse Event|34|||
145483924|NCT00596752|524624213|FG001|Overall Study|Adverse Event|34|||
145483925|NCT00596752|524624212|FG000|Overall Study|Lost to Follow-up|22|||
145483926|NCT00596752|524624213|FG001|Overall Study|Lost to Follow-up|38|||
145483927|NCT00596752|524624212|FG000|Overall Study|Withdrawal by Subject|12|||
145483928|NCT00596752|524624213|FG001|Overall Study|Withdrawal by Subject|9|||
145483929|NCT00596752|524624212|FG000|Overall Study|Unsatisfactory Compliance|9|||
145483930|NCT00596752|524624213|FG001|Overall Study|Unsatisfactory Compliance|6|||
145483931|NCT00596752|524624212|FG000|Overall Study|Lack of Efficacy|4|||
145483932|NCT00596752|524624213|FG001|Overall Study|Lack of Efficacy|7|||
145483933|NCT00596752|524624212|FG000|Overall Study|Protocol Violation|1|||
145483934|NCT00596752|524624213|FG001|Overall Study|Protocol Violation|0|||
145483935|NCT04797780|524624214|FG000|Overall Study|Lost to Follow-up|1|||
145483936|NCT04797780|524624215|FG001|Overall Study|Lost to Follow-up|1|||
145483937|NCT04797780|524624214|FG000|Overall Study|Withdrawal by Subject|14|||
145483938|NCT04797780|524624215|FG001|Overall Study|Withdrawal by Subject|9|||
145483939|NCT04797780|524624214|FG000|Overall Study|Death|49|||
145483940|NCT04797780|524624215|FG001|Overall Study|Death|20|||
145483941|NCT02940496|524624216|FG000|Overall Study|Adverse Event|1|||
145483942|NCT02940496|524624217|FG001|Overall Study|Adverse Event|0|||
145483943|NCT02940496|524624216|FG000|Overall Study|Death|2|||
145483944|NCT02940496|524624217|FG001|Overall Study|Death|0|||
145483945|NCT02940496|524624216|FG000|Overall Study|Hospice Care|1|||
145483946|NCT02940496|524624217|FG001|Overall Study|Hospice Care|0|||
145483947|NCT02940496|524624216|FG000|Overall Study|No MRE Done|1|||
145483948|NCT02940496|524624217|FG001|Overall Study|No MRE Done|0|||
145483949|NCT02940496|524624216|FG000|Overall Study|MRE Failure|1|||
145483950|NCT02940496|524624217|FG001|Overall Study|MRE Failure|0|||
145483951|NCT02586727|524624218|FG000|Overall Study|Lost to Follow-up|1|||
145483952|NCT02586727|524624219|FG001|Overall Study|Lost to Follow-up|0|||
145483953|NCT04089761|524624224|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
145638969|NCT00433199|525192455|FG001|Open-Label Period|Lack of Efficacy|2|||
145638970|NCT00433199|525192454|FG000|Open-Label Period|Lost to Follow-up|0|||
145638971|NCT00433199|525192455|FG001|Open-Label Period|Lost to Follow-up|3|||
145638972|NCT00433199|525192454|FG000|Open-Label Period|Withdrawal by Subject|0|||
145638973|NCT00433199|525192455|FG001|Open-Label Period|Withdrawal by Subject|7|||
145638974|NCT00433199|525192454|FG000|Open-Label Period|Protocol Violation|0|||
145638975|NCT00433199|525192455|FG001|Open-Label Period|Protocol Violation|2|||
145483954|NCT04089761|524624224|FG000|"Run In Phase"|Lost to Follow-up|1|||
145483955|NCT04089761|524624224|FG000|"Treatment Phase"|No evaluable data|5|||
145638976|NCT00433199|525192454|FG000|Open-Label Period|Administrative|0|||
145638977|NCT00433199|525192455|FG001|Open-Label Period|Administrative|1|||
145483956|NCT04089761|524624224|FG000|"Treatment Phase"|Lost to Follow-up|1|||
145483957|NCT02863328|524624226|FG000|Overall Study|Lost to Follow-up|4|||
145483958|NCT02863328|524624227|FG001|Overall Study|Lost to Follow-up|10|||
145483959|NCT02863328|524624226|FG000|Overall Study|Withdrawal by Subject|7|||
145483960|NCT02863328|524624227|FG001|Overall Study|Withdrawal by Subject|12|||
145483961|NCT02863328|524624226|FG000|Overall Study|Died|0|||
145638978|NCT00094575|525192456|FG000|Overall Study|Death|146|||
145483962|NCT02863328|524624227|FG001|Overall Study|Died|1|||
145483963|NCT01870726|524624228|FG000|Overall Study|Withdrawal of informed consent|0|||
145483964|NCT01870726|524624229|FG001|Overall Study|Withdrawal of informed consent|0|||
145483965|NCT01870726|524624230|FG002|Overall Study|Withdrawal of informed consent|0|||
145638979|NCT00094575|525192457|FG001|Overall Study|Death|146|||
145483966|NCT01870726|524624231|FG003|Overall Study|Withdrawal of informed consent|1|||
145483967|NCT01870726|524624232|FG004|Overall Study|Withdrawal of informed consent|0|||
145483968|NCT01870726|524624233|FG005|Overall Study|Withdrawal of informed consent|0|||
145483969|NCT01870726|524624234|FG006|Overall Study|Withdrawal of informed consent|0|||
145483970|NCT01870726|524624228|FG000|Overall Study|Withdrawal by Subject|0|||
145483971|NCT01870726|524624229|FG001|Overall Study|Withdrawal by Subject|1|||
145483972|NCT01870726|524624230|FG002|Overall Study|Withdrawal by Subject|0|||
145483973|NCT01870726|524624231|FG003|Overall Study|Withdrawal by Subject|0|||
145483974|NCT01870726|524624232|FG004|Overall Study|Withdrawal by Subject|0|||
145483975|NCT01870726|524624233|FG005|Overall Study|Withdrawal by Subject|0|||
145483976|NCT01870726|524624234|FG006|Overall Study|Withdrawal by Subject|0|||
145483977|NCT01870726|524624228|FG000|Overall Study|Adverse Event|0|||
145483978|NCT01870726|524624229|FG001|Overall Study|Adverse Event|0|||
145483979|NCT01870726|524624230|FG002|Overall Study|Adverse Event|0|||
145483980|NCT01870726|524624231|FG003|Overall Study|Adverse Event|0|||
145483981|NCT01870726|524624232|FG004|Overall Study|Adverse Event|1|||
145483982|NCT01870726|524624233|FG005|Overall Study|Adverse Event|1|||
145483983|NCT01870726|524624234|FG006|Overall Study|Adverse Event|0|||
145483984|NCT01870726|524624228|FG000|Overall Study|Progressive disease|5|||
145483985|NCT01870726|524624229|FG001|Overall Study|Progressive disease|5|||
145483986|NCT01870726|524624230|FG002|Overall Study|Progressive disease|4|||
145483987|NCT01870726|524624231|FG003|Overall Study|Progressive disease|5|||
145483988|NCT01870726|524624232|FG004|Overall Study|Progressive disease|6|||
145483989|NCT01870726|524624233|FG005|Overall Study|Progressive disease|4|||
145483990|NCT01870726|524624234|FG006|Overall Study|Progressive disease|10|||
145483991|NCT00595478|524624235|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
145483992|NCT00595478|524624236|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
145483993|NCT00595478|524624235|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
145483994|NCT00595478|524624236|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
145483995|NCT00950248|524624240|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
145483996|NCT00950248|524624241|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
145483997|NCT00950248|524624242|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
145483998|NCT00950248|524624240|FG000|Year 1: Baseline|worsening of symptoms|2|||
145483999|NCT00950248|524624241|FG001|Year 1: Baseline|worsening of symptoms|0|||
145484000|NCT00950248|524624242|FG002|Year 1: Baseline|worsening of symptoms|0|||
145484001|NCT00950248|524624240|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
145484002|NCT00950248|524624241|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
145484003|NCT00950248|524624242|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
145484004|NCT00950248|524624240|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
145484005|NCT00950248|524624241|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
145484006|NCT00950248|524624242|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
145484007|NCT00950248|524624240|FG000|Year 2&3 Treatment Randomization|Death|0|||
145484008|NCT00950248|524624241|FG001|Year 2&3 Treatment Randomization|Death|0|||
145484009|NCT00950248|524624242|FG002|Year 2&3 Treatment Randomization|Death|1|||
145484010|NCT00950248|524624240|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
145484011|NCT00950248|524624241|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
145484012|NCT00950248|524624242|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
145484013|NCT00003199|524624243|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
145484014|NCT00003199|524624243|FG000|Overall Study|Lack of insurance clearance|2|||
145484015|NCT00003199|524624243|FG000|Overall Study|Screen fail|15|||
145484016|NCT00940498|524624244|FG000|Overall Study|Death|2|||
145484017|NCT00940498|524624245|FG001|Overall Study|Death|0|||
145484018|NCT00940498|524624246|FG002|Overall Study|Death|0|||
145484019|NCT00940498|524624247|FG003|Overall Study|Death|1|||
145484020|NCT00940498|524624248|FG004|Overall Study|Death|5|||
145484021|NCT00940498|524624249|FG005|Overall Study|Death|0|||
145638980|NCT04305405|525192458|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145638981|NCT04305405|525192459|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145638982|NCT00206375|525192461|FG000|Overall Study|Lost to Follow-up|1|||
145638983|NCT00206375|525192462|FG001|Overall Study|Lost to Follow-up|0|||
145638984|NCT00206375|525192463|FG002|Overall Study|Lost to Follow-up|0|||
145638985|NCT00206375|525192461|FG000|Overall Study|Withdrawal by Subject|2|||
145638986|NCT00206375|525192462|FG001|Overall Study|Withdrawal by Subject|1|||
145638987|NCT00206375|525192463|FG002|Overall Study|Withdrawal by Subject|3|||
145638988|NCT00206375|525192461|FG000|Overall Study|Study terminated due to lack of funds|0|||
145638989|NCT00206375|525192462|FG001|Overall Study|Study terminated due to lack of funds|1|||
145638990|NCT00206375|525192463|FG002|Overall Study|Study terminated due to lack of funds|1|||
145638991|NCT03603717|525192464|FG000|Overall Study|Lost to Follow-up|20|||
145638992|NCT03603717|525192465|FG001|Overall Study|Lost to Follow-up|20|||
145638993|NCT03603717|525192464|FG000|Overall Study|Withdrawal by Subject|16|||
145484022|NCT00940498|524624250|FG006|Overall Study|Death|1|||
145638994|NCT03603717|525192465|FG001|Overall Study|Withdrawal by Subject|10|||
145638995|NCT00732381|525192468|FG000|Overall Study|Adverse Event|1|||
145484023|NCT00940498|524624251|FG007|Overall Study|Death|0|||
145484024|NCT00940498|524624244|FG000|Overall Study|Lost to Follow-up|1|||
145484025|NCT00940498|524624245|FG001|Overall Study|Lost to Follow-up|1|||
145484026|NCT00940498|524624246|FG002|Overall Study|Lost to Follow-up|2|||
145484027|NCT00940498|524624247|FG003|Overall Study|Lost to Follow-up|0|||
145484028|NCT00940498|524624248|FG004|Overall Study|Lost to Follow-up|1|||
145484029|NCT00940498|524624249|FG005|Overall Study|Lost to Follow-up|0|||
145484030|NCT00940498|524624250|FG006|Overall Study|Lost to Follow-up|0|||
145484031|NCT00940498|524624251|FG007|Overall Study|Lost to Follow-up|1|||
145484032|NCT00940498|524624244|FG000|Overall Study|Disease Progression|0|||
145484033|NCT00940498|524624245|FG001|Overall Study|Disease Progression|0|||
145484034|NCT00940498|524624246|FG002|Overall Study|Disease Progression|1|||
145484035|NCT00940498|524624247|FG003|Overall Study|Disease Progression|1|||
145484036|NCT00940498|524624248|FG004|Overall Study|Disease Progression|0|||
145484037|NCT00940498|524624249|FG005|Overall Study|Disease Progression|1|||
145484038|NCT00940498|524624250|FG006|Overall Study|Disease Progression|0|||
145484039|NCT00940498|524624251|FG007|Overall Study|Disease Progression|0|||
145484040|NCT00940498|524624244|FG000|Overall Study|Physician Decision|0|||
145484041|NCT00940498|524624245|FG001|Overall Study|Physician Decision|0|||
145484042|NCT00940498|524624246|FG002|Overall Study|Physician Decision|0|||
145484043|NCT00940498|524624247|FG003|Overall Study|Physician Decision|0|||
145484044|NCT00940498|524624248|FG004|Overall Study|Physician Decision|2|||
145484045|NCT00940498|524624249|FG005|Overall Study|Physician Decision|0|||
145484046|NCT00940498|524624250|FG006|Overall Study|Physician Decision|0|||
145484047|NCT00940498|524624251|FG007|Overall Study|Physician Decision|0|||
145484048|NCT00940498|524624244|FG000|Overall Study|Not treated due to disease related pain|0|||
145484049|NCT00940498|524624245|FG001|Overall Study|Not treated due to disease related pain|0|||
145484050|NCT00940498|524624246|FG002|Overall Study|Not treated due to disease related pain|0|||
145484051|NCT00940498|524624247|FG003|Overall Study|Not treated due to disease related pain|0|||
145484052|NCT00940498|524624248|FG004|Overall Study|Not treated due to disease related pain|1|||
145484053|NCT00940498|524624249|FG005|Overall Study|Not treated due to disease related pain|0|||
145484054|NCT00940498|524624250|FG006|Overall Study|Not treated due to disease related pain|0|||
145484055|NCT00940498|524624251|FG007|Overall Study|Not treated due to disease related pain|0|||
145484056|NCT00650845|524624252|FG000|Overall Study|Withdrawal by Subject|5|||
145484057|NCT00650845|524624253|FG001|Overall Study|Withdrawal by Subject|0|||
145484058|NCT00650845|524624252|FG000|Overall Study|Protocol Violation|0|||
145484059|NCT00650845|524624253|FG001|Overall Study|Protocol Violation|13|||
145484060|NCT03761810|524624254|FG000|Overall Study|Adverse Event|12|||
145484061|NCT03761810|524624255|FG001|Overall Study|Adverse Event|0|||
145484062|NCT03761810|524624254|FG000|Overall Study|Lost to Follow-up|15|||
145484063|NCT03761810|524624255|FG001|Overall Study|Lost to Follow-up|7|||
145484064|NCT03761810|524624254|FG000|Overall Study|Pregnancy|1|||
145484065|NCT03761810|524624255|FG001|Overall Study|Pregnancy|0|||
145484066|NCT03761810|524624254|FG000|Overall Study|Withdrawal by Subject|14|||
145604810|NCT05044325|525068848|FG002|Part A:Treatment Period 2|Physician Decision|0|||
145604811|NCT05044325|525068849|FG003|Part A:Treatment Period 2|Physician Decision|0|||
145604812|NCT05044325|525068850|FG004|Part A:Treatment Period 2|Physician Decision|0|||
145604813|NCT05044325|525068851|FG005|Part A:Treatment Period 2|Physician Decision|1|||
145604814|NCT05044325|525068852|FG006|Part A:Treatment Period 2|Physician Decision|0|||
145604815|NCT05044325|525068853|FG007|Part A:Treatment Period 2|Physician Decision|0|||
145604816|NCT05044325|525068854|FG008|Part A:Treatment Period 2|Physician Decision|0|||
145604817|NCT05044325|525068855|FG009|Part A:Treatment Period 2|Physician Decision|0|||
145604818|NCT05044325|525068846|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604819|NCT05044325|525068847|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604820|NCT05044325|525068848|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604821|NCT05044325|525068849|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
145604822|NCT05044325|525068850|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
145604823|NCT05044325|525068851|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604824|NCT05044325|525068852|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604825|NCT05044325|525068853|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604826|NCT05044325|525068854|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604827|NCT05044325|525068855|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
145604828|NCT03430063|525068862|FG000|Overall Study|Adverse Event|0|||
145604829|NCT03430063|525068863|FG001|Overall Study|Adverse Event|1|||
145604830|NCT03430063|525068864|FG002|Overall Study|Adverse Event|0|||
145604831|NCT03430063|525068862|FG000|Overall Study|Death|3|||
145604832|NCT03430063|525068863|FG001|Overall Study|Death|2|||
145604833|NCT03430063|525068864|FG002|Overall Study|Death|3|||
145604834|NCT03430063|525068862|FG000|Overall Study|Lost to Follow-up|0|||
145604835|NCT03430063|525068863|FG001|Overall Study|Lost to Follow-up|1|||
145604836|NCT03430063|525068864|FG002|Overall Study|Lost to Follow-up|0|||
145638996|NCT00732381|525192469|FG001|Overall Study|Adverse Event|0|||
145484067|NCT03761810|524624255|FG001|Overall Study|Withdrawal by Subject|5|||
145484068|NCT03761810|524624254|FG000|Overall Study|Physician Decision|1|||
145484069|NCT03761810|524624255|FG001|Overall Study|Physician Decision|0|||
145484070|NCT03761810|524624254|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
145484071|NCT03761810|524624255|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145484072|NCT03761810|524624254|FG000|Overall Study|Other Than Specified|1|||
145484073|NCT03761810|524624255|FG001|Overall Study|Other Than Specified|0|||
145484074|NCT03932760|524624256|FG000|Overall Study|Became Ineligible|2|||
145484075|NCT03932760|524624257|FG001|Overall Study|Became Ineligible|5|||
145484076|NCT03932760|524624256|FG000|Overall Study|Withdrawal by Subject|6|||
145484077|NCT03932760|524624257|FG001|Overall Study|Withdrawal by Subject|6|||
145484078|NCT00869518|524624258|FG000|Overall Study|Lost to Follow-up|1|||
145484079|NCT00869518|524624259|FG001|Overall Study|Lost to Follow-up|1|||
145484080|NCT03922620|524624262|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
145484081|NCT03922620|524624263|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
145484082|NCT00163020|524624265|FG000|Overall Study|Lost to Follow-up|0|||
145484083|NCT00163020|524624266|FG001|Overall Study|Lost to Follow-up|2|||
145484084|NCT03772665|524624267|FG000|Overall Study|Protocol Violation|1|||
145484085|NCT03772665|524624268|FG001|Overall Study|Protocol Violation|0|||
145484086|NCT02098746|524625892|FG000|Overall Study|Changes of Investigator|2|||
145484087|NCT02098746|524625892|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145484088|NCT02098746|524625892|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
145484089|NCT02098746|524625892|FG000|Overall Study|Data Not Available After Treatment|1|||
145484090|NCT00997035|524625893|FG000|3-week Followup Visit|Lost to Follow-up|9|||
145484091|NCT00997035|524625894|FG001|3-week Followup Visit|Lost to Follow-up|6|||
145484092|NCT00997035|524625893|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
145484093|NCT00997035|524625894|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
145484094|NCT02544503|524625898|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
145484095|NCT02544503|524625899|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
145484096|NCT02544503|524625898|FG000|Overall Study|Lost to Follow-up|9|||
145484097|NCT02544503|524625899|FG001|Overall Study|Lost to Follow-up|0|||
145484098|NCT02544503|524625898|FG000|Overall Study|Withdrawal by Subject|1|||
145484099|NCT02544503|524625899|FG001|Overall Study|Withdrawal by Subject|0|||
145484100|NCT04685798|524625900|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
145484101|NCT04640311|524625901|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
145484102|NCT04640311|524625902|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484103|NCT04640311|524625903|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484104|NCT04640311|524625904|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484105|NCT04640311|524625905|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484106|NCT04640311|524625906|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484107|NCT04640311|524625907|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484108|NCT04640311|524625908|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484109|NCT04640311|524625909|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484110|NCT04640311|524625910|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484111|NCT04640311|524625911|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484112|NCT04640311|524625912|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484113|NCT04640311|524625913|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484114|NCT04640311|524625901|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484115|NCT04640311|524625902|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
145484116|NCT04640311|524625903|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484117|NCT04640311|524625904|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484118|NCT04640311|524625905|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484119|NCT04640311|524625906|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484120|NCT04640311|524625907|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484121|NCT04640311|524625908|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484122|NCT04640311|524625909|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484123|NCT04640311|524625910|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484124|NCT04640311|524625911|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484125|NCT04640311|524625912|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484126|NCT04640311|524625913|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
145484127|NCT04640311|524625901|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484128|NCT04640311|524625902|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
145484129|NCT04640311|524625903|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484130|NCT04640311|524625904|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484131|NCT04640311|524625905|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484132|NCT04640311|524625906|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484133|NCT04640311|524625907|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484134|NCT04640311|524625908|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484135|NCT04640311|524625909|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484136|NCT04640311|524625910|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484137|NCT04640311|524625911|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484138|NCT04640311|524625912|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484139|NCT04640311|524625913|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484140|NCT04640311|524625901|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
145484141|NCT04640311|524625902|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
145484142|NCT04640311|524625903|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
145484143|NCT04640311|524625904|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484144|NCT04640311|524625905|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484145|NCT04640311|524625906|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484146|NCT04640311|524625907|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484147|NCT04640311|524625908|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484148|NCT04640311|524625909|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484149|NCT04640311|524625910|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484150|NCT04640311|524625911|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484151|NCT04640311|524625912|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484152|NCT04640311|524625913|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
145484153|NCT04640311|524625901|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484154|NCT04640311|524625902|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484155|NCT04640311|524625903|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
145484156|NCT04640311|524625904|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484157|NCT04640311|524625905|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484158|NCT04640311|524625906|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484159|NCT04640311|524625907|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484160|NCT04640311|524625908|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484161|NCT04640311|524625909|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484162|NCT04640311|524625910|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484163|NCT04640311|524625911|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484164|NCT04640311|524625912|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484165|NCT04640311|524625913|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
145484166|NCT04640311|524625901|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484167|NCT04640311|524625902|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484168|NCT04640311|524625903|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484169|NCT04640311|524625904|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
145484170|NCT04640311|524625905|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484171|NCT04640311|524625906|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484172|NCT04640311|524625907|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
145484173|NCT04640311|524625908|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484174|NCT04640311|524625909|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484175|NCT04640311|524625910|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484176|NCT04640311|524625911|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484177|NCT04640311|524625912|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484178|NCT04640311|524625913|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
145484179|NCT04640311|524625901|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484180|NCT04640311|524625902|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484181|NCT04640311|524625903|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484182|NCT04640311|524625904|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484183|NCT04640311|524625905|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484184|NCT04640311|524625906|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
145638997|NCT00732381|525192468|FG000|Overall Study|Treatment Failure|1|||
145638998|NCT00732381|525192469|FG001|Overall Study|Treatment Failure|1|||
145638999|NCT00457691|525192470|FG000|Overall Study|Adverse Event|4|||
145639000|NCT00457691|525192471|FG001|Overall Study|Adverse Event|1|||
145639001|NCT00457691|525192470|FG000|Overall Study|Death|163|||
145639002|NCT00457691|525192471|FG001|Overall Study|Death|148|||
145639003|NCT00457691|525192470|FG000|Overall Study|Protocol Violation|1|||
145639004|NCT00457691|525192471|FG001|Overall Study|Protocol Violation|3|||
145639005|NCT00457691|525192470|FG000|Overall Study|Lost to Follow-up|23|||
145639006|NCT00457691|525192471|FG001|Overall Study|Lost to Follow-up|14|||
145639007|NCT00457691|525192470|FG000|Overall Study|Study terminated by Sponsor|1|||
145639008|NCT00457691|525192471|FG001|Overall Study|Study terminated by Sponsor|1|||
145639009|NCT00457691|525192470|FG000|Overall Study|Subject refused (reason other than AE)|14|||
145639010|NCT00457691|525192471|FG001|Overall Study|Subject refused (reason other than AE)|19|||
145639011|NCT00457691|525192470|FG000|Overall Study|Disease progression, study terminated|180|||
145639012|NCT00457691|525192471|FG001|Overall Study|Disease progression, study terminated|196|||
145639013|NCT01420549|525192472|FG000|Overall Study|Adverse Event|1|||
145639014|NCT01420549|525192473|FG001|Overall Study|Adverse Event|1|||
145639015|NCT01420549|525192472|FG000|Overall Study|Lost to Follow-up|2|||
145639016|NCT01420549|525192473|FG001|Overall Study|Lost to Follow-up|2|||
145639017|NCT01420549|525192472|FG000|Overall Study|Protocol Violation|0|||
145639018|NCT01420549|525192473|FG001|Overall Study|Protocol Violation|1|||
145639019|NCT01420549|525192472|FG000|Overall Study|Non-adherence to medication|4|||
145639020|NCT01420549|525192473|FG001|Overall Study|Non-adherence to medication|1|||
145639021|NCT05777785|525194244|FG000|Overall Study|Withdrawal by Subject|5|||
145639022|NCT05777785|525194244|FG000|Overall Study|Lost to Follow-up|1|||
145639023|NCT05644444|525194249|FG000|Tolerance Phase|Adverse Event|0|||
145639024|NCT05644444|525194250|FG001|Tolerance Phase|Adverse Event|2|||
145639025|NCT05644444|525194249|FG000|Treatment Phase|Adverse Event|0|||
145639026|NCT05644444|525194250|FG001|Treatment Phase|Adverse Event|2|||
145639027|NCT04817670|525194251|FG000|Overall Study|Withdrawal by Subject|1|||
145639028|NCT04817670|525194252|FG001|Overall Study|Withdrawal by Subject|0|||
145639029|NCT04817670|525194253|FG002|Overall Study|Withdrawal by Subject|0|||
145639030|NCT04817670|525194254|FG003|Overall Study|Withdrawal by Subject|0|||
145639031|NCT04817670|525194255|FG004|Overall Study|Withdrawal by Subject|0|||
145639032|NCT04817670|525194251|FG000|Overall Study|Lost to Follow-up|0|||
145639033|NCT04817670|525194252|FG001|Overall Study|Lost to Follow-up|0|||
145639034|NCT04817670|525194253|FG002|Overall Study|Lost to Follow-up|1|||
145639035|NCT04817670|525194254|FG003|Overall Study|Lost to Follow-up|0|||
145639036|NCT04817670|525194255|FG004|Overall Study|Lost to Follow-up|0|||
145639037|NCT03073941|525194256|FG000|Overall Study|Received non-study device intraoperatively|0|||
145639038|NCT03073941|525194257|FG001|Overall Study|Received non-study device intraoperatively|2|||
145639039|NCT03073941|525194256|FG000|Overall Study|Death|1|||
145639040|NCT03073941|525194257|FG001|Overall Study|Death|0|||
145639041|NCT03073941|525194256|FG000|Overall Study|Withdrawal by Subject|1|||
145639042|NCT03073941|525194257|FG001|Overall Study|Withdrawal by Subject|3|||
145639043|NCT03073941|525194256|FG000|Overall Study|Lost to Follow-up|5|||
145639044|NCT03073941|525194257|FG001|Overall Study|Lost to Follow-up|4|||
145639045|NCT03073941|525194256|FG000|Overall Study|Adverse Event|4|||
145639046|NCT03073941|525194257|FG001|Overall Study|Adverse Event|2|||
145639047|NCT03073941|525194256|FG000|Overall Study|Met an exclusion criterion|0|||
145639048|NCT03073941|525194257|FG001|Overall Study|Met an exclusion criterion|1|||
145639049|NCT01188655|525194258|FG000|Overall Study|Lack of Efficacy|1|||
145639050|NCT01188655|525194258|FG000|Overall Study|Lost to Follow-up|1|||
145639051|NCT01188655|525194258|FG000|Overall Study|Other|11|||
145639052|NCT00925899|525194259|FG000|Part 1|Death|1|||
145639053|NCT00925899|525194260|FG001|Part 1|Death|2|||
145639054|NCT00925899|525194259|FG000|Part 1|Withdrawal by Subject|10|||
145639055|NCT00925899|525194260|FG001|Part 1|Withdrawal by Subject|9|||
145639056|NCT00089544|525194261|FG000|Overall Study|Ineligible|1|||
145639057|NCT00089544|525194262|FG001|Overall Study|Ineligible|0|||
145639058|NCT00683696|525194263|FG000|Overall Study|Withdrawn due to study closure|337|||
145639059|NCT00683696|525194264|FG001|Overall Study|Withdrawn due to study closure|338|||
145639060|NCT00683696|525194263|FG000|Overall Study|Withdrawn prior to study closure|13|||
145639061|NCT00683696|525194264|FG001|Overall Study|Withdrawn prior to study closure|28|||
145639062|NCT00683696|525194263|FG000|Overall Study|Lost to Follow-up|5|||
145639063|NCT00683696|525194264|FG001|Overall Study|Lost to Follow-up|6|||
145639064|NCT00683696|525194263|FG000|Overall Study|Vital status follow-up only|3|||
145639065|NCT00683696|525194264|FG001|Overall Study|Vital status follow-up only|3|||
145639066|NCT00683696|525194263|FG000|Overall Study|Death|46|||
145639067|NCT00683696|525194264|FG001|Overall Study|Death|30|||
145639068|NCT02396316|525194267|FG000|Overall Study|Physician Decision|1|||
145639069|NCT02396316|525194268|FG001|Overall Study|Physician Decision|0|||
145639070|NCT02396316|525194267|FG000|Overall Study|Progressive disease|6|||
145484185|NCT04640311|524625907|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145639071|NCT02396316|525194268|FG001|Overall Study|Progressive disease|3|||
145639072|NCT02396316|525194267|FG000|Overall Study|Protocol Violation|0|||
145639073|NCT02396316|525194268|FG001|Overall Study|Protocol Violation|1|||
145639074|NCT02396316|525194267|FG000|Overall Study|Treatment unblinded|0|||
145639075|NCT02396316|525194268|FG001|Overall Study|Treatment unblinded|1|||
145639076|NCT01823536|525194269|FG000|Overall Study|Lost to Follow-up|1|||
145639077|NCT01823536|525194270|FG001|Overall Study|Lost to Follow-up|0|||
145639078|NCT01823536|525194271|FG002|Overall Study|Lost to Follow-up|0|||
145639079|NCT01823536|525194272|FG003|Overall Study|Lost to Follow-up|1|||
145639080|NCT01823536|525194273|FG004|Overall Study|Lost to Follow-up|1|||
145639081|NCT01823536|525194274|FG005|Overall Study|Lost to Follow-up|0|||
145639082|NCT01823536|525194269|FG000|Overall Study|Protocol Violation|0|||
145639083|NCT01823536|525194270|FG001|Overall Study|Protocol Violation|1|||
145639084|NCT01823536|525194271|FG002|Overall Study|Protocol Violation|0|||
145639085|NCT01823536|525194272|FG003|Overall Study|Protocol Violation|0|||
145639086|NCT01823536|525194273|FG004|Overall Study|Protocol Violation|0|||
145639087|NCT01823536|525194274|FG005|Overall Study|Protocol Violation|0|||
145639088|NCT01823536|525194269|FG000|Overall Study|Withdrawal by Subject|1|||
145639089|NCT01823536|525194270|FG001|Overall Study|Withdrawal by Subject|1|||
145639090|NCT01823536|525194271|FG002|Overall Study|Withdrawal by Subject|0|||
145639091|NCT01823536|525194272|FG003|Overall Study|Withdrawal by Subject|0|||
145639092|NCT01823536|525194273|FG004|Overall Study|Withdrawal by Subject|0|||
145639093|NCT01823536|525194274|FG005|Overall Study|Withdrawal by Subject|0|||
145639094|NCT01823536|525194269|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
145639095|NCT01823536|525194270|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
145639096|NCT01823536|525194271|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
145639097|NCT01823536|525194272|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
145639098|NCT01823536|525194273|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
145639099|NCT01823536|525194274|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
145639100|NCT01823536|525194269|FG000|Overall Study|Met exclusion criterion No 6|0|||
145639101|NCT01823536|525194270|FG001|Overall Study|Met exclusion criterion No 6|0|||
145639102|NCT01823536|525194271|FG002|Overall Study|Met exclusion criterion No 6|0|||
145639103|NCT01823536|525194272|FG003|Overall Study|Met exclusion criterion No 6|1|||
145639104|NCT01823536|525194273|FG004|Overall Study|Met exclusion criterion No 6|0|||
145639105|NCT01823536|525194274|FG005|Overall Study|Met exclusion criterion No 6|0|||
145639106|NCT01823536|525194269|FG000|Overall Study|Subject moved out of the state|0|||
145639107|NCT01823536|525194270|FG001|Overall Study|Subject moved out of the state|0|||
145639108|NCT01823536|525194271|FG002|Overall Study|Subject moved out of the state|0|||
145639109|NCT01823536|525194272|FG003|Overall Study|Subject moved out of the state|0|||
145639110|NCT01823536|525194273|FG004|Overall Study|Subject moved out of the state|1|||
145639111|NCT01823536|525194274|FG005|Overall Study|Subject moved out of the state|0|||
145639112|NCT03648762|525194275|FG000|Overall Study|Lost to Follow-up|1|||
145639113|NCT03648762|525194276|FG001|Overall Study|Lost to Follow-up|2|||
145639114|NCT03648762|525194277|FG002|Overall Study|Lost to Follow-up|0|||
145639115|NCT03648762|525194275|FG000|Overall Study|Withdrawal by Subject|5|||
145639116|NCT03648762|525194276|FG001|Overall Study|Withdrawal by Subject|2|||
145639117|NCT03648762|525194277|FG002|Overall Study|Withdrawal by Subject|1|||
145639118|NCT00722046|525194283|FG000|Overall Study|Adverse Event|0|||
145639119|NCT00722046|525194284|FG001|Overall Study|Adverse Event|1|||
145639120|NCT00722046|525194285|FG002|Overall Study|Adverse Event|2|||
145639121|NCT00722046|525194286|FG003|Overall Study|Adverse Event|1|||
145639122|NCT00722046|525194287|FG004|Overall Study|Adverse Event|2|||
145639123|NCT00722046|525194288|FG005|Overall Study|Adverse Event|1|||
145639124|NCT00722046|525194289|FG006|Overall Study|Adverse Event|0|||
145639125|NCT00722046|525194283|FG000|Overall Study|Death|0|||
145639126|NCT00722046|525194284|FG001|Overall Study|Death|1|||
145639127|NCT00722046|525194285|FG002|Overall Study|Death|0|||
145639128|NCT00722046|525194286|FG003|Overall Study|Death|0|||
145639129|NCT00722046|525194287|FG004|Overall Study|Death|0|||
145639130|NCT00722046|525194288|FG005|Overall Study|Death|0|||
145639131|NCT00722046|525194289|FG006|Overall Study|Death|2|||
145639132|NCT00722046|525194283|FG000|Overall Study|Protocol Violation|1|||
145639133|NCT00722046|525194284|FG001|Overall Study|Protocol Violation|0|||
145639134|NCT00722046|525194285|FG002|Overall Study|Protocol Violation|0|||
145639135|NCT00722046|525194286|FG003|Overall Study|Protocol Violation|0|||
145639136|NCT00722046|525194287|FG004|Overall Study|Protocol Violation|0|||
145639137|NCT00722046|525194288|FG005|Overall Study|Protocol Violation|1|||
145639138|NCT00722046|525194289|FG006|Overall Study|Protocol Violation|0|||
145639139|NCT00722046|525194283|FG000|Overall Study|Withdrawal by Subject|3|||
145639140|NCT00722046|525194284|FG001|Overall Study|Withdrawal by Subject|3|||
145639141|NCT00722046|525194285|FG002|Overall Study|Withdrawal by Subject|4|||
145639142|NCT00722046|525194286|FG003|Overall Study|Withdrawal by Subject|4|||
145639143|NCT00722046|525194287|FG004|Overall Study|Withdrawal by Subject|4|||
145639144|NCT00722046|525194288|FG005|Overall Study|Withdrawal by Subject|7|||
145639145|NCT00722046|525194289|FG006|Overall Study|Withdrawal by Subject|3|||
145639146|NCT00722046|525194283|FG000|Overall Study|Randomized, but not treated|1|||
145639147|NCT00722046|525194284|FG001|Overall Study|Randomized, but not treated|1|||
145639148|NCT00722046|525194285|FG002|Overall Study|Randomized, but not treated|0|||
145639149|NCT00722046|525194286|FG003|Overall Study|Randomized, but not treated|2|||
145639150|NCT00722046|525194287|FG004|Overall Study|Randomized, but not treated|0|||
145639151|NCT00722046|525194288|FG005|Overall Study|Randomized, but not treated|0|||
145639152|NCT00722046|525194289|FG006|Overall Study|Randomized, but not treated|0|||
145639153|NCT00722046|525194283|FG000|Overall Study|Other|0|||
145639154|NCT00722046|525194284|FG001|Overall Study|Other|0|||
145639155|NCT00722046|525194285|FG002|Overall Study|Other|1|||
145639156|NCT00722046|525194286|FG003|Overall Study|Other|1|||
145639157|NCT00722046|525194287|FG004|Overall Study|Other|3|||
145639158|NCT00722046|525194288|FG005|Overall Study|Other|2|||
145639159|NCT00722046|525194289|FG006|Overall Study|Other|1|||
145639160|NCT00714714|525194293|FG000|Overall Study|Adverse Event|1|||
145639161|NCT01149369|525194294|FG000|Overall Study|Adverse Event|6|||
145639162|NCT01149369|525194295|FG001|Overall Study|Adverse Event|3|||
145639163|NCT03644849|525194298|FG000|Overall Study|Lost to Follow-up|1|||
145639164|NCT03644849|525194299|FG001|Overall Study|Lost to Follow-up|3|||
145639165|NCT00508924|525194300|FG000|Overall Study|Protocol Violation|0|||
145639166|NCT00508924|525194301|FG001|Overall Study|Protocol Violation|0|||
145639167|NCT00508924|525194302|FG002|Overall Study|Protocol Violation|1|||
145484186|NCT04640311|524625908|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484187|NCT04640311|524625909|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
145484188|NCT04640311|524625910|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484189|NCT04640311|524625911|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484190|NCT04640311|524625912|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484191|NCT04640311|524625913|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
145484192|NCT04640311|524625901|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484193|NCT04640311|524625902|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484194|NCT04640311|524625903|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484195|NCT04640311|524625904|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484196|NCT04640311|524625905|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484197|NCT04640311|524625906|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484198|NCT04640311|524625907|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
145484199|NCT04640311|524625908|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484200|NCT04640311|524625909|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484201|NCT04640311|524625910|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484202|NCT04640311|524625911|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
145484203|NCT04640311|524625912|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484204|NCT04640311|524625913|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
145484205|NCT04640311|524625901|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484206|NCT04640311|524625902|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484207|NCT04640311|524625903|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145639168|NCT00508924|525194303|FG003|Overall Study|Protocol Violation|1|||
145639169|NCT04532528|525194304|FG000|Overall Study|Adverse Event|12|||
145639170|NCT04532528|525194305|FG001|Overall Study|Adverse Event|17|||
145639171|NCT04532528|525194304|FG000|Overall Study|Withdrawal of consent|16|||
145639172|NCT04532528|525194305|FG001|Overall Study|Withdrawal of consent|17|||
145639173|NCT04532528|525194304|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
145639174|NCT04532528|525194305|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
145639175|NCT04532528|525194304|FG000|Overall Study|Lost to Follow-up|69|||
145639176|NCT04532528|525194305|FG001|Overall Study|Lost to Follow-up|68|||
145639177|NCT04532528|525194304|FG000|Overall Study|Administrative problems|12|||
145639178|NCT04532528|525194305|FG001|Overall Study|Administrative problems|14|||
145639179|NCT04532528|525194304|FG000|Overall Study|Death|3|||
145639180|NCT04532528|525194305|FG001|Overall Study|Death|3|||
145639181|NCT04532528|525194304|FG000|Overall Study|Other|38|||
145639182|NCT04532528|525194305|FG001|Overall Study|Other|46|||
145639183|NCT01140048|525194311|FG000|Overall Study|Physician Decision|1|||
145639184|NCT01140048|525194311|FG000|Overall Study|Withdrawal by Subject|13|||
145639185|NCT01140048|525194311|FG000|Overall Study|Lost to Follow-up|31|||
145484208|NCT04640311|524625904|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145639186|NCT02888080|525194312|FG000|Overall Study|Subject / Guardian decision|1|||
145639187|NCT02888080|525194313|FG001|Overall Study|Subject / Guardian decision|3|||
145639188|NCT02888080|525194312|FG000|Overall Study|New Therapy for study indication|1|||
145639189|NCT02888080|525194313|FG001|Overall Study|New Therapy for study indication|0|||
145639190|NCT02888080|525194312|FG000|Overall Study|Lack of Efficacy|0|||
145639191|NCT02888080|525194313|FG001|Overall Study|Lack of Efficacy|1|||
145639192|NCT02888080|525194312|FG000|Overall Study|Adverse Event|0|||
145639193|NCT02888080|525194313|FG001|Overall Study|Adverse Event|1|||
145639194|NCT00980330|525194314|FG000|Overall Study|Adverse Event|0|||
145639195|NCT00980330|525194315|FG001|Overall Study|Adverse Event|0|||
145639196|NCT00980330|525194316|FG002|Overall Study|Adverse Event|0|||
145639197|NCT00980330|525194317|FG003|Overall Study|Adverse Event|1|||
145639198|NCT00980330|525194318|FG004|Overall Study|Adverse Event|0|||
145484209|NCT04640311|524625905|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484210|NCT04640311|524625906|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145639199|NCT00980330|525194319|FG005|Overall Study|Adverse Event|0|||
145639200|NCT00980330|525194320|FG006|Overall Study|Adverse Event|0|||
145639201|NCT00980330|525194314|FG000|Overall Study|Lost to Follow-up|1|||
145639202|NCT00980330|525194315|FG001|Overall Study|Lost to Follow-up|1|||
145639203|NCT00980330|525194316|FG002|Overall Study|Lost to Follow-up|4|||
145639204|NCT00980330|525194317|FG003|Overall Study|Lost to Follow-up|2|||
145639205|NCT00980330|525194318|FG004|Overall Study|Lost to Follow-up|1|||
145639206|NCT00980330|525194319|FG005|Overall Study|Lost to Follow-up|1|||
145639207|NCT00980330|525194320|FG006|Overall Study|Lost to Follow-up|2|||
145639208|NCT00980330|525194314|FG000|Overall Study|Withdrawal by Subject|2|||
145639209|NCT00980330|525194315|FG001|Overall Study|Withdrawal by Subject|4|||
145639210|NCT00980330|525194316|FG002|Overall Study|Withdrawal by Subject|4|||
145639211|NCT00980330|525194317|FG003|Overall Study|Withdrawal by Subject|1|||
145639212|NCT00980330|525194318|FG004|Overall Study|Withdrawal by Subject|3|||
145639213|NCT00980330|525194319|FG005|Overall Study|Withdrawal by Subject|2|||
145639214|NCT00980330|525194320|FG006|Overall Study|Withdrawal by Subject|5|||
145639215|NCT00980330|525194314|FG000|Overall Study|(not specified)|2|||
145639216|NCT00980330|525194315|FG001|Overall Study|(not specified)|0|||
145639217|NCT00980330|525194316|FG002|Overall Study|(not specified)|0|||
145639218|NCT00980330|525194317|FG003|Overall Study|(not specified)|1|||
145639219|NCT00980330|525194318|FG004|Overall Study|(not specified)|1|||
145639220|NCT00980330|525194319|FG005|Overall Study|(not specified)|1|||
145639221|NCT00980330|525194320|FG006|Overall Study|(not specified)|0|||
145639222|NCT00666276|525194323|FG000|Overall Study|Protocol Violation|34|||
145639223|NCT01039688|525194324|FG000|Overall Study|Adverse Event|38|||
145639224|NCT01039688|525194325|FG001|Overall Study|Adverse Event|39|||
145639225|NCT01039688|525194326|FG002|Overall Study|Adverse Event|24|||
145639226|NCT01039688|525194324|FG000|Overall Study|Lack of Efficacy|20|||
145639227|NCT01039688|525194325|FG001|Overall Study|Lack of Efficacy|11|||
145639228|NCT01039688|525194326|FG002|Overall Study|Lack of Efficacy|26|||
145639229|NCT01039688|525194324|FG000|Overall Study|Lost to Follow-up|11|||
145639230|NCT01039688|525194325|FG001|Overall Study|Lost to Follow-up|9|||
145639231|NCT01039688|525194326|FG002|Overall Study|Lost to Follow-up|5|||
145639232|NCT01039688|525194324|FG000|Overall Study|Other|13|||
145639233|NCT01039688|525194325|FG001|Overall Study|Other|25|||
145639234|NCT01039688|525194326|FG002|Overall Study|Other|12|||
145639235|NCT01039688|525194324|FG000|Overall Study|Withdrawal by Subject|23|||
145639236|NCT01039688|525194325|FG001|Overall Study|Withdrawal by Subject|27|||
145639237|NCT01039688|525194326|FG002|Overall Study|Withdrawal by Subject|13|||
145639238|NCT01039688|525194324|FG000|Overall Study|Death|2|||
145639239|NCT01039688|525194325|FG001|Overall Study|Death|0|||
145639240|NCT01039688|525194326|FG002|Overall Study|Death|0|||
145639241|NCT02594735|525194327|FG000|Overall Study|Adverse Event|1|||
145639242|NCT03844269|525194331|FG000|Overall Study|Withdrawal pre-intervention|1|||
145639243|NCT03844269|525194331|FG000|Overall Study|Did not complete the intervention|2|||
145639244|NCT00665444|525194332|FG000|Overall Study|Physician Decision|1|||
145639245|NCT00665444|525194332|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
145639246|NCT00101010|525194336|FG000|Overall Study|Physician Decision|1|||
145639247|NCT03520413|525194337|FG000|Overall Study|Lost to Follow-up|1|||
145639248|NCT03520413|525194338|FG001|Overall Study|Lost to Follow-up|1|||
145639249|NCT03520413|525194337|FG000|Overall Study|Withdrawal by Subject|1|||
145639250|NCT03520413|525194338|FG001|Overall Study|Withdrawal by Subject|2|||
145639251|NCT03520413|525194337|FG000|Overall Study|Death|0|||
145639252|NCT03520413|525194338|FG001|Overall Study|Death|1|||
145639253|NCT03520413|525194337|FG000|Overall Study|Physician Decision|3|||
145639254|NCT03520413|525194338|FG001|Overall Study|Physician Decision|3|||
145639255|NCT03520413|525194337|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
145639256|NCT03520413|525194338|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
145639257|NCT00346151|525194339|FG000|Overall Study|Withdrawal by Subject|3|||
145639258|NCT04054635|525194340|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
145639259|NCT04054635|525194341|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
145639260|NCT04054635|525194342|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
145639261|NCT04054635|525194340|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
145639262|NCT04054635|525194341|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
145639263|NCT04054635|525194342|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
145639264|NCT00891930|525194343|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
145639265|NCT00891930|525194343|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
145639266|NCT00891930|525194343|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
145639267|NCT00891930|525194343|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
145639268|NCT00891930|525194343|FG000|Part 2 Panitumumab + AMG479|Death|30|||
145639269|NCT02507752|525194348|FG000|Overall Study|Adverse Event|1|||
145639270|NCT02507752|525194348|FG000|Overall Study|Protocol Violation|6|||
145639271|NCT02507752|525194348|FG000|Overall Study|Lost to Follow-up|7|||
145639272|NCT02507752|525194348|FG000|Overall Study|Infusion reaction at first infusion|1|||
145639273|NCT02507752|525194348|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
145639274|NCT02507752|525194348|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
145639275|NCT00535145|525194353|FG000|Phase I|Adverse Event|3|||
145639276|NCT00535145|525194353|FG000|Phase I|Lost to Follow-up|7|||
145639277|NCT00535145|525194353|FG000|Phase I|Withdrawal by Subject|6|||
145639278|NCT00535145|525194353|FG000|Phase I|(eligibility)|8|||
145639279|NCT00535145|525194353|FG000|Phase I|(protocol violation)|1|||
145639280|NCT00535145|525194353|FG000|Phase I|(PI decision)|1|||
145639281|NCT00535145|525194353|FG000|Phase I|(diagnosis)|3|||
145639282|NCT00535145|525194353|FG000|Phase II|Adverse Event|2|||
145639283|NCT00535145|525194353|FG000|Phase II|Lack of Efficacy|1|||
145639284|NCT00535145|525194353|FG000|Phase II|Lost to Follow-up|5|||
145639285|NCT00535145|525194353|FG000|Phase II|Withdrawal by Subject|5|||
145604837|NCT03430063|525068862|FG000|Overall Study|Withdrawal by Subject|0|||
145604838|NCT03430063|525068863|FG001|Overall Study|Withdrawal by Subject|0|||
145604839|NCT03430063|525068864|FG002|Overall Study|Withdrawal by Subject|1|||
145604840|NCT03430063|525068862|FG000|Overall Study|Withdrawal of consent|3|||
145604841|NCT03430063|525068863|FG001|Overall Study|Withdrawal of consent|1|||
145604842|NCT03430063|525068864|FG002|Overall Study|Withdrawal of consent|2|||
145604843|NCT03430063|525068862|FG000|Overall Study|Progressive disease|1|||
145604844|NCT03430063|525068863|FG001|Overall Study|Progressive disease|2|||
145604845|NCT03430063|525068864|FG002|Overall Study|Progressive disease|1|||
145604846|NCT03430063|525068862|FG000|Overall Study|Other un-specified|1|||
145604847|NCT03430063|525068863|FG001|Overall Study|Other un-specified|1|||
145604848|NCT03430063|525068864|FG002|Overall Study|Other un-specified|0|||
145604849|NCT03430063|525068862|FG000|Overall Study|Randomized, but never treated|0|||
145604850|NCT03430063|525068863|FG001|Overall Study|Randomized, but never treated|0|||
145604851|NCT03430063|525068864|FG002|Overall Study|Randomized, but never treated|1|||
145604852|NCT01959347|525068870|FG000|Overall Study|Protocol Violation|9|||
145604853|NCT01959347|525068871|FG001|Overall Study|Protocol Violation|7|||
145604854|NCT04581200|525068874|FG000|Overall Study|Lost to Follow-up|6|||
145604855|NCT04581200|525068875|FG001|Overall Study|Lost to Follow-up|5|||
145604856|NCT03131960|525068876|FG000|Overall Study|Adverse Event|0|||
145604857|NCT03131960|525068877|FG001|Overall Study|Adverse Event|1|||
145604858|NCT01781390|525068878|FG000|Overall Study|Withdrawal of Consent|0|||
145604859|NCT01781390|525068879|FG001|Overall Study|Withdrawal of Consent|3|||
145604860|NCT01781390|525068880|FG002|Overall Study|Withdrawal of Consent|1|||
145604861|NCT01781390|525068878|FG000|Overall Study|Lost to Follow-up|1|||
145604862|NCT01781390|525068879|FG001|Overall Study|Lost to Follow-up|1|||
145604863|NCT01781390|525068880|FG002|Overall Study|Lost to Follow-up|1|||
145604864|NCT01781390|525068878|FG000|Overall Study|Adverse Event|1|||
145604865|NCT01781390|525068879|FG001|Overall Study|Adverse Event|2|||
145604866|NCT01781390|525068880|FG002|Overall Study|Adverse Event|1|||
145604867|NCT01781390|525068878|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
145604868|NCT01781390|525068879|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
145604869|NCT01781390|525068880|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
145604870|NCT00622713|525068881|FG000|Overall Study|Adverse Event|35|||
145604871|NCT00622713|525068881|FG000|Overall Study|Administrative problems|4|||
145604872|NCT00622713|525068881|FG000|Overall Study|Withdrawal by Subject|11|||
145604873|NCT00622713|525068881|FG000|Overall Study|Lost to Follow-up|5|||
145604874|NCT00622713|525068881|FG000|Overall Study|Death|2|||
145604875|NCT00622713|525068881|FG000|Overall Study|Subject no longer required study drug|1|||
145604876|NCT00622713|525068881|FG000|Overall Study|Did not meet eligibility criteria|1|||
145604877|NCT03485911|525068885|FG000|Part 1|Perceived lack of efficacy|1|||
145604878|NCT03485911|525068886|FG001|Part 1|Perceived lack of efficacy|1|||
145604879|NCT03485911|525068887|FG002|Part 1|Perceived lack of efficacy|2|||
145604880|NCT03485911|525068888|FG003|Part 1|Perceived lack of efficacy|0|||
145604881|NCT03485911|525068885|FG000|Part 1|Subject withdrew consent|0|||
145604882|NCT03485911|525068886|FG001|Part 1|Subject withdrew consent|1|||
145604883|NCT03485911|525068887|FG002|Part 1|Subject withdrew consent|0|||
145604884|NCT03485911|525068888|FG003|Part 1|Subject withdrew consent|1|||
145604885|NCT03485911|525068885|FG000|Part 1|Lab abnormalities/AEs|3|||
145604886|NCT03485911|525068886|FG001|Part 1|Lab abnormalities/AEs|1|||
145604887|NCT03485911|525068887|FG002|Part 1|Lab abnormalities/AEs|1|||
145604888|NCT03485911|525068888|FG003|Part 1|Lab abnormalities/AEs|0|||
145604889|NCT03485911|525068885|FG000|Part 1|Withdrew Consent prior to dosing|0|||
145604890|NCT03485911|525068886|FG001|Part 1|Withdrew Consent prior to dosing|0|||
145604891|NCT03485911|525068887|FG002|Part 1|Withdrew Consent prior to dosing|0|||
145604892|NCT03485911|525068888|FG003|Part 1|Withdrew Consent prior to dosing|1|||
145604893|NCT03485911|525068885|FG000|Part 1|Other NOS|0|||
145604894|NCT03485911|525068886|FG001|Part 1|Other NOS|0|||
145604895|NCT03485911|525068887|FG002|Part 1|Other NOS|0|||
145604896|NCT03485911|525068888|FG003|Part 1|Other NOS|1|||
145604897|NCT03485911|525068885|FG000|Part 2|Perceived lack of efficacy|5|||
145604898|NCT03485911|525068886|FG001|Part 2|Perceived lack of efficacy|3|||
145604899|NCT03485911|525068887|FG002|Part 2|Perceived lack of efficacy|0|||
145604900|NCT03485911|525068888|FG003|Part 2|Perceived lack of efficacy|2|||
145604901|NCT03485911|525068885|FG000|Part 2|Subject withdrew consent|1|||
145604902|NCT03485911|525068886|FG001|Part 2|Subject withdrew consent|0|||
145604903|NCT03485911|525068887|FG002|Part 2|Subject withdrew consent|2|||
145604904|NCT03485911|525068888|FG003|Part 2|Subject withdrew consent|1|||
145604905|NCT03485911|525068885|FG000|Part 2|Lab abnormalities/AEs|1|||
145604906|NCT03485911|525068886|FG001|Part 2|Lab abnormalities/AEs|2|||
145604907|NCT03485911|525068887|FG002|Part 2|Lab abnormalities/AEs|0|||
145604908|NCT03485911|525068888|FG003|Part 2|Lab abnormalities/AEs|0|||
145604909|NCT03485911|525068885|FG000|Part 2|Other NOS|0|||
145604910|NCT03485911|525068886|FG001|Part 2|Other NOS|1|||
145604911|NCT03485911|525068887|FG002|Part 2|Other NOS|0|||
145604912|NCT03485911|525068888|FG003|Part 2|Other NOS|0|||
145604913|NCT03485911|525068885|FG000|Part 2|Intercurrent illness/new medical condition|1|||
145604914|NCT03485911|525068886|FG001|Part 2|Intercurrent illness/new medical condition|0|||
145604915|NCT03485911|525068887|FG002|Part 2|Intercurrent illness/new medical condition|0|||
145639286|NCT00535145|525194353|FG000|Phase II|Subject non-compliance|2|||
145639287|NCT02423798|525194354|FG000|Overall Study|Withdrawal by Subject|3|||
145639288|NCT02204982|525194356|FG000|Overall Study|Patient ineligible-medical monitor|1|||
145639289|NCT02204982|525194357|FG001|Overall Study|Patient ineligible-medical monitor|0|||
145639290|NCT02204982|525194356|FG000|Overall Study|Withdrawal by Subject|1|||
145639291|NCT02204982|525194357|FG001|Overall Study|Withdrawal by Subject|0|||
145639292|NCT02204982|525194356|FG000|Overall Study|Adverse Event|1|||
145639293|NCT02204982|525194357|FG001|Overall Study|Adverse Event|0|||
145639294|NCT02204982|525194356|FG000|Overall Study|Adverse Event and Investigator decision|1|||
145639295|NCT02204982|525194357|FG001|Overall Study|Adverse Event and Investigator decision|0|||
145639296|NCT02204982|525194356|FG000|Overall Study|Physician Decision|0|||
145639297|NCT02204982|525194357|FG001|Overall Study|Physician Decision|2|||
145639298|NCT02204982|525194356|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
145639299|NCT02204982|525194357|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
145639300|NCT02204982|525194356|FG000|Overall Study|Termination of Study bySponsor|0|||
145639301|NCT02204982|525194357|FG001|Overall Study|Termination of Study bySponsor|1|||
145639302|NCT01968226|525194358|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
145639303|NCT00566527|525194359|FG000|Overall Study|Reason not provided|3|||
145639304|NCT00566527|525194360|FG001|Overall Study|Reason not provided|11|||
145639305|NCT00566527|525194361|FG002|Overall Study|Reason not provided|10|||
145639306|NCT00566527|525194359|FG000|Overall Study|Adverse Event|2|||
145639307|NCT00566527|525194360|FG001|Overall Study|Adverse Event|0|||
145639308|NCT00566527|525194361|FG002|Overall Study|Adverse Event|1|||
145639309|NCT00566527|525194359|FG000|Overall Study|Physician Decision|3|||
145639310|NCT00566527|525194360|FG001|Overall Study|Physician Decision|8|||
145639311|NCT00566527|525194361|FG002|Overall Study|Physician Decision|20|||
145639312|NCT00566527|525194359|FG000|Overall Study|Lost to Follow-up|3|||
145639313|NCT00566527|525194360|FG001|Overall Study|Lost to Follow-up|4|||
145639314|NCT00566527|525194361|FG002|Overall Study|Lost to Follow-up|4|||
145639315|NCT00566527|525194359|FG000|Overall Study|Withdrawal by Subject|6|||
145639316|NCT00566527|525194360|FG001|Overall Study|Withdrawal by Subject|43|||
145639317|NCT00566527|525194361|FG002|Overall Study|Withdrawal by Subject|43|||
145639318|NCT00457743|525194362|FG000|Overall Study|Adverse Event|0|||
145639319|NCT00457743|525194363|FG001|Overall Study|Adverse Event|4|||
145639320|NCT00457743|525194364|FG002|Overall Study|Adverse Event|0|||
145639321|NCT00457743|525194362|FG000|Overall Study|Lack of Efficacy|3|||
145639322|NCT00457743|525194363|FG001|Overall Study|Lack of Efficacy|23|||
145639323|NCT00457743|525194364|FG002|Overall Study|Lack of Efficacy|3|||
145639324|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
145639325|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
145639326|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
145639327|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
145639328|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
145639329|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
145639330|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
145639331|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
145639332|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
145639333|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
145639334|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
145639335|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
145639336|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
145639337|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
145639338|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
145639339|NCT00958633|525194367|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
145639340|NCT00958633|525194368|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
145639341|NCT00958633|525194369|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
145639342|NCT00958633|525194367|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
145639343|NCT00958633|525194368|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
145639344|NCT00958633|525194369|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
145639345|NCT00357097|525194371|FG000|Overall Study|Did not meet inclusion criteria|5|||
145639346|NCT00357097|525194372|FG001|Overall Study|Did not meet inclusion criteria|3|||
145639347|NCT00357097|525194371|FG000|Overall Study|Adverse Event|34|||
145639348|NCT00357097|525194372|FG001|Overall Study|Adverse Event|6|||
145639349|NCT00357097|525194371|FG000|Overall Study|Withdrawal by Subject|8|||
145639350|NCT00357097|525194372|FG001|Overall Study|Withdrawal by Subject|7|||
145639351|NCT00357097|525194371|FG000|Overall Study|Non-compliance|1|||
145639352|NCT00357097|525194372|FG001|Overall Study|Non-compliance|2|||
145639353|NCT00357097|525194371|FG000|Overall Study|Lack of Efficacy|2|||
145639354|NCT00357097|525194372|FG001|Overall Study|Lack of Efficacy|8|||
145639355|NCT00357097|525194371|FG000|Overall Study|Met Exclusion Criteria|3|||
145639356|NCT00357097|525194372|FG001|Overall Study|Met Exclusion Criteria|1|||
145484211|NCT04640311|524625907|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484212|NCT04640311|524625908|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145604916|NCT03485911|525068888|FG003|Part 2|Intercurrent illness/new medical condition|0|||
145604917|NCT03485911|525068885|FG000|Part 2|Investigator judgement|1|||
145604918|NCT03485911|525068886|FG001|Part 2|Investigator judgement|0|||
145604919|NCT03485911|525068887|FG002|Part 2|Investigator judgement|0|||
145604920|NCT03485911|525068888|FG003|Part 2|Investigator judgement|0|||
145604921|NCT03485911|525068885|FG000|Part 3|Perceived lack of efficacy|2|||
145604922|NCT03485911|525068886|FG001|Part 3|Perceived lack of efficacy|2|||
145604923|NCT03485911|525068887|FG002|Part 3|Perceived lack of efficacy|2|||
145604924|NCT03485911|525068888|FG003|Part 3|Perceived lack of efficacy|0|||
145604925|NCT03485911|525068885|FG000|Part 3|Subject withdrew consent|1|||
145604926|NCT03485911|525068886|FG001|Part 3|Subject withdrew consent|4|||
145604927|NCT03485911|525068887|FG002|Part 3|Subject withdrew consent|0|||
145604928|NCT03485911|525068888|FG003|Part 3|Subject withdrew consent|1|||
145604929|NCT03485911|525068885|FG000|Part 3|Lab abnormalities/AEs|1|||
145604930|NCT03485911|525068886|FG001|Part 3|Lab abnormalities/AEs|1|||
145604931|NCT03485911|525068887|FG002|Part 3|Lab abnormalities/AEs|0|||
145604932|NCT03485911|525068888|FG003|Part 3|Lab abnormalities/AEs|2|||
145604933|NCT03485911|525068885|FG000|Part 3|Other NOS|1|||
145604934|NCT03485911|525068886|FG001|Part 3|Other NOS|1|||
145604935|NCT03485911|525068887|FG002|Part 3|Other NOS|0|||
145604936|NCT03485911|525068888|FG003|Part 3|Other NOS|0|||
145604937|NCT03485911|525068885|FG000|Part 3|Intercurrent illness/new medical condition|0|||
145604938|NCT03485911|525068886|FG001|Part 3|Intercurrent illness/new medical condition|1|||
145604939|NCT03485911|525068887|FG002|Part 3|Intercurrent illness/new medical condition|1|||
145604940|NCT03485911|525068888|FG003|Part 3|Intercurrent illness/new medical condition|0|||
145604941|NCT03485911|525068885|FG000|Part 3|Sponsor discontinuation|1|||
145604942|NCT03485911|525068886|FG001|Part 3|Sponsor discontinuation|0|||
145604943|NCT03485911|525068887|FG002|Part 3|Sponsor discontinuation|0|||
145604944|NCT03485911|525068888|FG003|Part 3|Sponsor discontinuation|0|||
145604945|NCT03485911|525068885|FG000|Part 3|Berotralstat provided by alternative means|13|||
145604946|NCT03485911|525068886|FG001|Part 3|Berotralstat provided by alternative means|13|||
145604947|NCT03485911|525068887|FG002|Part 3|Berotralstat provided by alternative means|7|||
145604948|NCT03485911|525068888|FG003|Part 3|Berotralstat provided by alternative means|7|||
145604949|NCT01215357|525068889|FG000|Overall Study|Withdrawal by Subject|3|||
145604950|NCT01215357|525068889|FG000|Overall Study|Protocol Violation|9|||
145604951|NCT01719237|525068890|FG000|Overall Study|Physician Decision|0|||
145604952|NCT01719237|525068891|FG001|Overall Study|Physician Decision|1|||
145604953|NCT02914314|525068895|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
145604954|NCT02914314|525068896|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
145604955|NCT02914314|525068897|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
145604956|NCT02914314|525068898|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
145604957|NCT02914314|525068895|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
145604958|NCT02914314|525068896|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
145604959|NCT02914314|525068897|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
145604960|NCT02914314|525068898|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
145604961|NCT02914314|525068895|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
145604962|NCT02914314|525068896|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
145604963|NCT02914314|525068897|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
145604964|NCT02914314|525068898|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
145604965|NCT02914314|525068895|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
145604966|NCT02914314|525068896|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
145604967|NCT02914314|525068897|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
145604968|NCT02914314|525068898|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
145604969|NCT02914314|525068895|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
145604970|NCT02914314|525068896|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
145604971|NCT02914314|525068897|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
145604972|NCT02914314|525068898|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
145604973|NCT01859793|525068901|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
145604974|NCT01859793|525068902|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
145604975|NCT01859793|525068901|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
145604976|NCT01859793|525068902|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
145604977|NCT01859793|525068901|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
145604978|NCT01859793|525068902|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145604979|NCT01859793|525068901|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
145604980|NCT01859793|525068902|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
145604981|NCT01597505|525068912|FG000|Overall Study|Physician Decision|5|||
145604982|NCT01597505|525068913|FG001|Overall Study|Physician Decision|0|||
145604983|NCT01597505|525068912|FG000|Overall Study|Adverse Event|19|||
145604984|NCT01597505|525068913|FG001|Overall Study|Adverse Event|7|||
145604985|NCT01597505|525068912|FG000|Overall Study|Lost to Follow-up|4|||
145604986|NCT01597505|525068913|FG001|Overall Study|Lost to Follow-up|2|||
145604987|NCT01597505|525068912|FG000|Overall Study|Withdrawal by Subject|10|||
145604988|NCT01597505|525068913|FG001|Overall Study|Withdrawal by Subject|18|||
145604989|NCT01597505|525068912|FG000|Overall Study|Other|5|||
145604990|NCT01597505|525068913|FG001|Overall Study|Other|6|||
145639357|NCT00357097|525194371|FG000|Overall Study|Other|1|||
145639358|NCT00357097|525194372|FG001|Overall Study|Other|1|||
145639359|NCT00357097|525194371|FG000|Overall Study|Increase of RLS Symptoms|0|||
145639360|NCT00357097|525194372|FG001|Overall Study|Increase of RLS Symptoms|1|||
145639361|NCT00837616|525194375|FG000|Overall Study|Withdrawal by Subject|0|||
145639362|NCT00837616|525194376|FG001|Overall Study|Withdrawal by Subject|1|||
145639363|NCT02674750|525194378|FG000|Overall Study|Death|4|||
145639364|NCT02674750|525194379|FG001|Overall Study|Death|5|||
145639365|NCT02674750|525194380|FG002|Overall Study|Death|8|||
145639366|NCT02674750|525194378|FG000|Overall Study|Lost to Follow-up|0|||
145639367|NCT02674750|525194379|FG001|Overall Study|Lost to Follow-up|8|||
145639368|NCT02674750|525194380|FG002|Overall Study|Lost to Follow-up|0|||
145639369|NCT02674750|525194378|FG000|Overall Study|Lack of Efficacy|1|||
145639370|NCT02674750|525194379|FG001|Overall Study|Lack of Efficacy|17|||
145639371|NCT02674750|525194380|FG002|Overall Study|Lack of Efficacy|3|||
145639372|NCT02674750|525194378|FG000|Overall Study|Withdrawal by Subject|0|||
145639373|NCT02674750|525194379|FG001|Overall Study|Withdrawal by Subject|7|||
145639374|NCT02674750|525194380|FG002|Overall Study|Withdrawal by Subject|1|||
145639375|NCT02674750|525194378|FG000|Overall Study|Other|0|||
145639376|NCT02674750|525194379|FG001|Overall Study|Other|8|||
145639377|NCT02674750|525194380|FG002|Overall Study|Other|0|||
145639378|NCT01685606|525194383|FG000|Overall Study|Withdrawal by Subject|1|||
145639379|NCT01787760|525194384|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
145639380|NCT01787760|525194385|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
145639381|NCT01787760|525194386|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
145639382|NCT01787760|525194384|FG000|Overall Study|Decompensated on left exotropia|0|||
145639383|NCT01787760|525194385|FG001|Overall Study|Decompensated on left exotropia|0|||
145639384|NCT01787760|525194386|FG002|Overall Study|Decompensated on left exotropia|1|||
145639385|NCT01787760|525194384|FG000|Overall Study|Dryness|0|||
145639386|NCT01787760|525194385|FG001|Overall Study|Dryness|1|||
145639387|NCT01787760|525194386|FG002|Overall Study|Dryness|0|||
145639388|NCT01787760|525194384|FG000|Overall Study|Relocation|1|||
145639389|NCT01787760|525194385|FG001|Overall Study|Relocation|1|||
145639390|NCT01787760|525194386|FG002|Overall Study|Relocation|0|||
145639391|NCT01787760|525194384|FG000|Overall Study|Lens discomfort|3|||
145639392|NCT01787760|525194385|FG001|Overall Study|Lens discomfort|0|||
145639393|NCT01787760|525194386|FG002|Overall Study|Lens discomfort|0|||
145639394|NCT01787760|525194384|FG000|Overall Study|Lens handling difficulty|1|||
145639395|NCT01787760|525194385|FG001|Overall Study|Lens handling difficulty|2|||
145639396|NCT01787760|525194386|FG002|Overall Study|Lens handling difficulty|0|||
145639397|NCT01787760|525194384|FG000|Overall Study|Protocol Violation|6|||
145639398|NCT01787760|525194385|FG001|Overall Study|Protocol Violation|0|||
145639399|NCT01787760|525194386|FG002|Overall Study|Protocol Violation|1|||
145639400|NCT01787760|525194384|FG000|Overall Study|Withdrawal by Subject|5|||
145639401|NCT01787760|525194385|FG001|Overall Study|Withdrawal by Subject|1|||
145639402|NCT01787760|525194386|FG002|Overall Study|Withdrawal by Subject|2|||
145639403|NCT01787760|525194384|FG000|Overall Study|Lost to Follow-up|1|||
145639404|NCT01787760|525194385|FG001|Overall Study|Lost to Follow-up|0|||
145639405|NCT01787760|525194386|FG002|Overall Study|Lost to Follow-up|1|||
145639406|NCT01787760|525194384|FG000|Overall Study|Stroke|1|||
145639407|NCT01787760|525194385|FG001|Overall Study|Stroke|0|||
145639408|NCT01787760|525194386|FG002|Overall Study|Stroke|0|||
145639409|NCT01787760|525194384|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
145639410|NCT01787760|525194385|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
145639411|NCT01787760|525194386|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
145639412|NCT01787760|525194384|FG000|Overall Study|Unsatisfactory physiological response|2|||
145639413|NCT01787760|525194385|FG001|Overall Study|Unsatisfactory physiological response|4|||
145639414|NCT01787760|525194386|FG002|Overall Study|Unsatisfactory physiological response|0|||
145639415|NCT01787760|525194384|FG000|Overall Study|Unsatisfactory visual response|1|||
145639416|NCT01787760|525194385|FG001|Overall Study|Unsatisfactory visual response|1|||
145639417|NCT01787760|525194386|FG002|Overall Study|Unsatisfactory visual response|0|||
145639418|NCT01787760|525194384|FG000|Overall Study|Near vision blur|1|||
145639419|NCT01787760|525194385|FG001|Overall Study|Near vision blur|0|||
145639420|NCT01787760|525194386|FG002|Overall Study|Near vision blur|0|||
145639421|NCT03512756|525194387|FG000|Part 1|Death|23|||
145639422|NCT03512756|525194388|FG001|Part 1|Death|18|||
145639423|NCT03512756|525194389|FG002|Part 1|Death|0|||
145639424|NCT03512756|525194390|FG003|Part 1|Death|0|||
145639425|NCT03512756|525194387|FG000|Part 1|Lost to Follow-up|0|||
145639426|NCT03512756|525194388|FG001|Part 1|Lost to Follow-up|3|||
145639427|NCT03512756|525194389|FG002|Part 1|Lost to Follow-up|0|||
145639428|NCT03512756|525194390|FG003|Part 1|Lost to Follow-up|0|||
145639429|NCT03512756|525194387|FG000|Part 1|Physician Decision|0|||
145639430|NCT03512756|525194388|FG001|Part 1|Physician Decision|1|||
145639431|NCT03512756|525194389|FG002|Part 1|Physician Decision|0|||
145639432|NCT03512756|525194390|FG003|Part 1|Physician Decision|0|||
145639433|NCT03512756|525194387|FG000|Part 1|Withdrawal by Subject|2|||
145639434|NCT03512756|525194388|FG001|Part 1|Withdrawal by Subject|2|||
145639435|NCT03512756|525194389|FG002|Part 1|Withdrawal by Subject|0|||
145639436|NCT03512756|525194390|FG003|Part 1|Withdrawal by Subject|0|||
145639437|NCT03512756|525194387|FG000|Part 2|Death|0|||
145639438|NCT03512756|525194388|FG001|Part 2|Death|0|||
145639439|NCT03512756|525194389|FG002|Part 2|Death|32|||
145639440|NCT03512756|525194390|FG003|Part 2|Death|21|||
145639441|NCT03512756|525194387|FG000|Part 2|Lost to Follow-up|0|||
145639442|NCT03512756|525194388|FG001|Part 2|Lost to Follow-up|0|||
145484213|NCT04640311|524625909|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484214|NCT04640311|524625910|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484215|NCT04640311|524625911|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484216|NCT04640311|524625912|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
145484217|NCT04640311|524625913|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
145484218|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
145484219|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
145484220|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
145484221|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
145604991|NCT01597505|525068912|FG000|Overall Study|Missing|1|||
145604992|NCT01597505|525068913|FG001|Overall Study|Missing|0|||
145604993|NCT03728972|525068914|FG000|Overall Study|Death|1|||
145604994|NCT03728972|525068915|FG001|Overall Study|Death|0|||
145604995|NCT03728972|525068914|FG000|Overall Study|Lack of Efficacy|1|||
145604996|NCT03728972|525068915|FG001|Overall Study|Lack of Efficacy|0|||
145604997|NCT03728972|525068914|FG000|Overall Study|Physician Decision|3|||
145604998|NCT03728972|525068915|FG001|Overall Study|Physician Decision|0|||
145604999|NCT03728972|525068914|FG000|Overall Study|Disease progression|4|||
145605000|NCT03728972|525068915|FG001|Overall Study|Disease progression|3|||
145605001|NCT04543188|525068916|FG000|Phase 1a|Adverse Event|0|||
145605002|NCT04543188|525068917|FG001|Phase 1a|Adverse Event|0|||
145605003|NCT04543188|525068918|FG002|Phase 1a|Adverse Event|0|||
145605004|NCT04543188|525068919|FG003|Phase 1a|Adverse Event|1|||
145605005|NCT04543188|525068920|FG004|Phase 1a|Adverse Event|0|||
145605006|NCT04543188|525068921|FG005|Phase 1a|Adverse Event|0|||
145605007|NCT04543188|525068922|FG006|Phase 1a|Adverse Event|1|||
145605008|NCT04543188|525068923|FG007|Phase 1a|Adverse Event|0|||
145605009|NCT04543188|525068924|FG008|Phase 1a|Adverse Event|0|||
145605010|NCT04543188|525068925|FG009|Phase 1a|Adverse Event|0|||
145605011|NCT04543188|525068926|FG010|Phase 1a|Adverse Event|0|||
145605012|NCT04543188|525068927|FG011|Phase 1a|Adverse Event|0|||
145605013|NCT04543188|525068928|FG012|Phase 1a|Adverse Event|0|||
145605014|NCT04543188|525068929|FG013|Phase 1a|Adverse Event|0|||
145605015|NCT04543188|525068930|FG014|Phase 1a|Adverse Event|0|||
145605016|NCT04543188|525068916|FG000|Phase 1a|Other (Death)|0|||
145605017|NCT04543188|525068917|FG001|Phase 1a|Other (Death)|1|||
145605018|NCT04543188|525068918|FG002|Phase 1a|Other (Death)|0|||
145605019|NCT04543188|525068919|FG003|Phase 1a|Other (Death)|0|||
145605020|NCT04543188|525068920|FG004|Phase 1a|Other (Death)|1|||
145605021|NCT04543188|525068921|FG005|Phase 1a|Other (Death)|0|||
145605022|NCT04543188|525068922|FG006|Phase 1a|Other (Death)|0|||
145605023|NCT04543188|525068923|FG007|Phase 1a|Other (Death)|0|||
145605024|NCT04543188|525068924|FG008|Phase 1a|Other (Death)|0|||
145605025|NCT04543188|525068925|FG009|Phase 1a|Other (Death)|1|||
145605026|NCT04543188|525068926|FG010|Phase 1a|Other (Death)|0|||
145605027|NCT04543188|525068927|FG011|Phase 1a|Other (Death)|0|||
145605028|NCT04543188|525068928|FG012|Phase 1a|Other (Death)|0|||
145605029|NCT04543188|525068929|FG013|Phase 1a|Other (Death)|0|||
145605030|NCT04543188|525068930|FG014|Phase 1a|Other (Death)|0|||
145605031|NCT04543188|525068916|FG000|Phase 1a|Lost to Follow-up|0|||
145605032|NCT04543188|525068917|FG001|Phase 1a|Lost to Follow-up|0|||
145605033|NCT04543188|525068918|FG002|Phase 1a|Lost to Follow-up|0|||
145605034|NCT04543188|525068919|FG003|Phase 1a|Lost to Follow-up|0|||
145605035|NCT04543188|525068920|FG004|Phase 1a|Lost to Follow-up|0|||
145605036|NCT04543188|525068921|FG005|Phase 1a|Lost to Follow-up|0|||
145605037|NCT04543188|525068922|FG006|Phase 1a|Lost to Follow-up|0|||
145605038|NCT04543188|525068923|FG007|Phase 1a|Lost to Follow-up|0|||
145605039|NCT04543188|525068924|FG008|Phase 1a|Lost to Follow-up|0|||
145605040|NCT04543188|525068925|FG009|Phase 1a|Lost to Follow-up|0|||
145605041|NCT04543188|525068926|FG010|Phase 1a|Lost to Follow-up|1|||
145605042|NCT04543188|525068927|FG011|Phase 1a|Lost to Follow-up|0|||
145605043|NCT04543188|525068928|FG012|Phase 1a|Lost to Follow-up|0|||
145605044|NCT04543188|525068929|FG013|Phase 1a|Lost to Follow-up|0|||
145605045|NCT04543188|525068930|FG014|Phase 1a|Lost to Follow-up|0|||
145484222|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
145605046|NCT04543188|525068916|FG000|Phase 1a|Progressive Disease|2|||
145639443|NCT03512756|525194389|FG002|Part 2|Lost to Follow-up|1|||
145605047|NCT04543188|525068917|FG001|Phase 1a|Progressive Disease|2|||
145605048|NCT04543188|525068918|FG002|Phase 1a|Progressive Disease|3|||
145605049|NCT04543188|525068919|FG003|Phase 1a|Progressive Disease|1|||
145605050|NCT04543188|525068920|FG004|Phase 1a|Progressive Disease|4|||
145605051|NCT04543188|525068921|FG005|Phase 1a|Progressive Disease|2|||
145605052|NCT04543188|525068922|FG006|Phase 1a|Progressive Disease|3|||
145605053|NCT04543188|525068923|FG007|Phase 1a|Progressive Disease|4|||
145605054|NCT04543188|525068924|FG008|Phase 1a|Progressive Disease|1|||
145639444|NCT03512756|525194390|FG003|Part 2|Lost to Follow-up|0|||
145639445|NCT03512756|525194387|FG000|Part 2|Physician Decision|0|||
145639446|NCT03512756|525194388|FG001|Part 2|Physician Decision|0|||
145639447|NCT03512756|525194389|FG002|Part 2|Physician Decision|2|||
145639448|NCT03512756|525194390|FG003|Part 2|Physician Decision|4|||
145639449|NCT03512756|525194387|FG000|Part 2|Study Terminated by Sponsor|0|||
145639450|NCT03512756|525194388|FG001|Part 2|Study Terminated by Sponsor|0|||
145639451|NCT03512756|525194389|FG002|Part 2|Study Terminated by Sponsor|2|||
145639452|NCT03512756|525194390|FG003|Part 2|Study Terminated by Sponsor|6|||
145639453|NCT03512756|525194387|FG000|Part 2|Protocol Violation|0|||
145639454|NCT03512756|525194388|FG001|Part 2|Protocol Violation|0|||
145639455|NCT03512756|525194389|FG002|Part 2|Protocol Violation|1|||
145639456|NCT03512756|525194390|FG003|Part 2|Protocol Violation|0|||
145639457|NCT03512756|525194387|FG000|Part 2|Withdrawal by Subject|0|||
145639458|NCT03512756|525194388|FG001|Part 2|Withdrawal by Subject|0|||
145484223|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
145484224|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
145484225|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
145484226|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
145484227|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
145484228|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
145484229|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
145484230|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
145484231|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
145484232|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
145484233|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
145484234|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
145484235|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
145484236|NCT01910402|524625917|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
145484237|NCT01910402|524625918|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
145484238|NCT01910402|524625919|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
145484239|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
145484240|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
145484241|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
145484242|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
145484243|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
145484244|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
145484245|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
145484246|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
145484247|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
145484248|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
145484249|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
145484250|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
145484251|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
145484252|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
145484253|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
145484254|NCT01910402|524625917|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
145484255|NCT01910402|524625918|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
145484256|NCT01910402|524625919|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
145484257|NCT03594773|524625920|FG000|Overall Study|Withdrawal by Subject|3|||
145484258|NCT03594773|524625921|FG001|Overall Study|Withdrawal by Subject|2|||
145484259|NCT03594773|524625920|FG000|Overall Study|Lost to Follow-up|3|||
145484260|NCT03594773|524625921|FG001|Overall Study|Lost to Follow-up|4|||
145484261|NCT00193206|524625922|FG000|Preoperative Therapy|Lack of Efficacy|2|||
145484262|NCT00193206|524625922|FG000|Preoperative Therapy|Adverse Event|2|||
145484263|NCT00193206|524625922|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
145639459|NCT03512756|525194389|FG002|Part 2|Withdrawal by Subject|3|||
145639460|NCT03512756|525194390|FG003|Part 2|Withdrawal by Subject|9|||
145639461|NCT04250883|525196162|FG000|Overall Study|Lost to Follow-up|1|||
145639462|NCT04250883|525196163|FG001|Overall Study|Lost to Follow-up|0|||
145639463|NCT04588259|525196164|FG000|Run-in Period|Run-in failure|0|||
145639464|NCT04588259|525196165|FG001|Run-in Period|Run-in failure|23|||
145639465|NCT04588259|525196164|FG000|Run-in Period|Withdrawn before randomisation|0|||
145639466|NCT04588259|525196165|FG001|Run-in Period|Withdrawn before randomisation|8|||
145484264|NCT00193206|524625922|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
145639467|NCT04588259|525196164|FG000|Treatment Period|Withdrawal by Subject|6|||
145639468|NCT04588259|525196165|FG001|Treatment Period|Withdrawal by Subject|6|||
145639469|NCT01391832|525196169|FG000|Overall Study|Withdrawal by Subject|21|||
145639470|NCT01391832|525196170|FG001|Overall Study|Withdrawal by Subject|22|||
145639471|NCT01391832|525196169|FG000|Overall Study|Lost to Follow-up|0|||
145639472|NCT01391832|525196170|FG001|Overall Study|Lost to Follow-up|1|||
145484265|NCT00193206|524625922|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
145484266|NCT00193206|524625922|FG000|Postoperative Therapy|Physician Decision|3|||
145484267|NCT00193206|524625922|FG000|Postoperative Therapy|Intercurrent Illness|2|||
145484268|NCT00193206|524625922|FG000|Postoperative Therapy|Lack of Efficacy|1|||
145484269|NCT00193206|524625922|FG000|Postoperative Therapy|Protocol Violation|1|||
145484270|NCT00740584|524625929|FG000|Overall Study|Withdrawal by Subject|1|||
145484271|NCT03461146|524625932|FG000|Overall Study|Adverse Event|2|||
145484272|NCT03461146|524625932|FG000|Overall Study|Physician Decision|1|||
145484273|NCT02915263|524625937|FG000|Overall Study|Covid|3|||
145484274|NCT02915263|524625938|FG001|Overall Study|Covid|2|||
145484275|NCT01479868|524625944|FG000|Overall Study|Adverse Event|1|||
145484276|NCT01479868|524625944|FG000|Overall Study|Lost to Follow-up|4|||
145484277|NCT01479868|524625944|FG000|Overall Study|Protocol Violation|1|||
145484278|NCT01479868|524625944|FG000|Overall Study|Withdrawal by Subject|1|||
145484279|NCT01479868|524625944|FG000|Overall Study|Sponsor's Decision|1|||
145484280|NCT01479868|524625944|FG000|Overall Study|Initiation of new HCV Therapy|1|||
145484281|NCT01618669|524625945|FG000|Overall Study|Lost to Follow-up|1|||
145484282|NCT01618669|524625946|FG001|Overall Study|Lost to Follow-up|1|||
145484283|NCT01618669|524625945|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
145484284|NCT01618669|524625946|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
145484285|NCT01618669|524625945|FG000|Overall Study|Adverse Event|16|||
145484286|NCT01618669|524625946|FG001|Overall Study|Adverse Event|7|||
145484287|NCT01618669|524625945|FG000|Overall Study|Protocol Violation|5|||
145484288|NCT01618669|524625946|FG001|Overall Study|Protocol Violation|3|||
145484289|NCT01618669|524625945|FG000|Overall Study|Withdrawal by Subject|9|||
145484290|NCT01618669|524625946|FG001|Overall Study|Withdrawal by Subject|9|||
145484291|NCT01618669|524625945|FG000|Overall Study|Miscellaneous Reason|0|||
145484292|NCT01618669|524625946|FG001|Overall Study|Miscellaneous Reason|1|||
145484293|NCT01177007|524625949|FG000|Overall Study|Lost to Follow-up|2|||
145484294|NCT01177007|524625949|FG000|Overall Study|Death|4|||
145484295|NCT01177007|524625949|FG000|Overall Study|Entered hospice care|5|||
145484296|NCT01177007|524625949|FG000|Overall Study|Required additional Y90 treatment|6|||
145484297|NCT01177007|524625949|FG000|Overall Study|Change in treatment modality|21|||
145484298|NCT03600740|524625951|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
145605055|NCT04543188|525068925|FG009|Phase 1a|Progressive Disease|0|||
145605056|NCT04543188|525068926|FG010|Phase 1a|Progressive Disease|4|||
145605057|NCT04543188|525068927|FG011|Phase 1a|Progressive Disease|0|||
145605058|NCT04543188|525068928|FG012|Phase 1a|Progressive Disease|0|||
145605059|NCT04543188|525068929|FG013|Phase 1a|Progressive Disease|0|||
145605060|NCT04543188|525068930|FG014|Phase 1a|Progressive Disease|0|||
145605061|NCT04543188|525068916|FG000|Phase 1a|Study terminated by sponsor|0|||
145605062|NCT04543188|525068917|FG001|Phase 1a|Study terminated by sponsor|0|||
145605063|NCT04543188|525068918|FG002|Phase 1a|Study terminated by sponsor|0|||
145605064|NCT04543188|525068919|FG003|Phase 1a|Study terminated by sponsor|0|||
145605065|NCT04543188|525068920|FG004|Phase 1a|Study terminated by sponsor|1|||
145605066|NCT04543188|525068921|FG005|Phase 1a|Study terminated by sponsor|0|||
145605067|NCT04543188|525068922|FG006|Phase 1a|Study terminated by sponsor|0|||
145605068|NCT04543188|525068923|FG007|Phase 1a|Study terminated by sponsor|0|||
145605069|NCT04543188|525068924|FG008|Phase 1a|Study terminated by sponsor|0|||
145605070|NCT04543188|525068925|FG009|Phase 1a|Study terminated by sponsor|0|||
145605071|NCT04543188|525068926|FG010|Phase 1a|Study terminated by sponsor|1|||
145605072|NCT04543188|525068927|FG011|Phase 1a|Study terminated by sponsor|0|||
145605073|NCT04543188|525068928|FG012|Phase 1a|Study terminated by sponsor|0|||
145605074|NCT04543188|525068929|FG013|Phase 1a|Study terminated by sponsor|0|||
145605075|NCT04543188|525068930|FG014|Phase 1a|Study terminated by sponsor|0|||
145605076|NCT04543188|525068916|FG000|Phase 1a|Withdrawal by Subject|0|||
145605077|NCT04543188|525068917|FG001|Phase 1a|Withdrawal by Subject|0|||
145605078|NCT04543188|525068918|FG002|Phase 1a|Withdrawal by Subject|0|||
145605079|NCT04543188|525068919|FG003|Phase 1a|Withdrawal by Subject|0|||
145605080|NCT04543188|525068920|FG004|Phase 1a|Withdrawal by Subject|3|||
145605081|NCT04543188|525068921|FG005|Phase 1a|Withdrawal by Subject|0|||
145605082|NCT04543188|525068922|FG006|Phase 1a|Withdrawal by Subject|0|||
145605083|NCT04543188|525068923|FG007|Phase 1a|Withdrawal by Subject|0|||
145605084|NCT04543188|525068924|FG008|Phase 1a|Withdrawal by Subject|1|||
145605085|NCT04543188|525068925|FG009|Phase 1a|Withdrawal by Subject|1|||
145605086|NCT04543188|525068926|FG010|Phase 1a|Withdrawal by Subject|2|||
145605087|NCT04543188|525068927|FG011|Phase 1a|Withdrawal by Subject|0|||
145605088|NCT04543188|525068928|FG012|Phase 1a|Withdrawal by Subject|0|||
145484299|NCT01702558|524625952|FG000|Overall Study|Withdrawal by Subject|0|||
145605089|NCT04543188|525068929|FG013|Phase 1a|Withdrawal by Subject|0|||
145605090|NCT04543188|525068930|FG014|Phase 1a|Withdrawal by Subject|0|||
145605091|NCT04543188|525068916|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
145605092|NCT04543188|525068917|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
145605093|NCT04543188|525068918|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
145605094|NCT04543188|525068919|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
145605095|NCT04543188|525068920|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
145605096|NCT04543188|525068921|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
145484300|NCT01702558|524625953|FG001|Overall Study|Withdrawal by Subject|0|||
145484301|NCT01702558|524625954|FG002|Overall Study|Withdrawal by Subject|0|||
145484302|NCT01702558|524625955|FG003|Overall Study|Withdrawal by Subject|12|||
145484303|NCT01702558|524625956|FG004|Overall Study|Withdrawal by Subject|4|||
145484304|NCT01702558|524625952|FG000|Overall Study|Lost to Follow-up|0|||
145484305|NCT01702558|524625953|FG001|Overall Study|Lost to Follow-up|0|||
145484306|NCT01702558|524625954|FG002|Overall Study|Lost to Follow-up|0|||
145484307|NCT01702558|524625955|FG003|Overall Study|Lost to Follow-up|3|||
145484308|NCT01702558|524625956|FG004|Overall Study|Lost to Follow-up|0|||
145484309|NCT01702558|524625952|FG000|Overall Study|Death|4|||
145484310|NCT01702558|524625953|FG001|Overall Study|Death|3|||
145484311|NCT01702558|524625954|FG002|Overall Study|Death|3|||
145484312|NCT01702558|524625955|FG003|Overall Study|Death|16|||
145484313|NCT01702558|524625956|FG004|Overall Study|Death|20|||
145484314|NCT01702558|524625952|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
145484315|NCT01702558|524625953|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
145484316|NCT01702558|524625954|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
145484317|NCT01702558|524625955|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
145484318|NCT01702558|524625956|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
145484319|NCT01702558|524625952|FG000|Overall Study|Study Terminated by Sponsor|0|||
145484320|NCT01702558|524625953|FG001|Overall Study|Study Terminated by Sponsor|1|||
145484321|NCT01702558|524625954|FG002|Overall Study|Study Terminated by Sponsor|0|||
145484322|NCT01702558|524625955|FG003|Overall Study|Study Terminated by Sponsor|0|||
145484323|NCT01702558|524625956|FG004|Overall Study|Study Terminated by Sponsor|1|||
145484324|NCT01702558|524625952|FG000|Overall Study|Other|0|||
145484325|NCT01702558|524625953|FG001|Overall Study|Other|0|||
145484326|NCT01702558|524625954|FG002|Overall Study|Other|0|||
145484327|NCT01702558|524625955|FG003|Overall Study|Other|16|||
145484328|NCT01702558|524625956|FG004|Overall Study|Other|17|||
145484329|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Progressive disease|50|||
145484330|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Progressive disease|110|||
145484331|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Progressive disease|0|||
145484332|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Progressive disease|0|||
145484333|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
145484334|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
145484335|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145484336|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
145484337|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Adverse Event|7|||
145484338|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Adverse Event|7|||
145484339|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Adverse Event|0|||
145484340|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Adverse Event|0|||
145484341|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Other|1|||
145484342|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Other|3|||
145484343|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Other|0|||
145484344|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Other|0|||
145484345|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Physician Decision|6|||
145484346|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Physician Decision|3|||
145484347|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Physician Decision|0|||
145484348|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Physician Decision|0|||
145484349|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Death|1|||
145484350|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Death|1|||
145484351|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Death|0|||
145484352|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Death|0|||
145484353|NCT01695135|524625963|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
145484354|NCT01695135|524625964|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
145484355|NCT01695135|524625965|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
145484356|NCT01695135|524625966|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
145484357|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
145484358|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
145484359|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
145484360|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
145484361|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
145484362|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
145484363|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
145484364|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
145484365|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
145484366|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
145484367|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
145484368|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
145484369|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Other|0|||
145484370|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Other|0|||
145484371|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Other|4|||
145484372|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Other|7|||
145484373|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
145484374|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
145484375|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
145484376|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
145484377|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Death|0|||
145484378|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Death|0|||
145484379|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Death|2|||
145484380|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Death|7|||
145484381|NCT01695135|524625963|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
145484382|NCT01695135|524625964|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
145484383|NCT01695135|524625965|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
145484384|NCT01695135|524625966|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
145484385|NCT02562716|524625969|FG000|Overall Study|Adverse Event|7|||
145484386|NCT02562716|524625970|FG001|Overall Study|Adverse Event|14|||
145484387|NCT02562716|524625969|FG000|Overall Study|Withdrawal unrelated to AE|7|||
145484388|NCT02562716|524625970|FG001|Overall Study|Withdrawal unrelated to AE|1|||
145484389|NCT02562716|524625969|FG000|Overall Study|Progression|8|||
145484390|NCT02562716|524625970|FG001|Overall Study|Progression|10|||
145484391|NCT02562716|524625969|FG000|Overall Study|Death|2|||
145484392|NCT02562716|524625970|FG001|Overall Study|Death|1|||
145484393|NCT02562716|524625969|FG000|Overall Study|Not protocol specified|4|||
145484394|NCT02562716|524625970|FG001|Overall Study|Not protocol specified|2|||
145484395|NCT02753946|524625971|FG000|Overall Study|Adverse Event|7|||
145484396|NCT02753946|524625972|FG001|Overall Study|Adverse Event|6|||
145484397|NCT02753946|524625971|FG000|Overall Study|Withdrawal by Subject|6|||
145484398|NCT02753946|524625972|FG001|Overall Study|Withdrawal by Subject|1|||
145484399|NCT02753946|524625971|FG000|Overall Study|Lack of Efficacy|1|||
145484400|NCT02753946|524625972|FG001|Overall Study|Lack of Efficacy|0|||
145484401|NCT02753946|524625971|FG000|Overall Study|Physician Decision|0|||
145484402|NCT02753946|524625972|FG001|Overall Study|Physician Decision|2|||
145484403|NCT02714569|524625973|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
145484404|NCT02714569|524625974|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
145484405|NCT02714569|524625975|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
145484406|NCT02714569|524625976|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
145484407|NCT02714569|524625977|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
145484408|NCT02714569|524625978|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
145484409|NCT02714569|524625979|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
145484410|NCT02714569|524625980|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
145639473|NCT03345901|525196173|FG000|Overall Study|The study was terminated|18|||
145639474|NCT00925587|525196174|FG000|Overall Study|Protocol Specified Criteria|6|||
145639475|NCT00925587|525196175|FG001|Overall Study|Protocol Specified Criteria|6|||
145639476|NCT00925587|525196174|FG000|Overall Study|Physician Decision|4|||
145639477|NCT00925587|525196175|FG001|Overall Study|Physician Decision|1|||
145639478|NCT00925587|525196174|FG000|Overall Study|Protocol Violation|6|||
145639479|NCT00925587|525196175|FG001|Overall Study|Protocol Violation|4|||
145639480|NCT00925587|525196174|FG000|Overall Study|Withdrawal by Subject|9|||
145639481|NCT00925587|525196175|FG001|Overall Study|Withdrawal by Subject|6|||
145639482|NCT00925587|525196174|FG000|Overall Study|Death|5|||
145639483|NCT00925587|525196175|FG001|Overall Study|Death|5|||
145639484|NCT00925587|525196174|FG000|Overall Study|Adverse Event|6|||
145639485|NCT00925587|525196175|FG001|Overall Study|Adverse Event|2|||
145639486|NCT00925587|525196174|FG000|Overall Study|Lost to Follow-up|0|||
145639487|NCT00925587|525196175|FG001|Overall Study|Lost to Follow-up|1|||
145639488|NCT01599104|525196178|FG000|Overall Study|Withdrawal by Subject|1|||
145639489|NCT01599104|525196179|FG001|Overall Study|Withdrawal by Subject|1|||
145639490|NCT01599104|525196180|FG002|Overall Study|Withdrawal by Subject|2|||
145639491|NCT01599104|525196178|FG000|Overall Study|Technical Problems|1|||
145639492|NCT01599104|525196179|FG001|Overall Study|Technical Problems|0|||
145639493|NCT01599104|525196180|FG002|Overall Study|Technical Problems|0|||
145639494|NCT01599104|525196178|FG000|Overall Study|Physician Decision|3|||
145639495|NCT01599104|525196179|FG001|Overall Study|Physician Decision|2|||
145484411|NCT02714569|524625981|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
145484412|NCT02714569|524625982|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
145484413|NCT02714569|524625983|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
145484414|NCT02714569|524625973|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484415|NCT02714569|524625974|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145639496|NCT01599104|525196180|FG002|Overall Study|Physician Decision|2|||
145639497|NCT01599104|525196178|FG000|Overall Study|Non-compliance with study treatment|0|||
145639498|NCT01599104|525196179|FG001|Overall Study|Non-compliance with study treatment|1|||
145639499|NCT01599104|525196180|FG002|Overall Study|Non-compliance with study treatment|0|||
145639500|NCT01599104|525196178|FG000|Overall Study|Lack of Efficacy|4|||
145639501|NCT01599104|525196179|FG001|Overall Study|Lack of Efficacy|4|||
145639502|NCT01599104|525196180|FG002|Overall Study|Lack of Efficacy|10|||
145484416|NCT02714569|524625975|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484417|NCT02714569|524625976|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
145484418|NCT02714569|524625977|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484419|NCT02714569|524625978|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484420|NCT02714569|524625979|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484421|NCT02714569|524625980|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484422|NCT02714569|524625981|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484423|NCT02714569|524625982|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484424|NCT02714569|524625983|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
145484425|NCT02714569|524625973|FG000|Part A Third Intervention|Adverse Event|0|||
145484426|NCT02714569|524625974|FG001|Part A Third Intervention|Adverse Event|0|||
145484427|NCT02714569|524625975|FG002|Part A Third Intervention|Adverse Event|1|||
145484428|NCT02714569|524625976|FG003|Part A Third Intervention|Adverse Event|0|||
145484429|NCT02714569|524625977|FG004|Part A Third Intervention|Adverse Event|0|||
145484430|NCT02714569|524625978|FG005|Part A Third Intervention|Adverse Event|0|||
145484431|NCT02714569|524625979|FG006|Part A Third Intervention|Adverse Event|0|||
145484432|NCT02714569|524625980|FG007|Part A Third Intervention|Adverse Event|0|||
145484433|NCT02714569|524625981|FG008|Part A Third Intervention|Adverse Event|0|||
145484434|NCT02714569|524625982|FG009|Part A Third Intervention|Adverse Event|0|||
145484435|NCT02714569|524625983|FG010|Part A Third Intervention|Adverse Event|0|||
145484436|NCT02714569|524625973|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
145484437|NCT02714569|524625974|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484438|NCT02714569|524625975|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484439|NCT02714569|524625976|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484440|NCT02714569|524625977|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484441|NCT02714569|524625978|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
145484442|NCT02714569|524625979|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484443|NCT02714569|524625980|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484444|NCT02714569|524625981|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484445|NCT02714569|524625982|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484446|NCT02714569|524625983|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
145484447|NCT02714569|524625973|FG000|Part B (Overall)|Lost to Follow-up|0|||
145484448|NCT02714569|524625974|FG001|Part B (Overall)|Lost to Follow-up|0|||
145484449|NCT02714569|524625975|FG002|Part B (Overall)|Lost to Follow-up|0|||
145484450|NCT02714569|524625976|FG003|Part B (Overall)|Lost to Follow-up|0|||
145484451|NCT02714569|524625977|FG004|Part B (Overall)|Lost to Follow-up|0|||
145484452|NCT02714569|524625978|FG005|Part B (Overall)|Lost to Follow-up|0|||
145484453|NCT02714569|524625979|FG006|Part B (Overall)|Lost to Follow-up|1|||
145484454|NCT02714569|524625980|FG007|Part B (Overall)|Lost to Follow-up|0|||
145484455|NCT02714569|524625981|FG008|Part B (Overall)|Lost to Follow-up|0|||
145484456|NCT02714569|524625982|FG009|Part B (Overall)|Lost to Follow-up|0|||
145484457|NCT02714569|524625983|FG010|Part B (Overall)|Lost to Follow-up|0|||
145484458|NCT02714569|524625973|FG000|Part B (Overall)|Withdrawal by Subject|0|||
145639503|NCT01599104|525196178|FG000|Overall Study|Adverse Event|7|||
145639504|NCT01599104|525196179|FG001|Overall Study|Adverse Event|6|||
145639505|NCT01599104|525196180|FG002|Overall Study|Adverse Event|12|||
145639506|NCT02271854|525196183|FG000|Overall Study|Withdrawal by Subject|2|||
145639507|NCT02271854|525196183|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
145639508|NCT02271854|525196183|FG000|Overall Study|Lost to Follow-up|1|||
145639509|NCT01308567|525196184|FG000|Overall Study|Lost to Follow-up|2|||
145639510|NCT01308567|525196185|FG001|Overall Study|Lost to Follow-up|4|||
145639511|NCT01308567|525196186|FG002|Overall Study|Lost to Follow-up|4|||
145639512|NCT01424397|525196191|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639513|NCT01424397|525196192|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639514|NCT01424397|525196193|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
145639515|NCT01424397|525196194|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639516|NCT01424397|525196195|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639517|NCT01424397|525196196|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639518|NCT01424397|525196197|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639519|NCT01424397|525196198|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639520|NCT01424397|525196199|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639521|NCT01424397|525196200|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639522|NCT01424397|525196201|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639523|NCT01424397|525196202|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
145639524|NCT02564744|525196203|FG000|Overall Study|Investigator decision|0|||
145639525|NCT02564744|525196204|FG001|Overall Study|Investigator decision|0|||
145484459|NCT02714569|524625974|FG001|Part B (Overall)|Withdrawal by Subject|0|||
145484460|NCT02714569|524625975|FG002|Part B (Overall)|Withdrawal by Subject|0|||
145484461|NCT02714569|524625976|FG003|Part B (Overall)|Withdrawal by Subject|0|||
145484462|NCT02714569|524625977|FG004|Part B (Overall)|Withdrawal by Subject|0|||
145484463|NCT02714569|524625978|FG005|Part B (Overall)|Withdrawal by Subject|0|||
145484464|NCT02714569|524625979|FG006|Part B (Overall)|Withdrawal by Subject|0|||
145484465|NCT02714569|524625980|FG007|Part B (Overall)|Withdrawal by Subject|1|||
145484466|NCT02714569|524625981|FG008|Part B (Overall)|Withdrawal by Subject|0|||
145484467|NCT02714569|524625982|FG009|Part B (Overall)|Withdrawal by Subject|1|||
145484468|NCT02714569|524625983|FG010|Part B (Overall)|Withdrawal by Subject|0|||
145484469|NCT02714569|524625973|FG000|Part B (Overall)|Adverse Event|0|||
145484470|NCT02714569|524625974|FG001|Part B (Overall)|Adverse Event|0|||
145484471|NCT02714569|524625975|FG002|Part B (Overall)|Adverse Event|0|||
145484472|NCT02714569|524625976|FG003|Part B (Overall)|Adverse Event|0|||
145484473|NCT02714569|524625977|FG004|Part B (Overall)|Adverse Event|0|||
145484474|NCT02714569|524625978|FG005|Part B (Overall)|Adverse Event|0|||
145484475|NCT02714569|524625979|FG006|Part B (Overall)|Adverse Event|0|||
145484476|NCT02714569|524625980|FG007|Part B (Overall)|Adverse Event|0|||
145484477|NCT02714569|524625981|FG008|Part B (Overall)|Adverse Event|0|||
145484478|NCT02714569|524625982|FG009|Part B (Overall)|Adverse Event|1|||
145484479|NCT02714569|524625983|FG010|Part B (Overall)|Adverse Event|0|||
145484480|NCT04915729|524625984|FG000|Overall Study|Lost to Follow-up|20|||
145484481|NCT04915729|524625985|FG001|Overall Study|Lost to Follow-up|10|||
145484482|NCT04915729|524625984|FG000|Overall Study|Withdrawal by Subject|12|||
145484483|NCT04915729|524625985|FG001|Overall Study|Withdrawal by Subject|5|||
145484484|NCT04915729|524625984|FG000|Overall Study|Death|34|||
145484485|NCT04915729|524625985|FG001|Overall Study|Death|44|||
145484486|NCT04915729|524625984|FG000|Overall Study|not treated|3|||
145484487|NCT04915729|524625985|FG001|Overall Study|not treated|6|||
145484488|NCT04915729|524625984|FG000|Overall Study|Investigator removed subject|1|||
145484489|NCT04915729|524625985|FG001|Overall Study|Investigator removed subject|2|||
145484490|NCT04915729|524625984|FG000|Overall Study|questionnaire result not evaluated|1|||
145484491|NCT04915729|524625985|FG001|Overall Study|questionnaire result not evaluated|0|||
145484492|NCT04915729|524625984|FG000|Overall Study|refuse of hospital visit|1|||
145484493|NCT04915729|524625985|FG001|Overall Study|refuse of hospital visit|3|||
145484494|NCT04915729|524625984|FG000|Overall Study|Subject withdrew|1|||
145484495|NCT04915729|524625985|FG001|Overall Study|Subject withdrew|0|||
145484496|NCT01684202|524625986|FG000|Dose-escalation Period|Adverse Event|0|||
145484497|NCT01684202|524625987|FG001|Dose-escalation Period|Adverse Event|1|||
145484498|NCT01684202|524625988|FG002|Dose-escalation Period|Adverse Event|0|||
145484499|NCT01684202|524625989|FG003|Dose-escalation Period|Adverse Event|0|||
145484500|NCT01684202|524625986|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
145484501|NCT01684202|524625987|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
145484502|NCT01684202|524625988|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
145484503|NCT01684202|524625989|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
145484504|NCT01684202|524625986|FG000|Maintenance Period|Adverse Event|1|||
145484505|NCT01684202|524625987|FG001|Maintenance Period|Adverse Event|1|||
145484506|NCT01684202|524625988|FG002|Maintenance Period|Adverse Event|1|||
145484507|NCT01684202|524625989|FG003|Maintenance Period|Adverse Event|1|||
145484508|NCT01684202|524625986|FG000|Maintenance Period|Physician Decision|0|||
145484509|NCT01684202|524625987|FG001|Maintenance Period|Physician Decision|1|||
145484510|NCT01684202|524625988|FG002|Maintenance Period|Physician Decision|0|||
145484511|NCT01684202|524625989|FG003|Maintenance Period|Physician Decision|0|||
145484512|NCT01684202|524625986|FG000|Maintenance Period|Withdrawal by Subject|0|||
145484513|NCT01684202|524625987|FG001|Maintenance Period|Withdrawal by Subject|1|||
145484514|NCT01684202|524625988|FG002|Maintenance Period|Withdrawal by Subject|0|||
145484515|NCT01684202|524625989|FG003|Maintenance Period|Withdrawal by Subject|0|||
145484516|NCT03710642|524625990|FG000|Overall Study|Adverse Event|5|||
145484517|NCT03710642|524625991|FG001|Overall Study|Adverse Event|1|||
145484518|NCT03710642|524625990|FG000|Overall Study|non-site physician recommendation|1|||
145484519|NCT03710642|524625991|FG001|Overall Study|non-site physician recommendation|0|||
145484520|NCT03710642|524625990|FG000|Overall Study|Participant unwilling or unable to participate|1|||
145484521|NCT03710642|524625991|FG001|Overall Study|Participant unwilling or unable to participate|1|||
145484522|NCT03710642|524625990|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
145484523|NCT03710642|524625991|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
145484524|NCT03710642|524625990|FG000|Overall Study|NA-no code provided|1|||
145484525|NCT03710642|524625991|FG001|Overall Study|NA-no code provided|0|||
145484526|NCT03710642|524625990|FG000|Overall Study|Withdrawal by Subject|1|||
145484527|NCT03710642|524625991|FG001|Overall Study|Withdrawal by Subject|0|||
145484528|NCT02864901|524625992|FG000|Overall Study|Withdrawal by Subject|1|||
145484529|NCT02864901|524625993|FG001|Overall Study|Withdrawal by Subject|0|||
145605097|NCT04543188|525068922|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
145605098|NCT04543188|525068923|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
145605099|NCT04543188|525068924|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
145605100|NCT04543188|525068925|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
145605101|NCT04543188|525068926|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
145484530|NCT01369784|524625994|FG000|Overall Study|Protocol Violation|12|||
145484531|NCT02446717|524625995|FG000|Overall Study|Adverse Event|0|||
145484532|NCT02446717|524625996|FG001|Overall Study|Adverse Event|0|||
145484533|NCT02446717|524625997|FG002|Overall Study|Adverse Event|1|||
145605102|NCT04543188|525068927|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
145484534|NCT02446717|524625998|FG003|Overall Study|Adverse Event|0|||
145484535|NCT02446717|524625999|FG004|Overall Study|Adverse Event|0|||
145484536|NCT02446717|524625995|FG000|Overall Study|Lost to Follow-up|0|||
145484537|NCT02446717|524625996|FG001|Overall Study|Lost to Follow-up|1|||
145484538|NCT02446717|524625997|FG002|Overall Study|Lost to Follow-up|1|||
145484539|NCT02446717|524625998|FG003|Overall Study|Lost to Follow-up|0|||
145484540|NCT02446717|524625999|FG004|Overall Study|Lost to Follow-up|1|||
145484541|NCT02446717|524625995|FG000|Overall Study|Withdrew consent|0|||
145484542|NCT02446717|524625996|FG001|Overall Study|Withdrew consent|0|||
145484543|NCT02446717|524625997|FG002|Overall Study|Withdrew consent|0|||
145484544|NCT02446717|524625998|FG003|Overall Study|Withdrew consent|1|||
145484545|NCT02446717|524625999|FG004|Overall Study|Withdrew consent|0|||
145484546|NCT02680665|524626000|FG000|Overall Study|No visit after the first prescription|5|||
145484547|NCT02905266|524626001|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
145484548|NCT02905266|524626002|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
145484549|NCT02905266|524626001|FG000|Treatment Phase Part 1|Disease Progression|6|||
145484550|NCT02905266|524626002|FG001|Treatment Phase Part 1|Disease Progression|7|||
145484551|NCT02905266|524626001|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
145484552|NCT02905266|524626002|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
145484553|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
145484554|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
145484555|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
145484556|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
145484557|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
145484558|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
145484559|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Death|0|||
145484560|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Death|1|||
145484561|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
145484562|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
145484563|NCT02905266|524626001|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
145484564|NCT02905266|524626002|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
145484565|NCT02905266|524626001|FG000|Maintenance Phase Part 2|Disease Progression|9|||
145484566|NCT02905266|524626002|FG001|Maintenance Phase Part 2|Disease Progression|2|||
145484567|NCT02905266|524626001|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
145484568|NCT02905266|524626002|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
145484569|NCT02905266|524626001|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
145484570|NCT02905266|524626002|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
145484571|NCT02292719|524626008|FG000|Overall Study|Withdrawal by Subject|0|||
145484572|NCT02292719|524626009|FG001|Overall Study|Withdrawal by Subject|0|||
145484573|NCT02292719|524626010|FG002|Overall Study|Withdrawal by Subject|0|||
145484574|NCT02292719|524626011|FG003|Overall Study|Withdrawal by Subject|1|||
145484575|NCT02292719|524626012|FG004|Overall Study|Withdrawal by Subject|1|||
145484576|NCT02292719|524626013|FG005|Overall Study|Withdrawal by Subject|0|||
145484577|NCT02292719|524626008|FG000|Overall Study|Subject enrolled in new study.|0|||
145484578|NCT02292719|524626009|FG001|Overall Study|Subject enrolled in new study.|0|||
145484579|NCT02292719|524626010|FG002|Overall Study|Subject enrolled in new study.|1|||
145484580|NCT02292719|524626011|FG003|Overall Study|Subject enrolled in new study.|0|||
145484581|NCT02292719|524626012|FG004|Overall Study|Subject enrolled in new study.|0|||
145484582|NCT02292719|524626013|FG005|Overall Study|Subject enrolled in new study.|0|||
145484583|NCT05973006|524626016|FG000|Overall Study|Early termination|3|||
145484584|NCT05973006|524626017|FG001|Overall Study|Early termination|9|||
145484585|NCT05167825|524626018|FG000|Overall Study|Ongoing|3|||
145484586|NCT02326597|524626023|FG000|Overall Study|Lost to Follow-up|42|||
145484587|NCT02326597|524626024|FG001|Overall Study|Lost to Follow-up|32|||
145484588|NCT00770601|524626027|FG000|Overall Study|Withdrawal by Subject|1|||
145484589|NCT00428948|524626028|FG000|Overall Study|Lost to Follow-up|15|||
145484590|NCT00428948|524626029|FG001|Overall Study|Lost to Follow-up|8|||
145484591|NCT00428948|524626028|FG000|Overall Study|Adverse Event|148|||
145484592|NCT00428948|524626029|FG001|Overall Study|Adverse Event|24|||
145484593|NCT00428948|524626028|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
145484594|NCT00428948|524626029|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
145484595|NCT00428948|524626028|FG000|Overall Study|Investigator Withdrew Subject|3|||
145484596|NCT00428948|524626029|FG001|Overall Study|Investigator Withdrew Subject|4|||
145484597|NCT00428948|524626028|FG000|Overall Study|Subject Withdrew Consent|50|||
145484598|NCT00428948|524626029|FG001|Overall Study|Subject Withdrew Consent|30|||
145484599|NCT00428948|524626028|FG000|Overall Study|Protocol Deviation|1|||
145484600|NCT00428948|524626029|FG001|Overall Study|Protocol Deviation|1|||
145484601|NCT05907395|524626032|FG000|Period 1|No longer met eligibility criteria|0|||
145484602|NCT05907395|524626033|FG001|Period 1|No longer met eligibility criteria|1|||
145484603|NCT05907395|524626034|FG002|Period 1|No longer met eligibility criteria|0|||
145484604|NCT05907395|524626035|FG003|Period 1|No longer met eligibility criteria|0|||
145484605|NCT05907395|524626036|FG004|Period 1|No longer met eligibility criteria|0|||
145484606|NCT05907395|524626037|FG005|Period 1|No longer met eligibility criteria|1|||
145484607|NCT05907395|524626038|FG006|Period 1|No longer met eligibility criteria|1|||
145484608|NCT05907395|524626039|FG007|Period 1|No longer met eligibility criteria|0|||
145484609|NCT05907395|524626040|FG008|Period 1|No longer met eligibility criteria|0|||
145484610|NCT05907395|524626041|FG009|Period 1|No longer met eligibility criteria|0|||
145484611|NCT05907395|524626042|FG010|Period 1|No longer met eligibility criteria|0|||
145484612|NCT05907395|524626043|FG011|Period 1|No longer met eligibility criteria|0|||
145484613|NCT05907395|524626032|FG000|Period 2|Adverse Event|0|||
145484614|NCT05907395|524626033|FG001|Period 2|Adverse Event|0|||
145484615|NCT05907395|524626034|FG002|Period 2|Adverse Event|0|||
145484616|NCT05907395|524626035|FG003|Period 2|Adverse Event|1|||
145484617|NCT05907395|524626036|FG004|Period 2|Adverse Event|0|||
145484618|NCT05907395|524626037|FG005|Period 2|Adverse Event|0|||
145484619|NCT05907395|524626038|FG006|Period 2|Adverse Event|0|||
145484620|NCT05907395|524626039|FG007|Period 2|Adverse Event|1|||
145484621|NCT05907395|524626040|FG008|Period 2|Adverse Event|0|||
145484622|NCT05907395|524626041|FG009|Period 2|Adverse Event|0|||
145484623|NCT05907395|524626042|FG010|Period 2|Adverse Event|0|||
145484624|NCT05907395|524626043|FG011|Period 2|Adverse Event|0|||
145484625|NCT05907395|524626032|FG000|Period 2|Personal reason|0|||
145484626|NCT05907395|524626033|FG001|Period 2|Personal reason|0|||
145484627|NCT05907395|524626034|FG002|Period 2|Personal reason|0|||
145484628|NCT05907395|524626035|FG003|Period 2|Personal reason|0|||
145484629|NCT05907395|524626036|FG004|Period 2|Personal reason|0|||
145484630|NCT05907395|524626037|FG005|Period 2|Personal reason|0|||
145484631|NCT05907395|524626038|FG006|Period 2|Personal reason|0|||
145484632|NCT05907395|524626039|FG007|Period 2|Personal reason|0|||
145484633|NCT05907395|524626040|FG008|Period 2|Personal reason|0|||
145484634|NCT05907395|524626041|FG009|Period 2|Personal reason|1|||
145484635|NCT05907395|524626042|FG010|Period 2|Personal reason|0|||
145484636|NCT05907395|524626043|FG011|Period 2|Personal reason|0|||
145484637|NCT05907395|524626032|FG000|Period 3|Adverse Event|0|||
145484638|NCT05907395|524626033|FG001|Period 3|Adverse Event|0|||
145484639|NCT05907395|524626034|FG002|Period 3|Adverse Event|0|||
145484640|NCT05907395|524626035|FG003|Period 3|Adverse Event|0|||
145484641|NCT05907395|524626036|FG004|Period 3|Adverse Event|1|||
145484642|NCT05907395|524626037|FG005|Period 3|Adverse Event|0|||
145484643|NCT05907395|524626038|FG006|Period 3|Adverse Event|0|||
145484644|NCT05907395|524626039|FG007|Period 3|Adverse Event|0|||
145484645|NCT05907395|524626040|FG008|Period 3|Adverse Event|0|||
145484646|NCT05907395|524626041|FG009|Period 3|Adverse Event|0|||
145484647|NCT05907395|524626042|FG010|Period 3|Adverse Event|0|||
145484648|NCT05907395|524626043|FG011|Period 3|Adverse Event|0|||
145484649|NCT04544956|524626044|FG000|Overall Study|Withdrawal by Subject|1|||
145484650|NCT02119663|524626045|FG000|Overall Study|Disease progression|26|||
145484651|NCT02119663|524626046|FG001|Overall Study|Disease progression|27|||
145484652|NCT02119663|524626045|FG000|Overall Study|Adverse Event|5|||
145484653|NCT02119663|524626046|FG001|Overall Study|Adverse Event|5|||
145484654|NCT02119663|524626045|FG000|Overall Study|Death|3|||
145484655|NCT02119663|524626046|FG001|Overall Study|Death|2|||
145484656|NCT02119663|524626045|FG000|Overall Study|Physician Decision|1|||
145484657|NCT02119663|524626046|FG001|Overall Study|Physician Decision|2|||
145484658|NCT02119663|524626045|FG000|Overall Study|Other unspecified|2|||
145484659|NCT02119663|524626046|FG001|Overall Study|Other unspecified|0|||
145639526|NCT02564744|525196205|FG002|Overall Study|Investigator decision|0|||
145639527|NCT02564744|525196206|FG003|Overall Study|Investigator decision|0|||
145639528|NCT02564744|525196207|FG004|Overall Study|Investigator decision|1|||
145639529|NCT02564744|525196203|FG000|Overall Study|Death|10|||
145639530|NCT02564744|525196204|FG001|Overall Study|Death|5|||
145639531|NCT02564744|525196205|FG002|Overall Study|Death|4|||
145639532|NCT02564744|525196206|FG003|Overall Study|Death|16|||
145639533|NCT02564744|525196207|FG004|Overall Study|Death|16|||
145639534|NCT02564744|525196203|FG000|Overall Study|End of study Page Missing|0|||
145484660|NCT02119663|524626045|FG000|Overall Study|Subject decision|0|||
145484661|NCT02119663|524626046|FG001|Overall Study|Subject decision|1|||
145484662|NCT02119663|524626045|FG000|Overall Study|Study Terminated by the Sponsor|3|||
145484663|NCT02119663|524626046|FG001|Overall Study|Study Terminated by the Sponsor|4|||
145639535|NCT02564744|525196204|FG001|Overall Study|End of study Page Missing|0|||
145639536|NCT02564744|525196205|FG002|Overall Study|End of study Page Missing|3|||
145484664|NCT00699660|524626047|FG000|Overall Study|Lost to Follow-up|4|||
145484665|NCT00699660|524626048|FG001|Overall Study|Lost to Follow-up|2|||
145484666|NCT00699660|524626047|FG000|Overall Study|missing reports and recording failures|10|||
145484667|NCT00699660|524626048|FG001|Overall Study|missing reports and recording failures|6|||
145639537|NCT02564744|525196206|FG003|Overall Study|End of study Page Missing|3|||
145639538|NCT02564744|525196207|FG004|Overall Study|End of study Page Missing|0|||
145484668|NCT00103740|524626053|FG000|Period 1 - Core|Adverse Event|1|||
145639539|NCT02564744|525196203|FG000|Overall Study|Subject Withdrew Consent|1|||
145484669|NCT00103740|524626054|FG001|Period 1 - Core|Adverse Event|0|||
145484670|NCT00103740|524626053|FG000|Period 1 - Core|Protocol Violation|3|||
145484671|NCT00103740|524626054|FG001|Period 1 - Core|Protocol Violation|2|||
145484672|NCT00103740|524626053|FG000|Period 1 - Core|Patient withdrew consent|3|||
145484673|NCT00103740|524626054|FG001|Period 1 - Core|Patient withdrew consent|2|||
145639540|NCT02564744|525196204|FG001|Overall Study|Subject Withdrew Consent|1|||
145639541|NCT02564744|525196205|FG002|Overall Study|Subject Withdrew Consent|1|||
145639542|NCT02564744|525196206|FG003|Overall Study|Subject Withdrew Consent|0|||
145639543|NCT02564744|525196207|FG004|Overall Study|Subject Withdrew Consent|2|||
145639544|NCT02564744|525196203|FG000|Overall Study|Lost to Follow-up|0|||
145639545|NCT02564744|525196204|FG001|Overall Study|Lost to Follow-up|1|||
145639546|NCT02564744|525196205|FG002|Overall Study|Lost to Follow-up|0|||
145639547|NCT02564744|525196206|FG003|Overall Study|Lost to Follow-up|0|||
145639548|NCT02564744|525196207|FG004|Overall Study|Lost to Follow-up|1|||
145639549|NCT02564744|525196203|FG000|Overall Study|Reason not specified|1|||
145639550|NCT02564744|525196204|FG001|Overall Study|Reason not specified|0|||
145639551|NCT02564744|525196205|FG002|Overall Study|Reason not specified|0|||
145639552|NCT02564744|525196206|FG003|Overall Study|Reason not specified|0|||
145639553|NCT02564744|525196207|FG004|Overall Study|Reason not specified|0|||
145639554|NCT01177670|525196215|FG000|Overall Study|Study Terminated|115|||
145639555|NCT01177670|525196215|FG000|Overall Study|Physician Decision|50|||
145639556|NCT01177670|525196215|FG000|Overall Study|Withdrawal by Subject|4|||
145639557|NCT01636687|525196219|FG000|Induction Period|Withdrawal by Subject|1|||
145639558|NCT01636687|525196220|FG001|Induction Period|Withdrawal by Subject|0|||
145639559|NCT01636687|525196221|FG002|Induction Period|Withdrawal by Subject|0|||
145639560|NCT01636687|525196222|FG003|Induction Period|Withdrawal by Subject|0|||
145639561|NCT01636687|525196223|FG004|Induction Period|Withdrawal by Subject|0|||
145639562|NCT01636687|525196219|FG000|Induction Period|Adverse Event|1|||
145639563|NCT01636687|525196220|FG001|Induction Period|Adverse Event|0|||
145639564|NCT01636687|525196221|FG002|Induction Period|Adverse Event|0|||
145639565|NCT01636687|525196222|FG003|Induction Period|Adverse Event|0|||
145639566|NCT01636687|525196223|FG004|Induction Period|Adverse Event|1|||
145639567|NCT01636687|525196219|FG000|Induction Period|Lack of Efficacy|0|||
145639568|NCT01636687|525196220|FG001|Induction Period|Lack of Efficacy|0|||
145639569|NCT01636687|525196221|FG002|Induction Period|Lack of Efficacy|0|||
145639570|NCT01636687|525196222|FG003|Induction Period|Lack of Efficacy|0|||
145639571|NCT01636687|525196223|FG004|Induction Period|Lack of Efficacy|1|||
145639572|NCT01636687|525196219|FG000|Induction Period|Physician Decision|1|||
145639573|NCT01636687|525196220|FG001|Induction Period|Physician Decision|0|||
145639574|NCT01636687|525196221|FG002|Induction Period|Physician Decision|0|||
145639575|NCT01636687|525196222|FG003|Induction Period|Physician Decision|0|||
145639576|NCT01636687|525196223|FG004|Induction Period|Physician Decision|0|||
145639577|NCT01636687|525196219|FG000|Maintenance Period|Withdrawal by Subject|2|||
145484674|NCT00103740|524626053|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
145484675|NCT00103740|524626054|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
145484676|NCT00103740|524626053|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
145484677|NCT00103740|524626054|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
145484678|NCT00103740|524626053|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
145484679|NCT00103740|524626054|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
145484680|NCT00103740|524626053|FG000|Period 2 - Extended Observation Period|Death|6|||
145484681|NCT00103740|524626054|FG001|Period 2 - Extended Observation Period|Death|2|||
145484682|NCT00103740|524626053|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
145484683|NCT00103740|524626054|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
145484684|NCT01099397|524626056|FG000|Overall Study|Lost to Follow-up|4|||
145484685|NCT01099397|524626056|FG000|Overall Study|Protocol Violation|4|||
145484686|NCT01099397|524626056|FG000|Overall Study|Withdrawal by Subject|5|||
145484687|NCT04178720|524626060|FG000|Overall Study|Withdrawal by Subject|2|||
145484688|NCT04178720|524626061|FG001|Overall Study|Withdrawal by Subject|0|||
145484689|NCT04178720|524626060|FG000|Overall Study|Relocation|0|||
145639578|NCT01636687|525196220|FG001|Maintenance Period|Withdrawal by Subject|0|||
145639579|NCT01636687|525196221|FG002|Maintenance Period|Withdrawal by Subject|2|||
145639580|NCT01636687|525196222|FG003|Maintenance Period|Withdrawal by Subject|0|||
145484690|NCT04178720|524626061|FG001|Overall Study|Relocation|1|||
145639581|NCT01636687|525196223|FG004|Maintenance Period|Withdrawal by Subject|0|||
145639582|NCT01636687|525196219|FG000|Maintenance Period|Adverse Event|1|||
145639583|NCT01636687|525196220|FG001|Maintenance Period|Adverse Event|0|||
145639584|NCT01636687|525196221|FG002|Maintenance Period|Adverse Event|0|||
145484691|NCT00983385|524626062|FG000|Observation Period|Not eligible to be dosed|20|||
145639585|NCT01636687|525196222|FG003|Maintenance Period|Adverse Event|0|||
145484692|NCT00983385|524626062|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
145639586|NCT01636687|525196223|FG004|Maintenance Period|Adverse Event|0|||
145639587|NCT01636687|525196219|FG000|Maintenance Period|Lack of Efficacy|4|||
145639588|NCT01636687|525196220|FG001|Maintenance Period|Lack of Efficacy|1|||
145639589|NCT01636687|525196221|FG002|Maintenance Period|Lack of Efficacy|0|||
145639590|NCT01636687|525196222|FG003|Maintenance Period|Lack of Efficacy|0|||
145639591|NCT01636687|525196223|FG004|Maintenance Period|Lack of Efficacy|0|||
145639592|NCT01636687|525196219|FG000|Maintenance Period|Lost to Follow-up|1|||
145639593|NCT01636687|525196220|FG001|Maintenance Period|Lost to Follow-up|1|||
145639594|NCT01636687|525196221|FG002|Maintenance Period|Lost to Follow-up|0|||
145639595|NCT01636687|525196222|FG003|Maintenance Period|Lost to Follow-up|0|||
145639596|NCT01636687|525196223|FG004|Maintenance Period|Lost to Follow-up|1|||
145639597|NCT01636687|525196219|FG000|Maintenance Period|Physician Decision|0|||
145639598|NCT01636687|525196220|FG001|Maintenance Period|Physician Decision|0|||
145639599|NCT01636687|525196221|FG002|Maintenance Period|Physician Decision|0|||
145639600|NCT01636687|525196222|FG003|Maintenance Period|Physician Decision|0|||
145639601|NCT01636687|525196223|FG004|Maintenance Period|Physician Decision|1|||
145639602|NCT01636687|525196219|FG000|Extension Period|technical problems|0|||
145639603|NCT01636687|525196220|FG001|Extension Period|technical problems|1|||
145639604|NCT01636687|525196221|FG002|Extension Period|technical problems|2|||
145639605|NCT01636687|525196222|FG003|Extension Period|technical problems|1|||
145639606|NCT01636687|525196223|FG004|Extension Period|technical problems|0|||
145639607|NCT01636687|525196219|FG000|Extension Period|Adverse Event|4|||
145639608|NCT01636687|525196220|FG001|Extension Period|Adverse Event|3|||
145639609|NCT01636687|525196221|FG002|Extension Period|Adverse Event|2|||
145639610|NCT01636687|525196222|FG003|Extension Period|Adverse Event|1|||
145639611|NCT01636687|525196223|FG004|Extension Period|Adverse Event|0|||
145639612|NCT01636687|525196219|FG000|Extension Period|Lack of Efficacy|7|||
145639613|NCT01636687|525196220|FG001|Extension Period|Lack of Efficacy|0|||
145639614|NCT01636687|525196221|FG002|Extension Period|Lack of Efficacy|2|||
145639615|NCT01636687|525196222|FG003|Extension Period|Lack of Efficacy|1|||
145639616|NCT01636687|525196223|FG004|Extension Period|Lack of Efficacy|0|||
145639617|NCT01636687|525196219|FG000|Extension Period|Lost to Follow-up|1|||
145639618|NCT01636687|525196220|FG001|Extension Period|Lost to Follow-up|0|||
145639619|NCT01636687|525196221|FG002|Extension Period|Lost to Follow-up|1|||
145639620|NCT01636687|525196222|FG003|Extension Period|Lost to Follow-up|0|||
145639621|NCT01636687|525196223|FG004|Extension Period|Lost to Follow-up|0|||
145639622|NCT01636687|525196219|FG000|Extension Period|Physician Decision|1|||
145639623|NCT01636687|525196220|FG001|Extension Period|Physician Decision|0|||
145605103|NCT04543188|525068928|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
145605104|NCT04543188|525068929|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
145605105|NCT04543188|525068930|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
145605106|NCT04543188|525068916|FG000|Phase 1a|Other|0|||
145605107|NCT04543188|525068917|FG001|Phase 1a|Other|0|||
145605108|NCT04543188|525068918|FG002|Phase 1a|Other|0|||
145605109|NCT04543188|525068919|FG003|Phase 1a|Other|0|||
145605110|NCT04543188|525068920|FG004|Phase 1a|Other|0|||
145605111|NCT04543188|525068921|FG005|Phase 1a|Other|0|||
145605112|NCT04543188|525068922|FG006|Phase 1a|Other|0|||
145605113|NCT04543188|525068923|FG007|Phase 1a|Other|0|||
145605114|NCT04543188|525068924|FG008|Phase 1a|Other|0|||
145605115|NCT04543188|525068925|FG009|Phase 1a|Other|1|||
145605116|NCT04543188|525068926|FG010|Phase 1a|Other|0|||
145605117|NCT04543188|525068927|FG011|Phase 1a|Other|0|||
145605118|NCT04543188|525068928|FG012|Phase 1a|Other|0|||
145605119|NCT04543188|525068929|FG013|Phase 1a|Other|0|||
145605120|NCT04543188|525068930|FG014|Phase 1a|Other|0|||
145605121|NCT04543188|525068916|FG000|Phase 1b|Adverse Event|0|||
145605122|NCT04543188|525068917|FG001|Phase 1b|Adverse Event|0|||
145605123|NCT04543188|525068918|FG002|Phase 1b|Adverse Event|0|||
145605124|NCT04543188|525068919|FG003|Phase 1b|Adverse Event|0|||
145605125|NCT04543188|525068920|FG004|Phase 1b|Adverse Event|0|||
145605126|NCT04543188|525068921|FG005|Phase 1b|Adverse Event|0|||
145605127|NCT04543188|525068922|FG006|Phase 1b|Adverse Event|0|||
145605128|NCT04543188|525068923|FG007|Phase 1b|Adverse Event|0|||
145605129|NCT04543188|525068924|FG008|Phase 1b|Adverse Event|0|||
145605130|NCT04543188|525068925|FG009|Phase 1b|Adverse Event|0|||
145605131|NCT04543188|525068926|FG010|Phase 1b|Adverse Event|0|||
145605132|NCT04543188|525068927|FG011|Phase 1b|Adverse Event|0|||
145605133|NCT04543188|525068928|FG012|Phase 1b|Adverse Event|0|||
145605134|NCT04543188|525068929|FG013|Phase 1b|Adverse Event|0|||
145605135|NCT04543188|525068930|FG014|Phase 1b|Adverse Event|2|||
145605136|NCT04543188|525068916|FG000|Phase 1b|Other (Death)|0|||
145605137|NCT04543188|525068917|FG001|Phase 1b|Other (Death)|0|||
145605138|NCT04543188|525068918|FG002|Phase 1b|Other (Death)|0|||
145639624|NCT01636687|525196221|FG002|Extension Period|Physician Decision|0|||
145639625|NCT01636687|525196222|FG003|Extension Period|Physician Decision|1|||
145639626|NCT01636687|525196223|FG004|Extension Period|Physician Decision|0|||
145639627|NCT01636687|525196219|FG000|Extension Period|study terminated by sponsor|33|||
145639628|NCT01636687|525196220|FG001|Extension Period|study terminated by sponsor|50|||
145639629|NCT01636687|525196221|FG002|Extension Period|study terminated by sponsor|17|||
145639630|NCT01636687|525196222|FG003|Extension Period|study terminated by sponsor|23|||
145484693|NCT01223183|524626063|FG000|Imaging Day 1|Physician Decision|0|||
145639631|NCT01636687|525196223|FG004|Extension Period|study terminated by sponsor|0|||
145265299|NCT03323034|523819271|FG000|Overall Study|Lack of Efficacy|5|||
145605139|NCT04543188|525068919|FG003|Phase 1b|Other (Death)|0|||
145605140|NCT04543188|525068920|FG004|Phase 1b|Other (Death)|0|||
145605141|NCT04543188|525068921|FG005|Phase 1b|Other (Death)|0|||
145605142|NCT04543188|525068922|FG006|Phase 1b|Other (Death)|0|||
145605143|NCT04543188|525068923|FG007|Phase 1b|Other (Death)|0|||
145605144|NCT04543188|525068924|FG008|Phase 1b|Other (Death)|0|||
145605145|NCT04543188|525068925|FG009|Phase 1b|Other (Death)|0|||
145605146|NCT04543188|525068926|FG010|Phase 1b|Other (Death)|0|||
145605147|NCT04543188|525068927|FG011|Phase 1b|Other (Death)|0|||
145605148|NCT04543188|525068928|FG012|Phase 1b|Other (Death)|1|||
145639632|NCT01636687|525196219|FG000|Extension Period|Withdrawal by Subject|1|||
145639633|NCT01636687|525196220|FG001|Extension Period|Withdrawal by Subject|0|||
145639634|NCT01636687|525196221|FG002|Extension Period|Withdrawal by Subject|1|||
145639635|NCT01636687|525196222|FG003|Extension Period|Withdrawal by Subject|1|||
145639636|NCT01636687|525196223|FG004|Extension Period|Withdrawal by Subject|0|||
145639637|NCT01636687|525196219|FG000|Follow-up Period|Withdrawal by Subject|1|||
145639638|NCT01636687|525196220|FG001|Follow-up Period|Withdrawal by Subject|0|||
145639639|NCT01636687|525196221|FG002|Follow-up Period|Withdrawal by Subject|0|||
145639640|NCT01636687|525196222|FG003|Follow-up Period|Withdrawal by Subject|0|||
145639641|NCT01636687|525196223|FG004|Follow-up Period|Withdrawal by Subject|1|||
145639642|NCT02918279|525196224|FG000|Overall Study|Lost to Follow-up|3|||
145639643|NCT02918279|525196225|FG001|Overall Study|Lost to Follow-up|6|||
145639644|NCT02918279|525196224|FG000|Overall Study|Withdrawal by Subject|5|||
145639645|NCT02918279|525196225|FG001|Overall Study|Withdrawal by Subject|15|||
145639646|NCT02918279|525196224|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145639647|NCT02918279|525196225|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145639648|NCT02918279|525196224|FG000|Overall Study|Other|3|||
145639649|NCT02918279|525196225|FG001|Overall Study|Other|1|||
145639650|NCT00636207|525196230|FG000|Overall Study|Adverse Event|1|||
145639651|NCT00636207|525196231|FG001|Overall Study|Adverse Event|0|||
145639652|NCT00636207|525196232|FG002|Overall Study|Adverse Event|0|||
145639653|NCT00636207|525196233|FG003|Overall Study|Adverse Event|0|||
145639654|NCT00636207|525196234|FG004|Overall Study|Adverse Event|0|||
145639655|NCT00636207|525196235|FG005|Overall Study|Adverse Event|0|||
145639656|NCT00636207|525196236|FG006|Overall Study|Adverse Event|0|||
145639657|NCT00636207|525196230|FG000|Overall Study|Withdrawal by Subject|0|||
145639658|NCT00636207|525196231|FG001|Overall Study|Withdrawal by Subject|1|||
145639659|NCT00636207|525196232|FG002|Overall Study|Withdrawal by Subject|0|||
145639660|NCT00636207|525196233|FG003|Overall Study|Withdrawal by Subject|0|||
145484694|NCT01223183|524626064|FG001|Imaging Day 1|Physician Decision|1|||
145484695|NCT01223183|524626063|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
145639661|NCT00636207|525196234|FG004|Overall Study|Withdrawal by Subject|1|||
145639662|NCT00636207|525196235|FG005|Overall Study|Withdrawal by Subject|0|||
145639663|NCT00636207|525196236|FG006|Overall Study|Withdrawal by Subject|0|||
145639664|NCT01641198|525196237|FG000|After 12 Months of Function|Lost to Follow-up|3|||
145639665|NCT01641198|525196238|FG001|After 12 Months of Function|Lost to Follow-up|2|||
145639666|NCT01641198|525196239|FG002|After 12 Months of Function|Lost to Follow-up|2|||
145639667|NCT01641198|525196237|FG000|After 12 Months of Function|Protocol Violation|1|||
145639668|NCT01641198|525196238|FG001|After 12 Months of Function|Protocol Violation|0|||
145639669|NCT01641198|525196239|FG002|After 12 Months of Function|Protocol Violation|0|||
145639670|NCT01641198|525196237|FG000|After 12 Months of Function|Adverse Event|0|||
145484696|NCT01223183|524626064|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
145484697|NCT01223183|524626063|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
145484698|NCT01223183|524626064|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
145484699|NCT03449758|524628905|FG000|Overall Study|Major protocol deviation|1|||
145484700|NCT03449758|524628905|FG000|Overall Study|Treatment inefficacy|5|||
145484701|NCT03449758|524628905|FG000|Overall Study|Adverse Event|9|||
145484702|NCT03449758|524628905|FG000|Overall Study|Consent withdrawal|1|||
145484703|NCT03449758|524628905|FG000|Overall Study|Other unspecified reason|3|||
145484704|NCT03310723|524628906|FG000|Overall Study|Withdrawal by Subject|0|||
145484705|NCT03310723|524628907|FG001|Overall Study|Withdrawal by Subject|1|||
145484706|NCT03310723|524628906|FG000|Overall Study|Protocol Violation|0|||
145484707|NCT03310723|524628907|FG001|Overall Study|Protocol Violation|2|||
145484708|NCT00330759|524628908|FG000|Overall Study|Death|316|||
145484709|NCT00330759|524628909|FG001|Overall Study|Death|310|||
145484710|NCT00330759|524628908|FG000|Overall Study|Disease progression|104|||
145484711|NCT00330759|524628909|FG001|Overall Study|Disease progression|126|||
145484712|NCT00330759|524628908|FG000|Overall Study|Withdrawal by Subject|143|||
145484713|NCT00330759|524628909|FG001|Overall Study|Withdrawal by Subject|124|||
145484714|NCT00330759|524628908|FG000|Overall Study|Adverse Event|48|||
145484715|NCT00330759|524628909|FG001|Overall Study|Adverse Event|36|||
145484716|NCT00330759|524628908|FG000|Overall Study|Participant request|31|||
145639671|NCT01641198|525196238|FG001|After 12 Months of Function|Adverse Event|1|||
145484717|NCT00330759|524628909|FG001|Overall Study|Participant request|22|||
145484718|NCT00330759|524628908|FG000|Overall Study|Lost to Follow-up|16|||
145484719|NCT00330759|524628909|FG001|Overall Study|Lost to Follow-up|22|||
145484720|NCT00330759|524628908|FG000|Overall Study|Noncompliance|15|||
145639672|NCT01641198|525196239|FG002|After 12 Months of Function|Adverse Event|0|||
145639673|NCT01641198|525196237|FG000|After 24 Months of Function|Lost to Follow-up|4|||
145639674|NCT01641198|525196238|FG001|After 24 Months of Function|Lost to Follow-up|9|||
145639675|NCT01641198|525196239|FG002|After 24 Months of Function|Lost to Follow-up|6|||
145639676|NCT01641198|525196237|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
145639677|NCT01641198|525196238|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
145639678|NCT01641198|525196239|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
145639679|NCT01641198|525196237|FG000|At 15-20 Years of Function|Death|1|||
145484721|NCT00330759|524628909|FG001|Overall Study|Noncompliance|17|||
145484722|NCT00330759|524628908|FG000|Overall Study|Physician Decision|1|||
145484723|NCT00330759|524628909|FG001|Overall Study|Physician Decision|2|||
145484724|NCT00330759|524628908|FG000|Overall Study|Protocol deviation|0|||
145484725|NCT00330759|524628909|FG001|Overall Study|Protocol deviation|2|||
145484726|NCT00330759|524628908|FG000|Overall Study|Ineligibility determined|2|||
145484727|NCT00330759|524628909|FG001|Overall Study|Ineligibility determined|1|||
145484728|NCT00330759|524628908|FG000|Overall Study|Other|36|||
145484729|NCT00330759|524628909|FG001|Overall Study|Other|44|||
145484730|NCT04070989|524628910|FG000|Overall Study|Death|1|||
145484731|NCT04070989|524628911|FG001|Overall Study|Death|0|||
145484732|NCT04070989|524628912|FG002|Overall Study|Death|0|||
145484733|NCT04070989|524628910|FG000|Overall Study|Study Terminated by Sponsor|7|||
145484734|NCT04070989|524628911|FG001|Overall Study|Study Terminated by Sponsor|8|||
145484735|NCT04070989|524628912|FG002|Overall Study|Study Terminated by Sponsor|23|||
145484736|NCT04070989|524628910|FG000|Overall Study|Withdrawal by Subject|0|||
145484737|NCT04070989|524628911|FG001|Overall Study|Withdrawal by Subject|1|||
145484738|NCT04070989|524628912|FG002|Overall Study|Withdrawal by Subject|0|||
145484739|NCT04070989|524628910|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
145484740|NCT04070989|524628911|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
145484741|NCT04070989|524628912|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
145484742|NCT04070989|524628910|FG000|Overall Study|Other|1|||
145484743|NCT04070989|524628911|FG001|Overall Study|Other|1|||
145484744|NCT04070989|524628912|FG002|Overall Study|Other|0|||
145484745|NCT00592904|524628932|FG000|Overall Study|Adverse Event|15|||
145484746|NCT00592904|524628933|FG001|Overall Study|Adverse Event|25|||
145484747|NCT00592904|524628934|FG002|Overall Study|Adverse Event|13|||
145484748|NCT00592904|524628935|FG003|Overall Study|Adverse Event|5|||
145484749|NCT00592904|524628932|FG000|Overall Study|Protocol Violation|1|||
145484750|NCT00592904|524628933|FG001|Overall Study|Protocol Violation|1|||
145484751|NCT00592904|524628934|FG002|Overall Study|Protocol Violation|0|||
145484752|NCT00592904|524628935|FG003|Overall Study|Protocol Violation|1|||
145484753|NCT00592904|524628932|FG000|Overall Study|Withdrawal by Subject|4|||
145484754|NCT00592904|524628933|FG001|Overall Study|Withdrawal by Subject|16|||
145484755|NCT00592904|524628934|FG002|Overall Study|Withdrawal by Subject|1|||
145484756|NCT00592904|524628935|FG003|Overall Study|Withdrawal by Subject|2|||
145484757|NCT00592904|524628932|FG000|Overall Study|Lack of Efficacy|2|||
145484758|NCT00592904|524628933|FG001|Overall Study|Lack of Efficacy|7|||
145484759|NCT00592904|524628934|FG002|Overall Study|Lack of Efficacy|2|||
145484760|NCT00592904|524628935|FG003|Overall Study|Lack of Efficacy|3|||
145484761|NCT00592904|524628932|FG000|Overall Study|Physician Decision|0|||
145484762|NCT00592904|524628933|FG001|Overall Study|Physician Decision|3|||
145484763|NCT00592904|524628934|FG002|Overall Study|Physician Decision|1|||
145484764|NCT00592904|524628935|FG003|Overall Study|Physician Decision|0|||
145484765|NCT00592904|524628932|FG000|Overall Study|Other|3|||
145484766|NCT00592904|524628933|FG001|Overall Study|Other|3|||
145484767|NCT00592904|524628934|FG002|Overall Study|Other|0|||
145484768|NCT00592904|524628935|FG003|Overall Study|Other|0|||
145484769|NCT01388907|524628936|FG000|Overall Study|Adverse Event|2|||
145484770|NCT01388907|524628937|FG001|Overall Study|Adverse Event|0|||
145484771|NCT00824473|524628938|FG000|Overall Study|Adverse Event|4|||
145484772|NCT00824473|524628939|FG001|Overall Study|Adverse Event|5|||
145484773|NCT00824473|524628938|FG000|Overall Study|Lack of Efficacy|2|||
145484774|NCT00824473|524628939|FG001|Overall Study|Lack of Efficacy|2|||
145484775|NCT00824473|524628938|FG000|Overall Study|Protocol Violation|2|||
145484776|NCT00824473|524628939|FG001|Overall Study|Protocol Violation|0|||
145484777|NCT00824473|524628938|FG000|Overall Study|Non-Compliance|4|||
145484778|NCT00824473|524628939|FG001|Overall Study|Non-Compliance|2|||
145484779|NCT00824473|524628938|FG000|Overall Study|Withdrawal by Subject|2|||
145484780|NCT00824473|524628939|FG001|Overall Study|Withdrawal by Subject|3|||
145484781|NCT00824473|524628938|FG000|Overall Study|Other|1|||
145484782|NCT00824473|524628939|FG001|Overall Study|Other|1|||
145484783|NCT01359904|524628940|FG000|Overall Study|Withdrawal by Subject|1|||
145484784|NCT01359904|524628941|FG001|Overall Study|Withdrawal by Subject|0|||
145484785|NCT01550757|524628943|FG000|Overall Study|Lost to Follow-up|21|||
145484786|NCT01550757|524628944|FG001|Overall Study|Lost to Follow-up|14|||
145484787|NCT01550757|524628945|FG002|Overall Study|Lost to Follow-up|42|||
145484788|NCT01550757|524628946|FG003|Overall Study|Lost to Follow-up|53|||
145484789|NCT01550757|524628943|FG000|Overall Study|Withdrawal by Subject|2|||
145484790|NCT01550757|524628944|FG001|Overall Study|Withdrawal by Subject|0|||
145484791|NCT01550757|524628945|FG002|Overall Study|Withdrawal by Subject|3|||
145484792|NCT01550757|524628946|FG003|Overall Study|Withdrawal by Subject|1|||
145484793|NCT03191630|524628947|FG000|Overall Study|Lost to Follow-up|7|||
145484794|NCT03191630|524628948|FG001|Overall Study|Lost to Follow-up|7|||
145484795|NCT01172535|524628952|FG000|Overall Study|Death|3|||
145484796|NCT01172535|524628952|FG000|Overall Study|Withdrawal by Subject|2|||
145484797|NCT01172535|524628952|FG000|Overall Study|Lost to Follow-up|1|||
145484798|NCT01172535|524628952|FG000|Overall Study|Ineligible at study entry|1|||
145484799|NCT01172535|524628952|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
145484800|NCT02698826|524628958|FG000|Overall Study|Death|13|||
145484801|NCT02698826|524628958|FG000|Overall Study|Adverse Event|1|||
145484802|NCT02478463|524628963|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
145484803|NCT02478463|524628963|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
145484804|NCT02478463|524628963|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
145484805|NCT01879683|524628964|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
145484806|NCT01508169|524628968|FG000|Overall Study|Adverse Event|1|||
145484807|NCT01508169|524628969|FG001|Overall Study|Adverse Event|0|||
145484808|NCT01508169|524628968|FG000|Overall Study|Withdrawal by Subject|1|||
145484809|NCT01508169|524628969|FG001|Overall Study|Withdrawal by Subject|0|||
145484810|NCT01508169|524628968|FG000|Overall Study|Lost to Follow-up|1|||
145484811|NCT01508169|524628969|FG001|Overall Study|Lost to Follow-up|2|||
145484812|NCT03259087|524628974|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
145484813|NCT03259087|524628975|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
145484814|NCT03259087|524628976|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
145484815|NCT03259087|524628977|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
145484816|NCT03259087|524628978|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
145484817|NCT03259087|524628974|FG000|Period 2 of Part 2|Adverse Event|0|||
145484818|NCT03259087|524628975|FG001|Period 2 of Part 2|Adverse Event|0|||
145484819|NCT03259087|524628976|FG002|Period 2 of Part 2|Adverse Event|0|||
145484820|NCT03259087|524628977|FG003|Period 2 of Part 2|Adverse Event|0|||
145484821|NCT03259087|524628978|FG004|Period 2 of Part 2|Adverse Event|1|||
145484822|NCT02396212|524628979|FG000|Overall Study|Adverse Event|1|||
145484823|NCT02396212|524628979|FG000|Overall Study|Lack of Efficacy|2|||
145484824|NCT01623115|524628980|FG000|Overall Study|Randomized but not treated|0|||
145484825|NCT01623115|524628981|FG001|Overall Study|Randomized but not treated|1|||
145484826|NCT01623115|524628980|FG000|Overall Study|Physician Decision|1|||
145484827|NCT01623115|524628981|FG001|Overall Study|Physician Decision|0|||
145484828|NCT01623115|524628980|FG000|Overall Study|Participants moved|1|||
145484829|NCT01623115|524628981|FG001|Overall Study|Participants moved|5|||
145484830|NCT01623115|524628980|FG000|Overall Study|Adverse Event|10|||
145484831|NCT01623115|524628981|FG001|Overall Study|Adverse Event|13|||
145484832|NCT01623115|524628980|FG000|Overall Study|Poor compliance to protocol|4|||
145484833|NCT01623115|524628981|FG001|Overall Study|Poor compliance to protocol|10|||
145484834|NCT01623115|524628980|FG000|Overall Study|Consent withdrawn by participant|2|||
145484835|NCT01623115|524628981|FG001|Overall Study|Consent withdrawn by participant|6|||
145639680|NCT01641198|525196238|FG001|At 15-20 Years of Function|Death|0|||
145639681|NCT01641198|525196239|FG002|At 15-20 Years of Function|Death|1|||
145639682|NCT02529995|525196241|FG000|Part A|Ongoing Study at Data Cut-off|14|||
145639683|NCT02529995|525196242|FG001|Part A|Ongoing Study at Data Cut-off|16|||
145639684|NCT02529995|525196241|FG000|Part A|Discontinued Study|1|||
145639685|NCT02529995|525196242|FG001|Part A|Discontinued Study|0|||
145639686|NCT02529995|525196241|FG000|Part B|Ongoing Study at Data Cut-off|0|||
145639687|NCT02529995|525196242|FG001|Part B|Ongoing Study at Data Cut-off|7|||
145639688|NCT02529995|525196241|FG000|Part B|Discontinued Study|6|||
145639689|NCT02529995|525196242|FG001|Part B|Discontinued Study|5|||
145639690|NCT03737240|525196251|FG000|Overall Study|Lost to Follow-up|16|||
145639691|NCT03737240|525196252|FG001|Overall Study|Lost to Follow-up|15|||
145639692|NCT00364013|525196253|FG000|Overall Study|Ineligibility determined|4|||
145639693|NCT00364013|525196254|FG001|Overall Study|Ineligibility determined|2|||
145639694|NCT00364013|525196253|FG000|Overall Study|Adverse Event|4|||
145639695|NCT00364013|525196254|FG001|Overall Study|Adverse Event|3|||
145639696|NCT00364013|525196253|FG000|Overall Study|Withdrawal by Subject|13|||
145639697|NCT00364013|525196254|FG001|Overall Study|Withdrawal by Subject|18|||
145639698|NCT00364013|525196253|FG000|Overall Study|Physician Decision|3|||
145639699|NCT00364013|525196254|FG001|Overall Study|Physician Decision|3|||
145639700|NCT00364013|525196253|FG000|Overall Study|Lost to Follow-up|10|||
145639701|NCT00364013|525196254|FG001|Overall Study|Lost to Follow-up|3|||
145639702|NCT00364013|525196253|FG000|Overall Study|Protocol-specified criteria|6|||
145639703|NCT00364013|525196254|FG001|Overall Study|Protocol-specified criteria|6|||
145639704|NCT00364013|525196253|FG000|Overall Study|Other|41|||
145639705|NCT00364013|525196254|FG001|Overall Study|Other|47|||
145639706|NCT00364013|525196253|FG000|Overall Study|Ongoing|20|||
145639707|NCT00364013|525196254|FG001|Overall Study|Ongoing|13|||
145639708|NCT01369498|525196259|FG000|Overall Study|Lack of Efficacy|9|||
145639709|NCT01369498|525196260|FG001|Overall Study|Lack of Efficacy|9|||
145639710|NCT01369498|525196261|FG002|Overall Study|Lack of Efficacy|1|||
145484836|NCT01623115|524628980|FG000|Overall Study|Related to study drug administration|0|||
145484837|NCT01623115|524628981|FG001|Overall Study|Related to study drug administration|2|||
145639711|NCT01369498|525196262|FG003|Overall Study|Lack of Efficacy|3|||
145639712|NCT01369498|525196259|FG000|Overall Study|Adverse Event|1|||
145639713|NCT01369498|525196260|FG001|Overall Study|Adverse Event|2|||
145639714|NCT01369498|525196261|FG002|Overall Study|Adverse Event|0|||
145639715|NCT01369498|525196262|FG003|Overall Study|Adverse Event|1|||
145639716|NCT01369498|525196259|FG000|Overall Study|Withdrawal of Consent|0|||
145484838|NCT01623115|524628980|FG000|Overall Study|Last visit outside protocol visit window|14|||
145484839|NCT01623115|524628981|FG001|Overall Study|Last visit outside protocol visit window|26|||
145484840|NCT01623115|524628980|FG000|Overall Study|Site closure|1|||
145484841|NCT01623115|524628981|FG001|Overall Study|Site closure|7|||
145484842|NCT01623115|524628980|FG000|Overall Study|Death|0|||
145484843|NCT01623115|524628981|FG001|Overall Study|Death|4|||
145484844|NCT01623115|524628980|FG000|Overall Study|Other than specified above|0|||
145484845|NCT01623115|524628981|FG001|Overall Study|Other than specified above|3|||
145484846|NCT04950465|524628982|FG000|Overall Study|Lost to Follow-up|1|||
145484847|NCT04950465|524628983|FG001|Overall Study|Lost to Follow-up|0|||
145484848|NCT04950465|524628984|FG002|Overall Study|Lost to Follow-up|0|||
145484849|NCT02366195|524628995|FG000|Overall Study|Protocol-specified criteria|3|||
145484850|NCT02366195|524628995|FG000|Overall Study|Withdrawal by Subject|9|||
145484851|NCT02366195|524628995|FG000|Overall Study|Lost to Follow-up|1|||
145484852|NCT02366195|524628995|FG000|Overall Study|Death|41|||
145484853|NCT01338818|524628998|FG000|Overall Study|Adverse Event|8|||
145484854|NCT01338818|524628998|FG000|Overall Study|Lack of Efficacy|5|||
145484855|NCT01338818|524628998|FG000|Overall Study|no longer require study drug|1|||
145484856|NCT01338818|524628998|FG000|Overall Study|Withdrawal by Subject|11|||
145484857|NCT01338818|524628998|FG000|Overall Study|Lost to Follow-up|4|||
145484858|NCT01338818|524628998|FG000|Overall Study|Administrative problems|3|||
145484859|NCT01338818|524628998|FG000|Overall Study|Protocol Deviation|4|||
145484860|NCT01620086|524628999|FG000|Overall Study|Withdrawal by Subject|3|||
145484861|NCT01620086|524629000|FG001|Overall Study|Withdrawal by Subject|3|||
145484862|NCT01620086|524629001|FG002|Overall Study|Withdrawal by Subject|0|||
145484863|NCT01620086|524628999|FG000|Overall Study|failed study criteria|1|||
145484864|NCT01620086|524629000|FG001|Overall Study|failed study criteria|4|||
145484865|NCT01620086|524629001|FG002|Overall Study|failed study criteria|0|||
145484866|NCT01620086|524628999|FG000|Overall Study|Physician Decision|1|||
145484867|NCT01620086|524629000|FG001|Overall Study|Physician Decision|0|||
145484868|NCT01620086|524629001|FG002|Overall Study|Physician Decision|0|||
145484869|NCT00580723|524629007|FG000|Overall Study|Did not want to participate in extension|3|||
145484870|NCT00580723|524629007|FG000|Overall Study|Lost to Follow-up|5|||
145484871|NCT05202418|524629008|FG000|Overall Study|Withdrawal by Subject|2|||
145484872|NCT05202418|524629009|FG001|Overall Study|Withdrawal by Subject|1|||
145484873|NCT05202418|524629008|FG000|Overall Study|Lost to Follow-up|1|||
145484874|NCT05202418|524629009|FG001|Overall Study|Lost to Follow-up|1|||
145484875|NCT00684996|524629010|FG000|Overall Study|Adverse Event|1|||
145484876|NCT00684996|524629010|FG000|Overall Study|Refusal unrelated to adverse event|1|||
145484877|NCT00684996|524629010|FG000|Overall Study|Progression/relapse|2|||
145484878|NCT00684996|524629010|FG000|Overall Study|Other reasons not protocol specified|1|||
145484879|NCT00556998|524629011|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
145484880|NCT00556998|524629011|FG000|Voriconazole Intravenous (IV)|Other|4|||
145484881|NCT00556998|524629011|FG000|Voriconazole Oral|Adverse Event|1|||
145484882|NCT00556998|524629011|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
145484883|NCT02519439|524629014|FG000|Overall Study|Study Termination|19|||
145484884|NCT02519439|524629014|FG000|Overall Study|Withdrawal by Subject|1|||
145484885|NCT02519439|524629014|FG000|Overall Study|Adverse Event|1|||
145484886|NCT03030417|524629017|FG000|Dose Expansion|Disease progression before treatment|0|||
145484887|NCT03030417|524629018|FG001|Dose Expansion|Disease progression before treatment|0|||
145484888|NCT03030417|524629019|FG002|Dose Expansion|Disease progression before treatment|0|||
145484889|NCT03030417|524629020|FG003|Dose Expansion|Disease progression before treatment|0|||
145484890|NCT03030417|524629021|FG004|Dose Expansion|Disease progression before treatment|0|||
145484891|NCT03030417|524629022|FG005|Dose Expansion|Disease progression before treatment|0|||
145484892|NCT03030417|524629023|FG006|Dose Expansion|Disease progression before treatment|0|||
145484893|NCT03030417|524629024|FG007|Dose Expansion|Disease progression before treatment|0|||
145484894|NCT03030417|524629025|FG008|Dose Expansion|Disease progression before treatment|0|||
145484895|NCT03030417|524629026|FG009|Dose Expansion|Disease progression before treatment|0|||
145484896|NCT03030417|524629027|FG010|Dose Expansion|Disease progression before treatment|0|||
145484897|NCT03030417|524629028|FG011|Dose Expansion|Disease progression before treatment|0|||
145484898|NCT03030417|524629029|FG012|Dose Expansion|Disease progression before treatment|1|||
145484899|NCT01078441|524629030|FG000|Overall Study|Withdrawal by Subject|1|||
145484900|NCT04961541|524629031|FG000|Overall Study|Adverse Event|0|||
145484901|NCT04961541|524629032|FG001|Overall Study|Adverse Event|0|||
145484902|NCT04961541|524629033|FG002|Overall Study|Adverse Event|0|||
145484903|NCT04961541|524629034|FG003|Overall Study|Adverse Event|0|||
145484904|NCT04961541|524629035|FG004|Overall Study|Adverse Event|0|||
145484905|NCT04961541|524629036|FG005|Overall Study|Adverse Event|1|||
145484906|NCT04961541|524629037|FG006|Overall Study|Adverse Event|0|||
145484907|NCT04961541|524629038|FG007|Overall Study|Adverse Event|0|||
145484908|NCT04961541|524629039|FG008|Overall Study|Adverse Event|0|||
145484909|NCT04961541|524629040|FG009|Overall Study|Adverse Event|0|||
145484910|NCT04961541|524629041|FG010|Overall Study|Adverse Event|0|||
145484911|NCT04961541|524629042|FG011|Overall Study|Adverse Event|0|||
145484912|NCT04961541|524629043|FG012|Overall Study|Adverse Event|0|||
145484913|NCT04961541|524629044|FG013|Overall Study|Adverse Event|0|||
145484914|NCT04961541|524629031|FG000|Overall Study|Lost to Follow-up|0|||
145605149|NCT04543188|525068929|FG013|Phase 1b|Other (Death)|0|||
145484915|NCT04961541|524629032|FG001|Overall Study|Lost to Follow-up|0|||
145484916|NCT04961541|524629033|FG002|Overall Study|Lost to Follow-up|3|||
145484917|NCT04961541|524629034|FG003|Overall Study|Lost to Follow-up|0|||
145484918|NCT04961541|524629035|FG004|Overall Study|Lost to Follow-up|0|||
145484919|NCT04961541|524629036|FG005|Overall Study|Lost to Follow-up|0|||
145484920|NCT04961541|524629037|FG006|Overall Study|Lost to Follow-up|1|||
145484921|NCT04961541|524629038|FG007|Overall Study|Lost to Follow-up|1|||
145484922|NCT04961541|524629039|FG008|Overall Study|Lost to Follow-up|0|||
145484923|NCT04961541|524629040|FG009|Overall Study|Lost to Follow-up|1|||
145484924|NCT04961541|524629041|FG010|Overall Study|Lost to Follow-up|0|||
145484925|NCT04961541|524629042|FG011|Overall Study|Lost to Follow-up|0|||
145484926|NCT04961541|524629043|FG012|Overall Study|Lost to Follow-up|1|||
145484927|NCT04961541|524629044|FG013|Overall Study|Lost to Follow-up|0|||
145484928|NCT04961541|524629031|FG000|Overall Study|Withdrawal by Subject|0|||
145484929|NCT04961541|524629032|FG001|Overall Study|Withdrawal by Subject|0|||
145484930|NCT04961541|524629033|FG002|Overall Study|Withdrawal by Subject|1|||
145484931|NCT04961541|524629034|FG003|Overall Study|Withdrawal by Subject|1|||
145484932|NCT04961541|524629035|FG004|Overall Study|Withdrawal by Subject|0|||
145484933|NCT04961541|524629036|FG005|Overall Study|Withdrawal by Subject|0|||
145484934|NCT04961541|524629037|FG006|Overall Study|Withdrawal by Subject|0|||
145484935|NCT04961541|524629038|FG007|Overall Study|Withdrawal by Subject|0|||
145639717|NCT01369498|525196260|FG001|Overall Study|Withdrawal of Consent|1|||
145639718|NCT01369498|525196261|FG002|Overall Study|Withdrawal of Consent|1|||
145639719|NCT01369498|525196262|FG003|Overall Study|Withdrawal of Consent|1|||
145639720|NCT01369498|525196259|FG000|Overall Study|Death|0|||
145484936|NCT04961541|524629039|FG008|Overall Study|Withdrawal by Subject|0|||
145484937|NCT04961541|524629040|FG009|Overall Study|Withdrawal by Subject|1|||
145484938|NCT04961541|524629041|FG010|Overall Study|Withdrawal by Subject|0|||
145484939|NCT04961541|524629042|FG011|Overall Study|Withdrawal by Subject|0|||
145484940|NCT04961541|524629043|FG012|Overall Study|Withdrawal by Subject|0|||
145484941|NCT04961541|524629044|FG013|Overall Study|Withdrawal by Subject|0|||
145484942|NCT01970306|524629046|FG000|Overall Study|Not eligible|3|||
145484943|NCT01970306|524629046|FG000|Overall Study|Not able to be treated|9|||
145484944|NCT00782717|524629047|FG000|Overall Study|Adverse Event|2|||
145484945|NCT00782717|524629048|FG001|Overall Study|Adverse Event|5|||
145484946|NCT00782717|524629047|FG000|Overall Study|Patient decision unrelated to AE|6|||
145484947|NCT00782717|524629048|FG001|Overall Study|Patient decision unrelated to AE|3|||
145484948|NCT00782717|524629047|FG000|Overall Study|Noncompliance|2|||
145484949|NCT00782717|524629048|FG001|Overall Study|Noncompliance|1|||
145484950|NCT00782717|524629047|FG000|Overall Study|Treatment failure|3|||
145484951|NCT00782717|524629048|FG001|Overall Study|Treatment failure|14|||
145484952|NCT00782717|524629047|FG000|Overall Study|Enrollment close prior to surgery|1|||
145484953|NCT00782717|524629048|FG001|Overall Study|Enrollment close prior to surgery|0|||
145484954|NCT00782717|524629047|FG000|Overall Study|Did not meet entrance criteria|1|||
145484955|NCT00782717|524629048|FG001|Overall Study|Did not meet entrance criteria|3|||
145484956|NCT00782717|524629047|FG000|Overall Study|Exited in error|0|||
145484957|NCT00782717|524629048|FG001|Overall Study|Exited in error|2|||
145484958|NCT04739436|524629049|FG000|Overall Study|Lost to Follow-up|21|||
145484959|NCT04739436|524629050|FG001|Overall Study|Lost to Follow-up|23|||
145484960|NCT04739436|524629049|FG000|Overall Study|Withdrawal by Subject|4|||
145484961|NCT04739436|524629050|FG001|Overall Study|Withdrawal by Subject|6|||
145484962|NCT04739436|524629049|FG000|Overall Study|not randomized properly|1|||
145484963|NCT04739436|524629050|FG001|Overall Study|not randomized properly|0|||
145484964|NCT02701283|524629052|FG000|Overall Study|Death|25|||
145484965|NCT02701283|524629053|FG001|Overall Study|Death|29|||
145484966|NCT02701283|524629054|FG002|Overall Study|Death|19|||
145484967|NCT02701283|524629052|FG000|Overall Study|Lost to Follow-up|3|||
145484968|NCT02701283|524629053|FG001|Overall Study|Lost to Follow-up|8|||
145484969|NCT02701283|524629054|FG002|Overall Study|Lost to Follow-up|1|||
145484970|NCT02701283|524629052|FG000|Overall Study|Withdrawal by Subject|12|||
145484971|NCT02701283|524629053|FG001|Overall Study|Withdrawal by Subject|41|||
145484972|NCT02701283|524629054|FG002|Overall Study|Withdrawal by Subject|1|||
145484973|NCT02701283|524629052|FG000|Overall Study|Missed 2-year visit|22|||
145484974|NCT02701283|524629053|FG001|Overall Study|Missed 2-year visit|27|||
145484975|NCT02701283|524629054|FG002|Overall Study|Missed 2-year visit|0|||
145484976|NCT02701283|524629052|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
145484977|NCT02701283|524629053|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
145484978|NCT02701283|524629054|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
145484979|NCT00892775|524629055|FG000|Overall Study|Protocol Violation|1|||
145484980|NCT00892775|524629056|FG001|Overall Study|Protocol Violation|0|||
145484981|NCT00892775|524629055|FG000|Overall Study|Subject difficulties with blood drawing|1|||
145484982|NCT00892775|524629056|FG001|Overall Study|Subject difficulties with blood drawing|0|||
145639721|NCT01369498|525196260|FG001|Overall Study|Death|0|||
145484983|NCT00892775|524629055|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
145484984|NCT00892775|524629056|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
145484985|NCT00892775|524629055|FG000|Overall Study|Migrated/ moved from study area|1|||
145484986|NCT00892775|524629056|FG001|Overall Study|Migrated/ moved from study area|0|||
145484987|NCT00892775|524629055|FG000|Overall Study|Withdrawal by Subject|0|||
145484988|NCT00892775|524629056|FG001|Overall Study|Withdrawal by Subject|1|||
145484989|NCT00892775|524629055|FG000|Overall Study|Lost to Follow-up|1|||
145484990|NCT00892775|524629056|FG001|Overall Study|Lost to Follow-up|0|||
145484991|NCT00398320|524629057|FG000|Overall Study|Death|1|||
145484992|NCT00398320|524629057|FG000|Overall Study|Adverse Event|4|||
145484993|NCT00398320|524629057|FG000|Overall Study|Physician Decision|1|||
145484994|NCT00064792|524629058|FG000|Overall Study|Withdrawal by Subject|2|||
145484995|NCT00064792|524629059|FG001|Overall Study|Withdrawal by Subject|0|||
145484996|NCT00064792|524629058|FG000|Overall Study|Adverse Event|3|||
145484997|NCT00064792|524629059|FG001|Overall Study|Adverse Event|0|||
145484998|NCT03160898|524629060|FG000|Overall Study|Adverse Event|4|||
145484999|NCT03160898|524629061|FG001|Overall Study|Adverse Event|8|||
145485000|NCT03160898|524629062|FG002|Overall Study|Adverse Event|7|||
145485001|NCT03160898|524629063|FG003|Overall Study|Adverse Event|10|||
145485002|NCT03160898|524629060|FG000|Overall Study|Death|1|||
145485003|NCT03160898|524629061|FG001|Overall Study|Death|0|||
145485004|NCT03160898|524629062|FG002|Overall Study|Death|0|||
145485005|NCT03160898|524629063|FG003|Overall Study|Death|1|||
145485006|NCT03160898|524629060|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
145485007|NCT03160898|524629061|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
145485008|NCT03160898|524629062|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
145485009|NCT03160898|524629063|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
145485010|NCT03160898|524629060|FG000|Overall Study|Lost to Follow-up|1|||
145485011|NCT03160898|524629061|FG001|Overall Study|Lost to Follow-up|1|||
145485012|NCT03160898|524629062|FG002|Overall Study|Lost to Follow-up|1|||
145485013|NCT03160898|524629063|FG003|Overall Study|Lost to Follow-up|2|||
145485014|NCT03160898|524629060|FG000|Overall Study|Physician Decision|1|||
145485015|NCT03160898|524629061|FG001|Overall Study|Physician Decision|0|||
145485016|NCT03160898|524629062|FG002|Overall Study|Physician Decision|0|||
145485017|NCT03160898|524629063|FG003|Overall Study|Physician Decision|1|||
145485018|NCT03160898|524629060|FG000|Overall Study|Progressive Disease|4|||
145485019|NCT03160898|524629061|FG001|Overall Study|Progressive Disease|1|||
145485020|NCT03160898|524629062|FG002|Overall Study|Progressive Disease|2|||
145485021|NCT03160898|524629063|FG003|Overall Study|Progressive Disease|1|||
145485022|NCT03160898|524629060|FG000|Overall Study|Protocol Violation|1|||
145485023|NCT03160898|524629061|FG001|Overall Study|Protocol Violation|0|||
145485024|NCT03160898|524629062|FG002|Overall Study|Protocol Violation|2|||
145485025|NCT03160898|524629063|FG003|Overall Study|Protocol Violation|0|||
145485026|NCT03160898|524629060|FG000|Overall Study|Sponsor Discretion|2|||
145485027|NCT03160898|524629061|FG001|Overall Study|Sponsor Discretion|0|||
145485028|NCT03160898|524629062|FG002|Overall Study|Sponsor Discretion|0|||
145485029|NCT03160898|524629063|FG003|Overall Study|Sponsor Discretion|0|||
145485030|NCT03160898|524629060|FG000|Overall Study|Withdrawal by Subject|1|||
145485031|NCT03160898|524629061|FG001|Overall Study|Withdrawal by Subject|3|||
145485032|NCT03160898|524629062|FG002|Overall Study|Withdrawal by Subject|2|||
145485033|NCT03160898|524629063|FG003|Overall Study|Withdrawal by Subject|1|||
145485034|NCT03160898|524629060|FG000|Overall Study|Other|2|||
145485035|NCT03160898|524629061|FG001|Overall Study|Other|0|||
145485036|NCT03160898|524629062|FG002|Overall Study|Other|2|||
145485037|NCT03160898|524629063|FG003|Overall Study|Other|2|||
145485038|NCT03405818|524629064|FG000|Overall Study|Withdrawal by Subject|4|||
145485039|NCT03405818|524629064|FG000|Overall Study|Lost to Follow-up|4|||
145485040|NCT00291486|524629066|FG000|Overall Study|Adverse Event|0|||
145485041|NCT00291486|524629067|FG001|Overall Study|Adverse Event|3|||
145485042|NCT00291486|524629068|FG002|Overall Study|Adverse Event|0|||
145485043|NCT00291486|524629069|FG003|Overall Study|Adverse Event|1|||
145485044|NCT00291486|524629070|FG004|Overall Study|Adverse Event|0|||
145485045|NCT00291486|524629066|FG000|Overall Study|Withdrawal by Subject|0|||
145485046|NCT00291486|524629067|FG001|Overall Study|Withdrawal by Subject|0|||
145485047|NCT00291486|524629068|FG002|Overall Study|Withdrawal by Subject|0|||
145485048|NCT00291486|524629069|FG003|Overall Study|Withdrawal by Subject|0|||
145485049|NCT00291486|524629070|FG004|Overall Study|Withdrawal by Subject|1|||
145485050|NCT00291486|524629066|FG000|Overall Study|Disease progression|1|||
145485051|NCT00291486|524629067|FG001|Overall Study|Disease progression|0|||
145485052|NCT00291486|524629068|FG002|Overall Study|Disease progression|1|||
145485053|NCT00291486|524629069|FG003|Overall Study|Disease progression|0|||
145485054|NCT00291486|524629070|FG004|Overall Study|Disease progression|0|||
145485055|NCT01408459|524629073|FG000|Overall Study|Withdrawal by Subject|1|||
145485056|NCT01408459|524629074|FG001|Overall Study|Withdrawal by Subject|1|||
145485057|NCT00992459|524629075|FG000|Overall Study|Withdrawal by Subject|0|||
145485058|NCT00992459|524629076|FG001|Overall Study|Withdrawal by Subject|1|||
145485059|NCT00992459|524629075|FG000|Overall Study|Adverse Event|1|||
145485060|NCT00992459|524629076|FG001|Overall Study|Adverse Event|0|||
145485061|NCT01657292|524629084|FG000|Overall Study|Adverse Event|6|||
145485062|NCT01657292|524629084|FG000|Overall Study|Withdrawal by Subject|2|||
145485063|NCT01657292|524629084|FG000|Overall Study|Violation of eligibility criteria|1|||
145485064|NCT01657292|524629084|FG000|Overall Study|Change of therapy|1|||
145485065|NCT04725500|524629086|FG000|Screening|Screen Failure|26|||
145485066|NCT04725500|524629086|FG000|Screening|Withdrawal by Subject|1|||
145485067|NCT04725500|524629086|FG000|2 Week Take Home|Screen Fail|5|||
145485068|NCT01633788|524631158|FG000|Overall Study|Adverse Event|1|||
145485069|NCT01633788|524631159|FG001|Overall Study|Adverse Event|3|||
145485070|NCT01633788|524631160|FG002|Overall Study|Adverse Event|3|||
145485071|NCT01633788|524631161|FG003|Overall Study|Adverse Event|3|||
145485072|NCT01633788|524631158|FG000|Overall Study|Lost to Follow-up|2|||
145485073|NCT01633788|524631159|FG001|Overall Study|Lost to Follow-up|2|||
145485074|NCT01633788|524631160|FG002|Overall Study|Lost to Follow-up|2|||
145485075|NCT01633788|524631161|FG003|Overall Study|Lost to Follow-up|0|||
145485076|NCT01633788|524631158|FG000|Overall Study|Personal Reasons|3|||
145485077|NCT01633788|524631159|FG001|Overall Study|Personal Reasons|1|||
145485078|NCT01633788|524631160|FG002|Overall Study|Personal Reasons|1|||
145485079|NCT01633788|524631161|FG003|Overall Study|Personal Reasons|3|||
145485080|NCT01633788|524631158|FG000|Overall Study|Protocol Violation|1|||
145485081|NCT01633788|524631159|FG001|Overall Study|Protocol Violation|0|||
145485082|NCT01633788|524631160|FG002|Overall Study|Protocol Violation|1|||
145485083|NCT01633788|524631161|FG003|Overall Study|Protocol Violation|0|||
145485084|NCT01633788|524631158|FG000|Overall Study|Other Reasons|0|||
145485085|NCT01633788|524631159|FG001|Overall Study|Other Reasons|2|||
145485086|NCT01633788|524631160|FG002|Overall Study|Other Reasons|3|||
145485087|NCT01633788|524631161|FG003|Overall Study|Other Reasons|7|||
145485088|NCT01929226|524631162|FG000|Overall Study|Lost to Follow-up|4|||
145485089|NCT01929226|524631163|FG001|Overall Study|Lost to Follow-up|0|||
145485090|NCT01929226|524631162|FG000|Overall Study|Withdrawal by Subject|1|||
145485091|NCT01929226|524631163|FG001|Overall Study|Withdrawal by Subject|1|||
145485092|NCT03553758|524631164|FG000|Overall Study|Lost to Follow-up|1|||
145485093|NCT01467505|524631169|FG000|Overall Study|Adverse Event|1|||
145485094|NCT01467505|524631170|FG001|Overall Study|Adverse Event|0|||
145485095|NCT01467505|524631169|FG000|Overall Study|Withdrawal by Subject|4|||
145485096|NCT01467505|524631170|FG001|Overall Study|Withdrawal by Subject|0|||
145485097|NCT01467505|524631169|FG000|Overall Study|Study Terminated by Sponsor|28|||
145485098|NCT01467505|524631170|FG001|Overall Study|Study Terminated by Sponsor|3|||
145485099|NCT02807623|524631171|FG000|Overall Study|Lost to Follow-up|23|||
145485100|NCT02807623|524631172|FG001|Overall Study|Lost to Follow-up|18|||
145485101|NCT02807623|524631173|FG002|Overall Study|Lost to Follow-up|22|||
145485102|NCT02807623|524631171|FG000|Overall Study|Drug intolerance|0|||
145485103|NCT02807623|524631172|FG001|Overall Study|Drug intolerance|1|||
145485104|NCT02807623|524631173|FG002|Overall Study|Drug intolerance|0|||
145485105|NCT02807623|524631171|FG000|Overall Study|incomplete blood draw|0|||
145485106|NCT02807623|524631172|FG001|Overall Study|incomplete blood draw|2|||
145485107|NCT02807623|524631173|FG002|Overall Study|incomplete blood draw|1|||
145485108|NCT03811340|524631177|FG000|Overall Study|subjects did not complete the survey.|90|||
145485109|NCT01045967|524631178|FG000|Second Intervention|Protocol Violation|0|||
145485110|NCT01045967|524631179|FG001|Second Intervention|Protocol Violation|1|||
145485111|NCT05104450|524631180|FG000|Overall Study|Death|1|||
145485112|NCT05104450|524631181|FG001|Overall Study|Death|2|||
145485113|NCT05104450|524631180|FG000|Overall Study|Withdrawal by Subject|3|||
145485114|NCT05104450|524631181|FG001|Overall Study|Withdrawal by Subject|1|||
145485115|NCT02562235|524631182|FG000|Overall Study|Adverse Event|3|||
145485116|NCT01380769|524631185|FG000|Overall Study|Withdrawal by Subject|7|||
145485117|NCT01380769|524631186|FG001|Overall Study|Withdrawal by Subject|11|||
145485118|NCT01380769|524631185|FG000|Overall Study|Physician Decision|1|||
145485119|NCT01380769|524631186|FG001|Overall Study|Physician Decision|1|||
145485120|NCT01380769|524631185|FG000|Overall Study|Adverse Event|1|||
145485121|NCT01380769|524631186|FG001|Overall Study|Adverse Event|1|||
145485122|NCT01380769|524631185|FG000|Overall Study|Protocol Violation|0|||
145485123|NCT01380769|524631186|FG001|Overall Study|Protocol Violation|1|||
145485124|NCT01080807|524631189|FG000|Overall Study|Adverse Event|9|||
145485125|NCT01080807|524631190|FG001|Overall Study|Adverse Event|1|||
145485126|NCT01080807|524631189|FG000|Overall Study|Lack of Efficacy|0|||
145485127|NCT01080807|524631190|FG001|Overall Study|Lack of Efficacy|1|||
145485128|NCT01080807|524631189|FG000|Overall Study|Withdrawal by Subject|7|||
145485129|NCT01080807|524631190|FG001|Overall Study|Withdrawal by Subject|2|||
145485130|NCT01080807|524631189|FG000|Overall Study|Protocol Violation|7|||
145485131|NCT01080807|524631190|FG001|Overall Study|Protocol Violation|6|||
145605150|NCT04543188|525068930|FG014|Phase 1b|Other (Death)|1|||
145605151|NCT04543188|525068916|FG000|Phase 1b|Progressive Disease|0|||
145605152|NCT04543188|525068917|FG001|Phase 1b|Progressive Disease|0|||
145605153|NCT04543188|525068918|FG002|Phase 1b|Progressive Disease|0|||
145605154|NCT04543188|525068919|FG003|Phase 1b|Progressive Disease|0|||
145605155|NCT04543188|525068920|FG004|Phase 1b|Progressive Disease|0|||
145605156|NCT04543188|525068921|FG005|Phase 1b|Progressive Disease|0|||
145605157|NCT04543188|525068922|FG006|Phase 1b|Progressive Disease|0|||
145605158|NCT04543188|525068923|FG007|Phase 1b|Progressive Disease|0|||
145605159|NCT04543188|525068924|FG008|Phase 1b|Progressive Disease|0|||
145605160|NCT04543188|525068925|FG009|Phase 1b|Progressive Disease|0|||
145605161|NCT04543188|525068926|FG010|Phase 1b|Progressive Disease|0|||
145639722|NCT01369498|525196261|FG002|Overall Study|Death|1|||
145485132|NCT01080807|524631189|FG000|Overall Study|Lost to Follow-up|6|||
145485133|NCT01080807|524631190|FG001|Overall Study|Lost to Follow-up|4|||
145485134|NCT01080807|524631189|FG000|Overall Study|Noncompliance with drug administration|1|||
145485135|NCT01080807|524631190|FG001|Overall Study|Noncompliance with drug administration|1|||
145485136|NCT01080807|524631189|FG000|Overall Study|Noncompliance to study procedures|1|||
145485137|NCT01080807|524631190|FG001|Overall Study|Noncompliance to study procedures|1|||
145485138|NCT01080807|524631189|FG000|Overall Study|Began working day shift|0|||
145485139|NCT01080807|524631190|FG001|Overall Study|Began working day shift|2|||
145485140|NCT01080807|524631189|FG000|Overall Study|Laid off or terminated from job|1|||
145485141|NCT01080807|524631190|FG001|Overall Study|Laid off or terminated from job|2|||
145485142|NCT01080807|524631189|FG000|Overall Study|Stopped working consistent night shifts|0|||
145485143|NCT01080807|524631190|FG001|Overall Study|Stopped working consistent night shifts|1|||
145485144|NCT01080807|524631189|FG000|Overall Study|Work schedule changing|1|||
145485145|NCT01080807|524631190|FG001|Overall Study|Work schedule changing|1|||
145485146|NCT01080807|524631189|FG000|Overall Study|Work schedule and travel|0|||
145485147|NCT01080807|524631190|FG001|Overall Study|Work schedule and travel|1|||
145485148|NCT01080807|524631189|FG000|Overall Study|Switched to first shift|1|||
145485149|NCT01080807|524631190|FG001|Overall Study|Switched to first shift|0|||
145485150|NCT01080807|524631189|FG000|Overall Study|Moved away without notifying center|1|||
145485151|NCT01080807|524631190|FG001|Overall Study|Moved away without notifying center|0|||
145485152|NCT02107703|524631203|FG000|Overall Study|Withdrawal by Subject|46|||
145485153|NCT02107703|524631204|FG001|Overall Study|Withdrawal by Subject|21|||
145485154|NCT02107703|524631203|FG000|Overall Study|Lost to Follow-up|20|||
145485155|NCT02107703|524631204|FG001|Overall Study|Lost to Follow-up|9|||
145485156|NCT02107703|524631203|FG000|Overall Study|On study treatment/follow up|48|||
145485157|NCT02107703|524631204|FG001|Overall Study|On study treatment/follow up|5|||
145485158|NCT03456076|524631209|FG000|Overall Study|Withdrawal by Subject|5|||
145485159|NCT03456076|524631210|FG001|Overall Study|Withdrawal by Subject|9|||
145485160|NCT03456076|524631209|FG000|Overall Study|Protocol deviation|0|||
145485161|NCT03456076|524631210|FG001|Overall Study|Protocol deviation|1|||
145485162|NCT03456076|524631209|FG000|Overall Study|Lost to Follow-up|0|||
145485163|NCT03456076|524631210|FG001|Overall Study|Lost to Follow-up|1|||
145485164|NCT03456076|524631209|FG000|Overall Study|Death|2|||
145485165|NCT03456076|524631210|FG001|Overall Study|Death|5|||
145485166|NCT03456076|524631209|FG000|Overall Study|Study ongoing|123|||
145485167|NCT03456076|524631210|FG001|Overall Study|Study ongoing|111|||
145485168|NCT02045095|524631211|FG000|Overall Study|Other|0|||
145485169|NCT02045095|524631212|FG001|Overall Study|Other|0|||
145485170|NCT02045095|524631213|FG002|Overall Study|Other|1|||
145485171|NCT02045095|524631214|FG003|Overall Study|Other|0|||
145485172|NCT02045095|524631215|FG004|Overall Study|Other|0|||
145485173|NCT02045095|524631216|FG005|Overall Study|Other|2|||
145485174|NCT02045095|524631217|FG006|Overall Study|Other|0|||
145485175|NCT02045095|524631211|FG000|Overall Study|Progressive Disease|3|||
145485176|NCT02045095|524631212|FG001|Overall Study|Progressive Disease|3|||
145485177|NCT02045095|524631213|FG002|Overall Study|Progressive Disease|2|||
145639723|NCT01369498|525196262|FG003|Overall Study|Death|0|||
145639724|NCT01369498|525196259|FG000|Overall Study|Investigator's Discretion|1|||
145639725|NCT01369498|525196260|FG001|Overall Study|Investigator's Discretion|0|||
145639726|NCT01369498|525196261|FG002|Overall Study|Investigator's Discretion|1|||
145639727|NCT01369498|525196262|FG003|Overall Study|Investigator's Discretion|3|||
145639728|NCT01369498|525196259|FG000|Overall Study|Unknown Reason|1|||
145485178|NCT02045095|524631214|FG003|Overall Study|Progressive Disease|4|||
145485179|NCT02045095|524631215|FG004|Overall Study|Progressive Disease|2|||
145485180|NCT02045095|524631216|FG005|Overall Study|Progressive Disease|4|||
145485181|NCT02045095|524631217|FG006|Overall Study|Progressive Disease|1|||
145485182|NCT02045095|524631211|FG000|Overall Study|Withdrawal by Subject|0|||
145485183|NCT02045095|524631212|FG001|Overall Study|Withdrawal by Subject|0|||
145485184|NCT02045095|524631213|FG002|Overall Study|Withdrawal by Subject|0|||
145485185|NCT02045095|524631214|FG003|Overall Study|Withdrawal by Subject|0|||
145485186|NCT02045095|524631215|FG004|Overall Study|Withdrawal by Subject|3|||
145485187|NCT02045095|524631216|FG005|Overall Study|Withdrawal by Subject|0|||
145485188|NCT02045095|524631217|FG006|Overall Study|Withdrawal by Subject|0|||
145485189|NCT02045095|524631211|FG000|Overall Study|Adverse Event|0|||
145485190|NCT02045095|524631212|FG001|Overall Study|Adverse Event|1|||
145485191|NCT02045095|524631213|FG002|Overall Study|Adverse Event|1|||
145485192|NCT02045095|524631214|FG003|Overall Study|Adverse Event|0|||
145485193|NCT02045095|524631215|FG004|Overall Study|Adverse Event|0|||
145639729|NCT01369498|525196260|FG001|Overall Study|Unknown Reason|0|||
145639730|NCT01369498|525196261|FG002|Overall Study|Unknown Reason|11|||
145485194|NCT02045095|524631216|FG005|Overall Study|Adverse Event|2|||
145485195|NCT02045095|524631217|FG006|Overall Study|Adverse Event|0|||
145485196|NCT02640547|524631218|FG000|Overall Study|Failure to Return|1|||
145485197|NCT02640547|524631218|FG000|Overall Study|Withdrawal by Subject|1|||
145485198|NCT02640547|524631218|FG000|Overall Study|Death|6|||
145639731|NCT01369498|525196262|FG003|Overall Study|Unknown Reason|6|||
145639732|NCT01369498|525196259|FG000|Overall Study|Disease Progression|0|||
145485199|NCT02640547|524631218|FG000|Overall Study|Miscellaneous|3|||
145485200|NCT02525588|524631219|FG000|Overall Study|Death|3|||
145485201|NCT02525588|524631220|FG001|Overall Study|Death|1|||
145485202|NCT02525588|524631219|FG000|Overall Study|Lost to Follow-up|2|||
145485203|NCT02525588|524631220|FG001|Overall Study|Lost to Follow-up|0|||
145485204|NCT02525588|524631219|FG000|Overall Study|Withdrawal by Subject|1|||
145485205|NCT02525588|524631220|FG001|Overall Study|Withdrawal by Subject|1|||
145485206|NCT02525588|524631219|FG000|Overall Study|Adverse Event|0|||
145485207|NCT02525588|524631220|FG001|Overall Study|Adverse Event|1|||
145485208|NCT03018691|524631224|FG000|Overall Study|Adverse Event|1|||
145485209|NCT03018691|524631225|FG001|Overall Study|Adverse Event|1|||
145485210|NCT03018691|524631226|FG002|Overall Study|Adverse Event|4|||
145485211|NCT03018691|524631224|FG000|Overall Study|Lack of Efficacy|0|||
145485212|NCT03018691|524631225|FG001|Overall Study|Lack of Efficacy|0|||
145485213|NCT03018691|524631226|FG002|Overall Study|Lack of Efficacy|1|||
145485214|NCT03018691|524631224|FG000|Overall Study|Withdrawal by Subject|0|||
145485215|NCT03018691|524631225|FG001|Overall Study|Withdrawal by Subject|0|||
145485216|NCT03018691|524631226|FG002|Overall Study|Withdrawal by Subject|1|||
145485217|NCT03018691|524631224|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145485218|NCT03018691|524631225|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145485219|NCT03018691|524631226|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145485220|NCT03369418|524631228|FG000|Overall Study|Withdrawal by Subject|3|||
145485221|NCT03369418|524631229|FG001|Overall Study|Withdrawal by Subject|3|||
145485222|NCT01485094|524631230|FG000|Overall Study|Adverse Event|1|||
145485223|NCT01485094|524631231|FG001|Overall Study|Adverse Event|1|||
145485224|NCT01485094|524631232|FG002|Overall Study|Adverse Event|1|||
145485225|NCT01485094|524631230|FG000|Overall Study|Lost to Follow-up|1|||
145485226|NCT01485094|524631231|FG001|Overall Study|Lost to Follow-up|0|||
145485227|NCT01485094|524631232|FG002|Overall Study|Lost to Follow-up|0|||
145485228|NCT01485094|524631230|FG000|Overall Study|Withdrawal by Subject|1|||
145485229|NCT01485094|524631231|FG001|Overall Study|Withdrawal by Subject|1|||
145485230|NCT01485094|524631232|FG002|Overall Study|Withdrawal by Subject|0|||
145485231|NCT01020786|524631233|FG000|Induction Period|Entry Criteria Not Met|2|||
145485232|NCT01020786|524631233|FG000|Induction Period|Adverse Event|10|||
145485233|NCT01020786|524631233|FG000|Induction Period|Progressive Disease|31|||
145485234|NCT01020786|524631233|FG000|Induction Period|Investigator Decision|3|||
145485235|NCT01020786|524631233|FG000|Induction Period|Withdrawal by Subject|3|||
145485236|NCT01020786|524631233|FG000|Maintenance Period|Adverse Event|8|||
145485237|NCT01020786|524631233|FG000|Maintenance Period|Progressive Disease|43|||
145485238|NCT01020786|524631233|FG000|Maintenance Period|Withdrawal by Subject|8|||
145485239|NCT01020786|524631233|FG000|Maintenance Period|Sponsor Decision|1|||
145485240|NCT01818596|524631234|FG000|Overall Study|Enrolled but Not Treated|4|||
145485241|NCT01818596|524631235|FG001|Overall Study|Enrolled but Not Treated|0|||
145485242|NCT01818596|524631234|FG000|Overall Study|Adverse Event|7|||
145485243|NCT01818596|524631235|FG001|Overall Study|Adverse Event|0|||
145485244|NCT01818596|524631234|FG000|Overall Study|Death|3|||
145485245|NCT01818596|524631235|FG001|Overall Study|Death|0|||
145485246|NCT01818596|524631234|FG000|Overall Study|Investigator's Discretion|4|||
145485247|NCT01818596|524631235|FG001|Overall Study|Investigator's Discretion|0|||
145485248|NCT01818596|524631234|FG000|Overall Study|Protocol Violation|1|||
145485249|NCT01818596|524631235|FG001|Overall Study|Protocol Violation|0|||
145485250|NCT01818596|524631234|FG000|Overall Study|Withdrew Consent|5|||
145485251|NCT01818596|524631235|FG001|Overall Study|Withdrew Consent|0|||
145485252|NCT01818596|524631234|FG000|Overall Study|Lost to Follow-up|7|||
145485253|NCT01818596|524631235|FG001|Overall Study|Lost to Follow-up|0|||
145485254|NCT00837213|524631241|FG000|Overall Study|Lost to Follow-up|3|||
145485255|NCT00837213|524631242|FG001|Overall Study|Lost to Follow-up|2|||
145485256|NCT00837213|524631241|FG000|Overall Study|Withdrawal by Subject|2|||
145485257|NCT00837213|524631242|FG001|Overall Study|Withdrawal by Subject|2|||
145485258|NCT00837213|524631241|FG000|Overall Study|not stated|1|||
145485259|NCT00837213|524631242|FG001|Overall Study|not stated|1|||
145485260|NCT04497116|524631245|FG000|Overall Study|Lost to Follow-up|1|||
145485261|NCT04497116|524631246|FG001|Overall Study|Lost to Follow-up|0|||
145485262|NCT04497116|524631247|FG002|Overall Study|Lost to Follow-up|0|||
145485263|NCT04497116|524631248|FG003|Overall Study|Lost to Follow-up|0|||
145485264|NCT04497116|524631249|FG004|Overall Study|Lost to Follow-up|0|||
145485265|NCT04497116|524631250|FG005|Overall Study|Lost to Follow-up|0|||
145485266|NCT04497116|524631251|FG006|Overall Study|Lost to Follow-up|0|||
145639733|NCT01369498|525196260|FG001|Overall Study|Disease Progression|0|||
145639734|NCT01369498|525196261|FG002|Overall Study|Disease Progression|0|||
145639735|NCT01369498|525196262|FG003|Overall Study|Disease Progression|1|||
145485267|NCT04497116|524631252|FG007|Overall Study|Lost to Follow-up|3|||
145485268|NCT04497116|524631253|FG008|Overall Study|Lost to Follow-up|3|||
145485269|NCT04497116|524631254|FG009|Overall Study|Lost to Follow-up|0|||
145485270|NCT04497116|524631255|FG010|Overall Study|Lost to Follow-up|0|||
145485271|NCT04497116|524631256|FG011|Overall Study|Lost to Follow-up|0|||
145485272|NCT04497116|524631257|FG012|Overall Study|Lost to Follow-up|0|||
145639736|NCT01444417|525196265|FG000|Overall Study|Ineligibility Determined|0|||
145485273|NCT04497116|524631258|FG013|Overall Study|Lost to Follow-up|0|||
145485274|NCT04497116|524631259|FG014|Overall Study|Lost to Follow-up|0|||
145485275|NCT04497116|524631260|FG015|Overall Study|Lost to Follow-up|0|||
145485276|NCT04497116|524631261|FG016|Overall Study|Lost to Follow-up|0|||
145485277|NCT04497116|524631262|FG017|Overall Study|Lost to Follow-up|0|||
145485278|NCT04497116|524631263|FG018|Overall Study|Lost to Follow-up|0|||
145485279|NCT04497116|524631264|FG019|Overall Study|Lost to Follow-up|0|||
145485280|NCT04497116|524631265|FG020|Overall Study|Lost to Follow-up|0|||
145485281|NCT04497116|524631266|FG021|Overall Study|Lost to Follow-up|0|||
145485282|NCT04497116|524631267|FG022|Overall Study|Lost to Follow-up|1|||
145485283|NCT04497116|524631268|FG023|Overall Study|Lost to Follow-up|0|||
145485284|NCT04497116|524631269|FG024|Overall Study|Lost to Follow-up|0|||
145485285|NCT04497116|524631245|FG000|Overall Study|Sponsor decision to terminate study|0|||
145485286|NCT04497116|524631246|FG001|Overall Study|Sponsor decision to terminate study|0|||
145485287|NCT04497116|524631247|FG002|Overall Study|Sponsor decision to terminate study|0|||
145485288|NCT04497116|524631248|FG003|Overall Study|Sponsor decision to terminate study|0|||
145485289|NCT04497116|524631249|FG004|Overall Study|Sponsor decision to terminate study|0|||
145485290|NCT04497116|524631250|FG005|Overall Study|Sponsor decision to terminate study|0|||
145485291|NCT04497116|524631251|FG006|Overall Study|Sponsor decision to terminate study|1|||
145485292|NCT04497116|524631252|FG007|Overall Study|Sponsor decision to terminate study|0|||
145485293|NCT04497116|524631253|FG008|Overall Study|Sponsor decision to terminate study|0|||
145639737|NCT01444417|525196266|FG001|Overall Study|Ineligibility Determined|1|||
145639738|NCT01444417|525196265|FG000|Overall Study|Withdrawal by Subject|2|||
145639739|NCT01444417|525196266|FG001|Overall Study|Withdrawal by Subject|0|||
145639740|NCT02214160|525196268|FG000|Overall Study|Withdrawal by Subject|1|||
145639741|NCT02214160|525196269|FG001|Overall Study|Withdrawal by Subject|0|||
145639742|NCT02214160|525196270|FG002|Overall Study|Withdrawal by Subject|6|||
145485294|NCT04497116|524631254|FG009|Overall Study|Sponsor decision to terminate study|1|||
145485295|NCT04497116|524631255|FG010|Overall Study|Sponsor decision to terminate study|0|||
145485296|NCT04497116|524631256|FG011|Overall Study|Sponsor decision to terminate study|0|||
145485297|NCT04497116|524631257|FG012|Overall Study|Sponsor decision to terminate study|0|||
145485298|NCT04497116|524631258|FG013|Overall Study|Sponsor decision to terminate study|0|||
145485299|NCT04497116|524631259|FG014|Overall Study|Sponsor decision to terminate study|0|||
145485300|NCT04497116|524631260|FG015|Overall Study|Sponsor decision to terminate study|0|||
145485301|NCT04497116|524631261|FG016|Overall Study|Sponsor decision to terminate study|0|||
145485302|NCT04497116|524631262|FG017|Overall Study|Sponsor decision to terminate study|0|||
145485303|NCT04497116|524631263|FG018|Overall Study|Sponsor decision to terminate study|0|||
145485304|NCT04497116|524631264|FG019|Overall Study|Sponsor decision to terminate study|1|||
145485305|NCT04497116|524631265|FG020|Overall Study|Sponsor decision to terminate study|0|||
145485306|NCT04497116|524631266|FG021|Overall Study|Sponsor decision to terminate study|0|||
145485307|NCT04497116|524631267|FG022|Overall Study|Sponsor decision to terminate study|0|||
145485308|NCT04497116|524631268|FG023|Overall Study|Sponsor decision to terminate study|0|||
145485309|NCT04497116|524631269|FG024|Overall Study|Sponsor decision to terminate study|0|||
145485310|NCT04497116|524631245|FG000|Overall Study|Death|4|||
145485311|NCT04497116|524631246|FG001|Overall Study|Death|5|||
145485312|NCT04497116|524631247|FG002|Overall Study|Death|2|||
145639743|NCT02214160|525196268|FG000|Overall Study|Death|2|||
145639744|NCT02214160|525196269|FG001|Overall Study|Death|2|||
145639745|NCT02214160|525196270|FG002|Overall Study|Death|1|||
145639746|NCT02214160|525196268|FG000|Overall Study|Subject Non-Compliance|0|||
145639747|NCT02214160|525196269|FG001|Overall Study|Subject Non-Compliance|3|||
145639748|NCT02214160|525196270|FG002|Overall Study|Subject Non-Compliance|1|||
145639749|NCT02214160|525196268|FG000|Overall Study|Adverse Event|0|||
145639750|NCT02214160|525196269|FG001|Overall Study|Adverse Event|1|||
145639751|NCT02214160|525196270|FG002|Overall Study|Adverse Event|1|||
145639752|NCT02214160|525196268|FG000|Overall Study|Sponsor Decision|0|||
145639753|NCT02214160|525196269|FG001|Overall Study|Sponsor Decision|2|||
145639754|NCT02214160|525196270|FG002|Overall Study|Sponsor Decision|0|||
145639755|NCT02214160|525196268|FG000|Overall Study|Protocol Violation|1|||
145639756|NCT02214160|525196269|FG001|Overall Study|Protocol Violation|0|||
145485313|NCT04497116|524631248|FG003|Overall Study|Death|2|||
145485314|NCT04497116|524631249|FG004|Overall Study|Death|1|||
145485315|NCT04497116|524631250|FG005|Overall Study|Death|1|||
145485316|NCT04497116|524631251|FG006|Overall Study|Death|3|||
145485317|NCT04497116|524631252|FG007|Overall Study|Death|10|||
145485318|NCT04497116|524631253|FG008|Overall Study|Death|37|||
145485319|NCT04497116|524631254|FG009|Overall Study|Death|17|||
145485320|NCT04497116|524631255|FG010|Overall Study|Death|2|||
145485321|NCT04497116|524631256|FG011|Overall Study|Death|1|||
145485322|NCT04497116|524631257|FG012|Overall Study|Death|1|||
145639757|NCT02214160|525196270|FG002|Overall Study|Protocol Violation|0|||
145639758|NCT02214160|525196268|FG000|Overall Study|Physician Decision|0|||
145639759|NCT02214160|525196269|FG001|Overall Study|Physician Decision|0|||
145639760|NCT02214160|525196270|FG002|Overall Study|Physician Decision|1|||
145639761|NCT01430611|525196273|FG000|Overall Study|Adverse Event|0|||
145639762|NCT01430611|525196274|FG001|Overall Study|Adverse Event|1|||
145639763|NCT01430611|525196273|FG000|Overall Study|Protocol Violation|1|||
145485323|NCT04497116|524631258|FG013|Overall Study|Death|3|||
145485324|NCT04497116|524631259|FG014|Overall Study|Death|18|||
145485325|NCT04497116|524631260|FG015|Overall Study|Death|3|||
145485326|NCT04497116|524631261|FG016|Overall Study|Death|2|||
145639764|NCT01430611|525196274|FG001|Overall Study|Protocol Violation|0|||
145485327|NCT04497116|524631262|FG017|Overall Study|Death|1|||
145485328|NCT04497116|524631263|FG018|Overall Study|Death|4|||
145485329|NCT04497116|524631264|FG019|Overall Study|Death|17|||
145485330|NCT04497116|524631265|FG020|Overall Study|Death|1|||
145485331|NCT04497116|524631266|FG021|Overall Study|Death|0|||
145485332|NCT04497116|524631267|FG022|Overall Study|Death|3|||
145485333|NCT04497116|524631268|FG023|Overall Study|Death|5|||
145485334|NCT04497116|524631269|FG024|Overall Study|Death|4|||
145485335|NCT04497116|524631245|FG000|Overall Study|Withdrawal by Subject|1|||
145485336|NCT04497116|524631246|FG001|Overall Study|Withdrawal by Subject|0|||
145485337|NCT04497116|524631247|FG002|Overall Study|Withdrawal by Subject|1|||
145485338|NCT04497116|524631248|FG003|Overall Study|Withdrawal by Subject|0|||
145485339|NCT04497116|524631249|FG004|Overall Study|Withdrawal by Subject|0|||
145485340|NCT04497116|524631250|FG005|Overall Study|Withdrawal by Subject|0|||
145485341|NCT04497116|524631251|FG006|Overall Study|Withdrawal by Subject|0|||
145485342|NCT04497116|524631252|FG007|Overall Study|Withdrawal by Subject|7|||
145485343|NCT04497116|524631253|FG008|Overall Study|Withdrawal by Subject|14|||
145485344|NCT04497116|524631254|FG009|Overall Study|Withdrawal by Subject|3|||
145485345|NCT04497116|524631255|FG010|Overall Study|Withdrawal by Subject|3|||
145485346|NCT04497116|524631256|FG011|Overall Study|Withdrawal by Subject|0|||
145485347|NCT04497116|524631257|FG012|Overall Study|Withdrawal by Subject|1|||
145485348|NCT04497116|524631258|FG013|Overall Study|Withdrawal by Subject|0|||
145485349|NCT04497116|524631259|FG014|Overall Study|Withdrawal by Subject|7|||
145485350|NCT04497116|524631260|FG015|Overall Study|Withdrawal by Subject|1|||
145485351|NCT04497116|524631261|FG016|Overall Study|Withdrawal by Subject|3|||
145485352|NCT04497116|524631262|FG017|Overall Study|Withdrawal by Subject|1|||
145485353|NCT04497116|524631263|FG018|Overall Study|Withdrawal by Subject|1|||
145485354|NCT04497116|524631264|FG019|Overall Study|Withdrawal by Subject|5|||
145485355|NCT04497116|524631265|FG020|Overall Study|Withdrawal by Subject|2|||
145485356|NCT04497116|524631266|FG021|Overall Study|Withdrawal by Subject|2|||
145485357|NCT04497116|524631267|FG022|Overall Study|Withdrawal by Subject|2|||
145485358|NCT04497116|524631268|FG023|Overall Study|Withdrawal by Subject|4|||
145485359|NCT04497116|524631269|FG024|Overall Study|Withdrawal by Subject|3|||
145485360|NCT04497116|524631245|FG000|Overall Study|Physician Decision|0|||
145485361|NCT04497116|524631246|FG001|Overall Study|Physician Decision|0|||
145485362|NCT04497116|524631247|FG002|Overall Study|Physician Decision|0|||
145485363|NCT04497116|524631248|FG003|Overall Study|Physician Decision|0|||
145485364|NCT04497116|524631249|FG004|Overall Study|Physician Decision|0|||
145485365|NCT04497116|524631250|FG005|Overall Study|Physician Decision|0|||
145485366|NCT04497116|524631251|FG006|Overall Study|Physician Decision|0|||
145485367|NCT04497116|524631252|FG007|Overall Study|Physician Decision|0|||
145485368|NCT04497116|524631253|FG008|Overall Study|Physician Decision|0|||
145485369|NCT04497116|524631254|FG009|Overall Study|Physician Decision|0|||
145485370|NCT04497116|524631255|FG010|Overall Study|Physician Decision|0|||
145485371|NCT04497116|524631256|FG011|Overall Study|Physician Decision|0|||
145485372|NCT04497116|524631257|FG012|Overall Study|Physician Decision|0|||
145485373|NCT04497116|524631258|FG013|Overall Study|Physician Decision|0|||
145485374|NCT04497116|524631259|FG014|Overall Study|Physician Decision|0|||
145485375|NCT04497116|524631260|FG015|Overall Study|Physician Decision|0|||
145485376|NCT04497116|524631261|FG016|Overall Study|Physician Decision|0|||
145485377|NCT04497116|524631262|FG017|Overall Study|Physician Decision|0|||
145605162|NCT04543188|525068927|FG011|Phase 1b|Progressive Disease|0|||
145605163|NCT04543188|525068928|FG012|Phase 1b|Progressive Disease|2|||
145605164|NCT04543188|525068929|FG013|Phase 1b|Progressive Disease|1|||
145485378|NCT04497116|524631263|FG018|Overall Study|Physician Decision|0|||
145485379|NCT04497116|524631264|FG019|Overall Study|Physician Decision|0|||
145605165|NCT04543188|525068930|FG014|Phase 1b|Progressive Disease|5|||
145485380|NCT04497116|524631265|FG020|Overall Study|Physician Decision|0|||
145485381|NCT04497116|524631266|FG021|Overall Study|Physician Decision|0|||
145485382|NCT04497116|524631267|FG022|Overall Study|Physician Decision|0|||
145485383|NCT04497116|524631268|FG023|Overall Study|Physician Decision|1|||
145485384|NCT04497116|524631269|FG024|Overall Study|Physician Decision|0|||
145485385|NCT04497116|524631245|FG000|Overall Study|Clinical Progression Related|0|||
145485386|NCT04497116|524631246|FG001|Overall Study|Clinical Progression Related|0|||
145485387|NCT04497116|524631247|FG002|Overall Study|Clinical Progression Related|0|||
145485388|NCT04497116|524631248|FG003|Overall Study|Clinical Progression Related|0|||
145485389|NCT04497116|524631249|FG004|Overall Study|Clinical Progression Related|0|||
145485390|NCT04497116|524631250|FG005|Overall Study|Clinical Progression Related|0|||
145485391|NCT04497116|524631251|FG006|Overall Study|Clinical Progression Related|0|||
145485392|NCT04497116|524631252|FG007|Overall Study|Clinical Progression Related|0|||
145485393|NCT04497116|524631253|FG008|Overall Study|Clinical Progression Related|0|||
145485394|NCT04497116|524631254|FG009|Overall Study|Clinical Progression Related|1|||
145605166|NCT04543188|525068916|FG000|Phase 1b|Study Terminated By Sponsor|0|||
145605167|NCT04543188|525068917|FG001|Phase 1b|Study Terminated By Sponsor|0|||
145605168|NCT04543188|525068918|FG002|Phase 1b|Study Terminated By Sponsor|0|||
145605169|NCT04543188|525068919|FG003|Phase 1b|Study Terminated By Sponsor|0|||
145605170|NCT04543188|525068920|FG004|Phase 1b|Study Terminated By Sponsor|0|||
145605171|NCT04543188|525068921|FG005|Phase 1b|Study Terminated By Sponsor|0|||
145485395|NCT04497116|524631255|FG010|Overall Study|Clinical Progression Related|0|||
145485396|NCT04497116|524631256|FG011|Overall Study|Clinical Progression Related|0|||
145485397|NCT04497116|524631257|FG012|Overall Study|Clinical Progression Related|0|||
145485398|NCT04497116|524631258|FG013|Overall Study|Clinical Progression Related|0|||
145485399|NCT04497116|524631259|FG014|Overall Study|Clinical Progression Related|0|||
145485400|NCT04497116|524631260|FG015|Overall Study|Clinical Progression Related|0|||
145485401|NCT04497116|524631261|FG016|Overall Study|Clinical Progression Related|0|||
145485402|NCT04497116|524631262|FG017|Overall Study|Clinical Progression Related|0|||
145485403|NCT04497116|524631263|FG018|Overall Study|Clinical Progression Related|0|||
145485404|NCT04497116|524631264|FG019|Overall Study|Clinical Progression Related|0|||
145485405|NCT04497116|524631265|FG020|Overall Study|Clinical Progression Related|0|||
145485406|NCT04497116|524631266|FG021|Overall Study|Clinical Progression Related|0|||
145485407|NCT04497116|524631267|FG022|Overall Study|Clinical Progression Related|0|||
145485408|NCT04497116|524631268|FG023|Overall Study|Clinical Progression Related|0|||
145485409|NCT04497116|524631269|FG024|Overall Study|Clinical Progression Related|0|||
145485410|NCT04524858|524631273|FG000|Overall Study|Adverse Event|1|||
145485411|NCT00113841|524631277|FG000|Overall Study|Disease progression|0|||
145485412|NCT00113841|524631278|FG001|Overall Study|Disease progression|2|||
145485413|NCT00113841|524631277|FG000|Overall Study|Non-compliant|1|||
145485414|NCT00113841|524631278|FG001|Overall Study|Non-compliant|0|||
145485415|NCT01788566|524631279|FG000|Overall Study|Death|4|||
145485416|NCT01788566|524631279|FG000|Overall Study|Adverse Event|1|||
145485417|NCT01788566|524631279|FG000|Overall Study|Clinical Progressive Disease|3|||
145485418|NCT01539759|524631282|FG000|Overall Study|Lost to Follow-up|6|||
145485419|NCT01539759|524631283|FG001|Overall Study|Lost to Follow-up|8|||
145485420|NCT01076959|524631284|FG000|Overall Study|Adverse Event|767|||
145485421|NCT01076959|524631284|FG000|Overall Study|Lack of Efficacy|849|||
145485422|NCT01076959|524631284|FG000|Overall Study|Non-compliance|274|||
145485423|NCT01076959|524631284|FG000|Overall Study|Lost to Follow-up|241|||
145485424|NCT01076959|524631284|FG000|Overall Study|Other|119|||
145485425|NCT01425801|524631285|FG000|Period 1|Withdrawal by Subject|0|||
145485426|NCT01425801|524631286|FG001|Period 1|Withdrawal by Subject|0|||
145485427|NCT01425801|524631287|FG002|Period 1|Withdrawal by Subject|0|||
145485428|NCT01425801|524631288|FG003|Period 1|Withdrawal by Subject|0|||
145485429|NCT01425801|524631289|FG004|Period 1|Withdrawal by Subject|1|||
145485430|NCT01425801|524631290|FG005|Period 1|Withdrawal by Subject|0|||
145485431|NCT01425801|524631285|FG000|Period 2|Withdrawal by Subject|0|||
145485432|NCT01425801|524631286|FG001|Period 2|Withdrawal by Subject|0|||
145485433|NCT01425801|524631287|FG002|Period 2|Withdrawal by Subject|0|||
145485434|NCT01425801|524631288|FG003|Period 2|Withdrawal by Subject|0|||
145485435|NCT01425801|524631289|FG004|Period 2|Withdrawal by Subject|1|||
145485436|NCT01425801|524631290|FG005|Period 2|Withdrawal by Subject|0|||
145485437|NCT01425801|524631285|FG000|Period 3|Stability criteria not fullfilled|0|||
145485438|NCT01425801|524631286|FG001|Period 3|Stability criteria not fullfilled|0|||
145485439|NCT01425801|524631287|FG002|Period 3|Stability criteria not fullfilled|1|||
145485440|NCT01425801|524631288|FG003|Period 3|Stability criteria not fullfilled|0|||
145485441|NCT01425801|524631289|FG004|Period 3|Stability criteria not fullfilled|0|||
145485442|NCT01425801|524631290|FG005|Period 3|Stability criteria not fullfilled|0|||
145485443|NCT01425801|524631285|FG000|Period 4|Not able to maintain visit schedule|0|||
145485444|NCT01425801|524631286|FG001|Period 4|Not able to maintain visit schedule|0|||
145485445|NCT01425801|524631287|FG002|Period 4|Not able to maintain visit schedule|1|||
145485446|NCT01425801|524631288|FG003|Period 4|Not able to maintain visit schedule|0|||
145485447|NCT01425801|524631289|FG004|Period 4|Not able to maintain visit schedule|0|||
145485448|NCT01425801|524631290|FG005|Period 4|Not able to maintain visit schedule|0|||
145485449|NCT02868554|524631291|FG000|Overall Study|Lost to Follow-up|3|||
145639765|NCT01430611|525196273|FG000|Overall Study|Lost to Follow-up|1|||
145485450|NCT02868554|524631292|FG001|Overall Study|Lost to Follow-up|0|||
145485451|NCT02868554|524631293|FG002|Overall Study|Lost to Follow-up|1|||
145485452|NCT02175017|524631294|FG000|Overall Study|Did not receive the investigational product|1|||
145485453|NCT02175017|524631295|FG001|Overall Study|Did not receive the investigational product|2|||
145485454|NCT02175017|524631294|FG000|Overall Study|Withdrawal by Subject|6|||
145485455|NCT02175017|524631295|FG001|Overall Study|Withdrawal by Subject|3|||
145485456|NCT02175017|524631294|FG000|Overall Study|Met an exclusion criteria|0|||
145485457|NCT02175017|524631295|FG001|Overall Study|Met an exclusion criteria|1|||
145485458|NCT02175017|524631294|FG000|Overall Study|Adverse Event|3|||
145485459|NCT02175017|524631295|FG001|Overall Study|Adverse Event|10|||
145485460|NCT02175017|524631294|FG000|Overall Study|Disease progression|20|||
145485461|NCT02175017|524631295|FG001|Overall Study|Disease progression|27|||
145485462|NCT02175017|524631294|FG000|Overall Study|Other than above reasons|3|||
145485463|NCT02175017|524631295|FG001|Overall Study|Other than above reasons|0|||
145485464|NCT02491983|524631296|FG000|Overall Study|Physician Decision|1|||
145485465|NCT02491983|524631297|FG001|Overall Study|Physician Decision|0|||
145485466|NCT02491983|524631296|FG000|Overall Study|Not meet selection criteria|1|||
145485467|NCT02491983|524631297|FG001|Overall Study|Not meet selection criteria|0|||
145485468|NCT02491983|524631296|FG000|Overall Study|Withdrawal by Subject|0|||
145485469|NCT02491983|524631297|FG001|Overall Study|Withdrawal by Subject|1|||
145485470|NCT00191308|524631298|FG000|Overall Study|Adverse Event|1|||
145485471|NCT03066596|524631299|FG000|Overall Study|Withdrawal by Subject|4|||
145485472|NCT03066596|524631300|FG001|Overall Study|Withdrawal by Subject|2|||
145485473|NCT03066596|524631299|FG000|Overall Study|Lost to Follow-up|14|||
145485474|NCT03066596|524631300|FG001|Overall Study|Lost to Follow-up|10|||
145485475|NCT02330055|524631301|FG000|Overall Study|technical issues|2|||
145485476|NCT02330055|524631302|FG001|Overall Study|technical issues|0|||
145485477|NCT02330055|524631301|FG000|Overall Study|participant forgot to wear device|5|||
145485478|NCT02330055|524631302|FG001|Overall Study|participant forgot to wear device|5|||
145485479|NCT02330055|524631301|FG000|Overall Study|data for less than 60 minutes|3|||
145485480|NCT02330055|524631302|FG001|Overall Study|data for less than 60 minutes|3|||
145485481|NCT02330055|524631301|FG000|Overall Study|participant did not sleep|0|||
145485482|NCT02330055|524631302|FG001|Overall Study|participant did not sleep|1|||
145485483|NCT03201419|524631305|FG000|Overall Study|Adverse Event|3|||
145485484|NCT03201419|524631306|FG001|Overall Study|Adverse Event|1|||
145485485|NCT03201419|524631307|FG002|Overall Study|Adverse Event|0|||
145485486|NCT03201419|524631308|FG003|Overall Study|Adverse Event|0|||
145485487|NCT03201419|524631309|FG004|Overall Study|Adverse Event|1|||
145485488|NCT03201419|524631310|FG005|Overall Study|Adverse Event|1|||
145485489|NCT03201419|524631311|FG006|Overall Study|Adverse Event|5|||
145485490|NCT03201419|524631312|FG007|Overall Study|Adverse Event|0|||
145485491|NCT03201419|524631313|FG008|Overall Study|Adverse Event|0|||
145485492|NCT03201419|524631305|FG000|Overall Study|Lost to Follow-up|1|||
145485493|NCT03201419|524631306|FG001|Overall Study|Lost to Follow-up|0|||
145485494|NCT03201419|524631307|FG002|Overall Study|Lost to Follow-up|0|||
145485495|NCT03201419|524631308|FG003|Overall Study|Lost to Follow-up|0|||
145485496|NCT03201419|524631309|FG004|Overall Study|Lost to Follow-up|0|||
145485497|NCT03201419|524631310|FG005|Overall Study|Lost to Follow-up|0|||
145485498|NCT03201419|524631311|FG006|Overall Study|Lost to Follow-up|0|||
145485499|NCT03201419|524631312|FG007|Overall Study|Lost to Follow-up|0|||
145485500|NCT03201419|524631313|FG008|Overall Study|Lost to Follow-up|0|||
145485501|NCT03201419|524631305|FG000|Overall Study|Protocol Deviation|0|||
145485502|NCT03201419|524631306|FG001|Overall Study|Protocol Deviation|0|||
145485503|NCT03201419|524631307|FG002|Overall Study|Protocol Deviation|0|||
145485504|NCT03201419|524631308|FG003|Overall Study|Protocol Deviation|0|||
145485505|NCT03201419|524631309|FG004|Overall Study|Protocol Deviation|0|||
145485506|NCT03201419|524631310|FG005|Overall Study|Protocol Deviation|0|||
145485507|NCT03201419|524631311|FG006|Overall Study|Protocol Deviation|1|||
145485508|NCT03201419|524631312|FG007|Overall Study|Protocol Deviation|0|||
145485509|NCT03201419|524631313|FG008|Overall Study|Protocol Deviation|0|||
145485510|NCT03201419|524631305|FG000|Overall Study|Withdrawal by Subject|4|||
145485511|NCT03201419|524631306|FG001|Overall Study|Withdrawal by Subject|2|||
145485512|NCT03201419|524631307|FG002|Overall Study|Withdrawal by Subject|1|||
145485513|NCT03201419|524631308|FG003|Overall Study|Withdrawal by Subject|0|||
145485514|NCT03201419|524631309|FG004|Overall Study|Withdrawal by Subject|0|||
145485515|NCT03201419|524631310|FG005|Overall Study|Withdrawal by Subject|0|||
145485516|NCT03201419|524631311|FG006|Overall Study|Withdrawal by Subject|0|||
145485517|NCT03201419|524631312|FG007|Overall Study|Withdrawal by Subject|1|||
145485518|NCT03201419|524631313|FG008|Overall Study|Withdrawal by Subject|2|||
145485519|NCT03201419|524631305|FG000|Overall Study|Other|0|||
145485520|NCT03201419|524631306|FG001|Overall Study|Other|0|||
145485521|NCT03201419|524631307|FG002|Overall Study|Other|1|||
145485522|NCT03201419|524631308|FG003|Overall Study|Other|0|||
145485523|NCT03201419|524631309|FG004|Overall Study|Other|0|||
145485524|NCT03201419|524631310|FG005|Overall Study|Other|0|||
145485525|NCT03201419|524631311|FG006|Overall Study|Other|0|||
145485526|NCT03201419|524631312|FG007|Overall Study|Other|0|||
145485527|NCT03201419|524631313|FG008|Overall Study|Other|0|||
145605172|NCT04543188|525068922|FG006|Phase 1b|Study Terminated By Sponsor|0|||
145605173|NCT04543188|525068923|FG007|Phase 1b|Study Terminated By Sponsor|0|||
145605174|NCT04543188|525068924|FG008|Phase 1b|Study Terminated By Sponsor|0|||
145605175|NCT04543188|525068925|FG009|Phase 1b|Study Terminated By Sponsor|0|||
145485528|NCT01045694|524631317|FG000|Overall Study|Withdrawal by Subject|2|||
145485529|NCT00549445|524631321|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
145485530|NCT00549445|524631322|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
145485531|NCT01900652|524631323|FG000|Overall Study|Progressive Disease|1|||
145605176|NCT04543188|525068926|FG010|Phase 1b|Study Terminated By Sponsor|0|||
145605177|NCT04543188|525068927|FG011|Phase 1b|Study Terminated By Sponsor|1|||
145605178|NCT04543188|525068928|FG012|Phase 1b|Study Terminated By Sponsor|1|||
145605179|NCT04543188|525068929|FG013|Phase 1b|Study Terminated By Sponsor|0|||
145605180|NCT04543188|525068930|FG014|Phase 1b|Study Terminated By Sponsor|1|||
145605181|NCT04543188|525068916|FG000|Phase 1b|Withdrawal by Subject|0|||
145605182|NCT04543188|525068917|FG001|Phase 1b|Withdrawal by Subject|0|||
145605183|NCT04543188|525068918|FG002|Phase 1b|Withdrawal by Subject|0|||
145605184|NCT04543188|525068919|FG003|Phase 1b|Withdrawal by Subject|0|||
145605185|NCT04543188|525068920|FG004|Phase 1b|Withdrawal by Subject|0|||
145605186|NCT04543188|525068921|FG005|Phase 1b|Withdrawal by Subject|0|||
145605187|NCT04543188|525068922|FG006|Phase 1b|Withdrawal by Subject|0|||
145485532|NCT01900652|524631324|FG001|Overall Study|Progressive Disease|0|||
145485533|NCT01900652|524631323|FG000|Overall Study|Consent withdrawn by subject|1|||
145485534|NCT01900652|524631324|FG001|Overall Study|Consent withdrawn by subject|1|||
145485535|NCT01900652|524631323|FG000|Overall Study|Death|3|||
145485536|NCT01900652|524631324|FG001|Overall Study|Death|0|||
145485537|NCT01900652|524631323|FG000|Overall Study|Adverse Event|2|||
145485538|NCT01900652|524631324|FG001|Overall Study|Adverse Event|1|||
145485539|NCT01900652|524631323|FG000|Overall Study|Physician Decision|1|||
145485540|NCT01900652|524631324|FG001|Overall Study|Physician Decision|1|||
145485541|NCT03566082|524631325|FG000|Overall Study|Death|7|||
145485542|NCT03566082|524631325|FG000|Overall Study|Failures (revision required)|2|||
145485543|NCT03566082|524631325|FG000|Overall Study|Lost to Follow-up|8|||
145485544|NCT01389882|524633133|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
145485545|NCT01389882|524633134|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
145485546|NCT01389882|524633133|FG000|Overall Study|Withdrawal by Subject|0|||
145485547|NCT01389882|524633134|FG001|Overall Study|Withdrawal by Subject|1|||
145485548|NCT03654690|524633137|FG000|Overall Study|Withdrawal by Subject|1|||
145485549|NCT03654690|524633138|FG001|Overall Study|Withdrawal by Subject|0|||
145485550|NCT03654690|524633139|FG002|Overall Study|Withdrawal by Subject|0|||
145485551|NCT00466440|524633140|FG000|Overall Study|Adverse Event|0|||
145485552|NCT00466440|524633141|FG001|Overall Study|Adverse Event|3|||
145485553|NCT00466440|524633142|FG002|Overall Study|Adverse Event|1|||
145485554|NCT00466440|524633140|FG000|Overall Study|Death|1|||
145485555|NCT00466440|524633141|FG001|Overall Study|Death|1|||
145485556|NCT00466440|524633142|FG002|Overall Study|Death|0|||
145485557|NCT00466440|524633140|FG000|Overall Study|Progressive disease|13|||
145485558|NCT00466440|524633141|FG001|Overall Study|Progressive disease|5|||
145485559|NCT00466440|524633142|FG002|Overall Study|Progressive disease|4|||
145485560|NCT00466440|524633140|FG000|Overall Study|Lost to Follow-up|0|||
145485561|NCT00466440|524633141|FG001|Overall Study|Lost to Follow-up|1|||
145485562|NCT00466440|524633142|FG002|Overall Study|Lost to Follow-up|0|||
145485563|NCT00466440|524633140|FG000|Overall Study|Physician Decision|0|||
145485564|NCT00466440|524633141|FG001|Overall Study|Physician Decision|1|||
145485565|NCT00466440|524633142|FG002|Overall Study|Physician Decision|2|||
145485566|NCT00466440|524633140|FG000|Overall Study|Protocol entry criteria not met|0|||
145485567|NCT00466440|524633141|FG001|Overall Study|Protocol entry criteria not met|0|||
145485568|NCT00466440|524633142|FG002|Overall Study|Protocol entry criteria not met|4|||
145485569|NCT00466440|524633140|FG000|Overall Study|Withdrawal by Subject|0|||
145485570|NCT00466440|524633141|FG001|Overall Study|Withdrawal by Subject|1|||
145485571|NCT00466440|524633142|FG002|Overall Study|Withdrawal by Subject|0|||
145485572|NCT00466440|524633140|FG000|Overall Study|Sponsor decision|0|||
145485573|NCT00466440|524633141|FG001|Overall Study|Sponsor decision|0|||
145485574|NCT00466440|524633142|FG002|Overall Study|Sponsor decision|1|||
145605188|NCT04543188|525068923|FG007|Phase 1b|Withdrawal by Subject|0|||
145605189|NCT04543188|525068924|FG008|Phase 1b|Withdrawal by Subject|0|||
145605190|NCT04543188|525068925|FG009|Phase 1b|Withdrawal by Subject|0|||
145605191|NCT04543188|525068926|FG010|Phase 1b|Withdrawal by Subject|0|||
145605192|NCT04543188|525068927|FG011|Phase 1b|Withdrawal by Subject|0|||
145605193|NCT04543188|525068928|FG012|Phase 1b|Withdrawal by Subject|0|||
145605194|NCT04543188|525068929|FG013|Phase 1b|Withdrawal by Subject|0|||
145605195|NCT04543188|525068930|FG014|Phase 1b|Withdrawal by Subject|2|||
145605196|NCT02487472|525068931|FG000|Overall Study|Did not complete telephonic interviews|9|||
145605197|NCT02487472|525068931|FG000|Overall Study|Other|2|||
145605198|NCT01313286|525068936|FG000|Period 1|Withdrawal by Subject|2|||
145605199|NCT01313286|525068937|FG001|Period 1|Withdrawal by Subject|0|||
145605200|NCT02034708|525068938|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
145605201|NCT02034708|525068939|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
145605202|NCT02034708|525068938|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
145605203|NCT02034708|525068939|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
145605204|NCT02034708|525068938|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
145605205|NCT02034708|525068939|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
145605206|NCT02034708|525068938|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
145605207|NCT02034708|525068939|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
145605208|NCT00654901|525068940|FG000|Overall Study|Lost to Follow-up|1|||
145605209|NCT00654901|525068941|FG001|Overall Study|Lost to Follow-up|0|||
145605210|NCT00654901|525068942|FG002|Overall Study|Lost to Follow-up|1|||
145605211|NCT00654901|525068943|FG003|Overall Study|Lost to Follow-up|0|||
145605212|NCT00654901|525068940|FG000|Overall Study|Withdrawal by Subject|3|||
145605213|NCT00654901|525068941|FG001|Overall Study|Withdrawal by Subject|0|||
145485575|NCT03187132|524633143|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
145485576|NCT03187132|524633144|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
145485577|NCT03187132|524633143|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
145485578|NCT03187132|524633144|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
145485579|NCT03187132|524633143|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
145485580|NCT03187132|524633144|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
145485581|NCT03187132|524633143|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
145485582|NCT03187132|524633144|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
145485583|NCT03187132|524633143|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
145485584|NCT03187132|524633144|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
145485585|NCT03187132|524633143|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
145485586|NCT03187132|524633144|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
145485587|NCT03187132|524633143|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
145485588|NCT03187132|524633144|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
145485589|NCT03187132|524633143|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
145485590|NCT03187132|524633144|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
145485591|NCT03187132|524633143|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
145485592|NCT03187132|524633144|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
145485593|NCT03187132|524633143|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
145485594|NCT03187132|524633144|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
145485595|NCT03187132|524633143|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
145485596|NCT03187132|524633144|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
145485597|NCT00965081|524633145|FG000|Overall Study|Adverse Event|14|||
145485598|NCT00965081|524633146|FG001|Overall Study|Adverse Event|9|||
145485599|NCT00965081|524633145|FG000|Overall Study|Lack of Efficacy|2|||
145485600|NCT00965081|524633146|FG001|Overall Study|Lack of Efficacy|5|||
145485601|NCT00965081|524633145|FG000|Overall Study|Lost to Follow-up|4|||
145485602|NCT00965081|524633146|FG001|Overall Study|Lost to Follow-up|5|||
145485603|NCT00965081|524633145|FG000|Overall Study|Physician Decision|2|||
145485604|NCT00965081|524633146|FG001|Overall Study|Physician Decision|0|||
145485605|NCT00965081|524633145|FG000|Overall Study|Protocol Violation|2|||
145485606|NCT00965081|524633146|FG001|Overall Study|Protocol Violation|5|||
145485607|NCT00965081|524633145|FG000|Overall Study|Sponsor Decision|1|||
145485608|NCT00965081|524633146|FG001|Overall Study|Sponsor Decision|0|||
145485609|NCT00965081|524633145|FG000|Overall Study|Withdrawal by Subject|4|||
145485610|NCT00965081|524633146|FG001|Overall Study|Withdrawal by Subject|7|||
145485611|NCT00965081|524633145|FG000|Overall Study|Switched to Rescue Arm|5|||
145485612|NCT00965081|524633146|FG001|Overall Study|Switched to Rescue Arm|12|||
145485613|NCT01367834|524633149|FG000|Overall Study|Withdrawal by Subject|2|||
145485614|NCT01367834|524633150|FG001|Overall Study|Withdrawal by Subject|2|||
145485615|NCT01367834|524633149|FG000|Overall Study|Study was ended.|0|||
145485616|NCT01367834|524633150|FG001|Overall Study|Study was ended.|1|||
145485617|NCT00988598|524633151|FG000|Overall Study|Withdrawal by Subject|2|||
145485618|NCT00988598|524633152|FG001|Overall Study|Withdrawal by Subject|0|||
145485619|NCT01141712|524633158|FG000|Overall Study|Disease progression|3|||
145485620|NCT04435366|524633166|FG000|Year 1 (12 Months)|Adverse Event|3|||
145485621|NCT04435366|524633167|FG001|Year 1 (12 Months)|Adverse Event|0|||
145485622|NCT04435366|524633168|FG002|Year 1 (12 Months)|Adverse Event|2|||
145485623|NCT04435366|524633166|FG000|Year 1 (12 Months)|Death|2|||
145485624|NCT04435366|524633167|FG001|Year 1 (12 Months)|Death|0|||
145485625|NCT04435366|524633168|FG002|Year 1 (12 Months)|Death|1|||
145485626|NCT04435366|524633166|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
145485627|NCT04435366|524633167|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
145485628|NCT04435366|524633168|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
145485629|NCT04435366|524633166|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
145485630|NCT04435366|524633167|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
145485631|NCT04435366|524633168|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
145485632|NCT04435366|524633166|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
145485633|NCT04435366|524633167|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
145485634|NCT04435366|524633168|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
145485635|NCT04435366|524633166|FG000|Year 1 (12 Months)|Not treated|0|||
145485636|NCT04435366|524633167|FG001|Year 1 (12 Months)|Not treated|0|||
145485637|NCT04435366|524633168|FG002|Year 1 (12 Months)|Not treated|1|||
145485638|NCT04435366|524633166|FG000|Year 2 (12 Months)|Death|1|||
145485639|NCT04435366|524633167|FG001|Year 2 (12 Months)|Death|4|||
145485640|NCT04435366|524633168|FG002|Year 2 (12 Months)|Death|6|||
145639766|NCT01430611|525196274|FG001|Overall Study|Lost to Follow-up|0|||
145639767|NCT01430611|525196273|FG000|Overall Study|Withdrawal by Subject|15|||
145639768|NCT01430611|525196274|FG001|Overall Study|Withdrawal by Subject|14|||
145639769|NCT02261467|525196275|FG000|Overall Study|Enrolled in Error|1|||
145639770|NCT02261467|525196276|FG001|Overall Study|Enrolled in Error|0|||
145485641|NCT04435366|524633166|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
145485642|NCT04435366|524633167|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
145485643|NCT04435366|524633168|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
145485644|NCT04435366|524633166|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
145485645|NCT04435366|524633167|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
145639771|NCT02261467|525196275|FG000|Overall Study|Protocol Violation|0|||
145485646|NCT04435366|524633168|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
145485647|NCT04435366|524633166|FG000|Year 2 (12 Months)|Adverse Event|2|||
145485648|NCT04435366|524633167|FG001|Year 2 (12 Months)|Adverse Event|1|||
145485649|NCT04435366|524633168|FG002|Year 2 (12 Months)|Adverse Event|6|||
145485650|NCT04112810|524633173|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
145485651|NCT05963022|524633174|FG000|Overall Study|Adverse Event|0|||
145485652|NCT05963022|524633175|FG001|Overall Study|Adverse Event|1|||
145485653|NCT05963022|524633176|FG002|Overall Study|Adverse Event|1|||
145485654|NCT05963022|524633177|FG003|Overall Study|Adverse Event|0|||
145485655|NCT05963022|524633174|FG000|Overall Study|Protocol Violation|0|||
145485656|NCT05963022|524633175|FG001|Overall Study|Protocol Violation|3|||
145485657|NCT05963022|524633176|FG002|Overall Study|Protocol Violation|0|||
145485658|NCT05963022|524633177|FG003|Overall Study|Protocol Violation|0|||
145485659|NCT05963022|524633174|FG000|Overall Study|Pregnancy|0|||
145485660|NCT05963022|524633175|FG001|Overall Study|Pregnancy|1|||
145485661|NCT05963022|524633176|FG002|Overall Study|Pregnancy|1|||
145485662|NCT05963022|524633177|FG003|Overall Study|Pregnancy|1|||
145485663|NCT05963022|524633174|FG000|Overall Study|Withdrawal by Subject|0|||
145485664|NCT05963022|524633175|FG001|Overall Study|Withdrawal by Subject|0|||
145485665|NCT05963022|524633176|FG002|Overall Study|Withdrawal by Subject|2|||
145485666|NCT05963022|524633177|FG003|Overall Study|Withdrawal by Subject|1|||
145485667|NCT05963022|524633174|FG000|Overall Study|Lost to Follow-up|0|||
145485668|NCT05963022|524633175|FG001|Overall Study|Lost to Follow-up|0|||
145485669|NCT05963022|524633176|FG002|Overall Study|Lost to Follow-up|0|||
145485670|NCT05963022|524633177|FG003|Overall Study|Lost to Follow-up|1|||
145485671|NCT05963022|524633174|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
145485672|NCT05963022|524633175|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
145485673|NCT05963022|524633176|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
145485674|NCT05963022|524633177|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
145485675|NCT01358825|524633178|FG000|Overall Study|Blood sample not drawn|0|||
145485676|NCT01358825|524633179|FG001|Overall Study|Blood sample not drawn|1|||
145485677|NCT01012258|524633180|FG000|Overall Study|Death|14|||
145485678|NCT01012258|524633180|FG000|Overall Study|Lost to Follow-up|1|||
145485679|NCT01012258|524633180|FG000|Overall Study|Adverse Event|1|||
145485680|NCT01012258|524633180|FG000|Overall Study|Progressive Disease (PD)|18|||
145485681|NCT01012258|524633180|FG000|Overall Study|Symptomatic Deterioration|1|||
145485682|NCT01012258|524633180|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
145485683|NCT01012258|524633180|FG000|Overall Study|Another Tumor Discovered|1|||
145485684|NCT01012258|524633180|FG000|Overall Study|Ongoing|29|||
145485685|NCT03081884|524633189|FG000|Overall Study|deferred prostate cancer treatment|1|||
145485686|NCT03081884|524633189|FG000|Overall Study|metastasis managed with systemic therapy|3|||
145485687|NCT03948334|524633190|FG000|Overall Study|Adverse Event|1|||
145485688|NCT03948334|524633191|FG001|Overall Study|Adverse Event|4|||
145485689|NCT03948334|524633190|FG000|Overall Study|Lack of Efficacy|2|||
145485690|NCT03948334|524633191|FG001|Overall Study|Lack of Efficacy|0|||
145485691|NCT03948334|524633190|FG000|Overall Study|Lost to Follow-up|1|||
145485692|NCT03948334|524633191|FG001|Overall Study|Lost to Follow-up|0|||
145485693|NCT03948334|524633190|FG000|Overall Study|Physician Decision|1|||
145485694|NCT03948334|524633191|FG001|Overall Study|Physician Decision|0|||
145485695|NCT03948334|524633190|FG000|Overall Study|Pregnancy|0|||
145485696|NCT03948334|524633191|FG001|Overall Study|Pregnancy|1|||
145485697|NCT03948334|524633190|FG000|Overall Study|Protocol Deviation|1|||
145485698|NCT03948334|524633191|FG001|Overall Study|Protocol Deviation|0|||
145485699|NCT03948334|524633190|FG000|Overall Study|Study terminated by Sponsor|50|||
145485700|NCT03948334|524633191|FG001|Overall Study|Study terminated by Sponsor|51|||
145485701|NCT03948334|524633190|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
145485702|NCT03948334|524633191|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
145485703|NCT03575403|524633192|FG000|Overall Study|Adverse Event|1|||
145485704|NCT03575403|524633193|FG001|Overall Study|Adverse Event|0|||
145485705|NCT03575403|524633194|FG002|Overall Study|Adverse Event|0|||
145485706|NCT03575403|524633192|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
145485707|NCT03575403|524633193|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
145485708|NCT03575403|524633194|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
145485709|NCT00773513|524633195|FG000|Overall Study|Renal Transplant|254|||
145485710|NCT00773513|524633196|FG001|Overall Study|Renal Transplant|263|||
145485711|NCT00773513|524633195|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
145485712|NCT00773513|524633196|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
145485713|NCT00773513|524633195|FG000|Overall Study|Withdrew Consent|68|||
145485714|NCT00773513|524633196|FG001|Overall Study|Withdrew Consent|69|||
145485715|NCT00773513|524633195|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
145485716|NCT00773513|524633196|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
145485717|NCT00773513|524633195|FG000|Overall Study|Failure to Return|22|||
145485718|NCT00773513|524633196|FG001|Overall Study|Failure to Return|8|||
145605214|NCT00654901|525068942|FG002|Overall Study|Withdrawal by Subject|1|||
145605215|NCT00654901|525068943|FG003|Overall Study|Withdrawal by Subject|0|||
145605216|NCT04843930|525068944|FG000|Randomization|Withdrawal by Subject|6|||
145605217|NCT04843930|525068945|FG001|Randomization|Withdrawal by Subject|6|||
145605218|NCT04843930|525068946|FG002|Randomization|Withdrawal by Subject|0|||
145605219|NCT04843930|525068947|FG003|Randomization|Withdrawal by Subject|0|||
145605220|NCT04843930|525068944|FG000|Week 6 Assessment|Adverse Event|3|||
145485719|NCT00773513|524633195|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145485720|NCT00773513|524633196|FG001|Overall Study|Insufficient Therapeutic Response|18|||
145485721|NCT00773513|524633195|FG000|Overall Study|Reason Not Specified|159|||
145485722|NCT00773513|524633196|FG001|Overall Study|Reason Not Specified|126|||
145485723|NCT00773513|524633195|FG000|Overall Study|Death|531|||
145485724|NCT00773513|524633196|FG001|Overall Study|Death|545|||
145485725|NCT02959437|524633197|FG000|Overall Study|Death|33|||
145485726|NCT02959437|524633198|FG001|Overall Study|Death|3|||
145485727|NCT02959437|524633199|FG002|Overall Study|Death|0|||
145485728|NCT02959437|524633200|FG003|Overall Study|Death|0|||
145485729|NCT02959437|524633197|FG000|Overall Study|Lost to Follow-up|3|||
145485730|NCT02959437|524633198|FG001|Overall Study|Lost to Follow-up|1|||
145485731|NCT02959437|524633199|FG002|Overall Study|Lost to Follow-up|0|||
145485732|NCT02959437|524633200|FG003|Overall Study|Lost to Follow-up|0|||
145485733|NCT02959437|524633197|FG000|Overall Study|Withdrawal by Subject|11|||
145485734|NCT02959437|524633198|FG001|Overall Study|Withdrawal by Subject|3|||
145485735|NCT02959437|524633199|FG002|Overall Study|Withdrawal by Subject|0|||
145485736|NCT02959437|524633200|FG003|Overall Study|Withdrawal by Subject|0|||
145485737|NCT02959437|524633197|FG000|Overall Study|Progressive Disease|9|||
145485738|NCT02959437|524633198|FG001|Overall Study|Progressive Disease|1|||
145485739|NCT02959437|524633199|FG002|Overall Study|Progressive Disease|0|||
145485740|NCT02959437|524633200|FG003|Overall Study|Progressive Disease|0|||
145485741|NCT02959437|524633197|FG000|Overall Study|Study Terminated by Sponsor|4|||
145485742|NCT02959437|524633198|FG001|Overall Study|Study Terminated by Sponsor|0|||
145485743|NCT02959437|524633199|FG002|Overall Study|Study Terminated by Sponsor|0|||
145485744|NCT02959437|524633200|FG003|Overall Study|Study Terminated by Sponsor|0|||
145485745|NCT02959437|524633197|FG000|Overall Study|Other Unspecified|2|||
145485746|NCT02959437|524633198|FG001|Overall Study|Other Unspecified|0|||
145485747|NCT02959437|524633199|FG002|Overall Study|Other Unspecified|0|||
145485748|NCT02959437|524633200|FG003|Overall Study|Other Unspecified|0|||
145485749|NCT04170543|524633204|FG000|Overall Study|Death|1|||
145485750|NCT04170543|524633205|FG001|Overall Study|Death|1|||
145485751|NCT04170543|524633206|FG002|Overall Study|Death|1|||
145485752|NCT04170543|524633207|FG003|Overall Study|Death|1|||
145485753|NCT04170543|524633208|FG004|Overall Study|Death|1|||
145485754|NCT04170543|524633204|FG000|Overall Study|Lost to Follow-up|3|||
145485755|NCT04170543|524633205|FG001|Overall Study|Lost to Follow-up|3|||
145485756|NCT04170543|524633206|FG002|Overall Study|Lost to Follow-up|0|||
145485757|NCT04170543|524633207|FG003|Overall Study|Lost to Follow-up|3|||
145485758|NCT04170543|524633208|FG004|Overall Study|Lost to Follow-up|1|||
145485759|NCT04170543|524633204|FG000|Overall Study|Withdrawal by Subject|13|||
145485760|NCT04170543|524633205|FG001|Overall Study|Withdrawal by Subject|6|||
145485761|NCT04170543|524633206|FG002|Overall Study|Withdrawal by Subject|5|||
145485762|NCT04170543|524633207|FG003|Overall Study|Withdrawal by Subject|4|||
145485763|NCT04170543|524633208|FG004|Overall Study|Withdrawal by Subject|9|||
145485764|NCT04170543|524633204|FG000|Overall Study|Not able to transition to phase 2b|8|||
145485765|NCT04170543|524633205|FG001|Overall Study|Not able to transition to phase 2b|0|||
145485766|NCT04170543|524633206|FG002|Overall Study|Not able to transition to phase 2b|10|||
145485767|NCT04170543|524633207|FG003|Overall Study|Not able to transition to phase 2b|0|||
145485768|NCT04170543|524633208|FG004|Overall Study|Not able to transition to phase 2b|6|||
145485769|NCT04170543|524633204|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
145485770|NCT04170543|524633205|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
145485771|NCT04170543|524633206|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
145485772|NCT04170543|524633207|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
145485773|NCT04170543|524633208|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
145485774|NCT04170543|524633204|FG000|Overall Study|Not Treated|0|||
145485775|NCT04170543|524633205|FG001|Overall Study|Not Treated|0|||
145485776|NCT04170543|524633206|FG002|Overall Study|Not Treated|0|||
145485777|NCT04170543|524633207|FG003|Overall Study|Not Treated|0|||
145485778|NCT04170543|524633208|FG004|Overall Study|Not Treated|2|||
145639772|NCT02261467|525196276|FG001|Overall Study|Protocol Violation|1|||
145639773|NCT02261467|525196275|FG000|Overall Study|Personal Reasons|17|||
145639774|NCT02261467|525196276|FG001|Overall Study|Personal Reasons|22|||
145485779|NCT04170543|524633204|FG000|Overall Study|(CRF)|16|||
145485780|NCT04170543|524633205|FG001|Overall Study|(CRF)|15|||
145639775|NCT02261467|525196275|FG000|Overall Study|Lost to Follow-up|2|||
145639776|NCT02261467|525196276|FG001|Overall Study|Lost to Follow-up|13|||
145639777|NCT02261467|525196275|FG000|Overall Study|Adverse Event|1|||
145639778|NCT02261467|525196276|FG001|Overall Study|Adverse Event|1|||
145485781|NCT04170543|524633206|FG002|Overall Study|(CRF)|12|||
145639779|NCT00794118|525196279|FG000|Overall Study|Lost to Follow-up|16|||
145485782|NCT04170543|524633207|FG003|Overall Study|(CRF)|17|||
145485783|NCT04170543|524633208|FG004|Overall Study|(CRF)|17|||
145485784|NCT04170543|524633204|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
145485785|NCT04170543|524633205|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
145485786|NCT04170543|524633206|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
145485787|NCT04170543|524633207|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
145485788|NCT04170543|524633208|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
145485789|NCT04628780|524633209|FG000|Overall Study|Death|0|||
145485790|NCT04628780|524633210|FG001|Overall Study|Death|1|||
145639780|NCT00794118|525196279|FG000|Overall Study|Withdrawal by Subject|9|||
145485791|NCT04628780|524633211|FG002|Overall Study|Death|0|||
145485792|NCT04628780|524633212|FG003|Overall Study|Death|0|||
145485793|NCT04628780|524633213|FG004|Overall Study|Death|1|||
145485794|NCT04628780|524633214|FG005|Overall Study|Death|0|||
145485795|NCT04628780|524633209|FG000|Overall Study|Physician Decision|2|||
145485796|NCT04628780|524633210|FG001|Overall Study|Physician Decision|0|||
145485797|NCT04628780|524633211|FG002|Overall Study|Physician Decision|0|||
145485798|NCT04628780|524633212|FG003|Overall Study|Physician Decision|0|||
145485799|NCT04628780|524633213|FG004|Overall Study|Physician Decision|2|||
145485800|NCT04628780|524633214|FG005|Overall Study|Physician Decision|0|||
145485801|NCT04628780|524633209|FG000|Overall Study|Progressive disease|2|||
145485802|NCT04628780|524633210|FG001|Overall Study|Progressive disease|2|||
145485803|NCT04628780|524633211|FG002|Overall Study|Progressive disease|2|||
145485804|NCT04628780|524633212|FG003|Overall Study|Progressive disease|3|||
145485805|NCT04628780|524633213|FG004|Overall Study|Progressive disease|9|||
145485806|NCT04628780|524633214|FG005|Overall Study|Progressive disease|4|||
145485807|NCT04628780|524633209|FG000|Overall Study|Withdrawal by Subject|0|||
145485808|NCT04628780|524633210|FG001|Overall Study|Withdrawal by Subject|1|||
145485809|NCT04628780|524633211|FG002|Overall Study|Withdrawal by Subject|2|||
145485810|NCT04628780|524633212|FG003|Overall Study|Withdrawal by Subject|0|||
145485811|NCT04628780|524633213|FG004|Overall Study|Withdrawal by Subject|3|||
145485812|NCT04628780|524633214|FG005|Overall Study|Withdrawal by Subject|1|||
145485813|NCT04628780|524633209|FG000|Overall Study|Global deterioration of health status|0|||
145485814|NCT04628780|524633210|FG001|Overall Study|Global deterioration of health status|0|||
145485815|NCT04628780|524633211|FG002|Overall Study|Global deterioration of health status|0|||
145485816|NCT04628780|524633212|FG003|Overall Study|Global deterioration of health status|0|||
145485817|NCT04628780|524633213|FG004|Overall Study|Global deterioration of health status|1|||
145485818|NCT04628780|524633214|FG005|Overall Study|Global deterioration of health status|1|||
145485819|NCT03622814|524633216|FG000|Overall Study|Lost to Follow-up|8|||
145485820|NCT03622814|524633217|FG001|Overall Study|Lost to Follow-up|14|||
145485821|NCT03269994|524633218|FG000|Overall Study|Withdrawal by Subject|4|||
145485822|NCT03269994|524633219|FG001|Overall Study|Withdrawal by Subject|5|||
145485823|NCT03269994|524633218|FG000|Overall Study|Unresectable at surgery|39|||
145485824|NCT03269994|524633219|FG001|Overall Study|Unresectable at surgery|58|||
145485825|NCT03269994|524633218|FG000|Overall Study|Patient canceled surgery|5|||
145485826|NCT03269994|524633219|FG001|Overall Study|Patient canceled surgery|14|||
145485827|NCT03269994|524633218|FG000|Overall Study|Preoperative progression|14|||
145485828|NCT03269994|524633219|FG001|Overall Study|Preoperative progression|9|||
145485829|NCT03269994|524633218|FG000|Overall Study|Preoperative infection|10|||
145485830|NCT03269994|524633219|FG001|Overall Study|Preoperative infection|4|||
145485831|NCT03269994|524633218|FG000|Overall Study|Kidney insufficiency|1|||
145485832|NCT03269994|524633219|FG001|Overall Study|Kidney insufficiency|0|||
145485833|NCT03269994|524633218|FG000|Overall Study|Drug allergy|0|||
145485834|NCT03269994|524633219|FG001|Overall Study|Drug allergy|2|||
145485835|NCT03269994|524633218|FG000|Overall Study|Operation changed to different resection|9|||
145485836|NCT03269994|524633219|FG001|Overall Study|Operation changed to different resection|0|||
145485837|NCT03269994|524633218|FG000|Overall Study|Preoperative steroid|0|||
145485838|NCT03269994|524633219|FG001|Overall Study|Preoperative steroid|3|||
145485839|NCT03269994|524633218|FG000|Overall Study|Accrual Closed|2|||
145485840|NCT03269994|524633219|FG001|Overall Study|Accrual Closed|0|||
145485841|NCT03269994|524633218|FG000|Overall Study|Operation changed to different resection|0|||
145485842|NCT03269994|524633219|FG001|Overall Study|Operation changed to different resection|10|||
145485843|NCT04417361|524633220|FG000|Overall Study|Withdrawal by Subject|1|||
145485844|NCT04417361|524633221|FG001|Overall Study|Withdrawal by Subject|0|||
145485845|NCT04417361|524633220|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
145485846|NCT04417361|524633221|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
145485847|NCT04303559|524633222|FG000|Overall Study|Study closed due to poor enrollment.|1|||
145485848|NCT04378270|524633227|FG000|Overall Study|Lack of Efficacy|1|||
145485849|NCT04378270|524633227|FG000|Overall Study|Withdrawal by Subject|1|||
145485850|NCT04378270|524633227|FG000|Overall Study|Screen Failure|1|||
145485851|NCT04378270|524633227|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
145485852|NCT01327599|524633228|FG000|Overall Study|Adverse Event|1|||
145485853|NCT01327599|524633228|FG000|Overall Study|Could Not Attend Visit|1|||
145485854|NCT01327599|524633228|FG000|Overall Study|Withdrawal of Consent|1|||
145485855|NCT01156714|524633229|FG000|Overall Study|Withdrawal by Subject|9|||
145485856|NCT01156714|524633230|FG001|Overall Study|Withdrawal by Subject|4|||
145485857|NCT01156714|524633231|FG002|Overall Study|Withdrawal by Subject|3|||
145485858|NCT01132313|524633232|FG000|Overall Study|Lack of Efficacy|1|||
145485859|NCT01132313|524633233|FG001|Overall Study|Lack of Efficacy|0|||
145485860|NCT01132313|524633234|FG002|Overall Study|Lack of Efficacy|0|||
145485861|NCT01132313|524633235|FG003|Overall Study|Lack of Efficacy|0|||
145485862|NCT01132313|524633236|FG004|Overall Study|Lack of Efficacy|0|||
145485863|NCT01132313|524633237|FG005|Overall Study|Lack of Efficacy|0|||
145485864|NCT01132313|524633238|FG006|Overall Study|Lack of Efficacy|0|||
145485865|NCT01132313|524633239|FG007|Overall Study|Lack of Efficacy|3|||
145485866|NCT01132313|524633240|FG008|Overall Study|Lack of Efficacy|14|||
145485867|NCT01132313|524633241|FG009|Overall Study|Lack of Efficacy|16|||
145485868|NCT01132313|524633242|FG010|Overall Study|Lack of Efficacy|0|||
145485869|NCT01132313|524633243|FG011|Overall Study|Lack of Efficacy|0|||
145485870|NCT01132313|524633232|FG000|Overall Study|Not treated|2|||
145485871|NCT01132313|524633233|FG001|Overall Study|Not treated|0|||
145485872|NCT01132313|524633234|FG002|Overall Study|Not treated|0|||
145485873|NCT01132313|524633235|FG003|Overall Study|Not treated|0|||
145485874|NCT01132313|524633236|FG004|Overall Study|Not treated|2|||
145485875|NCT01132313|524633237|FG005|Overall Study|Not treated|1|||
145485876|NCT01132313|524633238|FG006|Overall Study|Not treated|3|||
145485877|NCT01132313|524633239|FG007|Overall Study|Not treated|0|||
145485878|NCT01132313|524633240|FG008|Overall Study|Not treated|0|||
145485879|NCT01132313|524633241|FG009|Overall Study|Not treated|0|||
145485880|NCT01132313|524633242|FG010|Overall Study|Not treated|0|||
145485881|NCT01132313|524633243|FG011|Overall Study|Not treated|0|||
145485882|NCT01132313|524633232|FG000|Overall Study|Adverse Event|0|||
145485883|NCT01132313|524633233|FG001|Overall Study|Adverse Event|0|||
145485884|NCT01132313|524633234|FG002|Overall Study|Adverse Event|4|||
145485885|NCT01132313|524633235|FG003|Overall Study|Adverse Event|10|||
145485886|NCT01132313|524633236|FG004|Overall Study|Adverse Event|19|||
145485887|NCT01132313|524633237|FG005|Overall Study|Adverse Event|6|||
145485888|NCT01132313|524633238|FG006|Overall Study|Adverse Event|5|||
145485889|NCT01132313|524633239|FG007|Overall Study|Adverse Event|3|||
145485890|NCT01132313|524633240|FG008|Overall Study|Adverse Event|7|||
145485891|NCT01132313|524633241|FG009|Overall Study|Adverse Event|2|||
145485892|NCT01132313|524633242|FG010|Overall Study|Adverse Event|0|||
145485893|NCT01132313|524633243|FG011|Overall Study|Adverse Event|0|||
145485894|NCT01132313|524633232|FG000|Overall Study|Protocol Violation|0|||
145485895|NCT01132313|524633233|FG001|Overall Study|Protocol Violation|0|||
145485896|NCT01132313|524633234|FG002|Overall Study|Protocol Violation|0|||
145485897|NCT01132313|524633235|FG003|Overall Study|Protocol Violation|1|||
145485898|NCT01132313|524633236|FG004|Overall Study|Protocol Violation|0|||
145485899|NCT01132313|524633237|FG005|Overall Study|Protocol Violation|0|||
145485900|NCT01132313|524633238|FG006|Overall Study|Protocol Violation|0|||
145485901|NCT01132313|524633239|FG007|Overall Study|Protocol Violation|0|||
145485902|NCT01132313|524633240|FG008|Overall Study|Protocol Violation|0|||
145485903|NCT01132313|524633241|FG009|Overall Study|Protocol Violation|0|||
145485904|NCT01132313|524633242|FG010|Overall Study|Protocol Violation|0|||
145485905|NCT01132313|524633243|FG011|Overall Study|Protocol Violation|0|||
145485906|NCT01132313|524633232|FG000|Overall Study|Lost to Follow-up|0|||
145485907|NCT01132313|524633233|FG001|Overall Study|Lost to Follow-up|0|||
145485908|NCT01132313|524633234|FG002|Overall Study|Lost to Follow-up|1|||
145485909|NCT01132313|524633235|FG003|Overall Study|Lost to Follow-up|0|||
145485910|NCT01132313|524633236|FG004|Overall Study|Lost to Follow-up|0|||
145485911|NCT01132313|524633237|FG005|Overall Study|Lost to Follow-up|0|||
145485912|NCT01132313|524633238|FG006|Overall Study|Lost to Follow-up|0|||
145485913|NCT01132313|524633239|FG007|Overall Study|Lost to Follow-up|1|||
145485914|NCT01132313|524633240|FG008|Overall Study|Lost to Follow-up|0|||
145485915|NCT01132313|524633241|FG009|Overall Study|Lost to Follow-up|0|||
145485916|NCT01132313|524633242|FG010|Overall Study|Lost to Follow-up|0|||
145485917|NCT01132313|524633243|FG011|Overall Study|Lost to Follow-up|0|||
145485918|NCT01132313|524633232|FG000|Overall Study|Withdrawal by Subject|0|||
145485919|NCT01132313|524633233|FG001|Overall Study|Withdrawal by Subject|0|||
145485920|NCT01132313|524633234|FG002|Overall Study|Withdrawal by Subject|3|||
145485921|NCT01132313|524633235|FG003|Overall Study|Withdrawal by Subject|3|||
145485922|NCT01132313|524633236|FG004|Overall Study|Withdrawal by Subject|6|||
145485923|NCT01132313|524633237|FG005|Overall Study|Withdrawal by Subject|0|||
145485924|NCT01132313|524633238|FG006|Overall Study|Withdrawal by Subject|1|||
145485925|NCT01132313|524633239|FG007|Overall Study|Withdrawal by Subject|0|||
145485926|NCT01132313|524633240|FG008|Overall Study|Withdrawal by Subject|0|||
145485927|NCT01132313|524633241|FG009|Overall Study|Withdrawal by Subject|2|||
145485928|NCT01132313|524633242|FG010|Overall Study|Withdrawal by Subject|0|||
145485929|NCT01132313|524633243|FG011|Overall Study|Withdrawal by Subject|0|||
145485930|NCT01132313|524633232|FG000|Overall Study|Lack of antiviral response|0|||
145485931|NCT01132313|524633233|FG001|Overall Study|Lack of antiviral response|0|||
145485932|NCT01132313|524633234|FG002|Overall Study|Lack of antiviral response|12|||
145485933|NCT01132313|524633235|FG003|Overall Study|Lack of antiviral response|18|||
145485934|NCT01132313|524633236|FG004|Overall Study|Lack of antiviral response|18|||
145485935|NCT01132313|524633237|FG005|Overall Study|Lack of antiviral response|18|||
145485936|NCT01132313|524633238|FG006|Overall Study|Lack of antiviral response|21|||
145485937|NCT01132313|524633239|FG007|Overall Study|Lack of antiviral response|0|||
145485938|NCT01132313|524633240|FG008|Overall Study|Lack of antiviral response|0|||
145485939|NCT01132313|524633241|FG009|Overall Study|Lack of antiviral response|0|||
145485940|NCT01132313|524633242|FG010|Overall Study|Lack of antiviral response|1|||
145485941|NCT01132313|524633243|FG011|Overall Study|Lack of antiviral response|0|||
145485942|NCT01132313|524633232|FG000|Overall Study|Other reason not defined above|0|||
145485943|NCT01132313|524633233|FG001|Overall Study|Other reason not defined above|0|||
145485944|NCT01132313|524633234|FG002|Overall Study|Other reason not defined above|0|||
145485945|NCT01132313|524633235|FG003|Overall Study|Other reason not defined above|0|||
145485946|NCT01132313|524633236|FG004|Overall Study|Other reason not defined above|0|||
145485947|NCT01132313|524633237|FG005|Overall Study|Other reason not defined above|0|||
145485948|NCT01132313|524633238|FG006|Overall Study|Other reason not defined above|0|||
145485949|NCT01132313|524633239|FG007|Overall Study|Other reason not defined above|1|||
145639781|NCT00794118|525196279|FG000|Overall Study|Changed hospital center|2|||
145639782|NCT01597258|525196285|FG000|Overall Study|No Drug Administration|1|||
145639783|NCT00933400|525196286|FG000|Overall Study|Withdrawal by Subject|21|||
145639784|NCT00933400|525196287|FG001|Overall Study|Withdrawal by Subject|1|||
145639785|NCT01415349|525196288|FG000|Treatment Period 1|Adverse Event|0|||
145639786|NCT01415349|525196289|FG001|Treatment Period 1|Adverse Event|1|||
145639787|NCT01415349|525196288|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145639788|NCT01415349|525196289|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145639789|NCT01041417|525196290|FG000|Overall Study|Adverse Event|5|||
145639790|NCT01041417|525196291|FG001|Overall Study|Adverse Event|2|||
145639791|NCT01041417|525196290|FG000|Overall Study|Lost to Follow-up|1|||
145639792|NCT01041417|525196291|FG001|Overall Study|Lost to Follow-up|1|||
145639793|NCT01041417|525196290|FG000|Overall Study|Death|1|||
145639794|NCT01041417|525196291|FG001|Overall Study|Death|0|||
145639795|NCT01764464|525196292|FG000|First Intervention|Withdrawal by Subject|1|||
145639796|NCT01764464|525196293|FG001|First Intervention|Withdrawal by Subject|0|||
145485950|NCT01132313|524633240|FG008|Overall Study|Other reason not defined above|0|||
145485951|NCT01132313|524633241|FG009|Overall Study|Other reason not defined above|0|||
145485952|NCT01132313|524633242|FG010|Overall Study|Other reason not defined above|0|||
145485953|NCT01132313|524633243|FG011|Overall Study|Other reason not defined above|0|||
145485954|NCT01236521|524633244|FG000|Overall Study|Withdrawal by Subject|12|||
145485955|NCT01236521|524633245|FG001|Overall Study|Withdrawal by Subject|17|||
145485956|NCT01236521|524633244|FG000|Overall Study|Death|2|||
145485957|NCT01236521|524633245|FG001|Overall Study|Death|1|||
145485958|NCT01236521|524633244|FG000|Overall Study|Lost to Follow-up|9|||
145485959|NCT01236521|524633245|FG001|Overall Study|Lost to Follow-up|7|||
145485960|NCT04707469|524633251|FG000|Overall Study|Site closure|0|||
145485961|NCT04707469|524633252|FG001|Overall Study|Site closure|2|||
145485962|NCT04707469|524633253|FG002|Overall Study|Site closure|0|||
145485963|NCT04707469|524633251|FG000|Overall Study|Physician Decision|2|||
145485964|NCT04707469|524633252|FG001|Overall Study|Physician Decision|2|||
145485965|NCT04707469|524633253|FG002|Overall Study|Physician Decision|2|||
145485966|NCT04707469|524633251|FG000|Overall Study|Death|1|||
145485967|NCT04707469|524633252|FG001|Overall Study|Death|6|||
145485968|NCT04707469|524633253|FG002|Overall Study|Death|2|||
145485969|NCT04707469|524633251|FG000|Overall Study|Lost to Follow-up|9|||
145485970|NCT04707469|524633252|FG001|Overall Study|Lost to Follow-up|19|||
145485971|NCT04707469|524633253|FG002|Overall Study|Lost to Follow-up|14|||
145485972|NCT04707469|524633251|FG000|Overall Study|Withdrawal by Subject|17|||
145485973|NCT04707469|524633252|FG001|Overall Study|Withdrawal by Subject|16|||
145485974|NCT04707469|524633253|FG002|Overall Study|Withdrawal by Subject|12|||
145485975|NCT04661150|524633261|FG000|Overall Study|Ongoing in study|19|||
145485976|NCT04661150|524633262|FG001|Overall Study|Ongoing in study|20|||
145485977|NCT04661150|524633261|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
145485978|NCT04661150|524633262|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
145485979|NCT04661150|524633261|FG000|Overall Study|Death|2|||
145485980|NCT04661150|524633262|FG001|Overall Study|Death|0|||
145485981|NCT04965688|524633263|FG000|Overall Study|Withdrawal by Subject|2|||
145485982|NCT04266795|524633264|FG000|Overall Study|Adverse Event|10|||
145485983|NCT04266795|524633265|FG001|Overall Study|Adverse Event|19|||
145485984|NCT04266795|524633264|FG000|Overall Study|Death|7|||
145485985|NCT04266795|524633265|FG001|Overall Study|Death|8|||
145485986|NCT04266795|524633264|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
145485987|NCT04266795|524633265|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
145485988|NCT04266795|524633264|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
145485989|NCT04266795|524633265|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145485990|NCT04266795|524633264|FG000|Overall Study|Progressive Disease|12|||
145485991|NCT04266795|524633265|FG001|Overall Study|Progressive Disease|9|||
145485992|NCT04266795|524633264|FG000|Overall Study|Withdrawal by Patient|5|||
145485993|NCT04266795|524633265|FG001|Overall Study|Withdrawal by Patient|6|||
145639797|NCT01764464|525196292|FG000|First Intervention|Lost to Follow-up|1|||
145639798|NCT01764464|525196293|FG001|First Intervention|Lost to Follow-up|0|||
145485994|NCT04266795|524633264|FG000|Overall Study|Disease Relapse|3|||
145485995|NCT04266795|524633265|FG001|Overall Study|Disease Relapse|6|||
145485996|NCT04266795|524633264|FG000|Overall Study|Reason not Specified|12|||
145485997|NCT04266795|524633265|FG001|Overall Study|Reason not Specified|10|||
145485998|NCT04266795|524633264|FG000|Overall Study|Participants Ongoing on Treatment|25|||
145485999|NCT04266795|524633265|FG001|Overall Study|Participants Ongoing on Treatment|23|||
145639799|NCT01764464|525196292|FG000|First Intervention|Adverse Event|0|||
145639800|NCT01764464|525196293|FG001|First Intervention|Adverse Event|2|||
145639801|NCT01764464|525196292|FG000|First Intervention|did not receive study drug|0|||
145639802|NCT01764464|525196293|FG001|First Intervention|did not receive study drug|1|||
145486000|NCT03043872|524633266|FG000|Overall Study|Withdrawal by Subject|6|||
145639803|NCT01764464|525196292|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
145639804|NCT01764464|525196293|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
145639805|NCT03473340|525196294|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
145639806|NCT03473340|525196295|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
145639807|NCT03473340|525196294|FG000|Overall Study|Withdrawal by Subject|1|||
145639808|NCT03473340|525196295|FG001|Overall Study|Withdrawal by Subject|0|||
145639809|NCT03473340|525196294|FG000|Overall Study|Lost to Follow-up|1|||
145639810|NCT03473340|525196295|FG001|Overall Study|Lost to Follow-up|2|||
145639811|NCT02079844|525196296|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
145639812|NCT02079844|525196297|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
145639813|NCT02079844|525196298|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
145639814|NCT02079844|525196296|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
145639815|NCT02079844|525196297|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
145639816|NCT02079844|525196298|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
145639817|NCT00203411|525196303|FG000|Follow-up|Progressive Disease|4|||
145639818|NCT02531113|525196306|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
145639819|NCT02531113|525196306|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
145639820|NCT02531113|525196306|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
145639821|NCT02531113|525196306|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
145639822|NCT02531113|525196306|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
145639823|NCT02531113|525196306|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
145639824|NCT02531113|525196306|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
145639825|NCT02531113|525196306|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
145639826|NCT00632424|525196307|FG000|Overall Study|Disease Progression|17|||
145639827|NCT00632424|525196307|FG000|Overall Study|Study Drug Toxicity|1|||
145639828|NCT05135000|525196312|FG000|Overall Study|Adverse Event|2|||
145639829|NCT05135000|525196313|FG001|Overall Study|Adverse Event|0|||
145639830|NCT05135000|525196312|FG000|Overall Study|Lost to Follow-up|1|||
145639831|NCT05135000|525196313|FG001|Overall Study|Lost to Follow-up|0|||
145639832|NCT05135000|525196312|FG000|Overall Study|Study Terminated by Sponsor|6|||
145486001|NCT03043872|524633267|FG001|Overall Study|Withdrawal by Subject|6|||
145486002|NCT03043872|524633268|FG002|Overall Study|Withdrawal by Subject|15|||
145486003|NCT03043872|524633266|FG000|Overall Study|Lost to Follow-up|2|||
145486004|NCT03043872|524633267|FG001|Overall Study|Lost to Follow-up|1|||
145639833|NCT05135000|525196313|FG001|Overall Study|Study Terminated by Sponsor|3|||
145639834|NCT02763319|525198005|FG000|Overall Study|Adverse Event|12|||
145639835|NCT02763319|525198006|FG001|Overall Study|Adverse Event|3|||
145639836|NCT02763319|525198005|FG000|Overall Study|Death|123|||
145639837|NCT02763319|525198006|FG001|Overall Study|Death|123|||
145639838|NCT02763319|525198005|FG000|Overall Study|Lost to Follow-up|6|||
145639839|NCT02763319|525198006|FG001|Overall Study|Lost to Follow-up|7|||
145639840|NCT02763319|525198005|FG000|Overall Study|Noncompliance with Study Drug|2|||
145639841|NCT02763319|525198006|FG001|Overall Study|Noncompliance with Study Drug|0|||
145639842|NCT02763319|525198005|FG000|Overall Study|"Captured as Other in Database"|29|||
145639843|NCT02763319|525198006|FG001|Overall Study|"Captured as Other in Database"|34|||
145639844|NCT02763319|525198005|FG000|Overall Study|Physician Decision|1|||
145639845|NCT02763319|525198006|FG001|Overall Study|Physician Decision|7|||
145639846|NCT02763319|525198005|FG000|Overall Study|Progressive Disease|24|||
145639847|NCT02763319|525198006|FG001|Overall Study|Progressive Disease|27|||
145639848|NCT02763319|525198005|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
145639849|NCT02763319|525198006|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
145639850|NCT02763319|525198005|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
145639851|NCT02763319|525198006|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
145639852|NCT02763319|525198005|FG000|Overall Study|Withdrawal by Subject|26|||
145639853|NCT02763319|525198006|FG001|Overall Study|Withdrawal by Subject|25|||
145639854|NCT03936660|525198008|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
145639855|NCT03936660|525198009|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
145639856|NCT01875848|525198013|FG000|Overall Study|Withdrawal by Subject|2|||
145639857|NCT01875848|525198014|FG001|Overall Study|Withdrawal by Subject|0|||
145639858|NCT00840177|525198015|FG000|Overall Study|Adverse Event|5|||
145639859|NCT00840177|525198016|FG001|Overall Study|Adverse Event|1|||
145486005|NCT03043872|524633268|FG002|Overall Study|Lost to Follow-up|1|||
145639860|NCT00840177|525198017|FG002|Overall Study|Adverse Event|1|||
145639861|NCT00840177|525198015|FG000|Overall Study|Refusal unrelated to adverse events|1|||
145639862|NCT00840177|525198016|FG001|Overall Study|Refusal unrelated to adverse events|0|||
145639863|NCT00840177|525198017|FG002|Overall Study|Refusal unrelated to adverse events|1|||
145639864|NCT00840177|525198015|FG000|Overall Study|Progression/relapse|2|||
145639865|NCT00840177|525198016|FG001|Overall Study|Progression/relapse|0|||
145639866|NCT00840177|525198017|FG002|Overall Study|Progression/relapse|0|||
145639867|NCT00840177|525198015|FG000|Overall Study|Death|4|||
145639868|NCT00840177|525198016|FG001|Overall Study|Death|5|||
145639869|NCT00840177|525198017|FG002|Overall Study|Death|5|||
145639870|NCT00840177|525198015|FG000|Overall Study|not protocol specified|6|||
145486006|NCT03043872|524633266|FG000|Overall Study|Death|270|||
145486007|NCT03043872|524633267|FG001|Overall Study|Death|269|||
145486008|NCT03043872|524633268|FG002|Overall Study|Death|296|||
145486009|NCT03868943|524633269|FG000|Overall Study|Adverse Event|1|||
145486010|NCT02777827|524633270|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
145486011|NCT02777827|524633271|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
145486012|NCT02777827|524633272|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
145486013|NCT02777827|524633273|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
145486014|NCT02777827|524633274|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
145486015|NCT02777827|524633275|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
145486016|NCT04551066|524633276|FG000|Overall Study|Death|5|||
145486017|NCT04551066|524633277|FG001|Overall Study|Death|3|||
145486018|NCT04551066|524633276|FG000|Overall Study|Lost to Follow-up|1|||
145486019|NCT04551066|524633277|FG001|Overall Study|Lost to Follow-up|0|||
145486020|NCT04551066|524633276|FG000|Overall Study|Sponsor Decision|104|||
145486021|NCT04551066|524633277|FG001|Overall Study|Sponsor Decision|117|||
145486022|NCT04551066|524633276|FG000|Overall Study|Withdrawal by Subject|8|||
145486023|NCT04551066|524633277|FG001|Overall Study|Withdrawal by Subject|2|||
145486024|NCT04551066|524633276|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
145486025|NCT04551066|524633277|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
145486026|NCT04551066|524633276|FG000|Overall Study|Adverse Event|2|||
145486027|NCT04551066|524633277|FG001|Overall Study|Adverse Event|0|||
145486028|NCT04551066|524633276|FG000|Overall Study|Physician Decision|2|||
145486029|NCT04551066|524633277|FG001|Overall Study|Physician Decision|0|||
145486030|NCT04551066|524633276|FG000|Overall Study|Protocol Violation|1|||
145486031|NCT04551066|524633277|FG001|Overall Study|Protocol Violation|0|||
145486032|NCT04551066|524633276|FG000|Overall Study|Lack of Efficacy|0|||
145486033|NCT04551066|524633277|FG001|Overall Study|Lack of Efficacy|1|||
145486034|NCT04551066|524633276|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
145486035|NCT04551066|524633277|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
145486036|NCT00369577|524633278|FG000|Overall Study|Withdrawal by Subject|0|||
145486037|NCT00369577|524633279|FG001|Overall Study|Withdrawal by Subject|0|||
145486038|NCT00369577|524633280|FG002|Overall Study|Withdrawal by Subject|1|||
145486039|NCT03915470|524633281|FG000|Overall Study|Death|3|||
145486040|NCT03915470|524633282|FG001|Overall Study|Death|1|||
145486041|NCT03915470|524633281|FG000|Overall Study|Adverse Event|1|||
145486042|NCT03915470|524633282|FG001|Overall Study|Adverse Event|0|||
145605221|NCT04843930|525068945|FG001|Week 6 Assessment|Adverse Event|0|||
145605222|NCT04843930|525068946|FG002|Week 6 Assessment|Adverse Event|0|||
145605223|NCT04843930|525068947|FG003|Week 6 Assessment|Adverse Event|0|||
145639871|NCT00840177|525198016|FG001|Overall Study|not protocol specified|3|||
145486043|NCT03915470|524633281|FG000|Overall Study|Physician Decision|1|||
145605224|NCT04843930|525068944|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
145605225|NCT04843930|525068945|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
145605226|NCT04843930|525068946|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
145605227|NCT04843930|525068947|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
145605228|NCT04843930|525068944|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
145605229|NCT04843930|525068945|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
145605230|NCT04843930|525068946|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
145605231|NCT04843930|525068947|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
145605232|NCT02552238|525068950|FG000|Overall Study|Withdrawal by Subject|2|||
145605233|NCT02552238|525068950|FG000|Overall Study|Adverse Event|2|||
145605234|NCT04770779|525068951|FG000|Overall Study|Randomized, never treated|0|||
145605235|NCT04770779|525068952|FG001|Overall Study|Randomized, never treated|1|||
145605236|NCT04770779|525068951|FG000|Overall Study|Adverse Event|9|||
145605237|NCT04770779|525068952|FG001|Overall Study|Adverse Event|1|||
145605238|NCT04770779|525068951|FG000|Overall Study|Withdrawal by Subject|7|||
145605239|NCT04770779|525068952|FG001|Overall Study|Withdrawal by Subject|1|||
145605240|NCT04770779|525068951|FG000|Overall Study|Pregnancy|0|||
145605241|NCT04770779|525068952|FG001|Overall Study|Pregnancy|1|||
145605242|NCT03692052|525068953|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
145605243|NCT03692052|525068953|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
145605244|NCT03692052|525068953|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
145605245|NCT03692052|525068953|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
145605246|NCT04241094|525068954|FG000|Overall Study|Dropped out of treatment|4|||
145605247|NCT04241094|525068954|FG000|Overall Study|Ineligible after clinical assessment|2|||
145605248|NCT04241094|525068954|FG000|Overall Study|Lost to Follow-up|2|||
145605249|NCT01669798|525068955|FG000|Overall Study|Physician Decision|5|||
145605250|NCT05918978|525068959|FG000|Overall Study|Study Terminated by Sponsor|17|||
145605251|NCT05918978|525068960|FG001|Overall Study|Study Terminated by Sponsor|11|||
145605252|NCT05918978|525068959|FG000|Overall Study|Withdrawal by Subject|1|||
145605253|NCT05918978|525068960|FG001|Overall Study|Withdrawal by Subject|1|||
145605254|NCT05918978|525068959|FG000|Overall Study|Adverse Event|1|||
145605255|NCT05918978|525068960|FG001|Overall Study|Adverse Event|0|||
145605256|NCT05918978|525068959|FG000|Overall Study|Other|0|||
145486044|NCT03915470|524633282|FG001|Overall Study|Physician Decision|0|||
145486045|NCT03915470|524633281|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
145486046|NCT03915470|524633282|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
145486047|NCT00434109|524633285|FG000|Overall Study|Physician Decision|9|||
145486048|NCT00434109|524633285|FG000|Overall Study|Adverse Event|5|||
145486049|NCT00434109|524633285|FG000|Overall Study|Protocol Violation|1|||
145486050|NCT00434109|524633285|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
145486051|NCT03790917|524633288|FG000|Overall Study|Death|1|||
145486052|NCT04186871|524633289|FG000|Overall Study|Lack of Efficacy|0|||
145486053|NCT04186871|524633290|FG001|Overall Study|Lack of Efficacy|1|||
145486054|NCT04186871|524633291|FG002|Overall Study|Lack of Efficacy|0|||
145486055|NCT04186871|524633292|FG003|Overall Study|Lack of Efficacy|0|||
145486056|NCT04186871|524633293|FG004|Overall Study|Lack of Efficacy|1|||
145486057|NCT04186871|524633294|FG005|Overall Study|Lack of Efficacy|1|||
145486058|NCT04186871|524633289|FG000|Overall Study|Adverse Event|1|||
145486059|NCT04186871|524633290|FG001|Overall Study|Adverse Event|1|||
145486060|NCT04186871|524633291|FG002|Overall Study|Adverse Event|0|||
145486061|NCT04186871|524633292|FG003|Overall Study|Adverse Event|0|||
145486062|NCT04186871|524633293|FG004|Overall Study|Adverse Event|0|||
145486063|NCT04186871|524633294|FG005|Overall Study|Adverse Event|2|||
145486064|NCT04186871|524633289|FG000|Overall Study|Study terminated by sponsor|1|||
145486065|NCT04186871|524633290|FG001|Overall Study|Study terminated by sponsor|2|||
145486066|NCT04186871|524633291|FG002|Overall Study|Study terminated by sponsor|0|||
145486067|NCT04186871|524633292|FG003|Overall Study|Study terminated by sponsor|1|||
145486068|NCT04186871|524633293|FG004|Overall Study|Study terminated by sponsor|0|||
145486069|NCT04186871|524633294|FG005|Overall Study|Study terminated by sponsor|0|||
145486070|NCT04186871|524633289|FG000|Overall Study|Other reasons|0|||
145486071|NCT04186871|524633290|FG001|Overall Study|Other reasons|0|||
145486072|NCT04186871|524633291|FG002|Overall Study|Other reasons|0|||
145486073|NCT04186871|524633292|FG003|Overall Study|Other reasons|0|||
145486074|NCT04186871|524633293|FG004|Overall Study|Other reasons|0|||
145486075|NCT04186871|524633294|FG005|Overall Study|Other reasons|1|||
145486076|NCT04186871|524633289|FG000|Overall Study|Withdrawal by Subject|0|||
145486077|NCT04186871|524633290|FG001|Overall Study|Withdrawal by Subject|0|||
145486078|NCT04186871|524633291|FG002|Overall Study|Withdrawal by Subject|0|||
145486079|NCT04186871|524633292|FG003|Overall Study|Withdrawal by Subject|0|||
145486080|NCT04186871|524633293|FG004|Overall Study|Withdrawal by Subject|0|||
145486081|NCT04186871|524633294|FG005|Overall Study|Withdrawal by Subject|1|||
145486082|NCT04186871|524633289|FG000|Overall Study|Lost to Follow-up|0|||
145486083|NCT04186871|524633290|FG001|Overall Study|Lost to Follow-up|0|||
145486084|NCT04186871|524633291|FG002|Overall Study|Lost to Follow-up|0|||
145486085|NCT04186871|524633292|FG003|Overall Study|Lost to Follow-up|0|||
145486086|NCT04186871|524633293|FG004|Overall Study|Lost to Follow-up|0|||
145486087|NCT04186871|524633294|FG005|Overall Study|Lost to Follow-up|1|||
145486088|NCT00543387|524633304|FG000|Panel 1 + Panel 2|Adverse Event|0|||
145486089|NCT00543387|524633305|FG001|Panel 1 + Panel 2|Adverse Event|1|||
145486090|NCT00543387|524633306|FG002|Panel 1 + Panel 2|Adverse Event|0|||
145486091|NCT00543387|524633307|FG003|Panel 1 + Panel 2|Adverse Event|0|||
145486092|NCT00543387|524633308|FG004|Panel 1 + Panel 2|Adverse Event|0|||
145486093|NCT00543387|524633309|FG005|Panel 1 + Panel 2|Adverse Event|0|||
145486094|NCT00543387|524633310|FG006|Panel 1 + Panel 2|Adverse Event|0|||
145486095|NCT00543387|524633311|FG007|Panel 1 + Panel 2|Adverse Event|1|||
145486096|NCT00543387|524633312|FG008|Panel 1 + Panel 2|Adverse Event|1|||
145486097|NCT00543387|524633313|FG009|Panel 1 + Panel 2|Adverse Event|0|||
145486098|NCT00543387|524633314|FG010|Panel 1 + Panel 2|Adverse Event|0|||
145486099|NCT00543387|524633304|FG000|Panel 1 + Panel 2|Physician Decision|0|||
145486100|NCT00543387|524633305|FG001|Panel 1 + Panel 2|Physician Decision|0|||
145486101|NCT00543387|524633306|FG002|Panel 1 + Panel 2|Physician Decision|1|||
145486102|NCT00543387|524633307|FG003|Panel 1 + Panel 2|Physician Decision|0|||
145486103|NCT00543387|524633308|FG004|Panel 1 + Panel 2|Physician Decision|0|||
145486104|NCT00543387|524633309|FG005|Panel 1 + Panel 2|Physician Decision|0|||
145486105|NCT00543387|524633310|FG006|Panel 1 + Panel 2|Physician Decision|0|||
145486106|NCT00543387|524633311|FG007|Panel 1 + Panel 2|Physician Decision|1|||
145486107|NCT00543387|524633312|FG008|Panel 1 + Panel 2|Physician Decision|0|||
145486108|NCT00543387|524633313|FG009|Panel 1 + Panel 2|Physician Decision|0|||
145486109|NCT00543387|524633314|FG010|Panel 1 + Panel 2|Physician Decision|0|||
145486110|NCT00543387|524633304|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
145486111|NCT00543387|524633305|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
145486112|NCT00543387|524633306|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
145486113|NCT00543387|524633307|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
145486114|NCT00543387|524633308|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
145486115|NCT00543387|524633309|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
145486116|NCT00543387|524633310|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
145486117|NCT00543387|524633311|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
145486118|NCT00543387|524633312|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
145486119|NCT00543387|524633313|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
145605257|NCT05918978|525068960|FG001|Overall Study|Other|1|||
145486120|NCT00543387|524633314|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
145486121|NCT00543387|524633304|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486122|NCT00543387|524633305|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486123|NCT00543387|524633306|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486124|NCT00543387|524633307|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486125|NCT00543387|524633308|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486126|NCT00543387|524633309|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486127|NCT00543387|524633310|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
145486128|NCT00543387|524633311|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486129|NCT00543387|524633312|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486130|NCT00543387|524633313|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486131|NCT00543387|524633314|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
145486132|NCT00543387|524633304|FG000|Crossover Participants|Progressive Disease|0|||
145486133|NCT00543387|524633305|FG001|Crossover Participants|Progressive Disease|0|||
145486134|NCT00543387|524633306|FG002|Crossover Participants|Progressive Disease|0|||
145486135|NCT00543387|524633307|FG003|Crossover Participants|Progressive Disease|0|||
145486136|NCT00543387|524633308|FG004|Crossover Participants|Progressive Disease|0|||
145486137|NCT00543387|524633309|FG005|Crossover Participants|Progressive Disease|0|||
145486138|NCT00543387|524633310|FG006|Crossover Participants|Progressive Disease|0|||
145486139|NCT00543387|524633311|FG007|Crossover Participants|Progressive Disease|0|||
145486140|NCT00543387|524633312|FG008|Crossover Participants|Progressive Disease|0|||
145486141|NCT00543387|524633313|FG009|Crossover Participants|Progressive Disease|1|||
145486142|NCT00543387|524633314|FG010|Crossover Participants|Progressive Disease|2|||
145486143|NCT00543387|524633304|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
145486144|NCT00543387|524633305|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
145486145|NCT00543387|524633306|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
145486146|NCT00543387|524633307|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
145605258|NCT00622180|525068961|FG000|Overall Study|Lost to Follow-up|1|||
145605259|NCT00622180|525068962|FG001|Overall Study|Lost to Follow-up|2|||
145639872|NCT00840177|525198017|FG002|Overall Study|not protocol specified|0|||
145639873|NCT00840177|525198015|FG000|Overall Study|Ineligible|0|||
145639874|NCT00840177|525198016|FG001|Overall Study|Ineligible|0|||
145639875|NCT00840177|525198017|FG002|Overall Study|Ineligible|3|||
145639876|NCT00840177|525198015|FG000|Overall Study|Did not start treatment|0|||
145639877|NCT00840177|525198016|FG001|Overall Study|Did not start treatment|0|||
145639878|NCT00840177|525198017|FG002|Overall Study|Did not start treatment|1|||
145639879|NCT02407249|525198018|FG000|Overall Study|Did not complete 12-month follow-up|13|||
145639880|NCT02407249|525198018|FG000|Overall Study|Not treated|13|||
145639881|NCT01318382|525198020|FG000|Overall Study|Physician Decision|2|||
145639882|NCT01318382|525198020|FG000|Overall Study|Device Malfunction|10|||
145639883|NCT01318382|525198020|FG000|Overall Study|Protocol Violation|1|||
145639884|NCT01571596|525198023|FG000|Overall Study|Adverse Event|2|||
145639885|NCT01571596|525198024|FG001|Overall Study|Adverse Event|0|||
145639886|NCT01571596|525198025|FG002|Overall Study|Adverse Event|0|||
145639887|NCT01571596|525198023|FG000|Overall Study|Study Terminated by the Sponsor|0|||
145605260|NCT06387472|525068965|FG000|Overall Study|Withdrawal by Subject|1|||
145605261|NCT06387472|525068965|FG000|Overall Study|Lost to Follow-up|2|||
145605262|NCT06387472|525068965|FG000|Overall Study|Physician Decision|1|||
145605263|NCT02332590|525068968|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
145605264|NCT02332590|525068969|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
145605265|NCT02332590|525068968|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
145605266|NCT02332590|525068969|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
145605267|NCT02332590|525068968|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
145605268|NCT02332590|525068969|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
145605269|NCT02332590|525068968|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
145605270|NCT02332590|525068969|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
145605271|NCT02332590|525068968|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
145605272|NCT02332590|525068969|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
145605273|NCT02332590|525068968|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
145605274|NCT02332590|525068969|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
145605275|NCT02332590|525068968|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
145605276|NCT02332590|525068969|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
145605277|NCT02332590|525068968|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
145605278|NCT02332590|525068969|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
145605279|NCT02332590|525068968|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
145605280|NCT02332590|525068969|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
145605281|NCT00279201|525068970|FG000|Initiation|Death|1|||
145605282|NCT00279201|525068971|FG001|Initiation|Death|5|||
145605283|NCT00279201|525068972|FG002|Initiation|Death|0|||
145605284|NCT00279201|525068973|FG003|Initiation|Death|0|||
145605285|NCT00279201|525068974|FG004|Initiation|Death|0|||
145605286|NCT00279201|525068975|FG005|Initiation|Death|0|||
145605287|NCT00279201|525068970|FG000|Initiation|Adverse Event|6|||
145639888|NCT01571596|525198024|FG001|Overall Study|Study Terminated by the Sponsor|1|||
145639889|NCT01571596|525198025|FG002|Overall Study|Study Terminated by the Sponsor|1|||
145639890|NCT00434304|525198026|FG000|Overall Study|Adverse Event|14|||
145639891|NCT00434304|525198026|FG000|Overall Study|Lack of Efficacy|2|||
145639892|NCT00434304|525198026|FG000|Overall Study|Withdrawal by Subject|4|||
145639893|NCT05262738|525198027|FG000|Overall Study|Withdrawal by Subject|1|||
145639894|NCT05262738|525198028|FG001|Overall Study|Withdrawal by Subject|0|||
145639895|NCT02374463|525198031|FG000|Overall Study|Withdrawal by Subject|3|||
145639896|NCT02374463|525198032|FG001|Overall Study|Withdrawal by Subject|3|||
145639897|NCT00774397|525198042|FG000|Overall Study|Adverse Event|1|||
145639898|NCT00774397|525198043|FG001|Overall Study|Adverse Event|3|||
145639899|NCT00774397|525198044|FG002|Overall Study|Adverse Event|16|||
145639900|NCT00774397|525198045|FG003|Overall Study|Adverse Event|8|||
145639901|NCT00774397|525198046|FG004|Overall Study|Adverse Event|8|||
145639902|NCT00774397|525198047|FG005|Overall Study|Adverse Event|3|||
145639903|NCT00774397|525198048|FG006|Overall Study|Adverse Event|16|||
145639904|NCT00774397|525198042|FG000|Overall Study|Lack of Efficacy|11|||
145639905|NCT00774397|525198043|FG001|Overall Study|Lack of Efficacy|4|||
145639906|NCT00774397|525198044|FG002|Overall Study|Lack of Efficacy|5|||
145639907|NCT00774397|525198045|FG003|Overall Study|Lack of Efficacy|3|||
145639908|NCT00774397|525198046|FG004|Overall Study|Lack of Efficacy|27|||
145639909|NCT00774397|525198047|FG005|Overall Study|Lack of Efficacy|15|||
145639910|NCT00774397|525198048|FG006|Overall Study|Lack of Efficacy|9|||
145639911|NCT00774397|525198042|FG000|Overall Study|Protocol Violation|0|||
145639912|NCT00774397|525198043|FG001|Overall Study|Protocol Violation|1|||
145639913|NCT00774397|525198044|FG002|Overall Study|Protocol Violation|3|||
145639914|NCT00774397|525198045|FG003|Overall Study|Protocol Violation|1|||
145639915|NCT00774397|525198046|FG004|Overall Study|Protocol Violation|2|||
145639916|NCT00774397|525198047|FG005|Overall Study|Protocol Violation|1|||
145639917|NCT00774397|525198048|FG006|Overall Study|Protocol Violation|0|||
145639918|NCT00774397|525198042|FG000|Overall Study|Lost to Follow-up|0|||
145639919|NCT00774397|525198043|FG001|Overall Study|Lost to Follow-up|1|||
145639920|NCT00774397|525198044|FG002|Overall Study|Lost to Follow-up|1|||
145639921|NCT00774397|525198045|FG003|Overall Study|Lost to Follow-up|1|||
145639922|NCT00774397|525198046|FG004|Overall Study|Lost to Follow-up|0|||
145639923|NCT00774397|525198047|FG005|Overall Study|Lost to Follow-up|1|||
145639924|NCT00774397|525198048|FG006|Overall Study|Lost to Follow-up|0|||
145639925|NCT00774397|525198042|FG000|Overall Study|Refused to continue trial medication|1|||
145639926|NCT00774397|525198043|FG001|Overall Study|Refused to continue trial medication|3|||
145639927|NCT00774397|525198044|FG002|Overall Study|Refused to continue trial medication|2|||
145639928|NCT00774397|525198045|FG003|Overall Study|Refused to continue trial medication|2|||
145639929|NCT00774397|525198046|FG004|Overall Study|Refused to continue trial medication|6|||
145639930|NCT00774397|525198047|FG005|Overall Study|Refused to continue trial medication|2|||
145639931|NCT00774397|525198048|FG006|Overall Study|Refused to continue trial medication|3|||
145639932|NCT00774397|525198042|FG000|Overall Study|Not treated|0|||
145639933|NCT00774397|525198043|FG001|Overall Study|Not treated|0|||
145639934|NCT00774397|525198044|FG002|Overall Study|Not treated|0|||
145639935|NCT00774397|525198045|FG003|Overall Study|Not treated|0|||
145639936|NCT00774397|525198046|FG004|Overall Study|Not treated|1|||
145639937|NCT00774397|525198047|FG005|Overall Study|Not treated|0|||
145639938|NCT00774397|525198048|FG006|Overall Study|Not treated|1|||
145639939|NCT00774397|525198042|FG000|Overall Study|Other than those stated above|1|||
145639940|NCT00774397|525198043|FG001|Overall Study|Other than those stated above|1|||
145486147|NCT00543387|524633308|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
145486148|NCT00543387|524633309|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
145486149|NCT00543387|524633310|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
145486150|NCT00543387|524633311|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
145486151|NCT00543387|524633312|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
145486152|NCT00543387|524633313|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
145486153|NCT00543387|524633314|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
145639941|NCT00774397|525198044|FG002|Overall Study|Other than those stated above|3|||
145639942|NCT00774397|525198045|FG003|Overall Study|Other than those stated above|2|||
145639943|NCT00774397|525198046|FG004|Overall Study|Other than those stated above|2|||
145639944|NCT00774397|525198047|FG005|Overall Study|Other than those stated above|0|||
145639945|NCT00774397|525198048|FG006|Overall Study|Other than those stated above|1|||
145639946|NCT00858117|525198050|FG000|Treatment on Study|Adverse Event|2|||
145639947|NCT00858117|525198050|FG000|Follow up for 5 Years|Death|4|||
145639948|NCT00858117|525198050|FG000|Follow up for 5 Years|No further data collected for study|9|||
145639949|NCT00077675|525198053|FG000|Overall Study|Adverse Event|1|||
145639950|NCT00077675|525198054|FG001|Overall Study|Adverse Event|2|||
145639951|NCT00077675|525198053|FG000|Overall Study|Lost to Follow-up|6|||
145639952|NCT00077675|525198054|FG001|Overall Study|Lost to Follow-up|3|||
145639953|NCT00077675|525198053|FG000|Overall Study|Withdrawal by Subject|1|||
145639954|NCT00077675|525198054|FG001|Overall Study|Withdrawal by Subject|0|||
145639955|NCT00077675|525198053|FG000|Overall Study|Other|0|||
145639956|NCT00077675|525198054|FG001|Overall Study|Other|1|||
145639957|NCT00077675|525198053|FG000|Overall Study|Never received study treatment|3|||
145639958|NCT00077675|525198054|FG001|Overall Study|Never received study treatment|3|||
145639959|NCT02499159|525198055|FG000|Randomization|Protocol Violation|1|||
145639960|NCT02499159|525198056|FG001|Randomization|Protocol Violation|1|||
145639961|NCT02499159|525198055|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
145639962|NCT02499159|525198056|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
145639963|NCT02499159|525198055|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
145639964|NCT02499159|525198056|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
145639965|NCT02499159|525198055|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
145639966|NCT02499159|525198056|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
145639967|NCT02499159|525198055|FG000|30-Day Follow-Up Phone Call|Other|1|||
145639968|NCT02499159|525198056|FG001|30-Day Follow-Up Phone Call|Other|0|||
145639969|NCT04425863|525198057|FG000|Overall Study|Death|0|||
145639970|NCT04425863|525198058|FG001|Overall Study|Death|0|||
145639971|NCT04425863|525198059|FG002|Overall Study|Death|1|||
145639972|NCT02601820|525198061|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
145639973|NCT02601820|525198061|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
145639974|NCT02601820|525198061|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
145639975|NCT02601820|525198061|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
145639976|NCT01599793|525198062|FG000|Overall Study|Adverse Event|2|||
145639977|NCT00391898|525198070|FG000|Overall Study|Adverse Event|3|||
145639978|NCT00391898|525198071|FG001|Overall Study|Adverse Event|0|||
145639979|NCT00391898|525198070|FG000|Overall Study|Other|8|||
145639980|NCT00391898|525198071|FG001|Overall Study|Other|10|||
145639981|NCT00244855|525198076|FG000|Overall Study|Withdrawal by Subject|0|||
145639982|NCT00244855|525198077|FG001|Overall Study|Withdrawal by Subject|1|||
145639983|NCT00869258|525198078|FG000|Overall Study|Physician Decision|1|||
145639984|NCT03451721|525198081|FG000|Overall Study|Death|1|||
145639985|NCT00960141|525198082|FG000|Overall Study|Adverse Event|4|||
145639986|NCT00960141|525198083|FG001|Overall Study|Adverse Event|8|||
145639987|NCT00960141|525198084|FG002|Overall Study|Adverse Event|2|||
145639988|NCT00960141|525198082|FG000|Overall Study|Lack of Efficacy|3|||
145639989|NCT00960141|525198083|FG001|Overall Study|Lack of Efficacy|4|||
145639990|NCT00960141|525198084|FG002|Overall Study|Lack of Efficacy|2|||
145639991|NCT00960141|525198082|FG000|Overall Study|Lost to Follow-up|1|||
145639992|NCT00960141|525198083|FG001|Overall Study|Lost to Follow-up|0|||
145639993|NCT00960141|525198084|FG002|Overall Study|Lost to Follow-up|0|||
145639994|NCT00960141|525198082|FG000|Overall Study|Protocol Violation|1|||
145639995|NCT00960141|525198083|FG001|Overall Study|Protocol Violation|3|||
145639996|NCT00960141|525198084|FG002|Overall Study|Protocol Violation|2|||
145639997|NCT00960141|525198082|FG000|Overall Study|Withdrawal by Subject|1|||
145639998|NCT00960141|525198083|FG001|Overall Study|Withdrawal by Subject|2|||
145639999|NCT00960141|525198084|FG002|Overall Study|Withdrawal by Subject|1|||
145640000|NCT00939510|525198085|FG000|Overall Study|Withdrawal by Subject|1|||
145640001|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
145640002|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
145640003|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
145640004|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
145640005|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
145640006|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
145640007|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
145640008|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
145640009|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640010|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640011|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640012|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640013|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
145640014|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
145640015|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640016|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
145640017|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640018|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640019|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640020|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640021|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640022|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
145640023|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
145640024|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
145640025|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640026|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
145640027|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640028|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640029|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640030|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640031|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640032|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
145640033|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640034|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640035|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640036|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
145640037|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
145640038|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640039|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640040|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
145640041|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640042|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640043|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640044|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
145640045|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640046|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640047|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640048|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
145640049|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
145640050|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
145640051|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
145640052|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
145640053|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
145640054|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
145640055|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
145640056|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
145640057|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
145640058|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640059|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640060|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640061|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640062|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
145640063|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640064|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
145640065|NCT03903822|525198088|FG000|Treatment Phase (6 Weeks)|Other|2|||
145640066|NCT03903822|525198089|FG001|Treatment Phase (6 Weeks)|Other|1|||
145640067|NCT03903822|525198090|FG002|Treatment Phase (6 Weeks)|Other|0|||
145640068|NCT03903822|525198091|FG003|Treatment Phase (6 Weeks)|Other|0|||
145640069|NCT03903822|525198092|FG004|Treatment Phase (6 Weeks)|Other|1|||
145640070|NCT03903822|525198093|FG005|Treatment Phase (6 Weeks)|Other|1|||
145640071|NCT03903822|525198094|FG006|Treatment Phase (6 Weeks)|Other|0|||
145640072|NCT03903822|525198095|FG007|Treatment Phase (6 Weeks)|Other|0|||
145640073|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
145640074|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
145640075|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
145640076|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
145640077|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
145640078|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
145640079|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
145640080|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
145640081|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640082|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640083|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640084|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640085|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
145640086|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640087|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640088|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
145640089|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
145640090|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
145640091|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
145640092|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
145640093|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
145640094|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
145640095|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
145640096|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
145640097|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
145640098|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
145486154|NCT01792115|524633318|FG000|Overall Study|Lost to Follow-up|0|||
145486155|NCT01792115|524633319|FG001|Overall Study|Lost to Follow-up|1|||
145486156|NCT01792115|524633320|FG002|Overall Study|Lost to Follow-up|0|||
145640099|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
145486157|NCT03790111|524634913|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
145486158|NCT03057496|524634923|FG000|Overall Study|Withdrawal by Subject|8|||
145640100|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
145640101|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
145640102|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
145640103|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
145640104|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
145640105|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
145640106|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
145640107|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
145640108|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
145640109|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
145640110|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
145640111|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
145640112|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
145640113|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640114|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640115|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640116|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640117|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640118|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
145640119|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640120|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
145640121|NCT03903822|525198088|FG000|Follow up Phase (4 Weeks)|Other|1|||
145640122|NCT03903822|525198089|FG001|Follow up Phase (4 Weeks)|Other|1|||
145640123|NCT03903822|525198090|FG002|Follow up Phase (4 Weeks)|Other|0|||
145640124|NCT03903822|525198091|FG003|Follow up Phase (4 Weeks)|Other|0|||
145640125|NCT03903822|525198092|FG004|Follow up Phase (4 Weeks)|Other|0|||
145640126|NCT03903822|525198093|FG005|Follow up Phase (4 Weeks)|Other|0|||
145640127|NCT03903822|525198094|FG006|Follow up Phase (4 Weeks)|Other|0|||
145640128|NCT03903822|525198095|FG007|Follow up Phase (4 Weeks)|Other|0|||
145640129|NCT05274217|525198117|FG000|Overall Study|Study terminated.|11|||
145640130|NCT05274217|525198118|FG001|Overall Study|Study terminated.|0|||
145640131|NCT04594759|525198119|FG000|Overall Study|Lost to Follow-up|3|||
145640132|NCT03144674|525198128|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
145640133|NCT03144674|525198129|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
145640134|NCT03144674|525198130|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
145640135|NCT03144674|525198131|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
145640136|NCT03144674|525198128|FG000|Overall Study|Death|3|||
145640137|NCT03144674|525198129|FG001|Overall Study|Death|2|||
145640138|NCT03144674|525198130|FG002|Overall Study|Death|6|||
145640139|NCT03144674|525198131|FG003|Overall Study|Death|24|||
145640140|NCT03144674|525198128|FG000|Overall Study|Lost to Follow-up|0|||
145640141|NCT03144674|525198129|FG001|Overall Study|Lost to Follow-up|1|||
145640142|NCT03144674|525198130|FG002|Overall Study|Lost to Follow-up|0|||
145640143|NCT03144674|525198131|FG003|Overall Study|Lost to Follow-up|4|||
145640144|NCT03144674|525198128|FG000|Overall Study|Withdrawal by Participant|0|||
145640145|NCT03144674|525198129|FG001|Overall Study|Withdrawal by Participant|0|||
145640146|NCT03144674|525198130|FG002|Overall Study|Withdrawal by Participant|2|||
145640147|NCT03144674|525198131|FG003|Overall Study|Withdrawal by Participant|6|||
145640148|NCT03144674|525198128|FG000|Overall Study|Discharged from the Trust|0|||
145640149|NCT03144674|525198129|FG001|Overall Study|Discharged from the Trust|0|||
145640150|NCT03144674|525198130|FG002|Overall Study|Discharged from the Trust|1|||
145640151|NCT03144674|525198131|FG003|Overall Study|Discharged from the Trust|0|||
145640152|NCT03144674|525198128|FG000|Overall Study|Exclusion Criteria Met|0|||
145640153|NCT03144674|525198129|FG001|Overall Study|Exclusion Criteria Met|0|||
145640154|NCT03144674|525198130|FG002|Overall Study|Exclusion Criteria Met|1|||
145640155|NCT03144674|525198131|FG003|Overall Study|Exclusion Criteria Met|0|||
145640156|NCT03144674|525198128|FG000|Overall Study|Changed Physicians|0|||
145640157|NCT03144674|525198129|FG001|Overall Study|Changed Physicians|0|||
145640158|NCT03144674|525198130|FG002|Overall Study|Changed Physicians|0|||
145640159|NCT03144674|525198131|FG003|Overall Study|Changed Physicians|1|||
145486159|NCT03057496|524634923|FG000|Overall Study|Lost to Follow-up|5|||
145486160|NCT03057496|524634923|FG000|Overall Study|Did not use device during home trial|3|||
145486161|NCT03057496|524634923|FG000|Overall Study|Device failure|2|||
145486162|NCT00280917|524634927|FG000|Overall Study|Adverse Event|1|||
145486163|NCT00280917|524634928|FG001|Overall Study|Adverse Event|1|||
145486164|NCT00280917|524634929|FG002|Overall Study|Adverse Event|4|||
145640160|NCT03144674|525198128|FG000|Overall Study|Removed for Safety|0|||
145640161|NCT03144674|525198129|FG001|Overall Study|Removed for Safety|0|||
145640162|NCT03144674|525198130|FG002|Overall Study|Removed for Safety|0|||
145640163|NCT03144674|525198131|FG003|Overall Study|Removed for Safety|1|||
145486165|NCT00280917|524634930|FG003|Overall Study|Adverse Event|1|||
145640164|NCT03144674|525198128|FG000|Overall Study|Site Closed|0|||
145640165|NCT03144674|525198129|FG001|Overall Study|Site Closed|0|||
145640166|NCT03144674|525198130|FG002|Overall Study|Site Closed|0|||
145640167|NCT03144674|525198131|FG003|Overall Study|Site Closed|1|||
145640168|NCT03144674|525198128|FG000|Overall Study|Histological Criteria Not Met|0|||
145640169|NCT03144674|525198129|FG001|Overall Study|Histological Criteria Not Met|0|||
145640170|NCT03144674|525198130|FG002|Overall Study|Histological Criteria Not Met|0|||
145640171|NCT03144674|525198131|FG003|Overall Study|Histological Criteria Not Met|1|||
145640172|NCT03144674|525198128|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
145640173|NCT03144674|525198129|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
145640174|NCT03144674|525198130|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
145640175|NCT03144674|525198131|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
145640176|NCT03144674|525198128|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
145640177|NCT03144674|525198129|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
145640178|NCT03144674|525198130|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
145640179|NCT03144674|525198131|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
145640180|NCT01395758|525198132|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
145640181|NCT01395758|525198133|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145640182|NCT01395758|525198134|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
145640183|NCT03942042|525198138|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
145640184|NCT03942042|525198139|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
145640185|NCT03942042|525198138|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
145640186|NCT03942042|525198139|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
145640187|NCT00736853|525198140|FG000|Open-Label Period|Physician Decision|2|||
145640188|NCT00736853|525198141|FG001|Open-Label Period|Physician Decision|0|||
145640189|NCT00736853|525198142|FG002|Open-Label Period|Physician Decision|0|||
145640190|NCT00736853|525198140|FG000|Open-Label Period|Adverse Event|31|||
145640191|NCT00736853|525198141|FG001|Open-Label Period|Adverse Event|0|||
145640192|NCT00736853|525198142|FG002|Open-Label Period|Adverse Event|0|||
145640193|NCT00736853|525198140|FG000|Open-Label Period|Withdrawal by Subject|16|||
145640194|NCT00736853|525198141|FG001|Open-Label Period|Withdrawal by Subject|0|||
145640195|NCT00736853|525198142|FG002|Open-Label Period|Withdrawal by Subject|0|||
145640196|NCT00736853|525198140|FG000|Open-Label Period|Started but not treated|42|||
145640197|NCT00736853|525198141|FG001|Open-Label Period|Started but not treated|0|||
145640198|NCT00736853|525198142|FG002|Open-Label Period|Started but not treated|0|||
145640199|NCT00736853|525198140|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
145640200|NCT00736853|525198141|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
145640201|NCT00736853|525198142|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
145640202|NCT00736853|525198140|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
145640203|NCT00736853|525198141|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
145640204|NCT00736853|525198142|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
145640205|NCT00736853|525198140|FG000|Double-Blind Period|Lack of Efficacy|0|||
145640206|NCT00736853|525198141|FG001|Double-Blind Period|Lack of Efficacy|19|||
145640207|NCT00736853|525198142|FG002|Double-Blind Period|Lack of Efficacy|42|||
145640208|NCT00736853|525198140|FG000|Double-Blind Period|Adverse Event|0|||
145640209|NCT00736853|525198141|FG001|Double-Blind Period|Adverse Event|3|||
145640210|NCT00736853|525198142|FG002|Double-Blind Period|Adverse Event|2|||
145640211|NCT00736853|525198140|FG000|Double-Blind Period|Withdrawal by Subject|0|||
145640212|NCT00736853|525198141|FG001|Double-Blind Period|Withdrawal by Subject|1|||
145640213|NCT00736853|525198142|FG002|Double-Blind Period|Withdrawal by Subject|4|||
145640214|NCT00736853|525198140|FG000|Double-Blind Period|Ineligible to participate the study|0|||
145640215|NCT00736853|525198141|FG001|Double-Blind Period|Ineligible to participate the study|1|||
145640216|NCT00736853|525198142|FG002|Double-Blind Period|Ineligible to participate the study|0|||
145640217|NCT01199705|525198143|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
145640218|NCT04980755|525198144|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
145640219|NCT04980755|525198144|FG000|Body Reprogramming Courses|Work commitment|2|||
145640220|NCT04980755|525198144|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
145640221|NCT04980755|525198144|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
145640222|NCT01212991|525198145|FG000|Double-blind|Lost to Follow-up|8|||
145640223|NCT01212991|525198146|FG001|Double-blind|Lost to Follow-up|4|||
145640224|NCT01212991|525198147|FG002|Double-blind|Lost to Follow-up|0|||
145640225|NCT01212991|525198145|FG000|Double-blind|Death|699|||
145640226|NCT01212991|525198146|FG001|Double-blind|Death|550|||
145640227|NCT01212991|525198147|FG002|Double-blind|Death|0|||
145640228|NCT01212991|525198145|FG000|Double-blind|Withdrawal by Subject|16|||
145640229|NCT01212991|525198146|FG001|Double-blind|Withdrawal by Subject|19|||
145640230|NCT01212991|525198147|FG002|Double-blind|Withdrawal by Subject|0|||
145640231|NCT01212991|525198145|FG000|Double-blind|Other|7|||
145640232|NCT01212991|525198146|FG001|Double-blind|Other|0|||
145640233|NCT01212991|525198147|FG002|Double-blind|Other|0|||
145640234|NCT01212991|525198145|FG000|Double-blind|Sponsor decision|142|||
145640235|NCT01212991|525198146|FG001|Double-blind|Sponsor decision|38|||
145640236|NCT01212991|525198147|FG002|Double-blind|Sponsor decision|0|||
145640237|NCT01212991|525198145|FG000|Open-label|Death|0|||
145640238|NCT01212991|525198146|FG001|Open-label|Death|0|||
145640239|NCT01212991|525198147|FG002|Open-label|Death|166|||
145640240|NCT01212991|525198145|FG000|Open-label|Lost to Follow-up|0|||
145640241|NCT01212991|525198146|FG001|Open-label|Lost to Follow-up|0|||
145640242|NCT01212991|525198147|FG002|Open-label|Lost to Follow-up|5|||
145640243|NCT01212991|525198145|FG000|Open-label|Withdrawal by Subject|0|||
145640244|NCT01212991|525198146|FG001|Open-label|Withdrawal by Subject|0|||
145640245|NCT01212991|525198147|FG002|Open-label|Withdrawal by Subject|7|||
145640246|NCT01212991|525198145|FG000|Open-label|Sponsor decision|0|||
145640247|NCT01212991|525198146|FG001|Open-label|Sponsor decision|0|||
145640248|NCT01212991|525198147|FG002|Open-label|Sponsor decision|53|||
145640249|NCT01212991|525198145|FG000|Open-label|Other|0|||
145640250|NCT01212991|525198146|FG001|Open-label|Other|0|||
145640251|NCT01212991|525198147|FG002|Open-label|Other|3|||
145640252|NCT04623008|525200014|FG000|Baseline to T2|Withdrawal by Subject|4|||
145640253|NCT04623008|525200015|FG001|Baseline to T2|Withdrawal by Subject|2|||
145640254|NCT04623008|525200014|FG000|Baseline to T3|Withdrawal by Subject|4|||
145640255|NCT04623008|525200015|FG001|Baseline to T3|Withdrawal by Subject|2|||
145640256|NCT01622868|525200019|FG000|Overall Study|Protocol Violation|7|||
145640257|NCT01622868|525200020|FG001|Overall Study|Protocol Violation|0|||
145640258|NCT00542789|525200021|FG000|Overall Study|Adverse Event|18|||
145640259|NCT00542789|525200022|FG001|Overall Study|Adverse Event|17|||
145640260|NCT00542789|525200021|FG000|Overall Study|Withdrawal by Subject|7|||
145640261|NCT00542789|525200022|FG001|Overall Study|Withdrawal by Subject|3|||
145640262|NCT00542789|525200021|FG000|Overall Study|Protocol Violation|8|||
145640263|NCT00542789|525200022|FG001|Overall Study|Protocol Violation|1|||
145640264|NCT00542789|525200021|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
145640265|NCT00542789|525200022|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
145640266|NCT02584829|525200023|FG000|Overall Study|Physician Decision|1|||
145640267|NCT02584829|525200024|FG001|Overall Study|Physician Decision|0|||
145640268|NCT02584829|525200023|FG000|Overall Study|Withdrawal by Subject|0|||
145640269|NCT02584829|525200024|FG001|Overall Study|Withdrawal by Subject|1|||
145640270|NCT02584829|525200023|FG000|Overall Study|Progressive Disease|0|||
145640271|NCT02584829|525200024|FG001|Overall Study|Progressive Disease|3|||
145640272|NCT02767765|525200026|FG000|Overall Study|Adverse Event|4|||
145640273|NCT02767765|525200026|FG000|Overall Study|Death|1|||
145640274|NCT02767765|525200026|FG000|Overall Study|Insufficient response|1|||
145640275|NCT02767765|525200026|FG000|Overall Study|Lost to Follow-up|2|||
145640276|NCT02767765|525200026|FG000|Overall Study|Investigator decision|1|||
145640277|NCT02767765|525200026|FG000|Overall Study|Non-Compliance|1|||
145640278|NCT02767765|525200026|FG000|Overall Study|Withdrawal by Subject|1|||
145640279|NCT01951170|525200027|FG000|Overall Study|Investigator decision|1|||
145640280|NCT00585052|525200036|FG000|Overall Study|Withdrawal by Subject|1|||
145640281|NCT00446459|525200039|FG000|8 Months|Protocol Violation|12|||
145640282|NCT00446459|525200039|FG000|12 Months|Protocol Violation|4|||
145640283|NCT00446459|525200039|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
145640284|NCT00277355|525200045|FG000|Overall Study|Withdrawal by Subject|3|||
145640285|NCT00277355|525200046|FG001|Overall Study|Withdrawal by Subject|3|||
145640286|NCT00277355|525200045|FG000|Overall Study|Lost to Follow-up|2|||
145640287|NCT00277355|525200046|FG001|Overall Study|Lost to Follow-up|2|||
145640288|NCT00277355|525200045|FG000|Overall Study|Adverse Event|5|||
145640289|NCT00277355|525200046|FG001|Overall Study|Adverse Event|0|||
145640290|NCT00277355|525200045|FG000|Overall Study|Death|3|||
145640291|NCT00277355|525200046|FG001|Overall Study|Death|0|||
145640292|NCT00277355|525200045|FG000|Overall Study|Physician Decision|1|||
145640293|NCT00277355|525200046|FG001|Overall Study|Physician Decision|0|||
145640294|NCT02765100|525200047|FG000|Overall Study|subject found ineligible after baseline|1|||
145640295|NCT02765100|525200048|FG001|Overall Study|subject found ineligible after baseline|1|||
145640296|NCT02765100|525200047|FG000|Overall Study|Lost to Follow-up|0|||
145640297|NCT02765100|525200048|FG001|Overall Study|Lost to Follow-up|1|||
145640298|NCT02675244|525200051|FG000|Overall Study|Death|9|||
145640299|NCT02675244|525200052|FG001|Overall Study|Death|6|||
145640300|NCT02675244|525200051|FG000|Overall Study|Withdrawal by Subject|3|||
145486166|NCT00280917|524634927|FG000|Overall Study|Change Therapy|1|||
145486167|NCT00280917|524634928|FG001|Overall Study|Change Therapy|2|||
145486168|NCT00280917|524634929|FG002|Overall Study|Change Therapy|0|||
145640301|NCT02675244|525200052|FG001|Overall Study|Withdrawal by Subject|6|||
145640302|NCT02675244|525200051|FG000|Overall Study|Lost to Follow-up|1|||
145640303|NCT02675244|525200052|FG001|Overall Study|Lost to Follow-up|1|||
145486169|NCT00280917|524634930|FG003|Overall Study|Change Therapy|0|||
145486170|NCT00280917|524634927|FG000|Overall Study|Withdrawal by Subject|0|||
145486171|NCT00280917|524634928|FG001|Overall Study|Withdrawal by Subject|2|||
145486172|NCT00280917|524634929|FG002|Overall Study|Withdrawal by Subject|0|||
145640304|NCT02675244|525200051|FG000|Overall Study|Ongoing at 2 Years|190|||
145640305|NCT02675244|525200052|FG001|Overall Study|Ongoing at 2 Years|185|||
145640306|NCT02652442|525200056|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
145486173|NCT00280917|524634930|FG003|Overall Study|Withdrawal by Subject|1|||
145640307|NCT00309907|525200057|FG000|Overall Study|Death|4|||
145640308|NCT00309907|525200057|FG000|Overall Study|Physician Decision|1|||
145640309|NCT00309907|525200057|FG000|Overall Study|Ineligible|11|||
145640310|NCT00309907|525200057|FG000|Overall Study|Major infectious event|4|||
145640311|NCT01075217|525200058|FG000|Overall Study|Adverse Event|1|||
145640312|NCT01075217|525200059|FG001|Overall Study|Adverse Event|1|||
145640313|NCT01075217|525200058|FG000|Overall Study|Physician Decision|1|||
145640314|NCT01075217|525200059|FG001|Overall Study|Physician Decision|0|||
145640315|NCT00293293|525200062|FG000|Overall Study|Withdrawal by Subject|1|||
145640316|NCT00293293|525200063|FG001|Overall Study|Withdrawal by Subject|1|||
145640317|NCT00293293|525200062|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
145640318|NCT00293293|525200063|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
145640319|NCT00293293|525200062|FG000|Overall Study|Patient discontinued chemotherapy|0|||
145640320|NCT00293293|525200063|FG001|Overall Study|Patient discontinued chemotherapy|1|||
145640321|NCT02512965|525200066|FG000|Overall Study|Withdrawal by Subject|0|||
145640322|NCT02512965|525200067|FG001|Overall Study|Withdrawal by Subject|4|||
145640323|NCT00835770|525200068|FG000|Overall Study|MS Relapse|17|||
145640324|NCT00835770|525200069|FG001|Overall Study|MS Relapse|23|||
145640325|NCT00835770|525200068|FG000|Overall Study|MS Progression|14|||
145640326|NCT00835770|525200069|FG001|Overall Study|MS Progression|9|||
145640327|NCT00835770|525200068|FG000|Overall Study|Adverse Event|113|||
145640328|NCT00835770|525200069|FG001|Overall Study|Adverse Event|124|||
145640329|NCT00835770|525200068|FG000|Overall Study|Lost to Follow-up|22|||
145640330|NCT00835770|525200069|FG001|Overall Study|Lost to Follow-up|19|||
145640331|NCT00835770|525200068|FG000|Overall Study|Consent Withdrawn|144|||
145640332|NCT00835770|525200069|FG001|Overall Study|Consent Withdrawn|156|||
145640333|NCT00835770|525200068|FG000|Overall Study|Investigator Decision|42|||
145640334|NCT00835770|525200069|FG001|Overall Study|Investigator Decision|42|||
145640335|NCT00835770|525200068|FG000|Overall Study|Participant Non-Compliance|11|||
145640336|NCT00835770|525200069|FG001|Overall Study|Participant Non-Compliance|9|||
145640337|NCT00835770|525200068|FG000|Overall Study|Death|4|||
145640338|NCT00835770|525200069|FG001|Overall Study|Death|6|||
145640339|NCT00835770|525200068|FG000|Overall Study|Other|115|||
145640340|NCT00835770|525200069|FG001|Overall Study|Other|104|||
145640341|NCT00835770|525200068|FG000|Overall Study|Other|2|||
145640342|NCT00835770|525200069|FG001|Overall Study|Other|1|||
145640343|NCT01185782|525200070|FG000|Overall Study|Adverse Event|0|||
145640344|NCT01185782|525200071|FG001|Overall Study|Adverse Event|1|||
145640345|NCT01185782|525200070|FG000|Overall Study|Protocol Violation|1|||
145640346|NCT01185782|525200071|FG001|Overall Study|Protocol Violation|0|||
145640347|NCT01185782|525200070|FG000|Overall Study|Poor Response to Treatment|3|||
145640348|NCT01185782|525200071|FG001|Overall Study|Poor Response to Treatment|1|||
145640349|NCT01185782|525200070|FG000|Overall Study|Other|2|||
145640350|NCT01185782|525200071|FG001|Overall Study|Other|5|||
145640351|NCT01185782|525200070|FG000|Overall Study|Randomized but not treated|0|||
145640352|NCT01185782|525200071|FG001|Overall Study|Randomized but not treated|4|||
145640353|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
145640354|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
145640355|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
145640356|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
145640357|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
145640358|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
145640359|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
145640360|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
145640361|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
145640362|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
145640363|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
145640364|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
145640365|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
145640366|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
145640367|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
145640368|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
145640369|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
145640370|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
145640371|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
145640372|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
145640373|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
145640374|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
145640375|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
145640376|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
145640377|NCT01061151|525200073|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
145640378|NCT01061151|525200074|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
145640379|NCT01061151|525200075|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
145640380|NCT01061151|525200076|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
145640381|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
145640382|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
145640383|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
145265300|NCT03323034|523819272|FG001|Overall Study|Lack of Efficacy|5|||
145640384|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
145640385|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
145640386|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
145640387|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
145640388|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
145640389|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
145640390|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
145640391|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
145640392|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
145640393|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
145640394|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
145640395|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
145640396|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
145640397|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
145640398|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
145640399|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
145640400|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
145640401|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
145640402|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
145640403|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
145640404|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
145640405|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
145640406|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
145640407|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
145640408|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
145640409|NCT01061151|525200073|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
145640410|NCT01061151|525200074|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
145640411|NCT01061151|525200075|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
145640412|NCT01061151|525200076|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
145640413|NCT01236001|525200077|FG000|Overall Study|Adverse Event|5|||
145640414|NCT01236001|525200078|FG001|Overall Study|Adverse Event|14|||
145640415|NCT01236001|525200077|FG000|Overall Study|Lack of Efficacy|6|||
145640416|NCT01236001|525200078|FG001|Overall Study|Lack of Efficacy|6|||
145640417|NCT01236001|525200077|FG000|Overall Study|Lost to Follow-up|6|||
145640418|NCT01236001|525200078|FG001|Overall Study|Lost to Follow-up|1|||
145640419|NCT01236001|525200077|FG000|Overall Study|Incompliance|1|||
145640420|NCT01236001|525200078|FG001|Overall Study|Incompliance|0|||
145640421|NCT01236001|525200077|FG000|Overall Study|Planned Visit After End of Study|0|||
145640422|NCT01236001|525200078|FG001|Overall Study|Planned Visit After End of Study|1|||
145640423|NCT02988817|525200079|FG000|Overall Study|Withdrawal by Subject|1|||
145640424|NCT02988817|525200080|FG001|Overall Study|Withdrawal by Subject|0|||
145640425|NCT02988817|525200081|FG002|Overall Study|Withdrawal by Subject|0|||
145640426|NCT02988817|525200082|FG003|Overall Study|Withdrawal by Subject|1|||
145640427|NCT02988817|525200083|FG004|Overall Study|Withdrawal by Subject|3|||
145640428|NCT02988817|525200084|FG005|Overall Study|Withdrawal by Subject|1|||
145640429|NCT02988817|525200085|FG006|Overall Study|Withdrawal by Subject|2|||
145640430|NCT02988817|525200086|FG007|Overall Study|Withdrawal by Subject|1|||
145640431|NCT02988817|525200087|FG008|Overall Study|Withdrawal by Subject|1|||
145640432|NCT02988817|525200088|FG009|Overall Study|Withdrawal by Subject|1|||
145640433|NCT02988817|525200089|FG010|Overall Study|Withdrawal by Subject|1|||
145640434|NCT02988817|525200090|FG011|Overall Study|Withdrawal by Subject|12|||
145486174|NCT00280917|524634927|FG000|Overall Study|Noncompliance|0|||
145486175|NCT00280917|524634928|FG001|Overall Study|Noncompliance|1|||
145486176|NCT00280917|524634929|FG002|Overall Study|Noncompliance|2|||
145486177|NCT00280917|524634930|FG003|Overall Study|Noncompliance|0|||
145486178|NCT03529110|524634931|FG000|Overall Study|Progressive Disease|66|||
145640435|NCT02988817|525200091|FG012|Overall Study|Withdrawal by Subject|6|||
145640436|NCT02988817|525200092|FG013|Overall Study|Withdrawal by Subject|6|||
145640437|NCT02988817|525200093|FG014|Overall Study|Withdrawal by Subject|4|||
145640438|NCT02988817|525200094|FG015|Overall Study|Withdrawal by Subject|5|||
145640439|NCT02988817|525200095|FG016|Overall Study|Withdrawal by Subject|4|||
145640440|NCT02988817|525200096|FG017|Overall Study|Withdrawal by Subject|11|||
145640441|NCT02988817|525200097|FG018|Overall Study|Withdrawal by Subject|4|||
145640442|NCT02988817|525200098|FG019|Overall Study|Withdrawal by Subject|2|||
145640443|NCT02988817|525200079|FG000|Overall Study|Death|0|||
145640444|NCT02988817|525200080|FG001|Overall Study|Death|1|||
145640445|NCT02988817|525200081|FG002|Overall Study|Death|3|||
145640446|NCT02988817|525200082|FG003|Overall Study|Death|1|||
145640447|NCT02988817|525200083|FG004|Overall Study|Death|6|||
145486179|NCT03529110|524634932|FG001|Overall Study|Progressive Disease|158|||
145486180|NCT03529110|524634931|FG000|Overall Study|Clinical Progression|4|||
145486181|NCT03529110|524634932|FG001|Overall Study|Clinical Progression|12|||
145640448|NCT02988817|525200084|FG005|Overall Study|Death|10|||
145640449|NCT02988817|525200085|FG006|Overall Study|Death|1|||
145640450|NCT02988817|525200086|FG007|Overall Study|Death|2|||
145640451|NCT02988817|525200087|FG008|Overall Study|Death|1|||
145640452|NCT02988817|525200088|FG009|Overall Study|Death|5|||
145640453|NCT02988817|525200089|FG010|Overall Study|Death|1|||
145640454|NCT02988817|525200090|FG011|Overall Study|Death|8|||
145640455|NCT02988817|525200091|FG012|Overall Study|Death|9|||
145640456|NCT02988817|525200092|FG013|Overall Study|Death|17|||
145640457|NCT02988817|525200093|FG014|Overall Study|Death|18|||
145640458|NCT02988817|525200094|FG015|Overall Study|Death|30|||
145640459|NCT02988817|525200095|FG016|Overall Study|Death|17|||
145640460|NCT02988817|525200096|FG017|Overall Study|Death|38|||
145640461|NCT02988817|525200097|FG018|Overall Study|Death|14|||
145640462|NCT02988817|525200098|FG019|Overall Study|Death|16|||
145640463|NCT02988817|525200079|FG000|Overall Study|Other|0|||
145640464|NCT02988817|525200080|FG001|Overall Study|Other|0|||
145640465|NCT02988817|525200081|FG002|Overall Study|Other|0|||
145640466|NCT02988817|525200082|FG003|Overall Study|Other|1|||
145640467|NCT02988817|525200083|FG004|Overall Study|Other|1|||
145640468|NCT02988817|525200084|FG005|Overall Study|Other|0|||
145640469|NCT02988817|525200085|FG006|Overall Study|Other|0|||
145640470|NCT02988817|525200086|FG007|Overall Study|Other|0|||
145640471|NCT02988817|525200087|FG008|Overall Study|Other|0|||
145640472|NCT02988817|525200088|FG009|Overall Study|Other|0|||
145640473|NCT02988817|525200089|FG010|Overall Study|Other|0|||
145640474|NCT02988817|525200090|FG011|Overall Study|Other|0|||
145640475|NCT02988817|525200091|FG012|Overall Study|Other|0|||
145640476|NCT02988817|525200092|FG013|Overall Study|Other|0|||
145640477|NCT02988817|525200093|FG014|Overall Study|Other|0|||
145640478|NCT02988817|525200094|FG015|Overall Study|Other|1|||
145640479|NCT02988817|525200095|FG016|Overall Study|Other|0|||
145640480|NCT02988817|525200096|FG017|Overall Study|Other|0|||
145640481|NCT02988817|525200097|FG018|Overall Study|Other|0|||
145486182|NCT03529110|524634931|FG000|Overall Study|Adverse Event|35|||
145486183|NCT03529110|524634932|FG001|Overall Study|Adverse Event|17|||
145486184|NCT03529110|524634931|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
145486185|NCT03529110|524634932|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
145486186|NCT03529110|524634931|FG000|Overall Study|Lack of Efficacy|3|||
145486187|NCT03529110|524634932|FG001|Overall Study|Lack of Efficacy|3|||
145486188|NCT03529110|524634931|FG000|Overall Study|Physician Decision|2|||
145486189|NCT03529110|524634932|FG001|Overall Study|Physician Decision|8|||
145486190|NCT03529110|524634931|FG000|Overall Study|Miscellaneous|2|||
145640482|NCT02988817|525200098|FG019|Overall Study|Other|0|||
145640483|NCT02988817|525200079|FG000|Overall Study|Lost to Follow-up|0|||
145640484|NCT02988817|525200080|FG001|Overall Study|Lost to Follow-up|0|||
145640485|NCT02988817|525200081|FG002|Overall Study|Lost to Follow-up|0|||
145640486|NCT02988817|525200082|FG003|Overall Study|Lost to Follow-up|0|||
145640487|NCT02988817|525200083|FG004|Overall Study|Lost to Follow-up|0|||
145640488|NCT02988817|525200084|FG005|Overall Study|Lost to Follow-up|0|||
145640489|NCT02988817|525200085|FG006|Overall Study|Lost to Follow-up|0|||
145640490|NCT02988817|525200086|FG007|Overall Study|Lost to Follow-up|0|||
145640491|NCT02988817|525200087|FG008|Overall Study|Lost to Follow-up|1|||
145640492|NCT02988817|525200088|FG009|Overall Study|Lost to Follow-up|0|||
145640493|NCT02988817|525200089|FG010|Overall Study|Lost to Follow-up|1|||
145486191|NCT03529110|524634932|FG001|Overall Study|Miscellaneous|5|||
145486192|NCT01584232|524634933|FG000|Overall Study|Adverse Event|3|||
145486193|NCT01584232|524634934|FG001|Overall Study|Adverse Event|1|||
145640494|NCT02988817|525200090|FG011|Overall Study|Lost to Follow-up|1|||
145640495|NCT02988817|525200091|FG012|Overall Study|Lost to Follow-up|0|||
145640496|NCT02988817|525200092|FG013|Overall Study|Lost to Follow-up|0|||
145640497|NCT02988817|525200093|FG014|Overall Study|Lost to Follow-up|1|||
145640498|NCT02988817|525200094|FG015|Overall Study|Lost to Follow-up|1|||
145640499|NCT02988817|525200095|FG016|Overall Study|Lost to Follow-up|2|||
145640500|NCT02988817|525200096|FG017|Overall Study|Lost to Follow-up|3|||
145640501|NCT02988817|525200097|FG018|Overall Study|Lost to Follow-up|0|||
145640502|NCT02988817|525200098|FG019|Overall Study|Lost to Follow-up|0|||
145640503|NCT02988817|525200079|FG000|Overall Study|Sponsor decision|0|||
145486194|NCT01584232|524634933|FG000|Overall Study|Withdrawal by Subject|2|||
145486195|NCT01584232|524634934|FG001|Overall Study|Withdrawal by Subject|1|||
145640504|NCT02988817|525200080|FG001|Overall Study|Sponsor decision|0|||
145640505|NCT02988817|525200081|FG002|Overall Study|Sponsor decision|0|||
145486196|NCT01584232|524634933|FG000|Overall Study|Physician Decision|2|||
145486197|NCT01584232|524634934|FG001|Overall Study|Physician Decision|1|||
145486198|NCT01584232|524634933|FG000|Overall Study|Lost to Follow-up|1|||
145640506|NCT02988817|525200082|FG003|Overall Study|Sponsor decision|0|||
145640507|NCT02988817|525200083|FG004|Overall Study|Sponsor decision|0|||
145640508|NCT02988817|525200084|FG005|Overall Study|Sponsor decision|0|||
145640509|NCT02988817|525200085|FG006|Overall Study|Sponsor decision|0|||
145640510|NCT02988817|525200086|FG007|Overall Study|Sponsor decision|0|||
145640511|NCT02988817|525200087|FG008|Overall Study|Sponsor decision|0|||
145640512|NCT02988817|525200088|FG009|Overall Study|Sponsor decision|0|||
145640513|NCT02988817|525200089|FG010|Overall Study|Sponsor decision|0|||
145486199|NCT01584232|524634934|FG001|Overall Study|Lost to Follow-up|0|||
145486200|NCT02723773|524634936|FG000|Overall Study|Adverse Event|934|||
145486201|NCT02723773|524634937|FG001|Overall Study|Adverse Event|3|||
145486202|NCT02723773|524634938|FG002|Overall Study|Adverse Event|1|||
145486203|NCT02723773|524634939|FG003|Overall Study|Adverse Event|9|||
145486204|NCT02723773|524634936|FG000|Overall Study|Protocol Violation|1|||
145486205|NCT02723773|524634937|FG001|Overall Study|Protocol Violation|0|||
145605288|NCT00279201|525068971|FG001|Initiation|Adverse Event|15|||
145605289|NCT00279201|525068972|FG002|Initiation|Adverse Event|0|||
145605290|NCT00279201|525068973|FG003|Initiation|Adverse Event|0|||
145605291|NCT00279201|525068974|FG004|Initiation|Adverse Event|0|||
145605292|NCT00279201|525068975|FG005|Initiation|Adverse Event|0|||
145605293|NCT00279201|525068970|FG000|Initiation|Lost to Follow-up|42|||
145605294|NCT00279201|525068971|FG001|Initiation|Lost to Follow-up|41|||
145605295|NCT00279201|525068972|FG002|Initiation|Lost to Follow-up|0|||
145605296|NCT00279201|525068973|FG003|Initiation|Lost to Follow-up|0|||
145605297|NCT00279201|525068974|FG004|Initiation|Lost to Follow-up|0|||
145605298|NCT00279201|525068975|FG005|Initiation|Lost to Follow-up|0|||
145605299|NCT00279201|525068970|FG000|Initiation|Entry Criteria Exclusion|7|||
145605300|NCT00279201|525068971|FG001|Initiation|Entry Criteria Exclusion|9|||
145605301|NCT00279201|525068972|FG002|Initiation|Entry Criteria Exclusion|0|||
145605302|NCT00279201|525068973|FG003|Initiation|Entry Criteria Exclusion|0|||
145605303|NCT00279201|525068974|FG004|Initiation|Entry Criteria Exclusion|0|||
145605304|NCT00279201|525068975|FG005|Initiation|Entry Criteria Exclusion|0|||
145605305|NCT00279201|525068970|FG000|Initiation|Protocol Violation|9|||
145605306|NCT00279201|525068971|FG001|Initiation|Protocol Violation|10|||
145605307|NCT00279201|525068972|FG002|Initiation|Protocol Violation|0|||
145605308|NCT00279201|525068973|FG003|Initiation|Protocol Violation|0|||
145605309|NCT00279201|525068974|FG004|Initiation|Protocol Violation|0|||
145605310|NCT00279201|525068975|FG005|Initiation|Protocol Violation|0|||
145605311|NCT00279201|525068970|FG000|Initiation|Withdrawal by Subject|35|||
145605312|NCT00279201|525068971|FG001|Initiation|Withdrawal by Subject|41|||
145605313|NCT00279201|525068972|FG002|Initiation|Withdrawal by Subject|0|||
145605314|NCT00279201|525068973|FG003|Initiation|Withdrawal by Subject|0|||
145605315|NCT00279201|525068974|FG004|Initiation|Withdrawal by Subject|0|||
145605316|NCT00279201|525068975|FG005|Initiation|Withdrawal by Subject|0|||
145605317|NCT00279201|525068970|FG000|Initiation|Physician Decision|15|||
145605318|NCT00279201|525068971|FG001|Initiation|Physician Decision|18|||
145605319|NCT00279201|525068972|FG002|Initiation|Physician Decision|0|||
145605320|NCT00279201|525068973|FG003|Initiation|Physician Decision|0|||
145605321|NCT00279201|525068974|FG004|Initiation|Physician Decision|0|||
145605322|NCT00279201|525068975|FG005|Initiation|Physician Decision|0|||
145605323|NCT00279201|525068970|FG000|Initiation|Sponsor Decision|13|||
145605324|NCT00279201|525068971|FG001|Initiation|Sponsor Decision|5|||
145605325|NCT00279201|525068972|FG002|Initiation|Sponsor Decision|0|||
145605326|NCT00279201|525068973|FG003|Initiation|Sponsor Decision|0|||
145605327|NCT00279201|525068974|FG004|Initiation|Sponsor Decision|0|||
145605328|NCT00279201|525068975|FG005|Initiation|Sponsor Decision|0|||
145605329|NCT00279201|525068970|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
145605330|NCT00279201|525068971|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
145605331|NCT00279201|525068972|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
145605332|NCT00279201|525068973|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
145605333|NCT00279201|525068974|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
145605334|NCT00279201|525068975|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
145605335|NCT00279201|525068970|FG000|Maintenance|Lack of Efficacy|32|||
145605336|NCT00279201|525068971|FG001|Maintenance|Lack of Efficacy|30|||
145605337|NCT00279201|525068972|FG002|Maintenance|Lack of Efficacy|0|||
145605338|NCT00279201|525068973|FG003|Maintenance|Lack of Efficacy|0|||
145605339|NCT00279201|525068974|FG004|Maintenance|Lack of Efficacy|0|||
145605340|NCT00279201|525068975|FG005|Maintenance|Lack of Efficacy|0|||
145486206|NCT02723773|524634938|FG002|Overall Study|Protocol Violation|0|||
145486207|NCT02723773|524634939|FG003|Overall Study|Protocol Violation|0|||
145605341|NCT00279201|525068970|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
145605342|NCT00279201|525068971|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
145605343|NCT00279201|525068972|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
145605344|NCT00279201|525068973|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
145605345|NCT00279201|525068974|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
145605346|NCT00279201|525068975|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
145605347|NCT00279201|525068970|FG000|Maintenance|Adverse Event|4|||
145605348|NCT00279201|525068971|FG001|Maintenance|Adverse Event|4|||
145605349|NCT00279201|525068972|FG002|Maintenance|Adverse Event|0|||
145605350|NCT00279201|525068973|FG003|Maintenance|Adverse Event|0|||
145605351|NCT00279201|525068974|FG004|Maintenance|Adverse Event|0|||
145605352|NCT00279201|525068975|FG005|Maintenance|Adverse Event|0|||
145605353|NCT00279201|525068970|FG000|Maintenance|Death|4|||
145605354|NCT00279201|525068971|FG001|Maintenance|Death|4|||
145605355|NCT00279201|525068972|FG002|Maintenance|Death|0|||
145605356|NCT00279201|525068973|FG003|Maintenance|Death|0|||
145486208|NCT02723773|524634936|FG000|Overall Study|Withdrawal by Subject|360|||
145486209|NCT02723773|524634937|FG001|Overall Study|Withdrawal by Subject|5|||
145486210|NCT02723773|524634938|FG002|Overall Study|Withdrawal by Subject|6|||
145605357|NCT00279201|525068974|FG004|Maintenance|Death|0|||
145605358|NCT00279201|525068975|FG005|Maintenance|Death|0|||
145605359|NCT00279201|525068970|FG000|Maintenance|Lost to Follow-up|17|||
145605360|NCT00279201|525068971|FG001|Maintenance|Lost to Follow-up|13|||
145605361|NCT00279201|525068972|FG002|Maintenance|Lost to Follow-up|0|||
145605362|NCT00279201|525068973|FG003|Maintenance|Lost to Follow-up|0|||
145605363|NCT00279201|525068974|FG004|Maintenance|Lost to Follow-up|0|||
145605364|NCT00279201|525068975|FG005|Maintenance|Lost to Follow-up|0|||
145605365|NCT00279201|525068970|FG000|Maintenance|Entry Criteria Exclusion|1|||
145605366|NCT00279201|525068971|FG001|Maintenance|Entry Criteria Exclusion|4|||
145605367|NCT00279201|525068972|FG002|Maintenance|Entry Criteria Exclusion|0|||
145605368|NCT00279201|525068973|FG003|Maintenance|Entry Criteria Exclusion|0|||
145605369|NCT00279201|525068974|FG004|Maintenance|Entry Criteria Exclusion|0|||
145605370|NCT00279201|525068975|FG005|Maintenance|Entry Criteria Exclusion|0|||
145605371|NCT00279201|525068970|FG000|Maintenance|Protocol Violation|16|||
145605372|NCT00279201|525068971|FG001|Maintenance|Protocol Violation|24|||
145605373|NCT00279201|525068972|FG002|Maintenance|Protocol Violation|0|||
145605374|NCT00279201|525068973|FG003|Maintenance|Protocol Violation|0|||
145605375|NCT00279201|525068974|FG004|Maintenance|Protocol Violation|0|||
145605376|NCT00279201|525068975|FG005|Maintenance|Protocol Violation|0|||
145605377|NCT00279201|525068970|FG000|Maintenance|Withdrawal by Subject|18|||
145605378|NCT00279201|525068971|FG001|Maintenance|Withdrawal by Subject|18|||
145605379|NCT00279201|525068972|FG002|Maintenance|Withdrawal by Subject|0|||
145605380|NCT00279201|525068973|FG003|Maintenance|Withdrawal by Subject|0|||
145605381|NCT00279201|525068974|FG004|Maintenance|Withdrawal by Subject|0|||
145605382|NCT00279201|525068975|FG005|Maintenance|Withdrawal by Subject|0|||
145605383|NCT00279201|525068970|FG000|Maintenance|Physician Decision|9|||
145605384|NCT00279201|525068971|FG001|Maintenance|Physician Decision|9|||
145605385|NCT00279201|525068972|FG002|Maintenance|Physician Decision|0|||
145605386|NCT00279201|525068973|FG003|Maintenance|Physician Decision|0|||
145605387|NCT00279201|525068974|FG004|Maintenance|Physician Decision|0|||
145605388|NCT00279201|525068975|FG005|Maintenance|Physician Decision|0|||
145605389|NCT00279201|525068970|FG000|Maintenance|Sponsor Decision|4|||
145605390|NCT00279201|525068971|FG001|Maintenance|Sponsor Decision|0|||
145605391|NCT00279201|525068972|FG002|Maintenance|Sponsor Decision|0|||
145605392|NCT00279201|525068973|FG003|Maintenance|Sponsor Decision|0|||
145605393|NCT00279201|525068974|FG004|Maintenance|Sponsor Decision|0|||
145605394|NCT00279201|525068975|FG005|Maintenance|Sponsor Decision|0|||
145605395|NCT00279201|525068970|FG000|Maintenance|HbA1c>7.5%|123|||
145605396|NCT00279201|525068971|FG001|Maintenance|HbA1c>7.5%|126|||
145605397|NCT00279201|525068972|FG002|Maintenance|HbA1c>7.5%|0|||
145605398|NCT00279201|525068973|FG003|Maintenance|HbA1c>7.5%|0|||
145605399|NCT00279201|525068974|FG004|Maintenance|HbA1c>7.5%|0|||
145605400|NCT00279201|525068975|FG005|Maintenance|HbA1c>7.5%|0|||
145605401|NCT00279201|525068970|FG000|Intensification Addendum|Withdrawal by Subject|0|||
145605402|NCT00279201|525068971|FG001|Intensification Addendum|Withdrawal by Subject|0|||
145605403|NCT00279201|525068972|FG002|Intensification Addendum|Withdrawal by Subject|12|||
145605404|NCT00279201|525068973|FG003|Intensification Addendum|Withdrawal by Subject|14|||
145605405|NCT00279201|525068974|FG004|Intensification Addendum|Withdrawal by Subject|9|||
145605406|NCT00279201|525068975|FG005|Intensification Addendum|Withdrawal by Subject|18|||
145605407|NCT00279201|525068970|FG000|Intensification Addendum|Lost to Follow-up|0|||
145605408|NCT00279201|525068971|FG001|Intensification Addendum|Lost to Follow-up|0|||
145605409|NCT00279201|525068972|FG002|Intensification Addendum|Lost to Follow-up|4|||
145605410|NCT00279201|525068973|FG003|Intensification Addendum|Lost to Follow-up|6|||
145605411|NCT00279201|525068974|FG004|Intensification Addendum|Lost to Follow-up|7|||
145605412|NCT00279201|525068975|FG005|Intensification Addendum|Lost to Follow-up|7|||
145605413|NCT00279201|525068970|FG000|Intensification Addendum|Protocol Violation|0|||
145605414|NCT00279201|525068971|FG001|Intensification Addendum|Protocol Violation|0|||
145640514|NCT02988817|525200090|FG011|Overall Study|Sponsor decision|1|||
145486211|NCT02723773|524634939|FG003|Overall Study|Withdrawal by Subject|10|||
145605415|NCT00279201|525068972|FG002|Intensification Addendum|Protocol Violation|2|||
145605416|NCT00279201|525068973|FG003|Intensification Addendum|Protocol Violation|2|||
145605417|NCT00279201|525068974|FG004|Intensification Addendum|Protocol Violation|6|||
145605418|NCT00279201|525068975|FG005|Intensification Addendum|Protocol Violation|6|||
145605419|NCT00279201|525068970|FG000|Intensification Addendum|Adverse Event|0|||
145605420|NCT00279201|525068971|FG001|Intensification Addendum|Adverse Event|0|||
145605421|NCT00279201|525068972|FG002|Intensification Addendum|Adverse Event|0|||
145605422|NCT00279201|525068973|FG003|Intensification Addendum|Adverse Event|4|||
145605423|NCT00279201|525068974|FG004|Intensification Addendum|Adverse Event|1|||
145605424|NCT00279201|525068975|FG005|Intensification Addendum|Adverse Event|3|||
145605425|NCT00279201|525068970|FG000|Intensification Addendum|Physician Decision|0|||
145605426|NCT00279201|525068971|FG001|Intensification Addendum|Physician Decision|0|||
145605427|NCT00279201|525068972|FG002|Intensification Addendum|Physician Decision|4|||
145605428|NCT00279201|525068973|FG003|Intensification Addendum|Physician Decision|1|||
145605429|NCT00279201|525068974|FG004|Intensification Addendum|Physician Decision|3|||
145640515|NCT02988817|525200091|FG012|Overall Study|Sponsor decision|1|||
145605430|NCT00279201|525068975|FG005|Intensification Addendum|Physician Decision|2|||
145605431|NCT00279201|525068970|FG000|Intensification Addendum|Sponsor Decision|0|||
145605432|NCT00279201|525068971|FG001|Intensification Addendum|Sponsor Decision|0|||
145605433|NCT00279201|525068972|FG002|Intensification Addendum|Sponsor Decision|0|||
145605434|NCT00279201|525068973|FG003|Intensification Addendum|Sponsor Decision|0|||
145605435|NCT00279201|525068974|FG004|Intensification Addendum|Sponsor Decision|1|||
145605436|NCT00279201|525068975|FG005|Intensification Addendum|Sponsor Decision|1|||
145605437|NCT00279201|525068970|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
145605438|NCT00279201|525068971|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
145605439|NCT00279201|525068972|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
145605440|NCT00279201|525068973|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
145605441|NCT00279201|525068974|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
145605442|NCT00279201|525068975|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
145605443|NCT00279201|525068970|FG000|Intensification Addendum|Lack of Efficacy|0|||
145605444|NCT00279201|525068971|FG001|Intensification Addendum|Lack of Efficacy|0|||
145605445|NCT00279201|525068972|FG002|Intensification Addendum|Lack of Efficacy|0|||
145605446|NCT00279201|525068973|FG003|Intensification Addendum|Lack of Efficacy|1|||
145605447|NCT00279201|525068974|FG004|Intensification Addendum|Lack of Efficacy|1|||
145605448|NCT00279201|525068975|FG005|Intensification Addendum|Lack of Efficacy|0|||
145605449|NCT00279201|525068970|FG000|Intensification Addendum|Death|0|||
145605450|NCT00279201|525068971|FG001|Intensification Addendum|Death|0|||
145605451|NCT00279201|525068972|FG002|Intensification Addendum|Death|0|||
145605452|NCT00279201|525068973|FG003|Intensification Addendum|Death|0|||
145605453|NCT00279201|525068974|FG004|Intensification Addendum|Death|1|||
145605454|NCT00279201|525068975|FG005|Intensification Addendum|Death|0|||
145605455|NCT03881696|525068984|FG000|Overall Study|Adverse Event|2|||
145605456|NCT03881696|525068985|FG001|Overall Study|Adverse Event|0|||
145605457|NCT03881696|525068984|FG000|Overall Study|Withdrawal by Subject|2|||
145605458|NCT03881696|525068985|FG001|Overall Study|Withdrawal by Subject|0|||
145605459|NCT03881696|525068984|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
145605460|NCT03881696|525068985|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
145605461|NCT03881696|525068984|FG000|Overall Study|Failure to meet continuation criteria|1|||
145605462|NCT03881696|525068985|FG001|Overall Study|Failure to meet continuation criteria|0|||
145605463|NCT01061333|525068986|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
145605464|NCT01061333|525068987|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
145640516|NCT02988817|525200092|FG013|Overall Study|Sponsor decision|2|||
145640517|NCT02988817|525200093|FG014|Overall Study|Sponsor decision|2|||
145640518|NCT02988817|525200094|FG015|Overall Study|Sponsor decision|6|||
145640519|NCT02988817|525200095|FG016|Overall Study|Sponsor decision|2|||
145640520|NCT02988817|525200096|FG017|Overall Study|Sponsor decision|3|||
145640521|NCT02988817|525200097|FG018|Overall Study|Sponsor decision|2|||
145640522|NCT02988817|525200098|FG019|Overall Study|Sponsor decision|7|||
145640523|NCT02988817|525200079|FG000|Overall Study|Physician Decision|0|||
145640524|NCT02988817|525200080|FG001|Overall Study|Physician Decision|0|||
145640525|NCT02988817|525200081|FG002|Overall Study|Physician Decision|0|||
145640526|NCT02988817|525200082|FG003|Overall Study|Physician Decision|0|||
145640527|NCT02988817|525200083|FG004|Overall Study|Physician Decision|0|||
145640528|NCT02988817|525200084|FG005|Overall Study|Physician Decision|0|||
145640529|NCT02988817|525200085|FG006|Overall Study|Physician Decision|0|||
145640530|NCT02988817|525200086|FG007|Overall Study|Physician Decision|0|||
145640531|NCT02988817|525200087|FG008|Overall Study|Physician Decision|0|||
145640532|NCT02988817|525200088|FG009|Overall Study|Physician Decision|0|||
145640533|NCT02988817|525200089|FG010|Overall Study|Physician Decision|0|||
145640534|NCT02988817|525200090|FG011|Overall Study|Physician Decision|0|||
145640535|NCT02988817|525200091|FG012|Overall Study|Physician Decision|0|||
145640536|NCT02988817|525200092|FG013|Overall Study|Physician Decision|0|||
145640537|NCT02988817|525200093|FG014|Overall Study|Physician Decision|0|||
145640538|NCT02988817|525200094|FG015|Overall Study|Physician Decision|1|||
145640539|NCT02988817|525200095|FG016|Overall Study|Physician Decision|0|||
145640540|NCT02988817|525200096|FG017|Overall Study|Physician Decision|0|||
145640541|NCT02988817|525200097|FG018|Overall Study|Physician Decision|1|||
145640542|NCT02988817|525200098|FG019|Overall Study|Physician Decision|1|||
145640543|NCT05082935|525200105|FG000|Overall Study|Lost to Follow-up|549|||
145640544|NCT05082935|525200106|FG001|Overall Study|Lost to Follow-up|631|||
145640545|NCT05082935|525200105|FG000|Overall Study|Withdrawal by Subject|27|||
145640546|NCT05082935|525200106|FG001|Overall Study|Withdrawal by Subject|58|||
145640547|NCT04530747|525200110|FG000|Overall Study|Withdrawal by Subject|1|||
145640548|NCT04530747|525200111|FG001|Overall Study|Withdrawal by Subject|0|||
145640549|NCT03292913|525200112|FG000|Overall Study|Death|9|||
145640550|NCT03292913|525200113|FG001|Overall Study|Death|3|||
145640551|NCT03292913|525200112|FG000|Overall Study|Lost to Follow-up|49|||
145640552|NCT03292913|525200113|FG001|Overall Study|Lost to Follow-up|49|||
145640553|NCT03292913|525200112|FG000|Overall Study|Withdrawal by Subject|2|||
145640554|NCT03292913|525200113|FG001|Overall Study|Withdrawal by Subject|0|||
145640555|NCT03292913|525200112|FG000|Overall Study|Clinic closed due to COVID|22|||
145640556|NCT03292913|525200113|FG001|Overall Study|Clinic closed due to COVID|36|||
145640557|NCT04056624|525200114|FG000|Overall Study|Withdrawal by Subject|0|||
145640558|NCT04056624|525200115|FG001|Overall Study|Withdrawal by Subject|0|||
145640559|NCT04056624|525200116|FG002|Overall Study|Withdrawal by Subject|1|||
145640560|NCT04056624|525200114|FG000|Overall Study|Protocol Violation|1|||
145640561|NCT04056624|525200115|FG001|Overall Study|Protocol Violation|2|||
145640562|NCT04056624|525200116|FG002|Overall Study|Protocol Violation|0|||
145640563|NCT02092116|525200121|FG000|Overall Study|Withdrawal by Subject|0|||
145640564|NCT02092116|525200122|FG001|Overall Study|Withdrawal by Subject|3|||
145640565|NCT02092116|525200121|FG000|Overall Study|Adverse Event|0|||
145640566|NCT02092116|525200122|FG001|Overall Study|Adverse Event|1|||
145640567|NCT03531840|525200123|FG000|Overall Study|Death on study|3|||
145640568|NCT03531840|525200124|FG001|Overall Study|Death on study|2|||
145640569|NCT03531840|525200125|FG002|Overall Study|Death on study|1|||
145640570|NCT03531840|525200126|FG003|Overall Study|Death on study|2|||
145640571|NCT03531840|525200123|FG000|Overall Study|Death during follow up|2|||
145640572|NCT03531840|525200124|FG001|Overall Study|Death during follow up|3|||
145640573|NCT03531840|525200125|FG002|Overall Study|Death during follow up|4|||
145640574|NCT03531840|525200126|FG003|Overall Study|Death during follow up|1|||
145640575|NCT02267824|525200127|FG000|Overall Study|Pregnancy|1|||
145640576|NCT02267824|525200128|FG001|Overall Study|Pregnancy|1|||
145640577|NCT02267824|525200127|FG000|Overall Study|Lost to Follow-up|4|||
145640578|NCT02267824|525200128|FG001|Overall Study|Lost to Follow-up|0|||
145640579|NCT02267824|525200127|FG000|Overall Study|Protocol Violation|3|||
145640580|NCT02267824|525200128|FG001|Overall Study|Protocol Violation|0|||
145640581|NCT02267824|525200127|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
145640582|NCT02267824|525200128|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
145640583|NCT03074331|525200129|FG000|Overall Study|Enrolled but Not Treated|1|||
145640584|NCT03074331|525200129|FG000|Overall Study|Lost to Follow-up|5|||
145640585|NCT03074331|525200129|FG000|Overall Study|Withdrew Consent|1|||
145640586|NCT01792830|525200133|FG000|Overall Study|Withdrawal by Subject|22|||
145640587|NCT01792830|525200134|FG001|Overall Study|Withdrawal by Subject|0|||
145640588|NCT01792830|525200135|FG002|Overall Study|Withdrawal by Subject|0|||
145640589|NCT01792830|525200136|FG003|Overall Study|Withdrawal by Subject|2|||
145640590|NCT01792830|525200137|FG004|Overall Study|Withdrawal by Subject|1|||
145640591|NCT01792830|525200138|FG005|Overall Study|Withdrawal by Subject|1|||
145640592|NCT01792830|525200139|FG006|Overall Study|Withdrawal by Subject|1|||
145640593|NCT01792830|525200140|FG007|Overall Study|Withdrawal by Subject|1|||
145640594|NCT01792830|525200141|FG008|Overall Study|Withdrawal by Subject|7|||
145640595|NCT01792830|525200142|FG009|Overall Study|Withdrawal by Subject|0|||
145640596|NCT01792830|525200143|FG010|Overall Study|Withdrawal by Subject|2|||
145640597|NCT01792830|525200133|FG000|Overall Study|Death|3|||
145640598|NCT01792830|525200134|FG001|Overall Study|Death|0|||
145640599|NCT01792830|525200135|FG002|Overall Study|Death|0|||
145640600|NCT01792830|525200136|FG003|Overall Study|Death|1|||
145640601|NCT01792830|525200137|FG004|Overall Study|Death|0|||
145640602|NCT01792830|525200138|FG005|Overall Study|Death|0|||
145640603|NCT01792830|525200139|FG006|Overall Study|Death|1|||
145640604|NCT01792830|525200140|FG007|Overall Study|Death|0|||
145640605|NCT01792830|525200141|FG008|Overall Study|Death|1|||
145640606|NCT01792830|525200142|FG009|Overall Study|Death|0|||
145640607|NCT01792830|525200143|FG010|Overall Study|Death|1|||
145640608|NCT01792830|525200133|FG000|Overall Study|Adverse Event|0|||
145640609|NCT01792830|525200134|FG001|Overall Study|Adverse Event|0|||
145640610|NCT01792830|525200135|FG002|Overall Study|Adverse Event|0|||
145640611|NCT01792830|525200136|FG003|Overall Study|Adverse Event|0|||
145640612|NCT01792830|525200137|FG004|Overall Study|Adverse Event|0|||
145640613|NCT01792830|525200138|FG005|Overall Study|Adverse Event|0|||
145640614|NCT01792830|525200139|FG006|Overall Study|Adverse Event|0|||
145640615|NCT01792830|525200140|FG007|Overall Study|Adverse Event|0|||
145640616|NCT01792830|525200141|FG008|Overall Study|Adverse Event|1|||
145640617|NCT01792830|525200142|FG009|Overall Study|Adverse Event|0|||
145640618|NCT01792830|525200143|FG010|Overall Study|Adverse Event|0|||
145640619|NCT01943799|525200144|FG000|Overall Study|Lost to Follow-up|0|||
145640620|NCT01943799|525200145|FG001|Overall Study|Lost to Follow-up|1|||
145640621|NCT01943799|525200146|FG002|Overall Study|Lost to Follow-up|1|||
145640622|NCT01943799|525200147|FG003|Overall Study|Lost to Follow-up|0|||
145640623|NCT01943799|525200144|FG000|Overall Study|Protocol Violation|1|||
145265301|NCT03323034|523819273|FG002|Overall Study|Lack of Efficacy|6|||
145640624|NCT01943799|525200145|FG001|Overall Study|Protocol Violation|0|||
145640625|NCT01943799|525200146|FG002|Overall Study|Protocol Violation|0|||
145640626|NCT01943799|525200147|FG003|Overall Study|Protocol Violation|0|||
145640627|NCT01943799|525200144|FG000|Overall Study|Withdrawal by Subject|4|||
145640628|NCT01943799|525200145|FG001|Overall Study|Withdrawal by Subject|2|||
145640629|NCT01943799|525200146|FG002|Overall Study|Withdrawal by Subject|1|||
145640630|NCT01943799|525200147|FG003|Overall Study|Withdrawal by Subject|0|||
145640631|NCT03811574|525200150|FG000|Overall Study|Withdrawal by Subject|2|||
145640632|NCT03811574|525200151|FG001|Overall Study|Withdrawal by Subject|4|||
145640633|NCT03811574|525200152|FG002|Overall Study|Withdrawal by Subject|0|||
145640634|NCT01170962|525200154|FG000|Treatment Period|Lack of Efficacy|96|||
145640635|NCT01170962|525200155|FG001|Treatment Period|Lack of Efficacy|91|||
145640636|NCT01170962|525200156|FG002|Treatment Period|Lack of Efficacy|7|||
145640637|NCT01170962|525200154|FG000|Treatment Period|Adverse Event|11|||
145640638|NCT01170962|525200155|FG001|Treatment Period|Adverse Event|12|||
145640639|NCT01170962|525200156|FG002|Treatment Period|Adverse Event|3|||
145640640|NCT01170962|525200154|FG000|Treatment Period|Withdrawal by Subject|2|||
145640641|NCT01170962|525200155|FG001|Treatment Period|Withdrawal by Subject|1|||
145640642|NCT01170962|525200156|FG002|Treatment Period|Withdrawal by Subject|0|||
145640643|NCT01170962|525200154|FG000|Treatment Period|Lost to Follow-up|1|||
145640644|NCT01170962|525200155|FG001|Treatment Period|Lost to Follow-up|1|||
145640645|NCT01170962|525200156|FG002|Treatment Period|Lost to Follow-up|1|||
145640646|NCT01170962|525200154|FG000|Treatment Period|Participant no longer meets criteria|0|||
145640647|NCT01170962|525200155|FG001|Treatment Period|Participant no longer meets criteria|1|||
145640648|NCT01170962|525200156|FG002|Treatment Period|Participant no longer meets criteria|0|||
145640649|NCT01170962|525200154|FG000|Treatment Period|Request to discontinue treatment|7|||
145640650|NCT01170962|525200155|FG001|Treatment Period|Request to discontinue treatment|3|||
145640651|NCT01170962|525200156|FG002|Treatment Period|Request to discontinue treatment|1|||
145640652|NCT01170962|525200154|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
145640653|NCT01170962|525200155|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
145640654|NCT01170962|525200156|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
145640655|NCT01170962|525200154|FG000|Follow up Period|Withdrawal by Subject|14|||
145640656|NCT01170962|525200155|FG001|Follow up Period|Withdrawal by Subject|10|||
145640657|NCT01170962|525200156|FG002|Follow up Period|Withdrawal by Subject|2|||
145640658|NCT01170962|525200154|FG000|Follow up Period|Lost to Follow-up|13|||
145640659|NCT01170962|525200155|FG001|Follow up Period|Lost to Follow-up|8|||
145640660|NCT01170962|525200156|FG002|Follow up Period|Lost to Follow-up|1|||
145640661|NCT01170962|525200154|FG000|Follow up Period|Death|2|||
145640662|NCT01170962|525200155|FG001|Follow up Period|Death|2|||
145640663|NCT01170962|525200156|FG002|Follow up Period|Death|0|||
145640664|NCT01170962|525200154|FG000|Follow up Period|Others|10|||
145640665|NCT01170962|525200155|FG001|Follow up Period|Others|7|||
145640666|NCT01170962|525200156|FG002|Follow up Period|Others|3|||
145640667|NCT02918071|525200157|FG000|Overall Study|Withdrawal by Subject|2|||
145640668|NCT02918071|525200157|FG000|Overall Study|Lost to Follow-up|1|||
145640669|NCT01616459|525200158|FG000|Overall Study|Adverse Event|1|||
145640670|NCT01616459|525200159|FG001|Overall Study|Adverse Event|1|||
145640671|NCT01616459|525200160|FG002|Overall Study|Adverse Event|2|||
145640672|NCT01616459|525200161|FG003|Overall Study|Adverse Event|0|||
145640673|NCT01616459|525200158|FG000|Overall Study|Lost to Follow-up|1|||
145640674|NCT01616459|525200159|FG001|Overall Study|Lost to Follow-up|11|||
145640675|NCT01616459|525200160|FG002|Overall Study|Lost to Follow-up|3|||
145640676|NCT01616459|525200161|FG003|Overall Study|Lost to Follow-up|2|||
145640677|NCT01616459|525200158|FG000|Overall Study|Protocol Violation|0|||
145640678|NCT01616459|525200159|FG001|Overall Study|Protocol Violation|0|||
145640679|NCT01616459|525200160|FG002|Overall Study|Protocol Violation|0|||
145640680|NCT01616459|525200161|FG003|Overall Study|Protocol Violation|2|||
145640681|NCT01616459|525200158|FG000|Overall Study|Withdrawal by Subject|2|||
145640682|NCT01616459|525200159|FG001|Overall Study|Withdrawal by Subject|4|||
145640683|NCT01616459|525200160|FG002|Overall Study|Withdrawal by Subject|4|||
145640684|NCT01616459|525200161|FG003|Overall Study|Withdrawal by Subject|4|||
145640685|NCT01616459|525200158|FG000|Overall Study|Other reason|0|||
145640686|NCT01616459|525200159|FG001|Overall Study|Other reason|1|||
145640687|NCT01616459|525200160|FG002|Overall Study|Other reason|1|||
145640688|NCT01616459|525200161|FG003|Overall Study|Other reason|0|||
145640689|NCT03394885|525200162|FG000|Overall Study|Adverse Event|4|||
145640690|NCT03394885|525200162|FG000|Overall Study|Lack of Efficacy|1|||
145640691|NCT03394885|525200162|FG000|Overall Study|Physician Decision|1|||
145640692|NCT03394885|525200162|FG000|Overall Study|Withdrawal by Subject|8|||
145640693|NCT03394885|525200162|FG000|Overall Study|Alternative Therapy|1|||
145640694|NCT00801983|525200163|FG000|Period 1|Lost to Follow-up|2|||
145640695|NCT00801983|525200164|FG001|Period 1|Lost to Follow-up|0|||
145640696|NCT00801983|525200163|FG000|Period 1|Withdrawal by Subject|2|||
145640697|NCT00801983|525200164|FG001|Period 1|Withdrawal by Subject|8|||
145640698|NCT00801983|525200163|FG000|Period 2|Withdrawal by Subject|2|||
145640699|NCT00801983|525200164|FG001|Period 2|Withdrawal by Subject|1|||
145640700|NCT04411056|525201948|FG000|Overall Study|surgery cancelled|1|||
145640701|NCT04411056|525201949|FG001|Overall Study|surgery cancelled|0|||
145486212|NCT02723773|524634936|FG000|Overall Study|Migrated/moved from study area|37|||
145486213|NCT02723773|524634937|FG001|Overall Study|Migrated/moved from study area|0|||
145486214|NCT02723773|524634938|FG002|Overall Study|Migrated/moved from study area|0|||
145640702|NCT04411056|525201948|FG000|Overall Study|Equipment problem during intubation|0|||
145640703|NCT04411056|525201949|FG001|Overall Study|Equipment problem during intubation|1|||
145640704|NCT03122886|525201961|FG000|Overall Study|Withdrawal by Subject|1|||
145640705|NCT03122886|525201962|FG001|Overall Study|Withdrawal by Subject|2|||
145640706|NCT05985044|525201963|FG000|Overall Study|Death|6|||
145640707|NCT05985044|525201963|FG000|Overall Study|Lost to Follow-up|4|||
145640708|NCT05985044|525201963|FG000|Overall Study|Incapacitation|3|||
145640709|NCT05985044|525201963|FG000|Overall Study|Withdrawal by Subject|2|||
145640710|NCT03312907|525201966|FG000|Overall Study|Adverse Event|1|||
145640711|NCT03312907|525201967|FG001|Overall Study|Adverse Event|6|||
145640712|NCT03312907|525201968|FG002|Overall Study|Adverse Event|1|||
145640713|NCT03312907|525201966|FG000|Overall Study|Protocol Violation|2|||
145640714|NCT03312907|525201967|FG001|Overall Study|Protocol Violation|3|||
145640715|NCT03312907|525201968|FG002|Overall Study|Protocol Violation|4|||
145640716|NCT03312907|525201966|FG000|Overall Study|Lost to Follow-up|2|||
145640717|NCT03312907|525201967|FG001|Overall Study|Lost to Follow-up|3|||
145640718|NCT03312907|525201968|FG002|Overall Study|Lost to Follow-up|2|||
145640719|NCT03312907|525201966|FG000|Overall Study|Physician Decision|3|||
145640720|NCT03312907|525201967|FG001|Overall Study|Physician Decision|4|||
145640721|NCT03312907|525201968|FG002|Overall Study|Physician Decision|2|||
145640722|NCT03312907|525201966|FG000|Overall Study|Withdrawal by Subject|9|||
145640723|NCT03312907|525201967|FG001|Overall Study|Withdrawal by Subject|14|||
145640724|NCT03312907|525201968|FG002|Overall Study|Withdrawal by Subject|10|||
145640725|NCT04425629|525201972|FG000|Overall Study|Adverse Event|0|||
145640726|NCT04425629|525201973|FG001|Overall Study|Adverse Event|0|||
145640727|NCT04425629|525201974|FG002|Overall Study|Adverse Event|0|||
145640728|NCT04425629|525201975|FG003|Overall Study|Adverse Event|0|||
145640729|NCT04425629|525201976|FG004|Overall Study|Adverse Event|1|||
145640730|NCT04425629|525201977|FG005|Overall Study|Adverse Event|0|||
145640731|NCT04425629|525201978|FG006|Overall Study|Adverse Event|0|||
145640732|NCT04425629|525201979|FG007|Overall Study|Adverse Event|0|||
145640733|NCT04425629|525201980|FG008|Overall Study|Adverse Event|0|||
145640734|NCT04425629|525201981|FG009|Overall Study|Adverse Event|3|||
145640735|NCT04425629|525201982|FG010|Overall Study|Adverse Event|2|||
145640736|NCT04425629|525201983|FG011|Overall Study|Adverse Event|1|||
145640737|NCT04425629|525201984|FG012|Overall Study|Adverse Event|1|||
145640738|NCT04425629|525201985|FG013|Overall Study|Adverse Event|0|||
145640739|NCT04425629|525201986|FG014|Overall Study|Adverse Event|0|||
145640740|NCT04425629|525201987|FG015|Overall Study|Adverse Event|0|||
145640741|NCT04425629|525201988|FG016|Overall Study|Adverse Event|0|||
145640742|NCT04425629|525201989|FG017|Overall Study|Adverse Event|0|||
145640743|NCT04425629|525201990|FG018|Overall Study|Adverse Event|0|||
145640744|NCT04425629|525201972|FG000|Overall Study|Lost to Follow-up|1|||
145640745|NCT04425629|525201973|FG001|Overall Study|Lost to Follow-up|3|||
145640746|NCT04425629|525201974|FG002|Overall Study|Lost to Follow-up|1|||
145640747|NCT04425629|525201975|FG003|Overall Study|Lost to Follow-up|7|||
145640748|NCT04425629|525201976|FG004|Overall Study|Lost to Follow-up|1|||
145640749|NCT04425629|525201977|FG005|Overall Study|Lost to Follow-up|2|||
145640750|NCT04425629|525201978|FG006|Overall Study|Lost to Follow-up|1|||
145640751|NCT04425629|525201979|FG007|Overall Study|Lost to Follow-up|0|||
145640752|NCT04425629|525201980|FG008|Overall Study|Lost to Follow-up|1|||
145640753|NCT04425629|525201981|FG009|Overall Study|Lost to Follow-up|64|||
145640754|NCT04425629|525201982|FG010|Overall Study|Lost to Follow-up|70|||
145640755|NCT04425629|525201983|FG011|Overall Study|Lost to Follow-up|98|||
145640756|NCT04425629|525201984|FG012|Overall Study|Lost to Follow-up|30|||
145640757|NCT04425629|525201985|FG013|Overall Study|Lost to Follow-up|0|||
145640758|NCT04425629|525201986|FG014|Overall Study|Lost to Follow-up|5|||
145640759|NCT04425629|525201987|FG015|Overall Study|Lost to Follow-up|4|||
145640760|NCT04425629|525201988|FG016|Overall Study|Lost to Follow-up|0|||
145640761|NCT04425629|525201989|FG017|Overall Study|Lost to Follow-up|3|||
145640762|NCT04425629|525201990|FG018|Overall Study|Lost to Follow-up|1|||
145640763|NCT04425629|525201972|FG000|Overall Study|Subject Decision|0|||
145640764|NCT04425629|525201973|FG001|Overall Study|Subject Decision|2|||
145486215|NCT02723773|524634939|FG003|Overall Study|Migrated/moved from study area|1|||
145486216|NCT02723773|524634936|FG000|Overall Study|Lost to Follow-up|198|||
145640765|NCT04425629|525201974|FG002|Overall Study|Subject Decision|1|||
145640766|NCT04425629|525201975|FG003|Overall Study|Subject Decision|3|||
145640767|NCT04425629|525201976|FG004|Overall Study|Subject Decision|6|||
145640768|NCT04425629|525201977|FG005|Overall Study|Subject Decision|6|||
145640769|NCT04425629|525201978|FG006|Overall Study|Subject Decision|3|||
145640770|NCT04425629|525201979|FG007|Overall Study|Subject Decision|3|||
145640771|NCT04425629|525201980|FG008|Overall Study|Subject Decision|1|||
145640772|NCT04425629|525201981|FG009|Overall Study|Subject Decision|70|||
145640773|NCT04425629|525201982|FG010|Overall Study|Subject Decision|95|||
145640774|NCT04425629|525201983|FG011|Overall Study|Subject Decision|124|||
145640775|NCT04425629|525201984|FG012|Overall Study|Subject Decision|25|||
145486217|NCT02723773|524634937|FG001|Overall Study|Lost to Follow-up|0|||
145486218|NCT02723773|524634938|FG002|Overall Study|Lost to Follow-up|0|||
145640776|NCT04425629|525201985|FG013|Overall Study|Subject Decision|0|||
145640777|NCT04425629|525201986|FG014|Overall Study|Subject Decision|1|||
145640778|NCT04425629|525201987|FG015|Overall Study|Subject Decision|4|||
145640779|NCT04425629|525201988|FG016|Overall Study|Subject Decision|1|||
145640780|NCT04425629|525201989|FG017|Overall Study|Subject Decision|0|||
145640781|NCT04425629|525201990|FG018|Overall Study|Subject Decision|2|||
145640782|NCT04425629|525201972|FG000|Overall Study|Death|0|||
145640783|NCT04425629|525201973|FG001|Overall Study|Death|0|||
145640784|NCT04425629|525201974|FG002|Overall Study|Death|0|||
145640785|NCT04425629|525201975|FG003|Overall Study|Death|0|||
145640786|NCT04425629|525201976|FG004|Overall Study|Death|0|||
145640787|NCT04425629|525201977|FG005|Overall Study|Death|0|||
145640788|NCT04425629|525201978|FG006|Overall Study|Death|0|||
145640789|NCT04425629|525201979|FG007|Overall Study|Death|0|||
145640790|NCT04425629|525201980|FG008|Overall Study|Death|0|||
145640791|NCT04425629|525201981|FG009|Overall Study|Death|11|||
145640792|NCT04425629|525201982|FG010|Overall Study|Death|2|||
145640793|NCT04425629|525201983|FG011|Overall Study|Death|4|||
145640794|NCT04425629|525201984|FG012|Overall Study|Death|0|||
145640795|NCT04425629|525201985|FG013|Overall Study|Death|0|||
145640796|NCT04425629|525201986|FG014|Overall Study|Death|0|||
145640797|NCT04425629|525201987|FG015|Overall Study|Death|0|||
145640798|NCT04425629|525201988|FG016|Overall Study|Death|0|||
145640799|NCT04425629|525201989|FG017|Overall Study|Death|0|||
145640800|NCT04425629|525201990|FG018|Overall Study|Death|0|||
145640801|NCT04425629|525201972|FG000|Overall Study|Sponsor Request|0|||
145640802|NCT04425629|525201973|FG001|Overall Study|Sponsor Request|0|||
145640803|NCT04425629|525201974|FG002|Overall Study|Sponsor Request|0|||
145640804|NCT04425629|525201975|FG003|Overall Study|Sponsor Request|2|||
145640805|NCT04425629|525201976|FG004|Overall Study|Sponsor Request|2|||
145640806|NCT04425629|525201977|FG005|Overall Study|Sponsor Request|2|||
145640807|NCT04425629|525201978|FG006|Overall Study|Sponsor Request|1|||
145640808|NCT04425629|525201979|FG007|Overall Study|Sponsor Request|0|||
145640809|NCT04425629|525201980|FG008|Overall Study|Sponsor Request|0|||
145640810|NCT04425629|525201981|FG009|Overall Study|Sponsor Request|9|||
145640811|NCT04425629|525201982|FG010|Overall Study|Sponsor Request|9|||
145640812|NCT04425629|525201983|FG011|Overall Study|Sponsor Request|10|||
145640813|NCT04425629|525201984|FG012|Overall Study|Sponsor Request|8|||
145640814|NCT04425629|525201985|FG013|Overall Study|Sponsor Request|0|||
145640815|NCT04425629|525201986|FG014|Overall Study|Sponsor Request|0|||
145640816|NCT04425629|525201987|FG015|Overall Study|Sponsor Request|1|||
145640817|NCT04425629|525201988|FG016|Overall Study|Sponsor Request|0|||
145640818|NCT04425629|525201989|FG017|Overall Study|Sponsor Request|0|||
145640819|NCT04425629|525201990|FG018|Overall Study|Sponsor Request|0|||
145640820|NCT04425629|525201972|FG000|Overall Study|Physician Decision|0|||
145640821|NCT04425629|525201973|FG001|Overall Study|Physician Decision|0|||
145640822|NCT04425629|525201974|FG002|Overall Study|Physician Decision|0|||
145640823|NCT04425629|525201975|FG003|Overall Study|Physician Decision|0|||
145640824|NCT04425629|525201976|FG004|Overall Study|Physician Decision|0|||
145640825|NCT04425629|525201977|FG005|Overall Study|Physician Decision|0|||
145640826|NCT04425629|525201978|FG006|Overall Study|Physician Decision|0|||
145640827|NCT04425629|525201979|FG007|Overall Study|Physician Decision|0|||
145640828|NCT04425629|525201980|FG008|Overall Study|Physician Decision|0|||
145640829|NCT04425629|525201981|FG009|Overall Study|Physician Decision|4|||
145640830|NCT04425629|525201982|FG010|Overall Study|Physician Decision|3|||
145640831|NCT04425629|525201983|FG011|Overall Study|Physician Decision|5|||
145640832|NCT04425629|525201984|FG012|Overall Study|Physician Decision|1|||
145640833|NCT04425629|525201985|FG013|Overall Study|Physician Decision|0|||
145640834|NCT04425629|525201986|FG014|Overall Study|Physician Decision|0|||
145640835|NCT04425629|525201987|FG015|Overall Study|Physician Decision|1|||
145640836|NCT04425629|525201988|FG016|Overall Study|Physician Decision|0|||
145640837|NCT04425629|525201989|FG017|Overall Study|Physician Decision|0|||
145640838|NCT04425629|525201990|FG018|Overall Study|Physician Decision|0|||
145640839|NCT04425629|525201972|FG000|Overall Study|Lack of Efficacy|0|||
145640840|NCT04425629|525201973|FG001|Overall Study|Lack of Efficacy|0|||
145640841|NCT04425629|525201974|FG002|Overall Study|Lack of Efficacy|0|||
145640842|NCT04425629|525201975|FG003|Overall Study|Lack of Efficacy|0|||
145640843|NCT04425629|525201976|FG004|Overall Study|Lack of Efficacy|0|||
145640844|NCT04425629|525201977|FG005|Overall Study|Lack of Efficacy|0|||
145640845|NCT04425629|525201978|FG006|Overall Study|Lack of Efficacy|0|||
145640846|NCT04425629|525201979|FG007|Overall Study|Lack of Efficacy|0|||
145640847|NCT04425629|525201980|FG008|Overall Study|Lack of Efficacy|0|||
145640848|NCT04425629|525201981|FG009|Overall Study|Lack of Efficacy|0|||
145640849|NCT04425629|525201982|FG010|Overall Study|Lack of Efficacy|1|||
145640850|NCT04425629|525201983|FG011|Overall Study|Lack of Efficacy|0|||
145640851|NCT04425629|525201984|FG012|Overall Study|Lack of Efficacy|0|||
145640852|NCT04425629|525201985|FG013|Overall Study|Lack of Efficacy|0|||
145640853|NCT04425629|525201986|FG014|Overall Study|Lack of Efficacy|0|||
145640854|NCT04425629|525201987|FG015|Overall Study|Lack of Efficacy|0|||
145640855|NCT04425629|525201988|FG016|Overall Study|Lack of Efficacy|0|||
145640856|NCT04425629|525201989|FG017|Overall Study|Lack of Efficacy|0|||
145640857|NCT04425629|525201990|FG018|Overall Study|Lack of Efficacy|0|||
145640858|NCT00610649|525201992|FG000|Overall Study|Adverse Event|1|||
145640859|NCT00610649|525201993|FG001|Overall Study|Adverse Event|0|||
145640860|NCT00610649|525201994|FG002|Overall Study|Adverse Event|0|||
145640861|NCT00610649|525201995|FG003|Overall Study|Adverse Event|0|||
145640862|NCT00610649|525201996|FG004|Overall Study|Adverse Event|0|||
145640863|NCT00610649|525201997|FG005|Overall Study|Adverse Event|0|||
145640864|NCT00610649|525201998|FG006|Overall Study|Adverse Event|0|||
145640865|NCT00610649|525201999|FG007|Overall Study|Adverse Event|0|||
145640866|NCT00610649|525202000|FG008|Overall Study|Adverse Event|0|||
145640867|NCT00610649|525202001|FG009|Overall Study|Adverse Event|0|||
145640868|NCT00610649|525202002|FG010|Overall Study|Adverse Event|1|||
145640869|NCT00610649|525201992|FG000|Overall Study|Family Emergency|0|||
145640870|NCT00610649|525201993|FG001|Overall Study|Family Emergency|1|||
145640871|NCT00610649|525201994|FG002|Overall Study|Family Emergency|0|||
145640872|NCT00610649|525201995|FG003|Overall Study|Family Emergency|0|||
145640873|NCT00610649|525201996|FG004|Overall Study|Family Emergency|0|||
145640874|NCT00610649|525201997|FG005|Overall Study|Family Emergency|0|||
145640875|NCT00610649|525201998|FG006|Overall Study|Family Emergency|0|||
145640876|NCT00610649|525201999|FG007|Overall Study|Family Emergency|0|||
145640877|NCT00610649|525202000|FG008|Overall Study|Family Emergency|0|||
145640878|NCT00610649|525202001|FG009|Overall Study|Family Emergency|0|||
145640879|NCT00610649|525202002|FG010|Overall Study|Family Emergency|0|||
145640880|NCT00610649|525201992|FG000|Overall Study|Withdrawal by Subject|0|||
145640881|NCT00610649|525201993|FG001|Overall Study|Withdrawal by Subject|0|||
145640882|NCT00610649|525201994|FG002|Overall Study|Withdrawal by Subject|0|||
145640883|NCT00610649|525201995|FG003|Overall Study|Withdrawal by Subject|0|||
145640884|NCT00610649|525201996|FG004|Overall Study|Withdrawal by Subject|0|||
145640885|NCT00610649|525201997|FG005|Overall Study|Withdrawal by Subject|0|||
145640886|NCT00610649|525201998|FG006|Overall Study|Withdrawal by Subject|0|||
145640887|NCT00610649|525201999|FG007|Overall Study|Withdrawal by Subject|0|||
145640888|NCT00610649|525202000|FG008|Overall Study|Withdrawal by Subject|0|||
145640889|NCT00610649|525202001|FG009|Overall Study|Withdrawal by Subject|1|||
145640890|NCT00610649|525202002|FG010|Overall Study|Withdrawal by Subject|0|||
145640891|NCT04252586|525202003|FG000|Overall Study|Withdrawal by parent/guardian|3|||
145640892|NCT04252586|525202003|FG000|Overall Study|Adverse Event|1|||
145640893|NCT04252586|525202003|FG000|Overall Study|Death|2|||
145640894|NCT04252586|525202003|FG000|Overall Study|Study terminated by sponsor|4|||
145640895|NCT04252586|525202003|FG000|Overall Study|Sponsor request|10|||
145640896|NCT04252586|525202003|FG000|Overall Study|Did not complete treatment period|1|||
145640897|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Death|186|||
145640898|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Death|222|||
145640899|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Death|0|||
145640900|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
145640901|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
145640902|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
145640903|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
145640904|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
145640905|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
145640906|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
145640907|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
145640908|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
145640909|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Adverse Event|83|||
145640910|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Adverse Event|100|||
145640911|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Adverse Event|0|||
145640912|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Other|70|||
145640913|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Other|75|||
145640914|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Other|0|||
145640915|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
145640916|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
145640917|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
145640918|NCT00232180|525202004|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
145640919|NCT00232180|525202005|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
145640920|NCT00232180|525202006|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
145640921|NCT00232180|525202004|FG000|Open Label Phase|Death|0|||
145640922|NCT00232180|525202005|FG001|Open Label Phase|Death|0|||
145640923|NCT00232180|525202006|FG002|Open Label Phase|Death|48|||
145640924|NCT00232180|525202004|FG000|Open Label Phase|Lost to Follow-up|0|||
145640925|NCT00232180|525202005|FG001|Open Label Phase|Lost to Follow-up|0|||
145640926|NCT00232180|525202006|FG002|Open Label Phase|Lost to Follow-up|5|||
145640927|NCT00232180|525202004|FG000|Open Label Phase|Protocol Violation|0|||
145640928|NCT00232180|525202005|FG001|Open Label Phase|Protocol Violation|0|||
145640929|NCT00232180|525202006|FG002|Open Label Phase|Protocol Violation|3|||
145640930|NCT00232180|525202004|FG000|Open Label Phase|Study terminated by sponsor|0|||
145640931|NCT00232180|525202005|FG001|Open Label Phase|Study terminated by sponsor|0|||
145640932|NCT00232180|525202006|FG002|Open Label Phase|Study terminated by sponsor|3|||
145640933|NCT00232180|525202004|FG000|Open Label Phase|Withdrawal by Subject|0|||
145640934|NCT00232180|525202005|FG001|Open Label Phase|Withdrawal by Subject|0|||
145640935|NCT00232180|525202006|FG002|Open Label Phase|Withdrawal by Subject|37|||
145640936|NCT00232180|525202004|FG000|Open Label Phase|Other|0|||
145640937|NCT00232180|525202005|FG001|Open Label Phase|Other|0|||
145640938|NCT00232180|525202006|FG002|Open Label Phase|Other|16|||
145640939|NCT00232180|525202004|FG000|Open Label Phase|Adverse Event|0|||
145640940|NCT00232180|525202005|FG001|Open Label Phase|Adverse Event|0|||
145640941|NCT00232180|525202006|FG002|Open Label Phase|Adverse Event|25|||
145640942|NCT00232180|525202004|FG000|Open Label Phase|Laboratory abnormality|0|||
145640943|NCT00232180|525202005|FG001|Open Label Phase|Laboratory abnormality|0|||
145640944|NCT00232180|525202006|FG002|Open Label Phase|Laboratory abnormality|10|||
145640945|NCT00232180|525202004|FG000|Open Label Phase|Randomized but not treated|0|||
145640946|NCT00232180|525202005|FG001|Open Label Phase|Randomized but not treated|0|||
145640947|NCT00232180|525202006|FG002|Open Label Phase|Randomized but not treated|1|||
145640948|NCT00414544|525202007|FG000|Overall Study|Lost to Follow-up|14|||
145640949|NCT03740009|525202012|FG000|Overall Study|Physician Decision|9|||
145640950|NCT03740009|525202012|FG000|Overall Study|Lost to Follow-up|1|||
145640951|NCT02379819|525202014|FG000|Overall Study|Withdrawal by Subject|10|||
145640952|NCT02379819|525202014|FG000|Overall Study|Death|2|||
145640953|NCT02379819|525202014|FG000|Overall Study|Lack of Efficacy|1|||
145640954|NCT02379819|525202014|FG000|Overall Study|Lost to Follow-up|1|||
145640955|NCT03950622|525202015|FG000|Overall Study|Withdrawal by Subject|1|||
145640956|NCT03950622|525202016|FG001|Overall Study|Withdrawal by Subject|0|||
145640957|NCT03950622|525202015|FG000|Overall Study|Protocol Deviation|0|||
145640958|NCT03950622|525202016|FG001|Overall Study|Protocol Deviation|1|||
145640959|NCT03950622|525202015|FG000|Overall Study|Physician Decision|1|||
145640960|NCT03950622|525202016|FG001|Overall Study|Physician Decision|0|||
145640961|NCT03950622|525202015|FG000|Overall Study|Lost to Follow-up|5|||
145640962|NCT03950622|525202016|FG001|Overall Study|Lost to Follow-up|5|||
145640963|NCT03950622|525202015|FG000|Overall Study|Death|1|||
145640964|NCT03950622|525202016|FG001|Overall Study|Death|1|||
145640965|NCT01839331|525202017|FG000|Overall Study|Early Termination|3|||
145640966|NCT01839331|525202018|FG001|Overall Study|Early Termination|0|||
145640967|NCT01839331|525202019|FG002|Overall Study|Early Termination|1|||
145640968|NCT01839331|525202020|FG003|Overall Study|Early Termination|2|||
145640969|NCT01839331|525202017|FG000|Overall Study|Protocol Violation|1|||
145640970|NCT01839331|525202018|FG001|Overall Study|Protocol Violation|6|||
145640971|NCT01839331|525202019|FG002|Overall Study|Protocol Violation|4|||
145640972|NCT01839331|525202020|FG003|Overall Study|Protocol Violation|3|||
145640973|NCT03752151|525202021|FG000|Overall Study|Withdrawal by Subject|1|||
145640974|NCT03752151|525202021|FG000|Overall Study|Protocol Violation|1|||
145640975|NCT00350792|525202023|FG000|Overall Study|Adverse Event|11|||
145640976|NCT00350792|525202023|FG000|Overall Study|Death from Study Disease|1|||
145640977|NCT00350792|525202023|FG000|Overall Study|Death from Study Drug Toxicity|1|||
145640978|NCT00350792|525202023|FG000|Overall Study|Death Not Study Drug Related|2|||
145640979|NCT00350792|525202023|FG000|Overall Study|Protocol Violation|1|||
145640980|NCT00350792|525202023|FG000|Overall Study|Withdrawal by Subject|4|||
145640981|NCT00350792|525202023|FG000|Overall Study|Physician Decision|2|||
145640982|NCT00350792|525202023|FG000|Overall Study|Lack of Efficacy|11|||
145640983|NCT01832480|525202024|FG000|Overall Study|Lost to Follow-up|33|||
145640984|NCT01832480|525202025|FG001|Overall Study|Lost to Follow-up|30|||
145640985|NCT01832480|525202024|FG000|Overall Study|Withdrawal by Subject|0|||
145640986|NCT01832480|525202025|FG001|Overall Study|Withdrawal by Subject|2|||
145640987|NCT01832480|525202024|FG000|Overall Study|post randomization ineligible|8|||
145640988|NCT01832480|525202025|FG001|Overall Study|post randomization ineligible|10|||
145640989|NCT05609032|525202031|FG000|Overall Study|Lost to Follow-up|3|||
145640990|NCT05609032|525202032|FG001|Overall Study|Lost to Follow-up|1|||
145640991|NCT05609032|525202031|FG000|Overall Study|Withdrawal by Subject|1|||
145640992|NCT05609032|525202032|FG001|Overall Study|Withdrawal by Subject|0|||
145640993|NCT03764475|525202033|FG000|Overall Study|Adverse Event|11|||
145640994|NCT03764475|525202034|FG001|Overall Study|Adverse Event|2|||
145640995|NCT03764475|525202033|FG000|Overall Study|Lost to Follow-up|24|||
145640996|NCT03764475|525202034|FG001|Overall Study|Lost to Follow-up|10|||
145640997|NCT03764475|525202033|FG000|Overall Study|Withdrawal by Subject|26|||
145640998|NCT03764475|525202034|FG001|Overall Study|Withdrawal by Subject|10|||
145640999|NCT03764475|525202033|FG000|Overall Study|Lack of Efficacy|3|||
145641000|NCT03764475|525202034|FG001|Overall Study|Lack of Efficacy|0|||
145641001|NCT03764475|525202033|FG000|Overall Study|COVID-19 Disruption|2|||
145641002|NCT03764475|525202034|FG001|Overall Study|COVID-19 Disruption|0|||
145641003|NCT05510245|525202038|FG000|Overall Study|Withdrawal by Subject|1|||
145641004|NCT05510245|525202039|FG001|Overall Study|Withdrawal by Subject|0|||
145641005|NCT05510245|525202040|FG002|Overall Study|Withdrawal by Subject|0|||
145641006|NCT01373346|525202046|FG000|Overall Study|Death|1|||
145641007|NCT01198028|525202047|FG000|Overall Study|Adverse Event|5|||
145641008|NCT01198028|525202047|FG000|Overall Study|Death|3|||
145641009|NCT01198028|525202047|FG000|Overall Study|Physician Decision|2|||
145486219|NCT02723773|524634939|FG003|Overall Study|Lost to Follow-up|0|||
145641010|NCT00970359|525202051|FG000|Overall Study|Not Treated|4|||
145641011|NCT01565148|525202052|FG000|Overall Study|Withdrawal by Subject|1|||
145641012|NCT01565148|525202053|FG001|Overall Study|Withdrawal by Subject|1|||
145641013|NCT01565148|525202054|FG002|Overall Study|Withdrawal by Subject|1|||
145641014|NCT01565148|525202055|FG003|Overall Study|Withdrawal by Subject|2|||
145641015|NCT01565148|525202052|FG000|Overall Study|Lost to Follow-up|4|||
145486220|NCT02723773|524634936|FG000|Overall Study|Other|189|||
145641016|NCT01565148|525202053|FG001|Overall Study|Lost to Follow-up|4|||
145641017|NCT01565148|525202054|FG002|Overall Study|Lost to Follow-up|0|||
145641018|NCT01565148|525202055|FG003|Overall Study|Lost to Follow-up|3|||
145641019|NCT01565148|525202052|FG000|Overall Study|Rescue Therapy|8|||
145641020|NCT01565148|525202053|FG001|Overall Study|Rescue Therapy|5|||
145641021|NCT01565148|525202054|FG002|Overall Study|Rescue Therapy|5|||
145641022|NCT01565148|525202055|FG003|Overall Study|Rescue Therapy|8|||
145641023|NCT01565148|525202052|FG000|Overall Study|Death|0|||
145641024|NCT01565148|525202053|FG001|Overall Study|Death|0|||
145641025|NCT01565148|525202054|FG002|Overall Study|Death|1|||
145641026|NCT01565148|525202055|FG003|Overall Study|Death|0|||
145641027|NCT01565148|525202052|FG000|Overall Study|Physician Decision|2|||
145641028|NCT01565148|525202053|FG001|Overall Study|Physician Decision|5|||
145641029|NCT01565148|525202054|FG002|Overall Study|Physician Decision|0|||
145641030|NCT01565148|525202055|FG003|Overall Study|Physician Decision|0|||
145641031|NCT01759771|525202056|FG000|Overall Study|Withdrawal by Subject|1|||
145641032|NCT01759771|525202057|FG001|Overall Study|Withdrawal by Subject|1|||
145641033|NCT02528188|525202058|FG000|Overall Study|Adverse Event|23|||
145641034|NCT02528188|525202059|FG001|Overall Study|Adverse Event|22|||
145641035|NCT02528188|525202060|FG002|Overall Study|Adverse Event|8|||
145641036|NCT02528188|525202058|FG000|Overall Study|Protocol Violation|4|||
145641037|NCT02528188|525202059|FG001|Overall Study|Protocol Violation|6|||
145641038|NCT02528188|525202060|FG002|Overall Study|Protocol Violation|4|||
145641039|NCT02528188|525202058|FG000|Overall Study|Lack of Efficacy|19|||
145641040|NCT02528188|525202059|FG001|Overall Study|Lack of Efficacy|21|||
145641041|NCT02528188|525202060|FG002|Overall Study|Lack of Efficacy|22|||
145641042|NCT02528188|525202058|FG000|Overall Study|Withdrawal by Subject|97|||
145641043|NCT02528188|525202059|FG001|Overall Study|Withdrawal by Subject|104|||
145641044|NCT02528188|525202060|FG002|Overall Study|Withdrawal by Subject|100|||
145641045|NCT02528188|525202058|FG000|Overall Study|Lost to Follow-up|25|||
145641046|NCT02528188|525202059|FG001|Overall Study|Lost to Follow-up|21|||
145641047|NCT02528188|525202060|FG002|Overall Study|Lost to Follow-up|31|||
145641048|NCT02528188|525202058|FG000|Overall Study|Death|4|||
145641049|NCT02528188|525202059|FG001|Overall Study|Death|4|||
145641050|NCT02528188|525202060|FG002|Overall Study|Death|0|||
145641051|NCT02528188|525202058|FG000|Overall Study|Other|89|||
145641052|NCT02528188|525202059|FG001|Overall Study|Other|91|||
145641053|NCT02528188|525202060|FG002|Overall Study|Other|74|||
145641054|NCT02528188|525202058|FG000|Overall Study|Randomized but not treated|6|||
145641055|NCT02528188|525202059|FG001|Overall Study|Randomized but not treated|7|||
145641056|NCT02528188|525202060|FG002|Overall Study|Randomized but not treated|12|||
145641057|NCT05368831|525202061|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
145641058|NCT00529659|525202062|FG000|Overall Study|Adverse Event|8|||
145641059|NCT00529659|525202063|FG001|Overall Study|Adverse Event|7|||
145641060|NCT00529659|525202062|FG000|Overall Study|Lost to Follow-up|0|||
145641061|NCT00529659|525202063|FG001|Overall Study|Lost to Follow-up|2|||
145641062|NCT00529659|525202062|FG000|Overall Study|Physician Decision|0|||
145641063|NCT00529659|525202063|FG001|Overall Study|Physician Decision|2|||
145641064|NCT00529659|525202062|FG000|Overall Study|Protocol Violation|2|||
145641065|NCT00529659|525202063|FG001|Overall Study|Protocol Violation|6|||
145641066|NCT00529659|525202062|FG000|Overall Study|Withdrawal by Subject|1|||
145641067|NCT00529659|525202063|FG001|Overall Study|Withdrawal by Subject|6|||
145641068|NCT03887650|525202064|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
145641069|NCT03887650|525202065|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
145641070|NCT03887650|525202064|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
145641071|NCT03887650|525202065|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
145641072|NCT03887650|525202064|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
145641073|NCT03887650|525202065|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
145641074|NCT01692730|525202069|FG000|Overall Study|Lost to Follow-up|225|||
145641075|NCT01692730|525202070|FG001|Overall Study|Lost to Follow-up|227|||
145641076|NCT01849055|525202071|FG000|Overall Study|Withdrawal by Subject|0|||
145641077|NCT01849055|525202072|FG001|Overall Study|Withdrawal by Subject|0|||
145641078|NCT01849055|525202073|FG002|Overall Study|Withdrawal by Subject|1|||
145641079|NCT01849055|525202074|FG003|Overall Study|Withdrawal by Subject|0|||
145641080|NCT01849055|525202075|FG004|Overall Study|Withdrawal by Subject|0|||
145641081|NCT01849055|525202076|FG005|Overall Study|Withdrawal by Subject|0|||
145641082|NCT00223795|525202081|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
145641083|NCT00223795|525202082|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
145641084|NCT00223795|525202081|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
145641085|NCT00223795|525202082|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
145641086|NCT02299375|525202083|FG000|Overall Study|Adverse Event, serious fatal|1|||
145641087|NCT02299375|525202084|FG001|Overall Study|Adverse Event, serious fatal|3|||
145641088|NCT02299375|525202083|FG000|Overall Study|Adverse Event, non-fatal|8|||
145641089|NCT02299375|525202084|FG001|Overall Study|Adverse Event, non-fatal|9|||
145641090|NCT02299375|525202083|FG000|Overall Study|Lack of Efficacy|1|||
145641091|NCT02299375|525202084|FG001|Overall Study|Lack of Efficacy|3|||
145641092|NCT02299375|525202083|FG000|Overall Study|Protocol Violation|1|||
145641093|NCT02299375|525202084|FG001|Overall Study|Protocol Violation|3|||
145641094|NCT02299375|525202083|FG000|Overall Study|Other: Met stopping criteria|1|||
145641095|NCT02299375|525202084|FG001|Overall Study|Other: Met stopping criteria|0|||
145641096|NCT02299375|525202083|FG000|Overall Study|Other: Study closed/terminated|66|||
145641097|NCT02299375|525202084|FG001|Overall Study|Other: Study closed/terminated|55|||
145265302|NCT03323034|523819274|FG003|Overall Study|Lack of Efficacy|5|||
145641098|NCT02299375|525202083|FG000|Overall Study|Lost to Follow-up|0|||
145641099|NCT02299375|525202084|FG001|Overall Study|Lost to Follow-up|2|||
145641100|NCT02299375|525202083|FG000|Overall Study|Physician Decision|1|||
145641101|NCT02299375|525202084|FG001|Overall Study|Physician Decision|1|||
145641102|NCT02299375|525202083|FG000|Overall Study|Withdrawal by Subject|1|||
145641103|NCT02299375|525202084|FG001|Overall Study|Withdrawal by Subject|4|||
145641104|NCT00704184|525202089|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
145641105|NCT00704184|525202090|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
145641106|NCT00704184|525202091|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
145641107|NCT00704184|525202092|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
145641108|NCT00704184|525202093|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
145641109|NCT00704184|525202089|FG000|Open-Label Treatment|Adverse Event|0|||
145641110|NCT00704184|525202090|FG001|Open-Label Treatment|Adverse Event|0|||
145641111|NCT00704184|525202091|FG002|Open-Label Treatment|Adverse Event|2|||
145641112|NCT00704184|525202092|FG003|Open-Label Treatment|Adverse Event|0|||
145641113|NCT00704184|525202093|FG004|Open-Label Treatment|Adverse Event|1|||
145641114|NCT00704184|525202089|FG000|Open-Label Treatment|Lack of Efficacy|0|||
145641115|NCT00704184|525202090|FG001|Open-Label Treatment|Lack of Efficacy|2|||
145641116|NCT00704184|525202091|FG002|Open-Label Treatment|Lack of Efficacy|2|||
145641117|NCT00704184|525202092|FG003|Open-Label Treatment|Lack of Efficacy|2|||
145641118|NCT00704184|525202093|FG004|Open-Label Treatment|Lack of Efficacy|1|||
145641119|NCT00704184|525202089|FG000|Open-Label Treatment|Physician Decision|0|||
145641120|NCT00704184|525202090|FG001|Open-Label Treatment|Physician Decision|0|||
145641121|NCT00704184|525202091|FG002|Open-Label Treatment|Physician Decision|0|||
145641122|NCT00704184|525202092|FG003|Open-Label Treatment|Physician Decision|0|||
145641123|NCT00704184|525202093|FG004|Open-Label Treatment|Physician Decision|1|||
145641124|NCT00704184|525202089|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
145641125|NCT00704184|525202090|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
145641126|NCT00704184|525202091|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
145641127|NCT00704184|525202092|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
145641128|NCT00704184|525202093|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
145641129|NCT00716859|525202094|FG000|Overall Study|Adverse Event|4|||
145641130|NCT00716859|525202095|FG001|Overall Study|Adverse Event|1|||
145641131|NCT00716859|525202094|FG000|Overall Study|Lack of Efficacy|3|||
145641132|NCT00716859|525202095|FG001|Overall Study|Lack of Efficacy|0|||
145641133|NCT00716859|525202094|FG000|Overall Study|Withdrawal by Subject|1|||
145641134|NCT00716859|525202095|FG001|Overall Study|Withdrawal by Subject|3|||
145641135|NCT00716859|525202094|FG000|Overall Study|Not treated|1|||
145641136|NCT00716859|525202095|FG001|Overall Study|Not treated|1|||
145641137|NCT04688450|525203633|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
145641138|NCT04688450|525203633|FG000|Overall Study|Withdrawal by Subject|1|||
145641139|NCT02544074|525203634|FG000|Overall Study|Withdrawal by Subject|0|||
145641140|NCT02544074|525203635|FG001|Overall Study|Withdrawal by Subject|1|||
145641141|NCT02544074|525203636|FG002|Overall Study|Withdrawal by Subject|0|||
145641142|NCT02544074|525203637|FG003|Overall Study|Withdrawal by Subject|0|||
145641143|NCT02544074|525203638|FG004|Overall Study|Withdrawal by Subject|0|||
145641144|NCT02544074|525203639|FG005|Overall Study|Withdrawal by Subject|0|||
145641145|NCT02544074|525203640|FG006|Overall Study|Withdrawal by Subject|0|||
145641146|NCT02544074|525203641|FG007|Overall Study|Withdrawal by Subject|0|||
145641147|NCT02544074|525203642|FG008|Overall Study|Withdrawal by Subject|0|||
145641148|NCT02544074|525203643|FG009|Overall Study|Withdrawal by Subject|0|||
145641149|NCT02544074|525203644|FG010|Overall Study|Withdrawal by Subject|0|||
145641150|NCT02544074|525203645|FG011|Overall Study|Withdrawal by Subject|0|||
145641151|NCT02544074|525203646|FG012|Overall Study|Withdrawal by Subject|0|||
145641152|NCT02544074|525203647|FG013|Overall Study|Withdrawal by Subject|0|||
145641153|NCT02544074|525203648|FG014|Overall Study|Withdrawal by Subject|0|||
145641154|NCT02544074|525203649|FG015|Overall Study|Withdrawal by Subject|0|||
145641155|NCT02544074|525203650|FG016|Overall Study|Withdrawal by Subject|0|||
145641156|NCT02544074|525203651|FG017|Overall Study|Withdrawal by Subject|0|||
145641157|NCT02544074|525203652|FG018|Overall Study|Withdrawal by Subject|0|||
145641158|NCT02544074|525203653|FG019|Overall Study|Withdrawal by Subject|0|||
145641159|NCT02544074|525203654|FG020|Overall Study|Withdrawal by Subject|0|||
145641160|NCT02544074|525203634|FG000|Overall Study|Tablet error|0|||
145641161|NCT02544074|525203635|FG001|Overall Study|Tablet error|0|||
145641162|NCT02544074|525203636|FG002|Overall Study|Tablet error|0|||
145641163|NCT02544074|525203637|FG003|Overall Study|Tablet error|0|||
145641164|NCT02544074|525203638|FG004|Overall Study|Tablet error|0|||
145641165|NCT02544074|525203639|FG005|Overall Study|Tablet error|1|||
145641166|NCT02544074|525203640|FG006|Overall Study|Tablet error|0|||
145641167|NCT02544074|525203641|FG007|Overall Study|Tablet error|0|||
145641168|NCT02544074|525203642|FG008|Overall Study|Tablet error|0|||
145641169|NCT02544074|525203643|FG009|Overall Study|Tablet error|1|||
145641170|NCT02544074|525203644|FG010|Overall Study|Tablet error|0|||
145641171|NCT02544074|525203645|FG011|Overall Study|Tablet error|0|||
145641172|NCT02544074|525203646|FG012|Overall Study|Tablet error|0|||
145265303|NCT03323034|523819275|FG004|Overall Study|Lack of Efficacy|5|||
145486221|NCT02723773|524634937|FG001|Overall Study|Other|1|||
145486222|NCT02723773|524634938|FG002|Overall Study|Other|2|||
145486223|NCT02723773|524634939|FG003|Overall Study|Other|2|||
145486224|NCT00404651|524634950|FG000|Overall Study|Serious Adverse Event|0|||
145641173|NCT02544074|525203647|FG013|Overall Study|Tablet error|0|||
145641174|NCT02544074|525203648|FG014|Overall Study|Tablet error|0|||
145641175|NCT02544074|525203649|FG015|Overall Study|Tablet error|0|||
145641176|NCT02544074|525203650|FG016|Overall Study|Tablet error|0|||
145641177|NCT02544074|525203651|FG017|Overall Study|Tablet error|0|||
145641178|NCT02544074|525203652|FG018|Overall Study|Tablet error|0|||
145641179|NCT02544074|525203653|FG019|Overall Study|Tablet error|0|||
145641180|NCT02544074|525203654|FG020|Overall Study|Tablet error|0|||
145641181|NCT03189524|525203655|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
145641182|NCT03189524|525203656|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
145641183|NCT03189524|525203657|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
145641184|NCT03189524|525203655|FG000|Overall Study|Death|2|||
145641185|NCT03189524|525203656|FG001|Overall Study|Death|2|||
145641186|NCT03189524|525203657|FG002|Overall Study|Death|1|||
145641187|NCT03189524|525203655|FG000|Overall Study|Lost to Follow-up|1|||
145641188|NCT03189524|525203656|FG001|Overall Study|Lost to Follow-up|0|||
145641189|NCT03189524|525203657|FG002|Overall Study|Lost to Follow-up|8|||
145641190|NCT03189524|525203655|FG000|Overall Study|Withdrawal by Subject|1|||
145641191|NCT03189524|525203656|FG001|Overall Study|Withdrawal by Subject|1|||
145641192|NCT03189524|525203657|FG002|Overall Study|Withdrawal by Subject|3|||
145641193|NCT03189524|525203655|FG000|Overall Study|Progressive Disease|0|||
145641194|NCT03189524|525203656|FG001|Overall Study|Progressive Disease|2|||
145641195|NCT03189524|525203657|FG002|Overall Study|Progressive Disease|0|||
145641196|NCT01780298|525203659|FG000|Overall Study|Physician Decision|1|||
145641197|NCT01780298|525203660|FG001|Overall Study|Physician Decision|5|||
145641198|NCT01780298|525203661|FG002|Overall Study|Physician Decision|1|||
145641199|NCT01780298|525203662|FG003|Overall Study|Physician Decision|1|||
145641200|NCT01780298|525203659|FG000|Overall Study|Subject not matched|1|||
145641201|NCT01780298|525203660|FG001|Overall Study|Subject not matched|0|||
145641202|NCT01780298|525203661|FG002|Overall Study|Subject not matched|1|||
145641203|NCT01780298|525203662|FG003|Overall Study|Subject not matched|0|||
145641204|NCT01780298|525203659|FG000|Overall Study|Adverse Event|0|||
145641205|NCT01780298|525203660|FG001|Overall Study|Adverse Event|0|||
145641206|NCT01780298|525203661|FG002|Overall Study|Adverse Event|2|||
145641207|NCT01780298|525203662|FG003|Overall Study|Adverse Event|0|||
145641208|NCT04907474|525203667|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
145641209|NCT04907474|525203668|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
145641210|NCT03873779|525203669|FG000|Overall Study|Withdrawal by Subject|1|||
145641211|NCT02581215|525203670|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
145641212|NCT02581215|525203671|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
145641213|NCT02581215|525203670|FG000|Overall Study|Eligibility Criteria Not Met|0|||
145641214|NCT02581215|525203671|FG001|Overall Study|Eligibility Criteria Not Met|1|||
145641215|NCT04279574|525203679|FG000|Overall Study|Death|1|||
145641216|NCT04279574|525203680|FG001|Overall Study|Death|0|||
145641217|NCT04279574|525203679|FG000|Overall Study|lost restoration, tooth fracture|1|||
145641218|NCT04279574|525203680|FG001|Overall Study|lost restoration, tooth fracture|0|||
145641219|NCT04279574|525203679|FG000|Overall Study|Lost to Follow-up|0|||
145641220|NCT04279574|525203680|FG001|Overall Study|Lost to Follow-up|1|||
145641221|NCT02566902|525203683|FG000|Overall Study|Protocol Violation|2|||
145641222|NCT02566902|525203684|FG001|Overall Study|Protocol Violation|1|||
145641223|NCT02748317|525203687|FG000|Overall Study|Withdrawal by Subject|14|||
145641224|NCT02748317|525203687|FG000|Overall Study|Lost to Follow-up|8|||
145641225|NCT02748317|525203687|FG000|Overall Study|Death|1|||
145641226|NCT04259450|525203689|FG000|Overall Study|Adverse event/ Toxicity|0|||
145641227|NCT04259450|525203690|FG001|Overall Study|Adverse event/ Toxicity|3|||
145641228|NCT04259450|525203691|FG002|Overall Study|Adverse event/ Toxicity|0|||
145641229|NCT04259450|525203692|FG003|Overall Study|Adverse event/ Toxicity|1|||
145641230|NCT04259450|525203693|FG004|Overall Study|Adverse event/ Toxicity|0|||
145641231|NCT04259450|525203694|FG005|Overall Study|Adverse event/ Toxicity|0|||
145641232|NCT04259450|525203695|FG006|Overall Study|Adverse event/ Toxicity|0|||
145641233|NCT04259450|525203696|FG007|Overall Study|Adverse event/ Toxicity|1|||
145641234|NCT04259450|525203697|FG008|Overall Study|Adverse event/ Toxicity|0|||
145641235|NCT04259450|525203698|FG009|Overall Study|Adverse event/ Toxicity|3|||
145641236|NCT04259450|525203689|FG000|Overall Study|Disease progression|2|||
145641237|NCT04259450|525203690|FG001|Overall Study|Disease progression|3|||
145641238|NCT04259450|525203691|FG002|Overall Study|Disease progression|4|||
145641239|NCT04259450|525203692|FG003|Overall Study|Disease progression|4|||
145641240|NCT04259450|525203693|FG004|Overall Study|Disease progression|6|||
145641241|NCT04259450|525203694|FG005|Overall Study|Disease progression|6|||
145641242|NCT04259450|525203695|FG006|Overall Study|Disease progression|6|||
145641243|NCT04259450|525203696|FG007|Overall Study|Disease progression|15|||
145641244|NCT04259450|525203697|FG008|Overall Study|Disease progression|6|||
145641245|NCT04259450|525203698|FG009|Overall Study|Disease progression|18|||
145641246|NCT04259450|525203689|FG000|Overall Study|Death|0|||
145641247|NCT04259450|525203690|FG001|Overall Study|Death|0|||
145641248|NCT04259450|525203691|FG002|Overall Study|Death|0|||
145641249|NCT04259450|525203692|FG003|Overall Study|Death|0|||
145641250|NCT04259450|525203693|FG004|Overall Study|Death|0|||
145641251|NCT04259450|525203694|FG005|Overall Study|Death|0|||
145641252|NCT04259450|525203695|FG006|Overall Study|Death|0|||
145641253|NCT04259450|525203696|FG007|Overall Study|Death|1|||
145641254|NCT04259450|525203697|FG008|Overall Study|Death|1|||
145641255|NCT04259450|525203698|FG009|Overall Study|Death|0|||
145641256|NCT04259450|525203689|FG000|Overall Study|Withdrawal by Subject|0|||
145641257|NCT04259450|525203690|FG001|Overall Study|Withdrawal by Subject|0|||
145641258|NCT04259450|525203691|FG002|Overall Study|Withdrawal by Subject|0|||
145641259|NCT04259450|525203692|FG003|Overall Study|Withdrawal by Subject|0|||
145641260|NCT04259450|525203693|FG004|Overall Study|Withdrawal by Subject|0|||
145641261|NCT04259450|525203694|FG005|Overall Study|Withdrawal by Subject|0|||
145641262|NCT04259450|525203695|FG006|Overall Study|Withdrawal by Subject|0|||
145641263|NCT04259450|525203696|FG007|Overall Study|Withdrawal by Subject|1|||
145641264|NCT04259450|525203697|FG008|Overall Study|Withdrawal by Subject|0|||
145641265|NCT04259450|525203698|FG009|Overall Study|Withdrawal by Subject|0|||
145641266|NCT04259450|525203689|FG000|Overall Study|Other than listed|0|||
145641267|NCT04259450|525203690|FG001|Overall Study|Other than listed|0|||
145641268|NCT04259450|525203691|FG002|Overall Study|Other than listed|0|||
145641269|NCT04259450|525203692|FG003|Overall Study|Other than listed|0|||
145641270|NCT04259450|525203693|FG004|Overall Study|Other than listed|0|||
145641271|NCT04259450|525203694|FG005|Overall Study|Other than listed|0|||
145641272|NCT04259450|525203695|FG006|Overall Study|Other than listed|0|||
145641273|NCT04259450|525203696|FG007|Overall Study|Other than listed|1|||
145641274|NCT04259450|525203697|FG008|Overall Study|Other than listed|1|||
145641275|NCT04259450|525203698|FG009|Overall Study|Other than listed|2|||
145641276|NCT03452189|525203699|FG000|First Intervention (3 Months)|Adverse Event|1|||
145641277|NCT03452189|525203700|FG001|First Intervention (3 Months)|Adverse Event|0|||
145641278|NCT03452189|525203699|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
145641279|NCT03452189|525203700|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
145641280|NCT00332241|525203701|FG000|Overall Study|Lack of Efficacy|6|||
145641281|NCT00332241|525203702|FG001|Overall Study|Lack of Efficacy|1|||
145641282|NCT00332241|525203701|FG000|Overall Study|Adverse Event|3|||
145641283|NCT00332241|525203702|FG001|Overall Study|Adverse Event|5|||
145641284|NCT00332241|525203701|FG000|Overall Study|Withdrawal by Subject|2|||
145641285|NCT00332241|525203702|FG001|Overall Study|Withdrawal by Subject|1|||
145641286|NCT00332241|525203701|FG000|Overall Study|Lost to Follow-up|4|||
145641287|NCT00332241|525203702|FG001|Overall Study|Lost to Follow-up|1|||
145641288|NCT02724592|525203709|FG000|Overall Study|Lost to Follow-up|4|||
145641289|NCT02724592|525203710|FG001|Overall Study|Lost to Follow-up|1|||
145641290|NCT00802464|525203711|FG000|Month 0 - Month 8|Adverse Event|0|||
145641291|NCT00802464|525203712|FG001|Month 0 - Month 8|Adverse Event|1|||
145641292|NCT00802464|525203713|FG002|Month 0 - Month 8|Adverse Event|1|||
145641293|NCT00802464|525203714|FG003|Month 0 - Month 8|Adverse Event|2|||
145641294|NCT00802464|525203711|FG000|Month 0 - Month 8|Protocol Violation|0|||
145641295|NCT00802464|525203712|FG001|Month 0 - Month 8|Protocol Violation|0|||
145641296|NCT00802464|525203713|FG002|Month 0 - Month 8|Protocol Violation|1|||
145641297|NCT00802464|525203714|FG003|Month 0 - Month 8|Protocol Violation|0|||
145641298|NCT00802464|525203711|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
145641299|NCT00802464|525203712|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
145641300|NCT00802464|525203713|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
145641301|NCT00802464|525203714|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
145641302|NCT00802464|525203711|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
145641303|NCT00802464|525203712|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
145641304|NCT00802464|525203713|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
145641305|NCT00802464|525203714|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
145641306|NCT00802464|525203711|FG000|Month 0 - Month 8|Other|0|||
145641307|NCT00802464|525203712|FG001|Month 0 - Month 8|Other|0|||
145641308|NCT00802464|525203713|FG002|Month 0 - Month 8|Other|1|||
145641309|NCT00802464|525203714|FG003|Month 0 - Month 8|Other|0|||
145641310|NCT00802464|525203711|FG000|Month 8 - Month 14|Adverse Event|0|||
145641311|NCT00802464|525203712|FG001|Month 8 - Month 14|Adverse Event|1|||
145641312|NCT00802464|525203713|FG002|Month 8 - Month 14|Adverse Event|0|||
145641313|NCT00802464|525203714|FG003|Month 8 - Month 14|Adverse Event|0|||
145641314|NCT00802464|525203711|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
145641315|NCT00802464|525203712|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
145641316|NCT00802464|525203713|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
145641317|NCT00802464|525203714|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
145641318|NCT00802464|525203711|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
145641319|NCT00802464|525203712|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
145641320|NCT00802464|525203713|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
145641321|NCT00802464|525203714|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
145641322|NCT04512482|525203719|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
145641323|NCT04512482|525203720|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
145641324|NCT01939899|525203721|FG000|Lead-in Dose Finding Phase|Death|0|||
145641325|NCT01939899|525203722|FG001|Lead-in Dose Finding Phase|Death|3|||
145641326|NCT01939899|525203723|FG002|Lead-in Dose Finding Phase|Death|1|||
145641327|NCT01939899|525203724|FG003|Lead-in Dose Finding Phase|Death|0|||
145641328|NCT01939899|525203725|FG004|Lead-in Dose Finding Phase|Death|0|||
145641329|NCT01939899|525203721|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
145641330|NCT01939899|525203722|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
145641331|NCT01939899|525203723|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
145641332|NCT01939899|525203724|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
145641333|NCT01939899|525203725|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
145641334|NCT01939899|525203721|FG000|Lead-in Dose Finding Phase|Other|0|||
145641335|NCT01939899|525203722|FG001|Lead-in Dose Finding Phase|Other|0|||
145641336|NCT01939899|525203723|FG002|Lead-in Dose Finding Phase|Other|1|||
145641337|NCT01939899|525203724|FG003|Lead-in Dose Finding Phase|Other|0|||
145641338|NCT01939899|525203725|FG004|Lead-in Dose Finding Phase|Other|0|||
145641339|NCT01939899|525203721|FG000|Phase 2|Withdrawal by Subject|0|||
145641340|NCT01939899|525203722|FG001|Phase 2|Withdrawal by Subject|0|||
145641341|NCT01939899|525203723|FG002|Phase 2|Withdrawal by Subject|0|||
145641342|NCT01939899|525203724|FG003|Phase 2|Withdrawal by Subject|2|||
145641343|NCT01939899|525203725|FG004|Phase 2|Withdrawal by Subject|0|||
145641344|NCT01939899|525203721|FG000|Phase 2|Disease Progression|0|||
145641345|NCT01939899|525203722|FG001|Phase 2|Disease Progression|0|||
145641346|NCT01939899|525203723|FG002|Phase 2|Disease Progression|0|||
145641347|NCT01939899|525203724|FG003|Phase 2|Disease Progression|9|||
145641348|NCT01939899|525203725|FG004|Phase 2|Disease Progression|1|||
145641349|NCT04723394|525203726|FG000|Overall Study|Adverse Event|0|||
145641350|NCT04723394|525203727|FG001|Overall Study|Adverse Event|3|||
145641351|NCT04723394|525203726|FG000|Overall Study|Death|8|||
145641352|NCT04723394|525203727|FG001|Overall Study|Death|8|||
145641353|NCT04723394|525203726|FG000|Overall Study|Lost to Follow-up|20|||
145641354|NCT04723394|525203727|FG001|Overall Study|Lost to Follow-up|17|||
145641355|NCT04723394|525203726|FG000|Overall Study|Physician Decision|1|||
145641356|NCT04723394|525203727|FG001|Overall Study|Physician Decision|0|||
145641357|NCT04723394|525203726|FG000|Overall Study|Withdrawal by Subject|20|||
145641358|NCT04723394|525203727|FG001|Overall Study|Withdrawal by Subject|34|||
145641359|NCT04723394|525203726|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
145641360|NCT04723394|525203727|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
145641361|NCT00371787|525203728|FG000|Overall Study|Withdrawal by Subject|3|||
145641362|NCT00371787|525203729|FG001|Overall Study|Withdrawal by Subject|1|||
145641363|NCT01972724|525203730|FG000|Double-Blind|Rescue Criteria Met|1|||
145641364|NCT01972724|525203731|FG001|Double-Blind|Rescue Criteria Met|0|||
145641365|NCT01972724|525203732|FG002|Double-Blind|Rescue Criteria Met|0|||
145641366|NCT01972724|525203730|FG000|Double-Blind|Adverse Event|1|||
145641367|NCT01972724|525203731|FG001|Double-Blind|Adverse Event|0|||
145641368|NCT01972724|525203732|FG002|Double-Blind|Adverse Event|0|||
145641369|NCT01972724|525203730|FG000|Double-Blind|Withdrawal of Consent|2|||
145641370|NCT01972724|525203731|FG001|Double-Blind|Withdrawal of Consent|1|||
145641371|NCT01972724|525203732|FG002|Double-Blind|Withdrawal of Consent|0|||
145641372|NCT01972724|525203730|FG000|Double-Blind|Significant Protocol Deviation|5|||
145641373|NCT01972724|525203731|FG001|Double-Blind|Significant Protocol Deviation|8|||
145641374|NCT01972724|525203732|FG002|Double-Blind|Significant Protocol Deviation|0|||
145641375|NCT01972724|525203730|FG000|Open-Label|Withdrew Consent|0|||
145641376|NCT01972724|525203731|FG001|Open-Label|Withdrew Consent|0|||
145641377|NCT01972724|525203732|FG002|Open-Label|Withdrew Consent|3|||
145641378|NCT01972724|525203730|FG000|Open-Label|Significant Protocol Deviation|0|||
145641379|NCT01972724|525203731|FG001|Open-Label|Significant Protocol Deviation|0|||
145641380|NCT01972724|525203732|FG002|Open-Label|Significant Protocol Deviation|2|||
145641381|NCT02706717|525203740|FG000|Overall Study|Withdrawal by Subject|1|||
145641382|NCT02706717|525203741|FG001|Overall Study|Withdrawal by Subject|8|||
145641383|NCT02706717|525203740|FG000|Overall Study|Lost to Follow-up|0|||
145641384|NCT02706717|525203741|FG001|Overall Study|Lost to Follow-up|1|||
145641385|NCT02706717|525203740|FG000|Overall Study|Physician Decision|0|||
145641386|NCT02706717|525203741|FG001|Overall Study|Physician Decision|1|||
145641387|NCT02706717|525203740|FG000|Overall Study|Death|0|||
145641388|NCT02706717|525203741|FG001|Overall Study|Death|1|||
145641389|NCT00106080|525203745|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
145641390|NCT00106080|525203746|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
145641391|NCT01546753|525203750|FG000|Overall Study|anxiety|1|||
145641392|NCT01546753|525203751|FG001|Overall Study|anxiety|1|||
145641393|NCT01546753|525203750|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
145641394|NCT01546753|525203751|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
145641395|NCT00546754|525203752|FG000|Overall Study|Serious Adverse Event|1|||
145641396|NCT00546754|525203753|FG001|Overall Study|Serious Adverse Event|1|||
145641397|NCT00546754|525203752|FG000|Overall Study|Adverse Event|11|||
145641398|NCT00546754|525203753|FG001|Overall Study|Adverse Event|16|||
145641399|NCT00546754|525203752|FG000|Overall Study|Lack of Efficacy|1|||
145641400|NCT00546754|525203753|FG001|Overall Study|Lack of Efficacy|1|||
145641401|NCT00546754|525203752|FG000|Overall Study|Lost to Follow-up|9|||
145641402|NCT00546754|525203753|FG001|Overall Study|Lost to Follow-up|15|||
145641403|NCT00546754|525203752|FG000|Overall Study|Protocol Violation|3|||
145641404|NCT00546754|525203753|FG001|Overall Study|Protocol Violation|0|||
145641405|NCT00546754|525203752|FG000|Overall Study|Withdrawal by Subject|6|||
145641406|NCT00546754|525203753|FG001|Overall Study|Withdrawal by Subject|7|||
145641407|NCT00546754|525203752|FG000|Overall Study|Dyspnea|1|||
145641408|NCT00546754|525203753|FG001|Overall Study|Dyspnea|0|||
145641409|NCT00546754|525203752|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
145641410|NCT00546754|525203753|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
145641411|NCT00546754|525203752|FG000|Overall Study|Hip Replacement|1|||
145641412|NCT00546754|525203753|FG001|Overall Study|Hip Replacement|0|||
145641413|NCT00546754|525203752|FG000|Overall Study|Suicide|1|||
145641414|NCT00546754|525203753|FG001|Overall Study|Suicide|0|||
145641415|NCT00546754|525203752|FG000|Overall Study|Missing Cooperation|1|||
145641416|NCT00546754|525203753|FG001|Overall Study|Missing Cooperation|0|||
145641417|NCT00546754|525203752|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
145641418|NCT00546754|525203753|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
145641419|NCT00546754|525203752|FG000|Overall Study|Patient's Decision|0|||
145641420|NCT00546754|525203753|FG001|Overall Study|Patient's Decision|1|||
145641421|NCT00546754|525203752|FG000|Overall Study|Missing|14|||
145641422|NCT00546754|525203753|FG001|Overall Study|Missing|7|||
145641423|NCT00396084|525203756|FG000|Overall Study|Adverse Event|0|||
145641424|NCT00396084|525203757|FG001|Overall Study|Adverse Event|0|||
145641425|NCT00396084|525203758|FG002|Overall Study|Adverse Event|0|||
145641426|NCT00396084|525203759|FG003|Overall Study|Adverse Event|0|||
145641427|NCT00396084|525203760|FG004|Overall Study|Adverse Event|1|||
145641428|NCT00396084|525203761|FG005|Overall Study|Adverse Event|2|||
145641429|NCT00396084|525203756|FG000|Overall Study|Withdrawal by Subject|0|||
145641430|NCT00396084|525203757|FG001|Overall Study|Withdrawal by Subject|0|||
145641431|NCT00396084|525203758|FG002|Overall Study|Withdrawal by Subject|0|||
145641432|NCT00396084|525203759|FG003|Overall Study|Withdrawal by Subject|1|||
145641433|NCT00396084|525203760|FG004|Overall Study|Withdrawal by Subject|0|||
145641434|NCT00396084|525203761|FG005|Overall Study|Withdrawal by Subject|0|||
145641435|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
145641436|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
145641437|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
145641438|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
145641439|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
145641440|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
145641441|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
145641442|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
145641443|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
145641444|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
145641445|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
145641446|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
145641447|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
145641448|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
145641449|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
145641450|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
145641451|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
145641452|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
145641453|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
145641454|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
145641455|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
145641456|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
145641457|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
145641458|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
145641459|NCT00311363|525203762|FG000|24-Week Single-Blind Treatment Period|Death|1|||
145641460|NCT00311363|525203763|FG001|24-Week Single-Blind Treatment Period|Death|0|||
145641461|NCT00311363|525203764|FG002|24-Week Single-Blind Treatment Period|Death|0|||
145641462|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
145641463|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
145641464|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
145641465|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
145486225|NCT00404651|524634951|FG001|Overall Study|Serious Adverse Event|0|||
145486226|NCT00404651|524634952|FG002|Overall Study|Serious Adverse Event|2|||
145486227|NCT00404651|524634953|FG003|Overall Study|Serious Adverse Event|0|||
145641466|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
145641467|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
145486228|NCT00404651|524634950|FG000|Overall Study|Protocol Violation|10|||
145641468|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
145641469|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
145641470|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
145641471|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
145641472|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
145641473|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
145641474|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
145641475|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
145641476|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
145641477|NCT00311363|525203762|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
145641478|NCT00311363|525203763|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
145641479|NCT00311363|525203764|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
145641480|NCT01697969|525203765|FG000|Overall Study|Did not meet inc/exc criteria|3|||
145641481|NCT04200365|525203766|FG000|Overall Study|Adverse Event|2|||
145641482|NCT04200365|525203766|FG000|Overall Study|Progressive Disease|4|||
145641483|NCT04200365|525203766|FG000|Overall Study|Lack of Efficacy|1|||
145641484|NCT04200365|525203766|FG000|Overall Study|Study Closure|4|||
145641485|NCT01499199|525203769|FG000|Overall Study|Adverse Event|1|||
145641486|NCT01499199|525203769|FG000|Overall Study|Lack of Efficacy|1|||
145641487|NCT01199575|525203770|FG000|Overall Study|Withdrawal by Subject|5|||
145641488|NCT02139943|525203773|FG000|Overall Study|Adverse Event|0|||
145641489|NCT02139943|525203774|FG001|Overall Study|Adverse Event|1|||
145641490|NCT02139943|525203775|FG002|Overall Study|Adverse Event|2|||
145641491|NCT02139943|525203773|FG000|Overall Study|Lost to Follow-up|3|||
145641492|NCT02139943|525203774|FG001|Overall Study|Lost to Follow-up|2|||
145641493|NCT02139943|525203775|FG002|Overall Study|Lost to Follow-up|2|||
145641494|NCT02139943|525203773|FG000|Overall Study|Withdrawal by Subject|4|||
145641495|NCT02139943|525203774|FG001|Overall Study|Withdrawal by Subject|3|||
145641496|NCT02139943|525203775|FG002|Overall Study|Withdrawal by Subject|0|||
145641497|NCT02139943|525203773|FG000|Overall Study|Other|0|||
145641498|NCT02139943|525203774|FG001|Overall Study|Other|0|||
145641499|NCT02139943|525203775|FG002|Overall Study|Other|1|||
145641500|NCT02139943|525203773|FG000|Overall Study|Participant wishes to discontinue|2|||
145641501|NCT02139943|525203774|FG001|Overall Study|Participant wishes to discontinue|0|||
145641502|NCT02139943|525203775|FG002|Overall Study|Participant wishes to discontinue|0|||
145641503|NCT02139943|525203773|FG000|Overall Study|Participant in Poor Compliance|1|||
145641504|NCT02139943|525203774|FG001|Overall Study|Participant in Poor Compliance|0|||
145641505|NCT02139943|525203775|FG002|Overall Study|Participant in Poor Compliance|1|||
145641506|NCT02139943|525203773|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
145641507|NCT02139943|525203774|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
145641508|NCT02139943|525203775|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
145641509|NCT00411216|525203786|FG000|Overall Study|Ten participants were entered into the c|0|||
145641510|NCT00411216|525203787|FG001|Overall Study|Ten participants were entered into the c|2|||
145641511|NCT01251354|525203790|FG000|Overall Study|Adverse Event|1|||
145641512|NCT01251354|525203790|FG000|Overall Study|Investigator's Decision|1|||
145641513|NCT01251354|525203790|FG000|Overall Study|Disease Progression|4|||
145641514|NCT04139668|525205115|FG000|Overall Study|Withdrawal by Subject|1|||
145641515|NCT03112174|525205122|FG000|Overall Study|Withdrawal by Subject|3|||
145641516|NCT03112174|525205123|FG001|Overall Study|Withdrawal by Subject|0|||
145641517|NCT03112174|525205124|FG002|Overall Study|Withdrawal by Subject|11|||
145641518|NCT03112174|525205125|FG003|Overall Study|Withdrawal by Subject|9|||
145641519|NCT03112174|525205126|FG004|Overall Study|Withdrawal by Subject|7|||
145641520|NCT03112174|525205122|FG000|Overall Study|Lost to Follow-up|1|||
145641521|NCT03112174|525205123|FG001|Overall Study|Lost to Follow-up|1|||
145641522|NCT03112174|525205124|FG002|Overall Study|Lost to Follow-up|2|||
145641523|NCT03112174|525205125|FG003|Overall Study|Lost to Follow-up|3|||
145641524|NCT03112174|525205126|FG004|Overall Study|Lost to Follow-up|2|||
145641525|NCT03112174|525205122|FG000|Overall Study|Death|8|||
145641526|NCT03112174|525205123|FG001|Overall Study|Death|3|||
145641527|NCT03112174|525205124|FG002|Overall Study|Death|67|||
145641528|NCT03112174|525205125|FG003|Overall Study|Death|73|||
145641529|NCT03112174|525205126|FG004|Overall Study|Death|18|||
145641530|NCT03112174|525205122|FG000|Overall Study|Other, Not Specified|1|||
145641531|NCT03112174|525205123|FG001|Overall Study|Other, Not Specified|0|||
145486229|NCT00404651|524634951|FG001|Overall Study|Protocol Violation|5|||
145641532|NCT03112174|525205124|FG002|Overall Study|Other, Not Specified|1|||
145641533|NCT03112174|525205125|FG003|Overall Study|Other, Not Specified|2|||
145641534|NCT03112174|525205126|FG004|Overall Study|Other, Not Specified|0|||
145641535|NCT01414738|525205135|FG000|Overall Study|Death|26|||
145641536|NCT01414738|525205135|FG000|Overall Study|Refused testing|5|||
145641537|NCT01414738|525205135|FG000|Overall Study|Lost to Follow-up|2|||
145641538|NCT01414738|525205135|FG000|Overall Study|Refused, disease progression|8|||
145641539|NCT01414738|525205135|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
145641540|NCT01266122|525205137|FG000|Overall Study|Lost to Follow-up|6|||
145641541|NCT01266122|525205138|FG001|Overall Study|Lost to Follow-up|6|||
145641542|NCT03756571|525205139|FG000|Overall Study|Lost to Follow-up|1|||
145641543|NCT03756571|525205140|FG001|Overall Study|Lost to Follow-up|1|||
145641544|NCT00421889|525205141|FG000|Overall Study|Adverse Event|1|||
145641545|NCT00421889|525205142|FG001|Overall Study|Adverse Event|0|||
145641546|NCT00421889|525205143|FG002|Overall Study|Adverse Event|1|||
145641547|NCT00421889|525205144|FG003|Overall Study|Adverse Event|1|||
145641548|NCT00421889|525205145|FG004|Overall Study|Adverse Event|1|||
145641549|NCT00421889|525205146|FG005|Overall Study|Adverse Event|4|||
145641550|NCT00421889|525205147|FG006|Overall Study|Adverse Event|1|||
145641551|NCT00421889|525205148|FG007|Overall Study|Adverse Event|0|||
145641552|NCT00421889|525205149|FG008|Overall Study|Adverse Event|2|||
145641553|NCT00421889|525205141|FG000|Overall Study|Withdrawal by Subject|1|||
145641554|NCT00421889|525205142|FG001|Overall Study|Withdrawal by Subject|3|||
145641555|NCT00421889|525205143|FG002|Overall Study|Withdrawal by Subject|0|||
145641556|NCT00421889|525205144|FG003|Overall Study|Withdrawal by Subject|0|||
145641557|NCT00421889|525205145|FG004|Overall Study|Withdrawal by Subject|2|||
145641558|NCT00421889|525205146|FG005|Overall Study|Withdrawal by Subject|0|||
145641559|NCT00421889|525205147|FG006|Overall Study|Withdrawal by Subject|0|||
145641560|NCT00421889|525205148|FG007|Overall Study|Withdrawal by Subject|0|||
145641561|NCT00421889|525205149|FG008|Overall Study|Withdrawal by Subject|0|||
145641562|NCT00421889|525205141|FG000|Overall Study|Death|0|||
145641563|NCT00421889|525205142|FG001|Overall Study|Death|0|||
145641564|NCT00421889|525205143|FG002|Overall Study|Death|0|||
145641565|NCT00421889|525205144|FG003|Overall Study|Death|0|||
145641566|NCT00421889|525205145|FG004|Overall Study|Death|1|||
145641567|NCT00421889|525205146|FG005|Overall Study|Death|1|||
145641568|NCT00421889|525205147|FG006|Overall Study|Death|0|||
145641569|NCT00421889|525205148|FG007|Overall Study|Death|0|||
145641570|NCT00421889|525205149|FG008|Overall Study|Death|0|||
145641571|NCT00421889|525205141|FG000|Overall Study|Progressive disease|3|||
145641572|NCT00421889|525205142|FG001|Overall Study|Progressive disease|2|||
145641573|NCT00421889|525205143|FG002|Overall Study|Progressive disease|2|||
145641574|NCT00421889|525205144|FG003|Overall Study|Progressive disease|3|||
145641575|NCT00421889|525205145|FG004|Overall Study|Progressive disease|2|||
145641576|NCT00421889|525205146|FG005|Overall Study|Progressive disease|21|||
145641577|NCT00421889|525205147|FG006|Overall Study|Progressive disease|3|||
145641578|NCT00421889|525205148|FG007|Overall Study|Progressive disease|1|||
145641579|NCT00421889|525205149|FG008|Overall Study|Progressive disease|5|||
145641580|NCT00421889|525205141|FG000|Overall Study|Patient/Investigator request|0|||
145641581|NCT00421889|525205142|FG001|Overall Study|Patient/Investigator request|0|||
145641582|NCT00421889|525205143|FG002|Overall Study|Patient/Investigator request|0|||
145641583|NCT00421889|525205144|FG003|Overall Study|Patient/Investigator request|0|||
145641584|NCT00421889|525205145|FG004|Overall Study|Patient/Investigator request|0|||
145641585|NCT00421889|525205146|FG005|Overall Study|Patient/Investigator request|9|||
145641586|NCT00421889|525205147|FG006|Overall Study|Patient/Investigator request|0|||
145641587|NCT00421889|525205148|FG007|Overall Study|Patient/Investigator request|1|||
145641588|NCT00421889|525205149|FG008|Overall Study|Patient/Investigator request|3|||
145641589|NCT00421889|525205141|FG000|Overall Study|Lost to Follow-up|0|||
145641590|NCT00421889|525205142|FG001|Overall Study|Lost to Follow-up|0|||
145641591|NCT00421889|525205143|FG002|Overall Study|Lost to Follow-up|0|||
145641592|NCT00421889|525205144|FG003|Overall Study|Lost to Follow-up|0|||
145641593|NCT00421889|525205145|FG004|Overall Study|Lost to Follow-up|0|||
145641594|NCT00421889|525205146|FG005|Overall Study|Lost to Follow-up|0|||
145641595|NCT00421889|525205147|FG006|Overall Study|Lost to Follow-up|0|||
145641596|NCT00421889|525205148|FG007|Overall Study|Lost to Follow-up|0|||
145641597|NCT00421889|525205149|FG008|Overall Study|Lost to Follow-up|1|||
145641598|NCT00978042|525205150|FG000|Initial Treatment Period|Treated in Error|0|||
145641599|NCT00978042|525205151|FG001|Initial Treatment Period|Treated in Error|3|||
145641600|NCT00978042|525205150|FG000|Initial Treatment Period|Ineligibility|1|||
145641601|NCT00978042|525205151|FG001|Initial Treatment Period|Ineligibility|0|||
145641602|NCT00978042|525205150|FG000|Initial Treatment Period|Lost to Follow-up|21|||
145486230|NCT00404651|524634952|FG002|Overall Study|Protocol Violation|14|||
145486231|NCT00404651|524634953|FG003|Overall Study|Protocol Violation|5|||
145486232|NCT00404651|524634950|FG000|Overall Study|Lost to Follow-up|15|||
145486233|NCT00404651|524634951|FG001|Overall Study|Lost to Follow-up|11|||
145641603|NCT00978042|525205151|FG001|Initial Treatment Period|Lost to Follow-up|3|||
145641604|NCT00978042|525205150|FG000|Initial Treatment Period|Adverse Event|2|||
145641605|NCT00978042|525205151|FG001|Initial Treatment Period|Adverse Event|0|||
145641606|NCT00978042|525205150|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
145641607|NCT00978042|525205151|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
145641608|NCT00978042|525205150|FG000|Initial Treatment Period|Consent withdrawn|22|||
145641609|NCT00978042|525205151|FG001|Initial Treatment Period|Consent withdrawn|9|||
145641610|NCT00978042|525205150|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
145641611|NCT00978042|525205151|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
145641612|NCT00529516|525205152|FG000|Overall Study|Adverse Event|2|||
145641613|NCT00529516|525205153|FG001|Overall Study|Adverse Event|1|||
145486234|NCT00404651|524634952|FG002|Overall Study|Lost to Follow-up|13|||
145641614|NCT00529516|525205154|FG002|Overall Study|Adverse Event|0|||
145641615|NCT00529516|525205152|FG000|Overall Study|Withdrawal by Subject|1|||
145641616|NCT00529516|525205153|FG001|Overall Study|Withdrawal by Subject|1|||
145641617|NCT00529516|525205154|FG002|Overall Study|Withdrawal by Subject|0|||
145641618|NCT00529516|525205152|FG000|Overall Study|Lost to Follow-up|0|||
145641619|NCT00529516|525205153|FG001|Overall Study|Lost to Follow-up|0|||
145641620|NCT00529516|525205154|FG002|Overall Study|Lost to Follow-up|1|||
145641621|NCT00703820|525205157|FG000|Overall Study|Adverse Event|12|||
145641622|NCT00703820|525205158|FG001|Overall Study|Adverse Event|17|||
145641623|NCT00703820|525205157|FG000|Overall Study|Death|5|||
145641624|NCT00703820|525205158|FG001|Overall Study|Death|0|||
145641625|NCT00703820|525205157|FG000|Overall Study|Lack of Efficacy|11|||
145641626|NCT00703820|525205158|FG001|Overall Study|Lack of Efficacy|11|||
145641627|NCT00703820|525205157|FG000|Overall Study|Received non-protocol therapy|1|||
145641628|NCT00703820|525205158|FG001|Overall Study|Received non-protocol therapy|0|||
145641629|NCT00703820|525205157|FG000|Overall Study|Physician Decision|4|||
145641630|NCT00703820|525205158|FG001|Overall Study|Physician Decision|5|||
145641631|NCT00703820|525205157|FG000|Overall Study|Withdrawal by Subject|2|||
145641632|NCT00703820|525205158|FG001|Overall Study|Withdrawal by Subject|1|||
145641633|NCT00761605|525205163|FG000|Overall Study|Adverse Event|26|||
145641634|NCT00761605|525205163|FG000|Overall Study|Death|2|||
145641635|NCT00761605|525205163|FG000|Overall Study|Lack of Efficacy|26|||
145641636|NCT00761605|525205163|FG000|Overall Study|Lost to Follow-up|29|||
145641637|NCT00761605|525205163|FG000|Overall Study|Withdrawal by Subject|37|||
145641638|NCT00761605|525205163|FG000|Overall Study|Other|21|||
145641639|NCT01985334|525205167|FG000|Overall Study|Administrative problems|1|||
145641640|NCT01985334|525205168|FG001|Overall Study|Administrative problems|1|||
145641641|NCT01985334|525205169|FG002|Overall Study|Administrative problems|0|||
145641642|NCT01985334|525205170|FG003|Overall Study|Administrative problems|2|||
145641643|NCT01985334|525205171|FG004|Overall Study|Administrative problems|0|||
145641644|NCT01985334|525205172|FG005|Overall Study|Administrative problems|1|||
145641645|NCT01985334|525205173|FG006|Overall Study|Administrative problems|1|||
145641646|NCT01985334|525205174|FG007|Overall Study|Administrative problems|3|||
145641647|NCT01985334|525205167|FG000|Overall Study|Death|1|||
145641648|NCT01985334|525205168|FG001|Overall Study|Death|0|||
145641649|NCT01985334|525205169|FG002|Overall Study|Death|0|||
145641650|NCT01985334|525205170|FG003|Overall Study|Death|3|||
145641651|NCT01985334|525205171|FG004|Overall Study|Death|0|||
145641652|NCT01985334|525205172|FG005|Overall Study|Death|0|||
145641653|NCT01985334|525205173|FG006|Overall Study|Death|1|||
145641654|NCT01985334|525205174|FG007|Overall Study|Death|2|||
145641655|NCT01985334|525205167|FG000|Overall Study|Worsening of disease|0|||
145641656|NCT01985334|525205168|FG001|Overall Study|Worsening of disease|0|||
145641657|NCT01985334|525205169|FG002|Overall Study|Worsening of disease|0|||
145641658|NCT01985334|525205170|FG003|Overall Study|Worsening of disease|1|||
145641659|NCT01985334|525205171|FG004|Overall Study|Worsening of disease|0|||
145641660|NCT01985334|525205172|FG005|Overall Study|Worsening of disease|3|||
145641661|NCT01985334|525205173|FG006|Overall Study|Worsening of disease|0|||
145641662|NCT01985334|525205174|FG007|Overall Study|Worsening of disease|1|||
145641663|NCT01985334|525205167|FG000|Overall Study|Other|2|||
145641664|NCT01985334|525205168|FG001|Overall Study|Other|9|||
145641665|NCT01985334|525205169|FG002|Overall Study|Other|7|||
145641666|NCT01985334|525205170|FG003|Overall Study|Other|17|||
145641667|NCT01985334|525205171|FG004|Overall Study|Other|4|||
145641668|NCT01985334|525205172|FG005|Overall Study|Other|8|||
145641669|NCT01985334|525205173|FG006|Overall Study|Other|4|||
145641670|NCT01985334|525205174|FG007|Overall Study|Other|7|||
145641671|NCT01985334|525205167|FG000|Overall Study|Protocol deviation|6|||
145641672|NCT01985334|525205168|FG001|Overall Study|Protocol deviation|31|||
145641673|NCT01985334|525205169|FG002|Overall Study|Protocol deviation|25|||
145641674|NCT01985334|525205170|FG003|Overall Study|Protocol deviation|84|||
145641675|NCT01985334|525205171|FG004|Overall Study|Protocol deviation|17|||
145641676|NCT01985334|525205172|FG005|Overall Study|Protocol deviation|47|||
145641677|NCT01985334|525205173|FG006|Overall Study|Protocol deviation|15|||
145641678|NCT01985334|525205174|FG007|Overall Study|Protocol deviation|42|||
145641679|NCT01985334|525205167|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
145641680|NCT01985334|525205168|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
145641681|NCT01985334|525205169|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
145641682|NCT01985334|525205170|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
145641683|NCT01985334|525205171|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
145641684|NCT01985334|525205172|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
145486235|NCT00404651|524634953|FG003|Overall Study|Lost to Follow-up|10|||
145486236|NCT00404651|524634950|FG000|Overall Study|Withdrawal by Subject|14|||
145641685|NCT01985334|525205173|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
145641686|NCT01985334|525205174|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
145641687|NCT01985334|525205167|FG000|Overall Study|Subject withdrawal of consent|3|||
145641688|NCT01985334|525205168|FG001|Overall Study|Subject withdrawal of consent|6|||
145486237|NCT00404651|524634951|FG001|Overall Study|Withdrawal by Subject|12|||
145641689|NCT01985334|525205169|FG002|Overall Study|Subject withdrawal of consent|2|||
145641690|NCT01985334|525205170|FG003|Overall Study|Subject withdrawal of consent|28|||
145641691|NCT01985334|525205171|FG004|Overall Study|Subject withdrawal of consent|4|||
145641692|NCT01985334|525205172|FG005|Overall Study|Subject withdrawal of consent|19|||
145641693|NCT01985334|525205173|FG006|Overall Study|Subject withdrawal of consent|0|||
145641694|NCT01985334|525205174|FG007|Overall Study|Subject withdrawal of consent|20|||
145641695|NCT01985334|525205167|FG000|Overall Study|Adverse Event|0|||
145641696|NCT01985334|525205168|FG001|Overall Study|Adverse Event|8|||
145641697|NCT01985334|525205169|FG002|Overall Study|Adverse Event|2|||
145641698|NCT01985334|525205170|FG003|Overall Study|Adverse Event|26|||
145641699|NCT01985334|525205171|FG004|Overall Study|Adverse Event|3|||
145641700|NCT01985334|525205172|FG005|Overall Study|Adverse Event|18|||
145641701|NCT01985334|525205173|FG006|Overall Study|Adverse Event|3|||
145641702|NCT01985334|525205174|FG007|Overall Study|Adverse Event|15|||
145641703|NCT01985334|525205167|FG000|Overall Study|Other|4|||
145641704|NCT01985334|525205168|FG001|Overall Study|Other|2|||
145641705|NCT01985334|525205169|FG002|Overall Study|Other|3|||
145641706|NCT01985334|525205170|FG003|Overall Study|Other|10|||
145641707|NCT01985334|525205171|FG004|Overall Study|Other|1|||
145641708|NCT01985334|525205172|FG005|Overall Study|Other|6|||
145641709|NCT01985334|525205173|FG006|Overall Study|Other|2|||
145641710|NCT01985334|525205174|FG007|Overall Study|Other|2|||
145641711|NCT01985334|525205167|FG000|Overall Study|Medication non-compliance|0|||
145641712|NCT01985334|525205168|FG001|Overall Study|Medication non-compliance|4|||
145641713|NCT01985334|525205169|FG002|Overall Study|Medication non-compliance|1|||
145641714|NCT01985334|525205170|FG003|Overall Study|Medication non-compliance|6|||
145641715|NCT01985334|525205171|FG004|Overall Study|Medication non-compliance|2|||
145641716|NCT01985334|525205172|FG005|Overall Study|Medication non-compliance|3|||
145641717|NCT01985334|525205173|FG006|Overall Study|Medication non-compliance|1|||
145641718|NCT01985334|525205174|FG007|Overall Study|Medication non-compliance|3|||
145641719|NCT01985334|525205167|FG000|Overall Study|Use of prohibited treatment|1|||
145641720|NCT01985334|525205168|FG001|Overall Study|Use of prohibited treatment|4|||
145641721|NCT01985334|525205169|FG002|Overall Study|Use of prohibited treatment|1|||
145641722|NCT01985334|525205170|FG003|Overall Study|Use of prohibited treatment|2|||
145641723|NCT01985334|525205171|FG004|Overall Study|Use of prohibited treatment|1|||
145641724|NCT01985334|525205172|FG005|Overall Study|Use of prohibited treatment|6|||
145641725|NCT01985334|525205173|FG006|Overall Study|Use of prohibited treatment|2|||
145641726|NCT01985334|525205174|FG007|Overall Study|Use of prohibited treatment|0|||
145641727|NCT01985334|525205167|FG000|Overall Study|Investigator decision|0|||
145641728|NCT01985334|525205168|FG001|Overall Study|Investigator decision|3|||
145641729|NCT01985334|525205169|FG002|Overall Study|Investigator decision|0|||
145641730|NCT01985334|525205170|FG003|Overall Study|Investigator decision|7|||
145641731|NCT01985334|525205171|FG004|Overall Study|Investigator decision|1|||
145641732|NCT01985334|525205172|FG005|Overall Study|Investigator decision|1|||
145641733|NCT01985334|525205173|FG006|Overall Study|Investigator decision|0|||
145641734|NCT01985334|525205174|FG007|Overall Study|Investigator decision|4|||
145641735|NCT01985334|525205167|FG000|Overall Study|Lost to Follow-up|0|||
145641736|NCT01985334|525205168|FG001|Overall Study|Lost to Follow-up|2|||
145641737|NCT01985334|525205169|FG002|Overall Study|Lost to Follow-up|0|||
145641738|NCT01985334|525205170|FG003|Overall Study|Lost to Follow-up|3|||
145641739|NCT01985334|525205171|FG004|Overall Study|Lost to Follow-up|1|||
145641740|NCT01985334|525205172|FG005|Overall Study|Lost to Follow-up|4|||
145641741|NCT01985334|525205173|FG006|Overall Study|Lost to Follow-up|0|||
145641742|NCT01985334|525205174|FG007|Overall Study|Lost to Follow-up|3|||
145641743|NCT03036813|525205175|FG000|Overall Study|Adverse Event|6|||
145641744|NCT03036813|525205176|FG001|Overall Study|Adverse Event|11|||
145641745|NCT03036813|525205177|FG002|Overall Study|Adverse Event|6|||
145641746|NCT03036813|525205175|FG000|Overall Study|Withdrawal by Subject|12|||
145641747|NCT03036813|525205176|FG001|Overall Study|Withdrawal by Subject|6|||
145641748|NCT03036813|525205177|FG002|Overall Study|Withdrawal by Subject|10|||
145641749|NCT03036813|525205175|FG000|Overall Study|Lost to Follow-up|1|||
145641750|NCT03036813|525205176|FG001|Overall Study|Lost to Follow-up|1|||
145641751|NCT03036813|525205177|FG002|Overall Study|Lost to Follow-up|0|||
145641752|NCT03036813|525205175|FG000|Overall Study|Physician Decision|2|||
145641753|NCT03036813|525205176|FG001|Overall Study|Physician Decision|1|||
145641754|NCT03036813|525205177|FG002|Overall Study|Physician Decision|1|||
145641755|NCT03036813|525205175|FG000|Overall Study|Non-Compliance|1|||
145641756|NCT03036813|525205176|FG001|Overall Study|Non-Compliance|5|||
145641757|NCT03036813|525205177|FG002|Overall Study|Non-Compliance|3|||
145641758|NCT03036813|525205175|FG000|Overall Study|Pregnancy|0|||
145641759|NCT03036813|525205176|FG001|Overall Study|Pregnancy|0|||
145641760|NCT03036813|525205177|FG002|Overall Study|Pregnancy|1|||
145641761|NCT03036813|525205175|FG000|Overall Study|Other|0|||
145641762|NCT03036813|525205176|FG001|Overall Study|Other|3|||
145641763|NCT03036813|525205177|FG002|Overall Study|Other|5|||
145641764|NCT01102231|525205182|FG000|Overall Study|Protocol Violation|3|||
145641765|NCT01102231|525205182|FG000|Overall Study|Lack of Efficacy|2|||
145641766|NCT01102231|525205182|FG000|Overall Study|Death|2|||
145641767|NCT01102231|525205182|FG000|Overall Study|Adverse Event|3|||
145641768|NCT01102231|525205182|FG000|Overall Study|Withdrawal by Subject|1|||
145265304|NCT03323034|523819271|FG000|Overall Study|Physician Decision|0|||
145641769|NCT01102231|525205182|FG000|Overall Study|Did not received the treatment|4|||
145641770|NCT00785512|525205185|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
145641771|NCT00785512|525205186|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
145641772|NCT00785512|525205185|FG000|Overall Study|Adverse Event|0|||
145641773|NCT00785512|525205186|FG001|Overall Study|Adverse Event|0|||
145641774|NCT00785512|525205185|FG000|Overall Study|Lack of Efficacy|0|||
145641775|NCT00785512|525205186|FG001|Overall Study|Lack of Efficacy|2|||
145641776|NCT00785512|525205185|FG000|Overall Study|Withdrawal by Subject|0|||
145641777|NCT00785512|525205186|FG001|Overall Study|Withdrawal by Subject|1|||
145641778|NCT00785512|525205185|FG000|Overall Study|Lost to Follow-up|3|||
145641779|NCT00785512|525205186|FG001|Overall Study|Lost to Follow-up|0|||
145641780|NCT00785512|525205185|FG000|Overall Study|Precedure Refused|0|||
145641781|NCT00785512|525205186|FG001|Overall Study|Precedure Refused|0|||
145641782|NCT00785512|525205185|FG000|Overall Study|IVRS Programing Error|0|||
145641783|NCT00785512|525205186|FG001|Overall Study|IVRS Programing Error|0|||
145641784|NCT00785512|525205185|FG000|Overall Study|Physician Decision|0|||
145641785|NCT00785512|525205186|FG001|Overall Study|Physician Decision|0|||
145641786|NCT00785512|525205185|FG000|Overall Study|Lack of compliance|0|||
145641787|NCT00785512|525205186|FG001|Overall Study|Lack of compliance|1|||
145641788|NCT00603954|525205199|FG000|Overall Study|Protocol Violation|1|||
145641789|NCT00603954|525205200|FG001|Overall Study|Protocol Violation|2|||
145641790|NCT02568683|525205201|FG000|Overall Study|Death|0|||
145641791|NCT02568683|525205202|FG001|Overall Study|Death|2|||
145641792|NCT02568683|525205201|FG000|Overall Study|Withdrew Consent|1|||
145641793|NCT02568683|525205202|FG001|Overall Study|Withdrew Consent|0|||
145641794|NCT02568683|525205201|FG000|Overall Study|Study Terminated By Sponsor|5|||
145641795|NCT02568683|525205202|FG001|Overall Study|Study Terminated By Sponsor|2|||
145641796|NCT04556981|525205214|FG000|Overall Study|Death|0|||
145641797|NCT04556981|525205215|FG001|Overall Study|Death|1|||
145641798|NCT04556981|525205214|FG000|Overall Study|Lost to Follow-up|2|||
145641799|NCT04556981|525205215|FG001|Overall Study|Lost to Follow-up|11|||
145641800|NCT04556981|525205214|FG000|Overall Study|Moved from the study area|1|||
145641801|NCT04556981|525205215|FG001|Overall Study|Moved from the study area|4|||
145641802|NCT04556981|525205214|FG000|Overall Study|Withdrawal by Subject|2|||
145641803|NCT04556981|525205215|FG001|Overall Study|Withdrawal by Subject|2|||
145641804|NCT04556981|525205214|FG000|Overall Study|Other|2|||
145641805|NCT04556981|525205215|FG001|Overall Study|Other|1|||
145641806|NCT02477605|525205219|FG000|Overall Study|Discontinued prior to treatment|1|||
145641807|NCT02477605|525205220|FG001|Overall Study|Discontinued prior to treatment|0|||
145641808|NCT02477605|525205219|FG000|Overall Study|Lost to Follow-up|0|||
145641809|NCT02477605|525205220|FG001|Overall Study|Lost to Follow-up|2|||
145641810|NCT02477605|525205219|FG000|Overall Study|Withdrawal by Subject|0|||
145641811|NCT02477605|525205220|FG001|Overall Study|Withdrawal by Subject|1|||
145641812|NCT02477605|525205219|FG000|Overall Study|Administered gas during surgery|0|||
145641813|NCT02477605|525205220|FG001|Overall Study|Administered gas during surgery|1|||
145641814|NCT02574455|525205221|FG000|Overall Study|Death|197|||
145641815|NCT02574455|525205222|FG001|Overall Study|Death|210|||
145641816|NCT02574455|525205221|FG000|Overall Study|Withdrawal of Consent|11|||
145641817|NCT02574455|525205222|FG001|Overall Study|Withdrawal of Consent|28|||
145641818|NCT02574455|525205221|FG000|Overall Study|Lost to Follow-up|4|||
145641819|NCT02574455|525205222|FG001|Overall Study|Lost to Follow-up|4|||
145641820|NCT02574455|525205221|FG000|Overall Study|Sponsor's Decision|55|||
145641821|NCT02574455|525205222|FG001|Overall Study|Sponsor's Decision|20|||
145486238|NCT00404651|524634952|FG002|Overall Study|Withdrawal by Subject|16|||
145486239|NCT00404651|524634953|FG003|Overall Study|Withdrawal by Subject|6|||
145486240|NCT01121146|524634965|FG000|Overall Study|Death|17|||
145486241|NCT01121146|524634966|FG001|Overall Study|Death|15|||
145486242|NCT01121146|524634965|FG000|Overall Study|Adverse Event|2|||
145486243|NCT01121146|524634966|FG001|Overall Study|Adverse Event|11|||
145486244|NCT01121146|524634965|FG000|Overall Study|Lost to Follow-up|7|||
145486245|NCT01121146|524634966|FG001|Overall Study|Lost to Follow-up|16|||
145486246|NCT05030350|524634972|FG000|Overall Study|Adverse Event|13|||
145486247|NCT05030350|524634972|FG000|Overall Study|Lack of Efficacy|8|||
145486248|NCT05030350|524634972|FG000|Overall Study|Lost to Follow-up|35|||
145486249|NCT05030350|524634972|FG000|Overall Study|Pregnancy|2|||
145641822|NCT03565315|525205229|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
145641823|NCT03565315|525205230|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
145641824|NCT03565315|525205231|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
145641825|NCT03565315|525205232|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
145641826|NCT00440011|525205233|FG000|Overall Study|Adverse Event|2|||
145641827|NCT00440011|525205234|FG001|Overall Study|Adverse Event|0|||
145641828|NCT00440011|525205233|FG000|Overall Study|Lost to Follow-up|0|||
145641829|NCT00440011|525205234|FG001|Overall Study|Lost to Follow-up|2|||
145641830|NCT00440011|525205233|FG000|Overall Study|Protocol Violation|1|||
145641831|NCT00440011|525205234|FG001|Overall Study|Protocol Violation|1|||
145641832|NCT00440011|525205233|FG000|Overall Study|Withdrawal by Subject|1|||
145641833|NCT00440011|525205234|FG001|Overall Study|Withdrawal by Subject|0|||
145641834|NCT01083316|525205235|FG000|Overall Study|Adverse Event|2|||
145486250|NCT05030350|524634972|FG000|Overall Study|Protocol Violation|2|||
145486251|NCT05030350|524634972|FG000|Overall Study|Withdrawal by Subject|60|||
145486252|NCT05030350|524634972|FG000|Overall Study|Study terminated by sponsor|349|||
145486253|NCT05030350|524634972|FG000|Overall Study|Positive Drug Screen|4|||
145486254|NCT05030350|524634972|FG000|Overall Study|Other|8|||
145486255|NCT02711137|524634973|FG000|Overall Study|Death|1|||
145486256|NCT02711137|524634974|FG001|Overall Study|Death|4|||
145486257|NCT02711137|524634975|FG002|Overall Study|Death|5|||
145486258|NCT02711137|524634976|FG003|Overall Study|Death|5|||
145486259|NCT02711137|524634977|FG004|Overall Study|Death|3|||
145486260|NCT02711137|524634978|FG005|Overall Study|Death|1|||
145486261|NCT02711137|524634979|FG006|Overall Study|Death|61|||
145486262|NCT02711137|524634980|FG007|Overall Study|Death|3|||
145486263|NCT02711137|524634981|FG008|Overall Study|Death|0|||
145486264|NCT02711137|524634982|FG009|Overall Study|Death|1|||
145486265|NCT02711137|524634983|FG010|Overall Study|Death|1|||
145486266|NCT02711137|524634984|FG011|Overall Study|Death|1|||
145486267|NCT02711137|524634985|FG012|Overall Study|Death|0|||
145486268|NCT02711137|524634986|FG013|Overall Study|Death|0|||
145486269|NCT02711137|524634987|FG014|Overall Study|Death|0|||
145486270|NCT02711137|524634973|FG000|Overall Study|Study Terminated by Sponsor|0|||
145486271|NCT02711137|524634974|FG001|Overall Study|Study Terminated by Sponsor|0|||
145486272|NCT02711137|524634975|FG002|Overall Study|Study Terminated by Sponsor|1|||
145486273|NCT02711137|524634976|FG003|Overall Study|Study Terminated by Sponsor|0|||
145486274|NCT02711137|524634977|FG004|Overall Study|Study Terminated by Sponsor|0|||
145486275|NCT02711137|524634978|FG005|Overall Study|Study Terminated by Sponsor|0|||
145486276|NCT02711137|524634979|FG006|Overall Study|Study Terminated by Sponsor|1|||
145486277|NCT02711137|524634980|FG007|Overall Study|Study Terminated by Sponsor|0|||
145486278|NCT02711137|524634981|FG008|Overall Study|Study Terminated by Sponsor|0|||
145486279|NCT02711137|524634982|FG009|Overall Study|Study Terminated by Sponsor|0|||
145486280|NCT02711137|524634983|FG010|Overall Study|Study Terminated by Sponsor|0|||
145486281|NCT02711137|524634984|FG011|Overall Study|Study Terminated by Sponsor|0|||
145486282|NCT02711137|524634985|FG012|Overall Study|Study Terminated by Sponsor|0|||
145486283|NCT02711137|524634986|FG013|Overall Study|Study Terminated by Sponsor|0|||
145486284|NCT02711137|524634987|FG014|Overall Study|Study Terminated by Sponsor|0|||
145486285|NCT02711137|524634973|FG000|Overall Study|Physician Decision|1|||
145486286|NCT02711137|524634974|FG001|Overall Study|Physician Decision|0|||
145486287|NCT02711137|524634975|FG002|Overall Study|Physician Decision|2|||
145486288|NCT02711137|524634976|FG003|Overall Study|Physician Decision|1|||
145486289|NCT02711137|524634977|FG004|Overall Study|Physician Decision|1|||
145486290|NCT02711137|524634978|FG005|Overall Study|Physician Decision|0|||
145486291|NCT02711137|524634979|FG006|Overall Study|Physician Decision|12|||
145486292|NCT02711137|524634980|FG007|Overall Study|Physician Decision|2|||
145486293|NCT02711137|524634981|FG008|Overall Study|Physician Decision|1|||
145486294|NCT02711137|524634982|FG009|Overall Study|Physician Decision|1|||
145486295|NCT02711137|524634983|FG010|Overall Study|Physician Decision|3|||
145486296|NCT02711137|524634984|FG011|Overall Study|Physician Decision|2|||
145486297|NCT02711137|524634985|FG012|Overall Study|Physician Decision|1|||
145486298|NCT02711137|524634986|FG013|Overall Study|Physician Decision|1|||
145486299|NCT02711137|524634987|FG014|Overall Study|Physician Decision|2|||
145486300|NCT02711137|524634973|FG000|Overall Study|Other|0|||
145486301|NCT02711137|524634974|FG001|Overall Study|Other|1|||
145486302|NCT02711137|524634975|FG002|Overall Study|Other|0|||
145486303|NCT02711137|524634976|FG003|Overall Study|Other|0|||
145486304|NCT02711137|524634977|FG004|Overall Study|Other|0|||
145486305|NCT02711137|524634978|FG005|Overall Study|Other|0|||
145486306|NCT02711137|524634979|FG006|Overall Study|Other|3|||
145486307|NCT02711137|524634980|FG007|Overall Study|Other|0|||
145486308|NCT02711137|524634981|FG008|Overall Study|Other|0|||
145486309|NCT02711137|524634982|FG009|Overall Study|Other|0|||
145486310|NCT02711137|524634983|FG010|Overall Study|Other|0|||
145486311|NCT02711137|524634984|FG011|Overall Study|Other|0|||
145486312|NCT02711137|524634985|FG012|Overall Study|Other|0|||
145486313|NCT02711137|524634986|FG013|Overall Study|Other|0|||
145641835|NCT01083316|525205235|FG000|Overall Study|Withdrawal by Subject|1|||
145641836|NCT01239316|525205243|FG000|Overall Study|Progression/Relapse|11|||
145641837|NCT01239316|525205243|FG000|Overall Study|Adverse Event|1|||
145486314|NCT02711137|524634987|FG014|Overall Study|Other|1|||
145486315|NCT02711137|524634973|FG000|Overall Study|Withdrawal by Subject|1|||
145486316|NCT02711137|524634974|FG001|Overall Study|Withdrawal by Subject|0|||
145486317|NCT02711137|524634975|FG002|Overall Study|Withdrawal by Subject|0|||
145486318|NCT02711137|524634976|FG003|Overall Study|Withdrawal by Subject|1|||
145641838|NCT03960463|525206702|FG000|Overall Study|Withdrawal by Subject|2|||
145641839|NCT03960463|525206703|FG001|Overall Study|Withdrawal by Subject|0|||
145641840|NCT05568615|525206704|FG000|Overall Study|Death|1|||
145486319|NCT02711137|524634977|FG004|Overall Study|Withdrawal by Subject|1|||
145486320|NCT02711137|524634978|FG005|Overall Study|Withdrawal by Subject|0|||
145486321|NCT02711137|524634979|FG006|Overall Study|Withdrawal by Subject|7|||
145486322|NCT02711137|524634980|FG007|Overall Study|Withdrawal by Subject|0|||
145641841|NCT05568615|525206704|FG000|Overall Study|Physician Decision|1|||
145486323|NCT02711137|524634981|FG008|Overall Study|Withdrawal by Subject|0|||
145641842|NCT03422276|525206709|FG000|Overall Study|Withdrawal by Subject|21|||
145641843|NCT03422276|525206710|FG001|Overall Study|Withdrawal by Subject|25|||
145641844|NCT03422276|525206711|FG002|Overall Study|Withdrawal by Subject|14|||
145641845|NCT03422276|525206712|FG003|Overall Study|Withdrawal by Subject|16|||
145641846|NCT03422276|525206709|FG000|Overall Study|Death|14|||
145641847|NCT03422276|525206710|FG001|Overall Study|Death|21|||
145641848|NCT03422276|525206711|FG002|Overall Study|Death|3|||
145641849|NCT03422276|525206712|FG003|Overall Study|Death|1|||
145641850|NCT03422276|525206709|FG000|Overall Study|Discontinued, ineligible|4|||
145641851|NCT03422276|525206710|FG001|Overall Study|Discontinued, ineligible|3|||
145641852|NCT03422276|525206711|FG002|Overall Study|Discontinued, ineligible|0|||
145641853|NCT03422276|525206712|FG003|Overall Study|Discontinued, ineligible|0|||
145641854|NCT03422276|525206709|FG000|Overall Study|Lost to Follow-up|15|||
145641855|NCT03422276|525206710|FG001|Overall Study|Lost to Follow-up|8|||
145641856|NCT03422276|525206711|FG002|Overall Study|Lost to Follow-up|13|||
145641857|NCT03422276|525206712|FG003|Overall Study|Lost to Follow-up|4|||
145641858|NCT03422276|525206709|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
145641859|NCT03422276|525206710|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
145641860|NCT03422276|525206711|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
145641861|NCT03422276|525206712|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
145641862|NCT03422276|525206709|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
145641863|NCT03422276|525206710|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
145641864|NCT03422276|525206711|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
145641865|NCT03422276|525206712|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
145641866|NCT03422276|525206709|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
145641867|NCT03422276|525206710|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
145641868|NCT03422276|525206711|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
145641869|NCT03422276|525206712|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
145641870|NCT03422276|525206709|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
145641871|NCT03422276|525206710|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
145641872|NCT03422276|525206711|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
145641873|NCT03422276|525206712|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
145641874|NCT03422276|525206709|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
145641875|NCT03422276|525206710|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
145641876|NCT03422276|525206711|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
145641877|NCT03422276|525206712|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
145641878|NCT05194917|525206713|FG000|Overall Study|Lost to Follow-up|7|||
145641879|NCT05194917|525206714|FG001|Overall Study|Lost to Follow-up|5|||
145641880|NCT05194917|525206715|FG002|Overall Study|Lost to Follow-up|6|||
145641881|NCT05194917|525206716|FG003|Overall Study|Lost to Follow-up|5|||
145641882|NCT02279095|525206722|FG000|Overall Study|Non-Compliance|1|||
145641883|NCT02279095|525206722|FG000|Overall Study|Withdrawal by Subject|8|||
145641884|NCT02279095|525206722|FG000|Overall Study|Adverse Event|2|||
145641885|NCT02279095|525206722|FG000|Overall Study|Other|7|||
145641886|NCT02279095|525206722|FG000|Overall Study|Lost to Follow-up|1|||
145641887|NCT05938413|525206723|FG000|Overall Study|Lost to Follow-up|1|||
145641888|NCT05938413|525206724|FG001|Overall Study|Lost to Follow-up|7|||
145641889|NCT05938413|525206723|FG000|Overall Study|Withdrawal by Subject|1|||
145641890|NCT05938413|525206724|FG001|Overall Study|Withdrawal by Subject|1|||
145641891|NCT04922021|525206725|FG000|Overall Study|Withdrawal by Subject|4|||
145641892|NCT04922021|525206726|FG001|Overall Study|Withdrawal by Subject|10|||
145641893|NCT04922021|525206725|FG000|Overall Study|Adverse Event|2|||
145641894|NCT04922021|525206726|FG001|Overall Study|Adverse Event|2|||
145641895|NCT04922021|525206725|FG000|Overall Study|Lack of Efficacy|0|||
145641896|NCT04922021|525206726|FG001|Overall Study|Lack of Efficacy|1|||
145641897|NCT04922021|525206725|FG000|Overall Study|Multiple reasons|1|||
145641898|NCT04922021|525206726|FG001|Overall Study|Multiple reasons|0|||
145641899|NCT03237481|525206738|FG000|Overall Study|Lost to Follow-up|1|||
145641900|NCT03237481|525206739|FG001|Overall Study|Lost to Follow-up|0|||
145641901|NCT03237481|525206740|FG002|Overall Study|Lost to Follow-up|0|||
145641902|NCT03237481|525206738|FG000|Overall Study|Protocol Violation|1|||
145641903|NCT03237481|525206739|FG001|Overall Study|Protocol Violation|0|||
145641904|NCT03237481|525206740|FG002|Overall Study|Protocol Violation|0|||
145641905|NCT03237481|525206738|FG000|Overall Study|Withdrawal by Subject|3|||
145641906|NCT03237481|525206739|FG001|Overall Study|Withdrawal by Subject|2|||
145641907|NCT03237481|525206740|FG002|Overall Study|Withdrawal by Subject|1|||
145641908|NCT03481777|525206741|FG000|Overall Study|Withdrawal by Subject|36|||
145641909|NCT03481777|525206742|FG001|Overall Study|Withdrawal by Subject|31|||
145641910|NCT03481777|525206741|FG000|Overall Study|Non stroke = non target population|277|||
145641911|NCT03481777|525206742|FG001|Overall Study|Non stroke = non target population|254|||
145641912|NCT04300647|525206747|FG000|Pre-Crossover|Death|19|||
145641913|NCT04300647|525206748|FG001|Pre-Crossover|Death|58|||
145641914|NCT04300647|525206749|FG002|Pre-Crossover|Death|0|||
145641915|NCT04300647|525206747|FG000|Pre-Crossover|Lost to Follow-up|0|||
145641916|NCT04300647|525206748|FG001|Pre-Crossover|Lost to Follow-up|3|||
145641917|NCT04300647|525206749|FG002|Pre-Crossover|Lost to Follow-up|0|||
145641918|NCT04300647|525206747|FG000|Pre-Crossover|Withdrawal by Subject|2|||
145641919|NCT04300647|525206748|FG001|Pre-Crossover|Withdrawal by Subject|4|||
145641920|NCT04300647|525206749|FG002|Pre-Crossover|Withdrawal by Subject|0|||
145641921|NCT04300647|525206747|FG000|Pre-Crossover|On-going in Study|24|||
145641922|NCT04300647|525206748|FG001|Pre-Crossover|On-going in Study|61|||
145641923|NCT04300647|525206749|FG002|Pre-Crossover|On-going in Study|0|||
145641924|NCT04300647|525206747|FG000|Post-Crossover|Death|0|||
145641925|NCT04300647|525206748|FG001|Post-Crossover|Death|0|||
145641926|NCT04300647|525206749|FG002|Post-Crossover|Death|3|||
145641927|NCT04300647|525206747|FG000|Post-Crossover|Lost to Follow-up|0|||
145641928|NCT04300647|525206748|FG001|Post-Crossover|Lost to Follow-up|0|||
145641929|NCT04300647|525206749|FG002|Post-Crossover|Lost to Follow-up|1|||
145641930|NCT04300647|525206747|FG000|Post-Crossover|Withdrawal by Subject|0|||
145641931|NCT04300647|525206748|FG001|Post-Crossover|Withdrawal by Subject|0|||
145641932|NCT04300647|525206749|FG002|Post-Crossover|Withdrawal by Subject|1|||
145641933|NCT04300647|525206747|FG000|Post-Crossover|On-going in Study|0|||
145641934|NCT04300647|525206748|FG001|Post-Crossover|On-going in Study|0|||
145641935|NCT04300647|525206749|FG002|Post-Crossover|On-going in Study|8|||
145641936|NCT05386238|525206750|FG000|Overall Study|Lost to Follow-up|3|||
145641937|NCT05386238|525206751|FG001|Overall Study|Lost to Follow-up|2|||
145641938|NCT05386238|525206750|FG000|Overall Study|Withdrawal by Subject|0|||
145641939|NCT05386238|525206751|FG001|Overall Study|Withdrawal by Subject|1|||
145641940|NCT05057897|525206754|FG000|Overall Study|Site closure|2|||
145641941|NCT05057897|525206755|FG001|Overall Study|Site closure|2|||
145641942|NCT05057897|525206754|FG000|Overall Study|Death|1|||
145641943|NCT05057897|525206755|FG001|Overall Study|Death|0|||
145641944|NCT04714320|525206760|FG000|Overall Study|Voluntary Withdrawal|4|||
145641945|NCT04714320|525206761|FG001|Overall Study|Voluntary Withdrawal|1|||
145641946|NCT04714320|525206762|FG002|Overall Study|Voluntary Withdrawal|2|||
145641947|NCT04714320|525206760|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
145641948|NCT04714320|525206761|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
145641949|NCT04714320|525206762|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
145641950|NCT04714320|525206760|FG000|Overall Study|Reason Not Specified|1|||
145641951|NCT04714320|525206761|FG001|Overall Study|Reason Not Specified|3|||
145641952|NCT04714320|525206762|FG002|Overall Study|Reason Not Specified|3|||
145641953|NCT01353313|525206763|FG000|Overall Study|Lost to Follow-up|22|||
145641954|NCT01353313|525206764|FG001|Overall Study|Lost to Follow-up|23|||
145641955|NCT01353313|525206763|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
145641956|NCT01353313|525206764|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
145641957|NCT04755660|525206765|FG000|Overall Study|Lost to Follow-up|1|||
145641958|NCT04755660|525206766|FG001|Overall Study|Lost to Follow-up|1|||
145641959|NCT04755660|525206767|FG002|Overall Study|Lost to Follow-up|0|||
145641960|NCT04755660|525206765|FG000|Overall Study|Withdrawal by Subject|0|||
145641961|NCT04755660|525206766|FG001|Overall Study|Withdrawal by Subject|1|||
145641962|NCT04755660|525206767|FG002|Overall Study|Withdrawal by Subject|1|||
145641963|NCT04755660|525206765|FG000|Overall Study|Physician Decision|0|||
145641964|NCT04755660|525206766|FG001|Overall Study|Physician Decision|0|||
145641965|NCT04755660|525206767|FG002|Overall Study|Physician Decision|1|||
145641966|NCT02824029|525206769|FG000|Overall Study|Didn't receive treatment|2|||
145641967|NCT02824029|525206769|FG000|Overall Study|Patient decision to discontinue treatment|3|||
145641968|NCT02824029|525206769|FG000|Overall Study|Non-compliant|5|||
145641969|NCT02824029|525206769|FG000|Overall Study|Progression of disease|15|||
145641970|NCT02824029|525206769|FG000|Overall Study|Inadequate response to therapy|2|||
145641971|NCT02824029|525206769|FG000|Overall Study|Possible progression per treating physician|1|||
145641972|NCT04524390|525206770|FG000|Double Blind|Consent Withdrawal by subject|2|||
145641973|NCT04524390|525206771|FG001|Double Blind|Consent Withdrawal by subject|1|||
145641974|NCT04524390|525206772|FG002|Double Blind|Consent Withdrawal by subject|0|||
145641975|NCT04524390|525206770|FG000|Double Blind|Adverse Event|5|||
145641976|NCT04524390|525206771|FG001|Double Blind|Adverse Event|3|||
145641977|NCT04524390|525206772|FG002|Double Blind|Adverse Event|0|||
145641978|NCT04524390|525206770|FG000|Double Blind|Liver Transplant|5|||
145641979|NCT04524390|525206771|FG001|Double Blind|Liver Transplant|6|||
145486324|NCT02711137|524634982|FG009|Overall Study|Withdrawal by Subject|0|||
145641980|NCT04524390|525206772|FG002|Double Blind|Liver Transplant|0|||
145641981|NCT04524390|525206770|FG000|Double Blind|Disease Progression|0|||
145641982|NCT04524390|525206771|FG001|Double Blind|Disease Progression|1|||
145641983|NCT04524390|525206772|FG002|Double Blind|Disease Progression|0|||
145641984|NCT04524390|525206770|FG000|Open-Label|Drug interruption criteria|0|||
145641985|NCT04524390|525206771|FG001|Open-Label|Drug interruption criteria|0|||
145641986|NCT04524390|525206772|FG002|Open-Label|Drug interruption criteria|1|||
145641987|NCT04524390|525206770|FG000|Open-Label|Liver Transplant|0|||
145641988|NCT04524390|525206771|FG001|Open-Label|Liver Transplant|0|||
145641989|NCT04524390|525206772|FG002|Open-Label|Liver Transplant|1|||
145641990|NCT04524390|525206770|FG000|Open-Label|Disease Progression|0|||
145641991|NCT04524390|525206771|FG001|Open-Label|Disease Progression|0|||
145641992|NCT04524390|525206772|FG002|Open-Label|Disease Progression|1|||
145641993|NCT04524390|525206770|FG000|Open-Label|Adverse Event|0|||
145641994|NCT04524390|525206771|FG001|Open-Label|Adverse Event|0|||
145641995|NCT04524390|525206772|FG002|Open-Label|Adverse Event|3|||
145641996|NCT04524390|525206770|FG000|Open-Label|Study Termination by sponsor|0|||
145641997|NCT04524390|525206771|FG001|Open-Label|Study Termination by sponsor|0|||
145641998|NCT04524390|525206772|FG002|Open-Label|Study Termination by sponsor|45|||
145641999|NCT03088813|525206775|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
145642000|NCT03088813|525206776|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
145642001|NCT03088813|525206777|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
145642002|NCT03088813|525206778|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
145642003|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
145642004|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
145642005|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
145642006|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
145642007|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
145642008|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
145642009|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
145642010|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
145642011|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
145642012|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
145642013|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
145642014|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
145642015|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
145642016|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
145642017|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
145642018|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
145642019|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
145642020|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
145642021|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
145642022|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
145642023|NCT03088813|525206775|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
145642024|NCT03088813|525206776|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
145642025|NCT03088813|525206777|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
145642026|NCT03088813|525206778|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
145642027|NCT01903811|525206786|FG000|Overall Study|No measurable disease|1|||
145642028|NCT01903811|525206787|FG001|Overall Study|No measurable disease|1|||
145642029|NCT01903811|525206786|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
145642030|NCT01903811|525206787|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
145642031|NCT01903811|525206786|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
145642032|NCT01903811|525206787|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
145642033|NCT01903811|525206786|FG000|Overall Study|Withdrawal by Subject|0|||
145642034|NCT01903811|525206787|FG001|Overall Study|Withdrawal by Subject|1|||
145642035|NCT04540913|525206788|FG000|Overall Study|Withdrawal by Subject|14|||
145642036|NCT04540913|525206789|FG001|Overall Study|Withdrawal by Subject|3|||
145642037|NCT03613740|525206793|FG000|Overall Study|Lost to Follow-up|1|||
145642038|NCT03613740|525206794|FG001|Overall Study|Lost to Follow-up|1|||
145642039|NCT03575052|525206795|FG000|Overall Study|Adverse Event|6|||
145642040|NCT03575052|525206796|FG001|Overall Study|Adverse Event|10|||
145642041|NCT03575052|525206795|FG000|Overall Study|Not further specified|5|||
145642042|NCT03575052|525206796|FG001|Overall Study|Not further specified|7|||
145642043|NCT03575052|525206795|FG000|Overall Study|Withdrawal by Subject|5|||
145642044|NCT03575052|525206796|FG001|Overall Study|Withdrawal by Subject|6|||
145642045|NCT03575052|525206795|FG000|Overall Study|Lost to Follow-up|3|||
145642046|NCT03575052|525206796|FG001|Overall Study|Lost to Follow-up|0|||
145642047|NCT03575052|525206795|FG000|Overall Study|Death|2|||
145642048|NCT03575052|525206796|FG001|Overall Study|Death|1|||
145642049|NCT03575052|525206795|FG000|Overall Study|Lack of Efficacy|2|||
145642050|NCT03575052|525206796|FG001|Overall Study|Lack of Efficacy|1|||
145642051|NCT03575052|525206795|FG000|Overall Study|Study drug noncompliance|1|||
145642052|NCT03575052|525206796|FG001|Overall Study|Study drug noncompliance|2|||
145642053|NCT03575052|525206795|FG000|Overall Study|Protocol Violation|0|||
145642054|NCT03575052|525206796|FG001|Overall Study|Protocol Violation|2|||
145642055|NCT03575052|525206795|FG000|Overall Study|Physician Decision|1|||
145642056|NCT03575052|525206796|FG001|Overall Study|Physician Decision|0|||
145642057|NCT04188379|525206797|FG000|Overall Study|Withdrawal by Subject|10|||
145642058|NCT04188379|525206798|FG001|Overall Study|Withdrawal by Subject|3|||
145642059|NCT04188379|525206797|FG000|Overall Study|Physician Decision|0|||
145642060|NCT04188379|525206798|FG001|Overall Study|Physician Decision|1|||
145642061|NCT04188379|525206797|FG000|Overall Study|Adverse Event|3|||
145642062|NCT04188379|525206798|FG001|Overall Study|Adverse Event|1|||
145642063|NCT04188379|525206797|FG000|Overall Study|Pregnancy|1|||
145642064|NCT04188379|525206798|FG001|Overall Study|Pregnancy|0|||
145642065|NCT04188379|525206797|FG000|Overall Study|Lack of Efficacy|8|||
145642066|NCT04188379|525206798|FG001|Overall Study|Lack of Efficacy|5|||
145642067|NCT04188379|525206797|FG000|Overall Study|Other|0|||
145642068|NCT04188379|525206798|FG001|Overall Study|Other|3|||
145642069|NCT01693120|525206800|FG000|Enrollment|Lost to Follow-up|1|||
145642070|NCT01693120|525206800|FG000|Enrollment|Withdrawal by Subject|10|||
145642071|NCT01693120|525206800|FG000|Enrollment|Protocol Violation|46|||
145642072|NCT01693120|525206800|FG000|Enrollment|Physician Decision|3|||
145642073|NCT01693120|525206800|FG000|Enrollment|Adverse Event|1|||
145642074|NCT01693120|525206800|FG000|Enrollment|Study closed|8|||
145642075|NCT01693120|525206800|FG000|Enrollment|Other|1|||
145642076|NCT01693120|525206800|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
145642077|NCT01693120|525206800|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
145642078|NCT01693120|525206800|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
145642079|NCT01693120|525206800|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
145642080|NCT01693120|525206800|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
145642081|NCT02411084|525206808|FG000|Overall Study|Lack of Efficacy|6|||
145642082|NCT02411084|525206809|FG001|Overall Study|Lack of Efficacy|3|||
145642083|NCT02411084|525206808|FG000|Overall Study|Death|5|||
145486325|NCT02711137|524634983|FG010|Overall Study|Withdrawal by Subject|0|||
145486326|NCT02711137|524634984|FG011|Overall Study|Withdrawal by Subject|0|||
145486327|NCT02711137|524634985|FG012|Overall Study|Withdrawal by Subject|0|||
145486328|NCT02711137|524634986|FG013|Overall Study|Withdrawal by Subject|1|||
145486329|NCT02711137|524634987|FG014|Overall Study|Withdrawal by Subject|0|||
145486330|NCT02711137|524634973|FG000|Overall Study|Lost to Follow-up|1|||
145486331|NCT02711137|524634974|FG001|Overall Study|Lost to Follow-up|0|||
145642084|NCT02411084|525206809|FG001|Overall Study|Death|4|||
145642085|NCT02411084|525206808|FG000|Overall Study|Adverse Event|2|||
145642086|NCT02411084|525206809|FG001|Overall Study|Adverse Event|1|||
145642087|NCT02411084|525206808|FG000|Overall Study|Other reasons|0|||
145642088|NCT02411084|525206809|FG001|Overall Study|Other reasons|5|||
145642089|NCT01534494|525206812|FG000|Overall Study|Withdrawal by Subject|1|||
145642090|NCT05489484|525206820|FG000|Overall Study|withdrawn|1|||
145642091|NCT03051165|525206823|FG000|Overall Study|Withdrawal by Subject|1|||
145642092|NCT03051165|525206823|FG000|Overall Study|Early termination of study|12|||
145642093|NCT01290341|525206824|FG000|Overall Study|Protocol Violation|7|||
145642094|NCT01290341|525206825|FG001|Overall Study|Protocol Violation|3|||
145642095|NCT01290341|525206824|FG000|Overall Study|Adverse Event|1|||
145642096|NCT01290341|525206825|FG001|Overall Study|Adverse Event|0|||
145642097|NCT01290341|525206824|FG000|Overall Study|Lost to Follow-up|21|||
145642098|NCT01290341|525206825|FG001|Overall Study|Lost to Follow-up|10|||
145642099|NCT01290341|525206824|FG000|Overall Study|Withdrawal by Subject|19|||
145642100|NCT01290341|525206825|FG001|Overall Study|Withdrawal by Subject|5|||
145642101|NCT01290341|525206824|FG000|Overall Study|Negative baseline culture and others|44|||
145642102|NCT01290341|525206825|FG001|Overall Study|Negative baseline culture and others|11|||
145642103|NCT00529100|525206826|FG000|Overall Study|Adverse Event|0|||
145642104|NCT00529100|525206827|FG001|Overall Study|Adverse Event|5|||
145642105|NCT00529100|525206826|FG000|Overall Study|Protocol Violation|0|||
145642106|NCT00529100|525206827|FG001|Overall Study|Protocol Violation|1|||
145642107|NCT00529100|525206826|FG000|Overall Study|Progressive Disease|0|||
145642108|NCT00529100|525206827|FG001|Overall Study|Progressive Disease|1|||
145642109|NCT00529100|525206826|FG000|Overall Study|Withdrawal by Subject|0|||
145642110|NCT00529100|525206827|FG001|Overall Study|Withdrawal by Subject|1|||
145642111|NCT00529100|525206826|FG000|Overall Study|Participant Ineligibility|0|||
145642112|NCT00529100|525206827|FG001|Overall Study|Participant Ineligibility|1|||
145642113|NCT03684044|525206829|FG000|Overall Study|Adverse Event|3|||
145642114|NCT03684044|525206830|FG001|Overall Study|Adverse Event|0|||
145642115|NCT03684044|525206829|FG000|Overall Study|Death|4|||
145642116|NCT03684044|525206830|FG001|Overall Study|Death|7|||
145642117|NCT03684044|525206829|FG000|Overall Study|Lost to Follow-up|3|||
145642118|NCT03684044|525206830|FG001|Overall Study|Lost to Follow-up|2|||
145642119|NCT03684044|525206829|FG000|Overall Study|Patient Not Available|0|||
145642120|NCT03684044|525206830|FG001|Overall Study|Patient Not Available|2|||
145642121|NCT03684044|525206829|FG000|Overall Study|Physician Decision|1|||
145642122|NCT03684044|525206830|FG001|Overall Study|Physician Decision|0|||
145642123|NCT03684044|525206829|FG000|Overall Study|Withdrawal by Subject|11|||
145642124|NCT03684044|525206830|FG001|Overall Study|Withdrawal by Subject|9|||
145642125|NCT03703336|525206831|FG000|Overall Study|Parent withdrew consent|29|||
145642126|NCT03703336|525206832|FG001|Overall Study|Parent withdrew consent|8|||
145486332|NCT02711137|524634975|FG002|Overall Study|Lost to Follow-up|0|||
145486333|NCT02711137|524634976|FG003|Overall Study|Lost to Follow-up|0|||
145642127|NCT03703336|525206831|FG000|Overall Study|Migration|3|||
145642128|NCT03703336|525206832|FG001|Overall Study|Migration|3|||
145642129|NCT03703336|525206831|FG000|Overall Study|Protocol Violation|3|||
145642130|NCT03703336|525206832|FG001|Overall Study|Protocol Violation|1|||
145642131|NCT03703336|525206831|FG000|Overall Study|Physician Decision|2|||
145642132|NCT03703336|525206832|FG001|Overall Study|Physician Decision|0|||
145642133|NCT03703336|525206831|FG000|Overall Study|Adverse Event|0|||
145642134|NCT03703336|525206832|FG001|Overall Study|Adverse Event|2|||
145642135|NCT03703336|525206831|FG000|Overall Study|Lost to Follow-up|1|||
145642136|NCT03703336|525206832|FG001|Overall Study|Lost to Follow-up|0|||
145642137|NCT02708108|525206833|FG000|Overall Study|Death|1|||
145642138|NCT02708108|525206834|FG001|Overall Study|Death|2|||
145642139|NCT02708108|525206833|FG000|Overall Study|Regimen change|1|||
145642140|NCT02708108|525206834|FG001|Overall Study|Regimen change|0|||
145642141|NCT02708108|525206833|FG000|Overall Study|No MRD and no imaging available|0|||
145642142|NCT02708108|525206834|FG001|Overall Study|No MRD and no imaging available|1|||
145642143|NCT01388361|525206839|FG000|Overall Study|Adverse Event|0|||
145642144|NCT01388361|525206840|FG001|Overall Study|Adverse Event|5|||
145642145|NCT01388361|525206841|FG002|Overall Study|Adverse Event|1|||
145642146|NCT01388361|525206839|FG000|Overall Study|Protocol Violation|0|||
145642147|NCT01388361|525206840|FG001|Overall Study|Protocol Violation|0|||
145642148|NCT01388361|525206841|FG002|Overall Study|Protocol Violation|2|||
145642149|NCT01388361|525206839|FG000|Overall Study|Withdrawal criteria|12|||
145642150|NCT01388361|525206840|FG001|Overall Study|Withdrawal criteria|7|||
145642151|NCT01388361|525206841|FG002|Overall Study|Withdrawal criteria|10|||
145642152|NCT01388361|525206839|FG000|Overall Study|Unclassified|0|||
145642153|NCT01388361|525206840|FG001|Overall Study|Unclassified|0|||
145642154|NCT01388361|525206841|FG002|Overall Study|Unclassified|1|||
145642155|NCT01061671|525206842|FG000|Overall Study|Withdrawal by Subject|16|||
145642156|NCT01061671|525206843|FG001|Overall Study|Withdrawal by Subject|20|||
145642157|NCT01061671|525206842|FG000|Overall Study|Lost to Follow-up|3|||
145642158|NCT01061671|525206843|FG001|Overall Study|Lost to Follow-up|5|||
145642159|NCT01061671|525206842|FG000|Overall Study|Death|28|||
145642160|NCT01061671|525206843|FG001|Overall Study|Death|30|||
145642161|NCT00419341|525206847|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
145642162|NCT00419341|525206847|FG000|Wash in/Wash Out Period|Adverse Event|2|||
145642163|NCT00419341|525206847|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
145642164|NCT00419341|525206847|FG000|Efficacy Period|Withdrawal by Subject|6|||
145642165|NCT00419341|525206847|FG000|Efficacy Period|Protocol Violation|1|||
145642166|NCT00419341|525206847|FG000|Efficacy Period|Lost to Follow-up|1|||
145642167|NCT00419341|525206847|FG000|Efficacy Period|Non-compliance|1|||
145642168|NCT00419341|525206847|FG000|Efficacy Period|Termination of study site|1|||
145642169|NCT05505045|525208334|FG000|Overall Study|Withdrawal by Subject|2|||
145642170|NCT05505045|525208335|FG001|Overall Study|Withdrawal by Subject|1|||
145642171|NCT03346538|525208339|FG000|Overall Study|Physician Decision|0|||
145642172|NCT03346538|525208340|FG001|Overall Study|Physician Decision|1|||
145642173|NCT03346538|525208341|FG002|Overall Study|Physician Decision|0|||
145642174|NCT03346538|525208339|FG000|Overall Study|Withdrawal by Subject|3|||
145642175|NCT03346538|525208340|FG001|Overall Study|Withdrawal by Subject|2|||
145642176|NCT03346538|525208341|FG002|Overall Study|Withdrawal by Subject|0|||
145642177|NCT03346538|525208339|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
145642178|NCT03346538|525208340|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
145642179|NCT03346538|525208341|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
145642180|NCT05672667|525208342|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
145642181|NCT03624972|525208345|FG000|Overall Study|Lost to Follow-up|2|||
145642182|NCT03624972|525208346|FG001|Overall Study|Lost to Follow-up|0|||
145642183|NCT03624972|525208347|FG002|Overall Study|Lost to Follow-up|0|||
145642184|NCT03624972|525208345|FG000|Overall Study|Withdrawal by Subject|0|||
145642185|NCT03624972|525208346|FG001|Overall Study|Withdrawal by Subject|2|||
145642186|NCT03624972|525208347|FG002|Overall Study|Withdrawal by Subject|0|||
145642187|NCT05137236|525208348|FG000|Part A|Other than Specified|1|||
145642188|NCT05137236|525208349|FG001|Part A|Other than Specified|0|||
145642189|NCT05137236|525208350|FG002|Part A|Other than Specified|0|||
145642190|NCT05137236|525208351|FG003|Part A|Other than Specified|0|||
145642191|NCT05137236|525208352|FG004|Part A|Other than Specified|0|||
145642192|NCT05137236|525208353|FG005|Part A|Other than Specified|0|||
145642193|NCT05137236|525208354|FG006|Part A|Other than Specified|0|||
145642194|NCT05137236|525208355|FG007|Part A|Other than Specified|0|||
145642195|NCT05137236|525208348|FG000|Part A|Withdrawal by Subject|0|||
145642196|NCT05137236|525208349|FG001|Part A|Withdrawal by Subject|4|||
145642197|NCT05137236|525208350|FG002|Part A|Withdrawal by Subject|1|||
145642198|NCT05137236|525208351|FG003|Part A|Withdrawal by Subject|1|||
145642199|NCT05137236|525208352|FG004|Part A|Withdrawal by Subject|3|||
145642200|NCT05137236|525208353|FG005|Part A|Withdrawal by Subject|2|||
145642201|NCT05137236|525208354|FG006|Part A|Withdrawal by Subject|0|||
145642202|NCT05137236|525208355|FG007|Part A|Withdrawal by Subject|0|||
145642203|NCT05137236|525208348|FG000|Part A|Lost to Follow-up|5|||
145642204|NCT05137236|525208349|FG001|Part A|Lost to Follow-up|7|||
145642205|NCT05137236|525208350|FG002|Part A|Lost to Follow-up|1|||
145642206|NCT05137236|525208351|FG003|Part A|Lost to Follow-up|3|||
145642207|NCT05137236|525208352|FG004|Part A|Lost to Follow-up|3|||
145642208|NCT05137236|525208353|FG005|Part A|Lost to Follow-up|8|||
145642209|NCT05137236|525208354|FG006|Part A|Lost to Follow-up|0|||
145642210|NCT05137236|525208355|FG007|Part A|Lost to Follow-up|0|||
145642211|NCT05137236|525208348|FG000|Part B|Withdrawal by Subject|0|||
145642212|NCT05137236|525208349|FG001|Part B|Withdrawal by Subject|0|||
145642213|NCT05137236|525208350|FG002|Part B|Withdrawal by Subject|0|||
145642214|NCT05137236|525208351|FG003|Part B|Withdrawal by Subject|0|||
145642215|NCT05137236|525208352|FG004|Part B|Withdrawal by Subject|0|||
145642216|NCT05137236|525208353|FG005|Part B|Withdrawal by Subject|0|||
145642217|NCT05137236|525208354|FG006|Part B|Withdrawal by Subject|0|||
145642218|NCT05137236|525208355|FG007|Part B|Withdrawal by Subject|2|||
145642219|NCT05137236|525208348|FG000|Part B|Lost to Follow-up|0|||
145642220|NCT05137236|525208349|FG001|Part B|Lost to Follow-up|0|||
145642221|NCT05137236|525208350|FG002|Part B|Lost to Follow-up|0|||
145642222|NCT05137236|525208351|FG003|Part B|Lost to Follow-up|0|||
145642223|NCT05137236|525208352|FG004|Part B|Lost to Follow-up|0|||
145642224|NCT05137236|525208353|FG005|Part B|Lost to Follow-up|0|||
145642225|NCT05137236|525208354|FG006|Part B|Lost to Follow-up|5|||
145642226|NCT05137236|525208355|FG007|Part B|Lost to Follow-up|5|||
145642227|NCT05137236|525208348|FG000|Part B|Death|0|||
145642228|NCT05137236|525208349|FG001|Part B|Death|0|||
145642229|NCT05137236|525208350|FG002|Part B|Death|0|||
145642230|NCT05137236|525208351|FG003|Part B|Death|0|||
145642231|NCT05137236|525208352|FG004|Part B|Death|0|||
145642232|NCT05137236|525208353|FG005|Part B|Death|0|||
145642233|NCT05137236|525208354|FG006|Part B|Death|0|||
145642234|NCT05137236|525208355|FG007|Part B|Death|2|||
145642235|NCT00431834|525208356|FG000|Overall Study|Withdrawal by Subject|7|||
145642236|NCT00431834|525208356|FG000|Overall Study|Death|3|||
145642237|NCT00431834|525208356|FG000|Overall Study|Missed Endpoint Visit|2|||
145642238|NCT00431834|525208356|FG000|Overall Study|Lost to Follow-up|1|||
145642239|NCT02622568|525208359|FG000|Overall Study|Lost to Follow-up|5|||
145642240|NCT02622568|525208360|FG001|Overall Study|Lost to Follow-up|5|||
145642241|NCT02647905|525208361|FG000|Overall Study|Lost to Follow-up|1|||
145642242|NCT02647905|525208361|FG000|Overall Study|Withdrawal by Subject|2|||
145642243|NCT05119855|525208362|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
145642244|NCT05119855|525208363|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
145642245|NCT05119855|525208362|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
145642246|NCT05119855|525208363|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
145642247|NCT05119855|525208362|FG000|Overall Study|Lost to Follow-up|6|||
145642248|NCT05119855|525208363|FG001|Overall Study|Lost to Follow-up|8|||
145642249|NCT02597920|525208365|FG000|Overall Study|Worsening of other pre-existing disease|0|||
145642250|NCT02597920|525208366|FG001|Overall Study|Worsening of other pre-existing disease|1|||
145642251|NCT02597920|525208367|FG002|Overall Study|Worsening of other pre-existing disease|0|||
145642252|NCT02597920|525208365|FG000|Overall Study|Other adverse event|20|||
145642253|NCT02597920|525208366|FG001|Overall Study|Other adverse event|30|||
145642254|NCT02597920|525208367|FG002|Overall Study|Other adverse event|0|||
145642255|NCT02597920|525208365|FG000|Overall Study|Lost to Follow-up|7|||
145642256|NCT02597920|525208366|FG001|Overall Study|Lost to Follow-up|9|||
145642257|NCT02597920|525208367|FG002|Overall Study|Lost to Follow-up|0|||
145642258|NCT02597920|525208365|FG000|Overall Study|Refuse to continue in the study|3|||
145642259|NCT02597920|525208366|FG001|Overall Study|Refuse to continue in the study|13|||
145642260|NCT02597920|525208367|FG002|Overall Study|Refuse to continue in the study|1|||
145642261|NCT02597920|525208365|FG000|Overall Study|Other than specified|10|||
145642262|NCT02597920|525208366|FG001|Overall Study|Other than specified|31|||
145642263|NCT02597920|525208367|FG002|Overall Study|Other than specified|5|||
145642264|NCT02597920|525208365|FG000|Overall Study|Other|1|||
145642265|NCT02597920|525208366|FG001|Overall Study|Other|0|||
145642266|NCT02597920|525208367|FG002|Overall Study|Other|0|||
145642267|NCT00642850|525208368|FG000|Overall Study|Death|7|||
145642268|NCT00642850|525208368|FG000|Overall Study|Adverse Event|2|||
145642269|NCT00642850|525208368|FG000|Overall Study|Lack of Efficacy|1|||
145642270|NCT00642850|525208368|FG000|Overall Study|Protocol Violation|2|||
145642271|NCT00642850|525208368|FG000|Overall Study|Kidney transplantation|8|||
145642272|NCT00642850|525208368|FG000|Overall Study|Blood transfusion|6|||
145642273|NCT00642850|525208368|FG000|Overall Study|Other reasons|7|||
145642274|NCT00444600|525208375|FG000|Overall Study|Death|7|||
145642275|NCT00444600|525208376|FG001|Overall Study|Death|5|||
145642276|NCT00444600|525208377|FG002|Overall Study|Death|3|||
145642277|NCT00444600|525208378|FG003|Overall Study|Death|2|||
145642278|NCT00444600|525208375|FG000|Overall Study|Dropped|11|||
145642279|NCT00444600|525208376|FG001|Overall Study|Dropped|11|||
145642280|NCT00444600|525208377|FG002|Overall Study|Dropped|7|||
145642281|NCT00444600|525208378|FG003|Overall Study|Dropped|7|||
145642282|NCT00444600|525208375|FG000|Overall Study|Missed visit|1|||
145642283|NCT00444600|525208376|FG001|Overall Study|Missed visit|0|||
145642284|NCT00444600|525208377|FG002|Overall Study|Missed visit|0|||
145642285|NCT00444600|525208378|FG003|Overall Study|Missed visit|1|||
145642286|NCT05132478|525208379|FG000|Overall Study|did not complete survey after consent|1|||
145642287|NCT05132478|525208380|FG001|Overall Study|did not complete survey after consent|1|||
145642288|NCT05132478|525208379|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
145642289|NCT05132478|525208380|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
145642290|NCT02549170|525208381|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
145642291|NCT02549170|525208382|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
145642292|NCT02549170|525208383|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
145642293|NCT02549170|525208384|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
145642294|NCT02549170|525208385|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
145642295|NCT02549170|525208381|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
145642296|NCT02549170|525208382|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
145642297|NCT02549170|525208383|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
145642298|NCT02549170|525208384|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
145642299|NCT02549170|525208385|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
145642300|NCT02549170|525208381|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
145642301|NCT02549170|525208382|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
145642302|NCT02549170|525208383|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
145642303|NCT02549170|525208384|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
145642304|NCT02549170|525208385|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
145642305|NCT00111813|525208386|FG000|Overall Study|Adverse Event|1|||
145642306|NCT00111813|525208387|FG001|Overall Study|Adverse Event|2|||
145642307|NCT00111813|525208388|FG002|Overall Study|Adverse Event|4|||
145642308|NCT00111813|525208389|FG003|Overall Study|Adverse Event|2|||
145642309|NCT00111813|525208390|FG004|Overall Study|Adverse Event|2|||
145642310|NCT00111813|525208391|FG005|Overall Study|Adverse Event|2|||
145642311|NCT00111813|525208386|FG000|Overall Study|Progressive disease|2|||
145642312|NCT00111813|525208387|FG001|Overall Study|Progressive disease|1|||
145642313|NCT00111813|525208388|FG002|Overall Study|Progressive disease|5|||
145642314|NCT00111813|525208389|FG003|Overall Study|Progressive disease|3|||
145642315|NCT00111813|525208390|FG004|Overall Study|Progressive disease|4|||
145642316|NCT00111813|525208391|FG005|Overall Study|Progressive disease|3|||
145642317|NCT00111813|525208386|FG000|Overall Study|Lack of Efficacy|0|||
145642318|NCT00111813|525208387|FG001|Overall Study|Lack of Efficacy|0|||
145486334|NCT02711137|524634977|FG004|Overall Study|Lost to Follow-up|0|||
145486335|NCT02711137|524634978|FG005|Overall Study|Lost to Follow-up|0|||
145486336|NCT02711137|524634979|FG006|Overall Study|Lost to Follow-up|2|||
145642319|NCT00111813|525208388|FG002|Overall Study|Lack of Efficacy|0|||
145642320|NCT00111813|525208389|FG003|Overall Study|Lack of Efficacy|0|||
145642321|NCT00111813|525208390|FG004|Overall Study|Lack of Efficacy|0|||
145642322|NCT00111813|525208391|FG005|Overall Study|Lack of Efficacy|1|||
145642323|NCT00111813|525208386|FG000|Overall Study|Other|0|||
145642324|NCT00111813|525208387|FG001|Overall Study|Other|0|||
145642325|NCT00111813|525208388|FG002|Overall Study|Other|1|||
145642326|NCT00111813|525208389|FG003|Overall Study|Other|0|||
145642327|NCT00111813|525208390|FG004|Overall Study|Other|0|||
145642328|NCT00111813|525208391|FG005|Overall Study|Other|0|||
145642329|NCT00409838|525208395|FG000|Short-term Period|Adverse Event|0|||
145642330|NCT00409838|525208396|FG001|Short-term Period|Adverse Event|1|||
145642331|NCT00409838|525208395|FG000|Short-term Period|Lost to Follow-up|0|||
145642332|NCT00409838|525208396|FG001|Short-term Period|Lost to Follow-up|1|||
145642333|NCT00409838|525208395|FG000|Short-term Period|Withdrawal by Subject|2|||
145642334|NCT00409838|525208396|FG001|Short-term Period|Withdrawal by Subject|3|||
145642335|NCT00409838|525208395|FG000|Short-term Period|Never Treated|1|||
145642336|NCT00409838|525208396|FG001|Short-term Period|Never Treated|0|||
145642337|NCT00409838|525208395|FG000|Long-term Extension Period|Adverse Event|10|||
145642338|NCT00409838|525208396|FG001|Long-term Extension Period|Adverse Event|0|||
145642339|NCT00409838|525208395|FG000|Long-term Extension Period|Death|1|||
145486337|NCT02711137|524634980|FG007|Overall Study|Lost to Follow-up|0|||
145486338|NCT02711137|524634981|FG008|Overall Study|Lost to Follow-up|0|||
145486339|NCT02711137|524634982|FG009|Overall Study|Lost to Follow-up|0|||
145642340|NCT00409838|525208396|FG001|Long-term Extension Period|Death|0|||
145642341|NCT00409838|525208395|FG000|Long-term Extension Period|Lack of Efficacy|2|||
145642342|NCT00409838|525208396|FG001|Long-term Extension Period|Lack of Efficacy|0|||
145642343|NCT00409838|525208395|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
145642344|NCT00409838|525208396|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
145642345|NCT00409838|525208395|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
145642346|NCT00409838|525208396|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
145642347|NCT00409838|525208395|FG000|Long-term Extension Period|Pregnancy|1|||
145642348|NCT00409838|525208396|FG001|Long-term Extension Period|Pregnancy|0|||
145642349|NCT04788641|525208397|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
145642350|NCT04788641|525208398|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
145486340|NCT02711137|524634983|FG010|Overall Study|Lost to Follow-up|0|||
145486341|NCT02711137|524634984|FG011|Overall Study|Lost to Follow-up|0|||
145642351|NCT04788641|525208399|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
145642352|NCT04788641|525208400|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
145642353|NCT04788641|525208397|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
145642354|NCT04788641|525208398|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
145642355|NCT04788641|525208399|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
145642356|NCT04788641|525208400|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
145642357|NCT04788641|525208397|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
145642358|NCT04788641|525208398|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
145642359|NCT04788641|525208399|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
145642360|NCT04788641|525208400|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
145642361|NCT01250769|525208401|FG000|Overall Study|Withdrawal by Subject|0|||
145642362|NCT01250769|525208402|FG001|Overall Study|Withdrawal by Subject|1|||
145642363|NCT01250769|525208403|FG002|Overall Study|Withdrawal by Subject|1|||
145642364|NCT01250769|525208404|FG003|Overall Study|Withdrawal by Subject|0|||
145642365|NCT01250769|525208401|FG000|Overall Study|Adverse Event|0|||
145642366|NCT01250769|525208402|FG001|Overall Study|Adverse Event|0|||
145642367|NCT01250769|525208403|FG002|Overall Study|Adverse Event|1|||
145642368|NCT01250769|525208404|FG003|Overall Study|Adverse Event|0|||
145642369|NCT03283371|525208405|FG000|Placebo-controlled|Adverse Event|1|||
145642370|NCT03283371|525208406|FG001|Placebo-controlled|Adverse Event|1|||
145642371|NCT03283371|525208407|FG002|Placebo-controlled|Adverse Event|0|||
145642372|NCT03283371|525208408|FG003|Placebo-controlled|Adverse Event|0|||
145642373|NCT03283371|525208405|FG000|Placebo-controlled|Lack of Efficacy|1|||
145642374|NCT03283371|525208406|FG001|Placebo-controlled|Lack of Efficacy|0|||
145642375|NCT03283371|525208407|FG002|Placebo-controlled|Lack of Efficacy|0|||
145642376|NCT03283371|525208408|FG003|Placebo-controlled|Lack of Efficacy|0|||
145642377|NCT03283371|525208405|FG000|Placebo-controlled|Withdrawal by Subject|1|||
145642378|NCT03283371|525208406|FG001|Placebo-controlled|Withdrawal by Subject|1|||
145642379|NCT03283371|525208407|FG002|Placebo-controlled|Withdrawal by Subject|0|||
145642380|NCT03283371|525208408|FG003|Placebo-controlled|Withdrawal by Subject|0|||
145642381|NCT03283371|525208405|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
145642382|NCT03283371|525208406|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
145642383|NCT03283371|525208407|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
145642384|NCT03283371|525208408|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
145642385|NCT03283371|525208405|FG000|Open-label Phase|Adverse Event|0|||
145642386|NCT03283371|525208406|FG001|Open-label Phase|Adverse Event|0|||
145642387|NCT03283371|525208407|FG002|Open-label Phase|Adverse Event|2|||
145642388|NCT03283371|525208408|FG003|Open-label Phase|Adverse Event|0|||
145642389|NCT03283371|525208405|FG000|Open-label Phase|Withdrawal by Subject|0|||
145642390|NCT03283371|525208406|FG001|Open-label Phase|Withdrawal by Subject|0|||
145642391|NCT03283371|525208407|FG002|Open-label Phase|Withdrawal by Subject|1|||
145642392|NCT03283371|525208408|FG003|Open-label Phase|Withdrawal by Subject|0|||
145642393|NCT03283371|525208405|FG000|Open-label Phase|Other|0|||
145642394|NCT03283371|525208406|FG001|Open-label Phase|Other|0|||
145642395|NCT03283371|525208407|FG002|Open-label Phase|Other|1|||
145642396|NCT03283371|525208408|FG003|Open-label Phase|Other|1|||
145642397|NCT00243503|525208409|FG000|Overall Study|Adverse Event|11|||
145642398|NCT00243503|525208409|FG000|Overall Study|Withdrawal by Subject|1|||
145642399|NCT00243503|525208409|FG000|Overall Study|Lack of Efficacy|44|||
145642400|NCT00243503|525208409|FG000|Overall Study|Death|1|||
145642401|NCT00243503|525208409|FG000|Overall Study|Other|1|||
145642402|NCT00914589|525208410|FG000|Overall Study|Adverse Event|1|||
145642403|NCT00914589|525208411|FG001|Overall Study|Adverse Event|0|||
145642404|NCT00914589|525208412|FG002|Overall Study|Adverse Event|1|||
145642405|NCT00914589|525208410|FG000|Overall Study|Protocol Violation|8|||
145642406|NCT00914589|525208411|FG001|Overall Study|Protocol Violation|6|||
145642407|NCT00914589|525208412|FG002|Overall Study|Protocol Violation|3|||
145642408|NCT00914589|525208410|FG000|Overall Study|unclassified|16|||
145642409|NCT00914589|525208411|FG001|Overall Study|unclassified|9|||
145642410|NCT00914589|525208412|FG002|Overall Study|unclassified|7|||
145642411|NCT00914589|525208410|FG000|Overall Study|Death|0|||
145642412|NCT00914589|525208411|FG001|Overall Study|Death|1|||
145642413|NCT00914589|525208412|FG002|Overall Study|Death|1|||
145642414|NCT00093015|525208417|FG000|Overall Study|Withdrawal by Subject|194|||
145642415|NCT00093015|525208418|FG001|Overall Study|Withdrawal by Subject|171|||
145642416|NCT00093015|525208417|FG000|Overall Study|Lost to Follow-up|96|||
145642417|NCT00093015|525208418|FG001|Overall Study|Lost to Follow-up|108|||
145642418|NCT00093015|525208417|FG000|Overall Study|Death|375|||
145642419|NCT00093015|525208418|FG001|Overall Study|Death|385|||
145642420|NCT00520546|525208421|FG000|Overall Study|Withdrawal by Subject|1|||
145642421|NCT00520546|525208421|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
145642422|NCT03076515|525208422|FG000|Overall Study|DMC decision based on interim analysis|25|||
145642423|NCT03076515|525208423|FG001|Overall Study|DMC decision based on interim analysis|29|||
145642424|NCT03988023|525208427|FG000|Overall Study|Non-compliance|3|||
145642425|NCT03988023|525208428|FG001|Overall Study|Non-compliance|0|||
145642426|NCT03988023|525208427|FG000|Overall Study|Withdrawal by Subject|39|||
145642427|NCT03988023|525208428|FG001|Overall Study|Withdrawal by Subject|37|||
145642428|NCT03988023|525208427|FG000|Overall Study|Adverse Event|0|||
145642429|NCT03988023|525208428|FG001|Overall Study|Adverse Event|2|||
145642430|NCT03988023|525208427|FG000|Overall Study|Physician Decision|0|||
145642431|NCT03988023|525208428|FG001|Overall Study|Physician Decision|1|||
145642432|NCT03988023|525208427|FG000|Overall Study|Lost to Follow-up|5|||
145642433|NCT03988023|525208428|FG001|Overall Study|Lost to Follow-up|8|||
145642434|NCT03988023|525208427|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
145642435|NCT03988023|525208428|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
145642436|NCT03988023|525208427|FG000|Overall Study|Lack of Efficacy|3|||
145642437|NCT03988023|525208428|FG001|Overall Study|Lack of Efficacy|1|||
145642438|NCT03988023|525208427|FG000|Overall Study|COVID-19 pandemic|225|||
145642439|NCT03988023|525208428|FG001|Overall Study|COVID-19 pandemic|227|||
145642440|NCT02101281|525208429|FG000|Overall Study|Adverse Event|0|||
145642441|NCT02101281|525208430|FG001|Overall Study|Adverse Event|1|||
145642442|NCT00174382|525208431|FG000|Overall Study|Death|2|||
145642443|NCT00174382|525208431|FG000|Overall Study|Adverse Event|19|||
145642444|NCT00174382|525208431|FG000|Overall Study|Withdrawal by Subject|6|||
145642445|NCT00174382|525208431|FG000|Overall Study|Protocol Violation|3|||
145642446|NCT00174382|525208431|FG000|Overall Study|Arrived early for last visit in error|1|||
145642447|NCT00174382|525208431|FG000|Overall Study|Subject felt pill not effective enough|1|||
145642448|NCT00174382|525208431|FG000|Overall Study|Lost to Follow-up|1|||
145642449|NCT03733119|525208433|FG000|Overall Study|Physician Decision|2|||
145642450|NCT03733119|525208434|FG001|Overall Study|Physician Decision|1|||
145642451|NCT03733119|525208433|FG000|Overall Study|ineligible to treat per protocol|0|||
145642452|NCT03733119|525208434|FG001|Overall Study|ineligible to treat per protocol|1|||
145642453|NCT00595413|525208435|FG000|Overall Study|Adverse Event|0|||
145642454|NCT00595413|525208436|FG001|Overall Study|Adverse Event|2|||
145642455|NCT00595413|525208437|FG002|Overall Study|Adverse Event|1|||
145642456|NCT00595413|525208438|FG003|Overall Study|Adverse Event|1|||
145642457|NCT00595413|525208435|FG000|Overall Study|Lost to Follow-up|2|||
145642458|NCT00595413|525208436|FG001|Overall Study|Lost to Follow-up|2|||
145642459|NCT00595413|525208437|FG002|Overall Study|Lost to Follow-up|1|||
145642460|NCT00595413|525208438|FG003|Overall Study|Lost to Follow-up|3|||
145642461|NCT00595413|525208435|FG000|Overall Study|Death|0|||
145642462|NCT00595413|525208436|FG001|Overall Study|Death|0|||
145642463|NCT00595413|525208437|FG002|Overall Study|Death|1|||
145642464|NCT00595413|525208438|FG003|Overall Study|Death|0|||
145642465|NCT00595413|525208435|FG000|Overall Study|Other|5|||
145642466|NCT00595413|525208436|FG001|Overall Study|Other|1|||
145642467|NCT00595413|525208437|FG002|Overall Study|Other|5|||
145486342|NCT02711137|524634985|FG012|Overall Study|Lost to Follow-up|0|||
145486343|NCT02711137|524634986|FG013|Overall Study|Lost to Follow-up|0|||
145486344|NCT02711137|524634987|FG014|Overall Study|Lost to Follow-up|0|||
145486345|NCT00742183|524634990|FG000|Overall Study|Adverse Event|2|||
145486346|NCT00742183|524634991|FG001|Overall Study|Adverse Event|2|||
145486347|NCT00742183|524634990|FG000|Overall Study|Death|1|||
145486348|NCT00742183|524634991|FG001|Overall Study|Death|0|||
145486349|NCT00742183|524634990|FG000|Overall Study|Physician Decision|0|||
145486350|NCT00742183|524634991|FG001|Overall Study|Physician Decision|2|||
145486351|NCT00742183|524634990|FG000|Overall Study|Lost to Follow-up|4|||
145486352|NCT00742183|524634991|FG001|Overall Study|Lost to Follow-up|4|||
145486353|NCT00742183|524634990|FG000|Overall Study|Required skin-graft|1|||
145486354|NCT00742183|524634991|FG001|Overall Study|Required skin-graft|1|||
145486355|NCT00742183|524634990|FG000|Overall Study|Withdrawal by Subject|1|||
145642468|NCT00595413|525208438|FG003|Overall Study|Other|0|||
145642469|NCT00807937|525208439|FG000|Overall Study|Adverse Event|12|||
145642470|NCT00807937|525208440|FG001|Overall Study|Adverse Event|12|||
145642471|NCT00807937|525208441|FG002|Overall Study|Adverse Event|5|||
145486356|NCT00742183|524634991|FG001|Overall Study|Withdrawal by Subject|0|||
145642472|NCT00807937|525208442|FG003|Overall Study|Adverse Event|4|||
145642473|NCT00807937|525208439|FG000|Overall Study|Protocol Violation|4|||
145642474|NCT00807937|525208440|FG001|Overall Study|Protocol Violation|5|||
145642475|NCT00807937|525208441|FG002|Overall Study|Protocol Violation|3|||
145642476|NCT00807937|525208442|FG003|Overall Study|Protocol Violation|3|||
145642477|NCT00807937|525208439|FG000|Overall Study|Withdrawal by Subject|5|||
145642478|NCT00807937|525208440|FG001|Overall Study|Withdrawal by Subject|4|||
145642479|NCT00807937|525208441|FG002|Overall Study|Withdrawal by Subject|1|||
145642480|NCT00807937|525208442|FG003|Overall Study|Withdrawal by Subject|4|||
145642481|NCT00807937|525208439|FG000|Overall Study|Lost to Follow-up|4|||
145642482|NCT00807937|525208440|FG001|Overall Study|Lost to Follow-up|0|||
145642483|NCT00807937|525208441|FG002|Overall Study|Lost to Follow-up|2|||
145642484|NCT00807937|525208442|FG003|Overall Study|Lost to Follow-up|1|||
145642485|NCT00807937|525208439|FG000|Overall Study|Lack of Efficacy|0|||
145642486|NCT00807937|525208440|FG001|Overall Study|Lack of Efficacy|0|||
145642487|NCT00807937|525208441|FG002|Overall Study|Lack of Efficacy|1|||
145642488|NCT00807937|525208442|FG003|Overall Study|Lack of Efficacy|2|||
145642489|NCT00807937|525208439|FG000|Overall Study|Intake of prohibited medicine|0|||
145486357|NCT00742183|524634990|FG000|Overall Study|Lack of Efficacy|0|||
145486358|NCT00742183|524634991|FG001|Overall Study|Lack of Efficacy|3|||
145642490|NCT00807937|525208440|FG001|Overall Study|Intake of prohibited medicine|0|||
145642491|NCT00807937|525208441|FG002|Overall Study|Intake of prohibited medicine|2|||
145642492|NCT00807937|525208442|FG003|Overall Study|Intake of prohibited medicine|0|||
145642493|NCT00807937|525208439|FG000|Overall Study|All other reasons (not provided)|2|||
145642494|NCT00807937|525208440|FG001|Overall Study|All other reasons (not provided)|4|||
145642495|NCT00807937|525208441|FG002|Overall Study|All other reasons (not provided)|0|||
145642496|NCT00807937|525208442|FG003|Overall Study|All other reasons (not provided)|1|||
145642497|NCT04629950|525208445|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
145642498|NCT04629950|525208446|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
145642499|NCT04629950|525208447|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
145642500|NCT04629950|525208448|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
145642501|NCT04629950|525208445|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
145642502|NCT04629950|525208446|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
145642503|NCT04629950|525208447|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
145642504|NCT04629950|525208448|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
145642505|NCT04629950|525208445|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
145642506|NCT04629950|525208446|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
145642507|NCT04629950|525208447|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
145642508|NCT04629950|525208448|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
145642509|NCT04629950|525208445|FG000|Extension Study|Withdrawal by Subject|0|||
145642510|NCT04629950|525208446|FG001|Extension Study|Withdrawal by Subject|0|||
145642511|NCT04629950|525208447|FG002|Extension Study|Withdrawal by Subject|1|||
145642512|NCT04629950|525208448|FG003|Extension Study|Withdrawal by Subject|0|||
145642513|NCT04629950|525208445|FG000|Extension Study|Adverse Event|0|||
145642514|NCT04629950|525208446|FG001|Extension Study|Adverse Event|0|||
145642515|NCT04629950|525208447|FG002|Extension Study|Adverse Event|0|||
145642516|NCT04629950|525208448|FG003|Extension Study|Adverse Event|1|||
145642517|NCT03233633|525208449|FG000|Overall Study|Adverse Event|2|||
145642518|NCT03233633|525208449|FG000|Overall Study|Less Than 3 Days of Data|6|||
145642519|NCT02088853|525208450|FG000|Overall Study|Pregnancy|1|||
145642520|NCT02088853|525208451|FG001|Overall Study|Pregnancy|0|||
145642521|NCT01925339|525208452|FG000|Overall Study|Adverse Event|2|||
145642522|NCT01925339|525208453|FG001|Overall Study|Adverse Event|0|||
145642523|NCT01205048|525208456|FG000|Overall Study|Withdrawal by Subject|14|||
145642524|NCT01205048|525208456|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
145642525|NCT01205048|525208456|FG000|Overall Study|Lost to Follow-up|4|||
145642526|NCT01205048|525208456|FG000|Overall Study|Other|2|||
145642527|NCT01255670|525208457|FG000|Overall Study|Adverse Event|10|||
145642528|NCT01255670|525208458|FG001|Overall Study|Adverse Event|10|||
145642529|NCT01255670|525208457|FG000|Overall Study|Lost to Follow-up|16|||
145642530|NCT01255670|525208458|FG001|Overall Study|Lost to Follow-up|10|||
145642531|NCT03664960|525208459|FG000|Overall Study|Adverse Event|0|||
145642532|NCT03664960|525208460|FG001|Overall Study|Adverse Event|3|||
145642533|NCT03664960|525208459|FG000|Overall Study|Lost to Follow-up|3|||
145642534|NCT03664960|525208460|FG001|Overall Study|Lost to Follow-up|2|||
145642535|NCT03664960|525208459|FG000|Overall Study|Physician Decision|1|||
145642536|NCT03664960|525208460|FG001|Overall Study|Physician Decision|0|||
145642537|NCT03664960|525208459|FG000|Overall Study|Withdrawal by Subject|3|||
145642538|NCT03664960|525208460|FG001|Overall Study|Withdrawal by Subject|14|||
145642539|NCT03664960|525208459|FG000|Overall Study|Sponsor Decision|1|||
145642540|NCT03664960|525208460|FG001|Overall Study|Sponsor Decision|1|||
145642541|NCT03664960|525208459|FG000|Overall Study|Other|1|||
145642542|NCT03664960|525208460|FG001|Overall Study|Other|2|||
145642543|NCT00823472|525208461|FG000|Overall Study|Physician Decision|24|||
145642544|NCT00823472|525208462|FG001|Overall Study|Physician Decision|28|||
145642545|NCT04019444|525208463|FG000|Overall Study|Withdrawal by Subject|0|||
145642546|NCT04019444|525208464|FG001|Overall Study|Withdrawal by Subject|1|||
145642547|NCT04019444|525208465|FG002|Overall Study|Withdrawal by Subject|0|||
145642548|NCT04019444|525208466|FG003|Overall Study|Withdrawal by Subject|1|||
145642549|NCT04019444|525208463|FG000|Overall Study|Solicited Event|0|||
145486359|NCT03922581|524634996|FG000|Overall Study|Lost to Follow-up|20|||
145486360|NCT03922581|524634997|FG001|Overall Study|Lost to Follow-up|9|||
145642550|NCT04019444|525208464|FG001|Overall Study|Solicited Event|0|||
145642551|NCT04019444|525208465|FG002|Overall Study|Solicited Event|2|||
145642552|NCT04019444|525208466|FG003|Overall Study|Solicited Event|0|||
145642553|NCT03807778|525208475|FG000|Overall Study|Adverse Event|0|||
145642554|NCT03807778|525208476|FG001|Overall Study|Adverse Event|0|||
145642555|NCT03807778|525208477|FG002|Overall Study|Adverse Event|3|||
145642556|NCT03807778|525208478|FG003|Overall Study|Adverse Event|5|||
145642557|NCT03807778|525208475|FG000|Overall Study|Progressive Disease|4|||
145642558|NCT03807778|525208476|FG001|Overall Study|Progressive Disease|2|||
145642559|NCT03807778|525208477|FG002|Overall Study|Progressive Disease|8|||
145642560|NCT03807778|525208478|FG003|Overall Study|Progressive Disease|15|||
145642561|NCT03807778|525208475|FG000|Overall Study|Symptomatic Deterioration|0|||
145642562|NCT03807778|525208476|FG001|Overall Study|Symptomatic Deterioration|1|||
145642563|NCT03807778|525208477|FG002|Overall Study|Symptomatic Deterioration|0|||
145642564|NCT03807778|525208478|FG003|Overall Study|Symptomatic Deterioration|1|||
145642565|NCT03807778|525208475|FG000|Overall Study|Withdrawal by Subject|0|||
145642566|NCT03807778|525208476|FG001|Overall Study|Withdrawal by Subject|1|||
145642567|NCT03807778|525208477|FG002|Overall Study|Withdrawal by Subject|0|||
145642568|NCT03807778|525208478|FG003|Overall Study|Withdrawal by Subject|1|||
145642569|NCT03807778|525208475|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
145642570|NCT03807778|525208476|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
145642571|NCT03807778|525208477|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
145642572|NCT03807778|525208478|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
145642573|NCT02769858|525208479|FG000|Overall Study|Withdrawal by Subject|2|||
145642574|NCT03783026|525209588|FG000|Treatment Phase|Adverse Event|15|||
145642575|NCT03783026|525209588|FG000|Treatment Phase|Lack of Efficacy|11|||
145642576|NCT03783026|525209588|FG000|Treatment Phase|Withdrawal by Subject|6|||
145642577|NCT03783026|525209588|FG000|Treatment Phase|Lost to Follow-up|2|||
145642578|NCT03783026|525209588|FG000|Treatment Phase|Protocol Deviation|8|||
145642579|NCT03783026|525209588|FG000|Treatment Phase|Did Not Receive Treatment|1|||
145642580|NCT03783026|525209588|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
145642581|NCT01853748|525209592|FG000|Allocation|Withdrawal by Subject|1|||
145642582|NCT01853748|525209593|FG001|Allocation|Withdrawal by Subject|13|||
145642583|NCT01853748|525209592|FG000|Allocation|not sufficient to receive intervention|0|||
145642584|NCT01853748|525209593|FG001|Allocation|not sufficient to receive intervention|1|||
145642585|NCT01853748|525209592|FG000|Follow-Up|Withdrawal by Subject|7|||
145642586|NCT01853748|525209593|FG001|Follow-Up|Withdrawal by Subject|6|||
145642587|NCT01853748|525209592|FG000|Follow-Up|Adverse Event|67|||
145642588|NCT01853748|525209593|FG001|Follow-Up|Adverse Event|7|||
145642589|NCT01853748|525209592|FG000|Follow-Up|not available for data collection|16|||
145642590|NCT01853748|525209593|FG001|Follow-Up|not available for data collection|4|||
145642591|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
145642592|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
145642593|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
145642594|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
145642595|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
145642596|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
145642597|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
145642598|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
145642599|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
145642600|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
145642601|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
145642602|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
145642603|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
145642604|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
145642605|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
145642606|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
145642607|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
145642608|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
145642609|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
145642610|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
145642611|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
145642612|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
145642613|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
145642614|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
145642615|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
145642616|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
145642617|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
145642618|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
145642619|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
145642620|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
145642621|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
145642622|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
145642623|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
145642624|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
145642625|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
145642626|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
145642627|NCT04043455|525209595|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
145486361|NCT03922581|524634996|FG000|Overall Study|Physician Decision|1|||
145486362|NCT03922581|524634997|FG001|Overall Study|Physician Decision|1|||
145486363|NCT03922581|524634996|FG000|Overall Study|Withdrawal by Subject|1|||
145486364|NCT03922581|524634997|FG001|Overall Study|Withdrawal by Subject|0|||
145486365|NCT00764699|524634998|FG000|Overall Study|PI left and study terminated|3|||
145642628|NCT04043455|525209596|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
145642629|NCT04043455|525209597|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
145642630|NCT04043455|525209598|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
145642631|NCT04043455|525209599|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
145642632|NCT04043455|525209600|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
145642633|NCT04043455|525209595|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
145642634|NCT04043455|525209596|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
145642635|NCT04043455|525209597|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
145642636|NCT04043455|525209598|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
145642637|NCT04043455|525209599|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
145642638|NCT04043455|525209600|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
145642639|NCT04043455|525209595|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
145642640|NCT04043455|525209596|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
145642641|NCT04043455|525209597|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
145642642|NCT04043455|525209598|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
145642643|NCT04043455|525209599|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
145642644|NCT04043455|525209600|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
145642645|NCT04043455|525209595|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
145642646|NCT04043455|525209596|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
145642647|NCT04043455|525209597|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
145642648|NCT04043455|525209598|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
145642649|NCT04043455|525209599|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
145642650|NCT04043455|525209600|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
145642651|NCT04043455|525209595|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
145642652|NCT04043455|525209596|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
145642653|NCT04043455|525209597|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
145642654|NCT04043455|525209598|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
145642655|NCT04043455|525209599|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
145642656|NCT04043455|525209600|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
145642657|NCT01643070|525209603|FG000|Overall Study|Withdrawal by Subject|3|||
145642658|NCT01643070|525209604|FG001|Overall Study|Withdrawal by Subject|1|||
145642659|NCT01643070|525209603|FG000|Overall Study|Death|1|||
145642660|NCT01643070|525209604|FG001|Overall Study|Death|0|||
145642661|NCT01643070|525209603|FG000|Overall Study|Pregressive disease|0|||
145642662|NCT01643070|525209604|FG001|Overall Study|Pregressive disease|2|||
145642663|NCT04941287|525209605|FG000|Overall Study|Rapid decline before starting treatment|3|||
145642664|NCT04941287|525209606|FG001|Overall Study|Rapid decline before starting treatment|1|||
145642665|NCT02980276|525209607|FG000|Overall Study|Withdrawal by Subject|4|||
145642666|NCT02980276|525209608|FG001|Overall Study|Withdrawal by Subject|4|||
145642667|NCT02980276|525209607|FG000|Overall Study|Physician Decision|0|||
145642668|NCT02980276|525209608|FG001|Overall Study|Physician Decision|1|||
145642669|NCT02980276|525209607|FG000|Overall Study|Lost to Follow-up|18|||
145642670|NCT02980276|525209608|FG001|Overall Study|Lost to Follow-up|18|||
145642671|NCT02980276|525209607|FG000|Overall Study|Death|1|||
145642672|NCT02980276|525209608|FG001|Overall Study|Death|0|||
145642673|NCT02980276|525209607|FG000|Overall Study|Miscellaneous other|10|||
145642674|NCT02980276|525209608|FG001|Overall Study|Miscellaneous other|4|||
145642675|NCT01998984|525209609|FG000|Overall Study|Adverse Event|0|||
145642676|NCT01998984|525209610|FG001|Overall Study|Adverse Event|0|||
145642677|NCT01998984|525209611|FG002|Overall Study|Adverse Event|0|||
145642678|NCT01998984|525209612|FG003|Overall Study|Adverse Event|1|||
145642679|NCT01998984|525209609|FG000|Overall Study|Lost to Follow-up|0|||
145642680|NCT01998984|525209610|FG001|Overall Study|Lost to Follow-up|1|||
145642681|NCT01998984|525209611|FG002|Overall Study|Lost to Follow-up|0|||
145642682|NCT01998984|525209612|FG003|Overall Study|Lost to Follow-up|1|||
145642683|NCT01998984|525209609|FG000|Overall Study|Withdrawal by Subject|0|||
145642684|NCT01998984|525209610|FG001|Overall Study|Withdrawal by Subject|0|||
145642685|NCT01998984|525209611|FG002|Overall Study|Withdrawal by Subject|1|||
145642686|NCT01998984|525209612|FG003|Overall Study|Withdrawal by Subject|0|||
145642687|NCT01998984|525209609|FG000|Overall Study|Other|0|||
145642688|NCT01998984|525209610|FG001|Overall Study|Other|0|||
145642689|NCT01998984|525209611|FG002|Overall Study|Other|0|||
145642690|NCT01998984|525209612|FG003|Overall Study|Other|1|||
145642691|NCT00818246|525209613|FG000|Overall Study|Impossible to match pictures|5|||
145486366|NCT01508312|524635004|FG000|Overall Study|Lost to Follow-up|1|||
145642692|NCT01007396|525209615|FG000|Overall Study|Lost to Follow-up|47|||
145642693|NCT00296036|525209616|FG000|Overall Study|Withdrawal by Subject|1|||
145642694|NCT00296036|525209617|FG001|Overall Study|Withdrawal by Subject|0|||
145642695|NCT00296036|525209618|FG002|Overall Study|Withdrawal by Subject|2|||
145642696|NCT00296036|525209619|FG003|Overall Study|Withdrawal by Subject|1|||
145642697|NCT00296036|525209620|FG004|Overall Study|Withdrawal by Subject|2|||
145642698|NCT00296036|525209621|FG005|Overall Study|Withdrawal by Subject|1|||
145642699|NCT00296036|525209616|FG000|Overall Study|Protocol Violation|0|||
145642700|NCT00296036|525209617|FG001|Overall Study|Protocol Violation|0|||
145642701|NCT00296036|525209618|FG002|Overall Study|Protocol Violation|0|||
145642702|NCT00296036|525209619|FG003|Overall Study|Protocol Violation|0|||
145642703|NCT00296036|525209620|FG004|Overall Study|Protocol Violation|0|||
145642704|NCT00296036|525209621|FG005|Overall Study|Protocol Violation|3|||
145642705|NCT03403413|525209622|FG000|Overall Study|Lack of Efficacy|2|||
145642706|NCT03655262|525209623|FG000|Overall Study|Withdrawal by Subject|0|||
145642707|NCT03655262|525209624|FG001|Overall Study|Withdrawal by Subject|0|||
145642708|NCT03655262|525209625|FG002|Overall Study|Withdrawal by Subject|1|||
145642709|NCT05052996|525209629|FG000|Overall Study|Still on study|0|||
145642710|NCT05052996|525209630|FG001|Overall Study|Still on study|0|||
145642711|NCT05052996|525209631|FG002|Overall Study|Still on study|47|||
145642712|NCT05052996|525209632|FG003|Overall Study|Still on study|44|||
145642713|NCT05052996|525209629|FG000|Overall Study|Cohort terminated by sponsor|21|||
145642714|NCT05052996|525209630|FG001|Overall Study|Cohort terminated by sponsor|12|||
145642715|NCT05052996|525209631|FG002|Overall Study|Cohort terminated by sponsor|0|||
145642716|NCT05052996|525209632|FG003|Overall Study|Cohort terminated by sponsor|0|||
145642717|NCT05052996|525209629|FG000|Overall Study|Withdrew consent|1|||
145642718|NCT05052996|525209630|FG001|Overall Study|Withdrew consent|0|||
145642719|NCT05052996|525209631|FG002|Overall Study|Withdrew consent|1|||
145642720|NCT05052996|525209632|FG003|Overall Study|Withdrew consent|2|||
145642721|NCT05052996|525209629|FG000|Overall Study|Lost to Follow-up|1|||
145642722|NCT05052996|525209630|FG001|Overall Study|Lost to Follow-up|0|||
145642723|NCT05052996|525209631|FG002|Overall Study|Lost to Follow-up|0|||
145642724|NCT05052996|525209632|FG003|Overall Study|Lost to Follow-up|2|||
145642725|NCT05052996|525209629|FG000|Overall Study|Adverse Event|0|||
145642726|NCT05052996|525209630|FG001|Overall Study|Adverse Event|0|||
145642727|NCT05052996|525209631|FG002|Overall Study|Adverse Event|2|||
145642728|NCT05052996|525209632|FG003|Overall Study|Adverse Event|0|||
145642729|NCT05052996|525209629|FG000|Overall Study|Randomized but never treated|0|||
145642730|NCT05052996|525209630|FG001|Overall Study|Randomized but never treated|0|||
145642731|NCT05052996|525209631|FG002|Overall Study|Randomized but never treated|1|||
145642732|NCT05052996|525209632|FG003|Overall Study|Randomized but never treated|1|||
145642733|NCT05052996|525209629|FG000|Overall Study|Protocol Violation|1|||
145642734|NCT05052996|525209630|FG001|Overall Study|Protocol Violation|0|||
145642735|NCT05052996|525209631|FG002|Overall Study|Protocol Violation|0|||
145642736|NCT05052996|525209632|FG003|Overall Study|Protocol Violation|0|||
145642737|NCT03951805|525209633|FG000|Overall Study|Adverse Event|1|||
145642738|NCT03951805|525209634|FG001|Overall Study|Adverse Event|0|||
145642739|NCT03951805|525209635|FG002|Overall Study|Adverse Event|0|||
145642740|NCT03951805|525209636|FG003|Overall Study|Adverse Event|0|||
145642741|NCT05782231|525209638|FG000|Overall Study|Withdrawal by Subject|1|||
145642742|NCT01198145|525209639|FG000|Overall Study|Withdrawal by Subject|1|||
145642743|NCT01198145|525209640|FG001|Overall Study|Withdrawal by Subject|1|||
145642744|NCT03830866|525209641|FG000|Overall Study|Death|90|||
145642745|NCT03830866|525209642|FG001|Overall Study|Death|111|||
145642746|NCT03830866|525209641|FG000|Overall Study|Lost to Follow-up|7|||
145642747|NCT03830866|525209642|FG001|Overall Study|Lost to Follow-up|7|||
145642748|NCT03830866|525209641|FG000|Overall Study|Withdrawal by Subject|19|||
145642749|NCT03830866|525209642|FG001|Overall Study|Withdrawal by Subject|16|||
145642750|NCT03830866|525209641|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
145642751|NCT03830866|525209642|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
145642752|NCT03830866|525209641|FG000|Overall Study|Other|1|||
145642753|NCT03830866|525209642|FG001|Overall Study|Other|1|||
145642754|NCT00510887|525209644|FG000|Overall Study|Lost to Follow-up|1|||
145642755|NCT01561989|525209645|FG000|Overall Study|accural target not met.|5|||
145642756|NCT01561989|525209646|FG001|Overall Study|accural target not met.|6|||
145642757|NCT01736215|525209647|FG000|Overall Study|Early termination of erythropoietin use|1|||
145642758|NCT01736215|525209647|FG000|Overall Study|Adverse Event|4|||
145642759|NCT01736215|525209647|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
145642760|NCT01736215|525209647|FG000|Overall Study|Insufficient data to perform analysis|8|||
145642761|NCT03447249|525209648|FG000|Overall Study|Adverse Event|1|||
145642762|NCT03447249|525209649|FG001|Overall Study|Adverse Event|0|||
145642763|NCT03447249|525209648|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
145642764|NCT03447249|525209649|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
145642765|NCT03447249|525209648|FG000|Overall Study|Other|3|||
145642766|NCT03447249|525209649|FG001|Overall Study|Other|0|||
145642767|NCT01248936|525209650|FG000|Overall Study|Sponsor Decision|259|||
145642768|NCT01248936|525209650|FG000|Overall Study|Progression of Disease|50|||
145642769|NCT01248936|525209650|FG000|Overall Study|Death|26|||
145642770|NCT01248936|525209650|FG000|Overall Study|Withdrawal of Consent|20|||
145642771|NCT01248936|525209650|FG000|Overall Study|Adverse Event|8|||
145642772|NCT01248936|525209650|FG000|Overall Study|Lost to Follow-up|7|||
145642773|NCT01248936|525209650|FG000|Overall Study|Refused Treatment|1|||
145642774|NCT01248936|525209650|FG000|Overall Study|Other reason|3|||
145642775|NCT03485950|525209651|FG000|Overall Study|Adverse Event|1|||
145642776|NCT03485950|525209652|FG001|Overall Study|Adverse Event|0|||
145642777|NCT03485950|525209651|FG000|Overall Study|Death|3|||
145642778|NCT03485950|525209652|FG001|Overall Study|Death|2|||
145642779|NCT03485950|525209651|FG000|Overall Study|Withdrawal by Subject|3|||
145642780|NCT03485950|525209652|FG001|Overall Study|Withdrawal by Subject|0|||
145642781|NCT00988858|525209653|FG000|Overall Study|Adverse Event|7|||
145642782|NCT00988858|525209653|FG000|Overall Study|Death|1|||
145642783|NCT00988858|525209653|FG000|Overall Study|Physician Decision|1|||
145642784|NCT00988858|525209653|FG000|Overall Study|Sponsor Decision|1|||
145642785|NCT00580866|525209654|FG000|Overall Study|Lost to Follow-up|2|||
145642786|NCT00580866|525209655|FG001|Overall Study|Lost to Follow-up|2|||
145642787|NCT00609336|525209656|FG000|Overall Study|Protocol Violation|3|||
145642788|NCT00609336|525209656|FG000|Overall Study|Death|1|||
145642789|NCT00609336|525209656|FG000|Overall Study|LA or Met at Surgery|9|||
145642790|NCT00390299|525209657|FG000|Overall Study|Cancellation|1|||
145642791|NCT00390299|525209658|FG001|Overall Study|Cancellation|0|||
145642792|NCT00390299|525209659|FG002|Overall Study|Cancellation|0|||
145642793|NCT00390299|525209660|FG003|Overall Study|Cancellation|0|||
145642794|NCT00390299|525209661|FG004|Overall Study|Cancellation|0|||
145642795|NCT00068601|525209662|FG000|Overall Study|Ineligible|11|||
145642796|NCT00068601|525209663|FG001|Overall Study|Ineligible|13|||
145642797|NCT00068601|525209662|FG000|Overall Study|Not evaluable: withdrew consent|5|||
145642798|NCT00068601|525209663|FG001|Overall Study|Not evaluable: withdrew consent|4|||
145642799|NCT00068601|525209662|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
145642800|NCT00068601|525209663|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
145642801|NCT00068601|525209662|FG000|Overall Study|Death|11|||
145642802|NCT00068601|525209663|FG001|Overall Study|Death|3|||
145642803|NCT00068601|525209662|FG000|Overall Study|Lost to Follow-up|3|||
145642804|NCT00068601|525209663|FG001|Overall Study|Lost to Follow-up|2|||
145642805|NCT00068601|525209662|FG000|Overall Study|Missing primary outcome data|30|||
145642806|NCT00068601|525209663|FG001|Overall Study|Missing primary outcome data|34|||
145642807|NCT02692417|525209674|FG000|Overall Study|Withdrawal by Subject|5|||
145642808|NCT02692417|525209675|FG001|Overall Study|Withdrawal by Subject|1|||
145642809|NCT02692417|525209674|FG000|Overall Study|Adverse Event|1|||
145642810|NCT02692417|525209675|FG001|Overall Study|Adverse Event|0|||
145642811|NCT01803555|525209684|FG000|Overall Study|Adverse Event|3|||
145642812|NCT01803555|525209685|FG001|Overall Study|Adverse Event|2|||
145642813|NCT01803555|525209684|FG000|Overall Study|Withdrawal by Subject|3|||
145642814|NCT01803555|525209685|FG001|Overall Study|Withdrawal by Subject|3|||
145642815|NCT01803555|525209684|FG000|Overall Study|Non-compliance|1|||
145642816|NCT01803555|525209685|FG001|Overall Study|Non-compliance|1|||
145642817|NCT01803555|525209684|FG000|Overall Study|Protocol Violation|3|||
145642818|NCT01803555|525209685|FG001|Overall Study|Protocol Violation|5|||
145642819|NCT01803555|525209684|FG000|Overall Study|Lost to Follow-up|0|||
145642820|NCT01803555|525209685|FG001|Overall Study|Lost to Follow-up|2|||
145642821|NCT01803555|525209684|FG000|Overall Study|Other than specified|3|||
145642822|NCT01803555|525209685|FG001|Overall Study|Other than specified|5|||
145642823|NCT01551355|525209686|FG000|Overall Study|Lost to Follow-up|51|||
145642824|NCT01551355|525209687|FG001|Overall Study|Lost to Follow-up|49|||
145642825|NCT01551355|525209688|FG002|Overall Study|Lost to Follow-up|34|||
145642826|NCT01551355|525209689|FG003|Overall Study|Lost to Follow-up|24|||
145642827|NCT01551355|525209690|FG004|Overall Study|Lost to Follow-up|9|||
145642828|NCT01551355|525209691|FG005|Overall Study|Lost to Follow-up|6|||
145642829|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
145642830|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
145486367|NCT01508312|524635005|FG001|Overall Study|Lost to Follow-up|0|||
145486368|NCT01508312|524635006|FG002|Overall Study|Lost to Follow-up|0|||
145486369|NCT01508312|524635007|FG003|Overall Study|Lost to Follow-up|0|||
145486370|NCT01508312|524635004|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
145486371|NCT01508312|524635005|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
145642831|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
145642832|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
145642833|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
145642834|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
145642835|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
145642836|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
145642837|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
145642838|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
145642839|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
145642840|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
145642841|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
145642842|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
145642843|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
145642844|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
145642845|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
145642846|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
145642847|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
145642848|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
145642849|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
145642850|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
145642851|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
145642852|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
145642853|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
145642854|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
145642855|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
145642856|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
145642857|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
145642858|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
145642859|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
145642860|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
145642861|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
145642862|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
145642863|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
145642864|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
145642865|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
145642866|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
145642867|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
145642868|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
145642869|NCT02409667|525209692|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
145642870|NCT02409667|525209693|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
145642871|NCT02409667|525209694|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
145642872|NCT02409667|525209695|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
145642873|NCT02409667|525209696|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
145642874|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
145642875|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
145642876|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
145642877|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
145642878|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
145642879|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
145642880|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
145642881|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
145642882|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
145642883|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
145642884|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
145642885|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
145642886|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
145642887|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
145642888|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
145642889|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
145642890|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
145642891|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
145642892|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
145642893|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
145642894|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
145642895|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
145642896|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
145642897|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
145642898|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
145642899|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
145642900|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
145642901|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
145642902|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
145642903|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
145642904|NCT02409667|525209692|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
145642905|NCT02409667|525209693|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
145642906|NCT02409667|525209694|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
145642907|NCT02409667|525209695|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
145642908|NCT02409667|525209696|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
145642909|NCT03892564|525209697|FG000|Overall Study|Withdrawal by Subject|2|||
145642910|NCT03997916|525209698|FG000|Overall Study|Protocol Violation|35|||
145642911|NCT01207492|525209701|FG000|Overall Study|Still on study|1|||
145642912|NCT01207492|525209701|FG000|Overall Study|Withdrawal by Subject|9|||
145642913|NCT01207492|525209701|FG000|Overall Study|Physician Decision|1|||
145642914|NCT01207492|525209701|FG000|Overall Study|Progressive disease|3|||
145642915|NCT01207492|525209701|FG000|Overall Study|Toxicity|1|||
145642916|NCT05094141|525209703|FG000|Overall Study|Death|0|||
145642917|NCT05094141|525209704|FG001|Overall Study|Death|0|||
145642918|NCT05094141|525209705|FG002|Overall Study|Death|1|||
145642919|NCT05094141|525209703|FG000|Overall Study|Withdrawal by Subject|0|||
145642920|NCT05094141|525209704|FG001|Overall Study|Withdrawal by Subject|0|||
145642921|NCT05094141|525209705|FG002|Overall Study|Withdrawal by Subject|1|||
145642922|NCT05094141|525209703|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
145642923|NCT05094141|525209704|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
145642924|NCT05094141|525209705|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
145642925|NCT05094141|525209703|FG000|Overall Study|Did not participate in randomization|0|||
145642926|NCT05094141|525209704|FG001|Overall Study|Did not participate in randomization|0|||
145642927|NCT05094141|525209705|FG002|Overall Study|Did not participate in randomization|33|||
145642928|NCT04814186|525211746|FG000|Treatment Phase|Adverse Event|1|||
145642929|NCT04814186|525211746|FG000|Treatment Phase|Death|6|||
145642930|NCT04814186|525211746|FG000|Treatment Phase|Withdrawal by Subject|2|||
145642931|NCT04814186|525211746|FG000|Treatment Phase|Other|1|||
145642932|NCT04814186|525211746|FG000|Follow-Up Phase|Adverse Event|1|||
145642933|NCT04814186|525211746|FG000|Follow-Up Phase|Death|6|||
145642934|NCT04814186|525211746|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
145642935|NCT04814186|525211746|FG000|Follow-Up Phase|Other|1|||
145642936|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
145642937|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
145642938|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
145642939|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
145642940|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
145642941|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
145642942|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
145642943|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
145642944|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
145642945|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
145642946|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
145642947|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
145642948|NCT01600014|525211751|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
145642949|NCT01600014|525211752|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
145642950|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
145642951|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
145642952|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
145642953|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
145642954|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
145642955|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
145642956|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
145642957|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
145642958|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
145642959|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
145642960|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
145642961|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
145642962|NCT01600014|525211751|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
145642963|NCT01600014|525211752|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
145642964|NCT01600014|525211751|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
145642965|NCT01600014|525211752|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
145642966|NCT01600014|525211751|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
145642967|NCT01600014|525211752|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
145642968|NCT01600014|525211751|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
145642969|NCT01600014|525211752|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
145642970|NCT04278586|525211755|FG000|Overall Study|Withdrawal by Subject|13|||
145642971|NCT04278586|525211756|FG001|Overall Study|Withdrawal by Subject|6|||
145642972|NCT04278586|525211755|FG000|Overall Study|Lost to Follow-up|37|||
145642973|NCT04278586|525211756|FG001|Overall Study|Lost to Follow-up|24|||
145642974|NCT02791230|525211757|FG000|Overall Study|Adverse Event|10|||
145642975|NCT02791230|525211758|FG001|Overall Study|Adverse Event|9|||
145642976|NCT02791230|525211759|FG002|Overall Study|Adverse Event|66|||
145642977|NCT02791230|525211757|FG000|Overall Study|Death|38|||
145642978|NCT02791230|525211758|FG001|Overall Study|Death|25|||
145642979|NCT02791230|525211759|FG002|Overall Study|Death|184|||
145642980|NCT02791230|525211757|FG000|Overall Study|Lack of Efficacy|1|||
145642981|NCT02791230|525211758|FG001|Overall Study|Lack of Efficacy|0|||
145642982|NCT02791230|525211759|FG002|Overall Study|Lack of Efficacy|3|||
145642983|NCT02791230|525211757|FG000|Overall Study|Lost to Follow-up|0|||
145642984|NCT02791230|525211758|FG001|Overall Study|Lost to Follow-up|0|||
145642985|NCT02791230|525211759|FG002|Overall Study|Lost to Follow-up|10|||
145642986|NCT02791230|525211757|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
145642987|NCT02791230|525211758|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
145642988|NCT02791230|525211759|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
145642989|NCT02791230|525211757|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
145642990|NCT02791230|525211758|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
145642991|NCT02791230|525211759|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
145642992|NCT02791230|525211757|FG000|Overall Study|Study sites terminated by sponsor|1|||
145642993|NCT02791230|525211758|FG001|Overall Study|Study sites terminated by sponsor|0|||
145642994|NCT02791230|525211759|FG002|Overall Study|Study sites terminated by sponsor|5|||
145642995|NCT02791230|525211757|FG000|Overall Study|Other|9|||
145642996|NCT02791230|525211758|FG001|Overall Study|Other|1|||
145642997|NCT02791230|525211759|FG002|Overall Study|Other|28|||
145642998|NCT02791230|525211757|FG000|Overall Study|Protocol Violation|0|||
145642999|NCT02791230|525211758|FG001|Overall Study|Protocol Violation|0|||
145643000|NCT02791230|525211759|FG002|Overall Study|Protocol Violation|4|||
145643001|NCT02791230|525211757|FG000|Overall Study|Withdrawal by Subject|24|||
145643002|NCT02791230|525211758|FG001|Overall Study|Withdrawal by Subject|13|||
145643003|NCT02791230|525211759|FG002|Overall Study|Withdrawal by Subject|172|||
145643004|NCT02791230|525211757|FG000|Overall Study|Enrolled but not treated|0|||
145643005|NCT02791230|525211758|FG001|Overall Study|Enrolled but not treated|0|||
145643006|NCT02791230|525211759|FG002|Overall Study|Enrolled but not treated|5|||
145643007|NCT03025789|525211770|FG000|Overall Study|Lack of Efficacy|6|||
145643008|NCT03025789|525211771|FG001|Overall Study|Lack of Efficacy|1|||
145643009|NCT03025789|525211770|FG000|Overall Study|Death|1|||
145643010|NCT03025789|525211771|FG001|Overall Study|Death|0|||
145643011|NCT03025789|525211770|FG000|Overall Study|Withdrawal by Subject|0|||
145643012|NCT03025789|525211771|FG001|Overall Study|Withdrawal by Subject|2|||
145643013|NCT02723955|525211772|FG000|Escalation Phase|Death|1|||
145643014|NCT02723955|525211773|FG001|Escalation Phase|Death|1|||
145643015|NCT02723955|525211774|FG002|Escalation Phase|Death|2|||
145643016|NCT02723955|525211775|FG003|Escalation Phase|Death|7|||
145643017|NCT02723955|525211776|FG004|Escalation Phase|Death|18|||
145643018|NCT02723955|525211777|FG005|Escalation Phase|Death|17|||
145643019|NCT02723955|525211778|FG006|Escalation Phase|Death|11|||
145643020|NCT02723955|525211779|FG007|Escalation Phase|Death|21|||
145643021|NCT02723955|525211780|FG008|Escalation Phase|Death|3|||
145643022|NCT02723955|525211781|FG009|Escalation Phase|Death|0|||
145643023|NCT02723955|525211782|FG010|Escalation Phase|Death|0|||
145643024|NCT02723955|525211783|FG011|Escalation Phase|Death|0|||
145643025|NCT02723955|525211784|FG012|Escalation Phase|Death|2|||
145643026|NCT02723955|525211785|FG013|Escalation Phase|Death|4|||
145643027|NCT02723955|525211786|FG014|Escalation Phase|Death|5|||
145643028|NCT02723955|525211787|FG015|Escalation Phase|Death|6|||
145643029|NCT02723955|525211788|FG016|Escalation Phase|Death|6|||
145643030|NCT02723955|525211789|FG017|Escalation Phase|Death|7|||
145643031|NCT02723955|525211790|FG018|Escalation Phase|Death|1|||
145643032|NCT02723955|525211791|FG019|Escalation Phase|Death|3|||
145643033|NCT02723955|525211792|FG020|Escalation Phase|Death|13|||
145643034|NCT02723955|525211793|FG021|Escalation Phase|Death|3|||
145643035|NCT02723955|525211794|FG022|Escalation Phase|Death|2|||
145643036|NCT02723955|525211795|FG023|Escalation Phase|Death|4|||
145643037|NCT02723955|525211796|FG024|Escalation Phase|Death|31|||
145643038|NCT02723955|525211797|FG025|Escalation Phase|Death|7|||
145643039|NCT02723955|525211798|FG026|Escalation Phase|Death|13|||
145643040|NCT02723955|525211799|FG027|Escalation Phase|Death|0|||
145643041|NCT02723955|525211800|FG028|Escalation Phase|Death|1|||
145643042|NCT02723955|525211801|FG029|Escalation Phase|Death|0|||
145643043|NCT02723955|525211802|FG030|Escalation Phase|Death|0|||
145265305|NCT03323034|523819272|FG001|Overall Study|Physician Decision|0|||
145643044|NCT02723955|525211803|FG031|Escalation Phase|Death|0|||
145643045|NCT02723955|525211804|FG032|Escalation Phase|Death|0|||
145643046|NCT02723955|525211805|FG033|Escalation Phase|Death|0|||
145643047|NCT02723955|525211806|FG034|Escalation Phase|Death|0|||
145643048|NCT02723955|525211807|FG035|Escalation Phase|Death|0|||
145643049|NCT02723955|525211808|FG036|Escalation Phase|Death|0|||
145643050|NCT02723955|525211809|FG037|Escalation Phase|Death|0|||
145643051|NCT02723955|525211810|FG038|Escalation Phase|Death|0|||
145643052|NCT02723955|525211811|FG039|Escalation Phase|Death|0|||
145643053|NCT02723955|525211812|FG040|Escalation Phase|Death|0|||
145643054|NCT02723955|525211813|FG041|Escalation Phase|Death|0|||
145643055|NCT02723955|525211814|FG042|Escalation Phase|Death|0|||
145643056|NCT02723955|525211772|FG000|Escalation Phase|Lost to Follow-up|0|||
145643057|NCT02723955|525211773|FG001|Escalation Phase|Lost to Follow-up|0|||
145643058|NCT02723955|525211774|FG002|Escalation Phase|Lost to Follow-up|0|||
145643059|NCT02723955|525211775|FG003|Escalation Phase|Lost to Follow-up|0|||
145643060|NCT02723955|525211776|FG004|Escalation Phase|Lost to Follow-up|0|||
145643061|NCT02723955|525211777|FG005|Escalation Phase|Lost to Follow-up|2|||
145643062|NCT02723955|525211778|FG006|Escalation Phase|Lost to Follow-up|1|||
145643063|NCT02723955|525211779|FG007|Escalation Phase|Lost to Follow-up|1|||
145643064|NCT02723955|525211780|FG008|Escalation Phase|Lost to Follow-up|1|||
145643065|NCT02723955|525211781|FG009|Escalation Phase|Lost to Follow-up|0|||
145643066|NCT02723955|525211782|FG010|Escalation Phase|Lost to Follow-up|0|||
145643067|NCT02723955|525211783|FG011|Escalation Phase|Lost to Follow-up|0|||
145643068|NCT02723955|525211784|FG012|Escalation Phase|Lost to Follow-up|1|||
145643069|NCT02723955|525211785|FG013|Escalation Phase|Lost to Follow-up|0|||
145643070|NCT02723955|525211786|FG014|Escalation Phase|Lost to Follow-up|0|||
145643071|NCT02723955|525211787|FG015|Escalation Phase|Lost to Follow-up|0|||
145643072|NCT02723955|525211788|FG016|Escalation Phase|Lost to Follow-up|1|||
145643073|NCT02723955|525211789|FG017|Escalation Phase|Lost to Follow-up|2|||
145643074|NCT02723955|525211790|FG018|Escalation Phase|Lost to Follow-up|0|||
145643075|NCT02723955|525211791|FG019|Escalation Phase|Lost to Follow-up|1|||
145643076|NCT02723955|525211792|FG020|Escalation Phase|Lost to Follow-up|2|||
145643077|NCT02723955|525211793|FG021|Escalation Phase|Lost to Follow-up|1|||
145643078|NCT02723955|525211794|FG022|Escalation Phase|Lost to Follow-up|0|||
145643079|NCT02723955|525211795|FG023|Escalation Phase|Lost to Follow-up|0|||
145643080|NCT02723955|525211796|FG024|Escalation Phase|Lost to Follow-up|1|||
145643081|NCT02723955|525211797|FG025|Escalation Phase|Lost to Follow-up|1|||
145643082|NCT02723955|525211798|FG026|Escalation Phase|Lost to Follow-up|3|||
145643083|NCT02723955|525211799|FG027|Escalation Phase|Lost to Follow-up|0|||
145643084|NCT02723955|525211800|FG028|Escalation Phase|Lost to Follow-up|1|||
145643085|NCT02723955|525211801|FG029|Escalation Phase|Lost to Follow-up|0|||
145643086|NCT02723955|525211802|FG030|Escalation Phase|Lost to Follow-up|0|||
145643087|NCT02723955|525211803|FG031|Escalation Phase|Lost to Follow-up|0|||
145643088|NCT02723955|525211804|FG032|Escalation Phase|Lost to Follow-up|0|||
145643089|NCT02723955|525211805|FG033|Escalation Phase|Lost to Follow-up|0|||
145643090|NCT02723955|525211806|FG034|Escalation Phase|Lost to Follow-up|0|||
145643091|NCT02723955|525211807|FG035|Escalation Phase|Lost to Follow-up|0|||
145643092|NCT02723955|525211808|FG036|Escalation Phase|Lost to Follow-up|0|||
145643093|NCT02723955|525211809|FG037|Escalation Phase|Lost to Follow-up|0|||
145643094|NCT02723955|525211810|FG038|Escalation Phase|Lost to Follow-up|0|||
145643095|NCT02723955|525211811|FG039|Escalation Phase|Lost to Follow-up|0|||
145643096|NCT02723955|525211812|FG040|Escalation Phase|Lost to Follow-up|0|||
145643097|NCT02723955|525211813|FG041|Escalation Phase|Lost to Follow-up|0|||
145643098|NCT02723955|525211814|FG042|Escalation Phase|Lost to Follow-up|0|||
145643099|NCT02723955|525211772|FG000|Escalation Phase|Physician Decision|0|||
145643100|NCT02723955|525211773|FG001|Escalation Phase|Physician Decision|0|||
145643101|NCT02723955|525211774|FG002|Escalation Phase|Physician Decision|0|||
145643102|NCT02723955|525211775|FG003|Escalation Phase|Physician Decision|0|||
145643103|NCT02723955|525211776|FG004|Escalation Phase|Physician Decision|0|||
145643104|NCT02723955|525211777|FG005|Escalation Phase|Physician Decision|2|||
145643105|NCT02723955|525211778|FG006|Escalation Phase|Physician Decision|0|||
145643106|NCT02723955|525211779|FG007|Escalation Phase|Physician Decision|0|||
145643107|NCT02723955|525211780|FG008|Escalation Phase|Physician Decision|0|||
145643108|NCT02723955|525211781|FG009|Escalation Phase|Physician Decision|0|||
145643109|NCT02723955|525211782|FG010|Escalation Phase|Physician Decision|0|||
145643110|NCT02723955|525211783|FG011|Escalation Phase|Physician Decision|0|||
145643111|NCT02723955|525211784|FG012|Escalation Phase|Physician Decision|0|||
145486372|NCT01508312|524635006|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
145486373|NCT01508312|524635007|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
145486374|NCT01508312|524635004|FG000|Overall Study|Adverse Event|0|||
145486375|NCT01508312|524635005|FG001|Overall Study|Adverse Event|0|||
145486376|NCT01508312|524635006|FG002|Overall Study|Adverse Event|2|||
145486377|NCT01508312|524635007|FG003|Overall Study|Adverse Event|0|||
145643112|NCT02723955|525211785|FG013|Escalation Phase|Physician Decision|0|||
145643113|NCT02723955|525211786|FG014|Escalation Phase|Physician Decision|0|||
145643114|NCT02723955|525211787|FG015|Escalation Phase|Physician Decision|0|||
145643115|NCT02723955|525211788|FG016|Escalation Phase|Physician Decision|0|||
145643116|NCT02723955|525211789|FG017|Escalation Phase|Physician Decision|0|||
145486378|NCT01508312|524635004|FG000|Overall Study|Lack of Efficacy|0|||
145643117|NCT02723955|525211790|FG018|Escalation Phase|Physician Decision|0|||
145643118|NCT02723955|525211791|FG019|Escalation Phase|Physician Decision|0|||
145643119|NCT02723955|525211792|FG020|Escalation Phase|Physician Decision|0|||
145643120|NCT02723955|525211793|FG021|Escalation Phase|Physician Decision|0|||
145643121|NCT02723955|525211794|FG022|Escalation Phase|Physician Decision|0|||
145643122|NCT02723955|525211795|FG023|Escalation Phase|Physician Decision|0|||
145643123|NCT02723955|525211796|FG024|Escalation Phase|Physician Decision|0|||
145643124|NCT02723955|525211797|FG025|Escalation Phase|Physician Decision|0|||
145643125|NCT02723955|525211798|FG026|Escalation Phase|Physician Decision|2|||
145643126|NCT02723955|525211799|FG027|Escalation Phase|Physician Decision|0|||
145643127|NCT02723955|525211800|FG028|Escalation Phase|Physician Decision|0|||
145643128|NCT02723955|525211801|FG029|Escalation Phase|Physician Decision|0|||
145643129|NCT02723955|525211802|FG030|Escalation Phase|Physician Decision|0|||
145643130|NCT02723955|525211803|FG031|Escalation Phase|Physician Decision|0|||
145643131|NCT02723955|525211804|FG032|Escalation Phase|Physician Decision|0|||
145643132|NCT02723955|525211805|FG033|Escalation Phase|Physician Decision|0|||
145643133|NCT02723955|525211806|FG034|Escalation Phase|Physician Decision|0|||
145643134|NCT02723955|525211807|FG035|Escalation Phase|Physician Decision|0|||
145643135|NCT02723955|525211808|FG036|Escalation Phase|Physician Decision|0|||
145643136|NCT02723955|525211809|FG037|Escalation Phase|Physician Decision|0|||
145643137|NCT02723955|525211810|FG038|Escalation Phase|Physician Decision|0|||
145643138|NCT02723955|525211811|FG039|Escalation Phase|Physician Decision|0|||
145643139|NCT02723955|525211812|FG040|Escalation Phase|Physician Decision|0|||
145643140|NCT02723955|525211813|FG041|Escalation Phase|Physician Decision|0|||
145643141|NCT02723955|525211814|FG042|Escalation Phase|Physician Decision|0|||
145643142|NCT02723955|525211772|FG000|Escalation Phase|Withdrawal by Subject|0|||
145643143|NCT02723955|525211773|FG001|Escalation Phase|Withdrawal by Subject|0|||
145643144|NCT02723955|525211774|FG002|Escalation Phase|Withdrawal by Subject|0|||
145643145|NCT02723955|525211775|FG003|Escalation Phase|Withdrawal by Subject|0|||
145643146|NCT02723955|525211776|FG004|Escalation Phase|Withdrawal by Subject|1|||
145643147|NCT02723955|525211777|FG005|Escalation Phase|Withdrawal by Subject|1|||
145643148|NCT02723955|525211778|FG006|Escalation Phase|Withdrawal by Subject|1|||
145643149|NCT02723955|525211779|FG007|Escalation Phase|Withdrawal by Subject|1|||
145643150|NCT02723955|525211780|FG008|Escalation Phase|Withdrawal by Subject|0|||
145643151|NCT02723955|525211781|FG009|Escalation Phase|Withdrawal by Subject|0|||
145643152|NCT02723955|525211782|FG010|Escalation Phase|Withdrawal by Subject|0|||
145643153|NCT02723955|525211783|FG011|Escalation Phase|Withdrawal by Subject|0|||
145643154|NCT02723955|525211784|FG012|Escalation Phase|Withdrawal by Subject|1|||
145643155|NCT02723955|525211785|FG013|Escalation Phase|Withdrawal by Subject|0|||
145643156|NCT02723955|525211786|FG014|Escalation Phase|Withdrawal by Subject|0|||
145643157|NCT02723955|525211787|FG015|Escalation Phase|Withdrawal by Subject|0|||
145643158|NCT02723955|525211788|FG016|Escalation Phase|Withdrawal by Subject|1|||
145643159|NCT02723955|525211789|FG017|Escalation Phase|Withdrawal by Subject|0|||
145643160|NCT02723955|525211790|FG018|Escalation Phase|Withdrawal by Subject|0|||
145643161|NCT02723955|525211791|FG019|Escalation Phase|Withdrawal by Subject|0|||
145643162|NCT02723955|525211792|FG020|Escalation Phase|Withdrawal by Subject|0|||
145643163|NCT02723955|525211793|FG021|Escalation Phase|Withdrawal by Subject|0|||
145643164|NCT02723955|525211794|FG022|Escalation Phase|Withdrawal by Subject|0|||
145643165|NCT02723955|525211795|FG023|Escalation Phase|Withdrawal by Subject|2|||
145643166|NCT02723955|525211796|FG024|Escalation Phase|Withdrawal by Subject|0|||
145643167|NCT02723955|525211797|FG025|Escalation Phase|Withdrawal by Subject|1|||
145643168|NCT02723955|525211798|FG026|Escalation Phase|Withdrawal by Subject|0|||
145643169|NCT02723955|525211799|FG027|Escalation Phase|Withdrawal by Subject|0|||
145643170|NCT02723955|525211800|FG028|Escalation Phase|Withdrawal by Subject|1|||
145643171|NCT02723955|525211801|FG029|Escalation Phase|Withdrawal by Subject|0|||
145643172|NCT02723955|525211802|FG030|Escalation Phase|Withdrawal by Subject|0|||
145643173|NCT02723955|525211803|FG031|Escalation Phase|Withdrawal by Subject|0|||
145643174|NCT02723955|525211804|FG032|Escalation Phase|Withdrawal by Subject|0|||
145643175|NCT02723955|525211805|FG033|Escalation Phase|Withdrawal by Subject|0|||
145643176|NCT02723955|525211806|FG034|Escalation Phase|Withdrawal by Subject|0|||
145643177|NCT02723955|525211807|FG035|Escalation Phase|Withdrawal by Subject|0|||
145643178|NCT02723955|525211808|FG036|Escalation Phase|Withdrawal by Subject|0|||
145643179|NCT02723955|525211809|FG037|Escalation Phase|Withdrawal by Subject|0|||
145643180|NCT02723955|525211810|FG038|Escalation Phase|Withdrawal by Subject|0|||
145643181|NCT02723955|525211811|FG039|Escalation Phase|Withdrawal by Subject|0|||
145643182|NCT02723955|525211812|FG040|Escalation Phase|Withdrawal by Subject|0|||
145643183|NCT02723955|525211813|FG041|Escalation Phase|Withdrawal by Subject|0|||
145643184|NCT02723955|525211814|FG042|Escalation Phase|Withdrawal by Subject|0|||
145643185|NCT02723955|525211772|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643186|NCT02723955|525211773|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643187|NCT02723955|525211774|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643188|NCT02723955|525211775|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643189|NCT02723955|525211776|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
145643190|NCT02723955|525211777|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
145643191|NCT02723955|525211778|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
145486379|NCT01508312|524635005|FG001|Overall Study|Lack of Efficacy|0|||
145265306|NCT03323034|523819273|FG002|Overall Study|Physician Decision|0|||
145643192|NCT02723955|525211779|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
145643193|NCT02723955|525211780|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
145643194|NCT02723955|525211781|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643195|NCT02723955|525211782|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643196|NCT02723955|525211783|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643197|NCT02723955|525211784|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643198|NCT02723955|525211785|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643199|NCT02723955|525211786|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643200|NCT02723955|525211787|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643201|NCT02723955|525211788|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643202|NCT02723955|525211789|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643203|NCT02723955|525211790|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643204|NCT02723955|525211791|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643205|NCT02723955|525211792|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643206|NCT02723955|525211793|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643207|NCT02723955|525211794|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643208|NCT02723955|525211795|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643209|NCT02723955|525211796|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643210|NCT02723955|525211797|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643211|NCT02723955|525211798|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643212|NCT02723955|525211799|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643213|NCT02723955|525211800|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643214|NCT02723955|525211801|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643215|NCT02723955|525211802|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643216|NCT02723955|525211803|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643217|NCT02723955|525211804|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643218|NCT02723955|525211805|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643219|NCT02723955|525211806|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643220|NCT02723955|525211807|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643221|NCT02723955|525211808|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643222|NCT02723955|525211809|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643223|NCT02723955|525211810|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643224|NCT02723955|525211811|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643225|NCT02723955|525211812|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643226|NCT02723955|525211813|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643227|NCT02723955|525211814|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
145643228|NCT02723955|525211772|FG000|Escalation Phase|Site Closed|0|||
145643229|NCT02723955|525211773|FG001|Escalation Phase|Site Closed|0|||
145643230|NCT02723955|525211774|FG002|Escalation Phase|Site Closed|0|||
145643231|NCT02723955|525211775|FG003|Escalation Phase|Site Closed|0|||
145643232|NCT02723955|525211776|FG004|Escalation Phase|Site Closed|0|||
145643233|NCT02723955|525211777|FG005|Escalation Phase|Site Closed|0|||
145643234|NCT02723955|525211778|FG006|Escalation Phase|Site Closed|0|||
145643235|NCT02723955|525211779|FG007|Escalation Phase|Site Closed|0|||
145643236|NCT02723955|525211780|FG008|Escalation Phase|Site Closed|0|||
145643237|NCT02723955|525211781|FG009|Escalation Phase|Site Closed|0|||
145643238|NCT02723955|525211782|FG010|Escalation Phase|Site Closed|0|||
145643239|NCT02723955|525211783|FG011|Escalation Phase|Site Closed|0|||
145643240|NCT02723955|525211784|FG012|Escalation Phase|Site Closed|0|||
145643241|NCT02723955|525211785|FG013|Escalation Phase|Site Closed|0|||
145643242|NCT02723955|525211786|FG014|Escalation Phase|Site Closed|0|||
145643243|NCT02723955|525211787|FG015|Escalation Phase|Site Closed|1|||
145643244|NCT02723955|525211788|FG016|Escalation Phase|Site Closed|0|||
145643245|NCT02723955|525211789|FG017|Escalation Phase|Site Closed|2|||
145643246|NCT02723955|525211790|FG018|Escalation Phase|Site Closed|0|||
145643247|NCT02723955|525211791|FG019|Escalation Phase|Site Closed|0|||
145643248|NCT02723955|525211792|FG020|Escalation Phase|Site Closed|1|||
145643249|NCT02723955|525211793|FG021|Escalation Phase|Site Closed|0|||
145643250|NCT02723955|525211794|FG022|Escalation Phase|Site Closed|0|||
145643251|NCT02723955|525211795|FG023|Escalation Phase|Site Closed|0|||
145643252|NCT02723955|525211796|FG024|Escalation Phase|Site Closed|3|||
145643253|NCT02723955|525211797|FG025|Escalation Phase|Site Closed|1|||
145643254|NCT02723955|525211798|FG026|Escalation Phase|Site Closed|3|||
145643255|NCT02723955|525211799|FG027|Escalation Phase|Site Closed|1|||
145643256|NCT02723955|525211800|FG028|Escalation Phase|Site Closed|1|||
145643257|NCT02723955|525211801|FG029|Escalation Phase|Site Closed|0|||
145643258|NCT02723955|525211802|FG030|Escalation Phase|Site Closed|0|||
145643259|NCT02723955|525211803|FG031|Escalation Phase|Site Closed|0|||
145643260|NCT02723955|525211804|FG032|Escalation Phase|Site Closed|0|||
145643261|NCT02723955|525211805|FG033|Escalation Phase|Site Closed|0|||
145643262|NCT02723955|525211806|FG034|Escalation Phase|Site Closed|0|||
145643263|NCT02723955|525211807|FG035|Escalation Phase|Site Closed|0|||
145643264|NCT02723955|525211808|FG036|Escalation Phase|Site Closed|0|||
145643265|NCT02723955|525211809|FG037|Escalation Phase|Site Closed|0|||
145643266|NCT02723955|525211810|FG038|Escalation Phase|Site Closed|0|||
145643267|NCT02723955|525211811|FG039|Escalation Phase|Site Closed|0|||
145643268|NCT02723955|525211812|FG040|Escalation Phase|Site Closed|0|||
145643269|NCT02723955|525211813|FG041|Escalation Phase|Site Closed|0|||
145643270|NCT02723955|525211814|FG042|Escalation Phase|Site Closed|0|||
145643271|NCT02723955|525211772|FG000|Expansion Phase|Death|0|||
145643272|NCT02723955|525211773|FG001|Expansion Phase|Death|0|||
145643273|NCT02723955|525211774|FG002|Expansion Phase|Death|0|||
145643274|NCT02723955|525211775|FG003|Expansion Phase|Death|0|||
145643275|NCT02723955|525211776|FG004|Expansion Phase|Death|0|||
145643276|NCT02723955|525211777|FG005|Expansion Phase|Death|0|||
145643277|NCT02723955|525211778|FG006|Expansion Phase|Death|0|||
145643278|NCT02723955|525211779|FG007|Expansion Phase|Death|0|||
145643279|NCT02723955|525211780|FG008|Expansion Phase|Death|0|||
145643280|NCT02723955|525211781|FG009|Expansion Phase|Death|25|||
145643281|NCT02723955|525211782|FG010|Expansion Phase|Death|69|||
145643282|NCT02723955|525211783|FG011|Expansion Phase|Death|48|||
145643283|NCT02723955|525211784|FG012|Expansion Phase|Death|0|||
145643284|NCT02723955|525211785|FG013|Expansion Phase|Death|0|||
145643285|NCT02723955|525211786|FG014|Expansion Phase|Death|0|||
145643286|NCT02723955|525211787|FG015|Expansion Phase|Death|0|||
145643287|NCT02723955|525211788|FG016|Expansion Phase|Death|0|||
145643288|NCT02723955|525211789|FG017|Expansion Phase|Death|0|||
145643289|NCT02723955|525211790|FG018|Expansion Phase|Death|0|||
145643290|NCT02723955|525211791|FG019|Expansion Phase|Death|0|||
145643291|NCT02723955|525211792|FG020|Expansion Phase|Death|0|||
145643292|NCT02723955|525211793|FG021|Expansion Phase|Death|0|||
145643293|NCT02723955|525211794|FG022|Expansion Phase|Death|0|||
145643294|NCT02723955|525211795|FG023|Expansion Phase|Death|0|||
145643295|NCT02723955|525211796|FG024|Expansion Phase|Death|0|||
145643296|NCT02723955|525211797|FG025|Expansion Phase|Death|0|||
145643297|NCT02723955|525211798|FG026|Expansion Phase|Death|0|||
145643298|NCT02723955|525211799|FG027|Expansion Phase|Death|0|||
145643299|NCT02723955|525211800|FG028|Expansion Phase|Death|0|||
145643300|NCT02723955|525211801|FG029|Expansion Phase|Death|12|||
145643301|NCT02723955|525211802|FG030|Expansion Phase|Death|202|||
145643302|NCT02723955|525211803|FG031|Expansion Phase|Death|31|||
145643303|NCT02723955|525211804|FG032|Expansion Phase|Death|17|||
145643304|NCT02723955|525211805|FG033|Expansion Phase|Death|2|||
145643305|NCT02723955|525211806|FG034|Expansion Phase|Death|3|||
145643306|NCT02723955|525211807|FG035|Expansion Phase|Death|3|||
145643307|NCT02723955|525211808|FG036|Expansion Phase|Death|1|||
145643308|NCT02723955|525211809|FG037|Expansion Phase|Death|0|||
145643309|NCT02723955|525211810|FG038|Expansion Phase|Death|0|||
145486380|NCT01508312|524635006|FG002|Overall Study|Lack of Efficacy|1|||
145486381|NCT01508312|524635007|FG003|Overall Study|Lack of Efficacy|0|||
145486382|NCT01508312|524635004|FG000|Overall Study|Withdrawal by Subject|0|||
145486383|NCT01508312|524635005|FG001|Overall Study|Withdrawal by Subject|0|||
145643310|NCT02723955|525211811|FG039|Expansion Phase|Death|0|||
145643311|NCT02723955|525211812|FG040|Expansion Phase|Death|0|||
145643312|NCT02723955|525211813|FG041|Expansion Phase|Death|0|||
145643313|NCT02723955|525211814|FG042|Expansion Phase|Death|0|||
145643314|NCT02723955|525211772|FG000|Expansion Phase|Lost to Follow-up|0|||
145643315|NCT02723955|525211773|FG001|Expansion Phase|Lost to Follow-up|0|||
145643316|NCT02723955|525211774|FG002|Expansion Phase|Lost to Follow-up|0|||
145643317|NCT02723955|525211775|FG003|Expansion Phase|Lost to Follow-up|0|||
145643318|NCT02723955|525211776|FG004|Expansion Phase|Lost to Follow-up|0|||
145643319|NCT02723955|525211777|FG005|Expansion Phase|Lost to Follow-up|0|||
145643320|NCT02723955|525211778|FG006|Expansion Phase|Lost to Follow-up|0|||
145643321|NCT02723955|525211779|FG007|Expansion Phase|Lost to Follow-up|0|||
145486384|NCT01508312|524635006|FG002|Overall Study|Withdrawal by Subject|1|||
145643322|NCT02723955|525211780|FG008|Expansion Phase|Lost to Follow-up|0|||
145643323|NCT02723955|525211781|FG009|Expansion Phase|Lost to Follow-up|0|||
145643324|NCT02723955|525211782|FG010|Expansion Phase|Lost to Follow-up|4|||
145643325|NCT02723955|525211783|FG011|Expansion Phase|Lost to Follow-up|1|||
145643326|NCT02723955|525211784|FG012|Expansion Phase|Lost to Follow-up|0|||
145643327|NCT02723955|525211785|FG013|Expansion Phase|Lost to Follow-up|0|||
145643328|NCT02723955|525211786|FG014|Expansion Phase|Lost to Follow-up|0|||
145643329|NCT02723955|525211787|FG015|Expansion Phase|Lost to Follow-up|0|||
145643330|NCT02723955|525211788|FG016|Expansion Phase|Lost to Follow-up|0|||
145643331|NCT02723955|525211789|FG017|Expansion Phase|Lost to Follow-up|0|||
145643332|NCT02723955|525211790|FG018|Expansion Phase|Lost to Follow-up|0|||
145643333|NCT02723955|525211791|FG019|Expansion Phase|Lost to Follow-up|0|||
145643334|NCT02723955|525211792|FG020|Expansion Phase|Lost to Follow-up|0|||
145643335|NCT02723955|525211793|FG021|Expansion Phase|Lost to Follow-up|0|||
145643336|NCT02723955|525211794|FG022|Expansion Phase|Lost to Follow-up|0|||
145643337|NCT02723955|525211795|FG023|Expansion Phase|Lost to Follow-up|0|||
145643338|NCT02723955|525211796|FG024|Expansion Phase|Lost to Follow-up|0|||
145643339|NCT02723955|525211797|FG025|Expansion Phase|Lost to Follow-up|0|||
145643340|NCT02723955|525211798|FG026|Expansion Phase|Lost to Follow-up|0|||
145643341|NCT02723955|525211799|FG027|Expansion Phase|Lost to Follow-up|0|||
145643342|NCT02723955|525211800|FG028|Expansion Phase|Lost to Follow-up|0|||
145643343|NCT02723955|525211801|FG029|Expansion Phase|Lost to Follow-up|1|||
145643344|NCT02723955|525211802|FG030|Expansion Phase|Lost to Follow-up|19|||
145643345|NCT02723955|525211803|FG031|Expansion Phase|Lost to Follow-up|2|||
145643346|NCT02723955|525211804|FG032|Expansion Phase|Lost to Follow-up|1|||
145643347|NCT02723955|525211805|FG033|Expansion Phase|Lost to Follow-up|0|||
145643348|NCT02723955|525211806|FG034|Expansion Phase|Lost to Follow-up|0|||
145486385|NCT01508312|524635007|FG003|Overall Study|Withdrawal by Subject|0|||
145486386|NCT02223715|524635008|FG000|Overall Study|Death|31|||
145486387|NCT02223715|524635008|FG000|Overall Study|Lost to Follow-up|73|||
145486388|NCT01745367|524635009|FG000|Overall Study|Death|1|||
145486389|NCT01745367|524635010|FG001|Overall Study|Death|0|||
145486390|NCT01745367|524635009|FG000|Overall Study|Withdrawal by Subject|1|||
145486391|NCT01745367|524635010|FG001|Overall Study|Withdrawal by Subject|2|||
145486392|NCT01745367|524635009|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
145486393|NCT01745367|524635010|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
145486394|NCT01745367|524635009|FG000|Overall Study|Other Reasons Unspecified|0|||
145486395|NCT01745367|524635010|FG001|Overall Study|Other Reasons Unspecified|2|||
145486396|NCT00354679|524635013|FG000|Overall Study|Patient Not Treated|1|||
145486397|NCT03906071|524635014|FG000|Overall Study|Death|180|||
145486398|NCT03906071|524635015|FG001|Overall Study|Death|185|||
145486399|NCT03906071|524635014|FG000|Overall Study|Lost to Follow-up|3|||
145486400|NCT03906071|524635015|FG001|Overall Study|Lost to Follow-up|3|||
145486401|NCT03906071|524635014|FG000|Overall Study|Withdrawal by Subject|15|||
145486402|NCT03906071|524635015|FG001|Overall Study|Withdrawal by Subject|27|||
145486403|NCT03906071|524635014|FG000|Overall Study|Other|2|||
145486404|NCT03906071|524635015|FG001|Overall Study|Other|1|||
145486405|NCT01814527|524635016|FG000|Overall Study|RTP greater than 30 days|6|||
145486406|NCT01814527|524635017|FG001|Overall Study|RTP greater than 30 days|1|||
145486407|NCT03571204|524635018|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
145486408|NCT03571204|524635019|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
145486409|NCT03571204|524635020|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
145486410|NCT03571204|524635018|FG000|Overall Study|Physician Decision|0|||
145486411|NCT03571204|524635019|FG001|Overall Study|Physician Decision|1|||
145486412|NCT03571204|524635020|FG002|Overall Study|Physician Decision|0|||
145486413|NCT05114473|524635021|FG000|Overall Study|Lost to Follow-up|2|||
145486414|NCT05114473|524635022|FG001|Overall Study|Lost to Follow-up|2|||
145486415|NCT05114473|524635023|FG002|Overall Study|Lost to Follow-up|0|||
145486416|NCT03359174|524635026|FG000|Overall Study|Adverse Event|1|||
145486417|NCT04445662|524635033|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
145486418|NCT04445662|524635034|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
145486419|NCT04445662|524635033|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
145486420|NCT04445662|524635034|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
145486421|NCT04445662|524635033|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
145643349|NCT02723955|525211807|FG035|Expansion Phase|Lost to Follow-up|0|||
145643350|NCT02723955|525211808|FG036|Expansion Phase|Lost to Follow-up|0|||
145643351|NCT02723955|525211809|FG037|Expansion Phase|Lost to Follow-up|0|||
145486422|NCT04445662|524635034|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
145486423|NCT04445662|524635033|FG000|Post-treatment (12-24 weeks)|Death|1|||
145486424|NCT04445662|524635034|FG001|Post-treatment (12-24 weeks)|Death|0|||
145486425|NCT01332994|524635035|FG000|Overall Study|Adverse Event|34|||
145486426|NCT01332994|524635035|FG000|Overall Study|Death|1|||
145486427|NCT01332994|524635035|FG000|Overall Study|Lack of Efficacy|1|||
145643352|NCT02723955|525211810|FG038|Expansion Phase|Lost to Follow-up|0|||
145643353|NCT02723955|525211811|FG039|Expansion Phase|Lost to Follow-up|0|||
145643354|NCT02723955|525211812|FG040|Expansion Phase|Lost to Follow-up|0|||
145643355|NCT02723955|525211813|FG041|Expansion Phase|Lost to Follow-up|0|||
145643356|NCT02723955|525211814|FG042|Expansion Phase|Lost to Follow-up|0|||
145643357|NCT02723955|525211772|FG000|Expansion Phase|Physician Decision|0|||
145643358|NCT02723955|525211773|FG001|Expansion Phase|Physician Decision|0|||
145643359|NCT02723955|525211774|FG002|Expansion Phase|Physician Decision|0|||
145486428|NCT01332994|524635035|FG000|Overall Study|Lost to Follow-up|4|||
145486429|NCT01332994|524635035|FG000|Overall Study|Protocol Violation|6|||
145643360|NCT02723955|525211775|FG003|Expansion Phase|Physician Decision|0|||
145643361|NCT02723955|525211776|FG004|Expansion Phase|Physician Decision|0|||
145643362|NCT02723955|525211777|FG005|Expansion Phase|Physician Decision|0|||
145643363|NCT02723955|525211778|FG006|Expansion Phase|Physician Decision|0|||
145486430|NCT01332994|524635035|FG000|Overall Study|Withdrawal by Subject|15|||
145486431|NCT01332994|524635035|FG000|Overall Study|Administrative Problem|2|||
145486432|NCT01332994|524635035|FG000|Overall Study|Other|8|||
145486433|NCT00279916|524635036|FG000|Overall Study|Withdrawal by Subject|4|||
145643364|NCT02723955|525211779|FG007|Expansion Phase|Physician Decision|0|||
145643365|NCT02723955|525211780|FG008|Expansion Phase|Physician Decision|0|||
145643366|NCT02723955|525211781|FG009|Expansion Phase|Physician Decision|0|||
145643367|NCT02723955|525211782|FG010|Expansion Phase|Physician Decision|0|||
145643368|NCT02723955|525211783|FG011|Expansion Phase|Physician Decision|0|||
145643369|NCT02723955|525211784|FG012|Expansion Phase|Physician Decision|0|||
145643370|NCT02723955|525211785|FG013|Expansion Phase|Physician Decision|0|||
145643371|NCT02723955|525211786|FG014|Expansion Phase|Physician Decision|0|||
145643372|NCT02723955|525211787|FG015|Expansion Phase|Physician Decision|0|||
145643373|NCT02723955|525211788|FG016|Expansion Phase|Physician Decision|0|||
145643374|NCT02723955|525211789|FG017|Expansion Phase|Physician Decision|0|||
145643375|NCT02723955|525211790|FG018|Expansion Phase|Physician Decision|0|||
145643376|NCT02723955|525211791|FG019|Expansion Phase|Physician Decision|0|||
145643377|NCT02723955|525211792|FG020|Expansion Phase|Physician Decision|0|||
145643378|NCT02723955|525211793|FG021|Expansion Phase|Physician Decision|0|||
145643379|NCT02723955|525211794|FG022|Expansion Phase|Physician Decision|0|||
145643380|NCT02723955|525211795|FG023|Expansion Phase|Physician Decision|0|||
145643381|NCT02723955|525211796|FG024|Expansion Phase|Physician Decision|0|||
145643382|NCT02723955|525211797|FG025|Expansion Phase|Physician Decision|0|||
145643383|NCT02723955|525211798|FG026|Expansion Phase|Physician Decision|0|||
145643384|NCT02723955|525211799|FG027|Expansion Phase|Physician Decision|0|||
145643385|NCT02723955|525211800|FG028|Expansion Phase|Physician Decision|0|||
145643386|NCT02723955|525211801|FG029|Expansion Phase|Physician Decision|0|||
145643387|NCT02723955|525211802|FG030|Expansion Phase|Physician Decision|1|||
145643388|NCT02723955|525211803|FG031|Expansion Phase|Physician Decision|1|||
145643389|NCT02723955|525211804|FG032|Expansion Phase|Physician Decision|0|||
145643390|NCT02723955|525211805|FG033|Expansion Phase|Physician Decision|0|||
145643391|NCT02723955|525211806|FG034|Expansion Phase|Physician Decision|0|||
145643392|NCT02723955|525211807|FG035|Expansion Phase|Physician Decision|0|||
145643393|NCT02723955|525211808|FG036|Expansion Phase|Physician Decision|0|||
145643394|NCT02723955|525211809|FG037|Expansion Phase|Physician Decision|0|||
145643395|NCT02723955|525211810|FG038|Expansion Phase|Physician Decision|0|||
145643396|NCT02723955|525211811|FG039|Expansion Phase|Physician Decision|0|||
145643397|NCT02723955|525211812|FG040|Expansion Phase|Physician Decision|0|||
145643398|NCT02723955|525211813|FG041|Expansion Phase|Physician Decision|0|||
145643399|NCT02723955|525211814|FG042|Expansion Phase|Physician Decision|0|||
145643400|NCT02723955|525211772|FG000|Expansion Phase|Withdrawal by Subject|0|||
145643401|NCT02723955|525211773|FG001|Expansion Phase|Withdrawal by Subject|0|||
145643402|NCT02723955|525211774|FG002|Expansion Phase|Withdrawal by Subject|0|||
145643403|NCT02723955|525211775|FG003|Expansion Phase|Withdrawal by Subject|0|||
145643404|NCT02723955|525211776|FG004|Expansion Phase|Withdrawal by Subject|0|||
145643405|NCT02723955|525211777|FG005|Expansion Phase|Withdrawal by Subject|0|||
145643406|NCT02723955|525211778|FG006|Expansion Phase|Withdrawal by Subject|0|||
145643407|NCT02723955|525211779|FG007|Expansion Phase|Withdrawal by Subject|0|||
145643408|NCT02723955|525211780|FG008|Expansion Phase|Withdrawal by Subject|0|||
145643409|NCT02723955|525211781|FG009|Expansion Phase|Withdrawal by Subject|2|||
145643410|NCT02723955|525211782|FG010|Expansion Phase|Withdrawal by Subject|1|||
145643411|NCT02723955|525211783|FG011|Expansion Phase|Withdrawal by Subject|0|||
145643412|NCT02723955|525211784|FG012|Expansion Phase|Withdrawal by Subject|0|||
145643413|NCT02723955|525211785|FG013|Expansion Phase|Withdrawal by Subject|0|||
145643414|NCT02723955|525211786|FG014|Expansion Phase|Withdrawal by Subject|0|||
145643415|NCT02723955|525211787|FG015|Expansion Phase|Withdrawal by Subject|0|||
145643416|NCT02723955|525211788|FG016|Expansion Phase|Withdrawal by Subject|0|||
145643417|NCT02723955|525211789|FG017|Expansion Phase|Withdrawal by Subject|0|||
145643418|NCT02723955|525211790|FG018|Expansion Phase|Withdrawal by Subject|0|||
145643419|NCT02723955|525211791|FG019|Expansion Phase|Withdrawal by Subject|0|||
145643420|NCT02723955|525211792|FG020|Expansion Phase|Withdrawal by Subject|0|||
145643421|NCT02723955|525211793|FG021|Expansion Phase|Withdrawal by Subject|0|||
145643422|NCT02723955|525211794|FG022|Expansion Phase|Withdrawal by Subject|0|||
145643423|NCT02723955|525211795|FG023|Expansion Phase|Withdrawal by Subject|0|||
145643424|NCT02723955|525211796|FG024|Expansion Phase|Withdrawal by Subject|0|||
145643425|NCT02723955|525211797|FG025|Expansion Phase|Withdrawal by Subject|0|||
145643426|NCT02723955|525211798|FG026|Expansion Phase|Withdrawal by Subject|0|||
145643427|NCT02723955|525211799|FG027|Expansion Phase|Withdrawal by Subject|0|||
145643428|NCT02723955|525211800|FG028|Expansion Phase|Withdrawal by Subject|0|||
145643429|NCT02723955|525211801|FG029|Expansion Phase|Withdrawal by Subject|0|||
145643430|NCT02723955|525211802|FG030|Expansion Phase|Withdrawal by Subject|8|||
145643431|NCT02723955|525211803|FG031|Expansion Phase|Withdrawal by Subject|4|||
145643432|NCT02723955|525211804|FG032|Expansion Phase|Withdrawal by Subject|0|||
145643433|NCT02723955|525211805|FG033|Expansion Phase|Withdrawal by Subject|0|||
145643434|NCT02723955|525211806|FG034|Expansion Phase|Withdrawal by Subject|0|||
145643435|NCT02723955|525211807|FG035|Expansion Phase|Withdrawal by Subject|1|||
145643436|NCT02723955|525211808|FG036|Expansion Phase|Withdrawal by Subject|0|||
145643437|NCT02723955|525211809|FG037|Expansion Phase|Withdrawal by Subject|0|||
145643438|NCT02723955|525211810|FG038|Expansion Phase|Withdrawal by Subject|0|||
145643439|NCT02723955|525211811|FG039|Expansion Phase|Withdrawal by Subject|0|||
145643440|NCT02723955|525211812|FG040|Expansion Phase|Withdrawal by Subject|0|||
145643441|NCT02723955|525211813|FG041|Expansion Phase|Withdrawal by Subject|0|||
145643442|NCT02723955|525211814|FG042|Expansion Phase|Withdrawal by Subject|0|||
145643443|NCT02723955|525211772|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643444|NCT02723955|525211773|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643445|NCT02723955|525211774|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643446|NCT02723955|525211775|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643447|NCT02723955|525211776|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643448|NCT02723955|525211777|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643449|NCT02723955|525211778|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643450|NCT02723955|525211779|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643451|NCT02723955|525211780|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643452|NCT02723955|525211781|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
145643453|NCT02723955|525211782|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
145643454|NCT02723955|525211783|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
145643455|NCT02723955|525211784|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643456|NCT02723955|525211785|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643457|NCT02723955|525211786|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643458|NCT02723955|525211787|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643459|NCT02723955|525211788|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643460|NCT02723955|525211789|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643461|NCT02723955|525211790|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643462|NCT02723955|525211791|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643463|NCT02723955|525211792|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643464|NCT02723955|525211793|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643465|NCT02723955|525211794|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643466|NCT02723955|525211795|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643467|NCT02723955|525211796|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643468|NCT02723955|525211797|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643469|NCT02723955|525211798|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643470|NCT02723955|525211799|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643471|NCT02723955|525211800|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643472|NCT02723955|525211801|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643473|NCT02723955|525211802|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
145643474|NCT02723955|525211803|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643475|NCT02723955|525211804|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643476|NCT02723955|525211805|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643477|NCT02723955|525211806|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145655552|NCT02985957|525257254|FG001|Treatment Period|Participant withdrew consent|0|||
145486434|NCT00279916|524635037|FG001|Overall Study|Withdrawal by Subject|3|||
145486435|NCT00279916|524635036|FG000|Overall Study|Lost to Follow-up|3|||
145486436|NCT00279916|524635037|FG001|Overall Study|Lost to Follow-up|2|||
145486437|NCT00731679|524635041|FG000|Overall Study|Adverse Event|7|||
145486438|NCT00731679|524635042|FG001|Overall Study|Adverse Event|8|||
145486439|NCT00731679|524635041|FG000|Overall Study|Withdrawal by Subject|8|||
145486440|NCT00731679|524635042|FG001|Overall Study|Withdrawal by Subject|8|||
145486441|NCT00731679|524635041|FG000|Overall Study|Lost to Follow-up|7|||
145486442|NCT00731679|524635042|FG001|Overall Study|Lost to Follow-up|8|||
145486443|NCT00731679|524635041|FG000|Overall Study|Noncompliance|0|||
145486444|NCT00731679|524635042|FG001|Overall Study|Noncompliance|1|||
145486445|NCT00731679|524635041|FG000|Overall Study|Pregnancy|0|||
145486446|NCT00731679|524635042|FG001|Overall Study|Pregnancy|1|||
145486447|NCT02488005|524635043|FG000|Overall Study|Lost to Follow-up|2|||
145486448|NCT03384940|524635044|FG000|Overall Study|Progressive disease|36|||
145486449|NCT03384940|524635045|FG001|Overall Study|Progressive disease|11|||
145643478|NCT02723955|525211807|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643479|NCT02723955|525211808|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643480|NCT02723955|525211809|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643481|NCT02723955|525211810|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643482|NCT02723955|525211811|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643483|NCT02723955|525211812|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643484|NCT02723955|525211813|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643485|NCT02723955|525211814|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
145643486|NCT02723955|525211772|FG000|Expansion Phase|Site Closed|0|||
145643487|NCT02723955|525211773|FG001|Expansion Phase|Site Closed|0|||
145643488|NCT02723955|525211774|FG002|Expansion Phase|Site Closed|0|||
145643489|NCT02723955|525211775|FG003|Expansion Phase|Site Closed|0|||
145643490|NCT02723955|525211776|FG004|Expansion Phase|Site Closed|0|||
145643491|NCT02723955|525211777|FG005|Expansion Phase|Site Closed|0|||
145643492|NCT02723955|525211778|FG006|Expansion Phase|Site Closed|0|||
145643493|NCT02723955|525211779|FG007|Expansion Phase|Site Closed|0|||
145643494|NCT02723955|525211780|FG008|Expansion Phase|Site Closed|0|||
145643495|NCT02723955|525211781|FG009|Expansion Phase|Site Closed|1|||
145643496|NCT02723955|525211782|FG010|Expansion Phase|Site Closed|2|||
145643497|NCT02723955|525211783|FG011|Expansion Phase|Site Closed|6|||
145643498|NCT02723955|525211784|FG012|Expansion Phase|Site Closed|0|||
145643499|NCT02723955|525211785|FG013|Expansion Phase|Site Closed|0|||
145643500|NCT02723955|525211786|FG014|Expansion Phase|Site Closed|0|||
145643501|NCT02723955|525211787|FG015|Expansion Phase|Site Closed|0|||
145643502|NCT02723955|525211788|FG016|Expansion Phase|Site Closed|0|||
145643503|NCT02723955|525211789|FG017|Expansion Phase|Site Closed|0|||
145643504|NCT02723955|525211790|FG018|Expansion Phase|Site Closed|0|||
145643505|NCT02723955|525211791|FG019|Expansion Phase|Site Closed|0|||
145643506|NCT02723955|525211792|FG020|Expansion Phase|Site Closed|0|||
145643507|NCT02723955|525211793|FG021|Expansion Phase|Site Closed|0|||
145643508|NCT02723955|525211794|FG022|Expansion Phase|Site Closed|0|||
145643509|NCT02723955|525211795|FG023|Expansion Phase|Site Closed|0|||
145643510|NCT02723955|525211796|FG024|Expansion Phase|Site Closed|0|||
145643511|NCT02723955|525211797|FG025|Expansion Phase|Site Closed|0|||
145643512|NCT02723955|525211798|FG026|Expansion Phase|Site Closed|0|||
145643513|NCT02723955|525211799|FG027|Expansion Phase|Site Closed|0|||
145643514|NCT02723955|525211800|FG028|Expansion Phase|Site Closed|0|||
145643515|NCT02723955|525211801|FG029|Expansion Phase|Site Closed|0|||
145643516|NCT02723955|525211802|FG030|Expansion Phase|Site Closed|8|||
145643517|NCT02723955|525211803|FG031|Expansion Phase|Site Closed|4|||
145643518|NCT02723955|525211804|FG032|Expansion Phase|Site Closed|2|||
145643519|NCT02723955|525211805|FG033|Expansion Phase|Site Closed|2|||
145643520|NCT02723955|525211806|FG034|Expansion Phase|Site Closed|0|||
145643521|NCT02723955|525211807|FG035|Expansion Phase|Site Closed|0|||
145643522|NCT02723955|525211808|FG036|Expansion Phase|Site Closed|0|||
145643523|NCT02723955|525211809|FG037|Expansion Phase|Site Closed|0|||
145643524|NCT02723955|525211810|FG038|Expansion Phase|Site Closed|0|||
145643525|NCT02723955|525211811|FG039|Expansion Phase|Site Closed|0|||
145643526|NCT02723955|525211812|FG040|Expansion Phase|Site Closed|0|||
145643527|NCT02723955|525211813|FG041|Expansion Phase|Site Closed|0|||
145643528|NCT02723955|525211814|FG042|Expansion Phase|Site Closed|0|||
145643529|NCT02723955|525211772|FG000|Crossover/ Re-treatment Phase|Death|0|||
145643530|NCT02723955|525211773|FG001|Crossover/ Re-treatment Phase|Death|0|||
145643531|NCT02723955|525211774|FG002|Crossover/ Re-treatment Phase|Death|0|||
145643532|NCT02723955|525211775|FG003|Crossover/ Re-treatment Phase|Death|0|||
145643533|NCT02723955|525211776|FG004|Crossover/ Re-treatment Phase|Death|0|||
145643534|NCT02723955|525211777|FG005|Crossover/ Re-treatment Phase|Death|0|||
145643535|NCT02723955|525211778|FG006|Crossover/ Re-treatment Phase|Death|0|||
145643536|NCT02723955|525211779|FG007|Crossover/ Re-treatment Phase|Death|0|||
145643537|NCT02723955|525211780|FG008|Crossover/ Re-treatment Phase|Death|0|||
145643538|NCT02723955|525211781|FG009|Crossover/ Re-treatment Phase|Death|0|||
145643539|NCT02723955|525211782|FG010|Crossover/ Re-treatment Phase|Death|0|||
145643540|NCT02723955|525211783|FG011|Crossover/ Re-treatment Phase|Death|0|||
145643541|NCT02723955|525211784|FG012|Crossover/ Re-treatment Phase|Death|0|||
145643542|NCT02723955|525211785|FG013|Crossover/ Re-treatment Phase|Death|0|||
145643543|NCT02723955|525211786|FG014|Crossover/ Re-treatment Phase|Death|0|||
145643544|NCT02723955|525211787|FG015|Crossover/ Re-treatment Phase|Death|0|||
145643545|NCT02723955|525211788|FG016|Crossover/ Re-treatment Phase|Death|0|||
145643546|NCT02723955|525211789|FG017|Crossover/ Re-treatment Phase|Death|0|||
145643547|NCT02723955|525211790|FG018|Crossover/ Re-treatment Phase|Death|0|||
145643548|NCT02723955|525211791|FG019|Crossover/ Re-treatment Phase|Death|0|||
145643549|NCT02723955|525211792|FG020|Crossover/ Re-treatment Phase|Death|0|||
145643550|NCT02723955|525211793|FG021|Crossover/ Re-treatment Phase|Death|0|||
145643551|NCT02723955|525211794|FG022|Crossover/ Re-treatment Phase|Death|0|||
145643552|NCT02723955|525211795|FG023|Crossover/ Re-treatment Phase|Death|0|||
145643553|NCT02723955|525211796|FG024|Crossover/ Re-treatment Phase|Death|0|||
145643554|NCT02723955|525211797|FG025|Crossover/ Re-treatment Phase|Death|0|||
145643555|NCT02723955|525211798|FG026|Crossover/ Re-treatment Phase|Death|0|||
145643556|NCT02723955|525211799|FG027|Crossover/ Re-treatment Phase|Death|0|||
145643557|NCT02723955|525211800|FG028|Crossover/ Re-treatment Phase|Death|0|||
145643558|NCT02723955|525211801|FG029|Crossover/ Re-treatment Phase|Death|0|||
145643559|NCT02723955|525211802|FG030|Crossover/ Re-treatment Phase|Death|0|||
145643560|NCT02723955|525211803|FG031|Crossover/ Re-treatment Phase|Death|0|||
145643561|NCT02723955|525211804|FG032|Crossover/ Re-treatment Phase|Death|0|||
145643562|NCT02723955|525211805|FG033|Crossover/ Re-treatment Phase|Death|0|||
145643563|NCT02723955|525211806|FG034|Crossover/ Re-treatment Phase|Death|0|||
145643564|NCT02723955|525211807|FG035|Crossover/ Re-treatment Phase|Death|0|||
145643565|NCT02723955|525211808|FG036|Crossover/ Re-treatment Phase|Death|0|||
145643566|NCT02723955|525211809|FG037|Crossover/ Re-treatment Phase|Death|1|||
145643567|NCT02723955|525211810|FG038|Crossover/ Re-treatment Phase|Death|14|||
145643568|NCT02723955|525211811|FG039|Crossover/ Re-treatment Phase|Death|32|||
145643569|NCT02723955|525211812|FG040|Crossover/ Re-treatment Phase|Death|2|||
145643570|NCT02723955|525211813|FG041|Crossover/ Re-treatment Phase|Death|1|||
145643571|NCT02723955|525211814|FG042|Crossover/ Re-treatment Phase|Death|0|||
145643572|NCT02723955|525211772|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643573|NCT02723955|525211773|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643574|NCT02723955|525211774|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643575|NCT02723955|525211775|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643576|NCT02723955|525211776|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643577|NCT02723955|525211777|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643578|NCT02723955|525211778|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643579|NCT02723955|525211779|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643580|NCT02723955|525211780|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643581|NCT02723955|525211781|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643582|NCT02723955|525211782|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643583|NCT02723955|525211783|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643584|NCT02723955|525211784|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643585|NCT02723955|525211785|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643586|NCT02723955|525211786|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643587|NCT02723955|525211787|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643588|NCT02723955|525211788|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643589|NCT02723955|525211789|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643590|NCT02723955|525211790|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643591|NCT02723955|525211791|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643592|NCT02723955|525211792|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643593|NCT02723955|525211793|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643594|NCT02723955|525211794|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643595|NCT02723955|525211795|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643596|NCT02723955|525211796|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643597|NCT02723955|525211797|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643598|NCT02723955|525211798|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643599|NCT02723955|525211799|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643600|NCT02723955|525211800|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643601|NCT02723955|525211801|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643602|NCT02723955|525211802|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643603|NCT02723955|525211803|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643604|NCT02723955|525211804|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643605|NCT02723955|525211805|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643606|NCT02723955|525211806|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643607|NCT02723955|525211807|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643608|NCT02723955|525211808|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643609|NCT02723955|525211809|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643610|NCT02723955|525211810|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643611|NCT02723955|525211811|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
145643612|NCT02723955|525211812|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643613|NCT02723955|525211813|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643614|NCT02723955|525211814|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
145643615|NCT02723955|525211772|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643616|NCT02723955|525211773|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643617|NCT02723955|525211774|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643618|NCT02723955|525211775|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643619|NCT02723955|525211776|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643620|NCT02723955|525211777|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643621|NCT02723955|525211778|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643622|NCT02723955|525211779|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643623|NCT02723955|525211780|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643624|NCT02723955|525211781|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643625|NCT02723955|525211782|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643626|NCT02723955|525211783|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643627|NCT02723955|525211784|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643628|NCT02723955|525211785|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643629|NCT02723955|525211786|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643630|NCT02723955|525211787|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643631|NCT02723955|525211788|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643632|NCT02723955|525211789|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643633|NCT02723955|525211790|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643634|NCT02723955|525211791|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643635|NCT02723955|525211792|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643636|NCT02723955|525211793|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643637|NCT02723955|525211794|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643638|NCT02723955|525211795|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643639|NCT02723955|525211796|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643640|NCT02723955|525211797|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643641|NCT02723955|525211798|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643642|NCT02723955|525211799|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643643|NCT02723955|525211800|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643644|NCT02723955|525211801|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643645|NCT02723955|525211802|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643646|NCT02723955|525211803|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643647|NCT02723955|525211804|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643648|NCT02723955|525211805|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643649|NCT02723955|525211806|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643650|NCT02723955|525211807|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643651|NCT02723955|525211808|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643652|NCT02723955|525211809|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643653|NCT02723955|525211810|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
145643654|NCT02723955|525211811|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
145643655|NCT02723955|525211812|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643656|NCT02723955|525211813|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
145643657|NCT02723955|525211814|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
145643658|NCT02723955|525211772|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
145643659|NCT02723955|525211773|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
145643660|NCT02723955|525211774|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
145643661|NCT02723955|525211775|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
145643662|NCT02723955|525211776|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
145643663|NCT02723955|525211777|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
145643664|NCT02723955|525211778|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
145643665|NCT02723955|525211779|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
145643666|NCT02723955|525211780|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
145643667|NCT02723955|525211781|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
145643668|NCT02723955|525211782|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
145643669|NCT02723955|525211783|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
145643670|NCT02723955|525211784|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
145643671|NCT02723955|525211785|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
145643672|NCT02723955|525211786|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
145643673|NCT02723955|525211787|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
145643674|NCT02723955|525211788|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
145643675|NCT02723955|525211789|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
145643676|NCT02723955|525211790|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
145643677|NCT02723955|525211791|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
145643678|NCT02723955|525211792|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
145643679|NCT02723955|525211793|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
145643680|NCT02723955|525211794|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
145643681|NCT02723955|525211795|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
145643682|NCT02723955|525211796|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
145643683|NCT02723955|525211797|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
145643684|NCT02723955|525211798|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
145643685|NCT02723955|525211799|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
145643686|NCT02723955|525211800|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
145643687|NCT02723955|525211801|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
145643688|NCT02723955|525211802|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
145486450|NCT03384940|524635046|FG002|Overall Study|Progressive disease|13|||
145643689|NCT02723955|525211803|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
145643690|NCT02723955|525211804|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
145643691|NCT02723955|525211805|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
145643692|NCT02723955|525211806|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
145643693|NCT02723955|525211807|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
145643694|NCT02723955|525211808|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
145643695|NCT02723955|525211809|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
145643696|NCT02723955|525211810|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
145643697|NCT02723955|525211811|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
145643698|NCT02723955|525211812|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
145643699|NCT02723955|525211813|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
145643700|NCT02723955|525211814|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
145643701|NCT04999085|525211817|FG000|Overall Study|Death|1|||
145643702|NCT05056246|525211818|FG000|Overall Study|Adverse Event|0|||
145643703|NCT05056246|525211819|FG001|Overall Study|Adverse Event|0|||
145643704|NCT05056246|525211820|FG002|Overall Study|Adverse Event|0|||
145643705|NCT05056246|525211821|FG003|Overall Study|Adverse Event|0|||
145643706|NCT05056246|525211822|FG004|Overall Study|Adverse Event|1|||
145643707|NCT05056246|525211818|FG000|Overall Study|Lost to Follow-up|0|||
145643708|NCT05056246|525211819|FG001|Overall Study|Lost to Follow-up|0|||
145643709|NCT05056246|525211820|FG002|Overall Study|Lost to Follow-up|0|||
145643710|NCT05056246|525211821|FG003|Overall Study|Lost to Follow-up|2|||
145643711|NCT05056246|525211822|FG004|Overall Study|Lost to Follow-up|0|||
145643712|NCT05056246|525211818|FG000|Overall Study|Withdrawal by Subject|0|||
145643713|NCT05056246|525211819|FG001|Overall Study|Withdrawal by Subject|1|||
145643714|NCT05056246|525211820|FG002|Overall Study|Withdrawal by Subject|0|||
145643715|NCT05056246|525211821|FG003|Overall Study|Withdrawal by Subject|0|||
145643716|NCT05056246|525211822|FG004|Overall Study|Withdrawal by Subject|0|||
145643717|NCT05096819|525211827|FG000|Overall Study|Withdrawal by Subject|3|||
145643718|NCT05096819|525211828|FG001|Overall Study|Withdrawal by Subject|0|||
145643719|NCT03324984|525211829|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
145643720|NCT03324984|525211830|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
145643721|NCT02152137|525211832|FG000|Overall Study|Withdrawal by Subject|1|||
145643722|NCT02152137|525211832|FG000|Overall Study|Originally assigned to Arm B|3|||
145643723|NCT04878354|525211833|FG000|Overall Study|Adverse Event|4|||
145643724|NCT04878354|525211834|FG001|Overall Study|Adverse Event|13|||
145643725|NCT04878354|525211833|FG000|Overall Study|Withdrawal by Subject|14|||
145643726|NCT04878354|525211834|FG001|Overall Study|Withdrawal by Subject|12|||
145643727|NCT04878354|525211833|FG000|Overall Study|Lost to Follow-up|4|||
145643728|NCT04878354|525211834|FG001|Overall Study|Lost to Follow-up|1|||
145643729|NCT04878354|525211833|FG000|Overall Study|Lack of Efficacy|1|||
145643730|NCT04878354|525211834|FG001|Overall Study|Lack of Efficacy|0|||
145643731|NCT04878354|525211833|FG000|Overall Study|Protocol Violation|0|||
145643732|NCT04878354|525211834|FG001|Overall Study|Protocol Violation|1|||
145643733|NCT04878354|525211833|FG000|Overall Study|"Reason stated as other in CRF"|2|||
145643734|NCT04878354|525211834|FG001|Overall Study|"Reason stated as other in CRF"|3|||
145643735|NCT04440176|525211847|FG000|Overall Study|Withdrawal by Subject|5|||
145643736|NCT04440176|525211848|FG001|Overall Study|Withdrawal by Subject|3|||
145643737|NCT04440176|525211847|FG000|Overall Study|Withdrawal by parent/guardian|4|||
145643738|NCT04440176|525211848|FG001|Overall Study|Withdrawal by parent/guardian|5|||
145643739|NCT04440176|525211847|FG000|Overall Study|Adverse Event|2|||
145643740|NCT04440176|525211848|FG001|Overall Study|Adverse Event|6|||
145643741|NCT04440176|525211847|FG000|Overall Study|Lost to Follow-up|22|||
145643742|NCT04440176|525211848|FG001|Overall Study|Lost to Follow-up|23|||
145643743|NCT04440176|525211847|FG000|Overall Study|Medication error without associated adverse event|0|||
145643744|NCT04440176|525211848|FG001|Overall Study|Medication error without associated adverse event|1|||
145643745|NCT04440176|525211847|FG000|Overall Study|No longer met eligibility criteria|7|||
145643746|NCT04440176|525211848|FG001|Overall Study|No longer met eligibility criteria|1|||
145643747|NCT04440176|525211847|FG000|Overall Study|Other|1|||
145643748|NCT04440176|525211848|FG001|Overall Study|Other|2|||
145643749|NCT04440176|525211847|FG000|Overall Study|Protocol deviation|6|||
145643750|NCT04440176|525211848|FG001|Overall Study|Protocol deviation|8|||
145643751|NCT04440176|525211847|FG000|Overall Study|Randomized but not vaccinated|6|||
145643752|NCT04440176|525211848|FG001|Overall Study|Randomized but not vaccinated|3|||
145643753|NCT01631214|525211849|FG000|Overall Study|Withdrawal by Subject|276|||
145643754|NCT01631214|525211850|FG001|Overall Study|Withdrawal by Subject|290|||
145643755|NCT01631214|525211849|FG000|Overall Study|Death|113|||
145643756|NCT01631214|525211850|FG001|Overall Study|Death|106|||
145643757|NCT01631214|525211849|FG000|Overall Study|Lost to Follow-up|54|||
145486451|NCT03384940|524635044|FG000|Overall Study|Clinical progression|4|||
145486452|NCT03384940|524635045|FG001|Overall Study|Clinical progression|0|||
145643758|NCT01631214|525211850|FG001|Overall Study|Lost to Follow-up|40|||
145643759|NCT01631214|525211849|FG000|Overall Study|Adverse Event|45|||
145643760|NCT01631214|525211850|FG001|Overall Study|Adverse Event|45|||
145643761|NCT01631214|525211849|FG000|Overall Study|Other|22|||
145643762|NCT01631214|525211850|FG001|Overall Study|Other|19|||
145643763|NCT01631214|525211849|FG000|Overall Study|Noncompliance|16|||
145643764|NCT01631214|525211850|FG001|Overall Study|Noncompliance|15|||
145643765|NCT01631214|525211849|FG000|Overall Study|Requirement for Alternative Therapy|8|||
145643766|NCT01631214|525211850|FG001|Overall Study|Requirement for Alternative Therapy|3|||
145643767|NCT01631214|525211849|FG000|Overall Study|Protocol Deviation|4|||
145643768|NCT01631214|525211850|FG001|Overall Study|Protocol Deviation|3|||
145643769|NCT01631214|525211849|FG000|Overall Study|Ineligibility determined|5|||
145643770|NCT01631214|525211850|FG001|Overall Study|Ineligibility determined|2|||
145643771|NCT01631214|525211849|FG000|Overall Study|Administrative Decision|1|||
145643772|NCT01631214|525211850|FG001|Overall Study|Administrative Decision|0|||
145643773|NCT04847999|525211851|FG000|Overall Study|Lost to Follow-up|0|||
145643774|NCT04847999|525211852|FG001|Overall Study|Lost to Follow-up|1|||
145643775|NCT05288283|525211862|FG000|Overall Study|Study Terminated Early|1|||
145643776|NCT05288283|525211863|FG001|Overall Study|Study Terminated Early|1|||
145643777|NCT04153565|525211864|FG000|Overall Study|Death|13|||
145643778|NCT02991807|525211865|FG000|Overall Study|Withdrawal by Subject|2|||
145643779|NCT02991807|525211866|FG001|Overall Study|Withdrawal by Subject|1|||
145643780|NCT02991807|525211865|FG000|Overall Study|Physician Decision|0|||
145643781|NCT02991807|525211866|FG001|Overall Study|Physician Decision|1|||
145643782|NCT02991807|525211865|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
145486453|NCT03384940|524635046|FG002|Overall Study|Clinical progression|3|||
145486454|NCT03384940|524635044|FG000|Overall Study|Adverse Event|7|||
145486455|NCT03384940|524635045|FG001|Overall Study|Adverse Event|1|||
145486456|NCT03384940|524635046|FG002|Overall Study|Adverse Event|1|||
145486457|NCT03384940|524635044|FG000|Overall Study|Withdrawal by Subject|3|||
145486458|NCT03384940|524635045|FG001|Overall Study|Withdrawal by Subject|1|||
145486459|NCT03384940|524635046|FG002|Overall Study|Withdrawal by Subject|0|||
145486460|NCT03384940|524635044|FG000|Overall Study|Physician Decision|1|||
145486461|NCT03384940|524635045|FG001|Overall Study|Physician Decision|1|||
145486462|NCT03384940|524635046|FG002|Overall Study|Physician Decision|0|||
145486463|NCT03384940|524635044|FG000|Overall Study|Death|2|||
145486464|NCT03384940|524635045|FG001|Overall Study|Death|1|||
145486465|NCT03384940|524635046|FG002|Overall Study|Death|0|||
145486466|NCT03384940|524635044|FG000|Overall Study|Other|0|||
145486467|NCT03384940|524635045|FG001|Overall Study|Other|0|||
145486468|NCT03384940|524635046|FG002|Overall Study|Other|1|||
145486469|NCT03089580|524635052|FG000|Overall Study|Lost to Follow-up|2|||
145486470|NCT03087513|524635053|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
145486471|NCT05864586|524635054|FG000|Overall Study|Ineligible|4|||
145486472|NCT05864586|524635055|FG001|Overall Study|Ineligible|12|||
145486473|NCT05864586|524635054|FG000|Overall Study|Pregnancy|0|||
145486474|NCT05864586|524635055|FG001|Overall Study|Pregnancy|1|||
145486475|NCT05864586|524635054|FG000|Overall Study|Withdrawal by Subject|0|||
145486476|NCT05864586|524635055|FG001|Overall Study|Withdrawal by Subject|1|||
145486477|NCT03635424|524635056|FG000|Overall Study|Adverse Event|1|||
145486478|NCT03635424|524635056|FG000|Overall Study|Death|1|||
145486479|NCT03635424|524635056|FG000|Overall Study|Device not implanted|1|||
145486480|NCT02452424|524635059|FG000|Overall Study|Death|2|||
145486481|NCT02452424|524635060|FG001|Overall Study|Death|2|||
145486482|NCT02452424|524635061|FG002|Overall Study|Death|2|||
145486483|NCT02452424|524635062|FG003|Overall Study|Death|6|||
145486484|NCT02452424|524635063|FG004|Overall Study|Death|2|||
145486485|NCT02452424|524635064|FG005|Overall Study|Death|0|||
145486486|NCT02452424|524635065|FG006|Overall Study|Death|5|||
145486487|NCT02452424|524635066|FG007|Overall Study|Death|1|||
145486488|NCT02452424|524635067|FG008|Overall Study|Death|3|||
145486489|NCT02452424|524635068|FG009|Overall Study|Death|1|||
145486490|NCT02452424|524635069|FG010|Overall Study|Death|0|||
145486491|NCT02452424|524635059|FG000|Overall Study|Lost to Follow-up|0|||
145486492|NCT02452424|524635060|FG001|Overall Study|Lost to Follow-up|1|||
145486493|NCT02452424|524635061|FG002|Overall Study|Lost to Follow-up|1|||
145486494|NCT02452424|524635062|FG003|Overall Study|Lost to Follow-up|0|||
145486495|NCT02452424|524635063|FG004|Overall Study|Lost to Follow-up|0|||
145486496|NCT02452424|524635064|FG005|Overall Study|Lost to Follow-up|0|||
145486497|NCT02452424|524635065|FG006|Overall Study|Lost to Follow-up|0|||
145486498|NCT02452424|524635066|FG007|Overall Study|Lost to Follow-up|0|||
145486499|NCT02452424|524635067|FG008|Overall Study|Lost to Follow-up|0|||
145486500|NCT02452424|524635068|FG009|Overall Study|Lost to Follow-up|0|||
145486501|NCT02452424|524635069|FG010|Overall Study|Lost to Follow-up|0|||
145486502|NCT02452424|524635059|FG000|Overall Study|Withdrawal by Subject|0|||
145486503|NCT02452424|524635060|FG001|Overall Study|Withdrawal by Subject|0|||
145643783|NCT02991807|525211866|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
145643784|NCT02300298|525211869|FG000|Disposition for Nintedanib|Progressive disease|10|||
145643785|NCT02300298|525211870|FG001|Disposition for Nintedanib|Progressive disease|0|||
145643786|NCT02300298|525211869|FG000|Disposition for Docetaxel|Progressive disease|0|||
145486504|NCT02452424|524635061|FG002|Overall Study|Withdrawal by Subject|3|||
145486505|NCT02452424|524635062|FG003|Overall Study|Withdrawal by Subject|2|||
145486506|NCT02452424|524635063|FG004|Overall Study|Withdrawal by Subject|0|||
145486507|NCT02452424|524635064|FG005|Overall Study|Withdrawal by Subject|0|||
145486508|NCT02452424|524635065|FG006|Overall Study|Withdrawal by Subject|1|||
145643787|NCT02300298|525211870|FG001|Disposition for Docetaxel|Progressive disease|6|||
145643788|NCT02300298|525211869|FG000|Disposition for Docetaxel|other adverse event|0|||
145486509|NCT02452424|524635066|FG007|Overall Study|Withdrawal by Subject|0|||
145486510|NCT02452424|524635067|FG008|Overall Study|Withdrawal by Subject|1|||
145486511|NCT02452424|524635068|FG009|Overall Study|Withdrawal by Subject|1|||
145486512|NCT02452424|524635069|FG010|Overall Study|Withdrawal by Subject|0|||
145486513|NCT02452424|524635059|FG000|Overall Study|Other|0|||
145486514|NCT02452424|524635060|FG001|Overall Study|Other|0|||
145486515|NCT02452424|524635061|FG002|Overall Study|Other|1|||
145486516|NCT02452424|524635062|FG003|Overall Study|Other|0|||
145486517|NCT02452424|524635063|FG004|Overall Study|Other|0|||
145486518|NCT02452424|524635064|FG005|Overall Study|Other|1|||
145486519|NCT02452424|524635065|FG006|Overall Study|Other|4|||
145486520|NCT02452424|524635066|FG007|Overall Study|Other|3|||
145486521|NCT02452424|524635067|FG008|Overall Study|Other|0|||
145486522|NCT02452424|524635068|FG009|Overall Study|Other|0|||
145486523|NCT02452424|524635069|FG010|Overall Study|Other|1|||
145486524|NCT02452424|524635059|FG000|Overall Study|Progressive disease (per RECIST)|0|||
145486525|NCT02452424|524635060|FG001|Overall Study|Progressive disease (per RECIST)|0|||
145486526|NCT02452424|524635061|FG002|Overall Study|Progressive disease (per RECIST)|0|||
145486527|NCT02452424|524635062|FG003|Overall Study|Progressive disease (per RECIST)|0|||
145643789|NCT02300298|525211870|FG001|Disposition for Docetaxel|other adverse event|4|||
145643790|NCT03285763|525211871|FG000|Overall Study|Death|470|||
145643791|NCT03285763|525211871|FG000|Overall Study|Lost to Follow-up|18|||
145643792|NCT03285763|525211871|FG000|Overall Study|Physician Decision|2|||
145643793|NCT03285763|525211871|FG000|Overall Study|Study Terminated By Sponsor|79|||
145643794|NCT03285763|525211871|FG000|Overall Study|Withdrawal by Subject|33|||
145643795|NCT03990649|525211872|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
145643796|NCT03990649|525211873|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
145643797|NCT03990649|525211874|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
145643798|NCT03990649|525211872|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
145643799|NCT03990649|525211873|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
145643800|NCT03990649|525211874|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
145643801|NCT03990649|525211872|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
145643802|NCT03990649|525211873|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
145643803|NCT03990649|525211874|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
145643804|NCT03990649|525211872|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
145643805|NCT03990649|525211873|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
145643806|NCT03990649|525211874|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
145643807|NCT03990649|525211872|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
145643808|NCT03990649|525211873|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
145643809|NCT03990649|525211874|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
145643810|NCT03990649|525211872|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
145643811|NCT03990649|525211873|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
145643812|NCT03990649|525211874|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
145643813|NCT03990649|525211872|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
145643814|NCT03990649|525211873|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
145643815|NCT03990649|525211874|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
145643816|NCT05773313|525211875|FG000|Overall Study|Lost to Follow-up|3|||
145643817|NCT03050814|525211876|FG000|Overall Study|Screen failures|0|||
145643818|NCT03050814|525211877|FG001|Overall Study|Screen failures|0|||
145643819|NCT03050814|525211878|FG002|Overall Study|Screen failures|4|||
145643820|NCT01443845|525211882|FG000|Overall Study|Protocol Violation|43|||
145643821|NCT01443845|525211883|FG001|Overall Study|Protocol Violation|45|||
145643822|NCT01443845|525211882|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
145643823|NCT01443845|525211883|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
145643824|NCT01443845|525211882|FG000|Overall Study|Deterioration in pulmonary function|1|||
145643825|NCT01443845|525211883|FG001|Overall Study|Deterioration in pulmonary function|4|||
145643826|NCT01443845|525211882|FG000|Overall Study|Lack of Efficacy|10|||
145643827|NCT01443845|525211883|FG001|Overall Study|Lack of Efficacy|5|||
145643828|NCT01443845|525211882|FG000|Overall Study|Adverse Event|64|||
145643829|NCT01443845|525211883|FG001|Overall Study|Adverse Event|138|||
145643830|NCT01443845|525211882|FG000|Overall Study|Withdrawal by Subject|63|||
145486528|NCT02452424|524635063|FG004|Overall Study|Progressive disease (per RECIST)|0|||
145486529|NCT02452424|524635064|FG005|Overall Study|Progressive disease (per RECIST)|0|||
145643831|NCT01443845|525211883|FG001|Overall Study|Withdrawal by Subject|67|||
145643832|NCT01443845|525211882|FG000|Overall Study|Military Conflict - Site Terminated|20|||
145486530|NCT02452424|524635065|FG006|Overall Study|Progressive disease (per RECIST)|0|||
145486531|NCT02452424|524635066|FG007|Overall Study|Progressive disease (per RECIST)|0|||
145486532|NCT02452424|524635067|FG008|Overall Study|Progressive disease (per RECIST)|2|||
145486533|NCT02452424|524635068|FG009|Overall Study|Progressive disease (per RECIST)|0|||
145643833|NCT01443845|525211883|FG001|Overall Study|Military Conflict - Site Terminated|21|||
145643834|NCT01443845|525211882|FG000|Overall Study|Lost to Follow-up|9|||
145643835|NCT01443845|525211883|FG001|Overall Study|Lost to Follow-up|13|||
145486534|NCT02452424|524635069|FG010|Overall Study|Progressive disease (per RECIST)|0|||
145486535|NCT02452424|524635059|FG000|Overall Study|Adverse Event|0|||
145486536|NCT02452424|524635060|FG001|Overall Study|Adverse Event|0|||
145486537|NCT02452424|524635061|FG002|Overall Study|Adverse Event|0|||
145486538|NCT02452424|524635062|FG003|Overall Study|Adverse Event|0|||
145643836|NCT00402246|525211884|FG000|Overall Study|Death|62|||
145643837|NCT00402246|525211885|FG001|Overall Study|Death|58|||
145643838|NCT00402246|525211884|FG000|Overall Study|Lost to Follow-up|20|||
145643839|NCT00402246|525211885|FG001|Overall Study|Lost to Follow-up|28|||
145643840|NCT00402246|525211884|FG000|Overall Study|Withdrawal by Subject|72|||
145643841|NCT00402246|525211885|FG001|Overall Study|Withdrawal by Subject|87|||
145643842|NCT00402246|525211884|FG000|Overall Study|Physician Decision|24|||
145643843|NCT00402246|525211885|FG001|Overall Study|Physician Decision|26|||
145643844|NCT00402246|525211884|FG000|Overall Study|Protocol Violation|25|||
145643845|NCT00402246|525211885|FG001|Overall Study|Protocol Violation|24|||
145643846|NCT00402246|525211884|FG000|Overall Study|Missed Final Visit|1|||
145643847|NCT00402246|525211885|FG001|Overall Study|Missed Final Visit|2|||
145643848|NCT00402246|525211884|FG000|Overall Study|Insurance Issues|2|||
145643849|NCT00402246|525211885|FG001|Overall Study|Insurance Issues|1|||
145643850|NCT00402246|525211884|FG000|Overall Study|Heart Transplant|0|||
145643851|NCT00402246|525211885|FG001|Overall Study|Heart Transplant|1|||
145643852|NCT00402246|525211884|FG000|Overall Study|Patient's device explanted|6|||
145643853|NCT00402246|525211885|FG001|Overall Study|Patient's device explanted|2|||
145643854|NCT00402246|525211884|FG000|Overall Study|Center Closure|5|||
145643855|NCT00402246|525211885|FG001|Overall Study|Center Closure|3|||
145643856|NCT00402246|525211884|FG000|Overall Study|Deterioriating Condition|3|||
145643857|NCT00402246|525211885|FG001|Overall Study|Deterioriating Condition|2|||
145643858|NCT01471691|525211886|FG000|Overall Study|Lack of Efficacy|0|||
145643859|NCT01471691|525211887|FG001|Overall Study|Lack of Efficacy|1|||
145643860|NCT01808339|525211893|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643861|NCT01808339|525211894|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643862|NCT01808339|525211895|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643863|NCT01808339|525211896|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
145643864|NCT01808339|525211897|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
145643865|NCT01808339|525211898|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
145643866|NCT01808339|525211893|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145643867|NCT01808339|525211894|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145643868|NCT01808339|525211895|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145643869|NCT01808339|525211896|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
145643870|NCT01808339|525211897|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145643871|NCT01808339|525211898|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
145643872|NCT01808339|525211893|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643873|NCT01808339|525211894|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643874|NCT01808339|525211895|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
145643875|NCT01808339|525211896|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643876|NCT01808339|525211897|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643877|NCT01808339|525211898|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
145643878|NCT01854385|525211900|FG000|Pre-Treatment|Withdrawal by Subject|4|||
145643879|NCT01854385|525211900|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
145643880|NCT01854385|525211900|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
145643881|NCT01854385|525211900|FG000|Pre-Treatment|Unable to come for study visits|1|||
145643882|NCT01854385|525211900|FG000|Treatment|Lost to Follow-up|1|||
145643883|NCT02932579|525211901|FG000|Overall Study|Withdrawal by Subject|4|||
145643884|NCT02932579|525211902|FG001|Overall Study|Withdrawal by Subject|1|||
145643885|NCT01121991|525211904|FG000|Overall Study|Lack of Ovarian Response|2|||
145643886|NCT01121991|525211904|FG000|Overall Study|No Oocytes Retrieved|3|||
145643887|NCT01121991|525211904|FG000|Overall Study|No Fertilization|1|||
145643888|NCT02121002|525211905|FG000|Overall Study|Physician Decision|2|||
145643889|NCT02121002|525211906|FG001|Overall Study|Physician Decision|0|||
145643890|NCT02121002|525211907|FG002|Overall Study|Physician Decision|0|||
145643891|NCT02121002|525211905|FG000|Overall Study|Withdrawal by Subject|3|||
145643892|NCT02121002|525211906|FG001|Overall Study|Withdrawal by Subject|1|||
145643893|NCT02121002|525211907|FG002|Overall Study|Withdrawal by Subject|4|||
145643894|NCT02121002|525211905|FG000|Overall Study|Protocol Violation|1|||
145643895|NCT02121002|525211906|FG001|Overall Study|Protocol Violation|2|||
145643896|NCT02121002|525211907|FG002|Overall Study|Protocol Violation|4|||
145643897|NCT02121002|525211905|FG000|Overall Study|Concomitant therapy|0|||
145643898|NCT02121002|525211906|FG001|Overall Study|Concomitant therapy|1|||
145643899|NCT02121002|525211907|FG002|Overall Study|Concomitant therapy|1|||
145643900|NCT02121002|525211905|FG000|Overall Study|Others|1|||
145643901|NCT02121002|525211906|FG001|Overall Study|Others|0|||
145643902|NCT02121002|525211907|FG002|Overall Study|Others|1|||
145643903|NCT04583423|525211908|FG000|Overall Study|Lost to Follow-up|0|||
145643904|NCT04583423|525211909|FG001|Overall Study|Lost to Follow-up|1|||
145643905|NCT04583423|525211910|FG002|Overall Study|Lost to Follow-up|0|||
145643906|NCT04583423|525211911|FG003|Overall Study|Lost to Follow-up|2|||
145643907|NCT04583423|525211908|FG000|Overall Study|Study Terminated by Sponsor|32|||
145643908|NCT04583423|525211909|FG001|Overall Study|Study Terminated by Sponsor|35|||
145643909|NCT04583423|525211910|FG002|Overall Study|Study Terminated by Sponsor|36|||
145643910|NCT04583423|525211911|FG003|Overall Study|Study Terminated by Sponsor|33|||
145643911|NCT04583423|525211908|FG000|Overall Study|Withdrawal by Subject|3|||
145643912|NCT04583423|525211909|FG001|Overall Study|Withdrawal by Subject|1|||
145643913|NCT04583423|525211910|FG002|Overall Study|Withdrawal by Subject|2|||
145643914|NCT04583423|525211911|FG003|Overall Study|Withdrawal by Subject|1|||
145643915|NCT02238483|525211912|FG000|Overall Study|Withdrawal by Subject|2|||
145643916|NCT02238483|525211913|FG001|Overall Study|Withdrawal by Subject|7|||
145643917|NCT02238483|525211912|FG000|Overall Study|Lost to Follow-up|1|||
145643918|NCT02238483|525211913|FG001|Overall Study|Lost to Follow-up|1|||
145643919|NCT02238483|525211912|FG000|Overall Study|Protocol Violation|1|||
145643920|NCT02238483|525211913|FG001|Overall Study|Protocol Violation|2|||
145643921|NCT02238483|525211912|FG000|Overall Study|Death|1|||
145643922|NCT02238483|525211913|FG001|Overall Study|Death|0|||
145643923|NCT02238483|525211912|FG000|Overall Study|Adverse Event|7|||
145643924|NCT02238483|525211913|FG001|Overall Study|Adverse Event|3|||
145643925|NCT02238483|525211912|FG000|Overall Study|Withdrawn due to physician decision|1|||
145643926|NCT02238483|525211913|FG001|Overall Study|Withdrawn due to physician decision|0|||
145643927|NCT02238483|525211912|FG000|Overall Study|Completion status not recorded|1|||
145643928|NCT02238483|525211913|FG001|Overall Study|Completion status not recorded|1|||
145643929|NCT02238483|525211912|FG000|Overall Study|Illness in family member|1|||
145643930|NCT02238483|525211913|FG001|Overall Study|Illness in family member|0|||
145643931|NCT00567489|525211914|FG000|Overall Study|Adverse Event|6|||
145643932|NCT00567489|525211915|FG001|Overall Study|Adverse Event|14|||
145643933|NCT00567489|525211914|FG000|Overall Study|Physician Decision|0|||
145643934|NCT00567489|525211915|FG001|Overall Study|Physician Decision|4|||
145643935|NCT00567489|525211914|FG000|Overall Study|Withdrawal by Subject|0|||
145643936|NCT00567489|525211915|FG001|Overall Study|Withdrawal by Subject|2|||
145643937|NCT00567489|525211914|FG000|Overall Study|Renal Transplantation|0|||
145643938|NCT00567489|525211915|FG001|Overall Study|Renal Transplantation|3|||
145643939|NCT00567489|525211914|FG000|Overall Study|Other|1|||
145643940|NCT00567489|525211915|FG001|Overall Study|Other|0|||
145643941|NCT04732338|525211923|FG000|Overall Study|Lost to Follow-up|3|||
145643942|NCT04732338|525211924|FG001|Overall Study|Lost to Follow-up|3|||
145643943|NCT02372253|525211925|FG000|Overall Study|Non Compliance|2|||
145643944|NCT02372253|525211926|FG001|Overall Study|Non Compliance|0|||
145643945|NCT03750968|525211927|FG000|Overall Study|Adverse Event|2|||
145643946|NCT03750968|525211928|FG001|Overall Study|Adverse Event|0|||
145643947|NCT03750968|525211927|FG000|Overall Study|Lost to Follow-up|1|||
145643948|NCT03750968|525211928|FG001|Overall Study|Lost to Follow-up|3|||
145643949|NCT02576509|525213980|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
145643950|NCT02576509|525213981|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
145643951|NCT02576509|525213980|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
145643952|NCT02576509|525213981|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
145643953|NCT02576509|525213980|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
145643954|NCT02576509|525213981|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
145643955|NCT02576509|525213980|FG000|Treatment Period|Disease progression|263|||
145643956|NCT02576509|525213981|FG001|Treatment Period|Disease progression|244|||
145643957|NCT02576509|525213980|FG000|Treatment Period|Study drug toxicity|37|||
145643958|NCT02576509|525213981|FG001|Treatment Period|Study drug toxicity|41|||
145643959|NCT02576509|525213980|FG000|Treatment Period|Death|1|||
145643960|NCT02576509|525213981|FG001|Treatment Period|Death|1|||
145643961|NCT02576509|525213980|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
145643962|NCT02576509|525213981|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
145643963|NCT02576509|525213980|FG000|Treatment Period|Participant request to stop treatment|8|||
145643964|NCT02576509|525213981|FG001|Treatment Period|Participant request to stop treatment|18|||
145643965|NCT02576509|525213980|FG000|Treatment Period|Participant withdrew consent|3|||
145643966|NCT02576509|525213981|FG001|Treatment Period|Participant withdrew consent|7|||
145643967|NCT02576509|525213980|FG000|Treatment Period|Lost to Follow-up|0|||
145643968|NCT02576509|525213981|FG001|Treatment Period|Lost to Follow-up|1|||
145643969|NCT02576509|525213980|FG000|Treatment Period|Maximum clinical benefit|1|||
145643970|NCT02576509|525213981|FG001|Treatment Period|Maximum clinical benefit|0|||
145643971|NCT02576509|525213980|FG000|Treatment Period|Poor/non-compliance|1|||
145643972|NCT02576509|525213981|FG001|Treatment Period|Poor/non-compliance|1|||
145643973|NCT02576509|525213980|FG000|Treatment Period|Participant no longer meets criteria|1|||
145643974|NCT02576509|525213981|FG001|Treatment Period|Participant no longer meets criteria|0|||
145643975|NCT02576509|525213980|FG000|Treatment Period|Other reason|12|||
145643976|NCT02576509|525213981|FG001|Treatment Period|Other reason|8|||
145643977|NCT02576509|525213980|FG000|Treatment Period|NOT REPORTED|1|||
145643978|NCT02576509|525213981|FG001|Treatment Period|NOT REPORTED|0|||
145643979|NCT02576509|525213980|FG000|Treatment Period|Administrative reason by sponsor|0|||
145643980|NCT02576509|525213981|FG001|Treatment Period|Administrative reason by sponsor|1|||
145643981|NCT01216176|525213985|FG000|Overall Study|Adverse Event|0|||
145643982|NCT01216176|525213986|FG001|Overall Study|Adverse Event|8|||
145643983|NCT01216176|525213987|FG002|Overall Study|Adverse Event|0|||
145643984|NCT01216176|525213985|FG000|Overall Study|Physician Decision|0|||
145643985|NCT01216176|525213986|FG001|Overall Study|Physician Decision|0|||
145643986|NCT01216176|525213987|FG002|Overall Study|Physician Decision|1|||
145643987|NCT03398148|525213990|FG000|Substudy 1 Period 1|Adverse Event|5|||
145643988|NCT03398148|525213991|FG001|Substudy 1 Period 1|Adverse Event|2|||
145643989|NCT03398148|525213992|FG002|Substudy 1 Period 1|Adverse Event|2|||
145643990|NCT03398148|525213993|FG003|Substudy 1 Period 1|Adverse Event|0|||
145643991|NCT03398148|525213994|FG004|Substudy 1 Period 1|Adverse Event|8|||
145643992|NCT03398148|525213995|FG005|Substudy 1 Period 1|Adverse Event|0|||
145643993|NCT03398148|525213996|FG006|Substudy 1 Period 1|Adverse Event|0|||
145643994|NCT03398148|525213997|FG007|Substudy 1 Period 1|Adverse Event|0|||
145643995|NCT03398148|525213998|FG008|Substudy 1 Period 1|Adverse Event|0|||
145643996|NCT03398148|525213999|FG009|Substudy 1 Period 1|Adverse Event|0|||
145643997|NCT03398148|525214000|FG010|Substudy 1 Period 1|Adverse Event|0|||
145643998|NCT03398148|525214001|FG011|Substudy 1 Period 1|Adverse Event|0|||
145643999|NCT03398148|525214002|FG012|Substudy 1 Period 1|Adverse Event|0|||
145644000|NCT03398148|525214003|FG013|Substudy 1 Period 1|Adverse Event|0|||
145644001|NCT03398148|525214004|FG014|Substudy 1 Period 1|Adverse Event|0|||
145644002|NCT03398148|525213990|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
145644003|NCT03398148|525213991|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
145644004|NCT03398148|525213992|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644005|NCT03398148|525213993|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
145644006|NCT03398148|525213994|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
145644007|NCT03398148|525213995|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644008|NCT03398148|525213996|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644009|NCT03398148|525213997|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644010|NCT03398148|525213998|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644011|NCT03398148|525213999|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644012|NCT03398148|525214000|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644013|NCT03398148|525214001|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644014|NCT03398148|525214002|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644015|NCT03398148|525214003|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644016|NCT03398148|525214004|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
145644017|NCT03398148|525213990|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
145644018|NCT03398148|525213991|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
145644019|NCT03398148|525213992|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
145644020|NCT03398148|525213993|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
145644021|NCT03398148|525213994|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
145644022|NCT03398148|525213995|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
145644023|NCT03398148|525213996|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
145644024|NCT03398148|525213997|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
145644025|NCT03398148|525213998|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
145644026|NCT03398148|525213999|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
145644027|NCT03398148|525214000|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
145644028|NCT03398148|525214001|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
145644029|NCT03398148|525214002|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
145644030|NCT03398148|525214003|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
145644031|NCT03398148|525214004|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
145644032|NCT03398148|525213990|FG000|Substudy 1 Period 1|Other|0|||
145644033|NCT03398148|525213991|FG001|Substudy 1 Period 1|Other|1|||
145644034|NCT03398148|525213992|FG002|Substudy 1 Period 1|Other|0|||
145644035|NCT03398148|525213993|FG003|Substudy 1 Period 1|Other|0|||
145644036|NCT03398148|525213994|FG004|Substudy 1 Period 1|Other|3|||
145644037|NCT03398148|525213995|FG005|Substudy 1 Period 1|Other|0|||
145644038|NCT03398148|525213996|FG006|Substudy 1 Period 1|Other|0|||
145644039|NCT03398148|525213997|FG007|Substudy 1 Period 1|Other|0|||
145644040|NCT03398148|525213998|FG008|Substudy 1 Period 1|Other|0|||
145644041|NCT03398148|525213999|FG009|Substudy 1 Period 1|Other|0|||
145644042|NCT03398148|525214000|FG010|Substudy 1 Period 1|Other|0|||
145644043|NCT03398148|525214001|FG011|Substudy 1 Period 1|Other|0|||
145644044|NCT03398148|525214002|FG012|Substudy 1 Period 1|Other|0|||
145644045|NCT03398148|525214003|FG013|Substudy 1 Period 1|Other|0|||
145644046|NCT03398148|525214004|FG014|Substudy 1 Period 1|Other|0|||
145644047|NCT03398148|525213990|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644048|NCT03398148|525213991|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644049|NCT03398148|525213992|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644050|NCT03398148|525213993|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644051|NCT03398148|525213994|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
145644052|NCT03398148|525213995|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644053|NCT03398148|525213996|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644054|NCT03398148|525213997|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644055|NCT03398148|525213998|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644056|NCT03398148|525213999|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644057|NCT03398148|525214000|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644058|NCT03398148|525214001|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644059|NCT03398148|525214002|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644060|NCT03398148|525214003|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644061|NCT03398148|525214004|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
145644062|NCT03398148|525213990|FG000|Substudy 1 Period 2|Adverse Event|0|||
145644063|NCT03398148|525213991|FG001|Substudy 1 Period 2|Adverse Event|0|||
145644064|NCT03398148|525213992|FG002|Substudy 1 Period 2|Adverse Event|0|||
145644065|NCT03398148|525213993|FG003|Substudy 1 Period 2|Adverse Event|0|||
145644066|NCT03398148|525213994|FG004|Substudy 1 Period 2|Adverse Event|0|||
145644067|NCT03398148|525213995|FG005|Substudy 1 Period 2|Adverse Event|2|||
145644068|NCT03398148|525213996|FG006|Substudy 1 Period 2|Adverse Event|4|||
145644069|NCT03398148|525213997|FG007|Substudy 1 Period 2|Adverse Event|0|||
145644070|NCT03398148|525213998|FG008|Substudy 1 Period 2|Adverse Event|0|||
145644071|NCT03398148|525213999|FG009|Substudy 1 Period 2|Adverse Event|0|||
145644072|NCT03398148|525214000|FG010|Substudy 1 Period 2|Adverse Event|0|||
145644073|NCT03398148|525214001|FG011|Substudy 1 Period 2|Adverse Event|0|||
145644074|NCT03398148|525214002|FG012|Substudy 1 Period 2|Adverse Event|0|||
145644075|NCT03398148|525214003|FG013|Substudy 1 Period 2|Adverse Event|0|||
145644076|NCT03398148|525214004|FG014|Substudy 1 Period 2|Adverse Event|0|||
145644077|NCT03398148|525213990|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644078|NCT03398148|525213991|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644079|NCT03398148|525213992|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644080|NCT03398148|525213993|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644081|NCT03398148|525213994|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644082|NCT03398148|525213995|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644083|NCT03398148|525213996|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
145644084|NCT03398148|525213997|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
145644085|NCT03398148|525213998|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644086|NCT03398148|525213999|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644087|NCT03398148|525214000|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644088|NCT03398148|525214001|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644089|NCT03398148|525214002|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644090|NCT03398148|525214003|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644091|NCT03398148|525214004|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
145644092|NCT03398148|525213990|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
145644093|NCT03398148|525213991|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
145644094|NCT03398148|525213992|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
145644095|NCT03398148|525213993|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
145644096|NCT03398148|525213994|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
145644097|NCT03398148|525213995|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
145644098|NCT03398148|525213996|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
145644099|NCT03398148|525213997|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
145644100|NCT03398148|525213998|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
145644101|NCT03398148|525213999|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
145644102|NCT03398148|525214000|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
145644103|NCT03398148|525214001|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
145644104|NCT03398148|525214002|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
145644105|NCT03398148|525214003|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
145644106|NCT03398148|525214004|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
145644107|NCT03398148|525213990|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644108|NCT03398148|525213991|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644109|NCT03398148|525213992|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644110|NCT03398148|525213993|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644111|NCT03398148|525213994|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644112|NCT03398148|525213995|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644113|NCT03398148|525213996|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
145644114|NCT03398148|525213997|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644115|NCT03398148|525213998|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644116|NCT03398148|525213999|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644117|NCT03398148|525214000|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644118|NCT03398148|525214001|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644119|NCT03398148|525214002|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644120|NCT03398148|525214003|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644121|NCT03398148|525214004|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644122|NCT03398148|525213990|FG000|Substudy 1 Period 2|Other|0|||
145644123|NCT03398148|525213991|FG001|Substudy 1 Period 2|Other|0|||
145644124|NCT03398148|525213992|FG002|Substudy 1 Period 2|Other|0|||
145644125|NCT03398148|525213993|FG003|Substudy 1 Period 2|Other|0|||
145644126|NCT03398148|525213994|FG004|Substudy 1 Period 2|Other|0|||
145644127|NCT03398148|525213995|FG005|Substudy 1 Period 2|Other|0|||
145644128|NCT03398148|525213996|FG006|Substudy 1 Period 2|Other|1|||
145486539|NCT02452424|524635063|FG004|Overall Study|Adverse Event|0|||
145644129|NCT03398148|525213997|FG007|Substudy 1 Period 2|Other|0|||
145486540|NCT02452424|524635064|FG005|Overall Study|Adverse Event|0|||
145644130|NCT03398148|525213998|FG008|Substudy 1 Period 2|Other|0|||
145644131|NCT03398148|525213999|FG009|Substudy 1 Period 2|Other|0|||
145644132|NCT03398148|525214000|FG010|Substudy 1 Period 2|Other|0|||
145644133|NCT03398148|525214001|FG011|Substudy 1 Period 2|Other|0|||
145644134|NCT03398148|525214002|FG012|Substudy 1 Period 2|Other|0|||
145644135|NCT03398148|525214003|FG013|Substudy 1 Period 2|Other|0|||
145644136|NCT03398148|525214004|FG014|Substudy 1 Period 2|Other|0|||
145644137|NCT03398148|525213990|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644138|NCT03398148|525213991|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644139|NCT03398148|525213992|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644140|NCT03398148|525213993|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644141|NCT03398148|525213994|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644142|NCT03398148|525213995|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644143|NCT03398148|525213996|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
145644144|NCT03398148|525213997|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644145|NCT03398148|525213998|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644146|NCT03398148|525213999|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644147|NCT03398148|525214000|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644148|NCT03398148|525214001|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644149|NCT03398148|525214002|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644150|NCT03398148|525214003|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644151|NCT03398148|525214004|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
145644152|NCT03398148|525213990|FG000|Substudy 2 Period 1|Adverse Event|0|||
145644153|NCT03398148|525213991|FG001|Substudy 2 Period 1|Adverse Event|0|||
145644154|NCT03398148|525213992|FG002|Substudy 2 Period 1|Adverse Event|0|||
145644155|NCT03398148|525213993|FG003|Substudy 2 Period 1|Adverse Event|0|||
145644156|NCT03398148|525213994|FG004|Substudy 2 Period 1|Adverse Event|0|||
145644157|NCT03398148|525213995|FG005|Substudy 2 Period 1|Adverse Event|0|||
145644158|NCT03398148|525213996|FG006|Substudy 2 Period 1|Adverse Event|0|||
145644159|NCT03398148|525213997|FG007|Substudy 2 Period 1|Adverse Event|0|||
145644160|NCT03398148|525213998|FG008|Substudy 2 Period 1|Adverse Event|0|||
145644161|NCT03398148|525213999|FG009|Substudy 2 Period 1|Adverse Event|12|||
145644162|NCT03398148|525214000|FG010|Substudy 2 Period 1|Adverse Event|2|||
145644163|NCT03398148|525214001|FG011|Substudy 2 Period 1|Adverse Event|0|||
145644164|NCT03398148|525214002|FG012|Substudy 2 Period 1|Adverse Event|0|||
145644165|NCT03398148|525214003|FG013|Substudy 2 Period 1|Adverse Event|0|||
145644166|NCT03398148|525214004|FG014|Substudy 2 Period 1|Adverse Event|0|||
145644167|NCT03398148|525213990|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644168|NCT03398148|525213991|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644169|NCT03398148|525213992|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644170|NCT03398148|525213993|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644171|NCT03398148|525213994|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644172|NCT03398148|525213995|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644173|NCT03398148|525213996|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644174|NCT03398148|525213997|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644175|NCT03398148|525213998|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644176|NCT03398148|525213999|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
145644177|NCT03398148|525214000|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
145644178|NCT03398148|525214001|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644179|NCT03398148|525214002|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644180|NCT03398148|525214003|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644181|NCT03398148|525214004|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
145644182|NCT03398148|525213990|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
145644183|NCT03398148|525213991|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
145644184|NCT03398148|525213992|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
145644185|NCT03398148|525213993|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
145644186|NCT03398148|525213994|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
145644187|NCT03398148|525213995|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
145644188|NCT03398148|525213996|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
145644189|NCT03398148|525213997|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
145644190|NCT03398148|525213998|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
145644191|NCT03398148|525213999|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
145644192|NCT03398148|525214000|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
145644193|NCT03398148|525214001|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
145644194|NCT03398148|525214002|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
145644195|NCT03398148|525214003|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
145644196|NCT03398148|525214004|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
145644197|NCT03398148|525213990|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644198|NCT03398148|525213991|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644199|NCT03398148|525213992|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644200|NCT03398148|525213993|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644201|NCT03398148|525213994|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644202|NCT03398148|525213995|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644203|NCT03398148|525213996|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644204|NCT03398148|525213997|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644205|NCT03398148|525213998|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644206|NCT03398148|525213999|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644207|NCT03398148|525214000|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
145644208|NCT03398148|525214001|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644209|NCT03398148|525214002|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644210|NCT03398148|525214003|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644211|NCT03398148|525214004|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
145644212|NCT03398148|525213990|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644213|NCT03398148|525213991|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644214|NCT03398148|525213992|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644215|NCT03398148|525213993|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644216|NCT03398148|525213994|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644217|NCT03398148|525213995|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644218|NCT03398148|525213996|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644219|NCT03398148|525213997|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644220|NCT03398148|525213998|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644221|NCT03398148|525213999|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644222|NCT03398148|525214000|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
145644223|NCT03398148|525214001|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644224|NCT03398148|525214002|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644225|NCT03398148|525214003|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644226|NCT03398148|525214004|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
145644227|NCT03398148|525213990|FG000|Substudy 2 Period 1|Other|0|||
145644228|NCT03398148|525213991|FG001|Substudy 2 Period 1|Other|0|||
145644229|NCT03398148|525213992|FG002|Substudy 2 Period 1|Other|0|||
145644230|NCT03398148|525213993|FG003|Substudy 2 Period 1|Other|0|||
145644231|NCT03398148|525213994|FG004|Substudy 2 Period 1|Other|0|||
145644232|NCT03398148|525213995|FG005|Substudy 2 Period 1|Other|0|||
145644233|NCT03398148|525213996|FG006|Substudy 2 Period 1|Other|0|||
145644234|NCT03398148|525213997|FG007|Substudy 2 Period 1|Other|0|||
145644235|NCT03398148|525213998|FG008|Substudy 2 Period 1|Other|0|||
145644236|NCT03398148|525213999|FG009|Substudy 2 Period 1|Other|4|||
145644237|NCT03398148|525214000|FG010|Substudy 2 Period 1|Other|4|||
145644238|NCT03398148|525214001|FG011|Substudy 2 Period 1|Other|0|||
145644239|NCT03398148|525214002|FG012|Substudy 2 Period 1|Other|0|||
145644240|NCT03398148|525214003|FG013|Substudy 2 Period 1|Other|0|||
145644241|NCT03398148|525214004|FG014|Substudy 2 Period 1|Other|0|||
145644242|NCT03398148|525213990|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644243|NCT03398148|525213991|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644244|NCT03398148|525213992|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644245|NCT03398148|525213993|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644246|NCT03398148|525213994|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644247|NCT03398148|525213995|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644248|NCT03398148|525213996|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644249|NCT03398148|525213997|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644250|NCT03398148|525213998|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644251|NCT03398148|525213999|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644252|NCT03398148|525214000|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
145644253|NCT03398148|525214001|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644254|NCT03398148|525214002|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644255|NCT03398148|525214003|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644256|NCT03398148|525214004|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
145644257|NCT03398148|525213990|FG000|Substudy 2 Period 2|Adverse Event|0|||
145644258|NCT03398148|525213991|FG001|Substudy 2 Period 2|Adverse Event|0|||
145644259|NCT03398148|525213992|FG002|Substudy 2 Period 2|Adverse Event|0|||
145644260|NCT03398148|525213993|FG003|Substudy 2 Period 2|Adverse Event|0|||
145644261|NCT03398148|525213994|FG004|Substudy 2 Period 2|Adverse Event|0|||
145644262|NCT03398148|525213995|FG005|Substudy 2 Period 2|Adverse Event|0|||
145644263|NCT03398148|525213996|FG006|Substudy 2 Period 2|Adverse Event|0|||
145644264|NCT03398148|525213997|FG007|Substudy 2 Period 2|Adverse Event|0|||
145644265|NCT03398148|525213998|FG008|Substudy 2 Period 2|Adverse Event|0|||
145644266|NCT03398148|525213999|FG009|Substudy 2 Period 2|Adverse Event|0|||
145644267|NCT03398148|525214000|FG010|Substudy 2 Period 2|Adverse Event|0|||
145644268|NCT03398148|525214001|FG011|Substudy 2 Period 2|Adverse Event|0|||
145644269|NCT03398148|525214002|FG012|Substudy 2 Period 2|Adverse Event|0|||
145644270|NCT03398148|525214003|FG013|Substudy 2 Period 2|Adverse Event|1|||
145644271|NCT03398148|525214004|FG014|Substudy 2 Period 2|Adverse Event|3|||
145644272|NCT03398148|525213990|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
145644273|NCT03398148|525213991|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
145644274|NCT03398148|525213992|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
145644275|NCT03398148|525213993|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
145644276|NCT03398148|525213994|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
145644277|NCT03398148|525213995|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
145644278|NCT03398148|525213996|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
145644279|NCT03398148|525213997|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
145644280|NCT03398148|525213998|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
145644281|NCT03398148|525213999|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
145644282|NCT03398148|525214000|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
145644283|NCT03398148|525214001|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
145644284|NCT03398148|525214002|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
145644285|NCT03398148|525214003|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
145265307|NCT03323034|523819274|FG003|Overall Study|Physician Decision|0|||
145644286|NCT03398148|525214004|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
145644287|NCT03398148|525213990|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644288|NCT03398148|525213991|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644289|NCT03398148|525213992|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644290|NCT03398148|525213993|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644291|NCT03398148|525213994|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644292|NCT03398148|525213995|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644293|NCT03398148|525213996|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644294|NCT03398148|525213997|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644295|NCT03398148|525213998|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644296|NCT03398148|525213999|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644297|NCT03398148|525214000|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644298|NCT03398148|525214001|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
145644299|NCT03398148|525214002|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
145644300|NCT03398148|525214003|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
145644301|NCT03398148|525214004|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
145644302|NCT03398148|525213990|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
145644303|NCT03398148|525213991|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
145644304|NCT03398148|525213992|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
145644305|NCT03398148|525213993|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
145644306|NCT03398148|525213994|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
145644307|NCT03398148|525213995|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
145644308|NCT03398148|525213996|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
145644309|NCT03398148|525213997|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
145644310|NCT03398148|525213998|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
145644311|NCT03398148|525213999|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
145644312|NCT03398148|525214000|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
145644313|NCT03398148|525214001|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
145644314|NCT03398148|525214002|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
145644315|NCT03398148|525214003|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
145644316|NCT03398148|525214004|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
145644317|NCT03398148|525213990|FG000|Substudy 2 Period 2|Other|0|||
145644318|NCT03398148|525213991|FG001|Substudy 2 Period 2|Other|0|||
145644319|NCT03398148|525213992|FG002|Substudy 2 Period 2|Other|0|||
145644320|NCT03398148|525213993|FG003|Substudy 2 Period 2|Other|0|||
145644321|NCT03398148|525213994|FG004|Substudy 2 Period 2|Other|0|||
145644322|NCT03398148|525213995|FG005|Substudy 2 Period 2|Other|0|||
145644323|NCT03398148|525213996|FG006|Substudy 2 Period 2|Other|0|||
145644324|NCT03398148|525213997|FG007|Substudy 2 Period 2|Other|0|||
145644325|NCT03398148|525213998|FG008|Substudy 2 Period 2|Other|0|||
145644326|NCT03398148|525213999|FG009|Substudy 2 Period 2|Other|0|||
145644327|NCT03398148|525214000|FG010|Substudy 2 Period 2|Other|0|||
145644328|NCT03398148|525214001|FG011|Substudy 2 Period 2|Other|0|||
145644329|NCT03398148|525214002|FG012|Substudy 2 Period 2|Other|0|||
145644330|NCT03398148|525214003|FG013|Substudy 2 Period 2|Other|1|||
145644331|NCT03398148|525214004|FG014|Substudy 2 Period 2|Other|1|||
145644332|NCT03398148|525213990|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644333|NCT03398148|525213991|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644334|NCT03398148|525213992|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644335|NCT03398148|525213993|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644336|NCT03398148|525213994|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644337|NCT03398148|525213995|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644338|NCT03398148|525213996|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644339|NCT03398148|525213997|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644340|NCT03398148|525213998|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644341|NCT03398148|525213999|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644342|NCT03398148|525214000|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644343|NCT03398148|525214001|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644344|NCT03398148|525214002|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
145644345|NCT03398148|525214003|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
145644346|NCT03398148|525214004|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
145644347|NCT04201834|525214005|FG000|Overall Study|Screen fail|1|||
145644348|NCT00212355|525214006|FG000|Overall Study|Adverse Event|1|||
145644349|NCT00212355|525214006|FG000|Overall Study|Withdrawal by Subject|1|||
145644350|NCT00212355|525214006|FG000|Overall Study|A change of address|1|||
145644351|NCT04104321|525214012|FG000|Overall Study|didn't take the study drug|3|||
145644352|NCT03012841|525214013|FG000|Overall Study|Protocol Violation|0|||
145644353|NCT03012841|525214014|FG001|Overall Study|Protocol Violation|10|||
145644354|NCT03012841|525214013|FG000|Overall Study|Lost to Follow-up|6|||
145644355|NCT03012841|525214014|FG001|Overall Study|Lost to Follow-up|1|||
145644356|NCT03012841|525214013|FG000|Overall Study|Withdrawal by Subject|6|||
145644357|NCT03012841|525214014|FG001|Overall Study|Withdrawal by Subject|0|||
145644358|NCT03012841|525214013|FG000|Overall Study|Unable to complete 12 month visit|6|||
145644359|NCT03012841|525214014|FG001|Overall Study|Unable to complete 12 month visit|0|||
145644360|NCT03012841|525214013|FG000|Overall Study|Subject relocation|1|||
145644361|NCT03012841|525214014|FG001|Overall Study|Subject relocation|0|||
145644362|NCT03012841|525214013|FG000|Overall Study|Seasonal winter travel|1|||
145644363|NCT03012841|525214014|FG001|Overall Study|Seasonal winter travel|0|||
145644364|NCT03012841|525214013|FG000|Overall Study|Physician Decision|0|||
145644365|NCT03012841|525214014|FG001|Overall Study|Physician Decision|2|||
145644366|NCT03012841|525214013|FG000|Overall Study|No ablation performed|0|||
145644367|NCT03012841|525214014|FG001|Overall Study|No ablation performed|2|||
145644368|NCT03012841|525214013|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
145644369|NCT03012841|525214014|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
145644370|NCT03012841|525214013|FG000|Overall Study|Insurance change|0|||
145644371|NCT03012841|525214014|FG001|Overall Study|Insurance change|1|||
145644372|NCT03954184|525214015|FG000|Overall Study|Lost to Follow-up|500|||
145644373|NCT03954184|525214016|FG001|Overall Study|Lost to Follow-up|0|||
145644374|NCT04038957|525214017|FG000|Overall Study|Withdrawal by Subject|1|||
145644375|NCT04038957|525214017|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
145644376|NCT04065048|525214018|FG000|Overall Study|Withdrawal by Subject|1|||
145644377|NCT04065048|525214019|FG001|Overall Study|Withdrawal by Subject|2|||
145644378|NCT04065048|525214020|FG002|Overall Study|Withdrawal by Subject|1|||
145644379|NCT04065048|525214021|FG003|Overall Study|Withdrawal by Subject|1|||
145644380|NCT04065048|525214018|FG000|Overall Study|Adverse Event|1|||
145644381|NCT04065048|525214019|FG001|Overall Study|Adverse Event|0|||
145644382|NCT04065048|525214020|FG002|Overall Study|Adverse Event|1|||
145644383|NCT04065048|525214021|FG003|Overall Study|Adverse Event|0|||
145644384|NCT03397108|525214022|FG000|Overall Study|Lost to Follow-up|15|||
145644385|NCT03397108|525214023|FG001|Overall Study|Lost to Follow-up|0|||
145644386|NCT03397108|525214022|FG000|Overall Study|Insufficient milk production|3|||
145644387|NCT03397108|525214023|FG001|Overall Study|Insufficient milk production|2|||
145644388|NCT03397108|525214022|FG000|Overall Study|Withdrawal by Subject|2|||
145644389|NCT03397108|525214023|FG001|Overall Study|Withdrawal by Subject|0|||
145644390|NCT03554265|525214024|FG000|Overall Study|Withdrawal by Subject|2|||
145644391|NCT03554265|525214025|FG001|Overall Study|Withdrawal by Subject|2|||
145644392|NCT03554265|525214026|FG002|Overall Study|Withdrawal by Subject|3|||
145644393|NCT03554265|525214024|FG000|Overall Study|Physician Decision|0|||
145644394|NCT03554265|525214025|FG001|Overall Study|Physician Decision|0|||
145644395|NCT03554265|525214026|FG002|Overall Study|Physician Decision|1|||
145644396|NCT02652260|525214027|FG000|Base Study|Pregnancy|0|||
145644397|NCT02652260|525214028|FG001|Base Study|Pregnancy|1|||
145644398|NCT02652260|525214027|FG000|Base Study|Withdrawal by Subject|0|||
145644399|NCT02652260|525214028|FG001|Base Study|Withdrawal by Subject|1|||
145644400|NCT02652260|525214027|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
145644401|NCT02652260|525214028|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
145644402|NCT02652260|525214027|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
145644403|NCT02652260|525214028|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
145644404|NCT02652260|525214027|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
145644405|NCT02652260|525214028|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
145644406|NCT02652260|525214027|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
145644407|NCT02652260|525214028|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
145644408|NCT02652260|525214027|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
145644409|NCT02652260|525214028|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
145644410|NCT02652260|525214027|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
145644411|NCT02652260|525214028|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
145644412|NCT02652260|525214027|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
145644413|NCT02652260|525214028|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
145644414|NCT02652260|525214027|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
145644415|NCT02652260|525214028|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
145644416|NCT02652260|525214027|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
145644417|NCT02652260|525214028|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
145644418|NCT02652260|525214027|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
145644419|NCT02652260|525214028|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
145644420|NCT02652260|525214027|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
145644421|NCT02652260|525214028|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
145644422|NCT02652260|525214027|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
145644423|NCT02652260|525214028|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
145644424|NCT05104697|525214029|FG000|Overall Study|Withdrawal by Subject|0|||
145644425|NCT05104697|525214030|FG001|Overall Study|Withdrawal by Subject|1|||
145644426|NCT03358875|525214033|FG000|Overall Study|Death|409|||
145644427|NCT03358875|525214034|FG001|Overall Study|Death|223|||
145644428|NCT03358875|525214033|FG000|Overall Study|Study Closed by Sponsor|66|||
145644429|NCT03358875|525214034|FG001|Overall Study|Study Closed by Sponsor|29|||
145644430|NCT03358875|525214033|FG000|Overall Study|Withdrawal by Subject|13|||
145644431|NCT03358875|525214034|FG001|Overall Study|Withdrawal by Subject|16|||
145644432|NCT03358875|525214033|FG000|Overall Study|Lost to Follow-up|13|||
145644433|NCT03358875|525214034|FG001|Overall Study|Lost to Follow-up|2|||
145644434|NCT03358875|525214033|FG000|Overall Study|Miscellaneous|33|||
145644435|NCT03358875|525214034|FG001|Overall Study|Miscellaneous|0|||
145644436|NCT03358875|525214033|FG000|Overall Study|Remained on Study|1|||
145644437|NCT03358875|525214034|FG001|Overall Study|Remained on Study|0|||
145644438|NCT06194214|525214038|FG000|Overall Study|Adverse Event|1|||
145644439|NCT04468776|525214039|FG000|Overall Study|Lost to Follow-up|4|||
145644440|NCT04468776|525214040|FG001|Overall Study|Lost to Follow-up|3|||
145644441|NCT04468776|525214041|FG002|Overall Study|Lost to Follow-up|4|||
145644442|NCT04468776|525214039|FG000|Overall Study|Withdrawal by Subject|1|||
145644443|NCT04468776|525214040|FG001|Overall Study|Withdrawal by Subject|10|||
145644444|NCT04468776|525214041|FG002|Overall Study|Withdrawal by Subject|4|||
145644445|NCT04468776|525214039|FG000|Overall Study|Physician Decision|0|||
145486541|NCT02452424|524635065|FG006|Overall Study|Adverse Event|0|||
145486542|NCT02452424|524635066|FG007|Overall Study|Adverse Event|0|||
145486543|NCT02452424|524635067|FG008|Overall Study|Adverse Event|0|||
145486544|NCT02452424|524635068|FG009|Overall Study|Adverse Event|0|||
145486545|NCT02452424|524635069|FG010|Overall Study|Adverse Event|1|||
145486546|NCT01463306|524635070|FG000|Overall Study|Adverse Event|6|||
145486547|NCT01463306|524635071|FG001|Overall Study|Adverse Event|9|||
145486548|NCT01463306|524635072|FG002|Overall Study|Adverse Event|3|||
145486549|NCT01463306|524635070|FG000|Overall Study|Death|3|||
145486550|NCT01463306|524635071|FG001|Overall Study|Death|3|||
145486551|NCT01463306|524635072|FG002|Overall Study|Death|0|||
145486552|NCT01463306|524635070|FG000|Overall Study|Lack of Efficacy|22|||
145486553|NCT01463306|524635071|FG001|Overall Study|Lack of Efficacy|16|||
145486554|NCT01463306|524635072|FG002|Overall Study|Lack of Efficacy|1|||
145486555|NCT01463306|524635070|FG000|Overall Study|Lost to Follow-up|5|||
145644446|NCT04468776|525214040|FG001|Overall Study|Physician Decision|1|||
145644447|NCT04468776|525214041|FG002|Overall Study|Physician Decision|1|||
145644448|NCT05687903|525214042|FG000|Overall Study|Protocol Deviation|1|||
145644449|NCT05687903|525214043|FG001|Overall Study|Protocol Deviation|1|||
145644450|NCT05687903|525214044|FG002|Overall Study|Protocol Deviation|0|||
145644451|NCT05687903|525214045|FG003|Overall Study|Protocol Deviation|1|||
145644452|NCT05687903|525214046|FG004|Overall Study|Protocol Deviation|0|||
145644453|NCT05613205|525214047|FG000|Overall Study|Lost to Follow-up|0|||
145644454|NCT05613205|525214048|FG001|Overall Study|Lost to Follow-up|0|||
145644455|NCT05613205|525214049|FG002|Overall Study|Lost to Follow-up|1|||
145644456|NCT05613205|525214050|FG003|Overall Study|Lost to Follow-up|1|||
145644457|NCT05613205|525214051|FG004|Overall Study|Lost to Follow-up|0|||
145644458|NCT05613205|525214047|FG000|Overall Study|Withdrawal by Subject|0|||
145644459|NCT05613205|525214048|FG001|Overall Study|Withdrawal by Subject|0|||
145644460|NCT05613205|525214049|FG002|Overall Study|Withdrawal by Subject|1|||
145644461|NCT05613205|525214050|FG003|Overall Study|Withdrawal by Subject|1|||
145644462|NCT05613205|525214051|FG004|Overall Study|Withdrawal by Subject|0|||
145644463|NCT02879448|525214054|FG000|Overall Study|Death|251|||
145644464|NCT02879448|525214055|FG001|Overall Study|Death|263|||
145644465|NCT02879448|525214054|FG000|Overall Study|Lost to Follow-up|23|||
145644466|NCT02879448|525214055|FG001|Overall Study|Lost to Follow-up|28|||
145644467|NCT02879448|525214054|FG000|Overall Study|Withdrawal by Subject|42|||
145644468|NCT02879448|525214055|FG001|Overall Study|Withdrawal by Subject|79|||
145644469|NCT02879448|525214054|FG000|Overall Study|Other Reasons|8|||
145644470|NCT02879448|525214055|FG001|Overall Study|Other Reasons|12|||
145644471|NCT04300231|525214056|FG000|Overall Study|Protocol Violation|4|||
145644472|NCT04300231|525214057|FG001|Overall Study|Protocol Violation|3|||
145644473|NCT04300231|525214058|FG002|Overall Study|Protocol Violation|0|||
145644474|NCT04300231|525214059|FG003|Overall Study|Protocol Violation|2|||
145644475|NCT01610297|525214061|FG000|Overall Study|Lost to Follow-up|1|||
145644476|NCT02590432|525214062|FG000|Open-label Treatment Period|Adverse Event|97|||
145644477|NCT02590432|525214063|FG001|Open-label Treatment Period|Adverse Event|79|||
145644478|NCT02590432|525214064|FG002|Open-label Treatment Period|Adverse Event|0|||
145644479|NCT02590432|525214065|FG003|Open-label Treatment Period|Adverse Event|0|||
145644480|NCT02590432|525214066|FG004|Open-label Treatment Period|Adverse Event|0|||
145644481|NCT02590432|525214067|FG005|Open-label Treatment Period|Adverse Event|0|||
145644482|NCT02590432|525214068|FG006|Open-label Treatment Period|Adverse Event|0|||
145644483|NCT02590432|525214069|FG007|Open-label Treatment Period|Adverse Event|0|||
145486556|NCT01463306|524635071|FG001|Overall Study|Lost to Follow-up|2|||
145486557|NCT01463306|524635072|FG002|Overall Study|Lost to Follow-up|0|||
145486558|NCT01463306|524635070|FG000|Overall Study|Protocol Violation|4|||
145486559|NCT01463306|524635071|FG001|Overall Study|Protocol Violation|0|||
145644484|NCT02590432|525214070|FG008|Open-label Treatment Period|Adverse Event|0|||
145644485|NCT02590432|525214062|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
145644486|NCT02590432|525214063|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
145644487|NCT02590432|525214064|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
145486560|NCT01463306|524635072|FG002|Overall Study|Protocol Violation|0|||
145486561|NCT01463306|524635070|FG000|Overall Study|Withdrawal by Subject|19|||
145486562|NCT01463306|524635071|FG001|Overall Study|Withdrawal by Subject|9|||
145486563|NCT01463306|524635072|FG002|Overall Study|Withdrawal by Subject|1|||
145644488|NCT02590432|525214065|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
145644489|NCT02590432|525214066|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
145644490|NCT02590432|525214067|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
145644491|NCT02590432|525214068|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
145644492|NCT02590432|525214069|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
145644493|NCT02590432|525214070|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
145644494|NCT02590432|525214062|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
145644495|NCT02590432|525214063|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
145644496|NCT02590432|525214064|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
145644497|NCT02590432|525214065|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
145644498|NCT02590432|525214066|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
145644499|NCT02590432|525214067|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
145644500|NCT02590432|525214068|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
145644501|NCT02590432|525214069|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
145644502|NCT02590432|525214070|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
145644503|NCT02590432|525214062|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
145644504|NCT02590432|525214063|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
145644505|NCT02590432|525214064|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
145644506|NCT02590432|525214065|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
145644507|NCT02590432|525214066|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
145644508|NCT02590432|525214067|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
145644509|NCT02590432|525214068|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
145644510|NCT02590432|525214069|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
145644511|NCT02590432|525214070|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
145644512|NCT02590432|525214062|FG000|Open-label Treatment Period|Protocol Violation|10|||
145644513|NCT02590432|525214063|FG001|Open-label Treatment Period|Protocol Violation|4|||
145644514|NCT02590432|525214064|FG002|Open-label Treatment Period|Protocol Violation|0|||
145644515|NCT02590432|525214065|FG003|Open-label Treatment Period|Protocol Violation|0|||
145644516|NCT02590432|525214066|FG004|Open-label Treatment Period|Protocol Violation|0|||
145644517|NCT02590432|525214067|FG005|Open-label Treatment Period|Protocol Violation|0|||
145644518|NCT02590432|525214068|FG006|Open-label Treatment Period|Protocol Violation|0|||
145644519|NCT02590432|525214069|FG007|Open-label Treatment Period|Protocol Violation|0|||
145644520|NCT02590432|525214070|FG008|Open-label Treatment Period|Protocol Violation|0|||
145644521|NCT02590432|525214062|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
145644522|NCT02590432|525214063|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
145644523|NCT02590432|525214064|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644524|NCT02590432|525214065|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644525|NCT02590432|525214066|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644526|NCT02590432|525214067|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644527|NCT02590432|525214068|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644528|NCT02590432|525214069|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644529|NCT02590432|525214070|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
145644530|NCT02590432|525214062|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
145644531|NCT02590432|525214063|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
145644532|NCT02590432|525214064|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644533|NCT02590432|525214065|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644534|NCT02590432|525214066|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644535|NCT02590432|525214067|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644536|NCT02590432|525214068|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644537|NCT02590432|525214069|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644538|NCT02590432|525214070|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
145644539|NCT02590432|525214062|FG000|Double-blind Treatment Period|Adverse Event|0|||
145486564|NCT01463306|524635070|FG000|Overall Study|Other|26|||
145486565|NCT01463306|524635071|FG001|Overall Study|Other|13|||
145486566|NCT01463306|524635072|FG002|Overall Study|Other|0|||
145486567|NCT01463306|524635070|FG000|Overall Study|Approval expiry at site|1|||
145486568|NCT01463306|524635071|FG001|Overall Study|Approval expiry at site|0|||
145486569|NCT01463306|524635072|FG002|Overall Study|Approval expiry at site|0|||
145486570|NCT01059318|524635073|FG000|Core Study (26 Week)|Adverse Event|3|||
145486571|NCT01059318|524635073|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
145486572|NCT01059318|524635073|FG000|Extension (36 Week)|Adverse Event|3|||
145486573|NCT00176462|524635083|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
145486574|NCT00176462|524635084|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
145486575|NCT00176462|524635083|FG000|Induction (4 Weeks)|Death|1|||
145486576|NCT00176462|524635084|FG001|Induction (4 Weeks)|Death|2|||
145486577|NCT00176462|524635083|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
145486578|NCT00176462|524635084|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
145644540|NCT02590432|525214063|FG001|Double-blind Treatment Period|Adverse Event|0|||
145486579|NCT00176462|524635083|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
145486580|NCT00176462|524635084|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
145486581|NCT00176462|524635083|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
145486582|NCT00176462|524635084|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
145644541|NCT02590432|525214064|FG002|Double-blind Treatment Period|Adverse Event|14|||
145486583|NCT00176462|524635083|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
145486584|NCT00176462|524635084|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
145644542|NCT02590432|525214065|FG003|Double-blind Treatment Period|Adverse Event|12|||
145644543|NCT02590432|525214066|FG004|Double-blind Treatment Period|Adverse Event|6|||
145644544|NCT02590432|525214067|FG005|Double-blind Treatment Period|Adverse Event|22|||
145644545|NCT02590432|525214068|FG006|Double-blind Treatment Period|Adverse Event|20|||
145644546|NCT02590432|525214069|FG007|Double-blind Treatment Period|Adverse Event|0|||
145644547|NCT02590432|525214070|FG008|Double-blind Treatment Period|Adverse Event|0|||
145644548|NCT02590432|525214062|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
145644549|NCT02590432|525214063|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145644550|NCT02590432|525214064|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
145644551|NCT02590432|525214065|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
145644552|NCT02590432|525214066|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
145644553|NCT02590432|525214067|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
145644554|NCT02590432|525214068|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
145644555|NCT02590432|525214069|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
145644556|NCT02590432|525214070|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
145644557|NCT02590432|525214062|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
145644558|NCT02590432|525214063|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
145644559|NCT02590432|525214064|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
145644560|NCT02590432|525214065|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
145644561|NCT02590432|525214066|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
145644562|NCT02590432|525214067|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
145644563|NCT02590432|525214068|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
145644564|NCT02590432|525214069|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
145644565|NCT02590432|525214070|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
145644566|NCT02590432|525214062|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
145644567|NCT02590432|525214063|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145644568|NCT02590432|525214064|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
145644569|NCT02590432|525214065|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145644570|NCT02590432|525214066|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
145644571|NCT02590432|525214067|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
145644572|NCT02590432|525214068|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
145644573|NCT02590432|525214069|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
145644574|NCT02590432|525214070|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
145644575|NCT02590432|525214062|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644576|NCT02590432|525214063|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644577|NCT02590432|525214064|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644578|NCT02590432|525214065|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644579|NCT02590432|525214066|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644580|NCT02590432|525214067|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
145644581|NCT02590432|525214068|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644582|NCT02590432|525214069|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644583|NCT02590432|525214070|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
145644584|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644585|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644586|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644587|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644588|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644589|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644590|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
145644591|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
145644592|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
145644593|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145486585|NCT00176462|524635083|FG000|Consolidation (12 Weeks)|Not documented|0|||
145486586|NCT00176462|524635084|FG001|Consolidation (12 Weeks)|Not documented|1|||
145486587|NCT00176462|524635083|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
145486588|NCT00176462|524635084|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
145486589|NCT00176462|524635083|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
145486590|NCT00176462|524635084|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
145486591|NCT01150097|524635086|FG000|Months 24 to 36 Post-transplantation|Death|2|||
145486592|NCT01150097|524635087|FG001|Months 24 to 36 Post-transplantation|Death|0|||
145486593|NCT01150097|524635088|FG002|Months 24 to 36 Post-transplantation|Death|0|||
145486594|NCT01150097|524635086|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
145486595|NCT01150097|524635087|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
145486596|NCT01150097|524635088|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
145644594|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644595|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145486597|NCT01150097|524635086|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
145486598|NCT01150097|524635087|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
145486599|NCT01150097|524635088|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
145486600|NCT01150097|524635086|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
145486601|NCT01150097|524635087|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
145486602|NCT01150097|524635088|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
145486603|NCT01150097|524635086|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
145486604|NCT01150097|524635087|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
145486605|NCT01150097|524635088|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
145486606|NCT01150097|524635086|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
145486607|NCT01150097|524635087|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
145644596|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644597|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644598|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644599|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644600|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
145644601|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
145644602|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644603|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644604|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644605|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644606|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644607|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644608|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
145644609|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
145644610|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
145644611|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644612|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644613|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644614|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644615|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644616|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644617|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644618|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
145644619|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
145644620|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644621|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644622|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644623|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644624|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644625|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644626|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644627|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
145644628|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
145644629|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644630|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644631|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644632|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644633|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644634|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644635|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644636|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
145644637|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
145644638|NCT02590432|525214062|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644639|NCT02590432|525214063|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644640|NCT02590432|525214064|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644641|NCT02590432|525214065|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644642|NCT02590432|525214066|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644643|NCT02590432|525214067|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644644|NCT02590432|525214068|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644645|NCT02590432|525214069|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
145644646|NCT02590432|525214070|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
145644647|NCT02006758|525214071|FG000|Overall Study|Protocol Violation|1|||
145486608|NCT01150097|524635088|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
145486609|NCT01150097|524635086|FG000|Months 24 to 48 Post-transplantation|Death|2|||
145486610|NCT01150097|524635087|FG001|Months 24 to 48 Post-transplantation|Death|0|||
145486611|NCT01150097|524635088|FG002|Months 24 to 48 Post-transplantation|Death|0|||
145486612|NCT01301833|524635089|FG000|Overall Study|Adverse Event|7|||
145644648|NCT02006758|525214071|FG000|Overall Study|Death|1|||
145644649|NCT02006758|525214071|FG000|Overall Study|Lost to Follow-up|4|||
145644650|NCT02006758|525214071|FG000|Overall Study|Withdrawal by Subject|4|||
145644651|NCT02006758|525214071|FG000|Overall Study|Procedurally excluded|1|||
145644652|NCT02006758|525214071|FG000|Overall Study|Other|2|||
145644653|NCT04328727|525214075|FG000|Overall Study|Guardian Decision|1|||
145644654|NCT04328727|525214075|FG000|Overall Study|Participant decision|4|||
145644655|NCT04328727|525214075|FG000|Overall Study|Death|3|||
145644656|NCT04149002|525214076|FG000|Overall Study|Lost to Follow-up|1|||
145644657|NCT04149002|525214077|FG001|Overall Study|Lost to Follow-up|0|||
145644658|NCT04149002|525214076|FG000|Overall Study|Withdrawal by Subject|1|||
145644659|NCT04149002|525214077|FG001|Overall Study|Withdrawal by Subject|0|||
145644660|NCT04704284|525214078|FG000|Overall Study|Withdrawal by Subject|1|||
145644661|NCT02538341|525214082|FG000|Overall Study|Lost to Follow-up|51|||
145644662|NCT02538341|525214083|FG001|Overall Study|Lost to Follow-up|46|||
145644663|NCT02538341|525214082|FG000|Overall Study|Withdrawal by Subject|3|||
145644664|NCT02538341|525214083|FG001|Overall Study|Withdrawal by Subject|1|||
145644665|NCT02538341|525214082|FG000|Overall Study|Death|2|||
145644666|NCT02538341|525214083|FG001|Overall Study|Death|0|||
145644667|NCT00393484|525214088|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
145644668|NCT00393484|525214089|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
145644669|NCT00393484|525214088|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
145644670|NCT00393484|525214089|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
145644671|NCT00393484|525214088|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
145644672|NCT00393484|525214089|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
145644673|NCT00393484|525214088|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
145644674|NCT00393484|525214089|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
145644675|NCT00393484|525214088|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
145644676|NCT00393484|525214089|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
145644677|NCT00393484|525214088|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
145644678|NCT00393484|525214089|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
145644679|NCT00393484|525214088|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
145644680|NCT00393484|525214089|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
145644681|NCT00393484|525214088|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
145644682|NCT00393484|525214089|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
145644683|NCT00393484|525214088|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
145644684|NCT00393484|525214089|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
145644685|NCT00393484|525214088|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
145644686|NCT00393484|525214089|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
145644687|NCT02178098|525214095|FG000|Overall Study|Withdrawal by Subject|0|||
145644688|NCT02178098|525214096|FG001|Overall Study|Withdrawal by Subject|6|||
145644689|NCT02178098|525214095|FG000|Overall Study|Adverse Event|1|||
145644690|NCT02178098|525214096|FG001|Overall Study|Adverse Event|2|||
145644691|NCT02178098|525214095|FG000|Overall Study|Protocol Violation|1|||
145644692|NCT02178098|525214096|FG001|Overall Study|Protocol Violation|1|||
145644693|NCT02178098|525214095|FG000|Overall Study|Lost to Follow-up|0|||
145644694|NCT02178098|525214096|FG001|Overall Study|Lost to Follow-up|1|||
145644695|NCT02178098|525214095|FG000|Overall Study|Sponsor Request|1|||
145644696|NCT02178098|525214096|FG001|Overall Study|Sponsor Request|0|||
145644697|NCT02178098|525214095|FG000|Overall Study|Other|2|||
145644698|NCT02178098|525214096|FG001|Overall Study|Other|2|||
145644699|NCT00088413|525214097|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
145644700|NCT00088413|525214098|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
145644701|NCT00088413|525214099|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
145644702|NCT00088413|525214100|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
145644703|NCT00088413|525214097|FG000|Overall Study|Adverse Events/Side Effects|0|||
145644704|NCT00088413|525214098|FG001|Overall Study|Adverse Events/Side Effects|1|||
145644705|NCT00088413|525214099|FG002|Overall Study|Adverse Events/Side Effects|1|||
145644706|NCT00088413|525214100|FG003|Overall Study|Adverse Events/Side Effects|0|||
145644707|NCT00088413|525214097|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
145644708|NCT00088413|525214098|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
145644709|NCT00088413|525214099|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
145644710|NCT00088413|525214100|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
145644711|NCT00088413|525214097|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
145644712|NCT00088413|525214098|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
145644713|NCT00088413|525214099|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
145644714|NCT00088413|525214100|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
145644715|NCT00088413|525214097|FG000|Overall Study|Death|0|||
145644716|NCT00088413|525214098|FG001|Overall Study|Death|1|||
145644717|NCT00088413|525214099|FG002|Overall Study|Death|0|||
145644718|NCT00088413|525214100|FG003|Overall Study|Death|0|||
145644719|NCT00088413|525214097|FG000|Overall Study|Progressive disease|9|||
145644720|NCT00088413|525214098|FG001|Overall Study|Progressive disease|11|||
145644721|NCT00088413|525214099|FG002|Overall Study|Progressive disease|8|||
145644722|NCT00088413|525214100|FG003|Overall Study|Progressive disease|14|||
145644723|NCT00088413|525214097|FG000|Overall Study|Other|0|||
145644724|NCT00088413|525214098|FG001|Overall Study|Other|1|||
145644725|NCT00088413|525214099|FG002|Overall Study|Other|0|||
145644726|NCT00088413|525214100|FG003|Overall Study|Other|0|||
145644727|NCT00088413|525214097|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
145644728|NCT00088413|525214098|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
145644729|NCT00088413|525214099|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
145644730|NCT00088413|525214100|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
145644731|NCT03101371|525214104|FG000|Overall Study|Physician Decision|0|||
145644732|NCT03101371|525214105|FG001|Overall Study|Physician Decision|1|||
145644733|NCT03101371|525214104|FG000|Overall Study|Lost to Follow-up|1|||
145644734|NCT03101371|525214105|FG001|Overall Study|Lost to Follow-up|4|||
145644735|NCT03101371|525214104|FG000|Overall Study|Did not meet eligibility criteria|2|||
145644736|NCT03101371|525214105|FG001|Overall Study|Did not meet eligibility criteria|1|||
145644737|NCT01094184|525214112|FG000|Overall Study|Death|35|||
145644738|NCT01094184|525214113|FG001|Overall Study|Death|11|||
145644739|NCT04766034|525214114|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
145644740|NCT04766034|525214115|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
145644741|NCT04766034|525214116|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
145644742|NCT04766034|525214117|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
145644743|NCT04766034|525214118|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
145644744|NCT04766034|525214114|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
145644745|NCT04766034|525214115|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
145644746|NCT04766034|525214116|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
145644747|NCT04766034|525214117|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
145644748|NCT04766034|525214118|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
145644749|NCT04766034|525214114|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
145644750|NCT04766034|525214115|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
145644751|NCT04766034|525214116|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
145644752|NCT04766034|525214117|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
145644753|NCT04766034|525214118|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
145644754|NCT04766034|525214114|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
145644755|NCT04766034|525214115|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
145644756|NCT04766034|525214116|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
145644757|NCT04766034|525214117|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
145644758|NCT04766034|525214118|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
145644759|NCT01976312|525214119|FG000|Overall Study|Pregnancy|0|||
145644760|NCT01976312|525214120|FG001|Overall Study|Pregnancy|1|||
145644761|NCT01976312|525214119|FG000|Overall Study|Lost to Follow-up|2|||
145644762|NCT01976312|525214120|FG001|Overall Study|Lost to Follow-up|0|||
145644763|NCT01976312|525214119|FG000|Overall Study|Withdrawal by Subject|7|||
145644764|NCT01976312|525214120|FG001|Overall Study|Withdrawal by Subject|2|||
145644765|NCT01976312|525214119|FG000|Overall Study|Adverse Event|6|||
145644766|NCT01976312|525214120|FG001|Overall Study|Adverse Event|6|||
145644767|NCT01976312|525214119|FG000|Overall Study|Protocol Violation|2|||
145644768|NCT01976312|525214120|FG001|Overall Study|Protocol Violation|0|||
145644769|NCT00774852|525214127|FG000|Overall Study|Adverse Event|9|||
145644770|NCT00774852|525214128|FG001|Overall Study|Adverse Event|6|||
145644771|NCT00774852|525214127|FG000|Overall Study|Death|2|||
145644772|NCT00774852|525214128|FG001|Overall Study|Death|1|||
145644773|NCT00774852|525214127|FG000|Overall Study|Lack of Efficacy|3|||
145644774|NCT00774852|525214128|FG001|Overall Study|Lack of Efficacy|7|||
145644775|NCT00774852|525214127|FG000|Overall Study|Lost to Follow-up|9|||
145644776|NCT00774852|525214128|FG001|Overall Study|Lost to Follow-up|5|||
145644777|NCT00774852|525214127|FG000|Overall Study|Physician Decision|2|||
145644778|NCT00774852|525214128|FG001|Overall Study|Physician Decision|6|||
145644779|NCT00774852|525214127|FG000|Overall Study|Pregnancy|1|||
145644780|NCT00774852|525214128|FG001|Overall Study|Pregnancy|2|||
145644781|NCT00774852|525214127|FG000|Overall Study|Withdrawal by Subject|2|||
145644782|NCT00774852|525214128|FG001|Overall Study|Withdrawal by Subject|2|||
145644783|NCT00774852|525214127|FG000|Overall Study|Non-responder|15|||
145644784|NCT00774852|525214128|FG001|Overall Study|Non-responder|11|||
145644785|NCT00774852|525214127|FG000|Overall Study|Subject non-compliance|0|||
145644786|NCT00774852|525214128|FG001|Overall Study|Subject non-compliance|1|||
145644787|NCT00774852|525214127|FG000|Overall Study|Protocol Violation|1|||
145644788|NCT00774852|525214128|FG001|Overall Study|Protocol Violation|0|||
145644789|NCT00774852|525214127|FG000|Overall Study|Subject received prohibited medication|1|||
145644790|NCT00774852|525214128|FG001|Overall Study|Subject received prohibited medication|0|||
145644791|NCT04992390|525214132|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
145486613|NCT01301833|524635090|FG001|Overall Study|Adverse Event|5|||
145486614|NCT01301833|524635091|FG002|Overall Study|Adverse Event|5|||
145486615|NCT01301833|524635092|FG003|Overall Study|Adverse Event|5|||
145486616|NCT01301833|524635089|FG000|Overall Study|Lack of Efficacy|1|||
145486617|NCT01301833|524635090|FG001|Overall Study|Lack of Efficacy|1|||
145486618|NCT01301833|524635091|FG002|Overall Study|Lack of Efficacy|0|||
145486619|NCT01301833|524635092|FG003|Overall Study|Lack of Efficacy|0|||
145644792|NCT04992390|525214133|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
145644793|NCT04992390|525214134|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
145644794|NCT04992390|525214132|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
145644795|NCT04992390|525214133|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
145644796|NCT04992390|525214134|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
145644797|NCT04992390|525214132|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
145644798|NCT04992390|525214133|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
145644799|NCT04992390|525214134|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
145644800|NCT04992390|525214132|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
145644801|NCT04992390|525214133|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
145644802|NCT04992390|525214134|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
145644803|NCT04992390|525214132|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
145644804|NCT04992390|525214133|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
145644805|NCT04992390|525214134|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
145644806|NCT04992390|525214132|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
145644807|NCT04992390|525214133|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
145644808|NCT04992390|525214134|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
145486620|NCT01301833|524635089|FG000|Overall Study|Physician Decision|3|||
145486621|NCT01301833|524635090|FG001|Overall Study|Physician Decision|1|||
145486622|NCT01301833|524635091|FG002|Overall Study|Physician Decision|1|||
145644809|NCT04992390|525214132|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
145644810|NCT04992390|525214133|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
145644811|NCT04992390|525214134|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
145644812|NCT04992390|525214132|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
145644813|NCT04992390|525214133|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
145644814|NCT04992390|525214134|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
145644815|NCT04992390|525214132|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
145644816|NCT04992390|525214133|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
145644817|NCT04992390|525214134|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
145644818|NCT04992390|525214132|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
145644819|NCT04992390|525214133|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
145644820|NCT04992390|525214134|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
145644821|NCT04992390|525214132|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
145644822|NCT04992390|525214133|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
145644823|NCT04992390|525214134|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
145644824|NCT04992390|525214132|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
145644825|NCT04992390|525214133|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
145644826|NCT04992390|525214134|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
145644827|NCT04992390|525214132|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
145644828|NCT04992390|525214133|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
145644829|NCT04992390|525214134|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
145644830|NCT04992390|525214132|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
145644831|NCT04992390|525214133|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
145644832|NCT04992390|525214134|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
145644833|NCT04992390|525214132|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
145644834|NCT04992390|525214133|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
145644835|NCT04992390|525214134|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
145644836|NCT04992390|525214132|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
145644837|NCT04992390|525214133|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
145644838|NCT04992390|525214134|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
145644839|NCT02807779|525214135|FG000|Overall Study|Lost to Follow-up|1|||
145644840|NCT02807779|525214136|FG001|Overall Study|Lost to Follow-up|0|||
145644841|NCT02807779|525214137|FG002|Overall Study|Lost to Follow-up|0|||
145644842|NCT02807779|525214135|FG000|Overall Study|Physician Decision|2|||
145644843|NCT02807779|525214136|FG001|Overall Study|Physician Decision|0|||
145644844|NCT02807779|525214137|FG002|Overall Study|Physician Decision|1|||
145644845|NCT02807779|525214135|FG000|Overall Study|Death|1|||
145644846|NCT02807779|525214136|FG001|Overall Study|Death|1|||
145644847|NCT02807779|525214137|FG002|Overall Study|Death|0|||
145644848|NCT05028582|525214138|FG000|Overall Study|Lost to Follow-up|11|||
145644849|NCT05028582|525214139|FG001|Overall Study|Lost to Follow-up|9|||
145644850|NCT05028582|525214138|FG000|Overall Study|Withdrawal by Subject|9|||
145644851|NCT05028582|525214139|FG001|Overall Study|Withdrawal by Subject|10|||
145644852|NCT05028582|525214138|FG000|Overall Study|Adverse Event|5|||
145644853|NCT05028582|525214139|FG001|Overall Study|Adverse Event|2|||
145644854|NCT05028582|525214138|FG000|Overall Study|Miscellaneous|3|||
145644855|NCT05028582|525214139|FG001|Overall Study|Miscellaneous|2|||
145644856|NCT05028582|525214138|FG000|Overall Study|Lack of Efficacy|3|||
145644857|NCT05028582|525214139|FG001|Overall Study|Lack of Efficacy|1|||
145644858|NCT05028582|525214138|FG000|Overall Study|Physician Decision|0|||
145644859|NCT05028582|525214139|FG001|Overall Study|Physician Decision|1|||
145644860|NCT04939246|525214140|FG000|After Treatment|Death|4|||
145644861|NCT04939246|525214140|FG000|After Treatment|Lost to Follow-up|1|||
145644862|NCT04939246|525214140|FG000|After Treatment|Discharged to hospice|2|||
145644863|NCT04310735|525215939|FG000|Overall Study|Withdrawal by Subject|1|||
145644864|NCT04310735|525215940|FG001|Overall Study|Withdrawal by Subject|3|||
145644865|NCT04310735|525215941|FG002|Overall Study|Withdrawal by Subject|8|||
145644866|NCT04310735|525215939|FG000|Overall Study|Equipment malfunction|0|||
145644867|NCT04310735|525215940|FG001|Overall Study|Equipment malfunction|1|||
145644868|NCT04310735|525215941|FG002|Overall Study|Equipment malfunction|0|||
145644869|NCT03398200|525215942|FG000|Overall Study|Withdrawal by Subject|0|||
145644870|NCT03398200|525215943|FG001|Overall Study|Withdrawal by Subject|1|||
145644871|NCT04842500|525215946|FG000|Overall Study|Withdrawal by Subject|4|||
145644872|NCT04842500|525215947|FG001|Overall Study|Withdrawal by Subject|1|||
145644873|NCT04842500|525215948|FG002|Overall Study|Withdrawal by Subject|2|||
145644874|NCT04842500|525215949|FG003|Overall Study|Withdrawal by Subject|3|||
145644875|NCT04842500|525215946|FG000|Overall Study|Protocol Violation|1|||
145644876|NCT04842500|525215947|FG001|Overall Study|Protocol Violation|0|||
145644877|NCT04842500|525215948|FG002|Overall Study|Protocol Violation|0|||
145644878|NCT04842500|525215949|FG003|Overall Study|Protocol Violation|1|||
145644879|NCT03845465|525215952|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
145644880|NCT03845465|525215953|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
145644881|NCT03845465|525215952|FG000|6-month Data Collection|Withdrawal by Subject|0|||
145644882|NCT03845465|525215953|FG001|6-month Data Collection|Withdrawal by Subject|2|||
145644883|NCT03845465|525215952|FG000|12-month Data Collection|Withdrawal by Subject|0|||
145644884|NCT03845465|525215953|FG001|12-month Data Collection|Withdrawal by Subject|2|||
145644885|NCT05656911|525215954|FG000|Treatment Phase|Physician Decision|2|||
145644886|NCT05656911|525215955|FG001|Treatment Phase|Physician Decision|0|||
145644887|NCT05656911|525215954|FG000|Treatment Phase|Lack of Efficacy|6|||
145644888|NCT05656911|525215955|FG001|Treatment Phase|Lack of Efficacy|3|||
145644889|NCT05656911|525215954|FG000|Treatment Phase|Subject Decision|4|||
145644890|NCT05656911|525215955|FG001|Treatment Phase|Subject Decision|2|||
145644891|NCT05656911|525215954|FG000|Treatment Phase|Other Reasons|1|||
145644892|NCT05656911|525215955|FG001|Treatment Phase|Other Reasons|0|||
145644893|NCT05656911|525215954|FG000|Treatment Phase|Adverse Event|3|||
145644894|NCT05656911|525215955|FG001|Treatment Phase|Adverse Event|1|||
145644895|NCT05656911|525215954|FG000|Follow-up Phase|Subject Decision|0|||
145644896|NCT05656911|525215955|FG001|Follow-up Phase|Subject Decision|1|||
145644897|NCT05656911|525215954|FG000|Follow-up Phase|Missing|1|||
145644898|NCT05656911|525215955|FG001|Follow-up Phase|Missing|0|||
145644899|NCT03547908|525215956|FG000|Blinded Phase|Lost to Follow-up|3|||
145644900|NCT03547908|525215957|FG001|Blinded Phase|Lost to Follow-up|3|||
145644901|NCT03547908|525215958|FG002|Blinded Phase|Lost to Follow-up|0|||
145644902|NCT03547908|525215959|FG003|Blinded Phase|Lost to Follow-up|0|||
145644903|NCT03547908|525215956|FG000|Blinded Phase|Withdrew Consent|2|||
145644904|NCT03547908|525215957|FG001|Blinded Phase|Withdrew Consent|3|||
145644905|NCT03547908|525215958|FG002|Blinded Phase|Withdrew Consent|0|||
145644906|NCT03547908|525215959|FG003|Blinded Phase|Withdrew Consent|0|||
145644907|NCT03547908|525215956|FG000|Blinded Phase|Investigator's Discretion|2|||
145644908|NCT03547908|525215957|FG001|Blinded Phase|Investigator's Discretion|1|||
145644909|NCT03547908|525215958|FG002|Blinded Phase|Investigator's Discretion|0|||
145644910|NCT03547908|525215959|FG003|Blinded Phase|Investigator's Discretion|0|||
145644911|NCT03547908|525215956|FG000|Blinded Phase|Death|2|||
145644912|NCT03547908|525215957|FG001|Blinded Phase|Death|0|||
145644913|NCT03547908|525215958|FG002|Blinded Phase|Death|0|||
145644914|NCT03547908|525215959|FG003|Blinded Phase|Death|0|||
145644915|NCT03547908|525215956|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
145644916|NCT03547908|525215957|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
145644917|NCT03547908|525215958|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
145644918|NCT03547908|525215959|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
145644919|NCT03547908|525215956|FG000|Blinded Phase|Adverse Event|1|||
145644920|NCT03547908|525215957|FG001|Blinded Phase|Adverse Event|0|||
145644921|NCT03547908|525215958|FG002|Blinded Phase|Adverse Event|0|||
145644922|NCT03547908|525215959|FG003|Blinded Phase|Adverse Event|0|||
145644923|NCT03547908|525215956|FG000|Blinded Phase|Randomized But Never Treated|1|||
145644924|NCT03547908|525215957|FG001|Blinded Phase|Randomized But Never Treated|0|||
145644925|NCT03547908|525215958|FG002|Blinded Phase|Randomized But Never Treated|0|||
145644926|NCT03547908|525215959|FG003|Blinded Phase|Randomized But Never Treated|0|||
145644927|NCT03547908|525215956|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
145644928|NCT03547908|525215957|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
145644929|NCT03547908|525215958|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
145644930|NCT03547908|525215959|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
145644931|NCT03547908|525215956|FG000|Open-label Extension Phase|Death|0|||
145644932|NCT03547908|525215957|FG001|Open-label Extension Phase|Death|0|||
145644933|NCT03547908|525215958|FG002|Open-label Extension Phase|Death|1|||
145644934|NCT03547908|525215959|FG003|Open-label Extension Phase|Death|0|||
145644935|NCT05403801|525215962|FG000|Overall Study|Withdrawal by Subject|2|||
145644936|NCT05075408|525215963|FG000|Overall Study|Withdrawal by Subject|5|||
145644937|NCT05075408|525215964|FG001|Overall Study|Withdrawal by Subject|3|||
145644938|NCT05075408|525215965|FG002|Overall Study|Withdrawal by Subject|4|||
145644939|NCT05075408|525215963|FG000|Overall Study|Adverse Event|5|||
145644940|NCT05075408|525215964|FG001|Overall Study|Adverse Event|7|||
145644941|NCT05075408|525215965|FG002|Overall Study|Adverse Event|8|||
145644942|NCT05075408|525215963|FG000|Overall Study|Protocol Violation|0|||
145644943|NCT05075408|525215964|FG001|Overall Study|Protocol Violation|1|||
145644944|NCT05075408|525215965|FG002|Overall Study|Protocol Violation|0|||
145644945|NCT05075408|525215963|FG000|Overall Study|Lost to Follow-up|2|||
145644946|NCT05075408|525215964|FG001|Overall Study|Lost to Follow-up|1|||
145644947|NCT05075408|525215965|FG002|Overall Study|Lost to Follow-up|1|||
145644948|NCT05075408|525215963|FG000|Overall Study|Physician Decision|1|||
145644949|NCT05075408|525215964|FG001|Overall Study|Physician Decision|0|||
145644950|NCT05075408|525215965|FG002|Overall Study|Physician Decision|0|||
145644951|NCT05075408|525215963|FG000|Overall Study|Other-unspecified|3|||
145644952|NCT05075408|525215964|FG001|Overall Study|Other-unspecified|2|||
145644953|NCT05075408|525215965|FG002|Overall Study|Other-unspecified|0|||
145644954|NCT03103321|525215966|FG000|Overall Study|Protocol Violation|1|||
145644955|NCT03103321|525215967|FG001|Overall Study|Protocol Violation|1|||
145644956|NCT03103321|525215968|FG002|Overall Study|Protocol Violation|1|||
145644957|NCT03103321|525215969|FG003|Overall Study|Protocol Violation|0|||
145644958|NCT06629454|525215973|FG000|Overall Study|Withdraw by Clinician Decision|1|||
145644959|NCT01704079|525215974|FG000|Overall Study|Withdrawal by Subject|5|||
145644960|NCT01704079|525215975|FG001|Overall Study|Withdrawal by Subject|7|||
145644961|NCT01704079|525215974|FG000|Overall Study|Lost to Follow-up|2|||
145644962|NCT01704079|525215975|FG001|Overall Study|Lost to Follow-up|5|||
145644963|NCT01704079|525215974|FG000|Overall Study|Adverse Event|4|||
145644964|NCT01704079|525215975|FG001|Overall Study|Adverse Event|7|||
145644965|NCT01704079|525215974|FG000|Overall Study|Protocol Violation|1|||
145644966|NCT01704079|525215975|FG001|Overall Study|Protocol Violation|0|||
145644967|NCT01704079|525215974|FG000|Overall Study|Subject noncompliance|2|||
145644968|NCT01704079|525215975|FG001|Overall Study|Subject noncompliance|3|||
145644969|NCT01704079|525215974|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
145644970|NCT01704079|525215975|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
145644971|NCT02015520|525215985|FG000|Overall Study|Lack of Efficacy|1|||
145644972|NCT02015520|525215986|FG001|Overall Study|Lack of Efficacy|0|||
145644973|NCT02015520|525215987|FG002|Overall Study|Lack of Efficacy|3|||
145644974|NCT02015520|525215988|FG003|Overall Study|Lack of Efficacy|2|||
145644975|NCT02015520|525215985|FG000|Overall Study|Adverse Event|0|||
145644976|NCT02015520|525215986|FG001|Overall Study|Adverse Event|0|||
145486623|NCT01301833|524635092|FG003|Overall Study|Physician Decision|0|||
145486624|NCT01301833|524635089|FG000|Overall Study|Withdrawal by Subject|3|||
145486625|NCT01301833|524635090|FG001|Overall Study|Withdrawal by Subject|1|||
145486626|NCT01301833|524635091|FG002|Overall Study|Withdrawal by Subject|1|||
145486627|NCT01301833|524635092|FG003|Overall Study|Withdrawal by Subject|2|||
145486628|NCT01301833|524635089|FG000|Overall Study|Personal matter|1|||
145644977|NCT02015520|525215987|FG002|Overall Study|Adverse Event|0|||
145644978|NCT02015520|525215988|FG003|Overall Study|Adverse Event|1|||
145644979|NCT02015520|525215985|FG000|Overall Study|Withdrawal by Subject|2|||
145644980|NCT02015520|525215986|FG001|Overall Study|Withdrawal by Subject|2|||
145644981|NCT02015520|525215987|FG002|Overall Study|Withdrawal by Subject|1|||
145644982|NCT02015520|525215988|FG003|Overall Study|Withdrawal by Subject|0|||
145644983|NCT02015520|525215985|FG000|Overall Study|Death|1|||
145644984|NCT02015520|525215986|FG001|Overall Study|Death|0|||
145644985|NCT02015520|525215987|FG002|Overall Study|Death|0|||
145644986|NCT02015520|525215988|FG003|Overall Study|Death|0|||
145644987|NCT02015520|525215985|FG000|Overall Study|Lost to Follow-up|0|||
145644988|NCT02015520|525215986|FG001|Overall Study|Lost to Follow-up|0|||
145644989|NCT02015520|525215987|FG002|Overall Study|Lost to Follow-up|1|||
145644990|NCT02015520|525215988|FG003|Overall Study|Lost to Follow-up|0|||
145486629|NCT01301833|524635090|FG001|Overall Study|Personal matter|0|||
145644991|NCT02015520|525215985|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
145644992|NCT02015520|525215986|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
145644993|NCT02015520|525215987|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
145644994|NCT02015520|525215988|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
145644995|NCT02015520|525215985|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
145644996|NCT02015520|525215986|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
145644997|NCT02015520|525215987|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
145644998|NCT02015520|525215988|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
145486630|NCT01301833|524635091|FG002|Overall Study|Personal matter|0|||
145486631|NCT01301833|524635092|FG003|Overall Study|Personal matter|0|||
145486632|NCT02719171|524636711|FG000|Overall Study|Adverse Event|1|||
145486633|NCT02719171|524636712|FG001|Overall Study|Adverse Event|2|||
145644999|NCT02386553|525215989|FG000|Overall Study|Reason Not Specified|1|||
145645000|NCT02386553|525215990|FG001|Overall Study|Reason Not Specified|1|||
145645001|NCT02386553|525215989|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
145645002|NCT02386553|525215990|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
145645003|NCT01619410|525215995|FG000|Overall Study|Lost to Follow-up|7|||
145645004|NCT01619410|525215996|FG001|Overall Study|Lost to Follow-up|4|||
145645005|NCT02740231|525216001|FG000|Overall Study|Withdrawal by Subject|1|||
145645006|NCT02740231|525216002|FG001|Overall Study|Withdrawal by Subject|1|||
145645007|NCT02740231|525216003|FG002|Overall Study|Withdrawal by Subject|1|||
145645008|NCT02740231|525216004|FG003|Overall Study|Withdrawal by Subject|0|||
145645009|NCT02740231|525216001|FG000|Overall Study|Lack of Efficacy|0|||
145645010|NCT02740231|525216002|FG001|Overall Study|Lack of Efficacy|1|||
145645011|NCT02740231|525216003|FG002|Overall Study|Lack of Efficacy|0|||
145645012|NCT02740231|525216004|FG003|Overall Study|Lack of Efficacy|4|||
145645013|NCT02740231|525216001|FG000|Overall Study|Lost to Follow-up|1|||
145645014|NCT02740231|525216002|FG001|Overall Study|Lost to Follow-up|3|||
145645015|NCT02740231|525216003|FG002|Overall Study|Lost to Follow-up|0|||
145645016|NCT02740231|525216004|FG003|Overall Study|Lost to Follow-up|3|||
145645017|NCT02740231|525216001|FG000|Overall Study|Adverse Event|0|||
145645018|NCT02740231|525216002|FG001|Overall Study|Adverse Event|1|||
145645019|NCT02740231|525216003|FG002|Overall Study|Adverse Event|0|||
145645020|NCT02740231|525216004|FG003|Overall Study|Adverse Event|1|||
145645021|NCT04110054|525216005|FG000|Overall Study|COVID-19 reason other than AE|0|||
145645022|NCT04110054|525216006|FG001|Overall Study|COVID-19 reason other than AE|0|||
145645023|NCT04110054|525216007|FG002|Overall Study|COVID-19 reason other than AE|2|||
145645024|NCT04110054|525216008|FG003|Overall Study|COVID-19 reason other than AE|0|||
145645025|NCT04110054|525216005|FG000|Overall Study|Withdrawal by Subject|0|||
145645026|NCT04110054|525216006|FG001|Overall Study|Withdrawal by Subject|3|||
145645027|NCT04110054|525216007|FG002|Overall Study|Withdrawal by Subject|2|||
145645028|NCT04110054|525216008|FG003|Overall Study|Withdrawal by Subject|0|||
145645029|NCT04110054|525216005|FG000|Overall Study|Adverse Event|1|||
145645030|NCT04110054|525216006|FG001|Overall Study|Adverse Event|1|||
145645031|NCT04110054|525216007|FG002|Overall Study|Adverse Event|4|||
145645032|NCT04110054|525216008|FG003|Overall Study|Adverse Event|3|||
145645033|NCT01000480|525216010|FG000|Induction Phase|Adverse Event|2|||
145645034|NCT01000480|525216010|FG000|Induction Phase|Lost to Follow-up|1|||
145645035|NCT01000480|525216010|FG000|Induction Phase|Physician Decision|1|||
145645036|NCT01000480|525216010|FG000|Induction Phase|Entry Criteria Not Met|3|||
145645037|NCT01000480|525216010|FG000|Concurrent Therapy Phase|Adverse Event|4|||
145645038|NCT01000480|525216010|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
145645039|NCT01000480|525216010|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
145645040|NCT01000480|525216010|FG000|Concurrent Therapy Phase|Physician Decision|1|||
145645041|NCT02374307|525216015|FG000|3-months Follow-up|Lost to Follow-up|1|||
145645042|NCT02374307|525216016|FG001|3-months Follow-up|Lost to Follow-up|2|||
145645043|NCT02374307|525216015|FG000|3-months Follow-up|Withdrawal by Subject|1|||
145645044|NCT02374307|525216016|FG001|3-months Follow-up|Withdrawal by Subject|4|||
145645045|NCT02374307|525216015|FG000|3-months Follow-up|Death|1|||
145645046|NCT02374307|525216016|FG001|3-months Follow-up|Death|2|||
145645047|NCT02374307|525216015|FG000|3-months Follow-up|Missed first follow-up|5|||
145645048|NCT02374307|525216016|FG001|3-months Follow-up|Missed first follow-up|1|||
145645049|NCT02374307|525216015|FG000|6-months Follow-up|Lost to Follow-up|1|||
145645050|NCT02374307|525216016|FG001|6-months Follow-up|Lost to Follow-up|2|||
145645051|NCT02374307|525216015|FG000|6-months Follow-up|Death|2|||
145645052|NCT02374307|525216016|FG001|6-months Follow-up|Death|1|||
145645053|NCT02374307|525216015|FG000|6-months Follow-up|Withdrawal by Subject|0|||
145645054|NCT02374307|525216016|FG001|6-months Follow-up|Withdrawal by Subject|3|||
145265308|NCT03323034|523819275|FG004|Overall Study|Physician Decision|1|||
145486634|NCT02719171|524636713|FG002|Overall Study|Adverse Event|0|||
145645055|NCT00632203|525216017|FG000|Overall Study|Did not start study treatment|1|||
145645056|NCT00632203|525216018|FG001|Overall Study|Did not start study treatment|0|||
145645057|NCT04452318|525216021|FG000|Overall Study|Physician Decision|1|||
145645058|NCT04452318|525216022|FG001|Overall Study|Physician Decision|2|||
145645059|NCT04452318|525216023|FG002|Overall Study|Physician Decision|0|||
145645060|NCT04452318|525216024|FG003|Overall Study|Physician Decision|2|||
145645061|NCT04452318|525216025|FG004|Overall Study|Physician Decision|0|||
145645062|NCT04452318|525216026|FG005|Overall Study|Physician Decision|2|||
145645063|NCT04452318|525216027|FG006|Overall Study|Physician Decision|5|||
145645064|NCT04452318|525216021|FG000|Overall Study|Death|2|||
145645065|NCT04452318|525216022|FG001|Overall Study|Death|3|||
145645066|NCT04452318|525216023|FG002|Overall Study|Death|0|||
145645067|NCT04452318|525216024|FG003|Overall Study|Death|0|||
145645068|NCT04452318|525216025|FG004|Overall Study|Death|0|||
145645069|NCT04452318|525216026|FG005|Overall Study|Death|0|||
145645070|NCT04452318|525216027|FG006|Overall Study|Death|0|||
145645071|NCT04452318|525216021|FG000|Overall Study|Lost to Follow-up|38|||
145645072|NCT04452318|525216022|FG001|Overall Study|Lost to Follow-up|28|||
145645073|NCT04452318|525216023|FG002|Overall Study|Lost to Follow-up|0|||
145645074|NCT04452318|525216024|FG003|Overall Study|Lost to Follow-up|3|||
145645075|NCT04452318|525216025|FG004|Overall Study|Lost to Follow-up|3|||
145645076|NCT04452318|525216026|FG005|Overall Study|Lost to Follow-up|2|||
145645077|NCT04452318|525216027|FG006|Overall Study|Lost to Follow-up|1|||
145645078|NCT04452318|525216021|FG000|Overall Study|Withdrawal by Subject|46|||
145645079|NCT04452318|525216022|FG001|Overall Study|Withdrawal by Subject|40|||
145645080|NCT04452318|525216023|FG002|Overall Study|Withdrawal by Subject|0|||
145645081|NCT04452318|525216024|FG003|Overall Study|Withdrawal by Subject|18|||
145645082|NCT04452318|525216025|FG004|Overall Study|Withdrawal by Subject|6|||
145645083|NCT04452318|525216026|FG005|Overall Study|Withdrawal by Subject|8|||
145645084|NCT04452318|525216027|FG006|Overall Study|Withdrawal by Subject|6|||
145645085|NCT02554786|525216028|FG000|Overall Study|Subject/guardian decision|29|||
145645086|NCT02554786|525216029|FG001|Overall Study|Subject/guardian decision|17|||
145645087|NCT02554786|525216030|FG002|Overall Study|Subject/guardian decision|18|||
145645088|NCT02554786|525216031|FG003|Overall Study|Subject/guardian decision|30|||
145645089|NCT02554786|525216032|FG004|Overall Study|Subject/guardian decision|20|||
145645090|NCT02554786|525216028|FG000|Overall Study|Lost to Follow-up|4|||
145645091|NCT02554786|525216029|FG001|Overall Study|Lost to Follow-up|3|||
145645092|NCT02554786|525216030|FG002|Overall Study|Lost to Follow-up|4|||
145645093|NCT02554786|525216031|FG003|Overall Study|Lost to Follow-up|2|||
145645094|NCT02554786|525216032|FG004|Overall Study|Lost to Follow-up|2|||
145645095|NCT02554786|525216028|FG000|Overall Study|Protocol deviation|1|||
145645096|NCT02554786|525216029|FG001|Overall Study|Protocol deviation|3|||
145645097|NCT02554786|525216030|FG002|Overall Study|Protocol deviation|3|||
145645098|NCT02554786|525216031|FG003|Overall Study|Protocol deviation|4|||
145645099|NCT02554786|525216032|FG004|Overall Study|Protocol deviation|2|||
145645100|NCT02554786|525216028|FG000|Overall Study|Technical problems|1|||
145645101|NCT02554786|525216029|FG001|Overall Study|Technical problems|1|||
145645102|NCT02554786|525216030|FG002|Overall Study|Technical problems|0|||
145645103|NCT02554786|525216031|FG003|Overall Study|Technical problems|2|||
145645104|NCT02554786|525216032|FG004|Overall Study|Technical problems|1|||
145645105|NCT02554786|525216028|FG000|Overall Study|Adverse Event|0|||
145645106|NCT02554786|525216029|FG001|Overall Study|Adverse Event|0|||
145645107|NCT02554786|525216030|FG002|Overall Study|Adverse Event|0|||
145645108|NCT02554786|525216031|FG003|Overall Study|Adverse Event|0|||
145645109|NCT02554786|525216032|FG004|Overall Study|Adverse Event|2|||
145645110|NCT02554786|525216028|FG000|Overall Study|Death|0|||
145645111|NCT02554786|525216029|FG001|Overall Study|Death|0|||
145645112|NCT02554786|525216030|FG002|Overall Study|Death|0|||
145645113|NCT02554786|525216031|FG003|Overall Study|Death|1|||
145645114|NCT02554786|525216032|FG004|Overall Study|Death|0|||
145645115|NCT02554786|525216028|FG000|Overall Study|Non-compliance with study treatment|0|||
145645116|NCT02554786|525216029|FG001|Overall Study|Non-compliance with study treatment|1|||
145645117|NCT02554786|525216030|FG002|Overall Study|Non-compliance with study treatment|1|||
145645118|NCT02554786|525216031|FG003|Overall Study|Non-compliance with study treatment|0|||
145645119|NCT02554786|525216032|FG004|Overall Study|Non-compliance with study treatment|1|||
145645120|NCT02554786|525216028|FG000|Overall Study|Physician Decision|0|||
145645121|NCT02554786|525216029|FG001|Overall Study|Physician Decision|1|||
145486635|NCT02719171|524636714|FG003|Overall Study|Adverse Event|0|||
145645122|NCT02554786|525216030|FG002|Overall Study|Physician Decision|4|||
145645123|NCT02554786|525216031|FG003|Overall Study|Physician Decision|1|||
145645124|NCT02554786|525216032|FG004|Overall Study|Physician Decision|1|||
145486636|NCT02719171|524636715|FG004|Overall Study|Adverse Event|2|||
145645125|NCT02554786|525216028|FG000|Overall Study|Pregnancy|0|||
145645126|NCT02554786|525216029|FG001|Overall Study|Pregnancy|0|||
145645127|NCT02554786|525216030|FG002|Overall Study|Pregnancy|0|||
145645128|NCT02554786|525216031|FG003|Overall Study|Pregnancy|1|||
145645129|NCT02554786|525216032|FG004|Overall Study|Pregnancy|1|||
145645130|NCT00604669|525216033|FG000|Overall Study|lack of information in chart|7|||
145645131|NCT01695954|525216034|FG000|Overall Study|Withdrawal by Subject|4|||
145645132|NCT01695954|525216035|FG001|Overall Study|Withdrawal by Subject|0|||
145645133|NCT01695954|525216034|FG000|Overall Study|Adverse Event|0|||
145645134|NCT01695954|525216035|FG001|Overall Study|Adverse Event|2|||
145645135|NCT03330795|525216050|FG000|Overall Study|Death|3|||
145645136|NCT03330795|525216050|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
145645137|NCT03930420|525216055|FG000|Overall Study|Withdrawal by Subject|7|||
145645138|NCT03930420|525216056|FG001|Overall Study|Withdrawal by Subject|9|||
145645139|NCT00539734|525216057|FG000|Overall Study|Protocol Violation|1|||
145645140|NCT01070069|525216058|FG000|Overall Study|Death|1|||
145645141|NCT01070069|525216059|FG001|Overall Study|Death|0|||
145645142|NCT01070069|525216060|FG002|Overall Study|Death|2|||
145645143|NCT01070069|525216061|FG003|Overall Study|Death|0|||
145645144|NCT01070069|525216062|FG004|Overall Study|Death|1|||
145645145|NCT01070069|525216058|FG000|Overall Study|Withdrawal by Subject|1|||
145645146|NCT01070069|525216059|FG001|Overall Study|Withdrawal by Subject|1|||
145645147|NCT01070069|525216060|FG002|Overall Study|Withdrawal by Subject|4|||
145645148|NCT01070069|525216061|FG003|Overall Study|Withdrawal by Subject|0|||
145645149|NCT01070069|525216062|FG004|Overall Study|Withdrawal by Subject|0|||
145645150|NCT01070069|525216058|FG000|Overall Study|Lost to Follow-up|4|||
145645151|NCT01070069|525216059|FG001|Overall Study|Lost to Follow-up|1|||
145645152|NCT01070069|525216060|FG002|Overall Study|Lost to Follow-up|0|||
145645153|NCT01070069|525216061|FG003|Overall Study|Lost to Follow-up|0|||
145645154|NCT01070069|525216062|FG004|Overall Study|Lost to Follow-up|3|||
145645155|NCT01771731|525216063|FG000|Overall Study|Physician Decision|1|||
145645156|NCT01771731|525216064|FG001|Overall Study|Physician Decision|0|||
145645157|NCT01771731|525216063|FG000|Overall Study|Protocol Violation|0|||
145645158|NCT01771731|525216064|FG001|Overall Study|Protocol Violation|1|||
145645159|NCT01771731|525216063|FG000|Overall Study|Adverse event: Pain Crisis|1|||
145645160|NCT01771731|525216064|FG001|Overall Study|Adverse event: Pain Crisis|1|||
145645161|NCT00331136|525216067|FG000|Overall Study|Adverse Event|3|||
145645162|NCT00331136|525216068|FG001|Overall Study|Adverse Event|5|||
145645163|NCT00331136|525216069|FG002|Overall Study|Adverse Event|0|||
145645164|NCT00331136|525216070|FG003|Overall Study|Adverse Event|1|||
145486637|NCT02719171|524636711|FG000|Overall Study|Lost to Follow-up|0|||
145486638|NCT02719171|524636712|FG001|Overall Study|Lost to Follow-up|0|||
145486639|NCT02719171|524636713|FG002|Overall Study|Lost to Follow-up|1|||
145486640|NCT02719171|524636714|FG003|Overall Study|Lost to Follow-up|0|||
145486641|NCT02719171|524636715|FG004|Overall Study|Lost to Follow-up|0|||
145486642|NCT02719171|524636711|FG000|Overall Study|Subject Withdrawal|0|||
145486643|NCT02719171|524636712|FG001|Overall Study|Subject Withdrawal|2|||
145486644|NCT02719171|524636713|FG002|Overall Study|Subject Withdrawal|2|||
145486645|NCT02719171|524636714|FG003|Overall Study|Subject Withdrawal|1|||
145486646|NCT02719171|524636715|FG004|Overall Study|Subject Withdrawal|0|||
145486647|NCT02719171|524636711|FG000|Overall Study|Other|0|||
145486648|NCT02719171|524636712|FG001|Overall Study|Other|0|||
145486649|NCT02719171|524636713|FG002|Overall Study|Other|0|||
145486650|NCT02719171|524636714|FG003|Overall Study|Other|1|||
145486651|NCT02719171|524636715|FG004|Overall Study|Other|0|||
145486652|NCT02614729|524636716|FG000|Overall Study|Withdrawal by Subject|1|||
145486653|NCT02614729|524636717|FG001|Overall Study|Withdrawal by Subject|0|||
145486654|NCT00227721|524636718|FG000|Overall Study|On study, but never treated.|1|||
145645165|NCT00331136|525216067|FG000|Overall Study|Withdrawal by Subject|0|||
145645166|NCT00331136|525216068|FG001|Overall Study|Withdrawal by Subject|1|||
145645167|NCT00331136|525216069|FG002|Overall Study|Withdrawal by Subject|0|||
145645168|NCT00331136|525216070|FG003|Overall Study|Withdrawal by Subject|0|||
145645169|NCT00331136|525216067|FG000|Overall Study|Lost to Follow-up|0|||
145645170|NCT00331136|525216068|FG001|Overall Study|Lost to Follow-up|1|||
145645171|NCT00331136|525216069|FG002|Overall Study|Lost to Follow-up|0|||
145645172|NCT00331136|525216070|FG003|Overall Study|Lost to Follow-up|0|||
145645173|NCT00331136|525216067|FG000|Overall Study|Protocol Violation|1|||
145645174|NCT00331136|525216068|FG001|Overall Study|Protocol Violation|0|||
145645175|NCT00331136|525216069|FG002|Overall Study|Protocol Violation|0|||
145645176|NCT00331136|525216070|FG003|Overall Study|Protocol Violation|0|||
145645177|NCT00331136|525216067|FG000|Overall Study|Not treated|1|||
145645178|NCT00331136|525216068|FG001|Overall Study|Not treated|0|||
145645179|NCT00331136|525216069|FG002|Overall Study|Not treated|0|||
145645180|NCT00331136|525216070|FG003|Overall Study|Not treated|0|||
145645181|NCT02321514|525216071|FG000|Overall Study|Death|15|||
145645182|NCT02321514|525216071|FG000|Overall Study|Missed Visit|7|||
145645183|NCT02321514|525216071|FG000|Overall Study|Study Exit|3|||
145645184|NCT03201562|525216073|FG000|Overall Study|Physician Decision|0|||
145645185|NCT03201562|525216074|FG001|Overall Study|Physician Decision|0|||
145645186|NCT03201562|525216075|FG002|Overall Study|Physician Decision|1|||
145645187|NCT03201562|525216073|FG000|Overall Study|Adverse Event|0|||
145645188|NCT03201562|525216074|FG001|Overall Study|Adverse Event|0|||
145645189|NCT03201562|525216075|FG002|Overall Study|Adverse Event|1|||
145645190|NCT03201562|525216073|FG000|Overall Study|Lost to Follow-up|0|||
145645191|NCT03201562|525216074|FG001|Overall Study|Lost to Follow-up|1|||
145645192|NCT03201562|525216075|FG002|Overall Study|Lost to Follow-up|2|||
145645193|NCT00001277|525216076|FG000|Overall Study|Adverse Event|0|||
145645194|NCT00001277|525216077|FG001|Overall Study|Adverse Event|0|||
145645195|NCT00001277|525216078|FG002|Overall Study|Adverse Event|1|||
145645196|NCT00001277|525216076|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
145645197|NCT00001277|525216077|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
145645198|NCT00001277|525216078|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
145645199|NCT02539225|525216083|FG000|Part A|Adverse Event|13|||
145645200|NCT02539225|525216084|FG001|Part A|Adverse Event|4|||
145645201|NCT02539225|525216083|FG000|Part A|Withdrawal by Subject|2|||
145645202|NCT02539225|525216084|FG001|Part A|Withdrawal by Subject|4|||
145645203|NCT02539225|525216083|FG000|Part A|Physician Decision|4|||
145645204|NCT02539225|525216084|FG001|Part A|Physician Decision|7|||
145645205|NCT02539225|525216083|FG000|Part A|Did Not Receive study Drug|1|||
145645206|NCT02539225|525216084|FG001|Part A|Did Not Receive study Drug|1|||
145645207|NCT02539225|525216083|FG000|Pre Treatment for Part B|Progressive disease|1|||
145645208|NCT02539225|525216084|FG001|Pre Treatment for Part B|Progressive disease|1|||
145645209|NCT02539225|525216083|FG000|Pre Treatment for Part B|Adverse Event|1|||
145645210|NCT02539225|525216084|FG001|Pre Treatment for Part B|Adverse Event|1|||
145645211|NCT02539225|525216083|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
145645212|NCT02539225|525216084|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
145645213|NCT02539225|525216083|FG000|Pre Treatment for Part B|Physician Decision|2|||
145645214|NCT02539225|525216084|FG001|Pre Treatment for Part B|Physician Decision|0|||
145645215|NCT02539225|525216083|FG000|Part B|Adverse Event|4|||
145645216|NCT02539225|525216084|FG001|Part B|Adverse Event|4|||
145645217|NCT02539225|525216083|FG000|Part B|Withdrawal by Subject|0|||
145645218|NCT02539225|525216084|FG001|Part B|Withdrawal by Subject|3|||
145645219|NCT02539225|525216083|FG000|Part B|Physician Decision|0|||
145645220|NCT02539225|525216084|FG001|Part B|Physician Decision|9|||
145645221|NCT01109524|525216087|FG000|Overall Study|Disease Progression|29|||
145645222|NCT01109524|525216087|FG000|Overall Study|Study Drug toxicity|6|||
145645223|NCT01109524|525216087|FG000|Overall Study|Adverse Event|4|||
145645224|NCT01109524|525216087|FG000|Overall Study|Withdrawal by Subject|2|||
145645225|NCT01109524|525216087|FG000|Overall Study|Maximum clinical benefit|3|||
145645226|NCT01109524|525216087|FG000|Overall Study|Death|2|||
145645227|NCT01109524|525216087|FG000|Overall Study|No longer meets criteria|2|||
145645228|NCT01109524|525216087|FG000|Overall Study|Participant requested to end treatment|4|||
145645229|NCT01109524|525216087|FG000|Overall Study|Other|5|||
145645230|NCT02318134|525216090|FG000|Overall Study|Withdrawal by Subject|2|||
145645231|NCT02318134|525216091|FG001|Overall Study|Withdrawal by Subject|1|||
145645232|NCT00031694|525216096|FG000|Overall Study|Adverse Event|12|||
145645233|NCT00031694|525216096|FG000|Overall Study|Death|2|||
145645234|NCT00031694|525216096|FG000|Overall Study|Withdrawal by Subject|5|||
145645235|NCT01538719|525216097|FG000|Overall Study|Lost to Follow-up|2|||
145645236|NCT01538719|525216098|FG001|Overall Study|Lost to Follow-up|0|||
145645237|NCT02556138|525216099|FG000|Overall Study|Withdrawal by Subject|1|||
145645238|NCT01609218|525216103|FG000|Period 1|Adverse Event|3|||
145645239|NCT01609218|525216104|FG001|Period 1|Adverse Event|5|||
145645240|NCT01609218|525216103|FG000|Period 1|Sponsor Decision|0|||
145645241|NCT01609218|525216104|FG001|Period 1|Sponsor Decision|1|||
145645242|NCT01609218|525216103|FG000|Period 2|Adverse Event|1|||
145645243|NCT01609218|525216104|FG001|Period 2|Adverse Event|0|||
145645244|NCT04428112|525216105|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
145645245|NCT04428112|525216106|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
145645246|NCT04428112|525216105|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
145645247|NCT04428112|525216106|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
145645248|NCT04428112|525216105|FG000|Overall Study|Withdrawal by Subject|9|||
145645249|NCT04428112|525216106|FG001|Overall Study|Withdrawal by Subject|4|||
145645250|NCT04428112|525216105|FG000|Overall Study|Lost to Follow-up|27|||
145645251|NCT04428112|525216106|FG001|Overall Study|Lost to Follow-up|7|||
145645252|NCT06024174|525216108|FG000|Overall Study|Other Reasons|1|||
145645253|NCT06024174|525216108|FG000|Overall Study|Study terminated by Sponsor|4|||
145645254|NCT04607044|525217729|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
145645255|NCT04607044|525217729|FG000|Overall Study|Adverse Event|1|||
145645256|NCT04607044|525217729|FG000|Overall Study|Did not receive study device|3|||
145645257|NCT04607044|525217729|FG000|Overall Study|Death|1|||
145645258|NCT03416023|525217730|FG000|Overall Study|Exclusion criteria failure|1|||
145645259|NCT03416023|525217730|FG000|Overall Study|Withdrawal by Subject|6|||
145645260|NCT03416023|525217730|FG000|Overall Study|Explanted|7|||
145645261|NCT03416023|525217730|FG000|Overall Study|Physician Decision|1|||
145645262|NCT03416023|525217730|FG000|Overall Study|Lost to Follow-up|1|||
145645263|NCT03416023|525217730|FG000|Overall Study|Death|1|||
145645264|NCT03651895|525217731|FG000|First Drug Assignment|Adverse Event|4|||
145645265|NCT03651895|525217732|FG001|First Drug Assignment|Adverse Event|5|||
145645266|NCT03651895|525217731|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
145645267|NCT03651895|525217732|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
145645268|NCT05419505|525217734|FG000|Overall Study|Adverse Event|0|||
145645269|NCT05419505|525217735|FG001|Overall Study|Adverse Event|0|||
145645270|NCT05419505|525217736|FG002|Overall Study|Adverse Event|0|||
145645271|NCT05419505|525217737|FG003|Overall Study|Adverse Event|1|||
145645272|NCT05419505|525217738|FG004|Overall Study|Adverse Event|0|||
145645273|NCT05419505|525217739|FG005|Overall Study|Adverse Event|0|||
145645274|NCT05419505|525217740|FG006|Overall Study|Adverse Event|0|||
145645275|NCT05419505|525217741|FG007|Overall Study|Adverse Event|0|||
145486655|NCT02539797|524636730|FG000|Overall Study|Lost to Follow-up|0|||
145645276|NCT05419505|525217734|FG000|Overall Study|Withdrawal by Subject|1|||
145645277|NCT05419505|525217735|FG001|Overall Study|Withdrawal by Subject|2|||
145645278|NCT05419505|525217736|FG002|Overall Study|Withdrawal by Subject|0|||
145645279|NCT05419505|525217737|FG003|Overall Study|Withdrawal by Subject|0|||
145645280|NCT05419505|525217738|FG004|Overall Study|Withdrawal by Subject|0|||
145645281|NCT05419505|525217739|FG005|Overall Study|Withdrawal by Subject|0|||
145645282|NCT05419505|525217740|FG006|Overall Study|Withdrawal by Subject|1|||
145645283|NCT05419505|525217741|FG007|Overall Study|Withdrawal by Subject|0|||
145645284|NCT05419505|525217734|FG000|Overall Study|Lost to Follow-up|2|||
145645285|NCT05419505|525217735|FG001|Overall Study|Lost to Follow-up|1|||
145645286|NCT05419505|525217736|FG002|Overall Study|Lost to Follow-up|0|||
145645287|NCT05419505|525217737|FG003|Overall Study|Lost to Follow-up|0|||
145645288|NCT05419505|525217738|FG004|Overall Study|Lost to Follow-up|1|||
145645289|NCT05419505|525217739|FG005|Overall Study|Lost to Follow-up|2|||
145645290|NCT05419505|525217740|FG006|Overall Study|Lost to Follow-up|0|||
145645291|NCT05419505|525217741|FG007|Overall Study|Lost to Follow-up|1|||
145645292|NCT02780388|525217744|FG000|Overall Study|Lost to Follow-up|0|||
145645293|NCT02780388|525217745|FG001|Overall Study|Lost to Follow-up|1|||
145645294|NCT02780388|525217746|FG002|Overall Study|Lost to Follow-up|0|||
145645295|NCT02780388|525217747|FG003|Overall Study|Lost to Follow-up|0|||
145645296|NCT02780388|525217748|FG004|Overall Study|Lost to Follow-up|0|||
145645297|NCT02780388|525217744|FG000|Overall Study|Withdrawal by Subject|1|||
145645298|NCT02780388|525217745|FG001|Overall Study|Withdrawal by Subject|1|||
145645299|NCT02780388|525217746|FG002|Overall Study|Withdrawal by Subject|0|||
145645300|NCT02780388|525217747|FG003|Overall Study|Withdrawal by Subject|0|||
145645301|NCT02780388|525217748|FG004|Overall Study|Withdrawal by Subject|0|||
145645302|NCT05107401|525217749|FG000|Overall Study|Lost to Follow-up|13|||
145645303|NCT05107401|525217750|FG001|Overall Study|Lost to Follow-up|12|||
145645304|NCT04337372|525217752|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
145645305|NCT04337372|525217753|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
145645306|NCT04337372|525217754|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
145645307|NCT04337372|525217755|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
145645308|NCT04337372|525217752|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
145645309|NCT04337372|525217753|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
145645310|NCT04337372|525217754|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
145645311|NCT04337372|525217755|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
145645312|NCT04337372|525217752|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
145645313|NCT04337372|525217753|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
145645314|NCT04337372|525217754|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
145645315|NCT04337372|525217755|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
145645316|NCT04337372|525217752|FG000|Day 2: EEG Measures|Protocol Violation|6|||
145645317|NCT04337372|525217753|FG001|Day 2: EEG Measures|Protocol Violation|6|||
145645318|NCT04337372|525217754|FG002|Day 2: EEG Measures|Protocol Violation|5|||
145645319|NCT04337372|525217755|FG003|Day 2: EEG Measures|Protocol Violation|17|||
145645320|NCT05307783|525217756|FG000|Overall Study|Death|7|||
145645321|NCT05307783|525217756|FG000|Overall Study|Lost to Follow-up|4|||
145645322|NCT04883645|525217757|FG000|Overall Study|Death|1|||
145645323|NCT03460236|525217761|FG000|Overall Study|failed radiographic screening|16|||
145645324|NCT03460236|525217761|FG000|Overall Study|Withdrawal by Subject|11|||
145645325|NCT04869982|525217771|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
145645326|NCT04869982|525217772|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
145645327|NCT04869982|525217771|FG000|Overall Study|Migrated / moved from the study area|1|||
145645328|NCT04869982|525217772|FG001|Overall Study|Migrated / moved from the study area|1|||
145645329|NCT04869982|525217771|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
145645330|NCT04869982|525217772|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
145645331|NCT04869982|525217771|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
145645332|NCT04869982|525217772|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
145645333|NCT04869982|525217771|FG000|Overall Study|Solicited adverse event|2|||
145645334|NCT04869982|525217772|FG001|Overall Study|Solicited adverse event|1|||
145645335|NCT04608045|525217773|FG000|Overall Study|Physician Decision|1|||
145645336|NCT03857620|525217775|FG000|Overall Study|Death|4|||
145645337|NCT03857620|525217776|FG001|Overall Study|Death|5|||
145645338|NCT03857620|525217777|FG002|Overall Study|Death|7|||
145645339|NCT03857620|525217775|FG000|Overall Study|Lost to Follow-up|2|||
145645340|NCT03857620|525217776|FG001|Overall Study|Lost to Follow-up|5|||
145645341|NCT03857620|525217777|FG002|Overall Study|Lost to Follow-up|3|||
145645342|NCT03857620|525217775|FG000|Overall Study|Disease progression or relapse after study registration|1|||
145645343|NCT03857620|525217776|FG001|Overall Study|Disease progression or relapse after study registration|5|||
145645344|NCT03857620|525217777|FG002|Overall Study|Disease progression or relapse after study registration|1|||
145645345|NCT03857620|525217775|FG000|Overall Study|Ineligible|5|||
145645346|NCT03857620|525217776|FG001|Overall Study|Ineligible|0|||
145645347|NCT03857620|525217777|FG002|Overall Study|Ineligible|2|||
145645348|NCT03857620|525217775|FG000|Overall Study|No malignancy|1|||
145645349|NCT03857620|525217776|FG001|Overall Study|No malignancy|0|||
145645350|NCT03857620|525217777|FG002|Overall Study|No malignancy|1|||
145645351|NCT03857620|525217775|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
145645352|NCT03857620|525217776|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
145645353|NCT03857620|525217777|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
145645354|NCT03857620|525217775|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
145645355|NCT03857620|525217776|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
145645356|NCT03857620|525217777|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
145645357|NCT03857620|525217775|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
145645358|NCT03857620|525217776|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
145645359|NCT03857620|525217777|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
145645360|NCT03857620|525217775|FG000|Overall Study|Surgery not performed, patient decision|0|||
145645361|NCT03857620|525217776|FG001|Overall Study|Surgery not performed, patient decision|3|||
145645362|NCT03857620|525217777|FG002|Overall Study|Surgery not performed, patient decision|1|||
145645363|NCT03857620|525217775|FG000|Overall Study|Surgery not performed, other reason|3|||
145645364|NCT03857620|525217776|FG001|Overall Study|Surgery not performed, other reason|1|||
145645365|NCT03857620|525217777|FG002|Overall Study|Surgery not performed, other reason|4|||
145645366|NCT03857620|525217775|FG000|Overall Study|Worsening performance status after surgery performed|0|||
145645367|NCT03857620|525217776|FG001|Overall Study|Worsening performance status after surgery performed|1|||
145645368|NCT03857620|525217777|FG002|Overall Study|Worsening performance status after surgery performed|1|||
145645369|NCT02473250|525217778|FG000|Overall Study|Lost to Follow-up|10|||
145645370|NCT02473250|525217778|FG000|Overall Study|Physician Decision|5|||
145645371|NCT02473250|525217778|FG000|Overall Study|Did not tolerate medication washout|3|||
145645372|NCT02473250|525217778|FG000|Overall Study|Antidepressant effect of divalproex|2|||
145645373|NCT03271151|525217779|FG000|Overall Study|Lost to Follow-up|1|||
145645374|NCT03271151|525217780|FG001|Overall Study|Lost to Follow-up|3|||
145645375|NCT03271151|525217779|FG000|Overall Study|Withdrawal by Subject|1|||
145645376|NCT03271151|525217780|FG001|Overall Study|Withdrawal by Subject|0|||
145645377|NCT04118452|525217781|FG000|Overall Study|Lost to Follow-up|5|||
145645378|NCT04118452|525217782|FG001|Overall Study|Lost to Follow-up|5|||
145645379|NCT04118452|525217781|FG000|Overall Study|Withdrawal by Subject|17|||
145645380|NCT04118452|525217782|FG001|Overall Study|Withdrawal by Subject|17|||
145645381|NCT03215030|525217783|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
145645382|NCT03215030|525217784|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
145645383|NCT03215030|525217785|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645384|NCT03215030|525217786|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
145645385|NCT03215030|525217787|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645386|NCT03215030|525217788|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645387|NCT03215030|525217789|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645388|NCT03215030|525217790|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645389|NCT03215030|525217791|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645390|NCT03215030|525217792|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645391|NCT03215030|525217793|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645392|NCT03215030|525217794|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
145645393|NCT03215030|525217783|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
145645394|NCT03215030|525217784|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645395|NCT03215030|525217785|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645396|NCT03215030|525217786|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
145645397|NCT03215030|525217787|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645398|NCT03215030|525217788|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645399|NCT03215030|525217789|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645400|NCT03215030|525217790|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645401|NCT03215030|525217791|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145486656|NCT02539797|524636731|FG001|Overall Study|Lost to Follow-up|1|||
145486657|NCT02539797|524636732|FG002|Overall Study|Lost to Follow-up|0|||
145645402|NCT03215030|525217792|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645403|NCT03215030|525217793|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645404|NCT03215030|525217794|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145645405|NCT03215030|525217783|FG000|Part 1: Dose Escalation|Death|15|||
145645406|NCT03215030|525217784|FG001|Part 1: Dose Escalation|Death|6|||
145645407|NCT03215030|525217785|FG002|Part 1: Dose Escalation|Death|6|||
145645408|NCT03215030|525217786|FG003|Part 1: Dose Escalation|Death|8|||
145645409|NCT03215030|525217787|FG004|Part 1: Dose Escalation|Death|0|||
145645410|NCT03215030|525217788|FG005|Part 1: Dose Escalation|Death|0|||
145645411|NCT03215030|525217789|FG006|Part 1: Dose Escalation|Death|0|||
145645412|NCT03215030|525217790|FG007|Part 1: Dose Escalation|Death|0|||
145645413|NCT03215030|525217791|FG008|Part 1: Dose Escalation|Death|0|||
145645414|NCT03215030|525217792|FG009|Part 1: Dose Escalation|Death|0|||
145486658|NCT02796677|524636738|FG000|Overall Study|Adverse Event|11|||
145645415|NCT03215030|525217793|FG010|Part 1: Dose Escalation|Death|0|||
145645416|NCT03215030|525217794|FG011|Part 1: Dose Escalation|Death|0|||
145645417|NCT03215030|525217783|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
145645418|NCT03215030|525217784|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
145645419|NCT03215030|525217785|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
145645420|NCT03215030|525217786|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
145645421|NCT03215030|525217787|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
145645422|NCT03215030|525217788|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
145645423|NCT03215030|525217789|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
145645424|NCT03215030|525217790|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
145645425|NCT03215030|525217791|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
145645426|NCT03215030|525217792|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
145645427|NCT03215030|525217793|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
145645428|NCT03215030|525217794|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
145645429|NCT03215030|525217783|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645430|NCT03215030|525217784|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645431|NCT03215030|525217785|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645432|NCT03215030|525217786|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645433|NCT03215030|525217787|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645434|NCT03215030|525217788|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645435|NCT03215030|525217789|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645436|NCT03215030|525217790|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
145645437|NCT03215030|525217791|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645438|NCT03215030|525217792|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645439|NCT03215030|525217793|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645440|NCT03215030|525217794|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
145645441|NCT03215030|525217783|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645442|NCT03215030|525217784|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645443|NCT03215030|525217785|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645444|NCT03215030|525217786|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645445|NCT03215030|525217787|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
145645446|NCT03215030|525217788|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
145645447|NCT03215030|525217789|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
145645448|NCT03215030|525217790|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
145645449|NCT03215030|525217791|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645450|NCT03215030|525217792|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645451|NCT03215030|525217793|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645452|NCT03215030|525217794|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145645453|NCT03215030|525217783|FG000|Part 2: Dose Expansion|Death|0|||
145645454|NCT03215030|525217784|FG001|Part 2: Dose Expansion|Death|0|||
145645455|NCT03215030|525217785|FG002|Part 2: Dose Expansion|Death|0|||
145645456|NCT03215030|525217786|FG003|Part 2: Dose Expansion|Death|0|||
145645457|NCT03215030|525217787|FG004|Part 2: Dose Expansion|Death|3|||
145645458|NCT03215030|525217788|FG005|Part 2: Dose Expansion|Death|1|||
145645459|NCT03215030|525217789|FG006|Part 2: Dose Expansion|Death|5|||
145645460|NCT03215030|525217790|FG007|Part 2: Dose Expansion|Death|4|||
145645461|NCT03215030|525217791|FG008|Part 2: Dose Expansion|Death|0|||
145645462|NCT03215030|525217792|FG009|Part 2: Dose Expansion|Death|0|||
145645463|NCT03215030|525217793|FG010|Part 2: Dose Expansion|Death|0|||
145645464|NCT03215030|525217794|FG011|Part 2: Dose Expansion|Death|0|||
145645465|NCT03215030|525217783|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
145645466|NCT03215030|525217784|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
145645467|NCT03215030|525217785|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
145645468|NCT03215030|525217786|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
145645469|NCT03215030|525217787|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
145645470|NCT03215030|525217788|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
145645471|NCT03215030|525217789|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
145645472|NCT03215030|525217790|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
145645473|NCT03215030|525217791|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
145645474|NCT03215030|525217792|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
145645475|NCT03215030|525217793|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
145645476|NCT03215030|525217794|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
145645477|NCT03215030|525217783|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
145486659|NCT02796677|524636739|FG001|Overall Study|Adverse Event|22|||
145486660|NCT02796677|524636740|FG002|Overall Study|Adverse Event|14|||
145486661|NCT02796677|524636741|FG003|Overall Study|Adverse Event|14|||
145645478|NCT03215030|525217784|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
145645479|NCT03215030|525217785|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
145645480|NCT03215030|525217786|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
145645481|NCT03215030|525217787|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
145645482|NCT03215030|525217788|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
145645483|NCT03215030|525217789|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
145645484|NCT03215030|525217790|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
145645485|NCT03215030|525217791|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
145645486|NCT03215030|525217792|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
145645487|NCT03215030|525217793|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
145645488|NCT03215030|525217794|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
145645489|NCT03215030|525217783|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645490|NCT03215030|525217784|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645491|NCT03215030|525217785|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645492|NCT03215030|525217786|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645493|NCT03215030|525217787|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645494|NCT03215030|525217788|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645495|NCT03215030|525217789|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645496|NCT03215030|525217790|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645497|NCT03215030|525217791|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
145645498|NCT03215030|525217792|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
145645499|NCT03215030|525217793|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645500|NCT03215030|525217794|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
145645501|NCT03215030|525217783|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645502|NCT03215030|525217784|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645503|NCT03215030|525217785|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645504|NCT03215030|525217786|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645505|NCT03215030|525217787|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645506|NCT03215030|525217788|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645507|NCT03215030|525217789|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645508|NCT03215030|525217790|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645509|NCT03215030|525217791|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
145645510|NCT03215030|525217792|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
145645511|NCT03215030|525217793|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645512|NCT03215030|525217794|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
145645513|NCT03215030|525217783|FG000|Part 3: Dose Extension|Death|0|||
145645514|NCT03215030|525217784|FG001|Part 3: Dose Extension|Death|0|||
145645515|NCT03215030|525217785|FG002|Part 3: Dose Extension|Death|0|||
145645516|NCT03215030|525217786|FG003|Part 3: Dose Extension|Death|0|||
145645517|NCT03215030|525217787|FG004|Part 3: Dose Extension|Death|0|||
145645518|NCT03215030|525217788|FG005|Part 3: Dose Extension|Death|0|||
145645519|NCT03215030|525217789|FG006|Part 3: Dose Extension|Death|0|||
145645520|NCT03215030|525217790|FG007|Part 3: Dose Extension|Death|0|||
145645521|NCT03215030|525217791|FG008|Part 3: Dose Extension|Death|19|||
145645522|NCT03215030|525217792|FG009|Part 3: Dose Extension|Death|20|||
145645523|NCT03215030|525217793|FG010|Part 3: Dose Extension|Death|0|||
145645524|NCT03215030|525217794|FG011|Part 3: Dose Extension|Death|0|||
145645525|NCT03215030|525217783|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
145645526|NCT03215030|525217784|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
145645527|NCT03215030|525217785|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
145645528|NCT03215030|525217786|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
145645529|NCT03215030|525217787|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
145645530|NCT03215030|525217788|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
145645531|NCT03215030|525217789|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
145645532|NCT03215030|525217790|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
145645533|NCT03215030|525217791|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
145645534|NCT03215030|525217792|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
145645535|NCT03215030|525217793|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
145645536|NCT03215030|525217794|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
145645537|NCT03215030|525217783|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645538|NCT03215030|525217784|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645539|NCT03215030|525217785|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645540|NCT03215030|525217786|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645541|NCT03215030|525217787|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645542|NCT03215030|525217788|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645543|NCT03215030|525217789|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645544|NCT03215030|525217790|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645545|NCT03215030|525217791|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645546|NCT03215030|525217792|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
145645547|NCT03215030|525217793|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
145645548|NCT03215030|525217794|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
145645549|NCT03433339|525217795|FG000|Overall Study|Lost to Follow-up|2|||
145645550|NCT03433339|525217796|FG001|Overall Study|Lost to Follow-up|0|||
145645551|NCT03433339|525217795|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
145645552|NCT03433339|525217796|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
145645553|NCT03433339|525217795|FG000|Overall Study|Withdrawal by Subject|0|||
145645554|NCT03433339|525217796|FG001|Overall Study|Withdrawal by Subject|2|||
145645555|NCT05952076|525217797|FG000|Overall Study|Death|1|||
145645556|NCT05952076|525217798|FG001|Overall Study|Death|1|||
145645557|NCT05952076|525217797|FG000|Overall Study|Lost to Follow-up|0|||
145645558|NCT05952076|525217798|FG001|Overall Study|Lost to Follow-up|1|||
145645559|NCT06023082|525217804|FG000|Overall Study|Withdrawal by Subject|2|||
145645560|NCT06023082|525217804|FG000|Overall Study|Lost to Follow-up|15|||
145645561|NCT06023082|525217804|FG000|Overall Study|Side effects|5|||
145645562|NCT05136404|525217805|FG000|Period 1|Adverse Event|0|||
145645563|NCT05136404|525217806|FG001|Period 1|Adverse Event|1|||
145645564|NCT05136404|525217807|FG002|Period 1|Adverse Event|1|||
145645565|NCT05136404|525217805|FG000|Period 2|Inappropriate Behavior|0|||
145645566|NCT05136404|525217806|FG001|Period 2|Inappropriate Behavior|0|||
145645567|NCT05136404|525217807|FG002|Period 2|Inappropriate Behavior|1|||
145645568|NCT05136404|525217805|FG000|Period 3|Adverse Event|0|||
145645569|NCT05136404|525217806|FG001|Period 3|Adverse Event|0|||
145645570|NCT05136404|525217807|FG002|Period 3|Adverse Event|1|||
145645571|NCT03584516|525217808|FG000|Part 1|Death|2|||
145645572|NCT03584516|525217809|FG001|Part 1|Death|3|||
145645573|NCT03584516|525217810|FG002|Part 1|Death|0|||
145645574|NCT03584516|525217811|FG003|Part 1|Death|0|||
145645575|NCT03584516|525217812|FG004|Part 1|Death|0|||
145645576|NCT03584516|525217813|FG005|Part 1|Death|0|||
145645577|NCT03584516|525217808|FG000|Part 1|Withdrawal by Subject|2|||
145645578|NCT03584516|525217809|FG001|Part 1|Withdrawal by Subject|0|||
145645579|NCT03584516|525217810|FG002|Part 1|Withdrawal by Subject|0|||
145645580|NCT03584516|525217811|FG003|Part 1|Withdrawal by Subject|0|||
145645581|NCT03584516|525217812|FG004|Part 1|Withdrawal by Subject|0|||
145645582|NCT03584516|525217813|FG005|Part 1|Withdrawal by Subject|0|||
145645583|NCT03584516|525217808|FG000|Part 1|Lost to Follow-up|1|||
145645584|NCT03584516|525217809|FG001|Part 1|Lost to Follow-up|0|||
145645585|NCT03584516|525217810|FG002|Part 1|Lost to Follow-up|0|||
145645586|NCT03584516|525217811|FG003|Part 1|Lost to Follow-up|0|||
145645587|NCT03584516|525217812|FG004|Part 1|Lost to Follow-up|0|||
145645588|NCT03584516|525217813|FG005|Part 1|Lost to Follow-up|0|||
145645589|NCT03584516|525217808|FG000|Part 1|Study Terminated by Sponsor|0|||
145645590|NCT03584516|525217809|FG001|Part 1|Study Terminated by Sponsor|2|||
145645591|NCT03584516|525217810|FG002|Part 1|Study Terminated by Sponsor|0|||
145645592|NCT03584516|525217811|FG003|Part 1|Study Terminated by Sponsor|0|||
145645593|NCT03584516|525217812|FG004|Part 1|Study Terminated by Sponsor|0|||
145645594|NCT03584516|525217813|FG005|Part 1|Study Terminated by Sponsor|0|||
145645595|NCT03584516|525217808|FG000|Part 1 Expansion|Death|0|||
145645596|NCT03584516|525217809|FG001|Part 1 Expansion|Death|0|||
145645597|NCT03584516|525217810|FG002|Part 1 Expansion|Death|9|||
145645598|NCT03584516|525217811|FG003|Part 1 Expansion|Death|8|||
145645599|NCT03584516|525217812|FG004|Part 1 Expansion|Death|4|||
145645600|NCT03584516|525217813|FG005|Part 1 Expansion|Death|5|||
145645601|NCT03584516|525217808|FG000|Part 1 Expansion|Lost to Follow-up|0|||
145645602|NCT03584516|525217809|FG001|Part 1 Expansion|Lost to Follow-up|0|||
145645603|NCT03584516|525217810|FG002|Part 1 Expansion|Lost to Follow-up|0|||
145645604|NCT03584516|525217811|FG003|Part 1 Expansion|Lost to Follow-up|1|||
145645605|NCT03584516|525217812|FG004|Part 1 Expansion|Lost to Follow-up|0|||
145645606|NCT03584516|525217813|FG005|Part 1 Expansion|Lost to Follow-up|0|||
145645607|NCT03584516|525217808|FG000|Part 1 Expansion|Physician Decision|0|||
145645608|NCT03584516|525217809|FG001|Part 1 Expansion|Physician Decision|0|||
145645609|NCT03584516|525217810|FG002|Part 1 Expansion|Physician Decision|4|||
145645610|NCT03584516|525217811|FG003|Part 1 Expansion|Physician Decision|3|||
145645611|NCT03584516|525217812|FG004|Part 1 Expansion|Physician Decision|2|||
145645612|NCT03584516|525217813|FG005|Part 1 Expansion|Physician Decision|3|||
145645613|NCT03584516|525217808|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
145645614|NCT03584516|525217809|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
145645615|NCT03584516|525217810|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
145645616|NCT03584516|525217811|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
145645617|NCT03584516|525217812|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
145645618|NCT03584516|525217813|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
145645619|NCT03584516|525217808|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
145645620|NCT03584516|525217809|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
145645621|NCT03584516|525217810|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
145645622|NCT03584516|525217811|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
145645623|NCT03584516|525217812|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
145645624|NCT03584516|525217813|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
145645625|NCT03584516|525217808|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
145645626|NCT03584516|525217809|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
145645627|NCT03584516|525217810|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
145645628|NCT03584516|525217811|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
145645629|NCT03584516|525217812|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
145645630|NCT03584516|525217813|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
145645631|NCT03584516|525217808|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
145645632|NCT03584516|525217809|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
145645633|NCT03584516|525217810|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
145645634|NCT03584516|525217811|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
145645635|NCT03584516|525217812|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
145645636|NCT03584516|525217813|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
145645637|NCT05986565|525217814|FG000|Overall Study|Lost to Follow-up|8|||
145645638|NCT05986565|525217815|FG001|Overall Study|Lost to Follow-up|3|||
145645639|NCT05986565|525217814|FG000|Overall Study|Withdrawal by Subject|0|||
145645640|NCT05986565|525217815|FG001|Overall Study|Withdrawal by Subject|1|||
145645641|NCT05846646|525217818|FG000|Overall Study|Physician Decision|1|||
145645642|NCT05846646|525217819|FG001|Overall Study|Physician Decision|0|||
145645643|NCT05846646|525217820|FG002|Overall Study|Physician Decision|0|||
145645644|NCT05846646|525217818|FG000|Overall Study|Lack of Efficacy|1|||
145645645|NCT05846646|525217819|FG001|Overall Study|Lack of Efficacy|1|||
145645646|NCT05846646|525217820|FG002|Overall Study|Lack of Efficacy|0|||
145645647|NCT05846646|525217818|FG000|Overall Study|Early Study Termination|1|||
145645648|NCT05846646|525217819|FG001|Overall Study|Early Study Termination|2|||
145645649|NCT05846646|525217820|FG002|Overall Study|Early Study Termination|0|||
145645650|NCT00670046|525217821|FG000|Overall Study|Lost to Follow-up|1|||
145645651|NCT00670046|525217822|FG001|Overall Study|Lost to Follow-up|1|||
145645652|NCT00670046|525217821|FG000|Overall Study|Withdrawal by Subject|0|||
145645653|NCT00670046|525217822|FG001|Overall Study|Withdrawal by Subject|1|||
145645654|NCT00505934|525217831|FG000|Overall Study|Adverse Event|1|||
145645655|NCT00505934|525217831|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
145645656|NCT00505934|525217831|FG000|Overall Study|Other: IV dose needed to be changed|1|||
145645657|NCT02461628|525217832|FG000|Overall Study|Refused to complete survey|4|||
145645658|NCT02461628|525217833|FG001|Overall Study|Refused to complete survey|7|||
145645659|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
145645660|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
145645661|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
145645662|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
145645663|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
145645664|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
145645665|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
145645666|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
145645667|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
145645668|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
145645669|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
145645670|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
145645671|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
145645672|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
145645673|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
145645674|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
145645675|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
145645676|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
145645677|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
145645678|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
145645679|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
145645680|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
145645681|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
145645682|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
145645683|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
145645684|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
145645685|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
145645686|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
145645687|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
145645688|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
145645689|NCT04759833|525217834|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
145645690|NCT04759833|525217835|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
145645691|NCT04759833|525217836|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
145645692|NCT04759833|525217837|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
145645693|NCT04759833|525217838|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
145645694|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
145645695|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
145645696|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
145645697|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
145645698|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
145645699|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
145645700|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
145486662|NCT02796677|524636738|FG000|Overall Study|Protocol Violation|7|||
145645701|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
145645702|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
145645703|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
145645704|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
145645705|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
145645706|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
145645707|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
145645708|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
145645709|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
145645710|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
145645711|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
145645712|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
145645713|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
145645714|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
145645715|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
145645716|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
145645717|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
145645718|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
145645719|NCT04759833|525217834|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
145645720|NCT04759833|525217835|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
145645721|NCT04759833|525217836|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
145645722|NCT04759833|525217837|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
145645723|NCT04759833|525217838|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
145645724|NCT03446157|525217839|FG000|Overall Study|Death|11|||
145645725|NCT03446157|525217840|FG001|Overall Study|Death|9|||
145645726|NCT03446157|525217839|FG000|Overall Study|Lost to Follow-up|0|||
145645727|NCT03446157|525217840|FG001|Overall Study|Lost to Follow-up|1|||
145645728|NCT03446157|525217839|FG000|Overall Study|Withdrawal by Subject|2|||
145645729|NCT03446157|525217840|FG001|Overall Study|Withdrawal by Subject|1|||
145645730|NCT00998881|525217843|FG000|Overall Study|Adverse Event|2|||
145645731|NCT00998881|525217844|FG001|Overall Study|Adverse Event|2|||
145645732|NCT00998881|525217843|FG000|Overall Study|Lack of Efficacy|1|||
145645733|NCT00998881|525217844|FG001|Overall Study|Lack of Efficacy|0|||
145645734|NCT00998881|525217843|FG000|Overall Study|Physician Decision|3|||
145645735|NCT00998881|525217844|FG001|Overall Study|Physician Decision|0|||
145645736|NCT00998881|525217843|FG000|Overall Study|Withdrawal by Subject|1|||
145645737|NCT00998881|525217844|FG001|Overall Study|Withdrawal by Subject|0|||
145645738|NCT00998881|525217843|FG000|Overall Study|Personal matter|1|||
145645739|NCT00998881|525217844|FG001|Overall Study|Personal matter|0|||
145645740|NCT02462759|525217845|FG000|Part 1: Double Blind|Death|1|||
145645741|NCT02462759|525217846|FG001|Part 1: Double Blind|Death|0|||
145645742|NCT02462759|525217847|FG002|Part 1: Double Blind|Death|0|||
145645743|NCT00065260|525217852|FG000|Overall Study|Death|0|||
145645744|NCT00065260|525217853|FG001|Overall Study|Death|1|||
145645745|NCT04484935|525217855|FG000|Overall Study|Other|0|||
145645746|NCT04484935|525217856|FG001|Overall Study|Other|1|||
145645747|NCT04484935|525217855|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145645748|NCT04484935|525217856|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145645749|NCT04484935|525217855|FG000|Overall Study|Lost to Follow-up|1|||
145645750|NCT04484935|525217856|FG001|Overall Study|Lost to Follow-up|0|||
145645751|NCT04484935|525217855|FG000|Overall Study|Death|2|||
145645752|NCT04484935|525217856|FG001|Overall Study|Death|1|||
145645753|NCT01044303|525217862|FG000|Overall Study|Lost to Follow-up|2|||
145645754|NCT01037985|525217868|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
145645755|NCT01037985|525217869|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
145645756|NCT01037985|525217868|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
145645757|NCT01037985|525217869|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
145645758|NCT01037985|525217868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
145645759|NCT01037985|525217869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
145645760|NCT01037985|525217868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
145645761|NCT01037985|525217869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
145645762|NCT04402294|525217870|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
145645763|NCT04402294|525217871|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
145645764|NCT04402294|525217870|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
145645765|NCT04402294|525217871|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
145486663|NCT02796677|524636739|FG001|Overall Study|Protocol Violation|5|||
145486664|NCT02796677|524636740|FG002|Overall Study|Protocol Violation|4|||
145486665|NCT02796677|524636741|FG003|Overall Study|Protocol Violation|8|||
145486666|NCT02796677|524636738|FG000|Overall Study|Lost to Follow-up|1|||
145645766|NCT05134337|525219700|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
145645767|NCT05134337|525219701|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
145645768|NCT03725722|525219702|FG000|Overall Study|Lack of Efficacy|2|||
145645769|NCT03725722|525219703|FG001|Overall Study|Lack of Efficacy|1|||
145645770|NCT03725722|525219704|FG002|Overall Study|Lack of Efficacy|2|||
145645771|NCT03725722|525219705|FG003|Overall Study|Lack of Efficacy|0|||
145645772|NCT03725722|525219706|FG004|Overall Study|Lack of Efficacy|2|||
145645773|NCT03725722|525219702|FG000|Overall Study|Adverse Event|2|||
145645774|NCT03725722|525219703|FG001|Overall Study|Adverse Event|2|||
145645775|NCT03725722|525219704|FG002|Overall Study|Adverse Event|1|||
145645776|NCT03725722|525219705|FG003|Overall Study|Adverse Event|0|||
145645777|NCT03725722|525219706|FG004|Overall Study|Adverse Event|6|||
145645778|NCT03725722|525219702|FG000|Overall Study|Withdrawal by Subject|4|||
145645779|NCT03725722|525219703|FG001|Overall Study|Withdrawal by Subject|1|||
145645780|NCT03725722|525219704|FG002|Overall Study|Withdrawal by Subject|0|||
145486667|NCT02796677|524636739|FG001|Overall Study|Lost to Follow-up|5|||
145486668|NCT02796677|524636740|FG002|Overall Study|Lost to Follow-up|2|||
145486669|NCT02796677|524636741|FG003|Overall Study|Lost to Follow-up|2|||
145486670|NCT02796677|524636738|FG000|Overall Study|Lack of Efficacy|7|||
145486671|NCT02796677|524636739|FG001|Overall Study|Lack of Efficacy|9|||
145486672|NCT02796677|524636740|FG002|Overall Study|Lack of Efficacy|14|||
145486673|NCT02796677|524636741|FG003|Overall Study|Lack of Efficacy|20|||
145486674|NCT02796677|524636738|FG000|Overall Study|Withdrawal by Subject|4|||
145486675|NCT02796677|524636739|FG001|Overall Study|Withdrawal by Subject|14|||
145486676|NCT02796677|524636740|FG002|Overall Study|Withdrawal by Subject|6|||
145486677|NCT02796677|524636741|FG003|Overall Study|Withdrawal by Subject|7|||
145486678|NCT02796677|524636738|FG000|Overall Study|Progressive disease|6|||
145645781|NCT03725722|525219705|FG003|Overall Study|Withdrawal by Subject|4|||
145645782|NCT03725722|525219706|FG004|Overall Study|Withdrawal by Subject|4|||
145645783|NCT03725722|525219702|FG000|Overall Study|Lost to Follow-up|3|||
145645784|NCT03725722|525219703|FG001|Overall Study|Lost to Follow-up|1|||
145645785|NCT03725722|525219704|FG002|Overall Study|Lost to Follow-up|2|||
145645786|NCT03725722|525219705|FG003|Overall Study|Lost to Follow-up|2|||
145645787|NCT03725722|525219706|FG004|Overall Study|Lost to Follow-up|1|||
145645788|NCT03725722|525219702|FG000|Overall Study|Personal reasons|0|||
145645789|NCT03725722|525219703|FG001|Overall Study|Personal reasons|0|||
145645790|NCT03725722|525219704|FG002|Overall Study|Personal reasons|1|||
145645791|NCT03725722|525219705|FG003|Overall Study|Personal reasons|0|||
145645792|NCT03725722|525219706|FG004|Overall Study|Personal reasons|1|||
145645793|NCT03725722|525219702|FG000|Overall Study|COVID-19 situation|0|||
145645794|NCT03725722|525219703|FG001|Overall Study|COVID-19 situation|1|||
145645795|NCT03725722|525219704|FG002|Overall Study|COVID-19 situation|0|||
145645796|NCT03725722|525219705|FG003|Overall Study|COVID-19 situation|0|||
145645797|NCT03725722|525219706|FG004|Overall Study|COVID-19 situation|0|||
145645798|NCT03481660|525219710|FG000|Overall Study|Adverse Event|5|||
145645799|NCT03481660|525219711|FG001|Overall Study|Adverse Event|4|||
145645800|NCT03481660|525219710|FG000|Overall Study|Death|13|||
145645801|NCT03481660|525219711|FG001|Overall Study|Death|9|||
145645802|NCT03481660|525219710|FG000|Overall Study|Lost to Follow-up|2|||
145645803|NCT03481660|525219711|FG001|Overall Study|Lost to Follow-up|2|||
145645804|NCT03481660|525219710|FG000|Overall Study|Physician Decision|2|||
145645805|NCT03481660|525219711|FG001|Overall Study|Physician Decision|3|||
145645806|NCT03481660|525219710|FG000|Overall Study|Withdrawal by Subject|14|||
145645807|NCT03481660|525219711|FG001|Overall Study|Withdrawal by Subject|7|||
145645808|NCT01259401|525219712|FG000|4-month Follow-up|Death|0|||
145645809|NCT01259401|525219713|FG001|4-month Follow-up|Death|1|||
145645810|NCT01259401|525219712|FG000|4-month Follow-up|Lost to Follow-up|0|||
145645811|NCT01259401|525219713|FG001|4-month Follow-up|Lost to Follow-up|1|||
145645812|NCT00186992|525219714|FG000|Overall Study|Withdrawal by Subject|5|||
145645813|NCT00186992|525219714|FG000|Overall Study|Physician's discretion|13|||
145645814|NCT00186992|525219714|FG000|Overall Study|PI Discretion|4|||
145486679|NCT02796677|524636739|FG001|Overall Study|Progressive disease|15|||
145486680|NCT02796677|524636740|FG002|Overall Study|Progressive disease|13|||
145486681|NCT02796677|524636741|FG003|Overall Study|Progressive disease|18|||
145486682|NCT02796677|524636738|FG000|Overall Study|Reason not mentioned|2|||
145645815|NCT00186992|525219714|FG000|Overall Study|Ineligible|2|||
145645816|NCT00186992|525219714|FG000|Overall Study|Lost to Follow-up|2|||
145645817|NCT00186992|525219714|FG000|Overall Study|Still on Study|9|||
145486683|NCT02796677|524636739|FG001|Overall Study|Reason not mentioned|3|||
145486684|NCT02796677|524636740|FG002|Overall Study|Reason not mentioned|0|||
145486685|NCT02796677|524636741|FG003|Overall Study|Reason not mentioned|5|||
145645818|NCT03683069|525219715|FG000|Overall Study|see limitations|12|||
145645819|NCT03683069|525219716|FG001|Overall Study|see limitations|13|||
145645820|NCT05696080|525219717|FG000|Overall Study|Lost to Follow-up|2|||
145645821|NCT05696080|525219718|FG001|Overall Study|Lost to Follow-up|1|||
145645822|NCT05696080|525219717|FG000|Overall Study|Physician Decision|1|||
145645823|NCT05696080|525219718|FG001|Overall Study|Physician Decision|0|||
145486686|NCT03798717|524636742|FG000|Overall Study|Failed Screening|0|||
145486687|NCT03798717|524636743|FG001|Overall Study|Failed Screening|0|||
145645824|NCT05696080|525219717|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
145645825|NCT05696080|525219718|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
145645826|NCT05696080|525219717|FG000|Overall Study|Withdrawal by Subject|12|||
145645827|NCT05696080|525219718|FG001|Overall Study|Withdrawal by Subject|0|||
145645828|NCT05478525|525219721|FG000|Overall Study|Withdrawal by Subject|0|||
145645829|NCT05478525|525219722|FG001|Overall Study|Withdrawal by Subject|1|||
145645830|NCT05478525|525219723|FG002|Overall Study|Withdrawal by Subject|2|||
145645831|NCT05478525|525219724|FG003|Overall Study|Withdrawal by Subject|0|||
145645832|NCT05478525|525219721|FG000|Overall Study|COVID-19 Infection|2|||
145645833|NCT05478525|525219722|FG001|Overall Study|COVID-19 Infection|0|||
145645834|NCT05478525|525219723|FG002|Overall Study|COVID-19 Infection|1|||
145645835|NCT05478525|525219724|FG003|Overall Study|COVID-19 Infection|1|||
145645836|NCT01649271|525219725|FG000|Overall Study|Progressive disease|4|||
145645837|NCT01649271|525219726|FG001|Overall Study|Progressive disease|5|||
145645838|NCT01649271|525219725|FG000|Overall Study|Other Adverse Event|0|||
145645839|NCT01649271|525219726|FG001|Overall Study|Other Adverse Event|2|||
145645840|NCT01649271|525219725|FG000|Overall Study|Withdrawal by Subject|1|||
145645841|NCT01649271|525219726|FG001|Overall Study|Withdrawal by Subject|0|||
145645842|NCT01649271|525219725|FG000|Overall Study|Other than stated above|1|||
145645843|NCT01649271|525219726|FG001|Overall Study|Other than stated above|0|||
145645844|NCT05644002|525219727|FG000|Overall Study|Lost to Follow-up|1|||
145645845|NCT05644002|525219728|FG001|Overall Study|Lost to Follow-up|2|||
145645846|NCT05644002|525219727|FG000|Overall Study|Withdrawal by Subject|0|||
145645847|NCT05644002|525219728|FG001|Overall Study|Withdrawal by Subject|1|||
145645848|NCT05756075|525219731|FG000|Overall Study|Withdrawal by Subject|16|||
145645849|NCT05756075|525219732|FG001|Overall Study|Withdrawal by Subject|9|||
145645850|NCT01991977|525219733|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
145645851|NCT01991977|525219733|FG000|Overall Study|Withdrew after start of treatment|5|||
145645852|NCT02605837|525219736|FG000|Overall Study|Adverse Event|3|||
145645853|NCT02605837|525219737|FG001|Overall Study|Adverse Event|1|||
145645854|NCT02605837|525219736|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145645855|NCT02605837|525219737|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145645856|NCT02605837|525219736|FG000|Overall Study|Withdrawal by Subject|8|||
145645857|NCT02605837|525219737|FG001|Overall Study|Withdrawal by Subject|8|||
145645858|NCT02605837|525219736|FG000|Overall Study|Physician Decision|0|||
145645859|NCT02605837|525219737|FG001|Overall Study|Physician Decision|1|||
145645860|NCT05307978|525219738|FG000|Overall Study|Lost to Follow-up|0|||
145645861|NCT05307978|525219739|FG001|Overall Study|Lost to Follow-up|1|||
145645862|NCT05307978|525219740|FG002|Overall Study|Lost to Follow-up|0|||
145645863|NCT05307978|525219741|FG003|Overall Study|Lost to Follow-up|4|||
145645864|NCT05307978|525219742|FG004|Overall Study|Lost to Follow-up|0|||
145645865|NCT05307978|525219743|FG005|Overall Study|Lost to Follow-up|0|||
145645866|NCT05307978|525219744|FG006|Overall Study|Lost to Follow-up|1|||
145645867|NCT02837510|525219745|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
145645868|NCT02837510|525219746|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
145645869|NCT02837510|525219745|FG000|Washout (2 Weeks)|Adverse Event|0|||
145645870|NCT02837510|525219746|FG001|Washout (2 Weeks)|Adverse Event|1|||
145645871|NCT02837510|525219745|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
145645872|NCT02837510|525219746|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
145645873|NCT02837510|525219745|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
145645874|NCT02837510|525219746|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
145645875|NCT02837510|525219745|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
145645876|NCT02837510|525219746|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
145645877|NCT02837510|525219745|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
145645878|NCT02837510|525219746|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
145645879|NCT04527146|525219747|FG000|Overall Study|Withdrawal by Subject|12|||
145645880|NCT04527146|525219748|FG001|Overall Study|Withdrawal by Subject|15|||
145645881|NCT04527146|525219749|FG002|Overall Study|Withdrawal by Subject|7|||
145645882|NCT04527146|525219750|FG003|Overall Study|Withdrawal by Subject|16|||
145645883|NCT04527146|525219747|FG000|Overall Study|Lost to Follow-up|13|||
145645884|NCT04527146|525219748|FG001|Overall Study|Lost to Follow-up|9|||
145645885|NCT04527146|525219749|FG002|Overall Study|Lost to Follow-up|16|||
145645886|NCT04527146|525219750|FG003|Overall Study|Lost to Follow-up|13|||
145645887|NCT04527146|525219747|FG000|Overall Study|Death|0|||
145645888|NCT04527146|525219748|FG001|Overall Study|Death|1|||
145645889|NCT04527146|525219749|FG002|Overall Study|Death|1|||
145645890|NCT04527146|525219750|FG003|Overall Study|Death|0|||
145645891|NCT04527146|525219747|FG000|Overall Study|Adverse Event|0|||
145645892|NCT04527146|525219748|FG001|Overall Study|Adverse Event|0|||
145645893|NCT04527146|525219749|FG002|Overall Study|Adverse Event|1|||
145645894|NCT04527146|525219750|FG003|Overall Study|Adverse Event|0|||
145645895|NCT04527146|525219747|FG000|Overall Study|Ineligible after randomization|2|||
145645896|NCT04527146|525219748|FG001|Overall Study|Ineligible after randomization|0|||
145645897|NCT04527146|525219749|FG002|Overall Study|Ineligible after randomization|2|||
145645898|NCT04527146|525219750|FG003|Overall Study|Ineligible after randomization|2|||
145486688|NCT03798717|524636744|FG002|Overall Study|Failed Screening|0|||
145645899|NCT04527146|525219747|FG000|Overall Study|Moved to a different group|6|||
145645900|NCT04527146|525219748|FG001|Overall Study|Moved to a different group|3|||
145645901|NCT04527146|525219749|FG002|Overall Study|Moved to a different group|0|||
145645902|NCT04527146|525219750|FG003|Overall Study|Moved to a different group|2|||
145645903|NCT02201108|525219753|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
145645904|NCT02201108|525219754|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
145645905|NCT02201108|525219755|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
145645906|NCT02201108|525219753|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
145645907|NCT02201108|525219754|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
145645908|NCT02201108|525219755|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
145645909|NCT02201108|525219753|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
145645910|NCT02201108|525219754|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
145645911|NCT02201108|525219755|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
145645912|NCT02201108|525219753|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
145645913|NCT02201108|525219754|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
145645914|NCT02201108|525219755|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
145645915|NCT02201108|525219753|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
145645916|NCT02201108|525219754|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
145645917|NCT02201108|525219755|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
145645918|NCT02201108|525219753|FG000|Open Label Period (up to Week 192)|Other reason|4|||
145645919|NCT02201108|525219754|FG001|Open Label Period (up to Week 192)|Other reason|7|||
145486689|NCT03798717|524636745|FG003|Overall Study|Failed Screening|0|||
145486690|NCT03798717|524636746|FG004|Overall Study|Failed Screening|0|||
145486691|NCT03798717|524636747|FG005|Overall Study|Failed Screening|1|||
145486692|NCT03798717|524636742|FG000|Overall Study|Physician Decision|1|||
145645920|NCT02201108|525219755|FG002|Open Label Period (up to Week 192)|Other reason|0|||
145645921|NCT02201108|525219753|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
145645922|NCT02201108|525219754|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
145645923|NCT02201108|525219755|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
145645924|NCT02201108|525219753|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
145645925|NCT02201108|525219754|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
145645926|NCT02201108|525219755|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
145645927|NCT02201108|525219753|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
145645928|NCT02201108|525219754|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
145645929|NCT02201108|525219755|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
145645930|NCT03438188|525219756|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
145645931|NCT03438188|525219757|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
145645932|NCT03438188|525219758|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
145645933|NCT03438188|525219756|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
145645934|NCT03438188|525219757|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
145645935|NCT03438188|525219758|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
145645936|NCT03438188|525219756|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
145645937|NCT03438188|525219757|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
145645938|NCT03438188|525219758|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
145645939|NCT03438188|525219756|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
145645940|NCT03438188|525219757|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
145645941|NCT03438188|525219758|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
145645942|NCT03438188|525219756|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
145645943|NCT03438188|525219757|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
145645944|NCT03438188|525219758|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
145645945|NCT05215847|525219759|FG000|Overall Study|Lost to Follow-up|1|||
145645946|NCT03602014|525219764|FG000|Overall Study|Lost to Follow-up|2|||
145645947|NCT03602014|525219765|FG001|Overall Study|Lost to Follow-up|0|||
145645948|NCT03602014|525219766|FG002|Overall Study|Lost to Follow-up|0|||
145645949|NCT02819843|525219772|FG000|Overall Study|Disease progression before RT|0|||
145645950|NCT02819843|525219773|FG001|Overall Study|Disease progression before RT|1|||
145645951|NCT04732494|525219774|FG000|Overall Study|Death|39|||
145645952|NCT04732494|525219775|FG001|Overall Study|Death|36|||
145645953|NCT04732494|525219774|FG000|Overall Study|Study Closed by Sponsor|20|||
145645954|NCT04732494|525219775|FG001|Overall Study|Study Closed by Sponsor|15|||
145645955|NCT04732494|525219774|FG000|Overall Study|Withdrawal by Subject|2|||
145645956|NCT04732494|525219775|FG001|Overall Study|Withdrawal by Subject|7|||
145645957|NCT04732494|525219774|FG000|Overall Study|Lost to Follow-up|1|||
145645958|NCT04732494|525219775|FG001|Overall Study|Lost to Follow-up|5|||
145645959|NCT03055858|525219776|FG000|Overall Study|Death|9|||
145645960|NCT03055858|525219776|FG000|Overall Study|Withdrawal by Subject|11|||
145645961|NCT03055858|525219776|FG000|Overall Study|Lost to Follow-up|6|||
145486693|NCT03798717|524636743|FG001|Overall Study|Physician Decision|0|||
145486694|NCT03798717|524636744|FG002|Overall Study|Physician Decision|1|||
145645962|NCT03055858|525219776|FG000|Overall Study|Missed Follow-Up Visits|18|||
145645963|NCT04586920|525219777|FG000|Overall Study|Lost to Follow-up|0|||
145645964|NCT04586920|525219778|FG001|Overall Study|Lost to Follow-up|0|||
145645965|NCT04586920|525219779|FG002|Overall Study|Lost to Follow-up|0|||
145645966|NCT04586920|525219780|FG003|Overall Study|Lost to Follow-up|0|||
145645967|NCT04586920|525219781|FG004|Overall Study|Lost to Follow-up|0|||
145645968|NCT04586920|525219782|FG005|Overall Study|Lost to Follow-up|0|||
145645969|NCT04586920|525219783|FG006|Overall Study|Lost to Follow-up|1|||
145645970|NCT04586920|525219784|FG007|Overall Study|Lost to Follow-up|1|||
145645971|NCT04586920|525219785|FG008|Overall Study|Lost to Follow-up|0|||
145645972|NCT04586920|525219786|FG009|Overall Study|Lost to Follow-up|1|||
145645973|NCT04586920|525219787|FG010|Overall Study|Lost to Follow-up|0|||
145645974|NCT04586920|525219788|FG011|Overall Study|Lost to Follow-up|0|||
145645975|NCT04586920|525219789|FG012|Overall Study|Lost to Follow-up|0|||
145645976|NCT04586920|525219790|FG013|Overall Study|Lost to Follow-up|1|||
145645977|NCT04586920|525219791|FG014|Overall Study|Lost to Follow-up|0|||
145645978|NCT04586920|525219792|FG015|Overall Study|Lost to Follow-up|0|||
145645979|NCT04586920|525219793|FG016|Overall Study|Lost to Follow-up|0|||
145645980|NCT04586920|525219794|FG017|Overall Study|Lost to Follow-up|0|||
145645981|NCT04586920|525219777|FG000|Overall Study|Withdrawal by Subject|0|||
145645982|NCT04586920|525219778|FG001|Overall Study|Withdrawal by Subject|0|||
145645983|NCT04586920|525219779|FG002|Overall Study|Withdrawal by Subject|0|||
145645984|NCT04586920|525219780|FG003|Overall Study|Withdrawal by Subject|0|||
145645985|NCT04586920|525219781|FG004|Overall Study|Withdrawal by Subject|0|||
145645986|NCT04586920|525219782|FG005|Overall Study|Withdrawal by Subject|0|||
145645987|NCT04586920|525219783|FG006|Overall Study|Withdrawal by Subject|0|||
145645988|NCT04586920|525219784|FG007|Overall Study|Withdrawal by Subject|1|||
145645989|NCT04586920|525219785|FG008|Overall Study|Withdrawal by Subject|0|||
145645990|NCT04586920|525219786|FG009|Overall Study|Withdrawal by Subject|1|||
145645991|NCT04586920|525219787|FG010|Overall Study|Withdrawal by Subject|0|||
145645992|NCT04586920|525219788|FG011|Overall Study|Withdrawal by Subject|1|||
145645993|NCT04586920|525219789|FG012|Overall Study|Withdrawal by Subject|0|||
145645994|NCT04586920|525219790|FG013|Overall Study|Withdrawal by Subject|0|||
145645995|NCT04586920|525219791|FG014|Overall Study|Withdrawal by Subject|0|||
145645996|NCT04586920|525219792|FG015|Overall Study|Withdrawal by Subject|0|||
145645997|NCT04586920|525219793|FG016|Overall Study|Withdrawal by Subject|0|||
145645998|NCT04586920|525219794|FG017|Overall Study|Withdrawal by Subject|0|||
145645999|NCT02728557|525219795|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
145646000|NCT02728557|525219796|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
145646001|NCT02728557|525219795|FG000|Overall Study|Dissatisfaction with research tasks|0|||
145646002|NCT02728557|525219796|FG001|Overall Study|Dissatisfaction with research tasks|1|||
145646003|NCT02728557|525219795|FG000|Overall Study|Scheduling or change in availability|1|||
145646004|NCT02728557|525219796|FG001|Overall Study|Scheduling or change in availability|1|||
145646005|NCT01718743|525219797|FG000|Overall Study|Physician Decision|7|||
145646006|NCT01718743|525219797|FG000|Overall Study|Withdrawal by Subject|14|||
145646007|NCT01718743|525219797|FG000|Overall Study|Progressive Disease|22|||
145646008|NCT01718743|525219797|FG000|Overall Study|Toxicity|1|||
145646009|NCT01718743|525219797|FG000|Overall Study|Malignancy|1|||
145646010|NCT03416010|525219798|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
145646011|NCT03416010|525219799|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
145646012|NCT03416010|525219798|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
145646013|NCT03416010|525219799|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
145646014|NCT03416010|525219798|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
145486695|NCT03798717|524636745|FG003|Overall Study|Physician Decision|0|||
145486696|NCT03798717|524636746|FG004|Overall Study|Physician Decision|0|||
145486697|NCT03798717|524636747|FG005|Overall Study|Physician Decision|0|||
145486698|NCT03798717|524636742|FG000|Overall Study|Withdrawal by Subject|0|||
145486699|NCT03798717|524636743|FG001|Overall Study|Withdrawal by Subject|0|||
145486700|NCT03798717|524636744|FG002|Overall Study|Withdrawal by Subject|0|||
145486701|NCT03798717|524636745|FG003|Overall Study|Withdrawal by Subject|1|||
145486702|NCT03798717|524636746|FG004|Overall Study|Withdrawal by Subject|0|||
145486703|NCT03798717|524636747|FG005|Overall Study|Withdrawal by Subject|0|||
145486704|NCT03798717|524636742|FG000|Overall Study|Lost to Follow-up|1|||
145646015|NCT03416010|525219799|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
145646016|NCT03416010|525219798|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
145486705|NCT03798717|524636743|FG001|Overall Study|Lost to Follow-up|0|||
145486706|NCT03798717|524636744|FG002|Overall Study|Lost to Follow-up|0|||
145646017|NCT03416010|525219799|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
145646018|NCT03416010|525219798|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
145646019|NCT03416010|525219799|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
145486707|NCT03798717|524636745|FG003|Overall Study|Lost to Follow-up|1|||
145486708|NCT03798717|524636746|FG004|Overall Study|Lost to Follow-up|0|||
145486709|NCT03798717|524636747|FG005|Overall Study|Lost to Follow-up|0|||
145486710|NCT03798717|524636742|FG000|Overall Study|Adverse Event|0|||
145646020|NCT03416010|525219798|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
145646021|NCT03416010|525219799|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
145646022|NCT03416010|525219798|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
145646023|NCT03416010|525219799|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
145646024|NCT03948763|525219803|FG000|Overall Study|Sponsor's decision|0|||
145646025|NCT03948763|525219804|FG001|Overall Study|Sponsor's decision|2|||
145646026|NCT03948763|525219805|FG002|Overall Study|Sponsor's decision|6|||
145646027|NCT03948763|525219806|FG003|Overall Study|Sponsor's decision|4|||
145646028|NCT03948763|525219807|FG004|Overall Study|Sponsor's decision|0|||
145646029|NCT03948763|525219803|FG000|Overall Study|Physician Decision|0|||
145646030|NCT03948763|525219804|FG001|Overall Study|Physician Decision|0|||
145646031|NCT03948763|525219805|FG002|Overall Study|Physician Decision|1|||
145646032|NCT03948763|525219806|FG003|Overall Study|Physician Decision|0|||
145646033|NCT03948763|525219807|FG004|Overall Study|Physician Decision|0|||
145646034|NCT03948763|525219803|FG000|Overall Study|Lost to Follow-up|0|||
145646035|NCT03948763|525219804|FG001|Overall Study|Lost to Follow-up|0|||
145646036|NCT03948763|525219805|FG002|Overall Study|Lost to Follow-up|0|||
145646037|NCT03948763|525219806|FG003|Overall Study|Lost to Follow-up|0|||
145646038|NCT03948763|525219807|FG004|Overall Study|Lost to Follow-up|1|||
145646039|NCT03948763|525219803|FG000|Overall Study|Death|2|||
145646040|NCT03948763|525219804|FG001|Overall Study|Death|12|||
145646041|NCT03948763|525219805|FG002|Overall Study|Death|13|||
145646042|NCT03948763|525219806|FG003|Overall Study|Death|10|||
145646043|NCT03948763|525219807|FG004|Overall Study|Death|11|||
145646044|NCT03948763|525219803|FG000|Overall Study|Withdrawal by Subject|1|||
145646045|NCT03948763|525219804|FG001|Overall Study|Withdrawal by Subject|1|||
145646046|NCT03948763|525219805|FG002|Overall Study|Withdrawal by Subject|0|||
145646047|NCT03948763|525219806|FG003|Overall Study|Withdrawal by Subject|2|||
145646048|NCT03948763|525219807|FG004|Overall Study|Withdrawal by Subject|4|||
145646049|NCT04600752|525219809|FG000|Overall Study|Physician Decision|0|||
145646050|NCT04600752|525219810|FG001|Overall Study|Physician Decision|0|||
145646051|NCT04600752|525219811|FG002|Overall Study|Physician Decision|1|||
145646052|NCT04600752|525219809|FG000|Overall Study|Adverse Event|0|||
145646053|NCT04600752|525219810|FG001|Overall Study|Adverse Event|1|||
145646054|NCT04600752|525219811|FG002|Overall Study|Adverse Event|0|||
145646055|NCT04600752|525219809|FG000|Overall Study|Withdrawal by Subject|2|||
145646056|NCT04600752|525219810|FG001|Overall Study|Withdrawal by Subject|1|||
145646057|NCT04600752|525219811|FG002|Overall Study|Withdrawal by Subject|0|||
145646058|NCT04600752|525219809|FG000|Overall Study|Lack of Efficacy|1|||
145646059|NCT04600752|525219810|FG001|Overall Study|Lack of Efficacy|0|||
145646060|NCT04600752|525219811|FG002|Overall Study|Lack of Efficacy|0|||
145646061|NCT03732820|525219812|FG000|Overall Study|Death|168|||
145646062|NCT03732820|525219813|FG001|Overall Study|Death|203|||
145646063|NCT03732820|525219812|FG000|Overall Study|Other|2|||
145646064|NCT03732820|525219813|FG001|Overall Study|Other|2|||
145646065|NCT03732820|525219812|FG000|Overall Study|Failure to meet randomisation criteria|1|||
145646066|NCT03732820|525219813|FG001|Overall Study|Failure to meet randomisation criteria|1|||
145646067|NCT03732820|525219812|FG000|Overall Study|Patient decision|14|||
145646068|NCT03732820|525219813|FG001|Overall Study|Patient decision|10|||
145646069|NCT03732820|525219812|FG000|Overall Study|Screen failure|0|||
145646070|NCT03732820|525219813|FG001|Overall Study|Screen failure|1|||
145646071|NCT03732820|525219812|FG000|Overall Study|Patients ongoing study at data cut off|210|||
145646072|NCT03732820|525219813|FG001|Overall Study|Patients ongoing study at data cut off|178|||
145646073|NCT03732820|525219812|FG000|Overall Study|Lost to Follow-up|4|||
145646074|NCT03732820|525219813|FG001|Overall Study|Lost to Follow-up|2|||
145646075|NCT04238247|525219814|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
145646076|NCT04238247|525219815|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
145646077|NCT04238247|525219816|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
145646078|NCT04238247|525219817|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
145646079|NCT04238247|525219814|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
145646080|NCT04238247|525219815|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
145646081|NCT04238247|525219816|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
145646082|NCT04238247|525219817|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
145646083|NCT04238247|525219814|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
145646084|NCT04238247|525219815|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
145646085|NCT04238247|525219816|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
145646086|NCT04238247|525219817|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
145646087|NCT04238247|525219814|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
145646088|NCT04238247|525219815|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
145646089|NCT04238247|525219816|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
145646090|NCT04238247|525219817|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
145646091|NCT03380390|525219818|FG000|Overall Study|Adverse Event|3|||
145646092|NCT00522951|525219823|FG000|Period 1|body motion|0|||
145646093|NCT00522951|525219824|FG001|Period 1|body motion|1|||
145646094|NCT00522951|525219823|FG000|Washout Period|Adverse Event|0|||
145646095|NCT00522951|525219824|FG001|Washout Period|Adverse Event|1|||
145646096|NCT00522951|525219823|FG000|Washout Period|Death|0|||
145646097|NCT00522951|525219824|FG001|Washout Period|Death|1|||
145646098|NCT00522951|525219823|FG000|Period 2|Withdrawal by Subject|1|||
145646099|NCT00522951|525219824|FG001|Period 2|Withdrawal by Subject|0|||
145646100|NCT00522951|525219823|FG000|Period 2|residual contrast medium|1|||
145646101|NCT00522951|525219824|FG001|Period 2|residual contrast medium|1|||
145646102|NCT01426412|525219827|FG000|Overall Study|Withdrawal by Subject|1|||
145646103|NCT01426412|525219828|FG001|Overall Study|Withdrawal by Subject|0|||
145646104|NCT01426412|525219829|FG002|Overall Study|Withdrawal by Subject|0|||
145646105|NCT01426412|525219830|FG003|Overall Study|Withdrawal by Subject|0|||
145646106|NCT01426412|525219831|FG004|Overall Study|Withdrawal by Subject|1|||
145646107|NCT01426412|525219832|FG005|Overall Study|Withdrawal by Subject|0|||
145646108|NCT01426412|525219833|FG006|Overall Study|Withdrawal by Subject|0|||
145646109|NCT01426412|525219834|FG007|Overall Study|Withdrawal by Subject|3|||
145646110|NCT01426412|525219835|FG008|Overall Study|Withdrawal by Subject|1|||
145646111|NCT02376790|525219836|FG000|Overall Study|Withdrawal by Subject|43|||
145646112|NCT02376790|525219837|FG001|Overall Study|Withdrawal by Subject|36|||
145646113|NCT02376790|525219838|FG002|Overall Study|Withdrawal by Subject|37|||
145646114|NCT02376790|525219836|FG000|Overall Study|Decision by Sponsor|2|||
145646115|NCT02376790|525219837|FG001|Overall Study|Decision by Sponsor|1|||
145646116|NCT02376790|525219838|FG002|Overall Study|Decision by Sponsor|4|||
145646117|NCT02376790|525219836|FG000|Overall Study|Lost to Follow-up|15|||
145646118|NCT02376790|525219837|FG001|Overall Study|Lost to Follow-up|10|||
145646119|NCT02376790|525219838|FG002|Overall Study|Lost to Follow-up|12|||
145646120|NCT03014453|525219839|FG000|Overall Study|Lost to Follow-up|12|||
145646121|NCT03014453|525219839|FG000|Overall Study|Discontinued GER|3|||
145646122|NCT03014453|525219839|FG000|Overall Study|Excluded|19|||
145646123|NCT03014453|525219839|FG000|Overall Study|Refused to take part in|37|||
145646124|NCT05450458|525219840|FG000|Overall Study|Lost to Follow-up|4|||
145646125|NCT02141074|525219845|FG000|Pre-prophylaxis|Adverse Event|3|||
145646126|NCT02141074|525219846|FG001|Pre-prophylaxis|Adverse Event|0|||
145646127|NCT02141074|525219845|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
145646128|NCT02141074|525219846|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
145646129|NCT02141074|525219845|FG000|Prophylaxis|Adverse Event|0|||
145646130|NCT02141074|525219846|FG001|Prophylaxis|Adverse Event|4|||
145646131|NCT02141074|525219845|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
145646132|NCT02141074|525219846|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
145646133|NCT02141074|525219845|FG000|Prophylaxis|Withdrawal by Subject|0|||
145646134|NCT02141074|525219846|FG001|Prophylaxis|Withdrawal by Subject|1|||
145646135|NCT03101930|525219849|FG000|Overall Study|Withdrawal by Subject|2|||
145646136|NCT03101930|525219850|FG001|Overall Study|Withdrawal by Subject|1|||
145646137|NCT03101930|525219851|FG002|Overall Study|Withdrawal by Subject|2|||
145646138|NCT00262301|525219852|FG000|Double-blind Phase|Lost to Follow-up|1|||
145646139|NCT00262301|525219853|FG001|Double-blind Phase|Lost to Follow-up|0|||
145646140|NCT00262301|525219854|FG002|Double-blind Phase|Lost to Follow-up|0|||
145646141|NCT00262301|525219852|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
145646142|NCT00262301|525219853|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
145646143|NCT00262301|525219854|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
145646144|NCT01017146|525219855|FG000|Overall Study|Adverse Event|11|||
145646145|NCT01017146|525219856|FG001|Overall Study|Adverse Event|1|||
145646146|NCT01017146|525219855|FG000|Overall Study|Lost to Follow-up|14|||
145646147|NCT01017146|525219856|FG001|Overall Study|Lost to Follow-up|14|||
145646148|NCT01017146|525219855|FG000|Overall Study|Noncompliance with Study Product|1|||
145646149|NCT01017146|525219856|FG001|Overall Study|Noncompliance with Study Product|1|||
145646150|NCT01017146|525219855|FG000|Overall Study|Withdrawal by Subject|32|||
145646151|NCT01017146|525219856|FG001|Overall Study|Withdrawal by Subject|16|||
145646152|NCT01017146|525219855|FG000|Overall Study|Relocation|0|||
145646153|NCT01017146|525219856|FG001|Overall Study|Relocation|4|||
145646154|NCT01017146|525219855|FG000|Overall Study|Pregnancy|2|||
145646155|NCT01017146|525219856|FG001|Overall Study|Pregnancy|1|||
145646156|NCT01017146|525219855|FG000|Overall Study|Protocol Violation|2|||
145646157|NCT01017146|525219856|FG001|Overall Study|Protocol Violation|0|||
145646158|NCT01017146|525219855|FG000|Overall Study|Took Excluded Medication|2|||
145646159|NCT01017146|525219856|FG001|Overall Study|Took Excluded Medication|0|||
145646160|NCT01017146|525219855|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
145646161|NCT01017146|525219856|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
145646162|NCT01017146|525219855|FG000|Overall Study|Change in Work Situation|1|||
145646163|NCT01017146|525219856|FG001|Overall Study|Change in Work Situation|0|||
145646164|NCT01084707|525219857|FG000|Overall Study|Withdrawal by Subject|6|||
145486711|NCT03798717|524636743|FG001|Overall Study|Adverse Event|1|||
145646165|NCT01747486|525219861|FG000|Stage 1|Physician Decision|3|||
145646166|NCT01747486|525219862|FG001|Stage 1|Physician Decision|0|||
145646167|NCT01747486|525219861|FG000|Stage 1|Withdrawal by Subject|4|||
145646168|NCT01747486|525219862|FG001|Stage 1|Withdrawal by Subject|3|||
145646169|NCT01747486|525219861|FG000|Stage 1|Disease progression|4|||
145646170|NCT01747486|525219862|FG001|Stage 1|Disease progression|9|||
145646171|NCT01747486|525219861|FG000|Stage 1|Death|1|||
145646172|NCT01747486|525219862|FG001|Stage 1|Death|1|||
145646173|NCT01747486|525219861|FG000|Stage 2|Physician Decision|2|||
145646174|NCT01747486|525219862|FG001|Stage 2|Physician Decision|0|||
145646175|NCT01747486|525219861|FG000|Stage 2|Withdrawal by Subject|1|||
145646176|NCT01747486|525219862|FG001|Stage 2|Withdrawal by Subject|0|||
145646177|NCT01747486|525219861|FG000|Stage 2|New Cancer Therapy|3|||
145646178|NCT01747486|525219862|FG001|Stage 2|New Cancer Therapy|0|||
145646179|NCT01747486|525219861|FG000|Stage 2|Disease Progression|3|||
145646180|NCT01747486|525219862|FG001|Stage 2|Disease Progression|0|||
145646181|NCT00087139|525219863|FG000|Overall Study|Adverse Event|18|||
145646182|NCT00087139|525219864|FG001|Overall Study|Adverse Event|17|||
145646183|NCT00087139|525219865|FG002|Overall Study|Adverse Event|13|||
145646184|NCT00087139|525219863|FG000|Overall Study|Death|2|||
145646185|NCT00087139|525219864|FG001|Overall Study|Death|1|||
145646186|NCT00087139|525219865|FG002|Overall Study|Death|0|||
145646187|NCT00087139|525219863|FG000|Overall Study|Withdrawal by Subject|3|||
145646188|NCT00087139|525219864|FG001|Overall Study|Withdrawal by Subject|2|||
145646189|NCT00087139|525219865|FG002|Overall Study|Withdrawal by Subject|2|||
145646190|NCT00087139|525219863|FG000|Overall Study|Physician Decision|1|||
145646191|NCT00087139|525219864|FG001|Overall Study|Physician Decision|1|||
145646192|NCT00087139|525219865|FG002|Overall Study|Physician Decision|1|||
145646193|NCT00087139|525219863|FG000|Overall Study|Disease progression|9|||
145646194|NCT00087139|525219864|FG001|Overall Study|Disease progression|19|||
145646195|NCT00087139|525219865|FG002|Overall Study|Disease progression|12|||
145646196|NCT00087139|525219863|FG000|Overall Study|Ineligible|4|||
145646197|NCT00087139|525219864|FG001|Overall Study|Ineligible|7|||
145646198|NCT00087139|525219865|FG002|Overall Study|Ineligible|4|||
145646199|NCT00087139|525219863|FG000|Overall Study|Symptomatic deterioration|1|||
145646200|NCT00087139|525219864|FG001|Overall Study|Symptomatic deterioration|1|||
145646201|NCT00087139|525219865|FG002|Overall Study|Symptomatic deterioration|3|||
145646202|NCT00087139|525219863|FG000|Overall Study|Use of coumadin|1|||
145646203|NCT00087139|525219864|FG001|Overall Study|Use of coumadin|0|||
145646204|NCT00087139|525219865|FG002|Overall Study|Use of coumadin|0|||
145646205|NCT00087139|525219863|FG000|Overall Study|Response achieved|0|||
145646206|NCT00087139|525219864|FG001|Overall Study|Response achieved|1|||
145646207|NCT00087139|525219865|FG002|Overall Study|Response achieved|0|||
145646208|NCT00087139|525219863|FG000|Overall Study|Extradural disease|0|||
145646209|NCT00087139|525219864|FG001|Overall Study|Extradural disease|0|||
145646210|NCT00087139|525219865|FG002|Overall Study|Extradural disease|1|||
145646211|NCT00976495|525219866|FG000|Overall Study|Withdrawal by Subject|0|||
145646212|NCT00976495|525219867|FG001|Overall Study|Withdrawal by Subject|1|||
145646213|NCT00976495|525219868|FG002|Overall Study|Withdrawal by Subject|0|||
145646214|NCT05171777|525219869|FG000|Treatment Crossover Period|Adverse Event|9|||
145646215|NCT05171777|525219870|FG001|Treatment Crossover Period|Adverse Event|6|||
145646216|NCT05171777|525219871|FG002|Treatment Crossover Period|Adverse Event|0|||
145646217|NCT05171777|525219872|FG003|Treatment Crossover Period|Adverse Event|0|||
145646218|NCT05171777|525219869|FG000|Treatment Crossover Period|Death|5|||
145646219|NCT05171777|525219870|FG001|Treatment Crossover Period|Death|5|||
145646220|NCT05171777|525219871|FG002|Treatment Crossover Period|Death|0|||
145646221|NCT05171777|525219872|FG003|Treatment Crossover Period|Death|0|||
145646222|NCT05171777|525219869|FG000|Treatment Crossover Period|Disease Relapse|0|||
145646223|NCT05171777|525219870|FG001|Treatment Crossover Period|Disease Relapse|1|||
145646224|NCT05171777|525219871|FG002|Treatment Crossover Period|Disease Relapse|0|||
145646225|NCT05171777|525219872|FG003|Treatment Crossover Period|Disease Relapse|0|||
145646226|NCT05171777|525219869|FG000|Treatment Crossover Period|Reason not Specified|2|||
145646227|NCT05171777|525219870|FG001|Treatment Crossover Period|Reason not Specified|1|||
145646228|NCT05171777|525219871|FG002|Treatment Crossover Period|Reason not Specified|0|||
145646229|NCT05171777|525219872|FG003|Treatment Crossover Period|Reason not Specified|0|||
145646230|NCT05171777|525219869|FG000|Treatment Crossover Period|Physician Decision|0|||
145646231|NCT05171777|525219870|FG001|Treatment Crossover Period|Physician Decision|1|||
145486712|NCT03798717|524636744|FG002|Overall Study|Adverse Event|0|||
145486713|NCT03798717|524636745|FG003|Overall Study|Adverse Event|0|||
145486714|NCT03798717|524636746|FG004|Overall Study|Adverse Event|0|||
145486715|NCT03798717|524636747|FG005|Overall Study|Adverse Event|0|||
145486716|NCT03798717|524636742|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
145486717|NCT03798717|524636743|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
145486718|NCT03798717|524636744|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
145486719|NCT03798717|524636745|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
145486720|NCT03798717|524636746|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
145486721|NCT03798717|524636747|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
145486722|NCT04002960|524636749|FG000|Overall Study|Withdrawn prior to Completion|2|||
145486723|NCT00961181|524636752|FG000|Overall Study|Death|2|||
145646232|NCT05171777|525219871|FG002|Treatment Crossover Period|Physician Decision|0|||
145646233|NCT05171777|525219872|FG003|Treatment Crossover Period|Physician Decision|0|||
145646234|NCT05171777|525219869|FG000|Treatment Crossover Period|Progressive Disease|13|||
145646235|NCT05171777|525219870|FG001|Treatment Crossover Period|Progressive Disease|9|||
145646236|NCT05171777|525219871|FG002|Treatment Crossover Period|Progressive Disease|0|||
145646237|NCT05171777|525219872|FG003|Treatment Crossover Period|Progressive Disease|0|||
145646238|NCT05171777|525219869|FG000|Treatment Crossover Period|Protocol Violation|0|||
145646239|NCT05171777|525219870|FG001|Treatment Crossover Period|Protocol Violation|2|||
145646240|NCT05171777|525219871|FG002|Treatment Crossover Period|Protocol Violation|0|||
145646241|NCT05171777|525219872|FG003|Treatment Crossover Period|Protocol Violation|0|||
145646242|NCT05171777|525219869|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
145646243|NCT05171777|525219870|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
145646244|NCT05171777|525219871|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
145646245|NCT05171777|525219872|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
145646246|NCT05171777|525219869|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
145646247|NCT05171777|525219870|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
145646248|NCT05171777|525219871|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
145646249|NCT05171777|525219872|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
145646250|NCT05171777|525219869|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
145646251|NCT05171777|525219870|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
145646252|NCT05171777|525219871|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
145646253|NCT05171777|525219872|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
145646254|NCT05171777|525219869|FG000|Treatment Continuation Period|Death|0|||
145646255|NCT05171777|525219870|FG001|Treatment Continuation Period|Death|0|||
145646256|NCT05171777|525219871|FG002|Treatment Continuation Period|Death|1|||
145646257|NCT05171777|525219872|FG003|Treatment Continuation Period|Death|6|||
145646258|NCT05171777|525219869|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
145646259|NCT05171777|525219870|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
145646260|NCT05171777|525219871|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
145646261|NCT05171777|525219872|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
145646262|NCT02272816|525219873|FG000|Overall Study|Adverse Event|1|||
145646263|NCT02269475|525219877|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
145646264|NCT02269475|525219878|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
145646265|NCT02269475|525219877|FG000|Overall Study|Withdrawal by Subject|0|||
145646266|NCT02269475|525219878|FG001|Overall Study|Withdrawal by Subject|1|||
145646267|NCT03481816|525219879|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
145646268|NCT03481816|525219880|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
145646269|NCT03481816|525219879|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
145646270|NCT03481816|525219880|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
145646271|NCT03481816|525219879|FG000|Dose Expansion|Withdrawal by Subject|0|||
145646272|NCT03481816|525219880|FG001|Dose Expansion|Withdrawal by Subject|2|||
145646273|NCT03481816|525219879|FG000|Dose Expansion|Physician Decision|0|||
145646274|NCT03481816|525219880|FG001|Dose Expansion|Physician Decision|5|||
145646275|NCT04994509|525219881|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
145646276|NCT04994509|525219882|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
145646277|NCT04994509|525219883|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
145646278|NCT04994509|525219881|FG000|Overall Study|Withdrew Consent|73|||
145646279|NCT04994509|525219882|FG001|Overall Study|Withdrew Consent|72|||
145646280|NCT04994509|525219883|FG002|Overall Study|Withdrew Consent|46|||
145646281|NCT04994509|525219881|FG000|Overall Study|Lost to Follow-up|39|||
145646282|NCT04994509|525219882|FG001|Overall Study|Lost to Follow-up|36|||
145646283|NCT04994509|525219883|FG002|Overall Study|Lost to Follow-up|26|||
145646284|NCT04994509|525219881|FG000|Overall Study|HIV-1 Infection|4|||
145646285|NCT04994509|525219882|FG001|Overall Study|HIV-1 Infection|20|||
145646286|NCT04994509|525219883|FG002|Overall Study|HIV-1 Infection|12|||
145646287|NCT04994509|525219881|FG000|Overall Study|Investigator's Discretion|9|||
145646288|NCT04994509|525219882|FG001|Overall Study|Investigator's Discretion|8|||
145646289|NCT04994509|525219883|FG002|Overall Study|Investigator's Discretion|11|||
145646290|NCT04994509|525219881|FG000|Overall Study|Randomized but Never Treated|10|||
145646291|NCT04994509|525219882|FG001|Overall Study|Randomized but Never Treated|10|||
145646292|NCT04994509|525219883|FG002|Overall Study|Randomized but Never Treated|3|||
145646293|NCT04994509|525219881|FG000|Overall Study|Pregnancy|5|||
145646294|NCT04994509|525219882|FG001|Overall Study|Pregnancy|5|||
145646295|NCT04994509|525219883|FG002|Overall Study|Pregnancy|0|||
145646296|NCT04994509|525219881|FG000|Overall Study|Death|0|||
145646297|NCT04994509|525219882|FG001|Overall Study|Death|5|||
145646298|NCT04994509|525219883|FG002|Overall Study|Death|0|||
145646299|NCT04994509|525219881|FG000|Overall Study|Adverse Event|2|||
145646300|NCT04994509|525219882|FG001|Overall Study|Adverse Event|1|||
145646301|NCT04994509|525219883|FG002|Overall Study|Adverse Event|0|||
145646302|NCT04994509|525219881|FG000|Overall Study|Non-compliance With Study Drug|1|||
145646303|NCT04994509|525219882|FG001|Overall Study|Non-compliance With Study Drug|1|||
145646304|NCT04994509|525219883|FG002|Overall Study|Non-compliance With Study Drug|1|||
145646305|NCT04994509|525219881|FG000|Overall Study|Withdrew Assent|3|||
145646306|NCT04994509|525219882|FG001|Overall Study|Withdrew Assent|0|||
145646307|NCT04994509|525219883|FG002|Overall Study|Withdrew Assent|0|||
145646308|NCT04994509|525219881|FG000|Overall Study|Protocol Violation|1|||
145646309|NCT04994509|525219882|FG001|Overall Study|Protocol Violation|0|||
145646310|NCT04994509|525219883|FG002|Overall Study|Protocol Violation|0|||
145646311|NCT04459416|525221671|FG000|Overall Study|Lost to Follow-up|2|||
145646312|NCT04459416|525221672|FG001|Overall Study|Lost to Follow-up|0|||
145646313|NCT04459416|525221671|FG000|Overall Study|Withdrawal by Subject|8|||
145646314|NCT04459416|525221672|FG001|Overall Study|Withdrawal by Subject|10|||
145646315|NCT04459416|525221671|FG000|Overall Study|Disease progression|0|||
145646316|NCT04459416|525221672|FG001|Overall Study|Disease progression|3|||
145646317|NCT04579380|525221673|FG000|Overall Study|Death|9|||
145646318|NCT04579380|525221674|FG001|Overall Study|Death|22|||
145646319|NCT04579380|525221675|FG002|Overall Study|Death|22|||
145646320|NCT04579380|525221676|FG003|Overall Study|Death|17|||
145646321|NCT04579380|525221677|FG004|Overall Study|Death|6|||
145646322|NCT04579380|525221678|FG005|Overall Study|Death|21|||
145646323|NCT04579380|525221679|FG006|Overall Study|Death|10|||
145486724|NCT00961181|524636752|FG000|Overall Study|Withdrawal by Subject|2|||
145486725|NCT00961181|524636752|FG000|Overall Study|Lost to Follow-up|1|||
145486726|NCT03212326|524636753|FG000|Overall Study|Physician Decision|4|||
145486727|NCT00383786|524636756|FG000|Overall Study|Protocol Violation|2|||
145646324|NCT04579380|525221680|FG007|Overall Study|Death|11|||
145646325|NCT04579380|525221681|FG008|Overall Study|Death|25|||
145646326|NCT04579380|525221673|FG000|Overall Study|Withdrawal by Subject|0|||
145646327|NCT04579380|525221674|FG001|Overall Study|Withdrawal by Subject|3|||
145646328|NCT04579380|525221675|FG002|Overall Study|Withdrawal by Subject|4|||
145646329|NCT04579380|525221676|FG003|Overall Study|Withdrawal by Subject|0|||
145646330|NCT04579380|525221677|FG004|Overall Study|Withdrawal by Subject|1|||
145646331|NCT04579380|525221678|FG005|Overall Study|Withdrawal by Subject|2|||
145646332|NCT04579380|525221679|FG006|Overall Study|Withdrawal by Subject|0|||
145646333|NCT04579380|525221680|FG007|Overall Study|Withdrawal by Subject|1|||
145646334|NCT04579380|525221681|FG008|Overall Study|Withdrawal by Subject|2|||
145646335|NCT04579380|525221673|FG000|Overall Study|Ongoing|2|||
145646336|NCT04579380|525221674|FG001|Overall Study|Ongoing|6|||
145646337|NCT04579380|525221675|FG002|Overall Study|Ongoing|4|||
145646338|NCT04579380|525221676|FG003|Overall Study|Ongoing|8|||
145646339|NCT04579380|525221677|FG004|Overall Study|Ongoing|5|||
145646340|NCT04579380|525221678|FG005|Overall Study|Ongoing|8|||
145646341|NCT04579380|525221679|FG006|Overall Study|Ongoing|3|||
145646342|NCT04579380|525221680|FG007|Overall Study|Ongoing|19|||
145646343|NCT04579380|525221681|FG008|Overall Study|Ongoing|6|||
145646344|NCT03821844|525221682|FG000|Overall Study|Death|37|||
145646345|NCT03821844|525221683|FG001|Overall Study|Death|31|||
145646346|NCT03821844|525221682|FG000|Overall Study|Discharged|10|||
145646347|NCT03821844|525221683|FG001|Overall Study|Discharged|14|||
145646348|NCT03821844|525221682|FG000|Overall Study|Not present in facility at followup|2|||
145646349|NCT03821844|525221683|FG001|Overall Study|Not present in facility at followup|3|||
145646350|NCT03913195|525221684|FG000|Overall Study|Adverse Event|0|||
145646351|NCT03913195|525221685|FG001|Overall Study|Adverse Event|0|||
145646352|NCT03913195|525221686|FG002|Overall Study|Adverse Event|1|||
145646353|NCT03913195|525221687|FG003|Overall Study|Adverse Event|1|||
145646354|NCT03913195|525221688|FG004|Overall Study|Adverse Event|0|||
145646355|NCT03913195|525221684|FG000|Overall Study|Withdrawal by Subject|0|||
145646356|NCT03913195|525221685|FG001|Overall Study|Withdrawal by Subject|0|||
145646357|NCT03913195|525221686|FG002|Overall Study|Withdrawal by Subject|1|||
145646358|NCT03913195|525221687|FG003|Overall Study|Withdrawal by Subject|0|||
145646359|NCT03913195|525221688|FG004|Overall Study|Withdrawal by Subject|1|||
145646360|NCT03913195|525221684|FG000|Overall Study|non adherence to study|0|||
145646361|NCT03913195|525221685|FG001|Overall Study|non adherence to study|0|||
145646362|NCT03913195|525221686|FG002|Overall Study|non adherence to study|1|||
145646363|NCT03913195|525221687|FG003|Overall Study|non adherence to study|0|||
145646364|NCT03913195|525221688|FG004|Overall Study|non adherence to study|0|||
145646365|NCT02525692|525221689|FG000|Overall Study|Withdrawal by Subject|1|||
145646366|NCT02525692|525221690|FG001|Overall Study|Withdrawal by Subject|1|||
145646367|NCT02525692|525221691|FG002|Overall Study|Withdrawal by Subject|0|||
145646368|NCT02525692|525221692|FG003|Overall Study|Withdrawal by Subject|5|||
145646369|NCT02525692|525221693|FG004|Overall Study|Withdrawal by Subject|0|||
145646370|NCT02525692|525221694|FG005|Overall Study|Withdrawal by Subject|1|||
145646371|NCT02525692|525221689|FG000|Overall Study|Death|16|||
145646372|NCT02525692|525221690|FG001|Overall Study|Death|18|||
145646373|NCT02525692|525221691|FG002|Overall Study|Death|7|||
145646374|NCT02525692|525221692|FG003|Overall Study|Death|20|||
145646375|NCT02525692|525221693|FG004|Overall Study|Death|3|||
145646376|NCT02525692|525221694|FG005|Overall Study|Death|6|||
145646377|NCT02525692|525221689|FG000|Overall Study|Lost to Follow-up|0|||
145646378|NCT02525692|525221690|FG001|Overall Study|Lost to Follow-up|0|||
145646379|NCT02525692|525221691|FG002|Overall Study|Lost to Follow-up|1|||
145646380|NCT02525692|525221692|FG003|Overall Study|Lost to Follow-up|5|||
145486728|NCT00383786|524636757|FG001|Overall Study|Protocol Violation|6|||
145486729|NCT00383786|524636756|FG000|Overall Study|Withdrawal by Subject|2|||
145646381|NCT02525692|525221693|FG004|Overall Study|Lost to Follow-up|0|||
145646382|NCT02525692|525221694|FG005|Overall Study|Lost to Follow-up|0|||
145646383|NCT05510232|525221695|FG000|Overall Study|Withdrawal by Subject|2|||
145646384|NCT05510232|525221696|FG001|Overall Study|Withdrawal by Subject|7|||
145646385|NCT05510232|525221697|FG002|Overall Study|Withdrawal by Subject|6|||
145646386|NCT00979576|525221707|FG000|Combination Treatment Phase|Progressive disease|3|||
145646387|NCT00979576|525221708|FG001|Combination Treatment Phase|Progressive disease|1|||
145646388|NCT00979576|525221709|FG002|Combination Treatment Phase|Progressive disease|5|||
145646389|NCT00979576|525221707|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
145646390|NCT00979576|525221708|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
145646391|NCT00979576|525221709|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
145646392|NCT00979576|525221707|FG000|Combination Treatment Phase|Adverse Event|0|||
145646393|NCT00979576|525221708|FG001|Combination Treatment Phase|Adverse Event|2|||
145646394|NCT00979576|525221709|FG002|Combination Treatment Phase|Adverse Event|2|||
145646395|NCT00979576|525221707|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
145646396|NCT00979576|525221708|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
145646397|NCT00979576|525221709|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
145646398|NCT04855760|525221712|FG000|Overall Study|Adverse Event|21|||
145646399|NCT04855760|525221712|FG000|Overall Study|Withdrawal by Subject|116|||
145646400|NCT04855760|525221712|FG000|Overall Study|Lack of Efficacy|21|||
145646401|NCT04855760|525221712|FG000|Overall Study|Lost to Follow-up|49|||
145646402|NCT04855760|525221712|FG000|Overall Study|Protocol Violation|2|||
145646403|NCT04855760|525221712|FG000|Overall Study|Physician Decision|5|||
145646404|NCT04855760|525221712|FG000|Overall Study|Pregnancy|1|||
145646405|NCT04855760|525221712|FG000|Overall Study|Non-Compliance with Study Drug|11|||
145646406|NCT04855760|525221712|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
145646407|NCT04855760|525221712|FG000|Overall Study|Study Completed by Sponsor|202|||
145646408|NCT04855760|525221712|FG000|Overall Study|Other|13|||
145646409|NCT04840199|525221713|FG000|Overall Study|Study Terminated by Sponsor|8|||
145646410|NCT04840199|525221714|FG001|Overall Study|Study Terminated by Sponsor|9|||
145646411|NCT04840199|525221713|FG000|Overall Study|Lost to Follow-up|0|||
145646412|NCT04840199|525221714|FG001|Overall Study|Lost to Follow-up|2|||
145646413|NCT04840199|525221713|FG000|Overall Study|Withdrawal by Subject|2|||
145646414|NCT04840199|525221714|FG001|Overall Study|Withdrawal by Subject|0|||
145646415|NCT04840199|525221713|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
145646416|NCT04840199|525221714|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
145646417|NCT03424811|525221717|FG000|Overall Study|Lost to Follow-up|9|||
145646418|NCT03424811|525221718|FG001|Overall Study|Lost to Follow-up|0|||
145646419|NCT00567398|525221724|FG000|Overall Study|Adverse Event|6|||
145646420|NCT00567398|525221725|FG001|Overall Study|Adverse Event|14|||
145646421|NCT00567398|525221724|FG000|Overall Study|Physician Decision|0|||
145646422|NCT00567398|525221725|FG001|Overall Study|Physician Decision|4|||
145646423|NCT00567398|525221724|FG000|Overall Study|Withdrawal by Subject|0|||
145646424|NCT00567398|525221725|FG001|Overall Study|Withdrawal by Subject|2|||
145646425|NCT00567398|525221724|FG000|Overall Study|Renal Transplantation|0|||
145646426|NCT00567398|525221725|FG001|Overall Study|Renal Transplantation|3|||
145646427|NCT00567398|525221724|FG000|Overall Study|Other|1|||
145646428|NCT00567398|525221725|FG001|Overall Study|Other|0|||
145646429|NCT03517553|525221726|FG000|Overall Study|Withdrawal by Subject|2|||
145646430|NCT04247542|525221729|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
145646431|NCT04247542|525221730|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
145646432|NCT04247542|525221731|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
145646433|NCT04247542|525221729|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
145646434|NCT04247542|525221730|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
145646435|NCT04247542|525221731|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
145646436|NCT04143061|525221732|FG000|Overall Study|Protocol Deviation|0|||
145646437|NCT04143061|525221733|FG001|Overall Study|Protocol Deviation|0|||
145646438|NCT04143061|525221734|FG002|Overall Study|Protocol Deviation|0|||
145646439|NCT04143061|525221735|FG003|Overall Study|Protocol Deviation|0|||
145646440|NCT04143061|525221736|FG004|Overall Study|Protocol Deviation|0|||
145646441|NCT04143061|525221737|FG005|Overall Study|Protocol Deviation|0|||
145646442|NCT04143061|525221738|FG006|Overall Study|Protocol Deviation|5|||
145646443|NCT04143061|525221739|FG007|Overall Study|Protocol Deviation|5|||
145646444|NCT04143061|525221732|FG000|Overall Study|Withdrawal by Subject|2|||
145646445|NCT04143061|525221733|FG001|Overall Study|Withdrawal by Subject|0|||
145646446|NCT04143061|525221734|FG002|Overall Study|Withdrawal by Subject|0|||
145646447|NCT04143061|525221735|FG003|Overall Study|Withdrawal by Subject|0|||
145646448|NCT04143061|525221736|FG004|Overall Study|Withdrawal by Subject|0|||
145646449|NCT04143061|525221737|FG005|Overall Study|Withdrawal by Subject|1|||
145646450|NCT04143061|525221738|FG006|Overall Study|Withdrawal by Subject|0|||
145646451|NCT04143061|525221739|FG007|Overall Study|Withdrawal by Subject|0|||
145646452|NCT04143061|525221732|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145646453|NCT04143061|525221733|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145646454|NCT04143061|525221734|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145646455|NCT04143061|525221735|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
145486730|NCT00383786|524636757|FG001|Overall Study|Withdrawal by Subject|5|||
145646456|NCT04143061|525221736|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
145646457|NCT04143061|525221737|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
145646458|NCT04143061|525221738|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
145646459|NCT04143061|525221739|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
145646460|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
145646461|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
145646462|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
145646463|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
145646464|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
145646465|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
145646466|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
145646467|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
145646468|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
145646469|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
145646470|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
145646471|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
145646472|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
145646473|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
145646474|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
145646475|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
145646476|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
145646477|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
145646478|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
145646479|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
145646480|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
145646481|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
145646482|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
145646483|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
145646484|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
145646485|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
145646486|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
145646487|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
145646488|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
145646489|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
145646490|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
145646491|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
145646492|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
145646493|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
145646494|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
145646495|NCT01898494|525221743|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
145646496|NCT01898494|525221744|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
145646497|NCT01898494|525221745|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
145646498|NCT01898494|525221746|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
145646499|NCT01898494|525221747|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
145646500|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
145646501|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
145646502|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
145646503|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
145646504|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
145646505|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
145646506|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
145646507|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
145646508|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
145646509|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
145646510|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
145646511|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
145646512|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
145646513|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
145646514|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
145646515|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
145646516|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
145646517|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
145646518|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
145646519|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
145646520|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
145646521|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
145646522|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
145646523|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
145646524|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
145646525|NCT01898494|525221743|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
145646526|NCT01898494|525221744|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
145646527|NCT01898494|525221745|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
145646528|NCT01898494|525221746|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
145646529|NCT01898494|525221747|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
145646530|NCT03289039|525221748|FG000|Overall Study|Withdrawal by Subject|0|||
145646531|NCT03289039|525221749|FG001|Overall Study|Withdrawal by Subject|1|||
145646532|NCT03289039|525221748|FG000|Overall Study|Became ineligible prior to treatment start|0|||
145646533|NCT03289039|525221749|FG001|Overall Study|Became ineligible prior to treatment start|1|||
145646534|NCT03289039|525221748|FG000|Overall Study|progressed before treatment start|1|||
145646535|NCT03289039|525221749|FG001|Overall Study|progressed before treatment start|0|||
145646536|NCT04287985|525221757|FG000|Overall Study|Adverse Event|1|||
145646537|NCT04287985|525221758|FG001|Overall Study|Adverse Event|0|||
145646538|NCT04287985|525221759|FG002|Overall Study|Adverse Event|0|||
145646539|NCT04287985|525221760|FG003|Overall Study|Adverse Event|0|||
145646540|NCT04287985|525221757|FG000|Overall Study|Protocol Violation|0|||
145646541|NCT04287985|525221758|FG001|Overall Study|Protocol Violation|1|||
145646542|NCT04287985|525221759|FG002|Overall Study|Protocol Violation|0|||
145646543|NCT04287985|525221760|FG003|Overall Study|Protocol Violation|0|||
145646544|NCT04287985|525221757|FG000|Overall Study|Physician Decision|0|||
145646545|NCT04287985|525221758|FG001|Overall Study|Physician Decision|0|||
145646546|NCT04287985|525221759|FG002|Overall Study|Physician Decision|0|||
145646547|NCT04287985|525221760|FG003|Overall Study|Physician Decision|1|||
145646548|NCT04287985|525221757|FG000|Overall Study|Withdrawal by Subject|2|||
145646549|NCT04287985|525221758|FG001|Overall Study|Withdrawal by Subject|1|||
145646550|NCT04287985|525221759|FG002|Overall Study|Withdrawal by Subject|1|||
145646551|NCT04287985|525221760|FG003|Overall Study|Withdrawal by Subject|2|||
145646552|NCT01340066|525221761|FG000|Placebo Run in Period|Screen Failures|27|||
145646553|NCT01340066|525221762|FG001|Placebo Run in Period|Screen Failures|0|||
145646554|NCT01340066|525221763|FG002|Placebo Run in Period|Screen Failures|0|||
145646555|NCT01340066|525221761|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
145646556|NCT01340066|525221762|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
145646557|NCT01340066|525221763|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
145646558|NCT01340066|525221761|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
145646559|NCT01340066|525221762|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
145646560|NCT01340066|525221763|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
145646561|NCT01340066|525221761|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
145646562|NCT01340066|525221762|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
145646563|NCT01340066|525221763|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
145646564|NCT02789020|525221764|FG000|Overall Study|Withdrawal by Subject|6|||
145646565|NCT02789020|525221765|FG001|Overall Study|Withdrawal by Subject|5|||
145646566|NCT03771352|525221776|FG000|Overall Study|Screen failure|2|||
145646567|NCT03771352|525221776|FG000|Overall Study|Withdrawal by Subject|2|||
145646568|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
145646569|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
145646570|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
145646571|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
145646572|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
145646573|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
145646574|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
145646575|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
145646576|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
145646577|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
145646578|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
145646579|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
145646580|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
145646581|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
145646582|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
145646583|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
145646584|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
145646585|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
145646586|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
145646587|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
145646588|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
145646589|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
145646590|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
145646591|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
145646592|NCT03338816|525221777|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
145646593|NCT03338816|525221778|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
145646594|NCT03338816|525221779|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
145646595|NCT03338816|525221780|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
145646596|NCT03833167|525221790|FG000|Overall Study|Withdrawal by Subject|4|||
145646597|NCT03833167|525221791|FG001|Overall Study|Withdrawal by Subject|6|||
145646598|NCT03833167|525221790|FG000|Overall Study|Ongoing|186|||
145646599|NCT03833167|525221791|FG001|Overall Study|Ongoing|194|||
145646600|NCT03833167|525221790|FG000|Overall Study|Lost to Follow-up|1|||
145646601|NCT03833167|525221791|FG001|Overall Study|Lost to Follow-up|1|||
145646602|NCT03833167|525221790|FG000|Overall Study|Physician Decision|0|||
145646603|NCT03833167|525221791|FG001|Overall Study|Physician Decision|2|||
145646604|NCT03833167|525221790|FG000|Overall Study|Death|34|||
145646605|NCT03833167|525221791|FG001|Overall Study|Death|22|||
145646606|NCT01948661|525221792|FG000|Overall Study|Withdrawal by Subject|2|||
145646607|NCT01948661|525221793|FG001|Overall Study|Withdrawal by Subject|4|||
145646608|NCT06061081|525221794|FG000|Overall Study|Withdrawal by Subject|1|||
145646609|NCT06061081|525221795|FG001|Overall Study|Withdrawal by Subject|0|||
145646610|NCT06061081|525221796|FG002|Overall Study|Withdrawal by Subject|0|||
145646611|NCT06061081|525221797|FG003|Overall Study|Withdrawal by Subject|0|||
145646612|NCT06061081|525221798|FG004|Overall Study|Withdrawal by Subject|0|||
145646613|NCT02252172|525221799|FG000|Overall Study|Lost to Follow-up|9|||
145646614|NCT02252172|525221800|FG001|Overall Study|Lost to Follow-up|6|||
145646615|NCT02252172|525221799|FG000|Overall Study|Death|218|||
145646616|NCT02252172|525221800|FG001|Overall Study|Death|175|||
145646617|NCT02252172|525221799|FG000|Overall Study|Withdrawal by Subject|20|||
145646618|NCT02252172|525221800|FG001|Overall Study|Withdrawal by Subject|15|||
145646619|NCT02252172|525221799|FG000|Overall Study|Physician Decision|0|||
145646620|NCT02252172|525221800|FG001|Overall Study|Physician Decision|1|||
145646621|NCT02252172|525221799|FG000|Overall Study|End of data collection|122|||
145646622|NCT02252172|525221800|FG001|Overall Study|End of data collection|170|||
145646623|NCT02252172|525221799|FG000|Overall Study|Site closure|0|||
145646624|NCT02252172|525221800|FG001|Overall Study|Site closure|1|||
145646625|NCT05575076|525221801|FG000|Overall Study|Adverse Event|24|||
145646626|NCT05575076|525221801|FG000|Overall Study|Death|7|||
145646627|NCT05575076|525221801|FG000|Overall Study|Lost to Follow-up|16|||
145646628|NCT05575076|525221801|FG000|Overall Study|Non-Compliance|3|||
145646629|NCT05575076|525221801|FG000|Overall Study|Physician Decision|6|||
145646630|NCT05575076|525221801|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
145646631|NCT05575076|525221801|FG000|Overall Study|Withdrawal by Subject|71|||
145646632|NCT05575076|525221801|FG000|Overall Study|Study Terminated by Sponsor|630|||
145646633|NCT05575076|525221801|FG000|Overall Study|Other|17|||
145646634|NCT02886286|525221802|FG000|Overall Study|pump motor stall|0|||
145646635|NCT02886286|525221803|FG001|Overall Study|pump motor stall|1|||
145646636|NCT01127373|525221804|FG000|Overall Study|Not Treated|3|||
145646637|NCT01127373|525221804|FG000|Overall Study|Lost to Follow-up|7|||
145646638|NCT01127373|525221804|FG000|Overall Study|Withdrawal by Subject|1|||
145646639|NCT01127373|525221804|FG000|Overall Study|Disease progression|1|||
145646640|NCT04154384|525221808|FG000|Overall Study|Lost to Follow-up|24|||
145646641|NCT04154384|525221809|FG001|Overall Study|Lost to Follow-up|33|||
145646642|NCT04154384|525221810|FG002|Overall Study|Lost to Follow-up|0|||
145646643|NCT04154384|525221808|FG000|Overall Study|Withdrawal by Subject|7|||
145646644|NCT04154384|525221809|FG001|Overall Study|Withdrawal by Subject|18|||
145646645|NCT04154384|525221810|FG002|Overall Study|Withdrawal by Subject|0|||
145646646|NCT04154384|525221808|FG000|Overall Study|Missing outcome data|1|||
145646647|NCT04154384|525221809|FG001|Overall Study|Missing outcome data|0|||
145646648|NCT04154384|525221810|FG002|Overall Study|Missing outcome data|0|||
145646649|NCT01136876|525221811|FG000|Overall Study|Lost to Follow-up|0|||
145646650|NCT01136876|525221812|FG001|Overall Study|Lost to Follow-up|1|||
145646651|NCT01136876|525221811|FG000|Overall Study|Physician Decision|3|||
145646652|NCT01136876|525221812|FG001|Overall Study|Physician Decision|5|||
145646653|NCT01136876|525221811|FG000|Overall Study|Missing NGAL measurement|2|||
145646654|NCT01136876|525221812|FG001|Overall Study|Missing NGAL measurement|5|||
145646655|NCT05321069|525221813|FG000|Overall Study|Adverse Event|52|||
145646656|NCT05321069|525221814|FG001|Overall Study|Adverse Event|52|||
145646657|NCT05321069|525221815|FG002|Overall Study|Adverse Event|64|||
145646658|NCT05321069|525221813|FG000|Overall Study|Protocol Violation|1|||
145646659|NCT05321069|525221814|FG001|Overall Study|Protocol Violation|1|||
145646660|NCT05321069|525221815|FG002|Overall Study|Protocol Violation|0|||
145646661|NCT05321069|525221813|FG000|Overall Study|Withdrawal by Subject|23|||
145646662|NCT05321069|525221814|FG001|Overall Study|Withdrawal by Subject|18|||
145646663|NCT05321069|525221815|FG002|Overall Study|Withdrawal by Subject|12|||
145646664|NCT05321069|525221813|FG000|Overall Study|Lost to Follow-up|1|||
145646665|NCT05321069|525221814|FG001|Overall Study|Lost to Follow-up|0|||
145646666|NCT05321069|525221815|FG002|Overall Study|Lost to Follow-up|1|||
145646667|NCT05321069|525221813|FG000|Overall Study|No reason stated by the participants|23|||
145646668|NCT05321069|525221814|FG001|Overall Study|No reason stated by the participants|22|||
145646669|NCT05321069|525221815|FG002|Overall Study|No reason stated by the participants|16|||
145646670|NCT05321069|525221813|FG000|Overall Study|Lack of Efficacy|1|||
145646671|NCT05321069|525221814|FG001|Overall Study|Lack of Efficacy|1|||
145646672|NCT05321069|525221815|FG002|Overall Study|Lack of Efficacy|0|||
145646673|NCT02412748|525221818|FG000|Overall Study|Lost to Follow-up|38|||
145646674|NCT02412748|525221819|FG001|Overall Study|Lost to Follow-up|39|||
145646675|NCT04128319|525221820|FG000|Overall Study|Death|3|||
145646676|NCT00976937|525221823|FG000|Overall Study|Adverse Event|4|||
145646677|NCT00976937|525221824|FG001|Overall Study|Adverse Event|5|||
145646678|NCT00976937|525221823|FG000|Overall Study|Lost to Follow-up|2|||
145646679|NCT00976937|525221824|FG001|Overall Study|Lost to Follow-up|1|||
145646680|NCT00976937|525221823|FG000|Overall Study|Withdrawal by Subject|5|||
145646681|NCT00976937|525221824|FG001|Overall Study|Withdrawal by Subject|3|||
145646682|NCT00976937|525221823|FG000|Overall Study|Poor compliance to protocol|3|||
145646683|NCT00976937|525221824|FG001|Overall Study|Poor compliance to protocol|0|||
145646684|NCT00976937|525221823|FG000|Overall Study|Personal and Familial Reason|2|||
145646685|NCT00976937|525221824|FG001|Overall Study|Personal and Familial Reason|2|||
145646686|NCT03069313|525221825|FG000|Overall Study|Adverse Event|5|||
145646687|NCT04218266|525221826|FG000|Overall Study|Death|1|||
145646688|NCT04218266|525221827|FG001|Overall Study|Death|2|||
145646689|NCT04218266|525221828|FG002|Overall Study|Death|3|||
145646690|NCT04218266|525221826|FG000|Overall Study|Adverse Event|13|||
145646691|NCT04218266|525221827|FG001|Overall Study|Adverse Event|14|||
145646692|NCT04218266|525221828|FG002|Overall Study|Adverse Event|11|||
145646693|NCT04218266|525221826|FG000|Overall Study|Other|7|||
145646694|NCT04218266|525221827|FG001|Overall Study|Other|5|||
145646695|NCT04218266|525221828|FG002|Overall Study|Other|14|||
145646696|NCT04218266|525221826|FG000|Overall Study|Physician Decision|1|||
145646697|NCT04218266|525221827|FG001|Overall Study|Physician Decision|3|||
145646698|NCT04218266|525221828|FG002|Overall Study|Physician Decision|2|||
145646699|NCT04218266|525221826|FG000|Overall Study|Non-compliance with study drug|0|||
145646700|NCT04218266|525221827|FG001|Overall Study|Non-compliance with study drug|0|||
145646701|NCT04218266|525221828|FG002|Overall Study|Non-compliance with study drug|1|||
145646702|NCT04218266|525221826|FG000|Overall Study|Withdrawal by Subject|1|||
145646703|NCT04218266|525221827|FG001|Overall Study|Withdrawal by Subject|3|||
145646704|NCT04218266|525221828|FG002|Overall Study|Withdrawal by Subject|1|||
145646705|NCT04218266|525221826|FG000|Overall Study|Study drug never administered|2|||
145646706|NCT04218266|525221827|FG001|Overall Study|Study drug never administered|0|||
145646707|NCT04218266|525221828|FG002|Overall Study|Study drug never administered|0|||
145646708|NCT01011946|525221830|FG000|Overall Study|Transferred to another hospital|2|||
145646709|NCT01011946|525221830|FG000|Overall Study|No pathological lab value|1|||
145646710|NCT04048382|525221833|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
145646711|NCT04048382|525221834|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
145646712|NCT04048382|525221833|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
145646713|NCT04048382|525221834|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
145646714|NCT04048382|525221833|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
145646715|NCT04048382|525221834|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
145646716|NCT01227265|525221835|FG000|Overall Study|Did Not Receive Treatment|1|||
145646717|NCT01227265|525221836|FG001|Overall Study|Did Not Receive Treatment|2|||
145646718|NCT01227265|525221837|FG002|Overall Study|Did Not Receive Treatment|0|||
145646719|NCT01227265|525221835|FG000|Overall Study|Administrative|1|||
145646720|NCT01227265|525221836|FG001|Overall Study|Administrative|0|||
145646721|NCT01227265|525221837|FG002|Overall Study|Administrative|2|||
145646722|NCT01227265|525221835|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
145646723|NCT01227265|525221836|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
145646724|NCT01227265|525221837|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
145646725|NCT01227265|525221835|FG000|Overall Study|Protocol Violation|2|||
145646726|NCT01227265|525221836|FG001|Overall Study|Protocol Violation|1|||
145646727|NCT01227265|525221837|FG002|Overall Study|Protocol Violation|0|||
145646728|NCT01227265|525221835|FG000|Overall Study|Withdrawal by Subject|7|||
145646729|NCT01227265|525221836|FG001|Overall Study|Withdrawal by Subject|7|||
145646730|NCT01227265|525221837|FG002|Overall Study|Withdrawal by Subject|3|||
145646731|NCT01227265|525221835|FG000|Overall Study|Lost to Follow-up|2|||
145646732|NCT01227265|525221836|FG001|Overall Study|Lost to Follow-up|0|||
145646733|NCT01227265|525221837|FG002|Overall Study|Lost to Follow-up|3|||
145646734|NCT01227265|525221835|FG000|Overall Study|Adverse Event|6|||
145646735|NCT01227265|525221836|FG001|Overall Study|Adverse Event|10|||
145646736|NCT01227265|525221837|FG002|Overall Study|Adverse Event|5|||
145646737|NCT05368558|525221843|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
145646738|NCT05368558|525221844|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
145646739|NCT05368558|525221845|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
145646740|NCT05368558|525221846|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646741|NCT05368558|525221847|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646742|NCT05368558|525221848|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646743|NCT05368558|525221849|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646744|NCT05368558|525221850|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646745|NCT05368558|525221851|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145486731|NCT00383786|524636756|FG000|Overall Study|Physician Decision|0|||
145646746|NCT05368558|525221852|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646747|NCT05368558|525221853|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646748|NCT05368558|525221854|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
145646749|NCT05368558|525221843|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646750|NCT05368558|525221844|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646751|NCT05368558|525221845|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646752|NCT05368558|525221846|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
145646753|NCT05368558|525221847|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646754|NCT05368558|525221848|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
145646755|NCT05368558|525221849|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646756|NCT05368558|525221850|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646757|NCT05368558|525221851|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646758|NCT05368558|525221852|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646759|NCT05368558|525221853|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646760|NCT05368558|525221854|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
145646761|NCT05368558|525221843|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646762|NCT05368558|525221844|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646763|NCT05368558|525221845|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646764|NCT05368558|525221846|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
145646765|NCT05368558|525221847|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646766|NCT05368558|525221848|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646767|NCT05368558|525221849|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646768|NCT05368558|525221850|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646769|NCT05368558|525221851|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646770|NCT05368558|525221852|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646771|NCT05368558|525221853|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646772|NCT05368558|525221854|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
145646773|NCT05368558|525221843|FG000|Blinded Extension Period (BEP)|other|0|||
145646774|NCT05368558|525221844|FG001|Blinded Extension Period (BEP)|other|0|||
145646775|NCT05368558|525221845|FG002|Blinded Extension Period (BEP)|other|0|||
145646776|NCT05368558|525221846|FG003|Blinded Extension Period (BEP)|other|0|||
145646777|NCT05368558|525221847|FG004|Blinded Extension Period (BEP)|other|0|||
145646778|NCT05368558|525221848|FG005|Blinded Extension Period (BEP)|other|1|||
145646779|NCT05368558|525221849|FG006|Blinded Extension Period (BEP)|other|0|||
145646780|NCT05368558|525221850|FG007|Blinded Extension Period (BEP)|other|0|||
145646781|NCT05368558|525221851|FG008|Blinded Extension Period (BEP)|other|0|||
145646782|NCT05368558|525221852|FG009|Blinded Extension Period (BEP)|other|0|||
145646783|NCT05368558|525221853|FG010|Blinded Extension Period (BEP)|other|0|||
145646784|NCT05368558|525221854|FG011|Blinded Extension Period (BEP)|other|0|||
145646785|NCT04623775|525221855|FG000|Randomization|No Longer Meets Study Criteria|2|||
145646786|NCT04623775|525221856|FG001|Randomization|No Longer Meets Study Criteria|1|||
145646787|NCT04623775|525221857|FG002|Randomization|No Longer Meets Study Criteria|0|||
145646788|NCT04623775|525221858|FG003|Randomization|No Longer Meets Study Criteria|0|||
145646789|NCT04623775|525221855|FG000|Randomization|Withdrew Consent|0|||
145646790|NCT04623775|525221856|FG001|Randomization|Withdrew Consent|0|||
145646791|NCT04623775|525221857|FG002|Randomization|Withdrew Consent|0|||
145646792|NCT04623775|525221858|FG003|Randomization|Withdrew Consent|1|||
145646793|NCT04623775|525221855|FG000|Randomization|Other Reasons|0|||
145646794|NCT04623775|525221856|FG001|Randomization|Other Reasons|0|||
145646795|NCT04623775|525221857|FG002|Randomization|Other Reasons|0|||
145646796|NCT04623775|525221858|FG003|Randomization|Other Reasons|1|||
145646797|NCT04623775|525221855|FG000|Treatment Period|participant withdrew consent|4|||
145646798|NCT04623775|525221856|FG001|Treatment Period|participant withdrew consent|0|||
145646799|NCT04623775|525221857|FG002|Treatment Period|participant withdrew consent|1|||
145646800|NCT04623775|525221858|FG003|Treatment Period|participant withdrew consent|2|||
145646801|NCT04623775|525221855|FG000|Treatment Period|Death|3|||
145646802|NCT04623775|525221856|FG001|Treatment Period|Death|1|||
145646803|NCT04623775|525221857|FG002|Treatment Period|Death|4|||
145646804|NCT04623775|525221858|FG003|Treatment Period|Death|2|||
145646805|NCT04623775|525221855|FG000|Treatment Period|Lost to Follow-up|0|||
145646806|NCT04623775|525221856|FG001|Treatment Period|Lost to Follow-up|2|||
145646807|NCT04623775|525221857|FG002|Treatment Period|Lost to Follow-up|0|||
145646808|NCT04623775|525221858|FG003|Treatment Period|Lost to Follow-up|0|||
145646809|NCT04623775|525221855|FG000|Treatment Period|poor/non compliance|0|||
145646810|NCT04623775|525221856|FG001|Treatment Period|poor/non compliance|0|||
145646811|NCT04623775|525221857|FG002|Treatment Period|poor/non compliance|1|||
145646812|NCT04623775|525221858|FG003|Treatment Period|poor/non compliance|0|||
145646813|NCT04623775|525221855|FG000|Treatment Period|participant no longer meets study criteria|0|||
145646814|NCT04623775|525221856|FG001|Treatment Period|participant no longer meets study criteria|1|||
145646815|NCT04623775|525221857|FG002|Treatment Period|participant no longer meets study criteria|0|||
145646816|NCT04623775|525221858|FG003|Treatment Period|participant no longer meets study criteria|0|||
145646817|NCT04623775|525221855|FG000|Treatment Period|administrative reasons by sponsor|3|||
145646818|NCT04623775|525221856|FG001|Treatment Period|administrative reasons by sponsor|2|||
145646819|NCT04623775|525221857|FG002|Treatment Period|administrative reasons by sponsor|0|||
145646820|NCT04623775|525221858|FG003|Treatment Period|administrative reasons by sponsor|0|||
145646821|NCT04623775|525221855|FG000|Treatment Period|other reasons|2|||
145646822|NCT04623775|525221856|FG001|Treatment Period|other reasons|0|||
145646823|NCT04623775|525221857|FG002|Treatment Period|other reasons|1|||
145646824|NCT04623775|525221858|FG003|Treatment Period|other reasons|1|||
145646825|NCT04623775|525221855|FG000|Treatment Period|disease progression|40|||
145646826|NCT04623775|525221856|FG001|Treatment Period|disease progression|35|||
145646827|NCT04623775|525221857|FG002|Treatment Period|disease progression|63|||
145646828|NCT04623775|525221858|FG003|Treatment Period|disease progression|63|||
145646829|NCT04623775|525221855|FG000|Treatment Period|study drug toxicity|12|||
145646830|NCT04623775|525221856|FG001|Treatment Period|study drug toxicity|15|||
145646831|NCT04623775|525221857|FG002|Treatment Period|study drug toxicity|13|||
145646832|NCT04623775|525221858|FG003|Treatment Period|study drug toxicity|12|||
145646833|NCT04623775|525221855|FG000|Treatment Period|AE unrelated to study drug|4|||
145646834|NCT04623775|525221856|FG001|Treatment Period|AE unrelated to study drug|9|||
145646835|NCT04623775|525221857|FG002|Treatment Period|AE unrelated to study drug|12|||
145646836|NCT04623775|525221858|FG003|Treatment Period|AE unrelated to study drug|9|||
145646837|NCT04623775|525221855|FG000|Treatment Period|participant request to discontinue treatment|0|||
145646838|NCT04623775|525221856|FG001|Treatment Period|participant request to discontinue treatment|2|||
145646839|NCT04623775|525221857|FG002|Treatment Period|participant request to discontinue treatment|2|||
145646840|NCT04623775|525221858|FG003|Treatment Period|participant request to discontinue treatment|0|||
145646841|NCT03582722|525221860|FG000|Overall Study|Lost to Follow-up|1|||
145646842|NCT03582722|525221861|FG001|Overall Study|Lost to Follow-up|4|||
145646843|NCT03582722|525221860|FG000|Overall Study|Withdrawal by Subject|3|||
145646844|NCT03582722|525221861|FG001|Overall Study|Withdrawal by Subject|3|||
145646845|NCT01959698|525221862|FG000|Overall Study|Adverse Event|0|||
145646846|NCT01959698|525221863|FG001|Overall Study|Adverse Event|0|||
145646847|NCT01959698|525221864|FG002|Overall Study|Adverse Event|0|||
145646848|NCT01959698|525221865|FG003|Overall Study|Adverse Event|0|||
145646849|NCT01959698|525221866|FG004|Overall Study|Adverse Event|0|||
145646850|NCT01959698|525221867|FG005|Overall Study|Adverse Event|0|||
145646851|NCT01959698|525221868|FG006|Overall Study|Adverse Event|1|||
145646852|NCT01959698|525221862|FG000|Overall Study|Physician Decision|1|||
145646853|NCT01959698|525221863|FG001|Overall Study|Physician Decision|0|||
145646854|NCT01959698|525221864|FG002|Overall Study|Physician Decision|1|||
145646855|NCT01959698|525221865|FG003|Overall Study|Physician Decision|2|||
145646856|NCT01959698|525221866|FG004|Overall Study|Physician Decision|0|||
145646857|NCT01959698|525221867|FG005|Overall Study|Physician Decision|3|||
145646858|NCT01959698|525221868|FG006|Overall Study|Physician Decision|3|||
145646859|NCT03744312|525224417|FG000|Overall Study|Withdrawal by Subject|0|||
145646860|NCT03744312|525224418|FG001|Overall Study|Withdrawal by Subject|1|||
145646861|NCT03744312|525224417|FG000|Overall Study|Screen fail|0|||
145646862|NCT03744312|525224418|FG001|Overall Study|Screen fail|1|||
145646863|NCT04112316|525224419|FG000|First Period (8 Weeks)|Protocol Violation|1|||
145646864|NCT04112316|525224420|FG001|First Period (8 Weeks)|Protocol Violation|0|||
145646865|NCT04112316|525224419|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
145646866|NCT04112316|525224420|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
145646867|NCT03055377|525224421|FG000|Treatment Phase|Lost to Follow-up|28|||
145646868|NCT03055377|525224422|FG001|Treatment Phase|Lost to Follow-up|24|||
145646869|NCT03055377|525224421|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
145646870|NCT03055377|525224422|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
145646871|NCT02553642|525224427|FG000|Overall Study|Withdrawal by Subject|0|||
145646872|NCT02553642|525224428|FG001|Overall Study|Withdrawal by Subject|3|||
145646873|NCT02553642|525224427|FG000|Overall Study|Physician Decision|0|||
145646874|NCT02553642|525224428|FG001|Overall Study|Physician Decision|1|||
145646875|NCT02553642|525224427|FG000|Overall Study|Additional cancer dx|0|||
145646876|NCT02553642|525224428|FG001|Overall Study|Additional cancer dx|1|||
145646877|NCT02553642|525224427|FG000|Overall Study|Never started treatment|0|||
145646878|NCT02553642|525224428|FG001|Overall Study|Never started treatment|1|||
145646879|NCT05444192|525224431|FG000|Overall Study|Lost to Follow-up|1|||
145646880|NCT05444192|525224432|FG001|Overall Study|Lost to Follow-up|0|||
145646881|NCT04424927|525224434|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
145646882|NCT04424927|525224435|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
145646883|NCT04424927|525224436|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
145646884|NCT04424927|525224437|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
145646885|NCT04424927|525224438|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
145646886|NCT04424927|525224434|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
145646887|NCT04424927|525224435|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
145646888|NCT04424927|525224436|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
145646889|NCT04424927|525224437|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
145646890|NCT04424927|525224438|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
145646891|NCT04424927|525224434|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
145646892|NCT04424927|525224435|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
145646893|NCT04424927|525224436|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
145646894|NCT04424927|525224437|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
145646895|NCT04424927|525224438|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
145646896|NCT04424927|525224434|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
145646897|NCT04424927|525224435|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
145646898|NCT04424927|525224436|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
145646899|NCT04424927|525224437|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
145646900|NCT04424927|525224438|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
145646901|NCT04424927|525224434|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
145646902|NCT04424927|525224435|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
145646903|NCT04424927|525224436|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
145646904|NCT04424927|525224437|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
145646905|NCT04424927|525224438|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
145646906|NCT04424927|525224434|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
145646907|NCT04424927|525224435|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
145646908|NCT04424927|525224436|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
145646909|NCT04424927|525224437|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
145646910|NCT04424927|525224438|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
145646911|NCT04424927|525224434|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
145646912|NCT04424927|525224435|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
145646913|NCT04424927|525224436|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
145646914|NCT04424927|525224437|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
145646915|NCT04424927|525224438|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
145646916|NCT04424927|525224434|FG000|Double-blind Period (24 Weeks)|Other|0|||
145646917|NCT04424927|525224435|FG001|Double-blind Period (24 Weeks)|Other|1|||
145646918|NCT04424927|525224436|FG002|Double-blind Period (24 Weeks)|Other|3|||
145646919|NCT04424927|525224437|FG003|Double-blind Period (24 Weeks)|Other|1|||
145646920|NCT04424927|525224438|FG004|Double-blind Period (24 Weeks)|Other|0|||
145646921|NCT04791709|525224442|FG000|Overall Study|Withdrawal by Subject|3|||
145646922|NCT02724956|525224443|FG000|Overall Study|Physician Decision|1|||
145646923|NCT02724956|525224444|FG001|Overall Study|Physician Decision|0|||
145646924|NCT02724956|525224443|FG000|Overall Study|Lack of Efficacy|0|||
145646925|NCT02724956|525224444|FG001|Overall Study|Lack of Efficacy|1|||
145646926|NCT02724956|525224443|FG000|Overall Study|Withdrawal by Subject|0|||
145646927|NCT02724956|525224444|FG001|Overall Study|Withdrawal by Subject|1|||
145646928|NCT01532388|525224445|FG000|3-month Follow-up|Lost to Follow-up|68|||
145646929|NCT01532388|525224446|FG001|3-month Follow-up|Lost to Follow-up|68|||
145646930|NCT01532388|525224445|FG000|6-month Follow-up|Lost to Follow-up|74|||
145646931|NCT01532388|525224446|FG001|6-month Follow-up|Lost to Follow-up|66|||
145646932|NCT01532388|525224445|FG000|12-month Follow-up|Lost to Follow-up|69|||
145646933|NCT01532388|525224446|FG001|12-month Follow-up|Lost to Follow-up|67|||
145646934|NCT00792636|525224447|FG000|Overall Study|Protocol Violation|17|||
145646935|NCT00792636|525224448|FG001|Overall Study|Protocol Violation|23|||
145486732|NCT00383786|524636757|FG001|Overall Study|Physician Decision|1|||
145486733|NCT00985673|524636758|FG000|Overall Study|Lost to Follow-up|6|||
145486734|NCT00985673|524636759|FG001|Overall Study|Lost to Follow-up|7|||
145486735|NCT00985673|524636760|FG002|Overall Study|Lost to Follow-up|6|||
145486736|NCT00985673|524636761|FG003|Overall Study|Lost to Follow-up|10|||
145486737|NCT00985673|524636762|FG004|Overall Study|Lost to Follow-up|5|||
145486738|NCT00985673|524636763|FG005|Overall Study|Lost to Follow-up|3|||
145486739|NCT00985673|524636758|FG000|Overall Study|Withdrawal by Subject|0|||
145486740|NCT00985673|524636759|FG001|Overall Study|Withdrawal by Subject|4|||
145486741|NCT00985673|524636760|FG002|Overall Study|Withdrawal by Subject|5|||
145486742|NCT00985673|524636761|FG003|Overall Study|Withdrawal by Subject|2|||
145486743|NCT00985673|524636762|FG004|Overall Study|Withdrawal by Subject|2|||
145486744|NCT00985673|524636763|FG005|Overall Study|Withdrawal by Subject|3|||
145486745|NCT00985673|524636758|FG000|Overall Study|Other|1|||
145486746|NCT00985673|524636759|FG001|Overall Study|Other|0|||
145646936|NCT00792636|525224449|FG002|Overall Study|Protocol Violation|20|||
145646937|NCT00792636|525224447|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
145646938|NCT00792636|525224448|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
145486747|NCT00985673|524636760|FG002|Overall Study|Other|1|||
145646939|NCT00792636|525224449|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
145646940|NCT00792636|525224447|FG000|Overall Study|Lost to Follow-up|13|||
145646941|NCT00792636|525224448|FG001|Overall Study|Lost to Follow-up|19|||
145646942|NCT00792636|525224449|FG002|Overall Study|Lost to Follow-up|14|||
145646943|NCT00792636|525224447|FG000|Overall Study|Withdrew Consent|10|||
145486748|NCT00985673|524636761|FG003|Overall Study|Other|0|||
145486749|NCT00985673|524636762|FG004|Overall Study|Other|1|||
145486750|NCT00985673|524636763|FG005|Overall Study|Other|0|||
145486751|NCT02219464|524636766|FG000|Overall Study|Withdrawal by Subject|1|||
145486752|NCT02219464|524636767|FG001|Overall Study|Withdrawal by Subject|0|||
145486753|NCT02219464|524636766|FG000|Overall Study|case cancelled|1|||
145486754|NCT02219464|524636767|FG001|Overall Study|case cancelled|0|||
145486755|NCT02219464|524636766|FG000|Overall Study|catheter malfunction|1|||
145486756|NCT02219464|524636767|FG001|Overall Study|catheter malfunction|0|||
145486757|NCT00984256|524636768|FG000|Overall Study|Withdrawal by Subject|0|||
145486758|NCT00984256|524636769|FG001|Overall Study|Withdrawal by Subject|1|||
145486759|NCT01517750|524636770|FG000|Overall Study|Lost to Follow-up|1|||
145486760|NCT01517750|524636771|FG001|Overall Study|Lost to Follow-up|2|||
145486761|NCT01517750|524636772|FG002|Overall Study|Lost to Follow-up|4|||
145486762|NCT01517750|524636773|FG003|Overall Study|Lost to Follow-up|1|||
145486763|NCT02735239|524636774|FG000|Overall Study|Adverse Event|0|||
145486764|NCT02735239|524636775|FG001|Overall Study|Adverse Event|0|||
145646944|NCT00792636|525224448|FG001|Overall Study|Withdrew Consent|13|||
145646945|NCT00792636|525224449|FG002|Overall Study|Withdrew Consent|9|||
145646946|NCT00792636|525224447|FG000|Overall Study|Lack of Efficacy|3|||
145646947|NCT00792636|525224448|FG001|Overall Study|Lack of Efficacy|4|||
145646948|NCT00792636|525224449|FG002|Overall Study|Lack of Efficacy|13|||
145646949|NCT00792636|525224447|FG000|Overall Study|Adverse Event|4|||
145646950|NCT00792636|525224448|FG001|Overall Study|Adverse Event|2|||
145646951|NCT00792636|525224449|FG002|Overall Study|Adverse Event|3|||
145646952|NCT00792636|525224447|FG000|Overall Study|Investigator Discretion|2|||
145646953|NCT00792636|525224448|FG001|Overall Study|Investigator Discretion|0|||
145646954|NCT00792636|525224449|FG002|Overall Study|Investigator Discretion|2|||
145646955|NCT01046136|525224450|FG000|Overall Study|Withdrawal by Subject|0|||
145646956|NCT01046136|525224451|FG001|Overall Study|Withdrawal by Subject|4|||
145646957|NCT01046136|525224450|FG000|Overall Study|Physician Decision|1|||
145646958|NCT01046136|525224451|FG001|Overall Study|Physician Decision|1|||
145646959|NCT01046136|525224450|FG000|Overall Study|Lost to Follow-up|3|||
145646960|NCT01046136|525224451|FG001|Overall Study|Lost to Follow-up|3|||
145646961|NCT04579250|525224452|FG000|Overall Study|Withdrawal by Subject|1|||
145646962|NCT04579250|525224453|FG001|Overall Study|Withdrawal by Subject|1|||
145646963|NCT04579250|525224454|FG002|Overall Study|Withdrawal by Subject|0|||
145646964|NCT04579250|525224452|FG000|Overall Study|Lost to Follow-up|1|||
145646965|NCT04579250|525224453|FG001|Overall Study|Lost to Follow-up|1|||
145646966|NCT04579250|525224454|FG002|Overall Study|Lost to Follow-up|0|||
145646967|NCT04579250|525224452|FG000|Overall Study|Moved from area|0|||
145646968|NCT04579250|525224453|FG001|Overall Study|Moved from area|1|||
145646969|NCT04579250|525224454|FG002|Overall Study|Moved from area|2|||
145646970|NCT02058108|525224455|FG000|Overall Study|Abnormal Laboratory Values|0|||
145646971|NCT02058108|525224456|FG001|Overall Study|Abnormal Laboratory Values|1|||
145646972|NCT02058108|525224455|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
145646973|NCT02058108|525224456|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
145646974|NCT02058108|525224455|FG000|Overall Study|No longer requires study drug|0|||
145646975|NCT02058108|525224456|FG001|Overall Study|No longer requires study drug|1|||
145646976|NCT02058108|525224455|FG000|Overall Study|Withdrawal by Subject|1|||
145646977|NCT02058108|525224456|FG001|Overall Study|Withdrawal by Subject|0|||
145646978|NCT02058108|525224455|FG000|Overall Study|Administrative problems|3|||
145646979|NCT02058108|525224456|FG001|Overall Study|Administrative problems|3|||
145646980|NCT02058108|525224455|FG000|Overall Study|Protocol Violation|0|||
145646981|NCT02058108|525224456|FG001|Overall Study|Protocol Violation|1|||
145646982|NCT01376700|525224460|FG000|Overall Study|Sponsor terminated study early|8|||
145646983|NCT01376700|525224460|FG000|Overall Study|Low or high titer inhibitor|8|||
145646984|NCT00727909|525224461|FG000|Overall Study|Withdrawal by Subject|5|||
145646985|NCT00727909|525224462|FG001|Overall Study|Withdrawal by Subject|11|||
145646986|NCT00727909|525224463|FG002|Overall Study|Withdrawal by Subject|8|||
145646987|NCT00727909|525224464|FG003|Overall Study|Withdrawal by Subject|5|||
145646988|NCT00727909|525224461|FG000|Overall Study|Death|0|||
145646989|NCT00727909|525224462|FG001|Overall Study|Death|0|||
145646990|NCT00727909|525224463|FG002|Overall Study|Death|1|||
145646991|NCT00727909|525224464|FG003|Overall Study|Death|0|||
145486765|NCT02735239|524636776|FG002|Overall Study|Adverse Event|4|||
145486766|NCT02735239|524636777|FG003|Overall Study|Adverse Event|0|||
145646992|NCT01696773|525224465|FG000|Days 15-27, Washout|Adverse Event|1|||
145646993|NCT01696773|525224466|FG001|Days 15-27, Washout|Adverse Event|0|||
145646994|NCT05623345|525224475|FG000|Overall Study|Withdrawal by Subject|14|||
145646995|NCT05623345|525224476|FG001|Overall Study|Withdrawal by Subject|0|||
145646996|NCT05623345|525224477|FG002|Overall Study|Withdrawal by Subject|9|||
145486767|NCT02735239|524636778|FG004|Overall Study|Adverse Event|0|||
145646997|NCT05623345|525224478|FG003|Overall Study|Withdrawal by Subject|20|||
145646998|NCT05623345|525224475|FG000|Overall Study|Lost to Follow-up|3|||
145486768|NCT02735239|524636779|FG005|Overall Study|Adverse Event|0|||
145486769|NCT02735239|524636774|FG000|Overall Study|Death|1|||
145486770|NCT02735239|524636775|FG001|Overall Study|Death|1|||
145486771|NCT02735239|524636776|FG002|Overall Study|Death|0|||
145486772|NCT02735239|524636777|FG003|Overall Study|Death|0|||
145646999|NCT05623345|525224476|FG001|Overall Study|Lost to Follow-up|0|||
145647000|NCT05623345|525224477|FG002|Overall Study|Lost to Follow-up|7|||
145647001|NCT05623345|525224478|FG003|Overall Study|Lost to Follow-up|2|||
145647002|NCT05623345|525224475|FG000|Overall Study|Termination of Study By Sponsor|37|||
145647003|NCT05623345|525224476|FG001|Overall Study|Termination of Study By Sponsor|4|||
145647004|NCT05623345|525224477|FG002|Overall Study|Termination of Study By Sponsor|40|||
145647005|NCT05623345|525224478|FG003|Overall Study|Termination of Study By Sponsor|38|||
145647006|NCT05384730|525224479|FG000|Overall Study|Adverse Event|1|||
145647007|NCT05384730|525224480|FG001|Overall Study|Adverse Event|0|||
145647008|NCT05384730|525224479|FG000|Overall Study|Lack of social support|2|||
145647009|NCT05384730|525224480|FG001|Overall Study|Lack of social support|0|||
145647010|NCT05384730|525224479|FG000|Overall Study|Hospital readmission|2|||
145647011|NCT05384730|525224480|FG001|Overall Study|Hospital readmission|0|||
145647012|NCT05384730|525224479|FG000|Overall Study|Disease progression|5|||
145647013|NCT05384730|525224480|FG001|Overall Study|Disease progression|0|||
145647014|NCT05384730|525224479|FG000|Overall Study|Overwhelmed with College commitments|0|||
145647015|NCT05384730|525224480|FG001|Overall Study|Overwhelmed with College commitments|2|||
145647016|NCT00411151|525224481|FG000|Overall Study|Death|38|||
145647017|NCT00411151|525224481|FG000|Overall Study|Withdrawal by Subject|2|||
145647018|NCT00411151|525224481|FG000|Overall Study|Lost to Follow-up|2|||
145647019|NCT00411151|525224481|FG000|Overall Study|Protocol Violation|1|||
145647020|NCT00411151|525224481|FG000|Overall Study|Trial prematurely closed|4|||
145647021|NCT00999167|525224488|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
145647022|NCT00999167|525224489|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
145647023|NCT00999167|525224490|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
145647024|NCT00999167|525224488|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
145647025|NCT00999167|525224489|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
145647026|NCT00999167|525224490|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
145647027|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
145647028|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
145647029|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
145647030|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
145647031|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
145647032|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
145647033|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
145647034|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
145647035|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
145647036|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
145647037|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
145647038|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
145647039|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
145647040|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
145647041|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
145647042|NCT00999167|525224488|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
145647043|NCT00999167|525224489|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
145647044|NCT00999167|525224490|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
145647045|NCT02638337|525224495|FG000|Overall Study|Adverse Event|6|||
145647046|NCT02638337|525224496|FG001|Overall Study|Adverse Event|10|||
145647047|NCT02638337|525224495|FG000|Overall Study|Protocol Violation|3|||
145647048|NCT02638337|525224496|FG001|Overall Study|Protocol Violation|0|||
145647049|NCT02638337|525224495|FG000|Overall Study|Withdrawal by Subject|13|||
145647050|NCT02638337|525224496|FG001|Overall Study|Withdrawal by Subject|16|||
145647051|NCT02638337|525224495|FG000|Overall Study|Lost to Follow-up|7|||
145647052|NCT02638337|525224496|FG001|Overall Study|Lost to Follow-up|7|||
145647053|NCT02638337|525224495|FG000|Overall Study|Other - Miscellaneous|4|||
145647054|NCT02638337|525224496|FG001|Overall Study|Other - Miscellaneous|3|||
145647055|NCT04950127|525224497|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
145647056|NCT04950127|525224498|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
145647057|NCT04950127|525224499|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
145647058|NCT04950127|525224500|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
145647059|NCT04950127|525224501|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
145647060|NCT04950127|525224502|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
145647061|NCT04950127|525224497|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
145647062|NCT04950127|525224498|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
145647063|NCT04950127|525224499|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
145647064|NCT04950127|525224500|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
145647065|NCT04950127|525224501|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
145647066|NCT04950127|525224502|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
145647067|NCT04950127|525224497|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
145647068|NCT04950127|525224498|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
145647069|NCT04950127|525224499|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
145647070|NCT04950127|525224500|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
145647071|NCT04950127|525224501|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
145486773|NCT02735239|524636778|FG004|Overall Study|Death|0|||
145486774|NCT02735239|524636779|FG005|Overall Study|Death|0|||
145486775|NCT02735239|524636774|FG000|Overall Study|Physician Decision|0|||
145486776|NCT02735239|524636775|FG001|Overall Study|Physician Decision|0|||
145486777|NCT02735239|524636776|FG002|Overall Study|Physician Decision|1|||
145486778|NCT02735239|524636777|FG003|Overall Study|Physician Decision|0|||
145647072|NCT04950127|525224502|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
145647073|NCT04950127|525224497|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
145486779|NCT02735239|524636778|FG004|Overall Study|Physician Decision|0|||
145486780|NCT02735239|524636779|FG005|Overall Study|Physician Decision|0|||
145647074|NCT04950127|525224498|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
145647075|NCT04950127|525224499|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
145647076|NCT04950127|525224500|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
145647077|NCT04950127|525224501|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
145647078|NCT04950127|525224502|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
145647079|NCT04950127|525224497|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
145647080|NCT04950127|525224498|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
145647081|NCT04950127|525224499|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
145647082|NCT04950127|525224500|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
145647083|NCT04950127|525224501|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
145647084|NCT04950127|525224502|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
145647085|NCT01711632|525224503|FG000|Overall Study|Adverse Event|4|||
145647086|NCT01711632|525224503|FG000|Overall Study|Death|3|||
145647087|NCT01711632|525224503|FG000|Overall Study|Lost to Follow-up|3|||
145647088|NCT01711632|525224503|FG000|Overall Study|Withdrawal by Subject|4|||
145647089|NCT01711632|525224503|FG000|Overall Study|Progressive disease|2|||
145647090|NCT01711632|525224503|FG000|Overall Study|No follow up required in re-treatment|3|||
145647091|NCT01711632|525224503|FG000|Overall Study|No follow up required in re-treatment|3|||
145647092|NCT04315181|525224504|FG000|Overall Study|Non-responsive to drug conditions.|1|||
145647093|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Adverse Event|4|||
145647094|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Adverse Event|1|||
145647095|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
145647096|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
145647097|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
145647098|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
145647099|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
145647100|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
145647101|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
145647102|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
145647103|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Other|6|||
145647104|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Other|1|||
145647105|NCT03271489|525224506|FG000|Double-Blind (DB) Period|Missing|1|||
145647106|NCT03271489|525224507|FG001|Double-Blind (DB) Period|Missing|0|||
145647107|NCT03271489|525224506|FG000|Open-Label (OL) Period|Adverse Event|2|||
145647108|NCT03271489|525224507|FG001|Open-Label (OL) Period|Adverse Event|0|||
145647109|NCT03271489|525224506|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
145647110|NCT03271489|525224507|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
145647111|NCT03271489|525224506|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
145647112|NCT03271489|525224507|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
145647113|NCT03271489|525224506|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
145647114|NCT03271489|525224507|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
145647115|NCT03271489|525224506|FG000|Open-Label (OL) Period|No Specified|2|||
145647116|NCT03271489|525224507|FG001|Open-Label (OL) Period|No Specified|2|||
145647117|NCT03271489|525224506|FG000|Open-Label (OL) Period|Missing|2|||
145647118|NCT03271489|525224507|FG001|Open-Label (OL) Period|Missing|0|||
145647119|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
145647120|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
145647121|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
145647122|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
145647123|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
145647124|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
145647125|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
145647126|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
145647127|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
145647128|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
145647129|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
145647130|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
145486781|NCT02735239|524636774|FG000|Overall Study|Progressive disease|3|||
145486782|NCT02735239|524636775|FG001|Overall Study|Progressive disease|1|||
145647131|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
145647132|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
145647133|NCT03271489|525224506|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
145647134|NCT03271489|525224507|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
145647135|NCT02860130|525224508|FG000|Overall Study|Adverse Event|2|||
145647136|NCT02860130|525224509|FG001|Overall Study|Adverse Event|3|||
145647137|NCT02860130|525224508|FG000|Overall Study|Protocol Violation|1|||
145647138|NCT02860130|525224509|FG001|Overall Study|Protocol Violation|1|||
145647139|NCT02860130|525224508|FG000|Overall Study|Withdrawal by Subject|0|||
145647140|NCT02860130|525224509|FG001|Overall Study|Withdrawal by Subject|2|||
145647141|NCT02860130|525224508|FG000|Overall Study|Physician Decision|2|||
145647142|NCT02860130|525224509|FG001|Overall Study|Physician Decision|2|||
145647143|NCT02860130|525224508|FG000|Overall Study|Other|2|||
145647144|NCT02860130|525224509|FG001|Overall Study|Other|1|||
145647145|NCT01467427|525224510|FG000|Overall Study|Withdrawal by Subject|1|||
145647146|NCT01467427|525224511|FG001|Overall Study|Withdrawal by Subject|0|||
145647147|NCT01467427|525224510|FG000|Overall Study|Not continuing in extension phase|0|||
145647148|NCT01467427|525224511|FG001|Overall Study|Not continuing in extension phase|2|||
145647149|NCT01467427|525224510|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
145647150|NCT01467427|525224511|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
145647151|NCT01467427|525224510|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
145647152|NCT01467427|525224511|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
145647153|NCT01467427|525224510|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
145647154|NCT01467427|525224511|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
145647155|NCT01467427|525224510|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
145647156|NCT01467427|525224511|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
145647157|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
145647158|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
145647159|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
145647160|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
145647161|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
145647162|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
145647163|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
145647164|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
145647165|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
145647166|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
145647167|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
145647168|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
145647169|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
145647170|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
145647171|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
145647172|NCT02137850|525224517|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
145647173|NCT02137850|525224518|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
145647174|NCT02137850|525224519|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
145647175|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
145647176|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
145647177|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
145647178|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
145647179|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
145647180|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
145647181|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
145647182|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
145647183|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
145647184|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
145647185|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
145647186|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
145647187|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Other|0|||
145647188|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Other|1|||
145486783|NCT02735239|524636776|FG002|Overall Study|Progressive disease|3|||
145486784|NCT02735239|524636777|FG003|Overall Study|Progressive disease|0|||
145486785|NCT02735239|524636778|FG004|Overall Study|Progressive disease|0|||
145486786|NCT02735239|524636779|FG005|Overall Study|Progressive disease|2|||
145647189|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Other|0|||
145647190|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
145647191|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
145647192|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
145647193|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Early site closure|0|||
145647194|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Early site closure|2|||
145647195|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Early site closure|0|||
145647196|NCT02137850|525224517|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
145486787|NCT02735239|524636774|FG000|Overall Study|Withdrawal by Subject|0|||
145486788|NCT02735239|524636775|FG001|Overall Study|Withdrawal by Subject|1|||
145486789|NCT02735239|524636776|FG002|Overall Study|Withdrawal by Subject|0|||
145486790|NCT02735239|524636777|FG003|Overall Study|Withdrawal by Subject|0|||
145486791|NCT02735239|524636778|FG004|Overall Study|Withdrawal by Subject|0|||
145486792|NCT02735239|524636779|FG005|Overall Study|Withdrawal by Subject|0|||
145647197|NCT02137850|525224518|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
145647198|NCT02137850|525224519|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
145647199|NCT02137850|525224517|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
145647200|NCT02137850|525224518|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
145647201|NCT02137850|525224519|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
145647202|NCT02137850|525224517|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
145647203|NCT02137850|525224518|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
145647204|NCT02137850|525224519|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
145647205|NCT02137850|525224517|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
145647206|NCT02137850|525224518|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
145647207|NCT02137850|525224519|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
145647208|NCT02137850|525224517|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
145647209|NCT02137850|525224518|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
145647210|NCT02137850|525224519|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
145647211|NCT02137850|525224517|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
145647212|NCT02137850|525224518|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
145647213|NCT02137850|525224519|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
145647214|NCT02137850|525224517|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
145647215|NCT02137850|525224518|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
145647216|NCT02137850|525224519|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
145647217|NCT02137850|525224517|FG000|Extension Phase: Prophylaxis|Other|0|||
145647218|NCT02137850|525224518|FG001|Extension Phase: Prophylaxis|Other|1|||
145647219|NCT02137850|525224519|FG002|Extension Phase: Prophylaxis|Other|0|||
145647220|NCT02137850|525224517|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
145647221|NCT02137850|525224518|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
145647222|NCT02137850|525224519|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
145647223|NCT05494788|525224520|FG000|Initial Treatment Period|Adverse Event|2|||
145647224|NCT05494788|525224520|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
145647225|NCT05494788|525224520|FG000|Extension Period|Adverse Event|1|||
145647226|NCT05494788|525224520|FG000|Extension Period|Withdrawal by Subject|1|||
145647227|NCT05480943|525224521|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
145647228|NCT05480943|525224521|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
145647229|NCT05480943|525224521|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
145647230|NCT05480943|525224521|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
145647231|NCT00136435|525224522|FG000|Overall Study|Ineligible|8|||
145647232|NCT00136435|525224522|FG000|Overall Study|Induction Death|1|||
145647233|NCT00136435|525224522|FG000|Overall Study|Induction Failure|10|||
145647234|NCT00136435|525224522|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
145647235|NCT00136435|525224522|FG000|Overall Study|Withdrawal by Subject|3|||
145647236|NCT00136435|525224522|FG000|Overall Study|Adverse Event|19|||
145647237|NCT00136435|525224522|FG000|Overall Study|Relapse|4|||
145647238|NCT00136435|525224522|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
145647239|NCT02794480|525224523|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
145647240|NCT02794480|525224524|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
145647241|NCT02794480|525224525|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
145647242|NCT02794480|525224526|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
145647243|NCT02794480|525224523|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
145647244|NCT02794480|525224524|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
145647245|NCT02794480|525224525|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
145647246|NCT02794480|525224526|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
145647247|NCT02794480|525224523|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145647248|NCT02794480|525224524|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145647249|NCT02794480|525224525|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145647250|NCT02794480|525224526|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
145647251|NCT02794480|525224523|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145647252|NCT02794480|525224524|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
145647253|NCT02794480|525224525|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145647254|NCT02794480|525224526|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145486793|NCT01790594|524636781|FG000|Overall Study|Death|1|||
145647255|NCT02794480|525224523|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
145647256|NCT02794480|525224524|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145647257|NCT02794480|525224525|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145647258|NCT02794480|525224526|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
145486794|NCT01790594|524636782|FG001|Overall Study|Death|0|||
145647259|NCT00901901|525224527|FG000|Treatment Period|Adverse Event|120|||
145647260|NCT00901901|525224528|FG001|Treatment Period|Adverse Event|128|||
145647261|NCT00901901|525224527|FG000|Treatment Period|Withdrawal by Subject|26|||
145647262|NCT00901901|525224528|FG001|Treatment Period|Withdrawal by Subject|24|||
145647263|NCT00901901|525224527|FG000|Treatment Period|Physician Decision|2|||
145647264|NCT00901901|525224528|FG001|Treatment Period|Physician Decision|2|||
145647265|NCT00901901|525224527|FG000|Treatment Period|Lost to Follow-up|3|||
145647266|NCT00901901|525224528|FG001|Treatment Period|Lost to Follow-up|5|||
145647267|NCT00901901|525224527|FG000|Treatment Period|Noncompliance with study medication|4|||
145647268|NCT00901901|525224528|FG001|Treatment Period|Noncompliance with study medication|1|||
145647269|NCT00901901|525224527|FG000|Treatment Period|Missing|1|||
145647270|NCT00901901|525224528|FG001|Treatment Period|Missing|0|||
145647271|NCT00901901|525224527|FG000|Treatment Period|Never treated|0|||
145647272|NCT00901901|525224528|FG001|Treatment Period|Never treated|3|||
145647273|NCT00901901|525224527|FG000|Treatment Period|Protocol driven decision point|0|||
145647274|NCT00901901|525224528|FG001|Treatment Period|Protocol driven decision point|2|||
145647275|NCT00901901|525224527|FG000|Treatment Period|Study terminated by sponsor|2|||
145647276|NCT00901901|525224528|FG001|Treatment Period|Study terminated by sponsor|0|||
145647277|NCT00901901|525224527|FG000|Treatment Period|Protocol Violation|5|||
145647278|NCT00901901|525224528|FG001|Treatment Period|Protocol Violation|9|||
145647279|NCT00901901|525224527|FG000|Treatment Period|Switch to commercial drug|1|||
145647280|NCT00901901|525224528|FG001|Treatment Period|Switch to commercial drug|1|||
145647281|NCT00901901|525224527|FG000|Treatment Period|Transfer to treatment continuation study|5|||
145647282|NCT00901901|525224528|FG001|Treatment Period|Transfer to treatment continuation study|2|||
145647283|NCT00901901|525224527|FG000|Follow-up Period|Death|181|||
145647284|NCT00901901|525224528|FG001|Follow-up Period|Death|208|||
145647285|NCT00901901|525224527|FG000|Follow-up Period|Protocol driven decision point|47|||
145647286|NCT00901901|525224528|FG001|Follow-up Period|Protocol driven decision point|36|||
145647287|NCT00901901|525224527|FG000|Follow-up Period|Withdrawal by Subject|6|||
145647288|NCT00901901|525224528|FG001|Follow-up Period|Withdrawal by Subject|9|||
145647289|NCT00901901|525224527|FG000|Follow-up Period|Lost to Follow-up|12|||
145647290|NCT00901901|525224528|FG001|Follow-up Period|Lost to Follow-up|8|||
145647291|NCT00901901|525224527|FG000|Follow-up Period|Missing|94|||
145647292|NCT00901901|525224528|FG001|Follow-up Period|Missing|80|||
145647293|NCT00632749|525224531|FG000|Overall Study|Progressive disease|3|||
145647294|NCT00632749|525224532|FG001|Overall Study|Progressive disease|2|||
145647295|NCT00632749|525224533|FG002|Overall Study|Progressive disease|2|||
145647296|NCT00632749|525224534|FG003|Overall Study|Progressive disease|2|||
145647297|NCT00632749|525224535|FG004|Overall Study|Progressive disease|4|||
145647298|NCT00632749|525224536|FG005|Overall Study|Progressive disease|4|||
145647299|NCT00632749|525224537|FG006|Overall Study|Progressive disease|3|||
145647300|NCT00632749|525224538|FG007|Overall Study|Progressive disease|2|||
145647301|NCT00632749|525224539|FG008|Overall Study|Progressive disease|3|||
145647302|NCT00632749|525224540|FG009|Overall Study|Progressive disease|2|||
145647303|NCT00632749|525224541|FG010|Overall Study|Progressive disease|4|||
145647304|NCT00632749|525224542|FG011|Overall Study|Progressive disease|3|||
145647305|NCT00632749|525224543|FG012|Overall Study|Progressive disease|2|||
145647306|NCT00632749|525224544|FG013|Overall Study|Progressive disease|4|||
145647307|NCT00632749|525224531|FG000|Overall Study|Other Adverse event|1|||
145647308|NCT00632749|525224532|FG001|Overall Study|Other Adverse event|1|||
145647309|NCT00632749|525224533|FG002|Overall Study|Other Adverse event|1|||
145647310|NCT00632749|525224534|FG003|Overall Study|Other Adverse event|1|||
145647311|NCT00632749|525224535|FG004|Overall Study|Other Adverse event|2|||
145647312|NCT00632749|525224536|FG005|Overall Study|Other Adverse event|4|||
145647313|NCT00632749|525224537|FG006|Overall Study|Other Adverse event|1|||
145647314|NCT00632749|525224538|FG007|Overall Study|Other Adverse event|2|||
145647315|NCT00632749|525224539|FG008|Overall Study|Other Adverse event|2|||
145647316|NCT00632749|525224540|FG009|Overall Study|Other Adverse event|0|||
145647317|NCT00632749|525224541|FG010|Overall Study|Other Adverse event|1|||
145647318|NCT00632749|525224542|FG011|Overall Study|Other Adverse event|0|||
145647319|NCT00632749|525224543|FG012|Overall Study|Other Adverse event|1|||
145647320|NCT00632749|525224544|FG013|Overall Study|Other Adverse event|0|||
145647321|NCT00632749|525224531|FG000|Overall Study|Refuse to continue medication|0|||
145647322|NCT00632749|525224532|FG001|Overall Study|Refuse to continue medication|0|||
145647323|NCT00632749|525224533|FG002|Overall Study|Refuse to continue medication|0|||
145647324|NCT00632749|525224534|FG003|Overall Study|Refuse to continue medication|1|||
145647325|NCT00632749|525224535|FG004|Overall Study|Refuse to continue medication|0|||
145647326|NCT00632749|525224536|FG005|Overall Study|Refuse to continue medication|0|||
145647327|NCT00632749|525224537|FG006|Overall Study|Refuse to continue medication|0|||
145647328|NCT00632749|525224538|FG007|Overall Study|Refuse to continue medication|0|||
145647329|NCT00632749|525224539|FG008|Overall Study|Refuse to continue medication|0|||
145647330|NCT00632749|525224540|FG009|Overall Study|Refuse to continue medication|1|||
145647331|NCT00632749|525224541|FG010|Overall Study|Refuse to continue medication|0|||
145647332|NCT00632749|525224542|FG011|Overall Study|Refuse to continue medication|0|||
145647333|NCT00632749|525224543|FG012|Overall Study|Refuse to continue medication|0|||
145647334|NCT00632749|525224544|FG013|Overall Study|Refuse to continue medication|0|||
145647335|NCT00632749|525224531|FG000|Overall Study|Reason other than those specified above|0|||
145647336|NCT00632749|525224532|FG001|Overall Study|Reason other than those specified above|2|||
145647337|NCT00632749|525224533|FG002|Overall Study|Reason other than those specified above|0|||
145647338|NCT00632749|525224534|FG003|Overall Study|Reason other than those specified above|0|||
145647339|NCT00632749|525224535|FG004|Overall Study|Reason other than those specified above|1|||
145647340|NCT00632749|525224536|FG005|Overall Study|Reason other than those specified above|0|||
145647341|NCT00632749|525224537|FG006|Overall Study|Reason other than those specified above|1|||
145647342|NCT00632749|525224538|FG007|Overall Study|Reason other than those specified above|0|||
145486795|NCT01790594|524636783|FG002|Overall Study|Death|0|||
145486796|NCT01790594|524636781|FG000|Overall Study|Physician Decision|2|||
145486797|NCT01790594|524636782|FG001|Overall Study|Physician Decision|1|||
145486798|NCT01790594|524636783|FG002|Overall Study|Physician Decision|0|||
145486799|NCT01790594|524636781|FG000|Overall Study|Withdrawal by Subject|2|||
145486800|NCT01790594|524636782|FG001|Overall Study|Withdrawal by Subject|0|||
145647343|NCT00632749|525224539|FG008|Overall Study|Reason other than those specified above|0|||
145647344|NCT00632749|525224540|FG009|Overall Study|Reason other than those specified above|0|||
145647345|NCT00632749|525224541|FG010|Overall Study|Reason other than those specified above|2|||
145647346|NCT00632749|525224542|FG011|Overall Study|Reason other than those specified above|1|||
145647347|NCT00632749|525224543|FG012|Overall Study|Reason other than those specified above|0|||
145647348|NCT00632749|525224544|FG013|Overall Study|Reason other than those specified above|2|||
145647349|NCT03210714|525224545|FG000|Overall Study|Adverse Event|6|||
145647350|NCT03210714|525224545|FG000|Overall Study|Physician Decision|1|||
145647351|NCT03210714|525224545|FG000|Overall Study|Progressive disease|11|||
145647352|NCT03210714|525224545|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
145647353|NCT00879333|525224546|FG000|Overall Study|Adverse Event|94|||
145647354|NCT00879333|525224547|FG001|Overall Study|Adverse Event|34|||
145647355|NCT00879333|525224546|FG000|Overall Study|Abnormal Laboratory Value|1|||
145647356|NCT00879333|525224547|FG001|Overall Study|Abnormal Laboratory Value|0|||
145647357|NCT00879333|525224546|FG000|Overall Study|Withdrawal by Subject|20|||
145647358|NCT00879333|525224547|FG001|Overall Study|Withdrawal by Subject|7|||
145647359|NCT00879333|525224546|FG000|Overall Study|Lost to Follow-up|2|||
145647360|NCT00879333|525224547|FG001|Overall Study|Lost to Follow-up|1|||
145647361|NCT00879333|525224546|FG000|Overall Study|Administrative Problems|2|||
145647362|NCT00879333|525224547|FG001|Overall Study|Administrative Problems|0|||
145647363|NCT00879333|525224546|FG000|Overall Study|Death|16|||
145647364|NCT00879333|525224547|FG001|Overall Study|Death|5|||
145647365|NCT00879333|525224546|FG000|Overall Study|Disease Progression|292|||
145647366|NCT00879333|525224547|FG001|Overall Study|Disease Progression|169|||
145486801|NCT01790594|524636783|FG002|Overall Study|Withdrawal by Subject|0|||
145486802|NCT01790594|524636781|FG000|Overall Study|Transplant was not done|0|||
145486803|NCT01790594|524636782|FG001|Overall Study|Transplant was not done|0|||
145486804|NCT01790594|524636783|FG002|Overall Study|Transplant was not done|3|||
145486805|NCT01790594|524636781|FG000|Overall Study|Terminated prior to week 76|0|||
145486806|NCT01790594|524636782|FG001|Overall Study|Terminated prior to week 76|2|||
145486807|NCT01790594|524636783|FG002|Overall Study|Terminated prior to week 76|0|||
145486808|NCT01132807|524636784|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
145486809|NCT01132807|524636785|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
145486810|NCT01132807|524636786|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
145486811|NCT01132807|524636784|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
145486812|NCT01132807|524636785|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
145486813|NCT01132807|524636786|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
145647367|NCT00879333|525224546|FG000|Overall Study|Protocol Violation|1|||
145647368|NCT00879333|525224547|FG001|Overall Study|Protocol Violation|1|||
145647369|NCT02671435|525224555|FG000|Overall Study|Death|1|||
145647370|NCT02671435|525224556|FG001|Overall Study|Death|3|||
145647371|NCT02671435|525224557|FG002|Overall Study|Death|0|||
145647372|NCT02671435|525224558|FG003|Overall Study|Death|16|||
145647373|NCT02671435|525224559|FG004|Overall Study|Death|14|||
145647374|NCT02671435|525224560|FG005|Overall Study|Death|29|||
145647375|NCT02671435|525224561|FG006|Overall Study|Death|34|||
145647376|NCT02671435|525224562|FG007|Overall Study|Death|28|||
145647377|NCT02671435|525224563|FG008|Overall Study|Death|19|||
145647378|NCT02671435|525224564|FG009|Overall Study|Death|10|||
145647379|NCT02671435|525224565|FG010|Overall Study|Death|8|||
145647380|NCT02671435|525224566|FG011|Overall Study|Death|29|||
145647381|NCT02671435|525224567|FG012|Overall Study|Death|29|||
145647382|NCT02671435|525224568|FG013|Overall Study|Death|29|||
145647383|NCT02671435|525224569|FG014|Overall Study|Death|27|||
145647384|NCT02671435|525224555|FG000|Overall Study|Lost to Follow-up|0|||
145647385|NCT02671435|525224556|FG001|Overall Study|Lost to Follow-up|0|||
145647386|NCT02671435|525224557|FG002|Overall Study|Lost to Follow-up|1|||
145647387|NCT02671435|525224558|FG003|Overall Study|Lost to Follow-up|0|||
145647388|NCT02671435|525224559|FG004|Overall Study|Lost to Follow-up|1|||
145647389|NCT02671435|525224560|FG005|Overall Study|Lost to Follow-up|1|||
145486814|NCT02222558|524636787|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
145486815|NCT02222558|524636788|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
145647390|NCT02671435|525224561|FG006|Overall Study|Lost to Follow-up|2|||
145647391|NCT02671435|525224562|FG007|Overall Study|Lost to Follow-up|2|||
145647392|NCT02671435|525224563|FG008|Overall Study|Lost to Follow-up|0|||
145486816|NCT02222558|524636789|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
145486817|NCT02222558|524636790|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
145486818|NCT02222558|524636791|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
145486819|NCT02222558|524636792|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
145647393|NCT02671435|525224564|FG009|Overall Study|Lost to Follow-up|2|||
145647394|NCT02671435|525224565|FG010|Overall Study|Lost to Follow-up|0|||
145647395|NCT02671435|525224566|FG011|Overall Study|Lost to Follow-up|3|||
145647396|NCT02671435|525224567|FG012|Overall Study|Lost to Follow-up|3|||
145647397|NCT02671435|525224568|FG013|Overall Study|Lost to Follow-up|2|||
145647398|NCT02671435|525224569|FG014|Overall Study|Lost to Follow-up|0|||
145647399|NCT02671435|525224555|FG000|Overall Study|Withdrawal by Subject|2|||
145647400|NCT02671435|525224556|FG001|Overall Study|Withdrawal by Subject|0|||
145647401|NCT02671435|525224557|FG002|Overall Study|Withdrawal by Subject|2|||
145647402|NCT02671435|525224558|FG003|Overall Study|Withdrawal by Subject|2|||
145647403|NCT02671435|525224559|FG004|Overall Study|Withdrawal by Subject|2|||
145647404|NCT02671435|525224560|FG005|Overall Study|Withdrawal by Subject|7|||
145647405|NCT02671435|525224561|FG006|Overall Study|Withdrawal by Subject|2|||
145647406|NCT02671435|525224562|FG007|Overall Study|Withdrawal by Subject|7|||
145647407|NCT02671435|525224563|FG008|Overall Study|Withdrawal by Subject|1|||
145647408|NCT02671435|525224564|FG009|Overall Study|Withdrawal by Subject|1|||
145647409|NCT02671435|525224565|FG010|Overall Study|Withdrawal by Subject|2|||
145647410|NCT02671435|525224566|FG011|Overall Study|Withdrawal by Subject|4|||
145647411|NCT02671435|525224567|FG012|Overall Study|Withdrawal by Subject|4|||
145647412|NCT02671435|525224568|FG013|Overall Study|Withdrawal by Subject|4|||
145647413|NCT02671435|525224569|FG014|Overall Study|Withdrawal by Subject|2|||
145647414|NCT02671435|525224555|FG000|Overall Study|Un-specified|0|||
145647415|NCT02671435|525224556|FG001|Overall Study|Un-specified|0|||
145647416|NCT02671435|525224557|FG002|Overall Study|Un-specified|0|||
145647417|NCT02671435|525224558|FG003|Overall Study|Un-specified|0|||
145647418|NCT02671435|525224559|FG004|Overall Study|Un-specified|1|||
145647419|NCT02671435|525224560|FG005|Overall Study|Un-specified|3|||
145647420|NCT02671435|525224561|FG006|Overall Study|Un-specified|2|||
145647421|NCT02671435|525224562|FG007|Overall Study|Un-specified|3|||
145647422|NCT02671435|525224563|FG008|Overall Study|Un-specified|0|||
145647423|NCT02671435|525224564|FG009|Overall Study|Un-specified|5|||
145647424|NCT02671435|525224565|FG010|Overall Study|Un-specified|8|||
145647425|NCT02671435|525224566|FG011|Overall Study|Un-specified|4|||
145647426|NCT02671435|525224567|FG012|Overall Study|Un-specified|5|||
145647427|NCT02671435|525224568|FG013|Overall Study|Un-specified|9|||
145647428|NCT02671435|525224569|FG014|Overall Study|Un-specified|8|||
145647429|NCT03432858|525224570|FG000|Overall Study|Protocol Violation|2|||
145647430|NCT03432858|525224571|FG001|Overall Study|Protocol Violation|1|||
145647431|NCT03432858|525224572|FG002|Overall Study|Protocol Violation|9|||
145647432|NCT03432858|525224570|FG000|Overall Study|Withdrawal by Subject|0|||
145647433|NCT03432858|525224571|FG001|Overall Study|Withdrawal by Subject|1|||
145647434|NCT03432858|525224572|FG002|Overall Study|Withdrawal by Subject|1|||
145647435|NCT03432858|525224570|FG000|Overall Study|Procedure canceled/rescheduled|0|||
145647436|NCT03432858|525224571|FG001|Overall Study|Procedure canceled/rescheduled|9|||
145647437|NCT03432858|525224572|FG002|Overall Study|Procedure canceled/rescheduled|6|||
145647438|NCT03432858|525224570|FG000|Overall Study|Required postop mobilization with splinting|0|||
145647439|NCT03432858|525224571|FG001|Overall Study|Required postop mobilization with splinting|0|||
145647440|NCT03432858|525224572|FG002|Overall Study|Required postop mobilization with splinting|1|||
145647441|NCT01424670|525224573|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
145647442|NCT01424670|525224574|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
145647443|NCT01424670|525224573|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
145647444|NCT01424670|525224574|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
145647445|NCT01424670|525224573|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
145647446|NCT01424670|525224574|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
145647447|NCT01424670|525224573|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
145647448|NCT01424670|525224574|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
145647449|NCT01424670|525224573|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
145647450|NCT01424670|525224574|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
145647451|NCT01424670|525224573|FG000|Continuation Period|Adverse Event|13|||
145486820|NCT02222558|524636787|FG000|Period 3|Withdrawal by Subject|0|||
145647452|NCT01424670|525224574|FG001|Continuation Period|Adverse Event|5|||
145647453|NCT01424670|525224573|FG000|Continuation Period|Lost to Follow-up|2|||
145647454|NCT01424670|525224574|FG001|Continuation Period|Lost to Follow-up|0|||
145647455|NCT01424670|525224573|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
145647456|NCT01424670|525224574|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
145647457|NCT01424670|525224573|FG000|Continuation Period|Physician Decision|5|||
145647458|NCT01424670|525224574|FG001|Continuation Period|Physician Decision|4|||
145647459|NCT01424670|525224573|FG000|Continuation Period|Withdrawal by Subject|13|||
145647460|NCT01424670|525224574|FG001|Continuation Period|Withdrawal by Subject|4|||
145647461|NCT00761189|525224575|FG000|Overall Study|Adverse Event|42|||
145647462|NCT00761189|525224575|FG000|Overall Study|Lack of Efficacy|45|||
145647463|NCT00761189|525224575|FG000|Overall Study|Lost to Follow-up|36|||
145647464|NCT00761189|525224575|FG000|Overall Study|Withdrawal by Subject|49|||
145647465|NCT00761189|525224575|FG000|Overall Study|Other|13|||
145647466|NCT01494922|525224576|FG000|Overall Study|Adverse Event|1|||
145647467|NCT03988842|525224577|FG000|Overall Study|Death|1|||
145647468|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
145647469|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
145647470|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
145647471|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
145647472|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
145647473|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
145647474|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
145647475|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
145647476|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
145647477|NCT03939312|525224579|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
145647478|NCT03939312|525224579|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
145647479|NCT03939312|525224579|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
145647480|NCT02119650|525224580|FG000|Overall Study|Adverse Event|3|||
145647481|NCT02119650|525224581|FG001|Overall Study|Adverse Event|4|||
145647482|NCT02119650|525224580|FG000|Overall Study|Subject decision|2|||
145647483|NCT02119650|525224581|FG001|Overall Study|Subject decision|3|||
145647484|NCT02119650|525224580|FG000|Overall Study|Disease progression|11|||
145647485|NCT02119650|525224581|FG001|Overall Study|Disease progression|14|||
145647486|NCT02119650|525224580|FG000|Overall Study|Death|5|||
145647487|NCT02119650|525224581|FG001|Overall Study|Death|1|||
145647488|NCT02119650|525224580|FG000|Overall Study|Noncompliance with study treatment|1|||
145647489|NCT02119650|525224581|FG001|Overall Study|Noncompliance with study treatment|1|||
145647490|NCT02119650|525224580|FG000|Overall Study|Study terminated by the sponsor|1|||
145647491|NCT02119650|525224581|FG001|Overall Study|Study terminated by the sponsor|0|||
145647492|NCT02119650|525224580|FG000|Overall Study|Physician Decision|0|||
145647493|NCT02119650|525224581|FG001|Overall Study|Physician Decision|2|||
145647494|NCT02119650|525224580|FG000|Overall Study|Multiple reasons for termination|2|||
145647495|NCT02119650|525224581|FG001|Overall Study|Multiple reasons for termination|1|||
145647496|NCT02730871|525224582|FG000|Overall Study|Adverse Event|6|||
145647497|NCT02730871|525224583|FG001|Overall Study|Adverse Event|0|||
145647498|NCT01303445|525224586|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
145647499|NCT01303445|525224587|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
145647500|NCT01303445|525224586|FG000|Second Intervention (7 Days)|Adverse Event|0|||
145647501|NCT01303445|525224587|FG001|Second Intervention (7 Days)|Adverse Event|2|||
145647502|NCT01303445|525224586|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
145647503|NCT01303445|525224587|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
145647504|NCT01303445|525224586|FG000|Washout (14 Days)|Protocol Violation|1|||
145647505|NCT01303445|525224587|FG001|Washout (14 Days)|Protocol Violation|0|||
145647506|NCT01303445|525224586|FG000|Washout (14 Days)|Lost to Follow-up|0|||
145647507|NCT01303445|525224587|FG001|Washout (14 Days)|Lost to Follow-up|2|||
145647508|NCT01303445|525224586|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
145647509|NCT01303445|525224587|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
145647510|NCT01303445|525224586|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
145647511|NCT01303445|525224587|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
145647512|NCT03690206|525224588|FG000|Overall Study|Withdrawal by Subject|2|||
145647513|NCT03690206|525224589|FG001|Overall Study|Withdrawal by Subject|0|||
145647514|NCT03690206|525224590|FG002|Overall Study|Withdrawal by Subject|0|||
145647515|NCT03690206|525224588|FG000|Overall Study|ICF withdrawal|2|||
145647516|NCT03690206|525224589|FG001|Overall Study|ICF withdrawal|0|||
145647517|NCT03690206|525224590|FG002|Overall Study|ICF withdrawal|0|||
145486821|NCT02222558|524636788|FG001|Period 3|Withdrawal by Subject|0|||
145647518|NCT03978637|525224593|FG000|Overall Study|Death|0|||
145647519|NCT03978637|525224594|FG001|Overall Study|Death|2|||
145486822|NCT02222558|524636789|FG002|Period 3|Withdrawal by Subject|0|||
145647520|NCT03978637|525224595|FG002|Overall Study|Death|2|||
145647521|NCT03978637|525224596|FG003|Overall Study|Death|0|||
145647522|NCT03978637|525224593|FG000|Overall Study|Withdrawal by Subject|0|||
145647523|NCT03978637|525224594|FG001|Overall Study|Withdrawal by Subject|0|||
145647524|NCT03978637|525224595|FG002|Overall Study|Withdrawal by Subject|1|||
145647525|NCT03978637|525224596|FG003|Overall Study|Withdrawal by Subject|0|||
145486823|NCT02222558|524636790|FG003|Period 3|Withdrawal by Subject|0|||
145486824|NCT02222558|524636791|FG004|Period 3|Withdrawal by Subject|0|||
145647526|NCT03978637|525224593|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
145647527|NCT03978637|525224594|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
145486825|NCT02222558|524636792|FG005|Period 3|Withdrawal by Subject|1|||
145647528|NCT03978637|525224595|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
145647529|NCT03978637|525224596|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
145647530|NCT04924062|525226418|FG000|Overall Study|Death|49|||
145647531|NCT04924062|525226419|FG001|Overall Study|Death|63|||
145647532|NCT04924062|525226418|FG000|Overall Study|Participant On-going|26|||
145647533|NCT04924062|525226419|FG001|Overall Study|Participant On-going|20|||
145647534|NCT03899961|525226420|FG000|Overall Study|-delivery prior to|2|||
145647535|NCT03899961|525226421|FG001|Overall Study|-delivery prior to|7|||
145647536|NCT03899961|525226420|FG000|Overall Study|req general anesth|1|||
145647537|NCT03899961|525226421|FG001|Overall Study|req general anesth|2|||
145647538|NCT03899961|525226420|FG000|Overall Study|capacity|5|||
145647539|NCT03899961|525226421|FG001|Overall Study|capacity|6|||
145647540|NCT03899961|525226420|FG000|Overall Study|Withdrawal by Subject|1|||
145647541|NCT03899961|525226421|FG001|Overall Study|Withdrawal by Subject|1|||
145647542|NCT04059354|525226428|FG000|Overall Study|COVID-19 pandemic|3|||
145647543|NCT02396199|525226430|FG000|Overall Study|Lost to Follow-up|1|||
145647544|NCT02396199|525226430|FG000|Overall Study|Death|4|||
145647545|NCT04093362|525226431|FG000|Overall Study|Study Termination|1|||
145647546|NCT04093362|525226432|FG001|Overall Study|Study Termination|1|||
145647547|NCT04093362|525226431|FG000|Overall Study|Withdrawal of Consent|1|||
145647548|NCT04093362|525226432|FG001|Overall Study|Withdrawal of Consent|0|||
145647549|NCT04093362|525226431|FG000|Overall Study|Death|1|||
145647550|NCT04093362|525226432|FG001|Overall Study|Death|3|||
145647551|NCT04093362|525226431|FG000|Overall Study|Reason not Specified|1|||
145647552|NCT04093362|525226432|FG001|Overall Study|Reason not Specified|2|||
145647553|NCT04905407|525226450|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
145647554|NCT04905407|525226451|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
145647555|NCT04905407|525226452|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
145647556|NCT04905407|525226453|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
145647557|NCT04905407|525226450|FG000|Part 1 and Part 2|Death|7|||
145647558|NCT04905407|525226451|FG001|Part 1 and Part 2|Death|7|||
145647559|NCT04905407|525226452|FG002|Part 1 and Part 2|Death|7|||
145647560|NCT04905407|525226453|FG003|Part 1 and Part 2|Death|0|||
145647561|NCT04905407|525226450|FG000|Part 1 and Part 2|Other than specified|0|||
145647562|NCT04905407|525226451|FG001|Part 1 and Part 2|Other than specified|0|||
145647563|NCT04905407|525226452|FG002|Part 1 and Part 2|Other than specified|1|||
145647564|NCT04905407|525226453|FG003|Part 1 and Part 2|Other than specified|0|||
145647565|NCT04905407|525226450|FG000|Part 3|Death|0|||
145647566|NCT04905407|525226451|FG001|Part 3|Death|0|||
145647567|NCT04905407|525226452|FG002|Part 3|Death|0|||
145647568|NCT04905407|525226453|FG003|Part 3|Death|2|||
145647569|NCT01938547|525226456|FG000|Overall Study|Physician Decision|1|||
145647570|NCT04823611|525226459|FG000|Overall Study|Adverse Event|2|||
145647571|NCT04823611|525226460|FG001|Overall Study|Adverse Event|0|||
145647572|NCT04823611|525226461|FG002|Overall Study|Adverse Event|1|||
145647573|NCT04823611|525226462|FG003|Overall Study|Adverse Event|0|||
145647574|NCT04823611|525226463|FG004|Overall Study|Adverse Event|0|||
145647575|NCT04823611|525226464|FG005|Overall Study|Adverse Event|0|||
145647576|NCT04823611|525226465|FG006|Overall Study|Adverse Event|0|||
145647577|NCT03739996|525226471|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
145647578|NCT03739996|525226471|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
145647579|NCT03739996|525226471|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
145647580|NCT03739996|525226471|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
145647581|NCT03739996|525226471|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
145647582|NCT03739996|525226471|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
145647583|NCT03739996|525226471|FG000|Step 3 (SOC ART)|Death|1|||
145647584|NCT03739996|525226471|FG000|Step 3 (SOC ART)|Participant moved|1|||
145647585|NCT04716634|525226472|FG000|Overall Study|Death|24|||
145647586|NCT04716634|525226473|FG001|Overall Study|Death|24|||
145647587|NCT04716634|525226474|FG002|Overall Study|Death|8|||
145647588|NCT04716634|525226472|FG000|Overall Study|Closed by Sponsor|4|||
145647589|NCT04716634|525226473|FG001|Overall Study|Closed by Sponsor|4|||
145647590|NCT04716634|525226474|FG002|Overall Study|Closed by Sponsor|5|||
145647591|NCT04716634|525226472|FG000|Overall Study|Lost to Follow-up|1|||
145647592|NCT04716634|525226473|FG001|Overall Study|Lost to Follow-up|0|||
145647593|NCT04716634|525226474|FG002|Overall Study|Lost to Follow-up|1|||
145647594|NCT04716634|525226472|FG000|Overall Study|Withdrawal by Subject|0|||
145647595|NCT04716634|525226473|FG001|Overall Study|Withdrawal by Subject|0|||
145647596|NCT04716634|525226474|FG002|Overall Study|Withdrawal by Subject|1|||
145647597|NCT01673984|525226478|FG000|Overall Study|Adverse Event|1|||
145647598|NCT01673984|525226479|FG001|Overall Study|Adverse Event|0|||
145647599|NCT01673984|525226478|FG000|Overall Study|Study termination|9|||
145647600|NCT01673984|525226479|FG001|Overall Study|Study termination|6|||
145647601|NCT00150813|525226480|FG000|Overall Study|Adverse Event|1|||
145647602|NCT00150813|525226480|FG000|Overall Study|Lack of Efficacy|1|||
145647603|NCT00150813|525226480|FG000|Overall Study|Lost to Follow-up|5|||
145647604|NCT00150813|525226480|FG000|Overall Study|Withdrawal by Subject|5|||
145647605|NCT00150813|525226480|FG000|Overall Study|Remission|3|||
145647606|NCT00150813|525226480|FG000|Overall Study|Planned pregancy|1|||
145486826|NCT02322281|524636793|FG000|Overall Study|Progressive Disease|42|||
145486827|NCT02322281|524636794|FG001|Overall Study|Progressive Disease|14|||
145486828|NCT02322281|524636795|FG002|Overall Study|Progressive Disease|49|||
145486829|NCT02322281|524636793|FG000|Overall Study|Adverse Event|3|||
145486830|NCT02322281|524636794|FG001|Overall Study|Adverse Event|4|||
145486831|NCT02322281|524636795|FG002|Overall Study|Adverse Event|6|||
145647607|NCT00150813|525226480|FG000|Overall Study|Switch to commercially available LEV|2|||
145647608|NCT01820260|525226482|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647609|NCT01820260|525226483|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647610|NCT01820260|525226484|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647611|NCT01820260|525226485|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647612|NCT01820260|525226486|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647613|NCT01820260|525226487|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647614|NCT01820260|525226488|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
145647615|NCT01820260|525226489|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647616|NCT01820260|525226490|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647617|NCT01820260|525226491|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647618|NCT01820260|525226492|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647619|NCT01820260|525226493|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647620|NCT01820260|525226494|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647621|NCT01820260|525226495|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
145647622|NCT01820260|525226482|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647623|NCT01820260|525226483|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647624|NCT01820260|525226484|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647625|NCT01820260|525226485|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647626|NCT01820260|525226486|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647627|NCT01820260|525226487|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647628|NCT01820260|525226488|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647629|NCT01820260|525226489|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647630|NCT01820260|525226490|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647631|NCT01820260|525226491|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
145647632|NCT01820260|525226492|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647633|NCT01820260|525226493|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647634|NCT01820260|525226494|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647635|NCT01820260|525226495|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
145647636|NCT05415410|525226496|FG000|Overall Study|Death|3|||
145647637|NCT05415410|525226497|FG001|Overall Study|Death|6|||
145647638|NCT05415410|525226498|FG002|Overall Study|Death|1|||
145647639|NCT05415410|525226496|FG000|Overall Study|Trial Terminated by Sponsor|1|||
145647640|NCT05415410|525226497|FG001|Overall Study|Trial Terminated by Sponsor|5|||
145647641|NCT05415410|525226498|FG002|Overall Study|Trial Terminated by Sponsor|0|||
145647642|NCT05415410|525226496|FG000|Overall Study|Adverse Event|2|||
145647643|NCT05415410|525226497|FG001|Overall Study|Adverse Event|1|||
145647644|NCT05415410|525226498|FG002|Overall Study|Adverse Event|0|||
145647645|NCT05415410|525226496|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
145647646|NCT05415410|525226497|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
145647647|NCT05415410|525226498|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
145647648|NCT05415410|525226496|FG000|Overall Study|Withdrawal by Subject|1|||
145647649|NCT05415410|525226497|FG001|Overall Study|Withdrawal by Subject|0|||
145647650|NCT05415410|525226498|FG002|Overall Study|Withdrawal by Subject|0|||
145647651|NCT05415410|525226496|FG000|Overall Study|Pregnancy|5|||
145647652|NCT05415410|525226497|FG001|Overall Study|Pregnancy|2|||
145647653|NCT05415410|525226498|FG002|Overall Study|Pregnancy|0|||
145647654|NCT02365766|525226502|FG000|Overall Study|Withdrawal by Subject|0|||
145647655|NCT02365766|525226503|FG001|Overall Study|Withdrawal by Subject|0|||
145647656|NCT02365766|525226504|FG002|Overall Study|Withdrawal by Subject|1|||
145647657|NCT02365766|525226502|FG000|Overall Study|Eligibility Criteria Not Met|0|||
145647658|NCT02365766|525226503|FG001|Overall Study|Eligibility Criteria Not Met|0|||
145647659|NCT02365766|525226504|FG002|Overall Study|Eligibility Criteria Not Met|1|||
145647660|NCT02919449|525226508|FG000|Overall Study|Withdrawal by Subject|1|||
145647661|NCT02919449|525226508|FG000|Overall Study|Investigator decision|1|||
145647662|NCT04711135|525226509|FG000|Overall Study|Physician Decision|0|||
145647663|NCT04711135|525226510|FG001|Overall Study|Physician Decision|1|||
145647664|NCT04711135|525226509|FG000|Overall Study|Ongoing treatment|0|||
145647665|NCT04711135|525226510|FG001|Overall Study|Ongoing treatment|1|||
145647666|NCT03578536|525226512|FG000|Overall Study|Lost to Follow-up|1|||
145647667|NCT02874534|525226514|FG000|Overall Study|Withdrawal by Subject|5|||
145486832|NCT02322281|524636793|FG000|Overall Study|Death|3|||
145486833|NCT02322281|524636794|FG001|Overall Study|Death|3|||
145486834|NCT02322281|524636795|FG002|Overall Study|Death|3|||
145486835|NCT02322281|524636793|FG000|Overall Study|Withdrawal by Subject|1|||
145647668|NCT02874534|525226515|FG001|Overall Study|Withdrawal by Subject|8|||
145647669|NCT02874534|525226514|FG000|Overall Study|Lost to Follow-up|2|||
145647670|NCT02874534|525226515|FG001|Overall Study|Lost to Follow-up|2|||
145647671|NCT02874534|525226514|FG000|Overall Study|Ongoing in study|1|||
145647672|NCT02874534|525226515|FG001|Overall Study|Ongoing in study|1|||
145647673|NCT04431726|525226516|FG000|Overall Study|Ongoing in the Study|55|||
145647674|NCT05198310|525226517|FG000|Overall Study|Lost to Follow-up|0|||
145647675|NCT05198310|525226518|FG001|Overall Study|Lost to Follow-up|1|||
145647676|NCT05198310|525226519|FG002|Overall Study|Lost to Follow-up|0|||
145647677|NCT05198310|525226520|FG003|Overall Study|Lost to Follow-up|0|||
145647678|NCT05198310|525226521|FG004|Overall Study|Lost to Follow-up|0|||
145647679|NCT05198310|525226522|FG005|Overall Study|Lost to Follow-up|0|||
145647680|NCT05198310|525226523|FG006|Overall Study|Lost to Follow-up|0|||
145486836|NCT02322281|524636794|FG001|Overall Study|Withdrawal by Subject|1|||
145486837|NCT02322281|524636795|FG002|Overall Study|Withdrawal by Subject|6|||
145486838|NCT02322281|524636793|FG000|Overall Study|Physician Decision|2|||
145486839|NCT02322281|524636794|FG001|Overall Study|Physician Decision|0|||
145486840|NCT02322281|524636795|FG002|Overall Study|Physician Decision|5|||
145486841|NCT02322281|524636793|FG000|Overall Study|Study Terminated by Sponsor|2|||
145647681|NCT05198310|525226524|FG007|Overall Study|Lost to Follow-up|0|||
145647682|NCT05198310|525226517|FG000|Overall Study|Withdrawal by Subject|0|||
145647683|NCT05198310|525226518|FG001|Overall Study|Withdrawal by Subject|0|||
145647684|NCT05198310|525226519|FG002|Overall Study|Withdrawal by Subject|0|||
145647685|NCT05198310|525226520|FG003|Overall Study|Withdrawal by Subject|2|||
145647686|NCT05198310|525226521|FG004|Overall Study|Withdrawal by Subject|0|||
145647687|NCT05198310|525226522|FG005|Overall Study|Withdrawal by Subject|2|||
145647688|NCT05198310|525226523|FG006|Overall Study|Withdrawal by Subject|1|||
145647689|NCT05198310|525226524|FG007|Overall Study|Withdrawal by Subject|3|||
145647690|NCT04281485|525226525|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
145647691|NCT04281485|525226526|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
145647692|NCT04281485|525226525|FG000|Overall Study|Ongoing (Safety data collection)|10|||
145647693|NCT04281485|525226526|FG001|Overall Study|Ongoing (Safety data collection)|5|||
145647694|NCT04436107|525226527|FG000|Overall Study|Sponsor Ended Study|2|||
145647695|NCT04436107|525226528|FG001|Overall Study|Sponsor Ended Study|4|||
145647696|NCT04436107|525226529|FG002|Overall Study|Sponsor Ended Study|8|||
145647697|NCT04436107|525226530|FG003|Overall Study|Sponsor Ended Study|20|||
145647698|NCT04436107|525226527|FG000|Overall Study|Death|3|||
145647699|NCT04436107|525226528|FG001|Overall Study|Death|5|||
145647700|NCT04436107|525226529|FG002|Overall Study|Death|3|||
145647701|NCT04436107|525226530|FG003|Overall Study|Death|18|||
145647702|NCT04436107|525226527|FG000|Overall Study|Withdrawal by Subject|1|||
145647703|NCT04436107|525226528|FG001|Overall Study|Withdrawal by Subject|1|||
145647704|NCT04436107|525226529|FG002|Overall Study|Withdrawal by Subject|0|||
145647705|NCT04436107|525226530|FG003|Overall Study|Withdrawal by Subject|1|||
145647706|NCT01095796|525226531|FG000|Overall Study|Randomized but Not Treated|5|||
145647707|NCT01095796|525226532|FG001|Overall Study|Randomized but Not Treated|2|||
145647708|NCT01095796|525226531|FG000|Overall Study|Adverse Event|9|||
145647709|NCT01095796|525226532|FG001|Overall Study|Adverse Event|19|||
145647710|NCT01095796|525226531|FG000|Overall Study|Death|3|||
145647711|NCT01095796|525226532|FG001|Overall Study|Death|2|||
145647712|NCT01095796|525226531|FG000|Overall Study|Pregnancy|2|||
145647713|NCT01095796|525226532|FG001|Overall Study|Pregnancy|0|||
145647714|NCT01095796|525226531|FG000|Overall Study|Lack of Efficacy|5|||
145647715|NCT01095796|525226532|FG001|Overall Study|Lack of Efficacy|3|||
145647716|NCT01095796|525226531|FG000|Overall Study|Investigator's Discretion|7|||
145647717|NCT01095796|525226532|FG001|Overall Study|Investigator's Discretion|2|||
145647718|NCT01095796|525226531|FG000|Overall Study|Withdrew Consent|16|||
145647719|NCT01095796|525226532|FG001|Overall Study|Withdrew Consent|22|||
145647720|NCT01095796|525226531|FG000|Overall Study|Lost to Follow-up|27|||
145647721|NCT01095796|525226532|FG001|Overall Study|Lost to Follow-up|29|||
145647722|NCT01095796|525226531|FG000|Overall Study|Participant Noncompliance|5|||
145647723|NCT01095796|525226532|FG001|Overall Study|Participant Noncompliance|10|||
145647724|NCT01095796|525226531|FG000|Overall Study|Protocol Violation|1|||
145647725|NCT01095796|525226532|FG001|Overall Study|Protocol Violation|0|||
145647726|NCT01095796|525226531|FG000|Overall Study|Participant Transferred to Another Study|215|||
145647727|NCT01095796|525226532|FG001|Overall Study|Participant Transferred to Another Study|200|||
145647728|NCT01989455|525226537|FG000|Overall Study|Adverse Event|0|||
145647729|NCT01989455|525226538|FG001|Overall Study|Adverse Event|1|||
145647730|NCT01989455|525226539|FG002|Overall Study|Adverse Event|0|||
145647731|NCT01989455|525226540|FG003|Overall Study|Adverse Event|0|||
145647732|NCT01989455|525226541|FG004|Overall Study|Adverse Event|0|||
145647733|NCT01989455|525226537|FG000|Overall Study|Withdrawal by Subject|0|||
145647734|NCT01989455|525226538|FG001|Overall Study|Withdrawal by Subject|1|||
145486842|NCT02322281|524636794|FG001|Overall Study|Study Terminated by Sponsor|0|||
145486843|NCT02322281|524636795|FG002|Overall Study|Study Terminated by Sponsor|0|||
145647735|NCT01989455|525226539|FG002|Overall Study|Withdrawal by Subject|0|||
145647736|NCT01989455|525226540|FG003|Overall Study|Withdrawal by Subject|0|||
145486844|NCT02322281|524636793|FG000|Overall Study|Missing|0|||
145486845|NCT02322281|524636794|FG001|Overall Study|Missing|0|||
145486846|NCT02322281|524636795|FG002|Overall Study|Missing|1|||
145486847|NCT02322281|524636793|FG000|Overall Study|Miscellaneous|0|||
145486848|NCT02322281|524636794|FG001|Overall Study|Miscellaneous|0|||
145486849|NCT02322281|524636795|FG002|Overall Study|Miscellaneous|4|||
145486850|NCT01285401|524636796|FG000|Overall Study|Prematurely withdrawn from the study|17|||
145647737|NCT01989455|525226541|FG004|Overall Study|Withdrawal by Subject|0|||
145647738|NCT01989455|525226537|FG000|Overall Study|Technical problems with infusion|0|||
145647739|NCT01989455|525226538|FG001|Overall Study|Technical problems with infusion|0|||
145647740|NCT01989455|525226539|FG002|Overall Study|Technical problems with infusion|1|||
145647741|NCT01989455|525226540|FG003|Overall Study|Technical problems with infusion|0|||
145647742|NCT01989455|525226541|FG004|Overall Study|Technical problems with infusion|1|||
145647743|NCT00448669|525226542|FG000|Overall Study|Lost to Follow-up|52|||
145647744|NCT00448669|525226543|FG001|Overall Study|Lost to Follow-up|63|||
145647745|NCT00448669|525226542|FG000|Overall Study|Withdrawal by Subject|90|||
145647746|NCT00448669|525226543|FG001|Overall Study|Withdrawal by Subject|74|||
145647747|NCT00448669|525226542|FG000|Overall Study|Relocated|49|||
145647748|NCT00448669|525226543|FG001|Overall Study|Relocated|36|||
145647749|NCT00448669|525226542|FG000|Overall Study|Were withdrawn by investigator|10|||
145647750|NCT00448669|525226543|FG001|Overall Study|Were withdrawn by investigator|6|||
145647751|NCT00448669|525226542|FG000|Overall Study|Death|2|||
145647752|NCT00448669|525226543|FG001|Overall Study|Death|4|||
145647753|NCT00448669|525226542|FG000|Overall Study|Had other reasons|5|||
145647754|NCT00448669|525226543|FG001|Overall Study|Had other reasons|6|||
145647755|NCT00448669|525226542|FG000|Overall Study|HIV-infected at enrollment|1|||
145647756|NCT00448669|525226543|FG001|Overall Study|HIV-infected at enrollment|2|||
145647757|NCT00448669|525226542|FG000|Overall Study|Never started drug|9|||
145647758|NCT00448669|525226543|FG001|Overall Study|Never started drug|7|||
145647759|NCT04116736|525226544|FG000|Overall Study|Withdrew consent during study|3|||
145647760|NCT04116736|525226545|FG001|Overall Study|Withdrew consent during study|1|||
145647761|NCT04116736|525226544|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
145647762|NCT04116736|525226545|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
145647763|NCT04116736|525226544|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
145647764|NCT04116736|525226545|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
145647765|NCT04116736|525226544|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
145647766|NCT04116736|525226545|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
145647767|NCT04116736|525226544|FG000|Overall Study|Subject was enrolled in error|2|||
145647768|NCT04116736|525226545|FG001|Overall Study|Subject was enrolled in error|0|||
145647769|NCT04116736|525226544|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
145647770|NCT04116736|525226545|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
145647771|NCT04116736|525226544|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
145647772|NCT04116736|525226545|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
145647773|NCT04116736|525226544|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
145647774|NCT04116736|525226545|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
145647775|NCT00274469|525226546|FG000|Overall Study|Death|63|||
145647776|NCT00274469|525226547|FG001|Overall Study|Death|74|||
145647777|NCT00274469|525226546|FG000|Overall Study|Did not consent to OS follow-up|16|||
145647778|NCT00274469|525226547|FG001|Overall Study|Did not consent to OS follow-up|19|||
145647779|NCT05512962|525226548|FG000|Overall Study|Withdrawal by Subject|1|||
145647780|NCT05512962|525226549|FG001|Overall Study|Withdrawal by Subject|0|||
145647781|NCT03517969|525226550|FG000|Overall Study|Never started protocol treatment|3|||
145647782|NCT03517969|525226551|FG001|Overall Study|Never started protocol treatment|5|||
145647783|NCT03517969|525226550|FG000|Overall Study|Disease progression|11|||
145647784|NCT03517969|525226551|FG001|Overall Study|Disease progression|16|||
145647785|NCT03517969|525226550|FG000|Overall Study|PSA progression|8|||
145647786|NCT03517969|525226551|FG001|Overall Study|PSA progression|1|||
145647787|NCT03517969|525226550|FG000|Overall Study|Clinical progression|4|||
145647788|NCT03517969|525226551|FG001|Overall Study|Clinical progression|2|||
145647789|NCT03517969|525226550|FG000|Overall Study|Adverse Event|5|||
145647790|NCT03517969|525226551|FG001|Overall Study|Adverse Event|4|||
145647791|NCT03517969|525226550|FG000|Overall Study|Intercurrent illness|1|||
145647792|NCT03517969|525226551|FG001|Overall Study|Intercurrent illness|2|||
145647793|NCT03517969|525226550|FG000|Overall Study|Death|1|||
145647794|NCT03517969|525226551|FG001|Overall Study|Death|1|||
145486851|NCT01285401|524636797|FG001|Overall Study|Prematurely withdrawn from the study|29|||
145486852|NCT00936702|524636798|FG000|Overall Study|Disease progression|34|||
145486853|NCT00936702|524636798|FG000|Overall Study|Adverse Event|8|||
145647795|NCT03517969|525226550|FG000|Overall Study|Withdrawal by Subject|1|||
145647796|NCT03517969|525226551|FG001|Overall Study|Withdrawal by Subject|2|||
145647797|NCT03517969|525226550|FG000|Overall Study|Physician Decision|1|||
145647798|NCT03517969|525226551|FG001|Overall Study|Physician Decision|1|||
145647799|NCT03517969|525226550|FG000|Overall Study|No clinical benefit|1|||
145647800|NCT03517969|525226551|FG001|Overall Study|No clinical benefit|0|||
145647801|NCT03517969|525226550|FG000|Overall Study|Delayed treatment for dental treatment|1|||
145647802|NCT03517969|525226551|FG001|Overall Study|Delayed treatment for dental treatment|0|||
145647803|NCT03517969|525226550|FG000|Overall Study|Difficult to maintain appointment|0|||
145647804|NCT03517969|525226551|FG001|Overall Study|Difficult to maintain appointment|1|||
145647805|NCT03517969|525226550|FG000|Overall Study|Protocol Violation|0|||
145647806|NCT03517969|525226551|FG001|Overall Study|Protocol Violation|1|||
145647807|NCT04838613|525226552|FG000|Overall Study|Withdrawal by Subject|3|||
145647808|NCT04838613|525226553|FG001|Overall Study|Withdrawal by Subject|6|||
145647809|NCT04838613|525226552|FG000|Overall Study|Protocol Deviation|3|||
145647810|NCT04838613|525226553|FG001|Overall Study|Protocol Deviation|2|||
145647811|NCT04838613|525226552|FG000|Overall Study|Technical Problems|0|||
145647812|NCT04838613|525226553|FG001|Overall Study|Technical Problems|5|||
145647813|NCT04838613|525226552|FG000|Overall Study|Physician Decision|2|||
145647814|NCT04838613|525226553|FG001|Overall Study|Physician Decision|0|||
145647815|NCT04970654|525226554|FG000|Overall Study|Withdrawal by parents/guardian|1|||
145647816|NCT04970654|525226555|FG001|Overall Study|Withdrawal by parents/guardian|2|||
145647817|NCT04970654|525226554|FG000|Overall Study|Unclassified|2|||
145647818|NCT04970654|525226555|FG001|Overall Study|Unclassified|1|||
145647819|NCT04970654|525226554|FG000|Overall Study|Lost to Follow-up|1|||
145647820|NCT04970654|525226555|FG001|Overall Study|Lost to Follow-up|0|||
145647821|NCT04854096|525226556|FG000|Overall Study|Adverse Event|1|||
145647822|NCT04854096|525226557|FG001|Overall Study|Adverse Event|0|||
145647823|NCT04854096|525226556|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
145647824|NCT04854096|525226557|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
145647825|NCT04854096|525226556|FG000|Overall Study|Withdrawal by Subject|1|||
145647826|NCT04854096|525226557|FG001|Overall Study|Withdrawal by Subject|0|||
145647827|NCT04854096|525226556|FG000|Overall Study|Other reasons|1|||
145647828|NCT04854096|525226557|FG001|Overall Study|Other reasons|0|||
145647829|NCT04999592|525226558|FG000|Overall Study|Withdrawal by Subject|1|||
145647830|NCT04999592|525226559|FG001|Overall Study|Withdrawal by Subject|0|||
145647831|NCT04095104|525226561|FG000|Overall Study|Withdrawal by Subject|0|||
145647832|NCT04095104|525226562|FG001|Overall Study|Withdrawal by Subject|1|||
145647833|NCT04820686|525226564|FG000|Overall Study|Withdrawal by Subject|5|||
145647834|NCT04820686|525226565|FG001|Overall Study|Withdrawal by Subject|2|||
145647835|NCT04820686|525226566|FG002|Overall Study|Withdrawal by Subject|3|||
145647836|NCT04820686|525226564|FG000|Overall Study|Study Termination|25|||
145647837|NCT04820686|525226565|FG001|Overall Study|Study Termination|13|||
145647838|NCT04820686|525226566|FG002|Overall Study|Study Termination|14|||
145647839|NCT04820686|525226564|FG000|Overall Study|Adverse Event|0|||
145647840|NCT04820686|525226565|FG001|Overall Study|Adverse Event|1|||
145647841|NCT04820686|525226566|FG002|Overall Study|Adverse Event|0|||
145647842|NCT02759016|525226567|FG000|Overall Study|Not treated with BI 836826|1|||
145647843|NCT02759016|525226568|FG001|Overall Study|Not treated with BI 836826|0|||
145647844|NCT02759016|525226567|FG000|Overall Study|Progressive disease|1|||
145647845|NCT02759016|525226568|FG001|Overall Study|Progressive disease|0|||
145647846|NCT02759016|525226567|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
145647847|NCT02759016|525226568|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
145647848|NCT02759016|525226567|FG000|Overall Study|Other not defined above|2|||
145647849|NCT02759016|525226568|FG001|Overall Study|Other not defined above|1|||
145647850|NCT04377308|525226569|FG000|Overall Study|Withdrawal by Subject|0|||
145647851|NCT04377308|525226570|FG001|Overall Study|Withdrawal by Subject|1|||
145647852|NCT02891915|525226571|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
145647853|NCT02891915|525226572|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
145647854|NCT02891915|525226571|FG000|Overall Study|Withdrawal by Subject|3|||
145647855|NCT02891915|525226572|FG001|Overall Study|Withdrawal by Subject|3|||
145647856|NCT02891915|525226571|FG000|Overall Study|Became Ineligible After Enrollment|2|||
145647857|NCT02891915|525226572|FG001|Overall Study|Became Ineligible After Enrollment|1|||
145647858|NCT02891915|525226571|FG000|Overall Study|Lost to Follow-up|1|||
145647859|NCT02891915|525226572|FG001|Overall Study|Lost to Follow-up|4|||
145647860|NCT02891915|525226571|FG000|Overall Study|Physician Decision|1|||
145647861|NCT02891915|525226572|FG001|Overall Study|Physician Decision|0|||
145486854|NCT00936702|524636798|FG000|Overall Study|Withdrawal by Subject|2|||
145647862|NCT00709098|525226575|FG000|Double-blind Period|Withdrawal of consent|3|||
145647863|NCT00709098|525226576|FG001|Double-blind Period|Withdrawal of consent|3|||
145647864|NCT00709098|525226577|FG002|Double-blind Period|Withdrawal of consent|0|||
145647865|NCT00709098|525226575|FG000|Double-blind Period|Administrative reason|1|||
145647866|NCT00709098|525226576|FG001|Double-blind Period|Administrative reason|3|||
145647867|NCT00709098|525226577|FG002|Double-blind Period|Administrative reason|0|||
145486855|NCT00936702|524636798|FG000|Overall Study|Alternative Treatment|1|||
145647868|NCT00709098|525226575|FG000|Double-blind Period|Death|1|||
145486856|NCT00936702|524636798|FG000|Overall Study|Other|1|||
145486857|NCT02420093|524636799|FG000|Overall Study|Withdrawal by Subject|1|||
145647869|NCT00709098|525226576|FG001|Double-blind Period|Death|1|||
145647870|NCT00709098|525226577|FG002|Double-blind Period|Death|0|||
145647871|NCT00709098|525226575|FG000|Double-blind Period|Lost to Follow-up|1|||
145647872|NCT00709098|525226576|FG001|Double-blind Period|Lost to Follow-up|1|||
145647873|NCT00709098|525226577|FG002|Double-blind Period|Lost to Follow-up|0|||
145647874|NCT00709098|525226575|FG000|Open-label Period|Withdrawal of consent|0|||
145647875|NCT00709098|525226576|FG001|Open-label Period|Withdrawal of consent|0|||
145647876|NCT00709098|525226577|FG002|Open-label Period|Withdrawal of consent|7|||
145647877|NCT00709098|525226575|FG000|Open-label Period|Administrative reason|0|||
145647878|NCT00709098|525226576|FG001|Open-label Period|Administrative reason|0|||
145647879|NCT00709098|525226577|FG002|Open-label Period|Administrative reason|5|||
145647880|NCT00709098|525226575|FG000|Open-label Period|Death|0|||
145647881|NCT00709098|525226576|FG001|Open-label Period|Death|0|||
145647882|NCT00709098|525226577|FG002|Open-label Period|Death|1|||
145647883|NCT00709098|525226575|FG000|Open-label Period|Lost to Follow-up|0|||
145647884|NCT00709098|525226576|FG001|Open-label Period|Lost to Follow-up|0|||
145647885|NCT00709098|525226577|FG002|Open-label Period|Lost to Follow-up|1|||
145647886|NCT04533022|525227408|FG000|Overall Study|Withdrawal by Subject|15|||
145647887|NCT04533022|525227408|FG000|Overall Study|Adverse Event|6|||
145647888|NCT04533022|525227408|FG000|Overall Study|Death|1|||
145647889|NCT04533022|525227408|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
145647890|NCT04533022|525227408|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
145647891|NCT02163447|525227409|FG000|Overall Study|Withdrawal by Subject|2|||
145647892|NCT02163447|525227410|FG001|Overall Study|Withdrawal by Subject|0|||
145647893|NCT02163447|525227411|FG002|Overall Study|Withdrawal by Subject|1|||
145647894|NCT02163447|525227409|FG000|Overall Study|Lost to Follow-up|1|||
145647895|NCT02163447|525227410|FG001|Overall Study|Lost to Follow-up|3|||
145647896|NCT02163447|525227411|FG002|Overall Study|Lost to Follow-up|0|||
145647897|NCT02163447|525227409|FG000|Overall Study|Moved out of study area|2|||
145647898|NCT02163447|525227410|FG001|Overall Study|Moved out of study area|3|||
145647899|NCT02163447|525227411|FG002|Overall Study|Moved out of study area|2|||
145647900|NCT02163447|525227409|FG000|Overall Study|Became HIV infected at time of delivery|1|||
145647901|NCT02163447|525227410|FG001|Overall Study|Became HIV infected at time of delivery|0|||
145647902|NCT02163447|525227411|FG002|Overall Study|Became HIV infected at time of delivery|0|||
145647903|NCT05415436|525227412|FG000|Overall Study|Surgeon cancelled procedure|1|||
145647904|NCT05415436|525227413|FG001|Overall Study|Surgeon cancelled procedure|0|||
145647905|NCT05415436|525227412|FG000|Overall Study|Death|1|||
145647906|NCT05415436|525227413|FG001|Overall Study|Death|0|||
145647907|NCT03819686|525227415|FG000|Overall Study|Lost to Follow-up|2|||
145647908|NCT03819686|525227416|FG001|Overall Study|Lost to Follow-up|3|||
145647909|NCT03157167|525227419|FG000|Overall Study|Withdrawal by Subject|1|||
145647910|NCT03157167|525227420|FG001|Overall Study|Withdrawal by Subject|0|||
145647911|NCT03157167|525227421|FG002|Overall Study|Withdrawal by Subject|0|||
145647912|NCT02597946|525227422|FG000|Overall Study|Withdrawal by Subject|1|||
145647913|NCT02597946|525227422|FG000|Overall Study|Progressive disease|16|||
145647914|NCT02597946|525227422|FG000|Overall Study|Other than above|1|||
145647915|NCT03263026|525227431|FG000|Overall Study|Withdrawal by Subject|1|||
145647916|NCT03263026|525227432|FG001|Overall Study|Withdrawal by Subject|0|||
145647917|NCT03263026|525227431|FG000|Overall Study|Death|1|||
145647918|NCT03263026|525227432|FG001|Overall Study|Death|0|||
145647919|NCT03263026|525227431|FG000|Overall Study|Other/ Various|41|||
145647920|NCT03263026|525227432|FG001|Overall Study|Other/ Various|29|||
145647921|NCT04868110|525227433|FG000|Overall Study|Withdrawal by Subject|3|||
145647922|NCT04868110|525227434|FG001|Overall Study|Withdrawal by Subject|4|||
145647923|NCT05320432|525227442|FG000|Overall Study|Withdrawal by Subject|0|||
145647924|NCT05320432|525227443|FG001|Overall Study|Withdrawal by Subject|2|||
145647925|NCT05038566|525227444|FG000|Overall Study|Technical Difficulties with the Device|0|||
145647926|NCT05038566|525227445|FG001|Overall Study|Technical Difficulties with the Device|1|||
145647927|NCT00650104|525227453|FG000|Overall Study|Adverse Event|17|||
145647928|NCT00650104|525227453|FG000|Overall Study|Death|2|||
145647929|NCT00650104|525227453|FG000|Overall Study|Withdrawal by Subject|11|||
145647930|NCT00650104|525227453|FG000|Overall Study|Physician Decision|7|||
145647931|NCT00650104|525227453|FG000|Overall Study|Lost to Follow-up|1|||
145647932|NCT00650104|525227453|FG000|Overall Study|Non-compliance|2|||
145647933|NCT00650104|525227453|FG000|Overall Study|Sponsor Terminated Dosing|1|||
145647934|NCT00894543|525227454|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
145647935|NCT00894543|525227455|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
145647936|NCT00894543|525227454|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
145647937|NCT00894543|525227455|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
145647938|NCT04048681|525227456|FG000|Overall Study|family emergency|0|||
145647939|NCT04048681|525227457|FG001|Overall Study|family emergency|0|||
145647940|NCT04048681|525227458|FG002|Overall Study|family emergency|0|||
145647941|NCT04048681|525227459|FG003|Overall Study|family emergency|1|||
145647942|NCT04048681|525227460|FG004|Overall Study|family emergency|0|||
145647943|NCT03385629|525227466|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
145647944|NCT03385629|525227467|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
145647945|NCT03385629|525227466|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
145647946|NCT03385629|525227467|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
145647947|NCT03385629|525227466|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
145647948|NCT03385629|525227467|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
145647949|NCT02923180|525227470|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
145647950|NCT02923180|525227470|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
145647951|NCT02140645|525227474|FG000|Overall Study|Not linked|5489|||
145647952|NCT02140645|525227475|FG001|Overall Study|Not linked|61654|||
145647953|NCT02140645|525227476|FG002|Overall Study|Not linked|4236|||
145647954|NCT02140645|525227477|FG003|Overall Study|Not linked|13833|||
145647955|NCT02140645|525227478|FG004|Overall Study|Not linked|3286|||
145647956|NCT02140645|525227479|FG005|Overall Study|Not linked|70896|||
145647957|NCT01872078|525227480|FG000|Overall Study|Adverse Event|0|||
145647958|NCT01872078|525227481|FG001|Overall Study|Adverse Event|0|||
145647959|NCT01872078|525227482|FG002|Overall Study|Adverse Event|1|||
145647960|NCT01872078|525227483|FG003|Overall Study|Adverse Event|0|||
145647961|NCT01872078|525227480|FG000|Overall Study|Dose administration non-compliance|0|||
145647962|NCT01872078|525227481|FG001|Overall Study|Dose administration non-compliance|0|||
145647963|NCT01872078|525227482|FG002|Overall Study|Dose administration non-compliance|0|||
145647964|NCT01872078|525227483|FG003|Overall Study|Dose administration non-compliance|1|||
145647965|NCT01872078|525227480|FG000|Overall Study|Protocol Violation|0|||
145647966|NCT01872078|525227481|FG001|Overall Study|Protocol Violation|0|||
145647967|NCT01872078|525227482|FG002|Overall Study|Protocol Violation|1|||
145647968|NCT01872078|525227483|FG003|Overall Study|Protocol Violation|0|||
145647969|NCT01872078|525227480|FG000|Overall Study|Withdrawal by Subject|0|||
145647970|NCT01872078|525227481|FG001|Overall Study|Withdrawal by Subject|0|||
145647971|NCT01872078|525227482|FG002|Overall Study|Withdrawal by Subject|1|||
145647972|NCT01872078|525227483|FG003|Overall Study|Withdrawal by Subject|0|||
145647973|NCT01872078|525227480|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
145647974|NCT01872078|525227481|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
145647975|NCT01872078|525227482|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
145647976|NCT01872078|525227483|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
145647977|NCT01721291|525227486|FG000|Overall Study|Withdrawal by Subject|1|||
145647978|NCT01721291|525227487|FG001|Overall Study|Withdrawal by Subject|0|||
145647979|NCT01721291|525227486|FG000|Overall Study|did not like the treatment|1|||
145647980|NCT01721291|525227487|FG001|Overall Study|did not like the treatment|0|||
145647981|NCT01091168|525227488|FG000|Overall Study|Progressive disease|250|||
145647982|NCT01091168|525227489|FG001|Overall Study|Progressive disease|234|||
145647983|NCT01091168|525227488|FG000|Overall Study|Adverse Event|21|||
145647984|NCT01091168|525227489|FG001|Overall Study|Adverse Event|24|||
145647985|NCT01091168|525227488|FG000|Overall Study|Lost to Follow-up|0|||
145647986|NCT01091168|525227489|FG001|Overall Study|Lost to Follow-up|1|||
145647987|NCT01091168|525227488|FG000|Overall Study|Physician, patient's decision, other|27|||
145647988|NCT01091168|525227489|FG001|Overall Study|Physician, patient's decision, other|37|||
145647989|NCT03767517|525227490|FG000|Overall Study|Lost to Follow-up|16|||
145647990|NCT03767517|525227491|FG001|Overall Study|Lost to Follow-up|10|||
145647991|NCT03767517|525227490|FG000|Overall Study|Death|2|||
145647992|NCT03767517|525227491|FG001|Overall Study|Death|3|||
145647993|NCT03152786|525228498|FG000|Overall Study|Withdrawal by Subject|2|||
145647994|NCT03152786|525228499|FG001|Overall Study|Withdrawal by Subject|1|||
145647995|NCT02349412|525228502|FG000|Overall Study|Withdrawal by Subject|7|||
145647996|NCT02349412|525228503|FG001|Overall Study|Withdrawal by Subject|7|||
145647997|NCT06066541|525228504|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
145647998|NCT06066541|525228505|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
145647999|NCT06066541|525228506|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
145648000|NCT06066541|525228507|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
145648001|NCT06066541|525228508|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
145648002|NCT06066541|525228509|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
145648003|NCT06066541|525228510|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
145648004|NCT06066541|525228504|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
145648005|NCT06066541|525228505|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
145648006|NCT06066541|525228506|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
145648007|NCT06066541|525228507|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
145648008|NCT06066541|525228508|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
145648009|NCT06066541|525228509|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
145648010|NCT06066541|525228510|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
145648011|NCT03897686|525228512|FG000|Overall Study|Protocol Violation|1|||
145648012|NCT03897686|525228513|FG001|Overall Study|Protocol Violation|1|||
145648013|NCT03897686|525228512|FG000|Overall Study|Withdrawal by Subject|1|||
145648014|NCT03897686|525228513|FG001|Overall Study|Withdrawal by Subject|1|||
145648015|NCT00739648|525228522|FG000|Overall Study|Adverse Event|3|||
145648016|NCT00739648|525228523|FG001|Overall Study|Adverse Event|15|||
145648017|NCT00739648|525228522|FG000|Overall Study|Withdrawal by Subject|13|||
145648018|NCT00739648|525228523|FG001|Overall Study|Withdrawal by Subject|25|||
145486858|NCT02420093|524636800|FG001|Overall Study|Withdrawal by Subject|1|||
145648019|NCT00739648|525228522|FG000|Overall Study|Lost to Follow-up|4|||
145486859|NCT05470387|524636802|FG000|Overall Study|Protocol Violation|0|||
145648020|NCT00739648|525228523|FG001|Overall Study|Lost to Follow-up|7|||
145648021|NCT00739648|525228522|FG000|Overall Study|Death|2|||
145648022|NCT00739648|525228523|FG001|Overall Study|Death|0|||
145648023|NCT00739648|525228522|FG000|Overall Study|Do not know|4|||
145648024|NCT00739648|525228523|FG001|Overall Study|Do not know|6|||
145648025|NCT02840474|525228526|FG000|Overall Study|Lost to Follow-up|1|||
145648026|NCT02840474|525228527|FG001|Overall Study|Lost to Follow-up|0|||
145648027|NCT03192891|525228528|FG000|Overall Study|Lost to Follow-up|55|||
145648028|NCT04850807|525228529|FG000|Overall Study|Death|50|||
145648029|NCT04850807|525228530|FG001|Overall Study|Death|55|||
145648030|NCT04850807|525228529|FG000|Overall Study|Discharged|17|||
145648031|NCT04850807|525228530|FG001|Overall Study|Discharged|13|||
145648032|NCT04850807|525228529|FG000|Overall Study|Incomplete baseline data|3|||
145648033|NCT04850807|525228530|FG001|Overall Study|Incomplete baseline data|2|||
145648034|NCT05387447|525228531|FG000|Overall Study|Participants changed their minds about study participation.|3|||
145648035|NCT05387447|525228532|FG001|Overall Study|Participants changed their minds about study participation.|5|||
145648036|NCT03655132|525228535|FG000|Overall Study|Lost to Follow-up|2|||
145648037|NCT03655132|525228536|FG001|Overall Study|Lost to Follow-up|1|||
145648038|NCT03655132|525228535|FG000|Overall Study|Withdrawal by Subject|0|||
145648039|NCT03655132|525228536|FG001|Overall Study|Withdrawal by Subject|1|||
145648040|NCT03655132|525228535|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
145648041|NCT03655132|525228536|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
145648042|NCT02651324|525228538|FG000|Overall Study|drug not administered, due dispensing issue|1|||
145648043|NCT02651324|525228539|FG001|Overall Study|drug not administered, due dispensing issue|0|||
145648044|NCT04538417|525228542|FG000|Overall Study|Withdrawal by Subject|2|||
145648045|NCT02097420|525228546|FG000|Overall Study|Death|6|||
145648046|NCT02097420|525228546|FG000|Overall Study|Valve explanted|13|||
145648047|NCT02097420|525228546|FG000|Overall Study|Other Reason|1|||
145648048|NCT04649359|525228566|FG000|Overall Study|Withdrawal by Subject|7|||
145648049|NCT04649359|525228567|FG001|Overall Study|Withdrawal by Subject|7|||
145648050|NCT04649359|525228566|FG000|Overall Study|Death|41|||
145648051|NCT04649359|525228567|FG001|Overall Study|Death|26|||
145648052|NCT04649359|525228566|FG000|Overall Study|Ongoing in the study|75|||
145648053|NCT04649359|525228567|FG001|Overall Study|Ongoing in the study|31|||
145648054|NCT00601900|525228571|FG000|Overall Study|Withdrawal by Subject|0|||
145648055|NCT00601900|525228572|FG001|Overall Study|Withdrawal by Subject|3|||
145648056|NCT02697136|525228574|FG000|Overall Study|Adverse Event|3|||
145648057|NCT02697136|525228575|FG001|Overall Study|Adverse Event|0|||
145648058|NCT02500758|525228584|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
145648059|NCT02500758|525228585|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
145648060|NCT02500758|525228584|FG000|Washout (1 Week)|Lost to Follow-up|2|||
145648061|NCT02500758|525228585|FG001|Washout (1 Week)|Lost to Follow-up|2|||
145648062|NCT02500758|525228584|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
145648063|NCT02500758|525228585|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
145648064|NCT02500758|525228584|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
145648065|NCT02500758|525228585|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
145648066|NCT02500758|525228584|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
145648067|NCT02500758|525228585|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
145648068|NCT02538900|525228586|FG000|Overall Study|Death|2|||
145648069|NCT02538900|525228587|FG001|Overall Study|Death|2|||
145648070|NCT02538900|525228588|FG002|Overall Study|Death|2|||
145648071|NCT02538900|525228586|FG000|Overall Study|Withdrawal by Subject|18|||
145648072|NCT02538900|525228587|FG001|Overall Study|Withdrawal by Subject|16|||
145648073|NCT02538900|525228588|FG002|Overall Study|Withdrawal by Subject|15|||
145648074|NCT01101451|525228589|FG000|Overall Study|Eligible and never treated|0|||
145648075|NCT01101451|525228590|FG001|Overall Study|Eligible and never treated|5|||
145648076|NCT01101451|525228589|FG000|Overall Study|Ineligible and treated|12|||
145648077|NCT01101451|525228590|FG001|Overall Study|Ineligible and treated|8|||
145648078|NCT01101451|525228589|FG000|Overall Study|Ineligible and never treated|2|||
145648079|NCT01101451|525228590|FG001|Overall Study|Ineligible and never treated|2|||
145648080|NCT02965846|525228595|FG000|Overall Study|Lost to Follow-up|1|||
145648081|NCT02965846|525228596|FG001|Overall Study|Lost to Follow-up|0|||
145486860|NCT05470387|524636803|FG001|Overall Study|Protocol Violation|3|||
145486861|NCT03480152|524636807|FG000|Phase I|Signed consent. Died before treatment.|1|||
145486862|NCT03480152|524636808|FG001|Phase I|Signed consent. Died before treatment.|0|||
145486863|NCT03480152|524636809|FG002|Phase I|Signed consent. Died before treatment.|0|||
145486864|NCT01308736|524636810|FG000|Overall Study|Did not attend a single session|6|||
145486865|NCT01308736|524636811|FG001|Overall Study|Did not attend a single session|5|||
145486866|NCT01946139|524636812|FG000|Overall Study|Withdrawal by Subject|8|||
145648082|NCT02965846|525228597|FG002|Overall Study|Lost to Follow-up|0|||
145648083|NCT02965846|525228595|FG000|Overall Study|Withdrawal by Subject|0|||
145648084|NCT02965846|525228596|FG001|Overall Study|Withdrawal by Subject|1|||
145486867|NCT01946139|524636812|FG000|Overall Study|ineligible|8|||
145648085|NCT02965846|525228597|FG002|Overall Study|Withdrawal by Subject|0|||
145648086|NCT02965846|525228595|FG000|Overall Study|Study Terminated By Sponsor|4|||
145648087|NCT02965846|525228596|FG001|Overall Study|Study Terminated By Sponsor|4|||
145648088|NCT02965846|525228597|FG002|Overall Study|Study Terminated By Sponsor|0|||
145648089|NCT02965846|525228595|FG000|Overall Study|Participants not randomized|0|||
145648090|NCT02965846|525228596|FG001|Overall Study|Participants not randomized|0|||
145486868|NCT01946139|524636812|FG000|Overall Study|Specimens not available|4|||
145486869|NCT01363700|524636821|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
145486870|NCT01363700|524636822|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
145486871|NCT01363700|524636823|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
145486872|NCT01363700|524636824|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
145486873|NCT01363700|524636825|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
145486874|NCT02721875|524636826|FG000|Overall Study|Progressive disease/relapse|1|||
145486875|NCT02721875|524636827|FG001|Overall Study|Progressive disease/relapse|0|||
145486876|NCT00857285|524636828|FG000|Overall Study|Adverse Event|4|||
145486877|NCT00857285|524636829|FG001|Overall Study|Adverse Event|2|||
145486878|NCT00857285|524636828|FG000|Overall Study|Lack of Efficacy|0|||
145486879|NCT00857285|524636829|FG001|Overall Study|Lack of Efficacy|2|||
145486880|NCT00857285|524636828|FG000|Overall Study|Protocol Violation|3|||
145486881|NCT00857285|524636829|FG001|Overall Study|Protocol Violation|1|||
145486882|NCT00857285|524636828|FG000|Overall Study|Withdrawal by Subject|4|||
145486883|NCT00857285|524636829|FG001|Overall Study|Withdrawal by Subject|0|||
145486884|NCT00857285|524636828|FG000|Overall Study|Randomization criteria not met|1|||
145486885|NCT00857285|524636829|FG001|Overall Study|Randomization criteria not met|1|||
145648091|NCT02965846|525228597|FG002|Overall Study|Participants not randomized|33|||
145648092|NCT02814838|525228598|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
145648093|NCT02814838|525228599|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
145648094|NCT02814838|525228598|FG000|Overall Study|Consent withdrawal|1|||
145648095|NCT02814838|525228599|FG001|Overall Study|Consent withdrawal|1|||
145648096|NCT00593489|525228600|FG000|Allocation|did not attend workshop; allocation not|2|||
145648097|NCT00593489|525228601|FG001|Allocation|did not attend workshop; allocation not|1|||
145648098|NCT00073749|525228602|FG000|Overall Study|Disease Progression|2|||
145648099|NCT00073749|525228603|FG001|Overall Study|Disease Progression|0|||
145648100|NCT00073749|525228604|FG002|Overall Study|Disease Progression|3|||
145648101|NCT00073749|525228605|FG003|Overall Study|Disease Progression|2|||
145648102|NCT00073749|525228606|FG004|Overall Study|Disease Progression|3|||
145648103|NCT00073749|525228607|FG005|Overall Study|Disease Progression|1|||
145648104|NCT00073749|525228608|FG006|Overall Study|Disease Progression|3|||
145648105|NCT00073749|525228602|FG000|Overall Study|Death|0|||
145648106|NCT00073749|525228603|FG001|Overall Study|Death|1|||
145648107|NCT00073749|525228604|FG002|Overall Study|Death|1|||
145648108|NCT00073749|525228605|FG003|Overall Study|Death|0|||
145648109|NCT00073749|525228606|FG004|Overall Study|Death|0|||
145648110|NCT00073749|525228607|FG005|Overall Study|Death|0|||
145648111|NCT00073749|525228608|FG006|Overall Study|Death|29|||
145648112|NCT00073749|525228602|FG000|Overall Study|Adverse Event|0|||
145648113|NCT00073749|525228603|FG001|Overall Study|Adverse Event|3|||
145648114|NCT00073749|525228604|FG002|Overall Study|Adverse Event|6|||
145648115|NCT00073749|525228605|FG003|Overall Study|Adverse Event|4|||
145648116|NCT00073749|525228606|FG004|Overall Study|Adverse Event|2|||
145648117|NCT00073749|525228607|FG005|Overall Study|Adverse Event|1|||
145648118|NCT00073749|525228608|FG006|Overall Study|Adverse Event|0|||
145648119|NCT00073749|525228602|FG000|Overall Study|Physician Decision|0|||
145648120|NCT00073749|525228603|FG001|Overall Study|Physician Decision|0|||
145648121|NCT00073749|525228604|FG002|Overall Study|Physician Decision|1|||
145648122|NCT00073749|525228605|FG003|Overall Study|Physician Decision|0|||
145648123|NCT00073749|525228606|FG004|Overall Study|Physician Decision|0|||
145648124|NCT00073749|525228607|FG005|Overall Study|Physician Decision|2|||
145648125|NCT00073749|525228608|FG006|Overall Study|Physician Decision|0|||
145648126|NCT00073749|525228602|FG000|Overall Study|Withdrawal by Subject|0|||
145648127|NCT00073749|525228603|FG001|Overall Study|Withdrawal by Subject|1|||
145648128|NCT00073749|525228604|FG002|Overall Study|Withdrawal by Subject|0|||
145648129|NCT00073749|525228605|FG003|Overall Study|Withdrawal by Subject|0|||
145486886|NCT01329978|524636838|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
145486887|NCT01329978|524636839|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
145486888|NCT01329978|524636840|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
145486889|NCT01329978|524636841|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
145486890|NCT01329978|524636842|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
145648130|NCT00073749|525228606|FG004|Overall Study|Withdrawal by Subject|1|||
145648131|NCT00073749|525228607|FG005|Overall Study|Withdrawal by Subject|0|||
145648132|NCT00073749|525228608|FG006|Overall Study|Withdrawal by Subject|2|||
145648133|NCT00073749|525228602|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
145648134|NCT00073749|525228603|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
145648135|NCT00073749|525228604|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
145648136|NCT00073749|525228605|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
145648137|NCT00073749|525228606|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
145648138|NCT00073749|525228607|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
145648139|NCT00073749|525228608|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
145648140|NCT00073749|525228602|FG000|Overall Study|Lost to Follow-up|0|||
145648141|NCT00073749|525228603|FG001|Overall Study|Lost to Follow-up|0|||
145648142|NCT00073749|525228604|FG002|Overall Study|Lost to Follow-up|0|||
145648143|NCT00073749|525228605|FG003|Overall Study|Lost to Follow-up|0|||
145648144|NCT00073749|525228606|FG004|Overall Study|Lost to Follow-up|0|||
145648145|NCT00073749|525228607|FG005|Overall Study|Lost to Follow-up|0|||
145648146|NCT00073749|525228608|FG006|Overall Study|Lost to Follow-up|2|||
145648147|NCT00073749|525228602|FG000|Overall Study|Other|0|||
145648148|NCT00073749|525228603|FG001|Overall Study|Other|0|||
145648149|NCT00073749|525228604|FG002|Overall Study|Other|0|||
145648150|NCT00073749|525228605|FG003|Overall Study|Other|0|||
145648151|NCT00073749|525228606|FG004|Overall Study|Other|0|||
145648152|NCT00073749|525228607|FG005|Overall Study|Other|2|||
145648153|NCT00073749|525228608|FG006|Overall Study|Other|0|||
145648154|NCT00611559|525228609|FG000|Overall Study|Lost to Follow-up|0|||
145648155|NCT00611559|525228610|FG001|Overall Study|Lost to Follow-up|1|||
145648156|NCT00611559|525228611|FG002|Overall Study|Lost to Follow-up|0|||
145648157|NCT00611559|525228609|FG000|Overall Study|Protocol Violation|1|||
145648158|NCT00611559|525228610|FG001|Overall Study|Protocol Violation|0|||
145648159|NCT00611559|525228611|FG002|Overall Study|Protocol Violation|1|||
145648160|NCT05048186|525228614|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
145648161|NCT05048186|525228615|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
145648162|NCT05048186|525228614|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
145648163|NCT05048186|525228615|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
145648164|NCT00951379|525228616|FG000|Overall Study|Adverse Event|4|||
145648165|NCT00951379|525228617|FG001|Overall Study|Adverse Event|1|||
145648166|NCT00951379|525228616|FG000|Overall Study|Withdrawal by Subject|1|||
145648167|NCT00951379|525228617|FG001|Overall Study|Withdrawal by Subject|0|||
145648168|NCT00951379|525228616|FG000|Overall Study|Noncompliance|1|||
145648169|NCT00951379|525228617|FG001|Overall Study|Noncompliance|0|||
145648170|NCT00951379|525228616|FG000|Overall Study|Disease Progression|0|||
145648171|NCT00951379|525228617|FG001|Overall Study|Disease Progression|1|||
145648172|NCT02742519|525228621|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
145648173|NCT02742519|525228622|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
145648174|NCT02742519|525228623|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
145648175|NCT02742519|525228621|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
145648176|NCT02742519|525228622|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
145648177|NCT02742519|525228623|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
145648178|NCT02742519|525228621|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
145648179|NCT02742519|525228622|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
145648180|NCT02742519|525228623|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
145648181|NCT03580369|525228624|FG000|Overall Study|No treatment due to mis-randomization|1|||
145648182|NCT03580369|525228625|FG001|Overall Study|No treatment due to mis-randomization|0|||
145648183|NCT03580369|525228626|FG002|Overall Study|No treatment due to mis-randomization|0|||
145648184|NCT03580369|525228627|FG003|Overall Study|No treatment due to mis-randomization|0|||
145486891|NCT01329978|524636838|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
145486892|NCT01329978|524636839|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
145486893|NCT01329978|524636840|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
145486894|NCT01329978|524636841|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
145486895|NCT01329978|524636842|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
145486896|NCT01329978|524636838|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
145486897|NCT01329978|524636839|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
145486898|NCT01329978|524636840|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
145486899|NCT01329978|524636841|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
145486900|NCT01329978|524636842|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
145486901|NCT01329978|524636838|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
145486902|NCT01329978|524636839|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
145486903|NCT01329978|524636840|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
145486904|NCT01329978|524636841|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
145486905|NCT01329978|524636842|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
145486906|NCT01329978|524636838|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
145486907|NCT01329978|524636839|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
145486908|NCT01329978|524636840|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
145648185|NCT03580369|525228628|FG004|Overall Study|No treatment due to mis-randomization|3|||
145648186|NCT03580369|525228629|FG005|Overall Study|No treatment due to mis-randomization|0|||
145648187|NCT03580369|525228630|FG006|Overall Study|No treatment due to mis-randomization|0|||
145648188|NCT03580369|525228631|FG007|Overall Study|No treatment due to mis-randomization|0|||
145648189|NCT03580369|525228624|FG000|Overall Study|Reason unknown|0|||
145648190|NCT03580369|525228625|FG001|Overall Study|Reason unknown|0|||
145648191|NCT03580369|525228626|FG002|Overall Study|Reason unknown|1|||
145486909|NCT01329978|524636841|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
145486910|NCT01329978|524636842|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
145486911|NCT01329978|524636838|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
145486912|NCT01329978|524636839|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
145486913|NCT01329978|524636840|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
145486914|NCT01329978|524636841|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
145486915|NCT01329978|524636842|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
145486916|NCT01329978|524636838|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
145486917|NCT01329978|524636839|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
145486918|NCT01329978|524636840|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
145486919|NCT01329978|524636841|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
145486920|NCT01329978|524636842|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
145486921|NCT03901144|524636843|FG000|Overall Study|Lost to Follow-up|1|||
145486922|NCT03901144|524636844|FG001|Overall Study|Lost to Follow-up|1|||
145486923|NCT03901144|524636845|FG002|Overall Study|Lost to Follow-up|1|||
145486924|NCT03901144|524636846|FG003|Overall Study|Lost to Follow-up|1|||
145486925|NCT01807598|524636847|FG000|Overall Study|Withdrawal by Subject|4|||
145486926|NCT01807598|524636847|FG000|Overall Study|Adverse Event|1|||
145486927|NCT01807598|524636847|FG000|Overall Study|Other Physician Decision|1|||
145486928|NCT01987102|524636850|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
145486929|NCT01987102|524636851|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
145486930|NCT01987102|524636850|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
145486931|NCT01987102|524636851|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
145486932|NCT01987102|524636850|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
145486933|NCT01987102|524636851|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
145486934|NCT01987102|524636850|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
145486935|NCT01987102|524636851|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
145486936|NCT01987102|524636850|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
145486937|NCT01987102|524636851|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
145486938|NCT01987102|524636850|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
145486939|NCT01987102|524636851|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
145486940|NCT01288989|524636852|FG000|Overall Study|Death|0|||
145486941|NCT01288989|524636853|FG001|Overall Study|Death|0|||
145486942|NCT01288989|524636854|FG002|Overall Study|Death|0|||
145486943|NCT01288989|524636855|FG003|Overall Study|Death|1|||
145486944|NCT01288989|524636856|FG004|Overall Study|Death|0|||
145486945|NCT01288989|524636852|FG000|Overall Study|Dose limiting toxicity|1|||
145486946|NCT01288989|524636853|FG001|Overall Study|Dose limiting toxicity|0|||
145486947|NCT01288989|524636854|FG002|Overall Study|Dose limiting toxicity|0|||
145486948|NCT01288989|524636855|FG003|Overall Study|Dose limiting toxicity|0|||
145486949|NCT01288989|524636856|FG004|Overall Study|Dose limiting toxicity|0|||
145486950|NCT01288989|524636852|FG000|Overall Study|Adverse Event|0|||
145486951|NCT01288989|524636853|FG001|Overall Study|Adverse Event|0|||
145486952|NCT01288989|524636854|FG002|Overall Study|Adverse Event|0|||
145486953|NCT01288989|524636855|FG003|Overall Study|Adverse Event|0|||
145486954|NCT01288989|524636856|FG004|Overall Study|Adverse Event|2|||
145486955|NCT01288989|524636852|FG000|Overall Study|Physician Decision|0|||
145486956|NCT01288989|524636853|FG001|Overall Study|Physician Decision|0|||
145486957|NCT01288989|524636854|FG002|Overall Study|Physician Decision|0|||
145486958|NCT01288989|524636855|FG003|Overall Study|Physician Decision|0|||
145486959|NCT01288989|524636856|FG004|Overall Study|Physician Decision|1|||
145486960|NCT01288989|524636852|FG000|Overall Study|Withdrawal by Subject|0|||
145486961|NCT01288989|524636853|FG001|Overall Study|Withdrawal by Subject|0|||
145486962|NCT01288989|524636854|FG002|Overall Study|Withdrawal by Subject|0|||
145486963|NCT01288989|524636855|FG003|Overall Study|Withdrawal by Subject|0|||
145486964|NCT01288989|524636856|FG004|Overall Study|Withdrawal by Subject|3|||
145486965|NCT00165672|524636858|FG000|Overall Study|Adverse Event|0|||
145486966|NCT00165672|524636859|FG001|Overall Study|Adverse Event|1|||
145486967|NCT05081219|524636860|FG000|Overall Study|Withdrawal by Subject|4|||
145648192|NCT03580369|525228627|FG003|Overall Study|Reason unknown|0|||
145648193|NCT03580369|525228628|FG004|Overall Study|Reason unknown|0|||
145648194|NCT03580369|525228629|FG005|Overall Study|Reason unknown|0|||
145648195|NCT03580369|525228630|FG006|Overall Study|Reason unknown|0|||
145486968|NCT05081219|524636861|FG001|Overall Study|Withdrawal by Subject|0|||
145648196|NCT03580369|525228631|FG007|Overall Study|Reason unknown|0|||
145486969|NCT05081219|524636862|FG002|Overall Study|Withdrawal by Subject|0|||
145486970|NCT05081219|524636863|FG003|Overall Study|Withdrawal by Subject|1|||
145486971|NCT04896593|524636865|FG000|Overall Study|Withdrawal by Subject|2|||
145486972|NCT04896593|524636865|FG000|Overall Study|Lost to Follow-up|1|||
145486973|NCT04896593|524636865|FG000|Overall Study|Did not complete onboarding|2|||
145486974|NCT00452790|524636866|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
145486975|NCT00452790|524636867|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
145486976|NCT00452790|524636866|FG000|Infant Series|Parent/legal guardian request|8|||
145648197|NCT03580369|525228624|FG000|Overall Study|Technical problems|0|||
145486977|NCT00452790|524636867|FG001|Infant Series|Parent/legal guardian request|6|||
145486978|NCT00452790|524636866|FG000|Infant Series|Failed to return|4|||
145486979|NCT00452790|524636867|FG001|Infant Series|Failed to return|1|||
145486980|NCT00452790|524636866|FG000|Infant Series|Protocol Violation|1|||
145486981|NCT00452790|524636867|FG001|Infant Series|Protocol Violation|3|||
145486982|NCT00452790|524636866|FG000|Infant Series|Lost to Follow-up|2|||
145486983|NCT00452790|524636867|FG001|Infant Series|Lost to Follow-up|2|||
145486984|NCT00452790|524636866|FG000|Infant Series|Adverse Event|1|||
145486985|NCT00452790|524636867|FG001|Infant Series|Adverse Event|2|||
145486986|NCT00452790|524636866|FG000|Infant Series|Other reasons|1|||
145486987|NCT00452790|524636867|FG001|Infant Series|Other reasons|2|||
145486988|NCT00452790|524636866|FG000|Infant Series|Investigator request|0|||
145486989|NCT00452790|524636867|FG001|Infant Series|Investigator request|1|||
145486990|NCT00452790|524636866|FG000|Infant Series|Death|0|||
145486991|NCT00452790|524636867|FG001|Infant Series|Death|1|||
145486992|NCT00452790|524636866|FG000|After Infant Series|Investigator request|10|||
145486993|NCT00452790|524636867|FG001|After Infant Series|Investigator request|10|||
145486994|NCT00452790|524636866|FG000|After Infant Series|Adverse Event|4|||
145486995|NCT00452790|524636867|FG001|After Infant Series|Adverse Event|1|||
145486996|NCT00452790|524636866|FG000|After Infant Series|Parent/legal guardian request|1|||
145486997|NCT00452790|524636867|FG001|After Infant Series|Parent/legal guardian request|3|||
145486998|NCT00452790|524636866|FG000|After Infant Series|Lost to Follow-up|4|||
145486999|NCT00452790|524636867|FG001|After Infant Series|Lost to Follow-up|0|||
145487000|NCT00452790|524636866|FG000|After Infant Series|Failed to return|1|||
145487001|NCT00452790|524636867|FG001|After Infant Series|Failed to return|0|||
145487002|NCT00452790|524636866|FG000|After Infant Series|Other reasons|1|||
145487003|NCT00452790|524636867|FG001|After Infant Series|Other reasons|0|||
145487004|NCT00452790|524636866|FG000|Toddler Dose|Failed to return|0|||
145487005|NCT00452790|524636867|FG001|Toddler Dose|Failed to return|1|||
145487006|NCT00452790|524636866|FG000|Toddler Dose|Parent/legal guardian request|0|||
145487007|NCT00452790|524636867|FG001|Toddler Dose|Parent/legal guardian request|1|||
145487008|NCT04177212|524636876|FG000|Overall Study|Withdrawal by Subject|9|||
145487009|NCT04177212|524636877|FG001|Overall Study|Withdrawal by Subject|7|||
145487010|NCT04177212|524636876|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
145487011|NCT04177212|524636877|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
145487012|NCT04177212|524636876|FG000|Overall Study|Physician Decision|1|||
145487013|NCT04177212|524636877|FG001|Overall Study|Physician Decision|0|||
145487014|NCT04177212|524636876|FG000|Overall Study|Lost to Follow-up|0|||
145487015|NCT04177212|524636877|FG001|Overall Study|Lost to Follow-up|3|||
145487016|NCT04177212|524636876|FG000|Overall Study|Adverse Event|0|||
145487017|NCT04177212|524636877|FG001|Overall Study|Adverse Event|1|||
145487018|NCT04177212|524636876|FG000|Overall Study|Other|1|||
145487019|NCT04177212|524636877|FG001|Overall Study|Other|2|||
145487020|NCT01279681|524636878|FG000|Overall Study|Disease Progression|9|||
145487021|NCT01279681|524636879|FG001|Overall Study|Disease Progression|6|||
145487022|NCT01279681|524636878|FG000|Overall Study|Withdrawal by Subject|3|||
145487023|NCT01279681|524636879|FG001|Overall Study|Withdrawal by Subject|4|||
145487024|NCT01279681|524636878|FG000|Overall Study|Adverse Event|2|||
145487025|NCT01279681|524636879|FG001|Overall Study|Adverse Event|3|||
145487026|NCT01279681|524636878|FG000|Overall Study|Death|0|||
145487027|NCT01279681|524636879|FG001|Overall Study|Death|1|||
145487028|NCT01279681|524636878|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
145487029|NCT01279681|524636879|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
145487030|NCT01279681|524636878|FG000|Overall Study|Physician Decision|1|||
145487031|NCT01279681|524636879|FG001|Overall Study|Physician Decision|0|||
145487032|NCT01279681|524636878|FG000|Overall Study|Other Reason|0|||
145487033|NCT01279681|524636879|FG001|Overall Study|Other Reason|2|||
145487034|NCT01777308|524639383|FG000|Overall Study|Withdrawal by Subject|5|||
145487035|NCT01777308|524639384|FG001|Overall Study|Withdrawal by Subject|1|||
145487036|NCT01777308|524639383|FG000|Overall Study|Migrated/moved from study area|1|||
145487037|NCT01777308|524639384|FG001|Overall Study|Migrated/moved from study area|0|||
145487038|NCT01777308|524639383|FG000|Overall Study|Lost to Follow-up|7|||
145487039|NCT01777308|524639384|FG001|Overall Study|Lost to Follow-up|2|||
145487040|NCT01777308|524639383|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
145487041|NCT01777308|524639384|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
145648198|NCT03580369|525228625|FG001|Overall Study|Technical problems|0|||
145487042|NCT02252146|524639386|FG000|Overall Study|Lack of Efficacy|4|||
145487043|NCT02252146|524639386|FG000|Overall Study|Entered hospice care|1|||
145487044|NCT02252146|524639386|FG000|Overall Study|Inability to travel to study site|1|||
145487045|NCT00531284|524639387|FG000|Overall Study|Progressive Disease|1|||
145487046|NCT00531284|524639388|FG001|Overall Study|Progressive Disease|3|||
145487047|NCT00531284|524639389|FG002|Overall Study|Progressive Disease|5|||
145487048|NCT00531284|524639390|FG003|Overall Study|Progressive Disease|42|||
145487049|NCT00531284|524639391|FG004|Overall Study|Progressive Disease|4|||
145487050|NCT00531284|524639392|FG005|Overall Study|Progressive Disease|4|||
145487051|NCT00531284|524639393|FG006|Overall Study|Progressive Disease|3|||
145487052|NCT00531284|524639394|FG007|Overall Study|Progressive Disease|8|||
145487053|NCT00531284|524639395|FG008|Overall Study|Progressive Disease|6|||
145487054|NCT00531284|524639396|FG009|Overall Study|Progressive Disease|3|||
145487055|NCT00531284|524639397|FG010|Overall Study|Progressive Disease|3|||
145487056|NCT00531284|524639398|FG011|Overall Study|Progressive Disease|14|||
145487057|NCT00531284|524639399|FG012|Overall Study|Progressive Disease|2|||
145487058|NCT00531284|524639400|FG013|Overall Study|Progressive Disease|1|||
145487059|NCT00531284|524639401|FG014|Overall Study|Progressive Disease|2|||
145487060|NCT00531284|524639402|FG015|Overall Study|Progressive Disease|11|||
145487061|NCT00531284|524639403|FG016|Overall Study|Progressive Disease|5|||
145487062|NCT00531284|524639387|FG000|Overall Study|Adverse Event|0|||
145487063|NCT00531284|524639388|FG001|Overall Study|Adverse Event|1|||
145487064|NCT00531284|524639389|FG002|Overall Study|Adverse Event|1|||
145487065|NCT00531284|524639390|FG003|Overall Study|Adverse Event|7|||
145487066|NCT00531284|524639391|FG004|Overall Study|Adverse Event|0|||
145487067|NCT00531284|524639392|FG005|Overall Study|Adverse Event|2|||
145487068|NCT00531284|524639393|FG006|Overall Study|Adverse Event|3|||
145487069|NCT00531284|524639394|FG007|Overall Study|Adverse Event|2|||
145487070|NCT00531284|524639395|FG008|Overall Study|Adverse Event|3|||
145487071|NCT00531284|524639396|FG009|Overall Study|Adverse Event|0|||
145487072|NCT00531284|524639397|FG010|Overall Study|Adverse Event|0|||
145487073|NCT00531284|524639398|FG011|Overall Study|Adverse Event|5|||
145487074|NCT00531284|524639399|FG012|Overall Study|Adverse Event|0|||
145487075|NCT00531284|524639400|FG013|Overall Study|Adverse Event|1|||
145487076|NCT00531284|524639401|FG014|Overall Study|Adverse Event|1|||
145487077|NCT00531284|524639402|FG015|Overall Study|Adverse Event|0|||
145487078|NCT00531284|524639403|FG016|Overall Study|Adverse Event|2|||
145487079|NCT00531284|524639387|FG000|Overall Study|Withdrawal by Subject|1|||
145487080|NCT00531284|524639388|FG001|Overall Study|Withdrawal by Subject|0|||
145487081|NCT00531284|524639389|FG002|Overall Study|Withdrawal by Subject|0|||
145487082|NCT00531284|524639390|FG003|Overall Study|Withdrawal by Subject|4|||
145487083|NCT00531284|524639391|FG004|Overall Study|Withdrawal by Subject|0|||
145487084|NCT00531284|524639392|FG005|Overall Study|Withdrawal by Subject|0|||
145487085|NCT00531284|524639393|FG006|Overall Study|Withdrawal by Subject|0|||
145487086|NCT00531284|524639394|FG007|Overall Study|Withdrawal by Subject|0|||
145487087|NCT00531284|524639395|FG008|Overall Study|Withdrawal by Subject|0|||
145487088|NCT00531284|524639396|FG009|Overall Study|Withdrawal by Subject|0|||
145487089|NCT00531284|524639397|FG010|Overall Study|Withdrawal by Subject|0|||
145487090|NCT00531284|524639398|FG011|Overall Study|Withdrawal by Subject|3|||
145487091|NCT00531284|524639399|FG012|Overall Study|Withdrawal by Subject|0|||
145487092|NCT00531284|524639400|FG013|Overall Study|Withdrawal by Subject|1|||
145487093|NCT00531284|524639401|FG014|Overall Study|Withdrawal by Subject|0|||
145487094|NCT00531284|524639402|FG015|Overall Study|Withdrawal by Subject|1|||
145487095|NCT00531284|524639403|FG016|Overall Study|Withdrawal by Subject|1|||
145487096|NCT00531284|524639387|FG000|Overall Study|Other|1|||
145487097|NCT00531284|524639388|FG001|Overall Study|Other|0|||
145487098|NCT00531284|524639389|FG002|Overall Study|Other|0|||
145487099|NCT00531284|524639390|FG003|Overall Study|Other|10|||
145487100|NCT00531284|524639391|FG004|Overall Study|Other|2|||
145487101|NCT00531284|524639392|FG005|Overall Study|Other|1|||
145487102|NCT00531284|524639393|FG006|Overall Study|Other|0|||
145487103|NCT00531284|524639394|FG007|Overall Study|Other|0|||
145487104|NCT00531284|524639395|FG008|Overall Study|Other|2|||
145487105|NCT00531284|524639396|FG009|Overall Study|Other|1|||
145487106|NCT00531284|524639397|FG010|Overall Study|Other|0|||
145487107|NCT00531284|524639398|FG011|Overall Study|Other|2|||
145487108|NCT00531284|524639399|FG012|Overall Study|Other|0|||
145487109|NCT00531284|524639400|FG013|Overall Study|Other|0|||
145487110|NCT00531284|524639401|FG014|Overall Study|Other|1|||
145487111|NCT00531284|524639402|FG015|Overall Study|Other|0|||
145487112|NCT00531284|524639403|FG016|Overall Study|Other|0|||
145487113|NCT02544321|524639409|FG000|Overall Study|Withdrawal by Subject|1|||
145487114|NCT02544321|524639410|FG001|Overall Study|Withdrawal by Subject|2|||
145487115|NCT02544321|524639409|FG000|Overall Study|Adverse Event|1|||
145487116|NCT02544321|524639410|FG001|Overall Study|Adverse Event|1|||
145487117|NCT02544321|524639409|FG000|Overall Study|Protocol Violation|0|||
145487118|NCT02544321|524639410|FG001|Overall Study|Protocol Violation|1|||
145487119|NCT03493945|524639411|FG000|Phase I Dose Escalation|Ineligible|0|||
145487120|NCT03493945|524639412|FG001|Phase I Dose Escalation|Ineligible|0|||
145487121|NCT03493945|524639413|FG002|Phase I Dose Escalation|Ineligible|1|||
145487122|NCT03493945|524639414|FG003|Phase I Dose Escalation|Ineligible|0|||
145487123|NCT03493945|524639415|FG004|Phase I Dose Escalation|Ineligible|0|||
145487124|NCT03493945|524639416|FG005|Phase I Dose Escalation|Ineligible|0|||
145487125|NCT03493945|524639417|FG006|Phase I Dose Escalation|Ineligible|0|||
145487126|NCT03493945|524639411|FG000|Phase I Dose Escalation|New therapy|0|||
145487127|NCT03493945|524639412|FG001|Phase I Dose Escalation|New therapy|1|||
145487128|NCT03493945|524639413|FG002|Phase I Dose Escalation|New therapy|0|||
145487129|NCT03493945|524639414|FG003|Phase I Dose Escalation|New therapy|0|||
145487130|NCT03493945|524639415|FG004|Phase I Dose Escalation|New therapy|0|||
145487131|NCT03493945|524639416|FG005|Phase I Dose Escalation|New therapy|0|||
145487132|NCT03493945|524639417|FG006|Phase I Dose Escalation|New therapy|0|||
145487133|NCT03493945|524639411|FG000|Phase II Dose Expansion|Refused further treatment|0|||
145487134|NCT03493945|524639412|FG001|Phase II Dose Expansion|Refused further treatment|0|||
145487135|NCT03493945|524639413|FG002|Phase II Dose Expansion|Refused further treatment|0|||
145487136|NCT03493945|524639414|FG003|Phase II Dose Expansion|Refused further treatment|0|||
145487137|NCT03493945|524639415|FG004|Phase II Dose Expansion|Refused further treatment|1|||
145487138|NCT03493945|524639416|FG005|Phase II Dose Expansion|Refused further treatment|1|||
145487139|NCT03493945|524639417|FG006|Phase II Dose Expansion|Refused further treatment|0|||
145487140|NCT03493945|524639411|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487141|NCT03493945|524639412|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487142|NCT03493945|524639413|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487143|NCT03493945|524639414|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
145487144|NCT03493945|524639415|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487145|NCT03493945|524639416|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487146|NCT03493945|524639417|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
145487147|NCT01307319|524639418|FG000|Overall Study|Adverse Event|2|||
145487148|NCT01307319|524639419|FG001|Overall Study|Adverse Event|2|||
145487149|NCT01307319|524639420|FG002|Overall Study|Adverse Event|1|||
145487150|NCT01307319|524639418|FG000|Overall Study|Lost to Follow-up|1|||
145487151|NCT01307319|524639419|FG001|Overall Study|Lost to Follow-up|0|||
145487152|NCT01307319|524639420|FG002|Overall Study|Lost to Follow-up|1|||
145487153|NCT01307319|524639418|FG000|Overall Study|Protocol Violation|1|||
145487154|NCT01307319|524639419|FG001|Overall Study|Protocol Violation|1|||
145487155|NCT01307319|524639420|FG002|Overall Study|Protocol Violation|0|||
145487156|NCT01307319|524639418|FG000|Overall Study|Withdrawal by Subject|0|||
145487157|NCT01307319|524639419|FG001|Overall Study|Withdrawal by Subject|1|||
145487158|NCT01307319|524639420|FG002|Overall Study|Withdrawal by Subject|2|||
145487159|NCT01307319|524639418|FG000|Overall Study|Other|0|||
145487160|NCT01307319|524639419|FG001|Overall Study|Other|4|||
145487161|NCT01307319|524639420|FG002|Overall Study|Other|3|||
145487162|NCT04388111|524639421|FG000|Overall Study|Lost to Follow-up|5|||
145487163|NCT04388111|524639422|FG001|Overall Study|Lost to Follow-up|3|||
145487164|NCT04388111|524639421|FG000|Overall Study|Adverse Event|1|||
145487165|NCT04388111|524639422|FG001|Overall Study|Adverse Event|1|||
145487166|NCT04388111|524639421|FG000|Overall Study|Protocol Violation|2|||
145487167|NCT04388111|524639422|FG001|Overall Study|Protocol Violation|4|||
145487168|NCT04388111|524639421|FG000|Overall Study|Withdrawal by Subject|1|||
145487169|NCT04388111|524639422|FG001|Overall Study|Withdrawal by Subject|0|||
145487170|NCT02152631|524639423|FG000|Overall Study|Adverse Event|32|||
145487171|NCT02152631|524639424|FG001|Overall Study|Adverse Event|4|||
145487172|NCT02152631|524639423|FG000|Overall Study|Withdrawal by Subject|13|||
145487173|NCT02152631|524639424|FG001|Overall Study|Withdrawal by Subject|16|||
145487174|NCT02152631|524639423|FG000|Overall Study|Noncompliance with study drug|1|||
145487175|NCT02152631|524639424|FG001|Overall Study|Noncompliance with study drug|0|||
145487176|NCT02152631|524639423|FG000|Overall Study|Physician Decision|1|||
145487177|NCT02152631|524639424|FG001|Overall Study|Physician Decision|2|||
145487178|NCT02152631|524639423|FG000|Overall Study|Lost to Follow-up|0|||
145487179|NCT02152631|524639424|FG001|Overall Study|Lost to Follow-up|1|||
145487180|NCT02152631|524639423|FG000|Overall Study|On Treatment|19|||
145487181|NCT02152631|524639424|FG001|Overall Study|On Treatment|3|||
145487182|NCT00527735|524639425|FG000|Overall Study|Disease progression|47|||
145487183|NCT00527735|524639426|FG001|Overall Study|Disease progression|61|||
145487184|NCT00527735|524639427|FG002|Overall Study|Disease progression|53|||
145487185|NCT00527735|524639425|FG000|Overall Study|Death|23|||
145487186|NCT00527735|524639426|FG001|Overall Study|Death|13|||
145487187|NCT00527735|524639427|FG002|Overall Study|Death|15|||
145487188|NCT00527735|524639425|FG000|Overall Study|Completed treatment in treatment phase|14|||
145487189|NCT00527735|524639426|FG001|Overall Study|Completed treatment in treatment phase|13|||
145487190|NCT00527735|524639427|FG002|Overall Study|Completed treatment in treatment phase|18|||
145487191|NCT00527735|524639425|FG000|Overall Study|Adverse Event|10|||
145487192|NCT00527735|524639426|FG001|Overall Study|Adverse Event|6|||
145487193|NCT00527735|524639427|FG002|Overall Study|Adverse Event|7|||
145487194|NCT00527735|524639425|FG000|Overall Study|Not identified|5|||
145487195|NCT00527735|524639426|FG001|Overall Study|Not identified|5|||
145487196|NCT00527735|524639427|FG002|Overall Study|Not identified|5|||
145487197|NCT00527735|524639425|FG000|Overall Study|Withdrawal by Subject|5|||
145487198|NCT00527735|524639426|FG001|Overall Study|Withdrawal by Subject|4|||
145487199|NCT00527735|524639427|FG002|Overall Study|Withdrawal by Subject|3|||
145487200|NCT00527735|524639425|FG000|Overall Study|No longer met study criteria|2|||
145487201|NCT00527735|524639426|FG001|Overall Study|No longer met study criteria|2|||
145487202|NCT00527735|524639427|FG002|Overall Study|No longer met study criteria|1|||
145487203|NCT00527735|524639425|FG000|Overall Study|Lost to Follow-up|0|||
145487204|NCT00527735|524639426|FG001|Overall Study|Lost to Follow-up|0|||
145487205|NCT00527735|524639427|FG002|Overall Study|Lost to Follow-up|3|||
145487206|NCT00527735|524639425|FG000|Overall Study|Poor compliance or noncompliance|0|||
145487207|NCT00527735|524639426|FG001|Overall Study|Poor compliance or noncompliance|1|||
145487208|NCT00527735|524639427|FG002|Overall Study|Poor compliance or noncompliance|1|||
145487209|NCT00527735|524639425|FG000|Overall Study|Completed treatment during maintenance|2|||
145487210|NCT00527735|524639426|FG001|Overall Study|Completed treatment during maintenance|2|||
145487211|NCT00527735|524639427|FG002|Overall Study|Completed treatment during maintenance|1|||
145487212|NCT01855412|524639428|FG000|Overall Study|Death|77|||
145487213|NCT01855412|524639429|FG001|Overall Study|Death|123|||
145487214|NCT01855412|524639430|FG002|Overall Study|Death|30|||
145487215|NCT01855412|524639428|FG000|Overall Study|Lost to Follow-up|28|||
145487216|NCT01855412|524639429|FG001|Overall Study|Lost to Follow-up|46|||
145487217|NCT01855412|524639430|FG002|Overall Study|Lost to Follow-up|15|||
145487218|NCT01855412|524639428|FG000|Overall Study|Withdrawal by Subject|77|||
145487219|NCT01855412|524639429|FG001|Overall Study|Withdrawal by Subject|123|||
145487220|NCT01855412|524639430|FG002|Overall Study|Withdrawal by Subject|24|||
145487221|NCT01855412|524639428|FG000|Overall Study|Physician Decision|25|||
145487222|NCT01855412|524639429|FG001|Overall Study|Physician Decision|31|||
145487223|NCT01855412|524639430|FG002|Overall Study|Physician Decision|3|||
145487224|NCT01855412|524639428|FG000|Overall Study|Site Closure|4|||
145487225|NCT01855412|524639429|FG001|Overall Study|Site Closure|18|||
145487226|NCT01855412|524639430|FG002|Overall Study|Site Closure|1|||
145487227|NCT01855412|524639428|FG000|Overall Study|Reason not Specified|1|||
145487228|NCT01855412|524639429|FG001|Overall Study|Reason not Specified|2|||
145487229|NCT01855412|524639430|FG002|Overall Study|Reason not Specified|3|||
145487230|NCT03347123|524639434|FG000|Overall Study|Death|1|||
145487231|NCT03347123|524639435|FG001|Overall Study|Death|2|||
145487232|NCT03347123|524639436|FG002|Overall Study|Death|0|||
145487233|NCT03347123|524639437|FG003|Overall Study|Death|0|||
145487234|NCT03347123|524639438|FG004|Overall Study|Death|0|||
145487235|NCT03347123|524639439|FG005|Overall Study|Death|0|||
145487236|NCT03347123|524639440|FG006|Overall Study|Death|0|||
145487237|NCT03347123|524639434|FG000|Overall Study|Withdrawal by Subject|1|||
145487238|NCT03347123|524639435|FG001|Overall Study|Withdrawal by Subject|0|||
145487239|NCT03347123|524639436|FG002|Overall Study|Withdrawal by Subject|0|||
145487240|NCT03347123|524639437|FG003|Overall Study|Withdrawal by Subject|0|||
145487241|NCT03347123|524639438|FG004|Overall Study|Withdrawal by Subject|0|||
145487242|NCT03347123|524639439|FG005|Overall Study|Withdrawal by Subject|0|||
145487243|NCT03347123|524639440|FG006|Overall Study|Withdrawal by Subject|0|||
145487244|NCT03347123|524639434|FG000|Overall Study|Reason not Specified|3|||
145487245|NCT03347123|524639435|FG001|Overall Study|Reason not Specified|4|||
145487246|NCT03347123|524639436|FG002|Overall Study|Reason not Specified|0|||
145487247|NCT03347123|524639437|FG003|Overall Study|Reason not Specified|0|||
145487248|NCT03347123|524639438|FG004|Overall Study|Reason not Specified|0|||
145487249|NCT03347123|524639439|FG005|Overall Study|Reason not Specified|0|||
145487250|NCT03347123|524639440|FG006|Overall Study|Reason not Specified|0|||
145487251|NCT00346216|524639448|FG000|Overall Study|Other|181|||
145487252|NCT00346216|524639449|FG001|Overall Study|Other|231|||
145487253|NCT00346216|524639450|FG002|Overall Study|Other|205|||
145487254|NCT00346216|524639448|FG000|Overall Study|No longer willing to participate|600|||
145487255|NCT00346216|524639449|FG001|Overall Study|No longer willing to participate|606|||
145487256|NCT00346216|524639450|FG002|Overall Study|No longer willing to participate|585|||
145487257|NCT00346216|524639448|FG000|Overall Study|Withdrawal by Subject|661|||
145487258|NCT00346216|524639449|FG001|Overall Study|Withdrawal by Subject|692|||
145487259|NCT00346216|524639450|FG002|Overall Study|Withdrawal by Subject|651|||
145487260|NCT00346216|524639448|FG000|Overall Study|Lost to Follow-up|611|||
145487261|NCT00346216|524639449|FG001|Overall Study|Lost to Follow-up|588|||
145487262|NCT00346216|524639450|FG002|Overall Study|Lost to Follow-up|542|||
145487263|NCT00346216|524639448|FG000|Overall Study|Physician Decision|80|||
145487264|NCT00346216|524639449|FG001|Overall Study|Physician Decision|76|||
145487265|NCT00346216|524639450|FG002|Overall Study|Physician Decision|59|||
145487266|NCT00346216|524639448|FG000|Overall Study|Does not meet entrance criteria|13|||
145487267|NCT00346216|524639449|FG001|Overall Study|Does not meet entrance criteria|10|||
145487268|NCT00346216|524639450|FG002|Overall Study|Does not meet entrance criteria|8|||
145487269|NCT00346216|524639448|FG000|Overall Study|Death|189|||
145487270|NCT00346216|524639449|FG001|Overall Study|Death|192|||
145487271|NCT00346216|524639450|FG002|Overall Study|Death|228|||
145487272|NCT00346216|524639448|FG000|Overall Study|Study terminated by sponsor|11|||
145487273|NCT00346216|524639449|FG001|Overall Study|Study terminated by sponsor|4|||
145487274|NCT00346216|524639450|FG002|Overall Study|Study terminated by sponsor|8|||
145648199|NCT03580369|525228626|FG002|Overall Study|Technical problems|0|||
145487275|NCT00346216|524639448|FG000|Overall Study|Missing Subject Summary Status|62|||
145487276|NCT00346216|524639449|FG001|Overall Study|Missing Subject Summary Status|61|||
145487277|NCT00346216|524639450|FG002|Overall Study|Missing Subject Summary Status|62|||
145487278|NCT01276639|524639451|FG000|Week 0 to 16|Death|1|||
145487279|NCT01276639|524639452|FG001|Week 0 to 16|Death|0|||
145487280|NCT01276639|524639453|FG002|Week 0 to 16|Death|0|||
145487281|NCT01276639|524639454|FG003|Week 0 to 16|Death|0|||
145487282|NCT01276639|524639455|FG004|Week 0 to 16|Death|0|||
145487283|NCT01276639|524639451|FG000|Week 0 to 16|Adverse Event|11|||
145487284|NCT01276639|524639452|FG001|Week 0 to 16|Adverse Event|8|||
145487285|NCT01276639|524639453|FG002|Week 0 to 16|Adverse Event|11|||
145487286|NCT01276639|524639454|FG003|Week 0 to 16|Adverse Event|0|||
145487287|NCT01276639|524639455|FG004|Week 0 to 16|Adverse Event|0|||
145487288|NCT01276639|524639451|FG000|Week 0 to 16|Lack of Efficacy|20|||
145487289|NCT01276639|524639452|FG001|Week 0 to 16|Lack of Efficacy|15|||
145487290|NCT01276639|524639453|FG002|Week 0 to 16|Lack of Efficacy|25|||
145487291|NCT01276639|524639454|FG003|Week 0 to 16|Lack of Efficacy|0|||
145487292|NCT01276639|524639455|FG004|Week 0 to 16|Lack of Efficacy|0|||
145487293|NCT01276639|524639451|FG000|Week 0 to 16|Lost to Follow-up|3|||
145487294|NCT01276639|524639452|FG001|Week 0 to 16|Lost to Follow-up|5|||
145487295|NCT01276639|524639453|FG002|Week 0 to 16|Lost to Follow-up|3|||
145487296|NCT01276639|524639454|FG003|Week 0 to 16|Lost to Follow-up|0|||
145487297|NCT01276639|524639455|FG004|Week 0 to 16|Lost to Follow-up|0|||
145487298|NCT01276639|524639451|FG000|Week 0 to 16|Withdrawal by Subject|8|||
145487299|NCT01276639|524639452|FG001|Week 0 to 16|Withdrawal by Subject|5|||
145487300|NCT01276639|524639453|FG002|Week 0 to 16|Withdrawal by Subject|4|||
145487301|NCT01276639|524639454|FG003|Week 0 to 16|Withdrawal by Subject|0|||
145487302|NCT01276639|524639455|FG004|Week 0 to 16|Withdrawal by Subject|0|||
145487303|NCT01276639|524639451|FG000|Week 0 to 16|Other|7|||
145487304|NCT01276639|524639452|FG001|Week 0 to 16|Other|7|||
145487305|NCT01276639|524639453|FG002|Week 0 to 16|Other|2|||
145487306|NCT01276639|524639454|FG003|Week 0 to 16|Other|0|||
145487307|NCT01276639|524639455|FG004|Week 0 to 16|Other|0|||
145487308|NCT01276639|524639451|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
145487309|NCT01276639|524639452|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
145487310|NCT01276639|524639453|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
145487311|NCT01276639|524639454|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
145487312|NCT01276639|524639455|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
145487313|NCT01276639|524639451|FG000|Week 16 to 52|Death|1|||
145487314|NCT01276639|524639452|FG001|Week 16 to 52|Death|0|||
145487315|NCT01276639|524639453|FG002|Week 16 to 52|Death|0|||
145487316|NCT01276639|524639454|FG003|Week 16 to 52|Death|0|||
145487317|NCT01276639|524639455|FG004|Week 16 to 52|Death|0|||
145487318|NCT01276639|524639451|FG000|Week 16 to 52|Adverse Event|10|||
145487319|NCT01276639|524639452|FG001|Week 16 to 52|Adverse Event|13|||
145487320|NCT01276639|524639453|FG002|Week 16 to 52|Adverse Event|0|||
145487321|NCT01276639|524639454|FG003|Week 16 to 52|Adverse Event|1|||
145487322|NCT01276639|524639455|FG004|Week 16 to 52|Adverse Event|3|||
145487323|NCT01276639|524639451|FG000|Week 16 to 52|Lack of Efficacy|99|||
145487324|NCT01276639|524639452|FG001|Week 16 to 52|Lack of Efficacy|71|||
145487325|NCT01276639|524639453|FG002|Week 16 to 52|Lack of Efficacy|0|||
145487326|NCT01276639|524639454|FG003|Week 16 to 52|Lack of Efficacy|14|||
145487327|NCT01276639|524639455|FG004|Week 16 to 52|Lack of Efficacy|13|||
145487328|NCT01276639|524639451|FG000|Week 16 to 52|Lost to Follow-up|3|||
145487329|NCT01276639|524639452|FG001|Week 16 to 52|Lost to Follow-up|1|||
145487330|NCT01276639|524639453|FG002|Week 16 to 52|Lost to Follow-up|0|||
145487331|NCT01276639|524639454|FG003|Week 16 to 52|Lost to Follow-up|0|||
145487332|NCT01276639|524639455|FG004|Week 16 to 52|Lost to Follow-up|1|||
145487333|NCT01276639|524639451|FG000|Week 16 to 52|Withdrawal by Subject|4|||
145487334|NCT01276639|524639452|FG001|Week 16 to 52|Withdrawal by Subject|4|||
145487335|NCT01276639|524639453|FG002|Week 16 to 52|Withdrawal by Subject|0|||
145487336|NCT01276639|524639454|FG003|Week 16 to 52|Withdrawal by Subject|0|||
145487337|NCT01276639|524639455|FG004|Week 16 to 52|Withdrawal by Subject|1|||
145487338|NCT01276639|524639451|FG000|Week 16 to 52|Other|10|||
145487339|NCT01276639|524639452|FG001|Week 16 to 52|Other|12|||
145648200|NCT03580369|525228627|FG003|Overall Study|Technical problems|0|||
145648201|NCT03580369|525228628|FG004|Overall Study|Technical problems|1|||
145648202|NCT03580369|525228629|FG005|Overall Study|Technical problems|0|||
145648203|NCT03580369|525228630|FG006|Overall Study|Technical problems|2|||
145487340|NCT01276639|524639453|FG002|Week 16 to 52|Other|0|||
145487341|NCT01276639|524639454|FG003|Week 16 to 52|Other|1|||
145648204|NCT03580369|525228631|FG007|Overall Study|Technical problems|0|||
145648205|NCT03580369|525228624|FG000|Overall Study|Pregnancy|2|||
145648206|NCT03580369|525228625|FG001|Overall Study|Pregnancy|0|||
145648207|NCT03580369|525228626|FG002|Overall Study|Pregnancy|3|||
145648208|NCT03580369|525228627|FG003|Overall Study|Pregnancy|0|||
145648209|NCT03580369|525228628|FG004|Overall Study|Pregnancy|2|||
145648210|NCT03580369|525228629|FG005|Overall Study|Pregnancy|0|||
145648211|NCT03580369|525228630|FG006|Overall Study|Pregnancy|0|||
145648212|NCT03580369|525228631|FG007|Overall Study|Pregnancy|0|||
145487342|NCT01276639|524639455|FG004|Week 16 to 52|Other|3|||
145487343|NCT03431441|524639456|FG000|Overall Study|Withdrawal by Subject|2|||
145487344|NCT03431441|524639456|FG000|Overall Study|Adverse Event|2|||
145487345|NCT03431441|524639456|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
145487346|NCT03985761|524639459|FG000|Overall Study|Withdrawal by Subject|2|||
145487347|NCT03985761|524639460|FG001|Overall Study|Withdrawal by Subject|3|||
145487348|NCT03956550|524639461|FG000|Overall Study|Sponsor decision|65|||
145487349|NCT03956550|524639462|FG001|Overall Study|Sponsor decision|66|||
145487350|NCT03956550|524639463|FG002|Overall Study|Sponsor decision|64|||
145487351|NCT03956550|524639461|FG000|Overall Study|Adverse Event|0|||
145487352|NCT03956550|524639462|FG001|Overall Study|Adverse Event|1|||
145487353|NCT03956550|524639463|FG002|Overall Study|Adverse Event|0|||
145487354|NCT03956550|524639461|FG000|Overall Study|Withdrawal by Subject|5|||
145648213|NCT03580369|525228624|FG000|Overall Study|Lost to Follow-up|2|||
145487355|NCT03956550|524639462|FG001|Overall Study|Withdrawal by Subject|5|||
145487356|NCT03956550|524639463|FG002|Overall Study|Withdrawal by Subject|6|||
145487357|NCT02366312|524639469|FG000|Overall Study|Lost to Follow-up|0|||
145487358|NCT02366312|524639470|FG001|Overall Study|Lost to Follow-up|1|||
145487359|NCT02532465|524639471|FG000|Overall Study|Protocol Violation|1|||
145487360|NCT02532465|524639472|FG001|Overall Study|Protocol Violation|0|||
145487361|NCT02532465|524639471|FG000|Overall Study|Lack of Efficacy|0|||
145487362|NCT02532465|524639472|FG001|Overall Study|Lack of Efficacy|1|||
145487363|NCT03719131|524639474|FG000|Overall Study|Death|1|||
145487364|NCT03719131|524639475|FG001|Overall Study|Death|2|||
145487365|NCT01544920|524639476|FG000|Overall Study|Adverse Event|0|||
145487366|NCT01544920|524639477|FG001|Overall Study|Adverse Event|3|||
145487367|NCT01544920|524639476|FG000|Overall Study|Death|0|||
145487368|NCT01544920|524639477|FG001|Overall Study|Death|1|||
145487369|NCT01544920|524639476|FG000|Overall Study|Lost to Follow-up|11|||
145487370|NCT01544920|524639477|FG001|Overall Study|Lost to Follow-up|12|||
145487371|NCT01544920|524639476|FG000|Overall Study|Protocol Violation|0|||
145487372|NCT01544920|524639477|FG001|Overall Study|Protocol Violation|2|||
145487373|NCT01544920|524639476|FG000|Overall Study|Physician Decision|4|||
145487374|NCT01544920|524639477|FG001|Overall Study|Physician Decision|1|||
145487375|NCT01544920|524639476|FG000|Overall Study|Withdrawal by Subject|4|||
145487376|NCT01544920|524639477|FG001|Overall Study|Withdrawal by Subject|4|||
145487377|NCT03244917|524639486|FG000|Overall Study|Lost to Follow-up|2|||
145487378|NCT03244917|524639487|FG001|Overall Study|Lost to Follow-up|2|||
145487379|NCT03001557|524639488|FG000|Core Phase|Randomized but not treated|0|||
145487380|NCT03001557|524639489|FG001|Core Phase|Randomized but not treated|0|||
145487381|NCT03001557|524639490|FG002|Core Phase|Randomized but not treated|1|||
145487382|NCT03001557|524639491|FG003|Core Phase|Randomized but not treated|0|||
145487383|NCT03001557|524639492|FG004|Core Phase|Randomized but not treated|0|||
145487384|NCT03001557|524639493|FG005|Core Phase|Randomized but not treated|0|||
145487385|NCT03001557|524639494|FG006|Core Phase|Randomized but not treated|0|||
145487386|NCT03001557|524639495|FG007|Core Phase|Randomized but not treated|0|||
145487387|NCT03001557|524639488|FG000|Extension Phase|Adverse Event|0|||
145487388|NCT03001557|524639489|FG001|Extension Phase|Adverse Event|0|||
145487389|NCT03001557|524639490|FG002|Extension Phase|Adverse Event|0|||
145487390|NCT03001557|524639491|FG003|Extension Phase|Adverse Event|0|||
145487391|NCT03001557|524639492|FG004|Extension Phase|Adverse Event|0|||
145487392|NCT03001557|524639493|FG005|Extension Phase|Adverse Event|2|||
145487393|NCT03001557|524639494|FG006|Extension Phase|Adverse Event|0|||
145487394|NCT03001557|524639495|FG007|Extension Phase|Adverse Event|0|||
145487395|NCT03001557|524639488|FG000|Extension Phase|Withdrawal by Subject|0|||
145487396|NCT03001557|524639489|FG001|Extension Phase|Withdrawal by Subject|0|||
145487397|NCT03001557|524639490|FG002|Extension Phase|Withdrawal by Subject|0|||
145487398|NCT03001557|524639491|FG003|Extension Phase|Withdrawal by Subject|0|||
145487399|NCT03001557|524639492|FG004|Extension Phase|Withdrawal by Subject|0|||
145487400|NCT03001557|524639493|FG005|Extension Phase|Withdrawal by Subject|1|||
145487401|NCT03001557|524639494|FG006|Extension Phase|Withdrawal by Subject|5|||
145487402|NCT03001557|524639495|FG007|Extension Phase|Withdrawal by Subject|2|||
145487403|NCT03001557|524639488|FG000|Extension Phase|Lost to Follow-up|0|||
145487404|NCT03001557|524639489|FG001|Extension Phase|Lost to Follow-up|0|||
145487405|NCT03001557|524639490|FG002|Extension Phase|Lost to Follow-up|0|||
145487406|NCT03001557|524639491|FG003|Extension Phase|Lost to Follow-up|0|||
145487407|NCT03001557|524639492|FG004|Extension Phase|Lost to Follow-up|0|||
145487408|NCT03001557|524639493|FG005|Extension Phase|Lost to Follow-up|0|||
145487409|NCT03001557|524639494|FG006|Extension Phase|Lost to Follow-up|2|||
145487410|NCT03001557|524639495|FG007|Extension Phase|Lost to Follow-up|1|||
145487411|NCT03001557|524639488|FG000|Extension Phase|Administrative Reason|0|||
145487412|NCT03001557|524639489|FG001|Extension Phase|Administrative Reason|0|||
145487413|NCT03001557|524639490|FG002|Extension Phase|Administrative Reason|0|||
145487414|NCT03001557|524639491|FG003|Extension Phase|Administrative Reason|0|||
145487415|NCT03001557|524639492|FG004|Extension Phase|Administrative Reason|0|||
145487416|NCT03001557|524639493|FG005|Extension Phase|Administrative Reason|1|||
145487417|NCT03001557|524639494|FG006|Extension Phase|Administrative Reason|3|||
145487418|NCT03001557|524639495|FG007|Extension Phase|Administrative Reason|3|||
145487419|NCT03001557|524639488|FG000|Extension Phase|Loss of caregiver|0|||
145648214|NCT03580369|525228625|FG001|Overall Study|Lost to Follow-up|0|||
145487420|NCT03001557|524639489|FG001|Extension Phase|Loss of caregiver|0|||
145487421|NCT03001557|524639490|FG002|Extension Phase|Loss of caregiver|0|||
145487422|NCT03001557|524639491|FG003|Extension Phase|Loss of caregiver|0|||
145487423|NCT03001557|524639492|FG004|Extension Phase|Loss of caregiver|0|||
145487424|NCT03001557|524639493|FG005|Extension Phase|Loss of caregiver|0|||
145487425|NCT03001557|524639494|FG006|Extension Phase|Loss of caregiver|1|||
145487426|NCT03001557|524639495|FG007|Extension Phase|Loss of caregiver|0|||
145487427|NCT03001557|524639488|FG000|Extension Phase|Others|0|||
145487428|NCT03001557|524639489|FG001|Extension Phase|Others|0|||
145487429|NCT03001557|524639490|FG002|Extension Phase|Others|0|||
145487430|NCT03001557|524639491|FG003|Extension Phase|Others|0|||
145487431|NCT03001557|524639492|FG004|Extension Phase|Others|0|||
145487432|NCT03001557|524639493|FG005|Extension Phase|Others|1|||
145487433|NCT03001557|524639494|FG006|Extension Phase|Others|3|||
145487434|NCT03001557|524639495|FG007|Extension Phase|Others|0|||
145487435|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
145487436|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
145487437|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Death|1|||
145487438|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Death|2|||
145487439|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
145487440|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
145487441|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
145487442|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
145487443|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
145487444|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
145487445|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
145487446|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
145487447|NCT01794000|524639496|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
145487448|NCT01794000|524639497|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
145487449|NCT01794000|524639496|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
145487450|NCT01794000|524639497|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
145648215|NCT03580369|525228626|FG002|Overall Study|Lost to Follow-up|2|||
145648216|NCT03580369|525228627|FG003|Overall Study|Lost to Follow-up|0|||
145648217|NCT03580369|525228628|FG004|Overall Study|Lost to Follow-up|3|||
145648218|NCT03580369|525228629|FG005|Overall Study|Lost to Follow-up|0|||
145648219|NCT03580369|525228630|FG006|Overall Study|Lost to Follow-up|1|||
145648220|NCT03580369|525228631|FG007|Overall Study|Lost to Follow-up|0|||
145648221|NCT03580369|525228624|FG000|Overall Study|Physician Decision|4|||
145487451|NCT01272232|524639500|FG000|Weeks 0-56|Adverse Event|39|||
145487452|NCT01272232|524639501|FG001|Weeks 0-56|Adverse Event|18|||
145487453|NCT01272232|524639502|FG002|Weeks 0-56|Adverse Event|7|||
145487454|NCT01272232|524639500|FG000|Weeks 0-56|Lack of Efficacy|0|||
145487455|NCT01272232|524639501|FG001|Weeks 0-56|Lack of Efficacy|0|||
145487456|NCT01272232|524639502|FG002|Weeks 0-56|Lack of Efficacy|3|||
145487457|NCT01272232|524639500|FG000|Weeks 0-56|Protocol Violation|12|||
145487458|NCT01272232|524639501|FG001|Weeks 0-56|Protocol Violation|8|||
145487459|NCT01272232|524639502|FG002|Weeks 0-56|Protocol Violation|13|||
145487460|NCT01272232|524639500|FG000|Weeks 0-56|Withdrawal criteria|32|||
145487461|NCT01272232|524639501|FG001|Weeks 0-56|Withdrawal criteria|14|||
145487462|NCT01272232|524639502|FG002|Weeks 0-56|Withdrawal criteria|37|||
145487463|NCT01272232|524639500|FG000|Weeks 0-56|Unclassified|16|||
145487464|NCT01272232|524639501|FG001|Weeks 0-56|Unclassified|7|||
145487465|NCT01272232|524639502|FG002|Weeks 0-56|Unclassified|12|||
145487466|NCT01272232|524639500|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
145487467|NCT01272232|524639501|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
145487468|NCT01272232|524639502|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
145487469|NCT01272232|524639500|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
145487470|NCT01272232|524639501|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
145487471|NCT01272232|524639502|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
145487472|NCT01272232|524639500|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
145487473|NCT01272232|524639501|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
145487474|NCT01272232|524639502|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
145487475|NCT01272232|524639500|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
145487476|NCT01272232|524639501|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
145487477|NCT01272232|524639502|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
145487478|NCT01272232|524639500|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
145487479|NCT01272232|524639501|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
145487480|NCT01272232|524639502|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
145487481|NCT02159066|524639503|FG000|Part I|Adverse Event|7|||
145487482|NCT02159066|524639504|FG001|Part I|Adverse Event|5|||
145487483|NCT02159066|524639505|FG002|Part I|Adverse Event|0|||
145487484|NCT02159066|524639506|FG003|Part I|Adverse Event|0|||
145487485|NCT02159066|524639507|FG004|Part I|Adverse Event|0|||
145487486|NCT02159066|524639508|FG005|Part I|Adverse Event|0|||
145487487|NCT02159066|524639503|FG000|Part I|Death|11|||
145648222|NCT03580369|525228625|FG001|Overall Study|Physician Decision|0|||
145487488|NCT02159066|524639504|FG001|Part I|Death|9|||
145487489|NCT02159066|524639505|FG002|Part I|Death|0|||
145487490|NCT02159066|524639506|FG003|Part I|Death|0|||
145487491|NCT02159066|524639507|FG004|Part I|Death|0|||
145648223|NCT03580369|525228626|FG002|Overall Study|Physician Decision|4|||
145487492|NCT02159066|524639508|FG005|Part I|Death|0|||
145487493|NCT02159066|524639503|FG000|Part I|Progressive Disease|37|||
145648224|NCT03580369|525228627|FG003|Overall Study|Physician Decision|1|||
145487494|NCT02159066|524639504|FG001|Part I|Progressive Disease|46|||
145487495|NCT02159066|524639505|FG002|Part I|Progressive Disease|0|||
145487496|NCT02159066|524639506|FG003|Part I|Progressive Disease|0|||
145487497|NCT02159066|524639507|FG004|Part I|Progressive Disease|0|||
145487498|NCT02159066|524639508|FG005|Part I|Progressive Disease|0|||
145487499|NCT02159066|524639503|FG000|Part I|New Therapy for Study Indication|5|||
145648225|NCT03580369|525228628|FG004|Overall Study|Physician Decision|1|||
145487500|NCT02159066|524639504|FG001|Part I|New Therapy for Study Indication|4|||
145487501|NCT02159066|524639505|FG002|Part I|New Therapy for Study Indication|0|||
145487502|NCT02159066|524639506|FG003|Part I|New Therapy for Study Indication|0|||
145487503|NCT02159066|524639507|FG004|Part I|New Therapy for Study Indication|0|||
145487504|NCT02159066|524639508|FG005|Part I|New Therapy for Study Indication|0|||
145487505|NCT02159066|524639503|FG000|Part I|Termination of participants from the study|3|||
145487506|NCT02159066|524639504|FG001|Part I|Termination of participants from the study|3|||
145487507|NCT02159066|524639505|FG002|Part I|Termination of participants from the study|0|||
145487508|NCT02159066|524639506|FG003|Part I|Termination of participants from the study|0|||
145487509|NCT02159066|524639507|FG004|Part I|Termination of participants from the study|0|||
145487510|NCT02159066|524639508|FG005|Part I|Termination of participants from the study|0|||
145487511|NCT02159066|524639503|FG000|Part I|Physician Decision|2|||
145487512|NCT02159066|524639504|FG001|Part I|Physician Decision|9|||
145487513|NCT02159066|524639505|FG002|Part I|Physician Decision|0|||
145487514|NCT02159066|524639506|FG003|Part I|Physician Decision|0|||
145487515|NCT02159066|524639507|FG004|Part I|Physician Decision|0|||
145487516|NCT02159066|524639508|FG005|Part I|Physician Decision|0|||
145487517|NCT02159066|524639503|FG000|Part I|Participant/Guardian Decision|9|||
145487518|NCT02159066|524639504|FG001|Part I|Participant/Guardian Decision|3|||
145487519|NCT02159066|524639505|FG002|Part I|Participant/Guardian Decision|0|||
145487520|NCT02159066|524639506|FG003|Part I|Participant/Guardian Decision|0|||
145487521|NCT02159066|524639507|FG004|Part I|Participant/Guardian Decision|0|||
145487522|NCT02159066|524639508|FG005|Part I|Participant/Guardian Decision|0|||
145487523|NCT02159066|524639503|FG000|Part I|Missing Data|1|||
145487524|NCT02159066|524639504|FG001|Part I|Missing Data|0|||
145487525|NCT02159066|524639505|FG002|Part I|Missing Data|0|||
145487526|NCT02159066|524639506|FG003|Part I|Missing Data|0|||
145487527|NCT02159066|524639507|FG004|Part I|Missing Data|0|||
145487528|NCT02159066|524639508|FG005|Part I|Missing Data|0|||
145487529|NCT02159066|524639503|FG000|Part II|Adverse Event|0|||
145487530|NCT02159066|524639504|FG001|Part II|Adverse Event|0|||
145487531|NCT02159066|524639505|FG002|Part II|Adverse Event|1|||
145487532|NCT02159066|524639506|FG003|Part II|Adverse Event|0|||
145487533|NCT02159066|524639507|FG004|Part II|Adverse Event|1|||
145487534|NCT02159066|524639508|FG005|Part II|Adverse Event|1|||
145487535|NCT02159066|524639503|FG000|Part II|Death|0|||
145487536|NCT02159066|524639504|FG001|Part II|Death|0|||
145487537|NCT02159066|524639505|FG002|Part II|Death|1|||
145487538|NCT02159066|524639506|FG003|Part II|Death|0|||
145487539|NCT02159066|524639507|FG004|Part II|Death|2|||
145487540|NCT02159066|524639508|FG005|Part II|Death|1|||
145487541|NCT02159066|524639503|FG000|Part II|Progressive Disease|0|||
145487542|NCT02159066|524639504|FG001|Part II|Progressive Disease|0|||
145487543|NCT02159066|524639505|FG002|Part II|Progressive Disease|35|||
145487544|NCT02159066|524639506|FG003|Part II|Progressive Disease|1|||
145487545|NCT02159066|524639507|FG004|Part II|Progressive Disease|7|||
145487546|NCT02159066|524639508|FG005|Part II|Progressive Disease|4|||
145487547|NCT02159066|524639503|FG000|Part II|New Therapy for Study Indication|0|||
145487548|NCT02159066|524639504|FG001|Part II|New Therapy for Study Indication|0|||
145487549|NCT02159066|524639505|FG002|Part II|New Therapy for Study Indication|0|||
145648226|NCT03580369|525228629|FG005|Overall Study|Physician Decision|0|||
145648227|NCT03580369|525228630|FG006|Overall Study|Physician Decision|0|||
145648228|NCT03580369|525228631|FG007|Overall Study|Physician Decision|0|||
145648229|NCT03580369|525228624|FG000|Overall Study|Lack of Efficacy|3|||
145648230|NCT03580369|525228625|FG001|Overall Study|Lack of Efficacy|0|||
145648231|NCT03580369|525228626|FG002|Overall Study|Lack of Efficacy|7|||
145648232|NCT03580369|525228627|FG003|Overall Study|Lack of Efficacy|0|||
145648233|NCT03580369|525228628|FG004|Overall Study|Lack of Efficacy|2|||
145487550|NCT02159066|524639506|FG003|Part II|New Therapy for Study Indication|0|||
145487551|NCT02159066|524639507|FG004|Part II|New Therapy for Study Indication|1|||
145487552|NCT02159066|524639508|FG005|Part II|New Therapy for Study Indication|0|||
145487553|NCT02159066|524639503|FG000|Part II|Physician Decision|0|||
145648234|NCT03580369|525228629|FG005|Overall Study|Lack of Efficacy|0|||
145648235|NCT03580369|525228630|FG006|Overall Study|Lack of Efficacy|3|||
145487554|NCT02159066|524639504|FG001|Part II|Physician Decision|0|||
145487555|NCT02159066|524639505|FG002|Part II|Physician Decision|1|||
145487556|NCT02159066|524639506|FG003|Part II|Physician Decision|0|||
145487557|NCT02159066|524639507|FG004|Part II|Physician Decision|0|||
145487558|NCT02159066|524639508|FG005|Part II|Physician Decision|0|||
145487559|NCT02159066|524639503|FG000|Part II|Participant/Guardian Decision|0|||
145487560|NCT02159066|524639504|FG001|Part II|Participant/Guardian Decision|0|||
145648236|NCT03580369|525228631|FG007|Overall Study|Lack of Efficacy|0|||
145487561|NCT02159066|524639505|FG002|Part II|Participant/Guardian Decision|0|||
145487562|NCT02159066|524639506|FG003|Part II|Participant/Guardian Decision|0|||
145487563|NCT02159066|524639507|FG004|Part II|Participant/Guardian Decision|2|||
145487564|NCT02159066|524639508|FG005|Part II|Participant/Guardian Decision|0|||
145487565|NCT00796666|524639509|FG000|Overall Study|Death|2|||
145487566|NCT00796666|524639510|FG001|Overall Study|Death|4|||
145487567|NCT00796666|524639509|FG000|Overall Study|Withdrawal by Subject|2|||
145487568|NCT00796666|524639510|FG001|Overall Study|Withdrawal by Subject|0|||
145648237|NCT03580369|525228624|FG000|Overall Study|Protocol Violation|6|||
145487569|NCT00796666|524639509|FG000|Overall Study|Adverse Event|7|||
145487570|NCT00796666|524639510|FG001|Overall Study|Adverse Event|5|||
145487571|NCT00796666|524639509|FG000|Overall Study|Protocol Violation|1|||
145487572|NCT00796666|524639510|FG001|Overall Study|Protocol Violation|0|||
145487573|NCT00796666|524639509|FG000|Overall Study|Other|1|||
145487574|NCT00796666|524639510|FG001|Overall Study|Other|0|||
145487575|NCT00796666|524639509|FG000|Overall Study|Terminated by sponsor|53|||
145487576|NCT00796666|524639510|FG001|Overall Study|Terminated by sponsor|55|||
145487577|NCT00796666|524639509|FG000|Overall Study|Randomized and not treated|1|||
145487578|NCT00796666|524639510|FG001|Overall Study|Randomized and not treated|0|||
145487579|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
145487580|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
145487581|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
145487582|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487583|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487584|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487585|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487586|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487587|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487588|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487589|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487590|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487591|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
145487592|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487593|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
145487594|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487595|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
145487596|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487597|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487598|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
145487599|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
145487600|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
145487601|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
145487602|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487603|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
145487604|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487605|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487606|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
145487607|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
145487608|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
145487609|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
145487610|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
145487611|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
145487612|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
145487613|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
145487614|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
145487615|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
145487616|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
145487617|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
145487618|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
145487619|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
145487620|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
145648238|NCT03580369|525228625|FG001|Overall Study|Protocol Violation|0|||
145648239|NCT03580369|525228626|FG002|Overall Study|Protocol Violation|6|||
145648240|NCT03580369|525228627|FG003|Overall Study|Protocol Violation|1|||
145648241|NCT03580369|525228628|FG004|Overall Study|Protocol Violation|8|||
145648242|NCT03580369|525228629|FG005|Overall Study|Protocol Violation|2|||
145648243|NCT03580369|525228630|FG006|Overall Study|Protocol Violation|1|||
145648244|NCT03580369|525228631|FG007|Overall Study|Protocol Violation|0|||
145648245|NCT03580369|525228624|FG000|Overall Study|Adverse Event|7|||
145648246|NCT03580369|525228625|FG001|Overall Study|Adverse Event|0|||
145648247|NCT03580369|525228626|FG002|Overall Study|Adverse Event|14|||
145487621|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
145648248|NCT03580369|525228627|FG003|Overall Study|Adverse Event|1|||
145648249|NCT03580369|525228628|FG004|Overall Study|Adverse Event|6|||
145648250|NCT03580369|525228629|FG005|Overall Study|Adverse Event|0|||
145648251|NCT03580369|525228630|FG006|Overall Study|Adverse Event|1|||
145648252|NCT03580369|525228631|FG007|Overall Study|Adverse Event|0|||
145487622|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
145648253|NCT03580369|525228624|FG000|Overall Study|Withdrawal by Subject|19|||
145487623|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
145648254|NCT03580369|525228625|FG001|Overall Study|Withdrawal by Subject|0|||
145648255|NCT03580369|525228626|FG002|Overall Study|Withdrawal by Subject|17|||
145648256|NCT03580369|525228627|FG003|Overall Study|Withdrawal by Subject|0|||
145487624|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
145487625|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487626|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487627|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
145487628|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487629|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487630|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145648257|NCT03580369|525228628|FG004|Overall Study|Withdrawal by Subject|16|||
145648258|NCT03580369|525228629|FG005|Overall Study|Withdrawal by Subject|1|||
145648259|NCT03580369|525228630|FG006|Overall Study|Withdrawal by Subject|7|||
145648260|NCT03580369|525228631|FG007|Overall Study|Withdrawal by Subject|0|||
145648261|NCT03912831|525228632|FG000|Overall Study|Death|1|||
145648262|NCT03912831|525228633|FG001|Overall Study|Death|1|||
145648263|NCT03912831|525228634|FG002|Overall Study|Death|1|||
145648264|NCT03912831|525228635|FG003|Overall Study|Death|1|||
145648265|NCT03912831|525228636|FG004|Overall Study|Death|1|||
145648266|NCT03912831|525228637|FG005|Overall Study|Death|1|||
145648267|NCT03912831|525228632|FG000|Overall Study|Reason not Specified|0|||
145648268|NCT03912831|525228633|FG001|Overall Study|Reason not Specified|0|||
145648269|NCT03912831|525228634|FG002|Overall Study|Reason not Specified|0|||
145648270|NCT03912831|525228635|FG003|Overall Study|Reason not Specified|0|||
145648271|NCT03912831|525228636|FG004|Overall Study|Reason not Specified|1|||
145648272|NCT03912831|525228637|FG005|Overall Study|Reason not Specified|0|||
145648273|NCT03912831|525228632|FG000|Overall Study|Withdrawal by Participant|0|||
145648274|NCT03912831|525228633|FG001|Overall Study|Withdrawal by Participant|0|||
145648275|NCT03912831|525228634|FG002|Overall Study|Withdrawal by Participant|0|||
145648276|NCT03912831|525228635|FG003|Overall Study|Withdrawal by Participant|0|||
145648277|NCT03912831|525228636|FG004|Overall Study|Withdrawal by Participant|1|||
145648278|NCT03912831|525228637|FG005|Overall Study|Withdrawal by Participant|0|||
145487631|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487632|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487633|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487634|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
145487635|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487636|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487637|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487638|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
145487639|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487640|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487641|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487642|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487643|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487644|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487645|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487646|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487647|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487648|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487649|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487650|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487651|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487652|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
145487653|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
145487654|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487655|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487656|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487657|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
145487658|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487659|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487660|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487661|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145648279|NCT02112916|525228643|FG000|Overall Study|Adverse Event|6|||
145648280|NCT02112916|525228644|FG001|Overall Study|Adverse Event|9|||
145487662|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487663|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145648281|NCT02112916|525228645|FG002|Overall Study|Adverse Event|3|||
145648282|NCT02112916|525228646|FG003|Overall Study|Adverse Event|2|||
145648283|NCT02112916|525228643|FG000|Overall Study|Death|9|||
145648284|NCT02112916|525228644|FG001|Overall Study|Death|9|||
145648285|NCT02112916|525228645|FG002|Overall Study|Death|3|||
145648286|NCT02112916|525228646|FG003|Overall Study|Death|4|||
145648287|NCT02112916|525228643|FG000|Overall Study|Lost to Follow-up|1|||
145487664|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
145487665|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487666|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487667|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487668|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
145487669|NCT01147666|524639511|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487670|NCT01147666|524639512|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487671|NCT01147666|524639513|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487672|NCT01147666|524639514|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487673|NCT01147666|524639515|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487674|NCT01147666|524639516|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487675|NCT01147666|524639517|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487676|NCT01147666|524639518|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487677|NCT01147666|524639519|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487678|NCT01147666|524639520|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487679|NCT01147666|524639521|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487680|NCT01147666|524639522|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
145487681|NCT01147666|524639523|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
145487682|NCT01147666|524639524|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
145487683|NCT01147666|524639525|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
145487684|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
145487685|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
145487686|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
145487687|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
145487688|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
145487689|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
145487690|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
145487691|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
145487692|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
145487693|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
145487694|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
145487695|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
145487696|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
145487697|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
145487698|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
145487699|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487700|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487701|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487702|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487703|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
145487704|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
145487705|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
145487706|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
145487707|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487708|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
145487709|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487710|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487711|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
145487712|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
145487713|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
145487714|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487715|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487716|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487717|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
145487718|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487719|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487720|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487721|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487722|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487723|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487724|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487725|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487726|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487727|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487728|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
145487729|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145648288|NCT02112916|525228644|FG001|Overall Study|Lost to Follow-up|0|||
145487730|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487731|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487732|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487733|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
145487734|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
145487735|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487736|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
145487737|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487738|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
145487739|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487740|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487741|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487742|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
145487743|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
145487744|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487745|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487746|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487747|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
145487748|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487749|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487750|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487751|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487752|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487753|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487754|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
145487755|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487756|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487757|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145648289|NCT02112916|525228645|FG002|Overall Study|Lost to Follow-up|0|||
145648290|NCT02112916|525228646|FG003|Overall Study|Lost to Follow-up|0|||
145648291|NCT02112916|525228643|FG000|Overall Study|Physician Decision|94|||
145648292|NCT02112916|525228644|FG001|Overall Study|Physician Decision|72|||
145648293|NCT02112916|525228645|FG002|Overall Study|Physician Decision|24|||
145648294|NCT02112916|525228646|FG003|Overall Study|Physician Decision|15|||
145648295|NCT02112916|525228643|FG000|Overall Study|Withdrawal by Subject|5|||
145648296|NCT02112916|525228644|FG001|Overall Study|Withdrawal by Subject|3|||
145648297|NCT02112916|525228645|FG002|Overall Study|Withdrawal by Subject|1|||
145648298|NCT02112916|525228646|FG003|Overall Study|Withdrawal by Subject|1|||
145648299|NCT02112916|525228643|FG000|Overall Study|Ineligible|4|||
145648300|NCT02112916|525228644|FG001|Overall Study|Ineligible|8|||
145648301|NCT02112916|525228645|FG002|Overall Study|Ineligible|3|||
145648302|NCT02112916|525228646|FG003|Overall Study|Ineligible|8|||
145648303|NCT02112916|525228643|FG000|Overall Study|Inevaluable|6|||
145648304|NCT02112916|525228644|FG001|Overall Study|Inevaluable|4|||
145648305|NCT02112916|525228645|FG002|Overall Study|Inevaluable|5|||
145648306|NCT02112916|525228646|FG003|Overall Study|Inevaluable|5|||
145648307|NCT02112916|525228643|FG000|Overall Study|Refusal of further protocol therapy|19|||
145648308|NCT02112916|525228644|FG001|Overall Study|Refusal of further protocol therapy|16|||
145648309|NCT02112916|525228645|FG002|Overall Study|Refusal of further protocol therapy|1|||
145648310|NCT02112916|525228646|FG003|Overall Study|Refusal of further protocol therapy|7|||
145648311|NCT02112916|525228643|FG000|Overall Study|Development of SMN|1|||
145648312|NCT02112916|525228644|FG001|Overall Study|Development of SMN|0|||
145648313|NCT02112916|525228645|FG002|Overall Study|Development of SMN|0|||
145648314|NCT02112916|525228646|FG003|Overall Study|Development of SMN|1|||
145648315|NCT02112916|525228643|FG000|Overall Study|Relapse/Progression|10|||
145648316|NCT02112916|525228644|FG001|Overall Study|Relapse/Progression|18|||
145648317|NCT02112916|525228645|FG002|Overall Study|Relapse/Progression|15|||
145648318|NCT02112916|525228646|FG003|Overall Study|Relapse/Progression|2|||
145648319|NCT02112916|525228643|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
145648320|NCT02112916|525228644|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
145648321|NCT02112916|525228645|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
145648322|NCT02112916|525228646|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
145648323|NCT02112916|525228643|FG000|Overall Study|Still on Therapy|44|||
145648324|NCT02112916|525228644|FG001|Overall Study|Still on Therapy|47|||
145648325|NCT02112916|525228645|FG002|Overall Study|Still on Therapy|3|||
145648326|NCT02112916|525228646|FG003|Overall Study|Still on Therapy|2|||
145648327|NCT02112916|525228643|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
145648328|NCT02112916|525228644|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
145648329|NCT02112916|525228645|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
145648330|NCT02112916|525228646|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
145487758|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
145487759|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487760|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487761|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487762|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487763|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487764|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487765|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487766|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487767|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487768|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487769|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487770|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487771|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
145487772|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487773|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
145487774|NCT01147666|524639511|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487775|NCT01147666|524639512|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487776|NCT01147666|524639513|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487777|NCT01147666|524639514|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487778|NCT01147666|524639515|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487779|NCT01147666|524639516|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487780|NCT01147666|524639517|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487781|NCT01147666|524639518|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487782|NCT01147666|524639519|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487783|NCT01147666|524639520|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487784|NCT01147666|524639521|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487785|NCT01147666|524639522|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487786|NCT01147666|524639523|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
145487787|NCT01147666|524639524|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
145487788|NCT01147666|524639525|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
145487789|NCT00474955|524639527|FG000|Overall Study|Adverse Event|2|||
145487790|NCT00474955|524639527|FG000|Overall Study|Drug unavailability|1|||
145487791|NCT00474955|524639527|FG000|Overall Study|Personal reasons|5|||
145487792|NCT01135134|524639528|FG000|Overall Study|Adverse Event|1|||
145487793|NCT01135134|524639529|FG001|Overall Study|Adverse Event|1|||
145487794|NCT01135134|524639528|FG000|Overall Study|Did not meet protocol eligibility|1|||
145487795|NCT01135134|524639529|FG001|Overall Study|Did not meet protocol eligibility|0|||
145487796|NCT02576639|524639530|FG000|Overall Study|Withdrawal by Subject|1|||
145487797|NCT02576639|524639531|FG001|Overall Study|Withdrawal by Subject|2|||
145487798|NCT02576639|524639532|FG002|Overall Study|Withdrawal by Subject|1|||
145487799|NCT02576639|524639533|FG003|Overall Study|Withdrawal by Subject|0|||
145487800|NCT02576639|524639534|FG004|Overall Study|Withdrawal by Subject|1|||
145487801|NCT02576639|524639530|FG000|Overall Study|Adverse Event|1|||
145487802|NCT02576639|524639531|FG001|Overall Study|Adverse Event|0|||
145487803|NCT02576639|524639532|FG002|Overall Study|Adverse Event|1|||
145487804|NCT02576639|524639533|FG003|Overall Study|Adverse Event|1|||
145487805|NCT02576639|524639534|FG004|Overall Study|Adverse Event|2|||
145487806|NCT02576639|524639530|FG000|Overall Study|Physician Decision|0|||
145487807|NCT02576639|524639531|FG001|Overall Study|Physician Decision|0|||
145487808|NCT02576639|524639532|FG002|Overall Study|Physician Decision|0|||
145487809|NCT02576639|524639533|FG003|Overall Study|Physician Decision|0|||
145487810|NCT02576639|524639534|FG004|Overall Study|Physician Decision|1|||
145487811|NCT01176058|524639539|FG000|Overall Study|Adverse Event|1|||
145487812|NCT01176058|524639540|FG001|Overall Study|Adverse Event|0|||
145487813|NCT01176058|524639539|FG000|Overall Study|Insufficient clinical response|2|||
145648331|NCT02112916|525228643|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
145648332|NCT02112916|525228644|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
145648333|NCT02112916|525228645|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
145648334|NCT02112916|525228646|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
145648335|NCT05239039|525228647|FG000|Overall Study|Withdrawal by Subject|0|||
145648336|NCT05239039|525228648|FG001|Overall Study|Withdrawal by Subject|1|||
145648337|NCT04923347|525230262|FG000|Overall Study|Withdrawal by Subject|14|||
145648338|NCT04052516|525230265|FG000|Overall Study|Withdrawal by Subject|4|||
145487814|NCT01176058|524639540|FG001|Overall Study|Insufficient clinical response|2|||
145487815|NCT01176058|524639539|FG000|Overall Study|Insufficient mycological response|0|||
145487816|NCT01176058|524639540|FG001|Overall Study|Insufficient mycological response|1|||
145487817|NCT01176058|524639539|FG000|Overall Study|Withdrawal by Subject|1|||
145487818|NCT01176058|524639540|FG001|Overall Study|Withdrawal by Subject|0|||
145487819|NCT01217463|524639543|FG000|Overall Study|Adverse Event|8|||
145648339|NCT04052516|525230266|FG001|Overall Study|Withdrawal by Subject|5|||
145487820|NCT01217463|524639544|FG001|Overall Study|Adverse Event|5|||
145487821|NCT01217463|524639543|FG000|Overall Study|Physician Decision|0|||
145487822|NCT01217463|524639544|FG001|Overall Study|Physician Decision|1|||
145487823|NCT01217463|524639543|FG000|Overall Study|Withdrawal by Subject|3|||
145487824|NCT01217463|524639544|FG001|Overall Study|Withdrawal by Subject|0|||
145487825|NCT01217463|524639543|FG000|Overall Study|Surgery on the Target Limb|0|||
145487826|NCT01217463|524639544|FG001|Overall Study|Surgery on the Target Limb|1|||
145487827|NCT01217463|524639543|FG000|Overall Study|Patient Non-compliant|1|||
145487828|NCT01217463|524639544|FG001|Overall Study|Patient Non-compliant|0|||
145487829|NCT01217463|524639543|FG000|Overall Study|Other|1|||
145487830|NCT01217463|524639544|FG001|Overall Study|Other|1|||
145487831|NCT01569841|524639553|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
145487832|NCT01569841|524639554|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
145487833|NCT00057863|524639558|FG000|Overall Study|Death|1|||
145487834|NCT00057863|524639558|FG000|Overall Study|Withdrawal by Subject|2|||
145487835|NCT00764361|524639559|FG000|Overall Study|Withdrawal by Subject|2|||
145487836|NCT00764361|524639560|FG001|Overall Study|Withdrawal by Subject|3|||
145487837|NCT00764361|524639559|FG000|Overall Study|Adverse Event|0|||
145487838|NCT00764361|524639560|FG001|Overall Study|Adverse Event|1|||
145487839|NCT02090426|524639561|FG000|Overall Study|Lost to Follow-up|12|||
145487840|NCT02090426|524639562|FG001|Overall Study|Lost to Follow-up|6|||
145487841|NCT02079038|524639563|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
145487842|NCT02079038|524639564|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
145487843|NCT02079038|524639563|FG000|Modified Intent to Treat Population|Death|1|||
145487844|NCT02079038|524639564|FG001|Modified Intent to Treat Population|Death|0|||
145487845|NCT02079038|524639563|FG000|Completed 6 Months|Lost to Follow-up|2|||
145487846|NCT02079038|524639564|FG001|Completed 6 Months|Lost to Follow-up|1|||
145487847|NCT03634085|524639565|FG000|Overall Study|Adverse Event|1|||
145487848|NCT03634085|524639566|FG001|Overall Study|Adverse Event|0|||
145487849|NCT03634085|524639565|FG000|Overall Study|Withdrawal by Subject|0|||
145487850|NCT03634085|524639566|FG001|Overall Study|Withdrawal by Subject|2|||
145648340|NCT04052516|525230267|FG002|Overall Study|Withdrawal by Subject|6|||
145648341|NCT04052516|525230265|FG000|Overall Study|Adverse Event|3|||
145648342|NCT04052516|525230266|FG001|Overall Study|Adverse Event|2|||
145648343|NCT04052516|525230267|FG002|Overall Study|Adverse Event|8|||
145648344|NCT04052516|525230265|FG000|Overall Study|Lost to Follow-up|2|||
145648345|NCT04052516|525230266|FG001|Overall Study|Lost to Follow-up|5|||
145648346|NCT04052516|525230267|FG002|Overall Study|Lost to Follow-up|3|||
145648347|NCT04052516|525230265|FG000|Overall Study|Protocol Violation|1|||
145648348|NCT04052516|525230266|FG001|Overall Study|Protocol Violation|1|||
145648349|NCT04052516|525230267|FG002|Overall Study|Protocol Violation|0|||
145487851|NCT04276233|524639567|FG000|Overall Study|Adverse Event|1|||
145487852|NCT04276233|524639567|FG000|Overall Study|Lost to Follow-up|3|||
145487853|NCT04276233|524639567|FG000|Overall Study|Physician Decision|4|||
145487854|NCT04276233|524639567|FG000|Overall Study|Withdrawal by Subject|2|||
145487855|NCT00148759|524639570|FG000|Overall Study|Withdrawal by Subject|1|||
145487856|NCT00148759|524639571|FG001|Overall Study|Withdrawal by Subject|1|||
145487857|NCT00148759|524639570|FG000|Overall Study|Lost to Follow-up|1|||
145487858|NCT00148759|524639571|FG001|Overall Study|Lost to Follow-up|0|||
145487859|NCT01454596|524639572|FG000|Overall Study|Death|0|||
145487860|NCT01454596|524639573|FG001|Overall Study|Death|0|||
145487861|NCT01454596|524639574|FG002|Overall Study|Death|0|||
145487862|NCT01454596|524639575|FG003|Overall Study|Death|0|||
145487863|NCT01454596|524639576|FG004|Overall Study|Death|0|||
145487864|NCT01454596|524639577|FG005|Overall Study|Death|0|||
145487865|NCT01454596|524639578|FG006|Overall Study|Death|0|||
145487866|NCT01454596|524639579|FG007|Overall Study|Death|0|||
145487867|NCT01454596|524639580|FG008|Overall Study|Death|0|||
145487868|NCT01454596|524639581|FG009|Overall Study|Death|1|||
145487869|NCT01454596|524639582|FG010|Overall Study|Death|1|||
145487870|NCT01454596|524639583|FG011|Overall Study|Death|0|||
145487871|NCT02800863|524639592|FG000|Overall Study|Adverse Event|14|||
145648350|NCT04052516|525230265|FG000|Overall Study|Death|1|||
145487872|NCT02800863|524639592|FG000|Overall Study|Another Device Implanted|1|||
145648351|NCT04052516|525230266|FG001|Overall Study|Death|0|||
145648352|NCT04052516|525230267|FG002|Overall Study|Death|0|||
145648353|NCT04052516|525230265|FG000|Overall Study|Physician Decision|0|||
145487873|NCT02800863|524639592|FG000|Overall Study|Device Explanted|1|||
145487874|NCT02800863|524639592|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
145487875|NCT02800863|524639592|FG000|Overall Study|Health Issues|1|||
145648354|NCT04052516|525230266|FG001|Overall Study|Physician Decision|1|||
145487876|NCT02800863|524639592|FG000|Overall Study|Insurance Denial|8|||
145487877|NCT02800863|524639592|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
145487878|NCT02800863|524639592|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
145487879|NCT02800863|524639592|FG000|Overall Study|Screen Failure|1|||
145487880|NCT02800863|524639592|FG000|Overall Study|Sponsor Request|6|||
145487881|NCT02800863|524639592|FG000|Overall Study|Death|3|||
145487882|NCT02800863|524639592|FG000|Overall Study|Subject Implant at Another Facility|1|||
145648355|NCT04052516|525230267|FG002|Overall Study|Physician Decision|0|||
145648356|NCT04052516|525230265|FG000|Overall Study|Pregnancy|1|||
145487883|NCT02800863|524639592|FG000|Overall Study|Lost to Follow-up|26|||
145487884|NCT02800863|524639592|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
145487885|NCT02800863|524639592|FG000|Overall Study|Subject and/or Family Request|64|||
145487886|NCT02800863|524639592|FG000|Overall Study|Trial Failure|81|||
145487887|NCT02800863|524639592|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
145487888|NCT03957551|524639593|FG000|Overall Study|Adverse Event|2|||
145487889|NCT03957551|524639594|FG001|Overall Study|Adverse Event|2|||
145487890|NCT03957551|524639595|FG002|Overall Study|Adverse Event|6|||
145487891|NCT03957551|524639593|FG000|Overall Study|Physician Decision|1|||
145487892|NCT03957551|524639594|FG001|Overall Study|Physician Decision|0|||
145487893|NCT03957551|524639595|FG002|Overall Study|Physician Decision|2|||
145487894|NCT03957551|524639593|FG000|Overall Study|Withdrawal by Subject|1|||
145487895|NCT03957551|524639594|FG001|Overall Study|Withdrawal by Subject|0|||
145487896|NCT03957551|524639595|FG002|Overall Study|Withdrawal by Subject|2|||
145487897|NCT03957551|524639593|FG000|Overall Study|Disease progression|1|||
145487898|NCT03957551|524639594|FG001|Overall Study|Disease progression|0|||
145487899|NCT03957551|524639595|FG002|Overall Study|Disease progression|8|||
145487900|NCT03775486|524639596|FG000|Initial Therapy Phase|Other reason provided|0|||
145487901|NCT03775486|524639597|FG001|Initial Therapy Phase|Other reason provided|15|||
145487902|NCT03775486|524639596|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
145487903|NCT03775486|524639597|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
145487904|NCT03775486|524639596|FG000|Initial Therapy Phase|Protocol Violation|0|||
145487905|NCT03775486|524639597|FG001|Initial Therapy Phase|Protocol Violation|2|||
145487906|NCT03775486|524639596|FG000|Initial Therapy Phase|Adverse Event|0|||
145487907|NCT03775486|524639597|FG001|Initial Therapy Phase|Adverse Event|34|||
145487908|NCT03775486|524639596|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
145487909|NCT03775486|524639597|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
145487910|NCT03775486|524639596|FG000|Maintenance Phase|Withdrawal by Subject|13|||
145487911|NCT03775486|524639597|FG001|Maintenance Phase|Withdrawal by Subject|12|||
145487912|NCT03775486|524639596|FG000|Maintenance Phase|Death|44|||
145487913|NCT03775486|524639597|FG001|Maintenance Phase|Death|45|||
145487914|NCT01572480|524639598|FG000|Participants Enrolled|Withdrawal by Subject|1|||
145487915|NCT01572480|524639598|FG000|Drug Administration|Discontinued drug/Off Study|1|||
145487916|NCT01572480|524639598|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
145487917|NCT01572480|524639598|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
145487918|NCT04194944|524639599|FG000|Overall Study|Lost to Follow-up|3|||
145487919|NCT04194944|524639600|FG001|Overall Study|Lost to Follow-up|0|||
145487920|NCT04194944|524639599|FG000|Overall Study|Withdrawal by Subject|2|||
145487921|NCT04194944|524639600|FG001|Overall Study|Withdrawal by Subject|2|||
145487922|NCT04194944|524639599|FG000|Overall Study|On Treatment|93|||
145487923|NCT04194944|524639600|FG001|Overall Study|On Treatment|30|||
145487924|NCT06235905|524639601|FG000|Overall Study|Adverse Event|1|||
145487925|NCT06235905|524639601|FG000|Overall Study|Non-compliant with protocol procedures|1|||
145487926|NCT00319254|524639602|FG000|Overall Study|Withdrawal by Subject|4|||
145487927|NCT00319254|524639602|FG000|Overall Study|Death|46|||
145487928|NCT00319254|524639602|FG000|Overall Study|Lost to Follow-up|2|||
145487929|NCT00319254|524639602|FG000|Overall Study|Enrolled, Not Treated|2|||
145487930|NCT02038153|524641415|FG000|Overall Study|Withdrawal by Subject|1|||
145487931|NCT02647281|524641416|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487932|NCT02647281|524641417|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487933|NCT02647281|524641418|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487934|NCT02647281|524641419|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487935|NCT02647281|524641420|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487936|NCT02647281|524641421|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487937|NCT02647281|524641422|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487938|NCT02647281|524641423|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
145487939|NCT02647281|524641424|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
145487940|NCT01050634|524641425|FG000|Overall Study|Enrolled, but Not Treated|56|||
145487941|NCT01050634|524641425|FG000|Overall Study|Death|2|||
145648357|NCT04052516|525230266|FG001|Overall Study|Pregnancy|0|||
145648358|NCT04052516|525230267|FG002|Overall Study|Pregnancy|0|||
145648359|NCT04052516|525230265|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
145648360|NCT04052516|525230266|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
145648361|NCT04052516|525230267|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
145487942|NCT01050634|524641425|FG000|Overall Study|Adverse Event|42|||
145487943|NCT01050634|524641425|FG000|Overall Study|Lost to Follow-up|2|||
145648362|NCT04052516|525230265|FG000|Overall Study|Reason not recorded|0|||
145487944|NCT01050634|524641425|FG000|Overall Study|Other|21|||
145487945|NCT01050634|524641425|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
145487946|NCT03400852|524641426|FG000|Blinded Treatment Period|Physician Decision|0|||
145487947|NCT03400852|524641427|FG001|Blinded Treatment Period|Physician Decision|1|||
145487948|NCT03400852|524641428|FG002|Blinded Treatment Period|Physician Decision|0|||
145487949|NCT03400852|524641426|FG000|Blinded Treatment Period|Adverse Event|1|||
145487950|NCT03400852|524641427|FG001|Blinded Treatment Period|Adverse Event|1|||
145487951|NCT03400852|524641428|FG002|Blinded Treatment Period|Adverse Event|0|||
145487952|NCT03400852|524641426|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
145487953|NCT03400852|524641427|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
145487954|NCT03400852|524641428|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
145487955|NCT03400852|524641426|FG000|Open Label Period|Physician Decision|0|||
145487956|NCT03400852|524641427|FG001|Open Label Period|Physician Decision|0|||
145487957|NCT03400852|524641428|FG002|Open Label Period|Physician Decision|1|||
145487958|NCT03400852|524641426|FG000|Open Label Period|Study terminated by sponsor|0|||
145487959|NCT03400852|524641427|FG001|Open Label Period|Study terminated by sponsor|0|||
145487960|NCT03400852|524641428|FG002|Open Label Period|Study terminated by sponsor|21|||
145487961|NCT00255190|524641433|FG000|Overall Study|Adverse Event|17|||
145487962|NCT00255190|524641434|FG001|Overall Study|Adverse Event|36|||
145487963|NCT00255190|524641433|FG000|Overall Study|Protocol Violation|2|||
145487964|NCT00255190|524641434|FG001|Overall Study|Protocol Violation|2|||
145487965|NCT00255190|524641433|FG000|Overall Study|Lost to Follow-up|10|||
145487966|NCT00255190|524641434|FG001|Overall Study|Lost to Follow-up|27|||
145487967|NCT00255190|524641433|FG000|Overall Study|Withdrew Consent|17|||
145487968|NCT00255190|524641434|FG001|Overall Study|Withdrew Consent|48|||
145487969|NCT00255190|524641433|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
145487970|NCT00255190|524641434|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
145487971|NCT00255190|524641433|FG000|Overall Study|Erosive esophagitis not healed|0|||
145487972|NCT00255190|524641434|FG001|Overall Study|Erosive esophagitis not healed|20|||
145487973|NCT00255190|524641433|FG000|Overall Study|Various|4|||
145487974|NCT00255190|524641434|FG001|Overall Study|Various|23|||
145487975|NCT01156480|524641436|FG000|Overall Study|change in diagnosis|0|||
145487976|NCT01156480|524641437|FG001|Overall Study|change in diagnosis|1|||
145487977|NCT04537793|524641438|FG000|Part B (24 Weeks)|Adverse Event|0|||
145487978|NCT04537793|524641439|FG001|Part B (24 Weeks)|Adverse Event|1|||
145487979|NCT00256724|524641441|FG000|Overall Study|Physician Decision|2|||
145487980|NCT00256724|524641442|FG001|Overall Study|Physician Decision|5|||
145487981|NCT00256724|524641441|FG000|Overall Study|Protocol Violation|3|||
145487982|NCT00256724|524641442|FG001|Overall Study|Protocol Violation|3|||
145487983|NCT01858363|524641443|FG000|Overall Study|Death|35|||
145487984|NCT01858363|524641444|FG001|Overall Study|Death|9|||
145487985|NCT01858363|524641443|FG000|Overall Study|Withdrawal by Subject|28|||
145487986|NCT01858363|524641444|FG001|Overall Study|Withdrawal by Subject|14|||
145487987|NCT01858363|524641443|FG000|Overall Study|Lost to Follow-up|13|||
145487988|NCT01858363|524641444|FG001|Overall Study|Lost to Follow-up|3|||
145487989|NCT01859923|524641446|FG000|Overall Study|Adverse Event|0|||
145487990|NCT01859923|524641447|FG001|Overall Study|Adverse Event|0|||
145648363|NCT04052516|525230266|FG001|Overall Study|Reason not recorded|1|||
145648364|NCT04052516|525230267|FG002|Overall Study|Reason not recorded|0|||
145648365|NCT05113966|525230268|FG000|Overall Study|Death|21|||
145648366|NCT05113966|525230268|FG000|Overall Study|Study Terminated by Sponsor|9|||
145648367|NCT05386355|525230269|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
145648368|NCT05386355|525230270|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
145648369|NCT05386355|525230271|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
145648370|NCT05386355|525230272|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
145648371|NCT05058391|525230278|FG000|Overall Study|Adverse Event|1|||
145648372|NCT03775109|525230279|FG000|Overall Study|Adverse Event|1|||
145648373|NCT03775109|525230280|FG001|Overall Study|Adverse Event|0|||
145648374|NCT03775109|525230279|FG000|Overall Study|COVID-19 outbreak|2|||
145648375|NCT03775109|525230280|FG001|Overall Study|COVID-19 outbreak|0|||
145648376|NCT03775109|525230279|FG000|Overall Study|Lost to Follow-up|0|||
145648377|NCT03775109|525230280|FG001|Overall Study|Lost to Follow-up|2|||
145487991|NCT01859923|524641448|FG002|Overall Study|Adverse Event|1|||
145487992|NCT01859923|524641449|FG003|Overall Study|Adverse Event|1|||
145648378|NCT03775109|525230279|FG000|Overall Study|Withdrawal by Subject|1|||
145648379|NCT03775109|525230280|FG001|Overall Study|Withdrawal by Subject|1|||
145648380|NCT03775109|525230279|FG000|Overall Study|Death|0|||
145487993|NCT00296816|524641454|FG000|Overall Study|Disease Progression|37|||
145487994|NCT00296816|524641454|FG000|Overall Study|Adverse Event|18|||
145487995|NCT00296816|524641454|FG000|Overall Study|Investigator/Participant request|5|||
145487996|NCT00296816|524641454|FG000|Overall Study|Non-compliance|1|||
145487997|NCT00296816|524641454|FG000|Overall Study|Missing for end of treatment|4|||
145487998|NCT00296816|524641454|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
145487999|NCT00296816|524641454|FG000|Overall Study|Poor performance status|1|||
145648381|NCT03775109|525230280|FG001|Overall Study|Death|1|||
145488000|NCT00296816|524641454|FG000|Overall Study|Relocation to Florida|1|||
145488001|NCT00296816|524641454|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
145488002|NCT00296816|524641454|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
145488003|NCT00296816|524641454|FG000|Overall Study|Neuropathy/patient preference|1|||
145648382|NCT03775109|525230279|FG000|Overall Study|Lack of Efficacy|1|||
145648383|NCT03775109|525230280|FG001|Overall Study|Lack of Efficacy|0|||
145648384|NCT04842643|525230281|FG000|Overall Study|Physician Decision|1|||
145648385|NCT04842643|525230281|FG000|Overall Study|Other|1|||
145648386|NCT03484702|525230282|FG000|Treatment Period|Death|3|||
145648387|NCT03484702|525230283|FG001|Treatment Period|Death|1|||
145648388|NCT03484702|525230284|FG002|Treatment Period|Death|0|||
145648389|NCT03484702|525230285|FG003|Treatment Period|Death|0|||
145648390|NCT03484702|525230286|FG004|Treatment Period|Death|0|||
145648391|NCT03484702|525230287|FG005|Treatment Period|Death|0|||
145648392|NCT03484702|525230282|FG000|Treatment Period|Adverse Event|1|||
145648393|NCT03484702|525230283|FG001|Treatment Period|Adverse Event|0|||
145648394|NCT03484702|525230284|FG002|Treatment Period|Adverse Event|0|||
145648395|NCT03484702|525230285|FG003|Treatment Period|Adverse Event|0|||
145648396|NCT03484702|525230286|FG004|Treatment Period|Adverse Event|0|||
145648397|NCT03484702|525230287|FG005|Treatment Period|Adverse Event|0|||
145648398|NCT03484702|525230282|FG000|Treatment Period|Participant Withdrew from Study|0|||
145648399|NCT03484702|525230283|FG001|Treatment Period|Participant Withdrew from Study|1|||
145648400|NCT03484702|525230284|FG002|Treatment Period|Participant Withdrew from Study|0|||
145648401|NCT03484702|525230285|FG003|Treatment Period|Participant Withdrew from Study|0|||
145648402|NCT03484702|525230286|FG004|Treatment Period|Participant Withdrew from Study|0|||
145648403|NCT03484702|525230287|FG005|Treatment Period|Participant Withdrew from Study|0|||
145648404|NCT03484702|525230282|FG000|Treatment Period|Physician Decision|0|||
145648405|NCT03484702|525230283|FG001|Treatment Period|Physician Decision|1|||
145648406|NCT03484702|525230284|FG002|Treatment Period|Physician Decision|0|||
145648407|NCT03484702|525230285|FG003|Treatment Period|Physician Decision|0|||
145648408|NCT03484702|525230286|FG004|Treatment Period|Physician Decision|0|||
145648409|NCT03484702|525230287|FG005|Treatment Period|Physician Decision|1|||
145648410|NCT01894061|525230290|FG000|Overall Study|Screen failure|1|||
145648411|NCT01894061|525230290|FG000|Overall Study|Withdrawal by Subject|1|||
145488004|NCT00296816|524641454|FG000|Overall Study|Proteinuria|1|||
145488005|NCT00296816|524641454|FG000|Overall Study|ineligibility due to radiation treatment|1|||
145488006|NCT01054456|524641455|FG000|Overall Study|Other|1|||
145488007|NCT00687401|524641456|FG000|Overall Study|Protocol Violation|7|||
145488008|NCT00687401|524641456|FG000|Overall Study|Adverse Event|6|||
145488009|NCT00687401|524641456|FG000|Overall Study|Lack of Efficacy|6|||
145488010|NCT00687401|524641456|FG000|Overall Study|Withdrawal by Subject|4|||
145488011|NCT00687401|524641456|FG000|Overall Study|Did not return for visit|3|||
145488012|NCT00687401|524641456|FG000|Overall Study|For reasons different from those above|4|||
145488013|NCT01721161|524641459|FG000|Overall Study|Adverse Event|2|||
145488014|NCT01721161|524641460|FG001|Overall Study|Adverse Event|3|||
145488015|NCT01721161|524641459|FG000|Overall Study|Lost to Follow-up|1|||
145488016|NCT01721161|524641460|FG001|Overall Study|Lost to Follow-up|2|||
145488017|NCT01721161|524641459|FG000|Overall Study|Withdrawal by Subject|1|||
145488018|NCT01721161|524641460|FG001|Overall Study|Withdrawal by Subject|1|||
145488019|NCT01721161|524641459|FG000|Overall Study|Other|0|||
145488020|NCT01721161|524641460|FG001|Overall Study|Other|1|||
145488021|NCT02888106|524641468|FG000|Overall Study|Withdrawal by Subject|1|||
145488022|NCT02888106|524641469|FG001|Overall Study|Withdrawal by Subject|2|||
145488023|NCT02888106|524641470|FG002|Overall Study|Withdrawal by Subject|0|||
145488024|NCT02888106|524641471|FG003|Overall Study|Withdrawal by Subject|1|||
145488025|NCT02888106|524641472|FG004|Overall Study|Withdrawal by Subject|0|||
145488026|NCT02888106|524641473|FG005|Overall Study|Withdrawal by Subject|0|||
145488027|NCT02888106|524641468|FG000|Overall Study|Lost to Follow-up|1|||
145488028|NCT02888106|524641469|FG001|Overall Study|Lost to Follow-up|0|||
145488029|NCT02888106|524641470|FG002|Overall Study|Lost to Follow-up|0|||
145488030|NCT02888106|524641471|FG003|Overall Study|Lost to Follow-up|1|||
145488031|NCT02888106|524641472|FG004|Overall Study|Lost to Follow-up|0|||
145488032|NCT02888106|524641473|FG005|Overall Study|Lost to Follow-up|1|||
145488033|NCT02888106|524641468|FG000|Overall Study|Adverse Event|2|||
145488034|NCT02888106|524641469|FG001|Overall Study|Adverse Event|0|||
145488035|NCT02888106|524641470|FG002|Overall Study|Adverse Event|0|||
145648412|NCT05110495|525230291|FG000|Overall Study|Lost to Follow-up|1|||
145488036|NCT02888106|524641471|FG003|Overall Study|Adverse Event|0|||
145488037|NCT02888106|524641472|FG004|Overall Study|Adverse Event|0|||
145488038|NCT02888106|524641473|FG005|Overall Study|Adverse Event|0|||
145488039|NCT02888106|524641468|FG000|Overall Study|Withdrawal of consent|0|||
145488040|NCT02888106|524641469|FG001|Overall Study|Withdrawal of consent|0|||
145488041|NCT02888106|524641470|FG002|Overall Study|Withdrawal of consent|0|||
145488042|NCT02888106|524641471|FG003|Overall Study|Withdrawal of consent|0|||
145648413|NCT05110495|525230291|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
145648414|NCT05141903|525230292|FG000|Overall Study|Withdrawal by Subject|0|||
145648415|NCT05141903|525230293|FG001|Overall Study|Withdrawal by Subject|1|||
145488043|NCT02888106|524641472|FG004|Overall Study|Withdrawal of consent|1|||
145488044|NCT02888106|524641473|FG005|Overall Study|Withdrawal of consent|0|||
145648416|NCT05141903|525230294|FG002|Overall Study|Withdrawal by Subject|1|||
145648417|NCT05141903|525230295|FG003|Overall Study|Withdrawal by Subject|0|||
145648418|NCT05141903|525230296|FG004|Overall Study|Withdrawal by Subject|0|||
145488045|NCT02888106|524641468|FG000|Overall Study|Pregnancy|1|||
145488046|NCT02888106|524641469|FG001|Overall Study|Pregnancy|0|||
145488047|NCT02888106|524641470|FG002|Overall Study|Pregnancy|0|||
145488048|NCT02888106|524641471|FG003|Overall Study|Pregnancy|0|||
145488049|NCT02888106|524641472|FG004|Overall Study|Pregnancy|0|||
145488050|NCT02888106|524641473|FG005|Overall Study|Pregnancy|0|||
145488051|NCT00430716|524641478|FG000|Double Blind Phase|Death|1|||
145488052|NCT00430716|524641479|FG001|Double Blind Phase|Death|0|||
145488053|NCT00430716|524641480|FG002|Double Blind Phase|Death|0|||
145488054|NCT00430716|524641478|FG000|Double Blind Phase|No longer willing to participate|2|||
145488055|NCT00430716|524641479|FG001|Double Blind Phase|No longer willing to participate|1|||
145488056|NCT00430716|524641480|FG002|Double Blind Phase|No longer willing to participate|1|||
145488057|NCT00430716|524641478|FG000|Double Blind Phase|Other|0|||
145488058|NCT00430716|524641479|FG001|Double Blind Phase|Other|2|||
145488059|NCT00430716|524641480|FG002|Double Blind Phase|Other|0|||
145488060|NCT00430716|524641478|FG000|Double Blind Phase|Study terminated by sponsor|1|||
145488061|NCT00430716|524641479|FG001|Double Blind Phase|Study terminated by sponsor|1|||
145488062|NCT00430716|524641480|FG002|Double Blind Phase|Study terminated by sponsor|2|||
145488063|NCT00430716|524641478|FG000|Double Blind Phase|Adverse Event|1|||
145488064|NCT00430716|524641479|FG001|Double Blind Phase|Adverse Event|1|||
145488065|NCT00430716|524641480|FG002|Double Blind Phase|Adverse Event|3|||
145488066|NCT00430716|524641478|FG000|Double Blind Phase|Not treated|1|||
145488067|NCT00430716|524641479|FG001|Double Blind Phase|Not treated|0|||
145488068|NCT00430716|524641480|FG002|Double Blind Phase|Not treated|0|||
145488069|NCT00430716|524641478|FG000|Open Label Phase|Lost to Follow-up|1|||
145488070|NCT00430716|524641479|FG001|Open Label Phase|Lost to Follow-up|0|||
145488071|NCT00430716|524641480|FG002|Open Label Phase|Lost to Follow-up|1|||
145488072|NCT00430716|524641478|FG000|Open Label Phase|No longer willing to participate|0|||
145488073|NCT00430716|524641479|FG001|Open Label Phase|No longer willing to participate|1|||
145488074|NCT00430716|524641480|FG002|Open Label Phase|No longer willing to participate|1|||
145488075|NCT00430716|524641478|FG000|Open Label Phase|Other|3|||
145488076|NCT00430716|524641479|FG001|Open Label Phase|Other|1|||
145488077|NCT00430716|524641480|FG002|Open Label Phase|Other|1|||
145488078|NCT00430716|524641478|FG000|Open Label Phase|Protocol Violation|1|||
145488079|NCT00430716|524641479|FG001|Open Label Phase|Protocol Violation|0|||
145488080|NCT00430716|524641480|FG002|Open Label Phase|Protocol Violation|0|||
145488081|NCT00430716|524641478|FG000|Open Label Phase|Study terminated by sponsor|4|||
145488082|NCT00430716|524641479|FG001|Open Label Phase|Study terminated by sponsor|5|||
145488083|NCT00430716|524641480|FG002|Open Label Phase|Study terminated by sponsor|4|||
145488084|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
145488085|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
145488086|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
145488087|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
145488088|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
145488089|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
145488090|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Death|7|||
145488091|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Death|5|||
145488092|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Death|6|||
145488093|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
145488094|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
145488095|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
145488096|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
145488097|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
145488098|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
145488099|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Other|1|||
145488100|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Other|0|||
145488101|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Other|0|||
145648419|NCT05141903|525230292|FG000|Overall Study|Other|1|||
145648420|NCT05141903|525230293|FG001|Overall Study|Other|1|||
145648421|NCT05141903|525230294|FG002|Overall Study|Other|0|||
145488102|NCT00104650|524641481|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
145488103|NCT00104650|524641482|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
145488104|NCT00104650|524641483|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
145488105|NCT00104650|524641481|FG000|Follow-up Period|Physician Decision|1|||
145488106|NCT00104650|524641482|FG001|Follow-up Period|Physician Decision|1|||
145488107|NCT00104650|524641483|FG002|Follow-up Period|Physician Decision|0|||
145488108|NCT00104650|524641481|FG000|Follow-up Period|Adverse Event|1|||
145488109|NCT00104650|524641482|FG001|Follow-up Period|Adverse Event|0|||
145488110|NCT00104650|524641483|FG002|Follow-up Period|Adverse Event|1|||
145488111|NCT00104650|524641481|FG000|Follow-up Period|Withdrawal by Subject|0|||
145488112|NCT00104650|524641482|FG001|Follow-up Period|Withdrawal by Subject|3|||
145488113|NCT00104650|524641483|FG002|Follow-up Period|Withdrawal by Subject|3|||
145488114|NCT00104650|524641481|FG000|Follow-up Period|Death|6|||
145488115|NCT00104650|524641482|FG001|Follow-up Period|Death|6|||
145488116|NCT00104650|524641483|FG002|Follow-up Period|Death|4|||
145488117|NCT00104650|524641481|FG000|Follow-up Period|Disease progression|3|||
145488118|NCT00104650|524641482|FG001|Follow-up Period|Disease progression|1|||
145488119|NCT00104650|524641483|FG002|Follow-up Period|Disease progression|0|||
145488120|NCT00104650|524641481|FG000|Follow-up Period|Lost to Follow-up|0|||
145488121|NCT00104650|524641482|FG001|Follow-up Period|Lost to Follow-up|1|||
145488122|NCT00104650|524641483|FG002|Follow-up Period|Lost to Follow-up|2|||
145488123|NCT00104650|524641481|FG000|Follow-up Period|Other|0|||
145488124|NCT00104650|524641482|FG001|Follow-up Period|Other|1|||
145488125|NCT00104650|524641483|FG002|Follow-up Period|Other|0|||
145488126|NCT02294058|524641484|FG000|Overall Study|Adverse Event|16|||
145488127|NCT02294058|524641485|FG001|Overall Study|Adverse Event|7|||
145488128|NCT02294058|524641486|FG002|Overall Study|Adverse Event|13|||
145488129|NCT02294058|524641484|FG000|Overall Study|Lack of Efficacy|3|||
145488130|NCT02294058|524641485|FG001|Overall Study|Lack of Efficacy|3|||
145488131|NCT02294058|524641486|FG002|Overall Study|Lack of Efficacy|0|||
145488132|NCT02294058|524641484|FG000|Overall Study|Lost to Follow-up|1|||
145488133|NCT02294058|524641485|FG001|Overall Study|Lost to Follow-up|0|||
145488134|NCT02294058|524641486|FG002|Overall Study|Lost to Follow-up|2|||
145488135|NCT02294058|524641484|FG000|Overall Study|Withdrawal by Subject|10|||
145488136|NCT02294058|524641485|FG001|Overall Study|Withdrawal by Subject|14|||
145488137|NCT02294058|524641486|FG002|Overall Study|Withdrawal by Subject|13|||
145488138|NCT02294058|524641484|FG000|Overall Study|Physician Decision|2|||
145488139|NCT02294058|524641485|FG001|Overall Study|Physician Decision|1|||
145488140|NCT02294058|524641486|FG002|Overall Study|Physician Decision|0|||
145488141|NCT02294058|524641484|FG000|Overall Study|Miscellaneous|4|||
145488142|NCT02294058|524641485|FG001|Overall Study|Miscellaneous|1|||
145488143|NCT02294058|524641486|FG002|Overall Study|Miscellaneous|1|||
145488144|NCT03259555|524641491|FG000|Overall Study|Adverse Event|6|||
145488145|NCT03259555|524641492|FG001|Overall Study|Adverse Event|4|||
145488146|NCT03259555|524641491|FG000|Overall Study|Lack of Efficacy|6|||
145488147|NCT03259555|524641492|FG001|Overall Study|Lack of Efficacy|4|||
145488148|NCT03259555|524641491|FG000|Overall Study|Lost to Follow-up|0|||
145488149|NCT03259555|524641492|FG001|Overall Study|Lost to Follow-up|2|||
145488150|NCT03259555|524641491|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145488151|NCT03259555|524641492|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145488152|NCT03259555|524641491|FG000|Overall Study|Progressive Disease|0|||
145488153|NCT03259555|524641492|FG001|Overall Study|Progressive Disease|2|||
145488154|NCT03259555|524641491|FG000|Overall Study|Withdrawal by Subject|19|||
145488155|NCT03259555|524641492|FG001|Overall Study|Withdrawal by Subject|16|||
145488156|NCT03259555|524641491|FG000|Overall Study|Physician Decision|1|||
145488157|NCT03259555|524641492|FG001|Overall Study|Physician Decision|2|||
145488158|NCT03259555|524641491|FG000|Overall Study|Other|1|||
145488159|NCT03259555|524641492|FG001|Overall Study|Other|0|||
145488160|NCT00607087|524641493|FG000|Overall Study|Withdrawal by Subject|9|||
145488161|NCT00607087|524641494|FG001|Overall Study|Withdrawal by Subject|4|||
145488162|NCT00607087|524641495|FG002|Overall Study|Withdrawal by Subject|4|||
145488163|NCT00607087|524641493|FG000|Overall Study|Adverse Event|3|||
145488164|NCT00607087|524641494|FG001|Overall Study|Adverse Event|2|||
145488165|NCT00607087|524641495|FG002|Overall Study|Adverse Event|3|||
145488166|NCT00607087|524641493|FG000|Overall Study|Other reason|1|||
145488167|NCT00607087|524641494|FG001|Overall Study|Other reason|5|||
145488168|NCT00607087|524641495|FG002|Overall Study|Other reason|2|||
145488169|NCT00607087|524641493|FG000|Overall Study|Poor compliance to protocol|1|||
145488170|NCT00607087|524641494|FG001|Overall Study|Poor compliance to protocol|0|||
145488171|NCT00607087|524641495|FG002|Overall Study|Poor compliance to protocol|1|||
145488172|NCT00607087|524641493|FG000|Overall Study|Lost to Follow-up|1|||
145488173|NCT00607087|524641494|FG001|Overall Study|Lost to Follow-up|0|||
145488174|NCT00607087|524641495|FG002|Overall Study|Lost to Follow-up|0|||
145488175|NCT00607087|524641493|FG000|Period 1|Withdrawal by Subject|7|||
145488176|NCT00607087|524641494|FG001|Period 1|Withdrawal by Subject|2|||
145488177|NCT00607087|524641495|FG002|Period 1|Withdrawal by Subject|3|||
145488178|NCT00607087|524641493|FG000|Period 1|Adverse Event|3|||
145488179|NCT00607087|524641494|FG001|Period 1|Adverse Event|0|||
145488180|NCT00607087|524641495|FG002|Period 1|Adverse Event|0|||
145488181|NCT00607087|524641493|FG000|Period 1|Poor compliance to protocol|1|||
145488182|NCT00607087|524641494|FG001|Period 1|Poor compliance to protocol|0|||
145488183|NCT00607087|524641495|FG002|Period 1|Poor compliance to protocol|0|||
145488184|NCT00607087|524641493|FG000|Period 1|Lost to Follow-up|1|||
145488185|NCT00607087|524641494|FG001|Period 1|Lost to Follow-up|0|||
145488186|NCT00607087|524641495|FG002|Period 1|Lost to Follow-up|0|||
145488187|NCT00607087|524641493|FG000|Period 1|Other reason|0|||
145488188|NCT00607087|524641494|FG001|Period 1|Other reason|4|||
145648422|NCT05141903|525230295|FG003|Overall Study|Other|0|||
145488189|NCT00607087|524641495|FG002|Period 1|Other reason|2|||
145488190|NCT00607087|524641493|FG000|Period 2|Withdrawal by Subject|0|||
145488191|NCT00607087|524641494|FG001|Period 2|Withdrawal by Subject|1|||
145488192|NCT00607087|524641495|FG002|Period 2|Withdrawal by Subject|1|||
145488193|NCT00607087|524641493|FG000|Period 2|Other reason|1|||
145648423|NCT05141903|525230296|FG004|Overall Study|Other|0|||
145488194|NCT00607087|524641494|FG001|Period 2|Other reason|1|||
145488195|NCT00607087|524641495|FG002|Period 2|Other reason|0|||
145488196|NCT00607087|524641493|FG000|Period 2|Adverse Event|0|||
145488197|NCT00607087|524641494|FG001|Period 2|Adverse Event|1|||
145488198|NCT00607087|524641495|FG002|Period 2|Adverse Event|3|||
145488199|NCT00607087|524641493|FG000|Period 2|Poor compliance to protocol|0|||
145488200|NCT00607087|524641494|FG001|Period 2|Poor compliance to protocol|0|||
145488201|NCT00607087|524641495|FG002|Period 2|Poor compliance to protocol|1|||
145488202|NCT00607087|524641493|FG000|Period 3|Withdrawal by Subject|2|||
145488203|NCT00607087|524641494|FG001|Period 3|Withdrawal by Subject|1|||
145488204|NCT00607087|524641495|FG002|Period 3|Withdrawal by Subject|0|||
145488205|NCT00607087|524641493|FG000|Period 3|Adverse Event|0|||
145488206|NCT00607087|524641494|FG001|Period 3|Adverse Event|1|||
145488207|NCT00607087|524641495|FG002|Period 3|Adverse Event|0|||
145488208|NCT02717494|524641497|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
145488209|NCT02717494|524641498|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
145488210|NCT02717494|524641499|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
145488211|NCT02717494|524641497|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
145488212|NCT02717494|524641498|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
145488213|NCT02717494|524641499|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
145488214|NCT02717494|524641497|FG000|First Intervention (Step 1)|Death|0|||
145488215|NCT02717494|524641498|FG001|First Intervention (Step 1)|Death|0|||
145488216|NCT02717494|524641499|FG002|First Intervention (Step 1)|Death|1|||
145488217|NCT02717494|524641497|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
145488218|NCT02717494|524641498|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
145488219|NCT02717494|524641499|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
145488220|NCT05477485|524641504|FG000|Overall Study|Lost to Follow-up|0|||
145488221|NCT05477485|524641505|FG001|Overall Study|Lost to Follow-up|4|||
145488222|NCT03116685|524641506|FG000|Overall Study|Physician Decision|0|||
145488223|NCT03116685|524641507|FG001|Overall Study|Physician Decision|1|||
145488224|NCT00801216|524641508|FG000|Overall Study|Screening Failure|2|||
145488225|NCT05214768|524641509|FG000|Induction Period|Withdrawal by Subject|1|||
145488226|NCT05214768|524641510|FG001|Induction Period|Withdrawal by Subject|0|||
145488227|NCT05214768|524641511|FG002|Induction Period|Withdrawal by Subject|0|||
145488228|NCT05214768|524641512|FG003|Induction Period|Withdrawal by Subject|0|||
145488229|NCT05214768|524641513|FG004|Induction Period|Withdrawal by Subject|0|||
145488230|NCT05214768|524641514|FG005|Induction Period|Withdrawal by Subject|0|||
145488231|NCT05214768|524641509|FG000|Induction Period|Physician Decision|1|||
145488232|NCT05214768|524641510|FG001|Induction Period|Physician Decision|0|||
145488233|NCT05214768|524641511|FG002|Induction Period|Physician Decision|0|||
145488234|NCT05214768|524641512|FG003|Induction Period|Physician Decision|0|||
145488235|NCT05214768|524641513|FG004|Induction Period|Physician Decision|0|||
145488236|NCT05214768|524641514|FG005|Induction Period|Physician Decision|0|||
145488237|NCT05214768|524641509|FG000|Maintenance Period|Other Reasons|0|||
145488238|NCT05214768|524641510|FG001|Maintenance Period|Other Reasons|0|||
145488239|NCT05214768|524641511|FG002|Maintenance Period|Other Reasons|1|||
145488240|NCT05214768|524641512|FG003|Maintenance Period|Other Reasons|1|||
145488241|NCT05214768|524641513|FG004|Maintenance Period|Other Reasons|0|||
145488242|NCT05214768|524641514|FG005|Maintenance Period|Other Reasons|0|||
145488243|NCT05214768|524641509|FG000|Maintenance Period|Withdrawal by Subject|0|||
145488244|NCT05214768|524641510|FG001|Maintenance Period|Withdrawal by Subject|0|||
145488245|NCT05214768|524641511|FG002|Maintenance Period|Withdrawal by Subject|0|||
145488246|NCT05214768|524641512|FG003|Maintenance Period|Withdrawal by Subject|1|||
145488247|NCT05214768|524641513|FG004|Maintenance Period|Withdrawal by Subject|0|||
145488248|NCT05214768|524641514|FG005|Maintenance Period|Withdrawal by Subject|0|||
145488249|NCT05214768|524641509|FG000|Maintenance Period|Lack of Efficacy|0|||
145488250|NCT05214768|524641510|FG001|Maintenance Period|Lack of Efficacy|0|||
145488251|NCT05214768|524641511|FG002|Maintenance Period|Lack of Efficacy|1|||
145488252|NCT05214768|524641512|FG003|Maintenance Period|Lack of Efficacy|0|||
145488253|NCT05214768|524641513|FG004|Maintenance Period|Lack of Efficacy|1|||
145488254|NCT05214768|524641514|FG005|Maintenance Period|Lack of Efficacy|0|||
145488255|NCT05214768|524641509|FG000|Open Label Extension Period|Physician Decision|0|||
145488256|NCT05214768|524641510|FG001|Open Label Extension Period|Physician Decision|0|||
145488257|NCT05214768|524641511|FG002|Open Label Extension Period|Physician Decision|0|||
145488258|NCT05214768|524641512|FG003|Open Label Extension Period|Physician Decision|0|||
145488259|NCT05214768|524641513|FG004|Open Label Extension Period|Physician Decision|0|||
145488260|NCT05214768|524641514|FG005|Open Label Extension Period|Physician Decision|1|||
145488261|NCT05214768|524641509|FG000|Open Label Extension Period|Lack of Efficacy|0|||
145488262|NCT05214768|524641510|FG001|Open Label Extension Period|Lack of Efficacy|0|||
145488263|NCT05214768|524641511|FG002|Open Label Extension Period|Lack of Efficacy|0|||
145488264|NCT05214768|524641512|FG003|Open Label Extension Period|Lack of Efficacy|0|||
145488265|NCT05214768|524641513|FG004|Open Label Extension Period|Lack of Efficacy|0|||
145488266|NCT05214768|524641514|FG005|Open Label Extension Period|Lack of Efficacy|1|||
145488267|NCT05214768|524641509|FG000|Open Label Extension Period|Ongoing Study|0|||
145488268|NCT05214768|524641510|FG001|Open Label Extension Period|Ongoing Study|0|||
145488269|NCT05214768|524641511|FG002|Open Label Extension Period|Ongoing Study|0|||
145488270|NCT05214768|524641512|FG003|Open Label Extension Period|Ongoing Study|0|||
145648424|NCT02630823|525230300|FG000|Overall Study|Withdrawal by Subject|1|||
145488271|NCT05214768|524641513|FG004|Open Label Extension Period|Ongoing Study|0|||
145488272|NCT05214768|524641514|FG005|Open Label Extension Period|Ongoing Study|42|||
145488273|NCT05481359|524641515|FG000|Overall Study|Lost to Follow-up|3|||
145488274|NCT05481359|524641515|FG000|Overall Study|Withdrawal by Subject|1|||
145488275|NCT05579977|524641520|FG000|Treatment Phase|Other|0|||
145488276|NCT05579977|524641521|FG001|Treatment Phase|Other|0|||
145488277|NCT05579977|524641522|FG002|Treatment Phase|Other|0|||
145488278|NCT05579977|524641523|FG003|Treatment Phase|Other|2|||
145488279|NCT05579977|524641524|FG004|Treatment Phase|Other|1|||
145488280|NCT05579977|524641525|FG005|Treatment Phase|Other|2|||
145488281|NCT05579977|524641526|FG006|Treatment Phase|Other|1|||
145488282|NCT05579977|524641527|FG007|Treatment Phase|Other|2|||
145488283|NCT05579977|524641528|FG008|Treatment Phase|Other|2|||
145488284|NCT05579977|524641529|FG009|Treatment Phase|Other|1|||
145488285|NCT05579977|524641530|FG010|Treatment Phase|Other|0|||
145488286|NCT05579977|524641531|FG011|Treatment Phase|Other|0|||
145488287|NCT05579977|524641532|FG012|Treatment Phase|Other|3|||
145488288|NCT05579977|524641520|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
145488289|NCT05579977|524641521|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
145488290|NCT05579977|524641522|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
145488291|NCT05579977|524641523|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
145488292|NCT05579977|524641524|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
145488293|NCT05579977|524641525|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
145488294|NCT05579977|524641526|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
145488295|NCT05579977|524641527|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
145488296|NCT05579977|524641528|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
145488297|NCT05579977|524641529|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
145488298|NCT05579977|524641530|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
145488299|NCT05579977|524641531|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
145488300|NCT05579977|524641532|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
145488301|NCT05579977|524641520|FG000|Treatment Phase|Withdrawal by Subject|2|||
145488302|NCT05579977|524641521|FG001|Treatment Phase|Withdrawal by Subject|0|||
145488303|NCT05579977|524641522|FG002|Treatment Phase|Withdrawal by Subject|0|||
145488304|NCT05579977|524641523|FG003|Treatment Phase|Withdrawal by Subject|1|||
145488305|NCT05579977|524641524|FG004|Treatment Phase|Withdrawal by Subject|2|||
145488306|NCT05579977|524641525|FG005|Treatment Phase|Withdrawal by Subject|0|||
145488307|NCT05579977|524641526|FG006|Treatment Phase|Withdrawal by Subject|1|||
145488308|NCT05579977|524641527|FG007|Treatment Phase|Withdrawal by Subject|8|||
145488309|NCT05579977|524641528|FG008|Treatment Phase|Withdrawal by Subject|3|||
145488310|NCT05579977|524641529|FG009|Treatment Phase|Withdrawal by Subject|3|||
145488311|NCT05579977|524641530|FG010|Treatment Phase|Withdrawal by Subject|5|||
145488312|NCT05579977|524641531|FG011|Treatment Phase|Withdrawal by Subject|1|||
145488313|NCT05579977|524641532|FG012|Treatment Phase|Withdrawal by Subject|3|||
145488314|NCT05579977|524641520|FG000|Treatment Phase|Study terminated by sponsor|70|||
145488315|NCT05579977|524641521|FG001|Treatment Phase|Study terminated by sponsor|70|||
145488316|NCT05579977|524641522|FG002|Treatment Phase|Study terminated by sponsor|61|||
145488317|NCT05579977|524641523|FG003|Treatment Phase|Study terminated by sponsor|59|||
145488318|NCT05579977|524641524|FG004|Treatment Phase|Study terminated by sponsor|63|||
145488319|NCT05579977|524641525|FG005|Treatment Phase|Study terminated by sponsor|53|||
145488320|NCT05579977|524641526|FG006|Treatment Phase|Study terminated by sponsor|66|||
145488321|NCT05579977|524641527|FG007|Treatment Phase|Study terminated by sponsor|48|||
145488322|NCT05579977|524641528|FG008|Treatment Phase|Study terminated by sponsor|47|||
145488323|NCT05579977|524641529|FG009|Treatment Phase|Study terminated by sponsor|37|||
145488324|NCT05579977|524641530|FG010|Treatment Phase|Study terminated by sponsor|44|||
145488325|NCT05579977|524641531|FG011|Treatment Phase|Study terminated by sponsor|36|||
145488326|NCT05579977|524641532|FG012|Treatment Phase|Study terminated by sponsor|32|||
145488327|NCT05579977|524641520|FG000|Treatment Phase|Pregnancy|0|||
145488328|NCT05579977|524641521|FG001|Treatment Phase|Pregnancy|0|||
145488329|NCT05579977|524641522|FG002|Treatment Phase|Pregnancy|0|||
145488330|NCT05579977|524641523|FG003|Treatment Phase|Pregnancy|0|||
145488331|NCT05579977|524641524|FG004|Treatment Phase|Pregnancy|0|||
145488332|NCT05579977|524641525|FG005|Treatment Phase|Pregnancy|0|||
145488333|NCT05579977|524641526|FG006|Treatment Phase|Pregnancy|0|||
145488334|NCT05579977|524641527|FG007|Treatment Phase|Pregnancy|0|||
145488335|NCT05579977|524641528|FG008|Treatment Phase|Pregnancy|0|||
145488336|NCT05579977|524641529|FG009|Treatment Phase|Pregnancy|1|||
145488337|NCT05579977|524641530|FG010|Treatment Phase|Pregnancy|0|||
145488338|NCT05579977|524641531|FG011|Treatment Phase|Pregnancy|0|||
145488339|NCT05579977|524641532|FG012|Treatment Phase|Pregnancy|0|||
145488340|NCT05579977|524641520|FG000|Treatment Phase|Physician Decision|0|||
145488341|NCT05579977|524641521|FG001|Treatment Phase|Physician Decision|0|||
145488342|NCT05579977|524641522|FG002|Treatment Phase|Physician Decision|0|||
145488343|NCT05579977|524641523|FG003|Treatment Phase|Physician Decision|0|||
145488344|NCT05579977|524641524|FG004|Treatment Phase|Physician Decision|0|||
145488345|NCT05579977|524641525|FG005|Treatment Phase|Physician Decision|0|||
145488346|NCT05579977|524641526|FG006|Treatment Phase|Physician Decision|0|||
145488347|NCT05579977|524641527|FG007|Treatment Phase|Physician Decision|0|||
145488348|NCT05579977|524641528|FG008|Treatment Phase|Physician Decision|0|||
145488349|NCT05579977|524641529|FG009|Treatment Phase|Physician Decision|0|||
145488350|NCT05579977|524641530|FG010|Treatment Phase|Physician Decision|0|||
145488351|NCT05579977|524641531|FG011|Treatment Phase|Physician Decision|1|||
145488352|NCT05579977|524641532|FG012|Treatment Phase|Physician Decision|0|||
145488353|NCT05579977|524641520|FG000|Treatment Phase|Lost to Follow-up|0|||
145488354|NCT05579977|524641521|FG001|Treatment Phase|Lost to Follow-up|0|||
145488355|NCT05579977|524641522|FG002|Treatment Phase|Lost to Follow-up|0|||
145488356|NCT05579977|524641523|FG003|Treatment Phase|Lost to Follow-up|1|||
145488357|NCT05579977|524641524|FG004|Treatment Phase|Lost to Follow-up|1|||
145488358|NCT05579977|524641525|FG005|Treatment Phase|Lost to Follow-up|1|||
145488359|NCT05579977|524641526|FG006|Treatment Phase|Lost to Follow-up|0|||
145488360|NCT05579977|524641527|FG007|Treatment Phase|Lost to Follow-up|1|||
145488361|NCT05579977|524641528|FG008|Treatment Phase|Lost to Follow-up|2|||
145488362|NCT05579977|524641529|FG009|Treatment Phase|Lost to Follow-up|2|||
145488363|NCT05579977|524641530|FG010|Treatment Phase|Lost to Follow-up|1|||
145488364|NCT05579977|524641531|FG011|Treatment Phase|Lost to Follow-up|4|||
145488365|NCT05579977|524641532|FG012|Treatment Phase|Lost to Follow-up|3|||
145488366|NCT05579977|524641520|FG000|Treatment Phase|Death|1|||
145488367|NCT05579977|524641521|FG001|Treatment Phase|Death|0|||
145488368|NCT05579977|524641522|FG002|Treatment Phase|Death|0|||
145488369|NCT05579977|524641523|FG003|Treatment Phase|Death|0|||
145488370|NCT05579977|524641524|FG004|Treatment Phase|Death|0|||
145488371|NCT05579977|524641525|FG005|Treatment Phase|Death|0|||
145488372|NCT05579977|524641526|FG006|Treatment Phase|Death|0|||
145488373|NCT05579977|524641527|FG007|Treatment Phase|Death|0|||
145488374|NCT05579977|524641528|FG008|Treatment Phase|Death|0|||
145488375|NCT05579977|524641529|FG009|Treatment Phase|Death|0|||
145488376|NCT05579977|524641530|FG010|Treatment Phase|Death|0|||
145488377|NCT05579977|524641531|FG011|Treatment Phase|Death|0|||
145488378|NCT05579977|524641532|FG012|Treatment Phase|Death|0|||
145488379|NCT05579977|524641520|FG000|Treatment Phase|Adverse Event|0|||
145488380|NCT05579977|524641521|FG001|Treatment Phase|Adverse Event|3|||
145488381|NCT05579977|524641522|FG002|Treatment Phase|Adverse Event|11|||
145488382|NCT05579977|524641523|FG003|Treatment Phase|Adverse Event|10|||
145488383|NCT05579977|524641524|FG004|Treatment Phase|Adverse Event|5|||
145488384|NCT05579977|524641525|FG005|Treatment Phase|Adverse Event|17|||
145488385|NCT05579977|524641526|FG006|Treatment Phase|Adverse Event|5|||
145488386|NCT05579977|524641527|FG007|Treatment Phase|Adverse Event|5|||
145488387|NCT05579977|524641528|FG008|Treatment Phase|Adverse Event|12|||
145488388|NCT05579977|524641529|FG009|Treatment Phase|Adverse Event|20|||
145488389|NCT05579977|524641530|FG010|Treatment Phase|Adverse Event|15|||
145488390|NCT05579977|524641531|FG011|Treatment Phase|Adverse Event|24|||
145488391|NCT05579977|524641532|FG012|Treatment Phase|Adverse Event|23|||
145488392|NCT05579977|524641520|FG000|Treatment Phase|Randomized not treated|0|||
145488393|NCT05579977|524641521|FG001|Treatment Phase|Randomized not treated|0|||
145488394|NCT05579977|524641522|FG002|Treatment Phase|Randomized not treated|0|||
145488395|NCT05579977|524641523|FG003|Treatment Phase|Randomized not treated|0|||
145488396|NCT05579977|524641524|FG004|Treatment Phase|Randomized not treated|1|||
145488397|NCT05579977|524641525|FG005|Treatment Phase|Randomized not treated|0|||
145488398|NCT05579977|524641526|FG006|Treatment Phase|Randomized not treated|0|||
145488399|NCT05579977|524641527|FG007|Treatment Phase|Randomized not treated|0|||
145488400|NCT05579977|524641528|FG008|Treatment Phase|Randomized not treated|0|||
145488401|NCT05579977|524641529|FG009|Treatment Phase|Randomized not treated|0|||
145488402|NCT05579977|524641530|FG010|Treatment Phase|Randomized not treated|0|||
145488403|NCT05579977|524641531|FG011|Treatment Phase|Randomized not treated|0|||
145488404|NCT05579977|524641532|FG012|Treatment Phase|Randomized not treated|0|||
145488405|NCT05579977|524641520|FG000|Follow up|Death|1|||
145488406|NCT05579977|524641521|FG001|Follow up|Death|0|||
145488407|NCT05579977|524641522|FG002|Follow up|Death|0|||
145488408|NCT05579977|524641523|FG003|Follow up|Death|0|||
145488409|NCT05579977|524641524|FG004|Follow up|Death|0|||
145488410|NCT05579977|524641525|FG005|Follow up|Death|0|||
145488411|NCT05579977|524641526|FG006|Follow up|Death|0|||
145648425|NCT02630823|525230300|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
145488412|NCT05579977|524641527|FG007|Follow up|Death|0|||
145488413|NCT05579977|524641528|FG008|Follow up|Death|0|||
145488414|NCT05579977|524641529|FG009|Follow up|Death|0|||
145488415|NCT05579977|524641530|FG010|Follow up|Death|0|||
145488416|NCT05579977|524641531|FG011|Follow up|Death|0|||
145488417|NCT05579977|524641532|FG012|Follow up|Death|0|||
145488418|NCT05579977|524641520|FG000|Follow up|Lost to Follow-up|0|||
145488419|NCT05579977|524641521|FG001|Follow up|Lost to Follow-up|0|||
145488420|NCT05579977|524641522|FG002|Follow up|Lost to Follow-up|0|||
145488421|NCT05579977|524641523|FG003|Follow up|Lost to Follow-up|1|||
145488422|NCT05579977|524641524|FG004|Follow up|Lost to Follow-up|1|||
145488423|NCT05579977|524641525|FG005|Follow up|Lost to Follow-up|2|||
145488424|NCT05579977|524641526|FG006|Follow up|Lost to Follow-up|1|||
145488425|NCT05579977|524641527|FG007|Follow up|Lost to Follow-up|1|||
145488426|NCT05579977|524641528|FG008|Follow up|Lost to Follow-up|3|||
145488427|NCT05579977|524641529|FG009|Follow up|Lost to Follow-up|2|||
145488428|NCT05579977|524641530|FG010|Follow up|Lost to Follow-up|2|||
145488429|NCT05579977|524641531|FG011|Follow up|Lost to Follow-up|4|||
145488430|NCT05579977|524641532|FG012|Follow up|Lost to Follow-up|4|||
145488431|NCT05579977|524641520|FG000|Follow up|Withdrawal by Subject|2|||
145488432|NCT05579977|524641521|FG001|Follow up|Withdrawal by Subject|0|||
145488433|NCT05579977|524641522|FG002|Follow up|Withdrawal by Subject|0|||
145488434|NCT05579977|524641523|FG003|Follow up|Withdrawal by Subject|0|||
145488435|NCT05579977|524641524|FG004|Follow up|Withdrawal by Subject|1|||
145488436|NCT05579977|524641525|FG005|Follow up|Withdrawal by Subject|0|||
145488437|NCT05579977|524641526|FG006|Follow up|Withdrawal by Subject|1|||
145488438|NCT05579977|524641527|FG007|Follow up|Withdrawal by Subject|4|||
145488439|NCT05579977|524641528|FG008|Follow up|Withdrawal by Subject|2|||
145488440|NCT05579977|524641529|FG009|Follow up|Withdrawal by Subject|3|||
145488441|NCT05579977|524641530|FG010|Follow up|Withdrawal by Subject|3|||
145488442|NCT05579977|524641531|FG011|Follow up|Withdrawal by Subject|1|||
145488443|NCT05579977|524641532|FG012|Follow up|Withdrawal by Subject|3|||
145488444|NCT01611194|524641534|FG000|Overall Study|Lost to Follow-up|0|||
145488445|NCT01611194|524641535|FG001|Overall Study|Lost to Follow-up|1|||
145488446|NCT01611194|524641534|FG000|Overall Study|Withdrawal by Subject|0|||
145488447|NCT01611194|524641535|FG001|Overall Study|Withdrawal by Subject|1|||
145488448|NCT01611194|524641534|FG000|Overall Study|drug use|0|||
145488449|NCT01611194|524641535|FG001|Overall Study|drug use|1|||
145488450|NCT00348673|524641536|FG000|Stage 1|Randomized but not Treated|0|||
145488451|NCT00348673|524641537|FG001|Stage 1|Randomized but not Treated|0|||
145488452|NCT00348673|524641538|FG002|Stage 1|Randomized but not Treated|1|||
145488453|NCT00348673|524641539|FG003|Stage 1|Randomized but not Treated|0|||
145488454|NCT00348673|524641540|FG004|Stage 1|Randomized but not Treated|0|||
145488455|NCT00348673|524641541|FG005|Stage 1|Randomized but not Treated|0|||
145488456|NCT00348673|524641542|FG006|Stage 1|Randomized but not Treated|0|||
145488457|NCT00348673|524641543|FG007|Stage 1|Randomized but not Treated|0|||
145488458|NCT00348673|524641544|FG008|Stage 1|Randomized but not Treated|0|||
145488459|NCT01712204|524641546|FG000|Overall Study|Adverse Event|3|||
145488460|NCT01712204|524641547|FG001|Overall Study|Adverse Event|1|||
145488461|NCT01712204|524641546|FG000|Overall Study|Withdrawal by Subject|3|||
145488462|NCT01712204|524641547|FG001|Overall Study|Withdrawal by Subject|3|||
145488463|NCT01712204|524641546|FG000|Overall Study|Lost to Follow-up|1|||
145488464|NCT01712204|524641547|FG001|Overall Study|Lost to Follow-up|0|||
145488465|NCT01712204|524641546|FG000|Overall Study|Protocol Violation|1|||
145488466|NCT01712204|524641547|FG001|Overall Study|Protocol Violation|1|||
145488467|NCT02679287|524641548|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
145488468|NCT02679287|524641549|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
145488469|NCT02679287|524641548|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
145488470|NCT02679287|524641549|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
145488471|NCT02679287|524641548|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
145488472|NCT02679287|524641549|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
145488473|NCT02679287|524641548|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
145488474|NCT02679287|524641549|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
145488475|NCT02679287|524641548|FG000|Period 2|Work/Scheduling Conflict|1|||
145488476|NCT02679287|524641549|FG001|Period 2|Work/Scheduling Conflict|0|||
145488477|NCT02679287|524641548|FG000|Period 2|Disliked Mobile System|2|||
145488478|NCT02679287|524641549|FG001|Period 2|Disliked Mobile System|0|||
145488479|NCT02679287|524641548|FG000|Period 3|Work/Scheduling Conflict|0|||
145488480|NCT02679287|524641549|FG001|Period 3|Work/Scheduling Conflict|1|||
145488481|NCT01114828|524641550|FG000|Overall Study|Adverse Event|1|||
145488482|NCT01114828|524641551|FG001|Overall Study|Adverse Event|1|||
145488483|NCT01114828|524641550|FG000|Overall Study|Lack of Efficacy|0|||
145488484|NCT01114828|524641551|FG001|Overall Study|Lack of Efficacy|2|||
145488485|NCT01114828|524641550|FG000|Overall Study|Protocol Violation|2|||
145488486|NCT01114828|524641551|FG001|Overall Study|Protocol Violation|0|||
145488487|NCT01114828|524641550|FG000|Overall Study|Withdrawal by Subject|0|||
145488488|NCT01114828|524641551|FG001|Overall Study|Withdrawal by Subject|1|||
145488489|NCT01943591|524641554|FG000|Overall Study|Lost to Follow-up|3|||
145488490|NCT01943591|524641555|FG001|Overall Study|Lost to Follow-up|4|||
145488491|NCT01943591|524641554|FG000|Overall Study|Death|2|||
145488492|NCT01943591|524641555|FG001|Overall Study|Death|7|||
145488493|NCT05473026|524644243|FG000|Overall Study|Lost to Follow-up|5|||
145488494|NCT05473026|524644244|FG001|Overall Study|Lost to Follow-up|2|||
145488495|NCT03294590|524644253|FG000|Overall Study|Lost to Follow-up|105|||
145488496|NCT03294590|524644254|FG001|Overall Study|Lost to Follow-up|107|||
145488497|NCT00628030|524644255|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
145488498|NCT00628030|524644256|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
145488499|NCT00628030|524644255|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
145488500|NCT00628030|524644256|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
145488501|NCT00628030|524644255|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
145488502|NCT00628030|524644256|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
145488503|NCT01255423|524644257|FG000|Overall Study|Abnormal Laboratory value|3|||
145648426|NCT04178733|525230301|FG000|Overall Study|Investigator Decision|0|||
145648427|NCT04178733|525230302|FG001|Overall Study|Investigator Decision|0|||
145648428|NCT04178733|525230303|FG002|Overall Study|Investigator Decision|0|||
145648429|NCT04178733|525230304|FG003|Overall Study|Investigator Decision|1|||
145648430|NCT04178733|525230305|FG004|Overall Study|Investigator Decision|2|||
145648431|NCT05919082|525230306|FG000|Overall Study|Adverse Event|3|||
145648432|NCT05919082|525230307|FG001|Overall Study|Adverse Event|0|||
145648433|NCT05919082|525230306|FG000|Overall Study|Lost to Follow-up|0|||
145648434|NCT05919082|525230307|FG001|Overall Study|Lost to Follow-up|1|||
145648435|NCT05919082|525230306|FG000|Overall Study|Withdrawal by Subject|8|||
145648436|NCT05919082|525230307|FG001|Overall Study|Withdrawal by Subject|9|||
145648437|NCT05919082|525230306|FG000|Overall Study|Lack of Efficacy|0|||
145648438|NCT05919082|525230307|FG001|Overall Study|Lack of Efficacy|1|||
145648439|NCT05919082|525230306|FG000|Overall Study|Investigator Decision|1|||
145648440|NCT05919082|525230307|FG001|Overall Study|Investigator Decision|0|||
145648441|NCT05461131|525230309|FG000|Overall Study|Lost to Follow-up|0|||
145648442|NCT05461131|525230310|FG001|Overall Study|Lost to Follow-up|2|||
145648443|NCT04549168|525230312|FG000|Randomization Phase|Adverse Event|0|||
145648444|NCT04549168|525230313|FG001|Randomization Phase|Adverse Event|0|||
145648445|NCT04549168|525230314|FG002|Randomization Phase|Adverse Event|1|||
145648446|NCT04549168|525230312|FG000|Randomization Phase|Other|0|||
145648447|NCT04549168|525230313|FG001|Randomization Phase|Other|2|||
145648448|NCT04549168|525230314|FG002|Randomization Phase|Other|0|||
145648449|NCT04549168|525230312|FG000|Randomization Phase|Withdrawal by Subject|0|||
145648450|NCT04549168|525230313|FG001|Randomization Phase|Withdrawal by Subject|2|||
145648451|NCT04549168|525230314|FG002|Randomization Phase|Withdrawal by Subject|1|||
145648452|NCT00676715|525230319|FG000|Treatment Period (TP)|Adverse Event|0|||
145648453|NCT00676715|525230320|FG001|Treatment Period (TP)|Adverse Event|3|||
145648454|NCT00676715|525230321|FG002|Treatment Period (TP)|Adverse Event|2|||
145648455|NCT00676715|525230322|FG003|Treatment Period (TP)|Adverse Event|2|||
145648456|NCT00676715|525230319|FG000|Treatment Period (TP)|Death|0|||
145648457|NCT00676715|525230320|FG001|Treatment Period (TP)|Death|0|||
145648458|NCT00676715|525230321|FG002|Treatment Period (TP)|Death|1|||
145648459|NCT00676715|525230322|FG003|Treatment Period (TP)|Death|0|||
145648460|NCT00676715|525230319|FG000|Treatment Period (TP)|Failure to return|1|||
145648461|NCT00676715|525230320|FG001|Treatment Period (TP)|Failure to return|0|||
145648462|NCT00676715|525230321|FG002|Treatment Period (TP)|Failure to return|0|||
145648463|NCT00676715|525230322|FG003|Treatment Period (TP)|Failure to return|0|||
145648464|NCT00676715|525230319|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
145648465|NCT00676715|525230320|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
145648466|NCT00676715|525230321|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
145648467|NCT00676715|525230322|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
145648468|NCT00676715|525230319|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
145648469|NCT00676715|525230320|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
145648470|NCT00676715|525230321|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
145648471|NCT00676715|525230322|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
145648472|NCT00676715|525230319|FG000|Treatment Period (TP)|Withdrew consent|3|||
145648473|NCT00676715|525230320|FG001|Treatment Period (TP)|Withdrew consent|3|||
145648474|NCT00676715|525230321|FG002|Treatment Period (TP)|Withdrew consent|3|||
145648475|NCT00676715|525230322|FG003|Treatment Period (TP)|Withdrew consent|3|||
145648476|NCT00676715|525230319|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
145648477|NCT00676715|525230320|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
145648478|NCT00676715|525230321|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
145648479|NCT00676715|525230322|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
145648480|NCT00676715|525230319|FG000|Treatment Period (TP)|Administrative|0|||
145648481|NCT00676715|525230320|FG001|Treatment Period (TP)|Administrative|0|||
145648482|NCT00676715|525230321|FG002|Treatment Period (TP)|Administrative|0|||
145648483|NCT00676715|525230322|FG003|Treatment Period (TP)|Administrative|1|||
145648484|NCT00676715|525230319|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
145648485|NCT00676715|525230320|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
145648486|NCT00676715|525230321|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
145648487|NCT00676715|525230322|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
145648488|NCT00676715|525230319|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
145648489|NCT00676715|525230320|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
145648490|NCT00676715|525230321|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
145648491|NCT00676715|525230322|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
145648492|NCT00676715|525230319|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
145648493|NCT00676715|525230320|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
145648494|NCT00676715|525230321|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
145648495|NCT00676715|525230322|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
145648496|NCT00676715|525230319|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
145648497|NCT00676715|525230320|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
145648498|NCT00676715|525230321|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
145648499|NCT00676715|525230322|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
145648500|NCT00676715|525230319|FG000|Treatment-free Period (TFP)|Death|1|||
145648501|NCT00676715|525230320|FG001|Treatment-free Period (TFP)|Death|1|||
145648502|NCT00676715|525230321|FG002|Treatment-free Period (TFP)|Death|1|||
145648503|NCT00676715|525230322|FG003|Treatment-free Period (TFP)|Death|0|||
145648504|NCT00676715|525230319|FG000|Open Label Extension (OLE)|Reason not provided|3|||
145648505|NCT00676715|525230320|FG001|Open Label Extension (OLE)|Reason not provided|4|||
145648506|NCT00676715|525230321|FG002|Open Label Extension (OLE)|Reason not provided|1|||
145648507|NCT00676715|525230322|FG003|Open Label Extension (OLE)|Reason not provided|4|||
145648508|NCT00676715|525230319|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
145648509|NCT00676715|525230320|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
145648510|NCT00676715|525230321|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
145648511|NCT00676715|525230322|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
145648512|NCT00676715|525230319|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
145648513|NCT00676715|525230320|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
145648514|NCT00676715|525230321|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
145648515|NCT00676715|525230322|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
145648516|NCT00676715|525230319|FG000|Open Label Extension (OLE)|Adverse Event|0|||
145648517|NCT00676715|525230320|FG001|Open Label Extension (OLE)|Adverse Event|3|||
145648518|NCT00676715|525230321|FG002|Open Label Extension (OLE)|Adverse Event|1|||
145648519|NCT00676715|525230322|FG003|Open Label Extension (OLE)|Adverse Event|0|||
145648520|NCT00676715|525230319|FG000|Open Label Extension (OLE)|Death|2|||
145648521|NCT00676715|525230320|FG001|Open Label Extension (OLE)|Death|0|||
145648522|NCT00676715|525230321|FG002|Open Label Extension (OLE)|Death|2|||
145648523|NCT00676715|525230322|FG003|Open Label Extension (OLE)|Death|2|||
145648524|NCT05249439|525230323|FG000|Overall Study|Withdrawal by Subject|2|||
145648525|NCT05249439|525230324|FG001|Overall Study|Withdrawal by Subject|5|||
145648526|NCT05249439|525230323|FG000|Overall Study|Physician Decision|3|||
145648527|NCT05249439|525230324|FG001|Overall Study|Physician Decision|1|||
145648528|NCT02249949|525230325|FG000|Overall Study|Cancelled prior to treatment|2|||
145648529|NCT02549339|525230328|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
145648530|NCT02549339|525230329|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
145648531|NCT02549339|525230328|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
145648532|NCT02549339|525230329|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
145648533|NCT02549339|525230328|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
145648534|NCT02549339|525230329|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
145648535|NCT02549339|525230328|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
145648536|NCT02549339|525230329|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
145648537|NCT02549339|525230328|FG000|12-month Follow-up|Lack of Efficacy|0|||
145648538|NCT02549339|525230329|FG001|12-month Follow-up|Lack of Efficacy|2|||
145648539|NCT02549339|525230328|FG000|12-month Follow-up|Withdrawal by Subject|8|||
145648540|NCT02549339|525230329|FG001|12-month Follow-up|Withdrawal by Subject|3|||
145648541|NCT02549339|525230328|FG000|12-month Follow-up|Lost to Follow-up|1|||
145648542|NCT02549339|525230329|FG001|12-month Follow-up|Lost to Follow-up|3|||
145648543|NCT02549339|525230328|FG000|12-month Follow-up|Other|0|||
145648544|NCT02549339|525230329|FG001|12-month Follow-up|Other|3|||
145648545|NCT05054374|525230330|FG000|Overall Study|Withdrawal by Subject|1|||
145648546|NCT05054374|525230331|FG001|Overall Study|Withdrawal by Subject|0|||
145648547|NCT05054374|525230332|FG002|Overall Study|Withdrawal by Subject|0|||
145648548|NCT05054374|525230333|FG003|Overall Study|Withdrawal by Subject|0|||
145648549|NCT05054374|525230330|FG000|Overall Study|Progressive Disease|5|||
145648550|NCT05054374|525230331|FG001|Overall Study|Progressive Disease|0|||
145648551|NCT05054374|525230332|FG002|Overall Study|Progressive Disease|0|||
145648552|NCT05054374|525230333|FG003|Overall Study|Progressive Disease|0|||
145648553|NCT05691309|525230334|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
145648554|NCT05691309|525230334|FG000|Overall Study|vancomycin levels not evaluable|2|||
145648555|NCT01707030|525230335|FG000|Overall Study|Death|1|||
145648556|NCT01707030|525230336|FG001|Overall Study|Death|1|||
145648557|NCT01707030|525230335|FG000|Overall Study|Withdrawal by Subject|2|||
145648558|NCT01707030|525230336|FG001|Overall Study|Withdrawal by Subject|3|||
145648559|NCT01707030|525230335|FG000|Overall Study|Lost to Follow-up|8|||
145648560|NCT01707030|525230336|FG001|Overall Study|Lost to Follow-up|13|||
145648561|NCT04820855|525230338|FG000|Overall Study|Lost to Follow-up|6|||
145648562|NCT04820855|525230339|FG001|Overall Study|Lost to Follow-up|9|||
145648563|NCT04838262|525230340|FG000|Overall Study|Withdrawal by Subject|9|||
145648564|NCT04838262|525230341|FG001|Overall Study|Withdrawal by Subject|4|||
145648565|NCT04437433|525230342|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
145648566|NCT04437433|525230343|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
145648567|NCT04437433|525230342|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
145648568|NCT04437433|525230343|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
145648569|NCT04437433|525230342|FG000|Overall Study|Adverse Event|9|||
145648570|NCT04437433|525230343|FG001|Overall Study|Adverse Event|0|||
145648571|NCT04437433|525230342|FG000|Overall Study|Lack of Efficacy|4|||
145648572|NCT04437433|525230343|FG001|Overall Study|Lack of Efficacy|0|||
145648573|NCT04437433|525230342|FG000|Overall Study|Withdrawal by Subject|4|||
145648574|NCT04437433|525230343|FG001|Overall Study|Withdrawal by Subject|1|||
145648575|NCT04437433|525230342|FG000|Overall Study|Protocol Deviation|0|||
145648576|NCT04437433|525230343|FG001|Overall Study|Protocol Deviation|1|||
145648577|NCT04437433|525230342|FG000|Overall Study|Other, not specified|0|||
145648578|NCT04437433|525230343|FG001|Overall Study|Other, not specified|1|||
145648579|NCT04245501|525230344|FG000|Overall Study|Adverse Event|2|||
145648580|NCT04245501|525230345|FG001|Overall Study|Adverse Event|0|||
145648581|NCT04245501|525230344|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
145648582|NCT04245501|525230345|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
145648583|NCT04391894|525230351|FG000|Overall Study|Adverse Event|1|||
145648584|NCT04391894|525230352|FG001|Overall Study|Adverse Event|1|||
145648585|NCT04391894|525230353|FG002|Overall Study|Adverse Event|1|||
145648586|NCT04391894|525230354|FG003|Overall Study|Adverse Event|1|||
145648587|NCT04391894|525230355|FG004|Overall Study|Adverse Event|1|||
145648588|NCT04391894|525230351|FG000|Overall Study|Lost to Follow-up|1|||
145648589|NCT04391894|525230352|FG001|Overall Study|Lost to Follow-up|0|||
145648590|NCT04391894|525230353|FG002|Overall Study|Lost to Follow-up|0|||
145648591|NCT04391894|525230354|FG003|Overall Study|Lost to Follow-up|0|||
145648592|NCT04391894|525230355|FG004|Overall Study|Lost to Follow-up|0|||
145648593|NCT04391894|525230351|FG000|Overall Study|Protocol Violation|0|||
145648594|NCT04391894|525230352|FG001|Overall Study|Protocol Violation|0|||
145648595|NCT04391894|525230353|FG002|Overall Study|Protocol Violation|0|||
145648596|NCT04391894|525230354|FG003|Overall Study|Protocol Violation|1|||
145648597|NCT04391894|525230355|FG004|Overall Study|Protocol Violation|0|||
145648598|NCT04391894|525230351|FG000|Overall Study|Withdrawal by Subject|2|||
145648599|NCT04391894|525230352|FG001|Overall Study|Withdrawal by Subject|0|||
145648600|NCT04391894|525230353|FG002|Overall Study|Withdrawal by Subject|3|||
145648601|NCT04391894|525230354|FG003|Overall Study|Withdrawal by Subject|0|||
145648602|NCT04391894|525230355|FG004|Overall Study|Withdrawal by Subject|1|||
145648603|NCT04391894|525230351|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
145648604|NCT04391894|525230352|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
145648605|NCT04391894|525230353|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
145648606|NCT04391894|525230354|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
145648607|NCT04391894|525230355|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
145648608|NCT02323321|525230359|FG000|Overall Study|Re-Transplant|1|||
145648609|NCT02323321|525230359|FG000|Overall Study|Death|12|||
145648610|NCT00446225|525230360|FG000|Overall Study|Protocol Violation|1|||
145648611|NCT00446225|525230361|FG001|Overall Study|Protocol Violation|0|||
145648612|NCT04450342|525230362|FG000|Overall Study|Adverse Event|1|||
145648613|NCT04450342|525230363|FG001|Overall Study|Adverse Event|1|||
145648614|NCT04450342|525230364|FG002|Overall Study|Adverse Event|0|||
145648615|NCT04450342|525230362|FG000|Overall Study|Device not used|1|||
145648616|NCT04450342|525230363|FG001|Overall Study|Device not used|0|||
145648617|NCT04450342|525230364|FG002|Overall Study|Device not used|0|||
145648618|NCT04450342|525230362|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
145648619|NCT04450342|525230363|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
145648620|NCT04450342|525230364|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
145648621|NCT04450342|525230362|FG000|Overall Study|Physician Decision|1|||
145648622|NCT04450342|525230363|FG001|Overall Study|Physician Decision|0|||
145648623|NCT04450342|525230364|FG002|Overall Study|Physician Decision|1|||
145648624|NCT04450342|525230362|FG000|Overall Study|Protocol Deviation|0|||
145648625|NCT04450342|525230363|FG001|Overall Study|Protocol Deviation|1|||
145648626|NCT04450342|525230364|FG002|Overall Study|Protocol Deviation|0|||
145648627|NCT04450342|525230362|FG000|Overall Study|Reoperation|1|||
145648628|NCT04450342|525230363|FG001|Overall Study|Reoperation|1|||
145648629|NCT04450342|525230364|FG002|Overall Study|Reoperation|0|||
145648630|NCT04450342|525230362|FG000|Overall Study|Screen Failures|0|||
145488504|NCT01255423|524644258|FG001|Overall Study|Abnormal Laboratory value|2|||
145488505|NCT01255423|524644257|FG000|Overall Study|Use of prohibited medications|0|||
145488506|NCT01255423|524644258|FG001|Overall Study|Use of prohibited medications|1|||
145648631|NCT04450342|525230363|FG001|Overall Study|Screen Failures|0|||
145648632|NCT04450342|525230364|FG002|Overall Study|Screen Failures|2|||
145648633|NCT04450342|525230362|FG000|Overall Study|Site Terminated by Sponsor|1|||
145648634|NCT04450342|525230363|FG001|Overall Study|Site Terminated by Sponsor|1|||
145648635|NCT04450342|525230364|FG002|Overall Study|Site Terminated by Sponsor|1|||
145648636|NCT04450342|525230362|FG000|Overall Study|Study Terminated by Sponsor|31|||
145648637|NCT04450342|525230363|FG001|Overall Study|Study Terminated by Sponsor|29|||
145648638|NCT04450342|525230364|FG002|Overall Study|Study Terminated by Sponsor|6|||
145648639|NCT04450342|525230362|FG000|Overall Study|Withdrawal by Subject|0|||
145648640|NCT04450342|525230363|FG001|Overall Study|Withdrawal by Subject|1|||
145648641|NCT04450342|525230364|FG002|Overall Study|Withdrawal by Subject|2|||
145648642|NCT05633407|525230365|FG000|Overall Study|Physician Decision|2|||
145648643|NCT05633407|525230366|FG001|Overall Study|Physician Decision|0|||
145648644|NCT05633407|525230365|FG000|Overall Study|Adverse Event|1|||
145648645|NCT05633407|525230366|FG001|Overall Study|Adverse Event|0|||
145648646|NCT05633407|525230365|FG000|Overall Study|Withdrawal by Subject|1|||
145648647|NCT05633407|525230366|FG001|Overall Study|Withdrawal by Subject|0|||
145648648|NCT05633407|525230365|FG000|Overall Study|Other|1|||
145648649|NCT05633407|525230366|FG001|Overall Study|Other|1|||
145648650|NCT00220740|525230371|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
145648651|NCT00220740|525230372|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
145648652|NCT00220740|525230371|FG000|Efficacy Period|Adverse Event|1|||
145648653|NCT00220740|525230372|FG001|Efficacy Period|Adverse Event|1|||
145648654|NCT00220740|525230371|FG000|Efficacy Period|Withdrawal by Subject|1|||
145648655|NCT00220740|525230372|FG001|Efficacy Period|Withdrawal by Subject|0|||
145648656|NCT00220740|525230371|FG000|Efficacy Period|Protocol Violation|1|||
145648657|NCT00220740|525230372|FG001|Efficacy Period|Protocol Violation|0|||
145648658|NCT00220740|525230371|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
145648659|NCT00220740|525230372|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
145648660|NCT05268302|525230373|FG000|Overall Study|Death|0|||
145648661|NCT05268302|525230374|FG001|Overall Study|Death|1|||
145648662|NCT04093752|525230378|FG000|Overall Study|Adverse Event|7|||
145648663|NCT04093752|525230379|FG001|Overall Study|Adverse Event|19|||
145648664|NCT04093752|525230380|FG002|Overall Study|Adverse Event|18|||
145648665|NCT04093752|525230381|FG003|Overall Study|Adverse Event|4|||
145648666|NCT04093752|525230378|FG000|Overall Study|Withdrawal by Subject|6|||
145648667|NCT04093752|525230379|FG001|Overall Study|Withdrawal by Subject|6|||
145648668|NCT04093752|525230380|FG002|Overall Study|Withdrawal by Subject|8|||
145648669|NCT04093752|525230381|FG003|Overall Study|Withdrawal by Subject|20|||
145648670|NCT04093752|525230378|FG000|Overall Study|Lost to Follow-up|2|||
145648671|NCT04093752|525230379|FG001|Overall Study|Lost to Follow-up|1|||
145648672|NCT04093752|525230380|FG002|Overall Study|Lost to Follow-up|1|||
145648673|NCT04093752|525230381|FG003|Overall Study|Lost to Follow-up|1|||
145648674|NCT04093752|525230378|FG000|Overall Study|Death|0|||
145648675|NCT04093752|525230379|FG001|Overall Study|Death|0|||
145648676|NCT04093752|525230380|FG002|Overall Study|Death|1|||
145648677|NCT04093752|525230381|FG003|Overall Study|Death|2|||
145648678|NCT04093752|525230378|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
145648679|NCT04093752|525230379|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
145648680|NCT04093752|525230380|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
145648681|NCT04093752|525230381|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
145648682|NCT04093752|525230378|FG000|Overall Study|Covid 19|0|||
145648683|NCT04093752|525230379|FG001|Overall Study|Covid 19|0|||
145648684|NCT04093752|525230380|FG002|Overall Study|Covid 19|0|||
145648685|NCT04093752|525230381|FG003|Overall Study|Covid 19|1|||
145648686|NCT04093752|525230378|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
145648687|NCT04093752|525230379|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
145648688|NCT04093752|525230380|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
145648689|NCT04093752|525230381|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
145648690|NCT04093752|525230378|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
145648691|NCT04093752|525230379|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
145648692|NCT04093752|525230380|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
145648693|NCT04093752|525230381|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
145648694|NCT04093752|525230378|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
145648695|NCT04093752|525230379|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
145648696|NCT04093752|525230380|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
145648697|NCT04093752|525230381|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
145648698|NCT03527160|525230386|FG000|Overall Study|No urine collected|13|||
145648699|NCT03527160|525230386|FG000|Overall Study|No clinical serum creatinine collected|6|||
145648700|NCT03527160|525230386|FG000|Overall Study|Did not meet inclusion|2|||
145648701|NCT02910713|525230387|FG000|Overall Study|Protocol Violation|2|||
145648702|NCT02910713|525230387|FG000|Overall Study|Subject Choice|4|||
145648703|NCT02910713|525230387|FG000|Overall Study|Received One Application|10|||
145648704|NCT02910713|525230387|FG000|Overall Study|Received Neither Application|18|||
145648705|NCT02910713|525230387|FG000|Overall Study|Enrollment cap|7|||
145648706|NCT02910713|525230387|FG000|Overall Study|Investigator Discretion|1|||
145648707|NCT04442126|525230396|FG000|Overall Study|Withdrawal by Subject|0|||
145648708|NCT04442126|525230397|FG001|Overall Study|Withdrawal by Subject|0|||
145648709|NCT04442126|525230398|FG002|Overall Study|Withdrawal by Subject|0|||
145648710|NCT04442126|525230399|FG003|Overall Study|Withdrawal by Subject|2|||
145648711|NCT04442126|525230400|FG004|Overall Study|Withdrawal by Subject|1|||
145648712|NCT04442126|525230401|FG005|Overall Study|Withdrawal by Subject|0|||
145648713|NCT04442126|525230402|FG006|Overall Study|Withdrawal by Subject|1|||
145648714|NCT04442126|525230403|FG007|Overall Study|Withdrawal by Subject|1|||
145648715|NCT04442126|525230404|FG008|Overall Study|Withdrawal by Subject|3|||
145648716|NCT04442126|525230396|FG000|Overall Study|Death|1|||
145648717|NCT04442126|525230397|FG001|Overall Study|Death|0|||
145648718|NCT04442126|525230398|FG002|Overall Study|Death|0|||
145648719|NCT04442126|525230399|FG003|Overall Study|Death|1|||
145648720|NCT04442126|525230400|FG004|Overall Study|Death|2|||
145648721|NCT04442126|525230401|FG005|Overall Study|Death|2|||
145648722|NCT04442126|525230402|FG006|Overall Study|Death|4|||
145648723|NCT04442126|525230403|FG007|Overall Study|Death|1|||
145648724|NCT04442126|525230404|FG008|Overall Study|Death|5|||
145648725|NCT04442126|525230396|FG000|Overall Study|Study Terminated by Sponsor|0|||
145648726|NCT04442126|525230397|FG001|Overall Study|Study Terminated by Sponsor|0|||
145648727|NCT04442126|525230398|FG002|Overall Study|Study Terminated by Sponsor|0|||
145648728|NCT04442126|525230399|FG003|Overall Study|Study Terminated by Sponsor|0|||
145648729|NCT04442126|525230400|FG004|Overall Study|Study Terminated by Sponsor|0|||
145648730|NCT04442126|525230401|FG005|Overall Study|Study Terminated by Sponsor|1|||
145648731|NCT04442126|525230402|FG006|Overall Study|Study Terminated by Sponsor|4|||
145648732|NCT04442126|525230403|FG007|Overall Study|Study Terminated by Sponsor|2|||
145648733|NCT04442126|525230404|FG008|Overall Study|Study Terminated by Sponsor|10|||
145648734|NCT04442126|525230396|FG000|Overall Study|Lost to Follow-up|0|||
145648735|NCT04442126|525230397|FG001|Overall Study|Lost to Follow-up|0|||
145648736|NCT04442126|525230398|FG002|Overall Study|Lost to Follow-up|0|||
145648737|NCT04442126|525230399|FG003|Overall Study|Lost to Follow-up|0|||
145648738|NCT04442126|525230400|FG004|Overall Study|Lost to Follow-up|0|||
145648739|NCT04442126|525230401|FG005|Overall Study|Lost to Follow-up|0|||
145648740|NCT04442126|525230402|FG006|Overall Study|Lost to Follow-up|0|||
145648741|NCT04442126|525230403|FG007|Overall Study|Lost to Follow-up|1|||
145648742|NCT04442126|525230404|FG008|Overall Study|Lost to Follow-up|2|||
145648743|NCT04442126|525230396|FG000|Overall Study|Progressive Disease|0|||
145648744|NCT04442126|525230397|FG001|Overall Study|Progressive Disease|1|||
145648745|NCT04442126|525230398|FG002|Overall Study|Progressive Disease|3|||
145648746|NCT04442126|525230399|FG003|Overall Study|Progressive Disease|0|||
145648747|NCT04442126|525230400|FG004|Overall Study|Progressive Disease|3|||
145648748|NCT04442126|525230401|FG005|Overall Study|Progressive Disease|0|||
145648749|NCT04442126|525230402|FG006|Overall Study|Progressive Disease|0|||
145648750|NCT04442126|525230403|FG007|Overall Study|Progressive Disease|0|||
145648751|NCT04442126|525230404|FG008|Overall Study|Progressive Disease|0|||
145648752|NCT04442126|525230396|FG000|Overall Study|Other|0|||
145648753|NCT04442126|525230397|FG001|Overall Study|Other|0|||
145648754|NCT04442126|525230398|FG002|Overall Study|Other|0|||
145648755|NCT04442126|525230399|FG003|Overall Study|Other|0|||
145648756|NCT04442126|525230400|FG004|Overall Study|Other|0|||
145648757|NCT04442126|525230401|FG005|Overall Study|Other|0|||
145648758|NCT04442126|525230402|FG006|Overall Study|Other|0|||
145648759|NCT04442126|525230403|FG007|Overall Study|Other|0|||
145648760|NCT04442126|525230404|FG008|Overall Study|Other|1|||
145648761|NCT06450405|525230405|FG000|Overall Study|Study funding terminated.|0|||
145648762|NCT06450405|525230406|FG001|Overall Study|Study funding terminated.|2|||
145648763|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
145648764|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
145648765|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
145648766|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
145648767|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
145648768|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
145648769|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
145648770|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
145648771|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
145648772|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
145648773|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
145648774|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
145648775|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
145648776|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
145648777|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
145648778|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
145648779|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
145648780|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
145648781|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
145648782|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
145648783|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
145648784|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
145648785|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
145648786|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
145648787|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
145648788|NCT05338086|525231885|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
145648789|NCT05338086|525231886|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
145648790|NCT05338086|525231887|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
145648791|NCT05338086|525231888|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
145648792|NCT05338086|525231889|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
145648793|NCT05338086|525231885|FG000|Transition Period (M12 to M18)|Death|0|||
145648794|NCT05338086|525231886|FG001|Transition Period (M12 to M18)|Death|0|||
145648795|NCT05338086|525231887|FG002|Transition Period (M12 to M18)|Death|1|||
145648796|NCT05338086|525231888|FG003|Transition Period (M12 to M18)|Death|0|||
145648797|NCT05338086|525231889|FG004|Transition Period (M12 to M18)|Death|0|||
145648798|NCT05338086|525231885|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
145648799|NCT05338086|525231886|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
145648800|NCT05338086|525231887|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
145648801|NCT05338086|525231888|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
145648802|NCT05338086|525231889|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
145648803|NCT05338086|525231885|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
145648804|NCT05338086|525231886|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
145648805|NCT05338086|525231887|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
145648806|NCT05338086|525231888|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
145648807|NCT05338086|525231889|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
145648808|NCT05338086|525231885|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
145648809|NCT05338086|525231886|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
145648810|NCT05338086|525231887|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
145648811|NCT05338086|525231888|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
145648812|NCT05338086|525231889|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
145648813|NCT03940703|525231890|FG000|Overall Study|Still under treatment|31|||
145648814|NCT03940703|525231891|FG001|Overall Study|Still under treatment|0|||
145648815|NCT00753090|525231903|FG000|Overall Study|Withdrawal by Subject|10|||
145648816|NCT00753090|525231904|FG001|Overall Study|Withdrawal by Subject|10|||
145648817|NCT00753090|525231903|FG000|Overall Study|Death|17|||
145648818|NCT00753090|525231904|FG001|Overall Study|Death|6|||
145648819|NCT00753090|525231903|FG000|Overall Study|Study Prosthesis Removed|12|||
145648820|NCT00753090|525231904|FG001|Overall Study|Study Prosthesis Removed|3|||
145648821|NCT00753090|525231903|FG000|Overall Study|Lost to Follow-up|2|||
145648822|NCT00753090|525231904|FG001|Overall Study|Lost to Follow-up|2|||
145648823|NCT00753090|525231903|FG000|Overall Study|Other|127|||
145648824|NCT00753090|525231904|FG001|Overall Study|Other|75|||
145648825|NCT04521478|525231908|FG000|Overall Study|Protocol Violation|2|||
145648826|NCT04521478|525231909|FG001|Overall Study|Protocol Violation|0|||
145648827|NCT04521478|525231910|FG002|Overall Study|Protocol Violation|1|||
145648828|NCT04521478|525231911|FG003|Overall Study|Protocol Violation|0|||
145648829|NCT04521478|525231912|FG004|Overall Study|Protocol Violation|0|||
145648830|NCT04521478|525231913|FG005|Overall Study|Protocol Violation|0|||
145648831|NCT04521478|525231908|FG000|Overall Study|Technical Problems|0|||
145648832|NCT04521478|525231909|FG001|Overall Study|Technical Problems|0|||
145648833|NCT04521478|525231910|FG002|Overall Study|Technical Problems|0|||
145648834|NCT04521478|525231911|FG003|Overall Study|Technical Problems|1|||
145648835|NCT04521478|525231912|FG004|Overall Study|Technical Problems|0|||
145648836|NCT04521478|525231913|FG005|Overall Study|Technical Problems|0|||
145648837|NCT04521478|525231908|FG000|Overall Study|Burden of Study Procedures|1|||
145648838|NCT04521478|525231909|FG001|Overall Study|Burden of Study Procedures|0|||
145648839|NCT04521478|525231910|FG002|Overall Study|Burden of Study Procedures|0|||
145648840|NCT04521478|525231911|FG003|Overall Study|Burden of Study Procedures|1|||
145648841|NCT04521478|525231912|FG004|Overall Study|Burden of Study Procedures|0|||
145648842|NCT04521478|525231913|FG005|Overall Study|Burden of Study Procedures|1|||
145648843|NCT04521478|525231908|FG000|Overall Study|Lack of Efficacy|0|||
145648844|NCT04521478|525231909|FG001|Overall Study|Lack of Efficacy|0|||
145648845|NCT04521478|525231910|FG002|Overall Study|Lack of Efficacy|0|||
145648846|NCT04521478|525231911|FG003|Overall Study|Lack of Efficacy|0|||
145648847|NCT04521478|525231912|FG004|Overall Study|Lack of Efficacy|1|||
145648848|NCT04521478|525231913|FG005|Overall Study|Lack of Efficacy|1|||
145648849|NCT04521478|525231908|FG000|Overall Study|Adverse Event|7|||
145648850|NCT04521478|525231909|FG001|Overall Study|Adverse Event|0|||
145648851|NCT04521478|525231910|FG002|Overall Study|Adverse Event|2|||
145648852|NCT04521478|525231911|FG003|Overall Study|Adverse Event|1|||
145648853|NCT04521478|525231912|FG004|Overall Study|Adverse Event|2|||
145648854|NCT04521478|525231913|FG005|Overall Study|Adverse Event|7|||
145648855|NCT04521478|525231908|FG000|Overall Study|No Reason Available|0|||
145648856|NCT04521478|525231909|FG001|Overall Study|No Reason Available|2|||
145648857|NCT04521478|525231910|FG002|Overall Study|No Reason Available|0|||
145648858|NCT04521478|525231911|FG003|Overall Study|No Reason Available|0|||
145648859|NCT04521478|525231912|FG004|Overall Study|No Reason Available|1|||
145648860|NCT04521478|525231913|FG005|Overall Study|No Reason Available|0|||
145648861|NCT04521478|525231908|FG000|Overall Study|Other than listed|3|||
145648862|NCT04521478|525231909|FG001|Overall Study|Other than listed|3|||
145648863|NCT04521478|525231910|FG002|Overall Study|Other than listed|3|||
145648864|NCT04521478|525231911|FG003|Overall Study|Other than listed|2|||
145648865|NCT04521478|525231912|FG004|Overall Study|Other than listed|3|||
145648866|NCT04521478|525231913|FG005|Overall Study|Other than listed|3|||
145648867|NCT04521478|525231908|FG000|Overall Study|Not treated|0|||
145648868|NCT04521478|525231909|FG001|Overall Study|Not treated|0|||
145648869|NCT04521478|525231910|FG002|Overall Study|Not treated|0|||
145648870|NCT04521478|525231911|FG003|Overall Study|Not treated|0|||
145648871|NCT04521478|525231912|FG004|Overall Study|Not treated|0|||
145648872|NCT04521478|525231913|FG005|Overall Study|Not treated|1|||
145648873|NCT03625882|525231914|FG000|Overall Study|Protocol Violation|3|||
145648874|NCT03833245|525231915|FG000|Overall Study|Death|0|||
145648875|NCT03833245|525231916|FG001|Overall Study|Death|1|||
145648876|NCT03347383|525231918|FG000|Overall Study|Death|39|||
145648877|NCT03347383|525231918|FG000|Overall Study|Withdrawal by Subject|3|||
145648878|NCT03347383|525231918|FG000|Overall Study|Lost to Follow-up|9|||
145648879|NCT02287311|525231930|FG000|Cohort 1: Dose Level 1|Death|2|||
145648880|NCT02287311|525231931|FG001|Cohort 1: Dose Level 1|Death|0|||
145648881|NCT02287311|525231932|FG002|Cohort 1: Dose Level 1|Death|0|||
145648882|NCT02287311|525231933|FG003|Cohort 1: Dose Level 1|Death|3|||
145648883|NCT02287311|525231934|FG004|Cohort 1: Dose Level 1|Death|0|||
145648884|NCT02287311|525231935|FG005|Cohort 1: Dose Level 1|Death|0|||
145648885|NCT02287311|525231936|FG006|Cohort 1: Dose Level 1|Death|1|||
145648886|NCT02287311|525231937|FG007|Cohort 1: Dose Level 1|Death|0|||
145648887|NCT02287311|525231938|FG008|Cohort 1: Dose Level 1|Death|0|||
145648888|NCT02287311|525231930|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648889|NCT02287311|525231931|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648890|NCT02287311|525231932|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648891|NCT02287311|525231933|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
145648892|NCT02287311|525231934|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648893|NCT02287311|525231935|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648894|NCT02287311|525231936|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
145648895|NCT02287311|525231937|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648896|NCT02287311|525231938|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
145648897|NCT02287311|525231930|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
145648898|NCT02287311|525231931|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
145648899|NCT02287311|525231932|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
145648900|NCT02287311|525231933|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
145648901|NCT02287311|525231934|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
145648902|NCT02287311|525231935|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
145648903|NCT02287311|525231936|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
145648904|NCT02287311|525231937|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
145648905|NCT02287311|525231938|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
145648906|NCT02287311|525231930|FG000|Cohort 2: Dose Level 2|Death|0|||
145648907|NCT02287311|525231931|FG001|Cohort 2: Dose Level 2|Death|2|||
145648908|NCT02287311|525231932|FG002|Cohort 2: Dose Level 2|Death|0|||
145648909|NCT02287311|525231933|FG003|Cohort 2: Dose Level 2|Death|0|||
145648910|NCT02287311|525231934|FG004|Cohort 2: Dose Level 2|Death|2|||
145648911|NCT02287311|525231935|FG005|Cohort 2: Dose Level 2|Death|0|||
145648912|NCT02287311|525231936|FG006|Cohort 2: Dose Level 2|Death|0|||
145648913|NCT02287311|525231937|FG007|Cohort 2: Dose Level 2|Death|2|||
145648914|NCT02287311|525231938|FG008|Cohort 2: Dose Level 2|Death|0|||
145648915|NCT02287311|525231930|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648916|NCT02287311|525231931|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648917|NCT02287311|525231932|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648918|NCT02287311|525231933|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648919|NCT02287311|525231934|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
145648920|NCT02287311|525231935|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648921|NCT02287311|525231936|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648922|NCT02287311|525231937|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648923|NCT02287311|525231938|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
145648924|NCT02287311|525231930|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648925|NCT02287311|525231931|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
145648926|NCT02287311|525231932|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648927|NCT02287311|525231933|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648928|NCT02287311|525231934|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648929|NCT02287311|525231935|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648930|NCT02287311|525231936|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648931|NCT02287311|525231937|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648932|NCT02287311|525231938|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
145648933|NCT02287311|525231930|FG000|Cohort 3: Dose Level 3|Death|0|||
145648934|NCT02287311|525231931|FG001|Cohort 3: Dose Level 3|Death|0|||
145648935|NCT02287311|525231932|FG002|Cohort 3: Dose Level 3|Death|4|||
145648936|NCT02287311|525231933|FG003|Cohort 3: Dose Level 3|Death|0|||
145648937|NCT02287311|525231934|FG004|Cohort 3: Dose Level 3|Death|0|||
145648938|NCT02287311|525231935|FG005|Cohort 3: Dose Level 3|Death|4|||
145648939|NCT02287311|525231936|FG006|Cohort 3: Dose Level 3|Death|0|||
145648940|NCT02287311|525231937|FG007|Cohort 3: Dose Level 3|Death|0|||
145648941|NCT02287311|525231938|FG008|Cohort 3: Dose Level 3|Death|2|||
145648942|NCT02287311|525231930|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145488507|NCT03367858|524644259|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
145648943|NCT02287311|525231931|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648944|NCT02287311|525231932|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
145648945|NCT02287311|525231933|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648946|NCT02287311|525231934|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648947|NCT02287311|525231935|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
145648948|NCT02287311|525231936|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648949|NCT02287311|525231937|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648950|NCT02287311|525231938|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
145648951|NCT02287311|525231930|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648952|NCT02287311|525231931|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648953|NCT02287311|525231932|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648954|NCT02287311|525231933|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648955|NCT02287311|525231934|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648956|NCT02287311|525231935|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
145648957|NCT02287311|525231936|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648958|NCT02287311|525231937|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
145648959|NCT02287311|525231938|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
145648960|NCT03896516|525231939|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
145648961|NCT03896516|525231940|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
145648962|NCT03896516|525231939|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
145648963|NCT03896516|525231940|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
145648964|NCT03896516|525231939|FG000|Washout Period|Physician Decision|3|||
145648965|NCT03896516|525231940|FG001|Washout Period|Physician Decision|1|||
145648966|NCT03896516|525231939|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
145648967|NCT03896516|525231940|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
145648968|NCT02682316|525231945|FG000|Overall Study|Benign Final Pathology|27|||
145648969|NCT02682316|525231946|FG001|Overall Study|Benign Final Pathology|26|||
145648970|NCT02682316|525231945|FG000|Overall Study|Reoperation before 30 days|7|||
145648971|NCT02682316|525231946|FG001|Overall Study|Reoperation before 30 days|6|||
145648972|NCT02682316|525231945|FG000|Overall Study|Ineligible|1|||
145648973|NCT02682316|525231946|FG001|Overall Study|Ineligible|0|||
145648974|NCT02682316|525231945|FG000|Overall Study|Death|1|||
145648975|NCT02682316|525231946|FG001|Overall Study|Death|0|||
145648976|NCT02682316|525231945|FG000|Overall Study|Lost to Follow-up|7|||
145648977|NCT02682316|525231946|FG001|Overall Study|Lost to Follow-up|3|||
145648978|NCT02662062|525231950|FG000|Overall Study|Withdrawal by Subject|1|||
145648979|NCT05374837|525231951|FG000|Overall Study|Lost to Follow-up|17|||
145648980|NCT05374837|525231952|FG001|Overall Study|Lost to Follow-up|18|||
145648981|NCT05021640|525231961|FG000|Overall Study|Lost to Follow-up|0|||
145648982|NCT05021640|525231962|FG001|Overall Study|Lost to Follow-up|0|||
145648983|NCT05021640|525231963|FG002|Overall Study|Lost to Follow-up|0|||
145648984|NCT05021640|525231964|FG003|Overall Study|Lost to Follow-up|0|||
145648985|NCT05021640|525231965|FG004|Overall Study|Lost to Follow-up|1|||
145648986|NCT04737772|525231966|FG000|Phase 2 Study|Lost to Follow-up|15|||
145648987|NCT04737772|525231967|FG001|Phase 2 Study|Lost to Follow-up|15|||
145648988|NCT04737772|525231966|FG000|Phase 2 Study|Withdrawal by Subject|0|||
145648989|NCT04737772|525231967|FG001|Phase 2 Study|Withdrawal by Subject|1|||
145648990|NCT04737772|525231966|FG000|Phase 2 Study|Did not take any coaching calls|4|||
145648991|NCT04737772|525231967|FG001|Phase 2 Study|Did not take any coaching calls|0|||
145648992|NCT04737772|525231966|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
145648993|NCT04737772|525231967|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
145648994|NCT04737772|525231966|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
145648995|NCT04737772|525231967|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
145648996|NCT02728076|525231968|FG000|Overall Study|Physician Decision|4|||
145648997|NCT03526861|525231972|FG000|Initial Treatment Period|Not dosed|1|||
145648998|NCT03526861|525231973|FG001|Initial Treatment Period|Not dosed|1|||
145648999|NCT03526861|525231974|FG002|Initial Treatment Period|Not dosed|1|||
145649000|NCT03526861|525231975|FG003|Initial Treatment Period|Not dosed|0|||
145649001|NCT03526861|525231976|FG004|Initial Treatment Period|Not dosed|0|||
145649002|NCT03526861|525231977|FG005|Initial Treatment Period|Not dosed|0|||
145649003|NCT03526861|525231978|FG006|Initial Treatment Period|Not dosed|0|||
145649004|NCT03526861|525231979|FG007|Initial Treatment Period|Not dosed|0|||
145649005|NCT03526861|525231980|FG008|Initial Treatment Period|Not dosed|0|||
145649006|NCT03526861|525231972|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
145649007|NCT03526861|525231973|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
145649008|NCT03526861|525231974|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
145649009|NCT03526861|525231975|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649010|NCT03526861|525231976|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649011|NCT03526861|525231977|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649012|NCT03526861|525231978|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649013|NCT03526861|525231979|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649014|NCT03526861|525231980|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649015|NCT03526861|525231972|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
145649016|NCT03526861|525231973|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
145649017|NCT03526861|525231974|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
145649018|NCT03526861|525231975|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649019|NCT03526861|525231976|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649020|NCT03526861|525231977|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649021|NCT03526861|525231978|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649022|NCT03526861|525231979|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649023|NCT03526861|525231980|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
145649024|NCT03526861|525231972|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649025|NCT03526861|525231973|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649026|NCT03526861|525231974|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649027|NCT03526861|525231975|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
145649028|NCT03526861|525231976|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
145649029|NCT03526861|525231977|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649030|NCT03526861|525231978|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
145649031|NCT03526861|525231979|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649032|NCT03526861|525231980|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649033|NCT03526861|525231972|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
145649034|NCT03526861|525231973|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
145649035|NCT03526861|525231974|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
145649036|NCT03526861|525231975|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
145649037|NCT03526861|525231976|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
145649038|NCT03526861|525231977|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
145649039|NCT03526861|525231978|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
145649040|NCT03526861|525231979|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
145649041|NCT03526861|525231980|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
145649042|NCT03526861|525231972|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649043|NCT03526861|525231973|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649044|NCT03526861|525231974|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649045|NCT03526861|525231975|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
145649046|NCT03526861|525231976|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649047|NCT03526861|525231977|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649048|NCT03526861|525231978|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649049|NCT03526861|525231979|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649050|NCT03526861|525231980|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649051|NCT03526861|525231972|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649052|NCT03526861|525231973|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649053|NCT03526861|525231974|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649054|NCT03526861|525231975|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649055|NCT03526861|525231976|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649056|NCT03526861|525231977|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649057|NCT03526861|525231978|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649058|NCT03526861|525231979|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
145649059|NCT03526861|525231980|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
145649060|NCT03526861|525231972|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649061|NCT03526861|525231973|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649062|NCT03526861|525231974|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649063|NCT03526861|525231975|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649064|NCT03526861|525231976|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649065|NCT03526861|525231977|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649066|NCT03526861|525231978|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145649067|NCT03526861|525231979|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
145488508|NCT03367858|524644260|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
145488509|NCT03367858|524644259|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
145488510|NCT03367858|524644260|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
145488511|NCT03367858|524644259|FG000|3 Month Follow Up|Lost to Follow-up|8|||
145488512|NCT03367858|524644260|FG001|3 Month Follow Up|Lost to Follow-up|3|||
145488513|NCT03367858|524644259|FG000|3 Month Follow Up|Moved out of study area|2|||
145488514|NCT03367858|524644260|FG001|3 Month Follow Up|Moved out of study area|6|||
145488515|NCT03367858|524644259|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
145488516|NCT03367858|524644260|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
145488517|NCT03367858|524644259|FG000|3 Month Follow Up|MRI contraindication|2|||
145488518|NCT03367858|524644260|FG001|3 Month Follow Up|MRI contraindication|1|||
145488519|NCT03367858|524644259|FG000|3 Month Follow Up|Incarcerated|0|||
145488520|NCT03367858|524644260|FG001|3 Month Follow Up|Incarcerated|1|||
145488521|NCT03367858|524644259|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
145488522|NCT03367858|524644260|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
145488523|NCT03367858|524644259|FG000|6 Month Follow Up|Lost to Follow-up|5|||
145488524|NCT03367858|524644260|FG001|6 Month Follow Up|Lost to Follow-up|2|||
145488525|NCT03367858|524644259|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
145488526|NCT03367858|524644260|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
145488527|NCT03367858|524644259|FG000|12 Month Follow Up|Lost to Follow-up|3|||
145488528|NCT03367858|524644260|FG001|12 Month Follow Up|Lost to Follow-up|3|||
145488529|NCT03367858|524644259|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
145488530|NCT03367858|524644260|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
145488531|NCT04154943|524644261|FG000|Overall Study|Study Ongoing|68|||
145488532|NCT04154943|524644261|FG000|Overall Study|Lost to Follow-up|1|||
145488533|NCT04154943|524644261|FG000|Overall Study|Decision by the Investigator|1|||
145488534|NCT04154943|524644261|FG000|Overall Study|Death|5|||
145488535|NCT04154943|524644261|FG000|Overall Study|Withdrawal by Subject|4|||
145488536|NCT00101686|524644262|FG000|Overall Study|Progressive Disease|37|||
145488537|NCT00101686|524644263|FG001|Overall Study|Progressive Disease|28|||
145488538|NCT00101686|524644264|FG002|Overall Study|Progressive Disease|37|||
145488539|NCT00101686|524644265|FG003|Overall Study|Progressive Disease|38|||
145488540|NCT00101686|524644266|FG004|Overall Study|Progressive Disease|28|||
145488541|NCT00101686|524644267|FG005|Overall Study|Progressive Disease|25|||
145488542|NCT00101686|524644268|FG006|Overall Study|Progressive Disease|5|||
145488543|NCT00101686|524644269|FG007|Overall Study|Progressive Disease|7|||
145488544|NCT00101686|524644270|FG008|Overall Study|Progressive Disease|10|||
145488545|NCT00101686|524644271|FG009|Overall Study|Progressive Disease|8|||
145649068|NCT03526861|525231980|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
145649069|NCT03526861|525231972|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649070|NCT03526861|525231973|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649071|NCT03526861|525231974|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649072|NCT03526861|525231975|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649073|NCT03526861|525231976|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649074|NCT03526861|525231977|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649075|NCT03526861|525231978|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649076|NCT03526861|525231979|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
145649077|NCT03526861|525231980|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
145649078|NCT04089371|525231982|FG000|Overall Study|Withdrawal by Subject|0|||
145649079|NCT04089371|525231983|FG001|Overall Study|Withdrawal by Subject|1|||
145649080|NCT04089371|525231982|FG000|Overall Study|Study terminated early|0|||
145649081|NCT04089371|525231983|FG001|Overall Study|Study terminated early|9|||
145649082|NCT04382898|525231984|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
145649083|NCT04382898|525231985|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
145649084|NCT04382898|525231986|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
145649085|NCT04382898|525231987|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
145649086|NCT04382898|525231988|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
145488546|NCT00101686|524644262|FG000|Overall Study|initiation other anti-cancer treatment|4|||
145488547|NCT00101686|524644263|FG001|Overall Study|initiation other anti-cancer treatment|3|||
145488548|NCT00101686|524644264|FG002|Overall Study|initiation other anti-cancer treatment|4|||
145488549|NCT00101686|524644265|FG003|Overall Study|initiation other anti-cancer treatment|3|||
145488550|NCT00101686|524644266|FG004|Overall Study|initiation other anti-cancer treatment|1|||
145488551|NCT00101686|524644267|FG005|Overall Study|initiation other anti-cancer treatment|1|||
145488552|NCT00101686|524644268|FG006|Overall Study|initiation other anti-cancer treatment|2|||
145488553|NCT00101686|524644269|FG007|Overall Study|initiation other anti-cancer treatment|2|||
145488554|NCT00101686|524644270|FG008|Overall Study|initiation other anti-cancer treatment|3|||
145488555|NCT00101686|524644271|FG009|Overall Study|initiation other anti-cancer treatment|3|||
145488556|NCT00101686|524644262|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
145488557|NCT00101686|524644263|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
145488558|NCT00101686|524644264|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
145488559|NCT00101686|524644265|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
145488560|NCT00101686|524644266|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
145488561|NCT00101686|524644267|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
145488562|NCT00101686|524644268|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
145488563|NCT00101686|524644269|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
145488564|NCT00101686|524644270|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
145488565|NCT00101686|524644271|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
145488566|NCT00101686|524644262|FG000|Overall Study|unacceptable toxicity|3|||
145488567|NCT00101686|524644263|FG001|Overall Study|unacceptable toxicity|9|||
145488568|NCT00101686|524644264|FG002|Overall Study|unacceptable toxicity|10|||
145488569|NCT00101686|524644265|FG003|Overall Study|unacceptable toxicity|6|||
145488570|NCT00101686|524644266|FG004|Overall Study|unacceptable toxicity|16|||
145488571|NCT00101686|524644267|FG005|Overall Study|unacceptable toxicity|10|||
145488572|NCT00101686|524644268|FG006|Overall Study|unacceptable toxicity|4|||
145488573|NCT00101686|524644269|FG007|Overall Study|unacceptable toxicity|2|||
145488574|NCT00101686|524644270|FG008|Overall Study|unacceptable toxicity|1|||
145488575|NCT00101686|524644271|FG009|Overall Study|unacceptable toxicity|4|||
145488576|NCT00101686|524644262|FG000|Overall Study|Randomized but did not receive treament|1|||
145488577|NCT00101686|524644263|FG001|Overall Study|Randomized but did not receive treament|6|||
145488578|NCT00101686|524644264|FG002|Overall Study|Randomized but did not receive treament|2|||
145488579|NCT00101686|524644265|FG003|Overall Study|Randomized but did not receive treament|2|||
145488580|NCT00101686|524644266|FG004|Overall Study|Randomized but did not receive treament|2|||
145488581|NCT00101686|524644267|FG005|Overall Study|Randomized but did not receive treament|2|||
145488582|NCT00101686|524644268|FG006|Overall Study|Randomized but did not receive treament|0|||
145488583|NCT00101686|524644269|FG007|Overall Study|Randomized but did not receive treament|1|||
145488584|NCT00101686|524644270|FG008|Overall Study|Randomized but did not receive treament|0|||
145488585|NCT00101686|524644271|FG009|Overall Study|Randomized but did not receive treament|1|||
145488586|NCT00101686|524644262|FG000|Overall Study|intercurrent non-cancer related illness|0|||
145488587|NCT00101686|524644263|FG001|Overall Study|intercurrent non-cancer related illness|0|||
145488588|NCT00101686|524644264|FG002|Overall Study|intercurrent non-cancer related illness|2|||
145488589|NCT00101686|524644265|FG003|Overall Study|intercurrent non-cancer related illness|0|||
145488590|NCT00101686|524644266|FG004|Overall Study|intercurrent non-cancer related illness|1|||
145488591|NCT00101686|524644267|FG005|Overall Study|intercurrent non-cancer related illness|3|||
145488592|NCT00101686|524644268|FG006|Overall Study|intercurrent non-cancer related illness|1|||
145488593|NCT00101686|524644269|FG007|Overall Study|intercurrent non-cancer related illness|0|||
145488594|NCT00101686|524644270|FG008|Overall Study|intercurrent non-cancer related illness|1|||
145488595|NCT00101686|524644271|FG009|Overall Study|intercurrent non-cancer related illness|1|||
145488596|NCT00101686|524644262|FG000|Overall Study|Physician Decision|10|||
145488597|NCT00101686|524644263|FG001|Overall Study|Physician Decision|13|||
145488598|NCT00101686|524644264|FG002|Overall Study|Physician Decision|6|||
145488599|NCT00101686|524644265|FG003|Overall Study|Physician Decision|7|||
145488600|NCT00101686|524644266|FG004|Overall Study|Physician Decision|8|||
145488601|NCT00101686|524644267|FG005|Overall Study|Physician Decision|9|||
145488602|NCT00101686|524644268|FG006|Overall Study|Physician Decision|5|||
145488603|NCT00101686|524644269|FG007|Overall Study|Physician Decision|5|||
145488604|NCT00101686|524644270|FG008|Overall Study|Physician Decision|1|||
145488605|NCT00101686|524644271|FG009|Overall Study|Physician Decision|1|||
145488606|NCT00101686|524644262|FG000|Overall Study|Other|1|||
145488607|NCT00101686|524644263|FG001|Overall Study|Other|4|||
145488608|NCT00101686|524644264|FG002|Overall Study|Other|1|||
145488609|NCT00101686|524644265|FG003|Overall Study|Other|6|||
145488610|NCT00101686|524644266|FG004|Overall Study|Other|2|||
145649087|NCT04382898|525231984|FG000|Part 1: Dose Titration|Death|6|||
145488611|NCT00101686|524644267|FG005|Overall Study|Other|12|||
145649088|NCT04382898|525231985|FG001|Part 1: Dose Titration|Death|0|||
145649089|NCT04382898|525231986|FG002|Part 1: Dose Titration|Death|0|||
145649090|NCT04382898|525231987|FG003|Part 1: Dose Titration|Death|0|||
145649091|NCT04382898|525231988|FG004|Part 1: Dose Titration|Death|0|||
145649092|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145649093|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145649094|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
145649095|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145488612|NCT00101686|524644268|FG006|Overall Study|Other|1|||
145488613|NCT00101686|524644269|FG007|Overall Study|Other|5|||
145649096|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
145488614|NCT00101686|524644270|FG008|Overall Study|Other|3|||
145488615|NCT00101686|524644271|FG009|Overall Study|Other|3|||
145488616|NCT00101686|524644262|FG000|Overall Study|Withdrawal by Subject|9|||
145488617|NCT00101686|524644263|FG001|Overall Study|Withdrawal by Subject|8|||
145488618|NCT00101686|524644264|FG002|Overall Study|Withdrawal by Subject|6|||
145488619|NCT00101686|524644265|FG003|Overall Study|Withdrawal by Subject|8|||
145488620|NCT00101686|524644266|FG004|Overall Study|Withdrawal by Subject|8|||
145488621|NCT00101686|524644267|FG005|Overall Study|Withdrawal by Subject|7|||
145488622|NCT00101686|524644268|FG006|Overall Study|Withdrawal by Subject|7|||
145488623|NCT00101686|524644269|FG007|Overall Study|Withdrawal by Subject|7|||
145488624|NCT00101686|524644270|FG008|Overall Study|Withdrawal by Subject|8|||
145488625|NCT00101686|524644271|FG009|Overall Study|Withdrawal by Subject|9|||
145488626|NCT00985465|524644272|FG000|Overall Study|Withdrawal by Subject|1|||
145488627|NCT00985465|524644273|FG001|Overall Study|Withdrawal by Subject|2|||
145649097|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
145649098|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
145649099|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
145649100|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
145649101|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
145649102|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Death|0|||
145649103|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Death|17|||
145649104|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Death|13|||
145649105|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Death|1|||
145649106|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Death|0|||
145649107|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
145649108|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
145649109|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
145649110|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
145649111|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
145649112|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
145649113|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
145649114|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
145649115|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
145649116|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
145649117|NCT04382898|525231984|FG000|Part 2: Dose Expansion|Other|0|||
145649118|NCT04382898|525231985|FG001|Part 2: Dose Expansion|Other|0|||
145649119|NCT04382898|525231986|FG002|Part 2: Dose Expansion|Other|1|||
145649120|NCT04382898|525231987|FG003|Part 2: Dose Expansion|Other|0|||
145649121|NCT04382898|525231988|FG004|Part 2: Dose Expansion|Other|0|||
145649122|NCT05229120|525231989|FG000|Overall Study|Withdrawal by Subject|8|||
145649123|NCT03932682|525231990|FG000|Overall Study|Death|1|||
145649124|NCT03932682|525231991|FG001|Overall Study|Death|2|||
145649125|NCT03932682|525231990|FG000|Overall Study|Withdrawal by Subject|37|||
145649126|NCT03932682|525231991|FG001|Overall Study|Withdrawal by Subject|45|||
145649127|NCT03932682|525231990|FG000|Overall Study|Lost to Follow-up|19|||
145649128|NCT03932682|525231991|FG001|Overall Study|Lost to Follow-up|25|||
145649129|NCT03932682|525231990|FG000|Overall Study|Protocol Violation|0|||
145649130|NCT03932682|525231991|FG001|Overall Study|Protocol Violation|2|||
145649131|NCT03932682|525231990|FG000|Overall Study|Other|9|||
145649132|NCT03932682|525231991|FG001|Overall Study|Other|23|||
145649133|NCT02900924|525231992|FG000|Overall Study|Death|52|||
145649134|NCT02900924|525231992|FG000|Overall Study|Lost to Follow-up|4|||
145649135|NCT02900924|525231992|FG000|Overall Study|Withdrawal by Subject|20|||
145649136|NCT02900924|525231992|FG000|Overall Study|Missed Visit|33|||
145649137|NCT02307565|525231993|FG000|Overall Study|Adverse Event|3|||
145649138|NCT02307565|525231994|FG001|Overall Study|Adverse Event|2|||
145649139|NCT02307565|525231993|FG000|Overall Study|Withdrawal by Subject|2|||
145649140|NCT02307565|525231994|FG001|Overall Study|Withdrawal by Subject|2|||
145649141|NCT04936035|525231995|FG000|Overall Study|Adverse Event|0|||
145649142|NCT04936035|525231996|FG001|Overall Study|Adverse Event|1|||
145649143|NCT04936035|525231997|FG002|Overall Study|Adverse Event|0|||
145488628|NCT00985465|524644272|FG000|Overall Study|Considered to be part of the other group|0|||
145649144|NCT04936035|525231998|FG003|Overall Study|Adverse Event|0|||
145649145|NCT04936035|525231999|FG004|Overall Study|Adverse Event|0|||
145488629|NCT00985465|524644273|FG001|Overall Study|Considered to be part of the other group|1|||
145649146|NCT04936035|525231995|FG000|Overall Study|Death|0|||
145649147|NCT04936035|525231996|FG001|Overall Study|Death|0|||
145649148|NCT04936035|525231997|FG002|Overall Study|Death|0|||
145649149|NCT04936035|525231998|FG003|Overall Study|Death|1|||
145649150|NCT04936035|525231999|FG004|Overall Study|Death|0|||
145649151|NCT04936035|525231995|FG000|Overall Study|Lost to Follow-up|0|||
145649152|NCT04936035|525231996|FG001|Overall Study|Lost to Follow-up|1|||
145649153|NCT04936035|525231997|FG002|Overall Study|Lost to Follow-up|1|||
145649154|NCT04936035|525231998|FG003|Overall Study|Lost to Follow-up|2|||
145649155|NCT04936035|525231999|FG004|Overall Study|Lost to Follow-up|1|||
145488630|NCT01292187|524644274|FG000|Overall Study|Adverse Event|10|||
145488631|NCT01292187|524644275|FG001|Overall Study|Adverse Event|5|||
145488632|NCT01292187|524644274|FG000|Overall Study|Withdrawal by Subject|6|||
145649156|NCT04936035|525231995|FG000|Overall Study|Physician Decision|0|||
145649157|NCT04936035|525231996|FG001|Overall Study|Physician Decision|1|||
145649158|NCT04936035|525231997|FG002|Overall Study|Physician Decision|0|||
145649159|NCT04936035|525231998|FG003|Overall Study|Physician Decision|0|||
145649160|NCT04936035|525231999|FG004|Overall Study|Physician Decision|0|||
145649161|NCT04936035|525231995|FG000|Overall Study|Protocol Deviation|0|||
145649162|NCT04936035|525231996|FG001|Overall Study|Protocol Deviation|0|||
145649163|NCT04936035|525231997|FG002|Overall Study|Protocol Deviation|1|||
145649164|NCT04936035|525231998|FG003|Overall Study|Protocol Deviation|0|||
145649165|NCT04936035|525231999|FG004|Overall Study|Protocol Deviation|0|||
145649166|NCT04936035|525231995|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
145649167|NCT04936035|525231996|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
145649168|NCT04936035|525231997|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
145649169|NCT04936035|525231998|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
145649170|NCT04936035|525231999|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
145649171|NCT04936035|525231995|FG000|Overall Study|Reason Unknown|0|||
145649172|NCT04936035|525231996|FG001|Overall Study|Reason Unknown|0|||
145649173|NCT04936035|525231997|FG002|Overall Study|Reason Unknown|0|||
145649174|NCT04936035|525231998|FG003|Overall Study|Reason Unknown|0|||
145649175|NCT04936035|525231999|FG004|Overall Study|Reason Unknown|1|||
145649176|NCT04936035|525231995|FG000|Overall Study|Withdrawal by Subject|1|||
145649177|NCT04936035|525231996|FG001|Overall Study|Withdrawal by Subject|0|||
145649178|NCT04936035|525231997|FG002|Overall Study|Withdrawal by Subject|0|||
145649179|NCT04936035|525231998|FG003|Overall Study|Withdrawal by Subject|0|||
145649180|NCT04936035|525231999|FG004|Overall Study|Withdrawal by Subject|0|||
145649181|NCT04936035|525231995|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
145649182|NCT04936035|525231996|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
145649183|NCT04936035|525231997|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
145649184|NCT04936035|525231998|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
145649185|NCT04936035|525231999|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
145649186|NCT04936035|525231995|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
145649187|NCT04936035|525231996|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
145649188|NCT04936035|525231997|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
145649189|NCT04936035|525231998|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
145649190|NCT04936035|525231999|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
145649191|NCT04936035|525231995|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
145649192|NCT04936035|525231996|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
145649193|NCT04936035|525231997|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
145649194|NCT04936035|525231998|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
145649195|NCT04936035|525231999|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
145649196|NCT04401800|525232000|FG000|Overall Study|Death|17|||
145649197|NCT04401800|525232000|FG000|Overall Study|Lost to Follow-up|5|||
145649198|NCT04401800|525232000|FG000|Overall Study|Withdrawal by Subject|4|||
145649199|NCT01772472|525232003|FG000|Overall Study|Death|126|||
145649200|NCT01772472|525232004|FG001|Overall Study|Death|94|||
145649201|NCT01772472|525232003|FG000|Overall Study|Lost to Follow-up|51|||
145649202|NCT01772472|525232004|FG001|Overall Study|Lost to Follow-up|50|||
145649203|NCT01772472|525232003|FG000|Overall Study|Other|9|||
145649204|NCT01772472|525232004|FG001|Overall Study|Other|7|||
145649205|NCT01772472|525232003|FG000|Overall Study|Physician Decision|1|||
145649206|NCT01772472|525232004|FG001|Overall Study|Physician Decision|7|||
145649207|NCT01772472|525232003|FG000|Overall Study|Withdrawal by Subject|115|||
145649208|NCT01772472|525232004|FG001|Overall Study|Withdrawal by Subject|90|||
145649209|NCT01772472|525232003|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
145649210|NCT01772472|525232004|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
145649211|NCT01057433|525232005|FG000|Overall Study|Adverse Event|1|||
145649212|NCT04757610|525232007|FG000|Overall Study|Adverse Event|13|||
145649213|NCT04757610|525232008|FG001|Overall Study|Adverse Event|10|||
145649214|NCT04757610|525232009|FG002|Overall Study|Adverse Event|5|||
145649215|NCT04757610|525232007|FG000|Overall Study|Death|5|||
145649216|NCT04757610|525232008|FG001|Overall Study|Death|13|||
145649217|NCT04757610|525232009|FG002|Overall Study|Death|8|||
145649218|NCT04757610|525232007|FG000|Overall Study|Lack of Efficacy|1|||
145649219|NCT04757610|525232008|FG001|Overall Study|Lack of Efficacy|2|||
145649220|NCT04757610|525232009|FG002|Overall Study|Lack of Efficacy|3|||
145649221|NCT04757610|525232007|FG000|Overall Study|Lost to Follow-up|7|||
145649222|NCT04757610|525232008|FG001|Overall Study|Lost to Follow-up|2|||
145649223|NCT04757610|525232009|FG002|Overall Study|Lost to Follow-up|7|||
145649224|NCT04757610|525232007|FG000|Overall Study|Physician Decision|4|||
145649225|NCT04757610|525232008|FG001|Overall Study|Physician Decision|1|||
145649226|NCT04757610|525232009|FG002|Overall Study|Physician Decision|2|||
145649227|NCT04757610|525232007|FG000|Overall Study|Withdrawal by Subject|26|||
145649228|NCT04757610|525232008|FG001|Overall Study|Withdrawal by Subject|25|||
145649229|NCT04757610|525232009|FG002|Overall Study|Withdrawal by Subject|25|||
145649230|NCT04757610|525232007|FG000|Overall Study|Study Terminated by Sponsor|105|||
145649231|NCT04757610|525232008|FG001|Overall Study|Study Terminated by Sponsor|105|||
145649232|NCT04757610|525232009|FG002|Overall Study|Study Terminated by Sponsor|110|||
145649233|NCT04757610|525232007|FG000|Overall Study|Randomized in Error|1|||
145649234|NCT04757610|525232008|FG001|Overall Study|Randomized in Error|0|||
145649235|NCT04757610|525232009|FG002|Overall Study|Randomized in Error|0|||
145649236|NCT04774237|525232015|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
145649237|NCT04774237|525232016|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
145649238|NCT04774237|525232017|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
145649239|NCT04774237|525232018|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
145649240|NCT04774237|525232019|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
145649241|NCT04774237|525232020|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
145649242|NCT06143670|525233400|FG000|Overall Study|Lost to Follow-up|0|||
145649243|NCT06143670|525233401|FG001|Overall Study|Lost to Follow-up|1|||
145649244|NCT06143670|525233400|FG000|Overall Study|Withdrawal by Subject|3|||
145649245|NCT06143670|525233401|FG001|Overall Study|Withdrawal by Subject|0|||
145649246|NCT03747484|525233402|FG000|Overall Study|Lack of Efficacy|0|||
145649247|NCT03747484|525233403|FG001|Overall Study|Lack of Efficacy|1|||
145649248|NCT03747484|525233404|FG002|Overall Study|Lack of Efficacy|1|||
145649249|NCT03747484|525233405|FG003|Overall Study|Lack of Efficacy|2|||
145649250|NCT03747484|525233406|FG004|Overall Study|Lack of Efficacy|2|||
145649251|NCT04173663|525233414|FG000|Overall Study|Withdrawal by Subject|1|||
145649252|NCT04173663|525233415|FG001|Overall Study|Withdrawal by Subject|6|||
145649253|NCT04173663|525233414|FG000|Overall Study|Lost to Follow-up|17|||
145649254|NCT04173663|525233415|FG001|Overall Study|Lost to Follow-up|24|||
145649255|NCT04402489|525233416|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
145649256|NCT04402489|525233417|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
145649257|NCT04402489|525233418|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
145649258|NCT04402489|525233419|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
145649259|NCT04402489|525233420|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
145649260|NCT04402489|525233416|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
145649261|NCT04402489|525233417|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
145649262|NCT04402489|525233418|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
145649263|NCT04402489|525233419|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
145649264|NCT04402489|525233420|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
145649265|NCT04402489|525233416|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
145649266|NCT04402489|525233417|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
145649267|NCT04402489|525233418|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
145649268|NCT04402489|525233419|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
145649269|NCT04402489|525233420|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
145649270|NCT04402489|525233416|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
145649271|NCT04402489|525233417|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
145649272|NCT04402489|525233418|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
145649273|NCT04402489|525233419|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
145649274|NCT04402489|525233420|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
145649275|NCT04402489|525233416|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
145649276|NCT04402489|525233417|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
145649277|NCT04402489|525233418|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
145649278|NCT04402489|525233419|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
145649279|NCT04402489|525233420|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
145649280|NCT04402489|525233416|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
145649281|NCT04402489|525233417|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
145649282|NCT04402489|525233418|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
145649283|NCT04402489|525233419|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
145649284|NCT04402489|525233420|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
145649285|NCT05816551|525233426|FG000|Overall Study|Withdrawal by Subject|0|||
145649286|NCT05816551|525233427|FG001|Overall Study|Withdrawal by Subject|1|||
145649287|NCT05816551|525233426|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
145649288|NCT05816551|525233427|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
145649289|NCT03391466|525233434|FG000|Overall Study|Death|82|||
145649290|NCT03391466|525233435|FG001|Overall Study|Death|85|||
145649291|NCT03391466|525233434|FG000|Overall Study|Still on study|93|||
145649292|NCT03391466|525233435|FG001|Overall Study|Still on study|74|||
145649293|NCT03391466|525233434|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
145649294|NCT03391466|525233435|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
145649295|NCT03391466|525233434|FG000|Overall Study|Lost to Follow-up|5|||
145649296|NCT03391466|525233435|FG001|Overall Study|Lost to Follow-up|5|||
145649297|NCT03391466|525233434|FG000|Overall Study|Investigator decision|0|||
145649298|NCT03391466|525233435|FG001|Overall Study|Investigator decision|1|||
145649299|NCT03391466|525233434|FG000|Overall Study|Other|0|||
145649300|NCT03391466|525233435|FG001|Overall Study|Other|1|||
145649301|NCT03089398|525233445|FG000|Overall Study|Death|4|||
145649302|NCT03089398|525233446|FG001|Overall Study|Death|9|||
145649303|NCT03089398|525233445|FG000|Overall Study|Lost to Follow-up|21|||
145649304|NCT03089398|525233446|FG001|Overall Study|Lost to Follow-up|30|||
145649305|NCT03089398|525233445|FG000|Overall Study|Withdrawal by Subject|2|||
145649306|NCT03089398|525233446|FG001|Overall Study|Withdrawal by Subject|2|||
145649307|NCT05062265|525233447|FG000|Overall Study|Withdrawal by Subject|1|||
145649308|NCT05062265|525233448|FG001|Overall Study|Withdrawal by Subject|0|||
145649309|NCT05439603|525233449|FG000|Overall Study|met withdrawal criteria|2|||
145649310|NCT03101904|525233454|FG000|Wash Out (10 Days)|Adverse Event|1|||
145649311|NCT03101904|525233455|FG001|Wash Out (10 Days)|Adverse Event|0|||
145649312|NCT03101904|525233454|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
145649313|NCT03101904|525233455|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
145649314|NCT04703322|525233456|FG000|Overall Study|Ongoing|8|||
145649315|NCT04703322|525233456|FG000|Overall Study|Withdrawal by Subject|1|||
145649316|NCT03713086|525233459|FG000|Overall Study|Withdrawal by Subject|0|||
145649317|NCT03713086|525233460|FG001|Overall Study|Withdrawal by Subject|2|||
145649318|NCT03713086|525233461|FG002|Overall Study|Withdrawal by Subject|1|||
145649319|NCT03713086|525233462|FG003|Overall Study|Withdrawal by Subject|0|||
145649320|NCT03713086|525233459|FG000|Overall Study|Lost to Follow-up|0|||
145649321|NCT03713086|525233460|FG001|Overall Study|Lost to Follow-up|1|||
145649322|NCT03713086|525233461|FG002|Overall Study|Lost to Follow-up|0|||
145649323|NCT03713086|525233462|FG003|Overall Study|Lost to Follow-up|1|||
145649324|NCT05009251|525233463|FG000|Overall Study|Protocol Violation|100|||
145649325|NCT05009251|525233464|FG001|Overall Study|Protocol Violation|105|||
145649326|NCT05009251|525233465|FG002|Overall Study|Protocol Violation|119|||
145649327|NCT05009251|525233466|FG003|Overall Study|Protocol Violation|120|||
145649328|NCT05009251|525233467|FG004|Overall Study|Protocol Violation|119|||
145649329|NCT05009251|525233463|FG000|Overall Study|Death|25|||
145649330|NCT05009251|525233464|FG001|Overall Study|Death|22|||
145649331|NCT05009251|525233465|FG002|Overall Study|Death|24|||
145649332|NCT05009251|525233466|FG003|Overall Study|Death|19|||
145649333|NCT05009251|525233467|FG004|Overall Study|Death|15|||
145649334|NCT06311084|525233469|FG000|Overall Study|Lost to Follow-up|14|||
145649335|NCT05406921|525233475|FG000|Overall Study|Withdrawal by Subject|25|||
145649336|NCT05406921|525233476|FG001|Overall Study|Withdrawal by Subject|0|||
145649337|NCT05406921|525233477|FG002|Overall Study|Withdrawal by Subject|25|||
145649338|NCT05406921|525233475|FG000|Overall Study|Protocol Violation|0|||
145649339|NCT05406921|525233476|FG001|Overall Study|Protocol Violation|12|||
145649340|NCT05406921|525233477|FG002|Overall Study|Protocol Violation|0|||
145649341|NCT04831281|525233479|FG000|Overall Study|Adverse Event|1|||
145649342|NCT04831281|525233480|FG001|Overall Study|Adverse Event|0|||
145649343|NCT04831281|525233481|FG002|Overall Study|Adverse Event|3|||
145649344|NCT04831281|525233479|FG000|Overall Study|Withdrawal by Subject|0|||
145649345|NCT04831281|525233480|FG001|Overall Study|Withdrawal by Subject|1|||
145649346|NCT04831281|525233481|FG002|Overall Study|Withdrawal by Subject|2|||
145649347|NCT04831281|525233479|FG000|Overall Study|Undetermined|1|||
145649348|NCT04831281|525233480|FG001|Overall Study|Undetermined|1|||
145649349|NCT04831281|525233481|FG002|Overall Study|Undetermined|0|||
145649350|NCT05059262|525233482|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
145649351|NCT05059262|525233483|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
145649352|NCT05059262|525233482|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
145649353|NCT05059262|525233483|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
145649354|NCT05059262|525233482|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
145649355|NCT05059262|525233483|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
145649356|NCT05059262|525233482|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
145649357|NCT05059262|525233483|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
145649358|NCT05059262|525233482|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
145649359|NCT05059262|525233483|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
145649360|NCT05059262|525233482|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
145649361|NCT05059262|525233483|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
145649362|NCT05059262|525233482|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
145649363|NCT05059262|525233483|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
145649364|NCT05059262|525233482|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
145649365|NCT05059262|525233483|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
145649366|NCT05059262|525233482|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
145649367|NCT05059262|525233483|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
145649368|NCT03161379|525233490|FG000|Overall Study|Withdrawal by Subject|4|||
145649369|NCT03161379|525233490|FG000|Overall Study|disease progression during chemotherapy|5|||
145649370|NCT03161379|525233490|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
145649371|NCT03161379|525233490|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
145649372|NCT03393975|525233492|FG000|Urgent Treatment Period|Physician Decision|0|||
145649373|NCT03393975|525233493|FG001|Urgent Treatment Period|Physician Decision|0|||
145649374|NCT03393975|525233494|FG002|Urgent Treatment Period|Physician Decision|0|||
145649375|NCT03393975|525233495|FG003|Urgent Treatment Period|Physician Decision|1|||
145649376|NCT03393975|525233492|FG000|Prophylaxis Period 1|Reason not Specified|0|||
145649377|NCT03393975|525233493|FG001|Prophylaxis Period 1|Reason not Specified|1|||
145649378|NCT03393975|525233494|FG002|Prophylaxis Period 1|Reason not Specified|0|||
145649379|NCT03393975|525233495|FG003|Prophylaxis Period 1|Reason not Specified|0|||
145649380|NCT03393975|525233492|FG000|Prophylaxis Period 2|Reason not Specified|0|||
145649381|NCT03393975|525233493|FG001|Prophylaxis Period 2|Reason not Specified|1|||
145649382|NCT03393975|525233494|FG002|Prophylaxis Period 2|Reason not Specified|0|||
145649383|NCT03393975|525233495|FG003|Prophylaxis Period 2|Reason not Specified|0|||
145649384|NCT03315754|525233497|FG000|Overall Study|COVID-19 complications leading to death|1|||
145649385|NCT03315754|525233497|FG000|Overall Study|insurance coverage issue|1|||
145649386|NCT04024813|525233498|FG000|Overall Study|Study terminated by Sponsor|1|||
145649387|NCT05956002|525233503|FG000|Treatment Period 3|Adverse Event|0|||
145649388|NCT05956002|525233504|FG001|Treatment Period 3|Adverse Event|0|||
145649389|NCT05956002|525233505|FG002|Treatment Period 3|Adverse Event|1|||
145649390|NCT05956002|525233506|FG003|Treatment Period 3|Adverse Event|0|||
145649391|NCT00931710|525233509|FG000|Overall Study|Adverse Event|16|||
145649392|NCT00931710|525233510|FG001|Overall Study|Adverse Event|10|||
145649393|NCT00931710|525233509|FG000|Overall Study|Abnormal test procedure results|2|||
145649394|NCT00931710|525233510|FG001|Overall Study|Abnormal test procedure results|0|||
145649395|NCT00931710|525233509|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
145649396|NCT00931710|525233510|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
145649397|NCT00931710|525233509|FG000|Overall Study|Patient withdrew consent|4|||
145649398|NCT00931710|525233510|FG001|Overall Study|Patient withdrew consent|9|||
145649399|NCT00931710|525233509|FG000|Overall Study|Lost to Follow-up|6|||
145649400|NCT00931710|525233510|FG001|Overall Study|Lost to Follow-up|5|||
145649401|NCT00931710|525233509|FG000|Overall Study|Protocol deviation|1|||
145649402|NCT00931710|525233510|FG001|Overall Study|Protocol deviation|2|||
145649403|NCT03338790|525233516|FG000|Overall Study|Disease Progression|65|||
145649404|NCT03338790|525233517|FG001|Overall Study|Disease Progression|43|||
145649405|NCT03338790|525233518|FG002|Overall Study|Disease Progression|50|||
145649406|NCT03338790|525233519|FG003|Overall Study|Disease Progression|37|||
145649407|NCT03338790|525233516|FG000|Overall Study|Study Drug Toxicity|9|||
145649408|NCT03338790|525233517|FG001|Overall Study|Study Drug Toxicity|8|||
145649409|NCT03338790|525233518|FG002|Overall Study|Study Drug Toxicity|15|||
145649410|NCT03338790|525233519|FG003|Overall Study|Study Drug Toxicity|0|||
145649411|NCT03338790|525233516|FG000|Overall Study|Death|1|||
145649412|NCT03338790|525233517|FG001|Overall Study|Death|1|||
145649413|NCT03338790|525233518|FG002|Overall Study|Death|1|||
145649414|NCT03338790|525233519|FG003|Overall Study|Death|0|||
145649415|NCT03338790|525233516|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
145649416|NCT03338790|525233517|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
145649417|NCT03338790|525233518|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
145649418|NCT03338790|525233519|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
145649419|NCT03338790|525233516|FG000|Overall Study|Participant request to discontinue study treatment|3|||
145649420|NCT03338790|525233517|FG001|Overall Study|Participant request to discontinue study treatment|3|||
145649421|NCT03338790|525233518|FG002|Overall Study|Participant request to discontinue study treatment|2|||
145649422|NCT03338790|525233519|FG003|Overall Study|Participant request to discontinue study treatment|1|||
145649423|NCT03338790|525233516|FG000|Overall Study|Poor/non-compliance|0|||
145649424|NCT03338790|525233517|FG001|Overall Study|Poor/non-compliance|1|||
145649425|NCT03338790|525233518|FG002|Overall Study|Poor/non-compliance|0|||
145649426|NCT03338790|525233519|FG003|Overall Study|Poor/non-compliance|0|||
145649427|NCT03338790|525233516|FG000|Overall Study|Participant withdrew consent|1|||
145649428|NCT03338790|525233517|FG001|Overall Study|Participant withdrew consent|0|||
145649429|NCT03338790|525233518|FG002|Overall Study|Participant withdrew consent|1|||
145649430|NCT03338790|525233519|FG003|Overall Study|Participant withdrew consent|1|||
145649431|NCT03338790|525233516|FG000|Overall Study|Other reasons|0|||
145649432|NCT03338790|525233517|FG001|Overall Study|Other reasons|5|||
145649433|NCT03338790|525233518|FG002|Overall Study|Other reasons|0|||
145649434|NCT03338790|525233519|FG003|Overall Study|Other reasons|2|||
145649435|NCT03338790|525233516|FG000|Overall Study|Not reported|0|||
145649436|NCT03338790|525233517|FG001|Overall Study|Not reported|0|||
145649437|NCT03338790|525233518|FG002|Overall Study|Not reported|1|||
145649438|NCT03338790|525233519|FG003|Overall Study|Not reported|0|||
145649439|NCT03338790|525233516|FG000|Overall Study|Completed treatment period|1|||
145649440|NCT03338790|525233517|FG001|Overall Study|Completed treatment period|2|||
145649441|NCT03338790|525233518|FG002|Overall Study|Completed treatment period|0|||
145649442|NCT03338790|525233519|FG003|Overall Study|Completed treatment period|0|||
145649443|NCT02596126|525233522|FG000|Overall Study|Lost to Follow-up|12|||
145649444|NCT02596126|525233523|FG001|Overall Study|Lost to Follow-up|21|||
145649445|NCT02596126|525233522|FG000|Overall Study|Protocol Violation|7|||
145649446|NCT02596126|525233523|FG001|Overall Study|Protocol Violation|9|||
145649447|NCT05691452|525234725|FG000|Overall Study|Withdrawal by Subject|1|||
145649448|NCT05691452|525234726|FG001|Overall Study|Withdrawal by Subject|1|||
145649449|NCT05691452|525234727|FG002|Overall Study|Withdrawal by Subject|0|||
145649450|NCT05691452|525234725|FG000|Overall Study|Physician Decision|1|||
145649451|NCT05691452|525234726|FG001|Overall Study|Physician Decision|0|||
145649452|NCT05691452|525234727|FG002|Overall Study|Physician Decision|0|||
145649453|NCT05691452|525234725|FG000|Overall Study|Lost to Follow-up|0|||
145649454|NCT05691452|525234726|FG001|Overall Study|Lost to Follow-up|0|||
145649455|NCT05691452|525234727|FG002|Overall Study|Lost to Follow-up|1|||
145649456|NCT05691452|525234725|FG000|Overall Study|Adverse Event|0|||
145649457|NCT05691452|525234726|FG001|Overall Study|Adverse Event|0|||
145649458|NCT05691452|525234727|FG002|Overall Study|Adverse Event|1|||
145649459|NCT03648840|525234737|FG000|First IV Infusion Session|Adverse Event|0|||
145649460|NCT03648840|525234738|FG001|First IV Infusion Session|Adverse Event|2|||
145649461|NCT03648840|525234737|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
145649462|NCT03648840|525234738|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
145649463|NCT03648840|525234737|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
145649464|NCT03648840|525234738|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
145649465|NCT03648840|525234737|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
145649466|NCT03648840|525234738|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
145649467|NCT05418296|525234741|FG000|Overall Study|Withdrawal by Subject|4|||
145649468|NCT05418296|525234742|FG001|Overall Study|Withdrawal by Subject|1|||
145649469|NCT05382936|525234743|FG000|Overall Study|Progressive Disease|3|||
145649470|NCT05382936|525234744|FG001|Overall Study|Progressive Disease|5|||
145649471|NCT05382936|525234745|FG002|Overall Study|Progressive Disease|2|||
145649472|NCT05382936|525234746|FG003|Overall Study|Progressive Disease|5|||
145649473|NCT05382936|525234743|FG000|Overall Study|Adverse Event|0|||
145649474|NCT05382936|525234744|FG001|Overall Study|Adverse Event|1|||
145649475|NCT05382936|525234745|FG002|Overall Study|Adverse Event|1|||
145649476|NCT05382936|525234746|FG003|Overall Study|Adverse Event|0|||
145649477|NCT05382936|525234743|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
145649478|NCT05382936|525234744|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
145649479|NCT05382936|525234745|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
145649480|NCT05382936|525234746|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
145649481|NCT05382936|525234743|FG000|Overall Study|Withdrawal by Subject|0|||
145649482|NCT05382936|525234744|FG001|Overall Study|Withdrawal by Subject|0|||
145649483|NCT05382936|525234745|FG002|Overall Study|Withdrawal by Subject|1|||
145649484|NCT05382936|525234746|FG003|Overall Study|Withdrawal by Subject|1|||
145649485|NCT05063994|525234749|FG000|Cortef Run-In|Withdrawal of Consent|1|||
145649486|NCT05063994|525234750|FG001|Cortef Run-In|Withdrawal of Consent|0|||
145649487|NCT05063994|525234751|FG002|Cortef Run-In|Withdrawal of Consent|0|||
145649488|NCT05063994|525234749|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
145649489|NCT05063994|525234750|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
145649490|NCT05063994|525234751|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
145649491|NCT05063994|525234749|FG000|Treatment|Physician Decision|0|||
145649492|NCT05063994|525234750|FG001|Treatment|Physician Decision|0|||
145649493|NCT05063994|525234751|FG002|Treatment|Physician Decision|1|||
145649494|NCT05063994|525234749|FG000|Treatment|Withdrawal by Subject|0|||
145649495|NCT05063994|525234750|FG001|Treatment|Withdrawal by Subject|0|||
145649496|NCT05063994|525234751|FG002|Treatment|Withdrawal by Subject|1|||
145649497|NCT05063994|525234749|FG000|Treatment|Withdrawal of Consent|0|||
145649498|NCT05063994|525234750|FG001|Treatment|Withdrawal of Consent|0|||
145649499|NCT05063994|525234751|FG002|Treatment|Withdrawal of Consent|1|||
145649500|NCT04630262|525234753|FG000|Overall Study|Intraoperative Screen Failure|5|||
145649501|NCT04630262|525234753|FG000|Overall Study|Study terminated prematurely|71|||
145649502|NCT04630262|525234753|FG000|Overall Study|Withdrawal by Subject|2|||
145649503|NCT04630262|525234753|FG000|Overall Study|Physician Decision|2|||
145649504|NCT01195831|525234755|FG000|Overall Study|Lost to Follow-up|2|||
145649505|NCT01195831|525234756|FG001|Overall Study|Lost to Follow-up|4|||
145649506|NCT01195831|525234755|FG000|Overall Study|Withdrawal by Subject|2|||
145649507|NCT01195831|525234756|FG001|Overall Study|Withdrawal by Subject|2|||
145649508|NCT01195831|525234755|FG000|Overall Study|Adverse Event|4|||
145649509|NCT01195831|525234756|FG001|Overall Study|Adverse Event|2|||
145649510|NCT01195831|525234755|FG000|Overall Study|Protocol Violation|0|||
145649511|NCT01195831|525234756|FG001|Overall Study|Protocol Violation|2|||
145649512|NCT04638998|525234758|FG000|Overall Study|Withdrawal by Subject|1|||
145649513|NCT04638998|525234759|FG001|Overall Study|Withdrawal by Subject|3|||
145649514|NCT03692676|525234760|FG000|Overall Study|exclude patients with prior use|4424|||
145649515|NCT03692676|525234761|FG001|Overall Study|exclude patients with prior use|24726|||
145649516|NCT03692676|525234762|FG002|Overall Study|exclude patients with prior use|0|||
145649517|NCT03692676|525234763|FG003|Overall Study|exclude patients with prior use|0|||
145649518|NCT03692676|525234760|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
145488633|NCT01292187|524644275|FG001|Overall Study|Withdrawal by Subject|5|||
145488634|NCT01292187|524644274|FG000|Overall Study|All other reasons|1|||
145649519|NCT03692676|525234761|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
145649520|NCT03692676|525234762|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
145649521|NCT03692676|525234763|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
145649522|NCT03692676|525234760|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
145649523|NCT03692676|525234761|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
145649524|NCT03692676|525234762|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
145649525|NCT03692676|525234763|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
145649526|NCT03692676|525234760|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
145649527|NCT03692676|525234761|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
145649528|NCT03692676|525234762|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
145649529|NCT03692676|525234763|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
145649530|NCT03692676|525234760|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
145649531|NCT03692676|525234761|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
145649532|NCT03692676|525234762|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
145649533|NCT03692676|525234763|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
145649534|NCT03692676|525234760|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
145649535|NCT03692676|525234761|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
145649536|NCT03692676|525234762|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
145649537|NCT03692676|525234763|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
145649538|NCT03692676|525234760|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
145649539|NCT03692676|525234761|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
145649540|NCT03692676|525234762|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
145649541|NCT03692676|525234763|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
145649542|NCT03692676|525234760|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
145649543|NCT03692676|525234761|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
145649544|NCT03692676|525234762|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
145488635|NCT01292187|524644275|FG001|Overall Study|All other reasons|3|||
145649545|NCT03692676|525234763|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
145649546|NCT03692676|525234760|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
145649547|NCT03692676|525234761|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
145649548|NCT03692676|525234762|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
145649549|NCT03692676|525234763|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
145649550|NCT03692676|525234760|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
145649551|NCT03692676|525234761|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
145649552|NCT03692676|525234762|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
145649553|NCT03692676|525234763|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
145649554|NCT03692676|525234760|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
145649555|NCT03692676|525234761|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
145649556|NCT03692676|525234762|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
145649557|NCT03692676|525234763|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
145649558|NCT03692676|525234760|FG000|Overall Study|Other|0|||
145649559|NCT03692676|525234761|FG001|Overall Study|Other|805|||
145649560|NCT03692676|525234762|FG002|Overall Study|Other|758|||
145649561|NCT03692676|525234763|FG003|Overall Study|Other|277|||
145488636|NCT03827655|524644277|FG000|Overall Study|Death|0|||
145488637|NCT03827655|524644278|FG001|Overall Study|Death|0|||
145488638|NCT03827655|524644279|FG002|Overall Study|Death|0|||
145488639|NCT03827655|524644280|FG003|Overall Study|Death|0|||
145488640|NCT03827655|524644281|FG004|Overall Study|Death|1|||
145488641|NCT03827655|524644277|FG000|Overall Study|Protocol Deviation|1|||
145488642|NCT03827655|524644278|FG001|Overall Study|Protocol Deviation|0|||
145488643|NCT03827655|524644279|FG002|Overall Study|Protocol Deviation|1|||
145488644|NCT03827655|524644280|FG003|Overall Study|Protocol Deviation|1|||
145488645|NCT03827655|524644281|FG004|Overall Study|Protocol Deviation|0|||
145488646|NCT03827655|524644277|FG000|Overall Study|Withdrawal by Subject|3|||
145488647|NCT03827655|524644278|FG001|Overall Study|Withdrawal by Subject|2|||
145488648|NCT03827655|524644279|FG002|Overall Study|Withdrawal by Subject|2|||
145488649|NCT03827655|524644280|FG003|Overall Study|Withdrawal by Subject|0|||
145488650|NCT03827655|524644281|FG004|Overall Study|Withdrawal by Subject|1|||
145488651|NCT03827655|524644277|FG000|Overall Study|Reason not Specified|3|||
145488652|NCT03827655|524644278|FG001|Overall Study|Reason not Specified|1|||
145488653|NCT03827655|524644279|FG002|Overall Study|Reason not Specified|1|||
145488654|NCT03827655|524644280|FG003|Overall Study|Reason not Specified|1|||
145649562|NCT03692676|525234760|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
145649563|NCT03692676|525234761|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
145649564|NCT03692676|525234762|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
145649565|NCT03692676|525234763|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
145649566|NCT01180634|525234764|FG000|Overall Study|Adverse Event|4|||
145649567|NCT01180634|525234765|FG001|Overall Study|Adverse Event|1|||
145649568|NCT01180634|525234764|FG000|Overall Study|Miscellaneous|2|||
145649569|NCT01180634|525234765|FG001|Overall Study|Miscellaneous|0|||
145649570|NCT01180634|525234764|FG000|Overall Study|Withdrawal by Subject|4|||
145649571|NCT01180634|525234765|FG001|Overall Study|Withdrawal by Subject|0|||
145649572|NCT03692611|525234766|FG000|Overall Study|Found to be ineligible postrandomization|3|||
145649573|NCT03692611|525234767|FG001|Overall Study|Found to be ineligible postrandomization|0|||
145649574|NCT04419168|525234768|FG000|Overall Study|Protocol Violation|1|||
145649575|NCT04419168|525234769|FG001|Overall Study|Protocol Violation|1|||
145649576|NCT04419168|525234768|FG000|Overall Study|Lost to Follow-up|7|||
145649577|NCT04419168|525234769|FG001|Overall Study|Lost to Follow-up|7|||
145649578|NCT04419168|525234768|FG000|Overall Study|Missed 6-month Visit|48|||
145649579|NCT04419168|525234769|FG001|Overall Study|Missed 6-month Visit|45|||
145649580|NCT03988634|525234774|FG000|Double-Blind|Adverse Event|4|||
145649581|NCT03988634|525234775|FG001|Double-Blind|Adverse Event|0|||
145649582|NCT03988634|525234776|FG002|Double-Blind|Adverse Event|0|||
145649583|NCT03988634|525234774|FG000|Double-Blind|Death|18|||
145649584|NCT03988634|525234775|FG001|Double-Blind|Death|26|||
145649585|NCT03988634|525234776|FG002|Double-Blind|Death|0|||
145649586|NCT03988634|525234774|FG000|Double-Blind|Lost to Follow-up|6|||
145649587|NCT03988634|525234775|FG001|Double-Blind|Lost to Follow-up|7|||
145649588|NCT03988634|525234776|FG002|Double-Blind|Lost to Follow-up|0|||
145649589|NCT03988634|525234774|FG000|Double-Blind|Physician Decision|9|||
145649590|NCT03988634|525234775|FG001|Double-Blind|Physician Decision|5|||
145649591|NCT03988634|525234776|FG002|Double-Blind|Physician Decision|0|||
145649592|NCT03988634|525234774|FG000|Double-Blind|Subject decision|24|||
145649593|NCT03988634|525234775|FG001|Double-Blind|Subject decision|13|||
145649594|NCT03988634|525234776|FG002|Double-Blind|Subject decision|0|||
145649595|NCT03988634|525234774|FG000|Open-Label|Adverse Event|0|||
145649596|NCT03988634|525234775|FG001|Open-Label|Adverse Event|0|||
145649597|NCT03988634|525234776|FG002|Open-Label|Adverse Event|7|||
145649598|NCT03988634|525234774|FG000|Open-Label|Physician Decision|0|||
145649599|NCT03988634|525234775|FG001|Open-Label|Physician Decision|0|||
145649600|NCT03988634|525234776|FG002|Open-Label|Physician Decision|1|||
145649601|NCT03988634|525234774|FG000|Open-Label|Technical problems|0|||
145649602|NCT03988634|525234775|FG001|Open-Label|Technical problems|0|||
145649603|NCT03988634|525234776|FG002|Open-Label|Technical problems|1|||
145649604|NCT00616967|525234779|FG000|Overall Study|Withdrawal by Subject|0|||
145649605|NCT00616967|525234780|FG001|Overall Study|Withdrawal by Subject|0|||
145649606|NCT00616967|525234781|FG002|Overall Study|Withdrawal by Subject|1|||
145649607|NCT02910583|525234782|FG000|Overall Study|Death|7|||
145649608|NCT02910583|525234783|FG001|Overall Study|Death|3|||
145649609|NCT02910583|525234782|FG000|Overall Study|Lost to Follow-up|1|||
145649610|NCT02910583|525234783|FG001|Overall Study|Lost to Follow-up|0|||
145649611|NCT02910583|525234782|FG000|Overall Study|Withdrawal by Subject|12|||
145649612|NCT02910583|525234783|FG001|Overall Study|Withdrawal by Subject|8|||
145649613|NCT02910583|525234782|FG000|Overall Study|Other, Not Specified|6|||
145488655|NCT03827655|524644281|FG004|Overall Study|Reason not Specified|1|||
145488656|NCT01092728|524644282|FG000|Overall Study|Withdrawal by Subject|2|||
145488657|NCT01092728|524644283|FG001|Overall Study|Withdrawal by Subject|0|||
145488658|NCT01092728|524644282|FG000|Overall Study|Adverse Event|0|||
145488659|NCT01092728|524644283|FG001|Overall Study|Adverse Event|1|||
145488660|NCT01092728|524644282|FG000|Overall Study|Disease Progression|1|||
145488661|NCT01092728|524644283|FG001|Overall Study|Disease Progression|13|||
145488662|NCT01092728|524644282|FG000|Overall Study|Prohibited Concomitant Medications|1|||
145649614|NCT02910583|525234783|FG001|Overall Study|Other, Not Specified|3|||
145649615|NCT04263311|525234784|FG000|Overall Study|Lost to Follow-up|1|||
145649616|NCT04263311|525234785|FG001|Overall Study|Lost to Follow-up|2|||
145649617|NCT04263311|525234786|FG002|Overall Study|Lost to Follow-up|0|||
145649618|NCT04263311|525234784|FG000|Overall Study|Health Issues|1|||
145649619|NCT04263311|525234785|FG001|Overall Study|Health Issues|0|||
145649620|NCT04263311|525234786|FG002|Overall Study|Health Issues|0|||
145649621|NCT04263311|525234784|FG000|Overall Study|Left the country|1|||
145649622|NCT04263311|525234785|FG001|Overall Study|Left the country|0|||
145649623|NCT04263311|525234786|FG002|Overall Study|Left the country|0|||
145649624|NCT04263311|525234784|FG000|Overall Study|Unable to maintain time commitment|1|||
145649625|NCT04263311|525234785|FG001|Overall Study|Unable to maintain time commitment|0|||
145649626|NCT04263311|525234786|FG002|Overall Study|Unable to maintain time commitment|0|||
145649627|NCT04263311|525234784|FG000|Overall Study|No longer interested|1|||
145649628|NCT04263311|525234785|FG001|Overall Study|No longer interested|0|||
145488663|NCT01092728|524644283|FG001|Overall Study|Prohibited Concomitant Medications|0|||
145649629|NCT04263311|525234786|FG002|Overall Study|No longer interested|0|||
145649630|NCT04263311|525234784|FG000|Overall Study|Ineligible post consent|0|||
145649631|NCT04263311|525234785|FG001|Overall Study|Ineligible post consent|0|||
145649632|NCT04263311|525234786|FG002|Overall Study|Ineligible post consent|5|||
145649633|NCT03958955|525234787|FG000|Overall Study|Adverse Event|1|||
145649634|NCT04673929|525234788|FG000|Overall Study|Death|73|||
145649635|NCT04673929|525234788|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
145649636|NCT05536440|525234790|FG000|Overall Study|Adverse Event|0|||
145649637|NCT05536440|525234791|FG001|Overall Study|Adverse Event|0|||
145649638|NCT05536440|525234792|FG002|Overall Study|Adverse Event|0|||
145649639|NCT05536440|525234793|FG003|Overall Study|Adverse Event|0|||
145649640|NCT05536440|525234794|FG004|Overall Study|Adverse Event|0|||
145649641|NCT05536440|525234795|FG005|Overall Study|Adverse Event|0|||
145649642|NCT05536440|525234796|FG006|Overall Study|Adverse Event|0|||
145649643|NCT05536440|525234797|FG007|Overall Study|Adverse Event|0|||
145649644|NCT05536440|525234798|FG008|Overall Study|Adverse Event|1|||
145649645|NCT05569252|525234799|FG000|Overall Study|Adverse event (central vision loss)|1|||
145649646|NCT05569252|525234800|FG001|Overall Study|Adverse event (central vision loss)|0|||
145649647|NCT05569252|525234801|FG002|Overall Study|Adverse event (central vision loss)|0|||
145649648|NCT05569252|525234802|FG003|Overall Study|Adverse event (central vision loss)|0|||
145649649|NCT01494662|525234805|FG000|Overall Study|Withdrawal by Subject|0|||
145649650|NCT01494662|525234806|FG001|Overall Study|Withdrawal by Subject|0|||
145649651|NCT01494662|525234807|FG002|Overall Study|Withdrawal by Subject|1|||
145649652|NCT01494662|525234808|FG003|Overall Study|Withdrawal by Subject|0|||
145649653|NCT01494662|525234809|FG004|Overall Study|Withdrawal by Subject|0|||
145649654|NCT01494662|525234810|FG005|Overall Study|Withdrawal by Subject|0|||
145649655|NCT01494662|525234811|FG006|Overall Study|Withdrawal by Subject|0|||
145649656|NCT01494662|525234805|FG000|Overall Study|Physician Decision|0|||
145649657|NCT01494662|525234806|FG001|Overall Study|Physician Decision|0|||
145649658|NCT01494662|525234807|FG002|Overall Study|Physician Decision|1|||
145649659|NCT01494662|525234808|FG003|Overall Study|Physician Decision|0|||
145649660|NCT01494662|525234809|FG004|Overall Study|Physician Decision|0|||
145649661|NCT01494662|525234810|FG005|Overall Study|Physician Decision|0|||
145649662|NCT01494662|525234811|FG006|Overall Study|Physician Decision|0|||
145649663|NCT04072822|525234812|FG000|Treatment|Adverse Event|9|||
145649664|NCT04072822|525234813|FG001|Treatment|Adverse Event|5|||
145649665|NCT04072822|525234812|FG000|Treatment|Met Stopping Criteria|13|||
145649666|NCT04072822|525234813|FG001|Treatment|Met Stopping Criteria|24|||
145649667|NCT04072822|525234812|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
145649668|NCT04072822|525234813|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
145649669|NCT04072822|525234812|FG000|Treatment|Withdrawal by Subject|0|||
145649670|NCT04072822|525234813|FG001|Treatment|Withdrawal by Subject|2|||
145649671|NCT04072822|525234812|FG000|Treatment|Death|0|||
145649672|NCT04072822|525234813|FG001|Treatment|Death|2|||
145649673|NCT04072822|525234812|FG000|Treatment|Lost to Follow-up|11|||
145649674|NCT04072822|525234813|FG001|Treatment|Lost to Follow-up|3|||
145649675|NCT04072822|525234812|FG000|Treatment|Physician Decision|1|||
145649676|NCT04072822|525234813|FG001|Treatment|Physician Decision|0|||
145649677|NCT04072822|525234812|FG000|Treatment|Other|7|||
145649678|NCT04072822|525234813|FG001|Treatment|Other|9|||
145649679|NCT04072822|525234812|FG000|Follow-up|Withdrawal by Subject|1|||
145649680|NCT04072822|525234813|FG001|Follow-up|Withdrawal by Subject|0|||
145649681|NCT04072822|525234812|FG000|Follow-up|Lost to Follow-up|5|||
145649682|NCT04072822|525234813|FG001|Follow-up|Lost to Follow-up|4|||
145649683|NCT05481320|525234814|FG000|Overall Study|Withdrawal by Subject|1|||
145649684|NCT05481320|525234815|FG001|Overall Study|Withdrawal by Subject|1|||
145649685|NCT05481320|525234814|FG000|Overall Study|Care recipent passed away|0|||
145649686|NCT05481320|525234815|FG001|Overall Study|Care recipent passed away|1|||
145649687|NCT05481320|525234814|FG000|Overall Study|Out-of-window assessment|0|||
145649688|NCT05481320|525234815|FG001|Overall Study|Out-of-window assessment|1|||
145649689|NCT05481320|525234814|FG000|Overall Study|No longer a primary caregiver|3|||
145649690|NCT05481320|525234815|FG001|Overall Study|No longer a primary caregiver|0|||
145649691|NCT05481320|525234814|FG000|Overall Study|Unable to contact|1|||
145649692|NCT05481320|525234815|FG001|Overall Study|Unable to contact|0|||
145649693|NCT02811679|525234816|FG000|Overall Study|Adverse Event|1|||
145649694|NCT02811679|525234816|FG000|Overall Study|Lack of Efficacy|6|||
145649695|NCT02811679|525234816|FG000|Overall Study|Early study closure due to slow accrual|3|||
145649696|NCT05319860|525234820|FG000|Overall Study|Death|1|||
145649697|NCT05319860|525234821|FG001|Overall Study|Death|1|||
145649698|NCT05319860|525234820|FG000|Overall Study|Lost to Follow-up|3|||
145649699|NCT05319860|525234821|FG001|Overall Study|Lost to Follow-up|1|||
145649700|NCT05319860|525234820|FG000|Overall Study|Withdrawal by Subject|1|||
145649701|NCT05319860|525234821|FG001|Overall Study|Withdrawal by Subject|7|||
145649702|NCT04314895|525234822|FG000|Overall Study|Lost to Follow-up|1|||
145649703|NCT04314895|525234822|FG000|Overall Study|Death|10|||
145649704|NCT04314895|525234822|FG000|Overall Study|Physician Decision|2|||
145649705|NCT03941860|525234823|FG000|Overall Study|Withdrawal by Subject|0|||
145649706|NCT03941860|525234824|FG001|Overall Study|Withdrawal by Subject|1|||
145649707|NCT03361748|525234828|FG000|Overall Study|Death|77|||
145649708|NCT03361748|525234828|FG000|Overall Study|Lost to Follow-up|4|||
145649709|NCT03361748|525234828|FG000|Overall Study|Withdrawal by Subject|20|||
145649710|NCT01361711|525234830|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
145649711|NCT01361711|525234830|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
145649712|NCT01361711|525234830|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
145649713|NCT01361711|525234830|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
145649714|NCT01361711|525234830|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
145649715|NCT01361711|525234830|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
145649716|NCT01361711|525234830|FG000|Completed Week 18 of Treatment|Other|9|||
145649717|NCT01361711|525234830|FG000|10 Year Follow-up|Still in follow-up|22|||
145649718|NCT01361711|525234830|FG000|10 Year Follow-up|Death|7|||
145649719|NCT01361711|525234830|FG000|10 Year Follow-up|Developed new cancer|1|||
145649720|NCT01361711|525234830|FG000|10 Year Follow-up|Lost to Follow-up|2|||
145649721|NCT01361711|525234830|FG000|10 Year Follow-up|New treatment started|6|||
145649722|NCT01361711|525234830|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
145649723|NCT01361711|525234830|FG000|10 Year Follow-up|Progressive Disease|1|||
145649724|NCT03930342|525234831|FG000|Overall Study|Lost to Follow-up|70|||
145649725|NCT03930342|525234832|FG001|Overall Study|Lost to Follow-up|77|||
145649726|NCT05792423|525234835|FG000|Overall Study|Withdrawal by Subject|2|||
145649727|NCT02471638|525234836|FG000|Overall Study|Early Term Withdrawal|10|||
145649728|NCT04593472|525236528|FG000|Overall Study|Death|31|||
145649729|NCT04593472|525236529|FG001|Overall Study|Death|27|||
145649730|NCT04593472|525236528|FG000|Overall Study|Withdrawal by Subject|12|||
145649731|NCT04593472|525236529|FG001|Overall Study|Withdrawal by Subject|12|||
145649732|NCT04593472|525236528|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
145649733|NCT04593472|525236529|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
145649734|NCT04593472|525236528|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
145488664|NCT03649217|524644284|FG000|Overall Study|subject had severe ataxia not initially found|1|||
145488665|NCT03649217|524644284|FG000|Overall Study|subject had cognitive issues not initially found|1|||
145488666|NCT02520726|524644285|FG000|Overall Study|Lost to Follow-up|3|||
145488667|NCT02520726|524644286|FG001|Overall Study|Lost to Follow-up|2|||
145488668|NCT02336607|524644287|FG000|Overall Study|Physician Decision|1|||
145488669|NCT02336607|524644288|FG001|Overall Study|Physician Decision|4|||
145488670|NCT02336607|524644289|FG002|Overall Study|Physician Decision|3|||
145488671|NCT02336607|524644290|FG003|Overall Study|Physician Decision|15|||
145488672|NCT02336607|524644287|FG000|Overall Study|Lack of Efficacy|1|||
145488673|NCT02336607|524644288|FG001|Overall Study|Lack of Efficacy|0|||
145488674|NCT02336607|524644289|FG002|Overall Study|Lack of Efficacy|0|||
145488675|NCT02336607|524644290|FG003|Overall Study|Lack of Efficacy|2|||
145488676|NCT02336607|524644287|FG000|Overall Study|Lost to Follow-up|2|||
145488677|NCT02336607|524644288|FG001|Overall Study|Lost to Follow-up|1|||
145649735|NCT04593472|525236529|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
145649736|NCT04593472|525236528|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
145649737|NCT04593472|525236529|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
145649738|NCT04593472|525236528|FG000|Overall Study|Lost to Follow-up|0|||
145649739|NCT04593472|525236529|FG001|Overall Study|Lost to Follow-up|2|||
145649740|NCT04593472|525236528|FG000|Overall Study|Still collecting 24-month assessment|17|||
145649741|NCT04593472|525236529|FG001|Overall Study|Still collecting 24-month assessment|10|||
145649742|NCT04833777|525236533|FG000|Overall Study|Lost to Follow-up|1|||
145649743|NCT04833777|525236534|FG001|Overall Study|Lost to Follow-up|0|||
145649744|NCT04490915|525236541|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
145649745|NCT04490915|525236542|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
145649746|NCT04490915|525236541|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145649747|NCT04490915|525236542|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145649748|NCT04490915|525236541|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145649749|NCT04490915|525236542|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
145649750|NCT04490915|525236541|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
145649751|NCT04490915|525236542|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
145649752|NCT04490915|525236541|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
145649753|NCT04490915|525236542|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
145649754|NCT04490915|525236541|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
145649755|NCT04490915|525236542|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
145649756|NCT04490915|525236541|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
145649757|NCT04490915|525236542|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
145649758|NCT04725240|525236543|FG000|Overall Study|Adverse Event|2|||
145649759|NCT04083235|525236567|FG000|Overall Study|Death|252|||
145649760|NCT04083235|525236568|FG001|Overall Study|Death|277|||
145649761|NCT04083235|525236567|FG000|Overall Study|Withdrawal by Subject|13|||
145649762|NCT04083235|525236568|FG001|Overall Study|Withdrawal by Subject|17|||
145649763|NCT04083235|525236567|FG000|Overall Study|Lost to Follow-up|1|||
145649764|NCT04083235|525236568|FG001|Overall Study|Lost to Follow-up|1|||
145488678|NCT02336607|524644289|FG002|Overall Study|Lost to Follow-up|0|||
145488679|NCT02336607|524644290|FG003|Overall Study|Lost to Follow-up|21|||
145488680|NCT02336607|524644287|FG000|Overall Study|Protocol Violation|0|||
145488681|NCT02336607|524644288|FG001|Overall Study|Protocol Violation|1|||
145649765|NCT04083235|525236567|FG000|Overall Study|Does not meet entry criteria|1|||
145649766|NCT04083235|525236568|FG001|Overall Study|Does not meet entry criteria|0|||
145649767|NCT04083235|525236567|FG000|Overall Study|Did not receive treatment|13|||
145649768|NCT04083235|525236568|FG001|Overall Study|Did not receive treatment|8|||
145649769|NCT04083235|525236567|FG000|Overall Study|Ongoing at the time of DCO|44|||
145649770|NCT04083235|525236568|FG001|Overall Study|Ongoing at the time of DCO|7|||
145649771|NCT02312960|525236571|FG000|Overall Study|Death|24|||
145649772|NCT02312960|525236572|FG001|Overall Study|Death|32|||
145649773|NCT02312960|525236573|FG002|Overall Study|Death|25|||
145649774|NCT02312960|525236574|FG003|Overall Study|Death|11|||
145649775|NCT02312960|525236575|FG004|Overall Study|Death|5|||
145649776|NCT02312960|525236576|FG005|Overall Study|Death|5|||
145649777|NCT02312960|525236577|FG006|Overall Study|Death|8|||
145649778|NCT02312960|525236578|FG007|Overall Study|Death|5|||
145649779|NCT02312960|525236579|FG008|Overall Study|Death|7|||
145649780|NCT02312960|525236580|FG009|Overall Study|Death|3|||
145649781|NCT02312960|525236581|FG010|Overall Study|Death|3|||
145649782|NCT02312960|525236582|FG011|Overall Study|Death|1|||
145649783|NCT02312960|525236583|FG012|Overall Study|Death|25|||
145649784|NCT02312960|525236584|FG013|Overall Study|Death|19|||
145649785|NCT02312960|525236571|FG000|Overall Study|Missing|0|||
145649786|NCT02312960|525236572|FG001|Overall Study|Missing|0|||
145649787|NCT02312960|525236573|FG002|Overall Study|Missing|2|||
145649788|NCT02312960|525236574|FG003|Overall Study|Missing|0|||
145649789|NCT02312960|525236575|FG004|Overall Study|Missing|0|||
145649790|NCT02312960|525236576|FG005|Overall Study|Missing|0|||
145649791|NCT02312960|525236577|FG006|Overall Study|Missing|0|||
145649792|NCT02312960|525236578|FG007|Overall Study|Missing|0|||
145649793|NCT02312960|525236579|FG008|Overall Study|Missing|0|||
145649794|NCT02312960|525236580|FG009|Overall Study|Missing|0|||
145649795|NCT02312960|525236581|FG010|Overall Study|Missing|0|||
145649796|NCT02312960|525236582|FG011|Overall Study|Missing|0|||
145649797|NCT02312960|525236583|FG012|Overall Study|Missing|0|||
145649798|NCT02312960|525236584|FG013|Overall Study|Missing|0|||
145649799|NCT02312960|525236571|FG000|Overall Study|Lost to Follow-up|0|||
145649800|NCT02312960|525236572|FG001|Overall Study|Lost to Follow-up|0|||
145649801|NCT02312960|525236573|FG002|Overall Study|Lost to Follow-up|1|||
145649802|NCT02312960|525236574|FG003|Overall Study|Lost to Follow-up|0|||
145649803|NCT02312960|525236575|FG004|Overall Study|Lost to Follow-up|0|||
145649804|NCT02312960|525236576|FG005|Overall Study|Lost to Follow-up|0|||
145649805|NCT02312960|525236577|FG006|Overall Study|Lost to Follow-up|1|||
145649806|NCT02312960|525236578|FG007|Overall Study|Lost to Follow-up|1|||
145649807|NCT02312960|525236579|FG008|Overall Study|Lost to Follow-up|0|||
145649808|NCT02312960|525236580|FG009|Overall Study|Lost to Follow-up|1|||
145649809|NCT02312960|525236581|FG010|Overall Study|Lost to Follow-up|0|||
145649810|NCT02312960|525236582|FG011|Overall Study|Lost to Follow-up|0|||
145649811|NCT02312960|525236583|FG012|Overall Study|Lost to Follow-up|1|||
145649812|NCT02312960|525236584|FG013|Overall Study|Lost to Follow-up|0|||
145649813|NCT02312960|525236571|FG000|Overall Study|Withdrawal by Subject|1|||
145649814|NCT02312960|525236572|FG001|Overall Study|Withdrawal by Subject|2|||
145649815|NCT02312960|525236573|FG002|Overall Study|Withdrawal by Subject|0|||
145649816|NCT02312960|525236574|FG003|Overall Study|Withdrawal by Subject|0|||
145649817|NCT02312960|525236575|FG004|Overall Study|Withdrawal by Subject|1|||
145649818|NCT02312960|525236576|FG005|Overall Study|Withdrawal by Subject|0|||
145488682|NCT02336607|524644289|FG002|Overall Study|Protocol Violation|1|||
145488683|NCT02336607|524644290|FG003|Overall Study|Protocol Violation|3|||
145488684|NCT02336607|524644287|FG000|Overall Study|Adverse Event|0|||
145488685|NCT02336607|524644288|FG001|Overall Study|Adverse Event|2|||
145649819|NCT02312960|525236577|FG006|Overall Study|Withdrawal by Subject|1|||
145649820|NCT02312960|525236578|FG007|Overall Study|Withdrawal by Subject|2|||
145649821|NCT02312960|525236579|FG008|Overall Study|Withdrawal by Subject|2|||
145649822|NCT02312960|525236580|FG009|Overall Study|Withdrawal by Subject|3|||
145649823|NCT02312960|525236581|FG010|Overall Study|Withdrawal by Subject|0|||
145649824|NCT02312960|525236582|FG011|Overall Study|Withdrawal by Subject|0|||
145649825|NCT02312960|525236583|FG012|Overall Study|Withdrawal by Subject|2|||
145649826|NCT02312960|525236584|FG013|Overall Study|Withdrawal by Subject|0|||
145488686|NCT02336607|524644289|FG002|Overall Study|Adverse Event|2|||
145649827|NCT04060355|525236586|FG000|Overall Study|Lost to Follow-up|41|||
145649828|NCT01140880|525236587|FG000|Overall Study|Death|0|||
145649829|NCT01140880|525236588|FG001|Overall Study|Death|1|||
145649830|NCT01140880|525236587|FG000|Overall Study|Withdrawal by Subject|6|||
145649831|NCT01140880|525236588|FG001|Overall Study|Withdrawal by Subject|3|||
145488687|NCT02336607|524644290|FG003|Overall Study|Adverse Event|26|||
145649832|NCT01140880|525236587|FG000|Overall Study|Lost to Follow-up|8|||
145649833|NCT01140880|525236588|FG001|Overall Study|Lost to Follow-up|10|||
145649834|NCT01140880|525236587|FG000|Overall Study|Protocol Violation|0|||
145649835|NCT01140880|525236588|FG001|Overall Study|Protocol Violation|30|||
145649836|NCT02724878|525236589|FG000|Overall Study|Still on Active Therapy|15|||
145649837|NCT02724878|525236589|FG000|Overall Study|Disease Progression|31|||
145649838|NCT02724878|525236589|FG000|Overall Study|Toxicity|5|||
145649839|NCT02724878|525236589|FG000|Overall Study|Death|1|||
145649840|NCT02724878|525236589|FG000|Overall Study|Withdrawal by Subject|4|||
145649841|NCT02724878|525236589|FG000|Overall Study|Lost to Follow-up|2|||
145649842|NCT02724878|525236589|FG000|Overall Study|Protocol Violation|1|||
145649843|NCT02724878|525236589|FG000|Overall Study|Ineligible for Study Drug|5|||
145649844|NCT02724878|525236589|FG000|Overall Study|not started|1|||
145649845|NCT03779204|525236593|FG000|Overall Study|Lost to Follow-up|2|||
145649846|NCT03779204|525236594|FG001|Overall Study|Lost to Follow-up|0|||
145649847|NCT04421378|525236595|FG000|Overall Study|Adverse Event|2|||
145649848|NCT04421378|525236596|FG001|Overall Study|Adverse Event|7|||
145649849|NCT04421378|525236597|FG002|Overall Study|Adverse Event|0|||
145649850|NCT04421378|525236598|FG003|Overall Study|Adverse Event|1|||
145649851|NCT04421378|525236599|FG004|Overall Study|Adverse Event|0|||
145649852|NCT04421378|525236595|FG000|Overall Study|Physician Decision|1|||
145649853|NCT04421378|525236596|FG001|Overall Study|Physician Decision|2|||
145649854|NCT04421378|525236597|FG002|Overall Study|Physician Decision|0|||
145649855|NCT04421378|525236598|FG003|Overall Study|Physician Decision|0|||
145649856|NCT04421378|525236599|FG004|Overall Study|Physician Decision|0|||
145649857|NCT04421378|525236595|FG000|Overall Study|Progressive Disease|16|||
145649858|NCT04421378|525236596|FG001|Overall Study|Progressive Disease|4|||
145649859|NCT04421378|525236597|FG002|Overall Study|Progressive Disease|18|||
145649860|NCT04421378|525236598|FG003|Overall Study|Progressive Disease|11|||
145649861|NCT04421378|525236599|FG004|Overall Study|Progressive Disease|3|||
145649862|NCT04421378|525236595|FG000|Overall Study|Study Terminated by Sponsor|0|||
145649863|NCT04421378|525236596|FG001|Overall Study|Study Terminated by Sponsor|1|||
145649864|NCT04421378|525236597|FG002|Overall Study|Study Terminated by Sponsor|1|||
145649865|NCT04421378|525236598|FG003|Overall Study|Study Terminated by Sponsor|0|||
145649866|NCT04421378|525236599|FG004|Overall Study|Study Terminated by Sponsor|0|||
145649867|NCT04421378|525236595|FG000|Overall Study|Withdrawal by Subject|3|||
145649868|NCT04421378|525236596|FG001|Overall Study|Withdrawal by Subject|1|||
145649869|NCT04421378|525236597|FG002|Overall Study|Withdrawal by Subject|0|||
145649870|NCT04421378|525236598|FG003|Overall Study|Withdrawal by Subject|2|||
145649871|NCT04421378|525236599|FG004|Overall Study|Withdrawal by Subject|0|||
145649872|NCT04421378|525236595|FG000|Overall Study|Other|1|||
145649873|NCT04421378|525236596|FG001|Overall Study|Other|0|||
145649874|NCT04421378|525236597|FG002|Overall Study|Other|0|||
145649875|NCT04421378|525236598|FG003|Overall Study|Other|0|||
145649876|NCT04421378|525236599|FG004|Overall Study|Other|0|||
145649877|NCT04258709|525236600|FG000|Overall Study|Lost to Follow-up|10|||
145649878|NCT04258709|525236601|FG001|Overall Study|Lost to Follow-up|4|||
145649879|NCT04258709|525236600|FG000|Overall Study|Withdrawal by Subject|1|||
145649880|NCT04258709|525236601|FG001|Overall Study|Withdrawal by Subject|0|||
145649881|NCT04258709|525236600|FG000|Overall Study|Fetal demise|0|||
145649882|NCT04258709|525236601|FG001|Overall Study|Fetal demise|1|||
145649883|NCT04258709|525236600|FG000|Overall Study|Protocol Violation|1|||
145649884|NCT04258709|525236601|FG001|Overall Study|Protocol Violation|1|||
145488688|NCT02336607|524644287|FG000|Overall Study|Withdrawal by Subject|0|||
145488689|NCT02336607|524644288|FG001|Overall Study|Withdrawal by Subject|2|||
145488690|NCT02336607|524644289|FG002|Overall Study|Withdrawal by Subject|0|||
145488691|NCT02336607|524644290|FG003|Overall Study|Withdrawal by Subject|20|||
145488692|NCT02552966|524644293|FG000|Overall Study|Lost to Follow-up|2|||
145488693|NCT02552966|524644293|FG000|Overall Study|Withdrawal by Subject|3|||
145488694|NCT00721396|524644295|FG000|Overall Study|Adverse Event|4|||
145488695|NCT00721396|524644296|FG001|Overall Study|Adverse Event|7|||
145488696|NCT00721396|524644297|FG002|Overall Study|Adverse Event|2|||
145488697|NCT00721396|524644298|FG003|Overall Study|Adverse Event|0|||
145649885|NCT02592330|525236602|FG000|Overall Study|Withdrawal by Subject|1|||
145649886|NCT02592330|525236603|FG001|Overall Study|Withdrawal by Subject|0|||
145649887|NCT02592330|525236602|FG000|Overall Study|Failed Biopsy|1|||
145488698|NCT00721396|524644295|FG000|Overall Study|Withdrawal by Subject|12|||
145488699|NCT00721396|524644296|FG001|Overall Study|Withdrawal by Subject|15|||
145488700|NCT00721396|524644297|FG002|Overall Study|Withdrawal by Subject|3|||
145488701|NCT00721396|524644298|FG003|Overall Study|Withdrawal by Subject|7|||
145649888|NCT02592330|525236603|FG001|Overall Study|Failed Biopsy|0|||
145649889|NCT03090152|525236604|FG000|Overall Study|Withdrawal by Subject|0|||
145649890|NCT03090152|525236605|FG001|Overall Study|Withdrawal by Subject|2|||
145649891|NCT03090152|525236606|FG002|Overall Study|Withdrawal by Subject|1|||
145649892|NCT03090152|525236604|FG000|Overall Study|Surgery Canceled|1|||
145649893|NCT03090152|525236605|FG001|Overall Study|Surgery Canceled|0|||
145649894|NCT03090152|525236606|FG002|Overall Study|Surgery Canceled|0|||
145649895|NCT03090152|525236604|FG000|Overall Study|Epidural catheter could not be placed|0|||
145649896|NCT03090152|525236605|FG001|Overall Study|Epidural catheter could not be placed|2|||
145649897|NCT03090152|525236606|FG002|Overall Study|Epidural catheter could not be placed|0|||
145649898|NCT05082909|525236608|FG000|Overall Study|Protocol Violation|0|||
145488702|NCT00721396|524644295|FG000|Overall Study|Lost to Follow-up|7|||
145488703|NCT00721396|524644296|FG001|Overall Study|Lost to Follow-up|9|||
145649899|NCT05082909|525236609|FG001|Overall Study|Protocol Violation|0|||
145649900|NCT05082909|525236610|FG002|Overall Study|Protocol Violation|1|||
145649901|NCT05082909|525236611|FG003|Overall Study|Protocol Violation|0|||
145649902|NCT05082909|525236612|FG004|Overall Study|Protocol Violation|0|||
145649903|NCT05082909|525236613|FG005|Overall Study|Protocol Violation|0|||
145649904|NCT04088630|525236614|FG000|Overall Study|Lost to Follow-up|3|||
145649905|NCT04088630|525236615|FG001|Overall Study|Lost to Follow-up|2|||
145649906|NCT04088630|525236616|FG002|Overall Study|Lost to Follow-up|6|||
145649907|NCT04088630|525236614|FG000|Overall Study|Death|3|||
145649908|NCT04088630|525236615|FG001|Overall Study|Death|1|||
145649909|NCT04088630|525236616|FG002|Overall Study|Death|1|||
145649910|NCT04088630|525236614|FG000|Overall Study|Physician Decision|0|||
145649911|NCT04088630|525236615|FG001|Overall Study|Physician Decision|1|||
145649912|NCT04088630|525236616|FG002|Overall Study|Physician Decision|1|||
145649913|NCT03175029|525236617|FG000|Overall Study|Withdrawal by Subject|2|||
145649914|NCT03175029|525236618|FG001|Overall Study|Withdrawal by Subject|1|||
145649915|NCT03175029|525236617|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
145649916|NCT03175029|525236618|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
145649917|NCT02954341|525236619|FG000|Overall Study|Attempted Implant unsuccessful|5|||
145649918|NCT02954341|525236619|FG000|Overall Study|Death|90|||
145649919|NCT02954341|525236619|FG000|Overall Study|Withdrawal by Subject|4|||
145649920|NCT02954341|525236619|FG000|Overall Study|Physician Decision|13|||
145649921|NCT02954341|525236619|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
145649922|NCT02954341|525236619|FG000|Overall Study|Not implanted due to physician's decision|1|||
145649923|NCT02954341|525236619|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
145649924|NCT05862870|525236626|FG000|Overall Study|Lost to Follow-up|3|||
145649925|NCT04321031|525236627|FG000|Overall Study|Adverse Event|0|||
145649926|NCT04321031|525236628|FG001|Overall Study|Adverse Event|2|||
145649927|NCT04321031|525236629|FG002|Overall Study|Adverse Event|2|||
145649928|NCT04321031|525236630|FG003|Overall Study|Adverse Event|2|||
145649929|NCT04321031|525236631|FG004|Overall Study|Adverse Event|2|||
145649930|NCT04321031|525236632|FG005|Overall Study|Adverse Event|2|||
145649931|NCT04321031|525236633|FG006|Overall Study|Adverse Event|0|||
145649932|NCT04321031|525236627|FG000|Overall Study|Lost to Follow-up|0|||
145649933|NCT04321031|525236628|FG001|Overall Study|Lost to Follow-up|0|||
145649934|NCT04321031|525236629|FG002|Overall Study|Lost to Follow-up|0|||
145649935|NCT04321031|525236630|FG003|Overall Study|Lost to Follow-up|1|||
145649936|NCT04321031|525236631|FG004|Overall Study|Lost to Follow-up|0|||
145649937|NCT04321031|525236632|FG005|Overall Study|Lost to Follow-up|2|||
145649938|NCT04321031|525236633|FG006|Overall Study|Lost to Follow-up|1|||
145649939|NCT04321031|525236627|FG000|Overall Study|Withdrawal by Subject|2|||
145649940|NCT04321031|525236628|FG001|Overall Study|Withdrawal by Subject|2|||
145649941|NCT04321031|525236629|FG002|Overall Study|Withdrawal by Subject|1|||
145649942|NCT04321031|525236630|FG003|Overall Study|Withdrawal by Subject|3|||
145649943|NCT04321031|525236631|FG004|Overall Study|Withdrawal by Subject|1|||
145649944|NCT04321031|525236632|FG005|Overall Study|Withdrawal by Subject|0|||
145649945|NCT04321031|525236633|FG006|Overall Study|Withdrawal by Subject|1|||
145649946|NCT04321031|525236627|FG000|Overall Study|Non-compliance with study drug|0|||
145649947|NCT04321031|525236628|FG001|Overall Study|Non-compliance with study drug|0|||
145649948|NCT04321031|525236629|FG002|Overall Study|Non-compliance with study drug|0|||
145649949|NCT04321031|525236630|FG003|Overall Study|Non-compliance with study drug|0|||
145649950|NCT04321031|525236631|FG004|Overall Study|Non-compliance with study drug|0|||
145649951|NCT04321031|525236632|FG005|Overall Study|Non-compliance with study drug|1|||
145649952|NCT04321031|525236633|FG006|Overall Study|Non-compliance with study drug|0|||
145649953|NCT04321031|525236627|FG000|Overall Study|Other|0|||
145649954|NCT04321031|525236628|FG001|Overall Study|Other|0|||
145649955|NCT04321031|525236629|FG002|Overall Study|Other|0|||
145649956|NCT04321031|525236630|FG003|Overall Study|Other|1|||
145649957|NCT04321031|525236631|FG004|Overall Study|Other|0|||
145649958|NCT04321031|525236632|FG005|Overall Study|Other|0|||
145649959|NCT04321031|525236633|FG006|Overall Study|Other|0|||
145649960|NCT04237298|525236636|FG000|Overall Study|Lost to Follow-up|4|||
145649961|NCT04237298|525236637|FG001|Overall Study|Lost to Follow-up|5|||
145649962|NCT02530671|525236638|FG000|Overall Study|Lost to Follow-up|2|||
145649963|NCT02530671|525236639|FG001|Overall Study|Lost to Follow-up|0|||
145649964|NCT02530671|525236638|FG000|Overall Study|Withdrawal by Subject|1|||
145649965|NCT02530671|525236639|FG001|Overall Study|Withdrawal by Subject|0|||
145649966|NCT01566695|525236648|FG000|Overall Study|Lack of Efficacy|1|||
145649967|NCT01566695|525236649|FG001|Overall Study|Lack of Efficacy|0|||
145649968|NCT01566695|525236648|FG000|Overall Study|Adverse Event|3|||
145649969|NCT01566695|525236649|FG001|Overall Study|Adverse Event|0|||
145649970|NCT01566695|525236648|FG000|Overall Study|Death|79|||
145649971|NCT01566695|525236649|FG001|Overall Study|Death|86|||
145649972|NCT01566695|525236648|FG000|Overall Study|Withdrawal by Subject|13|||
145649973|NCT01566695|525236649|FG001|Overall Study|Withdrawal by Subject|12|||
145649974|NCT01566695|525236648|FG000|Overall Study|Lost to Follow-up|0|||
145649975|NCT01566695|525236649|FG001|Overall Study|Lost to Follow-up|3|||
145649976|NCT01566695|525236648|FG000|Overall Study|Other reasons|11|||
145649977|NCT01566695|525236649|FG001|Overall Study|Other reasons|8|||
145649978|NCT04812535|525236656|FG000|Overall Study|Withdrawal by Subject|0|||
145649979|NCT04812535|525236657|FG001|Overall Study|Withdrawal by Subject|0|||
145649980|NCT04812535|525236658|FG002|Overall Study|Withdrawal by Subject|0|||
145649981|NCT04812535|525236659|FG003|Overall Study|Withdrawal by Subject|1|||
145649982|NCT04812535|525236656|FG000|Overall Study|Death|7|||
145649983|NCT04812535|525236657|FG001|Overall Study|Death|2|||
145649984|NCT04812535|525236658|FG002|Overall Study|Death|4|||
145649985|NCT04812535|525236659|FG003|Overall Study|Death|1|||
145649986|NCT04812535|525236656|FG000|Overall Study|Due to premature study termination by sponsor|2|||
145649987|NCT04812535|525236657|FG001|Overall Study|Due to premature study termination by sponsor|0|||
145649988|NCT04812535|525236658|FG002|Overall Study|Due to premature study termination by sponsor|1|||
145649989|NCT04812535|525236659|FG003|Overall Study|Due to premature study termination by sponsor|3|||
145649990|NCT03436745|525236660|FG000|Overall Study|Ineligible|0|||
145649991|NCT03436745|525236661|FG001|Overall Study|Ineligible|0|||
145649992|NCT03436745|525236662|FG002|Overall Study|Ineligible|1|||
145649993|NCT04588298|525236665|FG000|Overall Study|Adverse Event|0|||
145649994|NCT04588298|525236666|FG001|Overall Study|Adverse Event|0|||
145649995|NCT04588298|525236667|FG002|Overall Study|Adverse Event|1|||
145649996|NCT04588298|525236668|FG003|Overall Study|Adverse Event|0|||
145649997|NCT04588298|525236669|FG004|Overall Study|Adverse Event|2|||
145649998|NCT04588298|525236665|FG000|Overall Study|Withdrawal by Subject|1|||
145649999|NCT04588298|525236666|FG001|Overall Study|Withdrawal by Subject|0|||
145650000|NCT04588298|525236667|FG002|Overall Study|Withdrawal by Subject|0|||
145650001|NCT04588298|525236668|FG003|Overall Study|Withdrawal by Subject|1|||
145650002|NCT04588298|525236669|FG004|Overall Study|Withdrawal by Subject|0|||
145650003|NCT03846505|525236670|FG000|Treatment Phase|Withdrawal by Subject|9|||
145650004|NCT03846505|525236671|FG001|Treatment Phase|Withdrawal by Subject|11|||
145650005|NCT03846505|525236670|FG000|Treatment Phase|Lost to Follow-up|6|||
145650006|NCT03846505|525236671|FG001|Treatment Phase|Lost to Follow-up|2|||
145650007|NCT03846505|525236670|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
145650008|NCT03846505|525236671|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
145650009|NCT03846505|525236670|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
145650010|NCT03846505|525236671|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
145650011|NCT05592418|525236672|FG000|Overall Study|Adverse Event|1|||
145650012|NCT05592418|525236673|FG001|Overall Study|Adverse Event|0|||
145650013|NCT05592418|525236672|FG000|Overall Study|Lost to Follow-up|1|||
145650014|NCT05592418|525236673|FG001|Overall Study|Lost to Follow-up|3|||
145650015|NCT05592418|525236672|FG000|Overall Study|Withdrawal by Subject|2|||
145650016|NCT05592418|525236673|FG001|Overall Study|Withdrawal by Subject|7|||
145650017|NCT03665597|525236674|FG000|Period 1|Adverse Event|1|||
145650018|NCT03665597|525236675|FG001|Period 1|Adverse Event|0|||
145650019|NCT03665597|525236676|FG002|Period 1|Adverse Event|0|||
145650020|NCT03665597|525236677|FG003|Period 1|Adverse Event|1|||
145650021|NCT03665597|525236678|FG004|Period 1|Adverse Event|0|||
145650022|NCT03665597|525236679|FG005|Period 1|Adverse Event|0|||
145650023|NCT03665597|525236680|FG006|Period 1|Adverse Event|0|||
145650024|NCT03665597|525236674|FG000|Period 1|Screen Failure|0|||
145650025|NCT03665597|525236675|FG001|Period 1|Screen Failure|0|||
145650026|NCT03665597|525236676|FG002|Period 1|Screen Failure|0|||
145650027|NCT03665597|525236677|FG003|Period 1|Screen Failure|1|||
145650028|NCT03665597|525236678|FG004|Period 1|Screen Failure|0|||
145650029|NCT03665597|525236679|FG005|Period 1|Screen Failure|0|||
145650030|NCT03665597|525236680|FG006|Period 1|Screen Failure|0|||
145650031|NCT03665597|525236674|FG000|Period 1|Death|0|||
145650032|NCT03665597|525236675|FG001|Period 1|Death|0|||
145650033|NCT03665597|525236676|FG002|Period 1|Death|0|||
145650034|NCT03665597|525236677|FG003|Period 1|Death|0|||
145650035|NCT03665597|525236678|FG004|Period 1|Death|0|||
145650036|NCT03665597|525236679|FG005|Period 1|Death|0|||
145650037|NCT03665597|525236680|FG006|Period 1|Death|45|||
145650038|NCT03665597|525236674|FG000|Period 1|Withdrawal by Subject|0|||
145650039|NCT03665597|525236675|FG001|Period 1|Withdrawal by Subject|0|||
145650040|NCT03665597|525236676|FG002|Period 1|Withdrawal by Subject|0|||
145650041|NCT03665597|525236677|FG003|Period 1|Withdrawal by Subject|0|||
145488704|NCT00721396|524644297|FG002|Overall Study|Lost to Follow-up|3|||
145488705|NCT00721396|524644298|FG003|Overall Study|Lost to Follow-up|3|||
145650042|NCT03665597|525236678|FG004|Period 1|Withdrawal by Subject|0|||
145650043|NCT03665597|525236679|FG005|Period 1|Withdrawal by Subject|0|||
145488706|NCT00721396|524644295|FG000|Overall Study|Protocol Violation|4|||
145488707|NCT00721396|524644296|FG001|Overall Study|Protocol Violation|3|||
145488708|NCT00721396|524644297|FG002|Overall Study|Protocol Violation|1|||
145488709|NCT00721396|524644298|FG003|Overall Study|Protocol Violation|0|||
145650044|NCT03665597|525236680|FG006|Period 1|Withdrawal by Subject|5|||
145650045|NCT03665597|525236674|FG000|Period 2|Adverse Event|0|||
145650046|NCT03665597|525236675|FG001|Period 2|Adverse Event|0|||
145650047|NCT03665597|525236676|FG002|Period 2|Adverse Event|0|||
145650048|NCT03665597|525236677|FG003|Period 2|Adverse Event|0|||
145650049|NCT03665597|525236678|FG004|Period 2|Adverse Event|0|||
145650050|NCT03665597|525236679|FG005|Period 2|Adverse Event|1|||
145650051|NCT03665597|525236680|FG006|Period 2|Adverse Event|0|||
145650052|NCT03665597|525236674|FG000|Period 3|Adverse Event|0|||
145650053|NCT03665597|525236675|FG001|Period 3|Adverse Event|1|||
145650054|NCT03665597|525236676|FG002|Period 3|Adverse Event|0|||
145650055|NCT03665597|525236677|FG003|Period 3|Adverse Event|0|||
145650056|NCT03665597|525236678|FG004|Period 3|Adverse Event|0|||
145650057|NCT03665597|525236679|FG005|Period 3|Adverse Event|0|||
145650058|NCT03665597|525236680|FG006|Period 3|Adverse Event|0|||
145650059|NCT03665597|525236674|FG000|Period 3|Death|0|||
145650060|NCT03665597|525236675|FG001|Period 3|Death|0|||
145650061|NCT03665597|525236676|FG002|Period 3|Death|0|||
145650062|NCT03665597|525236677|FG003|Period 3|Death|0|||
145650063|NCT03665597|525236678|FG004|Period 3|Death|1|||
145650064|NCT03665597|525236679|FG005|Period 3|Death|0|||
145650065|NCT03665597|525236680|FG006|Period 3|Death|0|||
145650066|NCT03665597|525236674|FG000|Period 4|Adverse Event|2|||
145650067|NCT03665597|525236675|FG001|Period 4|Adverse Event|2|||
145650068|NCT03665597|525236676|FG002|Period 4|Adverse Event|2|||
145650069|NCT03665597|525236677|FG003|Period 4|Adverse Event|2|||
145650070|NCT03665597|525236678|FG004|Period 4|Adverse Event|1|||
145650071|NCT03665597|525236679|FG005|Period 4|Adverse Event|0|||
145650072|NCT03665597|525236680|FG006|Period 4|Adverse Event|0|||
145650073|NCT03665597|525236674|FG000|Period 4|Death|0|||
145650074|NCT03665597|525236675|FG001|Period 4|Death|0|||
145650075|NCT03665597|525236676|FG002|Period 4|Death|2|||
145650076|NCT03665597|525236677|FG003|Period 4|Death|0|||
145650077|NCT03665597|525236678|FG004|Period 4|Death|0|||
145650078|NCT03665597|525236679|FG005|Period 4|Death|0|||
145650079|NCT03665597|525236680|FG006|Period 4|Death|0|||
145650080|NCT03665597|525236674|FG000|Period 4|Physician Decision|1|||
145650081|NCT03665597|525236675|FG001|Period 4|Physician Decision|2|||
145650082|NCT03665597|525236676|FG002|Period 4|Physician Decision|0|||
145650083|NCT03665597|525236677|FG003|Period 4|Physician Decision|0|||
145650084|NCT03665597|525236678|FG004|Period 4|Physician Decision|0|||
145650085|NCT03665597|525236679|FG005|Period 4|Physician Decision|0|||
145650086|NCT03665597|525236680|FG006|Period 4|Physician Decision|0|||
145650087|NCT04831216|525236681|FG000|Overall Study|Lost to Follow-up|32|||
145650088|NCT04410042|525236682|FG000|Overall Study|Not Eligible|1|||
145650089|NCT04410042|525236683|FG001|Overall Study|Not Eligible|1|||
145650090|NCT02187003|525238970|FG000|Overall Study|Adverse Event|2|||
145650091|NCT02187003|525238971|FG001|Overall Study|Adverse Event|0|||
145650092|NCT02187003|525238970|FG000|Overall Study|Lost to Follow-up|14|||
145650093|NCT02187003|525238971|FG001|Overall Study|Lost to Follow-up|10|||
145650094|NCT02187003|525238970|FG000|Overall Study|Withdrawal by Subject|3|||
145650095|NCT02187003|525238971|FG001|Overall Study|Withdrawal by Subject|7|||
145650096|NCT02187003|525238970|FG000|Overall Study|Protocol Violation|2|||
145650097|NCT02187003|525238971|FG001|Overall Study|Protocol Violation|4|||
145650098|NCT02187003|525238970|FG000|Overall Study|Other|5|||
145650099|NCT02187003|525238971|FG001|Overall Study|Other|5|||
145650100|NCT02187003|525238970|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145650101|NCT02187003|525238971|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
145650102|NCT01331005|525238975|FG000|Overall Study|Lost to Follow-up|2|||
145650103|NCT01331005|525238976|FG001|Overall Study|Lost to Follow-up|1|||
145650104|NCT01331005|525238975|FG000|Overall Study|Withdrawal by Subject|2|||
145650105|NCT01331005|525238976|FG001|Overall Study|Withdrawal by Subject|3|||
145650106|NCT03016169|525238977|FG000|Overall Study|Lost to Follow-up|4|||
145650107|NCT03016169|525238977|FG000|Overall Study|Death|54|||
145650108|NCT03016169|525238977|FG000|Overall Study|Device Explant|11|||
145650109|NCT03016169|525238977|FG000|Overall Study|Withdrawal by Subject|19|||
145650110|NCT03016169|525238977|FG000|Overall Study|Other Reasons|1|||
145650111|NCT02927769|525238984|FG000|Induction Phase|Study drug toxicity|1|||
145650112|NCT02927769|525238985|FG001|Induction Phase|Study drug toxicity|1|||
145650113|NCT02927769|525238984|FG000|Induction Phase|Disease progression|0|||
145650114|NCT02927769|525238985|FG001|Induction Phase|Disease progression|1|||
145488710|NCT00721396|524644295|FG000|Overall Study|Inappropriate enrollment|0|||
145650115|NCT02927769|525238984|FG000|Intensification Phase|Study drug toxicity|1|||
145650116|NCT02927769|525238985|FG001|Intensification Phase|Study drug toxicity|0|||
145650117|NCT02807636|525238988|FG000|Overall Study|Lost to Follow-up|10|||
145650118|NCT02807636|525238989|FG001|Overall Study|Lost to Follow-up|13|||
145650119|NCT02807636|525238990|FG002|Overall Study|Lost to Follow-up|6|||
145650120|NCT02807636|525238988|FG000|Overall Study|Protocol Deviation|1|||
145650121|NCT02807636|525238989|FG001|Overall Study|Protocol Deviation|0|||
145650122|NCT02807636|525238990|FG002|Overall Study|Protocol Deviation|0|||
145650123|NCT02807636|525238988|FG000|Overall Study|Symptomatic Deterioration|0|||
145650124|NCT02807636|525238989|FG001|Overall Study|Symptomatic Deterioration|1|||
145650125|NCT02807636|525238990|FG002|Overall Study|Symptomatic Deterioration|0|||
145650126|NCT02807636|525238988|FG000|Overall Study|Withdrawal by Subject|39|||
145650127|NCT02807636|525238989|FG001|Overall Study|Withdrawal by Subject|28|||
145650128|NCT02807636|525238990|FG002|Overall Study|Withdrawal by Subject|24|||
145650129|NCT02807636|525238988|FG000|Overall Study|Death|303|||
145650130|NCT02807636|525238989|FG001|Overall Study|Death|332|||
145650131|NCT02807636|525238990|FG002|Overall Study|Death|272|||
145650132|NCT02807636|525238988|FG000|Overall Study|Study Terminated By Sponsor|47|||
145650133|NCT02807636|525238989|FG001|Overall Study|Study Terminated By Sponsor|76|||
145650134|NCT02807636|525238990|FG002|Overall Study|Study Terminated By Sponsor|60|||
145650135|NCT02807636|525238988|FG000|Overall Study|Physician Decision|0|||
145650136|NCT02807636|525238989|FG001|Overall Study|Physician Decision|1|||
145650137|NCT02807636|525238990|FG002|Overall Study|Physician Decision|0|||
145650138|NCT05227209|525238994|FG000|Overall Study|Adverse Event|11|||
145650139|NCT05227209|525238994|FG000|Overall Study|Lost to Follow-up|1|||
145650140|NCT05227209|525238994|FG000|Overall Study|Withdrawal by Subject|7|||
145650141|NCT05227209|525238994|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
145650142|NCT05633953|525238995|FG000|Overall Study|Adverse Event|7|||
145650143|NCT05633953|525238995|FG000|Overall Study|Death|30|||
145650144|NCT05633953|525238995|FG000|Overall Study|Lost to Follow-up|1|||
145650145|NCT05633953|525238995|FG000|Overall Study|Osilodrostat discontinued|4|||
145650146|NCT05633953|525238995|FG000|Overall Study|Physician Decision|1|||
145650147|NCT05633953|525238995|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
145650148|NCT05633953|525238995|FG000|Overall Study|Progressive disease|2|||
145650149|NCT02729311|525238996|FG000|Overall Study|Withdrawal by Subject|8|||
145650150|NCT02729311|525238997|FG001|Overall Study|Withdrawal by Subject|2|||
145650151|NCT05324124|525238998|FG000|Period 1|Withdrawal by Subject|1|||
145650152|NCT05324124|525238999|FG001|Period 1|Withdrawal by Subject|0|||
145650153|NCT05324124|525238998|FG000|Period 1|Physician Decision|0|||
145650154|NCT05324124|525238999|FG001|Period 1|Physician Decision|1|||
145650155|NCT04034251|525239000|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
145650156|NCT04034251|525239001|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
145650157|NCT04034251|525239002|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
145650158|NCT02287610|525239003|FG000|Overall Study|Lost to Follow-up|3|||
145650159|NCT02287610|525239003|FG000|Overall Study|Withdrawal by Subject|8|||
145650160|NCT02287610|525239003|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
145650161|NCT04950660|525239004|FG000|Overall Study|Protocol Violation|4|||
145650162|NCT04950660|525239005|FG001|Overall Study|Protocol Violation|2|||
145650163|NCT04950660|525239004|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
145650164|NCT04950660|525239005|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
145650165|NCT04950660|525239004|FG000|Overall Study|Withdrawal by Subject|0|||
145650166|NCT04950660|525239005|FG001|Overall Study|Withdrawal by Subject|1|||
145650167|NCT04950660|525239004|FG000|Overall Study|Hypotension|1|||
145650168|NCT04950660|525239005|FG001|Overall Study|Hypotension|0|||
145650169|NCT04783935|525239012|FG000|Overall Study|Withdrawal by Subject|6|||
145650170|NCT04783935|525239012|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
145650171|NCT04783935|525239012|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
145650172|NCT04783935|525239012|FG000|Overall Study|Lost to Follow-up|3|||
145650173|NCT04783935|525239012|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
145650174|NCT02437318|525239014|FG000|Overall Study|Progressive disease|207|||
145650175|NCT02437318|525239015|FG001|Overall Study|Progressive disease|240|||
145650176|NCT02437318|525239014|FG000|Overall Study|Subject/guardian decision|24|||
145650177|NCT02437318|525239015|FG001|Overall Study|Subject/guardian decision|11|||
145650178|NCT02437318|525239014|FG000|Overall Study|Physician Decision|29|||
145650179|NCT02437318|525239015|FG001|Overall Study|Physician Decision|22|||
145650180|NCT02437318|525239014|FG000|Overall Study|Adverse Event|14|||
145650181|NCT02437318|525239015|FG001|Overall Study|Adverse Event|4|||
145650182|NCT02437318|525239014|FG000|Overall Study|Death|4|||
145650183|NCT02437318|525239015|FG001|Overall Study|Death|4|||
145650184|NCT02437318|525239014|FG000|Overall Study|Protocol deviation|5|||
145650185|NCT02437318|525239015|FG001|Overall Study|Protocol deviation|7|||
145650186|NCT02437318|525239014|FG000|Overall Study|Sponsor decision|1|||
145650187|NCT02437318|525239015|FG001|Overall Study|Sponsor decision|0|||
145650188|NCT00512070|525239022|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
145650189|NCT00512070|525239023|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
145650190|NCT00512070|525239024|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
145650191|NCT00512070|525239022|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
145650192|NCT00512070|525239023|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
145650193|NCT00512070|525239024|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
145650194|NCT00961571|525239025|FG000|Overall Study|Physician Decision|39|||
145650195|NCT05524233|525239026|FG000|Overall Study|Lost to Follow-up|2|||
145650196|NCT05524233|525239026|FG000|Overall Study|Adverse Event|2|||
145650197|NCT05524233|525239026|FG000|Overall Study|Withdrawal by Subject|1|||
145650198|NCT05337748|525239028|FG000|Overall Study|Withdrawal by Subject|1|||
145650199|NCT05337748|525239029|FG001|Overall Study|Withdrawal by Subject|0|||
145650200|NCT05337748|525239028|FG000|Overall Study|Death|1|||
145650201|NCT05337748|525239029|FG001|Overall Study|Death|0|||
145650202|NCT02506959|525239030|FG000|Overall Study|Physician Decision|2|||
145650203|NCT02506959|525239031|FG001|Overall Study|Physician Decision|1|||
145650204|NCT03453619|525239037|FG000|Core Study (Part A)|Physician Decision|0|||
145650205|NCT03453619|525239038|FG001|Core Study (Part A)|Physician Decision|0|||
145650206|NCT03453619|525239039|FG002|Core Study (Part A)|Physician Decision|2|||
145650207|NCT03453619|525239040|FG003|Core Study (Part A)|Physician Decision|0|||
145650208|NCT03453619|525239037|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
145488711|NCT00721396|524644296|FG001|Overall Study|Inappropriate enrollment|2|||
145650209|NCT03453619|525239038|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
145650210|NCT03453619|525239039|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
145650211|NCT03453619|525239040|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
145650212|NCT03453619|525239037|FG000|Core Study (Part A)|Other|0|||
145650213|NCT03453619|525239038|FG001|Core Study (Part A)|Other|1|||
145650214|NCT03453619|525239039|FG002|Core Study (Part A)|Other|0|||
145650215|NCT03453619|525239040|FG003|Core Study (Part A)|Other|0|||
145650216|NCT03453619|525239037|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
145650217|NCT03453619|525239038|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
145650218|NCT03453619|525239039|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
145650219|NCT03453619|525239040|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
145650220|NCT03453619|525239037|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
145650221|NCT03453619|525239038|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
145650222|NCT03453619|525239039|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
145650223|NCT03453619|525239040|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
145650224|NCT03453619|525239037|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
145650225|NCT03453619|525239038|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
145650226|NCT03453619|525239039|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
145650227|NCT03453619|525239040|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
145650228|NCT03453619|525239037|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
145650229|NCT03453619|525239038|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
145650230|NCT03453619|525239039|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
145650231|NCT03453619|525239040|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
145650232|NCT03143153|525239041|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
145650233|NCT03143153|525239042|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
145650234|NCT03143153|525239043|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
145650235|NCT03143153|525239041|FG000|Pre-Treatment|Participant withdrew consent|0|||
145650236|NCT03143153|525239042|FG001|Pre-Treatment|Participant withdrew consent|1|||
145650237|NCT03143153|525239043|FG002|Pre-Treatment|Participant withdrew consent|12|||
145650238|NCT03143153|525239041|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
145650239|NCT03143153|525239042|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
145650240|NCT03143153|525239043|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
145650241|NCT03143153|525239041|FG000|Pre-Treatment|Other Reasons|1|||
145650242|NCT03143153|525239042|FG001|Pre-Treatment|Other Reasons|2|||
145650243|NCT03143153|525239043|FG002|Pre-Treatment|Other Reasons|1|||
145650244|NCT03143153|525239041|FG000|Pre-Treatment|Disease Progression|1|||
145650245|NCT03143153|525239042|FG001|Pre-Treatment|Disease Progression|1|||
145650246|NCT03143153|525239043|FG002|Pre-Treatment|Disease Progression|2|||
145650247|NCT03143153|525239041|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
145650248|NCT03143153|525239042|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
145650249|NCT03143153|525239043|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
145650250|NCT03143153|525239041|FG000|Treatment|Disease progression|174|||
145650251|NCT03143153|525239042|FG001|Treatment|Disease progression|184|||
145650252|NCT03143153|525239043|FG002|Treatment|Disease progression|193|||
145650253|NCT03143153|525239041|FG000|Treatment|Study drug toxicity|59|||
145650254|NCT03143153|525239042|FG001|Treatment|Study drug toxicity|33|||
145650255|NCT03143153|525239043|FG002|Treatment|Study drug toxicity|40|||
145650256|NCT03143153|525239041|FG000|Treatment|Death|5|||
145650257|NCT03143153|525239042|FG001|Treatment|Death|3|||
145650258|NCT03143153|525239043|FG002|Treatment|Death|4|||
145650259|NCT03143153|525239041|FG000|Treatment|Adverse event unrelated to study drug|19|||
145650260|NCT03143153|525239042|FG001|Treatment|Adverse event unrelated to study drug|28|||
145650261|NCT03143153|525239043|FG002|Treatment|Adverse event unrelated to study drug|12|||
145650262|NCT03143153|525239041|FG000|Treatment|Participant request to discontinue study treatment|13|||
145650263|NCT03143153|525239042|FG001|Treatment|Participant request to discontinue study treatment|15|||
145650264|NCT03143153|525239043|FG002|Treatment|Participant request to discontinue study treatment|20|||
145650265|NCT03143153|525239041|FG000|Treatment|Participant withdrew consent|3|||
145650266|NCT03143153|525239042|FG001|Treatment|Participant withdrew consent|4|||
145650267|NCT03143153|525239043|FG002|Treatment|Participant withdrew consent|12|||
145650268|NCT03143153|525239041|FG000|Treatment|Pregnancy|1|||
145650269|NCT03143153|525239042|FG001|Treatment|Pregnancy|0|||
145650270|NCT03143153|525239043|FG002|Treatment|Pregnancy|0|||
145650271|NCT03143153|525239041|FG000|Treatment|Maximum clinical benefit|1|||
145650272|NCT03143153|525239042|FG001|Treatment|Maximum clinical benefit|3|||
145650273|NCT03143153|525239043|FG002|Treatment|Maximum clinical benefit|4|||
145650274|NCT03143153|525239041|FG000|Treatment|Completed treatment as per Protocol|13|||
145650275|NCT03143153|525239042|FG001|Treatment|Completed treatment as per Protocol|8|||
145650276|NCT03143153|525239043|FG002|Treatment|Completed treatment as per Protocol|0|||
145650277|NCT03143153|525239041|FG000|Treatment|Other reasons|12|||
145650278|NCT03143153|525239042|FG001|Treatment|Other reasons|7|||
145650279|NCT03143153|525239043|FG002|Treatment|Other reasons|15|||
145650280|NCT03143153|525239041|FG000|Treatment|Not reported|1|||
145650281|NCT03143153|525239042|FG001|Treatment|Not reported|0|||
145650282|NCT03143153|525239043|FG002|Treatment|Not reported|0|||
145650283|NCT03126019|525239044|FG000|Overall Study|Death|5|||
145650284|NCT03126019|525239045|FG001|Overall Study|Death|27|||
145650285|NCT03126019|525239044|FG000|Overall Study|Lost to Follow-up|2|||
145650286|NCT03126019|525239045|FG001|Overall Study|Lost to Follow-up|4|||
145650287|NCT03126019|525239044|FG000|Overall Study|Withdrawal by Subject|1|||
145650288|NCT03126019|525239045|FG001|Overall Study|Withdrawal by Subject|9|||
145650289|NCT03126019|525239044|FG000|Overall Study|Physician Decision|1|||
145650290|NCT03126019|525239045|FG001|Overall Study|Physician Decision|0|||
145650291|NCT03126019|525239044|FG000|Overall Study|Transitioned to Rollover Study|0|||
145650292|NCT03126019|525239045|FG001|Overall Study|Transitioned to Rollover Study|11|||
145650293|NCT03126019|525239044|FG000|Overall Study|Did Not Return to Site for Care|0|||
145650294|NCT03126019|525239045|FG001|Overall Study|Did Not Return to Site for Care|1|||
145650295|NCT03126019|525239044|FG000|Overall Study|Site Closed|0|||
145650296|NCT03126019|525239045|FG001|Overall Study|Site Closed|1|||
145650297|NCT00170573|525239047|FG000|Overall Study|Violation of inclusion criteria|13|||
145650298|NCT04556656|525239048|FG000|Overall Study|Withdrawal by Subject|14|||
145650299|NCT04556656|525239049|FG001|Overall Study|Withdrawal by Subject|12|||
145650300|NCT04556656|525239048|FG000|Overall Study|Physician Decision|1|||
145650301|NCT04556656|525239049|FG001|Overall Study|Physician Decision|0|||
145650302|NCT04556656|525239048|FG000|Overall Study|Adverse Event|4|||
145650303|NCT04556656|525239049|FG001|Overall Study|Adverse Event|7|||
145650304|NCT04556656|525239048|FG000|Overall Study|Death|4|||
145650305|NCT04556656|525239049|FG001|Overall Study|Death|0|||
145650306|NCT04556656|525239048|FG000|Overall Study|Lost to Follow-up|3|||
145650307|NCT04556656|525239049|FG001|Overall Study|Lost to Follow-up|2|||
145650308|NCT04556656|525239048|FG000|Overall Study|Not further specified|2|||
145650309|NCT04556656|525239049|FG001|Overall Study|Not further specified|1|||
145650310|NCT04541706|525239050|FG000|Overall Study|Withdrawal by Subject|3|||
145650311|NCT04541706|525239050|FG000|Overall Study|Progressive disease|33|||
145650312|NCT04541706|525239050|FG000|Overall Study|Physician Decision|1|||
145650313|NCT04541706|525239050|FG000|Overall Study|Lost to Follow-up|2|||
145650314|NCT04541706|525239050|FG000|Overall Study|Death|5|||
145650315|NCT04541706|525239050|FG000|Overall Study|Adverse Event|1|||
145650316|NCT05563246|525239061|FG000|Overall Study|Withdrawal by Subject|1|||
145650317|NCT05563246|525239062|FG001|Overall Study|Withdrawal by Subject|2|||
145650318|NCT05563246|525239063|FG002|Overall Study|Withdrawal by Subject|0|||
145650319|NCT05563246|525239064|FG003|Overall Study|Withdrawal by Subject|0|||
145650320|NCT05563246|525239061|FG000|Overall Study|Protocol Deviation|0|||
145650321|NCT05563246|525239062|FG001|Overall Study|Protocol Deviation|1|||
145650322|NCT05563246|525239063|FG002|Overall Study|Protocol Deviation|0|||
145650323|NCT05563246|525239064|FG003|Overall Study|Protocol Deviation|0|||
145650324|NCT05563246|525239061|FG000|Overall Study|Physician Decision|0|||
145650325|NCT05563246|525239062|FG001|Overall Study|Physician Decision|1|||
145650326|NCT05563246|525239063|FG002|Overall Study|Physician Decision|0|||
145650327|NCT05563246|525239064|FG003|Overall Study|Physician Decision|0|||
145650328|NCT05563246|525239061|FG000|Overall Study|Adverse Event|0|||
145650329|NCT05563246|525239062|FG001|Overall Study|Adverse Event|0|||
145650330|NCT05563246|525239063|FG002|Overall Study|Adverse Event|2|||
145650331|NCT05563246|525239064|FG003|Overall Study|Adverse Event|0|||
145650332|NCT05563246|525239061|FG000|Overall Study|Lost to Follow-up|0|||
145650333|NCT05563246|525239062|FG001|Overall Study|Lost to Follow-up|0|||
145650334|NCT05563246|525239063|FG002|Overall Study|Lost to Follow-up|1|||
145650335|NCT05563246|525239064|FG003|Overall Study|Lost to Follow-up|0|||
145650336|NCT03763708|525239065|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
145650337|NCT03763708|525239066|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650338|NCT03763708|525239067|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650339|NCT03763708|525239068|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650340|NCT03763708|525239069|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650341|NCT03763708|525239070|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650342|NCT03763708|525239071|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650343|NCT03763708|525239072|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650344|NCT03763708|525239073|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
145650345|NCT03763708|525239065|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650346|NCT03763708|525239066|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650347|NCT03763708|525239067|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
145650348|NCT03763708|525239068|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650349|NCT03763708|525239069|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650350|NCT03763708|525239070|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650351|NCT03763708|525239071|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650352|NCT03763708|525239072|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650353|NCT03763708|525239073|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
145650354|NCT03763708|525239065|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650355|NCT03763708|525239066|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650356|NCT03763708|525239067|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650357|NCT03763708|525239068|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
145650358|NCT03763708|525239069|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650359|NCT03763708|525239070|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650360|NCT03763708|525239071|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650361|NCT03763708|525239072|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650362|NCT03763708|525239073|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
145650363|NCT03763708|525239065|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650364|NCT03763708|525239066|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650365|NCT03763708|525239067|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650366|NCT03763708|525239068|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650367|NCT03763708|525239069|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
145650368|NCT03763708|525239070|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650369|NCT03763708|525239071|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650370|NCT03763708|525239072|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650371|NCT03763708|525239073|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
145650372|NCT03763708|525239065|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650373|NCT03763708|525239066|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650374|NCT03763708|525239067|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650375|NCT03763708|525239068|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650376|NCT03763708|525239069|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650377|NCT03763708|525239070|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
145650378|NCT03763708|525239071|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650379|NCT03763708|525239072|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650380|NCT03763708|525239073|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
145650381|NCT03763708|525239065|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650382|NCT03763708|525239066|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650383|NCT03763708|525239067|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650384|NCT03763708|525239068|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650385|NCT03763708|525239069|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650386|NCT03763708|525239070|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650387|NCT03763708|525239071|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
145650388|NCT03763708|525239072|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650389|NCT03763708|525239073|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
145650390|NCT03763708|525239065|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
145650391|NCT03763708|525239066|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
145650392|NCT03763708|525239067|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
145650393|NCT03763708|525239068|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
145650394|NCT03763708|525239069|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
145650395|NCT03763708|525239070|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
145650396|NCT03763708|525239071|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
145650397|NCT03763708|525239072|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
145650398|NCT03763708|525239073|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
145650399|NCT03763708|525239065|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
145650400|NCT03763708|525239066|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
145650401|NCT03763708|525239067|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
145650402|NCT03763708|525239068|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
145650403|NCT03763708|525239069|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
145650404|NCT03763708|525239070|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
145650405|NCT03763708|525239071|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
145650406|NCT03763708|525239072|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
145650407|NCT03763708|525239073|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
145650408|NCT03763708|525239065|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
145650409|NCT03763708|525239066|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
145650410|NCT03763708|525239067|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
145650411|NCT03763708|525239068|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
145650412|NCT03763708|525239069|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
145650413|NCT03763708|525239070|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
145650414|NCT03763708|525239071|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
145650415|NCT03763708|525239072|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
145650416|NCT03763708|525239073|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
145650417|NCT05470400|525239074|FG000|Overall Study|Lost to Follow-up|0|||
145650418|NCT05470400|525239075|FG001|Overall Study|Lost to Follow-up|0|||
145650419|NCT05470400|525239076|FG002|Overall Study|Lost to Follow-up|0|||
145650420|NCT05470400|525239077|FG003|Overall Study|Lost to Follow-up|0|||
145650421|NCT05470400|525239078|FG004|Overall Study|Lost to Follow-up|0|||
145650422|NCT05470400|525239079|FG005|Overall Study|Lost to Follow-up|0|||
145650423|NCT05470400|525239080|FG006|Overall Study|Lost to Follow-up|0|||
145650424|NCT05470400|525239081|FG007|Overall Study|Lost to Follow-up|1|||
145650425|NCT05470400|525239074|FG000|Overall Study|Withdrawal by Subject|1|||
145650426|NCT05470400|525239075|FG001|Overall Study|Withdrawal by Subject|0|||
145650427|NCT05470400|525239076|FG002|Overall Study|Withdrawal by Subject|0|||
145650428|NCT05470400|525239077|FG003|Overall Study|Withdrawal by Subject|0|||
145650429|NCT05470400|525239078|FG004|Overall Study|Withdrawal by Subject|0|||
145650430|NCT05470400|525239079|FG005|Overall Study|Withdrawal by Subject|1|||
145650431|NCT05470400|525239080|FG006|Overall Study|Withdrawal by Subject|0|||
145650432|NCT05470400|525239081|FG007|Overall Study|Withdrawal by Subject|2|||
145650433|NCT04294225|525239088|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
145650434|NCT04294225|525239088|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
145650435|NCT04294225|525239088|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
145650436|NCT04294225|525239088|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
145650437|NCT04294225|525239088|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
145650438|NCT01809691|525239089|FG000|Overall Study|Currently on Treatment|192|||
145650439|NCT01809691|525239090|FG001|Overall Study|Currently on Treatment|100|||
145650440|NCT01809691|525239089|FG000|Overall Study|No Protocol Treatment|10|||
145650441|NCT01809691|525239090|FG001|Overall Study|No Protocol Treatment|11|||
145650442|NCT01809691|525239089|FG000|Overall Study|Adverse Event|80|||
145650443|NCT01809691|525239090|FG001|Overall Study|Adverse Event|21|||
145650444|NCT01809691|525239089|FG000|Overall Study|Disease Progression|226|||
145650445|NCT01809691|525239090|FG001|Overall Study|Disease Progression|372|||
145650446|NCT01809691|525239089|FG000|Overall Study|Death|26|||
145650447|NCT01809691|525239090|FG001|Overall Study|Death|13|||
145650448|NCT01809691|525239089|FG000|Overall Study|Participant Refusal|70|||
145650449|NCT01809691|525239090|FG001|Overall Study|Participant Refusal|72|||
145650450|NCT01809691|525239089|FG000|Overall Study|Other, Not Specified|34|||
145650451|NCT01809691|525239090|FG001|Overall Study|Other, Not Specified|52|||
145650452|NCT02281955|525239104|FG000|Overall Study|Death|1|||
145650453|NCT02783300|525239110|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650454|NCT02783300|525239111|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650455|NCT02783300|525239112|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650456|NCT02783300|525239113|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650457|NCT02783300|525239114|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650458|NCT02783300|525239115|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650459|NCT02783300|525239116|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
145650460|NCT02783300|525239117|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650461|NCT02783300|525239118|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650462|NCT02783300|525239119|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650463|NCT02783300|525239120|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650464|NCT02783300|525239121|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650465|NCT02783300|525239122|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650466|NCT02783300|525239123|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650467|NCT02783300|525239124|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650468|NCT02783300|525239125|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650469|NCT02783300|525239126|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650470|NCT02783300|525239127|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650471|NCT02783300|525239128|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650472|NCT02783300|525239129|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650473|NCT02783300|525239130|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650474|NCT02783300|525239131|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650475|NCT02783300|525239132|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650476|NCT02783300|525239133|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650477|NCT02783300|525239134|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650478|NCT02783300|525239135|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650479|NCT02783300|525239136|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
145650480|NCT02783300|525239110|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650481|NCT02783300|525239111|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650482|NCT02783300|525239112|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650483|NCT02783300|525239113|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
145650484|NCT02783300|525239114|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650485|NCT02783300|525239115|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650486|NCT02783300|525239116|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650487|NCT02783300|525239117|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650488|NCT02783300|525239118|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650489|NCT02783300|525239119|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650490|NCT02783300|525239120|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650491|NCT02783300|525239121|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650492|NCT02783300|525239122|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650493|NCT02783300|525239123|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650494|NCT02783300|525239124|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650495|NCT02783300|525239125|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650496|NCT02783300|525239126|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650497|NCT02783300|525239127|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650498|NCT02783300|525239128|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650499|NCT02783300|525239129|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145488712|NCT00721396|524644297|FG002|Overall Study|Inappropriate enrollment|0|||
145488713|NCT00721396|524644298|FG003|Overall Study|Inappropriate enrollment|0|||
145650500|NCT02783300|525239130|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650501|NCT02783300|525239131|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650502|NCT02783300|525239132|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650503|NCT02783300|525239133|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650504|NCT02783300|525239134|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650505|NCT02783300|525239135|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650506|NCT02783300|525239136|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
145650507|NCT02783300|525239110|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
145650508|NCT02783300|525239111|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
145650509|NCT02783300|525239112|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
145650510|NCT02783300|525239113|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
145650511|NCT02783300|525239114|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
145650512|NCT02783300|525239115|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
145650513|NCT02783300|525239116|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
145650514|NCT02783300|525239117|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
145650515|NCT02783300|525239118|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
145650516|NCT02783300|525239119|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
145650517|NCT02783300|525239120|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
145650518|NCT02783300|525239121|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
145650519|NCT02783300|525239122|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
145650520|NCT02783300|525239123|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
145650521|NCT02783300|525239124|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
145650522|NCT02783300|525239125|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
145650523|NCT02783300|525239126|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
145650524|NCT02783300|525239127|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
145650525|NCT02783300|525239128|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
145650526|NCT02783300|525239129|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
145650527|NCT02783300|525239130|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
145650528|NCT02783300|525239131|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
145650529|NCT02783300|525239132|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
145650530|NCT02783300|525239133|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
145650531|NCT02783300|525239134|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
145650532|NCT02783300|525239135|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
145650533|NCT02783300|525239136|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
145650534|NCT02783300|525239110|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650535|NCT02783300|525239111|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650536|NCT02783300|525239112|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650537|NCT02783300|525239113|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650538|NCT02783300|525239114|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650539|NCT02783300|525239115|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650540|NCT02783300|525239116|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
145650541|NCT02783300|525239117|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650542|NCT02783300|525239118|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650543|NCT02783300|525239119|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650544|NCT02783300|525239120|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650545|NCT02783300|525239121|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650546|NCT02783300|525239122|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
145650547|NCT02783300|525239123|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650548|NCT02783300|525239124|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650549|NCT02783300|525239125|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650550|NCT02783300|525239126|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650551|NCT02783300|525239127|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650552|NCT02783300|525239128|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650553|NCT02783300|525239129|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650554|NCT02783300|525239130|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650555|NCT02783300|525239131|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650556|NCT02783300|525239132|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650557|NCT02783300|525239133|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650558|NCT02783300|525239134|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650559|NCT02783300|525239135|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650560|NCT02783300|525239136|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
145650561|NCT02783300|525239110|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650562|NCT02783300|525239111|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650563|NCT02783300|525239112|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650564|NCT02783300|525239113|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145488714|NCT00721396|524644295|FG000|Overall Study|Administrative reason|3|||
145650565|NCT02783300|525239114|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
145650566|NCT02783300|525239115|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650567|NCT02783300|525239116|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
145650568|NCT02783300|525239117|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650569|NCT02783300|525239118|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650570|NCT02783300|525239119|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
145650571|NCT02783300|525239120|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650572|NCT02783300|525239121|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650573|NCT02783300|525239122|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
145650574|NCT02783300|525239123|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650575|NCT02783300|525239124|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650576|NCT02783300|525239125|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650577|NCT02783300|525239126|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650578|NCT02783300|525239127|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650579|NCT02783300|525239128|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650580|NCT02783300|525239129|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650581|NCT02783300|525239130|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650582|NCT02783300|525239131|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650583|NCT02783300|525239132|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650584|NCT02783300|525239133|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650585|NCT02783300|525239134|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650586|NCT02783300|525239135|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650587|NCT02783300|525239136|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
145650588|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650589|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145488715|NCT00721396|524644296|FG001|Overall Study|Administrative reason|0|||
145488716|NCT00721396|524644297|FG002|Overall Study|Administrative reason|1|||
145488717|NCT00721396|524644298|FG003|Overall Study|Administrative reason|0|||
145488718|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488719|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488720|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488721|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
145488722|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488723|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488724|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488725|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488726|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488727|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
145488728|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
145488729|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
145488730|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
145488731|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
145488732|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
145488733|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
145488734|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
145488735|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
145488736|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
145488737|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
145488738|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
145488739|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
145488740|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
145488741|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
145488742|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
145488743|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
145488744|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
145488745|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
145488746|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
145650590|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650591|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145488747|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
145488748|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
145488749|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488750|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
145488751|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488752|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
145488753|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
145488754|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488755|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488756|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488757|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
145488758|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
145488759|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145488760|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
145650592|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650593|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650594|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650595|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650596|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650597|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650598|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650599|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650600|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650601|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650602|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650603|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
145650604|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650605|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
145650606|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
145650607|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
145650608|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650609|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650610|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650611|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650612|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
145650613|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650614|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
145650615|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650616|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650617|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650618|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650619|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650620|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650621|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650622|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650623|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650624|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650625|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650626|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650627|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650628|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650629|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650630|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650631|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
145650632|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650633|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
145650634|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
145650635|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650636|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650637|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650638|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650639|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650640|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650641|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
145650642|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650643|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650644|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650645|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650646|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650647|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650648|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650649|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650650|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650651|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650652|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650653|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650654|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650655|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650656|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650657|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650658|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
145650659|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650660|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
145650661|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
145650662|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
145650663|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650664|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650665|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650666|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650667|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650668|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
145650669|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650670|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650671|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650672|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650673|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650674|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650675|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650676|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650677|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650678|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650679|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650680|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650681|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650682|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650683|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650684|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
145650685|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650686|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650687|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650688|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650689|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650690|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650691|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
145650692|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650693|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650694|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650695|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
145650696|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650697|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650698|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650699|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650700|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650701|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650702|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650703|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650704|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650705|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650706|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650707|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650708|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145488761|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145650709|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
145650710|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
145650711|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
145650712|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
145650713|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650714|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
145650715|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
145650716|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650717|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650718|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650719|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650720|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650721|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650722|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
145650723|NCT02783300|525239110|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650724|NCT02783300|525239111|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650725|NCT02783300|525239112|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650726|NCT02783300|525239113|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650727|NCT02783300|525239114|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650728|NCT02783300|525239115|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650729|NCT02783300|525239116|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650730|NCT02783300|525239117|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650731|NCT02783300|525239118|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650732|NCT02783300|525239119|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650733|NCT02783300|525239120|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650734|NCT02783300|525239121|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650735|NCT02783300|525239122|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650736|NCT02783300|525239123|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
145650737|NCT02783300|525239124|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
145650738|NCT02783300|525239125|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
145650739|NCT02783300|525239126|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
145650740|NCT02783300|525239127|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
145650741|NCT02783300|525239128|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
145650742|NCT02783300|525239129|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
145650743|NCT02783300|525239130|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
145650744|NCT02783300|525239131|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
145650745|NCT02783300|525239132|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
145650746|NCT02783300|525239133|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
145650747|NCT02783300|525239134|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
145650748|NCT02783300|525239135|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
145650749|NCT02783300|525239136|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
145650750|NCT02783300|525239110|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650751|NCT02783300|525239111|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650752|NCT02783300|525239112|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650753|NCT02783300|525239113|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650754|NCT02783300|525239114|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650755|NCT02783300|525239115|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650756|NCT02783300|525239116|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650757|NCT02783300|525239117|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650758|NCT02783300|525239118|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650759|NCT02783300|525239119|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650760|NCT02783300|525239120|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650761|NCT02783300|525239121|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650762|NCT02783300|525239122|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650763|NCT02783300|525239123|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650764|NCT02783300|525239124|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650765|NCT02783300|525239125|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650766|NCT02783300|525239126|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650767|NCT02783300|525239127|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650768|NCT02783300|525239128|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650769|NCT02783300|525239129|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650770|NCT02783300|525239130|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650771|NCT02783300|525239131|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650772|NCT02783300|525239132|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650773|NCT02783300|525239133|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650774|NCT02783300|525239134|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650775|NCT02783300|525239135|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
145650776|NCT02783300|525239136|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
145650777|NCT02783300|525239110|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650778|NCT02783300|525239111|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650779|NCT02783300|525239112|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650780|NCT02783300|525239113|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650781|NCT02783300|525239114|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650782|NCT02783300|525239115|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650783|NCT02783300|525239116|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650784|NCT02783300|525239117|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650785|NCT02783300|525239118|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650786|NCT02783300|525239119|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650787|NCT02783300|525239120|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650788|NCT02783300|525239121|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650789|NCT02783300|525239122|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650790|NCT02783300|525239123|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650791|NCT02783300|525239124|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650792|NCT02783300|525239125|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650793|NCT02783300|525239126|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650794|NCT02783300|525239127|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650795|NCT02783300|525239128|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650796|NCT02783300|525239129|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650797|NCT02783300|525239130|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650798|NCT02783300|525239131|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650799|NCT02783300|525239132|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650800|NCT02783300|525239133|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650801|NCT02783300|525239134|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650802|NCT02783300|525239135|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
145650803|NCT02783300|525239136|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
145650804|NCT03535272|525239137|FG000|Overall Study|Lost to Follow-up|71|||
145650805|NCT03535272|525239138|FG001|Overall Study|Lost to Follow-up|73|||
145650806|NCT02913872|525239145|FG000|Overall Study|Withdrawal by Subject|1|||
145650807|NCT03519581|525239148|FG000|Overall Study|Lost to Follow-up|3|||
145650808|NCT03519581|525239149|FG001|Overall Study|Lost to Follow-up|2|||
145650809|NCT03519581|525239148|FG000|Overall Study|Adverse Event|5|||
145650810|NCT03519581|525239149|FG001|Overall Study|Adverse Event|2|||
145650811|NCT03519581|525239148|FG000|Overall Study|Withdrawal by Subject|2|||
145650812|NCT03519581|525239149|FG001|Overall Study|Withdrawal by Subject|0|||
145650813|NCT03519581|525239148|FG000|Overall Study|Change to insurance|2|||
145650814|NCT03519581|525239149|FG001|Overall Study|Change to insurance|1|||
145650815|NCT03519581|525239148|FG000|Overall Study|Other|2|||
145650816|NCT03519581|525239149|FG001|Overall Study|Other|4|||
145650817|NCT03110315|525239150|FG000|Overall Study|Withdrawal by Subject|1|||
145650818|NCT03110315|525239151|FG001|Overall Study|Withdrawal by Subject|0|||
145650819|NCT05371652|525239156|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
145650820|NCT05371652|525239156|FG000|Overall Study|Withdrawal by Subject|12|||
145650821|NCT05371652|525239156|FG000|Overall Study|Adverse Event|1|||
145650822|NCT05371652|525239156|FG000|Overall Study|Other|11|||
145650823|NCT03978871|525239157|FG000|Overall Study|Lost to Follow-up|11|||
145650824|NCT03978871|525239158|FG001|Overall Study|Lost to Follow-up|12|||
145650825|NCT03131648|525240439|FG000|Initial Treatment Period|Not dosed|2|||
145650826|NCT03131648|525240440|FG001|Initial Treatment Period|Not dosed|2|||
145650827|NCT03131648|525240441|FG002|Initial Treatment Period|Not dosed|0|||
145650828|NCT03131648|525240442|FG003|Initial Treatment Period|Not dosed|0|||
145650829|NCT03131648|525240443|FG004|Initial Treatment Period|Not dosed|0|||
145650830|NCT03131648|525240444|FG005|Initial Treatment Period|Not dosed|0|||
145650831|NCT03131648|525240445|FG006|Initial Treatment Period|Not dosed|0|||
145650832|NCT03131648|525240446|FG007|Initial Treatment Period|Not dosed|0|||
145650833|NCT03131648|525240439|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
145650834|NCT03131648|525240440|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
145650835|NCT03131648|525240441|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650836|NCT03131648|525240442|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650837|NCT03131648|525240443|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650838|NCT03131648|525240444|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650839|NCT03131648|525240445|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650840|NCT03131648|525240446|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145650841|NCT03131648|525240439|FG000|Open-label Treatment|Discontinued IMP|0|||
145650842|NCT03131648|525240440|FG001|Open-label Treatment|Discontinued IMP|0|||
145650843|NCT03131648|525240441|FG002|Open-label Treatment|Discontinued IMP|0|||
145650844|NCT03131648|525240442|FG003|Open-label Treatment|Discontinued IMP|0|||
145650845|NCT03131648|525240443|FG004|Open-label Treatment|Discontinued IMP|0|||
145650846|NCT03131648|525240444|FG005|Open-label Treatment|Discontinued IMP|0|||
145650847|NCT03131648|525240445|FG006|Open-label Treatment|Discontinued IMP|112|||
145650848|NCT03131648|525240446|FG007|Open-label Treatment|Discontinued IMP|0|||
145650849|NCT03131648|525240439|FG000|Open-label Treatment|Completed Week 50|0|||
145650850|NCT03131648|525240440|FG001|Open-label Treatment|Completed Week 50|0|||
145650851|NCT03131648|525240441|FG002|Open-label Treatment|Completed Week 50|0|||
145650852|NCT03131648|525240442|FG003|Open-label Treatment|Completed Week 50|0|||
145650853|NCT03131648|525240443|FG004|Open-label Treatment|Completed Week 50|0|||
145650854|NCT03131648|525240444|FG005|Open-label Treatment|Completed Week 50|0|||
145650855|NCT03131648|525240445|FG006|Open-label Treatment|Completed Week 50|6|||
145650856|NCT03131648|525240446|FG007|Open-label Treatment|Completed Week 50|0|||
145650857|NCT03131648|525240439|FG000|Maintenance Treatment Period|Not dosed|0|||
145650858|NCT03131648|525240440|FG001|Maintenance Treatment Period|Not dosed|0|||
145650859|NCT03131648|525240441|FG002|Maintenance Treatment Period|Not dosed|3|||
145650860|NCT03131648|525240442|FG003|Maintenance Treatment Period|Not dosed|2|||
145650861|NCT03131648|525240443|FG004|Maintenance Treatment Period|Not dosed|1|||
145650862|NCT03131648|525240444|FG005|Maintenance Treatment Period|Not dosed|0|||
145650863|NCT03131648|525240445|FG006|Maintenance Treatment Period|Not dosed|0|||
145650864|NCT03131648|525240446|FG007|Maintenance Treatment Period|Not dosed|0|||
145650865|NCT03131648|525240439|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
145650866|NCT03131648|525240440|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
145650867|NCT03131648|525240441|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
145650868|NCT03131648|525240442|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
145650869|NCT03131648|525240443|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
145650870|NCT03131648|525240444|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
145650871|NCT03131648|525240445|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
145650872|NCT03131648|525240446|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
145650873|NCT03131648|525240439|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145650874|NCT03131648|525240440|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145650875|NCT03131648|525240441|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
145650876|NCT03131648|525240442|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
145650877|NCT03131648|525240443|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
145650878|NCT03131648|525240444|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
145650879|NCT03131648|525240445|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145650880|NCT03131648|525240446|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145650881|NCT03131648|525240439|FG000|Maintenance Treatment Period|Completed Week 50|0|||
145650882|NCT03131648|525240440|FG001|Maintenance Treatment Period|Completed Week 50|0|||
145650883|NCT03131648|525240441|FG002|Maintenance Treatment Period|Completed Week 50|0|||
145650884|NCT03131648|525240442|FG003|Maintenance Treatment Period|Completed Week 50|0|||
145650885|NCT03131648|525240443|FG004|Maintenance Treatment Period|Completed Week 50|1|||
145650886|NCT03131648|525240444|FG005|Maintenance Treatment Period|Completed Week 50|0|||
145650887|NCT03131648|525240445|FG006|Maintenance Treatment Period|Completed Week 50|0|||
145650888|NCT03131648|525240446|FG007|Maintenance Treatment Period|Completed Week 50|0|||
145650889|NCT03131648|525240439|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650890|NCT03131648|525240440|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650891|NCT03131648|525240441|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650892|NCT03131648|525240442|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650893|NCT03131648|525240443|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650894|NCT03131648|525240444|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650895|NCT03131648|525240445|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
145650896|NCT03131648|525240446|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
145650897|NCT04150718|525240448|FG000|Overall Study|Withdrawal by Subject|2|||
145650898|NCT04150718|525240449|FG001|Overall Study|Withdrawal by Subject|7|||
145650899|NCT04150718|525240450|FG002|Overall Study|Withdrawal by Subject|1|||
145650900|NCT04150718|525240448|FG000|Overall Study|Lost to Follow-up|1|||
145650901|NCT04150718|525240449|FG001|Overall Study|Lost to Follow-up|2|||
145488762|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
145488763|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145488764|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145650902|NCT04150718|525240450|FG002|Overall Study|Lost to Follow-up|0|||
145650903|NCT04150718|525240448|FG000|Overall Study|Ineligible|1|||
145650904|NCT04150718|525240449|FG001|Overall Study|Ineligible|0|||
145650905|NCT04150718|525240450|FG002|Overall Study|Ineligible|10|||
145650906|NCT05034952|525240451|FG000|Overall Study|Adverse Event|1|||
145650907|NCT05034952|525240452|FG001|Overall Study|Adverse Event|0|||
145650908|NCT05034952|525240453|FG002|Overall Study|Adverse Event|0|||
145488765|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145650909|NCT05034952|525240454|FG003|Overall Study|Adverse Event|0|||
145650910|NCT05034952|525240451|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
145650911|NCT05034952|525240452|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
145650912|NCT05034952|525240453|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
145650913|NCT05034952|525240454|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
145650914|NCT05034952|525240451|FG000|Overall Study|Lost to Follow-up|1|||
145650915|NCT05034952|525240452|FG001|Overall Study|Lost to Follow-up|4|||
145650916|NCT05034952|525240453|FG002|Overall Study|Lost to Follow-up|3|||
145650917|NCT05034952|525240454|FG003|Overall Study|Lost to Follow-up|3|||
145650918|NCT05034952|525240451|FG000|Overall Study|Other|0|||
145650919|NCT05034952|525240452|FG001|Overall Study|Other|0|||
145650920|NCT05034952|525240453|FG002|Overall Study|Other|0|||
145650921|NCT05034952|525240454|FG003|Overall Study|Other|1|||
145650922|NCT00920621|525240471|FG000|Overall Study|Lost to Follow-up|16|||
145650923|NCT00920621|525240472|FG001|Overall Study|Lost to Follow-up|17|||
145650924|NCT00920621|525240473|FG002|Overall Study|Lost to Follow-up|19|||
145650925|NCT00920621|525240474|FG003|Overall Study|Lost to Follow-up|21|||
145650926|NCT00920621|525240471|FG000|Overall Study|Fetal/neonatal deaths|16|||
145650927|NCT00920621|525240472|FG001|Overall Study|Fetal/neonatal deaths|14|||
145650928|NCT00920621|525240473|FG002|Overall Study|Fetal/neonatal deaths|16|||
145650929|NCT00920621|525240474|FG003|Overall Study|Fetal/neonatal deaths|14|||
145650930|NCT00920621|525240471|FG000|Overall Study|Blood sample not collected|22|||
145650931|NCT00920621|525240472|FG001|Overall Study|Blood sample not collected|14|||
145650932|NCT00920621|525240473|FG002|Overall Study|Blood sample not collected|0|||
145650933|NCT00920621|525240474|FG003|Overall Study|Blood sample not collected|0|||
145650934|NCT06074523|525240475|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
145650935|NCT06074523|525240475|FG000|Overall Study|Withdrawal by Subject|1|||
145650936|NCT01426425|525240476|FG000|Overall Study|Exited prior to EP study|22|||
145650937|NCT01426425|525240476|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
145650938|NCT01426425|525240476|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
145650939|NCT03281291|525240477|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
145650940|NCT03281291|525240478|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
145650941|NCT03281291|525240479|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
145650942|NCT03281291|525240480|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
145650943|NCT03281291|525240481|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
145650944|NCT03281291|525240477|FG000|Overall Study|Protocol Deviation|2|||
145650945|NCT03281291|525240478|FG001|Overall Study|Protocol Deviation|0|||
145650946|NCT03281291|525240479|FG002|Overall Study|Protocol Deviation|1|||
145650947|NCT03281291|525240480|FG003|Overall Study|Protocol Deviation|2|||
145650948|NCT03281291|525240481|FG004|Overall Study|Protocol Deviation|1|||
145650949|NCT03281291|525240477|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
145650950|NCT03281291|525240478|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
145650951|NCT03281291|525240479|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
145488766|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145488767|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
145488768|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
145488769|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145650952|NCT03281291|525240480|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
145650953|NCT03281291|525240481|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
145650954|NCT03281291|525240477|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
145650955|NCT03281291|525240478|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
145650956|NCT03281291|525240479|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
145650957|NCT03281291|525240480|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
145650958|NCT03281291|525240481|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
145650959|NCT03281291|525240477|FG000|Overall Study|Lost to Follow-up|10|||
145650960|NCT03281291|525240478|FG001|Overall Study|Lost to Follow-up|10|||
145650961|NCT03281291|525240479|FG002|Overall Study|Lost to Follow-up|4|||
145650962|NCT03281291|525240480|FG003|Overall Study|Lost to Follow-up|6|||
145650963|NCT03281291|525240481|FG004|Overall Study|Lost to Follow-up|10|||
145650964|NCT03281291|525240477|FG000|Overall Study|Other|0|||
145650965|NCT03281291|525240478|FG001|Overall Study|Other|2|||
145650966|NCT03281291|525240479|FG002|Overall Study|Other|0|||
145650967|NCT03281291|525240480|FG003|Overall Study|Other|2|||
145650968|NCT03281291|525240481|FG004|Overall Study|Other|1|||
145650969|NCT04956861|525240482|FG000|Overall Study|Withdrawal by Subject|4|||
145650970|NCT04956861|525240483|FG001|Overall Study|Withdrawal by Subject|4|||
145650971|NCT04956861|525240484|FG002|Overall Study|Withdrawal by Subject|2|||
145650972|NCT04956861|525240482|FG000|Overall Study|Physician Decision|4|||
145488770|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145650973|NCT04956861|525240483|FG001|Overall Study|Physician Decision|5|||
145650974|NCT04956861|525240484|FG002|Overall Study|Physician Decision|1|||
145650975|NCT02312557|525240488|FG000|Overall Study|Survival follow-up|4|||
145650976|NCT02736409|525240489|FG000|Overall Study|Withdrawal by Subject|4|||
145650977|NCT02736409|525240490|FG001|Overall Study|Withdrawal by Subject|2|||
145650978|NCT02736409|525240491|FG002|Overall Study|Withdrawal by Subject|17|||
145650979|NCT02736409|525240492|FG003|Overall Study|Withdrawal by Subject|3|||
145650980|NCT02736409|525240489|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145650981|NCT02736409|525240490|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145650982|NCT02736409|525240491|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145650983|NCT02736409|525240492|FG003|Overall Study|Non-Compliance with Study Drug|1|||
145650984|NCT02736409|525240489|FG000|Overall Study|Adverse Event|0|||
145650985|NCT02736409|525240490|FG001|Overall Study|Adverse Event|1|||
145650986|NCT02736409|525240491|FG002|Overall Study|Adverse Event|5|||
145650987|NCT02736409|525240492|FG003|Overall Study|Adverse Event|4|||
145650988|NCT02736409|525240489|FG000|Overall Study|Other|0|||
145650989|NCT02736409|525240490|FG001|Overall Study|Other|0|||
145650990|NCT02736409|525240491|FG002|Overall Study|Other|1|||
145650991|NCT02736409|525240492|FG003|Overall Study|Other|1|||
145650992|NCT02736409|525240489|FG000|Overall Study|Pregnancy|0|||
145650993|NCT02736409|525240490|FG001|Overall Study|Pregnancy|0|||
145650994|NCT02736409|525240491|FG002|Overall Study|Pregnancy|1|||
145650995|NCT02736409|525240492|FG003|Overall Study|Pregnancy|0|||
145650996|NCT02736409|525240489|FG000|Overall Study|Lost to Follow-up|0|||
145650997|NCT02736409|525240490|FG001|Overall Study|Lost to Follow-up|0|||
145650998|NCT02736409|525240491|FG002|Overall Study|Lost to Follow-up|2|||
145650999|NCT02736409|525240492|FG003|Overall Study|Lost to Follow-up|1|||
145651000|NCT02736409|525240489|FG000|Overall Study|Physician Decision|0|||
145651001|NCT02736409|525240490|FG001|Overall Study|Physician Decision|0|||
145651002|NCT02736409|525240491|FG002|Overall Study|Physician Decision|0|||
145651003|NCT02736409|525240492|FG003|Overall Study|Physician Decision|2|||
145651004|NCT04390048|525240493|FG000|Overall Study|Withdrawal by Subject|1|||
145651005|NCT04390048|525240494|FG001|Overall Study|Withdrawal by Subject|3|||
145651006|NCT01415154|525240495|FG000|Overall Study|Lack of Efficacy|4|||
145651007|NCT01415154|525240496|FG001|Overall Study|Lack of Efficacy|5|||
145651008|NCT01415154|525240495|FG000|Overall Study|Withdrawal by Subject|7|||
145651009|NCT01415154|525240496|FG001|Overall Study|Withdrawal by Subject|8|||
145651010|NCT01415154|525240495|FG000|Overall Study|Lost to Follow-up|1|||
145651011|NCT01415154|525240496|FG001|Overall Study|Lost to Follow-up|4|||
145651012|NCT01415154|525240495|FG000|Overall Study|Protocol Violation|0|||
145651013|NCT01415154|525240496|FG001|Overall Study|Protocol Violation|1|||
145651014|NCT01415154|525240495|FG000|Overall Study|Satisfactory Response|0|||
145651015|NCT01415154|525240496|FG001|Overall Study|Satisfactory Response|1|||
145651016|NCT01415154|525240495|FG000|Overall Study|Adverse Event|1|||
145651017|NCT01415154|525240496|FG001|Overall Study|Adverse Event|1|||
145651018|NCT06283173|525240527|FG000|Overall Study|Did not show for first visit|10|||
145651019|NCT06283173|525240527|FG000|Overall Study|Lost to Follow-up|12|||
145651020|NCT06283173|525240527|FG000|Overall Study|Physician Decision|7|||
145651021|NCT01416831|525240533|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
145651022|NCT01416831|525240534|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
145651023|NCT04784559|525240537|FG000|Overall Study|Withdrawal by Subject|3|||
145651024|NCT04784559|525240538|FG001|Overall Study|Withdrawal by Subject|2|||
145651025|NCT04784559|525240539|FG002|Overall Study|Withdrawal by Subject|1|||
145651026|NCT04784559|525240537|FG000|Overall Study|Death|2|||
145651027|NCT04784559|525240538|FG001|Overall Study|Death|1|||
145651028|NCT04784559|525240539|FG002|Overall Study|Death|2|||
145651029|NCT04784559|525240537|FG000|Overall Study|Lost to Follow-up|0|||
145651030|NCT04784559|525240538|FG001|Overall Study|Lost to Follow-up|0|||
145651031|NCT04784559|525240539|FG002|Overall Study|Lost to Follow-up|2|||
145651032|NCT04784559|525240537|FG000|Overall Study|Participant worsened, PI decision|1|||
145651033|NCT04784559|525240538|FG001|Overall Study|Participant worsened, PI decision|0|||
145651034|NCT04784559|525240539|FG002|Overall Study|Participant worsened, PI decision|0|||
145651035|NCT04784559|525240537|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
145651036|NCT04784559|525240538|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
145651037|NCT04784559|525240539|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
145651038|NCT04784559|525240537|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
145651039|NCT04784559|525240538|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
145651040|NCT04784559|525240539|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
145651041|NCT04784559|525240537|FG000|Overall Study|Did not meet all inclusion criteria|0|||
145651042|NCT04784559|525240538|FG001|Overall Study|Did not meet all inclusion criteria|1|||
145651043|NCT04784559|525240539|FG002|Overall Study|Did not meet all inclusion criteria|0|||
145651044|NCT04784559|525240537|FG000|Overall Study|The participant was transferred to IRCU|0|||
145651045|NCT04784559|525240538|FG001|Overall Study|The participant was transferred to IRCU|1|||
145651046|NCT04784559|525240539|FG002|Overall Study|The participant was transferred to IRCU|0|||
145651047|NCT04784559|525240537|FG000|Overall Study|SAE|0|||
145651048|NCT04784559|525240538|FG001|Overall Study|SAE|1|||
145651049|NCT04784559|525240539|FG002|Overall Study|SAE|0|||
145651050|NCT04784559|525240537|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
145651051|NCT04784559|525240538|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
145651052|NCT04784559|525240539|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
145651053|NCT03138512|525240541|FG000|Randomization|Participants withdrew consent|0|||
145651054|NCT03138512|525240542|FG001|Randomization|Participants withdrew consent|1|||
145651055|NCT03138512|525240543|FG002|Randomization|Participants withdrew consent|1|||
145651056|NCT03138512|525240544|FG003|Randomization|Participants withdrew consent|0|||
145651057|NCT03138512|525240545|FG004|Randomization|Participants withdrew consent|0|||
145651058|NCT03138512|525240541|FG000|Randomization|Participant no longer meets study criteria|0|||
145651059|NCT03138512|525240542|FG001|Randomization|Participant no longer meets study criteria|3|||
145651060|NCT03138512|525240543|FG002|Randomization|Participant no longer meets study criteria|1|||
145651061|NCT03138512|525240544|FG003|Randomization|Participant no longer meets study criteria|1|||
145651062|NCT03138512|525240545|FG004|Randomization|Participant no longer meets study criteria|3|||
145651063|NCT03138512|525240541|FG000|Randomization|Other reasons|1|||
145651064|NCT03138512|525240542|FG001|Randomization|Other reasons|0|||
145651065|NCT03138512|525240543|FG002|Randomization|Other reasons|0|||
145651066|NCT03138512|525240544|FG003|Randomization|Other reasons|0|||
145651067|NCT03138512|525240545|FG004|Randomization|Other reasons|0|||
145651068|NCT03138512|525240541|FG000|Treatment Part A|Disease recurrence|10|||
145651069|NCT03138512|525240542|FG001|Treatment Part A|Disease recurrence|20|||
145651070|NCT03138512|525240543|FG002|Treatment Part A|Disease recurrence|0|||
145651071|NCT03138512|525240544|FG003|Treatment Part A|Disease recurrence|0|||
145651072|NCT03138512|525240545|FG004|Treatment Part A|Disease recurrence|0|||
145651073|NCT03138512|525240541|FG000|Treatment Part A|Study Drug Toxicity|132|||
145651074|NCT03138512|525240542|FG001|Treatment Part A|Study Drug Toxicity|5|||
145651075|NCT03138512|525240543|FG002|Treatment Part A|Study Drug Toxicity|0|||
145651076|NCT03138512|525240544|FG003|Treatment Part A|Study Drug Toxicity|0|||
145651077|NCT03138512|525240545|FG004|Treatment Part A|Study Drug Toxicity|0|||
145651078|NCT03138512|525240541|FG000|Treatment Part A|Death|1|||
145651079|NCT03138512|525240542|FG001|Treatment Part A|Death|0|||
145651080|NCT03138512|525240543|FG002|Treatment Part A|Death|0|||
145651081|NCT03138512|525240544|FG003|Treatment Part A|Death|0|||
145651082|NCT03138512|525240545|FG004|Treatment Part A|Death|0|||
145651083|NCT03138512|525240541|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
145651084|NCT03138512|525240542|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
145651085|NCT03138512|525240543|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
145651086|NCT03138512|525240544|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
145651087|NCT03138512|525240545|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
145651088|NCT03138512|525240541|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
145651089|NCT03138512|525240542|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
145651090|NCT03138512|525240543|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
145651091|NCT03138512|525240544|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
145651092|NCT03138512|525240545|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
145651093|NCT03138512|525240541|FG000|Treatment Part A|Participant withdrew consent|2|||
145651094|NCT03138512|525240542|FG001|Treatment Part A|Participant withdrew consent|4|||
145651095|NCT03138512|525240543|FG002|Treatment Part A|Participant withdrew consent|0|||
145651096|NCT03138512|525240544|FG003|Treatment Part A|Participant withdrew consent|0|||
145651097|NCT03138512|525240545|FG004|Treatment Part A|Participant withdrew consent|0|||
145651098|NCT03138512|525240541|FG000|Treatment Part A|Lost to Follow-up|0|||
145651099|NCT03138512|525240542|FG001|Treatment Part A|Lost to Follow-up|1|||
145651100|NCT03138512|525240543|FG002|Treatment Part A|Lost to Follow-up|0|||
145651101|NCT03138512|525240544|FG003|Treatment Part A|Lost to Follow-up|0|||
145651102|NCT03138512|525240545|FG004|Treatment Part A|Lost to Follow-up|0|||
145651103|NCT03138512|525240541|FG000|Treatment Part A|Poor/non-compliance|1|||
145651104|NCT03138512|525240542|FG001|Treatment Part A|Poor/non-compliance|0|||
145651105|NCT03138512|525240543|FG002|Treatment Part A|Poor/non-compliance|0|||
145651106|NCT03138512|525240544|FG003|Treatment Part A|Poor/non-compliance|0|||
145651107|NCT03138512|525240545|FG004|Treatment Part A|Poor/non-compliance|0|||
145651108|NCT03138512|525240541|FG000|Treatment Part A|Pregnancy|0|||
145651109|NCT03138512|525240542|FG001|Treatment Part A|Pregnancy|1|||
145651110|NCT03138512|525240543|FG002|Treatment Part A|Pregnancy|0|||
145651111|NCT03138512|525240544|FG003|Treatment Part A|Pregnancy|0|||
145651112|NCT03138512|525240545|FG004|Treatment Part A|Pregnancy|0|||
145651113|NCT03138512|525240541|FG000|Treatment Part A|Other reasons|11|||
145651114|NCT03138512|525240542|FG001|Treatment Part A|Other reasons|8|||
145651115|NCT03138512|525240543|FG002|Treatment Part A|Other reasons|0|||
145651116|NCT03138512|525240544|FG003|Treatment Part A|Other reasons|0|||
145651117|NCT03138512|525240545|FG004|Treatment Part A|Other reasons|0|||
145651118|NCT03138512|525240541|FG000|Treatment Part B|Disease recurrence|0|||
145651119|NCT03138512|525240542|FG001|Treatment Part B|Disease recurrence|0|||
145651120|NCT03138512|525240543|FG002|Treatment Part B|Disease recurrence|6|||
145651121|NCT03138512|525240544|FG003|Treatment Part B|Disease recurrence|12|||
145651122|NCT03138512|525240545|FG004|Treatment Part B|Disease recurrence|10|||
145651123|NCT03138512|525240541|FG000|Treatment Part B|Study drug toxicity|0|||
145651124|NCT03138512|525240542|FG001|Treatment Part B|Study drug toxicity|0|||
145651125|NCT03138512|525240543|FG002|Treatment Part B|Study drug toxicity|63|||
145651126|NCT03138512|525240544|FG003|Treatment Part B|Study drug toxicity|3|||
145488771|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145488772|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
145488773|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
145488774|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145488775|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145488776|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145488777|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
145488778|NCT02365649|524644302|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488779|NCT02365649|524644303|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488780|NCT02365649|524644304|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
145488781|NCT02365649|524644305|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488782|NCT02365649|524644306|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488783|NCT02365649|524644307|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488784|NCT02365649|524644308|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488785|NCT02365649|524644309|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488786|NCT02365649|524644310|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488787|NCT02365649|524644311|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
145488788|NCT02365649|524644302|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145651127|NCT03138512|525240545|FG004|Treatment Part B|Study drug toxicity|45|||
145651128|NCT03138512|525240541|FG000|Treatment Part B|Death|0|||
145651129|NCT03138512|525240542|FG001|Treatment Part B|Death|0|||
145651130|NCT03138512|525240543|FG002|Treatment Part B|Death|1|||
145651131|NCT03138512|525240544|FG003|Treatment Part B|Death|0|||
145651132|NCT03138512|525240545|FG004|Treatment Part B|Death|0|||
145651133|NCT03138512|525240541|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
145651134|NCT03138512|525240542|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
145651135|NCT03138512|525240543|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
145651136|NCT03138512|525240544|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
145651137|NCT03138512|525240545|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
145651138|NCT03138512|525240541|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
145651139|NCT03138512|525240542|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
145651140|NCT03138512|525240543|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
145651141|NCT03138512|525240544|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
145651142|NCT03138512|525240545|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
145651143|NCT03138512|525240541|FG000|Treatment Part B|Participant withdrew consent|0|||
145651144|NCT03138512|525240542|FG001|Treatment Part B|Participant withdrew consent|0|||
145651145|NCT03138512|525240543|FG002|Treatment Part B|Participant withdrew consent|1|||
145651146|NCT03138512|525240544|FG003|Treatment Part B|Participant withdrew consent|1|||
145651147|NCT03138512|525240545|FG004|Treatment Part B|Participant withdrew consent|2|||
145651148|NCT03138512|525240541|FG000|Treatment Part B|Lost to Follow-up|0|||
145651149|NCT03138512|525240542|FG001|Treatment Part B|Lost to Follow-up|0|||
145651150|NCT03138512|525240543|FG002|Treatment Part B|Lost to Follow-up|0|||
145651151|NCT03138512|525240544|FG003|Treatment Part B|Lost to Follow-up|1|||
145651152|NCT03138512|525240545|FG004|Treatment Part B|Lost to Follow-up|0|||
145651153|NCT03138512|525240541|FG000|Treatment Part B|Poor/non-compliance|0|||
145651154|NCT03138512|525240542|FG001|Treatment Part B|Poor/non-compliance|0|||
145651155|NCT03138512|525240543|FG002|Treatment Part B|Poor/non-compliance|1|||
145651156|NCT03138512|525240544|FG003|Treatment Part B|Poor/non-compliance|1|||
145651157|NCT03138512|525240545|FG004|Treatment Part B|Poor/non-compliance|1|||
145651158|NCT03138512|525240541|FG000|Treatment Part B|Other reasons|0|||
145651159|NCT03138512|525240542|FG001|Treatment Part B|Other reasons|0|||
145651160|NCT03138512|525240543|FG002|Treatment Part B|Other reasons|3|||
145651161|NCT03138512|525240544|FG003|Treatment Part B|Other reasons|1|||
145651162|NCT03138512|525240545|FG004|Treatment Part B|Other reasons|5|||
145651163|NCT05323084|525240547|FG000|Period 2 - Washout|Lost to Follow-up|0|||
145651164|NCT05323084|525240548|FG001|Period 2 - Washout|Lost to Follow-up|1|||
145651165|NCT04382404|525240549|FG000|Overall Study|Adverse Event|1|||
145651166|NCT04382404|525240549|FG000|Overall Study|Lost to Follow-up|2|||
145651167|NCT03332017|525240554|FG000|Overall Study|Lost to Follow-up|1|||
145651168|NCT03332017|525240555|FG001|Overall Study|Lost to Follow-up|2|||
145651169|NCT03332017|525240554|FG000|Overall Study|Death|17|||
145651170|NCT03332017|525240555|FG001|Overall Study|Death|16|||
145651171|NCT03332017|525240554|FG000|Overall Study|Withdrawal by Subject|6|||
145651172|NCT03332017|525240555|FG001|Overall Study|Withdrawal by Subject|14|||
145651173|NCT03332017|525240554|FG000|Overall Study|Other|1|||
145651174|NCT03332017|525240555|FG001|Overall Study|Other|3|||
145651175|NCT03332017|525240554|FG000|Overall Study|Remained in Study (Ongoing)|47|||
145651176|NCT03332017|525240555|FG001|Overall Study|Remained in Study (Ongoing)|110|||
145651177|NCT01580488|525240561|FG000|Overall Study|Withdrawal by Subject|1|||
145651178|NCT03699709|525240566|FG000|Overall Study|Death|1|||
145651179|NCT03699709|525240567|FG001|Overall Study|Death|2|||
145651180|NCT03699709|525240566|FG000|Overall Study|Lost to Follow-up|10|||
145651181|NCT03699709|525240567|FG001|Overall Study|Lost to Follow-up|3|||
145651182|NCT03699709|525240566|FG000|Overall Study|Withdrawal by Subject|5|||
145651183|NCT03699709|525240567|FG001|Overall Study|Withdrawal by Subject|0|||
145488789|NCT02365649|524644303|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488790|NCT02365649|524644304|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488791|NCT02365649|524644305|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488792|NCT02365649|524644306|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488793|NCT02365649|524644307|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488794|NCT02365649|524644308|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
145488795|NCT02365649|524644309|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488796|NCT02365649|524644310|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488797|NCT02365649|524644311|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
145488798|NCT02365649|524644302|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488799|NCT02365649|524644303|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488800|NCT02365649|524644304|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488801|NCT02365649|524644305|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488802|NCT02365649|524644306|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488803|NCT02365649|524644307|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488804|NCT02365649|524644308|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
145488805|NCT02365649|524644309|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
145488806|NCT02365649|524644310|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
145488807|NCT02365649|524644311|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
145488808|NCT02365649|524644302|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145488809|NCT02365649|524644303|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145488810|NCT02365649|524644304|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145488811|NCT02365649|524644305|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145651184|NCT03699709|525240566|FG000|Overall Study|incarcerated|1|||
145651185|NCT03699709|525240567|FG001|Overall Study|incarcerated|0|||
145651186|NCT03699709|525240566|FG000|Overall Study|scheduled, but no show|0|||
145651187|NCT03699709|525240567|FG001|Overall Study|scheduled, but no show|1|||
145651188|NCT02907099|525240568|FG000|Overall Study|Adverse Event|1|||
145651189|NCT02907099|525240568|FG000|Overall Study|Withdrawal by Subject|2|||
145651190|NCT02907099|525240568|FG000|Overall Study|Screen Fail|2|||
145651191|NCT04739956|525240569|FG000|Overall Study|Withdrawal by Subject|1|||
145651192|NCT04739956|525240570|FG001|Overall Study|Withdrawal by Subject|1|||
145651193|NCT05134233|525240575|FG000|Overall Study|Pregnancy|1|||
145651194|NCT05134233|525240575|FG000|Overall Study|MEP value too low|2|||
145651195|NCT05134233|525240575|FG000|Overall Study|Lost to Follow-up|1|||
145651196|NCT03652688|525240580|FG000|Baseline|Withdrawal by Subject|0|||
145651197|NCT03652688|525240581|FG001|Baseline|Withdrawal by Subject|3|||
145651198|NCT03652688|525240580|FG000|Follow-up|Lost to Follow-up|56|||
145651199|NCT03652688|525240581|FG001|Follow-up|Lost to Follow-up|54|||
145651200|NCT03468218|525240582|FG000|Overall Study|Adverse Event|5|||
145651201|NCT03468218|525240582|FG000|Overall Study|Progressive Disease|16|||
145651202|NCT03468218|525240582|FG000|Overall Study|Death|1|||
145651203|NCT03468218|525240582|FG000|Overall Study|Alternate therapy|1|||
145651204|NCT03468218|525240582|FG000|Overall Study|Withdrawal by Subject|2|||
145651205|NCT05089734|525240585|FG000|Overall Study|Still on study|122|||
145651206|NCT05089734|525240586|FG001|Overall Study|Still on study|101|||
145651207|NCT05089734|525240585|FG000|Overall Study|Death|161|||
145651208|NCT05089734|525240586|FG001|Overall Study|Death|179|||
145651209|NCT05089734|525240585|FG000|Overall Study|Withdrew consent|11|||
145651210|NCT05089734|525240586|FG001|Overall Study|Withdrew consent|24|||
145651211|NCT05089734|525240585|FG000|Overall Study|Lost to Follow-up|5|||
145651212|NCT05089734|525240586|FG001|Overall Study|Lost to Follow-up|0|||
145651213|NCT05687916|525242340|FG000|Overall Study|Adverse Event|1|||
145651214|NCT05687916|525242341|FG001|Overall Study|Adverse Event|2|||
145651215|NCT05687916|525242342|FG002|Overall Study|Adverse Event|0|||
145651216|NCT05687916|525242340|FG000|Overall Study|Withdrawal by Subject|1|||
145651217|NCT05687916|525242341|FG001|Overall Study|Withdrawal by Subject|0|||
145651218|NCT05687916|525242342|FG002|Overall Study|Withdrawal by Subject|1|||
145651219|NCT05687916|525242340|FG000|Overall Study|Protocol Violation|0|||
145651220|NCT05687916|525242341|FG001|Overall Study|Protocol Violation|2|||
145651221|NCT05687916|525242342|FG002|Overall Study|Protocol Violation|1|||
145651222|NCT05687916|525242340|FG000|Overall Study|Reason not Specified|1|||
145651223|NCT05687916|525242341|FG001|Overall Study|Reason not Specified|0|||
145651224|NCT05687916|525242342|FG002|Overall Study|Reason not Specified|0|||
145651225|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
145651226|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
145651227|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
145651228|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651229|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651230|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651231|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651232|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651233|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651234|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651235|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651236|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651237|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
145651238|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
145651239|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
145651240|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651241|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651242|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651243|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651244|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651245|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651246|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651247|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651248|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651249|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651250|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
145651251|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
145651252|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
145651253|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651254|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651255|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651256|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651257|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651258|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651259|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651260|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651261|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651262|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651263|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
145651264|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
145651265|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
145651266|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651267|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651268|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651269|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651270|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651271|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651272|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651273|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651274|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651275|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651276|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
145651277|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
145651278|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
145651279|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
145651280|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651281|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651282|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651283|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651284|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651285|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651286|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651287|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651288|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651289|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
145651290|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
145651291|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
145651292|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
145651293|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651294|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651295|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651296|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651297|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651298|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651299|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145488812|NCT02365649|524644306|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145488813|NCT02365649|524644307|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
145488814|NCT02365649|524644308|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
145488815|NCT02365649|524644309|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
145488816|NCT02365649|524644310|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
145488817|NCT02365649|524644311|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
145488818|NCT02365649|524644302|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488819|NCT02365649|524644303|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488820|NCT02365649|524644304|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488821|NCT02365649|524644305|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488822|NCT02365649|524644306|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488823|NCT02365649|524644307|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488824|NCT02365649|524644308|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
145488825|NCT02365649|524644309|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
145488826|NCT02365649|524644310|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
145488827|NCT02365649|524644311|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
145488828|NCT02365649|524644302|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488829|NCT02365649|524644303|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488830|NCT02365649|524644304|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488831|NCT02365649|524644305|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488832|NCT02365649|524644306|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488833|NCT02365649|524644307|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488834|NCT02365649|524644308|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
145488835|NCT02365649|524644309|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488836|NCT02365649|524644310|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
145488837|NCT02365649|524644311|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
145488838|NCT02021565|524644326|FG000|Baseline Through Intervention|Death|0|||
145488839|NCT02021565|524644327|FG001|Baseline Through Intervention|Death|1|||
145488840|NCT02021565|524644326|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
145488841|NCT02021565|524644327|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
145488842|NCT02021565|524644326|FG000|Baseline Through Intervention|Protocol Violation|0|||
145488843|NCT02021565|524644327|FG001|Baseline Through Intervention|Protocol Violation|7|||
145488844|NCT02021565|524644326|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
145488845|NCT02021565|524644327|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
145488846|NCT02021565|524644326|FG000|3-month Follow-up|Death|3|||
145488847|NCT02021565|524644327|FG001|3-month Follow-up|Death|0|||
145488848|NCT02021565|524644326|FG000|3-month Follow-up|Withdrawal by Subject|4|||
145488849|NCT02021565|524644327|FG001|3-month Follow-up|Withdrawal by Subject|0|||
145488850|NCT02021565|524644326|FG000|3-month Follow-up|Protocol Violation|3|||
145488851|NCT02021565|524644327|FG001|3-month Follow-up|Protocol Violation|2|||
145488852|NCT01188772|524644330|FG000|Overall Study|Randomized but Not Treated|0|||
145488853|NCT01188772|524644331|FG001|Overall Study|Randomized but Not Treated|1|||
145488854|NCT01188772|524644332|FG002|Overall Study|Randomized but Not Treated|0|||
145488855|NCT01188772|524644333|FG003|Overall Study|Randomized but Not Treated|0|||
145488856|NCT01188772|524644330|FG000|Overall Study|Adverse Event|0|||
145488857|NCT01188772|524644331|FG001|Overall Study|Adverse Event|1|||
145488858|NCT01188772|524644332|FG002|Overall Study|Adverse Event|2|||
145488859|NCT01188772|524644333|FG003|Overall Study|Adverse Event|0|||
145488860|NCT01188772|524644330|FG000|Overall Study|Lost to Follow-up|4|||
145488861|NCT01188772|524644331|FG001|Overall Study|Lost to Follow-up|1|||
145488862|NCT01188772|524644332|FG002|Overall Study|Lost to Follow-up|1|||
145651300|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145488863|NCT01188772|524644333|FG003|Overall Study|Lost to Follow-up|1|||
145488864|NCT01188772|524644330|FG000|Overall Study|Non-responder|0|||
145488865|NCT01188772|524644331|FG001|Overall Study|Non-responder|0|||
145488866|NCT01188772|524644332|FG002|Overall Study|Non-responder|3|||
145488867|NCT01188772|524644333|FG003|Overall Study|Non-responder|0|||
145488868|NCT01188772|524644330|FG000|Overall Study|Physician Decision|0|||
145488869|NCT01188772|524644331|FG001|Overall Study|Physician Decision|0|||
145488870|NCT01188772|524644332|FG002|Overall Study|Physician Decision|1|||
145488871|NCT01188772|524644333|FG003|Overall Study|Physician Decision|0|||
145488872|NCT01188772|524644330|FG000|Overall Study|Terminated by Sponsor|0|||
145488873|NCT01188772|524644331|FG001|Overall Study|Terminated by Sponsor|0|||
145488874|NCT01188772|524644332|FG002|Overall Study|Terminated by Sponsor|1|||
145488875|NCT01188772|524644333|FG003|Overall Study|Terminated by Sponsor|0|||
145488876|NCT01188772|524644330|FG000|Overall Study|Treatment Failure|0|||
145488877|NCT01188772|524644331|FG001|Overall Study|Treatment Failure|0|||
145488878|NCT01188772|524644332|FG002|Overall Study|Treatment Failure|1|||
145488879|NCT01188772|524644333|FG003|Overall Study|Treatment Failure|0|||
145488880|NCT01188772|524644330|FG000|Overall Study|Virologic Failure|1|||
145488881|NCT01188772|524644331|FG001|Overall Study|Virologic Failure|0|||
145488882|NCT01188772|524644332|FG002|Overall Study|Virologic Failure|0|||
145488883|NCT01188772|524644333|FG003|Overall Study|Virologic Failure|0|||
145488884|NCT01188772|524644330|FG000|Overall Study|Withdrawal by Subject|0|||
145488885|NCT01188772|524644331|FG001|Overall Study|Withdrawal by Subject|0|||
145488886|NCT01188772|524644332|FG002|Overall Study|Withdrawal by Subject|2|||
145488887|NCT01188772|524644333|FG003|Overall Study|Withdrawal by Subject|0|||
145488888|NCT01433172|524644334|FG000|Overall Study|Withdrawal by Subject|0|||
145488889|NCT01433172|524644335|FG001|Overall Study|Withdrawal by Subject|1|||
145488890|NCT01433172|524644336|FG002|Overall Study|Withdrawal by Subject|0|||
145651301|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651302|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
145651303|NCT01261312|525242343|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
145651304|NCT01261312|525242344|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651305|NCT01261312|525242345|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
145651306|NCT01261312|525242346|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651307|NCT01261312|525242347|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651308|NCT01261312|525242348|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651309|NCT01261312|525242349|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651310|NCT01261312|525242350|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651311|NCT01261312|525242351|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651312|NCT01261312|525242352|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651313|NCT01261312|525242353|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651314|NCT01261312|525242354|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651315|NCT01261312|525242355|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
145651316|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651317|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651318|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651319|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
145651320|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
145651321|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
145651322|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651323|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651324|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651325|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651326|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651327|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651328|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
145651329|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651330|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651331|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651332|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651333|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
145651334|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
145651335|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651336|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651337|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145488891|NCT01433172|524644334|FG000|Overall Study|Disease Progression|0|||
145488892|NCT01433172|524644335|FG001|Overall Study|Disease Progression|0|||
145488893|NCT01433172|524644336|FG002|Overall Study|Disease Progression|1|||
145488894|NCT01433172|524644334|FG000|Overall Study|Death|0|||
145488895|NCT01433172|524644335|FG001|Overall Study|Death|2|||
145488896|NCT01433172|524644336|FG002|Overall Study|Death|0|||
145488897|NCT01894607|524644340|FG000|Overall Study|Ineligible|1|||
145488898|NCT03084796|524644343|FG000|Overall Study|Adverse Event|4|||
145651338|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145651339|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145488899|NCT03084796|524644344|FG001|Overall Study|Adverse Event|5|||
145488900|NCT03084796|524644345|FG002|Overall Study|Adverse Event|6|||
145488901|NCT03084796|524644346|FG003|Overall Study|Adverse Event|2|||
145488902|NCT03084796|524644347|FG004|Overall Study|Adverse Event|3|||
145488903|NCT03084796|524644348|FG005|Overall Study|Adverse Event|5|||
145488904|NCT03084796|524644343|FG000|Overall Study|Withdrawal by Subject|3|||
145488905|NCT03084796|524644344|FG001|Overall Study|Withdrawal by Subject|5|||
145488906|NCT03084796|524644345|FG002|Overall Study|Withdrawal by Subject|2|||
145488907|NCT03084796|524644346|FG003|Overall Study|Withdrawal by Subject|1|||
145488908|NCT03084796|524644347|FG004|Overall Study|Withdrawal by Subject|3|||
145488909|NCT03084796|524644348|FG005|Overall Study|Withdrawal by Subject|0|||
145488910|NCT03084796|524644343|FG000|Overall Study|Protocol Violation|0|||
145488911|NCT03084796|524644344|FG001|Overall Study|Protocol Violation|0|||
145488912|NCT03084796|524644345|FG002|Overall Study|Protocol Violation|1|||
145488913|NCT03084796|524644346|FG003|Overall Study|Protocol Violation|0|||
145488914|NCT03084796|524644347|FG004|Overall Study|Protocol Violation|1|||
145488915|NCT03084796|524644348|FG005|Overall Study|Protocol Violation|1|||
145488916|NCT03084796|524644343|FG000|Overall Study|Lack of Efficacy|0|||
145488917|NCT03084796|524644344|FG001|Overall Study|Lack of Efficacy|0|||
145488918|NCT03084796|524644345|FG002|Overall Study|Lack of Efficacy|1|||
145488919|NCT03084796|524644346|FG003|Overall Study|Lack of Efficacy|0|||
145488920|NCT03084796|524644347|FG004|Overall Study|Lack of Efficacy|1|||
145488921|NCT03084796|524644348|FG005|Overall Study|Lack of Efficacy|0|||
145488922|NCT03084796|524644343|FG000|Overall Study|Lost to Follow-up|0|||
145488923|NCT03084796|524644344|FG001|Overall Study|Lost to Follow-up|0|||
145488924|NCT03084796|524644345|FG002|Overall Study|Lost to Follow-up|1|||
145488925|NCT03084796|524644346|FG003|Overall Study|Lost to Follow-up|1|||
145488926|NCT03084796|524644347|FG004|Overall Study|Lost to Follow-up|3|||
145488927|NCT03084796|524644348|FG005|Overall Study|Lost to Follow-up|1|||
145488928|NCT03084796|524644343|FG000|Overall Study|Randomization error|0|||
145488929|NCT03084796|524644344|FG001|Overall Study|Randomization error|0|||
145488930|NCT03084796|524644345|FG002|Overall Study|Randomization error|1|||
145488931|NCT03084796|524644346|FG003|Overall Study|Randomization error|0|||
145488932|NCT03084796|524644347|FG004|Overall Study|Randomization error|0|||
145488933|NCT03084796|524644348|FG005|Overall Study|Randomization error|0|||
145488934|NCT00154297|524644357|FG000|Overall Study|Death|5|||
145488935|NCT00154297|524644358|FG001|Overall Study|Death|2|||
145488936|NCT00154297|524644357|FG000|Overall Study|Withdrawal by Subject|0|||
145488937|NCT00154297|524644358|FG001|Overall Study|Withdrawal by Subject|5|||
145488938|NCT00154297|524644357|FG000|Overall Study|Lost to Follow-up|3|||
145488939|NCT00154297|524644358|FG001|Overall Study|Lost to Follow-up|0|||
145488940|NCT00650767|524644359|FG000|Overall Study|Adverse Event|0|||
145488941|NCT00650767|524644360|FG001|Overall Study|Adverse Event|3|||
145488942|NCT00650767|524644361|FG002|Overall Study|Adverse Event|10|||
145488943|NCT00650767|524644362|FG003|Overall Study|Adverse Event|8|||
145488944|NCT00650767|524644359|FG000|Overall Study|Death|1|||
145488945|NCT00650767|524644360|FG001|Overall Study|Death|0|||
145488946|NCT00650767|524644361|FG002|Overall Study|Death|0|||
145488947|NCT00650767|524644362|FG003|Overall Study|Death|0|||
145488948|NCT00650767|524644359|FG000|Overall Study|Withdrawal by Subject|2|||
145488949|NCT00650767|524644360|FG001|Overall Study|Withdrawal by Subject|4|||
145488950|NCT00650767|524644361|FG002|Overall Study|Withdrawal by Subject|3|||
145488951|NCT00650767|524644362|FG003|Overall Study|Withdrawal by Subject|3|||
145488952|NCT00650767|524644359|FG000|Overall Study|Lost to Follow-up|1|||
145488953|NCT00650767|524644360|FG001|Overall Study|Lost to Follow-up|1|||
145488954|NCT00650767|524644361|FG002|Overall Study|Lost to Follow-up|1|||
145488955|NCT00650767|524644362|FG003|Overall Study|Lost to Follow-up|0|||
145488956|NCT00650767|524644359|FG000|Overall Study|Other|1|||
145488957|NCT00650767|524644360|FG001|Overall Study|Other|1|||
145488958|NCT00650767|524644361|FG002|Overall Study|Other|0|||
145488959|NCT00650767|524644362|FG003|Overall Study|Other|0|||
145488960|NCT01774799|524644363|FG000|Overall Study|Lost to Follow-up|1|||
145651340|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145488961|NCT01774799|524644364|FG001|Overall Study|Lost to Follow-up|1|||
145488962|NCT01774799|524644365|FG002|Overall Study|Lost to Follow-up|0|||
145488963|NCT01774799|524644366|FG003|Overall Study|Lost to Follow-up|0|||
145488964|NCT04393493|524644367|FG000|First 4 Days of Intervention|Early improvement|5|||
145488965|NCT04393493|524644368|FG001|First 4 Days of Intervention|Early improvement|7|||
145651341|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
145488966|NCT02910466|524644369|FG000|Overall Study|Adverse Event|1|||
145488967|NCT02910466|524644369|FG000|Overall Study|Withdrawal by Subject|3|||
145488968|NCT02910466|524644369|FG000|Overall Study|Lost to Follow-up|5|||
145488969|NCT02910466|524644369|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
145488970|NCT02910466|524644369|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
145488971|NCT01125800|524644370|FG000|Phase I|Protocol Violation|0|||
145488972|NCT01125800|524644371|FG001|Phase I|Protocol Violation|3|||
145488973|NCT01125800|524644372|FG002|Phase I|Protocol Violation|1|||
145488974|NCT01125800|524644373|FG003|Phase I|Protocol Violation|1|||
145488975|NCT01125800|524644374|FG004|Phase I|Protocol Violation|0|||
145488976|NCT01125800|524644370|FG000|Phase I|Adverse Event|2|||
145488977|NCT01125800|524644371|FG001|Phase I|Adverse Event|2|||
145488978|NCT01125800|524644372|FG002|Phase I|Adverse Event|1|||
145651342|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651343|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651344|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651345|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651346|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
145651347|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
145651348|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651349|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651350|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651351|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651352|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651353|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651354|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
145651355|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651356|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
145488979|NCT01125800|524644373|FG003|Phase I|Adverse Event|7|||
145488980|NCT01125800|524644374|FG004|Phase I|Adverse Event|0|||
145488981|NCT01125800|524644370|FG000|Phase I|Administrative problems|1|||
145488982|NCT01125800|524644371|FG001|Phase I|Administrative problems|0|||
145488983|NCT01125800|524644372|FG002|Phase I|Administrative problems|0|||
145651357|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651358|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
145651359|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
145651360|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
145651361|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651362|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651363|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651364|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
145488984|NCT01125800|524644373|FG003|Phase I|Administrative problems|0|||
145488985|NCT01125800|524644374|FG004|Phase I|Administrative problems|0|||
145651365|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651366|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651367|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
145651368|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651369|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651370|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651371|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651372|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651373|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
145651374|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651375|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651376|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651377|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651378|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651379|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651380|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
145651381|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651382|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651383|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651384|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
145651385|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
145651386|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
145651387|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651388|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651389|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145488986|NCT01125800|524644370|FG000|Phase I|Withdrawal by Subject|0|||
145488987|NCT01125800|524644371|FG001|Phase I|Withdrawal by Subject|0|||
145488988|NCT01125800|524644372|FG002|Phase I|Withdrawal by Subject|1|||
145651390|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651391|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651392|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145488989|NCT01125800|524644373|FG003|Phase I|Withdrawal by Subject|0|||
145488990|NCT01125800|524644374|FG004|Phase I|Withdrawal by Subject|0|||
145488991|NCT01125800|524644370|FG000|Phase I|Disease progression|5|||
145651393|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
145651394|NCT01261312|525242343|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651395|NCT01261312|525242344|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651396|NCT01261312|525242345|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651397|NCT01261312|525242346|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
145488992|NCT01125800|524644371|FG001|Phase I|Disease progression|4|||
145488993|NCT01125800|524644372|FG002|Phase I|Disease progression|1|||
145488994|NCT01125800|524644373|FG003|Phase I|Disease progression|3|||
145488995|NCT01125800|524644374|FG004|Phase I|Disease progression|0|||
145488996|NCT01125800|524644370|FG000|Phase II|Protocol Violation|0|||
145488997|NCT01125800|524644371|FG001|Phase II|Protocol Violation|0|||
145488998|NCT01125800|524644372|FG002|Phase II|Protocol Violation|0|||
145488999|NCT01125800|524644373|FG003|Phase II|Protocol Violation|0|||
145489000|NCT01125800|524644374|FG004|Phase II|Protocol Violation|1|||
145489001|NCT01125800|524644370|FG000|Phase II|Adverse Event|0|||
145489002|NCT01125800|524644371|FG001|Phase II|Adverse Event|0|||
145489003|NCT01125800|524644372|FG002|Phase II|Adverse Event|0|||
145489004|NCT01125800|524644373|FG003|Phase II|Adverse Event|0|||
145489005|NCT01125800|524644374|FG004|Phase II|Adverse Event|2|||
145489006|NCT01125800|524644370|FG000|Phase II|Disease progression|0|||
145489007|NCT01125800|524644371|FG001|Phase II|Disease progression|0|||
145489008|NCT01125800|524644372|FG002|Phase II|Disease progression|0|||
145489009|NCT01125800|524644373|FG003|Phase II|Disease progression|1|||
145489010|NCT01125800|524644374|FG004|Phase II|Disease progression|8|||
145489011|NCT03370718|524644378|FG000|Overall Study|Withdrawal by Subject|1|||
145489012|NCT00141102|524644383|FG000|Overall Study|Adverse Event|233|||
145489013|NCT00141102|524644384|FG001|Overall Study|Adverse Event|305|||
145489014|NCT00141102|524644383|FG000|Overall Study|Laboratory Abnormality|9|||
145489015|NCT00141102|524644384|FG001|Overall Study|Laboratory Abnormality|33|||
145489016|NCT00141102|524644383|FG000|Overall Study|Lack of Efficacy|21|||
145489017|NCT00141102|524644384|FG001|Overall Study|Lack of Efficacy|26|||
145489018|NCT00141102|524644383|FG000|Overall Study|Lost to Follow-up|29|||
145489019|NCT00141102|524644384|FG001|Overall Study|Lost to Follow-up|32|||
145489020|NCT00141102|524644383|FG000|Overall Study|Other|87|||
145489021|NCT00141102|524644384|FG001|Overall Study|Other|76|||
145489022|NCT00141102|524644383|FG000|Overall Study|Withdrawal by Subject|112|||
145489023|NCT00141102|524644384|FG001|Overall Study|Withdrawal by Subject|142|||
145489024|NCT00141102|524644383|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
145489025|NCT00141102|524644384|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
145489026|NCT00141102|524644383|FG000|Overall Study|Death|2|||
145489027|NCT00141102|524644384|FG001|Overall Study|Death|2|||
145489028|NCT03061201|524644387|FG000|Overall Study|Participants Terminated at Month 36|0|||
145489029|NCT03061201|524644388|FG001|Overall Study|Participants Terminated at Month 36|1|||
145489030|NCT03061201|524644389|FG002|Overall Study|Participants Terminated at Month 36|0|||
145489031|NCT03061201|524644390|FG003|Overall Study|Participants Terminated at Month 36|1|||
145489032|NCT03061201|524644387|FG000|Overall Study|Lost to Follow-up|1|||
145489033|NCT03061201|524644388|FG001|Overall Study|Lost to Follow-up|0|||
145489034|NCT03061201|524644389|FG002|Overall Study|Lost to Follow-up|0|||
145489035|NCT03061201|524644390|FG003|Overall Study|Lost to Follow-up|0|||
145489036|NCT06172348|524644391|FG000|Treatment Period 2|Adverse Event|0|||
145489037|NCT06172348|524644392|FG001|Treatment Period 2|Adverse Event|0|||
145489038|NCT06172348|524644393|FG002|Treatment Period 2|Adverse Event|1|||
145489039|NCT06172348|524644394|FG003|Treatment Period 2|Adverse Event|0|||
145489040|NCT06172348|524644395|FG004|Treatment Period 2|Adverse Event|0|||
145489041|NCT06172348|524644396|FG005|Treatment Period 2|Adverse Event|0|||
145489042|NCT04037891|524644397|FG000|Open-label Period|Withdrawal by Subject|1|||
145489043|NCT04037891|524644398|FG001|Open-label Period|Withdrawal by Subject|0|||
145489044|NCT04037891|524644399|FG002|Open-label Period|Withdrawal by Subject|0|||
145489045|NCT04037891|524644397|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
145489046|NCT04037891|524644398|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
145489047|NCT04037891|524644399|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
145651398|NCT01261312|525242347|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
145651399|NCT01261312|525242348|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
145651400|NCT01261312|525242349|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651401|NCT01261312|525242350|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651402|NCT01261312|525242351|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651403|NCT01261312|525242352|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651404|NCT01261312|525242353|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651405|NCT01261312|525242354|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651406|NCT01261312|525242355|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
145651407|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651408|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651409|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145489048|NCT05274958|524644401|FG000|Overall Study|Only completed 1 set of PROMs|22|||
145489049|NCT05274958|524644402|FG001|Overall Study|Only completed 1 set of PROMs|35|||
145489050|NCT00866814|524644405|FG000|Overall Study|Lost to Follow-up|12|||
145489051|NCT00866814|524644405|FG000|Overall Study|Adverse Event|2|||
145489052|NCT00866814|524644405|FG000|Overall Study|Physician Decision|1|||
145489053|NCT00866814|524644405|FG000|Overall Study|Death|1|||
145489054|NCT00866814|524644405|FG000|Overall Study|No longer wished to participate|1|||
145489055|NCT00866814|524644405|FG000|Overall Study|Unable to meet follow-up requirements|2|||
145489056|NCT00866814|524644405|FG000|Overall Study|Moved to area without study site|1|||
145489057|NCT04491136|524644406|FG000|Overall Study|Patient withdraw informed consent|9|||
145489058|NCT04491136|524644406|FG000|Overall Study|Adverse Event|2|||
145489059|NCT04491136|524644406|FG000|Overall Study|Death|3|||
145489060|NCT04491136|524644406|FG000|Overall Study|Lost to Follow-up|3|||
145489061|NCT04491136|524644406|FG000|Overall Study|Physician Decision|45|||
145489062|NCT04491136|524644406|FG000|Overall Study|sponsor terminated the study early|16|||
145489063|NCT04491136|524644406|FG000|Overall Study|Patient/guardian's decision|1|||
145489064|NCT01505374|524644411|FG000|Overall Study|Lost to Follow-up|1|||
145489065|NCT01505374|524644412|FG001|Overall Study|Lost to Follow-up|0|||
145489066|NCT02360228|524644413|FG000|Overall Study|Withdrawal by Subject|1|||
145489067|NCT02360228|524644414|FG001|Overall Study|Withdrawal by Subject|0|||
145489068|NCT02360228|524644415|FG002|Overall Study|Withdrawal by Subject|0|||
145489069|NCT02360228|524644413|FG000|Overall Study|Self-discontinued medication|0|||
145489070|NCT02360228|524644414|FG001|Overall Study|Self-discontinued medication|1|||
145489071|NCT02360228|524644415|FG002|Overall Study|Self-discontinued medication|0|||
145489072|NCT02360228|524644413|FG000|Overall Study|Unstable symptoms during screening|0|||
145489073|NCT02360228|524644414|FG001|Overall Study|Unstable symptoms during screening|0|||
145489074|NCT02360228|524644415|FG002|Overall Study|Unstable symptoms during screening|1|||
145489075|NCT02464410|524644418|FG000|Overall Study|Death|3|||
145489076|NCT02464410|524644419|FG001|Overall Study|Death|4|||
145489077|NCT02464410|524644418|FG000|Overall Study|Lost to Follow-up|7|||
145489078|NCT02464410|524644419|FG001|Overall Study|Lost to Follow-up|9|||
145489079|NCT02464410|524644418|FG000|Overall Study|Withdrawal by Subject|12|||
145489080|NCT02464410|524644419|FG001|Overall Study|Withdrawal by Subject|3|||
145489081|NCT00794950|524644420|FG000|BCG Induction|Withdrawal by Subject|2|||
145489082|NCT00794950|524644420|FG000|BCG Induction|ineligible|3|||
145489083|NCT00794950|524644420|FG000|BCG Induction|noncompliant w. BCG|1|||
145489084|NCT00794950|524644420|FG000|BCG Induction|Adverse Event|1|||
145489085|NCT00794950|524644420|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
145651410|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651411|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651412|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651413|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
145651414|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
145651415|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
145651416|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651417|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651418|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651419|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
145651420|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651421|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651422|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651423|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651424|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651425|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651426|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651427|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
145651428|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
145651429|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651430|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651431|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651432|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
145651433|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651434|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651435|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651436|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651437|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651438|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651439|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
145651440|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
145651441|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
145651442|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651443|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145489086|NCT00794950|524644420|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
145489087|NCT00794950|524644420|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
145489088|NCT00794950|524644420|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
145489089|NCT02485704|524644421|FG000|Overall Study|Lost to Follow-up|4|||
145489090|NCT02485704|524644422|FG001|Overall Study|Lost to Follow-up|5|||
145651444|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651445|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
145651446|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
145489091|NCT02485704|524644421|FG000|Overall Study|Withdrawal by Subject|0|||
145489092|NCT02485704|524644422|FG001|Overall Study|Withdrawal by Subject|3|||
145489093|NCT02485704|524644421|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
145489094|NCT02485704|524644422|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
145489095|NCT01777776|524644425|FG000|Overall Study|Adverse Event|2|||
145489096|NCT01777776|524644426|FG001|Overall Study|Adverse Event|4|||
145489097|NCT01777776|524644427|FG002|Overall Study|Adverse Event|0|||
145489098|NCT01777776|524644428|FG003|Overall Study|Adverse Event|0|||
145489099|NCT01777776|524644425|FG000|Overall Study|Disease Progression|4|||
145489100|NCT01777776|524644426|FG001|Overall Study|Disease Progression|8|||
145489101|NCT01777776|524644427|FG002|Overall Study|Disease Progression|6|||
145489102|NCT01777776|524644428|FG003|Overall Study|Disease Progression|3|||
145489103|NCT01777776|524644425|FG000|Overall Study|Withdrawal by Subject|0|||
145489104|NCT01777776|524644426|FG001|Overall Study|Withdrawal by Subject|0|||
145489105|NCT01777776|524644427|FG002|Overall Study|Withdrawal by Subject|0|||
145489106|NCT01777776|524644428|FG003|Overall Study|Withdrawal by Subject|1|||
145489107|NCT00851786|524644429|FG000|Overall Study|Withdrawal by Subject|0|||
145489108|NCT00851786|524644430|FG001|Overall Study|Withdrawal by Subject|1|||
145489109|NCT00851786|524644429|FG000|Overall Study|Protocol Violation|0|||
145489110|NCT00851786|524644430|FG001|Overall Study|Protocol Violation|1|||
145489111|NCT00851786|524644429|FG000|Overall Study|Lost to Follow-up|1|||
145489112|NCT00851786|524644430|FG001|Overall Study|Lost to Follow-up|0|||
145489113|NCT00851786|524644429|FG000|Overall Study|Incarceration|1|||
145489114|NCT00851786|524644430|FG001|Overall Study|Incarceration|0|||
145489115|NCT00851786|524644429|FG000|Overall Study|Site Closure|1|||
145489116|NCT00851786|524644430|FG001|Overall Study|Site Closure|0|||
145489117|NCT00851786|524644429|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
145489118|NCT00851786|524644430|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
145489119|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
145489120|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
145489121|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
145489122|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
145489123|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
145489124|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
145489125|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
145489126|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
145489127|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
145489128|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
145489129|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
145489130|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
145489131|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
145489132|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
145489133|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
145489134|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
145489135|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
145489136|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
145489137|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
145489138|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
145489139|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
145489140|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
145651447|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
145651448|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
145651449|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
145651450|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
145651451|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
145651452|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
145651453|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
145651454|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
145651455|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
145651456|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
145651457|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
145651458|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
145651459|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651460|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651461|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651462|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651463|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651464|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651465|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
145489141|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
145489142|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
145651466|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
145489143|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
145489144|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
145489145|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
145489146|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
145489147|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
145489148|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
145489149|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
145489150|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
145489151|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
145489152|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
145489153|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
145489154|NCT02831764|524645582|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
145489155|NCT02831764|524645583|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
145489156|NCT02831764|524645584|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
145489157|NCT02831764|524645585|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
145489158|NCT02831764|524645586|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
145489159|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145489160|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145489161|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
145489162|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
145489163|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
145489164|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145489165|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145489166|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
145489167|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145489168|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
145489169|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145489170|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145489171|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
145489172|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
145489173|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
145489174|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
145489175|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
145489176|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
145489177|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
145489178|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
145489179|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145489180|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145489181|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
145489182|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
145489183|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
145489184|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145489185|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145489186|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
145489187|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
145489188|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
145489189|NCT02831764|524645582|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145489190|NCT02831764|524645583|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145489191|NCT02831764|524645584|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
145489192|NCT02831764|524645585|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
145489193|NCT02831764|524645586|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
145489194|NCT02831764|524645582|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145489195|NCT02831764|524645583|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145489196|NCT02831764|524645584|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145489197|NCT02831764|524645585|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
145489198|NCT02831764|524645586|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
145489199|NCT02831764|524645582|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145489200|NCT02831764|524645583|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145489201|NCT02831764|524645584|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145489202|NCT02831764|524645585|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
145489203|NCT02831764|524645586|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
145489204|NCT02831764|524645582|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145489205|NCT02831764|524645583|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145489206|NCT02831764|524645584|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145489207|NCT02831764|524645585|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
145489208|NCT02831764|524645586|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
145489209|NCT02831764|524645582|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145489210|NCT02831764|524645583|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145489211|NCT02831764|524645584|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145489212|NCT02831764|524645585|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
145489213|NCT02831764|524645586|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
145489214|NCT00865345|524645587|FG000|Overall Study|Withdrawal by Subject|2|||
145489215|NCT01519323|524645588|FG000|Overall Study|Death|3|||
145489216|NCT01519323|524645589|FG001|Overall Study|Death|2|||
145489217|NCT01519323|524645588|FG000|Overall Study|Study terminated by sponsor|0|||
145489218|NCT01519323|524645589|FG001|Overall Study|Study terminated by sponsor|1|||
145489219|NCT03858049|524645590|FG000|Overall Study|Adverse Event|16|||
145489220|NCT03858049|524645591|FG001|Overall Study|Adverse Event|9|||
145489221|NCT03858049|524645590|FG000|Overall Study|Other|1|||
145489222|NCT03858049|524645591|FG001|Overall Study|Other|1|||
145489223|NCT02079740|524645592|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
145489224|NCT02079740|524645593|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
145489225|NCT02079740|524645594|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
145489226|NCT02079740|524645595|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
145489227|NCT02079740|524645596|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
145489228|NCT02079740|524645597|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
145489229|NCT02079740|524645598|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
145489230|NCT02079740|524645599|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
145489231|NCT02079740|524645600|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
145489232|NCT02079740|524645601|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
145489233|NCT02079740|524645602|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
145489234|NCT02079740|524645603|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
145489235|NCT02079740|524645604|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
145489236|NCT02079740|524645592|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
145489237|NCT02079740|524645593|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
145489238|NCT02079740|524645594|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
145489239|NCT02079740|524645595|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
145489240|NCT02079740|524645596|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
145489241|NCT02079740|524645597|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
145489242|NCT02079740|524645598|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
145489243|NCT02079740|524645599|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
145489244|NCT02079740|524645600|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
145489245|NCT02079740|524645601|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
145489246|NCT02079740|524645602|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
145489247|NCT02079740|524645603|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
145489248|NCT02079740|524645604|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
145489249|NCT02079740|524645592|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489250|NCT02079740|524645593|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489251|NCT02079740|524645594|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489252|NCT02079740|524645595|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489253|NCT02079740|524645596|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489254|NCT02079740|524645597|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489255|NCT02079740|524645598|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489256|NCT02079740|524645599|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
145489257|NCT02079740|524645600|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489258|NCT02079740|524645601|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489259|NCT02079740|524645602|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489260|NCT02079740|524645603|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489261|NCT02079740|524645604|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
145489262|NCT02079740|524645592|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489263|NCT02079740|524645593|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489264|NCT02079740|524645594|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489265|NCT02079740|524645595|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489266|NCT02079740|524645596|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489267|NCT02079740|524645597|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489268|NCT02079740|524645598|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489269|NCT02079740|524645599|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
145489270|NCT02079740|524645600|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489271|NCT02079740|524645601|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489272|NCT02079740|524645602|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489273|NCT02079740|524645603|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145651467|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
145651468|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651469|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651470|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651471|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
145651472|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651473|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651474|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651475|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651476|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651477|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651478|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
145651479|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
145651480|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
145651481|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651482|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651483|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651484|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
145651485|NCT01261312|525242343|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651486|NCT01261312|525242344|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651487|NCT01261312|525242345|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651488|NCT01261312|525242346|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651489|NCT01261312|525242347|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651490|NCT01261312|525242348|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651491|NCT01261312|525242349|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
145651492|NCT01261312|525242350|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
145651493|NCT01261312|525242351|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
145651494|NCT01261312|525242352|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651495|NCT01261312|525242353|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651496|NCT01261312|525242354|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651497|NCT01261312|525242355|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
145651498|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651499|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651500|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651501|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651502|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651503|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651504|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651505|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651506|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
145651507|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
145489274|NCT02079740|524645604|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
145489275|NCT02079740|524645592|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489276|NCT02079740|524645593|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489277|NCT02079740|524645594|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489278|NCT02079740|524645595|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489279|NCT02079740|524645596|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489280|NCT02079740|524645597|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489281|NCT02079740|524645598|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489282|NCT02079740|524645599|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489283|NCT02079740|524645600|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489284|NCT02079740|524645601|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
145489285|NCT02079740|524645602|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
145489286|NCT02079740|524645603|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
145489287|NCT02079740|524645604|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
145489288|NCT04617782|524645605|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
145489289|NCT04617782|524645605|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
145489290|NCT04617782|524645605|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
145489291|NCT04617782|524645605|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
145489292|NCT04617782|524645605|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
145489293|NCT04617782|524645605|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
145489294|NCT01131507|524645610|FG000|Overall Study|Adverse Event|1|||
145489295|NCT01131507|524645610|FG000|Overall Study|Lost to Follow-up|1|||
145489296|NCT01131507|524645610|FG000|Overall Study|Withdrawal by Subject|1|||
145489297|NCT01535807|524645616|FG000|Overall Study|Withdrawal by Subject|1|||
145489298|NCT01535807|524645617|FG001|Overall Study|Withdrawal by Subject|1|||
145489299|NCT01535807|524645616|FG000|Overall Study|Data collection error|1|||
145489300|NCT01535807|524645617|FG001|Overall Study|Data collection error|1|||
145489301|NCT02730728|524645620|FG000|Overall Study|Withdrawal by Subject|0|||
145651508|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
145651509|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
145489302|NCT02730728|524645621|FG001|Overall Study|Withdrawal by Subject|1|||
145489303|NCT02730728|524645622|FG002|Overall Study|Withdrawal by Subject|0|||
145489304|NCT02730728|524645620|FG000|Overall Study|Lack of Efficacy|0|||
145489305|NCT02730728|524645621|FG001|Overall Study|Lack of Efficacy|1|||
145489306|NCT02730728|524645622|FG002|Overall Study|Lack of Efficacy|1|||
145489307|NCT02123134|524645634|FG000|Overall Study|Withdrawal of consent|3|||
145489308|NCT02123134|524645635|FG001|Overall Study|Withdrawal of consent|2|||
145489309|NCT02123134|524645634|FG000|Overall Study|Administrative decision|0|||
145489310|NCT02123134|524645635|FG001|Overall Study|Administrative decision|1|||
145489311|NCT01731912|524645641|FG000|Overall Study|noncompliance|2|||
145489312|NCT02043938|524645642|FG000|Overall Study|Withdrawal by Subject|7|||
145489313|NCT02043938|524645642|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
145489314|NCT02043938|524645642|FG000|Overall Study|No show by subject|1|||
145489315|NCT02043938|524645642|FG000|Overall Study|Investigator decision|1|||
145489316|NCT03010527|524645643|FG000|Overall Study|Death|0|||
145489317|NCT03010527|524645644|FG001|Overall Study|Death|0|||
145489318|NCT03010527|524645645|FG002|Overall Study|Death|1|||
145489319|NCT03010527|524645643|FG000|Overall Study|Adverse Event|0|||
145489320|NCT03010527|524645644|FG001|Overall Study|Adverse Event|4|||
145489321|NCT03010527|524645645|FG002|Overall Study|Adverse Event|2|||
145489322|NCT03010527|524645643|FG000|Overall Study|Protocol Violation|0|||
145489323|NCT03010527|524645644|FG001|Overall Study|Protocol Violation|1|||
145489324|NCT03010527|524645645|FG002|Overall Study|Protocol Violation|0|||
145489325|NCT03010527|524645643|FG000|Overall Study|Lost to Follow-up|0|||
145489326|NCT03010527|524645644|FG001|Overall Study|Lost to Follow-up|2|||
145489327|NCT03010527|524645645|FG002|Overall Study|Lost to Follow-up|1|||
145489328|NCT03010527|524645643|FG000|Overall Study|Withdrawal by Subject|0|||
145489329|NCT03010527|524645644|FG001|Overall Study|Withdrawal by Subject|3|||
145489330|NCT03010527|524645645|FG002|Overall Study|Withdrawal by Subject|4|||
145489331|NCT03010527|524645643|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
145489332|NCT03010527|524645644|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
145489333|NCT03010527|524645645|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
145489334|NCT03010527|524645643|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
145489335|NCT03010527|524645644|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
145489336|NCT03010527|524645645|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
145489337|NCT03010527|524645643|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
145489338|NCT03010527|524645644|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
145489339|NCT03010527|524645645|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
145489340|NCT01458639|524645646|FG000|Overall Study|Physician Decision|4|||
145489341|NCT01458639|524645646|FG000|Overall Study|Equipment issue|1|||
145489342|NCT01458639|524645646|FG000|Overall Study|Inability to obtain subject blood sample|1|||
145489343|NCT02656017|524645647|FG000|Overall Study|Study burden|3|||
145489344|NCT02656017|524645648|FG001|Overall Study|Study burden|3|||
145489345|NCT02656017|524645647|FG000|Overall Study|Adverse Event|2|||
145651510|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
145651511|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651512|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651513|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145489346|NCT02656017|524645648|FG001|Overall Study|Adverse Event|1|||
145489347|NCT02656017|524645647|FG000|Overall Study|Unable/unwilling to take study medication|2|||
145489348|NCT02656017|524645648|FG001|Overall Study|Unable/unwilling to take study medication|1|||
145489349|NCT02656017|524645647|FG000|Overall Study|Began Tolvaptan|1|||
145489350|NCT02656017|524645648|FG001|Overall Study|Began Tolvaptan|1|||
145489351|NCT02656017|524645647|FG000|Overall Study|Withdrawal by Subject|1|||
145489352|NCT02656017|524645648|FG001|Overall Study|Withdrawal by Subject|0|||
145489353|NCT01755234|524645649|FG000|Overall Study|Lost to Follow-up|11|||
145489354|NCT01755234|524645650|FG001|Overall Study|Lost to Follow-up|6|||
145489355|NCT01755234|524645649|FG000|Overall Study|Change in surgical case|2|||
145489356|NCT01755234|524645650|FG001|Overall Study|Change in surgical case|1|||
145651514|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651515|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145489357|NCT01755234|524645649|FG000|Overall Study|case cancelled|1|||
145489358|NCT01755234|524645650|FG001|Overall Study|case cancelled|0|||
145489359|NCT01755234|524645649|FG000|Overall Study|Withdrawal by Subject|0|||
145489360|NCT01755234|524645650|FG001|Overall Study|Withdrawal by Subject|1|||
145489361|NCT01755234|524645649|FG000|Overall Study|unblinded|1|||
145489362|NCT01755234|524645650|FG001|Overall Study|unblinded|0|||
145489363|NCT00248495|524645651|FG000|Overall Study|Withdrawal by Subject|1|||
145489364|NCT03812380|524645652|FG000|Overall Study|Protocol Violation|3|||
145489365|NCT03812380|524645653|FG001|Overall Study|Protocol Violation|3|||
145489366|NCT03812380|524645652|FG000|Overall Study|Withdrawal by Subject|5|||
145489367|NCT03812380|524645653|FG001|Overall Study|Withdrawal by Subject|4|||
145489368|NCT03812380|524645652|FG000|Overall Study|Early termination of study|14|||
145489369|NCT03812380|524645653|FG001|Overall Study|Early termination of study|14|||
145489370|NCT00981149|524645654|FG000|Overall Study|Lost to Follow-up|1|||
145489371|NCT00981149|524645655|FG001|Overall Study|Lost to Follow-up|2|||
145489372|NCT00981149|524645654|FG000|Overall Study|Withdrawal by Subject|1|||
145489373|NCT00981149|524645655|FG001|Overall Study|Withdrawal by Subject|1|||
145489374|NCT04244253|524645658|FG000|Overall Study|Adverse Event|2|||
145489375|NCT04244253|524645659|FG001|Overall Study|Adverse Event|2|||
145489376|NCT04244253|524645660|FG002|Overall Study|Adverse Event|4|||
145489377|NCT04244253|524645658|FG000|Overall Study|Protocol Violation|1|||
145489378|NCT04244253|524645659|FG001|Overall Study|Protocol Violation|2|||
145489379|NCT04244253|524645660|FG002|Overall Study|Protocol Violation|1|||
145651516|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651517|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651518|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651519|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651520|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
145651521|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
145651522|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
145651523|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
145651524|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651525|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145489380|NCT04244253|524645658|FG000|Overall Study|Withdrawal by Subject|0|||
145489381|NCT04244253|524645659|FG001|Overall Study|Withdrawal by Subject|1|||
145489382|NCT04244253|524645660|FG002|Overall Study|Withdrawal by Subject|6|||
145489383|NCT04244253|524645658|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145489384|NCT04244253|524645659|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145489385|NCT04244253|524645660|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145489386|NCT00622505|524645661|FG000|Overall Study|Adverse Event|9|||
145489387|NCT00622505|524645662|FG001|Overall Study|Adverse Event|7|||
145651526|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651527|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651528|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651529|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651530|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651531|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651532|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
145651533|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
145651534|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
145651535|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
145651536|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
145651537|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651538|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651539|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651540|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651541|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651542|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651543|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651544|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651545|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
145651546|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
145651547|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
145651548|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
145651549|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
145651550|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651551|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651552|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651553|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145489388|NCT00622505|524645661|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
145489389|NCT00622505|524645662|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
145651554|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651555|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145489390|NCT00622505|524645661|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
145489391|NCT00622505|524645662|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145489392|NCT00622505|524645661|FG000|Overall Study|Withdrawal by Subject|12|||
145489393|NCT00622505|524645662|FG001|Overall Study|Withdrawal by Subject|5|||
145489394|NCT00622505|524645661|FG000|Overall Study|Administrative Problems|2|||
145489395|NCT00622505|524645662|FG001|Overall Study|Administrative Problems|4|||
145489396|NCT00622505|524645661|FG000|Overall Study|Death|2|||
145489397|NCT00622505|524645662|FG001|Overall Study|Death|2|||
145489398|NCT00619515|524645663|FG000|Overall Study|Study Termination by IRB|73|||
145489399|NCT01216202|524645682|FG000|Overall Study|Withdrawal by Subject|8|||
145489400|NCT01216202|524645683|FG001|Overall Study|Withdrawal by Subject|0|||
145489401|NCT01216202|524645682|FG000|Overall Study|Death|0|||
145489402|NCT01216202|524645683|FG001|Overall Study|Death|2|||
145489403|NCT01216202|524645682|FG000|Overall Study|Lost to Follow-up|14|||
145489404|NCT01216202|524645683|FG001|Overall Study|Lost to Follow-up|0|||
145489405|NCT00614380|524645687|FG000|Overall Study|Adverse Event|14|||
145489406|NCT00614380|524645688|FG001|Overall Study|Adverse Event|4|||
145489407|NCT00614380|524645689|FG002|Overall Study|Adverse Event|0|||
145489408|NCT00614380|524645690|FG003|Overall Study|Adverse Event|0|||
145489409|NCT00614380|524645687|FG000|Overall Study|Lost to Follow-up|6|||
145489410|NCT00614380|524645688|FG001|Overall Study|Lost to Follow-up|1|||
145489411|NCT00614380|524645689|FG002|Overall Study|Lost to Follow-up|0|||
145489412|NCT00614380|524645690|FG003|Overall Study|Lost to Follow-up|0|||
145489413|NCT00614380|524645687|FG000|Overall Study|Non compliant with the protocol|12|||
145489414|NCT00614380|524645688|FG001|Overall Study|Non compliant with the protocol|2|||
145489415|NCT00614380|524645689|FG002|Overall Study|Non compliant with the protocol|1|||
145489416|NCT00614380|524645690|FG003|Overall Study|Non compliant with the protocol|2|||
145489417|NCT00614380|524645687|FG000|Overall Study|Consent withdrawn|3|||
145489418|NCT00614380|524645688|FG001|Overall Study|Consent withdrawn|1|||
145489419|NCT00614380|524645689|FG002|Overall Study|Consent withdrawn|0|||
145489420|NCT00614380|524645690|FG003|Overall Study|Consent withdrawn|0|||
145489421|NCT01506271|524645691|FG000|Overall Study|Progressive disease|0|||
145489422|NCT01506271|524645692|FG001|Overall Study|Progressive disease|1|||
145489423|NCT01506271|524645693|FG002|Overall Study|Progressive disease|0|||
145489424|NCT01506271|524645691|FG000|Overall Study|Protocol Violation|3|||
145489425|NCT01506271|524645692|FG001|Overall Study|Protocol Violation|1|||
145489426|NCT01506271|524645693|FG002|Overall Study|Protocol Violation|0|||
145489427|NCT01506271|524645691|FG000|Overall Study|Death|0|||
145489428|NCT01506271|524645692|FG001|Overall Study|Death|1|||
145489429|NCT01506271|524645693|FG002|Overall Study|Death|0|||
145489430|NCT01506271|524645691|FG000|Overall Study|Adverse Event|0|||
145489431|NCT01506271|524645692|FG001|Overall Study|Adverse Event|2|||
145489432|NCT01506271|524645693|FG002|Overall Study|Adverse Event|0|||
145651556|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651557|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651558|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
145651559|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
145651560|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
145651561|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
145651562|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
145651563|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651564|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651565|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651566|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651567|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651568|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651569|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651570|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651571|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
145651572|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
145651573|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
145651574|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
145651575|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
145651576|NCT01261312|525242343|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651577|NCT01261312|525242344|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651578|NCT01261312|525242345|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651579|NCT01261312|525242346|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651580|NCT01261312|525242347|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651581|NCT01261312|525242348|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145489433|NCT01506271|524645691|FG000|Overall Study|Insufficient supply of study drug|1|||
145489434|NCT01506271|524645692|FG001|Overall Study|Insufficient supply of study drug|0|||
145489435|NCT01506271|524645693|FG002|Overall Study|Insufficient supply of study drug|0|||
145489436|NCT01506271|524645691|FG000|Overall Study|Withdrawal by Subject|0|||
145489437|NCT01506271|524645692|FG001|Overall Study|Withdrawal by Subject|1|||
145489438|NCT01506271|524645693|FG002|Overall Study|Withdrawal by Subject|1|||
145489439|NCT01506271|524645691|FG000|Overall Study|Lost to Follow-up|0|||
145489440|NCT01506271|524645692|FG001|Overall Study|Lost to Follow-up|1|||
145489441|NCT01506271|524645693|FG002|Overall Study|Lost to Follow-up|2|||
145489442|NCT01808196|524645700|FG000|Overall Study|Lost to Follow-up|1|||
145489443|NCT03446313|524645701|FG000|Overall Study|Lost to Follow-up|1|||
145489444|NCT03446313|524645702|FG001|Overall Study|Lost to Follow-up|2|||
145489445|NCT03446313|524645701|FG000|Overall Study|Failed primary screening|3|||
145489446|NCT03446313|524645702|FG001|Overall Study|Failed primary screening|0|||
145489447|NCT03446313|524645701|FG000|Overall Study|Diagnosed with terminal cancer|1|||
145489448|NCT03446313|524645702|FG001|Overall Study|Diagnosed with terminal cancer|0|||
145489449|NCT03446313|524645701|FG000|Overall Study|Excluded from analysis|1|||
145489450|NCT03446313|524645702|FG001|Overall Study|Excluded from analysis|1|||
145489451|NCT01232868|524647497|FG000|Overall Study|Lost to Follow-up|2|||
145489452|NCT01232868|524647498|FG001|Overall Study|Lost to Follow-up|4|||
145489453|NCT04481243|524647499|FG000|Overall Study|Withdrawal by Subject|4|||
145489454|NCT04564846|524647500|FG000|Overall Study|Withdrawal by Subject|2|||
145489455|NCT04564846|524647501|FG001|Overall Study|Withdrawal by Subject|1|||
145489456|NCT04564846|524647500|FG000|Overall Study|Physician Decision|0|||
145489457|NCT04564846|524647501|FG001|Overall Study|Physician Decision|1|||
145489458|NCT04564846|524647500|FG000|Overall Study|Lost to Follow-up|0|||
145489459|NCT04564846|524647501|FG001|Overall Study|Lost to Follow-up|1|||
145489460|NCT04564846|524647500|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
145489461|NCT04564846|524647501|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
145489462|NCT04564846|524647500|FG000|Overall Study|Subject non-compliance|1|||
145489463|NCT04564846|524647501|FG001|Overall Study|Subject non-compliance|0|||
145489464|NCT03737123|524647502|FG000|Study Treatment|Adverse Event|2|||
145489465|NCT03737123|524647503|FG001|Study Treatment|Adverse Event|0|||
145489466|NCT03737123|524647502|FG000|Study Treatment|Disease Progression|2|||
145489467|NCT03737123|524647503|FG001|Study Treatment|Disease Progression|0|||
145489468|NCT03737123|524647502|FG000|Study Treatment|Withdrawal by Subject|2|||
145489469|NCT03737123|524647503|FG001|Study Treatment|Withdrawal by Subject|0|||
145489470|NCT03737123|524647502|FG000|Follow up|Death|1|||
145489471|NCT03737123|524647503|FG001|Follow up|Death|0|||
145489472|NCT03737123|524647502|FG000|Follow up|Withdrawal by Subject|1|||
145489473|NCT03737123|524647503|FG001|Follow up|Withdrawal by Subject|0|||
145489474|NCT03737123|524647502|FG000|Follow up|Termination of study|4|||
145489475|NCT03737123|524647503|FG001|Follow up|Termination of study|0|||
145489476|NCT01474317|524647521|FG000|Overall Study|Adverse Event|1|||
145489477|NCT01474317|524647521|FG000|Overall Study|Subject ineligible for study|1|||
145489478|NCT00387881|524647522|FG000|Overall Study|Lost to Follow-up|23|||
145489479|NCT00387881|524647523|FG001|Overall Study|Lost to Follow-up|23|||
145489480|NCT00387881|524647522|FG000|Overall Study|Protocol Violation|2|||
145489481|NCT00387881|524647523|FG001|Overall Study|Protocol Violation|12|||
145489482|NCT00387881|524647522|FG000|Overall Study|Withdrawal by Subject|15|||
145489483|NCT00387881|524647523|FG001|Overall Study|Withdrawal by Subject|18|||
145489484|NCT00387881|524647522|FG000|Overall Study|Sponsor terminated Study|0|||
145489485|NCT00387881|524647523|FG001|Overall Study|Sponsor terminated Study|1|||
145489486|NCT00387881|524647522|FG000|Overall Study|Not eligible|6|||
145489487|NCT00387881|524647523|FG001|Overall Study|Not eligible|7|||
145489488|NCT00387881|524647522|FG000|Overall Study|No opportunity to treat headache|32|||
145489489|NCT00387881|524647523|FG001|Overall Study|No opportunity to treat headache|34|||
145489490|NCT00387881|524647522|FG000|Overall Study|Not otherwise specified|11|||
145489491|NCT00387881|524647523|FG001|Overall Study|Not otherwise specified|7|||
145489492|NCT00453154|524647526|FG000|Double BIind Maintenance|Adverse Event|0|||
145489493|NCT00453154|524647527|FG001|Double BIind Maintenance|Adverse Event|0|||
145489494|NCT00453154|524647528|FG002|Double BIind Maintenance|Adverse Event|3|||
145489495|NCT00453154|524647529|FG003|Double BIind Maintenance|Adverse Event|12|||
145489496|NCT00453154|524647526|FG000|Double BIind Maintenance|Death|0|||
145489497|NCT00453154|524647527|FG001|Double BIind Maintenance|Death|0|||
145489498|NCT00453154|524647528|FG002|Double BIind Maintenance|Death|2|||
145489499|NCT00453154|524647529|FG003|Double BIind Maintenance|Death|1|||
145489500|NCT00453154|524647526|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
145489501|NCT00453154|524647527|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
145489502|NCT00453154|524647528|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
145489503|NCT00453154|524647529|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
145489504|NCT00453154|524647526|FG000|Double BIind Maintenance|Progression|0|||
145651582|NCT01261312|525242349|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651583|NCT01261312|525242350|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651584|NCT01261312|525242351|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
145651585|NCT01261312|525242352|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
145651586|NCT01261312|525242353|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
145651587|NCT01261312|525242354|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
145651588|NCT01261312|525242355|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
145489505|NCT00453154|524647527|FG001|Double BIind Maintenance|Progression|0|||
145489506|NCT00453154|524647528|FG002|Double BIind Maintenance|Progression|29|||
145489507|NCT00453154|524647529|FG003|Double BIind Maintenance|Progression|26|||
145489508|NCT00453154|524647526|FG000|Double BIind Maintenance|Medical Issues|0|||
145489509|NCT00453154|524647527|FG001|Double BIind Maintenance|Medical Issues|0|||
145489510|NCT00453154|524647528|FG002|Double BIind Maintenance|Medical Issues|3|||
145489511|NCT00453154|524647529|FG003|Double BIind Maintenance|Medical Issues|1|||
145489512|NCT00453154|524647526|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
145489513|NCT00453154|524647527|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
145651589|NCT03336333|525242358|FG000|Overall Study|Remained on study at time of data cut-off|202|||
145651590|NCT03336333|525242359|FG001|Overall Study|Remained on study at time of data cut-off|219|||
145651591|NCT03336333|525242360|FG002|Overall Study|Remained on study at time of data cut-off|102|||
145651592|NCT03336333|525242358|FG000|Overall Study|Death|14|||
145651593|NCT03336333|525242359|FG001|Overall Study|Death|16|||
145651594|NCT03336333|525242360|FG002|Overall Study|Death|8|||
145489514|NCT00453154|524647528|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
145489515|NCT00453154|524647529|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
145489516|NCT03629886|524647530|FG000|Overall Study|Migrated / moved from the study area|0|||
145489517|NCT03629886|524647531|FG001|Overall Study|Migrated / moved from the study area|55|||
145489518|NCT03629886|524647530|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
145489519|NCT03629886|524647531|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
145489520|NCT03629886|524647530|FG000|Overall Study|Study vaccine not administrated|0|||
145489521|NCT03629886|524647531|FG001|Overall Study|Study vaccine not administrated|3|||
145651595|NCT03336333|525242358|FG000|Overall Study|Withdrawal by Subject|16|||
145651596|NCT03336333|525242359|FG001|Overall Study|Withdrawal by Subject|5|||
145651597|NCT03336333|525242360|FG002|Overall Study|Withdrawal by Subject|1|||
145651598|NCT03336333|525242358|FG000|Overall Study|Physician Decision|5|||
145651599|NCT03336333|525242359|FG001|Overall Study|Physician Decision|1|||
145651600|NCT03336333|525242360|FG002|Overall Study|Physician Decision|0|||
145489522|NCT03629886|524647530|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
145489523|NCT03629886|524647531|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
145489524|NCT03629886|524647530|FG000|Overall Study|Refused vaccination step of the study|0|||
145489525|NCT03629886|524647531|FG001|Overall Study|Refused vaccination step of the study|44|||
145489526|NCT03291067|524647532|FG000|Overall Study|Adverse Event|0|||
145489527|NCT03291067|524647533|FG001|Overall Study|Adverse Event|2|||
145489528|NCT03291067|524647534|FG002|Overall Study|Adverse Event|17|||
145489529|NCT03291067|524647535|FG003|Overall Study|Adverse Event|3|||
145489530|NCT03291067|524647532|FG000|Overall Study|Lost to Follow-up|2|||
145489531|NCT03291067|524647533|FG001|Overall Study|Lost to Follow-up|1|||
145489532|NCT03291067|524647534|FG002|Overall Study|Lost to Follow-up|0|||
145489533|NCT03291067|524647535|FG003|Overall Study|Lost to Follow-up|1|||
145489534|NCT03291067|524647532|FG000|Overall Study|Physician Decision|0|||
145489535|NCT03291067|524647533|FG001|Overall Study|Physician Decision|0|||
145489536|NCT03291067|524647534|FG002|Overall Study|Physician Decision|1|||
145489537|NCT03291067|524647535|FG003|Overall Study|Physician Decision|0|||
145489538|NCT03291067|524647532|FG000|Overall Study|Protocol Violation|5|||
145651601|NCT03336333|525242358|FG000|Overall Study|Lost to Follow-up|1|||
145651602|NCT03336333|525242359|FG001|Overall Study|Lost to Follow-up|0|||
145651603|NCT03336333|525242360|FG002|Overall Study|Lost to Follow-up|0|||
145651604|NCT04927065|525242361|FG000|First Booster|Adverse Event|1|||
145651605|NCT04927065|525242362|FG001|First Booster|Adverse Event|0|||
145651606|NCT04927065|525242363|FG002|First Booster|Adverse Event|0|||
145651607|NCT04927065|525242364|FG003|First Booster|Adverse Event|0|||
145651608|NCT04927065|525242365|FG004|First Booster|Adverse Event|0|||
145651609|NCT04927065|525242366|FG005|First Booster|Adverse Event|0|||
145651610|NCT04927065|525242367|FG006|First Booster|Adverse Event|0|||
145651611|NCT04927065|525242368|FG007|First Booster|Adverse Event|1|||
145489539|NCT03291067|524647533|FG001|Overall Study|Protocol Violation|3|||
145489540|NCT03291067|524647534|FG002|Overall Study|Protocol Violation|4|||
145489541|NCT03291067|524647535|FG003|Overall Study|Protocol Violation|2|||
145651612|NCT04927065|525242369|FG008|First Booster|Adverse Event|0|||
145651613|NCT04927065|525242370|FG009|First Booster|Adverse Event|0|||
145651614|NCT04927065|525242371|FG010|First Booster|Adverse Event|0|||
145651615|NCT04927065|525242372|FG011|First Booster|Adverse Event|0|||
145651616|NCT04927065|525242373|FG012|First Booster|Adverse Event|0|||
145651617|NCT04927065|525242374|FG013|First Booster|Adverse Event|0|||
145489542|NCT03291067|524647532|FG000|Overall Study|Withdrawal by Subject|3|||
145489543|NCT03291067|524647533|FG001|Overall Study|Withdrawal by Subject|4|||
145489544|NCT03291067|524647534|FG002|Overall Study|Withdrawal by Subject|7|||
145489545|NCT03291067|524647535|FG003|Overall Study|Withdrawal by Subject|5|||
145489546|NCT03291067|524647532|FG000|Overall Study|Other|0|||
145489547|NCT03291067|524647533|FG001|Overall Study|Other|4|||
145651618|NCT04927065|525242375|FG014|First Booster|Adverse Event|0|||
145651619|NCT04927065|525242376|FG015|First Booster|Adverse Event|0|||
145651620|NCT04927065|525242361|FG000|First Booster|Death|1|||
145651621|NCT04927065|525242362|FG001|First Booster|Death|0|||
145489548|NCT03291067|524647534|FG002|Overall Study|Other|4|||
145489549|NCT03291067|524647535|FG003|Overall Study|Other|6|||
145489550|NCT03683173|524647536|FG000|Completed Follow-up|Unavailable|235|||
145489551|NCT03683173|524647537|FG001|Completed Follow-up|Unavailable|217|||
145489552|NCT03683173|524647536|FG000|Completed Follow-up|Refused|69|||
145489553|NCT03683173|524647537|FG001|Completed Follow-up|Refused|59|||
145489554|NCT03683173|524647536|FG000|Completed Follow-up|Disconnected phone|65|||
145489555|NCT03683173|524647537|FG001|Completed Follow-up|Disconnected phone|95|||
145489556|NCT03683173|524647536|FG000|Completed Follow-up|Health issue/deceased|10|||
145489557|NCT03683173|524647537|FG001|Completed Follow-up|Health issue/deceased|4|||
145489558|NCT03683173|524647536|FG000|Completed Follow-up|Moved away|8|||
145489559|NCT03683173|524647537|FG001|Completed Follow-up|Moved away|1|||
145489560|NCT03016312|524647538|FG000|Overall Study|discontinued before the treatment started|0|||
145489561|NCT03016312|524647539|FG001|Overall Study|discontinued before the treatment started|1|||
145489562|NCT03016312|524647538|FG000|Overall Study|Withdrawal by Subject|37|||
145489563|NCT03016312|524647539|FG001|Overall Study|Withdrawal by Subject|44|||
145489564|NCT03016312|524647538|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
145489565|NCT03016312|524647539|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
145489566|NCT03016312|524647538|FG000|Overall Study|Physician Decision|1|||
145489567|NCT03016312|524647539|FG001|Overall Study|Physician Decision|3|||
145489568|NCT03016312|524647538|FG000|Overall Study|Lost to Follow-up|12|||
145489569|NCT03016312|524647539|FG001|Overall Study|Lost to Follow-up|12|||
145489570|NCT03016312|524647538|FG000|Overall Study|Death|210|||
145489571|NCT03016312|524647539|FG001|Overall Study|Death|184|||
145489572|NCT03016312|524647538|FG000|Overall Study|loss to contact|1|||
145489573|NCT03016312|524647539|FG001|Overall Study|loss to contact|0|||
145489574|NCT03016312|524647538|FG000|Overall Study|started a new cancer therapy|1|||
145489575|NCT03016312|524647539|FG001|Overall Study|started a new cancer therapy|0|||
145489576|NCT00496015|524647540|FG000|Overall Study|Other|1|||
145489577|NCT00496015|524647541|FG001|Overall Study|Other|0|||
145489578|NCT00496015|524647542|FG002|Overall Study|Other|0|||
145489579|NCT00496015|524647543|FG003|Overall Study|Other|1|||
145489580|NCT00496015|524647544|FG004|Overall Study|Other|0|||
145489581|NCT02193776|524647548|FG000|Overall Study|Consent withdrawn|1|||
145489582|NCT02193776|524647549|FG001|Overall Study|Consent withdrawn|0|||
145489583|NCT02193776|524647550|FG002|Overall Study|Consent withdrawn|0|||
145489584|NCT02193776|524647551|FG003|Overall Study|Consent withdrawn|0|||
145489585|NCT02193776|524647548|FG000|Overall Study|Failure to comply with protocol|0|||
145651622|NCT04927065|525242363|FG002|First Booster|Death|0|||
145651623|NCT04927065|525242364|FG003|First Booster|Death|1|||
145651624|NCT04927065|525242365|FG004|First Booster|Death|0|||
145651625|NCT04927065|525242366|FG005|First Booster|Death|1|||
145651626|NCT04927065|525242367|FG006|First Booster|Death|0|||
145651627|NCT04927065|525242368|FG007|First Booster|Death|0|||
145651628|NCT04927065|525242369|FG008|First Booster|Death|0|||
145651629|NCT04927065|525242370|FG009|First Booster|Death|0|||
145651630|NCT04927065|525242371|FG010|First Booster|Death|0|||
145651631|NCT04927065|525242372|FG011|First Booster|Death|0|||
145651632|NCT04927065|525242373|FG012|First Booster|Death|0|||
145651633|NCT04927065|525242374|FG013|First Booster|Death|0|||
145651634|NCT04927065|525242375|FG014|First Booster|Death|0|||
145651635|NCT04927065|525242376|FG015|First Booster|Death|0|||
145651636|NCT04927065|525242361|FG000|First Booster|Lost to Follow-up|8|||
145651637|NCT04927065|525242362|FG001|First Booster|Lost to Follow-up|20|||
145651638|NCT04927065|525242363|FG002|First Booster|Lost to Follow-up|0|||
145651639|NCT04927065|525242364|FG003|First Booster|Lost to Follow-up|11|||
145651640|NCT04927065|525242365|FG004|First Booster|Lost to Follow-up|43|||
145651641|NCT04927065|525242366|FG005|First Booster|Lost to Follow-up|30|||
145651642|NCT04927065|525242367|FG006|First Booster|Lost to Follow-up|28|||
145651643|NCT04927065|525242368|FG007|First Booster|Lost to Follow-up|23|||
145489586|NCT02193776|524647549|FG001|Overall Study|Failure to comply with protocol|1|||
145489587|NCT02193776|524647550|FG002|Overall Study|Failure to comply with protocol|0|||
145489588|NCT02193776|524647551|FG003|Overall Study|Failure to comply with protocol|0|||
145489589|NCT02193776|524647548|FG000|Overall Study|Investigator/Sponsor decision|1|||
145651644|NCT04927065|525242369|FG008|First Booster|Lost to Follow-up|4|||
145651645|NCT04927065|525242370|FG009|First Booster|Lost to Follow-up|15|||
145651646|NCT04927065|525242371|FG010|First Booster|Lost to Follow-up|0|||
145489590|NCT02193776|524647549|FG001|Overall Study|Investigator/Sponsor decision|1|||
145489591|NCT02193776|524647550|FG002|Overall Study|Investigator/Sponsor decision|0|||
145489592|NCT02193776|524647551|FG003|Overall Study|Investigator/Sponsor decision|0|||
145489593|NCT02193776|524647548|FG000|Overall Study|Death|1|||
145489594|NCT02193776|524647549|FG001|Overall Study|Death|0|||
145651647|NCT04927065|525242372|FG011|First Booster|Lost to Follow-up|0|||
145651648|NCT04927065|525242373|FG012|First Booster|Lost to Follow-up|0|||
145651649|NCT04927065|525242374|FG013|First Booster|Lost to Follow-up|0|||
145489595|NCT02193776|524647550|FG002|Overall Study|Death|0|||
145489596|NCT02193776|524647551|FG003|Overall Study|Death|0|||
145489597|NCT02193776|524647548|FG000|Overall Study|Adverse event/Specific toxicity|5|||
145651650|NCT04927065|525242375|FG014|First Booster|Lost to Follow-up|0|||
145651651|NCT04927065|525242376|FG015|First Booster|Lost to Follow-up|0|||
145489598|NCT02193776|524647549|FG001|Overall Study|Adverse event/Specific toxicity|5|||
145489599|NCT02193776|524647550|FG002|Overall Study|Adverse event/Specific toxicity|2|||
145489600|NCT02193776|524647551|FG003|Overall Study|Adverse event/Specific toxicity|2|||
145489601|NCT01702844|524647552|FG000|Overall Study|Adverse Event|9|||
145489602|NCT01702844|524647552|FG000|Overall Study|Death|1|||
145489603|NCT01702844|524647552|FG000|Overall Study|Withdrawal by Subject|3|||
145489604|NCT01702844|524647552|FG000|Overall Study|Physician Decision|6|||
145489605|NCT01169103|524647554|FG000|Overall Study|Lost to Follow-up|3|||
145489606|NCT01169103|524647555|FG001|Overall Study|Lost to Follow-up|3|||
145489607|NCT01169103|524647554|FG000|Overall Study|Withdrawal by Subject|3|||
145489608|NCT01169103|524647555|FG001|Overall Study|Withdrawal by Subject|1|||
145489609|NCT02634333|524647556|FG000|Overall Study|Completed out of Window|3|||
145489610|NCT02634333|524647557|FG001|Overall Study|Completed out of Window|2|||
145489611|NCT02634333|524647556|FG000|Overall Study|Missed Visit|5|||
145489612|NCT02634333|524647557|FG001|Overall Study|Missed Visit|2|||
145489613|NCT02634333|524647556|FG000|Overall Study|Lost to Follow-up|12|||
145489614|NCT02634333|524647557|FG001|Overall Study|Lost to Follow-up|7|||
145489615|NCT02634333|524647556|FG000|Overall Study|Withdrawal by Subject|9|||
145489616|NCT02634333|524647557|FG001|Overall Study|Withdrawal by Subject|13|||
145489617|NCT02634333|524647556|FG000|Overall Study|Death|11|||
145489618|NCT02634333|524647557|FG001|Overall Study|Death|8|||
145489619|NCT02611479|524647558|FG000|Baseline Enrollment|Exited study|13|||
145489620|NCT02611479|524647558|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
145489621|NCT02611479|524647558|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
145489622|NCT02611479|524647558|FG000|Data Cleaning|No baseline function or pain metrics|2|||
145489623|NCT03275740|524647562|FG000|Overall Study|Adverse Event|0|||
145489624|NCT03275740|524647563|FG001|Overall Study|Adverse Event|0|||
145489625|NCT03275740|524647564|FG002|Overall Study|Adverse Event|0|||
145489626|NCT03275740|524647565|FG003|Overall Study|Adverse Event|0|||
145489627|NCT03275740|524647566|FG004|Overall Study|Adverse Event|1|||
145489628|NCT03275740|524647567|FG005|Overall Study|Adverse Event|0|||
145489629|NCT03275740|524647568|FG006|Overall Study|Adverse Event|0|||
145489630|NCT03275740|524647569|FG007|Overall Study|Adverse Event|0|||
145489631|NCT03275740|524647570|FG008|Overall Study|Adverse Event|0|||
145489632|NCT03275740|524647571|FG009|Overall Study|Adverse Event|0|||
145489633|NCT03275740|524647572|FG010|Overall Study|Adverse Event|0|||
145489634|NCT03275740|524647573|FG011|Overall Study|Adverse Event|0|||
145489635|NCT03275740|524647562|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489636|NCT03275740|524647563|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489637|NCT03275740|524647564|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489638|NCT03275740|524647565|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489639|NCT03275740|524647566|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489640|NCT03275740|524647567|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
145489641|NCT03275740|524647568|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489642|NCT03275740|524647569|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489643|NCT03275740|524647570|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489644|NCT03275740|524647571|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489645|NCT03275740|524647572|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489646|NCT03275740|524647573|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
145489647|NCT03275740|524647562|FG000|Overall Study|Withdrawal by Subject|0|||
145489648|NCT03275740|524647563|FG001|Overall Study|Withdrawal by Subject|0|||
145489649|NCT03275740|524647564|FG002|Overall Study|Withdrawal by Subject|0|||
145489650|NCT03275740|524647565|FG003|Overall Study|Withdrawal by Subject|0|||
145489651|NCT03275740|524647566|FG004|Overall Study|Withdrawal by Subject|0|||
145489652|NCT03275740|524647567|FG005|Overall Study|Withdrawal by Subject|0|||
145489653|NCT03275740|524647568|FG006|Overall Study|Withdrawal by Subject|0|||
145489654|NCT03275740|524647569|FG007|Overall Study|Withdrawal by Subject|0|||
145489655|NCT03275740|524647570|FG008|Overall Study|Withdrawal by Subject|1|||
145489656|NCT03275740|524647571|FG009|Overall Study|Withdrawal by Subject|1|||
145489657|NCT03275740|524647572|FG010|Overall Study|Withdrawal by Subject|0|||
145489658|NCT03275740|524647573|FG011|Overall Study|Withdrawal by Subject|0|||
145489659|NCT00890825|524647574|FG000|Overall Study|Withdrawal by Subject|1|||
145489660|NCT00890825|524647575|FG001|Overall Study|Withdrawal by Subject|0|||
145489661|NCT00890825|524647574|FG000|Overall Study|Alive at data cut off (DCO)|13|||
145489662|NCT00890825|524647575|FG001|Overall Study|Alive at data cut off (DCO)|14|||
145489663|NCT04701333|524647576|FG000|Overall Study|Lost to Follow-up|3|||
145489664|NCT04701333|524647577|FG001|Overall Study|Lost to Follow-up|7|||
145489665|NCT04701333|524647576|FG000|Overall Study|Withdrawal by Subject|0|||
145489666|NCT04701333|524647577|FG001|Overall Study|Withdrawal by Subject|1|||
145489667|NCT02920892|524647578|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
145489668|NCT02920892|524647579|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
145489669|NCT02920892|524647580|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
145489670|NCT02920892|524647578|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
145489671|NCT02920892|524647579|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
145489672|NCT02920892|524647580|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
145489673|NCT02920892|524647578|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
145489674|NCT02920892|524647579|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
145489675|NCT02920892|524647580|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
145489676|NCT02920892|524647578|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
145489677|NCT02920892|524647579|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
145489678|NCT02920892|524647580|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
145489679|NCT02920892|524647578|FG000|Placebo-Controlled Period|Physician Decision|0|||
145489680|NCT02920892|524647579|FG001|Placebo-Controlled Period|Physician Decision|0|||
145489681|NCT02920892|524647580|FG002|Placebo-Controlled Period|Physician Decision|1|||
145489682|NCT02920892|524647578|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
145489683|NCT02920892|524647579|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
145489684|NCT02920892|524647580|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
145489685|NCT02920892|524647578|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145489686|NCT02920892|524647579|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
145489687|NCT02920892|524647580|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
145489688|NCT02920892|524647578|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
145489689|NCT02920892|524647579|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
145489690|NCT02920892|524647580|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
145489691|NCT01391663|524647581|FG000|Overall Study|Withdrawal by Subject|0|||
145651652|NCT04927065|525242361|FG000|First Booster|Physician Decision|1|||
145651653|NCT04927065|525242362|FG001|First Booster|Physician Decision|0|||
145651654|NCT04927065|525242363|FG002|First Booster|Physician Decision|0|||
145651655|NCT04927065|525242364|FG003|First Booster|Physician Decision|3|||
145651656|NCT04927065|525242365|FG004|First Booster|Physician Decision|1|||
145651657|NCT04927065|525242366|FG005|First Booster|Physician Decision|1|||
145651658|NCT04927065|525242367|FG006|First Booster|Physician Decision|0|||
145651659|NCT04927065|525242368|FG007|First Booster|Physician Decision|3|||
145651660|NCT04927065|525242369|FG008|First Booster|Physician Decision|0|||
145651661|NCT04927065|525242370|FG009|First Booster|Physician Decision|0|||
145651662|NCT04927065|525242371|FG010|First Booster|Physician Decision|0|||
145651663|NCT04927065|525242372|FG011|First Booster|Physician Decision|0|||
145651664|NCT04927065|525242373|FG012|First Booster|Physician Decision|0|||
145651665|NCT04927065|525242374|FG013|First Booster|Physician Decision|0|||
145651666|NCT04927065|525242375|FG014|First Booster|Physician Decision|0|||
145651667|NCT04927065|525242376|FG015|First Booster|Physician Decision|0|||
145651668|NCT04927065|525242361|FG000|First Booster|Protocol Violation|4|||
145651669|NCT04927065|525242362|FG001|First Booster|Protocol Violation|4|||
145651670|NCT04927065|525242363|FG002|First Booster|Protocol Violation|0|||
145651671|NCT04927065|525242364|FG003|First Booster|Protocol Violation|3|||
145651672|NCT04927065|525242365|FG004|First Booster|Protocol Violation|0|||
145651673|NCT04927065|525242366|FG005|First Booster|Protocol Violation|0|||
145651674|NCT04927065|525242367|FG006|First Booster|Protocol Violation|0|||
145651675|NCT04927065|525242368|FG007|First Booster|Protocol Violation|2|||
145651676|NCT04927065|525242369|FG008|First Booster|Protocol Violation|0|||
145651677|NCT04927065|525242370|FG009|First Booster|Protocol Violation|0|||
145651678|NCT04927065|525242371|FG010|First Booster|Protocol Violation|0|||
145651679|NCT04927065|525242372|FG011|First Booster|Protocol Violation|0|||
145651680|NCT04927065|525242373|FG012|First Booster|Protocol Violation|0|||
145651681|NCT04927065|525242374|FG013|First Booster|Protocol Violation|0|||
145651682|NCT04927065|525242375|FG014|First Booster|Protocol Violation|0|||
145651683|NCT04927065|525242376|FG015|First Booster|Protocol Violation|0|||
145651684|NCT04927065|525242361|FG000|First Booster|Withdrawal by Subject|8|||
145651685|NCT04927065|525242362|FG001|First Booster|Withdrawal by Subject|23|||
145651686|NCT04927065|525242363|FG002|First Booster|Withdrawal by Subject|0|||
145651687|NCT04927065|525242364|FG003|First Booster|Withdrawal by Subject|19|||
145651688|NCT04927065|525242365|FG004|First Booster|Withdrawal by Subject|20|||
145651689|NCT04927065|525242366|FG005|First Booster|Withdrawal by Subject|15|||
145651690|NCT04927065|525242367|FG006|First Booster|Withdrawal by Subject|6|||
145651691|NCT04927065|525242368|FG007|First Booster|Withdrawal by Subject|24|||
145651692|NCT04927065|525242369|FG008|First Booster|Withdrawal by Subject|0|||
145651693|NCT04927065|525242370|FG009|First Booster|Withdrawal by Subject|4|||
145651694|NCT04927065|525242371|FG010|First Booster|Withdrawal by Subject|0|||
145651695|NCT04927065|525242372|FG011|First Booster|Withdrawal by Subject|0|||
145651696|NCT04927065|525242373|FG012|First Booster|Withdrawal by Subject|0|||
145651697|NCT04927065|525242374|FG013|First Booster|Withdrawal by Subject|0|||
145651698|NCT04927065|525242375|FG014|First Booster|Withdrawal by Subject|0|||
145651699|NCT04927065|525242376|FG015|First Booster|Withdrawal by Subject|0|||
145651700|NCT04927065|525242361|FG000|First Booster|Other Than Specified|1|||
145651701|NCT04927065|525242362|FG001|First Booster|Other Than Specified|1|||
145651702|NCT04927065|525242363|FG002|First Booster|Other Than Specified|0|||
145651703|NCT04927065|525242364|FG003|First Booster|Other Than Specified|1|||
145651704|NCT04927065|525242365|FG004|First Booster|Other Than Specified|2|||
145651705|NCT04927065|525242366|FG005|First Booster|Other Than Specified|3|||
145651706|NCT04927065|525242367|FG006|First Booster|Other Than Specified|2|||
145651707|NCT04927065|525242368|FG007|First Booster|Other Than Specified|6|||
145651708|NCT04927065|525242369|FG008|First Booster|Other Than Specified|0|||
145651709|NCT04927065|525242370|FG009|First Booster|Other Than Specified|4|||
145651710|NCT04927065|525242371|FG010|First Booster|Other Than Specified|0|||
145651711|NCT04927065|525242372|FG011|First Booster|Other Than Specified|0|||
145651712|NCT04927065|525242373|FG012|First Booster|Other Than Specified|0|||
145651713|NCT04927065|525242374|FG013|First Booster|Other Than Specified|0|||
145651714|NCT04927065|525242375|FG014|First Booster|Other Than Specified|0|||
145651715|NCT04927065|525242376|FG015|First Booster|Other Than Specified|0|||
145651716|NCT04927065|525242361|FG000|Second Booster|Death|0|||
145651717|NCT04927065|525242362|FG001|Second Booster|Death|0|||
145651718|NCT04927065|525242363|FG002|Second Booster|Death|0|||
145651719|NCT04927065|525242364|FG003|Second Booster|Death|0|||
145651720|NCT04927065|525242365|FG004|Second Booster|Death|0|||
145651721|NCT04927065|525242366|FG005|Second Booster|Death|0|||
145651722|NCT04927065|525242367|FG006|Second Booster|Death|0|||
145651723|NCT04927065|525242368|FG007|Second Booster|Death|0|||
145651724|NCT04927065|525242369|FG008|Second Booster|Death|0|||
145651725|NCT04927065|525242370|FG009|Second Booster|Death|0|||
145651726|NCT04927065|525242371|FG010|Second Booster|Death|2|||
145651727|NCT04927065|525242372|FG011|Second Booster|Death|0|||
145651728|NCT04927065|525242373|FG012|Second Booster|Death|2|||
145651729|NCT04927065|525242374|FG013|Second Booster|Death|2|||
145651730|NCT04927065|525242375|FG014|Second Booster|Death|0|||
145651731|NCT04927065|525242376|FG015|Second Booster|Death|0|||
145651732|NCT04927065|525242361|FG000|Second Booster|Lost to Follow-up|0|||
145651733|NCT04927065|525242362|FG001|Second Booster|Lost to Follow-up|0|||
145651734|NCT04927065|525242363|FG002|Second Booster|Lost to Follow-up|3|||
145651735|NCT04927065|525242364|FG003|Second Booster|Lost to Follow-up|0|||
145651736|NCT04927065|525242365|FG004|Second Booster|Lost to Follow-up|0|||
145651737|NCT04927065|525242366|FG005|Second Booster|Lost to Follow-up|0|||
145651738|NCT04927065|525242367|FG006|Second Booster|Lost to Follow-up|0|||
145651739|NCT04927065|525242368|FG007|Second Booster|Lost to Follow-up|0|||
145651740|NCT04927065|525242369|FG008|Second Booster|Lost to Follow-up|0|||
145651741|NCT04927065|525242370|FG009|Second Booster|Lost to Follow-up|0|||
145651742|NCT04927065|525242371|FG010|Second Booster|Lost to Follow-up|14|||
145651743|NCT04927065|525242372|FG011|Second Booster|Lost to Follow-up|10|||
145651744|NCT04927065|525242373|FG012|Second Booster|Lost to Follow-up|13|||
145651745|NCT04927065|525242374|FG013|Second Booster|Lost to Follow-up|16|||
145651746|NCT04927065|525242375|FG014|Second Booster|Lost to Follow-up|0|||
145651747|NCT04927065|525242376|FG015|Second Booster|Lost to Follow-up|0|||
145651748|NCT04927065|525242361|FG000|Second Booster|Physician Decision|0|||
145651749|NCT04927065|525242362|FG001|Second Booster|Physician Decision|0|||
145651750|NCT04927065|525242363|FG002|Second Booster|Physician Decision|0|||
145651751|NCT04927065|525242364|FG003|Second Booster|Physician Decision|0|||
145651752|NCT04927065|525242365|FG004|Second Booster|Physician Decision|0|||
145651753|NCT04927065|525242366|FG005|Second Booster|Physician Decision|0|||
145651754|NCT04927065|525242367|FG006|Second Booster|Physician Decision|0|||
145651755|NCT04927065|525242368|FG007|Second Booster|Physician Decision|0|||
145651756|NCT04927065|525242369|FG008|Second Booster|Physician Decision|0|||
145651757|NCT04927065|525242370|FG009|Second Booster|Physician Decision|0|||
145651758|NCT04927065|525242371|FG010|Second Booster|Physician Decision|0|||
145651759|NCT04927065|525242372|FG011|Second Booster|Physician Decision|3|||
145651760|NCT04927065|525242373|FG012|Second Booster|Physician Decision|0|||
145651761|NCT04927065|525242374|FG013|Second Booster|Physician Decision|1|||
145651762|NCT04927065|525242375|FG014|Second Booster|Physician Decision|0|||
145651763|NCT04927065|525242376|FG015|Second Booster|Physician Decision|0|||
145651764|NCT04927065|525242361|FG000|Second Booster|Withdrawal by Subject|0|||
145651765|NCT04927065|525242362|FG001|Second Booster|Withdrawal by Subject|0|||
145651766|NCT04927065|525242363|FG002|Second Booster|Withdrawal by Subject|4|||
145651767|NCT04927065|525242364|FG003|Second Booster|Withdrawal by Subject|0|||
145651768|NCT04927065|525242365|FG004|Second Booster|Withdrawal by Subject|0|||
145651769|NCT04927065|525242366|FG005|Second Booster|Withdrawal by Subject|0|||
145651770|NCT04927065|525242367|FG006|Second Booster|Withdrawal by Subject|0|||
145651771|NCT04927065|525242368|FG007|Second Booster|Withdrawal by Subject|0|||
145651772|NCT04927065|525242369|FG008|Second Booster|Withdrawal by Subject|0|||
145651773|NCT04927065|525242370|FG009|Second Booster|Withdrawal by Subject|0|||
145651774|NCT04927065|525242371|FG010|Second Booster|Withdrawal by Subject|3|||
145651775|NCT04927065|525242372|FG011|Second Booster|Withdrawal by Subject|16|||
145651776|NCT04927065|525242373|FG012|Second Booster|Withdrawal by Subject|13|||
145651777|NCT04927065|525242374|FG013|Second Booster|Withdrawal by Subject|9|||
145651778|NCT04927065|525242375|FG014|Second Booster|Withdrawal by Subject|0|||
145651779|NCT04927065|525242376|FG015|Second Booster|Withdrawal by Subject|0|||
145651780|NCT04927065|525242361|FG000|Second Booster|Other Than Specified|0|||
145651781|NCT04927065|525242362|FG001|Second Booster|Other Than Specified|0|||
145651782|NCT04927065|525242363|FG002|Second Booster|Other Than Specified|0|||
145651783|NCT04927065|525242364|FG003|Second Booster|Other Than Specified|0|||
145651784|NCT04927065|525242365|FG004|Second Booster|Other Than Specified|0|||
145651785|NCT04927065|525242366|FG005|Second Booster|Other Than Specified|0|||
145651786|NCT04927065|525242367|FG006|Second Booster|Other Than Specified|0|||
145651787|NCT04927065|525242368|FG007|Second Booster|Other Than Specified|0|||
145651788|NCT04927065|525242369|FG008|Second Booster|Other Than Specified|0|||
145651789|NCT04927065|525242370|FG009|Second Booster|Other Than Specified|0|||
145651790|NCT04927065|525242371|FG010|Second Booster|Other Than Specified|1|||
145651791|NCT04927065|525242372|FG011|Second Booster|Other Than Specified|1|||
145651792|NCT04927065|525242373|FG012|Second Booster|Other Than Specified|4|||
145651793|NCT04927065|525242374|FG013|Second Booster|Other Than Specified|0|||
145651794|NCT04927065|525242375|FG014|Second Booster|Other Than Specified|0|||
145651795|NCT04927065|525242376|FG015|Second Booster|Other Than Specified|0|||
145651796|NCT04927065|525242361|FG000|Third Booster|Lost to Follow-up|0|||
145651797|NCT04927065|525242362|FG001|Third Booster|Lost to Follow-up|0|||
145651798|NCT04927065|525242363|FG002|Third Booster|Lost to Follow-up|0|||
145651799|NCT04927065|525242364|FG003|Third Booster|Lost to Follow-up|0|||
145651800|NCT04927065|525242365|FG004|Third Booster|Lost to Follow-up|0|||
145651801|NCT04927065|525242366|FG005|Third Booster|Lost to Follow-up|0|||
145651802|NCT04927065|525242367|FG006|Third Booster|Lost to Follow-up|0|||
145651803|NCT04927065|525242368|FG007|Third Booster|Lost to Follow-up|0|||
145651804|NCT04927065|525242369|FG008|Third Booster|Lost to Follow-up|0|||
145651805|NCT04927065|525242370|FG009|Third Booster|Lost to Follow-up|0|||
145651806|NCT04927065|525242371|FG010|Third Booster|Lost to Follow-up|0|||
145651807|NCT04927065|525242372|FG011|Third Booster|Lost to Follow-up|0|||
145651808|NCT04927065|525242373|FG012|Third Booster|Lost to Follow-up|0|||
145651809|NCT04927065|525242374|FG013|Third Booster|Lost to Follow-up|0|||
145651810|NCT04927065|525242375|FG014|Third Booster|Lost to Follow-up|0|||
145651811|NCT04927065|525242376|FG015|Third Booster|Lost to Follow-up|1|||
145651812|NCT04927065|525242361|FG000|Third Booster|Withdrawal by Subject|0|||
145651813|NCT04927065|525242362|FG001|Third Booster|Withdrawal by Subject|0|||
145651814|NCT04927065|525242363|FG002|Third Booster|Withdrawal by Subject|0|||
145651815|NCT04927065|525242364|FG003|Third Booster|Withdrawal by Subject|0|||
145651816|NCT04927065|525242365|FG004|Third Booster|Withdrawal by Subject|0|||
145651817|NCT04927065|525242366|FG005|Third Booster|Withdrawal by Subject|0|||
145651818|NCT04927065|525242367|FG006|Third Booster|Withdrawal by Subject|0|||
145651819|NCT04927065|525242368|FG007|Third Booster|Withdrawal by Subject|0|||
145651820|NCT04927065|525242369|FG008|Third Booster|Withdrawal by Subject|0|||
145651821|NCT04927065|525242370|FG009|Third Booster|Withdrawal by Subject|0|||
145651822|NCT04927065|525242371|FG010|Third Booster|Withdrawal by Subject|0|||
145651823|NCT04927065|525242372|FG011|Third Booster|Withdrawal by Subject|0|||
145651824|NCT04927065|525242373|FG012|Third Booster|Withdrawal by Subject|0|||
145651825|NCT04927065|525242374|FG013|Third Booster|Withdrawal by Subject|0|||
145651826|NCT04927065|525242375|FG014|Third Booster|Withdrawal by Subject|0|||
145651827|NCT04927065|525242376|FG015|Third Booster|Withdrawal by Subject|1|||
145651828|NCT03406871|525242379|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
145651829|NCT03406871|525242380|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
145651830|NCT03406871|525242381|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
145651831|NCT03406871|525242379|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
145651832|NCT03406871|525242380|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
145651833|NCT03406871|525242381|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
145651834|NCT03406871|525242379|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
145651835|NCT03406871|525242380|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
145651836|NCT03406871|525242381|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
145651837|NCT03406871|525242379|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
145651838|NCT03406871|525242380|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
145651839|NCT03406871|525242381|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
145651840|NCT03406871|525242379|FG000|Expansion Cohort(Final Analysis)|Death|0|||
145651841|NCT03406871|525242380|FG001|Expansion Cohort(Final Analysis)|Death|1|||
145651842|NCT03406871|525242381|FG002|Expansion Cohort(Final Analysis)|Death|0|||
145651843|NCT03406871|525242379|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
145651844|NCT03406871|525242380|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
145651845|NCT03406871|525242381|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
145651846|NCT04005716|525242387|FG000|Overall Study|Death|175|||
145651847|NCT04005716|525242388|FG001|Overall Study|Death|196|||
145651848|NCT04005716|525242387|FG000|Overall Study|Withdrawal by Subject|1|||
145651849|NCT04005716|525242388|FG001|Overall Study|Withdrawal by Subject|6|||
145651850|NCT04005716|525242387|FG000|Overall Study|Lost to Follow-up|2|||
145651851|NCT04005716|525242388|FG001|Overall Study|Lost to Follow-up|2|||
145651852|NCT04021602|525242389|FG000|Overall Study|Lost to Follow-up|3|||
145651853|NCT04021602|525242390|FG001|Overall Study|Lost to Follow-up|3|||
145651854|NCT04021602|525242391|FG002|Overall Study|Lost to Follow-up|1|||
145651855|NCT04021602|525242389|FG000|Overall Study|Adverse Event|1|||
145651856|NCT04021602|525242390|FG001|Overall Study|Adverse Event|0|||
145651857|NCT04021602|525242391|FG002|Overall Study|Adverse Event|1|||
145651858|NCT03892616|525242392|FG000|Washout Period 2|Met discontinuation criterion|0|||
145651859|NCT03892616|525242393|FG001|Washout Period 2|Met discontinuation criterion|0|||
145651860|NCT03892616|525242394|FG002|Washout Period 2|Met discontinuation criterion|0|||
145651861|NCT03892616|525242395|FG003|Washout Period 2|Met discontinuation criterion|0|||
145651862|NCT03892616|525242396|FG004|Washout Period 2|Met discontinuation criterion|0|||
145651863|NCT03892616|525242397|FG005|Washout Period 2|Met discontinuation criterion|0|||
145651864|NCT03892616|525242398|FG006|Washout Period 2|Met discontinuation criterion|0|||
145651865|NCT03892616|525242399|FG007|Washout Period 2|Met discontinuation criterion|0|||
145651866|NCT03892616|525242400|FG008|Washout Period 2|Met discontinuation criterion|1|||
145651867|NCT03892616|525242401|FG009|Washout Period 2|Met discontinuation criterion|0|||
145651868|NCT03892616|525242402|FG010|Washout Period 2|Met discontinuation criterion|0|||
145651869|NCT03892616|525242403|FG011|Washout Period 2|Met discontinuation criterion|0|||
145651870|NCT02243709|525242404|FG000|Phase 1|Lost to Follow-up|0|||
145651871|NCT02243709|525242405|FG001|Phase 1|Lost to Follow-up|1|||
145651872|NCT02243709|525242404|FG000|Phase 1|Withdrawal by Subject|1|||
145651873|NCT02243709|525242405|FG001|Phase 1|Withdrawal by Subject|0|||
145651874|NCT02243709|525242404|FG000|Phase 1|Protocol Violation|0|||
145651875|NCT02243709|525242405|FG001|Phase 1|Protocol Violation|1|||
145651876|NCT02243709|525242404|FG000|Phase 1|Adverse Event|0|||
145651877|NCT02243709|525242405|FG001|Phase 1|Adverse Event|1|||
145651878|NCT04347161|525242410|FG000|Overall Study|Death|0|||
145651879|NCT04347161|525242411|FG001|Overall Study|Death|2|||
145651880|NCT04347161|525242410|FG000|Overall Study|Withdrawal by Subject|1|||
145651881|NCT04347161|525242411|FG001|Overall Study|Withdrawal by Subject|0|||
145651882|NCT04347161|525242410|FG000|Overall Study|Lost to Follow-up|0|||
145651883|NCT04347161|525242411|FG001|Overall Study|Lost to Follow-up|1|||
145651884|NCT04347161|525242410|FG000|Overall Study|No longer on study medication|1|||
145651885|NCT04347161|525242411|FG001|Overall Study|No longer on study medication|1|||
145651886|NCT04169373|525242412|FG000|Week 1 to Week 14|Adverse Event|1|||
145651887|NCT04169373|525242413|FG001|Week 1 to Week 14|Adverse Event|0|||
145651888|NCT04169373|525242414|FG002|Week 1 to Week 14|Adverse Event|1|||
145651889|NCT04169373|525242415|FG003|Week 1 to Week 14|Adverse Event|2|||
145651890|NCT04169373|525242412|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
145651891|NCT04169373|525242413|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
145651892|NCT04169373|525242414|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
145651893|NCT04169373|525242415|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
145651894|NCT04169373|525242412|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
145651895|NCT04169373|525242413|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
145651896|NCT04169373|525242414|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
145651897|NCT04169373|525242415|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
145651898|NCT04169373|525242412|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
145651899|NCT04169373|525242413|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
145651900|NCT04169373|525242414|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
145651901|NCT04169373|525242415|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
145651902|NCT04169373|525242412|FG000|Week 1 to Week 14|Other|1|||
145651903|NCT04169373|525242413|FG001|Week 1 to Week 14|Other|3|||
145651904|NCT04169373|525242414|FG002|Week 1 to Week 14|Other|3|||
145651905|NCT04169373|525242415|FG003|Week 1 to Week 14|Other|5|||
145651906|NCT04169373|525242412|FG000|Week 14 to Week 52|Adverse Event|1|||
145651907|NCT04169373|525242413|FG001|Week 14 to Week 52|Adverse Event|0|||
145651908|NCT04169373|525242414|FG002|Week 14 to Week 52|Adverse Event|0|||
145651909|NCT04169373|525242415|FG003|Week 14 to Week 52|Adverse Event|1|||
145651910|NCT04169373|525242412|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
145651911|NCT04169373|525242413|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
145651912|NCT04169373|525242414|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
145651913|NCT04169373|525242415|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
145651914|NCT04169373|525242412|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
145651915|NCT04169373|525242413|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
145651916|NCT04169373|525242414|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
145651917|NCT04169373|525242415|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
145651918|NCT04169373|525242412|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
145651919|NCT04169373|525242413|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
145651920|NCT04169373|525242414|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
145651921|NCT04169373|525242415|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
145651922|NCT04169373|525242412|FG000|Week 14 to Week 52|Other|4|||
145651923|NCT04169373|525242413|FG001|Week 14 to Week 52|Other|5|||
145651924|NCT04169373|525242414|FG002|Week 14 to Week 52|Other|4|||
145651925|NCT04169373|525242415|FG003|Week 14 to Week 52|Other|5|||
145651926|NCT04169373|525242412|FG000|Week 14 to Week 52|Ongoing|0|||
145651927|NCT04169373|525242413|FG001|Week 14 to Week 52|Ongoing|1|||
145651928|NCT04169373|525242414|FG002|Week 14 to Week 52|Ongoing|0|||
145651929|NCT04169373|525242415|FG003|Week 14 to Week 52|Ongoing|0|||
145651930|NCT04533347|525242416|FG000|Overall Study|Adverse Event|1|||
145651931|NCT04533347|525242417|FG001|Overall Study|Adverse Event|2|||
145651932|NCT04533347|525242416|FG000|Overall Study|Lost to Follow-up|2|||
145651933|NCT04533347|525242417|FG001|Overall Study|Lost to Follow-up|0|||
145651934|NCT04533347|525242416|FG000|Overall Study|Withdrawal by Subject|1|||
145651935|NCT04533347|525242417|FG001|Overall Study|Withdrawal by Subject|0|||
145651936|NCT04610892|525242418|FG000|Overall Study|Adverse Event|1|||
145651937|NCT04610892|525242419|FG001|Overall Study|Adverse Event|0|||
145651938|NCT04610892|525242420|FG002|Overall Study|Adverse Event|0|||
145651939|NCT04610892|525242421|FG003|Overall Study|Adverse Event|1|||
145651940|NCT04610892|525242422|FG004|Overall Study|Adverse Event|3|||
145651941|NCT04610892|525242418|FG000|Overall Study|Death|0|||
145651942|NCT04610892|525242419|FG001|Overall Study|Death|1|||
145651943|NCT04610892|525242420|FG002|Overall Study|Death|0|||
145651944|NCT04610892|525242421|FG003|Overall Study|Death|1|||
145651945|NCT04610892|525242422|FG004|Overall Study|Death|0|||
145651946|NCT04610892|525242418|FG000|Overall Study|Withdrawal by Subject|3|||
145651947|NCT04610892|525242419|FG001|Overall Study|Withdrawal by Subject|2|||
145651948|NCT04610892|525242420|FG002|Overall Study|Withdrawal by Subject|0|||
145651949|NCT04610892|525242421|FG003|Overall Study|Withdrawal by Subject|6|||
145651950|NCT04610892|525242422|FG004|Overall Study|Withdrawal by Subject|6|||
145651951|NCT04610892|525242418|FG000|Overall Study|Subjects who did not receive treatment|1|||
145651952|NCT04610892|525242419|FG001|Overall Study|Subjects who did not receive treatment|0|||
145651953|NCT04610892|525242420|FG002|Overall Study|Subjects who did not receive treatment|0|||
145651954|NCT04610892|525242421|FG003|Overall Study|Subjects who did not receive treatment|0|||
145651955|NCT04610892|525242422|FG004|Overall Study|Subjects who did not receive treatment|2|||
145651956|NCT05520190|525242423|FG000|Overall Study|Lost to Follow-up|7|||
145651957|NCT05520190|525242423|FG000|Overall Study|Withdrawal by Subject|2|||
145651958|NCT01748448|525242427|FG000|Treatment Period|Consent withdrawn by subject|1|||
145651959|NCT01748448|525242428|FG001|Treatment Period|Consent withdrawn by subject|0|||
145651960|NCT01748448|525242427|FG000|Treatment Period|Adverse Event|1|||
145651961|NCT01748448|525242428|FG001|Treatment Period|Adverse Event|0|||
145651962|NCT01748448|525242427|FG000|Treatment Period|Personal|0|||
145651963|NCT01748448|525242428|FG001|Treatment Period|Personal|1|||
145651964|NCT03924986|525242429|FG000|Overall Study|Death|57|||
145651965|NCT03924986|525242430|FG001|Overall Study|Death|66|||
145651966|NCT03924986|525242429|FG000|Overall Study|Study Concluded by Sponsor|51|||
145651967|NCT03924986|525242430|FG001|Overall Study|Study Concluded by Sponsor|41|||
145651968|NCT03924986|525242429|FG000|Overall Study|Withdrawal by Subject|15|||
145651969|NCT03924986|525242430|FG001|Overall Study|Withdrawal by Subject|20|||
145651970|NCT03924986|525242429|FG000|Overall Study|Lost to Follow-up|7|||
145651971|NCT03924986|525242430|FG001|Overall Study|Lost to Follow-up|5|||
145651972|NCT03924986|525242429|FG000|Overall Study|Miscellaneous|1|||
145651973|NCT03924986|525242430|FG001|Overall Study|Miscellaneous|0|||
145651974|NCT02689284|525242436|FG000|Overall Study|Adverse Event|1|||
145651975|NCT02689284|525242437|FG001|Overall Study|Adverse Event|8|||
145651976|NCT02689284|525242436|FG000|Overall Study|Death|0|||
145651977|NCT02689284|525242437|FG001|Overall Study|Death|1|||
145651978|NCT02689284|525242436|FG000|Overall Study|Physician Decision|1|||
145651979|NCT02689284|525242437|FG001|Overall Study|Physician Decision|2|||
145651980|NCT02689284|525242436|FG000|Overall Study|Withdrawal by Subject|0|||
145651981|NCT02689284|525242437|FG001|Overall Study|Withdrawal by Subject|1|||
145651982|NCT02689284|525242436|FG000|Overall Study|progression of cancer|1|||
145651983|NCT02689284|525242437|FG001|Overall Study|progression of cancer|72|||
145651984|NCT02689284|525242436|FG000|Overall Study|decreased heart function|0|||
145651985|NCT02689284|525242437|FG001|Overall Study|decreased heart function|1|||
145651986|NCT02689284|525242436|FG000|Overall Study|concern for anemia|0|||
145651987|NCT02689284|525242437|FG001|Overall Study|concern for anemia|1|||
145651988|NCT02689284|525242436|FG000|Overall Study|no measurable cancer for evaluation|0|||
145651989|NCT02689284|525242437|FG001|Overall Study|no measurable cancer for evaluation|1|||
145651990|NCT05268393|525242441|FG000|Overall Study|Withdrawal by Subject|2|||
145651991|NCT05268393|525242442|FG001|Overall Study|Withdrawal by Subject|1|||
145651992|NCT03396926|525242444|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
145651993|NCT03396926|525242445|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
145651994|NCT00450658|525242447|FG000|Overall Study|Adverse Event|24|||
145651995|NCT00450658|525242448|FG001|Overall Study|Adverse Event|15|||
145651996|NCT00450658|525242447|FG000|Overall Study|Withdrawal by Subject|43|||
145651997|NCT00450658|525242448|FG001|Overall Study|Withdrawal by Subject|26|||
145651998|NCT00450658|525242447|FG000|Overall Study|Lost to Follow-up|22|||
145651999|NCT00450658|525242448|FG001|Overall Study|Lost to Follow-up|5|||
145652000|NCT00450658|525242447|FG000|Overall Study|UGI ulcer|33|||
145652001|NCT00450658|525242448|FG001|Overall Study|UGI ulcer|34|||
145652002|NCT00450658|525242447|FG000|Overall Study|misc|21|||
145652003|NCT00450658|525242448|FG001|Overall Study|misc|10|||
145652004|NCT04727554|525242449|FG000|Overall Study|Lost to Follow-up|0|||
145652005|NCT04727554|525242450|FG001|Overall Study|Lost to Follow-up|1|||
145652006|NCT04727554|525242449|FG000|Overall Study|Death|2|||
145652007|NCT04727554|525242450|FG001|Overall Study|Death|6|||
145652008|NCT04727554|525242449|FG000|Overall Study|Withdrawal by Subject|1|||
145652009|NCT04727554|525242450|FG001|Overall Study|Withdrawal by Subject|0|||
145652010|NCT05763823|525242451|FG000|Overall Study|Death|6|||
145652011|NCT05763823|525242451|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145652012|NCT05763823|525242451|FG000|Overall Study|Withdrawal by Subject|6|||
145652013|NCT05256706|525242455|FG000|Overall Study|Lost to Follow-up|9|||
145652014|NCT05256706|525242456|FG001|Overall Study|Lost to Follow-up|3|||
145652015|NCT05256706|525242455|FG000|Overall Study|Withdrawal by Subject|7|||
145652016|NCT05256706|525242456|FG001|Overall Study|Withdrawal by Subject|11|||
145652017|NCT05256706|525242455|FG000|Overall Study|Screen Failures|3|||
145652018|NCT05256706|525242456|FG001|Overall Study|Screen Failures|0|||
145652019|NCT01997840|525242457|FG000|Overall Study|Lost to Follow-up|0|||
145652020|NCT01997840|525242458|FG001|Overall Study|Lost to Follow-up|0|||
145652021|NCT01997840|525242459|FG002|Overall Study|Lost to Follow-up|1|||
145652022|NCT01997840|525242460|FG003|Overall Study|Lost to Follow-up|0|||
145652023|NCT01997840|525242457|FG000|Overall Study|Withdrawal by participant|0|||
145652024|NCT01997840|525242458|FG001|Overall Study|Withdrawal by participant|0|||
145652025|NCT01997840|525242459|FG002|Overall Study|Withdrawal by participant|8|||
145652026|NCT01997840|525242460|FG003|Overall Study|Withdrawal by participant|1|||
145652027|NCT01997840|525242457|FG000|Overall Study|Physician Decision|0|||
145652028|NCT01997840|525242458|FG001|Overall Study|Physician Decision|0|||
145652029|NCT01997840|525242459|FG002|Overall Study|Physician Decision|3|||
145652030|NCT01997840|525242460|FG003|Overall Study|Physician Decision|0|||
145652031|NCT01997840|525242457|FG000|Overall Study|Progressive disease|3|||
145652032|NCT01997840|525242458|FG001|Overall Study|Progressive disease|4|||
145652033|NCT01997840|525242459|FG002|Overall Study|Progressive disease|57|||
145652034|NCT01997840|525242460|FG003|Overall Study|Progressive disease|8|||
145652035|NCT01997840|525242457|FG000|Overall Study|Other reasons|0|||
145652036|NCT01997840|525242458|FG001|Overall Study|Other reasons|0|||
145652037|NCT01997840|525242459|FG002|Overall Study|Other reasons|1|||
145652038|NCT01997840|525242460|FG003|Overall Study|Other reasons|0|||
145652039|NCT01997840|525242457|FG000|Overall Study|Adverse Event|0|||
145652040|NCT01997840|525242458|FG001|Overall Study|Adverse Event|0|||
145652041|NCT01997840|525242459|FG002|Overall Study|Adverse Event|15|||
145652042|NCT01997840|525242460|FG003|Overall Study|Adverse Event|2|||
145652043|NCT03850678|525242465|FG000|Overall Study|Withdrawal by Subject|3|||
145652044|NCT03850678|525242466|FG001|Overall Study|Withdrawal by Subject|0|||
145652045|NCT03850678|525242465|FG000|Overall Study|Experimenter Error|1|||
145652046|NCT03850678|525242466|FG001|Overall Study|Experimenter Error|1|||
145652047|NCT03850678|525242465|FG000|Overall Study|Did Not Condition To Experiment|7|||
145652048|NCT03850678|525242466|FG001|Overall Study|Did Not Condition To Experiment|2|||
145652049|NCT03720795|525242467|FG000|Phase 1|Lost to Follow-up|4|||
145652050|NCT03720795|525242467|FG000|Phase 1|Withdrawal by Subject|6|||
145652051|NCT03720795|525242467|FG000|Phase 1|Protocol Violation|1|||
145652052|NCT03720795|525242467|FG000|Phase 1|Other|1|||
145652053|NCT03720795|525242467|FG000|Phase 2|Lost to Follow-up|5|||
145652054|NCT03720795|525242467|FG000|Phase 2|Withdrawal by Subject|10|||
145652055|NCT03720795|525242467|FG000|Phase 2|Protocol Violation|2|||
145652056|NCT03720795|525242467|FG000|3 Month Follow Up|Lost to Follow-up|2|||
145652057|NCT05311384|525242471|FG000|Overall Study|Uncontrolled health conditions|2|||
145652058|NCT05311384|525242471|FG000|Overall Study|Withdrawal by Subject|1|||
145652059|NCT04322643|525242472|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
145652060|NCT03302494|525242473|FG000|Overall Study|Other|7|||
145652061|NCT03302494|525242474|FG001|Overall Study|Other|4|||
145652062|NCT03302494|525242475|FG002|Overall Study|Other|6|||
145652063|NCT03302494|525242473|FG000|Overall Study|Withdrawal by Subject|10|||
145652064|NCT03302494|525242474|FG001|Overall Study|Withdrawal by Subject|2|||
145652065|NCT03302494|525242475|FG002|Overall Study|Withdrawal by Subject|9|||
145652066|NCT03302494|525242473|FG000|Overall Study|Study Terminated by Sponsor|32|||
145652067|NCT03302494|525242474|FG001|Overall Study|Study Terminated by Sponsor|29|||
145652068|NCT03302494|525242475|FG002|Overall Study|Study Terminated by Sponsor|30|||
145652069|NCT03302494|525242473|FG000|Overall Study|Physician Decision|1|||
145652070|NCT03302494|525242474|FG001|Overall Study|Physician Decision|0|||
145652071|NCT03302494|525242475|FG002|Overall Study|Physician Decision|1|||
145652072|NCT03302494|525242473|FG000|Overall Study|Lost to Follow-up|1|||
145652073|NCT03302494|525242474|FG001|Overall Study|Lost to Follow-up|3|||
145652074|NCT03302494|525242475|FG002|Overall Study|Lost to Follow-up|3|||
145652075|NCT03302494|525242473|FG000|Overall Study|Death|13|||
145652076|NCT03302494|525242474|FG001|Overall Study|Death|11|||
145652077|NCT03302494|525242475|FG002|Overall Study|Death|4|||
145652078|NCT03302494|525242473|FG000|Overall Study|Adverse Event|1|||
145652079|NCT03302494|525242474|FG001|Overall Study|Adverse Event|2|||
145652080|NCT03302494|525242475|FG002|Overall Study|Adverse Event|0|||
145652081|NCT03302494|525242473|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
145652082|NCT03302494|525242474|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
145652083|NCT03302494|525242475|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
145489692|NCT01391663|524647582|FG001|Overall Study|Withdrawal by Subject|0|||
145489693|NCT01391663|524647583|FG002|Overall Study|Withdrawal by Subject|1|||
145489694|NCT01391663|524647584|FG003|Overall Study|Withdrawal by Subject|0|||
145489695|NCT00462306|524647585|FG000|Overall Study|insufficient data|0|||
145489696|NCT00462306|524647586|FG001|Overall Study|insufficient data|13|||
145652084|NCT01573442|525242476|FG000|Overall Study|Cancels|9|||
145652085|NCT01573442|525242477|FG001|Overall Study|Cancels|10|||
145652086|NCT05710107|525242481|FG000|Overall Study|Withdrawal by Subject|1|||
145652087|NCT05710107|525242482|FG001|Overall Study|Withdrawal by Subject|1|||
145489697|NCT03515824|524647587|FG000|Overall Study|Death|3|||
145489698|NCT03515824|524647588|FG001|Overall Study|Death|2|||
145489699|NCT03515824|524647589|FG002|Overall Study|Death|6|||
145489700|NCT03515824|524647590|FG003|Overall Study|Death|0|||
145652088|NCT05710107|525242481|FG000|Overall Study|Lost to Follow-up|8|||
145652089|NCT05710107|525242482|FG001|Overall Study|Lost to Follow-up|9|||
145652090|NCT05710107|525242481|FG000|Overall Study|Unable to place assigned block|2|||
145652091|NCT05710107|525242482|FG001|Overall Study|Unable to place assigned block|0|||
145652092|NCT05710107|525242481|FG000|Overall Study|Withdrawn by study team|0|||
145652093|NCT05710107|525242482|FG001|Overall Study|Withdrawn by study team|1|||
145652094|NCT04166773|525242483|FG000|Overall Study|Adverse Event|2|||
145652095|NCT04166773|525242484|FG001|Overall Study|Adverse Event|0|||
145652096|NCT04166773|525242485|FG002|Overall Study|Adverse Event|2|||
145652097|NCT04166773|525242486|FG003|Overall Study|Adverse Event|1|||
145652098|NCT04166773|525242483|FG000|Overall Study|Lost to Follow-up|4|||
145652099|NCT04166773|525242484|FG001|Overall Study|Lost to Follow-up|2|||
145652100|NCT04166773|525242485|FG002|Overall Study|Lost to Follow-up|1|||
145652101|NCT04166773|525242486|FG003|Overall Study|Lost to Follow-up|3|||
145652102|NCT04166773|525242483|FG000|Overall Study|Physician Decision|0|||
145652103|NCT04166773|525242484|FG001|Overall Study|Physician Decision|0|||
145652104|NCT04166773|525242485|FG002|Overall Study|Physician Decision|0|||
145652105|NCT04166773|525242486|FG003|Overall Study|Physician Decision|1|||
145652106|NCT04166773|525242483|FG000|Overall Study|Withdrawal by Subject|1|||
145652107|NCT04166773|525242484|FG001|Overall Study|Withdrawal by Subject|1|||
145652108|NCT04166773|525242485|FG002|Overall Study|Withdrawal by Subject|2|||
145652109|NCT04166773|525242486|FG003|Overall Study|Withdrawal by Subject|5|||
145652110|NCT04763265|525242487|FG000|Overall Study|Adverse Event|1|||
145652111|NCT04763265|525242488|FG001|Overall Study|Adverse Event|0|||
145652112|NCT04763265|525242487|FG000|Overall Study|Lost to Follow-up|2|||
145652113|NCT04763265|525242488|FG001|Overall Study|Lost to Follow-up|4|||
145652114|NCT04763265|525242487|FG000|Overall Study|Withdrawal by Subject|0|||
145652115|NCT04763265|525242488|FG001|Overall Study|Withdrawal by Subject|1|||
145652116|NCT05434078|525242493|FG000|Overall Study|Lost to Follow-up|2|||
145652117|NCT05434078|525242494|FG001|Overall Study|Lost to Follow-up|1|||
145652118|NCT05434078|525242493|FG000|Overall Study|Withdrawal by Subject|1|||
145652119|NCT05434078|525242494|FG001|Overall Study|Withdrawal by Subject|0|||
145652120|NCT04072380|525242495|FG000|Overall Study|Adverse Event|4|||
145652121|NCT04072380|525242496|FG001|Overall Study|Adverse Event|6|||
145652122|NCT04072380|525242497|FG002|Overall Study|Adverse Event|0|||
145652123|NCT04072380|525242495|FG000|Overall Study|Withdrawal by Subject|3|||
145652124|NCT04072380|525242496|FG001|Overall Study|Withdrawal by Subject|1|||
145652125|NCT04072380|525242497|FG002|Overall Study|Withdrawal by Subject|1|||
145652126|NCT04072380|525242495|FG000|Overall Study|Physician Decision|2|||
145652127|NCT04072380|525242496|FG001|Overall Study|Physician Decision|0|||
145652128|NCT04072380|525242497|FG002|Overall Study|Physician Decision|0|||
145652129|NCT04072380|525242495|FG000|Overall Study|Protocol Violation|0|||
145652130|NCT04072380|525242496|FG001|Overall Study|Protocol Violation|2|||
145652131|NCT04072380|525242497|FG002|Overall Study|Protocol Violation|3|||
145652132|NCT04072380|525242495|FG000|Overall Study|Intercurrent Illness and Others|3|||
145652133|NCT04072380|525242496|FG001|Overall Study|Intercurrent Illness and Others|5|||
145652134|NCT04072380|525242497|FG002|Overall Study|Intercurrent Illness and Others|6|||
145652135|NCT03557697|525242498|FG000|Overall Study|Withdrawal by Subject|2|||
145652136|NCT03557697|525242499|FG001|Overall Study|Withdrawal by Subject|4|||
145652137|NCT01214616|525242501|FG000|Overall Study|Progressive disease|2|||
145652138|NCT01214616|525242502|FG001|Overall Study|Progressive disease|2|||
145652139|NCT01214616|525242503|FG002|Overall Study|Progressive disease|2|||
145652140|NCT01214616|525242504|FG003|Overall Study|Progressive disease|4|||
145652141|NCT01214616|525242501|FG000|Overall Study|Dose limiting toxicity|0|||
145652142|NCT01214616|525242502|FG001|Overall Study|Dose limiting toxicity|2|||
145652143|NCT01214616|525242503|FG002|Overall Study|Dose limiting toxicity|0|||
145652144|NCT01214616|525242504|FG003|Overall Study|Dose limiting toxicity|0|||
145652145|NCT01214616|525242501|FG000|Overall Study|Other adverse events|0|||
145652146|NCT01214616|525242502|FG001|Overall Study|Other adverse events|1|||
145652147|NCT01214616|525242503|FG002|Overall Study|Other adverse events|1|||
145489701|NCT03515824|524647587|FG000|Overall Study|Lost to Follow-up|0|||
145489702|NCT03515824|524647588|FG001|Overall Study|Lost to Follow-up|1|||
145652148|NCT01214616|525242504|FG003|Overall Study|Other adverse events|1|||
145652149|NCT01214616|525242501|FG000|Overall Study|Withdrawal by Subject|1|||
145652150|NCT01214616|525242502|FG001|Overall Study|Withdrawal by Subject|0|||
145652151|NCT01214616|525242503|FG002|Overall Study|Withdrawal by Subject|0|||
145652152|NCT01214616|525242504|FG003|Overall Study|Withdrawal by Subject|1|||
145652153|NCT06037369|525242505|FG000|Overall Study|Lost to Follow-up|0|||
145652154|NCT06037369|525242506|FG001|Overall Study|Lost to Follow-up|1|||
145652155|NCT05008835|525242508|FG000|Overall Study|Adverse Event|5|||
145652156|NCT05008835|525242509|FG001|Overall Study|Adverse Event|2|||
145652157|NCT05008835|525242510|FG002|Overall Study|Adverse Event|1|||
145652158|NCT05008835|525242508|FG000|Overall Study|Lack of Efficacy|0|||
145489703|NCT03515824|524647589|FG002|Overall Study|Lost to Follow-up|1|||
145652159|NCT05008835|525242509|FG001|Overall Study|Lack of Efficacy|0|||
145652160|NCT05008835|525242510|FG002|Overall Study|Lack of Efficacy|1|||
145652161|NCT05008835|525242508|FG000|Overall Study|Study terminated by sponsor|0|||
145652162|NCT05008835|525242509|FG001|Overall Study|Study terminated by sponsor|0|||
145652163|NCT05008835|525242510|FG002|Overall Study|Study terminated by sponsor|1|||
145652164|NCT05008835|525242508|FG000|Overall Study|Not further specified|3|||
145652165|NCT05008835|525242509|FG001|Overall Study|Not further specified|2|||
145652166|NCT05008835|525242510|FG002|Overall Study|Not further specified|1|||
145652167|NCT04876118|525242515|FG000|Overall Study|Pregnancy|1|||
145652168|NCT04876118|525242515|FG000|Overall Study|Withdrawal by Subject|14|||
145652169|NCT03047928|525243792|FG000|Overall Study|Adverse Event|0|||
145652170|NCT03047928|525243793|FG001|Overall Study|Adverse Event|2|||
145652171|NCT03047928|525243794|FG002|Overall Study|Adverse Event|0|||
145652172|NCT03047928|525243792|FG000|Overall Study|Protocol Violation|0|||
145652173|NCT03047928|525243793|FG001|Overall Study|Protocol Violation|1|||
145652174|NCT03047928|525243794|FG002|Overall Study|Protocol Violation|0|||
145652175|NCT03047928|525243792|FG000|Overall Study|included in another protocol|0|||
145652176|NCT03047928|525243793|FG001|Overall Study|included in another protocol|1|||
145652177|NCT03047928|525243794|FG002|Overall Study|included in another protocol|0|||
145652178|NCT03623321|525243795|FG000|Overall Study|Adverse Event|32|||
145652179|NCT03623321|525243795|FG000|Overall Study|Death|9|||
145652180|NCT03623321|525243795|FG000|Overall Study|Lack of Efficacy|9|||
145652181|NCT03623321|525243795|FG000|Overall Study|Lost to Follow-up|6|||
145652182|NCT03623321|525243795|FG000|Overall Study|Noncompliance with study drug|6|||
145652183|NCT03623321|525243795|FG000|Overall Study|Use of prohibited medication|3|||
145652184|NCT03623321|525243795|FG000|Overall Study|Physician Decision|5|||
145652185|NCT03623321|525243795|FG000|Overall Study|Protocol Violation|1|||
145652186|NCT03623321|525243795|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
145652187|NCT03623321|525243795|FG000|Overall Study|Not further specified|43|||
145652188|NCT04241068|525243799|FG000|Core Treatment Period|Adverse Event|91|||
145652189|NCT04241068|525243799|FG000|Core Treatment Period|Change of Treatment|4|||
145652190|NCT04241068|525243799|FG000|Core Treatment Period|Consent Withdrawn|143|||
145652191|NCT04241068|525243799|FG000|Core Treatment Period|Death|26|||
145652192|NCT04241068|525243799|FG000|Core Treatment Period|Disease Progression|67|||
145652193|NCT04241068|525243799|FG000|Core Treatment Period|Investigator Decision|40|||
145652194|NCT04241068|525243799|FG000|Core Treatment Period|Loss of Capacity|9|||
145652195|NCT04241068|525243799|FG000|Core Treatment Period|Lost to Follow-up|11|||
145652196|NCT04241068|525243799|FG000|Core Treatment Period|Relocation|4|||
145652197|NCT04241068|525243799|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
145652198|NCT04241068|525243799|FG000|Core Treatment Period|Study Visit Burden|40|||
145652199|NCT04241068|525243799|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
145652200|NCT04241068|525243799|FG000|Core Treatment Period|Missing|2|||
145652201|NCT04241068|525243799|FG000|Core Treatment Period|Reason Not Specified|41|||
145652202|NCT04241068|525243799|FG000|LTE Period|Adverse Event|19|||
145652203|NCT04241068|525243799|FG000|LTE Period|Change of Treatment|1|||
145652204|NCT04241068|525243799|FG000|LTE Period|Consent Withdrawn|71|||
145652205|NCT04241068|525243799|FG000|LTE Period|Death|8|||
145652206|NCT04241068|525243799|FG000|LTE Period|Disease Progression|11|||
145652207|NCT04241068|525243799|FG000|LTE Period|Investigator Decision|12|||
145652208|NCT04241068|525243799|FG000|LTE Period|Loss of Capacity|2|||
145652209|NCT04241068|525243799|FG000|LTE Period|Lost to Follow-up|7|||
145652210|NCT04241068|525243799|FG000|LTE Period|Relocation|6|||
145652211|NCT04241068|525243799|FG000|LTE Period|Site Terminated by Sponsor|26|||
145652212|NCT04241068|525243799|FG000|LTE Period|Study Terminated by Sponsor|276|||
145652213|NCT04241068|525243799|FG000|LTE Period|Study Visit Burden|10|||
145652214|NCT04241068|525243799|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
145652215|NCT04241068|525243799|FG000|LTE Period|Reason Not Specified|65|||
145652216|NCT03443323|525243801|FG000|Overall Study|Lost to Follow-up|2|||
145652217|NCT03443323|525243802|FG001|Overall Study|Lost to Follow-up|2|||
145652218|NCT03443323|525243801|FG000|Overall Study|PI withdrawal|1|||
145652219|NCT03443323|525243802|FG001|Overall Study|PI withdrawal|0|||
145652220|NCT05178316|525243807|FG000|Overall Study|Adverse Event|5|||
145652221|NCT05178316|525243808|FG001|Overall Study|Adverse Event|4|||
145652222|NCT05178316|525243809|FG002|Overall Study|Adverse Event|9|||
145652223|NCT05178316|525243807|FG000|Overall Study|Enrolled in Error|1|||
145652224|NCT05178316|525243808|FG001|Overall Study|Enrolled in Error|2|||
145652225|NCT05178316|525243809|FG002|Overall Study|Enrolled in Error|1|||
145652226|NCT05178316|525243807|FG000|Overall Study|Lost to Follow-up|3|||
145652227|NCT05178316|525243808|FG001|Overall Study|Lost to Follow-up|15|||
145652228|NCT05178316|525243809|FG002|Overall Study|Lost to Follow-up|11|||
145652229|NCT05178316|525243807|FG000|Overall Study|Noncompliance|1|||
145652230|NCT05178316|525243808|FG001|Overall Study|Noncompliance|3|||
145652231|NCT05178316|525243809|FG002|Overall Study|Noncompliance|1|||
145652232|NCT05178316|525243807|FG000|Overall Study|Other|0|||
145652233|NCT05178316|525243808|FG001|Overall Study|Other|1|||
145652234|NCT05178316|525243809|FG002|Overall Study|Other|0|||
145652235|NCT05178316|525243807|FG000|Overall Study|Physician Decision|0|||
145652236|NCT05178316|525243808|FG001|Overall Study|Physician Decision|3|||
145652237|NCT05178316|525243809|FG002|Overall Study|Physician Decision|2|||
145652238|NCT05178316|525243807|FG000|Overall Study|Protocol deviation|1|||
145652239|NCT05178316|525243808|FG001|Overall Study|Protocol deviation|0|||
145652240|NCT05178316|525243809|FG002|Overall Study|Protocol deviation|1|||
145652241|NCT05178316|525243807|FG000|Overall Study|Sponsor decision|1|||
145652242|NCT05178316|525243808|FG001|Overall Study|Sponsor decision|0|||
145652243|NCT05178316|525243809|FG002|Overall Study|Sponsor decision|1|||
145652244|NCT05178316|525243807|FG000|Overall Study|Withdrawal by Subject|5|||
145652245|NCT05178316|525243808|FG001|Overall Study|Withdrawal by Subject|11|||
145652246|NCT05178316|525243809|FG002|Overall Study|Withdrawal by Subject|5|||
145652247|NCT03907397|525243813|FG000|Overall Study|Lost to Follow-up|0|||
145652248|NCT03907397|525243814|FG001|Overall Study|Lost to Follow-up|1|||
145652249|NCT03907397|525243813|FG000|Overall Study|Physician Decision|2|||
145652250|NCT03907397|525243814|FG001|Overall Study|Physician Decision|1|||
145652251|NCT03907397|525243813|FG000|Overall Study|Withdrawal by Subject|5|||
145652252|NCT03907397|525243814|FG001|Overall Study|Withdrawal by Subject|4|||
145652253|NCT03907397|525243813|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
145652254|NCT03907397|525243814|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
145652255|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
145652256|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
145652257|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
145652258|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
145652259|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
145652260|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
145652261|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
145652262|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
145652263|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
145652264|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
145652265|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
145652266|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
145652267|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
145652268|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
145652269|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
145652270|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
145652271|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
145652272|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
145652273|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
145652274|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
145652275|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
145652276|NCT05369403|525243815|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
145652277|NCT05369403|525243816|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
145652278|NCT05369403|525243817|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
145652279|NCT05369403|525243815|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
145652280|NCT05369403|525243816|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
145652281|NCT05369403|525243817|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
145652282|NCT05369403|525243815|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
145652283|NCT05369403|525243816|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
145652284|NCT05369403|525243817|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
145652285|NCT05369403|525243815|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
145652286|NCT05369403|525243816|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
145652287|NCT05369403|525243817|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
145652288|NCT03232138|525243818|FG000|Overall Study|Physician Decision|1|||
145652289|NCT03232138|525243819|FG001|Overall Study|Physician Decision|0|||
145652290|NCT03232138|525243818|FG000|Overall Study|Adverse Event|2|||
145652291|NCT03232138|525243819|FG001|Overall Study|Adverse Event|0|||
145652292|NCT03232138|525243818|FG000|Overall Study|Withdrawal by Subject|1|||
145652293|NCT03232138|525243819|FG001|Overall Study|Withdrawal by Subject|2|||
145652294|NCT03920111|525243820|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
145652295|NCT03920111|525243821|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
145652296|NCT03920111|525243822|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
145652297|NCT05516147|525243823|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
145652298|NCT02035787|525243824|FG000|Overall Study- 12 Months|Adverse Event|3|||
145652299|NCT02035787|525243825|FG001|Overall Study- 12 Months|Adverse Event|0|||
145652300|NCT02035787|525243824|FG000|Overall Study- 12 Months|Complete response|4|||
145652301|NCT02035787|525243825|FG001|Overall Study- 12 Months|Complete response|1|||
145652302|NCT02035787|525243824|FG000|Overall Study- 12 Months|Protocol Violation|1|||
145652303|NCT02035787|525243825|FG001|Overall Study- 12 Months|Protocol Violation|1|||
145652304|NCT06414213|525243826|FG000|Overall Study|Lost to Follow-up|1|||
145652305|NCT06414213|525243827|FG001|Overall Study|Lost to Follow-up|1|||
145652306|NCT06414213|525243828|FG002|Overall Study|Lost to Follow-up|3|||
145652307|NCT03853746|525243830|FG000|Overall Study|Withdrawal by Subject|1|||
145652308|NCT01084876|525243831|FG000|Main Study Treatment Period|Adverse Event|12|||
145652309|NCT01084876|525243832|FG001|Main Study Treatment Period|Adverse Event|7|||
145652310|NCT01084876|525243831|FG000|Main Study Treatment Period|Disease Progression|41|||
145652311|NCT01084876|525243832|FG001|Main Study Treatment Period|Disease Progression|24|||
145652312|NCT01084876|525243831|FG000|Main Study Treatment Period|Physician Decision|2|||
145652313|NCT01084876|525243832|FG001|Main Study Treatment Period|Physician Decision|0|||
145652314|NCT01084876|525243831|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
145652315|NCT01084876|525243832|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
145652316|NCT01084876|525243831|FG000|Main Study Treatment Period|Other Reason|0|||
145652317|NCT01084876|525243832|FG001|Main Study Treatment Period|Other Reason|1|||
145652318|NCT01084876|525243831|FG000|Main Study Treatment Period|Other|0|||
145652319|NCT01084876|525243832|FG001|Main Study Treatment Period|Other|1|||
145652320|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
145652321|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
145652322|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
145652323|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
145652324|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
145652325|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
145652326|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
145652327|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
145652328|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
145652329|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
145652330|NCT01084876|525243831|FG000|Treatment Period Beyond Cycle 8|Other|6|||
145652331|NCT01084876|525243832|FG001|Treatment Period Beyond Cycle 8|Other|9|||
145652332|NCT02724631|525243835|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
145652333|NCT04952909|525243836|FG000|Overall Study|Death|3|||
145652334|NCT06393088|525243840|FG000|Overall Study|Withdrawal by Subject|0|||
145652335|NCT06393088|525243841|FG001|Overall Study|Withdrawal by Subject|2|||
145652336|NCT02515773|525243842|FG000|Overall Study|Withdrawal by Subject|12|||
145652337|NCT02515773|525243843|FG001|Overall Study|Withdrawal by Subject|2|||
145652338|NCT02515773|525243842|FG000|Overall Study|Lost to Follow-up|119|||
145652339|NCT02515773|525243843|FG001|Overall Study|Lost to Follow-up|126|||
145652340|NCT02515773|525243842|FG000|Overall Study|Discharged from Clinic Services|53|||
145652341|NCT02515773|525243843|FG001|Overall Study|Discharged from Clinic Services|84|||
145652342|NCT02515773|525243842|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
145652343|NCT02515773|525243843|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
145652344|NCT02515773|525243842|FG000|Overall Study|Follow-up at non-study site|8|||
145652345|NCT02515773|525243843|FG001|Overall Study|Follow-up at non-study site|16|||
145652346|NCT02515773|525243842|FG000|Overall Study|Moved from area|9|||
145652347|NCT02515773|525243843|FG001|Overall Study|Moved from area|14|||
145652348|NCT03903146|525243844|FG000|Overall Study|Lost to Follow-up|6|||
145652349|NCT03903146|525243845|FG001|Overall Study|Lost to Follow-up|4|||
145652350|NCT03903146|525243844|FG000|Overall Study|Withdrawal by Subject|0|||
145652351|NCT03903146|525243845|FG001|Overall Study|Withdrawal by Subject|1|||
145652352|NCT03033576|525243854|FG000|Overall Study|Ineligible|1|||
145652353|NCT03033576|525243855|FG001|Overall Study|Ineligible|1|||
145652354|NCT03033576|525243854|FG000|Overall Study|Adverse Event|4|||
145652355|NCT03033576|525243855|FG001|Overall Study|Adverse Event|20|||
145652356|NCT03033576|525243854|FG000|Overall Study|Progression/relapse|9|||
145652357|NCT03033576|525243855|FG001|Overall Study|Progression/relapse|36|||
145652358|NCT03033576|525243854|FG000|Overall Study|Death|1|||
145652359|NCT03033576|525243855|FG001|Overall Study|Death|1|||
145652360|NCT03033576|525243854|FG000|Overall Study|Patient refusal|1|||
145652361|NCT03033576|525243855|FG001|Overall Study|Patient refusal|6|||
145652362|NCT03033576|525243854|FG000|Overall Study|Other, unspecified reasons|0|||
145652363|NCT03033576|525243855|FG001|Overall Study|Other, unspecified reasons|4|||
145652364|NCT03033576|525243854|FG000|Overall Study|Currently on protocol therapy|0|||
145652365|NCT03033576|525243855|FG001|Overall Study|Currently on protocol therapy|2|||
145652366|NCT06491433|525243856|FG000|Overall Study|Protocol Violation|51|||
145652367|NCT06491433|525243856|FG000|Overall Study|consent withdrawal|2|||
145652368|NCT06491433|525243856|FG000|Overall Study|screen failure|1|||
145652369|NCT05894577|525243862|FG000|Overall Study|No receipt of study drug|14|||
145652370|NCT05894577|525243863|FG001|Overall Study|No receipt of study drug|13|||
145652371|NCT05894577|525243862|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
145652372|NCT05894577|525243863|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
145652373|NCT05894577|525243862|FG000|Overall Study|Screen Fail|2|||
145652374|NCT05894577|525243863|FG001|Overall Study|Screen Fail|0|||
145652375|NCT05894577|525243862|FG000|Overall Study|Study drug recall|86|||
145652376|NCT05894577|525243863|FG001|Overall Study|Study drug recall|63|||
145652377|NCT03197662|525243865|FG000|Overall Study|Withdrawn by family|0|||
145652378|NCT03197662|525243866|FG001|Overall Study|Withdrawn by family|2|||
145652379|NCT02949362|525243870|FG000|Retrospective Period|Inform consent not signed by participant|4|||
145652380|NCT02949362|525243871|FG001|Retrospective Period|Inform consent not signed by participant|1|||
145652381|NCT02949362|525243872|FG002|Retrospective Period|Inform consent not signed by participant|0|||
145652382|NCT02949362|525243873|FG003|Retrospective Period|Inform consent not signed by participant|0|||
145652383|NCT02949362|525243870|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
145652384|NCT02949362|525243871|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
145652385|NCT02949362|525243872|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
145652386|NCT02949362|525243873|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
145652387|NCT02949362|525243870|FG000|Prospective Period|Other|0|||
145652388|NCT02949362|525243871|FG001|Prospective Period|Other|0|||
145652389|NCT02949362|525243872|FG002|Prospective Period|Other|0|||
145652390|NCT02949362|525243873|FG003|Prospective Period|Other|4|||
145652391|NCT03476460|525243874|FG000|Overall Study|Withdrawal by Subject|3|||
145652392|NCT03476460|525243875|FG001|Overall Study|Withdrawal by Subject|2|||
145652393|NCT03476460|525243874|FG000|Overall Study|Non-compliance with treatment|3|||
145652394|NCT03476460|525243875|FG001|Overall Study|Non-compliance with treatment|0|||
145652395|NCT03476460|525243874|FG000|Overall Study|Missing laboratory tests|5|||
145652396|NCT03476460|525243875|FG001|Overall Study|Missing laboratory tests|5|||
145652397|NCT03476460|525243874|FG000|Overall Study|Adverse Event|0|||
145652398|NCT03476460|525243875|FG001|Overall Study|Adverse Event|1|||
145652399|NCT04015167|525243887|FG000|Overall Study|Lost to Follow-up|40|||
145652400|NCT04015167|525243887|FG000|Overall Study|Adverse Event|5|||
145652401|NCT04015167|525243887|FG000|Overall Study|Withdrawal by Subject|2|||
145652402|NCT04015167|525243887|FG000|Overall Study|Subject went to jail|1|||
145652403|NCT03640312|525243888|FG000|Overall Study|Lost to Follow-up|3|||
145652404|NCT03640312|525243889|FG001|Overall Study|Lost to Follow-up|6|||
145652405|NCT02761057|525243895|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
145652406|NCT02761057|525243896|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
145652407|NCT02761057|525243897|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
145652408|NCT02761057|525243898|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
145652409|NCT02761057|525243895|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
145652410|NCT02761057|525243896|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
145652411|NCT02761057|525243897|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
145652412|NCT02761057|525243898|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
145652413|NCT02761057|525243895|FG000|Overall Study|Currently On Study Treatment|0|||
145652414|NCT02761057|525243896|FG001|Overall Study|Currently On Study Treatment|3|||
145652415|NCT02761057|525243897|FG002|Overall Study|Currently On Study Treatment|0|||
145652416|NCT02761057|525243898|FG003|Overall Study|Currently On Study Treatment|0|||
145652417|NCT02761057|525243895|FG000|Overall Study|Adverse Event|11|||
145652418|NCT02761057|525243896|FG001|Overall Study|Adverse Event|9|||
145652419|NCT02761057|525243897|FG002|Overall Study|Adverse Event|5|||
145652420|NCT02761057|525243898|FG003|Overall Study|Adverse Event|3|||
145652421|NCT02761057|525243895|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
145652422|NCT02761057|525243896|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
145652423|NCT02761057|525243897|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
145652424|NCT02761057|525243898|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
145652425|NCT02761057|525243895|FG000|Overall Study|Progression/Relapse|29|||
145652426|NCT02761057|525243896|FG001|Overall Study|Progression/Relapse|27|||
145652427|NCT02761057|525243897|FG002|Overall Study|Progression/Relapse|20|||
145652428|NCT02761057|525243898|FG003|Overall Study|Progression/Relapse|23|||
145652429|NCT02761057|525243895|FG000|Overall Study|Death|2|||
145652430|NCT02761057|525243896|FG001|Overall Study|Death|2|||
145652431|NCT02761057|525243897|FG002|Overall Study|Death|1|||
145652432|NCT02761057|525243898|FG003|Overall Study|Death|1|||
145652433|NCT02761057|525243895|FG000|Overall Study|Other - Not Protocol Specified|2|||
145652434|NCT02761057|525243896|FG001|Overall Study|Other - Not Protocol Specified|1|||
145652435|NCT02761057|525243897|FG002|Overall Study|Other - Not Protocol Specified|2|||
145652436|NCT02761057|525243898|FG003|Overall Study|Other - Not Protocol Specified|0|||
145652437|NCT05609760|525243906|FG000|Overall Study|Lost to Follow-up|0|||
145652438|NCT05609760|525243907|FG001|Overall Study|Lost to Follow-up|1|||
145652439|NCT05609760|525243906|FG000|Overall Study|Withdrawal by Subject|1|||
145652440|NCT05609760|525243907|FG001|Overall Study|Withdrawal by Subject|0|||
145652441|NCT03396588|525243908|FG000|Overall Study|Physician Decision|2|||
145652442|NCT03396588|525243909|FG001|Overall Study|Physician Decision|3|||
145652443|NCT05179395|525243910|FG000|Overall Study|Lack of Efficacy|1|||
145652444|NCT00812461|525243912|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
145652445|NCT00812461|525243913|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
145652446|NCT00812461|525243912|FG000|All Treated Patients|Adverse Event|8|||
145652447|NCT00812461|525243913|FG001|All Treated Patients|Adverse Event|15|||
145652448|NCT00812461|525243912|FG000|All Treated Patients|Lack of Efficacy|13|||
145652449|NCT00812461|525243913|FG001|All Treated Patients|Lack of Efficacy|7|||
145652450|NCT00812461|525243912|FG000|All Treated Patients|Non-compliance|6|||
145652451|NCT00812461|525243913|FG001|All Treated Patients|Non-compliance|9|||
145652452|NCT00812461|525243912|FG000|All Treated Patients|Protocol Violation|36|||
145652453|NCT00812461|525243913|FG001|All Treated Patients|Protocol Violation|27|||
145652454|NCT00812461|525243912|FG000|All Treated Patients|Withdrawal by Subject|45|||
145652455|NCT00812461|525243913|FG001|All Treated Patients|Withdrawal by Subject|54|||
145652456|NCT00812461|525243912|FG000|All Treated Patients|Lost to Follow-up|11|||
145652457|NCT00812461|525243913|FG001|All Treated Patients|Lost to Follow-up|14|||
145652458|NCT00812461|525243912|FG000|All Treated Patients|Other Reason|13|||
145652459|NCT00812461|525243913|FG001|All Treated Patients|Other Reason|21|||
145652460|NCT05351554|525243915|FG000|Overall Study|Study terminated by sponsor|1|||
145652461|NCT02671903|525246307|FG000|Period 0 (Run-In)|Death|0|||
145652462|NCT02671903|525246308|FG001|Period 0 (Run-In)|Death|0|||
145652463|NCT02671903|525246309|FG002|Period 0 (Run-In)|Death|3|||
145652464|NCT02671903|525246307|FG000|Period 0 (Run-In)|Physician Decision|0|||
145652465|NCT02671903|525246308|FG001|Period 0 (Run-In)|Physician Decision|0|||
145652466|NCT02671903|525246309|FG002|Period 0 (Run-In)|Physician Decision|4|||
145652467|NCT02671903|525246307|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
145652468|NCT02671903|525246308|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
145652469|NCT02671903|525246309|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
145652470|NCT02671903|525246307|FG000|Period 0 (Run-In)|Protocol Violation|0|||
145652471|NCT02671903|525246308|FG001|Period 0 (Run-In)|Protocol Violation|0|||
145652472|NCT02671903|525246309|FG002|Period 0 (Run-In)|Protocol Violation|1|||
145652473|NCT02671903|525246307|FG000|Period 0 (Run-In)|Adverse Event|0|||
145652474|NCT02671903|525246308|FG001|Period 0 (Run-In)|Adverse Event|0|||
145652475|NCT02671903|525246309|FG002|Period 0 (Run-In)|Adverse Event|1|||
145652476|NCT02671903|525246307|FG000|Period 0 (Run-In)|Implantation Failure|0|||
145652477|NCT02671903|525246308|FG001|Period 0 (Run-In)|Implantation Failure|0|||
145652478|NCT02671903|525246309|FG002|Period 0 (Run-In)|Implantation Failure|2|||
145652479|NCT02671903|525246307|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
145652480|NCT02671903|525246308|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
145652481|NCT02671903|525246309|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
145652482|NCT03376321|525246310|FG000|Overall Study|Other|5|||
145652483|NCT03376321|525246311|FG001|Overall Study|Other|1|||
145652484|NCT03376321|525246310|FG000|Overall Study|Withdrawal by Subject|8|||
145652485|NCT03376321|525246311|FG001|Overall Study|Withdrawal by Subject|14|||
145652486|NCT03376321|525246310|FG000|Overall Study|Lost to Follow-up|1|||
145652487|NCT03376321|525246311|FG001|Overall Study|Lost to Follow-up|7|||
145652488|NCT03376321|525246310|FG000|Overall Study|Death|4|||
145652489|NCT03376321|525246311|FG001|Overall Study|Death|0|||
145652490|NCT03376321|525246310|FG000|Overall Study|Randomized, not treated|5|||
145652491|NCT03376321|525246311|FG001|Overall Study|Randomized, not treated|3|||
145652492|NCT02992925|525246312|FG000|Cohort 2|Physician Decision|0|||
145652493|NCT02992925|525246313|FG001|Cohort 2|Physician Decision|0|||
145652494|NCT02992925|525246314|FG002|Cohort 2|Physician Decision|1|||
145652495|NCT02992925|525246315|FG003|Cohort 2|Physician Decision|0|||
145652496|NCT02992925|525246312|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
145652497|NCT02992925|525246313|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
145652498|NCT02992925|525246314|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
145652499|NCT02992925|525246315|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
145652500|NCT02995434|525246316|FG000|Overall Study|Adverse Event|1|||
145652501|NCT02995434|525246317|FG001|Overall Study|Adverse Event|0|||
145652502|NCT02995434|525246316|FG000|Overall Study|Withdrawal by Subject|6|||
145652503|NCT02995434|525246317|FG001|Overall Study|Withdrawal by Subject|3|||
145652504|NCT05273749|525246318|FG000|Overall Study|Adverse Event|14|||
145652505|NCT05273749|525246319|FG001|Overall Study|Adverse Event|8|||
145652506|NCT05273749|525246318|FG000|Overall Study|Lack of Efficacy|2|||
145652507|NCT05273749|525246319|FG001|Overall Study|Lack of Efficacy|8|||
145652508|NCT05273749|525246318|FG000|Overall Study|Physician Decision|0|||
145652509|NCT05273749|525246319|FG001|Overall Study|Physician Decision|2|||
145652510|NCT05273749|525246318|FG000|Overall Study|Withdrawal by Subject|14|||
145652511|NCT05273749|525246319|FG001|Overall Study|Withdrawal by Subject|16|||
145652512|NCT05273749|525246318|FG000|Overall Study|Lost to Follow-up|10|||
145652513|NCT05273749|525246319|FG001|Overall Study|Lost to Follow-up|10|||
145652514|NCT05273749|525246318|FG000|Overall Study|Pregnancy|1|||
145652515|NCT05273749|525246319|FG001|Overall Study|Pregnancy|0|||
145652516|NCT05273749|525246318|FG000|Overall Study|Non-Compliance|3|||
145652517|NCT05273749|525246319|FG001|Overall Study|Non-Compliance|2|||
145652518|NCT05273749|525246318|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
145652519|NCT05273749|525246319|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
145652520|NCT04806594|525246328|FG000|Overall Study|Withdrawal by Subject|2|||
145652521|NCT04806594|525246328|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
145652522|NCT02543281|525246329|FG000|Overall Study|Lost to Follow-up|0|||
145652523|NCT02543281|525246330|FG001|Overall Study|Lost to Follow-up|0|||
145652524|NCT02543281|525246331|FG002|Overall Study|Lost to Follow-up|1|||
145652525|NCT04318548|525246332|FG000|Overall Study|Adverse Event|0|||
145652526|NCT04318548|525246333|FG001|Overall Study|Adverse Event|0|||
145652527|NCT04318548|525246334|FG002|Overall Study|Adverse Event|1|||
145652528|NCT04318548|525246332|FG000|Overall Study|Lost to Follow-up|6|||
145652529|NCT04318548|525246333|FG001|Overall Study|Lost to Follow-up|13|||
145652530|NCT04318548|525246334|FG002|Overall Study|Lost to Follow-up|9|||
145652531|NCT04318548|525246332|FG000|Overall Study|Protocol Violation|1|||
145652532|NCT04318548|525246333|FG001|Overall Study|Protocol Violation|0|||
145652533|NCT04318548|525246334|FG002|Overall Study|Protocol Violation|2|||
145652534|NCT04318548|525246332|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
145652535|NCT04318548|525246333|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
145652536|NCT04318548|525246334|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
145652537|NCT04318548|525246332|FG000|Overall Study|Migrated / moved from the study area|0|||
145652538|NCT04318548|525246333|FG001|Overall Study|Migrated / moved from the study area|0|||
145652539|NCT04318548|525246334|FG002|Overall Study|Migrated / moved from the study area|1|||
145652540|NCT04318548|525246332|FG000|Overall Study|Other|1|||
145652541|NCT04318548|525246333|FG001|Overall Study|Other|2|||
145652542|NCT04318548|525246334|FG002|Overall Study|Other|3|||
145652543|NCT05247489|525246335|FG000|Overall Study|Lost to Follow-up|5|||
145652544|NCT05247489|525246336|FG001|Overall Study|Lost to Follow-up|1|||
145652545|NCT05247489|525246335|FG000|Overall Study|Withdrawal by Subject|6|||
145652546|NCT05247489|525246336|FG001|Overall Study|Withdrawal by Subject|7|||
145652547|NCT05247489|525246335|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
145652548|NCT05247489|525246336|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
145652549|NCT05247489|525246335|FG000|Overall Study|Left Country|1|||
145652550|NCT05247489|525246336|FG001|Overall Study|Left Country|0|||
145652551|NCT05247489|525246335|FG000|Overall Study|Noncompliance with Investigational Product|1|||
145652552|NCT05247489|525246336|FG001|Overall Study|Noncompliance with Investigational Product|0|||
145652553|NCT05247489|525246335|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
145652554|NCT05247489|525246336|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
145652555|NCT05215314|525246343|FG000|Overall Study|Lost to Follow-up|2|||
145652556|NCT05215314|525246344|FG001|Overall Study|Lost to Follow-up|2|||
145652557|NCT05215314|525246343|FG000|Overall Study|Withdrawal by Subject|2|||
145652558|NCT05215314|525246344|FG001|Overall Study|Withdrawal by Subject|0|||
145652559|NCT05215314|525246343|FG000|Overall Study|Physician Decision|1|||
145652560|NCT05215314|525246344|FG001|Overall Study|Physician Decision|0|||
145652561|NCT04179500|525246345|FG000|Treatment|Withdrawal by Subject|1|||
145652562|NCT04179500|525246345|FG000|Treatment|Adverse Event|2|||
145652563|NCT04179500|525246345|FG000|Treatment|pyrazinamide resistance|1|||
145652564|NCT03366649|525246351|FG000|Overall Study|Failed preoperative screening|4|||
145652565|NCT03366649|525246352|FG001|Overall Study|Failed preoperative screening|0|||
145652566|NCT03366649|525246353|FG002|Overall Study|Failed preoperative screening|0|||
145652567|NCT03366649|525246351|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
145652568|NCT03366649|525246352|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
145652569|NCT03366649|525246353|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
145652570|NCT03673111|525246354|FG000|Overall Study|Protocol Violation|0|||
145652571|NCT03673111|525246355|FG001|Overall Study|Protocol Violation|0|||
145652572|NCT03673111|525246356|FG002|Overall Study|Protocol Violation|0|||
145652573|NCT03673111|525246357|FG003|Overall Study|Protocol Violation|0|||
145652574|NCT03673111|525246358|FG004|Overall Study|Protocol Violation|0|||
145652575|NCT03673111|525246359|FG005|Overall Study|Protocol Violation|0|||
145652576|NCT03673111|525246360|FG006|Overall Study|Protocol Violation|0|||
145652577|NCT03673111|525246361|FG007|Overall Study|Protocol Violation|0|||
145652578|NCT03673111|525246362|FG008|Overall Study|Protocol Violation|0|||
145652579|NCT03673111|525246363|FG009|Overall Study|Protocol Violation|0|||
145652580|NCT03673111|525246364|FG010|Overall Study|Protocol Violation|1|||
145652581|NCT03673111|525246365|FG011|Overall Study|Protocol Violation|0|||
145652582|NCT03673111|525246366|FG012|Overall Study|Protocol Violation|0|||
145652583|NCT03673111|525246367|FG013|Overall Study|Protocol Violation|0|||
145652584|NCT03673111|525246354|FG000|Overall Study|Adverse Event|1|||
145652585|NCT03673111|525246355|FG001|Overall Study|Adverse Event|0|||
145652586|NCT03673111|525246356|FG002|Overall Study|Adverse Event|0|||
145652587|NCT03673111|525246357|FG003|Overall Study|Adverse Event|0|||
145652588|NCT03673111|525246358|FG004|Overall Study|Adverse Event|0|||
145652589|NCT03673111|525246359|FG005|Overall Study|Adverse Event|0|||
145652590|NCT03673111|525246360|FG006|Overall Study|Adverse Event|0|||
145489704|NCT03515824|524647590|FG003|Overall Study|Lost to Follow-up|0|||
145652591|NCT03673111|525246361|FG007|Overall Study|Adverse Event|0|||
145652592|NCT03673111|525246362|FG008|Overall Study|Adverse Event|0|||
145652593|NCT03673111|525246363|FG009|Overall Study|Adverse Event|0|||
145652594|NCT03673111|525246364|FG010|Overall Study|Adverse Event|0|||
145652595|NCT03673111|525246365|FG011|Overall Study|Adverse Event|0|||
145489705|NCT03515824|524647587|FG000|Overall Study|Study terminated by sponsor|0|||
145652596|NCT03673111|525246366|FG012|Overall Study|Adverse Event|0|||
145652597|NCT03673111|525246367|FG013|Overall Study|Adverse Event|0|||
145652598|NCT03792555|525246368|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
145652599|NCT03792555|525246369|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
145652600|NCT03792555|525246370|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
145652601|NCT03792555|525246368|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
145652602|NCT03792555|525246369|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
145652603|NCT03792555|525246370|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
145652604|NCT03792555|525246368|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
145652605|NCT03792555|525246369|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
145652606|NCT03792555|525246370|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
145652607|NCT04485039|525246374|FG000|TPOXX Only|Adverse Event|2|||
145652608|NCT04485039|525246374|FG000|TPOXX Only|Physician Decision|1|||
145652609|NCT04485039|525246374|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
145652610|NCT04485039|525246374|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
145652611|NCT00378105|525246376|FG000|Overall Study|Adverse Event|3|||
145652612|NCT00378105|525246377|FG001|Overall Study|Adverse Event|1|||
145652613|NCT00378105|525246376|FG000|Overall Study|Withdrawal by Subject|3|||
145652614|NCT00378105|525246377|FG001|Overall Study|Withdrawal by Subject|3|||
145652615|NCT00378105|525246376|FG000|Overall Study|Death|1|||
145652616|NCT00378105|525246377|FG001|Overall Study|Death|0|||
145652617|NCT00378105|525246376|FG000|Overall Study|Going to transplant|7|||
145652618|NCT00378105|525246377|FG001|Overall Study|Going to transplant|8|||
145652619|NCT00378105|525246376|FG000|Overall Study|Progressive disease|3|||
145652620|NCT00378105|525246377|FG001|Overall Study|Progressive disease|3|||
145652621|NCT00378105|525246376|FG000|Overall Study|remain on study|3|||
145652622|NCT00378105|525246377|FG001|Overall Study|remain on study|11|||
145652623|NCT00378105|525246376|FG000|Overall Study|Physician Decision|0|||
145652624|NCT00378105|525246377|FG001|Overall Study|Physician Decision|2|||
145652625|NCT00378105|525246376|FG000|Overall Study|Going non-protocol therapy|0|||
145652626|NCT00378105|525246377|FG001|Overall Study|Going non-protocol therapy|1|||
145652627|NCT00378105|525246376|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
145652628|NCT00378105|525246377|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
145652629|NCT02120456|525246378|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652630|NCT02120456|525246379|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652631|NCT02120456|525246380|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652632|NCT02120456|525246381|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652633|NCT02120456|525246382|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652634|NCT02120456|525246383|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652635|NCT02120456|525246384|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
145652636|NCT02120456|525246385|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652637|NCT02120456|525246386|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
145652638|NCT02120456|525246378|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652639|NCT02120456|525246379|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652640|NCT02120456|525246380|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652641|NCT02120456|525246381|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652642|NCT02120456|525246382|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652643|NCT02120456|525246383|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652644|NCT02120456|525246384|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
145652645|NCT02120456|525246385|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652646|NCT02120456|525246386|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
145652647|NCT02120456|525246378|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652648|NCT02120456|525246379|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652649|NCT02120456|525246380|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652650|NCT02120456|525246381|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652651|NCT02120456|525246382|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652652|NCT02120456|525246383|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652653|NCT02120456|525246384|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652654|NCT02120456|525246385|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
145652655|NCT02120456|525246386|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
145652656|NCT05192200|525246387|FG000|Treatment Period|Other|1|||
145652657|NCT05192200|525246387|FG000|Treatment Period|Lack of Efficacy|1|||
145652658|NCT05192200|525246387|FG000|Treatment Period|Withdrawal by Subject|1|||
145652659|NCT05192200|525246387|FG000|Follow-up|Withdrawal by Subject|1|||
145652660|NCT04492007|525246388|FG000|Overall Study|Lost to Follow-up|1|||
145652661|NCT04492007|525246389|FG001|Overall Study|Lost to Follow-up|1|||
145652662|NCT04492007|525246390|FG002|Overall Study|Lost to Follow-up|2|||
145652663|NCT04492007|525246391|FG003|Overall Study|Lost to Follow-up|2|||
145652664|NCT04492007|525246388|FG000|Overall Study|Protocol Violation|1|||
145652665|NCT04492007|525246389|FG001|Overall Study|Protocol Violation|1|||
145489706|NCT03515824|524647588|FG001|Overall Study|Study terminated by sponsor|1|||
145652666|NCT04492007|525246390|FG002|Overall Study|Protocol Violation|1|||
145652667|NCT04492007|525246391|FG003|Overall Study|Protocol Violation|1|||
145652668|NCT04492007|525246388|FG000|Overall Study|Withdrawal by Subject|0|||
145652669|NCT04492007|525246389|FG001|Overall Study|Withdrawal by Subject|0|||
145652670|NCT04492007|525246390|FG002|Overall Study|Withdrawal by Subject|1|||
145652671|NCT04492007|525246391|FG003|Overall Study|Withdrawal by Subject|1|||
145652672|NCT04177823|525246394|FG000|Overall Study|Physician Decision|1|||
145652673|NCT04177823|525246394|FG000|Overall Study|Withdrawal by Subject|1|||
145652674|NCT04229992|525246395|FG000|Overall Study|Withdrawal by Subject|0|||
145652675|NCT04229992|525246396|FG001|Overall Study|Withdrawal by Subject|2|||
145652676|NCT04229992|525246397|FG002|Overall Study|Withdrawal by Subject|1|||
145652677|NCT04229992|525246398|FG003|Overall Study|Withdrawal by Subject|1|||
145652678|NCT04229992|525246395|FG000|Overall Study|Adverse Event|1|||
145652679|NCT04229992|525246396|FG001|Overall Study|Adverse Event|1|||
145652680|NCT04229992|525246397|FG002|Overall Study|Adverse Event|3|||
145652681|NCT04229992|525246398|FG003|Overall Study|Adverse Event|1|||
145652682|NCT04229992|525246395|FG000|Overall Study|Lost to Follow-up|0|||
145652683|NCT04229992|525246396|FG001|Overall Study|Lost to Follow-up|0|||
145652684|NCT04229992|525246397|FG002|Overall Study|Lost to Follow-up|0|||
145652685|NCT04229992|525246398|FG003|Overall Study|Lost to Follow-up|1|||
145652686|NCT03770273|525246399|FG000|Overall Study|Adverse Event|2|||
145652687|NCT03770273|525246400|FG001|Overall Study|Adverse Event|0|||
145652688|NCT03770273|525246399|FG000|Overall Study|Lost to Follow-up|1|||
145652689|NCT03770273|525246400|FG001|Overall Study|Lost to Follow-up|1|||
145652690|NCT00418886|525246401|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
145652691|NCT00418886|525246402|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
145652692|NCT00418886|525246401|FG000|Randomized Period|Death|122|||
145652693|NCT00418886|525246402|FG001|Randomized Period|Death|147|||
145652694|NCT00418886|525246401|FG000|Randomized Period|Withdrawal by Subject|9|||
145652695|NCT00418886|525246402|FG001|Randomized Period|Withdrawal by Subject|10|||
145652696|NCT00418886|525246401|FG000|Randomized Period|Lost to Follow-up|4|||
145652697|NCT00418886|525246402|FG001|Randomized Period|Lost to Follow-up|6|||
145489707|NCT03515824|524647589|FG002|Overall Study|Study terminated by sponsor|6|||
145489708|NCT03515824|524647590|FG003|Overall Study|Study terminated by sponsor|0|||
145489709|NCT03515824|524647587|FG000|Overall Study|Status not recorded|0|||
145489710|NCT03515824|524647588|FG001|Overall Study|Status not recorded|0|||
145489711|NCT03515824|524647589|FG002|Overall Study|Status not recorded|2|||
145489712|NCT03515824|524647590|FG003|Overall Study|Status not recorded|0|||
145652698|NCT00418886|525246401|FG000|Randomized Period|withdrawn due to other reason|1|||
145652699|NCT00418886|525246402|FG001|Randomized Period|withdrawn due to other reason|0|||
145652700|NCT00418886|525246401|FG000|Randomized Period|randomised but no treatment received|0|||
145652701|NCT00418886|525246402|FG001|Randomized Period|randomised but no treatment received|1|||
145652702|NCT04060654|525246403|FG000|Overall Study|Withdrawal by Subject|1|||
145652703|NCT04060654|525246403|FG000|Overall Study|Lost to Follow-up|5|||
145652704|NCT03707951|525246404|FG000|Overall Study|Lost to Follow-up|8|||
145652705|NCT03707951|525246405|FG001|Overall Study|Lost to Follow-up|17|||
145652706|NCT03707951|525246404|FG000|Overall Study|Withdrawal by Subject|6|||
145652707|NCT03707951|525246405|FG001|Overall Study|Withdrawal by Subject|6|||
145652708|NCT04887129|525246406|FG000|Overall Study|Lost to Follow-up|0|||
145652709|NCT04887129|525246407|FG001|Overall Study|Lost to Follow-up|24|||
145652710|NCT04887129|525246406|FG000|Overall Study|Withdrawal by Subject|9|||
145652711|NCT04887129|525246407|FG001|Overall Study|Withdrawal by Subject|57|||
145652712|NCT04887129|525246406|FG000|Overall Study|Other|2|||
145652713|NCT04887129|525246407|FG001|Overall Study|Other|9|||
145652714|NCT01999075|525246409|FG000|Overall Study|Lost to Follow-up|0|||
145652715|NCT01999075|525246410|FG001|Overall Study|Lost to Follow-up|2|||
145652716|NCT01999075|525246409|FG000|Overall Study|Withdrawal by Subject|2|||
145652717|NCT01999075|525246410|FG001|Overall Study|Withdrawal by Subject|7|||
145652718|NCT01999075|525246409|FG000|Overall Study|Enrolled in drug trial|3|||
145652719|NCT01999075|525246410|FG001|Overall Study|Enrolled in drug trial|1|||
145652720|NCT01999075|525246409|FG000|Overall Study|Became ineligible|0|||
145652721|NCT01999075|525246410|FG001|Overall Study|Became ineligible|2|||
145652722|NCT03683719|525246411|FG000|Overall Study|Lack of Efficacy|1|||
145652723|NCT03683719|525246412|FG001|Overall Study|Lack of Efficacy|3|||
145652724|NCT03683719|525246413|FG002|Overall Study|Lack of Efficacy|4|||
145489713|NCT00920855|524647591|FG000|Overall Study|Adverse Event|1|||
145489714|NCT00920855|524647592|FG001|Overall Study|Adverse Event|1|||
145489715|NCT00920855|524647593|FG002|Overall Study|Adverse Event|4|||
145489716|NCT00920855|524647591|FG000|Overall Study|Withdrawal by Subject|2|||
145489717|NCT00920855|524647592|FG001|Overall Study|Withdrawal by Subject|1|||
145489718|NCT00920855|524647593|FG002|Overall Study|Withdrawal by Subject|6|||
145489719|NCT00920855|524647591|FG000|Overall Study|Disease progression|2|||
145489720|NCT00920855|524647592|FG001|Overall Study|Disease progression|1|||
145489721|NCT00920855|524647593|FG002|Overall Study|Disease progression|10|||
145489722|NCT00920855|524647591|FG000|Overall Study|Noncompliance to study medication|0|||
145489723|NCT00920855|524647592|FG001|Overall Study|Noncompliance to study medication|0|||
145489724|NCT00920855|524647593|FG002|Overall Study|Noncompliance to study medication|1|||
145489725|NCT00920855|524647591|FG000|Overall Study|Response plateau; started maintenance|0|||
145489726|NCT00920855|524647592|FG001|Overall Study|Response plateau; started maintenance|0|||
145489727|NCT00920855|524647593|FG002|Overall Study|Response plateau; started maintenance|1|||
145489728|NCT00510835|524647597|FG000|Overall Study|Withdrawal by Subject|6|||
145489729|NCT00510835|524647598|FG001|Overall Study|Withdrawal by Subject|2|||
145652725|NCT03683719|525246414|FG003|Overall Study|Lack of Efficacy|0|||
145652726|NCT03683719|525246415|FG004|Overall Study|Lack of Efficacy|4|||
145652727|NCT03683719|525246411|FG000|Overall Study|Adverse Event|6|||
145652728|NCT03683719|525246412|FG001|Overall Study|Adverse Event|6|||
145652729|NCT03683719|525246413|FG002|Overall Study|Adverse Event|0|||
145652730|NCT03683719|525246414|FG003|Overall Study|Adverse Event|1|||
145652731|NCT03683719|525246415|FG004|Overall Study|Adverse Event|3|||
145652732|NCT03683719|525246411|FG000|Overall Study|Withdrawal by Subject|4|||
145652733|NCT03683719|525246412|FG001|Overall Study|Withdrawal by Subject|4|||
145652734|NCT03683719|525246413|FG002|Overall Study|Withdrawal by Subject|3|||
145652735|NCT03683719|525246414|FG003|Overall Study|Withdrawal by Subject|5|||
145652736|NCT03683719|525246415|FG004|Overall Study|Withdrawal by Subject|5|||
145652737|NCT03683719|525246411|FG000|Overall Study|Lost to Follow-up|1|||
145652738|NCT03683719|525246412|FG001|Overall Study|Lost to Follow-up|0|||
145652739|NCT03683719|525246413|FG002|Overall Study|Lost to Follow-up|0|||
145652740|NCT03683719|525246414|FG003|Overall Study|Lost to Follow-up|1|||
145652741|NCT03683719|525246415|FG004|Overall Study|Lost to Follow-up|1|||
145652742|NCT03683719|525246411|FG000|Overall Study|Other personal reasons|0|||
145652743|NCT03683719|525246412|FG001|Overall Study|Other personal reasons|0|||
145652744|NCT03683719|525246413|FG002|Overall Study|Other personal reasons|1|||
145652745|NCT03683719|525246414|FG003|Overall Study|Other personal reasons|0|||
145652746|NCT03683719|525246415|FG004|Overall Study|Other personal reasons|1|||
145652747|NCT03792256|525246420|FG000|Overall Study|Death|0|||
145652748|NCT03792256|525246421|FG001|Overall Study|Death|1|||
145652749|NCT03792256|525246420|FG000|Overall Study|Lack of Efficacy|0|||
145652750|NCT03792256|525246421|FG001|Overall Study|Lack of Efficacy|1|||
145652751|NCT03792256|525246420|FG000|Overall Study|Withdrawal by Subject|0|||
145652752|NCT03792256|525246421|FG001|Overall Study|Withdrawal by Subject|1|||
145652753|NCT04760678|525246422|FG000|Overall Study|Death|13|||
145652754|NCT04760678|525246422|FG000|Overall Study|Lost to Follow-up|48|||
145652755|NCT04760678|525246422|FG000|Overall Study|Withdrawal by Subject|1|||
145652756|NCT04562649|525246423|FG000|Overall Study|Withdrawal by Subject|11|||
145652757|NCT04562649|525246424|FG001|Overall Study|Withdrawal by Subject|8|||
145652758|NCT04562649|525246423|FG000|Overall Study|Lost to Follow-up|26|||
145652759|NCT04562649|525246424|FG001|Overall Study|Lost to Follow-up|20|||
145652760|NCT03056040|525246425|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
145652761|NCT03056040|525246426|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
145652762|NCT03056040|525246425|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
145652763|NCT03056040|525246426|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
145652764|NCT03056040|525246425|FG000|Primary Evaluation Period|Pregnancy|0|||
145652765|NCT03056040|525246426|FG001|Primary Evaluation Period|Pregnancy|1|||
145652766|NCT03056040|525246425|FG000|Primary Evaluation Period|Randomized, not treated|1|||
145652767|NCT03056040|525246426|FG001|Primary Evaluation Period|Randomized, not treated|1|||
145652768|NCT03056040|525246425|FG000|Extension Period|Physician Decision|3|||
145652769|NCT03056040|525246426|FG001|Extension Period|Physician Decision|3|||
145652770|NCT03056040|525246425|FG000|Extension Period|Lost to Follow-up|0|||
145652771|NCT03056040|525246426|FG001|Extension Period|Lost to Follow-up|1|||
145652772|NCT03056040|525246425|FG000|Extension Period|Death|0|||
145652773|NCT03056040|525246426|FG001|Extension Period|Death|3|||
145652774|NCT03056040|525246425|FG000|Extension Period|Withdrawal by Subject|1|||
145652775|NCT03056040|525246426|FG001|Extension Period|Withdrawal by Subject|0|||
145652776|NCT03445988|525246429|FG000|Overall Study|Lost to Follow-up|14|||
145652777|NCT03445988|525246430|FG001|Overall Study|Lost to Follow-up|26|||
145652778|NCT03445988|525246431|FG002|Overall Study|Lost to Follow-up|27|||
145652779|NCT03445988|525246432|FG003|Overall Study|Lost to Follow-up|66|||
145652780|NCT03445988|525246429|FG000|Overall Study|Withdrawal by Subject|7|||
145652781|NCT03445988|525246430|FG001|Overall Study|Withdrawal by Subject|4|||
145652782|NCT03445988|525246431|FG002|Overall Study|Withdrawal by Subject|3|||
145652783|NCT03445988|525246432|FG003|Overall Study|Withdrawal by Subject|5|||
145652784|NCT03445988|525246429|FG000|Overall Study|Death (unrelated to study)|5|||
145652785|NCT03445988|525246430|FG001|Overall Study|Death (unrelated to study)|1|||
145652786|NCT03445988|525246431|FG002|Overall Study|Death (unrelated to study)|2|||
145652787|NCT03445988|525246432|FG003|Overall Study|Death (unrelated to study)|4|||
145652788|NCT05784662|525246433|FG000|Overall Study|Lost to Follow-up|21|||
145652789|NCT05784662|525246434|FG001|Overall Study|Lost to Follow-up|17|||
145652790|NCT04274764|525246435|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
145652791|NCT04274764|525246436|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
145652792|NCT03611621|525246439|FG000|Overall Study|Graft loss|3|||
145652793|NCT03611621|525246439|FG000|Overall Study|Death|3|||
145652794|NCT03611621|525246439|FG000|Overall Study|Lost to Follow-up|1|||
145652795|NCT05177848|525246457|FG000|Overall Study|Lost to Follow-up|1|||
145652796|NCT05177848|525246458|FG001|Overall Study|Lost to Follow-up|4|||
145652797|NCT05177848|525246457|FG000|Overall Study|Discontinued|2|||
145652798|NCT05177848|525246458|FG001|Overall Study|Discontinued|1|||
145652799|NCT05076708|525246461|FG000|Overall Study|Withdrawal by Subject|4|||
145652800|NCT05076708|525246461|FG000|Overall Study|Lost to study during switch phase|8|||
145652801|NCT04971395|525246462|FG000|Overall Study|Withdrawal by Subject|0|||
145652802|NCT04971395|525246463|FG001|Overall Study|Withdrawal by Subject|1|||
145652803|NCT04971395|525246464|FG002|Overall Study|Withdrawal by Subject|0|||
145652804|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Other|0|||
145652805|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Other|0|||
145652806|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Other|0|||
145652807|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Other|0|||
145652808|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Other|0|||
145652809|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Other|0|||
145652810|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Other|0|||
145652811|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Other|0|||
145652812|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Other|0|||
145652813|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Other|0|||
145652814|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Other|1|||
145652815|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Other|1|||
145652816|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Other|1|||
145652817|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Other|0|||
145652818|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Other|3|||
145652819|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Other|1|||
145652820|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Other|1|||
145652821|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Other|0|||
145652822|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652823|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652824|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652825|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652826|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652827|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652828|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
145652829|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652830|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
145652831|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652832|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652833|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652834|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
145652835|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652836|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652837|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652838|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652839|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
145652840|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652841|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652842|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652843|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652844|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652845|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652846|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652847|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
145652848|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652849|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652850|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652851|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652852|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652853|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652854|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652855|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652856|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652857|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
145652858|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652859|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652860|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652861|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652862|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652863|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652864|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652865|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652866|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652867|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
145652868|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652869|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652870|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652871|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652872|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652873|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652874|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652875|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
145652876|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Death|0|||
145652877|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Death|0|||
145652878|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Death|0|||
145652879|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Death|0|||
145652880|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Death|0|||
145652881|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Death|0|||
145652882|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Death|0|||
145652883|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Death|0|||
145652884|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Death|0|||
145652885|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Death|1|||
145652886|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Death|0|||
145652887|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Death|1|||
145652888|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Death|0|||
145652889|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Death|1|||
145652890|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Death|0|||
145652891|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Death|0|||
145652892|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Death|2|||
145652893|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Death|0|||
145652894|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
145652895|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
145652896|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
145652897|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
145652898|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
145652899|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
145652900|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
145652901|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
145652902|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
145652903|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
145652904|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
145652905|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
145652906|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
145652907|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
145652908|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
145652909|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
145652910|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
145652911|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
145652912|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Adverse Event|0|||
145652913|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Adverse Event|0|||
145652914|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Adverse Event|0|||
145652915|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Adverse Event|0|||
145652916|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Adverse Event|0|||
145652917|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Adverse Event|0|||
145652918|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Adverse Event|2|||
145652919|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Adverse Event|0|||
145652920|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Adverse Event|0|||
145652921|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Adverse Event|0|||
145652922|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Adverse Event|1|||
145652923|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Adverse Event|2|||
145652924|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Adverse Event|0|||
145652925|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Adverse Event|1|||
145652926|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Adverse Event|0|||
145652927|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Adverse Event|0|||
145652928|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Adverse Event|1|||
145652929|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Adverse Event|0|||
145652930|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
145652931|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
145652932|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
145652933|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
145652934|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
145652935|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
145489730|NCT00510835|524647599|FG002|Overall Study|Withdrawal by Subject|2|||
145489731|NCT05470985|524647600|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
145652936|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
145652937|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
145652938|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
145652939|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
145652940|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
145652941|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
145652942|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
145652943|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
145652944|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
145652945|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
145652946|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
145652947|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
145652948|NCT03269136|525246465|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652949|NCT03269136|525246466|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652950|NCT03269136|525246467|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652951|NCT03269136|525246468|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652952|NCT03269136|525246469|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652953|NCT03269136|525246470|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652954|NCT03269136|525246471|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652955|NCT03269136|525246472|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652956|NCT03269136|525246473|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652957|NCT03269136|525246474|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652958|NCT03269136|525246475|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652959|NCT03269136|525246476|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652960|NCT03269136|525246477|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
145652961|NCT03269136|525246478|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
145652962|NCT03269136|525246479|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
145652963|NCT03269136|525246480|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652964|NCT03269136|525246481|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
145652965|NCT03269136|525246482|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
145652966|NCT03269136|525246465|FG000|Part 2A: Dose Expansion|Other|0|||
145652967|NCT03269136|525246466|FG001|Part 2A: Dose Expansion|Other|0|||
145652968|NCT03269136|525246467|FG002|Part 2A: Dose Expansion|Other|0|||
145652969|NCT03269136|525246468|FG003|Part 2A: Dose Expansion|Other|0|||
145652970|NCT03269136|525246469|FG004|Part 2A: Dose Expansion|Other|0|||
145652971|NCT03269136|525246470|FG005|Part 2A: Dose Expansion|Other|0|||
145652972|NCT03269136|525246471|FG006|Part 2A: Dose Expansion|Other|0|||
145652973|NCT03269136|525246472|FG007|Part 2A: Dose Expansion|Other|0|||
145652974|NCT03269136|525246473|FG008|Part 2A: Dose Expansion|Other|0|||
145652975|NCT03269136|525246474|FG009|Part 2A: Dose Expansion|Other|0|||
145652976|NCT03269136|525246475|FG010|Part 2A: Dose Expansion|Other|0|||
145652977|NCT03269136|525246476|FG011|Part 2A: Dose Expansion|Other|0|||
145652978|NCT03269136|525246477|FG012|Part 2A: Dose Expansion|Other|0|||
145652979|NCT03269136|525246478|FG013|Part 2A: Dose Expansion|Other|0|||
145652980|NCT03269136|525246479|FG014|Part 2A: Dose Expansion|Other|0|||
145652981|NCT03269136|525246480|FG015|Part 2A: Dose Expansion|Other|0|||
145652982|NCT03269136|525246481|FG016|Part 2A: Dose Expansion|Other|0|||
145652983|NCT03269136|525246482|FG017|Part 2A: Dose Expansion|Other|1|||
145652984|NCT03269136|525246465|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652985|NCT03269136|525246466|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652986|NCT03269136|525246467|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652987|NCT03269136|525246468|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652988|NCT03269136|525246469|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652989|NCT03269136|525246470|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652990|NCT03269136|525246471|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652991|NCT03269136|525246472|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652992|NCT03269136|525246473|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652993|NCT03269136|525246474|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652994|NCT03269136|525246475|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652995|NCT03269136|525246476|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652996|NCT03269136|525246477|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652997|NCT03269136|525246478|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652998|NCT03269136|525246479|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145652999|NCT03269136|525246480|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145653000|NCT03269136|525246481|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
145653001|NCT03269136|525246482|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
145653002|NCT03269136|525246465|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
145653003|NCT03269136|525246466|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
145653004|NCT03269136|525246467|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
145653005|NCT03269136|525246468|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
145653006|NCT03269136|525246469|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
145653007|NCT03269136|525246470|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
145653008|NCT03269136|525246471|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
145653009|NCT03269136|525246472|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
145653010|NCT03269136|525246473|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
145653011|NCT03269136|525246474|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
145653012|NCT03269136|525246475|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
145653013|NCT03269136|525246476|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
145653014|NCT03269136|525246477|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
145653015|NCT03269136|525246478|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
145653016|NCT03269136|525246479|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
145653017|NCT03269136|525246480|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
145653018|NCT03269136|525246481|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
145653019|NCT03269136|525246482|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
145653020|NCT03269136|525246465|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
145653021|NCT03269136|525246466|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
145653022|NCT03269136|525246467|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
145653023|NCT03269136|525246468|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
145653024|NCT03269136|525246469|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
145653025|NCT03269136|525246470|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
145653026|NCT03269136|525246471|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
145653027|NCT03269136|525246472|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
145653028|NCT03269136|525246473|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
145653029|NCT03269136|525246474|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
145653030|NCT03269136|525246475|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
145653031|NCT03269136|525246476|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
145653032|NCT03269136|525246477|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
145653033|NCT03269136|525246478|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
145653034|NCT03269136|525246479|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
145653035|NCT03269136|525246480|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
145653036|NCT03269136|525246481|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
145653037|NCT03269136|525246482|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
145653038|NCT03269136|525246465|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
145653039|NCT03269136|525246466|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
145653040|NCT03269136|525246467|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
145653041|NCT03269136|525246468|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
145653042|NCT03269136|525246469|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
145653043|NCT03269136|525246470|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
145653044|NCT03269136|525246471|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
145653045|NCT03269136|525246472|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
145653046|NCT03269136|525246473|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
145653047|NCT03269136|525246474|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
145653048|NCT03269136|525246475|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
145653049|NCT03269136|525246476|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
145653050|NCT03269136|525246477|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
145653051|NCT03269136|525246478|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
145653052|NCT03269136|525246479|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
145653053|NCT03269136|525246480|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
145653054|NCT03269136|525246481|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
145653055|NCT03269136|525246482|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
145653056|NCT02924272|525246483|FG000|Overall Study|Site Terminated by Sponsor|4|||
145653057|NCT02924272|525246484|FG001|Overall Study|Site Terminated by Sponsor|1|||
145653058|NCT02924272|525246483|FG000|Overall Study|Withdrawal by Subject|2|||
145653059|NCT02924272|525246484|FG001|Overall Study|Withdrawal by Subject|0|||
145653060|NCT02924272|525246483|FG000|Overall Study|Adverse Event|3|||
145653061|NCT02924272|525246484|FG001|Overall Study|Adverse Event|0|||
145653062|NCT02924272|525246483|FG000|Overall Study|Progressive Disease|11|||
145653063|NCT02924272|525246484|FG001|Overall Study|Progressive Disease|8|||
145653064|NCT02924272|525246483|FG000|Overall Study|Clinical Deterioration|1|||
145653065|NCT02924272|525246484|FG001|Overall Study|Clinical Deterioration|0|||
145653066|NCT02924272|525246483|FG000|Overall Study|Death|1|||
145653067|NCT02924272|525246484|FG001|Overall Study|Death|0|||
145653068|NCT02924272|525246483|FG000|Overall Study|Reason Not Specified|1|||
145653069|NCT02924272|525246484|FG001|Overall Study|Reason Not Specified|0|||
145653070|NCT05071807|525246489|FG000|Overall Study|Withdrawal by Subject|4|||
145653071|NCT05071807|525246490|FG001|Overall Study|Withdrawal by Subject|0|||
145653072|NCT05071807|525246489|FG000|Overall Study|Unrelated medical issues|3|||
145653073|NCT05071807|525246490|FG001|Overall Study|Unrelated medical issues|0|||
145653074|NCT05071807|525246489|FG000|Overall Study|Relocated|0|||
145653075|NCT05071807|525246490|FG001|Overall Study|Relocated|1|||
145653076|NCT05308004|525246492|FG000|Overall Study|Not seen by Palliative Care NP|0|||
145653077|NCT05308004|525246493|FG001|Overall Study|Not seen by Palliative Care NP|1|||
145653078|NCT04552223|525246500|FG000|Overall Study|Withdrawal by Subject|1|||
145653079|NCT04856163|525246501|FG000|Overall Study|Lost to Follow-up|97|||
145653080|NCT04856163|525246502|FG001|Overall Study|Lost to Follow-up|100|||
145653081|NCT04359108|525246509|FG000|Overall Study|Withdrawal by Subject|1|||
145653082|NCT04359108|525246510|FG001|Overall Study|Withdrawal by Subject|0|||
145653083|NCT04359108|525246509|FG000|Overall Study|Unable or too feeble to walk independently|0|||
145653084|NCT04359108|525246510|FG001|Overall Study|Unable or too feeble to walk independently|2|||
145653085|NCT04359108|525246509|FG000|Overall Study|Argus II system stopped functioning|0|||
145653086|NCT04359108|525246510|FG001|Overall Study|Argus II system stopped functioning|1|||
145653087|NCT04359108|525246509|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
145653088|NCT04359108|525246510|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
145653089|NCT04176965|525246511|FG000|Overall Study|Death|1|||
145653090|NCT04176965|525246512|FG001|Overall Study|Death|2|||
145653091|NCT04176965|525246511|FG000|Overall Study|Lost to Follow-up|10|||
145653092|NCT04176965|525246512|FG001|Overall Study|Lost to Follow-up|2|||
145653093|NCT04176965|525246511|FG000|Overall Study|Withdrawal by Subject|6|||
145653094|NCT04176965|525246512|FG001|Overall Study|Withdrawal by Subject|1|||
145653095|NCT02919683|525246513|FG000|Post-Surgery Follow-Up|Death|2|||
145653096|NCT02919683|525246514|FG001|Post-Surgery Follow-Up|Death|2|||
145653097|NCT02919683|525246513|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
145653098|NCT02919683|525246514|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
145653099|NCT05551637|525246515|FG000|Overall Study|Lack of Efficacy|0|||
145653100|NCT05551637|525246516|FG001|Overall Study|Lack of Efficacy|6|||
145653101|NCT05551637|525246515|FG000|Overall Study|Lost to Follow-up|1|||
145653102|NCT05551637|525246516|FG001|Overall Study|Lost to Follow-up|1|||
145653103|NCT04924660|525246517|FG000|United States|Death|29|||
145653104|NCT04924660|525246518|FG001|United States|Death|32|||
145653105|NCT04924660|525246519|FG002|United States|Death|34|||
145653106|NCT04924660|525246520|FG003|United States|Death|25|||
145653107|NCT04924660|525246521|FG004|United States|Death|26|||
145653108|NCT04924660|525246522|FG005|United States|Death|23|||
145653109|NCT04924660|525246517|FG000|United States|Lost to Follow-up|15|||
145653110|NCT04924660|525246518|FG001|United States|Lost to Follow-up|10|||
145653111|NCT04924660|525246519|FG002|United States|Lost to Follow-up|13|||
145653112|NCT04924660|525246520|FG003|United States|Lost to Follow-up|5|||
145653113|NCT04924660|525246521|FG004|United States|Lost to Follow-up|19|||
145653114|NCT04924660|525246522|FG005|United States|Lost to Follow-up|20|||
145653115|NCT04924660|525246517|FG000|United States|Withdrawal by Subject|8|||
145653116|NCT04924660|525246518|FG001|United States|Withdrawal by Subject|3|||
145653117|NCT04924660|525246519|FG002|United States|Withdrawal by Subject|3|||
145653118|NCT04924660|525246520|FG003|United States|Withdrawal by Subject|3|||
145653119|NCT04924660|525246521|FG004|United States|Withdrawal by Subject|8|||
145653120|NCT04924660|525246522|FG005|United States|Withdrawal by Subject|4|||
145653121|NCT04924660|525246517|FG000|Spain|Death|0|||
145653122|NCT04924660|525246518|FG001|Spain|Death|0|||
145653123|NCT04924660|525246519|FG002|Spain|Death|0|||
145653124|NCT04924660|525246520|FG003|Spain|Death|0|||
145653125|NCT04924660|525246521|FG004|Spain|Death|0|||
145653126|NCT04924660|525246522|FG005|Spain|Death|2|||
145653127|NCT04924660|525246517|FG000|Spain|Lost to Follow-up|0|||
145653128|NCT04924660|525246518|FG001|Spain|Lost to Follow-up|0|||
145653129|NCT04924660|525246519|FG002|Spain|Lost to Follow-up|0|||
145653130|NCT04924660|525246520|FG003|Spain|Lost to Follow-up|0|||
145653131|NCT04924660|525246521|FG004|Spain|Lost to Follow-up|1|||
145653132|NCT04924660|525246522|FG005|Spain|Lost to Follow-up|0|||
145653133|NCT04924660|525246517|FG000|Brazil|Death|0|||
145653134|NCT04924660|525246518|FG001|Brazil|Death|0|||
145653135|NCT04924660|525246519|FG002|Brazil|Death|0|||
145653136|NCT04924660|525246520|FG003|Brazil|Death|0|||
145653137|NCT04924660|525246521|FG004|Brazil|Death|1|||
145653138|NCT04924660|525246522|FG005|Brazil|Death|0|||
145653139|NCT04924660|525246517|FG000|Italy|Lost to Follow-up|0|||
145653140|NCT04924660|525246518|FG001|Italy|Lost to Follow-up|0|||
145653141|NCT04924660|525246519|FG002|Italy|Lost to Follow-up|0|||
145653142|NCT04924660|525246520|FG003|Italy|Lost to Follow-up|0|||
145653143|NCT04924660|525246521|FG004|Italy|Lost to Follow-up|0|||
145653144|NCT04924660|525246522|FG005|Italy|Lost to Follow-up|1|||
145653145|NCT04924660|525246517|FG000|South Africa|Death|0|||
145653146|NCT04924660|525246518|FG001|South Africa|Death|0|||
145653147|NCT04924660|525246519|FG002|South Africa|Death|0|||
145653148|NCT04924660|525246520|FG003|South Africa|Death|0|||
145653149|NCT04924660|525246521|FG004|South Africa|Death|0|||
145653150|NCT04924660|525246522|FG005|South Africa|Death|1|||
145653151|NCT04924660|525246517|FG000|South Africa|Lost to Follow-up|0|||
145653152|NCT04924660|525246518|FG001|South Africa|Lost to Follow-up|0|||
145653153|NCT04924660|525246519|FG002|South Africa|Lost to Follow-up|0|||
145653154|NCT04924660|525246520|FG003|South Africa|Lost to Follow-up|0|||
145653155|NCT04924660|525246521|FG004|South Africa|Lost to Follow-up|0|||
145653156|NCT04924660|525246522|FG005|South Africa|Lost to Follow-up|1|||
145653157|NCT03721952|525246534|FG000|Overall Study|Lost to Follow-up|0|||
145653158|NCT03721952|525246535|FG001|Overall Study|Lost to Follow-up|0|||
145653159|NCT03721952|525246536|FG002|Overall Study|Lost to Follow-up|2|||
145653160|NCT03721952|525246537|FG003|Overall Study|Lost to Follow-up|0|||
145653161|NCT03721952|525246538|FG004|Overall Study|Lost to Follow-up|0|||
145653162|NCT03721952|525246534|FG000|Overall Study|Protocol Violation|0|||
145653163|NCT03721952|525246535|FG001|Overall Study|Protocol Violation|1|||
145653164|NCT03721952|525246536|FG002|Overall Study|Protocol Violation|0|||
145653165|NCT03721952|525246537|FG003|Overall Study|Protocol Violation|0|||
145653166|NCT03721952|525246538|FG004|Overall Study|Protocol Violation|0|||
145653167|NCT03721952|525246534|FG000|Overall Study|Withdrawal by Subject|1|||
145653168|NCT03721952|525246535|FG001|Overall Study|Withdrawal by Subject|0|||
145653169|NCT03721952|525246536|FG002|Overall Study|Withdrawal by Subject|40|||
145653170|NCT03721952|525246537|FG003|Overall Study|Withdrawal by Subject|28|||
145653171|NCT03721952|525246538|FG004|Overall Study|Withdrawal by Subject|0|||
145653172|NCT04505904|525246539|FG000|Overall Study|Withdrawal by Subject|1|||
145653173|NCT04505904|525246540|FG001|Overall Study|Withdrawal by Subject|2|||
145653174|NCT04505904|525246541|FG002|Overall Study|Withdrawal by Subject|0|||
145653175|NCT04505904|525246542|FG003|Overall Study|Withdrawal by Subject|0|||
145653176|NCT04505904|525246539|FG000|Overall Study|Physician Decision|1|||
145653177|NCT04505904|525246540|FG001|Overall Study|Physician Decision|0|||
145653178|NCT04505904|525246541|FG002|Overall Study|Physician Decision|0|||
145653179|NCT04505904|525246542|FG003|Overall Study|Physician Decision|0|||
145653180|NCT04505904|525246539|FG000|Overall Study|Adverse Event|0|||
145653181|NCT04505904|525246540|FG001|Overall Study|Adverse Event|1|||
145653182|NCT04505904|525246541|FG002|Overall Study|Adverse Event|0|||
145653183|NCT04505904|525246542|FG003|Overall Study|Adverse Event|0|||
145653184|NCT04277442|525246545|FG000|Overall Study|Death|1|||
145653185|NCT05093829|525246546|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
145653186|NCT05093829|525246547|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
145653187|NCT05093829|525246548|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
145653188|NCT05093829|525246549|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
145653189|NCT05093829|525246550|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
145653190|NCT04353661|525248226|FG000|Overall Study|Protocol Violation|0|||
145653191|NCT04353661|525248227|FG001|Overall Study|Protocol Violation|0|||
145653192|NCT04353661|525248228|FG002|Overall Study|Protocol Violation|1|||
145653193|NCT04353661|525248226|FG000|Overall Study|Study termination by the Sponsor|1|||
145653194|NCT04353661|525248227|FG001|Overall Study|Study termination by the Sponsor|1|||
145653195|NCT04353661|525248228|FG002|Overall Study|Study termination by the Sponsor|1|||
145653196|NCT02727699|525248229|FG000|Overall Study|Adverse Event|2|||
145653197|NCT02727699|525248230|FG001|Overall Study|Adverse Event|0|||
145653198|NCT02727699|525248229|FG000|Overall Study|Withdrawal by Subject|5|||
145653199|NCT02727699|525248230|FG001|Overall Study|Withdrawal by Subject|3|||
145653200|NCT02727699|525248229|FG000|Overall Study|Protocol Violation|0|||
145653201|NCT02727699|525248230|FG001|Overall Study|Protocol Violation|1|||
145653202|NCT02727699|525248229|FG000|Overall Study|Physician Decision|0|||
145653203|NCT02727699|525248230|FG001|Overall Study|Physician Decision|1|||
145653204|NCT02727699|525248229|FG000|Overall Study|Lost to Follow-up|1|||
145653205|NCT02727699|525248230|FG001|Overall Study|Lost to Follow-up|0|||
145653206|NCT02727699|525248229|FG000|Overall Study|Sponsor Decision|1|||
145653207|NCT02727699|525248230|FG001|Overall Study|Sponsor Decision|0|||
145653208|NCT03457142|525248231|FG000|Overall Study|Death|1|||
145653209|NCT01413100|525248232|FG000|Overall Study|Withdrawal by Subject|1|||
145653210|NCT04896476|525248240|FG000|Overall Study|Withdrawal by Subject|1|||
145653211|NCT04896476|525248240|FG000|Overall Study|Lost to Follow-up|2|||
145653212|NCT03476187|525248241|FG000|Overall Study|Protocol Violation|7|||
145653213|NCT03476187|525248241|FG000|Overall Study|Physician Decision|5|||
145653214|NCT05948670|525248243|FG000|Overall Study|Protocol Violation|6|||
145653215|NCT05948670|525248244|FG001|Overall Study|Protocol Violation|8|||
145653216|NCT05948670|525248243|FG000|Overall Study|Withdrawal by Subject|0|||
145653217|NCT05948670|525248244|FG001|Overall Study|Withdrawal by Subject|1|||
145653218|NCT05368103|525248246|FG000|Overall Study|Withdrawal by Subject|4|||
145653219|NCT05368103|525248246|FG000|Overall Study|Lost to Follow-up|1|||
145653220|NCT05368103|525248246|FG000|Overall Study|Lack of Efficacy|3|||
145653221|NCT03675282|525248249|FG000|Overall Study|Lost to Follow-up|4|||
145653222|NCT03675282|525248250|FG001|Overall Study|Lost to Follow-up|8|||
145653223|NCT03675282|525248251|FG002|Overall Study|Lost to Follow-up|1|||
145653224|NCT03675282|525248252|FG003|Overall Study|Lost to Follow-up|0|||
145653225|NCT03675282|525248253|FG004|Overall Study|Lost to Follow-up|2|||
145653226|NCT03675282|525248254|FG005|Overall Study|Lost to Follow-up|7|||
145653227|NCT03675282|525248249|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
145653228|NCT03675282|525248250|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
145653229|NCT03675282|525248251|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
145653230|NCT03675282|525248252|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
145653231|NCT03675282|525248253|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
145653232|NCT03675282|525248254|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
145653233|NCT03675282|525248249|FG000|Overall Study|Physician Decision|1|||
145653234|NCT03675282|525248250|FG001|Overall Study|Physician Decision|0|||
145653235|NCT03675282|525248251|FG002|Overall Study|Physician Decision|0|||
145653236|NCT03675282|525248252|FG003|Overall Study|Physician Decision|0|||
145489732|NCT05470985|524647601|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
145489733|NCT05470985|524647600|FG000|Double Blind Treatment Period|Physician Decision|0|||
145653237|NCT03675282|525248253|FG004|Overall Study|Physician Decision|0|||
145653238|NCT03675282|525248254|FG005|Overall Study|Physician Decision|0|||
145653239|NCT02921230|525248261|FG000|Overall Study|Withdrawal by Subject|20|||
145653240|NCT02921230|525248262|FG001|Overall Study|Withdrawal by Subject|8|||
145653241|NCT02921230|525248261|FG000|Overall Study|Death|12|||
145653242|NCT02921230|525248262|FG001|Overall Study|Death|3|||
145653243|NCT02921230|525248261|FG000|Overall Study|Protocol Violation|17|||
145653244|NCT02921230|525248262|FG001|Overall Study|Protocol Violation|6|||
145653245|NCT02921230|525248261|FG000|Overall Study|Early completion|5|||
145653246|NCT02921230|525248262|FG001|Overall Study|Early completion|1|||
145653247|NCT02921230|525248261|FG000|Overall Study|Pending data entry|1|||
145653248|NCT02921230|525248262|FG001|Overall Study|Pending data entry|0|||
145653249|NCT02677298|525248275|FG000|Double Blind Phase|Adverse Event|2|||
145653250|NCT02677298|525248276|FG001|Double Blind Phase|Adverse Event|1|||
145653251|NCT02677298|525248277|FG002|Double Blind Phase|Adverse Event|0|||
145653252|NCT02677298|525248275|FG000|Double Blind Phase|Physician Decision|5|||
145653253|NCT02677298|525248276|FG001|Double Blind Phase|Physician Decision|0|||
145653254|NCT02677298|525248277|FG002|Double Blind Phase|Physician Decision|0|||
145653255|NCT02677298|525248275|FG000|Double Blind Phase|Lost to Follow-up|11|||
145653256|NCT02677298|525248276|FG001|Double Blind Phase|Lost to Follow-up|7|||
145653257|NCT02677298|525248277|FG002|Double Blind Phase|Lost to Follow-up|0|||
145653258|NCT02677298|525248275|FG000|Double Blind Phase|Withdrawal by Subject|11|||
145653259|NCT02677298|525248276|FG001|Double Blind Phase|Withdrawal by Subject|8|||
145653260|NCT02677298|525248277|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145653261|NCT02677298|525248275|FG000|Double Blind Phase|No study drug available at site|0|||
145653262|NCT02677298|525248276|FG001|Double Blind Phase|No study drug available at site|1|||
145653263|NCT02677298|525248277|FG002|Double Blind Phase|No study drug available at site|0|||
145653264|NCT02677298|525248275|FG000|Open Label Phase|Adverse Event|0|||
145653265|NCT02677298|525248276|FG001|Open Label Phase|Adverse Event|0|||
145653266|NCT02677298|525248277|FG002|Open Label Phase|Adverse Event|4|||
145653267|NCT02677298|525248275|FG000|Open Label Phase|Physician Decision|0|||
145653268|NCT02677298|525248276|FG001|Open Label Phase|Physician Decision|0|||
145653269|NCT02677298|525248277|FG002|Open Label Phase|Physician Decision|1|||
145653270|NCT02677298|525248275|FG000|Open Label Phase|Lost to Follow-up|0|||
145653271|NCT02677298|525248276|FG001|Open Label Phase|Lost to Follow-up|0|||
145653272|NCT02677298|525248277|FG002|Open Label Phase|Lost to Follow-up|17|||
145653273|NCT02677298|525248275|FG000|Open Label Phase|Withdrawal by Subject|0|||
145653274|NCT02677298|525248276|FG001|Open Label Phase|Withdrawal by Subject|0|||
145653275|NCT02677298|525248277|FG002|Open Label Phase|Withdrawal by Subject|38|||
145653276|NCT03988608|525248278|FG000|Overall Study|Adverse Event|1|||
145653277|NCT03988608|525248278|FG000|Overall Study|Lost to Follow-up|1|||
145653278|NCT03988608|525248278|FG000|Overall Study|Withdrawal by Subject|3|||
145653279|NCT03988608|525248278|FG000|Overall Study|Death|1|||
145653280|NCT03338933|525248289|FG000|Screening Visit|Lost to Follow-up|1|||
145653281|NCT03338933|525248290|FG001|Screening Visit|Lost to Follow-up|3|||
145653282|NCT03338933|525248291|FG002|Screening Visit|Lost to Follow-up|1|||
145653283|NCT03338933|525248292|FG003|Screening Visit|Lost to Follow-up|4|||
145653284|NCT03338933|525248289|FG000|Screening Visit|Screen fail after consent|2|||
145653285|NCT03338933|525248290|FG001|Screening Visit|Screen fail after consent|7|||
145653286|NCT03338933|525248291|FG002|Screening Visit|Screen fail after consent|1|||
145653287|NCT03338933|525248292|FG003|Screening Visit|Screen fail after consent|4|||
145653288|NCT03338933|525248289|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
145653289|NCT03338933|525248290|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
145653290|NCT03338933|525248291|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
145653291|NCT03338933|525248292|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
145653292|NCT03338933|525248289|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
145653293|NCT03338933|525248290|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
145653294|NCT03338933|525248291|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
145653295|NCT03338933|525248292|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
145653296|NCT03338933|525248289|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
145653297|NCT03338933|525248290|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
145653298|NCT03338933|525248291|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
145653299|NCT03338933|525248292|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
145653300|NCT00999804|525248295|FG000|Overall Study|Lack of Efficacy|9|||
145653301|NCT00999804|525248296|FG001|Overall Study|Lack of Efficacy|2|||
145653302|NCT00999804|525248295|FG000|Overall Study|Adverse Event|4|||
145653303|NCT00999804|525248296|FG001|Overall Study|Adverse Event|3|||
145653304|NCT00999804|525248295|FG000|Overall Study|Withdrawal by Subject|4|||
145653305|NCT00999804|525248296|FG001|Overall Study|Withdrawal by Subject|0|||
145653306|NCT00999804|525248295|FG000|Overall Study|Death|1|||
145653307|NCT00999804|525248296|FG001|Overall Study|Death|0|||
145653308|NCT00999804|525248295|FG000|Overall Study|Ineligible|3|||
145653309|NCT00999804|525248296|FG001|Overall Study|Ineligible|0|||
145653310|NCT05486078|525248305|FG000|Overall Study|4 drop out and one withdrawn|5|||
145653311|NCT02908477|525248306|FG000|Overall Study|Withdrawal by Subject|8|||
145653312|NCT02908477|525248307|FG001|Overall Study|Withdrawal by Subject|28|||
145653313|NCT03150810|525248311|FG000|Overall Study|Death|4|||
145653314|NCT03150810|525248312|FG001|Overall Study|Death|8|||
145653315|NCT03150810|525248313|FG002|Overall Study|Death|7|||
145653316|NCT03150810|525248314|FG003|Overall Study|Death|2|||
145653317|NCT03150810|525248315|FG004|Overall Study|Death|2|||
145653318|NCT03150810|525248316|FG005|Overall Study|Death|10|||
145653319|NCT03150810|525248317|FG006|Overall Study|Death|8|||
145653320|NCT03150810|525248318|FG007|Overall Study|Death|6|||
145653321|NCT03150810|525248319|FG008|Overall Study|Death|18|||
145653322|NCT03150810|525248320|FG009|Overall Study|Death|3|||
145653323|NCT03150810|525248321|FG010|Overall Study|Death|19|||
145489734|NCT05470985|524647601|FG001|Double Blind Treatment Period|Physician Decision|1|||
145653324|NCT03150810|525248322|FG011|Overall Study|Death|1|||
145653325|NCT03150810|525248323|FG012|Overall Study|Death|19|||
145653326|NCT03150810|525248311|FG000|Overall Study|Withdrawal by Subject|0|||
145653327|NCT03150810|525248312|FG001|Overall Study|Withdrawal by Subject|1|||
145653328|NCT03150810|525248313|FG002|Overall Study|Withdrawal by Subject|1|||
145653329|NCT03150810|525248314|FG003|Overall Study|Withdrawal by Subject|1|||
145653330|NCT03150810|525248315|FG004|Overall Study|Withdrawal by Subject|0|||
145653331|NCT03150810|525248316|FG005|Overall Study|Withdrawal by Subject|0|||
145653332|NCT03150810|525248317|FG006|Overall Study|Withdrawal by Subject|2|||
145653333|NCT03150810|525248318|FG007|Overall Study|Withdrawal by Subject|0|||
145653334|NCT03150810|525248319|FG008|Overall Study|Withdrawal by Subject|2|||
145653335|NCT03150810|525248320|FG009|Overall Study|Withdrawal by Subject|0|||
145653336|NCT03150810|525248321|FG010|Overall Study|Withdrawal by Subject|1|||
145653337|NCT03150810|525248322|FG011|Overall Study|Withdrawal by Subject|0|||
145653338|NCT03150810|525248323|FG012|Overall Study|Withdrawal by Subject|1|||
145653339|NCT03150810|525248311|FG000|Overall Study|Sponsor Decision|0|||
145653340|NCT03150810|525248312|FG001|Overall Study|Sponsor Decision|2|||
145653341|NCT03150810|525248313|FG002|Overall Study|Sponsor Decision|0|||
145653342|NCT03150810|525248314|FG003|Overall Study|Sponsor Decision|0|||
145653343|NCT03150810|525248315|FG004|Overall Study|Sponsor Decision|1|||
145653344|NCT03150810|525248316|FG005|Overall Study|Sponsor Decision|1|||
145653345|NCT03150810|525248317|FG006|Overall Study|Sponsor Decision|0|||
145653346|NCT03150810|525248318|FG007|Overall Study|Sponsor Decision|0|||
145653347|NCT03150810|525248319|FG008|Overall Study|Sponsor Decision|1|||
145653348|NCT03150810|525248320|FG009|Overall Study|Sponsor Decision|0|||
145653349|NCT03150810|525248321|FG010|Overall Study|Sponsor Decision|0|||
145653350|NCT03150810|525248322|FG011|Overall Study|Sponsor Decision|0|||
145653351|NCT03150810|525248323|FG012|Overall Study|Sponsor Decision|5|||
145653352|NCT03150810|525248311|FG000|Overall Study|Lost to Follow-up|0|||
145653353|NCT03150810|525248312|FG001|Overall Study|Lost to Follow-up|1|||
145653354|NCT03150810|525248313|FG002|Overall Study|Lost to Follow-up|1|||
145653355|NCT03150810|525248314|FG003|Overall Study|Lost to Follow-up|0|||
145653356|NCT03150810|525248315|FG004|Overall Study|Lost to Follow-up|0|||
145653357|NCT03150810|525248316|FG005|Overall Study|Lost to Follow-up|0|||
145653358|NCT03150810|525248317|FG006|Overall Study|Lost to Follow-up|1|||
145653359|NCT03150810|525248318|FG007|Overall Study|Lost to Follow-up|0|||
145653360|NCT03150810|525248319|FG008|Overall Study|Lost to Follow-up|0|||
145653361|NCT03150810|525248320|FG009|Overall Study|Lost to Follow-up|0|||
145653362|NCT03150810|525248321|FG010|Overall Study|Lost to Follow-up|1|||
145653363|NCT03150810|525248322|FG011|Overall Study|Lost to Follow-up|0|||
145653364|NCT03150810|525248323|FG012|Overall Study|Lost to Follow-up|0|||
145653365|NCT03150810|525248311|FG000|Overall Study|Physician Decision|0|||
145653366|NCT03150810|525248312|FG001|Overall Study|Physician Decision|0|||
145653367|NCT03150810|525248313|FG002|Overall Study|Physician Decision|0|||
145653368|NCT03150810|525248314|FG003|Overall Study|Physician Decision|0|||
145653369|NCT03150810|525248315|FG004|Overall Study|Physician Decision|0|||
145653370|NCT03150810|525248316|FG005|Overall Study|Physician Decision|1|||
145653371|NCT03150810|525248317|FG006|Overall Study|Physician Decision|1|||
145653372|NCT03150810|525248318|FG007|Overall Study|Physician Decision|0|||
145653373|NCT03150810|525248319|FG008|Overall Study|Physician Decision|0|||
145653374|NCT03150810|525248320|FG009|Overall Study|Physician Decision|0|||
145653375|NCT03150810|525248321|FG010|Overall Study|Physician Decision|0|||
145653376|NCT03150810|525248322|FG011|Overall Study|Physician Decision|0|||
145653377|NCT03150810|525248323|FG012|Overall Study|Physician Decision|0|||
145653378|NCT03150810|525248311|FG000|Overall Study|Site withdrawal from study|0|||
145653379|NCT03150810|525248312|FG001|Overall Study|Site withdrawal from study|1|||
145653380|NCT03150810|525248313|FG002|Overall Study|Site withdrawal from study|0|||
145653381|NCT03150810|525248314|FG003|Overall Study|Site withdrawal from study|0|||
145653382|NCT03150810|525248315|FG004|Overall Study|Site withdrawal from study|0|||
145653383|NCT03150810|525248316|FG005|Overall Study|Site withdrawal from study|0|||
145653384|NCT03150810|525248317|FG006|Overall Study|Site withdrawal from study|0|||
145653385|NCT03150810|525248318|FG007|Overall Study|Site withdrawal from study|0|||
145653386|NCT03150810|525248319|FG008|Overall Study|Site withdrawal from study|0|||
145653387|NCT03150810|525248320|FG009|Overall Study|Site withdrawal from study|1|||
145653388|NCT03150810|525248321|FG010|Overall Study|Site withdrawal from study|1|||
145653389|NCT03150810|525248322|FG011|Overall Study|Site withdrawal from study|0|||
145653390|NCT03150810|525248323|FG012|Overall Study|Site withdrawal from study|0|||
145653391|NCT03150810|525248311|FG000|Overall Study|Hospice|0|||
145653392|NCT03150810|525248312|FG001|Overall Study|Hospice|0|||
145653393|NCT03150810|525248313|FG002|Overall Study|Hospice|0|||
145653394|NCT03150810|525248314|FG003|Overall Study|Hospice|0|||
145653395|NCT03150810|525248315|FG004|Overall Study|Hospice|0|||
145653396|NCT03150810|525248316|FG005|Overall Study|Hospice|1|||
145653397|NCT03150810|525248317|FG006|Overall Study|Hospice|0|||
145653398|NCT03150810|525248318|FG007|Overall Study|Hospice|0|||
145653399|NCT03150810|525248319|FG008|Overall Study|Hospice|0|||
145653400|NCT03150810|525248320|FG009|Overall Study|Hospice|0|||
145653401|NCT03150810|525248321|FG010|Overall Study|Hospice|0|||
145653402|NCT03150810|525248322|FG011|Overall Study|Hospice|0|||
145653403|NCT03150810|525248323|FG012|Overall Study|Hospice|0|||
145653404|NCT03150810|525248311|FG000|Overall Study|Participant relocated abroad.|0|||
145653405|NCT03150810|525248312|FG001|Overall Study|Participant relocated abroad.|0|||
145653406|NCT03150810|525248313|FG002|Overall Study|Participant relocated abroad.|0|||
145653407|NCT03150810|525248314|FG003|Overall Study|Participant relocated abroad.|0|||
145653408|NCT03150810|525248315|FG004|Overall Study|Participant relocated abroad.|0|||
145653409|NCT03150810|525248316|FG005|Overall Study|Participant relocated abroad.|1|||
145653410|NCT03150810|525248317|FG006|Overall Study|Participant relocated abroad.|0|||
145653411|NCT03150810|525248318|FG007|Overall Study|Participant relocated abroad.|0|||
145653412|NCT03150810|525248319|FG008|Overall Study|Participant relocated abroad.|0|||
145653413|NCT03150810|525248320|FG009|Overall Study|Participant relocated abroad.|0|||
145653414|NCT03150810|525248321|FG010|Overall Study|Participant relocated abroad.|0|||
145653415|NCT03150810|525248322|FG011|Overall Study|Participant relocated abroad.|0|||
145653416|NCT03150810|525248323|FG012|Overall Study|Participant relocated abroad.|0|||
145653417|NCT03150810|525248311|FG000|Overall Study|Transferred care to oncologist|0|||
145653418|NCT03150810|525248312|FG001|Overall Study|Transferred care to oncologist|0|||
145653419|NCT03150810|525248313|FG002|Overall Study|Transferred care to oncologist|0|||
145653420|NCT03150810|525248314|FG003|Overall Study|Transferred care to oncologist|0|||
145653421|NCT03150810|525248315|FG004|Overall Study|Transferred care to oncologist|0|||
145653422|NCT03150810|525248316|FG005|Overall Study|Transferred care to oncologist|0|||
145653423|NCT03150810|525248317|FG006|Overall Study|Transferred care to oncologist|2|||
145653424|NCT03150810|525248318|FG007|Overall Study|Transferred care to oncologist|0|||
145653425|NCT03150810|525248319|FG008|Overall Study|Transferred care to oncologist|0|||
145653426|NCT03150810|525248320|FG009|Overall Study|Transferred care to oncologist|0|||
145653427|NCT03150810|525248321|FG010|Overall Study|Transferred care to oncologist|0|||
145653428|NCT03150810|525248322|FG011|Overall Study|Transferred care to oncologist|0|||
145653429|NCT03150810|525248323|FG012|Overall Study|Transferred care to oncologist|0|||
145653430|NCT04526704|525248324|FG000|Overall Study|Adverse Event|1|||
145653431|NCT04526704|525248325|FG001|Overall Study|Adverse Event|0|||
145653432|NCT04526704|525248324|FG000|Overall Study|Physician Decision|1|||
145653433|NCT04526704|525248325|FG001|Overall Study|Physician Decision|0|||
145653434|NCT04526704|525248324|FG000|Overall Study|Withdrawal by Subject|2|||
145653435|NCT04526704|525248325|FG001|Overall Study|Withdrawal by Subject|0|||
145653436|NCT00881621|525248326|FG000|Overall Study|Physician Decision|34|||
145653437|NCT02737436|525248327|FG000|Washout Period|Lost to Follow-up|5|||
145653438|NCT02737436|525248328|FG001|Washout Period|Lost to Follow-up|11|||
145653439|NCT02737436|525248327|FG000|Data Analysis|Scanning data problems|5|||
145653440|NCT02737436|525248328|FG001|Data Analysis|Scanning data problems|8|||
145653441|NCT05292365|525248332|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
145653442|NCT05292365|525248333|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
145653443|NCT05292365|525248334|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
145653444|NCT05292365|525248335|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
145653445|NCT04495894|525248339|FG000|Overall Study|Withdrawal by Subject|2|||
145653446|NCT04495894|525248340|FG001|Overall Study|Withdrawal by Subject|0|||
145653447|NCT04495894|525248341|FG002|Overall Study|Withdrawal by Subject|2|||
145653448|NCT04495894|525248342|FG003|Overall Study|Withdrawal by Subject|3|||
145653449|NCT04495894|525248339|FG000|Overall Study|Early termination|0|||
145653450|NCT04495894|525248340|FG001|Overall Study|Early termination|0|||
145653451|NCT04495894|525248341|FG002|Overall Study|Early termination|3|||
145653452|NCT04495894|525248342|FG003|Overall Study|Early termination|0|||
145653453|NCT03364647|525248343|FG000|Overall Study|Withdrawal by Subject|3|||
145653454|NCT03364647|525248344|FG001|Overall Study|Withdrawal by Subject|1|||
145653455|NCT01000961|525248345|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
145653456|NCT01000961|525248346|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145653457|NCT01000961|525248345|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
145653458|NCT01000961|525248346|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
145653459|NCT05746455|525248358|FG000|Overall Study|Discharged from Clinical Service|1|||
145653460|NCT05746455|525248358|FG000|Overall Study|Lost to Follow-up|1|||
145653461|NCT03896789|525248363|FG000|Baseline|Lost to Follow-up|1|||
145653462|NCT03896789|525248364|FG001|Baseline|Lost to Follow-up|2|||
145653463|NCT03896789|525248363|FG000|Baseline|Death|3|||
145653464|NCT03896789|525248364|FG001|Baseline|Death|6|||
145489735|NCT05470985|524647600|FG000|Long Term Extension|Adverse Event|0|||
145653465|NCT03896789|525248363|FG000|Post-Randomization|Lost to Follow-up|12|||
145653466|NCT03896789|525248364|FG001|Post-Randomization|Lost to Follow-up|11|||
145653467|NCT03896789|525248363|FG000|Post-Randomization|Death|12|||
145489736|NCT05470985|524647601|FG001|Long Term Extension|Adverse Event|1|||
145653468|NCT03896789|525248364|FG001|Post-Randomization|Death|13|||
145653469|NCT03447470|525248366|FG000|Overall Study|Death|0|||
145653470|NCT03447470|525248367|FG001|Overall Study|Death|1|||
145653471|NCT03447470|525248368|FG002|Overall Study|Death|3|||
145653472|NCT03447470|525248369|FG003|Overall Study|Death|0|||
145653473|NCT03447470|525248370|FG004|Overall Study|Death|1|||
145653474|NCT03447470|525248371|FG005|Overall Study|Death|0|||
145653475|NCT03447470|525248372|FG006|Overall Study|Death|3|||
145653476|NCT03447470|525248373|FG007|Overall Study|Death|3|||
145653477|NCT03447470|525248374|FG008|Overall Study|Death|1|||
145653478|NCT03447470|525248366|FG000|Overall Study|Withdrawal by Subject|1|||
145653479|NCT03447470|525248367|FG001|Overall Study|Withdrawal by Subject|0|||
145653480|NCT03447470|525248368|FG002|Overall Study|Withdrawal by Subject|0|||
145653481|NCT03447470|525248369|FG003|Overall Study|Withdrawal by Subject|0|||
145653482|NCT03447470|525248370|FG004|Overall Study|Withdrawal by Subject|1|||
145653483|NCT03447470|525248371|FG005|Overall Study|Withdrawal by Subject|0|||
145653484|NCT03447470|525248372|FG006|Overall Study|Withdrawal by Subject|1|||
145653485|NCT03447470|525248373|FG007|Overall Study|Withdrawal by Subject|1|||
145653486|NCT03447470|525248374|FG008|Overall Study|Withdrawal by Subject|3|||
145653487|NCT03447470|525248366|FG000|Overall Study|Treatment discontinued|3|||
145653488|NCT03447470|525248367|FG001|Overall Study|Treatment discontinued|2|||
145653489|NCT03447470|525248368|FG002|Overall Study|Treatment discontinued|4|||
145653490|NCT03447470|525248369|FG003|Overall Study|Treatment discontinued|6|||
145653491|NCT03447470|525248370|FG004|Overall Study|Treatment discontinued|2|||
145653492|NCT03447470|525248371|FG005|Overall Study|Treatment discontinued|1|||
145653493|NCT03447470|525248372|FG006|Overall Study|Treatment discontinued|2|||
145653494|NCT03447470|525248373|FG007|Overall Study|Treatment discontinued|4|||
145653495|NCT03447470|525248374|FG008|Overall Study|Treatment discontinued|3|||
145653496|NCT05184192|525248376|FG000|Overall Study|Lost to Follow-up|4|||
145653497|NCT05184192|525248377|FG001|Overall Study|Lost to Follow-up|7|||
145653498|NCT05184192|525248376|FG000|Overall Study|Adverse Event|1|||
145653499|NCT05184192|525248377|FG001|Overall Study|Adverse Event|4|||
145653500|NCT05184192|525248376|FG000|Overall Study|PI withdrawal|1|||
145653501|NCT05184192|525248377|FG001|Overall Study|PI withdrawal|2|||
145653502|NCT05184192|525248376|FG000|Overall Study|Withdrew due to adverse effect|1|||
145653503|NCT05184192|525248377|FG001|Overall Study|Withdrew due to adverse effect|0|||
145653504|NCT05184192|525248376|FG000|Overall Study|Medication schedule|1|||
145653505|NCT05184192|525248377|FG001|Overall Study|Medication schedule|0|||
145653506|NCT05184192|525248376|FG000|Overall Study|Concern for adverse effects|0|||
145653507|NCT05184192|525248377|FG001|Overall Study|Concern for adverse effects|4|||
145653508|NCT04295798|525248383|FG000|Overall Study|Lost to Follow-up|1|||
145653509|NCT05603143|525248388|FG000|Overall Study|Withdrew consent|6|||
145653510|NCT05603143|525248389|FG001|Overall Study|Withdrew consent|2|||
145653511|NCT05603143|525248388|FG000|Overall Study|Randomized but never treated|0|||
145653512|NCT05603143|525248389|FG001|Overall Study|Randomized but never treated|3|||
145653513|NCT05603143|525248388|FG000|Overall Study|Adverse Event|2|||
145653514|NCT05603143|525248389|FG001|Overall Study|Adverse Event|0|||
145653515|NCT05603143|525248388|FG000|Overall Study|Death|0|||
145653516|NCT05603143|525248389|FG001|Overall Study|Death|1|||
145653517|NCT05603143|525248388|FG000|Overall Study|Investigator's discretion|1|||
145653518|NCT05603143|525248389|FG001|Overall Study|Investigator's discretion|0|||
145653519|NCT05603143|525248388|FG000|Overall Study|Lost to Follow-up|0|||
145653520|NCT05603143|525248389|FG001|Overall Study|Lost to Follow-up|1|||
145653521|NCT05603143|525248388|FG000|Overall Study|Protocol Violation|0|||
145653522|NCT05603143|525248389|FG001|Overall Study|Protocol Violation|1|||
145653523|NCT05084508|525248390|FG000|Overall Study|Lost to Follow-up|6|||
145653524|NCT05084508|525248391|FG001|Overall Study|Lost to Follow-up|3|||
145653525|NCT05084508|525248392|FG002|Overall Study|Lost to Follow-up|7|||
145653526|NCT05084508|525248393|FG003|Overall Study|Lost to Follow-up|3|||
145653527|NCT05084508|525248390|FG000|Overall Study|Withdrawal by Subject|0|||
145653528|NCT05084508|525248391|FG001|Overall Study|Withdrawal by Subject|2|||
145653529|NCT05084508|525248392|FG002|Overall Study|Withdrawal by Subject|3|||
145653530|NCT05084508|525248393|FG003|Overall Study|Withdrawal by Subject|1|||
145653531|NCT05084508|525248390|FG000|Overall Study|Other|0|||
145653532|NCT05084508|525248391|FG001|Overall Study|Other|0|||
145653533|NCT05084508|525248392|FG002|Overall Study|Other|0|||
145653534|NCT05084508|525248393|FG003|Overall Study|Other|1|||
145653535|NCT05302596|525248394|FG000|Overall Study|Withdrawal by Subject|1|||
145653536|NCT05302596|525248395|FG001|Overall Study|Withdrawal by Subject|1|||
145653537|NCT00667251|525250570|FG000|Overall Study|Disease progression|232|||
145653538|NCT00667251|525250571|FG001|Overall Study|Disease progression|203|||
145653539|NCT00667251|525250570|FG000|Overall Study|Toxicity|44|||
145653540|NCT00667251|525250571|FG001|Overall Study|Toxicity|23|||
145653541|NCT00667251|525250570|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
145653542|NCT00667251|525250571|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
145653543|NCT00667251|525250570|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
145653544|NCT00667251|525250571|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
145653545|NCT00667251|525250570|FG000|Overall Study|Symptomatic progression|8|||
145653546|NCT00667251|525250571|FG001|Overall Study|Symptomatic progression|4|||
145489737|NCT05470985|524647600|FG000|Long Term Extension|Study terminated by sponsor|2|||
145653547|NCT00667251|525250570|FG000|Overall Study|Death|6|||
145653548|NCT00667251|525250571|FG001|Overall Study|Death|11|||
145653549|NCT00667251|525250570|FG000|Overall Study|Intercurrent illness|5|||
145653550|NCT00667251|525250571|FG001|Overall Study|Intercurrent illness|6|||
145653551|NCT00667251|525250570|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
145653552|NCT00667251|525250571|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
145653553|NCT00667251|525250570|FG000|Overall Study|Randomized not Treated|4|||
145653554|NCT00667251|525250571|FG001|Overall Study|Randomized not Treated|1|||
145653555|NCT04256941|525250575|FG000|Overall Study|Withdrawal by Subject|0|||
145653556|NCT04256941|525250576|FG001|Overall Study|Withdrawal by Subject|1|||
145653557|NCT04256941|525250575|FG000|Overall Study|Death|1|||
145653558|NCT04256941|525250576|FG001|Overall Study|Death|0|||
145653559|NCT04256941|525250575|FG000|Overall Study|Disease Progession|0|||
145653560|NCT04256941|525250576|FG001|Overall Study|Disease Progession|2|||
145653561|NCT04717492|525250593|FG000|Overall Study|Withdrawal by Subject|2|||
145653562|NCT04717492|525250594|FG001|Overall Study|Withdrawal by Subject|13|||
145653563|NCT04717492|525250593|FG000|Overall Study|Lost to Follow-up|2|||
145653564|NCT04717492|525250594|FG001|Overall Study|Lost to Follow-up|9|||
145653565|NCT03766009|525250595|FG000|Usual Care|Death|0|||
145653566|NCT03766009|525250596|FG001|Usual Care|Death|0|||
145653567|NCT03766009|525250597|FG002|Usual Care|Death|0|||
145653568|NCT03766009|525250598|FG003|Usual Care|Death|1|||
145653569|NCT03766009|525250599|FG004|Usual Care|Death|0|||
145653570|NCT03766009|525250600|FG005|Usual Care|Death|0|||
145653571|NCT03766009|525250595|FG000|Usual Care|Lost to Follow-up|0|||
145653572|NCT03766009|525250596|FG001|Usual Care|Lost to Follow-up|0|||
145653573|NCT03766009|525250597|FG002|Usual Care|Lost to Follow-up|0|||
145653574|NCT03766009|525250598|FG003|Usual Care|Lost to Follow-up|1|||
145653575|NCT03766009|525250599|FG004|Usual Care|Lost to Follow-up|0|||
145653576|NCT03766009|525250600|FG005|Usual Care|Lost to Follow-up|0|||
145653577|NCT03766009|525250595|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
145653578|NCT03766009|525250596|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
145653579|NCT03766009|525250597|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
145653580|NCT03766009|525250598|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
145653581|NCT03766009|525250599|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
145653582|NCT03766009|525250600|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
145653583|NCT03766009|525250595|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
145653584|NCT03766009|525250596|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
145653585|NCT03766009|525250597|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
145653586|NCT03766009|525250598|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
145653587|NCT03766009|525250599|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
145653588|NCT03766009|525250600|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
145653589|NCT03766009|525250595|FG000|Usual Care|No treatment or declined surgery|0|||
145653590|NCT03766009|525250596|FG001|Usual Care|No treatment or declined surgery|0|||
145653591|NCT03766009|525250597|FG002|Usual Care|No treatment or declined surgery|0|||
145653592|NCT03766009|525250598|FG003|Usual Care|No treatment or declined surgery|2|||
145653593|NCT03766009|525250599|FG004|Usual Care|No treatment or declined surgery|0|||
145653594|NCT03766009|525250600|FG005|Usual Care|No treatment or declined surgery|0|||
145653595|NCT03766009|525250595|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
145653596|NCT03766009|525250596|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
145653597|NCT03766009|525250597|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
145653598|NCT03766009|525250598|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
145653599|NCT03766009|525250599|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
145653600|NCT03766009|525250600|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
145653601|NCT03766009|525250595|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
145653602|NCT03766009|525250596|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
145653603|NCT03766009|525250597|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
145653604|NCT03766009|525250598|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
145653605|NCT03766009|525250599|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
145653606|NCT03766009|525250600|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
145653607|NCT03766009|525250595|FG000|Usual Care|Ineligible|0|||
145489738|NCT05470985|524647601|FG001|Long Term Extension|Study terminated by sponsor|0|||
145653608|NCT03766009|525250596|FG001|Usual Care|Ineligible|1|||
145653609|NCT03766009|525250597|FG002|Usual Care|Ineligible|0|||
145653610|NCT03766009|525250598|FG003|Usual Care|Ineligible|0|||
145653611|NCT03766009|525250599|FG004|Usual Care|Ineligible|0|||
145653612|NCT03766009|525250600|FG005|Usual Care|Ineligible|0|||
145653613|NCT03766009|525250595|FG000|Usual Care|Other: Staff turnover|0|||
145653614|NCT03766009|525250596|FG001|Usual Care|Other: Staff turnover|0|||
145653615|NCT03766009|525250597|FG002|Usual Care|Other: Staff turnover|0|||
145653616|NCT03766009|525250598|FG003|Usual Care|Other: Staff turnover|0|||
145653617|NCT03766009|525250599|FG004|Usual Care|Other: Staff turnover|0|||
145653618|NCT03766009|525250600|FG005|Usual Care|Other: Staff turnover|2|||
145653619|NCT05116787|525250605|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
145653620|NCT05116787|525250606|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
145653621|NCT05116787|525250605|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
145653622|NCT05116787|525250606|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
145653623|NCT05116787|525250605|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
145653624|NCT05116787|525250606|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
145653625|NCT05116787|525250605|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
145653626|NCT05116787|525250606|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
145653627|NCT03936322|525250607|FG000|Overall Study|Lost to Follow-up|1|||
145653628|NCT03936322|525250607|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
145653629|NCT05179837|525250608|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
145653630|NCT05179837|525250608|FG000|Overall Study|Device malfunctioned|1|||
145653631|NCT05179837|525250608|FG000|Overall Study|Image quality too low|2|||
145653632|NCT03158129|525250609|FG000|Overall Study|Adverse Event|0|||
145653633|NCT03158129|525250610|FG001|Overall Study|Adverse Event|1|||
145653634|NCT03158129|525250611|FG002|Overall Study|Adverse Event|0|||
145653635|NCT03158129|525250612|FG003|Overall Study|Adverse Event|0|||
145653636|NCT03158129|525250609|FG000|Overall Study|Death|0|||
145653637|NCT03158129|525250610|FG001|Overall Study|Death|0|||
145653638|NCT03158129|525250611|FG002|Overall Study|Death|0|||
145653639|NCT03158129|525250612|FG003|Overall Study|Death|1|||
145653640|NCT03158129|525250609|FG000|Overall Study|High surgical risk|1|||
145653641|NCT03158129|525250610|FG001|Overall Study|High surgical risk|1|||
145653642|NCT03158129|525250611|FG002|Overall Study|High surgical risk|0|||
145653643|NCT03158129|525250612|FG003|Overall Study|High surgical risk|0|||
145653644|NCT03158129|525250609|FG000|Overall Study|Progression|1|||
145653645|NCT03158129|525250610|FG001|Overall Study|Progression|1|||
145653646|NCT03158129|525250611|FG002|Overall Study|Progression|0|||
145653647|NCT03158129|525250612|FG003|Overall Study|Progression|0|||
145653648|NCT03158129|525250609|FG000|Overall Study|Lack of resectability|0|||
145653649|NCT03158129|525250610|FG001|Overall Study|Lack of resectability|1|||
145653650|NCT03158129|525250611|FG002|Overall Study|Lack of resectability|0|||
145653651|NCT03158129|525250612|FG003|Overall Study|Lack of resectability|0|||
145653652|NCT03158129|525250609|FG000|Overall Study|Declined surgery|0|||
145653653|NCT03158129|525250610|FG001|Overall Study|Declined surgery|1|||
145653654|NCT03158129|525250611|FG002|Overall Study|Declined surgery|0|||
145653655|NCT03158129|525250612|FG003|Overall Study|Declined surgery|0|||
145653656|NCT03158129|525250609|FG000|Overall Study|No longer surgical candidate|0|||
145653657|NCT03158129|525250610|FG001|Overall Study|No longer surgical candidate|0|||
145653658|NCT03158129|525250611|FG002|Overall Study|No longer surgical candidate|0|||
145653659|NCT03158129|525250612|FG003|Overall Study|No longer surgical candidate|1|||
145653660|NCT03719443|525250613|FG000|Overall Study|Lost to Follow-up|0|||
145653661|NCT03719443|525250614|FG001|Overall Study|Lost to Follow-up|0|||
145653662|NCT03719443|525250615|FG002|Overall Study|Lost to Follow-up|1|||
145653663|NCT03719443|525250616|FG003|Overall Study|Lost to Follow-up|0|||
145653664|NCT03719443|525250617|FG004|Overall Study|Lost to Follow-up|1|||
145653665|NCT03719443|525250618|FG005|Overall Study|Lost to Follow-up|0|||
145653666|NCT03719443|525250619|FG006|Overall Study|Lost to Follow-up|1|||
145653667|NCT03719443|525250613|FG000|Overall Study|Withdrawal by Subject|0|||
145653668|NCT03719443|525250614|FG001|Overall Study|Withdrawal by Subject|0|||
145653669|NCT03719443|525250615|FG002|Overall Study|Withdrawal by Subject|1|||
145653670|NCT03719443|525250616|FG003|Overall Study|Withdrawal by Subject|0|||
145653671|NCT03719443|525250617|FG004|Overall Study|Withdrawal by Subject|0|||
145653672|NCT03719443|525250618|FG005|Overall Study|Withdrawal by Subject|0|||
145653673|NCT03719443|525250619|FG006|Overall Study|Withdrawal by Subject|0|||
145653674|NCT05051124|525250620|FG000|Overall Study|Lost to Follow-up|2|||
145653675|NCT05051124|525250620|FG000|Overall Study|Withdrawal by Subject|1|||
145653676|NCT05051124|525250620|FG000|Overall Study|Residential relocation|2|||
145489739|NCT02741245|524647603|FG000|Overall Study|Adverse Event|0|||
145489740|NCT02741245|524647604|FG001|Overall Study|Adverse Event|0|||
145489741|NCT02741245|524647605|FG002|Overall Study|Adverse Event|0|||
145489742|NCT02741245|524647606|FG003|Overall Study|Adverse Event|2|||
145489743|NCT02741245|524647607|FG004|Overall Study|Adverse Event|2|||
145489744|NCT02741245|524647603|FG000|Overall Study|Protocol Violation|0|||
145489745|NCT02741245|524647604|FG001|Overall Study|Protocol Violation|1|||
145653677|NCT05051124|525250620|FG000|Overall Study|Death|1|||
145653678|NCT04782973|525250621|FG000|Overall Study|Withdrawal by Subject|5|||
145653679|NCT04782973|525250621|FG000|Overall Study|Protocol Violation|6|||
145653680|NCT04782973|525250621|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
145653681|NCT00554788|525250622|FG000|Overall Study|Adverse Event|0|||
145653682|NCT00554788|525250623|FG001|Overall Study|Adverse Event|1|||
145653683|NCT00554788|525250624|FG002|Overall Study|Adverse Event|2|||
145653684|NCT00554788|525250622|FG000|Overall Study|Lost to Follow-up|4|||
145653685|NCT00554788|525250623|FG001|Overall Study|Lost to Follow-up|3|||
145653686|NCT00554788|525250624|FG002|Overall Study|Lost to Follow-up|3|||
145653687|NCT00554788|525250622|FG000|Overall Study|Physician Decision|1|||
145489746|NCT02741245|524647605|FG002|Overall Study|Protocol Violation|0|||
145653688|NCT00554788|525250623|FG001|Overall Study|Physician Decision|1|||
145653689|NCT00554788|525250624|FG002|Overall Study|Physician Decision|3|||
145653690|NCT00554788|525250622|FG000|Overall Study|Withdrawal by Subject|0|||
145653691|NCT00554788|525250623|FG001|Overall Study|Withdrawal by Subject|0|||
145653692|NCT00554788|525250624|FG002|Overall Study|Withdrawal by Subject|1|||
145653693|NCT00554788|525250622|FG000|Overall Study|Refusal of further protocol therapy|0|||
145653694|NCT00554788|525250623|FG001|Overall Study|Refusal of further protocol therapy|1|||
145653695|NCT00554788|525250624|FG002|Overall Study|Refusal of further protocol therapy|1|||
145653696|NCT00554788|525250622|FG000|Overall Study|Progressive disease|0|||
145653697|NCT00554788|525250623|FG001|Overall Study|Progressive disease|0|||
145653698|NCT00554788|525250624|FG002|Overall Study|Progressive disease|3|||
145653699|NCT00554788|525250622|FG000|Overall Study|Ineligible|2|||
145653700|NCT00554788|525250623|FG001|Overall Study|Ineligible|0|||
145653701|NCT00554788|525250624|FG002|Overall Study|Ineligible|1|||
145653702|NCT06205407|525250625|FG000|Period 2|Withdrawal by Subject|0|||
145653703|NCT06205407|525250626|FG001|Period 2|Withdrawal by Subject|1|||
145653704|NCT06205407|525250625|FG000|Period 2|Adverse Event|2|||
145653705|NCT06205407|525250626|FG001|Period 2|Adverse Event|1|||
145653706|NCT02577835|525250628|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
145653707|NCT04749615|525250629|FG000|Overall Study|Lost to Follow-up|6|||
145653708|NCT04749615|525250630|FG001|Overall Study|Lost to Follow-up|10|||
145653709|NCT02274662|525250635|FG000|Overall Study|Death|1|||
145653710|NCT02274662|525250635|FG000|Overall Study|Lost to Follow-up|3|||
145653711|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
145653712|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
145653713|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
145653714|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
145653715|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
145653716|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
145653717|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
145653718|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653719|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
145653720|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653721|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653722|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653723|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653724|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
145653725|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
145653726|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
145653727|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
145653728|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
145653729|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
145653730|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
145653731|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
145653732|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
145653733|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653734|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653735|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653736|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653737|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653738|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
145653739|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653740|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
145653741|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653742|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653743|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653744|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653745|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
145653746|NCT02962895|525250636|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653747|NCT02962895|525250637|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653748|NCT02962895|525250638|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653749|NCT02962895|525250639|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
145653750|NCT02962895|525250640|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653751|NCT02962895|525250641|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653752|NCT02962895|525250642|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
145653753|NCT02962895|525250636|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653754|NCT02962895|525250637|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653755|NCT02962895|525250638|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653756|NCT02962895|525250639|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653757|NCT02962895|525250640|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653758|NCT02962895|525250641|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
145653759|NCT02962895|525250642|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
145489747|NCT02741245|524647606|FG003|Overall Study|Protocol Violation|1|||
145489748|NCT02741245|524647607|FG004|Overall Study|Protocol Violation|0|||
145489749|NCT02741245|524647603|FG000|Overall Study|Withdrawal by Subject|0|||
145489750|NCT02741245|524647604|FG001|Overall Study|Withdrawal by Subject|0|||
145489751|NCT02741245|524647605|FG002|Overall Study|Withdrawal by Subject|0|||
145489752|NCT02741245|524647606|FG003|Overall Study|Withdrawal by Subject|1|||
145489753|NCT02741245|524647607|FG004|Overall Study|Withdrawal by Subject|0|||
145653760|NCT02962895|525250636|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
145653761|NCT02962895|525250637|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
145653762|NCT02962895|525250638|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
145653763|NCT02962895|525250639|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
145653764|NCT02962895|525250640|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
145653765|NCT02962895|525250641|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
145653766|NCT02962895|525250642|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
145653767|NCT02962895|525250636|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653768|NCT02962895|525250637|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653769|NCT02962895|525250638|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653770|NCT02962895|525250639|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653771|NCT02962895|525250640|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653772|NCT02962895|525250641|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
145653773|NCT02962895|525250642|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
145653774|NCT02962895|525250636|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653775|NCT02962895|525250637|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
145653776|NCT02962895|525250638|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653777|NCT02962895|525250639|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653778|NCT02962895|525250640|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653779|NCT02962895|525250641|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653780|NCT02962895|525250642|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
145653781|NCT02962895|525250636|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653782|NCT02962895|525250637|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653783|NCT02962895|525250638|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653784|NCT02962895|525250639|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653785|NCT02962895|525250640|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
145653786|NCT02962895|525250641|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653787|NCT02962895|525250642|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
145653788|NCT02962895|525250636|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653789|NCT02962895|525250637|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653790|NCT02962895|525250638|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653791|NCT02962895|525250639|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653792|NCT02962895|525250640|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
145653793|NCT02962895|525250641|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653794|NCT02962895|525250642|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
145653795|NCT02962895|525250636|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
145653796|NCT02962895|525250637|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
145653797|NCT02962895|525250638|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
145653798|NCT02962895|525250639|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
145653799|NCT02962895|525250640|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
145653800|NCT02962895|525250641|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
145653801|NCT02962895|525250642|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
145653802|NCT02962895|525250636|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
145653803|NCT02962895|525250637|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
145653804|NCT02962895|525250638|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
145653805|NCT02962895|525250639|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
145653806|NCT02962895|525250640|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
145653807|NCT02962895|525250641|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
145653808|NCT02962895|525250642|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
145653809|NCT02936752|525250643|FG000|Overall Study|Death|2|||
145653810|NCT02936752|525250644|FG001|Overall Study|Death|1|||
145653811|NCT02936752|525250643|FG000|Overall Study|Physician Decision|4|||
145653812|NCT02936752|525250644|FG001|Overall Study|Physician Decision|0|||
145653813|NCT02936752|525250643|FG000|Overall Study|Withdrawal by Subject|0|||
145653814|NCT02936752|525250644|FG001|Overall Study|Withdrawal by Subject|2|||
145489754|NCT00152503|524647608|FG000|Overall Study|Adverse Event|4|||
145653815|NCT05282173|525250655|FG000|Overall Study|Missed|3|||
145653816|NCT05282173|525250656|FG001|Overall Study|Missed|2|||
145653817|NCT05282173|525250657|FG002|Overall Study|Missed|4|||
145653818|NCT04719390|525250663|FG000|Overall Study|Withdrawal by Subject|1|||
145653819|NCT03307343|525250664|FG000|Overall Study|Withdrawal by Subject|1|||
145653820|NCT03307343|525250665|FG001|Overall Study|Withdrawal by Subject|2|||
145653821|NCT03307343|525250664|FG000|Overall Study|Pregnancy|0|||
145653822|NCT03307343|525250665|FG001|Overall Study|Pregnancy|2|||
145653823|NCT03307343|525250664|FG000|Overall Study|Physician Decision|1|||
145653824|NCT03307343|525250665|FG001|Overall Study|Physician Decision|0|||
145653825|NCT03307343|525250664|FG000|Overall Study|Lost to Follow-up|0|||
145653826|NCT03307343|525250665|FG001|Overall Study|Lost to Follow-up|2|||
145653827|NCT03016754|525250668|FG000|Overall Study|Death|5|||
145653828|NCT03016754|525250669|FG001|Overall Study|Death|4|||
145653829|NCT03016754|525250670|FG002|Overall Study|Death|5|||
145653830|NCT03016754|525250671|FG003|Overall Study|Death|1|||
145653831|NCT03016754|525250668|FG000|Overall Study|Lost to Follow-up|23|||
145653832|NCT03016754|525250669|FG001|Overall Study|Lost to Follow-up|17|||
145653833|NCT03016754|525250670|FG002|Overall Study|Lost to Follow-up|4|||
145653834|NCT03016754|525250671|FG003|Overall Study|Lost to Follow-up|2|||
145653835|NCT03016754|525250668|FG000|Overall Study|Withdrawal by Subject|6|||
145653836|NCT03016754|525250669|FG001|Overall Study|Withdrawal by Subject|6|||
145653837|NCT03016754|525250670|FG002|Overall Study|Withdrawal by Subject|2|||
145653838|NCT03016754|525250671|FG003|Overall Study|Withdrawal by Subject|2|||
145653839|NCT03016754|525250668|FG000|Overall Study|Other/Unknown|2|||
145653840|NCT03016754|525250669|FG001|Overall Study|Other/Unknown|4|||
145653841|NCT03016754|525250670|FG002|Overall Study|Other/Unknown|2|||
145653842|NCT03016754|525250671|FG003|Overall Study|Other/Unknown|1|||
145653843|NCT03016754|525250668|FG000|Overall Study|Protocol Violation|0|||
145653844|NCT03016754|525250669|FG001|Overall Study|Protocol Violation|0|||
145653845|NCT03016754|525250670|FG002|Overall Study|Protocol Violation|0|||
145653846|NCT03016754|525250671|FG003|Overall Study|Protocol Violation|4|||
145653847|NCT01798498|525250672|FG000|Overall Study|Lost to Follow-up|1|||
145653848|NCT01606215|525250677|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
145653849|NCT01606215|525250678|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
145653850|NCT04592549|525250679|FG000|Overall Study|Withdrawal by Subject|0|||
145653851|NCT04592549|525250680|FG001|Overall Study|Withdrawal by Subject|1|||
145653852|NCT04592549|525250681|FG002|Overall Study|Withdrawal by Subject|0|||
145653853|NCT04592549|525250682|FG003|Overall Study|Withdrawal by Subject|1|||
145653854|NCT04592549|525250683|FG004|Overall Study|Withdrawal by Subject|1|||
145653855|NCT04592549|525250684|FG005|Overall Study|Withdrawal by Subject|0|||
145653856|NCT04592549|525250679|FG000|Overall Study|Lost to Follow-up|2|||
145653857|NCT04592549|525250680|FG001|Overall Study|Lost to Follow-up|0|||
145653858|NCT04592549|525250681|FG002|Overall Study|Lost to Follow-up|0|||
145653859|NCT04592549|525250682|FG003|Overall Study|Lost to Follow-up|1|||
145653860|NCT04592549|525250683|FG004|Overall Study|Lost to Follow-up|1|||
145653861|NCT04592549|525250684|FG005|Overall Study|Lost to Follow-up|1|||
145653862|NCT04927364|525250685|FG000|Overall Study|Withdrawal by Subject|3|||
145653863|NCT04927364|525250685|FG000|Overall Study|Unable to complete preassessment MRI|1|||
145653864|NCT04624633|525250692|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
145653865|NCT04624633|525250693|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
145653866|NCT04624633|525250692|FG000|Overall Study|Death|1|||
145653867|NCT04624633|525250693|FG001|Overall Study|Death|0|||
145653868|NCT05087992|525250694|FG000|Overall Study|Adverse Event|0|||
145653869|NCT05087992|525250695|FG001|Overall Study|Adverse Event|1|||
145653870|NCT05087992|525250696|FG002|Overall Study|Adverse Event|0|||
145653871|NCT05087992|525250694|FG000|Overall Study|Withdrawal by Subject|2|||
145653872|NCT05087992|525250695|FG001|Overall Study|Withdrawal by Subject|0|||
145653873|NCT05087992|525250696|FG002|Overall Study|Withdrawal by Subject|0|||
145653874|NCT05087992|525250694|FG000|Overall Study|clinical disease progression|3|||
145653875|NCT05087992|525250695|FG001|Overall Study|clinical disease progression|1|||
145653876|NCT05087992|525250696|FG002|Overall Study|clinical disease progression|0|||
145653877|NCT05087992|525250694|FG000|Overall Study|objective disease progression|4|||
145653878|NCT05087992|525250695|FG001|Overall Study|objective disease progression|1|||
145653879|NCT05087992|525250696|FG002|Overall Study|objective disease progression|0|||
145653880|NCT06424236|525250697|FG000|Overall Study|Adverse Event|0|||
145653881|NCT06424236|525250698|FG001|Overall Study|Adverse Event|1|||
145653882|NCT06424236|525250699|FG002|Overall Study|Adverse Event|0|||
145653883|NCT06424236|525250697|FG000|Overall Study|Withdrawal by Subject|3|||
145653884|NCT06424236|525250698|FG001|Overall Study|Withdrawal by Subject|1|||
145653885|NCT06424236|525250699|FG002|Overall Study|Withdrawal by Subject|2|||
145653886|NCT06424236|525250697|FG000|Overall Study|Physician Decision|0|||
145653887|NCT06424236|525250698|FG001|Overall Study|Physician Decision|1|||
145653888|NCT06424236|525250699|FG002|Overall Study|Physician Decision|0|||
145653889|NCT06424236|525250697|FG000|Overall Study|Study Terminated by Sponsor|11|||
145653890|NCT06424236|525250698|FG001|Overall Study|Study Terminated by Sponsor|20|||
145653891|NCT06424236|525250699|FG002|Overall Study|Study Terminated by Sponsor|16|||
145653892|NCT06424236|525250697|FG000|Overall Study|Lost to Follow-up|0|||
145653893|NCT06424236|525250698|FG001|Overall Study|Lost to Follow-up|1|||
145653894|NCT06424236|525250699|FG002|Overall Study|Lost to Follow-up|0|||
145653895|NCT06424236|525250697|FG000|Overall Study|Disease Progression|0|||
145653896|NCT06424236|525250698|FG001|Overall Study|Disease Progression|1|||
145653897|NCT06424236|525250699|FG002|Overall Study|Disease Progression|2|||
145653898|NCT06424236|525250697|FG000|Overall Study|Other|0|||
145653899|NCT06424236|525250698|FG001|Overall Study|Other|0|||
145653900|NCT06424236|525250699|FG002|Overall Study|Other|1|||
145653901|NCT01959425|525250700|FG000|Overall Study|Withdrawal by Subject|5|||
145653902|NCT01959425|525250701|FG001|Overall Study|Withdrawal by Subject|4|||
145653903|NCT01959425|525250700|FG000|Overall Study|Lost to Follow-up|1|||
145653904|NCT01959425|525250701|FG001|Overall Study|Lost to Follow-up|0|||
145653905|NCT01959425|525250700|FG000|Overall Study|Discontinued Subjects|6|||
145653906|NCT01959425|525250701|FG001|Overall Study|Discontinued Subjects|4|||
145653907|NCT01902173|525250702|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
145653908|NCT01902173|525250703|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
145653909|NCT01902173|525250704|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
145653910|NCT01902173|525250705|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
145653911|NCT01902173|525250706|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
145653912|NCT01902173|525250707|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
145653913|NCT01902173|525250702|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
145653914|NCT01902173|525250703|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
145653915|NCT01902173|525250704|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
145653916|NCT01902173|525250705|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
145653917|NCT01902173|525250706|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
145653918|NCT01902173|525250707|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
145653919|NCT01902173|525250702|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
145653920|NCT01902173|525250703|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
145653921|NCT01902173|525250704|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
145653922|NCT01902173|525250705|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
145653923|NCT01902173|525250706|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
145653924|NCT01902173|525250707|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
145653925|NCT01902173|525250702|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
145653926|NCT01902173|525250703|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
145653927|NCT01902173|525250704|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
145653928|NCT01902173|525250705|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
145653929|NCT01902173|525250706|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
145653930|NCT01902173|525250707|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
145653931|NCT01902173|525250702|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
145653932|NCT01902173|525250703|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
145653933|NCT01902173|525250704|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
145653934|NCT01902173|525250705|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
145653935|NCT01902173|525250706|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
145653936|NCT01902173|525250707|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
145653937|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
145653938|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
145653939|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
145653940|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
145653941|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
145653942|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
145653943|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
145653944|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
145653945|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
145653946|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
145653947|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
145489755|NCT03253679|524647609|FG000|Overall Study|Screen Failure|1|||
145489756|NCT04816214|524647610|FG000|Overall Study|Progressive Disease|4|||
145653948|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
145489757|NCT04816214|524647611|FG001|Overall Study|Progressive Disease|0|||
145489758|NCT04816214|524647612|FG002|Overall Study|Progressive Disease|0|||
145489759|NCT04816214|524647610|FG000|Overall Study|Death|1|||
145489760|NCT04816214|524647611|FG001|Overall Study|Death|0|||
145489761|NCT04816214|524647612|FG002|Overall Study|Death|0|||
145653949|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
145489762|NCT04816214|524647610|FG000|Overall Study|Study Terminated by Sponsor|1|||
145489763|NCT04816214|524647611|FG001|Overall Study|Study Terminated by Sponsor|0|||
145489764|NCT04816214|524647612|FG002|Overall Study|Study Terminated by Sponsor|0|||
145653950|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
145653951|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
145653952|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
145653953|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
145653954|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
145653955|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
145653956|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
145653957|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
145653958|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
145653959|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
145653960|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
145653961|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
145653962|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
145653963|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
145653964|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
145653965|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
145653966|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
145653967|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
145653968|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
145653969|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
145653970|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
145653971|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
145653972|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
145653973|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
145653974|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
145653975|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
145653976|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
145653977|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
145653978|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
145653979|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
145653980|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
145653981|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
145653982|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
145653983|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
145653984|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
145653985|NCT01902173|525250702|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
145653986|NCT01902173|525250703|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
145653987|NCT01902173|525250704|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
145653988|NCT01902173|525250705|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
145653989|NCT01902173|525250706|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
145653990|NCT01902173|525250707|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
145653991|NCT04625283|525250709|FG000|Overall Study|post randomization exclusion|28|||
145653992|NCT04625283|525250710|FG001|Overall Study|post randomization exclusion|20|||
145653993|NCT02262728|525250711|FG000|Follow-up Phase (3 Years)|Death|0|||
145653994|NCT02262728|525250712|FG001|Follow-up Phase (3 Years)|Death|1|||
145653995|NCT02262728|525250711|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
145653996|NCT02262728|525250712|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
145653997|NCT02262728|525250711|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
145653998|NCT02262728|525250712|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
145653999|NCT01824394|525250715|FG000|Overall Study|Early Termination|1|||
145654000|NCT01824394|525250716|FG001|Overall Study|Early Termination|1|||
145654001|NCT01824394|525250717|FG002|Overall Study|Early Termination|3|||
145654002|NCT01824394|525250715|FG000|Overall Study|Withdrawn due to Study Termination|91|||
145654003|NCT01824394|525250716|FG001|Overall Study|Withdrawn due to Study Termination|83|||
145654004|NCT01824394|525250717|FG002|Overall Study|Withdrawn due to Study Termination|41|||
145654005|NCT01824394|525250715|FG000|Overall Study|Lost to Follow-up|0|||
145654006|NCT01824394|525250716|FG001|Overall Study|Lost to Follow-up|9|||
145654007|NCT01824394|525250717|FG002|Overall Study|Lost to Follow-up|3|||
145654008|NCT01824394|525250715|FG000|Overall Study|Death|3|||
145654009|NCT01824394|525250716|FG001|Overall Study|Death|2|||
145654010|NCT01824394|525250717|FG002|Overall Study|Death|4|||
145654011|NCT01824394|525250715|FG000|Overall Study|Discontinued Subjects|1|||
145654012|NCT01824394|525250716|FG001|Overall Study|Discontinued Subjects|1|||
145654013|NCT01824394|525250717|FG002|Overall Study|Discontinued Subjects|2|||
145489765|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
145489766|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
145489767|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
145654014|NCT01824394|525250715|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
145654015|NCT01824394|525250716|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
145654016|NCT01824394|525250717|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
145654017|NCT02619838|525250718|FG000|Overall Study|Lost to Follow-up|9|||
145654018|NCT02619838|525250718|FG000|Overall Study|Withdrawal by Subject|15|||
145654019|NCT00227344|525250719|FG000|Overall Study|study terminated early|12|||
145654020|NCT00227344|525250720|FG001|Overall Study|study terminated early|5|||
145654021|NCT01987895|525250721|FG000|Overall Study|Withdrawal by Subject|12|||
145654022|NCT01987895|525250722|FG001|Overall Study|Withdrawal by Subject|7|||
145654023|NCT01987895|525250721|FG000|Overall Study|Physician Decision|8|||
145654024|NCT01987895|525250722|FG001|Overall Study|Physician Decision|10|||
145654025|NCT01987895|525250721|FG000|Overall Study|Death|7|||
145654026|NCT01987895|525250722|FG001|Overall Study|Death|7|||
145654027|NCT01987895|525250721|FG000|Overall Study|Lost to Follow-up|3|||
145654028|NCT01987895|525250722|FG001|Overall Study|Lost to Follow-up|5|||
145654029|NCT01987895|525250721|FG000|Overall Study|randomized before giving IC|0|||
145654030|NCT01987895|525250722|FG001|Overall Study|randomized before giving IC|1|||
145654031|NCT05020249|525250723|FG000|Overall Study|Protocol Violation|1|||
145654032|NCT05020249|525250724|FG001|Overall Study|Protocol Violation|0|||
145654033|NCT05364671|525250725|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
145654034|NCT05364671|525250726|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
145654035|NCT05364671|525250725|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
145654036|NCT05364671|525250726|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
145654037|NCT05364671|525250725|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
145654038|NCT05364671|525250726|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
145654039|NCT05364671|525250725|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
145654040|NCT05364671|525250726|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
145654041|NCT05364671|525250725|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
145654042|NCT05364671|525250726|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
145654043|NCT03536754|525250729|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
145654044|NCT03536754|525250730|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
145654045|NCT03536754|525250731|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
145654046|NCT03536754|525250732|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
145654047|NCT03536754|525250733|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
145654048|NCT03536754|525250729|FG000|Open Label Extension|Other|0|||
145654049|NCT03536754|525250730|FG001|Open Label Extension|Other|0|||
145654050|NCT03536754|525250731|FG002|Open Label Extension|Other|0|||
145654051|NCT03536754|525250732|FG003|Open Label Extension|Other|0|||
145654052|NCT03536754|525250733|FG004|Open Label Extension|Other|1|||
145654053|NCT03382652|525250734|FG000|Overall Study|Lost to Follow-up|6|||
145654054|NCT03382652|525250734|FG000|Overall Study|Death|4|||
145654055|NCT03382652|525250734|FG000|Overall Study|Revision|5|||
145654056|NCT03382652|525250734|FG000|Overall Study|Patient withdrew|3|||
145654057|NCT03382652|525250734|FG000|Overall Study|Other reasons|21|||
145654058|NCT04810650|525250736|FG000|Overall Study|Disenrolled in error|0|||
145654059|NCT04810650|525250737|FG001|Overall Study|Disenrolled in error|0|||
145654060|NCT04810650|525250738|FG002|Overall Study|Disenrolled in error|0|||
145654061|NCT04810650|525250739|FG003|Overall Study|Disenrolled in error|0|||
145654062|NCT04810650|525250740|FG004|Overall Study|Disenrolled in error|0|||
145654063|NCT04810650|525250741|FG005|Overall Study|Disenrolled in error|0|||
145654064|NCT04810650|525250742|FG006|Overall Study|Disenrolled in error|0|||
145654065|NCT04810650|525250743|FG007|Overall Study|Disenrolled in error|0|||
145654066|NCT04810650|525250744|FG008|Overall Study|Disenrolled in error|1|||
145654067|NCT04810650|525250745|FG009|Overall Study|Disenrolled in error|0|||
145654068|NCT04810650|525250746|FG010|Overall Study|Disenrolled in error|0|||
145654069|NCT04810650|525250747|FG011|Overall Study|Disenrolled in error|0|||
145654070|NCT04810650|525250748|FG012|Overall Study|Disenrolled in error|0|||
145654071|NCT04810650|525250749|FG013|Overall Study|Disenrolled in error|0|||
145654072|NCT04810650|525250736|FG000|Overall Study|Death|0|||
145654073|NCT04810650|525250737|FG001|Overall Study|Death|0|||
145654074|NCT04810650|525250738|FG002|Overall Study|Death|0|||
145654075|NCT04810650|525250739|FG003|Overall Study|Death|0|||
145654076|NCT04810650|525250740|FG004|Overall Study|Death|0|||
145654077|NCT04810650|525250741|FG005|Overall Study|Death|0|||
145654078|NCT04810650|525250742|FG006|Overall Study|Death|2|||
145654079|NCT04810650|525250743|FG007|Overall Study|Death|2|||
145654080|NCT04810650|525250744|FG008|Overall Study|Death|0|||
145654081|NCT04810650|525250745|FG009|Overall Study|Death|1|||
145654082|NCT04810650|525250746|FG010|Overall Study|Death|0|||
145654083|NCT04810650|525250747|FG011|Overall Study|Death|0|||
145654084|NCT04810650|525250748|FG012|Overall Study|Death|2|||
145654085|NCT04810650|525250749|FG013|Overall Study|Death|1|||
145654086|NCT04810650|525250736|FG000|Overall Study|Moved/transferred care|0|||
145654087|NCT04810650|525250737|FG001|Overall Study|Moved/transferred care|0|||
145654088|NCT04810650|525250738|FG002|Overall Study|Moved/transferred care|0|||
145654089|NCT04810650|525250739|FG003|Overall Study|Moved/transferred care|0|||
145654090|NCT04810650|525250740|FG004|Overall Study|Moved/transferred care|0|||
145654091|NCT04810650|525250741|FG005|Overall Study|Moved/transferred care|0|||
145654092|NCT04810650|525250742|FG006|Overall Study|Moved/transferred care|0|||
145654093|NCT04810650|525250743|FG007|Overall Study|Moved/transferred care|1|||
145654094|NCT04810650|525250744|FG008|Overall Study|Moved/transferred care|12|||
145654095|NCT04810650|525250745|FG009|Overall Study|Moved/transferred care|10|||
145654096|NCT04810650|525250746|FG010|Overall Study|Moved/transferred care|0|||
145654097|NCT04810650|525250747|FG011|Overall Study|Moved/transferred care|0|||
145654098|NCT04810650|525250748|FG012|Overall Study|Moved/transferred care|0|||
145654099|NCT04810650|525250749|FG013|Overall Study|Moved/transferred care|0|||
145654100|NCT04810650|525250736|FG000|Overall Study|Lost to Follow-up|15|||
145654101|NCT04810650|525250737|FG001|Overall Study|Lost to Follow-up|12|||
145654102|NCT04810650|525250738|FG002|Overall Study|Lost to Follow-up|7|||
145654103|NCT04810650|525250739|FG003|Overall Study|Lost to Follow-up|9|||
145654104|NCT04810650|525250740|FG004|Overall Study|Lost to Follow-up|10|||
145654105|NCT04810650|525250741|FG005|Overall Study|Lost to Follow-up|6|||
145654106|NCT04810650|525250742|FG006|Overall Study|Lost to Follow-up|0|||
145654107|NCT04810650|525250743|FG007|Overall Study|Lost to Follow-up|0|||
145654108|NCT04810650|525250744|FG008|Overall Study|Lost to Follow-up|0|||
145654109|NCT04810650|525250745|FG009|Overall Study|Lost to Follow-up|0|||
145654110|NCT04810650|525250746|FG010|Overall Study|Lost to Follow-up|1|||
145654111|NCT04810650|525250747|FG011|Overall Study|Lost to Follow-up|0|||
145654112|NCT04810650|525250748|FG012|Overall Study|Lost to Follow-up|3|||
145654113|NCT04810650|525250749|FG013|Overall Study|Lost to Follow-up|9|||
145654114|NCT04810650|525250736|FG000|Overall Study|Participant declined|0|||
145654115|NCT04810650|525250737|FG001|Overall Study|Participant declined|0|||
145654116|NCT04810650|525250738|FG002|Overall Study|Participant declined|0|||
145654117|NCT04810650|525250739|FG003|Overall Study|Participant declined|0|||
145654118|NCT04810650|525250740|FG004|Overall Study|Participant declined|0|||
145654119|NCT04810650|525250741|FG005|Overall Study|Participant declined|0|||
145654120|NCT04810650|525250742|FG006|Overall Study|Participant declined|0|||
145654121|NCT04810650|525250743|FG007|Overall Study|Participant declined|0|||
145654122|NCT04810650|525250744|FG008|Overall Study|Participant declined|0|||
145654123|NCT04810650|525250745|FG009|Overall Study|Participant declined|0|||
145654124|NCT04810650|525250746|FG010|Overall Study|Participant declined|2|||
145654125|NCT04810650|525250747|FG011|Overall Study|Participant declined|0|||
145654126|NCT04810650|525250748|FG012|Overall Study|Participant declined|0|||
145654127|NCT04810650|525250749|FG013|Overall Study|Participant declined|0|||
145654128|NCT05794243|525250750|FG000|Overall Study|Withdrawal by Subject|1|||
145654129|NCT05794243|525250751|FG001|Overall Study|Withdrawal by Subject|0|||
145654130|NCT05794243|525250752|FG002|Overall Study|Withdrawal by Subject|1|||
145654131|NCT05794243|525250750|FG000|Overall Study|Physician Decision|0|||
145654132|NCT05794243|525250751|FG001|Overall Study|Physician Decision|3|||
145654133|NCT05794243|525250752|FG002|Overall Study|Physician Decision|1|||
145654134|NCT04971681|525250755|FG000|Followup|Lost to Follow-up|1|||
145654135|NCT04971681|525250756|FG001|Followup|Lost to Follow-up|0|||
145654136|NCT00686335|525250757|FG000|Run-in Period|Adverse Event|1|||
145654137|NCT00686335|525250757|FG000|Run-in Period|asthma exacerbation|1|||
145654138|NCT00686335|525250757|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
145654139|NCT04788511|525250758|FG000|Overall Study|Withdrawal by Subject|2|||
145654140|NCT04788511|525250759|FG001|Overall Study|Withdrawal by Subject|1|||
145654141|NCT04788511|525250758|FG000|Overall Study|Lost to Follow-up|2|||
145654142|NCT04788511|525250759|FG001|Overall Study|Lost to Follow-up|7|||
145654143|NCT04788511|525250758|FG000|Overall Study|Death|3|||
145654144|NCT04788511|525250759|FG001|Overall Study|Death|4|||
145654145|NCT04652700|525250760|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
145654146|NCT04652700|525250761|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
145654147|NCT04652700|525250760|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
145654148|NCT04652700|525250761|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
145654149|NCT04652700|525250760|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
145654150|NCT04652700|525250761|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
145654151|NCT04652700|525250760|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
145654152|NCT04652700|525250761|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
145654153|NCT04652700|525250760|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
145654154|NCT04652700|525250761|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
145654155|NCT04652700|525250760|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
145654156|NCT04652700|525250761|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
145654157|NCT04652700|525250760|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
145654158|NCT04652700|525250761|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
145654159|NCT04652700|525250760|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
145654160|NCT04652700|525250761|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
145654161|NCT04652700|525250760|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
145654162|NCT04652700|525250761|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
145654163|NCT04187833|525250762|FG000|Overall Study|Withdrawal by Subject|1|||
145654164|NCT04209465|525250765|FG000|Overall Study|Adverse Event|0|||
145654165|NCT04209465|525250766|FG001|Overall Study|Adverse Event|0|||
145654166|NCT04209465|525250767|FG002|Overall Study|Adverse Event|0|||
145654167|NCT04209465|525250768|FG003|Overall Study|Adverse Event|0|||
145654168|NCT04209465|525250769|FG004|Overall Study|Adverse Event|0|||
145654169|NCT04209465|525250770|FG005|Overall Study|Adverse Event|1|||
145654170|NCT04209465|525250771|FG006|Overall Study|Adverse Event|0|||
145654171|NCT04209465|525250772|FG007|Overall Study|Adverse Event|0|||
145654172|NCT04209465|525250773|FG008|Overall Study|Adverse Event|1|||
145654173|NCT04209465|525250774|FG009|Overall Study|Adverse Event|0|||
145654174|NCT04209465|525250775|FG010|Overall Study|Adverse Event|2|||
145654175|NCT04209465|525250776|FG011|Overall Study|Adverse Event|1|||
145654176|NCT04209465|525250777|FG012|Overall Study|Adverse Event|1|||
145654177|NCT04209465|525250765|FG000|Overall Study|Death|1|||
145654178|NCT04209465|525250766|FG001|Overall Study|Death|0|||
145654179|NCT04209465|525250767|FG002|Overall Study|Death|0|||
145654180|NCT04209465|525250768|FG003|Overall Study|Death|0|||
145654181|NCT04209465|525250769|FG004|Overall Study|Death|2|||
145654182|NCT04209465|525250770|FG005|Overall Study|Death|7|||
145654183|NCT04209465|525250771|FG006|Overall Study|Death|2|||
145654184|NCT04209465|525250772|FG007|Overall Study|Death|2|||
145654185|NCT04209465|525250773|FG008|Overall Study|Death|1|||
145654186|NCT04209465|525250774|FG009|Overall Study|Death|1|||
145654187|NCT04209465|525250775|FG010|Overall Study|Death|1|||
145654188|NCT04209465|525250776|FG011|Overall Study|Death|0|||
145654189|NCT04209465|525250777|FG012|Overall Study|Death|10|||
145654190|NCT04209465|525250765|FG000|Overall Study|Physician Decision|0|||
145654191|NCT04209465|525250766|FG001|Overall Study|Physician Decision|1|||
145654192|NCT04209465|525250767|FG002|Overall Study|Physician Decision|0|||
145654193|NCT04209465|525250768|FG003|Overall Study|Physician Decision|0|||
145654194|NCT04209465|525250769|FG004|Overall Study|Physician Decision|0|||
145654195|NCT04209465|525250770|FG005|Overall Study|Physician Decision|0|||
145654196|NCT04209465|525250771|FG006|Overall Study|Physician Decision|0|||
145654197|NCT04209465|525250772|FG007|Overall Study|Physician Decision|0|||
145654198|NCT04209465|525250773|FG008|Overall Study|Physician Decision|0|||
145654199|NCT04209465|525250774|FG009|Overall Study|Physician Decision|0|||
145654200|NCT04209465|525250775|FG010|Overall Study|Physician Decision|0|||
145654201|NCT04209465|525250776|FG011|Overall Study|Physician Decision|0|||
145654202|NCT04209465|525250777|FG012|Overall Study|Physician Decision|0|||
145654203|NCT04209465|525250765|FG000|Overall Study|Progressive Disease|0|||
145654204|NCT04209465|525250766|FG001|Overall Study|Progressive Disease|0|||
145654205|NCT04209465|525250767|FG002|Overall Study|Progressive Disease|1|||
145654206|NCT04209465|525250768|FG003|Overall Study|Progressive Disease|2|||
145654207|NCT04209465|525250769|FG004|Overall Study|Progressive Disease|8|||
145654208|NCT04209465|525250770|FG005|Overall Study|Progressive Disease|5|||
145654209|NCT04209465|525250771|FG006|Overall Study|Progressive Disease|3|||
145654210|NCT04209465|525250772|FG007|Overall Study|Progressive Disease|4|||
145654211|NCT04209465|525250773|FG008|Overall Study|Progressive Disease|1|||
145654212|NCT04209465|525250774|FG009|Overall Study|Progressive Disease|3|||
145654213|NCT04209465|525250775|FG010|Overall Study|Progressive Disease|2|||
145654214|NCT04209465|525250776|FG011|Overall Study|Progressive Disease|1|||
145654215|NCT04209465|525250777|FG012|Overall Study|Progressive Disease|0|||
145654216|NCT04209465|525250765|FG000|Overall Study|Withdrawal by Subject|0|||
145654217|NCT04209465|525250766|FG001|Overall Study|Withdrawal by Subject|0|||
145654218|NCT04209465|525250767|FG002|Overall Study|Withdrawal by Subject|0|||
145654219|NCT04209465|525250768|FG003|Overall Study|Withdrawal by Subject|0|||
145654220|NCT04209465|525250769|FG004|Overall Study|Withdrawal by Subject|0|||
145654221|NCT04209465|525250770|FG005|Overall Study|Withdrawal by Subject|1|||
145654222|NCT04209465|525250771|FG006|Overall Study|Withdrawal by Subject|2|||
145654223|NCT04209465|525250772|FG007|Overall Study|Withdrawal by Subject|0|||
145654224|NCT04209465|525250773|FG008|Overall Study|Withdrawal by Subject|1|||
145654225|NCT04209465|525250774|FG009|Overall Study|Withdrawal by Subject|0|||
145654226|NCT04209465|525250775|FG010|Overall Study|Withdrawal by Subject|0|||
145654227|NCT04209465|525250776|FG011|Overall Study|Withdrawal by Subject|2|||
145654228|NCT04209465|525250777|FG012|Overall Study|Withdrawal by Subject|2|||
145654229|NCT04209465|525250765|FG000|Overall Study|Lost to Follow-up|0|||
145654230|NCT04209465|525250766|FG001|Overall Study|Lost to Follow-up|0|||
145654231|NCT04209465|525250767|FG002|Overall Study|Lost to Follow-up|0|||
145654232|NCT04209465|525250768|FG003|Overall Study|Lost to Follow-up|0|||
145654233|NCT04209465|525250769|FG004|Overall Study|Lost to Follow-up|0|||
145654234|NCT04209465|525250770|FG005|Overall Study|Lost to Follow-up|1|||
145654235|NCT04209465|525250771|FG006|Overall Study|Lost to Follow-up|0|||
145654236|NCT04209465|525250772|FG007|Overall Study|Lost to Follow-up|0|||
145654237|NCT04209465|525250773|FG008|Overall Study|Lost to Follow-up|1|||
145654238|NCT04209465|525250774|FG009|Overall Study|Lost to Follow-up|0|||
145654239|NCT04209465|525250775|FG010|Overall Study|Lost to Follow-up|0|||
145654240|NCT04209465|525250776|FG011|Overall Study|Lost to Follow-up|1|||
145654241|NCT04209465|525250777|FG012|Overall Study|Lost to Follow-up|0|||
145654242|NCT04209465|525250765|FG000|Overall Study|Started new therapy|0|||
145654243|NCT04209465|525250766|FG001|Overall Study|Started new therapy|0|||
145654244|NCT04209465|525250767|FG002|Overall Study|Started new therapy|0|||
145654245|NCT04209465|525250768|FG003|Overall Study|Started new therapy|0|||
145654246|NCT04209465|525250769|FG004|Overall Study|Started new therapy|0|||
145654247|NCT04209465|525250770|FG005|Overall Study|Started new therapy|1|||
145654248|NCT04209465|525250771|FG006|Overall Study|Started new therapy|0|||
145654249|NCT04209465|525250772|FG007|Overall Study|Started new therapy|0|||
145654250|NCT04209465|525250773|FG008|Overall Study|Started new therapy|0|||
145654251|NCT04209465|525250774|FG009|Overall Study|Started new therapy|0|||
145654252|NCT04209465|525250775|FG010|Overall Study|Started new therapy|0|||
145654253|NCT04209465|525250776|FG011|Overall Study|Started new therapy|0|||
145654254|NCT04209465|525250777|FG012|Overall Study|Started new therapy|0|||
145654255|NCT04209465|525250765|FG000|Overall Study|Study terminated early by sponsor|0|||
145654256|NCT04209465|525250766|FG001|Overall Study|Study terminated early by sponsor|0|||
145654257|NCT04209465|525250767|FG002|Overall Study|Study terminated early by sponsor|0|||
145654258|NCT04209465|525250768|FG003|Overall Study|Study terminated early by sponsor|0|||
145654259|NCT04209465|525250769|FG004|Overall Study|Study terminated early by sponsor|0|||
145654260|NCT04209465|525250770|FG005|Overall Study|Study terminated early by sponsor|0|||
145654261|NCT04209465|525250771|FG006|Overall Study|Study terminated early by sponsor|3|||
145654262|NCT04209465|525250772|FG007|Overall Study|Study terminated early by sponsor|0|||
145654263|NCT04209465|525250773|FG008|Overall Study|Study terminated early by sponsor|0|||
145654264|NCT04209465|525250774|FG009|Overall Study|Study terminated early by sponsor|0|||
145654265|NCT04209465|525250775|FG010|Overall Study|Study terminated early by sponsor|0|||
145654266|NCT04209465|525250776|FG011|Overall Study|Study terminated early by sponsor|0|||
145654267|NCT04209465|525250777|FG012|Overall Study|Study terminated early by sponsor|3|||
145654268|NCT04209465|525250765|FG000|Overall Study|Other|0|||
145654269|NCT04209465|525250766|FG001|Overall Study|Other|0|||
145654270|NCT04209465|525250767|FG002|Overall Study|Other|0|||
145654271|NCT04209465|525250768|FG003|Overall Study|Other|0|||
145654272|NCT04209465|525250769|FG004|Overall Study|Other|0|||
145654273|NCT04209465|525250770|FG005|Overall Study|Other|0|||
145654274|NCT04209465|525250771|FG006|Overall Study|Other|0|||
145654275|NCT04209465|525250772|FG007|Overall Study|Other|0|||
145654276|NCT04209465|525250773|FG008|Overall Study|Other|1|||
145654277|NCT04209465|525250774|FG009|Overall Study|Other|0|||
145654278|NCT04209465|525250775|FG010|Overall Study|Other|0|||
145654279|NCT04209465|525250776|FG011|Overall Study|Other|0|||
145654280|NCT04209465|525250777|FG012|Overall Study|Other|0|||
145654281|NCT03097549|525250778|FG000|Overall Study|Withdrawal by Subject|1|||
145654282|NCT03097549|525250779|FG001|Overall Study|Withdrawal by Subject|0|||
145654283|NCT03097549|525250778|FG000|Overall Study|Lost to Follow-up|1|||
145654284|NCT03097549|525250779|FG001|Overall Study|Lost to Follow-up|0|||
145654285|NCT05783102|525250780|FG000|Overall Study|Lost to Follow-up|1|||
145654286|NCT05783102|525250780|FG000|Overall Study|Withdrawal by Subject|2|||
145654287|NCT01744782|525252667|FG000|Overall Study|Death|1|||
145654288|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Physician Decision|1|||
145654289|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Physician Decision|0|||
145654290|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
145654291|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
145654292|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
145654293|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
145654294|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Pregnancy|0|||
145654295|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Pregnancy|2|||
145654296|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
145654297|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
145654298|NCT01785719|525252668|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
145654299|NCT01785719|525252669|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
145654300|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
145654301|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
145654302|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
145654303|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
145654304|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
145654305|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
145654306|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
145654307|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
145654308|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
145654309|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
145654310|NCT01785719|525252668|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
145654311|NCT01785719|525252669|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
145654312|NCT01785719|525252668|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
145654313|NCT01785719|525252669|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
145654314|NCT01785719|525252668|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
145654315|NCT01785719|525252669|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
145654316|NCT01785719|525252668|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
145654317|NCT01785719|525252669|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
145654318|NCT04977947|525252672|FG000|Overall Study|Lost to Follow-up|1|||
145654319|NCT04977947|525252673|FG001|Overall Study|Lost to Follow-up|1|||
145654320|NCT05875142|525252674|FG000|Overall Study|Lost to Follow-up|0|||
145654321|NCT05875142|525252675|FG001|Overall Study|Lost to Follow-up|1|||
145654322|NCT05875142|525252676|FG002|Overall Study|Lost to Follow-up|1|||
145654323|NCT03436290|525252677|FG000|Overall Study|Post-randomization Exclusion|1|||
145654324|NCT03436290|525252678|FG001|Overall Study|Post-randomization Exclusion|0|||
145654325|NCT03436290|525252677|FG000|Overall Study|Death|6|||
145654326|NCT03436290|525252678|FG001|Overall Study|Death|0|||
145654327|NCT03436290|525252677|FG000|Overall Study|Withdrawal by Subject|4|||
145654328|NCT03436290|525252678|FG001|Overall Study|Withdrawal by Subject|0|||
145654329|NCT03436290|525252677|FG000|Overall Study|Protocol Violation|30|||
145654330|NCT03436290|525252678|FG001|Overall Study|Protocol Violation|0|||
145654331|NCT04142788|525252679|FG000|Overall Study|Trial terminated prematurely|2|||
145654332|NCT04142788|525252680|FG001|Overall Study|Trial terminated prematurely|2|||
145654333|NCT01396278|525252681|FG000|Overall Study|Adverse Event|0|||
145654334|NCT01396278|525252682|FG001|Overall Study|Adverse Event|0|||
145654335|NCT01396278|525252683|FG002|Overall Study|Adverse Event|0|||
145654336|NCT01396278|525252684|FG003|Overall Study|Adverse Event|2|||
145654337|NCT01396278|525252685|FG004|Overall Study|Adverse Event|0|||
145654338|NCT01396278|525252681|FG000|Overall Study|Withdraw due to trial termination|2|||
145654339|NCT01396278|525252682|FG001|Overall Study|Withdraw due to trial termination|1|||
145654340|NCT01396278|525252683|FG002|Overall Study|Withdraw due to trial termination|1|||
145654341|NCT01396278|525252684|FG003|Overall Study|Withdraw due to trial termination|0|||
145654342|NCT01396278|525252685|FG004|Overall Study|Withdraw due to trial termination|2|||
145654343|NCT04764448|525252688|FG000|Overall Study|Study terminated by sponsor|2|||
145654344|NCT04764448|525252689|FG001|Overall Study|Study terminated by sponsor|2|||
145654345|NCT04764448|525252690|FG002|Overall Study|Study terminated by sponsor|5|||
145654346|NCT04764448|525252688|FG000|Overall Study|Withdrawal by Subject|3|||
145654347|NCT04764448|525252689|FG001|Overall Study|Withdrawal by Subject|3|||
145654348|NCT04764448|525252690|FG002|Overall Study|Withdrawal by Subject|1|||
145654349|NCT04515576|525252691|FG000|Overall Study|Withdrawal by Subject|0|||
145654350|NCT04515576|525252692|FG001|Overall Study|Withdrawal by Subject|0|||
145654351|NCT04515576|525252693|FG002|Overall Study|Withdrawal by Subject|0|||
145654352|NCT04515576|525252694|FG003|Overall Study|Withdrawal by Subject|0|||
145654353|NCT04515576|525252695|FG004|Overall Study|Withdrawal by Subject|0|||
145654354|NCT04515576|525252696|FG005|Overall Study|Withdrawal by Subject|1|||
145654355|NCT03812679|525252697|FG000|Overall Study|Adverse Event|2|||
145654356|NCT03812679|525252697|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
145654357|NCT03812679|525252697|FG000|Overall Study|Renal transplant|1|||
145654358|NCT03812679|525252697|FG000|Overall Study|Withdrawal by Subject|1|||
145654359|NCT03812679|525252697|FG000|Overall Study|Termination of study|2|||
145654360|NCT03812679|525252697|FG000|Overall Study|Water device replacement|1|||
145654361|NCT05653427|525252698|FG000|Overall Study|Study Terminated by Sponsor|13|||
145654362|NCT03891667|525252706|FG000|Overall Study|Physician Decision|1|||
145654363|NCT03891667|525252707|FG001|Overall Study|Physician Decision|1|||
145654364|NCT03891667|525252706|FG000|Overall Study|COVID related pause|1|||
145654365|NCT03891667|525252707|FG001|Overall Study|COVID related pause|0|||
145654366|NCT03891667|525252706|FG000|Overall Study|Withdrawal by Subject|0|||
145654367|NCT03891667|525252707|FG001|Overall Study|Withdrawal by Subject|1|||
145654368|NCT03891667|525252706|FG000|Overall Study|Adverse Event|0|||
145654369|NCT03891667|525252707|FG001|Overall Study|Adverse Event|1|||
145654370|NCT05590403|525252708|FG000|Overall Study|Lost to Follow-up|13|||
145654371|NCT05590403|525252709|FG001|Overall Study|Lost to Follow-up|1|||
145654372|NCT05590403|525252710|FG002|Overall Study|Lost to Follow-up|7|||
145654373|NCT05590403|525252711|FG003|Overall Study|Lost to Follow-up|3|||
145654374|NCT05590403|525252712|FG004|Overall Study|Lost to Follow-up|4|||
145654375|NCT05590403|525252708|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
145489768|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
145489769|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
145489770|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
145654376|NCT05590403|525252709|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
145654377|NCT05590403|525252710|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
145654378|NCT05590403|525252711|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
145654379|NCT05590403|525252712|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
145654380|NCT05590403|525252708|FG000|Overall Study|Other|2|||
145654381|NCT05590403|525252709|FG001|Overall Study|Other|0|||
145654382|NCT05590403|525252710|FG002|Overall Study|Other|2|||
145654383|NCT05590403|525252711|FG003|Overall Study|Other|2|||
145489771|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
145489772|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
145489773|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
145489774|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
145489775|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
145489776|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
145489777|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
145654384|NCT05590403|525252712|FG004|Overall Study|Other|0|||
145654385|NCT05590403|525252708|FG000|Overall Study|Migrated / moved from the study area|1|||
145654386|NCT05590403|525252709|FG001|Overall Study|Migrated / moved from the study area|1|||
145654387|NCT05590403|525252710|FG002|Overall Study|Migrated / moved from the study area|0|||
145654388|NCT05590403|525252711|FG003|Overall Study|Migrated / moved from the study area|3|||
145654389|NCT05590403|525252712|FG004|Overall Study|Migrated / moved from the study area|1|||
145654390|NCT05590403|525252708|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
145654391|NCT05590403|525252709|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
145654392|NCT05590403|525252710|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
145654393|NCT05590403|525252711|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
145654394|NCT05590403|525252712|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
145654395|NCT05659537|525252713|FG000|Overall Study|Adverse Event|5|||
145654396|NCT05659537|525252713|FG000|Overall Study|Lost to Follow-up|4|||
145654397|NCT05659537|525252713|FG000|Overall Study|Withdrawal by Subject|13|||
145654398|NCT05659537|525252713|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
145654399|NCT05659537|525252713|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
145654400|NCT05659537|525252713|FG000|Overall Study|Participant was suffering from anaemia|1|||
145654401|NCT04456517|525252717|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
145654402|NCT04456517|525252718|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
145654403|NCT01160211|525252720|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
145654404|NCT01160211|525252721|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
145654405|NCT01160211|525252722|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
145654406|NCT01160211|525252720|FG000|Overall Study|Lost to Follow-up|4|||
145654407|NCT01160211|525252721|FG001|Overall Study|Lost to Follow-up|8|||
145654408|NCT01160211|525252722|FG002|Overall Study|Lost to Follow-up|4|||
145654409|NCT01160211|525252720|FG000|Overall Study|Physician Decision|1|||
145654410|NCT01160211|525252721|FG001|Overall Study|Physician Decision|0|||
145654411|NCT01160211|525252722|FG002|Overall Study|Physician Decision|0|||
145654412|NCT01160211|525252720|FG000|Overall Study|Withdrawal by Subject|4|||
145654413|NCT01160211|525252721|FG001|Overall Study|Withdrawal by Subject|2|||
145654414|NCT01160211|525252722|FG002|Overall Study|Withdrawal by Subject|2|||
145654415|NCT01160211|525252720|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
145654416|NCT01160211|525252721|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
145654417|NCT01160211|525252722|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
145654418|NCT02734290|525252723|FG000|Overall Study|Adverse Event|1|||
145654419|NCT02734290|525252724|FG001|Overall Study|Adverse Event|0|||
145654420|NCT02734290|525252723|FG000|Overall Study|Death|1|||
145654421|NCT02734290|525252724|FG001|Overall Study|Death|0|||
145654422|NCT03829410|525252726|FG000|Overall Study|Adverse Event|1|||
145654423|NCT03829410|525252727|FG001|Overall Study|Adverse Event|0|||
145654424|NCT03829410|525252728|FG002|Overall Study|Adverse Event|1|||
145654425|NCT03829410|525252729|FG003|Overall Study|Adverse Event|4|||
145654426|NCT03829410|525252726|FG000|Overall Study|Physician Decision|0|||
145654427|NCT03829410|525252727|FG001|Overall Study|Physician Decision|0|||
145654428|NCT03829410|525252728|FG002|Overall Study|Physician Decision|0|||
145654429|NCT03829410|525252729|FG003|Overall Study|Physician Decision|2|||
145654430|NCT03829410|525252726|FG000|Overall Study|Disease Progressing|3|||
145654431|NCT03829410|525252727|FG001|Overall Study|Disease Progressing|4|||
145654432|NCT03829410|525252728|FG002|Overall Study|Disease Progressing|2|||
145654433|NCT03829410|525252729|FG003|Overall Study|Disease Progressing|31|||
145654434|NCT03829410|525252726|FG000|Overall Study|Miscellaneous|2|||
145654435|NCT03829410|525252727|FG001|Overall Study|Miscellaneous|4|||
145654436|NCT03829410|525252728|FG002|Overall Study|Miscellaneous|3|||
145654437|NCT03829410|525252729|FG003|Overall Study|Miscellaneous|10|||
145654438|NCT03611491|525252734|FG000|Overall Study|Lost to Follow-up|1|||
145654439|NCT04676022|525252735|FG000|Overall Study|Screen Failure/|1|||
145654440|NCT04676022|525252736|FG001|Overall Study|Screen Failure/|1|||
145654441|NCT04676022|525252737|FG002|Overall Study|Screen Failure/|85|||
145654442|NCT04676022|525252735|FG000|Overall Study|Lost to Follow-up|1|||
145654443|NCT04676022|525252736|FG001|Overall Study|Lost to Follow-up|1|||
145654444|NCT04676022|525252737|FG002|Overall Study|Lost to Follow-up|0|||
145654445|NCT04676022|525252735|FG000|Overall Study|Adverse Event|2|||
145654446|NCT04676022|525252736|FG001|Overall Study|Adverse Event|0|||
145654447|NCT04676022|525252737|FG002|Overall Study|Adverse Event|1|||
145654448|NCT04676022|525252735|FG000|Overall Study|Physician Decision|2|||
145654449|NCT04676022|525252736|FG001|Overall Study|Physician Decision|0|||
145654450|NCT04676022|525252737|FG002|Overall Study|Physician Decision|1|||
145654451|NCT04676022|525252735|FG000|Overall Study|Withdrawal by Subject|3|||
145654452|NCT04676022|525252736|FG001|Overall Study|Withdrawal by Subject|1|||
145654453|NCT04676022|525252737|FG002|Overall Study|Withdrawal by Subject|6|||
145654454|NCT04676022|525252735|FG000|Overall Study|Will not move forward with permanent implant|6|||
145654455|NCT04676022|525252736|FG001|Overall Study|Will not move forward with permanent implant|0|||
145654456|NCT04676022|525252737|FG002|Overall Study|Will not move forward with permanent implant|0|||
145654457|NCT04676022|525252735|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
145654458|NCT04676022|525252736|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
145654459|NCT04676022|525252737|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
145654460|NCT05409183|525252739|FG000|Complete Study|Adverse Event|1|||
145654461|NCT05409183|525252740|FG001|Complete Study|Adverse Event|2|||
145654462|NCT05409183|525252739|FG000|Complete Study|Withdrawal by Subject|3|||
145654463|NCT05409183|525252740|FG001|Complete Study|Withdrawal by Subject|0|||
145654464|NCT03194217|525252741|FG000|Overall Study|Adverse Event|0|||
145654465|NCT03194217|525252742|FG001|Overall Study|Adverse Event|2|||
145654466|NCT03194217|525252743|FG002|Overall Study|Adverse Event|3|||
145654467|NCT03194217|525252744|FG003|Overall Study|Adverse Event|3|||
145654468|NCT03194217|525252741|FG000|Overall Study|Failure to meet randomisation criteria|0|||
145654469|NCT03194217|525252742|FG001|Overall Study|Failure to meet randomisation criteria|0|||
145654470|NCT03194217|525252743|FG002|Overall Study|Failure to meet randomisation criteria|0|||
145654471|NCT03194217|525252744|FG003|Overall Study|Failure to meet randomisation criteria|1|||
145654472|NCT03194217|525252741|FG000|Overall Study|Other|0|||
145654473|NCT03194217|525252742|FG001|Overall Study|Other|1|||
145654474|NCT03194217|525252743|FG002|Overall Study|Other|1|||
145654475|NCT03194217|525252744|FG003|Overall Study|Other|0|||
145654476|NCT04806451|525252745|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
145654477|NCT04806451|525252746|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
145654478|NCT04806451|525252745|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
145654479|NCT04806451|525252746|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
145654480|NCT04806451|525252745|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
145654481|NCT04806451|525252746|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
145654482|NCT03134196|525252758|FG000|Overall Study|Death|2|||
145654483|NCT03134196|525252759|FG001|Overall Study|Death|1|||
145654484|NCT03134196|525252758|FG000|Overall Study|Lost to Follow-up|13|||
145654485|NCT03134196|525252759|FG001|Overall Study|Lost to Follow-up|15|||
145654486|NCT03134196|525252758|FG000|Overall Study|Physician Decision|0|||
145654487|NCT03134196|525252759|FG001|Overall Study|Physician Decision|1|||
145654488|NCT03134196|525252758|FG000|Overall Study|Withdrawal by Subject|19|||
145654489|NCT03134196|525252759|FG001|Overall Study|Withdrawal by Subject|12|||
145654490|NCT03134196|525252758|FG000|Overall Study|Site Unable to Contact Participant|2|||
145654491|NCT03134196|525252759|FG001|Overall Study|Site Unable to Contact Participant|0|||
145654492|NCT03134196|525252758|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
145654493|NCT03134196|525252759|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
145654494|NCT03134196|525252758|FG000|Overall Study|Scheduling Conflict|1|||
145654495|NCT03134196|525252759|FG001|Overall Study|Scheduling Conflict|0|||
145654496|NCT04292223|525252764|FG000|Overall Study|Adverse Event|1|||
145654497|NCT04292223|525252764|FG000|Overall Study|Lost to Follow-up|1|||
145654498|NCT04292223|525252764|FG000|Overall Study|Noncompliance with study drug|2|||
145654499|NCT04292223|525252764|FG000|Overall Study|Patient moved out of the state|1|||
145654500|NCT04185298|525252771|FG000|Overall Study|Lost to Follow-up|1|||
145654501|NCT04185298|525252772|FG001|Overall Study|Lost to Follow-up|3|||
145654502|NCT04185298|525252771|FG000|Overall Study|Withdrawal by Subject|0|||
145654503|NCT04185298|525252772|FG001|Overall Study|Withdrawal by Subject|3|||
145654504|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
145654505|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
145654506|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
145654507|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
145654508|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
145654509|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
145654510|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
145654511|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
145654512|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
145654513|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
145654514|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
145654515|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
145654516|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
145654517|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
145654518|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
145654519|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
145654520|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
145654521|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
145654522|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654523|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
145654524|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
145654525|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654526|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654527|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
145654528|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654529|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654530|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
145654531|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
145654532|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
145654533|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
145654534|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
145654535|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
145654536|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
145654537|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
145654538|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
145654539|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
145654540|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
145654541|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
145654542|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
145654543|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
145654544|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
145654545|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
145654546|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
145654547|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
145654548|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
145654549|NCT01369355|525252779|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
145654550|NCT01369355|525252780|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
145654551|NCT01369355|525252781|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
145654552|NCT01369355|525252782|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
145654553|NCT01369355|525252783|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
145654554|NCT01369355|525252784|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
145654555|NCT01369355|525252785|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
145654556|NCT01369355|525252786|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
145654557|NCT01369355|525252787|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
145654558|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654559|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654560|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654561|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654562|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654563|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
145654564|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
145654565|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
145654566|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
145654567|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Death|0|||
145654568|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Death|0|||
145654569|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Death|0|||
145654570|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Death|0|||
145654571|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Death|0|||
145654572|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Death|0|||
145654573|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Death|0|||
145654574|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Death|1|||
145654575|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Death|3|||
145654576|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654577|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654578|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654579|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654580|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654581|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
145654582|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
145654583|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
145654584|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
145654585|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654586|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654587|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654588|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654589|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654590|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654591|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
145654592|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
145654593|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
145654594|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654595|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654596|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654597|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654598|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654599|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
145654600|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
145654601|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
145654602|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
145654603|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654604|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654605|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654606|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654607|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654608|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
145654609|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
145654610|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
145654611|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
145654612|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654613|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654614|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654615|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654616|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654617|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
145654618|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
145654619|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
145654620|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
145654621|NCT01369355|525252779|FG000|Long-term Extension (Week 44-272)|Other|0|||
145654622|NCT01369355|525252780|FG001|Long-term Extension (Week 44-272)|Other|0|||
145654623|NCT01369355|525252781|FG002|Long-term Extension (Week 44-272)|Other|0|||
145654624|NCT01369355|525252782|FG003|Long-term Extension (Week 44-272)|Other|0|||
145654625|NCT01369355|525252783|FG004|Long-term Extension (Week 44-272)|Other|0|||
145654626|NCT01369355|525252784|FG005|Long-term Extension (Week 44-272)|Other|0|||
145654627|NCT01369355|525252785|FG006|Long-term Extension (Week 44-272)|Other|110|||
145654628|NCT01369355|525252786|FG007|Long-term Extension (Week 44-272)|Other|9|||
145654629|NCT01369355|525252787|FG008|Long-term Extension (Week 44-272)|Other|17|||
145654630|NCT02319759|525252790|FG000|Week 0 - 16|Lack of Efficacy|1|||
145654631|NCT02319759|525252791|FG001|Week 0 - 16|Lack of Efficacy|0|||
145654632|NCT02319759|525252792|FG002|Week 0 - 16|Lack of Efficacy|0|||
145654633|NCT02319759|525252793|FG003|Week 0 - 16|Lack of Efficacy|0|||
145654634|NCT02319759|525252794|FG004|Week 0 - 16|Lack of Efficacy|0|||
145654635|NCT02319759|525252790|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
145654636|NCT02319759|525252791|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
145654637|NCT02319759|525252792|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
145654638|NCT02319759|525252793|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
145654639|NCT02319759|525252794|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
145654640|NCT02319759|525252790|FG000|Week 16 - 24|Lack of Efficacy|1|||
145654641|NCT02319759|525252791|FG001|Week 16 - 24|Lack of Efficacy|0|||
145654642|NCT02319759|525252792|FG002|Week 16 - 24|Lack of Efficacy|1|||
145654643|NCT02319759|525252793|FG003|Week 16 - 24|Lack of Efficacy|0|||
145654644|NCT02319759|525252794|FG004|Week 16 - 24|Lack of Efficacy|0|||
145654645|NCT02319759|525252790|FG000|Week 16 - 24|Lost to Follow-up|1|||
145654646|NCT02319759|525252791|FG001|Week 16 - 24|Lost to Follow-up|0|||
145654647|NCT02319759|525252792|FG002|Week 16 - 24|Lost to Follow-up|0|||
145654648|NCT02319759|525252793|FG003|Week 16 - 24|Lost to Follow-up|0|||
145654649|NCT02319759|525252794|FG004|Week 16 - 24|Lost to Follow-up|0|||
145654650|NCT02319759|525252790|FG000|Week 16 - 24|Withdrawal by Subject|0|||
145654651|NCT02319759|525252791|FG001|Week 16 - 24|Withdrawal by Subject|0|||
145654652|NCT02319759|525252792|FG002|Week 16 - 24|Withdrawal by Subject|2|||
145654653|NCT02319759|525252793|FG003|Week 16 - 24|Withdrawal by Subject|0|||
145654654|NCT02319759|525252794|FG004|Week 16 - 24|Withdrawal by Subject|0|||
145654655|NCT02319759|525252790|FG000|Week 24 - 56|Adverse Event|0|||
145654656|NCT02319759|525252791|FG001|Week 24 - 56|Adverse Event|0|||
145654657|NCT02319759|525252792|FG002|Week 24 - 56|Adverse Event|2|||
145654658|NCT02319759|525252793|FG003|Week 24 - 56|Adverse Event|0|||
145654659|NCT02319759|525252794|FG004|Week 24 - 56|Adverse Event|0|||
145654660|NCT02319759|525252790|FG000|Week 24 - 56|Lack of Efficacy|0|||
145654661|NCT02319759|525252791|FG001|Week 24 - 56|Lack of Efficacy|0|||
145654662|NCT02319759|525252792|FG002|Week 24 - 56|Lack of Efficacy|0|||
145654663|NCT02319759|525252793|FG003|Week 24 - 56|Lack of Efficacy|2|||
145654664|NCT02319759|525252794|FG004|Week 24 - 56|Lack of Efficacy|1|||
145654665|NCT02319759|525252790|FG000|Week 24 - 56|Withdrawal by Subject|0|||
145654666|NCT02319759|525252791|FG001|Week 24 - 56|Withdrawal by Subject|1|||
145654667|NCT02319759|525252792|FG002|Week 24 - 56|Withdrawal by Subject|0|||
145654668|NCT02319759|525252793|FG003|Week 24 - 56|Withdrawal by Subject|0|||
145654669|NCT02319759|525252794|FG004|Week 24 - 56|Withdrawal by Subject|0|||
145654670|NCT02319759|525252790|FG000|Week 24 - 56|Lost to Follow-up|0|||
145654671|NCT02319759|525252791|FG001|Week 24 - 56|Lost to Follow-up|0|||
145654672|NCT02319759|525252792|FG002|Week 24 - 56|Lost to Follow-up|0|||
145654673|NCT02319759|525252793|FG003|Week 24 - 56|Lost to Follow-up|0|||
145654674|NCT02319759|525252794|FG004|Week 24 - 56|Lost to Follow-up|1|||
145654675|NCT05780437|525252796|FG000|Overall Study|Withdrawal by Subject|22|||
145654676|NCT05780437|525252797|FG001|Overall Study|Withdrawal by Subject|16|||
145654677|NCT03452579|525252804|FG000|Overall Study|Death|0|||
145654678|NCT03452579|525252805|FG001|Overall Study|Death|1|||
145654679|NCT03452579|525252804|FG000|Overall Study|Withdrawal by Subject|2|||
145654680|NCT03452579|525252805|FG001|Overall Study|Withdrawal by Subject|0|||
145654681|NCT03452579|525252804|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
145654682|NCT03452579|525252805|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
145654683|NCT03452579|525252804|FG000|Overall Study|Physician Decision|1|||
145654684|NCT03452579|525252805|FG001|Overall Study|Physician Decision|1|||
145654685|NCT03452579|525252804|FG000|Overall Study|Adverse Event|1|||
145654686|NCT03452579|525252805|FG001|Overall Study|Adverse Event|4|||
145654687|NCT05006872|525252811|FG000|Overall Study|Lost to Follow-up|37|||
145654688|NCT05006872|525252812|FG001|Overall Study|Lost to Follow-up|31|||
145654689|NCT06181760|525252813|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
145654690|NCT06181760|525252814|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
145654691|NCT06181760|525252815|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
145654692|NCT06181760|525252816|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
145654693|NCT03524612|525252817|FG000|Overall Study|Lack of Efficacy|10|||
145654694|NCT03524612|525252817|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
145654695|NCT03524612|525252817|FG000|Overall Study|Adverse Event|10|||
145654696|NCT03524612|525252817|FG000|Overall Study|Withdrawal by Subject|7|||
145654697|NCT03524612|525252817|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
145654698|NCT03524612|525252817|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
145654699|NCT03524612|525252817|FG000|Overall Study|New therapy for study indication|6|||
145654700|NCT03524612|525252817|FG000|Overall Study|Death|3|||
145654701|NCT03524612|525252817|FG000|Overall Study|Lost to Follow-up|2|||
145654702|NCT03524612|525252817|FG000|Overall Study|Protocol Violation|1|||
145654703|NCT00613106|525252818|FG000|Overall Study|Adverse Event|3|||
145654704|NCT00613106|525252819|FG001|Overall Study|Adverse Event|1|||
145654705|NCT00613106|525252818|FG000|Overall Study|Withdrawal by Subject|6|||
145654706|NCT00613106|525252819|FG001|Overall Study|Withdrawal by Subject|3|||
145654707|NCT00613106|525252818|FG000|Overall Study|Lost to Follow-up|7|||
145654708|NCT00613106|525252819|FG001|Overall Study|Lost to Follow-up|2|||
145654709|NCT00613106|525252818|FG000|Overall Study|misc|4|||
145654710|NCT00613106|525252819|FG001|Overall Study|misc|3|||
145654711|NCT01420237|525252824|FG000|Overall Study|Death|13|||
145654712|NCT01420237|525252824|FG000|Overall Study|Withdrawal by Subject|41|||
145654713|NCT01420237|525252824|FG000|Overall Study|Lost to Follow-up|32|||
145654714|NCT01420237|525252824|FG000|Overall Study|Adverse Event|10|||
145654715|NCT01420237|525252824|FG000|Overall Study|Investigative Site Termination|43|||
145654716|NCT01420237|525252824|FG000|Overall Study|Censored because study device not implanted|21|||
145654717|NCT01420237|525252824|FG000|Overall Study|Censored because surgery not performed|2|||
145654718|NCT01420237|525252824|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
145654719|NCT01420237|525252824|FG000|Overall Study|Sponsor terminated study early|127|||
145489778|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
145654720|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
145654721|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
145654722|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
145654723|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
145654724|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
145654725|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
145654726|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
145654727|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
145654728|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
145654729|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
145654730|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
145654731|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
145654732|NCT04338061|525252825|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
145654733|NCT04338061|525252826|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
145654734|NCT04338061|525252825|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
145654735|NCT04338061|525252826|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
145654736|NCT04338061|525252825|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
145654737|NCT04338061|525252826|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
145654738|NCT04338061|525252825|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
145654739|NCT04338061|525252826|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
145654740|NCT04338061|525252825|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
145654741|NCT04338061|525252826|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
145654742|NCT04338061|525252825|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
145654743|NCT04338061|525252826|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
145654744|NCT04492722|525252828|FG000|Overall Study|Adverse Event|7|||
145654745|NCT04492722|525252829|FG001|Overall Study|Adverse Event|2|||
145654746|NCT04492722|525252830|FG002|Overall Study|Adverse Event|3|||
145654747|NCT04492722|525252831|FG003|Overall Study|Adverse Event|0|||
145654748|NCT04492722|525252828|FG000|Overall Study|Death|0|||
145654749|NCT04492722|525252829|FG001|Overall Study|Death|0|||
145654750|NCT04492722|525252830|FG002|Overall Study|Death|0|||
145654751|NCT04492722|525252831|FG003|Overall Study|Death|1|||
145654752|NCT04492722|525252828|FG000|Overall Study|Lost to Follow-up|0|||
145654753|NCT04492722|525252829|FG001|Overall Study|Lost to Follow-up|1|||
145654754|NCT04492722|525252830|FG002|Overall Study|Lost to Follow-up|0|||
145654755|NCT04492722|525252831|FG003|Overall Study|Lost to Follow-up|1|||
145654756|NCT04492722|525252828|FG000|Overall Study|Physician Decision|0|||
145654757|NCT04492722|525252829|FG001|Overall Study|Physician Decision|3|||
145654758|NCT04492722|525252830|FG002|Overall Study|Physician Decision|1|||
145654759|NCT04492722|525252831|FG003|Overall Study|Physician Decision|1|||
145654760|NCT04492722|525252828|FG000|Overall Study|Withdrawal by Subject|6|||
145654761|NCT04492722|525252829|FG001|Overall Study|Withdrawal by Subject|6|||
145654762|NCT04492722|525252830|FG002|Overall Study|Withdrawal by Subject|0|||
145654763|NCT04492722|525252831|FG003|Overall Study|Withdrawal by Subject|3|||
145654764|NCT04492722|525252828|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
145654765|NCT04492722|525252829|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
145654766|NCT04492722|525252830|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
145654767|NCT04492722|525252831|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
145654768|NCT04492722|525252828|FG000|Overall Study|Due to Covid-19 pandemic|7|||
145654769|NCT04492722|525252829|FG001|Overall Study|Due to Covid-19 pandemic|3|||
145654770|NCT04492722|525252830|FG002|Overall Study|Due to Covid-19 pandemic|7|||
145654771|NCT04492722|525252831|FG003|Overall Study|Due to Covid-19 pandemic|6|||
145654772|NCT04492722|525252828|FG000|Overall Study|Failure to meet randomisation criteria|2|||
145654773|NCT04492722|525252829|FG001|Overall Study|Failure to meet randomisation criteria|3|||
145654774|NCT04492722|525252830|FG002|Overall Study|Failure to meet randomisation criteria|4|||
145654775|NCT04492722|525252831|FG003|Overall Study|Failure to meet randomisation criteria|2|||
145654776|NCT04492722|525252828|FG000|Overall Study|Early termination from the study|54|||
145654777|NCT04492722|525252829|FG001|Overall Study|Early termination from the study|51|||
145654778|NCT04492722|525252830|FG002|Overall Study|Early termination from the study|50|||
145654779|NCT04492722|525252831|FG003|Overall Study|Early termination from the study|50|||
145654780|NCT04492722|525252828|FG000|Overall Study|Missing|3|||
145654781|NCT04492722|525252829|FG001|Overall Study|Missing|0|||
145654782|NCT04492722|525252830|FG002|Overall Study|Missing|0|||
145654783|NCT04492722|525252831|FG003|Overall Study|Missing|5|||
145654784|NCT04492722|525252828|FG000|Overall Study|Participants who did not receive treatment|0|||
145654785|NCT04492722|525252829|FG001|Overall Study|Participants who did not receive treatment|1|||
145654786|NCT04492722|525252830|FG002|Overall Study|Participants who did not receive treatment|4|||
145654787|NCT04492722|525252831|FG003|Overall Study|Participants who did not receive treatment|0|||
145654788|NCT05329220|525252835|FG000|Active Trial Period|Adverse Event|0|||
145654789|NCT05329220|525252836|FG001|Active Trial Period|Adverse Event|0|||
145654790|NCT05329220|525252837|FG002|Active Trial Period|Adverse Event|0|||
145654791|NCT05329220|525252838|FG003|Active Trial Period|Adverse Event|0|||
145654792|NCT05329220|525252839|FG004|Active Trial Period|Adverse Event|1|||
145654793|NCT05329220|525252840|FG005|Active Trial Period|Adverse Event|0|||
145654794|NCT05329220|525252835|FG000|Active Trial Period|Lost to Follow-up|0|||
145654795|NCT05329220|525252836|FG001|Active Trial Period|Lost to Follow-up|0|||
145654796|NCT05329220|525252837|FG002|Active Trial Period|Lost to Follow-up|0|||
145654797|NCT05329220|525252838|FG003|Active Trial Period|Lost to Follow-up|0|||
145654798|NCT05329220|525252839|FG004|Active Trial Period|Lost to Follow-up|32|||
145654799|NCT05329220|525252840|FG005|Active Trial Period|Lost to Follow-up|28|||
145654800|NCT05329220|525252835|FG000|Active Trial Period|Physician Decision|0|||
145654801|NCT05329220|525252836|FG001|Active Trial Period|Physician Decision|0|||
145654802|NCT05329220|525252837|FG002|Active Trial Period|Physician Decision|0|||
145654803|NCT05329220|525252838|FG003|Active Trial Period|Physician Decision|0|||
145654804|NCT05329220|525252839|FG004|Active Trial Period|Physician Decision|2|||
145654805|NCT05329220|525252840|FG005|Active Trial Period|Physician Decision|0|||
145654806|NCT05329220|525252835|FG000|Active Trial Period|Protocol Violation|0|||
145654807|NCT05329220|525252836|FG001|Active Trial Period|Protocol Violation|0|||
145654808|NCT05329220|525252837|FG002|Active Trial Period|Protocol Violation|0|||
145654809|NCT05329220|525252838|FG003|Active Trial Period|Protocol Violation|0|||
145654810|NCT05329220|525252839|FG004|Active Trial Period|Protocol Violation|1|||
145654811|NCT05329220|525252840|FG005|Active Trial Period|Protocol Violation|3|||
145654812|NCT05329220|525252835|FG000|Active Trial Period|Withdrawal by Subject|0|||
145654813|NCT05329220|525252836|FG001|Active Trial Period|Withdrawal by Subject|0|||
145654814|NCT05329220|525252837|FG002|Active Trial Period|Withdrawal by Subject|0|||
145654815|NCT05329220|525252838|FG003|Active Trial Period|Withdrawal by Subject|1|||
145654816|NCT05329220|525252839|FG004|Active Trial Period|Withdrawal by Subject|12|||
145654817|NCT05329220|525252840|FG005|Active Trial Period|Withdrawal by Subject|13|||
145654818|NCT05329220|525252835|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
145489779|NCT02586623|524647615|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
145654819|NCT05329220|525252836|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
145654820|NCT05329220|525252837|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
145654821|NCT05329220|525252838|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
145654822|NCT05329220|525252839|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
145654823|NCT05329220|525252840|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
145654824|NCT05329220|525252835|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
145654825|NCT05329220|525252836|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
145654826|NCT05329220|525252837|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
145654827|NCT05329220|525252838|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
145654828|NCT05329220|525252839|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
145654829|NCT05329220|525252840|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
145654830|NCT05329220|525252835|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
145654831|NCT05329220|525252836|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
145654832|NCT05329220|525252837|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
145654833|NCT05329220|525252838|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
145654834|NCT05329220|525252839|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
145654835|NCT05329220|525252840|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
145654836|NCT05329220|525252835|FG000|Follow-up Period|Adverse Event|0|||
145654837|NCT05329220|525252836|FG001|Follow-up Period|Adverse Event|0|||
145654838|NCT05329220|525252837|FG002|Follow-up Period|Adverse Event|0|||
145654839|NCT05329220|525252838|FG003|Follow-up Period|Adverse Event|0|||
145654840|NCT05329220|525252839|FG004|Follow-up Period|Adverse Event|2|||
145654841|NCT05329220|525252840|FG005|Follow-up Period|Adverse Event|1|||
145654842|NCT05329220|525252835|FG000|Follow-up Period|Death|0|||
145654843|NCT05329220|525252836|FG001|Follow-up Period|Death|0|||
145654844|NCT05329220|525252837|FG002|Follow-up Period|Death|1|||
145654845|NCT05329220|525252838|FG003|Follow-up Period|Death|1|||
145654846|NCT05329220|525252839|FG004|Follow-up Period|Death|0|||
145654847|NCT05329220|525252840|FG005|Follow-up Period|Death|1|||
145654848|NCT05329220|525252835|FG000|Follow-up Period|Lost to Follow-up|0|||
145654849|NCT05329220|525252836|FG001|Follow-up Period|Lost to Follow-up|1|||
145654850|NCT05329220|525252837|FG002|Follow-up Period|Lost to Follow-up|2|||
145654851|NCT05329220|525252838|FG003|Follow-up Period|Lost to Follow-up|2|||
145654852|NCT05329220|525252839|FG004|Follow-up Period|Lost to Follow-up|113|||
145654853|NCT05329220|525252840|FG005|Follow-up Period|Lost to Follow-up|89|||
145654854|NCT05329220|525252835|FG000|Follow-up Period|Physician Decision|0|||
145654855|NCT05329220|525252836|FG001|Follow-up Period|Physician Decision|0|||
145654856|NCT05329220|525252837|FG002|Follow-up Period|Physician Decision|0|||
145654857|NCT05329220|525252838|FG003|Follow-up Period|Physician Decision|0|||
145654858|NCT05329220|525252839|FG004|Follow-up Period|Physician Decision|2|||
145654859|NCT05329220|525252840|FG005|Follow-up Period|Physician Decision|2|||
145654860|NCT05329220|525252835|FG000|Follow-up Period|Protocol Violation|0|||
145654861|NCT05329220|525252836|FG001|Follow-up Period|Protocol Violation|0|||
145654862|NCT05329220|525252837|FG002|Follow-up Period|Protocol Violation|0|||
145654863|NCT05329220|525252838|FG003|Follow-up Period|Protocol Violation|0|||
145654864|NCT05329220|525252839|FG004|Follow-up Period|Protocol Violation|0|||
145654865|NCT05329220|525252840|FG005|Follow-up Period|Protocol Violation|1|||
145654866|NCT05329220|525252835|FG000|Follow-up Period|Withdrawal by Subject|0|||
145654867|NCT05329220|525252836|FG001|Follow-up Period|Withdrawal by Subject|0|||
145654868|NCT05329220|525252837|FG002|Follow-up Period|Withdrawal by Subject|1|||
145654869|NCT05329220|525252838|FG003|Follow-up Period|Withdrawal by Subject|1|||
145654870|NCT05329220|525252839|FG004|Follow-up Period|Withdrawal by Subject|34|||
145654871|NCT05329220|525252840|FG005|Follow-up Period|Withdrawal by Subject|35|||
145654872|NCT05329220|525252835|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145654873|NCT05329220|525252836|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145654874|NCT05329220|525252837|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
145654875|NCT05329220|525252838|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145654876|NCT05329220|525252839|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145654877|NCT05329220|525252840|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
145654878|NCT05329220|525252835|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
145654879|NCT05329220|525252836|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
145654880|NCT05329220|525252837|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
145654881|NCT05329220|525252838|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
145654882|NCT05329220|525252839|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
145654883|NCT05329220|525252840|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
145654884|NCT05329220|525252835|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
145654885|NCT05329220|525252836|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
145654886|NCT05329220|525252837|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
145654887|NCT05329220|525252838|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
145654888|NCT05329220|525252839|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
145654889|NCT05329220|525252840|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
145654890|NCT05329220|525252835|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
145654891|NCT05329220|525252836|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
145654892|NCT05329220|525252837|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
145654893|NCT05329220|525252838|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
145654894|NCT05329220|525252839|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
145654895|NCT05329220|525252840|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
145654896|NCT05329220|525252835|FG000|Follow-up Period|EARLY TERMINATION|0|||
145654897|NCT05329220|525252836|FG001|Follow-up Period|EARLY TERMINATION|0|||
145654898|NCT05329220|525252837|FG002|Follow-up Period|EARLY TERMINATION|0|||
145654899|NCT05329220|525252838|FG003|Follow-up Period|EARLY TERMINATION|0|||
145654900|NCT05329220|525252839|FG004|Follow-up Period|EARLY TERMINATION|0|||
145654901|NCT05329220|525252840|FG005|Follow-up Period|EARLY TERMINATION|1|||
145654902|NCT05329220|525252835|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
145654903|NCT05329220|525252836|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
145654904|NCT05329220|525252837|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
145654905|NCT05329220|525252838|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
145654906|NCT05329220|525252839|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
145654907|NCT05329220|525252840|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
145654908|NCT05329220|525252835|FG000|Follow-up Period|DROPPED|0|||
145654909|NCT05329220|525252836|FG001|Follow-up Period|DROPPED|0|||
145654910|NCT05329220|525252837|FG002|Follow-up Period|DROPPED|0|||
145654911|NCT05329220|525252838|FG003|Follow-up Period|DROPPED|0|||
145654912|NCT05329220|525252839|FG004|Follow-up Period|DROPPED|0|||
145654913|NCT05329220|525252840|FG005|Follow-up Period|DROPPED|1|||
145654914|NCT05329220|525252835|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
145654915|NCT05329220|525252836|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
145654916|NCT05329220|525252837|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
145654917|NCT05329220|525252838|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
145654918|NCT05329220|525252839|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
145654919|NCT05329220|525252840|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
145654920|NCT02465268|525252842|FG000|Overall Study|Withdrawal by Subject|4|||
145654921|NCT02465268|525252843|FG001|Overall Study|Withdrawal by Subject|3|||
145654922|NCT02465268|525252844|FG002|Overall Study|Withdrawal by Subject|1|||
145654923|NCT02465268|525252842|FG000|Overall Study|Not evaluable per protocol criteria|3|||
145654924|NCT02465268|525252843|FG001|Overall Study|Not evaluable per protocol criteria|2|||
145654925|NCT02465268|525252844|FG002|Overall Study|Not evaluable per protocol criteria|1|||
145654926|NCT02465268|525252842|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
145654927|NCT02465268|525252843|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
145654928|NCT02465268|525252844|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
145654929|NCT02465268|525252842|FG000|Overall Study|Study drug did not pass QA/QC|1|||
145654930|NCT02465268|525252843|FG001|Overall Study|Study drug did not pass QA/QC|0|||
145654931|NCT02465268|525252844|FG002|Overall Study|Study drug did not pass QA/QC|0|||
145654932|NCT02465268|525252842|FG000|Overall Study|Adverse Event|0|||
145654933|NCT02465268|525252843|FG001|Overall Study|Adverse Event|1|||
145654934|NCT02465268|525252844|FG002|Overall Study|Adverse Event|0|||
145654935|NCT02465268|525252842|FG000|Overall Study|Physician Decision|0|||
145654936|NCT02465268|525252843|FG001|Overall Study|Physician Decision|1|||
145654937|NCT02465268|525252844|FG002|Overall Study|Physician Decision|0|||
145654938|NCT04029688|525255149|FG000|Overall Study|Death|8|||
145654939|NCT04029688|525255150|FG001|Overall Study|Death|3|||
145654940|NCT04029688|525255151|FG002|Overall Study|Death|6|||
145654941|NCT04029688|525255152|FG003|Overall Study|Death|2|||
145654942|NCT04029688|525255153|FG004|Overall Study|Death|5|||
145654943|NCT04029688|525255154|FG005|Overall Study|Death|0|||
145654944|NCT04029688|525255155|FG006|Overall Study|Death|2|||
145654945|NCT04029688|525255156|FG007|Overall Study|Death|3|||
145654946|NCT04029688|525255149|FG000|Overall Study|Study Terminated by Sponsor|0|||
145654947|NCT04029688|525255150|FG001|Overall Study|Study Terminated by Sponsor|0|||
145654948|NCT04029688|525255151|FG002|Overall Study|Study Terminated by Sponsor|0|||
145654949|NCT04029688|525255152|FG003|Overall Study|Study Terminated by Sponsor|0|||
145654950|NCT04029688|525255153|FG004|Overall Study|Study Terminated by Sponsor|1|||
145654951|NCT04029688|525255154|FG005|Overall Study|Study Terminated by Sponsor|3|||
145654952|NCT04029688|525255155|FG006|Overall Study|Study Terminated by Sponsor|1|||
145654953|NCT04029688|525255156|FG007|Overall Study|Study Terminated by Sponsor|3|||
145654954|NCT04029688|525255149|FG000|Overall Study|Withdrawal by Subject|0|||
145654955|NCT04029688|525255150|FG001|Overall Study|Withdrawal by Subject|0|||
145654956|NCT04029688|525255151|FG002|Overall Study|Withdrawal by Subject|0|||
145654957|NCT04029688|525255152|FG003|Overall Study|Withdrawal by Subject|1|||
145654958|NCT04029688|525255153|FG004|Overall Study|Withdrawal by Subject|0|||
145654959|NCT04029688|525255154|FG005|Overall Study|Withdrawal by Subject|0|||
145654960|NCT04029688|525255155|FG006|Overall Study|Withdrawal by Subject|0|||
145654961|NCT04029688|525255156|FG007|Overall Study|Withdrawal by Subject|0|||
145654962|NCT04130438|525255157|FG000|Overall Study|Lost to Follow-up|0|||
145654963|NCT04130438|525255158|FG001|Overall Study|Lost to Follow-up|0|||
145654964|NCT04130438|525255159|FG002|Overall Study|Lost to Follow-up|1|||
145654965|NCT03953508|525255161|FG000|Baseline|Lost to Follow-up|3|||
145654966|NCT03953508|525255162|FG001|Baseline|Lost to Follow-up|2|||
145654967|NCT03953508|525255161|FG000|6-month Follow-up|Lost to Follow-up|62|||
145654968|NCT03953508|525255162|FG001|6-month Follow-up|Lost to Follow-up|70|||
145654969|NCT03771417|525255163|FG000|Overall Study|Withdrawal by Subject|1|||
145654970|NCT03771417|525255164|FG001|Overall Study|Withdrawal by Subject|0|||
145654971|NCT03771417|525255165|FG002|Overall Study|Withdrawal by Subject|0|||
145654972|NCT03771417|525255163|FG000|Overall Study|Covid-19 Shutdown|0|||
145654973|NCT03771417|525255164|FG001|Overall Study|Covid-19 Shutdown|1|||
145654974|NCT03771417|525255165|FG002|Overall Study|Covid-19 Shutdown|0|||
145654975|NCT03575897|525255166|FG000|Overall Study|Lost to Follow-up|12|||
145654976|NCT03575897|525255167|FG001|Overall Study|Lost to Follow-up|13|||
145654977|NCT05835336|525255172|FG000|Overall Study|Withdrawal by Subject|5|||
145654978|NCT05835336|525255172|FG000|Overall Study|Did not complete the personalization process|3|||
145654979|NCT04489771|525255173|FG000|Overall Study|Death|27|||
145654980|NCT04489771|525255174|FG001|Overall Study|Death|25|||
145654981|NCT04489771|525255173|FG000|Overall Study|Withdrawal by Subject|1|||
145654982|NCT04489771|525255174|FG001|Overall Study|Withdrawal by Subject|0|||
145654983|NCT04489771|525255173|FG000|Overall Study|Participants Ongoing in Study|50|||
145654984|NCT04489771|525255174|FG001|Overall Study|Participants Ongoing in Study|51|||
145654985|NCT04509674|525255175|FG000|Overall Study|Not treated|33|||
145654986|NCT04509674|525255176|FG001|Overall Study|Not treated|26|||
145654987|NCT04509674|525255175|FG000|Overall Study|Protocol Violation|9|||
145654988|NCT04509674|525255176|FG001|Overall Study|Protocol Violation|10|||
145654989|NCT04509674|525255175|FG000|Overall Study|Lost to Follow-up|31|||
145654990|NCT04509674|525255176|FG001|Overall Study|Lost to Follow-up|39|||
145654991|NCT04509674|525255175|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
145654992|NCT04509674|525255176|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
145654993|NCT04509674|525255175|FG000|Overall Study|Adverse event, serious fatal event|11|||
145654994|NCT04509674|525255176|FG001|Overall Study|Adverse event, serious fatal event|4|||
145654995|NCT04509674|525255175|FG000|Overall Study|Adverse event, non-fatal event|107|||
145654996|NCT04509674|525255176|FG001|Overall Study|Adverse event, non-fatal event|118|||
145654997|NCT04509674|525255175|FG000|Overall Study|Other reason than listed|106|||
145654998|NCT04509674|525255176|FG001|Overall Study|Other reason than listed|95|||
145654999|NCT04064164|525255182|FG000|Overall Study|Withdrawal by Subject|8|||
145655000|NCT04064164|525255183|FG001|Overall Study|Withdrawal by Subject|8|||
145655001|NCT04059484|525255185|FG000|Overall Study|Adverse Event|2|||
145655002|NCT04059484|525255186|FG001|Overall Study|Adverse Event|5|||
145655003|NCT04059484|525255185|FG000|Overall Study|Withdrawal by Subject|5|||
145655004|NCT04059484|525255186|FG001|Overall Study|Withdrawal by Subject|3|||
145655005|NCT04059484|525255185|FG000|Overall Study|Progressive disease|112|||
145655006|NCT04059484|525255186|FG001|Overall Study|Progressive disease|112|||
145655007|NCT04059484|525255185|FG000|Overall Study|Other|8|||
145655008|NCT04059484|525255186|FG001|Overall Study|Other|3|||
145655009|NCT04059484|525255185|FG000|Overall Study|Ongoing|20|||
145655010|NCT04059484|525255186|FG001|Overall Study|Ongoing|20|||
145655011|NCT06190691|525255187|FG000|Overall Study|Adverse Event|2|||
145655012|NCT06190691|525255188|FG001|Overall Study|Adverse Event|0|||
145655013|NCT06190691|525255189|FG002|Overall Study|Adverse Event|0|||
145655014|NCT06190691|525255190|FG003|Overall Study|Adverse Event|0|||
145655015|NCT02023866|525255192|FG000|Overall Study|Non-compliance|2|||
145655016|NCT02023866|525255192|FG000|Overall Study|Adverse Event|3|||
145655017|NCT02023866|525255192|FG000|Overall Study|Withdrawal by Subject|1|||
145655018|NCT03839940|525255193|FG000|Overall Study|Withdrawal by Subject|3|||
145655019|NCT03839940|525255194|FG001|Overall Study|Withdrawal by Subject|0|||
145655020|NCT03839940|525255193|FG000|Overall Study|Protocol Violation|0|||
145655021|NCT03839940|525255194|FG001|Overall Study|Protocol Violation|1|||
145655022|NCT03839940|525255193|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
145655023|NCT03839940|525255194|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
145655024|NCT03241745|525255195|FG000|Overall Study|Adverse Event|7|||
145655025|NCT03241745|525255195|FG000|Overall Study|Death|1|||
145655026|NCT03241745|525255195|FG000|Overall Study|Withdrawal by Subject|5|||
145655027|NCT03241745|525255195|FG000|Overall Study|Treatment delay >28 days|2|||
145655028|NCT03241745|525255195|FG000|Overall Study|Lack of Efficacy|14|||
145655029|NCT04019873|525255197|FG000|Overall Study|Discontinued from the treatment|1|||
145655030|NCT04019873|525255198|FG001|Overall Study|Discontinued from the treatment|39|||
145655031|NCT04019873|525255199|FG002|Overall Study|Discontinued from the treatment|2|||
145655032|NCT04683744|525255200|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
145655033|NCT04683744|525255201|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
145655034|NCT04683744|525255202|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
145655035|NCT04316871|525255204|FG000|Overall Study|Protocol Violation|2|||
145655036|NCT04316871|525255205|FG001|Overall Study|Protocol Violation|2|||
145655037|NCT04316871|525255206|FG002|Overall Study|Protocol Violation|2|||
145655038|NCT04316871|525255207|FG003|Overall Study|Protocol Violation|2|||
145655039|NCT04650269|525255208|FG000|Overall Study|Death|3|||
145655040|NCT04650269|525255208|FG000|Overall Study|Lost to Follow-up|6|||
145655041|NCT01437709|525255209|FG000|Overall Study|Adverse Event|0|||
145655042|NCT01437709|525255210|FG001|Overall Study|Adverse Event|1|||
145655043|NCT01437709|525255211|FG002|Overall Study|Adverse Event|0|||
145655044|NCT01437709|525255209|FG000|Overall Study|Pt trasnferred care|0|||
145655045|NCT01437709|525255210|FG001|Overall Study|Pt trasnferred care|1|||
145655046|NCT01437709|525255211|FG002|Overall Study|Pt trasnferred care|0|||
145655047|NCT04091750|525255212|FG000|Overall Study|Adverse Event|4|||
145655048|NCT04091750|525255212|FG000|Overall Study|Withdrawal by Subject|1|||
145655049|NCT01842542|525255213|FG000|Overall Study|Withdrawal by Subject|2|||
145655050|NCT01842542|525255213|FG000|Overall Study|Lack of Efficacy|1|||
145655051|NCT01842542|525255213|FG000|Overall Study|Protocol Non-compliance|2|||
145655052|NCT01842542|525255213|FG000|Overall Study|Lost to Follow-up|1|||
145655053|NCT02919306|525255214|FG000|Overall Study|Withdrawal by Subject|1|||
145655054|NCT02919306|525255215|FG001|Overall Study|Withdrawal by Subject|0|||
145655055|NCT02919306|525255214|FG000|Overall Study|Protocol Violation|1|||
145655056|NCT02919306|525255215|FG001|Overall Study|Protocol Violation|0|||
145655057|NCT04473222|525255216|FG000|Overall Study|Lost to Follow-up|13|||
145655058|NCT04473222|525255217|FG001|Overall Study|Lost to Follow-up|13|||
145655059|NCT04473222|525255216|FG000|Overall Study|Withdrawal by Subject|0|||
145655060|NCT04473222|525255217|FG001|Overall Study|Withdrawal by Subject|1|||
145655061|NCT04473222|525255216|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
145655062|NCT04473222|525255217|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
145655063|NCT04293055|525255218|FG000|Overall Study|Lost to Follow-up|1|||
145655064|NCT04293055|525255219|FG001|Overall Study|Lost to Follow-up|1|||
145655065|NCT04293055|525255218|FG000|Overall Study|Did not trigger randomization|6|||
145655066|NCT04293055|525255219|FG001|Overall Study|Did not trigger randomization|5|||
145655067|NCT03560609|525255220|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
145655068|NCT03560609|525255221|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
145655069|NCT04908722|525255230|FG000|Overall Study|Protocol deviation|1|||
145655070|NCT04908722|525255231|FG001|Overall Study|Protocol deviation|0|||
145655071|NCT04908722|525255232|FG002|Overall Study|Protocol deviation|0|||
145655072|NCT04908722|525255233|FG003|Overall Study|Protocol deviation|0|||
145655073|NCT04908722|525255234|FG004|Overall Study|Protocol deviation|0|||
145655074|NCT04908722|525255235|FG005|Overall Study|Protocol deviation|1|||
145655075|NCT04908722|525255230|FG000|Overall Study|Lost to Follow-up|33|||
145655076|NCT04908722|525255231|FG001|Overall Study|Lost to Follow-up|33|||
145655077|NCT04908722|525255232|FG002|Overall Study|Lost to Follow-up|36|||
145655078|NCT04908722|525255233|FG003|Overall Study|Lost to Follow-up|30|||
145655079|NCT04908722|525255234|FG004|Overall Study|Lost to Follow-up|32|||
145655080|NCT04908722|525255235|FG005|Overall Study|Lost to Follow-up|34|||
145655081|NCT04908722|525255230|FG000|Overall Study|Physician Decision|1|||
145655082|NCT04908722|525255231|FG001|Overall Study|Physician Decision|1|||
145655083|NCT04908722|525255232|FG002|Overall Study|Physician Decision|1|||
145655084|NCT04908722|525255233|FG003|Overall Study|Physician Decision|2|||
145655085|NCT04908722|525255234|FG004|Overall Study|Physician Decision|0|||
145655086|NCT04908722|525255235|FG005|Overall Study|Physician Decision|0|||
145655087|NCT04908722|525255230|FG000|Overall Study|Death|1|||
145655088|NCT04908722|525255231|FG001|Overall Study|Death|0|||
145655089|NCT04908722|525255232|FG002|Overall Study|Death|0|||
145655090|NCT04908722|525255233|FG003|Overall Study|Death|0|||
145655091|NCT04908722|525255234|FG004|Overall Study|Death|0|||
145655092|NCT04908722|525255235|FG005|Overall Study|Death|1|||
145655093|NCT04908722|525255230|FG000|Overall Study|Withdrawal by Subject|12|||
145655094|NCT04908722|525255231|FG001|Overall Study|Withdrawal by Subject|8|||
145655095|NCT04908722|525255232|FG002|Overall Study|Withdrawal by Subject|7|||
145655096|NCT04908722|525255233|FG003|Overall Study|Withdrawal by Subject|6|||
145655097|NCT04908722|525255234|FG004|Overall Study|Withdrawal by Subject|12|||
145655098|NCT04908722|525255235|FG005|Overall Study|Withdrawal by Subject|14|||
145655099|NCT04908722|525255230|FG000|Overall Study|Other|3|||
145655100|NCT04908722|525255231|FG001|Overall Study|Other|1|||
145655101|NCT04908722|525255232|FG002|Overall Study|Other|3|||
145655102|NCT04908722|525255233|FG003|Overall Study|Other|2|||
145655103|NCT04908722|525255234|FG004|Overall Study|Other|4|||
145655104|NCT04908722|525255235|FG005|Overall Study|Other|1|||
145655105|NCT04908722|525255230|FG000|Overall Study|Initiated prohibited medication|0|||
145655106|NCT04908722|525255231|FG001|Overall Study|Initiated prohibited medication|0|||
145655107|NCT04908722|525255232|FG002|Overall Study|Initiated prohibited medication|0|||
145655108|NCT04908722|525255233|FG003|Overall Study|Initiated prohibited medication|1|||
145655109|NCT04908722|525255234|FG004|Overall Study|Initiated prohibited medication|0|||
145655110|NCT04908722|525255235|FG005|Overall Study|Initiated prohibited medication|1|||
145655111|NCT04908722|525255230|FG000|Overall Study|Randomized but not vaccinated|3|||
145655112|NCT04908722|525255231|FG001|Overall Study|Randomized but not vaccinated|1|||
145655113|NCT04908722|525255232|FG002|Overall Study|Randomized but not vaccinated|2|||
145655114|NCT04908722|525255233|FG003|Overall Study|Randomized but not vaccinated|2|||
145655115|NCT04908722|525255234|FG004|Overall Study|Randomized but not vaccinated|3|||
145655116|NCT04908722|525255235|FG005|Overall Study|Randomized but not vaccinated|4|||
145655117|NCT02573493|525255238|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
145655118|NCT02573493|525255239|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
145655119|NCT02573493|525255240|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
145655120|NCT02573493|525255241|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
145655121|NCT04111536|525255242|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
145655122|NCT04111536|525255243|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145655123|NCT04111536|525255242|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
145655124|NCT04111536|525255243|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
145655125|NCT04111536|525255242|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
145655126|NCT04111536|525255243|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
145655127|NCT04111536|525255242|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
145655128|NCT04111536|525255243|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
145655129|NCT05647304|525255244|FG000|Overall Study|Withdrawal by Subject|1|||
145655130|NCT05647304|525255245|FG001|Overall Study|Withdrawal by Subject|0|||
145655131|NCT04171999|525255246|FG000|Overall Study|deemed ineligible after randomization|2|||
145655132|NCT04171999|525255247|FG001|Overall Study|deemed ineligible after randomization|1|||
145655133|NCT03544281|525255248|FG000|Main Study Phase|Death|3|||
145655134|NCT03544281|525255249|FG001|Main Study Phase|Death|2|||
145655135|NCT03544281|525255250|FG002|Main Study Phase|Death|6|||
145655136|NCT03544281|525255251|FG003|Main Study Phase|Death|8|||
145655137|NCT03544281|525255252|FG004|Main Study Phase|Death|4|||
145655138|NCT03544281|525255253|FG005|Main Study Phase|Death|2|||
145655139|NCT03544281|525255254|FG006|Main Study Phase|Death|4|||
145655140|NCT03544281|525255255|FG007|Main Study Phase|Death|5|||
145655141|NCT03544281|525255256|FG008|Main Study Phase|Death|5|||
145655142|NCT03544281|525255257|FG009|Main Study Phase|Death|8|||
145655143|NCT03544281|525255258|FG010|Main Study Phase|Death|6|||
145655144|NCT03544281|525255259|FG011|Main Study Phase|Death|4|||
145655145|NCT03544281|525255260|FG012|Main Study Phase|Death|0|||
145655146|NCT03544281|525255261|FG013|Main Study Phase|Death|0|||
145655147|NCT03544281|525255262|FG014|Main Study Phase|Death|0|||
145655148|NCT03544281|525255263|FG015|Main Study Phase|Death|0|||
145655149|NCT03544281|525255264|FG016|Main Study Phase|Death|0|||
145655150|NCT03544281|525255265|FG017|Main Study Phase|Death|0|||
145655151|NCT03544281|525255266|FG018|Main Study Phase|Death|0|||
145655152|NCT03544281|525255267|FG019|Main Study Phase|Death|0|||
145655153|NCT03544281|525255268|FG020|Main Study Phase|Death|0|||
145655154|NCT03544281|525255269|FG021|Main Study Phase|Death|0|||
145655155|NCT03544281|525255248|FG000|Main Study Phase|Lost to Follow-up|0|||
145655156|NCT03544281|525255249|FG001|Main Study Phase|Lost to Follow-up|0|||
145655157|NCT03544281|525255250|FG002|Main Study Phase|Lost to Follow-up|0|||
145655158|NCT03544281|525255251|FG003|Main Study Phase|Lost to Follow-up|0|||
145655159|NCT03544281|525255252|FG004|Main Study Phase|Lost to Follow-up|0|||
145655160|NCT03544281|525255253|FG005|Main Study Phase|Lost to Follow-up|0|||
145655161|NCT03544281|525255254|FG006|Main Study Phase|Lost to Follow-up|0|||
145655162|NCT03544281|525255255|FG007|Main Study Phase|Lost to Follow-up|0|||
145655163|NCT03544281|525255256|FG008|Main Study Phase|Lost to Follow-up|0|||
145655164|NCT03544281|525255257|FG009|Main Study Phase|Lost to Follow-up|0|||
145655165|NCT03544281|525255258|FG010|Main Study Phase|Lost to Follow-up|1|||
145655166|NCT03544281|525255259|FG011|Main Study Phase|Lost to Follow-up|0|||
145655167|NCT03544281|525255260|FG012|Main Study Phase|Lost to Follow-up|0|||
145655168|NCT03544281|525255261|FG013|Main Study Phase|Lost to Follow-up|0|||
145655169|NCT03544281|525255262|FG014|Main Study Phase|Lost to Follow-up|0|||
145655170|NCT03544281|525255263|FG015|Main Study Phase|Lost to Follow-up|0|||
145655171|NCT03544281|525255264|FG016|Main Study Phase|Lost to Follow-up|0|||
145655172|NCT03544281|525255265|FG017|Main Study Phase|Lost to Follow-up|0|||
145655173|NCT03544281|525255266|FG018|Main Study Phase|Lost to Follow-up|0|||
145655174|NCT03544281|525255267|FG019|Main Study Phase|Lost to Follow-up|0|||
145655175|NCT03544281|525255268|FG020|Main Study Phase|Lost to Follow-up|0|||
145655176|NCT03544281|525255269|FG021|Main Study Phase|Lost to Follow-up|0|||
145655177|NCT03544281|525255248|FG000|Main Study Phase|Physician Decision|0|||
145655178|NCT03544281|525255249|FG001|Main Study Phase|Physician Decision|0|||
145655179|NCT03544281|525255250|FG002|Main Study Phase|Physician Decision|0|||
145655180|NCT03544281|525255251|FG003|Main Study Phase|Physician Decision|0|||
145655181|NCT03544281|525255252|FG004|Main Study Phase|Physician Decision|0|||
145655182|NCT03544281|525255253|FG005|Main Study Phase|Physician Decision|0|||
145655183|NCT03544281|525255254|FG006|Main Study Phase|Physician Decision|0|||
145655184|NCT03544281|525255255|FG007|Main Study Phase|Physician Decision|1|||
145655185|NCT03544281|525255256|FG008|Main Study Phase|Physician Decision|0|||
145655186|NCT03544281|525255257|FG009|Main Study Phase|Physician Decision|0|||
145655187|NCT03544281|525255258|FG010|Main Study Phase|Physician Decision|0|||
145655188|NCT03544281|525255259|FG011|Main Study Phase|Physician Decision|0|||
145655189|NCT03544281|525255260|FG012|Main Study Phase|Physician Decision|0|||
145655190|NCT03544281|525255261|FG013|Main Study Phase|Physician Decision|0|||
145655191|NCT03544281|525255262|FG014|Main Study Phase|Physician Decision|0|||
145655192|NCT03544281|525255263|FG015|Main Study Phase|Physician Decision|0|||
145655193|NCT03544281|525255264|FG016|Main Study Phase|Physician Decision|0|||
145655194|NCT03544281|525255265|FG017|Main Study Phase|Physician Decision|0|||
145655195|NCT03544281|525255266|FG018|Main Study Phase|Physician Decision|0|||
145655196|NCT03544281|525255267|FG019|Main Study Phase|Physician Decision|0|||
145655197|NCT03544281|525255268|FG020|Main Study Phase|Physician Decision|0|||
145655198|NCT03544281|525255269|FG021|Main Study Phase|Physician Decision|0|||
145655199|NCT03544281|525255248|FG000|Main Study Phase|Withdrawal by Subject|2|||
145655200|NCT03544281|525255249|FG001|Main Study Phase|Withdrawal by Subject|0|||
145655201|NCT03544281|525255250|FG002|Main Study Phase|Withdrawal by Subject|1|||
145655202|NCT03544281|525255251|FG003|Main Study Phase|Withdrawal by Subject|2|||
145655203|NCT03544281|525255252|FG004|Main Study Phase|Withdrawal by Subject|0|||
145655204|NCT03544281|525255253|FG005|Main Study Phase|Withdrawal by Subject|0|||
145655205|NCT03544281|525255254|FG006|Main Study Phase|Withdrawal by Subject|0|||
145655206|NCT03544281|525255255|FG007|Main Study Phase|Withdrawal by Subject|0|||
145655207|NCT03544281|525255256|FG008|Main Study Phase|Withdrawal by Subject|2|||
145655208|NCT03544281|525255257|FG009|Main Study Phase|Withdrawal by Subject|3|||
145655209|NCT03544281|525255258|FG010|Main Study Phase|Withdrawal by Subject|0|||
145655210|NCT03544281|525255259|FG011|Main Study Phase|Withdrawal by Subject|4|||
145655211|NCT03544281|525255260|FG012|Main Study Phase|Withdrawal by Subject|0|||
145655212|NCT03544281|525255261|FG013|Main Study Phase|Withdrawal by Subject|0|||
145655213|NCT03544281|525255262|FG014|Main Study Phase|Withdrawal by Subject|0|||
145655214|NCT03544281|525255263|FG015|Main Study Phase|Withdrawal by Subject|0|||
145655215|NCT03544281|525255264|FG016|Main Study Phase|Withdrawal by Subject|0|||
145655216|NCT03544281|525255265|FG017|Main Study Phase|Withdrawal by Subject|0|||
145655217|NCT03544281|525255266|FG018|Main Study Phase|Withdrawal by Subject|0|||
145655218|NCT03544281|525255267|FG019|Main Study Phase|Withdrawal by Subject|0|||
145655219|NCT03544281|525255268|FG020|Main Study Phase|Withdrawal by Subject|0|||
145655220|NCT03544281|525255269|FG021|Main Study Phase|Withdrawal by Subject|0|||
145655221|NCT03544281|525255248|FG000|Main Study Phase|Ongoing|3|||
145655222|NCT03544281|525255249|FG001|Main Study Phase|Ongoing|1|||
145655223|NCT03544281|525255250|FG002|Main Study Phase|Ongoing|2|||
145655224|NCT03544281|525255251|FG003|Main Study Phase|Ongoing|4|||
145655225|NCT03544281|525255252|FG004|Main Study Phase|Ongoing|2|||
145655226|NCT03544281|525255253|FG005|Main Study Phase|Ongoing|4|||
145655227|NCT03544281|525255254|FG006|Main Study Phase|Ongoing|4|||
145655228|NCT03544281|525255255|FG007|Main Study Phase|Ongoing|0|||
145655229|NCT03544281|525255256|FG008|Main Study Phase|Ongoing|2|||
145655230|NCT03544281|525255257|FG009|Main Study Phase|Ongoing|2|||
145655231|NCT03544281|525255258|FG010|Main Study Phase|Ongoing|1|||
145655232|NCT03544281|525255259|FG011|Main Study Phase|Ongoing|0|||
145655233|NCT03544281|525255260|FG012|Main Study Phase|Ongoing|0|||
145655234|NCT03544281|525255261|FG013|Main Study Phase|Ongoing|0|||
145655235|NCT03544281|525255262|FG014|Main Study Phase|Ongoing|0|||
145655236|NCT03544281|525255263|FG015|Main Study Phase|Ongoing|0|||
145655237|NCT03544281|525255264|FG016|Main Study Phase|Ongoing|0|||
145655238|NCT03544281|525255265|FG017|Main Study Phase|Ongoing|0|||
145655239|NCT03544281|525255266|FG018|Main Study Phase|Ongoing|0|||
145655240|NCT03544281|525255267|FG019|Main Study Phase|Ongoing|0|||
145655241|NCT03544281|525255268|FG020|Main Study Phase|Ongoing|0|||
145655242|NCT03544281|525255269|FG021|Main Study Phase|Ongoing|0|||
145655243|NCT03544281|525255248|FG000|Main Study Phase|Investigator Site Closed|0|||
145655244|NCT03544281|525255249|FG001|Main Study Phase|Investigator Site Closed|0|||
145655245|NCT03544281|525255250|FG002|Main Study Phase|Investigator Site Closed|0|||
145655246|NCT03544281|525255251|FG003|Main Study Phase|Investigator Site Closed|0|||
145655247|NCT03544281|525255252|FG004|Main Study Phase|Investigator Site Closed|0|||
145655248|NCT03544281|525255253|FG005|Main Study Phase|Investigator Site Closed|0|||
145655249|NCT03544281|525255254|FG006|Main Study Phase|Investigator Site Closed|0|||
145655250|NCT03544281|525255255|FG007|Main Study Phase|Investigator Site Closed|0|||
145655251|NCT03544281|525255256|FG008|Main Study Phase|Investigator Site Closed|0|||
145655252|NCT03544281|525255257|FG009|Main Study Phase|Investigator Site Closed|1|||
145655253|NCT03544281|525255258|FG010|Main Study Phase|Investigator Site Closed|0|||
145655254|NCT03544281|525255259|FG011|Main Study Phase|Investigator Site Closed|0|||
145655255|NCT03544281|525255260|FG012|Main Study Phase|Investigator Site Closed|0|||
145655256|NCT03544281|525255261|FG013|Main Study Phase|Investigator Site Closed|0|||
145655257|NCT03544281|525255262|FG014|Main Study Phase|Investigator Site Closed|0|||
145655258|NCT03544281|525255263|FG015|Main Study Phase|Investigator Site Closed|0|||
145655259|NCT03544281|525255264|FG016|Main Study Phase|Investigator Site Closed|0|||
145655260|NCT03544281|525255265|FG017|Main Study Phase|Investigator Site Closed|0|||
145655261|NCT03544281|525255266|FG018|Main Study Phase|Investigator Site Closed|0|||
145655262|NCT03544281|525255267|FG019|Main Study Phase|Investigator Site Closed|0|||
145655263|NCT03544281|525255268|FG020|Main Study Phase|Investigator Site Closed|0|||
145655264|NCT03544281|525255269|FG021|Main Study Phase|Investigator Site Closed|0|||
145655265|NCT03544281|525255248|FG000|Main Study Phase|Did not receive study treatment|0|||
145655266|NCT03544281|525255249|FG001|Main Study Phase|Did not receive study treatment|0|||
145655267|NCT03544281|525255250|FG002|Main Study Phase|Did not receive study treatment|0|||
145655268|NCT03544281|525255251|FG003|Main Study Phase|Did not receive study treatment|0|||
145655269|NCT03544281|525255252|FG004|Main Study Phase|Did not receive study treatment|0|||
145655270|NCT03544281|525255253|FG005|Main Study Phase|Did not receive study treatment|0|||
145655271|NCT03544281|525255254|FG006|Main Study Phase|Did not receive study treatment|1|||
145655272|NCT03544281|525255255|FG007|Main Study Phase|Did not receive study treatment|0|||
145655273|NCT03544281|525255256|FG008|Main Study Phase|Did not receive study treatment|0|||
145655274|NCT03544281|525255257|FG009|Main Study Phase|Did not receive study treatment|0|||
145655275|NCT03544281|525255258|FG010|Main Study Phase|Did not receive study treatment|0|||
145655276|NCT03544281|525255259|FG011|Main Study Phase|Did not receive study treatment|0|||
145655277|NCT03544281|525255260|FG012|Main Study Phase|Did not receive study treatment|0|||
145655278|NCT03544281|525255261|FG013|Main Study Phase|Did not receive study treatment|0|||
145655279|NCT03544281|525255262|FG014|Main Study Phase|Did not receive study treatment|0|||
145655280|NCT03544281|525255263|FG015|Main Study Phase|Did not receive study treatment|0|||
145655281|NCT03544281|525255264|FG016|Main Study Phase|Did not receive study treatment|0|||
145655282|NCT03544281|525255265|FG017|Main Study Phase|Did not receive study treatment|0|||
145655283|NCT03544281|525255266|FG018|Main Study Phase|Did not receive study treatment|0|||
145655284|NCT03544281|525255267|FG019|Main Study Phase|Did not receive study treatment|0|||
145655285|NCT03544281|525255268|FG020|Main Study Phase|Did not receive study treatment|0|||
145655286|NCT03544281|525255269|FG021|Main Study Phase|Did not receive study treatment|0|||
145655287|NCT03544281|525255248|FG000|PACT Phase|Adverse Event|0|||
145655288|NCT03544281|525255249|FG001|PACT Phase|Adverse Event|0|||
145655289|NCT03544281|525255250|FG002|PACT Phase|Adverse Event|0|||
145655290|NCT03544281|525255251|FG003|PACT Phase|Adverse Event|0|||
145655291|NCT03544281|525255252|FG004|PACT Phase|Adverse Event|0|||
145655292|NCT03544281|525255253|FG005|PACT Phase|Adverse Event|0|||
145655293|NCT03544281|525255254|FG006|PACT Phase|Adverse Event|0|||
145655294|NCT03544281|525255255|FG007|PACT Phase|Adverse Event|0|||
145655295|NCT03544281|525255256|FG008|PACT Phase|Adverse Event|0|||
145655296|NCT03544281|525255257|FG009|PACT Phase|Adverse Event|0|||
145655297|NCT03544281|525255258|FG010|PACT Phase|Adverse Event|0|||
145655298|NCT03544281|525255259|FG011|PACT Phase|Adverse Event|0|||
145655299|NCT03544281|525255260|FG012|PACT Phase|Adverse Event|1|||
145655300|NCT03544281|525255261|FG013|PACT Phase|Adverse Event|0|||
145655301|NCT03544281|525255262|FG014|PACT Phase|Adverse Event|0|||
145655302|NCT03544281|525255263|FG015|PACT Phase|Adverse Event|0|||
145655303|NCT03544281|525255264|FG016|PACT Phase|Adverse Event|0|||
145655304|NCT03544281|525255265|FG017|PACT Phase|Adverse Event|1|||
145655305|NCT03544281|525255266|FG018|PACT Phase|Adverse Event|1|||
145655306|NCT03544281|525255267|FG019|PACT Phase|Adverse Event|0|||
145655307|NCT03544281|525255268|FG020|PACT Phase|Adverse Event|0|||
145655308|NCT03544281|525255269|FG021|PACT Phase|Adverse Event|0|||
145655309|NCT04282148|525255272|FG000|Overall Study|Death|7|||
145655310|NCT04282148|525255272|FG000|Overall Study|Withdrawal by Subject|1|||
145655311|NCT04282148|525255272|FG000|Overall Study|Physician Decision|1|||
145655312|NCT04938492|525255273|FG000|Overall Study|Lost to Follow-up|17|||
145655313|NCT04938492|525255274|FG001|Overall Study|Lost to Follow-up|18|||
145655314|NCT04623671|525255276|FG000|Overall Study|Adverse Event|0|||
145655315|NCT04623671|525255277|FG001|Overall Study|Adverse Event|1|||
145655316|NCT04623671|525255276|FG000|Overall Study|Lost to Follow-up|2|||
145655317|NCT04623671|525255277|FG001|Overall Study|Lost to Follow-up|1|||
145655318|NCT04623671|525255276|FG000|Overall Study|Death|5|||
145655319|NCT04623671|525255277|FG001|Overall Study|Death|5|||
145655320|NCT03448107|525255278|FG000|Overall Study|Lost to Follow-up|229|||
145655321|NCT03448107|525255279|FG001|Overall Study|Lost to Follow-up|258|||
145655322|NCT04025554|525255280|FG000|Overall Study|Adverse Event|3|||
145655323|NCT03115476|525255281|FG000|LP0084-1369|Death|1|||
145655324|NCT03115476|525255282|FG001|LP0084-1369|Death|0|||
145655325|NCT03115476|525255283|FG002|LP0084-1369|Death|2|||
145655326|NCT03115476|525255281|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
145655327|NCT03115476|525255282|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
145655328|NCT03115476|525255283|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
145655329|NCT05257486|525255287|FG000|Overall Study|Protocol Violation|3|||
145655330|NCT03865498|525255288|FG000|Overall Study|Lack of Efficacy|12|||
145655331|NCT03865498|525255289|FG001|Overall Study|Lack of Efficacy|11|||
145655332|NCT03865498|525255288|FG000|Overall Study|Lost to Follow-up|125|||
145655333|NCT03865498|525255289|FG001|Overall Study|Lost to Follow-up|133|||
145655334|NCT03865498|525255288|FG000|Overall Study|Withdrawal by Subject|2|||
145655335|NCT03865498|525255289|FG001|Overall Study|Withdrawal by Subject|4|||
145655336|NCT01648023|525255290|FG000|Overall Study|Screen Fail Post Randomization|1|||
145655337|NCT01648023|525255291|FG001|Overall Study|Screen Fail Post Randomization|2|||
145655338|NCT05296525|525255294|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
145655339|NCT05296525|525255295|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
145655340|NCT05296525|525255296|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
145655341|NCT05296525|525255297|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
145655342|NCT04307355|525255300|FG000|Overall Study|Non-Compliance|3|||
145655343|NCT04307355|525255301|FG001|Overall Study|Non-Compliance|3|||
145655344|NCT04307355|525255302|FG002|Overall Study|Non-Compliance|0|||
145655345|NCT04074759|525255303|FG000|Overall Study|Withdrawal by Subject|0|||
145655346|NCT04074759|525255304|FG001|Overall Study|Withdrawal by Subject|0|||
145655347|NCT04074759|525255305|FG002|Overall Study|Withdrawal by Subject|0|||
145655348|NCT04074759|525255306|FG003|Overall Study|Withdrawal by Subject|0|||
145655349|NCT04074759|525255307|FG004|Overall Study|Withdrawal by Subject|0|||
145655350|NCT04074759|525255308|FG005|Overall Study|Withdrawal by Subject|2|||
145655351|NCT04074759|525255309|FG006|Overall Study|Withdrawal by Subject|0|||
145655352|NCT04074759|525255310|FG007|Overall Study|Withdrawal by Subject|2|||
145655353|NCT04074759|525255311|FG008|Overall Study|Withdrawal by Subject|1|||
145655354|NCT04074759|525255312|FG009|Overall Study|Withdrawal by Subject|2|||
145655355|NCT04074759|525255313|FG010|Overall Study|Withdrawal by Subject|9|||
145655356|NCT04074759|525255314|FG011|Overall Study|Withdrawal by Subject|2|||
145655357|NCT04074759|525255315|FG012|Overall Study|Withdrawal by Subject|1|||
145655358|NCT04074759|525255316|FG013|Overall Study|Withdrawal by Subject|3|||
145655359|NCT04074759|525255317|FG014|Overall Study|Withdrawal by Subject|2|||
145655360|NCT04074759|525255318|FG015|Overall Study|Withdrawal by Subject|0|||
145655361|NCT04074759|525255319|FG016|Overall Study|Withdrawal by Subject|0|||
145655362|NCT04074759|525255320|FG017|Overall Study|Withdrawal by Subject|3|||
145655363|NCT04074759|525255321|FG018|Overall Study|Withdrawal by Subject|1|||
145655364|NCT04074759|525255303|FG000|Overall Study|Death|1|||
145655365|NCT04074759|525255304|FG001|Overall Study|Death|0|||
145655366|NCT04074759|525255305|FG002|Overall Study|Death|1|||
145655367|NCT04074759|525255306|FG003|Overall Study|Death|1|||
145655368|NCT04074759|525255307|FG004|Overall Study|Death|2|||
145655369|NCT04074759|525255308|FG005|Overall Study|Death|0|||
145655370|NCT04074759|525255309|FG006|Overall Study|Death|1|||
145655371|NCT04074759|525255310|FG007|Overall Study|Death|0|||
145655372|NCT04074759|525255311|FG008|Overall Study|Death|3|||
145655373|NCT04074759|525255312|FG009|Overall Study|Death|2|||
145655374|NCT04074759|525255313|FG010|Overall Study|Death|4|||
145655375|NCT04074759|525255314|FG011|Overall Study|Death|1|||
145655376|NCT04074759|525255315|FG012|Overall Study|Death|0|||
145655377|NCT04074759|525255316|FG013|Overall Study|Death|2|||
145655378|NCT04074759|525255317|FG014|Overall Study|Death|1|||
145655379|NCT04074759|525255318|FG015|Overall Study|Death|0|||
145655380|NCT04074759|525255319|FG016|Overall Study|Death|1|||
145655381|NCT04074759|525255320|FG017|Overall Study|Death|0|||
145655382|NCT04074759|525255321|FG018|Overall Study|Death|1|||
145655383|NCT04074759|525255303|FG000|Overall Study|Lost to Follow-up|0|||
145655384|NCT04074759|525255304|FG001|Overall Study|Lost to Follow-up|0|||
145655385|NCT04074759|525255305|FG002|Overall Study|Lost to Follow-up|0|||
145655386|NCT04074759|525255306|FG003|Overall Study|Lost to Follow-up|0|||
145655387|NCT04074759|525255307|FG004|Overall Study|Lost to Follow-up|0|||
145655388|NCT04074759|525255308|FG005|Overall Study|Lost to Follow-up|0|||
145655389|NCT04074759|525255309|FG006|Overall Study|Lost to Follow-up|0|||
145655390|NCT04074759|525255310|FG007|Overall Study|Lost to Follow-up|0|||
145655391|NCT04074759|525255311|FG008|Overall Study|Lost to Follow-up|0|||
145655392|NCT04074759|525255312|FG009|Overall Study|Lost to Follow-up|0|||
145655393|NCT04074759|525255313|FG010|Overall Study|Lost to Follow-up|1|||
145655394|NCT04074759|525255314|FG011|Overall Study|Lost to Follow-up|0|||
145655395|NCT04074759|525255315|FG012|Overall Study|Lost to Follow-up|0|||
145655396|NCT04074759|525255316|FG013|Overall Study|Lost to Follow-up|0|||
145655397|NCT04074759|525255317|FG014|Overall Study|Lost to Follow-up|0|||
145655398|NCT04074759|525255318|FG015|Overall Study|Lost to Follow-up|0|||
145655399|NCT04074759|525255319|FG016|Overall Study|Lost to Follow-up|1|||
145655400|NCT04074759|525255320|FG017|Overall Study|Lost to Follow-up|0|||
145655401|NCT04074759|525255321|FG018|Overall Study|Lost to Follow-up|1|||
145655402|NCT04074759|525255303|FG000|Overall Study|Other|0|||
145655403|NCT04074759|525255304|FG001|Overall Study|Other|1|||
145655404|NCT04074759|525255305|FG002|Overall Study|Other|1|||
145655405|NCT04074759|525255306|FG003|Overall Study|Other|0|||
145655406|NCT04074759|525255307|FG004|Overall Study|Other|2|||
145655407|NCT04074759|525255308|FG005|Overall Study|Other|1|||
145655408|NCT04074759|525255309|FG006|Overall Study|Other|2|||
145655409|NCT04074759|525255310|FG007|Overall Study|Other|1|||
145655410|NCT04074759|525255311|FG008|Overall Study|Other|1|||
145655411|NCT04074759|525255312|FG009|Overall Study|Other|4|||
145655412|NCT04074759|525255313|FG010|Overall Study|Other|4|||
145489780|NCT02586623|524647613|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
145489781|NCT02586623|524647614|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
145655413|NCT04074759|525255314|FG011|Overall Study|Other|2|||
145655414|NCT04074759|525255315|FG012|Overall Study|Other|0|||
145655415|NCT04074759|525255316|FG013|Overall Study|Other|0|||
145655416|NCT04074759|525255317|FG014|Overall Study|Other|0|||
145655417|NCT04074759|525255318|FG015|Overall Study|Other|1|||
145655418|NCT04074759|525255319|FG016|Overall Study|Other|0|||
145655419|NCT04074759|525255320|FG017|Overall Study|Other|0|||
145655420|NCT04074759|525255321|FG018|Overall Study|Other|0|||
145655421|NCT04074759|525255303|FG000|Overall Study|Missing end of study status|0|||
145655422|NCT04074759|525255304|FG001|Overall Study|Missing end of study status|0|||
145655423|NCT04074759|525255305|FG002|Overall Study|Missing end of study status|0|||
145655424|NCT04074759|525255306|FG003|Overall Study|Missing end of study status|0|||
145655425|NCT04074759|525255307|FG004|Overall Study|Missing end of study status|0|||
145655426|NCT04074759|525255308|FG005|Overall Study|Missing end of study status|0|||
145655427|NCT04074759|525255309|FG006|Overall Study|Missing end of study status|0|||
145655428|NCT04074759|525255310|FG007|Overall Study|Missing end of study status|0|||
145655429|NCT04074759|525255311|FG008|Overall Study|Missing end of study status|0|||
145655430|NCT04074759|525255312|FG009|Overall Study|Missing end of study status|0|||
145655431|NCT04074759|525255313|FG010|Overall Study|Missing end of study status|2|||
145655432|NCT04074759|525255314|FG011|Overall Study|Missing end of study status|0|||
145655433|NCT04074759|525255315|FG012|Overall Study|Missing end of study status|0|||
145655434|NCT04074759|525255316|FG013|Overall Study|Missing end of study status|0|||
145655435|NCT04074759|525255317|FG014|Overall Study|Missing end of study status|0|||
145655436|NCT04074759|525255318|FG015|Overall Study|Missing end of study status|0|||
145655437|NCT04074759|525255319|FG016|Overall Study|Missing end of study status|1|||
145655438|NCT04074759|525255320|FG017|Overall Study|Missing end of study status|0|||
145655439|NCT04074759|525255321|FG018|Overall Study|Missing end of study status|0|||
145655440|NCT03631784|525255322|FG000|Overall Study|Participants Ongoing|1|||
145655441|NCT03631784|525255323|FG001|Overall Study|Participants Ongoing|0|||
145655442|NCT03631784|525255322|FG000|Overall Study|Withdrawal by Subject|3|||
145655443|NCT03631784|525255323|FG001|Overall Study|Withdrawal by Subject|3|||
145655444|NCT03631784|525255322|FG000|Overall Study|Sponsor's Decision|36|||
145655445|NCT03631784|525255323|FG001|Overall Study|Sponsor's Decision|52|||
145655446|NCT03631784|525255322|FG000|Overall Study|Lost to Follow-up|1|||
145655447|NCT03631784|525255323|FG001|Overall Study|Lost to Follow-up|0|||
145655448|NCT03631784|525255322|FG000|Overall Study|Death|71|||
145655449|NCT03631784|525255323|FG001|Overall Study|Death|49|||
145655450|NCT02547363|525255326|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
145655451|NCT02547363|525255327|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
145655452|NCT02547363|525255326|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
145655453|NCT02547363|525255327|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
145655454|NCT02547363|525255326|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
145655455|NCT02547363|525255327|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
145655456|NCT02547363|525255326|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
145655457|NCT02547363|525255327|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
145655458|NCT02547363|525255326|FG000|12-month Follow-up|Withdrawal by Subject|4|||
145655459|NCT02547363|525255327|FG001|12-month Follow-up|Withdrawal by Subject|3|||
145655460|NCT02547363|525255326|FG000|12-month Follow-up|Lost to Follow-up|4|||
145655461|NCT02547363|525255327|FG001|12-month Follow-up|Lost to Follow-up|1|||
145655462|NCT02547363|525255326|FG000|12-month Follow-up|Lack of Efficacy|1|||
145655463|NCT02547363|525255327|FG001|12-month Follow-up|Lack of Efficacy|1|||
145655464|NCT02547363|525255326|FG000|12-month Follow-up|Other|1|||
145655465|NCT02547363|525255327|FG001|12-month Follow-up|Other|0|||
145655466|NCT05028634|525257221|FG000|Overall Study|Withdrawal by Subject|0|||
145655467|NCT05028634|525257222|FG001|Overall Study|Withdrawal by Subject|1|||
145655468|NCT02140554|525257223|FG000|Overall Study|Withdrawal of consent|1|||
145655469|NCT02140554|525257224|FG001|Overall Study|Withdrawal of consent|0|||
145655470|NCT02140554|525257225|FG002|Overall Study|Withdrawal of consent|4|||
145655471|NCT02140554|525257223|FG000|Overall Study|Physician Decision|1|||
145655472|NCT02140554|525257224|FG001|Overall Study|Physician Decision|0|||
145655473|NCT02140554|525257225|FG002|Overall Study|Physician Decision|2|||
145655474|NCT02140554|525257223|FG000|Overall Study|Death|0|||
145655475|NCT02140554|525257224|FG001|Overall Study|Death|0|||
145655476|NCT02140554|525257225|FG002|Overall Study|Death|1|||
145655477|NCT02140554|525257223|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
145655478|NCT02140554|525257224|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
145655479|NCT02140554|525257225|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
145655480|NCT02100813|525257229|FG000|Overall Study|Adverse Event|0|||
145655481|NCT02100813|525257230|FG001|Overall Study|Adverse Event|0|||
145655482|NCT02100813|525257231|FG002|Overall Study|Adverse Event|0|||
145655483|NCT02100813|525257232|FG003|Overall Study|Adverse Event|0|||
145655484|NCT02100813|525257233|FG004|Overall Study|Adverse Event|0|||
145655485|NCT02100813|525257234|FG005|Overall Study|Adverse Event|0|||
145655486|NCT02100813|525257235|FG006|Overall Study|Adverse Event|0|||
145655487|NCT02100813|525257236|FG007|Overall Study|Adverse Event|1|||
145655488|NCT00506519|525257242|FG000|Overall Study|Death|4|||
145655489|NCT00506519|525257243|FG001|Overall Study|Death|6|||
145655490|NCT00506519|525257244|FG002|Overall Study|Death|0|||
145655491|NCT00506519|525257242|FG000|Overall Study|Adverse Event|1|||
145655492|NCT00506519|525257243|FG001|Overall Study|Adverse Event|0|||
145655493|NCT00506519|525257244|FG002|Overall Study|Adverse Event|0|||
145655494|NCT02975882|525257245|FG000|Overall Study|Adverse Event|1|||
145655495|NCT02975882|525257246|FG001|Overall Study|Adverse Event|2|||
145655496|NCT02975882|525257247|FG002|Overall Study|Adverse Event|1|||
145655497|NCT02975882|525257248|FG003|Overall Study|Adverse Event|1|||
145655498|NCT02975882|525257245|FG000|Overall Study|Death|0|||
145655499|NCT02975882|525257246|FG001|Overall Study|Death|1|||
145655553|NCT02985957|525257255|FG002|Treatment Period|Participant withdrew consent|0|||
145655554|NCT02985957|525257256|FG003|Treatment Period|Participant withdrew consent|1|||
145655555|NCT02985957|525257257|FG004|Treatment Period|Participant withdrew consent|3|||
145655556|NCT02985957|525257258|FG005|Treatment Period|Participant withdrew consent|0|||
145655557|NCT02985957|525257259|FG006|Treatment Period|Participant withdrew consent|1|||
145655558|NCT02985957|525257253|FG000|Treatment Period|Lost to Follow-up|0|||
145655559|NCT02985957|525257254|FG001|Treatment Period|Lost to Follow-up|0|||
145655560|NCT02985957|525257255|FG002|Treatment Period|Lost to Follow-up|0|||
145655561|NCT02985957|525257256|FG003|Treatment Period|Lost to Follow-up|0|||
145655562|NCT02985957|525257257|FG004|Treatment Period|Lost to Follow-up|1|||
145655563|NCT02985957|525257258|FG005|Treatment Period|Lost to Follow-up|0|||
145655564|NCT02985957|525257259|FG006|Treatment Period|Lost to Follow-up|0|||
145655565|NCT02985957|525257253|FG000|Treatment Period|Other reasons|0|||
145655566|NCT02985957|525257254|FG001|Treatment Period|Other reasons|0|||
145655567|NCT02985957|525257255|FG002|Treatment Period|Other reasons|1|||
145655568|NCT02985957|525257256|FG003|Treatment Period|Other reasons|3|||
145655569|NCT02985957|525257257|FG004|Treatment Period|Other reasons|6|||
145655570|NCT02985957|525257258|FG005|Treatment Period|Other reasons|0|||
145655571|NCT02985957|525257259|FG006|Treatment Period|Other reasons|1|||
145655572|NCT02985957|525257253|FG000|Treatment Period|Not reported|0|||
145655573|NCT02985957|525257254|FG001|Treatment Period|Not reported|1|||
145655574|NCT02985957|525257255|FG002|Treatment Period|Not reported|2|||
145655575|NCT02985957|525257256|FG003|Treatment Period|Not reported|5|||
145655576|NCT02985957|525257257|FG004|Treatment Period|Not reported|0|||
145655577|NCT02985957|525257258|FG005|Treatment Period|Not reported|0|||
145655578|NCT02985957|525257259|FG006|Treatment Period|Not reported|0|||
145655579|NCT02985957|525257253|FG000|Treatment Period|Maximum clinical benefit|0|||
145655580|NCT02985957|525257254|FG001|Treatment Period|Maximum clinical benefit|0|||
145655581|NCT02985957|525257255|FG002|Treatment Period|Maximum clinical benefit|1|||
145655582|NCT02985957|525257256|FG003|Treatment Period|Maximum clinical benefit|1|||
145655583|NCT02985957|525257257|FG004|Treatment Period|Maximum clinical benefit|0|||
145655584|NCT02985957|525257258|FG005|Treatment Period|Maximum clinical benefit|0|||
145655585|NCT02985957|525257259|FG006|Treatment Period|Maximum clinical benefit|2|||
145655586|NCT02985957|525257253|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
145655587|NCT02985957|525257254|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
145655588|NCT02985957|525257255|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
145655589|NCT02985957|525257256|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
145655590|NCT02985957|525257257|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
145655591|NCT02985957|525257258|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
145655592|NCT02985957|525257259|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
145655593|NCT02985957|525257253|FG000|Treatment Period|Study drug toxicity|1|||
145655594|NCT02985957|525257254|FG001|Treatment Period|Study drug toxicity|23|||
145655595|NCT02985957|525257255|FG002|Treatment Period|Study drug toxicity|20|||
145655596|NCT02985957|525257256|FG003|Treatment Period|Study drug toxicity|11|||
145655597|NCT02985957|525257257|FG004|Treatment Period|Study drug toxicity|19|||
145655598|NCT02985957|525257258|FG005|Treatment Period|Study drug toxicity|3|||
145655599|NCT02985957|525257259|FG006|Treatment Period|Study drug toxicity|5|||
145655600|NCT02985957|525257253|FG000|Treatment Period|Disease progression|0|||
145655601|NCT02985957|525257254|FG001|Treatment Period|Disease progression|16|||
145655602|NCT02985957|525257255|FG002|Treatment Period|Disease progression|20|||
145655603|NCT02985957|525257256|FG003|Treatment Period|Disease progression|39|||
145655604|NCT02985957|525257257|FG004|Treatment Period|Disease progression|29|||
145655605|NCT02985957|525257258|FG005|Treatment Period|Disease progression|11|||
145655606|NCT02985957|525257259|FG006|Treatment Period|Disease progression|28|||
145655607|NCT02985957|525257253|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
145655608|NCT02985957|525257254|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
145655609|NCT02985957|525257255|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
145655610|NCT02985957|525257256|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
145655611|NCT02985957|525257257|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
145655612|NCT02985957|525257258|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
145655613|NCT02985957|525257259|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
145489881|NCT05051579|524647623|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
145655614|NCT02985957|525257253|FG000|Treatment Period|Poor/Non-Compliance|0|||
145655615|NCT02985957|525257254|FG001|Treatment Period|Poor/Non-Compliance|0|||
145655616|NCT02985957|525257255|FG002|Treatment Period|Poor/Non-Compliance|0|||
145655617|NCT02985957|525257256|FG003|Treatment Period|Poor/Non-Compliance|0|||
145655618|NCT02985957|525257257|FG004|Treatment Period|Poor/Non-Compliance|1|||
145655619|NCT02985957|525257258|FG005|Treatment Period|Poor/Non-Compliance|1|||
145655620|NCT02985957|525257259|FG006|Treatment Period|Poor/Non-Compliance|0|||
145655621|NCT02985957|525257253|FG000|Treatment Period|Continuing in Treatment Period|0|||
145655622|NCT02985957|525257254|FG001|Treatment Period|Continuing in Treatment Period|1|||
145655623|NCT02985957|525257255|FG002|Treatment Period|Continuing in Treatment Period|0|||
145489882|NCT05051579|524647624|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145489883|NCT05051579|524647625|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
145489884|NCT04332107|524647631|FG000|Day 3|Lost to Follow-up|23|||
145489885|NCT04332107|524647632|FG001|Day 3|Lost to Follow-up|14|||
145489886|NCT04332107|524647631|FG000|Day 3|Missing outcome data|3|||
145655624|NCT02985957|525257256|FG003|Treatment Period|Continuing in Treatment Period|4|||
145655625|NCT02985957|525257257|FG004|Treatment Period|Continuing in Treatment Period|4|||
145655626|NCT02985957|525257258|FG005|Treatment Period|Continuing in Treatment Period|0|||
145655627|NCT02985957|525257259|FG006|Treatment Period|Continuing in Treatment Period|0|||
145655628|NCT04342494|525257260|FG000|Overall Study|Questionnaire partially completed|1|||
145655629|NCT04342494|525257261|FG001|Overall Study|Questionnaire partially completed|0|||
145655630|NCT04342494|525257262|FG002|Overall Study|Questionnaire partially completed|2|||
145655631|NCT04342494|525257263|FG003|Overall Study|Questionnaire partially completed|0|||
145655632|NCT04342494|525257264|FG004|Overall Study|Questionnaire partially completed|1|||
145655633|NCT04342494|525257260|FG000|Overall Study|Lost to Follow-up|49|||
145655634|NCT04342494|525257261|FG001|Overall Study|Lost to Follow-up|38|||
145655635|NCT04342494|525257262|FG002|Overall Study|Lost to Follow-up|34|||
145655636|NCT04342494|525257263|FG003|Overall Study|Lost to Follow-up|34|||
145655637|NCT04342494|525257264|FG004|Overall Study|Lost to Follow-up|35|||
145655638|NCT05119023|525257265|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
145655639|NCT05119023|525257265|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
145655640|NCT05119023|525257265|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
145655641|NCT02485938|525257272|FG000|Overall Study|Withdrawal of consent|2|||
145655642|NCT02485938|525257273|FG001|Overall Study|Withdrawal of consent|0|||
145655643|NCT04633122|525257274|FG000|Overall Study|Remained on treatment|19|||
145655644|NCT04633122|525257275|FG001|Overall Study|Remained on treatment|14|||
145655645|NCT04633122|525257274|FG000|Overall Study|Survival follow-up stopped|22|||
145655646|NCT04633122|525257275|FG001|Overall Study|Survival follow-up stopped|25|||
145655647|NCT04799899|525257276|FG000|Overall Study|Lost to Follow-up|2|||
145655648|NCT04799899|525257277|FG001|Overall Study|Lost to Follow-up|4|||
145655649|NCT03524118|525257279|FG000|Overall Study|Lost to Follow-up|0|||
145655650|NCT03524118|525257280|FG001|Overall Study|Lost to Follow-up|0|||
145655651|NCT03524118|525257281|FG002|Overall Study|Lost to Follow-up|0|||
145655652|NCT03524118|525257282|FG003|Overall Study|Lost to Follow-up|0|||
145655653|NCT03524118|525257283|FG004|Overall Study|Lost to Follow-up|1|||
145655654|NCT03524118|525257284|FG005|Overall Study|Lost to Follow-up|0|||
145655655|NCT03524118|525257279|FG000|Overall Study|Other|0|||
145655656|NCT03524118|525257280|FG001|Overall Study|Other|1|||
145655657|NCT03524118|525257281|FG002|Overall Study|Other|0|||
145655658|NCT03524118|525257282|FG003|Overall Study|Other|0|||
145655659|NCT03524118|525257283|FG004|Overall Study|Other|1|||
145655660|NCT03524118|525257284|FG005|Overall Study|Other|1|||
145655661|NCT03524118|525257279|FG000|Overall Study|Physician Decision|0|||
145655662|NCT03524118|525257280|FG001|Overall Study|Physician Decision|0|||
145655663|NCT03524118|525257281|FG002|Overall Study|Physician Decision|0|||
145655664|NCT03524118|525257282|FG003|Overall Study|Physician Decision|0|||
145655665|NCT03524118|525257283|FG004|Overall Study|Physician Decision|1|||
145655666|NCT03524118|525257284|FG005|Overall Study|Physician Decision|0|||
145655667|NCT03524118|525257279|FG000|Overall Study|Protocol Violation|0|||
145655668|NCT03524118|525257280|FG001|Overall Study|Protocol Violation|0|||
145655669|NCT03524118|525257281|FG002|Overall Study|Protocol Violation|1|||
145655670|NCT03524118|525257282|FG003|Overall Study|Protocol Violation|0|||
145655671|NCT03524118|525257283|FG004|Overall Study|Protocol Violation|1|||
145655672|NCT03524118|525257284|FG005|Overall Study|Protocol Violation|0|||
145655673|NCT03524118|525257279|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145655674|NCT03524118|525257280|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145655675|NCT03524118|525257281|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
145655676|NCT03524118|525257282|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
145655677|NCT03524118|525257283|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
145655678|NCT03524118|525257284|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
145655679|NCT03339713|525257287|FG000|Overall Study|Lost to Follow-up|2|||
145655680|NCT03339713|525257288|FG001|Overall Study|Lost to Follow-up|1|||
145655681|NCT03339713|525257287|FG000|Overall Study|Protocol Violation|1|||
145655682|NCT03339713|525257288|FG001|Overall Study|Protocol Violation|0|||
145655683|NCT03339713|525257287|FG000|Overall Study|Withdrawal by Subject|1|||
145655684|NCT03339713|525257288|FG001|Overall Study|Withdrawal by Subject|1|||
145655685|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
145655686|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
145655687|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
145655688|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
145655689|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
145655690|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
145489887|NCT04332107|524647632|FG001|Day 3|Missing outcome data|6|||
145655691|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
145655692|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
145655693|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
145655694|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
145655695|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
145655696|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
145655697|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
145655698|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
145655699|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
145655700|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
145655701|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
145655702|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
145655703|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
145655704|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
145655705|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
145655706|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
145655707|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
145655708|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
145655709|NCT01715285|525257289|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
145655710|NCT01715285|525257290|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
145655711|NCT01715285|525257291|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
145655712|NCT01715285|525257289|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
145655713|NCT01715285|525257290|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
145655714|NCT01715285|525257291|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
145655715|NCT01715285|525257289|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
145655716|NCT01715285|525257290|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
145655717|NCT01715285|525257291|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
145655718|NCT01715285|525257289|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
145655719|NCT01715285|525257290|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
145655720|NCT01715285|525257291|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
145655721|NCT01715285|525257289|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
145655722|NCT01715285|525257290|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
145655723|NCT01715285|525257291|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
145655724|NCT01715285|525257289|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
145655725|NCT01715285|525257290|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
145655726|NCT01715285|525257291|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
145655727|NCT03474679|525257292|FG000|Overall Study|Death|7|||
145655728|NCT03474679|525257292|FG000|Overall Study|Withdrawal by Subject|1|||
145655729|NCT04858321|525257294|FG000|Overall Study|Withdrawal by Subject|3|||
145655730|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
145655731|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
145655732|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
145655733|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
145655734|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
145655735|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
145655736|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Death|6|||
145655737|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Death|0|||
145655738|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Death|0|||
145655739|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
145655740|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
145655741|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
145655742|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
145655743|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
145655744|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
145655745|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
145655746|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
145655747|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
145655748|NCT01539083|525257295|FG000|Before Randomization (VCD Induction)|Other|5|||
145655749|NCT01539083|525257296|FG001|Before Randomization (VCD Induction)|Other|0|||
145655750|NCT01539083|525257297|FG002|Before Randomization (VCD Induction)|Other|0|||
145655751|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
145655752|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
145655753|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
145655754|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Other|0|||
145655755|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Other|1|||
145655756|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Other|1|||
145655757|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
145655758|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
145655759|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
145655760|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
145655761|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
145655762|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
145655763|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
145655764|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
145655765|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
145655766|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
145655767|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
145655768|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
145655769|NCT01539083|525257295|FG000|After Randomization (TP and VTP)|Death|0|||
145655770|NCT01539083|525257296|FG001|After Randomization (TP and VTP)|Death|6|||
145655771|NCT01539083|525257297|FG002|After Randomization (TP and VTP)|Death|11|||
145655772|NCT05499377|525257307|FG000|Overall Study|Withdrawal by Subject|2|||
145655773|NCT05499377|525257308|FG001|Overall Study|Withdrawal by Subject|0|||
145655774|NCT05499377|525257307|FG000|Overall Study|Physician Decision|1|||
145655775|NCT05499377|525257308|FG001|Overall Study|Physician Decision|0|||
145655776|NCT02677805|525257312|FG000|Double Blind Phase|Lost to Follow-up|8|||
145655777|NCT02677805|525257313|FG001|Double Blind Phase|Lost to Follow-up|3|||
145489888|NCT04332107|524647631|FG000|Day 14|Lost to Follow-up|13|||
145489889|NCT04332107|524647632|FG001|Day 14|Lost to Follow-up|4|||
145489890|NCT04332107|524647631|FG000|Day 14|Missing outcome data|4|||
145489891|NCT04332107|524647632|FG001|Day 14|Missing outcome data|4|||
145489892|NCT04332107|524647631|FG000|Day 21|Lost to Follow-up|10|||
145489893|NCT04332107|524647632|FG001|Day 21|Lost to Follow-up|2|||
145489894|NCT00717249|524647633|FG000|Overall Study|Lens Discomfort|4|||
145489895|NCT00717249|524647634|FG001|Overall Study|Lens Discomfort|1|||
145489896|NCT00717249|524647633|FG000|Overall Study|Unsatisfactory visual Response|0|||
145489897|NCT00717249|524647634|FG001|Overall Study|Unsatisfactory visual Response|2|||
145489898|NCT00717249|524647633|FG000|Overall Study|Adverse Event|4|||
145489899|NCT00717249|524647634|FG001|Overall Study|Adverse Event|2|||
145489900|NCT00717249|524647633|FG000|Overall Study|Lost to Follow-up|2|||
145489901|NCT00717249|524647634|FG001|Overall Study|Lost to Follow-up|0|||
145489902|NCT00717249|524647633|FG000|Overall Study|Withdrawal by Subject|1|||
145489903|NCT00717249|524647634|FG001|Overall Study|Withdrawal by Subject|2|||
145489904|NCT00717249|524647633|FG000|Overall Study|Pregnancy|6|||
145489905|NCT00717249|524647634|FG001|Overall Study|Pregnancy|3|||
145489906|NCT00717249|524647633|FG000|Overall Study|Protocol Violation|0|||
145489907|NCT00717249|524647634|FG001|Overall Study|Protocol Violation|2|||
145489908|NCT00717249|524647633|FG000|Overall Study|Subject became Ineligible|1|||
145489909|NCT00717249|524647634|FG001|Overall Study|Subject became Ineligible|1|||
145489910|NCT00717249|524647633|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
145489911|NCT00717249|524647634|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
145489912|NCT00717249|524647633|FG000|Overall Study|Gastric Surgery|0|||
145489913|NCT00717249|524647634|FG001|Overall Study|Gastric Surgery|1|||
145489914|NCT00717249|524647633|FG000|Overall Study|Diagnosed with Diabetes|1|||
145489915|NCT00717249|524647634|FG001|Overall Study|Diagnosed with Diabetes|0|||
145489916|NCT00717249|524647633|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
145489917|NCT00717249|524647634|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
145489918|NCT00717249|524647633|FG000|Overall Study|Subject relocated|1|||
145489919|NCT00717249|524647634|FG001|Overall Study|Subject relocated|0|||
145489920|NCT00717249|524647633|FG000|Overall Study|Headaches|1|||
145489921|NCT00717249|524647634|FG001|Overall Study|Headaches|0|||
145489922|NCT00871871|524647635|FG000|Part I|Adverse Event|0|||
145489923|NCT00871871|524647636|FG001|Part I|Adverse Event|2|||
145489924|NCT00871871|524647637|FG002|Part I|Adverse Event|0|||
145489925|NCT00871871|524647638|FG003|Part I|Adverse Event|0|||
145489926|NCT00871871|524647635|FG000|Part I|Withdrawal by Subject|3|||
145489927|NCT00871871|524647636|FG001|Part I|Withdrawal by Subject|0|||
145489928|NCT00871871|524647637|FG002|Part I|Withdrawal by Subject|0|||
145489929|NCT00871871|524647638|FG003|Part I|Withdrawal by Subject|0|||
145489930|NCT00871871|524647635|FG000|Part I|Laboratory abnormality|0|||
145489931|NCT00871871|524647636|FG001|Part I|Laboratory abnormality|1|||
145489932|NCT00871871|524647637|FG002|Part I|Laboratory abnormality|0|||
145489933|NCT00871871|524647638|FG003|Part I|Laboratory abnormality|0|||
145489934|NCT00871871|524647635|FG000|Part II|Lack of Efficacy|0|||
145489935|NCT00871871|524647636|FG001|Part II|Lack of Efficacy|0|||
145489936|NCT00871871|524647637|FG002|Part II|Lack of Efficacy|1|||
145489937|NCT00871871|524647638|FG003|Part II|Lack of Efficacy|0|||
145489938|NCT00871871|524647635|FG000|Part II|Withdrawal by Subject|0|||
145489939|NCT00871871|524647636|FG001|Part II|Withdrawal by Subject|0|||
145489940|NCT00871871|524647637|FG002|Part II|Withdrawal by Subject|2|||
145489941|NCT00871871|524647638|FG003|Part II|Withdrawal by Subject|1|||
145489942|NCT00871871|524647635|FG000|Part II|Adverse Event|0|||
145489943|NCT00871871|524647636|FG001|Part II|Adverse Event|0|||
145655778|NCT02677805|525257314|FG002|Double Blind Phase|Lost to Follow-up|0|||
145655779|NCT02677805|525257312|FG000|Double Blind Phase|Withdrawal by Subject|5|||
145655780|NCT02677805|525257313|FG001|Double Blind Phase|Withdrawal by Subject|2|||
145489944|NCT00871871|524647637|FG002|Part II|Adverse Event|1|||
145489945|NCT00871871|524647638|FG003|Part II|Adverse Event|2|||
145489946|NCT00871871|524647635|FG000|Part II|Protocol Violation|0|||
145489947|NCT00871871|524647636|FG001|Part II|Protocol Violation|0|||
145489948|NCT00871871|524647637|FG002|Part II|Protocol Violation|0|||
145489949|NCT00871871|524647638|FG003|Part II|Protocol Violation|1|||
145489950|NCT01670721|524647639|FG000|Overall Study|Participant's decision|15|||
145489951|NCT01670721|524647639|FG000|Overall Study|Other than specified above|38|||
145489952|NCT00479713|524647642|FG000|Overall Study|Adverse Event|8|||
145489953|NCT00479713|524647643|FG001|Overall Study|Adverse Event|6|||
145489954|NCT00479713|524647642|FG000|Overall Study|Death|1|||
145489955|NCT00479713|524647643|FG001|Overall Study|Death|0|||
145489956|NCT00479713|524647642|FG000|Overall Study|Lost to Follow-up|0|||
145489957|NCT00479713|524647643|FG001|Overall Study|Lost to Follow-up|1|||
145489958|NCT00479713|524647642|FG000|Overall Study|Protocol Violation|0|||
145489959|NCT00479713|524647643|FG001|Overall Study|Protocol Violation|1|||
145489960|NCT00479713|524647642|FG000|Overall Study|Withdrawal by Subject|4|||
145489961|NCT00479713|524647643|FG001|Overall Study|Withdrawal by Subject|1|||
145489962|NCT03863509|524647644|FG000|Overall Study|COVID-19 shutdown period|0|||
145489963|NCT03863509|524647645|FG001|Overall Study|COVID-19 shutdown period|4|||
145489964|NCT03863509|524647646|FG002|Overall Study|COVID-19 shutdown period|0|||
145489965|NCT03863509|524647644|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
145489966|NCT03863509|524647645|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
145489967|NCT03863509|524647646|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
145489968|NCT03863509|524647644|FG000|Overall Study|Lost to Follow-up|8|||
145489969|NCT03863509|524647645|FG001|Overall Study|Lost to Follow-up|0|||
145489970|NCT03863509|524647646|FG002|Overall Study|Lost to Follow-up|2|||
145489971|NCT03863509|524647644|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
145489972|NCT03863509|524647645|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
145489973|NCT03863509|524647646|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
145489974|NCT03863509|524647644|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
145489975|NCT03863509|524647645|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
145489976|NCT03863509|524647646|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
145489977|NCT03799341|524647647|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
145489978|NCT03799341|524647648|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
145489979|NCT03799341|524647649|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
145489980|NCT03799341|524647647|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
145489981|NCT03799341|524647648|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
145489982|NCT03799341|524647649|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
145489983|NCT03799341|524647647|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
145489984|NCT03799341|524647648|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
145489985|NCT03799341|524647649|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
145489986|NCT03799341|524647647|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
145489987|NCT03799341|524647648|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
145489988|NCT03799341|524647649|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
145489989|NCT03799341|524647647|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
145489990|NCT03799341|524647648|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
145489991|NCT03799341|524647649|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
145489992|NCT03799341|524647647|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
145489993|NCT03799341|524647648|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
145489994|NCT03799341|524647649|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
145489995|NCT00990106|524647650|FG000|Overall Study|"too busy to continue"|1|||
145489996|NCT00990106|524647651|FG001|Overall Study|"too busy to continue"|2|||
145489997|NCT00990106|524647650|FG000|Overall Study|Lost to Follow-up|1|||
145489998|NCT00990106|524647651|FG001|Overall Study|Lost to Follow-up|3|||
145489999|NCT00990106|524647650|FG000|Overall Study|Withdrawal by Subject|2|||
145490000|NCT00990106|524647651|FG001|Overall Study|Withdrawal by Subject|1|||
145490001|NCT00990106|524647650|FG000|Overall Study|opted for open label prazosin|1|||
145490002|NCT00990106|524647651|FG001|Overall Study|opted for open label prazosin|1|||
145490003|NCT00990106|524647650|FG000|Overall Study|relocation/deployment|4|||
145490004|NCT00990106|524647651|FG001|Overall Study|relocation/deployment|1|||
145490005|NCT00990106|524647650|FG000|Overall Study|started exclusionary medication|0|||
145490006|NCT00990106|524647651|FG001|Overall Study|started exclusionary medication|1|||
145490007|NCT00990106|524647650|FG000|Overall Study|planned major surgery|0|||
145490008|NCT00990106|524647651|FG001|Overall Study|planned major surgery|1|||
145490009|NCT00990106|524647650|FG000|Overall Study|scheduling conflicts|0|||
145490010|NCT00990106|524647651|FG001|Overall Study|scheduling conflicts|2|||
145490011|NCT03100149|524647652|FG000|Overall Study|Adverse Event|0|||
145655781|NCT02677805|525257314|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145655782|NCT02677805|525257312|FG000|Open Label Phase|Lost to Follow-up|0|||
145655783|NCT02677805|525257313|FG001|Open Label Phase|Lost to Follow-up|0|||
145655784|NCT02677805|525257314|FG002|Open Label Phase|Lost to Follow-up|10|||
145655785|NCT02677805|525257312|FG000|Open Label Phase|Withdrawal by Subject|0|||
145655786|NCT02677805|525257313|FG001|Open Label Phase|Withdrawal by Subject|0|||
145655787|NCT02677805|525257314|FG002|Open Label Phase|Withdrawal by Subject|6|||
145655788|NCT04350463|525257319|FG000|Overall Study|Other reason|0|||
145655789|NCT04350463|525257320|FG001|Overall Study|Other reason|0|||
145655790|NCT04350463|525257321|FG002|Overall Study|Other reason|0|||
145655791|NCT04350463|525257322|FG003|Overall Study|Other reason|1|||
145655792|NCT04350463|525257319|FG000|Overall Study|Lost to Follow-up|0|||
145655793|NCT04350463|525257320|FG001|Overall Study|Lost to Follow-up|0|||
145655794|NCT04350463|525257321|FG002|Overall Study|Lost to Follow-up|0|||
145655795|NCT04350463|525257322|FG003|Overall Study|Lost to Follow-up|2|||
145655796|NCT04350463|525257319|FG000|Overall Study|Withdrawal by Subject|4|||
145655797|NCT04350463|525257320|FG001|Overall Study|Withdrawal by Subject|0|||
145655798|NCT04350463|525257321|FG002|Overall Study|Withdrawal by Subject|1|||
145655799|NCT04350463|525257322|FG003|Overall Study|Withdrawal by Subject|4|||
145655800|NCT04350463|525257319|FG000|Overall Study|Adverse Event|0|||
145655801|NCT04350463|525257320|FG001|Overall Study|Adverse Event|0|||
145655802|NCT04350463|525257321|FG002|Overall Study|Adverse Event|0|||
145655803|NCT04350463|525257322|FG003|Overall Study|Adverse Event|2|||
145655804|NCT04350463|525257319|FG000|Overall Study|Death|27|||
145655805|NCT04350463|525257320|FG001|Overall Study|Death|2|||
145655806|NCT04350463|525257321|FG002|Overall Study|Death|13|||
145655807|NCT04350463|525257322|FG003|Overall Study|Death|26|||
145655808|NCT05714761|525257323|FG000|Overall Study|Lost to Follow-up|3|||
145655809|NCT05714761|525257323|FG000|Overall Study|Withdrawal by Subject|3|||
145655810|NCT05714761|525257323|FG000|Overall Study|unblinding of sensor data|1|||
145655811|NCT05714761|525257323|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
145655812|NCT05714761|525257323|FG000|Overall Study|did not return second CGM sensor|4|||
145655813|NCT03092518|525257326|FG000|Overall Study|Ineligible|2|||
145655814|NCT02547987|525257327|FG000|Overall Study|Withdrawal by Subject|1|||
145655815|NCT02547987|525257327|FG000|Overall Study|Adverse Event|2|||
145655816|NCT05089019|525257328|FG000|Period 1|Withdrawal by Subject|0|||
145655817|NCT05089019|525257329|FG001|Period 1|Withdrawal by Subject|1|||
145655818|NCT05089019|525257328|FG000|Washout Period|Adverse Event|3|||
145655819|NCT05089019|525257329|FG001|Washout Period|Adverse Event|4|||
145655820|NCT05089019|525257328|FG000|Washout Period|Lost to Follow-up|1|||
145655821|NCT05089019|525257329|FG001|Washout Period|Lost to Follow-up|0|||
145655822|NCT05089019|525257328|FG000|Washout Period|Physician Decision|2|||
145655823|NCT05089019|525257329|FG001|Washout Period|Physician Decision|0|||
145655824|NCT05089019|525257328|FG000|Washout Period|Withdrawal by Subject|6|||
145655825|NCT05089019|525257329|FG001|Washout Period|Withdrawal by Subject|3|||
145655826|NCT05089019|525257328|FG000|Period 2|Adverse Event|4|||
145655827|NCT05089019|525257329|FG001|Period 2|Adverse Event|2|||
145655828|NCT05089019|525257328|FG000|Period 2|Lost to Follow-up|1|||
145655829|NCT05089019|525257329|FG001|Period 2|Lost to Follow-up|0|||
145655830|NCT05089019|525257328|FG000|Period 2|Withdrawal by Subject|0|||
145655831|NCT05089019|525257329|FG001|Period 2|Withdrawal by Subject|1|||
145655832|NCT05170009|525257330|FG000|Overall Study|Physician Decision|0|||
145655833|NCT05170009|525257331|FG001|Overall Study|Physician Decision|1|||
145655834|NCT04629716|525257333|FG000|Overall Study|Lost to Follow-up|7|||
145655835|NCT04629716|525257334|FG001|Overall Study|Lost to Follow-up|3|||
145655836|NCT04770532|525257335|FG000|Overall Study|Withdrawal by Subject|0|||
145655837|NCT04770532|525257336|FG001|Overall Study|Withdrawal by Subject|3|||
145655838|NCT04770532|525257335|FG000|Overall Study|Physician Decision|1|||
145655839|NCT04770532|525257336|FG001|Overall Study|Physician Decision|0|||
145655840|NCT04770532|525257335|FG000|Overall Study|Death|2|||
145655841|NCT04770532|525257336|FG001|Overall Study|Death|2|||
145655842|NCT05457647|525257338|FG000|Overall Study|Lost to Follow-up|3|||
145655843|NCT02683447|525257339|FG000|Overall Study|Lost to Follow-up|2|||
145655844|NCT04137289|525257347|FG000|Overall Study|Death|0|||
145655845|NCT04137289|525257348|FG001|Overall Study|Death|0|||
145655846|NCT04137289|525257349|FG002|Overall Study|Death|0|||
145655847|NCT04137289|525257350|FG003|Overall Study|Death|0|||
145655848|NCT04137289|525257351|FG004|Overall Study|Death|0|||
145655849|NCT04137289|525257352|FG005|Overall Study|Death|0|||
145655850|NCT04137289|525257353|FG006|Overall Study|Death|1|||
145655851|NCT04137289|525257354|FG007|Overall Study|Death|0|||
145655852|NCT04137289|525257355|FG008|Overall Study|Death|0|||
145655853|NCT04137289|525257347|FG000|Overall Study|Clinical disease progression|0|||
145655854|NCT04137289|525257348|FG001|Overall Study|Clinical disease progression|0|||
145655855|NCT04137289|525257349|FG002|Overall Study|Clinical disease progression|0|||
145655856|NCT04137289|525257350|FG003|Overall Study|Clinical disease progression|4|||
145655857|NCT04137289|525257351|FG004|Overall Study|Clinical disease progression|4|||
145655858|NCT04137289|525257352|FG005|Overall Study|Clinical disease progression|2|||
145655859|NCT04137289|525257353|FG006|Overall Study|Clinical disease progression|5|||
145655860|NCT04137289|525257354|FG007|Overall Study|Clinical disease progression|1|||
145655861|NCT04137289|525257355|FG008|Overall Study|Clinical disease progression|0|||
145655862|NCT04137289|525257347|FG000|Overall Study|Lost to Follow-up|0|||
145655863|NCT04137289|525257348|FG001|Overall Study|Lost to Follow-up|0|||
145655864|NCT04137289|525257349|FG002|Overall Study|Lost to Follow-up|0|||
145490012|NCT03100149|524647653|FG001|Overall Study|Adverse Event|1|||
145490013|NCT03100149|524647654|FG002|Overall Study|Adverse Event|0|||
145490014|NCT03100149|524647652|FG000|Overall Study|Participant Moved out of Country|0|||
145490015|NCT03100149|524647653|FG001|Overall Study|Participant Moved out of Country|0|||
145490016|NCT03100149|524647654|FG002|Overall Study|Participant Moved out of Country|1|||
145490017|NCT03100149|524647652|FG000|Overall Study|Withdrawal by Subject|0|||
145490018|NCT03100149|524647653|FG001|Overall Study|Withdrawal by Subject|3|||
145490019|NCT03100149|524647654|FG002|Overall Study|Withdrawal by Subject|1|||
145490020|NCT01871519|524647656|FG000|Overall Study|Death|26|||
145490021|NCT01871519|524647656|FG000|Overall Study|Lost to Follow-up|15|||
145490022|NCT01871519|524647656|FG000|Overall Study|Withdrawal by Subject|49|||
145490023|NCT00320515|524647657|FG000|Overall Study|Death|33|||
145490024|NCT00320515|524647657|FG000|Overall Study|Lost to Follow-up|6|||
145490025|NCT00320515|524647657|FG000|Overall Study|Physician Decision|2|||
145490026|NCT00320515|524647657|FG000|Overall Study|Withdrawal by Subject|8|||
145490027|NCT00445549|524648670|FG000|Overall Study|progressive disease|12|||
145655865|NCT04137289|525257350|FG003|Overall Study|Lost to Follow-up|1|||
145655866|NCT04137289|525257351|FG004|Overall Study|Lost to Follow-up|0|||
145655867|NCT04137289|525257352|FG005|Overall Study|Lost to Follow-up|0|||
145655868|NCT04137289|525257353|FG006|Overall Study|Lost to Follow-up|0|||
145655869|NCT04137289|525257354|FG007|Overall Study|Lost to Follow-up|0|||
145655870|NCT04137289|525257355|FG008|Overall Study|Lost to Follow-up|0|||
145655871|NCT04137289|525257347|FG000|Overall Study|Adverse Event|0|||
145655872|NCT04137289|525257348|FG001|Overall Study|Adverse Event|0|||
145655873|NCT04137289|525257349|FG002|Overall Study|Adverse Event|1|||
145655874|NCT04137289|525257350|FG003|Overall Study|Adverse Event|0|||
145655875|NCT04137289|525257351|FG004|Overall Study|Adverse Event|0|||
145655876|NCT04137289|525257352|FG005|Overall Study|Adverse Event|1|||
145655877|NCT04137289|525257353|FG006|Overall Study|Adverse Event|0|||
145655878|NCT04137289|525257354|FG007|Overall Study|Adverse Event|0|||
145655879|NCT04137289|525257355|FG008|Overall Study|Adverse Event|0|||
145655880|NCT04137289|525257347|FG000|Overall Study|Lack of clinical benefit|0|||
145655881|NCT04137289|525257348|FG001|Overall Study|Lack of clinical benefit|0|||
145655882|NCT04137289|525257349|FG002|Overall Study|Lack of clinical benefit|0|||
145655883|NCT04137289|525257350|FG003|Overall Study|Lack of clinical benefit|0|||
145655884|NCT04137289|525257351|FG004|Overall Study|Lack of clinical benefit|0|||
145655885|NCT04137289|525257352|FG005|Overall Study|Lack of clinical benefit|0|||
145655886|NCT04137289|525257353|FG006|Overall Study|Lack of clinical benefit|0|||
145655887|NCT04137289|525257354|FG007|Overall Study|Lack of clinical benefit|0|||
145655888|NCT04137289|525257355|FG008|Overall Study|Lack of clinical benefit|1|||
145655889|NCT04137289|525257347|FG000|Overall Study|Objective disease progression|1|||
145655890|NCT04137289|525257348|FG001|Overall Study|Objective disease progression|1|||
145655891|NCT04137289|525257349|FG002|Overall Study|Objective disease progression|6|||
145655892|NCT04137289|525257350|FG003|Overall Study|Objective disease progression|18|||
145655893|NCT04137289|525257351|FG004|Overall Study|Objective disease progression|12|||
145655894|NCT04137289|525257352|FG005|Overall Study|Objective disease progression|20|||
145655895|NCT04137289|525257353|FG006|Overall Study|Objective disease progression|18|||
145655896|NCT04137289|525257354|FG007|Overall Study|Objective disease progression|7|||
145655897|NCT04137289|525257355|FG008|Overall Study|Objective disease progression|6|||
145655898|NCT00324805|525257358|FG000|Overall Study|Adverse Event|62|||
145655899|NCT00324805|525257359|FG001|Overall Study|Adverse Event|203|||
145655900|NCT00324805|525257358|FG000|Overall Study|Progression|7|||
145655901|NCT00324805|525257359|FG001|Overall Study|Progression|35|||
145655902|NCT00324805|525257358|FG000|Overall Study|Withdrawal by Subject|51|||
145655903|NCT00324805|525257359|FG001|Overall Study|Withdrawal by Subject|174|||
145655904|NCT00324805|525257358|FG000|Overall Study|Death|6|||
145655905|NCT00324805|525257359|FG001|Overall Study|Death|9|||
145490028|NCT01405768|524648677|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
145655906|NCT00324805|525257358|FG000|Overall Study|Alternative therapy|4|||
145655907|NCT00324805|525257359|FG001|Overall Study|Alternative therapy|8|||
145655908|NCT00324805|525257358|FG000|Overall Study|Other complicating disease|1|||
145655909|NCT00324805|525257359|FG001|Overall Study|Other complicating disease|9|||
145655910|NCT00324805|525257358|FG000|Overall Study|Other reasons|7|||
145655911|NCT00324805|525257359|FG001|Overall Study|Other reasons|26|||
145655912|NCT00324805|525257358|FG000|Overall Study|Other|0|||
145490029|NCT01405768|524648678|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
145490030|NCT01342913|524648681|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
145490031|NCT01342913|524648682|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145490032|NCT01342913|524648683|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
145655913|NCT00324805|525257359|FG001|Overall Study|Other|2|||
145655914|NCT00324805|525257358|FG000|Overall Study|Did not start therapy|12|||
145655915|NCT00324805|525257359|FG001|Overall Study|Did not start therapy|17|||
145655916|NCT03931174|525257361|FG000|Providers|Staff left organization|26|||
145655917|NCT03931174|525257362|FG001|Providers|Staff left organization|25|||
145655918|NCT03931174|525257361|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
145490033|NCT01342913|524648681|FG000|2-week Run-in Period|Physician Decision|6|||
145490034|NCT01342913|524648682|FG001|2-week Run-in Period|Physician Decision|0|||
145490035|NCT01342913|524648683|FG002|2-week Run-in Period|Physician Decision|0|||
145490036|NCT01342913|524648681|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
145490037|NCT01342913|524648682|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145490038|NCT01342913|524648683|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145490039|NCT01342913|524648681|FG000|2-week Run-in Period|Adverse Event|2|||
145490040|NCT01342913|524648682|FG001|2-week Run-in Period|Adverse Event|0|||
145490041|NCT01342913|524648683|FG002|2-week Run-in Period|Adverse Event|0|||
145490042|NCT01342913|524648681|FG000|2-week Run-in Period|Protocol Violation|5|||
145490043|NCT01342913|524648682|FG001|2-week Run-in Period|Protocol Violation|0|||
145490044|NCT01342913|524648683|FG002|2-week Run-in Period|Protocol Violation|0|||
145490045|NCT01342913|524648681|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
145490046|NCT01342913|524648682|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
145490047|NCT01342913|524648683|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
145490048|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Adverse Event|0|||
145490049|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Adverse Event|3|||
145490050|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Adverse Event|6|||
145490051|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
145490052|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
145490053|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
145490054|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
145490055|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
145490056|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
145490057|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145490058|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145490059|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
145490060|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Physician Decision|0|||
145490061|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Physician Decision|2|||
145490062|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Physician Decision|0|||
145490063|NCT01342913|524648681|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
145490064|NCT01342913|524648682|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145490065|NCT01342913|524648683|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
145490066|NCT05482308|524648686|FG000|Overall Study|Withdrawal by Subject|1|||
145490067|NCT05482308|524648687|FG001|Overall Study|Withdrawal by Subject|0|||
145490068|NCT05482308|524648686|FG000|Overall Study|No longer meets eligibility criteria|0|||
145490069|NCT05482308|524648687|FG001|Overall Study|No longer meets eligibility criteria|1|||
145490070|NCT04319198|524648688|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
145490071|NCT04319198|524648689|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
145490072|NCT04319198|524648690|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
145490073|NCT04319198|524648688|FG000|Overall Study|Death|0|||
145490074|NCT04319198|524648689|FG001|Overall Study|Death|3|||
145490075|NCT04319198|524648690|FG002|Overall Study|Death|3|||
145490076|NCT04319198|524648688|FG000|Overall Study|Reason Not Specified|0|||
145490077|NCT04319198|524648689|FG001|Overall Study|Reason Not Specified|2|||
145490078|NCT04319198|524648690|FG002|Overall Study|Reason Not Specified|4|||
145490079|NCT04319198|524648688|FG000|Overall Study|Withdrawal of Consent|0|||
145490080|NCT04319198|524648689|FG001|Overall Study|Withdrawal of Consent|0|||
145490081|NCT04319198|524648690|FG002|Overall Study|Withdrawal of Consent|5|||
145490082|NCT04319198|524648688|FG000|Overall Study|Site Terminated by Sponsor|0|||
145490083|NCT04319198|524648689|FG001|Overall Study|Site Terminated by Sponsor|1|||
145490084|NCT04319198|524648690|FG002|Overall Study|Site Terminated by Sponsor|0|||
145490085|NCT05801991|524648691|FG000|Overall Study|Lost to Follow-up|1|||
145490086|NCT05801991|524648692|FG001|Overall Study|Lost to Follow-up|0|||
145490087|NCT03489863|524648694|FG000|Overall Study|Withdrawal by Subject|0|||
145490088|NCT03489863|524648695|FG001|Overall Study|Withdrawal by Subject|1|||
145655919|NCT03931174|525257362|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
145655920|NCT03931174|525257361|FG000|Providers|Lost to Follow-up|4|||
145655921|NCT03931174|525257362|FG001|Providers|Lost to Follow-up|4|||
145655922|NCT03931174|525257361|FG000|Patients|Post-consent screening failure|1|||
145655923|NCT03931174|525257362|FG001|Patients|Post-consent screening failure|1|||
145490089|NCT02995980|524648696|FG000|Overall Study|Lost to Follow-up|14|||
145655924|NCT03931174|525257361|FG000|Patients|Death|1|||
145490090|NCT02792231|524648697|FG000|Overall Study|Patient/guardian decision|32|||
145490091|NCT02792231|524648698|FG001|Overall Study|Patient/guardian decision|42|||
145490092|NCT02792231|524648697|FG000|Overall Study|Adverse Event|15|||
145490093|NCT02792231|524648698|FG001|Overall Study|Adverse Event|11|||
145490094|NCT02792231|524648697|FG000|Overall Study|Physician Decision|14|||
145490095|NCT02792231|524648698|FG001|Overall Study|Physician Decision|12|||
145490096|NCT02792231|524648697|FG000|Overall Study|Lack of Efficacy|7|||
145490097|NCT02792231|524648698|FG001|Overall Study|Lack of Efficacy|9|||
145490098|NCT02792231|524648697|FG000|Overall Study|Lost to Follow-up|9|||
145490099|NCT02792231|524648698|FG001|Overall Study|Lost to Follow-up|5|||
145655925|NCT03931174|525257362|FG001|Patients|Death|1|||
145490100|NCT02792231|524648697|FG000|Overall Study|Pregnancy|1|||
145490101|NCT02792231|524648698|FG001|Overall Study|Pregnancy|3|||
145490102|NCT02792231|524648697|FG000|Overall Study|Non-compliance with study treatment|2|||
145490103|NCT02792231|524648698|FG001|Overall Study|Non-compliance with study treatment|1|||
145490104|NCT02792231|524648697|FG000|Overall Study|Protocol deviation|2|||
145490105|NCT02792231|524648698|FG001|Overall Study|Protocol deviation|0|||
145490106|NCT02792231|524648697|FG000|Overall Study|Technical problems|0|||
145490107|NCT02792231|524648698|FG001|Overall Study|Technical problems|1|||
145490108|NCT05196828|524648699|FG000|Overall Study|Withdrawal by Subject|2|||
145490109|NCT05196828|524648700|FG001|Overall Study|Withdrawal by Subject|0|||
145490110|NCT05196828|524648699|FG000|Overall Study|Lost to Follow-up|0|||
145490111|NCT05196828|524648700|FG001|Overall Study|Lost to Follow-up|4|||
145490112|NCT05196828|524648699|FG000|Overall Study|Adverse Event|1|||
145490113|NCT05196828|524648700|FG001|Overall Study|Adverse Event|0|||
145490114|NCT04073186|524648701|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
145490115|NCT04073186|524648701|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
145490116|NCT04073186|524648701|FG000|First Wearing Cycle|Protocol Violation|1|||
145490117|NCT04073186|524648701|FG000|First Wearing Cycle|Lens Discomfort|2|||
145490118|NCT04073186|524648701|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
145490119|NCT04073186|524648701|FG000|Second Wearing Cycle|Adverse Event|1|||
145490120|NCT00473434|524648702|FG000|Overall Study|Physician Decision|3|||
145490121|NCT00473434|524648702|FG000|Overall Study|Withdrawal by Subject|9|||
145490122|NCT00473434|524648702|FG000|Overall Study|Compliance|3|||
145490123|NCT00473434|524648702|FG000|Overall Study|Lack of Efficacy|3|||
145490124|NCT00473434|524648702|FG000|Overall Study|Adverse Event|3|||
145490125|NCT00473434|524648702|FG000|Overall Study|Patient was selling medication to others|1|||
145490126|NCT00473434|524648702|FG000|Overall Study|Safety evaluation|1|||
145490127|NCT00473434|524648702|FG000|Overall Study|Reason not specified|6|||
145490128|NCT00473434|524648702|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
145490129|NCT00473434|524648702|FG000|Overall Study|Switching to trial medication|1|||
145490130|NCT00473434|524648702|FG000|Overall Study|No longer required|1|||
145490131|NCT00423657|524648703|FG000|Overall Study|Withdrew consent|10|||
145490132|NCT00423657|524648704|FG001|Overall Study|Withdrew consent|8|||
145490133|NCT00423657|524648703|FG000|Overall Study|Non-compliance|0|||
145490134|NCT00423657|524648704|FG001|Overall Study|Non-compliance|1|||
145490135|NCT00423657|524648703|FG000|Overall Study|Other|15|||
145490136|NCT00423657|524648704|FG001|Overall Study|Other|16|||
145490137|NCT00423657|524648703|FG000|Overall Study|Request of sponsor/investigator|1|||
145490138|NCT00423657|524648704|FG001|Overall Study|Request of sponsor/investigator|0|||
145490139|NCT02748863|524648705|FG000|Treatment Period 1|Adverse Event|0|||
145490140|NCT02748863|524648706|FG001|Treatment Period 1|Adverse Event|1|||
145490141|NCT02748863|524648707|FG002|Treatment Period 1|Adverse Event|0|||
145490142|NCT02748863|524648708|FG003|Treatment Period 1|Adverse Event|0|||
145490143|NCT02748863|524648709|FG004|Treatment Period 1|Adverse Event|0|||
145490144|NCT02748863|524648705|FG000|Treatment Period 1|Lack of Efficacy|0|||
145490145|NCT02748863|524648706|FG001|Treatment Period 1|Lack of Efficacy|0|||
145490146|NCT02748863|524648707|FG002|Treatment Period 1|Lack of Efficacy|1|||
145490147|NCT02748863|524648708|FG003|Treatment Period 1|Lack of Efficacy|0|||
145490148|NCT02748863|524648709|FG004|Treatment Period 1|Lack of Efficacy|0|||
145490149|NCT02748863|524648705|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145490150|NCT02748863|524648706|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145490151|NCT02748863|524648707|FG002|Treatment Period 1|Withdrawal by Subject|1|||
145490152|NCT02748863|524648708|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145490153|NCT02748863|524648709|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145490154|NCT02748863|524648705|FG000|Treatment Period 2|Lost to Follow-up|2|||
145490155|NCT02748863|524648706|FG001|Treatment Period 2|Lost to Follow-up|0|||
145490156|NCT02748863|524648707|FG002|Treatment Period 2|Lost to Follow-up|0|||
145490157|NCT02748863|524648708|FG003|Treatment Period 2|Lost to Follow-up|0|||
145490158|NCT02748863|524648709|FG004|Treatment Period 2|Lost to Follow-up|0|||
145490159|NCT02748863|524648705|FG000|Treatment Period 2|Adverse Event|3|||
145490160|NCT02748863|524648706|FG001|Treatment Period 2|Adverse Event|2|||
145490161|NCT02748863|524648707|FG002|Treatment Period 2|Adverse Event|0|||
145490162|NCT02748863|524648708|FG003|Treatment Period 2|Adverse Event|2|||
145490163|NCT02748863|524648709|FG004|Treatment Period 2|Adverse Event|0|||
145490164|NCT02748863|524648705|FG000|Treatment Period 2|Lack of Efficacy|0|||
145490165|NCT02748863|524648706|FG001|Treatment Period 2|Lack of Efficacy|1|||
145490166|NCT02748863|524648707|FG002|Treatment Period 2|Lack of Efficacy|0|||
145490167|NCT02748863|524648708|FG003|Treatment Period 2|Lack of Efficacy|0|||
145490168|NCT02748863|524648709|FG004|Treatment Period 2|Lack of Efficacy|0|||
145490169|NCT02748863|524648705|FG000|Treatment Period 2|Pregnancy|0|||
145490170|NCT02748863|524648706|FG001|Treatment Period 2|Pregnancy|0|||
145490171|NCT02748863|524648707|FG002|Treatment Period 2|Pregnancy|0|||
145490172|NCT02748863|524648708|FG003|Treatment Period 2|Pregnancy|0|||
145490173|NCT02748863|524648709|FG004|Treatment Period 2|Pregnancy|1|||
145490174|NCT02422498|524648710|FG000|Overall Study|Inevaluable|4|||
145490175|NCT03206216|524648711|FG000|Overall Study|Withdrawal by Subject|0|||
145490176|NCT03206216|524648712|FG001|Overall Study|Withdrawal by Subject|1|||
145655926|NCT03931174|525257361|FG000|Patients|Lost to Follow-up|60|||
145655927|NCT03931174|525257362|FG001|Patients|Lost to Follow-up|89|||
145655928|NCT05386030|525257365|FG000|Overall Study|Death|1|||
145655929|NCT05386030|525257366|FG001|Overall Study|Death|0|||
145655930|NCT05386030|525257365|FG000|Overall Study|Physician Decision|2|||
145655931|NCT05386030|525257366|FG001|Overall Study|Physician Decision|1|||
145655932|NCT05386030|525257365|FG000|Overall Study|Lost to Follow-up|19|||
145655933|NCT05386030|525257366|FG001|Overall Study|Lost to Follow-up|7|||
145655934|NCT05386030|525257365|FG000|Overall Study|Withdrawal by Subject|20|||
145655935|NCT05386030|525257366|FG001|Overall Study|Withdrawal by Subject|10|||
145655936|NCT05386030|525257365|FG000|Overall Study|Eligibility criteria violation|1|||
145655937|NCT05386030|525257366|FG001|Overall Study|Eligibility criteria violation|1|||
145655938|NCT05386030|525257365|FG000|Overall Study|Personal Reasons|1|||
145655939|NCT05386030|525257366|FG001|Overall Study|Personal Reasons|0|||
145655940|NCT03213691|525257367|FG000|Overall Study|Adverse Event|2|||
145655941|NCT03213691|525257367|FG000|Overall Study|Death|3|||
145655942|NCT03213691|525257367|FG000|Overall Study|Physician Decision|1|||
145655943|NCT03213691|525257367|FG000|Overall Study|Progressive Disease|14|||
145655944|NCT03213691|525257367|FG000|Overall Study|Ineligible|1|||
145655945|NCT03161028|525257368|FG000|Overall Study|Withdrawal by Subject|6|||
145655946|NCT03161028|525257369|FG001|Overall Study|Withdrawal by Subject|4|||
145655947|NCT03161028|525257368|FG000|Overall Study|Adverse Event|5|||
145655948|NCT03161028|525257369|FG001|Overall Study|Adverse Event|1|||
145655949|NCT03161028|525257368|FG000|Overall Study|Study drug side effects|2|||
145655950|NCT03161028|525257369|FG001|Overall Study|Study drug side effects|2|||
145655951|NCT03161028|525257368|FG000|Overall Study|Administrative PD/UP|4|||
145655952|NCT03161028|525257369|FG001|Overall Study|Administrative PD/UP|2|||
145655953|NCT03161028|525257368|FG000|Overall Study|Lost to Follow-up|2|||
145655954|NCT03161028|525257369|FG001|Overall Study|Lost to Follow-up|0|||
145655955|NCT03161028|525257368|FG000|Overall Study|Unable to comply with procedures|1|||
145655956|NCT03161028|525257369|FG001|Overall Study|Unable to comply with procedures|1|||
145655957|NCT00736723|525257370|FG000|Overall Study|Withdrawal by Subject|4|||
145655958|NCT00736723|525257371|FG001|Overall Study|Withdrawal by Subject|3|||
145655959|NCT01799265|525257375|FG000|Overall Study|Lost to Follow-up|1|||
145655960|NCT01799265|525257376|FG001|Overall Study|Lost to Follow-up|0|||
145655961|NCT01799265|525257375|FG000|Overall Study|Protocol Violation|2|||
145655962|NCT01799265|525257376|FG001|Overall Study|Protocol Violation|1|||
145655963|NCT01799265|525257375|FG000|Overall Study|inadequate sleep study|0|||
145655964|NCT01799265|525257376|FG001|Overall Study|inadequate sleep study|2|||
145655965|NCT04049643|525257380|FG000|Overall Study|Lack of Efficacy|1|||
145655966|NCT04049643|525257381|FG001|Overall Study|Lack of Efficacy|1|||
145655967|NCT04049643|525257382|FG002|Overall Study|Lack of Efficacy|0|||
145655968|NCT04049643|525257380|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
145655969|NCT04049643|525257381|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
145655970|NCT04049643|525257382|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
145655971|NCT04728347|525259486|FG000|Overall Study|Sponsor decision|0|||
145655972|NCT04728347|525259487|FG001|Overall Study|Sponsor decision|0|||
145655973|NCT04728347|525259488|FG002|Overall Study|Sponsor decision|1|||
145655974|NCT04728347|525259489|FG003|Overall Study|Sponsor decision|0|||
145655975|NCT03867500|525259490|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
145655976|NCT00753545|525259491|FG000|Overall Study|Death|98|||
145655977|NCT00753545|525259492|FG001|Overall Study|Death|112|||
145655978|NCT00753545|525259491|FG000|Overall Study|Lost to Follow-up|2|||
145655979|NCT00753545|525259492|FG001|Overall Study|Lost to Follow-up|3|||
145655980|NCT00753545|525259491|FG000|Overall Study|Protocol Violation|1|||
145655981|NCT00753545|525259492|FG001|Overall Study|Protocol Violation|0|||
145655982|NCT00753545|525259491|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
145655983|NCT00753545|525259492|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
145655984|NCT04149704|525259498|FG000|Three Month Follow-up|Death|2|||
145655985|NCT04149704|525259499|FG001|Three Month Follow-up|Death|0|||
145655986|NCT04149704|525259500|FG002|Three Month Follow-up|Death|0|||
145655987|NCT04149704|525259501|FG003|Three Month Follow-up|Death|0|||
145655988|NCT04149704|525259498|FG000|Three Month Follow-up|Lost to Follow-up|1|||
145655989|NCT04149704|525259499|FG001|Three Month Follow-up|Lost to Follow-up|4|||
145655990|NCT04149704|525259500|FG002|Three Month Follow-up|Lost to Follow-up|5|||
145655991|NCT04149704|525259501|FG003|Three Month Follow-up|Lost to Follow-up|5|||
145655992|NCT04149704|525259498|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
145655993|NCT04149704|525259499|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
145655994|NCT04149704|525259500|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
145655995|NCT04149704|525259501|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
145655996|NCT04149704|525259498|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
145655997|NCT04149704|525259499|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
145655998|NCT04149704|525259500|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
145655999|NCT04149704|525259501|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
145656000|NCT04632992|525259506|FG000|Overall Study|Adverse Event|0|||
145656001|NCT04632992|525259507|FG001|Overall Study|Adverse Event|0|||
145656002|NCT04632992|525259508|FG002|Overall Study|Adverse Event|0|||
145656003|NCT04632992|525259509|FG003|Overall Study|Adverse Event|0|||
145656004|NCT04632992|525259510|FG004|Overall Study|Adverse Event|0|||
145656005|NCT04632992|525259511|FG005|Overall Study|Adverse Event|0|||
145656006|NCT04632992|525259512|FG006|Overall Study|Adverse Event|0|||
145656007|NCT04632992|525259513|FG007|Overall Study|Adverse Event|0|||
145656008|NCT04632992|525259514|FG008|Overall Study|Adverse Event|0|||
145656009|NCT04632992|525259515|FG009|Overall Study|Adverse Event|0|||
145656010|NCT04632992|525259516|FG010|Overall Study|Adverse Event|0|||
145656011|NCT04632992|525259517|FG011|Overall Study|Adverse Event|0|||
145656012|NCT04632992|525259518|FG012|Overall Study|Adverse Event|1|||
145656013|NCT04632992|525259519|FG013|Overall Study|Adverse Event|0|||
145656014|NCT04632992|525259506|FG000|Overall Study|Death|17|||
145656015|NCT04632992|525259507|FG001|Overall Study|Death|1|||
145656016|NCT04632992|525259508|FG002|Overall Study|Death|14|||
145656017|NCT04632992|525259509|FG003|Overall Study|Death|14|||
145656018|NCT04632992|525259510|FG004|Overall Study|Death|13|||
145656019|NCT04632992|525259511|FG005|Overall Study|Death|6|||
145656020|NCT04632992|525259512|FG006|Overall Study|Death|7|||
145656021|NCT04632992|525259513|FG007|Overall Study|Death|12|||
145656022|NCT04632992|525259514|FG008|Overall Study|Death|15|||
145656023|NCT04632992|525259515|FG009|Overall Study|Death|20|||
145656024|NCT04632992|525259516|FG010|Overall Study|Death|8|||
145656025|NCT04632992|525259517|FG011|Overall Study|Death|2|||
145656026|NCT04632992|525259518|FG012|Overall Study|Death|10|||
145656027|NCT04632992|525259519|FG013|Overall Study|Death|1|||
145656028|NCT04632992|525259506|FG000|Overall Study|Lost to Follow-up|1|||
145656029|NCT04632992|525259507|FG001|Overall Study|Lost to Follow-up|0|||
145656030|NCT04632992|525259508|FG002|Overall Study|Lost to Follow-up|1|||
145656031|NCT04632992|525259509|FG003|Overall Study|Lost to Follow-up|0|||
145656032|NCT04632992|525259510|FG004|Overall Study|Lost to Follow-up|2|||
145656033|NCT04632992|525259511|FG005|Overall Study|Lost to Follow-up|0|||
145656034|NCT04632992|525259512|FG006|Overall Study|Lost to Follow-up|1|||
145656035|NCT04632992|525259513|FG007|Overall Study|Lost to Follow-up|1|||
145656036|NCT04632992|525259514|FG008|Overall Study|Lost to Follow-up|1|||
145656037|NCT04632992|525259515|FG009|Overall Study|Lost to Follow-up|1|||
145656038|NCT04632992|525259516|FG010|Overall Study|Lost to Follow-up|2|||
145656039|NCT04632992|525259517|FG011|Overall Study|Lost to Follow-up|0|||
145656040|NCT04632992|525259518|FG012|Overall Study|Lost to Follow-up|0|||
145656041|NCT04632992|525259519|FG013|Overall Study|Lost to Follow-up|0|||
145656042|NCT04632992|525259506|FG000|Overall Study|Reason not Specified|2|||
145656043|NCT04632992|525259507|FG001|Overall Study|Reason not Specified|0|||
145656044|NCT04632992|525259508|FG002|Overall Study|Reason not Specified|1|||
145656045|NCT04632992|525259509|FG003|Overall Study|Reason not Specified|1|||
145656046|NCT04632992|525259510|FG004|Overall Study|Reason not Specified|0|||
145656047|NCT04632992|525259511|FG005|Overall Study|Reason not Specified|0|||
145656048|NCT04632992|525259512|FG006|Overall Study|Reason not Specified|0|||
145656049|NCT04632992|525259513|FG007|Overall Study|Reason not Specified|0|||
145656050|NCT04632992|525259514|FG008|Overall Study|Reason not Specified|0|||
145656051|NCT04632992|525259515|FG009|Overall Study|Reason not Specified|0|||
145656052|NCT04632992|525259516|FG010|Overall Study|Reason not Specified|1|||
145656053|NCT04632992|525259517|FG011|Overall Study|Reason not Specified|0|||
145656054|NCT04632992|525259518|FG012|Overall Study|Reason not Specified|0|||
145656055|NCT04632992|525259519|FG013|Overall Study|Reason not Specified|0|||
145656056|NCT04632992|525259506|FG000|Overall Study|Physician Decision|0|||
145656057|NCT04632992|525259507|FG001|Overall Study|Physician Decision|0|||
145656058|NCT04632992|525259508|FG002|Overall Study|Physician Decision|0|||
145656059|NCT04632992|525259509|FG003|Overall Study|Physician Decision|2|||
145656060|NCT04632992|525259510|FG004|Overall Study|Physician Decision|1|||
145656061|NCT04632992|525259511|FG005|Overall Study|Physician Decision|0|||
145656062|NCT04632992|525259512|FG006|Overall Study|Physician Decision|0|||
145656063|NCT04632992|525259513|FG007|Overall Study|Physician Decision|0|||
145656064|NCT04632992|525259514|FG008|Overall Study|Physician Decision|0|||
145656065|NCT04632992|525259515|FG009|Overall Study|Physician Decision|0|||
145656066|NCT04632992|525259516|FG010|Overall Study|Physician Decision|0|||
145656067|NCT04632992|525259517|FG011|Overall Study|Physician Decision|0|||
145656068|NCT04632992|525259518|FG012|Overall Study|Physician Decision|3|||
145656069|NCT04632992|525259519|FG013|Overall Study|Physician Decision|0|||
145656070|NCT04632992|525259506|FG000|Overall Study|Progressive Disease|0|||
145656071|NCT04632992|525259507|FG001|Overall Study|Progressive Disease|0|||
145656072|NCT04632992|525259508|FG002|Overall Study|Progressive Disease|0|||
145656073|NCT04632992|525259509|FG003|Overall Study|Progressive Disease|0|||
145656074|NCT04632992|525259510|FG004|Overall Study|Progressive Disease|1|||
145656075|NCT04632992|525259511|FG005|Overall Study|Progressive Disease|0|||
145656076|NCT04632992|525259512|FG006|Overall Study|Progressive Disease|0|||
145656077|NCT04632992|525259513|FG007|Overall Study|Progressive Disease|0|||
145656078|NCT04632992|525259514|FG008|Overall Study|Progressive Disease|0|||
145656079|NCT04632992|525259515|FG009|Overall Study|Progressive Disease|1|||
145656080|NCT04632992|525259516|FG010|Overall Study|Progressive Disease|1|||
145656081|NCT04632992|525259517|FG011|Overall Study|Progressive Disease|0|||
145656082|NCT04632992|525259518|FG012|Overall Study|Progressive Disease|2|||
145656083|NCT04632992|525259519|FG013|Overall Study|Progressive Disease|0|||
145656084|NCT04632992|525259506|FG000|Overall Study|Withdrawal by Subject|4|||
145656085|NCT04632992|525259507|FG001|Overall Study|Withdrawal by Subject|1|||
145656086|NCT04632992|525259508|FG002|Overall Study|Withdrawal by Subject|5|||
145656087|NCT04632992|525259509|FG003|Overall Study|Withdrawal by Subject|4|||
145656088|NCT04632992|525259510|FG004|Overall Study|Withdrawal by Subject|3|||
145656089|NCT04632992|525259511|FG005|Overall Study|Withdrawal by Subject|3|||
145656090|NCT04632992|525259512|FG006|Overall Study|Withdrawal by Subject|0|||
145656091|NCT04632992|525259513|FG007|Overall Study|Withdrawal by Subject|5|||
145656092|NCT04632992|525259514|FG008|Overall Study|Withdrawal by Subject|0|||
145656093|NCT04632992|525259515|FG009|Overall Study|Withdrawal by Subject|2|||
145656094|NCT04632992|525259516|FG010|Overall Study|Withdrawal by Subject|8|||
145656095|NCT04632992|525259517|FG011|Overall Study|Withdrawal by Subject|0|||
145656096|NCT04632992|525259518|FG012|Overall Study|Withdrawal by Subject|1|||
145656097|NCT04632992|525259519|FG013|Overall Study|Withdrawal by Subject|1|||
145656098|NCT02268253|525259520|FG000|Stage 1|Withdrawal by Subject|1|||
145656099|NCT02268253|525259521|FG001|Stage 1|Withdrawal by Subject|0|||
145656100|NCT02268253|525259522|FG002|Stage 1|Withdrawal by Subject|0|||
145656101|NCT02268253|525259523|FG003|Stage 1|Withdrawal by Subject|0|||
145656102|NCT02268253|525259524|FG004|Stage 1|Withdrawal by Subject|0|||
145656103|NCT02268253|525259525|FG005|Stage 1|Withdrawal by Subject|0|||
145656104|NCT02268253|525259526|FG006|Stage 1|Withdrawal by Subject|0|||
145656105|NCT02268253|525259520|FG000|Stage 1|Death|0|||
145656106|NCT02268253|525259521|FG001|Stage 1|Death|2|||
145656107|NCT02268253|525259522|FG002|Stage 1|Death|2|||
145656108|NCT02268253|525259523|FG003|Stage 1|Death|2|||
145656109|NCT02268253|525259524|FG004|Stage 1|Death|1|||
145656110|NCT02268253|525259525|FG005|Stage 1|Death|1|||
145656111|NCT02268253|525259526|FG006|Stage 1|Death|0|||
145656112|NCT02268253|525259520|FG000|Stage 2|Disease Recurrence/ Progression|0|||
145656113|NCT02268253|525259521|FG001|Stage 2|Disease Recurrence/ Progression|0|||
145656114|NCT02268253|525259522|FG002|Stage 2|Disease Recurrence/ Progression|1|||
145656115|NCT02268253|525259523|FG003|Stage 2|Disease Recurrence/ Progression|0|||
145656116|NCT02268253|525259524|FG004|Stage 2|Disease Recurrence/ Progression|0|||
145656117|NCT02268253|525259525|FG005|Stage 2|Disease Recurrence/ Progression|0|||
145656118|NCT02268253|525259526|FG006|Stage 2|Disease Recurrence/ Progression|0|||
145656119|NCT02268253|525259520|FG000|Stage 2|Withdrawal by Subject|0|||
145656120|NCT02268253|525259521|FG001|Stage 2|Withdrawal by Subject|0|||
145656121|NCT02268253|525259522|FG002|Stage 2|Withdrawal by Subject|2|||
145656122|NCT02268253|525259523|FG003|Stage 2|Withdrawal by Subject|0|||
145656123|NCT02268253|525259524|FG004|Stage 2|Withdrawal by Subject|0|||
145656124|NCT02268253|525259525|FG005|Stage 2|Withdrawal by Subject|2|||
145656125|NCT02268253|525259526|FG006|Stage 2|Withdrawal by Subject|0|||
145656126|NCT02268253|525259520|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
145656127|NCT02268253|525259521|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
145656128|NCT02268253|525259522|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
145656129|NCT02268253|525259523|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
145490177|NCT06237049|524648713|FG000|Overall Study|Death|0|||
145656130|NCT02268253|525259524|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
145656131|NCT02268253|525259525|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
145656132|NCT02268253|525259526|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
145656133|NCT02268253|525259520|FG000|Stage 2|Death|0|||
145490178|NCT06237049|524648714|FG001|Overall Study|Death|0|||
145656134|NCT02268253|525259521|FG001|Stage 2|Death|0|||
145490179|NCT06237049|524648715|FG002|Overall Study|Death|0|||
145490180|NCT06237049|524648716|FG003|Overall Study|Death|1|||
145490181|NCT06237049|524648713|FG000|Overall Study|Lost to Follow-up|11|||
145490182|NCT06237049|524648714|FG001|Overall Study|Lost to Follow-up|5|||
145490183|NCT06237049|524648715|FG002|Overall Study|Lost to Follow-up|8|||
145490184|NCT06237049|524648716|FG003|Overall Study|Lost to Follow-up|8|||
145490185|NCT06237049|524648713|FG000|Overall Study|Protocol Violation|0|||
145490186|NCT06237049|524648714|FG001|Overall Study|Protocol Violation|1|||
145490187|NCT06237049|524648715|FG002|Overall Study|Protocol Violation|0|||
145490188|NCT06237049|524648716|FG003|Overall Study|Protocol Violation|1|||
145490189|NCT06237049|524648713|FG000|Overall Study|Withdrawal by Subject|4|||
145490190|NCT06237049|524648714|FG001|Overall Study|Withdrawal by Subject|2|||
145656135|NCT02268253|525259522|FG002|Stage 2|Death|19|||
145656136|NCT02268253|525259523|FG003|Stage 2|Death|0|||
145656137|NCT02268253|525259524|FG004|Stage 2|Death|0|||
145490191|NCT06237049|524648715|FG002|Overall Study|Withdrawal by Subject|1|||
145656138|NCT02268253|525259525|FG005|Stage 2|Death|20|||
145656139|NCT02268253|525259526|FG006|Stage 2|Death|1|||
145656140|NCT02268253|525259520|FG000|Stage 2|Lost to Follow-up|0|||
145656141|NCT02268253|525259521|FG001|Stage 2|Lost to Follow-up|0|||
145656142|NCT02268253|525259522|FG002|Stage 2|Lost to Follow-up|0|||
145656143|NCT02268253|525259523|FG003|Stage 2|Lost to Follow-up|0|||
145656144|NCT02268253|525259524|FG004|Stage 2|Lost to Follow-up|0|||
145656145|NCT02268253|525259525|FG005|Stage 2|Lost to Follow-up|4|||
145656146|NCT02268253|525259526|FG006|Stage 2|Lost to Follow-up|0|||
145656147|NCT02268253|525259520|FG000|Stage 2|Transferred to Hospice|0|||
145656148|NCT02268253|525259521|FG001|Stage 2|Transferred to Hospice|0|||
145656149|NCT02268253|525259522|FG002|Stage 2|Transferred to Hospice|0|||
145656150|NCT02268253|525259523|FG003|Stage 2|Transferred to Hospice|0|||
145656151|NCT02268253|525259524|FG004|Stage 2|Transferred to Hospice|0|||
145656152|NCT02268253|525259525|FG005|Stage 2|Transferred to Hospice|2|||
145656153|NCT02268253|525259526|FG006|Stage 2|Transferred to Hospice|0|||
145656154|NCT02268253|525259520|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
145656155|NCT02268253|525259521|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
145656156|NCT02268253|525259522|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
145656157|NCT02268253|525259523|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
145656158|NCT02268253|525259524|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
145656159|NCT02268253|525259525|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
145656160|NCT02268253|525259526|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
145656161|NCT02268253|525259520|FG000|Stage 3A|Withdrawal by Subject|0|||
145656162|NCT02268253|525259521|FG001|Stage 3A|Withdrawal by Subject|0|||
145656163|NCT02268253|525259522|FG002|Stage 3A|Withdrawal by Subject|2|||
145656164|NCT02268253|525259523|FG003|Stage 3A|Withdrawal by Subject|0|||
145656165|NCT02268253|525259524|FG004|Stage 3A|Withdrawal by Subject|0|||
145656166|NCT02268253|525259525|FG005|Stage 3A|Withdrawal by Subject|0|||
145656167|NCT02268253|525259526|FG006|Stage 3A|Withdrawal by Subject|0|||
145656168|NCT02268253|525259520|FG000|Stage 3A|Physician Decision|0|||
145656169|NCT02268253|525259521|FG001|Stage 3A|Physician Decision|0|||
145656170|NCT02268253|525259522|FG002|Stage 3A|Physician Decision|2|||
145656171|NCT02268253|525259523|FG003|Stage 3A|Physician Decision|0|||
145656172|NCT02268253|525259524|FG004|Stage 3A|Physician Decision|0|||
145656173|NCT02268253|525259525|FG005|Stage 3A|Physician Decision|0|||
145656174|NCT02268253|525259526|FG006|Stage 3A|Physician Decision|0|||
145656175|NCT02268253|525259520|FG000|Stage 3A|Study Terminated by Sponsor|0|||
145656176|NCT02268253|525259521|FG001|Stage 3A|Study Terminated by Sponsor|0|||
145656177|NCT02268253|525259522|FG002|Stage 3A|Study Terminated by Sponsor|2|||
145656178|NCT02268253|525259523|FG003|Stage 3A|Study Terminated by Sponsor|0|||
145656179|NCT02268253|525259524|FG004|Stage 3A|Study Terminated by Sponsor|0|||
145656180|NCT02268253|525259525|FG005|Stage 3A|Study Terminated by Sponsor|0|||
145656181|NCT02268253|525259526|FG006|Stage 3A|Study Terminated by Sponsor|0|||
145656182|NCT02268253|525259520|FG000|Stage 3A|Lost to Follow-up|0|||
145656183|NCT02268253|525259521|FG001|Stage 3A|Lost to Follow-up|0|||
145656184|NCT02268253|525259522|FG002|Stage 3A|Lost to Follow-up|1|||
145656185|NCT02268253|525259523|FG003|Stage 3A|Lost to Follow-up|0|||
145656186|NCT02268253|525259524|FG004|Stage 3A|Lost to Follow-up|0|||
145656187|NCT02268253|525259525|FG005|Stage 3A|Lost to Follow-up|0|||
145656188|NCT02268253|525259526|FG006|Stage 3A|Lost to Follow-up|0|||
145656189|NCT02268253|525259520|FG000|Stage 3A|Death|0|||
145656190|NCT02268253|525259521|FG001|Stage 3A|Death|0|||
145656191|NCT02268253|525259522|FG002|Stage 3A|Death|5|||
145656192|NCT02268253|525259523|FG003|Stage 3A|Death|0|||
145656193|NCT02268253|525259524|FG004|Stage 3A|Death|0|||
145656194|NCT02268253|525259525|FG005|Stage 3A|Death|0|||
145656195|NCT02268253|525259526|FG006|Stage 3A|Death|0|||
145656196|NCT02146378|525259527|FG000|Overall Study|No information of administration|2|||
145656197|NCT04096040|525259537|FG000|Overall Study|Protocol Violation|12|||
145656198|NCT04096040|525259537|FG000|Overall Study|Non-compliant site|4|||
145656199|NCT04973254|525259540|FG000|Overall Study|Not adherent|0|||
145656200|NCT04973254|525259541|FG001|Overall Study|Not adherent|1|||
145656201|NCT04973254|525259542|FG002|Overall Study|Not adherent|0|||
145656202|NCT03603600|525259543|FG000|Overall Study|Withdrawal by Subject|5|||
145656203|NCT03603600|525259544|FG001|Overall Study|Withdrawal by Subject|7|||
145656204|NCT03603600|525259543|FG000|Overall Study|Lost to Follow-up|2|||
145656205|NCT03603600|525259544|FG001|Overall Study|Lost to Follow-up|3|||
145656206|NCT03603600|525259543|FG000|Overall Study|Death|3|||
145656207|NCT03603600|525259544|FG001|Overall Study|Death|1|||
145656208|NCT03603600|525259543|FG000|Overall Study|Physician Decision|2|||
145656209|NCT03603600|525259544|FG001|Overall Study|Physician Decision|1|||
145656210|NCT03603600|525259543|FG000|Overall Study|Other reason|1|||
145656211|NCT03603600|525259544|FG001|Overall Study|Other reason|0|||
145656212|NCT04044768|525259545|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
145656213|NCT04044768|525259546|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
145656214|NCT04925986|525259550|FG000|Overall Study|Death|0|||
145656215|NCT04925986|525259551|FG001|Overall Study|Death|0|||
145656216|NCT04925986|525259552|FG002|Overall Study|Death|2|||
145656217|NCT04925986|525259553|FG003|Overall Study|Death|0|||
145656218|NCT04925986|525259550|FG000|Overall Study|Lack of Efficacy|1|||
145656219|NCT04925986|525259551|FG001|Overall Study|Lack of Efficacy|2|||
145656220|NCT04925986|525259552|FG002|Overall Study|Lack of Efficacy|0|||
145656221|NCT04925986|525259553|FG003|Overall Study|Lack of Efficacy|1|||
145656222|NCT04925986|525259550|FG000|Overall Study|Withdrawal by Subject|0|||
145656223|NCT04925986|525259551|FG001|Overall Study|Withdrawal by Subject|0|||
145656224|NCT04925986|525259552|FG002|Overall Study|Withdrawal by Subject|1|||
145656225|NCT04925986|525259553|FG003|Overall Study|Withdrawal by Subject|2|||
145656226|NCT03031470|525259555|FG000|Overall Study|Adverse Event|3|||
145656227|NCT03031470|525259556|FG001|Overall Study|Adverse Event|0|||
145656228|NCT03031470|525259555|FG000|Overall Study|Death|3|||
145656229|NCT03031470|525259556|FG001|Overall Study|Death|1|||
145656230|NCT03031470|525259555|FG000|Overall Study|Lost to Follow-up|1|||
145490192|NCT06237049|524648716|FG003|Overall Study|Withdrawal by Subject|0|||
145490193|NCT02525471|524648717|FG000|Overall Study|Screen Failure|6|||
145490194|NCT02525471|524648717|FG000|Overall Study|Withdrawal by Subject|4|||
145490195|NCT02525471|524648717|FG000|Overall Study|Death|1|||
145490196|NCT00844376|524648718|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
145490197|NCT00844376|524648719|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
145490198|NCT00988884|524648720|FG000|Overall Study|Adverse Event|0|||
145490199|NCT00988884|524648721|FG001|Overall Study|Adverse Event|1|||
145490200|NCT00988884|524648720|FG000|Overall Study|Lost to Follow-up|20|||
145490201|NCT00988884|524648721|FG001|Overall Study|Lost to Follow-up|16|||
145490202|NCT00988884|524648720|FG000|Overall Study|Protocol Violation|0|||
145490203|NCT00988884|524648721|FG001|Overall Study|Protocol Violation|1|||
145490204|NCT00988884|524648720|FG000|Overall Study|Withdrawal by Subject|15|||
145490205|NCT00988884|524648721|FG001|Overall Study|Withdrawal by Subject|18|||
145490206|NCT00468299|524648724|FG000|Overall Study|Withdrawal by Subject|0|||
145490207|NCT00468299|524648725|FG001|Overall Study|Withdrawal by Subject|1|||
145490208|NCT00377520|524648733|FG000|Overall Study|Ineligible (Prior radiation)|1|||
145490209|NCT00660192|524648734|FG000|Overall Study|Lost to Follow-up|2|||
145490210|NCT00660192|524648735|FG001|Overall Study|Lost to Follow-up|3|||
145490211|NCT04908397|524648736|FG000|Overall Study|Withdrawal by Subject|2|||
145490212|NCT01917747|524648737|FG000|Overall Study|Withdrawal by Subject|1|||
145490213|NCT01917747|524648738|FG001|Overall Study|Withdrawal by Subject|2|||
145490214|NCT01917747|524648737|FG000|Overall Study|Lost to Follow-up|18|||
145490215|NCT01917747|524648738|FG001|Overall Study|Lost to Follow-up|9|||
145490216|NCT01787461|524648740|FG000|Overall Study|Adverse Event|4|||
145490217|NCT01787461|524648741|FG001|Overall Study|Adverse Event|3|||
145490218|NCT01787461|524648740|FG000|Overall Study|Lost to Follow-up|3|||
145490219|NCT01787461|524648741|FG001|Overall Study|Lost to Follow-up|2|||
145490220|NCT01787461|524648740|FG000|Overall Study|No longer met eligibility criteria|1|||
145490221|NCT01787461|524648741|FG001|Overall Study|No longer met eligibility criteria|0|||
145490222|NCT01787461|524648740|FG000|Overall Study|Withdrawal by Subject|3|||
145490223|NCT01787461|524648741|FG001|Overall Study|Withdrawal by Subject|4|||
145490224|NCT01787461|524648740|FG000|Overall Study|Protocol Violation|3|||
145490225|NCT01787461|524648741|FG001|Overall Study|Protocol Violation|0|||
145490226|NCT03861273|524648749|FG000|Screening Phase (3 Weeks)|Other|1|||
145490227|NCT03861273|524648749|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
145490228|NCT03861273|524648749|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
145490229|NCT03861273|524648749|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
145490230|NCT03861273|524648749|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
145490231|NCT00191334|524648750|FG000|Overall Study|Adverse Event|4|||
145490232|NCT00191334|524648750|FG000|Overall Study|Disease Progression or Relapse|8|||
145490233|NCT00191334|524648750|FG000|Overall Study|Physician Decision|1|||
145490234|NCT00191334|524648750|FG000|Overall Study|Withdrawal by Subject|4|||
145490235|NCT01116648|524648751|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
145490236|NCT01116648|524648752|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
145490237|NCT01116648|524648753|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
145490238|NCT01116648|524648754|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
145490239|NCT01116648|524648755|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
145490240|NCT01116648|524648756|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
145490241|NCT01116648|524648757|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
145490242|NCT01116648|524648758|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
145490243|NCT01116648|524648759|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
145490244|NCT01116648|524648760|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
145490245|NCT01116648|524648761|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
145656231|NCT03031470|525259556|FG001|Overall Study|Lost to Follow-up|1|||
145656232|NCT03031470|525259555|FG000|Overall Study|Withdrawal by Subject|1|||
145656233|NCT03031470|525259556|FG001|Overall Study|Withdrawal by Subject|0|||
145656234|NCT03031470|525259555|FG000|Overall Study|Protocol entry criteria not met|0|||
145490246|NCT01116648|524648762|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
145490247|NCT01116648|524648763|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
145490248|NCT01116648|524648764|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
145490249|NCT01116648|524648765|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
145490250|NCT04539938|524648766|FG000|Overall Study|Death|30|||
145490251|NCT04539938|524648766|FG000|Overall Study|Withdrawal by Subject|4|||
145490252|NCT03064490|524648767|FG000|Overall Study|Physician Decision|5|||
145490253|NCT02926638|524648772|FG000|Overall Study|Progression|2|||
145490254|NCT02926638|524648773|FG001|Overall Study|Progression|5|||
145490255|NCT02926638|524648772|FG000|Overall Study|Ineligible|1|||
145490256|NCT02926638|524648773|FG001|Overall Study|Ineligible|0|||
145490257|NCT02926638|524648772|FG000|Overall Study|Not protocol specified|1|||
145490258|NCT02926638|524648773|FG001|Overall Study|Not protocol specified|0|||
145656235|NCT03031470|525259556|FG001|Overall Study|Protocol entry criteria not met|1|||
145656236|NCT03031470|525259555|FG000|Overall Study|Cancel the operation|0|||
145656237|NCT03031470|525259556|FG001|Overall Study|Cancel the operation|1|||
145656238|NCT01943409|525259560|FG000|Overall Study|resumed oral/entral|24|||
145656239|NCT01943409|525259561|FG001|Overall Study|resumed oral/entral|20|||
145656240|NCT01943409|525259560|FG000|Overall Study|Protocol Violation|14|||
145656241|NCT01943409|525259561|FG001|Overall Study|Protocol Violation|24|||
145656242|NCT01943409|525259560|FG000|Overall Study|Death|3|||
145656243|NCT01943409|525259561|FG001|Overall Study|Death|1|||
145656244|NCT01943409|525259560|FG000|Overall Study|Withdrawal by Subject|4|||
145656245|NCT01943409|525259561|FG001|Overall Study|Withdrawal by Subject|3|||
145656246|NCT02489903|525259562|FG000|Screening|Screen Failure|24|||
145656247|NCT02489903|525259563|FG001|Screening|Screen Failure|0|||
145656248|NCT02489903|525259564|FG002|Screening|Screen Failure|0|||
145656249|NCT02489903|525259565|FG003|Screening|Screen Failure|8|||
145656250|NCT02489903|525259562|FG000|Randomized and Received Treatment|Protocol Violation|0|||
145656251|NCT02489903|525259563|FG001|Randomized and Received Treatment|Protocol Violation|1|||
145656252|NCT02489903|525259564|FG002|Randomized and Received Treatment|Protocol Violation|0|||
145656253|NCT02489903|525259565|FG003|Randomized and Received Treatment|Protocol Violation|0|||
145656254|NCT02489903|525259562|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
145656255|NCT02489903|525259563|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
145656256|NCT02489903|525259564|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
145656257|NCT02489903|525259565|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
145656258|NCT02489903|525259562|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
145656259|NCT02489903|525259563|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
145656260|NCT02489903|525259564|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
145656261|NCT02489903|525259565|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
145656262|NCT02489903|525259562|FG000|Randomized and Received Treatment|Death|10|||
145656263|NCT02489903|525259563|FG001|Randomized and Received Treatment|Death|1|||
145656264|NCT02489903|525259564|FG002|Randomized and Received Treatment|Death|0|||
145656265|NCT02489903|525259565|FG003|Randomized and Received Treatment|Death|0|||
145656266|NCT04542317|525259566|FG000|Overall Study|Care recipients passed away|18|||
145656267|NCT04542317|525259567|FG001|Overall Study|Care recipients passed away|13|||
145656268|NCT04542317|525259566|FG000|Overall Study|No longer a primary caregiver|5|||
145656269|NCT04542317|525259567|FG001|Overall Study|No longer a primary caregiver|1|||
145656270|NCT04542317|525259566|FG000|Overall Study|Withdrawal by Subject|4|||
145656271|NCT04542317|525259567|FG001|Overall Study|Withdrawal by Subject|2|||
145656272|NCT04542317|525259566|FG000|Overall Study|Caregivers passed away|0|||
145656273|NCT04542317|525259567|FG001|Overall Study|Caregivers passed away|2|||
145656274|NCT02310646|525259570|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
145656275|NCT02310646|525259571|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
145656276|NCT02310646|525259570|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
145656277|NCT02310646|525259571|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
145656278|NCT03021096|525259572|FG000|Overall Study|Lost to Follow-up|4|||
145656279|NCT03021096|525259572|FG000|Overall Study|Protocol Violation|2|||
145656280|NCT04700163|525259573|FG000|Overall Study|Lost to Follow-up|0|||
145656281|NCT04700163|525259574|FG001|Overall Study|Lost to Follow-up|0|||
145656282|NCT04700163|525259575|FG002|Overall Study|Lost to Follow-up|0|||
145656283|NCT04700163|525259576|FG003|Overall Study|Lost to Follow-up|0|||
145656284|NCT04700163|525259577|FG004|Overall Study|Lost to Follow-up|0|||
145656285|NCT04700163|525259578|FG005|Overall Study|Lost to Follow-up|1|||
145656286|NCT03848065|525259581|FG000|Overall Study|Death|0|||
145656287|NCT03848065|525259582|FG001|Overall Study|Death|1|||
145656288|NCT03848065|525259583|FG002|Overall Study|Death|0|||
145656289|NCT03848065|525259581|FG000|Overall Study|Lost to Follow-up|0|||
145656290|NCT03848065|525259582|FG001|Overall Study|Lost to Follow-up|0|||
145656291|NCT03848065|525259583|FG002|Overall Study|Lost to Follow-up|1|||
145656292|NCT03848065|525259581|FG000|Overall Study|Physician Decision|0|||
145656293|NCT03848065|525259582|FG001|Overall Study|Physician Decision|0|||
145656294|NCT03848065|525259583|FG002|Overall Study|Physician Decision|1|||
145656295|NCT03496168|525259590|FG000|Overall Study|Other Reasons|1|||
145656296|NCT03496168|525259590|FG000|Overall Study|Adverse Event|1|||
145656297|NCT05543629|525259595|FG000|Overall Study|Death|1|||
145656298|NCT05543629|525259596|FG001|Overall Study|Death|0|||
145656299|NCT05543629|525259597|FG002|Overall Study|Death|1|||
145656300|NCT05543629|525259598|FG003|Overall Study|Death|0|||
145656301|NCT05543629|525259599|FG004|Overall Study|Death|0|||
145656302|NCT05543629|525259600|FG005|Overall Study|Death|1|||
145656303|NCT05543629|525259601|FG006|Overall Study|Death|2|||
145656304|NCT05543629|525259602|FG007|Overall Study|Death|2|||
145656305|NCT05543629|525259595|FG000|Overall Study|Other Reasons|0|||
145656306|NCT05543629|525259596|FG001|Overall Study|Other Reasons|0|||
145656307|NCT05543629|525259597|FG002|Overall Study|Other Reasons|0|||
145656308|NCT05543629|525259598|FG003|Overall Study|Other Reasons|0|||
145656309|NCT05543629|525259599|FG004|Overall Study|Other Reasons|1|||
145656310|NCT05543629|525259600|FG005|Overall Study|Other Reasons|0|||
145656311|NCT05543629|525259601|FG006|Overall Study|Other Reasons|0|||
145656312|NCT05543629|525259602|FG007|Overall Study|Other Reasons|0|||
145656313|NCT05543629|525259595|FG000|Overall Study|Physician Decision|0|||
145656314|NCT05543629|525259596|FG001|Overall Study|Physician Decision|0|||
145656315|NCT05543629|525259597|FG002|Overall Study|Physician Decision|3|||
145656316|NCT05543629|525259598|FG003|Overall Study|Physician Decision|0|||
145656317|NCT05543629|525259599|FG004|Overall Study|Physician Decision|0|||
145656318|NCT05543629|525259600|FG005|Overall Study|Physician Decision|0|||
145656319|NCT05543629|525259601|FG006|Overall Study|Physician Decision|1|||
145656320|NCT05543629|525259602|FG007|Overall Study|Physician Decision|0|||
145656321|NCT05543629|525259595|FG000|Overall Study|Study terminated by Sponsor|1|||
145656322|NCT05543629|525259596|FG001|Overall Study|Study terminated by Sponsor|0|||
145656323|NCT05543629|525259597|FG002|Overall Study|Study terminated by Sponsor|0|||
145656324|NCT05543629|525259598|FG003|Overall Study|Study terminated by Sponsor|1|||
145656325|NCT05543629|525259599|FG004|Overall Study|Study terminated by Sponsor|0|||
145656326|NCT05543629|525259600|FG005|Overall Study|Study terminated by Sponsor|4|||
145656327|NCT05543629|525259601|FG006|Overall Study|Study terminated by Sponsor|1|||
145656328|NCT05543629|525259602|FG007|Overall Study|Study terminated by Sponsor|0|||
145656329|NCT05543629|525259595|FG000|Overall Study|Withdrawal by Subject|1|||
145656330|NCT05543629|525259596|FG001|Overall Study|Withdrawal by Subject|1|||
145656331|NCT05543629|525259597|FG002|Overall Study|Withdrawal by Subject|0|||
145656332|NCT05543629|525259598|FG003|Overall Study|Withdrawal by Subject|2|||
145656333|NCT05543629|525259599|FG004|Overall Study|Withdrawal by Subject|1|||
145656334|NCT05543629|525259600|FG005|Overall Study|Withdrawal by Subject|1|||
145656335|NCT05543629|525259601|FG006|Overall Study|Withdrawal by Subject|1|||
145656336|NCT05543629|525259602|FG007|Overall Study|Withdrawal by Subject|1|||
145656337|NCT05543629|525259595|FG000|Overall Study|Not Reported|2|||
145656338|NCT05543629|525259596|FG001|Overall Study|Not Reported|2|||
145656339|NCT05543629|525259597|FG002|Overall Study|Not Reported|0|||
145656340|NCT05543629|525259598|FG003|Overall Study|Not Reported|0|||
145656341|NCT05543629|525259599|FG004|Overall Study|Not Reported|1|||
145656342|NCT05543629|525259600|FG005|Overall Study|Not Reported|1|||
145656343|NCT05543629|525259601|FG006|Overall Study|Not Reported|3|||
145656344|NCT05543629|525259602|FG007|Overall Study|Not Reported|0|||
145656345|NCT04564742|525259603|FG000|Overall Study|Lost to Follow-up|1|||
145656346|NCT04564742|525259604|FG001|Overall Study|Lost to Follow-up|0|||
145656347|NCT04564742|525259603|FG000|Overall Study|Consent Withdrawal|4|||
145656348|NCT04564742|525259604|FG001|Overall Study|Consent Withdrawal|4|||
145656349|NCT03313076|525259608|FG000|Overall Study|Withdrawal by Subject|2|||
145656350|NCT03313076|525259609|FG001|Overall Study|Withdrawal by Subject|0|||
145656351|NCT03313076|525259610|FG002|Overall Study|Withdrawal by Subject|0|||
145656352|NCT03313076|525259611|FG003|Overall Study|Withdrawal by Subject|0|||
145656353|NCT03313076|525259608|FG000|Overall Study|Lost to Follow-up|0|||
145656354|NCT03313076|525259609|FG001|Overall Study|Lost to Follow-up|2|||
145656355|NCT03313076|525259610|FG002|Overall Study|Lost to Follow-up|2|||
145656356|NCT03313076|525259611|FG003|Overall Study|Lost to Follow-up|2|||
145656357|NCT05869383|525259612|FG000|Overall Study|Withdrawal by Subject|2|||
145656358|NCT05869383|525259613|FG001|Overall Study|Withdrawal by Subject|0|||
145656359|NCT05126433|525259620|FG000|Overall Study|Withdrawal by Subject|3|||
145656360|NCT05126433|525259621|FG001|Overall Study|Withdrawal by Subject|0|||
145656361|NCT05126433|525259622|FG002|Overall Study|Withdrawal by Subject|4|||
145656362|NCT05126433|525259620|FG000|Overall Study|Death|9|||
145656363|NCT05126433|525259621|FG001|Overall Study|Death|3|||
145656364|NCT05126433|525259622|FG002|Overall Study|Death|5|||
145656365|NCT05126433|525259620|FG000|Overall Study|Study Terminated by sponsor|0|||
145656366|NCT05126433|525259621|FG001|Overall Study|Study Terminated by sponsor|1|||
145656367|NCT05126433|525259622|FG002|Overall Study|Study Terminated by sponsor|2|||
145656368|NCT05126433|525259620|FG000|Overall Study|Progressive Disease|1|||
145656369|NCT05126433|525259621|FG001|Overall Study|Progressive Disease|4|||
145656370|NCT05126433|525259622|FG002|Overall Study|Progressive Disease|3|||
145656371|NCT05126433|525259620|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
145656372|NCT05126433|525259621|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
145656373|NCT05126433|525259622|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
145656374|NCT04137367|525259623|FG000|Overall Study|Lost to Follow-up|8|||
145656375|NCT04137367|525259624|FG001|Overall Study|Lost to Follow-up|6|||
145656376|NCT04137367|525259625|FG002|Overall Study|Lost to Follow-up|4|||
145656377|NCT03270501|525259626|FG000|Overall Study|Screen failure|6|||
145656378|NCT03270501|525259626|FG000|Overall Study|Lost to Follow-up|2|||
145656379|NCT03270501|525259626|FG000|Overall Study|Adverse Event|1|||
145490259|NCT01063153|524648775|FG000|Overall Study|Found Ineligible During Screening|2|||
145656380|NCT00764751|525259627|FG000|Overall Study|Adverse Event|1|||
145656381|NCT00764751|525259628|FG001|Overall Study|Adverse Event|1|||
145656382|NCT00764751|525259627|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
145656383|NCT00764751|525259628|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
145656384|NCT04065841|525259640|FG000|Overall Study|Adverse Event|4|||
145656385|NCT04065841|525259641|FG001|Overall Study|Adverse Event|2|||
145656386|NCT04065841|525259642|FG002|Overall Study|Adverse Event|10|||
145656387|NCT04065841|525259643|FG003|Overall Study|Adverse Event|1|||
145656388|NCT04065841|525259640|FG000|Overall Study|Lost to Follow-up|1|||
145656389|NCT04065841|525259641|FG001|Overall Study|Lost to Follow-up|2|||
145656390|NCT04065841|525259642|FG002|Overall Study|Lost to Follow-up|2|||
145656391|NCT04065841|525259643|FG003|Overall Study|Lost to Follow-up|2|||
145656392|NCT04065841|525259640|FG000|Overall Study|Physician Decision|1|||
145656393|NCT04065841|525259641|FG001|Overall Study|Physician Decision|0|||
145656394|NCT04065841|525259642|FG002|Overall Study|Physician Decision|0|||
145656395|NCT04065841|525259643|FG003|Overall Study|Physician Decision|0|||
145656396|NCT04065841|525259640|FG000|Overall Study|Protocol Violation|0|||
145656397|NCT04065841|525259641|FG001|Overall Study|Protocol Violation|1|||
145656398|NCT04065841|525259642|FG002|Overall Study|Protocol Violation|0|||
145656399|NCT04065841|525259643|FG003|Overall Study|Protocol Violation|0|||
145656400|NCT04065841|525259640|FG000|Overall Study|Study terminated by Sponsor|22|||
145656401|NCT04065841|525259641|FG001|Overall Study|Study terminated by Sponsor|16|||
145656402|NCT04065841|525259642|FG002|Overall Study|Study terminated by Sponsor|28|||
145656403|NCT04065841|525259643|FG003|Overall Study|Study terminated by Sponsor|17|||
145656404|NCT04065841|525259640|FG000|Overall Study|Withdrawal by Subject|1|||
145656405|NCT04065841|525259641|FG001|Overall Study|Withdrawal by Subject|1|||
145656406|NCT04065841|525259642|FG002|Overall Study|Withdrawal by Subject|2|||
145656407|NCT04065841|525259643|FG003|Overall Study|Withdrawal by Subject|0|||
145656408|NCT04436276|525259645|FG000|Overall Study|Adverse Event|0|||
145656409|NCT04436276|525259646|FG001|Overall Study|Adverse Event|0|||
145656410|NCT04436276|525259647|FG002|Overall Study|Adverse Event|0|||
145656411|NCT04436276|525259648|FG003|Overall Study|Adverse Event|0|||
145656412|NCT04436276|525259649|FG004|Overall Study|Adverse Event|0|||
145656413|NCT04436276|525259650|FG005|Overall Study|Adverse Event|0|||
145656414|NCT04436276|525259651|FG006|Overall Study|Adverse Event|0|||
145656415|NCT04436276|525259652|FG007|Overall Study|Adverse Event|0|||
145656416|NCT04436276|525259653|FG008|Overall Study|Adverse Event|0|||
145656417|NCT04436276|525259654|FG009|Overall Study|Adverse Event|0|||
145656418|NCT04436276|525259655|FG010|Overall Study|Adverse Event|0|||
145656419|NCT04436276|525259656|FG011|Overall Study|Adverse Event|0|||
145656420|NCT04436276|525259657|FG012|Overall Study|Adverse Event|0|||
145656421|NCT04436276|525259658|FG013|Overall Study|Adverse Event|0|||
145656422|NCT04436276|525259659|FG014|Overall Study|Adverse Event|0|||
145656423|NCT04436276|525259660|FG015|Overall Study|Adverse Event|0|||
145656424|NCT04436276|525259661|FG016|Overall Study|Adverse Event|1|||
145656425|NCT04436276|525259662|FG017|Overall Study|Adverse Event|0|||
145656426|NCT04436276|525259663|FG018|Overall Study|Adverse Event|0|||
145656427|NCT04436276|525259664|FG019|Overall Study|Adverse Event|0|||
145656428|NCT04436276|525259665|FG020|Overall Study|Adverse Event|0|||
145656429|NCT04436276|525259666|FG021|Overall Study|Adverse Event|0|||
145656430|NCT04436276|525259667|FG022|Overall Study|Adverse Event|0|||
145656431|NCT04436276|525259645|FG000|Overall Study|Death|0|||
145656432|NCT04436276|525259646|FG001|Overall Study|Death|0|||
145656433|NCT04436276|525259647|FG002|Overall Study|Death|0|||
145656434|NCT04436276|525259648|FG003|Overall Study|Death|0|||
145656435|NCT04436276|525259649|FG004|Overall Study|Death|0|||
145656436|NCT04436276|525259650|FG005|Overall Study|Death|0|||
145656437|NCT04436276|525259651|FG006|Overall Study|Death|0|||
145656438|NCT04436276|525259652|FG007|Overall Study|Death|0|||
145656439|NCT04436276|525259653|FG008|Overall Study|Death|0|||
145656440|NCT04436276|525259654|FG009|Overall Study|Death|0|||
145656441|NCT04436276|525259655|FG010|Overall Study|Death|0|||
145656442|NCT04436276|525259656|FG011|Overall Study|Death|0|||
145656443|NCT04436276|525259657|FG012|Overall Study|Death|1|||
145656444|NCT04436276|525259658|FG013|Overall Study|Death|0|||
145656445|NCT04436276|525259659|FG014|Overall Study|Death|1|||
145656446|NCT04436276|525259660|FG015|Overall Study|Death|0|||
145656447|NCT04436276|525259661|FG016|Overall Study|Death|0|||
145656448|NCT04436276|525259662|FG017|Overall Study|Death|0|||
145656449|NCT04436276|525259663|FG018|Overall Study|Death|0|||
145656450|NCT04436276|525259664|FG019|Overall Study|Death|2|||
145656451|NCT04436276|525259665|FG020|Overall Study|Death|0|||
145656452|NCT04436276|525259666|FG021|Overall Study|Death|1|||
145656453|NCT04436276|525259667|FG022|Overall Study|Death|0|||
145656454|NCT04436276|525259645|FG000|Overall Study|Lost to Follow-up|0|||
145656455|NCT04436276|525259646|FG001|Overall Study|Lost to Follow-up|2|||
145656456|NCT04436276|525259647|FG002|Overall Study|Lost to Follow-up|2|||
145490260|NCT01063153|524648776|FG001|Overall Study|Found Ineligible During Screening|0|||
145656457|NCT04436276|525259648|FG003|Overall Study|Lost to Follow-up|1|||
145490261|NCT01063153|524648775|FG000|Overall Study|Lost to Follow-up|0|||
145656458|NCT04436276|525259649|FG004|Overall Study|Lost to Follow-up|4|||
145656459|NCT04436276|525259650|FG005|Overall Study|Lost to Follow-up|1|||
145656460|NCT04436276|525259651|FG006|Overall Study|Lost to Follow-up|0|||
145656461|NCT04436276|525259652|FG007|Overall Study|Lost to Follow-up|0|||
145656462|NCT04436276|525259653|FG008|Overall Study|Lost to Follow-up|1|||
145656463|NCT04436276|525259654|FG009|Overall Study|Lost to Follow-up|0|||
145656464|NCT04436276|525259655|FG010|Overall Study|Lost to Follow-up|5|||
145656465|NCT04436276|525259656|FG011|Overall Study|Lost to Follow-up|5|||
145656466|NCT04436276|525259657|FG012|Overall Study|Lost to Follow-up|4|||
145656467|NCT04436276|525259658|FG013|Overall Study|Lost to Follow-up|1|||
145656468|NCT04436276|525259659|FG014|Overall Study|Lost to Follow-up|7|||
145656469|NCT04436276|525259660|FG015|Overall Study|Lost to Follow-up|7|||
145656470|NCT04436276|525259661|FG016|Overall Study|Lost to Follow-up|1|||
145656471|NCT04436276|525259662|FG017|Overall Study|Lost to Follow-up|0|||
145656472|NCT04436276|525259663|FG018|Overall Study|Lost to Follow-up|1|||
145656473|NCT04436276|525259664|FG019|Overall Study|Lost to Follow-up|1|||
145656474|NCT04436276|525259665|FG020|Overall Study|Lost to Follow-up|2|||
145656475|NCT04436276|525259666|FG021|Overall Study|Lost to Follow-up|1|||
145656476|NCT04436276|525259667|FG022|Overall Study|Lost to Follow-up|1|||
145656477|NCT04436276|525259645|FG000|Overall Study|Physician Decision|1|||
145656478|NCT04436276|525259646|FG001|Overall Study|Physician Decision|0|||
145656479|NCT04436276|525259647|FG002|Overall Study|Physician Decision|2|||
145656480|NCT04436276|525259648|FG003|Overall Study|Physician Decision|1|||
145656481|NCT04436276|525259649|FG004|Overall Study|Physician Decision|0|||
145656482|NCT04436276|525259650|FG005|Overall Study|Physician Decision|0|||
145656483|NCT04436276|525259651|FG006|Overall Study|Physician Decision|0|||
145656484|NCT04436276|525259652|FG007|Overall Study|Physician Decision|0|||
145656485|NCT04436276|525259653|FG008|Overall Study|Physician Decision|0|||
145656486|NCT04436276|525259654|FG009|Overall Study|Physician Decision|0|||
145656487|NCT04436276|525259655|FG010|Overall Study|Physician Decision|0|||
145656488|NCT04436276|525259656|FG011|Overall Study|Physician Decision|1|||
145656489|NCT04436276|525259657|FG012|Overall Study|Physician Decision|2|||
145656490|NCT04436276|525259658|FG013|Overall Study|Physician Decision|0|||
145656491|NCT04436276|525259659|FG014|Overall Study|Physician Decision|0|||
145656492|NCT04436276|525259660|FG015|Overall Study|Physician Decision|0|||
145656493|NCT04436276|525259661|FG016|Overall Study|Physician Decision|0|||
145656494|NCT04436276|525259662|FG017|Overall Study|Physician Decision|0|||
145656495|NCT04436276|525259663|FG018|Overall Study|Physician Decision|0|||
145656496|NCT04436276|525259664|FG019|Overall Study|Physician Decision|0|||
145656497|NCT04436276|525259665|FG020|Overall Study|Physician Decision|1|||
145656498|NCT04436276|525259666|FG021|Overall Study|Physician Decision|2|||
145656499|NCT04436276|525259667|FG022|Overall Study|Physician Decision|0|||
145656500|NCT04436276|525259645|FG000|Overall Study|Protocol Violation|0|||
145656501|NCT04436276|525259646|FG001|Overall Study|Protocol Violation|0|||
145656502|NCT04436276|525259647|FG002|Overall Study|Protocol Violation|0|||
145656503|NCT04436276|525259648|FG003|Overall Study|Protocol Violation|0|||
145656504|NCT04436276|525259649|FG004|Overall Study|Protocol Violation|0|||
145656505|NCT04436276|525259650|FG005|Overall Study|Protocol Violation|0|||
145656506|NCT04436276|525259651|FG006|Overall Study|Protocol Violation|0|||
145656507|NCT04436276|525259652|FG007|Overall Study|Protocol Violation|0|||
145656508|NCT04436276|525259653|FG008|Overall Study|Protocol Violation|0|||
145656509|NCT04436276|525259654|FG009|Overall Study|Protocol Violation|0|||
145656510|NCT04436276|525259655|FG010|Overall Study|Protocol Violation|0|||
145656511|NCT04436276|525259656|FG011|Overall Study|Protocol Violation|0|||
145656512|NCT04436276|525259657|FG012|Overall Study|Protocol Violation|0|||
145656513|NCT04436276|525259658|FG013|Overall Study|Protocol Violation|1|||
145656514|NCT04436276|525259659|FG014|Overall Study|Protocol Violation|0|||
145656515|NCT04436276|525259660|FG015|Overall Study|Protocol Violation|1|||
145656516|NCT04436276|525259661|FG016|Overall Study|Protocol Violation|0|||
145656517|NCT04436276|525259662|FG017|Overall Study|Protocol Violation|0|||
145656518|NCT04436276|525259663|FG018|Overall Study|Protocol Violation|0|||
145656519|NCT04436276|525259664|FG019|Overall Study|Protocol Violation|0|||
145656520|NCT04436276|525259665|FG020|Overall Study|Protocol Violation|0|||
145656521|NCT04436276|525259666|FG021|Overall Study|Protocol Violation|0|||
145656522|NCT04436276|525259667|FG022|Overall Study|Protocol Violation|0|||
145656523|NCT04436276|525259645|FG000|Overall Study|Withdrawal by Subject|25|||
145490262|NCT01063153|524648776|FG001|Overall Study|Lost to Follow-up|7|||
145490263|NCT01063153|524648775|FG000|Overall Study|Withdrawal by Subject|0|||
145490264|NCT01063153|524648776|FG001|Overall Study|Withdrawal by Subject|1|||
145490265|NCT01063153|524648775|FG000|Overall Study|Physician Decision|0|||
145656524|NCT04436276|525259646|FG001|Overall Study|Withdrawal by Subject|22|||
145656525|NCT04436276|525259647|FG002|Overall Study|Withdrawal by Subject|24|||
145656526|NCT04436276|525259648|FG003|Overall Study|Withdrawal by Subject|23|||
145656527|NCT04436276|525259649|FG004|Overall Study|Withdrawal by Subject|14|||
145656528|NCT04436276|525259650|FG005|Overall Study|Withdrawal by Subject|0|||
145656529|NCT04436276|525259651|FG006|Overall Study|Withdrawal by Subject|0|||
145490266|NCT01063153|524648776|FG001|Overall Study|Physician Decision|4|||
145656530|NCT04436276|525259652|FG007|Overall Study|Withdrawal by Subject|1|||
145656531|NCT04436276|525259653|FG008|Overall Study|Withdrawal by Subject|0|||
145656532|NCT04436276|525259654|FG009|Overall Study|Withdrawal by Subject|1|||
145656533|NCT04436276|525259655|FG010|Overall Study|Withdrawal by Subject|17|||
145656534|NCT04436276|525259656|FG011|Overall Study|Withdrawal by Subject|7|||
145490267|NCT00350844|524648777|FG000|Overall Study|Lost to Follow-up|1|||
145656535|NCT04436276|525259657|FG012|Overall Study|Withdrawal by Subject|10|||
145656536|NCT04436276|525259658|FG013|Overall Study|Withdrawal by Subject|6|||
145656537|NCT04436276|525259659|FG014|Overall Study|Withdrawal by Subject|20|||
145656538|NCT04436276|525259660|FG015|Overall Study|Withdrawal by Subject|6|||
145656539|NCT04436276|525259661|FG016|Overall Study|Withdrawal by Subject|11|||
145656540|NCT04436276|525259662|FG017|Overall Study|Withdrawal by Subject|4|||
145656541|NCT04436276|525259663|FG018|Overall Study|Withdrawal by Subject|14|||
145656542|NCT04436276|525259664|FG019|Overall Study|Withdrawal by Subject|24|||
145656543|NCT04436276|525259665|FG020|Overall Study|Withdrawal by Subject|24|||
145656544|NCT04436276|525259666|FG021|Overall Study|Withdrawal by Subject|16|||
145656545|NCT04436276|525259667|FG022|Overall Study|Withdrawal by Subject|14|||
145656546|NCT04436276|525259645|FG000|Overall Study|Other|3|||
145656547|NCT04436276|525259646|FG001|Overall Study|Other|2|||
145656548|NCT04436276|525259647|FG002|Overall Study|Other|5|||
145656549|NCT04436276|525259648|FG003|Overall Study|Other|9|||
145656550|NCT04436276|525259649|FG004|Overall Study|Other|23|||
145656551|NCT04436276|525259650|FG005|Overall Study|Other|1|||
145656552|NCT04436276|525259651|FG006|Overall Study|Other|0|||
145656553|NCT04436276|525259652|FG007|Overall Study|Other|0|||
145656554|NCT04436276|525259653|FG008|Overall Study|Other|0|||
145656555|NCT04436276|525259654|FG009|Overall Study|Other|0|||
145656556|NCT04436276|525259655|FG010|Overall Study|Other|3|||
145656557|NCT04436276|525259656|FG011|Overall Study|Other|1|||
145656558|NCT04436276|525259657|FG012|Overall Study|Other|1|||
145656559|NCT04436276|525259658|FG013|Overall Study|Other|2|||
145656560|NCT04436276|525259659|FG014|Overall Study|Other|3|||
145656561|NCT04436276|525259660|FG015|Overall Study|Other|0|||
145656562|NCT04436276|525259661|FG016|Overall Study|Other|0|||
145656563|NCT04436276|525259662|FG017|Overall Study|Other|6|||
145656564|NCT04436276|525259663|FG018|Overall Study|Other|1|||
145490268|NCT01420926|524648778|FG000|Overall Study|Adverse Event|6|||
145490269|NCT01420926|524648779|FG001|Overall Study|Adverse Event|4|||
145490270|NCT01420926|524648778|FG000|Overall Study|Death|18|||
145490271|NCT01420926|524648779|FG001|Overall Study|Death|17|||
145490272|NCT01420926|524648778|FG000|Overall Study|Withdrawal by Subject|11|||
145490273|NCT01420926|524648779|FG001|Overall Study|Withdrawal by Subject|17|||
145490274|NCT01420926|524648778|FG000|Overall Study|Non-protocol treatment|17|||
145490275|NCT01420926|524648779|FG001|Overall Study|Non-protocol treatment|20|||
145490276|NCT01420926|524648778|FG000|Overall Study|Physician Decision|8|||
145490277|NCT01420926|524648779|FG001|Overall Study|Physician Decision|5|||
145490278|NCT00882440|524650248|FG000|Overall Study|Adverse Event|2|||
145490279|NCT00882440|524650249|FG001|Overall Study|Adverse Event|2|||
145490280|NCT00882440|524650250|FG002|Overall Study|Adverse Event|2|||
145490281|NCT00882440|524650251|FG003|Overall Study|Adverse Event|1|||
145490282|NCT00882440|524650252|FG004|Overall Study|Adverse Event|1|||
145490283|NCT00882440|524650253|FG005|Overall Study|Adverse Event|4|||
145490284|NCT00882440|524650254|FG006|Overall Study|Adverse Event|2|||
145490285|NCT00882440|524650248|FG000|Overall Study|Lack of Efficacy|3|||
145490286|NCT00882440|524650249|FG001|Overall Study|Lack of Efficacy|5|||
145490287|NCT00882440|524650250|FG002|Overall Study|Lack of Efficacy|2|||
145490288|NCT00882440|524650251|FG003|Overall Study|Lack of Efficacy|0|||
145490289|NCT00882440|524650252|FG004|Overall Study|Lack of Efficacy|0|||
145490290|NCT00882440|524650253|FG005|Overall Study|Lack of Efficacy|3|||
145490291|NCT00882440|524650254|FG006|Overall Study|Lack of Efficacy|0|||
145490292|NCT00882440|524650248|FG000|Overall Study|Lost to Follow-up|2|||
145490293|NCT00882440|524650249|FG001|Overall Study|Lost to Follow-up|0|||
145656565|NCT04436276|525259664|FG019|Overall Study|Other|0|||
145656566|NCT04436276|525259665|FG020|Overall Study|Other|2|||
145656567|NCT04436276|525259666|FG021|Overall Study|Other|2|||
145656568|NCT04436276|525259667|FG022|Overall Study|Other|60|||
145656569|NCT03322267|525259668|FG000|Overall Study|Lack of Efficacy|11|||
145656570|NCT03322267|525259668|FG000|Overall Study|Adverse Event|1|||
145656571|NCT03322267|525259668|FG000|Overall Study|Withdrawal by Subject|2|||
145656572|NCT05792085|525259669|FG000|Overall Study|Death|0|||
145656573|NCT05792085|525259670|FG001|Overall Study|Death|0|||
145656574|NCT05792085|525259671|FG002|Overall Study|Death|0|||
145656575|NCT05792085|525259672|FG003|Overall Study|Death|0|||
145656576|NCT05792085|525259673|FG004|Overall Study|Death|1|||
145656577|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
145656578|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
145656579|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
145490294|NCT00882440|524650250|FG002|Overall Study|Lost to Follow-up|1|||
145490295|NCT00882440|524650251|FG003|Overall Study|Lost to Follow-up|1|||
145490296|NCT00882440|524650252|FG004|Overall Study|Lost to Follow-up|1|||
145490297|NCT00882440|524650253|FG005|Overall Study|Lost to Follow-up|0|||
145656580|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
145656581|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
145656582|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
145656583|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
145656584|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
145656585|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
145656586|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
145656587|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
145656588|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
145656589|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
145490298|NCT00882440|524650254|FG006|Overall Study|Lost to Follow-up|1|||
145490299|NCT00882440|524650248|FG000|Overall Study|Protocol Violation|0|||
145656590|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
145656591|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
145656592|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
145656593|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
145656594|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
145656595|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
145656596|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
145656597|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
145656598|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
145656599|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
145656600|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
145656601|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
145656602|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
145656603|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
145656604|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
145656605|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
145656606|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
145656607|NCT03852472|525259680|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
145656608|NCT03852472|525259681|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
145656609|NCT03852472|525259682|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
145656610|NCT03852472|525259683|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
145656611|NCT03852472|525259684|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
145656612|NCT03852472|525259680|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
145656613|NCT03852472|525259681|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
145656614|NCT03852472|525259682|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
145656615|NCT03852472|525259683|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
145656616|NCT03852472|525259684|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
145656617|NCT03852472|525259680|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
145656618|NCT03852472|525259681|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
145656619|NCT03852472|525259682|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
145656620|NCT03852472|525259683|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
145656621|NCT03852472|525259684|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
145656622|NCT03852472|525259680|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
145656623|NCT03852472|525259681|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
145656624|NCT03852472|525259682|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
145656625|NCT03852472|525259683|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
145656626|NCT03852472|525259684|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
145656627|NCT03852472|525259680|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
145656628|NCT03852472|525259681|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
145656629|NCT03852472|525259682|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
145656630|NCT03852472|525259683|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
145656631|NCT03852472|525259684|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
145656632|NCT03852472|525259680|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
145656633|NCT03852472|525259681|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
145656634|NCT03852472|525259682|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
145656635|NCT03852472|525259683|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
145656636|NCT03852472|525259684|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
145656637|NCT03852472|525259680|FG000|Period 2 - Week 44|Adverse Event|0|||
145656638|NCT03852472|525259681|FG001|Period 2 - Week 44|Adverse Event|3|||
145656639|NCT03852472|525259682|FG002|Period 2 - Week 44|Adverse Event|1|||
145656640|NCT03852472|525259683|FG003|Period 2 - Week 44|Adverse Event|2|||
145656641|NCT03852472|525259684|FG004|Period 2 - Week 44|Adverse Event|2|||
145656642|NCT03852472|525259680|FG000|Period 2 - Week 44|COVID-19 Related|0|||
145656643|NCT03852472|525259681|FG001|Period 2 - Week 44|COVID-19 Related|0|||
145656644|NCT03852472|525259682|FG002|Period 2 - Week 44|COVID-19 Related|0|||
145656645|NCT03852472|525259683|FG003|Period 2 - Week 44|COVID-19 Related|1|||
145656646|NCT03852472|525259684|FG004|Period 2 - Week 44|COVID-19 Related|0|||
145656647|NCT03852472|525259680|FG000|Period 2 - Week 44|Reason not stated|0|||
145656648|NCT03852472|525259681|FG001|Period 2 - Week 44|Reason not stated|0|||
145656649|NCT03852472|525259682|FG002|Period 2 - Week 44|Reason not stated|0|||
145656650|NCT03852472|525259683|FG003|Period 2 - Week 44|Reason not stated|0|||
145656651|NCT03852472|525259684|FG004|Period 2 - Week 44|Reason not stated|1|||
145656652|NCT01919554|525259685|FG000|Overall Study|Withdrawal by Subject|0|||
145656653|NCT01919554|525259686|FG001|Overall Study|Withdrawal by Subject|0|||
145656654|NCT01919554|525259687|FG002|Overall Study|Withdrawal by Subject|1|||
145656655|NCT01919554|525259688|FG003|Overall Study|Withdrawal by Subject|1|||
145656656|NCT05977530|525259689|FG000|Overall Study|Withdrawal by Subject|1|||
145265337|NCT00953017|523819295|FG001|Overall Study|Brown stool prior to procedure|0|||
145656657|NCT05977530|525259689|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
145656658|NCT04719832|525259692|FG000|Overall Study|Adverse Event|2|||
145656659|NCT04719832|525259693|FG001|Overall Study|Adverse Event|0|||
145656660|NCT04719832|525259692|FG000|Overall Study|Lack of Efficacy|2|||
145656661|NCT04719832|525259693|FG001|Overall Study|Lack of Efficacy|4|||
145656662|NCT04719832|525259692|FG000|Overall Study|Lost to Follow-up|0|||
145656663|NCT04719832|525259693|FG001|Overall Study|Lost to Follow-up|2|||
145656664|NCT04719832|525259692|FG000|Overall Study|Physician Decision|0|||
145656665|NCT04719832|525259693|FG001|Overall Study|Physician Decision|1|||
145656666|NCT04719832|525259692|FG000|Overall Study|Pregnancy|1|||
145656667|NCT04719832|525259693|FG001|Overall Study|Pregnancy|1|||
145656668|NCT04719832|525259692|FG000|Overall Study|Withdrawal by Subject|5|||
145656669|NCT04719832|525259693|FG001|Overall Study|Withdrawal by Subject|5|||
145656670|NCT04719832|525259692|FG000|Overall Study|Randomized, not treated|0|||
145656671|NCT04719832|525259693|FG001|Overall Study|Randomized, not treated|2|||
145656672|NCT04719832|525259692|FG000|Overall Study|GCP violations|4|||
145656673|NCT04719832|525259693|FG001|Overall Study|GCP violations|7|||
145656674|NCT05228457|525259694|FG000|Overall Study|Withdrawal by Subject|1|||
145656675|NCT05228457|525259695|FG001|Overall Study|Withdrawal by Subject|1|||
145656676|NCT03492216|525259702|FG000|Overall Study|Death|1|||
145656677|NCT03492216|525259703|FG001|Overall Study|Death|0|||
145656678|NCT03492216|525259704|FG002|Overall Study|Death|4|||
145656679|NCT03492216|525259705|FG003|Overall Study|Death|0|||
145656680|NCT03492216|525259702|FG000|Overall Study|Withdrawal by Subject|5|||
145656681|NCT03492216|525259703|FG001|Overall Study|Withdrawal by Subject|3|||
145656682|NCT03492216|525259704|FG002|Overall Study|Withdrawal by Subject|1|||
145656683|NCT03492216|525259705|FG003|Overall Study|Withdrawal by Subject|1|||
145656684|NCT03492216|525259702|FG000|Overall Study|Lost to Follow-up|9|||
145656685|NCT03492216|525259703|FG001|Overall Study|Lost to Follow-up|2|||
145656686|NCT03492216|525259704|FG002|Overall Study|Lost to Follow-up|7|||
145656687|NCT03492216|525259705|FG003|Overall Study|Lost to Follow-up|8|||
145656688|NCT03492216|525259702|FG000|Overall Study|Moved|5|||
145656689|NCT03492216|525259703|FG001|Overall Study|Moved|3|||
145656690|NCT03492216|525259704|FG002|Overall Study|Moved|3|||
145656691|NCT03492216|525259705|FG003|Overall Study|Moved|5|||
145656692|NCT03492216|525259702|FG000|Overall Study|Too ill|0|||
145656693|NCT03492216|525259703|FG001|Overall Study|Too ill|1|||
145656694|NCT03492216|525259704|FG002|Overall Study|Too ill|0|||
145656695|NCT03492216|525259705|FG003|Overall Study|Too ill|0|||
145656696|NCT03492216|525259702|FG000|Overall Study|Incarcerated|0|||
145656697|NCT03492216|525259703|FG001|Overall Study|Incarcerated|0|||
145656698|NCT03492216|525259704|FG002|Overall Study|Incarcerated|2|||
145656699|NCT03492216|525259705|FG003|Overall Study|Incarcerated|0|||
145656700|NCT04797897|525259706|FG000|Overall Study|Study Termination by Sponsor|1|||
145656701|NCT04797897|525259707|FG001|Overall Study|Study Termination by Sponsor|1|||
145656702|NCT03774082|525259714|FG000|Overall Study|Death|6|||
145656703|NCT03774082|525259715|FG001|Overall Study|Death|3|||
145656704|NCT03774082|525259716|FG002|Overall Study|Death|2|||
145656705|NCT03774082|525259714|FG000|Overall Study|Subject decision|0|||
145656706|NCT03774082|525259715|FG001|Overall Study|Subject decision|3|||
145656707|NCT03774082|525259716|FG002|Overall Study|Subject decision|0|||
145656708|NCT03774082|525259714|FG000|Overall Study|Lost to Follow-up|2|||
145656709|NCT03774082|525259715|FG001|Overall Study|Lost to Follow-up|0|||
145656710|NCT03774082|525259716|FG002|Overall Study|Lost to Follow-up|0|||
145656711|NCT03774082|525259714|FG000|Overall Study|Guardian decision|0|||
145656712|NCT03774082|525259715|FG001|Overall Study|Guardian decision|0|||
145656713|NCT03774082|525259716|FG002|Overall Study|Guardian decision|1|||
145656714|NCT03774082|525259714|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
145656715|NCT03774082|525259715|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
145656716|NCT03774082|525259716|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
145656717|NCT05030233|525259717|FG000|Overall Study|withdrawn for transfer|1|||
145656718|NCT05030233|525259718|FG001|Overall Study|withdrawn for transfer|0|||
145656719|NCT04437615|525259719|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
145656720|NCT04828005|525259720|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
145656721|NCT04828005|525259721|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
145656722|NCT04828005|525259722|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
145656723|NCT04828005|525259723|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
145656724|NCT04828005|525259720|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
145656725|NCT04828005|525259721|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
145656726|NCT04828005|525259722|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
145656727|NCT04828005|525259723|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
145656728|NCT04828005|525259720|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
145656729|NCT04828005|525259721|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
145656730|NCT04828005|525259722|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
145656731|NCT04828005|525259723|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
145656732|NCT04828005|525259720|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
145656733|NCT04828005|525259721|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
145656734|NCT04828005|525259722|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
145656735|NCT04828005|525259723|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
145656736|NCT04828005|525259720|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
145656737|NCT04828005|525259721|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
145656738|NCT04828005|525259722|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
145656739|NCT04828005|525259723|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
145656740|NCT04828005|525259720|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
145656741|NCT04828005|525259721|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
145656742|NCT04828005|525259722|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
145656743|NCT04828005|525259723|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
145656744|NCT04828005|525259720|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
145656745|NCT04828005|525259721|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
145656746|NCT04828005|525259722|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
145656747|NCT04828005|525259723|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
145656748|NCT04828005|525259720|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
145656749|NCT04828005|525259721|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
145656750|NCT04828005|525259722|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
145656751|NCT04828005|525259723|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
145656752|NCT04828005|525259720|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
145656753|NCT04828005|525259721|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
145656754|NCT04828005|525259722|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
145656755|NCT04828005|525259723|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
145656756|NCT02696707|525261490|FG000|Per Protocol Population|Physician Decision|2|||
145656757|NCT02696707|525261491|FG001|Per Protocol Population|Physician Decision|1|||
145656758|NCT02696707|525261490|FG000|Per Protocol Population|Participant Decision|0|||
145656759|NCT02696707|525261491|FG001|Per Protocol Population|Participant Decision|2|||
145656760|NCT02696707|525261490|FG000|Completed Study as Planned|Reason = LVEF|2|||
145656761|NCT02696707|525261491|FG001|Completed Study as Planned|Reason = LVEF|2|||
145656762|NCT02696707|525261490|FG000|Completed Study as Planned|Protocol Violation|2|||
145656763|NCT02696707|525261491|FG001|Completed Study as Planned|Protocol Violation|6|||
145656764|NCT02696707|525261490|FG000|Completed Study as Planned|Metastatic disease|3|||
145656765|NCT02696707|525261491|FG001|Completed Study as Planned|Metastatic disease|0|||
145656766|NCT02696707|525261490|FG000|Completed Study as Planned|Location|1|||
145656767|NCT02696707|525261491|FG001|Completed Study as Planned|Location|1|||
145656768|NCT03869866|525261496|FG000|Overall Study|Protocol Violation|1|||
145656769|NCT03869866|525261496|FG000|Overall Study|Withdrawal by Subject|3|||
145656770|NCT01186367|525261497|FG000|Overall Study|Lost to Follow-up|7|||
145656771|NCT01186367|525261498|FG001|Overall Study|Lost to Follow-up|4|||
145656772|NCT01186367|525261499|FG002|Overall Study|Lost to Follow-up|7|||
145656773|NCT01186367|525261497|FG000|Overall Study|Did not receive study treatment|0|||
145656774|NCT01186367|525261498|FG001|Overall Study|Did not receive study treatment|1|||
145656775|NCT01186367|525261499|FG002|Overall Study|Did not receive study treatment|0|||
145656776|NCT06516705|525261500|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
145656777|NCT06516705|525261501|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
145656778|NCT06516705|525261500|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
145656779|NCT06516705|525261501|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
145656780|NCT06516705|525261500|FG000|T3 ( 3 Month After Education)|covid-19|1|||
145656781|NCT06516705|525261501|FG001|T3 ( 3 Month After Education)|covid-19|2|||
145656782|NCT06516705|525261500|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
145656783|NCT06516705|525261501|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
145656784|NCT06516705|525261500|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
145656785|NCT06516705|525261501|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
145656786|NCT06516705|525261500|FG000|T4 ( 6 Month After Education)|covid-19|3|||
145656787|NCT06516705|525261501|FG001|T4 ( 6 Month After Education)|covid-19|2|||
145656788|NCT06516705|525261500|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
145656789|NCT06516705|525261501|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
145656790|NCT05579899|525261502|FG000|Overall Study|Lost to Follow-up|3|||
145656791|NCT05579899|525261503|FG001|Overall Study|Lost to Follow-up|1|||
145656792|NCT05579899|525261502|FG000|Overall Study|Adverse Event|0|||
145656793|NCT05579899|525261503|FG001|Overall Study|Adverse Event|3|||
145656794|NCT05579899|525261502|FG000|Overall Study|Pregnancy|0|||
145656795|NCT05579899|525261503|FG001|Overall Study|Pregnancy|1|||
145656796|NCT05579899|525261502|FG000|Overall Study|Withdrawal by Subject|0|||
145656797|NCT05579899|525261503|FG001|Overall Study|Withdrawal by Subject|3|||
145656798|NCT05453773|525261504|FG000|Overall Study|Withdrawal by Subject|3|||
145656799|NCT05453773|525261504|FG000|Overall Study|Lost to Follow-up|3|||
145656800|NCT05453773|525261504|FG000|Overall Study|Difficult Blood Draw|3|||
145656801|NCT03023410|525261507|FG000|Overall Study|study termination|0|||
145656802|NCT03023410|525261508|FG001|Overall Study|study termination|1|||
145656803|NCT04963270|525261514|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
145656804|NCT04963270|525261515|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
145656805|NCT04963270|525261516|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
145656806|NCT04963270|525261517|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
145656807|NCT04963270|525261514|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145656808|NCT04963270|525261515|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
145656809|NCT04963270|525261516|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145656810|NCT04963270|525261517|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
145656811|NCT04963270|525261514|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
145656812|NCT04963270|525261515|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145656813|NCT04963270|525261516|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145656814|NCT04963270|525261517|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
145656815|NCT04963270|525261514|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
145656816|NCT04963270|525261515|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
145656817|NCT04963270|525261516|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
145656818|NCT04963270|525261517|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
145656819|NCT04963270|525261514|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
145656820|NCT04963270|525261515|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
145656821|NCT04963270|525261516|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
145656822|NCT04963270|525261517|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
145656823|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
145656824|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
145656825|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
145656826|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
145656827|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
145656828|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
145656829|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
145656830|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
145656831|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
145656832|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
145656833|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
145656834|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
145656835|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
145656836|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
145656837|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
145656838|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
145656839|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
145656840|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
145656841|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
145656842|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
145656843|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
145656844|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
145656845|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
145656846|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
145656847|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
145656848|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
145656849|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
145656850|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
145656851|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
145656852|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
145656853|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
145656854|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
145656855|NCT04963270|525261514|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
145656856|NCT04963270|525261515|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
145656857|NCT04963270|525261516|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
145656858|NCT04963270|525261517|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
145656859|NCT04802967|525261518|FG000|Part B|Withdrawal by Subject|0|||
145656860|NCT04802967|525261519|FG001|Part B|Withdrawal by Subject|0|||
145656861|NCT04802967|525261520|FG002|Part B|Withdrawal by Subject|0|||
145656862|NCT04802967|525261521|FG003|Part B|Withdrawal by Subject|0|||
145656863|NCT04802967|525261522|FG004|Part B|Withdrawal by Subject|0|||
145656864|NCT04802967|525261523|FG005|Part B|Withdrawal by Subject|1|||
145656865|NCT04802967|525261524|FG006|Part B|Withdrawal by Subject|0|||
145656866|NCT04802967|525261525|FG007|Part B|Withdrawal by Subject|0|||
145656867|NCT04802967|525261526|FG008|Part B|Withdrawal by Subject|0|||
145656868|NCT04802967|525261527|FG009|Part B|Withdrawal by Subject|0|||
145656869|NCT04195698|525261534|FG000|Overall Study|Adverse Event|4|||
145656870|NCT04195698|525261535|FG001|Overall Study|Adverse Event|11|||
145656871|NCT04195698|525261534|FG000|Overall Study|Withdrawal by Subject|9|||
145656872|NCT04195698|525261535|FG001|Overall Study|Withdrawal by Subject|10|||
145656873|NCT04195698|525261534|FG000|Overall Study|Lost to Follow-up|5|||
145656874|NCT04195698|525261535|FG001|Overall Study|Lost to Follow-up|4|||
145656875|NCT04195698|525261534|FG000|Overall Study|Lack of Efficacy|2|||
145656876|NCT04195698|525261535|FG001|Overall Study|Lack of Efficacy|10|||
145656877|NCT04195698|525261534|FG000|Overall Study|Other|5|||
145656878|NCT04195698|525261535|FG001|Overall Study|Other|4|||
145656879|NCT01098812|525261536|FG000|Overall Study|Death|2|||
145656880|NCT01098812|525261537|FG001|Overall Study|Death|0|||
145656881|NCT01098812|525261538|FG002|Overall Study|Death|1|||
145656882|NCT01098812|525261536|FG000|Overall Study|Lost to Follow-up|0|||
145656883|NCT01098812|525261537|FG001|Overall Study|Lost to Follow-up|1|||
145656884|NCT01098812|525261538|FG002|Overall Study|Lost to Follow-up|0|||
145656885|NCT05459688|525261539|FG000|Overall Study|Lost to Follow-up|6|||
145656886|NCT05459688|525261539|FG000|Overall Study|Physician Decision|1|||
145656887|NCT05459688|525261539|FG000|Overall Study|Withdrawal by Subject|19|||
145656888|NCT05459688|525261539|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
145656889|NCT01129102|525261540|FG000|Overall Study|No study drug treatment|2|||
145656890|NCT01129102|525261541|FG001|Overall Study|No study drug treatment|3|||
145656891|NCT01129102|525261542|FG002|Overall Study|No study drug treatment|1|||
145656892|NCT01129102|525261540|FG000|Overall Study|Withdrawal by Subject|2|||
145656893|NCT01129102|525261541|FG001|Overall Study|Withdrawal by Subject|0|||
145656894|NCT01129102|525261542|FG002|Overall Study|Withdrawal by Subject|3|||
145656895|NCT01129102|525261540|FG000|Overall Study|Protocol Violation|0|||
145656896|NCT01129102|525261541|FG001|Overall Study|Protocol Violation|1|||
145656897|NCT01129102|525261542|FG002|Overall Study|Protocol Violation|1|||
145656898|NCT01129102|525261540|FG000|Overall Study|Pregnancy|0|||
145656899|NCT01129102|525261541|FG001|Overall Study|Pregnancy|0|||
145656900|NCT01129102|525261542|FG002|Overall Study|Pregnancy|1|||
145656901|NCT01129102|525261540|FG000|Overall Study|Adverse Event|2|||
145656902|NCT01129102|525261541|FG001|Overall Study|Adverse Event|2|||
145656903|NCT01129102|525261542|FG002|Overall Study|Adverse Event|1|||
145656904|NCT01129102|525261540|FG000|Overall Study|Lost to Follow-up|2|||
145656905|NCT01129102|525261541|FG001|Overall Study|Lost to Follow-up|0|||
145656906|NCT01129102|525261542|FG002|Overall Study|Lost to Follow-up|0|||
145656907|NCT03379675|525261549|FG000|Overall Study|Lost to Follow-up|0|||
145656908|NCT03379675|525261550|FG001|Overall Study|Lost to Follow-up|1|||
145656909|NCT03379675|525261551|FG002|Overall Study|Lost to Follow-up|0|||
145656910|NCT03379675|525261549|FG000|Overall Study|Adverse Event|2|||
145656911|NCT03379675|525261550|FG001|Overall Study|Adverse Event|0|||
145656912|NCT03379675|525261551|FG002|Overall Study|Adverse Event|0|||
145656913|NCT03379675|525261549|FG000|Overall Study|Withdrawal by Subject|2|||
145656914|NCT03379675|525261550|FG001|Overall Study|Withdrawal by Subject|1|||
145656915|NCT03379675|525261551|FG002|Overall Study|Withdrawal by Subject|2|||
145656916|NCT04332926|525261568|FG000|Overall Study|Withdrawal by Subject|6|||
145656917|NCT04332926|525261568|FG000|Overall Study|Physician Decision|6|||
145656918|NCT05362487|525261573|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
145656919|NCT03808818|525261578|FG000|Overall Study|Death|6|||
145656920|NCT03808818|525261579|FG001|Overall Study|Death|6|||
145656921|NCT03808818|525261578|FG000|Overall Study|Withdrawal by Subject|7|||
145656922|NCT03808818|525261579|FG001|Overall Study|Withdrawal by Subject|18|||
145656923|NCT03808818|525261578|FG000|Overall Study|Lost to Follow-up|31|||
145656924|NCT03808818|525261579|FG001|Overall Study|Lost to Follow-up|33|||
145656925|NCT05415722|525261580|FG000|Overall Study|Lost to Follow-up|0|||
145656926|NCT05415722|525261581|FG001|Overall Study|Lost to Follow-up|2|||
145656927|NCT05415722|525261582|FG002|Overall Study|Lost to Follow-up|0|||
145656928|NCT05415722|525261583|FG003|Overall Study|Lost to Follow-up|1|||
145656929|NCT05415722|525261584|FG004|Overall Study|Lost to Follow-up|0|||
145656930|NCT05415722|525261585|FG005|Overall Study|Lost to Follow-up|0|||
145656931|NCT05415722|525261586|FG006|Overall Study|Lost to Follow-up|1|||
145656932|NCT05415722|525261580|FG000|Overall Study|Physician Decision|0|||
145656933|NCT05415722|525261581|FG001|Overall Study|Physician Decision|0|||
145656934|NCT05415722|525261582|FG002|Overall Study|Physician Decision|0|||
145656935|NCT05415722|525261583|FG003|Overall Study|Physician Decision|1|||
145656936|NCT05415722|525261584|FG004|Overall Study|Physician Decision|0|||
145656937|NCT05415722|525261585|FG005|Overall Study|Physician Decision|0|||
145656938|NCT05415722|525261586|FG006|Overall Study|Physician Decision|1|||
145490300|NCT00882440|524650249|FG001|Overall Study|Protocol Violation|0|||
145656939|NCT05415722|525261580|FG000|Overall Study|Protocol Violation|0|||
145656940|NCT05415722|525261581|FG001|Overall Study|Protocol Violation|0|||
145656941|NCT05415722|525261582|FG002|Overall Study|Protocol Violation|0|||
145656942|NCT05415722|525261583|FG003|Overall Study|Protocol Violation|1|||
145656943|NCT05415722|525261584|FG004|Overall Study|Protocol Violation|0|||
145656944|NCT05415722|525261585|FG005|Overall Study|Protocol Violation|0|||
145656945|NCT05415722|525261586|FG006|Overall Study|Protocol Violation|0|||
145656946|NCT05415722|525261580|FG000|Overall Study|Sponsor Discretion|0|||
145656947|NCT05415722|525261581|FG001|Overall Study|Sponsor Discretion|0|||
145656948|NCT05415722|525261582|FG002|Overall Study|Sponsor Discretion|0|||
145656949|NCT05415722|525261583|FG003|Overall Study|Sponsor Discretion|0|||
145656950|NCT05415722|525261584|FG004|Overall Study|Sponsor Discretion|1|||
145656951|NCT05415722|525261585|FG005|Overall Study|Sponsor Discretion|1|||
145656952|NCT05415722|525261586|FG006|Overall Study|Sponsor Discretion|0|||
145656953|NCT05415722|525261580|FG000|Overall Study|Withdrawal by Subject|0|||
145656954|NCT05415722|525261581|FG001|Overall Study|Withdrawal by Subject|1|||
145656955|NCT05415722|525261582|FG002|Overall Study|Withdrawal by Subject|0|||
145656956|NCT05415722|525261583|FG003|Overall Study|Withdrawal by Subject|1|||
145656957|NCT05415722|525261584|FG004|Overall Study|Withdrawal by Subject|1|||
145656958|NCT05415722|525261585|FG005|Overall Study|Withdrawal by Subject|0|||
145656959|NCT05415722|525261586|FG006|Overall Study|Withdrawal by Subject|1|||
145656960|NCT04948697|525261598|FG000|Overall Study|Progressive disease|27|||
145656961|NCT04948697|525261599|FG001|Overall Study|Progressive disease|18|||
145656962|NCT04948697|525261598|FG000|Overall Study|Adverse Event|14|||
145656963|NCT04948697|525261599|FG001|Overall Study|Adverse Event|4|||
145656964|NCT04948697|525261598|FG000|Overall Study|Participant moved to long term extension study|7|||
145656965|NCT04948697|525261599|FG001|Overall Study|Participant moved to long term extension study|4|||
145656966|NCT04948697|525261598|FG000|Overall Study|Withdrawal by Subject|10|||
145656967|NCT04948697|525261599|FG001|Overall Study|Withdrawal by Subject|0|||
145656968|NCT04948697|525261598|FG000|Overall Study|Closed by Sponsor|3|||
145656969|NCT04948697|525261599|FG001|Overall Study|Closed by Sponsor|2|||
145656970|NCT04948697|525261598|FG000|Overall Study|Physician Decision|0|||
145656971|NCT04948697|525261599|FG001|Overall Study|Physician Decision|2|||
145656972|NCT04948697|525261598|FG000|Overall Study|Lost to Follow-up|0|||
145656973|NCT04948697|525261599|FG001|Overall Study|Lost to Follow-up|1|||
145656974|NCT04948697|525261598|FG000|Overall Study|Other-Miscellaneous|1|||
145656975|NCT04948697|525261599|FG001|Overall Study|Other-Miscellaneous|0|||
145656976|NCT04948697|525261598|FG000|Overall Study|Randomized but not treated|0|||
145656977|NCT04948697|525261599|FG001|Overall Study|Randomized but not treated|1|||
145656978|NCT04599062|525261601|FG000|Overall Study|Physician Decision|1|||
145656979|NCT04599062|525261602|FG001|Overall Study|Physician Decision|0|||
145656980|NCT01175356|525261608|FG000|Overall Study|Death|1|||
145656981|NCT01175356|525261608|FG000|Overall Study|Lack of Efficacy|12|||
145656982|NCT01175356|525261608|FG000|Overall Study|Lost to Follow-up|1|||
145656983|NCT01175356|525261608|FG000|Overall Study|Physician Decision|23|||
145490301|NCT00882440|524650250|FG002|Overall Study|Protocol Violation|1|||
145490302|NCT00882440|524650251|FG003|Overall Study|Protocol Violation|1|||
145490303|NCT00882440|524650252|FG004|Overall Study|Protocol Violation|1|||
145490304|NCT00882440|524650253|FG005|Overall Study|Protocol Violation|0|||
145490305|NCT00882440|524650254|FG006|Overall Study|Protocol Violation|0|||
145490306|NCT00882440|524650248|FG000|Overall Study|Withdrawal by Subject|2|||
145490307|NCT00882440|524650249|FG001|Overall Study|Withdrawal by Subject|1|||
145490308|NCT00882440|524650250|FG002|Overall Study|Withdrawal by Subject|1|||
145490309|NCT00882440|524650251|FG003|Overall Study|Withdrawal by Subject|0|||
145490310|NCT00882440|524650252|FG004|Overall Study|Withdrawal by Subject|6|||
145490311|NCT00882440|524650253|FG005|Overall Study|Withdrawal by Subject|0|||
145490312|NCT00882440|524650254|FG006|Overall Study|Withdrawal by Subject|1|||
145490313|NCT00882440|524650248|FG000|Overall Study|Patient Uncooperative|2|||
145490314|NCT00882440|524650249|FG001|Overall Study|Patient Uncooperative|0|||
145490315|NCT00882440|524650250|FG002|Overall Study|Patient Uncooperative|0|||
145490316|NCT00882440|524650251|FG003|Overall Study|Patient Uncooperative|0|||
145490317|NCT00882440|524650252|FG004|Overall Study|Patient Uncooperative|1|||
145490318|NCT00882440|524650253|FG005|Overall Study|Patient Uncooperative|0|||
145490319|NCT00882440|524650254|FG006|Overall Study|Patient Uncooperative|0|||
145490320|NCT01451723|524650265|FG000|Overall Study|study halted|6|||
145490321|NCT01451723|524650266|FG001|Overall Study|study halted|5|||
145490322|NCT01329263|524650267|FG000|Overall Study|Lost to Follow-up|4|||
145490323|NCT01329263|524650268|FG001|Overall Study|Lost to Follow-up|21|||
145490324|NCT01329263|524650267|FG000|Overall Study|Withdrawal by Subject|1|||
145490325|NCT01329263|524650268|FG001|Overall Study|Withdrawal by Subject|2|||
145490326|NCT01631435|524650270|FG000|Overall Study|Adverse Event|2|||
145490327|NCT01631435|524650270|FG000|Overall Study|Withdrawal by Subject|2|||
145490328|NCT01631435|524650270|FG000|Overall Study|incomplete study procedure|5|||
145490329|NCT00833040|524650271|FG000|Overall Study|Adverse Event|0|||
145490330|NCT00833040|524650272|FG001|Overall Study|Adverse Event|0|||
145490331|NCT00833040|524650273|FG002|Overall Study|Adverse Event|0|||
145490332|NCT00833040|524650274|FG003|Overall Study|Adverse Event|0|||
145656984|NCT01175356|525261608|FG000|Overall Study|Ineligible|1|||
145656985|NCT01175356|525261608|FG000|Overall Study|Treatment Slot Not Available|18|||
145656986|NCT01175356|525261608|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
145656987|NCT01175356|525261608|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
145656988|NCT01175356|525261608|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
145656989|NCT01175356|525261608|FG000|Overall Study|Inadequate stem cell for transplant|1|||
145490333|NCT00833040|524650275|FG004|Overall Study|Adverse Event|0|||
145490334|NCT00833040|524650276|FG005|Overall Study|Adverse Event|1|||
145490335|NCT00416624|524650279|FG000|Overall Study|Withdrawal by Subject|1|||
145490336|NCT00416624|524650280|FG001|Overall Study|Withdrawal by Subject|6|||
145490337|NCT00416624|524650281|FG002|Overall Study|Withdrawal by Subject|4|||
145490338|NCT00416624|524650282|FG003|Overall Study|Withdrawal by Subject|9|||
145656990|NCT01175356|525261608|FG000|Overall Study|Initiation other tx prior to completion|9|||
145656991|NCT04880863|525261611|FG000|Overall Study|Adverse Event|1|||
145656992|NCT04880863|525261611|FG000|Overall Study|Patient decision|2|||
145656993|NCT04880863|525261611|FG000|Overall Study|Confirmed Disease Progression|15|||
145656994|NCT04880863|525261611|FG000|Overall Study|Death|3|||
145656995|NCT04880863|525261611|FG000|Overall Study|Physician Decision|4|||
145656996|NCT04880863|525261611|FG000|Overall Study|Unconfirmed Disease Progression|4|||
145656997|NCT04880863|525261611|FG000|Overall Study|Withdrawal by Subject|2|||
145656998|NCT04880863|525261611|FG000|Overall Study|Study discontinuation by the sponsor|4|||
145656999|NCT04880863|525261611|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
145657000|NCT04880863|525261611|FG000|Overall Study|Not received study drug NAP|2|||
145657001|NCT04898673|525261612|FG000|Overall Study|Screenfail|1|||
145657002|NCT04898673|525261613|FG001|Overall Study|Screenfail|0|||
145657003|NCT01152450|525261614|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
145657004|NCT01152450|525261615|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
145657005|NCT01152450|525261616|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
145657006|NCT01152450|525261617|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
145657007|NCT01152450|525261618|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
145657008|NCT01152450|525261619|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
145657009|NCT01152450|525261614|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
145657010|NCT01152450|525261615|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
145657011|NCT01152450|525261616|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
145657012|NCT01152450|525261617|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
145657013|NCT01152450|525261618|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
145657014|NCT01152450|525261619|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
145657015|NCT01152450|525261614|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145657016|NCT01152450|525261615|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
145657017|NCT01152450|525261616|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
145657018|NCT01152450|525261617|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145657019|NCT01152450|525261618|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145657020|NCT01152450|525261619|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
145657021|NCT03058289|525261620|FG000|Overall Study|Radiographic Deterioration|0|||
145657022|NCT03058289|525261621|FG001|Overall Study|Radiographic Deterioration|3|||
145657023|NCT03058289|525261622|FG002|Overall Study|Radiographic Deterioration|1|||
145657024|NCT03058289|525261623|FG003|Overall Study|Radiographic Deterioration|2|||
145657025|NCT03058289|525261624|FG004|Overall Study|Radiographic Deterioration|6|||
145657026|NCT03058289|525261625|FG005|Overall Study|Radiographic Deterioration|3|||
145657027|NCT03058289|525261626|FG006|Overall Study|Radiographic Deterioration|0|||
145657028|NCT03058289|525261627|FG007|Overall Study|Radiographic Deterioration|4|||
145657029|NCT03058289|525261628|FG008|Overall Study|Radiographic Deterioration|2|||
145657030|NCT03058289|525261620|FG000|Overall Study|Adverse Event|2|||
145657031|NCT03058289|525261621|FG001|Overall Study|Adverse Event|0|||
145657032|NCT03058289|525261622|FG002|Overall Study|Adverse Event|1|||
145657033|NCT03058289|525261623|FG003|Overall Study|Adverse Event|3|||
145657034|NCT03058289|525261624|FG004|Overall Study|Adverse Event|1|||
145657035|NCT03058289|525261625|FG005|Overall Study|Adverse Event|0|||
145657036|NCT03058289|525261626|FG006|Overall Study|Adverse Event|1|||
145657037|NCT03058289|525261627|FG007|Overall Study|Adverse Event|3|||
145657038|NCT03058289|525261628|FG008|Overall Study|Adverse Event|0|||
145657039|NCT03058289|525261620|FG000|Overall Study|Withdrawal by Subject|0|||
145657040|NCT03058289|525261621|FG001|Overall Study|Withdrawal by Subject|0|||
145657041|NCT03058289|525261622|FG002|Overall Study|Withdrawal by Subject|0|||
145657042|NCT03058289|525261623|FG003|Overall Study|Withdrawal by Subject|2|||
145657043|NCT03058289|525261624|FG004|Overall Study|Withdrawal by Subject|0|||
145657044|NCT03058289|525261625|FG005|Overall Study|Withdrawal by Subject|2|||
145657045|NCT03058289|525261626|FG006|Overall Study|Withdrawal by Subject|0|||
145657046|NCT03058289|525261627|FG007|Overall Study|Withdrawal by Subject|4|||
145657047|NCT03058289|525261628|FG008|Overall Study|Withdrawal by Subject|1|||
145657048|NCT03058289|525261620|FG000|Overall Study|Physician Decision|1|||
145657049|NCT03058289|525261621|FG001|Overall Study|Physician Decision|0|||
145657050|NCT03058289|525261622|FG002|Overall Study|Physician Decision|0|||
145657051|NCT03058289|525261623|FG003|Overall Study|Physician Decision|2|||
145657052|NCT03058289|525261624|FG004|Overall Study|Physician Decision|1|||
145657053|NCT03058289|525261625|FG005|Overall Study|Physician Decision|0|||
145657054|NCT03058289|525261626|FG006|Overall Study|Physician Decision|2|||
145657055|NCT03058289|525261627|FG007|Overall Study|Physician Decision|3|||
145657056|NCT03058289|525261628|FG008|Overall Study|Physician Decision|0|||
145657057|NCT03058289|525261620|FG000|Overall Study|Clinical Deterioration|2|||
145657058|NCT03058289|525261621|FG001|Overall Study|Clinical Deterioration|0|||
145657059|NCT03058289|525261622|FG002|Overall Study|Clinical Deterioration|0|||
145657060|NCT03058289|525261623|FG003|Overall Study|Clinical Deterioration|2|||
145657061|NCT03058289|525261624|FG004|Overall Study|Clinical Deterioration|1|||
145657062|NCT03058289|525261625|FG005|Overall Study|Clinical Deterioration|1|||
145657063|NCT03058289|525261626|FG006|Overall Study|Clinical Deterioration|0|||
145657064|NCT03058289|525261627|FG007|Overall Study|Clinical Deterioration|3|||
145657065|NCT03058289|525261628|FG008|Overall Study|Clinical Deterioration|2|||
145657066|NCT03058289|525261620|FG000|Overall Study|Lost to Follow-up|0|||
145657067|NCT03058289|525261621|FG001|Overall Study|Lost to Follow-up|0|||
145657068|NCT03058289|525261622|FG002|Overall Study|Lost to Follow-up|0|||
145657069|NCT03058289|525261623|FG003|Overall Study|Lost to Follow-up|0|||
145657070|NCT03058289|525261624|FG004|Overall Study|Lost to Follow-up|1|||
145657071|NCT03058289|525261625|FG005|Overall Study|Lost to Follow-up|0|||
145657072|NCT03058289|525261626|FG006|Overall Study|Lost to Follow-up|0|||
145657073|NCT03058289|525261627|FG007|Overall Study|Lost to Follow-up|0|||
145657074|NCT03058289|525261628|FG008|Overall Study|Lost to Follow-up|0|||
145657075|NCT03058289|525261620|FG000|Overall Study|Refused Further Treatment|0|||
145657076|NCT03058289|525261621|FG001|Overall Study|Refused Further Treatment|0|||
145657077|NCT03058289|525261622|FG002|Overall Study|Refused Further Treatment|1|||
145657078|NCT03058289|525261623|FG003|Overall Study|Refused Further Treatment|0|||
145657079|NCT03058289|525261624|FG004|Overall Study|Refused Further Treatment|1|||
145657080|NCT03058289|525261625|FG005|Overall Study|Refused Further Treatment|0|||
145657081|NCT03058289|525261626|FG006|Overall Study|Refused Further Treatment|0|||
145657082|NCT03058289|525261627|FG007|Overall Study|Refused Further Treatment|0|||
145657083|NCT03058289|525261628|FG008|Overall Study|Refused Further Treatment|0|||
145657084|NCT03058289|525261620|FG000|Overall Study|Rapid Progression of Disease|0|||
145657085|NCT03058289|525261621|FG001|Overall Study|Rapid Progression of Disease|0|||
145657086|NCT03058289|525261622|FG002|Overall Study|Rapid Progression of Disease|0|||
145657087|NCT03058289|525261623|FG003|Overall Study|Rapid Progression of Disease|1|||
145657088|NCT03058289|525261624|FG004|Overall Study|Rapid Progression of Disease|0|||
145657089|NCT03058289|525261625|FG005|Overall Study|Rapid Progression of Disease|0|||
145657090|NCT03058289|525261626|FG006|Overall Study|Rapid Progression of Disease|0|||
145657091|NCT03058289|525261627|FG007|Overall Study|Rapid Progression of Disease|0|||
145657092|NCT03058289|525261628|FG008|Overall Study|Rapid Progression of Disease|0|||
145657093|NCT05239455|525261629|FG000|Overall Study|Adverse Event|1|||
145657094|NCT05239455|525261629|FG000|Overall Study|Sponsor Decision|5|||
145657095|NCT05239455|525261629|FG000|Overall Study|Incomplete Blood Collection|1|||
145657096|NCT03800654|525261630|FG000|Overall Study|Time constraints|3|||
145657097|NCT03800654|525261631|FG001|Overall Study|Time constraints|3|||
145657098|NCT03800654|525261632|FG002|Overall Study|Time constraints|3|||
145657099|NCT03800654|525261630|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
145657100|NCT03800654|525261631|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
145657101|NCT03800654|525261632|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
145657102|NCT03800654|525261630|FG000|Overall Study|Lost to Follow-up|2|||
145657103|NCT03800654|525261631|FG001|Overall Study|Lost to Follow-up|1|||
145657104|NCT03800654|525261632|FG002|Overall Study|Lost to Follow-up|6|||
145657105|NCT03800654|525261630|FG000|Overall Study|Medical Health Issue|0|||
145657106|NCT03800654|525261631|FG001|Overall Study|Medical Health Issue|0|||
145657107|NCT03800654|525261632|FG002|Overall Study|Medical Health Issue|1|||
145657108|NCT03800654|525261630|FG000|Overall Study|Personal Issues|0|||
145657109|NCT03800654|525261631|FG001|Overall Study|Personal Issues|2|||
145657110|NCT03800654|525261632|FG002|Overall Study|Personal Issues|0|||
145657111|NCT03800654|525261630|FG000|Overall Study|Protocol Violation|0|||
145657112|NCT03800654|525261631|FG001|Overall Study|Protocol Violation|1|||
145657113|NCT03800654|525261632|FG002|Overall Study|Protocol Violation|0|||
145657114|NCT03084536|525261634|FG000|Overall Study|Determined to be ineligible|0|||
145657115|NCT03084536|525261635|FG001|Overall Study|Determined to be ineligible|0|||
145657116|NCT03084536|525261636|FG002|Overall Study|Determined to be ineligible|16|||
145657117|NCT03084536|525261634|FG000|Overall Study|Withdrawal by Subject|0|||
145657118|NCT03084536|525261635|FG001|Overall Study|Withdrawal by Subject|0|||
145657119|NCT03084536|525261636|FG002|Overall Study|Withdrawal by Subject|4|||
145657120|NCT03084536|525261634|FG000|Overall Study|Physician Decision|0|||
145657121|NCT03084536|525261635|FG001|Overall Study|Physician Decision|0|||
145657122|NCT03084536|525261636|FG002|Overall Study|Physician Decision|3|||
145657123|NCT03084536|525261634|FG000|Overall Study|Death|0|||
145657124|NCT03084536|525261635|FG001|Overall Study|Death|0|||
145657125|NCT03084536|525261636|FG002|Overall Study|Death|1|||
145657126|NCT03084536|525261634|FG000|Overall Study|Lost to Follow-up|0|||
145657127|NCT03084536|525261635|FG001|Overall Study|Lost to Follow-up|0|||
145657128|NCT03084536|525261636|FG002|Overall Study|Lost to Follow-up|1|||
145657129|NCT03084536|525261634|FG000|Overall Study|Protocol Violation|0|||
145657130|NCT03084536|525261635|FG001|Overall Study|Protocol Violation|0|||
145657131|NCT03084536|525261636|FG002|Overall Study|Protocol Violation|1|||
145657132|NCT03084536|525261634|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
145657133|NCT03084536|525261635|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
145657134|NCT03084536|525261636|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
145657135|NCT05192109|525261641|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145657136|NCT05192109|525261642|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145657137|NCT05192109|525261643|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145657138|NCT05192109|525261644|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145657139|NCT05192109|525261641|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
145657140|NCT05192109|525261642|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
145657141|NCT05192109|525261643|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145657142|NCT05192109|525261644|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
145657143|NCT04515849|525261645|FG000|Overall Study|Adverse Event|0|||
145657144|NCT04515849|525261646|FG001|Overall Study|Adverse Event|0|||
145657145|NCT04515849|525261647|FG002|Overall Study|Adverse Event|0|||
145657146|NCT04515849|525261648|FG003|Overall Study|Adverse Event|1|||
145657147|NCT04515849|525261649|FG004|Overall Study|Adverse Event|2|||
145657148|NCT04515849|525261645|FG000|Overall Study|Death|2|||
145657149|NCT04515849|525261646|FG001|Overall Study|Death|0|||
145657150|NCT04515849|525261647|FG002|Overall Study|Death|0|||
145657151|NCT04515849|525261648|FG003|Overall Study|Death|0|||
145657152|NCT04515849|525261649|FG004|Overall Study|Death|0|||
145657153|NCT04515849|525261645|FG000|Overall Study|Other:family emergency|0|||
145657154|NCT04515849|525261646|FG001|Overall Study|Other:family emergency|0|||
145657155|NCT04515849|525261647|FG002|Overall Study|Other:family emergency|0|||
145657156|NCT04515849|525261648|FG003|Overall Study|Other:family emergency|1|||
145657157|NCT04515849|525261649|FG004|Overall Study|Other:family emergency|0|||
145657158|NCT04515849|525261645|FG000|Overall Study|Other:randomised by error|0|||
145657159|NCT04515849|525261646|FG001|Overall Study|Other:randomised by error|1|||
145657160|NCT04515849|525261647|FG002|Overall Study|Other:randomised by error|0|||
145657161|NCT04515849|525261648|FG003|Overall Study|Other:randomised by error|0|||
145657162|NCT04515849|525261649|FG004|Overall Study|Other:randomised by error|0|||
145657163|NCT04515849|525261645|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
145657164|NCT04515849|525261646|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
145657165|NCT04515849|525261647|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
145657166|NCT04515849|525261648|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
145657167|NCT04515849|525261649|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
145657168|NCT04515849|525261645|FG000|Overall Study|Physician Decision|0|||
145657169|NCT04515849|525261646|FG001|Overall Study|Physician Decision|1|||
145657170|NCT04515849|525261647|FG002|Overall Study|Physician Decision|0|||
145657171|NCT04515849|525261648|FG003|Overall Study|Physician Decision|0|||
145657172|NCT04515849|525261649|FG004|Overall Study|Physician Decision|0|||
145657173|NCT04515849|525261645|FG000|Overall Study|Withdrawal by Subject|1|||
145657174|NCT04515849|525261646|FG001|Overall Study|Withdrawal by Subject|2|||
145657175|NCT04515849|525261647|FG002|Overall Study|Withdrawal by Subject|1|||
145657176|NCT04515849|525261648|FG003|Overall Study|Withdrawal by Subject|0|||
145657177|NCT04515849|525261649|FG004|Overall Study|Withdrawal by Subject|0|||
145657178|NCT04081103|525261653|FG000|Overall Study|Adverse Event|1|||
145657179|NCT04081103|525261654|FG001|Overall Study|Adverse Event|1|||
145657180|NCT04081103|525261655|FG002|Overall Study|Adverse Event|1|||
145657181|NCT04081103|525261653|FG000|Overall Study|Physician Decision|0|||
145657182|NCT04081103|525261654|FG001|Overall Study|Physician Decision|0|||
145657183|NCT04081103|525261655|FG002|Overall Study|Physician Decision|1|||
145657184|NCT03365882|525261658|FG000|Randomization|Still Receiving Protocol Treatment|2|||
145657185|NCT03365882|525261659|FG001|Randomization|Still Receiving Protocol Treatment|0|||
145657186|NCT03365882|525261658|FG000|Randomization|Adverse Event|1|||
145657187|NCT03365882|525261659|FG001|Randomization|Adverse Event|2|||
145657188|NCT03365882|525261658|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
145657189|NCT03365882|525261659|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
145657190|NCT03365882|525261658|FG000|Randomization|Progression/Relapse|21|||
145657191|NCT03365882|525261659|FG001|Randomization|Progression/Relapse|3|||
145657192|NCT03365882|525261658|FG000|Randomization|Death|1|||
145657193|NCT03365882|525261659|FG001|Randomization|Death|0|||
145657194|NCT03365882|525261658|FG000|Randomization|Other - Not Protocol Specified|1|||
145657195|NCT03365882|525261659|FG001|Randomization|Other - Not Protocol Specified|1|||
145657196|NCT03365882|525261658|FG000|Randomization|Major Protocol Deviation|0|||
145657197|NCT03365882|525261659|FG001|Randomization|Major Protocol Deviation|1|||
145657198|NCT03365882|525261658|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
145657199|NCT03365882|525261659|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
145490339|NCT00416624|524650279|FG000|Overall Study|Death|4|||
145490340|NCT00416624|524650280|FG001|Overall Study|Death|7|||
145490341|NCT00416624|524650281|FG002|Overall Study|Death|7|||
145657200|NCT03365882|525261658|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
145657201|NCT03365882|525261659|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
145657202|NCT03365882|525261658|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
145657203|NCT03365882|525261659|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
145657204|NCT03365882|525261658|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
145657205|NCT03365882|525261659|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
145657206|NCT03287817|525262941|FG000|Overall Study|Progressive disease|4|||
145657207|NCT03287817|525262942|FG001|Overall Study|Progressive disease|2|||
145657208|NCT03287817|525262943|FG002|Overall Study|Progressive disease|3|||
145657209|NCT03287817|525262944|FG003|Overall Study|Progressive disease|10|||
145490342|NCT00416624|524650282|FG003|Overall Study|Death|1|||
145657210|NCT03287817|525262945|FG004|Overall Study|Progressive disease|8|||
145657211|NCT03287817|525262941|FG000|Overall Study|Death|0|||
145657212|NCT03287817|525262942|FG001|Overall Study|Death|0|||
145657213|NCT03287817|525262943|FG002|Overall Study|Death|2|||
145657214|NCT03287817|525262944|FG003|Overall Study|Death|3|||
145657215|NCT03287817|525262945|FG004|Overall Study|Death|4|||
145657216|NCT03287817|525262941|FG000|Overall Study|Physician Decision|0|||
145657217|NCT03287817|525262942|FG001|Overall Study|Physician Decision|0|||
145657218|NCT03287817|525262943|FG002|Overall Study|Physician Decision|0|||
145657219|NCT03287817|525262944|FG003|Overall Study|Physician Decision|1|||
145657220|NCT03287817|525262945|FG004|Overall Study|Physician Decision|0|||
145657221|NCT03287817|525262941|FG000|Overall Study|Withdrawal by Subject|0|||
145657222|NCT03287817|525262942|FG001|Overall Study|Withdrawal by Subject|0|||
145657223|NCT03287817|525262943|FG002|Overall Study|Withdrawal by Subject|0|||
145657224|NCT03287817|525262944|FG003|Overall Study|Withdrawal by Subject|0|||
145657225|NCT03287817|525262945|FG004|Overall Study|Withdrawal by Subject|4|||
145657226|NCT06181227|525262946|FG000|Overall Study|Study terminated by sponsor|7|||
145657227|NCT06181227|525262947|FG001|Overall Study|Study terminated by sponsor|9|||
145657228|NCT05543915|525262948|FG000|Overall Study|Lost to Follow-up|0|||
145657229|NCT05543915|525262949|FG001|Overall Study|Lost to Follow-up|1|||
145657230|NCT00470704|525262952|FG000|Overall Study|Withdrawal by Subject|4|||
145657231|NCT00470704|525262953|FG001|Overall Study|Withdrawal by Subject|3|||
145657232|NCT00470704|525262952|FG000|Overall Study|Relapse/Progression|37|||
145657233|NCT00470704|525262953|FG001|Overall Study|Relapse/Progression|42|||
145657234|NCT00470704|525262952|FG000|Overall Study|toxicity|0|||
145657235|NCT00470704|525262953|FG001|Overall Study|toxicity|1|||
145657236|NCT02561247|525262954|FG000|Overall Study|Protocol Violation|1|||
145657237|NCT02561247|525262954|FG000|Overall Study|Withdrawal by Subject|1|||
145657238|NCT02561247|525262954|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
145657239|NCT04987320|525262956|FG000|Overall Study|Withdrawal by Subject|0|||
145657240|NCT04987320|525262957|FG001|Overall Study|Withdrawal by Subject|1|||
145657241|NCT00085735|525262958|FG000|Overall Study|Adverse Event|1|||
145657242|NCT00085735|525262959|FG001|Overall Study|Adverse Event|0|||
145657243|NCT00085735|525262960|FG002|Overall Study|Adverse Event|0|||
145657244|NCT00085735|525262961|FG003|Overall Study|Adverse Event|0|||
145657245|NCT00085735|525262962|FG004|Overall Study|Adverse Event|0|||
145657246|NCT00085735|525262963|FG005|Overall Study|Adverse Event|0|||
145657247|NCT00085735|525262958|FG000|Overall Study|Lack of Efficacy|2|||
145657248|NCT00085735|525262959|FG001|Overall Study|Lack of Efficacy|4|||
145657249|NCT00085735|525262960|FG002|Overall Study|Lack of Efficacy|6|||
145657250|NCT00085735|525262961|FG003|Overall Study|Lack of Efficacy|3|||
145657251|NCT00085735|525262962|FG004|Overall Study|Lack of Efficacy|4|||
145657252|NCT00085735|525262963|FG005|Overall Study|Lack of Efficacy|3|||
145657253|NCT00085735|525262958|FG000|Overall Study|Lost to Follow-up|0|||
145657254|NCT00085735|525262959|FG001|Overall Study|Lost to Follow-up|1|||
145657255|NCT00085735|525262960|FG002|Overall Study|Lost to Follow-up|0|||
145657256|NCT00085735|525262961|FG003|Overall Study|Lost to Follow-up|0|||
145657257|NCT00085735|525262962|FG004|Overall Study|Lost to Follow-up|1|||
145657258|NCT00085735|525262963|FG005|Overall Study|Lost to Follow-up|0|||
145657259|NCT00085735|525262958|FG000|Overall Study|Physician Decision|2|||
145657260|NCT00085735|525262959|FG001|Overall Study|Physician Decision|3|||
145657261|NCT00085735|525262960|FG002|Overall Study|Physician Decision|2|||
145657262|NCT00085735|525262961|FG003|Overall Study|Physician Decision|3|||
145657263|NCT00085735|525262962|FG004|Overall Study|Physician Decision|11|||
145657264|NCT00085735|525262963|FG005|Overall Study|Physician Decision|8|||
145657265|NCT00085735|525262958|FG000|Overall Study|Protocol Violation|1|||
145657266|NCT00085735|525262959|FG001|Overall Study|Protocol Violation|0|||
145657267|NCT00085735|525262960|FG002|Overall Study|Protocol Violation|0|||
145657268|NCT00085735|525262961|FG003|Overall Study|Protocol Violation|0|||
145657269|NCT00085735|525262962|FG004|Overall Study|Protocol Violation|0|||
145657270|NCT00085735|525262963|FG005|Overall Study|Protocol Violation|0|||
145657271|NCT00085735|525262958|FG000|Overall Study|Withdrawal by Subject|1|||
145657272|NCT00085735|525262959|FG001|Overall Study|Withdrawal by Subject|0|||
145657273|NCT00085735|525262960|FG002|Overall Study|Withdrawal by Subject|4|||
145657274|NCT00085735|525262961|FG003|Overall Study|Withdrawal by Subject|5|||
145657275|NCT00085735|525262962|FG004|Overall Study|Withdrawal by Subject|7|||
145657276|NCT00085735|525262963|FG005|Overall Study|Withdrawal by Subject|8|||
145657277|NCT00085735|525262958|FG000|Overall Study|Patient ineligible|1|||
145657278|NCT00085735|525262959|FG001|Overall Study|Patient ineligible|0|||
145657279|NCT00085735|525262960|FG002|Overall Study|Patient ineligible|3|||
145657280|NCT00085735|525262961|FG003|Overall Study|Patient ineligible|7|||
145657281|NCT00085735|525262962|FG004|Overall Study|Patient ineligible|17|||
145657282|NCT00085735|525262963|FG005|Overall Study|Patient ineligible|8|||
145657283|NCT00085735|525262958|FG000|Overall Study|Excess residual disease|2|||
145657284|NCT00085735|525262959|FG001|Overall Study|Excess residual disease|2|||
145657285|NCT00085735|525262960|FG002|Overall Study|Excess residual disease|1|||
145657286|NCT00085735|525262961|FG003|Overall Study|Excess residual disease|1|||
145657287|NCT00085735|525262962|FG004|Overall Study|Excess residual disease|1|||
145657288|NCT00085735|525262963|FG005|Overall Study|Excess residual disease|4|||
145657289|NCT00085735|525262958|FG000|Overall Study|Reason not documented|1|||
145657290|NCT00085735|525262959|FG001|Overall Study|Reason not documented|0|||
145657291|NCT00085735|525262960|FG002|Overall Study|Reason not documented|1|||
145657292|NCT00085735|525262961|FG003|Overall Study|Reason not documented|0|||
145657293|NCT00085735|525262962|FG004|Overall Study|Reason not documented|1|||
145657294|NCT00085735|525262963|FG005|Overall Study|Reason not documented|0|||
145657295|NCT00085735|525262958|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
145657296|NCT00085735|525262959|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
145657297|NCT00085735|525262960|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
145657298|NCT00085735|525262961|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
145657299|NCT00085735|525262962|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
145657300|NCT00085735|525262963|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
145657301|NCT01824875|525262964|FG000|Overall Study|Disease progression|22|||
145657302|NCT01824875|525262965|FG001|Overall Study|Disease progression|15|||
145657303|NCT01824875|525262964|FG000|Overall Study|Withdrawal by Subject|5|||
145657304|NCT01824875|525262965|FG001|Overall Study|Withdrawal by Subject|4|||
145657305|NCT01824875|525262964|FG000|Overall Study|Adverse Event|4|||
145657306|NCT01824875|525262965|FG001|Overall Study|Adverse Event|10|||
145657307|NCT01824875|525262964|FG000|Overall Study|Alternative therapy|3|||
145657308|NCT01824875|525262965|FG001|Overall Study|Alternative therapy|0|||
145657309|NCT01824875|525262964|FG000|Overall Study|Complicating disease|1|||
145657310|NCT01824875|525262965|FG001|Overall Study|Complicating disease|0|||
145657311|NCT01824875|525262964|FG000|Overall Study|Physician Decision|0|||
145657312|NCT01824875|525262965|FG001|Overall Study|Physician Decision|1|||
145657313|NCT01824875|525262964|FG000|Overall Study|Non-compliance|1|||
145657314|NCT01824875|525262965|FG001|Overall Study|Non-compliance|1|||
145657315|NCT01824875|525262964|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
145657316|NCT01824875|525262965|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
145657317|NCT01824875|525262964|FG000|Overall Study|Administrative issues|0|||
145657318|NCT01824875|525262965|FG001|Overall Study|Administrative issues|2|||
145657319|NCT01824875|525262964|FG000|Overall Study|Ineligible or never started treatment|9|||
145657320|NCT01824875|525262965|FG001|Overall Study|Ineligible or never started treatment|5|||
145657321|NCT01824875|525262964|FG000|Overall Study|Other|0|||
145657322|NCT01824875|525262965|FG001|Overall Study|Other|2|||
145657323|NCT02817776|525262966|FG000|Overall Study|Excluded|33|||
145657324|NCT02817776|525262966|FG000|Overall Study|Lost to Follow-up|20|||
145657325|NCT02817776|525262966|FG000|Overall Study|Withdrawal by Subject|33|||
145657326|NCT02817776|525262966|FG000|Overall Study|Death|2|||
145657327|NCT05540665|525262969|FG000|Overall Study|Study terminated by sponsor|6|||
145657328|NCT05540665|525262970|FG001|Overall Study|Study terminated by sponsor|6|||
145657329|NCT05540665|525262971|FG002|Overall Study|Study terminated by sponsor|7|||
145657330|NCT03462030|525262972|FG000|Overall Study|Withdrawal by Subject|1|||
145657331|NCT03462030|525262973|FG001|Overall Study|Withdrawal by Subject|1|||
145657332|NCT02675751|525262974|FG000|Overall Study|Lost to Follow-up|16|||
145657333|NCT03371381|525262975|FG000|Overall Study|Death|5|||
145657334|NCT03371381|525262975|FG000|Overall Study|Study terminated by sponsor|3|||
145657335|NCT03371381|525262975|FG000|Overall Study|Other|4|||
145657336|NCT02979327|525262976|FG000|First Intervention|Protocol Violation|1|||
145657337|NCT02979327|525262977|FG001|First Intervention|Protocol Violation|0|||
145657338|NCT01073566|525262978|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
145657339|NCT01073566|525262979|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
145657340|NCT04376502|525262984|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
145657341|NCT02547233|525262985|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
145490343|NCT00416624|524650279|FG000|Overall Study|Adverse Event|8|||
145490344|NCT00416624|524650280|FG001|Overall Study|Adverse Event|3|||
145490345|NCT00416624|524650281|FG002|Overall Study|Adverse Event|2|||
145490346|NCT00416624|524650282|FG003|Overall Study|Adverse Event|2|||
145490347|NCT00416624|524650279|FG000|Overall Study|Other|8|||
145490348|NCT00416624|524650280|FG001|Overall Study|Other|11|||
145490349|NCT00416624|524650281|FG002|Overall Study|Other|5|||
145490350|NCT00416624|524650282|FG003|Overall Study|Other|5|||
145490351|NCT00416624|524650279|FG000|Overall Study|Cancel|1|||
145490352|NCT00416624|524650280|FG001|Overall Study|Cancel|0|||
145490353|NCT00416624|524650281|FG002|Overall Study|Cancel|0|||
145490354|NCT00416624|524650282|FG003|Overall Study|Cancel|0|||
145490355|NCT01005251|524650283|FG000|Overall Study|Withdrawal by Subject|2|||
145490356|NCT01005251|524650284|FG001|Overall Study|Withdrawal by Subject|5|||
145490357|NCT01005251|524650285|FG002|Overall Study|Withdrawal by Subject|3|||
145657342|NCT02547233|525262986|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
145657343|NCT02547233|525262985|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
145657344|NCT02547233|525262986|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
145657345|NCT02547233|525262985|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
145657346|NCT02547233|525262986|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
145265338|NCT00953017|523819296|FG002|Overall Study|Brown stool prior to procedure|1|||
145490358|NCT01005251|524650286|FG003|Overall Study|Withdrawal by Subject|4|||
145657347|NCT02547233|525262985|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
145657348|NCT02547233|525262986|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
145657349|NCT02547233|525262985|FG000|12-month Follow-up|Withdrawal by Subject|10|||
145657350|NCT02547233|525262986|FG001|12-month Follow-up|Withdrawal by Subject|10|||
145657351|NCT02547233|525262985|FG000|12-month Follow-up|Lost to Follow-up|3|||
145657352|NCT02547233|525262986|FG001|12-month Follow-up|Lost to Follow-up|3|||
145657353|NCT02547233|525262985|FG000|12-month Follow-up|Lack of Efficacy|1|||
145657354|NCT02547233|525262986|FG001|12-month Follow-up|Lack of Efficacy|2|||
145657355|NCT02547233|525262985|FG000|12-month Follow-up|Protocol Violation|0|||
145657356|NCT02547233|525262986|FG001|12-month Follow-up|Protocol Violation|1|||
145657357|NCT02547233|525262985|FG000|12-month Follow-up|Other|0|||
145657358|NCT02547233|525262986|FG001|12-month Follow-up|Other|1|||
145657359|NCT06019559|525262987|FG000|Overall Study|Withdrawal by Subject|7|||
145657360|NCT06019559|525262988|FG001|Overall Study|Withdrawal by Subject|6|||
145657361|NCT06019559|525262989|FG002|Overall Study|Withdrawal by Subject|5|||
145657362|NCT06019559|525262987|FG000|Overall Study|Lost to Follow-up|2|||
145657363|NCT06019559|525262988|FG001|Overall Study|Lost to Follow-up|0|||
145657364|NCT06019559|525262989|FG002|Overall Study|Lost to Follow-up|3|||
145657365|NCT05949788|525262990|FG000|Overall Study|severe birth deformity|2|||
145657366|NCT05949788|525262991|FG001|Overall Study|severe birth deformity|7|||
145657367|NCT05949788|525262990|FG000|Overall Study|twin-twin transfusion syndrome|2|||
145657368|NCT05949788|525262991|FG001|Overall Study|twin-twin transfusion syndrome|7|||
145657369|NCT05949788|525262990|FG000|Overall Study|neonatal hemolytic disease|3|||
145657370|NCT05949788|525262991|FG001|Overall Study|neonatal hemolytic disease|8|||
145657371|NCT05949788|525262990|FG000|Overall Study|death within 14 days after birth|2|||
145657372|NCT05949788|525262991|FG001|Overall Study|death within 14 days after birth|6|||
145657373|NCT05949788|525262990|FG000|Overall Study|transfer to another hospital|2|||
145657374|NCT05949788|525262991|FG001|Overall Study|transfer to another hospital|6|||
145657375|NCT05213390|525262992|FG000|Overall Study|Withdrawal by Subject|2|||
145657376|NCT05213390|525262992|FG000|Overall Study|Lost to Follow-up|12|||
145657377|NCT05213390|525262992|FG000|Overall Study|Protocol Violation|9|||
145657378|NCT01824537|525262993|FG000|Overall Study|Lost to Follow-up|78|||
145657379|NCT01824537|525262994|FG001|Overall Study|Lost to Follow-up|87|||
145657380|NCT06215521|525262995|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
145657381|NCT06215521|525262996|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
145657382|NCT06215521|525262997|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
145657383|NCT06215521|525262998|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
145657384|NCT06215521|525262999|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
145657385|NCT06215521|525263000|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
145657386|NCT04537715|525263001|FG000|Overall Study|Death|3|||
145657387|NCT04537715|525263002|FG001|Overall Study|Death|1|||
145657388|NCT04537715|525263001|FG000|Overall Study|Withdrawal by Subject|3|||
145657389|NCT04537715|525263002|FG001|Overall Study|Withdrawal by Subject|1|||
145657390|NCT04537715|525263001|FG000|Overall Study|Other|4|||
145657391|NCT04537715|525263002|FG001|Overall Study|Other|3|||
145657392|NCT04537715|525263001|FG000|Overall Study|Progressive disease|1|||
145657393|NCT04537715|525263002|FG001|Overall Study|Progressive disease|0|||
145657394|NCT02191618|525263003|FG000|Overall Study|Withdrawal by Subject|3|||
145657395|NCT02191618|525263003|FG000|Overall Study|Missed Visit|4|||
145657396|NCT02043678|525263007|FG000|Overall Study|Never treated|11|||
145657397|NCT02043678|525263008|FG001|Overall Study|Never treated|9|||
145657398|NCT02043678|525263007|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
145657399|NCT02043678|525263008|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
145657400|NCT02043678|525263007|FG000|Overall Study|AE without clinical PD|54|||
145657401|NCT02043678|525263008|FG001|Overall Study|AE without clinical PD|36|||
145657402|NCT02043678|525263007|FG000|Overall Study|Lost to Follow-up|1|||
145657403|NCT02043678|525263008|FG001|Overall Study|Lost to Follow-up|1|||
145657404|NCT02043678|525263007|FG000|Overall Study|Other|10|||
145657405|NCT02043678|525263008|FG001|Overall Study|Other|14|||
145657406|NCT02043678|525263007|FG000|Overall Study|Clinical PD|114|||
145657407|NCT02043678|525263008|FG001|Overall Study|Clinical PD|148|||
145657408|NCT02043678|525263007|FG000|Overall Study|Radiological PD|100|||
145657409|NCT02043678|525263008|FG001|Overall Study|Radiological PD|90|||
145657410|NCT02043678|525263007|FG000|Overall Study|Protocol-driven decision point|59|||
145657411|NCT02043678|525263008|FG001|Overall Study|Protocol-driven decision point|58|||
145657412|NCT02043678|525263007|FG000|Overall Study|Withdrawal by Subject|16|||
145657413|NCT02043678|525263008|FG001|Overall Study|Withdrawal by Subject|20|||
145657414|NCT02043678|525263007|FG000|Overall Study|Protocol Violation|1|||
145657415|NCT02043678|525263008|FG001|Overall Study|Protocol Violation|0|||
145657416|NCT02043678|525263007|FG000|Overall Study|Deterioration of general conditions|1|||
145657417|NCT02043678|525263008|FG001|Overall Study|Deterioration of general conditions|1|||
145657418|NCT02043678|525263007|FG000|Overall Study|Logistical difficulties|2|||
145657419|NCT02043678|525263008|FG001|Overall Study|Logistical difficulties|0|||
145657420|NCT02043678|525263007|FG000|Overall Study|Non-compliance with study drug|3|||
145657421|NCT02043678|525263008|FG001|Overall Study|Non-compliance with study drug|1|||
145657422|NCT02043678|525263007|FG000|Overall Study|Physician Decision|4|||
145657423|NCT02043678|525263008|FG001|Overall Study|Physician Decision|3|||
145490359|NCT01005251|524650287|FG004|Overall Study|Withdrawal by Subject|9|||
145490360|NCT01005251|524650283|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
145490361|NCT01005251|524650284|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
145490362|NCT01005251|524650285|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
145490363|NCT01005251|524650286|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
145490364|NCT01005251|524650287|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
145490365|NCT01005251|524650283|FG000|Overall Study|Adverse Event|2|||
145490366|NCT01005251|524650284|FG001|Overall Study|Adverse Event|6|||
145490367|NCT01005251|524650285|FG002|Overall Study|Adverse Event|8|||
145490368|NCT01005251|524650286|FG003|Overall Study|Adverse Event|5|||
145490369|NCT01005251|524650287|FG004|Overall Study|Adverse Event|4|||
145490370|NCT01005251|524650283|FG000|Overall Study|Protocol Violation|1|||
145490371|NCT01005251|524650284|FG001|Overall Study|Protocol Violation|0|||
145490372|NCT01005251|524650285|FG002|Overall Study|Protocol Violation|0|||
145490373|NCT01005251|524650286|FG003|Overall Study|Protocol Violation|0|||
145490374|NCT01005251|524650287|FG004|Overall Study|Protocol Violation|2|||
145490375|NCT01005251|524650283|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
145490376|NCT01005251|524650284|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
145490377|NCT01005251|524650285|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
145490378|NCT01005251|524650286|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
145490379|NCT01005251|524650287|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
145490380|NCT01005251|524650283|FG000|Overall Study|Lost to Follow-up|1|||
145490381|NCT01005251|524650284|FG001|Overall Study|Lost to Follow-up|4|||
145490382|NCT01005251|524650285|FG002|Overall Study|Lost to Follow-up|2|||
145490383|NCT01005251|524650286|FG003|Overall Study|Lost to Follow-up|0|||
145490384|NCT01005251|524650287|FG004|Overall Study|Lost to Follow-up|0|||
145490385|NCT01005251|524650283|FG000|Overall Study|Physician Decision|0|||
145490386|NCT01005251|524650284|FG001|Overall Study|Physician Decision|0|||
145490387|NCT01005251|524650285|FG002|Overall Study|Physician Decision|0|||
145490388|NCT01005251|524650286|FG003|Overall Study|Physician Decision|0|||
145490389|NCT01005251|524650287|FG004|Overall Study|Physician Decision|2|||
145490390|NCT01005251|524650283|FG000|Overall Study|Patient moved|1|||
145490391|NCT01005251|524650284|FG001|Overall Study|Patient moved|0|||
145490392|NCT01005251|524650285|FG002|Overall Study|Patient moved|0|||
145490393|NCT01005251|524650286|FG003|Overall Study|Patient moved|0|||
145490394|NCT01005251|524650287|FG004|Overall Study|Patient moved|0|||
145490395|NCT01005251|524650283|FG000|Overall Study|Wrong drug dispensed|0|||
145490396|NCT01005251|524650284|FG001|Overall Study|Wrong drug dispensed|1|||
145490397|NCT01005251|524650285|FG002|Overall Study|Wrong drug dispensed|0|||
145657424|NCT02043678|525263007|FG000|Overall Study|Subject decision|0|||
145657425|NCT02043678|525263008|FG001|Overall Study|Subject decision|1|||
145657426|NCT02043678|525263007|FG000|Overall Study|Switching to other therapy|3|||
145657427|NCT02043678|525263008|FG001|Overall Study|Switching to other therapy|2|||
145657428|NCT02043678|525263007|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
145657429|NCT02043678|525263008|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
145657430|NCT02043678|525263007|FG000|Overall Study|Missing|1|||
145657431|NCT02043678|525263008|FG001|Overall Study|Missing|0|||
145657432|NCT02043678|525263007|FG000|Overall Study|Adverse Event|0|||
145657433|NCT02043678|525263008|FG001|Overall Study|Adverse Event|1|||
145657434|NCT03216057|525263009|FG000|Overall Study|Lost to Follow-up|2|||
145657435|NCT03216057|525263010|FG001|Overall Study|Lost to Follow-up|2|||
145657436|NCT04568603|525263011|FG000|Overall Study|Physician Decision|1|||
145657437|NCT05144009|525263012|FG000|Overall Study|Lost to Follow-up|0|||
145657438|NCT05144009|525263013|FG001|Overall Study|Lost to Follow-up|1|||
145657439|NCT05144009|525263012|FG000|Overall Study|Study Termination by the Sponsor|11|||
145657440|NCT05144009|525263013|FG001|Overall Study|Study Termination by the Sponsor|11|||
145657441|NCT05144009|525263012|FG000|Overall Study|Disease Progression|1|||
145657442|NCT05144009|525263013|FG001|Overall Study|Disease Progression|0|||
145657443|NCT05144009|525263012|FG000|Overall Study|Participant Decision|0|||
145657444|NCT05144009|525263013|FG001|Overall Study|Participant Decision|2|||
145657445|NCT05144009|525263012|FG000|Overall Study|Death|5|||
145657446|NCT05144009|525263013|FG001|Overall Study|Death|10|||
145657447|NCT05269667|525263014|FG000|Overall Study|Study Terminated by Sponsor|4|||
145657448|NCT05270408|525263015|FG000|Started Treatment|Withdrawal by Subject|0|||
145657449|NCT05270408|525263016|FG001|Started Treatment|Withdrawal by Subject|0|||
145657450|NCT05270408|525263017|FG002|Started Treatment|Withdrawal by Subject|3|||
145657451|NCT05270408|525263015|FG000|Started Treatment|Adverse Event|0|||
145657452|NCT05270408|525263016|FG001|Started Treatment|Adverse Event|0|||
145657453|NCT05270408|525263017|FG002|Started Treatment|Adverse Event|1|||
145657454|NCT05270408|525263015|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
145657455|NCT05270408|525263016|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
145490398|NCT01005251|524650286|FG003|Overall Study|Wrong drug dispensed|0|||
145490399|NCT01005251|524650287|FG004|Overall Study|Wrong drug dispensed|0|||
145490400|NCT01005251|524650283|FG000|Overall Study|Randomized in error|0|||
145490401|NCT01005251|524650284|FG001|Overall Study|Randomized in error|0|||
145657456|NCT05270408|525263017|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
145657457|NCT03768505|525263018|FG000|Overall Study|sponsor decision|76|||
145657458|NCT03768505|525263018|FG000|Overall Study|Death|35|||
145657459|NCT03768505|525263018|FG000|Overall Study|Other -Various|30|||
145657460|NCT03768505|525263018|FG000|Overall Study|Withdrawal by Subject|22|||
145657461|NCT03768505|525263018|FG000|Overall Study|Lost to Follow-up|6|||
145657462|NCT05399459|525263021|FG000|Overall Study|Randomized but not treated|29|||
145657463|NCT05399459|525263022|FG001|Overall Study|Randomized but not treated|30|||
145657464|NCT05399459|525263023|FG002|Overall Study|Randomized but not treated|38|||
145657465|NCT05399459|525263021|FG000|Overall Study|Lost to Follow-up|1|||
145657466|NCT05399459|525263022|FG001|Overall Study|Lost to Follow-up|0|||
145657467|NCT05399459|525263023|FG002|Overall Study|Lost to Follow-up|0|||
145657468|NCT04992520|525263024|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
145657469|NCT04992520|525263025|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
145657470|NCT04992520|525263026|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
145657471|NCT04992520|525263027|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
145657472|NCT04992520|525263028|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
145657473|NCT04992520|525263029|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
145657474|NCT04992520|525263024|FG000|Part A: First Challenge|Non-compliance|0|||
145657475|NCT04992520|525263025|FG001|Part A: First Challenge|Non-compliance|0|||
145657476|NCT04992520|525263026|FG002|Part A: First Challenge|Non-compliance|0|||
145657477|NCT04992520|525263027|FG003|Part A: First Challenge|Non-compliance|1|||
145657478|NCT04992520|525263028|FG004|Part A: First Challenge|Non-compliance|0|||
145657479|NCT04992520|525263029|FG005|Part A: First Challenge|Non-compliance|0|||
145657480|NCT04992520|525263024|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
145657481|NCT04992520|525263025|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
145657482|NCT04992520|525263026|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
145657483|NCT04992520|525263027|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
145657484|NCT04992520|525263028|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
145657485|NCT04992520|525263029|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
145657486|NCT04992520|525263024|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145657487|NCT04992520|525263025|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145657488|NCT04992520|525263026|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
145657489|NCT04992520|525263027|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145657490|NCT04992520|525263028|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145657491|NCT04992520|525263029|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
145657492|NCT03625167|525263031|FG000|Overall Study|Protocol Violation|5|||
145657493|NCT02231164|525263032|FG000|Overall Study|Adverse Event|1|||
145657494|NCT02231164|525263033|FG001|Overall Study|Adverse Event|1|||
145657495|NCT02231164|525263032|FG000|Overall Study|Lack of Efficacy|4|||
145657496|NCT02231164|525263033|FG001|Overall Study|Lack of Efficacy|3|||
145657497|NCT02231164|525263032|FG000|Overall Study|Withdrawal by Subject|1|||
145657498|NCT02231164|525263033|FG001|Overall Study|Withdrawal by Subject|2|||
145657499|NCT06103188|525263035|FG000|Overall Study|Lost to Follow-up|1|||
145657500|NCT06103188|525263036|FG001|Overall Study|Lost to Follow-up|6|||
145657501|NCT06103188|525263037|FG002|Overall Study|Lost to Follow-up|4|||
145657502|NCT05201079|525263042|FG000|Overall Study|Adverse Event|7|||
145657503|NCT05201079|525263043|FG001|Overall Study|Adverse Event|11|||
145657504|NCT05201079|525263042|FG000|Overall Study|Death|1|||
145657505|NCT05201079|525263043|FG001|Overall Study|Death|1|||
145657506|NCT05201079|525263042|FG000|Overall Study|Lack of Efficacy|0|||
145490402|NCT01005251|524650285|FG002|Overall Study|Randomized in error|1|||
145490403|NCT01005251|524650286|FG003|Overall Study|Randomized in error|1|||
145490404|NCT01005251|524650287|FG004|Overall Study|Randomized in error|0|||
145490405|NCT01005251|524650283|FG000|Overall Study|Lack of Efficacy|0|||
145490406|NCT01005251|524650284|FG001|Overall Study|Lack of Efficacy|0|||
145490407|NCT01005251|524650285|FG002|Overall Study|Lack of Efficacy|1|||
145657507|NCT05201079|525263043|FG001|Overall Study|Lack of Efficacy|2|||
145657508|NCT05201079|525263042|FG000|Overall Study|Lost to Follow-up|0|||
145657509|NCT05201079|525263043|FG001|Overall Study|Lost to Follow-up|1|||
145657510|NCT05201079|525263042|FG000|Overall Study|Physician Decision|1|||
145657511|NCT05201079|525263043|FG001|Overall Study|Physician Decision|1|||
145657512|NCT05201079|525263042|FG000|Overall Study|Protocol Violation|1|||
145657513|NCT05201079|525263043|FG001|Overall Study|Protocol Violation|0|||
145657514|NCT05201079|525263042|FG000|Overall Study|Withdrawal by Subject|1|||
145657515|NCT05201079|525263043|FG001|Overall Study|Withdrawal by Subject|0|||
145657516|NCT05201079|525263042|FG000|Overall Study|Forbidden medication|9|||
145657517|NCT05201079|525263043|FG001|Overall Study|Forbidden medication|5|||
145657518|NCT05201079|525263042|FG000|Overall Study|Transfer to another hospital|0|||
145490408|NCT01005251|524650286|FG003|Overall Study|Lack of Efficacy|1|||
145490409|NCT01005251|524650287|FG004|Overall Study|Lack of Efficacy|0|||
145657519|NCT05201079|525263043|FG001|Overall Study|Transfer to another hospital|1|||
145657520|NCT05201079|525263042|FG000|Overall Study|Clinical condition|1|||
145657521|NCT05201079|525263043|FG001|Overall Study|Clinical condition|0|||
145657522|NCT05201079|525263042|FG000|Overall Study|SAE and sepsis|1|||
145657523|NCT05201079|525263043|FG001|Overall Study|SAE and sepsis|0|||
145490410|NCT00962208|524650289|FG000|Overall Study|Could not achieve good vision|9|||
145657524|NCT04145440|525263044|FG000|Overall Study|Physician Decision|3|||
145657525|NCT04145440|525263045|FG001|Overall Study|Physician Decision|0|||
145657526|NCT04145440|525263044|FG000|Overall Study|Use of prohibited therapy|2|||
145657527|NCT04145440|525263045|FG001|Overall Study|Use of prohibited therapy|3|||
145657528|NCT05281562|525263046|FG000|Overall Study|Ineligible patient|1|||
145657529|NCT05281562|525263047|FG001|Overall Study|Ineligible patient|0|||
145657530|NCT06457802|525263050|FG000|Overall Study|Early termination of study prior to participant completion|2|||
145657531|NCT06457802|525263051|FG001|Overall Study|Early termination of study prior to participant completion|2|||
145657532|NCT04524442|525263053|FG000|Overall Study|Subject Decision|1|||
145657533|NCT02151981|525263061|FG000|Overall Study|Death|184|||
145657534|NCT02151981|525263062|FG001|Overall Study|Death|88|||
145657535|NCT02151981|525263061|FG000|Overall Study|Lost to Follow-up|7|||
145657536|NCT02151981|525263062|FG001|Overall Study|Lost to Follow-up|1|||
145657537|NCT02151981|525263061|FG000|Overall Study|Withdrawal by Subject|27|||
145657538|NCT02151981|525263062|FG001|Overall Study|Withdrawal by Subject|21|||
145657539|NCT02151981|525263061|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145657540|NCT02151981|525263062|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145657541|NCT02151981|525263061|FG000|Overall Study|Other reasons|1|||
145657542|NCT02151981|525263062|FG001|Overall Study|Other reasons|2|||
145657543|NCT05576155|525263070|FG000|Overall Study|Withdrawal by Subject|1|||
145657544|NCT05576155|525263071|FG001|Overall Study|Withdrawal by Subject|1|||
145657545|NCT05251909|525265219|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
145657546|NCT05251909|525265220|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
145657547|NCT03381196|525265223|FG000|Overall Study|Withdrawal by Subject|7|||
145657548|NCT03381196|525265224|FG001|Overall Study|Withdrawal by Subject|7|||
145657549|NCT03381196|525265223|FG000|Overall Study|Other|0|||
145657550|NCT03381196|525265224|FG001|Overall Study|Other|1|||
145657551|NCT03381196|525265223|FG000|Overall Study|Lost to Follow-up|5|||
145657552|NCT03381196|525265224|FG001|Overall Study|Lost to Follow-up|4|||
145657553|NCT03381196|525265223|FG000|Overall Study|Death|0|||
145657554|NCT03381196|525265224|FG001|Overall Study|Death|1|||
145657555|NCT03381196|525265223|FG000|Overall Study|Adverse Event|1|||
145657556|NCT03381196|525265224|FG001|Overall Study|Adverse Event|0|||
145657557|NCT03381196|525265223|FG000|Overall Study|Randomized, not treated|3|||
145657558|NCT03381196|525265224|FG001|Overall Study|Randomized, not treated|6|||
145657559|NCT02598388|525265225|FG000|Overall Study|Lost to Follow-up|1|||
145657560|NCT02598388|525265226|FG001|Overall Study|Lost to Follow-up|0|||
145657561|NCT02598388|525265227|FG002|Overall Study|Lost to Follow-up|1|||
145657562|NCT02598388|525265228|FG003|Overall Study|Lost to Follow-up|0|||
145657563|NCT02598388|525265229|FG004|Overall Study|Lost to Follow-up|5|||
145657564|NCT02598388|525265230|FG005|Overall Study|Lost to Follow-up|1|||
145657565|NCT02598388|525265231|FG006|Overall Study|Lost to Follow-up|2|||
145657566|NCT02598388|525265232|FG007|Overall Study|Lost to Follow-up|1|||
145657567|NCT02598388|525265233|FG008|Overall Study|Lost to Follow-up|0|||
145657568|NCT02598388|525265234|FG009|Overall Study|Lost to Follow-up|0|||
145657569|NCT02598388|525265235|FG010|Overall Study|Lost to Follow-up|1|||
145657570|NCT02598388|525265236|FG011|Overall Study|Lost to Follow-up|0|||
145657571|NCT02598388|525265225|FG000|Overall Study|Withdrawal by Subject|0|||
145657572|NCT02598388|525265226|FG001|Overall Study|Withdrawal by Subject|0|||
145657573|NCT02598388|525265227|FG002|Overall Study|Withdrawal by Subject|0|||
145657574|NCT02598388|525265228|FG003|Overall Study|Withdrawal by Subject|0|||
145657575|NCT02598388|525265229|FG004|Overall Study|Withdrawal by Subject|2|||
145657576|NCT02598388|525265230|FG005|Overall Study|Withdrawal by Subject|0|||
145657577|NCT02598388|525265231|FG006|Overall Study|Withdrawal by Subject|2|||
145657578|NCT02598388|525265232|FG007|Overall Study|Withdrawal by Subject|0|||
145657579|NCT02598388|525265233|FG008|Overall Study|Withdrawal by Subject|0|||
145657580|NCT02598388|525265234|FG009|Overall Study|Withdrawal by Subject|1|||
145657581|NCT02598388|525265235|FG010|Overall Study|Withdrawal by Subject|0|||
145657582|NCT02598388|525265236|FG011|Overall Study|Withdrawal by Subject|0|||
145657583|NCT02598388|525265225|FG000|Overall Study|Other|0|||
145657584|NCT02598388|525265226|FG001|Overall Study|Other|0|||
145657585|NCT02598388|525265227|FG002|Overall Study|Other|1|||
145657586|NCT02598388|525265228|FG003|Overall Study|Other|0|||
145657587|NCT02598388|525265229|FG004|Overall Study|Other|3|||
145657588|NCT02598388|525265230|FG005|Overall Study|Other|0|||
145657589|NCT02598388|525265231|FG006|Overall Study|Other|1|||
145657590|NCT02598388|525265232|FG007|Overall Study|Other|0|||
145657591|NCT02598388|525265233|FG008|Overall Study|Other|0|||
145657592|NCT02598388|525265234|FG009|Overall Study|Other|0|||
145657593|NCT02598388|525265235|FG010|Overall Study|Other|0|||
145657594|NCT02598388|525265236|FG011|Overall Study|Other|0|||
145657595|NCT02359890|525265238|FG000|Overall Study|Not meeting eligibility|4|||
145657596|NCT02359890|525265238|FG000|Overall Study|Never treated with study catheter|6|||
145657597|NCT03628924|525265239|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
145657598|NCT03628924|525265240|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657599|NCT03628924|525265241|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657600|NCT03628924|525265242|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657601|NCT03628924|525265243|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657602|NCT03628924|525265244|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657603|NCT03628924|525265245|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
145657604|NCT03628924|525265239|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657605|NCT03628924|525265240|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657606|NCT03628924|525265241|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
145657607|NCT03628924|525265242|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657608|NCT03628924|525265243|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657609|NCT03628924|525265244|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657610|NCT03628924|525265245|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
145657611|NCT03628924|525265239|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
145657612|NCT03628924|525265240|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
145657613|NCT03628924|525265241|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
145657614|NCT03628924|525265242|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
145657615|NCT03628924|525265243|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
145657616|NCT03628924|525265244|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
145657617|NCT03628924|525265245|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
145657618|NCT03628924|525265239|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657619|NCT03628924|525265240|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
145657620|NCT03628924|525265241|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657621|NCT03628924|525265242|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657622|NCT03628924|525265243|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657623|NCT03628924|525265244|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657624|NCT03628924|525265245|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145657625|NCT03628924|525265239|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
145657626|NCT03628924|525265240|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
145657627|NCT03628924|525265241|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
145657628|NCT03628924|525265242|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
145657629|NCT03628924|525265243|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
145657630|NCT03628924|525265244|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
145657631|NCT03628924|525265245|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
145657632|NCT03628924|525265239|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
145657633|NCT03628924|525265240|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
145657634|NCT03628924|525265241|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
145657635|NCT03628924|525265242|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
145657636|NCT03628924|525265243|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
145657637|NCT03628924|525265244|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
145657638|NCT03628924|525265245|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
145657639|NCT03628924|525265239|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
145657640|NCT03628924|525265240|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
145657641|NCT03628924|525265241|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
145657642|NCT03628924|525265242|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
145657643|NCT03628924|525265243|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
145657644|NCT03628924|525265244|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
145657645|NCT03628924|525265245|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
145657646|NCT03628924|525265239|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
145657647|NCT03628924|525265240|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
145657648|NCT03628924|525265241|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
145657649|NCT03628924|525265242|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
145657650|NCT03628924|525265243|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
145657651|NCT03628924|525265244|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
145657652|NCT03628924|525265245|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
145490411|NCT00962208|524650290|FG001|Overall Study|Could not achieve good vision|0|||
145490412|NCT00962208|524650289|FG000|Overall Study|Contraindicated to continue study|5|||
145490413|NCT00962208|524650290|FG001|Overall Study|Contraindicated to continue study|1|||
145490414|NCT00962208|524650289|FG000|Overall Study|Lost to Follow-up|0|||
145490415|NCT00962208|524650290|FG001|Overall Study|Lost to Follow-up|9|||
145490416|NCT00657540|524650291|FG000|Overall Study|Lost to Follow-up|1|||
145490417|NCT00657540|524650292|FG001|Overall Study|Lost to Follow-up|4|||
145490418|NCT04245111|524650293|FG000|Overall Study|Lost to Follow-up|5|||
145490419|NCT04245111|524650294|FG001|Overall Study|Lost to Follow-up|1|||
145490420|NCT04245111|524650295|FG002|Overall Study|Lost to Follow-up|1|||
145490421|NCT02469623|524650296|FG000|Overall Study|Not consented for long-term follow-up|4|||
145490422|NCT02469623|524650296|FG000|Overall Study|Lost to Follow-up|4|||
145490423|NCT02469623|524650296|FG000|Overall Study|Withdrawal by Subject|2|||
145490424|NCT02469623|524650296|FG000|Overall Study|Death|3|||
145657653|NCT03628924|525265239|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
145657654|NCT03628924|525265240|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
145657655|NCT03628924|525265241|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
145657656|NCT03628924|525265242|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
145657657|NCT03628924|525265243|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
145657658|NCT03628924|525265244|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
145657659|NCT03628924|525265245|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
145657660|NCT03628924|525265239|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
145657661|NCT03628924|525265240|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
145657662|NCT03628924|525265241|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
145657663|NCT03628924|525265242|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
145657664|NCT03628924|525265243|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
145657665|NCT03628924|525265244|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
145657666|NCT03628924|525265245|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
145657667|NCT05256017|525265246|FG000|Treatment Period|Withdrawal by Subject|1|||
145657668|NCT05256017|525265247|FG001|Treatment Period|Withdrawal by Subject|1|||
145657669|NCT05256017|525265246|FG000|Follow-up|Lost to Follow-up|7|||
145657670|NCT05256017|525265247|FG001|Follow-up|Lost to Follow-up|1|||
145657671|NCT05256017|525265246|FG000|Follow-up|Withdrawal by Subject|1|||
145657672|NCT05256017|525265247|FG001|Follow-up|Withdrawal by Subject|0|||
145657673|NCT05256017|525265246|FG000|Follow-up|Death|0|||
145657674|NCT05256017|525265247|FG001|Follow-up|Death|1|||
145657675|NCT05672069|525265250|FG000|Overall Study|Implant removal|1|||
145657676|NCT05672069|525265250|FG000|Overall Study|Lost to Follow-up|2|||
145657677|NCT03858634|525265253|FG000|Overall Study|Withdrawal by Subject|1|||
145657678|NCT03858634|525265254|FG001|Overall Study|Withdrawal by Subject|0|||
145657679|NCT03858634|525265253|FG000|Overall Study|Adverse Event|1|||
145657680|NCT03858634|525265254|FG001|Overall Study|Adverse Event|0|||
145657681|NCT03858634|525265253|FG000|Overall Study|Lost to Follow-up|0|||
145657682|NCT03858634|525265254|FG001|Overall Study|Lost to Follow-up|1|||
145657683|NCT03858634|525265253|FG000|Overall Study|Other, Not Specified|1|||
145657684|NCT03858634|525265254|FG001|Overall Study|Other, Not Specified|1|||
145657685|NCT03150173|525265255|FG000|Overall Study|Lost to Follow-up|13|||
145657686|NCT03150173|525265256|FG001|Overall Study|Lost to Follow-up|5|||
145657687|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
145657688|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
145657689|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
145657690|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
145657691|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
145657692|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
145657693|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
145657694|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
145657695|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
145657696|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
145657697|NCT03461276|525265263|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
145657698|NCT03461276|525265264|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
145657699|NCT03461276|525265263|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
145657700|NCT03461276|525265264|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
145657701|NCT03461276|525265263|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
145657702|NCT03461276|525265264|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
145657703|NCT03461276|525265263|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
145657704|NCT03461276|525265264|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
145657705|NCT03461276|525265263|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
145657706|NCT03461276|525265264|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
145657707|NCT04663737|525265265|FG000|Overall Study|Withdrawal by Subject|2|||
145657708|NCT04663737|525265266|FG001|Overall Study|Withdrawal by Subject|0|||
145657709|NCT04016662|525265267|FG000|Run-In Phase|Death|1|||
145657710|NCT04016662|525265267|FG000|Run-In Phase|Withdrawal by Subject|11|||
145657711|NCT04016662|525265267|FG000|Run-In Phase|Not meeting screening eligibility|9|||
145657712|NCT04016662|525265267|FG000|Run-In Phase|Physician Decision|3|||
145657713|NCT04016662|525265267|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
145490425|NCT03309878|524650297|FG000|Overall Study|Adverse Event|1|||
145657714|NCT04016662|525265267|FG000|PLGS (12 Weeks)|Death|1|||
145657715|NCT04016662|525265267|FG000|SAP (12 Weeks)|Death|1|||
145657716|NCT01802788|525265268|FG000|Overall Study|Withdrawal by Subject|102|||
145657717|NCT01802788|525265269|FG001|Overall Study|Withdrawal by Subject|5|||
145657718|NCT01802788|525265268|FG000|Overall Study|Death|382|||
145657719|NCT01802788|525265269|FG001|Overall Study|Death|18|||
145657720|NCT01802788|525265268|FG000|Overall Study|Lost to Follow-up|31|||
145657721|NCT01802788|525265269|FG001|Overall Study|Lost to Follow-up|2|||
145657722|NCT01802788|525265268|FG000|Overall Study|Physician Decision|3|||
145490426|NCT03309878|524650298|FG001|Overall Study|Adverse Event|0|||
145657723|NCT01802788|525265269|FG001|Overall Study|Physician Decision|0|||
145657724|NCT01802788|525265268|FG000|Overall Study|Patient Non-Compliance|1|||
145657725|NCT01802788|525265269|FG001|Overall Study|Patient Non-Compliance|0|||
145657726|NCT01802788|525265268|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
145657727|NCT01802788|525265269|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
145657728|NCT01802788|525265268|FG000|Overall Study|Other Reasons|19|||
145657729|NCT01802788|525265269|FG001|Overall Study|Other Reasons|0|||
145657730|NCT03907878|525265270|FG000|Treatment Period|Withdrawal by Subject|5|||
145657731|NCT03907878|525265270|FG000|Treatment Period|Adverse Event|4|||
145657732|NCT03907878|525265270|FG000|Treatment Period|Lack of Efficacy|1|||
145657733|NCT03907878|525265270|FG000|Treatment Period|Protocol Violation|1|||
145657734|NCT03907878|525265270|FG000|Follow-up Period|Adverse Event|3|||
145657735|NCT03907878|525265270|FG000|Follow-up Period|Withdrawal by Subject|3|||
145657736|NCT04499924|525265271|FG000|Overall Study|Study termination by sponsor|4|||
145657737|NCT04499924|525265272|FG001|Overall Study|Study termination by sponsor|6|||
145657738|NCT04499924|525265271|FG000|Overall Study|Withdrawal by Subject|1|||
145657739|NCT04499924|525265272|FG001|Overall Study|Withdrawal by Subject|3|||
145657740|NCT03904147|525265277|FG000|Overall Study|Death|15|||
145657741|NCT03904147|525265278|FG001|Overall Study|Death|13|||
145657742|NCT03904147|525265279|FG002|Overall Study|Death|15|||
145657743|NCT03904147|525265277|FG000|Overall Study|Withdrawal by Subject|7|||
145657744|NCT03904147|525265278|FG001|Overall Study|Withdrawal by Subject|12|||
145657745|NCT03904147|525265279|FG002|Overall Study|Withdrawal by Subject|1|||
145657746|NCT03904147|525265277|FG000|Overall Study|1Y visit completed after 365 days|1|||
145657747|NCT03904147|525265278|FG001|Overall Study|1Y visit completed after 365 days|1|||
145657748|NCT03904147|525265279|FG002|Overall Study|1Y visit completed after 365 days|0|||
145657749|NCT03011333|525265289|FG000|Overall Study|Lost to Follow-up|0|||
145657750|NCT03011333|525265290|FG001|Overall Study|Lost to Follow-up|1|||
145657751|NCT03011333|525265291|FG002|Overall Study|Lost to Follow-up|0|||
145657752|NCT03011333|525265292|FG003|Overall Study|Lost to Follow-up|1|||
145657753|NCT03011333|525265293|FG004|Overall Study|Lost to Follow-up|4|||
145657754|NCT03011333|525265294|FG005|Overall Study|Lost to Follow-up|4|||
145657755|NCT03011333|525265295|FG006|Overall Study|Lost to Follow-up|5|||
145657756|NCT02998268|525265296|FG000|Overall Study|Adverse Event|0|||
145657757|NCT02998268|525265297|FG001|Overall Study|Adverse Event|2|||
145657758|NCT02998268|525265296|FG000|Overall Study|Withdrawal by Subject|0|||
145657759|NCT02998268|525265297|FG001|Overall Study|Withdrawal by Subject|1|||
145657760|NCT04225273|525265298|FG000|Overall Study|Lost to Follow-up|3|||
145657761|NCT03652389|525265299|FG000|Overall Study|Lost to Follow-up|1|||
145657762|NCT03652389|525265300|FG001|Overall Study|Lost to Follow-up|5|||
145657763|NCT03652389|525265299|FG000|Overall Study|Withdrawal by Subject|5|||
145657764|NCT03652389|525265300|FG001|Overall Study|Withdrawal by Subject|1|||
145657765|NCT03652389|525265299|FG000|Overall Study|New diagnosis|2|||
145657766|NCT03652389|525265300|FG001|Overall Study|New diagnosis|0|||
145657767|NCT04413708|525265301|FG000|Overall Study|Lost to Follow-up|1|||
145657768|NCT04413708|525265302|FG001|Overall Study|Lost to Follow-up|2|||
145657769|NCT02815566|525265306|FG000|Overall Study|Adverse Event|1|||
145657770|NCT02815566|525265307|FG001|Overall Study|Adverse Event|1|||
145657771|NCT02815566|525265306|FG000|Overall Study|Withdrawal by Subject|1|||
145657772|NCT02815566|525265307|FG001|Overall Study|Withdrawal by Subject|0|||
145657773|NCT02815566|525265306|FG000|Overall Study|Lost to Follow-up|0|||
145657774|NCT02815566|525265307|FG001|Overall Study|Lost to Follow-up|1|||
145657775|NCT04032704|525265308|FG000|Part A|Withdrawal by Subject|0|||
145657776|NCT04032704|525265309|FG001|Part A|Withdrawal by Subject|0|||
145657777|NCT04032704|525265310|FG002|Part A|Withdrawal by Subject|3|||
145657778|NCT04032704|525265311|FG003|Part A|Withdrawal by Subject|0|||
145657779|NCT04032704|525265312|FG004|Part A|Withdrawal by Subject|1|||
145657780|NCT04032704|525265313|FG005|Part A|Withdrawal by Subject|7|||
145657781|NCT04032704|525265314|FG006|Part A|Withdrawal by Subject|0|||
145657782|NCT04032704|525265315|FG007|Part A|Withdrawal by Subject|0|||
145657783|NCT04032704|525265316|FG008|Part A|Withdrawal by Subject|0|||
145657784|NCT04032704|525265317|FG009|Part A|Withdrawal by Subject|0|||
145657785|NCT04032704|525265318|FG010|Part A|Withdrawal by Subject|0|||
145657786|NCT04032704|525265319|FG011|Part A|Withdrawal by Subject|0|||
145657787|NCT04032704|525265320|FG012|Part A|Withdrawal by Subject|0|||
145657788|NCT04032704|525265321|FG013|Part A|Withdrawal by Subject|0|||
145657789|NCT04032704|525265322|FG014|Part A|Withdrawal by Subject|0|||
145657790|NCT04032704|525265323|FG015|Part A|Withdrawal by Subject|0|||
145657791|NCT04032704|525265324|FG016|Part A|Withdrawal by Subject|0|||
145657792|NCT04032704|525265325|FG017|Part A|Withdrawal by Subject|0|||
145657793|NCT04032704|525265308|FG000|Part A|Lost to Follow-up|1|||
145657794|NCT04032704|525265309|FG001|Part A|Lost to Follow-up|0|||
145657795|NCT04032704|525265310|FG002|Part A|Lost to Follow-up|0|||
145657796|NCT04032704|525265311|FG003|Part A|Lost to Follow-up|0|||
145657797|NCT04032704|525265312|FG004|Part A|Lost to Follow-up|0|||
145657798|NCT04032704|525265313|FG005|Part A|Lost to Follow-up|0|||
145657799|NCT04032704|525265314|FG006|Part A|Lost to Follow-up|0|||
145657800|NCT04032704|525265315|FG007|Part A|Lost to Follow-up|0|||
145657801|NCT04032704|525265316|FG008|Part A|Lost to Follow-up|0|||
145657802|NCT04032704|525265317|FG009|Part A|Lost to Follow-up|0|||
145657803|NCT04032704|525265318|FG010|Part A|Lost to Follow-up|0|||
145657804|NCT04032704|525265319|FG011|Part A|Lost to Follow-up|0|||
145657805|NCT04032704|525265320|FG012|Part A|Lost to Follow-up|0|||
145657806|NCT04032704|525265321|FG013|Part A|Lost to Follow-up|0|||
145657807|NCT04032704|525265322|FG014|Part A|Lost to Follow-up|0|||
145657808|NCT04032704|525265323|FG015|Part A|Lost to Follow-up|0|||
145657809|NCT04032704|525265324|FG016|Part A|Lost to Follow-up|0|||
145657810|NCT04032704|525265325|FG017|Part A|Lost to Follow-up|0|||
145657811|NCT04032704|525265308|FG000|Part A|Death|9|||
145657812|NCT04032704|525265309|FG001|Part A|Death|2|||
145657813|NCT04032704|525265310|FG002|Part A|Death|10|||
145657814|NCT04032704|525265311|FG003|Part A|Death|7|||
145657815|NCT04032704|525265312|FG004|Part A|Death|4|||
145657816|NCT04032704|525265313|FG005|Part A|Death|5|||
145657817|NCT04032704|525265314|FG006|Part A|Death|0|||
145657818|NCT04032704|525265315|FG007|Part A|Death|0|||
145657819|NCT04032704|525265316|FG008|Part A|Death|0|||
145657820|NCT04032704|525265317|FG009|Part A|Death|0|||
145657821|NCT04032704|525265318|FG010|Part A|Death|0|||
145657822|NCT04032704|525265319|FG011|Part A|Death|0|||
145657823|NCT04032704|525265320|FG012|Part A|Death|0|||
145657824|NCT04032704|525265321|FG013|Part A|Death|0|||
145657825|NCT04032704|525265322|FG014|Part A|Death|0|||
145657826|NCT04032704|525265323|FG015|Part A|Death|0|||
145657827|NCT04032704|525265324|FG016|Part A|Death|0|||
145657828|NCT04032704|525265325|FG017|Part A|Death|0|||
145657829|NCT04032704|525265308|FG000|Part B|Other|0|||
145657830|NCT04032704|525265309|FG001|Part B|Other|0|||
145657831|NCT04032704|525265310|FG002|Part B|Other|0|||
145657832|NCT04032704|525265311|FG003|Part B|Other|0|||
145657833|NCT04032704|525265312|FG004|Part B|Other|0|||
145657834|NCT04032704|525265313|FG005|Part B|Other|0|||
145657835|NCT04032704|525265314|FG006|Part B|Other|0|||
145657836|NCT04032704|525265315|FG007|Part B|Other|1|||
145657837|NCT04032704|525265316|FG008|Part B|Other|2|||
145657838|NCT04032704|525265317|FG009|Part B|Other|1|||
145657839|NCT04032704|525265318|FG010|Part B|Other|1|||
145657840|NCT04032704|525265319|FG011|Part B|Other|1|||
145657841|NCT04032704|525265320|FG012|Part B|Other|5|||
145657842|NCT04032704|525265321|FG013|Part B|Other|13|||
145657843|NCT04032704|525265322|FG014|Part B|Other|0|||
145657844|NCT04032704|525265323|FG015|Part B|Other|0|||
145657845|NCT04032704|525265324|FG016|Part B|Other|0|||
145657846|NCT04032704|525265325|FG017|Part B|Other|0|||
145657847|NCT04032704|525265308|FG000|Part B|Study termination by Sponsor|0|||
145657848|NCT04032704|525265309|FG001|Part B|Study termination by Sponsor|0|||
145657849|NCT04032704|525265310|FG002|Part B|Study termination by Sponsor|0|||
145657850|NCT04032704|525265311|FG003|Part B|Study termination by Sponsor|0|||
145657851|NCT04032704|525265312|FG004|Part B|Study termination by Sponsor|0|||
145657852|NCT04032704|525265313|FG005|Part B|Study termination by Sponsor|0|||
145657853|NCT04032704|525265314|FG006|Part B|Study termination by Sponsor|0|||
145657854|NCT04032704|525265315|FG007|Part B|Study termination by Sponsor|0|||
145657855|NCT04032704|525265316|FG008|Part B|Study termination by Sponsor|1|||
145657856|NCT04032704|525265317|FG009|Part B|Study termination by Sponsor|0|||
145657857|NCT04032704|525265318|FG010|Part B|Study termination by Sponsor|0|||
145657858|NCT04032704|525265319|FG011|Part B|Study termination by Sponsor|0|||
145657859|NCT04032704|525265320|FG012|Part B|Study termination by Sponsor|0|||
145657860|NCT04032704|525265321|FG013|Part B|Study termination by Sponsor|0|||
145657861|NCT04032704|525265322|FG014|Part B|Study termination by Sponsor|0|||
145657862|NCT04032704|525265323|FG015|Part B|Study termination by Sponsor|0|||
145657863|NCT04032704|525265324|FG016|Part B|Study termination by Sponsor|0|||
145657864|NCT04032704|525265325|FG017|Part B|Study termination by Sponsor|0|||
145657865|NCT04032704|525265308|FG000|Part B|Withdrawal by Subject|0|||
145657866|NCT04032704|525265309|FG001|Part B|Withdrawal by Subject|0|||
145657867|NCT04032704|525265310|FG002|Part B|Withdrawal by Subject|0|||
145657868|NCT04032704|525265311|FG003|Part B|Withdrawal by Subject|0|||
145657869|NCT04032704|525265312|FG004|Part B|Withdrawal by Subject|0|||
145657870|NCT04032704|525265313|FG005|Part B|Withdrawal by Subject|0|||
145657871|NCT04032704|525265314|FG006|Part B|Withdrawal by Subject|3|||
145657872|NCT04032704|525265315|FG007|Part B|Withdrawal by Subject|2|||
145657873|NCT04032704|525265316|FG008|Part B|Withdrawal by Subject|2|||
145657874|NCT04032704|525265317|FG009|Part B|Withdrawal by Subject|1|||
145657875|NCT04032704|525265318|FG010|Part B|Withdrawal by Subject|4|||
145657876|NCT04032704|525265319|FG011|Part B|Withdrawal by Subject|6|||
145657877|NCT04032704|525265320|FG012|Part B|Withdrawal by Subject|2|||
145657878|NCT04032704|525265321|FG013|Part B|Withdrawal by Subject|1|||
145657879|NCT04032704|525265322|FG014|Part B|Withdrawal by Subject|0|||
145657880|NCT04032704|525265323|FG015|Part B|Withdrawal by Subject|1|||
145657881|NCT04032704|525265324|FG016|Part B|Withdrawal by Subject|0|||
145657882|NCT04032704|525265325|FG017|Part B|Withdrawal by Subject|0|||
145657883|NCT04032704|525265308|FG000|Part B|Lost to Follow-up|0|||
145657884|NCT04032704|525265309|FG001|Part B|Lost to Follow-up|0|||
145657885|NCT04032704|525265310|FG002|Part B|Lost to Follow-up|0|||
145657886|NCT04032704|525265311|FG003|Part B|Lost to Follow-up|0|||
145657887|NCT04032704|525265312|FG004|Part B|Lost to Follow-up|0|||
145657888|NCT04032704|525265313|FG005|Part B|Lost to Follow-up|0|||
145657889|NCT04032704|525265314|FG006|Part B|Lost to Follow-up|0|||
145657890|NCT04032704|525265315|FG007|Part B|Lost to Follow-up|0|||
145657891|NCT04032704|525265316|FG008|Part B|Lost to Follow-up|0|||
145657892|NCT04032704|525265317|FG009|Part B|Lost to Follow-up|0|||
145657893|NCT04032704|525265318|FG010|Part B|Lost to Follow-up|0|||
145657894|NCT04032704|525265319|FG011|Part B|Lost to Follow-up|1|||
145657895|NCT04032704|525265320|FG012|Part B|Lost to Follow-up|0|||
145657896|NCT04032704|525265321|FG013|Part B|Lost to Follow-up|0|||
145657897|NCT04032704|525265322|FG014|Part B|Lost to Follow-up|0|||
145657898|NCT04032704|525265323|FG015|Part B|Lost to Follow-up|0|||
145657899|NCT04032704|525265324|FG016|Part B|Lost to Follow-up|0|||
145657900|NCT04032704|525265325|FG017|Part B|Lost to Follow-up|0|||
145657901|NCT04032704|525265308|FG000|Part B|Death|0|||
145657902|NCT04032704|525265309|FG001|Part B|Death|0|||
145657903|NCT04032704|525265310|FG002|Part B|Death|0|||
145657904|NCT04032704|525265311|FG003|Part B|Death|0|||
145657905|NCT04032704|525265312|FG004|Part B|Death|0|||
145657906|NCT04032704|525265313|FG005|Part B|Death|0|||
145657907|NCT04032704|525265314|FG006|Part B|Death|13|||
145657908|NCT04032704|525265315|FG007|Part B|Death|13|||
145657909|NCT04032704|525265316|FG008|Part B|Death|14|||
145657910|NCT04032704|525265317|FG009|Part B|Death|12|||
145657911|NCT04032704|525265318|FG010|Part B|Death|12|||
145657912|NCT04032704|525265319|FG011|Part B|Death|13|||
145657913|NCT04032704|525265320|FG012|Part B|Death|7|||
145657914|NCT04032704|525265321|FG013|Part B|Death|17|||
145657915|NCT04032704|525265322|FG014|Part B|Death|2|||
145657916|NCT04032704|525265323|FG015|Part B|Death|1|||
145657917|NCT04032704|525265324|FG016|Part B|Death|2|||
145657918|NCT04032704|525265325|FG017|Part B|Death|2|||
145657919|NCT02861300|525265326|FG000|Overall Study|Death|0|||
145657920|NCT02861300|525265327|FG001|Overall Study|Death|0|||
145657921|NCT02861300|525265328|FG002|Overall Study|Death|0|||
145657922|NCT02861300|525265329|FG003|Overall Study|Death|0|||
145657923|NCT02861300|525265330|FG004|Overall Study|Death|0|||
145657924|NCT02861300|525265331|FG005|Overall Study|Death|0|||
145657925|NCT02861300|525265332|FG006|Overall Study|Death|24|||
145657926|NCT02861300|525265326|FG000|Overall Study|Delay in treatment|0|||
145657927|NCT02861300|525265327|FG001|Overall Study|Delay in treatment|0|||
145657928|NCT02861300|525265328|FG002|Overall Study|Delay in treatment|0|||
145657929|NCT02861300|525265329|FG003|Overall Study|Delay in treatment|0|||
145657930|NCT02861300|525265330|FG004|Overall Study|Delay in treatment|0|||
145657931|NCT02861300|525265331|FG005|Overall Study|Delay in treatment|1|||
145657932|NCT02861300|525265332|FG006|Overall Study|Delay in treatment|0|||
145657933|NCT02861300|525265326|FG000|Overall Study|Disease Progression|0|||
145657934|NCT02861300|525265327|FG001|Overall Study|Disease Progression|1|||
145657935|NCT02861300|525265328|FG002|Overall Study|Disease Progression|0|||
145657936|NCT02861300|525265329|FG003|Overall Study|Disease Progression|0|||
145657937|NCT02861300|525265330|FG004|Overall Study|Disease Progression|0|||
145657938|NCT02861300|525265331|FG005|Overall Study|Disease Progression|0|||
145657939|NCT02861300|525265332|FG006|Overall Study|Disease Progression|2|||
145657940|NCT02861300|525265326|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
145657941|NCT02861300|525265327|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
145657942|NCT02861300|525265328|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
145657943|NCT02861300|525265329|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
145657944|NCT02861300|525265330|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
145657945|NCT02861300|525265331|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
145657946|NCT02861300|525265332|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
145657947|NCT02861300|525265326|FG000|Overall Study|Clinical Complications|0|||
145657948|NCT02861300|525265327|FG001|Overall Study|Clinical Complications|0|||
145657949|NCT02861300|525265328|FG002|Overall Study|Clinical Complications|0|||
145657950|NCT02861300|525265329|FG003|Overall Study|Clinical Complications|0|||
145657951|NCT02861300|525265330|FG004|Overall Study|Clinical Complications|0|||
145657952|NCT02861300|525265331|FG005|Overall Study|Clinical Complications|0|||
145657953|NCT02861300|525265332|FG006|Overall Study|Clinical Complications|1|||
145657954|NCT03133546|525265338|FG000|Overall Study|Death|46|||
145657955|NCT03133546|525265339|FG001|Overall Study|Death|43|||
145657956|NCT03133546|525265338|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
145657957|NCT03133546|525265339|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
145657958|NCT01501955|525265343|FG000|Overall Study|Withdrawal by Subject|1|||
145657959|NCT01501955|525265344|FG001|Overall Study|Withdrawal by Subject|0|||
145657960|NCT01501955|525265343|FG000|Overall Study|Adverse Event|1|||
145657961|NCT01501955|525265344|FG001|Overall Study|Adverse Event|3|||
145657962|NCT05034328|525265345|FG000|Overall Study|Protocol Violation|1|||
145657963|NCT05034328|525265346|FG001|Overall Study|Protocol Violation|0|||
145657964|NCT05034328|525265345|FG000|Overall Study|Lost to Follow-up|0|||
145657965|NCT05034328|525265346|FG001|Overall Study|Lost to Follow-up|10|||
145657966|NCT02993159|525265347|FG000|Overall Study|Withdrawal by Subject|1|||
145657967|NCT02993159|525265348|FG001|Overall Study|Withdrawal by Subject|3|||
145657968|NCT02993159|525265347|FG000|Overall Study|Protocol Violation|1|||
145657969|NCT02993159|525265348|FG001|Overall Study|Protocol Violation|0|||
145657970|NCT02993159|525265347|FG000|Overall Study|Opted out of surgery|2|||
145657971|NCT02993159|525265348|FG001|Overall Study|Opted out of surgery|0|||
145657972|NCT02993159|525265347|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
145657973|NCT02993159|525265348|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
145657974|NCT02993159|525265347|FG000|Overall Study|Physician Decision|0|||
145657975|NCT02993159|525265348|FG001|Overall Study|Physician Decision|1|||
145657976|NCT05583578|525265351|FG000|Overall Study|Withdrawal by Subject|2|||
145657977|NCT05583578|525265352|FG001|Overall Study|Withdrawal by Subject|0|||
145657978|NCT04313972|525265353|FG000|Overall Study|Withdrawal by Subject|0|||
145657979|NCT04313972|525265354|FG001|Overall Study|Withdrawal by Subject|1|||
145657980|NCT04314713|525265355|FG000|Overall Study|Lost to Follow-up|0|||
145657981|NCT04314713|525265356|FG001|Overall Study|Lost to Follow-up|0|||
145657982|NCT04314713|525265357|FG002|Overall Study|Lost to Follow-up|0|||
145657983|NCT04314713|525265358|FG003|Overall Study|Lost to Follow-up|1|||
145657984|NCT04314713|525265359|FG004|Overall Study|Lost to Follow-up|0|||
145657985|NCT04314713|525265360|FG005|Overall Study|Lost to Follow-up|0|||
145657986|NCT00248287|525265362|FG000|Overall Study|Adverse Event|11|||
145657987|NCT00248287|525265363|FG001|Overall Study|Adverse Event|10|||
145657988|NCT00248287|525265362|FG000|Overall Study|Death|1|||
145657989|NCT00248287|525265363|FG001|Overall Study|Death|0|||
145657990|NCT00248287|525265362|FG000|Overall Study|Lost to Follow-up|0|||
145657991|NCT00248287|525265363|FG001|Overall Study|Lost to Follow-up|1|||
145657992|NCT00248287|525265362|FG000|Overall Study|Investigator Request|4|||
145657993|NCT00248287|525265363|FG001|Overall Study|Investigator Request|3|||
145657994|NCT00248287|525265362|FG000|Overall Study|Patient Request|5|||
145657995|NCT00248287|525265363|FG001|Overall Study|Patient Request|3|||
145657996|NCT00248287|525265362|FG000|Overall Study|Other|3|||
145657997|NCT00248287|525265363|FG001|Overall Study|Other|2|||
145657998|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
145657999|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
145658000|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
145658001|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
145658002|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
145658003|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
145658004|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
145658005|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
145658006|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
145658007|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
145658008|NCT04103580|525265366|FG000|Phase 1 Active Caregiving|Other|3|||
145658009|NCT04103580|525265367|FG001|Phase 1 Active Caregiving|Other|3|||
145658010|NCT04103580|525265366|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
145658011|NCT04103580|525265367|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
145658012|NCT04103580|525265366|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
145658013|NCT04103580|525265367|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
145658014|NCT04103580|525265366|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
145658015|NCT04103580|525265367|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
145658016|NCT04103580|525265366|FG000|Phase 2 Bereavement|Other|8|||
145658017|NCT04103580|525265367|FG001|Phase 2 Bereavement|Other|6|||
145658018|NCT04248725|525265372|FG000|Post-Treatment|Lost to Follow-up|6|||
145658019|NCT04248725|525265373|FG001|Post-Treatment|Lost to Follow-up|5|||
145658020|NCT04248725|525265372|FG000|6-Month Follow Up|Lost to Follow-up|9|||
145658021|NCT04248725|525265373|FG001|6-Month Follow Up|Lost to Follow-up|8|||
145658022|NCT01544114|525265381|FG000|Overall Study|Withdrawal by Subject|0|||
145658023|NCT01544114|525265382|FG001|Overall Study|Withdrawal by Subject|0|||
145658024|NCT01544114|525265383|FG002|Overall Study|Withdrawal by Subject|3|||
145658025|NCT01544114|525265381|FG000|Overall Study|Lost to Follow-up|0|||
145658026|NCT01544114|525265382|FG001|Overall Study|Lost to Follow-up|2|||
145658027|NCT01544114|525265383|FG002|Overall Study|Lost to Follow-up|0|||
145658028|NCT01544114|525265381|FG000|Overall Study|Adverse Event|1|||
145658029|NCT01544114|525265382|FG001|Overall Study|Adverse Event|1|||
145658030|NCT01544114|525265383|FG002|Overall Study|Adverse Event|2|||
145658031|NCT01544114|525265381|FG000|Overall Study|Protocol Violation|0|||
145658032|NCT01544114|525265382|FG001|Overall Study|Protocol Violation|1|||
145658033|NCT01544114|525265383|FG002|Overall Study|Protocol Violation|0|||
145658034|NCT02601313|525265392|FG000|Overall Study|Death|2|||
145658035|NCT02601313|525265393|FG001|Overall Study|Death|41|||
145658036|NCT02601313|525265394|FG002|Overall Study|Death|6|||
145658037|NCT02601313|525265392|FG000|Overall Study|Enrolled but never treated|0|||
145658038|NCT02601313|525265393|FG001|Overall Study|Enrolled but never treated|6|||
145658039|NCT02601313|525265394|FG002|Overall Study|Enrolled but never treated|3|||
145658040|NCT02601313|525265392|FG000|Overall Study|Enrolled, did not initiate AC|4|||
145658041|NCT02601313|525265393|FG001|Overall Study|Enrolled, did not initiate AC|0|||
145658042|NCT02601313|525265394|FG002|Overall Study|Enrolled, did not initiate AC|0|||
145658043|NCT02601313|525265392|FG000|Overall Study|Full consent withdrawal|0|||
145490427|NCT03309878|524650299|FG002|Overall Study|Adverse Event|0|||
145658044|NCT02601313|525265393|FG001|Overall Study|Full consent withdrawal|3|||
145658045|NCT02601313|525265394|FG002|Overall Study|Full consent withdrawal|2|||
145265339|NCT00953017|523819297|FG003|Overall Study|Brown stool prior to procedure|0|||
145658046|NCT02601313|525265392|FG000|Overall Study|Lost to Follow-up|0|||
145658047|NCT02601313|525265393|FG001|Overall Study|Lost to Follow-up|1|||
145658048|NCT02601313|525265394|FG002|Overall Study|Lost to Follow-up|1|||
145658049|NCT03459729|525265395|FG000|Overall Study|Physician Decision|2|||
145658050|NCT06182033|525265396|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
145658051|NCT06182033|525265397|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
145658052|NCT06182033|525265396|FG000|Overall Study|Target child relocation|1|||
145658053|NCT06182033|525265397|FG001|Overall Study|Target child relocation|1|||
145658054|NCT06182033|525265396|FG000|Overall Study|Withdrawal by Subject|1|||
145658055|NCT06182033|525265397|FG001|Overall Study|Withdrawal by Subject|0|||
145658056|NCT05704543|525265398|FG000|Overall Study|Withdrawal by Subject|1|||
145658057|NCT05704543|525265399|FG001|Overall Study|Withdrawal by Subject|1|||
145658058|NCT05704543|525265400|FG002|Overall Study|Withdrawal by Subject|0|||
145658059|NCT05704543|525265401|FG003|Overall Study|Withdrawal by Subject|2|||
145658060|NCT05704543|525265398|FG000|Overall Study|Lost to Follow-up|1|||
145658061|NCT05704543|525265399|FG001|Overall Study|Lost to Follow-up|2|||
145658062|NCT05704543|525265400|FG002|Overall Study|Lost to Follow-up|0|||
145658063|NCT05704543|525265401|FG003|Overall Study|Lost to Follow-up|0|||
145658064|NCT03257410|525267306|FG000|Overall Study|Adverse Event|2|||
145658065|NCT03257410|525267307|FG001|Overall Study|Adverse Event|3|||
145658066|NCT03257410|525267306|FG000|Overall Study|Protocol Violation|1|||
145658067|NCT03257410|525267307|FG001|Overall Study|Protocol Violation|2|||
145658068|NCT03257410|525267306|FG000|Overall Study|Lost to Follow-up|1|||
145658069|NCT03257410|525267307|FG001|Overall Study|Lost to Follow-up|0|||
145658070|NCT03257410|525267306|FG000|Overall Study|Withdrawal by Subject|1|||
145658071|NCT03257410|525267307|FG001|Overall Study|Withdrawal by Subject|2|||
145658072|NCT03257410|525267306|FG000|Overall Study|Physician Decision|1|||
145658073|NCT03257410|525267307|FG001|Overall Study|Physician Decision|1|||
145658074|NCT03257410|525267306|FG000|Overall Study|Renal transplantation|2|||
145658075|NCT03257410|525267307|FG001|Overall Study|Renal transplantation|0|||
145658076|NCT03257410|525267306|FG000|Overall Study|Switch to peritoneal dialysis|1|||
145658077|NCT03257410|525267307|FG001|Overall Study|Switch to peritoneal dialysis|0|||
145658078|NCT03257410|525267306|FG000|Overall Study|Death|3|||
145658079|NCT03257410|525267307|FG001|Overall Study|Death|2|||
145658080|NCT03257410|525267306|FG000|Overall Study|Change to another dialysis center|2|||
145658081|NCT03257410|525267307|FG001|Overall Study|Change to another dialysis center|2|||
145658082|NCT03257410|525267306|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
145658083|NCT03257410|525267307|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
145658084|NCT03257410|525267306|FG000|Overall Study|Miscellaneous|2|||
145658085|NCT03257410|525267307|FG001|Overall Study|Miscellaneous|2|||
145658086|NCT03257410|525267306|FG000|Overall Study|Other|0|||
145658087|NCT03257410|525267307|FG001|Overall Study|Other|1|||
145658088|NCT00433329|525267308|FG000|Overall Study|Adverse Event|9|||
145658089|NCT00433329|525267308|FG000|Overall Study|Death|4|||
145658090|NCT00433329|525267308|FG000|Overall Study|Withdrew consent|3|||
145658091|NCT00433329|525267308|FG000|Overall Study|Discontinued sildenafil|2|||
145658092|NCT00433329|525267308|FG000|Overall Study|Moved out of state|1|||
145658093|NCT00433329|525267308|FG000|Overall Study|Lost to Follow-up|1|||
145658094|NCT00433329|525267308|FG000|Overall Study|Physician Decision|1|||
145658095|NCT03854227|525267313|FG000|Overall Study|Adverse Event|0|||
145658096|NCT03854227|525267314|FG001|Overall Study|Adverse Event|0|||
145658097|NCT03854227|525267315|FG002|Overall Study|Adverse Event|0|||
145658098|NCT03854227|525267316|FG003|Overall Study|Adverse Event|1|||
145658099|NCT03854227|525267317|FG004|Overall Study|Adverse Event|0|||
145658100|NCT03854227|525267318|FG005|Overall Study|Adverse Event|0|||
145658101|NCT03854227|525267319|FG006|Overall Study|Adverse Event|1|||
145658102|NCT03854227|525267320|FG007|Overall Study|Adverse Event|0|||
145658103|NCT03854227|525267321|FG008|Overall Study|Adverse Event|0|||
145658104|NCT03854227|525267322|FG009|Overall Study|Adverse Event|3|||
145658105|NCT03854227|525267323|FG010|Overall Study|Adverse Event|0|||
145658106|NCT03854227|525267324|FG011|Overall Study|Adverse Event|1|||
145658107|NCT03854227|525267313|FG000|Overall Study|Death|0|||
145658108|NCT03854227|525267314|FG001|Overall Study|Death|0|||
145658109|NCT03854227|525267315|FG002|Overall Study|Death|0|||
145658110|NCT03854227|525267316|FG003|Overall Study|Death|0|||
145658111|NCT03854227|525267317|FG004|Overall Study|Death|0|||
145658112|NCT03854227|525267318|FG005|Overall Study|Death|1|||
145658113|NCT03854227|525267319|FG006|Overall Study|Death|0|||
145658114|NCT03854227|525267320|FG007|Overall Study|Death|0|||
145658115|NCT03854227|525267321|FG008|Overall Study|Death|0|||
145658116|NCT03854227|525267322|FG009|Overall Study|Death|1|||
145658117|NCT03854227|525267323|FG010|Overall Study|Death|0|||
145658118|NCT03854227|525267324|FG011|Overall Study|Death|1|||
145658119|NCT03854227|525267313|FG000|Overall Study|Physician Decision|0|||
145658120|NCT03854227|525267314|FG001|Overall Study|Physician Decision|0|||
145658121|NCT03854227|525267315|FG002|Overall Study|Physician Decision|0|||
145658122|NCT03854227|525267316|FG003|Overall Study|Physician Decision|0|||
145658123|NCT03854227|525267317|FG004|Overall Study|Physician Decision|0|||
145658124|NCT03854227|525267318|FG005|Overall Study|Physician Decision|1|||
145658125|NCT03854227|525267319|FG006|Overall Study|Physician Decision|0|||
145658126|NCT03854227|525267320|FG007|Overall Study|Physician Decision|0|||
145658127|NCT03854227|525267321|FG008|Overall Study|Physician Decision|1|||
145658128|NCT03854227|525267322|FG009|Overall Study|Physician Decision|1|||
145658129|NCT03854227|525267323|FG010|Overall Study|Physician Decision|0|||
145658130|NCT03854227|525267324|FG011|Overall Study|Physician Decision|1|||
145658131|NCT03854227|525267313|FG000|Overall Study|Progressive disease|1|||
145658132|NCT03854227|525267314|FG001|Overall Study|Progressive disease|1|||
145658133|NCT03854227|525267315|FG002|Overall Study|Progressive disease|1|||
145658134|NCT03854227|525267316|FG003|Overall Study|Progressive disease|2|||
145658135|NCT03854227|525267317|FG004|Overall Study|Progressive disease|3|||
145658136|NCT03854227|525267318|FG005|Overall Study|Progressive disease|1|||
145658137|NCT03854227|525267319|FG006|Overall Study|Progressive disease|2|||
145658138|NCT03854227|525267320|FG007|Overall Study|Progressive disease|5|||
145658139|NCT03854227|525267321|FG008|Overall Study|Progressive disease|2|||
145658140|NCT03854227|525267322|FG009|Overall Study|Progressive disease|5|||
145658141|NCT03854227|525267323|FG010|Overall Study|Progressive disease|1|||
145658142|NCT03854227|525267324|FG011|Overall Study|Progressive disease|6|||
145658143|NCT03854227|525267313|FG000|Overall Study|Study terminated by sponsor|0|||
145658144|NCT03854227|525267314|FG001|Overall Study|Study terminated by sponsor|0|||
145658145|NCT03854227|525267315|FG002|Overall Study|Study terminated by sponsor|0|||
145658146|NCT03854227|525267316|FG003|Overall Study|Study terminated by sponsor|0|||
145658147|NCT03854227|525267317|FG004|Overall Study|Study terminated by sponsor|0|||
145658148|NCT03854227|525267318|FG005|Overall Study|Study terminated by sponsor|0|||
145658149|NCT03854227|525267319|FG006|Overall Study|Study terminated by sponsor|0|||
145658150|NCT03854227|525267320|FG007|Overall Study|Study terminated by sponsor|0|||
145658151|NCT03854227|525267321|FG008|Overall Study|Study terminated by sponsor|0|||
145658152|NCT03854227|525267322|FG009|Overall Study|Study terminated by sponsor|1|||
145658153|NCT03854227|525267323|FG010|Overall Study|Study terminated by sponsor|0|||
145658154|NCT03854227|525267324|FG011|Overall Study|Study terminated by sponsor|0|||
145658155|NCT03854227|525267313|FG000|Overall Study|Withdrawal by Subject|0|||
145658156|NCT03854227|525267314|FG001|Overall Study|Withdrawal by Subject|0|||
145658157|NCT03854227|525267315|FG002|Overall Study|Withdrawal by Subject|1|||
145658158|NCT03854227|525267316|FG003|Overall Study|Withdrawal by Subject|0|||
145658159|NCT03854227|525267317|FG004|Overall Study|Withdrawal by Subject|0|||
145658160|NCT03854227|525267318|FG005|Overall Study|Withdrawal by Subject|0|||
145658161|NCT03854227|525267319|FG006|Overall Study|Withdrawal by Subject|0|||
145658162|NCT03854227|525267320|FG007|Overall Study|Withdrawal by Subject|0|||
145658163|NCT03854227|525267321|FG008|Overall Study|Withdrawal by Subject|0|||
145658164|NCT03854227|525267322|FG009|Overall Study|Withdrawal by Subject|1|||
145658165|NCT03854227|525267323|FG010|Overall Study|Withdrawal by Subject|1|||
145658166|NCT03854227|525267324|FG011|Overall Study|Withdrawal by Subject|0|||
145658167|NCT03854227|525267313|FG000|Overall Study|Disease relapse|0|||
145658168|NCT03854227|525267314|FG001|Overall Study|Disease relapse|0|||
145658169|NCT03854227|525267315|FG002|Overall Study|Disease relapse|0|||
145658170|NCT03854227|525267316|FG003|Overall Study|Disease relapse|0|||
145658171|NCT03854227|525267317|FG004|Overall Study|Disease relapse|0|||
145658172|NCT03854227|525267318|FG005|Overall Study|Disease relapse|0|||
145658173|NCT03854227|525267319|FG006|Overall Study|Disease relapse|0|||
145658174|NCT03854227|525267320|FG007|Overall Study|Disease relapse|0|||
145658175|NCT03854227|525267321|FG008|Overall Study|Disease relapse|1|||
145658176|NCT03854227|525267322|FG009|Overall Study|Disease relapse|0|||
145658177|NCT03854227|525267323|FG010|Overall Study|Disease relapse|0|||
145658178|NCT03854227|525267324|FG011|Overall Study|Disease relapse|0|||
145658179|NCT03854227|525267313|FG000|Overall Study|Global deterioration of health status|0|||
145658180|NCT03854227|525267314|FG001|Overall Study|Global deterioration of health status|0|||
145658181|NCT03854227|525267315|FG002|Overall Study|Global deterioration of health status|0|||
145658182|NCT03854227|525267316|FG003|Overall Study|Global deterioration of health status|0|||
145658183|NCT03854227|525267317|FG004|Overall Study|Global deterioration of health status|0|||
145658184|NCT03854227|525267318|FG005|Overall Study|Global deterioration of health status|1|||
145658185|NCT03854227|525267319|FG006|Overall Study|Global deterioration of health status|0|||
145658186|NCT03854227|525267320|FG007|Overall Study|Global deterioration of health status|1|||
145658187|NCT03854227|525267321|FG008|Overall Study|Global deterioration of health status|0|||
145658188|NCT03854227|525267322|FG009|Overall Study|Global deterioration of health status|0|||
145658189|NCT03854227|525267323|FG010|Overall Study|Global deterioration of health status|0|||
145658190|NCT03854227|525267324|FG011|Overall Study|Global deterioration of health status|0|||
145658191|NCT03854227|525267313|FG000|Overall Study|Refused further treatment|0|||
145658192|NCT03854227|525267314|FG001|Overall Study|Refused further treatment|0|||
145658193|NCT03854227|525267315|FG002|Overall Study|Refused further treatment|0|||
145658194|NCT03854227|525267316|FG003|Overall Study|Refused further treatment|0|||
145658195|NCT03854227|525267317|FG004|Overall Study|Refused further treatment|0|||
145658196|NCT03854227|525267318|FG005|Overall Study|Refused further treatment|0|||
145658197|NCT03854227|525267319|FG006|Overall Study|Refused further treatment|0|||
145658198|NCT03854227|525267320|FG007|Overall Study|Refused further treatment|0|||
145658199|NCT03854227|525267321|FG008|Overall Study|Refused further treatment|0|||
145658200|NCT03854227|525267322|FG009|Overall Study|Refused further treatment|1|||
145658201|NCT03854227|525267323|FG010|Overall Study|Refused further treatment|0|||
145658202|NCT03854227|525267324|FG011|Overall Study|Refused further treatment|1|||
145658203|NCT03854227|525267313|FG000|Overall Study|Other|0|||
145658204|NCT03854227|525267314|FG001|Overall Study|Other|0|||
145658205|NCT03854227|525267315|FG002|Overall Study|Other|0|||
145658206|NCT03854227|525267316|FG003|Overall Study|Other|0|||
145658207|NCT03854227|525267317|FG004|Overall Study|Other|0|||
145658208|NCT03854227|525267318|FG005|Overall Study|Other|0|||
145658209|NCT03854227|525267319|FG006|Overall Study|Other|0|||
145658210|NCT03854227|525267320|FG007|Overall Study|Other|0|||
145658211|NCT03854227|525267321|FG008|Overall Study|Other|1|||
145658212|NCT03854227|525267322|FG009|Overall Study|Other|1|||
145658213|NCT03854227|525267323|FG010|Overall Study|Other|0|||
145658214|NCT03854227|525267324|FG011|Overall Study|Other|0|||
145658215|NCT03668236|525267325|FG000|90-day Follow-up|Withdrawal by Subject|3|||
145658216|NCT03668236|525267326|FG001|90-day Follow-up|Withdrawal by Subject|2|||
145658217|NCT03668236|525267325|FG000|90-day Follow-up|Lost to Follow-up|3|||
145658218|NCT03668236|525267326|FG001|90-day Follow-up|Lost to Follow-up|1|||
145658219|NCT03668236|525267325|FG000|Baseline Characteristics|Lost to Follow-up|9|||
145658220|NCT03668236|525267326|FG001|Baseline Characteristics|Lost to Follow-up|5|||
145658221|NCT03668236|525267325|FG000|1-year Follow-up|Withdrawal by Subject|17|||
145658222|NCT03668236|525267326|FG001|1-year Follow-up|Withdrawal by Subject|15|||
145658223|NCT06132282|525267327|FG000|Overall Study|Lost to Follow-up|31|||
145658224|NCT03748953|525267328|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
145658225|NCT03748953|525267329|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
145658226|NCT03748953|525267328|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
145658227|NCT03748953|525267329|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
145658228|NCT03748953|525267328|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
145658229|NCT03748953|525267329|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
145658230|NCT03748953|525267328|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
145658231|NCT03748953|525267329|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
145658232|NCT03748953|525267328|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
145658233|NCT03748953|525267329|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
145658234|NCT02276885|525267330|FG000|Overall Study|Withdrawal by Subject|2|||
145658235|NCT02276885|525267331|FG001|Overall Study|Withdrawal by Subject|0|||
145658236|NCT02276885|525267330|FG000|Overall Study|Lost to Follow-up|5|||
145658237|NCT02276885|525267331|FG001|Overall Study|Lost to Follow-up|2|||
145658238|NCT01593917|525267337|FG000|Overall Study|Death|67|||
145658239|NCT01593917|525267337|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
145658240|NCT01593917|525267337|FG000|Overall Study|Withdrawal by Subject|23|||
145658241|NCT01593917|525267337|FG000|Overall Study|Lost to Follow-up|12|||
145658242|NCT01593917|525267337|FG000|Overall Study|Protocol Violation|5|||
145658243|NCT01593917|525267337|FG000|Overall Study|Physician Decision|3|||
145658244|NCT02841579|525267338|FG000|Overall Study|Death|1|||
145658245|NCT02841579|525267338|FG000|Overall Study|Adverse Event|1|||
145658246|NCT02841579|525267338|FG000|Overall Study|Lack of Efficacy|9|||
145658247|NCT02969707|525267342|FG000|Overall Study|Withdrawal by Subject|6|||
145658248|NCT02969707|525267343|FG001|Overall Study|Withdrawal by Subject|5|||
145658249|NCT02969707|525267342|FG000|Overall Study|Severe anxiety|0|||
145658250|NCT02969707|525267343|FG001|Overall Study|Severe anxiety|1|||
145658251|NCT02969707|525267342|FG000|Overall Study|Positive toxicology screen|0|||
145658252|NCT02969707|525267343|FG001|Overall Study|Positive toxicology screen|2|||
145658253|NCT02969707|525267342|FG000|Overall Study|Claustrophobia|2|||
145658254|NCT02969707|525267343|FG001|Overall Study|Claustrophobia|2|||
145658255|NCT02969707|525267342|FG000|Overall Study|Non-compliance|1|||
145658256|NCT02969707|525267343|FG001|Overall Study|Non-compliance|2|||
145658257|NCT03020199|525267344|FG000|Treatment Period|Adverse Event|0|||
145658258|NCT03020199|525267345|FG001|Treatment Period|Adverse Event|2|||
145658259|NCT03020199|525267344|FG000|Treatment Period|Lack of Efficacy|1|||
145658260|NCT03020199|525267345|FG001|Treatment Period|Lack of Efficacy|6|||
145658261|NCT03020199|525267344|FG000|Treatment Period|Lost to Follow-up|1|||
145658262|NCT03020199|525267345|FG001|Treatment Period|Lost to Follow-up|6|||
145658263|NCT03020199|525267344|FG000|Treatment Period|Physician Decision|0|||
145658264|NCT03020199|525267345|FG001|Treatment Period|Physician Decision|1|||
145658265|NCT03020199|525267344|FG000|Treatment Period|Subject/guardian decision|8|||
145658266|NCT03020199|525267345|FG001|Treatment Period|Subject/guardian decision|15|||
145658267|NCT03020199|525267344|FG000|Treatment Period|Subjects not treated|3|||
145658268|NCT03020199|525267345|FG001|Treatment Period|Subjects not treated|4|||
145658269|NCT03020199|525267344|FG000|Follow-up Period|Disease relapse|32|||
145658270|NCT03020199|525267345|FG001|Follow-up Period|Disease relapse|7|||
145658271|NCT03020199|525267344|FG000|Follow-up Period|Lack of Efficacy|1|||
145658272|NCT03020199|525267345|FG001|Follow-up Period|Lack of Efficacy|2|||
145658273|NCT03020199|525267344|FG000|Follow-up Period|Lost to Follow-up|4|||
145658274|NCT03020199|525267345|FG001|Follow-up Period|Lost to Follow-up|6|||
145658275|NCT03020199|525267344|FG000|Follow-up Period|Physician Decision|2|||
145658276|NCT03020199|525267345|FG001|Follow-up Period|Physician Decision|2|||
145658277|NCT03020199|525267344|FG000|Follow-up Period|Protocol Violation|1|||
145658278|NCT03020199|525267345|FG001|Follow-up Period|Protocol Violation|2|||
145658279|NCT03020199|525267344|FG000|Follow-up Period|Study terminated by Sponsor|6|||
145658280|NCT03020199|525267345|FG001|Follow-up Period|Study terminated by Sponsor|3|||
145658281|NCT03020199|525267344|FG000|Follow-up Period|Subject/guardian decision|14|||
145658282|NCT03020199|525267345|FG001|Follow-up Period|Subject/guardian decision|9|||
145658283|NCT04568486|525267360|FG000|Overall Study|Withdrawal by Subject|26|||
145658284|NCT04568486|525267360|FG000|Overall Study|Lost to Follow-up|7|||
145658285|NCT01210807|525267363|FG000|Overall Study|Lost to Follow-up|1|||
145658286|NCT01210807|525267364|FG001|Overall Study|Lost to Follow-up|2|||
145658287|NCT01210807|525267363|FG000|Overall Study|Not implanted bilaterally|2|||
145658288|NCT01210807|525267364|FG001|Overall Study|Not implanted bilaterally|1|||
145658289|NCT05477186|525267369|FG000|Overall Study|Vaccine not administered|0|||
145658290|NCT05477186|525267370|FG001|Overall Study|Vaccine not administered|2|||
145658291|NCT05477186|525267371|FG002|Overall Study|Vaccine not administered|1|||
145658292|NCT05477186|525267372|FG003|Overall Study|Vaccine not administered|0|||
145658293|NCT05477186|525267373|FG004|Overall Study|Vaccine not administered|1|||
145658294|NCT05477186|525267374|FG005|Overall Study|Vaccine not administered|0|||
145658295|NCT05477186|525267375|FG006|Overall Study|Vaccine not administered|0|||
145658296|NCT05477186|525267369|FG000|Overall Study|Withdrawal by Subject|1|||
145658297|NCT05477186|525267370|FG001|Overall Study|Withdrawal by Subject|0|||
145658298|NCT05477186|525267371|FG002|Overall Study|Withdrawal by Subject|0|||
145658299|NCT05477186|525267372|FG003|Overall Study|Withdrawal by Subject|0|||
145658300|NCT05477186|525267373|FG004|Overall Study|Withdrawal by Subject|0|||
145658301|NCT05477186|525267374|FG005|Overall Study|Withdrawal by Subject|1|||
145658302|NCT05477186|525267375|FG006|Overall Study|Withdrawal by Subject|0|||
145658303|NCT05477186|525267369|FG000|Overall Study|Lost to Follow-up|1|||
145658304|NCT05477186|525267370|FG001|Overall Study|Lost to Follow-up|0|||
145658305|NCT05477186|525267371|FG002|Overall Study|Lost to Follow-up|2|||
145658306|NCT05477186|525267372|FG003|Overall Study|Lost to Follow-up|1|||
145658307|NCT05477186|525267373|FG004|Overall Study|Lost to Follow-up|1|||
145658308|NCT05477186|525267374|FG005|Overall Study|Lost to Follow-up|0|||
145658309|NCT05477186|525267375|FG006|Overall Study|Lost to Follow-up|2|||
145658310|NCT01733316|525267384|FG000|RP103 Phase|Non-compliance|1|||
145658311|NCT01733316|525267384|FG000|Long Term Extension Phase|Adverse Event|1|||
145658312|NCT01733316|525267384|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
145658313|NCT01733316|525267384|FG000|Long Term Extension Phase|Sponsor Decision|2|||
145658314|NCT05526430|525267385|FG000|Overall Study|Withdrawal by Subject|0|||
145658315|NCT05526430|525267386|FG001|Overall Study|Withdrawal by Subject|2|||
145658316|NCT05526430|525267387|FG002|Overall Study|Withdrawal by Subject|0|||
145658317|NCT05526430|525267388|FG003|Overall Study|Withdrawal by Subject|0|||
145658318|NCT03024437|525267397|FG000|Overall Study|Adverse Event|0|||
145658319|NCT03024437|525267398|FG001|Overall Study|Adverse Event|1|||
145658320|NCT03024437|525267399|FG002|Overall Study|Adverse Event|3|||
145658321|NCT03024437|525267400|FG003|Overall Study|Adverse Event|5|||
145658322|NCT03024437|525267401|FG004|Overall Study|Adverse Event|0|||
145658323|NCT03024437|525267397|FG000|Overall Study|Physician Decision|1|||
145658324|NCT03024437|525267398|FG001|Overall Study|Physician Decision|0|||
145658325|NCT03024437|525267399|FG002|Overall Study|Physician Decision|0|||
145658326|NCT03024437|525267400|FG003|Overall Study|Physician Decision|1|||
145658327|NCT03024437|525267401|FG004|Overall Study|Physician Decision|0|||
145658328|NCT03024437|525267397|FG000|Overall Study|Disease progression, relapse|1|||
145658329|NCT03024437|525267398|FG001|Overall Study|Disease progression, relapse|0|||
145658330|NCT03024437|525267399|FG002|Overall Study|Disease progression, relapse|0|||
145658331|NCT03024437|525267400|FG003|Overall Study|Disease progression, relapse|3|||
145658332|NCT03024437|525267401|FG004|Overall Study|Disease progression, relapse|0|||
145658333|NCT03024437|525267397|FG000|Overall Study|Disease progression, refractory disease|4|||
145658334|NCT03024437|525267398|FG001|Overall Study|Disease progression, refractory disease|4|||
145658335|NCT03024437|525267399|FG002|Overall Study|Disease progression, refractory disease|2|||
145658336|NCT03024437|525267400|FG003|Overall Study|Disease progression, refractory disease|2|||
145658337|NCT03024437|525267401|FG004|Overall Study|Disease progression, refractory disease|1|||
145658338|NCT03024437|525267397|FG000|Overall Study|Newly diagnosed cancer|0|||
145658339|NCT03024437|525267398|FG001|Overall Study|Newly diagnosed cancer|0|||
145658340|NCT03024437|525267399|FG002|Overall Study|Newly diagnosed cancer|0|||
145658341|NCT03024437|525267400|FG003|Overall Study|Newly diagnosed cancer|1|||
145658342|NCT03024437|525267401|FG004|Overall Study|Newly diagnosed cancer|0|||
145658343|NCT03024437|525267397|FG000|Overall Study|Moved out of state|0|||
145658344|NCT03024437|525267398|FG001|Overall Study|Moved out of state|1|||
145658345|NCT03024437|525267399|FG002|Overall Study|Moved out of state|0|||
145265340|NCT01300741|523819298|FG000|Overall Study|Lens deposits|1|||
145658346|NCT03024437|525267400|FG003|Overall Study|Moved out of state|0|||
145658347|NCT03024437|525267401|FG004|Overall Study|Moved out of state|0|||
145658348|NCT03024437|525267397|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
145658349|NCT03024437|525267398|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
145658350|NCT03024437|525267399|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
145658351|NCT03024437|525267400|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
145658352|NCT03024437|525267401|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
145658353|NCT05566639|525267408|FG000|Overall Study|Adverse Event|1|||
145658354|NCT05566639|525267409|FG001|Overall Study|Adverse Event|1|||
145658355|NCT05566639|525267408|FG000|Overall Study|Serious Adverse Event|1|||
145658356|NCT05566639|525267409|FG001|Overall Study|Serious Adverse Event|3|||
145658357|NCT05566639|525267408|FG000|Overall Study|Death|44|||
145658358|NCT05566639|525267409|FG001|Overall Study|Death|45|||
145658359|NCT05566639|525267408|FG000|Overall Study|Lost to Follow-up|467|||
145658360|NCT05566639|525267409|FG001|Overall Study|Lost to Follow-up|461|||
145658361|NCT05566639|525267408|FG000|Overall Study|Physician Decision|45|||
145658362|NCT05566639|525267409|FG001|Overall Study|Physician Decision|44|||
145658363|NCT05566639|525267408|FG000|Overall Study|Protocol Deviation|4|||
145658364|NCT05566639|525267409|FG001|Overall Study|Protocol Deviation|4|||
145658365|NCT05566639|525267408|FG000|Overall Study|Withdrawal by Subject|277|||
145658366|NCT05566639|525267409|FG001|Overall Study|Withdrawal by Subject|271|||
145658367|NCT05566639|525267408|FG000|Overall Study|Other Than Specified|52|||
145658368|NCT05566639|525267409|FG001|Overall Study|Other Than Specified|64|||
145658369|NCT04054193|525267417|FG000|Cycle 1|Physician Decision|1|||
145658370|NCT04054193|525267417|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
145658371|NCT04054193|525267417|FG000|Cycle 1|Allocated but not treated|3|||
145658372|NCT04054193|525267417|FG000|Cycles 2-3|Physician Decision|2|||
145658373|NCT04054193|525267417|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
145658374|NCT04054193|525267417|FG000|Cycles 2-3|Various reasons|17|||
145658375|NCT04830800|525267423|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
145658376|NCT04830800|525267424|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
145658377|NCT04830800|525267425|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
145658378|NCT04830800|525267426|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
145658379|NCT04830800|525267427|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
145658380|NCT02626533|525267428|FG000|Overall Study|Protocol Violation|14|||
145658381|NCT02626533|525267428|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
145658382|NCT02626533|525267428|FG000|Overall Study|Withdrawal by Subject|1|||
145658383|NCT04753697|525267429|FG000|Induction Phase|Withdrawal by Subject|12|||
145658384|NCT04753697|525267430|FG001|Induction Phase|Withdrawal by Subject|5|||
145658385|NCT04753697|525267431|FG002|Induction Phase|Withdrawal by Subject|6|||
145658386|NCT04753697|525267429|FG000|Induction Phase|Physician Decision|1|||
145658387|NCT04753697|525267430|FG001|Induction Phase|Physician Decision|0|||
145658388|NCT04753697|525267431|FG002|Induction Phase|Physician Decision|0|||
145658389|NCT04753697|525267429|FG000|Induction Phase|Lost to Follow-up|2|||
145658390|NCT04753697|525267430|FG001|Induction Phase|Lost to Follow-up|2|||
145658391|NCT04753697|525267431|FG002|Induction Phase|Lost to Follow-up|1|||
145658392|NCT04753697|525267429|FG000|Induction Phase|Lack of Efficacy|1|||
145658393|NCT04753697|525267430|FG001|Induction Phase|Lack of Efficacy|0|||
145658394|NCT04753697|525267431|FG002|Induction Phase|Lack of Efficacy|0|||
145658395|NCT04753697|525267429|FG000|Maintenance Phase|Physician Decision|0|||
145658396|NCT04753697|525267430|FG001|Maintenance Phase|Physician Decision|0|||
145658397|NCT04753697|525267431|FG002|Maintenance Phase|Physician Decision|1|||
145658398|NCT04753697|525267429|FG000|Maintenance Phase|Withdrawal by Subject|3|||
145658399|NCT04753697|525267430|FG001|Maintenance Phase|Withdrawal by Subject|4|||
145658400|NCT04753697|525267431|FG002|Maintenance Phase|Withdrawal by Subject|6|||
145658401|NCT04753697|525267429|FG000|Maintenance Phase|Lost to Follow-up|2|||
145658402|NCT04753697|525267430|FG001|Maintenance Phase|Lost to Follow-up|2|||
145658403|NCT04753697|525267431|FG002|Maintenance Phase|Lost to Follow-up|0|||
145658404|NCT04753697|525267429|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
145658405|NCT04753697|525267430|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
145658406|NCT04753697|525267431|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
145658407|NCT04753697|525267429|FG000|Maintenance Phase|Adverse Event|0|||
145658408|NCT04753697|525267430|FG001|Maintenance Phase|Adverse Event|1|||
145658409|NCT04753697|525267431|FG002|Maintenance Phase|Adverse Event|1|||
145658410|NCT04753697|525267429|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
145658411|NCT04753697|525267430|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
145658412|NCT04753697|525267431|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
145658413|NCT03701763|525267434|FG000|Placebo-controlled Phase|Adverse Event|1|||
145658414|NCT03701763|525267435|FG001|Placebo-controlled Phase|Adverse Event|5|||
145658415|NCT03701763|525267436|FG002|Placebo-controlled Phase|Adverse Event|0|||
145658416|NCT03701763|525267437|FG003|Placebo-controlled Phase|Adverse Event|0|||
145658417|NCT03701763|525267434|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
145658418|NCT03701763|525267435|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
145658419|NCT03701763|525267436|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
145658420|NCT03701763|525267437|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
145658421|NCT03701763|525267434|FG000|Placebo-controlled Phase|Miscellaneous|2|||
145658422|NCT03701763|525267435|FG001|Placebo-controlled Phase|Miscellaneous|0|||
145658423|NCT03701763|525267436|FG002|Placebo-controlled Phase|Miscellaneous|0|||
145658424|NCT03701763|525267437|FG003|Placebo-controlled Phase|Miscellaneous|0|||
145658425|NCT03701763|525267434|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
145658426|NCT03701763|525267435|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
145658427|NCT03701763|525267436|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
145658428|NCT03701763|525267437|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
145658429|NCT03701763|525267434|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
145658430|NCT03701763|525267435|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
145658431|NCT03701763|525267436|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
145658432|NCT03701763|525267437|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
145658433|NCT03701763|525267434|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
145658434|NCT03701763|525267435|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
145658435|NCT03701763|525267436|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
145658436|NCT03701763|525267437|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
145658437|NCT03701763|525267434|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
145658438|NCT03701763|525267435|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
145658439|NCT03701763|525267436|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
145658440|NCT03701763|525267437|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
145658441|NCT03701763|525267434|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
145658442|NCT03701763|525267435|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
145658443|NCT03701763|525267436|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
145658444|NCT03701763|525267437|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
145658445|NCT03701763|525267434|FG000|Apremilast Extension Phase|Adverse Event|0|||
145658446|NCT03701763|525267435|FG001|Apremilast Extension Phase|Adverse Event|0|||
145658447|NCT03701763|525267436|FG002|Apremilast Extension Phase|Adverse Event|3|||
145658448|NCT03701763|525267437|FG003|Apremilast Extension Phase|Adverse Event|1|||
145658449|NCT03701763|525267434|FG000|Apremilast Extension Phase|Miscellaneous|0|||
145658450|NCT03701763|525267435|FG001|Apremilast Extension Phase|Miscellaneous|0|||
145658451|NCT03701763|525267436|FG002|Apremilast Extension Phase|Miscellaneous|2|||
145658452|NCT03701763|525267437|FG003|Apremilast Extension Phase|Miscellaneous|1|||
145658453|NCT03701763|525267434|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
145658454|NCT03701763|525267435|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
145658455|NCT03701763|525267436|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
145658456|NCT03701763|525267437|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
145658457|NCT03701763|525267434|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
145658458|NCT03701763|525267435|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
145658459|NCT03701763|525267436|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
145658460|NCT03701763|525267437|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
145658461|NCT03701763|525267434|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
145658462|NCT03701763|525267435|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
145658463|NCT03701763|525267436|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
145658464|NCT03701763|525267437|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
145658465|NCT03701763|525267434|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
145658466|NCT03701763|525267435|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
145658467|NCT03701763|525267436|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
145658468|NCT03701763|525267437|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
145658469|NCT03701763|525267434|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
145658470|NCT03701763|525267435|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
145658471|NCT03701763|525267436|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
145658472|NCT03701763|525267437|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
145658473|NCT03701763|525267434|FG000|14-Week Observational Follow-up Phase|Other|0|||
145658474|NCT03701763|525267435|FG001|14-Week Observational Follow-up Phase|Other|0|||
145658475|NCT03701763|525267436|FG002|14-Week Observational Follow-up Phase|Other|1|||
145658476|NCT03701763|525267437|FG003|14-Week Observational Follow-up Phase|Other|0|||
145658477|NCT03701763|525267434|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
145658478|NCT03701763|525267435|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
145658479|NCT03701763|525267436|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
145658480|NCT03701763|525267437|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
145658481|NCT03701763|525267434|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
145658482|NCT03701763|525267435|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
145658483|NCT03701763|525267436|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
145490428|NCT03309878|524650300|FG003|Overall Study|Adverse Event|0|||
145490429|NCT03309878|524650297|FG000|Overall Study|Did not maintain eligibility|2|||
145490430|NCT03309878|524650298|FG001|Overall Study|Did not maintain eligibility|1|||
145490431|NCT03309878|524650299|FG002|Overall Study|Did not maintain eligibility|0|||
145490432|NCT03309878|524650300|FG003|Overall Study|Did not maintain eligibility|0|||
145490433|NCT03309878|524650297|FG000|Overall Study|Withdrawal by Subject|0|||
145490434|NCT03309878|524650298|FG001|Overall Study|Withdrawal by Subject|1|||
145658484|NCT03701763|525267437|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
145658485|NCT04200456|525267438|FG000|Overall Study|Physician Decision|0|||
145658486|NCT04200456|525267439|FG001|Overall Study|Physician Decision|1|||
145658487|NCT04200456|525267438|FG000|Overall Study|Withdrawal by Subject|2|||
145658488|NCT04200456|525267439|FG001|Overall Study|Withdrawal by Subject|2|||
145658489|NCT04200456|525267438|FG000|Overall Study|Lack of Efficacy|1|||
145658490|NCT04200456|525267439|FG001|Overall Study|Lack of Efficacy|1|||
145658491|NCT04200456|525267438|FG000|Overall Study|Adverse event, non-fatal|0|||
145658492|NCT04200456|525267439|FG001|Overall Study|Adverse event, non-fatal|1|||
145658493|NCT04200456|525267438|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
145658494|NCT04200456|525267439|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
145658495|NCT03785964|525267440|FG000|Overall Study|Adverse Event|14|||
145658496|NCT03785964|525267441|FG001|Overall Study|Adverse Event|1|||
145658497|NCT03785964|525267440|FG000|Overall Study|Unqualified Clinical Progression|1|||
145658498|NCT03785964|525267441|FG001|Overall Study|Unqualified Clinical Progression|1|||
145658499|NCT03785964|525267440|FG000|Overall Study|Participant non-compliance|1|||
145658500|NCT03785964|525267441|FG001|Overall Study|Participant non-compliance|1|||
145658501|NCT03785964|525267440|FG000|Overall Study|Not treated|1|||
145658502|NCT03785964|525267441|FG001|Overall Study|Not treated|0|||
145658503|NCT03785964|525267440|FG000|Overall Study|Other reason|5|||
145658504|NCT03785964|525267441|FG001|Overall Study|Other reason|11|||
145658505|NCT03785964|525267440|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
145658506|NCT03785964|525267441|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
145658507|NCT05446168|525267442|FG000|Overall Study|Physician Decision|0|||
145658508|NCT05446168|525267443|FG001|Overall Study|Physician Decision|1|||
145658509|NCT03905798|525267447|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
145658510|NCT06473662|525267448|FG000|Overall Study|Withdrawal by Subject|1|||
145658511|NCT06473662|525267449|FG001|Overall Study|Withdrawal by Subject|6|||
145658512|NCT06473662|525267450|FG002|Overall Study|Withdrawal by Subject|5|||
145658513|NCT06473662|525267448|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
145658514|NCT06473662|525267449|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
145658515|NCT06473662|525267450|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
145658516|NCT06473662|525267448|FG000|Overall Study|Starting HbA1c below 7%|0|||
145658517|NCT06473662|525267449|FG001|Overall Study|Starting HbA1c below 7%|1|||
145658518|NCT06473662|525267450|FG002|Overall Study|Starting HbA1c below 7%|1|||
145658519|NCT06473662|525267448|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
145658520|NCT06473662|525267449|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
145658521|NCT06473662|525267450|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
145658522|NCT06473662|525267448|FG000|Overall Study|Did not take medication|2|||
145658523|NCT06473662|525267449|FG001|Overall Study|Did not take medication|3|||
145658524|NCT06473662|525267450|FG002|Overall Study|Did not take medication|2|||
145658525|NCT03463044|525267453|FG000|Overall Study|Lost to Follow-up|0|||
145658526|NCT03463044|525267454|FG001|Overall Study|Lost to Follow-up|0|||
145658527|NCT03463044|525267455|FG002|Overall Study|Lost to Follow-up|0|||
145658528|NCT03463044|525267456|FG003|Overall Study|Lost to Follow-up|0|||
145658529|NCT03463044|525267457|FG004|Overall Study|Lost to Follow-up|0|||
145658530|NCT03463044|525267458|FG005|Overall Study|Lost to Follow-up|0|||
145658531|NCT03463044|525267459|FG006|Overall Study|Lost to Follow-up|0|||
145658532|NCT03463044|525267460|FG007|Overall Study|Lost to Follow-up|1|||
145658533|NCT03463044|525267461|FG008|Overall Study|Lost to Follow-up|0|||
145658534|NCT02733159|525267465|FG000|Overall Study|Adverse Event|1|||
145658535|NCT02733159|525267465|FG000|Overall Study|Lack of disease progression|1|||
145658536|NCT01574274|525269193|FG000|Overall Study|Ineligible|0|||
145658537|NCT01574274|525269194|FG001|Overall Study|Ineligible|1|||
145658538|NCT01574274|525269193|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
145658539|NCT01574274|525269194|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
145658540|NCT01574274|525269193|FG000|Overall Study|Ph+ B-ALL|3|||
145658541|NCT01574274|525269194|FG001|Overall Study|Ph+ B-ALL|4|||
145658542|NCT01574274|525269193|FG000|Overall Study|Induction Death|2|||
145658543|NCT01574274|525269194|FG001|Overall Study|Induction Death|0|||
145658544|NCT01574274|525269193|FG000|Overall Study|Induction Failure|4|||
145658545|NCT01574274|525269194|FG001|Overall Study|Induction Failure|1|||
145658546|NCT01574274|525269193|FG000|Overall Study|Adverse Event|16|||
145658547|NCT01574274|525269194|FG001|Overall Study|Adverse Event|13|||
145658548|NCT01574274|525269193|FG000|Overall Study|Remission Death|1|||
145658549|NCT01574274|525269194|FG001|Overall Study|Remission Death|0|||
145658550|NCT01574274|525269193|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
145658551|NCT01574274|525269194|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
145658552|NCT01574274|525269193|FG000|Overall Study|Other, unknown|3|||
145658553|NCT01574274|525269194|FG001|Overall Study|Other, unknown|2|||
145658554|NCT04676763|525269195|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
145658555|NCT04676763|525269196|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
145658556|NCT04676763|525269197|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
145658557|NCT04676763|525269195|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
145658558|NCT04676763|525269196|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
145658559|NCT04676763|525269197|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
145658560|NCT04676763|525269195|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
145658561|NCT04676763|525269196|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
145658562|NCT04676763|525269197|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
145658563|NCT03314454|525269200|FG000|Overall Study|Protocol Violation|1|||
145658564|NCT05877976|525269209|FG000|Overall Study|Lost to Follow-up|31|||
145658565|NCT02714257|525269211|FG000|Overall Study|Withdrawal by Subject|6|||
145658566|NCT02714257|525269212|FG001|Overall Study|Withdrawal by Subject|11|||
145658567|NCT02714257|525269211|FG000|Overall Study|Death|3|||
145658568|NCT02714257|525269212|FG001|Overall Study|Death|4|||
145658569|NCT02714257|525269211|FG000|Overall Study|Lost to Follow-up|1|||
145658570|NCT02714257|525269212|FG001|Overall Study|Lost to Follow-up|6|||
145658571|NCT05808257|525269213|FG000|Overall Study|Lost to Follow-up|8|||
145658572|NCT05808257|525269214|FG001|Overall Study|Lost to Follow-up|8|||
145658573|NCT03656510|525269235|FG000|Overall Study|Lost to Follow-up|1|||
145658574|NCT03656510|525269236|FG001|Overall Study|Lost to Follow-up|0|||
145658575|NCT03656510|525269237|FG002|Overall Study|Lost to Follow-up|0|||
145658576|NCT03656510|525269238|FG003|Overall Study|Lost to Follow-up|0|||
145658577|NCT03656510|525269239|FG004|Overall Study|Lost to Follow-up|0|||
145658578|NCT03656510|525269240|FG005|Overall Study|Lost to Follow-up|0|||
145658579|NCT03656510|525269235|FG000|Overall Study|Withdrawal by Subject|1|||
145658580|NCT03656510|525269236|FG001|Overall Study|Withdrawal by Subject|1|||
145658581|NCT03656510|525269237|FG002|Overall Study|Withdrawal by Subject|0|||
145658582|NCT03656510|525269238|FG003|Overall Study|Withdrawal by Subject|1|||
145658583|NCT03656510|525269239|FG004|Overall Study|Withdrawal by Subject|0|||
145658584|NCT03656510|525269240|FG005|Overall Study|Withdrawal by Subject|0|||
145658585|NCT05496231|525269243|FG000|Overall Study|Adverse Event|1|||
145658586|NCT05496231|525269244|FG001|Overall Study|Adverse Event|1|||
145658587|NCT05496231|525269245|FG002|Overall Study|Adverse Event|0|||
145658588|NCT05496231|525269246|FG003|Overall Study|Adverse Event|4|||
145658589|NCT05496231|525269243|FG000|Overall Study|Withdrawal by Subject|5|||
145658590|NCT05496231|525269244|FG001|Overall Study|Withdrawal by Subject|5|||
145658591|NCT05496231|525269245|FG002|Overall Study|Withdrawal by Subject|4|||
145658592|NCT05496231|525269246|FG003|Overall Study|Withdrawal by Subject|11|||
145658593|NCT05496231|525269243|FG000|Overall Study|Migrated/moved from the study area|3|||
145658594|NCT05496231|525269244|FG001|Overall Study|Migrated/moved from the study area|5|||
145658595|NCT05496231|525269245|FG002|Overall Study|Migrated/moved from the study area|3|||
145658596|NCT05496231|525269246|FG003|Overall Study|Migrated/moved from the study area|3|||
145658597|NCT05496231|525269243|FG000|Overall Study|Lost to Follow-up|13|||
145658598|NCT05496231|525269244|FG001|Overall Study|Lost to Follow-up|6|||
145658599|NCT05496231|525269245|FG002|Overall Study|Lost to Follow-up|11|||
145658600|NCT05496231|525269246|FG003|Overall Study|Lost to Follow-up|6|||
145658601|NCT05496231|525269243|FG000|Overall Study|Other|9|||
145658602|NCT05496231|525269244|FG001|Overall Study|Other|7|||
145658603|NCT05496231|525269245|FG002|Overall Study|Other|7|||
145658604|NCT05496231|525269246|FG003|Overall Study|Other|8|||
145658605|NCT05670587|525269253|FG000|Overall Study|Withdrawal by Subject|3|||
145658606|NCT04508309|525269256|FG000|Overall Study|Death|0|||
145658607|NCT04508309|525269257|FG001|Overall Study|Death|0|||
145658608|NCT04508309|525269258|FG002|Overall Study|Death|0|||
145658609|NCT04508309|525269259|FG003|Overall Study|Death|0|||
145658610|NCT04508309|525269260|FG004|Overall Study|Death|1|||
145658611|NCT04508309|525269256|FG000|Overall Study|Lost to Follow-up|0|||
145658612|NCT04508309|525269257|FG001|Overall Study|Lost to Follow-up|0|||
145658613|NCT04508309|525269258|FG002|Overall Study|Lost to Follow-up|1|||
145658614|NCT04508309|525269259|FG003|Overall Study|Lost to Follow-up|1|||
145658615|NCT04508309|525269260|FG004|Overall Study|Lost to Follow-up|0|||
145658616|NCT04508309|525269256|FG000|Overall Study|Withdrawal by Subject|0|||
145658617|NCT04508309|525269257|FG001|Overall Study|Withdrawal by Subject|0|||
145658618|NCT04508309|525269258|FG002|Overall Study|Withdrawal by Subject|0|||
145658619|NCT04508309|525269259|FG003|Overall Study|Withdrawal by Subject|0|||
145658620|NCT04508309|525269260|FG004|Overall Study|Withdrawal by Subject|1|||
145658621|NCT02305888|525269261|FG000|Overall Study|Lost to Follow-up|0|||
145658622|NCT02305888|525269262|FG001|Overall Study|Lost to Follow-up|0|||
145658623|NCT02305888|525269263|FG002|Overall Study|Lost to Follow-up|1|||
145658624|NCT02305888|525269261|FG000|Overall Study|Adverse Event|0|||
145658625|NCT02305888|525269262|FG001|Overall Study|Adverse Event|1|||
145658626|NCT02305888|525269263|FG002|Overall Study|Adverse Event|0|||
145658627|NCT05940194|525269264|FG000|Overall Study|Adverse Event|0|||
145658628|NCT05940194|525269265|FG001|Overall Study|Adverse Event|1|||
145658629|NCT05940194|525269266|FG002|Overall Study|Adverse Event|0|||
145658630|NCT05940194|525269264|FG000|Overall Study|Migrated/Moved from the study area|2|||
145658631|NCT05940194|525269265|FG001|Overall Study|Migrated/Moved from the study area|2|||
145658632|NCT05940194|525269266|FG002|Overall Study|Migrated/Moved from the study area|4|||
145658633|NCT04914676|525269267|FG000|Overall Study|Study termination|3|||
145658634|NCT04914676|525269268|FG001|Overall Study|Study termination|0|||
145658635|NCT03085810|525269269|FG000|Main Study|Withdrawal by Subject|77|||
145658636|NCT03085810|525269270|FG001|Main Study|Withdrawal by Subject|0|||
145490435|NCT03309878|524650299|FG002|Overall Study|Withdrawal by Subject|0|||
145490436|NCT03309878|524650300|FG003|Overall Study|Withdrawal by Subject|0|||
145490437|NCT01096316|524650301|FG000|Overall Study|Lost to Follow-up|15|||
145490438|NCT01096316|524650302|FG001|Overall Study|Lost to Follow-up|9|||
145490439|NCT01884077|524650303|FG000|Overall Study|screen fail|0|||
145490440|NCT01884077|524650304|FG001|Overall Study|screen fail|2|||
145490441|NCT01884077|524650303|FG000|Overall Study|canceled surgery|2|||
145490442|NCT01884077|524650304|FG001|Overall Study|canceled surgery|0|||
145490443|NCT01884077|524650303|FG000|Overall Study|Lost to Follow-up|0|||
145490444|NCT01884077|524650304|FG001|Overall Study|Lost to Follow-up|4|||
145490445|NCT01884077|524650303|FG000|Overall Study|study closed|6|||
145490446|NCT01884077|524650304|FG001|Overall Study|study closed|4|||
145490447|NCT02836652|524650305|FG000|Overall Study|Death|3|||
145490448|NCT02836652|524650306|FG001|Overall Study|Death|3|||
145490449|NCT02836652|524650305|FG000|Overall Study|Transplant/Explant|3|||
145490450|NCT02836652|524650306|FG001|Overall Study|Transplant/Explant|4|||
145490451|NCT02836652|524650305|FG000|Overall Study|Withdrawn|9|||
145490452|NCT02836652|524650306|FG001|Overall Study|Withdrawn|9|||
145490453|NCT02836652|524650305|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
145490454|NCT02836652|524650306|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
145490455|NCT02349633|524650308|FG000|Overall Study|Death|0|||
145490456|NCT02349633|524650309|FG001|Overall Study|Death|1|||
145490457|NCT02349633|524650310|FG002|Overall Study|Death|0|||
145490458|NCT02349633|524650311|FG003|Overall Study|Death|0|||
145490459|NCT02349633|524650312|FG004|Overall Study|Death|0|||
145490460|NCT02349633|524650313|FG005|Overall Study|Death|1|||
145490461|NCT02349633|524650314|FG006|Overall Study|Death|1|||
145490462|NCT02349633|524650315|FG007|Overall Study|Death|1|||
145490463|NCT02349633|524650316|FG008|Overall Study|Death|0|||
145490464|NCT02349633|524650317|FG009|Overall Study|Death|1|||
145490465|NCT02349633|524650318|FG010|Overall Study|Death|0|||
145490466|NCT02349633|524650319|FG011|Overall Study|Death|0|||
145490467|NCT02349633|524650320|FG012|Overall Study|Death|0|||
145490468|NCT02349633|524650321|FG013|Overall Study|Death|0|||
145490469|NCT02349633|524650308|FG000|Overall Study|Withdrawal by Subject|0|||
145490470|NCT02349633|524650309|FG001|Overall Study|Withdrawal by Subject|0|||
145490471|NCT02349633|524650310|FG002|Overall Study|Withdrawal by Subject|0|||
145490472|NCT02349633|524650311|FG003|Overall Study|Withdrawal by Subject|1|||
145490473|NCT02349633|524650312|FG004|Overall Study|Withdrawal by Subject|0|||
145490474|NCT02349633|524650313|FG005|Overall Study|Withdrawal by Subject|0|||
145490475|NCT02349633|524650314|FG006|Overall Study|Withdrawal by Subject|0|||
145490476|NCT02349633|524650315|FG007|Overall Study|Withdrawal by Subject|2|||
145490477|NCT02349633|524650316|FG008|Overall Study|Withdrawal by Subject|2|||
145490478|NCT02349633|524650317|FG009|Overall Study|Withdrawal by Subject|1|||
145490479|NCT02349633|524650318|FG010|Overall Study|Withdrawal by Subject|0|||
145490480|NCT02349633|524650319|FG011|Overall Study|Withdrawal by Subject|0|||
145490481|NCT02349633|524650320|FG012|Overall Study|Withdrawal by Subject|0|||
145490482|NCT02349633|524650321|FG013|Overall Study|Withdrawal by Subject|0|||
145490483|NCT02349633|524650308|FG000|Overall Study|Withdrawal of informed consent|0|||
145490484|NCT02349633|524650309|FG001|Overall Study|Withdrawal of informed consent|0|||
145490485|NCT02349633|524650310|FG002|Overall Study|Withdrawal of informed consent|0|||
145490486|NCT02349633|524650311|FG003|Overall Study|Withdrawal of informed consent|1|||
145490487|NCT02349633|524650312|FG004|Overall Study|Withdrawal of informed consent|1|||
145490488|NCT02349633|524650313|FG005|Overall Study|Withdrawal of informed consent|0|||
145490489|NCT02349633|524650314|FG006|Overall Study|Withdrawal of informed consent|0|||
145658637|NCT03085810|525269271|FG002|Main Study|Withdrawal by Subject|0|||
145658638|NCT03085810|525269269|FG000|Main Study|Terminated By Sponsor|14|||
145658639|NCT03085810|525269270|FG001|Main Study|Terminated By Sponsor|0|||
145658640|NCT03085810|525269271|FG002|Main Study|Terminated By Sponsor|0|||
145658641|NCT03085810|525269269|FG000|Main Study|Protocol Violation|15|||
145658642|NCT03085810|525269270|FG001|Main Study|Protocol Violation|0|||
145658643|NCT03085810|525269271|FG002|Main Study|Protocol Violation|0|||
145658644|NCT03085810|525269269|FG000|Main Study|Physician Decision|13|||
145658645|NCT03085810|525269270|FG001|Main Study|Physician Decision|0|||
145658646|NCT03085810|525269271|FG002|Main Study|Physician Decision|0|||
145658647|NCT03085810|525269269|FG000|Main Study|Lost to Follow-up|17|||
145658648|NCT03085810|525269270|FG001|Main Study|Lost to Follow-up|0|||
145658649|NCT03085810|525269271|FG002|Main Study|Lost to Follow-up|0|||
145658650|NCT03085810|525269269|FG000|Main Study|Adverse Event|25|||
145658651|NCT03085810|525269270|FG001|Main Study|Adverse Event|0|||
145658652|NCT03085810|525269271|FG002|Main Study|Adverse Event|0|||
145490490|NCT02349633|524650315|FG007|Overall Study|Withdrawal of informed consent|3|||
145490491|NCT02349633|524650316|FG008|Overall Study|Withdrawal of informed consent|0|||
145490492|NCT02349633|524650317|FG009|Overall Study|Withdrawal of informed consent|0|||
145490493|NCT02349633|524650318|FG010|Overall Study|Withdrawal of informed consent|0|||
145490494|NCT02349633|524650319|FG011|Overall Study|Withdrawal of informed consent|0|||
145490495|NCT02349633|524650320|FG012|Overall Study|Withdrawal of informed consent|0|||
145490496|NCT02349633|524650321|FG013|Overall Study|Withdrawal of informed consent|0|||
145658653|NCT03085810|525269269|FG000|Main Study|Pregnancy|7|||
145658654|NCT03085810|525269270|FG001|Main Study|Pregnancy|0|||
145658655|NCT03085810|525269271|FG002|Main Study|Pregnancy|0|||
145658656|NCT03085810|525269269|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
145658657|NCT03085810|525269270|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
145658658|NCT03085810|525269271|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
145658659|NCT03085810|525269269|FG000|Main Study|Lack of Efficacy|10|||
145658660|NCT03085810|525269270|FG001|Main Study|Lack of Efficacy|0|||
145658661|NCT03085810|525269271|FG002|Main Study|Lack of Efficacy|0|||
145658662|NCT03085810|525269269|FG000|Main Study|Death|12|||
145658663|NCT03085810|525269270|FG001|Main Study|Death|0|||
145658664|NCT03085810|525269271|FG002|Main Study|Death|0|||
145658665|NCT03085810|525269269|FG000|Main Study|Disease progression|1|||
145658666|NCT03085810|525269270|FG001|Main Study|Disease progression|0|||
145658667|NCT03085810|525269271|FG002|Main Study|Disease progression|0|||
145658668|NCT03085810|525269269|FG000|Main Study|Site Closure|3|||
145658669|NCT03085810|525269270|FG001|Main Study|Site Closure|0|||
145658670|NCT03085810|525269271|FG002|Main Study|Site Closure|0|||
145658671|NCT03085810|525269269|FG000|Main Study|Planned pregnancy|17|||
145658672|NCT03085810|525269270|FG001|Main Study|Planned pregnancy|0|||
145658673|NCT03085810|525269271|FG002|Main Study|Planned pregnancy|0|||
145658674|NCT03085810|525269269|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
145658675|NCT03085810|525269270|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
145658676|NCT03085810|525269271|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
145658677|NCT03085810|525269269|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
145658678|NCT03085810|525269270|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
145658679|NCT03085810|525269271|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
145658680|NCT03085810|525269269|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
145658681|NCT03085810|525269270|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
145658682|NCT03085810|525269271|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
145658683|NCT03085810|525269269|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
145658684|NCT03085810|525269270|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
145658685|NCT03085810|525269271|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
145658686|NCT04625465|525269274|FG000|Overall Study|Lost to Follow-up|2|||
145658687|NCT04625465|525269275|FG001|Overall Study|Lost to Follow-up|2|||
145658688|NCT04625465|525269276|FG002|Overall Study|Lost to Follow-up|1|||
145658689|NCT04625465|525269277|FG003|Overall Study|Lost to Follow-up|0|||
145658690|NCT04625465|525269278|FG004|Overall Study|Lost to Follow-up|0|||
145658691|NCT04625465|525269279|FG005|Overall Study|Lost to Follow-up|2|||
145658692|NCT04625465|525269280|FG006|Overall Study|Lost to Follow-up|0|||
145658693|NCT04625465|525269281|FG007|Overall Study|Lost to Follow-up|0|||
145658694|NCT04625465|525269274|FG000|Overall Study|Death|1|||
145658695|NCT04625465|525269275|FG001|Overall Study|Death|0|||
145658696|NCT04625465|525269276|FG002|Overall Study|Death|0|||
145658697|NCT04625465|525269277|FG003|Overall Study|Death|0|||
145658698|NCT04625465|525269278|FG004|Overall Study|Death|0|||
145658699|NCT04625465|525269279|FG005|Overall Study|Death|0|||
145658700|NCT04625465|525269280|FG006|Overall Study|Death|0|||
145658701|NCT04625465|525269281|FG007|Overall Study|Death|0|||
145658702|NCT04625465|525269274|FG000|Overall Study|Withdrawal by Subject|1|||
145658703|NCT04625465|525269275|FG001|Overall Study|Withdrawal by Subject|0|||
145658704|NCT04625465|525269276|FG002|Overall Study|Withdrawal by Subject|4|||
145658705|NCT04625465|525269277|FG003|Overall Study|Withdrawal by Subject|4|||
145658706|NCT04625465|525269278|FG004|Overall Study|Withdrawal by Subject|4|||
145658707|NCT04625465|525269279|FG005|Overall Study|Withdrawal by Subject|0|||
145658708|NCT04625465|525269280|FG006|Overall Study|Withdrawal by Subject|0|||
145658709|NCT04625465|525269281|FG007|Overall Study|Withdrawal by Subject|0|||
145658710|NCT02966873|525269283|FG000|Overall Study|Lost to Follow-up|16|||
145658711|NCT02966873|525269284|FG001|Overall Study|Lost to Follow-up|15|||
145658712|NCT05436262|525269285|FG000|Pre-Randomization|Withdrawal by Subject|1|||
145658713|NCT05436262|525269286|FG001|Pre-Randomization|Withdrawal by Subject|0|||
145658714|NCT05436262|525269287|FG002|Pre-Randomization|Withdrawal by Subject|0|||
145658715|NCT05436262|525269285|FG000|Randomization|Withdrawal by Subject|0|||
145658716|NCT05436262|525269286|FG001|Randomization|Withdrawal by Subject|1|||
145658717|NCT05436262|525269287|FG002|Randomization|Withdrawal by Subject|0|||
145658718|NCT03710603|525269288|FG000|Overall Study|Adverse Event|1|||
145658719|NCT03710603|525269289|FG001|Overall Study|Adverse Event|0|||
145658720|NCT03710603|525269288|FG000|Overall Study|Death|44|||
145658721|NCT03710603|525269289|FG001|Overall Study|Death|34|||
145658722|NCT03710603|525269288|FG000|Overall Study|Lost to Follow-up|3|||
145658723|NCT03710603|525269289|FG001|Overall Study|Lost to Follow-up|5|||
145658724|NCT03710603|525269288|FG000|Overall Study|Withdrawal by Subject|11|||
145658725|NCT03710603|525269289|FG001|Overall Study|Withdrawal by Subject|10|||
145658726|NCT01456949|525269290|FG000|Enrollment|PI death- incomplete data|6|||
145658727|NCT01456949|525269290|FG000|Enrollment|Death|1|||
145658728|NCT01456949|525269290|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
145658729|NCT01456949|525269290|FG000|Enrollment|Physician Decision|10|||
145658730|NCT01456949|525269290|FG000|Enrollment|Withdrawal by Subject|7|||
145658731|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
145658732|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
145658733|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
145658734|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
145658735|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
145658736|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
145658737|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
145658738|NCT01456949|525269290|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
145658739|NCT04068181|525269292|FG000|Overall Study|Death|17|||
145658740|NCT04068181|525269293|FG001|Overall Study|Death|12|||
145658741|NCT04068181|525269294|FG002|Overall Study|Death|4|||
145658742|NCT04068181|525269295|FG003|Overall Study|Death|7|||
145658743|NCT04068181|525269292|FG000|Overall Study|Lost to Follow-up|1|||
145658744|NCT04068181|525269293|FG001|Overall Study|Lost to Follow-up|0|||
145658745|NCT04068181|525269294|FG002|Overall Study|Lost to Follow-up|0|||
145658746|NCT04068181|525269295|FG003|Overall Study|Lost to Follow-up|0|||
145658747|NCT04068181|525269292|FG000|Overall Study|Withdrawal of consent from study|3|||
145658748|NCT04068181|525269293|FG001|Overall Study|Withdrawal of consent from study|0|||
145658749|NCT04068181|525269294|FG002|Overall Study|Withdrawal of consent from study|0|||
145658750|NCT04068181|525269295|FG003|Overall Study|Withdrawal of consent from study|0|||
145658751|NCT02723591|525269298|FG000|Overall Study|Adverse Event|48|||
145658752|NCT02723591|525269299|FG001|Overall Study|Adverse Event|40|||
145658753|NCT02723591|525269298|FG000|Overall Study|Death|2|||
145658754|NCT02723591|525269299|FG001|Overall Study|Death|2|||
145658755|NCT02723591|525269298|FG000|Overall Study|Lack of Efficacy|4|||
145658756|NCT02723591|525269299|FG001|Overall Study|Lack of Efficacy|3|||
145658757|NCT02723591|525269298|FG000|Overall Study|Lost to Follow-up|1|||
145658758|NCT02723591|525269299|FG001|Overall Study|Lost to Follow-up|7|||
145658759|NCT02723591|525269298|FG000|Overall Study|Protocol Violation|20|||
145658760|NCT02723591|525269299|FG001|Overall Study|Protocol Violation|23|||
145658761|NCT02723591|525269298|FG000|Overall Study|Withdrawal by Subject|4|||
145658762|NCT02723591|525269299|FG001|Overall Study|Withdrawal by Subject|8|||
145658763|NCT02723591|525269298|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
145658764|NCT02723591|525269299|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
145658765|NCT02723591|525269298|FG000|Overall Study|Miscellaneous|5|||
145658766|NCT02723591|525269299|FG001|Overall Study|Miscellaneous|6|||
145658767|NCT05070728|525269300|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
145658768|NCT05070728|525269301|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
145658769|NCT03599661|525269302|FG000|Overall Study|Lost to Follow-up|9|||
145658770|NCT03691935|525269303|FG000|Overall Study|Physician Decision|2|||
145658771|NCT03691935|525269304|FG001|Overall Study|Physician Decision|1|||
145658772|NCT03691935|525269303|FG000|Overall Study|Adverse Event|3|||
145658773|NCT03691935|525269304|FG001|Overall Study|Adverse Event|0|||
145658774|NCT01275677|525269311|FG000|Overall Study|Not at risk for recurrence.|1|||
145658775|NCT01275677|525269312|FG001|Overall Study|Not at risk for recurrence.|1|||
145658776|NCT01275677|525269311|FG000|Overall Study|No follow-up|26|||
145658777|NCT01275677|525269312|FG001|Overall Study|No follow-up|37|||
145658778|NCT01275677|525269311|FG000|Overall Study|No clinical follow up.|1|||
145658779|NCT01275677|525269312|FG001|Overall Study|No clinical follow up.|4|||
145658780|NCT03478956|525269316|FG000|Randomized Treatment Period|Adverse Event|1|||
145658781|NCT03478956|525269317|FG001|Randomized Treatment Period|Adverse Event|0|||
145658782|NCT03478956|525269318|FG002|Randomized Treatment Period|Adverse Event|0|||
145658783|NCT03478956|525269319|FG003|Randomized Treatment Period|Adverse Event|0|||
145658784|NCT03478956|525269316|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
145658785|NCT03478956|525269317|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
145658786|NCT03478956|525269318|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
145658787|NCT03478956|525269319|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
145658788|NCT03478956|525269316|FG000|Open Label Extension Period|Adverse Event|0|||
145658789|NCT03478956|525269317|FG001|Open Label Extension Period|Adverse Event|0|||
145658790|NCT03478956|525269318|FG002|Open Label Extension Period|Adverse Event|4|||
145658791|NCT03478956|525269319|FG003|Open Label Extension Period|Adverse Event|0|||
145658792|NCT03478956|525269316|FG000|Open Label Extension Period|Lack of Efficacy|0|||
145658793|NCT03478956|525269317|FG001|Open Label Extension Period|Lack of Efficacy|0|||
145658794|NCT03478956|525269318|FG002|Open Label Extension Period|Lack of Efficacy|8|||
145658795|NCT03478956|525269319|FG003|Open Label Extension Period|Lack of Efficacy|0|||
145658796|NCT03478956|525269316|FG000|Open Label Extension Period|Reason Not Provided|0|||
145658797|NCT03478956|525269317|FG001|Open Label Extension Period|Reason Not Provided|0|||
145658798|NCT03478956|525269318|FG002|Open Label Extension Period|Reason Not Provided|1|||
145658799|NCT03478956|525269319|FG003|Open Label Extension Period|Reason Not Provided|0|||
145658800|NCT03478956|525269316|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
145658801|NCT03478956|525269317|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
145658802|NCT03478956|525269318|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
145658803|NCT03478956|525269319|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
145658804|NCT03478956|525269316|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
145658805|NCT03478956|525269317|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
145658806|NCT03478956|525269318|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
145658807|NCT03478956|525269319|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
145658808|NCT03478956|525269316|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
145658809|NCT03478956|525269317|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
145658810|NCT03478956|525269318|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
145658811|NCT03478956|525269319|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
145658812|NCT04865289|525269320|FG000|Overall Study|Participant ongoing in study|47|||
145658813|NCT04865289|525269321|FG001|Overall Study|Participant ongoing in study|35|||
145658814|NCT04865289|525269320|FG000|Overall Study|Death|27|||
145658815|NCT04865289|525269321|FG001|Overall Study|Death|21|||
145658816|NCT04171141|525271200|FG000|Overall Study|Adverse Event|0|||
145658817|NCT04171141|525271201|FG001|Overall Study|Adverse Event|0|||
145658818|NCT04171141|525271202|FG002|Overall Study|Adverse Event|2|||
145658819|NCT04171141|525271203|FG003|Overall Study|Adverse Event|0|||
145658820|NCT04171141|525271204|FG004|Overall Study|Adverse Event|0|||
145658821|NCT04171141|525271205|FG005|Overall Study|Adverse Event|0|||
145658822|NCT04171141|525271206|FG006|Overall Study|Adverse Event|0|||
145658823|NCT04171141|525271207|FG007|Overall Study|Adverse Event|0|||
145658824|NCT04171141|525271208|FG008|Overall Study|Adverse Event|0|||
145658825|NCT04171141|525271209|FG009|Overall Study|Adverse Event|0|||
145658826|NCT04171141|525271210|FG010|Overall Study|Adverse Event|0|||
145658827|NCT04171141|525271211|FG011|Overall Study|Adverse Event|0|||
145658828|NCT04171141|525271212|FG012|Overall Study|Adverse Event|0|||
145658829|NCT04171141|525271213|FG013|Overall Study|Adverse Event|2|||
145658830|NCT04171141|525271214|FG014|Overall Study|Adverse Event|0|||
145658831|NCT04171141|525271215|FG015|Overall Study|Adverse Event|0|||
145658832|NCT04171141|525271200|FG000|Overall Study|Physician Decision|0|||
145658833|NCT04171141|525271201|FG001|Overall Study|Physician Decision|0|||
145658834|NCT04171141|525271202|FG002|Overall Study|Physician Decision|0|||
145658835|NCT04171141|525271203|FG003|Overall Study|Physician Decision|0|||
145658836|NCT04171141|525271204|FG004|Overall Study|Physician Decision|1|||
145658837|NCT04171141|525271205|FG005|Overall Study|Physician Decision|0|||
145658838|NCT04171141|525271206|FG006|Overall Study|Physician Decision|0|||
145658839|NCT04171141|525271207|FG007|Overall Study|Physician Decision|0|||
145658840|NCT04171141|525271208|FG008|Overall Study|Physician Decision|0|||
145658841|NCT04171141|525271209|FG009|Overall Study|Physician Decision|0|||
145658842|NCT04171141|525271210|FG010|Overall Study|Physician Decision|0|||
145658843|NCT04171141|525271211|FG011|Overall Study|Physician Decision|0|||
145658844|NCT04171141|525271212|FG012|Overall Study|Physician Decision|0|||
145658845|NCT04171141|525271213|FG013|Overall Study|Physician Decision|0|||
145658846|NCT04171141|525271214|FG014|Overall Study|Physician Decision|0|||
145658847|NCT04171141|525271215|FG015|Overall Study|Physician Decision|1|||
145658848|NCT04171141|525271200|FG000|Overall Study|Progressive disease|2|||
145658849|NCT04171141|525271201|FG001|Overall Study|Progressive disease|3|||
145658850|NCT04171141|525271202|FG002|Overall Study|Progressive disease|4|||
145658851|NCT04171141|525271203|FG003|Overall Study|Progressive disease|7|||
145658852|NCT04171141|525271204|FG004|Overall Study|Progressive disease|1|||
145658853|NCT04171141|525271205|FG005|Overall Study|Progressive disease|8|||
145658854|NCT04171141|525271206|FG006|Overall Study|Progressive disease|4|||
145658855|NCT04171141|525271207|FG007|Overall Study|Progressive disease|6|||
145658856|NCT04171141|525271208|FG008|Overall Study|Progressive disease|7|||
145658857|NCT04171141|525271209|FG009|Overall Study|Progressive disease|3|||
145658858|NCT04171141|525271210|FG010|Overall Study|Progressive disease|4|||
145658859|NCT04171141|525271211|FG011|Overall Study|Progressive disease|3|||
145658860|NCT04171141|525271212|FG012|Overall Study|Progressive disease|4|||
145658861|NCT04171141|525271213|FG013|Overall Study|Progressive disease|2|||
145658862|NCT04171141|525271214|FG014|Overall Study|Progressive disease|4|||
145658863|NCT04171141|525271215|FG015|Overall Study|Progressive disease|1|||
145658864|NCT04171141|525271200|FG000|Overall Study|Withdrawal by Subject|0|||
145658865|NCT04171141|525271201|FG001|Overall Study|Withdrawal by Subject|0|||
145658866|NCT04171141|525271202|FG002|Overall Study|Withdrawal by Subject|0|||
145658867|NCT04171141|525271203|FG003|Overall Study|Withdrawal by Subject|1|||
145658868|NCT04171141|525271204|FG004|Overall Study|Withdrawal by Subject|0|||
145658869|NCT04171141|525271205|FG005|Overall Study|Withdrawal by Subject|0|||
145658870|NCT04171141|525271206|FG006|Overall Study|Withdrawal by Subject|1|||
145658871|NCT04171141|525271207|FG007|Overall Study|Withdrawal by Subject|0|||
145658872|NCT04171141|525271208|FG008|Overall Study|Withdrawal by Subject|0|||
145658873|NCT04171141|525271209|FG009|Overall Study|Withdrawal by Subject|1|||
145658874|NCT04171141|525271210|FG010|Overall Study|Withdrawal by Subject|0|||
145658875|NCT04171141|525271211|FG011|Overall Study|Withdrawal by Subject|0|||
145658876|NCT04171141|525271212|FG012|Overall Study|Withdrawal by Subject|0|||
145658877|NCT04171141|525271213|FG013|Overall Study|Withdrawal by Subject|0|||
145658878|NCT04171141|525271214|FG014|Overall Study|Withdrawal by Subject|0|||
145658879|NCT04171141|525271215|FG015|Overall Study|Withdrawal by Subject|0|||
145658880|NCT04171141|525271200|FG000|Overall Study|Global deterioration of health status|0|||
145658881|NCT04171141|525271201|FG001|Overall Study|Global deterioration of health status|0|||
145658882|NCT04171141|525271202|FG002|Overall Study|Global deterioration of health status|0|||
145658883|NCT04171141|525271203|FG003|Overall Study|Global deterioration of health status|1|||
145658884|NCT04171141|525271204|FG004|Overall Study|Global deterioration of health status|0|||
145658885|NCT04171141|525271205|FG005|Overall Study|Global deterioration of health status|2|||
145658886|NCT04171141|525271206|FG006|Overall Study|Global deterioration of health status|1|||
145658887|NCT04171141|525271207|FG007|Overall Study|Global deterioration of health status|0|||
145658888|NCT04171141|525271208|FG008|Overall Study|Global deterioration of health status|1|||
145658889|NCT04171141|525271209|FG009|Overall Study|Global deterioration of health status|0|||
145658890|NCT04171141|525271210|FG010|Overall Study|Global deterioration of health status|0|||
145658891|NCT04171141|525271211|FG011|Overall Study|Global deterioration of health status|0|||
145658892|NCT04171141|525271212|FG012|Overall Study|Global deterioration of health status|0|||
145658893|NCT04171141|525271213|FG013|Overall Study|Global deterioration of health status|0|||
145658894|NCT04171141|525271214|FG014|Overall Study|Global deterioration of health status|1|||
145658895|NCT04171141|525271215|FG015|Overall Study|Global deterioration of health status|1|||
145658896|NCT04858451|525271218|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
145658897|NCT04858451|525271219|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658898|NCT04858451|525271220|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658899|NCT04858451|525271221|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658900|NCT04858451|525271222|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658901|NCT04858451|525271223|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658902|NCT04858451|525271224|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658903|NCT04858451|525271225|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658904|NCT04858451|525271226|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
145658905|NCT04858451|525271218|FG000|Part 2|Discontinued|0|||
145658906|NCT04858451|525271219|FG001|Part 2|Discontinued|0|||
145658907|NCT04858451|525271220|FG002|Part 2|Discontinued|0|||
145658908|NCT04858451|525271221|FG003|Part 2|Discontinued|0|||
145658909|NCT04858451|525271222|FG004|Part 2|Discontinued|0|||
145658910|NCT04858451|525271223|FG005|Part 2|Discontinued|0|||
145658911|NCT04858451|525271224|FG006|Part 2|Discontinued|0|||
145658912|NCT04858451|525271225|FG007|Part 2|Discontinued|0|||
145658913|NCT04858451|525271226|FG008|Part 2|Discontinued|63|||
145658914|NCT04119843|525271227|FG000|Overall Study|Adverse Event|3|||
145658915|NCT04119843|525271227|FG000|Overall Study|Death|1|||
145658916|NCT04233216|525271229|FG000|Overall Study|Lost to Follow-up|1|||
145658917|NCT04233216|525271230|FG001|Overall Study|Lost to Follow-up|0|||
145658918|NCT04233216|525271231|FG002|Overall Study|Lost to Follow-up|2|||
145658919|NCT04233216|525271232|FG003|Overall Study|Lost to Follow-up|0|||
145658920|NCT04233216|525271229|FG000|Overall Study|Physician Decision|0|||
145658921|NCT04233216|525271230|FG001|Overall Study|Physician Decision|3|||
145658922|NCT04233216|525271231|FG002|Overall Study|Physician Decision|0|||
145658923|NCT04233216|525271232|FG003|Overall Study|Physician Decision|2|||
145658924|NCT04233216|525271229|FG000|Overall Study|Withdrawal by Subject|0|||
145658925|NCT04233216|525271230|FG001|Overall Study|Withdrawal by Subject|2|||
145658926|NCT04233216|525271231|FG002|Overall Study|Withdrawal by Subject|1|||
145658927|NCT04233216|525271232|FG003|Overall Study|Withdrawal by Subject|0|||
145658928|NCT04231149|525271233|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
145658929|NCT04231149|525271234|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
145658930|NCT04231149|525271235|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
145658931|NCT04231149|525271236|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
145658932|NCT04231149|525271237|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
145658933|NCT03252847|525271238|FG000|Overall Study|Withdrawal by Subject|0|||
145658934|NCT03252847|525271239|FG001|Overall Study|Withdrawal by Subject|0|||
145658935|NCT03252847|525271240|FG002|Overall Study|Withdrawal by Subject|1|||
145658936|NCT03252847|525271241|FG003|Overall Study|Withdrawal by Subject|0|||
145658937|NCT03252847|525271242|FG004|Overall Study|Withdrawal by Subject|0|||
145658938|NCT03252847|525271243|FG005|Overall Study|Withdrawal by Subject|0|||
145490497|NCT02349633|524650308|FG000|Overall Study|Transition to compassionate use|0|||
145490498|NCT02349633|524650309|FG001|Overall Study|Transition to compassionate use|0|||
145490499|NCT02349633|524650310|FG002|Overall Study|Transition to compassionate use|0|||
145490500|NCT02349633|524650311|FG003|Overall Study|Transition to compassionate use|0|||
145490501|NCT02349633|524650312|FG004|Overall Study|Transition to compassionate use|1|||
145658939|NCT03252847|525271244|FG006|Overall Study|Withdrawal by Subject|0|||
145658940|NCT03252847|525271238|FG000|Overall Study|Other: Patient decision|0|||
145658941|NCT03252847|525271239|FG001|Overall Study|Other: Patient decision|0|||
145658942|NCT03252847|525271240|FG002|Overall Study|Other: Patient decision|0|||
145658943|NCT03252847|525271241|FG003|Overall Study|Other: Patient decision|0|||
145658944|NCT03252847|525271242|FG004|Overall Study|Other: Patient decision|1|||
145658945|NCT03252847|525271243|FG005|Overall Study|Other: Patient decision|0|||
145658946|NCT03252847|525271244|FG006|Overall Study|Other: Patient decision|0|||
145658947|NCT04979442|525271247|FG000|Overall Study|Death|43|||
145658948|NCT04979442|525271248|FG001|Overall Study|Death|30|||
145658949|NCT04979442|525271247|FG000|Overall Study|Withdrawal by Subject|8|||
145658950|NCT04979442|525271248|FG001|Overall Study|Withdrawal by Subject|13|||
145658951|NCT04979442|525271247|FG000|Overall Study|Physician Decision|1|||
145658952|NCT04979442|525271248|FG001|Overall Study|Physician Decision|1|||
145658953|NCT04979442|525271247|FG000|Overall Study|Lost to Follow-up|0|||
145658954|NCT04979442|525271248|FG001|Overall Study|Lost to Follow-up|2|||
145658955|NCT04979442|525271247|FG000|Overall Study|do not want to continue|0|||
145658956|NCT04979442|525271248|FG001|Overall Study|do not want to continue|1|||
145658957|NCT04298983|525271249|FG000|Overall Study|Adverse Event|4|||
145658958|NCT04298983|525271249|FG000|Overall Study|Lack of Efficacy|3|||
145658959|NCT04005794|525271250|FG000|Overall Study|Lost to Follow-up|0|||
145658960|NCT04005794|525271251|FG001|Overall Study|Lost to Follow-up|4|||
145658961|NCT04005794|525271252|FG002|Overall Study|Lost to Follow-up|0|||
145658962|NCT04042233|525271253|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
145658963|NCT04042233|525271254|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
145658964|NCT04042233|525271253|FG000|Overall Study|Protocol Violation|0|||
145658965|NCT04042233|525271254|FG001|Overall Study|Protocol Violation|2|||
145658966|NCT04907851|525271255|FG000|Overall Study|Consent withdrawn|1|||
145658967|NCT04907851|525271256|FG001|Overall Study|Consent withdrawn|2|||
145658968|NCT04907851|525271257|FG002|Overall Study|Consent withdrawn|0|||
145658969|NCT04907851|525271255|FG000|Overall Study|Death|5|||
145658970|NCT04907851|525271256|FG001|Overall Study|Death|15|||
145658971|NCT04907851|525271257|FG002|Overall Study|Death|10|||
145658972|NCT05297565|525271258|FG000|Overall Study|Other Reasons|0|||
145658973|NCT05297565|525271259|FG001|Overall Study|Other Reasons|1|||
145658974|NCT05297565|525271258|FG000|Overall Study|Physician Decision|0|||
145658975|NCT05297565|525271259|FG001|Overall Study|Physician Decision|1|||
145658976|NCT05297565|525271258|FG000|Overall Study|Disease recurrence|1|||
145658977|NCT05297565|525271259|FG001|Overall Study|Disease recurrence|0|||
145658978|NCT03819153|525271260|FG000|Overall Study|Withdrawal by Subject|20|||
145658979|NCT03819153|525271261|FG001|Overall Study|Withdrawal by Subject|28|||
145490502|NCT02349633|524650313|FG005|Overall Study|Transition to compassionate use|0|||
145490503|NCT02349633|524650314|FG006|Overall Study|Transition to compassionate use|0|||
145490504|NCT02349633|524650315|FG007|Overall Study|Transition to compassionate use|3|||
145658980|NCT03819153|525271260|FG000|Overall Study|Lost to Follow-up|23|||
145658981|NCT03819153|525271261|FG001|Overall Study|Lost to Follow-up|30|||
145658982|NCT03974178|525271267|FG000|Overall Study|Death|0|||
145658983|NCT03974178|525271268|FG001|Overall Study|Death|1|||
145658984|NCT03899259|525271270|FG000|Overall Study|Adverse Event|5|||
145658985|NCT03899259|525271271|FG001|Overall Study|Adverse Event|4|||
145658986|NCT03899259|525271272|FG002|Overall Study|Adverse Event|6|||
145658987|NCT03899259|525271270|FG000|Overall Study|Lack of Efficacy|5|||
145658988|NCT03899259|525271271|FG001|Overall Study|Lack of Efficacy|0|||
145658989|NCT03899259|525271272|FG002|Overall Study|Lack of Efficacy|2|||
145658990|NCT03899259|525271270|FG000|Overall Study|Pregnancy|3|||
145658991|NCT03899259|525271271|FG001|Overall Study|Pregnancy|0|||
145658992|NCT03899259|525271272|FG002|Overall Study|Pregnancy|1|||
145658993|NCT03899259|525271270|FG000|Overall Study|Physician Decision|0|||
145658994|NCT03899259|525271271|FG001|Overall Study|Physician Decision|1|||
145658995|NCT03899259|525271272|FG002|Overall Study|Physician Decision|0|||
145658996|NCT03899259|525271270|FG000|Overall Study|Protocol Deviation|1|||
145658997|NCT03899259|525271271|FG001|Overall Study|Protocol Deviation|1|||
145658998|NCT03899259|525271272|FG002|Overall Study|Protocol Deviation|1|||
145658999|NCT03899259|525271270|FG000|Overall Study|Withdrawal by Subject|8|||
145659000|NCT03899259|525271271|FG001|Overall Study|Withdrawal by Subject|10|||
145659001|NCT03899259|525271272|FG002|Overall Study|Withdrawal by Subject|12|||
145659002|NCT03899259|525271270|FG000|Overall Study|Lost to Follow-up|5|||
145659003|NCT03899259|525271271|FG001|Overall Study|Lost to Follow-up|6|||
145659004|NCT03899259|525271272|FG002|Overall Study|Lost to Follow-up|2|||
145659005|NCT03899259|525271270|FG000|Overall Study|Lack of Adherence|1|||
145659006|NCT03899259|525271271|FG001|Overall Study|Lack of Adherence|0|||
145659007|NCT03899259|525271272|FG002|Overall Study|Lack of Adherence|0|||
145659008|NCT03899259|525271270|FG000|Overall Study|Screen Failure|1|||
145659009|NCT03899259|525271271|FG001|Overall Study|Screen Failure|0|||
145659010|NCT03899259|525271272|FG002|Overall Study|Screen Failure|0|||
145659011|NCT03899259|525271270|FG000|Overall Study|Ongoing Study Participation|127|||
145659012|NCT03899259|525271271|FG001|Overall Study|Ongoing Study Participation|134|||
145659013|NCT03899259|525271272|FG002|Overall Study|Ongoing Study Participation|210|||
145659014|NCT05139810|525271273|FG000|Overall Study|Voluntary Withdrawal|2|||
145659015|NCT05139810|525271274|FG001|Overall Study|Voluntary Withdrawal|1|||
145659016|NCT05139810|525271275|FG002|Overall Study|Voluntary Withdrawal|0|||
145659017|NCT05139810|525271273|FG000|Overall Study|Pregnancy|1|||
145659018|NCT05139810|525271274|FG001|Overall Study|Pregnancy|0|||
145659019|NCT05139810|525271275|FG002|Overall Study|Pregnancy|0|||
145659020|NCT05139810|525271273|FG000|Overall Study|Roll Over to CS7|19|||
145659021|NCT05139810|525271274|FG001|Overall Study|Roll Over to CS7|44|||
145659022|NCT05139810|525271275|FG002|Overall Study|Roll Over to CS7|20|||
145659023|NCT03240016|525271276|FG000|Overall Study|Adverse Event|9|||
145659024|NCT03240016|525271276|FG000|Overall Study|Withdrawal by Subject|7|||
145659025|NCT03240016|525271276|FG000|Overall Study|Death|1|||
145659026|NCT03240016|525271276|FG000|Overall Study|Physician Decision|2|||
145659027|NCT05200403|525271277|FG000|Overall Study|Withdrawal by Subject|4|||
145659028|NCT05200403|525271278|FG001|Overall Study|Withdrawal by Subject|2|||
145659029|NCT05200403|525271279|FG002|Overall Study|Withdrawal by Subject|6|||
145659030|NCT05299723|525271280|FG000|Overall Study|Withdrawal by Subject|0|||
145659031|NCT05299723|525271281|FG001|Overall Study|Withdrawal by Subject|2|||
145659032|NCT05299723|525271282|FG002|Overall Study|Withdrawal by Subject|0|||
145659033|NCT05546411|525271283|FG000|Overall Study|Progressive Disease|1|||
145659034|NCT05546411|525271284|FG001|Overall Study|Progressive Disease|0|||
145659035|NCT05546411|525271283|FG000|Overall Study|Adverse Event|0|||
145659036|NCT05546411|525271284|FG001|Overall Study|Adverse Event|1|||
145659037|NCT05546411|525271283|FG000|Overall Study|Metastatic disease|1|||
145659038|NCT05546411|525271284|FG001|Overall Study|Metastatic disease|0|||
145659039|NCT02606422|525271285|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
145659040|NCT02606422|525271286|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
145659041|NCT02606422|525271285|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
145659042|NCT02606422|525271286|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
145659043|NCT02606422|525271285|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
145659044|NCT02606422|525271286|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
145659045|NCT02606422|525271285|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
145659046|NCT02606422|525271286|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
145659047|NCT03235544|525271288|FG000|Overall Study|Death|11|||
145659048|NCT03235544|525271289|FG001|Overall Study|Death|31|||
145659049|NCT03235544|525271290|FG002|Overall Study|Death|19|||
145659050|NCT03235544|525271291|FG003|Overall Study|Death|34|||
145659051|NCT03235544|525271288|FG000|Overall Study|Lost to Follow-up|0|||
145659052|NCT03235544|525271289|FG001|Overall Study|Lost to Follow-up|1|||
145659053|NCT03235544|525271290|FG002|Overall Study|Lost to Follow-up|1|||
145659054|NCT03235544|525271291|FG003|Overall Study|Lost to Follow-up|1|||
145659055|NCT03235544|525271288|FG000|Overall Study|Withdrawal by Subject|0|||
145659056|NCT03235544|525271289|FG001|Overall Study|Withdrawal by Subject|3|||
145659057|NCT03235544|525271290|FG002|Overall Study|Withdrawal by Subject|1|||
145659058|NCT03235544|525271291|FG003|Overall Study|Withdrawal by Subject|5|||
145659059|NCT03235544|525271288|FG000|Overall Study|Disease Progression|0|||
145659060|NCT03235544|525271289|FG001|Overall Study|Disease Progression|1|||
145659061|NCT03235544|525271290|FG002|Overall Study|Disease Progression|0|||
145659062|NCT03235544|525271291|FG003|Overall Study|Disease Progression|2|||
145659063|NCT03235544|525271288|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
145659064|NCT03235544|525271289|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
145659065|NCT03235544|525271290|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
145659066|NCT03235544|525271291|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
145659067|NCT03235544|525271288|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
145659068|NCT03235544|525271289|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
145659069|NCT03235544|525271290|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
145659070|NCT03235544|525271291|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
145659071|NCT00950742|525271292|FG000|Overall Study|Other Adverse Event|1|||
145659072|NCT00950742|525271293|FG001|Overall Study|Other Adverse Event|0|||
145659073|NCT00950742|525271292|FG000|Overall Study|Withdrawal by Subject|3|||
145659074|NCT00950742|525271293|FG001|Overall Study|Withdrawal by Subject|0|||
145659075|NCT00950742|525271292|FG000|Overall Study|Progressive Disease|6|||
145659076|NCT00950742|525271293|FG001|Overall Study|Progressive Disease|2|||
145659077|NCT00950742|525271292|FG000|Overall Study|Dose limiting toxicity|6|||
145659078|NCT00950742|525271293|FG001|Overall Study|Dose limiting toxicity|0|||
145659079|NCT05002088|525271295|FG000|Overall Study|Withdrawal by Subject|9|||
145659080|NCT05002088|525271296|FG001|Overall Study|Withdrawal by Subject|0|||
145659081|NCT05002088|525271295|FG000|Overall Study|Lost to Follow-up|0|||
145659082|NCT05002088|525271296|FG001|Overall Study|Lost to Follow-up|1|||
145659083|NCT05002088|525271295|FG000|Overall Study|Death|16|||
145659084|NCT05002088|525271296|FG001|Overall Study|Death|2|||
145659085|NCT05002088|525271295|FG000|Overall Study|Protocol Violation|25|||
145659086|NCT05002088|525271296|FG001|Overall Study|Protocol Violation|7|||
145659087|NCT03511664|525271301|FG000|Overall Study|Death|457|||
145659088|NCT03511664|525271302|FG001|Overall Study|Death|201|||
145659089|NCT03511664|525271303|FG002|Overall Study|Death|21|||
145659090|NCT03511664|525271301|FG000|Overall Study|Withdrew consent|40|||
145659091|NCT03511664|525271302|FG001|Overall Study|Withdrew consent|63|||
145659092|NCT03511664|525271303|FG002|Overall Study|Withdrew consent|3|||
145659093|NCT03511664|525271301|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
145659094|NCT03511664|525271302|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
145659095|NCT03511664|525271303|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
145659096|NCT03511664|525271301|FG000|Overall Study|Lost to Follow-up|8|||
145659097|NCT03511664|525271302|FG001|Overall Study|Lost to Follow-up|5|||
145659098|NCT03511664|525271303|FG002|Overall Study|Lost to Follow-up|0|||
145659099|NCT03511664|525271301|FG000|Overall Study|Physician Decision|2|||
145659100|NCT03511664|525271302|FG001|Overall Study|Physician Decision|1|||
145659101|NCT03511664|525271303|FG002|Overall Study|Physician Decision|0|||
145659102|NCT03511664|525271301|FG000|Overall Study|Patient non-compliance|1|||
145659103|NCT03511664|525271302|FG001|Overall Study|Patient non-compliance|0|||
145659104|NCT03511664|525271303|FG002|Overall Study|Patient non-compliance|0|||
145659105|NCT05374798|525271322|FG000|Overall Study|Lost to Follow-up|2|||
145659106|NCT05374798|525271322|FG000|Overall Study|Withdrawal by Subject|2|||
145659107|NCT05374798|525271322|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
145659108|NCT04707625|525271323|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
145659109|NCT05764525|525271324|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
145659110|NCT05764525|525271325|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
145659111|NCT05764525|525271324|FG000|Overall Study|Withdrawal by Subject|4|||
145659112|NCT05764525|525271325|FG001|Overall Study|Withdrawal by Subject|8|||
145659113|NCT05764525|525271324|FG000|Overall Study|Physician Decision|1|||
145659114|NCT05764525|525271325|FG001|Overall Study|Physician Decision|0|||
145659115|NCT03334630|525271326|FG000|Overall Study|Withdrawal by Subject|7|||
145659116|NCT03334630|525271327|FG001|Overall Study|Withdrawal by Subject|7|||
145659117|NCT03334630|525271326|FG000|Overall Study|Lost to Follow-up|3|||
145659118|NCT03334630|525271327|FG001|Overall Study|Lost to Follow-up|1|||
145659119|NCT03334630|525271326|FG000|Overall Study|Adverse Event|0|||
145659120|NCT03334630|525271327|FG001|Overall Study|Adverse Event|1|||
145659121|NCT03334630|525271326|FG000|Overall Study|Physician Decision|1|||
145659122|NCT03334630|525271327|FG001|Overall Study|Physician Decision|1|||
145659123|NCT03334630|525271326|FG000|Overall Study|Enrollment closed|2|||
145659124|NCT03334630|525271327|FG001|Overall Study|Enrollment closed|1|||
145659125|NCT03334630|525271326|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
145659126|NCT03334630|525271327|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
145659127|NCT03334630|525271326|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
145659128|NCT03334630|525271327|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
145659129|NCT04079218|525271331|FG000|Overall Study|Death|1|||
145659130|NCT04079218|525271332|FG001|Overall Study|Death|0|||
145659131|NCT04079218|525271331|FG000|Overall Study|Withdrawal by Subject|3|||
145659132|NCT04079218|525271332|FG001|Overall Study|Withdrawal by Subject|0|||
145659133|NCT04079218|525271331|FG000|Overall Study|Physician Decision|4|||
145659134|NCT04079218|525271332|FG001|Overall Study|Physician Decision|0|||
145659135|NCT04079218|525271331|FG000|Overall Study|Lost to Follow-up|0|||
145659136|NCT04079218|525271332|FG001|Overall Study|Lost to Follow-up|1|||
145659137|NCT05907174|525271338|FG000|3-Month Assessment|Withdrawal by Subject|0|||
145659138|NCT05907174|525271339|FG001|3-Month Assessment|Withdrawal by Subject|0|||
145659139|NCT05907174|525271340|FG002|3-Month Assessment|Withdrawal by Subject|0|||
145659140|NCT05907174|525271341|FG003|3-Month Assessment|Withdrawal by Subject|1|||
145659141|NCT05907174|525271338|FG000|3-Month Assessment|Lost to Follow-up|1|||
145659142|NCT05907174|525271339|FG001|3-Month Assessment|Lost to Follow-up|1|||
145659143|NCT05907174|525271340|FG002|3-Month Assessment|Lost to Follow-up|1|||
145659144|NCT05907174|525271341|FG003|3-Month Assessment|Lost to Follow-up|1|||
145659145|NCT05907174|525271338|FG000|6-Month Assessment|Death|0|||
145659146|NCT05907174|525271339|FG001|6-Month Assessment|Death|0|||
145659147|NCT05907174|525271340|FG002|6-Month Assessment|Death|3|||
145659148|NCT05907174|525271341|FG003|6-Month Assessment|Death|0|||
145659149|NCT05907174|525271338|FG000|6-Month Assessment|Withdrawal by Subject|0|||
145659150|NCT05907174|525271339|FG001|6-Month Assessment|Withdrawal by Subject|0|||
145659151|NCT05907174|525271340|FG002|6-Month Assessment|Withdrawal by Subject|1|||
145659152|NCT05907174|525271341|FG003|6-Month Assessment|Withdrawal by Subject|1|||
145659153|NCT05907174|525271338|FG000|6-Month Assessment|Lost to Follow-up|0|||
145659154|NCT05907174|525271339|FG001|6-Month Assessment|Lost to Follow-up|1|||
145659155|NCT05907174|525271340|FG002|6-Month Assessment|Lost to Follow-up|1|||
145659156|NCT05907174|525271341|FG003|6-Month Assessment|Lost to Follow-up|1|||
145659157|NCT04498390|525271342|FG000|Overall Study|Adverse Event|0|||
145659158|NCT04498390|525271343|FG001|Overall Study|Adverse Event|0|||
145659159|NCT04498390|525271344|FG002|Overall Study|Adverse Event|1|||
145659160|NCT04498390|525271345|FG003|Overall Study|Adverse Event|0|||
145659161|NCT04498390|525271346|FG004|Overall Study|Adverse Event|0|||
145659162|NCT04498390|525271342|FG000|Overall Study|Withdrawal by Subject|0|||
145659163|NCT04498390|525271343|FG001|Overall Study|Withdrawal by Subject|0|||
145659164|NCT04498390|525271344|FG002|Overall Study|Withdrawal by Subject|0|||
145659165|NCT04498390|525271345|FG003|Overall Study|Withdrawal by Subject|1|||
145659166|NCT04498390|525271346|FG004|Overall Study|Withdrawal by Subject|0|||
145659167|NCT02052882|525271347|FG000|Overall Study|Not treated|11|||
145659168|NCT02052882|525271347|FG000|Overall Study|Protocol Violation|1|||
145659169|NCT02052882|525271347|FG000|Overall Study|Inadequate testing|1|||
145659170|NCT03734679|525271358|FG000|Overall Study|Missed Visit|1|||
145659171|NCT01346540|525271370|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
145659172|NCT01346540|525271371|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
145659173|NCT01346540|525271370|FG000|Overall Study|Adverse Event|0|||
145659174|NCT01346540|525271371|FG001|Overall Study|Adverse Event|4|||
145659175|NCT04690582|525271372|FG000|Overall Study|Withdrawal by Subject|6|||
145659176|NCT04690582|525271373|FG001|Overall Study|Withdrawal by Subject|4|||
145659177|NCT04577963|525271377|FG000|Part 2|Death|0|||
145659178|NCT04577963|525271378|FG001|Part 2|Death|1|||
145659179|NCT04577963|525271379|FG002|Part 2|Death|8|||
145659180|NCT04577963|525271380|FG003|Part 2|Death|0|||
145659181|NCT04577963|525271381|FG004|Part 2|Death|20|||
145659182|NCT04577963|525271377|FG000|Part 2|Lost to Follow-up|0|||
145659183|NCT04577963|525271378|FG001|Part 2|Lost to Follow-up|0|||
145659184|NCT04577963|525271379|FG002|Part 2|Lost to Follow-up|0|||
145659185|NCT04577963|525271380|FG003|Part 2|Lost to Follow-up|0|||
145659186|NCT04577963|525271381|FG004|Part 2|Lost to Follow-up|2|||
145659187|NCT04577963|525271377|FG000|Part 2|Withdrawal by Subject|0|||
145659188|NCT04577963|525271378|FG001|Part 2|Withdrawal by Subject|0|||
145659189|NCT04577963|525271379|FG002|Part 2|Withdrawal by Subject|0|||
145659190|NCT04577963|525271380|FG003|Part 2|Withdrawal by Subject|0|||
145659191|NCT04577963|525271381|FG004|Part 2|Withdrawal by Subject|10|||
145659192|NCT04577963|525271377|FG000|Part 2|Progressive disease|0|||
145659193|NCT04577963|525271378|FG001|Part 2|Progressive disease|0|||
145659194|NCT04577963|525271379|FG002|Part 2|Progressive disease|0|||
145659195|NCT04577963|525271380|FG003|Part 2|Progressive disease|0|||
145659196|NCT04577963|525271381|FG004|Part 2|Progressive disease|2|||
145659197|NCT04577963|525271377|FG000|Part 2|Investigator decision|0|||
145659198|NCT04577963|525271378|FG001|Part 2|Investigator decision|0|||
145659199|NCT04577963|525271379|FG002|Part 2|Investigator decision|0|||
145659200|NCT04577963|525271380|FG003|Part 2|Investigator decision|0|||
145659201|NCT04577963|525271381|FG004|Part 2|Investigator decision|1|||
145659202|NCT04577963|525271377|FG000|Part 2|Sponsor terminated study|0|||
145659203|NCT04577963|525271378|FG001|Part 2|Sponsor terminated study|0|||
145659204|NCT04577963|525271379|FG002|Part 2|Sponsor terminated study|3|||
145659205|NCT04577963|525271380|FG003|Part 2|Sponsor terminated study|1|||
145659206|NCT04577963|525271381|FG004|Part 2|Sponsor terminated study|4|||
145659207|NCT02709161|525271382|FG000|Overall Study|Withdrawal by Subject|1|||
145659208|NCT02709161|525271383|FG001|Overall Study|Withdrawal by Subject|0|||
145659209|NCT05209152|525271384|FG000|Overall Study|Sponsor decision|1|||
145659210|NCT05209152|525271385|FG001|Overall Study|Sponsor decision|2|||
145659211|NCT05209152|525271384|FG000|Overall Study|Death|3|||
145659212|NCT05209152|525271385|FG001|Overall Study|Death|1|||
145659213|NCT04857723|525271387|FG000|Overall Study|Withdrawal by Subject|2|||
145659214|NCT03663569|525273037|FG000|Overall Study|Discontinuation of study|11|||
145659215|NCT03663569|525273037|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
145659216|NCT03663569|525273037|FG000|Overall Study|Deceased patient|6|||
145659217|NCT03663569|525273037|FG000|Overall Study|Lost to Follow-up|18|||
145659218|NCT03663569|525273037|FG000|Overall Study|Withdrawal of consent|5|||
145659219|NCT03663569|525273037|FG000|Overall Study|Patient's request|11|||
145659220|NCT03663569|525273037|FG000|Overall Study|Adverse Event|4|||
145659221|NCT03663569|525273037|FG000|Overall Study|Not come to second visit|3|||
145659222|NCT03663569|525273037|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
145659223|NCT03663569|525273037|FG000|Overall Study|Serious adverse event|1|||
145659224|NCT05029622|525273040|FG000|Overall Study|Lost to Follow-up|1|||
145659225|NCT04850898|525273045|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
145659226|NCT04850898|525273046|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
145659227|NCT04770402|525273053|FG000|Overall Study|Lost to Follow-up|1|||
145659228|NCT04770402|525273054|FG001|Overall Study|Lost to Follow-up|2|||
145659229|NCT04770402|525273053|FG000|Overall Study|Non-compliance|1|||
145659230|NCT04770402|525273054|FG001|Overall Study|Non-compliance|0|||
145659231|NCT04770402|525273053|FG000|Overall Study|Withdrawal by Subject|0|||
145659232|NCT04770402|525273054|FG001|Overall Study|Withdrawal by Subject|1|||
145659233|NCT01946789|525273066|FG000|Overall Study|Death|0|||
145659234|NCT01946789|525273067|FG001|Overall Study|Death|2|||
145659235|NCT01946789|525273068|FG002|Overall Study|Death|1|||
145659236|NCT01946789|525273069|FG003|Overall Study|Death|1|||
145659237|NCT01946789|525273070|FG004|Overall Study|Death|1|||
145659238|NCT01946789|525273071|FG005|Overall Study|Death|1|||
145659239|NCT01946789|525273072|FG006|Overall Study|Death|3|||
145659240|NCT01946789|525273073|FG007|Overall Study|Death|1|||
145659241|NCT01946789|525273074|FG008|Overall Study|Death|2|||
145659242|NCT01946789|525273066|FG000|Overall Study|Progressive Disease|0|||
145490505|NCT02349633|524650316|FG008|Overall Study|Transition to compassionate use|0|||
145490506|NCT02349633|524650317|FG009|Overall Study|Transition to compassionate use|1|||
145659243|NCT01946789|525273067|FG001|Overall Study|Progressive Disease|0|||
145659244|NCT01946789|525273068|FG002|Overall Study|Progressive Disease|1|||
145659245|NCT01946789|525273069|FG003|Overall Study|Progressive Disease|0|||
145659246|NCT01946789|525273070|FG004|Overall Study|Progressive Disease|0|||
145659247|NCT01946789|525273071|FG005|Overall Study|Progressive Disease|2|||
145659248|NCT01946789|525273072|FG006|Overall Study|Progressive Disease|0|||
145659249|NCT01946789|525273073|FG007|Overall Study|Progressive Disease|0|||
145659250|NCT01946789|525273074|FG008|Overall Study|Progressive Disease|0|||
145659251|NCT01946789|525273066|FG000|Overall Study|Withdrawal by Subject|0|||
145659252|NCT01946789|525273067|FG001|Overall Study|Withdrawal by Subject|0|||
145659253|NCT01946789|525273068|FG002|Overall Study|Withdrawal by Subject|0|||
145659254|NCT01946789|525273069|FG003|Overall Study|Withdrawal by Subject|2|||
145659255|NCT01946789|525273070|FG004|Overall Study|Withdrawal by Subject|1|||
145659256|NCT01946789|525273071|FG005|Overall Study|Withdrawal by Subject|0|||
145659257|NCT01946789|525273072|FG006|Overall Study|Withdrawal by Subject|1|||
145659258|NCT01946789|525273073|FG007|Overall Study|Withdrawal by Subject|0|||
145659259|NCT01946789|525273074|FG008|Overall Study|Withdrawal by Subject|0|||
145659260|NCT04471246|525273075|FG000|Overall Study|Lost to Follow-up|2|||
145659261|NCT04471246|525273076|FG001|Overall Study|Lost to Follow-up|2|||
145659262|NCT03030261|525273078|FG000|Overall Study|Still receiving continuation therapy|5|||
145659263|NCT05093842|525273081|FG000|Overall Study|Pregnancy loss|1|||
145659264|NCT05093842|525273082|FG001|Overall Study|Pregnancy loss|1|||
145659265|NCT05093842|525273081|FG000|Overall Study|Lost to Follow-up|6|||
145659266|NCT05093842|525273082|FG001|Overall Study|Lost to Follow-up|0|||
145659267|NCT05093842|525273081|FG000|Overall Study|Physician Decision|0|||
145659268|NCT05093842|525273082|FG001|Overall Study|Physician Decision|1|||
145659269|NCT03910478|525273088|FG000|Overall Study|Death|13|||
145659270|NCT03910478|525273089|FG001|Overall Study|Death|6|||
145659271|NCT03910478|525273088|FG000|Overall Study|Withdrawal by Subject|23|||
145659272|NCT03910478|525273089|FG001|Overall Study|Withdrawal by Subject|2|||
145659273|NCT03910478|525273088|FG000|Overall Study|Physician Decision|5|||
145659274|NCT03910478|525273089|FG001|Overall Study|Physician Decision|0|||
145659275|NCT03910478|525273088|FG000|Overall Study|Protocol Violation|1|||
145659276|NCT03910478|525273089|FG001|Overall Study|Protocol Violation|0|||
145659277|NCT03910478|525273088|FG000|Overall Study|Failure to meet continuation criteria|2|||
145659278|NCT03910478|525273089|FG001|Overall Study|Failure to meet continuation criteria|0|||
145659279|NCT03910478|525273088|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
145659280|NCT03910478|525273089|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
145659281|NCT05293171|525273091|FG000|Washout 5 to 7 Days|Adverse Event|1|||
145659282|NCT05293171|525273092|FG001|Washout 5 to 7 Days|Adverse Event|1|||
145659283|NCT05293171|525273093|FG002|Washout 5 to 7 Days|Adverse Event|0|||
145659284|NCT05293171|525273094|FG003|Washout 5 to 7 Days|Adverse Event|0|||
145659285|NCT05293171|525273095|FG004|Washout 5 to 7 Days|Adverse Event|0|||
145659286|NCT05293171|525273096|FG005|Washout 5 to 7 Days|Adverse Event|0|||
145659287|NCT05293171|525273097|FG006|Washout 5 to 7 Days|Adverse Event|0|||
145659288|NCT05293171|525273098|FG007|Washout 5 to 7 Days|Adverse Event|0|||
145659289|NCT05293171|525273099|FG008|Washout 5 to 7 Days|Adverse Event|0|||
145659290|NCT05293171|525273100|FG009|Washout 5 to 7 Days|Adverse Event|0|||
145659291|NCT05293171|525273101|FG010|Washout 5 to 7 Days|Adverse Event|0|||
145659292|NCT05293171|525273102|FG011|Washout 5 to 7 Days|Adverse Event|0|||
145659293|NCT05293171|525273091|FG000|Washout 5 to 7 Days|Adverse Event|0|||
145659294|NCT05293171|525273092|FG001|Washout 5 to 7 Days|Adverse Event|0|||
145659295|NCT05293171|525273093|FG002|Washout 5 to 7 Days|Adverse Event|0|||
145659296|NCT05293171|525273094|FG003|Washout 5 to 7 Days|Adverse Event|0|||
145659297|NCT05293171|525273095|FG004|Washout 5 to 7 Days|Adverse Event|0|||
145659298|NCT05293171|525273096|FG005|Washout 5 to 7 Days|Adverse Event|1|||
145659299|NCT05293171|525273097|FG006|Washout 5 to 7 Days|Adverse Event|0|||
145659300|NCT05293171|525273098|FG007|Washout 5 to 7 Days|Adverse Event|0|||
145659301|NCT05293171|525273099|FG008|Washout 5 to 7 Days|Adverse Event|0|||
145659302|NCT05293171|525273100|FG009|Washout 5 to 7 Days|Adverse Event|0|||
145659303|NCT05293171|525273101|FG010|Washout 5 to 7 Days|Adverse Event|0|||
145659304|NCT05293171|525273102|FG011|Washout 5 to 7 Days|Adverse Event|0|||
145659305|NCT03987022|525273105|FG000|Overall Study|Lost to Follow-up|2|||
145659306|NCT03987022|525273106|FG001|Overall Study|Lost to Follow-up|2|||
145659307|NCT03987022|525273105|FG000|Overall Study|Withdrawal by Subject|1|||
145659308|NCT03987022|525273106|FG001|Overall Study|Withdrawal by Subject|0|||
145659309|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
145659310|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
145659311|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
145659312|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
145659313|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
145659314|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
145659315|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
145659316|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
145659317|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
145490507|NCT02349633|524650318|FG010|Overall Study|Transition to compassionate use|0|||
145490508|NCT02349633|524650319|FG011|Overall Study|Transition to compassionate use|0|||
145490509|NCT02349633|524650320|FG012|Overall Study|Transition to compassionate use|0|||
145659318|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
145659319|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
145659320|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
145659321|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
145659322|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
145659323|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
145659324|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
145659325|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
145659326|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
145659327|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
145659328|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
145659329|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
145659330|NCT04800211|525273109|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
145659331|NCT04800211|525273110|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
145659332|NCT04800211|525273111|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
145659333|NCT04800211|525273109|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
145659334|NCT04800211|525273110|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
145659335|NCT04800211|525273111|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
145659336|NCT04800211|525273109|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
145659337|NCT04800211|525273110|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
145659338|NCT04800211|525273111|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
145659339|NCT04800211|525273109|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
145659340|NCT04800211|525273110|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
145659341|NCT04800211|525273111|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
145659342|NCT05170841|525273112|FG000|Single Dose Phase|Adverse Event|1|||
145659343|NCT05170841|525273113|FG001|Single Dose Phase|Adverse Event|2|||
145659344|NCT05170841|525273114|FG002|Single Dose Phase|Adverse Event|0|||
145659345|NCT05170841|525273115|FG003|Single Dose Phase|Adverse Event|2|||
145659346|NCT05170841|525273112|FG000|Multiple Dose Phase|Adverse Event|1|||
145659347|NCT05170841|525273113|FG001|Multiple Dose Phase|Adverse Event|2|||
145659348|NCT05170841|525273114|FG002|Multiple Dose Phase|Adverse Event|1|||
145659349|NCT05170841|525273115|FG003|Multiple Dose Phase|Adverse Event|4|||
145659350|NCT05170841|525273112|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
145659351|NCT05170841|525273113|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
145659352|NCT05170841|525273114|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
145659353|NCT05170841|525273115|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
145659354|NCT05123586|525273118|FG000|Overall Study|Physician Decision|1|||
145659355|NCT05123586|525273119|FG001|Overall Study|Physician Decision|1|||
145659356|NCT05123586|525273118|FG000|Overall Study|Withdrawal by Subject|0|||
145659357|NCT05123586|525273119|FG001|Overall Study|Withdrawal by Subject|3|||
145659358|NCT02240238|525273127|FG000|Phase 1|Adverse Event|0|||
145659359|NCT02240238|525273128|FG001|Phase 1|Adverse Event|0|||
145659360|NCT02240238|525273129|FG002|Phase 1|Adverse Event|0|||
145659361|NCT02240238|525273130|FG003|Phase 1|Adverse Event|0|||
145659362|NCT02240238|525273131|FG004|Phase 1|Adverse Event|0|||
145659363|NCT02240238|525273132|FG005|Phase 1|Adverse Event|0|||
145659364|NCT02240238|525273133|FG006|Phase 1|Adverse Event|3|||
145659365|NCT02240238|525273134|FG007|Phase 1|Adverse Event|1|||
145659366|NCT02240238|525273135|FG008|Phase 1|Adverse Event|0|||
145659367|NCT02240238|525273136|FG009|Phase 1|Adverse Event|0|||
145659368|NCT02240238|525273137|FG010|Phase 1|Adverse Event|0|||
145659369|NCT02240238|525273138|FG011|Phase 1|Adverse Event|0|||
145659370|NCT02240238|525273127|FG000|Phase 1|Death|0|||
145659371|NCT02240238|525273128|FG001|Phase 1|Death|0|||
145659372|NCT02240238|525273129|FG002|Phase 1|Death|0|||
145659373|NCT02240238|525273130|FG003|Phase 1|Death|0|||
145659374|NCT02240238|525273131|FG004|Phase 1|Death|0|||
145659375|NCT02240238|525273132|FG005|Phase 1|Death|1|||
145659376|NCT02240238|525273133|FG006|Phase 1|Death|0|||
145659377|NCT02240238|525273134|FG007|Phase 1|Death|0|||
145659378|NCT02240238|525273135|FG008|Phase 1|Death|0|||
145659379|NCT02240238|525273136|FG009|Phase 1|Death|0|||
145659380|NCT02240238|525273137|FG010|Phase 1|Death|0|||
145659381|NCT02240238|525273138|FG011|Phase 1|Death|0|||
145659382|NCT02240238|525273127|FG000|Phase 1|Sponsor termination|0|||
145659383|NCT02240238|525273128|FG001|Phase 1|Sponsor termination|0|||
145659384|NCT02240238|525273129|FG002|Phase 1|Sponsor termination|0|||
145659385|NCT02240238|525273130|FG003|Phase 1|Sponsor termination|0|||
145659386|NCT02240238|525273131|FG004|Phase 1|Sponsor termination|0|||
145659387|NCT02240238|525273132|FG005|Phase 1|Sponsor termination|1|||
145659388|NCT02240238|525273133|FG006|Phase 1|Sponsor termination|0|||
145659389|NCT02240238|525273134|FG007|Phase 1|Sponsor termination|0|||
145659390|NCT02240238|525273135|FG008|Phase 1|Sponsor termination|0|||
145659391|NCT02240238|525273136|FG009|Phase 1|Sponsor termination|0|||
145659392|NCT02240238|525273137|FG010|Phase 1|Sponsor termination|0|||
145659393|NCT02240238|525273138|FG011|Phase 1|Sponsor termination|0|||
145659394|NCT02240238|525273127|FG000|Phase 1|Withdrawal by Subject|0|||
145659395|NCT02240238|525273128|FG001|Phase 1|Withdrawal by Subject|0|||
145659396|NCT02240238|525273129|FG002|Phase 1|Withdrawal by Subject|0|||
145265341|NCT01300741|523819298|FG000|Overall Study|Lost to Follow-up|1|||
145659397|NCT02240238|525273130|FG003|Phase 1|Withdrawal by Subject|0|||
145659398|NCT02240238|525273131|FG004|Phase 1|Withdrawal by Subject|0|||
145659399|NCT02240238|525273132|FG005|Phase 1|Withdrawal by Subject|2|||
145659400|NCT02240238|525273133|FG006|Phase 1|Withdrawal by Subject|0|||
145659401|NCT02240238|525273134|FG007|Phase 1|Withdrawal by Subject|0|||
145659402|NCT02240238|525273135|FG008|Phase 1|Withdrawal by Subject|0|||
145659403|NCT02240238|525273136|FG009|Phase 1|Withdrawal by Subject|0|||
145659404|NCT02240238|525273137|FG010|Phase 1|Withdrawal by Subject|0|||
145659405|NCT02240238|525273138|FG011|Phase 1|Withdrawal by Subject|0|||
145659406|NCT02240238|525273127|FG000|Phase 1|Physician Decision|0|||
145659407|NCT02240238|525273128|FG001|Phase 1|Physician Decision|0|||
145659408|NCT02240238|525273129|FG002|Phase 1|Physician Decision|0|||
145659409|NCT02240238|525273130|FG003|Phase 1|Physician Decision|0|||
145659410|NCT02240238|525273131|FG004|Phase 1|Physician Decision|0|||
145659411|NCT02240238|525273132|FG005|Phase 1|Physician Decision|2|||
145659412|NCT02240238|525273133|FG006|Phase 1|Physician Decision|0|||
145659413|NCT02240238|525273134|FG007|Phase 1|Physician Decision|0|||
145659414|NCT02240238|525273135|FG008|Phase 1|Physician Decision|0|||
145659415|NCT02240238|525273136|FG009|Phase 1|Physician Decision|0|||
145659416|NCT02240238|525273137|FG010|Phase 1|Physician Decision|0|||
145659417|NCT02240238|525273138|FG011|Phase 1|Physician Decision|0|||
145659418|NCT02240238|525273127|FG000|Phase 2|Adverse Event|0|||
145659419|NCT02240238|525273128|FG001|Phase 2|Adverse Event|0|||
145659420|NCT02240238|525273129|FG002|Phase 2|Adverse Event|0|||
145659421|NCT02240238|525273130|FG003|Phase 2|Adverse Event|0|||
145659422|NCT02240238|525273131|FG004|Phase 2|Adverse Event|0|||
145659423|NCT02240238|525273132|FG005|Phase 2|Adverse Event|0|||
145659424|NCT02240238|525273133|FG006|Phase 2|Adverse Event|0|||
145659425|NCT02240238|525273134|FG007|Phase 2|Adverse Event|0|||
145659426|NCT02240238|525273135|FG008|Phase 2|Adverse Event|0|||
145659427|NCT02240238|525273136|FG009|Phase 2|Adverse Event|7|||
145659428|NCT02240238|525273137|FG010|Phase 2|Adverse Event|14|||
145659429|NCT02240238|525273138|FG011|Phase 2|Adverse Event|2|||
145659430|NCT02240238|525273127|FG000|Phase 2|Death|0|||
145659431|NCT02240238|525273128|FG001|Phase 2|Death|0|||
145659432|NCT02240238|525273129|FG002|Phase 2|Death|0|||
145659433|NCT02240238|525273130|FG003|Phase 2|Death|0|||
145659434|NCT02240238|525273131|FG004|Phase 2|Death|0|||
145659435|NCT02240238|525273132|FG005|Phase 2|Death|0|||
145659436|NCT02240238|525273133|FG006|Phase 2|Death|0|||
145659437|NCT02240238|525273134|FG007|Phase 2|Death|0|||
145659438|NCT02240238|525273135|FG008|Phase 2|Death|0|||
145659439|NCT02240238|525273136|FG009|Phase 2|Death|3|||
145659440|NCT02240238|525273137|FG010|Phase 2|Death|2|||
145659441|NCT02240238|525273138|FG011|Phase 2|Death|1|||
145659442|NCT02240238|525273127|FG000|Phase 2|Disease progression|0|||
145659443|NCT02240238|525273128|FG001|Phase 2|Disease progression|0|||
145659444|NCT02240238|525273129|FG002|Phase 2|Disease progression|0|||
145659445|NCT02240238|525273130|FG003|Phase 2|Disease progression|0|||
145659446|NCT02240238|525273131|FG004|Phase 2|Disease progression|0|||
145659447|NCT02240238|525273132|FG005|Phase 2|Disease progression|0|||
145659448|NCT02240238|525273133|FG006|Phase 2|Disease progression|0|||
145659449|NCT02240238|525273134|FG007|Phase 2|Disease progression|0|||
145659450|NCT02240238|525273135|FG008|Phase 2|Disease progression|0|||
145659451|NCT02240238|525273136|FG009|Phase 2|Disease progression|5|||
145659452|NCT02240238|525273137|FG010|Phase 2|Disease progression|11|||
145659453|NCT02240238|525273138|FG011|Phase 2|Disease progression|1|||
145659454|NCT02240238|525273127|FG000|Phase 2|Withdrawal by Subject|0|||
145659455|NCT02240238|525273128|FG001|Phase 2|Withdrawal by Subject|0|||
145659456|NCT02240238|525273129|FG002|Phase 2|Withdrawal by Subject|0|||
145659457|NCT02240238|525273130|FG003|Phase 2|Withdrawal by Subject|0|||
145659458|NCT02240238|525273131|FG004|Phase 2|Withdrawal by Subject|0|||
145659459|NCT02240238|525273132|FG005|Phase 2|Withdrawal by Subject|0|||
145659460|NCT02240238|525273133|FG006|Phase 2|Withdrawal by Subject|0|||
145659461|NCT02240238|525273134|FG007|Phase 2|Withdrawal by Subject|0|||
145659462|NCT02240238|525273135|FG008|Phase 2|Withdrawal by Subject|0|||
145659463|NCT02240238|525273136|FG009|Phase 2|Withdrawal by Subject|1|||
145659464|NCT02240238|525273137|FG010|Phase 2|Withdrawal by Subject|1|||
145659465|NCT02240238|525273138|FG011|Phase 2|Withdrawal by Subject|0|||
145659466|NCT02240238|525273127|FG000|Phase 2|Physician Decision|0|||
145659467|NCT02240238|525273128|FG001|Phase 2|Physician Decision|0|||
145659468|NCT02240238|525273129|FG002|Phase 2|Physician Decision|0|||
145659469|NCT02240238|525273130|FG003|Phase 2|Physician Decision|0|||
145659470|NCT02240238|525273131|FG004|Phase 2|Physician Decision|0|||
145659471|NCT02240238|525273132|FG005|Phase 2|Physician Decision|0|||
145659472|NCT02240238|525273133|FG006|Phase 2|Physician Decision|0|||
145659473|NCT02240238|525273134|FG007|Phase 2|Physician Decision|0|||
145659474|NCT02240238|525273135|FG008|Phase 2|Physician Decision|0|||
145659475|NCT02240238|525273136|FG009|Phase 2|Physician Decision|1|||
145659476|NCT02240238|525273137|FG010|Phase 2|Physician Decision|3|||
145659477|NCT02240238|525273138|FG011|Phase 2|Physician Decision|0|||
145659478|NCT02240238|525273127|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659479|NCT02240238|525273128|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659480|NCT02240238|525273129|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659481|NCT02240238|525273130|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659482|NCT02240238|525273131|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659483|NCT02240238|525273132|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659484|NCT02240238|525273133|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659485|NCT02240238|525273134|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659486|NCT02240238|525273135|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659487|NCT02240238|525273136|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
145659488|NCT02240238|525273137|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659489|NCT02240238|525273138|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
145659490|NCT02240238|525273127|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659491|NCT02240238|525273128|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659492|NCT02240238|525273129|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659493|NCT02240238|525273130|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659494|NCT02240238|525273131|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659495|NCT02240238|525273132|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659496|NCT02240238|525273133|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659497|NCT02240238|525273134|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659498|NCT02240238|525273135|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659499|NCT02240238|525273136|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
145659500|NCT02240238|525273137|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659501|NCT02240238|525273138|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
145659502|NCT02240238|525273127|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659503|NCT02240238|525273128|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659504|NCT02240238|525273129|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659505|NCT02240238|525273130|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659506|NCT02240238|525273131|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659507|NCT02240238|525273132|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659508|NCT02240238|525273133|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659509|NCT02240238|525273134|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659510|NCT02240238|525273135|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659511|NCT02240238|525273136|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659512|NCT02240238|525273137|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
145659513|NCT02240238|525273138|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
145659514|NCT02240238|525273127|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659515|NCT02240238|525273128|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659516|NCT02240238|525273129|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659517|NCT02240238|525273130|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659518|NCT02240238|525273131|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659519|NCT02240238|525273132|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659520|NCT02240238|525273133|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659521|NCT02240238|525273134|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659522|NCT02240238|525273135|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659523|NCT02240238|525273136|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145659524|NCT02240238|525273137|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
145659525|NCT02240238|525273138|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
145490510|NCT02349633|524650321|FG013|Overall Study|Transition to compassionate use|0|||
145490511|NCT02349633|524650308|FG000|Overall Study|Early termination of survival follow-up|0|||
145490512|NCT02349633|524650309|FG001|Overall Study|Early termination of survival follow-up|0|||
145490513|NCT02349633|524650310|FG002|Overall Study|Early termination of survival follow-up|0|||
145659526|NCT02240238|525273127|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659527|NCT02240238|525273128|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659528|NCT02240238|525273129|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659529|NCT02240238|525273130|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659530|NCT02240238|525273131|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659531|NCT02240238|525273132|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659532|NCT02240238|525273133|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659533|NCT02240238|525273134|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659534|NCT02240238|525273135|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659535|NCT02240238|525273136|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145659536|NCT02240238|525273137|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
145659537|NCT02240238|525273138|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
145490514|NCT02349633|524650311|FG003|Overall Study|Early termination of survival follow-up|0|||
145490515|NCT02349633|524650312|FG004|Overall Study|Early termination of survival follow-up|0|||
145490516|NCT02349633|524650313|FG005|Overall Study|Early termination of survival follow-up|0|||
145490517|NCT02349633|524650314|FG006|Overall Study|Early termination of survival follow-up|0|||
145490518|NCT02349633|524650315|FG007|Overall Study|Early termination of survival follow-up|4|||
145490519|NCT02349633|524650316|FG008|Overall Study|Early termination of survival follow-up|0|||
145659538|NCT02240238|525273127|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659539|NCT02240238|525273128|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659540|NCT02240238|525273129|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659541|NCT02240238|525273130|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659542|NCT02240238|525273131|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659543|NCT02240238|525273132|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659544|NCT02240238|525273133|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659545|NCT02240238|525273134|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659546|NCT02240238|525273135|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659547|NCT02240238|525273136|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659548|NCT02240238|525273137|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
145659549|NCT02240238|525273138|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
145659550|NCT02240238|525273127|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659551|NCT02240238|525273128|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659552|NCT02240238|525273129|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659553|NCT02240238|525273130|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659554|NCT02240238|525273131|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659555|NCT02240238|525273132|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659556|NCT02240238|525273133|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145490520|NCT02349633|524650317|FG009|Overall Study|Early termination of survival follow-up|0|||
145659557|NCT02240238|525273134|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659558|NCT02240238|525273135|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659559|NCT02240238|525273136|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659560|NCT02240238|525273137|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
145659561|NCT02240238|525273138|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
145659562|NCT02240238|525273127|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659563|NCT02240238|525273128|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659564|NCT02240238|525273129|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659565|NCT02240238|525273130|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659566|NCT02240238|525273131|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659567|NCT02240238|525273132|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659568|NCT02240238|525273133|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659569|NCT02240238|525273134|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659570|NCT02240238|525273135|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659571|NCT02240238|525273136|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659572|NCT02240238|525273137|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
145659573|NCT02240238|525273138|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
145659574|NCT03088878|525273148|FG000|Overall Study|Adverse Event|0|||
145659575|NCT03088878|525273149|FG001|Overall Study|Adverse Event|0|||
145659576|NCT03088878|525273150|FG002|Overall Study|Adverse Event|0|||
145659577|NCT03088878|525273151|FG003|Overall Study|Adverse Event|0|||
145659578|NCT03088878|525273152|FG004|Overall Study|Adverse Event|4|||
145659579|NCT03088878|525273153|FG005|Overall Study|Adverse Event|2|||
145659580|NCT03088878|525273154|FG006|Overall Study|Adverse Event|1|||
145659581|NCT03088878|525273155|FG007|Overall Study|Adverse Event|0|||
145659582|NCT03088878|525273156|FG008|Overall Study|Adverse Event|0|||
145659583|NCT03088878|525273157|FG009|Overall Study|Adverse Event|0|||
145659584|NCT03088878|525273158|FG010|Overall Study|Adverse Event|0|||
145659585|NCT03088878|525273159|FG011|Overall Study|Adverse Event|0|||
145659586|NCT03088878|525273160|FG012|Overall Study|Adverse Event|5|||
145659587|NCT03088878|525273161|FG013|Overall Study|Adverse Event|3|||
145659588|NCT03088878|525273148|FG000|Overall Study|Clinical Progression|0|||
145659589|NCT03088878|525273149|FG001|Overall Study|Clinical Progression|0|||
145659590|NCT03088878|525273150|FG002|Overall Study|Clinical Progression|0|||
145659591|NCT03088878|525273151|FG003|Overall Study|Clinical Progression|0|||
145659592|NCT03088878|525273152|FG004|Overall Study|Clinical Progression|2|||
145659593|NCT03088878|525273153|FG005|Overall Study|Clinical Progression|0|||
145659594|NCT03088878|525273154|FG006|Overall Study|Clinical Progression|0|||
145659595|NCT03088878|525273155|FG007|Overall Study|Clinical Progression|0|||
145659596|NCT03088878|525273156|FG008|Overall Study|Clinical Progression|0|||
145490521|NCT02349633|524650318|FG010|Overall Study|Early termination of survival follow-up|0|||
145490522|NCT02349633|524650319|FG011|Overall Study|Early termination of survival follow-up|0|||
145490523|NCT02349633|524650320|FG012|Overall Study|Early termination of survival follow-up|0|||
145659597|NCT03088878|525273157|FG009|Overall Study|Clinical Progression|0|||
145659598|NCT03088878|525273158|FG010|Overall Study|Clinical Progression|0|||
145659599|NCT03088878|525273159|FG011|Overall Study|Clinical Progression|0|||
145659600|NCT03088878|525273160|FG012|Overall Study|Clinical Progression|0|||
145659601|NCT03088878|525273161|FG013|Overall Study|Clinical Progression|0|||
145659602|NCT03088878|525273148|FG000|Overall Study|Death|0|||
145659603|NCT03088878|525273149|FG001|Overall Study|Death|0|||
145659604|NCT03088878|525273150|FG002|Overall Study|Death|0|||
145659605|NCT03088878|525273151|FG003|Overall Study|Death|0|||
145659606|NCT03088878|525273152|FG004|Overall Study|Death|2|||
145659607|NCT03088878|525273153|FG005|Overall Study|Death|0|||
145659608|NCT03088878|525273154|FG006|Overall Study|Death|0|||
145659609|NCT03088878|525273155|FG007|Overall Study|Death|0|||
145659610|NCT03088878|525273156|FG008|Overall Study|Death|0|||
145659611|NCT03088878|525273157|FG009|Overall Study|Death|0|||
145659612|NCT03088878|525273158|FG010|Overall Study|Death|0|||
145659613|NCT03088878|525273159|FG011|Overall Study|Death|1|||
145659614|NCT03088878|525273160|FG012|Overall Study|Death|0|||
145659615|NCT03088878|525273161|FG013|Overall Study|Death|0|||
145659616|NCT03088878|525273148|FG000|Overall Study|Disease Progression|1|||
145659617|NCT03088878|525273149|FG001|Overall Study|Disease Progression|2|||
145659618|NCT03088878|525273150|FG002|Overall Study|Disease Progression|3|||
145659619|NCT03088878|525273151|FG003|Overall Study|Disease Progression|0|||
145659620|NCT03088878|525273152|FG004|Overall Study|Disease Progression|3|||
145659621|NCT03088878|525273153|FG005|Overall Study|Disease Progression|0|||
145659622|NCT03088878|525273154|FG006|Overall Study|Disease Progression|0|||
145659623|NCT03088878|525273155|FG007|Overall Study|Disease Progression|0|||
145659624|NCT03088878|525273156|FG008|Overall Study|Disease Progression|0|||
145659625|NCT03088878|525273157|FG009|Overall Study|Disease Progression|0|||
145659626|NCT03088878|525273158|FG010|Overall Study|Disease Progression|0|||
145659627|NCT03088878|525273159|FG011|Overall Study|Disease Progression|0|||
145659628|NCT03088878|525273160|FG012|Overall Study|Disease Progression|1|||
145659629|NCT03088878|525273161|FG013|Overall Study|Disease Progression|1|||
145659630|NCT03088878|525273148|FG000|Overall Study|Initiation of Alternative Treatment|0|||
145659631|NCT03088878|525273149|FG001|Overall Study|Initiation of Alternative Treatment|0|||
145659632|NCT03088878|525273150|FG002|Overall Study|Initiation of Alternative Treatment|0|||
145659633|NCT03088878|525273151|FG003|Overall Study|Initiation of Alternative Treatment|1|||
145659634|NCT03088878|525273152|FG004|Overall Study|Initiation of Alternative Treatment|0|||
145659635|NCT03088878|525273153|FG005|Overall Study|Initiation of Alternative Treatment|0|||
145659636|NCT03088878|525273154|FG006|Overall Study|Initiation of Alternative Treatment|0|||
145659637|NCT03088878|525273155|FG007|Overall Study|Initiation of Alternative Treatment|1|||
145659638|NCT03088878|525273156|FG008|Overall Study|Initiation of Alternative Treatment|1|||
145659639|NCT03088878|525273157|FG009|Overall Study|Initiation of Alternative Treatment|0|||
145659640|NCT03088878|525273158|FG010|Overall Study|Initiation of Alternative Treatment|0|||
145659641|NCT03088878|525273159|FG011|Overall Study|Initiation of Alternative Treatment|0|||
145659642|NCT03088878|525273160|FG012|Overall Study|Initiation of Alternative Treatment|0|||
145659643|NCT03088878|525273161|FG013|Overall Study|Initiation of Alternative Treatment|0|||
145659644|NCT03088878|525273148|FG000|Overall Study|Withdrawal by Subject|0|||
145659645|NCT03088878|525273149|FG001|Overall Study|Withdrawal by Subject|0|||
145659646|NCT03088878|525273150|FG002|Overall Study|Withdrawal by Subject|0|||
145659647|NCT03088878|525273151|FG003|Overall Study|Withdrawal by Subject|1|||
145659648|NCT03088878|525273152|FG004|Overall Study|Withdrawal by Subject|4|||
145659649|NCT03088878|525273153|FG005|Overall Study|Withdrawal by Subject|1|||
145659650|NCT03088878|525273154|FG006|Overall Study|Withdrawal by Subject|1|||
145659651|NCT03088878|525273155|FG007|Overall Study|Withdrawal by Subject|0|||
145659652|NCT03088878|525273156|FG008|Overall Study|Withdrawal by Subject|1|||
145659653|NCT03088878|525273157|FG009|Overall Study|Withdrawal by Subject|2|||
145659654|NCT03088878|525273158|FG010|Overall Study|Withdrawal by Subject|0|||
145659655|NCT03088878|525273159|FG011|Overall Study|Withdrawal by Subject|2|||
145659656|NCT03088878|525273160|FG012|Overall Study|Withdrawal by Subject|1|||
145659657|NCT03088878|525273161|FG013|Overall Study|Withdrawal by Subject|0|||
145659658|NCT03088878|525273148|FG000|Overall Study|Terminated by Sponsor|2|||
145659659|NCT03088878|525273149|FG001|Overall Study|Terminated by Sponsor|1|||
145659660|NCT03088878|525273150|FG002|Overall Study|Terminated by Sponsor|0|||
145659661|NCT03088878|525273151|FG003|Overall Study|Terminated by Sponsor|1|||
145659662|NCT03088878|525273152|FG004|Overall Study|Terminated by Sponsor|6|||
145659663|NCT03088878|525273153|FG005|Overall Study|Terminated by Sponsor|0|||
145659664|NCT03088878|525273154|FG006|Overall Study|Terminated by Sponsor|0|||
145659665|NCT03088878|525273155|FG007|Overall Study|Terminated by Sponsor|0|||
145659666|NCT03088878|525273156|FG008|Overall Study|Terminated by Sponsor|0|||
145659667|NCT03088878|525273157|FG009|Overall Study|Terminated by Sponsor|0|||
145659668|NCT03088878|525273158|FG010|Overall Study|Terminated by Sponsor|3|||
145659669|NCT03088878|525273159|FG011|Overall Study|Terminated by Sponsor|13|||
145659670|NCT03088878|525273160|FG012|Overall Study|Terminated by Sponsor|2|||
145659671|NCT03088878|525273161|FG013|Overall Study|Terminated by Sponsor|1|||
145659672|NCT03088878|525273148|FG000|Overall Study|Completed 2 years of Treatment|0|||
145659673|NCT03088878|525273149|FG001|Overall Study|Completed 2 years of Treatment|0|||
145659674|NCT03088878|525273150|FG002|Overall Study|Completed 2 years of Treatment|0|||
145659675|NCT03088878|525273151|FG003|Overall Study|Completed 2 years of Treatment|0|||
145659676|NCT03088878|525273152|FG004|Overall Study|Completed 2 years of Treatment|0|||
145659677|NCT03088878|525273153|FG005|Overall Study|Completed 2 years of Treatment|0|||
145659678|NCT03088878|525273154|FG006|Overall Study|Completed 2 years of Treatment|1|||
145659679|NCT03088878|525273155|FG007|Overall Study|Completed 2 years of Treatment|0|||
145659680|NCT03088878|525273156|FG008|Overall Study|Completed 2 years of Treatment|0|||
145659681|NCT03088878|525273157|FG009|Overall Study|Completed 2 years of Treatment|1|||
145659682|NCT03088878|525273158|FG010|Overall Study|Completed 2 years of Treatment|0|||
145659683|NCT03088878|525273159|FG011|Overall Study|Completed 2 years of Treatment|0|||
145659684|NCT03088878|525273160|FG012|Overall Study|Completed 2 years of Treatment|8|||
145659685|NCT03088878|525273161|FG013|Overall Study|Completed 2 years of Treatment|3|||
145659686|NCT03088878|525273148|FG000|Overall Study|Physician Decision|0|||
145659687|NCT03088878|525273149|FG001|Overall Study|Physician Decision|0|||
145659688|NCT03088878|525273150|FG002|Overall Study|Physician Decision|0|||
145659689|NCT03088878|525273151|FG003|Overall Study|Physician Decision|0|||
145659690|NCT03088878|525273152|FG004|Overall Study|Physician Decision|0|||
145659691|NCT03088878|525273153|FG005|Overall Study|Physician Decision|0|||
145659692|NCT03088878|525273154|FG006|Overall Study|Physician Decision|0|||
145659693|NCT03088878|525273155|FG007|Overall Study|Physician Decision|2|||
145659694|NCT03088878|525273156|FG008|Overall Study|Physician Decision|1|||
145659695|NCT03088878|525273157|FG009|Overall Study|Physician Decision|0|||
145659696|NCT03088878|525273158|FG010|Overall Study|Physician Decision|0|||
145659697|NCT03088878|525273159|FG011|Overall Study|Physician Decision|0|||
145659698|NCT03088878|525273160|FG012|Overall Study|Physician Decision|0|||
145659699|NCT03088878|525273161|FG013|Overall Study|Physician Decision|1|||
145659700|NCT03088878|525273148|FG000|Overall Study|COVID Related noncompliance|0|||
145659701|NCT03088878|525273149|FG001|Overall Study|COVID Related noncompliance|0|||
145659702|NCT03088878|525273150|FG002|Overall Study|COVID Related noncompliance|0|||
145659703|NCT03088878|525273151|FG003|Overall Study|COVID Related noncompliance|0|||
145659704|NCT03088878|525273152|FG004|Overall Study|COVID Related noncompliance|0|||
145659705|NCT03088878|525273153|FG005|Overall Study|COVID Related noncompliance|0|||
145659706|NCT03088878|525273154|FG006|Overall Study|COVID Related noncompliance|0|||
145659707|NCT03088878|525273155|FG007|Overall Study|COVID Related noncompliance|0|||
145659708|NCT03088878|525273156|FG008|Overall Study|COVID Related noncompliance|0|||
145659709|NCT03088878|525273157|FG009|Overall Study|COVID Related noncompliance|0|||
145659710|NCT03088878|525273158|FG010|Overall Study|COVID Related noncompliance|0|||
145659711|NCT03088878|525273159|FG011|Overall Study|COVID Related noncompliance|0|||
145659712|NCT03088878|525273160|FG012|Overall Study|COVID Related noncompliance|0|||
145659713|NCT03088878|525273161|FG013|Overall Study|COVID Related noncompliance|1|||
145659714|NCT03088878|525273148|FG000|Overall Study|Drug or Study Noncompliance|0|||
145659715|NCT03088878|525273149|FG001|Overall Study|Drug or Study Noncompliance|0|||
145659716|NCT03088878|525273150|FG002|Overall Study|Drug or Study Noncompliance|0|||
145659717|NCT03088878|525273151|FG003|Overall Study|Drug or Study Noncompliance|0|||
145659718|NCT03088878|525273152|FG004|Overall Study|Drug or Study Noncompliance|0|||
145659719|NCT03088878|525273153|FG005|Overall Study|Drug or Study Noncompliance|0|||
145659720|NCT03088878|525273154|FG006|Overall Study|Drug or Study Noncompliance|0|||
145659721|NCT03088878|525273155|FG007|Overall Study|Drug or Study Noncompliance|0|||
145659722|NCT03088878|525273156|FG008|Overall Study|Drug or Study Noncompliance|0|||
145659723|NCT03088878|525273157|FG009|Overall Study|Drug or Study Noncompliance|0|||
145659724|NCT03088878|525273158|FG010|Overall Study|Drug or Study Noncompliance|0|||
145659725|NCT03088878|525273159|FG011|Overall Study|Drug or Study Noncompliance|0|||
145659726|NCT03088878|525273160|FG012|Overall Study|Drug or Study Noncompliance|1|||
145659727|NCT03088878|525273161|FG013|Overall Study|Drug or Study Noncompliance|0|||
145659728|NCT02724969|525273162|FG000|Overall Study|Lost to Follow-up|12|||
145659729|NCT02724969|525273163|FG001|Overall Study|Lost to Follow-up|6|||
145659730|NCT02724969|525273162|FG000|Overall Study|Withdrawal by Subject|3|||
145659731|NCT02724969|525273163|FG001|Overall Study|Withdrawal by Subject|3|||
145659732|NCT02724969|525273162|FG000|Overall Study|Infant demise|0|||
145659733|NCT02724969|525273163|FG001|Overall Study|Infant demise|2|||
145659734|NCT03362476|525273164|FG000|Overall Study|Withdrawal by Subject|0|||
145659735|NCT03362476|525273165|FG001|Overall Study|Withdrawal by Subject|1|||
145659736|NCT05216406|525273168|FG000|Overall Study|Lost to Follow-up|8|||
145659737|NCT05216406|525273169|FG001|Overall Study|Lost to Follow-up|9|||
145659738|NCT04270942|525273173|FG000|Overall Study|Death|1|||
145659739|NCT03672916|525273181|FG000|Overall Study|Death|6|||
145659740|NCT03672916|525273181|FG000|Overall Study|Lost to Follow-up|29|||
145659741|NCT03672916|525273181|FG000|Overall Study|Adverse Event|6|||
145659742|NCT03672916|525273181|FG000|Overall Study|Withdrawal by Subject|11|||
145659743|NCT04797195|525273182|FG000|Overall Study|Death|8|||
145659744|NCT04797195|525273183|FG001|Overall Study|Death|15|||
145659745|NCT04797195|525273182|FG000|Overall Study|Change from PD|15|||
145659746|NCT04797195|525273183|FG001|Overall Study|Change from PD|15|||
145659747|NCT04797195|525273182|FG000|Overall Study|Withdrawal by Subject|3|||
145659748|NCT04797195|525273183|FG001|Overall Study|Withdrawal by Subject|2|||
145659749|NCT01236781|525273185|FG000|Overall Study|Ineligible|2|||
145659750|NCT01236781|525273186|FG001|Overall Study|Ineligible|1|||
145659751|NCT01236781|525273185|FG000|Overall Study|Did not complete study imaging|5|||
145659752|NCT01236781|525273186|FG001|Overall Study|Did not complete study imaging|0|||
145659753|NCT05167864|525273189|FG000|Overall Study|Lost to Follow-up|7|||
145659754|NCT05167864|525273190|FG001|Overall Study|Lost to Follow-up|6|||
145659755|NCT05167864|525273191|FG002|Overall Study|Lost to Follow-up|7|||
145659756|NCT05167864|525273192|FG003|Overall Study|Lost to Follow-up|9|||
145659757|NCT04059185|525273195|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
145659758|NCT04059185|525273196|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
145659759|NCT04059185|525273197|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
145659760|NCT04059185|525273195|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
145659761|NCT04059185|525273196|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
145659762|NCT04059185|525273197|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
145659763|NCT04059185|525273195|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
145659764|NCT04059185|525273196|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
145659765|NCT04059185|525273197|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
145659766|NCT04059185|525273195|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
145659767|NCT04059185|525273196|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
145659768|NCT04059185|525273197|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
145659769|NCT04059185|525273195|FG000|Longitudinal Assessment-Adults Only|Death|4|||
145659770|NCT04059185|525273196|FG001|Longitudinal Assessment-Adults Only|Death|4|||
145659771|NCT04059185|525273197|FG002|Longitudinal Assessment-Adults Only|Death|3|||
145659772|NCT04587453|525273205|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
145659773|NCT04587453|525273206|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
145659774|NCT05623228|525273209|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
145659775|NCT05623228|525273210|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659776|NCT05623228|525273211|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659777|NCT05623228|525273212|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659778|NCT05623228|525273213|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659779|NCT05623228|525273214|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659780|NCT05623228|525273215|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659781|NCT05623228|525273216|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
145659782|NCT05623228|525273209|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
145659783|NCT05623228|525273210|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145659784|NCT05623228|525273211|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
145659785|NCT05623228|525273212|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
145659786|NCT05623228|525273213|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145659787|NCT05623228|525273214|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145659788|NCT05623228|525273215|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145659789|NCT05623228|525273216|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
145659790|NCT04737330|525273218|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
145659791|NCT04737330|525273219|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
145659792|NCT04737330|525273218|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
145659793|NCT04737330|525273219|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
145659794|NCT04737330|525273218|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
145659795|NCT04737330|525273219|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
145659796|NCT04737330|525273218|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
145659797|NCT04737330|525273219|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
145659798|NCT04737330|525273218|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
145659799|NCT04737330|525273219|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
145659800|NCT04737330|525273218|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
145659801|NCT04737330|525273219|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
145659802|NCT05309291|525273228|FG000|Overall Study|Adverse Event|0|||
145659803|NCT05309291|525273229|FG001|Overall Study|Adverse Event|1|||
145659804|NCT03221426|525273230|FG000|Overall Study|Ongoing in study|212|||
145659805|NCT03221426|525273231|FG001|Overall Study|Ongoing in study|193|||
145659806|NCT03221426|525273232|FG002|Overall Study|Ongoing in study|61|||
145659807|NCT03221426|525273233|FG003|Overall Study|Ongoing in study|55|||
145659808|NCT03221426|525273230|FG000|Overall Study|Withdrawal by Subject|12|||
145659809|NCT03221426|525273231|FG001|Overall Study|Withdrawal by Subject|4|||
145659810|NCT03221426|525273232|FG002|Overall Study|Withdrawal by Subject|2|||
145659811|NCT03221426|525273233|FG003|Overall Study|Withdrawal by Subject|3|||
145659812|NCT03221426|525273230|FG000|Overall Study|Lost to Follow-up|4|||
145659813|NCT03221426|525273231|FG001|Overall Study|Lost to Follow-up|1|||
145659814|NCT03221426|525273232|FG002|Overall Study|Lost to Follow-up|1|||
145659815|NCT03221426|525273233|FG003|Overall Study|Lost to Follow-up|0|||
145659816|NCT03221426|525273230|FG000|Overall Study|Death|174|||
145659817|NCT03221426|525273231|FG001|Overall Study|Death|204|||
145659818|NCT03221426|525273232|FG002|Overall Study|Death|36|||
145659819|NCT03221426|525273233|FG003|Overall Study|Death|45|||
145659820|NCT03766685|525275430|FG000|Overall Study|Lost to Follow-up|1|||
145659821|NCT03766685|525275431|FG001|Overall Study|Lost to Follow-up|1|||
145659822|NCT03766685|525275432|FG002|Overall Study|Lost to Follow-up|0|||
145659823|NCT03766685|525275433|FG003|Overall Study|Lost to Follow-up|0|||
145659824|NCT03766685|525275430|FG000|Overall Study|Adverse Event, not fatal|0|||
145659825|NCT03766685|525275431|FG001|Overall Study|Adverse Event, not fatal|1|||
145659826|NCT03766685|525275432|FG002|Overall Study|Adverse Event, not fatal|0|||
145659827|NCT03766685|525275433|FG003|Overall Study|Adverse Event, not fatal|1|||
145659828|NCT03766685|525275430|FG000|Overall Study|Withdrawal by Subject|0|||
145659829|NCT03766685|525275431|FG001|Overall Study|Withdrawal by Subject|2|||
145659830|NCT03766685|525275432|FG002|Overall Study|Withdrawal by Subject|0|||
145659831|NCT03766685|525275433|FG003|Overall Study|Withdrawal by Subject|0|||
145659832|NCT03766685|525275430|FG000|Overall Study|Protocol Violation|0|||
145659833|NCT03766685|525275431|FG001|Overall Study|Protocol Violation|1|||
145659834|NCT03766685|525275432|FG002|Overall Study|Protocol Violation|0|||
145659835|NCT03766685|525275433|FG003|Overall Study|Protocol Violation|0|||
145659836|NCT03766685|525275430|FG000|Overall Study|Non-compliance|0|||
145659837|NCT03766685|525275431|FG001|Overall Study|Non-compliance|2|||
145659838|NCT03766685|525275432|FG002|Overall Study|Non-compliance|0|||
145659839|NCT03766685|525275433|FG003|Overall Study|Non-compliance|0|||
145659840|NCT02116530|525275434|FG000|Overall Study|Withdrawal by Subject|1|||
145659841|NCT02116530|525275435|FG001|Overall Study|Withdrawal by Subject|2|||
145659842|NCT02116530|525275434|FG000|Overall Study|Adverse Event|4|||
145659843|NCT02116530|525275435|FG001|Overall Study|Adverse Event|0|||
145659844|NCT02116530|525275434|FG000|Overall Study|Physician Decision|1|||
145659845|NCT02116530|525275435|FG001|Overall Study|Physician Decision|0|||
145659846|NCT02116530|525275434|FG000|Overall Study|Lost to Follow-up|1|||
145659847|NCT02116530|525275435|FG001|Overall Study|Lost to Follow-up|0|||
145659848|NCT02116530|525275434|FG000|Overall Study|Other Medical Problems|2|||
145659849|NCT02116530|525275435|FG001|Overall Study|Other Medical Problems|2|||
145659850|NCT02927236|525275438|FG000|Characterization Phase|Physician Decision|0|||
145659851|NCT02927236|525275439|FG001|Characterization Phase|Physician Decision|3|||
145659852|NCT02927236|525275440|FG002|Characterization Phase|Physician Decision|0|||
145659853|NCT02927236|525275441|FG003|Characterization Phase|Physician Decision|2|||
145659854|NCT02927236|525275438|FG000|Characterization Phase|Lost to Follow-up|0|||
145659855|NCT02927236|525275439|FG001|Characterization Phase|Lost to Follow-up|0|||
145659856|NCT02927236|525275440|FG002|Characterization Phase|Lost to Follow-up|0|||
145659857|NCT02927236|525275441|FG003|Characterization Phase|Lost to Follow-up|3|||
145659858|NCT02927236|525275438|FG000|Characterization Phase|Withdrawal by Subject|1|||
145659859|NCT02927236|525275439|FG001|Characterization Phase|Withdrawal by Subject|0|||
145659860|NCT02927236|525275440|FG002|Characterization Phase|Withdrawal by Subject|0|||
145659861|NCT02927236|525275441|FG003|Characterization Phase|Withdrawal by Subject|1|||
145659862|NCT02927236|525275438|FG000|Treatment Phase|Adverse Event|1|||
145659863|NCT02927236|525275439|FG001|Treatment Phase|Adverse Event|0|||
145659864|NCT02927236|525275440|FG002|Treatment Phase|Adverse Event|1|||
145659865|NCT02927236|525275441|FG003|Treatment Phase|Adverse Event|1|||
145659866|NCT02927236|525275438|FG000|Treatment Phase|Protocol Violation|3|||
145659867|NCT02927236|525275439|FG001|Treatment Phase|Protocol Violation|0|||
145659868|NCT02927236|525275440|FG002|Treatment Phase|Protocol Violation|0|||
145659869|NCT02927236|525275441|FG003|Treatment Phase|Protocol Violation|1|||
145659870|NCT02927236|525275438|FG000|Treatment Phase|Lost to Follow-up|1|||
145659871|NCT02927236|525275439|FG001|Treatment Phase|Lost to Follow-up|0|||
145659872|NCT02927236|525275440|FG002|Treatment Phase|Lost to Follow-up|0|||
145265342|NCT01300741|523819298|FG000|Overall Study|Discomfort|1|||
145490524|NCT02349633|524650321|FG013|Overall Study|Early termination of survival follow-up|0|||
145490525|NCT02349633|524650308|FG000|Overall Study|Termination by sponsor|0|||
145490526|NCT02349633|524650309|FG001|Overall Study|Termination by sponsor|0|||
145490527|NCT02349633|524650310|FG002|Overall Study|Termination by sponsor|0|||
145490528|NCT02349633|524650311|FG003|Overall Study|Termination by sponsor|0|||
145490529|NCT02349633|524650312|FG004|Overall Study|Termination by sponsor|0|||
145490530|NCT02349633|524650313|FG005|Overall Study|Termination by sponsor|0|||
145490531|NCT02349633|524650314|FG006|Overall Study|Termination by sponsor|0|||
145490532|NCT02349633|524650315|FG007|Overall Study|Termination by sponsor|1|||
145490533|NCT02349633|524650316|FG008|Overall Study|Termination by sponsor|0|||
145490534|NCT02349633|524650317|FG009|Overall Study|Termination by sponsor|2|||
145490535|NCT02349633|524650318|FG010|Overall Study|Termination by sponsor|0|||
145659873|NCT02927236|525275441|FG003|Treatment Phase|Lost to Follow-up|0|||
145659874|NCT02927236|525275438|FG000|Follow-up Phase|Lost to Follow-up|1|||
145659875|NCT02927236|525275439|FG001|Follow-up Phase|Lost to Follow-up|0|||
145659876|NCT02927236|525275440|FG002|Follow-up Phase|Lost to Follow-up|1|||
145659877|NCT02927236|525275441|FG003|Follow-up Phase|Lost to Follow-up|0|||
145659878|NCT01197378|525275442|FG000|Overall Study|Adverse Event|3|||
145659879|NCT01197378|525275442|FG000|Overall Study|Withdrawal by Subject|1|||
145659880|NCT01197378|525275442|FG000|Overall Study|Physician Decision|1|||
145659881|NCT01197378|525275442|FG000|Overall Study|Other|2|||
145659882|NCT06232590|525275446|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
145659883|NCT06232590|525275447|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
145659884|NCT01959607|525275448|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
145659885|NCT01959607|525275449|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
145659886|NCT01959607|525275450|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145659887|NCT01959607|525275451|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
145659888|NCT03913442|525275452|FG000|Overall Study|Adverse Event|0|||
145659889|NCT03913442|525275453|FG001|Overall Study|Adverse Event|3|||
145659890|NCT03913442|525275452|FG000|Overall Study|Withdrawal by Subject|5|||
145659891|NCT03913442|525275453|FG001|Overall Study|Withdrawal by Subject|5|||
145659892|NCT03913442|525275452|FG000|Overall Study|Terminations|2|||
145659893|NCT03913442|525275453|FG001|Overall Study|Terminations|1|||
145659894|NCT03913442|525275452|FG000|Overall Study|Lost to Follow-up|2|||
145659895|NCT03913442|525275453|FG001|Overall Study|Lost to Follow-up|2|||
145659896|NCT02433379|525275454|FG000|Overall Study|Screen Failures|55|||
145659897|NCT02433379|525275454|FG000|Overall Study|Death|57|||
145659898|NCT02433379|525275454|FG000|Overall Study|Total Withdrawals|209|||
145659899|NCT00592852|525275455|FG000|Overall Study|Non-compliance|1|||
145659900|NCT00592852|525275455|FG000|Overall Study|Adverse Event|3|||
145659901|NCT00592852|525275455|FG000|Overall Study|Found ineligible|1|||
145659902|NCT00592852|525275455|FG000|Overall Study|Withdrawal by Subject|1|||
145659903|NCT05274074|525275464|FG000|Overall Study|Lost to Follow-up|2|||
145659904|NCT05274074|525275465|FG001|Overall Study|Lost to Follow-up|3|||
145659905|NCT05274074|525275464|FG000|Overall Study|Withdrawal by Subject|1|||
145659906|NCT05274074|525275465|FG001|Overall Study|Withdrawal by Subject|2|||
145659907|NCT04117347|525275466|FG000|Overall Study|Adverse Event|0|||
145659908|NCT04117347|525275467|FG001|Overall Study|Adverse Event|0|||
145659909|NCT04117347|525275468|FG002|Overall Study|Adverse Event|1|||
145659910|NCT04117347|525275466|FG000|Overall Study|No time for study|0|||
145659911|NCT04117347|525275467|FG001|Overall Study|No time for study|2|||
145659912|NCT04117347|525275468|FG002|Overall Study|No time for study|0|||
145659913|NCT04117347|525275466|FG000|Overall Study|Family emergency|1|||
145659914|NCT04117347|525275467|FG001|Overall Study|Family emergency|0|||
145659915|NCT04117347|525275468|FG002|Overall Study|Family emergency|0|||
145659916|NCT03687086|525275469|FG000|Overall Study|Withdrawal by Subject|3|||
145659917|NCT03687086|525275470|FG001|Overall Study|Withdrawal by Subject|4|||
145659918|NCT03687086|525275469|FG000|Overall Study|Lost to Follow-up|1|||
145659919|NCT03687086|525275470|FG001|Overall Study|Lost to Follow-up|1|||
145659920|NCT03687086|525275469|FG000|Overall Study|Death|1|||
145659921|NCT03687086|525275470|FG001|Overall Study|Death|0|||
145659922|NCT03687086|525275469|FG000|Overall Study|Incomplete assessment|0|||
145659923|NCT03687086|525275470|FG001|Overall Study|Incomplete assessment|2|||
145659924|NCT02505984|525275471|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
145659925|NCT02505984|525275472|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
145659926|NCT02505984|525275471|FG000|Overall Study|Unreliable self-report data|1|||
145659927|NCT02505984|525275472|FG001|Overall Study|Unreliable self-report data|0|||
145659928|NCT02505984|525275471|FG000|Overall Study|Study blind opened during assessment|0|||
145659929|NCT02505984|525275472|FG001|Overall Study|Study blind opened during assessment|1|||
145659930|NCT02505984|525275471|FG000|Overall Study|Noncompliance with study protocol|0|||
145659931|NCT02505984|525275472|FG001|Overall Study|Noncompliance with study protocol|1|||
145659932|NCT05194956|525275473|FG000|Washout Period|Withdrawal by Subject|0|||
145659933|NCT05194956|525275474|FG001|Washout Period|Withdrawal by Subject|2|||
145659934|NCT02593773|525275476|FG000|Overall Study|Voluntary Withdrawal|3|||
145659935|NCT02593773|525275476|FG000|Overall Study|Study Terminated by Sponsor|31|||
145659936|NCT02593773|525275476|FG000|Overall Study|Death|1|||
145659937|NCT01828099|525275479|FG000|Treatment Period|Adverse Event|24|||
145659938|NCT01828099|525275480|FG001|Treatment Period|Adverse Event|23|||
145659939|NCT01828099|525275479|FG000|Treatment Period|Death|10|||
145659940|NCT01828099|525275480|FG001|Treatment Period|Death|12|||
145659941|NCT01828099|525275479|FG000|Treatment Period|Lost to Follow-up|2|||
145659942|NCT01828099|525275480|FG001|Treatment Period|Lost to Follow-up|1|||
145659943|NCT01828099|525275479|FG000|Treatment Period|Non-compliance with study treatment|1|||
145659944|NCT01828099|525275480|FG001|Treatment Period|Non-compliance with study treatment|0|||
145659945|NCT01828099|525275479|FG000|Treatment Period|Physician Decision|17|||
145659946|NCT01828099|525275480|FG001|Treatment Period|Physician Decision|16|||
145659947|NCT01828099|525275479|FG000|Treatment Period|Progressive disease|99|||
145659948|NCT01828099|525275480|FG001|Treatment Period|Progressive disease|107|||
145659949|NCT01828099|525275479|FG000|Treatment Period|Subject/guardian decision|22|||
145659950|NCT01828099|525275480|FG001|Treatment Period|Subject/guardian decision|26|||
145659951|NCT01828099|525275479|FG000|Treatment Period|Study terminated by Sponsor|13|||
145659952|NCT01828099|525275480|FG001|Treatment Period|Study terminated by Sponsor|1|||
145659953|NCT01828099|525275479|FG000|Treatment Period|Protocol deviation|1|||
145659954|NCT01828099|525275480|FG001|Treatment Period|Protocol deviation|0|||
145659955|NCT01828099|525275479|FG000|Treatment Period|No longer requires treatment|0|||
145659956|NCT01828099|525275480|FG001|Treatment Period|No longer requires treatment|1|||
145659957|NCT01828099|525275479|FG000|Extension-treatment Phase|Adverse Event|0|||
145659958|NCT01828099|525275480|FG001|Extension-treatment Phase|Adverse Event|17|||
145659959|NCT01828099|525275479|FG000|Extension-treatment Phase|Death|0|||
145659960|NCT01828099|525275480|FG001|Extension-treatment Phase|Death|11|||
145659961|NCT01828099|525275479|FG000|Extension-treatment Phase|Physician Decision|0|||
145659962|NCT01828099|525275480|FG001|Extension-treatment Phase|Physician Decision|5|||
145659963|NCT01828099|525275479|FG000|Extension-treatment Phase|Progressive disease|0|||
145659964|NCT01828099|525275480|FG001|Extension-treatment Phase|Progressive disease|54|||
145659965|NCT01828099|525275479|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
145659966|NCT01828099|525275480|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
145659967|NCT01828099|525275479|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
145659968|NCT01828099|525275480|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
145659969|NCT05934942|525275485|FG000|Run-in Period|Not treated|1|||
145659970|NCT05934942|525275485|FG000|Run-in Period|Withdrawal by Subject|1|||
145659971|NCT05645757|525275486|FG000|Overall Study|Enrolled but treatment not administered|0|||
145659972|NCT05645757|525275487|FG001|Overall Study|Enrolled but treatment not administered|0|||
145659973|NCT05645757|525275488|FG002|Overall Study|Enrolled but treatment not administered|0|||
145659974|NCT05645757|525275489|FG003|Overall Study|Enrolled but treatment not administered|0|||
145659975|NCT05645757|525275490|FG004|Overall Study|Enrolled but treatment not administered|1|||
145659976|NCT05645757|525275491|FG005|Overall Study|Enrolled but treatment not administered|1|||
145659977|NCT05645757|525275492|FG006|Overall Study|Enrolled but treatment not administered|0|||
145659978|NCT05645757|525275493|FG007|Overall Study|Enrolled but treatment not administered|0|||
145659979|NCT03924635|525275494|FG000|Overall Study|Withdrawal by Subject|2|||
145659980|NCT03924635|525275495|FG001|Overall Study|Withdrawal by Subject|4|||
145659981|NCT00539591|525275496|FG000|Overall Study|Toxicity|3|||
145659982|NCT00539591|525275497|FG001|Overall Study|Toxicity|0|||
145659983|NCT00539591|525275498|FG002|Overall Study|Toxicity|0|||
145659984|NCT00539591|525275496|FG000|Overall Study|Disease progression|2|||
145659985|NCT00539591|525275497|FG001|Overall Study|Disease progression|2|||
145659986|NCT00539591|525275498|FG002|Overall Study|Disease progression|3|||
145659987|NCT04362254|525275499|FG000|Overall Study|Adverse Event|1|||
145659988|NCT04362254|525275499|FG000|Overall Study|Protocol Violation|1|||
145659989|NCT04362254|525275499|FG000|Overall Study|Due to early termination of the trial|10|||
145659990|NCT04568434|525275500|FG000|Overall Study|Voluntary Withdrawal|0|||
145659991|NCT04568434|525275501|FG001|Overall Study|Voluntary Withdrawal|1|||
145659992|NCT04568434|525275502|FG002|Overall Study|Voluntary Withdrawal|1|||
145659993|NCT04568434|525275500|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
145659994|NCT04568434|525275501|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
145659995|NCT04568434|525275502|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
145659996|NCT04568434|525275500|FG000|Overall Study|Investigator Judgement|1|||
145659997|NCT04568434|525275501|FG001|Overall Study|Investigator Judgement|0|||
145659998|NCT04568434|525275502|FG002|Overall Study|Investigator Judgement|0|||
145659999|NCT05469464|525275503|FG000|Overall Study|Withdrawal by Subject|8|||
145660000|NCT05469464|525275504|FG001|Overall Study|Withdrawal by Subject|7|||
145660001|NCT05469464|525275505|FG002|Overall Study|Withdrawal by Subject|4|||
145660002|NCT05469464|525275506|FG003|Overall Study|Withdrawal by Subject|5|||
145660003|NCT05469464|525275503|FG000|Overall Study|Adverse Event|8|||
145660004|NCT05469464|525275504|FG001|Overall Study|Adverse Event|14|||
145660005|NCT05469464|525275505|FG002|Overall Study|Adverse Event|13|||
145660006|NCT05469464|525275506|FG003|Overall Study|Adverse Event|2|||
145660007|NCT05469464|525275503|FG000|Overall Study|Lost to Follow-up|2|||
145660008|NCT05469464|525275504|FG001|Overall Study|Lost to Follow-up|5|||
145660009|NCT05469464|525275505|FG002|Overall Study|Lost to Follow-up|3|||
145660010|NCT05469464|525275506|FG003|Overall Study|Lost to Follow-up|3|||
145660011|NCT05469464|525275503|FG000|Overall Study|Lack of Efficacy|4|||
145660012|NCT05469464|525275504|FG001|Overall Study|Lack of Efficacy|1|||
145660013|NCT05469464|525275505|FG002|Overall Study|Lack of Efficacy|2|||
145660014|NCT05469464|525275506|FG003|Overall Study|Lack of Efficacy|2|||
145660015|NCT05469464|525275503|FG000|Overall Study|Physician Decision|0|||
145660016|NCT05469464|525275504|FG001|Overall Study|Physician Decision|0|||
145660017|NCT05469464|525275505|FG002|Overall Study|Physician Decision|0|||
145660018|NCT05469464|525275506|FG003|Overall Study|Physician Decision|1|||
145660019|NCT01928394|525275507|FG000|Treatment Period|Disease progression|17|||
145660020|NCT01928394|525275508|FG001|Treatment Period|Disease progression|2|||
145660021|NCT01928394|525275509|FG002|Treatment Period|Disease progression|12|||
145660022|NCT01928394|525275510|FG003|Treatment Period|Disease progression|48|||
145660023|NCT01928394|525275511|FG004|Treatment Period|Disease progression|3|||
145660024|NCT01928394|525275512|FG005|Treatment Period|Disease progression|25|||
145660025|NCT01928394|525275513|FG006|Treatment Period|Disease progression|38|||
145660026|NCT01928394|525275514|FG007|Treatment Period|Disease progression|16|||
145660027|NCT01928394|525275515|FG008|Treatment Period|Disease progression|3|||
145660028|NCT01928394|525275516|FG009|Treatment Period|Disease progression|11|||
145660029|NCT01928394|525275517|FG010|Treatment Period|Disease progression|22|||
145490536|NCT02349633|524650319|FG011|Overall Study|Termination by sponsor|0|||
145660030|NCT01928394|525275518|FG011|Treatment Period|Disease progression|73|||
145660031|NCT01928394|525275519|FG012|Treatment Period|Disease progression|38|||
145660032|NCT01928394|525275520|FG013|Treatment Period|Disease progression|118|||
145660033|NCT01928394|525275521|FG014|Treatment Period|Disease progression|59|||
145660034|NCT01928394|525275522|FG015|Treatment Period|Disease progression|1|||
145660035|NCT01928394|525275523|FG016|Treatment Period|Disease progression|43|||
145660036|NCT01928394|525275524|FG017|Treatment Period|Disease progression|56|||
145660037|NCT01928394|525275525|FG018|Treatment Period|Disease progression|50|||
145660038|NCT01928394|525275526|FG019|Treatment Period|Disease progression|71|||
145660039|NCT01928394|525275527|FG020|Treatment Period|Disease progression|30|||
145660040|NCT01928394|525275528|FG021|Treatment Period|Disease progression|31|||
145660041|NCT01928394|525275529|FG022|Treatment Period|Disease progression|31|||
145660042|NCT01928394|525275507|FG000|Treatment Period|Study drug toxicity|1|||
145660043|NCT01928394|525275508|FG001|Treatment Period|Study drug toxicity|1|||
145660044|NCT01928394|525275509|FG002|Treatment Period|Study drug toxicity|3|||
145660045|NCT01928394|525275510|FG003|Treatment Period|Study drug toxicity|3|||
145660046|NCT01928394|525275511|FG004|Treatment Period|Study drug toxicity|0|||
145660047|NCT01928394|525275512|FG005|Treatment Period|Study drug toxicity|9|||
145660048|NCT01928394|525275513|FG006|Treatment Period|Study drug toxicity|7|||
145660049|NCT01928394|525275514|FG007|Treatment Period|Study drug toxicity|1|||
145660050|NCT01928394|525275515|FG008|Treatment Period|Study drug toxicity|0|||
145660051|NCT01928394|525275516|FG009|Treatment Period|Study drug toxicity|5|||
145660052|NCT01928394|525275517|FG010|Treatment Period|Study drug toxicity|2|||
145660053|NCT01928394|525275518|FG011|Treatment Period|Study drug toxicity|3|||
145660054|NCT01928394|525275519|FG012|Treatment Period|Study drug toxicity|7|||
145660055|NCT01928394|525275520|FG013|Treatment Period|Study drug toxicity|5|||
145660056|NCT01928394|525275521|FG014|Treatment Period|Study drug toxicity|12|||
145660057|NCT01928394|525275522|FG015|Treatment Period|Study drug toxicity|0|||
145660058|NCT01928394|525275523|FG016|Treatment Period|Study drug toxicity|3|||
145660059|NCT01928394|525275524|FG017|Treatment Period|Study drug toxicity|3|||
145660060|NCT01928394|525275525|FG018|Treatment Period|Study drug toxicity|12|||
145660061|NCT01928394|525275526|FG019|Treatment Period|Study drug toxicity|15|||
145660062|NCT01928394|525275527|FG020|Treatment Period|Study drug toxicity|4|||
145660063|NCT01928394|525275528|FG021|Treatment Period|Study drug toxicity|7|||
145660064|NCT01928394|525275529|FG022|Treatment Period|Study drug toxicity|4|||
145660065|NCT01928394|525275507|FG000|Treatment Period|AE unrelated to study drug|0|||
145660066|NCT01928394|525275508|FG001|Treatment Period|AE unrelated to study drug|0|||
145660067|NCT01928394|525275509|FG002|Treatment Period|AE unrelated to study drug|2|||
145660068|NCT01928394|525275510|FG003|Treatment Period|AE unrelated to study drug|3|||
145660069|NCT01928394|525275511|FG004|Treatment Period|AE unrelated to study drug|0|||
145660070|NCT01928394|525275512|FG005|Treatment Period|AE unrelated to study drug|5|||
145660071|NCT01928394|525275513|FG006|Treatment Period|AE unrelated to study drug|1|||
145660072|NCT01928394|525275514|FG007|Treatment Period|AE unrelated to study drug|0|||
145660073|NCT01928394|525275515|FG008|Treatment Period|AE unrelated to study drug|0|||
145660074|NCT01928394|525275516|FG009|Treatment Period|AE unrelated to study drug|2|||
145660075|NCT01928394|525275517|FG010|Treatment Period|AE unrelated to study drug|0|||
145660076|NCT01928394|525275518|FG011|Treatment Period|AE unrelated to study drug|12|||
145660077|NCT01928394|525275519|FG012|Treatment Period|AE unrelated to study drug|6|||
145660078|NCT01928394|525275520|FG013|Treatment Period|AE unrelated to study drug|13|||
145660079|NCT01928394|525275521|FG014|Treatment Period|AE unrelated to study drug|6|||
145660080|NCT01928394|525275522|FG015|Treatment Period|AE unrelated to study drug|1|||
145660081|NCT01928394|525275523|FG016|Treatment Period|AE unrelated to study drug|1|||
145660082|NCT01928394|525275524|FG017|Treatment Period|AE unrelated to study drug|6|||
145660083|NCT01928394|525275525|FG018|Treatment Period|AE unrelated to study drug|3|||
145660084|NCT01928394|525275526|FG019|Treatment Period|AE unrelated to study drug|5|||
145660085|NCT01928394|525275527|FG020|Treatment Period|AE unrelated to study drug|1|||
145660086|NCT01928394|525275528|FG021|Treatment Period|AE unrelated to study drug|1|||
145660087|NCT01928394|525275529|FG022|Treatment Period|AE unrelated to study drug|0|||
145660088|NCT01928394|525275507|FG000|Treatment Period|Participant request to stop therapy|0|||
145660089|NCT01928394|525275508|FG001|Treatment Period|Participant request to stop therapy|0|||
145660090|NCT01928394|525275509|FG002|Treatment Period|Participant request to stop therapy|0|||
145660091|NCT01928394|525275510|FG003|Treatment Period|Participant request to stop therapy|0|||
145660092|NCT01928394|525275511|FG004|Treatment Period|Participant request to stop therapy|0|||
145660093|NCT01928394|525275512|FG005|Treatment Period|Participant request to stop therapy|3|||
145660094|NCT01928394|525275513|FG006|Treatment Period|Participant request to stop therapy|3|||
145660095|NCT01928394|525275514|FG007|Treatment Period|Participant request to stop therapy|0|||
145660096|NCT01928394|525275515|FG008|Treatment Period|Participant request to stop therapy|0|||
145660097|NCT01928394|525275516|FG009|Treatment Period|Participant request to stop therapy|0|||
145660098|NCT01928394|525275517|FG010|Treatment Period|Participant request to stop therapy|3|||
145660099|NCT01928394|525275518|FG011|Treatment Period|Participant request to stop therapy|2|||
145660100|NCT01928394|525275519|FG012|Treatment Period|Participant request to stop therapy|1|||
145660101|NCT01928394|525275520|FG013|Treatment Period|Participant request to stop therapy|2|||
145660102|NCT01928394|525275521|FG014|Treatment Period|Participant request to stop therapy|4|||
145660103|NCT01928394|525275522|FG015|Treatment Period|Participant request to stop therapy|0|||
145660104|NCT01928394|525275523|FG016|Treatment Period|Participant request to stop therapy|1|||
145660105|NCT01928394|525275524|FG017|Treatment Period|Participant request to stop therapy|3|||
145660106|NCT01928394|525275525|FG018|Treatment Period|Participant request to stop therapy|1|||
145660107|NCT01928394|525275526|FG019|Treatment Period|Participant request to stop therapy|1|||
145660108|NCT01928394|525275527|FG020|Treatment Period|Participant request to stop therapy|3|||
145660109|NCT01928394|525275528|FG021|Treatment Period|Participant request to stop therapy|1|||
145660110|NCT01928394|525275529|FG022|Treatment Period|Participant request to stop therapy|3|||
145660111|NCT01928394|525275507|FG000|Treatment Period|Participant withdrew consent|0|||
145660112|NCT01928394|525275508|FG001|Treatment Period|Participant withdrew consent|0|||
145660113|NCT01928394|525275509|FG002|Treatment Period|Participant withdrew consent|1|||
145660114|NCT01928394|525275510|FG003|Treatment Period|Participant withdrew consent|1|||
145660115|NCT01928394|525275511|FG004|Treatment Period|Participant withdrew consent|0|||
145660116|NCT01928394|525275512|FG005|Treatment Period|Participant withdrew consent|1|||
145660117|NCT01928394|525275513|FG006|Treatment Period|Participant withdrew consent|0|||
145660118|NCT01928394|525275514|FG007|Treatment Period|Participant withdrew consent|1|||
145660119|NCT01928394|525275515|FG008|Treatment Period|Participant withdrew consent|0|||
145660120|NCT01928394|525275516|FG009|Treatment Period|Participant withdrew consent|0|||
145660121|NCT01928394|525275517|FG010|Treatment Period|Participant withdrew consent|1|||
145660122|NCT01928394|525275518|FG011|Treatment Period|Participant withdrew consent|1|||
145660123|NCT01928394|525275519|FG012|Treatment Period|Participant withdrew consent|1|||
145660124|NCT01928394|525275520|FG013|Treatment Period|Participant withdrew consent|0|||
145660125|NCT01928394|525275521|FG014|Treatment Period|Participant withdrew consent|2|||
145660126|NCT01928394|525275522|FG015|Treatment Period|Participant withdrew consent|0|||
145660127|NCT01928394|525275523|FG016|Treatment Period|Participant withdrew consent|2|||
145660128|NCT01928394|525275524|FG017|Treatment Period|Participant withdrew consent|1|||
145660129|NCT01928394|525275525|FG018|Treatment Period|Participant withdrew consent|1|||
145660130|NCT01928394|525275526|FG019|Treatment Period|Participant withdrew consent|1|||
145660131|NCT01928394|525275527|FG020|Treatment Period|Participant withdrew consent|0|||
145660132|NCT01928394|525275528|FG021|Treatment Period|Participant withdrew consent|2|||
145660133|NCT01928394|525275529|FG022|Treatment Period|Participant withdrew consent|0|||
145660134|NCT01928394|525275507|FG000|Treatment Period|Poor/non-compliance|0|||
145660135|NCT01928394|525275508|FG001|Treatment Period|Poor/non-compliance|0|||
145660136|NCT01928394|525275509|FG002|Treatment Period|Poor/non-compliance|0|||
145660137|NCT01928394|525275510|FG003|Treatment Period|Poor/non-compliance|1|||
145660138|NCT01928394|525275511|FG004|Treatment Period|Poor/non-compliance|0|||
145660139|NCT01928394|525275512|FG005|Treatment Period|Poor/non-compliance|0|||
145660140|NCT01928394|525275513|FG006|Treatment Period|Poor/non-compliance|0|||
145660141|NCT01928394|525275514|FG007|Treatment Period|Poor/non-compliance|0|||
145660142|NCT01928394|525275515|FG008|Treatment Period|Poor/non-compliance|0|||
145660143|NCT01928394|525275516|FG009|Treatment Period|Poor/non-compliance|0|||
145660144|NCT01928394|525275517|FG010|Treatment Period|Poor/non-compliance|0|||
145660145|NCT01928394|525275518|FG011|Treatment Period|Poor/non-compliance|0|||
145660146|NCT01928394|525275519|FG012|Treatment Period|Poor/non-compliance|1|||
145660147|NCT01928394|525275520|FG013|Treatment Period|Poor/non-compliance|0|||
145660148|NCT01928394|525275521|FG014|Treatment Period|Poor/non-compliance|1|||
145660149|NCT01928394|525275522|FG015|Treatment Period|Poor/non-compliance|0|||
145660150|NCT01928394|525275523|FG016|Treatment Period|Poor/non-compliance|0|||
145660151|NCT01928394|525275524|FG017|Treatment Period|Poor/non-compliance|1|||
145660152|NCT01928394|525275525|FG018|Treatment Period|Poor/non-compliance|0|||
145660153|NCT01928394|525275526|FG019|Treatment Period|Poor/non-compliance|1|||
145660154|NCT01928394|525275527|FG020|Treatment Period|Poor/non-compliance|0|||
145660155|NCT01928394|525275528|FG021|Treatment Period|Poor/non-compliance|0|||
145660156|NCT01928394|525275529|FG022|Treatment Period|Poor/non-compliance|0|||
145660157|NCT01928394|525275507|FG000|Treatment Period|other reason|0|||
145660158|NCT01928394|525275508|FG001|Treatment Period|other reason|0|||
145660159|NCT01928394|525275509|FG002|Treatment Period|other reason|0|||
145660160|NCT01928394|525275510|FG003|Treatment Period|other reason|0|||
145660161|NCT01928394|525275511|FG004|Treatment Period|other reason|0|||
145660162|NCT01928394|525275512|FG005|Treatment Period|other reason|0|||
145660163|NCT01928394|525275513|FG006|Treatment Period|other reason|0|||
145660164|NCT01928394|525275514|FG007|Treatment Period|other reason|0|||
145660165|NCT01928394|525275515|FG008|Treatment Period|other reason|0|||
145660166|NCT01928394|525275516|FG009|Treatment Period|other reason|0|||
145660167|NCT01928394|525275517|FG010|Treatment Period|other reason|1|||
145660168|NCT01928394|525275518|FG011|Treatment Period|other reason|1|||
145660169|NCT01928394|525275519|FG012|Treatment Period|other reason|1|||
145660170|NCT01928394|525275520|FG013|Treatment Period|other reason|0|||
145660171|NCT01928394|525275521|FG014|Treatment Period|other reason|1|||
145660172|NCT01928394|525275522|FG015|Treatment Period|other reason|0|||
145660173|NCT01928394|525275523|FG016|Treatment Period|other reason|0|||
145660174|NCT01928394|525275524|FG017|Treatment Period|other reason|0|||
145660175|NCT01928394|525275525|FG018|Treatment Period|other reason|2|||
145660176|NCT01928394|525275526|FG019|Treatment Period|other reason|2|||
145660177|NCT01928394|525275527|FG020|Treatment Period|other reason|0|||
145660178|NCT01928394|525275528|FG021|Treatment Period|other reason|0|||
145660179|NCT01928394|525275529|FG022|Treatment Period|other reason|0|||
145660180|NCT01928394|525275507|FG000|Treatment Period|Maximum clinical benefit|0|||
145660181|NCT01928394|525275508|FG001|Treatment Period|Maximum clinical benefit|0|||
145660182|NCT01928394|525275509|FG002|Treatment Period|Maximum clinical benefit|0|||
145660183|NCT01928394|525275510|FG003|Treatment Period|Maximum clinical benefit|0|||
145660184|NCT01928394|525275511|FG004|Treatment Period|Maximum clinical benefit|0|||
145660185|NCT01928394|525275512|FG005|Treatment Period|Maximum clinical benefit|0|||
145660186|NCT01928394|525275513|FG006|Treatment Period|Maximum clinical benefit|0|||
145660187|NCT01928394|525275514|FG007|Treatment Period|Maximum clinical benefit|0|||
145660188|NCT01928394|525275515|FG008|Treatment Period|Maximum clinical benefit|0|||
145660189|NCT01928394|525275516|FG009|Treatment Period|Maximum clinical benefit|0|||
145660190|NCT01928394|525275517|FG010|Treatment Period|Maximum clinical benefit|1|||
145660191|NCT01928394|525275518|FG011|Treatment Period|Maximum clinical benefit|1|||
145660192|NCT01928394|525275519|FG012|Treatment Period|Maximum clinical benefit|0|||
145660193|NCT01928394|525275520|FG013|Treatment Period|Maximum clinical benefit|0|||
145660194|NCT01928394|525275521|FG014|Treatment Period|Maximum clinical benefit|1|||
145660195|NCT01928394|525275522|FG015|Treatment Period|Maximum clinical benefit|0|||
145660196|NCT01928394|525275523|FG016|Treatment Period|Maximum clinical benefit|0|||
145660197|NCT01928394|525275524|FG017|Treatment Period|Maximum clinical benefit|1|||
145660198|NCT01928394|525275525|FG018|Treatment Period|Maximum clinical benefit|1|||
145660199|NCT01928394|525275526|FG019|Treatment Period|Maximum clinical benefit|0|||
145660200|NCT01928394|525275527|FG020|Treatment Period|Maximum clinical benefit|2|||
145660201|NCT01928394|525275528|FG021|Treatment Period|Maximum clinical benefit|0|||
145660202|NCT01928394|525275529|FG022|Treatment Period|Maximum clinical benefit|0|||
145660203|NCT01928394|525275507|FG000|Treatment Period|Lost to Follow-up|0|||
145660204|NCT01928394|525275508|FG001|Treatment Period|Lost to Follow-up|0|||
145660205|NCT01928394|525275509|FG002|Treatment Period|Lost to Follow-up|0|||
145660206|NCT01928394|525275510|FG003|Treatment Period|Lost to Follow-up|0|||
145660207|NCT01928394|525275511|FG004|Treatment Period|Lost to Follow-up|0|||
145660208|NCT01928394|525275512|FG005|Treatment Period|Lost to Follow-up|0|||
145660209|NCT01928394|525275513|FG006|Treatment Period|Lost to Follow-up|0|||
145660210|NCT01928394|525275514|FG007|Treatment Period|Lost to Follow-up|0|||
145660211|NCT01928394|525275515|FG008|Treatment Period|Lost to Follow-up|0|||
145660212|NCT01928394|525275516|FG009|Treatment Period|Lost to Follow-up|0|||
145660213|NCT01928394|525275517|FG010|Treatment Period|Lost to Follow-up|0|||
145660214|NCT01928394|525275518|FG011|Treatment Period|Lost to Follow-up|0|||
145660215|NCT01928394|525275519|FG012|Treatment Period|Lost to Follow-up|0|||
145660216|NCT01928394|525275520|FG013|Treatment Period|Lost to Follow-up|0|||
145660217|NCT01928394|525275521|FG014|Treatment Period|Lost to Follow-up|0|||
145660218|NCT01928394|525275522|FG015|Treatment Period|Lost to Follow-up|0|||
145660219|NCT01928394|525275523|FG016|Treatment Period|Lost to Follow-up|0|||
145660220|NCT01928394|525275524|FG017|Treatment Period|Lost to Follow-up|0|||
145660221|NCT01928394|525275525|FG018|Treatment Period|Lost to Follow-up|0|||
145660222|NCT01928394|525275526|FG019|Treatment Period|Lost to Follow-up|0|||
145660223|NCT01928394|525275527|FG020|Treatment Period|Lost to Follow-up|0|||
145660224|NCT01928394|525275528|FG021|Treatment Period|Lost to Follow-up|0|||
145660225|NCT01928394|525275529|FG022|Treatment Period|Lost to Follow-up|1|||
145660226|NCT01928394|525275507|FG000|Treatment Period|Death|0|||
145660227|NCT01928394|525275508|FG001|Treatment Period|Death|0|||
145660228|NCT01928394|525275509|FG002|Treatment Period|Death|0|||
145660229|NCT01928394|525275510|FG003|Treatment Period|Death|0|||
145660230|NCT01928394|525275511|FG004|Treatment Period|Death|0|||
145660231|NCT01928394|525275512|FG005|Treatment Period|Death|0|||
145660232|NCT01928394|525275513|FG006|Treatment Period|Death|0|||
145660233|NCT01928394|525275514|FG007|Treatment Period|Death|0|||
145660234|NCT01928394|525275515|FG008|Treatment Period|Death|0|||
145660235|NCT01928394|525275516|FG009|Treatment Period|Death|0|||
145660236|NCT01928394|525275517|FG010|Treatment Period|Death|0|||
145660237|NCT01928394|525275518|FG011|Treatment Period|Death|0|||
145660238|NCT01928394|525275519|FG012|Treatment Period|Death|0|||
145660239|NCT01928394|525275520|FG013|Treatment Period|Death|1|||
145660240|NCT01928394|525275521|FG014|Treatment Period|Death|2|||
145660241|NCT01928394|525275522|FG015|Treatment Period|Death|0|||
145660242|NCT01928394|525275523|FG016|Treatment Period|Death|0|||
145660243|NCT01928394|525275524|FG017|Treatment Period|Death|0|||
145660244|NCT01928394|525275525|FG018|Treatment Period|Death|0|||
145660245|NCT01928394|525275526|FG019|Treatment Period|Death|0|||
145660246|NCT01928394|525275527|FG020|Treatment Period|Death|0|||
145660247|NCT01928394|525275528|FG021|Treatment Period|Death|0|||
145660248|NCT01928394|525275529|FG022|Treatment Period|Death|0|||
145660249|NCT01928394|525275507|FG000|Follow-up Period|Participant withdrew consent|3|||
145660250|NCT01928394|525275508|FG001|Follow-up Period|Participant withdrew consent|0|||
145660251|NCT01928394|525275509|FG002|Follow-up Period|Participant withdrew consent|1|||
145660252|NCT01928394|525275510|FG003|Follow-up Period|Participant withdrew consent|4|||
145660253|NCT01928394|525275511|FG004|Follow-up Period|Participant withdrew consent|0|||
145660254|NCT01928394|525275512|FG005|Follow-up Period|Participant withdrew consent|2|||
145660255|NCT01928394|525275513|FG006|Follow-up Period|Participant withdrew consent|5|||
145660256|NCT01928394|525275514|FG007|Follow-up Period|Participant withdrew consent|1|||
145660257|NCT01928394|525275515|FG008|Follow-up Period|Participant withdrew consent|0|||
145660258|NCT01928394|525275516|FG009|Follow-up Period|Participant withdrew consent|0|||
145660259|NCT01928394|525275517|FG010|Follow-up Period|Participant withdrew consent|5|||
145660260|NCT01928394|525275518|FG011|Follow-up Period|Participant withdrew consent|8|||
145660261|NCT01928394|525275519|FG012|Follow-up Period|Participant withdrew consent|2|||
145660262|NCT01928394|525275520|FG013|Follow-up Period|Participant withdrew consent|12|||
145660263|NCT01928394|525275521|FG014|Follow-up Period|Participant withdrew consent|7|||
145660264|NCT01928394|525275522|FG015|Follow-up Period|Participant withdrew consent|0|||
145660265|NCT01928394|525275523|FG016|Follow-up Period|Participant withdrew consent|5|||
145660266|NCT01928394|525275524|FG017|Follow-up Period|Participant withdrew consent|3|||
145660267|NCT01928394|525275525|FG018|Follow-up Period|Participant withdrew consent|2|||
145660268|NCT01928394|525275526|FG019|Follow-up Period|Participant withdrew consent|7|||
145660269|NCT01928394|525275527|FG020|Follow-up Period|Participant withdrew consent|4|||
145660270|NCT01928394|525275528|FG021|Follow-up Period|Participant withdrew consent|6|||
145660271|NCT01928394|525275529|FG022|Follow-up Period|Participant withdrew consent|2|||
145660272|NCT01928394|525275507|FG000|Follow-up Period|Death|0|||
145660273|NCT01928394|525275508|FG001|Follow-up Period|Death|0|||
145660274|NCT01928394|525275509|FG002|Follow-up Period|Death|2|||
145660275|NCT01928394|525275510|FG003|Follow-up Period|Death|6|||
145660276|NCT01928394|525275511|FG004|Follow-up Period|Death|0|||
145660277|NCT01928394|525275512|FG005|Follow-up Period|Death|6|||
145660278|NCT01928394|525275513|FG006|Follow-up Period|Death|6|||
145660279|NCT01928394|525275514|FG007|Follow-up Period|Death|2|||
145660280|NCT01928394|525275515|FG008|Follow-up Period|Death|1|||
145660281|NCT01928394|525275516|FG009|Follow-up Period|Death|2|||
145660282|NCT01928394|525275517|FG010|Follow-up Period|Death|4|||
145660283|NCT01928394|525275518|FG011|Follow-up Period|Death|12|||
145660284|NCT01928394|525275519|FG012|Follow-up Period|Death|11|||
145660285|NCT01928394|525275520|FG013|Follow-up Period|Death|25|||
145660286|NCT01928394|525275521|FG014|Follow-up Period|Death|18|||
145660287|NCT01928394|525275522|FG015|Follow-up Period|Death|0|||
145660288|NCT01928394|525275523|FG016|Follow-up Period|Death|6|||
145660289|NCT01928394|525275524|FG017|Follow-up Period|Death|5|||
145660290|NCT01928394|525275525|FG018|Follow-up Period|Death|13|||
145660291|NCT01928394|525275526|FG019|Follow-up Period|Death|13|||
145660292|NCT01928394|525275527|FG020|Follow-up Period|Death|5|||
145660293|NCT01928394|525275528|FG021|Follow-up Period|Death|3|||
145660294|NCT01928394|525275529|FG022|Follow-up Period|Death|2|||
145660295|NCT01928394|525275507|FG000|Follow-up Period|other reason|0|||
145660296|NCT01928394|525275508|FG001|Follow-up Period|other reason|0|||
145660297|NCT01928394|525275509|FG002|Follow-up Period|other reason|0|||
145660298|NCT01928394|525275510|FG003|Follow-up Period|other reason|0|||
145660299|NCT01928394|525275511|FG004|Follow-up Period|other reason|0|||
145660300|NCT01928394|525275512|FG005|Follow-up Period|other reason|0|||
145660301|NCT01928394|525275513|FG006|Follow-up Period|other reason|1|||
145660302|NCT01928394|525275514|FG007|Follow-up Period|other reason|3|||
145660303|NCT01928394|525275515|FG008|Follow-up Period|other reason|0|||
145660304|NCT01928394|525275516|FG009|Follow-up Period|other reason|0|||
145660305|NCT01928394|525275517|FG010|Follow-up Period|other reason|2|||
145660306|NCT01928394|525275518|FG011|Follow-up Period|other reason|1|||
145660307|NCT01928394|525275519|FG012|Follow-up Period|other reason|0|||
145660308|NCT01928394|525275520|FG013|Follow-up Period|other reason|1|||
145660309|NCT01928394|525275521|FG014|Follow-up Period|other reason|4|||
145660310|NCT01928394|525275522|FG015|Follow-up Period|other reason|0|||
145660311|NCT01928394|525275523|FG016|Follow-up Period|other reason|2|||
145660312|NCT01928394|525275524|FG017|Follow-up Period|other reason|0|||
145660313|NCT01928394|525275525|FG018|Follow-up Period|other reason|1|||
145660314|NCT01928394|525275526|FG019|Follow-up Period|other reason|1|||
145660315|NCT01928394|525275527|FG020|Follow-up Period|other reason|0|||
145660316|NCT01928394|525275528|FG021|Follow-up Period|other reason|0|||
145660317|NCT01928394|525275529|FG022|Follow-up Period|other reason|1|||
145490537|NCT02349633|524650320|FG012|Overall Study|Termination by sponsor|0|||
145490538|NCT02349633|524650321|FG013|Overall Study|Termination by sponsor|0|||
145660318|NCT01928394|525275507|FG000|Follow-up Period|Lost to Follow-up|0|||
145660319|NCT01928394|525275508|FG001|Follow-up Period|Lost to Follow-up|0|||
145660320|NCT01928394|525275509|FG002|Follow-up Period|Lost to Follow-up|0|||
145660321|NCT01928394|525275510|FG003|Follow-up Period|Lost to Follow-up|0|||
145660322|NCT01928394|525275511|FG004|Follow-up Period|Lost to Follow-up|0|||
145660323|NCT01928394|525275512|FG005|Follow-up Period|Lost to Follow-up|0|||
145660324|NCT01928394|525275513|FG006|Follow-up Period|Lost to Follow-up|0|||
145660325|NCT01928394|525275514|FG007|Follow-up Period|Lost to Follow-up|0|||
145660326|NCT01928394|525275515|FG008|Follow-up Period|Lost to Follow-up|0|||
145660327|NCT01928394|525275516|FG009|Follow-up Period|Lost to Follow-up|0|||
145660328|NCT01928394|525275517|FG010|Follow-up Period|Lost to Follow-up|0|||
145660329|NCT01928394|525275518|FG011|Follow-up Period|Lost to Follow-up|1|||
145660330|NCT01928394|525275519|FG012|Follow-up Period|Lost to Follow-up|1|||
145660331|NCT01928394|525275520|FG013|Follow-up Period|Lost to Follow-up|0|||
145660332|NCT01928394|525275521|FG014|Follow-up Period|Lost to Follow-up|1|||
145660333|NCT01928394|525275522|FG015|Follow-up Period|Lost to Follow-up|0|||
145660334|NCT01928394|525275523|FG016|Follow-up Period|Lost to Follow-up|1|||
145660335|NCT01928394|525275524|FG017|Follow-up Period|Lost to Follow-up|0|||
145660336|NCT01928394|525275525|FG018|Follow-up Period|Lost to Follow-up|0|||
145660337|NCT01928394|525275526|FG019|Follow-up Period|Lost to Follow-up|0|||
145660338|NCT01928394|525275527|FG020|Follow-up Period|Lost to Follow-up|0|||
145660339|NCT01928394|525275528|FG021|Follow-up Period|Lost to Follow-up|0|||
145660340|NCT01928394|525275529|FG022|Follow-up Period|Lost to Follow-up|1|||
145660341|NCT05485779|525275532|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660342|NCT05485779|525275533|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660343|NCT05485779|525275534|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660344|NCT05485779|525275535|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660345|NCT05485779|525275536|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660346|NCT05485779|525275537|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660347|NCT05485779|525275538|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660348|NCT05485779|525275539|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
145660349|NCT05485779|525275540|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
145660350|NCT05485779|525275541|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660351|NCT05485779|525275542|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
145660352|NCT05485779|525275532|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660353|NCT05485779|525275533|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660354|NCT05485779|525275534|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660355|NCT05485779|525275535|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660356|NCT05485779|525275536|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660357|NCT05485779|525275537|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660358|NCT05485779|525275538|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660359|NCT05485779|525275539|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660360|NCT05485779|525275540|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660361|NCT05485779|525275541|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
145660362|NCT05485779|525275542|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
145660363|NCT05485779|525275532|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660364|NCT05485779|525275533|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660365|NCT05485779|525275534|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660366|NCT05485779|525275535|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
145660367|NCT05485779|525275536|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660368|NCT05485779|525275537|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660369|NCT05485779|525275538|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660370|NCT05485779|525275539|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660371|NCT05485779|525275540|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660372|NCT05485779|525275541|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660373|NCT05485779|525275542|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
145660374|NCT02038777|525275543|FG000|Overall Study|Death|0|||
145660375|NCT02038777|525275544|FG001|Overall Study|Death|2|||
145660376|NCT02038777|525275545|FG002|Overall Study|Death|0|||
145660377|NCT02038777|525275546|FG003|Overall Study|Death|1|||
145660378|NCT02038777|525275547|FG004|Overall Study|Death|2|||
145660379|NCT02038777|525275548|FG005|Overall Study|Death|4|||
145660380|NCT02038777|525275549|FG006|Overall Study|Death|0|||
145660381|NCT02038777|525275550|FG007|Overall Study|Death|11|||
145660382|NCT02038777|525275543|FG000|Overall Study|Lost to Follow-up|0|||
145660383|NCT02038777|525275544|FG001|Overall Study|Lost to Follow-up|0|||
145660384|NCT02038777|525275545|FG002|Overall Study|Lost to Follow-up|0|||
145660385|NCT02038777|525275546|FG003|Overall Study|Lost to Follow-up|1|||
145660386|NCT02038777|525275547|FG004|Overall Study|Lost to Follow-up|0|||
145660387|NCT02038777|525275548|FG005|Overall Study|Lost to Follow-up|0|||
145660388|NCT02038777|525275549|FG006|Overall Study|Lost to Follow-up|0|||
145660389|NCT02038777|525275550|FG007|Overall Study|Lost to Follow-up|0|||
145660390|NCT02038777|525275543|FG000|Overall Study|Other|0|||
145660391|NCT02038777|525275544|FG001|Overall Study|Other|1|||
145660392|NCT02038777|525275545|FG002|Overall Study|Other|0|||
145660393|NCT02038777|525275546|FG003|Overall Study|Other|2|||
145660394|NCT02038777|525275547|FG004|Overall Study|Other|1|||
145660395|NCT02038777|525275548|FG005|Overall Study|Other|0|||
145660396|NCT02038777|525275549|FG006|Overall Study|Other|0|||
145660397|NCT02038777|525275550|FG007|Overall Study|Other|0|||
145660398|NCT02038777|525275543|FG000|Overall Study|Randomized but not treated|0|||
145660399|NCT02038777|525275544|FG001|Overall Study|Randomized but not treated|1|||
145660400|NCT02038777|525275545|FG002|Overall Study|Randomized but not treated|0|||
145660401|NCT02038777|525275546|FG003|Overall Study|Randomized but not treated|0|||
145660402|NCT02038777|525275547|FG004|Overall Study|Randomized but not treated|0|||
145660403|NCT02038777|525275548|FG005|Overall Study|Randomized but not treated|0|||
145660404|NCT02038777|525275549|FG006|Overall Study|Randomized but not treated|0|||
145660405|NCT02038777|525275550|FG007|Overall Study|Randomized but not treated|0|||
145660406|NCT02038777|525275543|FG000|Overall Study|Started Chemotherapy|1|||
145660407|NCT02038777|525275544|FG001|Overall Study|Started Chemotherapy|0|||
145660408|NCT02038777|525275545|FG002|Overall Study|Started Chemotherapy|3|||
145660409|NCT02038777|525275546|FG003|Overall Study|Started Chemotherapy|0|||
145660410|NCT02038777|525275547|FG004|Overall Study|Started Chemotherapy|0|||
145660411|NCT02038777|525275548|FG005|Overall Study|Started Chemotherapy|0|||
145660412|NCT02038777|525275549|FG006|Overall Study|Started Chemotherapy|0|||
145660413|NCT02038777|525275550|FG007|Overall Study|Started Chemotherapy|0|||
145660414|NCT02038777|525275543|FG000|Overall Study|participation terminated by sponsor|0|||
145660415|NCT02038777|525275544|FG001|Overall Study|participation terminated by sponsor|0|||
145660416|NCT02038777|525275545|FG002|Overall Study|participation terminated by sponsor|0|||
145660417|NCT02038777|525275546|FG003|Overall Study|participation terminated by sponsor|0|||
145660418|NCT02038777|525275547|FG004|Overall Study|participation terminated by sponsor|0|||
145660419|NCT02038777|525275548|FG005|Overall Study|participation terminated by sponsor|0|||
145660420|NCT02038777|525275549|FG006|Overall Study|participation terminated by sponsor|1|||
145660421|NCT02038777|525275550|FG007|Overall Study|participation terminated by sponsor|1|||
145660422|NCT04299464|525275551|FG000|Overall Study|Adverse Event|1|||
145660423|NCT04299464|525275552|FG001|Overall Study|Adverse Event|0|||
145660424|NCT04299464|525275553|FG002|Overall Study|Adverse Event|2|||
145660425|NCT04299464|525275551|FG000|Overall Study|Non-compliance with Study Drug|1|||
145660426|NCT04299464|525275552|FG001|Overall Study|Non-compliance with Study Drug|0|||
145660427|NCT04299464|525275553|FG002|Overall Study|Non-compliance with Study Drug|0|||
145660428|NCT04299464|525275551|FG000|Overall Study|Reason not Specified|0|||
145660429|NCT04299464|525275552|FG001|Overall Study|Reason not Specified|1|||
145660430|NCT04299464|525275553|FG002|Overall Study|Reason not Specified|3|||
145660431|NCT04299464|525275551|FG000|Overall Study|Physician Decision|0|||
145660432|NCT04299464|525275552|FG001|Overall Study|Physician Decision|1|||
145660433|NCT04299464|525275553|FG002|Overall Study|Physician Decision|1|||
145660434|NCT04299464|525275551|FG000|Overall Study|Withdrawal by Subject|0|||
145660435|NCT04299464|525275552|FG001|Overall Study|Withdrawal by Subject|2|||
145660436|NCT04299464|525275553|FG002|Overall Study|Withdrawal by Subject|1|||
145660437|NCT04971109|525275565|FG000|Overall Study|Adverse Event|4|||
145660438|NCT04971109|525275566|FG001|Overall Study|Adverse Event|3|||
145660439|NCT04971109|525275565|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
145660440|NCT04971109|525275566|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
145660441|NCT04971109|525275565|FG000|Overall Study|Lost to Follow-up|8|||
145660442|NCT04971109|525275566|FG001|Overall Study|Lost to Follow-up|2|||
145660443|NCT04971109|525275565|FG000|Overall Study|Physician Decision|5|||
145660444|NCT04971109|525275566|FG001|Overall Study|Physician Decision|0|||
145660445|NCT04971109|525275565|FG000|Overall Study|Protocol Violation|0|||
145660446|NCT04971109|525275566|FG001|Overall Study|Protocol Violation|1|||
145660447|NCT04971109|525275565|FG000|Overall Study|Withdrawal by Subject|18|||
145660448|NCT04971109|525275566|FG001|Overall Study|Withdrawal by Subject|3|||
145660449|NCT04971109|525275565|FG000|Overall Study|Subject was randomized in error|1|||
145660450|NCT04971109|525275566|FG001|Overall Study|Subject was randomized in error|0|||
145660451|NCT03209973|525275567|FG000|Overall Study|Withdrawal by Subject|7|||
145660452|NCT03209973|525275567|FG000|Overall Study|Lost to Follow-up|2|||
145660453|NCT03209973|525275567|FG000|Overall Study|Death|8|||
145660454|NCT03209973|525275567|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
145660455|NCT03209973|525275567|FG000|Overall Study|Sponsor Decision|18|||
145660456|NCT03209973|525275567|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
145660457|NCT03209973|525275567|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
145660458|NCT04024020|525275571|FG000|Overall Study|Withdrawal by Subject|2|||
145660459|NCT04024020|525275572|FG001|Overall Study|Withdrawal by Subject|2|||
145660460|NCT00746096|525275579|FG000|Overall Study|Adverse Event|1|||
145660461|NCT00746096|525275580|FG001|Overall Study|Adverse Event|0|||
145660462|NCT00746096|525275579|FG000|Overall Study|Withdrawal by Subject|5|||
145660463|NCT00746096|525275580|FG001|Overall Study|Withdrawal by Subject|1|||
145660464|NCT00746096|525275579|FG000|Overall Study|Lost to Follow-up|2|||
145660465|NCT00746096|525275580|FG001|Overall Study|Lost to Follow-up|1|||
145660466|NCT00746096|525275579|FG000|Overall Study|Protocol Violation|1|||
145660467|NCT00746096|525275580|FG001|Overall Study|Protocol Violation|0|||
145660468|NCT00746096|525275579|FG000|Overall Study|No study drug treatment|1|||
145660469|NCT00746096|525275580|FG001|Overall Study|No study drug treatment|1|||
145660470|NCT03034356|525275585|FG000|Baseline|Lost to Follow-up|2|||
145660471|NCT03034356|525275586|FG001|Baseline|Lost to Follow-up|4|||
145660472|NCT03034356|525275585|FG000|Baseline|Withdrawal by Subject|2|||
145660473|NCT03034356|525275586|FG001|Baseline|Withdrawal by Subject|0|||
145660474|NCT03034356|525275585|FG000|Baseline|Physician Decision|0|||
145660475|NCT03034356|525275586|FG001|Baseline|Physician Decision|1|||
145660476|NCT03034356|525275585|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
145660477|NCT03034356|525275586|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
145660478|NCT03034356|525275585|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
145660479|NCT03034356|525275586|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
145660480|NCT03034356|525275585|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
145660481|NCT03034356|525275586|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
145660482|NCT03034356|525275585|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
145660483|NCT03034356|525275586|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
145660484|NCT02684227|525275588|FG000|Overall Study|Adverse Event|1|||
145660485|NCT02684227|525275589|FG001|Overall Study|Adverse Event|7|||
145660486|NCT02684227|525275588|FG000|Overall Study|Death|0|||
145660487|NCT02684227|525275589|FG001|Overall Study|Death|2|||
145660488|NCT02684227|525275588|FG000|Overall Study|Withdrawal by Subject|0|||
145660489|NCT02684227|525275589|FG001|Overall Study|Withdrawal by Subject|1|||
145660490|NCT02684227|525275588|FG000|Overall Study|Progressive Disease|0|||
145660491|NCT02684227|525275589|FG001|Overall Study|Progressive Disease|2|||
145660492|NCT04689256|525275590|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
145660493|NCT04689256|525275591|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
145660494|NCT04428203|525275594|FG000|Overall Study|Adverse Event|1|||
145660495|NCT04428203|525275595|FG001|Overall Study|Adverse Event|0|||
145660496|NCT04428203|525275596|FG002|Overall Study|Adverse Event|0|||
145660497|NCT04428203|525275594|FG000|Overall Study|Withdrawal by Subject|1|||
145660498|NCT04428203|525275595|FG001|Overall Study|Withdrawal by Subject|0|||
145660499|NCT04428203|525275596|FG002|Overall Study|Withdrawal by Subject|1|||
145660500|NCT02823145|525275597|FG000|Enrollment|Other|1|||
145660501|NCT02823145|525275598|FG001|Enrollment|Other|0|||
145660502|NCT02823145|525275597|FG000|Treatment|Adverse Event|0|||
145660503|NCT02823145|525275598|FG001|Treatment|Adverse Event|11|||
145660504|NCT02823145|525275597|FG000|Treatment|Death|0|||
145660505|NCT02823145|525275598|FG001|Treatment|Death|3|||
145660506|NCT02823145|525275597|FG000|Treatment|Family Decision|0|||
145660507|NCT02823145|525275598|FG001|Treatment|Family Decision|1|||
145660508|NCT02823145|525275597|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
145660509|NCT02823145|525275598|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
145660510|NCT02823145|525275597|FG000|Treatment|Lack of Efficacy|0|||
145660511|NCT02823145|525275598|FG001|Treatment|Lack of Efficacy|48|||
145660512|NCT02823145|525275597|FG000|Treatment|Non-Compliance With E-Diary|0|||
145660513|NCT02823145|525275598|FG001|Treatment|Non-Compliance With E-Diary|1|||
145660514|NCT02823145|525275597|FG000|Treatment|Physician Decision|0|||
145660515|NCT02823145|525275598|FG001|Treatment|Physician Decision|2|||
145660516|NCT02823145|525275597|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
145660517|NCT02823145|525275598|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
145660518|NCT02823145|525275597|FG000|Treatment|Subject needed to take prohibited medication|0|||
145660519|NCT02823145|525275598|FG001|Treatment|Subject needed to take prohibited medication|1|||
145660520|NCT02823145|525275597|FG000|Treatment|Subject transferred to direct access programme|0|||
145660521|NCT02823145|525275598|FG001|Treatment|Subject transferred to direct access programme|1|||
145660522|NCT02823145|525275597|FG000|Treatment|Switching to commercially available drug|0|||
145660523|NCT02823145|525275598|FG001|Treatment|Switching to commercially available drug|11|||
145660524|NCT02823145|525275597|FG000|Treatment|Transitioned to commercial supply of medication|0|||
145660525|NCT02823145|525275598|FG001|Treatment|Transitioned to commercial supply of medication|1|||
145660526|NCT02823145|525275597|FG000|Treatment|Withdrawal By Caregiver|0|||
145660527|NCT02823145|525275598|FG001|Treatment|Withdrawal By Caregiver|1|||
145660528|NCT02823145|525275597|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
145660529|NCT02823145|525275598|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
145660530|NCT02823145|525275597|FG000|Treatment|Withdrawal by Subject|0|||
145660531|NCT02823145|525275598|FG001|Treatment|Withdrawal by Subject|16|||
145660532|NCT02823145|525275597|FG000|Treatment|Reason unknown|0|||
145660533|NCT02823145|525275598|FG001|Treatment|Reason unknown|1|||
145660534|NCT04741776|525275599|FG000|Overall Study|Withdrawal by Subject|7|||
145660535|NCT04741776|525275600|FG001|Overall Study|Withdrawal by Subject|10|||
145660536|NCT04741776|525275601|FG002|Overall Study|Withdrawal by Subject|10|||
145660537|NCT04741776|525275602|FG003|Overall Study|Withdrawal by Subject|17|||
145660538|NCT04741776|525275599|FG000|Overall Study|Death|0|||
145660539|NCT04741776|525275600|FG001|Overall Study|Death|0|||
145660540|NCT04741776|525275601|FG002|Overall Study|Death|1|||
145660541|NCT04741776|525275602|FG003|Overall Study|Death|0|||
145660542|NCT02852655|525275613|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
145660543|NCT02852655|525275614|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
145660544|NCT02852655|525275615|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
145660545|NCT02852655|525275613|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
145660546|NCT02852655|525275614|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
145660547|NCT02852655|525275615|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
145660548|NCT02852655|525275613|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
145660549|NCT02852655|525275614|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
145660550|NCT02852655|525275615|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
145660551|NCT02852655|525275613|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
145660552|NCT02852655|525275614|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
145660553|NCT02852655|525275615|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
145660554|NCT02852655|525275613|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
145660555|NCT02852655|525275614|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
145660556|NCT02852655|525275615|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
145660557|NCT02852655|525275613|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
145660558|NCT02852655|525275614|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
145660559|NCT02852655|525275615|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
145660560|NCT02852655|525275613|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
145660561|NCT02852655|525275614|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
145660562|NCT02852655|525275615|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
145660563|NCT02852655|525275613|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
145660564|NCT02852655|525275614|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
145660565|NCT02852655|525275615|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
145660566|NCT02852655|525275613|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
145660567|NCT02852655|525275614|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
145660568|NCT02852655|525275615|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
145660569|NCT04086121|525275616|FG000|Overall Study|Other than listed|8|||
145660570|NCT04086121|525275616|FG000|Overall Study|Withdrawal by Subject|3|||
145660571|NCT04086121|525275616|FG000|Overall Study|Lost to Follow-up|2|||
145660572|NCT04086121|525275616|FG000|Overall Study|Adverse Event|1|||
145660573|NCT05292391|525275623|FG000|Overall Study|Lost to Follow-up|0|||
145660574|NCT05292391|525275624|FG001|Overall Study|Lost to Follow-up|0|||
145660575|NCT05292391|525275625|FG002|Overall Study|Lost to Follow-up|0|||
145660576|NCT05292391|525275626|FG003|Overall Study|Lost to Follow-up|1|||
145660577|NCT05292391|525275627|FG004|Overall Study|Lost to Follow-up|0|||
145660578|NCT05809453|525277035|FG000|Overall Study|Withdrawal by Subject|1|||
145660579|NCT05809453|525277036|FG001|Overall Study|Withdrawal by Subject|0|||
145660580|NCT05809453|525277037|FG002|Overall Study|Withdrawal by Subject|0|||
145660581|NCT05809453|525277038|FG003|Overall Study|Withdrawal by Subject|0|||
145660582|NCT00104676|525277044|FG000|Overall Study|Death|3|||
145660583|NCT00104676|525277045|FG001|Overall Study|Death|2|||
145660584|NCT00104676|525277044|FG000|Overall Study|Withdrawal by Subject|0|||
145660585|NCT00104676|525277045|FG001|Overall Study|Withdrawal by Subject|2|||
145660586|NCT00104676|525277044|FG000|Overall Study|treatment interruption|4|||
145660587|NCT00104676|525277045|FG001|Overall Study|treatment interruption|10|||
145660588|NCT05622812|525277046|FG000|Overall Study|Withdrawal by Subject|1|||
145660589|NCT05622812|525277047|FG001|Overall Study|Withdrawal by Subject|4|||
145660590|NCT05622812|525277046|FG000|Overall Study|Lost to Follow-up|2|||
145660591|NCT05622812|525277047|FG001|Overall Study|Lost to Follow-up|1|||
145660592|NCT03916185|525277048|FG000|Overall Study|Lost to Follow-up|0|||
145660593|NCT03916185|525277049|FG001|Overall Study|Lost to Follow-up|1|||
145660594|NCT03916185|525277050|FG002|Overall Study|Lost to Follow-up|0|||
145660595|NCT03916185|525277051|FG003|Overall Study|Lost to Follow-up|0|||
145660596|NCT03916185|525277048|FG000|Overall Study|Moved|1|||
145660597|NCT03916185|525277049|FG001|Overall Study|Moved|0|||
145660598|NCT03916185|525277050|FG002|Overall Study|Moved|0|||
145490539|NCT02349633|524650308|FG000|Overall Study|Other|0|||
145490540|NCT02349633|524650309|FG001|Overall Study|Other|0|||
145490541|NCT02349633|524650310|FG002|Overall Study|Other|0|||
145490542|NCT02349633|524650311|FG003|Overall Study|Other|0|||
145490543|NCT02349633|524650312|FG004|Overall Study|Other|0|||
145490544|NCT02349633|524650313|FG005|Overall Study|Other|0|||
145490545|NCT02349633|524650314|FG006|Overall Study|Other|0|||
145490546|NCT02349633|524650315|FG007|Overall Study|Other|2|||
145490547|NCT02349633|524650316|FG008|Overall Study|Other|0|||
145490548|NCT02349633|524650317|FG009|Overall Study|Other|0|||
145490549|NCT02349633|524650318|FG010|Overall Study|Other|0|||
145490550|NCT02349633|524650319|FG011|Overall Study|Other|0|||
145490551|NCT02349633|524650320|FG012|Overall Study|Other|0|||
145490552|NCT02349633|524650321|FG013|Overall Study|Other|0|||
145490553|NCT00667628|524650327|FG000|Overall Study|Lost to Follow-up|1|||
145490554|NCT00667628|524650328|FG001|Overall Study|Lost to Follow-up|0|||
145490555|NCT00667628|524650327|FG000|Overall Study|Death|6|||
145490556|NCT00667628|524650328|FG001|Overall Study|Death|6|||
145490557|NCT00667628|524650327|FG000|Overall Study|Investigator Considers in Best Interest|1|||
145490558|NCT00667628|524650328|FG001|Overall Study|Investigator Considers in Best Interest|0|||
145490559|NCT00667628|524650327|FG000|Overall Study|Sponsor Terminated Study|17|||
145490560|NCT00667628|524650328|FG001|Overall Study|Sponsor Terminated Study|21|||
145490561|NCT04663321|524650329|FG000|Overall Study|Study terminated by Sponsor|2|||
145660599|NCT03916185|525277051|FG003|Overall Study|Moved|1|||
145660600|NCT03916185|525277048|FG000|Overall Study|Not Able to Get to Clinic|1|||
145660601|NCT03916185|525277049|FG001|Overall Study|Not Able to Get to Clinic|0|||
145660602|NCT03916185|525277050|FG002|Overall Study|Not Able to Get to Clinic|0|||
145660603|NCT03916185|525277051|FG003|Overall Study|Not Able to Get to Clinic|0|||
145660604|NCT02844465|525277055|FG000|Overall Study|Screen Failure|36|||
145660605|NCT02844465|525277055|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
145660606|NCT02844465|525277055|FG000|Overall Study|Withdrawal by Subject|5|||
145660607|NCT02844465|525277055|FG000|Overall Study|Lost to Follow-up|1|||
145660608|NCT02844465|525277055|FG000|Overall Study|Retreatment|1|||
145660609|NCT05671653|525277057|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
145660610|NCT05671653|525277058|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
145660611|NCT05671653|525277059|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
145660612|NCT05671653|525277060|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
145660613|NCT05671653|525277061|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
145660614|NCT05671653|525277062|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
145660615|NCT05671653|525277063|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
145660616|NCT05671653|525277064|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
145660617|NCT05671653|525277065|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
145660618|NCT05671653|525277066|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
145660619|NCT05671653|525277067|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
145660620|NCT05671653|525277068|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
145660621|NCT05671653|525277069|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
145660622|NCT05671653|525277057|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660623|NCT05671653|525277058|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660624|NCT05671653|525277059|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660625|NCT05671653|525277060|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660626|NCT05671653|525277061|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660627|NCT05671653|525277062|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
145660628|NCT05671653|525277063|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660629|NCT05671653|525277064|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660630|NCT05671653|525277065|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660631|NCT05671653|525277066|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660632|NCT05671653|525277067|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660633|NCT05671653|525277068|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660634|NCT05671653|525277069|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
145660635|NCT05671653|525277057|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660636|NCT05671653|525277058|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660637|NCT05671653|525277059|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660638|NCT05671653|525277060|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660639|NCT05671653|525277061|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660640|NCT05671653|525277062|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
145660641|NCT05671653|525277063|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660642|NCT05671653|525277064|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660643|NCT05671653|525277065|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660644|NCT05671653|525277066|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660645|NCT05671653|525277067|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660646|NCT05671653|525277068|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660647|NCT05671653|525277069|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
145660648|NCT05671653|525277057|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660649|NCT05671653|525277058|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660650|NCT05671653|525277059|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660651|NCT05671653|525277060|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660652|NCT05671653|525277061|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660653|NCT05671653|525277062|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660654|NCT05671653|525277063|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660655|NCT05671653|525277064|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660656|NCT05671653|525277065|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
145660657|NCT05671653|525277066|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660658|NCT05671653|525277067|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660659|NCT05671653|525277068|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660660|NCT05671653|525277069|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
145660661|NCT05671653|525277057|FG000|Cohort 2 Period 2|Adverse Event|0|||
145660662|NCT05671653|525277058|FG001|Cohort 2 Period 2|Adverse Event|0|||
145660663|NCT05671653|525277059|FG002|Cohort 2 Period 2|Adverse Event|0|||
145660664|NCT05671653|525277060|FG003|Cohort 2 Period 2|Adverse Event|0|||
145660665|NCT05671653|525277061|FG004|Cohort 2 Period 2|Adverse Event|0|||
145660666|NCT05671653|525277062|FG005|Cohort 2 Period 2|Adverse Event|0|||
145660667|NCT05671653|525277063|FG006|Cohort 2 Period 2|Adverse Event|0|||
145660668|NCT05671653|525277064|FG007|Cohort 2 Period 2|Adverse Event|0|||
145660669|NCT05671653|525277065|FG008|Cohort 2 Period 2|Adverse Event|0|||
145660670|NCT05671653|525277066|FG009|Cohort 2 Period 2|Adverse Event|0|||
145660671|NCT05671653|525277067|FG010|Cohort 2 Period 2|Adverse Event|1|||
145660672|NCT05671653|525277068|FG011|Cohort 2 Period 2|Adverse Event|0|||
145660673|NCT05671653|525277069|FG012|Cohort 2 Period 2|Adverse Event|0|||
145660674|NCT05671653|525277057|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
145660675|NCT05671653|525277058|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
145660676|NCT05671653|525277059|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
145660677|NCT05671653|525277060|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
145660678|NCT05671653|525277061|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
145660679|NCT05671653|525277062|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
145660680|NCT05671653|525277063|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
145660681|NCT05671653|525277064|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
145660682|NCT05671653|525277065|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
145660683|NCT05671653|525277066|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
145660684|NCT05671653|525277067|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
145660685|NCT05671653|525277068|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
145660686|NCT05671653|525277069|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
145660687|NCT05671653|525277057|FG000|Cohort 2 Period 2|Pregnancy|0|||
145660688|NCT05671653|525277058|FG001|Cohort 2 Period 2|Pregnancy|0|||
145660689|NCT05671653|525277059|FG002|Cohort 2 Period 2|Pregnancy|0|||
145660690|NCT05671653|525277060|FG003|Cohort 2 Period 2|Pregnancy|0|||
145660691|NCT05671653|525277061|FG004|Cohort 2 Period 2|Pregnancy|0|||
145660692|NCT05671653|525277062|FG005|Cohort 2 Period 2|Pregnancy|0|||
145660693|NCT05671653|525277063|FG006|Cohort 2 Period 2|Pregnancy|0|||
145660694|NCT05671653|525277064|FG007|Cohort 2 Period 2|Pregnancy|0|||
145660695|NCT05671653|525277065|FG008|Cohort 2 Period 2|Pregnancy|0|||
145660696|NCT05671653|525277066|FG009|Cohort 2 Period 2|Pregnancy|0|||
145660697|NCT05671653|525277067|FG010|Cohort 2 Period 2|Pregnancy|1|||
145660698|NCT05671653|525277068|FG011|Cohort 2 Period 2|Pregnancy|0|||
145660699|NCT05671653|525277069|FG012|Cohort 2 Period 2|Pregnancy|0|||
145660700|NCT05671653|525277057|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660701|NCT05671653|525277058|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660702|NCT05671653|525277059|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660703|NCT05671653|525277060|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660704|NCT05671653|525277061|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660705|NCT05671653|525277062|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660706|NCT05671653|525277063|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660707|NCT05671653|525277064|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660708|NCT05671653|525277065|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660709|NCT05671653|525277066|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660710|NCT05671653|525277067|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
145660711|NCT05671653|525277068|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660712|NCT05671653|525277069|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
145660713|NCT05671653|525277057|FG000|Cohort 2 Period 2|Other|0|||
145660714|NCT05671653|525277058|FG001|Cohort 2 Period 2|Other|0|||
145660715|NCT05671653|525277059|FG002|Cohort 2 Period 2|Other|0|||
145660716|NCT05671653|525277060|FG003|Cohort 2 Period 2|Other|0|||
145660717|NCT05671653|525277061|FG004|Cohort 2 Period 2|Other|0|||
145660718|NCT05671653|525277062|FG005|Cohort 2 Period 2|Other|0|||
145660719|NCT05671653|525277063|FG006|Cohort 2 Period 2|Other|0|||
145660720|NCT05671653|525277064|FG007|Cohort 2 Period 2|Other|0|||
145660721|NCT05671653|525277065|FG008|Cohort 2 Period 2|Other|0|||
145660722|NCT05671653|525277066|FG009|Cohort 2 Period 2|Other|0|||
145660723|NCT05671653|525277067|FG010|Cohort 2 Period 2|Other|1|||
145660724|NCT05671653|525277068|FG011|Cohort 2 Period 2|Other|0|||
145660725|NCT05671653|525277069|FG012|Cohort 2 Period 2|Other|0|||
145660726|NCT05671653|525277057|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660727|NCT05671653|525277058|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660728|NCT05671653|525277059|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660729|NCT05671653|525277060|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660730|NCT05671653|525277061|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660731|NCT05671653|525277062|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660732|NCT05671653|525277063|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660733|NCT05671653|525277064|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660734|NCT05671653|525277065|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660735|NCT05671653|525277066|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660736|NCT05671653|525277067|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660737|NCT05671653|525277068|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
145660738|NCT05671653|525277069|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
145660739|NCT03952338|525277077|FG000|Overall Study|Lost to Follow-up|11|||
145660740|NCT03952338|525277078|FG001|Overall Study|Lost to Follow-up|17|||
145660741|NCT03952338|525277077|FG000|Overall Study|Withdrawal by Subject|1|||
145660742|NCT03952338|525277078|FG001|Overall Study|Withdrawal by Subject|1|||
145660743|NCT03952338|525277077|FG000|Overall Study|Protocol Violation|1|||
145660744|NCT03952338|525277078|FG001|Overall Study|Protocol Violation|0|||
145660745|NCT02589795|525277080|FG000|Overall Study|Lost to Follow-up|1|||
145660746|NCT02589795|525277081|FG001|Overall Study|Lost to Follow-up|0|||
145660747|NCT02589795|525277082|FG002|Overall Study|Lost to Follow-up|0|||
145660748|NCT02589795|525277080|FG000|Overall Study|Withdrawal by Subject|0|||
145660749|NCT02589795|525277081|FG001|Overall Study|Withdrawal by Subject|0|||
145660750|NCT02589795|525277082|FG002|Overall Study|Withdrawal by Subject|2|||
145660751|NCT02589795|525277080|FG000|Overall Study|Protocol Violation|0|||
145660752|NCT02589795|525277081|FG001|Overall Study|Protocol Violation|0|||
145660753|NCT02589795|525277082|FG002|Overall Study|Protocol Violation|1|||
145660754|NCT04550221|525277085|FG000|Overall Study|Lost to Follow-up|0|||
145660755|NCT04550221|525277086|FG001|Overall Study|Lost to Follow-up|4|||
145660756|NCT04550221|525277085|FG000|Overall Study|Withdrawn|3|||
145660757|NCT04550221|525277086|FG001|Overall Study|Withdrawn|0|||
145660758|NCT04550221|525277085|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
145660759|NCT04550221|525277086|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
145660760|NCT04811040|525277087|FG000|Overall Study|Lost to Follow-up|2|||
145660761|NCT04811040|525277088|FG001|Overall Study|Lost to Follow-up|0|||
145660762|NCT04811040|525277089|FG002|Overall Study|Lost to Follow-up|0|||
145660763|NCT04811040|525277090|FG003|Overall Study|Lost to Follow-up|0|||
145660764|NCT04811040|525277087|FG000|Overall Study|Withdrew consent|1|||
145660765|NCT04811040|525277088|FG001|Overall Study|Withdrew consent|1|||
145660766|NCT04811040|525277089|FG002|Overall Study|Withdrew consent|0|||
145660767|NCT04811040|525277090|FG003|Overall Study|Withdrew consent|0|||
145660768|NCT04447040|525277092|FG000|Overall Study|Lost to Follow-up|2|||
145660769|NCT04447040|525277093|FG001|Overall Study|Lost to Follow-up|1|||
145660770|NCT04447040|525277094|FG002|Overall Study|Lost to Follow-up|3|||
145660771|NCT04447040|525277095|FG003|Overall Study|Lost to Follow-up|3|||
145660772|NCT04447040|525277096|FG004|Overall Study|Lost to Follow-up|1|||
145660773|NCT04447040|525277097|FG005|Overall Study|Lost to Follow-up|3|||
145660774|NCT04447040|525277092|FG000|Overall Study|Withdrawal by Subject|0|||
145660775|NCT04447040|525277093|FG001|Overall Study|Withdrawal by Subject|1|||
145660776|NCT04447040|525277094|FG002|Overall Study|Withdrawal by Subject|1|||
145660777|NCT04447040|525277095|FG003|Overall Study|Withdrawal by Subject|1|||
145660778|NCT04447040|525277096|FG004|Overall Study|Withdrawal by Subject|0|||
145660779|NCT04447040|525277097|FG005|Overall Study|Withdrawal by Subject|0|||
145660780|NCT04076618|525277098|FG000|Overall Study|Lost to Follow-up|2|||
145660781|NCT04076618|525277099|FG001|Overall Study|Lost to Follow-up|1|||
145660782|NCT04076618|525277100|FG002|Overall Study|Lost to Follow-up|3|||
145660783|NCT04076618|525277098|FG000|Overall Study|Withdrawal by Subject|3|||
145660784|NCT04076618|525277099|FG001|Overall Study|Withdrawal by Subject|1|||
145660785|NCT04076618|525277100|FG002|Overall Study|Withdrawal by Subject|2|||
145660786|NCT04076618|525277098|FG000|Overall Study|Relocated out of state|0|||
145660787|NCT04076618|525277099|FG001|Overall Study|Relocated out of state|2|||
145660788|NCT04076618|525277100|FG002|Overall Study|Relocated out of state|0|||
145660789|NCT04076618|525277098|FG000|Overall Study|COVID concerns|0|||
145660790|NCT04076618|525277099|FG001|Overall Study|COVID concerns|1|||
145660791|NCT04076618|525277100|FG002|Overall Study|COVID concerns|0|||
145660792|NCT04076618|525277098|FG000|Overall Study|Adverse Event|0|||
145660793|NCT04076618|525277099|FG001|Overall Study|Adverse Event|0|||
145660794|NCT04076618|525277100|FG002|Overall Study|Adverse Event|2|||
145660795|NCT04826471|525277101|FG000|Overall Study|Lost to Follow-up|2|||
145660796|NCT04826471|525277101|FG000|Overall Study|Protocol Violation|3|||
145660797|NCT04826471|525277101|FG000|Overall Study|Withdrawal by Subject|1|||
145660798|NCT05370040|525277102|FG000|Overall Study|Lost to Follow-up|0|||
145660799|NCT05370040|525277103|FG001|Overall Study|Lost to Follow-up|0|||
145660800|NCT05370040|525277104|FG002|Overall Study|Lost to Follow-up|1|||
145660801|NCT05370040|525277105|FG003|Overall Study|Lost to Follow-up|0|||
145660802|NCT05370040|525277106|FG004|Overall Study|Lost to Follow-up|1|||
145660803|NCT05370040|525277107|FG005|Overall Study|Lost to Follow-up|0|||
145660804|NCT02296684|525277110|FG000|Overall Study|Withdrawal by Subject|0|||
145660805|NCT02296684|525277111|FG001|Overall Study|Withdrawal by Subject|1|||
145660806|NCT02296684|525277112|FG002|Overall Study|Withdrawal by Subject|1|||
145660807|NCT02296684|525277110|FG000|Overall Study|Death|2|||
145660808|NCT02296684|525277111|FG001|Overall Study|Death|0|||
145660809|NCT02296684|525277112|FG002|Overall Study|Death|0|||
145660810|NCT03571581|525277113|FG000|Overall Study|Death|2|||
145660811|NCT03571581|525277113|FG000|Overall Study|Withdrawal by Subject|2|||
145660812|NCT01651403|525277115|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
145660813|NCT01651403|525277116|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
145660814|NCT01651403|525277115|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
145660815|NCT01651403|525277116|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
145660816|NCT01651403|525277115|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
145660817|NCT01651403|525277116|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
145660818|NCT01651403|525277115|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
145660819|NCT01651403|525277116|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
145660820|NCT01651403|525277115|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
145660821|NCT01651403|525277116|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
145660822|NCT01651403|525277115|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
145660823|NCT01651403|525277116|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
145660824|NCT05090683|525277117|FG000|Overall Study|Lost to Follow-up|10|||
145660825|NCT05090683|525277118|FG001|Overall Study|Lost to Follow-up|2|||
145660826|NCT05090683|525277117|FG000|Overall Study|Withdrawal by Subject|15|||
145660827|NCT05090683|525277118|FG001|Overall Study|Withdrawal by Subject|0|||
145660828|NCT04032847|525277119|FG000|Overall Study|Study termination by sponsor|8|||
145660829|NCT04032847|525277120|FG001|Overall Study|Study termination by sponsor|0|||
145660830|NCT04032847|525277121|FG002|Overall Study|Study termination by sponsor|4|||
145660831|NCT04032847|525277119|FG000|Overall Study|Death|12|||
145660832|NCT04032847|525277120|FG001|Overall Study|Death|0|||
145660833|NCT04032847|525277121|FG002|Overall Study|Death|0|||
145660834|NCT04032847|525277119|FG000|Overall Study|Progressive disease|2|||
145660835|NCT04032847|525277120|FG001|Overall Study|Progressive disease|0|||
145660836|NCT04032847|525277121|FG002|Overall Study|Progressive disease|1|||
145660837|NCT03213665|525277122|FG000|Overall Study|Adverse Event|1|||
145660838|NCT03213665|525277122|FG000|Overall Study|Physician Decision|2|||
145660839|NCT03213665|525277122|FG000|Overall Study|Withdrawal by Subject|3|||
145660840|NCT03213665|525277122|FG000|Overall Study|Progressive Disease|13|||
145660841|NCT03325985|525277123|FG000|Overall Study|Lost to Follow-up|122|||
145660842|NCT03325985|525277124|FG001|Overall Study|Lost to Follow-up|26|||
145660843|NCT03325985|525277125|FG002|Overall Study|Lost to Follow-up|141|||
145660844|NCT03325985|525277126|FG003|Overall Study|Lost to Follow-up|28|||
145660845|NCT03325985|525277123|FG000|Overall Study|Death|99|||
145660846|NCT03325985|525277124|FG001|Overall Study|Death|36|||
145660847|NCT03325985|525277125|FG002|Overall Study|Death|94|||
145660848|NCT03325985|525277126|FG003|Overall Study|Death|32|||
145660849|NCT03056573|525277127|FG000|Overall Study|Death|2|||
145660850|NCT03056573|525277128|FG001|Overall Study|Death|4|||
145660851|NCT03056573|525277127|FG000|Overall Study|Withdrawal by Subject|2|||
145660852|NCT03056573|525277128|FG001|Overall Study|Withdrawal by Subject|0|||
145660853|NCT03056573|525277127|FG000|Overall Study|Lost to Follow-up|1|||
145660854|NCT03056573|525277128|FG001|Overall Study|Lost to Follow-up|1|||
145660855|NCT05267470|525277129|FG000|Overall Study|Decision by sponsor|0|||
145660856|NCT05267470|525277130|FG001|Overall Study|Decision by sponsor|3|||
145660857|NCT05267470|525277131|FG002|Overall Study|Decision by sponsor|19|||
145660858|NCT05267470|525277132|FG003|Overall Study|Decision by sponsor|7|||
145660859|NCT05267470|525277133|FG004|Overall Study|Decision by sponsor|3|||
145660860|NCT05267470|525277129|FG000|Overall Study|Withdrawal by Subject|1|||
145660861|NCT05267470|525277130|FG001|Overall Study|Withdrawal by Subject|1|||
145660862|NCT05267470|525277131|FG002|Overall Study|Withdrawal by Subject|2|||
145660863|NCT05267470|525277132|FG003|Overall Study|Withdrawal by Subject|2|||
145660864|NCT05267470|525277133|FG004|Overall Study|Withdrawal by Subject|0|||
145660865|NCT05267470|525277129|FG000|Overall Study|Death|3|||
145660866|NCT05267470|525277130|FG001|Overall Study|Death|5|||
145660867|NCT05267470|525277131|FG002|Overall Study|Death|8|||
145660868|NCT05267470|525277132|FG003|Overall Study|Death|18|||
145660869|NCT05267470|525277133|FG004|Overall Study|Death|1|||
145660870|NCT05267470|525277129|FG000|Overall Study|Lost to Follow-up|0|||
145660871|NCT05267470|525277130|FG001|Overall Study|Lost to Follow-up|0|||
145660872|NCT05267470|525277131|FG002|Overall Study|Lost to Follow-up|0|||
145660873|NCT05267470|525277132|FG003|Overall Study|Lost to Follow-up|1|||
145660874|NCT05267470|525277133|FG004|Overall Study|Lost to Follow-up|0|||
145660875|NCT05828017|525277134|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
145660876|NCT05425420|525277135|FG000|Overall Study|Physician Decision|1|||
145660877|NCT05425420|525277135|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
145660878|NCT04571619|525277136|FG000|Phase 1|Death|22|||
145660879|NCT04571619|525277137|FG001|Phase 1|Death|18|||
145660880|NCT04571619|525277136|FG000|Phase 1|Withdrawal by Subject|7|||
145660881|NCT04571619|525277137|FG001|Phase 1|Withdrawal by Subject|2|||
145660882|NCT04571619|525277136|FG000|Phase 2|Death|13|||
145660883|NCT04571619|525277137|FG001|Phase 2|Death|16|||
145660884|NCT04571619|525277136|FG000|Phase 2|Withdrawal by Subject|6|||
145660885|NCT04571619|525277137|FG001|Phase 2|Withdrawal by Subject|4|||
145660886|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
145660887|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
145660888|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
145660889|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
145660890|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
145660891|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
145660892|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
145660893|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
145660894|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
145660895|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
145660896|NCT02361216|525277138|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
145660897|NCT02361216|525277139|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
145660898|NCT00323856|525277140|FG000|Overall Study|Withdrawal by Subject|1|||
145660899|NCT00323856|525277140|FG000|Overall Study|Was uncooperative and noncompliant|1|||
145660900|NCT00323856|525277140|FG000|Overall Study|Reason not specified|1|||
145660901|NCT00323856|525277140|FG000|Overall Study|Missing|2|||
145660902|NCT02460458|525278727|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
145660903|NCT02460458|525278727|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
145660904|NCT02460458|525278727|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
145660905|NCT02460458|525278727|FG000|First Prospective Phase|Lost to Follow-up|84|||
145660906|NCT02460458|525278727|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
145660907|NCT03220035|525278728|FG000|Overall Study|Adverse Event|1|||
145660908|NCT03220035|525278728|FG000|Overall Study|Protocol Violation|1|||
145660909|NCT03220035|525278728|FG000|Overall Study|Progressive Disease|2|||
145660910|NCT00696111|525278729|FG000|Overall Study|Withdrawal by Subject|17|||
145660911|NCT05299073|525278730|FG000|Overall Study|Withdrawal by Subject|0|||
145660912|NCT05299073|525278731|FG001|Overall Study|Withdrawal by Subject|0|||
145660913|NCT05299073|525278732|FG002|Overall Study|Withdrawal by Subject|1|||
145660914|NCT05299073|525278730|FG000|Overall Study|Adverse Event|0|||
145660915|NCT05299073|525278731|FG001|Overall Study|Adverse Event|1|||
145660916|NCT05299073|525278732|FG002|Overall Study|Adverse Event|0|||
145660917|NCT05299073|525278730|FG000|Overall Study|Lost to Follow-up|0|||
145660918|NCT05299073|525278731|FG001|Overall Study|Lost to Follow-up|1|||
145660919|NCT05299073|525278732|FG002|Overall Study|Lost to Follow-up|0|||
145660920|NCT04909801|525278733|FG000|Overall Study|Lack of Efficacy|2|||
145660921|NCT04909801|525278734|FG001|Overall Study|Lack of Efficacy|1|||
145660922|NCT04909801|525278733|FG000|Overall Study|Adverse Event|1|||
145660923|NCT04909801|525278734|FG001|Overall Study|Adverse Event|2|||
145660924|NCT04909801|525278733|FG000|Overall Study|Participant request to discontinue study treatment|1|||
145660925|NCT04909801|525278734|FG001|Overall Study|Participant request to discontinue study treatment|2|||
145660926|NCT04909801|525278733|FG000|Overall Study|Withdrawal by Subject|2|||
145660927|NCT04909801|525278734|FG001|Overall Study|Withdrawal by Subject|1|||
145660928|NCT04909801|525278733|FG000|Overall Study|other reasons|1|||
145660929|NCT04909801|525278734|FG001|Overall Study|other reasons|1|||
145660930|NCT05452460|525278735|FG000|Overall Study|Lost to Follow-up|3|||
145660931|NCT05452460|525278736|FG001|Overall Study|Lost to Follow-up|3|||
145660932|NCT05452460|525278735|FG000|Overall Study|Did not receive intervention|1|||
145660933|NCT05452460|525278736|FG001|Overall Study|Did not receive intervention|0|||
145660934|NCT01208662|525278737|FG000|Induction and Consolidation|Disease Progression|23|||
145660935|NCT01208662|525278738|FG001|Induction and Consolidation|Disease Progression|13|||
145660936|NCT01208662|525278739|FG002|Induction and Consolidation|Disease Progression|0|||
145660937|NCT01208662|525278737|FG000|Induction and Consolidation|Adverse Event|16|||
145660938|NCT01208662|525278738|FG001|Induction and Consolidation|Adverse Event|18|||
145660939|NCT01208662|525278739|FG002|Induction and Consolidation|Adverse Event|2|||
145660940|NCT01208662|525278737|FG000|Induction and Consolidation|MD or Participant Decision|16|||
145660941|NCT01208662|525278738|FG001|Induction and Consolidation|MD or Participant Decision|34|||
145660942|NCT01208662|525278739|FG002|Induction and Consolidation|MD or Participant Decision|4|||
145660943|NCT01208662|525278737|FG000|Induction and Consolidation|Death|1|||
145660944|NCT01208662|525278738|FG001|Induction and Consolidation|Death|3|||
145660945|NCT01208662|525278739|FG002|Induction and Consolidation|Death|1|||
145660946|NCT01208662|525278737|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
145660947|NCT01208662|525278738|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
145660948|NCT01208662|525278739|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
145660949|NCT01208662|525278737|FG000|Maintenance|Disease Progression|156|||
145660950|NCT01208662|525278738|FG001|Maintenance|Disease Progression|102|||
145660951|NCT01208662|525278739|FG002|Maintenance|Disease Progression|0|||
145660952|NCT01208662|525278737|FG000|Maintenance|Adverse Event|12|||
145660953|NCT01208662|525278738|FG001|Maintenance|Adverse Event|28|||
145660954|NCT01208662|525278739|FG002|Maintenance|Adverse Event|0|||
145660955|NCT01208662|525278737|FG000|Maintenance|MD or Participant Decision|24|||
145660956|NCT01208662|525278738|FG001|Maintenance|MD or Participant Decision|36|||
145660957|NCT01208662|525278739|FG002|Maintenance|MD or Participant Decision|0|||
145660958|NCT01208662|525278737|FG000|Maintenance|Death|0|||
145660959|NCT01208662|525278738|FG001|Maintenance|Death|3|||
145660960|NCT01208662|525278739|FG002|Maintenance|Death|0|||
145660961|NCT01208662|525278737|FG000|Maintenance|Discontinued for other reasons|21|||
145660962|NCT01208662|525278738|FG001|Maintenance|Discontinued for other reasons|31|||
145660963|NCT01208662|525278739|FG002|Maintenance|Discontinued for other reasons|0|||
145660964|NCT01208662|525278737|FG000|Maintenance|Still on Treatment|78|||
145660965|NCT01208662|525278738|FG001|Maintenance|Still on Treatment|89|||
145660966|NCT01208662|525278739|FG002|Maintenance|Still on Treatment|0|||
145660967|NCT00321048|525278740|FG000|Overall Study|Withdrawal by Subject|6|||
145660968|NCT00321048|525278741|FG001|Overall Study|Withdrawal by Subject|8|||
145660969|NCT04433208|525278742|FG000|Overall Study|Withdrawal by Subject|0|||
145660970|NCT04433208|525278743|FG001|Overall Study|Withdrawal by Subject|1|||
145660971|NCT04433208|525278744|FG002|Overall Study|Withdrawal by Subject|1|||
145660972|NCT04433208|525278745|FG003|Overall Study|Withdrawal by Subject|0|||
145660973|NCT04433208|525278746|FG004|Overall Study|Withdrawal by Subject|2|||
145660974|NCT04433208|525278747|FG005|Overall Study|Withdrawal by Subject|1|||
145660975|NCT04433208|525278742|FG000|Overall Study|Lost to Follow-up|0|||
145660976|NCT04433208|525278743|FG001|Overall Study|Lost to Follow-up|0|||
145660977|NCT04433208|525278744|FG002|Overall Study|Lost to Follow-up|0|||
145660978|NCT04433208|525278745|FG003|Overall Study|Lost to Follow-up|0|||
145660979|NCT04433208|525278746|FG004|Overall Study|Lost to Follow-up|0|||
145660980|NCT04433208|525278747|FG005|Overall Study|Lost to Follow-up|1|||
145660981|NCT03676192|525278752|FG000|Induction Study Period|Adverse Event|21|||
145660982|NCT03676192|525278753|FG001|Induction Study Period|Adverse Event|20|||
145660983|NCT03676192|525278752|FG000|Induction Study Period|Death|23|||
145660984|NCT03676192|525278753|FG001|Induction Study Period|Death|20|||
145660985|NCT03676192|525278752|FG000|Induction Study Period|Lost to Follow-up|3|||
145660986|NCT03676192|525278753|FG001|Induction Study Period|Lost to Follow-up|3|||
145660987|NCT03676192|525278752|FG000|Induction Study Period|Physician Decision|6|||
145660988|NCT03676192|525278753|FG001|Induction Study Period|Physician Decision|3|||
145660989|NCT03676192|525278752|FG000|Induction Study Period|Progressive Disease|32|||
145660990|NCT03676192|525278753|FG001|Induction Study Period|Progressive Disease|21|||
145660991|NCT03676192|525278752|FG000|Induction Study Period|Protocol Violation|1|||
145660992|NCT03676192|525278753|FG001|Induction Study Period|Protocol Violation|2|||
145660993|NCT03676192|525278752|FG000|Induction Study Period|Withdrawal by Subject|20|||
145660994|NCT03676192|525278753|FG001|Induction Study Period|Withdrawal by Subject|15|||
145660995|NCT03386578|525278755|FG000|PK Component|Lost to Follow-up|0|||
145660996|NCT03386578|525278756|FG001|PK Component|Lost to Follow-up|1|||
145660997|NCT03386578|525278757|FG002|PK Component|Lost to Follow-up|0|||
145660998|NCT03386578|525278758|FG003|PK Component|Lost to Follow-up|0|||
145660999|NCT03386578|525278759|FG004|PK Component|Lost to Follow-up|0|||
145661000|NCT03386578|525278760|FG005|PK Component|Lost to Follow-up|0|||
145661001|NCT03386578|525278761|FG006|PK Component|Lost to Follow-up|1|||
145661002|NCT03386578|525278762|FG007|PK Component|Lost to Follow-up|0|||
145661003|NCT03386578|525278763|FG008|PK Component|Lost to Follow-up|0|||
145661004|NCT03386578|525278764|FG009|PK Component|Lost to Follow-up|0|||
145661005|NCT03386578|525278755|FG000|PK Component|Stillbirth/Abortion|0|||
145661006|NCT03386578|525278756|FG001|PK Component|Stillbirth/Abortion|0|||
145661007|NCT03386578|525278757|FG002|PK Component|Stillbirth/Abortion|0|||
145661008|NCT03386578|525278758|FG003|PK Component|Stillbirth/Abortion|0|||
145661009|NCT03386578|525278759|FG004|PK Component|Stillbirth/Abortion|0|||
145661010|NCT03386578|525278760|FG005|PK Component|Stillbirth/Abortion|2|||
145661011|NCT03386578|525278761|FG006|PK Component|Stillbirth/Abortion|0|||
145661012|NCT03386578|525278762|FG007|PK Component|Stillbirth/Abortion|0|||
145661013|NCT03386578|525278763|FG008|PK Component|Stillbirth/Abortion|0|||
145661014|NCT03386578|525278764|FG009|PK Component|Stillbirth/Abortion|0|||
145661015|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661016|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661017|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
145661018|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
145661019|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661020|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661021|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661022|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
145661023|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
145661024|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
145661025|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661026|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661027|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
145661028|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
145661029|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661030|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661031|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661032|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
145661033|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
145661034|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
145661035|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Death|0|||
145661036|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Death|0|||
145661037|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Death|1|||
145661038|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Death|0|||
145661039|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Death|0|||
145661040|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Death|0|||
145661041|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Death|0|||
145661042|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Death|9|||
145661043|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Death|5|||
145661044|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Death|0|||
145661045|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661046|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661047|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661048|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
145661049|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661050|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661051|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661052|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661053|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
145661054|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
145661055|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661056|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661057|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661058|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661059|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661060|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661061|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661062|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
145661063|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
145661064|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
145661065|NCT03386578|525278755|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661066|NCT03386578|525278756|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661067|NCT03386578|525278757|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661068|NCT03386578|525278758|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661069|NCT03386578|525278759|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661070|NCT03386578|525278760|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661071|NCT03386578|525278761|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661072|NCT03386578|525278762|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
145661073|NCT03386578|525278763|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
145661074|NCT03386578|525278764|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
145661075|NCT02694822|525278765|FG000|Phase 1|Death|2|||
145661076|NCT02694822|525278766|FG001|Phase 1|Death|1|||
145661077|NCT02694822|525278767|FG002|Phase 1|Death|6|||
145661078|NCT02694822|525278768|FG003|Phase 1|Death|6|||
145661079|NCT02694822|525278769|FG004|Phase 1|Death|3|||
145661080|NCT02694822|525278770|FG005|Phase 1|Death|0|||
145661081|NCT02694822|525278765|FG000|Phase 1|Withdrawal by Subject|2|||
145661082|NCT02694822|525278766|FG001|Phase 1|Withdrawal by Subject|2|||
145661083|NCT02694822|525278767|FG002|Phase 1|Withdrawal by Subject|4|||
145661084|NCT02694822|525278768|FG003|Phase 1|Withdrawal by Subject|8|||
145661085|NCT02694822|525278769|FG004|Phase 1|Withdrawal by Subject|1|||
145661086|NCT02694822|525278770|FG005|Phase 1|Withdrawal by Subject|0|||
145661087|NCT02694822|525278765|FG000|Phase 2|Death|0|||
145661088|NCT02694822|525278766|FG001|Phase 2|Death|0|||
145661089|NCT02694822|525278767|FG002|Phase 2|Death|0|||
145661090|NCT02694822|525278768|FG003|Phase 2|Death|0|||
145661091|NCT02694822|525278769|FG004|Phase 2|Death|0|||
145661092|NCT02694822|525278770|FG005|Phase 2|Death|26|||
145661093|NCT02694822|525278765|FG000|Phase 2|Withdrawal by Subject|0|||
145661094|NCT02694822|525278766|FG001|Phase 2|Withdrawal by Subject|0|||
145661095|NCT02694822|525278767|FG002|Phase 2|Withdrawal by Subject|0|||
145661096|NCT02694822|525278768|FG003|Phase 2|Withdrawal by Subject|0|||
145661097|NCT02694822|525278769|FG004|Phase 2|Withdrawal by Subject|0|||
145661098|NCT02694822|525278770|FG005|Phase 2|Withdrawal by Subject|13|||
145661099|NCT02694822|525278765|FG000|Phase 2|Administrative Study Closure|0|||
145661100|NCT02694822|525278766|FG001|Phase 2|Administrative Study Closure|0|||
145661101|NCT02694822|525278767|FG002|Phase 2|Administrative Study Closure|0|||
145661102|NCT02694822|525278768|FG003|Phase 2|Administrative Study Closure|0|||
145661103|NCT02694822|525278769|FG004|Phase 2|Administrative Study Closure|0|||
145661104|NCT02694822|525278770|FG005|Phase 2|Administrative Study Closure|2|||
145661105|NCT02694822|525278765|FG000|Phase 2|Lost to Follow-up|0|||
145661106|NCT02694822|525278766|FG001|Phase 2|Lost to Follow-up|0|||
145661107|NCT02694822|525278767|FG002|Phase 2|Lost to Follow-up|0|||
145661108|NCT02694822|525278768|FG003|Phase 2|Lost to Follow-up|0|||
145661109|NCT02694822|525278769|FG004|Phase 2|Lost to Follow-up|0|||
145661110|NCT02694822|525278770|FG005|Phase 2|Lost to Follow-up|1|||
145661111|NCT02694822|525278765|FG000|Phase 2|Participant Transferred to Another Site|0|||
145661112|NCT02694822|525278766|FG001|Phase 2|Participant Transferred to Another Site|0|||
145661113|NCT02694822|525278767|FG002|Phase 2|Participant Transferred to Another Site|0|||
145661114|NCT02694822|525278768|FG003|Phase 2|Participant Transferred to Another Site|0|||
145661115|NCT02694822|525278769|FG004|Phase 2|Participant Transferred to Another Site|0|||
145661116|NCT02694822|525278770|FG005|Phase 2|Participant Transferred to Another Site|1|||
145661117|NCT02424617|525278771|FG000|Overall Study|Adverse Event|0|||
145661118|NCT02424617|525278772|FG001|Overall Study|Adverse Event|1|||
145661119|NCT02424617|525278773|FG002|Overall Study|Adverse Event|0|||
145490562|NCT04663321|524650330|FG001|Overall Study|Study terminated by Sponsor|1|||
145661120|NCT02424617|525278774|FG003|Overall Study|Adverse Event|0|||
145661121|NCT02424617|525278771|FG000|Overall Study|Investigator Decision|0|||
145661122|NCT02424617|525278772|FG001|Overall Study|Investigator Decision|0|||
145661123|NCT02424617|525278773|FG002|Overall Study|Investigator Decision|0|||
145661124|NCT02424617|525278774|FG003|Overall Study|Investigator Decision|1|||
145661125|NCT02424617|525278771|FG000|Overall Study|Withdrawal by Subject|1|||
145661126|NCT02424617|525278772|FG001|Overall Study|Withdrawal by Subject|1|||
145661127|NCT02424617|525278773|FG002|Overall Study|Withdrawal by Subject|0|||
145661128|NCT02424617|525278774|FG003|Overall Study|Withdrawal by Subject|1|||
145661129|NCT02424617|525278771|FG000|Overall Study|Progressive Disease|7|||
145661130|NCT02424617|525278772|FG001|Overall Study|Progressive Disease|6|||
145661131|NCT02424617|525278773|FG002|Overall Study|Progressive Disease|11|||
145661132|NCT02424617|525278774|FG003|Overall Study|Progressive Disease|10|||
145661133|NCT02424617|525278771|FG000|Overall Study|Other|0|||
145661134|NCT02424617|525278772|FG001|Overall Study|Other|0|||
145661135|NCT02424617|525278773|FG002|Overall Study|Other|0|||
145661136|NCT02424617|525278774|FG003|Overall Study|Other|1|||
145661137|NCT01868997|525278775|FG000|Overall Study|Adverse Event|2|||
145661138|NCT01868997|525278776|FG001|Overall Study|Adverse Event|5|||
145661139|NCT01868997|525278775|FG000|Overall Study|Lack of Efficacy|2|||
145661140|NCT01868997|525278776|FG001|Overall Study|Lack of Efficacy|0|||
145661141|NCT01868997|525278775|FG000|Overall Study|Other|3|||
145661142|NCT01868997|525278776|FG001|Overall Study|Other|1|||
145661143|NCT01960452|525278777|FG000|Overall Study|Withdrawal by Subject|2|||
145661144|NCT01960452|525278778|FG001|Overall Study|Withdrawal by Subject|1|||
145661145|NCT01960452|525278777|FG000|Overall Study|Sleep apnea in Night 1|1|||
145661146|NCT01960452|525278778|FG001|Overall Study|Sleep apnea in Night 1|0|||
145661147|NCT01960452|525278777|FG000|Overall Study|Poor Sleep in Night 1|0|||
145661148|NCT01960452|525278778|FG001|Overall Study|Poor Sleep in Night 1|2|||
145661149|NCT01960452|525278777|FG000|Overall Study|No Sex/Age Match Night 1|1|||
145661150|NCT01960452|525278778|FG001|Overall Study|No Sex/Age Match Night 1|0|||
145661151|NCT01960452|525278777|FG000|Overall Study|No Sex/Age Match Night 2|0|||
145661152|NCT01960452|525278778|FG001|Overall Study|No Sex/Age Match Night 2|2|||
145661153|NCT01960452|525278777|FG000|Overall Study|Technical Difficulties Night 2|2|||
145661154|NCT01960452|525278778|FG001|Overall Study|Technical Difficulties Night 2|0|||
145661155|NCT04066205|525278779|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
145661156|NCT04066205|525278780|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
145661157|NCT04066205|525278779|FG000|T2 Immediate Post-Intervention|did not respond|5|||
145661158|NCT04066205|525278780|FG001|T2 Immediate Post-Intervention|did not respond|3|||
145661159|NCT04778397|525278782|FG000|Overall Study|Death|59|||
145661160|NCT04778397|525278783|FG001|Overall Study|Death|54|||
145661161|NCT04778397|525278784|FG002|Overall Study|Death|11|||
145661162|NCT04778397|525278785|FG003|Overall Study|Death|9|||
145661163|NCT04778397|525278782|FG000|Overall Study|Study Terminated by Sponsor|34|||
145661164|NCT04778397|525278783|FG001|Overall Study|Study Terminated by Sponsor|42|||
145661165|NCT04778397|525278784|FG002|Overall Study|Study Terminated by Sponsor|15|||
145661166|NCT04778397|525278785|FG003|Overall Study|Study Terminated by Sponsor|12|||
145661167|NCT04778397|525278782|FG000|Overall Study|Withdrew Consent|5|||
145661168|NCT04778397|525278783|FG001|Overall Study|Withdrew Consent|4|||
145661169|NCT04778397|525278784|FG002|Overall Study|Withdrew Consent|1|||
145661170|NCT04778397|525278785|FG003|Overall Study|Withdrew Consent|1|||
145661171|NCT04778397|525278782|FG000|Overall Study|Reason Not Specified|1|||
145661172|NCT04778397|525278783|FG001|Overall Study|Reason Not Specified|3|||
145661173|NCT04778397|525278784|FG002|Overall Study|Reason Not Specified|0|||
145661174|NCT04778397|525278785|FG003|Overall Study|Reason Not Specified|2|||
145661175|NCT04778397|525278782|FG000|Overall Study|Lost to Follow-up|2|||
145661176|NCT04778397|525278783|FG001|Overall Study|Lost to Follow-up|1|||
145661177|NCT04778397|525278784|FG002|Overall Study|Lost to Follow-up|0|||
145661178|NCT04778397|525278785|FG003|Overall Study|Lost to Follow-up|1|||
145661179|NCT04294641|525278786|FG000|Overall Study|Screen failure|4|||
145661180|NCT01627574|525278791|FG000|Overall Study|Withdrawal by Subject|8|||
145661181|NCT01627574|525278792|FG001|Overall Study|Withdrawal by Subject|5|||
145661182|NCT01627574|525278791|FG000|Overall Study|Lost to Follow-up|13|||
145661183|NCT01627574|525278792|FG001|Overall Study|Lost to Follow-up|13|||
145661184|NCT03249090|525278802|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
145661185|NCT03249090|525278803|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
145661186|NCT03249090|525278802|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
145661187|NCT03249090|525278803|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
145661188|NCT03249090|525278802|FG000|3 Month Time Point|Voluntary withdrawal|6|||
145661189|NCT03249090|525278803|FG001|3 Month Time Point|Voluntary withdrawal|3|||
145661190|NCT03249090|525278802|FG000|3 Month Time Point|Changed oncology practice|4|||
145661191|NCT03249090|525278803|FG001|3 Month Time Point|Changed oncology practice|2|||
145661192|NCT03249090|525278802|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
145661193|NCT03249090|525278803|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
145661194|NCT03249090|525278802|FG000|12 Month Time Point|Voluntary withdrawal|35|||
145661195|NCT03249090|525278803|FG001|12 Month Time Point|Voluntary withdrawal|4|||
145661196|NCT03249090|525278802|FG000|12 Month Time Point|Changed oncology practice|20|||
145661197|NCT03249090|525278803|FG001|12 Month Time Point|Changed oncology practice|9|||
145661198|NCT04359654|525278807|FG000|Overall Study|Withdrawal by Subject|1|||
145661199|NCT04359654|525278808|FG001|Overall Study|Withdrawal by Subject|0|||
145661200|NCT04359654|525278807|FG000|Overall Study|Adverse Event|0|||
145661201|NCT04359654|525278808|FG001|Overall Study|Adverse Event|1|||
145661202|NCT06122194|525278809|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
145661203|NCT06122194|525278810|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
145661204|NCT06122194|525278811|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
145661205|NCT06122194|525278812|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
145661206|NCT04314778|525278813|FG000|Overall Study|Lost to Follow-up|5|||
145661207|NCT04314778|525278814|FG001|Overall Study|Lost to Follow-up|3|||
145661208|NCT05646355|525278815|FG000|Overall Study|Lost to Follow-up|1|||
145661209|NCT05646355|525278816|FG001|Overall Study|Lost to Follow-up|0|||
145661210|NCT05646355|525278815|FG000|Overall Study|translated materials not available for pilot|2|||
145661211|NCT05646355|525278816|FG001|Overall Study|translated materials not available for pilot|0|||
145661212|NCT05646355|525278815|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
145661213|NCT05646355|525278816|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
145661214|NCT04685135|525278820|FG000|Overall Study|Death|126|||
145661215|NCT04685135|525278821|FG001|Overall Study|Death|53|||
145661216|NCT04685135|525278820|FG000|Overall Study|Withdrawal by Subject|12|||
145661217|NCT04685135|525278821|FG001|Overall Study|Withdrawal by Subject|16|||
145661218|NCT03711474|525278823|FG000|Overall Study|Physician Decision|2|||
145661219|NCT03711474|525278824|FG001|Overall Study|Physician Decision|0|||
145661220|NCT05974501|525278825|FG000|Overall Study|Physician Decision|0|||
145661221|NCT05974501|525278826|FG001|Overall Study|Physician Decision|1|||
145661222|NCT03513302|525278827|FG000|First Intervention (14 Days)|Screen failure|15|||
145661223|NCT03513302|525278828|FG001|First Intervention (14 Days)|Screen failure|16|||
145661224|NCT04862416|525278831|FG000|Overall Study|Withdrawal by Subject|0|||
145661225|NCT04862416|525278832|FG001|Overall Study|Withdrawal by Subject|1|||
145661226|NCT04862416|525278833|FG002|Overall Study|Withdrawal by Subject|0|||
145661227|NCT04862416|525278834|FG003|Overall Study|Withdrawal by Subject|1|||
145661228|NCT04862416|525278835|FG004|Overall Study|Withdrawal by Subject|0|||
145661229|NCT04862416|525278836|FG005|Overall Study|Withdrawal by Subject|0|||
145661230|NCT04862416|525278837|FG006|Overall Study|Withdrawal by Subject|0|||
145661231|NCT04862416|525278838|FG007|Overall Study|Withdrawal by Subject|0|||
145661232|NCT03852550|525278839|FG000|Overall Study|Lost to Follow-up|4|||
145661233|NCT03852550|525278840|FG001|Overall Study|Lost to Follow-up|3|||
145661234|NCT03852550|525278839|FG000|Overall Study|Only parent outcomes completed|0|||
145661235|NCT03852550|525278840|FG001|Overall Study|Only parent outcomes completed|1|||
145661236|NCT03852550|525278839|FG000|Overall Study|Withdrawal by Subject|1|||
145661237|NCT03852550|525278840|FG001|Overall Study|Withdrawal by Subject|0|||
145661238|NCT04141891|525278845|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
145661239|NCT04141891|525278846|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
145661240|NCT04141891|525278845|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
145661241|NCT04141891|525278846|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
145661242|NCT04141891|525278845|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
145661243|NCT04141891|525278846|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
145661244|NCT04141891|525278845|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
145661245|NCT04141891|525278846|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
145661246|NCT04141891|525278845|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
145661247|NCT04141891|525278846|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
145661248|NCT04141891|525278845|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
145661249|NCT04141891|525278846|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
145661250|NCT04141891|525278845|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
145661251|NCT04141891|525278846|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
145661252|NCT04141891|525278845|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
145661253|NCT04141891|525278846|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
145661254|NCT04141891|525278845|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
145661255|NCT04141891|525278846|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
145661256|NCT04141891|525278845|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
145661257|NCT04141891|525278846|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
145661258|NCT04141891|525278845|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
145661259|NCT04141891|525278846|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
145661260|NCT04141891|525278845|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
145661261|NCT04141891|525278846|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
145661262|NCT04141891|525278845|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
145661263|NCT04141891|525278846|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
145661264|NCT04141891|525278845|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
145661265|NCT04141891|525278846|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
145661266|NCT03626220|525278847|FG000|Overall Study|Withdrawal by Subject|2|||
145661267|NCT03626220|525278848|FG001|Overall Study|Withdrawal by Subject|0|||
145661268|NCT05565820|525278860|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
145661269|NCT05565820|525278861|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
145661270|NCT05565820|525278860|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
145661271|NCT05565820|525278861|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
145661272|NCT03295721|525278862|FG000|Overall Study|Adverse Event|1|||
145661273|NCT03295721|525278863|FG001|Overall Study|Adverse Event|0|||
145661274|NCT03295721|525278864|FG002|Overall Study|Adverse Event|0|||
145661275|NCT03295721|525278862|FG000|Overall Study|Lost to Follow-up|1|||
145661276|NCT03295721|525278863|FG001|Overall Study|Lost to Follow-up|1|||
145661277|NCT03295721|525278864|FG002|Overall Study|Lost to Follow-up|1|||
145661278|NCT03295721|525278862|FG000|Overall Study|Withdrawal by Subject|1|||
145661279|NCT03295721|525278863|FG001|Overall Study|Withdrawal by Subject|0|||
145661280|NCT03295721|525278864|FG002|Overall Study|Withdrawal by Subject|1|||
145661281|NCT03295721|525278862|FG000|Overall Study|Death|0|||
145661282|NCT03295721|525278863|FG001|Overall Study|Death|0|||
145661283|NCT03295721|525278864|FG002|Overall Study|Death|1|||
145661284|NCT00429364|525278866|FG000|Overall Study|Withdrawal by Subject|11|||
145661285|NCT00429364|525278867|FG001|Overall Study|Withdrawal by Subject|5|||
145661286|NCT00429364|525278866|FG000|Overall Study|Physician Decision|4|||
145661287|NCT00429364|525278867|FG001|Overall Study|Physician Decision|2|||
145661288|NCT00429364|525278866|FG000|Overall Study|Lost to Follow-up|7|||
145661289|NCT00429364|525278867|FG001|Overall Study|Lost to Follow-up|6|||
145661290|NCT00429364|525278866|FG000|Overall Study|Death|0|||
145661291|NCT00429364|525278867|FG001|Overall Study|Death|1|||
145661292|NCT00429364|525278866|FG000|Overall Study|Underwent aortic root surgery|10|||
145661293|NCT00429364|525278867|FG001|Overall Study|Underwent aortic root surgery|18|||
145661294|NCT00429364|525278866|FG000|Overall Study|Pregnancy|0|||
145661295|NCT00429364|525278867|FG001|Overall Study|Pregnancy|1|||
145661296|NCT04871529|525278868|FG000|Overall Study|Withdrawal by Subject|0|||
145661297|NCT04871529|525278869|FG001|Overall Study|Withdrawal by Subject|1|||
145661298|NCT04871529|525278868|FG000|Overall Study|Death|0|||
145661299|NCT04871529|525278869|FG001|Overall Study|Death|1|||
145661300|NCT04871529|525278868|FG000|Overall Study|Not protocol specified|0|||
145661301|NCT04871529|525278869|FG001|Overall Study|Not protocol specified|1|||
145661302|NCT05184452|525278870|FG000|Overall Study|Lost to Follow-up|0|||
145661303|NCT05184452|525278871|FG001|Overall Study|Lost to Follow-up|0|||
145661304|NCT05184452|525278872|FG002|Overall Study|Lost to Follow-up|0|||
145661305|NCT05184452|525278873|FG003|Overall Study|Lost to Follow-up|0|||
145661306|NCT05184452|525278874|FG004|Overall Study|Lost to Follow-up|0|||
145661307|NCT05184452|525278875|FG005|Overall Study|Lost to Follow-up|2|||
145661308|NCT05184452|525278876|FG006|Overall Study|Lost to Follow-up|0|||
145661309|NCT05184452|525278877|FG007|Overall Study|Lost to Follow-up|0|||
145661310|NCT05184452|525278878|FG008|Overall Study|Lost to Follow-up|0|||
145661311|NCT05184452|525278879|FG009|Overall Study|Lost to Follow-up|1|||
145661312|NCT05184452|525278870|FG000|Overall Study|Withdrawal by Subject|0|||
145661313|NCT05184452|525278871|FG001|Overall Study|Withdrawal by Subject|0|||
145661314|NCT05184452|525278872|FG002|Overall Study|Withdrawal by Subject|0|||
145661315|NCT05184452|525278873|FG003|Overall Study|Withdrawal by Subject|0|||
145661316|NCT05184452|525278874|FG004|Overall Study|Withdrawal by Subject|0|||
145661317|NCT05184452|525278875|FG005|Overall Study|Withdrawal by Subject|1|||
145661318|NCT05184452|525278876|FG006|Overall Study|Withdrawal by Subject|0|||
145661319|NCT05184452|525278877|FG007|Overall Study|Withdrawal by Subject|0|||
145661320|NCT05184452|525278878|FG008|Overall Study|Withdrawal by Subject|0|||
145661321|NCT05184452|525278879|FG009|Overall Study|Withdrawal by Subject|1|||
145661322|NCT05586490|525278880|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
145661323|NCT05586490|525278881|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
145661324|NCT05586490|525278882|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
145661325|NCT05586490|525278883|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
145661326|NCT05586490|525278884|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
145661327|NCT05586490|525278880|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
145661328|NCT05586490|525278881|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
145661329|NCT05586490|525278882|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
145661330|NCT05586490|525278883|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
145661331|NCT05586490|525278884|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
145661332|NCT05586490|525278880|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
145661333|NCT05586490|525278881|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
145661334|NCT05586490|525278882|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
145661335|NCT05586490|525278883|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
145661336|NCT05586490|525278884|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
145661337|NCT04183283|525280312|FG000|Period 1|Withdrawal by Subject|0|||
145661338|NCT04183283|525280313|FG001|Period 1|Withdrawal by Subject|1|||
145661339|NCT04183283|525280314|FG002|Period 1|Withdrawal by Subject|0|||
145661340|NCT04183283|525280315|FG003|Period 1|Withdrawal by Subject|0|||
145661341|NCT04183283|525280312|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
145661342|NCT04183283|525280313|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
145661343|NCT04183283|525280314|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
145661344|NCT04183283|525280315|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
145661345|NCT04730739|525280318|FG000|Overall Study|Death|1|||
145661346|NCT03308877|525280319|FG000|Overall Study|Lost to Follow-up|32|||
145661347|NCT03308877|525280320|FG001|Overall Study|Lost to Follow-up|28|||
145661348|NCT05218096|525280333|FG000|Primary Evaluation|Withdrawal by Subject|0|||
145661349|NCT05218096|525280334|FG001|Primary Evaluation|Withdrawal by Subject|0|||
145661350|NCT05218096|525280335|FG002|Primary Evaluation|Withdrawal by Subject|2|||
145661351|NCT05218096|525280336|FG003|Primary Evaluation|Withdrawal by Subject|0|||
145661352|NCT05218096|525280337|FG004|Primary Evaluation|Withdrawal by Subject|0|||
145661353|NCT05218096|525280333|FG000|Primary Evaluation|Physician Decision|1|||
145661354|NCT05218096|525280334|FG001|Primary Evaluation|Physician Decision|0|||
145661355|NCT05218096|525280335|FG002|Primary Evaluation|Physician Decision|0|||
145661356|NCT05218096|525280336|FG003|Primary Evaluation|Physician Decision|0|||
145661357|NCT05218096|525280337|FG004|Primary Evaluation|Physician Decision|0|||
145661358|NCT05218096|525280333|FG000|Extended Treatment|Clinical Deterioration|1|||
145661359|NCT05218096|525280334|FG001|Extended Treatment|Clinical Deterioration|1|||
145661360|NCT05218096|525280335|FG002|Extended Treatment|Clinical Deterioration|0|||
145661361|NCT05218096|525280336|FG003|Extended Treatment|Clinical Deterioration|0|||
145661362|NCT05218096|525280337|FG004|Extended Treatment|Clinical Deterioration|0|||
145661363|NCT05218096|525280333|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
145661364|NCT05218096|525280334|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
145661365|NCT05218096|525280335|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
145661366|NCT05218096|525280336|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
145661367|NCT05218096|525280337|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
145661368|NCT05218096|525280333|FG000|Extended Treatment|Withdrawal by Subject|1|||
145661369|NCT05218096|525280334|FG001|Extended Treatment|Withdrawal by Subject|3|||
145661370|NCT05218096|525280335|FG002|Extended Treatment|Withdrawal by Subject|0|||
145661371|NCT05218096|525280336|FG003|Extended Treatment|Withdrawal by Subject|2|||
145661372|NCT05218096|525280337|FG004|Extended Treatment|Withdrawal by Subject|2|||
145661373|NCT05218096|525280333|FG000|Extended Treatment|Lack of Efficacy|3|||
145661374|NCT05218096|525280334|FG001|Extended Treatment|Lack of Efficacy|0|||
145661375|NCT05218096|525280335|FG002|Extended Treatment|Lack of Efficacy|0|||
145661376|NCT05218096|525280336|FG003|Extended Treatment|Lack of Efficacy|0|||
145661377|NCT05218096|525280337|FG004|Extended Treatment|Lack of Efficacy|0|||
145661378|NCT05218096|525280333|FG000|Extended Treatment|Physician Decision|0|||
145661379|NCT05218096|525280334|FG001|Extended Treatment|Physician Decision|1|||
145661380|NCT05218096|525280335|FG002|Extended Treatment|Physician Decision|0|||
145661381|NCT05218096|525280336|FG003|Extended Treatment|Physician Decision|0|||
145661382|NCT05218096|525280337|FG004|Extended Treatment|Physician Decision|0|||
145661383|NCT05218096|525280333|FG000|Open-label Extension|Adverse Event|1|||
145661384|NCT05218096|525280334|FG001|Open-label Extension|Adverse Event|0|||
145661385|NCT05218096|525280335|FG002|Open-label Extension|Adverse Event|0|||
145661386|NCT05218096|525280336|FG003|Open-label Extension|Adverse Event|0|||
145661387|NCT05218096|525280337|FG004|Open-label Extension|Adverse Event|1|||
145661388|NCT05218096|525280333|FG000|Open-label Extension|Pregnancy|0|||
145661389|NCT05218096|525280334|FG001|Open-label Extension|Pregnancy|0|||
145661390|NCT05218096|525280335|FG002|Open-label Extension|Pregnancy|0|||
145661391|NCT05218096|525280336|FG003|Open-label Extension|Pregnancy|0|||
145661392|NCT05218096|525280337|FG004|Open-label Extension|Pregnancy|1|||
145661393|NCT05218096|525280333|FG000|Open-label Extension|Lack of Efficacy|1|||
145661394|NCT05218096|525280334|FG001|Open-label Extension|Lack of Efficacy|2|||
145490563|NCT04663321|524650331|FG002|Overall Study|Study terminated by Sponsor|2|||
145490564|NCT04663321|524650329|FG000|Overall Study|Withdrawal by Subject|10|||
145490565|NCT04663321|524650330|FG001|Overall Study|Withdrawal by Subject|3|||
145490566|NCT04663321|524650331|FG002|Overall Study|Withdrawal by Subject|2|||
145490567|NCT04663321|524650329|FG000|Overall Study|Not provided|0|||
145490568|NCT04663321|524650330|FG001|Overall Study|Not provided|0|||
145490569|NCT04663321|524650331|FG002|Overall Study|Not provided|1|||
145490570|NCT03360682|524650332|FG000|Overall Study|Adverse Event|3|||
145490571|NCT04862065|524650333|FG000|Screening|Protocol Violation|54|||
145490572|NCT04862065|524650334|FG001|Screening|Protocol Violation|0|||
145490573|NCT04862065|524650335|FG002|Screening|Protocol Violation|0|||
145490574|NCT04862065|524650333|FG000|Screening|Insufficient Sample|1|||
145490575|NCT04862065|524650334|FG001|Screening|Insufficient Sample|0|||
145490576|NCT04862065|524650335|FG002|Screening|Insufficient Sample|0|||
145490577|NCT04862065|524650333|FG000|Follow-Up|Lost to Follow-up|3|||
145490578|NCT04862065|524650334|FG001|Follow-Up|Lost to Follow-up|0|||
145490579|NCT04862065|524650335|FG002|Follow-Up|Lost to Follow-up|0|||
145490580|NCT01453140|524650336|FG000|Overall Study|Adverse Event|3|||
145490581|NCT00743249|524650337|FG000|Overall Study|Adverse Event|0|||
145490582|NCT00743249|524650338|FG001|Overall Study|Adverse Event|4|||
145490583|NCT00743249|524650337|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
145490584|NCT00743249|524650338|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
145490585|NCT00743249|524650337|FG000|Overall Study|Unsuccessful insertion of stent|2|||
145661395|NCT05218096|525280335|FG002|Open-label Extension|Lack of Efficacy|0|||
145490586|NCT00743249|524650338|FG001|Overall Study|Unsuccessful insertion of stent|1|||
145490587|NCT00718510|524650339|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
145490588|NCT00718510|524650340|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
145661396|NCT05218096|525280336|FG003|Open-label Extension|Lack of Efficacy|0|||
145661397|NCT05218096|525280337|FG004|Open-label Extension|Lack of Efficacy|0|||
145661398|NCT05218096|525280333|FG000|Open-label Extension|Lost to Follow-up|1|||
145661399|NCT05218096|525280334|FG001|Open-label Extension|Lost to Follow-up|0|||
145661400|NCT05218096|525280335|FG002|Open-label Extension|Lost to Follow-up|0|||
145661401|NCT05218096|525280336|FG003|Open-label Extension|Lost to Follow-up|0|||
145661402|NCT05218096|525280337|FG004|Open-label Extension|Lost to Follow-up|0|||
145661403|NCT05218096|525280333|FG000|Open-label Extension|Death|0|||
145661404|NCT05218096|525280334|FG001|Open-label Extension|Death|0|||
145661405|NCT05218096|525280335|FG002|Open-label Extension|Death|0|||
145661406|NCT05218096|525280336|FG003|Open-label Extension|Death|1|||
145661407|NCT05218096|525280337|FG004|Open-label Extension|Death|0|||
145661408|NCT05218096|525280333|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
145661409|NCT05218096|525280334|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
145661410|NCT05218096|525280335|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
145661411|NCT05218096|525280336|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
145661412|NCT05218096|525280337|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
145661413|NCT05863156|525280342|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
145661414|NCT05863156|525280343|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
145661415|NCT05863156|525280344|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
145661416|NCT05147116|525280345|FG000|Overall Study|Withdrawal by Subject|0|||
145661417|NCT05147116|525280346|FG001|Overall Study|Withdrawal by Subject|1|||
145661418|NCT04197336|525280347|FG000|Overall Study|Withdrawal by Subject|1|||
145661419|NCT04101357|525280348|FG000|Overall Study|Death|1|||
145661420|NCT04101357|525280349|FG001|Overall Study|Death|1|||
145661421|NCT04101357|525280350|FG002|Overall Study|Death|1|||
145661422|NCT04101357|525280351|FG003|Overall Study|Death|2|||
145661423|NCT04101357|525280352|FG004|Overall Study|Death|4|||
145661424|NCT04101357|525280353|FG005|Overall Study|Death|11|||
145661425|NCT04101357|525280354|FG006|Overall Study|Death|4|||
145661426|NCT04101357|525280355|FG007|Overall Study|Death|4|||
145661427|NCT04101357|525280356|FG008|Overall Study|Death|5|||
145661428|NCT04101357|525280357|FG009|Overall Study|Death|2|||
145661429|NCT04101357|525280358|FG010|Overall Study|Death|3|||
145661430|NCT04101357|525280348|FG000|Overall Study|Trial closure|0|||
145661431|NCT04101357|525280349|FG001|Overall Study|Trial closure|0|||
145661432|NCT04101357|525280350|FG002|Overall Study|Trial closure|0|||
145661433|NCT04101357|525280351|FG003|Overall Study|Trial closure|0|||
145661434|NCT04101357|525280352|FG004|Overall Study|Trial closure|0|||
145661435|NCT04101357|525280353|FG005|Overall Study|Trial closure|2|||
145661436|NCT04101357|525280354|FG006|Overall Study|Trial closure|2|||
145661437|NCT04101357|525280355|FG007|Overall Study|Trial closure|0|||
145661438|NCT04101357|525280356|FG008|Overall Study|Trial closure|0|||
145661439|NCT04101357|525280357|FG009|Overall Study|Trial closure|0|||
145661440|NCT04101357|525280358|FG010|Overall Study|Trial closure|1|||
145661441|NCT04101357|525280348|FG000|Overall Study|Lost to Follow-up|0|||
145661442|NCT04101357|525280349|FG001|Overall Study|Lost to Follow-up|0|||
145661443|NCT04101357|525280350|FG002|Overall Study|Lost to Follow-up|0|||
145661444|NCT04101357|525280351|FG003|Overall Study|Lost to Follow-up|1|||
145661445|NCT04101357|525280352|FG004|Overall Study|Lost to Follow-up|0|||
145661446|NCT04101357|525280353|FG005|Overall Study|Lost to Follow-up|0|||
145661447|NCT04101357|525280354|FG006|Overall Study|Lost to Follow-up|0|||
145661448|NCT04101357|525280355|FG007|Overall Study|Lost to Follow-up|1|||
145661449|NCT04101357|525280356|FG008|Overall Study|Lost to Follow-up|0|||
145661450|NCT04101357|525280357|FG009|Overall Study|Lost to Follow-up|0|||
145661451|NCT04101357|525280358|FG010|Overall Study|Lost to Follow-up|0|||
145661452|NCT04101357|525280348|FG000|Overall Study|Withdrawal by Subject|1|||
145661453|NCT04101357|525280349|FG001|Overall Study|Withdrawal by Subject|0|||
145661454|NCT04101357|525280350|FG002|Overall Study|Withdrawal by Subject|0|||
145490589|NCT00718510|524650339|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
145490590|NCT00718510|524650340|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
145490591|NCT02653326|524650344|FG000|Overall Study|Lost to Follow-up|10|||
145490592|NCT02653326|524650345|FG001|Overall Study|Lost to Follow-up|7|||
145490593|NCT00231777|524650348|FG000|Overall Study|Lost to Follow-up|3|||
145490594|NCT00231777|524650349|FG001|Overall Study|Lost to Follow-up|0|||
145661455|NCT04101357|525280351|FG003|Overall Study|Withdrawal by Subject|0|||
145661456|NCT04101357|525280352|FG004|Overall Study|Withdrawal by Subject|0|||
145661457|NCT04101357|525280353|FG005|Overall Study|Withdrawal by Subject|0|||
145490595|NCT00231777|524650348|FG000|Overall Study|Other|3|||
145490596|NCT00231777|524650349|FG001|Overall Study|Other|2|||
145661458|NCT04101357|525280354|FG006|Overall Study|Withdrawal by Subject|0|||
145661459|NCT04101357|525280355|FG007|Overall Study|Withdrawal by Subject|0|||
145661460|NCT04101357|525280356|FG008|Overall Study|Withdrawal by Subject|1|||
145661461|NCT04101357|525280357|FG009|Overall Study|Withdrawal by Subject|1|||
145661462|NCT04101357|525280358|FG010|Overall Study|Withdrawal by Subject|0|||
145661463|NCT04101357|525280348|FG000|Overall Study|Other|0|||
145490597|NCT00657046|524650352|FG000|Overall Study|Adverse Event|1|||
145661464|NCT04101357|525280349|FG001|Overall Study|Other|0|||
145661465|NCT04101357|525280350|FG002|Overall Study|Other|0|||
145661466|NCT04101357|525280351|FG003|Overall Study|Other|0|||
145661467|NCT04101357|525280352|FG004|Overall Study|Other|0|||
145661468|NCT04101357|525280353|FG005|Overall Study|Other|1|||
145661469|NCT04101357|525280354|FG006|Overall Study|Other|2|||
145661470|NCT04101357|525280355|FG007|Overall Study|Other|1|||
145661471|NCT04101357|525280356|FG008|Overall Study|Other|0|||
145661472|NCT04101357|525280357|FG009|Overall Study|Other|0|||
145661473|NCT04101357|525280358|FG010|Overall Study|Other|0|||
145661474|NCT04101357|525280348|FG000|Overall Study|Enrolled but not treated|0|||
145661475|NCT04101357|525280349|FG001|Overall Study|Enrolled but not treated|0|||
145661476|NCT04101357|525280350|FG002|Overall Study|Enrolled but not treated|0|||
145661477|NCT04101357|525280351|FG003|Overall Study|Enrolled but not treated|0|||
145661478|NCT04101357|525280352|FG004|Overall Study|Enrolled but not treated|0|||
145661479|NCT04101357|525280353|FG005|Overall Study|Enrolled but not treated|1|||
145661480|NCT04101357|525280354|FG006|Overall Study|Enrolled but not treated|1|||
145661481|NCT04101357|525280355|FG007|Overall Study|Enrolled but not treated|0|||
145661482|NCT04101357|525280356|FG008|Overall Study|Enrolled but not treated|0|||
145661483|NCT04101357|525280357|FG009|Overall Study|Enrolled but not treated|0|||
145661484|NCT04101357|525280358|FG010|Overall Study|Enrolled but not treated|0|||
145661485|NCT05868382|525280359|FG000|Overall Study|Lost to Follow-up|5|||
145661486|NCT05868382|525280360|FG001|Overall Study|Lost to Follow-up|0|||
145661487|NCT05868382|525280361|FG002|Overall Study|Lost to Follow-up|6|||
145661488|NCT05868382|525280362|FG003|Overall Study|Lost to Follow-up|4|||
145661489|NCT05868382|525280363|FG004|Overall Study|Lost to Follow-up|2|||
145661490|NCT05868382|525280364|FG005|Overall Study|Lost to Follow-up|6|||
145661491|NCT05868382|525280359|FG000|Overall Study|Withdrawal by Subject|1|||
145661492|NCT05868382|525280360|FG001|Overall Study|Withdrawal by Subject|0|||
145661493|NCT05868382|525280361|FG002|Overall Study|Withdrawal by Subject|0|||
145661494|NCT05868382|525280362|FG003|Overall Study|Withdrawal by Subject|0|||
145661495|NCT05868382|525280363|FG004|Overall Study|Withdrawal by Subject|1|||
145661496|NCT05868382|525280364|FG005|Overall Study|Withdrawal by Subject|0|||
145661497|NCT02497950|525280367|FG000|Overall Study|Death|209|||
145661498|NCT02497950|525280367|FG000|Overall Study|Transplanted|85|||
145661499|NCT02497950|525280367|FG000|Overall Study|Explanted|8|||
145661500|NCT02497950|525280367|FG000|Overall Study|Device Permanently Deactivated|4|||
145661501|NCT02497950|525280367|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
145661502|NCT02497950|525280367|FG000|Overall Study|Lost to Follow-up|6|||
145661503|NCT02497950|525280367|FG000|Overall Study|Withdrawal by Subject|2|||
145661504|NCT02497950|525280367|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
145661505|NCT02497950|525280367|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
145661506|NCT04660539|525280368|FG000|Overall Study|Adverse Event|10|||
145661507|NCT04660539|525280368|FG000|Overall Study|Lack of Efficacy|4|||
145661508|NCT04660539|525280368|FG000|Overall Study|Lost to Follow-up|5|||
145661509|NCT04660539|525280368|FG000|Overall Study|Non-Compliance With Study Drug|3|||
145661510|NCT04660539|525280368|FG000|Overall Study|Reason not Specified|12|||
145661511|NCT04660539|525280368|FG000|Overall Study|Pregnancy|2|||
145661512|NCT04660539|525280368|FG000|Overall Study|Protocol Violation|2|||
145661513|NCT04660539|525280368|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
145661514|NCT04660539|525280368|FG000|Overall Study|Withdrawal by Subject|21|||
145661515|NCT03655028|525280371|FG000|12-weeks Follow up|Death|1|||
145661516|NCT03655028|525280372|FG001|12-weeks Follow up|Death|0|||
145661517|NCT03655028|525280371|FG000|12-weeks Follow up|Physician Decision|3|||
145661518|NCT03655028|525280372|FG001|12-weeks Follow up|Physician Decision|3|||
145661519|NCT03655028|525280371|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
145661520|NCT03655028|525280372|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
145661521|NCT03655028|525280371|FG000|12-weeks Follow up|Lost to Follow-up|4|||
145661522|NCT03655028|525280372|FG001|12-weeks Follow up|Lost to Follow-up|4|||
145661523|NCT03655028|525280371|FG000|24-weeks|Lost to Follow-up|1|||
145661524|NCT03655028|525280372|FG001|24-weeks|Lost to Follow-up|1|||
145661525|NCT03655028|525280371|FG000|24-weeks|Death|0|||
145661526|NCT03655028|525280372|FG001|24-weeks|Death|1|||
145661527|NCT05256654|525280373|FG000|Overall Study|Adverse Event|0|||
145661528|NCT05256654|525280374|FG001|Overall Study|Adverse Event|0|||
145661529|NCT05256654|525280375|FG002|Overall Study|Adverse Event|1|||
145661530|NCT05256654|525280376|FG003|Overall Study|Adverse Event|0|||
145661531|NCT05256654|525280373|FG000|Overall Study|Lost to Follow-up|0|||
145661532|NCT05256654|525280374|FG001|Overall Study|Lost to Follow-up|0|||
145661533|NCT05256654|525280375|FG002|Overall Study|Lost to Follow-up|0|||
145661534|NCT05256654|525280376|FG003|Overall Study|Lost to Follow-up|1|||
145661535|NCT05256654|525280373|FG000|Overall Study|Withdrawal by Subject|1|||
145661536|NCT05256654|525280374|FG001|Overall Study|Withdrawal by Subject|2|||
145661537|NCT05256654|525280375|FG002|Overall Study|Withdrawal by Subject|1|||
145661538|NCT05256654|525280376|FG003|Overall Study|Withdrawal by Subject|3|||
145661539|NCT05256654|525280373|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
145661540|NCT05256654|525280374|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
145661541|NCT05256654|525280375|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
145661542|NCT05256654|525280376|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
145661543|NCT05256654|525280373|FG000|Overall Study|Other|0|||
145661544|NCT05256654|525280374|FG001|Overall Study|Other|0|||
145661545|NCT05256654|525280375|FG002|Overall Study|Other|0|||
145661546|NCT05256654|525280376|FG003|Overall Study|Other|1|||
145661547|NCT01221948|525280386|FG000|Overall Study|Physician Decision|5|||
145661548|NCT01221948|525280386|FG000|Overall Study|Withdrawal by Subject|2|||
145661549|NCT01221948|525280386|FG000|Overall Study|not disclosed|2|||
145661550|NCT01221948|525280386|FG000|Overall Study|Death|1|||
145661551|NCT01221948|525280386|FG000|Overall Study|Protocol Violation|4|||
145661552|NCT03756662|525280387|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
145661553|NCT04295512|525280388|FG000|Overall Study|Lack of family response to schedule assessment|0|||
145661554|NCT04295512|525280389|FG001|Overall Study|Lack of family response to schedule assessment|0|||
145661555|NCT04295512|525280390|FG002|Overall Study|Lack of family response to schedule assessment|0|||
145661556|NCT04295512|525280391|FG003|Overall Study|Lack of family response to schedule assessment|2|||
145661557|NCT04295512|525280388|FG000|Overall Study|Therapist did not refer eligible family|7|||
145661558|NCT04295512|525280389|FG001|Overall Study|Therapist did not refer eligible family|7|||
145661559|NCT04295512|525280390|FG002|Overall Study|Therapist did not refer eligible family|0|||
145661560|NCT04295512|525280391|FG003|Overall Study|Therapist did not refer eligible family|0|||
145661561|NCT01009788|525280400|FG000|Overall Study|Withdrawal by Subject|1|||
145661562|NCT01009788|525280401|FG001|Overall Study|Withdrawal by Subject|0|||
145661563|NCT01309672|525280403|FG000|Overall Study|Lack of Efficacy|20|||
145661564|NCT01309672|525280403|FG000|Overall Study|Other|9|||
145661565|NCT01309672|525280403|FG000|Overall Study|Adverse Event|5|||
145661566|NCT01309672|525280403|FG000|Overall Study|Withdrawal by Subject|3|||
145661567|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
145661568|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
145661569|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
145661570|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
145661571|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
145661572|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
145661573|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
145661574|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
145661575|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
145661576|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
145661577|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
145661578|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
145661579|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
145661580|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
145661581|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
145661582|NCT01254864|525280406|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
145661583|NCT01254864|525280407|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
145661584|NCT01254864|525280408|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
145661585|NCT01254864|525280406|FG000|Randomization Phase|Adverse Event|0|||
145661586|NCT01254864|525280407|FG001|Randomization Phase|Adverse Event|5|||
145661587|NCT01254864|525280408|FG002|Randomization Phase|Adverse Event|17|||
145661588|NCT01254864|525280406|FG000|Randomization Phase|Death|0|||
145661589|NCT01254864|525280407|FG001|Randomization Phase|Death|1|||
145661590|NCT01254864|525280408|FG002|Randomization Phase|Death|0|||
145661591|NCT01254864|525280406|FG000|Randomization Phase|Lost to Follow-up|0|||
145661592|NCT01254864|525280407|FG001|Randomization Phase|Lost to Follow-up|0|||
145661593|NCT01254864|525280408|FG002|Randomization Phase|Lost to Follow-up|1|||
145661594|NCT01254864|525280406|FG000|Randomization Phase|Physician Decision|0|||
145661595|NCT01254864|525280407|FG001|Randomization Phase|Physician Decision|20|||
145661596|NCT01254864|525280408|FG002|Randomization Phase|Physician Decision|25|||
145661597|NCT01254864|525280406|FG000|Randomization Phase|Withdrawal by Subject|0|||
145661598|NCT01254864|525280407|FG001|Randomization Phase|Withdrawal by Subject|4|||
145661599|NCT01254864|525280408|FG002|Randomization Phase|Withdrawal by Subject|2|||
145661600|NCT01254864|525280406|FG000|Randomization Phase|Non-Compliance|0|||
145661601|NCT01254864|525280407|FG001|Randomization Phase|Non-Compliance|1|||
145661602|NCT01254864|525280408|FG002|Randomization Phase|Non-Compliance|0|||
145661603|NCT01254864|525280406|FG000|Randomization Phase|Comorbidities|0|||
145661604|NCT01254864|525280407|FG001|Randomization Phase|Comorbidities|2|||
145661605|NCT01254864|525280408|FG002|Randomization Phase|Comorbidities|1|||
145661606|NCT04625725|525280410|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
145661607|NCT04625725|525280411|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145661608|NCT04625725|525280412|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145661609|NCT04625725|525280413|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145661610|NCT04625725|525280414|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145661611|NCT04625725|525280415|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
145661612|NCT04625725|525280410|FG000|Provent Main Study|Withdrawal by Subject|242|||
145661613|NCT04625725|525280411|FG001|Provent Main Study|Withdrawal by Subject|144|||
145661614|NCT04625725|525280412|FG002|Provent Main Study|Withdrawal by Subject|0|||
145661615|NCT04625725|525280413|FG003|Provent Main Study|Withdrawal by Subject|0|||
145661616|NCT04625725|525280414|FG004|Provent Main Study|Withdrawal by Subject|0|||
145661617|NCT04625725|525280415|FG005|Provent Main Study|Withdrawal by Subject|0|||
145661618|NCT04625725|525280410|FG000|Provent Main Study|Physician Decision|5|||
145661619|NCT04625725|525280411|FG001|Provent Main Study|Physician Decision|0|||
145661620|NCT04625725|525280412|FG002|Provent Main Study|Physician Decision|0|||
145661621|NCT04625725|525280413|FG003|Provent Main Study|Physician Decision|0|||
145661622|NCT04625725|525280414|FG004|Provent Main Study|Physician Decision|0|||
145661623|NCT04625725|525280415|FG005|Provent Main Study|Physician Decision|0|||
145661624|NCT04625725|525280410|FG000|Provent Main Study|Protocol Violation|1|||
145661625|NCT04625725|525280411|FG001|Provent Main Study|Protocol Violation|0|||
145661626|NCT04625725|525280412|FG002|Provent Main Study|Protocol Violation|0|||
145661627|NCT04625725|525280413|FG003|Provent Main Study|Protocol Violation|0|||
145661628|NCT04625725|525280414|FG004|Provent Main Study|Protocol Violation|0|||
145661629|NCT04625725|525280415|FG005|Provent Main Study|Protocol Violation|0|||
145661630|NCT04625725|525280410|FG000|Provent Main Study|Lost to Follow-up|357|||
145661631|NCT04625725|525280411|FG001|Provent Main Study|Lost to Follow-up|200|||
145661632|NCT04625725|525280412|FG002|Provent Main Study|Lost to Follow-up|0|||
145661633|NCT04625725|525280413|FG003|Provent Main Study|Lost to Follow-up|0|||
145661634|NCT04625725|525280414|FG004|Provent Main Study|Lost to Follow-up|0|||
145661635|NCT04625725|525280415|FG005|Provent Main Study|Lost to Follow-up|0|||
145661636|NCT04625725|525280410|FG000|Provent Main Study|Death|22|||
145661637|NCT04625725|525280411|FG001|Provent Main Study|Death|10|||
145661638|NCT04625725|525280412|FG002|Provent Main Study|Death|0|||
145661639|NCT04625725|525280413|FG003|Provent Main Study|Death|0|||
145661640|NCT04625725|525280414|FG004|Provent Main Study|Death|0|||
145661641|NCT04625725|525280415|FG005|Provent Main Study|Death|0|||
145661642|NCT04625725|525280410|FG000|Provent Main Study|Adverse Event|2|||
145661643|NCT04625725|525280411|FG001|Provent Main Study|Adverse Event|1|||
145661644|NCT04625725|525280412|FG002|Provent Main Study|Adverse Event|0|||
145661645|NCT04625725|525280413|FG003|Provent Main Study|Adverse Event|0|||
145661646|NCT04625725|525280414|FG004|Provent Main Study|Adverse Event|0|||
145661647|NCT04625725|525280415|FG005|Provent Main Study|Adverse Event|0|||
145661648|NCT04625725|525280410|FG000|Provent Main Study|Participants dosed in sub-study|310|||
145661649|NCT04625725|525280411|FG001|Provent Main Study|Participants dosed in sub-study|193|||
145661650|NCT04625725|525280412|FG002|Provent Main Study|Participants dosed in sub-study|0|||
145661651|NCT04625725|525280413|FG003|Provent Main Study|Participants dosed in sub-study|0|||
145661652|NCT04625725|525280414|FG004|Provent Main Study|Participants dosed in sub-study|0|||
145661653|NCT04625725|525280415|FG005|Provent Main Study|Participants dosed in sub-study|0|||
145661654|NCT04625725|525280410|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
145661655|NCT04625725|525280411|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
145661656|NCT04625725|525280412|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
145661657|NCT04625725|525280413|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
145661658|NCT04625725|525280414|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
145661659|NCT04625725|525280415|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
145661660|NCT04625725|525280410|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
145661661|NCT04625725|525280411|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
145661662|NCT04625725|525280412|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
145661663|NCT04625725|525280413|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
145661664|NCT04625725|525280414|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
145661665|NCT04625725|525280415|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
145661666|NCT04625725|525280410|FG000|Provent Main Study|INCARCERATION|3|||
145661667|NCT04625725|525280411|FG001|Provent Main Study|INCARCERATION|0|||
145661668|NCT04625725|525280412|FG002|Provent Main Study|INCARCERATION|0|||
145661669|NCT04625725|525280413|FG003|Provent Main Study|INCARCERATION|0|||
145661670|NCT04625725|525280414|FG004|Provent Main Study|INCARCERATION|0|||
145661671|NCT04625725|525280415|FG005|Provent Main Study|INCARCERATION|0|||
145661672|NCT04625725|525280410|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
145661673|NCT04625725|525280411|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
145661674|NCT04625725|525280412|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
145661675|NCT04625725|525280413|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
145661676|NCT04625725|525280414|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
145661677|NCT04625725|525280415|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
145661678|NCT04625725|525280410|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
145661679|NCT04625725|525280411|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
145661680|NCT04625725|525280412|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
145661681|NCT04625725|525280413|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
145661682|NCT04625725|525280414|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
145661683|NCT04625725|525280415|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
145661684|NCT04625725|525280410|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
145661685|NCT04625725|525280411|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
145661686|NCT04625725|525280412|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145661687|NCT04625725|525280413|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145661688|NCT04625725|525280414|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145661689|NCT04625725|525280415|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
145661690|NCT04625725|525280410|FG000|Provent Main Study|MISSING REASON|0|||
145661691|NCT04625725|525280411|FG001|Provent Main Study|MISSING REASON|1|||
145661692|NCT04625725|525280412|FG002|Provent Main Study|MISSING REASON|0|||
145661693|NCT04625725|525280413|FG003|Provent Main Study|MISSING REASON|0|||
145661694|NCT04625725|525280414|FG004|Provent Main Study|MISSING REASON|0|||
145661695|NCT04625725|525280415|FG005|Provent Main Study|MISSING REASON|0|||
145661696|NCT04625725|525280410|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145661697|NCT04625725|525280411|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145661698|NCT04625725|525280412|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145661699|NCT04625725|525280413|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
145661700|NCT04625725|525280414|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145661701|NCT04625725|525280415|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
145661702|NCT04625725|525280410|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
145661703|NCT04625725|525280411|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
145661704|NCT04625725|525280412|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
145661705|NCT04625725|525280413|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
145661706|NCT04625725|525280414|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
145661707|NCT04625725|525280415|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
145661708|NCT04625725|525280410|FG000|Provent Sub Study|Lost to Follow-up|0|||
145661709|NCT04625725|525280411|FG001|Provent Sub Study|Lost to Follow-up|0|||
145661710|NCT04625725|525280412|FG002|Provent Sub Study|Lost to Follow-up|20|||
145661711|NCT04625725|525280413|FG003|Provent Sub Study|Lost to Follow-up|10|||
145661712|NCT04625725|525280414|FG004|Provent Sub Study|Lost to Follow-up|6|||
145661713|NCT04625725|525280415|FG005|Provent Sub Study|Lost to Follow-up|4|||
145661714|NCT04625725|525280410|FG000|Provent Sub Study|Death|0|||
145661715|NCT04625725|525280411|FG001|Provent Sub Study|Death|0|||
145661716|NCT04625725|525280412|FG002|Provent Sub Study|Death|8|||
145661717|NCT04625725|525280413|FG003|Provent Sub Study|Death|5|||
145661718|NCT04625725|525280414|FG004|Provent Sub Study|Death|0|||
145661719|NCT04625725|525280415|FG005|Provent Sub Study|Death|1|||
145661720|NCT04625725|525280410|FG000|Provent Sub Study|Adverse Event|0|||
145661721|NCT04625725|525280411|FG001|Provent Sub Study|Adverse Event|0|||
145661722|NCT04625725|525280412|FG002|Provent Sub Study|Adverse Event|0|||
145661723|NCT04625725|525280413|FG003|Provent Sub Study|Adverse Event|0|||
145661724|NCT04625725|525280414|FG004|Provent Sub Study|Adverse Event|0|||
145661725|NCT04625725|525280415|FG005|Provent Sub Study|Adverse Event|1|||
145661726|NCT04625725|525280410|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
145661727|NCT04625725|525280411|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
145661728|NCT04625725|525280412|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
145661729|NCT04625725|525280413|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
145661730|NCT04625725|525280414|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
145661731|NCT04625725|525280415|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
145661732|NCT04625725|525280410|FG000|Provent Sub Study|Withdrawal by Subject|0|||
145661733|NCT04625725|525280411|FG001|Provent Sub Study|Withdrawal by Subject|0|||
145661734|NCT04625725|525280412|FG002|Provent Sub Study|Withdrawal by Subject|11|||
145661735|NCT04625725|525280413|FG003|Provent Sub Study|Withdrawal by Subject|13|||
145661736|NCT04625725|525280414|FG004|Provent Sub Study|Withdrawal by Subject|5|||
145661737|NCT04625725|525280415|FG005|Provent Sub Study|Withdrawal by Subject|6|||
145661738|NCT04625725|525280410|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
145661739|NCT04625725|525280411|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
145661740|NCT04625725|525280412|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
145661741|NCT04625725|525280413|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
145661742|NCT04625725|525280414|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
145661743|NCT04625725|525280415|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
145661744|NCT03556293|525280418|FG000|Overall Study|Ineligible for analysis|1904|||
145661745|NCT03556293|525280419|FG001|Overall Study|Ineligible for analysis|1471|||
145661746|NCT03556293|525280420|FG002|Overall Study|Ineligible for analysis|1091|||
145661747|NCT03556293|525280421|FG003|Overall Study|Ineligible for analysis|1269|||
145661748|NCT05104463|525280422|FG000|Overall Study|Adverse Event|1|||
145661749|NCT05104463|525280423|FG001|Overall Study|Adverse Event|1|||
145661750|NCT05104463|525280422|FG000|Overall Study|Lost to Follow-up|1|||
145661751|NCT05104463|525280423|FG001|Overall Study|Lost to Follow-up|1|||
145661752|NCT05104463|525280422|FG000|Overall Study|Physician Decision|1|||
145661753|NCT05104463|525280423|FG001|Overall Study|Physician Decision|0|||
145661754|NCT05104463|525280422|FG000|Overall Study|Protocol Violation|0|||
145661755|NCT05104463|525280423|FG001|Overall Study|Protocol Violation|2|||
145661756|NCT05104463|525280422|FG000|Overall Study|Withdrawal by Subject|1|||
145661757|NCT05104463|525280423|FG001|Overall Study|Withdrawal by Subject|1|||
145661758|NCT04132518|525280426|FG000|Overall Study|Prematurely withdrawn from the study|0|||
145661759|NCT04132518|525280427|FG001|Overall Study|Prematurely withdrawn from the study|9|||
145661760|NCT04132518|525280428|FG002|Overall Study|Prematurely withdrawn from the study|1|||
145661761|NCT04056611|525280431|FG000|Overall Study|Physician Decision|1|||
145661762|NCT02631746|525280432|FG000|Overall Study|Lack of Efficacy|3|||
145661763|NCT05069896|525280434|FG000|Overall Study|Adverse Event|0|||
145661764|NCT05069896|525280435|FG001|Overall Study|Adverse Event|1|||
145661765|NCT05069896|525280436|FG002|Overall Study|Adverse Event|1|||
145661766|NCT05069896|525280437|FG003|Overall Study|Adverse Event|0|||
145661767|NCT05069896|525280438|FG004|Overall Study|Adverse Event|0|||
145661768|NCT05069896|525280439|FG005|Overall Study|Adverse Event|0|||
145661769|NCT05069896|525280434|FG000|Overall Study|Lost to Follow-up|0|||
145661770|NCT05069896|525280435|FG001|Overall Study|Lost to Follow-up|0|||
145661771|NCT05069896|525280436|FG002|Overall Study|Lost to Follow-up|1|||
145661772|NCT05069896|525280437|FG003|Overall Study|Lost to Follow-up|0|||
145661773|NCT05069896|525280438|FG004|Overall Study|Lost to Follow-up|1|||
145661774|NCT05069896|525280439|FG005|Overall Study|Lost to Follow-up|2|||
145661775|NCT04068831|525280440|FG000|Overall Study|Disease Progression|10|||
145661776|NCT04068831|525280441|FG001|Overall Study|Disease Progression|8|||
145661777|NCT02839265|525280443|FG000|Overall Study|Screen Failure|2|||
145661778|NCT02839265|525280443|FG000|Overall Study|Death|1|||
145661779|NCT02839265|525280443|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
145661780|NCT04167553|525280446|FG000|Overall Study|Withdrawal by Subject|1|||
145661781|NCT04167553|525280447|FG001|Overall Study|Withdrawal by Subject|0|||
145661782|NCT04167553|525280448|FG002|Overall Study|Withdrawal by Subject|1|||
145661783|NCT04167553|525280449|FG003|Overall Study|Withdrawal by Subject|2|||
145661784|NCT04167553|525280450|FG004|Overall Study|Withdrawal by Subject|1|||
145661785|NCT04167553|525280451|FG005|Overall Study|Withdrawal by Subject|0|||
145661786|NCT04167553|525280452|FG006|Overall Study|Withdrawal by Subject|0|||
145661787|NCT04167553|525280446|FG000|Overall Study|Physician Decision|0|||
145661788|NCT04167553|525280447|FG001|Overall Study|Physician Decision|0|||
145661789|NCT04167553|525280448|FG002|Overall Study|Physician Decision|0|||
145661790|NCT04167553|525280449|FG003|Overall Study|Physician Decision|0|||
145661791|NCT04167553|525280450|FG004|Overall Study|Physician Decision|2|||
145661792|NCT04167553|525280451|FG005|Overall Study|Physician Decision|2|||
145661793|NCT04167553|525280452|FG006|Overall Study|Physician Decision|0|||
145661794|NCT04167553|525280446|FG000|Overall Study|Lost to Follow-up|0|||
145661795|NCT04167553|525280447|FG001|Overall Study|Lost to Follow-up|0|||
145661796|NCT04167553|525280448|FG002|Overall Study|Lost to Follow-up|2|||
145661797|NCT04167553|525280449|FG003|Overall Study|Lost to Follow-up|0|||
145661798|NCT04167553|525280450|FG004|Overall Study|Lost to Follow-up|0|||
145661799|NCT04167553|525280451|FG005|Overall Study|Lost to Follow-up|0|||
145661800|NCT04167553|525280452|FG006|Overall Study|Lost to Follow-up|0|||
145661801|NCT05660434|525280454|FG000|Overall Study|Never obtained study materials|2|||
145661802|NCT05660434|525280455|FG001|Overall Study|Never obtained study materials|1|||
145661803|NCT04479761|525280470|FG000|Overall Study|could not perform the balance tasks|1|||
145661804|NCT04479761|525280471|FG001|Overall Study|could not perform the balance tasks|0|||
145661805|NCT04479761|525280472|FG002|Overall Study|could not perform the balance tasks|0|||
145661806|NCT04479761|525280470|FG000|Overall Study|Adverse Event|1|||
145661807|NCT04479761|525280471|FG001|Overall Study|Adverse Event|0|||
145661808|NCT04479761|525280472|FG002|Overall Study|Adverse Event|0|||
145661809|NCT04479761|525280470|FG000|Overall Study|one control did not meet screening criteria|0|||
145661810|NCT04479761|525280471|FG001|Overall Study|one control did not meet screening criteria|0|||
145661811|NCT04479761|525280472|FG002|Overall Study|one control did not meet screening criteria|1|||
145661812|NCT04479761|525280470|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
145661813|NCT04479761|525280471|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
145661814|NCT04479761|525280472|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
145661815|NCT03523572|525282107|FG000|Dose Escalation|Progressive disease|1|||
145661816|NCT03523572|525282108|FG001|Dose Escalation|Progressive disease|0|||
145661817|NCT03523572|525282109|FG002|Dose Escalation|Progressive disease|0|||
145661818|NCT03523572|525282110|FG003|Dose Escalation|Progressive disease|0|||
145661819|NCT03523572|525282111|FG004|Dose Escalation|Progressive disease|0|||
145661820|NCT03523572|525282112|FG005|Dose Escalation|Progressive disease|0|||
145661821|NCT03523572|525282107|FG000|Dose Escalation|Clinical Progression|0|||
145661822|NCT03523572|525282108|FG001|Dose Escalation|Clinical Progression|1|||
145661823|NCT03523572|525282109|FG002|Dose Escalation|Clinical Progression|0|||
145661824|NCT03523572|525282110|FG003|Dose Escalation|Clinical Progression|0|||
145661825|NCT03523572|525282111|FG004|Dose Escalation|Clinical Progression|0|||
145661826|NCT03523572|525282112|FG005|Dose Escalation|Clinical Progression|0|||
145661827|NCT03523572|525282107|FG000|Dose Escalation|Adverse Event|2|||
145661828|NCT03523572|525282108|FG001|Dose Escalation|Adverse Event|0|||
145661829|NCT03523572|525282109|FG002|Dose Escalation|Adverse Event|0|||
145661830|NCT03523572|525282110|FG003|Dose Escalation|Adverse Event|0|||
145661831|NCT03523572|525282111|FG004|Dose Escalation|Adverse Event|0|||
145661832|NCT03523572|525282112|FG005|Dose Escalation|Adverse Event|0|||
145661833|NCT03523572|525282107|FG000|Dose Escalation|Physician Decision|1|||
145661834|NCT03523572|525282108|FG001|Dose Escalation|Physician Decision|1|||
145661835|NCT03523572|525282109|FG002|Dose Escalation|Physician Decision|0|||
145661836|NCT03523572|525282110|FG003|Dose Escalation|Physician Decision|0|||
145661837|NCT03523572|525282111|FG004|Dose Escalation|Physician Decision|0|||
145661838|NCT03523572|525282112|FG005|Dose Escalation|Physician Decision|0|||
145661839|NCT03523572|525282107|FG000|Dose Expansion|Progressive Disease|0|||
145661840|NCT03523572|525282108|FG001|Dose Expansion|Progressive Disease|0|||
145661841|NCT03523572|525282109|FG002|Dose Expansion|Progressive Disease|9|||
145661842|NCT03523572|525282110|FG003|Dose Expansion|Progressive Disease|11|||
145661843|NCT03523572|525282111|FG004|Dose Expansion|Progressive Disease|15|||
145661844|NCT03523572|525282112|FG005|Dose Expansion|Progressive Disease|2|||
145661845|NCT03523572|525282107|FG000|Dose Expansion|Clinical Progression|0|||
145661846|NCT03523572|525282108|FG001|Dose Expansion|Clinical Progression|0|||
145661847|NCT03523572|525282109|FG002|Dose Expansion|Clinical Progression|2|||
145661848|NCT03523572|525282110|FG003|Dose Expansion|Clinical Progression|2|||
145661849|NCT03523572|525282111|FG004|Dose Expansion|Clinical Progression|2|||
145661850|NCT03523572|525282112|FG005|Dose Expansion|Clinical Progression|0|||
145661851|NCT03523572|525282107|FG000|Dose Expansion|Adverse Event|0|||
145661852|NCT03523572|525282108|FG001|Dose Expansion|Adverse Event|0|||
145661853|NCT03523572|525282109|FG002|Dose Expansion|Adverse Event|10|||
145661854|NCT03523572|525282110|FG003|Dose Expansion|Adverse Event|1|||
145661855|NCT03523572|525282111|FG004|Dose Expansion|Adverse Event|5|||
145661856|NCT03523572|525282112|FG005|Dose Expansion|Adverse Event|2|||
145661857|NCT03523572|525282107|FG000|Dose Expansion|Withdrawal by Subject|0|||
145661858|NCT03523572|525282108|FG001|Dose Expansion|Withdrawal by Subject|0|||
145661859|NCT03523572|525282109|FG002|Dose Expansion|Withdrawal by Subject|1|||
145661860|NCT03523572|525282110|FG003|Dose Expansion|Withdrawal by Subject|1|||
145661861|NCT03523572|525282111|FG004|Dose Expansion|Withdrawal by Subject|0|||
145661862|NCT03523572|525282112|FG005|Dose Expansion|Withdrawal by Subject|0|||
145661863|NCT03523572|525282107|FG000|Dose Expansion|Physician Decision|0|||
145661864|NCT03523572|525282108|FG001|Dose Expansion|Physician Decision|0|||
145661865|NCT03523572|525282109|FG002|Dose Expansion|Physician Decision|1|||
145661866|NCT03523572|525282110|FG003|Dose Expansion|Physician Decision|0|||
145661867|NCT03523572|525282111|FG004|Dose Expansion|Physician Decision|1|||
145661868|NCT03523572|525282112|FG005|Dose Expansion|Physician Decision|0|||
145661869|NCT03523572|525282107|FG000|Dose Expansion|Miscellaneous|0|||
145661870|NCT03523572|525282108|FG001|Dose Expansion|Miscellaneous|0|||
145661871|NCT03523572|525282109|FG002|Dose Expansion|Miscellaneous|0|||
145661872|NCT03523572|525282110|FG003|Dose Expansion|Miscellaneous|0|||
145661873|NCT03523572|525282111|FG004|Dose Expansion|Miscellaneous|3|||
145661874|NCT03523572|525282112|FG005|Dose Expansion|Miscellaneous|0|||
145661875|NCT05269966|525282113|FG000|Overall Study|Adverse Event|4|||
145661876|NCT05269966|525282113|FG000|Overall Study|Withdrawal by Subject|1|||
145661877|NCT05269966|525282113|FG000|Overall Study|Lost to Follow-up|4|||
145661878|NCT05269966|525282113|FG000|Overall Study|Physician Decision|1|||
145661879|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
145661880|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
145661881|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
145661882|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
145661883|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
145661884|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
145661885|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
145661886|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
145661887|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
145661888|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
145661889|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
145661890|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
145661891|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
145661892|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
145661893|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
145661894|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
145661895|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661896|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661897|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661898|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661899|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661900|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
145661901|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
145661902|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
145661903|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661904|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661905|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661906|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661907|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661908|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661909|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
145661910|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
145661911|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
145661912|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
145661913|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
145661914|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
145661915|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
145661916|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
145661917|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
145661918|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
145661919|NCT02315703|525282119|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
145661920|NCT02315703|525282120|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
145661921|NCT02315703|525282121|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
145661922|NCT02315703|525282122|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
145661923|NCT02315703|525282123|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
145661924|NCT02315703|525282124|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
145661925|NCT02315703|525282125|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
145661926|NCT02315703|525282126|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
145661927|NCT02315703|525282119|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
145661928|NCT02315703|525282120|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
145661929|NCT02315703|525282121|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661930|NCT02315703|525282122|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661931|NCT02315703|525282123|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661932|NCT02315703|525282124|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661933|NCT02315703|525282125|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661934|NCT02315703|525282126|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
145661935|NCT02315703|525282119|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661936|NCT02315703|525282120|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
145661937|NCT02315703|525282121|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661938|NCT02315703|525282122|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661939|NCT02315703|525282123|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661940|NCT02315703|525282124|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661941|NCT02315703|525282125|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661942|NCT02315703|525282126|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
145661943|NCT02315703|525282119|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
145661944|NCT02315703|525282120|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
145661945|NCT02315703|525282121|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
145661946|NCT02315703|525282122|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
145661947|NCT02315703|525282123|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
145661948|NCT02315703|525282124|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
145661949|NCT02315703|525282125|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
145661950|NCT02315703|525282126|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
145661951|NCT03625115|525282127|FG000|Overall Study|Withdrawal by Subject|4|||
145661952|NCT03625115|525282128|FG001|Overall Study|Withdrawal by Subject|7|||
145661953|NCT03625115|525282127|FG000|Overall Study|Lost to Follow-up|17|||
145661954|NCT03625115|525282128|FG001|Overall Study|Lost to Follow-up|24|||
145661955|NCT04304144|525282129|FG000|DLT Observation Period|Physician Decision|0|||
145661956|NCT04304144|525282130|FG001|DLT Observation Period|Physician Decision|1|||
145661957|NCT04304144|525282131|FG002|DLT Observation Period|Physician Decision|0|||
145661958|NCT04304144|525282132|FG003|DLT Observation Period|Physician Decision|0|||
145661959|NCT04304144|525282129|FG000|Continued Treatment Period|Adverse Event|0|||
145661960|NCT04304144|525282130|FG001|Continued Treatment Period|Adverse Event|1|||
145661961|NCT04304144|525282131|FG002|Continued Treatment Period|Adverse Event|0|||
145661962|NCT04304144|525282132|FG003|Continued Treatment Period|Adverse Event|0|||
145661963|NCT04304144|525282129|FG000|Continued Treatment Period|Death|0|||
145661964|NCT04304144|525282130|FG001|Continued Treatment Period|Death|0|||
145661965|NCT04304144|525282131|FG002|Continued Treatment Period|Death|1|||
145661966|NCT04304144|525282132|FG003|Continued Treatment Period|Death|2|||
145661967|NCT04304144|525282129|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
145661968|NCT04304144|525282130|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
145661969|NCT04304144|525282131|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
145661970|NCT04304144|525282132|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
145265343|NCT00558831|523819303|FG000|Overall Study|Lost to Follow-up|1|||
145661971|NCT04304144|525282129|FG000|Continued Treatment Period|Other than specified|2|||
145661972|NCT04304144|525282130|FG001|Continued Treatment Period|Other than specified|0|||
145661973|NCT04304144|525282131|FG002|Continued Treatment Period|Other than specified|1|||
145661974|NCT04304144|525282132|FG003|Continued Treatment Period|Other than specified|1|||
145661975|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
145661976|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
145661977|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
145661978|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
145661979|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
145661980|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
145661981|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
145661982|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Death|0|||
145661983|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Death|1|||
145661984|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Death|0|||
145661985|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Death|0|||
145661986|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Death|0|||
145661987|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Death|0|||
145661988|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Death|0|||
145661989|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
145661990|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661991|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661992|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661993|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661994|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661995|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
145661996|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145661997|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
145661998|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145661999|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145662000|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145662001|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145662002|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
145662003|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Other|1|||
145662004|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Other|0|||
145662005|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Other|0|||
145662006|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Other|0|||
145662007|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Other|0|||
145662008|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Other|0|||
145662009|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Other|0|||
145662010|NCT04585815|525282133|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
145662011|NCT04585815|525282134|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
145662012|NCT04585815|525282135|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
145662013|NCT04585815|525282136|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
145662014|NCT04585815|525282137|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
145662015|NCT04585815|525282138|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
145662016|NCT04585815|525282139|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
145662017|NCT04585815|525282133|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662018|NCT04585815|525282134|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
145662019|NCT04585815|525282135|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662020|NCT04585815|525282136|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662021|NCT04585815|525282137|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662022|NCT04585815|525282138|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662023|NCT04585815|525282139|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
145662024|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
145662025|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
145662026|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
145662027|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
145662028|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
145662029|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
145662030|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
145662031|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Death|0|||
145662032|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Death|0|||
145662033|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Death|0|||
145662034|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Death|1|||
145662035|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Death|0|||
145662036|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Death|0|||
145662037|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Death|0|||
145662038|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
145662039|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
145662040|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
145662041|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
145662042|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
145662043|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
145662044|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
145662045|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662046|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662047|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662048|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
145662049|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662050|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662051|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
145662052|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662053|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662054|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662055|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662056|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662057|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
145662058|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
145662059|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
145662060|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
145662061|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
145662062|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
145662063|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
145662064|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
145662065|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
145662066|NCT04585815|525282133|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
145662067|NCT04585815|525282134|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
145662068|NCT04585815|525282135|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
145662069|NCT04585815|525282136|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
145662070|NCT04585815|525282137|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
145662071|NCT04585815|525282138|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
145662072|NCT04585815|525282139|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
145662073|NCT04585815|525282133|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
145662074|NCT04585815|525282134|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
145662075|NCT04585815|525282135|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
145662076|NCT04585815|525282136|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
145662077|NCT04585815|525282137|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
145662078|NCT04585815|525282138|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
145662079|NCT04585815|525282139|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
145662080|NCT04585815|525282133|FG000|Sub-study B- Follow-up Phase|Death|0|||
145662081|NCT04585815|525282134|FG001|Sub-study B- Follow-up Phase|Death|0|||
145662082|NCT04585815|525282135|FG002|Sub-study B- Follow-up Phase|Death|1|||
145662083|NCT04585815|525282136|FG003|Sub-study B- Follow-up Phase|Death|3|||
145662084|NCT04585815|525282137|FG004|Sub-study B- Follow-up Phase|Death|0|||
145662085|NCT04585815|525282138|FG005|Sub-study B- Follow-up Phase|Death|0|||
145662086|NCT04585815|525282139|FG006|Sub-study B- Follow-up Phase|Death|1|||
145662087|NCT05618587|525282140|FG000|Overall Study|Lost to Follow-up|2|||
145662088|NCT05618587|525282141|FG001|Overall Study|Lost to Follow-up|0|||
145662089|NCT03442309|525282144|FG000|Overall Study|Lost to Follow-up|1676|||
145662090|NCT03442309|525282145|FG001|Overall Study|Lost to Follow-up|1642|||
145662091|NCT05204654|525282146|FG000|Overall Study|Study terminated due to time restraint|2|||
145662092|NCT05204654|525282147|FG001|Overall Study|Study terminated due to time restraint|2|||
145662093|NCT05207956|525282154|FG000|Overall Study|Lost to follow up|1|||
145662094|NCT05207956|525282155|FG001|Overall Study|Lost to follow up|2|||
145662095|NCT01828112|525282158|FG000|Treatment Phase|Adverse Event|7|||
145662096|NCT01828112|525282159|FG001|Treatment Phase|Adverse Event|8|||
145662097|NCT01828112|525282160|FG002|Treatment Phase|Adverse Event|0|||
145662098|NCT01828112|525282158|FG000|Treatment Phase|Death|9|||
145662099|NCT01828112|525282159|FG001|Treatment Phase|Death|5|||
145662100|NCT01828112|525282160|FG002|Treatment Phase|Death|0|||
145662101|NCT01828112|525282158|FG000|Treatment Phase|No longer required treatment|0|||
145662102|NCT01828112|525282159|FG001|Treatment Phase|No longer required treatment|1|||
145662103|NCT01828112|525282160|FG002|Treatment Phase|No longer required treatment|0|||
145662104|NCT01828112|525282158|FG000|Treatment Phase|Physician Decision|6|||
145662105|NCT01828112|525282159|FG001|Treatment Phase|Physician Decision|7|||
145662106|NCT01828112|525282160|FG002|Treatment Phase|Physician Decision|0|||
145662107|NCT01828112|525282158|FG000|Treatment Phase|Pregnancy|1|||
145662108|NCT01828112|525282159|FG001|Treatment Phase|Pregnancy|0|||
145490598|NCT00657046|524650353|FG001|Overall Study|Adverse Event|1|||
145265344|NCT04311411|523819306|FG000|Overall Study|Adverse Event|2|||
145662109|NCT01828112|525282160|FG002|Treatment Phase|Pregnancy|0|||
145662110|NCT01828112|525282158|FG000|Treatment Phase|Progressive disease|79|||
145662111|NCT01828112|525282159|FG001|Treatment Phase|Progressive disease|87|||
145662112|NCT01828112|525282160|FG002|Treatment Phase|Progressive disease|0|||
145662113|NCT01828112|525282158|FG000|Treatment Phase|Study terminated by sponsor|1|||
145662114|NCT01828112|525282159|FG001|Treatment Phase|Study terminated by sponsor|0|||
145662115|NCT01828112|525282160|FG002|Treatment Phase|Study terminated by sponsor|0|||
145662116|NCT01828112|525282158|FG000|Treatment Phase|Subject/guardian decision|12|||
145662117|NCT01828112|525282159|FG001|Treatment Phase|Subject/guardian decision|8|||
145662118|NCT01828112|525282160|FG002|Treatment Phase|Subject/guardian decision|0|||
145662119|NCT01828112|525282158|FG000|Extension Treatment Phase|Adverse Event|0|||
145662120|NCT01828112|525282159|FG001|Extension Treatment Phase|Adverse Event|0|||
145662121|NCT01828112|525282160|FG002|Extension Treatment Phase|Adverse Event|6|||
145662122|NCT01828112|525282158|FG000|Extension Treatment Phase|Death|0|||
145662123|NCT01828112|525282159|FG001|Extension Treatment Phase|Death|0|||
145662124|NCT01828112|525282160|FG002|Extension Treatment Phase|Death|17|||
145662125|NCT01828112|525282158|FG000|Extension Treatment Phase|Physician Decision|0|||
145662126|NCT01828112|525282159|FG001|Extension Treatment Phase|Physician Decision|0|||
145662127|NCT01828112|525282160|FG002|Extension Treatment Phase|Physician Decision|5|||
145662128|NCT01828112|525282158|FG000|Extension Treatment Phase|Progressive disease|0|||
145662129|NCT01828112|525282159|FG001|Extension Treatment Phase|Progressive disease|0|||
145662130|NCT01828112|525282160|FG002|Extension Treatment Phase|Progressive disease|46|||
145662131|NCT01828112|525282158|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
145662132|NCT01828112|525282159|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
145662133|NCT01828112|525282160|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
145662134|NCT01828112|525282158|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
145662135|NCT01828112|525282159|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
145662136|NCT01828112|525282160|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
145662137|NCT04308681|525282166|FG000|Pre-Treatment|Not reported|1|||
145662138|NCT04308681|525282167|FG001|Pre-Treatment|Not reported|1|||
145662139|NCT04308681|525282168|FG002|Pre-Treatment|Not reported|0|||
145662140|NCT04308681|525282169|FG003|Pre-Treatment|Not reported|0|||
145662141|NCT04308681|525282170|FG004|Pre-Treatment|Not reported|0|||
145662142|NCT04308681|525282171|FG005|Pre-Treatment|Not reported|2|||
145662143|NCT04308681|525282172|FG006|Pre-Treatment|Not reported|0|||
145662144|NCT04308681|525282173|FG007|Pre-Treatment|Not reported|0|||
145662145|NCT04308681|525282166|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
145662146|NCT04308681|525282167|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
145662147|NCT04308681|525282168|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
145662148|NCT04308681|525282169|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
145662149|NCT04308681|525282170|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
145662150|NCT04308681|525282171|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
145662151|NCT04308681|525282172|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
145662152|NCT04308681|525282173|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
145662153|NCT04308681|525282166|FG000|Treatment up to Week 26|Other reasons|2|||
145662154|NCT04308681|525282167|FG001|Treatment up to Week 26|Other reasons|0|||
145662155|NCT04308681|525282168|FG002|Treatment up to Week 26|Other reasons|0|||
145662156|NCT04308681|525282169|FG003|Treatment up to Week 26|Other reasons|0|||
145662157|NCT04308681|525282170|FG004|Treatment up to Week 26|Other reasons|1|||
145662158|NCT04308681|525282171|FG005|Treatment up to Week 26|Other reasons|1|||
145662159|NCT04308681|525282172|FG006|Treatment up to Week 26|Other reasons|0|||
145662160|NCT04308681|525282173|FG007|Treatment up to Week 26|Other reasons|0|||
145662161|NCT04308681|525282166|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
145662162|NCT04308681|525282167|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
145662163|NCT04308681|525282168|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
145662164|NCT04308681|525282169|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
145662165|NCT04308681|525282170|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
145662166|NCT04308681|525282171|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
145662167|NCT04308681|525282172|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
145662168|NCT04308681|525282173|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
145662169|NCT04308681|525282166|FG000|Treatment up to Week 26|Adverse Event|6|||
145662170|NCT04308681|525282167|FG001|Treatment up to Week 26|Adverse Event|5|||
145662171|NCT04308681|525282168|FG002|Treatment up to Week 26|Adverse Event|5|||
145662172|NCT04308681|525282169|FG003|Treatment up to Week 26|Adverse Event|0|||
145662173|NCT04308681|525282170|FG004|Treatment up to Week 26|Adverse Event|6|||
145662174|NCT04308681|525282171|FG005|Treatment up to Week 26|Adverse Event|1|||
145662175|NCT04308681|525282172|FG006|Treatment up to Week 26|Adverse Event|0|||
145662176|NCT04308681|525282173|FG007|Treatment up to Week 26|Adverse Event|0|||
145662177|NCT04308681|525282166|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662178|NCT04308681|525282167|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
145662179|NCT04308681|525282168|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
145662180|NCT04308681|525282169|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662181|NCT04308681|525282170|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662182|NCT04308681|525282171|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662183|NCT04308681|525282172|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662184|NCT04308681|525282173|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
145662185|NCT04308681|525282166|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
145662186|NCT04308681|525282167|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
145662187|NCT04308681|525282168|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
145662188|NCT04308681|525282169|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
145662189|NCT04308681|525282170|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
145662190|NCT04308681|525282171|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
145662191|NCT04308681|525282172|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
145662192|NCT04308681|525282173|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
145662193|NCT04308681|525282166|FG000|OTE - 26 Weeks|Death|0|||
145662194|NCT04308681|525282167|FG001|OTE - 26 Weeks|Death|1|||
145662195|NCT04308681|525282168|FG002|OTE - 26 Weeks|Death|0|||
145662196|NCT04308681|525282169|FG003|OTE - 26 Weeks|Death|0|||
145662197|NCT04308681|525282170|FG004|OTE - 26 Weeks|Death|0|||
145662198|NCT04308681|525282171|FG005|OTE - 26 Weeks|Death|0|||
145662199|NCT04308681|525282172|FG006|OTE - 26 Weeks|Death|1|||
145662200|NCT04308681|525282173|FG007|OTE - 26 Weeks|Death|0|||
145662201|NCT04308681|525282166|FG000|OTE - 26 Weeks|Adverse Event|0|||
145662202|NCT04308681|525282167|FG001|OTE - 26 Weeks|Adverse Event|2|||
145662203|NCT04308681|525282168|FG002|OTE - 26 Weeks|Adverse Event|8|||
145662204|NCT04308681|525282169|FG003|OTE - 26 Weeks|Adverse Event|3|||
145662205|NCT04308681|525282170|FG004|OTE - 26 Weeks|Adverse Event|0|||
145662206|NCT04308681|525282171|FG005|OTE - 26 Weeks|Adverse Event|1|||
145662207|NCT04308681|525282172|FG006|OTE - 26 Weeks|Adverse Event|2|||
145662208|NCT04308681|525282173|FG007|OTE - 26 Weeks|Adverse Event|0|||
145662209|NCT04308681|525282166|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
145662210|NCT04308681|525282167|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
145662211|NCT04308681|525282168|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
145662212|NCT04308681|525282169|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
145662213|NCT04308681|525282170|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
145662214|NCT04308681|525282171|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
145662215|NCT04308681|525282172|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
145662216|NCT04308681|525282173|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
145662217|NCT02446236|525282174|FG000|Overall Study|Screen Failure|1|||
145662218|NCT02446236|525282175|FG001|Overall Study|Screen Failure|0|||
145662219|NCT02446236|525282176|FG002|Overall Study|Screen Failure|1|||
145662220|NCT02446236|525282174|FG000|Overall Study|Actively Receiving Therapy|0|||
145662221|NCT02446236|525282175|FG001|Overall Study|Actively Receiving Therapy|0|||
145662222|NCT02446236|525282176|FG002|Overall Study|Actively Receiving Therapy|1|||
145662223|NCT05873556|525282183|FG000|Overall Study|Lost to Follow-up|4|||
145662224|NCT05873556|525282184|FG001|Overall Study|Lost to Follow-up|1|||
145662225|NCT03606408|525282185|FG000|Overall Study|Adverse Event|13|||
145662226|NCT03606408|525282185|FG000|Overall Study|Withdrawal by Subject|7|||
145662227|NCT03606408|525282185|FG000|Overall Study|Physician Decision|4|||
145662228|NCT03606408|525282185|FG000|Overall Study|Lack of Efficacy|2|||
145662229|NCT03606408|525282185|FG000|Overall Study|Death|1|||
145662230|NCT03606408|525282185|FG000|Overall Study|new therapy for study indication|1|||
145662231|NCT04862234|525282191|FG000|Overall Study|Surgery cancellation|1|||
145662232|NCT04862234|525282192|FG001|Overall Study|Surgery cancellation|2|||
145662233|NCT04862234|525282191|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
145662234|NCT04862234|525282192|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
145662235|NCT04862234|525282191|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
145662236|NCT04862234|525282192|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
145662237|NCT03292484|525282193|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
145662238|NCT03292484|525282193|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
145662239|NCT03292484|525282193|FG000|Overall Study|Protocol Violation|2|||
145662240|NCT03292484|525282193|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
145662241|NCT03292484|525282193|FG000|Overall Study|Sponsor decision|349|||
145662242|NCT03292484|525282193|FG000|Overall Study|Lost to Follow-up|7|||
145662243|NCT03292484|525282193|FG000|Overall Study|Coronavirus Disease 2019|1|||
145662244|NCT03292484|525282193|FG000|Overall Study|Other|20|||
145662245|NCT05290493|525282200|FG000|Overall Study|Withdrawal by Subject|2|||
145662246|NCT05290493|525282201|FG001|Overall Study|Withdrawal by Subject|2|||
145662247|NCT05290493|525282200|FG000|Overall Study|Adverse Event|1|||
145662248|NCT05290493|525282201|FG001|Overall Study|Adverse Event|0|||
145662249|NCT05012163|525282205|FG000|Overall Study|Protocol Violation|0|||
145662250|NCT05012163|525282206|FG001|Overall Study|Protocol Violation|0|||
145662251|NCT05012163|525282207|FG002|Overall Study|Protocol Violation|1|||
145662252|NCT05012163|525282208|FG003|Overall Study|Protocol Violation|1|||
145662253|NCT04003246|525282211|FG000|Overall Study|Death|9|||
145662254|NCT05524402|525282223|FG000|Overall Study|Withdrawal by Subject|3|||
145662255|NCT05524402|525282224|FG001|Overall Study|Withdrawal by Subject|1|||
145662256|NCT05524402|525282223|FG000|Overall Study|Lost to Follow-up|2|||
145662257|NCT05524402|525282224|FG001|Overall Study|Lost to Follow-up|1|||
145662258|NCT03381586|525282225|FG000|Overall Study|Adverse Event|1|||
145662259|NCT03381586|525282226|FG001|Overall Study|Adverse Event|1|||
145662260|NCT03381586|525282225|FG000|Overall Study|Protocol Violation|1|||
145662261|NCT03381586|525282226|FG001|Overall Study|Protocol Violation|0|||
145662262|NCT03381586|525282225|FG000|Overall Study|Withdrawal by Subject|1|||
145662263|NCT03381586|525282226|FG001|Overall Study|Withdrawal by Subject|2|||
145662264|NCT03673501|525282230|FG000|Overall Study|Participants ongoing.|36|||
145662265|NCT03673501|525282231|FG001|Overall Study|Participants ongoing.|24|||
145662266|NCT05237284|525282232|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
145662267|NCT05237284|525282233|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
145662268|NCT05237284|525282234|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
145662269|NCT05237284|525282235|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
145662270|NCT05237284|525282232|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
145662271|NCT05237284|525282233|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
145662272|NCT05237284|525282234|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
145662273|NCT05237284|525282235|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
145662274|NCT05237284|525282232|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
145662275|NCT05237284|525282233|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
145662276|NCT05237284|525282234|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
145662277|NCT05237284|525282235|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
145662278|NCT05237284|525282232|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
145662279|NCT05237284|525282233|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
145662280|NCT05237284|525282234|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
145662281|NCT05237284|525282235|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
145662282|NCT05237284|525282232|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
145662283|NCT05237284|525282233|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
145662284|NCT05237284|525282234|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
145662285|NCT05237284|525282235|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
145662286|NCT05237284|525282232|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
145662287|NCT05237284|525282233|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
145662288|NCT05237284|525282234|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
145662289|NCT05237284|525282235|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
145662290|NCT05237284|525282232|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
145662291|NCT05237284|525282233|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
145662292|NCT05237284|525282234|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
145662293|NCT05237284|525282235|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
145662294|NCT05237284|525282232|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
145662295|NCT05237284|525282233|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
145662296|NCT05237284|525282234|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
145662297|NCT05237284|525282235|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
145662298|NCT05237284|525282232|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
145662299|NCT05237284|525282233|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
145662300|NCT05237284|525282234|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
145662301|NCT05237284|525282235|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
145662302|NCT04599634|525282236|FG000|Overall Study|Dose limiting toxicity|0|||
145662303|NCT04599634|525282237|FG001|Overall Study|Dose limiting toxicity|0|||
145662304|NCT04599634|525282238|FG002|Overall Study|Dose limiting toxicity|2|||
145662305|NCT04599634|525282239|FG003|Overall Study|Dose limiting toxicity|0|||
145662306|NCT03714815|525282242|FG000|Overall Study|Physician Decision|2|||
145662307|NCT03714815|525282242|FG000|Overall Study|Withdrawal by Subject|2|||
145662308|NCT03714815|525282242|FG000|Overall Study|Death|11|||
145662309|NCT03733925|525282247|FG000|Overall Study|Lost to Follow-up|1|||
145662310|NCT03733925|525282247|FG000|Overall Study|Withdrawal by Subject|2|||
145662311|NCT03733925|525282247|FG000|Overall Study|Adverse Event|2|||
145662312|NCT03733925|525282247|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145662313|NCT02224144|525282248|FG000|Overall Study|Lost to Follow-up|3|||
145662314|NCT02224144|525282249|FG001|Overall Study|Lost to Follow-up|1|||
145662315|NCT02224144|525282248|FG000|Overall Study|Death|2|||
145662316|NCT02224144|525282249|FG001|Overall Study|Death|0|||
145662317|NCT02224144|525282248|FG000|Overall Study|Withdrawal by Subject|0|||
145662318|NCT02224144|525282249|FG001|Overall Study|Withdrawal by Subject|1|||
145662319|NCT03276676|525282252|FG000|Overall Study|Withdrawal by Subject|2|||
145662320|NCT03276676|525282253|FG001|Overall Study|Withdrawal by Subject|1|||
145490599|NCT00657046|524650354|FG002|Overall Study|Adverse Event|0|||
145662321|NCT02962076|525282255|FG000|Overall Study|MHED tracer not available|5|||
145662322|NCT02962076|525282255|FG000|Overall Study|Protocol Violation|1|||
145662323|NCT02962076|525282255|FG000|Overall Study|Physician Decision|1|||
145662324|NCT02988661|525282256|FG000|Overall Study|Death|2|||
145662325|NCT02988661|525282257|FG001|Overall Study|Death|18|||
145662326|NCT02988661|525282256|FG000|Overall Study|Lost to Follow-up|0|||
145662327|NCT02988661|525282257|FG001|Overall Study|Lost to Follow-up|33|||
145662328|NCT02988661|525282256|FG000|Overall Study|Withdrawal by Subject|0|||
145662329|NCT02988661|525282257|FG001|Overall Study|Withdrawal by Subject|6|||
145662330|NCT02988661|525282256|FG000|Overall Study|Unable to complete the 18-month survey|1|||
145662331|NCT02988661|525282257|FG001|Overall Study|Unable to complete the 18-month survey|27|||
145662332|NCT05736458|525282258|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
145662333|NCT05736458|525282259|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
145662334|NCT05736458|525282260|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
145662335|NCT05736458|525282258|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
145662336|NCT05736458|525282259|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
145662337|NCT05736458|525282260|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
145662338|NCT05736458|525282258|FG000|TMS/fMRI #1|Physician Decision|0|||
145662339|NCT05736458|525282259|FG001|TMS/fMRI #1|Physician Decision|0|||
145662340|NCT05736458|525282260|FG002|TMS/fMRI #1|Physician Decision|2|||
145662341|NCT05736458|525282258|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
145662342|NCT05736458|525282259|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
145662343|NCT05736458|525282260|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
145662344|NCT03106740|525283721|FG000|Overall Study|Lost to Follow-up|2|||
145662345|NCT03106740|525283722|FG001|Overall Study|Lost to Follow-up|2|||
145662346|NCT03106740|525283721|FG000|Overall Study|Withdrawal by Subject|2|||
145662347|NCT03106740|525283722|FG001|Overall Study|Withdrawal by Subject|4|||
145662348|NCT03106740|525283721|FG000|Overall Study|Physician Decision|0|||
145662349|NCT03106740|525283722|FG001|Overall Study|Physician Decision|1|||
145662350|NCT03106740|525283721|FG000|Overall Study|Partial data|1|||
145662351|NCT03106740|525283722|FG001|Overall Study|Partial data|0|||
145662352|NCT04565990|525283723|FG000|Overall Study|Death|5|||
145662353|NCT04565990|525283723|FG000|Overall Study|Lost to Follow-up|1|||
145662354|NCT04565990|525283723|FG000|Overall Study|Withdrawal by Subject|1|||
145662355|NCT04797858|525283724|FG000|Overall Study|Withdrawal by Subject|0|||
145662356|NCT04797858|525283725|FG001|Overall Study|Withdrawal by Subject|1|||
145662357|NCT04797858|525283724|FG000|Overall Study|Excluded due to administrative error|7|||
145662358|NCT04797858|525283725|FG001|Overall Study|Excluded due to administrative error|8|||
145662359|NCT04414722|525283731|FG000|Overall Study|Lost to Follow-up|3|||
145662360|NCT04414722|525283732|FG001|Overall Study|Lost to Follow-up|4|||
145662361|NCT04414722|525283733|FG002|Overall Study|Lost to Follow-up|3|||
145662362|NCT04414722|525283734|FG003|Overall Study|Lost to Follow-up|2|||
145662363|NCT04414722|525283735|FG004|Overall Study|Lost to Follow-up|3|||
145662364|NCT04414722|525283731|FG000|Overall Study|Withdrawal by Subject|6|||
145662365|NCT04414722|525283732|FG001|Overall Study|Withdrawal by Subject|3|||
145662366|NCT04414722|525283733|FG002|Overall Study|Withdrawal by Subject|1|||
145662367|NCT04414722|525283734|FG003|Overall Study|Withdrawal by Subject|5|||
145662368|NCT04414722|525283735|FG004|Overall Study|Withdrawal by Subject|1|||
145662369|NCT04414722|525283731|FG000|Overall Study|Physician Decision|0|||
145662370|NCT04414722|525283732|FG001|Overall Study|Physician Decision|1|||
145662371|NCT04414722|525283733|FG002|Overall Study|Physician Decision|2|||
145662372|NCT04414722|525283734|FG003|Overall Study|Physician Decision|0|||
145662373|NCT04414722|525283735|FG004|Overall Study|Physician Decision|0|||
145662374|NCT04414722|525283731|FG000|Overall Study|Non-participatory|0|||
145662375|NCT04414722|525283732|FG001|Overall Study|Non-participatory|1|||
145662376|NCT04414722|525283733|FG002|Overall Study|Non-participatory|1|||
145662377|NCT04414722|525283734|FG003|Overall Study|Non-participatory|0|||
145662378|NCT04414722|525283735|FG004|Overall Study|Non-participatory|0|||
145662379|NCT04766892|525283737|FG000|Overall Study|Withdrawal by Subject|1|||
145662380|NCT04766892|525283737|FG000|Overall Study|Lost to Follow-up|1|||
145662381|NCT04766892|525283737|FG000|Overall Study|Adverse Event|3|||
145662382|NCT04766892|525283737|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
145662383|NCT05906784|525283738|FG000|Overall Study|Lost to Follow-up|2|||
145662384|NCT05906784|525283739|FG001|Overall Study|Lost to Follow-up|1|||
145662385|NCT05906784|525283740|FG002|Overall Study|Lost to Follow-up|1|||
145662386|NCT05906784|525283741|FG003|Overall Study|Lost to Follow-up|1|||
145662387|NCT02668692|525283742|FG000|Overall Study|Adverse Event|1|||
145662388|NCT02668692|525283743|FG001|Overall Study|Adverse Event|0|||
145662389|NCT03476343|525283757|FG000|Overall Study|Clinical exam moved to another scanner|7|||
145662390|NCT03476343|525283757|FG000|Overall Study|Clinical order cancelled|4|||
145490600|NCT00657046|524650352|FG000|Overall Study|Protocol Violation|2|||
145662391|NCT03476343|525283757|FG000|Overall Study|Neonate did not settle down for the scan|1|||
145662392|NCT05280574|525283762|FG000|Overall Study|Withdrawal by Subject|0|||
145662393|NCT05280574|525283763|FG001|Overall Study|Withdrawal by Subject|2|||
145662394|NCT05280574|525283764|FG002|Overall Study|Withdrawal by Subject|0|||
145662395|NCT05838027|525283767|FG000|Overall Study|Lost to Follow-up|5|||
145662396|NCT05838027|525283768|FG001|Overall Study|Lost to Follow-up|1|||
145662397|NCT05838027|525283767|FG000|Overall Study|Withdrawal by Subject|1|||
145662398|NCT05838027|525283768|FG001|Overall Study|Withdrawal by Subject|0|||
145662399|NCT03213873|525283769|FG000|Overall Study|Withdrawal by Subject|8|||
145662400|NCT03213873|525283770|FG001|Overall Study|Withdrawal by Subject|9|||
145662401|NCT03213873|525283769|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
145662402|NCT03213873|525283770|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
145662403|NCT03213873|525283769|FG000|Overall Study|Lost to Follow-up|0|||
145662404|NCT03213873|525283770|FG001|Overall Study|Lost to Follow-up|2|||
145662405|NCT04709419|525283777|FG000|Overall Study|Physician Decision|1|||
145662406|NCT04709419|525283778|FG001|Overall Study|Physician Decision|0|||
145662407|NCT05683340|525283779|FG000|Overall Study|Adverse Event|1|||
145662408|NCT05683340|525283780|FG001|Overall Study|Adverse Event|1|||
145662409|NCT05683340|525283779|FG000|Overall Study|Protocol Violation|1|||
145662410|NCT05683340|525283780|FG001|Overall Study|Protocol Violation|0|||
145662411|NCT05683340|525283779|FG000|Overall Study|Withdrawal by Subject|0|||
145662412|NCT05683340|525283780|FG001|Overall Study|Withdrawal by Subject|2|||
145662413|NCT03505008|525283781|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
145662414|NCT03505008|525283782|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
145662415|NCT03505008|525283783|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
145662416|NCT03505008|525283784|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
145662417|NCT03505008|525283781|FG000|Before Week 24 Randomization|Adverse Event|10|||
145662418|NCT03505008|525283782|FG001|Before Week 24 Randomization|Adverse Event|0|||
145662419|NCT03505008|525283783|FG002|Before Week 24 Randomization|Adverse Event|0|||
145662420|NCT03505008|525283784|FG003|Before Week 24 Randomization|Adverse Event|0|||
145662421|NCT03505008|525283781|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
145662422|NCT03505008|525283782|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
145662423|NCT03505008|525283783|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
145662424|NCT03505008|525283784|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
145662425|NCT03505008|525283781|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
145662426|NCT03505008|525283782|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
145662427|NCT03505008|525283783|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
145662428|NCT03505008|525283784|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
145662429|NCT03505008|525283781|FG000|Before Week 24 Randomization|Physician Decision|2|||
145662430|NCT03505008|525283782|FG001|Before Week 24 Randomization|Physician Decision|0|||
145662431|NCT03505008|525283783|FG002|Before Week 24 Randomization|Physician Decision|0|||
145662432|NCT03505008|525283784|FG003|Before Week 24 Randomization|Physician Decision|0|||
145662433|NCT03505008|525283781|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
145662434|NCT03505008|525283782|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
145662435|NCT03505008|525283783|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
145662436|NCT03505008|525283784|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
145662437|NCT03505008|525283781|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
145662438|NCT03505008|525283782|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
145662439|NCT03505008|525283783|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
145662440|NCT03505008|525283784|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
145662441|NCT03505008|525283781|FG000|Before Week 24 Randomization|Complication|1|||
145662442|NCT03505008|525283782|FG001|Before Week 24 Randomization|Complication|0|||
145662443|NCT03505008|525283783|FG002|Before Week 24 Randomization|Complication|0|||
145662444|NCT03505008|525283784|FG003|Before Week 24 Randomization|Complication|0|||
145662445|NCT03505008|525283781|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
145662446|NCT03505008|525283782|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
145662447|NCT03505008|525283783|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
145662448|NCT03505008|525283784|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
145662449|NCT03505008|525283781|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
145662450|NCT03505008|525283782|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
145490601|NCT00657046|524650353|FG001|Overall Study|Protocol Violation|2|||
145490602|NCT00657046|524650354|FG002|Overall Study|Protocol Violation|0|||
145490603|NCT00657046|524650352|FG000|Overall Study|Withdrawal by Subject|1|||
145490604|NCT00657046|524650353|FG001|Overall Study|Withdrawal by Subject|0|||
145490605|NCT00657046|524650354|FG002|Overall Study|Withdrawal by Subject|0|||
145490606|NCT00657046|524650352|FG000|Overall Study|Death|0|||
145490607|NCT00657046|524650353|FG001|Overall Study|Death|0|||
145490608|NCT00657046|524650354|FG002|Overall Study|Death|1|||
145490609|NCT00657046|524650352|FG000|Overall Study|Surgery|0|||
145490610|NCT00657046|524650353|FG001|Overall Study|Surgery|0|||
145490611|NCT00657046|524650354|FG002|Overall Study|Surgery|1|||
145490612|NCT01239381|524650355|FG000|Overall Study|Protocol Violation|1|||
145490613|NCT01239381|524650355|FG000|Overall Study|Withdrawal by Subject|1|||
145490614|NCT00867165|524650356|FG000|Overall Study|Adverse Event|3|||
145490615|NCT00867165|524650357|FG001|Overall Study|Adverse Event|0|||
145490616|NCT00867165|524650356|FG000|Overall Study|Withdrawal by Subject|1|||
145490617|NCT00867165|524650357|FG001|Overall Study|Withdrawal by Subject|0|||
145490618|NCT04621448|524650358|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
145490619|NCT04621448|524650359|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
145490620|NCT04621448|524650360|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
145662451|NCT03505008|525283783|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
145662452|NCT03505008|525283784|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
145662453|NCT03505008|525283781|FG000|After Week 24 Randomization|Adverse Event|0|||
145662454|NCT03505008|525283782|FG001|After Week 24 Randomization|Adverse Event|1|||
145662455|NCT03505008|525283783|FG002|After Week 24 Randomization|Adverse Event|2|||
145662456|NCT03505008|525283784|FG003|After Week 24 Randomization|Adverse Event|2|||
145490621|NCT04621448|524650361|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
145490622|NCT04621448|524650358|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
145490623|NCT04621448|524650359|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
145490624|NCT04621448|524650360|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
145490625|NCT04621448|524650361|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
145662457|NCT03505008|525283781|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
145662458|NCT03505008|525283782|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
145662459|NCT03505008|525283783|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
145662460|NCT03505008|525283784|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
145662461|NCT03505008|525283781|FG000|After Week 24 Randomization|Protocol Violation|0|||
145662462|NCT03505008|525283782|FG001|After Week 24 Randomization|Protocol Violation|0|||
145662463|NCT03505008|525283783|FG002|After Week 24 Randomization|Protocol Violation|1|||
145662464|NCT03505008|525283784|FG003|After Week 24 Randomization|Protocol Violation|0|||
145662465|NCT02780700|525283785|FG000|Overall Study|Progressive disease|1|||
145662466|NCT03926130|525283786|FG000|Overall Study|Adverse Event|9|||
145662467|NCT03926130|525283787|FG001|Overall Study|Adverse Event|11|||
145662468|NCT03926130|525283788|FG002|Overall Study|Adverse Event|2|||
145662469|NCT03926130|525283789|FG003|Overall Study|Adverse Event|0|||
145662470|NCT03926130|525283786|FG000|Overall Study|Death|2|||
145662471|NCT03926130|525283787|FG001|Overall Study|Death|0|||
145662472|NCT03926130|525283788|FG002|Overall Study|Death|1|||
145662473|NCT03926130|525283789|FG003|Overall Study|Death|0|||
145662474|NCT03926130|525283786|FG000|Overall Study|Lack of Efficacy|14|||
145662475|NCT03926130|525283787|FG001|Overall Study|Lack of Efficacy|11|||
145662476|NCT03926130|525283788|FG002|Overall Study|Lack of Efficacy|7|||
145662477|NCT03926130|525283789|FG003|Overall Study|Lack of Efficacy|1|||
145662478|NCT03926130|525283786|FG000|Overall Study|Lost to Follow-up|0|||
145662479|NCT03926130|525283787|FG001|Overall Study|Lost to Follow-up|7|||
145662480|NCT03926130|525283788|FG002|Overall Study|Lost to Follow-up|1|||
145662481|NCT03926130|525283789|FG003|Overall Study|Lost to Follow-up|0|||
145662482|NCT03926130|525283786|FG000|Overall Study|As Reported by Investigator|2|||
145662483|NCT03926130|525283787|FG001|Overall Study|As Reported by Investigator|6|||
145662484|NCT03926130|525283788|FG002|Overall Study|As Reported by Investigator|6|||
145662485|NCT03926130|525283789|FG003|Overall Study|As Reported by Investigator|0|||
145662486|NCT03926130|525283786|FG000|Overall Study|Physician Decision|3|||
145662487|NCT03926130|525283787|FG001|Overall Study|Physician Decision|2|||
145662488|NCT03926130|525283788|FG002|Overall Study|Physician Decision|1|||
145662489|NCT03926130|525283789|FG003|Overall Study|Physician Decision|0|||
145662490|NCT03926130|525283786|FG000|Overall Study|Pregnancy|2|||
145662491|NCT03926130|525283787|FG001|Overall Study|Pregnancy|2|||
145662492|NCT03926130|525283788|FG002|Overall Study|Pregnancy|1|||
145662493|NCT03926130|525283789|FG003|Overall Study|Pregnancy|0|||
145662494|NCT03926130|525283786|FG000|Overall Study|Withdrawal by Subject|20|||
145662495|NCT03926130|525283787|FG001|Overall Study|Withdrawal by Subject|28|||
145662496|NCT03926130|525283788|FG002|Overall Study|Withdrawal by Subject|18|||
145662497|NCT03926130|525283789|FG003|Overall Study|Withdrawal by Subject|1|||
145662498|NCT03926130|525283786|FG000|Overall Study|Non-Compliance|1|||
145662499|NCT03926130|525283787|FG001|Overall Study|Non-Compliance|1|||
145662500|NCT03926130|525283788|FG002|Overall Study|Non-Compliance|0|||
145662501|NCT03926130|525283789|FG003|Overall Study|Non-Compliance|0|||
145662502|NCT03926130|525283786|FG000|Overall Study|Disposition Not Captured|0|||
145662503|NCT03926130|525283787|FG001|Overall Study|Disposition Not Captured|2|||
145662504|NCT03926130|525283788|FG002|Overall Study|Disposition Not Captured|1|||
145662505|NCT03926130|525283789|FG003|Overall Study|Disposition Not Captured|0|||
145662506|NCT03583333|525283790|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
145662507|NCT03583333|525283791|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
145662508|NCT03583333|525283790|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
145662509|NCT03583333|525283791|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
145662510|NCT03583333|525283790|FG000|Overall Study|Withdrawal by Subject|9|||
145662511|NCT03583333|525283791|FG001|Overall Study|Withdrawal by Subject|5|||
145662512|NCT03583333|525283790|FG000|Overall Study|Physician Decision|3|||
145662513|NCT03583333|525283791|FG001|Overall Study|Physician Decision|2|||
145662514|NCT03583333|525283790|FG000|Overall Study|Death|12|||
145662515|NCT03583333|525283791|FG001|Overall Study|Death|7|||
145662516|NCT03824366|525283808|FG000|Overall Study|Death|1|||
145662517|NCT03824366|525283808|FG000|Overall Study|Previously unidentified metal artifact|1|||
145662518|NCT03824366|525283808|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
145490626|NCT04621448|524650358|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
145490627|NCT04621448|524650359|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
145490628|NCT04621448|524650360|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
145662519|NCT03824366|525283808|FG000|Overall Study|Withdrawal by Subject|1|||
145662520|NCT04544007|525283811|FG000|Overall Study|Withdrawal by Subject|1|||
145662521|NCT04544007|525283811|FG000|Overall Study|Confirmed Progressive Disease|1|||
145662522|NCT03485729|525283815|FG000|Overall Study|Withdrawal by Subject|0|||
145662523|NCT03485729|525283816|FG001|Overall Study|Withdrawal by Subject|0|||
145662524|NCT03485729|525283817|FG002|Overall Study|Withdrawal by Subject|1|||
145662525|NCT03485729|525283815|FG000|Overall Study|Disease progression|8|||
145662526|NCT03485729|525283816|FG001|Overall Study|Disease progression|13|||
145662527|NCT03485729|525283817|FG002|Overall Study|Disease progression|1|||
145662528|NCT03485729|525283815|FG000|Overall Study|Hospice care|1|||
145662529|NCT03485729|525283816|FG001|Overall Study|Hospice care|0|||
145662530|NCT03485729|525283817|FG002|Overall Study|Hospice care|0|||
145662531|NCT03485729|525283815|FG000|Overall Study|Poor performance status|1|||
145662532|NCT03485729|525283816|FG001|Overall Study|Poor performance status|0|||
145662533|NCT03485729|525283817|FG002|Overall Study|Poor performance status|0|||
145662534|NCT03485729|525283815|FG000|Overall Study|Illness|0|||
145662535|NCT03485729|525283816|FG001|Overall Study|Illness|1|||
145662536|NCT03485729|525283817|FG002|Overall Study|Illness|0|||
145662537|NCT05856435|525283823|FG000|Overall Study|Lost to Follow-up|6|||
145662538|NCT02323880|525283824|FG000|Overall Study|Adverse Event|2|||
145662539|NCT02323880|525283825|FG001|Overall Study|Adverse Event|0|||
145662540|NCT02323880|525283826|FG002|Overall Study|Adverse Event|1|||
145662541|NCT02323880|525283827|FG003|Overall Study|Adverse Event|1|||
145662542|NCT02323880|525283828|FG004|Overall Study|Adverse Event|1|||
145662543|NCT02323880|525283829|FG005|Overall Study|Adverse Event|0|||
145662544|NCT02323880|525283830|FG006|Overall Study|Adverse Event|1|||
145662545|NCT02323880|525283831|FG007|Overall Study|Adverse Event|0|||
145662546|NCT02323880|525283824|FG000|Overall Study|Death|0|||
145662547|NCT02323880|525283825|FG001|Overall Study|Death|0|||
145662548|NCT02323880|525283826|FG002|Overall Study|Death|0|||
145662549|NCT02323880|525283827|FG003|Overall Study|Death|0|||
145662550|NCT02323880|525283828|FG004|Overall Study|Death|0|||
145662551|NCT02323880|525283829|FG005|Overall Study|Death|1|||
145662552|NCT02323880|525283830|FG006|Overall Study|Death|0|||
145662553|NCT02323880|525283831|FG007|Overall Study|Death|0|||
145662554|NCT02323880|525283824|FG000|Overall Study|Lack of Efficacy|4|||
145662555|NCT02323880|525283825|FG001|Overall Study|Lack of Efficacy|11|||
145662556|NCT02323880|525283826|FG002|Overall Study|Lack of Efficacy|5|||
145662557|NCT02323880|525283827|FG003|Overall Study|Lack of Efficacy|5|||
145662558|NCT02323880|525283828|FG004|Overall Study|Lack of Efficacy|4|||
145662559|NCT02323880|525283829|FG005|Overall Study|Lack of Efficacy|8|||
145662560|NCT02323880|525283830|FG006|Overall Study|Lack of Efficacy|4|||
145662561|NCT02323880|525283831|FG007|Overall Study|Lack of Efficacy|6|||
145662562|NCT02323880|525283824|FG000|Overall Study|Physician Decision|0|||
145662563|NCT02323880|525283825|FG001|Overall Study|Physician Decision|0|||
145662564|NCT02323880|525283826|FG002|Overall Study|Physician Decision|0|||
145662565|NCT02323880|525283827|FG003|Overall Study|Physician Decision|0|||
145662566|NCT02323880|525283828|FG004|Overall Study|Physician Decision|1|||
145662567|NCT02323880|525283829|FG005|Overall Study|Physician Decision|1|||
145662568|NCT02323880|525283830|FG006|Overall Study|Physician Decision|1|||
145662569|NCT02323880|525283831|FG007|Overall Study|Physician Decision|0|||
145662570|NCT02323880|525283824|FG000|Overall Study|Withdrawal by Subject|0|||
145662571|NCT02323880|525283825|FG001|Overall Study|Withdrawal by Subject|2|||
145662572|NCT02323880|525283826|FG002|Overall Study|Withdrawal by Subject|0|||
145662573|NCT02323880|525283827|FG003|Overall Study|Withdrawal by Subject|0|||
145662574|NCT02323880|525283828|FG004|Overall Study|Withdrawal by Subject|0|||
145662575|NCT02323880|525283829|FG005|Overall Study|Withdrawal by Subject|0|||
145662576|NCT02323880|525283830|FG006|Overall Study|Withdrawal by Subject|0|||
145662577|NCT02323880|525283831|FG007|Overall Study|Withdrawal by Subject|0|||
145662578|NCT02828358|525283835|FG000|Overall Study|Physician Decision|7|||
145662579|NCT02828358|525283836|FG001|Overall Study|Physician Decision|1|||
145662580|NCT02828358|525283835|FG000|Overall Study|Treatment Failure|6|||
145662581|NCT02828358|525283836|FG001|Overall Study|Treatment Failure|0|||
145662582|NCT02828358|525283835|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
145662583|NCT02828358|525283836|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
145662584|NCT02828358|525283835|FG000|Overall Study|Refusal of further protocol therapy|2|||
145662585|NCT02828358|525283836|FG001|Overall Study|Refusal of further protocol therapy|0|||
145662586|NCT02828358|525283835|FG000|Overall Study|Relapse|25|||
145662587|NCT02828358|525283836|FG001|Overall Study|Relapse|0|||
145662588|NCT02828358|525283835|FG000|Overall Study|Still on therapy|5|||
145662589|NCT02828358|525283836|FG001|Overall Study|Still on therapy|0|||
145662590|NCT04218851|525283838|FG000|Overall Study|Death|1|||
145662591|NCT04218851|525283839|FG001|Overall Study|Death|3|||
145662592|NCT03174275|525283842|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
145662593|NCT03174275|525283842|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
145662594|NCT03174275|525283842|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
145662595|NCT03174275|525283842|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
145662596|NCT03174275|525283842|FG000|Adjuvant Chemotherapy|Progression|1|||
145662597|NCT03174275|525283842|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
145662598|NCT03174275|525283842|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
145662599|NCT03174275|525283842|FG000|Adjuvant Durvalumab|Progression|1|||
145662600|NCT03174275|525283842|FG000|Adjuvant Durvalumab|Adverse Event|3|||
145662601|NCT03174275|525283842|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
145662602|NCT03174275|525283842|FG000|Adjuvant Radiotherapy|Progression|1|||
145662603|NCT03174275|525283842|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
145662604|NCT02413489|525283843|FG000|Overall Study|Death|11|||
145662605|NCT02413489|525283844|FG001|Overall Study|Death|3|||
145662606|NCT02413489|525283845|FG002|Overall Study|Death|4|||
145662607|NCT02413489|525283843|FG000|Overall Study|Withdrawal by Subject|2|||
145662608|NCT02413489|525283844|FG001|Overall Study|Withdrawal by Subject|0|||
145662609|NCT02413489|525283845|FG002|Overall Study|Withdrawal by Subject|0|||
145662610|NCT02413489|525283843|FG000|Overall Study|Study Terminated By Sponsor|2|||
145662611|NCT02413489|525283844|FG001|Overall Study|Study Terminated By Sponsor|13|||
145662612|NCT02413489|525283845|FG002|Overall Study|Study Terminated By Sponsor|1|||
145662613|NCT05285137|525283846|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
145662614|NCT05285137|525283847|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
145662615|NCT05285137|525283848|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
145662616|NCT05285137|525283849|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
145662617|NCT05285137|525283850|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
145662618|NCT05285137|525283851|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
145662619|NCT05285137|525283852|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
145662620|NCT05285137|525283853|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
145662621|NCT05285137|525283854|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
145662622|NCT05285137|525283846|FG000|Overall Study|Lost to Follow-up|0|||
145662623|NCT05285137|525283847|FG001|Overall Study|Lost to Follow-up|0|||
145662624|NCT05285137|525283848|FG002|Overall Study|Lost to Follow-up|1|||
145662625|NCT05285137|525283849|FG003|Overall Study|Lost to Follow-up|3|||
145662626|NCT05285137|525283850|FG004|Overall Study|Lost to Follow-up|0|||
145662627|NCT05285137|525283851|FG005|Overall Study|Lost to Follow-up|0|||
145662628|NCT05285137|525283852|FG006|Overall Study|Lost to Follow-up|1|||
145662629|NCT05285137|525283853|FG007|Overall Study|Lost to Follow-up|0|||
145662630|NCT05285137|525283854|FG008|Overall Study|Lost to Follow-up|0|||
145662631|NCT05285137|525283846|FG000|Overall Study|Physician Decision|0|||
145662632|NCT05285137|525283847|FG001|Overall Study|Physician Decision|1|||
145662633|NCT05285137|525283848|FG002|Overall Study|Physician Decision|0|||
145662634|NCT05285137|525283849|FG003|Overall Study|Physician Decision|0|||
145662635|NCT05285137|525283850|FG004|Overall Study|Physician Decision|0|||
145662636|NCT05285137|525283851|FG005|Overall Study|Physician Decision|0|||
145662637|NCT05285137|525283852|FG006|Overall Study|Physician Decision|0|||
145662638|NCT05285137|525283853|FG007|Overall Study|Physician Decision|0|||
145662639|NCT05285137|525283854|FG008|Overall Study|Physician Decision|0|||
145662640|NCT05285137|525283846|FG000|Overall Study|Pregnancy|0|||
145662641|NCT05285137|525283847|FG001|Overall Study|Pregnancy|0|||
145662642|NCT05285137|525283848|FG002|Overall Study|Pregnancy|0|||
145662643|NCT05285137|525283849|FG003|Overall Study|Pregnancy|0|||
145662644|NCT05285137|525283850|FG004|Overall Study|Pregnancy|0|||
145662645|NCT05285137|525283851|FG005|Overall Study|Pregnancy|0|||
145662646|NCT05285137|525283852|FG006|Overall Study|Pregnancy|1|||
145662647|NCT05285137|525283853|FG007|Overall Study|Pregnancy|0|||
145662648|NCT05285137|525283854|FG008|Overall Study|Pregnancy|0|||
145662649|NCT05285137|525283846|FG000|Overall Study|Withdrawal by Subject|0|||
145662650|NCT05285137|525283847|FG001|Overall Study|Withdrawal by Subject|1|||
145662651|NCT05285137|525283848|FG002|Overall Study|Withdrawal by Subject|2|||
145662652|NCT05285137|525283849|FG003|Overall Study|Withdrawal by Subject|1|||
145662653|NCT05285137|525283850|FG004|Overall Study|Withdrawal by Subject|0|||
145662654|NCT05285137|525283851|FG005|Overall Study|Withdrawal by Subject|0|||
145662655|NCT05285137|525283852|FG006|Overall Study|Withdrawal by Subject|0|||
145662656|NCT05285137|525283853|FG007|Overall Study|Withdrawal by Subject|0|||
145662657|NCT05285137|525283854|FG008|Overall Study|Withdrawal by Subject|1|||
145662658|NCT03717935|525283859|FG000|Overall Study|Withdrawal by Subject|0|||
145662659|NCT03717935|525283860|FG001|Overall Study|Withdrawal by Subject|2|||
145662660|NCT01447719|525283863|FG000|Overall Study|Image acquisition failure|2|||
145662661|NCT01447719|525283863|FG000|Overall Study|Invalid image or not imaged|3|||
145662662|NCT01447719|525283863|FG000|Overall Study|Subject still living at end of study|79|||
145662663|NCT01447719|525283863|FG000|Overall Study|Withdrawal by Subject|2|||
145662664|NCT01447719|525283863|FG000|Overall Study|Family withdrew autopsy consent|7|||
145662665|NCT05100628|525283864|FG000|Overall Study|Progressive Disease|1|||
145662666|NCT05100628|525283865|FG001|Overall Study|Progressive Disease|0|||
145662667|NCT05100628|525283866|FG002|Overall Study|Progressive Disease|0|||
145662668|NCT05100628|525283867|FG003|Overall Study|Progressive Disease|0|||
145662669|NCT05100628|525283864|FG000|Overall Study|Study Terminated by Sponsor|0|||
145662670|NCT05100628|525283865|FG001|Overall Study|Study Terminated by Sponsor|0|||
145662671|NCT05100628|525283866|FG002|Overall Study|Study Terminated by Sponsor|3|||
145662672|NCT05100628|525283867|FG003|Overall Study|Study Terminated by Sponsor|0|||
145662673|NCT05100628|525283864|FG000|Overall Study|unkown|0|||
145662674|NCT05100628|525283865|FG001|Overall Study|unkown|1|||
145662675|NCT05100628|525283866|FG002|Overall Study|unkown|0|||
145662676|NCT05100628|525283867|FG003|Overall Study|unkown|0|||
145662677|NCT02575950|525283868|FG000|Overall Study|Withdrawal by Subject|0|||
145662678|NCT02575950|525283869|FG001|Overall Study|Withdrawal by Subject|0|||
145662679|NCT02575950|525283870|FG002|Overall Study|Withdrawal by Subject|0|||
145662680|NCT02575950|525283871|FG003|Overall Study|Withdrawal by Subject|2|||
145662681|NCT02575950|525283868|FG000|Overall Study|Lost to Follow-up|0|||
145662682|NCT02575950|525283869|FG001|Overall Study|Lost to Follow-up|1|||
145662683|NCT02575950|525283870|FG002|Overall Study|Lost to Follow-up|0|||
145662684|NCT02575950|525283871|FG003|Overall Study|Lost to Follow-up|3|||
145662685|NCT04271046|525283872|FG000|Overall Study|Death|0|||
145662686|NCT04271046|525283873|FG001|Overall Study|Death|2|||
145662687|NCT04271046|525283874|FG002|Overall Study|Death|0|||
145662688|NCT04271046|525283875|FG003|Overall Study|Death|2|||
145662689|NCT04271046|525283872|FG000|Overall Study|Lost to Follow-up|12|||
145662690|NCT04271046|525283873|FG001|Overall Study|Lost to Follow-up|12|||
145662691|NCT04271046|525283874|FG002|Overall Study|Lost to Follow-up|11|||
145662692|NCT04271046|525283875|FG003|Overall Study|Lost to Follow-up|11|||
145662693|NCT04271046|525283872|FG000|Overall Study|Patient with Dementia Died|2|||
145662694|NCT04271046|525283873|FG001|Overall Study|Patient with Dementia Died|0|||
145662695|NCT04271046|525283874|FG002|Overall Study|Patient with Dementia Died|2|||
145662696|NCT04271046|525283875|FG003|Overall Study|Patient with Dementia Died|0|||
145662697|NCT04271046|525283872|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
145662698|NCT04271046|525283873|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
145662699|NCT04271046|525283874|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
145662700|NCT04271046|525283875|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
145662701|NCT04230681|525283876|FG000|Overall Study|Physician Decision|2|||
145662702|NCT04230681|525283877|FG001|Overall Study|Physician Decision|3|||
145662703|NCT04230681|525283876|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
145662704|NCT04230681|525283877|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
145662705|NCT04230681|525283876|FG000|Overall Study|IV inadvertently removed|0|||
145662706|NCT04230681|525283877|FG001|Overall Study|IV inadvertently removed|1|||
145662707|NCT01314105|525284917|FG000|Overall Study|Progressive Disease|6|||
145662708|NCT01314105|525284918|FG001|Overall Study|Progressive Disease|10|||
145662709|NCT01314105|525284917|FG000|Overall Study|Refused to continue taking medication|0|||
145662710|NCT01314105|525284918|FG001|Overall Study|Refused to continue taking medication|1|||
145662711|NCT01314105|525284917|FG000|Overall Study|Other Adverse Event|1|||
145662712|NCT01314105|525284918|FG001|Overall Study|Other Adverse Event|1|||
145662713|NCT04526886|525284919|FG000|Overall Study|Physician Decision|4|||
145662714|NCT04820322|525284923|FG000|Overall Study|Adverse Event|1|||
145662715|NCT04820322|525284924|FG001|Overall Study|Adverse Event|0|||
145662716|NCT03156465|525284925|FG000|Overall Study|Withdrawal by Subject|2|||
145662717|NCT03640286|525284926|FG000|Overall Study|Adverse Event|6|||
145662718|NCT03640286|525284927|FG001|Overall Study|Adverse Event|6|||
145662719|NCT03640286|525284926|FG000|Overall Study|Lost to Follow-up|3|||
145662720|NCT03640286|525284927|FG001|Overall Study|Lost to Follow-up|6|||
145662721|NCT03640286|525284926|FG000|Overall Study|Pregnancy|1|||
145662722|NCT03640286|525284927|FG001|Overall Study|Pregnancy|0|||
145662723|NCT03640286|525284926|FG000|Overall Study|Withdrawal by Subject|10|||
145662724|NCT03640286|525284927|FG001|Overall Study|Withdrawal by Subject|10|||
145662725|NCT03640286|525284926|FG000|Overall Study|Non-compliance|4|||
145662726|NCT03640286|525284927|FG001|Overall Study|Non-compliance|10|||
145662727|NCT03640286|525284926|FG000|Overall Study|Medication change|1|||
145662728|NCT03640286|525284927|FG001|Overall Study|Medication change|0|||
145662729|NCT03640286|525284926|FG000|Overall Study|Other|1|||
145662730|NCT03640286|525284927|FG001|Overall Study|Other|2|||
145662731|NCT03640286|525284926|FG000|Overall Study|Joined another lifestyle program|0|||
145662732|NCT03640286|525284927|FG001|Overall Study|Joined another lifestyle program|1|||
145662733|NCT03181516|525284929|FG000|Overall Study|Withdrawal by Subject|14|||
145662734|NCT03181516|525284930|FG001|Overall Study|Withdrawal by Subject|7|||
145662735|NCT03181516|525284929|FG000|Overall Study|Lost to Follow-up|2|||
145662736|NCT03181516|525284930|FG001|Overall Study|Lost to Follow-up|2|||
145662737|NCT04580914|525284933|FG000|Overall Study|Withdrawal by Subject|6|||
145662738|NCT04580914|525284933|FG000|Overall Study|Lost to Follow-up|2|||
145662739|NCT05715528|525284934|FG000|Overall Study|Randomized but never treated|11|||
145662740|NCT05715528|525284935|FG001|Overall Study|Randomized but never treated|13|||
145662741|NCT05715528|525284934|FG000|Overall Study|Withdrew consent|7|||
145662742|NCT05715528|525284935|FG001|Overall Study|Withdrew consent|15|||
145662743|NCT05715528|525284934|FG000|Overall Study|Lost to Follow-up|5|||
145662744|NCT05715528|525284935|FG001|Overall Study|Lost to Follow-up|13|||
145662745|NCT05715528|525284934|FG000|Overall Study|Investigator's discretion|3|||
145662746|NCT05715528|525284935|FG001|Overall Study|Investigator's discretion|1|||
145662747|NCT05715528|525284934|FG000|Overall Study|Protocol Violation|2|||
145662748|NCT05715528|525284935|FG001|Overall Study|Protocol Violation|0|||
145662749|NCT05715528|525284934|FG000|Overall Study|Non-compliance with study drug|0|||
145662750|NCT05715528|525284935|FG001|Overall Study|Non-compliance with study drug|1|||
145662751|NCT03118518|525284936|FG000|Overall Study|Early Exit after treatment|2|||
145662752|NCT03118518|525284937|FG001|Overall Study|Early Exit after treatment|8|||
145662753|NCT03118518|525284936|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
145662754|NCT03118518|525284937|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
145662755|NCT02998528|525284943|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
145662756|NCT02998528|525284944|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
145662757|NCT02998528|525284945|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
145662758|NCT02998528|525284943|FG000|Randomization Period|Participant withdrew consent|0|||
145662759|NCT02998528|525284944|FG001|Randomization Period|Participant withdrew consent|3|||
145662760|NCT02998528|525284945|FG002|Randomization Period|Participant withdrew consent|0|||
145662761|NCT02998528|525284943|FG000|Randomization Period|Participant no longer meets study criteria|1|||
145662762|NCT02998528|525284944|FG001|Randomization Period|Participant no longer meets study criteria|3|||
145662763|NCT02998528|525284945|FG002|Randomization Period|Participant no longer meets study criteria|2|||
145662764|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
145662765|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
145662766|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
145662767|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
145662768|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
145662769|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
145662770|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
145662771|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
145662772|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
145662773|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
145662774|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
145662775|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
145662776|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
145662777|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
145662778|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
145662779|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Death|1|||
145662780|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Death|0|||
145662781|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Death|0|||
145662782|NCT02998528|525284943|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
145662783|NCT02998528|525284944|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
145662784|NCT02998528|525284945|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
145662785|NCT02998528|525284943|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
145662786|NCT02998528|525284944|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
145662787|NCT02998528|525284945|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
145662788|NCT02998528|525284943|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
145662789|NCT02998528|525284944|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
145662790|NCT02998528|525284945|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
145662791|NCT02998528|525284943|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
145662792|NCT02998528|525284944|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
145662793|NCT02998528|525284945|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
145662794|NCT02998528|525284943|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
145662795|NCT02998528|525284944|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
145662796|NCT02998528|525284945|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
145662797|NCT02998528|525284943|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
145662798|NCT02998528|525284944|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
145662799|NCT02998528|525284945|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
145662800|NCT05035654|525284948|FG000|Overall Study|Physician Decision|0|||
145662801|NCT05035654|525284949|FG001|Overall Study|Physician Decision|1|||
145662802|NCT05035654|525284950|FG002|Overall Study|Physician Decision|0|||
145662803|NCT05035654|525284948|FG000|Overall Study|Adverse Event|0|||
145662804|NCT05035654|525284949|FG001|Overall Study|Adverse Event|1|||
145662805|NCT05035654|525284950|FG002|Overall Study|Adverse Event|0|||
145662806|NCT05035654|525284948|FG000|Overall Study|Withdrawal by Subject|0|||
145662807|NCT05035654|525284949|FG001|Overall Study|Withdrawal by Subject|0|||
145662808|NCT05035654|525284950|FG002|Overall Study|Withdrawal by Subject|4|||
145662809|NCT05035654|525284948|FG000|Overall Study|Bilateral Dislodgement|1|||
145662810|NCT05035654|525284949|FG001|Overall Study|Bilateral Dislodgement|0|||
145662811|NCT05035654|525284950|FG002|Overall Study|Bilateral Dislodgement|0|||
145662812|NCT04880733|525284951|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
145662813|NCT04880733|525284952|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
145662814|NCT04880733|525284953|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
145662815|NCT04880733|525284951|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
145662816|NCT04880733|525284952|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
145662817|NCT04880733|525284953|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
145662818|NCT04880733|525284951|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
145662819|NCT04880733|525284952|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
145662820|NCT04880733|525284953|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
145662821|NCT04880733|525284951|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
145662822|NCT04880733|525284952|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
145662823|NCT04880733|525284953|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
145662824|NCT04880733|525284951|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
145662825|NCT04880733|525284952|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
145662826|NCT04880733|525284953|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
145662827|NCT05533190|525284956|FG000|Overall Study|Lost to Follow-up|19|||
145662828|NCT05533190|525284957|FG001|Overall Study|Lost to Follow-up|7|||
145662829|NCT05533190|525284956|FG000|Overall Study|Failed to download app|1|||
145662830|NCT05533190|525284957|FG001|Overall Study|Failed to download app|0|||
145662831|NCT05533190|525284956|FG000|Overall Study|Thought app was a scam|1|||
145662832|NCT05533190|525284957|FG001|Overall Study|Thought app was a scam|0|||
145662833|NCT05533190|525284956|FG000|Overall Study|Withdrawal by Subject|2|||
145662834|NCT05533190|525284957|FG001|Overall Study|Withdrawal by Subject|0|||
145662835|NCT04934072|525284959|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
145662836|NCT04934072|525284960|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
145662837|NCT04934072|525284961|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
145662838|NCT04934072|525284962|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
145662839|NCT04934072|525284963|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
145662840|NCT04934072|525284959|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
145662841|NCT04934072|525284960|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
145662842|NCT04934072|525284961|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
145662843|NCT04934072|525284962|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
145662844|NCT04934072|525284963|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
145662845|NCT04934072|525284959|FG000|Day 0 to Week 52|Other|3|||
145662846|NCT04934072|525284960|FG001|Day 0 to Week 52|Other|1|||
145662847|NCT04934072|525284961|FG002|Day 0 to Week 52|Other|0|||
145662848|NCT04934072|525284962|FG003|Day 0 to Week 52|Other|0|||
145662849|NCT04934072|525284963|FG004|Day 0 to Week 52|Other|0|||
145662850|NCT04934072|525284959|FG000|Day 0 to Week 52|Adverse Event|1|||
145662851|NCT04934072|525284960|FG001|Day 0 to Week 52|Adverse Event|3|||
145662852|NCT04934072|525284961|FG002|Day 0 to Week 52|Adverse Event|0|||
145662853|NCT04934072|525284962|FG003|Day 0 to Week 52|Adverse Event|0|||
145662854|NCT04934072|525284963|FG004|Day 0 to Week 52|Adverse Event|0|||
145662855|NCT04934072|525284959|FG000|Week 52 to Week 78|Adverse Event|0|||
145662856|NCT04934072|525284960|FG001|Week 52 to Week 78|Adverse Event|0|||
145662857|NCT04934072|525284961|FG002|Week 52 to Week 78|Adverse Event|0|||
145662858|NCT04934072|525284962|FG003|Week 52 to Week 78|Adverse Event|1|||
145662859|NCT04934072|525284963|FG004|Week 52 to Week 78|Adverse Event|1|||
145662860|NCT04934072|525284959|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
145662861|NCT04934072|525284960|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
145662862|NCT04934072|525284961|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
145662863|NCT04934072|525284962|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
145662864|NCT04934072|525284963|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
145662865|NCT04934072|525284959|FG000|Week 52 to Week 78|Other|0|||
145662866|NCT04934072|525284960|FG001|Week 52 to Week 78|Other|0|||
145662867|NCT04934072|525284961|FG002|Week 52 to Week 78|Other|1|||
145662868|NCT04934072|525284962|FG003|Week 52 to Week 78|Other|0|||
145662869|NCT04934072|525284963|FG004|Week 52 to Week 78|Other|0|||
145662870|NCT03213678|525284973|FG000|Overall Study|Death|1|||
145662871|NCT03213678|525284973|FG000|Overall Study|Physician Decision|1|||
145662872|NCT03213678|525284973|FG000|Overall Study|Progressive disease|16|||
145662873|NCT01820611|525284974|FG000|Overall Study|Death|8|||
145662874|NCT01820611|525284974|FG000|Overall Study|Adverse Event|1|||
145662875|NCT01820611|525284974|FG000|Overall Study|Withdrawal by Subject|9|||
145662876|NCT05970861|525284975|FG000|Overall Study|Physician Decision|4|||
145662877|NCT05970861|525284976|FG001|Overall Study|Physician Decision|4|||
145662878|NCT05970861|525284975|FG000|Overall Study|Lost to Follow-up|4|||
145662879|NCT05970861|525284976|FG001|Overall Study|Lost to Follow-up|3|||
145662880|NCT04456296|525284977|FG000|Overall Study|Withdrawal by Subject|14|||
145662881|NCT04456296|525284978|FG001|Overall Study|Withdrawal by Subject|21|||
145662882|NCT04456296|525284979|FG002|Overall Study|Withdrawal by Subject|21|||
145662883|NCT04456296|525284977|FG000|Overall Study|Adverse Event|2|||
145662884|NCT04456296|525284978|FG001|Overall Study|Adverse Event|2|||
145490629|NCT04621448|524650361|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
145490630|NCT04621448|524650358|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
145662885|NCT04456296|525284979|FG002|Overall Study|Adverse Event|2|||
145662886|NCT04456296|525284977|FG000|Overall Study|Death|1|||
145662887|NCT04456296|525284978|FG001|Overall Study|Death|0|||
145490631|NCT04621448|524650359|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
145662888|NCT04456296|525284979|FG002|Overall Study|Death|0|||
145490632|NCT04621448|524650360|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
145662889|NCT04456296|525284977|FG000|Overall Study|Lost to Follow-up|3|||
145662890|NCT04456296|525284978|FG001|Overall Study|Lost to Follow-up|5|||
145662891|NCT04456296|525284979|FG002|Overall Study|Lost to Follow-up|6|||
145662892|NCT04456296|525284977|FG000|Overall Study|Other than specified|0|||
145662893|NCT04456296|525284978|FG001|Overall Study|Other than specified|1|||
145662894|NCT04456296|525284979|FG002|Overall Study|Other than specified|4|||
145662895|NCT04456296|525284977|FG000|Overall Study|Randomized, not treated|2|||
145662896|NCT04456296|525284978|FG001|Overall Study|Randomized, not treated|1|||
145662897|NCT04456296|525284979|FG002|Overall Study|Randomized, not treated|0|||
145662898|NCT01199133|525284986|FG000|Year 1|Adverse Event|16|||
145662899|NCT01199133|525284987|FG001|Year 1|Adverse Event|4|||
145662900|NCT01199133|525284986|FG000|Year 1|Withdrawal by Subject|8|||
145662901|NCT01199133|525284987|FG001|Year 1|Withdrawal by Subject|4|||
145662902|NCT01199133|525284986|FG000|Year 1|Any other reason not above-mentioned|6|||
145662903|NCT01199133|525284987|FG001|Year 1|Any other reason not above-mentioned|7|||
145662904|NCT01199133|525284986|FG000|Year 2|Adverse Event|1|||
145662905|NCT01199133|525284987|FG001|Year 2|Adverse Event|0|||
145662906|NCT01199133|525284986|FG000|Year 2|Withdrawal by Subject|1|||
145662907|NCT01199133|525284987|FG001|Year 2|Withdrawal by Subject|1|||
145662908|NCT01199133|525284986|FG000|Year 2|Any other reason not above-mentioned|1|||
145662909|NCT01199133|525284987|FG001|Year 2|Any other reason not above-mentioned|2|||
145662910|NCT03252288|525284991|FG000|Overall Study|Death|1|||
145662911|NCT03252288|525284992|FG001|Overall Study|Death|0|||
145662912|NCT03252288|525284993|FG002|Overall Study|Death|0|||
145662913|NCT03252288|525284991|FG000|Overall Study|Death|11|||
145662914|NCT03252288|525284992|FG001|Overall Study|Death|0|||
145662915|NCT03252288|525284993|FG002|Overall Study|Death|0|||
145662916|NCT03252288|525284991|FG000|Overall Study|Withdrawal by Subject|2|||
145662917|NCT03252288|525284992|FG001|Overall Study|Withdrawal by Subject|0|||
145662918|NCT03252288|525284993|FG002|Overall Study|Withdrawal by Subject|0|||
145662919|NCT03252288|525284991|FG000|Overall Study|Lost to Follow-up|79|||
145662920|NCT03252288|525284992|FG001|Overall Study|Lost to Follow-up|0|||
145662921|NCT03252288|525284993|FG002|Overall Study|Lost to Follow-up|0|||
145662922|NCT03252288|525284991|FG000|Overall Study|Loss of baseline data on tablets|6|||
145662923|NCT03252288|525284992|FG001|Overall Study|Loss of baseline data on tablets|0|||
145662924|NCT03252288|525284993|FG002|Overall Study|Loss of baseline data on tablets|0|||
145662925|NCT02905331|525284995|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
145662926|NCT02905331|525284996|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
145662927|NCT02905331|525284997|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
145662928|NCT02905331|525284995|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
145662929|NCT02905331|525284996|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
145662930|NCT02905331|525284997|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
145662931|NCT02905331|525284995|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
145662932|NCT02905331|525284996|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
145662933|NCT02905331|525284997|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
145662934|NCT02905331|525284995|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
145662935|NCT02905331|525284996|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
145662936|NCT02905331|525284997|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
145662937|NCT02905331|525284995|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
145662938|NCT02905331|525284996|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
145662939|NCT02905331|525284997|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
145662940|NCT02542631|525284998|FG000|Overall Study|Adverse Event|1|||
145662941|NCT02542631|525284999|FG001|Overall Study|Adverse Event|1|||
145662942|NCT02542631|525284998|FG000|Overall Study|Sponsor Termination|1|||
145662943|NCT02542631|525284999|FG001|Overall Study|Sponsor Termination|0|||
145662944|NCT02542631|525284998|FG000|Overall Study|Withdrawal by Subject|11|||
145662945|NCT02542631|525284999|FG001|Overall Study|Withdrawal by Subject|16|||
145662946|NCT02542631|525284998|FG000|Overall Study|Protocol Violation|1|||
145662947|NCT02542631|525284999|FG001|Overall Study|Protocol Violation|1|||
145662948|NCT02542631|525284998|FG000|Overall Study|Physician Decision|6|||
145662949|NCT02542631|525284999|FG001|Overall Study|Physician Decision|4|||
145662950|NCT02542631|525284998|FG000|Overall Study|Lost to Follow-up|6|||
145662951|NCT02542631|525284999|FG001|Overall Study|Lost to Follow-up|5|||
145662952|NCT02542631|525284998|FG000|Overall Study|Death|1|||
145662953|NCT02542631|525284999|FG001|Overall Study|Death|2|||
145662954|NCT02542631|525284998|FG000|Overall Study|Other|2|||
145662955|NCT02542631|525284999|FG001|Overall Study|Other|1|||
145662956|NCT02542631|525284998|FG000|Overall Study|Used Prohibited Medication|2|||
145662957|NCT02542631|525284999|FG001|Overall Study|Used Prohibited Medication|1|||
145662958|NCT00721149|525285000|FG000|Overall Study|Physician Decision|1|||
145662959|NCT03993392|525285003|FG000|Overall Study|Withdrawal by Subject|3|||
145662960|NCT03993392|525285003|FG000|Overall Study|Lost to Follow-up|2|||
145662961|NCT03993392|525285003|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
145662962|NCT02518048|525285004|FG000|Overall Study|Withdrawal by Subject|1|||
145662963|NCT05654662|525285005|FG000|Overall Study|Withdrawal by Subject|1|||
145662964|NCT05654662|525285006|FG001|Overall Study|Withdrawal by Subject|0|||
145662965|NCT05654662|525285005|FG000|Overall Study|A death in the family|1|||
145662966|NCT05654662|525285006|FG001|Overall Study|A death in the family|0|||
145662967|NCT06262477|525286318|FG000|Overall Study|Withdrawal by Subject|1|||
145662968|NCT06262477|525286319|FG001|Overall Study|Withdrawal by Subject|0|||
145662969|NCT06262477|525286318|FG000|Overall Study|Adverse Event|0|||
145662970|NCT06262477|525286319|FG001|Overall Study|Adverse Event|1|||
145662971|NCT06262477|525286318|FG000|Overall Study|Lost to Follow-up|0|||
145662972|NCT06262477|525286319|FG001|Overall Study|Lost to Follow-up|1|||
145265345|NCT04311411|523819307|FG001|Overall Study|Adverse Event|3|||
145265346|NCT04311411|523819308|FG002|Overall Study|Adverse Event|2|||
145265347|NCT04311411|523819306|FG000|Overall Study|Withdrawal by Subject|3|||
145265348|NCT04311411|523819307|FG001|Overall Study|Withdrawal by Subject|3|||
145265349|NCT04311411|523819308|FG002|Overall Study|Withdrawal by Subject|0|||
145265350|NCT00489411|523819309|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
145265351|NCT00489411|523819310|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
145265352|NCT00489411|523819309|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
145265353|NCT00489411|523819310|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
145265354|NCT00489411|523819309|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
145265355|NCT00489411|523819310|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
145265356|NCT00489411|523819309|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
145265357|NCT00489411|523819310|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
145265358|NCT00489411|523819309|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
145265359|NCT00489411|523819310|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
145265360|NCT03219372|523819311|FG000|Overall Study|Withdrawal by Subject|1|||
145265361|NCT03219372|523819312|FG001|Overall Study|Withdrawal by Subject|0|||
145265362|NCT01428882|523819313|FG000|Overall Study|Lack of Efficacy|2|||
145265363|NCT01428882|523819314|FG001|Overall Study|Lack of Efficacy|7|||
145265364|NCT01428882|523819313|FG000|Overall Study|Protocol Violation|4|||
145265365|NCT01428882|523819314|FG001|Overall Study|Protocol Violation|3|||
145265366|NCT02219477|523819315|FG000|Overall Study|Adverse Event|0|||
145265367|NCT02219477|523819316|FG001|Overall Study|Adverse Event|1|||
145265368|NCT02219477|523819317|FG002|Overall Study|Adverse Event|1|||
145265369|NCT02219477|523819315|FG000|Overall Study|Withdrawal by Subject|0|||
145265370|NCT02219477|523819316|FG001|Overall Study|Withdrawal by Subject|1|||
145265371|NCT02219477|523819317|FG002|Overall Study|Withdrawal by Subject|0|||
145265372|NCT02304484|523819318|FG000|Overall Study|Death|9|||
145265373|NCT02304484|523819318|FG000|Overall Study|Withdrawal by Subject|14|||
145265374|NCT02304484|523819318|FG000|Overall Study|Lost to Follow-up|2|||
145265375|NCT00752206|523819319|FG000|Overall Study|Disease progression|8|||
145265376|NCT00752206|523819320|FG001|Overall Study|Disease progression|11|||
145265377|NCT00752206|523819319|FG000|Overall Study|Pregnancy|1|||
145265378|NCT00752206|523819320|FG001|Overall Study|Pregnancy|0|||
145265379|NCT01539512|523819321|FG000|Overall Study|Adverse Event|9|||
145265380|NCT01539512|523819322|FG001|Overall Study|Adverse Event|7|||
145265381|NCT01539512|523819321|FG000|Overall Study|Physician Decision|1|||
145265382|NCT01539512|523819322|FG001|Overall Study|Physician Decision|1|||
145265383|NCT01539512|523819321|FG000|Overall Study|Withdrawal by Subject|12|||
145265384|NCT01539512|523819322|FG001|Overall Study|Withdrawal by Subject|5|||
145265385|NCT01539512|523819321|FG000|Overall Study|Richter's Transformation|1|||
145265386|NCT01539512|523819322|FG001|Overall Study|Richter's Transformation|0|||
145490633|NCT04621448|524650361|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
145265387|NCT02283411|523819329|FG000|Overall Study|Withdrawal by Subject|3|||
145265388|NCT02283411|523819329|FG000|Overall Study|Screen Failed|28|||
145265389|NCT01683565|523819330|FG000|Overall Study|Lost to Follow-up|2|||
145265390|NCT01683565|523819331|FG001|Overall Study|Lost to Follow-up|0|||
145265391|NCT01683565|523819330|FG000|Overall Study|Discontinued Intervention|1|||
145265392|NCT01683565|523819331|FG001|Overall Study|Discontinued Intervention|1|||
145265393|NCT04479358|523819332|FG000|Overall Study|Withdrawal by Subject|0|||
145265394|NCT04479358|523819333|FG001|Overall Study|Withdrawal by Subject|0|||
145662973|NCT04108130|525286320|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
145662974|NCT04108130|525286321|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
145662975|NCT04108130|525286320|FG000|Overall Study|Consent Withdrawn|9|||
145662976|NCT04108130|525286321|FG001|Overall Study|Consent Withdrawn|6|||
145662977|NCT04108130|525286320|FG000|Overall Study|Surgery Cancelled|4|||
145662978|NCT04108130|525286321|FG001|Overall Study|Surgery Cancelled|4|||
145662979|NCT04108130|525286320|FG000|Overall Study|Found Ineligible for Study|4|||
145662980|NCT04108130|525286321|FG001|Overall Study|Found Ineligible for Study|3|||
145662981|NCT04108130|525286320|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
145662982|NCT04108130|525286321|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
145662983|NCT04108130|525286320|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
145662984|NCT04108130|525286321|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
145662985|NCT05507333|525286322|FG000|Overall Study|Protocol Violation|1|||
145662986|NCT04615273|525286325|FG000|Overall Study|Withdrawal by Subject|3|||
145662987|NCT04615273|525286326|FG001|Overall Study|Withdrawal by Subject|1|||
145662988|NCT04615273|525286327|FG002|Overall Study|Withdrawal by Subject|2|||
145662989|NCT04615273|525286325|FG000|Overall Study|Adverse Event|1|||
145662990|NCT04615273|525286326|FG001|Overall Study|Adverse Event|0|||
145662991|NCT04615273|525286327|FG002|Overall Study|Adverse Event|1|||
145662992|NCT04615273|525286325|FG000|Overall Study|Lost to Follow-up|0|||
145662993|NCT04615273|525286326|FG001|Overall Study|Lost to Follow-up|1|||
145662994|NCT04615273|525286327|FG002|Overall Study|Lost to Follow-up|0|||
145662995|NCT04615273|525286325|FG000|Overall Study|Physician Decision|0|||
145662996|NCT04615273|525286326|FG001|Overall Study|Physician Decision|0|||
145662997|NCT04615273|525286327|FG002|Overall Study|Physician Decision|1|||
145662998|NCT04615273|525286325|FG000|Overall Study|Other|0|||
145662999|NCT04615273|525286326|FG001|Overall Study|Other|1|||
145663000|NCT04615273|525286327|FG002|Overall Study|Other|0|||
145663001|NCT04615273|525286325|FG000|Overall Study|Randomized but not treated|1|||
145663002|NCT04615273|525286326|FG001|Overall Study|Randomized but not treated|3|||
145663003|NCT04615273|525286327|FG002|Overall Study|Randomized but not treated|1|||
145663004|NCT03677141|525286328|FG000|Overall Study|Death|2|||
145663005|NCT03677141|525286329|FG001|Overall Study|Death|1|||
145663006|NCT03677141|525286330|FG002|Overall Study|Death|6|||
145663007|NCT03677141|525286331|FG003|Overall Study|Death|9|||
145663008|NCT03677141|525286332|FG004|Overall Study|Death|5|||
145663009|NCT03677141|525286333|FG005|Overall Study|Death|3|||
145663010|NCT03677141|525286328|FG000|Overall Study|Lost to Follow-up|0|||
145663011|NCT03677141|525286329|FG001|Overall Study|Lost to Follow-up|0|||
145663012|NCT03677141|525286330|FG002|Overall Study|Lost to Follow-up|0|||
145663013|NCT03677141|525286331|FG003|Overall Study|Lost to Follow-up|2|||
145663014|NCT03677141|525286332|FG004|Overall Study|Lost to Follow-up|0|||
145663015|NCT03677141|525286333|FG005|Overall Study|Lost to Follow-up|0|||
145663016|NCT03677141|525286328|FG000|Overall Study|Screen failure or enrolled in error|0|||
145663017|NCT03677141|525286329|FG001|Overall Study|Screen failure or enrolled in error|0|||
145663018|NCT03677141|525286330|FG002|Overall Study|Screen failure or enrolled in error|0|||
145663019|NCT03677141|525286331|FG003|Overall Study|Screen failure or enrolled in error|0|||
145663020|NCT03677141|525286332|FG004|Overall Study|Screen failure or enrolled in error|2|||
145663021|NCT03677141|525286333|FG005|Overall Study|Screen failure or enrolled in error|0|||
145663022|NCT03677141|525286328|FG000|Overall Study|Physician Decision|0|||
145663023|NCT03677141|525286329|FG001|Overall Study|Physician Decision|0|||
145663024|NCT03677141|525286330|FG002|Overall Study|Physician Decision|0|||
145663025|NCT03677141|525286331|FG003|Overall Study|Physician Decision|0|||
145663026|NCT03677141|525286332|FG004|Overall Study|Physician Decision|1|||
145663027|NCT03677141|525286333|FG005|Overall Study|Physician Decision|0|||
145663028|NCT03677141|525286328|FG000|Overall Study|Withdrawal by Subject|0|||
145663029|NCT03677141|525286329|FG001|Overall Study|Withdrawal by Subject|0|||
145663030|NCT03677141|525286330|FG002|Overall Study|Withdrawal by Subject|1|||
145663031|NCT03677141|525286331|FG003|Overall Study|Withdrawal by Subject|1|||
145663032|NCT03677141|525286332|FG004|Overall Study|Withdrawal by Subject|1|||
145663033|NCT03677141|525286333|FG005|Overall Study|Withdrawal by Subject|0|||
145663034|NCT05976334|525286341|FG000|Part B|Death|0|||
145663035|NCT05976334|525286342|FG001|Part B|Death|1|||
145663036|NCT05976334|525286341|FG000|Part B|Study Terminated by Sponsor|0|||
145663037|NCT05976334|525286342|FG001|Part B|Study Terminated by Sponsor|1|||
145663038|NCT05976334|525286341|FG000|Part B|Reason Not Specified|0|||
145663039|NCT05976334|525286342|FG001|Part B|Reason Not Specified|1|||
145663040|NCT05363163|525286343|FG000|Overall Study|Withdrawal by Subject|13|||
145663041|NCT02909686|525286354|FG000|Overall Study|Physician Decision|3|||
145663042|NCT02909686|525286354|FG000|Overall Study|Withdrawal by Subject|2|||
145663043|NCT02473445|525286355|FG000|Overall Study|Withdrawal by Subject|2|||
145663044|NCT02473445|525286355|FG000|Overall Study|Sponsor Decision|20|||
145663045|NCT03484819|525286356|FG000|Overall Study|Death|2|||
145663046|NCT03484819|525286356|FG000|Overall Study|Adverse Event|2|||
145663047|NCT03484819|525286356|FG000|Overall Study|Physician Decision|1|||
145663048|NCT03484819|525286356|FG000|Overall Study|Withdrawal by Subject|2|||
145663049|NCT03484819|525286356|FG000|Overall Study|Disease Progression|4|||
145663050|NCT03484819|525286356|FG000|Overall Study|Complicating Condition|1|||
145663051|NCT02990338|525286357|FG000|Overall Study|Randomized and not treated|4|||
145663052|NCT02990338|525286358|FG001|Overall Study|Randomized and not treated|2|||
145663053|NCT02990338|525286357|FG000|Overall Study|Adverse Event|23|||
145663054|NCT02990338|525286358|FG001|Overall Study|Adverse Event|22|||
145663055|NCT02990338|525286357|FG000|Overall Study|Progressive disease|118|||
145663056|NCT02990338|525286358|FG001|Overall Study|Progressive disease|107|||
145663057|NCT02990338|525286357|FG000|Overall Study|Poor compliance to protocol|0|||
145663058|NCT02990338|525286358|FG001|Overall Study|Poor compliance to protocol|1|||
145663059|NCT02990338|525286357|FG000|Overall Study|Withdrawal by Subject|6|||
145663060|NCT02990338|525286358|FG001|Overall Study|Withdrawal by Subject|8|||
145663061|NCT02990338|525286357|FG000|Overall Study|Physician's decision|2|||
145663062|NCT02990338|525286358|FG001|Overall Study|Physician's decision|6|||
145663063|NCT02990338|525286357|FG000|Overall Study|Treatment extension study|0|||
145663064|NCT02990338|525286358|FG001|Overall Study|Treatment extension study|6|||
145663065|NCT02990338|525286357|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
145663066|NCT02990338|525286358|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
145663067|NCT02990338|525286357|FG000|Overall Study|Continue with therapy available commercially|0|||
145663068|NCT02990338|525286358|FG001|Overall Study|Continue with therapy available commercially|1|||
145663069|NCT04186819|525286359|FG000|Overall Study|Adverse Event|1|||
145663070|NCT04186819|525286359|FG000|Overall Study|Lost to Follow-up|1|||
145663071|NCT04186819|525286359|FG000|Overall Study|Opted for EBRT|1|||
145663072|NCT04186819|525286359|FG000|Overall Study|Opted SBRT|1|||
145663073|NCT04186819|525286359|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
145663074|NCT04186819|525286359|FG000|Overall Study|Physician Decision|1|||
145663075|NCT04186819|525286359|FG000|Overall Study|RP Delayed|1|||
145663076|NCT04186819|525286359|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
145663077|NCT04186819|525286359|FG000|Overall Study|Subject declined for financial reasons|1|||
145663078|NCT04186819|525286359|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
145663079|NCT04186819|525286359|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
145663080|NCT04186819|525286359|FG000|Overall Study|The subject opted for other treatment option|2|||
145663081|NCT04186819|525286359|FG000|Overall Study|The subject opted for other treatment options|1|||
145663082|NCT04186819|525286359|FG000|Overall Study|Withdrawal by Subject|3|||
145663083|NCT04186819|525286359|FG000|Overall Study|Reason not specified|1|||
145663084|NCT03988621|525286361|FG000|Overall Study|Lost to Follow-up|16|||
145663085|NCT03988621|525286362|FG001|Overall Study|Lost to Follow-up|17|||
145663086|NCT03988621|525286361|FG000|Overall Study|Withdrawal by Subject|14|||
145663087|NCT03988621|525286362|FG001|Overall Study|Withdrawal by Subject|7|||
145663088|NCT03988621|525286361|FG000|Overall Study|Patient Lost to Follow Up|15|||
145663089|NCT03988621|525286362|FG001|Overall Study|Patient Lost to Follow Up|15|||
145663090|NCT03988621|525286361|FG000|Overall Study|Patient death|1|||
145663091|NCT03988621|525286362|FG001|Overall Study|Patient death|5|||
145663092|NCT05013385|525286363|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
145663093|NCT04247802|525286364|FG000|Overall Study|Withdrawal by Subject|1|||
145663094|NCT04247802|525286365|FG001|Overall Study|Withdrawal by Subject|3|||
145663095|NCT04247802|525286364|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
145663096|NCT04247802|525286365|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
145663097|NCT03334695|525286367|FG000|Overall Study|Lost to Follow-up|3|||
145663098|NCT03334695|525286368|FG001|Overall Study|Lost to Follow-up|3|||
145663099|NCT03334695|525286367|FG000|Overall Study|Physician Decision|1|||
145663100|NCT03334695|525286368|FG001|Overall Study|Physician Decision|2|||
145663101|NCT03334695|525286367|FG000|Overall Study|Protocol Violation|0|||
145663102|NCT03334695|525286368|FG001|Overall Study|Protocol Violation|1|||
145663103|NCT02641730|525286369|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
145663104|NCT02641730|525286370|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145663105|NCT02641730|525286371|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
145663106|NCT02641730|525286372|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
145663107|NCT02641730|525286373|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
145663108|NCT02641730|525286369|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
145663109|NCT02641730|525286370|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
145663110|NCT02641730|525286371|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
145663111|NCT02641730|525286372|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
145663112|NCT02641730|525286373|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
145663113|NCT02641730|525286369|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
145663114|NCT02641730|525286370|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
145663115|NCT02641730|525286371|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
145663116|NCT02641730|525286372|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
145663117|NCT02641730|525286373|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
145663118|NCT02641730|525286369|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145663119|NCT02641730|525286370|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145663120|NCT02641730|525286371|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
145663121|NCT02641730|525286372|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
145663122|NCT02641730|525286373|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
145663123|NCT02641730|525286369|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
145663124|NCT02641730|525286370|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
145663125|NCT02641730|525286371|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
145663126|NCT02641730|525286372|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
145663127|NCT02641730|525286373|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
145663128|NCT02641730|525286369|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
145663129|NCT02641730|525286370|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
145663130|NCT02641730|525286371|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
145663131|NCT02641730|525286372|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
145663132|NCT02641730|525286373|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
145663133|NCT05460871|525286374|FG000|Overall Study|Withdrawal by Subject|1|||
145663134|NCT05460871|525286375|FG001|Overall Study|Withdrawal by Subject|2|||
145663135|NCT02938923|525286376|FG000|Overall Study|Death|1|||
145663136|NCT02938923|525286377|FG001|Overall Study|Death|0|||
145663137|NCT02938923|525286378|FG002|Overall Study|Death|0|||
145663138|NCT02938923|525286376|FG000|Overall Study|Physician Decision|0|||
145663139|NCT02938923|525286377|FG001|Overall Study|Physician Decision|2|||
145663140|NCT02938923|525286378|FG002|Overall Study|Physician Decision|0|||
145663141|NCT02938923|525286376|FG000|Overall Study|Withdrawal by Subject|0|||
145663142|NCT02938923|525286377|FG001|Overall Study|Withdrawal by Subject|1|||
145663143|NCT02938923|525286378|FG002|Overall Study|Withdrawal by Subject|1|||
145663144|NCT04583280|525286381|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
145663145|NCT04583280|525286382|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
145663146|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
145663147|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
145663148|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
145663149|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
145663150|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
145663151|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
145663152|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
145663153|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
145663154|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
145663155|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
145663156|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
145663157|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
145663158|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
145663159|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
145663160|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
145663161|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
145663162|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
145663163|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
145663164|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
145663165|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
145663166|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
145663167|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
145663168|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
145663169|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
145663170|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
145663171|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
145663172|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
145663173|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
145663174|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
145663175|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
145663176|NCT04614948|525286383|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
145663177|NCT04614948|525286384|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
145663178|NCT04614948|525286385|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
145663179|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
145663180|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
145663181|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
145663182|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
145663183|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
145663184|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
145663185|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
145663186|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
145663187|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
145663188|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
145663189|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
145663190|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
145663191|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
145663192|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
145663193|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
145663194|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
145663195|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
145663196|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
145663197|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
145663198|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
145663199|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
145663200|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
145663201|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
145663202|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
145663203|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
145663204|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
145663205|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
145663206|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
145663207|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
145663208|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
145663209|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
145663210|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
145663211|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
145663212|NCT04614948|525286383|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
145663213|NCT04614948|525286384|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
145663214|NCT04614948|525286385|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
145663215|NCT00631475|525286386|FG000|Overall Study|Death|18|||
145663216|NCT00631475|525286386|FG000|Overall Study|Adverse Event|14|||
145663217|NCT00631475|525286386|FG000|Overall Study|Withdrew consent|5|||
145663218|NCT00631475|525286386|FG000|Overall Study|Preparation for lung transplant|8|||
145663219|NCT00303459|525286387|FG000|Overall Study|Death|33|||
145663220|NCT00303459|525286388|FG001|Overall Study|Death|44|||
145663221|NCT00303459|525286387|FG000|Overall Study|Withdrawal of consent|32|||
145663222|NCT00303459|525286388|FG001|Overall Study|Withdrawal of consent|26|||
145663223|NCT00303459|525286387|FG000|Overall Study|Lost to Follow-up|5|||
145663224|NCT00303459|525286388|FG001|Overall Study|Lost to Follow-up|4|||
145663225|NCT00303459|525286387|FG000|Overall Study|Administrative reason|7|||
145663226|NCT00303459|525286388|FG001|Overall Study|Administrative reason|7|||
145663227|NCT00303459|525286387|FG000|Overall Study|Decision by the investigator|5|||
145663228|NCT00303459|525286388|FG001|Overall Study|Decision by the investigator|7|||
145663229|NCT00303459|525286387|FG000|Overall Study|Lung transplantation|1|||
145663230|NCT00303459|525286388|FG001|Overall Study|Lung transplantation|1|||
145663231|NCT04129554|525286389|FG000|Overall Study|Withdrawal by Subject|4|||
145663232|NCT04129554|525286390|FG001|Overall Study|Withdrawal by Subject|3|||
145663233|NCT04129554|525286389|FG000|Overall Study|Other|0|||
145663234|NCT04129554|525286390|FG001|Overall Study|Other|2|||
145663235|NCT01570361|525286391|FG000|Overall Study|Subject discontinued|1|||
145663236|NCT01570361|525286392|FG001|Overall Study|Subject discontinued|2|||
145663237|NCT01570361|525286391|FG000|Overall Study|Sponsor closing the study|51|||
145663238|NCT01570361|525286392|FG001|Overall Study|Sponsor closing the study|50|||
145663239|NCT01570361|525286391|FG000|Overall Study|Subject excluded|5|||
145663240|NCT01570361|525286392|FG001|Overall Study|Subject excluded|3|||
145663241|NCT01570361|525286391|FG000|Overall Study|Subject withdrew consent|14|||
145663242|NCT01570361|525286392|FG001|Overall Study|Subject withdrew consent|9|||
145663243|NCT01570361|525286391|FG000|Overall Study|Adverse Event|2|||
145663244|NCT01570361|525286392|FG001|Overall Study|Adverse Event|1|||
145663245|NCT01570361|525286391|FG000|Overall Study|Lost to Follow-up|4|||
145663246|NCT01570361|525286392|FG001|Overall Study|Lost to Follow-up|4|||
145663247|NCT01570361|525286391|FG000|Overall Study|Death|5|||
145663248|NCT01570361|525286392|FG001|Overall Study|Death|4|||
145663249|NCT01570361|525286391|FG000|Overall Study|Other|0|||
145663250|NCT01570361|525286392|FG001|Overall Study|Other|2|||
145663251|NCT05158504|525286393|FG000|Overall Study|Lost to Follow-up|2|||
145663252|NCT05158504|525286394|FG001|Overall Study|Lost to Follow-up|3|||
145663253|NCT03606512|525286397|FG000|Overall Study|Lost to Follow-up|0|||
145663254|NCT03606512|525286398|FG001|Overall Study|Lost to Follow-up|1|||
145663255|NCT03606512|525286397|FG000|Overall Study|'moved from study area|0|||
145663256|NCT03606512|525286398|FG001|Overall Study|'moved from study area|1|||
145663257|NCT05513937|525286399|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
145663258|NCT05513937|525286400|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
145663259|NCT05513937|525286401|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
145663260|NCT05513937|525286402|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
145663261|NCT05513937|525286399|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
145663262|NCT05513937|525286400|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
145663263|NCT05513937|525286401|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
145663264|NCT05513937|525286402|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
145663265|NCT05513937|525286399|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
145663266|NCT05513937|525286400|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
145663267|NCT05513937|525286401|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
145663268|NCT05513937|525286402|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
145663269|NCT05513937|525286399|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
145490634|NCT04486235|524650368|FG000|Overall Study|Pregnancy|1|||
145663270|NCT05513937|525286400|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
145663271|NCT05513937|525286401|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
145663272|NCT05513937|525286402|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
145663273|NCT05513937|525286399|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
145663274|NCT05513937|525286400|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
145663275|NCT05513937|525286401|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
145663276|NCT05513937|525286402|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
145663277|NCT05513937|525286399|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
145663278|NCT05513937|525286400|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
145663279|NCT05513937|525286401|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
145663280|NCT05513937|525286402|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
145663281|NCT02846545|525286403|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
145663282|NCT02846545|525286404|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
145663283|NCT02846545|525286403|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
145663284|NCT02846545|525286404|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
145663285|NCT02846545|525286403|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
145663286|NCT02846545|525286404|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
145663287|NCT02846545|525286403|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
145663288|NCT02846545|525286404|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
145663289|NCT02846545|525286403|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
145663290|NCT02846545|525286404|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
145663291|NCT03691298|525286407|FG000|Overall Study|Lost to Follow-up|8|||
145663292|NCT03691298|525286407|FG000|Overall Study|Sponsor terminated study|2|||
145663293|NCT03663205|525286411|FG000|Overall Study|Death|144|||
145663294|NCT03663205|525286412|FG001|Overall Study|Death|69|||
145663295|NCT03663205|525286411|FG000|Overall Study|Sponsor decision|53|||
145663296|NCT03663205|525286412|FG001|Overall Study|Sponsor decision|19|||
145663297|NCT03663205|525286411|FG000|Overall Study|Withdrawal by Subject|8|||
145663298|NCT03663205|525286412|FG001|Overall Study|Withdrawal by Subject|11|||
145663299|NCT03663205|525286411|FG000|Overall Study|Lost to Follow-up|7|||
145663300|NCT03663205|525286412|FG001|Overall Study|Lost to Follow-up|9|||
145663301|NCT03663205|525286411|FG000|Overall Study|Transferred to long term extension study|11|||
145663302|NCT03663205|525286412|FG001|Overall Study|Transferred to long term extension study|3|||
145663303|NCT04633538|525286413|FG000|Overall Study|Death|1|||
145663304|NCT04633538|525286413|FG000|Overall Study|Lost to Follow-up|3|||
145663305|NCT04633538|525286413|FG000|Overall Study|Withdrawal by Subject|1|||
145663306|NCT05962814|525286419|FG000|Overall Study|failed eligibility|1|||
145663307|NCT03057054|525286420|FG000|Overall Study|Death|4|||
145663308|NCT03057054|525286421|FG001|Overall Study|Death|4|||
145663309|NCT03057054|525286420|FG000|Overall Study|Withdrawal by Subject|6|||
145663310|NCT03057054|525286421|FG001|Overall Study|Withdrawal by Subject|3|||
145663311|NCT03057054|525286420|FG000|Overall Study|Ineligible|1|||
145663312|NCT03057054|525286421|FG001|Overall Study|Ineligible|1|||
145663313|NCT05507437|525288258|FG000|Overall Study|Withdrawal by Subject|1|||
145663314|NCT05507437|525288259|FG001|Overall Study|Withdrawal by Subject|1|||
145663315|NCT05507437|525288258|FG000|Overall Study|Death|3|||
145663316|NCT05507437|525288259|FG001|Overall Study|Death|0|||
145663317|NCT01064440|525288260|FG000|Overall Study|Lost to Follow-up|1|||
145663318|NCT01064440|525288261|FG001|Overall Study|Lost to Follow-up|1|||
145663319|NCT01064440|525288262|FG002|Overall Study|Lost to Follow-up|1|||
145663320|NCT01064440|525288260|FG000|Overall Study|Non-compliance|0|||
145663321|NCT01064440|525288261|FG001|Overall Study|Non-compliance|1|||
145663322|NCT01064440|525288262|FG002|Overall Study|Non-compliance|0|||
145663323|NCT01064440|525288260|FG000|Overall Study|Death|1|||
145663324|NCT01064440|525288261|FG001|Overall Study|Death|0|||
145663325|NCT01064440|525288262|FG002|Overall Study|Death|1|||
145663326|NCT01064440|525288260|FG000|Overall Study|Withdrawal by Subject|0|||
145663327|NCT01064440|525288261|FG001|Overall Study|Withdrawal by Subject|1|||
145663328|NCT01064440|525288262|FG002|Overall Study|Withdrawal by Subject|1|||
145663329|NCT01064440|525288260|FG000|Overall Study|Other: amputation|1|||
145663330|NCT01064440|525288261|FG001|Overall Study|Other: amputation|0|||
145663331|NCT01064440|525288262|FG002|Overall Study|Other: amputation|0|||
145663332|NCT01130883|525288263|FG000|Overall Study|Patient Noncompliance|6|||
145663333|NCT01130883|525288263|FG000|Overall Study|Reason Unknown|1|||
145663334|NCT01130883|525288263|FG000|Overall Study|Adverse Event|3|||
145663335|NCT02585323|525288264|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
145663336|NCT02585323|525288265|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
145663337|NCT02585323|525288264|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
145663338|NCT02585323|525288265|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
145663339|NCT02585323|525288264|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
145663340|NCT02585323|525288265|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
145663341|NCT02585323|525288264|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
145663342|NCT02585323|525288265|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
145663343|NCT01880515|525288271|FG000|Overall Study|Lost to Follow-up|3|||
145663344|NCT01880515|525288272|FG001|Overall Study|Lost to Follow-up|2|||
145663345|NCT01880515|525288271|FG000|Overall Study|Disease Progression|5|||
145663346|NCT01880515|525288272|FG001|Overall Study|Disease Progression|7|||
145663347|NCT05247034|525288274|FG000|Overall Study|Lost to Follow-up|3|||
145663348|NCT05247034|525288275|FG001|Overall Study|Lost to Follow-up|2|||
145663349|NCT05247034|525288274|FG000|Overall Study|Organizational problems when attending appointments|1|||
145663350|NCT05247034|525288275|FG001|Overall Study|Organizational problems when attending appointments|0|||
145663351|NCT03972150|525288278|FG000|Overall Study|Adverse Event|0|||
145663352|NCT03972150|525288279|FG001|Overall Study|Adverse Event|1|||
145663353|NCT03972150|525288280|FG002|Overall Study|Adverse Event|1|||
145663354|NCT03972150|525288281|FG003|Overall Study|Adverse Event|0|||
145663355|NCT03972150|525288282|FG004|Overall Study|Adverse Event|0|||
145663356|NCT03972150|525288278|FG000|Overall Study|Progressive disease|3|||
145663357|NCT03972150|525288279|FG001|Overall Study|Progressive disease|5|||
145663358|NCT03972150|525288280|FG002|Overall Study|Progressive disease|2|||
145663359|NCT03972150|525288281|FG003|Overall Study|Progressive disease|2|||
145663360|NCT03972150|525288282|FG004|Overall Study|Progressive disease|3|||
145663361|NCT03981926|525288283|FG000|Overall Study|Lost to Follow-up|5|||
145663362|NCT03981926|525288284|FG001|Overall Study|Lost to Follow-up|9|||
145663363|NCT06262347|525288285|FG000|Overall Study|Lost to Follow-up|4|||
145663364|NCT06262347|525288286|FG001|Overall Study|Lost to Follow-up|3|||
145663365|NCT06262347|525288285|FG000|Overall Study|Withdrawal by Subject|0|||
145663366|NCT06262347|525288286|FG001|Overall Study|Withdrawal by Subject|1|||
145663367|NCT05464069|525288287|FG000|Overall Study|Protocol Violation|3|||
145663368|NCT05464069|525288288|FG001|Overall Study|Protocol Violation|2|||
145663369|NCT04136912|525288294|FG000|Overall Study|Operational reasons|0|||
145663370|NCT04136912|525288295|FG001|Overall Study|Operational reasons|0|||
145663371|NCT04136912|525288296|FG002|Overall Study|Operational reasons|2|||
145663372|NCT04999111|525288297|FG000|Overall Study|Lost to Follow-up|21|||
145663373|NCT04999111|525288298|FG001|Overall Study|Lost to Follow-up|16|||
145663374|NCT04999111|525288299|FG002|Overall Study|Lost to Follow-up|2|||
145663375|NCT04999111|525288300|FG003|Overall Study|Lost to Follow-up|26|||
145663376|NCT04999111|525288301|FG004|Overall Study|Lost to Follow-up|30|||
145663377|NCT04999111|525288302|FG005|Overall Study|Lost to Follow-up|6|||
145663378|NCT04999111|525288297|FG000|Overall Study|Physician Decision|1|||
145663379|NCT04999111|525288298|FG001|Overall Study|Physician Decision|3|||
145663380|NCT04999111|525288299|FG002|Overall Study|Physician Decision|0|||
145663381|NCT04999111|525288300|FG003|Overall Study|Physician Decision|1|||
145663382|NCT04999111|525288301|FG004|Overall Study|Physician Decision|2|||
145663383|NCT04999111|525288302|FG005|Overall Study|Physician Decision|0|||
145663384|NCT04999111|525288297|FG000|Overall Study|Withdrawal by Subject|23|||
145663385|NCT04999111|525288298|FG001|Overall Study|Withdrawal by Subject|29|||
145663386|NCT04999111|525288299|FG002|Overall Study|Withdrawal by Subject|15|||
145663387|NCT04999111|525288300|FG003|Overall Study|Withdrawal by Subject|30|||
145663388|NCT04999111|525288301|FG004|Overall Study|Withdrawal by Subject|35|||
145663389|NCT04999111|525288302|FG005|Overall Study|Withdrawal by Subject|10|||
145663390|NCT04999111|525288297|FG000|Overall Study|Other|6|||
145663391|NCT04999111|525288298|FG001|Overall Study|Other|6|||
145663392|NCT04999111|525288299|FG002|Overall Study|Other|3|||
145663393|NCT04999111|525288300|FG003|Overall Study|Other|8|||
145663394|NCT04999111|525288301|FG004|Overall Study|Other|8|||
145663395|NCT04999111|525288302|FG005|Overall Study|Other|5|||
145663396|NCT04999111|525288297|FG000|Overall Study|Non-compliance with study schedule|1|||
145663397|NCT04999111|525288298|FG001|Overall Study|Non-compliance with study schedule|0|||
145663398|NCT04999111|525288299|FG002|Overall Study|Non-compliance with study schedule|0|||
145663399|NCT04999111|525288300|FG003|Overall Study|Non-compliance with study schedule|1|||
145663400|NCT04999111|525288301|FG004|Overall Study|Non-compliance with study schedule|1|||
145663401|NCT04999111|525288302|FG005|Overall Study|Non-compliance with study schedule|1|||
145663402|NCT04999111|525288297|FG000|Overall Study|Randomized but not vaccinated|1|||
145663403|NCT04999111|525288298|FG001|Overall Study|Randomized but not vaccinated|2|||
145663404|NCT04999111|525288299|FG002|Overall Study|Randomized but not vaccinated|0|||
145663405|NCT04999111|525288300|FG003|Overall Study|Randomized but not vaccinated|3|||
145663406|NCT04999111|525288301|FG004|Overall Study|Randomized but not vaccinated|3|||
145663407|NCT04999111|525288302|FG005|Overall Study|Randomized but not vaccinated|0|||
145663408|NCT04999111|525288297|FG000|Overall Study|Adverse Event|1|||
145663409|NCT04999111|525288298|FG001|Overall Study|Adverse Event|1|||
145663410|NCT04999111|525288299|FG002|Overall Study|Adverse Event|0|||
145663411|NCT04999111|525288300|FG003|Overall Study|Adverse Event|0|||
145490635|NCT04486235|524650369|FG001|Overall Study|Pregnancy|0|||
145663412|NCT04999111|525288301|FG004|Overall Study|Adverse Event|0|||
145663413|NCT04999111|525288302|FG005|Overall Study|Adverse Event|0|||
145663414|NCT04999111|525288297|FG000|Overall Study|Initiated prohibited medication|0|||
145663415|NCT04999111|525288298|FG001|Overall Study|Initiated prohibited medication|0|||
145663416|NCT04999111|525288299|FG002|Overall Study|Initiated prohibited medication|0|||
145663417|NCT04999111|525288300|FG003|Overall Study|Initiated prohibited medication|0|||
145663418|NCT04999111|525288301|FG004|Overall Study|Initiated prohibited medication|1|||
145663419|NCT04999111|525288302|FG005|Overall Study|Initiated prohibited medication|0|||
145663420|NCT02437136|525288308|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
145663421|NCT02437136|525288309|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663422|NCT02437136|525288310|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663423|NCT02437136|525288311|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663424|NCT02437136|525288312|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663425|NCT02437136|525288313|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663426|NCT02437136|525288314|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
145663427|NCT02437136|525288308|FG000|Expansion (Phase 2)|Death|0|||
145663428|NCT02437136|525288309|FG001|Expansion (Phase 2)|Death|0|||
145663429|NCT02437136|525288310|FG002|Expansion (Phase 2)|Death|0|||
145663430|NCT02437136|525288311|FG003|Expansion (Phase 2)|Death|6|||
145663431|NCT02437136|525288312|FG004|Expansion (Phase 2)|Death|37|||
145663432|NCT02437136|525288313|FG005|Expansion (Phase 2)|Death|29|||
145663433|NCT02437136|525288314|FG006|Expansion (Phase 2)|Death|24|||
145663434|NCT02437136|525288308|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
145663435|NCT02437136|525288309|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
145663436|NCT02437136|525288310|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
145663437|NCT02437136|525288311|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
145663438|NCT02437136|525288312|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
145663439|NCT02437136|525288313|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
145663440|NCT02437136|525288314|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
145663441|NCT02437136|525288308|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
145663442|NCT02437136|525288309|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
145663443|NCT02437136|525288310|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
145663444|NCT02437136|525288311|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
145663445|NCT02437136|525288312|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
145663446|NCT02437136|525288313|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
145663447|NCT02437136|525288314|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
145663448|NCT02056834|525288317|FG000|Overall Study|Lost to Follow-up|7|||
145663449|NCT06106022|525288319|FG000|Overall Study|Lost to Follow-up|1|||
145663450|NCT06106022|525288320|FG001|Overall Study|Lost to Follow-up|0|||
145663451|NCT06106022|525288319|FG000|Overall Study|Voluntary Withdrawal|0|||
145663452|NCT06106022|525288320|FG001|Overall Study|Voluntary Withdrawal|2|||
145663453|NCT04089865|525288322|FG000|Overall Study|Withdrawal by Subject|2|||
145663454|NCT04089865|525288323|FG001|Overall Study|Withdrawal by Subject|2|||
145663455|NCT04089865|525288324|FG002|Overall Study|Withdrawal by Subject|7|||
145663456|NCT04089865|525288325|FG003|Overall Study|Withdrawal by Subject|2|||
145663457|NCT05524116|525288338|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
145663458|NCT05524116|525288339|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
145663459|NCT05524116|525288338|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
145663460|NCT05524116|525288339|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
145663461|NCT05524116|525288338|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
145663462|NCT05524116|525288339|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
145663463|NCT05524116|525288338|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
145663464|NCT05524116|525288339|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
145663465|NCT05524116|525288338|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
145663466|NCT05524116|525288339|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
145663467|NCT03580356|525288347|FG000|Treatment Period|Withdrawal by Subject|13|||
145663468|NCT03580356|525288348|FG001|Treatment Period|Withdrawal by Subject|0|||
145663469|NCT03580356|525288349|FG002|Treatment Period|Withdrawal by Subject|13|||
145663470|NCT03580356|525288350|FG003|Treatment Period|Withdrawal by Subject|1|||
145663471|NCT03580356|525288351|FG004|Treatment Period|Withdrawal by Subject|17|||
145663472|NCT03580356|525288352|FG005|Treatment Period|Withdrawal by Subject|0|||
145663473|NCT03580356|525288353|FG006|Treatment Period|Withdrawal by Subject|5|||
145663474|NCT03580356|525288354|FG007|Treatment Period|Withdrawal by Subject|0|||
145663475|NCT03580356|525288347|FG000|Treatment Period|Adverse Event|10|||
145663476|NCT03580356|525288348|FG001|Treatment Period|Adverse Event|0|||
145663477|NCT03580356|525288349|FG002|Treatment Period|Adverse Event|13|||
145663478|NCT03580356|525288350|FG003|Treatment Period|Adverse Event|0|||
145663479|NCT03580356|525288351|FG004|Treatment Period|Adverse Event|5|||
145663480|NCT03580356|525288352|FG005|Treatment Period|Adverse Event|0|||
145663481|NCT03580356|525288353|FG006|Treatment Period|Adverse Event|8|||
145663482|NCT03580356|525288354|FG007|Treatment Period|Adverse Event|0|||
145663483|NCT03580356|525288347|FG000|Treatment Period|Protocol Violation|5|||
145663484|NCT03580356|525288348|FG001|Treatment Period|Protocol Violation|0|||
145663485|NCT03580356|525288349|FG002|Treatment Period|Protocol Violation|6|||
145663486|NCT03580356|525288350|FG003|Treatment Period|Protocol Violation|1|||
145663487|NCT03580356|525288351|FG004|Treatment Period|Protocol Violation|9|||
145663488|NCT03580356|525288352|FG005|Treatment Period|Protocol Violation|1|||
145663489|NCT03580356|525288353|FG006|Treatment Period|Protocol Violation|1|||
145663490|NCT03580356|525288354|FG007|Treatment Period|Protocol Violation|0|||
145663491|NCT03580356|525288347|FG000|Treatment Period|Lack of Efficacy|6|||
145663492|NCT03580356|525288348|FG001|Treatment Period|Lack of Efficacy|0|||
145663493|NCT03580356|525288349|FG002|Treatment Period|Lack of Efficacy|2|||
145663494|NCT03580356|525288350|FG003|Treatment Period|Lack of Efficacy|0|||
145663495|NCT03580356|525288351|FG004|Treatment Period|Lack of Efficacy|3|||
145663496|NCT03580356|525288352|FG005|Treatment Period|Lack of Efficacy|0|||
145663497|NCT03580356|525288353|FG006|Treatment Period|Lack of Efficacy|3|||
145663498|NCT03580356|525288354|FG007|Treatment Period|Lack of Efficacy|0|||
145663499|NCT03580356|525288347|FG000|Treatment Period|Pregnancy|1|||
145663500|NCT03580356|525288348|FG001|Treatment Period|Pregnancy|0|||
145663501|NCT03580356|525288349|FG002|Treatment Period|Pregnancy|7|||
145663502|NCT03580356|525288350|FG003|Treatment Period|Pregnancy|0|||
145663503|NCT03580356|525288351|FG004|Treatment Period|Pregnancy|2|||
145663504|NCT03580356|525288352|FG005|Treatment Period|Pregnancy|0|||
145663505|NCT03580356|525288353|FG006|Treatment Period|Pregnancy|1|||
145663506|NCT03580356|525288354|FG007|Treatment Period|Pregnancy|0|||
145663507|NCT03580356|525288347|FG000|Treatment Period|Physician Decision|2|||
145663508|NCT03580356|525288348|FG001|Treatment Period|Physician Decision|0|||
145663509|NCT03580356|525288349|FG002|Treatment Period|Physician Decision|1|||
145663510|NCT03580356|525288350|FG003|Treatment Period|Physician Decision|0|||
145663511|NCT03580356|525288351|FG004|Treatment Period|Physician Decision|4|||
145663512|NCT03580356|525288352|FG005|Treatment Period|Physician Decision|0|||
145663513|NCT03580356|525288353|FG006|Treatment Period|Physician Decision|2|||
145663514|NCT03580356|525288354|FG007|Treatment Period|Physician Decision|0|||
145663515|NCT03580356|525288347|FG000|Treatment Period|Lost to Follow-up|1|||
145663516|NCT03580356|525288348|FG001|Treatment Period|Lost to Follow-up|1|||
145663517|NCT03580356|525288349|FG002|Treatment Period|Lost to Follow-up|1|||
145663518|NCT03580356|525288350|FG003|Treatment Period|Lost to Follow-up|0|||
145663519|NCT03580356|525288351|FG004|Treatment Period|Lost to Follow-up|3|||
145663520|NCT03580356|525288352|FG005|Treatment Period|Lost to Follow-up|0|||
145663521|NCT03580356|525288353|FG006|Treatment Period|Lost to Follow-up|1|||
145663522|NCT03580356|525288354|FG007|Treatment Period|Lost to Follow-up|0|||
145663523|NCT03580356|525288347|FG000|Treatment Period|Death|0|||
145663524|NCT03580356|525288348|FG001|Treatment Period|Death|0|||
145663525|NCT03580356|525288349|FG002|Treatment Period|Death|1|||
145663526|NCT03580356|525288350|FG003|Treatment Period|Death|0|||
145663527|NCT03580356|525288351|FG004|Treatment Period|Death|0|||
145663528|NCT03580356|525288352|FG005|Treatment Period|Death|0|||
145663529|NCT03580356|525288353|FG006|Treatment Period|Death|0|||
145663530|NCT03580356|525288354|FG007|Treatment Period|Death|0|||
145663531|NCT03580356|525288347|FG000|Treatment Period|Technical problems|0|||
145663532|NCT03580356|525288348|FG001|Treatment Period|Technical problems|0|||
145663533|NCT03580356|525288349|FG002|Treatment Period|Technical problems|0|||
145663534|NCT03580356|525288350|FG003|Treatment Period|Technical problems|0|||
145663535|NCT03580356|525288351|FG004|Treatment Period|Technical problems|1|||
145663536|NCT03580356|525288352|FG005|Treatment Period|Technical problems|0|||
145663537|NCT03580356|525288353|FG006|Treatment Period|Technical problems|0|||
145663538|NCT03580356|525288354|FG007|Treatment Period|Technical problems|0|||
145663539|NCT03580356|525288347|FG000|Treatment Period|Misrandomized, no treatment|0|||
145663540|NCT03580356|525288348|FG001|Treatment Period|Misrandomized, no treatment|0|||
145663541|NCT03580356|525288349|FG002|Treatment Period|Misrandomized, no treatment|1|||
145663542|NCT03580356|525288350|FG003|Treatment Period|Misrandomized, no treatment|0|||
145663543|NCT03580356|525288351|FG004|Treatment Period|Misrandomized, no treatment|2|||
145663544|NCT03580356|525288352|FG005|Treatment Period|Misrandomized, no treatment|0|||
145663545|NCT03580356|525288353|FG006|Treatment Period|Misrandomized, no treatment|0|||
145663546|NCT03580356|525288354|FG007|Treatment Period|Misrandomized, no treatment|0|||
145663547|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
145663548|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
145663549|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
145663550|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
145663551|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
145663552|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
145663553|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
145663554|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
145663555|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
145663556|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145663557|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
145663558|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145663559|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
145663560|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145663561|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145663562|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
145663563|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
145663564|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
145663565|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
145663566|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
145663567|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
145663568|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
145663569|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
145663570|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
145663571|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663572|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663573|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
145663574|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663575|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
145663576|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663577|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663578|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
145663579|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
145663580|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
145663581|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
145663582|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
145663583|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
145663584|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
145663585|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
145663586|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
145663587|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
145663588|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
145663589|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
145663590|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
145663591|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
145663592|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
145663593|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
145663594|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
145663595|NCT03580356|525288347|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
145663596|NCT03580356|525288348|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
145663597|NCT03580356|525288349|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
145663598|NCT03580356|525288350|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
145663599|NCT03580356|525288351|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
145663600|NCT03580356|525288352|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
145663601|NCT03580356|525288353|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
145663602|NCT03580356|525288354|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
145663603|NCT02834390|525288356|FG000|Induction Phase|Progressive disease|0|||
145663604|NCT02834390|525288357|FG001|Induction Phase|Progressive disease|1|||
145663605|NCT02834390|525288356|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
145663606|NCT02834390|525288357|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
145663607|NCT02834390|525288356|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
145663608|NCT02834390|525288357|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
145663609|NCT02834390|525288356|FG000|Consolidation Phase|Physician Decision|1|||
145663610|NCT02834390|525288357|FG001|Consolidation Phase|Physician Decision|1|||
145663611|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
145663612|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
145663613|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663614|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663615|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663616|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663617|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663618|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663619|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663620|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663621|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663622|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
145663623|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663624|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
145663625|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663626|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663627|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663628|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663629|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663630|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663631|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663632|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663633|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663634|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
145663635|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
145663636|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
145663637|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663638|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145490636|NCT04486235|524650368|FG000|Overall Study|Lost to Follow-up|1|||
145490637|NCT04486235|524650369|FG001|Overall Study|Lost to Follow-up|0|||
145663639|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663640|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663641|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663642|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663643|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663644|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663645|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663646|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
145663647|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663648|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
145663649|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663650|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663651|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663652|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663653|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663654|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663655|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663656|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663657|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663658|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
145663659|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663660|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
145663661|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663662|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663663|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663664|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145490638|NCT04590014|524650370|FG000|Overall Study|Withdrawal by Subject|1|||
145490639|NCT04590014|524650371|FG001|Overall Study|Withdrawal by Subject|0|||
145663665|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663666|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663667|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663668|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663669|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663670|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
145663671|NCT03536884|525288360|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663672|NCT03536884|525288361|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
145663673|NCT03536884|525288362|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663674|NCT03536884|525288363|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663675|NCT03536884|525288364|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663676|NCT03536884|525288365|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663677|NCT03536884|525288366|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663678|NCT03536884|525288367|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663679|NCT03536884|525288368|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663680|NCT03536884|525288369|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663681|NCT03536884|525288370|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663682|NCT03536884|525288371|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
145663683|NCT03536884|525288360|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663684|NCT03536884|525288361|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663685|NCT03536884|525288362|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
145663686|NCT03536884|525288363|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663687|NCT03536884|525288364|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
145663688|NCT03536884|525288365|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663689|NCT03536884|525288366|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663690|NCT03536884|525288367|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663691|NCT03536884|525288368|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663692|NCT03536884|525288369|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663693|NCT03536884|525288370|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663694|NCT03536884|525288371|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
145663695|NCT03536884|525288360|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663696|NCT03536884|525288361|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145490640|NCT03935126|524650372|FG000|Overall Study|Study termination by sponsor|3|||
145663697|NCT03536884|525288362|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
145663698|NCT03536884|525288363|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
145663699|NCT03536884|525288364|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
145663700|NCT03536884|525288365|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663701|NCT03536884|525288366|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663702|NCT03536884|525288367|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663703|NCT03536884|525288368|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663704|NCT03536884|525288369|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663705|NCT03536884|525288370|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663706|NCT03536884|525288371|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
145663707|NCT03536884|525288360|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663708|NCT03536884|525288361|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663709|NCT03536884|525288362|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663710|NCT03536884|525288363|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
145663711|NCT03536884|525288364|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
145663712|NCT03536884|525288365|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663713|NCT03536884|525288366|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663714|NCT03536884|525288367|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663715|NCT03536884|525288368|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663716|NCT03536884|525288369|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663717|NCT03536884|525288370|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663718|NCT03536884|525288371|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
145663719|NCT03536884|525288360|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663720|NCT03536884|525288361|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663721|NCT03536884|525288362|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
145663722|NCT03536884|525288363|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
145663723|NCT03536884|525288364|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
145663724|NCT03536884|525288365|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663725|NCT03536884|525288366|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663726|NCT03536884|525288367|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663727|NCT03536884|525288368|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663728|NCT03536884|525288369|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663729|NCT03536884|525288370|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663730|NCT03536884|525288371|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
145663731|NCT03536884|525288360|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663732|NCT03536884|525288361|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663733|NCT03536884|525288362|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
145663734|NCT03536884|525288363|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
145663735|NCT03536884|525288364|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
145663736|NCT03536884|525288365|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663737|NCT03536884|525288366|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663738|NCT03536884|525288367|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663739|NCT03536884|525288368|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663740|NCT03536884|525288369|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663741|NCT03536884|525288370|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663742|NCT03536884|525288371|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
145663743|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663744|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663745|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663746|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663747|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663748|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
145663749|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
145663750|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
145663751|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
145663752|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663753|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663754|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
145663755|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663756|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663757|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663758|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663759|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663760|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
145663761|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
145663762|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
145663763|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
145663764|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145490641|NCT00399516|524650373|FG000|Overall Study|Lost to Follow-up|2|||
145663765|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663766|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
145663767|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663768|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663769|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663770|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663771|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663772|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
145663773|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663774|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
145663775|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663776|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663777|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663778|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
145663779|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663780|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663781|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663782|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663783|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663784|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
145663785|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663786|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
145663787|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
145663788|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663789|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663790|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
145663791|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663792|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663793|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663794|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663795|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663796|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
145663797|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
145663798|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
145663799|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
145663800|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663801|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663802|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
145663803|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663804|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663805|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663806|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663807|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663808|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
145663809|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663810|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663811|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663812|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663813|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663814|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
145663815|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663816|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663817|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663818|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663819|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663820|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663821|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
145663822|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663823|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663824|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663825|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663826|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
145663827|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663828|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663829|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145490642|NCT03546621|524650374|FG000|Overall Study|Withdrawal by Subject|0|||
145663830|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663831|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663832|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663833|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
145663834|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663835|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663836|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663837|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663838|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
145663839|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663840|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663841|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663842|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663843|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663844|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
145663845|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663846|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663847|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663848|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663849|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663850|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
145663851|NCT03536884|525288360|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663852|NCT03536884|525288361|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663853|NCT03536884|525288362|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663854|NCT03536884|525288363|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663855|NCT03536884|525288364|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663856|NCT03536884|525288365|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663857|NCT03536884|525288366|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663858|NCT03536884|525288367|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663859|NCT03536884|525288368|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
145663860|NCT03536884|525288369|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663861|NCT03536884|525288370|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663862|NCT03536884|525288371|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
145663863|NCT03536884|525288360|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663864|NCT03536884|525288361|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663865|NCT03536884|525288362|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663866|NCT03536884|525288363|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663867|NCT03536884|525288364|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663868|NCT03536884|525288365|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663869|NCT03536884|525288366|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663870|NCT03536884|525288367|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663871|NCT03536884|525288368|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
145663872|NCT03536884|525288369|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
145663873|NCT03536884|525288370|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
145663874|NCT03536884|525288371|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
145663875|NCT03536884|525288360|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663876|NCT03536884|525288361|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663877|NCT03536884|525288362|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663878|NCT03536884|525288363|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663879|NCT03536884|525288364|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663880|NCT03536884|525288365|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663881|NCT03536884|525288366|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663882|NCT03536884|525288367|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663883|NCT03536884|525288368|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
145663884|NCT03536884|525288369|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
145663885|NCT03536884|525288370|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
145663886|NCT03536884|525288371|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
145663887|NCT03536884|525288360|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663888|NCT03536884|525288361|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663889|NCT03536884|525288362|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663890|NCT03536884|525288363|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663891|NCT03536884|525288364|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663892|NCT03536884|525288365|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663893|NCT03536884|525288366|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145490643|NCT03546621|524650375|FG001|Overall Study|Withdrawal by Subject|1|||
145663894|NCT03536884|525288367|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663895|NCT03536884|525288368|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663896|NCT03536884|525288369|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663897|NCT03536884|525288370|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
145663898|NCT03536884|525288371|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
145663899|NCT03536884|525288360|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663900|NCT03536884|525288361|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663901|NCT03536884|525288362|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663902|NCT03536884|525288363|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663903|NCT03536884|525288364|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663904|NCT03536884|525288365|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663905|NCT03536884|525288366|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663906|NCT03536884|525288367|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663907|NCT03536884|525288368|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663908|NCT03536884|525288369|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663909|NCT03536884|525288370|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
145663910|NCT03536884|525288371|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
145663911|NCT03536884|525288360|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663912|NCT03536884|525288361|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663913|NCT03536884|525288362|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663914|NCT03536884|525288363|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663915|NCT03536884|525288364|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663916|NCT03536884|525288365|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663917|NCT03536884|525288366|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663918|NCT03536884|525288367|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663919|NCT03536884|525288368|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663920|NCT03536884|525288369|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663921|NCT03536884|525288370|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
145663922|NCT03536884|525288371|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
145663923|NCT04778410|525288394|FG000|Safety Run-in Period|Death|5|||
145663924|NCT04778410|525288395|FG001|Safety Run-in Period|Death|6|||
145663925|NCT04778410|525288396|FG002|Safety Run-in Period|Death|0|||
145663926|NCT04778410|525288397|FG003|Safety Run-in Period|Death|0|||
145663927|NCT04778410|525288398|FG004|Safety Run-in Period|Death|0|||
145663928|NCT04778410|525288399|FG005|Safety Run-in Period|Death|0|||
145663929|NCT04778410|525288394|FG000|Phase 2 Period|Death|0|||
145663930|NCT04778410|525288395|FG001|Phase 2 Period|Death|0|||
145663931|NCT04778410|525288396|FG002|Phase 2 Period|Death|0|||
145663932|NCT04778410|525288397|FG003|Phase 2 Period|Death|5|||
145663933|NCT04778410|525288398|FG004|Phase 2 Period|Death|18|||
145663934|NCT04778410|525288399|FG005|Phase 2 Period|Death|0|||
145663935|NCT04778410|525288394|FG000|Phase 2 Period|Lost to Follow-up|0|||
145663936|NCT04778410|525288395|FG001|Phase 2 Period|Lost to Follow-up|0|||
145663937|NCT04778410|525288396|FG002|Phase 2 Period|Lost to Follow-up|0|||
145663938|NCT04778410|525288397|FG003|Phase 2 Period|Lost to Follow-up|1|||
145663939|NCT04778410|525288398|FG004|Phase 2 Period|Lost to Follow-up|1|||
145663940|NCT04778410|525288399|FG005|Phase 2 Period|Lost to Follow-up|0|||
145663941|NCT04778410|525288394|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
145663942|NCT04778410|525288395|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
145663943|NCT04778410|525288396|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
145663944|NCT04778410|525288397|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
145663945|NCT04778410|525288398|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
145663946|NCT04778410|525288399|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
145663947|NCT04778410|525288394|FG000|Phase 2 Period|Withdrew Consent|0|||
145663948|NCT04778410|525288395|FG001|Phase 2 Period|Withdrew Consent|0|||
145663949|NCT04778410|525288396|FG002|Phase 2 Period|Withdrew Consent|0|||
145663950|NCT04778410|525288397|FG003|Phase 2 Period|Withdrew Consent|0|||
145663951|NCT04778410|525288398|FG004|Phase 2 Period|Withdrew Consent|2|||
145663952|NCT04778410|525288399|FG005|Phase 2 Period|Withdrew Consent|0|||
145663953|NCT05900154|525288403|FG000|Follow-Up Period|Lost to Follow-up|1|||
145663954|NCT05900154|525288404|FG001|Follow-Up Period|Lost to Follow-up|2|||
145663955|NCT05900154|525288405|FG002|Follow-Up Period|Lost to Follow-up|1|||
145663956|NCT05900154|525288406|FG003|Follow-Up Period|Lost to Follow-up|0|||
145663957|NCT05900154|525288407|FG004|Follow-Up Period|Lost to Follow-up|1|||
145663958|NCT05900154|525288408|FG005|Follow-Up Period|Lost to Follow-up|1|||
145663959|NCT01121588|525288409|FG000|Overall Study|Death|5|||
145490644|NCT03546621|524650376|FG002|Overall Study|Withdrawal by Subject|2|||
145663960|NCT01121588|525288410|FG001|Overall Study|Death|3|||
145663961|NCT01121588|525288411|FG002|Overall Study|Death|13|||
145663962|NCT01121588|525288409|FG000|Overall Study|Study Terminated by Sponsor|1|||
145663963|NCT01121588|525288410|FG001|Overall Study|Study Terminated by Sponsor|1|||
145663964|NCT01121588|525288411|FG002|Overall Study|Study Terminated by Sponsor|0|||
145663965|NCT01121588|525288409|FG000|Overall Study|Participant Refused Further Followup|2|||
145663966|NCT01121588|525288410|FG001|Overall Study|Participant Refused Further Followup|0|||
145663967|NCT01121588|525288411|FG002|Overall Study|Participant Refused Further Followup|2|||
145663968|NCT01121588|525288409|FG000|Overall Study|Lost to Follow-up|0|||
145663969|NCT01121588|525288410|FG001|Overall Study|Lost to Follow-up|1|||
145663970|NCT01121588|525288411|FG002|Overall Study|Lost to Follow-up|1|||
145663971|NCT01121588|525288409|FG000|Overall Study|Non-Specified Reasons|9|||
145663972|NCT01121588|525288410|FG001|Overall Study|Non-Specified Reasons|4|||
145663973|NCT01121588|525288411|FG002|Overall Study|Non-Specified Reasons|2|||
145663974|NCT02944968|525288414|FG000|Overall Study|Subject excluded before study procedure|1|||
145663975|NCT02944968|525288414|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
145663976|NCT04102111|525288422|FG000|Overall Study|Withdrawal by Subject|2|||
145663977|NCT04102111|525288423|FG001|Overall Study|Withdrawal by Subject|3|||
145663978|NCT04102111|525288422|FG000|Overall Study|Adverse Event|1|||
145663979|NCT04102111|525288423|FG001|Overall Study|Adverse Event|1|||
145663980|NCT04102111|525288422|FG000|Overall Study|Study terminated by sponsor|1|||
145663981|NCT04102111|525288423|FG001|Overall Study|Study terminated by sponsor|3|||
145663982|NCT02492711|525288426|FG000|Overall Study|Adverse Event|9|||
145663983|NCT02492711|525288427|FG001|Overall Study|Adverse Event|9|||
145663984|NCT02492711|525288428|FG002|Overall Study|Adverse Event|2|||
145663985|NCT02492711|525288426|FG000|Overall Study|Death|3|||
145663986|NCT02492711|525288427|FG001|Overall Study|Death|3|||
145663987|NCT02492711|525288428|FG002|Overall Study|Death|0|||
145663988|NCT02492711|525288426|FG000|Overall Study|Withdrawal by Subject|10|||
145663989|NCT02492711|525288427|FG001|Overall Study|Withdrawal by Subject|16|||
145663990|NCT02492711|525288428|FG002|Overall Study|Withdrawal by Subject|5|||
145663991|NCT02492711|525288426|FG000|Overall Study|Physician Decision|10|||
145663992|NCT02492711|525288427|FG001|Overall Study|Physician Decision|6|||
145663993|NCT02492711|525288428|FG002|Overall Study|Physician Decision|4|||
145663994|NCT02492711|525288426|FG000|Overall Study|Lost to Follow-up|0|||
145663995|NCT02492711|525288427|FG001|Overall Study|Lost to Follow-up|0|||
145663996|NCT02492711|525288428|FG002|Overall Study|Lost to Follow-up|1|||
145663997|NCT02492711|525288426|FG000|Overall Study|study treatment delay|2|||
145663998|NCT02492711|525288427|FG001|Overall Study|study treatment delay|1|||
145663999|NCT02492711|525288428|FG002|Overall Study|study treatment delay|0|||
145664000|NCT02492711|525288426|FG000|Overall Study|change in chemotherapy|0|||
145664001|NCT02492711|525288427|FG001|Overall Study|change in chemotherapy|1|||
145664002|NCT02492711|525288428|FG002|Overall Study|change in chemotherapy|0|||
145664003|NCT02492711|525288426|FG000|Overall Study|never treated|2|||
145664004|NCT02492711|525288427|FG001|Overall Study|never treated|4|||
145664005|NCT02492711|525288428|FG002|Overall Study|never treated|0|||
145664006|NCT02492711|525288426|FG000|Overall Study|Other|0|||
145664007|NCT02492711|525288427|FG001|Overall Study|Other|0|||
145664008|NCT02492711|525288428|FG002|Overall Study|Other|1|||
145664009|NCT02938520|525288433|FG000|Overall Study|On-going at the time of analysis|258|||
145664010|NCT02938520|525288434|FG001|Overall Study|On-going at the time of analysis|261|||
145664011|NCT02938520|525288433|FG000|Overall Study|Physician Decision|2|||
145664012|NCT02938520|525288434|FG001|Overall Study|Physician Decision|5|||
145664013|NCT02938520|525288433|FG000|Overall Study|Lost to Follow-up|2|||
145664014|NCT02938520|525288434|FG001|Overall Study|Lost to Follow-up|2|||
145664015|NCT02938520|525288433|FG000|Overall Study|Withdrawal by Subject|7|||
145664016|NCT02938520|525288434|FG001|Overall Study|Withdrawal by Subject|7|||
145664017|NCT02938520|525288433|FG000|Overall Study|Protocol Violation|0|||
145664018|NCT02938520|525288434|FG001|Overall Study|Protocol Violation|1|||
145664019|NCT02938520|525288433|FG000|Overall Study|Lack of Efficacy|5|||
145664020|NCT02938520|525288434|FG001|Overall Study|Lack of Efficacy|3|||
145664021|NCT02938520|525288433|FG000|Overall Study|Adverse Event|9|||
145664022|NCT02938520|525288434|FG001|Overall Study|Adverse Event|4|||
145664023|NCT03245840|525288435|FG000|Overall Study|Adverse Event|6|||
145664024|NCT03245840|525288436|FG001|Overall Study|Adverse Event|0|||
145664025|NCT03245840|525288435|FG000|Overall Study|Death|2|||
145664026|NCT03245840|525288436|FG001|Overall Study|Death|0|||
145664027|NCT03245840|525288435|FG000|Overall Study|Withdrawal by Subject|31|||
145664028|NCT03245840|525288436|FG001|Overall Study|Withdrawal by Subject|1|||
145664029|NCT03245840|525288435|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
145664030|NCT03245840|525288436|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145664031|NCT03245840|525288435|FG000|Overall Study|Physician Decision|4|||
145664032|NCT03245840|525288436|FG001|Overall Study|Physician Decision|1|||
145664033|NCT03245840|525288435|FG000|Overall Study|Study Terminated by Sponsor|56|||
145664034|NCT03245840|525288436|FG001|Overall Study|Study Terminated by Sponsor|6|||
145664035|NCT03245840|525288435|FG000|Overall Study|Site Terminated by Sponsor|4|||
145664036|NCT03245840|525288436|FG001|Overall Study|Site Terminated by Sponsor|0|||
145664037|NCT03245840|525288435|FG000|Overall Study|Lost to Follow-up|12|||
145664038|NCT03245840|525288436|FG001|Overall Study|Lost to Follow-up|2|||
145664039|NCT03245840|525288435|FG000|Overall Study|Pregnancy|2|||
145664040|NCT03245840|525288436|FG001|Overall Study|Pregnancy|0|||
145664041|NCT03245840|525288435|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145664042|NCT03245840|525288436|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145664043|NCT03245840|525288435|FG000|Overall Study|Not treated|1|||
145664044|NCT03245840|525288436|FG001|Overall Study|Not treated|1|||
145664045|NCT05311176|525289880|FG000|Overall Study|Death|6|||
145664046|NCT05311176|525289880|FG000|Overall Study|Sponsor discontinued the study|1|||
145664047|NCT03505710|525289881|FG000|Overall Study|Progressive Disease|24|||
145664048|NCT03505710|525289882|FG001|Overall Study|Progressive Disease|17|||
145664049|NCT03505710|525289883|FG002|Overall Study|Progressive Disease|43|||
145664050|NCT03505710|525289881|FG000|Overall Study|Clinical Progression|6|||
145664051|NCT03505710|525289882|FG001|Overall Study|Clinical Progression|8|||
145664052|NCT03505710|525289883|FG002|Overall Study|Clinical Progression|3|||
145664053|NCT03505710|525289881|FG000|Overall Study|Adverse Event|12|||
145664054|NCT03505710|525289882|FG001|Overall Study|Adverse Event|6|||
145664055|NCT03505710|525289883|FG002|Overall Study|Adverse Event|28|||
145664056|NCT03505710|525289881|FG000|Overall Study|Withdrawal by Subject|1|||
145664057|NCT03505710|525289882|FG001|Overall Study|Withdrawal by Subject|3|||
145664058|NCT03505710|525289883|FG002|Overall Study|Withdrawal by Subject|7|||
145664059|NCT03505710|525289881|FG000|Overall Study|Physician Decision|1|||
145664060|NCT03505710|525289882|FG001|Overall Study|Physician Decision|1|||
145664061|NCT03505710|525289883|FG002|Overall Study|Physician Decision|2|||
145664062|NCT03505710|525289881|FG000|Overall Study|Death|4|||
145664063|NCT03505710|525289882|FG001|Overall Study|Death|5|||
145664064|NCT03505710|525289883|FG002|Overall Study|Death|6|||
145664065|NCT03505710|525289881|FG000|Overall Study|Other Reasons|1|||
145664066|NCT03505710|525289882|FG001|Overall Study|Other Reasons|1|||
145664067|NCT03505710|525289883|FG002|Overall Study|Other Reasons|1|||
145664068|NCT03505710|525289881|FG000|Overall Study|Study Terminated by Sponsor|0|||
145664069|NCT03505710|525289882|FG001|Overall Study|Study Terminated by Sponsor|0|||
145664070|NCT03505710|525289883|FG002|Overall Study|Study Terminated by Sponsor|1|||
145664071|NCT05552508|525289892|FG000|Overall Study|Adverse Event|3|||
145664072|NCT04605159|525289893|FG000|Overall Study|Adverse Event|6|||
145664073|NCT04605159|525289894|FG001|Overall Study|Adverse Event|3|||
145664074|NCT04605159|525289895|FG002|Overall Study|Adverse Event|21|||
145664075|NCT04605159|525289896|FG003|Overall Study|Adverse Event|4|||
145664076|NCT04605159|525289893|FG000|Overall Study|Lost to Follow-up|74|||
145664077|NCT04605159|525289894|FG001|Overall Study|Lost to Follow-up|45|||
145664078|NCT04605159|525289895|FG002|Overall Study|Lost to Follow-up|119|||
145664079|NCT04605159|525289896|FG003|Overall Study|Lost to Follow-up|80|||
145664080|NCT04605159|525289893|FG000|Overall Study|Protocol Violation|4|||
145664081|NCT04605159|525289894|FG001|Overall Study|Protocol Violation|5|||
145664082|NCT04605159|525289895|FG002|Overall Study|Protocol Violation|2|||
145664083|NCT04605159|525289896|FG003|Overall Study|Protocol Violation|0|||
145664084|NCT04605159|525289893|FG000|Overall Study|Withdrawal by Subject|66|||
145664085|NCT04605159|525289894|FG001|Overall Study|Withdrawal by Subject|37|||
145664086|NCT04605159|525289895|FG002|Overall Study|Withdrawal by Subject|68|||
145664087|NCT04605159|525289896|FG003|Overall Study|Withdrawal by Subject|50|||
145664088|NCT04605159|525289893|FG000|Overall Study|Migrated / moved from the study area|32|||
145664089|NCT04605159|525289894|FG001|Overall Study|Migrated / moved from the study area|22|||
145664090|NCT04605159|525289895|FG002|Overall Study|Migrated / moved from the study area|41|||
145664091|NCT04605159|525289896|FG003|Overall Study|Migrated / moved from the study area|21|||
145664092|NCT04605159|525289893|FG000|Overall Study|Other|1|||
145664093|NCT04605159|525289894|FG001|Overall Study|Other|2|||
145664094|NCT04605159|525289895|FG002|Overall Study|Other|7|||
145664095|NCT04605159|525289896|FG003|Overall Study|Other|3|||
145664096|NCT05424380|525289900|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
145664097|NCT05424380|525289901|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145664098|NCT05424380|525289902|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145664099|NCT05424380|525289903|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145664100|NCT05424380|525289904|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145664101|NCT05424380|525289905|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
145664102|NCT05424380|525289900|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
145664103|NCT05424380|525289901|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
145664104|NCT05424380|525289902|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
145664105|NCT05424380|525289903|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
145664106|NCT05424380|525289904|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
145664107|NCT05424380|525289905|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
145664108|NCT05424380|525289900|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
145664109|NCT05424380|525289901|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
145664110|NCT05424380|525289902|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
145664111|NCT05424380|525289903|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
145664112|NCT05424380|525289904|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
145664113|NCT05424380|525289905|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
145490645|NCT03546621|524650377|FG003|Overall Study|Withdrawal by Subject|1|||
145490646|NCT03546621|524650374|FG000|Overall Study|Lost to Follow-up|0|||
145490647|NCT03546621|524650375|FG001|Overall Study|Lost to Follow-up|1|||
145490648|NCT03546621|524650376|FG002|Overall Study|Lost to Follow-up|0|||
145664114|NCT05424380|525289900|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
145664115|NCT05424380|525289901|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
145664116|NCT05424380|525289902|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
145664117|NCT05424380|525289903|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
145664118|NCT05424380|525289904|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
145664119|NCT05424380|525289905|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
145664120|NCT05424380|525289900|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145664121|NCT05424380|525289901|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
145664122|NCT05424380|525289902|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145664123|NCT05424380|525289903|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145664124|NCT05424380|525289904|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145664125|NCT05424380|525289905|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
145664126|NCT05424380|525289900|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145664127|NCT05424380|525289901|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145664128|NCT05424380|525289902|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
145664129|NCT05424380|525289903|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145664130|NCT05424380|525289904|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145664131|NCT05424380|525289905|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
145664132|NCT05424380|525289900|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145664133|NCT05424380|525289901|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145664134|NCT05424380|525289902|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
145664135|NCT05424380|525289903|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145664136|NCT05424380|525289904|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145664137|NCT05424380|525289905|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
145664138|NCT05424380|525289900|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
145664139|NCT05424380|525289901|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
145664140|NCT05424380|525289902|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
145664141|NCT05424380|525289903|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
145664142|NCT05424380|525289904|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
145664143|NCT05424380|525289905|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
145664144|NCT05424380|525289900|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664145|NCT05424380|525289901|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664146|NCT05424380|525289902|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664147|NCT05424380|525289903|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
145664148|NCT05424380|525289904|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664149|NCT05424380|525289905|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664150|NCT05424380|525289900|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
145664151|NCT05424380|525289901|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
145664152|NCT05424380|525289902|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
145664153|NCT05424380|525289903|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
145664154|NCT05424380|525289904|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
145664155|NCT05424380|525289905|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
145664156|NCT05424380|525289900|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
145664157|NCT05424380|525289901|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
145664158|NCT05424380|525289902|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
145664159|NCT05424380|525289903|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
145664160|NCT05424380|525289904|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
145664161|NCT05424380|525289905|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
145664162|NCT05424380|525289900|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
145664163|NCT05424380|525289901|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
145664164|NCT05424380|525289902|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
145664165|NCT05424380|525289903|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
145664166|NCT05424380|525289904|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
145664167|NCT05424380|525289905|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
145664168|NCT05424380|525289900|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664169|NCT05424380|525289901|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664170|NCT05424380|525289902|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664171|NCT05424380|525289903|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664172|NCT05424380|525289904|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
145664173|NCT05424380|525289905|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
145664174|NCT05424380|525289900|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
145664175|NCT05424380|525289901|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
145664176|NCT05424380|525289902|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
145664177|NCT05424380|525289903|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
145664178|NCT05424380|525289904|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
145490649|NCT03546621|524650377|FG003|Overall Study|Lost to Follow-up|0|||
145664179|NCT05424380|525289905|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
145490650|NCT03546621|524650374|FG000|Overall Study|Adverse Event|0|||
145490651|NCT03546621|524650375|FG001|Overall Study|Adverse Event|1|||
145490652|NCT03546621|524650376|FG002|Overall Study|Adverse Event|0|||
145664180|NCT00844415|525289912|FG000|Overall Study|Withdrawal by Subject|1|||
145664181|NCT03015532|525289913|FG000|Overall Study|Adverse Event|0|||
145664182|NCT03015532|525289914|FG001|Overall Study|Adverse Event|0|||
145664183|NCT03015532|525289915|FG002|Overall Study|Adverse Event|0|||
145664184|NCT03015532|525289916|FG003|Overall Study|Adverse Event|0|||
145664185|NCT03015532|525289917|FG004|Overall Study|Adverse Event|0|||
145664186|NCT03015532|525289918|FG005|Overall Study|Adverse Event|2|||
145664187|NCT03015532|525289919|FG006|Overall Study|Adverse Event|1|||
145664188|NCT03015532|525289920|FG007|Overall Study|Adverse Event|0|||
145664189|NCT03015532|525289913|FG000|Overall Study|Withdrawal by Subject|0|||
145664190|NCT03015532|525289914|FG001|Overall Study|Withdrawal by Subject|0|||
145664191|NCT03015532|525289915|FG002|Overall Study|Withdrawal by Subject|0|||
145664192|NCT03015532|525289916|FG003|Overall Study|Withdrawal by Subject|0|||
145664193|NCT03015532|525289917|FG004|Overall Study|Withdrawal by Subject|0|||
145664194|NCT03015532|525289918|FG005|Overall Study|Withdrawal by Subject|0|||
145664195|NCT03015532|525289919|FG006|Overall Study|Withdrawal by Subject|1|||
145664196|NCT03015532|525289920|FG007|Overall Study|Withdrawal by Subject|0|||
145664197|NCT04629339|525289921|FG000|Overall Study|Death|1|||
145664198|NCT04629339|525289922|FG001|Overall Study|Death|0|||
145664199|NCT04629339|525289923|FG002|Overall Study|Death|2|||
145664200|NCT04629339|525289924|FG003|Overall Study|Death|2|||
145664201|NCT04629339|525289925|FG004|Overall Study|Death|0|||
145664202|NCT04629339|525289921|FG000|Overall Study|Disease Progression|0|||
145664203|NCT04629339|525289922|FG001|Overall Study|Disease Progression|0|||
145664204|NCT04629339|525289923|FG002|Overall Study|Disease Progression|1|||
145664205|NCT04629339|525289924|FG003|Overall Study|Disease Progression|1|||
145664206|NCT04629339|525289925|FG004|Overall Study|Disease Progression|0|||
145664207|NCT04629339|525289921|FG000|Overall Study|Lost to Follow-up|0|||
145664208|NCT04629339|525289922|FG001|Overall Study|Lost to Follow-up|0|||
145664209|NCT04629339|525289923|FG002|Overall Study|Lost to Follow-up|0|||
145664210|NCT04629339|525289924|FG003|Overall Study|Lost to Follow-up|1|||
145664211|NCT04629339|525289925|FG004|Overall Study|Lost to Follow-up|0|||
145664212|NCT04629339|525289921|FG000|Overall Study|Physician Decision|0|||
145664213|NCT04629339|525289922|FG001|Overall Study|Physician Decision|1|||
145664214|NCT04629339|525289923|FG002|Overall Study|Physician Decision|0|||
145664215|NCT04629339|525289924|FG003|Overall Study|Physician Decision|0|||
145664216|NCT04629339|525289925|FG004|Overall Study|Physician Decision|0|||
145664217|NCT04629339|525289921|FG000|Overall Study|Study Terminated by Sponsor|0|||
145664218|NCT04629339|525289922|FG001|Overall Study|Study Terminated by Sponsor|0|||
145664219|NCT04629339|525289923|FG002|Overall Study|Study Terminated by Sponsor|0|||
145664220|NCT04629339|525289924|FG003|Overall Study|Study Terminated by Sponsor|1|||
145664221|NCT04629339|525289925|FG004|Overall Study|Study Terminated by Sponsor|0|||
145664222|NCT04629339|525289921|FG000|Overall Study|Withdrawal by Subject|0|||
145664223|NCT04629339|525289922|FG001|Overall Study|Withdrawal by Subject|0|||
145664224|NCT04629339|525289923|FG002|Overall Study|Withdrawal by Subject|2|||
145664225|NCT04629339|525289924|FG003|Overall Study|Withdrawal by Subject|2|||
145664226|NCT04629339|525289925|FG004|Overall Study|Withdrawal by Subject|0|||
145664227|NCT03914469|525289926|FG000|Overall Study|Lost to Follow-up|1|||
145664228|NCT03914469|525289927|FG001|Overall Study|Lost to Follow-up|4|||
145664229|NCT00677365|525289928|FG000|Overall Study|Adverse Event|2|||
145664230|NCT00677365|525289929|FG001|Overall Study|Adverse Event|1|||
145664231|NCT00677365|525289930|FG002|Overall Study|Adverse Event|1|||
145664232|NCT00677365|525289931|FG003|Overall Study|Adverse Event|2|||
145664233|NCT00677365|525289928|FG000|Overall Study|Withdrawal by Subject|0|||
145664234|NCT00677365|525289929|FG001|Overall Study|Withdrawal by Subject|0|||
145664235|NCT00677365|525289930|FG002|Overall Study|Withdrawal by Subject|1|||
145664236|NCT00677365|525289931|FG003|Overall Study|Withdrawal by Subject|0|||
145664237|NCT00677365|525289928|FG000|Overall Study|Other reason|0|||
145664238|NCT00677365|525289929|FG001|Overall Study|Other reason|0|||
145664239|NCT00677365|525289930|FG002|Overall Study|Other reason|0|||
145664240|NCT00677365|525289931|FG003|Overall Study|Other reason|1|||
145664241|NCT04084574|525289932|FG000|Overall Study|Lost to Follow-up|1|||
145664242|NCT04084574|525289933|FG001|Overall Study|Lost to Follow-up|0|||
145664243|NCT04084574|525289932|FG000|Overall Study|Physician Decision|1|||
145664244|NCT04084574|525289933|FG001|Overall Study|Physician Decision|0|||
145664245|NCT04084574|525289932|FG000|Overall Study|Relocated out of state|1|||
145664246|NCT04084574|525289933|FG001|Overall Study|Relocated out of state|0|||
145664247|NCT02874742|525289934|FG000|Overall Study|Death|0|||
145664248|NCT02874742|525289935|FG001|Overall Study|Death|1|||
145664249|NCT02874742|525289936|FG002|Overall Study|Death|0|||
145664250|NCT02874742|525289934|FG000|Overall Study|Lost to Follow-up|5|||
145664251|NCT02874742|525289935|FG001|Overall Study|Lost to Follow-up|4|||
145490653|NCT03546621|524650377|FG003|Overall Study|Adverse Event|1|||
145490654|NCT03546621|524650374|FG000|Overall Study|Progressive disease|0|||
145664252|NCT02874742|525289936|FG002|Overall Study|Lost to Follow-up|1|||
145664253|NCT02874742|525289934|FG000|Overall Study|Withdrawal by Subject|17|||
145664254|NCT02874742|525289935|FG001|Overall Study|Withdrawal by Subject|8|||
145664255|NCT02874742|525289936|FG002|Overall Study|Withdrawal by Subject|0|||
145664256|NCT02874742|525289934|FG000|Overall Study|Other|4|||
145664257|NCT02874742|525289935|FG001|Overall Study|Other|1|||
145664258|NCT02874742|525289936|FG002|Overall Study|Other|0|||
145664259|NCT02874742|525289934|FG000|Overall Study|Progressive Disease|1|||
145664260|NCT02874742|525289935|FG001|Overall Study|Progressive Disease|0|||
145664261|NCT02874742|525289936|FG002|Overall Study|Progressive Disease|0|||
145664262|NCT02874742|525289934|FG000|Overall Study|Screen Failure|0|||
145664263|NCT02874742|525289935|FG001|Overall Study|Screen Failure|2|||
145664264|NCT02874742|525289936|FG002|Overall Study|Screen Failure|0|||
145664265|NCT00964392|525289939|FG000|Overall Study|Withdrawal by Subject|4|||
145664266|NCT00964392|525289940|FG001|Overall Study|Withdrawal by Subject|6|||
145664267|NCT00964392|525289939|FG000|Overall Study|Lost to Follow-up|4|||
145664268|NCT00964392|525289940|FG001|Overall Study|Lost to Follow-up|10|||
145664269|NCT00964392|525289939|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
145664270|NCT00964392|525289940|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
145664271|NCT00964392|525289939|FG000|Overall Study|Not completed|44|||
145664272|NCT00964392|525289940|FG001|Overall Study|Not completed|168|||
145664273|NCT02577354|525289943|FG000|Overall Study|Lack of Efficacy|4|||
145664274|NCT02577354|525289944|FG001|Overall Study|Lack of Efficacy|4|||
145664275|NCT02577354|525289943|FG000|Overall Study|Lost to Follow-up|3|||
145664276|NCT02577354|525289944|FG001|Overall Study|Lost to Follow-up|1|||
145664277|NCT02577354|525289943|FG000|Overall Study|Missed Visit|4|||
145664278|NCT02577354|525289944|FG001|Overall Study|Missed Visit|3|||
145664279|NCT02577354|525289943|FG000|Overall Study|Adverse Event|4|||
145664280|NCT02577354|525289944|FG001|Overall Study|Adverse Event|5|||
145664281|NCT04424316|525289947|FG000|Overall Study|Adverse Event|0|||
145664282|NCT04424316|525289948|FG001|Overall Study|Adverse Event|1|||
145664283|NCT04424316|525289949|FG002|Overall Study|Adverse Event|0|||
145664284|NCT04424316|525289950|FG003|Overall Study|Adverse Event|0|||
145664285|NCT04424316|525289947|FG000|Overall Study|Death|1|||
145664286|NCT04424316|525289948|FG001|Overall Study|Death|0|||
145664287|NCT04424316|525289949|FG002|Overall Study|Death|8|||
145664288|NCT04424316|525289950|FG003|Overall Study|Death|14|||
145664289|NCT04424316|525289947|FG000|Overall Study|Lost to Follow-up|93|||
145664290|NCT04424316|525289948|FG001|Overall Study|Lost to Follow-up|88|||
145664291|NCT04424316|525289949|FG002|Overall Study|Lost to Follow-up|224|||
145664292|NCT04424316|525289950|FG003|Overall Study|Lost to Follow-up|211|||
145664293|NCT04424316|525289947|FG000|Overall Study|No longer met eligibility criteria|1|||
145664294|NCT04424316|525289948|FG001|Overall Study|No longer met eligibility criteria|0|||
145664295|NCT04424316|525289949|FG002|Overall Study|No longer met eligibility criteria|0|||
145664296|NCT04424316|525289950|FG003|Overall Study|No longer met eligibility criteria|0|||
145664297|NCT04424316|525289947|FG000|Overall Study|Other|15|||
145664298|NCT04424316|525289948|FG001|Overall Study|Other|11|||
145664299|NCT04424316|525289949|FG002|Overall Study|Other|34|||
145664300|NCT04424316|525289950|FG003|Overall Study|Other|45|||
145664301|NCT04424316|525289947|FG000|Overall Study|Physician Decision|1|||
145664302|NCT04424316|525289948|FG001|Overall Study|Physician Decision|0|||
145664303|NCT04424316|525289949|FG002|Overall Study|Physician Decision|1|||
145664304|NCT04424316|525289950|FG003|Overall Study|Physician Decision|1|||
145664305|NCT04424316|525289947|FG000|Overall Study|Protocol Violation|0|||
145664306|NCT04424316|525289948|FG001|Overall Study|Protocol Violation|1|||
145664307|NCT04424316|525289949|FG002|Overall Study|Protocol Violation|0|||
145664308|NCT04424316|525289950|FG003|Overall Study|Protocol Violation|0|||
145664309|NCT04424316|525289947|FG000|Overall Study|Withdrawal by Subject|71|||
145664310|NCT04424316|525289948|FG001|Overall Study|Withdrawal by Subject|77|||
145664311|NCT04424316|525289949|FG002|Overall Study|Withdrawal by Subject|0|||
145664312|NCT04424316|525289950|FG003|Overall Study|Withdrawal by Subject|0|||
145664313|NCT04424316|525289947|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145664314|NCT04424316|525289948|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145664315|NCT04424316|525289949|FG002|Overall Study|Withdrawal by parent/guardian|74|||
145664316|NCT04424316|525289950|FG003|Overall Study|Withdrawal by parent/guardian|81|||
145664317|NCT04424316|525289947|FG000|Overall Study|Randomized but not vaccinated|13|||
145664318|NCT04424316|525289948|FG001|Overall Study|Randomized but not vaccinated|21|||
145664319|NCT04424316|525289949|FG002|Overall Study|Randomized but not vaccinated|0|||
145664320|NCT04424316|525289950|FG003|Overall Study|Randomized but not vaccinated|0|||
145664321|NCT04424316|525289947|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
145664322|NCT04424316|525289948|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
145664323|NCT04424316|525289949|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
145664324|NCT04424316|525289950|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
145664325|NCT04109066|525289951|FG000|Pre-treatment|Participant withdrew consent|2|||
145664326|NCT04109066|525289952|FG001|Pre-treatment|Participant withdrew consent|0|||
145664327|NCT04109066|525289951|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
145664328|NCT04109066|525289952|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
145664329|NCT04109066|525289951|FG000|Treatment|Lack of Efficacy|2|||
145664330|NCT04109066|525289952|FG001|Treatment|Lack of Efficacy|4|||
145664331|NCT04109066|525289951|FG000|Treatment|Adverse Event|23|||
145664332|NCT04109066|525289952|FG001|Treatment|Adverse Event|7|||
145664333|NCT04109066|525289951|FG000|Treatment|Participant request to discontinue Study treatment|15|||
145664334|NCT04109066|525289952|FG001|Treatment|Participant request to discontinue Study treatment|14|||
145664335|NCT04109066|525289951|FG000|Treatment|Withdrawal by Subject|8|||
145664336|NCT04109066|525289952|FG001|Treatment|Withdrawal by Subject|8|||
145664337|NCT04109066|525289951|FG000|Treatment|Death|3|||
145664338|NCT04109066|525289952|FG001|Treatment|Death|0|||
145664339|NCT04109066|525289951|FG000|Treatment|Participant no longer meets study criteria|2|||
145664340|NCT04109066|525289952|FG001|Treatment|Participant no longer meets study criteria|2|||
145664341|NCT04109066|525289951|FG000|Treatment|Administrative reasons by sponsor|2|||
145664342|NCT04109066|525289952|FG001|Treatment|Administrative reasons by sponsor|3|||
145664343|NCT04109066|525289951|FG000|Treatment|Other reasons|17|||
145664344|NCT04109066|525289952|FG001|Treatment|Other reasons|23|||
145664345|NCT04109066|525289951|FG000|Treatment|Disease Progression|4|||
145664346|NCT04109066|525289952|FG001|Treatment|Disease Progression|7|||
145664347|NCT04109066|525289951|FG000|Treatment|Study drug toxicity|12|||
145664348|NCT04109066|525289952|FG001|Treatment|Study drug toxicity|5|||
145664349|NCT04109066|525289951|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
145664350|NCT04109066|525289952|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
145664351|NCT04109066|525289951|FG000|Treatment|Disease Recurrence|0|||
145664352|NCT04109066|525289952|FG001|Treatment|Disease Recurrence|2|||
145664353|NCT04109066|525289951|FG000|Treatment|Not reported|4|||
145664354|NCT04109066|525289952|FG001|Treatment|Not reported|8|||
145664355|NCT05953740|525289956|FG000|Period 1|Physician Decision|0|||
145664356|NCT05953740|525289957|FG001|Period 1|Physician Decision|1|||
145664357|NCT05953740|525289958|FG002|Period 1|Physician Decision|0|||
145664358|NCT05953740|525289959|FG003|Period 1|Physician Decision|0|||
145664359|NCT05953740|525289960|FG004|Period 1|Physician Decision|0|||
145664360|NCT05953740|525289961|FG005|Period 1|Physician Decision|0|||
145664361|NCT05953740|525289962|FG006|Period 1|Physician Decision|0|||
145664362|NCT05953740|525289963|FG007|Period 1|Physician Decision|0|||
145664363|NCT05953740|525289956|FG000|Period 2|Withdrawal by Subject|0|||
145664364|NCT05953740|525289957|FG001|Period 2|Withdrawal by Subject|1|||
145664365|NCT05953740|525289958|FG002|Period 2|Withdrawal by Subject|1|||
145664366|NCT05953740|525289959|FG003|Period 2|Withdrawal by Subject|0|||
145664367|NCT05953740|525289960|FG004|Period 2|Withdrawal by Subject|0|||
145664368|NCT05953740|525289961|FG005|Period 2|Withdrawal by Subject|0|||
145664369|NCT05953740|525289962|FG006|Period 2|Withdrawal by Subject|0|||
145664370|NCT05953740|525289963|FG007|Period 2|Withdrawal by Subject|0|||
145664371|NCT05890105|525289964|FG000|Overall Study|Adverse Event|1|||
145664372|NCT05890105|525289965|FG001|Overall Study|Adverse Event|0|||
145664373|NCT05890105|525289966|FG002|Overall Study|Adverse Event|0|||
145664374|NCT05890105|525289964|FG000|Overall Study|Other|1|||
145664375|NCT05890105|525289965|FG001|Overall Study|Other|2|||
145664376|NCT05890105|525289966|FG002|Overall Study|Other|0|||
145664377|NCT04505410|525289968|FG000|Overall Study|Adverse Event|2|||
145664378|NCT04505410|525289969|FG001|Overall Study|Adverse Event|0|||
145664379|NCT04505410|525289968|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
145664380|NCT04505410|525289969|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
145664381|NCT04505410|525289968|FG000|Overall Study|did not want to follow diet|1|||
145664382|NCT04505410|525289969|FG001|Overall Study|did not want to follow diet|0|||
145664383|NCT04505410|525289968|FG000|Overall Study|flare up of ulcerative colitis|0|||
145664384|NCT04505410|525289969|FG001|Overall Study|flare up of ulcerative colitis|1|||
145664385|NCT04505410|525289968|FG000|Overall Study|Lost to Follow-up|0|||
145664386|NCT04505410|525289969|FG001|Overall Study|Lost to Follow-up|2|||
145664387|NCT04505410|525289968|FG000|Overall Study|Lost to Follow-up|1|||
145664388|NCT04505410|525289969|FG001|Overall Study|Lost to Follow-up|0|||
145664389|NCT04505410|525289968|FG000|Overall Study|initiated another diet on their own|0|||
145664390|NCT04505410|525289969|FG001|Overall Study|initiated another diet on their own|2|||
145664391|NCT05123027|525289974|FG000|Overall Study|Lost to Follow-up|17|||
145664392|NCT05123027|525289975|FG001|Overall Study|Lost to Follow-up|22|||
145664393|NCT05123027|525289974|FG000|Overall Study|Incarceration|3|||
145664394|NCT05123027|525289975|FG001|Overall Study|Incarceration|4|||
145664395|NCT05123027|525289974|FG000|Overall Study|Death|2|||
145664396|NCT05123027|525289975|FG001|Overall Study|Death|2|||
145664397|NCT05123027|525289974|FG000|Overall Study|Other|2|||
145664398|NCT05123027|525289975|FG001|Overall Study|Other|0|||
145664399|NCT04389957|525291249|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
145664400|NCT04389957|525291250|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
145664401|NCT04389957|525291251|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
145490655|NCT03546621|524650375|FG001|Overall Study|Progressive disease|0|||
145664402|NCT04389957|525291252|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
145664403|NCT04389957|525291253|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
145664404|NCT05405985|525291254|FG000|Overall Study|Withdrawal by Subject|1|||
145664405|NCT05405985|525291255|FG001|Overall Study|Withdrawal by Subject|0|||
145664406|NCT03571386|525291256|FG000|Overall Study|scheduling conflict|4|||
145664407|NCT03571386|525291257|FG001|Overall Study|scheduling conflict|0|||
145664408|NCT03571386|525291256|FG000|Overall Study|Withdrawal by Subject|15|||
145664409|NCT03571386|525291257|FG001|Overall Study|Withdrawal by Subject|5|||
145664410|NCT04451772|525291258|FG000|Overall Study|Adverse Event|1|||
145664411|NCT04451772|525291259|FG001|Overall Study|Adverse Event|0|||
145664412|NCT04451772|525291260|FG002|Overall Study|Adverse Event|1|||
145664413|NCT04451772|525291261|FG003|Overall Study|Adverse Event|1|||
145664414|NCT04451772|525291262|FG004|Overall Study|Adverse Event|0|||
145664415|NCT04451772|525291263|FG005|Overall Study|Adverse Event|3|||
145664416|NCT04451772|525291258|FG000|Overall Study|Withdrawal by Subject|2|||
145664417|NCT04451772|525291259|FG001|Overall Study|Withdrawal by Subject|7|||
145664418|NCT04451772|525291260|FG002|Overall Study|Withdrawal by Subject|2|||
145664419|NCT04451772|525291261|FG003|Overall Study|Withdrawal by Subject|1|||
145664420|NCT04451772|525291262|FG004|Overall Study|Withdrawal by Subject|1|||
145664421|NCT04451772|525291263|FG005|Overall Study|Withdrawal by Subject|0|||
145664422|NCT04451772|525291258|FG000|Overall Study|Other, not specified|1|||
145664423|NCT04451772|525291259|FG001|Overall Study|Other, not specified|2|||
145490656|NCT03546621|524650376|FG002|Overall Study|Progressive disease|0|||
145490657|NCT03546621|524650377|FG003|Overall Study|Progressive disease|1|||
145490658|NCT01091675|524650382|FG000|Overall Study|Adverse Event|7|||
145490659|NCT01091675|524650382|FG000|Overall Study|Lack of Efficacy|27|||
145664424|NCT04451772|525291260|FG002|Overall Study|Other, not specified|1|||
145664425|NCT04451772|525291261|FG003|Overall Study|Other, not specified|0|||
145664426|NCT04451772|525291262|FG004|Overall Study|Other, not specified|0|||
145664427|NCT04451772|525291263|FG005|Overall Study|Other, not specified|1|||
145664428|NCT04451772|525291258|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
145664429|NCT04451772|525291259|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
145664430|NCT04451772|525291260|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
145664431|NCT04451772|525291261|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
145664432|NCT04451772|525291262|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
145664433|NCT04451772|525291263|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
145664434|NCT04311632|525291264|FG000|Overall Study|Withdrawal by Subject|0|||
145664435|NCT04311632|525291265|FG001|Overall Study|Withdrawal by Subject|0|||
145664436|NCT04311632|525291266|FG002|Overall Study|Withdrawal by Subject|1|||
145664437|NCT04632225|525291267|FG000|Overall Study|Withdrawal by Subject|2|||
145664438|NCT04632225|525291268|FG001|Overall Study|Withdrawal by Subject|2|||
145664439|NCT02278211|525291269|FG000|Overall Study|Unable to analyse PET scan|2|||
145664440|NCT03858517|525291270|FG000|Overall Study|Adverse Event|1|||
145664441|NCT03858517|525291270|FG000|Overall Study|Lost to Follow-up|1|||
145664442|NCT03858517|525291270|FG000|Overall Study|removed for being incarcerated|1|||
145664443|NCT03858517|525291270|FG000|Overall Study|Sponsor Closure|48|||
145664444|NCT06037668|525291271|FG000|Overall Study|Lost to Follow-up|1|||
145664445|NCT06037668|525291272|FG001|Overall Study|Lost to Follow-up|1|||
145664446|NCT06037668|525291271|FG000|Overall Study|Protocol Violation|1|||
145664447|NCT06037668|525291272|FG001|Overall Study|Protocol Violation|0|||
145664448|NCT06037668|525291271|FG000|Overall Study|Withdrawal by Subject|1|||
145664449|NCT06037668|525291272|FG001|Overall Study|Withdrawal by Subject|0|||
145664450|NCT06037668|525291271|FG000|Overall Study|Other Study Discontinuation Reason|1|||
145664451|NCT06037668|525291272|FG001|Overall Study|Other Study Discontinuation Reason|0|||
145664452|NCT05224544|525291273|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
145664453|NCT05224544|525291274|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
145664454|NCT04804540|525291275|FG000|Overall Study|Adverse Event|26|||
145664455|NCT04804540|525291276|FG001|Overall Study|Adverse Event|13|||
145664456|NCT05172232|525291277|FG000|Overall Study|Lost to Follow-up|3|||
145664457|NCT01828021|525291278|FG000|Overall Study|Adverse Event|5|||
145664458|NCT01828021|525291278|FG000|Overall Study|Lack of Efficacy|17|||
145664459|NCT01828021|525291278|FG000|Overall Study|Withdrawal by Subject|2|||
145664460|NCT01828021|525291278|FG000|Overall Study|Ileal obstruction, unrelated|1|||
145664461|NCT04881461|525291280|FG000|Overall Study|Adverse Event|2|||
145664462|NCT04881461|525291281|FG001|Overall Study|Adverse Event|4|||
145664463|NCT04881461|525291280|FG000|Overall Study|Withdrawal by Subject|19|||
145664464|NCT04881461|525291281|FG001|Overall Study|Withdrawal by Subject|19|||
145490660|NCT03040141|524650384|FG000|Overall Study|Death|1|||
145490661|NCT03040141|524650385|FG001|Overall Study|Death|2|||
145664465|NCT04881461|525291280|FG000|Overall Study|Lost to Follow-up|4|||
145664466|NCT04881461|525291281|FG001|Overall Study|Lost to Follow-up|4|||
145664467|NCT04881461|525291280|FG000|Overall Study|Lack of Efficacy|1|||
145664468|NCT04881461|525291281|FG001|Overall Study|Lack of Efficacy|0|||
145664469|NCT04881461|525291280|FG000|Overall Study|"Reason stated as other in CRF"|1|||
145664470|NCT04881461|525291281|FG001|Overall Study|"Reason stated as other in CRF"|2|||
145664471|NCT02997202|525291282|FG000|Overall Study|Miscellaneous|2|||
145664472|NCT02997202|525291283|FG001|Overall Study|Miscellaneous|2|||
145664473|NCT02997202|525291282|FG000|Overall Study|Withdrawal by Subject|8|||
145490662|NCT03040141|524650386|FG002|Overall Study|Death|3|||
145490663|NCT03040141|524650384|FG000|Overall Study|Withdrawal by Subject|3|||
145490664|NCT03040141|524650385|FG001|Overall Study|Withdrawal by Subject|1|||
145664474|NCT02997202|525291283|FG001|Overall Study|Withdrawal by Subject|12|||
145664475|NCT02997202|525291282|FG000|Overall Study|Lost to Follow-up|5|||
145664476|NCT02997202|525291283|FG001|Overall Study|Lost to Follow-up|3|||
145664477|NCT02997202|525291282|FG000|Overall Study|Death|41|||
145664478|NCT02997202|525291283|FG001|Overall Study|Death|45|||
145664479|NCT04158739|525291293|FG000|Overall Study|Adverse Event|1|||
145664480|NCT04158739|525291294|FG001|Overall Study|Adverse Event|0|||
145664481|NCT04158739|525291293|FG000|Overall Study|Death|0|||
145664482|NCT04158739|525291294|FG001|Overall Study|Death|1|||
145664483|NCT04158739|525291293|FG000|Overall Study|Lack of Efficacy|3|||
145664484|NCT04158739|525291294|FG001|Overall Study|Lack of Efficacy|7|||
145664485|NCT04158739|525291293|FG000|Overall Study|Physician Decision|0|||
145664486|NCT04158739|525291294|FG001|Overall Study|Physician Decision|1|||
145664487|NCT04158739|525291293|FG000|Overall Study|Withdrawal by Subject|3|||
145664488|NCT04158739|525291294|FG001|Overall Study|Withdrawal by Subject|0|||
145664489|NCT05422885|525291298|FG000|Overall Study|Lost to Follow-up|1|||
145664490|NCT05422885|525291298|FG000|Overall Study|Withdrawal by Subject|2|||
145664491|NCT00942877|525291299|FG000|Overall Study|Refused further treatment|1|||
145664492|NCT00942877|525291300|FG001|Overall Study|Refused further treatment|1|||
145664493|NCT00942877|525291299|FG000|Overall Study|Patient was not treated|1|||
145664494|NCT00942877|525291300|FG001|Overall Study|Patient was not treated|0|||
145664495|NCT00942877|525291299|FG000|Overall Study|Adverse Event|1|||
145664496|NCT00942877|525291300|FG001|Overall Study|Adverse Event|0|||
145664497|NCT00942877|525291299|FG000|Overall Study|Progressive disease|42|||
145664498|NCT00942877|525291300|FG001|Overall Study|Progressive disease|3|||
145664499|NCT01385202|525291301|FG000|Overall Study|Lost to Follow-up|6|||
145664500|NCT01385202|525291301|FG000|Overall Study|Not Eligible|11|||
145664501|NCT01385202|525291301|FG000|Overall Study|Withdrawn|1|||
145664502|NCT04055012|525291302|FG000|Overall Study|Withdrawal by Subject|1|||
145664503|NCT04055012|525291303|FG001|Overall Study|Withdrawal by Subject|3|||
145664504|NCT04055012|525291304|FG002|Overall Study|Withdrawal by Subject|1|||
145664505|NCT04055012|525291305|FG003|Overall Study|Withdrawal by Subject|0|||
145664506|NCT04055012|525291302|FG000|Overall Study|Metformin Recall|1|||
145664507|NCT04055012|525291303|FG001|Overall Study|Metformin Recall|1|||
145664508|NCT04055012|525291304|FG002|Overall Study|Metformin Recall|1|||
145664509|NCT04055012|525291305|FG003|Overall Study|Metformin Recall|0|||
145664510|NCT03652272|525291308|FG000|3 Month|Withdrawal by Subject|1|||
145664511|NCT03652272|525291309|FG001|3 Month|Withdrawal by Subject|1|||
145664512|NCT03652272|525291308|FG000|3 Month|Lost to Follow-up|16|||
145664513|NCT03652272|525291309|FG001|3 Month|Lost to Follow-up|14|||
145664514|NCT02326974|525291310|FG000|Overall Study|Withdrawal by Subject|2|||
145664515|NCT02326974|525291310|FG000|Overall Study|failed heterogenity evaluation|5|||
145664516|NCT04924400|525291317|FG000|Overall Study|Lost to Follow-up|3|||
145664517|NCT04924400|525291318|FG001|Overall Study|Lost to Follow-up|0|||
145664518|NCT05070741|525291319|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
145664519|NCT03582033|525291320|FG000|Part A|Other|0|||
145664520|NCT03582033|525291321|FG001|Part A|Other|0|||
145664521|NCT03582033|525291322|FG002|Part A|Other|0|||
145664522|NCT03582033|525291323|FG003|Part A|Other|0|||
145664523|NCT03582033|525291324|FG004|Part A|Other|2|||
145664524|NCT03582033|525291325|FG005|Part A|Other|0|||
145664525|NCT03582033|525291326|FG006|Part A|Other|0|||
145664526|NCT03582033|525291327|FG007|Part A|Other|0|||
145664527|NCT03582033|525291328|FG008|Part A|Other|0|||
145664528|NCT03582033|525291329|FG009|Part A|Other|0|||
145664529|NCT03582033|525291320|FG000|Part A|Death|1|||
145664530|NCT03582033|525291321|FG001|Part A|Death|1|||
145664531|NCT03582033|525291322|FG002|Part A|Death|2|||
145664532|NCT03582033|525291323|FG003|Part A|Death|4|||
145664533|NCT03582033|525291324|FG004|Part A|Death|11|||
145664534|NCT03582033|525291325|FG005|Part A|Death|0|||
145664535|NCT03582033|525291326|FG006|Part A|Death|0|||
145664536|NCT03582033|525291327|FG007|Part A|Death|0|||
145664537|NCT03582033|525291328|FG008|Part A|Death|0|||
145664538|NCT03582033|525291329|FG009|Part A|Death|0|||
145490665|NCT03040141|524650386|FG002|Overall Study|Withdrawal by Subject|1|||
145664539|NCT03582033|525291320|FG000|Part A|Lost to Follow-up|0|||
145664540|NCT03582033|525291321|FG001|Part A|Lost to Follow-up|0|||
145664541|NCT03582033|525291322|FG002|Part A|Lost to Follow-up|0|||
145664542|NCT03582033|525291323|FG003|Part A|Lost to Follow-up|0|||
145664543|NCT03582033|525291324|FG004|Part A|Lost to Follow-up|1|||
145664544|NCT03582033|525291325|FG005|Part A|Lost to Follow-up|0|||
145664545|NCT03582033|525291326|FG006|Part A|Lost to Follow-up|0|||
145664546|NCT03582033|525291327|FG007|Part A|Lost to Follow-up|0|||
145664547|NCT03582033|525291328|FG008|Part A|Lost to Follow-up|0|||
145664548|NCT03582033|525291329|FG009|Part A|Lost to Follow-up|0|||
145664549|NCT03582033|525291320|FG000|Part A|Study terminated by sponsor|0|||
145490666|NCT03040141|524650384|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
145664550|NCT03582033|525291321|FG001|Part A|Study terminated by sponsor|0|||
145664551|NCT03582033|525291322|FG002|Part A|Study terminated by sponsor|0|||
145664552|NCT03582033|525291323|FG003|Part A|Study terminated by sponsor|2|||
145664553|NCT03582033|525291324|FG004|Part A|Study terminated by sponsor|1|||
145664554|NCT03582033|525291325|FG005|Part A|Study terminated by sponsor|0|||
145664555|NCT03582033|525291326|FG006|Part A|Study terminated by sponsor|0|||
145664556|NCT03582033|525291327|FG007|Part A|Study terminated by sponsor|0|||
145664557|NCT03582033|525291328|FG008|Part A|Study terminated by sponsor|0|||
145664558|NCT03582033|525291329|FG009|Part A|Study terminated by sponsor|0|||
145664559|NCT03582033|525291320|FG000|Part A|Withdrawal by Subject|1|||
145664560|NCT03582033|525291321|FG001|Part A|Withdrawal by Subject|1|||
145664561|NCT03582033|525291322|FG002|Part A|Withdrawal by Subject|0|||
145664562|NCT03582033|525291323|FG003|Part A|Withdrawal by Subject|1|||
145664563|NCT03582033|525291324|FG004|Part A|Withdrawal by Subject|7|||
145664564|NCT03582033|525291325|FG005|Part A|Withdrawal by Subject|0|||
145664565|NCT03582033|525291326|FG006|Part A|Withdrawal by Subject|0|||
145664566|NCT03582033|525291327|FG007|Part A|Withdrawal by Subject|0|||
145664567|NCT03582033|525291328|FG008|Part A|Withdrawal by Subject|0|||
145664568|NCT03582033|525291329|FG009|Part A|Withdrawal by Subject|0|||
145664569|NCT03582033|525291320|FG000|Part B|Death|0|||
145664570|NCT03582033|525291321|FG001|Part B|Death|0|||
145664571|NCT03582033|525291322|FG002|Part B|Death|0|||
145664572|NCT03582033|525291323|FG003|Part B|Death|0|||
145664573|NCT03582033|525291324|FG004|Part B|Death|0|||
145664574|NCT03582033|525291325|FG005|Part B|Death|2|||
145664575|NCT03582033|525291326|FG006|Part B|Death|0|||
145664576|NCT03582033|525291327|FG007|Part B|Death|0|||
145664577|NCT03582033|525291328|FG008|Part B|Death|0|||
145664578|NCT03582033|525291329|FG009|Part B|Death|0|||
145664579|NCT03582033|525291320|FG000|Part B|Study terminated by sponsor|0|||
145664580|NCT03582033|525291321|FG001|Part B|Study terminated by sponsor|0|||
145664581|NCT03582033|525291322|FG002|Part B|Study terminated by sponsor|0|||
145664582|NCT03582033|525291323|FG003|Part B|Study terminated by sponsor|0|||
145664583|NCT03582033|525291324|FG004|Part B|Study terminated by sponsor|0|||
145664584|NCT03582033|525291325|FG005|Part B|Study terminated by sponsor|12|||
145664585|NCT03582033|525291326|FG006|Part B|Study terminated by sponsor|0|||
145664586|NCT03582033|525291327|FG007|Part B|Study terminated by sponsor|0|||
145664587|NCT03582033|525291328|FG008|Part B|Study terminated by sponsor|0|||
145664588|NCT03582033|525291329|FG009|Part B|Study terminated by sponsor|0|||
145664589|NCT03582033|525291320|FG000|Part B|Withdrawal by Subject|0|||
145664590|NCT03582033|525291321|FG001|Part B|Withdrawal by Subject|0|||
145664591|NCT03582033|525291322|FG002|Part B|Withdrawal by Subject|0|||
145664592|NCT03582033|525291323|FG003|Part B|Withdrawal by Subject|0|||
145664593|NCT03582033|525291324|FG004|Part B|Withdrawal by Subject|0|||
145664594|NCT03582033|525291325|FG005|Part B|Withdrawal by Subject|6|||
145664595|NCT03582033|525291326|FG006|Part B|Withdrawal by Subject|0|||
145664596|NCT03582033|525291327|FG007|Part B|Withdrawal by Subject|0|||
145664597|NCT03582033|525291328|FG008|Part B|Withdrawal by Subject|0|||
145664598|NCT03582033|525291329|FG009|Part B|Withdrawal by Subject|0|||
145664599|NCT03582033|525291320|FG000|Part C|Other|0|||
145664600|NCT03582033|525291321|FG001|Part C|Other|0|||
145664601|NCT03582033|525291322|FG002|Part C|Other|0|||
145664602|NCT03582033|525291323|FG003|Part C|Other|0|||
145664603|NCT03582033|525291324|FG004|Part C|Other|0|||
145664604|NCT03582033|525291325|FG005|Part C|Other|0|||
145664605|NCT03582033|525291326|FG006|Part C|Other|2|||
145664606|NCT03582033|525291327|FG007|Part C|Other|0|||
145664607|NCT03582033|525291328|FG008|Part C|Other|0|||
145664608|NCT03582033|525291329|FG009|Part C|Other|0|||
145664609|NCT03582033|525291320|FG000|Part C|Death|0|||
145664610|NCT03582033|525291321|FG001|Part C|Death|0|||
145664611|NCT03582033|525291322|FG002|Part C|Death|0|||
145664612|NCT03582033|525291323|FG003|Part C|Death|0|||
145664613|NCT03582033|525291324|FG004|Part C|Death|0|||
145664614|NCT03582033|525291325|FG005|Part C|Death|0|||
145664615|NCT03582033|525291326|FG006|Part C|Death|6|||
145664616|NCT03582033|525291327|FG007|Part C|Death|1|||
145664617|NCT03582033|525291328|FG008|Part C|Death|2|||
145664618|NCT03582033|525291329|FG009|Part C|Death|0|||
145664619|NCT03582033|525291320|FG000|Part C|Study terminated by sponsor|0|||
145664620|NCT03582033|525291321|FG001|Part C|Study terminated by sponsor|0|||
145490667|NCT03040141|524650385|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
145664621|NCT03582033|525291322|FG002|Part C|Study terminated by sponsor|0|||
145664622|NCT03582033|525291323|FG003|Part C|Study terminated by sponsor|0|||
145664623|NCT03582033|525291324|FG004|Part C|Study terminated by sponsor|0|||
145664624|NCT03582033|525291325|FG005|Part C|Study terminated by sponsor|0|||
145664625|NCT03582033|525291326|FG006|Part C|Study terminated by sponsor|3|||
145664626|NCT03582033|525291327|FG007|Part C|Study terminated by sponsor|3|||
145664627|NCT03582033|525291328|FG008|Part C|Study terminated by sponsor|2|||
145664628|NCT03582033|525291329|FG009|Part C|Study terminated by sponsor|0|||
145664629|NCT03582033|525291320|FG000|Part C|Withdrawal by Subject|0|||
145664630|NCT03582033|525291321|FG001|Part C|Withdrawal by Subject|0|||
145664631|NCT03582033|525291322|FG002|Part C|Withdrawal by Subject|0|||
145664632|NCT03582033|525291323|FG003|Part C|Withdrawal by Subject|0|||
145664633|NCT03582033|525291324|FG004|Part C|Withdrawal by Subject|0|||
145664634|NCT03582033|525291325|FG005|Part C|Withdrawal by Subject|0|||
145664635|NCT03582033|525291326|FG006|Part C|Withdrawal by Subject|1|||
145664636|NCT03582033|525291327|FG007|Part C|Withdrawal by Subject|2|||
145664637|NCT03582033|525291328|FG008|Part C|Withdrawal by Subject|1|||
145664638|NCT03582033|525291329|FG009|Part C|Withdrawal by Subject|0|||
145664639|NCT03582033|525291320|FG000|Part D|Death|0|||
145664640|NCT03582033|525291321|FG001|Part D|Death|0|||
145664641|NCT03582033|525291322|FG002|Part D|Death|0|||
145664642|NCT03582033|525291323|FG003|Part D|Death|0|||
145664643|NCT03582033|525291324|FG004|Part D|Death|0|||
145664644|NCT03582033|525291325|FG005|Part D|Death|0|||
145664645|NCT03582033|525291326|FG006|Part D|Death|0|||
145664646|NCT03582033|525291327|FG007|Part D|Death|0|||
145664647|NCT03582033|525291328|FG008|Part D|Death|0|||
145664648|NCT03582033|525291329|FG009|Part D|Death|1|||
145664649|NCT03582033|525291320|FG000|Part D|Study terminated by sponsor|0|||
145664650|NCT03582033|525291321|FG001|Part D|Study terminated by sponsor|0|||
145664651|NCT03582033|525291322|FG002|Part D|Study terminated by sponsor|0|||
145664652|NCT03582033|525291323|FG003|Part D|Study terminated by sponsor|0|||
145664653|NCT03582033|525291324|FG004|Part D|Study terminated by sponsor|0|||
145664654|NCT03582033|525291325|FG005|Part D|Study terminated by sponsor|0|||
145664655|NCT03582033|525291326|FG006|Part D|Study terminated by sponsor|0|||
145664656|NCT03582033|525291327|FG007|Part D|Study terminated by sponsor|0|||
145664657|NCT03582033|525291328|FG008|Part D|Study terminated by sponsor|0|||
145664658|NCT03582033|525291329|FG009|Part D|Study terminated by sponsor|4|||
145664659|NCT06010836|525291330|FG000|Overall Study|Lost to Follow-up|2|||
145664660|NCT06010836|525291331|FG001|Overall Study|Lost to Follow-up|2|||
145664661|NCT06010836|525291330|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
145664662|NCT06010836|525291331|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
145664663|NCT06010836|525291330|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
145664664|NCT06010836|525291331|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
145664665|NCT06010836|525291330|FG000|Overall Study|Did not receive intervention discussion|0|||
145664666|NCT06010836|525291331|FG001|Overall Study|Did not receive intervention discussion|4|||
145664667|NCT05205161|525291332|FG000|Overall Study|Study terminated by sponsor|3|||
145664668|NCT05205161|525291333|FG001|Overall Study|Study terminated by sponsor|3|||
145664669|NCT05205161|525291334|FG002|Overall Study|Study terminated by sponsor|1|||
145664670|NCT05652010|525291335|FG000|First Intervention|Withdrawal by Subject|0|||
145664671|NCT05652010|525291336|FG001|First Intervention|Withdrawal by Subject|1|||
145664672|NCT05652010|525291335|FG000|Second Intervention|Withdrawal by Subject|1|||
145664673|NCT05652010|525291336|FG001|Second Intervention|Withdrawal by Subject|0|||
145664674|NCT02510235|525291341|FG000|Overall Study|Withdrawal by Subject|1|||
145664675|NCT02510235|525291342|FG001|Overall Study|Withdrawal by Subject|0|||
145664676|NCT04206787|525291343|FG000|Overall Study|Other than listed|2|||
145664677|NCT04206787|525291343|FG000|Overall Study|Investigator decision|1|||
145664678|NCT04206787|525291343|FG000|Overall Study|Death|25|||
145664679|NCT04206787|525291343|FG000|Overall Study|Lost to Follow-up|9|||
145664680|NCT04206787|525291343|FG000|Overall Study|Withdrawal of consent|9|||
145664681|NCT00319111|525291349|FG000|Overall Study|Adverse Event|20|||
145664682|NCT00319111|525291349|FG000|Overall Study|Withdrawal of consent|11|||
145664683|NCT00319111|525291349|FG000|Overall Study|Death|9|||
145664684|NCT00319111|525291349|FG000|Overall Study|Lack of clinical improvement|4|||
145664685|NCT00319111|525291349|FG000|Overall Study|Administrative|2|||
145664686|NCT00319111|525291349|FG000|Overall Study|Treatment failure|1|||
145664687|NCT03165955|525291350|FG000|Treatment|Withdrawal by Subject|3|||
145664688|NCT03165955|525291350|FG000|Treatment|Death|1|||
145664689|NCT03165955|525291350|FG000|Treatment|Adverse Event|1|||
145664690|NCT03165955|525291350|FG000|Treatment|Progressive disease|3|||
145664691|NCT05525104|525291353|FG000|Overall Study|Failed caudal analgesia|1|||
145664692|NCT05525104|525291354|FG001|Overall Study|Failed caudal analgesia|3|||
145664693|NCT05525104|525291353|FG000|Overall Study|Premedication needed|0|||
145664694|NCT05525104|525291354|FG001|Overall Study|Premedication needed|1|||
145664695|NCT05525104|525291353|FG000|Overall Study|Protocol Violation|10|||
145664696|NCT05525104|525291354|FG001|Overall Study|Protocol Violation|0|||
145664697|NCT05525104|525291353|FG000|Overall Study|Cancelled operation|1|||
145664698|NCT05525104|525291354|FG001|Overall Study|Cancelled operation|0|||
145664699|NCT02039401|525291355|FG000|Overall Study|Adverse Event|0|||
145664700|NCT02039401|525291356|FG001|Overall Study|Adverse Event|1|||
145664701|NCT02865538|525291357|FG000|Overall Study|Withdrawal by Subject|0|||
145490668|NCT03040141|524650386|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
145490669|NCT03040141|524650384|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
145490670|NCT03040141|524650385|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
145664702|NCT02865538|525291358|FG001|Overall Study|Withdrawal by Subject|0|||
145664703|NCT02865538|525291359|FG002|Overall Study|Withdrawal by Subject|1|||
145664704|NCT02865538|525291360|FG003|Overall Study|Withdrawal by Subject|0|||
145664705|NCT02865538|525291361|FG004|Overall Study|Withdrawal by Subject|0|||
145664706|NCT02865538|525291357|FG000|Overall Study|Lost to Follow-up|1|||
145664707|NCT02865538|525291358|FG001|Overall Study|Lost to Follow-up|0|||
145664708|NCT02865538|525291359|FG002|Overall Study|Lost to Follow-up|0|||
145664709|NCT02865538|525291360|FG003|Overall Study|Lost to Follow-up|0|||
145664710|NCT02865538|525291361|FG004|Overall Study|Lost to Follow-up|0|||
145664711|NCT04678856|525291362|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
145664712|NCT04678856|525291363|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
145664713|NCT04678856|525291362|FG000|Overall Study|Withdrawal by Subject|5|||
145664714|NCT04678856|525291363|FG001|Overall Study|Withdrawal by Subject|1|||
145664715|NCT03681262|525292457|FG000|Overall Study|Continuing on study|3|||
145664716|NCT03681262|525292458|FG001|Overall Study|Continuing on study|3|||
145664717|NCT03681262|525292457|FG000|Overall Study|Lost to Follow-up|1|||
145664718|NCT03681262|525292458|FG001|Overall Study|Lost to Follow-up|0|||
145664719|NCT02782676|525292460|FG000|Overall Study|Lost to Follow-up|0|||
145664720|NCT02782676|525292461|FG001|Overall Study|Lost to Follow-up|1|||
145664721|NCT04214834|525292464|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
145664722|NCT04214834|525292465|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
145664723|NCT03812614|525292472|FG000|Intervention|Withdrawal by Subject|7|||
145664724|NCT03812614|525292473|FG001|Intervention|Withdrawal by Subject|2|||
145664725|NCT03812614|525292474|FG002|Intervention|Withdrawal by Subject|7|||
145664726|NCT03812614|525292475|FG003|Intervention|Withdrawal by Subject|2|||
145664727|NCT03812614|525292472|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
145664728|NCT03812614|525292473|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
145664729|NCT03812614|525292474|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
145664730|NCT03812614|525292475|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
145664731|NCT03812614|525292472|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
145664732|NCT03812614|525292473|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
145664733|NCT03812614|525292474|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
145664734|NCT03812614|525292475|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
145664735|NCT03812614|525292472|FG000|6-month Follow-up|Lost to Follow-up|0|||
145664736|NCT03812614|525292473|FG001|6-month Follow-up|Lost to Follow-up|0|||
145664737|NCT03812614|525292474|FG002|6-month Follow-up|Lost to Follow-up|12|||
145664738|NCT03812614|525292475|FG003|6-month Follow-up|Lost to Follow-up|8|||
145664739|NCT03812614|525292472|FG000|12-month Follow-up|Lost to Follow-up|18|||
145664740|NCT03812614|525292473|FG001|12-month Follow-up|Lost to Follow-up|17|||
145664741|NCT03812614|525292474|FG002|12-month Follow-up|Lost to Follow-up|5|||
145664742|NCT03812614|525292475|FG003|12-month Follow-up|Lost to Follow-up|2|||
145664743|NCT05451693|525292477|FG000|Overall Study|Withdrawal by Subject|1|||
145664744|NCT05451693|525292478|FG001|Overall Study|Withdrawal by Subject|1|||
145664745|NCT05741294|525292479|FG000|Overall Study|Lost to Follow-up|3|||
145664746|NCT05741294|525292479|FG000|Overall Study|Protocol deviation|3|||
145664747|NCT05741294|525292479|FG000|Overall Study|Withdrawal by Subject|1|||
145664748|NCT04707768|525292494|FG000|Overall Study|Adverse Event|9|||
145664749|NCT04707768|525292495|FG001|Overall Study|Adverse Event|18|||
145664750|NCT04707768|525292496|FG002|Overall Study|Adverse Event|3|||
145664751|NCT04707768|525292494|FG000|Overall Study|Investigator's Discretion|8|||
145664752|NCT04707768|525292495|FG001|Overall Study|Investigator's Discretion|4|||
145664753|NCT04707768|525292496|FG002|Overall Study|Investigator's Discretion|3|||
145664754|NCT04707768|525292494|FG000|Overall Study|Withdrawal by Subject|6|||
145664755|NCT04707768|525292495|FG001|Overall Study|Withdrawal by Subject|8|||
145664756|NCT04707768|525292496|FG002|Overall Study|Withdrawal by Subject|2|||
145664757|NCT04707768|525292494|FG000|Overall Study|Lack of Efficacy|1|||
145664758|NCT04707768|525292495|FG001|Overall Study|Lack of Efficacy|3|||
145664759|NCT04707768|525292496|FG002|Overall Study|Lack of Efficacy|0|||
145664760|NCT04707768|525292494|FG000|Overall Study|Lost to Follow-up|0|||
145664761|NCT04707768|525292495|FG001|Overall Study|Lost to Follow-up|0|||
145664762|NCT04707768|525292496|FG002|Overall Study|Lost to Follow-up|3|||
145664763|NCT04707768|525292494|FG000|Overall Study|Death|13|||
145664764|NCT04707768|525292495|FG001|Overall Study|Death|11|||
145664765|NCT04707768|525292496|FG002|Overall Study|Death|13|||
145664766|NCT04707768|525292494|FG000|Overall Study|Protocol Violation|2|||
145664767|NCT04707768|525292495|FG001|Overall Study|Protocol Violation|1|||
145664768|NCT04707768|525292496|FG002|Overall Study|Protocol Violation|0|||
145664769|NCT04707768|525292494|FG000|Overall Study|Non Compliance with Study Drug|1|||
145664770|NCT04707768|525292495|FG001|Overall Study|Non Compliance with Study Drug|0|||
145664771|NCT04707768|525292496|FG002|Overall Study|Non Compliance with Study Drug|0|||
145664772|NCT04707768|525292494|FG000|Overall Study|Transplant|4|||
145664773|NCT04707768|525292495|FG001|Overall Study|Transplant|4|||
145664774|NCT04707768|525292496|FG002|Overall Study|Transplant|8|||
145664775|NCT04707768|525292494|FG000|Overall Study|Other|9|||
145664776|NCT04707768|525292495|FG001|Overall Study|Other|5|||
145664777|NCT04707768|525292496|FG002|Overall Study|Other|2|||
145664778|NCT04163991|525292497|FG000|Overall Study|Adverse Event|0|||
145664779|NCT04163991|525292498|FG001|Overall Study|Adverse Event|0|||
145664780|NCT04163991|525292499|FG002|Overall Study|Adverse Event|0|||
145664781|NCT04163991|525292500|FG003|Overall Study|Adverse Event|1|||
145664782|NCT04163991|525292501|FG004|Overall Study|Adverse Event|0|||
145664783|NCT04163991|525292497|FG000|Overall Study|Death|0|||
145664784|NCT04163991|525292498|FG001|Overall Study|Death|0|||
145664785|NCT04163991|525292499|FG002|Overall Study|Death|1|||
145664786|NCT04163991|525292500|FG003|Overall Study|Death|0|||
145664787|NCT04163991|525292501|FG004|Overall Study|Death|0|||
145664788|NCT04163991|525292497|FG000|Overall Study|Lost to Follow-up|0|||
145664789|NCT04163991|525292498|FG001|Overall Study|Lost to Follow-up|1|||
145664790|NCT04163991|525292499|FG002|Overall Study|Lost to Follow-up|0|||
145664791|NCT04163991|525292500|FG003|Overall Study|Lost to Follow-up|0|||
145664792|NCT04163991|525292501|FG004|Overall Study|Lost to Follow-up|0|||
145664793|NCT04163991|525292497|FG000|Overall Study|Withdrawal by Subject|1|||
145664794|NCT04163991|525292498|FG001|Overall Study|Withdrawal by Subject|1|||
145664795|NCT04163991|525292499|FG002|Overall Study|Withdrawal by Subject|3|||
145664796|NCT04163991|525292500|FG003|Overall Study|Withdrawal by Subject|1|||
145664797|NCT04163991|525292501|FG004|Overall Study|Withdrawal by Subject|1|||
145664798|NCT04163991|525292497|FG000|Overall Study|Other, Not Specified|0|||
145664799|NCT04163991|525292498|FG001|Overall Study|Other, Not Specified|1|||
145664800|NCT04163991|525292499|FG002|Overall Study|Other, Not Specified|1|||
145664801|NCT04163991|525292500|FG003|Overall Study|Other, Not Specified|1|||
145664802|NCT04163991|525292501|FG004|Overall Study|Other, Not Specified|0|||
145664803|NCT03372057|525292502|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
145664804|NCT03372057|525292503|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
145664805|NCT03372057|525292504|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
145664806|NCT03372057|525292502|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
145664807|NCT03372057|525292503|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
145664808|NCT03372057|525292504|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
145664809|NCT03372057|525292502|FG000|Dose Optimization Phase|Death|16|||
145664810|NCT03372057|525292503|FG001|Dose Optimization Phase|Death|11|||
145664811|NCT03372057|525292504|FG002|Dose Optimization Phase|Death|0|||
145664812|NCT03372057|525292502|FG000|Expansion Phase|Withdrawal by Subject|0|||
145664813|NCT03372057|525292503|FG001|Expansion Phase|Withdrawal by Subject|0|||
145664814|NCT03372057|525292504|FG002|Expansion Phase|Withdrawal by Subject|4|||
145664815|NCT03372057|525292502|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
145664816|NCT03372057|525292503|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
145664817|NCT03372057|525292504|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
145664818|NCT03372057|525292502|FG000|Expansion Phase|Death|0|||
145664819|NCT03372057|525292503|FG001|Expansion Phase|Death|0|||
145664820|NCT03372057|525292504|FG002|Expansion Phase|Death|78|||
145664821|NCT03372057|525292502|FG000|Expansion Phase|Progressive Disease|0|||
145664822|NCT03372057|525292503|FG001|Expansion Phase|Progressive Disease|0|||
145664823|NCT03372057|525292504|FG002|Expansion Phase|Progressive Disease|1|||
145664824|NCT03372057|525292502|FG000|Expansion Phase|Adverse Event|0|||
145664825|NCT03372057|525292503|FG001|Expansion Phase|Adverse Event|0|||
145664826|NCT03372057|525292504|FG002|Expansion Phase|Adverse Event|1|||
145664827|NCT03880955|525292505|FG000|Overall Study|Adverse Event|1|||
145664828|NCT03880955|525292505|FG000|Overall Study|Death|1|||
145664829|NCT03880955|525292505|FG000|Overall Study|Lost to Follow-up|12|||
145664830|NCT03880955|525292505|FG000|Overall Study|Withdrawal by Subject|4|||
145664831|NCT03880955|525292505|FG000|Overall Study|Missing- Study Site Closed|27|||
145664832|NCT03817983|525292506|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
145664833|NCT03817983|525292507|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
145664834|NCT03817983|525292508|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
145664835|NCT03744676|525292509|FG000|Pre-Treatment Phase|Disease related complications|2|||
145664836|NCT03744676|525292509|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
145664837|NCT03744676|525292509|FG000|Pre-Treatment Phase|Death|7|||
145664838|NCT03744676|525292509|FG000|Pre-Treatment Phase|Other Reasons|7|||
145664839|NCT03744676|525292509|FG000|Treatment Phase|Participant withdrew consent|8|||
145664840|NCT03744676|525292509|FG000|Treatment Phase|Death|33|||
145664841|NCT03744676|525292509|FG000|Treatment Phase|other reasons|6|||
145664842|NCT04078152|525292510|FG000|Overall Study|Other|83|||
145664843|NCT04078152|525292511|FG001|Overall Study|Other|22|||
145664844|NCT04078152|525292512|FG002|Overall Study|Other|25|||
145664845|NCT04078152|525292510|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
145664846|NCT04078152|525292511|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
145664847|NCT04078152|525292512|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
145664848|NCT04078152|525292510|FG000|Overall Study|Withdrawal by Subject|5|||
145664849|NCT04078152|525292511|FG001|Overall Study|Withdrawal by Subject|0|||
145664850|NCT04078152|525292512|FG002|Overall Study|Withdrawal by Subject|1|||
145664851|NCT04078152|525292510|FG000|Overall Study|Death|10|||
145664852|NCT04078152|525292511|FG001|Overall Study|Death|2|||
145664853|NCT04078152|525292512|FG002|Overall Study|Death|12|||
145664854|NCT04078152|525292510|FG000|Overall Study|Adverse Event|1|||
145664855|NCT04078152|525292511|FG001|Overall Study|Adverse Event|0|||
145664856|NCT04078152|525292512|FG002|Overall Study|Adverse Event|0|||
145664857|NCT00450216|525292514|FG000|Overall Study|Adverse Event|38|||
145664858|NCT00450216|525292515|FG001|Overall Study|Adverse Event|23|||
145664859|NCT00450216|525292514|FG000|Overall Study|Withdrawal by Subject|48|||
145664860|NCT00450216|525292515|FG001|Overall Study|Withdrawal by Subject|26|||
145664861|NCT00450216|525292514|FG000|Overall Study|Lost to Follow-up|16|||
145664862|NCT00450216|525292515|FG001|Overall Study|Lost to Follow-up|9|||
145664863|NCT00450216|525292514|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
145664864|NCT00450216|525292515|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
145664865|NCT00450216|525292514|FG000|Overall Study|misc|21|||
145664866|NCT00450216|525292515|FG001|Overall Study|misc|20|||
145664867|NCT05008055|525292516|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
145664868|NCT05008055|525292517|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
145664869|NCT05008055|525292518|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
145664870|NCT03011034|525292523|FG000|Overall Study|Adverse Event|1|||
145664871|NCT03011034|525292524|FG001|Overall Study|Adverse Event|0|||
145664872|NCT03735979|525292525|FG000|Overall Study|Lost to Follow-up|1|||
145664873|NCT03735979|525292526|FG001|Overall Study|Lost to Follow-up|12|||
145664874|NCT03735979|525292527|FG002|Overall Study|Lost to Follow-up|14|||
145664875|NCT03735979|525292525|FG000|Overall Study|Withdrawal by Subject|1|||
145664876|NCT03735979|525292526|FG001|Overall Study|Withdrawal by Subject|5|||
145664877|NCT03735979|525292527|FG002|Overall Study|Withdrawal by Subject|2|||
145664878|NCT03735979|525292525|FG000|Overall Study|Not due to the above reasons|1|||
145664879|NCT03735979|525292526|FG001|Overall Study|Not due to the above reasons|0|||
145664880|NCT03735979|525292527|FG002|Overall Study|Not due to the above reasons|0|||
145664881|NCT05112900|525292528|FG000|Overall Study|Withdrawal by Subject|960|||
145664882|NCT05112900|525292529|FG001|Overall Study|Withdrawal by Subject|921|||
145664883|NCT05112900|525292530|FG002|Overall Study|Withdrawal by Subject|968|||
145664884|NCT01438853|525292533|FG000|Overall Study|Death|0|||
145664885|NCT01438853|525292534|FG001|Overall Study|Death|0|||
145664886|NCT01438853|525292535|FG002|Overall Study|Death|0|||
145664887|NCT01438853|525292536|FG003|Overall Study|Death|1|||
145664888|NCT01438853|525292533|FG000|Overall Study|Withdrawal by Subject|0|||
145664889|NCT01438853|525292534|FG001|Overall Study|Withdrawal by Subject|0|||
145664890|NCT01438853|525292535|FG002|Overall Study|Withdrawal by Subject|1|||
145664891|NCT01438853|525292536|FG003|Overall Study|Withdrawal by Subject|0|||
145664892|NCT02919917|525292537|FG000|Overall Study|Withdrawal by Subject|4|||
145664893|NCT02919917|525292538|FG001|Overall Study|Withdrawal by Subject|8|||
145664894|NCT04743973|525292540|FG000|Overall Study|Withdrawal by Subject|5|||
145664895|NCT04761198|525292542|FG000|Overall Study|Progressive Disease|1|||
145664896|NCT04761198|525292543|FG001|Overall Study|Progressive Disease|0|||
145664897|NCT04761198|525292544|FG002|Overall Study|Progressive Disease|0|||
145664898|NCT04761198|525292545|FG003|Overall Study|Progressive Disease|1|||
145664899|NCT04761198|525292546|FG004|Overall Study|Progressive Disease|4|||
145664900|NCT04761198|525292547|FG005|Overall Study|Progressive Disease|1|||
145664901|NCT04761198|525292548|FG006|Overall Study|Progressive Disease|2|||
145664902|NCT04761198|525292542|FG000|Overall Study|Protocol Violation|0|||
145664903|NCT04761198|525292543|FG001|Overall Study|Protocol Violation|0|||
145664904|NCT04761198|525292544|FG002|Overall Study|Protocol Violation|0|||
145490671|NCT03040141|524650386|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
145490672|NCT03318549|524650387|FG000|Overall Study|Withdrawal by Subject|5|||
145490673|NCT03318549|524650388|FG001|Overall Study|Withdrawal by Subject|19|||
145490674|NCT03318549|524650389|FG002|Overall Study|Withdrawal by Subject|2|||
145490675|NCT03318549|524650390|FG003|Overall Study|Withdrawal by Subject|0|||
145490676|NCT03318549|524650391|FG004|Overall Study|Withdrawal by Subject|0|||
145490677|NCT03318549|524650392|FG005|Overall Study|Withdrawal by Subject|0|||
145490678|NCT03318549|524650393|FG006|Overall Study|Withdrawal by Subject|0|||
145490679|NCT03318549|524650387|FG000|Overall Study|Physician Decision|0|||
145490680|NCT03318549|524650388|FG001|Overall Study|Physician Decision|4|||
145490681|NCT03318549|524650389|FG002|Overall Study|Physician Decision|1|||
145490682|NCT03318549|524650390|FG003|Overall Study|Physician Decision|0|||
145490683|NCT03318549|524650391|FG004|Overall Study|Physician Decision|0|||
145490684|NCT03318549|524650392|FG005|Overall Study|Physician Decision|0|||
145490685|NCT03318549|524650393|FG006|Overall Study|Physician Decision|0|||
145490686|NCT03318549|524650387|FG000|Overall Study|Lost to Follow-up|0|||
145490687|NCT03318549|524650388|FG001|Overall Study|Lost to Follow-up|3|||
145490688|NCT03318549|524650389|FG002|Overall Study|Lost to Follow-up|3|||
145490689|NCT03318549|524650390|FG003|Overall Study|Lost to Follow-up|0|||
145490690|NCT03318549|524650391|FG004|Overall Study|Lost to Follow-up|0|||
145490691|NCT03318549|524650392|FG005|Overall Study|Lost to Follow-up|0|||
145490692|NCT03318549|524650393|FG006|Overall Study|Lost to Follow-up|0|||
145490693|NCT00539994|524650394|FG000|Overall Study|Lost to Follow-up|2|||
145490694|NCT00539994|524650395|FG001|Overall Study|Lost to Follow-up|1|||
145490695|NCT00539994|524650396|FG002|Overall Study|Lost to Follow-up|0|||
145490696|NCT00539994|524650394|FG000|Overall Study|Withdrawal by Subject|1|||
145490697|NCT00539994|524650395|FG001|Overall Study|Withdrawal by Subject|0|||
145490698|NCT00539994|524650396|FG002|Overall Study|Withdrawal by Subject|1|||
145490699|NCT00539994|524650394|FG000|Overall Study|Physician Decision|0|||
145490700|NCT00539994|524650395|FG001|Overall Study|Physician Decision|0|||
145664905|NCT04761198|525292545|FG003|Overall Study|Protocol Violation|0|||
145664906|NCT04761198|525292546|FG004|Overall Study|Protocol Violation|1|||
145664907|NCT04761198|525292547|FG005|Overall Study|Protocol Violation|0|||
145664908|NCT04761198|525292548|FG006|Overall Study|Protocol Violation|0|||
145664909|NCT04761198|525292542|FG000|Overall Study|Death|2|||
145664910|NCT04761198|525292543|FG001|Overall Study|Death|1|||
145664911|NCT04761198|525292544|FG002|Overall Study|Death|2|||
145664912|NCT04761198|525292545|FG003|Overall Study|Death|5|||
145664913|NCT04761198|525292546|FG004|Overall Study|Death|14|||
145664914|NCT04761198|525292547|FG005|Overall Study|Death|2|||
145664915|NCT04761198|525292548|FG006|Overall Study|Death|5|||
145664916|NCT04761198|525292542|FG000|Overall Study|Lost to Follow-up|0|||
145664917|NCT04761198|525292543|FG001|Overall Study|Lost to Follow-up|0|||
145664918|NCT04761198|525292544|FG002|Overall Study|Lost to Follow-up|0|||
145664919|NCT04761198|525292545|FG003|Overall Study|Lost to Follow-up|0|||
145664920|NCT04761198|525292546|FG004|Overall Study|Lost to Follow-up|1|||
145664921|NCT04761198|525292547|FG005|Overall Study|Lost to Follow-up|0|||
145664922|NCT04761198|525292548|FG006|Overall Study|Lost to Follow-up|0|||
145664923|NCT04761198|525292542|FG000|Overall Study|Withdrawal by Subject|2|||
145664924|NCT04761198|525292543|FG001|Overall Study|Withdrawal by Subject|0|||
145664925|NCT04761198|525292544|FG002|Overall Study|Withdrawal by Subject|1|||
145664926|NCT04761198|525292545|FG003|Overall Study|Withdrawal by Subject|0|||
145664927|NCT04761198|525292546|FG004|Overall Study|Withdrawal by Subject|2|||
145664928|NCT04761198|525292547|FG005|Overall Study|Withdrawal by Subject|0|||
145664929|NCT04761198|525292548|FG006|Overall Study|Withdrawal by Subject|1|||
145664930|NCT04761198|525292542|FG000|Overall Study|Study Terminated by Sponsor|6|||
145664931|NCT04761198|525292543|FG001|Overall Study|Study Terminated by Sponsor|0|||
145664932|NCT04761198|525292544|FG002|Overall Study|Study Terminated by Sponsor|5|||
145664933|NCT04761198|525292545|FG003|Overall Study|Study Terminated by Sponsor|3|||
145664934|NCT04761198|525292546|FG004|Overall Study|Study Terminated by Sponsor|10|||
145664935|NCT04761198|525292547|FG005|Overall Study|Study Terminated by Sponsor|1|||
145664936|NCT04761198|525292548|FG006|Overall Study|Study Terminated by Sponsor|2|||
145664937|NCT02994927|525292549|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145664938|NCT02994927|525292550|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145664939|NCT02994927|525292549|FG000|Overall Study|Did not meet eligibility criteria|0|||
145664940|NCT02994927|525292550|FG001|Overall Study|Did not meet eligibility criteria|1|||
145664941|NCT02994927|525292549|FG000|Overall Study|Physician Decision|4|||
145664942|NCT02994927|525292550|FG001|Overall Study|Physician Decision|3|||
145664943|NCT02994927|525292549|FG000|Overall Study|Death|4|||
145664944|NCT02994927|525292550|FG001|Overall Study|Death|2|||
145664945|NCT02994927|525292549|FG000|Overall Study|Adverse Event|2|||
145664946|NCT02994927|525292550|FG001|Overall Study|Adverse Event|1|||
145664947|NCT02994927|525292549|FG000|Overall Study|Withdrawal by Subject|3|||
145664948|NCT02994927|525292550|FG001|Overall Study|Withdrawal by Subject|6|||
145664949|NCT02994927|525292549|FG000|Overall Study|Lost to Follow-up|2|||
145664950|NCT02994927|525292550|FG001|Overall Study|Lost to Follow-up|1|||
145664951|NCT00626795|525292551|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
145664952|NCT00626795|525292552|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
145664953|NCT00626795|525292553|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
145664954|NCT00626795|525292551|FG000|Blinded Treatment|Lack of Efficacy|2|||
145664955|NCT00626795|525292552|FG001|Blinded Treatment|Lack of Efficacy|0|||
145664956|NCT00626795|525292553|FG002|Blinded Treatment|Lack of Efficacy|0|||
145664957|NCT00626795|525292551|FG000|Blinded Treatment|Unacceptable adverse event|0|||
145664958|NCT00626795|525292552|FG001|Blinded Treatment|Unacceptable adverse event|0|||
145664959|NCT00626795|525292553|FG002|Blinded Treatment|Unacceptable adverse event|1|||
145664960|NCT00626795|525292551|FG000|Blinded Treatment|Protocol Violation|0|||
145664961|NCT00626795|525292552|FG001|Blinded Treatment|Protocol Violation|1|||
145664962|NCT00626795|525292553|FG002|Blinded Treatment|Protocol Violation|1|||
145664963|NCT00626795|525292551|FG000|Blinded Treatment|Withdrawal by Subject|1|||
145664964|NCT00626795|525292552|FG001|Blinded Treatment|Withdrawal by Subject|1|||
145664965|NCT00626795|525292553|FG002|Blinded Treatment|Withdrawal by Subject|0|||
145664966|NCT00626795|525292551|FG000|Blinded Treatment|Other reasons|2|||
145664967|NCT00626795|525292552|FG001|Blinded Treatment|Other reasons|0|||
145664968|NCT00626795|525292553|FG002|Blinded Treatment|Other reasons|2|||
145664969|NCT00626795|525292551|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
145664970|NCT00626795|525292552|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
145664971|NCT00626795|525292553|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
145664972|NCT03533257|525292561|FG000|Overall Study|Adverse Event|4|||
145664973|NCT03533257|525292562|FG001|Overall Study|Adverse Event|2|||
145664974|NCT03533257|525292561|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
145664975|NCT03533257|525292562|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
145664976|NCT04499521|525292565|FG000|Overall Study|Disease Progression|1|||
145664977|NCT04499521|525292566|FG001|Overall Study|Disease Progression|0|||
145664978|NCT03734029|525292567|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
145664979|NCT03734029|525292568|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
145664980|NCT03734029|525292567|FG000|Overall Study|Adverse Event|60|||
145490701|NCT00539994|524650396|FG002|Overall Study|Physician Decision|1|||
145664981|NCT03734029|525292568|FG001|Overall Study|Adverse Event|14|||
145664982|NCT03734029|525292567|FG000|Overall Study|Withdrawal by Subject|12|||
145664983|NCT03734029|525292568|FG001|Overall Study|Withdrawal by Subject|11|||
145664984|NCT03734029|525292567|FG000|Overall Study|Clinical progression by investigator|10|||
145664985|NCT03734029|525292568|FG001|Overall Study|Clinical progression by investigator|8|||
145664986|NCT03734029|525292567|FG000|Overall Study|Death|5|||
145664987|NCT03734029|525292568|FG001|Overall Study|Death|2|||
145664988|NCT03734029|525292567|FG000|Overall Study|Physician Decision|4|||
145664989|NCT03734029|525292568|FG001|Overall Study|Physician Decision|3|||
145664990|NCT03734029|525292567|FG000|Overall Study|Other|2|||
145664991|NCT03734029|525292568|FG001|Overall Study|Other|0|||
145664992|NCT03734029|525292567|FG000|Overall Study|Lost to Follow-up|0|||
145664993|NCT03734029|525292568|FG001|Overall Study|Lost to Follow-up|1|||
145664994|NCT03734029|525292567|FG000|Overall Study|Randomized, but not treated|2|||
145664995|NCT03734029|525292568|FG001|Overall Study|Randomized, but not treated|12|||
145664996|NCT04427007|525293373|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
145664997|NCT04427007|525293374|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
145664998|NCT01917084|525293383|FG000|Overall Study|Withdrawal by Subject|1|||
145664999|NCT05007080|525293396|FG000|Overall Study|Lost to Follow-up|0|||
145665000|NCT05007080|525293397|FG001|Overall Study|Lost to Follow-up|1|||
145665001|NCT05007080|525293398|FG002|Overall Study|Lost to Follow-up|0|||
145665002|NCT05007080|525293399|FG003|Overall Study|Lost to Follow-up|1|||
145665003|NCT05007080|525293400|FG004|Overall Study|Lost to Follow-up|1|||
145665004|NCT05007080|525293401|FG005|Overall Study|Lost to Follow-up|1|||
145665005|NCT05007080|525293396|FG000|Overall Study|Death|0|||
145665006|NCT05007080|525293397|FG001|Overall Study|Death|1|||
145665007|NCT05007080|525293398|FG002|Overall Study|Death|0|||
145665008|NCT05007080|525293399|FG003|Overall Study|Death|0|||
145665009|NCT05007080|525293400|FG004|Overall Study|Death|0|||
145665010|NCT05007080|525293401|FG005|Overall Study|Death|0|||
145665011|NCT05007080|525293396|FG000|Overall Study|Withdrawal by Subject|1|||
145665012|NCT05007080|525293397|FG001|Overall Study|Withdrawal by Subject|2|||
145665013|NCT05007080|525293398|FG002|Overall Study|Withdrawal by Subject|0|||
145665014|NCT05007080|525293399|FG003|Overall Study|Withdrawal by Subject|2|||
145665015|NCT05007080|525293400|FG004|Overall Study|Withdrawal by Subject|1|||
145665016|NCT05007080|525293401|FG005|Overall Study|Withdrawal by Subject|1|||
145665017|NCT05007080|525293396|FG000|Overall Study|Other|1|||
145665018|NCT05007080|525293397|FG001|Overall Study|Other|0|||
145665019|NCT05007080|525293398|FG002|Overall Study|Other|1|||
145665020|NCT05007080|525293399|FG003|Overall Study|Other|1|||
145665021|NCT05007080|525293400|FG004|Overall Study|Other|0|||
145665022|NCT05007080|525293401|FG005|Overall Study|Other|2|||
145665023|NCT05007080|525293396|FG000|Overall Study|Randomized not vaccinated|0|||
145665024|NCT05007080|525293397|FG001|Overall Study|Randomized not vaccinated|0|||
145665025|NCT05007080|525293398|FG002|Overall Study|Randomized not vaccinated|0|||
145665026|NCT05007080|525293399|FG003|Overall Study|Randomized not vaccinated|0|||
145665027|NCT05007080|525293400|FG004|Overall Study|Randomized not vaccinated|0|||
145665028|NCT05007080|525293401|FG005|Overall Study|Randomized not vaccinated|1|||
145665029|NCT04173247|525293405|FG000|Overall Study|Withdrawal by Subject|0|||
145665030|NCT04173247|525293406|FG001|Overall Study|Withdrawal by Subject|2|||
145665031|NCT04173247|525293405|FG000|Overall Study|Death|1|||
145665032|NCT04173247|525293406|FG001|Overall Study|Death|0|||
145665033|NCT04173247|525293405|FG000|Overall Study|Physician Decision|1|||
145665034|NCT04173247|525293406|FG001|Overall Study|Physician Decision|0|||
145665035|NCT03884101|525293409|FG000|Overall Study|Participant Ongoing in Study|202|||
145665036|NCT03884101|525293410|FG001|Overall Study|Participant Ongoing in Study|186|||
145665037|NCT03884101|525293409|FG000|Overall Study|Death|212|||
145665038|NCT03884101|525293410|FG001|Overall Study|Death|224|||
145665039|NCT03884101|525293409|FG000|Overall Study|Lost to Follow-up|0|||
145665040|NCT03884101|525293410|FG001|Overall Study|Lost to Follow-up|1|||
145665041|NCT03884101|525293409|FG000|Overall Study|Withdrawal by Subject|6|||
145665042|NCT03884101|525293410|FG001|Overall Study|Withdrawal by Subject|11|||
145665043|NCT03370913|525293411|FG000|Overall Study|Death|1|||
145665044|NCT03370913|525293411|FG000|Overall Study|Lost to Follow-up|1|||
145665045|NCT04631016|525293415|FG000|Overall Study|Adverse Event|3|||
145665046|NCT04631016|525293416|FG001|Overall Study|Adverse Event|0|||
145665047|NCT04631016|525293415|FG000|Overall Study|Withdrawal by Subject|5|||
145665048|NCT04631016|525293416|FG001|Overall Study|Withdrawal by Subject|4|||
145665049|NCT04631016|525293415|FG000|Overall Study|Reason unspecified|1|||
145665050|NCT04631016|525293416|FG001|Overall Study|Reason unspecified|0|||
145665051|NCT04631016|525293415|FG000|Overall Study|Failure to meet randomization criteria|2|||
145665052|NCT04631016|525293416|FG001|Overall Study|Failure to meet randomization criteria|1|||
145665053|NCT04967599|525293417|FG000|Overall Study|Lost to Follow-up|35|||
145665054|NCT04967599|525293418|FG001|Overall Study|Lost to Follow-up|19|||
145665055|NCT04967599|525293419|FG002|Overall Study|Lost to Follow-up|23|||
145665056|NCT04490109|525293420|FG000|Overall Study|Lost to Follow-up|3|||
145665057|NCT04490109|525293421|FG001|Overall Study|Lost to Follow-up|10|||
145665058|NCT04490109|525293422|FG002|Overall Study|Lost to Follow-up|4|||
145665059|NCT04490109|525293420|FG000|Overall Study|Withdrawal by Subject|8|||
145665060|NCT04490109|525293421|FG001|Overall Study|Withdrawal by Subject|6|||
145665061|NCT04490109|525293422|FG002|Overall Study|Withdrawal by Subject|9|||
145665062|NCT04490109|525293420|FG000|Overall Study|Physician Decision|0|||
145665063|NCT04490109|525293421|FG001|Overall Study|Physician Decision|2|||
145665064|NCT04490109|525293422|FG002|Overall Study|Physician Decision|3|||
145665065|NCT04490109|525293420|FG000|Overall Study|Adverse Event|2|||
145665066|NCT04490109|525293421|FG001|Overall Study|Adverse Event|1|||
145665067|NCT04490109|525293422|FG002|Overall Study|Adverse Event|0|||
145665068|NCT04490109|525293420|FG000|Overall Study|Significant Non-Compliance|2|||
145665069|NCT04490109|525293421|FG001|Overall Study|Significant Non-Compliance|4|||
145665070|NCT04490109|525293422|FG002|Overall Study|Significant Non-Compliance|4|||
145665071|NCT04490109|525293420|FG000|Overall Study|Significant Clinical Event|0|||
145665072|NCT04490109|525293421|FG001|Overall Study|Significant Clinical Event|1|||
145665073|NCT04490109|525293422|FG002|Overall Study|Significant Clinical Event|0|||
145665074|NCT04490109|525293420|FG000|Overall Study|Other Reason|4|||
145665075|NCT04490109|525293421|FG001|Overall Study|Other Reason|1|||
145665076|NCT04490109|525293422|FG002|Overall Study|Other Reason|1|||
145665077|NCT03279978|525293430|FG000|Overall Study|Withdrawal by Subject|0|||
145665078|NCT03279978|525293431|FG001|Overall Study|Withdrawal by Subject|1|||
145665079|NCT03279978|525293432|FG002|Overall Study|Withdrawal by Subject|0|||
145665080|NCT03279978|525293433|FG003|Overall Study|Withdrawal by Subject|0|||
145665081|NCT03279978|525293434|FG004|Overall Study|Withdrawal by Subject|0|||
145665082|NCT03279978|525293435|FG005|Overall Study|Withdrawal by Subject|0|||
145665083|NCT03279978|525293436|FG006|Overall Study|Withdrawal by Subject|0|||
145665084|NCT03279978|525293437|FG007|Overall Study|Withdrawal by Subject|0|||
145665085|NCT03279978|525293438|FG008|Overall Study|Withdrawal by Subject|0|||
145665086|NCT03279978|525293439|FG009|Overall Study|Withdrawal by Subject|1|||
145665087|NCT03279978|525293430|FG000|Overall Study|Lost to Follow-up|1|||
145665088|NCT03279978|525293431|FG001|Overall Study|Lost to Follow-up|0|||
145665089|NCT03279978|525293432|FG002|Overall Study|Lost to Follow-up|1|||
145665090|NCT03279978|525293433|FG003|Overall Study|Lost to Follow-up|0|||
145665091|NCT03279978|525293434|FG004|Overall Study|Lost to Follow-up|0|||
145665092|NCT03279978|525293435|FG005|Overall Study|Lost to Follow-up|0|||
145665093|NCT03279978|525293436|FG006|Overall Study|Lost to Follow-up|0|||
145665094|NCT03279978|525293437|FG007|Overall Study|Lost to Follow-up|0|||
145665095|NCT03279978|525293438|FG008|Overall Study|Lost to Follow-up|0|||
145665096|NCT03279978|525293439|FG009|Overall Study|Lost to Follow-up|0|||
145665097|NCT03279978|525293430|FG000|Overall Study|Other than stated above|0|||
145665098|NCT03279978|525293431|FG001|Overall Study|Other than stated above|0|||
145665099|NCT03279978|525293432|FG002|Overall Study|Other than stated above|0|||
145665100|NCT03279978|525293433|FG003|Overall Study|Other than stated above|0|||
145665101|NCT03279978|525293434|FG004|Overall Study|Other than stated above|0|||
145665102|NCT03279978|525293435|FG005|Overall Study|Other than stated above|0|||
145665103|NCT03279978|525293436|FG006|Overall Study|Other than stated above|1|||
145665104|NCT03279978|525293437|FG007|Overall Study|Other than stated above|0|||
145665105|NCT03279978|525293438|FG008|Overall Study|Other than stated above|0|||
145665106|NCT03279978|525293439|FG009|Overall Study|Other than stated above|0|||
145665107|NCT04330040|525293440|FG000|Overall Study|Other: Adverse event|5|||
145665108|NCT04330040|525293441|FG001|Overall Study|Other: Adverse event|0|||
145665109|NCT04330040|525293442|FG002|Overall Study|Other: Adverse event|0|||
145665110|NCT04330040|525293440|FG000|Overall Study|Disease progression|38|||
145665111|NCT04330040|525293441|FG001|Overall Study|Disease progression|10|||
145665112|NCT04330040|525293442|FG002|Overall Study|Disease progression|0|||
145665113|NCT04330040|525293440|FG000|Overall Study|Physician Decision|5|||
145665114|NCT04330040|525293441|FG001|Overall Study|Physician Decision|3|||
145665115|NCT04330040|525293442|FG002|Overall Study|Physician Decision|0|||
145665116|NCT04330040|525293440|FG000|Overall Study|Lost to Follow-up|1|||
145665117|NCT04330040|525293441|FG001|Overall Study|Lost to Follow-up|1|||
145665118|NCT04330040|525293442|FG002|Overall Study|Lost to Follow-up|0|||
145665119|NCT04330040|525293440|FG000|Overall Study|Death|2|||
145665120|NCT04330040|525293441|FG001|Overall Study|Death|1|||
145665121|NCT04330040|525293442|FG002|Overall Study|Death|0|||
145665122|NCT04330040|525293440|FG000|Overall Study|Withdrawal by Subject|3|||
145665123|NCT04330040|525293441|FG001|Overall Study|Withdrawal by Subject|3|||
145665124|NCT04330040|525293442|FG002|Overall Study|Withdrawal by Subject|0|||
145665125|NCT04330040|525293440|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
145665126|NCT04330040|525293441|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
145665127|NCT04330040|525293442|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
145665128|NCT04330040|525293440|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
145665129|NCT04330040|525293441|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
145665130|NCT04330040|525293442|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
145665131|NCT04330040|525293440|FG000|Overall Study|Other: Disease progression|1|||
145665132|NCT04330040|525293441|FG001|Overall Study|Other: Disease progression|0|||
145665133|NCT04330040|525293442|FG002|Overall Study|Other: Disease progression|0|||
145665134|NCT04330040|525293440|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
145665135|NCT04330040|525293441|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
145665136|NCT04330040|525293442|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
145665137|NCT04330040|525293440|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
145665138|NCT04330040|525293441|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
145665139|NCT04330040|525293442|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
145665140|NCT04330040|525293440|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
145665141|NCT04330040|525293441|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
145665142|NCT04330040|525293442|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
145665143|NCT02461134|525293443|FG000|Overall Study|Adverse Event|1|||
145665144|NCT03493542|525293444|FG000|Base Study|Withdrawal by Subject|0|||
145665145|NCT03493542|525293445|FG001|Base Study|Withdrawal by Subject|4|||
145665146|NCT03493542|525293446|FG002|Base Study|Withdrawal by Subject|0|||
145665147|NCT03493542|525293444|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
145665148|NCT03493542|525293445|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
145665149|NCT03493542|525293446|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
145665150|NCT03493542|525293444|FG000|Extension Study|Withdrawal by Subject|0|||
145665151|NCT03493542|525293445|FG001|Extension Study|Withdrawal by Subject|0|||
145665152|NCT03493542|525293446|FG002|Extension Study|Withdrawal by Subject|25|||
145665153|NCT04244175|525294119|FG000|Overall Study|Adverse Event|3|||
145665154|NCT04244175|525294120|FG001|Overall Study|Adverse Event|2|||
145665155|NCT04244175|525294121|FG002|Overall Study|Adverse Event|5|||
145665156|NCT04244175|525294119|FG000|Overall Study|Lack of Efficacy|1|||
145665157|NCT04244175|525294120|FG001|Overall Study|Lack of Efficacy|0|||
145665158|NCT04244175|525294121|FG002|Overall Study|Lack of Efficacy|1|||
145665159|NCT04244175|525294119|FG000|Overall Study|Lost to Follow-up|1|||
145665160|NCT04244175|525294120|FG001|Overall Study|Lost to Follow-up|0|||
145665161|NCT04244175|525294121|FG002|Overall Study|Lost to Follow-up|0|||
145665162|NCT04244175|525294119|FG000|Overall Study|Non-compliance with study drug|1|||
145665163|NCT04244175|525294120|FG001|Overall Study|Non-compliance with study drug|0|||
145665164|NCT04244175|525294121|FG002|Overall Study|Non-compliance with study drug|1|||
145665165|NCT04244175|525294119|FG000|Overall Study|Protocol deviation|0|||
145665166|NCT04244175|525294120|FG001|Overall Study|Protocol deviation|1|||
145665167|NCT04244175|525294121|FG002|Overall Study|Protocol deviation|0|||
145665168|NCT04244175|525294119|FG000|Overall Study|Withdrawal by Subject|1|||
145665169|NCT04244175|525294120|FG001|Overall Study|Withdrawal by Subject|3|||
145665170|NCT04244175|525294121|FG002|Overall Study|Withdrawal by Subject|1|||
145665171|NCT04244175|525294119|FG000|Overall Study|Other, not specified|0|||
145665172|NCT04244175|525294120|FG001|Overall Study|Other, not specified|1|||
145665173|NCT04244175|525294121|FG002|Overall Study|Other, not specified|2|||
145665174|NCT04165213|525294130|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
145665175|NCT04165213|525294131|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
145665176|NCT04165213|525294130|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
145665177|NCT04165213|525294131|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
145665178|NCT04165213|525294130|FG000|Clinician Enrollment|Termination from site|0|||
145665179|NCT04165213|525294131|FG001|Clinician Enrollment|Termination from site|1|||
145665180|NCT04165213|525294130|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
145665181|NCT04165213|525294131|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
145665182|NCT04165213|525294130|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
145665183|NCT04165213|525294131|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
145665184|NCT04165213|525294130|FG000|Caregiver Enrollment|Physician Decision|1|||
145665185|NCT04165213|525294131|FG001|Caregiver Enrollment|Physician Decision|0|||
145665186|NCT04165213|525294130|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
145665187|NCT04165213|525294131|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
145665188|NCT04165213|525294130|FG000|Caregiver Enrollment|PLWD death|2|||
145665189|NCT04165213|525294131|FG001|Caregiver Enrollment|PLWD death|0|||
145665190|NCT04165213|525294130|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
145665191|NCT04165213|525294131|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
145665192|NCT04165213|525294130|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
145665193|NCT04165213|525294131|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
145665194|NCT04165213|525294130|FG000|PLWD Enrollment|Lost to Follow-up|1|||
145665195|NCT04165213|525294131|FG001|PLWD Enrollment|Lost to Follow-up|1|||
145665196|NCT04165213|525294130|FG000|PLWD Enrollment|Physician Decision|1|||
145665197|NCT04165213|525294131|FG001|PLWD Enrollment|Physician Decision|0|||
145665198|NCT04165213|525294130|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
145665199|NCT04165213|525294131|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
145665200|NCT04165213|525294130|FG000|PLWD Enrollment|Death|2|||
145665201|NCT04165213|525294131|FG001|PLWD Enrollment|Death|0|||
145665202|NCT04165213|525294130|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
145665203|NCT04165213|525294131|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
145665204|NCT04464564|525294132|FG000|Period A (Placebo lead-in)|Other|5|||
145665205|NCT04464564|525294133|FG001|Period A (Placebo lead-in)|Other|0|||
145665206|NCT04464564|525294134|FG002|Period A (Placebo lead-in)|Other|0|||
145665207|NCT04464564|525294135|FG003|Period A (Placebo lead-in)|Other|0|||
145665208|NCT04464564|525294132|FG000|Period B (Randomization Period)|Adverse Event|0|||
145665209|NCT04464564|525294133|FG001|Period B (Randomization Period)|Adverse Event|1|||
145665210|NCT04464564|525294134|FG002|Period B (Randomization Period)|Adverse Event|2|||
145665211|NCT04464564|525294135|FG003|Period B (Randomization Period)|Adverse Event|8|||
145665212|NCT04464564|525294132|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
145665213|NCT04464564|525294133|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
145665214|NCT04464564|525294134|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
145665215|NCT04464564|525294135|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
145665216|NCT04464564|525294132|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
145665217|NCT04464564|525294133|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
145665218|NCT04464564|525294134|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
145665219|NCT04464564|525294135|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
145665220|NCT04464564|525294132|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
145665221|NCT04464564|525294133|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
145665222|NCT04464564|525294134|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
145665223|NCT04464564|525294135|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
145665224|NCT04464564|525294132|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
145665225|NCT04464564|525294133|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
145665226|NCT04464564|525294134|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
145665227|NCT04464564|525294135|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
145665228|NCT04464564|525294132|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
145665229|NCT04464564|525294133|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
145665230|NCT04464564|525294134|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
145665231|NCT04464564|525294135|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
145665232|NCT04464564|525294132|FG000|Period B (Randomization Period)|Reason not Specified|0|||
145665233|NCT04464564|525294133|FG001|Period B (Randomization Period)|Reason not Specified|3|||
145665234|NCT04464564|525294134|FG002|Period B (Randomization Period)|Reason not Specified|3|||
145665235|NCT04464564|525294135|FG003|Period B (Randomization Period)|Reason not Specified|3|||
145665236|NCT04282980|525294136|FG000|Overall Study|Remained on treatment|6|||
145665237|NCT04282980|525294136|FG000|Overall Study|Survival follow-up|11|||
145665238|NCT04282980|525294136|FG000|Overall Study|Withdrawal of informed consent|1|||
145665239|NCT04282980|525294136|FG000|Overall Study|Lost to Follow-up|1|||
145665240|NCT02095691|525294137|FG000|Overall Study|Physician Decision|1|||
145665241|NCT00887198|525294138|FG000|Randomized Period|Ongoing|42|||
145665242|NCT00887198|525294139|FG001|Randomized Period|Ongoing|0|||
145665243|NCT00887198|525294140|FG002|Randomized Period|Ongoing|0|||
145665244|NCT00887198|525294138|FG000|Randomized Period|Adverse Event|50|||
145665245|NCT00887198|525294139|FG001|Randomized Period|Adverse Event|33|||
145665246|NCT00887198|525294140|FG002|Randomized Period|Adverse Event|0|||
145665247|NCT00887198|525294138|FG000|Randomized Period|Lost to Follow-up|1|||
145665248|NCT00887198|525294139|FG001|Randomized Period|Lost to Follow-up|0|||
145665249|NCT00887198|525294140|FG002|Randomized Period|Lost to Follow-up|0|||
145665250|NCT00887198|525294138|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
145665251|NCT00887198|525294139|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
145665252|NCT00887198|525294140|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
145665253|NCT00887198|525294138|FG000|Randomized Period|Withdrawal by Subject|41|||
145665254|NCT00887198|525294139|FG001|Randomized Period|Withdrawal by Subject|56|||
145665255|NCT00887198|525294140|FG002|Randomized Period|Withdrawal by Subject|0|||
145490702|NCT04879628|524650401|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
145490703|NCT04879628|524650402|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
145490704|NCT04879628|524650403|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
145490705|NCT04879628|524650404|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
145490706|NCT04879628|524650401|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
145490707|NCT04879628|524650402|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
145490708|NCT04879628|524650403|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
145490709|NCT04879628|524650404|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
145490710|NCT04879628|524650401|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
145490711|NCT04879628|524650402|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
145490712|NCT04879628|524650403|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
145490713|NCT04879628|524650404|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
145665256|NCT00887198|525294138|FG000|Randomized Period|Progressive disease|366|||
145665257|NCT00887198|525294139|FG001|Randomized Period|Progressive disease|370|||
145665258|NCT00887198|525294140|FG002|Randomized Period|Progressive disease|0|||
145665259|NCT00887198|525294138|FG000|Randomized Period|Other|42|||
145665260|NCT00887198|525294139|FG001|Randomized Period|Other|30|||
145665261|NCT00887198|525294140|FG002|Randomized Period|Other|0|||
145665262|NCT00887198|525294138|FG000|Randomized Period|Randomized, Not treated|4|||
145265395|NCT04479358|523819334|FG002|Overall Study|Withdrawal by Subject|1|||
145665263|NCT00887198|525294139|FG001|Randomized Period|Randomized, Not treated|2|||
145665264|NCT00887198|525294140|FG002|Randomized Period|Randomized, Not treated|0|||
145665265|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
145665266|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
145665267|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
145665268|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
145665269|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
145665270|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
145665271|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
145665272|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
145665273|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
145665274|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
145665275|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
145665276|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
145665277|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
145665278|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
145665279|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
145665280|NCT00887198|525294138|FG000|Cross Over (Placebo to AA)|Other|0|||
145665281|NCT00887198|525294139|FG001|Cross Over (Placebo to AA)|Other|0|||
145665282|NCT00887198|525294140|FG002|Cross Over (Placebo to AA)|Other|19|||
145665283|NCT05147584|525294141|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
145665284|NCT05830799|525294150|FG000|Overall Study|Withdrawal by Subject|1|||
145665285|NCT02163694|525294151|FG000|Overall Study|Adverse event- related to progression|4|||
145665286|NCT02163694|525294152|FG001|Overall Study|Adverse event- related to progression|10|||
145665287|NCT02163694|525294151|FG000|Overall Study|Adverse event- not related to progression|7|||
145665288|NCT02163694|525294152|FG001|Overall Study|Adverse event- not related to progression|22|||
145665289|NCT02163694|525294151|FG000|Overall Study|Withdrew consent|13|||
145665290|NCT02163694|525294152|FG001|Overall Study|Withdrew consent|28|||
145665291|NCT02163694|525294151|FG000|Overall Study|Lost to Follow-up|2|||
145665292|NCT02163694|525294152|FG001|Overall Study|Lost to Follow-up|2|||
145665293|NCT02163694|525294151|FG000|Overall Study|Sponsor discontinued study|3|||
145665294|NCT02163694|525294152|FG001|Overall Study|Sponsor discontinued study|29|||
145665295|NCT02163694|525294151|FG000|Overall Study|Progressive disease per protocol|125|||
145665296|NCT02163694|525294152|FG001|Overall Study|Progressive disease per protocol|224|||
145665297|NCT02163694|525294151|FG000|Overall Study|Other, not specified|17|||
145665298|NCT02163694|525294152|FG001|Overall Study|Other, not specified|22|||
145665299|NCT02163694|525294151|FG000|Overall Study|Randomized but Not Treated|1|||
145665300|NCT02163694|525294152|FG001|Overall Study|Randomized but Not Treated|0|||
145665301|NCT02163694|525294151|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
145665302|NCT02163694|525294152|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
145665303|NCT04560179|525294157|FG000|Overall Study|Physician Decision|1|||
145665304|NCT04560179|525294158|FG001|Overall Study|Physician Decision|0|||
145665305|NCT04560179|525294159|FG002|Overall Study|Physician Decision|0|||
145665306|NCT04560179|525294160|FG003|Overall Study|Physician Decision|0|||
145665307|NCT04560179|525294161|FG004|Overall Study|Physician Decision|0|||
145665308|NCT04560179|525294157|FG000|Overall Study|Adverse Event|0|||
145665309|NCT04560179|525294158|FG001|Overall Study|Adverse Event|0|||
145665310|NCT04560179|525294159|FG002|Overall Study|Adverse Event|0|||
145665311|NCT04560179|525294160|FG003|Overall Study|Adverse Event|1|||
145665312|NCT04560179|525294161|FG004|Overall Study|Adverse Event|0|||
145665313|NCT04369911|525294162|FG000|Overall Study|Lost to Follow-up|3|||
145665314|NCT04369911|525294163|FG001|Overall Study|Lost to Follow-up|3|||
145665315|NCT04369911|525294162|FG000|Overall Study|Withdrawal by Subject|1|||
145665316|NCT04369911|525294163|FG001|Overall Study|Withdrawal by Subject|2|||
145665317|NCT04214418|525294164|FG000|Overall Study|Withdrawal by Subject|1|||
145665318|NCT04214418|525294165|FG001|Overall Study|Withdrawal by Subject|0|||
145665319|NCT04214418|525294166|FG002|Overall Study|Withdrawal by Subject|0|||
145665320|NCT04214418|525294167|FG003|Overall Study|Withdrawal by Subject|0|||
145665321|NCT04214418|525294168|FG004|Overall Study|Withdrawal by Subject|0|||
145665322|NCT04214418|525294169|FG005|Overall Study|Withdrawal by Subject|0|||
145665323|NCT04214418|525294164|FG000|Overall Study|Adverse Event|0|||
145665324|NCT04214418|525294165|FG001|Overall Study|Adverse Event|2|||
145665325|NCT04214418|525294166|FG002|Overall Study|Adverse Event|0|||
145665326|NCT04214418|525294167|FG003|Overall Study|Adverse Event|0|||
145665327|NCT04214418|525294168|FG004|Overall Study|Adverse Event|0|||
145665328|NCT04214418|525294169|FG005|Overall Study|Adverse Event|0|||
145665329|NCT04214418|525294164|FG000|Overall Study|Death|1|||
145665330|NCT04214418|525294165|FG001|Overall Study|Death|0|||
145665331|NCT04214418|525294166|FG002|Overall Study|Death|0|||
145665332|NCT04214418|525294167|FG003|Overall Study|Death|0|||
145665333|NCT04214418|525294168|FG004|Overall Study|Death|0|||
145665334|NCT04214418|525294169|FG005|Overall Study|Death|0|||
145665335|NCT02624050|525294174|FG000|Overall Study|Physician Decision|4|||
145665336|NCT02624050|525294175|FG001|Overall Study|Physician Decision|0|||
145665337|NCT02624050|525294174|FG000|Overall Study|Protocol Violation|2|||
145665338|NCT02624050|525294175|FG001|Overall Study|Protocol Violation|0|||
145665339|NCT04159519|525294177|FG000|Overall Study|Adverse Event|1|||
145665340|NCT04159519|525294178|FG001|Overall Study|Adverse Event|1|||
145665341|NCT04159519|525294177|FG000|Overall Study|Lack of Efficacy|1|||
145665342|NCT04159519|525294178|FG001|Overall Study|Lack of Efficacy|0|||
145665343|NCT04159519|525294177|FG000|Overall Study|Discontinued from study|1|||
145665344|NCT04159519|525294178|FG001|Overall Study|Discontinued from study|0|||
145665345|NCT04159519|525294177|FG000|Overall Study|Protocol Violation|1|||
145665346|NCT04159519|525294178|FG001|Overall Study|Protocol Violation|1|||
145665347|NCT04159519|525294177|FG000|Overall Study|Withdrawal by Subject|4|||
145665348|NCT04159519|525294178|FG001|Overall Study|Withdrawal by Subject|4|||
145665349|NCT01756300|525294182|FG000|Overall Study|Death|1|||
145665350|NCT01756300|525294182|FG000|Overall Study|Withdrawal by Subject|1|||
145665351|NCT02765412|525294183|FG000|Overall Study|Death|482|||
145665352|NCT02765412|525294184|FG001|Overall Study|Death|855|||
145665353|NCT03417284|525294797|FG000|Overall Study|Inadequate supply on study drug|1|||
145665354|NCT03417284|525294798|FG001|Overall Study|Inadequate supply on study drug|0|||
145665355|NCT03417284|525294799|FG002|Overall Study|Inadequate supply on study drug|0|||
145665356|NCT03417284|525294800|FG003|Overall Study|Inadequate supply on study drug|0|||
145665357|NCT03417284|525294797|FG000|Overall Study|Disease Progression|0|||
145665358|NCT03417284|525294798|FG001|Overall Study|Disease Progression|0|||
145665359|NCT03417284|525294799|FG002|Overall Study|Disease Progression|1|||
145665360|NCT03417284|525294800|FG003|Overall Study|Disease Progression|0|||
145665361|NCT03662022|525294807|FG000|Year 1 2019|prevalent case|83|||
145665362|NCT03662022|525294808|FG001|Year 1 2019|prevalent case|116|||
145665363|NCT03662022|525294809|FG002|Year 1 2019|prevalent case|158|||
145665364|NCT03662022|525294810|FG003|Year 1 2019|prevalent case|99|||
145665365|NCT03662022|525294807|FG000|Year 2 2020|incident case|18|||
145665366|NCT03662022|525294808|FG001|Year 2 2020|incident case|18|||
145665367|NCT03662022|525294809|FG002|Year 2 2020|incident case|16|||
145665368|NCT03662022|525294810|FG003|Year 2 2020|incident case|26|||
145665369|NCT03662022|525294807|FG000|Year 2 2020|other case|18|||
145665370|NCT03662022|525294808|FG001|Year 2 2020|other case|16|||
145665371|NCT03662022|525294809|FG002|Year 2 2020|other case|16|||
145665372|NCT03662022|525294810|FG003|Year 2 2020|other case|24|||
145665373|NCT03662022|525294807|FG000|Year 2 2020|Lost to Follow-up|1633|||
145665374|NCT03662022|525294808|FG001|Year 2 2020|Lost to Follow-up|1183|||
145665375|NCT03662022|525294809|FG002|Year 2 2020|Lost to Follow-up|1381|||
145665376|NCT03662022|525294810|FG003|Year 2 2020|Lost to Follow-up|2858|||
145665377|NCT03662022|525294807|FG000|Year 3 2021|incident case|24|||
145665378|NCT03662022|525294808|FG001|Year 3 2021|incident case|27|||
145665379|NCT03662022|525294809|FG002|Year 3 2021|incident case|24|||
145665380|NCT03662022|525294810|FG003|Year 3 2021|incident case|11|||
145665381|NCT03662022|525294807|FG000|Year 3 2021|other case|4|||
145665382|NCT03662022|525294808|FG001|Year 3 2021|other case|15|||
145665383|NCT03662022|525294809|FG002|Year 3 2021|other case|10|||
145665384|NCT03662022|525294810|FG003|Year 3 2021|other case|14|||
145665385|NCT03662022|525294807|FG000|Year 3 2021|Lost to Follow-up|179|||
145665386|NCT03662022|525294808|FG001|Year 3 2021|Lost to Follow-up|244|||
145665387|NCT03662022|525294809|FG002|Year 3 2021|Lost to Follow-up|480|||
145665388|NCT03662022|525294810|FG003|Year 3 2021|Lost to Follow-up|477|||
145665389|NCT03662022|525294807|FG000|Year 4 2022|incident case|25|||
145665390|NCT03662022|525294808|FG001|Year 4 2022|incident case|41|||
145665391|NCT03662022|525294809|FG002|Year 4 2022|incident case|28|||
145665392|NCT03662022|525294810|FG003|Year 4 2022|incident case|7|||
145665393|NCT03662022|525294807|FG000|Year 4 2022|other case|8|||
145665394|NCT03662022|525294808|FG001|Year 4 2022|other case|19|||
145665395|NCT03662022|525294809|FG002|Year 4 2022|other case|13|||
145665396|NCT03662022|525294810|FG003|Year 4 2022|other case|7|||
145665397|NCT03662022|525294807|FG000|Year 4 2022|Lost to Follow-up|986|||
145665398|NCT03662022|525294808|FG001|Year 4 2022|Lost to Follow-up|1079|||
145665399|NCT03662022|525294809|FG002|Year 4 2022|Lost to Follow-up|1236|||
145665400|NCT03662022|525294810|FG003|Year 4 2022|Lost to Follow-up|1826|||
145665401|NCT04679389|525294811|FG000|Overall Study|Adverse Event|1|||
145665402|NCT04679389|525294812|FG001|Overall Study|Adverse Event|0|||
145665403|NCT04679389|525294811|FG000|Overall Study|Protocol Violation|2|||
145665404|NCT04679389|525294812|FG001|Overall Study|Protocol Violation|0|||
145665405|NCT04679389|525294811|FG000|Overall Study|Physician Decision|3|||
145665406|NCT04679389|525294812|FG001|Overall Study|Physician Decision|5|||
145665407|NCT04679389|525294811|FG000|Overall Study|Withdrawal by Subject|5|||
145665408|NCT04679389|525294812|FG001|Overall Study|Withdrawal by Subject|7|||
145665409|NCT05454514|525294820|FG000|Overall Study|Withdrawal by Subject|4|||
145665410|NCT05541484|525294823|FG000|Overall Study|Withdrawal by Subject|1|||
145665411|NCT05541484|525294824|FG001|Overall Study|Withdrawal by Subject|0|||
145665412|NCT05785130|525294828|FG000|Overall Study|Withdrawal by Subject|1|||
145665413|NCT05785130|525294829|FG001|Overall Study|Withdrawal by Subject|0|||
145665414|NCT05785130|525294828|FG000|Overall Study|Lack of Efficacy|0|||
145665415|NCT05785130|525294829|FG001|Overall Study|Lack of Efficacy|1|||
145665416|NCT01475786|525294842|FG000|Overall Study|Adverse Event|0|||
145665417|NCT01475786|525294843|FG001|Overall Study|Adverse Event|1|||
145665418|NCT01475786|525294844|FG002|Overall Study|Adverse Event|0|||
145665419|NCT01475786|525294842|FG000|Overall Study|Lost to Follow-up|1|||
145665420|NCT01475786|525294843|FG001|Overall Study|Lost to Follow-up|2|||
145665421|NCT01475786|525294844|FG002|Overall Study|Lost to Follow-up|1|||
145665422|NCT01475786|525294842|FG000|Overall Study|Withdrawal by Subject|0|||
145665423|NCT01475786|525294843|FG001|Overall Study|Withdrawal by Subject|1|||
145665424|NCT01475786|525294844|FG002|Overall Study|Withdrawal by Subject|1|||
145665425|NCT01475786|525294842|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
145665426|NCT01475786|525294843|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
145665427|NCT01475786|525294844|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
145665428|NCT04157517|525294845|FG000|Overall Study|Death|1|||
145665429|NCT04157517|525294846|FG001|Overall Study|Death|2|||
145665430|NCT04157517|525294847|FG002|Overall Study|Death|2|||
145665431|NCT04157517|525294848|FG003|Overall Study|Death|3|||
145665432|NCT04157517|525294849|FG004|Overall Study|Death|3|||
145665433|NCT04157517|525294850|FG005|Overall Study|Death|4|||
145665434|NCT04157517|525294851|FG006|Overall Study|Death|1|||
145665435|NCT04157517|525294852|FG007|Overall Study|Death|2|||
145665436|NCT04157517|525294853|FG008|Overall Study|Death|4|||
145665437|NCT04157517|525294854|FG009|Overall Study|Death|0|||
145665438|NCT04157517|525294845|FG000|Overall Study|Withdrawal by Subject|1|||
145665439|NCT04157517|525294846|FG001|Overall Study|Withdrawal by Subject|1|||
145665440|NCT04157517|525294847|FG002|Overall Study|Withdrawal by Subject|1|||
145665441|NCT04157517|525294848|FG003|Overall Study|Withdrawal by Subject|0|||
145665442|NCT04157517|525294849|FG004|Overall Study|Withdrawal by Subject|0|||
145665443|NCT04157517|525294850|FG005|Overall Study|Withdrawal by Subject|1|||
145665444|NCT04157517|525294851|FG006|Overall Study|Withdrawal by Subject|0|||
145665445|NCT04157517|525294852|FG007|Overall Study|Withdrawal by Subject|0|||
145665446|NCT04157517|525294853|FG008|Overall Study|Withdrawal by Subject|1|||
145665447|NCT04157517|525294854|FG009|Overall Study|Withdrawal by Subject|0|||
145665448|NCT04157517|525294845|FG000|Overall Study|Other|1|||
145665449|NCT04157517|525294846|FG001|Overall Study|Other|0|||
145665450|NCT04157517|525294847|FG002|Overall Study|Other|0|||
145665451|NCT04157517|525294848|FG003|Overall Study|Other|0|||
145665452|NCT04157517|525294849|FG004|Overall Study|Other|0|||
145665453|NCT04157517|525294850|FG005|Overall Study|Other|1|||
145665454|NCT04157517|525294851|FG006|Overall Study|Other|2|||
145665455|NCT04157517|525294852|FG007|Overall Study|Other|7|||
145665456|NCT04157517|525294853|FG008|Overall Study|Other|7|||
145665457|NCT04157517|525294854|FG009|Overall Study|Other|0|||
145665458|NCT04780581|525294859|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
145665459|NCT04780581|525294860|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
145665460|NCT04780581|525294859|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
145665461|NCT04780581|525294860|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
145665462|NCT01651000|525294861|FG000|Overall Study|Adverse Event|2|||
145665463|NCT01651000|525294862|FG001|Overall Study|Adverse Event|8|||
145665464|NCT01651000|525294861|FG000|Overall Study|Lost to Follow-up|3|||
145665465|NCT01651000|525294862|FG001|Overall Study|Lost to Follow-up|2|||
145665466|NCT01651000|525294861|FG000|Overall Study|Protocol Violation|0|||
145665467|NCT01651000|525294862|FG001|Overall Study|Protocol Violation|3|||
145665468|NCT01651000|525294861|FG000|Overall Study|Withdrawal by Subject|2|||
145665469|NCT01651000|525294862|FG001|Overall Study|Withdrawal by Subject|10|||
145665470|NCT01651000|525294861|FG000|Overall Study|Subject noncompliance|0|||
145665471|NCT01651000|525294862|FG001|Overall Study|Subject noncompliance|3|||
145665472|NCT01651000|525294861|FG000|Overall Study|Lack of Efficacy|1|||
145665473|NCT01651000|525294862|FG001|Overall Study|Lack of Efficacy|1|||
145665474|NCT01651000|525294861|FG000|Overall Study|Physician Decision|1|||
145665475|NCT01651000|525294862|FG001|Overall Study|Physician Decision|0|||
145665476|NCT01651000|525294861|FG000|Overall Study|Administrative reason|1|||
145665477|NCT01651000|525294862|FG001|Overall Study|Administrative reason|0|||
145665478|NCT01651000|525294861|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
145665479|NCT01651000|525294862|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
145665480|NCT03781089|525295590|FG000|Overall Study|Constipation|1|||
145665481|NCT03781089|525295591|FG001|Overall Study|Constipation|0|||
145665482|NCT03781089|525295590|FG000|Overall Study|Positive pregnancy test|0|||
145665483|NCT03781089|525295591|FG001|Overall Study|Positive pregnancy test|1|||
145665484|NCT04633278|525295592|FG000|Overall Study|Adverse Event|1|||
145665485|NCT04633278|525295593|FG001|Overall Study|Adverse Event|0|||
145665486|NCT04633278|525295592|FG000|Overall Study|Withdrawal by Subject|1|||
145665487|NCT04633278|525295593|FG001|Overall Study|Withdrawal by Subject|0|||
145665488|NCT04633278|525295592|FG000|Overall Study|Death|11|||
145665489|NCT04633278|525295593|FG001|Overall Study|Death|7|||
145665490|NCT04633278|525295592|FG000|Overall Study|Sponsor Decision|3|||
145665491|NCT04633278|525295593|FG001|Overall Study|Sponsor Decision|0|||
145665492|NCT04633278|525295592|FG000|Overall Study|Not Listed|1|||
145665493|NCT04633278|525295593|FG001|Overall Study|Not Listed|0|||
145665494|NCT03636490|525295594|FG000|Overall Study|Dropped out or incomplete data|141|||
145665495|NCT02246127|525295595|FG000|First Course Treatment|Adverse Event|9|||
145665496|NCT02246127|525295596|FG001|First Course Treatment|Adverse Event|7|||
145665497|NCT02246127|525295595|FG000|First Course Treatment|Withdrawal by Subject|6|||
145665498|NCT02246127|525295596|FG001|First Course Treatment|Withdrawal by Subject|7|||
145665499|NCT02246127|525295595|FG000|First Course Treatment|Physician Decision|9|||
145665500|NCT02246127|525295596|FG001|First Course Treatment|Physician Decision|9|||
145665501|NCT02246127|525295595|FG000|First Course Treatment|Death|3|||
145665502|NCT02246127|525295596|FG001|First Course Treatment|Death|3|||
145665503|NCT02246127|525295595|FG000|First Course Treatment|Not reported reasons|6|||
145665504|NCT02246127|525295596|FG001|First Course Treatment|Not reported reasons|7|||
145665505|NCT02246127|525295595|FG000|First Course Treatment|Not treated|3|||
145665506|NCT02246127|525295596|FG001|First Course Treatment|Not treated|3|||
145665507|NCT03635567|525295597|FG000|Overall Study|Lost to Follow-up|4|||
145665508|NCT03635567|525295598|FG001|Overall Study|Lost to Follow-up|1|||
145665509|NCT03635567|525295597|FG000|Overall Study|Withdrawal by Subject|11|||
145665510|NCT03635567|525295598|FG001|Overall Study|Withdrawal by Subject|16|||
145665511|NCT03635567|525295597|FG000|Overall Study|Sponsor Decision|99|||
145665512|NCT03635567|525295598|FG001|Overall Study|Sponsor Decision|57|||
145665513|NCT03635567|525295597|FG000|Overall Study|Death|194|||
145665514|NCT03635567|525295598|FG001|Overall Study|Death|235|||
145665515|NCT04496752|525295606|FG000|Second Assessment|Lost to Follow-up|3|||
145665516|NCT04496752|525295607|FG001|Second Assessment|Lost to Follow-up|3|||
145665517|NCT04496752|525295606|FG000|Second Assessment|Adverse Event|2|||
145665518|NCT04496752|525295607|FG001|Second Assessment|Adverse Event|0|||
145665519|NCT04675034|525295608|FG000|Overall Study|Lost to Follow-up|1|||
145665520|NCT04675034|525295609|FG001|Overall Study|Lost to Follow-up|1|||
145665521|NCT04675034|525295610|FG002|Overall Study|Lost to Follow-up|0|||
145665522|NCT04675034|525295611|FG003|Overall Study|Lost to Follow-up|2|||
145665523|NCT04675034|525295612|FG004|Overall Study|Lost to Follow-up|0|||
145665524|NCT04675034|525295608|FG000|Overall Study|Protocol Violation|1|||
145665525|NCT04675034|525295609|FG001|Overall Study|Protocol Violation|0|||
145665526|NCT04675034|525295610|FG002|Overall Study|Protocol Violation|0|||
145665527|NCT04675034|525295611|FG003|Overall Study|Protocol Violation|1|||
145665528|NCT04675034|525295612|FG004|Overall Study|Protocol Violation|3|||
145665529|NCT04675034|525295608|FG000|Overall Study|Withdrawal by Subject|9|||
145665530|NCT04675034|525295609|FG001|Overall Study|Withdrawal by Subject|3|||
145665531|NCT04675034|525295610|FG002|Overall Study|Withdrawal by Subject|4|||
145665532|NCT04675034|525295611|FG003|Overall Study|Withdrawal by Subject|8|||
145665533|NCT04675034|525295612|FG004|Overall Study|Withdrawal by Subject|6|||
145665534|NCT03248479|525295613|FG000|Overall Study|Death|12|||
145665535|NCT03248479|525295614|FG001|Overall Study|Death|44|||
145665536|NCT03248479|525295615|FG002|Overall Study|Death|1|||
145665537|NCT03248479|525295616|FG003|Overall Study|Death|72|||
145665538|NCT03248479|525295617|FG004|Overall Study|Death|17|||
145665539|NCT03248479|525295618|FG005|Overall Study|Death|6|||
145665540|NCT03248479|525295619|FG006|Overall Study|Death|1|||
145665541|NCT03248479|525295620|FG007|Overall Study|Death|14|||
145665542|NCT03248479|525295621|FG008|Overall Study|Death|3|||
145665543|NCT03248479|525295622|FG009|Overall Study|Death|7|||
145665544|NCT03248479|525295623|FG010|Overall Study|Death|3|||
145665545|NCT03248479|525295624|FG011|Overall Study|Death|1|||
145665546|NCT03248479|525295625|FG012|Overall Study|Death|1|||
145665547|NCT03248479|525295613|FG000|Overall Study|Study terminated by sponsor|12|||
145665548|NCT03248479|525295614|FG001|Overall Study|Study terminated by sponsor|15|||
145665549|NCT03248479|525295615|FG002|Overall Study|Study terminated by sponsor|0|||
145665550|NCT03248479|525295616|FG003|Overall Study|Study terminated by sponsor|5|||
145665551|NCT03248479|525295617|FG004|Overall Study|Study terminated by sponsor|0|||
145665552|NCT03248479|525295618|FG005|Overall Study|Study terminated by sponsor|0|||
145665553|NCT03248479|525295619|FG006|Overall Study|Study terminated by sponsor|0|||
145665554|NCT03248479|525295620|FG007|Overall Study|Study terminated by sponsor|1|||
145665555|NCT03248479|525295621|FG008|Overall Study|Study terminated by sponsor|1|||
145665556|NCT03248479|525295622|FG009|Overall Study|Study terminated by sponsor|0|||
145665557|NCT03248479|525295623|FG010|Overall Study|Study terminated by sponsor|5|||
145665558|NCT03248479|525295624|FG011|Overall Study|Study terminated by sponsor|4|||
145665559|NCT03248479|525295625|FG012|Overall Study|Study terminated by sponsor|0|||
145665560|NCT03248479|525295613|FG000|Overall Study|Consent withdrawn|6|||
145665561|NCT03248479|525295614|FG001|Overall Study|Consent withdrawn|3|||
145665562|NCT03248479|525295615|FG002|Overall Study|Consent withdrawn|0|||
145665563|NCT03248479|525295616|FG003|Overall Study|Consent withdrawn|9|||
145665564|NCT03248479|525295617|FG004|Overall Study|Consent withdrawn|1|||
145665565|NCT03248479|525295618|FG005|Overall Study|Consent withdrawn|0|||
145665566|NCT03248479|525295619|FG006|Overall Study|Consent withdrawn|0|||
145665567|NCT03248479|525295620|FG007|Overall Study|Consent withdrawn|1|||
145665568|NCT03248479|525295621|FG008|Overall Study|Consent withdrawn|0|||
145665569|NCT03248479|525295622|FG009|Overall Study|Consent withdrawn|3|||
145665570|NCT03248479|525295623|FG010|Overall Study|Consent withdrawn|1|||
145665571|NCT03248479|525295624|FG011|Overall Study|Consent withdrawn|0|||
145665572|NCT03248479|525295625|FG012|Overall Study|Consent withdrawn|1|||
145665573|NCT03248479|525295613|FG000|Overall Study|Lost to Follow-up|2|||
145665574|NCT03248479|525295614|FG001|Overall Study|Lost to Follow-up|1|||
145665575|NCT03248479|525295615|FG002|Overall Study|Lost to Follow-up|0|||
145665576|NCT03248479|525295616|FG003|Overall Study|Lost to Follow-up|0|||
145665577|NCT03248479|525295617|FG004|Overall Study|Lost to Follow-up|0|||
145665578|NCT03248479|525295618|FG005|Overall Study|Lost to Follow-up|0|||
145665579|NCT03248479|525295619|FG006|Overall Study|Lost to Follow-up|0|||
145665580|NCT03248479|525295620|FG007|Overall Study|Lost to Follow-up|0|||
145665581|NCT03248479|525295621|FG008|Overall Study|Lost to Follow-up|0|||
145665582|NCT03248479|525295622|FG009|Overall Study|Lost to Follow-up|0|||
145665583|NCT03248479|525295623|FG010|Overall Study|Lost to Follow-up|0|||
145665584|NCT03248479|525295624|FG011|Overall Study|Lost to Follow-up|0|||
145665585|NCT03248479|525295625|FG012|Overall Study|Lost to Follow-up|1|||
145665586|NCT03248479|525295613|FG000|Overall Study|Not reported|0|||
145665587|NCT03248479|525295614|FG001|Overall Study|Not reported|0|||
145665588|NCT03248479|525295615|FG002|Overall Study|Not reported|0|||
145665589|NCT03248479|525295616|FG003|Overall Study|Not reported|1|||
145665590|NCT03248479|525295617|FG004|Overall Study|Not reported|1|||
145665591|NCT03248479|525295618|FG005|Overall Study|Not reported|0|||
145665592|NCT03248479|525295619|FG006|Overall Study|Not reported|0|||
145665593|NCT03248479|525295620|FG007|Overall Study|Not reported|1|||
145665594|NCT03248479|525295621|FG008|Overall Study|Not reported|1|||
145665595|NCT03248479|525295622|FG009|Overall Study|Not reported|0|||
145665596|NCT03248479|525295623|FG010|Overall Study|Not reported|0|||
145665597|NCT03248479|525295624|FG011|Overall Study|Not reported|0|||
145665598|NCT03248479|525295625|FG012|Overall Study|Not reported|0|||
145665599|NCT03547271|525295632|FG000|Overall Study|Adverse Event|1|||
145665600|NCT03547271|525295633|FG001|Overall Study|Adverse Event|1|||
145665601|NCT03547271|525295634|FG002|Overall Study|Adverse Event|0|||
145665602|NCT03547271|525295635|FG003|Overall Study|Adverse Event|0|||
145665603|NCT03547271|525295632|FG000|Overall Study|Protocol deviation|5|||
145665604|NCT03547271|525295633|FG001|Overall Study|Protocol deviation|7|||
145665605|NCT03547271|525295634|FG002|Overall Study|Protocol deviation|3|||
145665606|NCT03547271|525295635|FG003|Overall Study|Protocol deviation|0|||
145665607|NCT03547271|525295632|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
145665608|NCT03547271|525295633|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
145665609|NCT03547271|525295634|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
145665610|NCT03547271|525295635|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
145665611|NCT03547271|525295632|FG000|Overall Study|Lost to Follow-up|3|||
145665612|NCT03547271|525295633|FG001|Overall Study|Lost to Follow-up|3|||
145665613|NCT03547271|525295634|FG002|Overall Study|Lost to Follow-up|1|||
145665614|NCT03547271|525295635|FG003|Overall Study|Lost to Follow-up|0|||
145665615|NCT04795245|525295636|FG000|Overall Study|Unkown reason|7|||
145665616|NCT04795245|525295636|FG000|Overall Study|Death|17|||
145665617|NCT04795245|525295636|FG000|Overall Study|Other than listed|19|||
145665618|NCT04795245|525295636|FG000|Overall Study|Adverse Event|143|||
145665619|NCT04795245|525295636|FG000|Overall Study|Progressive disease|512|||
145665620|NCT04795245|525295636|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
145665621|NCT03904576|525295637|FG000|Washout Period|Protocol Violation|1|||
145665622|NCT03904576|525295638|FG001|Washout Period|Protocol Violation|1|||
145665623|NCT03418740|525295639|FG000|Overall Study|Lost to Follow-up|13|||
145665624|NCT03418740|525295639|FG000|Overall Study|Scheduling Issues|7|||
145665625|NCT03418740|525295639|FG000|Overall Study|Withdrawal by Subject|2|||
145665626|NCT03418740|525295639|FG000|Overall Study|Unable to Continue Consent|1|||
145665627|NCT05215054|525295640|FG000|Overall Study|Lost to Follow-up|1|||
145665628|NCT05215054|525295641|FG001|Overall Study|Lost to Follow-up|1|||
145665629|NCT05215054|525295640|FG000|Overall Study|Protocol Violation|1|||
145665630|NCT05215054|525295641|FG001|Overall Study|Protocol Violation|1|||
145665631|NCT05215054|525295640|FG000|Overall Study|Withdrawal by Subject|4|||
145665632|NCT05215054|525295641|FG001|Overall Study|Withdrawal by Subject|4|||
145665633|NCT01897441|525295642|FG000|Overall Study|Lost to Follow-up|0|||
145665634|NCT01897441|525295643|FG001|Overall Study|Lost to Follow-up|0|||
145665635|NCT01897441|525295644|FG002|Overall Study|Lost to Follow-up|1|||
145665636|NCT01897441|525295645|FG003|Overall Study|Lost to Follow-up|0|||
145665637|NCT01897441|525295646|FG004|Overall Study|Lost to Follow-up|0|||
145665638|NCT01897441|525295647|FG005|Overall Study|Lost to Follow-up|0|||
145665639|NCT01897441|525295642|FG000|Overall Study|Withdrawal by Subject|0|||
145665640|NCT01897441|525295643|FG001|Overall Study|Withdrawal by Subject|0|||
145665641|NCT01897441|525295644|FG002|Overall Study|Withdrawal by Subject|0|||
145665642|NCT01897441|525295645|FG003|Overall Study|Withdrawal by Subject|0|||
145665643|NCT01897441|525295646|FG004|Overall Study|Withdrawal by Subject|1|||
145665644|NCT01897441|525295647|FG005|Overall Study|Withdrawal by Subject|0|||
145665645|NCT01897441|525295642|FG000|Overall Study|Withdrawn by Provider|0|||
145665646|NCT01897441|525295643|FG001|Overall Study|Withdrawn by Provider|2|||
145665647|NCT01897441|525295644|FG002|Overall Study|Withdrawn by Provider|0|||
145665648|NCT01897441|525295645|FG003|Overall Study|Withdrawn by Provider|0|||
145665649|NCT01897441|525295646|FG004|Overall Study|Withdrawn by Provider|0|||
145665650|NCT01897441|525295647|FG005|Overall Study|Withdrawn by Provider|0|||
145665651|NCT05132400|525296267|FG000|Overall Study|Withdrawal by Subject|14|||
145665652|NCT05132400|525296268|FG001|Overall Study|Withdrawal by Subject|8|||
145665653|NCT05132400|525296267|FG000|Overall Study|Lost to Follow-up|132|||
145665654|NCT05132400|525296268|FG001|Overall Study|Lost to Follow-up|121|||
145665655|NCT02076009|525296270|FG000|Overall Study|Death|172|||
145665656|NCT02076009|525296271|FG001|Overall Study|Death|153|||
145665657|NCT02076009|525296270|FG000|Overall Study|Withdrawal by Subject|16|||
145665658|NCT02076009|525296271|FG001|Overall Study|Withdrawal by Subject|12|||
145665659|NCT02076009|525296270|FG000|Overall Study|Lost to Follow-up|4|||
145665660|NCT02076009|525296271|FG001|Overall Study|Lost to Follow-up|2|||
145665661|NCT02076009|525296270|FG000|Overall Study|Progressive Disease|1|||
145665662|NCT02076009|525296271|FG001|Overall Study|Progressive Disease|0|||
145665663|NCT02076009|525296270|FG000|Overall Study|Physician Decision|0|||
145665664|NCT02076009|525296271|FG001|Overall Study|Physician Decision|1|||
145665665|NCT02076009|525296270|FG000|Overall Study|End of data collection|90|||
145665666|NCT02076009|525296271|FG001|Overall Study|End of data collection|118|||
145665667|NCT00942734|525296277|FG000|Overall Study|Adverse Event|2|||
145665668|NCT00942734|525296277|FG000|Overall Study|Protocol Violation|3|||
145665669|NCT00942734|525296277|FG000|Overall Study|Disease Progression|2|||
145665670|NCT00942734|525296277|FG000|Overall Study|Physician Decision|1|||
145665671|NCT06655818|525296278|FG000|Overall Study|Withdrawal by Subject|1|||
145665672|NCT00319046|525296279|FG000|Overall Study|withdrawal of subject's consent|7|||
145665673|NCT00319046|525296279|FG000|Overall Study|administrative reason|1|||
145665674|NCT00412607|525296288|FG000|Overall Study|Withdrawal by Subject|9|||
145665675|NCT00412607|525296288|FG000|Overall Study|Lost to Follow-up|19|||
145665676|NCT00412607|525296288|FG000|Overall Study|Death|61|||
145665677|NCT00412607|525296288|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
145665678|NCT03522298|525296299|FG000|Overall Study|Adverse Event|1|||
145665679|NCT03522298|525296300|FG001|Overall Study|Adverse Event|0|||
145665680|NCT03522298|525296301|FG002|Overall Study|Adverse Event|0|||
145665681|NCT03522298|525296302|FG003|Overall Study|Adverse Event|1|||
145665682|NCT03522298|525296299|FG000|Overall Study|Death|2|||
145665683|NCT03522298|525296300|FG001|Overall Study|Death|4|||
145665684|NCT03522298|525296301|FG002|Overall Study|Death|8|||
145665685|NCT03522298|525296302|FG003|Overall Study|Death|8|||
145665686|NCT03522298|525296299|FG000|Overall Study|Patient decision|0|||
145665687|NCT03522298|525296300|FG001|Overall Study|Patient decision|2|||
145665688|NCT03522298|525296301|FG002|Overall Study|Patient decision|2|||
145665689|NCT03522298|525296302|FG003|Overall Study|Patient decision|2|||
145665690|NCT05718687|525296303|FG000|Overall Study|Withdrawal by Subject|3|||
145665691|NCT01499368|525296308|FG000|Overall Study|Did not meet I/E criteria|8|||
145665692|NCT01499368|525296309|FG001|Overall Study|Did not meet I/E criteria|4|||
145665693|NCT01499368|525296310|FG002|Overall Study|Did not meet I/E criteria|4|||
145665694|NCT01499368|525296308|FG000|Overall Study|Prohibited Concomitant medication|1|||
145665695|NCT01499368|525296309|FG001|Overall Study|Prohibited Concomitant medication|1|||
145665696|NCT01499368|525296310|FG002|Overall Study|Prohibited Concomitant medication|0|||
145665697|NCT01499368|525296308|FG000|Overall Study|Withdrawal by Subject|11|||
145665698|NCT01499368|525296309|FG001|Overall Study|Withdrawal by Subject|10|||
145665699|NCT01499368|525296310|FG002|Overall Study|Withdrawal by Subject|8|||
145665700|NCT01499368|525296308|FG000|Overall Study|Lost to Follow-up|3|||
145665701|NCT01499368|525296309|FG001|Overall Study|Lost to Follow-up|2|||
145665702|NCT01499368|525296310|FG002|Overall Study|Lost to Follow-up|5|||
145665703|NCT01499368|525296308|FG000|Overall Study|Adverse Event|4|||
145665704|NCT01499368|525296309|FG001|Overall Study|Adverse Event|0|||
145665705|NCT01499368|525296310|FG002|Overall Study|Adverse Event|2|||
145665706|NCT01499368|525296308|FG000|Overall Study|Physician Decision|0|||
145665707|NCT01499368|525296309|FG001|Overall Study|Physician Decision|1|||
145665708|NCT01499368|525296310|FG002|Overall Study|Physician Decision|0|||
145665709|NCT01499368|525296308|FG000|Overall Study|Deviation from visit window|0|||
145665710|NCT01499368|525296309|FG001|Overall Study|Deviation from visit window|0|||
145665711|NCT01499368|525296310|FG002|Overall Study|Deviation from visit window|1|||
145665712|NCT01499368|525296308|FG000|Overall Study|Error of Prescriptions|0|||
145665713|NCT01499368|525296309|FG001|Overall Study|Error of Prescriptions|0|||
145665714|NCT01499368|525296310|FG002|Overall Study|Error of Prescriptions|1|||
145665715|NCT04626427|525296311|FG000|Overall Study|Death|1|||
145665716|NCT04626427|525296311|FG000|Overall Study|Withdrawal by Subject|1|||
145665717|NCT04626427|525296311|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
145665718|NCT04626427|525296311|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
145665719|NCT01553149|525296312|FG000|Overall Study|Adverse Event|0|||
145665720|NCT01553149|525296313|FG001|Overall Study|Adverse Event|9|||
145665721|NCT01553149|525296312|FG000|Overall Study|Physician Decision|5|||
145665722|NCT01553149|525296313|FG001|Overall Study|Physician Decision|10|||
145665723|NCT01553149|525296312|FG000|Overall Study|Ineligible|0|||
145665724|NCT01553149|525296313|FG001|Overall Study|Ineligible|1|||
145665725|NCT02325154|525296314|FG000|Overall Study|Physician Decision|1|||
145665726|NCT01265537|525296315|FG000|Overall Study|Adverse Event|2|||
145665727|NCT01265537|525296316|FG001|Overall Study|Adverse Event|1|||
145665728|NCT01265537|525296315|FG000|Overall Study|Physician Decision|0|||
145490714|NCT04879628|524650401|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
145665729|NCT01265537|525296316|FG001|Overall Study|Physician Decision|1|||
145665730|NCT05866926|525296317|FG000|Overall Study|Death|16|||
145665731|NCT05866926|525296318|FG001|Overall Study|Death|9|||
145665732|NCT05866926|525296317|FG000|Overall Study|Lost to Follow-up|0|||
145665733|NCT05866926|525296318|FG001|Overall Study|Lost to Follow-up|1|||
145665734|NCT05866926|525296317|FG000|Overall Study|Adverse Event|1|||
145665735|NCT05866926|525296318|FG001|Overall Study|Adverse Event|0|||
145665736|NCT05866926|525296317|FG000|Overall Study|Withdrawal by Subject|5|||
145665737|NCT05866926|525296318|FG001|Overall Study|Withdrawal by Subject|1|||
145665738|NCT05866926|525296317|FG000|Overall Study|Disease progression|1|||
145665739|NCT05866926|525296318|FG001|Overall Study|Disease progression|0|||
145665740|NCT05866926|525296317|FG000|Overall Study|other causes|2|||
145665741|NCT05866926|525296318|FG001|Overall Study|other causes|1|||
145665742|NCT03990883|525296319|FG000|Blinded Treatment Phase|Adverse Event|1|||
145665743|NCT03990883|525296320|FG001|Blinded Treatment Phase|Adverse Event|1|||
145665744|NCT03990883|525296321|FG002|Blinded Treatment Phase|Adverse Event|0|||
145665745|NCT03990883|525296319|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
145665746|NCT03990883|525296320|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
145665747|NCT03990883|525296321|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
145665748|NCT03990883|525296319|FG000|Blinded Treatment Phase|Physician Decision|1|||
145665749|NCT03990883|525296320|FG001|Blinded Treatment Phase|Physician Decision|0|||
145665750|NCT03990883|525296321|FG002|Blinded Treatment Phase|Physician Decision|0|||
145665751|NCT03990883|525296319|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
145665752|NCT03990883|525296320|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
145665753|NCT03990883|525296321|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
145665754|NCT03990883|525296319|FG000|Blinded Treatment Phase|COVID-19|3|||
145665755|NCT03990883|525296320|FG001|Blinded Treatment Phase|COVID-19|2|||
145665756|NCT03990883|525296321|FG002|Blinded Treatment Phase|COVID-19|0|||
145665757|NCT03990883|525296319|FG000|Blinded Treatment Phase|Personal Reasons|6|||
145665758|NCT03990883|525296320|FG001|Blinded Treatment Phase|Personal Reasons|3|||
145665759|NCT03990883|525296321|FG002|Blinded Treatment Phase|Personal Reasons|0|||
145665760|NCT03990883|525296319|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
145665761|NCT03990883|525296320|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
145665762|NCT03990883|525296321|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
145665763|NCT03990883|525296319|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
145665764|NCT03990883|525296320|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
145665765|NCT03990883|525296321|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
145665766|NCT03990883|525296319|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
145665767|NCT03990883|525296320|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
145665768|NCT03990883|525296321|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
145665769|NCT04595331|525297402|FG000|Overall Study|Withdrawal by Subject|0|||
145665770|NCT04595331|525297403|FG001|Overall Study|Withdrawal by Subject|1|||
145665771|NCT04595331|525297402|FG000|Overall Study|Lost to Follow-up|0|||
145665772|NCT04595331|525297403|FG001|Overall Study|Lost to Follow-up|5|||
145665773|NCT04595331|525297402|FG000|Overall Study|Medical reason|0|||
145665774|NCT04595331|525297403|FG001|Overall Study|Medical reason|1|||
145665775|NCT05412004|525297404|FG000|Overall Study|Adverse Event|0|||
145665776|NCT05412004|525297405|FG001|Overall Study|Adverse Event|2|||
145665777|NCT05412004|525297406|FG002|Overall Study|Adverse Event|1|||
145665778|NCT05412004|525297407|FG003|Overall Study|Adverse Event|5|||
145665779|NCT05412004|525297404|FG000|Overall Study|Assigned Treatment by Mistake|5|||
145665780|NCT05412004|525297405|FG001|Overall Study|Assigned Treatment by Mistake|10|||
145665781|NCT05412004|525297406|FG002|Overall Study|Assigned Treatment by Mistake|2|||
145665782|NCT05412004|525297407|FG003|Overall Study|Assigned Treatment by Mistake|5|||
145665783|NCT05412004|525297404|FG000|Overall Study|Lost to Follow-up|3|||
145665784|NCT05412004|525297405|FG001|Overall Study|Lost to Follow-up|0|||
145665785|NCT05412004|525297406|FG002|Overall Study|Lost to Follow-up|0|||
145665786|NCT05412004|525297407|FG003|Overall Study|Lost to Follow-up|0|||
145665787|NCT05412004|525297404|FG000|Overall Study|Patient could not travel to site|0|||
145665788|NCT05412004|525297405|FG001|Overall Study|Patient could not travel to site|1|||
145665789|NCT05412004|525297406|FG002|Overall Study|Patient could not travel to site|0|||
145665790|NCT05412004|525297407|FG003|Overall Study|Patient could not travel to site|0|||
145665791|NCT05412004|525297404|FG000|Overall Study|Physician Decision|0|||
145665792|NCT05412004|525297405|FG001|Overall Study|Physician Decision|1|||
145665793|NCT05412004|525297406|FG002|Overall Study|Physician Decision|0|||
145665794|NCT05412004|525297407|FG003|Overall Study|Physician Decision|0|||
145665795|NCT05412004|525297404|FG000|Overall Study|Pregnancy|0|||
145665796|NCT05412004|525297405|FG001|Overall Study|Pregnancy|1|||
145665797|NCT05412004|525297406|FG002|Overall Study|Pregnancy|0|||
145665798|NCT05412004|525297407|FG003|Overall Study|Pregnancy|0|||
145665799|NCT05412004|525297404|FG000|Overall Study|Protocol Violation|1|||
145665800|NCT05412004|525297405|FG001|Overall Study|Protocol Violation|0|||
145665801|NCT05412004|525297406|FG002|Overall Study|Protocol Violation|0|||
145665802|NCT05412004|525297407|FG003|Overall Study|Protocol Violation|0|||
145665803|NCT05412004|525297404|FG000|Overall Study|Withdrawal by Subject|4|||
145665804|NCT05412004|525297405|FG001|Overall Study|Withdrawal by Subject|19|||
145665805|NCT05412004|525297406|FG002|Overall Study|Withdrawal by Subject|4|||
145665806|NCT05412004|525297407|FG003|Overall Study|Withdrawal by Subject|14|||
145665807|NCT05412004|525297404|FG000|Overall Study|Screen Failure|0|||
145665808|NCT05412004|525297405|FG001|Overall Study|Screen Failure|0|||
145665809|NCT05412004|525297406|FG002|Overall Study|Screen Failure|0|||
145665810|NCT05412004|525297407|FG003|Overall Study|Screen Failure|1|||
145665811|NCT05412004|525297404|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
145665812|NCT05412004|525297405|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
145665813|NCT05412004|525297406|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
145665814|NCT05412004|525297407|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
145665815|NCT04644029|525297408|FG000|Overall Study|Death|1|||
145665816|NCT04644029|525297409|FG001|Overall Study|Death|0|||
145665817|NCT04644029|525297408|FG000|Overall Study|Physician Decision|1|||
145665818|NCT04644029|525297409|FG001|Overall Study|Physician Decision|2|||
145665819|NCT04644029|525297408|FG000|Overall Study|Withdrawal by Subject|21|||
145665820|NCT04644029|525297409|FG001|Overall Study|Withdrawal by Subject|19|||
145665821|NCT04644029|525297408|FG000|Overall Study|Lost to Follow-up|31|||
145665822|NCT04644029|525297409|FG001|Overall Study|Lost to Follow-up|34|||
145665823|NCT04644029|525297408|FG000|Overall Study|Study Terminated by Sponsor|308|||
145665824|NCT04644029|525297409|FG001|Overall Study|Study Terminated by Sponsor|309|||
145665825|NCT04644029|525297408|FG000|Overall Study|Randomized in Error|2|||
145665826|NCT04644029|525297409|FG001|Overall Study|Randomized in Error|1|||
145665827|NCT04644029|525297408|FG000|Overall Study|Other|0|||
145665828|NCT04644029|525297409|FG001|Overall Study|Other|1|||
145665829|NCT05020353|525297410|FG000|Overall Study|Protocol Violation|7|||
145665830|NCT05020353|525297410|FG000|Overall Study|Withdrawal by Subject|33|||
145665831|NCT05875701|525297412|FG000|Overall Study|Lost to Follow-up|2|||
145665832|NCT05875701|525297413|FG001|Overall Study|Lost to Follow-up|0|||
145665833|NCT05875701|525297412|FG000|Overall Study|Withdrawal by Subject|1|||
145665834|NCT05875701|525297413|FG001|Overall Study|Withdrawal by Subject|1|||
145665835|NCT05988398|525297415|FG000|Overall Study|Lack of time|21|||
145665836|NCT05988398|525297416|FG001|Overall Study|Lack of time|0|||
145665837|NCT05988398|525297415|FG000|Overall Study|Absent from school|0|||
145665838|NCT05988398|525297416|FG001|Overall Study|Absent from school|38|||
145665839|NCT05988398|525297415|FG000|Overall Study|Chose not to participate|0|||
145665840|NCT05988398|525297416|FG001|Overall Study|Chose not to participate|42|||
145665841|NCT05988398|525297415|FG000|Overall Study|Other commitments (e.g., sports)|0|||
145665842|NCT05988398|525297416|FG001|Overall Study|Other commitments (e.g., sports)|25|||
145665843|NCT04408755|525297417|FG000|Period A (Placebo lead-in)|Other|11|||
145665844|NCT04408755|525297418|FG001|Period A (Placebo lead-in)|Other|0|||
145665845|NCT04408755|525297419|FG002|Period A (Placebo lead-in)|Other|0|||
145665846|NCT04408755|525297420|FG003|Period A (Placebo lead-in)|Other|0|||
145665847|NCT04408755|525297417|FG000|Period B (Randomization Period)|Adverse Event|0|||
145665848|NCT04408755|525297418|FG001|Period B (Randomization Period)|Adverse Event|3|||
145665849|NCT04408755|525297419|FG002|Period B (Randomization Period)|Adverse Event|0|||
145665850|NCT04408755|525297420|FG003|Period B (Randomization Period)|Adverse Event|1|||
145665851|NCT04408755|525297417|FG000|Period B (Randomization Period)|Death|0|||
145665852|NCT04408755|525297418|FG001|Period B (Randomization Period)|Death|0|||
145665853|NCT04408755|525297419|FG002|Period B (Randomization Period)|Death|1|||
145665854|NCT04408755|525297420|FG003|Period B (Randomization Period)|Death|0|||
145665855|NCT04408755|525297417|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
145665856|NCT04408755|525297418|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
145665857|NCT04408755|525297419|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
145665858|NCT04408755|525297420|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
145665859|NCT04408755|525297417|FG000|Period B (Randomization Period)|Physician Decision|0|||
145665860|NCT04408755|525297418|FG001|Period B (Randomization Period)|Physician Decision|0|||
145665861|NCT04408755|525297419|FG002|Period B (Randomization Period)|Physician Decision|1|||
145665862|NCT04408755|525297420|FG003|Period B (Randomization Period)|Physician Decision|0|||
145665863|NCT04408755|525297417|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
145665864|NCT04408755|525297418|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
145665865|NCT04408755|525297419|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
145665866|NCT04408755|525297420|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
145665867|NCT04408755|525297417|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
145665868|NCT04408755|525297418|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
145665869|NCT04408755|525297419|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
145665870|NCT04408755|525297420|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
145665871|NCT04408755|525297417|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
145665872|NCT04408755|525297418|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
145665873|NCT04408755|525297419|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
145665874|NCT04408755|525297420|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
145665875|NCT04408755|525297417|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
145490715|NCT04879628|524650402|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
145665876|NCT04408755|525297418|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
145665877|NCT04408755|525297419|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
145490716|NCT04879628|524650403|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
145665878|NCT04408755|525297420|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
145665879|NCT04408755|525297417|FG000|Period B (Randomization Period)|Reason not Specified|0|||
145665880|NCT04408755|525297418|FG001|Period B (Randomization Period)|Reason not Specified|1|||
145665881|NCT04408755|525297419|FG002|Period B (Randomization Period)|Reason not Specified|0|||
145665882|NCT04408755|525297420|FG003|Period B (Randomization Period)|Reason not Specified|2|||
145665883|NCT03816397|525297427|FG000|Overall Study|Censored at interim analysis date.|13|||
145665884|NCT03816397|525297428|FG001|Overall Study|Censored at interim analysis date.|6|||
145665885|NCT03816397|525297427|FG000|Overall Study|Withdrawal by Subject|1|||
145665886|NCT03816397|525297428|FG001|Overall Study|Withdrawal by Subject|1|||
145665887|NCT05836012|525297439|FG000|Overall Study|Lost to Follow-up|1|||
145665888|NCT05836012|525297440|FG001|Overall Study|Lost to Follow-up|0|||
145665889|NCT05836012|525297439|FG000|Overall Study|Withdrawal by Subject|1|||
145665890|NCT05836012|525297440|FG001|Overall Study|Withdrawal by Subject|3|||
145665891|NCT05836012|525297439|FG000|Overall Study|Reason not included in pre-specified categories|2|||
145665892|NCT05836012|525297440|FG001|Overall Study|Reason not included in pre-specified categories|1|||
145665893|NCT05985395|525297441|FG000|Overall Study|Physician Decision|2|||
145665894|NCT05985395|525297442|FG001|Overall Study|Physician Decision|1|||
145665895|NCT05985395|525297441|FG000|Overall Study|Withdrawal by Subject|1|||
145665896|NCT05985395|525297442|FG001|Overall Study|Withdrawal by Subject|0|||
145665897|NCT04908930|525297448|FG000|Overall Study|Lost to Follow-up|1|||
145665898|NCT04908930|525297449|FG001|Overall Study|Lost to Follow-up|1|||
145665899|NCT04908930|525297450|FG002|Overall Study|Lost to Follow-up|0|||
145665900|NCT04908930|525297451|FG003|Overall Study|Lost to Follow-up|0|||
145665901|NCT04908930|525297452|FG004|Overall Study|Lost to Follow-up|0|||
145665902|NCT04908930|525297448|FG000|Overall Study|hardware in mouth|1|||
145665903|NCT04908930|525297449|FG001|Overall Study|hardware in mouth|1|||
145665904|NCT04908930|525297450|FG002|Overall Study|hardware in mouth|0|||
145665905|NCT04908930|525297451|FG003|Overall Study|hardware in mouth|0|||
145665906|NCT04908930|525297452|FG004|Overall Study|hardware in mouth|0|||
145665907|NCT04908930|525297448|FG000|Overall Study|wrong team|1|||
145665908|NCT04908930|525297449|FG001|Overall Study|wrong team|0|||
145665909|NCT04908930|525297450|FG002|Overall Study|wrong team|0|||
145665910|NCT04908930|525297451|FG003|Overall Study|wrong team|0|||
145665911|NCT04908930|525297452|FG004|Overall Study|wrong team|0|||
145665912|NCT04908930|525297448|FG000|Overall Study|quit team|2|||
145665913|NCT04908930|525297449|FG001|Overall Study|quit team|4|||
145665914|NCT04908930|525297450|FG002|Overall Study|quit team|0|||
145665915|NCT04908930|525297451|FG003|Overall Study|quit team|0|||
145665916|NCT04908930|525297452|FG004|Overall Study|quit team|0|||
145665917|NCT04908930|525297448|FG000|Overall Study|Withdrawal by Subject|1|||
145665918|NCT04908930|525297449|FG001|Overall Study|Withdrawal by Subject|2|||
145665919|NCT04908930|525297450|FG002|Overall Study|Withdrawal by Subject|0|||
145665920|NCT04908930|525297451|FG003|Overall Study|Withdrawal by Subject|0|||
145665921|NCT04908930|525297452|FG004|Overall Study|Withdrawal by Subject|0|||
145665922|NCT04908930|525297448|FG000|Overall Study|parent not liking program|0|||
145665923|NCT04908930|525297449|FG001|Overall Study|parent not liking program|1|||
145665924|NCT04908930|525297450|FG002|Overall Study|parent not liking program|0|||
145665925|NCT04908930|525297451|FG003|Overall Study|parent not liking program|0|||
145665926|NCT04908930|525297452|FG004|Overall Study|parent not liking program|0|||
145665927|NCT02777593|525297455|FG000|Overall Study|Still in study|1|||
145665928|NCT02777593|525297456|FG001|Overall Study|Still in study|32|||
145665929|NCT02777593|525297457|FG002|Overall Study|Still in study|3|||
145665930|NCT02777593|525297458|FG003|Overall Study|Still in study|6|||
145665931|NCT02777593|525297459|FG004|Overall Study|Still in study|5|||
145665932|NCT02777593|525297455|FG000|Overall Study|Death|21|||
145665933|NCT02777593|525297456|FG001|Overall Study|Death|28|||
145665934|NCT02777593|525297457|FG002|Overall Study|Death|0|||
145665935|NCT02777593|525297458|FG003|Overall Study|Death|5|||
145665936|NCT02777593|525297459|FG004|Overall Study|Death|0|||
145665937|NCT02777593|525297455|FG000|Overall Study|Withdrawal by Subject|8|||
145665938|NCT02777593|525297456|FG001|Overall Study|Withdrawal by Subject|4|||
145665939|NCT02777593|525297457|FG002|Overall Study|Withdrawal by Subject|1|||
145665940|NCT02777593|525297458|FG003|Overall Study|Withdrawal by Subject|1|||
145665941|NCT02777593|525297459|FG004|Overall Study|Withdrawal by Subject|0|||
145665942|NCT02777593|525297455|FG000|Overall Study|Lost to Follow-up|8|||
145665943|NCT02777593|525297456|FG001|Overall Study|Lost to Follow-up|16|||
145665944|NCT02777593|525297457|FG002|Overall Study|Lost to Follow-up|5|||
145665945|NCT02777593|525297458|FG003|Overall Study|Lost to Follow-up|0|||
145665946|NCT02777593|525297459|FG004|Overall Study|Lost to Follow-up|1|||
145490717|NCT04879628|524650404|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
145665947|NCT02777593|525297455|FG000|Overall Study|Physician Decision|2|||
145665948|NCT02777593|525297456|FG001|Overall Study|Physician Decision|2|||
145665949|NCT02777593|525297457|FG002|Overall Study|Physician Decision|0|||
145665950|NCT02777593|525297458|FG003|Overall Study|Physician Decision|0|||
145665951|NCT02777593|525297459|FG004|Overall Study|Physician Decision|0|||
145665952|NCT02777593|525297455|FG000|Overall Study|Discontinued due to Other|1|||
145665953|NCT02777593|525297456|FG001|Overall Study|Discontinued due to Other|0|||
145665954|NCT02777593|525297457|FG002|Overall Study|Discontinued due to Other|0|||
145665955|NCT02777593|525297458|FG003|Overall Study|Discontinued due to Other|0|||
145665956|NCT02777593|525297459|FG004|Overall Study|Discontinued due to Other|0|||
145665957|NCT03884439|525297460|FG000|Overall Study|No informed consent for publication of study results|38|||
145665958|NCT03884439|525297460|FG000|Overall Study|Contract violation/deficiency|7|||
145665959|NCT06065735|525297466|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
145665960|NCT06065735|525297467|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
145665961|NCT06065735|525297468|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
145665962|NCT06065735|525297466|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
145665963|NCT06065735|525297467|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
145665964|NCT06065735|525297468|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
145665965|NCT06065735|525297466|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
145665966|NCT06065735|525297467|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
145665967|NCT06065735|525297468|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
145665968|NCT06065735|525297466|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
145665969|NCT06065735|525297467|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
145665970|NCT06065735|525297468|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
145665971|NCT06065735|525297466|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
145665972|NCT06065735|525297467|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
145665973|NCT06065735|525297468|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
145665974|NCT02532621|525297469|FG000|Overall Study|Death|3|||
145665975|NCT02532621|525297469|FG000|Overall Study|Lost to Follow-up|3|||
145665976|NCT02532621|525297469|FG000|Overall Study|Withdrawal by Subject|6|||
145665977|NCT02532621|525297469|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
145665978|NCT02532621|525297469|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
145665979|NCT02933489|525297474|FG000|Overall Study|Ineligible|3|||
145665980|NCT02933489|525297475|FG001|Overall Study|Ineligible|3|||
145665981|NCT02933489|525297474|FG000|Overall Study|Withdrawal by Subject|27|||
145665982|NCT02933489|525297475|FG001|Overall Study|Withdrawal by Subject|18|||
145665983|NCT02933489|525297474|FG000|Overall Study|Unable to complete exams (other)|14|||
145665984|NCT02933489|525297475|FG001|Overall Study|Unable to complete exams (other)|7|||
145665985|NCT05485935|525297476|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
145665986|NCT05485935|525297477|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
145665987|NCT05485935|525297476|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
145665988|NCT05485935|525297477|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
145665989|NCT05485935|525297476|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
145665990|NCT05485935|525297477|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
145665991|NCT05485935|525297476|FG000|Period 2 (T2 and V3)|loss of contact|0|||
145665992|NCT05485935|525297477|FG001|Period 2 (T2 and V3)|loss of contact|1|||
145665993|NCT04093869|525297479|FG000|Overall Study|Death|0|||
145665994|NCT04093869|525297480|FG001|Overall Study|Death|1|||
145665995|NCT04093869|525297479|FG000|Overall Study|Withdrawal by Subject|1|||
145665996|NCT04093869|525297480|FG001|Overall Study|Withdrawal by Subject|0|||
145665997|NCT02806726|525297481|FG000|Overall Study|Lost to Follow-up|1|||
145665998|NCT03250676|525297482|FG000|Overall Study|Adverse Event|0|||
145665999|NCT03250676|525297483|FG001|Overall Study|Adverse Event|0|||
145666000|NCT03250676|525297484|FG002|Overall Study|Adverse Event|0|||
145666001|NCT03250676|525297485|FG003|Overall Study|Adverse Event|1|||
145666002|NCT03250676|525297486|FG004|Overall Study|Adverse Event|2|||
145666003|NCT03250676|525297487|FG005|Overall Study|Adverse Event|9|||
145666004|NCT03250676|525297482|FG000|Overall Study|Withdrawal by Subject|1|||
145666005|NCT03250676|525297483|FG001|Overall Study|Withdrawal by Subject|0|||
145666006|NCT03250676|525297484|FG002|Overall Study|Withdrawal by Subject|0|||
145666007|NCT03250676|525297485|FG003|Overall Study|Withdrawal by Subject|1|||
145666008|NCT03250676|525297486|FG004|Overall Study|Withdrawal by Subject|1|||
145666009|NCT03250676|525297487|FG005|Overall Study|Withdrawal by Subject|2|||
145666010|NCT03250676|525297482|FG000|Overall Study|Physician Decision|0|||
145666011|NCT03250676|525297483|FG001|Overall Study|Physician Decision|0|||
145666012|NCT03250676|525297484|FG002|Overall Study|Physician Decision|0|||
145666013|NCT03250676|525297485|FG003|Overall Study|Physician Decision|2|||
145666014|NCT03250676|525297486|FG004|Overall Study|Physician Decision|0|||
145666015|NCT03250676|525297487|FG005|Overall Study|Physician Decision|3|||
145666016|NCT03250676|525297482|FG000|Overall Study|Withdrawal of consent|0|||
145666017|NCT03250676|525297483|FG001|Overall Study|Withdrawal of consent|0|||
145666018|NCT03250676|525297484|FG002|Overall Study|Withdrawal of consent|2|||
145666019|NCT03250676|525297485|FG003|Overall Study|Withdrawal of consent|0|||
145666020|NCT03250676|525297486|FG004|Overall Study|Withdrawal of consent|0|||
145666021|NCT03250676|525297487|FG005|Overall Study|Withdrawal of consent|2|||
145666022|NCT03250676|525297482|FG000|Overall Study|Other|1|||
145666023|NCT03250676|525297483|FG001|Overall Study|Other|0|||
145666024|NCT03250676|525297484|FG002|Overall Study|Other|0|||
145666025|NCT03250676|525297485|FG003|Overall Study|Other|0|||
145666026|NCT03250676|525297486|FG004|Overall Study|Other|0|||
145666027|NCT03250676|525297487|FG005|Overall Study|Other|0|||
145666028|NCT03250676|525297482|FG000|Overall Study|Disease progression|4|||
145666029|NCT03250676|525297483|FG001|Overall Study|Disease progression|12|||
145666030|NCT03250676|525297484|FG002|Overall Study|Disease progression|9|||
145666031|NCT03250676|525297485|FG003|Overall Study|Disease progression|7|||
145666032|NCT03250676|525297486|FG004|Overall Study|Disease progression|4|||
145666033|NCT03250676|525297487|FG005|Overall Study|Disease progression|88|||
145666034|NCT03092674|525297490|FG000|Overall Study|Adverse Event or Side Effects|1|||
145666035|NCT03092674|525297491|FG001|Overall Study|Adverse Event or Side Effects|4|||
145666036|NCT03092674|525297492|FG002|Overall Study|Adverse Event or Side Effects|4|||
145666037|NCT03092674|525297490|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
145666038|NCT03092674|525297491|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
145666039|NCT03092674|525297492|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
145666040|NCT03092674|525297490|FG000|Overall Study|Progression/Relapse|5|||
145666041|NCT03092674|525297491|FG001|Overall Study|Progression/Relapse|4|||
145666042|NCT03092674|525297492|FG002|Overall Study|Progression/Relapse|8|||
145666043|NCT03092674|525297490|FG000|Overall Study|Death|4|||
145666044|NCT03092674|525297491|FG001|Overall Study|Death|8|||
145666045|NCT03092674|525297492|FG002|Overall Study|Death|2|||
145666046|NCT03092674|525297490|FG000|Overall Study|Other - Not Protocol Specified|11|||
145666047|NCT03092674|525297491|FG001|Overall Study|Other - Not Protocol Specified|8|||
145666048|NCT03092674|525297492|FG002|Overall Study|Other - Not Protocol Specified|8|||
145666049|NCT01527188|525297493|FG000|Overall Study|Adverse Event|5|||
145666050|NCT01527188|525297494|FG001|Overall Study|Adverse Event|5|||
145666051|NCT01527188|525297495|FG002|Overall Study|Adverse Event|11|||
145666052|NCT01527188|525297496|FG003|Overall Study|Adverse Event|0|||
145666053|NCT01527188|525297493|FG000|Overall Study|Withdrawal by Subject|3|||
145666054|NCT01527188|525297494|FG001|Overall Study|Withdrawal by Subject|6|||
145666055|NCT01527188|525297495|FG002|Overall Study|Withdrawal by Subject|4|||
145666056|NCT01527188|525297496|FG003|Overall Study|Withdrawal by Subject|4|||
145666057|NCT01527188|525297493|FG000|Overall Study|Any other reason not above-mentioned|6|||
145666058|NCT01527188|525297494|FG001|Overall Study|Any other reason not above-mentioned|7|||
145666059|NCT01527188|525297495|FG002|Overall Study|Any other reason not above-mentioned|8|||
145666060|NCT01527188|525297496|FG003|Overall Study|Any other reason not above-mentioned|8|||
145666061|NCT03982186|525297499|FG000|Overall Study|Lost to Follow-up|0|||
145666062|NCT03982186|525297500|FG001|Overall Study|Lost to Follow-up|1|||
145666063|NCT03982186|525297501|FG002|Overall Study|Lost to Follow-up|2|||
145666064|NCT03982186|525297502|FG003|Overall Study|Lost to Follow-up|1|||
145666065|NCT03982186|525297503|FG004|Overall Study|Lost to Follow-up|1|||
145666066|NCT03982186|525297504|FG005|Overall Study|Lost to Follow-up|0|||
145666067|NCT03982186|525297499|FG000|Overall Study|Physician Decision|0|||
145666068|NCT03982186|525297500|FG001|Overall Study|Physician Decision|1|||
145666069|NCT03982186|525297501|FG002|Overall Study|Physician Decision|0|||
145666070|NCT03982186|525297502|FG003|Overall Study|Physician Decision|0|||
145666071|NCT03982186|525297503|FG004|Overall Study|Physician Decision|0|||
145666072|NCT03982186|525297504|FG005|Overall Study|Physician Decision|0|||
145666073|NCT03982186|525297499|FG000|Overall Study|Withdrawal by Subject|3|||
145666074|NCT03982186|525297500|FG001|Overall Study|Withdrawal by Subject|4|||
145666075|NCT03982186|525297501|FG002|Overall Study|Withdrawal by Subject|1|||
145666076|NCT03982186|525297502|FG003|Overall Study|Withdrawal by Subject|7|||
145666077|NCT03982186|525297503|FG004|Overall Study|Withdrawal by Subject|2|||
145666078|NCT03982186|525297504|FG005|Overall Study|Withdrawal by Subject|0|||
145666079|NCT03982186|525297499|FG000|Overall Study|Randomized and not treated|0|||
145666080|NCT03982186|525297500|FG001|Overall Study|Randomized and not treated|0|||
145666081|NCT03982186|525297501|FG002|Overall Study|Randomized and not treated|0|||
145666082|NCT03982186|525297502|FG003|Overall Study|Randomized and not treated|1|||
145666083|NCT03982186|525297503|FG004|Overall Study|Randomized and not treated|0|||
145666084|NCT03982186|525297504|FG005|Overall Study|Randomized and not treated|0|||
145666085|NCT05267639|525298208|FG000|Overall Study|Withdrawal by Subject|1|||
145666086|NCT05267639|525298209|FG001|Overall Study|Withdrawal by Subject|0|||
145666087|NCT03512301|525298219|FG000|Overall Study|Protocol Violation|2|||
145666088|NCT03512301|525298219|FG000|Overall Study|Did Not Qualify|3|||
145666089|NCT03512301|525298219|FG000|Overall Study|Age-ineligible|1|||
145666090|NCT03512301|525298219|FG000|Overall Study|Inadequate fluency with the English language|3|||
145666091|NCT02611687|525298224|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
145666092|NCT02611687|525298225|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
145666093|NCT03934931|525298226|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
145666094|NCT03934931|525298227|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
145666095|NCT03934931|525298228|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
145666096|NCT04933474|525298233|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
145666097|NCT04933474|525298234|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
145666098|NCT04933474|525298233|FG000|Overall Study|Lost to Follow-up|19|||
145666099|NCT04933474|525298234|FG001|Overall Study|Lost to Follow-up|9|||
145666100|NCT04933474|525298233|FG000|Overall Study|Life Burden - unable to participate|6|||
145666101|NCT04933474|525298234|FG001|Overall Study|Life Burden - unable to participate|2|||
145666102|NCT04933474|525298233|FG000|Overall Study|Disease Burden - unable to participate|4|||
145666103|NCT04933474|525298234|FG001|Overall Study|Disease Burden - unable to participate|1|||
145666104|NCT04933474|525298233|FG000|Overall Study|Surgery/Hospitalization|1|||
145666105|NCT04933474|525298234|FG001|Overall Study|Surgery/Hospitalization|2|||
145666106|NCT04933474|525298233|FG000|Overall Study|Dissatisfied with Intervention|1|||
145666107|NCT04933474|525298234|FG001|Overall Study|Dissatisfied with Intervention|1|||
145666108|NCT04933474|525298233|FG000|Overall Study|Withdrew interest in participation|1|||
145666109|NCT04933474|525298234|FG001|Overall Study|Withdrew interest in participation|0|||
145666110|NCT04933474|525298233|FG000|Overall Study|Had previously enrolled in the study|0|||
145666111|NCT04933474|525298234|FG001|Overall Study|Had previously enrolled in the study|1|||
145666112|NCT04772534|525298239|FG000|Overall Study|Physician Decision|1|||
145666113|NCT04772534|525298240|FG001|Overall Study|Physician Decision|0|||
145666114|NCT04772534|525298241|FG002|Overall Study|Physician Decision|0|||
145666115|NCT04772534|525298239|FG000|Overall Study|Withdrawal by Subject|3|||
145666116|NCT04772534|525298240|FG001|Overall Study|Withdrawal by Subject|0|||
145666117|NCT04772534|525298241|FG002|Overall Study|Withdrawal by Subject|1|||
145666118|NCT03786926|525298244|FG000|Overall Study|Adverse Event|0|||
145666119|NCT03786926|525298245|FG001|Overall Study|Adverse Event|0|||
145666120|NCT03786926|525298246|FG002|Overall Study|Adverse Event|0|||
145666121|NCT03786926|525298247|FG003|Overall Study|Adverse Event|0|||
145666122|NCT03786926|525298248|FG004|Overall Study|Adverse Event|0|||
145666123|NCT03786926|525298249|FG005|Overall Study|Adverse Event|0|||
145490718|NCT03649074|524650405|FG000|Overall Study|Lost to Follow-up|2|||
145490719|NCT03649074|524650406|FG001|Overall Study|Lost to Follow-up|1|||
145490720|NCT03649074|524650405|FG000|Overall Study|Adverse Event|1|||
145490721|NCT03649074|524650406|FG001|Overall Study|Adverse Event|0|||
145490722|NCT03649074|524650405|FG000|Overall Study|Physician Decision|1|||
145490723|NCT03649074|524650406|FG001|Overall Study|Physician Decision|0|||
145490724|NCT03649074|524650405|FG000|Overall Study|Withdrawal by Subject|0|||
145490725|NCT03649074|524650406|FG001|Overall Study|Withdrawal by Subject|2|||
145490726|NCT03649074|524650405|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
145490727|NCT03649074|524650406|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
145490728|NCT03649074|524650405|FG000|Overall Study|Other|1|||
145490729|NCT03649074|524650406|FG001|Overall Study|Other|0|||
145490730|NCT02775916|524650409|FG000|Overall Study|Adverse Event|1|||
145490731|NCT02775916|524650410|FG001|Overall Study|Adverse Event|0|||
145490732|NCT02775916|524650409|FG000|Overall Study|Subject/Guardian Decision|2|||
145490733|NCT02775916|524650410|FG001|Overall Study|Subject/Guardian Decision|0|||
145490734|NCT02426580|524652198|FG000|Overall Study|Death|2|||
145490735|NCT02426580|524652199|FG001|Overall Study|Death|2|||
145490736|NCT02426580|524652198|FG000|Overall Study|Lost to Follow-up|0|||
145490737|NCT02426580|524652199|FG001|Overall Study|Lost to Follow-up|9|||
145490738|NCT02426580|524652198|FG000|Overall Study|transfer to hemodialysis|5|||
145490739|NCT02426580|524652199|FG001|Overall Study|transfer to hemodialysis|5|||
145490740|NCT02426580|524652198|FG000|Overall Study|Kidney transplant|3|||
145490741|NCT02426580|524652199|FG001|Overall Study|Kidney transplant|0|||
145490742|NCT02426580|524652198|FG000|Overall Study|Allergic to egg white|1|||
145490743|NCT02426580|524652199|FG001|Overall Study|Allergic to egg white|0|||
145490744|NCT00383552|524652202|FG000|Overall Study|Adverse Event|7|||
145490745|NCT00383552|524652203|FG001|Overall Study|Adverse Event|6|||
145490746|NCT00383552|524652204|FG002|Overall Study|Adverse Event|9|||
145666124|NCT03786926|525298250|FG006|Overall Study|Adverse Event|0|||
145666125|NCT03786926|525298251|FG007|Overall Study|Adverse Event|1|||
145666126|NCT03786926|525298252|FG008|Overall Study|Adverse Event|1|||
145666127|NCT03786926|525298253|FG009|Overall Study|Adverse Event|0|||
145666128|NCT03786926|525298254|FG010|Overall Study|Adverse Event|1|||
145666129|NCT03786926|525298244|FG000|Overall Study|Progressive disease|3|||
145666130|NCT03786926|525298245|FG001|Overall Study|Progressive disease|0|||
145666131|NCT03786926|525298246|FG002|Overall Study|Progressive disease|3|||
145666132|NCT03786926|525298247|FG003|Overall Study|Progressive disease|1|||
145666133|NCT03786926|525298248|FG004|Overall Study|Progressive disease|2|||
145666134|NCT03786926|525298249|FG005|Overall Study|Progressive disease|2|||
145666135|NCT03786926|525298250|FG006|Overall Study|Progressive disease|1|||
145666136|NCT03786926|525298251|FG007|Overall Study|Progressive disease|6|||
145666137|NCT03786926|525298252|FG008|Overall Study|Progressive disease|1|||
145666138|NCT03786926|525298253|FG009|Overall Study|Progressive disease|1|||
145666139|NCT03786926|525298254|FG010|Overall Study|Progressive disease|1|||
145666140|NCT03786926|525298244|FG000|Overall Study|Death|0|||
145666141|NCT03786926|525298245|FG001|Overall Study|Death|1|||
145666142|NCT03786926|525298246|FG002|Overall Study|Death|1|||
145666143|NCT03786926|525298247|FG003|Overall Study|Death|0|||
145666144|NCT03786926|525298248|FG004|Overall Study|Death|0|||
145666145|NCT03786926|525298249|FG005|Overall Study|Death|0|||
145666146|NCT03786926|525298250|FG006|Overall Study|Death|0|||
145666147|NCT03786926|525298251|FG007|Overall Study|Death|0|||
145666148|NCT03786926|525298252|FG008|Overall Study|Death|0|||
145666149|NCT03786926|525298253|FG009|Overall Study|Death|1|||
145490747|NCT00383552|524652205|FG003|Overall Study|Adverse Event|6|||
145490748|NCT00383552|524652202|FG000|Overall Study|Lack of Efficacy|4|||
145490749|NCT00383552|524652203|FG001|Overall Study|Lack of Efficacy|13|||
145490750|NCT00383552|524652204|FG002|Overall Study|Lack of Efficacy|29|||
145666150|NCT03786926|525298254|FG010|Overall Study|Death|2|||
145666151|NCT03786926|525298244|FG000|Overall Study|Physician Decision|0|||
145666152|NCT03786926|525298245|FG001|Overall Study|Physician Decision|1|||
145666153|NCT03786926|525298246|FG002|Overall Study|Physician Decision|0|||
145666154|NCT03786926|525298247|FG003|Overall Study|Physician Decision|1|||
145666155|NCT03786926|525298248|FG004|Overall Study|Physician Decision|2|||
145666156|NCT03786926|525298249|FG005|Overall Study|Physician Decision|0|||
145666157|NCT03786926|525298250|FG006|Overall Study|Physician Decision|0|||
145666158|NCT03786926|525298251|FG007|Overall Study|Physician Decision|2|||
145666159|NCT03786926|525298252|FG008|Overall Study|Physician Decision|1|||
145666160|NCT03786926|525298253|FG009|Overall Study|Physician Decision|1|||
145666161|NCT03786926|525298254|FG010|Overall Study|Physician Decision|0|||
145666162|NCT03786926|525298244|FG000|Overall Study|Withdrawal by Subject|0|||
145666163|NCT03786926|525298245|FG001|Overall Study|Withdrawal by Subject|1|||
145666164|NCT03786926|525298246|FG002|Overall Study|Withdrawal by Subject|1|||
145666165|NCT03786926|525298247|FG003|Overall Study|Withdrawal by Subject|0|||
145666166|NCT03786926|525298248|FG004|Overall Study|Withdrawal by Subject|0|||
145666167|NCT03786926|525298249|FG005|Overall Study|Withdrawal by Subject|0|||
145666168|NCT03786926|525298250|FG006|Overall Study|Withdrawal by Subject|1|||
145666169|NCT03786926|525298251|FG007|Overall Study|Withdrawal by Subject|0|||
145666170|NCT03786926|525298252|FG008|Overall Study|Withdrawal by Subject|1|||
145666171|NCT03786926|525298253|FG009|Overall Study|Withdrawal by Subject|0|||
145666172|NCT03786926|525298254|FG010|Overall Study|Withdrawal by Subject|1|||
145666173|NCT03786926|525298244|FG000|Overall Study|Study terminated by Sponsor|0|||
145666174|NCT03786926|525298245|FG001|Overall Study|Study terminated by Sponsor|0|||
145666175|NCT03786926|525298246|FG002|Overall Study|Study terminated by Sponsor|0|||
145666176|NCT03786926|525298247|FG003|Overall Study|Study terminated by Sponsor|0|||
145666177|NCT03786926|525298248|FG004|Overall Study|Study terminated by Sponsor|1|||
145666178|NCT03786926|525298249|FG005|Overall Study|Study terminated by Sponsor|0|||
145666179|NCT03786926|525298250|FG006|Overall Study|Study terminated by Sponsor|0|||
145666180|NCT03786926|525298251|FG007|Overall Study|Study terminated by Sponsor|4|||
145666181|NCT03786926|525298252|FG008|Overall Study|Study terminated by Sponsor|0|||
145666182|NCT03786926|525298253|FG009|Overall Study|Study terminated by Sponsor|0|||
145666183|NCT03786926|525298254|FG010|Overall Study|Study terminated by Sponsor|0|||
145666184|NCT03786926|525298244|FG000|Overall Study|Anti-neoplasm treatment|0|||
145666185|NCT03786926|525298245|FG001|Overall Study|Anti-neoplasm treatment|0|||
145666186|NCT03786926|525298246|FG002|Overall Study|Anti-neoplasm treatment|0|||
145666187|NCT03786926|525298247|FG003|Overall Study|Anti-neoplasm treatment|0|||
145666188|NCT03786926|525298248|FG004|Overall Study|Anti-neoplasm treatment|1|||
145666189|NCT03786926|525298249|FG005|Overall Study|Anti-neoplasm treatment|0|||
145666190|NCT03786926|525298250|FG006|Overall Study|Anti-neoplasm treatment|1|||
145666191|NCT03786926|525298251|FG007|Overall Study|Anti-neoplasm treatment|0|||
145666192|NCT03786926|525298252|FG008|Overall Study|Anti-neoplasm treatment|0|||
145666193|NCT03786926|525298253|FG009|Overall Study|Anti-neoplasm treatment|0|||
145666194|NCT03786926|525298254|FG010|Overall Study|Anti-neoplasm treatment|0|||
145666195|NCT03786926|525298244|FG000|Overall Study|Other|0|||
145666196|NCT03786926|525298245|FG001|Overall Study|Other|0|||
145666197|NCT03786926|525298246|FG002|Overall Study|Other|0|||
145666198|NCT03786926|525298247|FG003|Overall Study|Other|1|||
145666199|NCT03786926|525298248|FG004|Overall Study|Other|0|||
145666200|NCT03786926|525298249|FG005|Overall Study|Other|1|||
145666201|NCT03786926|525298250|FG006|Overall Study|Other|0|||
145666202|NCT03786926|525298251|FG007|Overall Study|Other|0|||
145666203|NCT03786926|525298252|FG008|Overall Study|Other|2|||
145666204|NCT03786926|525298253|FG009|Overall Study|Other|0|||
145666205|NCT03786926|525298254|FG010|Overall Study|Other|0|||
145666206|NCT00308997|525298262|FG000|Overall Study|Subject feigned clinical data|0|||
145666207|NCT00308997|525298263|FG001|Overall Study|Subject feigned clinical data|1|||
145666208|NCT00308997|525298262|FG000|Overall Study|Unable to tolerate intervention|1|||
145666209|NCT00308997|525298263|FG001|Overall Study|Unable to tolerate intervention|0|||
145666210|NCT04490356|525298264|FG000|Overall Study|Lost to Follow-up|1|||
145666211|NCT03733626|525298270|FG000|Overall Study|Physician Decision|4|||
145666212|NCT03733626|525298271|FG001|Overall Study|Physician Decision|4|||
145666213|NCT05129501|525298272|FG000|Overall Study|Lost to Follow-up|54|||
145666214|NCT05129501|525298273|FG001|Overall Study|Lost to Follow-up|41|||
145666215|NCT00709956|525298274|FG000|Overall Study|Withdrawal by Subject|1|||
145666216|NCT00709956|525298275|FG001|Overall Study|Withdrawal by Subject|1|||
145666217|NCT00709956|525298274|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
145666218|NCT00709956|525298275|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
145666219|NCT01105091|525298276|FG000|Overall Study|Death|2|||
145666220|NCT01105091|525298277|FG001|Overall Study|Death|0|||
145666221|NCT03705793|525299248|FG000|Overall Study|Lost to Follow-up|3|||
145666222|NCT03705793|525299249|FG001|Overall Study|Lost to Follow-up|4|||
145666223|NCT03705793|525299248|FG000|Overall Study|Withdrawal by Subject|2|||
145666224|NCT03705793|525299249|FG001|Overall Study|Withdrawal by Subject|1|||
145666225|NCT00447980|525299250|FG000|Overall Study|Withdrawal by Subject|1|||
145666226|NCT00447980|525299251|FG001|Overall Study|Withdrawal by Subject|1|||
145666227|NCT00447980|525299252|FG002|Overall Study|Withdrawal by Subject|4|||
145666228|NCT00447980|525299253|FG003|Overall Study|Withdrawal by Subject|4|||
145666229|NCT00447980|525299250|FG000|Overall Study|Lost to Follow-up|1|||
145666230|NCT00447980|525299251|FG001|Overall Study|Lost to Follow-up|1|||
145666231|NCT00447980|525299252|FG002|Overall Study|Lost to Follow-up|0|||
145666232|NCT00447980|525299253|FG003|Overall Study|Lost to Follow-up|0|||
145666233|NCT00447980|525299250|FG000|Overall Study|Did not proceed with surgery|3|||
145666234|NCT00447980|525299251|FG001|Overall Study|Did not proceed with surgery|3|||
145666235|NCT00447980|525299252|FG002|Overall Study|Did not proceed with surgery|2|||
145666236|NCT00447980|525299253|FG003|Overall Study|Did not proceed with surgery|2|||
145666237|NCT02720068|525299254|FG000|Overall Study|Adverse Event|0|||
145666238|NCT02720068|525299255|FG001|Overall Study|Adverse Event|0|||
145666239|NCT02720068|525299256|FG002|Overall Study|Adverse Event|0|||
145666240|NCT02720068|525299257|FG003|Overall Study|Adverse Event|0|||
145666241|NCT02720068|525299258|FG004|Overall Study|Adverse Event|0|||
145666242|NCT02720068|525299259|FG005|Overall Study|Adverse Event|0|||
145666243|NCT02720068|525299260|FG006|Overall Study|Adverse Event|0|||
145666244|NCT02720068|525299261|FG007|Overall Study|Adverse Event|0|||
145666245|NCT02720068|525299262|FG008|Overall Study|Adverse Event|0|||
145666246|NCT02720068|525299263|FG009|Overall Study|Adverse Event|0|||
145666247|NCT02720068|525299264|FG010|Overall Study|Adverse Event|0|||
145666248|NCT02720068|525299265|FG011|Overall Study|Adverse Event|1|||
145666249|NCT02720068|525299266|FG012|Overall Study|Adverse Event|0|||
145666250|NCT02720068|525299267|FG013|Overall Study|Adverse Event|0|||
145666251|NCT02720068|525299268|FG014|Overall Study|Adverse Event|0|||
145666252|NCT02720068|525299269|FG015|Overall Study|Adverse Event|0|||
145666253|NCT02720068|525299270|FG016|Overall Study|Adverse Event|0|||
145666254|NCT02720068|525299271|FG017|Overall Study|Adverse Event|0|||
145666255|NCT02720068|525299254|FG000|Overall Study|Death|1|||
145666256|NCT02720068|525299255|FG001|Overall Study|Death|3|||
145666257|NCT02720068|525299256|FG002|Overall Study|Death|2|||
145666258|NCT02720068|525299257|FG003|Overall Study|Death|1|||
145666259|NCT02720068|525299258|FG004|Overall Study|Death|2|||
145666260|NCT02720068|525299259|FG005|Overall Study|Death|1|||
145666261|NCT02720068|525299260|FG006|Overall Study|Death|2|||
145666262|NCT02720068|525299261|FG007|Overall Study|Death|2|||
145666263|NCT02720068|525299262|FG008|Overall Study|Death|3|||
145666264|NCT02720068|525299263|FG009|Overall Study|Death|1|||
145666265|NCT02720068|525299264|FG010|Overall Study|Death|20|||
145666266|NCT02720068|525299265|FG011|Overall Study|Death|166|||
145666267|NCT02720068|525299266|FG012|Overall Study|Death|34|||
145666268|NCT02720068|525299267|FG013|Overall Study|Death|30|||
145666269|NCT02720068|525299268|FG014|Overall Study|Death|45|||
145666270|NCT02720068|525299269|FG015|Overall Study|Death|16|||
145666271|NCT02720068|525299270|FG016|Overall Study|Death|20|||
145666272|NCT02720068|525299271|FG017|Overall Study|Death|28|||
145666273|NCT02720068|525299254|FG000|Overall Study|Lost to Follow-up|0|||
145666274|NCT02720068|525299255|FG001|Overall Study|Lost to Follow-up|0|||
145666275|NCT02720068|525299256|FG002|Overall Study|Lost to Follow-up|0|||
145666276|NCT02720068|525299257|FG003|Overall Study|Lost to Follow-up|0|||
145666277|NCT02720068|525299258|FG004|Overall Study|Lost to Follow-up|0|||
145666278|NCT02720068|525299259|FG005|Overall Study|Lost to Follow-up|0|||
145666279|NCT02720068|525299260|FG006|Overall Study|Lost to Follow-up|0|||
145666280|NCT02720068|525299261|FG007|Overall Study|Lost to Follow-up|0|||
145666281|NCT02720068|525299262|FG008|Overall Study|Lost to Follow-up|0|||
145666282|NCT02720068|525299263|FG009|Overall Study|Lost to Follow-up|0|||
145666283|NCT02720068|525299264|FG010|Overall Study|Lost to Follow-up|0|||
145666284|NCT02720068|525299265|FG011|Overall Study|Lost to Follow-up|1|||
145666285|NCT02720068|525299266|FG012|Overall Study|Lost to Follow-up|0|||
145666286|NCT02720068|525299267|FG013|Overall Study|Lost to Follow-up|1|||
145666287|NCT02720068|525299268|FG014|Overall Study|Lost to Follow-up|2|||
145666288|NCT02720068|525299269|FG015|Overall Study|Lost to Follow-up|0|||
145666289|NCT02720068|525299270|FG016|Overall Study|Lost to Follow-up|0|||
145666290|NCT02720068|525299271|FG017|Overall Study|Lost to Follow-up|1|||
145666291|NCT02720068|525299254|FG000|Overall Study|Physician Decision|0|||
145666292|NCT02720068|525299255|FG001|Overall Study|Physician Decision|0|||
145666293|NCT02720068|525299256|FG002|Overall Study|Physician Decision|0|||
145666294|NCT02720068|525299257|FG003|Overall Study|Physician Decision|1|||
145666295|NCT02720068|525299258|FG004|Overall Study|Physician Decision|0|||
145666296|NCT02720068|525299259|FG005|Overall Study|Physician Decision|0|||
145666297|NCT02720068|525299260|FG006|Overall Study|Physician Decision|0|||
145666298|NCT02720068|525299261|FG007|Overall Study|Physician Decision|0|||
145666299|NCT02720068|525299262|FG008|Overall Study|Physician Decision|0|||
145666300|NCT02720068|525299263|FG009|Overall Study|Physician Decision|0|||
145666301|NCT02720068|525299264|FG010|Overall Study|Physician Decision|0|||
145666302|NCT02720068|525299265|FG011|Overall Study|Physician Decision|1|||
145666303|NCT02720068|525299266|FG012|Overall Study|Physician Decision|0|||
145666304|NCT02720068|525299267|FG013|Overall Study|Physician Decision|0|||
145666305|NCT02720068|525299268|FG014|Overall Study|Physician Decision|0|||
145666306|NCT02720068|525299269|FG015|Overall Study|Physician Decision|0|||
145666307|NCT02720068|525299270|FG016|Overall Study|Physician Decision|0|||
145666308|NCT02720068|525299271|FG017|Overall Study|Physician Decision|1|||
145666309|NCT02720068|525299254|FG000|Overall Study|Progressive Disease|2|||
145666310|NCT02720068|525299255|FG001|Overall Study|Progressive Disease|3|||
145666311|NCT02720068|525299256|FG002|Overall Study|Progressive Disease|1|||
145666312|NCT02720068|525299257|FG003|Overall Study|Progressive Disease|1|||
145666313|NCT02720068|525299258|FG004|Overall Study|Progressive Disease|1|||
145666314|NCT02720068|525299259|FG005|Overall Study|Progressive Disease|2|||
145666315|NCT02720068|525299260|FG006|Overall Study|Progressive Disease|1|||
145666316|NCT02720068|525299261|FG007|Overall Study|Progressive Disease|1|||
145666317|NCT02720068|525299262|FG008|Overall Study|Progressive Disease|0|||
145666318|NCT02720068|525299263|FG009|Overall Study|Progressive Disease|1|||
145666319|NCT02720068|525299264|FG010|Overall Study|Progressive Disease|0|||
145666320|NCT02720068|525299265|FG011|Overall Study|Progressive Disease|4|||
145666321|NCT02720068|525299266|FG012|Overall Study|Progressive Disease|1|||
145666322|NCT02720068|525299267|FG013|Overall Study|Progressive Disease|0|||
145666323|NCT02720068|525299268|FG014|Overall Study|Progressive Disease|0|||
145666324|NCT02720068|525299269|FG015|Overall Study|Progressive Disease|0|||
145666325|NCT02720068|525299270|FG016|Overall Study|Progressive Disease|0|||
145666326|NCT02720068|525299271|FG017|Overall Study|Progressive Disease|0|||
145666327|NCT02720068|525299254|FG000|Overall Study|Sponsor Decision|0|||
145666328|NCT02720068|525299255|FG001|Overall Study|Sponsor Decision|0|||
145666329|NCT02720068|525299256|FG002|Overall Study|Sponsor Decision|0|||
145666330|NCT02720068|525299257|FG003|Overall Study|Sponsor Decision|0|||
145666331|NCT02720068|525299258|FG004|Overall Study|Sponsor Decision|0|||
145666332|NCT02720068|525299259|FG005|Overall Study|Sponsor Decision|0|||
145666333|NCT02720068|525299260|FG006|Overall Study|Sponsor Decision|0|||
145666334|NCT02720068|525299261|FG007|Overall Study|Sponsor Decision|0|||
145666335|NCT02720068|525299262|FG008|Overall Study|Sponsor Decision|0|||
145666336|NCT02720068|525299263|FG009|Overall Study|Sponsor Decision|0|||
145666337|NCT02720068|525299264|FG010|Overall Study|Sponsor Decision|0|||
145666338|NCT02720068|525299265|FG011|Overall Study|Sponsor Decision|6|||
145666339|NCT02720068|525299266|FG012|Overall Study|Sponsor Decision|3|||
145666340|NCT02720068|525299267|FG013|Overall Study|Sponsor Decision|2|||
145666341|NCT02720068|525299268|FG014|Overall Study|Sponsor Decision|4|||
145666342|NCT02720068|525299269|FG015|Overall Study|Sponsor Decision|4|||
145666343|NCT02720068|525299270|FG016|Overall Study|Sponsor Decision|0|||
145666344|NCT02720068|525299271|FG017|Overall Study|Sponsor Decision|8|||
145666345|NCT02720068|525299254|FG000|Overall Study|Withdrawal by Subject|0|||
145666346|NCT02720068|525299255|FG001|Overall Study|Withdrawal by Subject|0|||
145666347|NCT02720068|525299256|FG002|Overall Study|Withdrawal by Subject|0|||
145666348|NCT02720068|525299257|FG003|Overall Study|Withdrawal by Subject|0|||
145666349|NCT02720068|525299258|FG004|Overall Study|Withdrawal by Subject|0|||
145666350|NCT02720068|525299259|FG005|Overall Study|Withdrawal by Subject|0|||
145666351|NCT02720068|525299260|FG006|Overall Study|Withdrawal by Subject|0|||
145666352|NCT02720068|525299261|FG007|Overall Study|Withdrawal by Subject|0|||
145666353|NCT02720068|525299262|FG008|Overall Study|Withdrawal by Subject|0|||
145666354|NCT02720068|525299263|FG009|Overall Study|Withdrawal by Subject|1|||
145666355|NCT02720068|525299264|FG010|Overall Study|Withdrawal by Subject|0|||
145666356|NCT02720068|525299265|FG011|Overall Study|Withdrawal by Subject|27|||
145666357|NCT02720068|525299266|FG012|Overall Study|Withdrawal by Subject|2|||
145666358|NCT02720068|525299267|FG013|Overall Study|Withdrawal by Subject|8|||
145666359|NCT02720068|525299268|FG014|Overall Study|Withdrawal by Subject|7|||
145666360|NCT02720068|525299269|FG015|Overall Study|Withdrawal by Subject|0|||
145666361|NCT02720068|525299270|FG016|Overall Study|Withdrawal by Subject|0|||
145666362|NCT02720068|525299271|FG017|Overall Study|Withdrawal by Subject|2|||
145666363|NCT02720068|525299254|FG000|Overall Study|Protocol Violation|0|||
145666364|NCT02720068|525299255|FG001|Overall Study|Protocol Violation|0|||
145666365|NCT02720068|525299256|FG002|Overall Study|Protocol Violation|0|||
145666366|NCT02720068|525299257|FG003|Overall Study|Protocol Violation|0|||
145666367|NCT02720068|525299258|FG004|Overall Study|Protocol Violation|0|||
145666368|NCT02720068|525299259|FG005|Overall Study|Protocol Violation|0|||
145666369|NCT02720068|525299260|FG006|Overall Study|Protocol Violation|0|||
145666370|NCT02720068|525299261|FG007|Overall Study|Protocol Violation|0|||
145666371|NCT02720068|525299262|FG008|Overall Study|Protocol Violation|0|||
145666372|NCT02720068|525299263|FG009|Overall Study|Protocol Violation|0|||
145666373|NCT02720068|525299264|FG010|Overall Study|Protocol Violation|1|||
145666374|NCT02720068|525299265|FG011|Overall Study|Protocol Violation|0|||
145666375|NCT02720068|525299266|FG012|Overall Study|Protocol Violation|0|||
145666376|NCT02720068|525299267|FG013|Overall Study|Protocol Violation|0|||
145666377|NCT02720068|525299268|FG014|Overall Study|Protocol Violation|1|||
145666378|NCT02720068|525299269|FG015|Overall Study|Protocol Violation|0|||
145666379|NCT02720068|525299270|FG016|Overall Study|Protocol Violation|1|||
145666380|NCT02720068|525299271|FG017|Overall Study|Protocol Violation|0|||
145666381|NCT02467270|525299284|FG000|Overall Study|Participants Never Treated|0|||
145666382|NCT02467270|525299285|FG001|Overall Study|Participants Never Treated|1|||
145666383|NCT02467270|525299286|FG002|Overall Study|Participants Never Treated|0|||
145666384|NCT02467270|525299284|FG000|Overall Study|Ongoing|50|||
145666385|NCT02467270|525299285|FG001|Overall Study|Ongoing|41|||
145666386|NCT02467270|525299286|FG002|Overall Study|Ongoing|43|||
145666387|NCT02467270|525299284|FG000|Overall Study|Adverse Event|16|||
145666388|NCT02467270|525299285|FG001|Overall Study|Adverse Event|15|||
145666389|NCT02467270|525299286|FG002|Overall Study|Adverse Event|14|||
145666390|NCT02467270|525299284|FG000|Overall Study|Progressive Disease|7|||
145666391|NCT02467270|525299285|FG001|Overall Study|Progressive Disease|7|||
145666392|NCT02467270|525299286|FG002|Overall Study|Progressive Disease|4|||
145666393|NCT02467270|525299284|FG000|Overall Study|Death|2|||
145666394|NCT02467270|525299285|FG001|Overall Study|Death|0|||
145666395|NCT02467270|525299286|FG002|Overall Study|Death|2|||
145666396|NCT02467270|525299284|FG000|Overall Study|Lack of Efficacy|12|||
145666397|NCT02467270|525299285|FG001|Overall Study|Lack of Efficacy|18|||
145666398|NCT02467270|525299286|FG002|Overall Study|Lack of Efficacy|23|||
145666399|NCT02467270|525299284|FG000|Overall Study|Non-compliance With Study Drug|0|||
145666400|NCT02467270|525299285|FG001|Overall Study|Non-compliance With Study Drug|2|||
145666401|NCT02467270|525299286|FG002|Overall Study|Non-compliance With Study Drug|1|||
145666402|NCT02467270|525299284|FG000|Overall Study|Lost to Follow-up|2|||
145666403|NCT02467270|525299285|FG001|Overall Study|Lost to Follow-up|1|||
145666404|NCT02467270|525299286|FG002|Overall Study|Lost to Follow-up|0|||
145666405|NCT02467270|525299284|FG000|Overall Study|Pregnancy|0|||
145666406|NCT02467270|525299285|FG001|Overall Study|Pregnancy|1|||
145666407|NCT02467270|525299286|FG002|Overall Study|Pregnancy|0|||
145666408|NCT02467270|525299284|FG000|Overall Study|Physician Decision|0|||
145666409|NCT02467270|525299285|FG001|Overall Study|Physician Decision|4|||
145666410|NCT02467270|525299286|FG002|Overall Study|Physician Decision|1|||
145666411|NCT02467270|525299284|FG000|Overall Study|Withdrawal by Subject|4|||
145666412|NCT02467270|525299285|FG001|Overall Study|Withdrawal by Subject|3|||
145666413|NCT02467270|525299286|FG002|Overall Study|Withdrawal by Subject|5|||
145666414|NCT02467270|525299284|FG000|Overall Study|Reason not Specified|1|||
145666415|NCT02467270|525299285|FG001|Overall Study|Reason not Specified|2|||
145666416|NCT02467270|525299286|FG002|Overall Study|Reason not Specified|1|||
145666417|NCT00739908|525299287|FG000|Overall Study|Adverse Event|5|||
145666418|NCT00739908|525299288|FG001|Overall Study|Adverse Event|6|||
145666419|NCT00739908|525299287|FG000|Overall Study|Withdrawal by Subject|4|||
145666420|NCT00739908|525299288|FG001|Overall Study|Withdrawal by Subject|2|||
145666421|NCT00739908|525299287|FG000|Overall Study|Lost to Follow-up|14|||
145666422|NCT00739908|525299288|FG001|Overall Study|Lost to Follow-up|9|||
145666423|NCT00739908|525299287|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
145666424|NCT00739908|525299288|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
145666425|NCT00739908|525299287|FG000|Overall Study|Non-Compliance With Study Medication|0|||
145666426|NCT00739908|525299288|FG001|Overall Study|Non-Compliance With Study Medication|3|||
145666427|NCT00739908|525299287|FG000|Overall Study|Lack of Efficacy|0|||
145666428|NCT00739908|525299288|FG001|Overall Study|Lack of Efficacy|1|||
145666429|NCT00739908|525299287|FG000|Overall Study|Relocation|0|||
145666430|NCT00739908|525299288|FG001|Overall Study|Relocation|1|||
145666431|NCT05157841|525299289|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
145666432|NCT05157841|525299290|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
145666433|NCT05157841|525299291|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
145666434|NCT05157841|525299289|FG000|Part A (14 Days)|Adverse Event|1|||
145666435|NCT05157841|525299290|FG001|Part A (14 Days)|Adverse Event|0|||
145666436|NCT05157841|525299291|FG002|Part A (14 Days)|Adverse Event|0|||
145666437|NCT05157841|525299289|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
145666438|NCT05157841|525299290|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
145666439|NCT05157841|525299291|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
145666440|NCT02075554|525299295|FG000|Overall Study|Lost to Follow-up|7|||
145666441|NCT02075554|525299295|FG000|Overall Study|Withdrawal by Subject|5|||
145666442|NCT02075554|525299295|FG000|Overall Study|Physician Decision|3|||
145666443|NCT01773993|525299301|FG000|Overall Study|No Visit After Treatment|35|||
145666444|NCT04993677|525299302|FG000|Overall Study|Lost to Follow-up|1|||
145666445|NCT04993677|525299303|FG001|Overall Study|Lost to Follow-up|0|||
145666446|NCT04993677|525299304|FG002|Overall Study|Lost to Follow-up|0|||
145666447|NCT04993677|525299305|FG003|Overall Study|Lost to Follow-up|0|||
145666448|NCT04993677|525299302|FG000|Overall Study|Death|11|||
145666449|NCT04993677|525299303|FG001|Overall Study|Death|8|||
145666450|NCT04993677|525299304|FG002|Overall Study|Death|3|||
145666451|NCT04993677|525299305|FG003|Overall Study|Death|1|||
145666452|NCT04993677|525299302|FG000|Overall Study|Subject withdrawal of consent|4|||
145666453|NCT04993677|525299303|FG001|Overall Study|Subject withdrawal of consent|3|||
145666454|NCT04993677|525299304|FG002|Overall Study|Subject withdrawal of consent|0|||
145666455|NCT04993677|525299305|FG003|Overall Study|Subject withdrawal of consent|2|||
145666456|NCT04993677|525299302|FG000|Overall Study|Study termination by sponsor|3|||
145666457|NCT04993677|525299303|FG001|Overall Study|Study termination by sponsor|25|||
145666458|NCT04993677|525299304|FG002|Overall Study|Study termination by sponsor|3|||
145666459|NCT04993677|525299305|FG003|Overall Study|Study termination by sponsor|3|||
145666460|NCT04993677|525299302|FG000|Overall Study|Other|2|||
145666461|NCT04993677|525299303|FG001|Overall Study|Other|3|||
145666462|NCT04993677|525299304|FG002|Overall Study|Other|3|||
145666463|NCT04993677|525299305|FG003|Overall Study|Other|2|||
145666464|NCT04174170|525299306|FG000|Placebo Run-in Period|Not Randomized|38|||
145666465|NCT04174170|525299307|FG001|Placebo Run-in Period|Not Randomized|0|||
145666466|NCT04174170|525299308|FG002|Placebo Run-in Period|Not Randomized|0|||
145666467|NCT04174170|525299309|FG003|Placebo Run-in Period|Not Randomized|0|||
145666468|NCT04174170|525299306|FG000|Double Blind Treatment Period|Adverse Event|0|||
145666469|NCT04174170|525299307|FG001|Double Blind Treatment Period|Adverse Event|9|||
145666470|NCT04174170|525299308|FG002|Double Blind Treatment Period|Adverse Event|9|||
145666471|NCT04174170|525299309|FG003|Double Blind Treatment Period|Adverse Event|8|||
145666472|NCT04174170|525299306|FG000|Double Blind Treatment Period|Death|0|||
145666473|NCT04174170|525299307|FG001|Double Blind Treatment Period|Death|1|||
145666474|NCT04174170|525299308|FG002|Double Blind Treatment Period|Death|0|||
145666475|NCT04174170|525299309|FG003|Double Blind Treatment Period|Death|0|||
145666476|NCT04174170|525299306|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
145666477|NCT04174170|525299307|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
145666478|NCT04174170|525299308|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
145666479|NCT04174170|525299309|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
145666480|NCT04174170|525299306|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
145666481|NCT04174170|525299307|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
145666482|NCT04174170|525299308|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
145666483|NCT04174170|525299309|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
145666484|NCT04174170|525299306|FG000|Double Blind Treatment Period|Physician Decision|0|||
145666485|NCT04174170|525299307|FG001|Double Blind Treatment Period|Physician Decision|1|||
145666486|NCT04174170|525299308|FG002|Double Blind Treatment Period|Physician Decision|0|||
145666487|NCT04174170|525299309|FG003|Double Blind Treatment Period|Physician Decision|1|||
145666488|NCT04174170|525299306|FG000|Double Blind Treatment Period|Pregnancy|0|||
145666489|NCT04174170|525299307|FG001|Double Blind Treatment Period|Pregnancy|1|||
145666490|NCT04174170|525299308|FG002|Double Blind Treatment Period|Pregnancy|0|||
145666491|NCT04174170|525299309|FG003|Double Blind Treatment Period|Pregnancy|1|||
145666492|NCT04174170|525299306|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
145666493|NCT04174170|525299307|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
145666494|NCT04174170|525299308|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
145666495|NCT04174170|525299309|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
145666496|NCT04174170|525299306|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
145666497|NCT04174170|525299307|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
145666498|NCT04174170|525299308|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
145666499|NCT04174170|525299309|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
145666500|NCT04174170|525299306|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
145666501|NCT04174170|525299307|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
145666502|NCT04174170|525299308|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
145666503|NCT04174170|525299309|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
145666504|NCT04664881|525299310|FG000|Overall Study|Withdrawal by Subject|1|||
145666505|NCT04664881|525299311|FG001|Overall Study|Withdrawal by Subject|8|||
145666506|NCT04664881|525299310|FG000|Overall Study|Physician Decision|0|||
145666507|NCT04664881|525299311|FG001|Overall Study|Physician Decision|5|||
145666508|NCT04664881|525299310|FG000|Overall Study|Lost to Follow-up|1|||
145666509|NCT04664881|525299311|FG001|Overall Study|Lost to Follow-up|0|||
145666510|NCT04194450|525299322|FG000|Overall Study|not eligible|1|||
145666511|NCT04194450|525299323|FG001|Overall Study|not eligible|0|||
145666512|NCT04281498|525299345|FG000|Overall Study|Progression of disease|1|||
145666513|NCT04281498|525299345|FG000|Overall Study|Planned SCT|1|||
145666514|NCT04281498|525299345|FG000|Overall Study|Alternative Treatment|1|||
145666515|NCT03587805|525299348|FG000|Overall Study|Adverse Event|72|||
145666516|NCT03587805|525299348|FG000|Overall Study|Death|1|||
145666517|NCT03587805|525299348|FG000|Overall Study|Lost to Follow-up|78|||
145666518|NCT03587805|525299348|FG000|Overall Study|Withdrawal by Subject|105|||
145666519|NCT03587805|525299348|FG000|Overall Study|Lack of Efficacy|119|||
145666520|NCT03587805|525299348|FG000|Overall Study|Reason unknown|26|||
145666521|NCT03587805|525299348|FG000|Overall Study|COVID_19 pandemic|4|||
145666522|NCT03587805|525299348|FG000|Overall Study|Various reasons|121|||
145666523|NCT03587805|525299348|FG000|Overall Study|Withdrawal by parent/guardian|3|||
145666524|NCT01220531|525299349|FG000|Overall Study|Death|7|||
145666525|NCT01220531|525299349|FG000|Overall Study|Lost to Follow-up|1|||
145666526|NCT03008382|525299350|FG000|Overall Study|Withdrawal by Subject|2|||
145666527|NCT03008382|525299351|FG001|Overall Study|Withdrawal by Subject|5|||
145666528|NCT03008382|525299352|FG002|Overall Study|Withdrawal by Subject|2|||
145666529|NCT03008382|525299353|FG003|Overall Study|Withdrawal by Subject|0|||
145666530|NCT03008382|525299350|FG000|Overall Study|Protocol Violation|1|||
145666531|NCT03008382|525299351|FG001|Overall Study|Protocol Violation|0|||
145666532|NCT03008382|525299352|FG002|Overall Study|Protocol Violation|0|||
145666533|NCT03008382|525299353|FG003|Overall Study|Protocol Violation|0|||
145666534|NCT03008382|525299350|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
145666535|NCT03008382|525299351|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
145666536|NCT03008382|525299352|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
145666537|NCT03008382|525299353|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
145666538|NCT03008382|525299350|FG000|Overall Study|Lost to Follow-up|0|||
145666539|NCT03008382|525299351|FG001|Overall Study|Lost to Follow-up|0|||
145666540|NCT03008382|525299352|FG002|Overall Study|Lost to Follow-up|1|||
145666541|NCT03008382|525299353|FG003|Overall Study|Lost to Follow-up|0|||
145666542|NCT03008382|525299350|FG000|Overall Study|Screenfail|0|||
145666543|NCT03008382|525299351|FG001|Overall Study|Screenfail|0|||
145666544|NCT03008382|525299352|FG002|Overall Study|Screenfail|2|||
145666545|NCT03008382|525299353|FG003|Overall Study|Screenfail|0|||
145666546|NCT03215706|525299354|FG000|Randomization|Adverse Event unrelated to study drug|1|||
145666547|NCT03215706|525299355|FG001|Randomization|Adverse Event unrelated to study drug|0|||
145666548|NCT03215706|525299354|FG000|Randomization|participant withdrew consent|1|||
145666549|NCT03215706|525299355|FG001|Randomization|participant withdrew consent|3|||
145666550|NCT03215706|525299354|FG000|Randomization|no longer meets study criteria|1|||
145666551|NCT03215706|525299355|FG001|Randomization|no longer meets study criteria|4|||
145666552|NCT03215706|525299354|FG000|Randomization|other reasons|0|||
145666553|NCT03215706|525299355|FG001|Randomization|other reasons|2|||
145666554|NCT03215706|525299354|FG000|Treatment Period|Disease Progression|150|||
145666555|NCT03215706|525299355|FG001|Treatment Period|Disease Progression|142|||
145666556|NCT03215706|525299354|FG000|Treatment Period|Study Drug Toxicity|53|||
145666557|NCT03215706|525299355|FG001|Treatment Period|Study Drug Toxicity|21|||
145666558|NCT03215706|525299354|FG000|Treatment Period|Death|2|||
145666559|NCT03215706|525299355|FG001|Treatment Period|Death|1|||
145666560|NCT03215706|525299354|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
145666561|NCT03215706|525299355|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
145666562|NCT03215706|525299354|FG000|Treatment Period|Request to D/C treatment|1|||
145666563|NCT03215706|525299355|FG001|Treatment Period|Request to D/C treatment|6|||
145666564|NCT03215706|525299354|FG000|Treatment Period|Participant withdrew consent|3|||
145666565|NCT03215706|525299355|FG001|Treatment Period|Participant withdrew consent|4|||
145666566|NCT03215706|525299354|FG000|Treatment Period|Lost to Follow-up|0|||
145666567|NCT03215706|525299355|FG001|Treatment Period|Lost to Follow-up|1|||
145666568|NCT03215706|525299354|FG000|Treatment Period|Other Reasons|4|||
145666569|NCT03215706|525299355|FG001|Treatment Period|Other Reasons|5|||
145666570|NCT03215706|525299354|FG000|Treatment Period|Ongoing in the treatment period|105|||
145666571|NCT03215706|525299355|FG001|Treatment Period|Ongoing in the treatment period|43|||
145666572|NCT00945724|525299356|FG000|Overall Study|Withdrawal by Subject|2|||
145666573|NCT00945724|525299356|FG000|Overall Study|Physician Decision|1|||
145666574|NCT00945724|525299356|FG000|Overall Study|Adverse Event|5|||
145666575|NCT00945724|525299356|FG000|Overall Study|Second malignancy|1|||
145666576|NCT04757753|525299738|FG000|Overall Study|Lost to Follow-up|7|||
145666577|NCT04757753|525299739|FG001|Overall Study|Lost to Follow-up|7|||
145666578|NCT04757753|525299738|FG000|Overall Study|Withdrawal by Subject|0|||
145666579|NCT04757753|525299739|FG001|Overall Study|Withdrawal by Subject|3|||
145666580|NCT04757753|525299738|FG000|Overall Study|Endodontic treatment failure|1|||
145666581|NCT04757753|525299739|FG001|Overall Study|Endodontic treatment failure|2|||
145666582|NCT04757753|525299738|FG000|Overall Study|Tooth fracture/extraction|3|||
145666583|NCT04757753|525299739|FG001|Overall Study|Tooth fracture/extraction|0|||
145666584|NCT03201939|525299742|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
145666585|NCT03201939|525299743|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
145666586|NCT03333915|525299744|FG000|Overall Study|Lost to Follow-up|0|||
145666587|NCT03333915|525299745|FG001|Overall Study|Lost to Follow-up|0|||
145666588|NCT03333915|525299746|FG002|Overall Study|Lost to Follow-up|1|||
145666589|NCT03333915|525299747|FG003|Overall Study|Lost to Follow-up|0|||
145666590|NCT03333915|525299748|FG004|Overall Study|Lost to Follow-up|0|||
145666591|NCT03333915|525299744|FG000|Overall Study|Disease Progression|0|||
145666592|NCT03333915|525299745|FG001|Overall Study|Disease Progression|1|||
145666593|NCT03333915|525299746|FG002|Overall Study|Disease Progression|0|||
145666594|NCT03333915|525299747|FG003|Overall Study|Disease Progression|0|||
145666595|NCT03333915|525299748|FG004|Overall Study|Disease Progression|0|||
145666596|NCT03333915|525299744|FG000|Overall Study|Death|0|||
145666597|NCT03333915|525299745|FG001|Overall Study|Death|0|||
145666598|NCT03333915|525299746|FG002|Overall Study|Death|0|||
145666599|NCT03333915|525299747|FG003|Overall Study|Death|37|||
145666600|NCT03333915|525299748|FG004|Overall Study|Death|18|||
145666601|NCT03333915|525299744|FG000|Overall Study|Sponsor's Decision|0|||
145666602|NCT03333915|525299745|FG001|Overall Study|Sponsor's Decision|0|||
145666603|NCT03333915|525299746|FG002|Overall Study|Sponsor's Decision|0|||
145666604|NCT03333915|525299747|FG003|Overall Study|Sponsor's Decision|48|||
145666605|NCT03333915|525299748|FG004|Overall Study|Sponsor's Decision|4|||
145666606|NCT03333915|525299744|FG000|Overall Study|Withdrawal by Subject|0|||
145666607|NCT03333915|525299745|FG001|Overall Study|Withdrawal by Subject|0|||
145666608|NCT03333915|525299746|FG002|Overall Study|Withdrawal by Subject|0|||
145666609|NCT03333915|525299747|FG003|Overall Study|Withdrawal by Subject|5|||
145666610|NCT03333915|525299748|FG004|Overall Study|Withdrawal by Subject|1|||
145666611|NCT03142009|525299755|FG000|Overall Study|Lost to Follow-up|45|||
145666612|NCT03142009|525299756|FG001|Overall Study|Lost to Follow-up|30|||
145666613|NCT03872466|525299757|FG000|Overall Study|Withdrawal by Subject|1|||
145666614|NCT03872466|525299758|FG001|Overall Study|Withdrawal by Subject|0|||
145666615|NCT03872466|525299757|FG000|Overall Study|Physician Decision|2|||
145666616|NCT03872466|525299758|FG001|Overall Study|Physician Decision|0|||
145666617|NCT01778686|525299759|FG000|Overall Study|Adverse Event|0|||
145666618|NCT01778686|525299760|FG001|Overall Study|Adverse Event|0|||
145666619|NCT01778686|525299761|FG002|Overall Study|Adverse Event|1|||
145666620|NCT04012567|525299762|FG000|Overall Study|Lost to Follow-up|0|||
145666621|NCT04012567|525299763|FG001|Overall Study|Lost to Follow-up|1|||
145666622|NCT04012567|525299762|FG000|Overall Study|Withdrawal by Subject|1|||
145666623|NCT04012567|525299763|FG001|Overall Study|Withdrawal by Subject|0|||
145666624|NCT06059443|525299764|FG000|Overall Study|Withdrawal by Subject|2|||
145666625|NCT06059443|525299765|FG001|Overall Study|Withdrawal by Subject|0|||
145666626|NCT06059443|525299764|FG000|Overall Study|Lost to Follow-up|2|||
145666627|NCT06059443|525299765|FG001|Overall Study|Lost to Follow-up|2|||
145666628|NCT02206828|525299773|FG000|Overall Study|Lost to Follow-up|7|||
145666629|NCT05180539|525300373|FG000|Overall Study|Lost to Follow-up|27|||
145666630|NCT05180539|525300374|FG001|Overall Study|Lost to Follow-up|30|||
145666631|NCT00994643|525300377|FG000|Overall Study|Withdrawal by Subject|1|||
145666632|NCT04518943|525300379|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
145666633|NCT04518943|525300380|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
145666634|NCT04518943|525300381|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
145666635|NCT04518943|525300382|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
145666636|NCT04518943|525300383|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
145666637|NCT04518943|525300384|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
145666638|NCT04518943|525300385|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
145666639|NCT04518943|525300386|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
145666640|NCT04518943|525300387|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
145666641|NCT04518943|525300388|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
145666642|NCT04518943|525300389|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
145666643|NCT04518943|525300390|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
145666644|NCT04518943|525300391|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
145666645|NCT04518943|525300392|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
145666646|NCT04518943|525300393|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
145666647|NCT04518943|525300394|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
145666648|NCT00968149|525300395|FG000|Overall Study|Adverse Event|5|||
145666649|NCT00968149|525300396|FG001|Overall Study|Adverse Event|1|||
145666650|NCT00968149|525300395|FG000|Overall Study|Lack of Efficacy|0|||
145666651|NCT00968149|525300396|FG001|Overall Study|Lack of Efficacy|4|||
145666652|NCT00968149|525300395|FG000|Overall Study|Lost to Follow-up|0|||
145666653|NCT00968149|525300396|FG001|Overall Study|Lost to Follow-up|1|||
145666654|NCT00968149|525300395|FG000|Overall Study|Protocol Violation|4|||
145666655|NCT00968149|525300396|FG001|Overall Study|Protocol Violation|0|||
145666656|NCT00968149|525300395|FG000|Overall Study|Withdrawal by Subject|2|||
145666657|NCT00968149|525300396|FG001|Overall Study|Withdrawal by Subject|0|||
145666658|NCT02231749|525300404|FG000|Overall Study|Disease progression|229|||
145666659|NCT02231749|525300405|FG001|Overall Study|Disease progression|297|||
145666660|NCT02231749|525300404|FG000|Overall Study|Study Drug Toxicity|134|||
145666661|NCT02231749|525300405|FG001|Overall Study|Study Drug Toxicity|63|||
145666662|NCT02231749|525300404|FG000|Overall Study|Death|1|||
145666663|NCT02231749|525300405|FG001|Overall Study|Death|1|||
145666664|NCT02231749|525300404|FG000|Overall Study|AE unrelated to Study drug|32|||
145666665|NCT02231749|525300405|FG001|Overall Study|AE unrelated to Study drug|31|||
145666666|NCT02231749|525300404|FG000|Overall Study|Participant's request to discontinue|10|||
145666667|NCT02231749|525300405|FG001|Overall Study|Participant's request to discontinue|21|||
145666668|NCT02231749|525300404|FG000|Overall Study|Participant withdrew Consent|8|||
145666669|NCT02231749|525300405|FG001|Overall Study|Participant withdrew Consent|15|||
145666670|NCT02231749|525300404|FG000|Overall Study|Lost to Follow-up|1|||
145666671|NCT02231749|525300405|FG001|Overall Study|Lost to Follow-up|2|||
145666672|NCT02231749|525300404|FG000|Overall Study|Maximum Clinical Benefit|5|||
145666673|NCT02231749|525300405|FG001|Overall Study|Maximum Clinical Benefit|8|||
145666674|NCT02231749|525300404|FG000|Overall Study|Poor/Non-Compliance|0|||
145666675|NCT02231749|525300405|FG001|Overall Study|Poor/Non-Compliance|3|||
145666676|NCT02231749|525300404|FG000|Overall Study|Pregnancy|1|||
145666677|NCT02231749|525300405|FG001|Overall Study|Pregnancy|0|||
145666678|NCT02231749|525300404|FG000|Overall Study|other|0|||
145666679|NCT02231749|525300405|FG001|Overall Study|other|8|||
145666680|NCT02231749|525300404|FG000|Overall Study|No longer meets Study Criteria|1|||
145666681|NCT02231749|525300405|FG001|Overall Study|No longer meets Study Criteria|0|||
145666682|NCT00328783|525300406|FG000|Overall Study|Could not tolerate ABC|21|||
145666683|NCT00328783|525300406|FG000|Overall Study|No heart in RT field|4|||
145490751|NCT00383552|524652205|FG003|Overall Study|Lack of Efficacy|42|||
145666684|NCT00328783|525300406|FG000|Overall Study|Withdrawal by Subject|1|||
145666685|NCT03660930|525300408|FG000|Overall Study|Adverse Event|0|||
145666686|NCT03660930|525300409|FG001|Overall Study|Adverse Event|0|||
145666687|NCT03660930|525300410|FG002|Overall Study|Adverse Event|0|||
145666688|NCT03660930|525300411|FG003|Overall Study|Adverse Event|2|||
145666689|NCT03660930|525300412|FG004|Overall Study|Adverse Event|0|||
145666690|NCT03660930|525300413|FG005|Overall Study|Adverse Event|1|||
145666691|NCT03660930|525300414|FG006|Overall Study|Adverse Event|0|||
145666692|NCT03660930|525300415|FG007|Overall Study|Adverse Event|0|||
145666693|NCT03660930|525300408|FG000|Overall Study|Withdrawal by Subject|0|||
145666694|NCT03660930|525300409|FG001|Overall Study|Withdrawal by Subject|0|||
145666695|NCT03660930|525300410|FG002|Overall Study|Withdrawal by Subject|0|||
145666696|NCT03660930|525300411|FG003|Overall Study|Withdrawal by Subject|0|||
145666697|NCT03660930|525300412|FG004|Overall Study|Withdrawal by Subject|0|||
145666698|NCT03660930|525300413|FG005|Overall Study|Withdrawal by Subject|1|||
145666699|NCT03660930|525300414|FG006|Overall Study|Withdrawal by Subject|0|||
145666700|NCT03660930|525300415|FG007|Overall Study|Withdrawal by Subject|0|||
145666701|NCT02656706|525300416|FG000|Overall Study|Insurance Denial|1|||
145666702|NCT03725332|525300417|FG000|Overall Study|Adverse Event|5|||
145666703|NCT03725332|525300418|FG001|Overall Study|Adverse Event|10|||
145666704|NCT03725332|525300417|FG000|Overall Study|Death|1|||
145666705|NCT03725332|525300418|FG001|Overall Study|Death|3|||
145666706|NCT03725332|525300417|FG000|Overall Study|Lost to Follow-up|43|||
145666707|NCT03725332|525300418|FG001|Overall Study|Lost to Follow-up|122|||
145666708|NCT03725332|525300417|FG000|Overall Study|Withdrawal by Subject|0|||
145666709|NCT03725332|525300418|FG001|Overall Study|Withdrawal by Subject|1|||
145666710|NCT03725332|525300417|FG000|Overall Study|Duplicate enrollment|0|||
145666711|NCT03725332|525300418|FG001|Overall Study|Duplicate enrollment|1|||
145666712|NCT03725332|525300417|FG000|Overall Study|Did not consent|0|||
145666713|NCT03725332|525300418|FG001|Overall Study|Did not consent|1|||
145666714|NCT03242915|525300421|FG000|Overall Study|Adverse Event|5|||
145666715|NCT03242915|525300422|FG001|Overall Study|Adverse Event|1|||
145666716|NCT03242915|525300421|FG000|Overall Study|Withdrawal by Subject|0|||
145666717|NCT03242915|525300422|FG001|Overall Study|Withdrawal by Subject|2|||
145666718|NCT03242915|525300421|FG000|Overall Study|Physician Decision|4|||
145666719|NCT03242915|525300422|FG001|Overall Study|Physician Decision|1|||
145666720|NCT05771467|525300424|FG000|Overall Study|Lost to Follow-up|6|||
145666721|NCT05771467|525300425|FG001|Overall Study|Lost to Follow-up|3|||
145666722|NCT04940624|525300431|FG000|Overall Study|Adverse Event|4|||
145666723|NCT04940624|525300432|FG001|Overall Study|Adverse Event|11|||
145666724|NCT04940624|525300431|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
145666725|NCT04940624|525300432|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
145666726|NCT04940624|525300431|FG000|Overall Study|Physician Decision|1|||
145666727|NCT04940624|525300432|FG001|Overall Study|Physician Decision|0|||
145666728|NCT04940624|525300431|FG000|Overall Study|Lost to Follow-up|1|||
145666729|NCT04940624|525300432|FG001|Overall Study|Lost to Follow-up|0|||
145666730|NCT04940624|525300431|FG000|Overall Study|Reason Not Specified|1|||
145666731|NCT04940624|525300432|FG001|Overall Study|Reason Not Specified|0|||
145666732|NCT03782116|525300433|FG000|Completed Intervetion|Lost to Follow-up|11|||
145666733|NCT03782116|525300434|FG001|Completed Intervetion|Lost to Follow-up|7|||
145666734|NCT03782116|525300433|FG000|Completed Intervetion|Withdrawal by Subject|6|||
145666735|NCT03782116|525300434|FG001|Completed Intervetion|Withdrawal by Subject|5|||
145666736|NCT03782116|525300433|FG000|Included in Analysis|Protocol Violation|5|||
145666737|NCT03782116|525300434|FG001|Included in Analysis|Protocol Violation|5|||
145666738|NCT00113360|525301042|FG000|Overall Study|Adverse Event|3|||
145666739|NCT00113360|525301042|FG000|Overall Study|Subject required surgery|1|||
145666740|NCT00113360|525301042|FG000|Overall Study|Did not meet eligibility criteria|3|||
145666741|NCT03705390|525301046|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
145666742|NCT03705390|525301046|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
145666743|NCT02989662|525301048|FG000|Overall Study|Lost to Follow-up|0|||
145666744|NCT02989662|525301049|FG001|Overall Study|Lost to Follow-up|0|||
145666745|NCT02989662|525301050|FG002|Overall Study|Lost to Follow-up|0|||
145666746|NCT02989662|525301051|FG003|Overall Study|Lost to Follow-up|2|||
145666747|NCT02989662|525301048|FG000|Overall Study|Physician Decision|3|||
145666748|NCT02989662|525301049|FG001|Overall Study|Physician Decision|0|||
145666749|NCT02989662|525301050|FG002|Overall Study|Physician Decision|0|||
145666750|NCT02989662|525301051|FG003|Overall Study|Physician Decision|0|||
145666751|NCT02989662|525301048|FG000|Overall Study|Withdrawal by Subject|1|||
145666752|NCT02989662|525301049|FG001|Overall Study|Withdrawal by Subject|0|||
145666753|NCT02989662|525301050|FG002|Overall Study|Withdrawal by Subject|0|||
145666754|NCT02989662|525301051|FG003|Overall Study|Withdrawal by Subject|0|||
145666755|NCT00357682|525301052|FG000|Overall Study|Did not receive allocated Treatment|10|||
145666756|NCT00357682|525301053|FG001|Overall Study|Did not receive allocated Treatment|9|||
145666757|NCT00357682|525301054|FG002|Overall Study|Did not receive allocated Treatment|9|||
145666758|NCT00357682|525301055|FG003|Overall Study|Did not receive allocated Treatment|10|||
145666759|NCT00357682|525301052|FG000|Overall Study|Withdrew consent|6|||
145666760|NCT00357682|525301053|FG001|Overall Study|Withdrew consent|6|||
145666761|NCT00357682|525301054|FG002|Overall Study|Withdrew consent|5|||
145490752|NCT00383552|524652202|FG000|Overall Study|Lost to Follow-up|0|||
145666762|NCT00357682|525301055|FG003|Overall Study|Withdrew consent|5|||
145666763|NCT00357682|525301052|FG000|Overall Study|Lost to Follow-up|39|||
145666764|NCT00357682|525301053|FG001|Overall Study|Lost to Follow-up|33|||
145666765|NCT00357682|525301054|FG002|Overall Study|Lost to Follow-up|26|||
145666766|NCT00357682|525301055|FG003|Overall Study|Lost to Follow-up|35|||
145666767|NCT00357682|525301052|FG000|Overall Study|Adverse Event|24|||
145666768|NCT00357682|525301053|FG001|Overall Study|Adverse Event|32|||
145666769|NCT00357682|525301054|FG002|Overall Study|Adverse Event|22|||
145666770|NCT00357682|525301055|FG003|Overall Study|Adverse Event|27|||
145666771|NCT00357682|525301052|FG000|Overall Study|Physician Decision|32|||
145666772|NCT00357682|525301053|FG001|Overall Study|Physician Decision|20|||
145666773|NCT00357682|525301054|FG002|Overall Study|Physician Decision|24|||
145666774|NCT00357682|525301055|FG003|Overall Study|Physician Decision|30|||
145666775|NCT00357682|525301052|FG000|Overall Study|Patient decision|73|||
145666776|NCT00357682|525301053|FG001|Overall Study|Patient decision|80|||
145666777|NCT00357682|525301054|FG002|Overall Study|Patient decision|51|||
145666778|NCT00357682|525301055|FG003|Overall Study|Patient decision|59|||
145666779|NCT00357682|525301052|FG000|Overall Study|Other reason|157|||
145666780|NCT00357682|525301053|FG001|Overall Study|Other reason|130|||
145666781|NCT00357682|525301054|FG002|Overall Study|Other reason|114|||
145666782|NCT00357682|525301055|FG003|Overall Study|Other reason|99|||
145666783|NCT02726386|525301062|FG000|Overall Study|Adverse Event|17|||
145666784|NCT02726386|525301063|FG001|Overall Study|Adverse Event|20|||
145666785|NCT02726386|525301062|FG000|Overall Study|Withdrawal by Subject|14|||
145666786|NCT02726386|525301063|FG001|Overall Study|Withdrawal by Subject|28|||
145666787|NCT02726386|525301062|FG000|Overall Study|Other reasons|7|||
145666788|NCT02726386|525301063|FG001|Overall Study|Other reasons|8|||
145666789|NCT04174560|525301086|FG000|Overall Study|Lost to Follow-up|1|||
145666790|NCT04174560|525301087|FG001|Overall Study|Lost to Follow-up|0|||
145666791|NCT04174560|525301088|FG002|Overall Study|Lost to Follow-up|0|||
145666792|NCT04174560|525301089|FG003|Overall Study|Lost to Follow-up|0|||
145666793|NCT04174560|525301086|FG000|Overall Study|Withdrawal by Subject|0|||
145666794|NCT04174560|525301087|FG001|Overall Study|Withdrawal by Subject|0|||
145666795|NCT04174560|525301088|FG002|Overall Study|Withdrawal by Subject|2|||
145666796|NCT04174560|525301089|FG003|Overall Study|Withdrawal by Subject|0|||
145666797|NCT05424718|525301093|FG000|Overall Study|Lost to Follow-up|5|||
145666798|NCT05424718|525301094|FG001|Overall Study|Lost to Follow-up|4|||
145666799|NCT04046549|525301095|FG000|Overall Study|Adverse Event|1|||
145666800|NCT04046549|525301095|FG000|Overall Study|Physician Decision|1|||
145666801|NCT04046549|525301095|FG000|Overall Study|Withdrawal by Subject|3|||
145666802|NCT04046549|525301095|FG000|Overall Study|Other, Not Specified|5|||
145666803|NCT04899674|525301099|FG000|Test|Adverse Event|1|||
145666804|NCT03774472|525301100|FG000|Overall Study|Physician Decision|1|||
145666805|NCT03774472|525301101|FG001|Overall Study|Physician Decision|0|||
145666806|NCT03774472|525301102|FG002|Overall Study|Physician Decision|0|||
145666807|NCT03774472|525301100|FG000|Overall Study|Progression prior to 4 weeks|0|||
145666808|NCT03774472|525301101|FG001|Overall Study|Progression prior to 4 weeks|1|||
145666809|NCT03774472|525301102|FG002|Overall Study|Progression prior to 4 weeks|0|||
145666810|NCT03774472|525301100|FG000|Overall Study|Withdrawal by Subject|0|||
145666811|NCT03774472|525301101|FG001|Overall Study|Withdrawal by Subject|1|||
145666812|NCT03774472|525301102|FG002|Overall Study|Withdrawal by Subject|0|||
145666813|NCT03150862|525301103|FG000|Overall Study|Death|2|||
145666814|NCT03150862|525301104|FG001|Overall Study|Death|7|||
145666815|NCT03150862|525301105|FG002|Overall Study|Death|8|||
145666816|NCT03150862|525301106|FG003|Overall Study|Death|27|||
145666817|NCT03150862|525301107|FG004|Overall Study|Death|4|||
145666818|NCT03150862|525301108|FG005|Overall Study|Death|8|||
145666819|NCT03150862|525301109|FG006|Overall Study|Death|6|||
145666820|NCT03150862|525301110|FG007|Overall Study|Death|21|||
145666821|NCT03150862|525301103|FG000|Overall Study|Withdrawal by Subject|1|||
145666822|NCT03150862|525301104|FG001|Overall Study|Withdrawal by Subject|1|||
145666823|NCT03150862|525301105|FG002|Overall Study|Withdrawal by Subject|0|||
145666824|NCT03150862|525301106|FG003|Overall Study|Withdrawal by Subject|3|||
145666825|NCT03150862|525301107|FG004|Overall Study|Withdrawal by Subject|1|||
145666826|NCT03150862|525301108|FG005|Overall Study|Withdrawal by Subject|1|||
145666827|NCT03150862|525301109|FG006|Overall Study|Withdrawal by Subject|1|||
145666828|NCT03150862|525301110|FG007|Overall Study|Withdrawal by Subject|3|||
145666829|NCT03150862|525301103|FG000|Overall Study|Lost to Follow-up|0|||
145666830|NCT03150862|525301104|FG001|Overall Study|Lost to Follow-up|0|||
145666831|NCT03150862|525301105|FG002|Overall Study|Lost to Follow-up|1|||
145666832|NCT03150862|525301106|FG003|Overall Study|Lost to Follow-up|0|||
145666833|NCT03150862|525301107|FG004|Overall Study|Lost to Follow-up|0|||
145666834|NCT03150862|525301108|FG005|Overall Study|Lost to Follow-up|0|||
145490753|NCT00383552|524652203|FG001|Overall Study|Lost to Follow-up|1|||
145666835|NCT03150862|525301109|FG006|Overall Study|Lost to Follow-up|0|||
145666836|NCT03150862|525301110|FG007|Overall Study|Lost to Follow-up|2|||
145666837|NCT03150862|525301103|FG000|Overall Study|Sponsor's decision|0|||
145666838|NCT03150862|525301104|FG001|Overall Study|Sponsor's decision|0|||
145666839|NCT03150862|525301105|FG002|Overall Study|Sponsor's decision|0|||
145666840|NCT03150862|525301106|FG003|Overall Study|Sponsor's decision|10|||
145666841|NCT03150862|525301107|FG004|Overall Study|Sponsor's decision|3|||
145666842|NCT03150862|525301108|FG005|Overall Study|Sponsor's decision|0|||
145666843|NCT03150862|525301109|FG006|Overall Study|Sponsor's decision|1|||
145666844|NCT03150862|525301110|FG007|Overall Study|Sponsor's decision|1|||
145666845|NCT03150862|525301103|FG000|Overall Study|Change in Methylation status|0|||
145666846|NCT03150862|525301104|FG001|Overall Study|Change in Methylation status|0|||
145666847|NCT03150862|525301105|FG002|Overall Study|Change in Methylation status|0|||
145666848|NCT03150862|525301106|FG003|Overall Study|Change in Methylation status|0|||
145666849|NCT03150862|525301107|FG004|Overall Study|Change in Methylation status|1|||
145666850|NCT03150862|525301108|FG005|Overall Study|Change in Methylation status|0|||
145666851|NCT03150862|525301109|FG006|Overall Study|Change in Methylation status|0|||
145666852|NCT03150862|525301110|FG007|Overall Study|Change in Methylation status|0|||
145666853|NCT03150862|525301103|FG000|Overall Study|Roll over in to Long Term Extension|0|||
145666854|NCT03150862|525301104|FG001|Overall Study|Roll over in to Long Term Extension|0|||
145666855|NCT03150862|525301105|FG002|Overall Study|Roll over in to Long Term Extension|0|||
145666856|NCT03150862|525301106|FG003|Overall Study|Roll over in to Long Term Extension|0|||
145666857|NCT03150862|525301107|FG004|Overall Study|Roll over in to Long Term Extension|0|||
145666858|NCT03150862|525301108|FG005|Overall Study|Roll over in to Long Term Extension|0|||
145666859|NCT03150862|525301109|FG006|Overall Study|Roll over in to Long Term Extension|0|||
145666860|NCT03150862|525301110|FG007|Overall Study|Roll over in to Long Term Extension|1|||
145666861|NCT03150862|525301103|FG000|Overall Study|Progressive Disease|0|||
145666862|NCT03150862|525301104|FG001|Overall Study|Progressive Disease|0|||
145666863|NCT03150862|525301105|FG002|Overall Study|Progressive Disease|0|||
145666864|NCT03150862|525301106|FG003|Overall Study|Progressive Disease|0|||
145666865|NCT03150862|525301107|FG004|Overall Study|Progressive Disease|0|||
145666866|NCT03150862|525301108|FG005|Overall Study|Progressive Disease|0|||
145666867|NCT03150862|525301109|FG006|Overall Study|Progressive Disease|0|||
145666868|NCT03150862|525301110|FG007|Overall Study|Progressive Disease|2|||
145666869|NCT04039113|525301115|FG000|Overall Study|Withdrawal by Subject|8|||
145666870|NCT04039113|525301116|FG001|Overall Study|Withdrawal by Subject|11|||
145666871|NCT04039113|525301115|FG000|Overall Study|Lost to Follow-up|1|||
145666872|NCT04039113|525301116|FG001|Overall Study|Lost to Follow-up|1|||
145666873|NCT04039113|525301115|FG000|Overall Study|Adverse Event|2|||
145666874|NCT04039113|525301116|FG001|Overall Study|Adverse Event|2|||
145666875|NCT04039113|525301115|FG000|Overall Study|Death|2|||
145666876|NCT04039113|525301116|FG001|Overall Study|Death|4|||
145666877|NCT04039113|525301115|FG000|Overall Study|Site Closure|6|||
145666878|NCT04039113|525301116|FG001|Overall Study|Site Closure|0|||
145666879|NCT04039113|525301115|FG000|Overall Study|Failure to meet randomisation criteria|4|||
145666880|NCT04039113|525301116|FG001|Overall Study|Failure to meet randomisation criteria|0|||
145666881|NCT00353496|525301117|FG000|Overall Study|Adverse Event|1|||
145666882|NCT00353496|525301118|FG001|Overall Study|Adverse Event|0|||
145666883|NCT00353496|525301117|FG000|Overall Study|Protocol Violation|2|||
145666884|NCT00353496|525301118|FG001|Overall Study|Protocol Violation|2|||
145666885|NCT00353496|525301117|FG000|Overall Study|Withdrawal by Subject|3|||
145666886|NCT00353496|525301118|FG001|Overall Study|Withdrawal by Subject|4|||
145666887|NCT00353496|525301117|FG000|Overall Study|Physician Decision|6|||
145666888|NCT00353496|525301118|FG001|Overall Study|Physician Decision|9|||
145666889|NCT00353496|525301117|FG000|Overall Study|Not otherwise specified|4|||
145666890|NCT00353496|525301118|FG001|Overall Study|Not otherwise specified|2|||
145666891|NCT05039021|525301613|FG000|Overall Study|Death|1|||
145666892|NCT05039021|525301613|FG000|Overall Study|Lost to Follow-up|3|||
145666893|NCT02566889|525301616|FG000|Overall Study|Withdrawal by Subject|3|||
145666894|NCT02566889|525301617|FG001|Overall Study|Withdrawal by Subject|1|||
145666895|NCT02566889|525301616|FG000|Overall Study|Adverse Event|4|||
145666896|NCT02566889|525301617|FG001|Overall Study|Adverse Event|2|||
145666897|NCT02566889|525301616|FG000|Overall Study|Other|6|||
145666898|NCT02566889|525301617|FG001|Overall Study|Other|2|||
145666899|NCT00495677|525301620|FG000|Stage 1 (25 Days)|Adverse Event|0|||
145666900|NCT00495677|525301621|FG001|Stage 1 (25 Days)|Adverse Event|0|||
145666901|NCT00495677|525301622|FG002|Stage 1 (25 Days)|Adverse Event|1|||
145666902|NCT00495677|525301623|FG003|Stage 1 (25 Days)|Adverse Event|0|||
145666903|NCT00495677|525301624|FG004|Stage 1 (25 Days)|Adverse Event|0|||
145666904|NCT00495677|525301625|FG005|Stage 1 (25 Days)|Adverse Event|0|||
145666905|NCT00495677|525301626|FG006|Stage 1 (25 Days)|Adverse Event|0|||
145666906|NCT04129164|525301632|FG000|Overall Study|Non-compliance with procedures|0|||
145666907|NCT04129164|525301633|FG001|Overall Study|Non-compliance with procedures|0|||
145666908|NCT04129164|525301634|FG002|Overall Study|Non-compliance with procedures|2|||
145666909|NCT04129164|525301635|FG003|Overall Study|Non-compliance with procedures|0|||
145666910|NCT04129164|525301632|FG000|Overall Study|Adverse Event|0|||
145666911|NCT04129164|525301633|FG001|Overall Study|Adverse Event|0|||
145666912|NCT04129164|525301634|FG002|Overall Study|Adverse Event|2|||
145666913|NCT04129164|525301635|FG003|Overall Study|Adverse Event|0|||
145666914|NCT04129164|525301632|FG000|Overall Study|Pregnancy|0|||
145666915|NCT04129164|525301633|FG001|Overall Study|Pregnancy|0|||
145666916|NCT04129164|525301634|FG002|Overall Study|Pregnancy|0|||
145666917|NCT04129164|525301635|FG003|Overall Study|Pregnancy|1|||
145666918|NCT04129164|525301632|FG000|Overall Study|Withdrawal by Subject|3|||
145666919|NCT04129164|525301633|FG001|Overall Study|Withdrawal by Subject|2|||
145666920|NCT04129164|525301634|FG002|Overall Study|Withdrawal by Subject|4|||
145666921|NCT04129164|525301635|FG003|Overall Study|Withdrawal by Subject|6|||
145666922|NCT04129164|525301632|FG000|Overall Study|Death|0|||
145666923|NCT04129164|525301633|FG001|Overall Study|Death|1|||
145666924|NCT04129164|525301634|FG002|Overall Study|Death|0|||
145666925|NCT04129164|525301635|FG003|Overall Study|Death|0|||
145666926|NCT04129164|525301632|FG000|Overall Study|Lost to Follow-up|0|||
145666927|NCT04129164|525301633|FG001|Overall Study|Lost to Follow-up|1|||
145666928|NCT04129164|525301634|FG002|Overall Study|Lost to Follow-up|0|||
145666929|NCT04129164|525301635|FG003|Overall Study|Lost to Follow-up|0|||
145666930|NCT03653364|525301638|FG000|Overall Study|Withdrawal by Subject|1|||
145666931|NCT03653364|525301638|FG000|Overall Study|Enrolled in Error|1|||
145666932|NCT03653364|525301638|FG000|Overall Study|Death|1|||
145666933|NCT03983382|525301641|FG000|Overall Study|Death|1|||
145666934|NCT03983382|525301641|FG000|Overall Study|Lost to Follow-up|3|||
145666935|NCT03983382|525301641|FG000|Overall Study|Physician Decision|2|||
145666936|NCT03983382|525301641|FG000|Overall Study|Withdrawal by Subject|10|||
145666937|NCT03983382|525301641|FG000|Overall Study|Change in cancer treatment|2|||
145666938|NCT05934292|525301650|FG000|Overall Study|Lost to Follow-up|0|||
145666939|NCT05934292|525301651|FG001|Overall Study|Lost to Follow-up|0|||
145666940|NCT05934292|525301652|FG002|Overall Study|Lost to Follow-up|1|||
145666941|NCT05934292|525301653|FG003|Overall Study|Lost to Follow-up|0|||
145666942|NCT04479787|525301654|FG000|Through 6 Months|Withdrawal by Subject|16|||
145666943|NCT04479787|525301655|FG001|Through 6 Months|Withdrawal by Subject|14|||
145666944|NCT04479787|525301654|FG000|Through 6 Months|Unsuccessful Trial|17|||
145666945|NCT04479787|525301655|FG001|Through 6 Months|Unsuccessful Trial|0|||
145666946|NCT04479787|525301654|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
145666947|NCT04479787|525301655|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
145666948|NCT04479787|525301654|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
145666949|NCT04479787|525301655|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
145666950|NCT04479787|525301654|FG000|Through 6 Months|Lost to Follow-up|3|||
145666951|NCT04479787|525301655|FG001|Through 6 Months|Lost to Follow-up|2|||
145666952|NCT04479787|525301654|FG000|Through 6 Months|Death|3|||
145666953|NCT04479787|525301655|FG001|Through 6 Months|Death|0|||
145666954|NCT04479787|525301654|FG000|Through 6 Months|Inclusion/Exclusion|2|||
145666955|NCT04479787|525301655|FG001|Through 6 Months|Inclusion/Exclusion|1|||
145666956|NCT04479787|525301654|FG000|Through 6 Months|Subject Became Pregnant|1|||
145666957|NCT04479787|525301655|FG001|Through 6 Months|Subject Became Pregnant|1|||
145666958|NCT04479787|525301654|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
145666959|NCT04479787|525301655|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
145666960|NCT04479787|525301654|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
145666961|NCT04479787|525301655|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
145666962|NCT04479787|525301654|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
145666963|NCT04479787|525301655|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
145666964|NCT04479787|525301654|FG000|After 6 Months|Withdrawal by Subject|3|||
145666965|NCT04479787|525301655|FG001|After 6 Months|Withdrawal by Subject|13|||
145666966|NCT04479787|525301654|FG000|After 6 Months|Unsuccessful Trial|0|||
145666967|NCT04479787|525301655|FG001|After 6 Months|Unsuccessful Trial|7|||
145666968|NCT04479787|525301654|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
145666969|NCT04479787|525301655|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
145666970|NCT04479787|525301654|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
145666971|NCT04479787|525301655|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
145666972|NCT04479787|525301654|FG000|After 6 Months|Death|2|||
145666973|NCT04479787|525301655|FG001|After 6 Months|Death|0|||
145666974|NCT04479787|525301654|FG000|After 6 Months|Lost to Follow-up|1|||
145666975|NCT04479787|525301655|FG001|After 6 Months|Lost to Follow-up|1|||
145666976|NCT04479787|525301654|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
145666977|NCT04479787|525301655|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
145666978|NCT04479787|525301654|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
145666979|NCT04479787|525301655|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
145666980|NCT04479787|525301654|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
145666981|NCT04479787|525301655|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
145666982|NCT04479787|525301654|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
145666983|NCT04479787|525301655|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
145666984|NCT05714059|525301656|FG000|Overall Study|Withdrawal by Subject|2|||
145666985|NCT05714059|525301657|FG001|Overall Study|Withdrawal by Subject|2|||
145666986|NCT05714059|525301656|FG000|Overall Study|Adverse Event|0|||
145666987|NCT05714059|525301657|FG001|Overall Study|Adverse Event|1|||
145666988|NCT05714059|525301656|FG000|Overall Study|Lost to Follow-up|0|||
145666989|NCT05714059|525301657|FG001|Overall Study|Lost to Follow-up|1|||
145666990|NCT05714059|525301656|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
145666991|NCT05714059|525301657|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
145666992|NCT05714059|525301656|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
145666993|NCT05714059|525301657|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
145265396|NCT04479358|523819335|FG003|Overall Study|Withdrawal by Subject|0|||
145666994|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Other|0|||
145666995|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Other|2|||
145666996|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Other|1|||
145666997|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Other|2|||
145666998|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Other|2|||
145666999|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Other|0|||
145667000|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Other|0|||
145667001|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Other|0|||
145667002|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Other|0|||
145667003|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Other|0|||
145667004|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Other|0|||
145667005|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Other|0|||
145667006|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Other|0|||
145667007|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Other|0|||
145667008|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Other|0|||
145667009|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Other|0|||
145667010|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Other|0|||
145667011|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
145667012|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
145667013|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
145667014|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
145667015|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
145667016|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
145667017|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667018|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667019|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667020|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667021|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667022|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667023|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667024|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667025|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667026|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667027|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
145667028|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667029|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
145667030|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
145667031|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667032|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
145667033|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
145667034|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667035|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667036|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667037|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667038|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667039|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667040|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667041|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667042|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667043|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667044|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
145667045|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Death|2|||
145667046|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Death|1|||
145667047|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Death|1|||
145667048|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Death|0|||
145667049|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Death|0|||
145667050|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Death|0|||
145667051|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Death|0|||
145667052|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Death|0|||
145667053|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Death|0|||
145490754|NCT00383552|524652204|FG002|Overall Study|Lost to Follow-up|5|||
145490755|NCT00383552|524652205|FG003|Overall Study|Lost to Follow-up|1|||
145490756|NCT00383552|524652202|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
145490757|NCT00383552|524652203|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
145490758|NCT00383552|524652204|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
145490759|NCT00383552|524652205|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
145667054|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Death|0|||
145667055|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Death|0|||
145667056|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Death|0|||
145667057|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Death|0|||
145667058|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Death|0|||
145667059|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Death|0|||
145667060|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Death|0|||
145667061|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Death|0|||
145667062|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667063|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
145667064|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667065|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667066|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
145490760|NCT00383552|524652202|FG000|Overall Study|Did not wish to continue (related)|1|||
145667067|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
145667068|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667069|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667070|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667071|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667072|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667073|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667074|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667075|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667076|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667077|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667078|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
145667079|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667080|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667081|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667082|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667083|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
145667084|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
145667085|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667086|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667087|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667088|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667089|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667090|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667091|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667092|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667093|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667094|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667095|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
145667096|NCT02719574|525302250|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667097|NCT02719574|525302251|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667098|NCT02719574|525302252|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
145667099|NCT02719574|525302253|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667100|NCT02719574|525302254|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667101|NCT02719574|525302255|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667102|NCT02719574|525302256|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667103|NCT02719574|525302257|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667104|NCT02719574|525302258|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667105|NCT02719574|525302259|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667106|NCT02719574|525302260|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667107|NCT02719574|525302261|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667108|NCT02719574|525302262|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667109|NCT02719574|525302263|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667110|NCT02719574|525302264|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667111|NCT02719574|525302265|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667112|NCT02719574|525302266|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
145667113|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667114|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667115|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667116|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667117|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667118|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667119|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
145667120|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
145667121|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
145667122|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667123|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667124|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667125|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667126|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667127|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667128|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667129|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
145667130|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667131|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667132|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667133|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667134|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145490761|NCT00383552|524652203|FG001|Overall Study|Did not wish to continue (related)|0|||
145490762|NCT00383552|524652204|FG002|Overall Study|Did not wish to continue (related)|2|||
145667135|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667136|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
145667137|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
145667138|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667139|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667140|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667141|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667142|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667143|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667144|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667145|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667146|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
145667147|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|Death|0|||
145667148|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|Death|0|||
145667149|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|Death|0|||
145667150|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|Death|0|||
145667151|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|Death|0|||
145667152|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|Death|0|||
145667153|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|Death|1|||
145667154|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|Death|6|||
145667155|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|Death|0|||
145667156|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|Death|0|||
145667157|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|Death|0|||
145667158|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|Death|0|||
145667159|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|Death|0|||
145667160|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|Death|0|||
145667161|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|Death|0|||
145667162|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|Death|0|||
145667163|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|Death|0|||
145667164|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667165|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667166|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667167|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667168|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667169|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667170|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
145667171|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
145667172|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667173|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667174|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667175|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667176|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667177|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667178|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667179|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667180|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
145667181|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667182|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667183|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667184|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667185|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667186|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667187|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
145667188|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
145667189|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667190|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667191|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667192|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667193|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667194|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667195|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667196|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667197|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
145667198|NCT02719574|525302250|FG000|Phase 1 (Dose Expansion)|Other|0|||
145667199|NCT02719574|525302251|FG001|Phase 1 (Dose Expansion)|Other|0|||
145667200|NCT02719574|525302252|FG002|Phase 1 (Dose Expansion)|Other|0|||
145667201|NCT02719574|525302253|FG003|Phase 1 (Dose Expansion)|Other|0|||
145667202|NCT02719574|525302254|FG004|Phase 1 (Dose Expansion)|Other|0|||
145667203|NCT02719574|525302255|FG005|Phase 1 (Dose Expansion)|Other|0|||
145490763|NCT00383552|524652205|FG003|Overall Study|Did not wish to continue (related)|3|||
145667204|NCT02719574|525302256|FG006|Phase 1 (Dose Expansion)|Other|1|||
145667205|NCT02719574|525302257|FG007|Phase 1 (Dose Expansion)|Other|7|||
145667206|NCT02719574|525302258|FG008|Phase 1 (Dose Expansion)|Other|0|||
145667207|NCT02719574|525302259|FG009|Phase 1 (Dose Expansion)|Other|0|||
145667208|NCT02719574|525302260|FG010|Phase 1 (Dose Expansion)|Other|0|||
145667209|NCT02719574|525302261|FG011|Phase 1 (Dose Expansion)|Other|0|||
145667210|NCT02719574|525302262|FG012|Phase 1 (Dose Expansion)|Other|0|||
145667211|NCT02719574|525302263|FG013|Phase 1 (Dose Expansion)|Other|0|||
145667212|NCT02719574|525302264|FG014|Phase 1 (Dose Expansion)|Other|0|||
145667213|NCT02719574|525302265|FG015|Phase 1 (Dose Expansion)|Other|0|||
145667214|NCT02719574|525302266|FG016|Phase 1 (Dose Expansion)|Other|0|||
145667215|NCT02719574|525302250|FG000|Phase 2|Protocol Defined Disease Progression|0|||
145667216|NCT02719574|525302251|FG001|Phase 2|Protocol Defined Disease Progression|0|||
145667217|NCT02719574|525302252|FG002|Phase 2|Protocol Defined Disease Progression|0|||
145667218|NCT02719574|525302253|FG003|Phase 2|Protocol Defined Disease Progression|0|||
145667219|NCT02719574|525302254|FG004|Phase 2|Protocol Defined Disease Progression|0|||
145667220|NCT02719574|525302255|FG005|Phase 2|Protocol Defined Disease Progression|0|||
145667221|NCT02719574|525302256|FG006|Phase 2|Protocol Defined Disease Progression|0|||
145667222|NCT02719574|525302257|FG007|Phase 2|Protocol Defined Disease Progression|0|||
145667223|NCT02719574|525302258|FG008|Phase 2|Protocol Defined Disease Progression|0|||
145667224|NCT02719574|525302259|FG009|Phase 2|Protocol Defined Disease Progression|65|||
145667225|NCT02719574|525302260|FG010|Phase 2|Protocol Defined Disease Progression|8|||
145667226|NCT02719574|525302261|FG011|Phase 2|Protocol Defined Disease Progression|2|||
145667227|NCT02719574|525302262|FG012|Phase 2|Protocol Defined Disease Progression|4|||
145667228|NCT02719574|525302263|FG013|Phase 2|Protocol Defined Disease Progression|9|||
145667229|NCT02719574|525302264|FG014|Phase 2|Protocol Defined Disease Progression|11|||
145667230|NCT02719574|525302265|FG015|Phase 2|Protocol Defined Disease Progression|3|||
145667231|NCT02719574|525302266|FG016|Phase 2|Protocol Defined Disease Progression|4|||
145667232|NCT02719574|525302250|FG000|Phase 2|Adverse Event|0|||
145667233|NCT02719574|525302251|FG001|Phase 2|Adverse Event|0|||
145667234|NCT02719574|525302252|FG002|Phase 2|Adverse Event|0|||
145667235|NCT02719574|525302253|FG003|Phase 2|Adverse Event|0|||
145667236|NCT02719574|525302254|FG004|Phase 2|Adverse Event|0|||
145667237|NCT02719574|525302255|FG005|Phase 2|Adverse Event|0|||
145667238|NCT02719574|525302256|FG006|Phase 2|Adverse Event|0|||
145667239|NCT02719574|525302257|FG007|Phase 2|Adverse Event|0|||
145667240|NCT02719574|525302258|FG008|Phase 2|Adverse Event|0|||
145667241|NCT02719574|525302259|FG009|Phase 2|Adverse Event|27|||
145667242|NCT02719574|525302260|FG010|Phase 2|Adverse Event|0|||
145667243|NCT02719574|525302261|FG011|Phase 2|Adverse Event|1|||
145667244|NCT02719574|525302262|FG012|Phase 2|Adverse Event|1|||
145667245|NCT02719574|525302263|FG013|Phase 2|Adverse Event|1|||
145667246|NCT02719574|525302264|FG014|Phase 2|Adverse Event|2|||
145667247|NCT02719574|525302265|FG015|Phase 2|Adverse Event|2|||
145667248|NCT02719574|525302266|FG016|Phase 2|Adverse Event|3|||
145667249|NCT02719574|525302250|FG000|Phase 2|Other|0|||
145667250|NCT02719574|525302251|FG001|Phase 2|Other|0|||
145667251|NCT02719574|525302252|FG002|Phase 2|Other|0|||
145667252|NCT02719574|525302253|FG003|Phase 2|Other|0|||
145667253|NCT02719574|525302254|FG004|Phase 2|Other|0|||
145667254|NCT02719574|525302255|FG005|Phase 2|Other|0|||
145667255|NCT02719574|525302256|FG006|Phase 2|Other|0|||
145667256|NCT02719574|525302257|FG007|Phase 2|Other|0|||
145667257|NCT02719574|525302258|FG008|Phase 2|Other|0|||
145667258|NCT02719574|525302259|FG009|Phase 2|Other|20|||
145667259|NCT02719574|525302260|FG010|Phase 2|Other|7|||
145667260|NCT02719574|525302261|FG011|Phase 2|Other|0|||
145667261|NCT02719574|525302262|FG012|Phase 2|Other|5|||
145667262|NCT02719574|525302263|FG013|Phase 2|Other|7|||
145667263|NCT02719574|525302264|FG014|Phase 2|Other|0|||
145667264|NCT02719574|525302265|FG015|Phase 2|Other|1|||
145667265|NCT02719574|525302266|FG016|Phase 2|Other|4|||
145667266|NCT02719574|525302250|FG000|Phase 2|Transplant|0|||
145667267|NCT02719574|525302251|FG001|Phase 2|Transplant|0|||
145667268|NCT02719574|525302252|FG002|Phase 2|Transplant|0|||
145667269|NCT02719574|525302253|FG003|Phase 2|Transplant|0|||
145667270|NCT02719574|525302254|FG004|Phase 2|Transplant|0|||
145667271|NCT02719574|525302255|FG005|Phase 2|Transplant|0|||
145667272|NCT02719574|525302256|FG006|Phase 2|Transplant|0|||
145667273|NCT02719574|525302257|FG007|Phase 2|Transplant|0|||
145667274|NCT02719574|525302258|FG008|Phase 2|Transplant|0|||
145667275|NCT02719574|525302259|FG009|Phase 2|Transplant|15|||
145667276|NCT02719574|525302260|FG010|Phase 2|Transplant|2|||
145667277|NCT02719574|525302261|FG011|Phase 2|Transplant|0|||
145667278|NCT02719574|525302262|FG012|Phase 2|Transplant|6|||
145667279|NCT02719574|525302263|FG013|Phase 2|Transplant|1|||
145667280|NCT02719574|525302264|FG014|Phase 2|Transplant|1|||
145667281|NCT02719574|525302265|FG015|Phase 2|Transplant|0|||
145667282|NCT02719574|525302266|FG016|Phase 2|Transplant|0|||
145667283|NCT02719574|525302250|FG000|Phase 2|Death|0|||
145667284|NCT02719574|525302251|FG001|Phase 2|Death|0|||
145667285|NCT02719574|525302252|FG002|Phase 2|Death|0|||
145667286|NCT02719574|525302253|FG003|Phase 2|Death|0|||
145667287|NCT02719574|525302254|FG004|Phase 2|Death|0|||
145667288|NCT02719574|525302255|FG005|Phase 2|Death|0|||
145667289|NCT02719574|525302256|FG006|Phase 2|Death|0|||
145667290|NCT02719574|525302257|FG007|Phase 2|Death|0|||
145667291|NCT02719574|525302258|FG008|Phase 2|Death|0|||
145667292|NCT02719574|525302259|FG009|Phase 2|Death|14|||
145667293|NCT02719574|525302260|FG010|Phase 2|Death|0|||
145667294|NCT02719574|525302261|FG011|Phase 2|Death|0|||
145667295|NCT02719574|525302262|FG012|Phase 2|Death|1|||
145667296|NCT02719574|525302263|FG013|Phase 2|Death|1|||
145667297|NCT02719574|525302264|FG014|Phase 2|Death|2|||
145667298|NCT02719574|525302265|FG015|Phase 2|Death|0|||
145667299|NCT02719574|525302266|FG016|Phase 2|Death|0|||
145667300|NCT02719574|525302250|FG000|Phase 2|Investigator Decision|0|||
145667301|NCT02719574|525302251|FG001|Phase 2|Investigator Decision|0|||
145667302|NCT02719574|525302252|FG002|Phase 2|Investigator Decision|0|||
145667303|NCT02719574|525302253|FG003|Phase 2|Investigator Decision|0|||
145667304|NCT02719574|525302254|FG004|Phase 2|Investigator Decision|0|||
145667305|NCT02719574|525302255|FG005|Phase 2|Investigator Decision|0|||
145667306|NCT02719574|525302256|FG006|Phase 2|Investigator Decision|0|||
145667307|NCT02719574|525302257|FG007|Phase 2|Investigator Decision|0|||
145667308|NCT02719574|525302258|FG008|Phase 2|Investigator Decision|0|||
145667309|NCT02719574|525302259|FG009|Phase 2|Investigator Decision|6|||
145667310|NCT02719574|525302260|FG010|Phase 2|Investigator Decision|1|||
145667311|NCT02719574|525302261|FG011|Phase 2|Investigator Decision|2|||
145667312|NCT02719574|525302262|FG012|Phase 2|Investigator Decision|3|||
145667313|NCT02719574|525302263|FG013|Phase 2|Investigator Decision|1|||
145667314|NCT02719574|525302264|FG014|Phase 2|Investigator Decision|3|||
145667315|NCT02719574|525302265|FG015|Phase 2|Investigator Decision|2|||
145667316|NCT02719574|525302266|FG016|Phase 2|Investigator Decision|0|||
145667317|NCT02719574|525302250|FG000|Phase 2|Withdrawal by Subject|0|||
145667318|NCT02719574|525302251|FG001|Phase 2|Withdrawal by Subject|0|||
145667319|NCT02719574|525302252|FG002|Phase 2|Withdrawal by Subject|0|||
145667320|NCT02719574|525302253|FG003|Phase 2|Withdrawal by Subject|0|||
145667321|NCT02719574|525302254|FG004|Phase 2|Withdrawal by Subject|0|||
145667322|NCT02719574|525302255|FG005|Phase 2|Withdrawal by Subject|0|||
145667323|NCT02719574|525302256|FG006|Phase 2|Withdrawal by Subject|0|||
145667324|NCT02719574|525302257|FG007|Phase 2|Withdrawal by Subject|0|||
145667325|NCT02719574|525302258|FG008|Phase 2|Withdrawal by Subject|0|||
145667326|NCT02719574|525302259|FG009|Phase 2|Withdrawal by Subject|5|||
145667327|NCT02719574|525302260|FG010|Phase 2|Withdrawal by Subject|0|||
145667328|NCT02719574|525302261|FG011|Phase 2|Withdrawal by Subject|0|||
145667329|NCT02719574|525302262|FG012|Phase 2|Withdrawal by Subject|0|||
145667330|NCT02719574|525302263|FG013|Phase 2|Withdrawal by Subject|1|||
145667331|NCT02719574|525302264|FG014|Phase 2|Withdrawal by Subject|1|||
145667332|NCT02719574|525302265|FG015|Phase 2|Withdrawal by Subject|2|||
145667333|NCT02719574|525302266|FG016|Phase 2|Withdrawal by Subject|0|||
145667334|NCT02719574|525302250|FG000|Phase 2|Protocol Violation|0|||
145667335|NCT02719574|525302251|FG001|Phase 2|Protocol Violation|0|||
145667336|NCT02719574|525302252|FG002|Phase 2|Protocol Violation|0|||
145667337|NCT02719574|525302253|FG003|Phase 2|Protocol Violation|0|||
145667338|NCT02719574|525302254|FG004|Phase 2|Protocol Violation|0|||
145667339|NCT02719574|525302255|FG005|Phase 2|Protocol Violation|0|||
145667340|NCT02719574|525302256|FG006|Phase 2|Protocol Violation|0|||
145667341|NCT02719574|525302257|FG007|Phase 2|Protocol Violation|0|||
145667342|NCT02719574|525302258|FG008|Phase 2|Protocol Violation|0|||
145667343|NCT02719574|525302259|FG009|Phase 2|Protocol Violation|1|||
145667344|NCT02719574|525302260|FG010|Phase 2|Protocol Violation|0|||
145667345|NCT02719574|525302261|FG011|Phase 2|Protocol Violation|0|||
145667346|NCT02719574|525302262|FG012|Phase 2|Protocol Violation|0|||
145667347|NCT02719574|525302263|FG013|Phase 2|Protocol Violation|0|||
145667348|NCT02719574|525302264|FG014|Phase 2|Protocol Violation|0|||
145667349|NCT02719574|525302265|FG015|Phase 2|Protocol Violation|0|||
145667350|NCT02719574|525302266|FG016|Phase 2|Protocol Violation|0|||
145667351|NCT02111096|525302268|FG000|Overall Study|Adverse Event|4|||
145667352|NCT02111096|525302269|FG001|Overall Study|Adverse Event|1|||
145667353|NCT02111096|525302270|FG002|Overall Study|Adverse Event|2|||
145667354|NCT02111096|525302268|FG000|Overall Study|Non-Compliance with Study Drug|1|||
145667355|NCT02111096|525302269|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145667356|NCT02111096|525302270|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145667357|NCT02111096|525302268|FG000|Overall Study|Lost to Follow Up|1|||
145667358|NCT02111096|525302269|FG001|Overall Study|Lost to Follow Up|1|||
145667359|NCT02111096|525302270|FG002|Overall Study|Lost to Follow Up|1|||
145667360|NCT02111096|525302268|FG000|Overall Study|Physician Decision|0|||
145667361|NCT02111096|525302269|FG001|Overall Study|Physician Decision|1|||
145667362|NCT02111096|525302270|FG002|Overall Study|Physician Decision|0|||
145667363|NCT02111096|525302268|FG000|Overall Study|Protocol Violation|1|||
145667364|NCT02111096|525302269|FG001|Overall Study|Protocol Violation|0|||
145667365|NCT02111096|525302270|FG002|Overall Study|Protocol Violation|1|||
145667366|NCT02111096|525302268|FG000|Overall Study|Terminated by Sponsor|53|||
145667367|NCT02111096|525302269|FG001|Overall Study|Terminated by Sponsor|35|||
145667368|NCT02111096|525302270|FG002|Overall Study|Terminated by Sponsor|54|||
145667369|NCT02111096|525302268|FG000|Overall Study|Withdrawal by Subject|4|||
145667370|NCT02111096|525302269|FG001|Overall Study|Withdrawal by Subject|2|||
145667371|NCT02111096|525302270|FG002|Overall Study|Withdrawal by Subject|8|||
145667372|NCT00686595|525302273|FG000|Overall Study|Adverse Event|3|||
145667373|NCT00686595|525302273|FG000|Overall Study|Protocol Violation|1|||
145667374|NCT00686595|525302273|FG000|Overall Study|Lost to Follow-up|1|||
145667375|NCT00686595|525302273|FG000|Overall Study|Lack of Efficacy|1|||
145667376|NCT00686595|525302273|FG000|Overall Study|Poor Compliance|1|||
145667377|NCT03286114|525302276|FG000|Overall Study|Adverse Event|6|||
145667378|NCT03286114|525302276|FG000|Overall Study|Death|3|||
145667379|NCT01260896|525302279|FG000|First Intervention|Withdrawn Due to Emesis|2|||
145667380|NCT01260896|525302280|FG001|First Intervention|Withdrawn Due to Emesis|0|||
145667381|NCT00003222|525302283|FG000|Overall Study|Physician Decision|0|||
145667382|NCT00003222|525302284|FG001|Overall Study|Physician Decision|1|||
145667383|NCT03767335|525302296|FG000|Overall Study|Physician Decision|1|||
145667384|NCT03767335|525302297|FG001|Overall Study|Physician Decision|1|||
145667385|NCT03767335|525302298|FG002|Overall Study|Physician Decision|0|||
145667386|NCT03767335|525302296|FG000|Overall Study|Withdrawal by Subject|0|||
145667387|NCT03767335|525302297|FG001|Overall Study|Withdrawal by Subject|0|||
145667388|NCT03767335|525302298|FG002|Overall Study|Withdrawal by Subject|6|||
145667389|NCT03767335|525302296|FG000|Overall Study|Participant excluded from efficacy population|0|||
145667390|NCT03767335|525302297|FG001|Overall Study|Participant excluded from efficacy population|0|||
145667391|NCT03767335|525302298|FG002|Overall Study|Participant excluded from efficacy population|1|||
145667392|NCT03767335|525302296|FG000|Overall Study|Death|0|||
145667393|NCT03767335|525302297|FG001|Overall Study|Death|0|||
145667394|NCT03767335|525302298|FG002|Overall Study|Death|2|||
145667395|NCT03767335|525302296|FG000|Overall Study|Progressive Disease|2|||
145667396|NCT03767335|525302297|FG001|Overall Study|Progressive Disease|2|||
145667397|NCT03767335|525302298|FG002|Overall Study|Progressive Disease|2|||
145667398|NCT03767335|525302296|FG000|Overall Study|Disease progression needing additional medication|0|||
145667399|NCT03767335|525302297|FG001|Overall Study|Disease progression needing additional medication|0|||
145667400|NCT03767335|525302298|FG002|Overall Study|Disease progression needing additional medication|17|||
145667401|NCT03767335|525302296|FG000|Overall Study|Sponsor decision|0|||
145667402|NCT03767335|525302297|FG001|Overall Study|Sponsor decision|0|||
145490764|NCT00383552|524652202|FG000|Overall Study|Noncompliance with the protocol|11|||
145490765|NCT00383552|524652203|FG001|Overall Study|Noncompliance with the protocol|6|||
145490766|NCT00383552|524652204|FG002|Overall Study|Noncompliance with the protocol|8|||
145667403|NCT03767335|525302298|FG002|Overall Study|Sponsor decision|2|||
145667404|NCT03767335|525302296|FG000|Overall Study|Other Medical Reasons|0|||
145667405|NCT03767335|525302297|FG001|Overall Study|Other Medical Reasons|0|||
145667406|NCT03767335|525302298|FG002|Overall Study|Other Medical Reasons|3|||
145667407|NCT01313559|525302299|FG000|Overall Study|Withdrawal by Subject|1|||
145667408|NCT01313559|525302300|FG001|Overall Study|Withdrawal by Subject|2|||
145667409|NCT01313559|525302299|FG000|Overall Study|Disease progression|1|||
145667410|NCT01313559|525302300|FG001|Overall Study|Disease progression|0|||
145667411|NCT01313559|525302299|FG000|Overall Study|Rising PSA|2|||
145667412|NCT01313559|525302300|FG001|Overall Study|Rising PSA|0|||
145667413|NCT02754596|525302301|FG000|Overall Study|Withdrawal by Subject|3|||
145667414|NCT02754596|525302302|FG001|Overall Study|Withdrawal by Subject|4|||
145667415|NCT02754596|525302303|FG002|Overall Study|Withdrawal by Subject|0|||
145667416|NCT02754596|525302301|FG000|Overall Study|Physician Decision|1|||
145667417|NCT02754596|525302302|FG001|Overall Study|Physician Decision|1|||
145667418|NCT02754596|525302303|FG002|Overall Study|Physician Decision|1|||
145667419|NCT02754596|525302301|FG000|Overall Study|Lost to Follow-up|1|||
145667420|NCT02754596|525302302|FG001|Overall Study|Lost to Follow-up|1|||
145667421|NCT02754596|525302303|FG002|Overall Study|Lost to Follow-up|2|||
145667422|NCT02754596|525302301|FG000|Overall Study|Death|0|||
145667423|NCT02754596|525302302|FG001|Overall Study|Death|2|||
145667424|NCT02754596|525302303|FG002|Overall Study|Death|0|||
145667425|NCT02754596|525302301|FG000|Overall Study|Adverse Event|1|||
145667426|NCT02754596|525302302|FG001|Overall Study|Adverse Event|0|||
145667427|NCT02754596|525302303|FG002|Overall Study|Adverse Event|1|||
145667428|NCT02754596|525302301|FG000|Overall Study|Other|1|||
145667429|NCT02754596|525302302|FG001|Overall Study|Other|0|||
145667430|NCT02754596|525302303|FG002|Overall Study|Other|0|||
145667431|NCT04908514|525302305|FG000|Overall Study|Lost to Follow-up|2|||
145667432|NCT04908514|525302305|FG000|Overall Study|Withdrawal by Subject|1|||
145667433|NCT04059406|525302307|FG000|Overall Study|Early Treatment Termination|5|||
145667434|NCT04059406|525302308|FG001|Overall Study|Early Treatment Termination|5|||
145667435|NCT04059406|525302309|FG002|Overall Study|Early Treatment Termination|15|||
145667436|NCT03473223|525302311|FG000|Overall Study|Lost to Follow-up|1|||
145667437|NCT03473223|525302312|FG001|Overall Study|Lost to Follow-up|1|||
145667438|NCT03473223|525302311|FG000|Overall Study|Withdrawal by Subject|47|||
145667439|NCT03473223|525302312|FG001|Overall Study|Withdrawal by Subject|42|||
145667440|NCT03473223|525302311|FG000|Overall Study|Indirect contact|32|||
145490767|NCT00383552|524652205|FG003|Overall Study|Noncompliance with the protocol|10|||
145667441|NCT03473223|525302312|FG001|Overall Study|Indirect contact|29|||
145667442|NCT03473223|525302311|FG000|Overall Study|Other (Not specified)|32|||
145667443|NCT03473223|525302312|FG001|Overall Study|Other (Not specified)|20|||
145667444|NCT04755595|525302313|FG000|Overall Study|Lost to Follow-up|1|||
145667445|NCT00319696|525302314|FG000|Overall Study|Adverse Event|36|||
145667446|NCT00319696|525302314|FG000|Overall Study|withdrawal of consent|14|||
145667447|NCT00319696|525302314|FG000|Overall Study|administrative|7|||
145667448|NCT00319696|525302314|FG000|Overall Study|Lost to Follow-up|3|||
145667449|NCT00655499|525303444|FG000|Overall Study|not eligible|4|||
145667450|NCT03140670|525303445|FG000|Overall Study|Withdrawal by Subject|2|||
145667451|NCT03140670|525303445|FG000|Overall Study|Lost to Follow-up|1|||
145667452|NCT03140670|525303445|FG000|Overall Study|Physician Decision|1|||
145667453|NCT00220805|525303446|FG000|Overall Study|Adverse Event|1|||
145667454|NCT00220805|525303447|FG001|Overall Study|Adverse Event|3|||
145667455|NCT00220805|525303446|FG000|Overall Study|Withdrawal by Subject|3|||
145667456|NCT00220805|525303447|FG001|Overall Study|Withdrawal by Subject|0|||
145667457|NCT00220805|525303446|FG000|Overall Study|Lack of Efficacy|1|||
145667458|NCT00220805|525303447|FG001|Overall Study|Lack of Efficacy|0|||
145667459|NCT00220805|525303446|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
145667460|NCT00220805|525303447|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
145667461|NCT02325466|525303448|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
145667462|NCT02325466|525303449|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
145667463|NCT02325466|525303450|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
145667464|NCT02325466|525303448|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
145667465|NCT02325466|525303449|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
145667466|NCT02325466|525303450|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
145667467|NCT02325466|525303448|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
145667468|NCT02325466|525303449|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
145667469|NCT02325466|525303450|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
145667470|NCT02325466|525303448|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
145667471|NCT02325466|525303449|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
145667472|NCT02325466|525303450|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
145667473|NCT02325466|525303448|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
145667474|NCT02325466|525303449|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
145667475|NCT02325466|525303450|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
145667476|NCT02325466|525303448|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
145667477|NCT02325466|525303449|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
145667478|NCT02325466|525303450|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
145667479|NCT02325466|525303448|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
145667480|NCT02325466|525303449|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
145667481|NCT02325466|525303450|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
145667482|NCT02325466|525303448|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
145667483|NCT02325466|525303449|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
145667484|NCT02325466|525303450|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
145667485|NCT02325466|525303448|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
145667486|NCT02325466|525303449|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
145667487|NCT02325466|525303450|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
145667488|NCT03699163|525303451|FG000|Overall Study|Physician Decision|12|||
145667489|NCT03699163|525303452|FG001|Overall Study|Physician Decision|0|||
145667490|NCT03699163|525303451|FG000|Overall Study|failed QC measures|205|||
145667491|NCT03699163|525303452|FG001|Overall Study|failed QC measures|206|||
145667492|NCT01288443|525303460|FG000|Overall Study|Adverse Event|0|||
145667493|NCT01288443|525303461|FG001|Overall Study|Adverse Event|0|||
145667494|NCT01288443|525303462|FG002|Overall Study|Adverse Event|1|||
145667495|NCT01288443|525303463|FG003|Overall Study|Adverse Event|1|||
145667496|NCT01288443|525303464|FG004|Overall Study|Adverse Event|3|||
145667497|NCT01288443|525303465|FG005|Overall Study|Adverse Event|1|||
145667498|NCT01288443|525303460|FG000|Overall Study|Poor compliance to protocol|0|||
145667499|NCT01288443|525303461|FG001|Overall Study|Poor compliance to protocol|0|||
145667500|NCT01288443|525303462|FG002|Overall Study|Poor compliance to protocol|0|||
145667501|NCT01288443|525303463|FG003|Overall Study|Poor compliance to protocol|0|||
145667502|NCT01288443|525303464|FG004|Overall Study|Poor compliance to protocol|0|||
145667503|NCT01288443|525303465|FG005|Overall Study|Poor compliance to protocol|1|||
145667504|NCT01288443|525303460|FG000|Overall Study|Participant Moved|0|||
145667505|NCT01288443|525303461|FG001|Overall Study|Participant Moved|0|||
145667506|NCT01288443|525303462|FG002|Overall Study|Participant Moved|0|||
145667507|NCT01288443|525303463|FG003|Overall Study|Participant Moved|1|||
145667508|NCT01288443|525303464|FG004|Overall Study|Participant Moved|2|||
145667509|NCT01288443|525303465|FG005|Overall Study|Participant Moved|1|||
145667510|NCT01288443|525303460|FG000|Overall Study|Consent withdrawn by Participant|0|||
145667511|NCT01288443|525303461|FG001|Overall Study|Consent withdrawn by Participant|0|||
145667512|NCT01288443|525303462|FG002|Overall Study|Consent withdrawn by Participant|0|||
145667513|NCT01288443|525303463|FG003|Overall Study|Consent withdrawn by Participant|0|||
145667514|NCT01288443|525303464|FG004|Overall Study|Consent withdrawn by Participant|0|||
145667515|NCT01288443|525303465|FG005|Overall Study|Consent withdrawn by Participant|1|||
145667516|NCT01288443|525303460|FG000|Overall Study|Lost to Follow-up|0|||
145667517|NCT01288443|525303461|FG001|Overall Study|Lost to Follow-up|1|||
145667518|NCT01288443|525303462|FG002|Overall Study|Lost to Follow-up|0|||
145667519|NCT01288443|525303463|FG003|Overall Study|Lost to Follow-up|0|||
145667520|NCT01288443|525303464|FG004|Overall Study|Lost to Follow-up|0|||
145667521|NCT01288443|525303465|FG005|Overall Study|Lost to Follow-up|0|||
145667522|NCT01288443|525303460|FG000|Overall Study|Study drug auto-injector administration|0|||
145667523|NCT01288443|525303461|FG001|Overall Study|Study drug auto-injector administration|0|||
145667524|NCT01288443|525303462|FG002|Overall Study|Study drug auto-injector administration|0|||
145667525|NCT01288443|525303463|FG003|Overall Study|Study drug auto-injector administration|0|||
145667526|NCT01288443|525303464|FG004|Overall Study|Study drug auto-injector administration|1|||
145667527|NCT01288443|525303465|FG005|Overall Study|Study drug auto-injector administration|1|||
145667528|NCT01288443|525303460|FG000|Overall Study|Other than above|0|||
145667529|NCT01288443|525303461|FG001|Overall Study|Other than above|0|||
145667530|NCT01288443|525303462|FG002|Overall Study|Other than above|0|||
145667531|NCT01288443|525303463|FG003|Overall Study|Other than above|2|||
145667532|NCT01288443|525303464|FG004|Overall Study|Other than above|1|||
145667533|NCT01288443|525303465|FG005|Overall Study|Other than above|0|||
145667534|NCT01596972|525303466|FG000|Overall Study|Physician Decision|1|||
145667535|NCT01596972|525303467|FG001|Overall Study|Physician Decision|9|||
145667536|NCT01596972|525303466|FG000|Overall Study|Lost to Follow-up|0|||
145667537|NCT01596972|525303467|FG001|Overall Study|Lost to Follow-up|4|||
145667538|NCT01596972|525303466|FG000|Overall Study|Withdrawal by Subject|0|||
145667539|NCT01596972|525303467|FG001|Overall Study|Withdrawal by Subject|1|||
145667540|NCT01639131|525303469|FG000|Overall Study|Disease Progression|6|||
145667541|NCT01964300|525303471|FG000|Overall Study|Ineligible after enrollment|0|||
145667542|NCT01964300|525303472|FG001|Overall Study|Ineligible after enrollment|1|||
145667543|NCT01964300|525303471|FG000|Overall Study|Adverse Event|1|||
145667544|NCT01964300|525303472|FG001|Overall Study|Adverse Event|1|||
145667545|NCT01964300|525303471|FG000|Overall Study|Lack of Efficacy|3|||
145667546|NCT01964300|525303472|FG001|Overall Study|Lack of Efficacy|5|||
145667547|NCT01964300|525303471|FG000|Overall Study|Withdrawal by Subject|0|||
145667548|NCT01964300|525303472|FG001|Overall Study|Withdrawal by Subject|1|||
145667549|NCT01964300|525303471|FG000|Overall Study|To receive alternative therapy|1|||
145667550|NCT01964300|525303472|FG001|Overall Study|To receive alternative therapy|2|||
145667551|NCT01964300|525303471|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
145667552|NCT01964300|525303472|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
145667553|NCT01964300|525303471|FG000|Overall Study|Weight criteria not met|0|||
145667554|NCT01964300|525303472|FG001|Overall Study|Weight criteria not met|1|||
145667555|NCT00557492|525303473|FG000|Overall Study|Change in health insurance|1|||
145667556|NCT03621735|525303475|FG000|Overall Study|Withdrawal by Subject|13|||
145667557|NCT03621735|525303476|FG001|Overall Study|Withdrawal by Subject|13|||
145667558|NCT03875313|525303480|FG000|Overall Study|Withdrawal by Subject|1|||
145667559|NCT03875313|525303481|FG001|Overall Study|Withdrawal by Subject|3|||
145667560|NCT03875313|525303482|FG002|Overall Study|Withdrawal by Subject|0|||
145667561|NCT03875313|525303483|FG003|Overall Study|Withdrawal by Subject|0|||
145667562|NCT03875313|525303484|FG004|Overall Study|Withdrawal by Subject|0|||
145667563|NCT03875313|525303480|FG000|Overall Study|Death|0|||
145667564|NCT03875313|525303481|FG001|Overall Study|Death|0|||
145667565|NCT03875313|525303482|FG002|Overall Study|Death|0|||
145667566|NCT03875313|525303483|FG003|Overall Study|Death|0|||
145667567|NCT03875313|525303484|FG004|Overall Study|Death|1|||
145667568|NCT03875313|525303480|FG000|Overall Study|Lost to Follow-up|0|||
145667569|NCT03875313|525303481|FG001|Overall Study|Lost to Follow-up|0|||
145667570|NCT03875313|525303482|FG002|Overall Study|Lost to Follow-up|0|||
145667571|NCT03875313|525303483|FG003|Overall Study|Lost to Follow-up|0|||
145667572|NCT03875313|525303484|FG004|Overall Study|Lost to Follow-up|1|||
145667573|NCT03875313|525303480|FG000|Overall Study|Study Termination by Sponsor|0|||
145667574|NCT03875313|525303481|FG001|Overall Study|Study Termination by Sponsor|1|||
145667575|NCT03875313|525303482|FG002|Overall Study|Study Termination by Sponsor|1|||
145667576|NCT03875313|525303483|FG003|Overall Study|Study Termination by Sponsor|0|||
145667577|NCT03875313|525303484|FG004|Overall Study|Study Termination by Sponsor|1|||
145667578|NCT03875313|525303480|FG000|Overall Study|New Anticancer Treatment|0|||
145490768|NCT00383552|524652202|FG000|Overall Study|Did not meet protocol eligibility|8|||
145490769|NCT00383552|524652203|FG001|Overall Study|Did not meet protocol eligibility|6|||
145490770|NCT00383552|524652204|FG002|Overall Study|Did not meet protocol eligibility|2|||
145490771|NCT00383552|524652205|FG003|Overall Study|Did not meet protocol eligibility|3|||
145490772|NCT00383552|524652202|FG000|Overall Study|Administrative|1|||
145490773|NCT00383552|524652203|FG001|Overall Study|Administrative|0|||
145490774|NCT00383552|524652204|FG002|Overall Study|Administrative|1|||
145490775|NCT00383552|524652205|FG003|Overall Study|Administrative|1|||
145490776|NCT01393158|524652210|FG000|Overall Study|Adverse Event|1|||
145490777|NCT01393158|524652211|FG001|Overall Study|Adverse Event|0|||
145490778|NCT02173769|524652213|FG000|Overall Study|Protocol Violation|4|||
145667579|NCT03875313|525303481|FG001|Overall Study|New Anticancer Treatment|1|||
145667580|NCT03875313|525303482|FG002|Overall Study|New Anticancer Treatment|2|||
145667581|NCT03875313|525303483|FG003|Overall Study|New Anticancer Treatment|1|||
145667582|NCT03875313|525303484|FG004|Overall Study|New Anticancer Treatment|0|||
145667583|NCT03875313|525303480|FG000|Overall Study|Other, Not Specified|2|||
145667584|NCT03875313|525303481|FG001|Overall Study|Other, Not Specified|11|||
145667585|NCT03875313|525303482|FG002|Overall Study|Other, Not Specified|3|||
145490779|NCT02869633|524652214|FG000|Overall Study|Death|2|||
145490780|NCT02869633|524652215|FG001|Overall Study|Death|1|||
145490781|NCT02869633|524652214|FG000|Overall Study|Patient refused follow-up|1|||
145490782|NCT02869633|524652215|FG001|Overall Study|Patient refused follow-up|0|||
145490783|NCT02869633|524652214|FG000|Overall Study|Provider discretion|1|||
145490784|NCT02869633|524652215|FG001|Overall Study|Provider discretion|0|||
145490785|NCT02869633|524652214|FG000|Overall Study|Investigator decision|1|||
145490786|NCT02869633|524652215|FG001|Overall Study|Investigator decision|0|||
145490787|NCT02869633|524652214|FG000|Overall Study|Lost to Follow-up|0|||
145490788|NCT02869633|524652215|FG001|Overall Study|Lost to Follow-up|1|||
145490789|NCT02869633|524652214|FG000|Overall Study|Not eligible|6|||
145490790|NCT02869633|524652215|FG001|Overall Study|Not eligible|1|||
145490791|NCT02869633|524652214|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
145490792|NCT02869633|524652215|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
145490793|NCT02869633|524652214|FG000|Overall Study|Withdrawal by Subject|0|||
145490794|NCT02869633|524652215|FG001|Overall Study|Withdrawal by Subject|1|||
145490795|NCT04024891|524652216|FG000|Overall Study|Pregnancy|0|||
145490796|NCT04024891|524652217|FG001|Overall Study|Pregnancy|1|||
145490797|NCT01381016|524652218|FG000|Overall Study|Lost to Follow-up|1|||
145490798|NCT01381016|524652219|FG001|Overall Study|Lost to Follow-up|1|||
145490799|NCT01381016|524652218|FG000|Overall Study|Screen Failure|2|||
145490800|NCT01381016|524652219|FG001|Overall Study|Screen Failure|2|||
145490801|NCT01381016|524652218|FG000|Overall Study|Withdrawal by Subject|0|||
145490802|NCT01381016|524652219|FG001|Overall Study|Withdrawal by Subject|1|||
145490803|NCT01381016|524652218|FG000|Overall Study|Physician Decision|0|||
145490804|NCT01381016|524652219|FG001|Overall Study|Physician Decision|2|||
145490805|NCT01693029|524652220|FG000|Overall Study|Withdrawal by Subject|15|||
145490806|NCT01693029|524652221|FG001|Overall Study|Withdrawal by Subject|22|||
145490807|NCT01693029|524652220|FG000|Overall Study|Kidney transplantation|7|||
145490808|NCT01693029|524652221|FG001|Overall Study|Kidney transplantation|7|||
145490809|NCT01693029|524652220|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
145490810|NCT01693029|524652221|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
145490811|NCT01693029|524652220|FG000|Overall Study|Protocol Violation|6|||
145490812|NCT01693029|524652221|FG001|Overall Study|Protocol Violation|7|||
145490813|NCT01693029|524652220|FG000|Overall Study|Change in dialysis modality|2|||
145490814|NCT01693029|524652221|FG001|Overall Study|Change in dialysis modality|1|||
145490815|NCT01693029|524652220|FG000|Overall Study|Physician Decision|0|||
145490816|NCT01693029|524652221|FG001|Overall Study|Physician Decision|2|||
145490817|NCT01693029|524652220|FG000|Overall Study|Lost to Follow-up|0|||
145490818|NCT01693029|524652221|FG001|Overall Study|Lost to Follow-up|1|||
145490819|NCT01693029|524652220|FG000|Overall Study|Adverse Event|1|||
145490820|NCT01693029|524652221|FG001|Overall Study|Adverse Event|6|||
145490821|NCT01693029|524652220|FG000|Overall Study|Death|5|||
145490822|NCT01693029|524652221|FG001|Overall Study|Death|8|||
145490823|NCT01693029|524652220|FG000|Overall Study|Non-compliance|2|||
145490824|NCT01693029|524652221|FG001|Overall Study|Non-compliance|1|||
145490825|NCT00308139|524652222|FG000|Overall Study|Adverse Event|20|||
145667586|NCT03875313|525303483|FG003|Overall Study|Other, Not Specified|3|||
145667587|NCT03875313|525303484|FG004|Overall Study|Other, Not Specified|1|||
145667588|NCT04121546|525303485|FG000|Overall Study|Lost to Follow-up|1|||
145667589|NCT04121546|525303486|FG001|Overall Study|Lost to Follow-up|3|||
145667590|NCT00982644|525303493|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
145667591|NCT00982644|525303494|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
145667592|NCT00982644|525303493|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
145667593|NCT00982644|525303494|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
145667594|NCT00982644|525303493|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
145667595|NCT00982644|525303494|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
145667596|NCT00982644|525303493|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
145667597|NCT00982644|525303494|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
145667598|NCT00982644|525303493|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
145667599|NCT00982644|525303494|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
145667600|NCT00982644|525303493|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
145667601|NCT00982644|525303494|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
145667602|NCT00982644|525303493|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
145667603|NCT00982644|525303494|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
145667604|NCT00982644|525303493|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
145667605|NCT00982644|525303494|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
145667606|NCT00982644|525303493|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
145667607|NCT00982644|525303494|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
145667608|NCT00982644|525303493|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
145667609|NCT00982644|525303494|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
145667610|NCT00943917|525303495|FG000|Stage I|Adverse Event|1|||
145667611|NCT00943917|525303496|FG001|Stage I|Adverse Event|2|||
145667612|NCT00943917|525303497|FG002|Stage I|Adverse Event|2|||
145490826|NCT00308139|524652223|FG001|Overall Study|Adverse Event|14|||
145490827|NCT00308139|524652222|FG000|Overall Study|Lost to Follow-up|13|||
145490828|NCT00308139|524652223|FG001|Overall Study|Lost to Follow-up|8|||
145667613|NCT00943917|525303498|FG003|Stage I|Adverse Event|0|||
145667614|NCT00943917|525303499|FG004|Stage I|Adverse Event|0|||
145667615|NCT00943917|525303500|FG005|Stage I|Adverse Event|0|||
145667616|NCT00943917|525303501|FG006|Stage I|Adverse Event|0|||
145667617|NCT00943917|525303502|FG007|Stage I|Adverse Event|0|||
145667618|NCT00943917|525303503|FG008|Stage I|Adverse Event|0|||
145667619|NCT00943917|525303504|FG009|Stage I|Adverse Event|0|||
145667620|NCT00943917|525303505|FG010|Stage I|Adverse Event|0|||
145667621|NCT00943917|525303506|FG011|Stage I|Adverse Event|0|||
145667622|NCT00943917|525303507|FG012|Stage I|Adverse Event|0|||
145667623|NCT00943917|525303508|FG013|Stage I|Adverse Event|0|||
145667624|NCT00943917|525303509|FG014|Stage I|Adverse Event|0|||
145667625|NCT00943917|525303495|FG000|Stage I|Lost to Follow-up|0|||
145667626|NCT00943917|525303496|FG001|Stage I|Lost to Follow-up|0|||
145667627|NCT00943917|525303497|FG002|Stage I|Lost to Follow-up|1|||
145667628|NCT00943917|525303498|FG003|Stage I|Lost to Follow-up|0|||
145667629|NCT00943917|525303499|FG004|Stage I|Lost to Follow-up|0|||
145667630|NCT00943917|525303500|FG005|Stage I|Lost to Follow-up|0|||
145667631|NCT00943917|525303501|FG006|Stage I|Lost to Follow-up|0|||
145667632|NCT00943917|525303502|FG007|Stage I|Lost to Follow-up|0|||
145667633|NCT00943917|525303503|FG008|Stage I|Lost to Follow-up|0|||
145667634|NCT00943917|525303504|FG009|Stage I|Lost to Follow-up|0|||
145667635|NCT00943917|525303505|FG010|Stage I|Lost to Follow-up|0|||
145667636|NCT00943917|525303506|FG011|Stage I|Lost to Follow-up|0|||
145667637|NCT00943917|525303507|FG012|Stage I|Lost to Follow-up|0|||
145667638|NCT00943917|525303508|FG013|Stage I|Lost to Follow-up|0|||
145667639|NCT00943917|525303509|FG014|Stage I|Lost to Follow-up|0|||
145667640|NCT00943917|525303495|FG000|Stage I|hyperglycemia|0|||
145667641|NCT00943917|525303496|FG001|Stage I|hyperglycemia|0|||
145667642|NCT00943917|525303497|FG002|Stage I|hyperglycemia|1|||
145667643|NCT00943917|525303498|FG003|Stage I|hyperglycemia|0|||
145667644|NCT00943917|525303499|FG004|Stage I|hyperglycemia|0|||
145667645|NCT00943917|525303500|FG005|Stage I|hyperglycemia|0|||
145667646|NCT00943917|525303501|FG006|Stage I|hyperglycemia|0|||
145667647|NCT00943917|525303502|FG007|Stage I|hyperglycemia|0|||
145667648|NCT00943917|525303503|FG008|Stage I|hyperglycemia|0|||
145667649|NCT00943917|525303504|FG009|Stage I|hyperglycemia|0|||
145667650|NCT00943917|525303505|FG010|Stage I|hyperglycemia|0|||
145667651|NCT00943917|525303506|FG011|Stage I|hyperglycemia|0|||
145667652|NCT00943917|525303507|FG012|Stage I|hyperglycemia|0|||
145667653|NCT00943917|525303508|FG013|Stage I|hyperglycemia|0|||
145667654|NCT00943917|525303509|FG014|Stage I|hyperglycemia|0|||
145667655|NCT00943917|525303495|FG000|Stage I|A1C elevation|1|||
145667656|NCT00943917|525303496|FG001|Stage I|A1C elevation|0|||
145667657|NCT00943917|525303497|FG002|Stage I|A1C elevation|0|||
145667658|NCT00943917|525303498|FG003|Stage I|A1C elevation|0|||
145667659|NCT00943917|525303499|FG004|Stage I|A1C elevation|0|||
145667660|NCT00943917|525303500|FG005|Stage I|A1C elevation|0|||
145667661|NCT00943917|525303501|FG006|Stage I|A1C elevation|0|||
145667662|NCT00943917|525303502|FG007|Stage I|A1C elevation|0|||
145667663|NCT00943917|525303503|FG008|Stage I|A1C elevation|0|||
145667664|NCT00943917|525303504|FG009|Stage I|A1C elevation|0|||
145667665|NCT00943917|525303505|FG010|Stage I|A1C elevation|0|||
145667666|NCT00943917|525303506|FG011|Stage I|A1C elevation|0|||
145667667|NCT00943917|525303507|FG012|Stage I|A1C elevation|0|||
145667668|NCT00943917|525303508|FG013|Stage I|A1C elevation|0|||
145667669|NCT00943917|525303509|FG014|Stage I|A1C elevation|0|||
145667670|NCT00943917|525303495|FG000|Stage I|Withdrawal by Subject|2|||
145667671|NCT00943917|525303496|FG001|Stage I|Withdrawal by Subject|1|||
145667672|NCT00943917|525303497|FG002|Stage I|Withdrawal by Subject|2|||
145667673|NCT00943917|525303498|FG003|Stage I|Withdrawal by Subject|0|||
145667674|NCT00943917|525303499|FG004|Stage I|Withdrawal by Subject|0|||
145667675|NCT00943917|525303500|FG005|Stage I|Withdrawal by Subject|0|||
145490829|NCT00308139|524652222|FG000|Overall Study|Protocol Violation|3|||
145490830|NCT00308139|524652223|FG001|Overall Study|Protocol Violation|2|||
145490831|NCT00308139|524652222|FG000|Overall Study|Withdrawal of Consent|40|||
145667676|NCT00943917|525303501|FG006|Stage I|Withdrawal by Subject|0|||
145667677|NCT00943917|525303502|FG007|Stage I|Withdrawal by Subject|0|||
145667678|NCT00943917|525303503|FG008|Stage I|Withdrawal by Subject|0|||
145667679|NCT00943917|525303504|FG009|Stage I|Withdrawal by Subject|0|||
145667680|NCT00943917|525303505|FG010|Stage I|Withdrawal by Subject|0|||
145667681|NCT00943917|525303506|FG011|Stage I|Withdrawal by Subject|0|||
145667682|NCT00943917|525303507|FG012|Stage I|Withdrawal by Subject|0|||
145667683|NCT00943917|525303508|FG013|Stage I|Withdrawal by Subject|0|||
145667684|NCT00943917|525303509|FG014|Stage I|Withdrawal by Subject|0|||
145667685|NCT00943917|525303495|FG000|Stage II|Adverse Event|0|||
145667686|NCT00943917|525303496|FG001|Stage II|Adverse Event|0|||
145667687|NCT00943917|525303497|FG002|Stage II|Adverse Event|0|||
145667688|NCT00943917|525303498|FG003|Stage II|Adverse Event|0|||
145667689|NCT00943917|525303499|FG004|Stage II|Adverse Event|0|||
145667690|NCT00943917|525303500|FG005|Stage II|Adverse Event|1|||
145667691|NCT00943917|525303501|FG006|Stage II|Adverse Event|3|||
145667692|NCT00943917|525303502|FG007|Stage II|Adverse Event|0|||
145667693|NCT00943917|525303503|FG008|Stage II|Adverse Event|1|||
145667694|NCT00943917|525303504|FG009|Stage II|Adverse Event|0|||
145667695|NCT00943917|525303505|FG010|Stage II|Adverse Event|0|||
145667696|NCT00943917|525303506|FG011|Stage II|Adverse Event|0|||
145667697|NCT00943917|525303507|FG012|Stage II|Adverse Event|0|||
145667698|NCT00943917|525303508|FG013|Stage II|Adverse Event|0|||
145667699|NCT00943917|525303509|FG014|Stage II|Adverse Event|0|||
145667700|NCT00943917|525303495|FG000|Stage II|Withdrawal by Subject|0|||
145667701|NCT00943917|525303496|FG001|Stage II|Withdrawal by Subject|0|||
145667702|NCT00943917|525303497|FG002|Stage II|Withdrawal by Subject|0|||
145667703|NCT00943917|525303498|FG003|Stage II|Withdrawal by Subject|0|||
145667704|NCT00943917|525303499|FG004|Stage II|Withdrawal by Subject|0|||
145667705|NCT00943917|525303500|FG005|Stage II|Withdrawal by Subject|1|||
145667706|NCT00943917|525303501|FG006|Stage II|Withdrawal by Subject|0|||
145667707|NCT00943917|525303502|FG007|Stage II|Withdrawal by Subject|0|||
145667708|NCT00943917|525303503|FG008|Stage II|Withdrawal by Subject|0|||
145667709|NCT00943917|525303504|FG009|Stage II|Withdrawal by Subject|0|||
145667710|NCT00943917|525303505|FG010|Stage II|Withdrawal by Subject|0|||
145667711|NCT00943917|525303506|FG011|Stage II|Withdrawal by Subject|0|||
145667712|NCT00943917|525303507|FG012|Stage II|Withdrawal by Subject|0|||
145667713|NCT00943917|525303508|FG013|Stage II|Withdrawal by Subject|0|||
145667714|NCT00943917|525303509|FG014|Stage II|Withdrawal by Subject|0|||
145667715|NCT00943917|525303495|FG000|Stage II|Pregnancy|0|||
145667716|NCT00943917|525303496|FG001|Stage II|Pregnancy|0|||
145667717|NCT00943917|525303497|FG002|Stage II|Pregnancy|0|||
145667718|NCT00943917|525303498|FG003|Stage II|Pregnancy|0|||
145667719|NCT00943917|525303499|FG004|Stage II|Pregnancy|0|||
145667720|NCT00943917|525303500|FG005|Stage II|Pregnancy|1|||
145667721|NCT00943917|525303501|FG006|Stage II|Pregnancy|0|||
145667722|NCT00943917|525303502|FG007|Stage II|Pregnancy|0|||
145667723|NCT00943917|525303503|FG008|Stage II|Pregnancy|0|||
145667724|NCT00943917|525303504|FG009|Stage II|Pregnancy|0|||
145667725|NCT00943917|525303505|FG010|Stage II|Pregnancy|0|||
145667726|NCT00943917|525303506|FG011|Stage II|Pregnancy|0|||
145667727|NCT00943917|525303507|FG012|Stage II|Pregnancy|0|||
145667728|NCT00943917|525303508|FG013|Stage II|Pregnancy|0|||
145667729|NCT00943917|525303509|FG014|Stage II|Pregnancy|0|||
145667730|NCT00943917|525303495|FG000|Stage II Continuation|Adverse Event|0|||
145667731|NCT00943917|525303496|FG001|Stage II Continuation|Adverse Event|0|||
145667732|NCT00943917|525303497|FG002|Stage II Continuation|Adverse Event|0|||
145667733|NCT00943917|525303498|FG003|Stage II Continuation|Adverse Event|0|||
145667734|NCT00943917|525303499|FG004|Stage II Continuation|Adverse Event|0|||
145667735|NCT00943917|525303500|FG005|Stage II Continuation|Adverse Event|0|||
145667736|NCT00943917|525303501|FG006|Stage II Continuation|Adverse Event|0|||
145667737|NCT00943917|525303502|FG007|Stage II Continuation|Adverse Event|0|||
145667738|NCT00943917|525303503|FG008|Stage II Continuation|Adverse Event|0|||
145667739|NCT00943917|525303504|FG009|Stage II Continuation|Adverse Event|0|||
145667740|NCT00943917|525303505|FG010|Stage II Continuation|Adverse Event|0|||
145667741|NCT00943917|525303506|FG011|Stage II Continuation|Adverse Event|1|||
145667742|NCT00943917|525303507|FG012|Stage II Continuation|Adverse Event|2|||
145667743|NCT00943917|525303508|FG013|Stage II Continuation|Adverse Event|1|||
145667744|NCT00943917|525303509|FG014|Stage II Continuation|Adverse Event|1|||
145667745|NCT00943917|525303495|FG000|Stage II Continuation|Withdrawal by Subject|0|||
145667746|NCT00943917|525303496|FG001|Stage II Continuation|Withdrawal by Subject|0|||
145667747|NCT00943917|525303497|FG002|Stage II Continuation|Withdrawal by Subject|0|||
145667748|NCT00943917|525303498|FG003|Stage II Continuation|Withdrawal by Subject|0|||
145667749|NCT00943917|525303499|FG004|Stage II Continuation|Withdrawal by Subject|0|||
145667750|NCT00943917|525303500|FG005|Stage II Continuation|Withdrawal by Subject|0|||
145667751|NCT00943917|525303501|FG006|Stage II Continuation|Withdrawal by Subject|0|||
145667752|NCT00943917|525303502|FG007|Stage II Continuation|Withdrawal by Subject|0|||
145667753|NCT00943917|525303503|FG008|Stage II Continuation|Withdrawal by Subject|0|||
145667754|NCT00943917|525303504|FG009|Stage II Continuation|Withdrawal by Subject|0|||
145667755|NCT00943917|525303505|FG010|Stage II Continuation|Withdrawal by Subject|0|||
145667756|NCT00943917|525303506|FG011|Stage II Continuation|Withdrawal by Subject|0|||
145667757|NCT00943917|525303507|FG012|Stage II Continuation|Withdrawal by Subject|0|||
145667758|NCT00943917|525303508|FG013|Stage II Continuation|Withdrawal by Subject|1|||
145667759|NCT00943917|525303509|FG014|Stage II Continuation|Withdrawal by Subject|3|||
145667760|NCT00943917|525303495|FG000|Stage II Continuation|Protocol Violation|0|||
145667761|NCT00943917|525303496|FG001|Stage II Continuation|Protocol Violation|0|||
145667762|NCT00943917|525303497|FG002|Stage II Continuation|Protocol Violation|0|||
145667763|NCT00943917|525303498|FG003|Stage II Continuation|Protocol Violation|0|||
145667764|NCT00943917|525303499|FG004|Stage II Continuation|Protocol Violation|0|||
145667765|NCT00943917|525303500|FG005|Stage II Continuation|Protocol Violation|0|||
145667766|NCT00943917|525303501|FG006|Stage II Continuation|Protocol Violation|0|||
145667767|NCT00943917|525303502|FG007|Stage II Continuation|Protocol Violation|0|||
145667768|NCT00943917|525303503|FG008|Stage II Continuation|Protocol Violation|0|||
145667769|NCT00943917|525303504|FG009|Stage II Continuation|Protocol Violation|1|||
145667770|NCT00943917|525303505|FG010|Stage II Continuation|Protocol Violation|0|||
145667771|NCT00943917|525303506|FG011|Stage II Continuation|Protocol Violation|1|||
145667772|NCT00943917|525303507|FG012|Stage II Continuation|Protocol Violation|0|||
145667773|NCT00943917|525303508|FG013|Stage II Continuation|Protocol Violation|0|||
145667774|NCT00943917|525303509|FG014|Stage II Continuation|Protocol Violation|0|||
145667775|NCT00943917|525303495|FG000|Stage II Continuation|hypoglycemia|0|||
145667776|NCT00943917|525303496|FG001|Stage II Continuation|hypoglycemia|0|||
145667777|NCT00943917|525303497|FG002|Stage II Continuation|hypoglycemia|0|||
145667778|NCT00943917|525303498|FG003|Stage II Continuation|hypoglycemia|0|||
145667779|NCT00943917|525303499|FG004|Stage II Continuation|hypoglycemia|0|||
145667780|NCT00943917|525303500|FG005|Stage II Continuation|hypoglycemia|0|||
145667781|NCT00943917|525303501|FG006|Stage II Continuation|hypoglycemia|0|||
145667782|NCT00943917|525303502|FG007|Stage II Continuation|hypoglycemia|0|||
145667783|NCT00943917|525303503|FG008|Stage II Continuation|hypoglycemia|0|||
145667784|NCT00943917|525303504|FG009|Stage II Continuation|hypoglycemia|0|||
145667785|NCT00943917|525303505|FG010|Stage II Continuation|hypoglycemia|0|||
145667786|NCT00943917|525303506|FG011|Stage II Continuation|hypoglycemia|0|||
145667787|NCT00943917|525303507|FG012|Stage II Continuation|hypoglycemia|1|||
145667788|NCT00943917|525303508|FG013|Stage II Continuation|hypoglycemia|0|||
145667789|NCT00943917|525303509|FG014|Stage II Continuation|hypoglycemia|0|||
145667790|NCT00943917|525303495|FG000|Stage II Continuation|A1C elevation|0|||
145667791|NCT00943917|525303496|FG001|Stage II Continuation|A1C elevation|0|||
145667792|NCT00943917|525303497|FG002|Stage II Continuation|A1C elevation|0|||
145667793|NCT00943917|525303498|FG003|Stage II Continuation|A1C elevation|0|||
145667794|NCT00943917|525303499|FG004|Stage II Continuation|A1C elevation|0|||
145667795|NCT00943917|525303500|FG005|Stage II Continuation|A1C elevation|0|||
145667796|NCT00943917|525303501|FG006|Stage II Continuation|A1C elevation|0|||
145667797|NCT00943917|525303502|FG007|Stage II Continuation|A1C elevation|0|||
145667798|NCT00943917|525303503|FG008|Stage II Continuation|A1C elevation|0|||
145667799|NCT00943917|525303504|FG009|Stage II Continuation|A1C elevation|0|||
145667800|NCT00943917|525303505|FG010|Stage II Continuation|A1C elevation|0|||
145667801|NCT00943917|525303506|FG011|Stage II Continuation|A1C elevation|0|||
145667802|NCT00943917|525303507|FG012|Stage II Continuation|A1C elevation|0|||
145667803|NCT00943917|525303508|FG013|Stage II Continuation|A1C elevation|1|||
145667804|NCT00943917|525303509|FG014|Stage II Continuation|A1C elevation|0|||
145667805|NCT01171976|525303510|FG000|Overall Study|Protocol Violation|0|||
145667806|NCT01171976|525303511|FG001|Overall Study|Protocol Violation|0|||
145667807|NCT01171976|525303512|FG002|Overall Study|Protocol Violation|1|||
145667808|NCT01171976|525303510|FG000|Overall Study|Death|2|||
145667809|NCT01171976|525303511|FG001|Overall Study|Death|4|||
145667810|NCT01171976|525303512|FG002|Overall Study|Death|1|||
145667811|NCT01171976|525303510|FG000|Overall Study|Lost to Follow-up|4|||
145667812|NCT01171976|525303511|FG001|Overall Study|Lost to Follow-up|0|||
145667813|NCT01171976|525303512|FG002|Overall Study|Lost to Follow-up|2|||
145667814|NCT01171976|525303510|FG000|Overall Study|Withdrawal by Subject|1|||
145667815|NCT01171976|525303511|FG001|Overall Study|Withdrawal by Subject|5|||
145667816|NCT01171976|525303512|FG002|Overall Study|Withdrawal by Subject|6|||
145667817|NCT01171976|525303510|FG000|Overall Study|Abnormal test result|1|||
145667818|NCT01171976|525303511|FG001|Overall Study|Abnormal test result|0|||
145667819|NCT01171976|525303512|FG002|Overall Study|Abnormal test result|0|||
145667820|NCT01171976|525303510|FG000|Overall Study|Adverse Event|6|||
145667821|NCT01171976|525303511|FG001|Overall Study|Adverse Event|2|||
145667822|NCT01171976|525303512|FG002|Overall Study|Adverse Event|5|||
145667823|NCT03248492|525303517|FG000|Overall Study|Progressive Disease|24|||
145667824|NCT03248492|525303518|FG001|Overall Study|Progressive Disease|23|||
145667825|NCT03248492|525303519|FG002|Overall Study|Progressive Disease|11|||
145667826|NCT03248492|525303520|FG003|Overall Study|Progressive Disease|66|||
145667827|NCT03248492|525303521|FG004|Overall Study|Progressive Disease|1|||
145667828|NCT03248492|525303517|FG000|Overall Study|Adverse Event|14|||
145667829|NCT03248492|525303518|FG001|Overall Study|Adverse Event|13|||
145667830|NCT03248492|525303519|FG002|Overall Study|Adverse Event|9|||
145667831|NCT03248492|525303520|FG003|Overall Study|Adverse Event|22|||
145667832|NCT03248492|525303521|FG004|Overall Study|Adverse Event|2|||
145667833|NCT03248492|525303517|FG000|Overall Study|Withdrawal by Subject|5|||
145667834|NCT03248492|525303518|FG001|Overall Study|Withdrawal by Subject|4|||
145667835|NCT03248492|525303519|FG002|Overall Study|Withdrawal by Subject|0|||
145667836|NCT03248492|525303520|FG003|Overall Study|Withdrawal by Subject|8|||
145667837|NCT03248492|525303521|FG004|Overall Study|Withdrawal by Subject|1|||
145667838|NCT03248492|525303517|FG000|Overall Study|Physician Decision|1|||
145667839|NCT03248492|525303518|FG001|Overall Study|Physician Decision|1|||
145667840|NCT03248492|525303519|FG002|Overall Study|Physician Decision|1|||
145667841|NCT03248492|525303520|FG003|Overall Study|Physician Decision|7|||
145667842|NCT03248492|525303521|FG004|Overall Study|Physician Decision|0|||
145667843|NCT03248492|525303517|FG000|Overall Study|Death|1|||
145667844|NCT03248492|525303518|FG001|Overall Study|Death|1|||
145667845|NCT03248492|525303519|FG002|Overall Study|Death|0|||
145667846|NCT03248492|525303520|FG003|Overall Study|Death|6|||
145667847|NCT03248492|525303521|FG004|Overall Study|Death|0|||
145667848|NCT03248492|525303517|FG000|Overall Study|Study Terminated by Sponsor|3|||
145667849|NCT03248492|525303518|FG001|Overall Study|Study Terminated by Sponsor|1|||
145667850|NCT03248492|525303519|FG002|Overall Study|Study Terminated by Sponsor|0|||
145667851|NCT03248492|525303520|FG003|Overall Study|Study Terminated by Sponsor|7|||
145667852|NCT03248492|525303521|FG004|Overall Study|Study Terminated by Sponsor|0|||
145667853|NCT03248492|525303517|FG000|Overall Study|Other|2|||
145667854|NCT03248492|525303518|FG001|Overall Study|Other|5|||
145667855|NCT03248492|525303519|FG002|Overall Study|Other|0|||
145667856|NCT03248492|525303520|FG003|Overall Study|Other|14|||
145667857|NCT03248492|525303521|FG004|Overall Study|Other|0|||
145667858|NCT01315132|525303522|FG000|Overall Study|not treated due to disease progression|1|||
145667859|NCT04495621|525303523|FG000|Overall Study|Withdrawal by Subject|0|||
145667860|NCT04495621|525303524|FG001|Overall Study|Withdrawal by Subject|3|||
145667861|NCT04495621|525303523|FG000|Overall Study|Death|7|||
145667862|NCT04495621|525303524|FG001|Overall Study|Death|11|||
145667863|NCT04495621|525303523|FG000|Overall Study|Investigator Decision|0|||
145667864|NCT04495621|525303524|FG001|Overall Study|Investigator Decision|7|||
145667865|NCT04495621|525303523|FG000|Overall Study|Lost to Follow-up|0|||
145667866|NCT04495621|525303524|FG001|Overall Study|Lost to Follow-up|1|||
145667867|NCT05707351|525303530|FG000|Overall Study|Withdrawal by Subject|2|||
145667868|NCT05707351|525303530|FG000|Overall Study|Reason Not Specified|1|||
145667869|NCT03213457|525303535|FG000|Screening Period|Withdrawal by Subject|0|||
145667870|NCT03213457|525303536|FG001|Screening Period|Withdrawal by Subject|1|||
145667871|NCT03213457|525303537|FG002|Screening Period|Withdrawal by Subject|0|||
145667872|NCT03213457|525303535|FG000|Screening Period|Other|1|||
145667873|NCT03213457|525303536|FG001|Screening Period|Other|0|||
145667874|NCT03213457|525303537|FG002|Screening Period|Other|0|||
145667875|NCT03213457|525303535|FG000|Double-Blind Period|Adverse Event|3|||
145667876|NCT03213457|525303536|FG001|Double-Blind Period|Adverse Event|2|||
145667877|NCT03213457|525303537|FG002|Double-Blind Period|Adverse Event|7|||
145667878|NCT03213457|525303535|FG000|Double-Blind Period|Withdrawal by Subject|14|||
145667879|NCT03213457|525303536|FG001|Double-Blind Period|Withdrawal by Subject|2|||
145667880|NCT03213457|525303537|FG002|Double-Blind Period|Withdrawal by Subject|14|||
145667881|NCT03213457|525303535|FG000|Double-Blind Period|Lost to Follow-up|2|||
145667882|NCT03213457|525303536|FG001|Double-Blind Period|Lost to Follow-up|3|||
145667883|NCT03213457|525303537|FG002|Double-Blind Period|Lost to Follow-up|9|||
145667884|NCT03213457|525303535|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
145667885|NCT03213457|525303536|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
145667886|NCT03213457|525303537|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
145667887|NCT03213457|525303535|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
145667888|NCT03213457|525303536|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
145667889|NCT03213457|525303537|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
145667890|NCT03213457|525303535|FG000|Double-Blind Period|Pregnancy|5|||
145667891|NCT03213457|525303536|FG001|Double-Blind Period|Pregnancy|0|||
145667892|NCT03213457|525303537|FG002|Double-Blind Period|Pregnancy|0|||
145667893|NCT03213457|525303535|FG000|Double-Blind Period|Other|10|||
145667894|NCT03213457|525303536|FG001|Double-Blind Period|Other|3|||
145667895|NCT03213457|525303537|FG002|Double-Blind Period|Other|17|||
145667896|NCT03213457|525303535|FG000|Open-Label Period|Adverse Event|1|||
145667897|NCT03213457|525303536|FG001|Open-Label Period|Adverse Event|2|||
145667898|NCT03213457|525303537|FG002|Open-Label Period|Adverse Event|2|||
145667899|NCT03213457|525303535|FG000|Open-Label Period|Withdrawal by Subject|12|||
145667900|NCT03213457|525303536|FG001|Open-Label Period|Withdrawal by Subject|5|||
145667901|NCT03213457|525303537|FG002|Open-Label Period|Withdrawal by Subject|24|||
145667902|NCT03213457|525303535|FG000|Open-Label Period|Lost to Follow-up|1|||
145667903|NCT03213457|525303536|FG001|Open-Label Period|Lost to Follow-up|2|||
145667904|NCT03213457|525303537|FG002|Open-Label Period|Lost to Follow-up|8|||
145667905|NCT03213457|525303535|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
145667906|NCT03213457|525303536|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
145667907|NCT03213457|525303537|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
145667908|NCT03213457|525303535|FG000|Open-Label Period|Non-compliance with study procedures|1|||
145667909|NCT03213457|525303536|FG001|Open-Label Period|Non-compliance with study procedures|1|||
145667910|NCT03213457|525303537|FG002|Open-Label Period|Non-compliance with study procedures|2|||
145667911|NCT03213457|525303535|FG000|Open-Label Period|Exclusionary medications|0|||
145667912|NCT03213457|525303536|FG001|Open-Label Period|Exclusionary medications|0|||
145667913|NCT03213457|525303537|FG002|Open-Label Period|Exclusionary medications|1|||
145667914|NCT03213457|525303535|FG000|Open-Label Period|Other|1|||
145667915|NCT03213457|525303536|FG001|Open-Label Period|Other|1|||
145667916|NCT03213457|525303537|FG002|Open-Label Period|Other|6|||
145667917|NCT03213457|525303535|FG000|Follow-Up Period|Adverse Event|16|||
145667918|NCT03213457|525303536|FG001|Follow-Up Period|Adverse Event|8|||
145667919|NCT03213457|525303537|FG002|Follow-Up Period|Adverse Event|37|||
145667920|NCT03213457|525303535|FG000|Follow-Up Period|Withdrawal by Subject|18|||
145667921|NCT03213457|525303536|FG001|Follow-Up Period|Withdrawal by Subject|11|||
145667922|NCT03213457|525303537|FG002|Follow-Up Period|Withdrawal by Subject|55|||
145667923|NCT03213457|525303535|FG000|Follow-Up Period|Lost to Follow-up|28|||
145667924|NCT03213457|525303536|FG001|Follow-Up Period|Lost to Follow-up|15|||
145667925|NCT03213457|525303537|FG002|Follow-Up Period|Lost to Follow-up|50|||
145667926|NCT03213457|525303535|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
145667927|NCT03213457|525303536|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
145667928|NCT03213457|525303537|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
145667929|NCT03213457|525303535|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
145667930|NCT03213457|525303536|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
145667931|NCT03213457|525303537|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
145667932|NCT03213457|525303535|FG000|Follow-Up Period|Pregnancy|7|||
145667933|NCT03213457|525303536|FG001|Follow-Up Period|Pregnancy|0|||
145667934|NCT03213457|525303537|FG002|Follow-Up Period|Pregnancy|18|||
145667935|NCT03213457|525303535|FG000|Follow-Up Period|Exclusionary medications|1|||
145667936|NCT03213457|525303536|FG001|Follow-Up Period|Exclusionary medications|1|||
145667937|NCT03213457|525303537|FG002|Follow-Up Period|Exclusionary medications|5|||
145667938|NCT03213457|525303535|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
145667939|NCT03213457|525303536|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
145667940|NCT03213457|525303537|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
145667941|NCT03213457|525303535|FG000|Follow-Up Period|Other|14|||
145667942|NCT03213457|525303536|FG001|Follow-Up Period|Other|10|||
145667943|NCT03213457|525303537|FG002|Follow-Up Period|Other|31|||
145667944|NCT02951052|525303538|FG000|Overall Study|Adverse Event|13|||
145667945|NCT02951052|525303539|FG001|Overall Study|Adverse Event|5|||
145667946|NCT02951052|525303538|FG000|Overall Study|Withdrawal by Subject|1|||
145667947|NCT02951052|525303539|FG001|Overall Study|Withdrawal by Subject|5|||
145667948|NCT02951052|525303538|FG000|Overall Study|Physician Decision|2|||
145667949|NCT02951052|525303539|FG001|Overall Study|Physician Decision|0|||
145667950|NCT02951052|525303538|FG000|Overall Study|Lost to Follow-up|1|||
145667951|NCT02951052|525303539|FG001|Overall Study|Lost to Follow-up|1|||
145667952|NCT02951052|525303538|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
145667953|NCT02951052|525303539|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
145667954|NCT02951052|525303538|FG000|Overall Study|Protocol Violation|5|||
145667955|NCT02951052|525303539|FG001|Overall Study|Protocol Violation|3|||
145667956|NCT02951052|525303538|FG000|Overall Study|Lack of Efficacy|3|||
145667957|NCT02951052|525303539|FG001|Overall Study|Lack of Efficacy|4|||
145667958|NCT02951052|525303538|FG000|Overall Study|Ongoing|1|||
145667959|NCT02951052|525303539|FG001|Overall Study|Ongoing|0|||
145667960|NCT04977583|525304196|FG000|Overall Study|Lost to Follow-up|8|||
145667961|NCT04977583|525304197|FG001|Overall Study|Lost to Follow-up|4|||
145667962|NCT04977583|525304198|FG002|Overall Study|Lost to Follow-up|13|||
145667963|NCT04977583|525304196|FG000|Overall Study|Withdrawal by Subject|3|||
145667964|NCT04977583|525304197|FG001|Overall Study|Withdrawal by Subject|2|||
145667965|NCT04977583|525304198|FG002|Overall Study|Withdrawal by Subject|1|||
145667966|NCT05155306|525304207|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
145667967|NCT05155306|525304208|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
145667968|NCT05155306|525304209|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
145667969|NCT05155306|525304210|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
145667970|NCT05155306|525304207|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
145667971|NCT05155306|525304208|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
145667972|NCT05155306|525304209|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
145667973|NCT05155306|525304210|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
145667974|NCT04158141|525304214|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
145667975|NCT04158141|525304215|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
145667976|NCT04158141|525304216|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
145667977|NCT04158141|525304214|FG000|Step 1: Registration|Adverse Event|1|||
145667978|NCT04158141|525304215|FG001|Step 1: Registration|Adverse Event|0|||
145667979|NCT04158141|525304216|FG002|Step 1: Registration|Adverse Event|0|||
145667980|NCT04158141|525304214|FG000|Step 1: Registration|Withdrawal by Subject|1|||
145667981|NCT04158141|525304215|FG001|Step 1: Registration|Withdrawal by Subject|0|||
145667982|NCT04158141|525304216|FG002|Step 1: Registration|Withdrawal by Subject|0|||
145667983|NCT04158141|525304214|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
145667984|NCT04158141|525304215|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
145667985|NCT04158141|525304216|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
145667986|NCT04121741|525304217|FG000|Overall Study|Protocol Violation|1|||
145667987|NCT04121741|525304218|FG001|Overall Study|Protocol Violation|0|||
145667988|NCT04121741|525304219|FG002|Overall Study|Protocol Violation|0|||
145667989|NCT04121741|525304220|FG003|Overall Study|Protocol Violation|0|||
145667990|NCT04121741|525304221|FG004|Overall Study|Protocol Violation|0|||
145490832|NCT00308139|524652223|FG001|Overall Study|Withdrawal of Consent|42|||
145490833|NCT00308139|524652222|FG000|Overall Study|Investigator Decision|11|||
145667991|NCT04121741|525304222|FG005|Overall Study|Protocol Violation|0|||
145667992|NCT01084863|525304223|FG000|Main Study Treatment Period|Disease progression|11|||
145667993|NCT01084863|525304224|FG001|Main Study Treatment Period|Disease progression|7|||
145667994|NCT01084863|525304223|FG000|Main Study Treatment Period|Adverse Event|5|||
145667995|NCT01084863|525304224|FG001|Main Study Treatment Period|Adverse Event|3|||
145667996|NCT01084863|525304223|FG000|Main Study Treatment Period|Other Reason|0|||
145667997|NCT01084863|525304224|FG001|Main Study Treatment Period|Other Reason|1|||
145667998|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
145667999|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
145668000|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
145668001|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
145668002|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
145668003|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
145668004|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
145668005|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
145668006|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Other|0|||
145668007|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Other|1|||
145668008|NCT01084863|525304223|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
145668009|NCT01084863|525304224|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
145668010|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
145668011|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
145668012|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
145668013|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
145668014|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
145668015|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
145668016|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
145668017|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
145668018|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
145668019|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
145668020|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
145668021|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
145668022|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
145668023|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
145668024|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
145668025|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
145668026|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
145668027|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
145668028|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
145668029|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
145668030|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
145668031|NCT04505722|525304225|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
145668032|NCT04505722|525304226|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
145668033|NCT04505722|525304227|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
145668034|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
145668035|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
145668036|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
145668037|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
145668038|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
145668039|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
145668040|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
145668041|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
145668042|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
145668043|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
145668044|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
145668045|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
145668046|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
145668047|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
145668048|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
145668049|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
145668050|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
145668051|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
145668052|NCT04505722|525304225|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
145668053|NCT04505722|525304226|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
145668054|NCT04505722|525304227|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
145668055|NCT03275285|525304228|FG000|Overall Study|Ongoing|45|||
145668056|NCT03275285|525304229|FG001|Overall Study|Ongoing|69|||
145668057|NCT02500576|525304233|FG000|Overall Study|Adverse Event|0|||
145668058|NCT02500576|525304234|FG001|Overall Study|Adverse Event|1|||
145668059|NCT02500576|525304233|FG000|Overall Study|Death|2|||
145668060|NCT02500576|525304234|FG001|Overall Study|Death|1|||
145668061|NCT02500576|525304233|FG000|Overall Study|Lack of Efficacy|5|||
145668062|NCT02500576|525304234|FG001|Overall Study|Lack of Efficacy|5|||
145668063|NCT02500576|525304233|FG000|Overall Study|Withdrawal by Subject|1|||
145668064|NCT02500576|525304234|FG001|Overall Study|Withdrawal by Subject|1|||
145668065|NCT05827068|525304240|FG000|Overall Study|Lost to Follow-up|1|||
145668066|NCT05827068|525304241|FG001|Overall Study|Lost to Follow-up|4|||
145668067|NCT05827068|525304242|FG002|Overall Study|Lost to Follow-up|1|||
145668068|NCT05827068|525304243|FG003|Overall Study|Lost to Follow-up|1|||
145668069|NCT05827068|525304244|FG004|Overall Study|Lost to Follow-up|2|||
145668070|NCT05827068|525304245|FG005|Overall Study|Lost to Follow-up|4|||
145668071|NCT05827068|525304246|FG006|Overall Study|Lost to Follow-up|1|||
145668072|NCT05827068|525304240|FG000|Overall Study|Withdrawal by Subject|4|||
145668073|NCT05827068|525304241|FG001|Overall Study|Withdrawal by Subject|0|||
145668074|NCT05827068|525304242|FG002|Overall Study|Withdrawal by Subject|1|||
145668075|NCT05827068|525304243|FG003|Overall Study|Withdrawal by Subject|2|||
145668076|NCT05827068|525304244|FG004|Overall Study|Withdrawal by Subject|3|||
145668077|NCT05827068|525304245|FG005|Overall Study|Withdrawal by Subject|0|||
145668078|NCT05827068|525304246|FG006|Overall Study|Withdrawal by Subject|1|||
145668079|NCT05827068|525304240|FG000|Overall Study|Physician Decision|0|||
145668080|NCT05827068|525304241|FG001|Overall Study|Physician Decision|0|||
145668081|NCT05827068|525304242|FG002|Overall Study|Physician Decision|0|||
145668082|NCT05827068|525304243|FG003|Overall Study|Physician Decision|0|||
145668083|NCT05827068|525304244|FG004|Overall Study|Physician Decision|1|||
145668084|NCT05827068|525304245|FG005|Overall Study|Physician Decision|0|||
145668085|NCT05827068|525304246|FG006|Overall Study|Physician Decision|1|||
145668086|NCT05827068|525304240|FG000|Overall Study|Other Than Specified|0|||
145668087|NCT05827068|525304241|FG001|Overall Study|Other Than Specified|1|||
145668088|NCT05827068|525304242|FG002|Overall Study|Other Than Specified|0|||
145668089|NCT05827068|525304243|FG003|Overall Study|Other Than Specified|0|||
145668090|NCT05827068|525304244|FG004|Overall Study|Other Than Specified|0|||
145668091|NCT05827068|525304245|FG005|Overall Study|Other Than Specified|0|||
145668092|NCT05827068|525304246|FG006|Overall Study|Other Than Specified|0|||
145668093|NCT00319020|525304247|FG000|Overall Study|Death|2|||
145668094|NCT00319020|525304248|FG001|Overall Study|Death|2|||
145668095|NCT00319020|525304247|FG000|Overall Study|Withdrawal by Subject|4|||
145668096|NCT00319020|525304248|FG001|Overall Study|Withdrawal by Subject|1|||
145668097|NCT00319020|525304247|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
145668098|NCT00319020|525304248|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
145668099|NCT00319020|525304247|FG000|Overall Study|Administrative reason|0|||
145668100|NCT00319020|525304248|FG001|Overall Study|Administrative reason|5|||
145668101|NCT00319020|525304247|FG000|Overall Study|Disease progression|0|||
145668102|NCT00319020|525304248|FG001|Overall Study|Disease progression|2|||
145668103|NCT00319020|525304247|FG000|Overall Study|Transplant|0|||
145668104|NCT00319020|525304248|FG001|Overall Study|Transplant|1|||
145668105|NCT00319020|525304247|FG000|Overall Study|Treatment failure|0|||
145668106|NCT00319020|525304248|FG001|Overall Study|Treatment failure|1|||
145668107|NCT00319020|525304247|FG000|Overall Study|Adverse Event|0|||
145668108|NCT00319020|525304248|FG001|Overall Study|Adverse Event|1|||
145668109|NCT04530487|525305030|FG000|Overall Study|Death|1|||
145668110|NCT02285270|525305038|FG000|Overall Study|Lost to Follow-up|1|||
145668111|NCT02285270|525305038|FG000|Overall Study|Physician Decision|3|||
145668112|NCT02285270|525305038|FG000|Overall Study|Determined to be ineligible|1|||
145668113|NCT00439270|525305039|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
145668114|NCT00439270|525305040|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
145668115|NCT00439270|525305041|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
145668116|NCT00439270|525305042|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
145668117|NCT00439270|525305043|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
145668118|NCT00439270|525305039|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
145668119|NCT00439270|525305040|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
145668120|NCT00439270|525305041|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
145668121|NCT00439270|525305042|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
145668122|NCT00439270|525305043|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
145668123|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
145668124|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
145668125|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
145668126|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
145668127|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
145668128|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
145668129|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
145668130|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
145668131|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
145668132|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
145668133|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
145668134|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
145668135|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
145668136|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
145668137|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
145668138|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
145668139|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
145668140|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
145668141|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
145668142|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
145668143|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
145265397|NCT04479358|523819336|FG004|Overall Study|Withdrawal by Subject|0|||
145668144|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
145668145|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
145668146|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
145668147|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
145668148|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
145668149|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
145668150|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
145668151|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
145668152|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
145668153|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
145668154|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
145668155|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
145668156|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
145668157|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
145668158|NCT00439270|525305039|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
145668159|NCT00439270|525305040|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
145668160|NCT00439270|525305041|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
145668161|NCT00439270|525305042|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
145668162|NCT00439270|525305043|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
145668163|NCT04334317|525305044|FG000|Overall Study|Adverse Event|1|||
145668164|NCT04334317|525305045|FG001|Overall Study|Adverse Event|2|||
145668165|NCT04334317|525305046|FG002|Overall Study|Adverse Event|0|||
145668166|NCT04334317|525305047|FG003|Overall Study|Adverse Event|0|||
145668167|NCT04334317|525305044|FG000|Overall Study|Protocol Deviation|0|||
145668168|NCT04334317|525305045|FG001|Overall Study|Protocol Deviation|1|||
145668169|NCT04334317|525305046|FG002|Overall Study|Protocol Deviation|0|||
145668170|NCT04334317|525305047|FG003|Overall Study|Protocol Deviation|0|||
145668171|NCT04334317|525305044|FG000|Overall Study|Withdrawal by Subject|2|||
145668172|NCT04334317|525305045|FG001|Overall Study|Withdrawal by Subject|2|||
145668173|NCT04334317|525305046|FG002|Overall Study|Withdrawal by Subject|0|||
145668174|NCT04334317|525305047|FG003|Overall Study|Withdrawal by Subject|0|||
145668175|NCT03709706|525305049|FG000|Overall Study|Adverse Event|0|||
145668176|NCT03709706|525305050|FG001|Overall Study|Adverse Event|1|||
145668177|NCT03709706|525305049|FG000|Overall Study|Physician Decision|14|||
145668178|NCT03709706|525305050|FG001|Overall Study|Physician Decision|8|||
145668179|NCT03709706|525305049|FG000|Overall Study|Withdrawal by Subject|2|||
145668180|NCT03709706|525305050|FG001|Overall Study|Withdrawal by Subject|1|||
145668181|NCT03709706|525305049|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
145668182|NCT03709706|525305050|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
145668183|NCT03183050|525305051|FG000|Overall Study|Lost to Follow-up|23|||
145668184|NCT02797132|525305052|FG000|Part A (15 Days)|Adverse Event|1|||
145668185|NCT02797132|525305052|FG000|Part B (24 Weeks)|Adverse Event|3|||
145668186|NCT02284113|525305055|FG000|Overall Study|Adverse Event|1|||
145668187|NCT02284113|525305056|FG001|Overall Study|Adverse Event|0|||
145668188|NCT02284113|525305055|FG000|Overall Study|non-compliance|0|||
145668189|NCT02284113|525305056|FG001|Overall Study|non-compliance|1|||
145668190|NCT02284113|525305055|FG000|Overall Study|Withdrawal by Subject|0|||
145668191|NCT02284113|525305056|FG001|Overall Study|Withdrawal by Subject|1|||
145668192|NCT02284113|525305055|FG000|Overall Study|not provided|0|||
145668193|NCT02284113|525305056|FG001|Overall Study|not provided|1|||
145668194|NCT02284113|525305055|FG000|Overall Study|surgery cancelled|2|||
145668195|NCT02284113|525305056|FG001|Overall Study|surgery cancelled|0|||
145668196|NCT04191824|525305057|FG000|Overall Study|Death|13|||
145668197|NCT04191824|525305058|FG001|Overall Study|Death|12|||
145668198|NCT04191824|525305057|FG000|Overall Study|Lost to Follow-up|456|||
145668199|NCT04191824|525305058|FG001|Overall Study|Lost to Follow-up|435|||
145668200|NCT04191824|525305057|FG000|Overall Study|Physician Decision|2|||
145668201|NCT04191824|525305058|FG001|Overall Study|Physician Decision|1|||
145668202|NCT04191824|525305057|FG000|Overall Study|Protocol Violation|0|||
145668203|NCT04191824|525305058|FG001|Overall Study|Protocol Violation|2|||
145668204|NCT04191824|525305057|FG000|Overall Study|Withdrawal by Subject|16|||
145668205|NCT04191824|525305058|FG001|Overall Study|Withdrawal by Subject|18|||
145668206|NCT04191824|525305057|FG000|Overall Study|Early site closure|24|||
145668207|NCT04191824|525305058|FG001|Overall Study|Early site closure|22|||
145668208|NCT01218009|525305059|FG000|Overall Study|Protocol Violation|2|||
145668209|NCT01218009|525305060|FG001|Overall Study|Protocol Violation|1|||
145668210|NCT01218009|525305059|FG000|Overall Study|Withdrawal by Subject|3|||
145668211|NCT01218009|525305060|FG001|Overall Study|Withdrawal by Subject|1|||
145668212|NCT01218009|525305059|FG000|Overall Study|Sponsor terminated study|161|||
145668213|NCT01218009|525305060|FG001|Overall Study|Sponsor terminated study|163|||
145668214|NCT01324310|525305061|FG000|Overall Study|Adverse Event|1|||
145668215|NCT01324310|525305061|FG000|Overall Study|Disease Progression|1|||
145668216|NCT03170882|525305062|FG000|Overall Study|Death|17|||
145668217|NCT03170882|525305063|FG001|Overall Study|Death|29|||
145668218|NCT03170882|525305062|FG000|Overall Study|Lost to Follow-up|0|||
145668219|NCT03170882|525305063|FG001|Overall Study|Lost to Follow-up|1|||
145668220|NCT03170882|525305062|FG000|Overall Study|Withdrawal by Subject|4|||
145668221|NCT03170882|525305063|FG001|Overall Study|Withdrawal by Subject|7|||
145668222|NCT03170882|525305062|FG000|Overall Study|Reason not Specified|28|||
145668223|NCT03170882|525305063|FG001|Overall Study|Reason not Specified|36|||
145668224|NCT01371994|525305064|FG000|Overall Study|Adverse Event|3|||
145668225|NCT01371994|525305065|FG001|Overall Study|Adverse Event|6|||
145668226|NCT01371994|525305064|FG000|Overall Study|Lack of Efficacy|3|||
145668227|NCT01371994|525305065|FG001|Overall Study|Lack of Efficacy|0|||
145668228|NCT01371994|525305064|FG000|Overall Study|Withdrawal by Subject|13|||
145668229|NCT01371994|525305065|FG001|Overall Study|Withdrawal by Subject|7|||
145668230|NCT01371994|525305064|FG000|Overall Study|Lost to Follow-up|1|||
145668231|NCT01371994|525305065|FG001|Overall Study|Lost to Follow-up|1|||
145668232|NCT01371994|525305064|FG000|Overall Study|Protocol Violation|24|||
145668233|NCT01371994|525305065|FG001|Overall Study|Protocol Violation|17|||
145668234|NCT01371994|525305064|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
145668235|NCT01371994|525305065|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
145668236|NCT01371994|525305064|FG000|Overall Study|Physician Decision|1|||
145668237|NCT01371994|525305065|FG001|Overall Study|Physician Decision|1|||
145668238|NCT01371994|525305064|FG000|Overall Study|Miscellaneous Reasons|6|||
145668239|NCT01371994|525305065|FG001|Overall Study|Miscellaneous Reasons|4|||
145668240|NCT00087685|525305066|FG000|Overall Study|Adverse Event|5|||
145668241|NCT00087685|525305066|FG000|Overall Study|Non-Compliance|1|||
145668242|NCT00087685|525305066|FG000|Overall Study|Progressive Disease|5|||
145668243|NCT00087685|525305066|FG000|Overall Study|Withdrawal by Subject|3|||
145668244|NCT01830595|525305067|FG000|First Period|Withdrawal by Subject|1|||
145668245|NCT01830595|525305068|FG001|First Period|Withdrawal by Subject|3|||
145668246|NCT01830595|525305067|FG000|Washout|Withdrawal by Subject|2|||
145668247|NCT01830595|525305068|FG001|Washout|Withdrawal by Subject|2|||
145668248|NCT04018495|525305069|FG000|Overall Study|Physician Decision|1|||
145668249|NCT05116774|525305070|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
145668250|NCT05116774|525305071|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
145668251|NCT05116774|525305070|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
145668252|NCT05116774|525305071|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
145668253|NCT05116774|525305070|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
145668254|NCT05116774|525305071|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
145668255|NCT05116774|525305070|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
145668256|NCT05116774|525305071|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
145668257|NCT04305327|525305075|FG000|Overall Study|Study early termination|2|||
145668258|NCT04305327|525305076|FG001|Overall Study|Study early termination|5|||
145668259|NCT04305327|525305077|FG002|Overall Study|Study early termination|2|||
145668260|NCT04305327|525305078|FG003|Overall Study|Study early termination|2|||
145668261|NCT04305327|525305075|FG000|Overall Study|Withdrawal by Subject|0|||
145668262|NCT04305327|525305076|FG001|Overall Study|Withdrawal by Subject|1|||
145668263|NCT04305327|525305077|FG002|Overall Study|Withdrawal by Subject|0|||
145668264|NCT04305327|525305078|FG003|Overall Study|Withdrawal by Subject|0|||
145668265|NCT00115934|525305079|FG000|Overall Study|Lost to Follow-up|1|||
145668266|NCT00115934|525305080|FG001|Overall Study|Lost to Follow-up|0|||
145668267|NCT00115934|525305079|FG000|Overall Study|Did not receive intervention|3|||
145668268|NCT00115934|525305080|FG001|Overall Study|Did not receive intervention|2|||
145668269|NCT00747565|525305081|FG000|Overall Study|Withdrawal by Subject|10|||
145668270|NCT00747565|525305082|FG001|Overall Study|Withdrawal by Subject|6|||
145668271|NCT00747565|525305081|FG000|Overall Study|Lost to Follow-up|4|||
145668272|NCT00747565|525305082|FG001|Overall Study|Lost to Follow-up|1|||
145668273|NCT01983683|525305083|FG000|Overall Study|Withdrawal by Subject|14|||
145668274|NCT01983683|525305084|FG001|Overall Study|Withdrawal by Subject|18|||
145668275|NCT01983683|525305083|FG000|Overall Study|Death|11|||
145668276|NCT01983683|525305084|FG001|Overall Study|Death|15|||
145668277|NCT01983683|525305083|FG000|Overall Study|Physician Decision|8|||
145668278|NCT01983683|525305084|FG001|Overall Study|Physician Decision|9|||
145668279|NCT01983683|525305083|FG000|Overall Study|Lost to Follow-up|4|||
145668280|NCT01983683|525305084|FG001|Overall Study|Lost to Follow-up|8|||
145668281|NCT01983683|525305083|FG000|Overall Study|Sponsor Decision|1|||
145668282|NCT01983683|525305084|FG001|Overall Study|Sponsor Decision|1|||
145668283|NCT04882917|525305092|FG000|Overall Study|Adverse Event|0|||
145668284|NCT04882917|525305093|FG001|Overall Study|Adverse Event|1|||
145668285|NCT04882917|525305094|FG002|Overall Study|Adverse Event|2|||
145668286|NCT04882917|525305095|FG003|Overall Study|Adverse Event|2|||
145668287|NCT04882917|525305092|FG000|Overall Study|Withdrawal by Subject|1|||
145668288|NCT04882917|525305093|FG001|Overall Study|Withdrawal by Subject|0|||
145668289|NCT04882917|525305094|FG002|Overall Study|Withdrawal by Subject|2|||
145668290|NCT04882917|525305095|FG003|Overall Study|Withdrawal by Subject|1|||
145668291|NCT04882917|525305092|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
145668292|NCT04882917|525305093|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
145668293|NCT04882917|525305094|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
145668294|NCT04882917|525305095|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
145668295|NCT04926740|525305101|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
145668296|NCT04926740|525305102|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
145668297|NCT04926740|525305101|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
145668298|NCT04926740|525305102|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
145668299|NCT04980300|525305103|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
145668300|NCT04980300|525305104|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
145668301|NCT04980300|525305103|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
145668302|NCT04980300|525305104|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
145668303|NCT04980300|525305103|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
145668304|NCT04980300|525305104|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
145668305|NCT04980300|525305103|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
145668306|NCT04980300|525305104|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
145668307|NCT05864209|525305828|FG000|Overall Study|Lost to Follow-up|2|||
145668308|NCT05864209|525305829|FG001|Overall Study|Lost to Follow-up|3|||
145668309|NCT03876457|525305835|FG000|Overall Study|Lost to Follow-up|1|||
145668310|NCT03876457|525305836|FG001|Overall Study|Lost to Follow-up|3|||
145668311|NCT02422615|525305837|FG000|Treatment Period|Progressive disease|314|||
145668312|NCT02422615|525305838|FG001|Treatment Period|Progressive disease|200|||
145668313|NCT02422615|525305837|FG000|Treatment Period|Adverse Event|51|||
145668314|NCT02422615|525305838|FG001|Treatment Period|Adverse Event|9|||
145668315|NCT02422615|525305837|FG000|Treatment Period|Physician Decision|32|||
145668316|NCT02422615|525305838|FG001|Treatment Period|Physician Decision|8|||
145668317|NCT02422615|525305837|FG000|Treatment Period|Subject/guardian decision|38|||
145668318|NCT02422615|525305838|FG001|Treatment Period|Subject/guardian decision|8|||
145668319|NCT02422615|525305837|FG000|Treatment Period|Death|2|||
145668320|NCT02422615|525305838|FG001|Treatment Period|Death|1|||
145668321|NCT02422615|525305837|FG000|Treatment Period|Technical problems|0|||
145668322|NCT02422615|525305838|FG001|Treatment Period|Technical problems|1|||
145668323|NCT02422615|525305837|FG000|Treatment Period|Protocol deviation|1|||
145668324|NCT02422615|525305838|FG001|Treatment Period|Protocol deviation|1|||
145668325|NCT02422615|525305837|FG000|Treatment Period|Study terminated as per protocol|46|||
145668326|NCT02422615|525305838|FG001|Treatment Period|Study terminated as per protocol|14|||
145668327|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
145668328|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145668329|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Death|2|||
145668330|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Death|1|||
145668331|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
145668332|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145668333|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
145668334|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
145668335|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
145668336|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
145668337|NCT02422615|525305837|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
145668338|NCT02422615|525305838|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
145668339|NCT01036724|525305839|FG000|Overall Study|Adverse Event|1|||
145668340|NCT01036724|525305840|FG001|Overall Study|Adverse Event|2|||
145668341|NCT01036724|525305839|FG000|Overall Study|Lack of Efficacy|1|||
145668342|NCT01036724|525305840|FG001|Overall Study|Lack of Efficacy|1|||
145668343|NCT01036724|525305839|FG000|Overall Study|Protocol Violation|4|||
145668344|NCT01036724|525305840|FG001|Overall Study|Protocol Violation|5|||
145668345|NCT01574716|525305843|FG000|Part 1|Death|3|||
145668346|NCT01574716|525305844|FG001|Part 1|Death|1|||
145668347|NCT01574716|525305845|FG002|Part 1|Death|8|||
145668348|NCT01574716|525305846|FG003|Part 1|Death|0|||
145668349|NCT01574716|525305847|FG004|Part 1|Death|0|||
145668350|NCT01574716|525305843|FG000|Part 1|Discontinuation of study by sponsor|0|||
145668351|NCT01574716|525305844|FG001|Part 1|Discontinuation of study by sponsor|0|||
145668352|NCT01574716|525305845|FG002|Part 1|Discontinuation of study by sponsor|1|||
145668353|NCT01574716|525305846|FG003|Part 1|Discontinuation of study by sponsor|0|||
145668354|NCT01574716|525305847|FG004|Part 1|Discontinuation of study by sponsor|0|||
145668355|NCT01574716|525305843|FG000|Part 1|Withdrawal by Subject|0|||
145668356|NCT01574716|525305844|FG001|Part 1|Withdrawal by Subject|2|||
145668357|NCT01574716|525305845|FG002|Part 1|Withdrawal by Subject|0|||
145668358|NCT01574716|525305846|FG003|Part 1|Withdrawal by Subject|0|||
145668359|NCT01574716|525305847|FG004|Part 1|Withdrawal by Subject|0|||
145668360|NCT01574716|525305843|FG000|Part 1|Lost to Follow-up|0|||
145668361|NCT01574716|525305844|FG001|Part 1|Lost to Follow-up|1|||
145668362|NCT01574716|525305845|FG002|Part 1|Lost to Follow-up|0|||
145668363|NCT01574716|525305846|FG003|Part 1|Lost to Follow-up|0|||
145668364|NCT01574716|525305847|FG004|Part 1|Lost to Follow-up|0|||
145668365|NCT01574716|525305843|FG000|Part 2|Progressive disease|0|||
145668366|NCT01574716|525305844|FG001|Part 2|Progressive disease|0|||
145668367|NCT01574716|525305845|FG002|Part 2|Progressive disease|0|||
145668368|NCT01574716|525305846|FG003|Part 2|Progressive disease|1|||
145668369|NCT01574716|525305847|FG004|Part 2|Progressive disease|0|||
145668370|NCT01574716|525305843|FG000|Part 2|Death|0|||
145668371|NCT01574716|525305844|FG001|Part 2|Death|0|||
145668372|NCT01574716|525305845|FG002|Part 2|Death|0|||
145668373|NCT01574716|525305846|FG003|Part 2|Death|76|||
145668374|NCT01574716|525305847|FG004|Part 2|Death|35|||
145668375|NCT01574716|525305843|FG000|Part 2|Discontinuation of study by sponsor|0|||
145668376|NCT01574716|525305844|FG001|Part 2|Discontinuation of study by sponsor|0|||
145668377|NCT01574716|525305845|FG002|Part 2|Discontinuation of study by sponsor|0|||
145668378|NCT01574716|525305846|FG003|Part 2|Discontinuation of study by sponsor|51|||
145668379|NCT01574716|525305847|FG004|Part 2|Discontinuation of study by sponsor|31|||
145668380|NCT01574716|525305843|FG000|Part 2|Withdrawal by Subject|0|||
145668381|NCT01574716|525305844|FG001|Part 2|Withdrawal by Subject|0|||
145668382|NCT01574716|525305845|FG002|Part 2|Withdrawal by Subject|0|||
145668383|NCT01574716|525305846|FG003|Part 2|Withdrawal by Subject|5|||
145668384|NCT01574716|525305847|FG004|Part 2|Withdrawal by Subject|4|||
145668385|NCT01574716|525305843|FG000|Part 2|Brain metastases|0|||
145668386|NCT01574716|525305844|FG001|Part 2|Brain metastases|0|||
145668387|NCT01574716|525305845|FG002|Part 2|Brain metastases|0|||
145668388|NCT01574716|525305846|FG003|Part 2|Brain metastases|1|||
145668389|NCT01574716|525305847|FG004|Part 2|Brain metastases|0|||
145668390|NCT01574716|525305843|FG000|Part 2|Lost to Follow-up|0|||
145668391|NCT01574716|525305844|FG001|Part 2|Lost to Follow-up|0|||
145668392|NCT01574716|525305845|FG002|Part 2|Lost to Follow-up|0|||
145668393|NCT01574716|525305846|FG003|Part 2|Lost to Follow-up|3|||
145668394|NCT01574716|525305847|FG004|Part 2|Lost to Follow-up|0|||
145668395|NCT02438137|525305848|FG000|Overall Study|Lost to Follow-up|3|||
145668396|NCT02438137|525305849|FG001|Overall Study|Lost to Follow-up|2|||
145668397|NCT02438137|525305848|FG000|Overall Study|Adverse Event|1|||
145668398|NCT02438137|525305849|FG001|Overall Study|Adverse Event|0|||
145668399|NCT02438137|525305848|FG000|Overall Study|Withdrawal by Subject|4|||
145668400|NCT02438137|525305849|FG001|Overall Study|Withdrawal by Subject|3|||
145668401|NCT02438137|525305848|FG000|Overall Study|Physician Decision|0|||
145668402|NCT02438137|525305849|FG001|Overall Study|Physician Decision|1|||
145668403|NCT01268306|525305853|FG000|Overall Study|Lost to Follow-up|1|||
145668404|NCT01105975|525305854|FG000|Overall Study|Adverse Event|2|||
145668405|NCT01105975|525305855|FG001|Overall Study|Adverse Event|1|||
145668406|NCT01105975|525305856|FG002|Overall Study|Adverse Event|5|||
145668407|NCT01105975|525305857|FG003|Overall Study|Adverse Event|1|||
145668408|NCT01105975|525305858|FG004|Overall Study|Adverse Event|0|||
145668409|NCT01105975|525305859|FG005|Overall Study|Adverse Event|1|||
145668410|NCT01105975|525305860|FG006|Overall Study|Adverse Event|2|||
145668411|NCT01105975|525305861|FG007|Overall Study|Adverse Event|4|||
145668412|NCT01105975|525305862|FG008|Overall Study|Adverse Event|1|||
145668413|NCT01105975|525305863|FG009|Overall Study|Adverse Event|4|||
145668414|NCT01105975|525305854|FG000|Overall Study|Withdrawal by Subject|2|||
145668415|NCT01105975|525305855|FG001|Overall Study|Withdrawal by Subject|2|||
145668416|NCT01105975|525305856|FG002|Overall Study|Withdrawal by Subject|2|||
145668417|NCT01105975|525305857|FG003|Overall Study|Withdrawal by Subject|0|||
145668418|NCT01105975|525305858|FG004|Overall Study|Withdrawal by Subject|4|||
145668419|NCT01105975|525305859|FG005|Overall Study|Withdrawal by Subject|1|||
145668420|NCT01105975|525305860|FG006|Overall Study|Withdrawal by Subject|2|||
145668421|NCT01105975|525305861|FG007|Overall Study|Withdrawal by Subject|1|||
145668422|NCT01105975|525305862|FG008|Overall Study|Withdrawal by Subject|0|||
145668423|NCT01105975|525305863|FG009|Overall Study|Withdrawal by Subject|3|||
145668424|NCT01105975|525305854|FG000|Overall Study|Lost to Follow-up|1|||
145668425|NCT01105975|525305855|FG001|Overall Study|Lost to Follow-up|0|||
145668426|NCT01105975|525305856|FG002|Overall Study|Lost to Follow-up|0|||
145668427|NCT01105975|525305857|FG003|Overall Study|Lost to Follow-up|1|||
145668428|NCT01105975|525305858|FG004|Overall Study|Lost to Follow-up|1|||
145668429|NCT01105975|525305859|FG005|Overall Study|Lost to Follow-up|0|||
145668430|NCT01105975|525305860|FG006|Overall Study|Lost to Follow-up|0|||
145668431|NCT01105975|525305861|FG007|Overall Study|Lost to Follow-up|0|||
145668432|NCT01105975|525305862|FG008|Overall Study|Lost to Follow-up|1|||
145668433|NCT01105975|525305863|FG009|Overall Study|Lost to Follow-up|0|||
145668434|NCT01105975|525305854|FG000|Overall Study|Physician Decision|0|||
145668435|NCT01105975|525305855|FG001|Overall Study|Physician Decision|0|||
145668436|NCT01105975|525305856|FG002|Overall Study|Physician Decision|0|||
145668437|NCT01105975|525305857|FG003|Overall Study|Physician Decision|0|||
145668438|NCT01105975|525305858|FG004|Overall Study|Physician Decision|0|||
145668439|NCT01105975|525305859|FG005|Overall Study|Physician Decision|0|||
145668440|NCT01105975|525305860|FG006|Overall Study|Physician Decision|2|||
145668441|NCT01105975|525305861|FG007|Overall Study|Physician Decision|0|||
145668442|NCT01105975|525305862|FG008|Overall Study|Physician Decision|0|||
145668443|NCT01105975|525305863|FG009|Overall Study|Physician Decision|0|||
145668444|NCT01105975|525305854|FG000|Overall Study|Protocol Violation|0|||
145668445|NCT01105975|525305855|FG001|Overall Study|Protocol Violation|2|||
145668446|NCT01105975|525305856|FG002|Overall Study|Protocol Violation|2|||
145668447|NCT01105975|525305857|FG003|Overall Study|Protocol Violation|0|||
145668448|NCT01105975|525305858|FG004|Overall Study|Protocol Violation|1|||
145668449|NCT01105975|525305859|FG005|Overall Study|Protocol Violation|1|||
145668450|NCT01105975|525305860|FG006|Overall Study|Protocol Violation|1|||
145668451|NCT01105975|525305861|FG007|Overall Study|Protocol Violation|1|||
145668452|NCT01105975|525305862|FG008|Overall Study|Protocol Violation|2|||
145668453|NCT01105975|525305863|FG009|Overall Study|Protocol Violation|2|||
145668454|NCT01105975|525305854|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145668455|NCT01105975|525305855|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145668456|NCT01105975|525305856|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145668457|NCT01105975|525305857|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145668458|NCT01105975|525305858|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145668459|NCT01105975|525305859|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
145668460|NCT01105975|525305860|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145668461|NCT01105975|525305861|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
145668462|NCT01105975|525305862|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
145668463|NCT01105975|525305863|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
145668464|NCT04868617|525305864|FG000|Overall Study|Death|1|||
145668465|NCT04868617|525305865|FG001|Overall Study|Death|0|||
145668466|NCT04868617|525305864|FG000|Overall Study|Adverse Event|1|||
145668467|NCT04868617|525305865|FG001|Overall Study|Adverse Event|0|||
145668468|NCT04868617|525305864|FG000|Overall Study|Withdrawal by Subject|1|||
145668469|NCT04868617|525305865|FG001|Overall Study|Withdrawal by Subject|0|||
145668470|NCT04868617|525305864|FG000|Overall Study|Device deficiency|1|||
145668471|NCT04868617|525305865|FG001|Overall Study|Device deficiency|0|||
145668472|NCT02502526|525305867|FG000|Overall Study|Lost to Follow-up|2|||
145668473|NCT02502526|525305868|FG001|Overall Study|Lost to Follow-up|2|||
145668474|NCT02502526|525305869|FG002|Overall Study|Lost to Follow-up|3|||
145668475|NCT02502526|525305867|FG000|Overall Study|Withdrawal by Subject|0|||
145668476|NCT02502526|525305868|FG001|Overall Study|Withdrawal by Subject|1|||
145668477|NCT02502526|525305869|FG002|Overall Study|Withdrawal by Subject|1|||
145668478|NCT02502526|525305867|FG000|Overall Study|Disqualified due to cataract grading|0|||
145668479|NCT02502526|525305868|FG001|Overall Study|Disqualified due to cataract grading|0|||
145668480|NCT02502526|525305869|FG002|Overall Study|Disqualified due to cataract grading|1|||
145668481|NCT02502526|525305867|FG000|Overall Study|Enrollment suspension|4|||
145668482|NCT02502526|525305868|FG001|Overall Study|Enrollment suspension|1|||
145668483|NCT02502526|525305869|FG002|Overall Study|Enrollment suspension|1|||
145668484|NCT01342367|525305870|FG000|Overall Study|Death|1|||
145668485|NCT01342367|525305871|FG001|Overall Study|Death|0|||
145668486|NCT01342367|525305870|FG000|Overall Study|Withdrawal by Subject|1|||
145668487|NCT01342367|525305871|FG001|Overall Study|Withdrawal by Subject|2|||
145668488|NCT02964741|525305872|FG000|Overall Study|Protocol Violation|1|||
145668489|NCT02964741|525305873|FG001|Overall Study|Protocol Violation|0|||
145668490|NCT02964741|525305874|FG002|Overall Study|Protocol Violation|0|||
145668491|NCT02964741|525305872|FG000|Overall Study|Withdrawal by Subject|0|||
145668492|NCT02964741|525305873|FG001|Overall Study|Withdrawal by Subject|1|||
145668493|NCT02964741|525305874|FG002|Overall Study|Withdrawal by Subject|0|||
145668494|NCT02964741|525305872|FG000|Overall Study|claustrophobia|1|||
145668495|NCT02964741|525305873|FG001|Overall Study|claustrophobia|0|||
145668496|NCT02964741|525305874|FG002|Overall Study|claustrophobia|0|||
145668497|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
145668498|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
145668499|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
145668500|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
145668501|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
145668502|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
145668503|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
145668504|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
145668505|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
145668506|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
145668507|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
145668508|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
145668509|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
145668510|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
145668511|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
145668512|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
145668513|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
145668514|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
145668515|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
145668516|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
145668517|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
145668518|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
145668519|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
145668520|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
145668521|NCT01074294|525305878|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
145668522|NCT01074294|525305879|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
145668523|NCT01074294|525305880|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
145668524|NCT01074294|525305881|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
145668525|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
145668526|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
145668527|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
145668528|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
145668529|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
145668530|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
145668531|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
145668532|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
145668533|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
145668534|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
145668535|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
145668536|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
145668537|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
145668538|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
145668539|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
145668540|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
145668541|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
145668542|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
145668543|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
145668544|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
145668545|NCT01074294|525305878|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
145668546|NCT01074294|525305879|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
145668547|NCT01074294|525305880|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
145668548|NCT01074294|525305881|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
145668549|NCT00640159|525305882|FG000|Overall Study|Lost to Follow-up|2|||
145668550|NCT00112359|525305883|FG000|Overall Study|Unrelated adverse event|16|||
145668551|NCT00112359|525305884|FG001|Overall Study|Unrelated adverse event|8|||
145668552|NCT00112359|525305883|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
145668553|NCT00112359|525305884|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
145668554|NCT00112359|525305883|FG000|Overall Study|Related adverse event|5|||
145668555|NCT00112359|525305884|FG001|Overall Study|Related adverse event|3|||
145668556|NCT00112359|525305883|FG000|Overall Study|Lost to Follow-up|0|||
145668557|NCT00112359|525305884|FG001|Overall Study|Lost to Follow-up|1|||
145668558|NCT00112359|525305883|FG000|Overall Study|Personal/administrative|1|||
145668559|NCT00112359|525305884|FG001|Overall Study|Personal/administrative|1|||
145668560|NCT00112359|525305883|FG000|Overall Study|Other|3|||
145668561|NCT00112359|525305884|FG001|Overall Study|Other|0|||
145668562|NCT05018143|525305885|FG000|Overall Study|Lost to Follow-up|5|||
145668563|NCT05018143|525305886|FG001|Overall Study|Lost to Follow-up|4|||
145668564|NCT05018143|525305885|FG000|Overall Study|Withdrawal by Subject|0|||
145668565|NCT05018143|525305886|FG001|Overall Study|Withdrawal by Subject|1|||
145668566|NCT05521516|525305889|FG000|Overall Study|Withdrawal by Subject|1|||
145668567|NCT05521516|525305890|FG001|Overall Study|Withdrawal by Subject|1|||
145668568|NCT03891758|525305891|FG000|Overall Study|Adverse Event|2|||
145668569|NCT03891758|525305892|FG001|Overall Study|Adverse Event|0|||
145668570|NCT03891758|525305891|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145668571|NCT03891758|525305892|FG001|Overall Study|Withdrawal by parent/guardian|2|||
145668572|NCT00227266|525305893|FG000|Overall Study|Withdrawal by Subject|0|||
145668573|NCT00227266|525305894|FG001|Overall Study|Withdrawal by Subject|0|||
145668574|NCT00227266|525305895|FG002|Overall Study|Withdrawal by Subject|1|||
145668575|NCT00227266|525305893|FG000|Overall Study|Protocol Violation|1|||
145668576|NCT00227266|525305894|FG001|Overall Study|Protocol Violation|0|||
145668577|NCT00227266|525305895|FG002|Overall Study|Protocol Violation|1|||
145668578|NCT00227266|525305893|FG000|Overall Study|Excessive weight gain|0|||
145668579|NCT00227266|525305894|FG001|Overall Study|Excessive weight gain|0|||
145668580|NCT00227266|525305895|FG002|Overall Study|Excessive weight gain|2|||
145668581|NCT00210106|525306878|FG000|Overall Study|Death|1|||
145668582|NCT00210106|525306878|FG000|Overall Study|Protocol Violation|13|||
145668583|NCT01184326|525306882|FG000|Overall Study|Adverse Event|1|||
145668584|NCT01184326|525306883|FG001|Overall Study|Adverse Event|2|||
145668585|NCT01184326|525306884|FG002|Overall Study|Adverse Event|0|||
145668586|NCT01184326|525306882|FG000|Overall Study|Death|0|||
145490834|NCT00308139|524652223|FG001|Overall Study|Investigator Decision|10|||
145490835|NCT00308139|524652222|FG000|Overall Study|Loss of Glucose Control|5|||
145668587|NCT01184326|525306883|FG001|Overall Study|Death|0|||
145668588|NCT01184326|525306884|FG002|Overall Study|Death|1|||
145668589|NCT01184326|525306882|FG000|Overall Study|Withdrawal by Subject|0|||
145668590|NCT01184326|525306883|FG001|Overall Study|Withdrawal by Subject|0|||
145668591|NCT01184326|525306884|FG002|Overall Study|Withdrawal by Subject|1|||
145668592|NCT01184326|525306882|FG000|Overall Study|Physician Decision|1|||
145668593|NCT01184326|525306883|FG001|Overall Study|Physician Decision|1|||
145668594|NCT01184326|525306884|FG002|Overall Study|Physician Decision|0|||
145668595|NCT01184326|525306882|FG000|Overall Study|Disease Progression|1|||
145668596|NCT01184326|525306883|FG001|Overall Study|Disease Progression|3|||
145668597|NCT01184326|525306884|FG002|Overall Study|Disease Progression|12|||
145668598|NCT00945321|525306888|FG000|Period 1|Adverse Event|0|||
145668599|NCT00945321|525306889|FG001|Period 1|Adverse Event|0|||
145668600|NCT00945321|525306890|FG002|Period 1|Adverse Event|0|||
145668601|NCT00945321|525306891|FG003|Period 1|Adverse Event|0|||
145668602|NCT00945321|525306892|FG004|Period 1|Adverse Event|1|||
145668603|NCT00945321|525306893|FG005|Period 1|Adverse Event|0|||
145668604|NCT00945321|525306888|FG000|Period 4|Lost to Follow-up|0|||
145668605|NCT00945321|525306889|FG001|Period 4|Lost to Follow-up|0|||
145668606|NCT00945321|525306890|FG002|Period 4|Lost to Follow-up|0|||
145668607|NCT00945321|525306891|FG003|Period 4|Lost to Follow-up|0|||
145668608|NCT00945321|525306892|FG004|Period 4|Lost to Follow-up|0|||
145668609|NCT00945321|525306893|FG005|Period 4|Lost to Follow-up|1|||
145668610|NCT00692913|525306894|FG000|Overall Study|Adverse Event|8|||
145668611|NCT00692913|525306895|FG001|Overall Study|Adverse Event|4|||
145668612|NCT00692913|525306894|FG000|Overall Study|Lost to Follow-up|3|||
145668613|NCT00692913|525306895|FG001|Overall Study|Lost to Follow-up|5|||
145668614|NCT00692913|525306894|FG000|Overall Study|Physician Decision|2|||
145668615|NCT00692913|525306895|FG001|Overall Study|Physician Decision|0|||
145668616|NCT00692913|525306894|FG000|Overall Study|Protocol Violation|1|||
145668617|NCT00692913|525306895|FG001|Overall Study|Protocol Violation|1|||
145668618|NCT00692913|525306894|FG000|Overall Study|Withdrawal by Subject|15|||
145668619|NCT00692913|525306895|FG001|Overall Study|Withdrawal by Subject|20|||
145668620|NCT04017611|525306896|FG000|Overall Study|Withdrawn prior to completion|1|||
145668621|NCT02291913|525306897|FG000|Overall Study|Progressive Disease|32|||
145668622|NCT02291913|525306897|FG000|Overall Study|Adverse Event|11|||
145668623|NCT02291913|525306897|FG000|Overall Study|Death|2|||
145668624|NCT02291913|525306897|FG000|Overall Study|Physician Decision|1|||
145668625|NCT02291913|525306897|FG000|Overall Study|Withdrawal by Subject|1|||
145668626|NCT02291913|525306897|FG000|Overall Study|Protocol Violation|1|||
145668627|NCT01637402|525306906|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
145668628|NCT01637402|525306907|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
145668629|NCT01637402|525306906|FG000|Standard Dose Regimen|Adverse Event|1|||
145668630|NCT01637402|525306907|FG001|Standard Dose Regimen|Adverse Event|0|||
145668631|NCT01637402|525306906|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
145668632|NCT01637402|525306907|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
145668633|NCT01637402|525306906|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
145668634|NCT01637402|525306907|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
145668635|NCT01637402|525306906|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
145668636|NCT01637402|525306907|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
145668637|NCT01637402|525306906|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
145668638|NCT01637402|525306907|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
145668639|NCT04876417|525306910|FG000|Overall Study|Lost to Follow-up|5|||
145668640|NCT04876417|525306911|FG001|Overall Study|Lost to Follow-up|8|||
145668641|NCT04876417|525306912|FG002|Overall Study|Lost to Follow-up|0|||
145668642|NCT04876417|525306913|FG003|Overall Study|Lost to Follow-up|0|||
145668643|NCT01952366|525306916|FG000|Overall Study|Death|22|||
145668644|NCT01952366|525306916|FG000|Overall Study|Withdrawal by Subject|9|||
145668645|NCT00623194|525306917|FG000|Overall Study|Lack of Efficacy|1|||
145668646|NCT00623194|525306917|FG000|Overall Study|Protocol Violation|3|||
145668647|NCT00623194|525306917|FG000|Overall Study|Unclassified|1|||
145668648|NCT04860505|525306918|FG000|Overall Study|Lost to Follow-up|2|||
145668649|NCT00857766|525306919|FG000|Overall Study|Adverse Event|13|||
145668650|NCT00857766|525306920|FG001|Overall Study|Adverse Event|12|||
145668651|NCT00857766|525306919|FG000|Overall Study|Protocol Violation|11|||
145668652|NCT00857766|525306920|FG001|Overall Study|Protocol Violation|11|||
145668653|NCT00857766|525306919|FG000|Overall Study|Lost to Follow-up|1|||
145668654|NCT00857766|525306920|FG001|Overall Study|Lost to Follow-up|0|||
145668655|NCT00857766|525306919|FG000|Overall Study|Investigator Discretion|2|||
145668656|NCT00857766|525306920|FG001|Overall Study|Investigator Discretion|3|||
145668657|NCT00857766|525306919|FG000|Overall Study|Participant Withdrew Consent|4|||
145668658|NCT00857766|525306920|FG001|Overall Study|Participant Withdrew Consent|4|||
145668659|NCT01988402|525306921|FG000|Overall Study|Adverse Event|1|||
145668660|NCT01988402|525306922|FG001|Overall Study|Adverse Event|2|||
145490836|NCT00308139|524652223|FG001|Overall Study|Loss of Glucose Control|7|||
145668661|NCT01988402|525306921|FG000|Overall Study|Withdrawal by Subject|1|||
145490837|NCT00308139|524652222|FG000|Overall Study|Administrative|1|||
145668662|NCT01988402|525306922|FG001|Overall Study|Withdrawal by Subject|0|||
145668663|NCT01961609|525306923|FG000|Initiation|Missing|3|||
145668664|NCT01961609|525306924|FG001|Initiation|Missing|2|||
145668665|NCT01961609|525306925|FG002|Initiation|Missing|0|||
145668666|NCT01961609|525306926|FG003|Initiation|Missing|0|||
145668667|NCT01961609|525306923|FG000|Initiation|Protocol deviation|1|||
145668668|NCT01961609|525306924|FG001|Initiation|Protocol deviation|0|||
145668669|NCT01961609|525306925|FG002|Initiation|Protocol deviation|0|||
145668670|NCT01961609|525306926|FG003|Initiation|Protocol deviation|0|||
145668671|NCT01961609|525306923|FG000|Initiation|Death|0|||
145668672|NCT01961609|525306924|FG001|Initiation|Death|1|||
145668673|NCT01961609|525306925|FG002|Initiation|Death|0|||
145668674|NCT01961609|525306926|FG003|Initiation|Death|0|||
145668675|NCT01961609|525306923|FG000|Initiation|Administrative problems|1|||
145668676|NCT01961609|525306924|FG001|Initiation|Administrative problems|0|||
145668677|NCT01961609|525306925|FG002|Initiation|Administrative problems|0|||
145668678|NCT01961609|525306926|FG003|Initiation|Administrative problems|0|||
145668679|NCT01961609|525306923|FG000|Initiation|Withdrawal by Subject|1|||
145668680|NCT01961609|525306924|FG001|Initiation|Withdrawal by Subject|2|||
145668681|NCT01961609|525306925|FG002|Initiation|Withdrawal by Subject|0|||
145668682|NCT01961609|525306926|FG003|Initiation|Withdrawal by Subject|0|||
145668683|NCT01961609|525306923|FG000|Initiation|Lack of Efficacy|2|||
145668684|NCT01961609|525306924|FG001|Initiation|Lack of Efficacy|1|||
145668685|NCT01961609|525306925|FG002|Initiation|Lack of Efficacy|0|||
145668686|NCT01961609|525306926|FG003|Initiation|Lack of Efficacy|0|||
145668687|NCT01961609|525306923|FG000|Initiation|Abnormal lab values|0|||
145668688|NCT01961609|525306924|FG001|Initiation|Abnormal lab values|1|||
145668689|NCT01961609|525306925|FG002|Initiation|Abnormal lab values|0|||
145668690|NCT01961609|525306926|FG003|Initiation|Abnormal lab values|0|||
145668691|NCT01961609|525306923|FG000|Initiation|Adverse Event|3|||
145668692|NCT01961609|525306924|FG001|Initiation|Adverse Event|5|||
145668693|NCT01961609|525306925|FG002|Initiation|Adverse Event|0|||
145668694|NCT01961609|525306926|FG003|Initiation|Adverse Event|0|||
145668695|NCT01961609|525306923|FG000|Initiation|Randomized but not treated|1|||
145668696|NCT01961609|525306924|FG001|Initiation|Randomized but not treated|1|||
145668697|NCT01961609|525306925|FG002|Initiation|Randomized but not treated|0|||
145668698|NCT01961609|525306926|FG003|Initiation|Randomized but not treated|0|||
145668699|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
145668700|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
145668701|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
145668702|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
145668703|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
145668704|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
145668705|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
145668706|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
145668707|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
145668708|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
145668709|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
145668710|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
145668711|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
145668712|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
145668713|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
145668714|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
145668715|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
145668716|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
145668717|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
145668718|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
145668719|NCT01961609|525306923|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
145668720|NCT01961609|525306924|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
145668721|NCT01961609|525306925|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
145668722|NCT01961609|525306926|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
145668723|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
145668724|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
145668725|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
145668726|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
145668727|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
145668728|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
145668729|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
145668730|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
145668731|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
145668732|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
145668733|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
145668734|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
145668735|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
145668736|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
145668737|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
145668738|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
145668739|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
145668740|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
145668741|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
145668742|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
145668743|NCT01961609|525306923|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
145668744|NCT01961609|525306924|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
145668745|NCT01961609|525306925|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
145668746|NCT01961609|525306926|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
145668747|NCT00312208|525306927|FG000|Overall Study|Adverse Event|97|||
145668748|NCT00312208|525306928|FG001|Overall Study|Adverse Event|61|||
145668749|NCT00312208|525306927|FG000|Overall Study|Protocol Violation|5|||
145668750|NCT00312208|525306928|FG001|Overall Study|Protocol Violation|3|||
145668751|NCT00312208|525306927|FG000|Overall Study|Death|2|||
145668752|NCT00312208|525306928|FG001|Overall Study|Death|1|||
145668753|NCT00312208|525306927|FG000|Overall Study|Lack of Efficacy|7|||
145668754|NCT00312208|525306928|FG001|Overall Study|Lack of Efficacy|4|||
145668755|NCT00312208|525306927|FG000|Overall Study|Lost to Follow-up|3|||
145668756|NCT00312208|525306928|FG001|Overall Study|Lost to Follow-up|5|||
145668757|NCT00312208|525306927|FG000|Overall Study|Withdrawal by Subject|53|||
145668758|NCT00312208|525306928|FG001|Overall Study|Withdrawal by Subject|42|||
145668759|NCT00312208|525306927|FG000|Overall Study|Other|5|||
145668760|NCT00312208|525306928|FG001|Overall Study|Other|7|||
145668761|NCT05601882|525306953|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
145668762|NCT05601882|525306954|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
145668763|NCT05601882|525306955|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
145668764|NCT05601882|525306956|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
145668765|NCT05601882|525306953|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
145668766|NCT05601882|525306954|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
145668767|NCT05601882|525306955|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
145668768|NCT05601882|525306956|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
145668769|NCT05601882|525306953|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
145668770|NCT05601882|525306954|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
145668771|NCT05601882|525306955|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
145668772|NCT05601882|525306956|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
145668773|NCT05601882|525306953|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
145668774|NCT05601882|525306954|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
145668775|NCT05601882|525306955|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
145668776|NCT05601882|525306956|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
145668777|NCT05601882|525306953|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
145668778|NCT05601882|525306954|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
145668779|NCT05601882|525306955|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
145668780|NCT05601882|525306956|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
145668781|NCT05601882|525306953|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
145668782|NCT05601882|525306954|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
145668783|NCT05601882|525306955|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
145668784|NCT05601882|525306956|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
145668785|NCT03222609|525306957|FG000|Overall Study|Withdrew consent|2|||
145668786|NCT03222609|525306958|FG001|Overall Study|Withdrew consent|3|||
145668787|NCT03222609|525306959|FG002|Overall Study|Withdrew consent|4|||
145668788|NCT03222609|525306960|FG003|Overall Study|Withdrew consent|2|||
145668789|NCT03222609|525306957|FG000|Overall Study|Lost to Follow-up|1|||
145668790|NCT03222609|525306958|FG001|Overall Study|Lost to Follow-up|0|||
145668791|NCT03222609|525306959|FG002|Overall Study|Lost to Follow-up|0|||
145668792|NCT03222609|525306960|FG003|Overall Study|Lost to Follow-up|0|||
145668793|NCT03222609|525306957|FG000|Overall Study|Death|16|||
145668794|NCT03222609|525306958|FG001|Overall Study|Death|13|||
145668795|NCT03222609|525306959|FG002|Overall Study|Death|9|||
145668796|NCT03222609|525306960|FG003|Overall Study|Death|6|||
145668797|NCT03222609|525306957|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
145668798|NCT03222609|525306958|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
145668799|NCT03222609|525306959|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
145668800|NCT03222609|525306960|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
145668801|NCT03834740|525306961|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
145668802|NCT03834740|525306962|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
145668803|NCT03834740|525306963|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
145668804|NCT01208974|525306964|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
145668805|NCT01208974|525306965|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
145668806|NCT01208974|525306966|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
145668807|NCT01208974|525306967|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
145668808|NCT01208974|525306964|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
145668809|NCT01208974|525306965|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
145668810|NCT01208974|525306966|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
145668811|NCT01208974|525306967|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
145668812|NCT01208974|525306964|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
145668813|NCT01208974|525306965|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
145668814|NCT01208974|525306966|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
145668815|NCT01208974|525306967|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
145668816|NCT03593226|525306968|FG000|Overall Study|Disease progression|6|||
145668817|NCT03593226|525306969|FG001|Overall Study|Disease progression|13|||
145668818|NCT03593226|525306970|FG002|Overall Study|Disease progression|5|||
145668819|NCT03593226|525306971|FG003|Overall Study|Disease progression|6|||
145668820|NCT03593226|525306968|FG000|Overall Study|Adverse Event|0|||
145668821|NCT03593226|525306969|FG001|Overall Study|Adverse Event|1|||
145668822|NCT03593226|525306970|FG002|Overall Study|Adverse Event|0|||
145668823|NCT03593226|525306971|FG003|Overall Study|Adverse Event|0|||
145668824|NCT03593226|525306968|FG000|Overall Study|Withdrawal by Subject|0|||
145668825|NCT03593226|525306969|FG001|Overall Study|Withdrawal by Subject|4|||
145668826|NCT03593226|525306970|FG002|Overall Study|Withdrawal by Subject|1|||
145668827|NCT03593226|525306971|FG003|Overall Study|Withdrawal by Subject|0|||
145668828|NCT03593226|525306968|FG000|Overall Study|Physician Decision|0|||
145668829|NCT03593226|525306969|FG001|Overall Study|Physician Decision|1|||
145668830|NCT03593226|525306970|FG002|Overall Study|Physician Decision|0|||
145668831|NCT03593226|525306971|FG003|Overall Study|Physician Decision|0|||
145668832|NCT03593226|525306968|FG000|Overall Study|Clinical disease progression|0|||
145668833|NCT03593226|525306969|FG001|Overall Study|Clinical disease progression|0|||
145668834|NCT03593226|525306970|FG002|Overall Study|Clinical disease progression|1|||
145668835|NCT03593226|525306971|FG003|Overall Study|Clinical disease progression|0|||
145668836|NCT03777657|525306972|FG000|Overall Study|Death|397|||
145668837|NCT03777657|525306973|FG001|Overall Study|Death|431|||
145668838|NCT03777657|525306972|FG000|Overall Study|Study Closed by Sponsor|77|||
145668839|NCT03777657|525306973|FG001|Overall Study|Study Closed by Sponsor|38|||
145668840|NCT03777657|525306972|FG000|Overall Study|Withdrawal by Subject|20|||
145668841|NCT03777657|525306973|FG001|Overall Study|Withdrawal by Subject|17|||
145668842|NCT03777657|525306972|FG000|Overall Study|Lost to Follow-up|6|||
145668843|NCT03777657|525306973|FG001|Overall Study|Lost to Follow-up|10|||
145668844|NCT03789110|525306974|FG000|Overall Study|Adverse Event|2|||
145668845|NCT03789110|525306974|FG000|Overall Study|Physician Decision|1|||
145668846|NCT03789110|525306974|FG000|Overall Study|Withdrawal by Subject|2|||
145668847|NCT03789110|525306974|FG000|Overall Study|Lack of Efficacy|22|||
145668848|NCT03789110|525306974|FG000|Overall Study|still on treatment|3|||
145668849|NCT03691493|525306975|FG000|Overall Study|Withdrawal by Subject|1|||
145668850|NCT05464732|525306985|FG000|Overall Study|Lost to Follow-up|0|||
145668851|NCT05464732|525306986|FG001|Overall Study|Lost to Follow-up|1|||
145668852|NCT05464732|525306985|FG000|Overall Study|Adverse Event|1|||
145668853|NCT05464732|525306986|FG001|Overall Study|Adverse Event|0|||
145668854|NCT03959423|525306991|FG000|Overall Study|Withdrawal by Subject|2|||
145668855|NCT03959423|525306992|FG001|Overall Study|Withdrawal by Subject|3|||
145668856|NCT03959423|525306991|FG000|Overall Study|Physician Decision|0|||
145668857|NCT03959423|525306992|FG001|Overall Study|Physician Decision|1|||
145668858|NCT03959423|525306991|FG000|Overall Study|Lost to Follow-up|1|||
145668859|NCT03959423|525306992|FG001|Overall Study|Lost to Follow-up|0|||
145668860|NCT03959423|525306991|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
145668861|NCT03959423|525306992|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
145668862|NCT05704725|525306993|FG000|Overall Study|Lost to Follow-up|0|||
145668863|NCT05704725|525306994|FG001|Overall Study|Lost to Follow-up|1|||
145668864|NCT05704725|525306993|FG000|Overall Study|Withdrawal by Subject|1|||
145668865|NCT05704725|525306994|FG001|Overall Study|Withdrawal by Subject|0|||
145668866|NCT01470144|525306995|FG000|Overall Study|Adverse Event|2|||
145668867|NCT01470144|525306995|FG000|Overall Study|Death|1|||
145668868|NCT01470144|525306995|FG000|Overall Study|Lung transplant|6|||
145668869|NCT01470144|525306995|FG000|Overall Study|Patient's and investigator's decision|1|||
145668870|NCT00593840|525306996|FG000|Overall Study|Withdrawal by Subject|1|||
145668871|NCT00536120|525308155|FG000|Overall Study|Lost to Follow-up|1|||
145668872|NCT00536120|525308156|FG001|Overall Study|Lost to Follow-up|0|||
145668873|NCT00536120|525308155|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
145668874|NCT00536120|525308156|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
145668875|NCT00536120|525308155|FG000|Overall Study|Non-compliance|1|||
145668876|NCT00536120|525308156|FG001|Overall Study|Non-compliance|0|||
145668877|NCT00536120|525308155|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
145668878|NCT00536120|525308156|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
145668879|NCT00536120|525308155|FG000|Overall Study|Steroid Use|0|||
145668880|NCT00536120|525308156|FG001|Overall Study|Steroid Use|2|||
145668881|NCT00536120|525308155|FG000|Overall Study|Missed Study Visit|0|||
145668882|NCT00536120|525308156|FG001|Overall Study|Missed Study Visit|1|||
145668883|NCT02722434|525308157|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
145668884|NCT02722434|525308158|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
145668885|NCT02722434|525308157|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
145668886|NCT02722434|525308158|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
145668887|NCT04559698|525308159|FG000|Overall Study|Lost to Follow-up|14|||
145668888|NCT04559698|525308160|FG001|Overall Study|Lost to Follow-up|15|||
145668889|NCT04559698|525308159|FG000|Overall Study|Withdrawal by Subject|0|||
145668890|NCT04559698|525308160|FG001|Overall Study|Withdrawal by Subject|1|||
145668891|NCT03437733|525308162|FG000|Overall Study|Eligibility criteria not met|0|||
145668892|NCT03437733|525308163|FG001|Overall Study|Eligibility criteria not met|3|||
145668893|NCT01982682|525308164|FG000|Overall Study|Physician Decision|1|||
145668894|NCT02760654|525308165|FG000|Overall Study|Lost to Follow-up|3|||
145668895|NCT02760654|525308166|FG001|Overall Study|Lost to Follow-up|3|||
145668896|NCT02760654|525308165|FG000|Overall Study|Withdrawal by Subject|4|||
145668897|NCT02760654|525308166|FG001|Overall Study|Withdrawal by Subject|3|||
145668898|NCT00146172|525308167|FG000|Overall Study|Adverse Event|0|||
145668899|NCT00146172|525308168|FG001|Overall Study|Adverse Event|0|||
145668900|NCT00146172|525308169|FG002|Overall Study|Adverse Event|1|||
145668901|NCT00146172|525308170|FG003|Overall Study|Adverse Event|1|||
145668902|NCT00146172|525308171|FG004|Overall Study|Adverse Event|0|||
145668903|NCT00146172|525308172|FG005|Overall Study|Adverse Event|2|||
145668904|NCT00146172|525308173|FG006|Overall Study|Adverse Event|3|||
145668905|NCT00146172|525308174|FG007|Overall Study|Adverse Event|10|||
145668906|NCT00146172|525308167|FG000|Overall Study|Lost to Follow-up|0|||
145668907|NCT00146172|525308168|FG001|Overall Study|Lost to Follow-up|0|||
145668908|NCT00146172|525308169|FG002|Overall Study|Lost to Follow-up|0|||
145668909|NCT00146172|525308170|FG003|Overall Study|Lost to Follow-up|0|||
145668910|NCT00146172|525308171|FG004|Overall Study|Lost to Follow-up|0|||
145668911|NCT00146172|525308172|FG005|Overall Study|Lost to Follow-up|0|||
145668912|NCT00146172|525308173|FG006|Overall Study|Lost to Follow-up|0|||
145668913|NCT00146172|525308174|FG007|Overall Study|Lost to Follow-up|1|||
145668914|NCT00146172|525308167|FG000|Overall Study|Disease Progression|2|||
145668915|NCT00146172|525308168|FG001|Overall Study|Disease Progression|4|||
145668916|NCT00146172|525308169|FG002|Overall Study|Disease Progression|2|||
145668917|NCT00146172|525308170|FG003|Overall Study|Disease Progression|5|||
145668918|NCT00146172|525308171|FG004|Overall Study|Disease Progression|2|||
145668919|NCT00146172|525308172|FG005|Overall Study|Disease Progression|2|||
145668920|NCT00146172|525308173|FG006|Overall Study|Disease Progression|1|||
145668921|NCT00146172|525308174|FG007|Overall Study|Disease Progression|22|||
145668922|NCT00146172|525308167|FG000|Overall Study|Death|0|||
145668923|NCT00146172|525308168|FG001|Overall Study|Death|0|||
145668924|NCT00146172|525308169|FG002|Overall Study|Death|0|||
145668925|NCT00146172|525308170|FG003|Overall Study|Death|0|||
145668926|NCT00146172|525308171|FG004|Overall Study|Death|0|||
145668927|NCT00146172|525308172|FG005|Overall Study|Death|0|||
145668928|NCT00146172|525308173|FG006|Overall Study|Death|1|||
145668929|NCT00146172|525308174|FG007|Overall Study|Death|0|||
145668930|NCT00146172|525308167|FG000|Overall Study|Physician Decision|0|||
145668931|NCT00146172|525308168|FG001|Overall Study|Physician Decision|0|||
145668932|NCT00146172|525308169|FG002|Overall Study|Physician Decision|0|||
145668933|NCT00146172|525308170|FG003|Overall Study|Physician Decision|0|||
145668934|NCT00146172|525308171|FG004|Overall Study|Physician Decision|0|||
145668935|NCT00146172|525308172|FG005|Overall Study|Physician Decision|0|||
145668936|NCT00146172|525308173|FG006|Overall Study|Physician Decision|0|||
145668937|NCT00146172|525308174|FG007|Overall Study|Physician Decision|1|||
145668938|NCT00146172|525308167|FG000|Overall Study|Withdrawal by Subject|0|||
145668939|NCT00146172|525308168|FG001|Overall Study|Withdrawal by Subject|0|||
145668940|NCT00146172|525308169|FG002|Overall Study|Withdrawal by Subject|0|||
145668941|NCT00146172|525308170|FG003|Overall Study|Withdrawal by Subject|0|||
145668942|NCT00146172|525308171|FG004|Overall Study|Withdrawal by Subject|0|||
145668943|NCT00146172|525308172|FG005|Overall Study|Withdrawal by Subject|1|||
145668944|NCT00146172|525308173|FG006|Overall Study|Withdrawal by Subject|1|||
145668945|NCT00146172|525308174|FG007|Overall Study|Withdrawal by Subject|4|||
145668946|NCT00146172|525308167|FG000|Overall Study|Symptomatic Deterioration|1|||
145668947|NCT00146172|525308168|FG001|Overall Study|Symptomatic Deterioration|0|||
145668948|NCT00146172|525308169|FG002|Overall Study|Symptomatic Deterioration|1|||
145668949|NCT00146172|525308170|FG003|Overall Study|Symptomatic Deterioration|0|||
145668950|NCT00146172|525308171|FG004|Overall Study|Symptomatic Deterioration|1|||
145668951|NCT00146172|525308172|FG005|Overall Study|Symptomatic Deterioration|2|||
145265398|NCT04479358|523819337|FG005|Overall Study|Withdrawal by Subject|1|||
145668952|NCT00146172|525308173|FG006|Overall Study|Symptomatic Deterioration|0|||
145668953|NCT00146172|525308174|FG007|Overall Study|Symptomatic Deterioration|2|||
145668954|NCT00786864|525308175|FG000|Overall Study|Lost to Follow-up|0|||
145668955|NCT00786864|525308176|FG001|Overall Study|Lost to Follow-up|1|||
145668956|NCT00786864|525308175|FG000|Overall Study|Sustained serious back injury|1|||
145668957|NCT00786864|525308176|FG001|Overall Study|Sustained serious back injury|0|||
145668958|NCT01084694|525308177|FG000|Overall Study|Withdrawal by Subject|2|||
145668959|NCT01084694|525308178|FG001|Overall Study|Withdrawal by Subject|1|||
145668960|NCT01084694|525308177|FG000|Overall Study|Death|2|||
145668961|NCT01084694|525308178|FG001|Overall Study|Death|12|||
145668962|NCT01084694|525308177|FG000|Overall Study|eligibility not maintained|2|||
145668963|NCT01084694|525308178|FG001|Overall Study|eligibility not maintained|7|||
145668964|NCT01128595|525308184|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145668965|NCT01128595|525308185|FG001|Treatment Period 3|Withdrawal by Subject|1|||
145668966|NCT01128595|525308186|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145668967|NCT01128595|525308187|FG003|Treatment Period 3|Withdrawal by Subject|0|||
145668968|NCT00605306|525308188|FG000|Overall Study|Adverse Event|0|||
145668969|NCT00605306|525308189|FG001|Overall Study|Adverse Event|1|||
145668970|NCT01561300|525308190|FG000|Run in on Placebo|Adverse Event|1|||
145668971|NCT01561300|525308191|FG001|Run in on Placebo|Adverse Event|0|||
145668972|NCT00777049|525308192|FG000|Overall Study|Withdrawal by Subject|1|||
145668973|NCT00777049|525308193|FG001|Overall Study|Withdrawal by Subject|0|||
145668974|NCT00777049|525308192|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
145668975|NCT00777049|525308193|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
145668976|NCT00246805|525308194|FG000|Phase 1|Lost to Follow-up|1|||
145668977|NCT00246805|525308195|FG001|Phase 1|Lost to Follow-up|0|||
145668978|NCT03478969|525308196|FG000|Overall Study|Withdrawal by Subject|4|||
145668979|NCT03478969|525308197|FG001|Overall Study|Withdrawal by Subject|7|||
145668980|NCT03478969|525308198|FG002|Overall Study|Withdrawal by Subject|6|||
145668981|NCT03478969|525308196|FG000|Overall Study|Adverse Event|2|||
145668982|NCT03478969|525308197|FG001|Overall Study|Adverse Event|0|||
145668983|NCT03478969|525308198|FG002|Overall Study|Adverse Event|1|||
145668984|NCT03478969|525308196|FG000|Overall Study|Pregnancy|1|||
145668985|NCT03478969|525308197|FG001|Overall Study|Pregnancy|0|||
145668986|NCT03478969|525308198|FG002|Overall Study|Pregnancy|0|||
145668987|NCT03478969|525308196|FG000|Overall Study|Personal Reasons|1|||
145668988|NCT03478969|525308197|FG001|Overall Study|Personal Reasons|0|||
145668989|NCT03478969|525308198|FG002|Overall Study|Personal Reasons|1|||
145668990|NCT03478969|525308196|FG000|Overall Study|Covid-19|1|||
145668991|NCT03478969|525308197|FG001|Overall Study|Covid-19|4|||
145668992|NCT03478969|525308198|FG002|Overall Study|Covid-19|3|||
145668993|NCT03478969|525308196|FG000|Overall Study|Multiple Reasons|0|||
145668994|NCT03478969|525308197|FG001|Overall Study|Multiple Reasons|1|||
145668995|NCT03478969|525308198|FG002|Overall Study|Multiple Reasons|1|||
145668996|NCT03478969|525308196|FG000|Overall Study|Eligibility Criteria|0|||
145668997|NCT03478969|525308197|FG001|Overall Study|Eligibility Criteria|0|||
145668998|NCT03478969|525308198|FG002|Overall Study|Eligibility Criteria|5|||
145668999|NCT03478969|525308196|FG000|Overall Study|Lost to Follow-up|0|||
145669000|NCT03478969|525308197|FG001|Overall Study|Lost to Follow-up|0|||
145669001|NCT03478969|525308198|FG002|Overall Study|Lost to Follow-up|1|||
145669002|NCT01185600|525308199|FG000|Overall Study|Adverse Event|1|||
145669003|NCT01185600|525308200|FG001|Overall Study|Adverse Event|1|||
145669004|NCT01185600|525308199|FG000|Overall Study|Death|0|||
145669005|NCT01185600|525308200|FG001|Overall Study|Death|1|||
145669006|NCT01185600|525308199|FG000|Overall Study|Lost to Follow-up|0|||
145669007|NCT01185600|525308200|FG001|Overall Study|Lost to Follow-up|5|||
145669008|NCT01185600|525308199|FG000|Overall Study|Physician Decision|29|||
145669009|NCT01185600|525308200|FG001|Overall Study|Physician Decision|35|||
145669010|NCT01185600|525308199|FG000|Overall Study|Withdrawal by Subject|1|||
145669011|NCT01185600|525308200|FG001|Overall Study|Withdrawal by Subject|1|||
145669012|NCT01185600|525308199|FG000|Overall Study|Hold by DSMB|1|||
145669013|NCT01185600|525308200|FG001|Overall Study|Hold by DSMB|2|||
145669014|NCT00724126|525308201|FG000|Overall Study|Adverse Event|2|||
145669015|NCT00724126|525308202|FG001|Overall Study|Adverse Event|0|||
145669016|NCT00724126|525308201|FG000|Overall Study|Withdrawal by Subject|8|||
145669017|NCT00724126|525308202|FG001|Overall Study|Withdrawal by Subject|6|||
145669018|NCT00724126|525308201|FG000|Overall Study|Lost to Follow-up|6|||
145669019|NCT00724126|525308202|FG001|Overall Study|Lost to Follow-up|6|||
145669020|NCT00724126|525308201|FG000|Overall Study|Noncompliance|2|||
145669021|NCT00724126|525308202|FG001|Overall Study|Noncompliance|1|||
145669022|NCT00724126|525308201|FG000|Overall Study|Subject randomized although ineligible|1|||
145669023|NCT00724126|525308202|FG001|Overall Study|Subject randomized although ineligible|1|||
145669024|NCT00724126|525308201|FG000|Overall Study|Subject had to leave vicinity of site|0|||
145669025|NCT00724126|525308202|FG001|Overall Study|Subject had to leave vicinity of site|1|||
145669026|NCT01500200|525308205|FG000|Stage 1|Adverse Event|1|||
145490838|NCT00308139|524652223|FG001|Overall Study|Administrative|4|||
145490839|NCT00308139|524652222|FG000|Overall Study|Other|1|||
145669027|NCT01500200|525308206|FG001|Stage 1|Adverse Event|4|||
145669028|NCT01500200|525308207|FG002|Stage 1|Adverse Event|5|||
145669029|NCT01500200|525308208|FG003|Stage 1|Adverse Event|0|||
145669030|NCT01500200|525308209|FG004|Stage 1|Adverse Event|0|||
145669031|NCT01500200|525308210|FG005|Stage 1|Adverse Event|0|||
145669032|NCT01500200|525308205|FG000|Stage 1|Lost to Follow-up|2|||
145669033|NCT01500200|525308206|FG001|Stage 1|Lost to Follow-up|2|||
145265399|NCT05437211|523819346|FG000|Overall Study|Patient's decision|1|||
145669034|NCT01500200|525308207|FG002|Stage 1|Lost to Follow-up|1|||
145669035|NCT01500200|525308208|FG003|Stage 1|Lost to Follow-up|0|||
145669036|NCT01500200|525308209|FG004|Stage 1|Lost to Follow-up|0|||
145669037|NCT01500200|525308210|FG005|Stage 1|Lost to Follow-up|0|||
145669038|NCT01500200|525308205|FG000|Stage 1|Withdrawal by Subject|3|||
145669039|NCT01500200|525308206|FG001|Stage 1|Withdrawal by Subject|0|||
145669040|NCT01500200|525308207|FG002|Stage 1|Withdrawal by Subject|0|||
145669041|NCT01500200|525308208|FG003|Stage 1|Withdrawal by Subject|0|||
145669042|NCT01500200|525308209|FG004|Stage 1|Withdrawal by Subject|0|||
145669043|NCT01500200|525308210|FG005|Stage 1|Withdrawal by Subject|0|||
145669044|NCT01500200|525308205|FG000|Stage 1|Noncompliance with Study Drug|1|||
145669045|NCT01500200|525308206|FG001|Stage 1|Noncompliance with Study Drug|0|||
145669046|NCT01500200|525308207|FG002|Stage 1|Noncompliance with Study Drug|0|||
145669047|NCT01500200|525308208|FG003|Stage 1|Noncompliance with Study Drug|0|||
145669048|NCT01500200|525308209|FG004|Stage 1|Noncompliance with Study Drug|0|||
145669049|NCT01500200|525308210|FG005|Stage 1|Noncompliance with Study Drug|0|||
145669050|NCT01500200|525308205|FG000|Stage 1|Physician Decision|1|||
145669051|NCT01500200|525308206|FG001|Stage 1|Physician Decision|0|||
145669052|NCT01500200|525308207|FG002|Stage 1|Physician Decision|0|||
145669053|NCT01500200|525308208|FG003|Stage 1|Physician Decision|0|||
145669054|NCT01500200|525308209|FG004|Stage 1|Physician Decision|0|||
145669055|NCT01500200|525308210|FG005|Stage 1|Physician Decision|0|||
145669056|NCT01500200|525308205|FG000|Stage 2|Adverse Event|0|||
145669057|NCT01500200|525308206|FG001|Stage 2|Adverse Event|0|||
145669058|NCT01500200|525308207|FG002|Stage 2|Adverse Event|0|||
145669059|NCT01500200|525308208|FG003|Stage 2|Adverse Event|0|||
145669060|NCT01500200|525308209|FG004|Stage 2|Adverse Event|5|||
145669061|NCT01500200|525308210|FG005|Stage 2|Adverse Event|4|||
145669062|NCT01212744|525308213|FG000|Overall Study|Withdrawal by Subject|1|||
145669063|NCT02167451|525308215|FG000|Overall Study|Withdrawal by Subject|1|||
145669064|NCT00571649|525308216|FG000|Treatment Period|Adverse Event|438|||
145669065|NCT00571649|525308217|FG001|Treatment Period|Adverse Event|385|||
145669066|NCT00571649|525308216|FG000|Treatment Period|Clinical endpoint reached|50|||
145669067|NCT00571649|525308217|FG001|Treatment Period|Clinical endpoint reached|56|||
145669068|NCT00571649|525308216|FG000|Treatment Period|Withdrawal by Subject|285|||
145669069|NCT00571649|525308217|FG001|Treatment Period|Withdrawal by Subject|255|||
145669070|NCT00571649|525308216|FG000|Treatment Period|Death|76|||
145669071|NCT00571649|525308217|FG001|Treatment Period|Death|59|||
145669072|NCT00571649|525308216|FG000|Treatment Period|Physician Decision|8|||
145669073|NCT00571649|525308217|FG001|Treatment Period|Physician Decision|9|||
145669074|NCT00571649|525308216|FG000|Treatment Period|Lost to Follow-up|43|||
145669075|NCT00571649|525308217|FG001|Treatment Period|Lost to Follow-up|41|||
145669076|NCT00571649|525308216|FG000|Treatment Period|Non-compliant with study medication|88|||
145669077|NCT00571649|525308217|FG001|Treatment Period|Non-compliant with study medication|89|||
145669078|NCT00571649|525308216|FG000|Treatment Period|Patient convenience|11|||
145669079|NCT00571649|525308217|FG001|Treatment Period|Patient convenience|13|||
145669080|NCT00571649|525308216|FG000|Treatment Period|Protocol Violation|90|||
145669081|NCT00571649|525308217|FG001|Treatment Period|Protocol Violation|92|||
145669082|NCT00571649|525308216|FG000|Treatment Period|Technical problems|3|||
145669083|NCT00571649|525308217|FG001|Treatment Period|Technical problems|5|||
145669084|NCT00571649|525308216|FG000|Follow-up Period|Adverse Event|46|||
145669085|NCT00571649|525308217|FG001|Follow-up Period|Adverse Event|40|||
145669086|NCT00571649|525308216|FG000|Follow-up Period|Clinical endpoint reached|5|||
145669087|NCT00571649|525308217|FG001|Follow-up Period|Clinical endpoint reached|2|||
145669088|NCT00571649|525308216|FG000|Follow-up Period|Withdrawal by Subject|119|||
145669089|NCT00571649|525308217|FG001|Follow-up Period|Withdrawal by Subject|115|||
145669090|NCT00571649|525308216|FG000|Follow-up Period|Death|132|||
145669091|NCT00571649|525308217|FG001|Follow-up Period|Death|133|||
145669092|NCT00571649|525308216|FG000|Follow-up Period|Physician Decision|7|||
145669093|NCT00571649|525308217|FG001|Follow-up Period|Physician Decision|13|||
145669094|NCT00571649|525308216|FG000|Follow-up Period|Lost to Follow-up|95|||
145669095|NCT00571649|525308217|FG001|Follow-up Period|Lost to Follow-up|92|||
145669096|NCT00571649|525308216|FG000|Follow-up Period|Patient convenience|136|||
145669097|NCT00571649|525308217|FG001|Follow-up Period|Patient convenience|121|||
145669098|NCT00571649|525308216|FG000|Follow-up Period|Protocol Violation|5|||
145669099|NCT00571649|525308217|FG001|Follow-up Period|Protocol Violation|12|||
145669100|NCT01218659|525308218|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
145669101|NCT01218659|525308219|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
145669102|NCT01218659|525308220|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
145669103|NCT01218659|525308218|FG000|18-Month Randomized Period|Did not receive study drug|0|||
145669104|NCT01218659|525308219|FG001|18-Month Randomized Period|Did not receive study drug|3|||
145669105|NCT01218659|525308220|FG002|18-Month Randomized Period|Did not receive study drug|0|||
145669106|NCT01218659|525308218|FG000|12-Month OLE|Withdrawal by Subject|0|||
145669107|NCT01218659|525308219|FG001|12-Month OLE|Withdrawal by Subject|0|||
145669108|NCT01218659|525308220|FG002|12-Month OLE|Withdrawal by Subject|2|||
145669109|NCT01218659|525308218|FG000|12-Month OLE|Physician Decision|0|||
145669110|NCT01218659|525308219|FG001|12-Month OLE|Physician Decision|0|||
145669111|NCT01218659|525308220|FG002|12-Month OLE|Physician Decision|1|||
145490840|NCT00308139|524652223|FG001|Overall Study|Other|0|||
145490841|NCT02313766|524652226|FG000|Overall Study|surgery cancelled|1|||
145669112|NCT01218659|525308218|FG000|12-Month OLE|Lost to Follow-up|0|||
145669113|NCT01218659|525308219|FG001|12-Month OLE|Lost to Follow-up|0|||
145669114|NCT01218659|525308220|FG002|12-Month OLE|Lost to Follow-up|1|||
145669115|NCT01218659|525308218|FG000|12-Month OLE|Pregnancy|0|||
145669116|NCT01218659|525308219|FG001|12-Month OLE|Pregnancy|0|||
145669117|NCT01218659|525308220|FG002|12-Month OLE|Pregnancy|1|||
145669118|NCT01218659|525308218|FG000|12-Month OLE|Lack of Efficacy|0|||
145669119|NCT01218659|525308219|FG001|12-Month OLE|Lack of Efficacy|0|||
145669120|NCT01218659|525308220|FG002|12-Month OLE|Lack of Efficacy|1|||
145669121|NCT01218659|525308218|FG000|12-Month OLE|Declined to participate in the OLE|0|||
145669122|NCT01218659|525308219|FG001|12-Month OLE|Declined to participate in the OLE|0|||
145669123|NCT01218659|525308220|FG002|12-Month OLE|Declined to participate in the OLE|4|||
145669124|NCT03066609|525308227|FG000|INDUCTION|Pregnancy|0|||
145669125|NCT03066609|525308228|FG001|INDUCTION|Pregnancy|0|||
145669126|NCT03066609|525308229|FG002|INDUCTION|Pregnancy|1|||
145669127|NCT03066609|525308230|FG003|INDUCTION|Pregnancy|0|||
145669128|NCT03066609|525308227|FG000|INDUCTION|Lack of Efficacy|0|||
145669129|NCT03066609|525308228|FG001|INDUCTION|Lack of Efficacy|0|||
145669130|NCT03066609|525308229|FG002|INDUCTION|Lack of Efficacy|1|||
145669131|NCT03066609|525308230|FG003|INDUCTION|Lack of Efficacy|0|||
145669132|NCT03066609|525308227|FG000|INDUCTION|Adverse Event|2|||
145669133|NCT03066609|525308228|FG001|INDUCTION|Adverse Event|2|||
145669134|NCT03066609|525308229|FG002|INDUCTION|Adverse Event|0|||
145669135|NCT03066609|525308230|FG003|INDUCTION|Adverse Event|0|||
145669136|NCT03066609|525308227|FG000|MAINTENANCE|Adverse Event|0|||
145669137|NCT03066609|525308228|FG001|MAINTENANCE|Adverse Event|0|||
145669138|NCT03066609|525308229|FG002|MAINTENANCE|Adverse Event|0|||
145669139|NCT03066609|525308230|FG003|MAINTENANCE|Adverse Event|1|||
145669140|NCT03066609|525308227|FG000|MAINTENANCE|Withdrawal by Subject|4|||
145669141|NCT03066609|525308228|FG001|MAINTENANCE|Withdrawal by Subject|2|||
145669142|NCT03066609|525308229|FG002|MAINTENANCE|Withdrawal by Subject|1|||
145669143|NCT03066609|525308230|FG003|MAINTENANCE|Withdrawal by Subject|1|||
145669144|NCT03066609|525308227|FG000|MAINTENANCE|Lost to Follow-up|0|||
145669145|NCT03066609|525308228|FG001|MAINTENANCE|Lost to Follow-up|1|||
145669146|NCT03066609|525308229|FG002|MAINTENANCE|Lost to Follow-up|1|||
145669147|NCT03066609|525308230|FG003|MAINTENANCE|Lost to Follow-up|0|||
145669148|NCT03066609|525308227|FG000|MAINTENANCE|Pregnancy|1|||
145669149|NCT03066609|525308228|FG001|MAINTENANCE|Pregnancy|0|||
145669150|NCT03066609|525308229|FG002|MAINTENANCE|Pregnancy|0|||
145669151|NCT03066609|525308230|FG003|MAINTENANCE|Pregnancy|0|||
145669152|NCT03066609|525308227|FG000|MAINTENANCE|Lack of Efficacy|2|||
145669153|NCT03066609|525308228|FG001|MAINTENANCE|Lack of Efficacy|1|||
145669154|NCT03066609|525308229|FG002|MAINTENANCE|Lack of Efficacy|0|||
145669155|NCT03066609|525308230|FG003|MAINTENANCE|Lack of Efficacy|1|||
145669156|NCT03066609|525308227|FG000|OVERALL STUDY|Adverse Event|2|||
145669157|NCT03066609|525308228|FG001|OVERALL STUDY|Adverse Event|2|||
145669158|NCT03066609|525308229|FG002|OVERALL STUDY|Adverse Event|0|||
145669159|NCT03066609|525308230|FG003|OVERALL STUDY|Adverse Event|1|||
145669160|NCT03066609|525308227|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
145669161|NCT03066609|525308228|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
145669162|NCT03066609|525308229|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
145669163|NCT03066609|525308230|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
145669164|NCT03066609|525308227|FG000|OVERALL STUDY|Lost to Follow-up|1|||
145669165|NCT03066609|525308228|FG001|OVERALL STUDY|Lost to Follow-up|1|||
145669166|NCT03066609|525308229|FG002|OVERALL STUDY|Lost to Follow-up|1|||
145669167|NCT03066609|525308230|FG003|OVERALL STUDY|Lost to Follow-up|1|||
145669168|NCT03066609|525308227|FG000|OVERALL STUDY|Pregnancy|1|||
145669169|NCT03066609|525308228|FG001|OVERALL STUDY|Pregnancy|0|||
145669170|NCT03066609|525308229|FG002|OVERALL STUDY|Pregnancy|1|||
145669171|NCT03066609|525308230|FG003|OVERALL STUDY|Pregnancy|0|||
145669172|NCT03066609|525308227|FG000|OVERALL STUDY|Lack of Efficacy|2|||
145669173|NCT03066609|525308228|FG001|OVERALL STUDY|Lack of Efficacy|1|||
145669174|NCT03066609|525308229|FG002|OVERALL STUDY|Lack of Efficacy|1|||
145669175|NCT03066609|525308230|FG003|OVERALL STUDY|Lack of Efficacy|1|||
145669176|NCT03066609|525308227|FG000|OVERALL STUDY|discontinued follow up|0|||
145669177|NCT03066609|525308228|FG001|OVERALL STUDY|discontinued follow up|2|||
145669178|NCT03066609|525308229|FG002|OVERALL STUDY|discontinued follow up|0|||
145669179|NCT03066609|525308230|FG003|OVERALL STUDY|discontinued follow up|0|||
145669180|NCT03355573|525308231|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
145669181|NCT03355573|525308231|FG000|Overall Study|Sponsor's decision|1|||
145669182|NCT03355573|525308231|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
145669183|NCT03355573|525308231|FG000|Overall Study|PI's decision|2|||
145669184|NCT03355573|525308231|FG000|Overall Study|Withdrawal by Subject|23|||
145669185|NCT03355573|525308231|FG000|Overall Study|Lost to Follow-up|4|||
145669186|NCT03355573|525308231|FG000|Overall Study|Lack of Efficacy|2|||
145669187|NCT03355573|525308231|FG000|Overall Study|Adverse Event, non-fatal|17|||
145669188|NCT03355573|525308231|FG000|Overall Study|Adverse Event, serious fatal|2|||
145669189|NCT01566890|525308232|FG000|Overall Study|Adverse Event|1|||
145669190|NCT01566890|525308233|FG001|Overall Study|Adverse Event|0|||
145669191|NCT01566890|525308234|FG002|Overall Study|Adverse Event|0|||
145669192|NCT01566890|525308235|FG003|Overall Study|Adverse Event|0|||
145669193|NCT01566890|525308236|FG004|Overall Study|Adverse Event|0|||
145669194|NCT01566890|525308232|FG000|Overall Study|Withdrawal by Subject|3|||
145669195|NCT01566890|525308233|FG001|Overall Study|Withdrawal by Subject|1|||
145669196|NCT01566890|525308234|FG002|Overall Study|Withdrawal by Subject|1|||
145669197|NCT01566890|525308235|FG003|Overall Study|Withdrawal by Subject|1|||
145669198|NCT01566890|525308236|FG004|Overall Study|Withdrawal by Subject|0|||
145669199|NCT01566890|525308232|FG000|Overall Study|Screen failure|6|||
145669200|NCT01566890|525308233|FG001|Overall Study|Screen failure|0|||
145669201|NCT01566890|525308234|FG002|Overall Study|Screen failure|1|||
145669202|NCT01566890|525308235|FG003|Overall Study|Screen failure|1|||
145669203|NCT01566890|525308236|FG004|Overall Study|Screen failure|0|||
145669204|NCT01566890|525308232|FG000|Overall Study|Incomplete CEU data|1|||
145669205|NCT01566890|525308233|FG001|Overall Study|Incomplete CEU data|3|||
145669206|NCT01566890|525308234|FG002|Overall Study|Incomplete CEU data|5|||
145669207|NCT01566890|525308235|FG003|Overall Study|Incomplete CEU data|8|||
145669208|NCT01566890|525308236|FG004|Overall Study|Incomplete CEU data|0|||
145669209|NCT01566890|525308232|FG000|Overall Study|Lost to Follow-up|0|||
145669210|NCT01566890|525308233|FG001|Overall Study|Lost to Follow-up|0|||
145669211|NCT01566890|525308234|FG002|Overall Study|Lost to Follow-up|4|||
145669212|NCT01566890|525308235|FG003|Overall Study|Lost to Follow-up|4|||
145669213|NCT01566890|525308236|FG004|Overall Study|Lost to Follow-up|0|||
145669214|NCT01566890|525308232|FG000|Overall Study|Other|0|||
145669215|NCT01566890|525308233|FG001|Overall Study|Other|0|||
145669216|NCT01566890|525308234|FG002|Overall Study|Other|0|||
145669217|NCT01566890|525308235|FG003|Overall Study|Other|0|||
145669218|NCT01566890|525308236|FG004|Overall Study|Other|7|||
145669219|NCT00523419|525308247|FG000|Overall Study|Adverse Event|1|||
145669220|NCT00523419|525308247|FG000|Overall Study|Withdrawal by Subject|1|||
145669221|NCT00523419|525308247|FG000|Overall Study|Physician Decision|2|||
145669222|NCT00523419|525308247|FG000|Overall Study|Progressive Disease|22|||
145669223|NCT00523419|525308247|FG000|Overall Study|Death due to Study Disease|4|||
145669224|NCT00523419|525308247|FG000|Overall Study|Death due to Adverse Event|2|||
145669225|NCT01211184|525308248|FG000|Overall Study|Withdrawal by Subject|0|||
145669226|NCT01211184|525308249|FG001|Overall Study|Withdrawal by Subject|2|||
145669227|NCT01211184|525308250|FG002|Overall Study|Withdrawal by Subject|1|||
145669228|NCT01421667|525308251|FG000|Overall Study|Withdrawal by Subject|0|||
145669229|NCT01421667|525308252|FG001|Overall Study|Withdrawal by Subject|1|||
145669230|NCT01421667|525308253|FG002|Overall Study|Withdrawal by Subject|2|||
145669231|NCT01421667|525308254|FG003|Overall Study|Withdrawal by Subject|1|||
145669232|NCT01421667|525308251|FG000|Overall Study|Lost to Follow-up|0|||
145669233|NCT01421667|525308252|FG001|Overall Study|Lost to Follow-up|1|||
145669234|NCT01421667|525308253|FG002|Overall Study|Lost to Follow-up|0|||
145669235|NCT01421667|525308254|FG003|Overall Study|Lost to Follow-up|0|||
145669236|NCT00822120|525308255|FG000|Initial Registration|Adverse Event|1|||
145669237|NCT00822120|525308256|FG001|Initial Registration|Adverse Event|0|||
145669238|NCT00822120|525308257|FG002|Initial Registration|Adverse Event|0|||
145669239|NCT00822120|525308258|FG003|Initial Registration|Adverse Event|0|||
145669240|NCT00822120|525308259|FG004|Initial Registration|Adverse Event|0|||
145669241|NCT00822120|525308260|FG005|Initial Registration|Adverse Event|0|||
145669242|NCT00822120|525308255|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
145669243|NCT00822120|525308256|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145669244|NCT00822120|525308257|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145669245|NCT00822120|525308258|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145669246|NCT00822120|525308259|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145669247|NCT00822120|525308260|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
145669248|NCT00822120|525308255|FG000|Initial Registration|Reasons not Protocol Specified|2|||
145669249|NCT00822120|525308256|FG001|Initial Registration|Reasons not Protocol Specified|0|||
145669250|NCT00822120|525308257|FG002|Initial Registration|Reasons not Protocol Specified|0|||
145669251|NCT00822120|525308258|FG003|Initial Registration|Reasons not Protocol Specified|0|||
145669252|NCT00822120|525308259|FG004|Initial Registration|Reasons not Protocol Specified|0|||
145669253|NCT00822120|525308260|FG005|Initial Registration|Reasons not Protocol Specified|0|||
145669254|NCT00822120|525308255|FG000|Initial Registration|Ineligible|22|||
145669255|NCT00822120|525308256|FG001|Initial Registration|Ineligible|1|||
145669256|NCT00822120|525308257|FG002|Initial Registration|Ineligible|0|||
145669257|NCT00822120|525308258|FG003|Initial Registration|Ineligible|0|||
145669258|NCT00822120|525308259|FG004|Initial Registration|Ineligible|0|||
145669259|NCT00822120|525308260|FG005|Initial Registration|Ineligible|0|||
145669260|NCT00822120|525308255|FG000|PET-directed Therapy|Adverse Event|0|||
145669261|NCT00822120|525308256|FG001|PET-directed Therapy|Adverse Event|0|||
145669262|NCT00822120|525308257|FG002|PET-directed Therapy|Adverse Event|0|||
145669263|NCT00822120|525308258|FG003|PET-directed Therapy|Adverse Event|1|||
145669264|NCT00822120|525308259|FG004|PET-directed Therapy|Adverse Event|0|||
145669265|NCT00822120|525308260|FG005|PET-directed Therapy|Adverse Event|0|||
145669266|NCT00822120|525308255|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
145669267|NCT00822120|525308256|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
145669268|NCT00822120|525308257|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
145669269|NCT00822120|525308258|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
145669270|NCT00822120|525308259|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
145669271|NCT00822120|525308260|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
145669272|NCT00822120|525308255|FG000|PET-directed Therapy|Death|0|||
145669273|NCT00822120|525308256|FG001|PET-directed Therapy|Death|0|||
145669274|NCT00822120|525308257|FG002|PET-directed Therapy|Death|0|||
145669275|NCT00822120|525308258|FG003|PET-directed Therapy|Death|2|||
145669276|NCT00822120|525308259|FG004|PET-directed Therapy|Death|0|||
145669277|NCT00822120|525308260|FG005|PET-directed Therapy|Death|0|||
145669278|NCT00822120|525308255|FG000|PET-directed Therapy|Protocol Violation|0|||
145669279|NCT00822120|525308256|FG001|PET-directed Therapy|Protocol Violation|0|||
145669280|NCT00822120|525308257|FG002|PET-directed Therapy|Protocol Violation|0|||
145669281|NCT00822120|525308258|FG003|PET-directed Therapy|Protocol Violation|6|||
145669282|NCT00822120|525308259|FG004|PET-directed Therapy|Protocol Violation|0|||
145669283|NCT00822120|525308260|FG005|PET-directed Therapy|Protocol Violation|0|||
145669284|NCT04060212|525308262|FG000|Overall Study|Withdrawal by Subject|7|||
145669285|NCT00811941|525308266|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
145669286|NCT00811941|525308267|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
145669287|NCT00811941|525308266|FG000|All Treated Patients|Adverse Event|2|||
145669288|NCT00811941|525308267|FG001|All Treated Patients|Adverse Event|43|||
145669289|NCT00811941|525308266|FG000|All Treated Patients|Lack of Efficacy|2|||
145669290|NCT00811941|525308267|FG001|All Treated Patients|Lack of Efficacy|3|||
145669291|NCT00811941|525308266|FG000|All Treated Patients|Non-compliance|1|||
145669292|NCT00811941|525308267|FG001|All Treated Patients|Non-compliance|8|||
145669293|NCT00811941|525308266|FG000|All Treated Patients|Protocol Violation|5|||
145669294|NCT00811941|525308267|FG001|All Treated Patients|Protocol Violation|17|||
145669295|NCT00811941|525308266|FG000|All Treated Patients|Withdrawal by Subject|35|||
145669296|NCT00811941|525308267|FG001|All Treated Patients|Withdrawal by Subject|94|||
145669297|NCT00811941|525308266|FG000|All Treated Patients|Lost to Follow-up|3|||
145669298|NCT00811941|525308267|FG001|All Treated Patients|Lost to Follow-up|12|||
145669299|NCT00811941|525308266|FG000|All Treated Patients|Other Reason|4|||
145669300|NCT00811941|525308267|FG001|All Treated Patients|Other Reason|14|||
145669301|NCT03885232|525308268|FG000|Overall Study|Lost to Follow-up|74|||
145669302|NCT03885232|525308269|FG001|Overall Study|Lost to Follow-up|32|||
145669303|NCT03885232|525308268|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
145669304|NCT03885232|525308269|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
145669305|NCT02397096|525308270|FG000|Day 1 to Week 24|Adverse Event|7|||
145669306|NCT02397096|525308271|FG001|Day 1 to Week 24|Adverse Event|1|||
145669307|NCT02397096|525308270|FG000|Day 1 to Week 24|Death|1|||
145669308|NCT02397096|525308271|FG001|Day 1 to Week 24|Death|0|||
145669309|NCT02397096|525308270|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
145669310|NCT02397096|525308271|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
145669311|NCT02397096|525308270|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
145669312|NCT02397096|525308271|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
145669313|NCT02397096|525308270|FG000|Day 1 to Week 24|Physician Decision|2|||
145669314|NCT02397096|525308271|FG001|Day 1 to Week 24|Physician Decision|3|||
145669315|NCT02397096|525308270|FG000|Day 1 to Week 24|Protocol Violation|1|||
145669316|NCT02397096|525308271|FG001|Day 1 to Week 24|Protocol Violation|4|||
145669317|NCT02397096|525308270|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
145669318|NCT02397096|525308271|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
145669319|NCT02397096|525308270|FG000|Day 1 to Week 24|Randomized, not treated|3|||
145669320|NCT02397096|525308271|FG001|Day 1 to Week 24|Randomized, not treated|0|||
145669321|NCT02397096|525308270|FG000|Week 24 to Week 48|Adverse Event|6|||
145669322|NCT02397096|525308271|FG001|Week 24 to Week 48|Adverse Event|2|||
145669323|NCT02397096|525308270|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
145669324|NCT02397096|525308271|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
145669325|NCT02397096|525308270|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
145669326|NCT02397096|525308271|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
145669327|NCT02397096|525308270|FG000|Week 24 to Week 48|Physician Decision|2|||
145669328|NCT02397096|525308271|FG001|Week 24 to Week 48|Physician Decision|1|||
145669329|NCT02397096|525308270|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
145669330|NCT02397096|525308271|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
145669331|NCT02397096|525308270|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
145669332|NCT02397096|525308271|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
145669333|NCT02397096|525308270|FG000|Study Extension 1|Adverse Event|7|||
145669334|NCT02397096|525308271|FG001|Study Extension 1|Adverse Event|5|||
145669335|NCT02397096|525308270|FG000|Study Extension 1|Death|1|||
145669336|NCT02397096|525308271|FG001|Study Extension 1|Death|0|||
145669337|NCT02397096|525308270|FG000|Study Extension 1|Lack of Efficacy|2|||
145669338|NCT02397096|525308271|FG001|Study Extension 1|Lack of Efficacy|5|||
145669339|NCT02397096|525308270|FG000|Study Extension 1|Lost to Follow-up|2|||
145669340|NCT02397096|525308271|FG001|Study Extension 1|Lost to Follow-up|3|||
145669341|NCT02397096|525308270|FG000|Study Extension 1|Non-compliance with study drug|3|||
145669342|NCT02397096|525308271|FG001|Study Extension 1|Non-compliance with study drug|0|||
145669343|NCT02397096|525308270|FG000|Study Extension 1|Physician Decision|4|||
145669344|NCT02397096|525308271|FG001|Study Extension 1|Physician Decision|2|||
145669345|NCT02397096|525308270|FG000|Study Extension 1|Pregnancy|1|||
145669346|NCT02397096|525308271|FG001|Study Extension 1|Pregnancy|0|||
145669347|NCT02397096|525308270|FG000|Study Extension 1|Protocol Violation|0|||
145669348|NCT02397096|525308271|FG001|Study Extension 1|Protocol Violation|1|||
145669349|NCT02397096|525308270|FG000|Study Extension 1|Withdrawal by Subject|21|||
145669350|NCT02397096|525308271|FG001|Study Extension 1|Withdrawal by Subject|7|||
145669351|NCT02397096|525308270|FG000|Study Extension 2|Adverse Event|3|||
145669352|NCT02397096|525308271|FG001|Study Extension 2|Adverse Event|3|||
145669353|NCT02397096|525308270|FG000|Study Extension 2|Availability of study medication locally|152|||
145669354|NCT02397096|525308271|FG001|Study Extension 2|Availability of study medication locally|64|||
145669355|NCT02397096|525308270|FG000|Study Extension 2|Death|2|||
145669356|NCT02397096|525308271|FG001|Study Extension 2|Death|0|||
145669357|NCT02397096|525308270|FG000|Study Extension 2|Lack of Efficacy|1|||
145669358|NCT02397096|525308271|FG001|Study Extension 2|Lack of Efficacy|0|||
145669359|NCT02397096|525308270|FG000|Study Extension 2|Lost to Follow-up|2|||
145669360|NCT02397096|525308271|FG001|Study Extension 2|Lost to Follow-up|1|||
145669361|NCT02397096|525308270|FG000|Study Extension 2|Non-compliance with study drug|1|||
145669362|NCT02397096|525308271|FG001|Study Extension 2|Non-compliance with study drug|0|||
145669363|NCT02397096|525308270|FG000|Study Extension 2|Physician Decision|2|||
145669364|NCT02397096|525308271|FG001|Study Extension 2|Physician Decision|5|||
145669365|NCT02397096|525308270|FG000|Study Extension 2|Pregnancy|1|||
145669366|NCT02397096|525308271|FG001|Study Extension 2|Pregnancy|0|||
145669367|NCT02397096|525308270|FG000|Study Extension 2|Withdrawal by Subject|10|||
145669368|NCT02397096|525308271|FG001|Study Extension 2|Withdrawal by Subject|3|||
145669369|NCT02397096|525308270|FG000|Study Extension 3|Adverse Event|1|||
145669370|NCT02397096|525308271|FG001|Study Extension 3|Adverse Event|0|||
145669371|NCT02397096|525308270|FG000|Study Extension 3|Availability of study medication locally|11|||
145669372|NCT02397096|525308271|FG001|Study Extension 3|Availability of study medication locally|3|||
145669373|NCT02397096|525308270|FG000|Study Extension 3|Lost to Follow-up|1|||
145669374|NCT02397096|525308271|FG001|Study Extension 3|Lost to Follow-up|0|||
145669375|NCT02397096|525308270|FG000|Study Extension 3|Withdrawal by Subject|2|||
145669376|NCT02397096|525308271|FG001|Study Extension 3|Withdrawal by Subject|1|||
145669377|NCT03840902|525308272|FG000|Overall Study|Randomized but not treated|1|||
145669378|NCT03840902|525308273|FG001|Overall Study|Randomized but not treated|1|||
145669379|NCT06688357|525308275|FG000|Overall Study|Adverse Event|0|||
145669380|NCT06688357|525308276|FG001|Overall Study|Adverse Event|1|||
145669381|NCT05139992|525308279|FG000|Overall Study|Withdrawal by Subject|12|||
145669382|NCT05139992|525308279|FG000|Overall Study|Lost to Follow-up|6|||
145669383|NCT04517435|525308296|FG000|Overall Study|Withdrawal by Subject|0|||
145669384|NCT04517435|525308297|FG001|Overall Study|Withdrawal by Subject|0|||
145669385|NCT04517435|525308298|FG002|Overall Study|Withdrawal by Subject|1|||
145669386|NCT04517435|525308296|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
145669387|NCT04517435|525308297|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
145669388|NCT04517435|525308298|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
145669389|NCT06191679|525308299|FG000|Baseline|Lost to Follow-up|1|||
145669390|NCT06191679|525308300|FG001|Baseline|Lost to Follow-up|0|||
145669391|NCT06191679|525308301|FG002|Baseline|Lost to Follow-up|1|||
145669392|NCT06191679|525308302|FG003|Baseline|Lost to Follow-up|0|||
145669393|NCT06191679|525308299|FG000|Allocation to Group|Withdrawal by Subject|0|||
145669394|NCT06191679|525308300|FG001|Allocation to Group|Withdrawal by Subject|1|||
145669395|NCT06191679|525308301|FG002|Allocation to Group|Withdrawal by Subject|2|||
145669396|NCT06191679|525308302|FG003|Allocation to Group|Withdrawal by Subject|0|||
145669397|NCT06191679|525308299|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
145669398|NCT06191679|525308300|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
145669399|NCT06191679|525308301|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
145669400|NCT06191679|525308302|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
145669401|NCT06191679|525308299|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
145669402|NCT06191679|525308300|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
145669403|NCT06191679|525308301|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
145669404|NCT06191679|525308302|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
145669405|NCT06191679|525308299|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
145669406|NCT06191679|525308300|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
145669407|NCT06191679|525308301|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
145669408|NCT06191679|525308302|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
145669409|NCT02415127|525308303|FG000|Overall Study|Adverse Event|1|||
145669410|NCT02415127|525308304|FG001|Overall Study|Adverse Event|0|||
145669411|NCT00545545|525308305|FG000|Overall Study|Progressive Neoplastic Disease|1|||
145669412|NCT00545545|525308306|FG001|Overall Study|Progressive Neoplastic Disease|5|||
145669413|NCT00545545|525308307|FG002|Overall Study|Progressive Neoplastic Disease|0|||
145669414|NCT00545545|525308308|FG003|Overall Study|Progressive Neoplastic Disease|4|||
145669415|NCT00545545|525308309|FG004|Overall Study|Progressive Neoplastic Disease|8|||
145669416|NCT00545545|525308310|FG005|Overall Study|Progressive Neoplastic Disease|7|||
145669417|NCT00545545|525308305|FG000|Overall Study|Withdrawal by Subject|0|||
145669418|NCT00545545|525308306|FG001|Overall Study|Withdrawal by Subject|1|||
145669419|NCT00545545|525308307|FG002|Overall Study|Withdrawal by Subject|0|||
145669420|NCT00545545|525308308|FG003|Overall Study|Withdrawal by Subject|0|||
145669421|NCT00545545|525308309|FG004|Overall Study|Withdrawal by Subject|0|||
145669422|NCT00545545|525308310|FG005|Overall Study|Withdrawal by Subject|0|||
145669423|NCT00545545|525308305|FG000|Overall Study|Physician Decision|1|||
145669424|NCT00545545|525308306|FG001|Overall Study|Physician Decision|0|||
145669425|NCT00545545|525308307|FG002|Overall Study|Physician Decision|0|||
145669426|NCT00545545|525308308|FG003|Overall Study|Physician Decision|0|||
145669427|NCT00545545|525308309|FG004|Overall Study|Physician Decision|0|||
145669428|NCT00545545|525308310|FG005|Overall Study|Physician Decision|1|||
145669429|NCT00545545|525308305|FG000|Overall Study|Irinotecan intolerance|1|||
145669430|NCT00545545|525308306|FG001|Overall Study|Irinotecan intolerance|1|||
145669431|NCT00545545|525308307|FG002|Overall Study|Irinotecan intolerance|0|||
145669432|NCT00545545|525308308|FG003|Overall Study|Irinotecan intolerance|0|||
145669433|NCT00545545|525308309|FG004|Overall Study|Irinotecan intolerance|0|||
145669434|NCT00545545|525308310|FG005|Overall Study|Irinotecan intolerance|0|||
145669435|NCT00545545|525308305|FG000|Overall Study|No target lesions to track post surgery|0|||
145669436|NCT00545545|525308306|FG001|Overall Study|No target lesions to track post surgery|0|||
145669437|NCT00545545|525308307|FG002|Overall Study|No target lesions to track post surgery|0|||
145669438|NCT00545545|525308308|FG003|Overall Study|No target lesions to track post surgery|0|||
145669439|NCT00545545|525308309|FG004|Overall Study|No target lesions to track post surgery|1|||
145669440|NCT00545545|525308310|FG005|Overall Study|No target lesions to track post surgery|1|||
145669441|NCT02678689|525308311|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
145669442|NCT02678689|525308312|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
145669443|NCT02549352|525308313|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
145669444|NCT02549352|525308314|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
145669445|NCT02549352|525308313|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
145669446|NCT02549352|525308314|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
145669447|NCT02549352|525308313|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
145669448|NCT02549352|525308314|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
145669449|NCT02549352|525308313|FG000|12-month Follow-up|Withdrawal by Subject|4|||
145669450|NCT02549352|525308314|FG001|12-month Follow-up|Withdrawal by Subject|5|||
145669451|NCT02549352|525308313|FG000|12-month Follow-up|Lost to Follow-up|3|||
145669452|NCT02549352|525308314|FG001|12-month Follow-up|Lost to Follow-up|2|||
145669453|NCT02549352|525308313|FG000|12-month Follow-up|Death|0|||
145669454|NCT02549352|525308314|FG001|12-month Follow-up|Death|1|||
145669455|NCT02549352|525308313|FG000|12-month Follow-up|Protocol Violation|0|||
145669456|NCT02549352|525308314|FG001|12-month Follow-up|Protocol Violation|1|||
145669457|NCT02549352|525308313|FG000|12-month Follow-up|Other|1|||
145669458|NCT02549352|525308314|FG001|12-month Follow-up|Other|3|||
145669459|NCT03459196|525309900|FG000|Overall Study|Subject didn't receive study catheter|2|||
145669460|NCT04503681|525309903|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
145669461|NCT04503681|525309904|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
145669462|NCT03752684|525309905|FG000|Overall Study|Lost to Follow-up|4|||
145669463|NCT03352713|525309908|FG000|Overall Study|Lost to Follow-up|8|||
145669464|NCT03352713|525309908|FG000|Overall Study|Withdrawn by investigator|5|||
145669465|NCT03352713|525309908|FG000|Overall Study|Completed 0 EMAs|8|||
145669466|NCT03352713|525309908|FG000|Overall Study|Device incompatible/stolen|5|||
145669467|NCT01812759|525309909|FG000|Overall Study|Physician Decision|0|||
145669468|NCT01812759|525309910|FG001|Overall Study|Physician Decision|0|||
145669469|NCT01812759|525309911|FG002|Overall Study|Physician Decision|1|||
145669470|NCT04989816|525309912|FG000|Overall Study|Death|77|||
145669471|NCT04989816|525309912|FG000|Overall Study|Lost to Follow-up|3|||
145669472|NCT04213807|525309914|FG000|Overall Study|Physician Decision|0|||
145669473|NCT04213807|525309915|FG001|Overall Study|Physician Decision|0|||
145669474|NCT04213807|525309916|FG002|Overall Study|Physician Decision|1|||
145669475|NCT03801148|525309917|FG000|Period 1 (2 Days)|Adverse Event|1|||
145669476|NCT03801148|525309918|FG001|Period 1 (2 Days)|Adverse Event|1|||
145669477|NCT03801148|525309919|FG002|Period 1 (2 Days)|Adverse Event|0|||
145669478|NCT03801148|525309920|FG003|Period 1 (2 Days)|Adverse Event|0|||
145669479|NCT03801148|525309917|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
145669480|NCT03801148|525309918|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
145669481|NCT03801148|525309919|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
145669482|NCT03801148|525309920|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
145669483|NCT03801148|525309917|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145669484|NCT03801148|525309918|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145669485|NCT03801148|525309919|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
145490842|NCT02313766|524652227|FG001|Overall Study|surgery cancelled|0|||
145490843|NCT02313766|524652228|FG002|Overall Study|surgery cancelled|0|||
145669486|NCT03801148|525309920|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
145669487|NCT03801148|525309917|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
145669488|NCT03801148|525309918|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
145669489|NCT03801148|525309919|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
145669490|NCT03801148|525309920|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
145669491|NCT00372775|525309921|FG000|Overall Study|Adverse Event|8|||
145669492|NCT00372775|525309921|FG000|Overall Study|Death|15|||
145669493|NCT00372775|525309921|FG000|Overall Study|Objective progression or relapse|30|||
145669494|NCT00372775|525309921|FG000|Overall Study|Global deterioration of health status|6|||
145669495|NCT00372775|525309921|FG000|Overall Study|Withdrawal by Subject|1|||
145669496|NCT00372775|525309921|FG000|Overall Study|Other|1|||
145669497|NCT00372775|525309921|FG000|Overall Study|Not Treated|2|||
145669498|NCT01750684|525309922|FG000|Overall Study|Death|1|||
145669499|NCT01750684|525309923|FG001|Overall Study|Death|0|||
145669500|NCT01750684|525309922|FG000|Overall Study|Non-compliance with Study Drug|0|||
145669501|NCT01750684|525309923|FG001|Overall Study|Non-compliance with Study Drug|1|||
145669502|NCT01750684|525309922|FG000|Overall Study|Withdrawn by Sponsor|0|||
145669503|NCT01750684|525309923|FG001|Overall Study|Withdrawn by Sponsor|1|||
145669504|NCT01750684|525309922|FG000|Overall Study|Protocol Violation|1|||
145669505|NCT01750684|525309923|FG001|Overall Study|Protocol Violation|0|||
145669506|NCT02185794|525309926|FG000|Overall Study|Enrolled but Never Dosed|1|||
145669507|NCT02185794|525309927|FG001|Overall Study|Enrolled but Never Dosed|6|||
145669508|NCT02185794|525309928|FG002|Overall Study|Enrolled but Never Dosed|3|||
145669509|NCT02185794|525309929|FG003|Overall Study|Enrolled but Never Dosed|1|||
145669510|NCT02185794|525309930|FG004|Overall Study|Enrolled but Never Dosed|1|||
145669511|NCT02185794|525309931|FG005|Overall Study|Enrolled but Never Dosed|0|||
145669512|NCT02185794|525309926|FG000|Overall Study|Investigator's Discretion|1|||
145669513|NCT02185794|525309927|FG001|Overall Study|Investigator's Discretion|0|||
145669514|NCT02185794|525309928|FG002|Overall Study|Investigator's Discretion|1|||
145669515|NCT02185794|525309929|FG003|Overall Study|Investigator's Discretion|2|||
145669516|NCT02185794|525309930|FG004|Overall Study|Investigator's Discretion|2|||
145669517|NCT02185794|525309931|FG005|Overall Study|Investigator's Discretion|15|||
145669518|NCT02185794|525309926|FG000|Overall Study|Withdrew Consent|2|||
145669519|NCT02185794|525309927|FG001|Overall Study|Withdrew Consent|5|||
145669520|NCT02185794|525309928|FG002|Overall Study|Withdrew Consent|10|||
145669521|NCT02185794|525309929|FG003|Overall Study|Withdrew Consent|2|||
145669522|NCT02185794|525309930|FG004|Overall Study|Withdrew Consent|0|||
145669523|NCT02185794|525309931|FG005|Overall Study|Withdrew Consent|0|||
145669524|NCT02185794|525309926|FG000|Overall Study|Lost to Follow-up|1|||
145669525|NCT02185794|525309927|FG001|Overall Study|Lost to Follow-up|2|||
145669526|NCT02185794|525309928|FG002|Overall Study|Lost to Follow-up|2|||
145669527|NCT02185794|525309929|FG003|Overall Study|Lost to Follow-up|3|||
145669528|NCT02185794|525309930|FG004|Overall Study|Lost to Follow-up|0|||
145669529|NCT02185794|525309931|FG005|Overall Study|Lost to Follow-up|1|||
145669530|NCT00336505|525309932|FG000|Overall Study|Adverse Event|10|||
145669531|NCT00336505|525309933|FG001|Overall Study|Adverse Event|9|||
145669532|NCT00336505|525309932|FG000|Overall Study|Lack of Efficacy|8|||
145669533|NCT00336505|525309933|FG001|Overall Study|Lack of Efficacy|4|||
145669534|NCT00336505|525309932|FG000|Overall Study|Lost to Follow-up|7|||
145669535|NCT00336505|525309933|FG001|Overall Study|Lost to Follow-up|4|||
145669536|NCT00336505|525309932|FG000|Overall Study|Withdrawal by Subject|5|||
145669537|NCT00336505|525309933|FG001|Overall Study|Withdrawal by Subject|3|||
145669538|NCT00336505|525309932|FG000|Overall Study|Other|7|||
145669539|NCT00336505|525309933|FG001|Overall Study|Other|7|||
145669540|NCT01092416|525309934|FG000|Enrollment|Atherectomy device not inserted|3|||
145669541|NCT01092416|525309934|FG000|30-Day Follow-up|Death|2|||
145669542|NCT01092416|525309934|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
145669543|NCT01092416|525309934|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
145669544|NCT01092416|525309934|FG000|12-Month Follow-up|Death|16|||
145669545|NCT01092416|525309934|FG000|12-Month Follow-up|Lost to Follow-up|4|||
145669546|NCT01092416|525309934|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
145669547|NCT01092416|525309934|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
145669548|NCT01092416|525309934|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
145669549|NCT00366249|525309935|FG000|Overall Study|Adverse Event|53|||
145669550|NCT00366249|525309936|FG001|Overall Study|Adverse Event|28|||
145669551|NCT00366249|525309935|FG000|Overall Study|Death|0|||
145669552|NCT00366249|525309936|FG001|Overall Study|Death|1|||
145669553|NCT00366249|525309935|FG000|Overall Study|Physician Decision|5|||
145669554|NCT00366249|525309936|FG001|Overall Study|Physician Decision|2|||
145669555|NCT00366249|525309935|FG000|Overall Study|Lost to Follow-up|2|||
145265400|NCT05437211|523819347|FG001|Overall Study|Patient's decision|1|||
145669556|NCT00366249|525309936|FG001|Overall Study|Lost to Follow-up|0|||
145669557|NCT00366249|525309935|FG000|Overall Study|Protocol Violation|1|||
145669558|NCT00366249|525309936|FG001|Overall Study|Protocol Violation|2|||
145669559|NCT00366249|525309935|FG000|Overall Study|Withdrawal by Subject|18|||
145669560|NCT00366249|525309936|FG001|Overall Study|Withdrawal by Subject|4|||
145669561|NCT00366249|525309935|FG000|Overall Study|Lack of Efficacy|21|||
145669562|NCT00366249|525309936|FG001|Overall Study|Lack of Efficacy|21|||
145669563|NCT00366249|525309935|FG000|Overall Study|Most due to osteomylitis status|31|||
145669564|NCT00366249|525309936|FG001|Overall Study|Most due to osteomylitis status|20|||
145669565|NCT00739934|525309945|FG000|Voriconazole IV|Adverse Event|6|||
145669566|NCT00739934|525309945|FG000|Voriconazole Oral|Other|3|||
145669567|NCT03418922|525309946|FG000|Overall Study|Withdrawal by Subject|0|||
145669568|NCT03418922|525309947|FG001|Overall Study|Withdrawal by Subject|2|||
145669569|NCT03418922|525309946|FG000|Overall Study|Adverse Event|2|||
145669570|NCT03418922|525309947|FG001|Overall Study|Adverse Event|2|||
145669571|NCT03418922|525309946|FG000|Overall Study|Death|0|||
145669572|NCT03418922|525309947|FG001|Overall Study|Death|1|||
145669573|NCT03418922|525309946|FG000|Overall Study|Physician Decision|0|||
145669574|NCT03418922|525309947|FG001|Overall Study|Physician Decision|1|||
145669575|NCT03577106|525309948|FG000|Overall Study|Withdrawal by Subject|3|||
145669576|NCT01579318|525309949|FG000|Overall Study|Disease Progression|1|||
145669577|NCT02347332|525309952|FG000|Overall Study|Not treated|5|||
145669578|NCT02347332|525309953|FG001|Overall Study|Not treated|2|||
145669579|NCT02347332|525309952|FG000|Overall Study|Progressive disease|141|||
145669580|NCT02347332|525309953|FG001|Overall Study|Progressive disease|159|||
145669581|NCT02347332|525309952|FG000|Overall Study|Adverse Event|50|||
145669582|NCT02347332|525309953|FG001|Overall Study|Adverse Event|41|||
145669583|NCT02347332|525309952|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
145669584|NCT02347332|525309953|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
145669585|NCT02347332|525309952|FG000|Overall Study|Protocol Violation|1|||
145669586|NCT02347332|525309953|FG001|Overall Study|Protocol Violation|1|||
145669587|NCT02347332|525309952|FG000|Overall Study|Lost to Follow-up|2|||
145669588|NCT02347332|525309953|FG001|Overall Study|Lost to Follow-up|1|||
145669589|NCT02347332|525309952|FG000|Overall Study|Physician Decision|4|||
145669590|NCT02347332|525309953|FG001|Overall Study|Physician Decision|3|||
145669591|NCT02347332|525309952|FG000|Overall Study|Withdrawal by Subject|20|||
145669592|NCT02347332|525309953|FG001|Overall Study|Withdrawal by Subject|14|||
145669593|NCT02347332|525309952|FG000|Overall Study|Protocol requirement|1|||
145669594|NCT02347332|525309953|FG001|Overall Study|Protocol requirement|1|||
145669595|NCT02347332|525309952|FG000|Overall Study|Switch Post-Trial program|0|||
145669596|NCT02347332|525309953|FG001|Overall Study|Switch Post-Trial program|1|||
145669597|NCT01970007|525309955|FG000|Overall Study|Death|5|||
145669598|NCT01970007|525309955|FG000|Overall Study|Withdrawal by Subject|23|||
145669599|NCT01970007|525309955|FG000|Overall Study|Lost to Follow-up|24|||
145669600|NCT01970007|525309955|FG000|Overall Study|"Other endpoint"|3|||
145669601|NCT03802994|525309956|FG000|Overall Study|Lost to Follow-up|0|||
145669602|NCT03802994|525309957|FG001|Overall Study|Lost to Follow-up|2|||
145669603|NCT03802994|525309958|FG002|Overall Study|Lost to Follow-up|3|||
145669604|NCT03802994|525309959|FG003|Overall Study|Lost to Follow-up|2|||
145669605|NCT03802994|525309960|FG004|Overall Study|Lost to Follow-up|2|||
145669606|NCT03611556|525309961|FG000|Overall Study|Death|7|||
145669607|NCT03611556|525309962|FG001|Overall Study|Death|7|||
145669608|NCT03611556|525309963|FG002|Overall Study|Death|3|||
145669609|NCT03611556|525309964|FG003|Overall Study|Death|8|||
145669610|NCT03611556|525309965|FG004|Overall Study|Death|47|||
145669611|NCT03611556|525309966|FG005|Overall Study|Death|32|||
145669612|NCT03611556|525309967|FG006|Overall Study|Death|53|||
145669613|NCT03611556|525309961|FG000|Overall Study|Withdrawal by Subject|0|||
145669614|NCT03611556|525309962|FG001|Overall Study|Withdrawal by Subject|0|||
145669615|NCT03611556|525309963|FG002|Overall Study|Withdrawal by Subject|0|||
145669616|NCT03611556|525309964|FG003|Overall Study|Withdrawal by Subject|0|||
145669617|NCT03611556|525309965|FG004|Overall Study|Withdrawal by Subject|4|||
145669618|NCT03611556|525309966|FG005|Overall Study|Withdrawal by Subject|2|||
145669619|NCT03611556|525309967|FG006|Overall Study|Withdrawal by Subject|4|||
145669620|NCT03611556|525309961|FG000|Overall Study|Sponsor decision|0|||
145669621|NCT03611556|525309962|FG001|Overall Study|Sponsor decision|0|||
145669622|NCT03611556|525309963|FG002|Overall Study|Sponsor decision|0|||
145669623|NCT03611556|525309964|FG003|Overall Study|Sponsor decision|0|||
145669624|NCT03611556|525309965|FG004|Overall Study|Sponsor decision|9|||
145669625|NCT03611556|525309966|FG005|Overall Study|Sponsor decision|4|||
145669626|NCT03611556|525309967|FG006|Overall Study|Sponsor decision|12|||
145669627|NCT03611556|525309961|FG000|Overall Study|Reasons|0|||
145669628|NCT03611556|525309962|FG001|Overall Study|Reasons|0|||
145669629|NCT03611556|525309963|FG002|Overall Study|Reasons|0|||
145669630|NCT03611556|525309964|FG003|Overall Study|Reasons|0|||
145669631|NCT03611556|525309965|FG004|Overall Study|Reasons|2|||
145669632|NCT03611556|525309966|FG005|Overall Study|Reasons|0|||
145669633|NCT03611556|525309967|FG006|Overall Study|Reasons|1|||
145669634|NCT02844439|525309969|FG000|Overall Study|Withdrawal by Subject|1|||
145669635|NCT02844439|525309969|FG000|Overall Study|Lost to Follow-up|2|||
145669636|NCT02844439|525309969|FG000|Overall Study|Termination by Sponsor|4|||
145669637|NCT02844439|525309969|FG000|Overall Study|Death|28|||
145669638|NCT02844439|525309969|FG000|Overall Study|Other|5|||
145669639|NCT02646618|525309970|FG000|Overall Study|Lost to Follow-up|10|||
145669640|NCT02646618|525309971|FG001|Overall Study|Lost to Follow-up|14|||
145669641|NCT05580003|525309975|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669642|NCT05580003|525309976|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669643|NCT05580003|525309977|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669644|NCT05580003|525309978|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669645|NCT05580003|525309979|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669646|NCT05580003|525309980|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669647|NCT05580003|525309981|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
145669648|NCT05580003|525309982|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669649|NCT05580003|525309983|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669650|NCT05580003|525309984|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669651|NCT05580003|525309985|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669652|NCT05580003|525309986|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669653|NCT05580003|525309987|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669654|NCT05580003|525309988|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669655|NCT05580003|525309989|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669656|NCT05580003|525309990|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669657|NCT05580003|525309991|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669658|NCT05580003|525309992|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669659|NCT05580003|525309993|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669660|NCT05580003|525309994|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669661|NCT05580003|525309995|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669662|NCT05580003|525309996|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669663|NCT05580003|525309997|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669664|NCT05580003|525309998|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669665|NCT05580003|525309999|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669666|NCT05580003|525310000|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669667|NCT05580003|525310001|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669668|NCT05580003|525310002|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
145669669|NCT05580003|525309975|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669670|NCT05580003|525309976|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669671|NCT05580003|525309977|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669672|NCT05580003|525309978|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669673|NCT05580003|525309979|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669674|NCT05580003|525309980|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
145669675|NCT05580003|525309981|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669676|NCT05580003|525309982|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669677|NCT05580003|525309983|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669678|NCT05580003|525309984|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669679|NCT05580003|525309985|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669680|NCT05580003|525309986|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669681|NCT05580003|525309987|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669682|NCT05580003|525309988|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669683|NCT05580003|525309989|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669684|NCT05580003|525309990|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669685|NCT05580003|525309991|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669686|NCT05580003|525309992|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669687|NCT05580003|525309993|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669688|NCT05580003|525309994|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669689|NCT05580003|525309995|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669690|NCT05580003|525309996|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669691|NCT05580003|525309997|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669692|NCT05580003|525309998|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669693|NCT05580003|525309999|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669694|NCT05580003|525310000|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669695|NCT05580003|525310001|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669696|NCT05580003|525310002|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
145669697|NCT05580003|525309975|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669698|NCT05580003|525309976|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669699|NCT05580003|525309977|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669700|NCT05580003|525309978|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
145669701|NCT05580003|525309979|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669702|NCT05580003|525309980|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669703|NCT05580003|525309981|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669704|NCT05580003|525309982|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669705|NCT05580003|525309983|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669706|NCT05580003|525309984|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669707|NCT05580003|525309985|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669708|NCT05580003|525309986|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669709|NCT05580003|525309987|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669710|NCT05580003|525309988|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669711|NCT05580003|525309989|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669712|NCT05580003|525309990|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669713|NCT05580003|525309991|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669714|NCT05580003|525309992|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669715|NCT05580003|525309993|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669716|NCT05580003|525309994|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669717|NCT05580003|525309995|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669718|NCT05580003|525309996|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669719|NCT05580003|525309997|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669720|NCT05580003|525309998|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669721|NCT05580003|525309999|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669722|NCT05580003|525310000|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669723|NCT05580003|525310001|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669724|NCT05580003|525310002|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
145669725|NCT05580003|525309975|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669726|NCT05580003|525309976|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
145669727|NCT05580003|525309977|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669728|NCT05580003|525309978|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669729|NCT05580003|525309979|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669730|NCT05580003|525309980|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669731|NCT05580003|525309981|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669732|NCT05580003|525309982|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669733|NCT05580003|525309983|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669734|NCT05580003|525309984|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669735|NCT05580003|525309985|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669736|NCT05580003|525309986|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669737|NCT05580003|525309987|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669738|NCT05580003|525309988|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669739|NCT05580003|525309989|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669740|NCT05580003|525309990|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669741|NCT05580003|525309991|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669742|NCT05580003|525309992|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669743|NCT05580003|525309993|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669744|NCT05580003|525309994|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669745|NCT05580003|525309995|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669746|NCT05580003|525309996|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669747|NCT05580003|525309997|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669748|NCT05580003|525309998|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669749|NCT05580003|525309999|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669750|NCT05580003|525310000|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669751|NCT05580003|525310001|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669752|NCT05580003|525310002|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
145669753|NCT05580003|525309975|FG000|Part 2 (up to 10 Days)|Other|0|||
145669754|NCT05580003|525309976|FG001|Part 2 (up to 10 Days)|Other|0|||
145669755|NCT05580003|525309977|FG002|Part 2 (up to 10 Days)|Other|0|||
145669756|NCT05580003|525309978|FG003|Part 2 (up to 10 Days)|Other|0|||
145669757|NCT05580003|525309979|FG004|Part 2 (up to 10 Days)|Other|0|||
145669758|NCT05580003|525309980|FG005|Part 2 (up to 10 Days)|Other|0|||
145669759|NCT05580003|525309981|FG006|Part 2 (up to 10 Days)|Other|0|||
145669760|NCT05580003|525309982|FG007|Part 2 (up to 10 Days)|Other|0|||
145669761|NCT05580003|525309983|FG008|Part 2 (up to 10 Days)|Other|0|||
145669762|NCT05580003|525309984|FG009|Part 2 (up to 10 Days)|Other|1|||
145669763|NCT05580003|525309985|FG010|Part 2 (up to 10 Days)|Other|0|||
145669764|NCT05580003|525309986|FG011|Part 2 (up to 10 Days)|Other|0|||
145669765|NCT05580003|525309987|FG012|Part 2 (up to 10 Days)|Other|0|||
145669766|NCT05580003|525309988|FG013|Part 2 (up to 10 Days)|Other|0|||
145669767|NCT05580003|525309989|FG014|Part 2 (up to 10 Days)|Other|0|||
145669768|NCT05580003|525309990|FG015|Part 2 (up to 10 Days)|Other|0|||
145669769|NCT05580003|525309991|FG016|Part 2 (up to 10 Days)|Other|0|||
145669770|NCT05580003|525309992|FG017|Part 2 (up to 10 Days)|Other|0|||
145669771|NCT05580003|525309993|FG018|Part 2 (up to 10 Days)|Other|0|||
145669772|NCT05580003|525309994|FG019|Part 2 (up to 10 Days)|Other|0|||
145669773|NCT05580003|525309995|FG020|Part 2 (up to 10 Days)|Other|0|||
145669774|NCT05580003|525309996|FG021|Part 2 (up to 10 Days)|Other|0|||
145669775|NCT05580003|525309997|FG022|Part 2 (up to 10 Days)|Other|0|||
145669776|NCT05580003|525309998|FG023|Part 2 (up to 10 Days)|Other|0|||
145669777|NCT05580003|525309999|FG024|Part 2 (up to 10 Days)|Other|0|||
145669778|NCT05580003|525310000|FG025|Part 2 (up to 10 Days)|Other|0|||
145669779|NCT05580003|525310001|FG026|Part 2 (up to 10 Days)|Other|0|||
145669780|NCT05580003|525310002|FG027|Part 2 (up to 10 Days)|Other|0|||
145490844|NCT02313766|524652226|FG000|Overall Study|Lost to Follow-up|0|||
145490845|NCT02313766|524652227|FG001|Overall Study|Lost to Follow-up|2|||
145669781|NCT05580003|525309975|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669782|NCT05580003|525309976|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669783|NCT05580003|525309977|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669784|NCT05580003|525309978|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669785|NCT05580003|525309979|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669786|NCT05580003|525309980|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669787|NCT05580003|525309981|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669788|NCT05580003|525309982|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669789|NCT05580003|525309983|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669790|NCT05580003|525309984|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669791|NCT05580003|525309985|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669792|NCT05580003|525309986|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669793|NCT05580003|525309987|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669794|NCT05580003|525309988|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669795|NCT05580003|525309989|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669796|NCT05580003|525309990|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669797|NCT05580003|525309991|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669798|NCT05580003|525309992|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669799|NCT05580003|525309993|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669800|NCT05580003|525309994|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
145669801|NCT05580003|525309995|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669802|NCT05580003|525309996|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669803|NCT05580003|525309997|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669804|NCT05580003|525309998|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669805|NCT05580003|525309999|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669806|NCT05580003|525310000|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669807|NCT05580003|525310001|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669808|NCT05580003|525310002|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
145669809|NCT05580003|525309975|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669810|NCT05580003|525309976|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669811|NCT05580003|525309977|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669812|NCT05580003|525309978|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669813|NCT05580003|525309979|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669814|NCT05580003|525309980|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669815|NCT05580003|525309981|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669816|NCT05580003|525309982|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669817|NCT05580003|525309983|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669818|NCT05580003|525309984|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669819|NCT05580003|525309985|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669820|NCT05580003|525309986|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669821|NCT05580003|525309987|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669822|NCT05580003|525309988|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669823|NCT05580003|525309989|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669824|NCT05580003|525309990|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669825|NCT05580003|525309991|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669826|NCT05580003|525309992|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669827|NCT05580003|525309993|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669828|NCT05580003|525309994|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669829|NCT05580003|525309995|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
145669830|NCT05580003|525309996|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669831|NCT05580003|525309997|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669832|NCT05580003|525309998|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669833|NCT05580003|525309999|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669834|NCT05580003|525310000|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669835|NCT05580003|525310001|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669836|NCT05580003|525310002|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
145669837|NCT05580003|525309975|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669838|NCT05580003|525309976|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669839|NCT05580003|525309977|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669840|NCT05580003|525309978|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669841|NCT05580003|525309979|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669842|NCT05580003|525309980|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669843|NCT05580003|525309981|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669844|NCT05580003|525309982|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669845|NCT05580003|525309983|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669846|NCT05580003|525309984|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669847|NCT05580003|525309985|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669848|NCT05580003|525309986|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669849|NCT05580003|525309987|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669850|NCT05580003|525309988|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669851|NCT05580003|525309989|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669852|NCT05580003|525309990|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669853|NCT05580003|525309991|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669854|NCT05580003|525309992|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669855|NCT05580003|525309993|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669856|NCT05580003|525309994|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669857|NCT05580003|525309995|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669858|NCT05580003|525309996|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
145669859|NCT05580003|525309997|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669860|NCT05580003|525309998|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669861|NCT05580003|525309999|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669862|NCT05580003|525310000|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669863|NCT05580003|525310001|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669864|NCT05580003|525310002|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
145669865|NCT05580003|525309975|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669866|NCT05580003|525309976|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669867|NCT05580003|525309977|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669868|NCT05580003|525309978|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669869|NCT05580003|525309979|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669870|NCT05580003|525309980|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669871|NCT05580003|525309981|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669872|NCT05580003|525309982|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669873|NCT05580003|525309983|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669874|NCT05580003|525309984|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669875|NCT05580003|525309985|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669876|NCT05580003|525309986|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669877|NCT05580003|525309987|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669878|NCT05580003|525309988|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669879|NCT05580003|525309989|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669880|NCT05580003|525309990|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669881|NCT05580003|525309991|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669882|NCT05580003|525309992|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669883|NCT05580003|525309993|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669884|NCT05580003|525309994|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669885|NCT05580003|525309995|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669886|NCT05580003|525309996|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669887|NCT05580003|525309997|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669888|NCT05580003|525309998|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669889|NCT05580003|525309999|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669890|NCT05580003|525310000|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669891|NCT05580003|525310001|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
145669892|NCT05580003|525310002|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
145669893|NCT05580003|525309975|FG000|Part 6 Period 2 (Day 1)|Other|0|||
145669894|NCT05580003|525309976|FG001|Part 6 Period 2 (Day 1)|Other|0|||
145669895|NCT05580003|525309977|FG002|Part 6 Period 2 (Day 1)|Other|0|||
145669896|NCT05580003|525309978|FG003|Part 6 Period 2 (Day 1)|Other|0|||
145669897|NCT05580003|525309979|FG004|Part 6 Period 2 (Day 1)|Other|0|||
145669898|NCT05580003|525309980|FG005|Part 6 Period 2 (Day 1)|Other|0|||
145669899|NCT05580003|525309981|FG006|Part 6 Period 2 (Day 1)|Other|0|||
145669900|NCT05580003|525309982|FG007|Part 6 Period 2 (Day 1)|Other|0|||
145669901|NCT05580003|525309983|FG008|Part 6 Period 2 (Day 1)|Other|0|||
145669902|NCT05580003|525309984|FG009|Part 6 Period 2 (Day 1)|Other|0|||
145669903|NCT05580003|525309985|FG010|Part 6 Period 2 (Day 1)|Other|0|||
145669904|NCT05580003|525309986|FG011|Part 6 Period 2 (Day 1)|Other|0|||
145669905|NCT05580003|525309987|FG012|Part 6 Period 2 (Day 1)|Other|0|||
145669906|NCT05580003|525309988|FG013|Part 6 Period 2 (Day 1)|Other|0|||
145669907|NCT05580003|525309989|FG014|Part 6 Period 2 (Day 1)|Other|0|||
145669908|NCT05580003|525309990|FG015|Part 6 Period 2 (Day 1)|Other|0|||
145669909|NCT05580003|525309991|FG016|Part 6 Period 2 (Day 1)|Other|0|||
145669910|NCT05580003|525309992|FG017|Part 6 Period 2 (Day 1)|Other|0|||
145669911|NCT05580003|525309993|FG018|Part 6 Period 2 (Day 1)|Other|0|||
145669912|NCT05580003|525309994|FG019|Part 6 Period 2 (Day 1)|Other|0|||
145669913|NCT05580003|525309995|FG020|Part 6 Period 2 (Day 1)|Other|0|||
145669914|NCT05580003|525309996|FG021|Part 6 Period 2 (Day 1)|Other|0|||
145669915|NCT05580003|525309997|FG022|Part 6 Period 2 (Day 1)|Other|0|||
145669916|NCT05580003|525309998|FG023|Part 6 Period 2 (Day 1)|Other|0|||
145669917|NCT05580003|525309999|FG024|Part 6 Period 2 (Day 1)|Other|1|||
145669918|NCT05580003|525310000|FG025|Part 6 Period 2 (Day 1)|Other|0|||
145669919|NCT05580003|525310001|FG026|Part 6 Period 2 (Day 1)|Other|0|||
145669920|NCT05580003|525310002|FG027|Part 6 Period 2 (Day 1)|Other|0|||
145669921|NCT03500549|525310003|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
145669922|NCT03500549|525310004|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
145669923|NCT03500549|525310003|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
145669924|NCT03500549|525310004|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
145669925|NCT01738438|525310008|FG000|Overall Study|Disease Progression|32|||
145669926|NCT01738438|525310008|FG000|Overall Study|Adverse Event|3|||
145669927|NCT00918203|525310012|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
145669928|NCT00918203|525310013|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
145669929|NCT00918203|525310014|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
145669930|NCT00918203|525310012|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
145669931|NCT00918203|525310013|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
145669932|NCT00918203|525310014|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
145669933|NCT00918203|525310012|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
145669934|NCT00918203|525310013|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
145669935|NCT00918203|525310014|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
145669936|NCT00918203|525310012|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
145669937|NCT00918203|525310013|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
145669938|NCT00918203|525310014|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
145669939|NCT00701701|525310015|FG000|Overall Study|Withdrawal by Subject|0|||
145669940|NCT00701701|525310016|FG001|Overall Study|Withdrawal by Subject|1|||
145669941|NCT00701701|525310015|FG000|Overall Study|Adverse Event|0|||
145669942|NCT00701701|525310016|FG001|Overall Study|Adverse Event|1|||
145669943|NCT00589875|525310017|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
145669944|NCT00589875|525310017|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
145669945|NCT03357952|525310020|FG000|Overall Study|Withdrawal by Subject|0|||
145669946|NCT03357952|525310021|FG001|Overall Study|Withdrawal by Subject|1|||
145669947|NCT03357952|525310020|FG000|Overall Study|Sponsor Decision|9|||
145669948|NCT03357952|525310021|FG001|Overall Study|Sponsor Decision|0|||
145669949|NCT02016872|525310022|FG000|Overall Study|Withdrawal by Subject|10|||
145669950|NCT02016872|525310022|FG000|Overall Study|Death Progression|2|||
145669951|NCT02016872|525310022|FG000|Overall Study|No FMISO scan|1|||
145669952|NCT02016872|525310022|FG000|Overall Study|Ineligible|2|||
145669953|NCT03280030|525310023|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
145669954|NCT03280030|525310024|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
145669955|NCT03280030|525310025|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
145669956|NCT03280030|525310023|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
145669957|NCT03280030|525310024|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
145669958|NCT03280030|525310025|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
145669959|NCT03280030|525310023|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
145669960|NCT03280030|525310024|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
145669961|NCT03280030|525310025|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
145669962|NCT03280030|525310023|FG000|Part 2 - Efficacy|Adverse Event|0|||
145669963|NCT03280030|525310024|FG001|Part 2 - Efficacy|Adverse Event|4|||
145669964|NCT03280030|525310025|FG002|Part 2 - Efficacy|Adverse Event|6|||
145669965|NCT03280030|525310023|FG000|Part 2 - Efficacy|Death|0|||
145669966|NCT03280030|525310024|FG001|Part 2 - Efficacy|Death|3|||
145669967|NCT03280030|525310025|FG002|Part 2 - Efficacy|Death|0|||
145669968|NCT03280030|525310023|FG000|Part 2 - Efficacy|Physician Decision|0|||
145669969|NCT03280030|525310024|FG001|Part 2 - Efficacy|Physician Decision|10|||
145669970|NCT03280030|525310025|FG002|Part 2 - Efficacy|Physician Decision|16|||
145669971|NCT03280030|525310023|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
145669972|NCT03280030|525310024|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
145669973|NCT03280030|525310025|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
145669974|NCT03280030|525310023|FG000|Part 2 - Efficacy|Progressive disease|0|||
145669975|NCT03280030|525310024|FG001|Part 2 - Efficacy|Progressive disease|7|||
145669976|NCT03280030|525310025|FG002|Part 2 - Efficacy|Progressive disease|5|||
145669977|NCT03211247|525310026|FG000|Overall Study|Adverse Event|8|||
145669978|NCT03211247|525310027|FG001|Overall Study|Adverse Event|0|||
145669979|NCT03211247|525310028|FG002|Overall Study|Adverse Event|1|||
145669980|NCT03211247|525310029|FG003|Overall Study|Adverse Event|0|||
145669981|NCT03211247|525310030|FG004|Overall Study|Adverse Event|0|||
145669982|NCT03211247|525310026|FG000|Overall Study|Lost to Follow-up|2|||
145669983|NCT03211247|525310027|FG001|Overall Study|Lost to Follow-up|1|||
145669984|NCT03211247|525310028|FG002|Overall Study|Lost to Follow-up|0|||
145669985|NCT03211247|525310029|FG003|Overall Study|Lost to Follow-up|0|||
145669986|NCT03211247|525310030|FG004|Overall Study|Lost to Follow-up|0|||
145669987|NCT03211247|525310026|FG000|Overall Study|Physician Decision|1|||
145669988|NCT03211247|525310027|FG001|Overall Study|Physician Decision|2|||
145669989|NCT03211247|525310028|FG002|Overall Study|Physician Decision|0|||
145669990|NCT03211247|525310029|FG003|Overall Study|Physician Decision|0|||
145669991|NCT03211247|525310030|FG004|Overall Study|Physician Decision|0|||
145669992|NCT03211247|525310026|FG000|Overall Study|Non-compliance with study drug|2|||
145669993|NCT03211247|525310027|FG001|Overall Study|Non-compliance with study drug|0|||
145669994|NCT03211247|525310028|FG002|Overall Study|Non-compliance with study drug|0|||
145669995|NCT03211247|525310029|FG003|Overall Study|Non-compliance with study drug|0|||
145669996|NCT03211247|525310030|FG004|Overall Study|Non-compliance with study drug|0|||
145669997|NCT03211247|525310026|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
145669998|NCT03211247|525310027|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
145669999|NCT03211247|525310028|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
145670000|NCT03211247|525310029|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
145670001|NCT03211247|525310030|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
145670002|NCT03211247|525310026|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
145670003|NCT03211247|525310027|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
145670004|NCT03211247|525310028|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
145670005|NCT03211247|525310029|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
145670006|NCT03211247|525310030|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
145670007|NCT03211247|525310026|FG000|Overall Study|Protocol Violation|0|||
145670008|NCT03211247|525310027|FG001|Overall Study|Protocol Violation|1|||
145670009|NCT03211247|525310028|FG002|Overall Study|Protocol Violation|0|||
145670010|NCT03211247|525310029|FG003|Overall Study|Protocol Violation|0|||
145670011|NCT03211247|525310030|FG004|Overall Study|Protocol Violation|0|||
145670012|NCT03997474|525310033|FG000|Overall Study|Death|6|||
145670013|NCT03997474|525310034|FG001|Overall Study|Death|2|||
145670014|NCT03997474|525310035|FG002|Overall Study|Death|1|||
145670015|NCT03997474|525310033|FG000|Overall Study|Physician Decision|2|||
145670016|NCT03997474|525310034|FG001|Overall Study|Physician Decision|0|||
145670017|NCT03997474|525310035|FG002|Overall Study|Physician Decision|0|||
145670018|NCT03997474|525310033|FG000|Overall Study|study terminated by sponsor|1|||
145670019|NCT03997474|525310034|FG001|Overall Study|study terminated by sponsor|0|||
145670020|NCT03997474|525310035|FG002|Overall Study|study terminated by sponsor|1|||
145670021|NCT05630833|525310038|FG000|Overall Study|Adverse Event|3|||
145670022|NCT05630833|525310039|FG001|Overall Study|Adverse Event|0|||
145670023|NCT05630833|525310038|FG000|Overall Study|Lack of Efficacy|0|||
145670024|NCT05630833|525310039|FG001|Overall Study|Lack of Efficacy|1|||
145670025|NCT05630833|525310038|FG000|Overall Study|Lost to Follow-up|1|||
145670026|NCT05630833|525310039|FG001|Overall Study|Lost to Follow-up|0|||
145670027|NCT05630833|525310038|FG000|Overall Study|Withdrawal by Subject|3|||
145670028|NCT05630833|525310039|FG001|Overall Study|Withdrawal by Subject|1|||
145670029|NCT03277989|525310041|FG000|Overall Study|Lost to Follow-up|6|||
145670030|NCT03277989|525310041|FG000|Overall Study|Adverse Event|6|||
145670031|NCT03277989|525310041|FG000|Overall Study|Withdrawal by Subject|3|||
145670032|NCT03277989|525310041|FG000|Overall Study|Didn't Receive Study Device|7|||
145670033|NCT03277989|525310041|FG000|Overall Study|Site Closure|26|||
145670034|NCT03277989|525310041|FG000|Overall Study|Sponsor Closure|107|||
145670035|NCT03083366|525311617|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
145670036|NCT03083366|525311618|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
145670037|NCT03083366|525311617|FG000|Enrollment Period|Lack of Efficacy|1|||
145670038|NCT03083366|525311618|FG001|Enrollment Period|Lack of Efficacy|0|||
145670039|NCT06056310|525311623|FG000|Overall Study|Other Reasons|2|||
145670040|NCT06056310|525311623|FG000|Overall Study|Sponsor Request|16|||
145670041|NCT02702843|525311624|FG000|Overall Study|Insufficient data to analyze|15|||
145670042|NCT02702843|525311625|FG001|Overall Study|Insufficient data to analyze|23|||
145670043|NCT02633215|525311634|FG000|Overall Study|Lost to Follow-up|2|||
145670044|NCT02633215|525311635|FG001|Overall Study|Lost to Follow-up|3|||
145670045|NCT00754325|525311636|FG000|Initial Treatment|Continuing Active Treatment|4|||
145670046|NCT00754325|525311637|FG001|Initial Treatment|Continuing Active Treatment|5|||
145670047|NCT00754325|525311636|FG000|Initial Treatment|Adverse Event|7|||
145670048|NCT00754325|525311637|FG001|Initial Treatment|Adverse Event|6|||
145670049|NCT00754325|525311636|FG000|Initial Treatment|Withdrawal by Subject|2|||
145670050|NCT00754325|525311637|FG001|Initial Treatment|Withdrawal by Subject|2|||
145670051|NCT00754325|525311636|FG000|Initial Treatment|Physician Decision|2|||
145670052|NCT00754325|525311637|FG001|Initial Treatment|Physician Decision|0|||
145670053|NCT00754325|525311636|FG000|Initial Treatment|Sponsor Request|0|||
145670054|NCT00754325|525311637|FG001|Initial Treatment|Sponsor Request|1|||
145670055|NCT00754325|525311636|FG000|Initial Treatment|Disease Progression|35|||
145670056|NCT00754325|525311637|FG001|Initial Treatment|Disease Progression|35|||
145670057|NCT03442777|525311638|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
145670058|NCT03442777|525311639|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
145670059|NCT03442777|525311640|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
145670060|NCT00609869|525311641|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
145670061|NCT00609869|525311641|FG000|Overall Study|Severe hematologic toxicity|1|||
145670062|NCT00609869|525311641|FG000|Overall Study|Withdrawal by Subject|1|||
145670063|NCT00609869|525311641|FG000|Overall Study|Seizures|1|||
145670064|NCT00609869|525311641|FG000|Overall Study|Severe tumor flare reaction|1|||
145670065|NCT00609869|525311641|FG000|Overall Study|Hepatitis B infection|1|||
145670066|NCT00609869|525311641|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
145670067|NCT00609869|525311641|FG000|Overall Study|Mantle cell: not evaluable|4|||
145670068|NCT01627561|525311642|FG000|Overall Study|Lost to Follow-up|1|||
145670069|NCT01627561|525311643|FG001|Overall Study|Lost to Follow-up|0|||
145490846|NCT02313766|524652228|FG002|Overall Study|Lost to Follow-up|0|||
145490847|NCT02313766|524652226|FG000|Overall Study|Adverse Event|0|||
145670070|NCT01627561|525311642|FG000|Overall Study|Withdrawal by Subject|0|||
145670071|NCT01627561|525311643|FG001|Overall Study|Withdrawal by Subject|1|||
145670072|NCT01627561|525311642|FG000|Overall Study|Migrated/moved from study area|0|||
145670073|NCT01627561|525311643|FG001|Overall Study|Migrated/moved from study area|2|||
145670074|NCT00890591|525311647|FG000|Overall Study|Lack of Efficacy|20|||
145670075|NCT01436175|525311648|FG000|Overall Study|Adverse Event|111|||
145670076|NCT01436175|525311648|FG000|Overall Study|Protocol Violation|49|||
145670077|NCT01436175|525311648|FG000|Overall Study|Withdrawal by Subject|108|||
145670078|NCT01436175|525311648|FG000|Overall Study|Lost to Follow-up|89|||
145670079|NCT01436175|525311648|FG000|Overall Study|Lack of Efficacy|24|||
145670080|NCT01436175|525311648|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
145670081|NCT01436175|525311648|FG000|Overall Study|Other|826|||
145670082|NCT05405244|525311649|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
145670083|NCT05405244|525311650|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
145670084|NCT05405244|525311649|FG000|Washout (2 Weeks)|Adverse Event|2|||
145670085|NCT05405244|525311650|FG001|Washout (2 Weeks)|Adverse Event|0|||
145670086|NCT05405244|525311649|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
145670087|NCT05405244|525311650|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
145670088|NCT03601715|525311651|FG000|Second Intervention|Lost to Follow-up|1|||
145670089|NCT03601715|525311652|FG001|Second Intervention|Lost to Follow-up|1|||
145670090|NCT03601715|525311653|FG002|Second Intervention|Lost to Follow-up|0|||
145670091|NCT01478594|525311654|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
145670092|NCT01478594|525311655|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
145670093|NCT01478594|525311654|FG000|Overall Study|Death|45|||
145670094|NCT01478594|525311655|FG001|Overall Study|Death|18|||
145670095|NCT01478594|525311654|FG000|Overall Study|Lost to Follow-up|3|||
145670096|NCT01478594|525311655|FG001|Overall Study|Lost to Follow-up|1|||
145670097|NCT01478594|525311654|FG000|Overall Study|Withdrawal by Subject|9|||
145670098|NCT01478594|525311655|FG001|Overall Study|Withdrawal by Subject|3|||
145670099|NCT01478594|525311654|FG000|Overall Study|Study Closed by Sponsor|8|||
145670100|NCT01478594|525311655|FG001|Overall Study|Study Closed by Sponsor|5|||
145670101|NCT01313884|525311657|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
145670102|NCT02854436|525311658|FG000|Overall Study|Adverse Event|1|||
145670103|NCT02854436|525311658|FG000|Overall Study|Death|208|||
145670104|NCT02854436|525311658|FG000|Overall Study|Lost to Follow-up|5|||
145670105|NCT02854436|525311658|FG000|Overall Study|Withdrawal by Subject|24|||
145670106|NCT02854436|525311658|FG000|Overall Study|Other|45|||
145670107|NCT02854436|525311658|FG000|Overall Study|Physician Decision|6|||
145670108|NCT04250194|525311659|FG000|Overall Study|Declined to schedule biopsy|6|||
145670109|NCT04250194|525311660|FG001|Overall Study|Declined to schedule biopsy|10|||
145670110|NCT04250194|525311659|FG000|Overall Study|Medically Unfit for Biopsy|2|||
145670111|NCT04250194|525311660|FG001|Overall Study|Medically Unfit for Biopsy|1|||
145670112|NCT04250194|525311659|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
145670113|NCT04250194|525311660|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
145670114|NCT04250194|525311659|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
145670115|NCT04250194|525311660|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
145670116|NCT04250194|525311659|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
145670117|NCT04250194|525311660|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
145670118|NCT02101775|525311667|FG000|Overall Study|Adverse Event|4|||
145670119|NCT02101775|525311668|FG001|Overall Study|Adverse Event|0|||
145670120|NCT02101775|525311669|FG002|Overall Study|Adverse Event|0|||
145670121|NCT02101775|525311667|FG000|Overall Study|Admission to Hospital|0|||
145670122|NCT02101775|525311668|FG001|Overall Study|Admission to Hospital|1|||
145670123|NCT02101775|525311669|FG002|Overall Study|Admission to Hospital|0|||
145670124|NCT00503906|525311670|FG000|Overall Study|Withdrawal by Subject|1|||
145670125|NCT01499849|525311671|FG000|Overall Study|Adverse Event|28|||
145670126|NCT01499849|525311672|FG001|Overall Study|Adverse Event|32|||
145670127|NCT01499849|525311671|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
145670128|NCT01499849|525311672|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
145670129|NCT01499849|525311671|FG000|Overall Study|Withdrawal by Subject|43|||
145670130|NCT01499849|525311672|FG001|Overall Study|Withdrawal by Subject|43|||
145670131|NCT01499849|525311671|FG000|Overall Study|Death|5|||
145670132|NCT01499849|525311672|FG001|Overall Study|Death|7|||
145670133|NCT01499849|525311671|FG000|Overall Study|Disease Progression|11|||
145670134|NCT01499849|525311672|FG001|Overall Study|Disease Progression|10|||
145670135|NCT01499849|525311671|FG000|Overall Study|Protocol Violation|11|||
145670136|NCT01499849|525311672|FG001|Overall Study|Protocol Violation|11|||
145670137|NCT01499849|525311671|FG000|Overall Study|Physician Decision|20|||
145670138|NCT01499849|525311672|FG001|Overall Study|Physician Decision|19|||
145670139|NCT01499849|525311671|FG000|Overall Study|Lack of Efficacy|3|||
145670140|NCT01499849|525311672|FG001|Overall Study|Lack of Efficacy|4|||
145670141|NCT01499849|525311671|FG000|Overall Study|Lost to Follow-up|6|||
145670142|NCT01499849|525311672|FG001|Overall Study|Lost to Follow-up|3|||
145670143|NCT01499849|525311671|FG000|Overall Study|Other Reasons|27|||
145670144|NCT01499849|525311672|FG001|Overall Study|Other Reasons|30|||
145670145|NCT00174252|525311673|FG000|Overall Study|Protocol Violation|2|||
145670146|NCT00622700|525311679|FG000|Core Treatment Period|Randomized but Not Treated|0|||
145670147|NCT00622700|525311680|FG001|Core Treatment Period|Randomized but Not Treated|2|||
145670148|NCT00622700|525311681|FG002|Core Treatment Period|Randomized but Not Treated|2|||
145670149|NCT00622700|525311682|FG003|Core Treatment Period|Randomized but Not Treated|0|||
145670150|NCT00622700|525311683|FG004|Core Treatment Period|Randomized but Not Treated|0|||
145670151|NCT00622700|525311684|FG005|Core Treatment Period|Randomized but Not Treated|0|||
145670152|NCT00622700|525311685|FG006|Core Treatment Period|Randomized but Not Treated|0|||
145670153|NCT00622700|525311679|FG000|Core Treatment Period|Adverse Event|18|||
145670154|NCT00622700|525311680|FG001|Core Treatment Period|Adverse Event|25|||
145670155|NCT00622700|525311681|FG002|Core Treatment Period|Adverse Event|18|||
145670156|NCT00622700|525311682|FG003|Core Treatment Period|Adverse Event|0|||
145670157|NCT00622700|525311683|FG004|Core Treatment Period|Adverse Event|0|||
145670158|NCT00622700|525311684|FG005|Core Treatment Period|Adverse Event|0|||
145670159|NCT00622700|525311685|FG006|Core Treatment Period|Adverse Event|0|||
145670160|NCT00622700|525311679|FG000|Core Treatment Period|Lack of Efficacy|19|||
145670161|NCT00622700|525311680|FG001|Core Treatment Period|Lack of Efficacy|6|||
145670162|NCT00622700|525311681|FG002|Core Treatment Period|Lack of Efficacy|12|||
145670163|NCT00622700|525311682|FG003|Core Treatment Period|Lack of Efficacy|0|||
145670164|NCT00622700|525311683|FG004|Core Treatment Period|Lack of Efficacy|0|||
145670165|NCT00622700|525311684|FG005|Core Treatment Period|Lack of Efficacy|0|||
145670166|NCT00622700|525311685|FG006|Core Treatment Period|Lack of Efficacy|0|||
145670167|NCT00622700|525311679|FG000|Core Treatment Period|Lost to Follow-up|1|||
145670168|NCT00622700|525311680|FG001|Core Treatment Period|Lost to Follow-up|1|||
145670169|NCT00622700|525311681|FG002|Core Treatment Period|Lost to Follow-up|1|||
145670170|NCT00622700|525311682|FG003|Core Treatment Period|Lost to Follow-up|0|||
145670171|NCT00622700|525311683|FG004|Core Treatment Period|Lost to Follow-up|0|||
145670172|NCT00622700|525311684|FG005|Core Treatment Period|Lost to Follow-up|0|||
145670173|NCT00622700|525311685|FG006|Core Treatment Period|Lost to Follow-up|0|||
145670174|NCT00622700|525311679|FG000|Core Treatment Period|Death|1|||
145670175|NCT00622700|525311680|FG001|Core Treatment Period|Death|0|||
145670176|NCT00622700|525311681|FG002|Core Treatment Period|Death|0|||
145670177|NCT00622700|525311682|FG003|Core Treatment Period|Death|0|||
145670178|NCT00622700|525311683|FG004|Core Treatment Period|Death|0|||
145670179|NCT00622700|525311684|FG005|Core Treatment Period|Death|0|||
145670180|NCT00622700|525311685|FG006|Core Treatment Period|Death|0|||
145670181|NCT00622700|525311679|FG000|Core Treatment Period|Progressive Disease|3|||
145670182|NCT00622700|525311680|FG001|Core Treatment Period|Progressive Disease|1|||
145670183|NCT00622700|525311681|FG002|Core Treatment Period|Progressive Disease|0|||
145670184|NCT00622700|525311682|FG003|Core Treatment Period|Progressive Disease|0|||
145670185|NCT00622700|525311683|FG004|Core Treatment Period|Progressive Disease|0|||
145670186|NCT00622700|525311684|FG005|Core Treatment Period|Progressive Disease|0|||
145670187|NCT00622700|525311685|FG006|Core Treatment Period|Progressive Disease|0|||
145670188|NCT00622700|525311679|FG000|Core Treatment Period|Withdrawal by Subject|12|||
145670189|NCT00622700|525311680|FG001|Core Treatment Period|Withdrawal by Subject|18|||
145670190|NCT00622700|525311681|FG002|Core Treatment Period|Withdrawal by Subject|15|||
145670191|NCT00622700|525311682|FG003|Core Treatment Period|Withdrawal by Subject|0|||
145670192|NCT00622700|525311683|FG004|Core Treatment Period|Withdrawal by Subject|0|||
145670193|NCT00622700|525311684|FG005|Core Treatment Period|Withdrawal by Subject|0|||
145670194|NCT00622700|525311685|FG006|Core Treatment Period|Withdrawal by Subject|0|||
145670195|NCT00622700|525311679|FG000|Core Treatment Period|Other than specified above|2|||
145670196|NCT00622700|525311680|FG001|Core Treatment Period|Other than specified above|2|||
145670197|NCT00622700|525311681|FG002|Core Treatment Period|Other than specified above|5|||
145670198|NCT00622700|525311682|FG003|Core Treatment Period|Other than specified above|0|||
145670199|NCT00622700|525311683|FG004|Core Treatment Period|Other than specified above|0|||
145670200|NCT00622700|525311684|FG005|Core Treatment Period|Other than specified above|0|||
145670201|NCT00622700|525311685|FG006|Core Treatment Period|Other than specified above|0|||
145670202|NCT00622700|525311679|FG000|Extension Treatment Period|Adverse Event|0|||
145670203|NCT00622700|525311680|FG001|Extension Treatment Period|Adverse Event|0|||
145670204|NCT00622700|525311681|FG002|Extension Treatment Period|Adverse Event|0|||
145670205|NCT00622700|525311682|FG003|Extension Treatment Period|Adverse Event|5|||
145670206|NCT00622700|525311683|FG004|Extension Treatment Period|Adverse Event|9|||
145670207|NCT00622700|525311684|FG005|Extension Treatment Period|Adverse Event|6|||
145490848|NCT02313766|524652227|FG001|Overall Study|Adverse Event|1|||
145670208|NCT00622700|525311685|FG006|Extension Treatment Period|Adverse Event|8|||
145670209|NCT00622700|525311679|FG000|Extension Treatment Period|Lack of Efficacy|0|||
145670210|NCT00622700|525311680|FG001|Extension Treatment Period|Lack of Efficacy|0|||
145670211|NCT00622700|525311681|FG002|Extension Treatment Period|Lack of Efficacy|0|||
145670212|NCT00622700|525311682|FG003|Extension Treatment Period|Lack of Efficacy|2|||
145670213|NCT00622700|525311683|FG004|Extension Treatment Period|Lack of Efficacy|8|||
145670214|NCT00622700|525311684|FG005|Extension Treatment Period|Lack of Efficacy|1|||
145670215|NCT00622700|525311685|FG006|Extension Treatment Period|Lack of Efficacy|9|||
145670216|NCT00622700|525311679|FG000|Extension Treatment Period|Protocol Violation|0|||
145670217|NCT00622700|525311680|FG001|Extension Treatment Period|Protocol Violation|0|||
145670218|NCT00622700|525311681|FG002|Extension Treatment Period|Protocol Violation|0|||
145670219|NCT00622700|525311682|FG003|Extension Treatment Period|Protocol Violation|0|||
145670220|NCT00622700|525311683|FG004|Extension Treatment Period|Protocol Violation|0|||
145670221|NCT00622700|525311684|FG005|Extension Treatment Period|Protocol Violation|2|||
145670222|NCT00622700|525311685|FG006|Extension Treatment Period|Protocol Violation|0|||
145670223|NCT00622700|525311679|FG000|Extension Treatment Period|Lost to Follow-up|0|||
145670224|NCT00622700|525311680|FG001|Extension Treatment Period|Lost to Follow-up|0|||
145670225|NCT00622700|525311681|FG002|Extension Treatment Period|Lost to Follow-up|0|||
145670226|NCT00622700|525311682|FG003|Extension Treatment Period|Lost to Follow-up|0|||
145670227|NCT00622700|525311683|FG004|Extension Treatment Period|Lost to Follow-up|1|||
145670228|NCT00622700|525311684|FG005|Extension Treatment Period|Lost to Follow-up|0|||
145670229|NCT00622700|525311685|FG006|Extension Treatment Period|Lost to Follow-up|0|||
145670230|NCT00622700|525311679|FG000|Extension Treatment Period|Progressive Disease|0|||
145670231|NCT00622700|525311680|FG001|Extension Treatment Period|Progressive Disease|0|||
145670232|NCT00622700|525311681|FG002|Extension Treatment Period|Progressive Disease|0|||
145670233|NCT00622700|525311682|FG003|Extension Treatment Period|Progressive Disease|1|||
145670234|NCT00622700|525311683|FG004|Extension Treatment Period|Progressive Disease|2|||
145670235|NCT00622700|525311684|FG005|Extension Treatment Period|Progressive Disease|0|||
145670236|NCT00622700|525311685|FG006|Extension Treatment Period|Progressive Disease|2|||
145670237|NCT00622700|525311679|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
145670238|NCT00622700|525311680|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
145670239|NCT00622700|525311681|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
145670240|NCT00622700|525311682|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
145670241|NCT00622700|525311683|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
145670242|NCT00622700|525311684|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
145670243|NCT00622700|525311685|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
145670244|NCT00622700|525311679|FG000|Extension Treatment Period|Missing|0|||
145670245|NCT00622700|525311680|FG001|Extension Treatment Period|Missing|0|||
145670246|NCT00622700|525311681|FG002|Extension Treatment Period|Missing|0|||
145670247|NCT00622700|525311682|FG003|Extension Treatment Period|Missing|2|||
145670248|NCT00622700|525311683|FG004|Extension Treatment Period|Missing|3|||
145670249|NCT00622700|525311684|FG005|Extension Treatment Period|Missing|1|||
145670250|NCT00622700|525311685|FG006|Extension Treatment Period|Missing|0|||
145670251|NCT00622700|525311679|FG000|Extension Treatment Period|Other than specified above|0|||
145670252|NCT00622700|525311680|FG001|Extension Treatment Period|Other than specified above|0|||
145670253|NCT00622700|525311681|FG002|Extension Treatment Period|Other than specified above|0|||
145670254|NCT00622700|525311682|FG003|Extension Treatment Period|Other than specified above|0|||
145670255|NCT00622700|525311683|FG004|Extension Treatment Period|Other than specified above|0|||
145670256|NCT00622700|525311684|FG005|Extension Treatment Period|Other than specified above|1|||
145670257|NCT00622700|525311685|FG006|Extension Treatment Period|Other than specified above|1|||
145670258|NCT00942266|525311686|FG000|Overall Study|Withdrawal by Subject|1|||
145670259|NCT00942266|525311687|FG001|Overall Study|Withdrawal by Subject|0|||
145670260|NCT00942266|525311686|FG000|Overall Study|Adverse Event|2|||
145670261|NCT00942266|525311687|FG001|Overall Study|Adverse Event|1|||
145670262|NCT00942266|525311686|FG000|Overall Study|Disease Progression|38|||
145670263|NCT00942266|525311687|FG001|Overall Study|Disease Progression|11|||
145670264|NCT00942266|525311686|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
145670265|NCT00942266|525311687|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
145670266|NCT00942266|525311686|FG000|Overall Study|Intercurrent illness|0|||
145670267|NCT00942266|525311687|FG001|Overall Study|Intercurrent illness|1|||
145670268|NCT00942266|525311686|FG000|Overall Study|Physician Decision|2|||
145670269|NCT00942266|525311687|FG001|Overall Study|Physician Decision|0|||
145670270|NCT00942266|525311686|FG000|Overall Study|medical deterioration (pneumonia)|0|||
145670271|NCT00942266|525311687|FG001|Overall Study|medical deterioration (pneumonia)|1|||
145670272|NCT04035447|525311694|FG000|Treatment Period|Lost to Follow-up|6|||
145670273|NCT04035447|525311695|FG001|Treatment Period|Lost to Follow-up|5|||
145670274|NCT04035447|525311694|FG000|Treatment Period|Physician Decision|0|||
145670275|NCT04035447|525311695|FG001|Treatment Period|Physician Decision|2|||
145670276|NCT03304587|525311696|FG000|Overall Study|Headache after intervention|0|||
145670277|NCT03304587|525311697|FG001|Overall Study|Headache after intervention|1|||
145670278|NCT03304587|525311696|FG000|Overall Study|Withdrawal by Subject|1|||
145670279|NCT03304587|525311697|FG001|Overall Study|Withdrawal by Subject|0|||
145670280|NCT01753999|525311698|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
145670281|NCT01753999|525311699|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
145670282|NCT01753999|525311698|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
145670283|NCT01753999|525311699|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
145670284|NCT01753999|525311698|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
145670285|NCT01753999|525311699|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
145670286|NCT01753999|525311698|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
145670287|NCT01753999|525311699|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
145670288|NCT01753999|525311698|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
145670289|NCT01753999|525311699|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
145670290|NCT01753999|525311698|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
145670291|NCT01753999|525311699|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
145670292|NCT02029235|525311700|FG000|Overall Study|Non-compliance with study meds or diary|4|||
145670293|NCT02029235|525311701|FG001|Overall Study|Non-compliance with study meds or diary|1|||
145670294|NCT04337931|525311702|FG000|Overall Study|Death|4|||
145670295|NCT04337931|525311703|FG001|Overall Study|Death|1|||
145670296|NCT04337931|525311704|FG002|Overall Study|Death|7|||
145670297|NCT04337931|525311702|FG000|Overall Study|Withdrawal by Subject|0|||
145670298|NCT04337931|525311703|FG001|Overall Study|Withdrawal by Subject|1|||
145670299|NCT04337931|525311704|FG002|Overall Study|Withdrawal by Subject|0|||
145670300|NCT04337931|525311702|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
145670301|NCT04337931|525311703|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
145670302|NCT04337931|525311704|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
145670303|NCT04337931|525311702|FG000|Overall Study|Study terminated by sponsor|3|||
145670304|NCT04337931|525311703|FG001|Overall Study|Study terminated by sponsor|6|||
145670305|NCT04337931|525311704|FG002|Overall Study|Study terminated by sponsor|2|||
145670306|NCT04337931|525311702|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
145670307|NCT04337931|525311703|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
145670308|NCT04337931|525311704|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
145670309|NCT04337931|525311702|FG000|Overall Study|Colorectal cancer treatment|1|||
145670310|NCT04337931|525311703|FG001|Overall Study|Colorectal cancer treatment|0|||
145670311|NCT04337931|525311704|FG002|Overall Study|Colorectal cancer treatment|0|||
145670312|NCT04337931|525311702|FG000|Overall Study|Participant decision|0|||
145670313|NCT04337931|525311703|FG001|Overall Study|Participant decision|1|||
145670314|NCT04337931|525311704|FG002|Overall Study|Participant decision|0|||
145670315|NCT04436289|525311705|FG000|Overall Study|Death prior to hospital discharge|8|||
145670316|NCT04436289|525311706|FG001|Overall Study|Death prior to hospital discharge|5|||
145670317|NCT04436289|525311707|FG002|Overall Study|Death prior to hospital discharge|0|||
145670318|NCT04436289|525311708|FG003|Overall Study|Death prior to hospital discharge|1|||
145670319|NCT04436289|525311705|FG000|Overall Study|Withdrawal by Subject|0|||
145670320|NCT04436289|525311706|FG001|Overall Study|Withdrawal by Subject|1|||
145670321|NCT04436289|525311707|FG002|Overall Study|Withdrawal by Subject|4|||
145670322|NCT04436289|525311708|FG003|Overall Study|Withdrawal by Subject|0|||
145670323|NCT04436289|525311705|FG000|Overall Study|Extended hospital stay|0|||
145670324|NCT04436289|525311706|FG001|Overall Study|Extended hospital stay|1|||
145670325|NCT04436289|525311707|FG002|Overall Study|Extended hospital stay|0|||
145670326|NCT04436289|525311708|FG003|Overall Study|Extended hospital stay|0|||
145670327|NCT04436289|525311705|FG000|Overall Study|Lost to Follow-up|0|||
145670328|NCT04436289|525311706|FG001|Overall Study|Lost to Follow-up|4|||
145670329|NCT04436289|525311707|FG002|Overall Study|Lost to Follow-up|1|||
145670330|NCT04436289|525311708|FG003|Overall Study|Lost to Follow-up|3|||
145670331|NCT01532999|525311709|FG000|Overall Study|Lost to Follow-up|14|||
145670332|NCT01532999|525311710|FG001|Overall Study|Lost to Follow-up|8|||
145670333|NCT01532999|525311709|FG000|Overall Study|Physician Decision|1|||
145670334|NCT01532999|525311710|FG001|Overall Study|Physician Decision|2|||
145670335|NCT01532999|525311709|FG000|Overall Study|Withdrawal by Subject|5|||
145670336|NCT01532999|525311710|FG001|Overall Study|Withdrawal by Subject|0|||
145670337|NCT01532999|525311709|FG000|Overall Study|Relocated|2|||
145670338|NCT01532999|525311710|FG001|Overall Study|Relocated|0|||
145670339|NCT01532999|525311709|FG000|Overall Study|should not have been randomized|1|||
145670340|NCT01532999|525311710|FG001|Overall Study|should not have been randomized|0|||
145670341|NCT01532999|525311709|FG000|Overall Study|substantial noncompliance|2|||
145670342|NCT01532999|525311710|FG001|Overall Study|substantial noncompliance|0|||
145670343|NCT01532999|525311709|FG000|Overall Study|no show for week 9 assessments|6|||
145670344|NCT01532999|525311710|FG001|Overall Study|no show for week 9 assessments|4|||
145670345|NCT01532999|525311709|FG000|Overall Study|Adverse Event|0|||
145670346|NCT01532999|525311710|FG001|Overall Study|Adverse Event|1|||
145670347|NCT01532999|525311709|FG000|Overall Study|incarcerated|0|||
145670348|NCT01532999|525311710|FG001|Overall Study|incarcerated|1|||
145670349|NCT01532999|525311709|FG000|Overall Study|New job|0|||
145670350|NCT01532999|525311710|FG001|Overall Study|New job|2|||
145670351|NCT02928172|525311711|FG000|Overall Study|Device did not record data|1|||
145670352|NCT02408887|525311712|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
145670353|NCT02408887|525311713|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
145670354|NCT02408887|525311712|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
145670355|NCT02408887|525311713|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
145670356|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
145670357|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
145670358|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
145670359|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145670360|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
145670361|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
145670362|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
145670363|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
145670364|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
145670365|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
145670366|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
145670367|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
145670368|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
145670369|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
145670370|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
145670371|NCT03333109|525311714|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
145670372|NCT03333109|525311715|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
145670373|NCT03333109|525311716|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
145670374|NCT03333109|525311714|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
145670375|NCT03333109|525311715|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
145670376|NCT03333109|525311716|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
145670377|NCT03333109|525311714|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
145670378|NCT03333109|525311715|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
145670379|NCT03333109|525311716|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
145670380|NCT03160885|525311719|FG000|Initial Treatment Period|Not dosed|2|||
145670381|NCT03160885|525311720|FG001|Initial Treatment Period|Not dosed|0|||
145670382|NCT03160885|525311721|FG002|Initial Treatment Period|Not dosed|0|||
145670383|NCT03160885|525311722|FG003|Initial Treatment Period|Not dosed|0|||
145670384|NCT03160885|525311723|FG004|Initial Treatment Period|Not dosed|0|||
145670385|NCT03160885|525311724|FG005|Initial Treatment Period|Not dosed|0|||
145670386|NCT03160885|525311725|FG006|Initial Treatment Period|Not dosed|0|||
145670387|NCT03160885|525311719|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
145670388|NCT03160885|525311720|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
145670389|NCT03160885|525311721|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145670390|NCT03160885|525311722|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145670391|NCT03160885|525311723|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145670392|NCT03160885|525311724|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145670393|NCT03160885|525311725|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
145670394|NCT03160885|525311719|FG000|Open-label Treatment|Not dosed|0|||
145670395|NCT03160885|525311720|FG001|Open-label Treatment|Not dosed|0|||
145670396|NCT03160885|525311721|FG002|Open-label Treatment|Not dosed|0|||
145670397|NCT03160885|525311722|FG003|Open-label Treatment|Not dosed|0|||
145670398|NCT03160885|525311723|FG004|Open-label Treatment|Not dosed|0|||
145670399|NCT03160885|525311724|FG005|Open-label Treatment|Not dosed|0|||
145670400|NCT03160885|525311725|FG006|Open-label Treatment|Not dosed|2|||
145670401|NCT03160885|525311719|FG000|Open-label Treatment|Discontinued IMP|0|||
145670402|NCT03160885|525311720|FG001|Open-label Treatment|Discontinued IMP|0|||
145670403|NCT03160885|525311721|FG002|Open-label Treatment|Discontinued IMP|0|||
145670404|NCT03160885|525311722|FG003|Open-label Treatment|Discontinued IMP|0|||
145670405|NCT03160885|525311723|FG004|Open-label Treatment|Discontinued IMP|0|||
145670406|NCT03160885|525311724|FG005|Open-label Treatment|Discontinued IMP|0|||
145670407|NCT03160885|525311725|FG006|Open-label Treatment|Discontinued IMP|131|||
145670408|NCT03160885|525311719|FG000|Open-label Treatment|Completed Week 50|0|||
145670409|NCT03160885|525311720|FG001|Open-label Treatment|Completed Week 50|0|||
145670410|NCT03160885|525311721|FG002|Open-label Treatment|Completed Week 50|0|||
145670411|NCT03160885|525311722|FG003|Open-label Treatment|Completed Week 50|0|||
145670412|NCT03160885|525311723|FG004|Open-label Treatment|Completed Week 50|0|||
145670413|NCT03160885|525311724|FG005|Open-label Treatment|Completed Week 50|0|||
145670414|NCT03160885|525311725|FG006|Open-label Treatment|Completed Week 50|4|||
145670415|NCT03160885|525311719|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145670416|NCT03160885|525311720|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145670417|NCT03160885|525311721|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145670418|NCT03160885|525311722|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
145670419|NCT03160885|525311723|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145490849|NCT02313766|524652228|FG002|Overall Study|Adverse Event|0|||
145490850|NCT00791388|524652232|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
145490851|NCT00791388|524652233|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
145670420|NCT03160885|525311724|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145670421|NCT03160885|525311725|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
145670422|NCT03160885|525311719|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
145670423|NCT03160885|525311720|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
145670424|NCT03160885|525311721|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
145670425|NCT03160885|525311722|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
145670426|NCT03160885|525311723|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
145490852|NCT00791388|524652234|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
145670427|NCT03160885|525311724|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
145670428|NCT03160885|525311725|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
145670429|NCT03160885|525311719|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145670430|NCT03160885|525311720|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145670431|NCT03160885|525311721|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
145670432|NCT03160885|525311722|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
145670433|NCT03160885|525311723|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
145670434|NCT03160885|525311724|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
145670435|NCT03160885|525311725|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
145670436|NCT03160885|525311719|FG000|Maintenance Treatment Period|Completed Week 50|0|||
145670437|NCT03160885|525311720|FG001|Maintenance Treatment Period|Completed Week 50|0|||
145670438|NCT03160885|525311721|FG002|Maintenance Treatment Period|Completed Week 50|1|||
145670439|NCT03160885|525311722|FG003|Maintenance Treatment Period|Completed Week 50|0|||
145670440|NCT03160885|525311723|FG004|Maintenance Treatment Period|Completed Week 50|0|||
145670441|NCT03160885|525311724|FG005|Maintenance Treatment Period|Completed Week 50|0|||
145670442|NCT03160885|525311725|FG006|Maintenance Treatment Period|Completed Week 50|0|||
145670443|NCT02761187|525311726|FG000|Overall Study|Too ill to Participate|13|||
145670444|NCT02761187|525311727|FG001|Overall Study|Too ill to Participate|8|||
145670445|NCT02761187|525311726|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
145670446|NCT02761187|525311727|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
145670447|NCT02761187|525311726|FG000|Overall Study|Patient withdrew consent|64|||
145670448|NCT02761187|525311727|FG001|Overall Study|Patient withdrew consent|58|||
145670449|NCT02761187|525311726|FG000|Overall Study|Physician discretion|4|||
145670450|NCT02761187|525311727|FG001|Overall Study|Physician discretion|8|||
145670451|NCT02761187|525311726|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
145670452|NCT02761187|525311727|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
145670453|NCT02761187|525311726|FG000|Overall Study|On Hospice|20|||
145670454|NCT02761187|525311727|FG001|Overall Study|On Hospice|26|||
145670455|NCT02761187|525311726|FG000|Overall Study|Deceased|474|||
145670456|NCT02761187|525311727|FG001|Overall Study|Deceased|642|||
145670457|NCT02761187|525311726|FG000|Overall Study|Lost to Follow-up|73|||
145670458|NCT02761187|525311727|FG001|Overall Study|Lost to Follow-up|63|||
145670459|NCT02761187|525311726|FG000|Overall Study|Due to study discontinued at site|100|||
145670460|NCT02761187|525311727|FG001|Overall Study|Due to study discontinued at site|85|||
145670461|NCT02761187|525311726|FG000|Overall Study|Reason not Specified|1484|||
145670462|NCT02761187|525311727|FG001|Overall Study|Reason not Specified|937|||
145670463|NCT04153890|525311728|FG000|Overall Study|Lost to Follow-up|9|||
145670464|NCT04153890|525311729|FG001|Overall Study|Lost to Follow-up|0|||
145670465|NCT04153890|525311730|FG002|Overall Study|Lost to Follow-up|9|||
145670466|NCT04153890|525311731|FG003|Overall Study|Lost to Follow-up|0|||
145670467|NCT04153890|525311728|FG000|Overall Study|Death|0|||
145670468|NCT04153890|525311729|FG001|Overall Study|Death|2|||
145670469|NCT04153890|525311730|FG002|Overall Study|Death|0|||
145670470|NCT04153890|525311731|FG003|Overall Study|Death|0|||
145670471|NCT04153890|525311728|FG000|Overall Study|Withdrawal by Subject|0|||
145670472|NCT04153890|525311729|FG001|Overall Study|Withdrawal by Subject|0|||
145670473|NCT04153890|525311730|FG002|Overall Study|Withdrawal by Subject|0|||
145670474|NCT04153890|525311731|FG003|Overall Study|Withdrawal by Subject|2|||
145670475|NCT05786612|525311733|FG000|Overall Study|Adverse Event|1|||
145670476|NCT05786612|525311734|FG001|Overall Study|Adverse Event|2|||
145670477|NCT05786612|525311733|FG000|Overall Study|one screening failure|0|||
145670478|NCT05786612|525311734|FG001|Overall Study|one screening failure|2|||
145670479|NCT05485805|525311735|FG000|Overall Study|Withdrawal by Subject|1|||
145670480|NCT05485805|525311736|FG001|Overall Study|Withdrawal by Subject|2|||
145670481|NCT05485805|525311737|FG002|Overall Study|Withdrawal by Subject|2|||
145670482|NCT05485805|525311738|FG003|Overall Study|Withdrawal by Subject|0|||
145670483|NCT05485805|525311739|FG004|Overall Study|Withdrawal by Subject|2|||
145670484|NCT05485805|525311735|FG000|Overall Study|Adverse Event|0|||
145670485|NCT05485805|525311736|FG001|Overall Study|Adverse Event|1|||
145670486|NCT05485805|525311737|FG002|Overall Study|Adverse Event|0|||
145670487|NCT05485805|525311738|FG003|Overall Study|Adverse Event|0|||
145670488|NCT05485805|525311739|FG004|Overall Study|Adverse Event|0|||
145670489|NCT05485805|525311735|FG000|Overall Study|Lost to Follow-up|1|||
145670490|NCT05485805|525311736|FG001|Overall Study|Lost to Follow-up|1|||
145670491|NCT05485805|525311737|FG002|Overall Study|Lost to Follow-up|3|||
145670492|NCT05485805|525311738|FG003|Overall Study|Lost to Follow-up|1|||
145670493|NCT05485805|525311739|FG004|Overall Study|Lost to Follow-up|0|||
145670494|NCT00490139|525311740|FG000|Overall Study|Lost to Follow-up|249|||
145670495|NCT00490139|525311741|FG001|Overall Study|Lost to Follow-up|216|||
145670496|NCT00490139|525311742|FG002|Overall Study|Lost to Follow-up|205|||
145265401|NCT04410991|523819349|FG000|Overall Study|Poor compliance to protocol|5|||
145490853|NCT00791388|524652235|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
145670497|NCT00490139|525311743|FG003|Overall Study|Lost to Follow-up|229|||
145670498|NCT00490139|525311740|FG000|Overall Study|Withdrawal by Subject|333|||
145670499|NCT00490139|525311741|FG001|Overall Study|Withdrawal by Subject|322|||
145670500|NCT00490139|525311742|FG002|Overall Study|Withdrawal by Subject|396|||
145670501|NCT00490139|525311743|FG003|Overall Study|Withdrawal by Subject|295|||
145670502|NCT00490139|525311740|FG000|Overall Study|Patient did not sign ICF 12|169|||
145670503|NCT00490139|525311741|FG001|Overall Study|Patient did not sign ICF 12|176|||
145670504|NCT00490139|525311742|FG002|Overall Study|Patient did not sign ICF 12|139|||
145670505|NCT00490139|525311743|FG003|Overall Study|Patient did not sign ICF 12|167|||
145670506|NCT00490139|525311740|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
145670507|NCT00490139|525311741|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
145670508|NCT00490139|525311742|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
145670509|NCT00490139|525311743|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
145670510|NCT00490139|525311740|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
145670511|NCT00490139|525311741|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
145670512|NCT00490139|525311742|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
145670513|NCT00490139|525311743|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
145670514|NCT00490139|525311740|FG000|Overall Study|Other reasons as defined per protocol|98|||
145670515|NCT00490139|525311741|FG001|Overall Study|Other reasons as defined per protocol|84|||
145670516|NCT00490139|525311742|FG002|Overall Study|Other reasons as defined per protocol|82|||
145670517|NCT00490139|525311743|FG003|Overall Study|Other reasons as defined per protocol|105|||
145670518|NCT06140290|525311744|FG000|Period 1|Adverse Event|1|||
145670519|NCT06140290|525311745|FG001|Period 1|Adverse Event|0|||
145670520|NCT06140290|525311744|FG000|Period 2|Assigned but not treated|0|||
145670521|NCT06140290|525311745|FG001|Period 2|Assigned but not treated|1|||
145670522|NCT06140290|525311744|FG000|Period 2|Withdrawal by Subject|0|||
145670523|NCT06140290|525311745|FG001|Period 2|Withdrawal by Subject|1|||
145670524|NCT02798471|525311748|FG000|Overall Study|Adverse Event|7|||
145670525|NCT02798471|525311749|FG001|Overall Study|Adverse Event|2|||
145670526|NCT02798471|525311748|FG000|Overall Study|Physician Decision|3|||
145670527|NCT02798471|525311749|FG001|Overall Study|Physician Decision|7|||
145670528|NCT02798471|525311748|FG000|Overall Study|Death|2|||
145670529|NCT02798471|525311749|FG001|Overall Study|Death|3|||
145670530|NCT02798471|525311748|FG000|Overall Study|Lost to Follow-up|0|||
145670531|NCT02798471|525311749|FG001|Overall Study|Lost to Follow-up|1|||
145670532|NCT02798471|525311748|FG000|Overall Study|Other|5|||
145670533|NCT02798471|525311749|FG001|Overall Study|Other|3|||
145670534|NCT02798471|525311748|FG000|Overall Study|Subject withdrew consent|0|||
145670535|NCT02798471|525311749|FG001|Overall Study|Subject withdrew consent|6|||
145670536|NCT02798471|525311748|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
145670537|NCT02798471|525311749|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
145670538|NCT02798471|525311748|FG000|Overall Study|Randomized, but not treated|0|||
145670539|NCT02798471|525311749|FG001|Overall Study|Randomized, but not treated|2|||
145670540|NCT05250115|525313099|FG000|Overall Study|Premature study end|40|||
145670541|NCT05250115|525313099|FG000|Overall Study|Adverse Event|8|||
145670542|NCT05250115|525313099|FG000|Overall Study|Lost to Follow-up|7|||
145670543|NCT05250115|525313099|FG000|Overall Study|Withdrawal by Subject|6|||
145670544|NCT05250115|525313099|FG000|Overall Study|Withdrawal of informed consent|1|||
145670545|NCT05250115|525313099|FG000|Overall Study|Other|7|||
145670546|NCT03758638|525313100|FG000|Overall Study|Pregnancy|17|||
145670547|NCT03758638|525313101|FG001|Overall Study|Pregnancy|25|||
145670548|NCT03758638|525313100|FG000|Overall Study|Lost to Follow-up|60|||
145670549|NCT03758638|525313101|FG001|Overall Study|Lost to Follow-up|54|||
145670550|NCT03758638|525313100|FG000|Overall Study|Protocol Violation|2|||
145670551|NCT03758638|525313101|FG001|Overall Study|Protocol Violation|0|||
145670552|NCT03758638|525313100|FG000|Overall Study|Withdrawal by Subject|8|||
145670553|NCT03758638|525313101|FG001|Overall Study|Withdrawal by Subject|2|||
145670554|NCT03758638|525313100|FG000|Overall Study|Providers not included in the primary outcome.|183|||
145670555|NCT03758638|525313101|FG001|Overall Study|Providers not included in the primary outcome.|128|||
145670556|NCT01314118|525313102|FG000|Overall Study|Adverse Event|9|||
145670557|NCT01314118|525313102|FG000|Overall Study|Progressive disease|27|||
145670558|NCT01314118|525313102|FG000|Overall Study|Physician Decision|11|||
145670559|NCT01314118|525313102|FG000|Overall Study|Death|4|||
145670560|NCT01314118|525313102|FG000|Overall Study|Protocol Violation|5|||
145670561|NCT01314118|525313102|FG000|Overall Study|Withdrawal by Subject|11|||
145670562|NCT01314118|525313102|FG000|Overall Study|Other|2|||
145670563|NCT01314118|525313102|FG000|Overall Study|Ongoing|62|||
145670564|NCT00065182|525313106|FG000|Overall Study|Adverse Event|24|||
145490854|NCT00791388|524652236|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
145670565|NCT00065182|525313107|FG001|Overall Study|Adverse Event|17|||
145670566|NCT00065182|525313106|FG000|Overall Study|Lost to Follow-up|0|||
145670567|NCT00065182|525313107|FG001|Overall Study|Lost to Follow-up|4|||
145670568|NCT00065182|525313106|FG000|Overall Study|Protocol Violation|3|||
145670569|NCT00065182|525313107|FG001|Overall Study|Protocol Violation|4|||
145670570|NCT00065182|525313106|FG000|Overall Study|Serious adverse events (SAE)|1|||
145670571|NCT00065182|525313107|FG001|Overall Study|Serious adverse events (SAE)|0|||
145670572|NCT00065182|525313106|FG000|Overall Study|Sponsor Decision|11|||
145670573|NCT00065182|525313107|FG001|Overall Study|Sponsor Decision|7|||
145670574|NCT00065182|525313106|FG000|Overall Study|Withdrawal by Subject|8|||
145670575|NCT00065182|525313107|FG001|Overall Study|Withdrawal by Subject|3|||
145670576|NCT00065182|525313106|FG000|Overall Study|No clinical benefit|1|||
145670577|NCT00065182|525313107|FG001|Overall Study|No clinical benefit|0|||
145670578|NCT00065182|525313106|FG000|Overall Study|Death|0|||
145670579|NCT00065182|525313107|FG001|Overall Study|Death|1|||
145670580|NCT00065182|525313106|FG000|Overall Study|Decline in Status|0|||
145670581|NCT00065182|525313107|FG001|Overall Study|Decline in Status|1|||
145670582|NCT00790569|525313108|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
145670583|NCT00790569|525313109|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
145670584|NCT00790569|525313110|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
145670585|NCT00790569|525313108|FG000|End of Treatment (6 Month Interview)|Death|0|||
145670586|NCT00790569|525313109|FG001|End of Treatment (6 Month Interview)|Death|2|||
145670587|NCT00790569|525313110|FG002|End of Treatment (6 Month Interview)|Death|1|||
145670588|NCT00790569|525313108|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
145670589|NCT00790569|525313109|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
145670590|NCT00790569|525313110|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
145670591|NCT00790569|525313108|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
145670592|NCT00790569|525313109|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
145670593|NCT00790569|525313110|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
145670594|NCT00790569|525313108|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
145670595|NCT00790569|525313109|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
145670596|NCT00790569|525313110|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
145670597|NCT00790569|525313108|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
145670598|NCT00790569|525313109|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
145670599|NCT00790569|525313110|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
145670600|NCT03244800|525313111|FG000|Overall Study|Adverse Event|0|||
145670601|NCT03244800|525313112|FG001|Overall Study|Adverse Event|1|||
145670602|NCT03244800|525313113|FG002|Overall Study|Adverse Event|0|||
145670603|NCT03244800|525313114|FG003|Overall Study|Adverse Event|1|||
145670604|NCT03244800|525313111|FG000|Overall Study|Withdrew treatment|0|||
145670605|NCT03244800|525313112|FG001|Overall Study|Withdrew treatment|0|||
145670606|NCT03244800|525313113|FG002|Overall Study|Withdrew treatment|0|||
145670607|NCT03244800|525313114|FG003|Overall Study|Withdrew treatment|1|||
145670608|NCT02941549|525313115|FG000|Overall Study|Adverse Event|1|||
145670609|NCT02941549|525313116|FG001|Overall Study|Adverse Event|0|||
145670610|NCT02941549|525313117|FG002|Overall Study|Adverse Event|0|||
145670611|NCT02941549|525313115|FG000|Overall Study|Withdrawal by Subject|2|||
145670612|NCT02941549|525313116|FG001|Overall Study|Withdrawal by Subject|1|||
145670613|NCT02941549|525313117|FG002|Overall Study|Withdrawal by Subject|2|||
145670614|NCT03451422|525313121|FG000|Overall Study|Lost to Follow-up|0|||
145670615|NCT03451422|525313122|FG001|Overall Study|Lost to Follow-up|0|||
145670616|NCT03451422|525313123|FG002|Overall Study|Lost to Follow-up|0|||
145670617|NCT03451422|525313124|FG003|Overall Study|Lost to Follow-up|0|||
145670618|NCT03451422|525313125|FG004|Overall Study|Lost to Follow-up|0|||
145670619|NCT03451422|525313126|FG005|Overall Study|Lost to Follow-up|1|||
145670620|NCT03451422|525313121|FG000|Overall Study|Decision by sponsor|1|||
145670621|NCT03451422|525313122|FG001|Overall Study|Decision by sponsor|0|||
145670622|NCT03451422|525313123|FG002|Overall Study|Decision by sponsor|1|||
145670623|NCT03451422|525313124|FG003|Overall Study|Decision by sponsor|0|||
145670624|NCT03451422|525313125|FG004|Overall Study|Decision by sponsor|0|||
145670625|NCT03451422|525313126|FG005|Overall Study|Decision by sponsor|0|||
145670626|NCT03451422|525313121|FG000|Overall Study|Withdrawal by Subject|0|||
145670627|NCT03451422|525313122|FG001|Overall Study|Withdrawal by Subject|0|||
145670628|NCT03451422|525313123|FG002|Overall Study|Withdrawal by Subject|2|||
145670629|NCT03451422|525313124|FG003|Overall Study|Withdrawal by Subject|3|||
145670630|NCT03451422|525313125|FG004|Overall Study|Withdrawal by Subject|2|||
145670631|NCT03451422|525313126|FG005|Overall Study|Withdrawal by Subject|1|||
145670632|NCT00918333|525313127|FG000|Overall Study|Drug not taken per protocol|1|||
145670633|NCT00918333|525313128|FG001|Overall Study|Drug not taken per protocol|0|||
145670634|NCT00918333|525313127|FG000|Overall Study|Inadequate amount of drugs provided|1|||
145670635|NCT00918333|525313128|FG001|Overall Study|Inadequate amount of drugs provided|4|||
145670636|NCT00918333|525313127|FG000|Overall Study|Ineligible|1|||
145670637|NCT00918333|525313128|FG001|Overall Study|Ineligible|0|||
145670638|NCT00918333|525313127|FG000|Overall Study|Withdrawal by Subject|0|||
145670639|NCT00918333|525313128|FG001|Overall Study|Withdrawal by Subject|1|||
145670640|NCT00263757|525313129|FG000|Overall Study|Withdrawal by Subject|5|||
145670641|NCT00263757|525313130|FG001|Overall Study|Withdrawal by Subject|4|||
145670642|NCT00263757|525313129|FG000|Overall Study|Screen failure|0|||
145670643|NCT00263757|525313130|FG001|Overall Study|Screen failure|1|||
145670644|NCT00263757|525313129|FG000|Overall Study|Adverse Event|3|||
145670645|NCT00263757|525313130|FG001|Overall Study|Adverse Event|3|||
145670646|NCT00713596|525313131|FG000|Overall Study|Study was terminated|2|||
145670647|NCT00713596|525313132|FG001|Overall Study|Study was terminated|3|||
145670648|NCT00713596|525313133|FG002|Overall Study|Study was terminated|2|||
145670649|NCT04545619|525313134|FG000|Overall Study|due to equipment challenges|1|||
145670650|NCT00754065|525313139|FG000|Overall Study|Never received treatment|12|||
145670651|NCT00754065|525313140|FG001|Overall Study|Never received treatment|2|||
145670652|NCT00754065|525313139|FG000|Overall Study|Adverse Event|19|||
145670653|NCT00754065|525313140|FG001|Overall Study|Adverse Event|25|||
145670654|NCT00754065|525313139|FG000|Overall Study|Lost to Follow-up|7|||
145670655|NCT00754065|525313140|FG001|Overall Study|Lost to Follow-up|11|||
145670656|NCT00754065|525313139|FG000|Overall Study|Protocol Violation|12|||
145670657|NCT00754065|525313140|FG001|Overall Study|Protocol Violation|10|||
145670658|NCT00754065|525313139|FG000|Overall Study|Withdrawal by Subject|4|||
145670659|NCT00754065|525313140|FG001|Overall Study|Withdrawal by Subject|5|||
145670660|NCT00754065|525313139|FG000|Overall Study|Pregnancy|6|||
145670661|NCT00754065|525313140|FG001|Overall Study|Pregnancy|0|||
145670662|NCT00754065|525313139|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
145670663|NCT00754065|525313140|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
145670664|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
145670665|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
145670666|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670667|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670668|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670669|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
145670670|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
145670671|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670672|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670673|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670674|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670675|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670676|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670677|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
145670678|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670679|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670680|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670681|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670682|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670683|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
145670684|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
145670685|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670686|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670687|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670688|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670689|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670690|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670691|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
145670692|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
145670693|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670694|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670695|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670696|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670697|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670698|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
145670699|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670700|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670701|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670702|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670703|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670704|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670705|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
145670706|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670707|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670708|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670709|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670710|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670711|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
145670712|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
145670713|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670714|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670715|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670716|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670717|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670718|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670719|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
145670720|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670721|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670722|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670723|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670724|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670725|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670726|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
145670727|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670728|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670729|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670730|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670731|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670732|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670733|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
145670734|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
145670735|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
145670736|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
145670737|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670738|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670739|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
145670740|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
145670741|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670742|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670743|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670744|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670745|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670746|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670747|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
145670748|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670749|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
145670750|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670751|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670752|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670753|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
145670754|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670755|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670756|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670757|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670758|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670759|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670760|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670761|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
145670762|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
145670763|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670764|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670765|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670766|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670767|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
145670768|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670769|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670770|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670771|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670772|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670773|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670774|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670775|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
145670776|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670777|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670778|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670779|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
145670780|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
145490855|NCT00791388|524652232|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
145490856|NCT00791388|524652233|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
145670781|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670782|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670783|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
145670784|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
145670785|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145490857|NCT00791388|524652234|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
145490858|NCT00791388|524652235|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
145490859|NCT00791388|524652236|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
145490860|NCT00791388|524652232|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
145490861|NCT00791388|524652233|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
145490862|NCT00791388|524652234|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
145490863|NCT00791388|524652235|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
145490864|NCT00791388|524652236|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
145490865|NCT00141453|524652244|FG000|Overall Study|Protocol Violation|6|||
145490866|NCT00141453|524652245|FG001|Overall Study|Protocol Violation|5|||
145490867|NCT00443040|524652248|FG000|Overall Study|Withdrawal by Subject|1|||
145490868|NCT00443040|524652249|FG001|Overall Study|Withdrawal by Subject|0|||
145490869|NCT00443040|524652250|FG002|Overall Study|Withdrawal by Subject|0|||
145490870|NCT00443040|524652248|FG000|Overall Study|Converted to an open laparotomy|3|||
145490871|NCT00443040|524652249|FG001|Overall Study|Converted to an open laparotomy|0|||
145490872|NCT00443040|524652250|FG002|Overall Study|Converted to an open laparotomy|1|||
145490873|NCT06039579|524652255|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145490874|NCT06039579|524652256|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145490875|NCT06039579|524652257|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145670786|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145490876|NCT06039579|524652258|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145670787|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670788|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670789|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
145670790|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670791|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670792|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670793|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670794|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670795|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670796|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670797|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
145670798|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
145670799|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670800|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670801|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670802|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670803|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
145670804|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670805|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670806|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670807|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670808|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670809|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670810|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670811|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670812|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
145670813|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670814|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670815|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670816|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670817|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
145670818|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670819|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670820|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670821|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
145490877|NCT06039579|524652259|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145490878|NCT06039579|524652260|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145490879|NCT06039579|524652261|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
145490880|NCT06039579|524652262|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
145490881|NCT02763644|524652267|FG000|Overall Study|Patient/guardian decision|1|||
145490882|NCT02763644|524652268|FG001|Overall Study|Patient/guardian decision|0|||
145490883|NCT02763644|524652267|FG000|Overall Study|Death|1|||
145670822|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670823|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670824|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670825|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670826|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670827|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670828|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670829|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670830|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670831|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
145670832|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670833|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670834|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670835|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670836|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670837|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670838|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670839|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
145670840|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
145670841|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670842|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670843|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670844|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670845|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
145670846|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670847|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670848|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670849|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670850|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670851|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670852|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670853|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
145670854|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670855|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670856|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670857|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670858|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670859|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
145670860|NCT04033445|525313141|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670861|NCT04033445|525313142|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670862|NCT04033445|525313143|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670863|NCT04033445|525313144|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670864|NCT04033445|525313145|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670865|NCT04033445|525313146|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670866|NCT04033445|525313147|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670867|NCT04033445|525313148|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
145670868|NCT04033445|525313149|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670869|NCT04033445|525313150|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670870|NCT04033445|525313151|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670871|NCT04033445|525313152|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670872|NCT04033445|525313153|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670873|NCT04033445|525313154|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
145670874|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670875|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670876|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670877|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670878|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670879|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670880|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670881|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145490884|NCT02763644|524652268|FG001|Overall Study|Death|1|||
145490885|NCT02763644|524652267|FG000|Overall Study|Adverse Event|1|||
145490886|NCT02763644|524652268|FG001|Overall Study|Adverse Event|1|||
145490887|NCT02648204|524652269|FG000|Overall Study|Withdrawal by Subject|12|||
145670882|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
145670883|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
145670884|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
145670885|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
145670886|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
145670887|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
145670888|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670889|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670890|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670891|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670892|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670893|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670894|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670895|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670896|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
145670897|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
145670898|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
145670899|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
145670900|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
145670901|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
145670902|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670903|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670904|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670905|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670906|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670907|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670908|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670909|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670910|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670911|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670912|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
145670913|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
145670914|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
145670915|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
145670916|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670917|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670918|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670919|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670920|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670921|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670922|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670923|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670924|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670925|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
145670926|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
145670927|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
145670928|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
145670929|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
145670930|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670931|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670932|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670933|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670934|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670935|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670936|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670937|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670938|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
145670939|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
145670940|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
145670941|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
145670942|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
145670943|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
145670944|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670945|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670946|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670947|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670948|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670949|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670950|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670951|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670952|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670953|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670954|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670955|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670956|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
145670957|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
145670958|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670959|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670960|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670961|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670962|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670963|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670964|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670965|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670966|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
145670967|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
145670968|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
145670969|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
145670970|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
145670971|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
145670972|NCT04033445|525313141|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670973|NCT04033445|525313142|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670974|NCT04033445|525313143|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670975|NCT04033445|525313144|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670976|NCT04033445|525313145|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670977|NCT04033445|525313146|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670978|NCT04033445|525313147|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670979|NCT04033445|525313148|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670980|NCT04033445|525313149|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670981|NCT04033445|525313150|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
145670982|NCT04033445|525313151|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670983|NCT04033445|525313152|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
145670984|NCT04033445|525313153|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
145670985|NCT04033445|525313154|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
145670986|NCT04353492|525313157|FG000|Overall Study|Subject decision|24|||
145670987|NCT04353492|525313157|FG000|Overall Study|Physician Decision|5|||
145670988|NCT04353492|525313157|FG000|Overall Study|Adverse Event|3|||
145670989|NCT04353492|525313157|FG000|Overall Study|Pregnancy|3|||
145670990|NCT04353492|525313157|FG000|Overall Study|Lost to Follow-up|2|||
145670991|NCT04353492|525313157|FG000|Overall Study|Protocol deviation|1|||
145670992|NCT04353492|525313157|FG000|Overall Study|Technical problems|1|||
145670993|NCT00776009|525313158|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
145670994|NCT00776009|525313159|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
145670995|NCT00776009|525313160|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
145670996|NCT00776009|525313161|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
145670997|NCT00776009|525313162|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
145670998|NCT00776009|525313163|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
145670999|NCT00776009|525313158|FG000|Period 1: First Intervention|Protocol Violation|0|||
145671000|NCT00776009|525313159|FG001|Period 1: First Intervention|Protocol Violation|1|||
145671001|NCT00776009|525313160|FG002|Period 1: First Intervention|Protocol Violation|0|||
145671002|NCT00776009|525313161|FG003|Period 1: First Intervention|Protocol Violation|0|||
145671003|NCT00776009|525313162|FG004|Period 1: First Intervention|Protocol Violation|1|||
145671004|NCT00776009|525313163|FG005|Period 1: First Intervention|Protocol Violation|0|||
145671005|NCT00776009|525313158|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
145671006|NCT00776009|525313159|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
145671007|NCT00776009|525313160|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
145671008|NCT00776009|525313161|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
145671009|NCT00776009|525313162|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
145671010|NCT00776009|525313163|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
145671011|NCT00776009|525313158|FG000|Period 2: Second Intervention|Protocol Violation|1|||
145671012|NCT00776009|525313159|FG001|Period 2: Second Intervention|Protocol Violation|0|||
145671013|NCT00776009|525313160|FG002|Period 2: Second Intervention|Protocol Violation|1|||
145671014|NCT00776009|525313161|FG003|Period 2: Second Intervention|Protocol Violation|0|||
145671015|NCT00776009|525313162|FG004|Period 2: Second Intervention|Protocol Violation|0|||
145671016|NCT00776009|525313163|FG005|Period 2: Second Intervention|Protocol Violation|0|||
145671017|NCT00776009|525313158|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
145671018|NCT00776009|525313159|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
145671019|NCT00776009|525313160|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
145671020|NCT00776009|525313161|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
145671021|NCT00776009|525313162|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
145671022|NCT00776009|525313163|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
145671023|NCT00582972|525313164|FG000|Overall Study|Protocol Violation|2|||
145671024|NCT00293397|525313166|FG000|Overall Study|Death|2|||
145671025|NCT03473743|525313169|FG000|Overall Study|Withdrawal by Subject|0|||
145671026|NCT03473743|525313170|FG001|Overall Study|Withdrawal by Subject|0|||
145671027|NCT03473743|525313171|FG002|Overall Study|Withdrawal by Subject|0|||
145671028|NCT03473743|525313172|FG003|Overall Study|Withdrawal by Subject|0|||
145671029|NCT03473743|525313173|FG004|Overall Study|Withdrawal by Subject|0|||
145671030|NCT03473743|525313174|FG005|Overall Study|Withdrawal by Subject|0|||
145671031|NCT03473743|525313175|FG006|Overall Study|Withdrawal by Subject|0|||
145671032|NCT03473743|525313176|FG007|Overall Study|Withdrawal by Subject|3|||
145671033|NCT03473743|525313169|FG000|Overall Study|Other|0|||
145671034|NCT03473743|525313170|FG001|Overall Study|Other|0|||
145671035|NCT03473743|525313171|FG002|Overall Study|Other|0|||
145671036|NCT03473743|525313172|FG003|Overall Study|Other|1|||
145671037|NCT03473743|525313173|FG004|Overall Study|Other|0|||
145671038|NCT03473743|525313174|FG005|Overall Study|Other|0|||
145671039|NCT03473743|525313175|FG006|Overall Study|Other|0|||
145671040|NCT03473743|525313176|FG007|Overall Study|Other|0|||
145671041|NCT03473743|525313169|FG000|Overall Study|Ongoing|0|||
145671042|NCT03473743|525313170|FG001|Overall Study|Ongoing|0|||
145671043|NCT03473743|525313171|FG002|Overall Study|Ongoing|6|||
145671044|NCT03473743|525313172|FG003|Overall Study|Ongoing|8|||
145671045|NCT03473743|525313173|FG004|Overall Study|Ongoing|1|||
145671046|NCT03473743|525313174|FG005|Overall Study|Ongoing|1|||
145671047|NCT03473743|525313175|FG006|Overall Study|Ongoing|22|||
145671048|NCT03473743|525313176|FG007|Overall Study|Ongoing|24|||
145671049|NCT03473743|525313169|FG000|Overall Study|Randomized but not treated|0|||
145671050|NCT03473743|525313170|FG001|Overall Study|Randomized but not treated|0|||
145671051|NCT03473743|525313171|FG002|Overall Study|Randomized but not treated|0|||
145671052|NCT03473743|525313172|FG003|Overall Study|Randomized but not treated|0|||
145671053|NCT03473743|525313173|FG004|Overall Study|Randomized but not treated|0|||
145671054|NCT03473743|525313174|FG005|Overall Study|Randomized but not treated|0|||
145671055|NCT03473743|525313175|FG006|Overall Study|Randomized but not treated|1|||
145671056|NCT03473743|525313176|FG007|Overall Study|Randomized but not treated|1|||
145671057|NCT01458366|525313182|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
145671058|NCT01458366|525313183|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
145671059|NCT01458366|525313184|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
145671060|NCT01458366|525313185|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
145671061|NCT01458366|525313186|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
145671062|NCT01458366|525313182|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
145671063|NCT01458366|525313183|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
145671064|NCT01458366|525313184|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
145671065|NCT01458366|525313185|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
145671066|NCT01458366|525313186|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
145671067|NCT02787005|525313187|FG000|Overall Study|Adverse Event|24|||
145671068|NCT02787005|525313188|FG001|Overall Study|Adverse Event|9|||
145671069|NCT02787005|525313189|FG002|Overall Study|Adverse Event|9|||
145671070|NCT02787005|525313190|FG003|Overall Study|Adverse Event|7|||
145671071|NCT02787005|525313191|FG004|Overall Study|Adverse Event|2|||
145671072|NCT02787005|525313187|FG000|Overall Study|Death|100|||
145671073|NCT02787005|525313188|FG001|Overall Study|Death|53|||
145490888|NCT02648204|524652270|FG001|Overall Study|Withdrawal by Subject|8|||
145490889|NCT02648204|524652271|FG002|Overall Study|Withdrawal by Subject|2|||
145490890|NCT02648204|524652272|FG003|Overall Study|Withdrawal by Subject|6|||
145671074|NCT02787005|525313189|FG002|Overall Study|Death|48|||
145490891|NCT02648204|524652269|FG000|Overall Study|Lost to Follow-up|5|||
145671075|NCT02787005|525313190|FG003|Overall Study|Death|69|||
145671076|NCT02787005|525313191|FG004|Overall Study|Death|38|||
145671077|NCT02787005|525313187|FG000|Overall Study|Sponsor Decision|7|||
145671078|NCT02787005|525313188|FG001|Overall Study|Sponsor Decision|4|||
145671079|NCT02787005|525313189|FG002|Overall Study|Sponsor Decision|0|||
145671080|NCT02787005|525313190|FG003|Overall Study|Sponsor Decision|4|||
145671081|NCT02787005|525313191|FG004|Overall Study|Sponsor Decision|5|||
145671082|NCT02787005|525313187|FG000|Overall Study|Withdrawal by Subject|2|||
145671083|NCT02787005|525313188|FG001|Overall Study|Withdrawal by Subject|1|||
145671084|NCT02787005|525313189|FG002|Overall Study|Withdrawal by Subject|1|||
145671085|NCT02787005|525313190|FG003|Overall Study|Withdrawal by Subject|0|||
145671086|NCT02787005|525313191|FG004|Overall Study|Withdrawal by Subject|1|||
145671087|NCT02787005|525313187|FG000|Overall Study|Screen Failure|0|||
145671088|NCT02787005|525313188|FG001|Overall Study|Screen Failure|2|||
145671089|NCT02787005|525313189|FG002|Overall Study|Screen Failure|0|||
145671090|NCT02787005|525313190|FG003|Overall Study|Screen Failure|0|||
145671091|NCT02787005|525313191|FG004|Overall Study|Screen Failure|1|||
145671092|NCT02787005|525313187|FG000|Overall Study|Lost to Follow-up|0|||
145671093|NCT02787005|525313188|FG001|Overall Study|Lost to Follow-up|0|||
145671094|NCT02787005|525313189|FG002|Overall Study|Lost to Follow-up|0|||
145671095|NCT02787005|525313190|FG003|Overall Study|Lost to Follow-up|1|||
145671096|NCT02787005|525313191|FG004|Overall Study|Lost to Follow-up|0|||
145671097|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
145671098|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
145671099|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
145671100|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
145671101|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
145671102|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
145671103|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
145671104|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
145671105|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
145671106|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
145671107|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
145671108|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
145671109|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145671110|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145671111|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145671112|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145671113|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
145671114|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
145671115|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
145671116|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
145671117|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
145671118|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
145671119|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
145671120|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
145671121|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
145671122|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
145671123|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
145671124|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
145671125|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
145671126|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
145671127|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
145671128|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
145671129|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
145671130|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
145671131|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
145671132|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
145671133|NCT02392234|525313192|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
145671134|NCT02392234|525313193|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
145671135|NCT02392234|525313194|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
145671136|NCT02392234|525313195|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
145671137|NCT02392234|525313196|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
145671138|NCT02392234|525313197|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
145671139|NCT02392234|525313192|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
145671140|NCT02392234|525313193|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
145671141|NCT02392234|525313194|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
145671142|NCT02392234|525313195|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
145671143|NCT02392234|525313196|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
145671144|NCT02392234|525313197|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
145671145|NCT01387516|525313198|FG000|Overall Study|Lost to Follow-up|4|||
145671146|NCT01387516|525313199|FG001|Overall Study|Lost to Follow-up|4|||
145671147|NCT01387516|525313200|FG002|Overall Study|Lost to Follow-up|2|||
145490892|NCT02648204|524652270|FG001|Overall Study|Lost to Follow-up|8|||
145671148|NCT01387516|525313201|FG003|Overall Study|Lost to Follow-up|3|||
145490893|NCT02648204|524652271|FG002|Overall Study|Lost to Follow-up|4|||
145671149|NCT01387516|525313198|FG000|Overall Study|Withdrawal by Subject|1|||
145671150|NCT01387516|525313199|FG001|Overall Study|Withdrawal by Subject|1|||
145671151|NCT01387516|525313200|FG002|Overall Study|Withdrawal by Subject|2|||
145671152|NCT01387516|525313201|FG003|Overall Study|Withdrawal by Subject|0|||
145671153|NCT01387516|525313198|FG000|Overall Study|Death|0|||
145671154|NCT01387516|525313199|FG001|Overall Study|Death|0|||
145671155|NCT01387516|525313200|FG002|Overall Study|Death|0|||
145671156|NCT01387516|525313201|FG003|Overall Study|Death|1|||
145671157|NCT03170648|525313204|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
145671158|NCT03170648|525313204|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
145671159|NCT02052440|525313205|FG000|Overall Study|Withdrawal by Subject|0|||
145671160|NCT02052440|525313206|FG001|Overall Study|Withdrawal by Subject|1|||
145671161|NCT03509909|525313207|FG000|Overall Study|Withdrawal by Subject|16|||
145671162|NCT03509909|525313208|FG001|Overall Study|Withdrawal by Subject|9|||
145671163|NCT03509909|525313207|FG000|Overall Study|Lost to Follow-up|3|||
145671164|NCT03509909|525313208|FG001|Overall Study|Lost to Follow-up|4|||
145671165|NCT03509909|525313207|FG000|Overall Study|Adverse Event|2|||
145671166|NCT03509909|525313208|FG001|Overall Study|Adverse Event|0|||
145671167|NCT02107261|525313209|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
145671168|NCT02107261|525313210|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
145671169|NCT02107261|525313209|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
145671170|NCT02107261|525313210|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
145671171|NCT02130557|525313213|FG000|Overall Study|Withdrawal by Subject|12|||
145671172|NCT02130557|525313214|FG001|Overall Study|Withdrawal by Subject|12|||
145671173|NCT02130557|525313213|FG000|Overall Study|Investigator Request|0|||
145671174|NCT02130557|525313214|FG001|Overall Study|Investigator Request|2|||
145671175|NCT02130557|525313213|FG000|Overall Study|Deceased|14|||
145671176|NCT02130557|525313214|FG001|Overall Study|Deceased|14|||
145671177|NCT02130557|525313213|FG000|Overall Study|Lost to Follow-up|6|||
145671178|NCT02130557|525313214|FG001|Overall Study|Lost to Follow-up|7|||
145671179|NCT02130557|525313213|FG000|Overall Study|Other|2|||
145671180|NCT02130557|525313214|FG001|Overall Study|Other|1|||
145671181|NCT02130557|525313213|FG000|Overall Study|Missing|2|||
145671182|NCT02130557|525313214|FG001|Overall Study|Missing|1|||
145671183|NCT04066075|525313215|FG000|Overall Study|Lost to Follow-up|3|||
145671184|NCT04066075|525313216|FG001|Overall Study|Lost to Follow-up|3|||
145671185|NCT04066075|525313215|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
145671186|NCT04066075|525313216|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
145671187|NCT04066075|525313215|FG000|Overall Study|Withdrawal by Subject|2|||
145671188|NCT04066075|525313216|FG001|Overall Study|Withdrawal by Subject|2|||
145671189|NCT00309166|525313217|FG000|Overall Study|Adverse event, non-fatal|1|||
145671190|NCT00309166|525313218|FG001|Overall Study|Adverse event, non-fatal|0|||
145671191|NCT00309166|525313217|FG000|Overall Study|Withdrawal by Subject|4|||
145671192|NCT00309166|525313218|FG001|Overall Study|Withdrawal by Subject|3|||
145671193|NCT04088227|525313223|FG000|Overall Study|Withdrawal by Subject|1|||
145671194|NCT04088227|525313224|FG001|Overall Study|Withdrawal by Subject|0|||
145671195|NCT04088227|525313223|FG000|Overall Study|Surgery postponed >5weeks|1|||
145671196|NCT04088227|525313224|FG001|Overall Study|Surgery postponed >5weeks|0|||
145671197|NCT05349838|525313227|FG000|Overall Study|Virological Failure|1|||
145671198|NCT05349838|525313228|FG001|Overall Study|Virological Failure|2|||
145671199|NCT05349838|525313227|FG000|Overall Study|Withdrawal by Subject|2|||
145671200|NCT05349838|525313228|FG001|Overall Study|Withdrawal by Subject|3|||
145671201|NCT05349838|525313227|FG000|Overall Study|Adverse Event|3|||
145671202|NCT05349838|525313228|FG001|Overall Study|Adverse Event|1|||
145671203|NCT05349838|525313227|FG000|Overall Study|Lost to Follow-up|1|||
145671204|NCT05349838|525313228|FG001|Overall Study|Lost to Follow-up|2|||
145671205|NCT05349838|525313227|FG000|Overall Study|Other reasons|5|||
145671206|NCT05349838|525313228|FG001|Overall Study|Other reasons|1|||
145671207|NCT04484623|525313230|FG000|Overall Study|Lost to Follow-up|0|||
145671208|NCT04484623|525313231|FG001|Overall Study|Lost to Follow-up|1|||
145671209|NCT04484623|525313230|FG000|Overall Study|Protocol Deviation|1|||
145671210|NCT04484623|525313231|FG001|Overall Study|Protocol Deviation|0|||
145671211|NCT04484623|525313230|FG000|Overall Study|Physician Decision|1|||
145671212|NCT04484623|525313231|FG001|Overall Study|Physician Decision|0|||
145671213|NCT04484623|525313230|FG000|Overall Study|Withdrawal by Subject|11|||
145671214|NCT04484623|525313231|FG001|Overall Study|Withdrawal by Subject|8|||
145671215|NCT04484623|525313230|FG000|Overall Study|Ongoing|94|||
145671216|NCT04484623|525313231|FG001|Overall Study|Ongoing|84|||
145671217|NCT03664804|525313233|FG000|Overall Study|Withdrawal by Subject|7|||
145671218|NCT05529992|525313234|FG000|Overall Study|Withdrawal by Subject|1|||
145671219|NCT03595124|525314409|FG000|Overall Study|Physician Decision|1|||
145671220|NCT03595124|525314410|FG001|Overall Study|Physician Decision|1|||
145671221|NCT03595124|525314411|FG002|Overall Study|Physician Decision|1|||
145671222|NCT03595124|525314409|FG000|Overall Study|Ineligible|1|||
145671223|NCT03595124|525314410|FG001|Overall Study|Ineligible|1|||
145671224|NCT03595124|525314411|FG002|Overall Study|Ineligible|0|||
145671225|NCT03595124|525314409|FG000|Overall Study|Disease Progression|4|||
145671226|NCT03595124|525314410|FG001|Overall Study|Disease Progression|1|||
145671227|NCT03595124|525314411|FG002|Overall Study|Disease Progression|4|||
145671228|NCT02200705|525314414|FG000|Overall Study|Excluded|12|||
145671229|NCT02200705|525314414|FG000|Overall Study|Death|21|||
145671230|NCT02200705|525314414|FG000|Overall Study|Withdrawal by Subject|22|||
145671231|NCT02200705|525314414|FG000|Overall Study|Lost to Follow-up|13|||
145671232|NCT02200705|525314414|FG000|Overall Study|Physician Decision|5|||
145671233|NCT02200705|525314414|FG000|Overall Study|Adverse Event|2|||
145671234|NCT03738228|525314416|FG000|Overall Study|Never received study treatment|2|||
145671235|NCT03738228|525314417|FG001|Overall Study|Never received study treatment|2|||
145671236|NCT02866942|525314418|FG000|Overall Study|Invalid consent|1|||
145671237|NCT06212752|525314419|FG000|Overall Study|Death|5|||
145671238|NCT06212752|525314420|FG001|Overall Study|Death|3|||
145671239|NCT06212752|525314419|FG000|Overall Study|Participants ongoing|23|||
145671240|NCT06212752|525314420|FG001|Overall Study|Participants ongoing|8|||
145671241|NCT04162210|525314421|FG000|Overall Study|Lost to Follow-up|4|||
145671242|NCT04162210|525314422|FG001|Overall Study|Lost to Follow-up|1|||
145671243|NCT04162210|525314421|FG000|Overall Study|Withdrawal by Subject|17|||
145671244|NCT04162210|525314422|FG001|Overall Study|Withdrawal by Subject|9|||
145671245|NCT04162210|525314421|FG000|Overall Study|Ongoing|113|||
145671246|NCT04162210|525314422|FG001|Overall Study|Ongoing|59|||
145671247|NCT02568215|525314423|FG000|Overall Study|Death|1|||
145671248|NCT02568215|525314424|FG001|Overall Study|Death|2|||
145671249|NCT02568215|525314425|FG002|Overall Study|Death|0|||
145671250|NCT02568215|525314423|FG000|Overall Study|Physician Decision|2|||
145671251|NCT02568215|525314424|FG001|Overall Study|Physician Decision|2|||
145671252|NCT02568215|525314425|FG002|Overall Study|Physician Decision|2|||
145671253|NCT02568215|525314423|FG000|Overall Study|Lost to Follow-up|29|||
145671254|NCT02568215|525314424|FG001|Overall Study|Lost to Follow-up|32|||
145671255|NCT02568215|525314425|FG002|Overall Study|Lost to Follow-up|41|||
145671256|NCT02568215|525314423|FG000|Overall Study|Withdrawal by Subject|21|||
145671257|NCT02568215|525314424|FG001|Overall Study|Withdrawal by Subject|19|||
145671258|NCT02568215|525314425|FG002|Overall Study|Withdrawal by Subject|22|||
145671259|NCT02568215|525314423|FG000|Overall Study|Protocol Violation|1|||
145671260|NCT02568215|525314424|FG001|Overall Study|Protocol Violation|1|||
145671261|NCT02568215|525314425|FG002|Overall Study|Protocol Violation|0|||
145671262|NCT02568215|525314423|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
145671263|NCT02568215|525314424|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
145671264|NCT02568215|525314425|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
145671265|NCT02568215|525314423|FG000|Overall Study|Other|0|||
145671266|NCT02568215|525314424|FG001|Overall Study|Other|1|||
145671267|NCT02568215|525314425|FG002|Overall Study|Other|4|||
145671268|NCT01641900|525314426|FG000|Overall Study|Withdrawal by Subject|2|||
145671269|NCT01641900|525314427|FG001|Overall Study|Withdrawal by Subject|2|||
145671270|NCT00371345|525314428|FG000|Overall Study|Disease Progression|21|||
145671271|NCT00371345|525314429|FG001|Overall Study|Disease Progression|35|||
145671272|NCT00371345|525314428|FG000|Overall Study|Study Drug Toxicity|1|||
145671273|NCT00371345|525314429|FG001|Overall Study|Study Drug Toxicity|7|||
145671274|NCT00371345|525314428|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
145671275|NCT00371345|525314429|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
145671276|NCT00371345|525314428|FG000|Overall Study|Participant Request|1|||
145671277|NCT00371345|525314429|FG001|Overall Study|Participant Request|1|||
145671278|NCT00371345|525314428|FG000|Overall Study|Participant Withdrew Consent|0|||
145671279|NCT00371345|525314429|FG001|Overall Study|Participant Withdrew Consent|1|||
145671280|NCT04384172|525314435|FG000|Overall Study|Lost to Follow-up|0|||
145671281|NCT04384172|525314436|FG001|Overall Study|Lost to Follow-up|2|||
145671282|NCT04384172|525314435|FG000|Overall Study|Pregnancy|1|||
145671283|NCT04384172|525314436|FG001|Overall Study|Pregnancy|0|||
145671284|NCT04384172|525314435|FG000|Overall Study|Withdrawal by Subject|0|||
145671285|NCT04384172|525314436|FG001|Overall Study|Withdrawal by Subject|1|||
145671286|NCT02463448|525314437|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
145671287|NCT02463448|525314437|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
145671288|NCT02463448|525314437|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
145671289|NCT02463448|525314437|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
145671290|NCT01640951|525314438|FG000|Overall Study|Adverse Event|8|||
145671291|NCT01640951|525314439|FG001|Overall Study|Adverse Event|3|||
145671292|NCT01640951|525314440|FG002|Overall Study|Adverse Event|10|||
145671293|NCT01640951|525314441|FG003|Overall Study|Adverse Event|6|||
145671294|NCT01640951|525314442|FG004|Overall Study|Adverse Event|1|||
145671295|NCT01640951|525314443|FG005|Overall Study|Adverse Event|11|||
145671296|NCT01640951|525314444|FG006|Overall Study|Adverse Event|1|||
145671297|NCT01640951|525314445|FG007|Overall Study|Adverse Event|3|||
145490894|NCT02648204|524652272|FG003|Overall Study|Lost to Follow-up|6|||
145490895|NCT02648204|524652269|FG000|Overall Study|Missing follow-up information|4|||
145671298|NCT01640951|525314438|FG000|Overall Study|Lack of Efficacy|20|||
145671299|NCT01640951|525314439|FG001|Overall Study|Lack of Efficacy|1|||
145671300|NCT01640951|525314440|FG002|Overall Study|Lack of Efficacy|7|||
145671301|NCT01640951|525314441|FG003|Overall Study|Lack of Efficacy|14|||
145490896|NCT02648204|524652270|FG001|Overall Study|Missing follow-up information|4|||
145671302|NCT01640951|525314442|FG004|Overall Study|Lack of Efficacy|0|||
145671303|NCT01640951|525314443|FG005|Overall Study|Lack of Efficacy|6|||
145671304|NCT01640951|525314444|FG006|Overall Study|Lack of Efficacy|5|||
145671305|NCT01640951|525314445|FG007|Overall Study|Lack of Efficacy|6|||
145671306|NCT01640951|525314438|FG000|Overall Study|Lost to Follow-up|1|||
145671307|NCT01640951|525314439|FG001|Overall Study|Lost to Follow-up|0|||
145671308|NCT01640951|525314440|FG002|Overall Study|Lost to Follow-up|6|||
145671309|NCT01640951|525314441|FG003|Overall Study|Lost to Follow-up|2|||
145671310|NCT01640951|525314442|FG004|Overall Study|Lost to Follow-up|2|||
145671311|NCT01640951|525314443|FG005|Overall Study|Lost to Follow-up|3|||
145671312|NCT01640951|525314444|FG006|Overall Study|Lost to Follow-up|1|||
145671313|NCT01640951|525314445|FG007|Overall Study|Lost to Follow-up|1|||
145671314|NCT01640951|525314438|FG000|Overall Study|Non-compliance with study treatment|0|||
145671315|NCT01640951|525314439|FG001|Overall Study|Non-compliance with study treatment|0|||
145671316|NCT01640951|525314440|FG002|Overall Study|Non-compliance with study treatment|1|||
145671317|NCT01640951|525314441|FG003|Overall Study|Non-compliance with study treatment|1|||
145671318|NCT01640951|525314442|FG004|Overall Study|Non-compliance with study treatment|1|||
145671319|NCT01640951|525314443|FG005|Overall Study|Non-compliance with study treatment|4|||
145671320|NCT01640951|525314444|FG006|Overall Study|Non-compliance with study treatment|1|||
145671321|NCT01640951|525314445|FG007|Overall Study|Non-compliance with study treatment|0|||
145671322|NCT01640951|525314438|FG000|Overall Study|Physician Decision|2|||
145671323|NCT01640951|525314439|FG001|Overall Study|Physician Decision|5|||
145671324|NCT01640951|525314440|FG002|Overall Study|Physician Decision|2|||
145671325|NCT01640951|525314441|FG003|Overall Study|Physician Decision|2|||
145671326|NCT01640951|525314442|FG004|Overall Study|Physician Decision|2|||
145671327|NCT01640951|525314443|FG005|Overall Study|Physician Decision|3|||
145671328|NCT01640951|525314444|FG006|Overall Study|Physician Decision|3|||
145671329|NCT01640951|525314445|FG007|Overall Study|Physician Decision|0|||
145671330|NCT01640951|525314438|FG000|Overall Study|Pregnancy|3|||
145671331|NCT01640951|525314439|FG001|Overall Study|Pregnancy|0|||
145671332|NCT01640951|525314440|FG002|Overall Study|Pregnancy|0|||
145671333|NCT01640951|525314441|FG003|Overall Study|Pregnancy|4|||
145671334|NCT01640951|525314442|FG004|Overall Study|Pregnancy|0|||
145671335|NCT01640951|525314443|FG005|Overall Study|Pregnancy|0|||
145671336|NCT01640951|525314444|FG006|Overall Study|Pregnancy|2|||
145671337|NCT01640951|525314445|FG007|Overall Study|Pregnancy|0|||
145671338|NCT01640951|525314438|FG000|Overall Study|Protocol Deviation|0|||
145671339|NCT01640951|525314439|FG001|Overall Study|Protocol Deviation|1|||
145671340|NCT01640951|525314440|FG002|Overall Study|Protocol Deviation|2|||
145671341|NCT01640951|525314441|FG003|Overall Study|Protocol Deviation|1|||
145671342|NCT01640951|525314442|FG004|Overall Study|Protocol Deviation|0|||
145671343|NCT01640951|525314443|FG005|Overall Study|Protocol Deviation|1|||
145671344|NCT01640951|525314444|FG006|Overall Study|Protocol Deviation|0|||
145671345|NCT01640951|525314445|FG007|Overall Study|Protocol Deviation|0|||
145671346|NCT01640951|525314438|FG000|Overall Study|Subject/Guardian decision|12|||
145671347|NCT01640951|525314439|FG001|Overall Study|Subject/Guardian decision|4|||
145671348|NCT01640951|525314440|FG002|Overall Study|Subject/Guardian decision|13|||
145671349|NCT01640951|525314441|FG003|Overall Study|Subject/Guardian decision|15|||
145671350|NCT01640951|525314442|FG004|Overall Study|Subject/Guardian decision|7|||
145671351|NCT01640951|525314443|FG005|Overall Study|Subject/Guardian decision|19|||
145671352|NCT01640951|525314444|FG006|Overall Study|Subject/Guardian decision|5|||
145671353|NCT01640951|525314445|FG007|Overall Study|Subject/Guardian decision|4|||
145671354|NCT01640951|525314438|FG000|Overall Study|Death|0|||
145671355|NCT01640951|525314439|FG001|Overall Study|Death|1|||
145671356|NCT01640951|525314440|FG002|Overall Study|Death|1|||
145671357|NCT01640951|525314441|FG003|Overall Study|Death|0|||
145671358|NCT01640951|525314442|FG004|Overall Study|Death|0|||
145671359|NCT01640951|525314443|FG005|Overall Study|Death|0|||
145671360|NCT01640951|525314444|FG006|Overall Study|Death|0|||
145671361|NCT01640951|525314445|FG007|Overall Study|Death|2|||
145671362|NCT04949542|525314446|FG000|Overall Study|Lost to Follow-up|4|||
145671363|NCT04949542|525314447|FG001|Overall Study|Lost to Follow-up|1|||
145671364|NCT01536093|525314448|FG000|Overall Study|Death|1|||
145671365|NCT01536093|525314449|FG001|Overall Study|Death|2|||
145671366|NCT01536093|525314448|FG000|Overall Study|absence of maternal colostrum|2|||
145671367|NCT01536093|525314449|FG001|Overall Study|absence of maternal colostrum|0|||
145671368|NCT01536093|525314448|FG000|Overall Study|Withdrawal by Subject|0|||
145671369|NCT01536093|525314449|FG001|Overall Study|Withdrawal by Subject|1|||
145671370|NCT02365597|525314450|FG000|Overall Study|Lost to Follow-up|0|||
145671371|NCT02365597|525314451|FG001|Overall Study|Lost to Follow-up|1|||
145671372|NCT02365597|525314452|FG002|Overall Study|Lost to Follow-up|0|||
145671373|NCT02365597|525314453|FG003|Overall Study|Lost to Follow-up|1|||
145490897|NCT02648204|524652271|FG002|Overall Study|Missing follow-up information|4|||
145671374|NCT02365597|525314450|FG000|Overall Study|Withdrawal by Subject|1|||
145671375|NCT02365597|525314451|FG001|Overall Study|Withdrawal by Subject|8|||
145671376|NCT02365597|525314452|FG002|Overall Study|Withdrawal by Subject|5|||
145490898|NCT02648204|524652272|FG003|Overall Study|Missing follow-up information|2|||
145671377|NCT02365597|525314453|FG003|Overall Study|Withdrawal by Subject|1|||
145671378|NCT02365597|525314450|FG000|Overall Study|Sponsor's decision|1|||
145671379|NCT02365597|525314451|FG001|Overall Study|Sponsor's decision|3|||
145671380|NCT02365597|525314452|FG002|Overall Study|Sponsor's decision|13|||
145671381|NCT02365597|525314453|FG003|Overall Study|Sponsor's decision|0|||
145671382|NCT02365597|525314450|FG000|Overall Study|Other|0|||
145671383|NCT02365597|525314451|FG001|Overall Study|Other|4|||
145671384|NCT02365597|525314452|FG002|Overall Study|Other|0|||
145671385|NCT02365597|525314453|FG003|Overall Study|Other|0|||
145671386|NCT02365597|525314450|FG000|Overall Study|Enrolled but not treated|0|||
145671387|NCT02365597|525314451|FG001|Overall Study|Enrolled but not treated|1|||
145671388|NCT02365597|525314452|FG002|Overall Study|Enrolled but not treated|1|||
145671389|NCT02365597|525314453|FG003|Overall Study|Enrolled but not treated|0|||
145671390|NCT02365597|525314450|FG000|Overall Study|Ongoing|0|||
145671391|NCT02365597|525314451|FG001|Overall Study|Ongoing|0|||
145671392|NCT02365597|525314452|FG002|Overall Study|Ongoing|0|||
145671393|NCT02365597|525314453|FG003|Overall Study|Ongoing|17|||
145671394|NCT02275611|525314454|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
145671395|NCT02275611|525314455|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
145671396|NCT02275611|525314456|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
145671397|NCT02275611|525314457|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
145671398|NCT01759862|525314463|FG000|Overall Study|Physician Decision|3|||
145671399|NCT01759862|525314464|FG001|Overall Study|Physician Decision|1|||
145671400|NCT01759862|525314463|FG000|Overall Study|Adverse Event|0|||
145671401|NCT01759862|525314464|FG001|Overall Study|Adverse Event|1|||
145671402|NCT03631407|525314465|FG000|Overall Study|Withdrawal by Subject|3|||
145671403|NCT03631407|525314466|FG001|Overall Study|Withdrawal by Subject|2|||
145671404|NCT03631407|525314465|FG000|Overall Study|Sponsor Decision|0|||
145671405|NCT03631407|525314466|FG001|Overall Study|Sponsor Decision|2|||
145671406|NCT03631407|525314465|FG000|Overall Study|Death|16|||
145671407|NCT03631407|525314466|FG001|Overall Study|Death|16|||
145671408|NCT03631407|525314465|FG000|Overall Study|Randomized by mistake without study treatment|1|||
145671409|NCT03631407|525314466|FG001|Overall Study|Randomized by mistake without study treatment|0|||
145671410|NCT01437319|525314467|FG000|Phase I|Lost to Follow-up|2|||
145671411|NCT01437319|525314468|FG001|Phase I|Lost to Follow-up|0|||
145671412|NCT01437319|525314469|FG002|Phase I|Lost to Follow-up|0|||
145671413|NCT01437319|525314467|FG000|Phase I|Protocol Violation|1|||
145671414|NCT01437319|525314468|FG001|Phase I|Protocol Violation|0|||
145671415|NCT01437319|525314469|FG002|Phase I|Protocol Violation|0|||
145671416|NCT01437319|525314467|FG000|Phase I|Study related symptoms/complaints|27|||
145671417|NCT01437319|525314468|FG001|Phase I|Study related symptoms/complaints|0|||
145671418|NCT01437319|525314469|FG002|Phase I|Study related symptoms/complaints|0|||
145671419|NCT01437319|525314467|FG000|Phase I|Withdrawal by Subject|25|||
145671420|NCT01437319|525314468|FG001|Phase I|Withdrawal by Subject|0|||
145671421|NCT01437319|525314469|FG002|Phase I|Withdrawal by Subject|0|||
145671422|NCT01437319|525314467|FG000|Phase II|Withdrawal by Subject|0|||
145671423|NCT01437319|525314468|FG001|Phase II|Withdrawal by Subject|8|||
145671424|NCT01437319|525314469|FG002|Phase II|Withdrawal by Subject|16|||
145671425|NCT01437319|525314467|FG000|Phase II|Lost to Follow-up|0|||
145671426|NCT01437319|525314468|FG001|Phase II|Lost to Follow-up|7|||
145671427|NCT01437319|525314469|FG002|Phase II|Lost to Follow-up|2|||
145671428|NCT01437319|525314467|FG000|Phase II|Study related symptoms/complaints|0|||
145671429|NCT01437319|525314468|FG001|Phase II|Study related symptoms/complaints|28|||
145671430|NCT01437319|525314469|FG002|Phase II|Study related symptoms/complaints|19|||
145671431|NCT01437319|525314467|FG000|Phase II|Protocol Violation|0|||
145671432|NCT01437319|525314468|FG001|Phase II|Protocol Violation|1|||
145671433|NCT01437319|525314469|FG002|Phase II|Protocol Violation|0|||
145671434|NCT00983294|525314470|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
145671435|NCT00983294|525314470|FG000|Colchicine With Azithromycin|Adverse Event|1|||
145671436|NCT00390884|525314471|FG000|Overall Study|Withdrawal by Subject|2|||
145671437|NCT00390884|525314472|FG001|Overall Study|Withdrawal by Subject|2|||
145671438|NCT04622332|525314473|FG000|Overall Study|Withdrawal by Subject|4|||
145671439|NCT04622332|525314474|FG001|Overall Study|Withdrawal by Subject|2|||
145671440|NCT04622332|525314473|FG000|Overall Study|Physician Decision|1|||
145671441|NCT04622332|525314474|FG001|Overall Study|Physician Decision|1|||
145671442|NCT04622332|525314473|FG000|Overall Study|Adverse Event|0|||
145671443|NCT04622332|525314474|FG001|Overall Study|Adverse Event|2|||
145671444|NCT04622332|525314473|FG000|Overall Study|Protocol Violation|0|||
145671445|NCT04622332|525314474|FG001|Overall Study|Protocol Violation|1|||
145671446|NCT05966155|525314475|FG000|Overall Study|Death|1|||
145671447|NCT05966155|525314476|FG001|Overall Study|Death|2|||
145671448|NCT05966155|525314475|FG000|Overall Study|Lost to Follow-up|63|||
145671449|NCT05966155|525314476|FG001|Overall Study|Lost to Follow-up|67|||
145671450|NCT05966155|525314475|FG000|Overall Study|Protocol Violation|1|||
145671451|NCT05966155|525314476|FG001|Overall Study|Protocol Violation|0|||
145671452|NCT05966155|525314475|FG000|Overall Study|Withdrawal by Subject|8|||
145671453|NCT05966155|525314476|FG001|Overall Study|Withdrawal by Subject|9|||
145671454|NCT05966155|525314475|FG000|Overall Study|Enrolled Erroneously|0|||
145671455|NCT05966155|525314476|FG001|Overall Study|Enrolled Erroneously|1|||
145671456|NCT05966155|525314475|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
145671457|NCT05966155|525314476|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
145671458|NCT00980954|525314477|FG000|Overall Study|Protocol Violation|9|||
145671459|NCT00980954|525314478|FG001|Overall Study|Protocol Violation|15|||
145671460|NCT05036278|525314481|FG000|Overall Study|Withdrawal by Subject|1|||
145671461|NCT05036278|525314481|FG000|Overall Study|Adverse Event|1|||
145671462|NCT04647487|525314482|FG000|Overall Study|Protocol Deviation|0|||
145671463|NCT04647487|525314483|FG001|Overall Study|Protocol Deviation|0|||
145671464|NCT04647487|525314484|FG002|Overall Study|Protocol Deviation|1|||
145671465|NCT04647487|525314482|FG000|Overall Study|Withdrawal by Subject|1|||
145671466|NCT04647487|525314483|FG001|Overall Study|Withdrawal by Subject|0|||
145671467|NCT04647487|525314484|FG002|Overall Study|Withdrawal by Subject|2|||
145671468|NCT03375320|525314485|FG000|Overall Study|Adverse Event|34|||
145671469|NCT03375320|525314486|FG001|Overall Study|Adverse Event|9|||
145671470|NCT03375320|525314487|FG002|Overall Study|Adverse Event|10|||
145671471|NCT03375320|525314488|FG003|Overall Study|Adverse Event|0|||
145671472|NCT03375320|525314485|FG000|Overall Study|Death|6|||
145671473|NCT03375320|525314486|FG001|Overall Study|Death|3|||
145671474|NCT03375320|525314487|FG002|Overall Study|Death|0|||
145671475|NCT03375320|525314488|FG003|Overall Study|Death|0|||
145671476|NCT03375320|525314485|FG000|Overall Study|Withdrawal by Subject|7|||
145671477|NCT03375320|525314486|FG001|Overall Study|Withdrawal by Subject|4|||
145671478|NCT03375320|525314487|FG002|Overall Study|Withdrawal by Subject|5|||
145671479|NCT03375320|525314488|FG003|Overall Study|Withdrawal by Subject|4|||
145671480|NCT03375320|525314485|FG000|Overall Study|Progressive disease|55|||
145671481|NCT03375320|525314486|FG001|Overall Study|Progressive disease|41|||
145671482|NCT03375320|525314487|FG002|Overall Study|Progressive disease|29|||
145671483|NCT03375320|525314488|FG003|Overall Study|Progressive disease|24|||
145671484|NCT03375320|525314485|FG000|Overall Study|Alternative treatment|6|||
145671485|NCT03375320|525314486|FG001|Overall Study|Alternative treatment|1|||
145671486|NCT03375320|525314487|FG002|Overall Study|Alternative treatment|1|||
145671487|NCT03375320|525314488|FG003|Overall Study|Alternative treatment|0|||
145671488|NCT03375320|525314485|FG000|Overall Study|Other disease|1|||
145671489|NCT03375320|525314486|FG001|Overall Study|Other disease|1|||
145671490|NCT03375320|525314487|FG002|Overall Study|Other disease|3|||
145671491|NCT03375320|525314488|FG003|Overall Study|Other disease|0|||
145671492|NCT03375320|525314485|FG000|Overall Study|Withdrawal prior to initiation|2|||
145671493|NCT03375320|525314486|FG001|Overall Study|Withdrawal prior to initiation|2|||
145671494|NCT03375320|525314487|FG002|Overall Study|Withdrawal prior to initiation|1|||
145671495|NCT03375320|525314488|FG003|Overall Study|Withdrawal prior to initiation|0|||
145671496|NCT03375320|525314485|FG000|Overall Study|Physician Decision|1|||
145671497|NCT03375320|525314486|FG001|Overall Study|Physician Decision|1|||
145671498|NCT03375320|525314487|FG002|Overall Study|Physician Decision|1|||
145671499|NCT03375320|525314488|FG003|Overall Study|Physician Decision|1|||
145671500|NCT03375320|525314485|FG000|Overall Study|Non-compliance|1|||
145671501|NCT03375320|525314486|FG001|Overall Study|Non-compliance|0|||
145671502|NCT03375320|525314487|FG002|Overall Study|Non-compliance|0|||
145671503|NCT03375320|525314488|FG003|Overall Study|Non-compliance|0|||
145671504|NCT00274261|525314489|FG000|Overall Study|Adverse Event|19|||
145671505|NCT00274261|525314490|FG001|Overall Study|Adverse Event|11|||
145671506|NCT00274261|525314489|FG000|Overall Study|Pregnancy|114|||
145671507|NCT00274261|525314490|FG001|Overall Study|Pregnancy|83|||
145671508|NCT00274261|525314489|FG000|Overall Study|Withdrawal by Subject|179|||
145671509|NCT00274261|525314490|FG001|Overall Study|Withdrawal by Subject|126|||
145671510|NCT00274261|525314489|FG000|Overall Study|Protocol Violation|71|||
145671511|NCT00274261|525314490|FG001|Overall Study|Protocol Violation|42|||
145671512|NCT00274261|525314489|FG000|Overall Study|Lost to Follow-up|106|||
145671513|NCT00274261|525314490|FG001|Overall Study|Lost to Follow-up|75|||
145671514|NCT03431350|525314491|FG000|Overall Study|ONGOING|0|||
145671515|NCT03431350|525314492|FG001|Overall Study|ONGOING|0|||
145671516|NCT03431350|525314493|FG002|Overall Study|ONGOING|2|||
145671517|NCT03431350|525314494|FG003|Overall Study|ONGOING|0|||
145671518|NCT03431350|525314495|FG004|Overall Study|ONGOING|1|||
145671519|NCT03431350|525314496|FG005|Overall Study|ONGOING|3|||
145671520|NCT03431350|525314497|FG006|Overall Study|ONGOING|0|||
145671521|NCT03431350|525314498|FG007|Overall Study|ONGOING|1|||
145671522|NCT03431350|525314499|FG008|Overall Study|ONGOING|3|||
145671523|NCT03431350|525314500|FG009|Overall Study|ONGOING|4|||
145671524|NCT03431350|525314501|FG010|Overall Study|ONGOING|2|||
145671525|NCT03431350|525314502|FG011|Overall Study|ONGOING|1|||
145671526|NCT03431350|525314491|FG000|Overall Study|Death|6|||
145671527|NCT03431350|525314492|FG001|Overall Study|Death|5|||
145490899|NCT02648204|524652269|FG000|Overall Study|Death|1|||
145671528|NCT03431350|525314493|FG002|Overall Study|Death|18|||
145671529|NCT03431350|525314494|FG003|Overall Study|Death|7|||
145671530|NCT03431350|525314495|FG004|Overall Study|Death|4|||
145490900|NCT02648204|524652270|FG001|Overall Study|Death|1|||
145490901|NCT02648204|524652271|FG002|Overall Study|Death|2|||
145671531|NCT03431350|525314496|FG005|Overall Study|Death|3|||
145671532|NCT03431350|525314497|FG006|Overall Study|Death|2|||
145671533|NCT03431350|525314498|FG007|Overall Study|Death|0|||
145671534|NCT03431350|525314499|FG008|Overall Study|Death|0|||
145671535|NCT03431350|525314500|FG009|Overall Study|Death|0|||
145671536|NCT03431350|525314501|FG010|Overall Study|Death|4|||
145671537|NCT03431350|525314502|FG011|Overall Study|Death|0|||
145671538|NCT03431350|525314491|FG000|Overall Study|Lost to Follow-up|0|||
145490902|NCT02648204|524652272|FG003|Overall Study|Death|2|||
145671539|NCT03431350|525314492|FG001|Overall Study|Lost to Follow-up|1|||
145671540|NCT03431350|525314493|FG002|Overall Study|Lost to Follow-up|0|||
145671541|NCT03431350|525314494|FG003|Overall Study|Lost to Follow-up|0|||
145671542|NCT03431350|525314495|FG004|Overall Study|Lost to Follow-up|0|||
145671543|NCT03431350|525314496|FG005|Overall Study|Lost to Follow-up|0|||
145671544|NCT03431350|525314497|FG006|Overall Study|Lost to Follow-up|0|||
145671545|NCT03431350|525314498|FG007|Overall Study|Lost to Follow-up|0|||
145671546|NCT03431350|525314499|FG008|Overall Study|Lost to Follow-up|0|||
145671547|NCT03431350|525314500|FG009|Overall Study|Lost to Follow-up|0|||
145671548|NCT03431350|525314501|FG010|Overall Study|Lost to Follow-up|0|||
145671549|NCT03431350|525314502|FG011|Overall Study|Lost to Follow-up|0|||
145671550|NCT03431350|525314491|FG000|Overall Study|Withdrawal by Subject|0|||
145671551|NCT03431350|525314492|FG001|Overall Study|Withdrawal by Subject|0|||
145671552|NCT03431350|525314493|FG002|Overall Study|Withdrawal by Subject|0|||
145671553|NCT03431350|525314494|FG003|Overall Study|Withdrawal by Subject|1|||
145671554|NCT03431350|525314495|FG004|Overall Study|Withdrawal by Subject|1|||
145671555|NCT03431350|525314496|FG005|Overall Study|Withdrawal by Subject|1|||
145671556|NCT03431350|525314497|FG006|Overall Study|Withdrawal by Subject|0|||
145671557|NCT03431350|525314498|FG007|Overall Study|Withdrawal by Subject|0|||
145671558|NCT03431350|525314499|FG008|Overall Study|Withdrawal by Subject|0|||
145671559|NCT03431350|525314500|FG009|Overall Study|Withdrawal by Subject|2|||
145671560|NCT03431350|525314501|FG010|Overall Study|Withdrawal by Subject|0|||
145671561|NCT03431350|525314502|FG011|Overall Study|Withdrawal by Subject|1|||
145671562|NCT03431350|525314491|FG000|Overall Study|Other|0|||
145671563|NCT03431350|525314492|FG001|Overall Study|Other|0|||
145671564|NCT03431350|525314493|FG002|Overall Study|Other|1|||
145671565|NCT03431350|525314494|FG003|Overall Study|Other|3|||
145671566|NCT03431350|525314495|FG004|Overall Study|Other|2|||
145671567|NCT03431350|525314496|FG005|Overall Study|Other|2|||
145671568|NCT03431350|525314497|FG006|Overall Study|Other|4|||
145671569|NCT03431350|525314498|FG007|Overall Study|Other|0|||
145671570|NCT03431350|525314499|FG008|Overall Study|Other|14|||
145671571|NCT03431350|525314500|FG009|Overall Study|Other|11|||
145671572|NCT03431350|525314501|FG010|Overall Study|Other|11|||
145671573|NCT03431350|525314502|FG011|Overall Study|Other|15|||
145671574|NCT04325828|525314503|FG000|Overall Study|Ongoing|26|||
145671575|NCT05509816|525314504|FG000|Overall Study|Lost to Follow-up|1|||
145671576|NCT04801420|525314505|FG000|Overall Study|Other|1|||
145671577|NCT04801420|525314506|FG001|Overall Study|Other|2|||
145671578|NCT04801420|525314507|FG002|Overall Study|Other|1|||
145671579|NCT04801420|525314505|FG000|Overall Study|Lost to Follow-up|7|||
145671580|NCT04801420|525314506|FG001|Overall Study|Lost to Follow-up|9|||
145671581|NCT04801420|525314507|FG002|Overall Study|Lost to Follow-up|10|||
145671582|NCT04801420|525314505|FG000|Overall Study|Moved from study area|0|||
145671583|NCT04801420|525314506|FG001|Overall Study|Moved from study area|1|||
145671584|NCT04801420|525314507|FG002|Overall Study|Moved from study area|1|||
145671585|NCT04801420|525314505|FG000|Overall Study|Withdrawal by Subject|5|||
145671586|NCT04801420|525314506|FG001|Overall Study|Withdrawal by Subject|1|||
145671587|NCT04801420|525314507|FG002|Overall Study|Withdrawal by Subject|4|||
145671588|NCT04801420|525314505|FG000|Overall Study|Individual stopping criteria reached|0|||
145671589|NCT04801420|525314506|FG001|Overall Study|Individual stopping criteria reached|1|||
145671590|NCT04801420|525314507|FG002|Overall Study|Individual stopping criteria reached|0|||
145671591|NCT04801420|525314505|FG000|Overall Study|Ongoing in the study|195|||
145671592|NCT04801420|525314506|FG001|Overall Study|Ongoing in the study|195|||
145671593|NCT04801420|525314507|FG002|Overall Study|Ongoing in the study|192|||
145671594|NCT03907488|525314508|FG000|Overall Study|Adverse Event|20|||
145671595|NCT03907488|525314509|FG001|Overall Study|Adverse Event|20|||
145671596|NCT03907488|525314508|FG000|Overall Study|Withdrawal by Subject|9|||
145671597|NCT03907488|525314509|FG001|Overall Study|Withdrawal by Subject|13|||
145671598|NCT03907488|525314508|FG000|Overall Study|Lack of Efficacy|0|||
145671599|NCT03907488|525314509|FG001|Overall Study|Lack of Efficacy|9|||
145671600|NCT03907488|525314508|FG000|Overall Study|Death|3|||
145671601|NCT03907488|525314509|FG001|Overall Study|Death|8|||
145671602|NCT03907488|525314508|FG000|Overall Study|not protocol specified|5|||
145671603|NCT03907488|525314509|FG001|Overall Study|not protocol specified|8|||
145671604|NCT03907488|525314508|FG000|Overall Study|Ineligible|9|||
145671605|NCT03907488|525314509|FG001|Overall Study|Ineligible|15|||
145671606|NCT03414684|525314510|FG000|First-course Treatment|Complete response|0|||
145671607|NCT03414684|525314511|FG001|First-course Treatment|Complete response|1|||
145671608|NCT03414684|525314510|FG000|First-course Treatment|Intercurrent illness|1|||
145671609|NCT03414684|525314511|FG001|First-course Treatment|Intercurrent illness|0|||
145671610|NCT03414684|525314510|FG000|First-course Treatment|Progressive Disease|31|||
145671611|NCT03414684|525314511|FG001|First-course Treatment|Progressive Disease|32|||
145671612|NCT03414684|525314510|FG000|First-course Treatment|Adverse Event|1|||
145671613|NCT03414684|525314511|FG001|First-course Treatment|Adverse Event|2|||
145671614|NCT03414684|525314510|FG000|First-course Treatment|Physician Decision|0|||
145671615|NCT03414684|525314511|FG001|First-course Treatment|Physician Decision|1|||
145671616|NCT03414684|525314510|FG000|First-course Treatment|Withdrawal by Subject|0|||
145671617|NCT03414684|525314511|FG001|First-course Treatment|Withdrawal by Subject|1|||
145671618|NCT03414684|525314510|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
145671619|NCT03414684|525314511|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
145671620|NCT03414684|525314510|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
145671621|NCT03414684|525314511|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
145671622|NCT03414684|525314510|FG000|First-course Treatment|Still on treatment|3|||
145671623|NCT03414684|525314511|FG001|First-course Treatment|Still on treatment|0|||
145671624|NCT03414684|525314510|FG000|First-course Treatment|Never started protocol therapy|2|||
145671625|NCT03414684|525314511|FG001|First-course Treatment|Never started protocol therapy|1|||
145671626|NCT03414684|525314510|FG000|Crossover Treatment|Progressive disease|0|||
145671627|NCT03414684|525314511|FG001|Crossover Treatment|Progressive disease|12|||
145671628|NCT03414684|525314510|FG000|Crossover Treatment|Adverse Event|0|||
145671629|NCT03414684|525314511|FG001|Crossover Treatment|Adverse Event|3|||
145671630|NCT03414684|525314510|FG000|Crossover Treatment|Physician Decision|0|||
145671631|NCT03414684|525314511|FG001|Crossover Treatment|Physician Decision|1|||
145671632|NCT03414684|525314510|FG000|Crossover Treatment|Still on treatment|0|||
145671633|NCT03414684|525314511|FG001|Crossover Treatment|Still on treatment|2|||
145671634|NCT02078648|525314512|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
145671635|NCT02078648|525314513|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
145671636|NCT02078648|525314512|FG000|Overall Study|Adverse Event|0|||
145671637|NCT02078648|525314513|FG001|Overall Study|Adverse Event|1|||
145671638|NCT02078648|525314512|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
145671639|NCT02078648|525314513|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
145671640|NCT02078648|525314512|FG000|Overall Study|Withdrawal by Subject|3|||
145671641|NCT02078648|525314513|FG001|Overall Study|Withdrawal by Subject|1|||
145671642|NCT02078648|525314512|FG000|Overall Study|Investigator Decision|5|||
145671643|NCT02078648|525314513|FG001|Overall Study|Investigator Decision|7|||
145671644|NCT02078648|525314512|FG000|Overall Study|Death|1|||
145671645|NCT02078648|525314513|FG001|Overall Study|Death|1|||
145671646|NCT02078648|525314512|FG000|Overall Study|Undefined|0|||
145671647|NCT02078648|525314513|FG001|Overall Study|Undefined|1|||
145671648|NCT01675492|525314514|FG000|Overall Study|study completed early - product approval|42|||
145671649|NCT04306367|525314519|FG000|Overall Study|Progression of Disease|9|||
145671650|NCT04306367|525314519|FG000|Overall Study|Adverse Event|3|||
145671651|NCT04306367|525314519|FG000|Overall Study|Withdrawal by Subject|1|||
145671652|NCT02401815|525314520|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671653|NCT02401815|525314521|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671654|NCT02401815|525314522|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671655|NCT02401815|525314523|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
145671656|NCT02401815|525314524|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671657|NCT02401815|525314525|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671658|NCT02401815|525314526|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671659|NCT02401815|525314527|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671660|NCT02401815|525314528|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671661|NCT02401815|525314529|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
145671662|NCT02401815|525314520|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
145671663|NCT02401815|525314521|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671664|NCT02401815|525314522|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671665|NCT02401815|525314523|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
145671666|NCT02401815|525314524|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671667|NCT02401815|525314525|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671668|NCT02401815|525314526|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671669|NCT02401815|525314527|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671670|NCT02401815|525314528|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671671|NCT02401815|525314529|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
145671672|NCT02401815|525314520|FG000|Dose Escalation (up to 670 Days)|Death|1|||
145671673|NCT02401815|525314521|FG001|Dose Escalation (up to 670 Days)|Death|2|||
145671674|NCT02401815|525314522|FG002|Dose Escalation (up to 670 Days)|Death|3|||
145671675|NCT02401815|525314523|FG003|Dose Escalation (up to 670 Days)|Death|5|||
145671676|NCT02401815|525314524|FG004|Dose Escalation (up to 670 Days)|Death|4|||
145671677|NCT02401815|525314525|FG005|Dose Escalation (up to 670 Days)|Death|0|||
145671678|NCT02401815|525314526|FG006|Dose Escalation (up to 670 Days)|Death|0|||
145671679|NCT02401815|525314527|FG007|Dose Escalation (up to 670 Days)|Death|0|||
145671680|NCT02401815|525314528|FG008|Dose Escalation (up to 670 Days)|Death|0|||
145671681|NCT02401815|525314529|FG009|Dose Escalation (up to 670 Days)|Death|0|||
145671682|NCT02401815|525314520|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671683|NCT02401815|525314521|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
145671684|NCT02401815|525314522|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671685|NCT02401815|525314523|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671686|NCT02401815|525314524|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
145671687|NCT02401815|525314525|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671688|NCT02401815|525314526|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671689|NCT02401815|525314527|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671690|NCT02401815|525314528|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671691|NCT02401815|525314529|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
145671692|NCT02401815|525314520|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
145671693|NCT02401815|525314521|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671694|NCT02401815|525314522|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671695|NCT02401815|525314523|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671696|NCT02401815|525314524|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
145671697|NCT02401815|525314525|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671698|NCT02401815|525314526|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671699|NCT02401815|525314527|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671700|NCT02401815|525314528|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671701|NCT02401815|525314529|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
145671702|NCT02401815|525314520|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671703|NCT02401815|525314521|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671704|NCT02401815|525314522|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671705|NCT02401815|525314523|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671706|NCT02401815|525314524|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671707|NCT02401815|525314525|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
145671708|NCT02401815|525314526|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671709|NCT02401815|525314527|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671710|NCT02401815|525314528|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671711|NCT02401815|525314529|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
145671712|NCT02401815|525314520|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671713|NCT02401815|525314521|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671714|NCT02401815|525314522|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671715|NCT02401815|525314523|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671716|NCT02401815|525314524|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671717|NCT02401815|525314525|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671718|NCT02401815|525314526|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
145671719|NCT02401815|525314527|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671720|NCT02401815|525314528|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671721|NCT02401815|525314529|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671722|NCT02401815|525314520|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671723|NCT02401815|525314521|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671724|NCT02401815|525314522|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671725|NCT02401815|525314523|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671726|NCT02401815|525314524|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671727|NCT02401815|525314525|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
145671728|NCT02401815|525314526|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
145671729|NCT02401815|525314527|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671730|NCT02401815|525314528|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671731|NCT02401815|525314529|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
145671732|NCT02401815|525314520|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671733|NCT02401815|525314521|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671734|NCT02401815|525314522|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671735|NCT02401815|525314523|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671736|NCT02401815|525314524|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671737|NCT02401815|525314525|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
145671738|NCT02401815|525314526|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671739|NCT02401815|525314527|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671740|NCT02401815|525314528|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671741|NCT02401815|525314529|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
145671742|NCT02401815|525314520|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671743|NCT02401815|525314521|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671744|NCT02401815|525314522|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671745|NCT02401815|525314523|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671746|NCT02401815|525314524|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671747|NCT02401815|525314525|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671748|NCT02401815|525314526|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
145671749|NCT02401815|525314527|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
145671750|NCT02401815|525314528|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
145671751|NCT02401815|525314529|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
145671752|NCT02401815|525314520|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671753|NCT02401815|525314521|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671754|NCT02401815|525314522|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671755|NCT02401815|525314523|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671756|NCT02401815|525314524|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671757|NCT02401815|525314525|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671758|NCT02401815|525314526|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671759|NCT02401815|525314527|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
145671760|NCT02401815|525314528|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
145671761|NCT02401815|525314529|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
145671762|NCT02401815|525314520|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671763|NCT02401815|525314521|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671764|NCT02401815|525314522|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671765|NCT02401815|525314523|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671766|NCT02401815|525314524|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671767|NCT02401815|525314525|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671768|NCT02401815|525314526|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671769|NCT02401815|525314527|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671770|NCT02401815|525314528|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
145671771|NCT02401815|525314529|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
145671772|NCT02401815|525314520|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671773|NCT02401815|525314521|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671774|NCT02401815|525314522|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671775|NCT02401815|525314523|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671776|NCT02401815|525314524|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671777|NCT02401815|525314525|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671778|NCT02401815|525314526|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671779|NCT02401815|525314527|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671780|NCT02401815|525314528|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
145671781|NCT02401815|525314529|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
145671782|NCT02401815|525314520|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671783|NCT02401815|525314521|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671784|NCT02401815|525314522|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671785|NCT02401815|525314523|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671786|NCT02401815|525314524|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671787|NCT02401815|525314525|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671788|NCT02401815|525314526|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671789|NCT02401815|525314527|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
145671790|NCT02401815|525314528|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
145671791|NCT02401815|525314529|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
145671792|NCT04218357|525314530|FG000|1st Allocation|Withdrawal by Subject|1|||
145671793|NCT04218357|525314531|FG001|1st Allocation|Withdrawal by Subject|0|||
145671794|NCT05199571|525315990|FG000|Treatment Period|Participant decision|3|||
145671795|NCT05199571|525315990|FG000|Treatment Period|Physician Decision|1|||
145671796|NCT05199571|525315990|FG000|Post-treatment Follow up Period|Participant decision|3|||
145671797|NCT03367156|525315991|FG000|Overall Study|Lack of interest|3|||
145671798|NCT03367156|525315992|FG001|Overall Study|Lack of interest|1|||
145671799|NCT03367156|525315991|FG000|Overall Study|Death|2|||
145671800|NCT03367156|525315992|FG001|Overall Study|Death|0|||
145671801|NCT03367156|525315991|FG000|Overall Study|Lost to Follow-up|2|||
145671802|NCT03367156|525315992|FG001|Overall Study|Lost to Follow-up|1|||
145671803|NCT03367156|525315991|FG000|Overall Study|Became ineligible|1|||
145671804|NCT03367156|525315992|FG001|Overall Study|Became ineligible|2|||
145671805|NCT03367156|525315991|FG000|Overall Study|Hospitalization|1|||
145671806|NCT03367156|525315992|FG001|Overall Study|Hospitalization|0|||
145671807|NCT03367156|525315991|FG000|Overall Study|Concerned about Treatment|11|||
145671808|NCT03367156|525315992|FG001|Overall Study|Concerned about Treatment|3|||
145671809|NCT03367156|525315991|FG000|Overall Study|Started new treatment|4|||
145671810|NCT03367156|525315992|FG001|Overall Study|Started new treatment|1|||
145671811|NCT03762850|525315993|FG000|Overall Study|Death|0|||
145671812|NCT03762850|525315994|FG001|Overall Study|Death|1|||
145671813|NCT03762850|525315993|FG000|Overall Study|Lost to Follow-up|0|||
145671814|NCT03762850|525315994|FG001|Overall Study|Lost to Follow-up|1|||
145671815|NCT03762850|525315993|FG000|Overall Study|Physician Decision|0|||
145671816|NCT03762850|525315994|FG001|Overall Study|Physician Decision|1|||
145671817|NCT03762850|525315993|FG000|Overall Study|Withdrawal by Subject|4|||
145671818|NCT03762850|525315994|FG001|Overall Study|Withdrawal by Subject|9|||
145671819|NCT00092534|525315995|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
145671820|NCT00092534|525315996|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
145671821|NCT00092534|525315997|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145671822|NCT00092534|525315998|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145671823|NCT00092534|525315999|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
145671824|NCT00092534|525315995|FG000|Base Study Vaccination Period|Adverse Event|3|||
145671825|NCT00092534|525315996|FG001|Base Study Vaccination Period|Adverse Event|1|||
145671826|NCT00092534|525315997|FG002|Base Study Vaccination Period|Adverse Event|0|||
145671827|NCT00092534|525315998|FG003|Base Study Vaccination Period|Adverse Event|0|||
145671828|NCT00092534|525315999|FG004|Base Study Vaccination Period|Adverse Event|0|||
145671829|NCT00092534|525315995|FG000|Base Study Vaccination Period|Death|5|||
145671830|NCT00092534|525315996|FG001|Base Study Vaccination Period|Death|4|||
145671831|NCT00092534|525315997|FG002|Base Study Vaccination Period|Death|0|||
145671832|NCT00092534|525315998|FG003|Base Study Vaccination Period|Death|0|||
145671833|NCT00092534|525315999|FG004|Base Study Vaccination Period|Death|0|||
145671834|NCT00092534|525315995|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
145671835|NCT00092534|525315996|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
145671836|NCT00092534|525315997|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
145671837|NCT00092534|525315998|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
145671838|NCT00092534|525315999|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
145671839|NCT00092534|525315995|FG000|Base Study Vaccination Period|Physician Decision|1|||
145671840|NCT00092534|525315996|FG001|Base Study Vaccination Period|Physician Decision|0|||
145671841|NCT00092534|525315997|FG002|Base Study Vaccination Period|Physician Decision|0|||
145671842|NCT00092534|525315998|FG003|Base Study Vaccination Period|Physician Decision|0|||
145671843|NCT00092534|525315999|FG004|Base Study Vaccination Period|Physician Decision|0|||
145671844|NCT00092534|525315995|FG000|Base Study Vaccination Period|Pregnancy|9|||
145671845|NCT00092534|525315996|FG001|Base Study Vaccination Period|Pregnancy|7|||
145671846|NCT00092534|525315997|FG002|Base Study Vaccination Period|Pregnancy|0|||
145671847|NCT00092534|525315998|FG003|Base Study Vaccination Period|Pregnancy|0|||
145671848|NCT00092534|525315999|FG004|Base Study Vaccination Period|Pregnancy|0|||
145671849|NCT00092534|525315995|FG000|Base Study Vaccination Period|Protocol Violation|2|||
145671850|NCT00092534|525315996|FG001|Base Study Vaccination Period|Protocol Violation|1|||
145671851|NCT00092534|525315997|FG002|Base Study Vaccination Period|Protocol Violation|0|||
145671852|NCT00092534|525315998|FG003|Base Study Vaccination Period|Protocol Violation|0|||
145671853|NCT00092534|525315999|FG004|Base Study Vaccination Period|Protocol Violation|0|||
145671854|NCT00092534|525315995|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
145671855|NCT00092534|525315996|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
145671856|NCT00092534|525315997|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
145671857|NCT00092534|525315998|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
145671858|NCT00092534|525315999|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
145671859|NCT00092534|525315995|FG000|Base Study Vaccination Period|Moved|14|||
145671860|NCT00092534|525315996|FG001|Base Study Vaccination Period|Moved|12|||
145671861|NCT00092534|525315997|FG002|Base Study Vaccination Period|Moved|0|||
145671862|NCT00092534|525315998|FG003|Base Study Vaccination Period|Moved|0|||
145671863|NCT00092534|525315999|FG004|Base Study Vaccination Period|Moved|0|||
145671864|NCT00092534|525315995|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
145671865|NCT00092534|525315996|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
145671866|NCT00092534|525315997|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
145671867|NCT00092534|525315998|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
145671868|NCT00092534|525315999|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
145671869|NCT00092534|525315995|FG000|Base Study Vaccination Period|Travel|1|||
145671870|NCT00092534|525315996|FG001|Base Study Vaccination Period|Travel|0|||
145671871|NCT00092534|525315997|FG002|Base Study Vaccination Period|Travel|0|||
145671872|NCT00092534|525315998|FG003|Base Study Vaccination Period|Travel|0|||
145671873|NCT00092534|525315999|FG004|Base Study Vaccination Period|Travel|0|||
145671874|NCT00092534|525315995|FG000|Base Study Vaccination Period|Site Closed|0|||
145671875|NCT00092534|525315996|FG001|Base Study Vaccination Period|Site Closed|1|||
145671876|NCT00092534|525315997|FG002|Base Study Vaccination Period|Site Closed|0|||
145671877|NCT00092534|525315998|FG003|Base Study Vaccination Period|Site Closed|0|||
145671878|NCT00092534|525315999|FG004|Base Study Vaccination Period|Site Closed|0|||
145671879|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Adverse Event|2|||
145671880|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Adverse Event|4|||
145671881|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Adverse Event|0|||
145671882|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Adverse Event|0|||
145671883|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Adverse Event|0|||
145671884|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Death|2|||
145671885|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Death|1|||
145671886|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Death|0|||
145671887|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Death|0|||
145671888|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Death|0|||
145671889|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
145671890|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
145671891|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
145671892|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
145671893|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
145671894|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Pregnancy|6|||
145671895|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Pregnancy|10|||
145671896|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Pregnancy|0|||
145671897|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Pregnancy|0|||
145671898|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Pregnancy|0|||
145671899|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
145671900|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
145671901|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
145671902|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
145671903|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
145671904|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
145671905|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
145671906|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
145671907|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
145671908|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
145671909|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Moved|62|||
145671910|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Moved|58|||
145671911|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Moved|0|||
145671912|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Moved|0|||
145671913|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Moved|0|||
145671914|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Travel|10|||
145671915|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Travel|7|||
145671916|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Travel|0|||
145671917|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Travel|0|||
145671918|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Travel|0|||
145671919|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Site Closed|0|||
145671920|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Site Closed|2|||
145671921|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Site Closed|0|||
145671922|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Site Closed|0|||
145671923|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Site Closed|0|||
145671924|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
145671925|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
145671926|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
145671927|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
145671928|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
145671929|NCT00092534|525315995|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
145671930|NCT00092534|525315996|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
145671931|NCT00092534|525315997|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
145671932|NCT00092534|525315998|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
145671933|NCT00092534|525315999|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
145671934|NCT00092534|525315995|FG000|Base Study EXT|Lost to Follow-up|0|||
145671935|NCT00092534|525315996|FG001|Base Study EXT|Lost to Follow-up|0|||
145671936|NCT00092534|525315997|FG002|Base Study EXT|Lost to Follow-up|41|||
145671937|NCT00092534|525315998|FG003|Base Study EXT|Lost to Follow-up|0|||
145671938|NCT00092534|525315999|FG004|Base Study EXT|Lost to Follow-up|0|||
145671939|NCT00092534|525315995|FG000|Base Study EXT|Physician Decision|0|||
145671940|NCT00092534|525315996|FG001|Base Study EXT|Physician Decision|0|||
145671941|NCT00092534|525315997|FG002|Base Study EXT|Physician Decision|1|||
145671942|NCT00092534|525315998|FG003|Base Study EXT|Physician Decision|0|||
145671943|NCT00092534|525315999|FG004|Base Study EXT|Physician Decision|0|||
145671944|NCT00092534|525315995|FG000|Base Study EXT|Pregnancy|0|||
145671945|NCT00092534|525315996|FG001|Base Study EXT|Pregnancy|0|||
145671946|NCT00092534|525315997|FG002|Base Study EXT|Pregnancy|12|||
145671947|NCT00092534|525315998|FG003|Base Study EXT|Pregnancy|0|||
145671948|NCT00092534|525315999|FG004|Base Study EXT|Pregnancy|0|||
145671949|NCT00092534|525315995|FG000|Base Study EXT|Withdrawal by Subject|0|||
145671950|NCT00092534|525315996|FG001|Base Study EXT|Withdrawal by Subject|0|||
145671951|NCT00092534|525315997|FG002|Base Study EXT|Withdrawal by Subject|18|||
145671952|NCT00092534|525315998|FG003|Base Study EXT|Withdrawal by Subject|0|||
145671953|NCT00092534|525315999|FG004|Base Study EXT|Withdrawal by Subject|0|||
145671954|NCT00092534|525315995|FG000|Base Study EXT|Participant moved|0|||
145671955|NCT00092534|525315996|FG001|Base Study EXT|Participant moved|0|||
145671956|NCT00092534|525315997|FG002|Base Study EXT|Participant moved|6|||
145671957|NCT00092534|525315998|FG003|Base Study EXT|Participant moved|0|||
145671958|NCT00092534|525315999|FG004|Base Study EXT|Participant moved|0|||
145671959|NCT00092534|525315995|FG000|Base Study EXT|Travel|0|||
145671960|NCT00092534|525315996|FG001|Base Study EXT|Travel|0|||
145671961|NCT00092534|525315997|FG002|Base Study EXT|Travel|2|||
145671962|NCT00092534|525315998|FG003|Base Study EXT|Travel|0|||
145671963|NCT00092534|525315999|FG004|Base Study EXT|Travel|0|||
145671964|NCT00092534|525315995|FG000|Base Study EXT|Site closed|0|||
145671965|NCT00092534|525315996|FG001|Base Study EXT|Site closed|0|||
145671966|NCT00092534|525315997|FG002|Base Study EXT|Site closed|21|||
145671967|NCT00092534|525315998|FG003|Base Study EXT|Site closed|0|||
145671968|NCT00092534|525315999|FG004|Base Study EXT|Site closed|0|||
145671969|NCT00092534|525315995|FG000|Base Study EXT|Study ended|0|||
145671970|NCT00092534|525315996|FG001|Base Study EXT|Study ended|0|||
145671971|NCT00092534|525315997|FG002|Base Study EXT|Study ended|29|||
145671972|NCT00092534|525315998|FG003|Base Study EXT|Study ended|0|||
145671973|NCT00092534|525315999|FG004|Base Study EXT|Study ended|0|||
145671974|NCT00092534|525315995|FG000|Base Study EXT|Protocol Violation|0|||
145671975|NCT00092534|525315996|FG001|Base Study EXT|Protocol Violation|0|||
145671976|NCT00092534|525315997|FG002|Base Study EXT|Protocol Violation|15|||
145671977|NCT00092534|525315998|FG003|Base Study EXT|Protocol Violation|0|||
145671978|NCT00092534|525315999|FG004|Base Study EXT|Protocol Violation|0|||
145671979|NCT00092534|525315995|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
145671980|NCT00092534|525315996|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
145671981|NCT00092534|525315997|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
145671982|NCT00092534|525315998|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
145671983|NCT00092534|525315999|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
145671984|NCT02036970|525316003|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
145671985|NCT02036970|525316004|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
145671986|NCT02036970|525316005|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
145671987|NCT02036970|525316006|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
145671988|NCT02036970|525316007|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
145671989|NCT02036970|525316008|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
145671990|NCT02036970|525316009|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
145671991|NCT02036970|525316010|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
145671992|NCT02036970|525316011|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
145671993|NCT02036970|525316012|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
145671994|NCT02036970|525316003|FG000|Part 1: Day 1 Through Week 16|Death|0|||
145671995|NCT02036970|525316004|FG001|Part 1: Day 1 Through Week 16|Death|0|||
145671996|NCT02036970|525316005|FG002|Part 1: Day 1 Through Week 16|Death|0|||
145671997|NCT02036970|525316006|FG003|Part 1: Day 1 Through Week 16|Death|0|||
145671998|NCT02036970|525316007|FG004|Part 1: Day 1 Through Week 16|Death|0|||
145671999|NCT02036970|525316008|FG005|Part 1: Day 1 Through Week 16|Death|0|||
145672000|NCT02036970|525316009|FG006|Part 1: Day 1 Through Week 16|Death|0|||
145672001|NCT02036970|525316010|FG007|Part 1: Day 1 Through Week 16|Death|0|||
145672002|NCT02036970|525316011|FG008|Part 1: Day 1 Through Week 16|Death|1|||
145672003|NCT02036970|525316012|FG009|Part 1: Day 1 Through Week 16|Death|0|||
145672004|NCT02036970|525316003|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
145672005|NCT02036970|525316004|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672006|NCT02036970|525316005|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
145672007|NCT02036970|525316006|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672008|NCT02036970|525316007|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672009|NCT02036970|525316008|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672010|NCT02036970|525316009|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672011|NCT02036970|525316010|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672012|NCT02036970|525316011|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
145672013|NCT02036970|525316012|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
145672014|NCT02036970|525316003|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672015|NCT02036970|525316004|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672016|NCT02036970|525316005|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672017|NCT02036970|525316006|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672018|NCT02036970|525316007|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
145672019|NCT02036970|525316008|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672020|NCT02036970|525316009|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672021|NCT02036970|525316010|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
145672022|NCT02036970|525316011|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
145672023|NCT02036970|525316012|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
145672024|NCT02036970|525316003|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672025|NCT02036970|525316004|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672026|NCT02036970|525316005|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672027|NCT02036970|525316006|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
145672028|NCT02036970|525316007|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672029|NCT02036970|525316008|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672030|NCT02036970|525316009|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672031|NCT02036970|525316010|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672032|NCT02036970|525316011|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672033|NCT02036970|525316012|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
145672034|NCT02036970|525316003|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
145672035|NCT02036970|525316004|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
145672036|NCT02036970|525316005|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
145672037|NCT02036970|525316006|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
145672038|NCT02036970|525316007|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
145672039|NCT02036970|525316008|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
145672040|NCT02036970|525316009|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
145672041|NCT02036970|525316010|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
145672042|NCT02036970|525316011|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
145672043|NCT02036970|525316012|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
145672044|NCT02036970|525316003|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672045|NCT02036970|525316004|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672046|NCT02036970|525316005|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672047|NCT02036970|525316006|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672048|NCT02036970|525316007|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672049|NCT02036970|525316008|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672050|NCT02036970|525316009|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672051|NCT02036970|525316010|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
145672052|NCT02036970|525316011|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672053|NCT02036970|525316012|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
145672054|NCT02036970|525316003|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672055|NCT02036970|525316004|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
145672056|NCT02036970|525316005|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
145672057|NCT02036970|525316006|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672058|NCT02036970|525316007|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672059|NCT02036970|525316008|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672060|NCT02036970|525316009|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672061|NCT02036970|525316010|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672062|NCT02036970|525316011|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
145672063|NCT02036970|525316012|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
145672064|NCT02036970|525316003|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672065|NCT02036970|525316004|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
145672066|NCT02036970|525316005|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
145672067|NCT02036970|525316006|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
145672068|NCT02036970|525316007|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672069|NCT02036970|525316008|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672070|NCT02036970|525316009|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672071|NCT02036970|525316010|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672072|NCT02036970|525316011|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
145672073|NCT02036970|525316012|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
145672074|NCT01171898|525316017|FG000|Overall Study|Death|0|||
145672075|NCT01171898|525316018|FG001|Overall Study|Death|0|||
145672076|NCT01171898|525316019|FG002|Overall Study|Death|2|||
145672077|NCT01171898|525316020|FG003|Overall Study|Death|0|||
145672078|NCT01171898|525316017|FG000|Overall Study|Lost to Follow-up|0|||
145672079|NCT01171898|525316018|FG001|Overall Study|Lost to Follow-up|1|||
145672080|NCT01171898|525316019|FG002|Overall Study|Lost to Follow-up|1|||
145672081|NCT01171898|525316020|FG003|Overall Study|Lost to Follow-up|1|||
145672082|NCT01171898|525316017|FG000|Overall Study|Withdrawal by Subject|1|||
145672083|NCT01171898|525316018|FG001|Overall Study|Withdrawal by Subject|4|||
145672084|NCT01171898|525316019|FG002|Overall Study|Withdrawal by Subject|6|||
145672085|NCT01171898|525316020|FG003|Overall Study|Withdrawal by Subject|3|||
145672086|NCT01171898|525316017|FG000|Overall Study|Terminated by Sponsor|1|||
145672087|NCT01171898|525316018|FG001|Overall Study|Terminated by Sponsor|0|||
145672088|NCT01171898|525316019|FG002|Overall Study|Terminated by Sponsor|0|||
145672089|NCT01171898|525316020|FG003|Overall Study|Terminated by Sponsor|0|||
145672090|NCT01171898|525316017|FG000|Overall Study|Ongoing|1|||
145672091|NCT01171898|525316018|FG001|Overall Study|Ongoing|9|||
145672092|NCT01171898|525316019|FG002|Overall Study|Ongoing|3|||
145672093|NCT01171898|525316020|FG003|Overall Study|Ongoing|0|||
145672094|NCT01171898|525316017|FG000|Overall Study|Other|1|||
145672095|NCT01171898|525316018|FG001|Overall Study|Other|5|||
145672096|NCT01171898|525316019|FG002|Overall Study|Other|0|||
145672097|NCT01171898|525316020|FG003|Overall Study|Other|2|||
145672098|NCT05802173|525316021|FG000|Overall Study|Withdrawal by Subject|2|||
145672099|NCT05802173|525316022|FG001|Overall Study|Withdrawal by Subject|0|||
145672100|NCT05802173|525316023|FG002|Overall Study|Withdrawal by Subject|0|||
145672101|NCT05802173|525316021|FG000|Overall Study|Protocol Violation|1|||
145672102|NCT05802173|525316022|FG001|Overall Study|Protocol Violation|0|||
145672103|NCT05802173|525316023|FG002|Overall Study|Protocol Violation|0|||
145672104|NCT05802173|525316021|FG000|Overall Study|Lost to Follow-up|0|||
145672105|NCT05802173|525316022|FG001|Overall Study|Lost to Follow-up|6|||
145672106|NCT05802173|525316023|FG002|Overall Study|Lost to Follow-up|4|||
145672107|NCT05802173|525316021|FG000|Overall Study|non-compliance|0|||
145672108|NCT05802173|525316022|FG001|Overall Study|non-compliance|1|||
145672109|NCT05802173|525316023|FG002|Overall Study|non-compliance|0|||
145672110|NCT02932410|525316024|FG000|Overall Study|Death|7|||
145672111|NCT02932410|525316025|FG001|Overall Study|Death|6|||
145672112|NCT02932410|525316026|FG002|Overall Study|Death|0|||
145672113|NCT02932410|525316027|FG003|Overall Study|Death|0|||
145672114|NCT02932410|525316024|FG000|Overall Study|Lost to Follow-up|1|||
145672115|NCT02932410|525316025|FG001|Overall Study|Lost to Follow-up|2|||
145490903|NCT02648204|524652269|FG000|Overall Study|Adverse Event|0|||
145490904|NCT02648204|524652270|FG001|Overall Study|Adverse Event|0|||
145490905|NCT02648204|524652271|FG002|Overall Study|Adverse Event|1|||
145490906|NCT02648204|524652272|FG003|Overall Study|Adverse Event|0|||
145490907|NCT01220167|524652277|FG000|Period 3|Urine positive for substance abuse|0|||
145490908|NCT01220167|524652278|FG001|Period 3|Urine positive for substance abuse|1|||
145672116|NCT02932410|525316026|FG002|Overall Study|Lost to Follow-up|0|||
145672117|NCT02932410|525316027|FG003|Overall Study|Lost to Follow-up|0|||
145672118|NCT02932410|525316024|FG000|Overall Study|Parent/Subjects decision|6|||
145672119|NCT02932410|525316025|FG001|Overall Study|Parent/Subjects decision|6|||
145672120|NCT02932410|525316026|FG002|Overall Study|Parent/Subjects decision|1|||
145672121|NCT02932410|525316027|FG003|Overall Study|Parent/Subjects decision|0|||
145672122|NCT02932410|525316024|FG000|Overall Study|Physician Decision|0|||
145672123|NCT02932410|525316025|FG001|Overall Study|Physician Decision|1|||
145672124|NCT02932410|525316026|FG002|Overall Study|Physician Decision|0|||
145672125|NCT02932410|525316027|FG003|Overall Study|Physician Decision|0|||
145672126|NCT00360269|525316030|FG000|Overall Study|Lost to Follow-up|7|||
145672127|NCT00360269|525316031|FG001|Overall Study|Lost to Follow-up|9|||
145672128|NCT00360269|525316030|FG000|Overall Study|Physician Decision|1|||
145672129|NCT00360269|525316031|FG001|Overall Study|Physician Decision|2|||
145672130|NCT00360269|525316030|FG000|Overall Study|Adverse Event|1|||
145672131|NCT00360269|525316031|FG001|Overall Study|Adverse Event|0|||
145672132|NCT00360269|525316030|FG000|Overall Study|Withdrawal by Subject|1|||
145672133|NCT00360269|525316031|FG001|Overall Study|Withdrawal by Subject|1|||
145672134|NCT03002194|525316032|FG000|Overall Study|Lost to Follow-up|6|||
145672135|NCT03002194|525316032|FG000|Overall Study|Adverse Event|1|||
145672136|NCT03002194|525316032|FG000|Overall Study|Lack of Efficacy|1|||
145672137|NCT03002194|525316032|FG000|Overall Study|Withdrawal by Subject|2|||
145672138|NCT00048932|525316035|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
145672139|NCT00048932|525316036|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
145672140|NCT00048932|525316037|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
145672141|NCT00048932|525316035|FG000|Double Blind Period (DB)|Adverse Event|51|||
145672142|NCT00048932|525316036|FG001|Double Blind Period (DB)|Adverse Event|19|||
145672143|NCT00048932|525316037|FG002|Double Blind Period (DB)|Adverse Event|0|||
145672144|NCT00048932|525316035|FG000|Double Blind Period (DB)|Death|5|||
145672145|NCT00048932|525316036|FG001|Double Blind Period (DB)|Death|3|||
145672146|NCT00048932|525316037|FG002|Double Blind Period (DB)|Death|0|||
145672147|NCT00048932|525316035|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
145490909|NCT01220167|524652279|FG002|Period 3|Urine positive for substance abuse|0|||
145490910|NCT01008943|524652280|FG000|Overall Study|Withdrawal by Subject|1|||
145490911|NCT06418152|524652281|FG000|Overall Study|Frequent DBS setting changes|1|||
145490912|NCT06418152|524652281|FG000|Overall Study|Withdrawal by Subject|2|||
145490913|NCT05789745|524652282|FG000|Overall Study|Withdrawal by Subject|0|||
145490914|NCT05789745|524652283|FG001|Overall Study|Withdrawal by Subject|0|||
145490915|NCT05789745|524652284|FG002|Overall Study|Withdrawal by Subject|0|||
145490916|NCT05789745|524652285|FG003|Overall Study|Withdrawal by Subject|0|||
145490917|NCT05789745|524652286|FG004|Overall Study|Withdrawal by Subject|1|||
145490918|NCT01962441|524652293|FG000|Randomized Period|Randomized but Never Treated|4|||
145490919|NCT01962441|524652294|FG001|Randomized Period|Randomized but Never Treated|2|||
145490920|NCT01962441|524652295|FG002|Randomized Period|Randomized but Never Treated|3|||
145490921|NCT01962441|524652293|FG000|Randomized Period|Lost to Follow-up|2|||
145490922|NCT01962441|524652294|FG001|Randomized Period|Lost to Follow-up|4|||
145490923|NCT01962441|524652295|FG002|Randomized Period|Lost to Follow-up|4|||
145490924|NCT01962441|524652293|FG000|Randomized Period|Withdrew Consent|3|||
145490925|NCT01962441|524652294|FG001|Randomized Period|Withdrew Consent|3|||
145490926|NCT01962441|524652295|FG002|Randomized Period|Withdrew Consent|2|||
145490927|NCT01962441|524652293|FG000|Randomized Period|Adverse Event|1|||
145490928|NCT01962441|524652294|FG001|Randomized Period|Adverse Event|1|||
145490929|NCT01962441|524652295|FG002|Randomized Period|Adverse Event|0|||
145672148|NCT00048932|525316036|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
145672149|NCT00048932|525316037|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
145672150|NCT00048932|525316035|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
145672151|NCT00048932|525316036|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
145672152|NCT00048932|525316037|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
145672153|NCT00048932|525316035|FG000|Double Blind Period (DB)|Relocation|1|||
145672154|NCT00048932|525316036|FG001|Double Blind Period (DB)|Relocation|0|||
145672155|NCT00048932|525316037|FG002|Double Blind Period (DB)|Relocation|0|||
145672156|NCT00048932|525316035|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
145672157|NCT00048932|525316036|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
145490930|NCT01962441|524652293|FG000|Randomized Period|Death|0|||
145490931|NCT01962441|524652294|FG001|Randomized Period|Death|0|||
145490932|NCT01962441|524652295|FG002|Randomized Period|Death|2|||
145490933|NCT01962441|524652293|FG000|Randomized Period|Protocol Violation|0|||
145490934|NCT01962441|524652294|FG001|Randomized Period|Protocol Violation|1|||
145490935|NCT01962441|524652295|FG002|Randomized Period|Protocol Violation|0|||
145490936|NCT01962441|524652293|FG000|Retreatment Substudy|Lack of Efficacy|1|||
145672158|NCT00048932|525316037|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
145672159|NCT00048932|525316035|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
145672160|NCT00048932|525316036|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
145672161|NCT00048932|525316037|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
145672162|NCT00048932|525316035|FG000|Double Blind Period (DB)|Pregnancy|1|||
145672163|NCT00048932|525316036|FG001|Double Blind Period (DB)|Pregnancy|0|||
145672164|NCT00048932|525316037|FG002|Double Blind Period (DB)|Pregnancy|0|||
145672165|NCT00048932|525316035|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
145672166|NCT00048932|525316036|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
145672167|NCT00048932|525316037|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
145672168|NCT00048932|525316035|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
145672169|NCT00048932|525316036|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
145672170|NCT00048932|525316037|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
145672171|NCT00048932|525316035|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
145672172|NCT00048932|525316036|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
145672173|NCT00048932|525316037|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
145672174|NCT00048932|525316035|FG000|Open Label Period (OL)|Death|0|||
145672175|NCT00048932|525316036|FG001|Open Label Period (OL)|Death|0|||
145672176|NCT00048932|525316037|FG002|Open Label Period (OL)|Death|25|||
145672177|NCT00048932|525316035|FG000|Open Label Period (OL)|Adverse Event|0|||
145672178|NCT00048932|525316036|FG001|Open Label Period (OL)|Adverse Event|0|||
145672179|NCT00048932|525316037|FG002|Open Label Period (OL)|Adverse Event|103|||
145672180|NCT00048932|525316035|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
145672181|NCT00048932|525316036|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
145672182|NCT00048932|525316037|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
145672183|NCT00048932|525316035|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
145672184|NCT00048932|525316036|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
145672185|NCT00048932|525316037|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
145672186|NCT00048932|525316035|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
145672187|NCT00048932|525316036|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
145672188|NCT00048932|525316037|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
145672189|NCT00048932|525316035|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
145672190|NCT00048932|525316036|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
145672191|NCT00048932|525316037|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
145672192|NCT00048932|525316035|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
145672193|NCT00048932|525316036|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
145672194|NCT00048932|525316037|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
145672195|NCT00048932|525316035|FG000|Open Label Period (OL)|Pregnancy|0|||
145672196|NCT00048932|525316036|FG001|Open Label Period (OL)|Pregnancy|0|||
145672197|NCT00048932|525316037|FG002|Open Label Period (OL)|Pregnancy|6|||
145672198|NCT00048932|525316035|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
145672199|NCT00048932|525316036|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
145672200|NCT00048932|525316037|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
145672201|NCT00048932|525316035|FG000|Open Label Period (OL)|Investigator Retiring|0|||
145672202|NCT00048932|525316036|FG001|Open Label Period (OL)|Investigator Retiring|0|||
145672203|NCT00048932|525316037|FG002|Open Label Period (OL)|Investigator Retiring|2|||
145672204|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
145672205|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
145672206|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
145672207|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Relocated|0|||
145672208|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Relocated|0|||
145672209|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Relocated|6|||
145672210|NCT00048932|525316035|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
145672211|NCT00048932|525316036|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
145672212|NCT00048932|525316037|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
145672213|NCT00048932|525316035|FG000|Open Label Period (OL)|Site Closure|0|||
145672214|NCT00048932|525316036|FG001|Open Label Period (OL)|Site Closure|0|||
145672215|NCT00048932|525316037|FG002|Open Label Period (OL)|Site Closure|3|||
145672216|NCT00048932|525316035|FG000|Open Label Period (OL)|Trial Terminated|0|||
145672217|NCT00048932|525316036|FG001|Open Label Period (OL)|Trial Terminated|0|||
145672218|NCT00048932|525316037|FG002|Open Label Period (OL)|Trial Terminated|1|||
145672219|NCT00048932|525316035|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
145672220|NCT00048932|525316036|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
145672221|NCT00048932|525316037|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
145672222|NCT00048932|525316035|FG000|Open Label Period (OL)|Patient Decision|0|||
145672223|NCT00048932|525316036|FG001|Open Label Period (OL)|Patient Decision|0|||
145490937|NCT01962441|524652294|FG001|Retreatment Substudy|Lack of Efficacy|0|||
145672224|NCT00048932|525316037|FG002|Open Label Period (OL)|Patient Decision|4|||
145672225|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
145672226|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
145672227|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
145672228|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
145672229|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
145672230|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
145672231|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
145672232|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
145672233|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
145672234|NCT00048932|525316035|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
145672235|NCT00048932|525316036|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
145672236|NCT00048932|525316037|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
145672237|NCT00048932|525316035|FG000|Open Label Period (OL)|Investigator Decision|0|||
145672238|NCT00048932|525316036|FG001|Open Label Period (OL)|Investigator Decision|0|||
145672239|NCT00048932|525316037|FG002|Open Label Period (OL)|Investigator Decision|4|||
145672240|NCT00048932|525316035|FG000|Open Label Period (OL)|Site Staff Issues|0|||
145672241|NCT00048932|525316036|FG001|Open Label Period (OL)|Site Staff Issues|0|||
145672242|NCT00048932|525316037|FG002|Open Label Period (OL)|Site Staff Issues|2|||
145672243|NCT00048932|525316035|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
145672244|NCT00048932|525316036|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
145672245|NCT00048932|525316037|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
145672246|NCT00048932|525316035|FG000|Open Label Period (OL)|Participant Surgery|0|||
145672247|NCT00048932|525316036|FG001|Open Label Period (OL)|Participant Surgery|0|||
145672248|NCT00048932|525316037|FG002|Open Label Period (OL)|Participant Surgery|1|||
145672249|NCT02232737|525316038|FG000|Overall Study|Lost to Follow-up|18|||
145672250|NCT02232737|525316039|FG001|Overall Study|Lost to Follow-up|28|||
145672251|NCT02232737|525316040|FG002|Overall Study|Lost to Follow-up|33|||
145672252|NCT02232737|525316038|FG000|Overall Study|Personal reasons|7|||
145672253|NCT02232737|525316039|FG001|Overall Study|Personal reasons|8|||
145672254|NCT02232737|525316040|FG002|Overall Study|Personal reasons|14|||
145672255|NCT02232737|525316038|FG000|Overall Study|Adverse Event|6|||
145672256|NCT02232737|525316039|FG001|Overall Study|Adverse Event|3|||
145672257|NCT02232737|525316040|FG002|Overall Study|Adverse Event|8|||
145672258|NCT02232737|525316038|FG000|Overall Study|Incarcerated|2|||
145672259|NCT02232737|525316039|FG001|Overall Study|Incarcerated|1|||
145672260|NCT02232737|525316040|FG002|Overall Study|Incarcerated|2|||
145672261|NCT02232737|525316038|FG000|Overall Study|Withdrawal by Subject|0|||
145672262|NCT02232737|525316039|FG001|Overall Study|Withdrawal by Subject|1|||
145672263|NCT02232737|525316040|FG002|Overall Study|Withdrawal by Subject|2|||
145672264|NCT02232737|525316038|FG000|Overall Study|Death|0|||
145672265|NCT02232737|525316039|FG001|Overall Study|Death|1|||
145672266|NCT02232737|525316040|FG002|Overall Study|Death|1|||
145672267|NCT02232737|525316038|FG000|Overall Study|Physician Decision|1|||
145672268|NCT02232737|525316039|FG001|Overall Study|Physician Decision|3|||
145672269|NCT02232737|525316040|FG002|Overall Study|Physician Decision|1|||
145672270|NCT02232737|525316038|FG000|Overall Study|Protocol Violation|1|||
145672271|NCT02232737|525316039|FG001|Overall Study|Protocol Violation|0|||
145672272|NCT02232737|525316040|FG002|Overall Study|Protocol Violation|1|||
145672273|NCT02232737|525316038|FG000|Overall Study|Reason unknown|1|||
145672274|NCT02232737|525316039|FG001|Overall Study|Reason unknown|0|||
145672275|NCT02232737|525316040|FG002|Overall Study|Reason unknown|0|||
145672276|NCT03021993|525316041|FG000|Overall Study|Withdrawal by Subject|4|||
145672277|NCT03021993|525316041|FG000|Overall Study|Physician Decision|1|||
145672278|NCT03021993|525316041|FG000|Overall Study|enrolled but were not treated|1|||
145672279|NCT03021993|525316041|FG000|Overall Study|Death|3|||
145672280|NCT00756574|525316044|FG000|Overall Study|Withdrawal by Subject|9|||
145672281|NCT00756574|525316045|FG001|Overall Study|Withdrawal by Subject|7|||
145672282|NCT00756574|525316044|FG000|Overall Study|Lost to Follow-up|4|||
145672283|NCT00756574|525316045|FG001|Overall Study|Lost to Follow-up|4|||
145672284|NCT03348631|525316050|FG000|Overall Study|Not Eligible, No treatment|0|||
145672285|NCT03348631|525316051|FG001|Overall Study|Not Eligible, No treatment|1|||
145672286|NCT03348631|525316050|FG000|Overall Study|Not Eligible, Treated|2|||
145672287|NCT03348631|525316051|FG001|Overall Study|Not Eligible, Treated|0|||
145672288|NCT03348631|525316050|FG000|Overall Study|Eligible, No Treatment|1|||
145672289|NCT03348631|525316051|FG001|Overall Study|Eligible, No Treatment|0|||
145672290|NCT01946204|525316052|FG000|Overall Study|Death|38|||
145672291|NCT01946204|525316053|FG001|Overall Study|Death|59|||
145672292|NCT01946204|525316052|FG000|Overall Study|Withdrawal by Subject|37|||
145672293|NCT01946204|525316053|FG001|Overall Study|Withdrawal by Subject|50|||
145672294|NCT01946204|525316052|FG000|Overall Study|Lost to Follow-up|3|||
145672295|NCT01946204|525316053|FG001|Overall Study|Lost to Follow-up|7|||
145672296|NCT01946204|525316052|FG000|Overall Study|Ongoing|316|||
145672297|NCT01946204|525316053|FG001|Overall Study|Ongoing|687|||
145672298|NCT01946204|525316052|FG000|Overall Study|Other|7|||
145672299|NCT01946204|525316053|FG001|Overall Study|Other|3|||
145672300|NCT03466411|525316054|FG000|Overall Study|Lost to Follow-up|0|||
145672301|NCT03466411|525316055|FG001|Overall Study|Lost to Follow-up|1|||
145672302|NCT03466411|525316056|FG002|Overall Study|Lost to Follow-up|1|||
145672303|NCT03466411|525316057|FG003|Overall Study|Lost to Follow-up|0|||
145672304|NCT03466411|525316058|FG004|Overall Study|Lost to Follow-up|0|||
145672305|NCT03466411|525316059|FG005|Overall Study|Lost to Follow-up|0|||
145672306|NCT03466411|525316060|FG006|Overall Study|Lost to Follow-up|1|||
145672307|NCT03466411|525316061|FG007|Overall Study|Lost to Follow-up|1|||
145672308|NCT03466411|525316062|FG008|Overall Study|Lost to Follow-up|0|||
145672309|NCT03466411|525316063|FG009|Overall Study|Lost to Follow-up|1|||
145672310|NCT03466411|525316064|FG010|Overall Study|Lost to Follow-up|1|||
145672311|NCT03466411|525316065|FG011|Overall Study|Lost to Follow-up|1|||
145672312|NCT03466411|525316066|FG012|Overall Study|Lost to Follow-up|0|||
145672313|NCT03466411|525316054|FG000|Overall Study|Withdrawal by Subject|14|||
145672314|NCT03466411|525316055|FG001|Overall Study|Withdrawal by Subject|7|||
145672315|NCT03466411|525316056|FG002|Overall Study|Withdrawal by Subject|8|||
145672316|NCT03466411|525316057|FG003|Overall Study|Withdrawal by Subject|4|||
145672317|NCT03466411|525316058|FG004|Overall Study|Withdrawal by Subject|6|||
145672318|NCT03466411|525316059|FG005|Overall Study|Withdrawal by Subject|3|||
145672319|NCT03466411|525316060|FG006|Overall Study|Withdrawal by Subject|6|||
145672320|NCT03466411|525316061|FG007|Overall Study|Withdrawal by Subject|9|||
145672321|NCT03466411|525316062|FG008|Overall Study|Withdrawal by Subject|6|||
145672322|NCT03466411|525316063|FG009|Overall Study|Withdrawal by Subject|11|||
145672323|NCT03466411|525316064|FG010|Overall Study|Withdrawal by Subject|14|||
145672324|NCT03466411|525316065|FG011|Overall Study|Withdrawal by Subject|12|||
145672325|NCT03466411|525316066|FG012|Overall Study|Withdrawal by Subject|7|||
145672326|NCT03466411|525316054|FG000|Overall Study|Other|1|||
145672327|NCT03466411|525316055|FG001|Overall Study|Other|1|||
145672328|NCT03466411|525316056|FG002|Overall Study|Other|0|||
145672329|NCT03466411|525316057|FG003|Overall Study|Other|1|||
145672330|NCT03466411|525316058|FG004|Overall Study|Other|2|||
145672331|NCT03466411|525316059|FG005|Overall Study|Other|0|||
145672332|NCT03466411|525316060|FG006|Overall Study|Other|0|||
145672333|NCT03466411|525316061|FG007|Overall Study|Other|0|||
145672334|NCT03466411|525316062|FG008|Overall Study|Other|0|||
145672335|NCT03466411|525316063|FG009|Overall Study|Other|1|||
145672336|NCT03466411|525316064|FG010|Overall Study|Other|2|||
145672337|NCT03466411|525316065|FG011|Overall Study|Other|0|||
145672338|NCT03466411|525316066|FG012|Overall Study|Other|0|||
145672339|NCT03466411|525316054|FG000|Overall Study|Randomized but not Treated|0|||
145672340|NCT03466411|525316055|FG001|Overall Study|Randomized but not Treated|0|||
145672341|NCT03466411|525316056|FG002|Overall Study|Randomized but not Treated|0|||
145672342|NCT03466411|525316057|FG003|Overall Study|Randomized but not Treated|0|||
145672343|NCT03466411|525316058|FG004|Overall Study|Randomized but not Treated|0|||
145672344|NCT03466411|525316059|FG005|Overall Study|Randomized but not Treated|0|||
145672345|NCT03466411|525316060|FG006|Overall Study|Randomized but not Treated|1|||
145672346|NCT03466411|525316061|FG007|Overall Study|Randomized but not Treated|0|||
145672347|NCT03466411|525316062|FG008|Overall Study|Randomized but not Treated|0|||
145672348|NCT03466411|525316063|FG009|Overall Study|Randomized but not Treated|0|||
145672349|NCT03466411|525316064|FG010|Overall Study|Randomized but not Treated|0|||
145672350|NCT03466411|525316065|FG011|Overall Study|Randomized but not Treated|0|||
145672351|NCT03466411|525316066|FG012|Overall Study|Randomized but not Treated|0|||
145672352|NCT03516812|525316077|FG000|Overall Study|Adverse Event|4|||
145672353|NCT03516812|525316077|FG000|Overall Study|Lack of Efficacy|2|||
145672354|NCT04795167|525316078|FG000|Overall Study|Death|1|||
145672355|NCT04795167|525316079|FG001|Overall Study|Death|18|||
145672356|NCT04795167|525316080|FG002|Overall Study|Death|1|||
145672357|NCT04795167|525316078|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
145672358|NCT04795167|525316079|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
145672359|NCT04795167|525316080|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
145672360|NCT03582475|525316085|FG000|Treatment Period|Withdrawal by Subject|0|||
145672361|NCT03582475|525316086|FG001|Treatment Period|Withdrawal by Subject|1|||
145672362|NCT03582475|525316085|FG000|Follow-up Period|Withdrawal by Subject|0|||
145490938|NCT01962441|524652295|FG002|Retreatment Substudy|Lack of Efficacy|0|||
145490939|NCT01962441|524652293|FG000|Retreatment Substudy|Lost to Follow-up|1|||
145672363|NCT03582475|525316086|FG001|Follow-up Period|Withdrawal by Subject|1|||
145672364|NCT02257736|525316087|FG000|Overall Study|Progressive disease|365|||
145672365|NCT02257736|525316088|FG001|Overall Study|Progressive disease|327|||
145672366|NCT02257736|525316087|FG000|Overall Study|Adverse Event|45|||
145672367|NCT02257736|525316088|FG001|Overall Study|Adverse Event|56|||
145672368|NCT02257736|525316087|FG000|Overall Study|Withdrawal by Subject|21|||
145672369|NCT02257736|525316088|FG001|Overall Study|Withdrawal by Subject|38|||
145672370|NCT02257736|525316087|FG000|Overall Study|Death|11|||
145672371|NCT02257736|525316088|FG001|Overall Study|Death|6|||
145672372|NCT02257736|525316087|FG000|Overall Study|Physician Decision|5|||
145672373|NCT02257736|525316088|FG001|Overall Study|Physician Decision|9|||
145672374|NCT02257736|525316087|FG000|Overall Study|Non-Compliance with study drug|1|||
145672375|NCT02257736|525316088|FG001|Overall Study|Non-Compliance with study drug|2|||
145672376|NCT02257736|525316087|FG000|Overall Study|Protocol Violation|1|||
145672377|NCT02257736|525316088|FG001|Overall Study|Protocol Violation|0|||
145672378|NCT02257736|525316087|FG000|Overall Study|Other|1|||
145672379|NCT02257736|525316088|FG001|Overall Study|Other|7|||
145672380|NCT02257736|525316087|FG000|Overall Study|Randomized, not treated|1|||
145672381|NCT02257736|525316088|FG001|Overall Study|Randomized, not treated|2|||
145672382|NCT05628103|525316090|FG000|Overall Study|Adverse Event|7|||
145672383|NCT05628103|525316090|FG000|Overall Study|Withdrawal by Subject|3|||
145672384|NCT05628103|525316090|FG000|Overall Study|Lost to Follow-up|3|||
145672385|NCT05628103|525316090|FG000|Overall Study|Lack of Efficacy|1|||
145672386|NCT05628103|525316090|FG000|Overall Study|Non-Compliance With Study Drug|4|||
145672387|NCT03492177|525316092|FG000|Overall Study|Adverse Event|1|||
145672388|NCT03492177|525316093|FG001|Overall Study|Adverse Event|0|||
145672389|NCT03492177|525316094|FG002|Overall Study|Adverse Event|0|||
145672390|NCT03492177|525316092|FG000|Overall Study|Death|3|||
145672391|NCT03492177|525316093|FG001|Overall Study|Death|0|||
145672392|NCT03492177|525316094|FG002|Overall Study|Death|3|||
145672393|NCT03492177|525316092|FG000|Overall Study|Lack of Efficacy|1|||
145672394|NCT03492177|525316093|FG001|Overall Study|Lack of Efficacy|2|||
145672395|NCT03492177|525316094|FG002|Overall Study|Lack of Efficacy|0|||
145672396|NCT03492177|525316092|FG000|Overall Study|Other|1|||
145672397|NCT03492177|525316093|FG001|Overall Study|Other|0|||
145672398|NCT03492177|525316094|FG002|Overall Study|Other|0|||
145672399|NCT03492177|525316092|FG000|Overall Study|Ongoing|16|||
145672400|NCT03492177|525316093|FG001|Overall Study|Ongoing|19|||
145672401|NCT03492177|525316094|FG002|Overall Study|Ongoing|17|||
145672402|NCT02499328|525316095|FG000|Overall Study|Withdrawal by Subject|1|||
145672403|NCT02499328|525316096|FG001|Overall Study|Withdrawal by Subject|1|||
145672404|NCT02499328|525316097|FG002|Overall Study|Withdrawal by Subject|5|||
145672405|NCT02499328|525316098|FG003|Overall Study|Withdrawal by Subject|3|||
145672406|NCT02499328|525316099|FG004|Overall Study|Withdrawal by Subject|5|||
145672407|NCT02499328|525316100|FG005|Overall Study|Withdrawal by Subject|0|||
145672408|NCT02499328|525316101|FG006|Overall Study|Withdrawal by Subject|0|||
145672409|NCT02499328|525316102|FG007|Overall Study|Withdrawal by Subject|0|||
145672410|NCT02499328|525316103|FG008|Overall Study|Withdrawal by Subject|2|||
145672411|NCT02499328|525316104|FG009|Overall Study|Withdrawal by Subject|2|||
145672412|NCT02499328|525316105|FG010|Overall Study|Withdrawal by Subject|0|||
145672413|NCT02499328|525316106|FG011|Overall Study|Withdrawal by Subject|3|||
145672414|NCT02499328|525316107|FG012|Overall Study|Withdrawal by Subject|7|||
145672415|NCT02499328|525316108|FG013|Overall Study|Withdrawal by Subject|3|||
145672416|NCT02499328|525316109|FG014|Overall Study|Withdrawal by Subject|1|||
145672417|NCT02499328|525316110|FG015|Overall Study|Withdrawal by Subject|0|||
145672418|NCT02499328|525316111|FG016|Overall Study|Withdrawal by Subject|0|||
145672419|NCT02499328|525316112|FG017|Overall Study|Withdrawal by Subject|3|||
145672420|NCT02499328|525316113|FG018|Overall Study|Withdrawal by Subject|0|||
145672421|NCT02499328|525316095|FG000|Overall Study|Lost to Follow-up|0|||
145672422|NCT02499328|525316096|FG001|Overall Study|Lost to Follow-up|1|||
145672423|NCT02499328|525316097|FG002|Overall Study|Lost to Follow-up|1|||
145672424|NCT02499328|525316098|FG003|Overall Study|Lost to Follow-up|2|||
145672425|NCT02499328|525316099|FG004|Overall Study|Lost to Follow-up|0|||
145672426|NCT02499328|525316100|FG005|Overall Study|Lost to Follow-up|0|||
145672427|NCT02499328|525316101|FG006|Overall Study|Lost to Follow-up|0|||
145672428|NCT02499328|525316102|FG007|Overall Study|Lost to Follow-up|2|||
145672429|NCT02499328|525316103|FG008|Overall Study|Lost to Follow-up|3|||
145672430|NCT02499328|525316104|FG009|Overall Study|Lost to Follow-up|0|||
145672431|NCT02499328|525316105|FG010|Overall Study|Lost to Follow-up|0|||
145672432|NCT02499328|525316106|FG011|Overall Study|Lost to Follow-up|0|||
145672433|NCT02499328|525316107|FG012|Overall Study|Lost to Follow-up|0|||
145672434|NCT02499328|525316108|FG013|Overall Study|Lost to Follow-up|0|||
145672435|NCT02499328|525316109|FG014|Overall Study|Lost to Follow-up|0|||
145672436|NCT02499328|525316110|FG015|Overall Study|Lost to Follow-up|0|||
145672437|NCT02499328|525316111|FG016|Overall Study|Lost to Follow-up|0|||
145672438|NCT02499328|525316112|FG017|Overall Study|Lost to Follow-up|0|||
145672439|NCT02499328|525316113|FG018|Overall Study|Lost to Follow-up|1|||
145672440|NCT02499328|525316095|FG000|Overall Study|Death|0|||
145672441|NCT02499328|525316096|FG001|Overall Study|Death|3|||
145672442|NCT02499328|525316097|FG002|Overall Study|Death|3|||
145672443|NCT02499328|525316098|FG003|Overall Study|Death|2|||
145672444|NCT02499328|525316099|FG004|Overall Study|Death|4|||
145672445|NCT02499328|525316100|FG005|Overall Study|Death|7|||
145672446|NCT02499328|525316101|FG006|Overall Study|Death|3|||
145672447|NCT02499328|525316102|FG007|Overall Study|Death|0|||
145672448|NCT02499328|525316103|FG008|Overall Study|Death|2|||
145672449|NCT02499328|525316104|FG009|Overall Study|Death|6|||
145672450|NCT02499328|525316105|FG010|Overall Study|Death|6|||
145672451|NCT02499328|525316106|FG011|Overall Study|Death|20|||
145672452|NCT02499328|525316107|FG012|Overall Study|Death|9|||
145672453|NCT02499328|525316108|FG013|Overall Study|Death|7|||
145672454|NCT02499328|525316109|FG014|Overall Study|Death|3|||
145672455|NCT02499328|525316110|FG015|Overall Study|Death|1|||
145672456|NCT02499328|525316111|FG016|Overall Study|Death|1|||
145672457|NCT02499328|525316112|FG017|Overall Study|Death|16|||
145672458|NCT02499328|525316113|FG018|Overall Study|Death|5|||
145672459|NCT02499328|525316095|FG000|Overall Study|"Other"|2|||
145672460|NCT02499328|525316096|FG001|Overall Study|"Other"|2|||
145672461|NCT02499328|525316097|FG002|Overall Study|"Other"|1|||
145672462|NCT02499328|525316098|FG003|Overall Study|"Other"|3|||
145672463|NCT02499328|525316099|FG004|Overall Study|"Other"|6|||
145672464|NCT02499328|525316100|FG005|Overall Study|"Other"|2|||
145672465|NCT02499328|525316101|FG006|Overall Study|"Other"|3|||
145672466|NCT02499328|525316102|FG007|Overall Study|"Other"|4|||
145672467|NCT02499328|525316103|FG008|Overall Study|"Other"|6|||
145672468|NCT02499328|525316104|FG009|Overall Study|"Other"|16|||
145672469|NCT02499328|525316105|FG010|Overall Study|"Other"|13|||
145672470|NCT02499328|525316106|FG011|Overall Study|"Other"|31|||
145672471|NCT02499328|525316107|FG012|Overall Study|"Other"|8|||
145672472|NCT02499328|525316108|FG013|Overall Study|"Other"|7|||
145672473|NCT02499328|525316109|FG014|Overall Study|"Other"|6|||
145672474|NCT02499328|525316110|FG015|Overall Study|"Other"|0|||
145672475|NCT02499328|525316111|FG016|Overall Study|"Other"|0|||
145672476|NCT02499328|525316112|FG017|Overall Study|"Other"|34|||
145672477|NCT02499328|525316113|FG018|Overall Study|"Other"|43|||
145672478|NCT02499328|525316095|FG000|Overall Study|Disease Progression|0|||
145672479|NCT02499328|525316096|FG001|Overall Study|Disease Progression|0|||
145672480|NCT02499328|525316097|FG002|Overall Study|Disease Progression|0|||
145672481|NCT02499328|525316098|FG003|Overall Study|Disease Progression|0|||
145672482|NCT02499328|525316099|FG004|Overall Study|Disease Progression|0|||
145672483|NCT02499328|525316100|FG005|Overall Study|Disease Progression|0|||
145672484|NCT02499328|525316101|FG006|Overall Study|Disease Progression|1|||
145672485|NCT02499328|525316102|FG007|Overall Study|Disease Progression|0|||
145672486|NCT02499328|525316103|FG008|Overall Study|Disease Progression|1|||
145672487|NCT02499328|525316104|FG009|Overall Study|Disease Progression|0|||
145672488|NCT02499328|525316105|FG010|Overall Study|Disease Progression|1|||
145672489|NCT02499328|525316106|FG011|Overall Study|Disease Progression|0|||
145672490|NCT02499328|525316107|FG012|Overall Study|Disease Progression|0|||
145672491|NCT02499328|525316108|FG013|Overall Study|Disease Progression|0|||
145672492|NCT02499328|525316109|FG014|Overall Study|Disease Progression|0|||
145672493|NCT02499328|525316110|FG015|Overall Study|Disease Progression|0|||
145672494|NCT02499328|525316111|FG016|Overall Study|Disease Progression|0|||
145672495|NCT02499328|525316112|FG017|Overall Study|Disease Progression|2|||
145672496|NCT02499328|525316113|FG018|Overall Study|Disease Progression|0|||
145672497|NCT02499328|525316095|FG000|Overall Study|Adverse Event|1|||
145672498|NCT02499328|525316096|FG001|Overall Study|Adverse Event|0|||
145672499|NCT02499328|525316097|FG002|Overall Study|Adverse Event|0|||
145672500|NCT02499328|525316098|FG003|Overall Study|Adverse Event|1|||
145672501|NCT02499328|525316099|FG004|Overall Study|Adverse Event|0|||
145672502|NCT02499328|525316100|FG005|Overall Study|Adverse Event|0|||
145672503|NCT02499328|525316101|FG006|Overall Study|Adverse Event|0|||
145672504|NCT02499328|525316102|FG007|Overall Study|Adverse Event|0|||
145672505|NCT02499328|525316103|FG008|Overall Study|Adverse Event|0|||
145672506|NCT02499328|525316104|FG009|Overall Study|Adverse Event|0|||
145672507|NCT02499328|525316105|FG010|Overall Study|Adverse Event|0|||
145672508|NCT02499328|525316106|FG011|Overall Study|Adverse Event|0|||
145672509|NCT02499328|525316107|FG012|Overall Study|Adverse Event|1|||
145672510|NCT02499328|525316108|FG013|Overall Study|Adverse Event|0|||
145672511|NCT02499328|525316109|FG014|Overall Study|Adverse Event|0|||
145672512|NCT02499328|525316110|FG015|Overall Study|Adverse Event|0|||
145672513|NCT02499328|525316111|FG016|Overall Study|Adverse Event|0|||
145672514|NCT02499328|525316112|FG017|Overall Study|Adverse Event|0|||
145672515|NCT02499328|525316113|FG018|Overall Study|Adverse Event|0|||
145672516|NCT05663866|525316118|FG000|Overall Study|Adverse Event|0|||
145672517|NCT05663866|525316119|FG001|Overall Study|Adverse Event|0|||
145672518|NCT05663866|525316120|FG002|Overall Study|Adverse Event|1|||
145672519|NCT05663866|525316121|FG003|Overall Study|Adverse Event|0|||
145672520|NCT05663866|525316118|FG000|Overall Study|Physician Decision|0|||
145672521|NCT05663866|525316119|FG001|Overall Study|Physician Decision|0|||
145672522|NCT05663866|525316120|FG002|Overall Study|Physician Decision|0|||
145672523|NCT05663866|525316121|FG003|Overall Study|Physician Decision|1|||
145672524|NCT05663866|525316118|FG000|Overall Study|Withdrawal by Subject|0|||
145672525|NCT05663866|525316119|FG001|Overall Study|Withdrawal by Subject|2|||
145672526|NCT05663866|525316120|FG002|Overall Study|Withdrawal by Subject|1|||
145672527|NCT05663866|525316121|FG003|Overall Study|Withdrawal by Subject|2|||
145672528|NCT05663866|525316118|FG000|Overall Study|Progressive disease|4|||
145672529|NCT05663866|525316119|FG001|Overall Study|Progressive disease|8|||
145672530|NCT05663866|525316120|FG002|Overall Study|Progressive disease|5|||
145672531|NCT05663866|525316121|FG003|Overall Study|Progressive disease|2|||
145672532|NCT05663866|525316118|FG000|Overall Study|Other|1|||
145672533|NCT05663866|525316119|FG001|Overall Study|Other|0|||
145672534|NCT05663866|525316120|FG002|Overall Study|Other|0|||
145672535|NCT05663866|525316121|FG003|Overall Study|Other|0|||
145672536|NCT05663866|525316118|FG000|Overall Study|Ongoing|1|||
145672537|NCT05663866|525316119|FG001|Overall Study|Ongoing|27|||
145672538|NCT05663866|525316120|FG002|Overall Study|Ongoing|6|||
145672539|NCT05663866|525316121|FG003|Overall Study|Ongoing|1|||
145672540|NCT03598907|525316126|FG000|Overall Study|Physician Decision|14|||
145672541|NCT03598907|525316127|FG001|Overall Study|Physician Decision|19|||
145672542|NCT05741528|525316128|FG000|Overall Study|Withdrawal by Subject|11|||
145672543|NCT05741528|525316128|FG000|Overall Study|Lost to Follow-up|3|||
145672544|NCT05741528|525316128|FG000|Overall Study|Adverse Event|2|||
145672545|NCT05741528|525316128|FG000|Overall Study|Non-Compliance With Study Drug|2|||
145672546|NCT05741528|525316128|FG000|Overall Study|Reason Not Specified|1|||
145672547|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
145672548|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
145672549|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
145672550|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
145672551|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
145672552|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
145672553|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
145672554|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
145672555|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
145672556|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
145672557|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
145672558|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
145672559|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
145672560|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
145672561|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
145672562|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
145672563|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
145672564|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
145672565|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
145672566|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
145672567|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
145672568|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
145672569|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
145672570|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
145672571|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
145672572|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
145672573|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
145672574|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
145672575|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
145672576|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
145672577|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
145672578|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
145672579|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
145672580|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
145672581|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
145672582|NCT03656718|525316131|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
145672583|NCT03656718|525316132|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
145672584|NCT03656718|525316133|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
145672585|NCT03656718|525316134|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
145672586|NCT03656718|525316135|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
145672587|NCT03656718|525316136|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
145672588|NCT03656718|525316137|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
145672589|NCT03656718|525316131|FG000|Treatment Period Part C|Disease progression|0|||
145672590|NCT03656718|525316132|FG001|Treatment Period Part C|Disease progression|0|||
145672591|NCT03656718|525316133|FG002|Treatment Period Part C|Disease progression|0|||
145672592|NCT03656718|525316134|FG003|Treatment Period Part C|Disease progression|0|||
145672593|NCT03656718|525316135|FG004|Treatment Period Part C|Disease progression|12|||
145672594|NCT03656718|525316136|FG005|Treatment Period Part C|Disease progression|0|||
145672595|NCT03656718|525316137|FG006|Treatment Period Part C|Disease progression|0|||
145672596|NCT03656718|525316131|FG000|Treatment Period Part C|Death|0|||
145672597|NCT03656718|525316132|FG001|Treatment Period Part C|Death|0|||
145672598|NCT03656718|525316133|FG002|Treatment Period Part C|Death|0|||
145672599|NCT03656718|525316134|FG003|Treatment Period Part C|Death|0|||
145672600|NCT03656718|525316135|FG004|Treatment Period Part C|Death|1|||
145672601|NCT03656718|525316136|FG005|Treatment Period Part C|Death|0|||
145672602|NCT03656718|525316137|FG006|Treatment Period Part C|Death|0|||
145672603|NCT03656718|525316131|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145672604|NCT03656718|525316132|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145490940|NCT01962441|524652294|FG001|Retreatment Substudy|Lost to Follow-up|0|||
145490941|NCT01962441|524652295|FG002|Retreatment Substudy|Lost to Follow-up|0|||
145490942|NCT02055898|524652296|FG000|First Intervention (5 Days)|Physician Decision|2|||
145490943|NCT02055898|524652297|FG001|First Intervention (5 Days)|Physician Decision|0|||
145672605|NCT03656718|525316133|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145672606|NCT03656718|525316134|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145672607|NCT03656718|525316135|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
145672608|NCT03656718|525316136|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145672609|NCT03656718|525316137|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
145672610|NCT03656718|525316131|FG000|Treatment Period Part C|Other reasons|0|||
145672611|NCT03656718|525316132|FG001|Treatment Period Part C|Other reasons|0|||
145672612|NCT03656718|525316133|FG002|Treatment Period Part C|Other reasons|0|||
145672613|NCT03656718|525316134|FG003|Treatment Period Part C|Other reasons|0|||
145672614|NCT03656718|525316135|FG004|Treatment Period Part C|Other reasons|1|||
145672615|NCT03656718|525316136|FG005|Treatment Period Part C|Other reasons|0|||
145672616|NCT03656718|525316137|FG006|Treatment Period Part C|Other reasons|0|||
145672617|NCT03656718|525316131|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
145672618|NCT03656718|525316132|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
145672619|NCT03656718|525316133|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
145672620|NCT03656718|525316134|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
145672621|NCT03656718|525316135|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
145672622|NCT03656718|525316136|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
145672623|NCT03656718|525316137|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
145672624|NCT05379270|525316138|FG000|Overall Study|Withdrawal by Subject|1|||
145672625|NCT05379270|525316139|FG001|Overall Study|Withdrawal by Subject|1|||
145672626|NCT04686266|525316141|FG000|Overall Study|Withdrawal by Subject|0|||
145672627|NCT04686266|525316142|FG001|Overall Study|Withdrawal by Subject|1|||
145672628|NCT03227861|525316145|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
145672629|NCT03227861|525316145|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
145672630|NCT03227861|525316145|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
145672631|NCT03227861|525316145|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
145672632|NCT03227861|525316145|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
145672633|NCT03227861|525316145|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
145672634|NCT03227861|525316145|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
145672635|NCT03227861|525316145|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
145672636|NCT03227861|525316145|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
145672637|NCT03227861|525316145|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
145672638|NCT00748709|525316146|FG000|Overall Study|Progressive disease|15|||
145672639|NCT00748709|525316146|FG000|Overall Study|Drug reducing Toxity|2|||
145672640|NCT00748709|525316146|FG000|Overall Study|Other Adverse Event|1|||
145672641|NCT00748709|525316146|FG000|Overall Study|Withdrawal by Subject|1|||
145672642|NCT00748709|525316146|FG000|Overall Study|Other Reasons|1|||
145672643|NCT02751528|525316151|FG000|Overall Study|Withdrawal by Subject|1|||
145672644|NCT02751528|525316151|FG000|Overall Study|Adverse Event|1|||
145672645|NCT01958021|525316153|FG000|Treatment|Progressive disease|206|||
145672646|NCT01958021|525316154|FG001|Treatment|Progressive disease|265|||
145672647|NCT01958021|525316153|FG000|Treatment|Adverse Event|38|||
145672648|NCT01958021|525316154|FG001|Treatment|Adverse Event|10|||
145672649|NCT01958021|525316153|FG000|Treatment|Subject/guardian decision|29|||
145672650|NCT01958021|525316154|FG001|Treatment|Subject/guardian decision|25|||
145672651|NCT01958021|525316153|FG000|Treatment|Physician Decision|28|||
145672652|NCT01958021|525316154|FG001|Treatment|Physician Decision|21|||
145672653|NCT01958021|525316153|FG000|Treatment|Death|6|||
145672654|NCT01958021|525316154|FG001|Treatment|Death|1|||
145672655|NCT01958021|525316153|FG000|Treatment|Protocol deviation|3|||
145672656|NCT01958021|525316154|FG001|Treatment|Protocol deviation|1|||
145672657|NCT01958021|525316153|FG000|Treatment|Sponsor decision|24|||
145672658|NCT01958021|525316154|FG001|Treatment|Sponsor decision|11|||
145672659|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
145672660|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
145672661|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Death|1|||
145672662|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Death|0|||
145672663|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
145672664|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
145672665|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
145672666|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
145672667|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
145672668|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
145672669|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
145672670|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
145672671|NCT01958021|525316153|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
145672672|NCT01958021|525316154|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
145672673|NCT07204444|525316155|FG000|Overall Study|Medical/Hospitalization|6|||
145672674|NCT07204444|525316156|FG001|Overall Study|Medical/Hospitalization|9|||
145672675|NCT07204444|525316157|FG002|Overall Study|Medical/Hospitalization|6|||
145672676|NCT07204444|525316155|FG000|Overall Study|Treatment Provider Issue|1|||
145672677|NCT07204444|525316156|FG001|Overall Study|Treatment Provider Issue|3|||
145672678|NCT07204444|525316157|FG002|Overall Study|Treatment Provider Issue|0|||
145672679|NCT07204444|525316155|FG000|Overall Study|Withdrawal by Subject|11|||
145672680|NCT07204444|525316156|FG001|Overall Study|Withdrawal by Subject|5|||
145672681|NCT07204444|525316157|FG002|Overall Study|Withdrawal by Subject|5|||
145672682|NCT07204444|525316155|FG000|Overall Study|Death|3|||
145672683|NCT07204444|525316156|FG001|Overall Study|Death|6|||
145672684|NCT07204444|525316157|FG002|Overall Study|Death|1|||
145672685|NCT07204444|525316155|FG000|Overall Study|Unable To Reach|29|||
145672686|NCT07204444|525316156|FG001|Overall Study|Unable To Reach|26|||
145672687|NCT07204444|525316157|FG002|Overall Study|Unable To Reach|17|||
145672688|NCT07204444|525316155|FG000|Overall Study|Protocol Deviation|3|||
145672689|NCT07204444|525316156|FG001|Overall Study|Protocol Deviation|2|||
145672690|NCT07204444|525316157|FG002|Overall Study|Protocol Deviation|0|||
145672691|NCT04083976|525317264|FG000|Overall Study|Lost to Follow-up|3|||
145672692|NCT04083976|525317265|FG001|Overall Study|Lost to Follow-up|0|||
145672693|NCT04083976|525317266|FG002|Overall Study|Lost to Follow-up|0|||
145672694|NCT04083976|525317267|FG003|Overall Study|Lost to Follow-up|1|||
145672695|NCT04083976|525317264|FG000|Overall Study|Withdrawal by Subject|16|||
145672696|NCT04083976|525317265|FG001|Overall Study|Withdrawal by Subject|1|||
145672697|NCT04083976|525317266|FG002|Overall Study|Withdrawal by Subject|9|||
145672698|NCT04083976|525317267|FG003|Overall Study|Withdrawal by Subject|0|||
145672699|NCT04083976|525317264|FG000|Overall Study|Sponsor Decision|14|||
145672700|NCT04083976|525317265|FG001|Overall Study|Sponsor Decision|0|||
145672701|NCT04083976|525317266|FG002|Overall Study|Sponsor Decision|0|||
145672702|NCT04083976|525317267|FG003|Overall Study|Sponsor Decision|7|||
145672703|NCT04083976|525317264|FG000|Overall Study|Other|1|||
145672704|NCT04083976|525317265|FG001|Overall Study|Other|0|||
145672705|NCT04083976|525317266|FG002|Overall Study|Other|1|||
145672706|NCT04083976|525317267|FG003|Overall Study|Other|0|||
145672707|NCT00512252|525317271|FG000|Overall Study|Lost to Follow-up|0|||
145672708|NCT00512252|525317272|FG001|Overall Study|Lost to Follow-up|0|||
145672709|NCT00512252|525317273|FG002|Overall Study|Lost to Follow-up|1|||
145672710|NCT00512252|525317271|FG000|Overall Study|Protocol Violation|0|||
145672711|NCT00512252|525317272|FG001|Overall Study|Protocol Violation|0|||
145672712|NCT00512252|525317273|FG002|Overall Study|Protocol Violation|1|||
145672713|NCT00512252|525317271|FG000|Overall Study|Death|0|||
145672714|NCT00512252|525317272|FG001|Overall Study|Death|0|||
145672715|NCT00512252|525317273|FG002|Overall Study|Death|1|||
145672716|NCT02357966|525317274|FG000|Overall Study|Death|0|||
145672717|NCT02357966|525317275|FG001|Overall Study|Death|0|||
145672718|NCT02357966|525317276|FG002|Overall Study|Death|1|||
145672719|NCT02357966|525317277|FG003|Overall Study|Death|0|||
145672720|NCT02357966|525317278|FG004|Overall Study|Death|2|||
145672721|NCT02357966|525317279|FG005|Overall Study|Death|0|||
145672722|NCT02357966|525317274|FG000|Overall Study|Physician Decision|1|||
145672723|NCT02357966|525317275|FG001|Overall Study|Physician Decision|0|||
145672724|NCT02357966|525317276|FG002|Overall Study|Physician Decision|0|||
145672725|NCT02357966|525317277|FG003|Overall Study|Physician Decision|0|||
145672726|NCT02357966|525317278|FG004|Overall Study|Physician Decision|1|||
145672727|NCT02357966|525317279|FG005|Overall Study|Physician Decision|0|||
145672728|NCT01779700|525317280|FG000|Overall Study|Adverse Event|4|||
145672729|NCT01779700|525317281|FG001|Overall Study|Adverse Event|3|||
145672730|NCT01779700|525317280|FG000|Overall Study|Withdrawal by Subject|0|||
145672731|NCT01779700|525317281|FG001|Overall Study|Withdrawal by Subject|2|||
145672732|NCT04608409|525317284|FG000|Overall Study|Physician Decision|1|||
145672733|NCT04608409|525317285|FG001|Overall Study|Physician Decision|1|||
145672734|NCT04608409|525317286|FG002|Overall Study|Physician Decision|2|||
145672735|NCT04497415|525317287|FG000|Overall Study|Lost to Follow-up|43|||
145672736|NCT04497415|525317288|FG001|Overall Study|Lost to Follow-up|27|||
145672737|NCT03683576|525317294|FG000|Overall Study|Withdrawal by Subject|2|||
145672738|NCT03683576|525317295|FG001|Overall Study|Withdrawal by Subject|0|||
145672739|NCT03683576|525317296|FG002|Overall Study|Withdrawal by Subject|8|||
145672740|NCT03683576|525317297|FG003|Overall Study|Withdrawal by Subject|3|||
145672741|NCT03683576|525317294|FG000|Overall Study|Adverse Event|3|||
145672742|NCT03683576|525317295|FG001|Overall Study|Adverse Event|0|||
145672743|NCT03683576|525317296|FG002|Overall Study|Adverse Event|0|||
145672744|NCT03683576|525317297|FG003|Overall Study|Adverse Event|4|||
145672745|NCT03683576|525317294|FG000|Overall Study|Lack of Efficacy|1|||
145672746|NCT03683576|525317295|FG001|Overall Study|Lack of Efficacy|0|||
145672747|NCT03683576|525317296|FG002|Overall Study|Lack of Efficacy|1|||
145672748|NCT03683576|525317297|FG003|Overall Study|Lack of Efficacy|1|||
145672749|NCT03683576|525317294|FG000|Overall Study|Lost to Follow-up|0|||
145672750|NCT03683576|525317295|FG001|Overall Study|Lost to Follow-up|1|||
145672751|NCT03683576|525317296|FG002|Overall Study|Lost to Follow-up|2|||
145672752|NCT03683576|525317297|FG003|Overall Study|Lost to Follow-up|0|||
145672753|NCT03683576|525317294|FG000|Overall Study|Other, Not Specified|0|||
145672754|NCT03683576|525317295|FG001|Overall Study|Other, Not Specified|2|||
145672755|NCT03683576|525317296|FG002|Overall Study|Other, Not Specified|0|||
145672756|NCT03683576|525317297|FG003|Overall Study|Other, Not Specified|0|||
145672757|NCT03683576|525317294|FG000|Overall Study|Protocol Violation|0|||
145672758|NCT03683576|525317295|FG001|Overall Study|Protocol Violation|1|||
145672759|NCT03683576|525317296|FG002|Overall Study|Protocol Violation|1|||
145672760|NCT03683576|525317297|FG003|Overall Study|Protocol Violation|0|||
145672761|NCT02628626|525317298|FG000|Overall Study|Withdrawal by Subject|2|||
145672762|NCT02628626|525317299|FG001|Overall Study|Withdrawal by Subject|2|||
145672763|NCT02744066|525317300|FG000|Overall Study|Withdrawal by parent|0|||
145672764|NCT02744066|525317301|FG001|Overall Study|Withdrawal by parent|1|||
145672765|NCT02744066|525317300|FG000|Overall Study|Discharged from NICU prior to completion|0|||
145672766|NCT02744066|525317301|FG001|Overall Study|Discharged from NICU prior to completion|4|||
145672767|NCT01400958|525317304|FG000|Overall Study|Physician Decision|0|||
145672768|NCT01400958|525317305|FG001|Overall Study|Physician Decision|1|||
145672769|NCT01400958|525317304|FG000|Overall Study|Withdrawal by Subject|0|||
145672770|NCT01400958|525317305|FG001|Overall Study|Withdrawal by Subject|1|||
145672771|NCT01400958|525317304|FG000|Overall Study|Adverse Event|1|||
145672772|NCT01400958|525317305|FG001|Overall Study|Adverse Event|0|||
145672773|NCT03102034|525317308|FG000|Overall Study|Withdrawal by Subject|1|||
145672774|NCT03102034|525317309|FG001|Overall Study|Withdrawal by Subject|0|||
145672775|NCT02972359|525317310|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
145672776|NCT02972359|525317310|FG000|Overall Study|Lack of Efficacy|1|||
145672777|NCT02972359|525317310|FG000|Overall Study|Adverse Event|4|||
145672778|NCT02972359|525317310|FG000|Overall Study|Death|1|||
145672779|NCT02972359|525317310|FG000|Overall Study|Withdrawal by Subject|30|||
145672780|NCT02972359|525317310|FG000|Overall Study|Protocol Violation|1|||
145672781|NCT02972359|525317310|FG000|Overall Study|Lost to Follow-up|26|||
145672782|NCT02972359|525317310|FG000|Overall Study|Other reasons|5|||
145672783|NCT02972359|525317310|FG000|Overall Study|Missing|1|||
145672784|NCT05251363|525317317|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
145672785|NCT05251363|525317317|FG000|Overall Study After Implant Period|Death|9|||
145672786|NCT05251363|525317317|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
145672787|NCT05251363|525317317|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
145672788|NCT05251363|525317317|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
145672789|NCT05251363|525317317|FG000|Overall Study After Implant Period|Physician Decision|1|||
145672790|NCT05251363|525317317|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
145672791|NCT03425682|525317318|FG000|Overall Study|Lost to Follow-up|2|||
145672792|NCT03425682|525317319|FG001|Overall Study|Lost to Follow-up|4|||
145672793|NCT03425682|525317318|FG000|Overall Study|Withdrawal by Subject|0|||
145672794|NCT03425682|525317319|FG001|Overall Study|Withdrawal by Subject|3|||
145672795|NCT03425682|525317318|FG000|Overall Study|Subject did not meet I/E|4|||
145672796|NCT03425682|525317319|FG001|Overall Study|Subject did not meet I/E|10|||
145672797|NCT03610581|525317320|FG000|Overall Study|Study terminated by sponsor|2|||
145672798|NCT03610581|525317321|FG001|Overall Study|Study terminated by sponsor|0|||
145672799|NCT03610581|525317320|FG000|Overall Study|Other|0|||
145672800|NCT03610581|525317321|FG001|Overall Study|Other|1|||
145672801|NCT03610581|525317320|FG000|Overall Study|Withdrawal by Subject|1|||
145672802|NCT03610581|525317321|FG001|Overall Study|Withdrawal by Subject|0|||
145672803|NCT00489307|525317324|FG000|Overall Study|Death|1|||
145672804|NCT00489307|525317325|FG001|Overall Study|Death|1|||
145672805|NCT00489307|525317324|FG000|Overall Study|Lost to Follow-up|2|||
145672806|NCT00489307|525317325|FG001|Overall Study|Lost to Follow-up|2|||
145672807|NCT00489307|525317324|FG000|Overall Study|Physician Decision|1|||
145672808|NCT00489307|525317325|FG001|Overall Study|Physician Decision|0|||
145672809|NCT00489307|525317324|FG000|Overall Study|Withdrawal by Subject|2|||
145672810|NCT00489307|525317325|FG001|Overall Study|Withdrawal by Subject|4|||
145672811|NCT00489307|525317324|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
145672812|NCT00489307|525317325|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
145672813|NCT00489307|525317324|FG000|Overall Study|Surgery after assignment|1|||
145672814|NCT00489307|525317325|FG001|Overall Study|Surgery after assignment|0|||
145672815|NCT00489307|525317324|FG000|Overall Study|Did not fill up the forms|2|||
145672816|NCT00489307|525317325|FG001|Overall Study|Did not fill up the forms|1|||
145672817|NCT00489307|525317324|FG000|Overall Study|Patient or family refusal|5|||
145672818|NCT00489307|525317325|FG001|Overall Study|Patient or family refusal|9|||
145672819|NCT02307682|525317326|FG000|Overall Study|Adverse Event|9|||
145672820|NCT02307682|525317327|FG001|Overall Study|Adverse Event|8|||
145672821|NCT02307682|525317328|FG002|Overall Study|Adverse Event|12|||
145672822|NCT02307682|525317326|FG000|Overall Study|Lack of Efficacy|1|||
145672823|NCT02307682|525317327|FG001|Overall Study|Lack of Efficacy|0|||
145672824|NCT02307682|525317328|FG002|Overall Study|Lack of Efficacy|1|||
145672825|NCT02307682|525317326|FG000|Overall Study|Physician Decision|2|||
145672826|NCT02307682|525317327|FG001|Overall Study|Physician Decision|2|||
145672827|NCT02307682|525317328|FG002|Overall Study|Physician Decision|8|||
145672828|NCT02307682|525317326|FG000|Overall Study|Progressive Disease|1|||
145672829|NCT02307682|525317327|FG001|Overall Study|Progressive Disease|0|||
145672830|NCT02307682|525317328|FG002|Overall Study|Progressive Disease|0|||
145672831|NCT02307682|525317326|FG000|Overall Study|Withdrawal by Subject|26|||
145672832|NCT02307682|525317327|FG001|Overall Study|Withdrawal by Subject|34|||
145672833|NCT02307682|525317328|FG002|Overall Study|Withdrawal by Subject|23|||
145672834|NCT02307682|525317326|FG000|Overall Study|Death|9|||
145672835|NCT02307682|525317327|FG001|Overall Study|Death|7|||
145672836|NCT02307682|525317328|FG002|Overall Study|Death|12|||
145672837|NCT02307682|525317326|FG000|Overall Study|Lost to Follow-up|1|||
145672838|NCT02307682|525317327|FG001|Overall Study|Lost to Follow-up|5|||
145672839|NCT02307682|525317328|FG002|Overall Study|Lost to Follow-up|6|||
145672840|NCT02307682|525317326|FG000|Overall Study|Protocol Deviation|0|||
145672841|NCT02307682|525317327|FG001|Overall Study|Protocol Deviation|0|||
145672842|NCT02307682|525317328|FG002|Overall Study|Protocol Deviation|2|||
145672843|NCT02307682|525317326|FG000|Overall Study|Other|1|||
145672844|NCT02307682|525317327|FG001|Overall Study|Other|1|||
145672845|NCT02307682|525317328|FG002|Overall Study|Other|0|||
145672846|NCT02517268|525317331|FG000|Overall Study|Withdrawal by Subject|1|||
145672847|NCT02517268|525317332|FG001|Overall Study|Withdrawal by Subject|0|||
145672848|NCT05071430|525317335|FG000|Overall Study|Adverse Event|1|||
145672849|NCT05071430|525317336|FG001|Overall Study|Adverse Event|2|||
145672850|NCT05071430|525317335|FG000|Overall Study|Lost to Follow-up|4|||
145672851|NCT05071430|525317336|FG001|Overall Study|Lost to Follow-up|4|||
145672852|NCT05071430|525317335|FG000|Overall Study|Protocol Violation|1|||
145672853|NCT05071430|525317336|FG001|Overall Study|Protocol Violation|0|||
145672854|NCT05071430|525317335|FG000|Overall Study|Withdrawal by Subject|3|||
145672855|NCT05071430|525317336|FG001|Overall Study|Withdrawal by Subject|2|||
145672856|NCT05071430|525317335|FG000|Overall Study|Other|1|||
145672857|NCT05071430|525317336|FG001|Overall Study|Other|1|||
145672858|NCT05810285|525317340|FG000|Overall Study|Death|4|||
145672859|NCT05810285|525317341|FG001|Overall Study|Death|21|||
145672860|NCT05810285|525317340|FG000|Overall Study|Adverse Event|18|||
145672861|NCT05810285|525317341|FG001|Overall Study|Adverse Event|16|||
145672862|NCT05470114|525317342|FG000|Overall Study|Withdrawal by Subject|1|||
145672863|NCT05470114|525317343|FG001|Overall Study|Withdrawal by Subject|0|||
145672864|NCT05470114|525317342|FG000|Overall Study|Lost to Follow-up|1|||
145672865|NCT05470114|525317343|FG001|Overall Study|Lost to Follow-up|0|||
145672866|NCT04649047|525317344|FG000|Overall Study|Withdrawal by Subject|3|||
145672867|NCT02488408|525317345|FG000|Part A|Adverse Event|2|||
145672868|NCT02488408|525317346|FG001|Part A|Adverse Event|0|||
145672869|NCT02488408|525317347|FG002|Part A|Adverse Event|0|||
145672870|NCT02488408|525317348|FG003|Part A|Adverse Event|0|||
145672871|NCT02488408|525317349|FG004|Part A|Adverse Event|0|||
145672872|NCT02488408|525317350|FG005|Part A|Adverse Event|0|||
145672873|NCT02488408|525317351|FG006|Part A|Adverse Event|0|||
145672874|NCT02488408|525317352|FG007|Part A|Adverse Event|0|||
145672875|NCT02488408|525317353|FG008|Part A|Adverse Event|0|||
145672876|NCT02488408|525317354|FG009|Part A|Adverse Event|0|||
145672877|NCT02488408|525317345|FG000|Part A|Death|1|||
145672878|NCT02488408|525317346|FG001|Part A|Death|5|||
145672879|NCT02488408|525317347|FG002|Part A|Death|0|||
145672880|NCT02488408|525317348|FG003|Part A|Death|0|||
145672881|NCT02488408|525317349|FG004|Part A|Death|3|||
145672882|NCT02488408|525317350|FG005|Part A|Death|0|||
145490944|NCT02055898|524652296|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
145490945|NCT02055898|524652297|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
145490946|NCT02201524|524652299|FG000|Overall Study|Adverse Event|0|||
145490947|NCT02201524|524652300|FG001|Overall Study|Adverse Event|2|||
145490948|NCT02201524|524652301|FG002|Overall Study|Adverse Event|1|||
145490949|NCT02201524|524652302|FG003|Overall Study|Adverse Event|0|||
145672883|NCT02488408|525317351|FG006|Part A|Death|0|||
145672884|NCT02488408|525317352|FG007|Part A|Death|0|||
145672885|NCT02488408|525317353|FG008|Part A|Death|0|||
145672886|NCT02488408|525317354|FG009|Part A|Death|0|||
145672887|NCT02488408|525317345|FG000|Part A|Disease Progression|2|||
145672888|NCT02488408|525317346|FG001|Part A|Disease Progression|8|||
145672889|NCT02488408|525317347|FG002|Part A|Disease Progression|2|||
145672890|NCT02488408|525317348|FG003|Part A|Disease Progression|3|||
145672891|NCT02488408|525317349|FG004|Part A|Disease Progression|4|||
145672892|NCT02488408|525317350|FG005|Part A|Disease Progression|0|||
145672893|NCT02488408|525317351|FG006|Part A|Disease Progression|0|||
145672894|NCT02488408|525317352|FG007|Part A|Disease Progression|0|||
145672895|NCT02488408|525317353|FG008|Part A|Disease Progression|0|||
145672896|NCT02488408|525317354|FG009|Part A|Disease Progression|0|||
145672897|NCT02488408|525317345|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
145672898|NCT02488408|525317346|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
145672899|NCT02488408|525317347|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
145672900|NCT02488408|525317348|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
145672901|NCT02488408|525317349|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
145672902|NCT02488408|525317350|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
145490950|NCT02201524|524652299|FG000|Overall Study|Insufficient clinical response|1|||
145672903|NCT02488408|525317351|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
145672904|NCT02488408|525317352|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
145672905|NCT02488408|525317353|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
145672906|NCT02488408|525317354|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
145672907|NCT02488408|525317345|FG000|Part A|Investigator Decision|0|||
145672908|NCT02488408|525317346|FG001|Part A|Investigator Decision|1|||
145672909|NCT02488408|525317347|FG002|Part A|Investigator Decision|1|||
145672910|NCT02488408|525317348|FG003|Part A|Investigator Decision|0|||
145672911|NCT02488408|525317349|FG004|Part A|Investigator Decision|0|||
145672912|NCT02488408|525317350|FG005|Part A|Investigator Decision|0|||
145672913|NCT02488408|525317351|FG006|Part A|Investigator Decision|0|||
145672914|NCT02488408|525317352|FG007|Part A|Investigator Decision|0|||
145672915|NCT02488408|525317353|FG008|Part A|Investigator Decision|0|||
145672916|NCT02488408|525317354|FG009|Part A|Investigator Decision|0|||
145672917|NCT02488408|525317345|FG000|Part A|Withdrawal by Subject|0|||
145672918|NCT02488408|525317346|FG001|Part A|Withdrawal by Subject|0|||
145672919|NCT02488408|525317347|FG002|Part A|Withdrawal by Subject|2|||
145672920|NCT02488408|525317348|FG003|Part A|Withdrawal by Subject|0|||
145672921|NCT02488408|525317349|FG004|Part A|Withdrawal by Subject|0|||
145672922|NCT02488408|525317350|FG005|Part A|Withdrawal by Subject|0|||
145672923|NCT02488408|525317351|FG006|Part A|Withdrawal by Subject|0|||
145672924|NCT02488408|525317352|FG007|Part A|Withdrawal by Subject|0|||
145672925|NCT02488408|525317353|FG008|Part A|Withdrawal by Subject|0|||
145672926|NCT02488408|525317354|FG009|Part A|Withdrawal by Subject|0|||
145672927|NCT02488408|525317345|FG000|Part A|Other|1|||
145672928|NCT02488408|525317346|FG001|Part A|Other|0|||
145672929|NCT02488408|525317347|FG002|Part A|Other|0|||
145672930|NCT02488408|525317348|FG003|Part A|Other|0|||
145672931|NCT02488408|525317349|FG004|Part A|Other|0|||
145672932|NCT02488408|525317350|FG005|Part A|Other|0|||
145672933|NCT02488408|525317351|FG006|Part A|Other|0|||
145672934|NCT02488408|525317352|FG007|Part A|Other|0|||
145672935|NCT02488408|525317353|FG008|Part A|Other|0|||
145672936|NCT02488408|525317354|FG009|Part A|Other|0|||
145672937|NCT02488408|525317345|FG000|Part B|Adverse Event|0|||
145672938|NCT02488408|525317346|FG001|Part B|Adverse Event|0|||
145672939|NCT02488408|525317347|FG002|Part B|Adverse Event|0|||
145672940|NCT02488408|525317348|FG003|Part B|Adverse Event|0|||
145672941|NCT02488408|525317349|FG004|Part B|Adverse Event|0|||
145672942|NCT02488408|525317350|FG005|Part B|Adverse Event|2|||
145672943|NCT02488408|525317351|FG006|Part B|Adverse Event|2|||
145672944|NCT02488408|525317352|FG007|Part B|Adverse Event|7|||
145672945|NCT02488408|525317353|FG008|Part B|Adverse Event|2|||
145672946|NCT02488408|525317354|FG009|Part B|Adverse Event|2|||
145672947|NCT02488408|525317345|FG000|Part B|Death|0|||
145672948|NCT02488408|525317346|FG001|Part B|Death|0|||
145672949|NCT02488408|525317347|FG002|Part B|Death|0|||
145672950|NCT02488408|525317348|FG003|Part B|Death|0|||
145672951|NCT02488408|525317349|FG004|Part B|Death|0|||
145672952|NCT02488408|525317350|FG005|Part B|Death|3|||
145672953|NCT02488408|525317351|FG006|Part B|Death|1|||
145672954|NCT02488408|525317352|FG007|Part B|Death|2|||
145672955|NCT02488408|525317353|FG008|Part B|Death|2|||
145672956|NCT02488408|525317354|FG009|Part B|Death|2|||
145672957|NCT02488408|525317345|FG000|Part B|Death due to Disease Progression|0|||
145672958|NCT02488408|525317346|FG001|Part B|Death due to Disease Progression|0|||
145672959|NCT02488408|525317347|FG002|Part B|Death due to Disease Progression|0|||
145672960|NCT02488408|525317348|FG003|Part B|Death due to Disease Progression|0|||
145672961|NCT02488408|525317349|FG004|Part B|Death due to Disease Progression|0|||
145672962|NCT02488408|525317350|FG005|Part B|Death due to Disease Progression|2|||
145672963|NCT02488408|525317351|FG006|Part B|Death due to Disease Progression|2|||
145672964|NCT02488408|525317352|FG007|Part B|Death due to Disease Progression|1|||
145672965|NCT02488408|525317353|FG008|Part B|Death due to Disease Progression|1|||
145672966|NCT02488408|525317354|FG009|Part B|Death due to Disease Progression|1|||
145672967|NCT02488408|525317345|FG000|Part B|Disease Progression|0|||
145672968|NCT02488408|525317346|FG001|Part B|Disease Progression|0|||
145672969|NCT02488408|525317347|FG002|Part B|Disease Progression|0|||
145672970|NCT02488408|525317348|FG003|Part B|Disease Progression|0|||
145672971|NCT02488408|525317349|FG004|Part B|Disease Progression|0|||
145672972|NCT02488408|525317350|FG005|Part B|Disease Progression|6|||
145672973|NCT02488408|525317351|FG006|Part B|Disease Progression|9|||
145672974|NCT02488408|525317352|FG007|Part B|Disease Progression|7|||
145672975|NCT02488408|525317353|FG008|Part B|Disease Progression|9|||
145672976|NCT02488408|525317354|FG009|Part B|Disease Progression|11|||
145672977|NCT02488408|525317345|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
145672978|NCT02488408|525317346|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
145672979|NCT02488408|525317347|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
145672980|NCT02488408|525317348|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
145672981|NCT02488408|525317349|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
145672982|NCT02488408|525317350|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
145672983|NCT02488408|525317351|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
145672984|NCT02488408|525317352|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
145672985|NCT02488408|525317353|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
145672986|NCT02488408|525317354|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
145672987|NCT02488408|525317345|FG000|Part B|Investigator Decision|0|||
145672988|NCT02488408|525317346|FG001|Part B|Investigator Decision|0|||
145672989|NCT02488408|525317347|FG002|Part B|Investigator Decision|0|||
145672990|NCT02488408|525317348|FG003|Part B|Investigator Decision|0|||
145672991|NCT02488408|525317349|FG004|Part B|Investigator Decision|0|||
145672992|NCT02488408|525317350|FG005|Part B|Investigator Decision|0|||
145672993|NCT02488408|525317351|FG006|Part B|Investigator Decision|1|||
145672994|NCT02488408|525317352|FG007|Part B|Investigator Decision|0|||
145672995|NCT02488408|525317353|FG008|Part B|Investigator Decision|2|||
145672996|NCT02488408|525317354|FG009|Part B|Investigator Decision|1|||
145672997|NCT05037513|525317355|FG000|Intervention Period|Lost to Follow-up|1|||
145672998|NCT05037513|525317356|FG001|Intervention Period|Lost to Follow-up|2|||
145672999|NCT05037513|525317355|FG000|Follow Up Period|Lost to Follow-up|16|||
145673000|NCT05037513|525317356|FG001|Follow Up Period|Lost to Follow-up|21|||
145673001|NCT05037513|525317355|FG000|Follow Up Period|Death|0|||
145673002|NCT05037513|525317356|FG001|Follow Up Period|Death|1|||
145673003|NCT05037513|525317355|FG000|Follow Up Period|Incarcerated|4|||
145673004|NCT05037513|525317356|FG001|Follow Up Period|Incarcerated|2|||
145673005|NCT05886777|525317357|FG000|Overall Study|Lost to Follow-up|1|||
145673006|NCT05886777|525317358|FG001|Overall Study|Lost to Follow-up|0|||
145673007|NCT05886777|525317359|FG002|Overall Study|Lost to Follow-up|2|||
145673008|NCT05886777|525317360|FG003|Overall Study|Lost to Follow-up|1|||
145673009|NCT05886777|525317361|FG004|Overall Study|Lost to Follow-up|0|||
145673010|NCT05886777|525317362|FG005|Overall Study|Lost to Follow-up|2|||
145673011|NCT05886777|525317363|FG006|Overall Study|Lost to Follow-up|0|||
145673012|NCT05886777|525317357|FG000|Overall Study|Other|0|||
145673013|NCT05886777|525317358|FG001|Overall Study|Other|2|||
145673014|NCT05886777|525317359|FG002|Overall Study|Other|1|||
145673015|NCT05886777|525317360|FG003|Overall Study|Other|0|||
145673016|NCT05886777|525317361|FG004|Overall Study|Other|0|||
145673017|NCT05886777|525317362|FG005|Overall Study|Other|0|||
145673018|NCT05886777|525317363|FG006|Overall Study|Other|0|||
145673019|NCT05886777|525317357|FG000|Overall Study|Withdrawal by Subject|1|||
145673020|NCT05886777|525317358|FG001|Overall Study|Withdrawal by Subject|0|||
145673021|NCT05886777|525317359|FG002|Overall Study|Withdrawal by Subject|1|||
145673022|NCT05886777|525317360|FG003|Overall Study|Withdrawal by Subject|4|||
145673023|NCT05886777|525317361|FG004|Overall Study|Withdrawal by Subject|3|||
145673024|NCT05886777|525317362|FG005|Overall Study|Withdrawal by Subject|1|||
145673025|NCT05886777|525317363|FG006|Overall Study|Withdrawal by Subject|1|||
145673026|NCT05886777|525317357|FG000|Overall Study|Protocol Violation|0|||
145673027|NCT05886777|525317358|FG001|Overall Study|Protocol Violation|0|||
145673028|NCT05886777|525317359|FG002|Overall Study|Protocol Violation|1|||
145673029|NCT05886777|525317360|FG003|Overall Study|Protocol Violation|0|||
145673030|NCT05886777|525317361|FG004|Overall Study|Protocol Violation|0|||
145673031|NCT05886777|525317362|FG005|Overall Study|Protocol Violation|0|||
145673032|NCT05886777|525317363|FG006|Overall Study|Protocol Violation|0|||
145673033|NCT05886777|525317357|FG000|Overall Study|No longer met eligibility criteria|0|||
145673034|NCT05886777|525317358|FG001|Overall Study|No longer met eligibility criteria|1|||
145673035|NCT05886777|525317359|FG002|Overall Study|No longer met eligibility criteria|0|||
145673036|NCT05886777|525317360|FG003|Overall Study|No longer met eligibility criteria|0|||
145673037|NCT05886777|525317361|FG004|Overall Study|No longer met eligibility criteria|0|||
145673038|NCT05886777|525317362|FG005|Overall Study|No longer met eligibility criteria|0|||
145673039|NCT05886777|525317363|FG006|Overall Study|No longer met eligibility criteria|0|||
145673040|NCT03773107|525317364|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
145673041|NCT03773107|525317365|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
145673042|NCT03773107|525317366|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
145673043|NCT03773107|525317367|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
145673044|NCT04577651|525317370|FG000|Overall Study|Screen Failure|7|||
145673045|NCT04577651|525317370|FG000|Overall Study|Adverse Event|1|||
145673046|NCT04577651|525317370|FG000|Overall Study|Death|1|||
145673047|NCT04577651|525317370|FG000|Overall Study|Physician Decision|1|||
145673048|NCT04577651|525317370|FG000|Overall Study|Withdrawal by Subject|3|||
145673049|NCT00705406|525318523|FG000|Overall Study|Lost to Follow-up|3|||
145673050|NCT00705406|525318524|FG001|Overall Study|Lost to Follow-up|3|||
145673051|NCT00705406|525318523|FG000|Overall Study|Did not receive study drug|1|||
145673052|NCT00705406|525318524|FG001|Overall Study|Did not receive study drug|2|||
145673053|NCT00442104|525318526|FG000|Overall Study|Adverse Event|5|||
145673054|NCT00442104|525318526|FG000|Overall Study|Death|2|||
145673055|NCT00442104|525318526|FG000|Overall Study|Lost to Follow-up|3|||
145673056|NCT00442104|525318526|FG000|Overall Study|Withdrawal by Subject|5|||
145673057|NCT00442104|525318526|FG000|Overall Study|Insufficient Clinical Response|10|||
145673058|NCT00442104|525318526|FG000|Overall Study|Other|21|||
145673059|NCT00442104|525318526|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
145673060|NCT02362035|525318529|FG000|Overall Study|Death|67|||
145673061|NCT02362035|525318529|FG000|Overall Study|Lost to Follow-up|3|||
145673062|NCT02362035|525318529|FG000|Overall Study|Adverse Event|1|||
145673063|NCT02362035|525318529|FG000|Overall Study|Physician Decision|1|||
145673064|NCT02362035|525318529|FG000|Overall Study|Subject started another cancer therapy|10|||
145673065|NCT02362035|525318529|FG000|Overall Study|Study terminated by sponsor|45|||
145673066|NCT02362035|525318529|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
145673067|NCT02362035|525318529|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
145673068|NCT02362035|525318529|FG000|Overall Study|Disease progression|11|||
145673069|NCT02362035|525318529|FG000|Overall Study|Withdrawal by Subject|20|||
145673070|NCT00975585|525318533|FG000|Overall Study|Adverse Event|0|||
145673071|NCT00975585|525318534|FG001|Overall Study|Adverse Event|4|||
145673072|NCT00975585|525318533|FG000|Overall Study|Lost to Follow-up|3|||
145673073|NCT00975585|525318534|FG001|Overall Study|Lost to Follow-up|5|||
145673074|NCT00975585|525318533|FG000|Overall Study|Withdrawal by Subject|2|||
145673075|NCT00975585|525318534|FG001|Overall Study|Withdrawal by Subject|1|||
145673076|NCT00975585|525318533|FG000|Overall Study|Lens issue|2|||
145673077|NCT00975585|525318534|FG001|Overall Study|Lens issue|2|||
145673078|NCT01953224|525318535|FG000|Overall Study|Lost to Follow-up|1|||
145673079|NCT01953224|525318536|FG001|Overall Study|Lost to Follow-up|1|||
145673080|NCT01953224|525318535|FG000|Overall Study|Withdrawal by Subject|1|||
145673081|NCT01953224|525318536|FG001|Overall Study|Withdrawal by Subject|2|||
145673082|NCT00683800|525318538|FG000|Overall Study|Adverse Event|195|||
145673083|NCT00683800|525318539|FG001|Overall Study|Adverse Event|102|||
145673084|NCT00683800|525318538|FG000|Overall Study|Death|0|||
145673085|NCT00683800|525318539|FG001|Overall Study|Death|1|||
145673086|NCT00683800|525318538|FG000|Overall Study|Lost to Follow-up|57|||
145673087|NCT00683800|525318539|FG001|Overall Study|Lost to Follow-up|44|||
145673088|NCT00683800|525318538|FG000|Overall Study|Other|5|||
145673089|NCT00683800|525318539|FG001|Overall Study|Other|2|||
145673090|NCT00683800|525318538|FG000|Overall Study|Protocol Violation|13|||
145673091|NCT00683800|525318539|FG001|Overall Study|Protocol Violation|16|||
145673092|NCT00683800|525318538|FG000|Overall Study|Withdrawal by Subject|66|||
145673093|NCT00683800|525318539|FG001|Overall Study|Withdrawal by Subject|64|||
145673094|NCT00683800|525318538|FG000|Overall Study|Lack of Efficacy|61|||
145673095|NCT00683800|525318539|FG001|Overall Study|Lack of Efficacy|104|||
145673096|NCT00683800|525318538|FG000|Overall Study|Randomized, not treated|35|||
145673097|NCT00683800|525318539|FG001|Overall Study|Randomized, not treated|33|||
145673098|NCT00205179|525318542|FG000|Overall Study|Death|0|||
145673099|NCT00205179|525318543|FG001|Overall Study|Death|2|||
145673100|NCT00205179|525318542|FG000|Overall Study|Physician Decision|1|||
145673101|NCT00205179|525318543|FG001|Overall Study|Physician Decision|1|||
145673102|NCT00205179|525318542|FG000|Overall Study|Adverse Event|1|||
145673103|NCT00205179|525318543|FG001|Overall Study|Adverse Event|1|||
145673104|NCT00463229|525318546|FG000|Overall Study|Lost to Follow-up|5|||
145673105|NCT00463229|525318547|FG001|Overall Study|Lost to Follow-up|7|||
145673106|NCT00463229|525318546|FG000|Overall Study|Death|4|||
145673107|NCT00463229|525318547|FG001|Overall Study|Death|3|||
145673108|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
145673109|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
145673110|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
145673111|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
145673112|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
145673113|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
145673114|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
145673115|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
145673116|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
145673117|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
145673118|NCT01767467|525318554|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
145673119|NCT01767467|525318555|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
145673120|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
145673121|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
145673122|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
145673123|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
145673124|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
145673125|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
145673126|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
145673127|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
145673128|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
145673129|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
145490951|NCT02201524|524652300|FG001|Overall Study|Insufficient clinical response|0|||
145673130|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
145673131|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
145673132|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
145673133|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
145673134|NCT01767467|525318554|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
145673135|NCT01767467|525318555|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
145673136|NCT01359150|525318556|FG000|Overall Study|Lack of Efficacy|1|||
145673137|NCT01359150|525318557|FG001|Overall Study|Lack of Efficacy|1|||
145673138|NCT01359150|525318556|FG000|Overall Study|Withdrawal by Subject|1|||
145673139|NCT01359150|525318557|FG001|Overall Study|Withdrawal by Subject|1|||
145673140|NCT01359150|525318556|FG000|Overall Study|Adverse Event|4|||
145673141|NCT01359150|525318557|FG001|Overall Study|Adverse Event|3|||
145673142|NCT01359150|525318556|FG000|Overall Study|Other|1|||
145673143|NCT01359150|525318557|FG001|Overall Study|Other|0|||
145673144|NCT01787032|525318560|FG000|Overall Study|Protocol Violation|0|||
145673145|NCT01787032|525318561|FG001|Overall Study|Protocol Violation|0|||
145673146|NCT01787032|525318562|FG002|Overall Study|Protocol Violation|0|||
145673147|NCT01787032|525318563|FG003|Overall Study|Protocol Violation|0|||
145673148|NCT01787032|525318564|FG004|Overall Study|Protocol Violation|1|||
145673149|NCT01787032|525318565|FG005|Overall Study|Protocol Violation|1|||
145673150|NCT02040870|525318566|FG000|Overall Study|Completed treatment phase|6|||
145673151|NCT02040870|525318566|FG000|Overall Study|Adverse Event|7|||
145673152|NCT02040870|525318566|FG000|Overall Study|Progressive disease|58|||
145673153|NCT02040870|525318566|FG000|Overall Study|Physician Decision|6|||
145673154|NCT02040870|525318566|FG000|Overall Study|Subject/guardian decision|10|||
145673155|NCT02040870|525318566|FG000|Overall Study|Lost to Follow-up|3|||
145673156|NCT02040870|525318566|FG000|Overall Study|Death|13|||
145673157|NCT03041233|525318567|FG000|Overall Study|Death|5|||
145673158|NCT03041233|525318567|FG000|Overall Study|Physician Decision|1|||
145673159|NCT03041233|525318567|FG000|Overall Study|Lost to Follow-up|16|||
145673160|NCT03041233|525318567|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
145673161|NCT03041233|525318567|FG000|Overall Study|Sponsor Request|1|||
145673162|NCT03041233|525318567|FG000|Overall Study|Duplicate subject|1|||
145673163|NCT03041233|525318567|FG000|Overall Study|Re-ablation|1|||
145673164|NCT00853593|525318571|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
145673165|NCT00853593|525318571|FG000|Overall Study|Model 4396 lead not attempted|29|||
145673166|NCT00853593|525318571|FG000|Overall Study|Implant not attempted|4|||
145673167|NCT03362190|525318581|FG000|Overall Study|Adverse Event|0|||
145673168|NCT03362190|525318582|FG001|Overall Study|Adverse Event|0|||
145673169|NCT03362190|525318583|FG002|Overall Study|Adverse Event|0|||
145673170|NCT03362190|525318584|FG003|Overall Study|Adverse Event|1|||
145673171|NCT03362190|525318581|FG000|Overall Study|Withdrawal by Subject|0|||
145673172|NCT03362190|525318582|FG001|Overall Study|Withdrawal by Subject|0|||
145673173|NCT03362190|525318583|FG002|Overall Study|Withdrawal by Subject|0|||
145673174|NCT03362190|525318584|FG003|Overall Study|Withdrawal by Subject|1|||
145673175|NCT00687219|525318585|FG000|Overall Study|Adverse Event|8|||
145673176|NCT00687219|525318585|FG000|Overall Study|Discontinuance criteria met|7|||
145673177|NCT00687219|525318585|FG000|Overall Study|HCV-RNA positive conversion|34|||
145673178|NCT00687219|525318585|FG000|Overall Study|Withdrawal by Subject|1|||
145673179|NCT00687219|525318585|FG000|Overall Study|Lack of Efficacy|1|||
145673180|NCT02235298|525318593|FG000|Overall Study|Lost to Follow-up|6|||
145673181|NCT02235298|525318594|FG001|Overall Study|Lost to Follow-up|5|||
145673182|NCT02235298|525318593|FG000|Overall Study|Adverse Event|2|||
145673183|NCT02235298|525318594|FG001|Overall Study|Adverse Event|2|||
145673184|NCT02235298|525318593|FG000|Overall Study|Withdrawal by Subject|0|||
145673185|NCT02235298|525318594|FG001|Overall Study|Withdrawal by Subject|1|||
145673186|NCT01588951|525318598|FG000|Overall Study|Ineligible in retrospect|0|||
145673187|NCT01588951|525318599|FG001|Overall Study|Ineligible in retrospect|0|||
145673188|NCT01588951|525318600|FG002|Overall Study|Ineligible in retrospect|1|||
145673189|NCT01593020|525318605|FG000|Overall Study|Adverse Event|1|||
145673190|NCT01593020|525318606|FG001|Overall Study|Adverse Event|1|||
145673191|NCT01593020|525318605|FG000|Overall Study|Death|0|||
145673192|NCT01593020|525318606|FG001|Overall Study|Death|1|||
145673193|NCT01593020|525318605|FG000|Overall Study|Ineligible|1|||
145673194|NCT01593020|525318606|FG001|Overall Study|Ineligible|0|||
145673195|NCT02350634|525318607|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
145673196|NCT02063659|525318621|FG000|Double-Blind Treatment Period|Adverse Event|1|||
145673197|NCT02063659|525318622|FG001|Double-Blind Treatment Period|Adverse Event|2|||
145673198|NCT02063659|525318623|FG002|Double-Blind Treatment Period|Adverse Event|0|||
145673199|NCT02063659|525318624|FG003|Double-Blind Treatment Period|Adverse Event|0|||
145673200|NCT02063659|525318621|FG000|Double-Blind Treatment Period|Physician Decision|1|||
145673201|NCT02063659|525318622|FG001|Double-Blind Treatment Period|Physician Decision|0|||
145673202|NCT02063659|525318623|FG002|Double-Blind Treatment Period|Physician Decision|0|||
145673203|NCT02063659|525318624|FG003|Double-Blind Treatment Period|Physician Decision|0|||
145673204|NCT02063659|525318621|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
145673205|NCT02063659|525318622|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
145673206|NCT02063659|525318623|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
145673207|NCT02063659|525318624|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
145673208|NCT02063659|525318621|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
145673209|NCT02063659|525318622|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
145673210|NCT02063659|525318623|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
145673211|NCT02063659|525318624|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
145673212|NCT02063659|525318621|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145673213|NCT02063659|525318622|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145673214|NCT02063659|525318623|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
145673215|NCT02063659|525318624|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
145673216|NCT02063659|525318621|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145673217|NCT02063659|525318622|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145673218|NCT02063659|525318623|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
145673219|NCT02063659|525318624|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
145673220|NCT02063659|525318621|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
145673221|NCT02063659|525318622|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
145673222|NCT02063659|525318623|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
145673223|NCT02063659|525318624|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
145673224|NCT02063659|525318621|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145673225|NCT02063659|525318622|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145673226|NCT02063659|525318623|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
145673227|NCT02063659|525318624|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
145673228|NCT00914966|525318625|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
145673229|NCT00914966|525318625|FG000|Step 1: 1500 Units|Physician Decision|1|||
145673230|NCT00914966|525318625|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
145673231|NCT03488719|525318626|FG000|Overall Study|Adverse Event|0|||
145673232|NCT03488719|525318627|FG001|Overall Study|Adverse Event|4|||
145673233|NCT03488719|525318628|FG002|Overall Study|Adverse Event|2|||
145673234|NCT03488719|525318626|FG000|Overall Study|Other|0|||
145673235|NCT03488719|525318627|FG001|Overall Study|Other|0|||
145673236|NCT03488719|525318628|FG002|Overall Study|Other|5|||
145673237|NCT03477175|525318629|FG000|Overall Study|Unable to travel due to COVID-19|0|||
145673238|NCT03477175|525318630|FG001|Overall Study|Unable to travel due to COVID-19|1|||
145673239|NCT03477175|525318629|FG000|Overall Study|Physician Decision|1|||
145673240|NCT03477175|525318630|FG001|Overall Study|Physician Decision|0|||
145673241|NCT03477175|525318629|FG000|Overall Study|Transitioned to commercial drug|6|||
145673242|NCT03477175|525318630|FG001|Overall Study|Transitioned to commercial drug|6|||
145673243|NCT03477175|525318629|FG000|Overall Study|Lost to Follow-up|1|||
145673244|NCT03477175|525318630|FG001|Overall Study|Lost to Follow-up|1|||
145673245|NCT03477175|525318629|FG000|Overall Study|Withdrawal by Subject|3|||
145673246|NCT03477175|525318630|FG001|Overall Study|Withdrawal by Subject|1|||
145673247|NCT03477175|525318629|FG000|Overall Study|Adverse Event|1|||
145673248|NCT03477175|525318630|FG001|Overall Study|Adverse Event|5|||
145673249|NCT03477175|525318629|FG000|Overall Study|Disease Progression|7|||
145673250|NCT03477175|525318630|FG001|Overall Study|Disease Progression|7|||
145673251|NCT03371017|525318631|FG000|Overall Study|Physician Decision|0|||
145673252|NCT03371017|525318632|FG001|Overall Study|Physician Decision|1|||
145673253|NCT03371017|525318631|FG000|Overall Study|Reason not Specified|0|||
145673254|NCT03371017|525318632|FG001|Overall Study|Reason not Specified|1|||
145673255|NCT03371017|525318631|FG000|Overall Study|Lost to Follow-up|13|||
145673256|NCT03371017|525318632|FG001|Overall Study|Lost to Follow-up|16|||
145673257|NCT03371017|525318631|FG000|Overall Study|Death|228|||
145673258|NCT03371017|525318632|FG001|Overall Study|Death|215|||
145673259|NCT03371017|525318631|FG000|Overall Study|Withdrawal by Subject|20|||
145673260|NCT03371017|525318632|FG001|Overall Study|Withdrawal by Subject|25|||
145673261|NCT03371017|525318631|FG000|Overall Study|Study Ended by Sponsor|37|||
145673262|NCT03371017|525318632|FG001|Overall Study|Study Ended by Sponsor|38|||
145673263|NCT03371017|525318631|FG000|Overall Study|Protocol Deviation|0|||
145673264|NCT03371017|525318632|FG001|Overall Study|Protocol Deviation|1|||
145673265|NCT01855750|525318633|FG000|Overall Study|Death|78|||
145673266|NCT01855750|525318634|FG001|Overall Study|Death|78|||
145673267|NCT01855750|525318633|FG000|Overall Study|Lost to Follow-up|9|||
145673268|NCT01855750|525318634|FG001|Overall Study|Lost to Follow-up|23|||
145673269|NCT01855750|525318633|FG000|Overall Study|Withdrawal by Subject|35|||
145673270|NCT01855750|525318634|FG001|Overall Study|Withdrawal by Subject|28|||
145673271|NCT01855750|525318633|FG000|Overall Study|Sponsor ends the study|297|||
145673272|NCT01855750|525318634|FG001|Overall Study|Sponsor ends the study|290|||
145673273|NCT04300023|525318635|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
145673274|NCT04300023|525318636|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
145673275|NCT05525572|525318637|FG000|Overall Study|Lost to Follow-up|2|||
145673276|NCT05025384|525318638|FG000|Overall Study|Physician Decision|5|||
145673277|NCT05025384|525318639|FG001|Overall Study|Physician Decision|6|||
145673278|NCT00719888|525318640|FG000|Overall Study|Death|24|||
145673279|NCT00719888|525318641|FG001|Overall Study|Death|9|||
145673280|NCT00719888|525318640|FG000|Overall Study|Relapse|8|||
145673281|NCT00719888|525318641|FG001|Overall Study|Relapse|3|||
145673282|NCT00719888|525318640|FG000|Overall Study|Physician Decision|1|||
145673283|NCT00719888|525318641|FG001|Overall Study|Physician Decision|0|||
145673284|NCT00719888|525318640|FG000|Overall Study|Withdrawal by Subject|1|||
145673285|NCT00719888|525318641|FG001|Overall Study|Withdrawal by Subject|0|||
145673286|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
145673287|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
145673288|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
145673289|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
145673290|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
145673291|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
145673292|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
145673293|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
145673294|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
145673295|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
145673296|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
145673297|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
145673298|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
145673299|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
145673300|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
145673301|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
145673302|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
145673303|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
145673304|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
145673305|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
145673306|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
145673307|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
145673308|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
145673309|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
145673310|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
145673311|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Other|1|||
145673312|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Other|0|||
145673313|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Other|0|||
145673314|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Other|0|||
145673315|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Other|0|||
145673316|NCT02386098|525319968|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
145673317|NCT02386098|525319969|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
145673318|NCT02386098|525319970|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
145673319|NCT02386098|525319971|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
145673320|NCT02386098|525319972|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
145673321|NCT03861052|525319973|FG000|Overall Study|Adverse Event|1|||
145673322|NCT03861052|525319974|FG001|Overall Study|Adverse Event|1|||
145673323|NCT03861052|525319975|FG002|Overall Study|Adverse Event|2|||
145673324|NCT03861052|525319976|FG003|Overall Study|Adverse Event|4|||
145673325|NCT03861052|525319973|FG000|Overall Study|Lost to Follow-up|0|||
145673326|NCT03861052|525319974|FG001|Overall Study|Lost to Follow-up|0|||
145673327|NCT03861052|525319975|FG002|Overall Study|Lost to Follow-up|0|||
145673328|NCT03861052|525319976|FG003|Overall Study|Lost to Follow-up|1|||
145673329|NCT03861052|525319973|FG000|Overall Study|Physician Decision|0|||
145673330|NCT03861052|525319974|FG001|Overall Study|Physician Decision|1|||
145673331|NCT03861052|525319975|FG002|Overall Study|Physician Decision|0|||
145673332|NCT03861052|525319976|FG003|Overall Study|Physician Decision|0|||
145673333|NCT03861052|525319973|FG000|Overall Study|Withdrawal by Subject|2|||
145673334|NCT03861052|525319974|FG001|Overall Study|Withdrawal by Subject|5|||
145673335|NCT03861052|525319975|FG002|Overall Study|Withdrawal by Subject|3|||
145673336|NCT03861052|525319976|FG003|Overall Study|Withdrawal by Subject|0|||
145673337|NCT03861052|525319973|FG000|Overall Study|Relocation to other city|1|||
145673338|NCT03861052|525319974|FG001|Overall Study|Relocation to other city|0|||
145673339|NCT03861052|525319975|FG002|Overall Study|Relocation to other city|0|||
145673340|NCT03861052|525319976|FG003|Overall Study|Relocation to other city|0|||
145673341|NCT03712371|525319980|FG000|Overall Study|Lack of Efficacy|0|||
145673342|NCT03712371|525319981|FG001|Overall Study|Lack of Efficacy|0|||
145673343|NCT03712371|525319982|FG002|Overall Study|Lack of Efficacy|0|||
145673344|NCT03712371|525319983|FG003|Overall Study|Lack of Efficacy|1|||
145673345|NCT00229658|525319992|FG000|Overall Study|Administrative|2|||
145673346|NCT00229658|525319993|FG001|Overall Study|Administrative|1|||
145673347|NCT00229658|525319992|FG000|Overall Study|Investigator decision|13|||
145673348|NCT00229658|525319993|FG001|Overall Study|Investigator decision|10|||
145673349|NCT00229658|525319992|FG000|Overall Study|Other|80|||
145673350|NCT00229658|525319993|FG001|Overall Study|Other|60|||
145673351|NCT00229658|525319992|FG000|Overall Study|Lost to Follow-up|82|||
145673352|NCT00229658|525319993|FG001|Overall Study|Lost to Follow-up|55|||
145673353|NCT00229658|525319992|FG000|Overall Study|Serious Adverse Event|2|||
145673354|NCT00229658|525319993|FG001|Overall Study|Serious Adverse Event|2|||
145673355|NCT00229658|525319992|FG000|Overall Study|Withdrawal of consent|46|||
145673356|NCT00229658|525319993|FG001|Overall Study|Withdrawal of consent|39|||
145673357|NCT02157116|525319994|FG000|Overall Study|Withdrawal by Subject|4|||
145673358|NCT02157116|525319994|FG000|Overall Study|Physician Decision|3|||
145673359|NCT02157116|525319994|FG000|Overall Study|Failed Screening|2|||
145673360|NCT00093496|525319995|FG000|Overall Study|Protocol Violation|1|||
145673361|NCT00093496|525319996|FG001|Overall Study|Protocol Violation|3|||
145490952|NCT02201524|524652301|FG002|Overall Study|Insufficient clinical response|0|||
145673362|NCT01932970|525319997|FG000|Overall Study|Withdrawal by Subject|5|||
145673363|NCT01932970|525319997|FG000|Overall Study|Death|1|||
145673364|NCT01932970|525319997|FG000|Overall Study|Lost to Follow-up|2|||
145673365|NCT01932970|525319997|FG000|Overall Study|Protocol Specified Criteria|10|||
145673366|NCT00853580|525319998|FG000|Overall Study|Lost to Follow-up|3|||
145673367|NCT00853580|525319999|FG001|Overall Study|Lost to Follow-up|5|||
145673368|NCT00853580|525319998|FG000|Overall Study|Protocol Violation|2|||
145673369|NCT00853580|525319999|FG001|Overall Study|Protocol Violation|1|||
145673370|NCT00853580|525319998|FG000|Overall Study|Withdrawal by Subject|2|||
145673371|NCT00853580|525319999|FG001|Overall Study|Withdrawal by Subject|8|||
145673372|NCT00853580|525319998|FG000|Overall Study|Commenced contraindicated therapy|0|||
145673373|NCT00853580|525319999|FG001|Overall Study|Commenced contraindicated therapy|2|||
145673374|NCT01700205|525320000|FG000|Overall Study|Withdrawal by Subject|13|||
145673375|NCT01700205|525320001|FG001|Overall Study|Withdrawal by Subject|13|||
145673376|NCT01700205|525320000|FG000|Overall Study|Protocol Violation|2|||
145673377|NCT01700205|525320001|FG001|Overall Study|Protocol Violation|2|||
145673378|NCT01728324|525320002|FG000|Termination of DBV|Adverse Event|14|||
145673379|NCT01728324|525320003|FG001|Termination of DBV|Adverse Event|13|||
145673380|NCT01728324|525320004|FG002|Termination of DBV|Adverse Event|4|||
145673381|NCT01728324|525320002|FG000|Termination of DBV|Lack of Efficacy|14|||
145673382|NCT01728324|525320003|FG001|Termination of DBV|Lack of Efficacy|12|||
145673383|NCT01728324|525320004|FG002|Termination of DBV|Lack of Efficacy|8|||
145673384|NCT01728324|525320002|FG000|Termination of DBV|Withdrawal by Subject|9|||
145673385|NCT01728324|525320003|FG001|Termination of DBV|Withdrawal by Subject|6|||
145673386|NCT01728324|525320004|FG002|Termination of DBV|Withdrawal by Subject|2|||
145673387|NCT01728324|525320002|FG000|Termination of DBV|Other than stated|1|||
145673388|NCT01728324|525320003|FG001|Termination of DBV|Other than stated|3|||
145673389|NCT01728324|525320004|FG002|Termination of DBV|Other than stated|0|||
145673390|NCT01728324|525320002|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
145673391|NCT01728324|525320003|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
145673392|NCT01728324|525320004|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
145673393|NCT01728324|525320002|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
145673394|NCT01728324|525320003|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
145673395|NCT01728324|525320004|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
145673396|NCT01728324|525320002|FG000|Termination of FDV|Adverse Event|14|||
145673397|NCT01728324|525320003|FG001|Termination of FDV|Adverse Event|13|||
145673398|NCT01728324|525320004|FG002|Termination of FDV|Adverse Event|4|||
145673399|NCT01728324|525320002|FG000|Termination of FDV|Lack of Efficacy|14|||
145673400|NCT01728324|525320003|FG001|Termination of FDV|Lack of Efficacy|12|||
145673401|NCT01728324|525320004|FG002|Termination of FDV|Lack of Efficacy|8|||
145673402|NCT01728324|525320002|FG000|Termination of FDV|Withdrawal by Subject|9|||
145673403|NCT01728324|525320003|FG001|Termination of FDV|Withdrawal by Subject|6|||
145673404|NCT01728324|525320004|FG002|Termination of FDV|Withdrawal by Subject|2|||
145673405|NCT01728324|525320002|FG000|Termination of FDV|Other than stated|1|||
145673406|NCT01728324|525320003|FG001|Termination of FDV|Other than stated|3|||
145673407|NCT01728324|525320004|FG002|Termination of FDV|Other than stated|0|||
145673408|NCT01728324|525320002|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
145673409|NCT01728324|525320003|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
145673410|NCT01728324|525320004|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
145673411|NCT01728324|525320002|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
145673412|NCT01728324|525320003|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
145673413|NCT01728324|525320004|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
145673414|NCT01728324|525320002|FG000|Termination of RBV|Adverse Event|15|||
145673415|NCT01728324|525320003|FG001|Termination of RBV|Adverse Event|16|||
145673416|NCT01728324|525320004|FG002|Termination of RBV|Adverse Event|5|||
145673417|NCT01728324|525320002|FG000|Termination of RBV|Lack of Efficacy|14|||
145673418|NCT01728324|525320003|FG001|Termination of RBV|Lack of Efficacy|11|||
145673419|NCT01728324|525320004|FG002|Termination of RBV|Lack of Efficacy|7|||
145673420|NCT01728324|525320002|FG000|Termination of RBV|Withdrawal by Subject|9|||
145673421|NCT01728324|525320003|FG001|Termination of RBV|Withdrawal by Subject|5|||
145673422|NCT01728324|525320004|FG002|Termination of RBV|Withdrawal by Subject|2|||
145673423|NCT01728324|525320002|FG000|Termination of RBV|Other than stated|1|||
145673424|NCT01728324|525320003|FG001|Termination of RBV|Other than stated|3|||
145673425|NCT01728324|525320004|FG002|Termination of RBV|Other than stated|1|||
145673426|NCT01728324|525320002|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
145673427|NCT01728324|525320003|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
145673428|NCT01728324|525320004|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
145673429|NCT01728324|525320002|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
145673430|NCT01728324|525320003|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
145673431|NCT01728324|525320004|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
145673432|NCT03113409|525320007|FG000|Overall Study|Withdrawal by Subject|5|||
145673433|NCT03113409|525320008|FG001|Overall Study|Withdrawal by Subject|0|||
145673434|NCT03113409|525320009|FG002|Overall Study|Withdrawal by Subject|0|||
145673435|NCT03335488|525320014|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
145673436|NCT03335488|525320015|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
145673437|NCT03335488|525320014|FG000|Safety Extension Period|Adverse Event|1|||
145265402|NCT04410991|523819350|FG001|Overall Study|Poor compliance to protocol|4|||
145490953|NCT02201524|524652302|FG003|Overall Study|Insufficient clinical response|0|||
145673438|NCT03335488|525320015|FG001|Safety Extension Period|Adverse Event|0|||
145673439|NCT03335488|525320014|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
145673440|NCT03335488|525320015|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
145673441|NCT00388726|525320016|FG000|Overall Study|Adverse Event|50|||
145673442|NCT00388726|525320017|FG001|Overall Study|Adverse Event|24|||
145673443|NCT00388726|525320016|FG000|Overall Study|Progressive Disease|336|||
145673444|NCT00388726|525320017|FG001|Overall Study|Progressive Disease|153|||
145673445|NCT00388726|525320016|FG000|Overall Study|Clinical Progression|61|||
145673446|NCT00388726|525320017|FG001|Overall Study|Clinical Progression|36|||
145673447|NCT00388726|525320016|FG000|Overall Study|Withdrawal by Subject|10|||
145673448|NCT00388726|525320017|FG001|Overall Study|Withdrawal by Subject|7|||
145673449|NCT00388726|525320016|FG000|Overall Study|Administrative|6|||
145673450|NCT00388726|525320017|FG001|Overall Study|Administrative|9|||
145673451|NCT00388726|525320016|FG000|Overall Study|Physician Decision|18|||
145673452|NCT00388726|525320017|FG001|Overall Study|Physician Decision|13|||
145673453|NCT00388726|525320016|FG000|Overall Study|Death|3|||
145673454|NCT00388726|525320017|FG001|Overall Study|Death|2|||
145673455|NCT04971733|525320018|FG000|Overall Study|Adverse Event|1|||
145673456|NCT04971733|525320019|FG001|Overall Study|Adverse Event|1|||
145673457|NCT04971733|525320018|FG000|Overall Study|Subject choice|2|||
145673458|NCT04971733|525320019|FG001|Overall Study|Subject choice|0|||
145673459|NCT04971733|525320018|FG000|Overall Study|Withdrawal by Subject|1|||
145673460|NCT04971733|525320019|FG001|Overall Study|Withdrawal by Subject|0|||
145673461|NCT04971733|525320018|FG000|Overall Study|Other|1|||
145673462|NCT04971733|525320019|FG001|Overall Study|Other|0|||
145673463|NCT02406092|525320028|FG000|Overall Study|Screen failure|10|||
145673464|NCT02406092|525320029|FG001|Overall Study|Screen failure|7|||
145673465|NCT02406092|525320028|FG000|Overall Study|Death|22|||
145673466|NCT02406092|525320029|FG001|Overall Study|Death|5|||
145673467|NCT02406092|525320028|FG000|Overall Study|Lost to Follow-up|4|||
145673468|NCT02406092|525320029|FG001|Overall Study|Lost to Follow-up|1|||
145673469|NCT02406092|525320028|FG000|Overall Study|Adverse Event|1|||
145673470|NCT02406092|525320029|FG001|Overall Study|Adverse Event|0|||
145673471|NCT02406092|525320028|FG000|Overall Study|Withdrawal by Subject|1|||
145673472|NCT02406092|525320029|FG001|Overall Study|Withdrawal by Subject|0|||
145673473|NCT03229408|525320030|FG000|Overall Study|Withdrawal by Subject|4|||
145673474|NCT03229408|525320031|FG001|Overall Study|Withdrawal by Subject|1|||
145673475|NCT03229408|525320030|FG000|Overall Study|Adverse Event|2|||
145673476|NCT03229408|525320031|FG001|Overall Study|Adverse Event|0|||
145673477|NCT03229408|525320030|FG000|Overall Study|Pregnancy|0|||
145673478|NCT03229408|525320031|FG001|Overall Study|Pregnancy|1|||
145673479|NCT03229408|525320030|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
145673480|NCT03229408|525320031|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
145673481|NCT04200664|525320032|FG000|Overall Study|Withdrawal by Subject|1|||
145673482|NCT04200664|525320033|FG001|Overall Study|Withdrawal by Subject|0|||
145673483|NCT04200664|525320034|FG002|Overall Study|Withdrawal by Subject|0|||
145673484|NCT03890289|525320039|FG000|Overall Study|Adverse Event|1|||
145673485|NCT03890289|525320039|FG000|Overall Study|Physician Decision|1|||
145673486|NCT03890289|525320039|FG000|Overall Study|Lack of Efficacy|2|||
145673487|NCT02816398|525320040|FG000|Overall Study|Death|5|||
145673488|NCT02816398|525320040|FG000|Overall Study|Lack of Efficacy|8|||
145673489|NCT02816398|525320040|FG000|Overall Study|Lost to Follow-up|1|||
145673490|NCT01367236|525320041|FG000|Overall Study|Withdrawal by Subject|3|||
145673491|NCT01367236|525320042|FG001|Overall Study|Withdrawal by Subject|1|||
145673492|NCT04038580|525320051|FG000|Washout 1|Death|0|||
145673493|NCT04038580|525320052|FG001|Washout 1|Death|0|||
145673494|NCT04038580|525320053|FG002|Washout 1|Death|0|||
145673495|NCT04038580|525320054|FG003|Washout 1|Death|1|||
145673496|NCT04038580|525320055|FG004|Washout 1|Death|0|||
145673497|NCT04038580|525320056|FG005|Washout 1|Death|0|||
145673498|NCT04038580|525320051|FG000|Washout 1|Withdrawal by Subject|0|||
145673499|NCT04038580|525320052|FG001|Washout 1|Withdrawal by Subject|0|||
145673500|NCT04038580|525320053|FG002|Washout 1|Withdrawal by Subject|0|||
145673501|NCT04038580|525320054|FG003|Washout 1|Withdrawal by Subject|0|||
145673502|NCT04038580|525320055|FG004|Washout 1|Withdrawal by Subject|1|||
145673503|NCT04038580|525320056|FG005|Washout 1|Withdrawal by Subject|0|||
145673504|NCT04038580|525320051|FG000|Wash-out 2|Withdrawal by Subject|1|||
145673505|NCT04038580|525320052|FG001|Wash-out 2|Withdrawal by Subject|0|||
145673506|NCT04038580|525320053|FG002|Wash-out 2|Withdrawal by Subject|0|||
145673507|NCT04038580|525320054|FG003|Wash-out 2|Withdrawal by Subject|2|||
145673508|NCT04038580|525320055|FG004|Wash-out 2|Withdrawal by Subject|0|||
145673509|NCT04038580|525320056|FG005|Wash-out 2|Withdrawal by Subject|1|||
145673510|NCT04038580|525320051|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
145673511|NCT04038580|525320052|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
145673512|NCT04038580|525320053|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
145673513|NCT04038580|525320054|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
145673514|NCT04038580|525320055|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
145673515|NCT04038580|525320056|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
145673516|NCT04038580|525320051|FG000|Wash-out 3|Withdrawal by Subject|1|||
145673517|NCT04038580|525320052|FG001|Wash-out 3|Withdrawal by Subject|0|||
145673518|NCT04038580|525320053|FG002|Wash-out 3|Withdrawal by Subject|2|||
145673519|NCT04038580|525320054|FG003|Wash-out 3|Withdrawal by Subject|0|||
145673520|NCT04038580|525320055|FG004|Wash-out 3|Withdrawal by Subject|0|||
145673521|NCT04038580|525320056|FG005|Wash-out 3|Withdrawal by Subject|0|||
145673522|NCT04021862|525320057|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145673523|NCT04021862|525320058|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
145673524|NCT04021862|525320059|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145673525|NCT04021862|525320060|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145673526|NCT04021862|525320061|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145673527|NCT04021862|525320062|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
145673528|NCT04021862|525320057|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
145673529|NCT04021862|525320058|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145673530|NCT04021862|525320059|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145673531|NCT04021862|525320060|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145673532|NCT04021862|525320061|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145673533|NCT04021862|525320062|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
145673534|NCT04021862|525320057|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145673535|NCT04021862|525320058|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145673536|NCT04021862|525320059|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
145673537|NCT04021862|525320060|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145673538|NCT04021862|525320061|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145673539|NCT04021862|525320062|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
145673540|NCT04021862|525320057|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
145673541|NCT04021862|525320058|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
145673542|NCT04021862|525320059|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
145673543|NCT04021862|525320060|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
145673544|NCT04021862|525320061|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
145673545|NCT04021862|525320062|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
145673546|NCT04021862|525320057|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145673547|NCT04021862|525320058|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145673548|NCT04021862|525320059|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145673549|NCT04021862|525320060|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
145673550|NCT04021862|525320061|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145673551|NCT04021862|525320062|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
145673552|NCT04057131|525320063|FG000|Overall Study|Protocol Violation|24|||
145673553|NCT03835754|525320064|FG000|Overall Study|Death|4|||
145673554|NCT04445831|525320065|FG000|Overall Study|Withdrawal by Subject|2|||
145673555|NCT04445831|525320066|FG001|Overall Study|Withdrawal by Subject|1|||
145673556|NCT04445831|525320067|FG002|Overall Study|Withdrawal by Subject|1|||
145673557|NCT04445831|525320068|FG003|Overall Study|Withdrawal by Subject|0|||
145673558|NCT04445831|525320069|FG004|Overall Study|Withdrawal by Subject|0|||
145673559|NCT04445831|525320070|FG005|Overall Study|Withdrawal by Subject|0|||
145673560|NCT04445831|525320071|FG006|Overall Study|Withdrawal by Subject|0|||
145673561|NCT04445831|525320065|FG000|Overall Study|Subject withdrawal by caregiver|0|||
145673562|NCT04445831|525320066|FG001|Overall Study|Subject withdrawal by caregiver|1|||
145673563|NCT04445831|525320067|FG002|Overall Study|Subject withdrawal by caregiver|0|||
145673564|NCT04445831|525320068|FG003|Overall Study|Subject withdrawal by caregiver|0|||
145673565|NCT04445831|525320069|FG004|Overall Study|Subject withdrawal by caregiver|0|||
145673566|NCT04445831|525320070|FG005|Overall Study|Subject withdrawal by caregiver|0|||
145673567|NCT04445831|525320071|FG006|Overall Study|Subject withdrawal by caregiver|0|||
145673568|NCT05613907|525320072|FG000|Overall Study|Lost to Follow-up|5|||
145673569|NCT05613907|525320072|FG000|Overall Study|Death|3|||
145673570|NCT05613907|525320072|FG000|Overall Study|Withdrawal by Subject|2|||
145673571|NCT04701203|525320089|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
145673572|NCT04701203|525320090|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
145673573|NCT04701203|525320091|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
145673574|NCT04701203|525320089|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
145673575|NCT04701203|525320090|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
145673576|NCT04701203|525320091|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
145673577|NCT04701203|525320089|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
145673578|NCT04701203|525320090|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
145673579|NCT04701203|525320091|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
145673580|NCT04701203|525320089|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
145673581|NCT04701203|525320090|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
145673582|NCT04701203|525320091|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
145673583|NCT05422339|525321038|FG000|Overall Study|Withdrawal by Subject|17|||
145673584|NCT05422339|525321039|FG001|Overall Study|Withdrawal by Subject|15|||
145673585|NCT04172675|525321040|FG000|Overall Study|Withdrawal by Subject|7|||
145490954|NCT02201524|524652299|FG000|Overall Study|Lost to Follow-up|0|||
145673586|NCT04172675|525321041|FG001|Overall Study|Withdrawal by Subject|5|||
145673587|NCT04172675|525321042|FG002|Overall Study|Withdrawal by Subject|1|||
145673588|NCT04172675|525321043|FG003|Overall Study|Withdrawal by Subject|4|||
145673589|NCT03070392|525321044|FG000|Overall Study|Not Treated|7|||
145673590|NCT03070392|525321045|FG001|Overall Study|Not Treated|0|||
145673591|NCT03070392|525321046|FG002|Overall Study|Not Treated|3|||
145673592|NCT03070392|525321047|FG003|Overall Study|Not Treated|12|||
145673593|NCT03070392|525321044|FG000|Overall Study|Death|3|||
145673594|NCT03070392|525321045|FG001|Overall Study|Death|0|||
145673595|NCT03070392|525321046|FG002|Overall Study|Death|0|||
145673596|NCT03070392|525321047|FG003|Overall Study|Death|1|||
145673597|NCT03070392|525321044|FG000|Overall Study|Withdrawal by Subject|7|||
145673598|NCT03070392|525321045|FG001|Overall Study|Withdrawal by Subject|0|||
145673599|NCT03070392|525321046|FG002|Overall Study|Withdrawal by Subject|0|||
145673600|NCT03070392|525321047|FG003|Overall Study|Withdrawal by Subject|3|||
145673601|NCT03070392|525321044|FG000|Overall Study|Physician Decision|1|||
145673602|NCT03070392|525321045|FG001|Overall Study|Physician Decision|0|||
145673603|NCT03070392|525321046|FG002|Overall Study|Physician Decision|0|||
145673604|NCT03070392|525321047|FG003|Overall Study|Physician Decision|2|||
145673605|NCT03070392|525321044|FG000|Overall Study|Progressive Disease|154|||
145673606|NCT03070392|525321045|FG001|Overall Study|Progressive Disease|6|||
145673607|NCT03070392|525321046|FG002|Overall Study|Progressive Disease|2|||
145673608|NCT03070392|525321047|FG003|Overall Study|Progressive Disease|70|||
145673609|NCT03070392|525321044|FG000|Overall Study|Adverse Event|6|||
145673610|NCT03070392|525321045|FG001|Overall Study|Adverse Event|1|||
145673611|NCT03070392|525321046|FG002|Overall Study|Adverse Event|1|||
145673612|NCT03070392|525321047|FG003|Overall Study|Adverse Event|3|||
145673613|NCT03070392|525321044|FG000|Overall Study|Alternate anticancer treatment|1|||
145673614|NCT03070392|525321045|FG001|Overall Study|Alternate anticancer treatment|0|||
145673615|NCT03070392|525321046|FG002|Overall Study|Alternate anticancer treatment|0|||
145673616|NCT03070392|525321047|FG003|Overall Study|Alternate anticancer treatment|1|||
145673617|NCT03070392|525321044|FG000|Overall Study|Ongoing|73|||
145673618|NCT03070392|525321045|FG001|Overall Study|Ongoing|0|||
145673619|NCT03070392|525321046|FG002|Overall Study|Ongoing|0|||
145673620|NCT03070392|525321047|FG003|Overall Study|Ongoing|11|||
145673621|NCT01278030|525321048|FG000|Overall Study|Withdrawal by Subject|8|||
145673622|NCT01278030|525321049|FG001|Overall Study|Withdrawal by Subject|4|||
145673623|NCT00458783|525321051|FG000|Overall Study|Protocol Violation|1228|||
145673624|NCT00458783|525321052|FG001|Overall Study|Protocol Violation|1220|||
145673625|NCT01737398|525321053|FG000|Overall Study|Adverse event or SAE|16|||
145673626|NCT01737398|525321054|FG001|Overall Study|Adverse event or SAE|1|||
145673627|NCT01737398|525321053|FG000|Overall Study|Stopping rule met|2|||
145673628|NCT01737398|525321054|FG001|Overall Study|Stopping rule met|1|||
145673629|NCT01737398|525321053|FG000|Overall Study|Voluntary withdrawal|2|||
145673630|NCT01737398|525321054|FG001|Overall Study|Voluntary withdrawal|3|||
145673631|NCT01737398|525321053|FG000|Overall Study|Ineligibility|1|||
145673632|NCT01737398|525321054|FG001|Overall Study|Ineligibility|0|||
145673633|NCT01737398|525321053|FG000|Overall Study|Liver transplant|1|||
145673634|NCT01737398|525321054|FG001|Overall Study|Liver transplant|0|||
145673635|NCT01737398|525321053|FG000|Overall Study|Disease progression|2|||
145673636|NCT01737398|525321054|FG001|Overall Study|Disease progression|3|||
145673637|NCT01737398|525321053|FG000|Overall Study|Sponsor's decision|2|||
145673638|NCT01737398|525321054|FG001|Overall Study|Sponsor's decision|0|||
145673639|NCT03220724|525321058|FG000|Overall Study|Lost to Follow-up|2|||
145673640|NCT03220724|525321059|FG001|Overall Study|Lost to Follow-up|2|||
145673641|NCT03220724|525321060|FG002|Overall Study|Lost to Follow-up|0|||
145673642|NCT03220724|525321061|FG003|Overall Study|Lost to Follow-up|3|||
145673643|NCT03220724|525321062|FG004|Overall Study|Lost to Follow-up|1|||
145673644|NCT03220724|525321063|FG005|Overall Study|Lost to Follow-up|0|||
145673645|NCT03220724|525321064|FG006|Overall Study|Lost to Follow-up|2|||
145673646|NCT03220724|525321065|FG007|Overall Study|Lost to Follow-up|1|||
145673647|NCT03220724|525321066|FG008|Overall Study|Lost to Follow-up|0|||
145673648|NCT03220724|525321058|FG000|Overall Study|Withdrawal by Subject|1|||
145673649|NCT03220724|525321059|FG001|Overall Study|Withdrawal by Subject|0|||
145673650|NCT03220724|525321060|FG002|Overall Study|Withdrawal by Subject|1|||
145673651|NCT03220724|525321061|FG003|Overall Study|Withdrawal by Subject|0|||
145673652|NCT03220724|525321062|FG004|Overall Study|Withdrawal by Subject|0|||
145673653|NCT03220724|525321063|FG005|Overall Study|Withdrawal by Subject|0|||
145673654|NCT03220724|525321064|FG006|Overall Study|Withdrawal by Subject|0|||
145673655|NCT03220724|525321065|FG007|Overall Study|Withdrawal by Subject|0|||
145673656|NCT03220724|525321066|FG008|Overall Study|Withdrawal by Subject|0|||
145673657|NCT00019604|525321067|FG000|Overall Study|Death|1|||
145673658|NCT00019604|525321067|FG000|Overall Study|Progressive disease|23|||
145673659|NCT00019604|525321067|FG000|Overall Study|Refused treatment|1|||
145673660|NCT00019604|525321067|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
145673661|NCT00019604|525321067|FG000|Overall Study|Going to have liver transplant|1|||
145673662|NCT00019604|525321067|FG000|Overall Study|Move to a different study|1|||
145673663|NCT00019604|525321067|FG000|Overall Study|Non compliant on systemic CH|1|||
145490955|NCT02201524|524652300|FG001|Overall Study|Lost to Follow-up|0|||
145673664|NCT00019604|525321067|FG000|Overall Study|Non compliant|1|||
145673665|NCT00019604|525321067|FG000|Overall Study|Resectable disease|1|||
145673666|NCT00019604|525321067|FG000|Overall Study|Started new chemo regimen|1|||
145673667|NCT00019604|525321067|FG000|Overall Study|Pt going to immunotherapy study|1|||
145673668|NCT00019604|525321067|FG000|Overall Study|Too much disease|1|||
145673669|NCT00019604|525321067|FG000|Overall Study|Unable to evaluate|1|||
145673670|NCT00019604|525321067|FG000|Overall Study|Details for other not available|4|||
145673671|NCT01160354|525321088|FG000|Overall Study|Death|0|||
145673672|NCT01160354|525321089|FG001|Overall Study|Death|1|||
145673673|NCT01160354|525321090|FG002|Overall Study|Death|1|||
145673674|NCT00600353|525321092|FG000|Overall Study|history of malignancy within 5 years|1|||
145673675|NCT00600353|525321093|FG001|Overall Study|history of malignancy within 5 years|0|||
145673676|NCT00600353|525321092|FG000|Overall Study|History of prepartive regimen|0|||
145673677|NCT00600353|525321093|FG001|Overall Study|History of prepartive regimen|1|||
145673678|NCT04941482|525321094|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
145673679|NCT04941482|525321095|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
145673680|NCT03745313|525321096|FG000|At 30 Days Follow-up|Death|2|||
145673681|NCT03745313|525321096|FG000|At 6 Months Follow-up|Death|1|||
145673682|NCT03745313|525321096|FG000|At 6 Months Follow-up|Missed Visit|1|||
145673683|NCT03745313|525321096|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
145673684|NCT03745313|525321096|FG000|At 1 Year Follow-up|Death|2|||
145673685|NCT03745313|525321096|FG000|At 1 Year Follow-up|Missed Visit|2|||
145673686|NCT03745313|525321096|FG000|At 2 Year Follow-up|Missed Visit|1|||
145673687|NCT03611075|525321098|FG000|Overall Study|Physician Decision|0|||
145673688|NCT03611075|525321099|FG001|Overall Study|Physician Decision|1|||
145673689|NCT03611075|525321100|FG002|Overall Study|Physician Decision|1|||
145673690|NCT03611075|525321101|FG003|Overall Study|Physician Decision|0|||
145673691|NCT03611075|525321102|FG004|Overall Study|Physician Decision|0|||
145673692|NCT03611075|525321103|FG005|Overall Study|Physician Decision|0|||
145673693|NCT03611075|525321104|FG006|Overall Study|Physician Decision|0|||
145673694|NCT03611075|525321105|FG007|Overall Study|Physician Decision|0|||
145673695|NCT03611075|525321106|FG008|Overall Study|Physician Decision|0|||
145673696|NCT03611075|525321098|FG000|Overall Study|Lost to Follow-up|1|||
145673697|NCT03611075|525321099|FG001|Overall Study|Lost to Follow-up|0|||
145673698|NCT03611075|525321100|FG002|Overall Study|Lost to Follow-up|0|||
145673699|NCT03611075|525321101|FG003|Overall Study|Lost to Follow-up|2|||
145673700|NCT03611075|525321102|FG004|Overall Study|Lost to Follow-up|0|||
145673701|NCT03611075|525321103|FG005|Overall Study|Lost to Follow-up|0|||
145673702|NCT03611075|525321104|FG006|Overall Study|Lost to Follow-up|0|||
145673703|NCT03611075|525321105|FG007|Overall Study|Lost to Follow-up|0|||
145673704|NCT03611075|525321106|FG008|Overall Study|Lost to Follow-up|0|||
145673705|NCT03611075|525321098|FG000|Overall Study|Withdrawal by Subject|0|||
145673706|NCT03611075|525321099|FG001|Overall Study|Withdrawal by Subject|1|||
145673707|NCT03611075|525321100|FG002|Overall Study|Withdrawal by Subject|1|||
145673708|NCT03611075|525321101|FG003|Overall Study|Withdrawal by Subject|1|||
145673709|NCT03611075|525321102|FG004|Overall Study|Withdrawal by Subject|0|||
145673710|NCT03611075|525321103|FG005|Overall Study|Withdrawal by Subject|0|||
145673711|NCT03611075|525321104|FG006|Overall Study|Withdrawal by Subject|1|||
145673712|NCT03611075|525321105|FG007|Overall Study|Withdrawal by Subject|0|||
145673713|NCT03611075|525321106|FG008|Overall Study|Withdrawal by Subject|0|||
145673714|NCT03611075|525321098|FG000|Overall Study|Reason unknown|0|||
145673715|NCT03611075|525321099|FG001|Overall Study|Reason unknown|0|||
145673716|NCT03611075|525321100|FG002|Overall Study|Reason unknown|0|||
145673717|NCT03611075|525321101|FG003|Overall Study|Reason unknown|1|||
145673718|NCT03611075|525321102|FG004|Overall Study|Reason unknown|0|||
145673719|NCT03611075|525321103|FG005|Overall Study|Reason unknown|0|||
145673720|NCT03611075|525321104|FG006|Overall Study|Reason unknown|1|||
145673721|NCT03611075|525321105|FG007|Overall Study|Reason unknown|0|||
145673722|NCT03611075|525321106|FG008|Overall Study|Reason unknown|0|||
145673723|NCT01701401|525321107|FG000|Overall Study|Randomized But Not Treated|3|||
145673724|NCT01701401|525321108|FG001|Overall Study|Randomized But Not Treated|1|||
145673725|NCT01701401|525321109|FG002|Overall Study|Randomized But Not Treated|0|||
145673726|NCT01701401|525321110|FG003|Overall Study|Randomized But Not Treated|1|||
145673727|NCT01701401|525321107|FG000|Overall Study|Lost to Follow-up|5|||
145673728|NCT01701401|525321108|FG001|Overall Study|Lost to Follow-up|5|||
145673729|NCT01701401|525321109|FG002|Overall Study|Lost to Follow-up|1|||
145673730|NCT01701401|525321110|FG003|Overall Study|Lost to Follow-up|3|||
145673731|NCT01701401|525321107|FG000|Overall Study|Withdrew Consent|0|||
145673732|NCT01701401|525321108|FG001|Overall Study|Withdrew Consent|3|||
145673733|NCT01701401|525321109|FG002|Overall Study|Withdrew Consent|1|||
145673734|NCT01701401|525321110|FG003|Overall Study|Withdrew Consent|2|||
145673735|NCT01701401|525321107|FG000|Overall Study|Lack of Efficacy|1|||
145673736|NCT01701401|525321108|FG001|Overall Study|Lack of Efficacy|0|||
145490956|NCT02201524|524652301|FG002|Overall Study|Lost to Follow-up|2|||
145673737|NCT01701401|525321109|FG002|Overall Study|Lack of Efficacy|2|||
145673738|NCT01701401|525321110|FG003|Overall Study|Lack of Efficacy|0|||
145673739|NCT01701401|525321107|FG000|Overall Study|Adverse Event|1|||
145673740|NCT01701401|525321108|FG001|Overall Study|Adverse Event|0|||
145673741|NCT01701401|525321109|FG002|Overall Study|Adverse Event|0|||
145673742|NCT01701401|525321110|FG003|Overall Study|Adverse Event|0|||
145673743|NCT01701401|525321107|FG000|Overall Study|Protocol Violation|0|||
145673744|NCT01701401|525321108|FG001|Overall Study|Protocol Violation|0|||
145673745|NCT01701401|525321109|FG002|Overall Study|Protocol Violation|1|||
145673746|NCT01701401|525321110|FG003|Overall Study|Protocol Violation|0|||
145673747|NCT04827732|525321114|FG000|Overall Study|Did not start treatment|0|||
145673748|NCT04827732|525321115|FG001|Overall Study|Did not start treatment|1|||
145673749|NCT04827732|525321116|FG002|Overall Study|Did not start treatment|0|||
145673750|NCT04827732|525321117|FG003|Overall Study|Did not start treatment|1|||
145673751|NCT02830204|525321118|FG000|Overall Study|Death|9|||
145673752|NCT02830204|525321118|FG000|Overall Study|Withdrawal by Subject|1|||
145673753|NCT00491894|525321126|FG000|Overall Study|Adverse Event|14|||
145673754|NCT00491894|525321126|FG000|Overall Study|Withdrawal by Subject|5|||
145673755|NCT00491894|525321126|FG000|Overall Study|Death|3|||
145673756|NCT00491894|525321126|FG000|Overall Study|Lost to Follow-up|3|||
145673757|NCT00491894|525321126|FG000|Overall Study|Lack of Efficacy|2|||
145673758|NCT00491894|525321126|FG000|Overall Study|Other-Failed to meet any criteria|2|||
145673759|NCT00491894|525321126|FG000|Overall Study|Physician Decision|2|||
145673760|NCT00491894|525321126|FG000|Overall Study|Protocol Violation|2|||
145673761|NCT00491894|525321126|FG000|Overall Study|Other-Intake of prohibited medication|1|||
145673762|NCT01563185|525321127|FG000|Overall Study|Withdrawal by Subject|1|||
145673763|NCT01563185|525321127|FG000|Overall Study|Non-Compliance with study drug|1|||
145673764|NCT05293717|525321129|FG000|Overall Study|Physician Decision|1|||
145673765|NCT03147287|525321130|FG000|Overall Study|Randomized Not Treated|2|||
145673766|NCT03147287|525321131|FG001|Overall Study|Randomized Not Treated|1|||
145673767|NCT03147287|525321132|FG002|Overall Study|Randomized Not Treated|1|||
145673768|NCT03147287|525321130|FG000|Overall Study|Progressive Disease RECIST|31|||
145673769|NCT03147287|525321131|FG001|Overall Study|Progressive Disease RECIST|72|||
145673770|NCT03147287|525321132|FG002|Overall Study|Progressive Disease RECIST|32|||
145673771|NCT03147287|525321130|FG000|Overall Study|Progressive Disease not RECIST|13|||
145673772|NCT03147287|525321131|FG001|Overall Study|Progressive Disease not RECIST|21|||
145673773|NCT03147287|525321132|FG002|Overall Study|Progressive Disease not RECIST|13|||
145673774|NCT03147287|525321130|FG000|Overall Study|Physician Decision|1|||
145673775|NCT03147287|525321131|FG001|Overall Study|Physician Decision|2|||
145673776|NCT03147287|525321132|FG002|Overall Study|Physician Decision|1|||
145673777|NCT03147287|525321130|FG000|Overall Study|Intercurrent illness|0|||
145673778|NCT03147287|525321131|FG001|Overall Study|Intercurrent illness|1|||
145673779|NCT03147287|525321132|FG002|Overall Study|Intercurrent illness|0|||
145673780|NCT03147287|525321130|FG000|Overall Study|Withdrawal by Subject|2|||
145673781|NCT03147287|525321131|FG001|Overall Study|Withdrawal by Subject|3|||
145673782|NCT03147287|525321132|FG002|Overall Study|Withdrawal by Subject|2|||
145673783|NCT03147287|525321130|FG000|Overall Study|Patient Non-Compliance|0|||
145673784|NCT03147287|525321131|FG001|Overall Study|Patient Non-Compliance|2|||
145673785|NCT03147287|525321132|FG002|Overall Study|Patient Non-Compliance|0|||
145673786|NCT03147287|525321130|FG000|Overall Study|Patient moved|0|||
145673787|NCT03147287|525321131|FG001|Overall Study|Patient moved|1|||
145673788|NCT03147287|525321132|FG002|Overall Study|Patient moved|0|||
145673789|NCT03147287|525321130|FG000|Overall Study|Arm A crossover without PD|1|||
145673790|NCT03147287|525321131|FG001|Overall Study|Arm A crossover without PD|0|||
145673791|NCT03147287|525321132|FG002|Overall Study|Arm A crossover without PD|0|||
145673792|NCT03147287|525321130|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
145673793|NCT03147287|525321131|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
145673794|NCT03147287|525321132|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
145673795|NCT02328014|525322616|FG000|Overall Study|Adverse Event|1|||
145673796|NCT02328014|525322617|FG001|Overall Study|Adverse Event|0|||
145673797|NCT02328014|525322618|FG002|Overall Study|Adverse Event|0|||
145673798|NCT02328014|525322619|FG003|Overall Study|Adverse Event|1|||
145673799|NCT02328014|525322616|FG000|Overall Study|Death|0|||
145673800|NCT02328014|525322617|FG001|Overall Study|Death|0|||
145673801|NCT02328014|525322618|FG002|Overall Study|Death|0|||
145673802|NCT02328014|525322619|FG003|Overall Study|Death|4|||
145673803|NCT02328014|525322616|FG000|Overall Study|Physician Decision|0|||
145490957|NCT02201524|524652302|FG003|Overall Study|Lost to Follow-up|0|||
145673804|NCT02328014|525322617|FG001|Overall Study|Physician Decision|0|||
145673805|NCT02328014|525322618|FG002|Overall Study|Physician Decision|0|||
145490958|NCT02201524|524652299|FG000|Overall Study|No longer meets eligibility criteria|0|||
145673806|NCT02328014|525322619|FG003|Overall Study|Physician Decision|1|||
145673807|NCT02328014|525322616|FG000|Overall Study|Disease Progression|1|||
145673808|NCT02328014|525322617|FG001|Overall Study|Disease Progression|0|||
145673809|NCT02328014|525322618|FG002|Overall Study|Disease Progression|1|||
145673810|NCT02328014|525322619|FG003|Overall Study|Disease Progression|3|||
145673811|NCT02328014|525322616|FG000|Overall Study|Study Terminated by Sponsor|4|||
145673812|NCT02328014|525322617|FG001|Overall Study|Study Terminated by Sponsor|1|||
145673813|NCT02328014|525322618|FG002|Overall Study|Study Terminated by Sponsor|1|||
145673814|NCT02328014|525322619|FG003|Overall Study|Study Terminated by Sponsor|0|||
145673815|NCT02328014|525322616|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
145673816|NCT02328014|525322617|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
145673817|NCT02328014|525322618|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
145673818|NCT02328014|525322619|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
145673819|NCT02328014|525322616|FG000|Overall Study|Withdrawal by Subject|0|||
145673820|NCT02328014|525322617|FG001|Overall Study|Withdrawal by Subject|0|||
145673821|NCT02328014|525322618|FG002|Overall Study|Withdrawal by Subject|0|||
145673822|NCT02328014|525322619|FG003|Overall Study|Withdrawal by Subject|1|||
145673823|NCT05029284|525322626|FG000|Overall Study|Lost to Follow-up|1|||
145673824|NCT02972034|525322627|FG000|Overall Study|Death|11|||
145673825|NCT02972034|525322628|FG001|Overall Study|Death|1|||
145673826|NCT02972034|525322629|FG002|Overall Study|Death|3|||
145673827|NCT02972034|525322630|FG003|Overall Study|Death|3|||
145673828|NCT02972034|525322631|FG004|Overall Study|Death|2|||
145673829|NCT02972034|525322632|FG005|Overall Study|Death|2|||
145673830|NCT02972034|525322633|FG006|Overall Study|Death|3|||
145673831|NCT02972034|525322634|FG007|Overall Study|Death|4|||
145673832|NCT02972034|525322635|FG008|Overall Study|Death|8|||
145673833|NCT02972034|525322636|FG009|Overall Study|Death|11|||
145673834|NCT02972034|525322637|FG010|Overall Study|Death|3|||
145673835|NCT02972034|525322638|FG011|Overall Study|Death|2|||
145673836|NCT02972034|525322639|FG012|Overall Study|Death|11|||
145673837|NCT02972034|525322640|FG013|Overall Study|Death|10|||
145673838|NCT02972034|525322641|FG014|Overall Study|Death|9|||
145673839|NCT02972034|525322627|FG000|Overall Study|Lost to Follow-up|0|||
145673840|NCT02972034|525322628|FG001|Overall Study|Lost to Follow-up|0|||
145673841|NCT02972034|525322629|FG002|Overall Study|Lost to Follow-up|0|||
145673842|NCT02972034|525322630|FG003|Overall Study|Lost to Follow-up|0|||
145673843|NCT02972034|525322631|FG004|Overall Study|Lost to Follow-up|1|||
145673844|NCT02972034|525322632|FG005|Overall Study|Lost to Follow-up|0|||
145673845|NCT02972034|525322633|FG006|Overall Study|Lost to Follow-up|0|||
145673846|NCT02972034|525322634|FG007|Overall Study|Lost to Follow-up|1|||
145673847|NCT02972034|525322635|FG008|Overall Study|Lost to Follow-up|0|||
145673848|NCT02972034|525322636|FG009|Overall Study|Lost to Follow-up|0|||
145673849|NCT02972034|525322637|FG010|Overall Study|Lost to Follow-up|0|||
145673850|NCT02972034|525322638|FG011|Overall Study|Lost to Follow-up|0|||
145673851|NCT02972034|525322639|FG012|Overall Study|Lost to Follow-up|0|||
145673852|NCT02972034|525322640|FG013|Overall Study|Lost to Follow-up|0|||
145673853|NCT02972034|525322641|FG014|Overall Study|Lost to Follow-up|1|||
145673854|NCT02972034|525322627|FG000|Overall Study|Physician Decision|0|||
145673855|NCT02972034|525322628|FG001|Overall Study|Physician Decision|0|||
145673856|NCT02972034|525322629|FG002|Overall Study|Physician Decision|0|||
145673857|NCT02972034|525322630|FG003|Overall Study|Physician Decision|0|||
145673858|NCT02972034|525322631|FG004|Overall Study|Physician Decision|0|||
145673859|NCT02972034|525322632|FG005|Overall Study|Physician Decision|0|||
145673860|NCT02972034|525322633|FG006|Overall Study|Physician Decision|0|||
145673861|NCT02972034|525322634|FG007|Overall Study|Physician Decision|1|||
145673862|NCT02972034|525322635|FG008|Overall Study|Physician Decision|0|||
145673863|NCT02972034|525322636|FG009|Overall Study|Physician Decision|0|||
145673864|NCT02972034|525322637|FG010|Overall Study|Physician Decision|1|||
145673865|NCT02972034|525322638|FG011|Overall Study|Physician Decision|0|||
145673866|NCT02972034|525322639|FG012|Overall Study|Physician Decision|0|||
145673867|NCT02972034|525322640|FG013|Overall Study|Physician Decision|0|||
145673868|NCT02972034|525322641|FG014|Overall Study|Physician Decision|0|||
145673869|NCT02972034|525322627|FG000|Overall Study|Sponsor Decision|0|||
145673870|NCT02972034|525322628|FG001|Overall Study|Sponsor Decision|0|||
145673871|NCT02972034|525322629|FG002|Overall Study|Sponsor Decision|0|||
145673872|NCT02972034|525322630|FG003|Overall Study|Sponsor Decision|1|||
145673873|NCT02972034|525322631|FG004|Overall Study|Sponsor Decision|0|||
145673874|NCT02972034|525322632|FG005|Overall Study|Sponsor Decision|0|||
145673875|NCT02972034|525322633|FG006|Overall Study|Sponsor Decision|1|||
145673876|NCT02972034|525322634|FG007|Overall Study|Sponsor Decision|1|||
145673877|NCT02972034|525322635|FG008|Overall Study|Sponsor Decision|1|||
145673878|NCT02972034|525322636|FG009|Overall Study|Sponsor Decision|2|||
145265403|NCT04410991|523819349|FG000|Overall Study|Withdrawal by Subject|59|||
145490959|NCT02201524|524652300|FG001|Overall Study|No longer meets eligibility criteria|0|||
145673879|NCT02972034|525322637|FG010|Overall Study|Sponsor Decision|2|||
145673880|NCT02972034|525322638|FG011|Overall Study|Sponsor Decision|0|||
145673881|NCT02972034|525322639|FG012|Overall Study|Sponsor Decision|1|||
145673882|NCT02972034|525322640|FG013|Overall Study|Sponsor Decision|0|||
145673883|NCT02972034|525322641|FG014|Overall Study|Sponsor Decision|1|||
145673884|NCT02972034|525322627|FG000|Overall Study|Withdrawal by Subject|3|||
145673885|NCT02972034|525322628|FG001|Overall Study|Withdrawal by Subject|0|||
145673886|NCT02972034|525322629|FG002|Overall Study|Withdrawal by Subject|0|||
145673887|NCT02972034|525322630|FG003|Overall Study|Withdrawal by Subject|0|||
145673888|NCT02972034|525322631|FG004|Overall Study|Withdrawal by Subject|1|||
145673889|NCT02972034|525322632|FG005|Overall Study|Withdrawal by Subject|1|||
145673890|NCT02972034|525322633|FG006|Overall Study|Withdrawal by Subject|0|||
145673891|NCT02972034|525322634|FG007|Overall Study|Withdrawal by Subject|0|||
145673892|NCT02972034|525322635|FG008|Overall Study|Withdrawal by Subject|1|||
145673893|NCT02972034|525322636|FG009|Overall Study|Withdrawal by Subject|1|||
145673894|NCT02972034|525322637|FG010|Overall Study|Withdrawal by Subject|2|||
145673895|NCT02972034|525322638|FG011|Overall Study|Withdrawal by Subject|1|||
145673896|NCT02972034|525322639|FG012|Overall Study|Withdrawal by Subject|1|||
145673897|NCT02972034|525322640|FG013|Overall Study|Withdrawal by Subject|1|||
145673898|NCT02972034|525322641|FG014|Overall Study|Withdrawal by Subject|0|||
145673899|NCT02972034|525322627|FG000|Overall Study|Screen Failure|0|||
145673900|NCT02972034|525322628|FG001|Overall Study|Screen Failure|0|||
145673901|NCT02972034|525322629|FG002|Overall Study|Screen Failure|0|||
145673902|NCT02972034|525322630|FG003|Overall Study|Screen Failure|0|||
145673903|NCT02972034|525322631|FG004|Overall Study|Screen Failure|0|||
145673904|NCT02972034|525322632|FG005|Overall Study|Screen Failure|0|||
145673905|NCT02972034|525322633|FG006|Overall Study|Screen Failure|0|||
145673906|NCT02972034|525322634|FG007|Overall Study|Screen Failure|0|||
145673907|NCT02972034|525322635|FG008|Overall Study|Screen Failure|0|||
145673908|NCT02972034|525322636|FG009|Overall Study|Screen Failure|0|||
145673909|NCT02972034|525322637|FG010|Overall Study|Screen Failure|0|||
145673910|NCT02972034|525322638|FG011|Overall Study|Screen Failure|0|||
145673911|NCT02972034|525322639|FG012|Overall Study|Screen Failure|1|||
145673912|NCT02972034|525322640|FG013|Overall Study|Screen Failure|0|||
145673913|NCT02972034|525322641|FG014|Overall Study|Screen Failure|0|||
145673914|NCT03009344|525322642|FG000|Overall Study|Lack of Efficacy|5|||
145673915|NCT03009344|525322642|FG000|Overall Study|Withdrawal by Subject|1|||
145673916|NCT03009344|525322642|FG000|Overall Study|Adverse Event|1|||
145673917|NCT00378898|525322643|FG000|Overall Study|Withdrawal by Subject|10|||
145673918|NCT00378898|525322644|FG001|Overall Study|Withdrawal by Subject|5|||
145673919|NCT00378898|525322643|FG000|Overall Study|Protocol Violation|1|||
145673920|NCT00378898|525322644|FG001|Overall Study|Protocol Violation|1|||
145673921|NCT02534233|525322647|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
145673922|NCT02278796|525322654|FG000|Overall Study|Death|2|||
145673923|NCT02278796|525322655|FG001|Overall Study|Death|3|||
145673924|NCT03214081|525322656|FG000|Overall Study|Case Report Forms Uncollected|9|||
145673925|NCT03214081|525322656|FG000|Overall Study|Protocol Deviation|54|||
145673926|NCT02962284|525322657|FG000|Overall Study|Death|2|||
145673927|NCT02962284|525322658|FG001|Overall Study|Death|0|||
145673928|NCT02962284|525322657|FG000|Overall Study|Progressive disease|2|||
145673929|NCT02962284|525322658|FG001|Overall Study|Progressive disease|3|||
145673930|NCT02962284|525322657|FG000|Overall Study|Withdrawal by Subject|1|||
145673931|NCT02962284|525322658|FG001|Overall Study|Withdrawal by Subject|0|||
145673932|NCT02372799|525322661|FG000|Treatment Period|Adverse Event|3|||
145673933|NCT02372799|525322662|FG001|Treatment Period|Adverse Event|10|||
145673934|NCT02372799|525322663|FG002|Treatment Period|Adverse Event|6|||
145673935|NCT02372799|525322661|FG000|Treatment Period|Insufficient therapeutic response|2|||
145673936|NCT02372799|525322662|FG001|Treatment Period|Insufficient therapeutic response|2|||
145673937|NCT02372799|525322663|FG002|Treatment Period|Insufficient therapeutic response|0|||
145673938|NCT02372799|525322661|FG000|Treatment Period|Withdrawal by Subject|10|||
145673939|NCT02372799|525322662|FG001|Treatment Period|Withdrawal by Subject|10|||
145673940|NCT02372799|525322663|FG002|Treatment Period|Withdrawal by Subject|2|||
145673941|NCT02372799|525322661|FG000|Treatment Period|Lost to Follow-up|11|||
145673942|NCT02372799|525322662|FG001|Treatment Period|Lost to Follow-up|5|||
145673943|NCT02372799|525322663|FG002|Treatment Period|Lost to Follow-up|3|||
145673944|NCT02372799|525322661|FG000|Treatment Period|Protocol Violation|3|||
145673945|NCT02372799|525322662|FG001|Treatment Period|Protocol Violation|0|||
145673946|NCT02372799|525322663|FG002|Treatment Period|Protocol Violation|0|||
145673947|NCT02372799|525322661|FG000|Treatment Period|Non-compliance with study drug|4|||
145673948|NCT02372799|525322662|FG001|Treatment Period|Non-compliance with study drug|4|||
145673949|NCT02372799|525322663|FG002|Treatment Period|Non-compliance with study drug|4|||
145673950|NCT02372799|525322661|FG000|Treatment Period|Miscellaneous Reasons|1|||
145673951|NCT02372799|525322662|FG001|Treatment Period|Miscellaneous Reasons|1|||
145673952|NCT02372799|525322663|FG002|Treatment Period|Miscellaneous Reasons|0|||
145673953|NCT02372799|525322661|FG000|Down-taper Period|Lost to Follow-up|1|||
145673954|NCT02372799|525322662|FG001|Down-taper Period|Lost to Follow-up|2|||
145673955|NCT02372799|525322663|FG002|Down-taper Period|Lost to Follow-up|2|||
145673956|NCT00089609|525322664|FG000|Overall Study|Withdrawal by Subject|3|||
145673957|NCT00089609|525322665|FG001|Overall Study|Withdrawal by Subject|1|||
145673958|NCT05815342|525322667|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
145673959|NCT05815342|525322667|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
145673960|NCT05815342|525322667|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
145673961|NCT05815342|525322667|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
145673962|NCT05815342|525322667|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
145673963|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
145673964|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
145673965|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
145673966|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
145673967|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
145673968|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
145673969|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
145673970|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
145673971|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
145673972|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
145673973|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
145673974|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
145673975|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
145673976|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
145673977|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
145673978|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
145673979|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
145673980|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
145673981|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
145673982|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
145673983|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
145673984|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
145673985|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
145673986|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
145673987|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
145673988|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
145673989|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
145673990|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
145673991|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
145673992|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
145673993|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
145673994|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
145673995|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
145673996|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
145673997|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
145673998|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
145673999|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
145674000|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
145674001|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
145674002|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
145674003|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
145674004|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
145674005|NCT03732807|525322671|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674006|NCT03732807|525322672|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674007|NCT03732807|525322673|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674008|NCT03732807|525322674|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674009|NCT03732807|525322675|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674010|NCT03732807|525322676|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
145674011|NCT03732807|525322677|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
145674012|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
145674013|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
145674014|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
145674015|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
145674016|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
145674017|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
145490960|NCT02201524|524652301|FG002|Overall Study|No longer meets eligibility criteria|0|||
145490961|NCT02201524|524652302|FG003|Overall Study|No longer meets eligibility criteria|2|||
145490962|NCT02201524|524652299|FG000|Overall Study|Protocol Violation|0|||
145490963|NCT02201524|524652300|FG001|Overall Study|Protocol Violation|0|||
145490964|NCT02201524|524652301|FG002|Overall Study|Protocol Violation|0|||
145490965|NCT02201524|524652302|FG003|Overall Study|Protocol Violation|1|||
145490966|NCT02201524|524652299|FG000|Overall Study|Withdrawal by Subject|0|||
145490967|NCT02201524|524652300|FG001|Overall Study|Withdrawal by Subject|0|||
145490968|NCT02201524|524652301|FG002|Overall Study|Withdrawal by Subject|1|||
145490969|NCT02201524|524652302|FG003|Overall Study|Withdrawal by Subject|1|||
145490970|NCT02201524|524652299|FG000|Overall Study|Other|1|||
145490971|NCT02201524|524652300|FG001|Overall Study|Other|1|||
145490972|NCT02201524|524652301|FG002|Overall Study|Other|0|||
145490973|NCT02201524|524652302|FG003|Overall Study|Other|0|||
145490974|NCT02314052|524652303|FG000|Cycle One|Adverse Event|0|||
145490975|NCT02314052|524652304|FG001|Cycle One|Adverse Event|0|||
145674018|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
145490976|NCT02314052|524652305|FG002|Cycle One|Adverse Event|0|||
145490977|NCT02314052|524652306|FG003|Cycle One|Adverse Event|1|||
145490978|NCT02314052|524652307|FG004|Cycle One|Adverse Event|0|||
145490979|NCT02314052|524652308|FG005|Cycle One|Adverse Event|0|||
145490980|NCT01960140|524652313|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
145490981|NCT03915717|524652318|FG000|Overall Study|EchoMark Not Implanted|6|||
145490982|NCT03748823|524652320|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
145674019|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
145674020|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
145674021|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
145674022|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
145674023|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
145674024|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
145674025|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
145674026|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
145674027|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
145674028|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
145674029|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
145674030|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
145674031|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
145674032|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
145674033|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674034|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
145674035|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674036|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674037|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674038|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674039|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
145674040|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
145674041|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
145674042|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
145674043|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
145674044|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
145674045|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
145674046|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
145674047|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
145674048|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
145674049|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
145674050|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
145674051|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
145674052|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
145674053|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
145674054|NCT03732807|525322671|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
145674055|NCT03732807|525322672|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
145674056|NCT03732807|525322673|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
145674057|NCT03732807|525322674|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
145674058|NCT03732807|525322675|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
145674059|NCT03732807|525322676|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
145674060|NCT03732807|525322677|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
145674061|NCT00599196|525322678|FG000|Overall Study|Lack of Efficacy|22|||
145674062|NCT00599196|525322678|FG000|Overall Study|Adverse Event|93|||
145674063|NCT00599196|525322678|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
145674064|NCT00599196|525322678|FG000|Overall Study|Subject withdrew consent|43|||
145674065|NCT00599196|525322678|FG000|Overall Study|Study ended per sponsor|197|||
145674066|NCT00599196|525322678|FG000|Overall Study|Lost to Follow-up|17|||
145674067|NCT00599196|525322678|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
145674068|NCT00599196|525322678|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
145674069|NCT00599196|525322678|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
145674070|NCT00599196|525322678|FG000|Overall Study|Other: Pt Moved To Australia|1|||
145674071|NCT00599196|525322678|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
145674072|NCT00599196|525322678|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
145674073|NCT00454194|525322680|FG000|Overall Study|Adverse Event|7|||
145674074|NCT00454194|525322681|FG001|Overall Study|Adverse Event|2|||
145674075|NCT00454194|525322680|FG000|Overall Study|Withdrawal by Subject|12|||
145674076|NCT00454194|525322681|FG001|Overall Study|Withdrawal by Subject|8|||
145674077|NCT00454194|525322680|FG000|Overall Study|Other Medical Problems|1|||
145674078|NCT00454194|525322681|FG001|Overall Study|Other Medical Problems|2|||
145674079|NCT00454194|525322680|FG000|Overall Study|Other Unspecified Reason|2|||
145490983|NCT03748823|524652321|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
145490984|NCT03748823|524652320|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
145674080|NCT00454194|525322681|FG001|Overall Study|Other Unspecified Reason|2|||
145674081|NCT03274076|525322687|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
145674082|NCT03274076|525322688|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
145674083|NCT03274076|525322689|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
145674084|NCT03274076|525322690|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
145674085|NCT03274076|525322687|FG000|24 Weeks Open Label|Adverse Event|0|||
145674086|NCT03274076|525322688|FG001|24 Weeks Open Label|Adverse Event|0|||
145674087|NCT03274076|525322689|FG002|24 Weeks Open Label|Adverse Event|2|||
145674088|NCT03274076|525322690|FG003|24 Weeks Open Label|Adverse Event|0|||
145674089|NCT03274076|525322687|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
145674090|NCT03274076|525322688|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
145674091|NCT03274076|525322689|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
145674092|NCT03274076|525322690|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
145674093|NCT00586313|525322691|FG000|Overall Study|Lack of Efficacy|2|||
145674094|NCT03205566|525322693|FG000|Phase 1|Protocol Violation|1|||
145674095|NCT03205566|525322694|FG001|Phase 1|Protocol Violation|1|||
145674096|NCT03184987|525322695|FG000|Overall Study|Withdrawal by Subject|0|||
145674097|NCT03184987|525322696|FG001|Overall Study|Withdrawal by Subject|1|||
145674098|NCT03184987|525322697|FG002|Overall Study|Withdrawal by Subject|2|||
145674099|NCT03184987|525322695|FG000|Overall Study|Physician Decision|0|||
145674100|NCT03184987|525322696|FG001|Overall Study|Physician Decision|0|||
145674101|NCT03184987|525322697|FG002|Overall Study|Physician Decision|1|||
145674102|NCT03184987|525322695|FG000|Overall Study|Adverse Event|1|||
145674103|NCT03184987|525322696|FG001|Overall Study|Adverse Event|0|||
145674104|NCT03184987|525322697|FG002|Overall Study|Adverse Event|1|||
145674105|NCT01619059|525322702|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
145674106|NCT01619059|525322703|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
145674107|NCT01619059|525322702|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
145674108|NCT01619059|525322703|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
145674109|NCT01619059|525322702|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
145674110|NCT01619059|525322703|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
145674111|NCT01619059|525322702|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
145674112|NCT01619059|525322703|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
145674113|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
145674114|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
145674115|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
145674116|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
145674117|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
145674118|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
145674119|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Death|1|||
145674120|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Death|0|||
145674121|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
145674122|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
145674123|NCT01619059|525322702|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
145674124|NCT01619059|525322703|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
145674125|NCT01170208|525322706|FG000|Overall Study|Withdrawal by Subject|5|||
145674126|NCT01170208|525322707|FG001|Overall Study|Withdrawal by Subject|0|||
145674127|NCT01170208|525322708|FG002|Overall Study|Withdrawal by Subject|1|||
145674128|NCT01170208|525322706|FG000|Overall Study|Protocol Violation|1|||
145674129|NCT01170208|525322707|FG001|Overall Study|Protocol Violation|0|||
145674130|NCT01170208|525322708|FG002|Overall Study|Protocol Violation|1|||
145674131|NCT02743819|525322712|FG000|Overall Study|Lack of Efficacy|5|||
145674132|NCT02743819|525322712|FG000|Overall Study|Death|2|||
145674133|NCT02743819|525322712|FG000|Overall Study|Adverse Event|1|||
145674134|NCT03389802|525322713|FG000|Overall Study|Lack of Efficacy|3|||
145674135|NCT03389802|525322714|FG001|Overall Study|Lack of Efficacy|3|||
145674136|NCT03389802|525322715|FG002|Overall Study|Lack of Efficacy|13|||
145674137|NCT03389802|525322716|FG003|Overall Study|Lack of Efficacy|6|||
145674138|NCT03389802|525322717|FG004|Overall Study|Lack of Efficacy|1|||
145674139|NCT03389802|525322713|FG000|Overall Study|Adverse Event|0|||
145674140|NCT03389802|525322714|FG001|Overall Study|Adverse Event|0|||
145674141|NCT03389802|525322715|FG002|Overall Study|Adverse Event|1|||
145674142|NCT03389802|525322716|FG003|Overall Study|Adverse Event|0|||
145674143|NCT03389802|525322717|FG004|Overall Study|Adverse Event|4|||
145674144|NCT03389802|525322713|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
145674145|NCT03389802|525322714|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
145674146|NCT03389802|525322715|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
145674147|NCT03389802|525322716|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
145674148|NCT03389802|525322717|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
145674149|NCT01706159|525322718|FG000|Overall Study|Withdrawal Criteria|2|||
145674150|NCT01706159|525322719|FG001|Overall Study|Withdrawal Criteria|1|||
145674151|NCT01706159|525322718|FG000|Overall Study|Unclassified|6|||
145674152|NCT01706159|525322719|FG001|Overall Study|Unclassified|1|||
145674153|NCT02454959|525322721|FG000|Overall Study|Protocol-Specified Criteria|3|||
145674154|NCT02454959|525322721|FG000|Overall Study|Physician Decision|1|||
145674155|NCT02454959|525322721|FG000|Overall Study|Withdrawal by Subject|3|||
145674156|NCT02454959|525322721|FG000|Overall Study|Adverse Event|2|||
145674157|NCT00989196|525322722|FG000|Treatment Period|Lost to Follow-up|1|||
145674158|NCT00989196|525322723|FG001|Treatment Period|Lost to Follow-up|0|||
145674159|NCT02409680|525322724|FG000|Overall Study|Lost to Follow-up|15|||
145674160|NCT02409680|525322725|FG001|Overall Study|Lost to Follow-up|30|||
145674161|NCT05366751|525322726|FG000|Overall Study|Adverse Event|25|||
145674162|NCT05366751|525322726|FG000|Overall Study|Physician Decision|3|||
145674163|NCT05366751|525322726|FG000|Overall Study|Lost to Follow-up|2|||
145674164|NCT05366751|525322726|FG000|Overall Study|Withdrawal by Subject|14|||
145674165|NCT05366751|525322726|FG000|Overall Study|Study Terminated by Sponsor|50|||
145674166|NCT05366751|525322726|FG000|Overall Study|Site Terminated by Sponsor|3|||
145674167|NCT01690624|525322729|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
145674168|NCT01690624|525322730|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
145674169|NCT01690624|525322731|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
145674170|NCT01690624|525322732|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
145674171|NCT01690624|525322729|FG000|Overall Study|Adverse event (other than DLT)|3|||
145674172|NCT01690624|525322730|FG001|Overall Study|Adverse event (other than DLT)|1|||
145674173|NCT01690624|525322731|FG002|Overall Study|Adverse event (other than DLT)|1|||
145674174|NCT01690624|525322732|FG003|Overall Study|Adverse event (other than DLT)|1|||
145674175|NCT01690624|525322729|FG000|Overall Study|Withdrawal by Subject|0|||
145674176|NCT01690624|525322730|FG001|Overall Study|Withdrawal by Subject|0|||
145674177|NCT01690624|525322731|FG002|Overall Study|Withdrawal by Subject|1|||
145674178|NCT01690624|525322732|FG003|Overall Study|Withdrawal by Subject|0|||
145674179|NCT01690624|525322729|FG000|Overall Study|Sponsor is ending trial|0|||
145674180|NCT01690624|525322730|FG001|Overall Study|Sponsor is ending trial|0|||
145674181|NCT01690624|525322731|FG002|Overall Study|Sponsor is ending trial|0|||
145674182|NCT01690624|525322732|FG003|Overall Study|Sponsor is ending trial|1|||
145674183|NCT01690624|525322729|FG000|Overall Study|Physician Decision|0|||
145674184|NCT01690624|525322730|FG001|Overall Study|Physician Decision|0|||
145674185|NCT01690624|525322731|FG002|Overall Study|Physician Decision|0|||
145674186|NCT01690624|525322732|FG003|Overall Study|Physician Decision|1|||
145674187|NCT01690624|525322729|FG000|Overall Study|Withdrawal by Subject|0|||
145674188|NCT01690624|525322730|FG001|Overall Study|Withdrawal by Subject|1|||
145674189|NCT01690624|525322731|FG002|Overall Study|Withdrawal by Subject|0|||
145674190|NCT01690624|525322732|FG003|Overall Study|Withdrawal by Subject|0|||
145674191|NCT01690624|525322729|FG000|Overall Study|Lack of Efficacy|1|||
145674192|NCT01690624|525322730|FG001|Overall Study|Lack of Efficacy|1|||
145674193|NCT01690624|525322731|FG002|Overall Study|Lack of Efficacy|3|||
145674194|NCT01690624|525322732|FG003|Overall Study|Lack of Efficacy|0|||
145674195|NCT04912856|525322736|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
145674196|NCT04912856|525322737|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
145674197|NCT04912856|525322736|FG000|Overall Study|Not reported in synoptic CSR.|0|||
145674198|NCT04912856|525322737|FG001|Overall Study|Not reported in synoptic CSR.|1|||
145674199|NCT03789656|525322738|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
145674200|NCT03789656|525322739|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
145674201|NCT03789656|525322740|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
145674202|NCT03789656|525322741|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
145674203|NCT03789656|525322742|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
145674204|NCT03789656|525322738|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
145674205|NCT03789656|525322739|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
145674206|NCT03789656|525322740|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
145674207|NCT03789656|525322741|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
145674208|NCT03789656|525322742|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
145674209|NCT03789656|525322738|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
145674210|NCT03789656|525322739|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
145674211|NCT03789656|525322740|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
145674212|NCT03789656|525322741|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
145674213|NCT03789656|525322742|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
145674214|NCT03789656|525322738|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
145674215|NCT03789656|525322739|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
145674216|NCT03789656|525322740|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
145674217|NCT03789656|525322741|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
145674218|NCT03789656|525322742|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
145674219|NCT05325294|525322747|FG000|Overall Study|Adverse Event|3|||
145674220|NCT05325294|525322748|FG001|Overall Study|Adverse Event|3|||
145490985|NCT03748823|524652321|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
145674221|NCT05325294|525322747|FG000|Overall Study|Physician Decision|0|||
145674222|NCT05325294|525322748|FG001|Overall Study|Physician Decision|1|||
145674223|NCT05325294|525322747|FG000|Overall Study|Withdrawal by Subject|0|||
145674224|NCT05325294|525322748|FG001|Overall Study|Withdrawal by Subject|3|||
145674225|NCT05325294|525322747|FG000|Overall Study|Lost to Follow-up|1|||
145674226|NCT05325294|525322748|FG001|Overall Study|Lost to Follow-up|0|||
145674227|NCT05325294|525322747|FG000|Overall Study|Sponsor Request|0|||
145674228|NCT05325294|525322748|FG001|Overall Study|Sponsor Request|2|||
145674229|NCT02434328|525322750|FG000|Overall Study|Adverse Event|9|||
145674230|NCT02434328|525322751|FG001|Overall Study|Adverse Event|4|||
145674231|NCT02434328|525322750|FG000|Overall Study|Lack of Efficacy|0|||
145674232|NCT02434328|525322751|FG001|Overall Study|Lack of Efficacy|2|||
145674233|NCT02434328|525322750|FG000|Overall Study|Physician Decision|0|||
145674234|NCT02434328|525322751|FG001|Overall Study|Physician Decision|1|||
145674235|NCT02434328|525322750|FG000|Overall Study|Withdrawal by Subject|12|||
145674236|NCT02434328|525322751|FG001|Overall Study|Withdrawal by Subject|21|||
145674237|NCT02434328|525322750|FG000|Overall Study|Death|4|||
145674238|NCT02434328|525322751|FG001|Overall Study|Death|7|||
145674239|NCT02434328|525322750|FG000|Overall Study|Lost to Follow-up|1|||
145674240|NCT02434328|525322751|FG001|Overall Study|Lost to Follow-up|6|||
145674241|NCT02434328|525322750|FG000|Overall Study|Other|4|||
145674242|NCT02434328|525322751|FG001|Overall Study|Other|1|||
145674243|NCT00925548|525324307|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
145674244|NCT00925548|525324308|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
145674245|NCT03116464|525324309|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
145674246|NCT00747006|525324310|FG000|Overall Study|Adverse Event|1|||
145674247|NCT00747006|525324311|FG001|Overall Study|Adverse Event|0|||
145674248|NCT00747006|525324312|FG002|Overall Study|Adverse Event|0|||
145674249|NCT00747006|525324310|FG000|Overall Study|Lost to Follow-up|0|||
145674250|NCT00747006|525324311|FG001|Overall Study|Lost to Follow-up|1|||
145674251|NCT00747006|525324312|FG002|Overall Study|Lost to Follow-up|0|||
145674252|NCT00747006|525324310|FG000|Overall Study|Physician Decision|2|||
145674253|NCT00747006|525324311|FG001|Overall Study|Physician Decision|0|||
145674254|NCT00747006|525324312|FG002|Overall Study|Physician Decision|1|||
145674255|NCT00357994|525324313|FG000|Overall Study|Adverse Event|1|||
145674256|NCT00357994|525324314|FG001|Overall Study|Adverse Event|2|||
145674257|NCT00357994|525324313|FG000|Overall Study|Lack of Efficacy|0|||
145674258|NCT00357994|525324314|FG001|Overall Study|Lack of Efficacy|1|||
145674259|NCT00357994|525324313|FG000|Overall Study|Protocol Violation|1|||
145674260|NCT00357994|525324314|FG001|Overall Study|Protocol Violation|0|||
145674261|NCT00345046|525324317|FG000|Overall Study|Protocol Violation|1|||
145674262|NCT00345046|525324318|FG001|Overall Study|Protocol Violation|1|||
145674263|NCT00345046|525324319|FG002|Overall Study|Protocol Violation|2|||
145674264|NCT04652869|525324324|FG000|Overall Study|Withdrawal by Subject|0|||
145674265|NCT04652869|525324325|FG001|Overall Study|Withdrawal by Subject|2|||
145674266|NCT04652869|525324326|FG002|Overall Study|Withdrawal by Subject|0|||
145674267|NCT01372085|525324327|FG000|Washout Period 2|Physician Decision|0|||
145674268|NCT01372085|525324328|FG001|Washout Period 2|Physician Decision|0|||
145674269|NCT01372085|525324329|FG002|Washout Period 2|Physician Decision|0|||
145674270|NCT01372085|525324330|FG003|Washout Period 2|Physician Decision|0|||
145674271|NCT01372085|525324331|FG004|Washout Period 2|Physician Decision|1|||
145674272|NCT01372085|525324332|FG005|Washout Period 2|Physician Decision|0|||
145674273|NCT01372085|525324333|FG006|Washout Period 2|Physician Decision|0|||
145674274|NCT01372085|525324334|FG007|Washout Period 2|Physician Decision|0|||
145674275|NCT01372085|525324335|FG008|Washout Period 2|Physician Decision|0|||
145674276|NCT01372085|525324336|FG009|Washout Period 2|Physician Decision|0|||
145674277|NCT01372085|525324327|FG000|Washout Period 3|Withdrawal by Subject|0|||
145674278|NCT01372085|525324328|FG001|Washout Period 3|Withdrawal by Subject|0|||
145674279|NCT01372085|525324329|FG002|Washout Period 3|Withdrawal by Subject|0|||
145674280|NCT01372085|525324330|FG003|Washout Period 3|Withdrawal by Subject|0|||
145674281|NCT01372085|525324331|FG004|Washout Period 3|Withdrawal by Subject|0|||
145674282|NCT01372085|525324332|FG005|Washout Period 3|Withdrawal by Subject|2|||
145674283|NCT01372085|525324333|FG006|Washout Period 3|Withdrawal by Subject|0|||
145674284|NCT01372085|525324334|FG007|Washout Period 3|Withdrawal by Subject|0|||
145674285|NCT01372085|525324335|FG008|Washout Period 3|Withdrawal by Subject|0|||
145674286|NCT01372085|525324336|FG009|Washout Period 3|Withdrawal by Subject|0|||
145674287|NCT00562094|525324337|FG000|Overall Study|Lost to Follow-up|62|||
145674288|NCT03689946|525324338|FG000|Overall Study|Withdrawal by Subject|3|||
145674289|NCT03689946|525324338|FG000|Overall Study|Lost to Follow-up|3|||
145674290|NCT03689946|525324338|FG000|Overall Study|Data corruption|2|||
145674291|NCT01555138|525324339|FG000|Overall Study|Death|0|||
145674292|NCT01555138|525324340|FG001|Overall Study|Death|1|||
145674293|NCT01555138|525324339|FG000|Overall Study|Lost to Follow-up|1|||
145674294|NCT01555138|525324340|FG001|Overall Study|Lost to Follow-up|0|||
145674295|NCT01555138|525324339|FG000|Overall Study|Abnormal Lab reults|1|||
145674296|NCT01555138|525324340|FG001|Overall Study|Abnormal Lab reults|3|||
145674297|NCT01555138|525324339|FG000|Overall Study|Lack of Efficacy|2|||
145674298|NCT01555138|525324340|FG001|Overall Study|Lack of Efficacy|2|||
145674299|NCT01555138|525324339|FG000|Overall Study|Protocol Violation|5|||
145674300|NCT01555138|525324340|FG001|Overall Study|Protocol Violation|3|||
145674301|NCT01555138|525324339|FG000|Overall Study|Administrative problems|8|||
145674302|NCT01555138|525324340|FG001|Overall Study|Administrative problems|0|||
145674303|NCT01555138|525324339|FG000|Overall Study|Withdrawal by Subject|16|||
145674304|NCT01555138|525324340|FG001|Overall Study|Withdrawal by Subject|15|||
145674305|NCT01555138|525324339|FG000|Overall Study|Adverse Event|14|||
145674306|NCT01555138|525324340|FG001|Overall Study|Adverse Event|14|||
145674307|NCT01613417|525324341|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
145674308|NCT01613417|525324342|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
145674309|NCT01079806|525324345|FG000|Day 1 to Week 96|Adverse Event|0|||
145674310|NCT01079806|525324346|FG001|Day 1 to Week 96|Adverse Event|3|||
145674311|NCT01079806|525324345|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
145674312|NCT01079806|525324346|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
145674313|NCT01079806|525324345|FG000|Day 1 to Week 96|Pregnancy|0|||
145674314|NCT01079806|525324346|FG001|Day 1 to Week 96|Pregnancy|1|||
145674315|NCT01079806|525324345|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
145674316|NCT01079806|525324346|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
145674317|NCT01079806|525324345|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
145674318|NCT01079806|525324346|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
145674319|NCT01079806|525324345|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
145674320|NCT01079806|525324346|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
145674321|NCT01079806|525324345|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
145674322|NCT01079806|525324346|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
145674323|NCT01079806|525324345|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
145674324|NCT01079806|525324346|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
145674325|NCT01079806|525324345|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
145674326|NCT01079806|525324346|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
145674327|NCT01079806|525324345|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
145674328|NCT01079806|525324346|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
145674329|NCT01009645|525324349|FG000|Overall Study|Lost to Follow-up|2|||
145674330|NCT01009645|525324350|FG001|Overall Study|Lost to Follow-up|8|||
145674331|NCT01009645|525324351|FG002|Overall Study|Lost to Follow-up|4|||
145674332|NCT01009645|525324352|FG003|Overall Study|Lost to Follow-up|5|||
145674333|NCT03345979|525324353|FG000|Overall Study|Withdrawal by Subject|20|||
145674334|NCT03345979|525324354|FG001|Overall Study|Withdrawal by Subject|31|||
145674335|NCT03345979|525324353|FG000|Overall Study|Adverse Event|10|||
145674336|NCT03345979|525324354|FG001|Overall Study|Adverse Event|11|||
145674337|NCT03345979|525324353|FG000|Overall Study|Lost to Follow-up|8|||
145674338|NCT03345979|525324354|FG001|Overall Study|Lost to Follow-up|9|||
145674339|NCT03345979|525324353|FG000|Overall Study|Lack of Efficacy|4|||
145674340|NCT03345979|525324354|FG001|Overall Study|Lack of Efficacy|2|||
145674341|NCT03345979|525324353|FG000|Overall Study|Protocol Violation|1|||
145674342|NCT03345979|525324354|FG001|Overall Study|Protocol Violation|3|||
145674343|NCT03345979|525324353|FG000|Overall Study|Physician Decision|0|||
145674344|NCT03345979|525324354|FG001|Overall Study|Physician Decision|2|||
145674345|NCT00999596|525324355|FG000|Overall Study|Statistical population not required|101|||
145674346|NCT02085941|525324357|FG000|Overall Study|Lack of Efficacy|1|||
145674347|NCT02085941|525324358|FG001|Overall Study|Lack of Efficacy|0|||
145674348|NCT02085941|525324357|FG000|Overall Study|Death|6|||
145674349|NCT02085941|525324358|FG001|Overall Study|Death|1|||
145674350|NCT02085941|525324357|FG000|Overall Study|Lost to Follow-up|1|||
145674351|NCT02085941|525324358|FG001|Overall Study|Lost to Follow-up|0|||
145674352|NCT02085941|525324357|FG000|Overall Study|Physician Decision|0|||
145674353|NCT02085941|525324358|FG001|Overall Study|Physician Decision|2|||
145674354|NCT02788981|525324364|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
145674355|NCT02788981|525324365|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
145674356|NCT00249769|525324366|FG000|Overall Study|Withdrawal by Subject|1|||
145674357|NCT00249769|525324367|FG001|Overall Study|Withdrawal by Subject|10|||
145674358|NCT00249769|525324368|FG002|Overall Study|Withdrawal by Subject|6|||
145674359|NCT00249769|525324366|FG000|Overall Study|Migration from Study Area|1|||
145674360|NCT00249769|525324367|FG001|Overall Study|Migration from Study Area|3|||
145674361|NCT00249769|525324368|FG002|Overall Study|Migration from Study Area|14|||
145674362|NCT00249769|525324366|FG000|Overall Study|Miscellaneous|0|||
145674363|NCT00249769|525324367|FG001|Overall Study|Miscellaneous|2|||
145674364|NCT00249769|525324368|FG002|Overall Study|Miscellaneous|2|||
145674365|NCT00249769|525324366|FG000|Overall Study|Adverse Event|0|||
145674366|NCT00249769|525324367|FG001|Overall Study|Adverse Event|0|||
145674367|NCT00249769|525324368|FG002|Overall Study|Adverse Event|1|||
145674368|NCT00249769|525324366|FG000|Overall Study|Physician Decision|0|||
145674369|NCT00249769|525324367|FG001|Overall Study|Physician Decision|0|||
145674370|NCT00249769|525324368|FG002|Overall Study|Physician Decision|2|||
145674371|NCT00249769|525324366|FG000|Overall Study|Lost to Follow-up|0|||
145674372|NCT00249769|525324367|FG001|Overall Study|Lost to Follow-up|0|||
145674373|NCT00249769|525324368|FG002|Overall Study|Lost to Follow-up|3|||
145674374|NCT02022657|525324369|FG000|Overall Study|Withdrawal by Subject|2|||
145674375|NCT02022657|525324370|FG001|Overall Study|Withdrawal by Subject|0|||
145674376|NCT02022657|525324371|FG002|Overall Study|Withdrawal by Subject|1|||
145674377|NCT02022657|525324372|FG003|Overall Study|Withdrawal by Subject|0|||
145674378|NCT02022657|525324373|FG004|Overall Study|Withdrawal by Subject|0|||
145674379|NCT02022657|525324374|FG005|Overall Study|Withdrawal by Subject|0|||
145674380|NCT02022657|525324369|FG000|Overall Study|Physician Decision|0|||
145674381|NCT02022657|525324370|FG001|Overall Study|Physician Decision|0|||
145674382|NCT02022657|525324371|FG002|Overall Study|Physician Decision|0|||
145674383|NCT02022657|525324372|FG003|Overall Study|Physician Decision|0|||
145674384|NCT02022657|525324373|FG004|Overall Study|Physician Decision|0|||
145674385|NCT02022657|525324374|FG005|Overall Study|Physician Decision|1|||
145674386|NCT03739866|525324400|FG000|Overall Study|Lost to Follow-up|0|||
145674387|NCT03739866|525324401|FG001|Overall Study|Lost to Follow-up|0|||
145674388|NCT03739866|525324402|FG002|Overall Study|Lost to Follow-up|0|||
145674389|NCT03739866|525324403|FG003|Overall Study|Lost to Follow-up|1|||
145674390|NCT03739866|525324404|FG004|Overall Study|Lost to Follow-up|0|||
145674391|NCT03739866|525324405|FG005|Overall Study|Lost to Follow-up|0|||
145674392|NCT03739866|525324406|FG006|Overall Study|Lost to Follow-up|0|||
145674393|NCT03739866|525324407|FG007|Overall Study|Lost to Follow-up|0|||
145674394|NCT03739866|525324400|FG000|Overall Study|Enrolled but not treated|0|||
145674395|NCT03739866|525324401|FG001|Overall Study|Enrolled but not treated|0|||
145674396|NCT03739866|525324402|FG002|Overall Study|Enrolled but not treated|1|||
145674397|NCT03739866|525324403|FG003|Overall Study|Enrolled but not treated|0|||
145674398|NCT03739866|525324404|FG004|Overall Study|Enrolled but not treated|1|||
145674399|NCT03739866|525324405|FG005|Overall Study|Enrolled but not treated|0|||
145674400|NCT03739866|525324406|FG006|Overall Study|Enrolled but not treated|0|||
145674401|NCT03739866|525324407|FG007|Overall Study|Enrolled but not treated|0|||
145674402|NCT03057600|525324408|FG000|Overall Study|Adverse Event|0|||
145674403|NCT03057600|525324409|FG001|Overall Study|Adverse Event|0|||
145674404|NCT03057600|525324410|FG002|Overall Study|Adverse Event|4|||
145674405|NCT03057600|525324411|FG003|Overall Study|Adverse Event|0|||
145674406|NCT03057600|525324408|FG000|Overall Study|Radiologic Disease Progression|8|||
145674407|NCT03057600|525324409|FG001|Overall Study|Radiologic Disease Progression|7|||
145674408|NCT03057600|525324410|FG002|Overall Study|Radiologic Disease Progression|13|||
145674409|NCT03057600|525324411|FG003|Overall Study|Radiologic Disease Progression|10|||
145674410|NCT03057600|525324408|FG000|Overall Study|Symptomatic Deterioration|0|||
145674411|NCT03057600|525324409|FG001|Overall Study|Symptomatic Deterioration|1|||
145674412|NCT03057600|525324410|FG002|Overall Study|Symptomatic Deterioration|1|||
145674413|NCT03057600|525324411|FG003|Overall Study|Symptomatic Deterioration|0|||
145674414|NCT03057600|525324408|FG000|Overall Study|Investigator Decision|0|||
145674415|NCT03057600|525324409|FG001|Overall Study|Investigator Decision|0|||
145674416|NCT03057600|525324410|FG002|Overall Study|Investigator Decision|1|||
145674417|NCT03057600|525324411|FG003|Overall Study|Investigator Decision|0|||
145674418|NCT03057600|525324408|FG000|Overall Study|Study Termination by Sponsor|0|||
145674419|NCT03057600|525324409|FG001|Overall Study|Study Termination by Sponsor|0|||
145674420|NCT03057600|525324410|FG002|Overall Study|Study Termination by Sponsor|0|||
145674421|NCT03057600|525324411|FG003|Overall Study|Study Termination by Sponsor|2|||
145674422|NCT03057600|525324408|FG000|Overall Study|Withdrawal by Subject|0|||
145674423|NCT03057600|525324409|FG001|Overall Study|Withdrawal by Subject|1|||
145674424|NCT03057600|525324410|FG002|Overall Study|Withdrawal by Subject|0|||
145674425|NCT03057600|525324411|FG003|Overall Study|Withdrawal by Subject|0|||
145674426|NCT03057600|525324408|FG000|Overall Study|Other, Not Specified|1|||
145674427|NCT03057600|525324409|FG001|Overall Study|Other, Not Specified|1|||
145674428|NCT03057600|525324410|FG002|Overall Study|Other, Not Specified|1|||
145674429|NCT03057600|525324411|FG003|Overall Study|Other, Not Specified|1|||
145674430|NCT01953692|525324414|FG000|Overall Study|Adverse Event|5|||
145674431|NCT01953692|525324415|FG001|Overall Study|Adverse Event|2|||
145674432|NCT01953692|525324416|FG002|Overall Study|Adverse Event|4|||
145674433|NCT01953692|525324417|FG003|Overall Study|Adverse Event|2|||
145674434|NCT01953692|525324418|FG004|Overall Study|Adverse Event|1|||
145674435|NCT01953692|525324419|FG005|Overall Study|Adverse Event|2|||
145674436|NCT01953692|525324420|FG006|Overall Study|Adverse Event|0|||
145674437|NCT01953692|525324421|FG007|Overall Study|Adverse Event|0|||
145674438|NCT01953692|525324422|FG008|Overall Study|Adverse Event|0|||
145674439|NCT01953692|525324414|FG000|Overall Study|Clinical Progression|0|||
145674440|NCT01953692|525324415|FG001|Overall Study|Clinical Progression|15|||
145674441|NCT01953692|525324416|FG002|Overall Study|Clinical Progression|7|||
145674442|NCT01953692|525324417|FG003|Overall Study|Clinical Progression|5|||
145674443|NCT01953692|525324418|FG004|Overall Study|Clinical Progression|0|||
145674444|NCT01953692|525324419|FG005|Overall Study|Clinical Progression|7|||
145674445|NCT01953692|525324420|FG006|Overall Study|Clinical Progression|20|||
145674446|NCT01953692|525324421|FG007|Overall Study|Clinical Progression|3|||
145674447|NCT01953692|525324422|FG008|Overall Study|Clinical Progression|3|||
145674448|NCT01953692|525324414|FG000|Overall Study|Death|5|||
145674449|NCT01953692|525324415|FG001|Overall Study|Death|0|||
145674450|NCT01953692|525324416|FG002|Overall Study|Death|2|||
145674451|NCT01953692|525324417|FG003|Overall Study|Death|2|||
145674452|NCT01953692|525324418|FG004|Overall Study|Death|1|||
145674453|NCT01953692|525324419|FG005|Overall Study|Death|3|||
145674454|NCT01953692|525324420|FG006|Overall Study|Death|6|||
145674455|NCT01953692|525324421|FG007|Overall Study|Death|2|||
145674456|NCT01953692|525324422|FG008|Overall Study|Death|1|||
145674457|NCT01953692|525324414|FG000|Overall Study|Excluded Medication|1|||
145674458|NCT01953692|525324415|FG001|Overall Study|Excluded Medication|0|||
145674459|NCT01953692|525324416|FG002|Overall Study|Excluded Medication|0|||
145674460|NCT01953692|525324417|FG003|Overall Study|Excluded Medication|0|||
145674461|NCT01953692|525324418|FG004|Overall Study|Excluded Medication|0|||
145674462|NCT01953692|525324419|FG005|Overall Study|Excluded Medication|0|||
145674463|NCT01953692|525324420|FG006|Overall Study|Excluded Medication|0|||
145674464|NCT01953692|525324421|FG007|Overall Study|Excluded Medication|0|||
145674465|NCT01953692|525324422|FG008|Overall Study|Excluded Medication|0|||
145674466|NCT01953692|525324414|FG000|Overall Study|Lost to Follow-up|1|||
145674467|NCT01953692|525324415|FG001|Overall Study|Lost to Follow-up|0|||
145674468|NCT01953692|525324416|FG002|Overall Study|Lost to Follow-up|3|||
145674469|NCT01953692|525324417|FG003|Overall Study|Lost to Follow-up|1|||
145674470|NCT01953692|525324418|FG004|Overall Study|Lost to Follow-up|0|||
145674471|NCT01953692|525324419|FG005|Overall Study|Lost to Follow-up|1|||
145674472|NCT01953692|525324420|FG006|Overall Study|Lost to Follow-up|0|||
145674473|NCT01953692|525324421|FG007|Overall Study|Lost to Follow-up|0|||
145674474|NCT01953692|525324422|FG008|Overall Study|Lost to Follow-up|0|||
145674475|NCT01953692|525324414|FG000|Overall Study|Physician Decision|11|||
145674476|NCT01953692|525324415|FG001|Overall Study|Physician Decision|4|||
145674477|NCT01953692|525324416|FG002|Overall Study|Physician Decision|2|||
145674478|NCT01953692|525324417|FG003|Overall Study|Physician Decision|2|||
145674479|NCT01953692|525324418|FG004|Overall Study|Physician Decision|1|||
145674480|NCT01953692|525324419|FG005|Overall Study|Physician Decision|2|||
145674481|NCT01953692|525324420|FG006|Overall Study|Physician Decision|4|||
145674482|NCT01953692|525324421|FG007|Overall Study|Physician Decision|1|||
145674483|NCT01953692|525324422|FG008|Overall Study|Physician Decision|0|||
145674484|NCT01953692|525324414|FG000|Overall Study|Protocol Violation|0|||
145674485|NCT01953692|525324415|FG001|Overall Study|Protocol Violation|2|||
145674486|NCT01953692|525324416|FG002|Overall Study|Protocol Violation|1|||
145674487|NCT01953692|525324417|FG003|Overall Study|Protocol Violation|0|||
145674488|NCT01953692|525324418|FG004|Overall Study|Protocol Violation|0|||
145674489|NCT01953692|525324419|FG005|Overall Study|Protocol Violation|0|||
145674490|NCT01953692|525324420|FG006|Overall Study|Protocol Violation|0|||
145674491|NCT01953692|525324421|FG007|Overall Study|Protocol Violation|1|||
145674492|NCT01953692|525324422|FG008|Overall Study|Protocol Violation|0|||
145674493|NCT01953692|525324414|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674494|NCT01953692|525324415|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674495|NCT01953692|525324416|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674496|NCT01953692|525324417|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674497|NCT01953692|525324418|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674498|NCT01953692|525324419|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674499|NCT01953692|525324420|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674500|NCT01953692|525324421|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
145674501|NCT01953692|525324422|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
145674502|NCT01953692|525324414|FG000|Overall Study|Withdrawal by Subject|4|||
145674503|NCT01953692|525324415|FG001|Overall Study|Withdrawal by Subject|2|||
145674504|NCT01953692|525324416|FG002|Overall Study|Withdrawal by Subject|1|||
145674505|NCT01953692|525324417|FG003|Overall Study|Withdrawal by Subject|2|||
145674506|NCT01953692|525324418|FG004|Overall Study|Withdrawal by Subject|0|||
145674507|NCT01953692|525324419|FG005|Overall Study|Withdrawal by Subject|3|||
145674508|NCT01953692|525324420|FG006|Overall Study|Withdrawal by Subject|2|||
145674509|NCT01953692|525324421|FG007|Overall Study|Withdrawal by Subject|1|||
145674510|NCT01953692|525324422|FG008|Overall Study|Withdrawal by Subject|1|||
145674511|NCT00641537|525324427|FG000|96-week Period|Adverse Event|0|||
145674512|NCT00641537|525324428|FG001|96-week Period|Adverse Event|1|||
145674513|NCT00641537|525324429|FG002|96-week Period|Adverse Event|3|||
145674514|NCT00641537|525324430|FG003|96-week Period|Adverse Event|0|||
145674515|NCT00641537|525324431|FG004|96-week Period|Adverse Event|2|||
145674516|NCT00641537|525324432|FG005|96-week Period|Adverse Event|0|||
145674517|NCT00641537|525324433|FG006|96-week Period|Adverse Event|0|||
145674518|NCT00641537|525324434|FG007|96-week Period|Adverse Event|0|||
145674519|NCT00641537|525324427|FG000|96-week Period|Lost to Follow-up|3|||
145674520|NCT00641537|525324428|FG001|96-week Period|Lost to Follow-up|1|||
145674521|NCT00641537|525324429|FG002|96-week Period|Lost to Follow-up|2|||
145674522|NCT00641537|525324430|FG003|96-week Period|Lost to Follow-up|2|||
145674523|NCT00641537|525324431|FG004|96-week Period|Lost to Follow-up|4|||
145674524|NCT00641537|525324432|FG005|96-week Period|Lost to Follow-up|0|||
145674525|NCT00641537|525324433|FG006|96-week Period|Lost to Follow-up|1|||
145674526|NCT00641537|525324434|FG007|96-week Period|Lost to Follow-up|0|||
145674527|NCT00641537|525324427|FG000|96-week Period|Protocol Violation|0|||
145674528|NCT00641537|525324428|FG001|96-week Period|Protocol Violation|1|||
145674529|NCT00641537|525324429|FG002|96-week Period|Protocol Violation|0|||
145674530|NCT00641537|525324430|FG003|96-week Period|Protocol Violation|1|||
145674531|NCT00641537|525324431|FG004|96-week Period|Protocol Violation|0|||
145674532|NCT00641537|525324432|FG005|96-week Period|Protocol Violation|1|||
145265404|NCT04410991|523819350|FG001|Overall Study|Withdrawal by Subject|55|||
145265405|NCT04410991|523819349|FG000|Overall Study|Other|10|||
145674533|NCT00641537|525324433|FG006|96-week Period|Protocol Violation|0|||
145674534|NCT00641537|525324434|FG007|96-week Period|Protocol Violation|0|||
145674535|NCT00641537|525324427|FG000|96-week Period|Death|2|||
145674536|NCT00641537|525324428|FG001|96-week Period|Death|0|||
145674537|NCT00641537|525324429|FG002|96-week Period|Death|1|||
145674538|NCT00641537|525324430|FG003|96-week Period|Death|0|||
145674539|NCT00641537|525324431|FG004|96-week Period|Death|0|||
145674540|NCT00641537|525324432|FG005|96-week Period|Death|0|||
145674541|NCT00641537|525324433|FG006|96-week Period|Death|0|||
145674542|NCT00641537|525324434|FG007|96-week Period|Death|0|||
145674543|NCT00641537|525324427|FG000|96-week Period|Other|4|||
145674544|NCT00641537|525324428|FG001|96-week Period|Other|7|||
145674545|NCT00641537|525324429|FG002|96-week Period|Other|14|||
145674546|NCT00641537|525324430|FG003|96-week Period|Other|9|||
145674547|NCT00641537|525324431|FG004|96-week Period|Other|11|||
145674548|NCT00641537|525324432|FG005|96-week Period|Other|6|||
145674549|NCT00641537|525324433|FG006|96-week Period|Other|4|||
145674550|NCT00641537|525324434|FG007|96-week Period|Other|6|||
145674551|NCT00641537|525324427|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
145674552|NCT00641537|525324428|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
145674553|NCT00641537|525324429|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
145674554|NCT00641537|525324430|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
145674555|NCT00641537|525324431|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
145674556|NCT00641537|525324432|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
145674557|NCT00641537|525324433|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
145674558|NCT00641537|525324434|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
145674559|NCT00641537|525324427|FG000|24-Week Supplemental Follow-up Period|Other|0|||
145674560|NCT00641537|525324428|FG001|24-Week Supplemental Follow-up Period|Other|2|||
145674561|NCT00641537|525324429|FG002|24-Week Supplemental Follow-up Period|Other|2|||
145674562|NCT00641537|525324430|FG003|24-Week Supplemental Follow-up Period|Other|1|||
145674563|NCT00641537|525324431|FG004|24-Week Supplemental Follow-up Period|Other|3|||
145674564|NCT00641537|525324432|FG005|24-Week Supplemental Follow-up Period|Other|0|||
145674565|NCT00641537|525324433|FG006|24-Week Supplemental Follow-up Period|Other|1|||
145674566|NCT00641537|525324434|FG007|24-Week Supplemental Follow-up Period|Other|1|||
145674567|NCT01801007|525324435|FG000|Overall Study|Adverse Event|2|||
145674568|NCT01801007|525324435|FG000|Overall Study|Lost to Follow-up|4|||
145674569|NCT01801007|525324435|FG000|Overall Study|Withdrawal by Subject|5|||
145674570|NCT00665392|525324436|FG000|Overall Study|not treated|1|||
145674571|NCT02426138|525324437|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145674572|NCT02426138|525324438|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
145674573|NCT00553332|525324444|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
145674574|NCT03924869|525324457|FG000|Overall Study|Death|66|||
145674575|NCT03924869|525324458|FG001|Overall Study|Death|53|||
145674576|NCT03924869|525324457|FG000|Overall Study|Lost to Follow-up|2|||
145674577|NCT03924869|525324458|FG001|Overall Study|Lost to Follow-up|0|||
145674578|NCT03924869|525324457|FG000|Overall Study|Physician Decision|0|||
145674579|NCT03924869|525324458|FG001|Overall Study|Physician Decision|3|||
145674580|NCT03924869|525324457|FG000|Overall Study|Withdrawal by Subject|5|||
145674581|NCT03924869|525324458|FG001|Overall Study|Withdrawal by Subject|1|||
145674582|NCT03924869|525324457|FG000|Overall Study|Participants Ongoing|154|||
145674583|NCT03924869|525324458|FG001|Overall Study|Participants Ongoing|164|||
145674584|NCT04762277|525324461|FG000|Overall Study|Withdrawal by Subject|0|||
145674585|NCT04762277|525324462|FG001|Overall Study|Withdrawal by Subject|2|||
145674586|NCT04762277|525324461|FG000|Overall Study|Protocol Violation|0|||
145674587|NCT04762277|525324462|FG001|Overall Study|Protocol Violation|1|||
145674588|NCT04762277|525324461|FG000|Overall Study|Adverse Event|1|||
145674589|NCT04762277|525324462|FG001|Overall Study|Adverse Event|0|||
145674590|NCT05824559|525324463|FG000|Overall Study|Adverse Event|2|||
145674591|NCT05824559|525324463|FG000|Overall Study|Physician Decision|2|||
145674592|NCT05824559|525324463|FG000|Overall Study|Progressive Disease|16|||
145674593|NCT05824559|525324463|FG000|Overall Study|Study Terminated by Sponsor|1|||
145674594|NCT05824559|525324463|FG000|Overall Study|Withdrawal by Subject|2|||
145674595|NCT00647387|525324467|FG000|Overall Study|Lost to Follow-up|6|||
145674596|NCT00647387|525324467|FG000|Overall Study|Unsuccessful implant|5|||
145674597|NCT00647387|525324467|FG000|Overall Study|Device explanted|3|||
145674598|NCT00647387|525324467|FG000|Overall Study|Other Reason|3|||
145674599|NCT00647387|525324467|FG000|Overall Study|Death|2|||
145674600|NCT03678688|525326409|FG000|Overall Study|Reason not Specified|0|||
145674601|NCT03678688|525326410|FG001|Overall Study|Reason not Specified|0|||
145674602|NCT03678688|525326411|FG002|Overall Study|Reason not Specified|3|||
145674603|NCT03678688|525326412|FG003|Overall Study|Reason not Specified|0|||
145674604|NCT03678688|525326413|FG004|Overall Study|Reason not Specified|1|||
145674605|NCT03678688|525326414|FG005|Overall Study|Reason not Specified|0|||
145674606|NCT03678688|525326415|FG006|Overall Study|Reason not Specified|0|||
145674607|NCT03678688|525326416|FG007|Overall Study|Reason not Specified|0|||
145674608|NCT03678688|525326417|FG008|Overall Study|Reason not Specified|0|||
145674609|NCT03678688|525326409|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
145674610|NCT03678688|525326410|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
145674611|NCT03678688|525326411|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
145674612|NCT03678688|525326412|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
145674613|NCT03678688|525326413|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
145674614|NCT03678688|525326414|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
145674615|NCT03678688|525326415|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
145674616|NCT03678688|525326416|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
145674617|NCT03678688|525326417|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
145674618|NCT03678688|525326409|FG000|Overall Study|Covid Related Adverse Event|0|||
145674619|NCT03678688|525326410|FG001|Overall Study|Covid Related Adverse Event|0|||
145674620|NCT03678688|525326411|FG002|Overall Study|Covid Related Adverse Event|0|||
145674621|NCT03678688|525326412|FG003|Overall Study|Covid Related Adverse Event|0|||
145674622|NCT03678688|525326413|FG004|Overall Study|Covid Related Adverse Event|0|||
145674623|NCT03678688|525326414|FG005|Overall Study|Covid Related Adverse Event|3|||
145674624|NCT03678688|525326415|FG006|Overall Study|Covid Related Adverse Event|1|||
145674625|NCT03678688|525326416|FG007|Overall Study|Covid Related Adverse Event|1|||
145674626|NCT03678688|525326417|FG008|Overall Study|Covid Related Adverse Event|0|||
145674627|NCT03678688|525326409|FG000|Overall Study|Physician Decision|0|||
145674628|NCT03678688|525326410|FG001|Overall Study|Physician Decision|0|||
145674629|NCT03678688|525326411|FG002|Overall Study|Physician Decision|0|||
145674630|NCT03678688|525326412|FG003|Overall Study|Physician Decision|0|||
145674631|NCT03678688|525326413|FG004|Overall Study|Physician Decision|0|||
145674632|NCT03678688|525326414|FG005|Overall Study|Physician Decision|1|||
145674633|NCT03678688|525326415|FG006|Overall Study|Physician Decision|0|||
145674634|NCT03678688|525326416|FG007|Overall Study|Physician Decision|0|||
145674635|NCT03678688|525326417|FG008|Overall Study|Physician Decision|0|||
145674636|NCT03678688|525326409|FG000|Overall Study|Withdrawal by Subject|0|||
145674637|NCT03678688|525326410|FG001|Overall Study|Withdrawal by Subject|0|||
145674638|NCT03678688|525326411|FG002|Overall Study|Withdrawal by Subject|0|||
145674639|NCT03678688|525326412|FG003|Overall Study|Withdrawal by Subject|0|||
145674640|NCT03678688|525326413|FG004|Overall Study|Withdrawal by Subject|0|||
145674641|NCT03678688|525326414|FG005|Overall Study|Withdrawal by Subject|0|||
145674642|NCT03678688|525326415|FG006|Overall Study|Withdrawal by Subject|2|||
145674643|NCT03678688|525326416|FG007|Overall Study|Withdrawal by Subject|1|||
145674644|NCT03678688|525326417|FG008|Overall Study|Withdrawal by Subject|0|||
145674645|NCT03137459|525326418|FG000|2-month Assessment|Withdrawal by Subject|13|||
145674646|NCT03137459|525326419|FG001|2-month Assessment|Withdrawal by Subject|3|||
145674647|NCT03137459|525326418|FG000|2-month Assessment|Unable to reach|42|||
145674648|NCT03137459|525326419|FG001|2-month Assessment|Unable to reach|32|||
145674649|NCT03137459|525326418|FG000|2-month Assessment|Refused assessment|7|||
145674650|NCT03137459|525326419|FG001|2-month Assessment|Refused assessment|5|||
145674651|NCT03137459|525326418|FG000|2-month Assessment|Acutely ill|6|||
145674652|NCT03137459|525326419|FG001|2-month Assessment|Acutely ill|2|||
145674653|NCT03137459|525326418|FG000|4-month Assessment|Death|4|||
145674654|NCT03137459|525326419|FG001|4-month Assessment|Death|2|||
145674655|NCT03137459|525326418|FG000|4-month Assessment|Withdrawal by Subject|4|||
145674656|NCT03137459|525326419|FG001|4-month Assessment|Withdrawal by Subject|2|||
145674657|NCT03137459|525326418|FG000|4-month Assessment|Unable to reach|44|||
145674658|NCT03137459|525326419|FG001|4-month Assessment|Unable to reach|29|||
145674659|NCT03137459|525326418|FG000|4-month Assessment|Refused assessment|24|||
145674660|NCT03137459|525326419|FG001|4-month Assessment|Refused assessment|10|||
145674661|NCT03137459|525326418|FG000|4-month Assessment|Acutely ill|2|||
145674662|NCT03137459|525326419|FG001|4-month Assessment|Acutely ill|3|||
145674663|NCT03137459|525326418|FG000|6-months|Lost to Follow-up|14|||
145674664|NCT03137459|525326419|FG001|6-months|Lost to Follow-up|11|||
145674665|NCT03137459|525326418|FG000|6-months|Death|0|||
145674666|NCT03137459|525326419|FG001|6-months|Death|2|||
145674667|NCT03137459|525326418|FG000|6-months|Refused assessment|6|||
145674668|NCT03137459|525326419|FG001|6-months|Refused assessment|3|||
145674669|NCT03137459|525326418|FG000|6-months|Acutely ill|1|||
145674670|NCT03137459|525326419|FG001|6-months|Acutely ill|1|||
145674671|NCT01732757|525326420|FG000|Overall Study|Lost to Follow-up|1|||
145674672|NCT01732757|525326421|FG001|Overall Study|Lost to Follow-up|0|||
145674673|NCT01732757|525326422|FG002|Overall Study|Lost to Follow-up|0|||
145674674|NCT00491400|525326423|FG000|Overall Study|Withdrawal by Subject|5|||
145674675|NCT00491400|525326424|FG001|Overall Study|Withdrawal by Subject|4|||
145674676|NCT01583166|525326429|FG000|Overall Study|Withdrawal by Subject|4|||
145674677|NCT01583166|525326430|FG001|Overall Study|Withdrawal by Subject|6|||
145674678|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
145674679|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
145674680|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
145674681|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
145674682|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
145674683|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
145674684|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
145674685|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
145674686|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
145674687|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
145674688|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
145674689|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
145674690|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Other|1|||
145674691|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Other|0|||
145674692|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Other|0|||
145674693|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
145674694|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
145674695|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
145674696|NCT00887224|525326431|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
145674697|NCT00887224|525326432|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
145674698|NCT00887224|525326433|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
145674699|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
145674700|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
145674701|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
145674702|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
145674703|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
145674704|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
145674705|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
145674706|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
145674707|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
145674708|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
145674709|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
145674710|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
145674711|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Other|1|||
145674712|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Other|0|||
145674713|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Other|0|||
145674714|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
145674715|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
145674716|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
145674717|NCT00887224|525326431|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
145674718|NCT00887224|525326432|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
145674719|NCT00887224|525326433|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
145674720|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
145674721|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
145674722|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
145674723|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
145674724|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
145674725|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
145674726|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
145674727|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
145674728|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
145674729|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
145674730|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
145674731|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
145674732|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Other|30|||
145674733|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Other|0|||
145674734|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Other|0|||
145674735|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
145674736|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
145674737|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
145674738|NCT00887224|525326431|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
145674739|NCT00887224|525326432|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
145674740|NCT00887224|525326433|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
145674741|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Adverse Event|0|||
145674742|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Adverse Event|7|||
145674743|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Adverse Event|2|||
145674744|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Failed to return|0|||
145674745|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Failed to return|2|||
145674746|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Failed to return|2|||
145674747|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
145674748|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
145674749|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
145674750|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
145490986|NCT03748823|524652320|FG000|Extension Period|Withdrawal by Subject|9|||
145490987|NCT03748823|524652321|FG001|Extension Period|Withdrawal by Subject|12|||
145674751|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
145674752|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
145490988|NCT03748823|524652320|FG000|Extension Period|Death|2|||
145674753|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Other|0|||
145674754|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Other|2|||
145490989|NCT03748823|524652321|FG001|Extension Period|Death|2|||
145674755|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Other|0|||
145674756|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
145674757|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
145674758|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
145674759|NCT00887224|525326431|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
145674760|NCT00887224|525326432|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
145674761|NCT00887224|525326433|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
145674762|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
145674763|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
145674764|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
145674765|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
145674766|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
145674767|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
145674768|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
145674769|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
145674770|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
145674771|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
145674772|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
145674773|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
145674774|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
145674775|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
145674776|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
145674777|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
145674778|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
145674779|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
145674780|NCT00887224|525326431|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
145674781|NCT00887224|525326432|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
145674782|NCT00887224|525326433|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
145674783|NCT02000752|525326438|FG000|Overall Study|Dystocic delivery|19|||
145674784|NCT02000752|525326439|FG001|Overall Study|Dystocic delivery|8|||
145674785|NCT02000752|525326438|FG000|Overall Study|Shift Changes|12|||
145674786|NCT02000752|525326439|FG001|Overall Study|Shift Changes|5|||
145674787|NCT00047385|525326441|FG000|Overall Study|Death before any screening|2|||
145674788|NCT00047385|525326442|FG001|Overall Study|Death before any screening|5|||
145674789|NCT00047385|525326441|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
145674790|NCT00047385|525326442|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
145674791|NCT00047385|525326441|FG000|Overall Study|Eligible for screening but had no screen|260|||
145674792|NCT00047385|525326442|FG001|Overall Study|Eligible for screening but had no screen|492|||
145674793|NCT03865732|525326443|FG000|Overall Study|Adverse Event|0|||
145674794|NCT03865732|525326444|FG001|Overall Study|Adverse Event|1|||
145674795|NCT03392194|525326445|FG000|Overall Study|Withdrawal by Subject|1|||
145674796|NCT03392194|525326446|FG001|Overall Study|Withdrawal by Subject|2|||
145674797|NCT03392194|525326445|FG000|Overall Study|Conflicts with personal schedule|1|||
145674798|NCT03392194|525326446|FG001|Overall Study|Conflicts with personal schedule|0|||
145674799|NCT00620854|525326451|FG000|Washout 1|Withdrawal by Subject|0|||
145674800|NCT00620854|525326452|FG001|Washout 1|Withdrawal by Subject|0|||
145674801|NCT00620854|525326453|FG002|Washout 1|Withdrawal by Subject|1|||
145674802|NCT00620854|525326454|FG003|Washout 1|Withdrawal by Subject|1|||
145674803|NCT00620854|525326455|FG004|Washout 1|Withdrawal by Subject|0|||
145674804|NCT00620854|525326456|FG005|Washout 1|Withdrawal by Subject|0|||
145674805|NCT00734578|525326457|FG000|Overall Study|Adverse Event|4|||
145674806|NCT00734578|525326458|FG001|Overall Study|Adverse Event|6|||
145674807|NCT00734578|525326459|FG002|Overall Study|Adverse Event|1|||
145674808|NCT00734578|525326457|FG000|Overall Study|Protocol Violation|8|||
145674809|NCT00734578|525326458|FG001|Overall Study|Protocol Violation|6|||
145674810|NCT00734578|525326459|FG002|Overall Study|Protocol Violation|3|||
145674811|NCT00734578|525326457|FG000|Overall Study|Withdrawal by Subject|7|||
145674812|NCT00734578|525326458|FG001|Overall Study|Withdrawal by Subject|8|||
145674813|NCT00734578|525326459|FG002|Overall Study|Withdrawal by Subject|11|||
145674814|NCT00734578|525326457|FG000|Overall Study|Lost to Follow-up|9|||
145674815|NCT00734578|525326458|FG001|Overall Study|Lost to Follow-up|3|||
145674816|NCT00734578|525326459|FG002|Overall Study|Lost to Follow-up|5|||
145674817|NCT00734578|525326457|FG000|Overall Study|Lack of Efficacy|3|||
145674818|NCT00734578|525326458|FG001|Overall Study|Lack of Efficacy|2|||
145674819|NCT00734578|525326459|FG002|Overall Study|Lack of Efficacy|5|||
145674820|NCT00734578|525326457|FG000|Overall Study|Randomized in error|1|||
145674821|NCT00734578|525326458|FG001|Overall Study|Randomized in error|0|||
145490990|NCT03748823|524652320|FG000|Extension Period|Other than Specified|0|||
145674822|NCT00734578|525326459|FG002|Overall Study|Randomized in error|0|||
145674823|NCT00734578|525326457|FG000|Overall Study|Exclusion criteria|1|||
145674824|NCT00734578|525326458|FG001|Overall Study|Exclusion criteria|0|||
145674825|NCT00734578|525326459|FG002|Overall Study|Exclusion criteria|0|||
145674826|NCT01698918|525326460|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
145674827|NCT01698918|525326460|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
145674828|NCT01698918|525326460|FG000|First Line Treatment (Core+Extension)|Death|2|||
145674829|NCT01698918|525326460|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
145674830|NCT01698918|525326460|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
145674831|NCT01698918|525326460|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
145674832|NCT01698918|525326460|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
145674833|NCT01698918|525326460|FG000|Second Line Treatment (Core+Extension)|Death|1|||
145674834|NCT01698918|525326460|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
145674835|NCT01698918|525326460|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
145674836|NCT02095145|525326461|FG000|Overall Study|Withdrawal by Subject|1|||
145674837|NCT02095145|525326462|FG001|Overall Study|Withdrawal by Subject|0|||
145674838|NCT04693637|525326466|FG000|Overall Study|Death|4|||
145674839|NCT04693637|525326466|FG000|Overall Study|Withdrawal by Subject|3|||
145674840|NCT04693637|525326466|FG000|Overall Study|Physician Decision|2|||
145674841|NCT04693637|525326466|FG000|Overall Study|Lost to Follow-up|1|||
145674842|NCT05553366|525326473|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
145674843|NCT05553366|525326474|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
145674844|NCT05553366|525326475|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
145674845|NCT05553366|525326473|FG000|Overall Study|Lost to Follow-up|3|||
145674846|NCT05553366|525326474|FG001|Overall Study|Lost to Follow-up|3|||
145674847|NCT05553366|525326475|FG002|Overall Study|Lost to Follow-up|3|||
145674848|NCT05553366|525326473|FG000|Overall Study|Other non-compliance|1|||
145674849|NCT05553366|525326474|FG001|Overall Study|Other non-compliance|1|||
145674850|NCT05553366|525326475|FG002|Overall Study|Other non-compliance|0|||
145674851|NCT05553366|525326473|FG000|Overall Study|Randomized but not dosed|0|||
145674852|NCT05553366|525326474|FG001|Overall Study|Randomized but not dosed|0|||
145674853|NCT05553366|525326475|FG002|Overall Study|Randomized but not dosed|2|||
145674854|NCT00795184|525326481|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
145674855|NCT00795184|525326482|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
145674856|NCT03781375|525326483|FG000|Double-blind Phase|Adverse Event|0|||
145674857|NCT03781375|525326484|FG001|Double-blind Phase|Adverse Event|1|||
145674858|NCT03781375|525326483|FG000|Double-blind Phase|Lack of Response|6|||
145674859|NCT03781375|525326484|FG001|Double-blind Phase|Lack of Response|2|||
145674860|NCT03781375|525326483|FG000|Double-blind Phase|Other|1|||
145674861|NCT03781375|525326484|FG001|Double-blind Phase|Other|3|||
145674862|NCT03781375|525326483|FG000|Open-label Phase|Protocol Issues|0|||
145674863|NCT03781375|525326484|FG001|Open-label Phase|Protocol Issues|1|||
145674864|NCT03781375|525326483|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
145674865|NCT03781375|525326484|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
145674866|NCT03781375|525326483|FG000|Open-label Phase|Other|2|||
145674867|NCT03781375|525326484|FG001|Open-label Phase|Other|2|||
145674868|NCT02079649|525326485|FG000|Overall Study|Lost to Follow-up|0|||
145674869|NCT02079649|525326486|FG001|Overall Study|Lost to Follow-up|0|||
145674870|NCT02079649|525326487|FG002|Overall Study|Lost to Follow-up|0|||
145674871|NCT02079649|525326488|FG003|Overall Study|Lost to Follow-up|1|||
145674872|NCT02079649|525326485|FG000|Overall Study|Withdrawal by Subject|0|||
145674873|NCT02079649|525326486|FG001|Overall Study|Withdrawal by Subject|0|||
145674874|NCT02079649|525326487|FG002|Overall Study|Withdrawal by Subject|0|||
145674875|NCT02079649|525326488|FG003|Overall Study|Withdrawal by Subject|1|||
145674876|NCT02079649|525326485|FG000|Overall Study|Randomization error (prior to treatment)|1|||
145674877|NCT02079649|525326486|FG001|Overall Study|Randomization error (prior to treatment)|0|||
145674878|NCT02079649|525326487|FG002|Overall Study|Randomization error (prior to treatment)|1|||
145674879|NCT02079649|525326488|FG003|Overall Study|Randomization error (prior to treatment)|0|||
145674880|NCT01034306|525326489|FG000|Overall Study|Adverse Event|1|||
145674881|NCT01034306|525326490|FG001|Overall Study|Adverse Event|0|||
145674882|NCT01034306|525326489|FG000|Overall Study|Lost to Follow-up|0|||
145674883|NCT01034306|525326490|FG001|Overall Study|Lost to Follow-up|1|||
145674884|NCT01034306|525326489|FG000|Overall Study|Withdrawal by Subject|2|||
145674885|NCT01034306|525326490|FG001|Overall Study|Withdrawal by Subject|2|||
145674886|NCT01034306|525326489|FG000|Overall Study|hospitalized and decided to stop|1|||
145674887|NCT01034306|525326490|FG001|Overall Study|hospitalized and decided to stop|0|||
145674888|NCT01034306|525326489|FG000|Overall Study|Noncomplience|1|||
145674889|NCT01034306|525326490|FG001|Overall Study|Noncomplience|0|||
145674890|NCT03489369|525326491|FG000|Overall Study|Documented Progressive Disease|3|||
145674891|NCT03489369|525326492|FG001|Overall Study|Documented Progressive Disease|2|||
145674892|NCT03489369|525326493|FG002|Overall Study|Documented Progressive Disease|3|||
145674893|NCT03489369|525326494|FG003|Overall Study|Documented Progressive Disease|6|||
145674894|NCT03489369|525326491|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
145674895|NCT03489369|525326492|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
145674896|NCT03489369|525326493|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
145674897|NCT03489369|525326494|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
145674898|NCT01968967|525326495|FG000|Treatment Period|Other|22|||
145674899|NCT01968967|525326496|FG001|Treatment Period|Other|22|||
145674900|NCT01968967|525326497|FG002|Treatment Period|Other|0|||
145674901|NCT01968967|525326498|FG003|Treatment Period|Other|0|||
145674902|NCT01968967|525326499|FG004|Treatment Period|Other|0|||
145674903|NCT01968967|525326495|FG000|Treatment Period|Withdrawal by Subject|71|||
145674904|NCT01968967|525326496|FG001|Treatment Period|Withdrawal by Subject|61|||
145674905|NCT01968967|525326497|FG002|Treatment Period|Withdrawal by Subject|0|||
145674906|NCT01968967|525326498|FG003|Treatment Period|Withdrawal by Subject|0|||
145674907|NCT01968967|525326499|FG004|Treatment Period|Withdrawal by Subject|0|||
145674908|NCT01968967|525326495|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
145674909|NCT01968967|525326496|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
145674910|NCT01968967|525326497|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
145674911|NCT01968967|525326498|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
145674912|NCT01968967|525326499|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
145674913|NCT01968967|525326495|FG000|Treatment Period|Lost to Follow-up|26|||
145674914|NCT01968967|525326496|FG001|Treatment Period|Lost to Follow-up|31|||
145674915|NCT01968967|525326497|FG002|Treatment Period|Lost to Follow-up|0|||
145674916|NCT01968967|525326498|FG003|Treatment Period|Lost to Follow-up|0|||
145674917|NCT01968967|525326499|FG004|Treatment Period|Lost to Follow-up|0|||
145674918|NCT01968967|525326495|FG000|Treatment Period|Protocol Violation|1|||
145674919|NCT01968967|525326496|FG001|Treatment Period|Protocol Violation|2|||
145674920|NCT01968967|525326497|FG002|Treatment Period|Protocol Violation|0|||
145674921|NCT01968967|525326498|FG003|Treatment Period|Protocol Violation|0|||
145674922|NCT01968967|525326499|FG004|Treatment Period|Protocol Violation|0|||
145674923|NCT01968967|525326495|FG000|Treatment Period|Adverse Event|9|||
145674924|NCT01968967|525326496|FG001|Treatment Period|Adverse Event|8|||
145674925|NCT01968967|525326497|FG002|Treatment Period|Adverse Event|0|||
145674926|NCT01968967|525326498|FG003|Treatment Period|Adverse Event|0|||
145674927|NCT01968967|525326499|FG004|Treatment Period|Adverse Event|0|||
145674928|NCT01968967|525326495|FG000|Treatment Period|Death|9|||
145674929|NCT01968967|525326496|FG001|Treatment Period|Death|2|||
145674930|NCT01968967|525326497|FG002|Treatment Period|Death|0|||
145674931|NCT01968967|525326498|FG003|Treatment Period|Death|0|||
145674932|NCT01968967|525326499|FG004|Treatment Period|Death|0|||
145674933|NCT01968967|525326495|FG000|Treatment Period|Randomized Not Treated|6|||
145674934|NCT01968967|525326496|FG001|Treatment Period|Randomized Not Treated|5|||
145674935|NCT01968967|525326497|FG002|Treatment Period|Randomized Not Treated|0|||
145674936|NCT01968967|525326498|FG003|Treatment Period|Randomized Not Treated|0|||
145674937|NCT01968967|525326499|FG004|Treatment Period|Randomized Not Treated|0|||
145674938|NCT01968967|525326495|FG000|Extension Period|Withdrew Consent|0|||
145674939|NCT01968967|525326496|FG001|Extension Period|Withdrew Consent|0|||
145674940|NCT01968967|525326497|FG002|Extension Period|Withdrew Consent|2|||
145674941|NCT01968967|525326498|FG003|Extension Period|Withdrew Consent|0|||
145674942|NCT01968967|525326499|FG004|Extension Period|Withdrew Consent|5|||
145674943|NCT02203799|525326506|FG000|Overall Study|Withdrawal by Subject|3|||
145674944|NCT02022670|525326507|FG000|Overall Study|Adverse Event|1|||
145674945|NCT02022670|525326508|FG001|Overall Study|Adverse Event|0|||
145674946|NCT02022670|525326509|FG002|Overall Study|Adverse Event|1|||
145674947|NCT02630966|525326519|FG000|Overall Study|Adverse Event|1|||
145674948|NCT02630966|525326520|FG001|Overall Study|Adverse Event|3|||
145674949|NCT02630966|525326519|FG000|Overall Study|Significant Protocol Deviation|0|||
145674950|NCT02630966|525326520|FG001|Overall Study|Significant Protocol Deviation|2|||
145674951|NCT02630966|525326519|FG000|Overall Study|Voluntary Withdrawal|1|||
145674952|NCT02630966|525326520|FG001|Overall Study|Voluntary Withdrawal|1|||
145674953|NCT02630966|525326519|FG000|Overall Study|Lack of Efficacy|0|||
145674954|NCT02630966|525326520|FG001|Overall Study|Lack of Efficacy|2|||
145674955|NCT03822832|525326525|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
145674956|NCT03822832|525326526|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
145674957|NCT03822832|525326525|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
145674958|NCT03822832|525326526|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
145674959|NCT03822832|525326525|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
145674960|NCT03822832|525326526|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
145674961|NCT03822832|525326525|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
145674962|NCT03822832|525326526|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
145674963|NCT03822832|525326525|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
145674964|NCT03822832|525326526|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
145674965|NCT03822832|525326525|FG000|Re-allocation|Not re-allocated to open label period|2|||
145674966|NCT03822832|525326526|FG001|Re-allocation|Not re-allocated to open label period|6|||
145674967|NCT03822832|525326525|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
145674968|NCT03822832|525326526|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
145674969|NCT03822832|525326525|FG000|Period 2 - Open Label Period|Adverse Event|0|||
145674970|NCT03822832|525326526|FG001|Period 2 - Open Label Period|Adverse Event|3|||
145674971|NCT04677738|525326531|FG000|Overall Study|Withdrawal by Subject|4|||
145674972|NCT04677738|525326532|FG001|Overall Study|Withdrawal by Subject|2|||
145674973|NCT03697603|525326539|FG000|Overall Study|Adverse Event|3|||
145674974|NCT03697603|525326540|FG001|Overall Study|Adverse Event|18|||
145674975|NCT03697603|525326541|FG002|Overall Study|Adverse Event|3|||
145265406|NCT04410991|523819350|FG001|Overall Study|Other|4|||
145674976|NCT03697603|525326539|FG000|Overall Study|Physician Decision|1|||
145674977|NCT03697603|525326540|FG001|Overall Study|Physician Decision|0|||
145674978|NCT03697603|525326541|FG002|Overall Study|Physician Decision|2|||
145674979|NCT03697603|525326539|FG000|Overall Study|Protocol Violation|3|||
145674980|NCT03697603|525326540|FG001|Overall Study|Protocol Violation|8|||
145674981|NCT03697603|525326541|FG002|Overall Study|Protocol Violation|5|||
145674982|NCT03697603|525326539|FG000|Overall Study|Withdrawal by Subject|5|||
145674983|NCT03697603|525326540|FG001|Overall Study|Withdrawal by Subject|1|||
145674984|NCT03697603|525326541|FG002|Overall Study|Withdrawal by Subject|1|||
145674985|NCT03697603|525326539|FG000|Overall Study|Protocol Violation|0|||
145674986|NCT03697603|525326540|FG001|Overall Study|Protocol Violation|0|||
145674987|NCT03697603|525326541|FG002|Overall Study|Protocol Violation|1|||
145674988|NCT01683409|525326544|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
145674989|NCT01683409|525326545|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
145674990|NCT01683409|525326546|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
145674991|NCT01683409|525326547|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
145674992|NCT01683409|525326548|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
145674993|NCT01683409|525326544|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
145674994|NCT01683409|525326545|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
145674995|NCT01683409|525326546|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
145674996|NCT01683409|525326547|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
145674997|NCT01683409|525326548|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
145674998|NCT01683409|525326544|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
145674999|NCT01683409|525326545|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
145675000|NCT01683409|525326546|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
145675001|NCT01683409|525326547|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
145675002|NCT01683409|525326548|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
145675003|NCT01683409|525326544|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
145675004|NCT01683409|525326545|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
145675005|NCT01683409|525326546|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
145675006|NCT01683409|525326547|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
145675007|NCT01683409|525326548|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
145675008|NCT01683409|525326544|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
145675009|NCT01683409|525326545|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
145675010|NCT01683409|525326546|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
145675011|NCT01683409|525326547|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
145675012|NCT01683409|525326548|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
145675013|NCT01683409|525326544|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
145675014|NCT01683409|525326545|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
145675015|NCT01683409|525326546|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
145675016|NCT01683409|525326547|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
145675017|NCT01683409|525326548|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
145675018|NCT01683409|525326544|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
145675019|NCT01683409|525326545|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
145675020|NCT01683409|525326546|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
145675021|NCT01683409|525326547|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
145675022|NCT01683409|525326548|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
145675023|NCT01683409|525326544|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
145675024|NCT01683409|525326545|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
145675025|NCT01683409|525326546|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
145675026|NCT01683409|525326547|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
145675027|NCT01683409|525326548|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
145675028|NCT01683409|525326544|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
145675029|NCT01683409|525326545|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
145675030|NCT01683409|525326546|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
145675031|NCT01683409|525326547|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
145675032|NCT01683409|525326548|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
145675033|NCT01683409|525326544|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
145675034|NCT01683409|525326545|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
145675035|NCT01683409|525326546|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
145675036|NCT01683409|525326547|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
145675037|NCT01683409|525326548|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
145675038|NCT01683409|525326544|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
145675039|NCT01683409|525326545|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
145675040|NCT01683409|525326546|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
145675041|NCT01683409|525326547|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
145675042|NCT01683409|525326548|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
145675043|NCT04218864|525326549|FG000|Overall Study|Lost to Follow-up|8|||
145265407|NCT03282123|523819351|FG000|Overall Study|Withdrawal by Subject|5|||
145675044|NCT04218864|525326550|FG001|Overall Study|Lost to Follow-up|4|||
145675045|NCT04218864|525326549|FG000|Overall Study|Withdrawal by Subject|1|||
145675046|NCT04218864|525326550|FG001|Overall Study|Withdrawal by Subject|3|||
145675047|NCT03520036|525326551|FG000|Overall Study|Adverse Event|1|||
145675048|NCT03520036|525326552|FG001|Overall Study|Adverse Event|2|||
145675049|NCT03520036|525326553|FG002|Overall Study|Adverse Event|0|||
145675050|NCT03520036|525326551|FG000|Overall Study|Protocol Violation|1|||
145675051|NCT03520036|525326552|FG001|Overall Study|Protocol Violation|0|||
145675052|NCT03520036|525326553|FG002|Overall Study|Protocol Violation|0|||
145675053|NCT03520036|525326551|FG000|Overall Study|Withdrawal by Subject|0|||
145675054|NCT03520036|525326552|FG001|Overall Study|Withdrawal by Subject|1|||
145675055|NCT03520036|525326553|FG002|Overall Study|Withdrawal by Subject|4|||
145675056|NCT03520036|525326551|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
145675057|NCT03520036|525326552|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
145675058|NCT03520036|525326553|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
145675059|NCT00467272|525326554|FG000|Overall Study|Pneumonia|2|||
145675060|NCT00467272|525326554|FG000|Overall Study|Thrombophlebitis|1|||
145675061|NCT00614614|525326559|FG000|Primary Vaccination Phase|Adverse Event|6|||
145675062|NCT00614614|525326560|FG001|Primary Vaccination Phase|Adverse Event|0|||
145675063|NCT00614614|525326561|FG002|Primary Vaccination Phase|Adverse Event|0|||
145675064|NCT00614614|525326562|FG003|Primary Vaccination Phase|Adverse Event|0|||
145675065|NCT00614614|525326563|FG004|Primary Vaccination Phase|Adverse Event|0|||
145675066|NCT00614614|525326559|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
145675067|NCT00614614|525326560|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
145675068|NCT00614614|525326561|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
145675069|NCT00614614|525326562|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
145675070|NCT00614614|525326563|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
145675071|NCT00614614|525326559|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
145675072|NCT00614614|525326560|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
145675073|NCT00614614|525326561|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
145675074|NCT00614614|525326562|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
145675075|NCT00614614|525326563|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
145675076|NCT00614614|525326559|FG000|Primary Vaccination Phase|Protocol Violation|9|||
145675077|NCT00614614|525326560|FG001|Primary Vaccination Phase|Protocol Violation|3|||
145675078|NCT00614614|525326561|FG002|Primary Vaccination Phase|Protocol Violation|0|||
145675079|NCT00614614|525326562|FG003|Primary Vaccination Phase|Protocol Violation|0|||
145675080|NCT00614614|525326563|FG004|Primary Vaccination Phase|Protocol Violation|0|||
145675081|NCT00614614|525326559|FG000|Primary Vaccination Phase|Other|4|||
145675082|NCT00614614|525326560|FG001|Primary Vaccination Phase|Other|0|||
145675083|NCT00614614|525326561|FG002|Primary Vaccination Phase|Other|0|||
145675084|NCT00614614|525326562|FG003|Primary Vaccination Phase|Other|0|||
145675085|NCT00614614|525326563|FG004|Primary Vaccination Phase|Other|0|||
145675086|NCT00614614|525326559|FG000|Booster Vaccination Phase|Adverse Event|0|||
145675087|NCT00614614|525326560|FG001|Booster Vaccination Phase|Adverse Event|0|||
145675088|NCT00614614|525326561|FG002|Booster Vaccination Phase|Adverse Event|1|||
145675089|NCT00614614|525326562|FG003|Booster Vaccination Phase|Adverse Event|1|||
145675090|NCT00614614|525326563|FG004|Booster Vaccination Phase|Adverse Event|0|||
145675091|NCT00614614|525326559|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
145675092|NCT00614614|525326560|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
145675093|NCT00614614|525326561|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
145675094|NCT00614614|525326562|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
145675095|NCT00614614|525326563|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
145675096|NCT00614614|525326559|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
145675097|NCT00614614|525326560|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
145675098|NCT00614614|525326561|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
145675099|NCT00614614|525326562|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
145675100|NCT00614614|525326563|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
145675101|NCT00614614|525326559|FG000|Booster Vaccination Phase|Protocol Violation|0|||
145675102|NCT00614614|525326560|FG001|Booster Vaccination Phase|Protocol Violation|0|||
145675103|NCT00614614|525326561|FG002|Booster Vaccination Phase|Protocol Violation|2|||
145675104|NCT00614614|525326562|FG003|Booster Vaccination Phase|Protocol Violation|3|||
145675105|NCT00614614|525326563|FG004|Booster Vaccination Phase|Protocol Violation|0|||
145490991|NCT03748823|524652321|FG001|Extension Period|Other than Specified|1|||
145490992|NCT03748823|524652320|FG000|Extension Period|Protocol Violation|1|||
145490993|NCT03748823|524652321|FG001|Extension Period|Protocol Violation|0|||
145490994|NCT03748823|524652320|FG000|Extension Period|Lost to Follow-up|0|||
145675106|NCT00614614|525326559|FG000|Booster Vaccination Phase|Other|0|||
145675107|NCT00614614|525326560|FG001|Booster Vaccination Phase|Other|1|||
145675108|NCT00614614|525326561|FG002|Booster Vaccination Phase|Other|3|||
145675109|NCT00614614|525326562|FG003|Booster Vaccination Phase|Other|2|||
145675110|NCT00614614|525326563|FG004|Booster Vaccination Phase|Other|1|||
145675111|NCT04745676|525326564|FG000|Overall Study|Death|1|||
145675112|NCT04745676|525326565|FG001|Overall Study|Death|0|||
145675113|NCT04745676|525326566|FG002|Overall Study|Death|0|||
145675114|NCT05212285|525326567|FG000|Overall Study|Lack of Efficacy|12|||
145675115|NCT05212285|525326568|FG001|Overall Study|Lack of Efficacy|8|||
145490995|NCT03748823|524652321|FG001|Extension Period|Lost to Follow-up|1|||
145490996|NCT03748823|524652320|FG000|Extension Period|Lack of Efficacy|0|||
145490997|NCT03748823|524652321|FG001|Extension Period|Lack of Efficacy|1|||
145490998|NCT03748823|524652320|FG000|Extension Period|Physician Decision|1|||
145675116|NCT05212285|525326567|FG000|Overall Study|Withdrawal by Subject|8|||
145675117|NCT05212285|525326568|FG001|Overall Study|Withdrawal by Subject|1|||
145675118|NCT05212285|525326567|FG000|Overall Study|Lost to Follow-up|13|||
145675119|NCT05212285|525326568|FG001|Overall Study|Lost to Follow-up|1|||
145675120|NCT05212285|525326567|FG000|Overall Study|miss data|21|||
145675121|NCT05212285|525326568|FG001|Overall Study|miss data|2|||
145675122|NCT03683030|525326569|FG000|Overall Study|Enrolled but screen failures|12|||
145675123|NCT03683030|525326570|FG001|Overall Study|Enrolled but screen failures|7|||
145675124|NCT03683030|525326569|FG000|Overall Study|Enrolled but no catheter inserted|11|||
145675125|NCT03683030|525326570|FG001|Overall Study|Enrolled but no catheter inserted|13|||
145675126|NCT03683030|525326569|FG000|Overall Study|Withdrawal by Subject|0|||
145675127|NCT03683030|525326570|FG001|Overall Study|Withdrawal by Subject|2|||
145675128|NCT03683030|525326569|FG000|Overall Study|Early termination by subject|1|||
145675129|NCT03683030|525326570|FG001|Overall Study|Early termination by subject|0|||
145675130|NCT03683030|525326569|FG000|Overall Study|Lost to Follow-up|0|||
145675131|NCT03683030|525326570|FG001|Overall Study|Lost to Follow-up|6|||
145675132|NCT03683030|525326569|FG000|Overall Study|Death|0|||
145675133|NCT03683030|525326570|FG001|Overall Study|Death|2|||
145675134|NCT03683030|525326569|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
145675135|NCT03683030|525326570|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
145675136|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
145675137|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
145675138|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
145675139|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
145675140|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
145675141|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
145675142|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
145675143|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
145675144|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
145675145|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
145675146|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
145675147|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
145675148|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
145675149|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
145675150|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
145675151|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
145675152|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
145675153|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
145675154|NCT02222493|525326573|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
145675155|NCT02222493|525326574|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
145675156|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
145675157|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
145675158|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
145675159|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
145675160|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
145675161|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
145675162|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
145675163|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
145675164|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
145675165|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
145675166|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
145675167|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
145675168|NCT02222493|525326573|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
145675169|NCT02222493|525326574|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
145675170|NCT02222493|525326573|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
145675171|NCT02222493|525326574|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
145675172|NCT02222493|525326573|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
145675173|NCT02222493|525326574|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
145490999|NCT03748823|524652321|FG001|Extension Period|Physician Decision|2|||
145491000|NCT02903160|524652322|FG000|Overall Study|Adverse Event|2|||
145675174|NCT02222493|525326573|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
145675175|NCT02222493|525326574|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
145491001|NCT02903160|524652322|FG000|Overall Study|Death|1|||
145675176|NCT02222493|525326573|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
145675177|NCT02222493|525326574|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
145675178|NCT02222493|525326573|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
145675179|NCT02222493|525326574|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
145675180|NCT00145470|525326575|FG000|Overall Study|Adverse Event|19|||
145675181|NCT00145470|525326576|FG001|Overall Study|Adverse Event|25|||
145675182|NCT00145470|525326575|FG000|Overall Study|Lack of Efficacy|27|||
145675183|NCT00145470|525326576|FG001|Overall Study|Lack of Efficacy|13|||
145675184|NCT00145470|525326575|FG000|Overall Study|Withdrawal by Subject|36|||
145675185|NCT00145470|525326576|FG001|Overall Study|Withdrawal by Subject|34|||
145491002|NCT02903160|524652322|FG000|Overall Study|Lost to Follow-up|2|||
145491003|NCT02903160|524652322|FG000|Overall Study|Withdrawal by Subject|1|||
145491004|NCT02903160|524652322|FG000|Overall Study|Medical Insurance Barriers|1|||
145491005|NCT01664910|524652325|FG000|Overall Study|Adverse Event|0|||
145491006|NCT01664910|524652326|FG001|Overall Study|Adverse Event|0|||
145491007|NCT01664910|524652327|FG002|Overall Study|Adverse Event|1|||
145491008|NCT04678115|524652332|FG000|Overall Study|Lost to Follow-up|1|||
145491009|NCT04678115|524652333|FG001|Overall Study|Lost to Follow-up|0|||
145491010|NCT02738008|524652334|FG000|Overall Study|Study Terminated by Sponsor|1|||
145491011|NCT02738008|524652335|FG001|Overall Study|Study Terminated by Sponsor|5|||
145491012|NCT02738008|524652336|FG002|Overall Study|Study Terminated by Sponsor|3|||
145491013|NCT02738008|524652334|FG000|Overall Study|Adverse Event|0|||
145491014|NCT02738008|524652335|FG001|Overall Study|Adverse Event|1|||
145491015|NCT02738008|524652336|FG002|Overall Study|Adverse Event|2|||
145491016|NCT03550378|524652339|FG000|Overall Study|Death|0|||
145491017|NCT03550378|524652340|FG001|Overall Study|Death|1|||
145491018|NCT02734693|524652341|FG000|Overall Study|Adverse Event|1|||
145491019|NCT02734693|524652342|FG001|Overall Study|Adverse Event|3|||
145491020|NCT02734693|524652343|FG002|Overall Study|Adverse Event|3|||
145491021|NCT02734693|524652341|FG000|Overall Study|Lack of Efficacy|1|||
145491022|NCT02734693|524652342|FG001|Overall Study|Lack of Efficacy|0|||
145491023|NCT02734693|524652343|FG002|Overall Study|Lack of Efficacy|0|||
145491024|NCT02734693|524652341|FG000|Overall Study|Lost to Follow-up|2|||
145491025|NCT02734693|524652342|FG001|Overall Study|Lost to Follow-up|0|||
145491026|NCT02734693|524652343|FG002|Overall Study|Lost to Follow-up|0|||
145491027|NCT02734693|524652341|FG000|Overall Study|Protocol Violation|1|||
145491028|NCT02734693|524652342|FG001|Overall Study|Protocol Violation|0|||
145491029|NCT02734693|524652343|FG002|Overall Study|Protocol Violation|0|||
145491030|NCT02734693|524652341|FG000|Overall Study|Withdrawal by Subject|1|||
145491031|NCT02734693|524652342|FG001|Overall Study|Withdrawal by Subject|0|||
145491032|NCT02734693|524652343|FG002|Overall Study|Withdrawal by Subject|0|||
145491033|NCT01384734|524652348|FG000|Overall Study|Adverse Event|0|||
145675186|NCT00145470|525326575|FG000|Overall Study|Lost to Follow-up|21|||
145675187|NCT00145470|525326576|FG001|Overall Study|Lost to Follow-up|17|||
145675188|NCT00145470|525326575|FG000|Overall Study|Reason Not Reported|9|||
145675189|NCT00145470|525326576|FG001|Overall Study|Reason Not Reported|9|||
145675190|NCT00676091|525326579|FG000|Infant Series|Parent or legal guardian request|10|||
145675191|NCT00676091|525326580|FG001|Infant Series|Parent or legal guardian request|8|||
145675192|NCT00676091|525326579|FG000|Infant Series|Protocol Violation|6|||
145675193|NCT00676091|525326580|FG001|Infant Series|Protocol Violation|3|||
145675194|NCT00676091|525326579|FG000|Infant Series|Adverse Event|2|||
145675195|NCT00676091|525326580|FG001|Infant Series|Adverse Event|3|||
145675196|NCT00676091|525326579|FG000|Infant Series|Failed to return|1|||
145675197|NCT00676091|525326580|FG001|Infant Series|Failed to return|3|||
145675198|NCT00676091|525326579|FG000|Infant Series|Lost to Follow-up|1|||
145675199|NCT00676091|525326580|FG001|Infant Series|Lost to Follow-up|0|||
145675200|NCT00676091|525326579|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
145675201|NCT00676091|525326580|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
145675202|NCT00676091|525326579|FG000|After Infant Series|Adverse Event|0|||
145675203|NCT00676091|525326580|FG001|After Infant Series|Adverse Event|1|||
145675204|NCT00676091|525326579|FG000|After Infant Series|Protocol Violation|0|||
145675205|NCT00676091|525326580|FG001|After Infant Series|Protocol Violation|1|||
145675206|NCT00676091|525326579|FG000|After Infant Series|Failed to return|1|||
145675207|NCT00676091|525326580|FG001|After Infant Series|Failed to return|1|||
145491034|NCT01384734|524652349|FG001|Overall Study|Adverse Event|3|||
145491035|NCT01384734|524652350|FG002|Overall Study|Adverse Event|0|||
145491036|NCT01384734|524652351|FG003|Overall Study|Adverse Event|2|||
145675208|NCT00676091|525326579|FG000|Toddler Dose|Failed to return|2|||
145675209|NCT00676091|525326580|FG001|Toddler Dose|Failed to return|0|||
145675210|NCT00676091|525326579|FG000|Toddler Dose|Parent or legal guardian request|1|||
145675211|NCT00676091|525326580|FG001|Toddler Dose|Parent or legal guardian request|0|||
145675212|NCT00933270|525326584|FG000|Overall Study|Withdrawal by Subject|26|||
145675213|NCT00933270|525326584|FG000|Overall Study|Insufficient Follow-up|10|||
145491037|NCT01384734|524652352|FG004|Overall Study|Adverse Event|7|||
145491038|NCT01384734|524652348|FG000|Overall Study|Death|1|||
145491039|NCT01384734|524652349|FG001|Overall Study|Death|0|||
145491040|NCT01384734|524652350|FG002|Overall Study|Death|1|||
145491041|NCT01384734|524652351|FG003|Overall Study|Death|0|||
145675214|NCT00933270|525326584|FG000|Overall Study|Lost to Follow-up|14|||
145675215|NCT00933270|525326584|FG000|Overall Study|Adverse Event|1|||
145675216|NCT00933270|525326584|FG000|Overall Study|Missed Visit|2|||
145675217|NCT00933270|525326584|FG000|Overall Study|Death|24|||
145675218|NCT00933270|525326584|FG000|Overall Study|Moved or would not return|10|||
145675219|NCT01000805|525326585|FG000|Overall Study|Adverse Event|21|||
145675220|NCT01000805|525326586|FG001|Overall Study|Adverse Event|9|||
145675221|NCT01000805|525326585|FG000|Overall Study|Lack of Efficacy|5|||
145675222|NCT01000805|525326586|FG001|Overall Study|Lack of Efficacy|16|||
145675223|NCT01000805|525326585|FG000|Overall Study|Lost to Follow-up|16|||
145675224|NCT01000805|525326586|FG001|Overall Study|Lost to Follow-up|21|||
145675225|NCT01000805|525326585|FG000|Overall Study|Physician Decision|0|||
145675226|NCT01000805|525326586|FG001|Overall Study|Physician Decision|1|||
145675227|NCT01000805|525326585|FG000|Overall Study|Protocol Violation|12|||
145675228|NCT01000805|525326586|FG001|Overall Study|Protocol Violation|8|||
145675229|NCT01000805|525326585|FG000|Overall Study|Withdrawal by Subject|16|||
145675230|NCT01000805|525326586|FG001|Overall Study|Withdrawal by Subject|6|||
145675231|NCT01000805|525326585|FG000|Overall Study|Sponsor Decision|0|||
145675232|NCT01000805|525326586|FG001|Overall Study|Sponsor Decision|1|||
145675233|NCT03343704|525326587|FG000|Overall Study|Refused to complete follow up|0|||
145675234|NCT03343704|525326588|FG001|Overall Study|Refused to complete follow up|1|||
145675235|NCT03343704|525326587|FG000|Overall Study|Death|0|||
145675236|NCT03343704|525326588|FG001|Overall Study|Death|1|||
145675237|NCT03343704|525326587|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
145675238|NCT03343704|525326588|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
145675239|NCT05349721|525328453|FG000|Part A (24 Weeks)|Adverse Event|9|||
145675240|NCT05349721|525328454|FG001|Part A (24 Weeks)|Adverse Event|2|||
145675241|NCT05349721|525328453|FG000|Part A (24 Weeks)|Death|8|||
145675242|NCT05349721|525328454|FG001|Part A (24 Weeks)|Death|3|||
145675243|NCT05349721|525328453|FG000|Part A (24 Weeks)|Disease Progression|1|||
145675244|NCT05349721|525328454|FG001|Part A (24 Weeks)|Disease Progression|1|||
145675245|NCT05349721|525328453|FG000|Part A (24 Weeks)|Screen Failure|2|||
145675246|NCT05349721|525328454|FG001|Part A (24 Weeks)|Screen Failure|0|||
145675247|NCT05349721|525328453|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
145675248|NCT05349721|525328454|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
145675249|NCT05349721|525328453|FG000|Part A (24 Weeks)|Other Than Specified|5|||
145675250|NCT05349721|525328454|FG001|Part A (24 Weeks)|Other Than Specified|1|||
145675251|NCT05349721|525328453|FG000|Part B (28 Weeks)|Adverse Event|3|||
145675252|NCT05349721|525328454|FG001|Part B (28 Weeks)|Adverse Event|0|||
145675253|NCT05349721|525328453|FG000|Part B (28 Weeks)|Death|21|||
145675254|NCT05349721|525328454|FG001|Part B (28 Weeks)|Death|11|||
145675255|NCT05349721|525328453|FG000|Part B (28 Weeks)|Disease Progression|2|||
145675256|NCT05349721|525328454|FG001|Part B (28 Weeks)|Disease Progression|1|||
145675257|NCT05349721|525328453|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
145675258|NCT05349721|525328454|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
145675259|NCT05349721|525328453|FG000|Part B (28 Weeks)|Physician Decision|1|||
145675260|NCT05349721|525328454|FG001|Part B (28 Weeks)|Physician Decision|0|||
145675261|NCT05349721|525328453|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
145675262|NCT05349721|525328454|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
145675263|NCT05349721|525328453|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
145675264|NCT05349721|525328454|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
145675265|NCT05349721|525328453|FG000|Part B (28 Weeks)|Other Than Specified|4|||
145675266|NCT05349721|525328454|FG001|Part B (28 Weeks)|Other Than Specified|2|||
145675267|NCT05349721|525328453|FG000|Part C (108 Weeks)|Death|0|||
145675268|NCT05349721|525328454|FG001|Part C (108 Weeks)|Death|1|||
145675269|NCT05349721|525328453|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
145675270|NCT05349721|525328454|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
145675271|NCT05349721|525328453|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
145491042|NCT01384734|524652352|FG004|Overall Study|Death|0|||
145491043|NCT01384734|524652348|FG000|Overall Study|Continuation criteria not met|0|||
145491044|NCT01384734|524652349|FG001|Overall Study|Continuation criteria not met|0|||
145675272|NCT05349721|525328454|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
145675273|NCT05349721|525328453|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
145675274|NCT05349721|525328454|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
145675275|NCT03136159|525328456|FG000|Overall Study|chorioamnionitis|2|||
145675276|NCT03136159|525328457|FG001|Overall Study|chorioamnionitis|0|||
145675277|NCT03136159|525328456|FG000|Overall Study|vertical skin incision|1|||
145675278|NCT03136159|525328457|FG001|Overall Study|vertical skin incision|0|||
145675279|NCT03136159|525328456|FG000|Overall Study|additional dressing|1|||
145675280|NCT03136159|525328457|FG001|Overall Study|additional dressing|0|||
145675281|NCT03136159|525328456|FG000|Overall Study|never got dressing placed|1|||
145675282|NCT03136159|525328457|FG001|Overall Study|never got dressing placed|0|||
145675283|NCT03823703|525328458|FG000|Overall Study|Sponsor request|0|||
145675284|NCT03823703|525328459|FG001|Overall Study|Sponsor request|3|||
145675285|NCT03823703|525328460|FG002|Overall Study|Sponsor request|4|||
145675286|NCT03823703|525328458|FG000|Overall Study|Adverse Event|3|||
145675287|NCT03823703|525328459|FG001|Overall Study|Adverse Event|1|||
145675288|NCT03823703|525328460|FG002|Overall Study|Adverse Event|0|||
145675289|NCT03823703|525328458|FG000|Overall Study|Withdrawal by Subject|0|||
145675290|NCT03823703|525328459|FG001|Overall Study|Withdrawal by Subject|1|||
145675291|NCT03823703|525328460|FG002|Overall Study|Withdrawal by Subject|0|||
145675292|NCT00985088|525328461|FG000|Overall Study|Serious Adverse Event|1|||
145675293|NCT00985088|525328462|FG001|Overall Study|Serious Adverse Event|1|||
145675294|NCT00985088|525328463|FG002|Overall Study|Serious Adverse Event|0|||
145675295|NCT00985088|525328464|FG003|Overall Study|Serious Adverse Event|0|||
145675296|NCT00985088|525328465|FG004|Overall Study|Serious Adverse Event|0|||
145675297|NCT00985088|525328466|FG005|Overall Study|Serious Adverse Event|0|||
145675298|NCT00985088|525328467|FG006|Overall Study|Serious Adverse Event|0|||
145675299|NCT00985088|525328468|FG007|Overall Study|Serious Adverse Event|1|||
145675300|NCT00985088|525328461|FG000|Overall Study|Adverse Event|0|||
145675301|NCT00985088|525328462|FG001|Overall Study|Adverse Event|0|||
145675302|NCT00985088|525328463|FG002|Overall Study|Adverse Event|1|||
145675303|NCT00985088|525328464|FG003|Overall Study|Adverse Event|0|||
145675304|NCT00985088|525328465|FG004|Overall Study|Adverse Event|0|||
145675305|NCT00985088|525328466|FG005|Overall Study|Adverse Event|0|||
145675306|NCT00985088|525328467|FG006|Overall Study|Adverse Event|0|||
145675307|NCT00985088|525328468|FG007|Overall Study|Adverse Event|0|||
145675308|NCT00985088|525328461|FG000|Overall Study|Withdrawal by Subject|4|||
145675309|NCT00985088|525328462|FG001|Overall Study|Withdrawal by Subject|0|||
145675310|NCT00985088|525328463|FG002|Overall Study|Withdrawal by Subject|0|||
145675311|NCT00985088|525328464|FG003|Overall Study|Withdrawal by Subject|1|||
145675312|NCT00985088|525328465|FG004|Overall Study|Withdrawal by Subject|3|||
145675313|NCT00985088|525328466|FG005|Overall Study|Withdrawal by Subject|2|||
145675314|NCT00985088|525328467|FG006|Overall Study|Withdrawal by Subject|1|||
145675315|NCT00985088|525328468|FG007|Overall Study|Withdrawal by Subject|2|||
145675316|NCT00985088|525328461|FG000|Overall Study|Migrated/moved from study area|0|||
145675317|NCT00985088|525328462|FG001|Overall Study|Migrated/moved from study area|0|||
145675318|NCT00985088|525328463|FG002|Overall Study|Migrated/moved from study area|1|||
145675319|NCT00985088|525328464|FG003|Overall Study|Migrated/moved from study area|0|||
145675320|NCT00985088|525328465|FG004|Overall Study|Migrated/moved from study area|0|||
145675321|NCT00985088|525328466|FG005|Overall Study|Migrated/moved from study area|0|||
145675322|NCT00985088|525328467|FG006|Overall Study|Migrated/moved from study area|0|||
145675323|NCT00985088|525328468|FG007|Overall Study|Migrated/moved from study area|1|||
145675324|NCT00985088|525328461|FG000|Overall Study|Lost to Follow-up|6|||
145675325|NCT00985088|525328462|FG001|Overall Study|Lost to Follow-up|1|||
145675326|NCT00985088|525328463|FG002|Overall Study|Lost to Follow-up|2|||
145675327|NCT00985088|525328464|FG003|Overall Study|Lost to Follow-up|6|||
145675328|NCT00985088|525328465|FG004|Overall Study|Lost to Follow-up|6|||
145675329|NCT00985088|525328466|FG005|Overall Study|Lost to Follow-up|5|||
145675330|NCT00985088|525328467|FG006|Overall Study|Lost to Follow-up|3|||
145675331|NCT00985088|525328468|FG007|Overall Study|Lost to Follow-up|2|||
145675332|NCT01970878|525328469|FG000|Overall Study|Withdrawal by Subject|11|||
145675333|NCT01970878|525328470|FG001|Overall Study|Withdrawal by Subject|10|||
145675334|NCT01970878|525328471|FG002|Overall Study|Withdrawal by Subject|14|||
145675335|NCT01970878|525328472|FG003|Overall Study|Withdrawal by Subject|7|||
145675336|NCT01970878|525328469|FG000|Overall Study|Lost to Follow-up|1|||
145675337|NCT01970878|525328470|FG001|Overall Study|Lost to Follow-up|3|||
145675338|NCT01970878|525328471|FG002|Overall Study|Lost to Follow-up|2|||
145675339|NCT01970878|525328472|FG003|Overall Study|Lost to Follow-up|4|||
145675340|NCT01970878|525328469|FG000|Overall Study|Administrative Reasons|1|||
145675341|NCT01970878|525328470|FG001|Overall Study|Administrative Reasons|0|||
145675342|NCT01970878|525328471|FG002|Overall Study|Administrative Reasons|0|||
145675343|NCT01970878|525328472|FG003|Overall Study|Administrative Reasons|4|||
145675344|NCT01970878|525328469|FG000|Overall Study|Lack of Efficacy|2|||
145675345|NCT01970878|525328470|FG001|Overall Study|Lack of Efficacy|1|||
145675346|NCT01970878|525328471|FG002|Overall Study|Lack of Efficacy|2|||
145675347|NCT01970878|525328472|FG003|Overall Study|Lack of Efficacy|0|||
145675348|NCT01970878|525328469|FG000|Overall Study|Adverse Event|12|||
145675349|NCT01970878|525328470|FG001|Overall Study|Adverse Event|7|||
145491045|NCT01384734|524652350|FG002|Overall Study|Continuation criteria not met|1|||
145491046|NCT01384734|524652351|FG003|Overall Study|Continuation criteria not met|1|||
145491047|NCT01384734|524652352|FG004|Overall Study|Continuation criteria not met|0|||
145675350|NCT01970878|525328471|FG002|Overall Study|Adverse Event|4|||
145675351|NCT01970878|525328472|FG003|Overall Study|Adverse Event|3|||
145675352|NCT01970878|525328469|FG000|Overall Study|Protocol Specified Criteria|10|||
145675353|NCT01970878|525328470|FG001|Overall Study|Protocol Specified Criteria|4|||
145675354|NCT01970878|525328471|FG002|Overall Study|Protocol Specified Criteria|3|||
145675355|NCT01970878|525328472|FG003|Overall Study|Protocol Specified Criteria|6|||
145675356|NCT01970878|525328469|FG000|Overall Study|Physician Decision|0|||
145675357|NCT01970878|525328470|FG001|Overall Study|Physician Decision|1|||
145675358|NCT01970878|525328471|FG002|Overall Study|Physician Decision|1|||
145675359|NCT01970878|525328472|FG003|Overall Study|Physician Decision|0|||
145675360|NCT01970878|525328469|FG000|Overall Study|No Completion Status|0|||
145675361|NCT01970878|525328470|FG001|Overall Study|No Completion Status|1|||
145675362|NCT01970878|525328471|FG002|Overall Study|No Completion Status|0|||
145675363|NCT01970878|525328472|FG003|Overall Study|No Completion Status|0|||
145675364|NCT06571695|525328474|FG000|Overall Study|Lost to Follow-up|1|||
145675365|NCT06571695|525328475|FG001|Overall Study|Lost to Follow-up|6|||
145675366|NCT04921358|525328476|FG000|Overall Study|Withdrawal by Subject|6|||
145675367|NCT04921358|525328477|FG001|Overall Study|Withdrawal by Subject|13|||
145675368|NCT04921358|525328476|FG000|Overall Study|Lost to Follow-up|3|||
145675369|NCT04921358|525328477|FG001|Overall Study|Lost to Follow-up|6|||
145675370|NCT04921358|525328476|FG000|Overall Study|Study Terminated by Sponsor|86|||
145675371|NCT04921358|525328477|FG001|Overall Study|Study Terminated by Sponsor|89|||
145675372|NCT04921358|525328476|FG000|Overall Study|Death|92|||
145675373|NCT04921358|525328477|FG001|Overall Study|Death|82|||
145675374|NCT04926857|525328478|FG000|Overall Study|Withdrawal by Subject|40|||
145675375|NCT04926857|525328478|FG000|Overall Study|Death|9|||
145675376|NCT04926857|525328478|FG000|Overall Study|Study product no longer in use|44|||
145675377|NCT04926857|525328478|FG000|Overall Study|Inadequate data to address primary objective|16|||
145675378|NCT02637063|525328479|FG000|Overall Study|Lost to Follow-up|3|||
145675379|NCT02637063|525328480|FG001|Overall Study|Lost to Follow-up|2|||
145675380|NCT02637063|525328481|FG002|Overall Study|Lost to Follow-up|3|||
145675381|NCT02637063|525328479|FG000|Overall Study|Withdrawal by Subject|2|||
145675382|NCT02637063|525328480|FG001|Overall Study|Withdrawal by Subject|2|||
145675383|NCT02637063|525328481|FG002|Overall Study|Withdrawal by Subject|3|||
145675384|NCT02132949|525328486|FG000|Overall Study|Death|7|||
145675385|NCT02132949|525328487|FG001|Overall Study|Death|13|||
145675386|NCT02132949|525328486|FG000|Overall Study|Lost to Follow-up|14|||
145675387|NCT02132949|525328487|FG001|Overall Study|Lost to Follow-up|4|||
145675388|NCT02132949|525328486|FG000|Overall Study|Withdrawal by Subject|6|||
145675389|NCT02132949|525328487|FG001|Overall Study|Withdrawal by Subject|5|||
145675390|NCT02132949|525328486|FG000|Overall Study|Noncompliance|5|||
145675391|NCT02132949|525328487|FG001|Overall Study|Noncompliance|1|||
145675392|NCT02132949|525328486|FG000|Overall Study|Physician Decision|3|||
145675393|NCT02132949|525328487|FG001|Overall Study|Physician Decision|1|||
145675394|NCT02132949|525328486|FG000|Overall Study|Disease Progression|3|||
145675395|NCT02132949|525328487|FG001|Overall Study|Disease Progression|0|||
145675396|NCT02132949|525328486|FG000|Overall Study|Adverse Event|2|||
145675397|NCT02132949|525328487|FG001|Overall Study|Adverse Event|1|||
145675398|NCT02132949|525328486|FG000|Overall Study|Withdrew Prior to Treatment|1|||
145675399|NCT02132949|525328487|FG001|Overall Study|Withdrew Prior to Treatment|2|||
145675400|NCT02132949|525328486|FG000|Overall Study|Reason Unspecified|0|||
145675401|NCT02132949|525328487|FG001|Overall Study|Reason Unspecified|1|||
145675402|NCT00745875|525328491|FG000|Overall Study|Continuing study treatment|4|||
145675403|NCT00745875|525328492|FG001|Overall Study|Continuing study treatment|4|||
145675404|NCT02310581|525328493|FG000|Overall Study|Adverse Event|1|||
145675405|NCT02310581|525328494|FG001|Overall Study|Adverse Event|1|||
145675406|NCT02310581|525328495|FG002|Overall Study|Adverse Event|1|||
145675407|NCT02310581|525328496|FG003|Overall Study|Adverse Event|0|||
145675408|NCT02310581|525328493|FG000|Overall Study|Withdrawal by Subject|2|||
145675409|NCT02310581|525328494|FG001|Overall Study|Withdrawal by Subject|1|||
145675410|NCT02310581|525328495|FG002|Overall Study|Withdrawal by Subject|0|||
145675411|NCT02310581|525328496|FG003|Overall Study|Withdrawal by Subject|1|||
145675412|NCT02824198|525328497|FG000|Overall Study|Non-compliance with the protocol|5|||
145675413|NCT02824198|525328498|FG001|Overall Study|Non-compliance with the protocol|1|||
145675414|NCT02824198|525328497|FG000|Overall Study|Lost to Follow-up|5|||
145675415|NCT02824198|525328498|FG001|Overall Study|Lost to Follow-up|2|||
145675416|NCT02824198|525328497|FG000|Overall Study|Withdrawal by Subject|5|||
145675417|NCT02824198|525328498|FG001|Overall Study|Withdrawal by Subject|0|||
145675418|NCT03883828|525328499|FG000|Overall Study|Did not start radiotherapy|1|||
145675419|NCT03883828|525328500|FG001|Overall Study|Did not start radiotherapy|2|||
145675420|NCT01256359|525328501|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
145675421|NCT01256359|525328502|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
145675422|NCT01256359|525328501|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
145675423|NCT01256359|525328502|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
145675424|NCT00487240|525328503|FG000|Overall Study|Withdrawal by Subject|12|||
145675425|NCT00487240|525328504|FG001|Overall Study|Withdrawal by Subject|6|||
145675426|NCT00487240|525328503|FG000|Overall Study|Lost to Follow-up|7|||
145675427|NCT00487240|525328504|FG001|Overall Study|Lost to Follow-up|6|||
145675428|NCT00487240|525328503|FG000|Overall Study|Adverse Event|0|||
145675429|NCT00487240|525328504|FG001|Overall Study|Adverse Event|4|||
145675430|NCT00487240|525328503|FG000|Overall Study|Protocol Violation|5|||
145675431|NCT00487240|525328504|FG001|Overall Study|Protocol Violation|5|||
145675432|NCT00487240|525328503|FG000|Overall Study|Entry Criteria Not Met|3|||
145675433|NCT00487240|525328504|FG001|Overall Study|Entry Criteria Not Met|4|||
145675434|NCT00487240|525328503|FG000|Overall Study|Sponsor Decision|2|||
145675435|NCT00487240|525328504|FG001|Overall Study|Sponsor Decision|1|||
145675436|NCT00487240|525328503|FG000|Overall Study|Physician Decision|2|||
145675437|NCT00487240|525328504|FG001|Overall Study|Physician Decision|0|||
145675438|NCT01019135|525328505|FG000|Overall Study|Did not receive allocated intervention|12|||
145675439|NCT01019135|525328506|FG001|Overall Study|Did not receive allocated intervention|6|||
145675440|NCT01019135|525328507|FG002|Overall Study|Did not receive allocated intervention|25|||
145675441|NCT01019135|525328505|FG000|Overall Study|Did not attend CR|8|||
145675442|NCT01019135|525328506|FG001|Overall Study|Did not attend CR|13|||
145675443|NCT01019135|525328507|FG002|Overall Study|Did not attend CR|6|||
145675444|NCT04237792|525328509|FG000|Treatment (Day 1)|Adverse Event|1|||
145675445|NCT04237792|525328510|FG001|Treatment (Day 1)|Adverse Event|0|||
145675446|NCT04237792|525328511|FG002|Treatment (Day 1)|Adverse Event|0|||
145675447|NCT04237792|525328512|FG003|Treatment (Day 1)|Adverse Event|0|||
145675448|NCT04237792|525328513|FG004|Treatment (Day 1)|Adverse Event|1|||
145675449|NCT04237792|525328514|FG005|Treatment (Day 1)|Adverse Event|1|||
145675450|NCT04237792|525328509|FG000|Treatment (Day 1)|Other|0|||
145675451|NCT04237792|525328510|FG001|Treatment (Day 1)|Other|0|||
145675452|NCT04237792|525328511|FG002|Treatment (Day 1)|Other|1|||
145675453|NCT04237792|525328512|FG003|Treatment (Day 1)|Other|0|||
145675454|NCT04237792|525328513|FG004|Treatment (Day 1)|Other|0|||
145675455|NCT04237792|525328514|FG005|Treatment (Day 1)|Other|1|||
145675456|NCT04237792|525328509|FG000|Treatment (Day 1)|Not treated|1|||
145675457|NCT04237792|525328510|FG001|Treatment (Day 1)|Not treated|1|||
145675458|NCT04237792|525328511|FG002|Treatment (Day 1)|Not treated|2|||
145675459|NCT04237792|525328512|FG003|Treatment (Day 1)|Not treated|1|||
145675460|NCT04237792|525328513|FG004|Treatment (Day 1)|Not treated|0|||
145675461|NCT04237792|525328514|FG005|Treatment (Day 1)|Not treated|1|||
145675462|NCT04885998|525328515|FG000|Overall Study|Withdrawal by Subject|0|||
145675463|NCT04885998|525328516|FG001|Overall Study|Withdrawal by Subject|2|||
145675464|NCT04885998|525328517|FG002|Overall Study|Withdrawal by Subject|0|||
145675465|NCT04885998|525328518|FG003|Overall Study|Withdrawal by Subject|3|||
145675466|NCT04885998|525328515|FG000|Overall Study|Lost to Follow-up|1|||
145675467|NCT04885998|525328516|FG001|Overall Study|Lost to Follow-up|1|||
145675468|NCT04885998|525328517|FG002|Overall Study|Lost to Follow-up|0|||
145675469|NCT04885998|525328518|FG003|Overall Study|Lost to Follow-up|0|||
145675470|NCT04885998|525328515|FG000|Overall Study|Death|2|||
145675471|NCT04885998|525328516|FG001|Overall Study|Death|1|||
145675472|NCT04885998|525328517|FG002|Overall Study|Death|2|||
145675473|NCT04885998|525328518|FG003|Overall Study|Death|2|||
145675474|NCT04885998|525328515|FG000|Overall Study|Decision by sponsor|1|||
145675475|NCT04885998|525328516|FG001|Overall Study|Decision by sponsor|1|||
145675476|NCT04885998|525328517|FG002|Overall Study|Decision by sponsor|0|||
145675477|NCT04885998|525328518|FG003|Overall Study|Decision by sponsor|0|||
145675478|NCT00910962|525328519|FG000|Overall Study|Adverse Event|5|||
145675479|NCT00910962|525328520|FG001|Overall Study|Adverse Event|20|||
145675480|NCT00910962|525328521|FG002|Overall Study|Adverse Event|17|||
145675481|NCT00910962|525328519|FG000|Overall Study|Protocol Violation|1|||
145675482|NCT00910962|525328520|FG001|Overall Study|Protocol Violation|3|||
145675483|NCT00910962|525328521|FG002|Overall Study|Protocol Violation|3|||
145675484|NCT00910962|525328519|FG000|Overall Study|Lost to Follow-up|0|||
145675485|NCT00910962|525328520|FG001|Overall Study|Lost to Follow-up|3|||
145675486|NCT00910962|525328521|FG002|Overall Study|Lost to Follow-up|1|||
145675487|NCT00910962|525328519|FG000|Overall Study|Physician Decision|0|||
145675488|NCT00910962|525328520|FG001|Overall Study|Physician Decision|6|||
145675489|NCT00910962|525328521|FG002|Overall Study|Physician Decision|6|||
145675490|NCT00910962|525328519|FG000|Overall Study|Withdrawal by Subject|25|||
145675491|NCT00910962|525328520|FG001|Overall Study|Withdrawal by Subject|32|||
145675492|NCT00910962|525328521|FG002|Overall Study|Withdrawal by Subject|32|||
145675493|NCT00910962|525328519|FG000|Overall Study|Reached defined stopping criteria|12|||
145675494|NCT00910962|525328520|FG001|Overall Study|Reached defined stopping criteria|14|||
145675495|NCT00910962|525328521|FG002|Overall Study|Reached defined stopping criteria|17|||
145675496|NCT01485887|525328523|FG000|Overall Study|Withdrawal by Subject|2|||
145675497|NCT01485887|525328523|FG000|Overall Study|Adverse Event|8|||
145675498|NCT01485887|525328523|FG000|Overall Study|Deterioration of primary disease|1|||
145675499|NCT01485887|525328523|FG000|Overall Study|Primary disease markedly improved|1|||
145675500|NCT00836498|525328528|FG000|Overall Study|Adverse Event|1|||
145675501|NCT00836498|525328529|FG001|Overall Study|Adverse Event|0|||
145675502|NCT00836498|525328528|FG000|Overall Study|Lost to Follow-up|1|||
145675503|NCT00836498|525328529|FG001|Overall Study|Lost to Follow-up|0|||
145675504|NCT00836498|525328528|FG000|Overall Study|Withdrawal by Subject|2|||
145675505|NCT00836498|525328529|FG001|Overall Study|Withdrawal by Subject|1|||
145675506|NCT02384382|525328530|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
145675507|NCT02384382|525328530|FG000|Overall Study|Death|1|||
145675508|NCT02384382|525328530|FG000|Overall Study|Adverse Event|1|||
145675509|NCT02384382|525328530|FG000|Overall Study|Disease progression|16|||
145675510|NCT02113449|525328531|FG000|Overall Study|Adverse Event|4|||
145675511|NCT01328496|525328532|FG000|Overall Study|Significant Change in Health Status|1|||
145675512|NCT01328496|525328533|FG001|Overall Study|Significant Change in Health Status|0|||
145675513|NCT02091752|525328536|FG000|Overall Study|Study terminated by Sponsor|2|||
145675514|NCT02091752|525328536|FG000|Overall Study|Adverse Event|1|||
145675515|NCT04029090|525328537|FG000|Overall Study|Protocol Violation|1|||
145675516|NCT04029090|525328538|FG001|Overall Study|Protocol Violation|0|||
145675517|NCT04029090|525328539|FG002|Overall Study|Protocol Violation|0|||
145675518|NCT04029090|525328537|FG000|Overall Study|Withdrawal by Subject|0|||
145675519|NCT04029090|525328538|FG001|Overall Study|Withdrawal by Subject|1|||
145675520|NCT04029090|525328539|FG002|Overall Study|Withdrawal by Subject|0|||
145675521|NCT01065779|525328540|FG000|Overall Study|Duplicate Investigation|1|||
145675522|NCT01065779|525328540|FG000|Overall Study|Investigation Before Contract Date|37|||
145675523|NCT01065779|525328540|FG000|Overall Study|Non-enrollment Period Administration|10|||
145675524|NCT01065779|525328540|FG000|Overall Study|Not Administered With Study Drug|17|||
145675525|NCT01065779|525328540|FG000|Overall Study|Failed to Follow-up|10|||
145675526|NCT01065779|525328540|FG000|Overall Study|Inclusion Criteria Violation|7|||
145675527|NCT02157948|525328541|FG000|Overall Study|Withdrawal by Subject|4|||
145675528|NCT02157948|525328542|FG001|Overall Study|Withdrawal by Subject|5|||
145675529|NCT02157948|525328541|FG000|Overall Study|Lost to Follow-up|3|||
145675530|NCT02157948|525328542|FG001|Overall Study|Lost to Follow-up|2|||
145675531|NCT02157948|525328541|FG000|Overall Study|Protocol Specified Criteria|2|||
145675532|NCT02157948|525328542|FG001|Overall Study|Protocol Specified Criteria|1|||
145675533|NCT02157948|525328541|FG000|Overall Study|Decision by Sponsor|0|||
145675534|NCT02157948|525328542|FG001|Overall Study|Decision by Sponsor|1|||
145675535|NCT01604824|525328543|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
145675536|NCT01604824|525328544|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
145675537|NCT01604824|525328545|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
145675538|NCT01604824|525328546|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
145675539|NCT01604824|525328547|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
145675540|NCT01604824|525328548|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
145675541|NCT01604824|525328543|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
145675542|NCT01604824|525328544|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
145675543|NCT01604824|525328545|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
145675544|NCT01604824|525328546|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
145675545|NCT01604824|525328547|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
145675546|NCT01604824|525328548|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
145675547|NCT04248803|525328550|FG000|Overall Study|Lost to Follow-up|7|||
145675548|NCT04248803|525328551|FG001|Overall Study|Lost to Follow-up|7|||
145675549|NCT04248803|525328552|FG002|Overall Study|Lost to Follow-up|7|||
145675550|NCT04248803|525328553|FG003|Overall Study|Lost to Follow-up|7|||
145675551|NCT04248803|525328554|FG004|Overall Study|Lost to Follow-up|7|||
145675552|NCT04248803|525328555|FG005|Overall Study|Lost to Follow-up|7|||
145675553|NCT05352230|525328556|FG000|First Intervention (3 Months)|study terminated|2|||
145675554|NCT05352230|525328557|FG001|First Intervention (3 Months)|study terminated|2|||
145675555|NCT04399837|525328558|FG000|Overall Study|Other than listed|0|||
145675556|NCT04399837|525328559|FG001|Overall Study|Other than listed|2|||
145675557|NCT04399837|525328560|FG002|Overall Study|Other than listed|2|||
145675558|NCT04399837|525328561|FG003|Overall Study|Other than listed|3|||
145675559|NCT04399837|525328558|FG000|Overall Study|Withdrawal by Subject|1|||
145675560|NCT04399837|525328559|FG001|Overall Study|Withdrawal by Subject|2|||
145675561|NCT04399837|525328560|FG002|Overall Study|Withdrawal by Subject|1|||
145675562|NCT04399837|525328561|FG003|Overall Study|Withdrawal by Subject|1|||
145675563|NCT01227421|525328562|FG000|Overall Study|Lost to Follow-up|6|||
145675564|NCT01227421|525328563|FG001|Overall Study|Lost to Follow-up|7|||
145675565|NCT01227421|525328564|FG002|Overall Study|Lost to Follow-up|5|||
145675566|NCT01227421|525328562|FG000|Overall Study|Adverse Event|2|||
145675567|NCT01227421|525328563|FG001|Overall Study|Adverse Event|7|||
145675568|NCT01227421|525328564|FG002|Overall Study|Adverse Event|2|||
145675569|NCT01227421|525328562|FG000|Overall Study|Withdrawal by Subject|1|||
145675570|NCT01227421|525328563|FG001|Overall Study|Withdrawal by Subject|2|||
145675571|NCT01227421|525328564|FG002|Overall Study|Withdrawal by Subject|1|||
145675572|NCT01227421|525328562|FG000|Overall Study|Protocol Violation|1|||
145675573|NCT01227421|525328563|FG001|Overall Study|Protocol Violation|1|||
145675574|NCT01227421|525328564|FG002|Overall Study|Protocol Violation|2|||
145675575|NCT01227421|525328562|FG000|Overall Study|Randomized in error|1|||
145675576|NCT01227421|525328563|FG001|Overall Study|Randomized in error|1|||
145675577|NCT01227421|525328564|FG002|Overall Study|Randomized in error|0|||
145675578|NCT01827839|525328567|FG000|Overall Study|Adverse Event|1|||
145675579|NCT01827839|525328567|FG000|Overall Study|Consent Withdrawal|2|||
145675580|NCT05426109|525328568|FG000|Overall Study|Withdrawal by Subject|0|||
145675581|NCT05426109|525328569|FG001|Overall Study|Withdrawal by Subject|1|||
145675582|NCT04447027|525328572|FG000|Dose Escalation|Withdrawal by Subject|1|||
145675583|NCT04447027|525328573|FG001|Dose Escalation|Withdrawal by Subject|4|||
145675584|NCT04447027|525328574|FG002|Dose Escalation|Withdrawal by Subject|3|||
145675585|NCT04447027|525328575|FG003|Dose Escalation|Withdrawal by Subject|3|||
145675586|NCT04447027|525328576|FG004|Dose Escalation|Withdrawal by Subject|1|||
145675587|NCT04447027|525328577|FG005|Dose Escalation|Withdrawal by Subject|0|||
145675588|NCT04447027|525328578|FG006|Dose Escalation|Withdrawal by Subject|0|||
145675589|NCT04447027|525328579|FG007|Dose Escalation|Withdrawal by Subject|0|||
145675590|NCT04447027|525328580|FG008|Dose Escalation|Withdrawal by Subject|0|||
145675591|NCT04447027|525328572|FG000|Dose Escalation|Refused further treatment|0|||
145675592|NCT04447027|525328573|FG001|Dose Escalation|Refused further treatment|1|||
145675593|NCT04447027|525328574|FG002|Dose Escalation|Refused further treatment|1|||
145675594|NCT04447027|525328575|FG003|Dose Escalation|Refused further treatment|0|||
145675595|NCT04447027|525328576|FG004|Dose Escalation|Refused further treatment|0|||
145675596|NCT04447027|525328577|FG005|Dose Escalation|Refused further treatment|0|||
145675597|NCT04447027|525328578|FG006|Dose Escalation|Refused further treatment|0|||
145675598|NCT04447027|525328579|FG007|Dose Escalation|Refused further treatment|0|||
145675599|NCT04447027|525328580|FG008|Dose Escalation|Refused further treatment|0|||
145675600|NCT04447027|525328572|FG000|Dose Expansion|Withdrawal by Subject|0|||
145675601|NCT04447027|525328573|FG001|Dose Expansion|Withdrawal by Subject|0|||
145675602|NCT04447027|525328574|FG002|Dose Expansion|Withdrawal by Subject|0|||
145675603|NCT04447027|525328575|FG003|Dose Expansion|Withdrawal by Subject|0|||
145675604|NCT04447027|525328576|FG004|Dose Expansion|Withdrawal by Subject|0|||
145675605|NCT04447027|525328577|FG005|Dose Expansion|Withdrawal by Subject|2|||
145675606|NCT04447027|525328578|FG006|Dose Expansion|Withdrawal by Subject|0|||
145675607|NCT04447027|525328579|FG007|Dose Expansion|Withdrawal by Subject|2|||
145675608|NCT04447027|525328580|FG008|Dose Expansion|Withdrawal by Subject|0|||
145675609|NCT00302211|525328584|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
145675610|NCT00302211|525328585|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
145675611|NCT00302211|525328586|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
145675612|NCT00302211|525328587|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
145675613|NCT00302211|525328588|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
145675614|NCT00302211|525328584|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
145675615|NCT00302211|525328585|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
145675616|NCT00302211|525328586|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
145675617|NCT00302211|525328587|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
145675618|NCT00302211|525328588|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
145675619|NCT00302211|525328584|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
145675620|NCT00302211|525328585|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
145675621|NCT00302211|525328586|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
145675622|NCT00302211|525328587|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
145675623|NCT00302211|525328588|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
145675624|NCT00302211|525328584|FG000|Double Blind Period (New Patients)|Disease progression|0|||
145675625|NCT00302211|525328585|FG001|Double Blind Period (New Patients)|Disease progression|1|||
145675626|NCT00302211|525328586|FG002|Double Blind Period (New Patients)|Disease progression|1|||
145675627|NCT00302211|525328587|FG003|Double Blind Period (New Patients)|Disease progression|0|||
145675628|NCT00302211|525328588|FG004|Double Blind Period (New Patients)|Disease progression|0|||
145675629|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
145675630|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
145675631|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
145675632|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
145675633|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
145675634|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
145675635|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
145675636|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
145675637|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
145675638|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
145675639|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
145675640|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
145675641|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
145675642|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
145675643|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
145675644|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
145675645|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
145675646|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
145675647|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
145675648|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
145675649|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Death|0|||
145675650|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Death|0|||
145675651|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Death|0|||
145675652|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Death|1|||
145675653|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Death|1|||
145675654|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
145675655|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
145675656|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
145675657|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
145675658|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
145675659|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
145675660|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
145675661|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
145675662|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
145675663|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
145675664|NCT00302211|525328584|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
145675665|NCT00302211|525328585|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
145675666|NCT00302211|525328586|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
145675667|NCT00302211|525328587|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
145675668|NCT00302211|525328588|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
145675669|NCT05432986|525328591|FG000|Overall Study|Withdrawal by Subject|2|||
145675670|NCT05432986|525328591|FG000|Overall Study|incomplete measurement|7|||
145675671|NCT00597376|525329605|FG000|Overall Study|Withdrawal by Subject|4|||
145675672|NCT00597376|525329606|FG001|Overall Study|Withdrawal by Subject|3|||
145675673|NCT00597376|525329605|FG000|Overall Study|Adverse Event|4|||
145675674|NCT00597376|525329606|FG001|Overall Study|Adverse Event|1|||
145675675|NCT02634307|525329607|FG000|Overall Study|Adverse Event|50|||
145675676|NCT02634307|525329608|FG001|Overall Study|Adverse Event|24|||
145675677|NCT02634307|525329609|FG002|Overall Study|Adverse Event|14|||
145675678|NCT02634307|525329607|FG000|Overall Study|Lost to Follow-up|21|||
145675679|NCT02634307|525329608|FG001|Overall Study|Lost to Follow-up|5|||
145675680|NCT02634307|525329609|FG002|Overall Study|Lost to Follow-up|6|||
145675681|NCT02634307|525329607|FG000|Overall Study|Pregnancy|5|||
145675682|NCT02634307|525329608|FG001|Overall Study|Pregnancy|1|||
145675683|NCT02634307|525329609|FG002|Overall Study|Pregnancy|3|||
145675684|NCT02634307|525329607|FG000|Overall Study|Withdrawal by Subject|38|||
145675685|NCT02634307|525329608|FG001|Overall Study|Withdrawal by Subject|24|||
145675686|NCT02634307|525329609|FG002|Overall Study|Withdrawal by Subject|18|||
145675687|NCT02634307|525329607|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145675688|NCT02634307|525329608|FG001|Overall Study|Non-Compliance with Study Drug|2|||
145675689|NCT02634307|525329609|FG002|Overall Study|Non-Compliance with Study Drug|2|||
145675690|NCT02634307|525329607|FG000|Overall Study|Lack of Efficacy|1|||
145675691|NCT02634307|525329608|FG001|Overall Study|Lack of Efficacy|5|||
145675692|NCT02634307|525329609|FG002|Overall Study|Lack of Efficacy|3|||
145675693|NCT02634307|525329607|FG000|Overall Study|Physician Decision|7|||
145675694|NCT02634307|525329608|FG001|Overall Study|Physician Decision|5|||
145675695|NCT02634307|525329609|FG002|Overall Study|Physician Decision|5|||
145675696|NCT02634307|525329607|FG000|Overall Study|Reason not Specified|3|||
145675697|NCT02634307|525329608|FG001|Overall Study|Reason not Specified|5|||
145675698|NCT02634307|525329609|FG002|Overall Study|Reason not Specified|10|||
145675699|NCT00667017|525329614|FG000|Overall Study|Withdrawal by Subject|1|||
145675700|NCT01823224|525329615|FG000|Overall Study|Lost to Follow-up|5|||
145675701|NCT01823224|525329616|FG001|Overall Study|Lost to Follow-up|6|||
145675702|NCT01823224|525329615|FG000|Overall Study|didn't qualify|1|||
145675703|NCT01823224|525329616|FG001|Overall Study|didn't qualify|2|||
145675704|NCT01823224|525329615|FG000|Overall Study|pharmacy error|0|||
145675705|NCT01823224|525329616|FG001|Overall Study|pharmacy error|1|||
145675706|NCT01823224|525329615|FG000|Overall Study|missed med dose|0|||
145675707|NCT01823224|525329616|FG001|Overall Study|missed med dose|1|||
145675708|NCT01823224|525329615|FG000|Overall Study|Withdrawal by Subject|0|||
145675709|NCT01823224|525329616|FG001|Overall Study|Withdrawal by Subject|1|||
145675710|NCT01532648|525329617|FG000|Overall Study|Lost to Follow-up|3|||
145675711|NCT01532648|525329618|FG001|Overall Study|Lost to Follow-up|4|||
145675712|NCT01532648|525329617|FG000|Overall Study|Lack of Efficacy|4|||
145675713|NCT01532648|525329618|FG001|Overall Study|Lack of Efficacy|1|||
145675714|NCT01532648|525329617|FG000|Overall Study|Protocol Violation|1|||
145675715|NCT01532648|525329618|FG001|Overall Study|Protocol Violation|1|||
145675716|NCT01532648|525329617|FG000|Overall Study|Adverse Event|12|||
145675717|NCT01532648|525329618|FG001|Overall Study|Adverse Event|9|||
145675718|NCT01532648|525329617|FG000|Overall Study|Withdrawal by Subject|16|||
145675719|NCT01532648|525329618|FG001|Overall Study|Withdrawal by Subject|2|||
145675720|NCT01833455|525329619|FG000|Overall Study|Withdrawal by Subject|1|||
145675721|NCT01833455|525329620|FG001|Overall Study|Withdrawal by Subject|0|||
145675722|NCT00022672|525329622|FG000|Main Phase: 24 Months|Adverse Event|6|||
145675723|NCT00022672|525329623|FG001|Main Phase: 24 Months|Adverse Event|0|||
145675724|NCT00022672|525329622|FG000|Main Phase: 24 Months|Death|0|||
145675725|NCT00022672|525329623|FG001|Main Phase: 24 Months|Death|3|||
145675726|NCT00022672|525329622|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
145675727|NCT00022672|525329623|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
145675728|NCT00022672|525329622|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
145675729|NCT00022672|525329623|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
145491048|NCT01384734|524652348|FG000|Overall Study|Lack of Efficacy|3|||
145491049|NCT01384734|524652349|FG001|Overall Study|Lack of Efficacy|7|||
145675730|NCT00022672|525329622|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
145675731|NCT00022672|525329623|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
145675732|NCT00022672|525329622|FG000|Main Phase: 24 Months|Refused Treatment|3|||
145675733|NCT00022672|525329623|FG001|Main Phase: 24 Months|Refused Treatment|4|||
145675734|NCT00022672|525329622|FG000|Main Phase: 24 Months|Failure to Return|1|||
145675735|NCT00022672|525329623|FG001|Main Phase: 24 Months|Failure to Return|1|||
145675736|NCT00022672|525329622|FG000|Main Phase: 24 Months|Other|1|||
145675737|NCT00022672|525329623|FG001|Main Phase: 24 Months|Other|0|||
145675738|NCT00022672|525329622|FG000|Extension Phase|Adverse Event|1|||
145675739|NCT00022672|525329623|FG001|Extension Phase|Adverse Event|3|||
145675740|NCT00022672|525329622|FG000|Extension Phase|Death|0|||
145675741|NCT00022672|525329623|FG001|Extension Phase|Death|1|||
145675742|NCT00022672|525329622|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
145675743|NCT00022672|525329623|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
145675744|NCT00022672|525329622|FG000|Extension Phase|Refused Treatment|0|||
145675745|NCT00022672|525329623|FG001|Extension Phase|Refused Treatment|2|||
145675746|NCT00022672|525329622|FG000|Extension Phase|Other|1|||
145675747|NCT00022672|525329623|FG001|Extension Phase|Other|1|||
145675748|NCT00403494|525329624|FG000|Overall Study|Adverse Event|10|||
145675749|NCT00403494|525329625|FG001|Overall Study|Adverse Event|8|||
145675750|NCT00403494|525329624|FG000|Overall Study|Withdrew Consent|3|||
145675751|NCT00403494|525329625|FG001|Overall Study|Withdrew Consent|2|||
145675752|NCT00403494|525329624|FG000|Overall Study|Inappropriately enrolled|0|||
145675753|NCT00403494|525329625|FG001|Overall Study|Inappropriately enrolled|1|||
145675754|NCT00403494|525329624|FG000|Overall Study|Lost to Follow-up|0|||
145675755|NCT00403494|525329625|FG001|Overall Study|Lost to Follow-up|2|||
145675756|NCT00403494|525329624|FG000|Overall Study|Protocol noncompliance|0|||
145675757|NCT00403494|525329625|FG001|Overall Study|Protocol noncompliance|1|||
145675758|NCT00403494|525329624|FG000|Overall Study|Death|1|||
145675759|NCT00403494|525329625|FG001|Overall Study|Death|0|||
145675760|NCT00403494|525329624|FG000|Overall Study|Sponsor Request|1|||
145675761|NCT00403494|525329625|FG001|Overall Study|Sponsor Request|0|||
145675762|NCT02575365|525329628|FG000|Overall Study|Lost to Follow-up|4|||
145675763|NCT02708498|525329632|FG000|Overall Study|Death|20|||
145675764|NCT02708498|525329633|FG001|Overall Study|Death|19|||
145675765|NCT02708498|525329634|FG002|Overall Study|Death|0|||
145675766|NCT02708498|525329635|FG003|Overall Study|Death|0|||
145675767|NCT02708498|525329636|FG004|Overall Study|Death|1|||
145675768|NCT02708498|525329637|FG005|Overall Study|Death|0|||
145675769|NCT02708498|525329638|FG006|Overall Study|Death|0|||
145675770|NCT02708498|525329639|FG007|Overall Study|Death|0|||
145675771|NCT02708498|525329632|FG000|Overall Study|Unknown reason, missing data|0|||
145675772|NCT02708498|525329633|FG001|Overall Study|Unknown reason, missing data|0|||
145675773|NCT02708498|525329634|FG002|Overall Study|Unknown reason, missing data|62|||
145675774|NCT02708498|525329635|FG003|Overall Study|Unknown reason, missing data|51|||
145675775|NCT02708498|525329636|FG004|Overall Study|Unknown reason, missing data|195|||
145675776|NCT02708498|525329637|FG005|Overall Study|Unknown reason, missing data|132|||
145675777|NCT02708498|525329638|FG006|Overall Study|Unknown reason, missing data|0|||
145675778|NCT02708498|525329639|FG007|Overall Study|Unknown reason, missing data|0|||
145675779|NCT01124045|525329640|FG000|Overall Study|Lost to Follow-up|0|||
145675780|NCT01124045|525329641|FG001|Overall Study|Lost to Follow-up|1|||
145675781|NCT01124045|525329640|FG000|Overall Study|Physician Decision|0|||
145675782|NCT01124045|525329641|FG001|Overall Study|Physician Decision|2|||
145675783|NCT00822900|525329642|FG000|Overall Study|Withdrawal by Subject|14|||
145675784|NCT00822900|525329643|FG001|Overall Study|Withdrawal by Subject|14|||
145675785|NCT00822900|525329642|FG000|Overall Study|Lost to Follow-up|9|||
145675786|NCT00822900|525329643|FG001|Overall Study|Lost to Follow-up|9|||
145675787|NCT00822900|525329642|FG000|Overall Study|Death|83|||
145675788|NCT00822900|525329643|FG001|Overall Study|Death|69|||
145675789|NCT00822900|525329642|FG000|Overall Study|Became a ward of the state|2|||
145675790|NCT00822900|525329643|FG001|Overall Study|Became a ward of the state|1|||
145675791|NCT02234141|525329644|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675792|NCT02234141|525329645|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675793|NCT02234141|525329646|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675794|NCT02234141|525329647|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
145675795|NCT02234141|525329648|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675796|NCT02234141|525329649|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675797|NCT02234141|525329650|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
145675798|NCT02234141|525329644|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145675799|NCT02234141|525329645|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
145675800|NCT02234141|525329646|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145675801|NCT02234141|525329647|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145675802|NCT02234141|525329648|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145491050|NCT01384734|524652350|FG002|Overall Study|Lack of Efficacy|4|||
145491051|NCT01384734|524652351|FG003|Overall Study|Lack of Efficacy|4|||
145675803|NCT02234141|525329649|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145675804|NCT02234141|525329650|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
145675805|NCT02234141|525329644|FG000|Treatment Period (24 Weeks)|Death|1|||
145675806|NCT02234141|525329645|FG001|Treatment Period (24 Weeks)|Death|2|||
145675807|NCT02234141|525329646|FG002|Treatment Period (24 Weeks)|Death|0|||
145675808|NCT02234141|525329647|FG003|Treatment Period (24 Weeks)|Death|1|||
145675809|NCT02234141|525329648|FG004|Treatment Period (24 Weeks)|Death|0|||
145675810|NCT02234141|525329649|FG005|Treatment Period (24 Weeks)|Death|0|||
145675811|NCT02234141|525329650|FG006|Treatment Period (24 Weeks)|Death|0|||
145675812|NCT02234141|525329644|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
145675813|NCT02234141|525329645|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
145675814|NCT02234141|525329646|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
145675815|NCT02234141|525329647|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
145675816|NCT02234141|525329648|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
145675817|NCT02234141|525329649|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
145675818|NCT02234141|525329650|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
145675819|NCT02234141|525329644|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675820|NCT02234141|525329645|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
145675821|NCT02234141|525329646|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675822|NCT02234141|525329647|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675823|NCT02234141|525329648|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675824|NCT02234141|525329649|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675825|NCT02234141|525329650|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
145675826|NCT02234141|525329644|FG000|Long-Term Treatment Period|Death|0|||
145675827|NCT02234141|525329645|FG001|Long-Term Treatment Period|Death|0|||
145675828|NCT02234141|525329646|FG002|Long-Term Treatment Period|Death|0|||
145675829|NCT02234141|525329647|FG003|Long-Term Treatment Period|Death|0|||
145675830|NCT02234141|525329648|FG004|Long-Term Treatment Period|Death|0|||
145675831|NCT02234141|525329649|FG005|Long-Term Treatment Period|Death|1|||
145675832|NCT02234141|525329650|FG006|Long-Term Treatment Period|Death|0|||
145675833|NCT02234141|525329644|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
145675834|NCT02234141|525329645|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
145675835|NCT02234141|525329646|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
145675836|NCT02234141|525329647|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
145675837|NCT02234141|525329648|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
145675838|NCT02234141|525329649|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
145675839|NCT02234141|525329650|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
145675840|NCT02234141|525329644|FG000|Long-Term Treatment Period|Adverse Event|4|||
145675841|NCT02234141|525329645|FG001|Long-Term Treatment Period|Adverse Event|0|||
145675842|NCT02234141|525329646|FG002|Long-Term Treatment Period|Adverse Event|5|||
145675843|NCT02234141|525329647|FG003|Long-Term Treatment Period|Adverse Event|0|||
145675844|NCT02234141|525329648|FG004|Long-Term Treatment Period|Adverse Event|1|||
145675845|NCT02234141|525329649|FG005|Long-Term Treatment Period|Adverse Event|1|||
145675846|NCT02234141|525329650|FG006|Long-Term Treatment Period|Adverse Event|1|||
145675847|NCT02234141|525329644|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
145675848|NCT02234141|525329645|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
145675849|NCT02234141|525329646|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
145675850|NCT02234141|525329647|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
145675851|NCT02234141|525329648|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
145675852|NCT02234141|525329649|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
145675853|NCT02234141|525329650|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
145675854|NCT02234141|525329644|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
145675855|NCT02234141|525329645|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
145675856|NCT02234141|525329646|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
145675857|NCT02234141|525329647|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
145675858|NCT02234141|525329648|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
145675859|NCT02234141|525329649|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
145675860|NCT02234141|525329650|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
145675861|NCT03418545|525329651|FG000|Overall Study|Withdrawal by Participant|2|||
145675862|NCT03418545|525329652|FG001|Overall Study|Withdrawal by Participant|4|||
145675863|NCT03418545|525329651|FG000|Overall Study|Lost to Follow-up|3|||
145675864|NCT03418545|525329652|FG001|Overall Study|Lost to Follow-up|5|||
145675865|NCT03418545|525329651|FG000|Overall Study|Reason Not Specified|0|||
145675866|NCT03418545|525329652|FG001|Overall Study|Reason Not Specified|1|||
145675867|NCT03418545|525329651|FG000|Overall Study|Missing Completion Status|0|||
145675868|NCT03418545|525329652|FG001|Overall Study|Missing Completion Status|1|||
145675869|NCT02106884|525329653|FG000|Overall Study|Change of diagnosis/exclusion|0|||
145675870|NCT02106884|525329654|FG001|Overall Study|Change of diagnosis/exclusion|1|||
145675871|NCT04638816|525329660|FG000|Overall Study|Withdrawal by Subject|0|||
145675872|NCT04638816|525329661|FG001|Overall Study|Withdrawal by Subject|1|||
145675873|NCT04638816|525329660|FG000|Overall Study|Lost to Follow-up|0|||
145675874|NCT04638816|525329661|FG001|Overall Study|Lost to Follow-up|1|||
145675875|NCT02251652|525329662|FG000|Overall Study|Withdrawal by Subject|1|||
145675876|NCT01074242|525329665|FG000|Overall Study|Case report before date of contract|40|||
145675877|NCT01074242|525329665|FG000|Overall Study|Lost to Follow-up|1|||
145675878|NCT01074242|525329665|FG000|Overall Study|Case report unclear|6|||
145675879|NCT01074242|525329665|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
145675880|NCT01074242|525329665|FG000|Overall Study|Duplicate Case Report Form|5|||
145675881|NCT00109031|525329666|FG000|Overall Study|Adverse Event|0|||
145675882|NCT00109031|525329667|FG001|Overall Study|Adverse Event|0|||
145675883|NCT00109031|525329668|FG002|Overall Study|Adverse Event|1|||
145675884|NCT00109031|525329669|FG003|Overall Study|Adverse Event|0|||
145675885|NCT00109031|525329666|FG000|Overall Study|Withdrawal by Subject|0|||
145675886|NCT00109031|525329667|FG001|Overall Study|Withdrawal by Subject|1|||
145675887|NCT00109031|525329668|FG002|Overall Study|Withdrawal by Subject|0|||
145675888|NCT00109031|525329669|FG003|Overall Study|Withdrawal by Subject|0|||
145675889|NCT00109031|525329666|FG000|Overall Study|Physician Decision|0|||
145675890|NCT00109031|525329667|FG001|Overall Study|Physician Decision|1|||
145675891|NCT00109031|525329668|FG002|Overall Study|Physician Decision|0|||
145675892|NCT00109031|525329669|FG003|Overall Study|Physician Decision|0|||
145675893|NCT00109031|525329666|FG000|Overall Study|Protocol Violation|0|||
145675894|NCT00109031|525329667|FG001|Overall Study|Protocol Violation|0|||
145675895|NCT00109031|525329668|FG002|Overall Study|Protocol Violation|1|||
145675896|NCT00109031|525329669|FG003|Overall Study|Protocol Violation|0|||
145675897|NCT01822756|525329670|FG000|Overall Study|Adverse Event|0|||
145675898|NCT01822756|525329671|FG001|Overall Study|Adverse Event|0|||
145675899|NCT01822756|525329672|FG002|Overall Study|Adverse Event|0|||
145675900|NCT01822756|525329673|FG003|Overall Study|Adverse Event|2|||
145675901|NCT01822756|525329674|FG004|Overall Study|Adverse Event|0|||
145675902|NCT01822756|525329670|FG000|Overall Study|Disease progression|11|||
145675903|NCT01822756|525329671|FG001|Overall Study|Disease progression|1|||
145675904|NCT01822756|525329672|FG002|Overall Study|Disease progression|7|||
145675905|NCT01822756|525329673|FG003|Overall Study|Disease progression|2|||
145675906|NCT01822756|525329674|FG004|Overall Study|Disease progression|6|||
145675907|NCT01822756|525329670|FG000|Overall Study|Death|2|||
145675908|NCT01822756|525329671|FG001|Overall Study|Death|2|||
145675909|NCT01822756|525329672|FG002|Overall Study|Death|1|||
145675910|NCT01822756|525329673|FG003|Overall Study|Death|0|||
145675911|NCT01822756|525329674|FG004|Overall Study|Death|0|||
145675912|NCT01822756|525329670|FG000|Overall Study|Lost to Follow-up|1|||
145675913|NCT01822756|525329671|FG001|Overall Study|Lost to Follow-up|0|||
145675914|NCT01822756|525329672|FG002|Overall Study|Lost to Follow-up|1|||
145675915|NCT01822756|525329673|FG003|Overall Study|Lost to Follow-up|0|||
145675916|NCT01822756|525329674|FG004|Overall Study|Lost to Follow-up|1|||
145675917|NCT01822756|525329670|FG000|Overall Study|Physician Decision|0|||
145675918|NCT01822756|525329671|FG001|Overall Study|Physician Decision|1|||
145675919|NCT01822756|525329672|FG002|Overall Study|Physician Decision|0|||
145675920|NCT01822756|525329673|FG003|Overall Study|Physician Decision|0|||
145675921|NCT01822756|525329674|FG004|Overall Study|Physician Decision|0|||
145675922|NCT01822756|525329670|FG000|Overall Study|disease progression & patient preference|2|||
145675923|NCT01822756|525329671|FG001|Overall Study|disease progression & patient preference|0|||
145675924|NCT01822756|525329672|FG002|Overall Study|disease progression & patient preference|1|||
145675925|NCT01822756|525329673|FG003|Overall Study|disease progression & patient preference|0|||
145675926|NCT01822756|525329674|FG004|Overall Study|disease progression & patient preference|0|||
145675927|NCT01957163|525329675|FG000|Overall Study|Adverse Event|5|||
145675928|NCT01957163|525329676|FG001|Overall Study|Adverse Event|2|||
145675929|NCT01957163|525329677|FG002|Overall Study|Adverse Event|4|||
145675930|NCT01957163|525329675|FG000|Overall Study|Lack of Efficacy|5|||
145675931|NCT01957163|525329676|FG001|Overall Study|Lack of Efficacy|4|||
145675932|NCT01957163|525329677|FG002|Overall Study|Lack of Efficacy|9|||
145675933|NCT01957163|525329675|FG000|Overall Study|Protocol Violation|1|||
145675934|NCT01957163|525329676|FG001|Overall Study|Protocol Violation|2|||
145675935|NCT01957163|525329677|FG002|Overall Study|Protocol Violation|0|||
145675936|NCT01957163|525329675|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
145675937|NCT01957163|525329676|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
145675938|NCT01957163|525329677|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
145675939|NCT01957163|525329675|FG000|Overall Study|Lost to Follow-up|0|||
145675940|NCT01957163|525329676|FG001|Overall Study|Lost to Follow-up|1|||
145675941|NCT01957163|525329677|FG002|Overall Study|Lost to Follow-up|0|||
145675942|NCT01957163|525329675|FG000|Overall Study|Withdrawal by Subject|4|||
145675943|NCT01957163|525329676|FG001|Overall Study|Withdrawal by Subject|2|||
145675944|NCT01957163|525329677|FG002|Overall Study|Withdrawal by Subject|4|||
145675945|NCT00243867|525329682|FG000|Overall Study|Adverse Event|24|||
145675946|NCT00243867|525329683|FG001|Overall Study|Adverse Event|34|||
145675947|NCT00243867|525329682|FG000|Overall Study|Lack of Efficacy|115|||
145675948|NCT00243867|525329683|FG001|Overall Study|Lack of Efficacy|78|||
145675949|NCT00243867|525329682|FG000|Overall Study|Withdrawal by Subject|11|||
145675950|NCT00243867|525329683|FG001|Overall Study|Withdrawal by Subject|23|||
145675951|NCT00243867|525329682|FG000|Overall Study|Lost to Follow-up|2|||
145675952|NCT00243867|525329683|FG001|Overall Study|Lost to Follow-up|1|||
145675953|NCT00243867|525329682|FG000|Overall Study|Physician Decision|2|||
145675954|NCT00243867|525329683|FG001|Overall Study|Physician Decision|7|||
145675955|NCT00243867|525329682|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
145675956|NCT00243867|525329683|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
145675957|NCT02060487|525329693|FG000|Overall Study|Other|1|||
145675958|NCT02060487|525329694|FG001|Overall Study|Other|2|||
145675959|NCT02060487|525329695|FG002|Overall Study|Other|1|||
145675960|NCT02060487|525329693|FG000|Overall Study|Lack of Efficacy|0|||
145675961|NCT02060487|525329694|FG001|Overall Study|Lack of Efficacy|1|||
145675962|NCT02060487|525329695|FG002|Overall Study|Lack of Efficacy|0|||
145675963|NCT02060487|525329693|FG000|Overall Study|Withdrawal by Subject|3|||
145675964|NCT02060487|525329694|FG001|Overall Study|Withdrawal by Subject|10|||
145675965|NCT02060487|525329695|FG002|Overall Study|Withdrawal by Subject|4|||
145675966|NCT02060487|525329693|FG000|Overall Study|Study Terminated By Sponsor|87|||
145675967|NCT02060487|525329694|FG001|Overall Study|Study Terminated By Sponsor|89|||
145675968|NCT02060487|525329695|FG002|Overall Study|Study Terminated By Sponsor|100|||
145675969|NCT02060487|525329693|FG000|Overall Study|Randomized in error|1|||
145675970|NCT02060487|525329694|FG001|Overall Study|Randomized in error|0|||
145675971|NCT02060487|525329695|FG002|Overall Study|Randomized in error|0|||
145675972|NCT02060487|525329693|FG000|Overall Study|Protocol Violation|0|||
145675973|NCT02060487|525329694|FG001|Overall Study|Protocol Violation|1|||
145675974|NCT02060487|525329695|FG002|Overall Study|Protocol Violation|1|||
145675975|NCT02060487|525329693|FG000|Overall Study|Lost to Follow-up|3|||
145675976|NCT02060487|525329694|FG001|Overall Study|Lost to Follow-up|0|||
145675977|NCT02060487|525329695|FG002|Overall Study|Lost to Follow-up|2|||
145675978|NCT02060487|525329693|FG000|Overall Study|Death|34|||
145675979|NCT02060487|525329694|FG001|Overall Study|Death|25|||
145675980|NCT02060487|525329695|FG002|Overall Study|Death|19|||
145675981|NCT02060487|525329693|FG000|Overall Study|Adverse Event|0|||
145675982|NCT02060487|525329694|FG001|Overall Study|Adverse Event|0|||
145675983|NCT02060487|525329695|FG002|Overall Study|Adverse Event|1|||
145675984|NCT05182606|525329701|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
145675985|NCT02686658|525329702|FG000|Overall Study|Adverse Event|0|||
145675986|NCT02686658|525329703|FG001|Overall Study|Adverse Event|0|||
145675987|NCT02686658|525329704|FG002|Overall Study|Adverse Event|1|||
145675988|NCT02686658|525329705|FG003|Overall Study|Adverse Event|1|||
145675989|NCT02686658|525329706|FG004|Overall Study|Adverse Event|2|||
145675990|NCT02686658|525329707|FG005|Overall Study|Adverse Event|1|||
145675991|NCT02686658|525329702|FG000|Overall Study|Investigator decision|0|||
145675992|NCT02686658|525329703|FG001|Overall Study|Investigator decision|0|||
145675993|NCT02686658|525329704|FG002|Overall Study|Investigator decision|0|||
145675994|NCT02686658|525329705|FG003|Overall Study|Investigator decision|1|||
145675995|NCT02686658|525329706|FG004|Overall Study|Investigator decision|2|||
145675996|NCT02686658|525329707|FG005|Overall Study|Investigator decision|1|||
145675997|NCT02686658|525329702|FG000|Overall Study|Sponsor decision|1|||
145675998|NCT02686658|525329703|FG001|Overall Study|Sponsor decision|2|||
145675999|NCT02686658|525329704|FG002|Overall Study|Sponsor decision|1|||
145676000|NCT02686658|525329705|FG003|Overall Study|Sponsor decision|5|||
145676001|NCT02686658|525329706|FG004|Overall Study|Sponsor decision|13|||
145676002|NCT02686658|525329707|FG005|Overall Study|Sponsor decision|2|||
145676003|NCT02686658|525329702|FG000|Overall Study|Lost to Follow-up|0|||
145676004|NCT02686658|525329703|FG001|Overall Study|Lost to Follow-up|0|||
145676005|NCT02686658|525329704|FG002|Overall Study|Lost to Follow-up|2|||
145676006|NCT02686658|525329705|FG003|Overall Study|Lost to Follow-up|0|||
145676007|NCT02686658|525329706|FG004|Overall Study|Lost to Follow-up|0|||
145676008|NCT02686658|525329707|FG005|Overall Study|Lost to Follow-up|1|||
145676009|NCT02686658|525329702|FG000|Overall Study|Death|1|||
145676010|NCT02686658|525329703|FG001|Overall Study|Death|0|||
145676011|NCT02686658|525329704|FG002|Overall Study|Death|0|||
145676012|NCT02686658|525329705|FG003|Overall Study|Death|1|||
145676013|NCT02686658|525329706|FG004|Overall Study|Death|1|||
145676014|NCT02686658|525329707|FG005|Overall Study|Death|1|||
145676015|NCT02686658|525329702|FG000|Overall Study|Withdrawal by Subject|2|||
145676016|NCT02686658|525329703|FG001|Overall Study|Withdrawal by Subject|5|||
145676017|NCT02686658|525329704|FG002|Overall Study|Withdrawal by Subject|4|||
145676018|NCT02686658|525329705|FG003|Overall Study|Withdrawal by Subject|4|||
145676019|NCT02686658|525329706|FG004|Overall Study|Withdrawal by Subject|17|||
145676020|NCT02686658|525329707|FG005|Overall Study|Withdrawal by Subject|8|||
145676021|NCT02686658|525329702|FG000|Overall Study|Placed in hospice care|0|||
145676022|NCT02686658|525329703|FG001|Overall Study|Placed in hospice care|0|||
145676023|NCT02686658|525329704|FG002|Overall Study|Placed in hospice care|1|||
145676024|NCT02686658|525329705|FG003|Overall Study|Placed in hospice care|0|||
145676025|NCT02686658|525329706|FG004|Overall Study|Placed in hospice care|0|||
145676026|NCT02686658|525329707|FG005|Overall Study|Placed in hospice care|0|||
145676027|NCT02686658|525329702|FG000|Overall Study|Participant non-compliance|0|||
145676028|NCT02686658|525329703|FG001|Overall Study|Participant non-compliance|0|||
145676029|NCT02686658|525329704|FG002|Overall Study|Participant non-compliance|0|||
145676030|NCT02686658|525329705|FG003|Overall Study|Participant non-compliance|0|||
145676031|NCT02686658|525329706|FG004|Overall Study|Participant non-compliance|0|||
145676032|NCT02686658|525329707|FG005|Overall Study|Participant non-compliance|1|||
145676033|NCT02686658|525329702|FG000|Overall Study|Concern over coronavirus disease care|0|||
145676034|NCT02686658|525329703|FG001|Overall Study|Concern over coronavirus disease care|0|||
145676035|NCT02686658|525329704|FG002|Overall Study|Concern over coronavirus disease care|0|||
145676036|NCT02686658|525329705|FG003|Overall Study|Concern over coronavirus disease care|0|||
145676037|NCT02686658|525329706|FG004|Overall Study|Concern over coronavirus disease care|2|||
145676038|NCT02686658|525329707|FG005|Overall Study|Concern over coronavirus disease care|1|||
145676039|NCT02309294|525329710|FG000|Overall Study|Withdrawal by Subject|2|||
145676040|NCT02542943|525329711|FG000|Overall Study|Lost to Follow-up|1|||
145676041|NCT02542943|525329712|FG001|Overall Study|Lost to Follow-up|0|||
145676042|NCT02542943|525329713|FG002|Overall Study|Lost to Follow-up|0|||
145676043|NCT02542943|525329711|FG000|Overall Study|Withdrawal by Subject|0|||
145676044|NCT02542943|525329712|FG001|Overall Study|Withdrawal by Subject|1|||
145676045|NCT02542943|525329713|FG002|Overall Study|Withdrawal by Subject|0|||
145676046|NCT03476798|525329714|FG000|Overall Study|Death|1|||
145676047|NCT03476798|525329714|FG000|Overall Study|Withdrawal by Subject|2|||
145676048|NCT03476798|525329714|FG000|Overall Study|Protocol Violation|2|||
145676049|NCT06269003|525329715|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
145676050|NCT06269003|525329716|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
145676051|NCT06269003|525329717|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
145676052|NCT06269003|525329718|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
145676053|NCT05865392|525329722|FG000|Overall Study|Withdrawal by Subject|4|||
145676054|NCT05865392|525329723|FG001|Overall Study|Withdrawal by Subject|0|||
145676055|NCT05865392|525329722|FG000|Overall Study|Didn't meet inclusion criteria|4|||
145676056|NCT05865392|525329723|FG001|Overall Study|Didn't meet inclusion criteria|0|||
145676057|NCT04118894|525329726|FG000|Overall Study|Lost to Follow-up|21|||
145676058|NCT04118894|525329726|FG000|Overall Study|Withdrawal by Subject|10|||
145676059|NCT04118894|525329726|FG000|Overall Study|Adverse Event|4|||
145676060|NCT02556918|525331051|FG000|Overall Study|Protocol Violation|5|||
145676061|NCT02556918|525331052|FG001|Overall Study|Protocol Violation|6|||
145676062|NCT02556918|525331051|FG000|Overall Study|Withdrawal by Subject|4|||
145676063|NCT02556918|525331052|FG001|Overall Study|Withdrawal by Subject|4|||
145676064|NCT00551421|525331055|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
145676065|NCT00799409|525331057|FG000|Overall Study|Withdrawal by Subject|1|||
145676066|NCT00799409|525331058|FG001|Overall Study|Withdrawal by Subject|0|||
145676067|NCT00799409|525331059|FG002|Overall Study|Withdrawal by Subject|0|||
145676068|NCT00799409|525331057|FG000|Overall Study|Lost to Follow-up|1|||
145676069|NCT00799409|525331058|FG001|Overall Study|Lost to Follow-up|0|||
145676070|NCT00799409|525331059|FG002|Overall Study|Lost to Follow-up|0|||
145676071|NCT00799409|525331057|FG000|Overall Study|Optimal Dose Not Achieved|2|||
145676072|NCT00799409|525331058|FG001|Overall Study|Optimal Dose Not Achieved|0|||
145676073|NCT00799409|525331059|FG002|Overall Study|Optimal Dose Not Achieved|0|||
145676074|NCT00799409|525331057|FG000|Overall Study|Failure to follow study protocol)|1|||
145676075|NCT00799409|525331058|FG001|Overall Study|Failure to follow study protocol)|0|||
145676076|NCT00799409|525331059|FG002|Overall Study|Failure to follow study protocol)|0|||
145676077|NCT00799409|525331057|FG000|Overall Study|Did not attend lab school day 1|1|||
145676078|NCT00799409|525331058|FG001|Overall Study|Did not attend lab school day 1|0|||
145676079|NCT00799409|525331059|FG002|Overall Study|Did not attend lab school day 1|0|||
145676080|NCT00799409|525331057|FG000|Overall Study|medication compliance|1|||
145676081|NCT00799409|525331058|FG001|Overall Study|medication compliance|0|||
145676082|NCT00799409|525331059|FG002|Overall Study|medication compliance|0|||
145676083|NCT04323800|525331061|FG000|Overall Study|Withdrawal by Subject|4|||
145676084|NCT04323800|525331062|FG001|Overall Study|Withdrawal by Subject|4|||
145676085|NCT04323800|525331061|FG000|Overall Study|Incomplete transfusion|1|||
145676086|NCT04323800|525331062|FG001|Overall Study|Incomplete transfusion|0|||
145676087|NCT04323800|525331061|FG000|Overall Study|Other|0|||
145676088|NCT04323800|525331062|FG001|Overall Study|Other|1|||
145676089|NCT04323800|525331061|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
145676090|NCT04323800|525331062|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
145676091|NCT00489554|525331063|FG000|Overall Study|Adverse Event|2|||
145676092|NCT00489554|525331063|FG000|Overall Study|Withdrawal by Subject|1|||
145676093|NCT00489554|525331063|FG000|Overall Study|Lost to Follow-up|1|||
145676094|NCT00731692|525331064|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
145676095|NCT00731692|525331065|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
145676096|NCT00731692|525331066|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
145676097|NCT00731692|525331064|FG000|Core Study (36 Months)|Physician Decision|1|||
145676098|NCT00731692|525331065|FG001|Core Study (36 Months)|Physician Decision|0|||
145676099|NCT00731692|525331066|FG002|Core Study (36 Months)|Physician Decision|2|||
145676100|NCT00731692|525331064|FG000|Core Study (36 Months)|Death|2|||
145676101|NCT00731692|525331065|FG001|Core Study (36 Months)|Death|1|||
145676102|NCT00731692|525331066|FG002|Core Study (36 Months)|Death|2|||
145676103|NCT00731692|525331064|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
145491052|NCT01384734|524652352|FG004|Overall Study|Lack of Efficacy|2|||
145676104|NCT00731692|525331065|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
145676105|NCT00731692|525331066|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
145676106|NCT00731692|525331064|FG000|Core Study (36 Months)|Administrative|2|||
145676107|NCT00731692|525331065|FG001|Core Study (36 Months)|Administrative|2|||
145676108|NCT00731692|525331066|FG002|Core Study (36 Months)|Administrative|6|||
145676109|NCT00731692|525331064|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
145676110|NCT00731692|525331065|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
145676111|NCT00731692|525331066|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
145676112|NCT00731692|525331064|FG000|Core Study (36 Months)|Protocol Violation|4|||
145676113|NCT00731692|525331065|FG001|Core Study (36 Months)|Protocol Violation|5|||
145676114|NCT00731692|525331066|FG002|Core Study (36 Months)|Protocol Violation|8|||
145676115|NCT00731692|525331064|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
145676116|NCT00731692|525331065|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
145676117|NCT00731692|525331066|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
145676118|NCT00731692|525331064|FG000|Core Study (36 Months)|Adverse Event|25|||
145676119|NCT00731692|525331065|FG001|Core Study (36 Months)|Adverse Event|28|||
145676120|NCT00731692|525331066|FG002|Core Study (36 Months)|Adverse Event|29|||
145676121|NCT00731692|525331064|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
145676122|NCT00731692|525331065|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
145676123|NCT00731692|525331066|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
145676124|NCT00731692|525331064|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
145676125|NCT00731692|525331065|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
145676126|NCT00731692|525331066|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
145676127|NCT00731692|525331064|FG000|Extension Phase|Abnormal test procedure|0|||
145676128|NCT00731692|525331065|FG001|Extension Phase|Abnormal test procedure|0|||
145676129|NCT00731692|525331066|FG002|Extension Phase|Abnormal test procedure|1|||
145676130|NCT00731692|525331064|FG000|Extension Phase|Abnormal lab values|0|||
145676131|NCT00731692|525331065|FG001|Extension Phase|Abnormal lab values|0|||
145676132|NCT00731692|525331066|FG002|Extension Phase|Abnormal lab values|1|||
145676133|NCT00731692|525331064|FG000|Extension Phase|Lost to Follow-up|0|||
145676134|NCT00731692|525331065|FG001|Extension Phase|Lost to Follow-up|1|||
145676135|NCT00731692|525331066|FG002|Extension Phase|Lost to Follow-up|4|||
145676136|NCT00731692|525331064|FG000|Extension Phase|Withdrawal by Subject|4|||
145676137|NCT00731692|525331065|FG001|Extension Phase|Withdrawal by Subject|5|||
145676138|NCT00731692|525331066|FG002|Extension Phase|Withdrawal by Subject|3|||
145676139|NCT00731692|525331064|FG000|Extension Phase|Adverse Event|1|||
145676140|NCT00731692|525331065|FG001|Extension Phase|Adverse Event|1|||
145676141|NCT00731692|525331066|FG002|Extension Phase|Adverse Event|15|||
145676142|NCT01214200|525331067|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
145676143|NCT01214200|525331067|FG000|Overall Study|Withdrawal by Subject|2|||
145676144|NCT03960645|525331068|FG000|Overall Study|Protocol Violation|1|||
145676145|NCT03960645|525331069|FG001|Overall Study|Protocol Violation|0|||
145676146|NCT04938453|525331070|FG000|Washout Period 1|Adverse Event|1|||
145676147|NCT04938453|525331071|FG001|Washout Period 1|Adverse Event|0|||
145676148|NCT04938453|525331070|FG000|Washout Period 1|Physician Decision|0|||
145676149|NCT04938453|525331071|FG001|Washout Period 1|Physician Decision|1|||
145676150|NCT03292406|525331074|FG000|Overall Study|Progressive Disease|6|||
145676151|NCT03292406|525331075|FG001|Overall Study|Progressive Disease|3|||
145676152|NCT03292406|525331076|FG002|Overall Study|Progressive Disease|4|||
145676153|NCT03292406|525331074|FG000|Overall Study|Adverse Event|7|||
145676154|NCT03292406|525331075|FG001|Overall Study|Adverse Event|1|||
145676155|NCT03292406|525331076|FG002|Overall Study|Adverse Event|4|||
145676156|NCT03292406|525331074|FG000|Overall Study|Withdrawal by Subject|0|||
145676157|NCT03292406|525331075|FG001|Overall Study|Withdrawal by Subject|7|||
145676158|NCT03292406|525331076|FG002|Overall Study|Withdrawal by Subject|2|||
145676159|NCT03292406|525331074|FG000|Overall Study|Protocol Violation|0|||
145676160|NCT03292406|525331075|FG001|Overall Study|Protocol Violation|1|||
145676161|NCT03292406|525331076|FG002|Overall Study|Protocol Violation|1|||
145676162|NCT03292406|525331074|FG000|Overall Study|Other|0|||
145676163|NCT03292406|525331075|FG001|Overall Study|Other|1|||
145676164|NCT03292406|525331076|FG002|Overall Study|Other|2|||
145676165|NCT04658784|525331081|FG000|6-month Follow-up|Lost to Follow-up|2|||
145676166|NCT04658784|525331082|FG001|6-month Follow-up|Lost to Follow-up|5|||
145676167|NCT00670488|525331084|FG000|Overall Study|Adverse Event|0|||
145676168|NCT00670488|525331085|FG001|Overall Study|Adverse Event|7|||
145676169|NCT00670488|525331086|FG002|Overall Study|Adverse Event|0|||
145676170|NCT00670488|525331087|FG003|Overall Study|Adverse Event|3|||
145676171|NCT00670488|525331088|FG004|Overall Study|Adverse Event|1|||
145676172|NCT00670488|525331089|FG005|Overall Study|Adverse Event|1|||
145676173|NCT00670488|525331090|FG006|Overall Study|Adverse Event|5|||
145676174|NCT00670488|525331091|FG007|Overall Study|Adverse Event|1|||
145676175|NCT00670488|525331092|FG008|Overall Study|Adverse Event|0|||
145676176|NCT00670488|525331093|FG009|Overall Study|Adverse Event|1|||
145676177|NCT00670488|525331084|FG000|Overall Study|Physician Decision|1|||
145676178|NCT00670488|525331085|FG001|Overall Study|Physician Decision|9|||
145676179|NCT00670488|525331086|FG002|Overall Study|Physician Decision|0|||
145676180|NCT00670488|525331087|FG003|Overall Study|Physician Decision|1|||
145676181|NCT00670488|525331088|FG004|Overall Study|Physician Decision|0|||
145676182|NCT00670488|525331089|FG005|Overall Study|Physician Decision|0|||
145676183|NCT00670488|525331090|FG006|Overall Study|Physician Decision|0|||
145676184|NCT00670488|525331091|FG007|Overall Study|Physician Decision|0|||
145676185|NCT00670488|525331092|FG008|Overall Study|Physician Decision|0|||
145676186|NCT00670488|525331093|FG009|Overall Study|Physician Decision|0|||
145676187|NCT00670488|525331084|FG000|Overall Study|Progressive Disease|2|||
145676188|NCT00670488|525331085|FG001|Overall Study|Progressive Disease|41|||
145676189|NCT00670488|525331086|FG002|Overall Study|Progressive Disease|3|||
145676190|NCT00670488|525331087|FG003|Overall Study|Progressive Disease|2|||
145676191|NCT00670488|525331088|FG004|Overall Study|Progressive Disease|2|||
145676192|NCT00670488|525331089|FG005|Overall Study|Progressive Disease|4|||
145676193|NCT00670488|525331090|FG006|Overall Study|Progressive Disease|11|||
145676194|NCT00670488|525331091|FG007|Overall Study|Progressive Disease|2|||
145676195|NCT00670488|525331092|FG008|Overall Study|Progressive Disease|2|||
145676196|NCT00670488|525331093|FG009|Overall Study|Progressive Disease|1|||
145676197|NCT00670488|525331084|FG000|Overall Study|Withdrawal by Subject|0|||
145676198|NCT00670488|525331085|FG001|Overall Study|Withdrawal by Subject|1|||
145676199|NCT00670488|525331086|FG002|Overall Study|Withdrawal by Subject|0|||
145676200|NCT00670488|525331087|FG003|Overall Study|Withdrawal by Subject|1|||
145676201|NCT00670488|525331088|FG004|Overall Study|Withdrawal by Subject|0|||
145676202|NCT00670488|525331089|FG005|Overall Study|Withdrawal by Subject|0|||
145676203|NCT00670488|525331090|FG006|Overall Study|Withdrawal by Subject|1|||
145676204|NCT00670488|525331091|FG007|Overall Study|Withdrawal by Subject|0|||
145676205|NCT00670488|525331092|FG008|Overall Study|Withdrawal by Subject|1|||
145676206|NCT00670488|525331093|FG009|Overall Study|Withdrawal by Subject|0|||
145676207|NCT03052517|525331094|FG000|Overall Study|Study Terminated By Sponsor|928|||
145676208|NCT03052517|525331095|FG001|Overall Study|Study Terminated By Sponsor|938|||
145676209|NCT03052517|525331096|FG002|Overall Study|Study Terminated By Sponsor|296|||
145676210|NCT03052517|525331094|FG000|Overall Study|Subject/Guardian Decision|50|||
145676211|NCT03052517|525331095|FG001|Overall Study|Subject/Guardian Decision|45|||
145676212|NCT03052517|525331096|FG002|Overall Study|Subject/Guardian Decision|22|||
145676213|NCT03052517|525331094|FG000|Overall Study|Lack of Efficacy|23|||
145676214|NCT03052517|525331095|FG001|Overall Study|Lack of Efficacy|14|||
145676215|NCT03052517|525331096|FG002|Overall Study|Lack of Efficacy|7|||
145676216|NCT03052517|525331094|FG000|Overall Study|Adverse Event|6|||
145676217|NCT03052517|525331095|FG001|Overall Study|Adverse Event|5|||
145676218|NCT03052517|525331096|FG002|Overall Study|Adverse Event|0|||
145676219|NCT03052517|525331094|FG000|Overall Study|Physician Decision|4|||
145676220|NCT03052517|525331095|FG001|Overall Study|Physician Decision|5|||
145676221|NCT03052517|525331096|FG002|Overall Study|Physician Decision|1|||
145676222|NCT03052517|525331094|FG000|Overall Study|Death|3|||
145676223|NCT03052517|525331095|FG001|Overall Study|Death|0|||
145676224|NCT03052517|525331096|FG002|Overall Study|Death|1|||
145676225|NCT03052517|525331094|FG000|Overall Study|Lost to Follow-up|2|||
145676226|NCT03052517|525331095|FG001|Overall Study|Lost to Follow-up|4|||
145676227|NCT03052517|525331096|FG002|Overall Study|Lost to Follow-up|0|||
145676228|NCT03052517|525331094|FG000|Overall Study|Pregnancy|1|||
145676229|NCT03052517|525331095|FG001|Overall Study|Pregnancy|0|||
145676230|NCT03052517|525331096|FG002|Overall Study|Pregnancy|1|||
145676231|NCT03052517|525331094|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
145676232|NCT03052517|525331095|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
145676233|NCT03052517|525331096|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
145676234|NCT03052517|525331094|FG000|Overall Study|Technical Problems|0|||
145676235|NCT03052517|525331095|FG001|Overall Study|Technical Problems|1|||
145676236|NCT03052517|525331096|FG002|Overall Study|Technical Problems|0|||
145676237|NCT05260437|525331099|FG000|Overall Study|Lost to Follow-up|5|||
145676238|NCT05260437|525331100|FG001|Overall Study|Lost to Follow-up|2|||
145676239|NCT05260437|525331101|FG002|Overall Study|Lost to Follow-up|1|||
145676240|NCT05260437|525331102|FG003|Overall Study|Lost to Follow-up|2|||
145676241|NCT05260437|525331103|FG004|Overall Study|Lost to Follow-up|2|||
145676242|NCT05260437|525331099|FG000|Overall Study|Withdrawal by Subject|3|||
145676243|NCT05260437|525331100|FG001|Overall Study|Withdrawal by Subject|0|||
145676244|NCT05260437|525331101|FG002|Overall Study|Withdrawal by Subject|4|||
145676245|NCT05260437|525331102|FG003|Overall Study|Withdrawal by Subject|5|||
145676246|NCT05260437|525331103|FG004|Overall Study|Withdrawal by Subject|0|||
145676247|NCT05260437|525331099|FG000|Overall Study|Vaccine Not Administered|0|||
145676248|NCT05260437|525331100|FG001|Overall Study|Vaccine Not Administered|1|||
145676249|NCT05260437|525331101|FG002|Overall Study|Vaccine Not Administered|0|||
145676250|NCT05260437|525331102|FG003|Overall Study|Vaccine Not Administered|0|||
145676251|NCT05260437|525331103|FG004|Overall Study|Vaccine Not Administered|0|||
145676252|NCT01858688|525331104|FG000|Overall Study|Withdrawal by Subject|8|||
145676253|NCT01858688|525331104|FG000|Overall Study|Participant began another therapy|3|||
145676254|NCT01858688|525331104|FG000|Overall Study|Physician Decision|2|||
145676255|NCT01858688|525331104|FG000|Overall Study|Progressive Disease|2|||
145676256|NCT01858688|525331104|FG000|Overall Study|Reason not reproted|5|||
145676257|NCT00195819|525331105|FG000|Double-Blind|Withdrawal by Subject|1|||
145676258|NCT00195819|525331106|FG001|Double-Blind|Withdrawal by Subject|0|||
145676259|NCT00195819|525331105|FG000|Double-Blind|Moved|1|||
145676260|NCT00195819|525331106|FG001|Double-Blind|Moved|0|||
145676261|NCT00195819|525331105|FG000|Open-label|Adverse Event|0|||
145676262|NCT00195819|525331106|FG001|Open-label|Adverse Event|9|||
145676263|NCT00195819|525331105|FG000|Open-label|Lack of Efficacy|0|||
145676264|NCT00195819|525331106|FG001|Open-label|Lack of Efficacy|2|||
145676265|NCT00195819|525331105|FG000|Open-label|Pregnancy|0|||
145676266|NCT00195819|525331106|FG001|Open-label|Pregnancy|1|||
145676267|NCT00195819|525331105|FG000|Open-label|Protocol Violation|0|||
145676268|NCT00195819|525331106|FG001|Open-label|Protocol Violation|2|||
145676269|NCT00195819|525331105|FG000|Open-label|Moved|0|||
145676270|NCT00195819|525331106|FG001|Open-label|Moved|1|||
145676271|NCT00195819|525331105|FG000|Open-label|Withdrawal by Subject|0|||
145676272|NCT00195819|525331106|FG001|Open-label|Withdrawal by Subject|5|||
145676273|NCT03298087|525331108|FG000|Overall Study|Withdrawal by Subject|4|||
145676274|NCT01530334|525331109|FG000|Overall Study|Adverse Event|3|||
145676275|NCT01530334|525331109|FG000|Overall Study|unknown reason|1|||
145676276|NCT01530334|525331109|FG000|Overall Study|Progressive disease|47|||
145676277|NCT01629589|525331110|FG000|Overall Study|Protocol Violation|4|||
145676278|NCT01629589|525331111|FG001|Overall Study|Protocol Violation|2|||
145676279|NCT01629589|525331110|FG000|Overall Study|Lost to Follow-up|2|||
145676280|NCT01629589|525331111|FG001|Overall Study|Lost to Follow-up|1|||
145676281|NCT01629589|525331110|FG000|Overall Study|Withdrawal by Subject|2|||
145676282|NCT01629589|525331111|FG001|Overall Study|Withdrawal by Subject|3|||
145676283|NCT01629589|525331110|FG000|Overall Study|Did not receive study vaccine|0|||
145676284|NCT01629589|525331111|FG001|Overall Study|Did not receive study vaccine|1|||
145676285|NCT01303510|525331112|FG000|Overall Study|Lost to Follow-up|1|||
145676286|NCT01303510|525331113|FG001|Overall Study|Lost to Follow-up|0|||
145676287|NCT00701415|525331116|FG000|Overall Study|Adverse Event|0|||
145676288|NCT00701415|525331117|FG001|Overall Study|Adverse Event|1|||
145676289|NCT00701415|525331116|FG000|Overall Study|Social/family issues and needle phobia|1|||
145676290|NCT00701415|525331117|FG001|Overall Study|Social/family issues and needle phobia|0|||
145676291|NCT02208843|525331118|FG000|Overall Study|Clinical symptoms of progression|2|||
145676292|NCT02208843|525331118|FG000|Overall Study|Progression disease according to RECIST|24|||
145676293|NCT02208843|525331118|FG000|Overall Study|Adverse Event|12|||
145676294|NCT02208843|525331118|FG000|Overall Study|Protocol Violation|1|||
145676295|NCT02208843|525331118|FG000|Overall Study|Withdrawal by Subject|1|||
145676296|NCT02208843|525331118|FG000|Overall Study|Switched to commercial afatinib|20|||
145676297|NCT03162614|525331123|FG000|Overall Study|Lost to Follow-up|2|||
145676298|NCT03162614|525331124|FG001|Overall Study|Lost to Follow-up|1|||
145676299|NCT03162614|525331125|FG002|Overall Study|Lost to Follow-up|1|||
145676300|NCT03162614|525331126|FG003|Overall Study|Lost to Follow-up|1|||
145676301|NCT03162614|525331127|FG004|Overall Study|Lost to Follow-up|2|||
145676302|NCT03162614|525331128|FG005|Overall Study|Lost to Follow-up|0|||
145676303|NCT03162614|525331123|FG000|Overall Study|Protocol Violation|0|||
145676304|NCT03162614|525331124|FG001|Overall Study|Protocol Violation|1|||
145676305|NCT03162614|525331125|FG002|Overall Study|Protocol Violation|0|||
145676306|NCT03162614|525331126|FG003|Overall Study|Protocol Violation|1|||
145676307|NCT03162614|525331127|FG004|Overall Study|Protocol Violation|0|||
145676308|NCT03162614|525331128|FG005|Overall Study|Protocol Violation|0|||
145676309|NCT03162614|525331123|FG000|Overall Study|Withdrawal by Subject|2|||
145676310|NCT03162614|525331124|FG001|Overall Study|Withdrawal by Subject|1|||
145676311|NCT03162614|525331125|FG002|Overall Study|Withdrawal by Subject|1|||
145676312|NCT03162614|525331126|FG003|Overall Study|Withdrawal by Subject|1|||
145676313|NCT03162614|525331127|FG004|Overall Study|Withdrawal by Subject|0|||
145676314|NCT03162614|525331128|FG005|Overall Study|Withdrawal by Subject|0|||
145676315|NCT03162614|525331123|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
145676316|NCT03162614|525331124|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
145676317|NCT03162614|525331125|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
145676318|NCT03162614|525331126|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
145676319|NCT03162614|525331127|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
145676320|NCT03162614|525331128|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
145676321|NCT01321073|525331133|FG000|Overall Study|Did not attempt implant|4|||
145676322|NCT01321073|525331133|FG000|Overall Study|Death|3|||
145676323|NCT02609048|525331150|FG000|Overall Study|Adverse Event|3|||
145676324|NCT02609048|525331151|FG001|Overall Study|Adverse Event|0|||
145676325|NCT02609048|525331152|FG002|Overall Study|Adverse Event|0|||
145676326|NCT02609048|525331150|FG000|Overall Study|Randomized but never treated|1|||
145676327|NCT02609048|525331151|FG001|Overall Study|Randomized but never treated|1|||
145676328|NCT02609048|525331152|FG002|Overall Study|Randomized but never treated|1|||
145676329|NCT02609048|525331150|FG000|Overall Study|Withdrawal of informed consent|1|||
145676330|NCT02609048|525331151|FG001|Overall Study|Withdrawal of informed consent|0|||
145265408|NCT00764465|523819352|FG000|Overall Study|Adverse Event|2|||
145491053|NCT01384734|524652348|FG000|Overall Study|Lost to Follow-up|5|||
145676331|NCT02609048|525331152|FG002|Overall Study|Withdrawal of informed consent|0|||
145676332|NCT02609048|525331150|FG000|Overall Study|Reason not specified|6|||
145676333|NCT02609048|525331151|FG001|Overall Study|Reason not specified|9|||
145676334|NCT02609048|525331152|FG002|Overall Study|Reason not specified|9|||
145676335|NCT04186247|525331155|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
145676336|NCT04186247|525331156|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
145676337|NCT04186247|525331157|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
145676338|NCT04186247|525331158|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
145676339|NCT04186247|525331159|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
145676340|NCT02969356|525331164|FG000|Overall Study|Adverse Event|7|||
145676341|NCT02969356|525331164|FG000|Overall Study|Consent withdrawn|2|||
145676342|NCT02969356|525331164|FG000|Overall Study|Lost to Follow-up|3|||
145676343|NCT02969356|525331164|FG000|Overall Study|Did not need to be reinjected|6|||
145676344|NCT02969356|525331164|FG000|Overall Study|Personal reasons|5|||
145676345|NCT04511702|525332264|FG000|Overall Study|Lost to Follow-up|3|||
145676346|NCT04511702|525332265|FG001|Overall Study|Lost to Follow-up|0|||
145676347|NCT04511702|525332266|FG002|Overall Study|Lost to Follow-up|4|||
145676348|NCT04511702|525332264|FG000|Overall Study|Withdrawal by Subject|17|||
145676349|NCT04511702|525332265|FG001|Overall Study|Withdrawal by Subject|1|||
145676350|NCT04511702|525332266|FG002|Overall Study|Withdrawal by Subject|8|||
145676351|NCT04493424|525332267|FG000|Overall Study|Termination of the trial by the sponsor|89|||
145676352|NCT04493424|525332267|FG000|Overall Study|Withdrawal by Subject|9|||
145676353|NCT04493424|525332267|FG000|Overall Study|Lost to Follow-up|2|||
145676354|NCT04493424|525332267|FG000|Overall Study|Lack of Efficacy|3|||
145676355|NCT04493424|525332267|FG000|Overall Study|Adverse Event|5|||
145676356|NCT00108355|525332271|FG000|Overall Study|Peritonitis at index paracentesis|1|||
145676357|NCT00108355|525332272|FG001|Overall Study|Peritonitis at index paracentesis|1|||
145676358|NCT00108355|525332271|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
145676359|NCT00108355|525332272|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
145676360|NCT04992273|525332273|FG000|Overall Study|Lost to Follow-up|0|||
145676361|NCT04992273|525332274|FG001|Overall Study|Lost to Follow-up|1|||
145676362|NCT01364597|525332275|FG000|Overall Study|Adverse Event|4|||
145676363|NCT01364597|525332276|FG001|Overall Study|Adverse Event|5|||
145676364|NCT01364597|525332277|FG002|Overall Study|Adverse Event|16|||
145676365|NCT01364597|525332278|FG003|Overall Study|Adverse Event|7|||
145676366|NCT01364597|525332275|FG000|Overall Study|Lack of Efficacy|4|||
145676367|NCT01364597|525332276|FG001|Overall Study|Lack of Efficacy|4|||
145676368|NCT01364597|525332277|FG002|Overall Study|Lack of Efficacy|23|||
145676369|NCT01364597|525332278|FG003|Overall Study|Lack of Efficacy|8|||
145676370|NCT01364597|525332275|FG000|Overall Study|Protocol Violation|0|||
145676371|NCT01364597|525332276|FG001|Overall Study|Protocol Violation|0|||
145676372|NCT01364597|525332277|FG002|Overall Study|Protocol Violation|2|||
145676373|NCT01364597|525332278|FG003|Overall Study|Protocol Violation|0|||
145676374|NCT01364597|525332275|FG000|Overall Study|Lost to Follow-up|0|||
145676375|NCT01364597|525332276|FG001|Overall Study|Lost to Follow-up|0|||
145676376|NCT01364597|525332277|FG002|Overall Study|Lost to Follow-up|5|||
145676377|NCT01364597|525332278|FG003|Overall Study|Lost to Follow-up|3|||
145676378|NCT01364597|525332275|FG000|Overall Study|Withdrawal by Subject|4|||
145676379|NCT01364597|525332276|FG001|Overall Study|Withdrawal by Subject|1|||
145676380|NCT01364597|525332277|FG002|Overall Study|Withdrawal by Subject|18|||
145676381|NCT01364597|525332278|FG003|Overall Study|Withdrawal by Subject|6|||
145676382|NCT01364597|525332275|FG000|Overall Study|Non compliance|1|||
145676383|NCT01364597|525332276|FG001|Overall Study|Non compliance|0|||
145676384|NCT01364597|525332277|FG002|Overall Study|Non compliance|1|||
145676385|NCT01364597|525332278|FG003|Overall Study|Non compliance|0|||
145676386|NCT01364597|525332275|FG000|Overall Study|Lack of compliance|1|||
145676387|NCT01364597|525332276|FG001|Overall Study|Lack of compliance|0|||
145676388|NCT01364597|525332277|FG002|Overall Study|Lack of compliance|0|||
145676389|NCT01364597|525332278|FG003|Overall Study|Lack of compliance|0|||
145676390|NCT01364597|525332275|FG000|Overall Study|End of treatment epilepsy|1|||
145676391|NCT01364597|525332276|FG001|Overall Study|End of treatment epilepsy|0|||
145676392|NCT01364597|525332277|FG002|Overall Study|End of treatment epilepsy|0|||
145676393|NCT01364597|525332278|FG003|Overall Study|End of treatment epilepsy|0|||
145676394|NCT01364597|525332275|FG000|Overall Study|No Seizures|1|||
145676395|NCT01364597|525332276|FG001|Overall Study|No Seizures|0|||
145676396|NCT01364597|525332277|FG002|Overall Study|No Seizures|0|||
145676397|NCT01364597|525332278|FG003|Overall Study|No Seizures|0|||
145676398|NCT01364597|525332275|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
145676399|NCT01364597|525332276|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
145676400|NCT01364597|525332277|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
145676401|NCT01364597|525332278|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
145676402|NCT01364597|525332275|FG000|Overall Study|Cure|1|||
145676403|NCT01364597|525332276|FG001|Overall Study|Cure|0|||
145676404|NCT01364597|525332277|FG002|Overall Study|Cure|0|||
145676405|NCT01364597|525332278|FG003|Overall Study|Cure|0|||
145676406|NCT01364597|525332275|FG000|Overall Study|Patient was moving|0|||
145676407|NCT01364597|525332276|FG001|Overall Study|Patient was moving|1|||
145676408|NCT01364597|525332277|FG002|Overall Study|Patient was moving|0|||
145676409|NCT01364597|525332278|FG003|Overall Study|Patient was moving|0|||
145676410|NCT01364597|525332275|FG000|Overall Study|Seizures resolved|0|||
145676411|NCT01364597|525332276|FG001|Overall Study|Seizures resolved|0|||
145676412|NCT01364597|525332277|FG002|Overall Study|Seizures resolved|1|||
145676413|NCT01364597|525332278|FG003|Overall Study|Seizures resolved|0|||
145676414|NCT01364597|525332275|FG000|Overall Study|Patient became seizure-free after surgery|0|||
145676415|NCT01364597|525332276|FG001|Overall Study|Patient became seizure-free after surgery|0|||
145676416|NCT01364597|525332277|FG002|Overall Study|Patient became seizure-free after surgery|1|||
145676417|NCT01364597|525332278|FG003|Overall Study|Patient became seizure-free after surgery|0|||
145676418|NCT01364597|525332275|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
145676419|NCT01364597|525332276|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
145676420|NCT01364597|525332277|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
145676421|NCT01364597|525332278|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
145676422|NCT01364597|525332275|FG000|Overall Study|Patient cured from Epilepsy|0|||
145676423|NCT01364597|525332276|FG001|Overall Study|Patient cured from Epilepsy|0|||
145676424|NCT01364597|525332277|FG002|Overall Study|Patient cured from Epilepsy|1|||
145676425|NCT01364597|525332278|FG003|Overall Study|Patient cured from Epilepsy|0|||
145676426|NCT01364597|525332275|FG000|Overall Study|Investigator decision|0|||
145676427|NCT01364597|525332276|FG001|Overall Study|Investigator decision|0|||
145676428|NCT01364597|525332277|FG002|Overall Study|Investigator decision|1|||
145676429|NCT01364597|525332278|FG003|Overall Study|Investigator decision|0|||
145676430|NCT01364597|525332275|FG000|Overall Study|Sponsor recommended discontinuation|0|||
145676431|NCT01364597|525332276|FG001|Overall Study|Sponsor recommended discontinuation|0|||
145676432|NCT01364597|525332277|FG002|Overall Study|Sponsor recommended discontinuation|0|||
145676433|NCT01364597|525332278|FG003|Overall Study|Sponsor recommended discontinuation|1|||
145676434|NCT01364597|525332275|FG000|Overall Study|Parents went abroad with the patient|0|||
145676435|NCT01364597|525332276|FG001|Overall Study|Parents went abroad with the patient|0|||
145676436|NCT01364597|525332277|FG002|Overall Study|Parents went abroad with the patient|1|||
145676437|NCT01364597|525332278|FG003|Overall Study|Parents went abroad with the patient|0|||
145676438|NCT01364597|525332275|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
145676439|NCT01364597|525332276|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
145676440|NCT01364597|525332277|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
145676441|NCT01364597|525332278|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
145676442|NCT01364597|525332275|FG000|Overall Study|BRV administration dropout|0|||
145676443|NCT01364597|525332276|FG001|Overall Study|BRV administration dropout|0|||
145676444|NCT01364597|525332277|FG002|Overall Study|BRV administration dropout|1|||
145676445|NCT01364597|525332278|FG003|Overall Study|BRV administration dropout|0|||
145676446|NCT01364597|525332275|FG000|Overall Study|Dropout|0|||
145676447|NCT01364597|525332276|FG001|Overall Study|Dropout|0|||
145676448|NCT01364597|525332277|FG002|Overall Study|Dropout|3|||
145676449|NCT01364597|525332278|FG003|Overall Study|Dropout|1|||
145676450|NCT01364597|525332275|FG000|Overall Study|Unreliable subject|0|||
145676451|NCT01364597|525332276|FG001|Overall Study|Unreliable subject|0|||
145676452|NCT01364597|525332277|FG002|Overall Study|Unreliable subject|0|||
145676453|NCT01364597|525332278|FG003|Overall Study|Unreliable subject|1|||
145676454|NCT01364597|525332275|FG000|Overall Study|Other|0|||
145676455|NCT01364597|525332276|FG001|Overall Study|Other|0|||
145676456|NCT01364597|525332277|FG002|Overall Study|Other|0|||
145676457|NCT01364597|525332278|FG003|Overall Study|Other|1|||
145676458|NCT03493282|525332282|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
145676459|NCT03493282|525332283|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
145676460|NCT03493282|525332284|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
145676461|NCT03493282|525332282|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
145676462|NCT03493282|525332283|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
145676463|NCT03493282|525332284|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
145676464|NCT01380145|525332285|FG000|Overall Study|Progressive disease|4|||
145676465|NCT02698475|525332286|FG000|Main Study Period|Lack of Efficacy|1|||
145676466|NCT02698475|525332286|FG000|Main Study Period|Protocol Violation|2|||
145676467|NCT02698475|525332286|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
145676468|NCT02698475|525332286|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
145676469|NCT02698475|525332286|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
145676470|NCT02698475|525332286|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
145676471|NCT02698475|525332286|FG000|Long-Term Extension Period|Other|1|||
145676472|NCT02038049|525332287|FG000|Overall Study|Lost to Follow-up|1|||
145676473|NCT02038049|525332288|FG001|Overall Study|Lost to Follow-up|0|||
145676474|NCT02771366|525332289|FG000|Period 1|Withdrawal by Subject|0|||
145676475|NCT02771366|525332290|FG001|Period 1|Withdrawal by Subject|2|||
145676476|NCT02771366|525332289|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
145676477|NCT02771366|525332290|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
145676478|NCT00587171|525332293|FG000|Overall Study|Lost to Follow-up|1|||
145676479|NCT00587171|525332294|FG001|Overall Study|Lost to Follow-up|1|||
145676480|NCT02148705|525332298|FG000|Overall Study|Death|2|||
145676481|NCT02148705|525332299|FG001|Overall Study|Death|0|||
145676482|NCT02148705|525332300|FG002|Overall Study|Death|0|||
145676483|NCT02148705|525332298|FG000|Overall Study|Lost to Follow-up|13|||
145676484|NCT02148705|525332299|FG001|Overall Study|Lost to Follow-up|4|||
145676485|NCT02148705|525332300|FG002|Overall Study|Lost to Follow-up|10|||
145676486|NCT02148705|525332298|FG000|Overall Study|Withdrawal by Subject|3|||
145676487|NCT02148705|525332299|FG001|Overall Study|Withdrawal by Subject|0|||
145676488|NCT02148705|525332300|FG002|Overall Study|Withdrawal by Subject|2|||
145676489|NCT02148705|525332298|FG000|Overall Study|Not Treated|0|||
145676490|NCT02148705|525332299|FG001|Overall Study|Not Treated|1|||
145676491|NCT02148705|525332300|FG002|Overall Study|Not Treated|5|||
145676492|NCT01737021|525332303|FG000|Overall Study|Lost to Follow-up|5|||
145676493|NCT01737021|525332304|FG001|Overall Study|Lost to Follow-up|3|||
145676494|NCT01673594|525332305|FG000|Overall Study|Adverse Event|3|||
145676495|NCT01673594|525332306|FG001|Overall Study|Adverse Event|1|||
145676496|NCT01673594|525332305|FG000|Overall Study|Lost to Follow-up|1|||
145676497|NCT01673594|525332306|FG001|Overall Study|Lost to Follow-up|0|||
145676498|NCT01673594|525332305|FG000|Overall Study|Physician Decision|2|||
145676499|NCT01673594|525332306|FG001|Overall Study|Physician Decision|4|||
145676500|NCT01673594|525332305|FG000|Overall Study|Withdrawal by Subject|0|||
145676501|NCT01673594|525332306|FG001|Overall Study|Withdrawal by Subject|1|||
145676502|NCT02605174|525332310|FG000|Overall Study|Adverse Event|0|||
145676503|NCT02605174|525332311|FG001|Overall Study|Adverse Event|0|||
145676504|NCT02605174|525332312|FG002|Overall Study|Adverse Event|1|||
145676505|NCT02605174|525332313|FG003|Overall Study|Adverse Event|0|||
145676506|NCT02605174|525332314|FG004|Overall Study|Adverse Event|4|||
145676507|NCT02605174|525332315|FG005|Overall Study|Adverse Event|0|||
145676508|NCT02605174|525332316|FG006|Overall Study|Adverse Event|0|||
145676509|NCT02605174|525332310|FG000|Overall Study|Lost to Follow-up|20|||
145676510|NCT02605174|525332311|FG001|Overall Study|Lost to Follow-up|7|||
145676511|NCT02605174|525332312|FG002|Overall Study|Lost to Follow-up|27|||
145676512|NCT02605174|525332313|FG003|Overall Study|Lost to Follow-up|10|||
145676513|NCT02605174|525332314|FG004|Overall Study|Lost to Follow-up|20|||
145676514|NCT02605174|525332315|FG005|Overall Study|Lost to Follow-up|10|||
145676515|NCT02605174|525332316|FG006|Overall Study|Lost to Follow-up|29|||
145676516|NCT02605174|525332310|FG000|Overall Study|Protocol Violation|10|||
145676517|NCT02605174|525332311|FG001|Overall Study|Protocol Violation|4|||
145676518|NCT02605174|525332312|FG002|Overall Study|Protocol Violation|14|||
145676519|NCT02605174|525332313|FG003|Overall Study|Protocol Violation|6|||
145676520|NCT02605174|525332314|FG004|Overall Study|Protocol Violation|7|||
145676521|NCT02605174|525332315|FG005|Overall Study|Protocol Violation|7|||
145676522|NCT02605174|525332316|FG006|Overall Study|Protocol Violation|12|||
145676523|NCT02605174|525332310|FG000|Overall Study|Pregnancy|1|||
145676524|NCT02605174|525332311|FG001|Overall Study|Pregnancy|0|||
145676525|NCT02605174|525332312|FG002|Overall Study|Pregnancy|0|||
145676526|NCT02605174|525332313|FG003|Overall Study|Pregnancy|2|||
145676527|NCT02605174|525332314|FG004|Overall Study|Pregnancy|0|||
145676528|NCT02605174|525332315|FG005|Overall Study|Pregnancy|0|||
145676529|NCT02605174|525332316|FG006|Overall Study|Pregnancy|0|||
145676530|NCT02605174|525332310|FG000|Overall Study|Withdrawal by Subject|9|||
145676531|NCT02605174|525332311|FG001|Overall Study|Withdrawal by Subject|6|||
145676532|NCT02605174|525332312|FG002|Overall Study|Withdrawal by Subject|14|||
145676533|NCT02605174|525332313|FG003|Overall Study|Withdrawal by Subject|11|||
145676534|NCT02605174|525332314|FG004|Overall Study|Withdrawal by Subject|6|||
145676535|NCT02605174|525332315|FG005|Overall Study|Withdrawal by Subject|4|||
145676536|NCT02605174|525332316|FG006|Overall Study|Withdrawal by Subject|15|||
145676537|NCT02605174|525332310|FG000|Overall Study|Physician Decision|2|||
145676538|NCT02605174|525332311|FG001|Overall Study|Physician Decision|0|||
145676539|NCT02605174|525332312|FG002|Overall Study|Physician Decision|0|||
145676540|NCT02605174|525332313|FG003|Overall Study|Physician Decision|0|||
145676541|NCT02605174|525332314|FG004|Overall Study|Physician Decision|0|||
145676542|NCT02605174|525332315|FG005|Overall Study|Physician Decision|0|||
145676543|NCT02605174|525332316|FG006|Overall Study|Physician Decision|3|||
145676544|NCT02605174|525332310|FG000|Overall Study|Randomization Failure|22|||
145676545|NCT02605174|525332311|FG001|Overall Study|Randomization Failure|6|||
145676546|NCT02605174|525332312|FG002|Overall Study|Randomization Failure|20|||
145676547|NCT02605174|525332313|FG003|Overall Study|Randomization Failure|7|||
145676548|NCT02605174|525332314|FG004|Overall Study|Randomization Failure|16|||
145676549|NCT02605174|525332315|FG005|Overall Study|Randomization Failure|11|||
145676550|NCT02605174|525332316|FG006|Overall Study|Randomization Failure|30|||
145676551|NCT04250636|525332317|FG000|Overall Study|Lost to Follow-up|2|||
145676552|NCT01779050|525332319|FG000|Overall Study|Withdrawal by Subject|1|||
145676553|NCT01779050|525332320|FG001|Overall Study|Withdrawal by Subject|0|||
145676554|NCT01353274|525332321|FG000|Overall Study|No case report form (CRF) collected|28|||
145676555|NCT03737110|525332324|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
145676556|NCT03737110|525332325|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
145676557|NCT03737110|525332326|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
145676558|NCT03737110|525332327|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
145676559|NCT03737110|525332328|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
145676560|NCT03737110|525332329|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
145676561|NCT03737110|525332324|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
145676562|NCT03737110|525332325|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
145676563|NCT03737110|525332326|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
145676564|NCT03737110|525332327|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
145676565|NCT03737110|525332328|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
145676566|NCT03737110|525332329|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
145676567|NCT03737110|525332324|FG000|Run-in (RI) Period|Adverse Event|4|||
145676568|NCT03737110|525332325|FG001|Run-in (RI) Period|Adverse Event|0|||
145676569|NCT03737110|525332326|FG002|Run-in (RI) Period|Adverse Event|0|||
145676570|NCT03737110|525332327|FG003|Run-in (RI) Period|Adverse Event|0|||
145676571|NCT03737110|525332328|FG004|Run-in (RI) Period|Adverse Event|0|||
145676572|NCT03737110|525332329|FG005|Run-in (RI) Period|Adverse Event|0|||
145676573|NCT03737110|525332324|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
145676574|NCT03737110|525332325|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
145676575|NCT03737110|525332326|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
145676576|NCT03737110|525332327|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
145676577|NCT03737110|525332328|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
145676578|NCT03737110|525332329|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
145676579|NCT03737110|525332324|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145676580|NCT03737110|525332325|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145676581|NCT03737110|525332326|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
145676582|NCT03737110|525332327|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145676583|NCT03737110|525332328|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145676584|NCT03737110|525332329|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
145676585|NCT03737110|525332324|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145676586|NCT03737110|525332325|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145676587|NCT03737110|525332326|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145676588|NCT03737110|525332327|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
145676589|NCT03737110|525332328|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145676590|NCT03737110|525332329|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
145676591|NCT03737110|525332324|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
145676592|NCT03737110|525332325|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
145676593|NCT03737110|525332326|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
145676594|NCT03737110|525332327|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
145676595|NCT03737110|525332328|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
145676596|NCT03737110|525332329|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
145676597|NCT03737110|525332324|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
145676598|NCT03737110|525332325|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
145676599|NCT03737110|525332326|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
145676600|NCT03737110|525332327|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
145676601|NCT03737110|525332328|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
145676602|NCT03737110|525332329|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
145676603|NCT03648541|525332330|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
145676604|NCT03648541|525332331|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
145676605|NCT03648541|525332330|FG000|Re-induction Period Only|Lack of Efficacy|7|||
145676606|NCT03648541|525332331|FG001|Re-induction Period Only|Lack of Efficacy|0|||
145676607|NCT03648541|525332330|FG000|Maintenance Period Only|Missing|0|||
145676608|NCT03648541|525332331|FG001|Maintenance Period Only|Missing|1|||
145676609|NCT03648541|525332330|FG000|Maintenance Period Only|Other not listed below|0|||
145676610|NCT03648541|525332331|FG001|Maintenance Period Only|Other not listed below|4|||
145676611|NCT03648541|525332330|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
145676612|NCT03648541|525332331|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
145676613|NCT03648541|525332330|FG000|Maintenance Period Only|Protocol Violation|0|||
145676614|NCT03648541|525332331|FG001|Maintenance Period Only|Protocol Violation|1|||
145676615|NCT03648541|525332330|FG000|Maintenance Period Only|Lack of Efficacy|0|||
145676616|NCT03648541|525332331|FG001|Maintenance Period Only|Lack of Efficacy|18|||
145676617|NCT03648541|525332330|FG000|Maintenance Period Only|Adverse Event|0|||
145676618|NCT03648541|525332331|FG001|Maintenance Period Only|Adverse Event|4|||
145676619|NCT03648541|525332330|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
145676620|NCT03648541|525332331|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
145676621|NCT00895245|525332333|FG000|Overall Study|Lack of Efficacy|6|||
145676622|NCT02095678|525332334|FG000|Overall Study|Withdrawal by Subject|0|||
145676623|NCT02095678|525332335|FG001|Overall Study|Withdrawal by Subject|1|||
145676624|NCT02095678|525332334|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
145676625|NCT02095678|525332335|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
145676626|NCT02095678|525332334|FG000|Overall Study|lesion impacted by previous treatment|1|||
145676627|NCT02095678|525332335|FG001|Overall Study|lesion impacted by previous treatment|1|||
145676628|NCT02095678|525332334|FG000|Overall Study|No Confirmed Diagnosis|0|||
145676629|NCT02095678|525332335|FG001|Overall Study|No Confirmed Diagnosis|3|||
145676630|NCT02095678|525332334|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
145676631|NCT02095678|525332335|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
145676632|NCT02095678|525332334|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
145676633|NCT02095678|525332335|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
145676634|NCT00681109|525332336|FG000|Overall Study|Lost to Follow-up|2|||
145676635|NCT00681109|525332337|FG001|Overall Study|Lost to Follow-up|6|||
145676636|NCT00681109|525332338|FG002|Overall Study|Lost to Follow-up|0|||
145676637|NCT03131713|525332341|FG000|Overall Study|Lost to Follow-up|5|||
145676638|NCT03131713|525332342|FG001|Overall Study|Lost to Follow-up|0|||
145676639|NCT01972776|525332351|FG000|Part 1|Withdrawal by Subject|0|||
145676640|NCT01972776|525332352|FG001|Part 1|Withdrawal by Subject|0|||
145676641|NCT01972776|525332353|FG002|Part 1|Withdrawal by Subject|1|||
145676642|NCT01972776|525332354|FG003|Part 1|Withdrawal by Subject|0|||
145676643|NCT01972776|525332355|FG004|Part 1|Withdrawal by Subject|0|||
145676644|NCT01972776|525332356|FG005|Part 1|Withdrawal by Subject|0|||
145676645|NCT01972776|525332351|FG000|Part 1|Adverse Event|0|||
145676646|NCT01972776|525332352|FG001|Part 1|Adverse Event|0|||
145676647|NCT01972776|525332353|FG002|Part 1|Adverse Event|1|||
145676648|NCT01972776|525332354|FG003|Part 1|Adverse Event|1|||
145676649|NCT01972776|525332355|FG004|Part 1|Adverse Event|0|||
145676650|NCT01972776|525332356|FG005|Part 1|Adverse Event|0|||
145676651|NCT01972776|525332351|FG000|Part 2|Adverse Event|0|||
145676652|NCT01972776|525332352|FG001|Part 2|Adverse Event|0|||
145676653|NCT01972776|525332353|FG002|Part 2|Adverse Event|0|||
145676654|NCT01972776|525332354|FG003|Part 2|Adverse Event|0|||
145676655|NCT01972776|525332355|FG004|Part 2|Adverse Event|3|||
145676656|NCT01972776|525332356|FG005|Part 2|Adverse Event|0|||
145676657|NCT01972776|525332351|FG000|Part 2|Administrative problems|0|||
145676658|NCT01972776|525332352|FG001|Part 2|Administrative problems|0|||
145676659|NCT01972776|525332353|FG002|Part 2|Administrative problems|0|||
145676660|NCT01972776|525332354|FG003|Part 2|Administrative problems|0|||
145676661|NCT01972776|525332355|FG004|Part 2|Administrative problems|10|||
145676662|NCT01972776|525332356|FG005|Part 2|Administrative problems|7|||
145676663|NCT02382640|525332366|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
145676664|NCT02382640|525332367|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
145676665|NCT02382640|525332368|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
145676666|NCT02382640|525332369|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
145676667|NCT01560429|525332370|FG000|Overall Study|Protocol Violation|3|||
145676668|NCT01560429|525332371|FG001|Overall Study|Protocol Violation|6|||
145676669|NCT00570505|525332374|FG000|Overall Study|Adverse Event|7|||
145676670|NCT00570505|525332374|FG000|Overall Study|Withdrawal by Subject|7|||
145676671|NCT00570505|525332374|FG000|Overall Study|Lost to Follow-up|23|||
145676672|NCT00570505|525332374|FG000|Overall Study|Other loss to follow-up|4|||
145676673|NCT04224272|525332375|FG000|Part 1 - Dose Finding|Death|4|||
145676674|NCT04224272|525332375|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
145676675|NCT04224272|525332375|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
145676676|NCT04224272|525332375|FG000|Part 2 - Dose Expansion|Death|10|||
145676677|NCT04224272|525332375|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
145676678|NCT02485925|525332376|FG000|Overall Study|Withdrawal by Subject|3|||
145676679|NCT02485925|525332376|FG000|Overall Study|Death|1|||
145676680|NCT02485925|525332376|FG000|Overall Study|Lost to Follow-up|11|||
145676681|NCT04924608|525334228|FG000|Overall Study|Adverse Event|10|||
145676682|NCT04924608|525334229|FG001|Overall Study|Adverse Event|6|||
145676683|NCT04924608|525334228|FG000|Overall Study|Lost to Follow-up|1|||
145676684|NCT04924608|525334229|FG001|Overall Study|Lost to Follow-up|1|||
145676685|NCT04924608|525334228|FG000|Overall Study|Ongoing at the data cut-off date|54|||
145676686|NCT04924608|525334229|FG001|Overall Study|Ongoing at the data cut-off date|60|||
145676687|NCT04924608|525334228|FG000|Overall Study|Progressive Disease|2|||
145676688|NCT04924608|525334229|FG001|Overall Study|Progressive Disease|0|||
145676689|NCT04924608|525334228|FG000|Overall Study|Withdrawal by Subject|3|||
145676690|NCT04924608|525334229|FG001|Overall Study|Withdrawal by Subject|6|||
145676691|NCT04924608|525334228|FG000|Overall Study|Other reason|1|||
145676692|NCT04924608|525334229|FG001|Overall Study|Other reason|1|||
145676693|NCT00949117|525334230|FG000|Overall Study|Lack of Efficacy|2|||
145676694|NCT00949117|525334231|FG001|Overall Study|Lack of Efficacy|3|||
145676695|NCT00949117|525334230|FG000|Overall Study|Protocol Violation|1|||
145676696|NCT00949117|525334231|FG001|Overall Study|Protocol Violation|1|||
145676697|NCT00949117|525334230|FG000|Overall Study|Adverse Event|0|||
145676698|NCT00949117|525334231|FG001|Overall Study|Adverse Event|1|||
145676699|NCT03769090|525334232|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
145676700|NCT03769090|525334233|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
145676701|NCT03769090|525334234|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
145676702|NCT03769090|525334232|FG000|Overall Study|Withdrawal by Subject|52|||
145676703|NCT03769090|525334233|FG001|Overall Study|Withdrawal by Subject|62|||
145676704|NCT03769090|525334234|FG002|Overall Study|Withdrawal by Subject|74|||
145676705|NCT03769090|525334232|FG000|Overall Study|Death|4|||
145676706|NCT03769090|525334233|FG001|Overall Study|Death|2|||
145676707|NCT03769090|525334234|FG002|Overall Study|Death|2|||
145676708|NCT03769090|525334232|FG000|Overall Study|Adverse Event|7|||
145676709|NCT03769090|525334233|FG001|Overall Study|Adverse Event|7|||
145676710|NCT03769090|525334234|FG002|Overall Study|Adverse Event|8|||
145676711|NCT03769090|525334232|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
145676712|NCT03769090|525334233|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
145676713|NCT03769090|525334234|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
145676714|NCT03769090|525334232|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
145676715|NCT03769090|525334233|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
145676716|NCT03769090|525334234|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
145676717|NCT03769090|525334232|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
145676718|NCT03769090|525334233|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
145676719|NCT03769090|525334234|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
145676720|NCT03769090|525334232|FG000|Overall Study|Protocol Violation|5|||
145676721|NCT03769090|525334233|FG001|Overall Study|Protocol Violation|6|||
145676722|NCT03769090|525334234|FG002|Overall Study|Protocol Violation|8|||
145676723|NCT03769090|525334232|FG000|Overall Study|Pregnancy|1|||
145676724|NCT03769090|525334233|FG001|Overall Study|Pregnancy|0|||
145676725|NCT03769090|525334234|FG002|Overall Study|Pregnancy|3|||
145676726|NCT03769090|525334232|FG000|Overall Study|Lost to Follow-up|19|||
145676727|NCT03769090|525334233|FG001|Overall Study|Lost to Follow-up|25|||
145676728|NCT03769090|525334234|FG002|Overall Study|Lost to Follow-up|21|||
145676729|NCT03769090|525334232|FG000|Overall Study|Condition under investigation worsened|2|||
145676730|NCT03769090|525334233|FG001|Overall Study|Condition under investigation worsened|0|||
145676731|NCT03769090|525334234|FG002|Overall Study|Condition under investigation worsened|1|||
145676732|NCT03769090|525334232|FG000|Overall Study|Lack of Efficacy|1|||
145676733|NCT03769090|525334233|FG001|Overall Study|Lack of Efficacy|2|||
145676734|NCT03769090|525334234|FG002|Overall Study|Lack of Efficacy|2|||
145676735|NCT03769090|525334232|FG000|Overall Study|Other reasons|8|||
145676736|NCT03769090|525334233|FG001|Overall Study|Other reasons|12|||
145676737|NCT03769090|525334234|FG002|Overall Study|Other reasons|15|||
145676738|NCT03964974|525334235|FG000|Overall Study|Lost to Follow-up|3|||
145676739|NCT03964974|525334236|FG001|Overall Study|Lost to Follow-up|2|||
145676740|NCT03964974|525334235|FG000|Overall Study|Withdrawal by Subject|0|||
145676741|NCT03964974|525334236|FG001|Overall Study|Withdrawal by Subject|3|||
145676742|NCT02014402|525334237|FG000|Overall Study|Adverse Event|1|||
145676743|NCT02014402|525334238|FG001|Overall Study|Adverse Event|0|||
145676744|NCT02014402|525334239|FG002|Overall Study|Adverse Event|0|||
145676745|NCT02014402|525334240|FG003|Overall Study|Adverse Event|0|||
145676746|NCT02014402|525334237|FG000|Overall Study|Withdrawal by Subject|1|||
145676747|NCT02014402|525334238|FG001|Overall Study|Withdrawal by Subject|2|||
145676748|NCT02014402|525334239|FG002|Overall Study|Withdrawal by Subject|2|||
145676749|NCT02014402|525334240|FG003|Overall Study|Withdrawal by Subject|1|||
145676750|NCT02014402|525334237|FG000|Overall Study|Subject did not have transportation|0|||
145676751|NCT02014402|525334238|FG001|Overall Study|Subject did not have transportation|1|||
145676752|NCT02014402|525334239|FG002|Overall Study|Subject did not have transportation|0|||
145676753|NCT02014402|525334240|FG003|Overall Study|Subject did not have transportation|0|||
145676754|NCT02014402|525334237|FG000|Overall Study|Lost to Follow-up|0|||
145676755|NCT02014402|525334238|FG001|Overall Study|Lost to Follow-up|0|||
145676756|NCT02014402|525334239|FG002|Overall Study|Lost to Follow-up|1|||
145676757|NCT02014402|525334240|FG003|Overall Study|Lost to Follow-up|2|||
145676758|NCT02713594|525334244|FG000|Overall Study|Withdrawal by Subject|32|||
145676759|NCT02713594|525334245|FG001|Overall Study|Withdrawal by Subject|22|||
145676760|NCT02713594|525334244|FG000|Overall Study|Lost to Follow-up|358|||
145676761|NCT02713594|525334245|FG001|Overall Study|Lost to Follow-up|374|||
145676762|NCT02660086|525334246|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
145676763|NCT02660086|525334247|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
145676764|NCT02660086|525334246|FG000|Overall Study- 12-month|Left full-time employment|12|||
145676765|NCT02660086|525334247|FG001|Overall Study- 12-month|Left full-time employment|20|||
145676766|NCT02660086|525334246|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
145676767|NCT02660086|525334247|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
145676768|NCT02660086|525334246|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
145676769|NCT02660086|525334247|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
145676770|NCT02660086|525334246|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
145676771|NCT02660086|525334247|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
145676772|NCT02660086|525334246|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
145676773|NCT02660086|525334247|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
145676774|NCT03928743|525334253|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
145676775|NCT03928743|525334254|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
145676776|NCT03928743|525334255|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
145676777|NCT03928743|525334253|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
145676778|NCT03928743|525334254|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
145676779|NCT03928743|525334255|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
145676780|NCT03928743|525334253|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
145676781|NCT03928743|525334254|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
145676782|NCT03928743|525334255|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
145676783|NCT03928743|525334253|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
145676784|NCT03928743|525334254|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
145676785|NCT03928743|525334255|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
145676786|NCT03928743|525334253|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
145676787|NCT03928743|525334254|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
145676788|NCT03928743|525334255|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
145676789|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
145676790|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
145676791|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
145676792|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
145676793|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
145676794|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
145676795|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
145676796|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
145676797|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
145676798|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
145676799|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
145676800|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
145676801|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
145676802|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
145676803|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
145676804|NCT03928743|525334253|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
145676805|NCT03928743|525334254|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
145676806|NCT03928743|525334255|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
145676807|NCT05005247|525334256|FG000|Overall Study|Withdrawal by Subject|0|||
145676808|NCT05005247|525334257|FG001|Overall Study|Withdrawal by Subject|1|||
145676809|NCT05005247|525334258|FG002|Overall Study|Withdrawal by Subject|0|||
145676810|NCT01450007|525334259|FG000|Overall Study|Late exclusion before treatment|2|||
145676811|NCT01450007|525334260|FG001|Overall Study|Late exclusion before treatment|3|||
145676812|NCT01450007|525334261|FG002|Overall Study|Late exclusion before treatment|2|||
145676813|NCT01450007|525334259|FG000|Overall Study|Protocol Violation|0|||
145676814|NCT01450007|525334260|FG001|Overall Study|Protocol Violation|1|||
145676815|NCT01450007|525334261|FG002|Overall Study|Protocol Violation|1|||
145676816|NCT01450007|525334259|FG000|Overall Study|Adverse Event|0|||
145676817|NCT01450007|525334260|FG001|Overall Study|Adverse Event|1|||
145676818|NCT01450007|525334261|FG002|Overall Study|Adverse Event|0|||
145676819|NCT02958553|525334262|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
145676820|NCT02958553|525334262|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
145676821|NCT00273052|525334276|FG000|Overall Study|Withdrawal by Subject|16|||
145676822|NCT00273052|525334277|FG001|Overall Study|Withdrawal by Subject|19|||
145676823|NCT00273052|525334276|FG000|Overall Study|Adverse Event|21|||
145676824|NCT00273052|525334277|FG001|Overall Study|Adverse Event|19|||
145676825|NCT00273052|525334276|FG000|Overall Study|Protocol Violation|14|||
145676826|NCT00273052|525334277|FG001|Overall Study|Protocol Violation|18|||
145676827|NCT00273052|525334276|FG000|Overall Study|Lost to Follow-up|7|||
145676828|NCT00273052|525334277|FG001|Overall Study|Lost to Follow-up|25|||
145676829|NCT00273052|525334276|FG000|Overall Study|Lack of Efficacy|6|||
145676830|NCT00273052|525334277|FG001|Overall Study|Lack of Efficacy|4|||
145676831|NCT00273052|525334276|FG000|Overall Study|Non-Compliance|3|||
145676832|NCT00273052|525334277|FG001|Overall Study|Non-Compliance|1|||
145676833|NCT00273052|525334276|FG000|Overall Study|Other|2|||
145676834|NCT00273052|525334277|FG001|Overall Study|Other|0|||
145676835|NCT00273052|525334276|FG000|Overall Study|Worsening serum lipid levels|0|||
145676836|NCT00273052|525334277|FG001|Overall Study|Worsening serum lipid levels|2|||
145676837|NCT02224755|525334278|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
145676838|NCT02224755|525334279|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
145676839|NCT02224755|525334278|FG000|Two Year Follow up Post-implant|Death|103|||
145676840|NCT02224755|525334279|FG001|Two Year Follow up Post-implant|Death|98|||
145676841|NCT02224755|525334278|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
145676842|NCT02224755|525334279|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
145676843|NCT02224755|525334278|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
145676844|NCT02224755|525334279|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
145676845|NCT02224755|525334278|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
145676846|NCT02224755|525334279|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
145676847|NCT01951703|525334280|FG000|First Intervention|Withdrawal by Subject|1|||
145676848|NCT01951703|525334281|FG001|First Intervention|Withdrawal by Subject|0|||
145676849|NCT01951703|525334280|FG000|First Intervention|Subject was not compliant|1|||
145676850|NCT01951703|525334281|FG001|First Intervention|Subject was not compliant|1|||
145676851|NCT01951703|525334280|FG000|First Intervention|Physician Decision|1|||
145676852|NCT01951703|525334281|FG001|First Intervention|Physician Decision|0|||
145676853|NCT01951703|525334280|FG000|Second Intervention|Protocol Violation|0|||
145676854|NCT01951703|525334281|FG001|Second Intervention|Protocol Violation|1|||
145676855|NCT01951703|525334280|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
145676856|NCT01951703|525334281|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
145676857|NCT01852045|525334282|FG000|Overall Study|Adverse Event|1|||
145676858|NCT01852045|525334283|FG001|Overall Study|Adverse Event|0|||
145676859|NCT01852045|525334284|FG002|Overall Study|Adverse Event|0|||
145676860|NCT01852045|525334282|FG000|Overall Study|Lack of Efficacy|3|||
145676861|NCT01852045|525334283|FG001|Overall Study|Lack of Efficacy|0|||
145676862|NCT01852045|525334284|FG002|Overall Study|Lack of Efficacy|0|||
145676863|NCT01852045|525334282|FG000|Overall Study|Lost to Follow-up|0|||
145676864|NCT01852045|525334283|FG001|Overall Study|Lost to Follow-up|1|||
145676865|NCT01852045|525334284|FG002|Overall Study|Lost to Follow-up|1|||
145676866|NCT01852045|525334282|FG000|Overall Study|Withdrawal by Subject|1|||
145676867|NCT01852045|525334283|FG001|Overall Study|Withdrawal by Subject|0|||
145676868|NCT01852045|525334284|FG002|Overall Study|Withdrawal by Subject|1|||
145676869|NCT01852045|525334282|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145676870|NCT01852045|525334283|FG001|Overall Study|Other Miscellaneous Reasons|3|||
145676871|NCT01852045|525334284|FG002|Overall Study|Other Miscellaneous Reasons|2|||
145676872|NCT02827201|525334285|FG000|Overall Study|Death|1|||
145676873|NCT02827201|525334286|FG001|Overall Study|Death|2|||
145676874|NCT02827201|525334285|FG000|Overall Study|Patients not treated|1|||
145676875|NCT02827201|525334286|FG001|Overall Study|Patients not treated|1|||
145676876|NCT02736188|525334289|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
145676877|NCT02736188|525334289|FG000|Overall Study|Adverse Event|1|||
145676878|NCT02736188|525334289|FG000|Overall Study|Withdrawal by Subject|1|||
145676879|NCT02736188|525334289|FG000|Overall Study|Other|6|||
145676880|NCT00240994|525334290|FG000|Overall Study|Lost to Follow-up|1|||
145676881|NCT00240994|525334290|FG000|Overall Study|Protocol Violation|1|||
145676882|NCT00240994|525334290|FG000|Overall Study|Graft failure|1|||
145676883|NCT02630186|525334291|FG000|Overall Study|Withdrawal by Subject|1|||
145676884|NCT00439218|525334292|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
145676885|NCT03176407|525334293|FG000|Overall Study|Protocol Violation|1|||
145676886|NCT03176407|525334293|FG000|Overall Study|human failure|1|||
145676887|NCT03176407|525334293|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
145676888|NCT05124210|525334294|FG000|Overall Study|Lost to Follow-up|1|||
145676889|NCT05124210|525334295|FG001|Overall Study|Lost to Follow-up|0|||
145676890|NCT05124210|525334294|FG000|Overall Study|Withdrawal by Subject|1|||
145676891|NCT05124210|525334295|FG001|Overall Study|Withdrawal by Subject|0|||
145676892|NCT01428583|525334296|FG000|Overall Study|Adverse Event|75|||
145676893|NCT01428583|525334296|FG000|Overall Study|Withdrawal by Subject|51|||
145676894|NCT01428583|525334296|FG000|Overall Study|Lack of Efficacy|37|||
145676895|NCT01428583|525334296|FG000|Overall Study|Lost to Follow-up|17|||
145676896|NCT01428583|525334296|FG000|Overall Study|Death|1|||
145676897|NCT01428583|525334296|FG000|Overall Study|Pregnancy|1|||
145676898|NCT01428583|525334296|FG000|Overall Study|Protocol Violation|1|||
145676899|NCT01428583|525334296|FG000|Overall Study|Physician Decision|12|||
145676900|NCT01428583|525334296|FG000|Overall Study|Non-compliant|25|||
145676901|NCT01428583|525334296|FG000|Overall Study|Confirmed positive urine drug test|8|||
145676902|NCT01428583|525334296|FG000|Overall Study|Sponsor's request|3|||
145676903|NCT01428583|525334296|FG000|Overall Study|Other|6|||
145676904|NCT00768755|525334299|FG000|Phase 1|Death|6|||
145676905|NCT00768755|525334300|FG001|Phase 1|Death|0|||
145676906|NCT00768755|525334301|FG002|Phase 1|Death|0|||
145676907|NCT00768755|525334302|FG003|Phase 1|Death|0|||
145676908|NCT00768755|525334299|FG000|Phase 1|Other|4|||
145676909|NCT00768755|525334300|FG001|Phase 1|Other|0|||
145676910|NCT00768755|525334301|FG002|Phase 1|Other|0|||
145676911|NCT00768755|525334302|FG003|Phase 1|Other|0|||
145676912|NCT00768755|525334299|FG000|Phase 2|Death|0|||
145676913|NCT00768755|525334300|FG001|Phase 2|Death|37|||
145676914|NCT00768755|525334301|FG002|Phase 2|Death|48|||
145676915|NCT00768755|525334302|FG003|Phase 2|Death|31|||
145676916|NCT00768755|525334299|FG000|Phase 2|Protocol Violation|0|||
145676917|NCT00768755|525334300|FG001|Phase 2|Protocol Violation|2|||
145676918|NCT00768755|525334301|FG002|Phase 2|Protocol Violation|0|||
145676919|NCT00768755|525334302|FG003|Phase 2|Protocol Violation|1|||
145491054|NCT01384734|524652349|FG001|Overall Study|Lost to Follow-up|3|||
145676920|NCT00768755|525334299|FG000|Phase 2|Lost to Follow-up|0|||
145676921|NCT00768755|525334300|FG001|Phase 2|Lost to Follow-up|1|||
145676922|NCT00768755|525334301|FG002|Phase 2|Lost to Follow-up|1|||
145491055|NCT01384734|524652350|FG002|Overall Study|Lost to Follow-up|3|||
145676923|NCT00768755|525334302|FG003|Phase 2|Lost to Follow-up|4|||
145676924|NCT00768755|525334299|FG000|Phase 2|Withdrawal by Subject|0|||
145676925|NCT00768755|525334300|FG001|Phase 2|Withdrawal by Subject|1|||
145676926|NCT00768755|525334301|FG002|Phase 2|Withdrawal by Subject|0|||
145676927|NCT00768755|525334302|FG003|Phase 2|Withdrawal by Subject|1|||
145676928|NCT00768755|525334299|FG000|Phase 2|Other|0|||
145676929|NCT00768755|525334300|FG001|Phase 2|Other|1|||
145676930|NCT00768755|525334301|FG002|Phase 2|Other|2|||
145676931|NCT00768755|525334302|FG003|Phase 2|Other|4|||
145676932|NCT00768755|525334299|FG000|Phase 2|Study Terminated by Sponsor|0|||
145676933|NCT00768755|525334300|FG001|Phase 2|Study Terminated by Sponsor|13|||
145676934|NCT00768755|525334301|FG002|Phase 2|Study Terminated by Sponsor|7|||
145676935|NCT00768755|525334302|FG003|Phase 2|Study Terminated by Sponsor|14|||
145676936|NCT00768755|525334299|FG000|Phase 2|Randomized but not treated|0|||
145676937|NCT00768755|525334300|FG001|Phase 2|Randomized but not treated|0|||
145676938|NCT00768755|525334301|FG002|Phase 2|Randomized but not treated|0|||
145676939|NCT00768755|525334302|FG003|Phase 2|Randomized but not treated|2|||
145676940|NCT03142932|525334306|FG000|Overall Study|Lost to Follow-up|2|||
145676941|NCT03142932|525334307|FG001|Overall Study|Lost to Follow-up|11|||
145676942|NCT02128269|525334310|FG000|Treatment Period|Adverse Event|1|||
145676943|NCT02128269|525334310|FG000|Treatment Period|Physician Decision|1|||
145676944|NCT00878189|525334311|FG000|Overall Study|Death|0|||
145676945|NCT00878189|525334312|FG001|Overall Study|Death|1|||
145676946|NCT00878189|525334313|FG002|Overall Study|Death|0|||
145676947|NCT00878189|525334314|FG003|Overall Study|Death|1|||
145676948|NCT00878189|525334315|FG004|Overall Study|Death|0|||
145676949|NCT00878189|525334316|FG005|Overall Study|Death|0|||
145676950|NCT00878189|525334317|FG006|Overall Study|Death|0|||
145676951|NCT00878189|525334318|FG007|Overall Study|Death|0|||
145676952|NCT00878189|525334319|FG008|Overall Study|Death|1|||
145676953|NCT00878189|525334311|FG000|Overall Study|Participant Refused to Follow-up|0|||
145676954|NCT00878189|525334312|FG001|Overall Study|Participant Refused to Follow-up|0|||
145676955|NCT00878189|525334313|FG002|Overall Study|Participant Refused to Follow-up|0|||
145676956|NCT00878189|525334314|FG003|Overall Study|Participant Refused to Follow-up|0|||
145676957|NCT00878189|525334315|FG004|Overall Study|Participant Refused to Follow-up|0|||
145676958|NCT00878189|525334316|FG005|Overall Study|Participant Refused to Follow-up|4|||
145676959|NCT00878189|525334317|FG006|Overall Study|Participant Refused to Follow-up|0|||
145676960|NCT00878189|525334318|FG007|Overall Study|Participant Refused to Follow-up|0|||
145676961|NCT00878189|525334319|FG008|Overall Study|Participant Refused to Follow-up|0|||
145676962|NCT00878189|525334311|FG000|Overall Study|Other|3|||
145676963|NCT00878189|525334312|FG001|Overall Study|Other|2|||
145676964|NCT00878189|525334313|FG002|Overall Study|Other|4|||
145676965|NCT00878189|525334314|FG003|Overall Study|Other|7|||
145676966|NCT00878189|525334315|FG004|Overall Study|Other|4|||
145676967|NCT00878189|525334316|FG005|Overall Study|Other|18|||
145676968|NCT00878189|525334317|FG006|Overall Study|Other|15|||
145676969|NCT00878189|525334318|FG007|Overall Study|Other|3|||
145676970|NCT00878189|525334319|FG008|Overall Study|Other|4|||
145676971|NCT00878189|525334311|FG000|Overall Study|Lost to Follow-up|0|||
145676972|NCT00878189|525334312|FG001|Overall Study|Lost to Follow-up|0|||
145676973|NCT00878189|525334313|FG002|Overall Study|Lost to Follow-up|0|||
145676974|NCT00878189|525334314|FG003|Overall Study|Lost to Follow-up|0|||
145676975|NCT00878189|525334315|FG004|Overall Study|Lost to Follow-up|0|||
145676976|NCT00878189|525334316|FG005|Overall Study|Lost to Follow-up|1|||
145676977|NCT00878189|525334317|FG006|Overall Study|Lost to Follow-up|1|||
145676978|NCT00878189|525334318|FG007|Overall Study|Lost to Follow-up|0|||
145676979|NCT00878189|525334319|FG008|Overall Study|Lost to Follow-up|0|||
145676980|NCT00878189|525334311|FG000|Overall Study|Objection Progression or Relapse|0|||
145676981|NCT00878189|525334312|FG001|Overall Study|Objection Progression or Relapse|0|||
145676982|NCT00878189|525334313|FG002|Overall Study|Objection Progression or Relapse|0|||
145676983|NCT00878189|525334314|FG003|Overall Study|Objection Progression or Relapse|0|||
145676984|NCT00878189|525334315|FG004|Overall Study|Objection Progression or Relapse|0|||
145676985|NCT00878189|525334316|FG005|Overall Study|Objection Progression or Relapse|0|||
145676986|NCT00878189|525334317|FG006|Overall Study|Objection Progression or Relapse|0|||
145676987|NCT00878189|525334318|FG007|Overall Study|Objection Progression or Relapse|0|||
145676988|NCT00878189|525334319|FG008|Overall Study|Objection Progression or Relapse|3|||
145676989|NCT00638456|525334320|FG000|Overall Study|Withdrawal by Subject|6|||
145676990|NCT00638456|525334321|FG001|Overall Study|Withdrawal by Subject|2|||
145676991|NCT02007070|525334322|FG000|Overall Study|Adverse Event|4|||
145676992|NCT02007070|525334322|FG000|Overall Study|Clinical Progression|4|||
145676993|NCT02007070|525334322|FG000|Overall Study|Death|1|||
145676994|NCT02007070|525334322|FG000|Overall Study|Protocol Violation|2|||
145676995|NCT02007070|525334322|FG000|Overall Study|Physician Decision|1|||
145676996|NCT02007070|525334322|FG000|Overall Study|Progressive Disease|21|||
145676997|NCT00703092|525334323|FG000|Overall Study|Withdrawal by Subject|2|||
145676998|NCT01480258|525334324|FG000|Infant Series|Protocol Violation|2|||
145676999|NCT01480258|525334325|FG001|Infant Series|Protocol Violation|0|||
145677000|NCT01480258|525334324|FG000|Infant Series|Physician Decision|0|||
145677001|NCT01480258|525334325|FG001|Infant Series|Physician Decision|1|||
145677002|NCT01480258|525334324|FG000|Infant Series|Not Vaccinated|3|||
145677003|NCT01480258|525334325|FG001|Infant Series|Not Vaccinated|0|||
145677004|NCT01480258|525334324|FG000|Infant Series|Adverse Event|1|||
145677005|NCT01480258|525334325|FG001|Infant Series|Adverse Event|1|||
145677006|NCT01480258|525334324|FG000|Infant Series|Withdrawal by Subject|1|||
145677007|NCT01480258|525334325|FG001|Infant Series|Withdrawal by Subject|6|||
145677008|NCT01480258|525334324|FG000|Interim Period|Lost to Follow-up|0|||
145677009|NCT01480258|525334325|FG001|Interim Period|Lost to Follow-up|2|||
145677010|NCT01480258|525334324|FG000|Interim Period|Physician Decision|1|||
145677011|NCT01480258|525334325|FG001|Interim Period|Physician Decision|0|||
145677012|NCT01480258|525334324|FG000|Interim Period|Protocol Violation|0|||
145677013|NCT01480258|525334325|FG001|Interim Period|Protocol Violation|1|||
145677014|NCT01480258|525334324|FG000|Interim Period|Withdrawal by Subject|9|||
145677015|NCT01480258|525334325|FG001|Interim Period|Withdrawal by Subject|6|||
145677016|NCT01640288|525334328|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
145677017|NCT01640288|525334329|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
145677018|NCT01640288|525334328|FG000|Overall Study|Screen Failure|20|||
145677019|NCT01640288|525334329|FG001|Overall Study|Screen Failure|18|||
145677020|NCT01640288|525334328|FG000|Overall Study|Withdrawn by PI|5|||
145677021|NCT01640288|525334329|FG001|Overall Study|Withdrawn by PI|0|||
145677022|NCT01640288|525334328|FG000|Overall Study|Withdrawal by Subject|1|||
145677023|NCT01640288|525334329|FG001|Overall Study|Withdrawal by Subject|0|||
145677024|NCT00787176|525334331|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
145677025|NCT00787176|525334332|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
145677026|NCT00787176|525334333|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
145677027|NCT00787176|525334334|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
145677028|NCT04660799|525334339|FG000|Overall Study|Progressive Disease|1|||
145677029|NCT04660799|525334340|FG001|Overall Study|Progressive Disease|1|||
145677030|NCT04660799|525334339|FG000|Overall Study|Death|2|||
145677031|NCT04660799|525334340|FG001|Overall Study|Death|1|||
145677032|NCT04660799|525334339|FG000|Overall Study|Adverse Event|2|||
145677033|NCT04660799|525334340|FG001|Overall Study|Adverse Event|1|||
145677034|NCT04660799|525334339|FG000|Overall Study|Withdrawal by Subject|2|||
145677035|NCT04660799|525334340|FG001|Overall Study|Withdrawal by Subject|5|||
145677036|NCT02706483|525334341|FG000|Overall Study|Adverse Event|97|||
145677037|NCT02706483|525334341|FG000|Overall Study|Death|1|||
145677038|NCT02706483|525334341|FG000|Overall Study|Lack of Efficacy|39|||
145677039|NCT02706483|525334341|FG000|Overall Study|Lost to Follow-up|101|||
145677040|NCT02706483|525334341|FG000|Overall Study|Non-compliance with study drug|15|||
145677041|NCT02706483|525334341|FG000|Overall Study|Physician Decision|6|||
145677042|NCT02706483|525334341|FG000|Overall Study|Pregnancy|6|||
145677043|NCT02706483|525334341|FG000|Overall Study|Protocol Violation|18|||
145677044|NCT02706483|525334341|FG000|Overall Study|Withdrawal by Subject|136|||
145677045|NCT02706483|525334341|FG000|Overall Study|Non-compliance with visits|6|||
145677046|NCT02706483|525334341|FG000|Overall Study|Site closure|4|||
145677047|NCT02706483|525334341|FG000|Overall Study|Subject moved|1|||
145677048|NCT00659373|525334343|FG000|Overall Study|Withdrawal by Subject|3|||
145677049|NCT00659373|525334344|FG001|Overall Study|Withdrawal by Subject|5|||
145677050|NCT00659373|525334343|FG000|Overall Study|Assessment Missed|2|||
145677051|NCT00659373|525334344|FG001|Overall Study|Assessment Missed|2|||
145677052|NCT03042767|525334345|FG000|Overall Study|Lost to Follow-up|1|||
145677053|NCT03042767|525334346|FG001|Overall Study|Lost to Follow-up|2|||
145677054|NCT01543204|525334347|FG000|Overall Study|Non-compliance|1|||
145677055|NCT01543204|525334347|FG000|Overall Study|Adverse Event|1|||
145677056|NCT01543204|525334347|FG000|Overall Study|Withdrawal by Subject|4|||
145677057|NCT01543204|525334347|FG000|Overall Study|Requirement for Alternative Therapy|1|||
145677058|NCT01543204|525334347|FG000|Overall Study|Lost to Follow-up|1|||
145677059|NCT01220999|525334348|FG000|Overall Study|Progressive disease|0|||
145677060|NCT01220999|525334349|FG001|Overall Study|Progressive disease|0|||
145677061|NCT01220999|525334350|FG002|Overall Study|Progressive disease|1|||
145677062|NCT01220999|525334351|FG003|Overall Study|Progressive disease|0|||
145677063|NCT01220999|525334352|FG004|Overall Study|Progressive disease|0|||
145677064|NCT03326856|525334354|FG000|Overall Study|Lost to Follow-up|1|||
145677065|NCT03326856|525334355|FG001|Overall Study|Lost to Follow-up|1|||
145677066|NCT03326856|525334356|FG002|Overall Study|Lost to Follow-up|0|||
145677067|NCT03326856|525334357|FG003|Overall Study|Lost to Follow-up|0|||
145677068|NCT03326856|525334358|FG004|Overall Study|Lost to Follow-up|0|||
145677069|NCT02037568|525334359|FG000|Overall Study|Withdrawal by Subject|17|||
145677070|NCT02037568|525334360|FG001|Overall Study|Withdrawal by Subject|24|||
145677071|NCT02037568|525334359|FG000|Overall Study|Lost to Follow-up|16|||
145677072|NCT02037568|525334360|FG001|Overall Study|Lost to Follow-up|13|||
145677073|NCT02037568|525334359|FG000|Overall Study|Screen Failure|3|||
145677074|NCT02037568|525334360|FG001|Overall Study|Screen Failure|1|||
145677075|NCT02037568|525334359|FG000|Overall Study|Patient did not receive transplant|0|||
145677076|NCT02037568|525334360|FG001|Overall Study|Patient did not receive transplant|1|||
145677077|NCT00721734|525334363|FG000|Overall Study|Progressive Disease|3|||
145677078|NCT00721734|525334364|FG001|Overall Study|Progressive Disease|10|||
145677079|NCT00721734|525334365|FG002|Overall Study|Progressive Disease|4|||
145677080|NCT00721734|525334366|FG003|Overall Study|Progressive Disease|5|||
145677081|NCT00721734|525334367|FG004|Overall Study|Progressive Disease|2|||
145677082|NCT00721734|525334363|FG000|Overall Study|Adverse Event|3|||
145677083|NCT00721734|525334364|FG001|Overall Study|Adverse Event|1|||
145677084|NCT00721734|525334365|FG002|Overall Study|Adverse Event|4|||
145677085|NCT00721734|525334366|FG003|Overall Study|Adverse Event|0|||
145677086|NCT00721734|525334367|FG004|Overall Study|Adverse Event|3|||
145677087|NCT00721734|525334363|FG000|Overall Study|Withdrawal by Subject|2|||
145677088|NCT00721734|525334364|FG001|Overall Study|Withdrawal by Subject|1|||
145677089|NCT00721734|525334365|FG002|Overall Study|Withdrawal by Subject|0|||
145677090|NCT00721734|525334366|FG003|Overall Study|Withdrawal by Subject|0|||
145677091|NCT00721734|525334367|FG004|Overall Study|Withdrawal by Subject|1|||
145677092|NCT00721734|525334363|FG000|Overall Study|Other|0|||
145677093|NCT00721734|525334364|FG001|Overall Study|Other|0|||
145677094|NCT00721734|525334365|FG002|Overall Study|Other|0|||
145677095|NCT00721734|525334366|FG003|Overall Study|Other|1|||
145677096|NCT00721734|525334367|FG004|Overall Study|Other|0|||
145677097|NCT02833948|525334370|FG000|Overall Study|Death|2|||
145677098|NCT02833948|525334371|FG001|Overall Study|Death|3|||
145677099|NCT02833948|525334370|FG000|Overall Study|were not scanned|8|||
145677100|NCT02833948|525334371|FG001|Overall Study|were not scanned|13|||
145677101|NCT02833948|525334370|FG000|Overall Study|scans could not be evaluated|5|||
145677102|NCT02833948|525334371|FG001|Overall Study|scans could not be evaluated|2|||
145677103|NCT05169684|525334375|FG000|Overall Study|Adverse Event|1|||
145677104|NCT05169684|525334376|FG001|Overall Study|Adverse Event|3|||
145677105|NCT05169684|525334375|FG000|Overall Study|Physician Decision|0|||
145677106|NCT05169684|525334376|FG001|Overall Study|Physician Decision|1|||
145677107|NCT05169684|525334375|FG000|Overall Study|Progressive Disease|1|||
145677108|NCT05169684|525334376|FG001|Overall Study|Progressive Disease|1|||
145677109|NCT05169684|525334375|FG000|Overall Study|Participant request to discontinue treatment|0|||
145677110|NCT05169684|525334376|FG001|Overall Study|Participant request to discontinue treatment|1|||
145677111|NCT05169684|525334375|FG000|Overall Study|Other Reason|0|||
145677112|NCT05169684|525334376|FG001|Overall Study|Other Reason|1|||
145677113|NCT03539055|525334377|FG000|Overall Study|Death|4|||
145677114|NCT03539055|525334377|FG000|Overall Study|Lost to Follow-up|1|||
145677115|NCT03539055|525334377|FG000|Overall Study|Withdrawal by Subject|2|||
145677116|NCT03539055|525334377|FG000|Overall Study|Screen Fail|7|||
145677117|NCT03539055|525334377|FG000|Overall Study|Drug Intolerance|2|||
145677118|NCT01638000|525334384|FG000|Overall Study|Randomized but Never Received Drug|7|||
145677119|NCT01638000|525334385|FG001|Overall Study|Randomized but Never Received Drug|10|||
145677120|NCT01638000|525334384|FG000|Overall Study|Adverse Event|14|||
145677121|NCT01638000|525334385|FG001|Overall Study|Adverse Event|16|||
145677122|NCT01638000|525334384|FG000|Overall Study|Lack of Efficacy|5|||
145677123|NCT01638000|525334385|FG001|Overall Study|Lack of Efficacy|6|||
145677124|NCT01638000|525334384|FG000|Overall Study|Protocol Violation|11|||
145677125|NCT01638000|525334385|FG001|Overall Study|Protocol Violation|13|||
145677126|NCT01638000|525334384|FG000|Overall Study|Withdrawal by Subject|21|||
145677127|NCT01638000|525334385|FG001|Overall Study|Withdrawal by Subject|24|||
145677128|NCT01638000|525334384|FG000|Overall Study|Miscellaneous|2|||
145677129|NCT01638000|525334385|FG001|Overall Study|Miscellaneous|2|||
145677130|NCT05484661|525334386|FG000|Overall Study|Withdrawal by Subject|1|||
145677131|NCT05484661|525334387|FG001|Overall Study|Withdrawal by Subject|0|||
145677132|NCT03775213|525334388|FG000|Overall Study|Withdrawal by Subject|51|||
145677133|NCT03775213|525334389|FG001|Overall Study|Withdrawal by Subject|53|||
145677134|NCT03775213|525334388|FG000|Overall Study|Incomplete Survey|7|||
145677135|NCT03775213|525334389|FG001|Overall Study|Incomplete Survey|7|||
145677136|NCT05163353|525334390|FG000|Overall Study|Adverse Event|1|||
145677137|NCT05163353|525334391|FG001|Overall Study|Adverse Event|0|||
145677138|NCT05163353|525334390|FG000|Overall Study|Withdrawal by Subject|21|||
145677139|NCT05163353|525334391|FG001|Overall Study|Withdrawal by Subject|6|||
145677140|NCT05163353|525334390|FG000|Overall Study|Protocol Violation|0|||
145677141|NCT05163353|525334391|FG001|Overall Study|Protocol Violation|1|||
145677142|NCT05163353|525334390|FG000|Overall Study|Lost to Follow-up|13|||
145677143|NCT05163353|525334391|FG001|Overall Study|Lost to Follow-up|2|||
145677144|NCT06086028|525334392|FG000|Overall Study|Withdrawal by Subject|1|||
145677145|NCT06086028|525334393|FG001|Overall Study|Withdrawal by Subject|1|||
145677146|NCT06086028|525334392|FG000|Overall Study|Lost to Follow-up|2|||
145677147|NCT06086028|525334393|FG001|Overall Study|Lost to Follow-up|3|||
145677148|NCT02521493|525334395|FG000|Overall Study|Death|3|||
145677149|NCT02521493|525334396|FG001|Overall Study|Death|4|||
145677150|NCT02521493|525334397|FG002|Overall Study|Death|1|||
145677151|NCT02521493|525334395|FG000|Overall Study|Physician Decision|19|||
145491056|NCT01384734|524652351|FG003|Overall Study|Lost to Follow-up|8|||
145677152|NCT02521493|525334396|FG001|Overall Study|Physician Decision|1|||
145677153|NCT02521493|525334397|FG002|Overall Study|Physician Decision|2|||
145677154|NCT02521493|525334395|FG000|Overall Study|Withdrawal by Subject|3|||
145677155|NCT02521493|525334396|FG001|Overall Study|Withdrawal by Subject|0|||
145677156|NCT02521493|525334397|FG002|Overall Study|Withdrawal by Subject|0|||
145677157|NCT02521493|525334395|FG000|Overall Study|Ineligible|0|||
145677158|NCT02521493|525334396|FG001|Overall Study|Ineligible|1|||
145677159|NCT02521493|525334397|FG002|Overall Study|Ineligible|0|||
145677160|NCT02521493|525334395|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
145677161|NCT02521493|525334396|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
145677162|NCT02521493|525334397|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
145677163|NCT02521493|525334395|FG000|Overall Study|No MRD result|0|||
145677164|NCT02521493|525334396|FG001|Overall Study|No MRD result|0|||
145677165|NCT02521493|525334397|FG002|Overall Study|No MRD result|4|||
145677166|NCT05615363|525334398|FG000|Overall Study|Adverse Event|0|||
145677167|NCT05615363|525334399|FG001|Overall Study|Adverse Event|4|||
145677168|NCT05615363|525334400|FG002|Overall Study|Adverse Event|4|||
145677169|NCT05615363|525334401|FG003|Overall Study|Adverse Event|3|||
145677170|NCT05615363|525334402|FG004|Overall Study|Adverse Event|1|||
145677171|NCT05615363|525334398|FG000|Overall Study|Physician Decision|2|||
145677172|NCT05615363|525334399|FG001|Overall Study|Physician Decision|0|||
145677173|NCT05615363|525334400|FG002|Overall Study|Physician Decision|4|||
145677174|NCT05615363|525334401|FG003|Overall Study|Physician Decision|1|||
145677175|NCT05615363|525334402|FG004|Overall Study|Physician Decision|3|||
145677176|NCT05615363|525334398|FG000|Overall Study|Protocol Violation|2|||
145677177|NCT05615363|525334399|FG001|Overall Study|Protocol Violation|0|||
145677178|NCT05615363|525334400|FG002|Overall Study|Protocol Violation|0|||
145677179|NCT05615363|525334401|FG003|Overall Study|Protocol Violation|0|||
145677180|NCT05615363|525334402|FG004|Overall Study|Protocol Violation|1|||
145677181|NCT05615363|525334398|FG000|Overall Study|Withdrawal by Subject|0|||
145677182|NCT05615363|525334399|FG001|Overall Study|Withdrawal by Subject|0|||
145677183|NCT05615363|525334400|FG002|Overall Study|Withdrawal by Subject|1|||
145677184|NCT05615363|525334401|FG003|Overall Study|Withdrawal by Subject|0|||
145677185|NCT05615363|525334402|FG004|Overall Study|Withdrawal by Subject|0|||
145677186|NCT01021748|525336623|FG000|Overall Study|Adverse Event|2|||
145677187|NCT01021748|525336624|FG001|Overall Study|Adverse Event|1|||
145677188|NCT01021748|525336625|FG002|Overall Study|Adverse Event|2|||
145677189|NCT01021748|525336626|FG003|Overall Study|Adverse Event|0|||
145677190|NCT01021748|525336627|FG004|Overall Study|Adverse Event|2|||
145677191|NCT01021748|525336628|FG005|Overall Study|Adverse Event|0|||
145677192|NCT01021748|525336629|FG006|Overall Study|Adverse Event|1|||
145677193|NCT01021748|525336630|FG007|Overall Study|Adverse Event|0|||
145677194|NCT01021748|525336631|FG008|Overall Study|Adverse Event|7|||
145677195|NCT01021748|525336623|FG000|Overall Study|Physician Decision|1|||
145677196|NCT01021748|525336624|FG001|Overall Study|Physician Decision|0|||
145677197|NCT01021748|525336625|FG002|Overall Study|Physician Decision|1|||
145677198|NCT01021748|525336626|FG003|Overall Study|Physician Decision|1|||
145677199|NCT01021748|525336627|FG004|Overall Study|Physician Decision|0|||
145677200|NCT01021748|525336628|FG005|Overall Study|Physician Decision|0|||
145677201|NCT01021748|525336629|FG006|Overall Study|Physician Decision|1|||
145677202|NCT01021748|525336630|FG007|Overall Study|Physician Decision|1|||
145677203|NCT01021748|525336631|FG008|Overall Study|Physician Decision|2|||
145677204|NCT01021748|525336623|FG000|Overall Study|Progressive Disease|3|||
145677205|NCT01021748|525336624|FG001|Overall Study|Progressive Disease|3|||
145677206|NCT01021748|525336625|FG002|Overall Study|Progressive Disease|4|||
145677207|NCT01021748|525336626|FG003|Overall Study|Progressive Disease|6|||
145677208|NCT01021748|525336627|FG004|Overall Study|Progressive Disease|7|||
145677209|NCT01021748|525336628|FG005|Overall Study|Progressive Disease|3|||
145677210|NCT01021748|525336629|FG006|Overall Study|Progressive Disease|0|||
145677211|NCT01021748|525336630|FG007|Overall Study|Progressive Disease|5|||
145677212|NCT01021748|525336631|FG008|Overall Study|Progressive Disease|6|||
145677213|NCT01021748|525336623|FG000|Overall Study|Withdrawal by Subject|0|||
145677214|NCT01021748|525336624|FG001|Overall Study|Withdrawal by Subject|0|||
145677215|NCT01021748|525336625|FG002|Overall Study|Withdrawal by Subject|0|||
145677216|NCT01021748|525336626|FG003|Overall Study|Withdrawal by Subject|0|||
145677217|NCT01021748|525336627|FG004|Overall Study|Withdrawal by Subject|0|||
145677218|NCT01021748|525336628|FG005|Overall Study|Withdrawal by Subject|0|||
145677219|NCT01021748|525336629|FG006|Overall Study|Withdrawal by Subject|1|||
145677220|NCT01021748|525336630|FG007|Overall Study|Withdrawal by Subject|0|||
145677221|NCT01021748|525336631|FG008|Overall Study|Withdrawal by Subject|1|||
145677222|NCT01021748|525336623|FG000|Overall Study|Not Treated|0|||
145677223|NCT01021748|525336624|FG001|Overall Study|Not Treated|1|||
145677224|NCT01021748|525336625|FG002|Overall Study|Not Treated|0|||
145677225|NCT01021748|525336626|FG003|Overall Study|Not Treated|0|||
145677226|NCT01021748|525336627|FG004|Overall Study|Not Treated|0|||
145677227|NCT01021748|525336628|FG005|Overall Study|Not Treated|0|||
145677228|NCT01021748|525336629|FG006|Overall Study|Not Treated|0|||
145677229|NCT01021748|525336630|FG007|Overall Study|Not Treated|0|||
145677230|NCT01021748|525336631|FG008|Overall Study|Not Treated|0|||
145677231|NCT01829711|525336632|FG000|Overall Study|Lost to Follow-up|2|||
145677232|NCT01829711|525336632|FG000|Overall Study|Withdrawal by Subject|3|||
145677233|NCT01829711|525336632|FG000|Overall Study|Death|4|||
145677234|NCT01829711|525336632|FG000|Overall Study|Started new therapies|17|||
145677235|NCT01829711|525336632|FG000|Overall Study|Adverse Event|3|||
145677236|NCT01829711|525336632|FG000|Overall Study|Due to progression of disease|13|||
145677237|NCT01829711|525336632|FG000|Overall Study|Due to lack of response|1|||
145677238|NCT02935673|525336633|FG000|Overall Study|Adverse Event|0|||
145677239|NCT02935673|525336634|FG001|Overall Study|Adverse Event|1|||
145677240|NCT02935673|525336635|FG002|Overall Study|Adverse Event|0|||
145677241|NCT02935673|525336633|FG000|Overall Study|Withdrawal by Subject|1|||
145677242|NCT02935673|525336634|FG001|Overall Study|Withdrawal by Subject|2|||
145677243|NCT02935673|525336635|FG002|Overall Study|Withdrawal by Subject|0|||
145677244|NCT01228734|525336639|FG000|Overall Study|Randomized, but not treated|0|||
145677245|NCT01228734|525336640|FG001|Overall Study|Randomized, but not treated|4|||
145677246|NCT00089791|525336641|FG000|Overall Study|Physician Decision|6|||
145677247|NCT00089791|525336642|FG001|Overall Study|Physician Decision|3|||
145677248|NCT00089791|525336641|FG000|Overall Study|Adverse Event|81|||
145677249|NCT00089791|525336642|FG001|Overall Study|Adverse Event|93|||
145677250|NCT00089791|525336641|FG000|Overall Study|Withdrawal by Subject|403|||
145677251|NCT00089791|525336642|FG001|Overall Study|Withdrawal by Subject|344|||
145677252|NCT00089791|525336641|FG000|Overall Study|Death|78|||
145677253|NCT00089791|525336642|FG001|Overall Study|Death|62|||
145677254|NCT00089791|525336641|FG000|Overall Study|Disease progression|7|||
145677255|NCT00089791|525336642|FG001|Overall Study|Disease progression|3|||
145677256|NCT00089791|525336641|FG000|Overall Study|Ineligibility determined|12|||
145677257|NCT00089791|525336642|FG001|Overall Study|Ineligibility determined|9|||
145677258|NCT00089791|525336641|FG000|Overall Study|Lost to Follow-up|57|||
145677259|NCT00089791|525336642|FG001|Overall Study|Lost to Follow-up|57|||
145677260|NCT00089791|525336641|FG000|Overall Study|Noncompliance|17|||
145677261|NCT00089791|525336642|FG001|Overall Study|Noncompliance|13|||
145677262|NCT00089791|525336641|FG000|Overall Study|Other|20|||
145677263|NCT00089791|525336642|FG001|Overall Study|Other|32|||
145677264|NCT00089791|525336641|FG000|Overall Study|Protocol deviation|12|||
145677265|NCT00089791|525336642|FG001|Overall Study|Protocol deviation|10|||
145677266|NCT00089791|525336641|FG000|Overall Study|Requirement for alternative therapy|7|||
145677267|NCT00089791|525336642|FG001|Overall Study|Requirement for alternative therapy|4|||
145677268|NCT00621842|525336643|FG000|Overall Study|Adverse Event|6|||
145677269|NCT00621842|525336643|FG000|Overall Study|Withdrawal by Subject|7|||
145677270|NCT00621842|525336643|FG000|Overall Study|Protocol Violation|4|||
145677271|NCT00621842|525336643|FG000|Overall Study|Lack of Efficacy|2|||
145677272|NCT05074433|525336646|FG000|Overall Study|Adverse Event|0|||
145677273|NCT05074433|525336647|FG001|Overall Study|Adverse Event|2|||
145677274|NCT05074433|525336648|FG002|Overall Study|Adverse Event|0|||
145677275|NCT05074433|525336649|FG003|Overall Study|Adverse Event|1|||
145677276|NCT05074433|525336646|FG000|Overall Study|Sponsor Request|0|||
145677277|NCT05074433|525336647|FG001|Overall Study|Sponsor Request|1|||
145677278|NCT05074433|525336648|FG002|Overall Study|Sponsor Request|1|||
145677279|NCT05074433|525336649|FG003|Overall Study|Sponsor Request|0|||
145677280|NCT05074433|525336646|FG000|Overall Study|Death|1|||
145677281|NCT05074433|525336647|FG001|Overall Study|Death|0|||
145677282|NCT05074433|525336648|FG002|Overall Study|Death|0|||
145677283|NCT05074433|525336649|FG003|Overall Study|Death|0|||
145677284|NCT05074433|525336646|FG000|Overall Study|Lost to Follow-up|0|||
145677285|NCT05074433|525336647|FG001|Overall Study|Lost to Follow-up|0|||
145677286|NCT05074433|525336648|FG002|Overall Study|Lost to Follow-up|2|||
145677287|NCT05074433|525336649|FG003|Overall Study|Lost to Follow-up|0|||
145677288|NCT05074433|525336646|FG000|Overall Study|Subject Decision|8|||
145677289|NCT05074433|525336647|FG001|Overall Study|Subject Decision|6|||
145677290|NCT05074433|525336648|FG002|Overall Study|Subject Decision|4|||
145677291|NCT05074433|525336649|FG003|Overall Study|Subject Decision|5|||
145677292|NCT04397263|525336650|FG000|Overall Study|Withdrawal by Subject|2|||
145677293|NCT01989689|525336651|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
145677294|NCT01989689|525336652|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
145677295|NCT01989689|525336651|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
145677296|NCT01989689|525336652|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
145677297|NCT02066636|525336653|FG000|Overall Study|Disease progression|51|||
145677298|NCT02066636|525336654|FG001|Overall Study|Disease progression|60|||
145677299|NCT02066636|525336655|FG002|Overall Study|Disease progression|700|||
145677300|NCT02066636|525336653|FG000|Overall Study|Study drug toxicity|13|||
145677301|NCT02066636|525336654|FG001|Overall Study|Study drug toxicity|2|||
145677302|NCT02066636|525336655|FG002|Overall Study|Study drug toxicity|58|||
145677303|NCT02066636|525336653|FG000|Overall Study|Death|4|||
145677304|NCT02066636|525336654|FG001|Overall Study|Death|2|||
145677305|NCT02066636|525336655|FG002|Overall Study|Death|158|||
145677306|NCT02066636|525336653|FG000|Overall Study|Adverse event unrelated to study drug|6|||
145677307|NCT02066636|525336654|FG001|Overall Study|Adverse event unrelated to study drug|4|||
145677308|NCT02066636|525336655|FG002|Overall Study|Adverse event unrelated to study drug|45|||
145677309|NCT02066636|525336653|FG000|Overall Study|Participant request to discontinue treatment|12|||
145677310|NCT02066636|525336654|FG001|Overall Study|Participant request to discontinue treatment|12|||
145677311|NCT02066636|525336655|FG002|Overall Study|Participant request to discontinue treatment|70|||
145677312|NCT02066636|525336653|FG000|Overall Study|Participant withdrew consent|10|||
145677313|NCT02066636|525336654|FG001|Overall Study|Participant withdrew consent|18|||
145677314|NCT02066636|525336655|FG002|Overall Study|Participant withdrew consent|61|||
145677315|NCT02066636|525336653|FG000|Overall Study|Lost to Follow-up|0|||
145677316|NCT02066636|525336654|FG001|Overall Study|Lost to Follow-up|2|||
145677317|NCT02066636|525336655|FG002|Overall Study|Lost to Follow-up|2|||
145677318|NCT02066636|525336653|FG000|Overall Study|Maximum clinical benefit|2|||
145677319|NCT02066636|525336654|FG001|Overall Study|Maximum clinical benefit|2|||
145265409|NCT00764465|523819353|FG001|Overall Study|Adverse Event|0|||
145677320|NCT02066636|525336655|FG002|Overall Study|Maximum clinical benefit|3|||
145677321|NCT02066636|525336653|FG000|Overall Study|Poor/non-compliance|2|||
145677322|NCT02066636|525336654|FG001|Overall Study|Poor/non-compliance|1|||
145677323|NCT02066636|525336655|FG002|Overall Study|Poor/non-compliance|1|||
145677324|NCT02066636|525336653|FG000|Overall Study|Participant no loner meets study criteria|3|||
145677325|NCT02066636|525336654|FG001|Overall Study|Participant no loner meets study criteria|2|||
145677326|NCT02066636|525336655|FG002|Overall Study|Participant no loner meets study criteria|28|||
145677327|NCT02066636|525336653|FG000|Overall Study|Administrative reasons by sponsor|8|||
145677328|NCT02066636|525336654|FG001|Overall Study|Administrative reasons by sponsor|5|||
145677329|NCT02066636|525336655|FG002|Overall Study|Administrative reasons by sponsor|0|||
145677330|NCT02066636|525336653|FG000|Overall Study|Other reasons|16|||
145677331|NCT02066636|525336654|FG001|Overall Study|Other reasons|15|||
145677332|NCT02066636|525336655|FG002|Overall Study|Other reasons|50|||
145677333|NCT00391170|525336662|FG000|Overall Study|Withdrawal by Subject|1|||
145677334|NCT00391170|525336663|FG001|Overall Study|Withdrawal by Subject|0|||
145677335|NCT00391170|525336662|FG000|Overall Study|Adverse Event|3|||
145677336|NCT00391170|525336663|FG001|Overall Study|Adverse Event|2|||
145677337|NCT00391170|525336662|FG000|Overall Study|Physician Decision|2|||
145677338|NCT00391170|525336663|FG001|Overall Study|Physician Decision|2|||
145677339|NCT03567616|525336670|FG000|Overall Study|Disease progression|4|||
145677340|NCT03567616|525336670|FG000|Overall Study|Withdrawal by Subject|1|||
145677341|NCT03567616|525336670|FG000|Overall Study|Physician Decision|1|||
145677342|NCT03567616|525336670|FG000|Overall Study|Death|1|||
145677343|NCT03567616|525336670|FG000|Overall Study|Adverse Event|1|||
145677344|NCT00526994|525336675|FG000|Overall Study|Lost to Follow-up|98|||
145677345|NCT00526994|525336676|FG001|Overall Study|Lost to Follow-up|108|||
145677346|NCT00526994|525336677|FG002|Overall Study|Lost to Follow-up|96|||
145677347|NCT00526994|525336675|FG000|Overall Study|Death|4|||
145677348|NCT00526994|525336676|FG001|Overall Study|Death|3|||
145677349|NCT00526994|525336677|FG002|Overall Study|Death|3|||
145677350|NCT00526994|525336675|FG000|Overall Study|Withdrawal by Subject|2|||
145677351|NCT00526994|525336676|FG001|Overall Study|Withdrawal by Subject|7|||
145677352|NCT00526994|525336677|FG002|Overall Study|Withdrawal by Subject|5|||
145677353|NCT00526994|525336675|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
145677354|NCT00526994|525336676|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
145677355|NCT00526994|525336677|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
145677356|NCT03026166|525336680|FG000|Overall Study|Death|22|||
145677357|NCT03026166|525336681|FG001|Overall Study|Death|7|||
145677358|NCT03026166|525336680|FG000|Overall Study|Physician Decision|2|||
145677359|NCT03026166|525336681|FG001|Overall Study|Physician Decision|0|||
145677360|NCT03026166|525336680|FG000|Overall Study|Withdrawal by Subject|1|||
145677361|NCT03026166|525336681|FG001|Overall Study|Withdrawal by Subject|2|||
145677362|NCT03026166|525336680|FG000|Overall Study|Lost to Follow-up|1|||
145677363|NCT03026166|525336681|FG001|Overall Study|Lost to Follow-up|0|||
145677364|NCT03026166|525336680|FG000|Overall Study|Study Terminated by Sponsor|3|||
145677365|NCT03026166|525336681|FG001|Overall Study|Study Terminated by Sponsor|3|||
145677366|NCT03026166|525336680|FG000|Overall Study|Other|1|||
145677367|NCT03026166|525336681|FG001|Overall Study|Other|0|||
145677368|NCT05270460|525336682|FG000|Overall Study|Adverse Event|0|||
145677369|NCT05270460|525336683|FG001|Overall Study|Adverse Event|1|||
145677370|NCT05270460|525336684|FG002|Overall Study|Adverse Event|0|||
145677371|NCT05270460|525336682|FG000|Overall Study|Early Termination|0|||
145677372|NCT05270460|525336683|FG001|Overall Study|Early Termination|1|||
145677373|NCT05270460|525336684|FG002|Overall Study|Early Termination|0|||
145677374|NCT00380250|525336685|FG000|Overall Study|Withdrawal by Subject|39|||
145677375|NCT00380250|525336686|FG001|Overall Study|Withdrawal by Subject|28|||
145677376|NCT00380250|525336685|FG000|Overall Study|Adverse Event|20|||
145677377|NCT00380250|525336686|FG001|Overall Study|Adverse Event|9|||
145677378|NCT00380250|525336685|FG000|Overall Study|Lack of Efficacy|10|||
145677379|NCT00380250|525336686|FG001|Overall Study|Lack of Efficacy|8|||
145677380|NCT00380250|525336685|FG000|Overall Study|Protocol Violation|15|||
145677381|NCT00380250|525336686|FG001|Overall Study|Protocol Violation|5|||
145677382|NCT00380250|525336685|FG000|Overall Study|Lost to Follow-up|14|||
145677383|NCT00380250|525336686|FG001|Overall Study|Lost to Follow-up|5|||
145677384|NCT00380250|525336685|FG000|Overall Study|Physician Decision|1|||
145677385|NCT00380250|525336686|FG001|Overall Study|Physician Decision|0|||
145677386|NCT05613088|525336687|FG000|Treatment|Ongoing Study Treatment|9|||
145677387|NCT05613088|525336688|FG001|Treatment|Ongoing Study Treatment|2|||
145677388|NCT05613088|525336687|FG000|Treatment|Adverse Event|3|||
145677389|NCT05613088|525336688|FG001|Treatment|Adverse Event|1|||
145677390|NCT05613088|525336687|FG000|Treatment|Other Reasons|0|||
145677391|NCT05613088|525336688|FG001|Treatment|Other Reasons|1|||
145677392|NCT05613088|525336687|FG000|Treatment|Progressive Disease|58|||
145677393|NCT05613088|525336688|FG001|Treatment|Progressive Disease|26|||
145677394|NCT05613088|525336687|FG000|Treatment|Withdrawal by Subject|0|||
145677395|NCT05613088|525336688|FG001|Treatment|Withdrawal by Subject|4|||
145677396|NCT01668719|525336689|FG000|Phase I|On treatment|1|||
145677397|NCT01668719|525336690|FG001|Phase I|On treatment|0|||
145677398|NCT01668719|525336691|FG002|Phase I|On treatment|0|||
145677399|NCT01668719|525336689|FG000|Phase I|Adverse Event|2|||
145677400|NCT01668719|525336690|FG001|Phase I|Adverse Event|0|||
145677401|NCT01668719|525336691|FG002|Phase I|Adverse Event|0|||
145677402|NCT01668719|525336689|FG000|Phase I|Progression/relapse|1|||
145677403|NCT01668719|525336690|FG001|Phase I|Progression/relapse|0|||
145677404|NCT01668719|525336691|FG002|Phase I|Progression/relapse|0|||
145677405|NCT01668719|525336689|FG000|Phase I|not protocol specified|2|||
145677406|NCT01668719|525336690|FG001|Phase I|not protocol specified|0|||
145677407|NCT01668719|525336691|FG002|Phase I|not protocol specified|0|||
145677408|NCT01668719|525336689|FG000|Phase II|On treatment|0|||
145677409|NCT01668719|525336690|FG001|Phase II|On treatment|4|||
145677410|NCT01668719|525336691|FG002|Phase II|On treatment|3|||
145677411|NCT01668719|525336689|FG000|Phase II|Adverse Event|0|||
145677412|NCT01668719|525336690|FG001|Phase II|Adverse Event|18|||
145677413|NCT01668719|525336691|FG002|Phase II|Adverse Event|18|||
145677414|NCT01668719|525336689|FG000|Phase II|Refusal unrelated to adverse event|0|||
145677415|NCT01668719|525336690|FG001|Phase II|Refusal unrelated to adverse event|4|||
145677416|NCT01668719|525336691|FG002|Phase II|Refusal unrelated to adverse event|1|||
145677417|NCT01668719|525336689|FG000|Phase II|Progression/relapse|0|||
145677418|NCT01668719|525336690|FG001|Phase II|Progression/relapse|13|||
145677419|NCT01668719|525336691|FG002|Phase II|Progression/relapse|17|||
145677420|NCT01668719|525336689|FG000|Phase II|Death|0|||
145677421|NCT01668719|525336690|FG001|Phase II|Death|0|||
145677422|NCT01668719|525336691|FG002|Phase II|Death|2|||
145677423|NCT01668719|525336689|FG000|Phase II|not protocol specified|0|||
145677424|NCT01668719|525336690|FG001|Phase II|not protocol specified|13|||
145677425|NCT01668719|525336691|FG002|Phase II|not protocol specified|7|||
145677426|NCT00875706|525336694|FG000|Overall Study|Withdrawal by Subject|1|||
145677427|NCT00875706|525336695|FG001|Overall Study|Withdrawal by Subject|0|||
145677428|NCT00875706|525336696|FG002|Overall Study|Withdrawal by Subject|0|||
145677429|NCT03205488|525336697|FG000|Overall Study|Adverse Event|1|||
145677430|NCT03205488|525336698|FG001|Overall Study|Adverse Event|2|||
145677431|NCT03205488|525336699|FG002|Overall Study|Adverse Event|4|||
145677432|NCT03205488|525336697|FG000|Overall Study|Protocol Violation|0|||
145677433|NCT03205488|525336698|FG001|Overall Study|Protocol Violation|0|||
145677434|NCT03205488|525336699|FG002|Overall Study|Protocol Violation|1|||
145677435|NCT00786188|525336700|FG000|Overall Study|Adverse Event|3|||
145677436|NCT00786188|525336701|FG001|Overall Study|Adverse Event|1|||
145677437|NCT00786188|525336700|FG000|Overall Study|Withdrawal by Subject|2|||
145677438|NCT00786188|525336701|FG001|Overall Study|Withdrawal by Subject|0|||
145677439|NCT00824408|525336706|FG000|Run-in Phase|Progressive disease|4|||
145677440|NCT00824408|525336707|FG001|Run-in Phase|Progressive disease|4|||
145677441|NCT00824408|525336708|FG002|Run-in Phase|Progressive disease|0|||
145677442|NCT00824408|525336709|FG003|Run-in Phase|Progressive disease|0|||
145677443|NCT00824408|525336710|FG004|Run-in Phase|Progressive disease|0|||
145677444|NCT00824408|525336706|FG000|Run-in Phase|Adverse Event|1|||
145677445|NCT00824408|525336707|FG001|Run-in Phase|Adverse Event|1|||
145677446|NCT00824408|525336708|FG002|Run-in Phase|Adverse Event|0|||
145677447|NCT00824408|525336709|FG003|Run-in Phase|Adverse Event|0|||
145677448|NCT00824408|525336710|FG004|Run-in Phase|Adverse Event|0|||
145677449|NCT00824408|525336706|FG000|Run-in Phase|Refused to continue medication|1|||
145677450|NCT00824408|525336707|FG001|Run-in Phase|Refused to continue medication|0|||
145677451|NCT00824408|525336708|FG002|Run-in Phase|Refused to continue medication|0|||
145677452|NCT00824408|525336709|FG003|Run-in Phase|Refused to continue medication|0|||
145677453|NCT00824408|525336710|FG004|Run-in Phase|Refused to continue medication|0|||
145677454|NCT00824408|525336706|FG000|Run-in Phase|Other reason not defined above|0|||
145677455|NCT00824408|525336707|FG001|Run-in Phase|Other reason not defined above|1|||
145677456|NCT00824408|525336708|FG002|Run-in Phase|Other reason not defined above|0|||
145677457|NCT00824408|525336709|FG003|Run-in Phase|Other reason not defined above|0|||
145677458|NCT00824408|525336710|FG004|Run-in Phase|Other reason not defined above|0|||
145677459|NCT00824408|525336706|FG000|Randomized Phase|Not treated|0|||
145677460|NCT00824408|525336707|FG001|Randomized Phase|Not treated|0|||
145677461|NCT00824408|525336708|FG002|Randomized Phase|Not treated|1|||
145677462|NCT00824408|525336709|FG003|Randomized Phase|Not treated|1|||
145677463|NCT00824408|525336710|FG004|Randomized Phase|Not treated|1|||
145677464|NCT00824408|525336706|FG000|Randomized Phase|Progressive disease|0|||
145677465|NCT00824408|525336707|FG001|Randomized Phase|Progressive disease|0|||
145677466|NCT00824408|525336708|FG002|Randomized Phase|Progressive disease|25|||
145677467|NCT00824408|525336709|FG003|Randomized Phase|Progressive disease|36|||
145677468|NCT00824408|525336710|FG004|Randomized Phase|Progressive disease|34|||
145677469|NCT00824408|525336706|FG000|Randomized Phase|Adverse Event|0|||
145677470|NCT00824408|525336707|FG001|Randomized Phase|Adverse Event|0|||
145677471|NCT00824408|525336708|FG002|Randomized Phase|Adverse Event|4|||
145677472|NCT00824408|525336709|FG003|Randomized Phase|Adverse Event|5|||
145677473|NCT00824408|525336710|FG004|Randomized Phase|Adverse Event|5|||
145677474|NCT00824408|525336706|FG000|Randomized Phase|Refused to continue medication|0|||
145677475|NCT00824408|525336707|FG001|Randomized Phase|Refused to continue medication|0|||
145677476|NCT00824408|525336708|FG002|Randomized Phase|Refused to continue medication|2|||
145677477|NCT00824408|525336709|FG003|Randomized Phase|Refused to continue medication|2|||
145677478|NCT00824408|525336710|FG004|Randomized Phase|Refused to continue medication|2|||
145677479|NCT00824408|525336706|FG000|Randomized Phase|Other reason not defined above|0|||
145677480|NCT00824408|525336707|FG001|Randomized Phase|Other reason not defined above|0|||
145677481|NCT00824408|525336708|FG002|Randomized Phase|Other reason not defined above|4|||
145677482|NCT00824408|525336709|FG003|Randomized Phase|Other reason not defined above|2|||
145677483|NCT00824408|525336710|FG004|Randomized Phase|Other reason not defined above|4|||
145677484|NCT04821271|525336711|FG000|Period 1|Withdrawal by Subject|2|||
145677485|NCT04821271|525336712|FG001|Period 1|Withdrawal by Subject|0|||
145677486|NCT04083781|525336713|FG000|Main Part|Physician Decision|0|||
145677487|NCT04083781|525336714|FG001|Main Part|Physician Decision|1|||
145677488|NCT04083781|525336715|FG002|Main Part|Physician Decision|2|||
145677489|NCT04083781|525336716|FG003|Main Part|Physician Decision|0|||
145677490|NCT04083781|525336713|FG000|Main Part|Death|1|||
145677491|NCT04083781|525336714|FG001|Main Part|Death|3|||
145677492|NCT04083781|525336715|FG002|Main Part|Death|1|||
145677493|NCT04083781|525336716|FG003|Main Part|Death|0|||
145677494|NCT04083781|525336713|FG000|Main Part|Withdrawal by Subject|5|||
145677495|NCT04083781|525336714|FG001|Main Part|Withdrawal by Subject|2|||
145677496|NCT04083781|525336715|FG002|Main Part|Withdrawal by Subject|3|||
145677497|NCT04083781|525336716|FG003|Main Part|Withdrawal by Subject|7|||
145677498|NCT04083781|525336713|FG000|Extension Part|Physician Decision|0|||
145677499|NCT04083781|525336714|FG001|Extension Part|Physician Decision|0|||
145677500|NCT04083781|525336715|FG002|Extension Part|Physician Decision|0|||
145677501|NCT04083781|525336716|FG003|Extension Part|Physician Decision|1|||
145677502|NCT04083781|525336713|FG000|Extension Part|Death|0|||
145677503|NCT04083781|525336714|FG001|Extension Part|Death|1|||
145677504|NCT04083781|525336715|FG002|Extension Part|Death|0|||
145677505|NCT04083781|525336716|FG003|Extension Part|Death|1|||
145677506|NCT04083781|525336713|FG000|Extension Part|Withdrawal by Subject|0|||
145677507|NCT04083781|525336714|FG001|Extension Part|Withdrawal by Subject|1|||
145677508|NCT04083781|525336715|FG002|Extension Part|Withdrawal by Subject|0|||
145677509|NCT04083781|525336716|FG003|Extension Part|Withdrawal by Subject|0|||
145677510|NCT04083781|525336713|FG000|Extension Part|Ongoing|13|||
145677511|NCT04083781|525336714|FG001|Extension Part|Ongoing|25|||
145677512|NCT04083781|525336715|FG002|Extension Part|Ongoing|15|||
145677513|NCT04083781|525336716|FG003|Extension Part|Ongoing|51|||
145677514|NCT01218594|525336717|FG000|Overall Study|Death|1|||
145677515|NCT01218594|525336717|FG000|Overall Study|Withdrawal by Subject|3|||
145677516|NCT01218594|525336717|FG000|Overall Study|Adverse Event|2|||
145677517|NCT01218594|525336717|FG000|Overall Study|Physician Decision|6|||
145677518|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
145677519|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
145677520|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
145677521|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
145677522|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
145677523|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
145677524|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
145677525|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
145677526|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
145677527|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
145677528|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
145677529|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
145677530|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
145677531|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
145677532|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
145677533|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
145677534|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
145677535|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
145677536|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
145677537|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
145677538|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
145677539|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
145677540|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
145677541|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
145677542|NCT02203032|525336719|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
145677543|NCT02203032|525336720|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
145677544|NCT02203032|525336721|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
145677545|NCT02203032|525336722|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
145677546|NCT02203032|525336719|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
145677547|NCT02203032|525336720|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
145677548|NCT02203032|525336721|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
145677549|NCT02203032|525336722|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
145677550|NCT02203032|525336719|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
145677551|NCT02203032|525336720|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
145677552|NCT02203032|525336721|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
145677553|NCT02203032|525336722|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
145677554|NCT02203032|525336719|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
145677555|NCT02203032|525336720|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
145677556|NCT02203032|525336721|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
145677557|NCT02203032|525336722|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
145677558|NCT02203032|525336719|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
145677559|NCT02203032|525336720|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
145677560|NCT02203032|525336721|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
145677561|NCT02203032|525336722|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
145677562|NCT02203032|525336719|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
145677563|NCT02203032|525336720|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
145677564|NCT02203032|525336721|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
145677565|NCT02203032|525336722|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
145677566|NCT02241785|525336725|FG000|Overall Study|Sponsor Termination|43|||
145677567|NCT02241785|525336725|FG000|Overall Study|Withdrawal by Subject|1|||
145677568|NCT02241785|525336725|FG000|Overall Study|Lost to Follow-up|2|||
145677569|NCT02241785|525336725|FG000|Overall Study|Adverse Event|1|||
145677570|NCT04748341|525336726|FG000|Overall Study|Lost to Follow-up|1|||
145677571|NCT04748341|525336727|FG001|Overall Study|Lost to Follow-up|1|||
145677572|NCT00452114|525336730|FG000|Overall Study|Physician Decision|3|||
145677573|NCT00452114|525336731|FG001|Overall Study|Physician Decision|3|||
145677574|NCT04197713|525336732|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
145677575|NCT04197713|525336733|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
145677576|NCT02334215|525336738|FG000|Overall Study|Death|1|||
145677577|NCT02334215|525336739|FG001|Overall Study|Death|1|||
145677578|NCT02334215|525336740|FG002|Overall Study|Death|0|||
145677579|NCT02334215|525336738|FG000|Overall Study|Lost to Follow-up|1|||
145677580|NCT02334215|525336739|FG001|Overall Study|Lost to Follow-up|0|||
145677581|NCT02334215|525336740|FG002|Overall Study|Lost to Follow-up|4|||
145677582|NCT02334215|525336738|FG000|Overall Study|Withdrawal by Subject|2|||
145677583|NCT02334215|525336739|FG001|Overall Study|Withdrawal by Subject|2|||
145677584|NCT02334215|525336740|FG002|Overall Study|Withdrawal by Subject|1|||
145677585|NCT02334215|525336738|FG000|Overall Study|Not released from incarceration on time|3|||
145677586|NCT02334215|525336739|FG001|Overall Study|Not released from incarceration on time|3|||
145677587|NCT02334215|525336740|FG002|Overall Study|Not released from incarceration on time|3|||
145677588|NCT02334215|525336738|FG000|Overall Study|Incarcerated|0|||
145677589|NCT02334215|525336739|FG001|Overall Study|Incarcerated|0|||
145677590|NCT02334215|525336740|FG002|Overall Study|Incarcerated|7|||
145677591|NCT04602728|525336745|FG000|Overall Study|Lost to Follow-up|4|||
145677592|NCT04602728|525336746|FG001|Overall Study|Lost to Follow-up|4|||
145677593|NCT03905642|525336750|FG000|Overall Study|Withdrawal by Subject|3|||
145677594|NCT03905642|525336750|FG000|Overall Study|Pregnancy|1|||
145677595|NCT03905642|525336750|FG000|Overall Study|Adverse Event|1|||
145677596|NCT03905642|525336750|FG000|Overall Study|Lack of Efficacy|1|||
145677597|NCT03905642|525336750|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
145677598|NCT02159989|525336756|FG000|Overall Study|Adverse Event|1|||
145677599|NCT02159989|525336757|FG001|Overall Study|Adverse Event|0|||
145677600|NCT02159989|525336758|FG002|Overall Study|Adverse Event|0|||
145677601|NCT02159989|525336759|FG003|Overall Study|Adverse Event|0|||
145677602|NCT02159989|525336760|FG004|Overall Study|Adverse Event|1|||
145677603|NCT02159989|525336761|FG005|Overall Study|Adverse Event|0|||
145677604|NCT02159989|525336762|FG006|Overall Study|Adverse Event|1|||
145677605|NCT02159989|525336763|FG007|Overall Study|Adverse Event|2|||
145677606|NCT02159989|525336764|FG008|Overall Study|Adverse Event|0|||
145677607|NCT02159989|525336765|FG009|Overall Study|Adverse Event|2|||
145677608|NCT02159989|525336766|FG010|Overall Study|Adverse Event|1|||
145677609|NCT02159989|525336756|FG000|Overall Study|Death|0|||
145677610|NCT02159989|525336757|FG001|Overall Study|Death|0|||
145677611|NCT02159989|525336758|FG002|Overall Study|Death|0|||
145677612|NCT02159989|525336759|FG003|Overall Study|Death|0|||
145677613|NCT02159989|525336760|FG004|Overall Study|Death|0|||
145677614|NCT02159989|525336761|FG005|Overall Study|Death|0|||
145677615|NCT02159989|525336762|FG006|Overall Study|Death|0|||
145677616|NCT02159989|525336763|FG007|Overall Study|Death|0|||
145677617|NCT02159989|525336764|FG008|Overall Study|Death|0|||
145677618|NCT02159989|525336765|FG009|Overall Study|Death|0|||
145677619|NCT02159989|525336766|FG010|Overall Study|Death|1|||
145677620|NCT02159989|525336756|FG000|Overall Study|Lack of Efficacy|2|||
145491057|NCT01384734|524652352|FG004|Overall Study|Lost to Follow-up|5|||
145677621|NCT02159989|525336757|FG001|Overall Study|Lack of Efficacy|3|||
145677622|NCT02159989|525336758|FG002|Overall Study|Lack of Efficacy|3|||
145677623|NCT02159989|525336759|FG003|Overall Study|Lack of Efficacy|0|||
145677624|NCT02159989|525336760|FG004|Overall Study|Lack of Efficacy|2|||
145677625|NCT02159989|525336761|FG005|Overall Study|Lack of Efficacy|3|||
145677626|NCT02159989|525336762|FG006|Overall Study|Lack of Efficacy|3|||
145677627|NCT02159989|525336763|FG007|Overall Study|Lack of Efficacy|1|||
145677628|NCT02159989|525336764|FG008|Overall Study|Lack of Efficacy|3|||
145677629|NCT02159989|525336765|FG009|Overall Study|Lack of Efficacy|6|||
145677630|NCT02159989|525336766|FG010|Overall Study|Lack of Efficacy|7|||
145677631|NCT02159989|525336756|FG000|Overall Study|Lost to Follow-up|0|||
145677632|NCT02159989|525336757|FG001|Overall Study|Lost to Follow-up|0|||
145677633|NCT02159989|525336758|FG002|Overall Study|Lost to Follow-up|0|||
145677634|NCT02159989|525336759|FG003|Overall Study|Lost to Follow-up|1|||
145677635|NCT02159989|525336760|FG004|Overall Study|Lost to Follow-up|0|||
145677636|NCT02159989|525336761|FG005|Overall Study|Lost to Follow-up|0|||
145677637|NCT02159989|525336762|FG006|Overall Study|Lost to Follow-up|0|||
145677638|NCT02159989|525336763|FG007|Overall Study|Lost to Follow-up|0|||
145677639|NCT02159989|525336764|FG008|Overall Study|Lost to Follow-up|0|||
145677640|NCT02159989|525336765|FG009|Overall Study|Lost to Follow-up|0|||
145677641|NCT02159989|525336766|FG010|Overall Study|Lost to Follow-up|1|||
145677642|NCT02159989|525336756|FG000|Overall Study|Withdrawal by Subject|2|||
145677643|NCT02159989|525336757|FG001|Overall Study|Withdrawal by Subject|0|||
145677644|NCT02159989|525336758|FG002|Overall Study|Withdrawal by Subject|0|||
145677645|NCT02159989|525336759|FG003|Overall Study|Withdrawal by Subject|2|||
145677646|NCT02159989|525336760|FG004|Overall Study|Withdrawal by Subject|1|||
145677647|NCT02159989|525336761|FG005|Overall Study|Withdrawal by Subject|0|||
145677648|NCT02159989|525336762|FG006|Overall Study|Withdrawal by Subject|3|||
145677649|NCT02159989|525336763|FG007|Overall Study|Withdrawal by Subject|1|||
145677650|NCT02159989|525336764|FG008|Overall Study|Withdrawal by Subject|0|||
145677651|NCT02159989|525336765|FG009|Overall Study|Withdrawal by Subject|0|||
145677652|NCT02159989|525336766|FG010|Overall Study|Withdrawal by Subject|0|||
145677653|NCT02159989|525336756|FG000|Overall Study|New treatment|0|||
145677654|NCT02159989|525336757|FG001|Overall Study|New treatment|1|||
145677655|NCT02159989|525336758|FG002|Overall Study|New treatment|0|||
145677656|NCT02159989|525336759|FG003|Overall Study|New treatment|0|||
145677657|NCT02159989|525336760|FG004|Overall Study|New treatment|0|||
145677658|NCT02159989|525336761|FG005|Overall Study|New treatment|0|||
145677659|NCT02159989|525336762|FG006|Overall Study|New treatment|0|||
145677660|NCT02159989|525336763|FG007|Overall Study|New treatment|0|||
145677661|NCT02159989|525336764|FG008|Overall Study|New treatment|0|||
145677662|NCT02159989|525336765|FG009|Overall Study|New treatment|0|||
145677663|NCT02159989|525336766|FG010|Overall Study|New treatment|0|||
145677664|NCT02159989|525336756|FG000|Overall Study|Insurance Issues|0|||
145677665|NCT02159989|525336757|FG001|Overall Study|Insurance Issues|0|||
145677666|NCT02159989|525336758|FG002|Overall Study|Insurance Issues|0|||
145677667|NCT02159989|525336759|FG003|Overall Study|Insurance Issues|0|||
145677668|NCT02159989|525336760|FG004|Overall Study|Insurance Issues|0|||
145677669|NCT02159989|525336761|FG005|Overall Study|Insurance Issues|0|||
145677670|NCT02159989|525336762|FG006|Overall Study|Insurance Issues|0|||
145677671|NCT02159989|525336763|FG007|Overall Study|Insurance Issues|0|||
145677672|NCT02159989|525336764|FG008|Overall Study|Insurance Issues|0|||
145677673|NCT02159989|525336765|FG009|Overall Study|Insurance Issues|1|||
145677674|NCT02159989|525336766|FG010|Overall Study|Insurance Issues|0|||
145677675|NCT05338476|525336768|FG000|Period 2|Adverse Event|0|||
145677676|NCT05338476|525336769|FG001|Period 2|Adverse Event|1|||
145677677|NCT05289037|525336774|FG000|Overall Study|Withdrawal by Subject|7|||
145677678|NCT05289037|525336775|FG001|Overall Study|Withdrawal by Subject|0|||
145677679|NCT05289037|525336776|FG002|Overall Study|Withdrawal by Subject|3|||
145677680|NCT05289037|525336777|FG003|Overall Study|Withdrawal by Subject|3|||
145677681|NCT05289037|525336778|FG004|Overall Study|Withdrawal by Subject|1|||
145677682|NCT05289037|525336779|FG005|Overall Study|Withdrawal by Subject|5|||
145677683|NCT05289037|525336780|FG006|Overall Study|Withdrawal by Subject|2|||
145677684|NCT05289037|525336781|FG007|Overall Study|Withdrawal by Subject|1|||
145677685|NCT05289037|525336782|FG008|Overall Study|Withdrawal by Subject|2|||
145677686|NCT05289037|525336783|FG009|Overall Study|Withdrawal by Subject|2|||
145677687|NCT05289037|525336784|FG010|Overall Study|Withdrawal by Subject|1|||
145677688|NCT05289037|525336785|FG011|Overall Study|Withdrawal by Subject|0|||
145677689|NCT05289037|525336786|FG012|Overall Study|Withdrawal by Subject|1|||
145677690|NCT05289037|525336787|FG013|Overall Study|Withdrawal by Subject|2|||
145677691|NCT05289037|525336788|FG014|Overall Study|Withdrawal by Subject|0|||
145677692|NCT05289037|525336789|FG015|Overall Study|Withdrawal by Subject|3|||
145677693|NCT05289037|525336790|FG016|Overall Study|Withdrawal by Subject|3|||
145677694|NCT05289037|525336774|FG000|Overall Study|Lost to Follow-up|1|||
145677695|NCT05289037|525336775|FG001|Overall Study|Lost to Follow-up|4|||
145677696|NCT05289037|525336776|FG002|Overall Study|Lost to Follow-up|3|||
145677697|NCT05289037|525336777|FG003|Overall Study|Lost to Follow-up|3|||
145491058|NCT01384734|524652348|FG000|Overall Study|Non-compliance with study drug|1|||
145677698|NCT05289037|525336778|FG004|Overall Study|Lost to Follow-up|3|||
145677699|NCT05289037|525336779|FG005|Overall Study|Lost to Follow-up|2|||
145677700|NCT05289037|525336780|FG006|Overall Study|Lost to Follow-up|3|||
145677701|NCT05289037|525336781|FG007|Overall Study|Lost to Follow-up|2|||
145677702|NCT05289037|525336782|FG008|Overall Study|Lost to Follow-up|2|||
145677703|NCT05289037|525336783|FG009|Overall Study|Lost to Follow-up|1|||
145677704|NCT05289037|525336784|FG010|Overall Study|Lost to Follow-up|3|||
145677705|NCT05289037|525336785|FG011|Overall Study|Lost to Follow-up|4|||
145677706|NCT05289037|525336786|FG012|Overall Study|Lost to Follow-up|2|||
145677707|NCT05289037|525336787|FG013|Overall Study|Lost to Follow-up|7|||
145677708|NCT05289037|525336788|FG014|Overall Study|Lost to Follow-up|4|||
145677709|NCT05289037|525336789|FG015|Overall Study|Lost to Follow-up|6|||
145677710|NCT05289037|525336790|FG016|Overall Study|Lost to Follow-up|4|||
145677711|NCT05289037|525336774|FG000|Overall Study|Death|0|||
145677712|NCT05289037|525336775|FG001|Overall Study|Death|0|||
145677713|NCT05289037|525336776|FG002|Overall Study|Death|0|||
145677714|NCT05289037|525336777|FG003|Overall Study|Death|0|||
145677715|NCT05289037|525336778|FG004|Overall Study|Death|0|||
145677716|NCT05289037|525336779|FG005|Overall Study|Death|1|||
145677717|NCT05289037|525336780|FG006|Overall Study|Death|0|||
145677718|NCT05289037|525336781|FG007|Overall Study|Death|0|||
145677719|NCT05289037|525336782|FG008|Overall Study|Death|0|||
145677720|NCT05289037|525336783|FG009|Overall Study|Death|0|||
145677721|NCT05289037|525336784|FG010|Overall Study|Death|0|||
145677722|NCT05289037|525336785|FG011|Overall Study|Death|0|||
145677723|NCT05289037|525336786|FG012|Overall Study|Death|0|||
145677724|NCT05289037|525336787|FG013|Overall Study|Death|0|||
145677725|NCT05289037|525336788|FG014|Overall Study|Death|1|||
145677726|NCT05289037|525336789|FG015|Overall Study|Death|0|||
145677727|NCT05289037|525336790|FG016|Overall Study|Death|0|||
145677728|NCT05289037|525336774|FG000|Overall Study|Did not receive vaccine|0|||
145677729|NCT05289037|525336775|FG001|Overall Study|Did not receive vaccine|3|||
145677730|NCT05289037|525336776|FG002|Overall Study|Did not receive vaccine|0|||
145677731|NCT05289037|525336777|FG003|Overall Study|Did not receive vaccine|0|||
145677732|NCT05289037|525336778|FG004|Overall Study|Did not receive vaccine|1|||
145677733|NCT05289037|525336779|FG005|Overall Study|Did not receive vaccine|1|||
145677734|NCT05289037|525336780|FG006|Overall Study|Did not receive vaccine|1|||
145677735|NCT05289037|525336781|FG007|Overall Study|Did not receive vaccine|0|||
145677736|NCT05289037|525336782|FG008|Overall Study|Did not receive vaccine|0|||
145677737|NCT05289037|525336783|FG009|Overall Study|Did not receive vaccine|0|||
145677738|NCT05289037|525336784|FG010|Overall Study|Did not receive vaccine|0|||
145677739|NCT05289037|525336785|FG011|Overall Study|Did not receive vaccine|0|||
145677740|NCT05289037|525336786|FG012|Overall Study|Did not receive vaccine|0|||
145677741|NCT05289037|525336787|FG013|Overall Study|Did not receive vaccine|0|||
145677742|NCT05289037|525336788|FG014|Overall Study|Did not receive vaccine|1|||
145677743|NCT05289037|525336789|FG015|Overall Study|Did not receive vaccine|0|||
145677744|NCT05289037|525336790|FG016|Overall Study|Did not receive vaccine|0|||
145677745|NCT05289037|525336774|FG000|Overall Study|Unable to make last visit|0|||
145677746|NCT05289037|525336775|FG001|Overall Study|Unable to make last visit|0|||
145677747|NCT05289037|525336776|FG002|Overall Study|Unable to make last visit|1|||
145677748|NCT05289037|525336777|FG003|Overall Study|Unable to make last visit|0|||
145677749|NCT05289037|525336778|FG004|Overall Study|Unable to make last visit|0|||
145677750|NCT05289037|525336779|FG005|Overall Study|Unable to make last visit|0|||
145677751|NCT05289037|525336780|FG006|Overall Study|Unable to make last visit|0|||
145677752|NCT05289037|525336781|FG007|Overall Study|Unable to make last visit|0|||
145677753|NCT05289037|525336782|FG008|Overall Study|Unable to make last visit|0|||
145677754|NCT05289037|525336783|FG009|Overall Study|Unable to make last visit|0|||
145677755|NCT05289037|525336784|FG010|Overall Study|Unable to make last visit|0|||
145677756|NCT05289037|525336785|FG011|Overall Study|Unable to make last visit|0|||
145677757|NCT05289037|525336786|FG012|Overall Study|Unable to make last visit|0|||
145677758|NCT05289037|525336787|FG013|Overall Study|Unable to make last visit|0|||
145677759|NCT05289037|525336788|FG014|Overall Study|Unable to make last visit|0|||
145677760|NCT05289037|525336789|FG015|Overall Study|Unable to make last visit|0|||
145677761|NCT05289037|525336790|FG016|Overall Study|Unable to make last visit|0|||
145677762|NCT05289037|525336774|FG000|Overall Study|Protocol deviation|0|||
145677763|NCT05289037|525336775|FG001|Overall Study|Protocol deviation|0|||
145677764|NCT05289037|525336776|FG002|Overall Study|Protocol deviation|0|||
145677765|NCT05289037|525336777|FG003|Overall Study|Protocol deviation|0|||
145677766|NCT05289037|525336778|FG004|Overall Study|Protocol deviation|0|||
145677767|NCT05289037|525336779|FG005|Overall Study|Protocol deviation|0|||
145677768|NCT05289037|525336780|FG006|Overall Study|Protocol deviation|0|||
145677769|NCT05289037|525336781|FG007|Overall Study|Protocol deviation|0|||
145677770|NCT05289037|525336782|FG008|Overall Study|Protocol deviation|0|||
145677771|NCT05289037|525336783|FG009|Overall Study|Protocol deviation|0|||
145677772|NCT05289037|525336784|FG010|Overall Study|Protocol deviation|0|||
145677773|NCT05289037|525336785|FG011|Overall Study|Protocol deviation|0|||
145677774|NCT05289037|525336786|FG012|Overall Study|Protocol deviation|0|||
145677775|NCT05289037|525336787|FG013|Overall Study|Protocol deviation|0|||
145677776|NCT05289037|525336788|FG014|Overall Study|Protocol deviation|0|||
145677777|NCT05289037|525336789|FG015|Overall Study|Protocol deviation|1|||
145677778|NCT05289037|525336790|FG016|Overall Study|Protocol deviation|0|||
145677779|NCT02831049|525336791|FG000|Overall Study|Lost to Follow-up|0|||
145677780|NCT02831049|525336792|FG001|Overall Study|Lost to Follow-up|0|||
145677781|NCT02831049|525336793|FG002|Overall Study|Lost to Follow-up|1|||
145677782|NCT02831049|525336791|FG000|Overall Study|Withdrawal by Subject|0|||
145677783|NCT02831049|525336792|FG001|Overall Study|Withdrawal by Subject|1|||
145677784|NCT02831049|525336793|FG002|Overall Study|Withdrawal by Subject|1|||
145677785|NCT02831049|525336791|FG000|Overall Study|Pandemic shutdown|1|||
145677786|NCT02831049|525336792|FG001|Overall Study|Pandemic shutdown|0|||
145677787|NCT02831049|525336793|FG002|Overall Study|Pandemic shutdown|0|||
145677788|NCT04937504|525336794|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
145677789|NCT04937504|525336795|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
145677790|NCT04937504|525336794|FG000|9 Months Assessment|Lost to Follow-up|3|||
145677791|NCT04937504|525336795|FG001|9 Months Assessment|Lost to Follow-up|2|||
145677792|NCT03662659|525336796|FG000|Pre-treatment|Participant no longer met study criteria|1|||
145677793|NCT03662659|525336797|FG001|Pre-treatment|Participant no longer met study criteria|1|||
145677794|NCT03662659|525336796|FG000|Pre-treatment|Other reasons|1|||
145677795|NCT03662659|525336797|FG001|Pre-treatment|Other reasons|0|||
145677796|NCT03662659|525336796|FG000|Treatment|Completed Treatment|0|||
145677797|NCT03662659|525336797|FG001|Treatment|Completed Treatment|2|||
145677798|NCT03662659|525336796|FG000|Treatment|Disease Progression|85|||
145677799|NCT03662659|525336797|FG001|Treatment|Disease Progression|97|||
145677800|NCT03662659|525336796|FG000|Treatment|Study Drug Toxicity|19|||
145677801|NCT03662659|525336797|FG001|Treatment|Study Drug Toxicity|9|||
145677802|NCT03662659|525336796|FG000|Treatment|Death|11|||
145677803|NCT03662659|525336797|FG001|Treatment|Death|9|||
145677804|NCT03662659|525336796|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
145677805|NCT03662659|525336797|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
145677806|NCT03662659|525336796|FG000|Treatment|Withdrawal by Subject|1|||
145677807|NCT03662659|525336797|FG001|Treatment|Withdrawal by Subject|1|||
145677808|NCT03662659|525336796|FG000|Treatment|Poor/Non-compliance|1|||
145677809|NCT03662659|525336797|FG001|Treatment|Poor/Non-compliance|0|||
145677810|NCT03662659|525336796|FG000|Treatment|Participant no longer meets study criteria|1|||
145677811|NCT03662659|525336797|FG001|Treatment|Participant no longer meets study criteria|0|||
145677812|NCT03662659|525336796|FG000|Treatment|Other reasons|10|||
145677813|NCT03662659|525336797|FG001|Treatment|Other reasons|8|||
145677814|NCT03662659|525336796|FG000|Treatment|Administrative reasons by sponsor|1|||
145677815|NCT03662659|525336797|FG001|Treatment|Administrative reasons by sponsor|0|||
145677816|NCT03662659|525336796|FG000|Treatment|maximum clinical benefit|0|||
145677817|NCT03662659|525336797|FG001|Treatment|maximum clinical benefit|2|||
145677818|NCT01668355|525338480|FG000|Overall Study|Death|3|||
145677819|NCT01668355|525338481|FG001|Overall Study|Death|1|||
145677820|NCT01668355|525338480|FG000|Overall Study|Withdrawal by Subject|6|||
145677821|NCT01668355|525338481|FG001|Overall Study|Withdrawal by Subject|1|||
145677822|NCT01277302|525338485|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
145677823|NCT01277302|525338486|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
145677824|NCT01277302|525338487|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
145677825|NCT01277302|525338485|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
145677826|NCT01277302|525338486|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
145677827|NCT01277302|525338487|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
145677828|NCT01277302|525338485|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
145677829|NCT01277302|525338486|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
145677830|NCT01277302|525338487|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
145677831|NCT01277302|525338485|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
145677832|NCT01277302|525338486|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
145677833|NCT01277302|525338487|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
145677834|NCT01277302|525338485|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
145677835|NCT01277302|525338486|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
145677836|NCT01277302|525338487|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
145677837|NCT01277302|525338485|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
145677838|NCT01277302|525338486|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
145677839|NCT01277302|525338487|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
145677840|NCT01277302|525338485|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
145677841|NCT01277302|525338486|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
145677842|NCT01277302|525338487|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
145677843|NCT01277302|525338485|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
145677844|NCT01277302|525338486|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
145677845|NCT01277302|525338487|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
145677846|NCT01277302|525338485|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
145677847|NCT01277302|525338486|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
145677848|NCT01277302|525338487|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
145677849|NCT02710669|525338490|FG000|Overall Study|Physician Decision|2|||
145677850|NCT02710669|525338491|FG001|Overall Study|Physician Decision|1|||
145677851|NCT02710669|525338492|FG002|Overall Study|Physician Decision|0|||
145677852|NCT02710669|525338490|FG000|Overall Study|Institutional delays (including COVID)|2|||
145677853|NCT02710669|525338491|FG001|Overall Study|Institutional delays (including COVID)|2|||
145677854|NCT02710669|525338492|FG002|Overall Study|Institutional delays (including COVID)|0|||
145677855|NCT02710669|525338490|FG000|Overall Study|arrived in afib/aflutter|10|||
145677856|NCT02710669|525338491|FG001|Overall Study|arrived in afib/aflutter|8|||
145677857|NCT02710669|525338492|FG002|Overall Study|arrived in afib/aflutter|2|||
145677858|NCT01190124|525338494|FG000|Overall Study|Death|3|||
145677859|NCT01190124|525338495|FG001|Overall Study|Death|0|||
145677860|NCT01190124|525338496|FG002|Overall Study|Death|0|||
145677861|NCT01190124|525338494|FG000|Overall Study|Therapeutic Failure|12|||
145677862|NCT01190124|525338495|FG001|Overall Study|Therapeutic Failure|0|||
145677863|NCT01190124|525338496|FG002|Overall Study|Therapeutic Failure|1|||
145677864|NCT01190124|525338494|FG000|Overall Study|Lost to Follow-up|2|||
145677865|NCT01190124|525338495|FG001|Overall Study|Lost to Follow-up|0|||
145677866|NCT01190124|525338496|FG002|Overall Study|Lost to Follow-up|0|||
145677867|NCT00070707|525338497|FG000|Overall Study|Adverse Event|1|||
145677868|NCT00070707|525338498|FG001|Overall Study|Adverse Event|2|||
145677869|NCT00070707|525338497|FG000|Overall Study|Lack of Efficacy|4|||
145677870|NCT00070707|525338498|FG001|Overall Study|Lack of Efficacy|1|||
145677871|NCT00070707|525338497|FG000|Overall Study|Protocol Violation|8|||
145677872|NCT00070707|525338498|FG001|Overall Study|Protocol Violation|4|||
145677873|NCT00070707|525338497|FG000|Overall Study|Unrelated to Study Medication|1|||
145677874|NCT00070707|525338498|FG001|Overall Study|Unrelated to Study Medication|0|||
145677875|NCT00670449|525338499|FG000|Overall Study|Adverse Event|6|||
145677876|NCT00670449|525338500|FG001|Overall Study|Adverse Event|2|||
145677877|NCT00670449|525338501|FG002|Overall Study|Adverse Event|8|||
145677878|NCT00670449|525338502|FG003|Overall Study|Adverse Event|5|||
145677879|NCT00670449|525338499|FG000|Overall Study|Protocol Deviation|1|||
145677880|NCT00670449|525338500|FG001|Overall Study|Protocol Deviation|2|||
145677881|NCT00670449|525338501|FG002|Overall Study|Protocol Deviation|0|||
145677882|NCT00670449|525338502|FG003|Overall Study|Protocol Deviation|1|||
145677883|NCT00670449|525338499|FG000|Overall Study|Administrative Problems|0|||
145677884|NCT00670449|525338500|FG001|Overall Study|Administrative Problems|2|||
145677885|NCT00670449|525338501|FG002|Overall Study|Administrative Problems|0|||
145677886|NCT00670449|525338502|FG003|Overall Study|Administrative Problems|1|||
145677887|NCT00670449|525338499|FG000|Overall Study|Subject Withdrew Consent|0|||
145677888|NCT00670449|525338500|FG001|Overall Study|Subject Withdrew Consent|2|||
145677889|NCT00670449|525338501|FG002|Overall Study|Subject Withdrew Consent|0|||
145677890|NCT00670449|525338502|FG003|Overall Study|Subject Withdrew Consent|1|||
145677891|NCT00670449|525338499|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
145677892|NCT00670449|525338500|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145677893|NCT00670449|525338501|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
145677894|NCT00670449|525338502|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
145677895|NCT00670449|525338499|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
145677896|NCT00670449|525338500|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
145677897|NCT00670449|525338501|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
145677898|NCT00670449|525338502|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
145677899|NCT03690219|525338503|FG000|Overall Study|no injuries|9|||
145677900|NCT03690219|525338504|FG001|Overall Study|no injuries|20|||
145677901|NCT03690219|525338503|FG000|Overall Study|missing information|7|||
145677902|NCT03690219|525338504|FG001|Overall Study|missing information|7|||
145677903|NCT01523392|525338505|FG000|Treatment Period 1|Withdrawal by Subject|2|||
145677904|NCT01523392|525338506|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145677905|NCT01523392|525338505|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
145677906|NCT01523392|525338506|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
145677907|NCT01523392|525338505|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
145677908|NCT01523392|525338506|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
145677909|NCT04809623|525338507|FG000|Overall Study|Study Terminated by Sponsor|1|||
145677910|NCT04809623|525338508|FG001|Overall Study|Study Terminated by Sponsor|0|||
145677911|NCT00413283|525338509|FG000|Overall Study|Withdrawal by Subject|1|||
145677912|NCT00413283|525338510|FG001|Overall Study|Withdrawal by Subject|0|||
145677913|NCT00413283|525338511|FG002|Overall Study|Withdrawal by Subject|0|||
145677914|NCT00413283|525338512|FG003|Overall Study|Withdrawal by Subject|1|||
145677915|NCT00413283|525338509|FG000|Overall Study|Death|0|||
145677916|NCT00413283|525338510|FG001|Overall Study|Death|0|||
145677917|NCT00413283|525338511|FG002|Overall Study|Death|1|||
145677918|NCT00413283|525338512|FG003|Overall Study|Death|1|||
145677919|NCT00413283|525338509|FG000|Overall Study|Adverse Event|0|||
145677920|NCT00413283|525338510|FG001|Overall Study|Adverse Event|0|||
145677921|NCT00413283|525338511|FG002|Overall Study|Adverse Event|0|||
145677922|NCT00413283|525338512|FG003|Overall Study|Adverse Event|1|||
145677923|NCT00413283|525338509|FG000|Overall Study|Ineligibility determined|0|||
145677924|NCT00413283|525338510|FG001|Overall Study|Ineligibility determined|0|||
145677925|NCT00413283|525338511|FG002|Overall Study|Ineligibility determined|0|||
145677926|NCT00413283|525338512|FG003|Overall Study|Ineligibility determined|1|||
145677927|NCT00413283|525338509|FG000|Overall Study|Protocol deviation|0|||
145677928|NCT00413283|525338510|FG001|Overall Study|Protocol deviation|1|||
145677929|NCT00413283|525338511|FG002|Overall Study|Protocol deviation|0|||
145677930|NCT00413283|525338512|FG003|Overall Study|Protocol deviation|0|||
145677931|NCT00413283|525338509|FG000|Overall Study|Requirement for alternative therapy|0|||
145677932|NCT00413283|525338510|FG001|Overall Study|Requirement for alternative therapy|2|||
145677933|NCT00413283|525338511|FG002|Overall Study|Requirement for alternative therapy|0|||
145677934|NCT00413283|525338512|FG003|Overall Study|Requirement for alternative therapy|0|||
145677935|NCT00413283|525338509|FG000|Overall Study|Other|0|||
145677936|NCT00413283|525338510|FG001|Overall Study|Other|0|||
145677937|NCT00413283|525338511|FG002|Overall Study|Other|1|||
145677938|NCT00413283|525338512|FG003|Overall Study|Other|0|||
145677939|NCT02002689|525338513|FG000|Overall Study|Disease Progression|7|||
145677940|NCT02002689|525338513|FG000|Overall Study|Adverse Event|3|||
145677941|NCT00671853|525338514|FG000|Overall Study|Lack of Efficacy|3|||
145677942|NCT00671853|525338515|FG001|Overall Study|Lack of Efficacy|7|||
145677943|NCT00671853|525338514|FG000|Overall Study|Adverse Event|7|||
145677944|NCT00671853|525338515|FG001|Overall Study|Adverse Event|1|||
145677945|NCT00671853|525338514|FG000|Overall Study|Withdrawal by Subject|1|||
145677946|NCT00671853|525338515|FG001|Overall Study|Withdrawal by Subject|5|||
145677947|NCT00671853|525338514|FG000|Overall Study|Lost to Follow-up|8|||
145677948|NCT00671853|525338515|FG001|Overall Study|Lost to Follow-up|8|||
145677949|NCT00671853|525338514|FG000|Overall Study|Physician Decision|0|||
145677950|NCT00671853|525338515|FG001|Overall Study|Physician Decision|2|||
145677951|NCT00671853|525338514|FG000|Overall Study|Non-adherence with study procedures|1|||
145677952|NCT00671853|525338515|FG001|Overall Study|Non-adherence with study procedures|4|||
145677953|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
145677954|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145677955|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145677956|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145677957|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
145677958|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145677959|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145677960|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145677961|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
145677962|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145677963|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145677964|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145677965|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
145677966|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145677967|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145677968|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145677969|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
145677970|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145677971|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145677972|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145677973|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
145677974|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145677975|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145677976|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145677977|NCT01185340|525338518|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
145677978|NCT01185340|525338519|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145677979|NCT01185340|525338520|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145677980|NCT01185340|525338521|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145677981|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
145677982|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
145677983|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
145677984|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
145677985|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
145677986|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
145677987|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
145677988|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
145677989|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
145677990|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
145677991|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
145677992|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
145677993|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145677994|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
145677995|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145677996|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
145677997|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
145677998|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145677999|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
145678000|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145678001|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
145678002|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
145678003|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
145678004|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
145678005|NCT01185340|525338518|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145678006|NCT01185340|525338519|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145678007|NCT01185340|525338520|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
145678008|NCT01185340|525338521|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
145678009|NCT01719172|525338522|FG000|Overall Study|Lost to Follow-up|1|||
145678010|NCT01719172|525338522|FG000|Overall Study|Death|1|||
145678011|NCT01148017|525338523|FG000|Overall Study|Withdrawal by Subject|31|||
145678012|NCT01148017|525338524|FG001|Overall Study|Withdrawal by Subject|14|||
145678013|NCT01148017|525338525|FG002|Overall Study|Withdrawal by Subject|0|||
145678014|NCT01148017|525338526|FG003|Overall Study|Withdrawal by Subject|0|||
145678015|NCT01148017|525338523|FG000|Overall Study|Lost to Follow-up|23|||
145678016|NCT01148017|525338524|FG001|Overall Study|Lost to Follow-up|10|||
145678017|NCT01148017|525338525|FG002|Overall Study|Lost to Follow-up|0|||
145678018|NCT01148017|525338526|FG003|Overall Study|Lost to Follow-up|0|||
145678019|NCT01148017|525338523|FG000|Overall Study|Inappropriate enrollment|1|||
145678020|NCT01148017|525338524|FG001|Overall Study|Inappropriate enrollment|0|||
145678021|NCT01148017|525338525|FG002|Overall Study|Inappropriate enrollment|0|||
145678022|NCT01148017|525338526|FG003|Overall Study|Inappropriate enrollment|0|||
145678023|NCT01148017|525338523|FG000|Overall Study|Administrative reason|22|||
145678024|NCT01148017|525338524|FG001|Overall Study|Administrative reason|9|||
145678025|NCT01148017|525338525|FG002|Overall Study|Administrative reason|0|||
145678026|NCT01148017|525338526|FG003|Overall Study|Administrative reason|0|||
145678027|NCT01148017|525338523|FG000|Overall Study|Unable to classify|3|||
145678028|NCT01148017|525338524|FG001|Overall Study|Unable to classify|1|||
145678029|NCT01148017|525338525|FG002|Overall Study|Unable to classify|0|||
145678030|NCT01148017|525338526|FG003|Overall Study|Unable to classify|0|||
145678031|NCT01848483|525338527|FG000|Overall Study|Death|2|||
145678032|NCT01848483|525338528|FG001|Overall Study|Death|1|||
145678033|NCT01848483|525338527|FG000|Overall Study|Lost to Follow-up|6|||
145678034|NCT01848483|525338528|FG001|Overall Study|Lost to Follow-up|8|||
145678035|NCT01848483|525338527|FG000|Overall Study|Withdrawal by Subject|1|||
145678036|NCT01848483|525338528|FG001|Overall Study|Withdrawal by Subject|0|||
145678037|NCT01848483|525338527|FG000|Overall Study|Incarceration|2|||
145678038|NCT01848483|525338528|FG001|Overall Study|Incarceration|2|||
145678039|NCT00246129|525338533|FG000|Overall Study|Lost to Follow-up|1|||
145678040|NCT00246129|525338534|FG001|Overall Study|Lost to Follow-up|0|||
145678041|NCT00246129|525338533|FG000|Overall Study|Death|2|||
145678042|NCT00246129|525338534|FG001|Overall Study|Death|1|||
145678043|NCT00246129|525338533|FG000|Overall Study|suffered primary non-function|1|||
145678044|NCT00246129|525338534|FG001|Overall Study|suffered primary non-function|0|||
145678045|NCT00246129|525338533|FG000|Overall Study|grafts failed|3|||
145678046|NCT00246129|525338534|FG001|Overall Study|grafts failed|1|||
145678047|NCT03740737|525338535|FG000|Overall Study|Protocol deviation|13|||
145678048|NCT03740737|525338536|FG001|Overall Study|Protocol deviation|0|||
145678049|NCT03740737|525338535|FG000|Overall Study|Adverse Event|2|||
145678050|NCT03740737|525338536|FG001|Overall Study|Adverse Event|0|||
145678051|NCT03740737|525338535|FG000|Overall Study|Lost to Follow-up|1|||
145678052|NCT03740737|525338536|FG001|Overall Study|Lost to Follow-up|0|||
145678053|NCT03740737|525338535|FG000|Overall Study|Randomization failure|1|||
145678054|NCT03740737|525338536|FG001|Overall Study|Randomization failure|0|||
145678055|NCT03740737|525338535|FG000|Overall Study|Participant withdrew consent|1|||
145678056|NCT03740737|525338536|FG001|Overall Study|Participant withdrew consent|0|||
145678057|NCT03740737|525338535|FG000|Overall Study|Participant withdrew from trial|2|||
145678058|NCT03740737|525338536|FG001|Overall Study|Participant withdrew from trial|1|||
145678059|NCT03469258|525338537|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
145678060|NCT02236611|525338542|FG000|Overall Study|Adverse Event|10|||
145678061|NCT02236611|525338543|FG001|Overall Study|Adverse Event|16|||
145678062|NCT02236611|525338542|FG000|Overall Study|Lack of Efficacy|4|||
145678063|NCT02236611|525338543|FG001|Overall Study|Lack of Efficacy|7|||
145678064|NCT02236611|525338542|FG000|Overall Study|Lost to Follow-up|0|||
145678065|NCT02236611|525338543|FG001|Overall Study|Lost to Follow-up|2|||
145678066|NCT02236611|525338542|FG000|Overall Study|Protocol deviation|3|||
145678067|NCT02236611|525338543|FG001|Overall Study|Protocol deviation|5|||
145678068|NCT02236611|525338542|FG000|Overall Study|Withdrew consent|9|||
145678069|NCT02236611|525338543|FG001|Overall Study|Withdrew consent|4|||
145678070|NCT03041090|525338544|FG000|Overall Study|technical error|0|||
145678071|NCT03041090|525338545|FG001|Overall Study|technical error|3|||
145678072|NCT03403036|525338546|FG000|Overall Study|Lack of Efficacy|5|||
145678073|NCT01128959|525338547|FG000|Lead in Period|Adverse Event|3|||
145678074|NCT01128959|525338547|FG000|Treatment Period|Adverse Event|3|||
145678075|NCT01128959|525338547|FG000|Treatment Period|Withdrawal by Subject|1|||
145678076|NCT02338999|525338548|FG000|First Intervention|Withdrawal by Subject|3|||
145678077|NCT02338999|525338549|FG001|First Intervention|Withdrawal by Subject|1|||
145678078|NCT02338999|525338548|FG000|Washout Period|Withdrawal by Subject|0|||
145265410|NCT00764465|523819354|FG002|Overall Study|Adverse Event|0|||
145678079|NCT02338999|525338549|FG001|Washout Period|Withdrawal by Subject|2|||
145678080|NCT02338999|525338548|FG000|Second Intervention|Withdrawal by Subject|0|||
145678081|NCT02338999|525338549|FG001|Second Intervention|Withdrawal by Subject|2|||
145678082|NCT02701296|525338550|FG000|Overall Study|Incomplete Data|0|||
145678083|NCT02701296|525338551|FG001|Overall Study|Incomplete Data|2|||
145678084|NCT01409837|525338554|FG000|Overall Study|Withdrawal by Subject|2|||
145678085|NCT01409837|525338555|FG001|Overall Study|Withdrawal by Subject|1|||
145678086|NCT01409837|525338554|FG000|Overall Study|Lost to Follow-up|1|||
145678087|NCT01409837|525338555|FG001|Overall Study|Lost to Follow-up|0|||
145678088|NCT01409837|525338554|FG000|Overall Study|Physician Decision|0|||
145678089|NCT01409837|525338555|FG001|Overall Study|Physician Decision|1|||
145678090|NCT03490032|525338557|FG000|Overall Study|family issue (child custody)|1|||
145678091|NCT03490032|525338558|FG001|Overall Study|family issue (child custody)|0|||
145678092|NCT03490032|525338559|FG002|Overall Study|family issue (child custody)|0|||
145678093|NCT00308308|525338560|FG000|Overall Study|Adverse Event|17|||
145678094|NCT00308308|525338561|FG001|Overall Study|Adverse Event|2|||
145678095|NCT00308308|525338560|FG000|Overall Study|Lost to Follow-up|5|||
145678096|NCT00308308|525338561|FG001|Overall Study|Lost to Follow-up|5|||
145678097|NCT00308308|525338560|FG000|Overall Study|Physician Decision|15|||
145678098|NCT00308308|525338561|FG001|Overall Study|Physician Decision|7|||
145678099|NCT00308308|525338560|FG000|Overall Study|Protocol Violation|3|||
145678100|NCT00308308|525338561|FG001|Overall Study|Protocol Violation|14|||
145678101|NCT00308308|525338560|FG000|Overall Study|Withdrawal by Subject|47|||
145678102|NCT00308308|525338561|FG001|Overall Study|Withdrawal by Subject|19|||
145678103|NCT00308308|525338560|FG000|Overall Study|Various|7|||
145678104|NCT00308308|525338561|FG001|Overall Study|Various|5|||
145678105|NCT00308308|525338560|FG000|Overall Study|Randomized but not dosed|8|||
145678106|NCT00308308|525338561|FG001|Overall Study|Randomized but not dosed|16|||
145678107|NCT00308308|525338560|FG000|Overall Study|Other|1|||
145678108|NCT00308308|525338561|FG001|Overall Study|Other|0|||
145678109|NCT04679675|525338566|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
145678110|NCT04679675|525338567|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
145678111|NCT04679675|525338568|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
145678112|NCT04679675|525338569|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
145678113|NCT04679675|525338566|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
145678114|NCT04679675|525338567|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
145678115|NCT04679675|525338568|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
145678116|NCT04679675|525338569|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
145678117|NCT02449902|525338572|FG000|Overall Study|Adverse Event|0|||
145678118|NCT02449902|525338573|FG001|Overall Study|Adverse Event|1|||
145678119|NCT02449902|525338572|FG000|Overall Study|Withdrawal by Subject|0|||
145678120|NCT02449902|525338573|FG001|Overall Study|Withdrawal by Subject|1|||
145678121|NCT02362789|525338577|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
145678122|NCT02362789|525338578|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
145678123|NCT02362789|525338579|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
145678124|NCT02362789|525338577|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
145678125|NCT02362789|525338578|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
145678126|NCT02362789|525338579|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
145678127|NCT02362789|525338577|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
145678128|NCT02362789|525338578|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
145678129|NCT02362789|525338579|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
145678130|NCT02362789|525338577|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
145678131|NCT02362789|525338578|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
145678132|NCT02362789|525338579|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
145678133|NCT02362789|525338577|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
145678134|NCT02362789|525338578|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
145678135|NCT02362789|525338579|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
145678136|NCT01365546|525338580|FG000|Overall Study|Withdrawal by Subject|1|||
145678137|NCT01365546|525338580|FG000|Overall Study|Screen failure|9|||
145678138|NCT01365546|525338580|FG000|Overall Study|Study termination|1|||
145678139|NCT03861234|525338582|FG000|Overall Study|Not treated|0|||
145678140|NCT03861234|525338583|FG001|Overall Study|Not treated|0|||
145678141|NCT03861234|525338584|FG002|Overall Study|Not treated|0|||
145678142|NCT03861234|525338585|FG003|Overall Study|Not treated|0|||
145678143|NCT03861234|525338586|FG004|Overall Study|Not treated|0|||
145678144|NCT03861234|525338587|FG005|Overall Study|Not treated|1|||
145678145|NCT03861234|525338588|FG006|Overall Study|Not treated|0|||
145678146|NCT03861234|525338589|FG007|Overall Study|Not treated|0|||
145678147|NCT03861234|525338582|FG000|Overall Study|Adverse Event|0|||
145678148|NCT03861234|525338583|FG001|Overall Study|Adverse Event|0|||
145678149|NCT03861234|525338584|FG002|Overall Study|Adverse Event|0|||
145678150|NCT03861234|525338585|FG003|Overall Study|Adverse Event|0|||
145678151|NCT03861234|525338586|FG004|Overall Study|Adverse Event|0|||
145678152|NCT03861234|525338587|FG005|Overall Study|Adverse Event|1|||
145678153|NCT03861234|525338588|FG006|Overall Study|Adverse Event|0|||
145678154|NCT03861234|525338589|FG007|Overall Study|Adverse Event|0|||
145678155|NCT03861234|525338582|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
145678156|NCT03861234|525338583|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
145678157|NCT03861234|525338584|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
145678158|NCT03861234|525338585|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
145678159|NCT03861234|525338586|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
145678160|NCT03861234|525338587|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
145678161|NCT03861234|525338588|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
145678162|NCT03861234|525338589|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
145678163|NCT03861234|525338582|FG000|Overall Study|As per sponsor decision|0|||
145678164|NCT03861234|525338583|FG001|Overall Study|As per sponsor decision|0|||
145678165|NCT03861234|525338584|FG002|Overall Study|As per sponsor decision|0|||
145678166|NCT03861234|525338585|FG003|Overall Study|As per sponsor decision|0|||
145678167|NCT03861234|525338586|FG004|Overall Study|As per sponsor decision|0|||
145678168|NCT03861234|525338587|FG005|Overall Study|As per sponsor decision|0|||
145678169|NCT03861234|525338588|FG006|Overall Study|As per sponsor decision|1|||
145678170|NCT03861234|525338589|FG007|Overall Study|As per sponsor decision|0|||
145678171|NCT03861234|525338582|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
145678172|NCT03861234|525338583|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
145678173|NCT03861234|525338584|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
145678174|NCT03861234|525338585|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
145678175|NCT03861234|525338586|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
145678176|NCT03861234|525338587|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
145678177|NCT03861234|525338588|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
145678178|NCT03861234|525338589|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
145678179|NCT03200574|525338592|FG000|Overall Study|Death|4|||
145678180|NCT03200574|525338592|FG000|Overall Study|Withdrawal by Subject|8|||
145678181|NCT03200574|525338592|FG000|Overall Study|Long-Term need for anticoagulation|1|||
145678182|NCT03200574|525338592|FG000|Overall Study|Relocation|2|||
145678183|NCT03200574|525338592|FG000|Overall Study|Lost to Follow-up|2|||
145678184|NCT00705159|525338596|FG000|Overall Study|Withdrawal by Subject|0|||
145678185|NCT00705159|525338597|FG001|Overall Study|Withdrawal by Subject|1|||
145678186|NCT00705159|525338598|FG002|Overall Study|Withdrawal by Subject|1|||
145678187|NCT00705159|525338599|FG003|Overall Study|Withdrawal by Subject|1|||
145678188|NCT00705159|525338596|FG000|Overall Study|Protocol Violation|0|||
145678189|NCT00705159|525338597|FG001|Overall Study|Protocol Violation|1|||
145678190|NCT00705159|525338598|FG002|Overall Study|Protocol Violation|0|||
145678191|NCT00705159|525338599|FG003|Overall Study|Protocol Violation|0|||
145678192|NCT00705159|525338596|FG000|Overall Study|Adverse Event|0|||
145678193|NCT00705159|525338597|FG001|Overall Study|Adverse Event|0|||
145678194|NCT00705159|525338598|FG002|Overall Study|Adverse Event|1|||
145678195|NCT00705159|525338599|FG003|Overall Study|Adverse Event|0|||
145678196|NCT00705159|525338596|FG000|Overall Study|Lost to Follow-up|0|||
145678197|NCT00705159|525338597|FG001|Overall Study|Lost to Follow-up|0|||
145678198|NCT00705159|525338598|FG002|Overall Study|Lost to Follow-up|3|||
145678199|NCT00705159|525338599|FG003|Overall Study|Lost to Follow-up|2|||
145678200|NCT00705159|525338596|FG000|Overall Study|Screen Failure|0|||
145678201|NCT00705159|525338597|FG001|Overall Study|Screen Failure|0|||
145678202|NCT00705159|525338598|FG002|Overall Study|Screen Failure|0|||
145678203|NCT00705159|525338599|FG003|Overall Study|Screen Failure|1|||
145678204|NCT03035942|525338600|FG000|Overall Study|Adverse Event|8|||
145678205|NCT03035942|525338601|FG001|Overall Study|Adverse Event|4|||
145678206|NCT03035942|525338602|FG002|Overall Study|Adverse Event|5|||
145678207|NCT02538094|525338603|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
145678208|NCT02538094|525338604|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
145678209|NCT02538094|525338603|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
145678210|NCT02538094|525338604|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
145678211|NCT01989104|525338605|FG000|Overall Study|Withdrawal by Subject|3|||
145678212|NCT01989104|525338606|FG001|Overall Study|Withdrawal by Subject|0|||
145678213|NCT01989104|525338607|FG002|Overall Study|Withdrawal by Subject|0|||
145678214|NCT01989104|525338608|FG003|Overall Study|Withdrawal by Subject|0|||
145678215|NCT01989104|525338609|FG004|Overall Study|Withdrawal by Subject|0|||
145678216|NCT00680771|525338610|FG000|Overall Study|Withdrawal by Subject|1|||
145678217|NCT00680771|525338611|FG001|Overall Study|Withdrawal by Subject|0|||
145678218|NCT00680771|525338610|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
145678219|NCT00680771|525338611|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
145678220|NCT00680771|525338610|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
145678221|NCT00680771|525338611|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
145678222|NCT02691702|525338612|FG000|Overall Study|Adverse Event|1|||
145678223|NCT02691702|525338613|FG001|Overall Study|Adverse Event|0|||
145678224|NCT02691702|525338614|FG002|Overall Study|Adverse Event|0|||
145678225|NCT02691702|525338615|FG003|Overall Study|Adverse Event|0|||
145678226|NCT02691702|525338616|FG004|Overall Study|Adverse Event|0|||
145678227|NCT02691702|525338617|FG005|Overall Study|Adverse Event|0|||
145678228|NCT02691702|525338618|FG006|Overall Study|Adverse Event|0|||
145678229|NCT02691702|525338619|FG007|Overall Study|Adverse Event|0|||
145678230|NCT02691702|525338620|FG008|Overall Study|Adverse Event|1|||
145678231|NCT02691702|525338621|FG009|Overall Study|Adverse Event|0|||
145678232|NCT02691702|525338622|FG010|Overall Study|Adverse Event|1|||
145678233|NCT02691702|525338612|FG000|Overall Study|Lost to Follow-up|0|||
145678234|NCT02691702|525338613|FG001|Overall Study|Lost to Follow-up|0|||
145678235|NCT02691702|525338614|FG002|Overall Study|Lost to Follow-up|1|||
145678236|NCT02691702|525338615|FG003|Overall Study|Lost to Follow-up|0|||
145678237|NCT02691702|525338616|FG004|Overall Study|Lost to Follow-up|0|||
145678238|NCT02691702|525338617|FG005|Overall Study|Lost to Follow-up|2|||
145678239|NCT02691702|525338618|FG006|Overall Study|Lost to Follow-up|0|||
145678240|NCT02691702|525338619|FG007|Overall Study|Lost to Follow-up|0|||
145678241|NCT02691702|525338620|FG008|Overall Study|Lost to Follow-up|0|||
145678242|NCT02691702|525338621|FG009|Overall Study|Lost to Follow-up|0|||
145678243|NCT02691702|525338622|FG010|Overall Study|Lost to Follow-up|1|||
145678244|NCT02691702|525338612|FG000|Overall Study|Withdrawal by Subject|1|||
145678245|NCT02691702|525338613|FG001|Overall Study|Withdrawal by Subject|1|||
145678246|NCT02691702|525338614|FG002|Overall Study|Withdrawal by Subject|0|||
145678247|NCT02691702|525338615|FG003|Overall Study|Withdrawal by Subject|0|||
145678248|NCT02691702|525338616|FG004|Overall Study|Withdrawal by Subject|0|||
145678249|NCT02691702|525338617|FG005|Overall Study|Withdrawal by Subject|1|||
145678250|NCT02691702|525338618|FG006|Overall Study|Withdrawal by Subject|2|||
145678251|NCT02691702|525338619|FG007|Overall Study|Withdrawal by Subject|0|||
145678252|NCT02691702|525338620|FG008|Overall Study|Withdrawal by Subject|0|||
145678253|NCT02691702|525338621|FG009|Overall Study|Withdrawal by Subject|0|||
145678254|NCT02691702|525338622|FG010|Overall Study|Withdrawal by Subject|0|||
145678255|NCT02691702|525338612|FG000|Overall Study|Other|0|||
145678256|NCT02691702|525338613|FG001|Overall Study|Other|0|||
145678257|NCT02691702|525338614|FG002|Overall Study|Other|0|||
145678258|NCT02691702|525338615|FG003|Overall Study|Other|0|||
145678259|NCT02691702|525338616|FG004|Overall Study|Other|0|||
145678260|NCT02691702|525338617|FG005|Overall Study|Other|0|||
145678261|NCT02691702|525338618|FG006|Overall Study|Other|1|||
145678262|NCT02691702|525338619|FG007|Overall Study|Other|0|||
145678263|NCT02691702|525338620|FG008|Overall Study|Other|1|||
145678264|NCT02691702|525338621|FG009|Overall Study|Other|0|||
145678265|NCT02691702|525338622|FG010|Overall Study|Other|0|||
145678266|NCT02691702|525338612|FG000|Overall Study|Protocol Violation|0|||
145678267|NCT02691702|525338613|FG001|Overall Study|Protocol Violation|0|||
145678268|NCT02691702|525338614|FG002|Overall Study|Protocol Violation|0|||
145678269|NCT02691702|525338615|FG003|Overall Study|Protocol Violation|0|||
145678270|NCT02691702|525338616|FG004|Overall Study|Protocol Violation|0|||
145678271|NCT02691702|525338617|FG005|Overall Study|Protocol Violation|0|||
145678272|NCT02691702|525338618|FG006|Overall Study|Protocol Violation|0|||
145678273|NCT02691702|525338619|FG007|Overall Study|Protocol Violation|0|||
145678274|NCT02691702|525338620|FG008|Overall Study|Protocol Violation|0|||
145678275|NCT02691702|525338621|FG009|Overall Study|Protocol Violation|2|||
145678276|NCT02691702|525338622|FG010|Overall Study|Protocol Violation|0|||
145678277|NCT01860079|525338623|FG000|Overall Study|Physician Decision|14|||
145678278|NCT01860079|525338624|FG001|Overall Study|Physician Decision|22|||
145678279|NCT00326183|525338625|FG000|Overall Study|Lost to Follow-up|104|||
145678280|NCT00326183|525338626|FG001|Overall Study|Lost to Follow-up|56|||
145678281|NCT00326183|525338625|FG000|Overall Study|Protocol Violation|6|||
145678282|NCT00326183|525338626|FG001|Overall Study|Protocol Violation|3|||
145678283|NCT00326183|525338625|FG000|Overall Study|Withdrawal by Subject|35|||
145678284|NCT00326183|525338626|FG001|Overall Study|Withdrawal by Subject|7|||
145678285|NCT00326183|525338625|FG000|Overall Study|Subject Moved|7|||
145678286|NCT00326183|525338626|FG001|Overall Study|Subject Moved|4|||
145678287|NCT00326183|525338625|FG000|Overall Study|Other|47|||
145678288|NCT00326183|525338626|FG001|Overall Study|Other|13|||
145678289|NCT00326183|525338625|FG000|Overall Study|Adverse Event|1|||
145678290|NCT00326183|525338626|FG001|Overall Study|Adverse Event|0|||
145678291|NCT03803475|525338633|FG000|Overall Study|Physician Decision|1|||
145678292|NCT05995977|525338634|FG000|Overall Study|Withdrawal by Subject|1|||
145678293|NCT05995977|525338635|FG001|Overall Study|Withdrawal by Subject|4|||
145678294|NCT05995977|525338634|FG000|Overall Study|Lost to Follow-up|2|||
145678295|NCT05995977|525338635|FG001|Overall Study|Lost to Follow-up|0|||
145678296|NCT04181788|525338636|FG000|TREATMENT|Adverse Event|0|||
145678297|NCT04181788|525338637|FG001|TREATMENT|Adverse Event|2|||
145678298|NCT04181788|525338638|FG002|TREATMENT|Adverse Event|1|||
145678299|NCT04181788|525338639|FG003|TREATMENT|Adverse Event|0|||
145678300|NCT04181788|525338640|FG004|TREATMENT|Adverse Event|1|||
145678301|NCT04181788|525338641|FG005|TREATMENT|Adverse Event|3|||
145678302|NCT04181788|525338636|FG000|TREATMENT|Death|0|||
145678303|NCT04181788|525338637|FG001|TREATMENT|Death|0|||
145678304|NCT04181788|525338638|FG002|TREATMENT|Death|0|||
145678305|NCT04181788|525338639|FG003|TREATMENT|Death|0|||
145678306|NCT04181788|525338640|FG004|TREATMENT|Death|8|||
145678307|NCT04181788|525338641|FG005|TREATMENT|Death|8|||
145678308|NCT04181788|525338636|FG000|TREATMENT|Physician Decision|0|||
145678309|NCT04181788|525338637|FG001|TREATMENT|Physician Decision|0|||
145678310|NCT04181788|525338638|FG002|TREATMENT|Physician Decision|0|||
145678311|NCT04181788|525338639|FG003|TREATMENT|Physician Decision|0|||
145678312|NCT04181788|525338640|FG004|TREATMENT|Physician Decision|0|||
145678313|NCT04181788|525338641|FG005|TREATMENT|Physician Decision|1|||
145678314|NCT04181788|525338636|FG000|TREATMENT|Progressive disease|3|||
145678315|NCT04181788|525338637|FG001|TREATMENT|Progressive disease|3|||
145678316|NCT04181788|525338638|FG002|TREATMENT|Progressive disease|5|||
145678317|NCT04181788|525338639|FG003|TREATMENT|Progressive disease|7|||
145678318|NCT04181788|525338640|FG004|TREATMENT|Progressive disease|20|||
145678319|NCT04181788|525338641|FG005|TREATMENT|Progressive disease|38|||
145678320|NCT04181788|525338636|FG000|TREATMENT|Global deterioration of health status|0|||
145678321|NCT04181788|525338637|FG001|TREATMENT|Global deterioration of health status|2|||
145678322|NCT04181788|525338638|FG002|TREATMENT|Global deterioration of health status|0|||
145678323|NCT04181788|525338639|FG003|TREATMENT|Global deterioration of health status|0|||
145678324|NCT04181788|525338640|FG004|TREATMENT|Global deterioration of health status|2|||
145678325|NCT04181788|525338641|FG005|TREATMENT|Global deterioration of health status|8|||
145678326|NCT04181788|525338636|FG000|TREATMENT|Withdrawal by Subject|1|||
145678327|NCT04181788|525338637|FG001|TREATMENT|Withdrawal by Subject|2|||
145678328|NCT04181788|525338638|FG002|TREATMENT|Withdrawal by Subject|0|||
145678329|NCT04181788|525338639|FG003|TREATMENT|Withdrawal by Subject|0|||
145678330|NCT04181788|525338640|FG004|TREATMENT|Withdrawal by Subject|3|||
145678331|NCT04181788|525338641|FG005|TREATMENT|Withdrawal by Subject|5|||
145678332|NCT04181788|525338636|FG000|TREATMENT|Other unspecified|0|||
145678333|NCT04181788|525338637|FG001|TREATMENT|Other unspecified|0|||
145678334|NCT04181788|525338638|FG002|TREATMENT|Other unspecified|0|||
145678335|NCT04181788|525338639|FG003|TREATMENT|Other unspecified|0|||
145678336|NCT04181788|525338640|FG004|TREATMENT|Other unspecified|0|||
145678337|NCT04181788|525338641|FG005|TREATMENT|Other unspecified|2|||
145678338|NCT04181788|525338636|FG000|TREATMENT|Ongoing|0|||
145678339|NCT04181788|525338637|FG001|TREATMENT|Ongoing|3|||
145678340|NCT04181788|525338638|FG002|TREATMENT|Ongoing|0|||
145678341|NCT04181788|525338639|FG003|TREATMENT|Ongoing|5|||
145678342|NCT04181788|525338640|FG004|TREATMENT|Ongoing|7|||
145678343|NCT04181788|525338641|FG005|TREATMENT|Ongoing|15|||
145678344|NCT04181788|525338636|FG000|FOLLOW-UP|Death|0|||
145678345|NCT04181788|525338637|FG001|FOLLOW-UP|Death|0|||
145678346|NCT04181788|525338638|FG002|FOLLOW-UP|Death|1|||
145678347|NCT04181788|525338639|FG003|FOLLOW-UP|Death|2|||
145678348|NCT04181788|525338640|FG004|FOLLOW-UP|Death|8|||
145678349|NCT04181788|525338641|FG005|FOLLOW-UP|Death|20|||
145678350|NCT04181788|525338636|FG000|FOLLOW-UP|Lost to Follow-up|0|||
145678351|NCT04181788|525338637|FG001|FOLLOW-UP|Lost to Follow-up|0|||
145678352|NCT04181788|525338638|FG002|FOLLOW-UP|Lost to Follow-up|0|||
145678353|NCT04181788|525338639|FG003|FOLLOW-UP|Lost to Follow-up|0|||
145678354|NCT04181788|525338640|FG004|FOLLOW-UP|Lost to Follow-up|0|||
145678355|NCT04181788|525338641|FG005|FOLLOW-UP|Lost to Follow-up|2|||
145678356|NCT04181788|525338636|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
145678357|NCT04181788|525338637|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
145678358|NCT04181788|525338638|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
145678359|NCT04181788|525338639|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
145678360|NCT04181788|525338640|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
145678361|NCT04181788|525338641|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
145678362|NCT04181788|525338636|FG000|FOLLOW-UP|Other unspecified|0|||
145678363|NCT04181788|525338637|FG001|FOLLOW-UP|Other unspecified|1|||
145678364|NCT04181788|525338638|FG002|FOLLOW-UP|Other unspecified|0|||
145678365|NCT04181788|525338639|FG003|FOLLOW-UP|Other unspecified|0|||
145678366|NCT04181788|525338640|FG004|FOLLOW-UP|Other unspecified|0|||
145678367|NCT04181788|525338641|FG005|FOLLOW-UP|Other unspecified|3|||
145678368|NCT04181788|525338636|FG000|FOLLOW-UP|Ongoing|0|||
145678369|NCT04181788|525338637|FG001|FOLLOW-UP|Ongoing|0|||
145678370|NCT04181788|525338638|FG002|FOLLOW-UP|Ongoing|1|||
145678371|NCT04181788|525338639|FG003|FOLLOW-UP|Ongoing|3|||
145678372|NCT04181788|525338640|FG004|FOLLOW-UP|Ongoing|2|||
145678373|NCT04181788|525338641|FG005|FOLLOW-UP|Ongoing|2|||
145678374|NCT04535414|525338643|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
145678375|NCT04535414|525338644|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
145678376|NCT04535414|525338643|FG000|Overall Study|Cancelled appointment|1|||
145678377|NCT04535414|525338644|FG001|Overall Study|Cancelled appointment|0|||
145678378|NCT04535414|525338643|FG000|Overall Study|cancelled - food in stomach|2|||
145678379|NCT04535414|525338644|FG001|Overall Study|cancelled - food in stomach|0|||
145678380|NCT04535414|525338643|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
145678381|NCT04535414|525338644|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
145678382|NCT04535414|525338643|FG000|Overall Study|Withdrawal by Subject|0|||
145678383|NCT04535414|525338644|FG001|Overall Study|Withdrawal by Subject|1|||
145678384|NCT01276509|525340744|FG000|Overall Study|Adverse Event|9|||
145678385|NCT01276509|525340745|FG001|Overall Study|Adverse Event|8|||
145678386|NCT01276509|525340746|FG002|Overall Study|Adverse Event|4|||
145678387|NCT01276509|525340747|FG003|Overall Study|Adverse Event|3|||
145678388|NCT01276509|525340744|FG000|Overall Study|Lack of Efficacy|2|||
145678389|NCT01276509|525340745|FG001|Overall Study|Lack of Efficacy|1|||
145678390|NCT01276509|525340746|FG002|Overall Study|Lack of Efficacy|1|||
145678391|NCT01276509|525340747|FG003|Overall Study|Lack of Efficacy|2|||
145678392|NCT01276509|525340744|FG000|Overall Study|Pregnancy|1|||
145678393|NCT01276509|525340745|FG001|Overall Study|Pregnancy|0|||
145678394|NCT01276509|525340746|FG002|Overall Study|Pregnancy|0|||
145678395|NCT01276509|525340747|FG003|Overall Study|Pregnancy|0|||
145678396|NCT01276509|525340744|FG000|Overall Study|Withdrawal by Subject|1|||
145678397|NCT01276509|525340745|FG001|Overall Study|Withdrawal by Subject|2|||
145678398|NCT01276509|525340746|FG002|Overall Study|Withdrawal by Subject|0|||
145678399|NCT01276509|525340747|FG003|Overall Study|Withdrawal by Subject|0|||
145678400|NCT01276509|525340744|FG000|Overall Study|Other|0|||
145678401|NCT01276509|525340745|FG001|Overall Study|Other|1|||
145678402|NCT01276509|525340746|FG002|Overall Study|Other|0|||
145678403|NCT01276509|525340747|FG003|Overall Study|Other|0|||
145678404|NCT00535626|525340751|FG000|Overall Study|Death|15|||
145678405|NCT00535626|525340751|FG000|Overall Study|Lost to Follow-up|29|||
145678406|NCT00535626|525340751|FG000|Overall Study|Withdrawal by Subject|20|||
145678407|NCT00535626|525340751|FG000|Overall Study|Removal/revision of study component|8|||
145678408|NCT00535626|525340751|FG000|Overall Study|Subject terminated|31|||
145678409|NCT00535626|525340751|FG000|Overall Study|Unable to return|2|||
145678410|NCT02830893|525340752|FG000|Overall Study|Relocation to out of the country|1|||
145678411|NCT02830893|525340753|FG001|Overall Study|Relocation to out of the country|0|||
145678412|NCT02830893|525340752|FG000|Overall Study|Lost to Follow-up|0|||
145678413|NCT02830893|525340753|FG001|Overall Study|Lost to Follow-up|2|||
145678414|NCT02830893|525340752|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
145678415|NCT02830893|525340753|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
145678416|NCT01567852|525340754|FG000|Overall Study|Withdrawal by Subject|3|||
145678417|NCT01567852|525340755|FG001|Overall Study|Withdrawal by Subject|6|||
145678418|NCT01567852|525340754|FG000|Overall Study|ECT discontinued|1|||
145678419|NCT01567852|525340755|FG001|Overall Study|ECT discontinued|1|||
145678420|NCT01808534|525340765|FG000|Overall Study|Disease progression|3|||
145678421|NCT01808534|525340765|FG000|Overall Study|Physician Decision|1|||
145678422|NCT02354417|525340766|FG000|Overall Study|Physician Decision|1|||
145678423|NCT02202317|525340770|FG000|Overall Study|Lost to Follow-up|1|||
145678424|NCT00569166|525340772|FG000|Overall Study|Withdrawal by Subject|7|||
145678425|NCT00569166|525340773|FG001|Overall Study|Withdrawal by Subject|5|||
145678426|NCT00569166|525340774|FG002|Overall Study|Withdrawal by Subject|3|||
145678427|NCT00569166|525340772|FG000|Overall Study|Lost to Follow-up|2|||
145678428|NCT00569166|525340773|FG001|Overall Study|Lost to Follow-up|1|||
145678429|NCT00569166|525340774|FG002|Overall Study|Lost to Follow-up|1|||
145678430|NCT03851094|525340776|FG000|Overall Study|Withdrawal by Subject|0|||
145678431|NCT03851094|525340777|FG001|Overall Study|Withdrawal by Subject|1|||
145678432|NCT03851094|525340776|FG000|Overall Study|Participant lost device|0|||
145678433|NCT03851094|525340777|FG001|Overall Study|Participant lost device|1|||
145678434|NCT03851094|525340776|FG000|Overall Study|Participant returned device|0|||
145678435|NCT03851094|525340777|FG001|Overall Study|Participant returned device|2|||
145678436|NCT01332266|525340778|FG000|Phase 1b|Death|3|||
145678437|NCT01332266|525340779|FG001|Phase 1b|Death|3|||
145678438|NCT01332266|525340780|FG002|Phase 1b|Death|2|||
145678439|NCT01332266|525340781|FG003|Phase 1b|Death|0|||
145678440|NCT01332266|525340782|FG004|Phase 1b|Death|0|||
145678441|NCT01332266|525340778|FG000|Phase 1b|Lost to Follow-up|0|||
145678442|NCT01332266|525340779|FG001|Phase 1b|Lost to Follow-up|1|||
145678443|NCT01332266|525340780|FG002|Phase 1b|Lost to Follow-up|0|||
145678444|NCT01332266|525340781|FG003|Phase 1b|Lost to Follow-up|0|||
145678445|NCT01332266|525340782|FG004|Phase 1b|Lost to Follow-up|0|||
145678446|NCT01332266|525340778|FG000|Phase 1b|Withdrawal by Subject|1|||
145678447|NCT01332266|525340779|FG001|Phase 1b|Withdrawal by Subject|1|||
145678448|NCT01332266|525340780|FG002|Phase 1b|Withdrawal by Subject|1|||
145678449|NCT01332266|525340781|FG003|Phase 1b|Withdrawal by Subject|0|||
145678450|NCT01332266|525340782|FG004|Phase 1b|Withdrawal by Subject|0|||
145678451|NCT01332266|525340778|FG000|Phase 2|Death|0|||
145678452|NCT01332266|525340779|FG001|Phase 2|Death|0|||
145678453|NCT01332266|525340780|FG002|Phase 2|Death|0|||
145678454|NCT01332266|525340781|FG003|Phase 2|Death|33|||
145678455|NCT01332266|525340782|FG004|Phase 2|Death|36|||
145678456|NCT01332266|525340778|FG000|Phase 2|Lost to Follow-up|0|||
145678457|NCT01332266|525340779|FG001|Phase 2|Lost to Follow-up|0|||
145678458|NCT01332266|525340780|FG002|Phase 2|Lost to Follow-up|0|||
145678459|NCT01332266|525340781|FG003|Phase 2|Lost to Follow-up|2|||
145678460|NCT01332266|525340782|FG004|Phase 2|Lost to Follow-up|0|||
145678461|NCT01332266|525340778|FG000|Phase 2|Physician Decision|0|||
145678462|NCT01332266|525340779|FG001|Phase 2|Physician Decision|0|||
145678463|NCT01332266|525340780|FG002|Phase 2|Physician Decision|0|||
145678464|NCT01332266|525340781|FG003|Phase 2|Physician Decision|3|||
145678465|NCT01332266|525340782|FG004|Phase 2|Physician Decision|1|||
145678466|NCT01332266|525340778|FG000|Phase 2|Symptomatic deterioration|0|||
145678467|NCT01332266|525340779|FG001|Phase 2|Symptomatic deterioration|0|||
145678468|NCT01332266|525340780|FG002|Phase 2|Symptomatic deterioration|0|||
145678469|NCT01332266|525340781|FG003|Phase 2|Symptomatic deterioration|0|||
145678470|NCT01332266|525340782|FG004|Phase 2|Symptomatic deterioration|1|||
145678471|NCT01332266|525340778|FG000|Phase 2|Progression Disease|0|||
145678472|NCT01332266|525340779|FG001|Phase 2|Progression Disease|0|||
145678473|NCT01332266|525340780|FG002|Phase 2|Progression Disease|0|||
145678474|NCT01332266|525340781|FG003|Phase 2|Progression Disease|2|||
145678475|NCT01332266|525340782|FG004|Phase 2|Progression Disease|1|||
145678476|NCT01332266|525340778|FG000|Phase 2|Withdrawal by Subject|0|||
145678477|NCT01332266|525340779|FG001|Phase 2|Withdrawal by Subject|0|||
145678478|NCT01332266|525340780|FG002|Phase 2|Withdrawal by Subject|0|||
145678479|NCT01332266|525340781|FG003|Phase 2|Withdrawal by Subject|2|||
145678480|NCT01332266|525340782|FG004|Phase 2|Withdrawal by Subject|2|||
145678481|NCT01536704|525340785|FG000|Washout Period 1|Withdrawal by Subject|1|||
145678482|NCT01536704|525340786|FG001|Washout Period 1|Withdrawal by Subject|2|||
145678483|NCT01536704|525340787|FG002|Washout Period 1|Withdrawal by Subject|0|||
145678484|NCT01536704|525340788|FG003|Washout Period 1|Withdrawal by Subject|0|||
145678485|NCT01536704|525340785|FG000|Washout Period 2|Adverse Event|1|||
145678486|NCT01536704|525340786|FG001|Washout Period 2|Adverse Event|0|||
145678487|NCT01536704|525340787|FG002|Washout Period 2|Adverse Event|0|||
145678488|NCT01536704|525340788|FG003|Washout Period 2|Adverse Event|0|||
145678489|NCT01536704|525340785|FG000|Washout Period 2|Withdrawal by Subject|0|||
145678490|NCT01536704|525340786|FG001|Washout Period 2|Withdrawal by Subject|0|||
145678491|NCT01536704|525340787|FG002|Washout Period 2|Withdrawal by Subject|0|||
145678492|NCT01536704|525340788|FG003|Washout Period 2|Withdrawal by Subject|1|||
145678493|NCT01536704|525340785|FG000|Period 3|Adverse Event|0|||
145678494|NCT01536704|525340786|FG001|Period 3|Adverse Event|0|||
145678495|NCT01536704|525340787|FG002|Period 3|Adverse Event|0|||
145678496|NCT01536704|525340788|FG003|Period 3|Adverse Event|1|||
145678497|NCT01536704|525340785|FG000|Washout Period 3|Adverse Event|0|||
145678498|NCT01536704|525340786|FG001|Washout Period 3|Adverse Event|0|||
145678499|NCT01536704|525340787|FG002|Washout Period 3|Adverse Event|1|||
145678500|NCT01536704|525340788|FG003|Washout Period 3|Adverse Event|0|||
145678501|NCT02392507|525340789|FG000|Induction Regimen|Death|3|||
145678502|NCT02392507|525340789|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
145678503|NCT02392507|525340789|FG000|Induction Regimen|Physician Decision|1|||
145678504|NCT02392507|525340789|FG000|Induction Regimen|Withdrawal by Subject|2|||
145678505|NCT02392507|525340789|FG000|Maintenance Regimen|Death|1|||
145678506|NCT02392507|525340789|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
145678507|NCT01802333|525340790|FG000|Overall Study|Ineligible|2|||
145678508|NCT01802333|525340791|FG001|Overall Study|Ineligible|6|||
145678509|NCT01802333|525340792|FG002|Overall Study|Ineligible|8|||
145678510|NCT01802333|525340790|FG000|Overall Study|Adverse Event|1|||
145678511|NCT01802333|525340791|FG001|Overall Study|Adverse Event|8|||
145678512|NCT01802333|525340792|FG002|Overall Study|Adverse Event|8|||
145678513|NCT01802333|525340790|FG000|Overall Study|Withdrawal by Subject|6|||
145678514|NCT01802333|525340791|FG001|Overall Study|Withdrawal by Subject|6|||
145678515|NCT01802333|525340792|FG002|Overall Study|Withdrawal by Subject|5|||
145678516|NCT01802333|525340790|FG000|Overall Study|Progression/relapse|1|||
145678517|NCT01802333|525340791|FG001|Overall Study|Progression/relapse|3|||
145678518|NCT01802333|525340792|FG002|Overall Study|Progression/relapse|0|||
145678519|NCT01802333|525340790|FG000|Overall Study|Death|7|||
145678520|NCT01802333|525340791|FG001|Overall Study|Death|14|||
145678521|NCT01802333|525340792|FG002|Overall Study|Death|13|||
145678522|NCT01802333|525340790|FG000|Overall Study|Other - not protocol specified|32|||
145678523|NCT01802333|525340791|FG001|Overall Study|Other - not protocol specified|22|||
145678524|NCT01802333|525340792|FG002|Overall Study|Other - not protocol specified|24|||
145678525|NCT01802333|525340790|FG000|Overall Study|Did not start treatment|0|||
145678526|NCT01802333|525340791|FG001|Overall Study|Did not start treatment|2|||
145678527|NCT01802333|525340792|FG002|Overall Study|Did not start treatment|5|||
145678528|NCT02067663|525340794|FG000|Overall Study|Lost to Follow-up|13|||
145678529|NCT02067663|525340795|FG001|Overall Study|Lost to Follow-up|14|||
145678530|NCT00486954|525340800|FG000|Pilot Part|Adverse Event|4|||
145491059|NCT01384734|524652349|FG001|Overall Study|Non-compliance with study drug|2|||
145678531|NCT00486954|525340801|FG001|Pilot Part|Adverse Event|0|||
145678532|NCT00486954|525340802|FG002|Pilot Part|Adverse Event|5|||
145678533|NCT00486954|525340803|FG003|Pilot Part|Adverse Event|0|||
145678534|NCT00486954|525340804|FG004|Pilot Part|Adverse Event|0|||
145678535|NCT00486954|525340800|FG000|Pilot Part|Disease Progression|2|||
145678536|NCT00486954|525340801|FG001|Pilot Part|Disease Progression|0|||
145678537|NCT00486954|525340802|FG002|Pilot Part|Disease Progression|1|||
145678538|NCT00486954|525340803|FG003|Pilot Part|Disease Progression|0|||
145678539|NCT00486954|525340804|FG004|Pilot Part|Disease Progression|0|||
145678540|NCT00486954|525340800|FG000|Randomized Part|Lost to Follow-up|0|||
145678541|NCT00486954|525340801|FG001|Randomized Part|Lost to Follow-up|0|||
145678542|NCT00486954|525340802|FG002|Randomized Part|Lost to Follow-up|0|||
145678543|NCT00486954|525340803|FG003|Randomized Part|Lost to Follow-up|0|||
145678544|NCT00486954|525340804|FG004|Randomized Part|Lost to Follow-up|1|||
145678545|NCT00486954|525340800|FG000|Randomized Part|Withdrawal by Subject|0|||
145678546|NCT00486954|525340801|FG001|Randomized Part|Withdrawal by Subject|0|||
145678547|NCT00486954|525340802|FG002|Randomized Part|Withdrawal by Subject|0|||
145678548|NCT00486954|525340803|FG003|Randomized Part|Withdrawal by Subject|1|||
145678549|NCT00486954|525340804|FG004|Randomized Part|Withdrawal by Subject|0|||
145678550|NCT00486954|525340800|FG000|Randomized Part|Sponsor Terminated Study|0|||
145678551|NCT00486954|525340801|FG001|Randomized Part|Sponsor Terminated Study|0|||
145678552|NCT00486954|525340802|FG002|Randomized Part|Sponsor Terminated Study|0|||
145678553|NCT00486954|525340803|FG003|Randomized Part|Sponsor Terminated Study|19|||
145678554|NCT00486954|525340804|FG004|Randomized Part|Sponsor Terminated Study|13|||
145678555|NCT03236779|525340805|FG000|Overall Study|Lost to Follow-up|13|||
145678556|NCT03236779|525340806|FG001|Overall Study|Lost to Follow-up|21|||
145678557|NCT00929526|525340811|FG000|Overall Study|Withdrawal by Subject|1|||
145678558|NCT00929526|525340812|FG001|Overall Study|Withdrawal by Subject|11|||
145678559|NCT00929526|525340811|FG000|Overall Study|Lost to Follow-up|8|||
145678560|NCT00929526|525340812|FG001|Overall Study|Lost to Follow-up|12|||
145678561|NCT00929526|525340811|FG000|Overall Study|Other|8|||
145678562|NCT00929526|525340812|FG001|Overall Study|Other|6|||
145678563|NCT03316170|525340813|FG000|Overall Study|Death|1|||
145678564|NCT03316170|525340814|FG001|Overall Study|Death|0|||
145678565|NCT03316170|525340813|FG000|Overall Study|Lost to Follow-up|6|||
145678566|NCT03316170|525340814|FG001|Overall Study|Lost to Follow-up|7|||
145678567|NCT00578344|525340815|FG000|Overall Study|Insurance problems|1|||
145678568|NCT00578344|525340815|FG000|Overall Study|Graft failure|1|||
145678569|NCT02169414|525340816|FG000|Overall Study|Withdrawal by Subject|1|||
145678570|NCT02169414|525340817|FG001|Overall Study|Withdrawal by Subject|0|||
145678571|NCT02169414|525340818|FG002|Overall Study|Withdrawal by Subject|0|||
145678572|NCT02169414|525340819|FG003|Overall Study|Withdrawal by Subject|0|||
145678573|NCT02169414|525340816|FG000|Overall Study|Adverse Event|0|||
145678574|NCT02169414|525340817|FG001|Overall Study|Adverse Event|1|||
145678575|NCT02169414|525340818|FG002|Overall Study|Adverse Event|0|||
145678576|NCT02169414|525340819|FG003|Overall Study|Adverse Event|0|||
145678577|NCT01836523|525340820|FG000|Overall Study|Adverse Event|15|||
145678578|NCT01836523|525340821|FG001|Overall Study|Adverse Event|41|||
145678579|NCT01836523|525340822|FG002|Overall Study|Adverse Event|49|||
145678580|NCT01836523|525340823|FG003|Overall Study|Adverse Event|14|||
145678581|NCT01836523|525340820|FG000|Overall Study|Protocol Violation|6|||
145678582|NCT01836523|525340821|FG001|Overall Study|Protocol Violation|3|||
145678583|NCT01836523|525340822|FG002|Overall Study|Protocol Violation|2|||
145678584|NCT01836523|525340823|FG003|Overall Study|Protocol Violation|4|||
145678585|NCT01836523|525340820|FG000|Overall Study|Met Withdrawal Criteria|13|||
145678586|NCT01836523|525340821|FG001|Overall Study|Met Withdrawal Criteria|13|||
145678587|NCT01836523|525340822|FG002|Overall Study|Met Withdrawal Criteria|21|||
145678588|NCT01836523|525340823|FG003|Overall Study|Met Withdrawal Criteria|27|||
145678589|NCT01836523|525340820|FG000|Overall Study|Unclassified|17|||
145678590|NCT01836523|525340821|FG001|Overall Study|Unclassified|28|||
145678591|NCT01836523|525340822|FG002|Overall Study|Unclassified|19|||
145678592|NCT01836523|525340823|FG003|Overall Study|Unclassified|29|||
145678593|NCT03374254|525340824|FG000|Overall Study|Death|5|||
145678594|NCT03374254|525340825|FG001|Overall Study|Death|16|||
145678595|NCT03374254|525340826|FG002|Overall Study|Death|13|||
145678596|NCT03374254|525340827|FG003|Overall Study|Death|11|||
145678597|NCT03374254|525340828|FG004|Overall Study|Death|9|||
145678598|NCT03374254|525340829|FG005|Overall Study|Death|12|||
145678599|NCT03374254|525340830|FG006|Overall Study|Death|11|||
145678600|NCT03374254|525340831|FG007|Overall Study|Death|6|||
145678601|NCT03374254|525340832|FG008|Overall Study|Death|7|||
145678602|NCT03374254|525340824|FG000|Overall Study|Lost to Follow-up|0|||
145678603|NCT03374254|525340825|FG001|Overall Study|Lost to Follow-up|0|||
145678604|NCT03374254|525340826|FG002|Overall Study|Lost to Follow-up|0|||
145678605|NCT03374254|525340827|FG003|Overall Study|Lost to Follow-up|0|||
145678606|NCT03374254|525340828|FG004|Overall Study|Lost to Follow-up|0|||
145678607|NCT03374254|525340829|FG005|Overall Study|Lost to Follow-up|0|||
145678608|NCT03374254|525340830|FG006|Overall Study|Lost to Follow-up|2|||
145678609|NCT03374254|525340831|FG007|Overall Study|Lost to Follow-up|0|||
145678610|NCT03374254|525340832|FG008|Overall Study|Lost to Follow-up|0|||
145678611|NCT03374254|525340824|FG000|Overall Study|Sponsor Decision|1|||
145678612|NCT03374254|525340825|FG001|Overall Study|Sponsor Decision|0|||
145678613|NCT03374254|525340826|FG002|Overall Study|Sponsor Decision|2|||
145678614|NCT03374254|525340827|FG003|Overall Study|Sponsor Decision|3|||
145678615|NCT03374254|525340828|FG004|Overall Study|Sponsor Decision|2|||
145678616|NCT03374254|525340829|FG005|Overall Study|Sponsor Decision|3|||
145678617|NCT03374254|525340830|FG006|Overall Study|Sponsor Decision|3|||
145678618|NCT03374254|525340831|FG007|Overall Study|Sponsor Decision|3|||
145678619|NCT03374254|525340832|FG008|Overall Study|Sponsor Decision|4|||
145678620|NCT03374254|525340824|FG000|Overall Study|Withdrawal by Subject|0|||
145678621|NCT03374254|525340825|FG001|Overall Study|Withdrawal by Subject|0|||
145678622|NCT03374254|525340826|FG002|Overall Study|Withdrawal by Subject|0|||
145265411|NCT00764465|523819355|FG003|Overall Study|Adverse Event|1|||
145678623|NCT03374254|525340827|FG003|Overall Study|Withdrawal by Subject|2|||
145678624|NCT03374254|525340828|FG004|Overall Study|Withdrawal by Subject|0|||
145678625|NCT03374254|525340829|FG005|Overall Study|Withdrawal by Subject|1|||
145678626|NCT03374254|525340830|FG006|Overall Study|Withdrawal by Subject|0|||
145678627|NCT03374254|525340831|FG007|Overall Study|Withdrawal by Subject|0|||
145678628|NCT03374254|525340832|FG008|Overall Study|Withdrawal by Subject|0|||
145678629|NCT04803734|525340833|FG000|Overall Study|Withdrawal by Subject|0|||
145678630|NCT04803734|525340834|FG001|Overall Study|Withdrawal by Subject|1|||
145678631|NCT04803734|525340833|FG000|Overall Study|Protocol Violation|0|||
145678632|NCT04803734|525340834|FG001|Overall Study|Protocol Violation|1|||
145678633|NCT04070105|525340839|FG000|Overall Study|Lost to Follow-up|0|||
145678634|NCT04070105|525340840|FG001|Overall Study|Lost to Follow-up|0|||
145678635|NCT04070105|525340841|FG002|Overall Study|Lost to Follow-up|0|||
145678636|NCT04070105|525340842|FG003|Overall Study|Lost to Follow-up|0|||
145678637|NCT04070105|525340843|FG004|Overall Study|Lost to Follow-up|0|||
145678638|NCT04070105|525340844|FG005|Overall Study|Lost to Follow-up|1|||
145678639|NCT00749944|525340845|FG000|Overall Study|Lost to Follow-up|2|||
145678640|NCT00749944|525340846|FG001|Overall Study|Lost to Follow-up|1|||
145678641|NCT00749944|525340845|FG000|Overall Study|Other|1|||
145678642|NCT00749944|525340846|FG001|Overall Study|Other|0|||
145678643|NCT00749944|525340845|FG000|Overall Study|Withdrawal by Subject|2|||
145678644|NCT00749944|525340846|FG001|Overall Study|Withdrawal by Subject|0|||
145678645|NCT02547974|525340847|FG000|Overall Study|Withdrawal by Subject|1|||
145678646|NCT02547974|525340848|FG001|Overall Study|Withdrawal by Subject|0|||
145678647|NCT02547974|525340849|FG002|Overall Study|Withdrawal by Subject|0|||
145678648|NCT02547974|525340850|FG003|Overall Study|Withdrawal by Subject|0|||
145678649|NCT02245620|525340856|FG000|Overall Study|Physician Decision|1|||
145678650|NCT02245620|525340857|FG001|Overall Study|Physician Decision|1|||
145678651|NCT01999335|525340858|FG000|Overall Study|Discontinued before receiving treatment|0|||
145678652|NCT01999335|525340859|FG001|Overall Study|Discontinued before receiving treatment|0|||
145678653|NCT01999335|525340860|FG002|Overall Study|Discontinued before receiving treatment|0|||
145678654|NCT01999335|525340861|FG003|Overall Study|Discontinued before receiving treatment|0|||
145678655|NCT01999335|525340862|FG004|Overall Study|Discontinued before receiving treatment|2|||
145678656|NCT03909100|525340863|FG000|Overall Study|Protocol Deviation|2|||
145678657|NCT03909100|525340863|FG000|Overall Study|Technical Problems|4|||
145678658|NCT03909100|525340863|FG000|Overall Study|Withdrawal by Subject|4|||
145678659|NCT03909100|525340863|FG000|Overall Study|Lost to Follow-up|1|||
145678660|NCT03909100|525340863|FG000|Overall Study|Reason not Specified|4|||
145678661|NCT03259568|525340864|FG000|Overall Study|Participant performance was low|3|||
145678662|NCT04248868|525340865|FG000|Overall Study|Death|1|||
145678663|NCT04248868|525340865|FG000|Overall Study|Lost to Follow-up|3|||
145678664|NCT04248868|525340865|FG000|Overall Study|Protocol Violation|2|||
145678665|NCT03128099|525340868|FG000|Overall Study|High dose task was too long|0|||
145678666|NCT03128099|525340869|FG001|Overall Study|High dose task was too long|4|||
145678667|NCT03128099|525340870|FG002|Overall Study|High dose task was too long|0|||
145678668|NCT03128099|525340868|FG000|Overall Study|Participant got a full time job.|1|||
145678669|NCT03128099|525340869|FG001|Overall Study|Participant got a full time job.|0|||
145678670|NCT03128099|525340870|FG002|Overall Study|Participant got a full time job.|0|||
145678671|NCT03128099|525340868|FG000|Overall Study|Became homeless and lost contact|1|||
145678672|NCT03128099|525340869|FG001|Overall Study|Became homeless and lost contact|0|||
145678673|NCT03128099|525340870|FG002|Overall Study|Became homeless and lost contact|0|||
145678674|NCT03128099|525340868|FG000|Overall Study|Did not complete all the assessments|0|||
145678675|NCT03128099|525340869|FG001|Overall Study|Did not complete all the assessments|0|||
145678676|NCT03128099|525340870|FG002|Overall Study|Did not complete all the assessments|1|||
145678677|NCT00148122|525340871|FG000|Overall Study|Withdrawal by Subject|2|||
145678678|NCT00274287|525340874|FG000|Overall Study|Withdrawal by Subject|1|||
145678679|NCT00274287|525340874|FG000|Overall Study|subject non-compliance|1|||
145678680|NCT03652610|525340875|FG000|Overall Study|Lost to Follow-up|1|||
145678681|NCT03652610|525340876|FG001|Overall Study|Lost to Follow-up|0|||
145678682|NCT03652610|525340875|FG000|Overall Study|Withdrawal by Subject|3|||
145678683|NCT03652610|525340876|FG001|Overall Study|Withdrawal by Subject|5|||
145678684|NCT01880736|525340877|FG000|Overall Study|Adverse Event|0|||
145678685|NCT01880736|525340878|FG001|Overall Study|Adverse Event|0|||
145678686|NCT01880736|525340879|FG002|Overall Study|Adverse Event|0|||
145678687|NCT01880736|525340880|FG003|Overall Study|Adverse Event|1|||
145678688|NCT01880736|525340877|FG000|Overall Study|Withdrawal Criteria|1|||
145678689|NCT01880736|525340878|FG001|Overall Study|Withdrawal Criteria|2|||
145678690|NCT01880736|525340879|FG002|Overall Study|Withdrawal Criteria|1|||
145678691|NCT01880736|525340880|FG003|Overall Study|Withdrawal Criteria|5|||
145678692|NCT01263496|525340884|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
145678693|NCT01263496|525340885|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678694|NCT01263496|525340886|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678695|NCT01263496|525340887|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678696|NCT01263496|525340888|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678697|NCT01263496|525340889|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678698|NCT01263496|525340890|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678699|NCT01263496|525340891|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678700|NCT01263496|525340892|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
145678701|NCT01263496|525340884|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678702|NCT01263496|525340885|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678703|NCT01263496|525340886|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678704|NCT01263496|525340887|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
145678705|NCT01263496|525340888|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
145678706|NCT01263496|525340889|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678707|NCT01263496|525340890|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678708|NCT01263496|525340891|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678709|NCT01263496|525340892|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
145678710|NCT01263496|525340884|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
145678711|NCT01263496|525340885|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
145678712|NCT01263496|525340886|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
145678713|NCT01263496|525340887|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
145678714|NCT01263496|525340888|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
145678715|NCT01263496|525340889|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
145678716|NCT01263496|525340890|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
145678717|NCT01263496|525340891|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
145678718|NCT01263496|525340892|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
145678719|NCT01263496|525340884|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678720|NCT01263496|525340885|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
145678721|NCT01263496|525340886|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678722|NCT01263496|525340887|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678723|NCT01263496|525340888|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678724|NCT01263496|525340889|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678725|NCT01263496|525340890|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678726|NCT01263496|525340891|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678727|NCT01263496|525340892|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
145678728|NCT01263496|525340884|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145678729|NCT01263496|525340885|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145678730|NCT01263496|525340886|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145678731|NCT01263496|525340887|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145678732|NCT01263496|525340888|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
145678733|NCT01263496|525340889|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145678734|NCT01263496|525340890|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145678735|NCT01263496|525340891|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145678736|NCT01263496|525340892|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145678737|NCT01263496|525340884|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
145678738|NCT01263496|525340885|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
145678739|NCT01263496|525340886|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
145678740|NCT01263496|525340887|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145678741|NCT01263496|525340888|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
145678742|NCT01263496|525340889|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145678743|NCT01263496|525340890|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145678744|NCT01263496|525340891|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145678745|NCT01263496|525340892|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145678746|NCT01263496|525340884|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678747|NCT01263496|525340885|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678748|NCT01263496|525340886|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678749|NCT01263496|525340887|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678750|NCT01263496|525340888|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678751|NCT01263496|525340889|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678752|NCT01263496|525340890|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678753|NCT01263496|525340891|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
145678754|NCT01263496|525340892|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145678755|NCT00266656|525340896|FG000|Overall Study|Death|1|||
145678756|NCT00266656|525340897|FG001|Overall Study|Death|0|||
145678757|NCT00266656|525340896|FG000|Overall Study|Lost to Follow-up|4|||
145678758|NCT00266656|525340897|FG001|Overall Study|Lost to Follow-up|1|||
145678759|NCT00266656|525340896|FG000|Overall Study|Withdrawal by Subject|4|||
145678760|NCT00266656|525340897|FG001|Overall Study|Withdrawal by Subject|2|||
145678761|NCT00266656|525340896|FG000|Overall Study|Did Not Reach Final Height|4|||
145678762|NCT00266656|525340897|FG001|Overall Study|Did Not Reach Final Height|8|||
145678763|NCT00266656|525340896|FG000|Overall Study|Parent/Caregiver Decision|1|||
145678764|NCT00266656|525340897|FG001|Overall Study|Parent/Caregiver Decision|2|||
145678765|NCT04852978|525340900|FG000|Overall Study|Physician Decision|0|||
145678766|NCT04852978|525340901|FG001|Overall Study|Physician Decision|1|||
145678767|NCT04852978|525340902|FG002|Overall Study|Physician Decision|0|||
145678768|NCT04852978|525340903|FG003|Overall Study|Physician Decision|0|||
145678769|NCT04852978|525340904|FG004|Overall Study|Physician Decision|0|||
145678770|NCT04852978|525340905|FG005|Overall Study|Physician Decision|0|||
145678771|NCT04852978|525340906|FG006|Overall Study|Physician Decision|0|||
145678772|NCT04852978|525340907|FG007|Overall Study|Physician Decision|2|||
145678773|NCT04852978|525340908|FG008|Overall Study|Physician Decision|0|||
145678774|NCT04852978|525340900|FG000|Overall Study|Sponsor request|0|||
145678775|NCT04852978|525340901|FG001|Overall Study|Sponsor request|0|||
145678776|NCT04852978|525340902|FG002|Overall Study|Sponsor request|1|||
145678777|NCT04852978|525340903|FG003|Overall Study|Sponsor request|0|||
145678778|NCT04852978|525340904|FG004|Overall Study|Sponsor request|0|||
145678779|NCT04852978|525340905|FG005|Overall Study|Sponsor request|0|||
145678780|NCT04852978|525340906|FG006|Overall Study|Sponsor request|0|||
145678781|NCT04852978|525340907|FG007|Overall Study|Sponsor request|0|||
145678782|NCT04852978|525340908|FG008|Overall Study|Sponsor request|0|||
145678783|NCT04852978|525340900|FG000|Overall Study|Death|0|||
145678784|NCT04852978|525340901|FG001|Overall Study|Death|0|||
145678785|NCT04852978|525340902|FG002|Overall Study|Death|0|||
145678786|NCT04852978|525340903|FG003|Overall Study|Death|0|||
145678787|NCT04852978|525340904|FG004|Overall Study|Death|0|||
145678788|NCT04852978|525340905|FG005|Overall Study|Death|0|||
145678789|NCT04852978|525340906|FG006|Overall Study|Death|1|||
145678790|NCT04852978|525340907|FG007|Overall Study|Death|0|||
145678791|NCT04852978|525340908|FG008|Overall Study|Death|0|||
145678792|NCT04852978|525340900|FG000|Overall Study|Lost to Follow-up|3|||
145678793|NCT04852978|525340901|FG001|Overall Study|Lost to Follow-up|2|||
145678794|NCT04852978|525340902|FG002|Overall Study|Lost to Follow-up|2|||
145678795|NCT04852978|525340903|FG003|Overall Study|Lost to Follow-up|0|||
145678796|NCT04852978|525340904|FG004|Overall Study|Lost to Follow-up|2|||
145678797|NCT04852978|525340905|FG005|Overall Study|Lost to Follow-up|4|||
145678798|NCT04852978|525340906|FG006|Overall Study|Lost to Follow-up|1|||
145678799|NCT04852978|525340907|FG007|Overall Study|Lost to Follow-up|2|||
145678800|NCT04852978|525340908|FG008|Overall Study|Lost to Follow-up|2|||
145678801|NCT04852978|525340900|FG000|Overall Study|Withdrawal by Subject|4|||
145678802|NCT04852978|525340901|FG001|Overall Study|Withdrawal by Subject|2|||
145678803|NCT04852978|525340902|FG002|Overall Study|Withdrawal by Subject|2|||
145678804|NCT04852978|525340903|FG003|Overall Study|Withdrawal by Subject|1|||
145678805|NCT04852978|525340904|FG004|Overall Study|Withdrawal by Subject|5|||
145678806|NCT04852978|525340905|FG005|Overall Study|Withdrawal by Subject|3|||
145678807|NCT04852978|525340906|FG006|Overall Study|Withdrawal by Subject|2|||
145678808|NCT04852978|525340907|FG007|Overall Study|Withdrawal by Subject|2|||
145678809|NCT04852978|525340908|FG008|Overall Study|Withdrawal by Subject|1|||
145678810|NCT03332589|525342352|FG000|Overall Study|Lack of Efficacy|2|||
145678811|NCT03332589|525342353|FG001|Overall Study|Lack of Efficacy|0|||
145678812|NCT03332589|525342354|FG002|Overall Study|Lack of Efficacy|0|||
145678813|NCT03332589|525342352|FG000|Overall Study|Adverse Event|1|||
145678814|NCT03332589|525342353|FG001|Overall Study|Adverse Event|0|||
145678815|NCT03332589|525342354|FG002|Overall Study|Adverse Event|0|||
145678816|NCT03332589|525342352|FG000|Overall Study|Death|1|||
145678817|NCT03332589|525342353|FG001|Overall Study|Death|0|||
145678818|NCT03332589|525342354|FG002|Overall Study|Death|0|||
145678819|NCT00443820|525342355|FG000|Overall Study|Adverse Event|1|||
145678820|NCT00443820|525342356|FG001|Overall Study|Adverse Event|1|||
145678821|NCT00443820|525342357|FG002|Overall Study|Adverse Event|0|||
145678822|NCT00443820|525342358|FG003|Overall Study|Adverse Event|0|||
145678823|NCT00443820|525342355|FG000|Overall Study|Lack of Efficacy|3|||
145678824|NCT00443820|525342356|FG001|Overall Study|Lack of Efficacy|2|||
145678825|NCT00443820|525342357|FG002|Overall Study|Lack of Efficacy|1|||
145678826|NCT00443820|525342358|FG003|Overall Study|Lack of Efficacy|1|||
145678827|NCT00443820|525342355|FG000|Overall Study|Protocol Violation|2|||
145678828|NCT00443820|525342356|FG001|Overall Study|Protocol Violation|1|||
145678829|NCT00443820|525342357|FG002|Overall Study|Protocol Violation|2|||
145678830|NCT00443820|525342358|FG003|Overall Study|Protocol Violation|1|||
145678831|NCT00443820|525342355|FG000|Overall Study|Withdrawal by Subject|6|||
145678832|NCT00443820|525342356|FG001|Overall Study|Withdrawal by Subject|7|||
145678833|NCT00443820|525342357|FG002|Overall Study|Withdrawal by Subject|8|||
145678834|NCT00443820|525342358|FG003|Overall Study|Withdrawal by Subject|9|||
145678835|NCT00443820|525342355|FG000|Overall Study|Lost to Follow-up|9|||
145678836|NCT00443820|525342356|FG001|Overall Study|Lost to Follow-up|8|||
145678837|NCT00443820|525342357|FG002|Overall Study|Lost to Follow-up|6|||
145678838|NCT00443820|525342358|FG003|Overall Study|Lost to Follow-up|5|||
145678839|NCT00443820|525342355|FG000|Overall Study|Administrative problems|0|||
145678840|NCT00443820|525342356|FG001|Overall Study|Administrative problems|0|||
145678841|NCT00443820|525342357|FG002|Overall Study|Administrative problems|0|||
145678842|NCT00443820|525342358|FG003|Overall Study|Administrative problems|1|||
145678843|NCT00443820|525342355|FG000|Overall Study|Death|0|||
145678844|NCT00443820|525342356|FG001|Overall Study|Death|0|||
145678845|NCT00443820|525342357|FG002|Overall Study|Death|1|||
145678846|NCT00443820|525342358|FG003|Overall Study|Death|0|||
145265412|NCT00764465|523819356|FG004|Overall Study|Adverse Event|1|||
145678847|NCT04633200|525342359|FG000|Overall Study|Lost to Follow-up|3|||
145678848|NCT04633200|525342360|FG001|Overall Study|Lost to Follow-up|5|||
145678849|NCT01377844|525342361|FG000|Overall Study|Withdrawal by Subject|25|||
145678850|NCT01377844|525342362|FG001|Overall Study|Withdrawal by Subject|28|||
145678851|NCT01377844|525342361|FG000|Overall Study|Protocol Violation|2|||
145678852|NCT01377844|525342362|FG001|Overall Study|Protocol Violation|3|||
145678853|NCT01377844|525342361|FG000|Overall Study|Adverse Event|3|||
145678854|NCT01377844|525342362|FG001|Overall Study|Adverse Event|0|||
145678855|NCT01377844|525342361|FG000|Overall Study|Physician Decision|6|||
145678856|NCT01377844|525342362|FG001|Overall Study|Physician Decision|3|||
145678857|NCT01377844|525342361|FG000|Overall Study|Study terminated by Sponsor|0|||
145678858|NCT01377844|525342362|FG001|Overall Study|Study terminated by Sponsor|1|||
145678859|NCT02092285|525342363|FG000|Induction Phase|Adverse Event|7|||
145678860|NCT02092285|525342363|FG000|Induction Phase|Physician Decision|4|||
145678861|NCT02092285|525342363|FG000|Induction Phase|Pregnancy|1|||
145678862|NCT02092285|525342363|FG000|Induction Phase|Relapse/Recurrence|7|||
145678863|NCT02092285|525342363|FG000|Induction Phase|Withdrawal by Subject|2|||
145678864|NCT02092285|525342363|FG000|Induction Phase|Lack of Efficacy|14|||
145678865|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
145678866|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
145678867|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
145678868|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
145678869|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
145678870|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
145678871|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
145678872|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
145678873|NCT02092285|525342363|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
145678874|NCT00087516|525342364|FG000|Overall Study|Adverse Event|10|||
145678875|NCT00087516|525342365|FG001|Overall Study|Adverse Event|10|||
145678876|NCT00087516|525342366|FG002|Overall Study|Adverse Event|3|||
145678877|NCT00087516|525342367|FG003|Overall Study|Adverse Event|6|||
145678878|NCT00087516|525342364|FG000|Overall Study|Lack of Efficacy|82|||
145678879|NCT00087516|525342365|FG001|Overall Study|Lack of Efficacy|80|||
145678880|NCT00087516|525342366|FG002|Overall Study|Lack of Efficacy|39|||
145678881|NCT00087516|525342367|FG003|Overall Study|Lack of Efficacy|29|||
145678882|NCT00087516|525342364|FG000|Overall Study|Lost to Follow-up|8|||
145678883|NCT00087516|525342365|FG001|Overall Study|Lost to Follow-up|6|||
145678884|NCT00087516|525342366|FG002|Overall Study|Lost to Follow-up|5|||
145678885|NCT00087516|525342367|FG003|Overall Study|Lost to Follow-up|5|||
145678886|NCT00087516|525342364|FG000|Overall Study|Protocol Violation|4|||
145678887|NCT00087516|525342365|FG001|Overall Study|Protocol Violation|8|||
145678888|NCT00087516|525342366|FG002|Overall Study|Protocol Violation|3|||
145678889|NCT00087516|525342367|FG003|Overall Study|Protocol Violation|6|||
145678890|NCT00087516|525342364|FG000|Overall Study|Withdrawal by Subject|16|||
145678891|NCT00087516|525342365|FG001|Overall Study|Withdrawal by Subject|27|||
145678892|NCT00087516|525342366|FG002|Overall Study|Withdrawal by Subject|11|||
145678893|NCT00087516|525342367|FG003|Overall Study|Withdrawal by Subject|12|||
145678894|NCT00087516|525342364|FG000|Overall Study|Site terminated|0|||
145678895|NCT00087516|525342365|FG001|Overall Study|Site terminated|2|||
145678896|NCT00087516|525342366|FG002|Overall Study|Site terminated|1|||
145678897|NCT00087516|525342367|FG003|Overall Study|Site terminated|0|||
145678898|NCT00087516|525342364|FG000|Overall Study|Protocol specified discontinuation|35|||
145678899|NCT00087516|525342365|FG001|Overall Study|Protocol specified discontinuation|33|||
145678900|NCT00087516|525342366|FG002|Overall Study|Protocol specified discontinuation|33|||
145678901|NCT00087516|525342367|FG003|Overall Study|Protocol specified discontinuation|26|||
145678902|NCT00087516|525342364|FG000|Overall Study|Patient moved|3|||
145678903|NCT00087516|525342365|FG001|Overall Study|Patient moved|2|||
145678904|NCT00087516|525342366|FG002|Overall Study|Patient moved|1|||
145678905|NCT00087516|525342367|FG003|Overall Study|Patient moved|0|||
145678906|NCT00087516|525342364|FG000|Overall Study|Patient was non-compliant|3|||
145678907|NCT00087516|525342365|FG001|Overall Study|Patient was non-compliant|1|||
145678908|NCT00087516|525342366|FG002|Overall Study|Patient was non-compliant|0|||
145678909|NCT00087516|525342367|FG003|Overall Study|Patient was non-compliant|0|||
145678910|NCT00087516|525342364|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
145678911|NCT00087516|525342365|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
145678912|NCT00087516|525342366|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
145678913|NCT00087516|525342367|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
145678914|NCT00087516|525342364|FG000|Overall Study|Other|0|||
145678915|NCT00087516|525342365|FG001|Overall Study|Other|0|||
145678916|NCT00087516|525342366|FG002|Overall Study|Other|1|||
145678917|NCT00087516|525342367|FG003|Overall Study|Other|0|||
145678918|NCT00278395|525342370|FG000|Overall Study|Adverse Event|2|||
145678919|NCT00278395|525342370|FG000|Overall Study|Nonevaluable|1|||
145678920|NCT00484198|525342373|FG000|Overall Study|Participant Withdrew Consent|12|||
145678921|NCT00484198|525342374|FG001|Overall Study|Participant Withdrew Consent|21|||
145678922|NCT00484198|525342375|FG002|Overall Study|Participant Withdrew Consent|47|||
145678923|NCT00484198|525342376|FG003|Overall Study|Participant Withdrew Consent|59|||
145678924|NCT00484198|525342373|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
145678925|NCT00484198|525342374|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
145678926|NCT00484198|525342375|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
145678927|NCT00484198|525342376|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
145678928|NCT00484198|525342373|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
145678929|NCT00484198|525342374|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
145678930|NCT00484198|525342375|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
145678931|NCT00484198|525342376|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
145678932|NCT00484198|525342373|FG000|Overall Study|Adverse Event|3|||
145678933|NCT00484198|525342374|FG001|Overall Study|Adverse Event|11|||
145678934|NCT00484198|525342375|FG002|Overall Study|Adverse Event|32|||
145678935|NCT00484198|525342376|FG003|Overall Study|Adverse Event|31|||
145678936|NCT00484198|525342373|FG000|Overall Study|Protocol Violation|0|||
145678937|NCT00484198|525342374|FG001|Overall Study|Protocol Violation|5|||
145678938|NCT00484198|525342375|FG002|Overall Study|Protocol Violation|6|||
145678939|NCT00484198|525342376|FG003|Overall Study|Protocol Violation|8|||
145678940|NCT00484198|525342373|FG000|Overall Study|Other|7|||
145678941|NCT00484198|525342374|FG001|Overall Study|Other|10|||
145678942|NCT00484198|525342375|FG002|Overall Study|Other|31|||
145678943|NCT00484198|525342376|FG003|Overall Study|Other|28|||
145678944|NCT01853384|525342377|FG000|Randomized|Adverse Event|5|||
145678945|NCT01853384|525342378|FG001|Randomized|Adverse Event|3|||
145678946|NCT01853384|525342377|FG000|Randomized|Death|1|||
145678947|NCT01853384|525342378|FG001|Randomized|Death|2|||
145678948|NCT01853384|525342377|FG000|Randomized|Lost to Follow-up|1|||
145678949|NCT01853384|525342378|FG001|Randomized|Lost to Follow-up|1|||
145678950|NCT01853384|525342377|FG000|Randomized|Withdrawal by Subject|5|||
145678951|NCT01853384|525342378|FG001|Randomized|Withdrawal by Subject|3|||
145678952|NCT01853384|525342377|FG000|Randomized|Sponsor Decision|47|||
145678953|NCT01853384|525342378|FG001|Randomized|Sponsor Decision|34|||
145678954|NCT01853384|525342377|FG000|Randomized|Other|3|||
145678955|NCT01853384|525342378|FG001|Randomized|Other|3|||
145678956|NCT01853384|525342377|FG000|Completed Follow up Visit 1|Early Termination|13|||
145678957|NCT01853384|525342378|FG001|Completed Follow up Visit 1|Early Termination|9|||
145678958|NCT01853384|525342377|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
145678959|NCT01853384|525342378|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
145678960|NCT01853384|525342377|FG000|Completed Follow up Visit 2|Adverse Event|1|||
145678961|NCT01853384|525342378|FG001|Completed Follow up Visit 2|Adverse Event|0|||
145678962|NCT01853384|525342377|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
145678963|NCT01853384|525342378|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
145678964|NCT01853384|525342377|FG000|Completed Follow up Visit 2|Death|1|||
145678965|NCT01853384|525342378|FG001|Completed Follow up Visit 2|Death|0|||
145678966|NCT01853384|525342377|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
145678967|NCT01853384|525342378|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
145678968|NCT01947491|525342379|FG000|Overall Study|Lost to Follow-up|5|||
145678969|NCT01947491|525342380|FG001|Overall Study|Lost to Follow-up|3|||
145678970|NCT01947491|525342381|FG002|Overall Study|Lost to Follow-up|1|||
145678971|NCT01947491|525342382|FG003|Overall Study|Lost to Follow-up|2|||
145678972|NCT01947491|525342379|FG000|Overall Study|Lack of Efficacy|1|||
145678973|NCT01947491|525342380|FG001|Overall Study|Lack of Efficacy|0|||
145678974|NCT01947491|525342381|FG002|Overall Study|Lack of Efficacy|0|||
145678975|NCT01947491|525342382|FG003|Overall Study|Lack of Efficacy|1|||
145678976|NCT01947491|525342379|FG000|Overall Study|Protocol Violation|1|||
145678977|NCT01947491|525342380|FG001|Overall Study|Protocol Violation|0|||
145678978|NCT01947491|525342381|FG002|Overall Study|Protocol Violation|0|||
145678979|NCT01947491|525342382|FG003|Overall Study|Protocol Violation|0|||
145678980|NCT01947491|525342379|FG000|Overall Study|Withdrawal by Subject|1|||
145678981|NCT01947491|525342380|FG001|Overall Study|Withdrawal by Subject|1|||
145678982|NCT01947491|525342381|FG002|Overall Study|Withdrawal by Subject|1|||
145678983|NCT01947491|525342382|FG003|Overall Study|Withdrawal by Subject|0|||
145678984|NCT01947491|525342379|FG000|Overall Study|Worsening of condition|0|||
145678985|NCT01947491|525342380|FG001|Overall Study|Worsening of condition|1|||
145678986|NCT01947491|525342381|FG002|Overall Study|Worsening of condition|0|||
145678987|NCT01947491|525342382|FG003|Overall Study|Worsening of condition|0|||
145678988|NCT01947491|525342379|FG000|Overall Study|Adverse Event|0|||
145678989|NCT01947491|525342380|FG001|Overall Study|Adverse Event|1|||
145678990|NCT01947491|525342381|FG002|Overall Study|Adverse Event|0|||
145678991|NCT01947491|525342382|FG003|Overall Study|Adverse Event|2|||
145678992|NCT00704340|525342383|FG000|Overall Study|Lost to Follow-up|2|||
145678993|NCT00704340|525342384|FG001|Overall Study|Lost to Follow-up|1|||
145678994|NCT00704340|525342383|FG000|Overall Study|Death|0|||
145678995|NCT00704340|525342384|FG001|Overall Study|Death|1|||
145678996|NCT00403845|525342385|FG000|Treatment Period 1|Subject withdrew consent|1|||
145678997|NCT00403845|525342386|FG001|Treatment Period 1|Subject withdrew consent|0|||
145678998|NCT00403845|525342387|FG002|Treatment Period 1|Subject withdrew consent|0|||
145678999|NCT00403845|525342388|FG003|Treatment Period 1|Subject withdrew consent|0|||
145679000|NCT00403845|525342385|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
145679001|NCT00403845|525342386|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
145679002|NCT00403845|525342387|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
145679003|NCT00403845|525342388|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
145679004|NCT00403845|525342385|FG000|Treatment Period 2|Subject withdrew consent|1|||
145679005|NCT00403845|525342386|FG001|Treatment Period 2|Subject withdrew consent|0|||
145679006|NCT00403845|525342387|FG002|Treatment Period 2|Subject withdrew consent|0|||
145679007|NCT00403845|525342388|FG003|Treatment Period 2|Subject withdrew consent|0|||
145679008|NCT00403845|525342385|FG000|Treatment Period 3|Subject withdrew consent|0|||
145679009|NCT00403845|525342386|FG001|Treatment Period 3|Subject withdrew consent|0|||
145679010|NCT00403845|525342387|FG002|Treatment Period 3|Subject withdrew consent|0|||
145679011|NCT00403845|525342388|FG003|Treatment Period 3|Subject withdrew consent|1|||
145679012|NCT00403845|525342385|FG000|Treatment Period 3|Adverse Event|0|||
145679013|NCT00403845|525342386|FG001|Treatment Period 3|Adverse Event|0|||
145679014|NCT00403845|525342387|FG002|Treatment Period 3|Adverse Event|0|||
145679015|NCT00403845|525342388|FG003|Treatment Period 3|Adverse Event|1|||
145679016|NCT02309515|525342391|FG000|Overall Study|Withdrawal by Subject|0|||
145679017|NCT02309515|525342392|FG001|Overall Study|Withdrawal by Subject|1|||
145679018|NCT00624377|525342400|FG000|Overall Study|Lost to Follow-up|355|||
145679019|NCT00624377|525342400|FG000|Overall Study|Withdrawal by Subject|100|||
145679020|NCT00624377|525342400|FG000|Overall Study|Adverse Event|14|||
145679021|NCT00624377|525342400|FG000|Overall Study|Other|91|||
145679022|NCT00624377|525342400|FG000|Overall Study|Non-evaluable population|84|||
145679023|NCT00923078|525342404|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
145679024|NCT00923078|525342405|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
145679025|NCT00923078|525342406|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
145679026|NCT00923078|525342404|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
145679027|NCT00923078|525342405|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
145679028|NCT00923078|525342406|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
145679029|NCT04766996|525342407|FG000|Overall Study|Withdrawal by Subject|1|||
145679030|NCT04766996|525342408|FG001|Overall Study|Withdrawal by Subject|0|||
145679031|NCT04766996|525342409|FG002|Overall Study|Withdrawal by Subject|13|||
145679032|NCT01102426|525342412|FG000|Overall Study|Randomized but not treated|4|||
145679033|NCT01102426|525342413|FG001|Overall Study|Randomized but not treated|1|||
145679034|NCT01102426|525342412|FG000|Overall Study|Adverse Events (treatment-related)|15|||
145679035|NCT01102426|525342413|FG001|Overall Study|Adverse Events (treatment-related)|8|||
145679036|NCT01102426|525342412|FG000|Overall Study|Physician Decision|9|||
145679037|NCT01102426|525342413|FG001|Overall Study|Physician Decision|6|||
145679038|NCT01102426|525342412|FG000|Overall Study|Progressive Disease|85|||
145679039|NCT01102426|525342413|FG001|Overall Study|Progressive Disease|44|||
145679040|NCT01102426|525342412|FG000|Overall Study|Adverse Events (unrelated to|9|||
145679041|NCT01102426|525342413|FG001|Overall Study|Adverse Events (unrelated to|1|||
145679042|NCT01102426|525342412|FG000|Overall Study|Patient Refusal|24|||
145679043|NCT01102426|525342413|FG001|Overall Study|Patient Refusal|12|||
145679044|NCT01102426|525342412|FG000|Overall Study|Death (due to adverse events|0|||
145679045|NCT01102426|525342413|FG001|Overall Study|Death (due to adverse events|1|||
145679046|NCT01102426|525342412|FG000|Overall Study|Death (non-related to the study|19|||
145679047|NCT01102426|525342413|FG001|Overall Study|Death (non-related to the study|8|||
145679048|NCT01393964|525342424|FG000|Overall Study|Disease Progression|4|||
145679049|NCT01393964|525342425|FG001|Overall Study|Disease Progression|3|||
145679050|NCT01393964|525342426|FG002|Overall Study|Disease Progression|5|||
145679051|NCT01393964|525342424|FG000|Overall Study|Study drug toxicity|1|||
145679052|NCT01393964|525342425|FG001|Overall Study|Study drug toxicity|0|||
145679053|NCT01393964|525342426|FG002|Overall Study|Study drug toxicity|0|||
145679054|NCT01393964|525342424|FG000|Overall Study|Withdrawal by Subject|0|||
145679055|NCT01393964|525342425|FG001|Overall Study|Withdrawal by Subject|0|||
145679056|NCT01393964|525342426|FG002|Overall Study|Withdrawal by Subject|1|||
145679057|NCT01393964|525342424|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145679058|NCT01393964|525342425|FG001|Overall Study|Adverse event unrelated to study drug|3|||
145679059|NCT01393964|525342426|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145679060|NCT01393964|525342424|FG000|Overall Study|Subject request stop study treatment|0|||
145679061|NCT01393964|525342425|FG001|Overall Study|Subject request stop study treatment|1|||
145679062|NCT01393964|525342426|FG002|Overall Study|Subject request stop study treatment|0|||
145679063|NCT01393964|525342424|FG000|Overall Study|Subject decided to move to transplant|1|||
145679064|NCT01393964|525342425|FG001|Overall Study|Subject decided to move to transplant|0|||
145679065|NCT01393964|525342426|FG002|Overall Study|Subject decided to move to transplant|0|||
145679066|NCT01393964|525342424|FG000|Overall Study|Subject switched to commercial supply|1|||
145679067|NCT01393964|525342425|FG001|Overall Study|Subject switched to commercial supply|0|||
145679068|NCT01393964|525342426|FG002|Overall Study|Subject switched to commercial supply|2|||
145679069|NCT01393964|525342424|FG000|Overall Study|Subject plateaued in terms of effect|1|||
145679070|NCT01393964|525342425|FG001|Overall Study|Subject plateaued in terms of effect|0|||
145679071|NCT01393964|525342426|FG002|Overall Study|Subject plateaued in terms of effect|0|||
145679072|NCT01393964|525342424|FG000|Overall Study|Investigator removed subject from study|0|||
145679073|NCT01393964|525342425|FG001|Overall Study|Investigator removed subject from study|1|||
145679074|NCT01393964|525342426|FG002|Overall Study|Investigator removed subject from study|0|||
145679075|NCT01393964|525342424|FG000|Overall Study|Subject converted to roll-over study|0|||
145679076|NCT01393964|525342425|FG001|Overall Study|Subject converted to roll-over study|1|||
145679077|NCT01393964|525342426|FG002|Overall Study|Subject converted to roll-over study|0|||
145679078|NCT01393964|525342424|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
145679079|NCT01393964|525342425|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
145679080|NCT01393964|525342426|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
145679081|NCT02988713|525342430|FG000|Overall Study|Withdrawal by Subject|1|||
145679082|NCT02988713|525342430|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
145679083|NCT01918033|525342431|FG000|Overall Study|Adverse Event|1|||
145679084|NCT01918033|525342432|FG001|Overall Study|Adverse Event|0|||
145679085|NCT01918033|525342433|FG002|Overall Study|Adverse Event|2|||
145679086|NCT01918033|525342431|FG000|Overall Study|Lost to Follow-up|0|||
145679087|NCT01918033|525342432|FG001|Overall Study|Lost to Follow-up|1|||
145679088|NCT01918033|525342433|FG002|Overall Study|Lost to Follow-up|0|||
145679089|NCT01918033|525342431|FG000|Overall Study|Protocol Violation|2|||
145679090|NCT01918033|525342432|FG001|Overall Study|Protocol Violation|0|||
145679091|NCT01918033|525342433|FG002|Overall Study|Protocol Violation|1|||
145679092|NCT01918033|525342431|FG000|Overall Study|Withdrawal by Subject|2|||
145679093|NCT01918033|525342432|FG001|Overall Study|Withdrawal by Subject|1|||
145679094|NCT01918033|525342433|FG002|Overall Study|Withdrawal by Subject|0|||
145679095|NCT04492475|525342434|FG000|Overall Study|Enrolled but not treated|8|||
145679096|NCT04492475|525342435|FG001|Overall Study|Enrolled but not treated|8|||
145679097|NCT04492475|525342434|FG000|Overall Study|Withdrawal by Subject|4|||
145679098|NCT04492475|525342435|FG001|Overall Study|Withdrawal by Subject|0|||
145679099|NCT04492475|525342434|FG000|Overall Study|Became ineligible after enrollment|2|||
145679100|NCT04492475|525342435|FG001|Overall Study|Became ineligible after enrollment|0|||
145679101|NCT03938272|525342445|FG000|Overall Study|Withdrawal by Subject|1|||
145679102|NCT03938272|525342446|FG001|Overall Study|Withdrawal by Subject|0|||
145679103|NCT03938272|525342445|FG000|Overall Study|Physician Decision|0|||
145679104|NCT03938272|525342446|FG001|Overall Study|Physician Decision|2|||
145679105|NCT03938272|525342445|FG000|Overall Study|Study termination by sponsor|10|||
145679106|NCT03938272|525342446|FG001|Overall Study|Study termination by sponsor|8|||
145679107|NCT03692871|525342449|FG000|Overall Study|Death|1|||
145679108|NCT03692871|525342450|FG001|Overall Study|Death|1|||
145679109|NCT03692871|525342449|FG000|Overall Study|Lost to Follow-up|24|||
145679110|NCT03692871|525342450|FG001|Overall Study|Lost to Follow-up|9|||
145679111|NCT03692871|525342449|FG000|Overall Study|Physician Decision|22|||
145679112|NCT03692871|525342450|FG001|Overall Study|Physician Decision|7|||
145679113|NCT03692871|525342449|FG000|Overall Study|Protocol Deviation|1|||
145679114|NCT03692871|525342450|FG001|Overall Study|Protocol Deviation|0|||
145679115|NCT03692871|525342449|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
145679116|NCT03692871|525342450|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
145679117|NCT02852824|525342454|FG000|Overall Study|Withdrawal by Subject|1|||
145679118|NCT02852824|525342455|FG001|Overall Study|Withdrawal by Subject|0|||
145679119|NCT02852824|525342456|FG002|Overall Study|Withdrawal by Subject|0|||
145679120|NCT02852824|525342457|FG003|Overall Study|Withdrawal by Subject|0|||
145679121|NCT02852824|525342458|FG004|Overall Study|Withdrawal by Subject|0|||
145679122|NCT02852824|525342459|FG005|Overall Study|Withdrawal by Subject|0|||
145679123|NCT02852824|525342460|FG006|Overall Study|Withdrawal by Subject|0|||
145679124|NCT02852824|525342454|FG000|Overall Study|Adverse Event|0|||
145679125|NCT02852824|525342455|FG001|Overall Study|Adverse Event|0|||
145679126|NCT02852824|525342456|FG002|Overall Study|Adverse Event|0|||
145679127|NCT02852824|525342457|FG003|Overall Study|Adverse Event|0|||
145679128|NCT02852824|525342458|FG004|Overall Study|Adverse Event|2|||
145679129|NCT02852824|525342459|FG005|Overall Study|Adverse Event|0|||
145679130|NCT02852824|525342460|FG006|Overall Study|Adverse Event|0|||
145679131|NCT01323790|525342463|FG000|Overall Study|Other|3|||
145679132|NCT01323790|525342464|FG001|Overall Study|Other|2|||
145679133|NCT01323790|525342465|FG002|Overall Study|Other|1|||
145679134|NCT01323790|525342463|FG000|Overall Study|Lost to Follow-up|11|||
145679135|NCT01323790|525342464|FG001|Overall Study|Lost to Follow-up|9|||
145679136|NCT01323790|525342465|FG002|Overall Study|Lost to Follow-up|9|||
145679137|NCT01323790|525342463|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
145679138|NCT01323790|525342464|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
145679139|NCT01323790|525342465|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
145679140|NCT01323790|525342463|FG000|Overall Study|Lack of Efficacy|3|||
145679141|NCT01323790|525342464|FG001|Overall Study|Lack of Efficacy|0|||
145679142|NCT01323790|525342465|FG002|Overall Study|Lack of Efficacy|3|||
145679143|NCT01323790|525342463|FG000|Overall Study|Adverse Event|11|||
145679144|NCT01323790|525342464|FG001|Overall Study|Adverse Event|24|||
145679145|NCT01323790|525342465|FG002|Overall Study|Adverse Event|12|||
145679146|NCT01323790|525342463|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145679147|NCT01323790|525342464|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
145679148|NCT01323790|525342465|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
145679149|NCT01323790|525342463|FG000|Overall Study|Withdrawal by Subject|23|||
145679150|NCT01323790|525342464|FG001|Overall Study|Withdrawal by Subject|20|||
145679151|NCT01323790|525342465|FG002|Overall Study|Withdrawal by Subject|13|||
145679152|NCT01323790|525342463|FG000|Overall Study|Did Not Receive Treatment|2|||
145679153|NCT01323790|525342464|FG001|Overall Study|Did Not Receive Treatment|0|||
145679154|NCT01323790|525342465|FG002|Overall Study|Did Not Receive Treatment|1|||
145679155|NCT01323790|525342463|FG000|Overall Study|Severe non-compliance with protocol|2|||
145679156|NCT01323790|525342464|FG001|Overall Study|Severe non-compliance with protocol|2|||
145679157|NCT01323790|525342465|FG002|Overall Study|Severe non-compliance with protocol|2|||
145679158|NCT02950961|525342470|FG000|Overall Study|Study had to stop due to COVID.|7|||
145679159|NCT01915914|525342473|FG000|Acute Phase|Withdrawal by Subject|4|||
145679160|NCT01915914|525342474|FG001|Acute Phase|Withdrawal by Subject|0|||
145679161|NCT01915914|525342475|FG002|Acute Phase|Withdrawal by Subject|0|||
145679162|NCT01915914|525342476|FG003|Acute Phase|Withdrawal by Subject|0|||
145679163|NCT01915914|525342473|FG000|Acute Phase|Lost to Follow-up|4|||
145679164|NCT01915914|525342474|FG001|Acute Phase|Lost to Follow-up|0|||
145679165|NCT01915914|525342475|FG002|Acute Phase|Lost to Follow-up|0|||
145679166|NCT01915914|525342476|FG003|Acute Phase|Lost to Follow-up|0|||
145679167|NCT01915914|525342473|FG000|Acute Phase|Physician Decision|1|||
145679168|NCT01915914|525342474|FG001|Acute Phase|Physician Decision|0|||
145679169|NCT01915914|525342475|FG002|Acute Phase|Physician Decision|0|||
145679170|NCT01915914|525342476|FG003|Acute Phase|Physician Decision|0|||
145679171|NCT01915914|525342473|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
145679172|NCT01915914|525342474|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
145679173|NCT01915914|525342475|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
145679174|NCT01915914|525342476|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
145679175|NCT01915914|525342473|FG000|Acute Phase|"Not Achieved treatment success"|1|||
145679176|NCT01915914|525342474|FG001|Acute Phase|"Not Achieved treatment success"|0|||
145679177|NCT01915914|525342475|FG002|Acute Phase|"Not Achieved treatment success"|0|||
145679178|NCT01915914|525342476|FG003|Acute Phase|"Not Achieved treatment success"|0|||
145679179|NCT01915914|525342473|FG000|Acute Phase|Missing|1|||
145679180|NCT01915914|525342474|FG001|Acute Phase|Missing|0|||
145679181|NCT01915914|525342475|FG002|Acute Phase|Missing|0|||
145679182|NCT01915914|525342476|FG003|Acute Phase|Missing|0|||
145679183|NCT01915914|525342473|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145679184|NCT01915914|525342474|FG001|Maintenance Phase|Withdrawal by Subject|1|||
145679185|NCT01915914|525342475|FG002|Maintenance Phase|Withdrawal by Subject|1|||
145679186|NCT01915914|525342476|FG003|Maintenance Phase|Withdrawal by Subject|0|||
145679187|NCT01915914|525342473|FG000|Maintenance Phase|Lost to Follow-up|0|||
145679188|NCT01915914|525342474|FG001|Maintenance Phase|Lost to Follow-up|4|||
145679189|NCT01915914|525342475|FG002|Maintenance Phase|Lost to Follow-up|1|||
145679190|NCT01915914|525342476|FG003|Maintenance Phase|Lost to Follow-up|0|||
145679191|NCT01915914|525342473|FG000|Maintenance Phase|Missing|0|||
145679192|NCT01915914|525342474|FG001|Maintenance Phase|Missing|1|||
145679193|NCT01915914|525342475|FG002|Maintenance Phase|Missing|0|||
145679194|NCT01915914|525342476|FG003|Maintenance Phase|Missing|0|||
145679195|NCT01915914|525342473|FG000|Follow-up Phase|Withdrawal by Subject|0|||
145679196|NCT01915914|525342474|FG001|Follow-up Phase|Withdrawal by Subject|0|||
145679197|NCT01915914|525342475|FG002|Follow-up Phase|Withdrawal by Subject|0|||
145679198|NCT01915914|525342476|FG003|Follow-up Phase|Withdrawal by Subject|1|||
145679199|NCT01915914|525342473|FG000|Follow-up Phase|Physician Decision|0|||
145679200|NCT01915914|525342474|FG001|Follow-up Phase|Physician Decision|0|||
145679201|NCT01915914|525342475|FG002|Follow-up Phase|Physician Decision|0|||
145679202|NCT01915914|525342476|FG003|Follow-up Phase|Physician Decision|1|||
145679203|NCT00428714|525342477|FG000|Overall Study|Progressive Disease|28|||
145679204|NCT00428714|525342478|FG001|Overall Study|Progressive Disease|36|||
145679205|NCT00428714|525342477|FG000|Overall Study|Withdrawal by Subject|0|||
145679206|NCT00428714|525342478|FG001|Overall Study|Withdrawal by Subject|3|||
145679207|NCT00428714|525342477|FG000|Overall Study|Adverse Event|0|||
145679208|NCT00428714|525342478|FG001|Overall Study|Adverse Event|2|||
145679209|NCT00428714|525342477|FG000|Overall Study|Physician Decision|1|||
145679210|NCT00428714|525342478|FG001|Overall Study|Physician Decision|1|||
145679211|NCT00428714|525342477|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
145679212|NCT00428714|525342478|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
145679213|NCT00428714|525342477|FG000|Overall Study|Death due to other then PD|1|||
145679214|NCT00428714|525342478|FG001|Overall Study|Death due to other then PD|0|||
145679215|NCT01736475|525342479|FG000|Overall Study|Adverse Event|4|||
145679216|NCT01736475|525342480|FG001|Overall Study|Adverse Event|0|||
145679217|NCT01736475|525342479|FG000|Overall Study|Withdrawal by Subject|2|||
145679218|NCT01736475|525342480|FG001|Overall Study|Withdrawal by Subject|0|||
145679219|NCT01736475|525342479|FG000|Overall Study|Protocol Violation|4|||
145679220|NCT01736475|525342480|FG001|Overall Study|Protocol Violation|0|||
145679221|NCT01736475|525342479|FG000|Overall Study|Other - Screen failure|1|||
145491060|NCT01384734|524652350|FG002|Overall Study|Non-compliance with study drug|6|||
145679222|NCT01736475|525342480|FG001|Overall Study|Other - Screen failure|0|||
145679223|NCT01736475|525342479|FG000|Overall Study|Other - Surgical procedure|1|||
145679224|NCT01736475|525342480|FG001|Overall Study|Other - Surgical procedure|0|||
145679225|NCT00513071|525342481|FG000|Overall Study|Adverse Event|1|||
145679226|NCT00513071|525342481|FG000|Overall Study|Withdrawal by Subject|1|||
145679227|NCT00513071|525342481|FG000|Overall Study|Physician Decision|3|||
145679228|NCT02114515|525342485|FG000|Overall Study|Lost to Follow-up|52|||
145679229|NCT02114515|525342486|FG001|Overall Study|Lost to Follow-up|55|||
145679230|NCT02114515|525342485|FG000|Overall Study|Death|12|||
145679231|NCT02114515|525342486|FG001|Overall Study|Death|12|||
145679232|NCT02114515|525342485|FG000|Overall Study|Withdrawal by Subject|4|||
145679233|NCT02114515|525342486|FG001|Overall Study|Withdrawal by Subject|22|||
145679234|NCT02114515|525342485|FG000|Overall Study|Other|65|||
145679235|NCT02114515|525342486|FG001|Overall Study|Other|61|||
145679236|NCT00667732|525342487|FG000|Run -In (8 Weeks)|Adverse Event|4|||
145679237|NCT00667732|525342488|FG001|Run -In (8 Weeks)|Adverse Event|0|||
145679238|NCT00667732|525342489|FG002|Run -In (8 Weeks)|Adverse Event|0|||
145679239|NCT00667732|525342487|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
145679240|NCT00667732|525342488|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
145679241|NCT00667732|525342489|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
145679242|NCT00667732|525342487|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
145679243|NCT00667732|525342488|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
145679244|NCT00667732|525342489|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
145679245|NCT02106325|525342492|FG000|Phase 1|Lost to Follow-up|2|||
145679246|NCT02106325|525342493|FG001|Phase 1|Lost to Follow-up|2|||
145679247|NCT02106325|525342492|FG000|Phase 2|Lost to Follow-up|2|||
145679248|NCT02106325|525342493|FG001|Phase 2|Lost to Follow-up|3|||
145679249|NCT02106325|525342492|FG000|Phase 3|Lost to Follow-up|2|||
145679250|NCT02106325|525342493|FG001|Phase 3|Lost to Follow-up|1|||
145679251|NCT00824850|525342495|FG000|Overall Study|Withdrawal by Subject|0|||
145679252|NCT00824850|525342496|FG001|Overall Study|Withdrawal by Subject|1|||
145679253|NCT03242863|525342497|FG000|Study Week 1|Withdrawal by Subject|0|||
145679254|NCT03242863|525342498|FG001|Study Week 1|Withdrawal by Subject|1|||
145679255|NCT03242863|525342499|FG002|Study Week 1|Withdrawal by Subject|0|||
145679256|NCT03242863|525342500|FG003|Study Week 1|Withdrawal by Subject|0|||
145679257|NCT03242863|525342501|FG004|Study Week 1|Withdrawal by Subject|3|||
145679258|NCT03242863|525342502|FG005|Study Week 1|Withdrawal by Subject|0|||
145679259|NCT04820491|525342503|FG000|Overall Study|Withdrawal by Subject|1|||
145679260|NCT04820491|525342504|FG001|Overall Study|Withdrawal by Subject|0|||
145679261|NCT04369664|525343956|FG000|Overall Study|Physician Decision|1|||
145679262|NCT04369664|525343957|FG001|Overall Study|Physician Decision|0|||
145679263|NCT00215943|525343958|FG000|Overall Study|Disease Progression|3|||
145679264|NCT00215943|525343959|FG001|Overall Study|Disease Progression|5|||
145679265|NCT00215943|525343958|FG000|Overall Study|Alternate therapy|0|||
145679266|NCT00215943|525343959|FG001|Overall Study|Alternate therapy|1|||
145679267|NCT00215943|525343958|FG000|Overall Study|Adverse Event|3|||
145679268|NCT00215943|525343959|FG001|Overall Study|Adverse Event|6|||
145679269|NCT00215943|525343958|FG000|Overall Study|Other disease|0|||
145679270|NCT00215943|525343959|FG001|Overall Study|Other disease|1|||
145679271|NCT00215943|525343958|FG000|Overall Study|Other complications|3|||
145679272|NCT00215943|525343959|FG001|Overall Study|Other complications|1|||
145679273|NCT02507297|525343960|FG000|Overall Study|Withdrawal by Subject|1|||
145679274|NCT02507297|525343961|FG001|Overall Study|Withdrawal by Subject|0|||
145679275|NCT02507297|525343960|FG000|Overall Study|Lost to Follow-up|0|||
145679276|NCT02507297|525343961|FG001|Overall Study|Lost to Follow-up|1|||
145679277|NCT04909593|525343962|FG000|Overall Study|Withdrawal by Subject|1|||
145679278|NCT01018992|525343963|FG000|Overall Study|Adverse Event|8|||
145679279|NCT01018992|525343964|FG001|Overall Study|Adverse Event|3|||
145679280|NCT01018992|525343963|FG000|Overall Study|Withdrawal by Subject|3|||
145679281|NCT01018992|525343964|FG001|Overall Study|Withdrawal by Subject|8|||
145679282|NCT01018992|525343963|FG000|Overall Study|Protocol Violation|0|||
145679283|NCT01018992|525343964|FG001|Overall Study|Protocol Violation|4|||
145679284|NCT01018992|525343963|FG000|Overall Study|Lost to Follow-up|5|||
145679285|NCT01018992|525343964|FG001|Overall Study|Lost to Follow-up|1|||
145679286|NCT01825785|525343965|FG000|Overall Study|Adverse Event|0|||
145679287|NCT01825785|525343966|FG001|Overall Study|Adverse Event|0|||
145679288|NCT01825785|525343967|FG002|Overall Study|Adverse Event|0|||
145679289|NCT01825785|525343968|FG003|Overall Study|Adverse Event|0|||
145679290|NCT01825785|525343969|FG004|Overall Study|Adverse Event|1|||
145679291|NCT01825785|525343970|FG005|Overall Study|Adverse Event|0|||
145679292|NCT01825785|525343971|FG006|Overall Study|Adverse Event|0|||
145679293|NCT01825785|525343965|FG000|Overall Study|Withdrawal by Subject|0|||
145679294|NCT01825785|525343966|FG001|Overall Study|Withdrawal by Subject|0|||
145679295|NCT01825785|525343967|FG002|Overall Study|Withdrawal by Subject|0|||
145679296|NCT01825785|525343968|FG003|Overall Study|Withdrawal by Subject|0|||
145679297|NCT01825785|525343969|FG004|Overall Study|Withdrawal by Subject|1|||
145679298|NCT01825785|525343970|FG005|Overall Study|Withdrawal by Subject|1|||
145679299|NCT01825785|525343971|FG006|Overall Study|Withdrawal by Subject|0|||
145679300|NCT01304940|525343973|FG000|Overall Study|not meet symptom severity requirement|3|||
145679301|NCT01304940|525343974|FG001|Overall Study|not meet symptom severity requirement|0|||
145679302|NCT02065895|525343975|FG000|Overall Study|Protocol Violation|1|||
145679303|NCT02065895|525343976|FG001|Overall Study|Protocol Violation|0|||
145679304|NCT02065895|525343977|FG002|Overall Study|Protocol Violation|0|||
145679305|NCT02065895|525343978|FG003|Overall Study|Protocol Violation|1|||
145679306|NCT02065895|525343979|FG004|Overall Study|Protocol Violation|0|||
145679307|NCT02065895|525343980|FG005|Overall Study|Protocol Violation|0|||
145679308|NCT02065895|525343975|FG000|Overall Study|Scheduling conflicts|0|||
145679309|NCT02065895|525343976|FG001|Overall Study|Scheduling conflicts|1|||
145679310|NCT02065895|525343977|FG002|Overall Study|Scheduling conflicts|0|||
145679311|NCT02065895|525343978|FG003|Overall Study|Scheduling conflicts|0|||
145679312|NCT02065895|525343979|FG004|Overall Study|Scheduling conflicts|0|||
145679313|NCT02065895|525343980|FG005|Overall Study|Scheduling conflicts|0|||
145679314|NCT01686152|525343981|FG000|Overall Study|Withdrawal by Subject|11|||
145679315|NCT01686152|525343982|FG001|Overall Study|Withdrawal by Subject|11|||
145679316|NCT01686152|525343983|FG002|Overall Study|Withdrawal by Subject|3|||
145679317|NCT01686152|525343981|FG000|Overall Study|Drug Code Unblinded|0|||
145679318|NCT01686152|525343982|FG001|Overall Study|Drug Code Unblinded|1|||
145679319|NCT01686152|525343983|FG002|Overall Study|Drug Code Unblinded|0|||
145679320|NCT01686152|525343981|FG000|Overall Study|Protocol Violation|6|||
145679321|NCT01686152|525343982|FG001|Overall Study|Protocol Violation|1|||
145679322|NCT01686152|525343983|FG002|Overall Study|Protocol Violation|0|||
145679323|NCT01686152|525343981|FG000|Overall Study|Adverse Event|12|||
145679324|NCT01686152|525343982|FG001|Overall Study|Adverse Event|11|||
145679325|NCT01686152|525343983|FG002|Overall Study|Adverse Event|0|||
145679326|NCT01686152|525343981|FG000|Overall Study|Lack of Efficacy|0|||
145679327|NCT01686152|525343982|FG001|Overall Study|Lack of Efficacy|0|||
145679328|NCT01686152|525343983|FG002|Overall Study|Lack of Efficacy|1|||
145679329|NCT01686152|525343981|FG000|Overall Study|IP Non-compliance|5|||
145679330|NCT01686152|525343982|FG001|Overall Study|IP Non-compliance|5|||
145679331|NCT01686152|525343983|FG002|Overall Study|IP Non-compliance|0|||
145679332|NCT01686152|525343981|FG000|Overall Study|Lost to Follow-up|7|||
145679333|NCT01686152|525343982|FG001|Overall Study|Lost to Follow-up|6|||
145679334|NCT01686152|525343983|FG002|Overall Study|Lost to Follow-up|5|||
145679335|NCT03137784|525343984|FG000|Overall Study|Adverse Event|1|||
145679336|NCT03137784|525343985|FG001|Overall Study|Adverse Event|1|||
145679337|NCT03137784|525343986|FG002|Overall Study|Adverse Event|0|||
145679338|NCT03137784|525343987|FG003|Overall Study|Adverse Event|0|||
145679339|NCT03137784|525343988|FG004|Overall Study|Adverse Event|0|||
145679340|NCT03137784|525343989|FG005|Overall Study|Adverse Event|0|||
145679341|NCT03137784|525343984|FG000|Overall Study|Subject/guardian decision|1|||
145679342|NCT03137784|525343985|FG001|Overall Study|Subject/guardian decision|0|||
145679343|NCT03137784|525343986|FG002|Overall Study|Subject/guardian decision|0|||
145679344|NCT03137784|525343987|FG003|Overall Study|Subject/guardian decision|0|||
145679345|NCT03137784|525343988|FG004|Overall Study|Subject/guardian decision|0|||
145679346|NCT03137784|525343989|FG005|Overall Study|Subject/guardian decision|0|||
145679347|NCT03137784|525343984|FG000|Overall Study|Non-compliance with study treatment|0|||
145679348|NCT03137784|525343985|FG001|Overall Study|Non-compliance with study treatment|0|||
145679349|NCT03137784|525343986|FG002|Overall Study|Non-compliance with study treatment|0|||
145679350|NCT03137784|525343987|FG003|Overall Study|Non-compliance with study treatment|0|||
145679351|NCT03137784|525343988|FG004|Overall Study|Non-compliance with study treatment|1|||
145679352|NCT03137784|525343989|FG005|Overall Study|Non-compliance with study treatment|0|||
145679353|NCT01205126|525343990|FG000|Titration Phase|Adverse Event|5|||
145679354|NCT01205126|525343991|FG001|Titration Phase|Adverse Event|3|||
145679355|NCT01205126|525343990|FG000|Titration Phase|Withdrawal by Subject|5|||
145679356|NCT01205126|525343991|FG001|Titration Phase|Withdrawal by Subject|5|||
145679357|NCT01205126|525343990|FG000|Titration Phase|Lost to Follow-up|2|||
145679358|NCT01205126|525343991|FG001|Titration Phase|Lost to Follow-up|2|||
145679359|NCT01205126|525343990|FG000|Titration Phase|No stable titration dose|1|||
145679360|NCT01205126|525343991|FG001|Titration Phase|No stable titration dose|0|||
145679361|NCT01205126|525343990|FG000|Titration Phase|More than maximum dosage required|2|||
145679362|NCT01205126|525343991|FG001|Titration Phase|More than maximum dosage required|3|||
145679363|NCT01205126|525343990|FG000|Titration Phase|Other|8|||
145679364|NCT01205126|525343991|FG001|Titration Phase|Other|6|||
145679365|NCT01205126|525343990|FG000|Between Titration & Maintenance Phase|Other|0|||
145679366|NCT01205126|525343991|FG001|Between Titration & Maintenance Phase|Other|4|||
145679367|NCT01205126|525343990|FG000|Maintenance Phase|Adverse Event|3|||
145679368|NCT01205126|525343991|FG001|Maintenance Phase|Adverse Event|7|||
145679369|NCT01205126|525343990|FG000|Maintenance Phase|Death|4|||
145679370|NCT01205126|525343991|FG001|Maintenance Phase|Death|4|||
145679371|NCT01205126|525343990|FG000|Maintenance Phase|More than the maximum dosage required|5|||
145679372|NCT01205126|525343991|FG001|Maintenance Phase|More than the maximum dosage required|5|||
145679373|NCT01205126|525343990|FG000|Maintenance Phase|Prohibited drugs used|1|||
145679374|NCT01205126|525343991|FG001|Maintenance Phase|Prohibited drugs used|0|||
145679375|NCT01205126|525343990|FG000|Maintenance Phase|Other|11|||
145679376|NCT01205126|525343991|FG001|Maintenance Phase|Other|8|||
145679377|NCT01205126|525343990|FG000|Maintenance Phase|Lost to Follow-up|5|||
145679378|NCT01205126|525343991|FG001|Maintenance Phase|Lost to Follow-up|5|||
145679379|NCT01205126|525343990|FG000|Maintenance Phase|Withdrawal by Subject|8|||
145679380|NCT01205126|525343991|FG001|Maintenance Phase|Withdrawal by Subject|11|||
145679381|NCT00805792|525343994|FG000|Overall Study|Death|3|||
145679382|NCT00805792|525343994|FG000|Overall Study|Lost to Follow-up|2|||
145679383|NCT04328467|525344000|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
145679384|NCT04328467|525344001|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
145679385|NCT04328467|525344002|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
145679386|NCT01393600|525344004|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
145679387|NCT01393600|525344005|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
145679388|NCT01393600|525344006|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
145679389|NCT01393600|525344007|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
145679390|NCT01393600|525344004|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
145679391|NCT01393600|525344005|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
145679392|NCT01393600|525344006|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
145679393|NCT01393600|525344007|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
145679394|NCT01393600|525344004|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
145679395|NCT01393600|525344005|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
145679396|NCT01393600|525344006|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
145679397|NCT01393600|525344007|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
145679398|NCT01393600|525344004|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
145679399|NCT01393600|525344005|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
145679400|NCT01393600|525344006|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
145679401|NCT01393600|525344007|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
145679402|NCT01393600|525344004|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
145679403|NCT01393600|525344005|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
145679404|NCT01393600|525344006|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
145679405|NCT01393600|525344007|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
145679406|NCT01393600|525344004|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
145679407|NCT01393600|525344005|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
145679408|NCT01393600|525344006|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
145679409|NCT01393600|525344007|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
145679410|NCT01393600|525344004|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
145679411|NCT01393600|525344005|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
145679412|NCT01393600|525344006|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
145679413|NCT01393600|525344007|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
145679414|NCT02784834|525344008|FG000|Overall Study|Lack of Efficacy|1|||
145679415|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
145679416|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
145679417|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
145679418|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
145679419|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Adverse Event|7|||
145679420|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Adverse Event|8|||
145679421|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Adverse Event|8|||
145679422|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Adverse Event|9|||
145679423|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
145679424|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
145679425|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
145679426|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
145679427|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
145679428|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
145679429|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
145679430|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
145679431|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Pregnancy|0|||
145679432|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Pregnancy|2|||
145679433|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Pregnancy|2|||
145679434|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Pregnancy|0|||
145679435|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Non-compliance|1|||
145679436|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Non-compliance|0|||
145679437|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Non-compliance|0|||
145679438|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Non-compliance|3|||
145679439|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Other|3|||
145679440|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Other|0|||
145679441|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Other|3|||
145679442|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Other|2|||
145679443|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
145679444|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
145679445|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
145679446|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
145679447|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
145679448|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
145679449|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
145679450|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
145679451|NCT02143713|525344009|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
145679452|NCT02143713|525344010|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
145679453|NCT02143713|525344011|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
145679454|NCT02143713|525344012|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
145679455|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
145679456|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
145679457|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
145679458|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
145679459|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
145679460|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
145679461|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
145679462|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
145679463|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
145679464|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
145679465|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
145679466|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
145679467|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
145679468|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
145679469|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
145679470|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
145679471|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
145679472|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
145679473|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
145679474|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
145679475|NCT02143713|525344009|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
145679476|NCT02143713|525344010|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
145679477|NCT02143713|525344011|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
145679478|NCT02143713|525344012|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
145679479|NCT01768572|525344013|FG000|Overall Study|Adverse Event|7|||
145679480|NCT01768572|525344014|FG001|Overall Study|Adverse Event|8|||
145679481|NCT01768572|525344015|FG002|Overall Study|Adverse Event|4|||
145679482|NCT01768572|525344013|FG000|Overall Study|Lack of Efficacy|1|||
145679483|NCT01768572|525344014|FG001|Overall Study|Lack of Efficacy|3|||
145679484|NCT01768572|525344015|FG002|Overall Study|Lack of Efficacy|1|||
145679485|NCT01768572|525344013|FG000|Overall Study|Other, Not due to an adverse event|1|||
145679486|NCT01768572|525344014|FG001|Overall Study|Other, Not due to an adverse event|1|||
145679487|NCT01768572|525344015|FG002|Overall Study|Other, Not due to an adverse event|1|||
145679488|NCT00080119|525344018|FG000|Overall Study|Discontinued because of study closure|0|||
145679489|NCT00080119|525344019|FG001|Overall Study|Discontinued because of study closure|0|||
145679490|NCT00080119|525344020|FG002|Overall Study|Discontinued because of study closure|130|||
145679491|NCT00080119|525344021|FG003|Overall Study|Discontinued because of study closure|141|||
145679492|NCT00080119|525344018|FG000|Overall Study|Unable to get to clinic|24|||
145679493|NCT00080119|525344019|FG001|Overall Study|Unable to get to clinic|24|||
145679494|NCT00080119|525344020|FG002|Overall Study|Unable to get to clinic|7|||
145679495|NCT00080119|525344021|FG003|Overall Study|Unable to get to clinic|1|||
145679496|NCT00080119|525344018|FG000|Overall Study|Consent withdrawn|13|||
145679497|NCT00080119|525344019|FG001|Overall Study|Consent withdrawn|17|||
145679498|NCT00080119|525344020|FG002|Overall Study|Consent withdrawn|4|||
145679499|NCT00080119|525344021|FG003|Overall Study|Consent withdrawn|6|||
145679500|NCT00080119|525344018|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
145679501|NCT00080119|525344019|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
145679502|NCT00080119|525344020|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
145679503|NCT00080119|525344021|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
145679504|NCT00080119|525344018|FG000|Overall Study|Lost to Follow-up|16|||
145679505|NCT00080119|525344019|FG001|Overall Study|Lost to Follow-up|19|||
145679506|NCT00080119|525344020|FG002|Overall Study|Lost to Follow-up|19|||
145679507|NCT00080119|525344021|FG003|Overall Study|Lost to Follow-up|14|||
145679508|NCT01322386|525344022|FG000|Overall Study|Protocol Violation|0|||
145679509|NCT01322386|525344023|FG001|Overall Study|Protocol Violation|1|||
145679510|NCT01322386|525344022|FG000|Overall Study|Physician Decision|0|||
145679511|NCT01322386|525344023|FG001|Overall Study|Physician Decision|1|||
145679512|NCT02404441|525344029|FG000|Phase 1 Part|Adverse Event|1|||
145679513|NCT02404441|525344030|FG001|Phase 1 Part|Adverse Event|0|||
145679514|NCT02404441|525344031|FG002|Phase 1 Part|Adverse Event|0|||
145679515|NCT02404441|525344032|FG003|Phase 1 Part|Adverse Event|0|||
145491061|NCT01384734|524652351|FG003|Overall Study|Non-compliance with study drug|0|||
145679516|NCT02404441|525344033|FG004|Phase 1 Part|Adverse Event|0|||
145679517|NCT02404441|525344034|FG005|Phase 1 Part|Adverse Event|0|||
145679518|NCT02404441|525344035|FG006|Phase 1 Part|Adverse Event|0|||
145679519|NCT02404441|525344036|FG007|Phase 1 Part|Adverse Event|0|||
145679520|NCT02404441|525344037|FG008|Phase 1 Part|Adverse Event|0|||
145679521|NCT02404441|525344038|FG009|Phase 1 Part|Adverse Event|0|||
145679522|NCT02404441|525344029|FG000|Phase 1 Part|Physician Decision|0|||
145679523|NCT02404441|525344030|FG001|Phase 1 Part|Physician Decision|1|||
145679524|NCT02404441|525344031|FG002|Phase 1 Part|Physician Decision|0|||
145679525|NCT02404441|525344032|FG003|Phase 1 Part|Physician Decision|0|||
145679526|NCT02404441|525344033|FG004|Phase 1 Part|Physician Decision|0|||
145679527|NCT02404441|525344034|FG005|Phase 1 Part|Physician Decision|0|||
145679528|NCT02404441|525344035|FG006|Phase 1 Part|Physician Decision|0|||
145679529|NCT02404441|525344036|FG007|Phase 1 Part|Physician Decision|0|||
145679530|NCT02404441|525344037|FG008|Phase 1 Part|Physician Decision|0|||
145679531|NCT02404441|525344038|FG009|Phase 1 Part|Physician Decision|0|||
145679532|NCT02404441|525344029|FG000|Phase 1 Part|Progressive Disease|14|||
145679533|NCT02404441|525344030|FG001|Phase 1 Part|Progressive Disease|11|||
145679534|NCT02404441|525344031|FG002|Phase 1 Part|Progressive Disease|7|||
145679535|NCT02404441|525344032|FG003|Phase 1 Part|Progressive Disease|6|||
145679536|NCT02404441|525344033|FG004|Phase 1 Part|Progressive Disease|9|||
145679537|NCT02404441|525344034|FG005|Phase 1 Part|Progressive Disease|0|||
145679538|NCT02404441|525344035|FG006|Phase 1 Part|Progressive Disease|0|||
145679539|NCT02404441|525344036|FG007|Phase 1 Part|Progressive Disease|0|||
145679540|NCT02404441|525344037|FG008|Phase 1 Part|Progressive Disease|0|||
145679541|NCT02404441|525344038|FG009|Phase 1 Part|Progressive Disease|0|||
145679542|NCT02404441|525344029|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
145679543|NCT02404441|525344030|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
145679544|NCT02404441|525344031|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
145679545|NCT02404441|525344032|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
145679546|NCT02404441|525344033|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
145679547|NCT02404441|525344034|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
145679548|NCT02404441|525344035|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
145679549|NCT02404441|525344036|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
145679550|NCT02404441|525344037|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
145679551|NCT02404441|525344038|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
145679552|NCT02404441|525344029|FG000|Phase 1 Part|Death|1|||
145679553|NCT02404441|525344030|FG001|Phase 1 Part|Death|1|||
145679554|NCT02404441|525344031|FG002|Phase 1 Part|Death|1|||
145679555|NCT02404441|525344032|FG003|Phase 1 Part|Death|0|||
145679556|NCT02404441|525344033|FG004|Phase 1 Part|Death|1|||
145679557|NCT02404441|525344034|FG005|Phase 1 Part|Death|0|||
145679558|NCT02404441|525344035|FG006|Phase 1 Part|Death|0|||
145679559|NCT02404441|525344036|FG007|Phase 1 Part|Death|0|||
145679560|NCT02404441|525344037|FG008|Phase 1 Part|Death|0|||
145679561|NCT02404441|525344038|FG009|Phase 1 Part|Death|0|||
145679562|NCT02404441|525344029|FG000|Phase 2 Part|Adverse Event|0|||
145679563|NCT02404441|525344030|FG001|Phase 2 Part|Adverse Event|0|||
145679564|NCT02404441|525344031|FG002|Phase 2 Part|Adverse Event|0|||
145679565|NCT02404441|525344032|FG003|Phase 2 Part|Adverse Event|0|||
145679566|NCT02404441|525344033|FG004|Phase 2 Part|Adverse Event|0|||
145679567|NCT02404441|525344034|FG005|Phase 2 Part|Adverse Event|2|||
145679568|NCT02404441|525344035|FG006|Phase 2 Part|Adverse Event|3|||
145679569|NCT02404441|525344036|FG007|Phase 2 Part|Adverse Event|3|||
145679570|NCT02404441|525344037|FG008|Phase 2 Part|Adverse Event|6|||
145679571|NCT02404441|525344038|FG009|Phase 2 Part|Adverse Event|1|||
145679572|NCT02404441|525344029|FG000|Phase 2 Part|Physician Decision|0|||
145679573|NCT02404441|525344030|FG001|Phase 2 Part|Physician Decision|0|||
145679574|NCT02404441|525344031|FG002|Phase 2 Part|Physician Decision|0|||
145679575|NCT02404441|525344032|FG003|Phase 2 Part|Physician Decision|0|||
145679576|NCT02404441|525344033|FG004|Phase 2 Part|Physician Decision|0|||
145679577|NCT02404441|525344034|FG005|Phase 2 Part|Physician Decision|7|||
145679578|NCT02404441|525344035|FG006|Phase 2 Part|Physician Decision|9|||
145679579|NCT02404441|525344036|FG007|Phase 2 Part|Physician Decision|2|||
145679580|NCT02404441|525344037|FG008|Phase 2 Part|Physician Decision|1|||
145679581|NCT02404441|525344038|FG009|Phase 2 Part|Physician Decision|3|||
145679582|NCT02404441|525344029|FG000|Phase 2 Part|Progressive disease|0|||
145679583|NCT02404441|525344030|FG001|Phase 2 Part|Progressive disease|0|||
145679584|NCT02404441|525344031|FG002|Phase 2 Part|Progressive disease|0|||
145679585|NCT02404441|525344032|FG003|Phase 2 Part|Progressive disease|0|||
145679586|NCT02404441|525344033|FG004|Phase 2 Part|Progressive disease|0|||
145679587|NCT02404441|525344034|FG005|Phase 2 Part|Progressive disease|43|||
145679588|NCT02404441|525344035|FG006|Phase 2 Part|Progressive disease|32|||
145679589|NCT02404441|525344036|FG007|Phase 2 Part|Progressive disease|31|||
145265413|NCT00764465|523819357|FG005|Overall Study|Adverse Event|1|||
145679590|NCT02404441|525344037|FG008|Phase 2 Part|Progressive disease|39|||
145679591|NCT02404441|525344038|FG009|Phase 2 Part|Progressive disease|27|||
145679592|NCT02404441|525344029|FG000|Phase 2 Part|Subject/guardian decision|0|||
145679593|NCT02404441|525344030|FG001|Phase 2 Part|Subject/guardian decision|0|||
145679594|NCT02404441|525344031|FG002|Phase 2 Part|Subject/guardian decision|0|||
145679595|NCT02404441|525344032|FG003|Phase 2 Part|Subject/guardian decision|0|||
145679596|NCT02404441|525344033|FG004|Phase 2 Part|Subject/guardian decision|0|||
145679597|NCT02404441|525344034|FG005|Phase 2 Part|Subject/guardian decision|3|||
145679598|NCT02404441|525344035|FG006|Phase 2 Part|Subject/guardian decision|9|||
145679599|NCT02404441|525344036|FG007|Phase 2 Part|Subject/guardian decision|0|||
145679600|NCT02404441|525344037|FG008|Phase 2 Part|Subject/guardian decision|3|||
145679601|NCT02404441|525344038|FG009|Phase 2 Part|Subject/guardian decision|2|||
145679602|NCT02404441|525344029|FG000|Phase 2 Part|Death|0|||
145679603|NCT02404441|525344030|FG001|Phase 2 Part|Death|0|||
145679604|NCT02404441|525344031|FG002|Phase 2 Part|Death|0|||
145679605|NCT02404441|525344032|FG003|Phase 2 Part|Death|0|||
145679606|NCT02404441|525344033|FG004|Phase 2 Part|Death|0|||
145679607|NCT02404441|525344034|FG005|Phase 2 Part|Death|4|||
145679608|NCT02404441|525344035|FG006|Phase 2 Part|Death|8|||
145679609|NCT02404441|525344036|FG007|Phase 2 Part|Death|4|||
145679610|NCT02404441|525344037|FG008|Phase 2 Part|Death|10|||
145679611|NCT02404441|525344038|FG009|Phase 2 Part|Death|9|||
145679612|NCT03265132|525344039|FG000|Overall Study|Adverse Event|0|||
145679613|NCT03265132|525344040|FG001|Overall Study|Adverse Event|1|||
145679614|NCT03265132|525344039|FG000|Overall Study|Lack of Efficacy|0|||
145679615|NCT03265132|525344040|FG001|Overall Study|Lack of Efficacy|2|||
145679616|NCT03265132|525344039|FG000|Overall Study|Progressive disease|0|||
145679617|NCT03265132|525344040|FG001|Overall Study|Progressive disease|2|||
145679618|NCT03265132|525344039|FG000|Overall Study|Withdrawal by Subject|0|||
145679619|NCT03265132|525344040|FG001|Overall Study|Withdrawal by Subject|1|||
145679620|NCT01976507|525344044|FG000|Overall Study|Adverse Event|6|||
145679621|NCT01976507|525344044|FG000|Overall Study|ablation not done, drug not given|1|||
145679622|NCT01794299|525344046|FG000|Overall Study|ATIR manufacturing not possible|1|||
145679623|NCT01794299|525344046|FG000|Overall Study|Death|14|||
145679624|NCT01794299|525344046|FG000|Overall Study|Graft failure|1|||
145679625|NCT01794299|525344046|FG000|Overall Study|ATIR batch rejected|2|||
145679626|NCT01794299|525344046|FG000|Overall Study|Relapse|2|||
145679627|NCT01794299|525344046|FG000|Overall Study|Discontinued from active follow-up|1|||
145679628|NCT01794299|525344046|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
145679629|NCT03006393|525344047|FG000|Overall Study|Withdrawal by Subject|1|||
145679630|NCT03006393|525344048|FG001|Overall Study|Withdrawal by Subject|1|||
145679631|NCT03006393|525344047|FG000|Overall Study|Pregnancy|0|||
145679632|NCT03006393|525344048|FG001|Overall Study|Pregnancy|1|||
145679633|NCT03006393|525344047|FG000|Overall Study|Lost to Follow-up|0|||
145679634|NCT03006393|525344048|FG001|Overall Study|Lost to Follow-up|1|||
145679635|NCT02161458|525344049|FG000|Overall Study|Withdrawal by Subject|0|||
145679636|NCT02161458|525344050|FG001|Overall Study|Withdrawal by Subject|4|||
145679637|NCT02161458|525344051|FG002|Overall Study|Withdrawal by Subject|4|||
145679638|NCT02161458|525344052|FG003|Overall Study|Withdrawal by Subject|0|||
145679639|NCT02161458|525344049|FG000|Overall Study|Lost to Follow-up|0|||
145679640|NCT02161458|525344050|FG001|Overall Study|Lost to Follow-up|2|||
145679641|NCT02161458|525344051|FG002|Overall Study|Lost to Follow-up|1|||
145679642|NCT02161458|525344052|FG003|Overall Study|Lost to Follow-up|0|||
145679643|NCT03136861|525344056|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
145679644|NCT03136861|525344057|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
145679645|NCT03136861|525344058|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145679646|NCT03136861|525344059|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145679647|NCT03136861|525344060|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145679648|NCT03136861|525344061|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145679649|NCT03136861|525344062|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
145679650|NCT03136861|525344056|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
145679651|NCT03136861|525344057|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
145679652|NCT03136861|525344058|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145679653|NCT03136861|525344059|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145679654|NCT03136861|525344060|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145679655|NCT03136861|525344061|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145679656|NCT03136861|525344062|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
145679657|NCT03136861|525344056|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
145679658|NCT03136861|525344057|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
145679659|NCT03136861|525344058|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
145679660|NCT03136861|525344059|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
145679661|NCT03136861|525344060|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
145679662|NCT03136861|525344061|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
145679663|NCT03136861|525344062|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
145679664|NCT03136861|525344056|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145679665|NCT03136861|525344057|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
145679666|NCT03136861|525344058|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145491062|NCT01384734|524652352|FG004|Overall Study|Non-compliance with study drug|2|||
145679667|NCT03136861|525344059|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145679668|NCT03136861|525344060|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145679669|NCT03136861|525344061|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145679670|NCT03136861|525344062|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
145679671|NCT03136861|525344056|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
145679672|NCT03136861|525344057|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
145679673|NCT03136861|525344058|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145679674|NCT03136861|525344059|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145679675|NCT03136861|525344060|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145679676|NCT03136861|525344061|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145679677|NCT03136861|525344062|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
145679678|NCT03136861|525344056|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
145679679|NCT03136861|525344057|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
145679680|NCT03136861|525344058|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
145679681|NCT03136861|525344059|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
145679682|NCT03136861|525344060|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
145679683|NCT03136861|525344061|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
145679684|NCT03136861|525344062|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
145679685|NCT03136861|525344056|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679686|NCT03136861|525344057|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679687|NCT03136861|525344058|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
145679688|NCT03136861|525344059|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679689|NCT03136861|525344060|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679690|NCT03136861|525344061|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679691|NCT03136861|525344062|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
145679692|NCT03136861|525344056|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679693|NCT03136861|525344057|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679694|NCT03136861|525344058|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
145679695|NCT03136861|525344059|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679696|NCT03136861|525344060|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679697|NCT03136861|525344061|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679698|NCT03136861|525344062|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
145679699|NCT03390166|525344063|FG000|Overall Study|Death|0|||
145679700|NCT03390166|525344064|FG001|Overall Study|Death|1|||
145679701|NCT03390166|525344063|FG000|Overall Study|Lost to Follow-up|6|||
145679702|NCT03390166|525344064|FG001|Overall Study|Lost to Follow-up|4|||
145679703|NCT03390166|525344063|FG000|Overall Study|Physician Decision|2|||
145679704|NCT03390166|525344064|FG001|Overall Study|Physician Decision|1|||
145679705|NCT03390166|525344063|FG000|Overall Study|Move from study area|3|||
145679706|NCT03390166|525344064|FG001|Overall Study|Move from study area|2|||
145679707|NCT03390166|525344063|FG000|Overall Study|To militarycamp for conscript|1|||
145679708|NCT03390166|525344064|FG001|Overall Study|To militarycamp for conscript|0|||
145679709|NCT03390166|525344063|FG000|Overall Study|To drug therapy course|0|||
145679710|NCT03390166|525344064|FG001|Overall Study|To drug therapy course|1|||
145679711|NCT03390166|525344063|FG000|Overall Study|Move to work oversea|0|||
145679712|NCT03390166|525344064|FG001|Overall Study|Move to work oversea|1|||
145679713|NCT01328756|525344068|FG000|Overall Study|Protocol Violation|4|||
145679714|NCT01328756|525344068|FG000|Overall Study|Adverse Event|39|||
145679715|NCT01328756|525344068|FG000|Overall Study|Lack of Efficacy|5|||
145679716|NCT01328756|525344068|FG000|Overall Study|Withdrawal by Subject|41|||
145679717|NCT01328756|525344068|FG000|Overall Study|Lost to Follow-up|5|||
145679718|NCT01328756|525344068|FG000|Overall Study|Other|29|||
145679719|NCT01262456|525344071|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
145679720|NCT01262456|525344072|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
145679721|NCT01262456|525344073|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
145679722|NCT01262456|525344071|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
145491063|NCT01384734|524652348|FG000|Overall Study|Pregnancy|0|||
145491064|NCT01384734|524652349|FG001|Overall Study|Pregnancy|1|||
145491065|NCT01384734|524652350|FG002|Overall Study|Pregnancy|0|||
145491066|NCT01384734|524652351|FG003|Overall Study|Pregnancy|0|||
145491067|NCT01384734|524652352|FG004|Overall Study|Pregnancy|1|||
145679723|NCT01262456|525344072|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
145679724|NCT01262456|525344073|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
145679725|NCT01262456|525344071|FG000|3-Month Double-Blind Period|Adverse Event|6|||
145679726|NCT01262456|525344072|FG001|3-Month Double-Blind Period|Adverse Event|4|||
145491068|NCT01384734|524652348|FG000|Overall Study|Sponsor terminated|0|||
145679727|NCT01262456|525344073|FG002|3-Month Double-Blind Period|Adverse Event|8|||
145679728|NCT01262456|525344071|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
145679729|NCT01262456|525344072|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
145679730|NCT01262456|525344073|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
145679731|NCT01262456|525344071|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
145491069|NCT01384734|524652349|FG001|Overall Study|Sponsor terminated|0|||
145491070|NCT01384734|524652350|FG002|Overall Study|Sponsor terminated|0|||
145679732|NCT01262456|525344072|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
145679733|NCT01262456|525344073|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
145679734|NCT01262456|525344071|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
145679735|NCT01262456|525344072|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
145679736|NCT01262456|525344073|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
145679737|NCT01262456|525344071|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
145679738|NCT01262456|525344072|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
145679739|NCT01262456|525344073|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
145679740|NCT01262456|525344071|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
145679741|NCT01262456|525344072|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
145679742|NCT01262456|525344073|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
145679743|NCT01262456|525344071|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
145679744|NCT01262456|525344072|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
145679745|NCT01262456|525344073|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
145679746|NCT01316913|525344076|FG000|Overall Study|Adverse Event|17|||
145679747|NCT01316913|525344077|FG001|Overall Study|Adverse Event|20|||
145679748|NCT01316913|525344078|FG002|Overall Study|Adverse Event|15|||
145679749|NCT01316913|525344079|FG003|Overall Study|Adverse Event|11|||
145679750|NCT01316913|525344076|FG000|Overall Study|Lack of Efficacy|22|||
145679751|NCT01316913|525344077|FG001|Overall Study|Lack of Efficacy|12|||
145679752|NCT01316913|525344078|FG002|Overall Study|Lack of Efficacy|9|||
145679753|NCT01316913|525344079|FG003|Overall Study|Lack of Efficacy|13|||
145679754|NCT01316913|525344076|FG000|Overall Study|Protocol Violation|1|||
145679755|NCT01316913|525344077|FG001|Overall Study|Protocol Violation|4|||
145679756|NCT01316913|525344078|FG002|Overall Study|Protocol Violation|4|||
145679757|NCT01316913|525344079|FG003|Overall Study|Protocol Violation|1|||
145679758|NCT01316913|525344076|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
145679759|NCT01316913|525344077|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
145679760|NCT01316913|525344078|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
145679761|NCT01316913|525344079|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
145679762|NCT01316913|525344076|FG000|Overall Study|Lost to Follow-up|0|||
145679763|NCT01316913|525344077|FG001|Overall Study|Lost to Follow-up|1|||
145679764|NCT01316913|525344078|FG002|Overall Study|Lost to Follow-up|0|||
145679765|NCT01316913|525344079|FG003|Overall Study|Lost to Follow-up|2|||
145679766|NCT01316913|525344076|FG000|Overall Study|Withdrawal by Subject|10|||
145679767|NCT01316913|525344077|FG001|Overall Study|Withdrawal by Subject|9|||
145679768|NCT01316913|525344078|FG002|Overall Study|Withdrawal by Subject|10|||
145679769|NCT01316913|525344079|FG003|Overall Study|Withdrawal by Subject|6|||
145679770|NCT05445557|525344080|FG000|Double Blind Part|Lost to Follow-up|1|||
145679771|NCT02915783|525344081|FG000|Overall Study|Death|21|||
145679772|NCT02915783|525344081|FG000|Overall Study|Lost to Follow-up|1|||
145679773|NCT02915783|525344081|FG000|Overall Study|Withdrawal by Subject|2|||
145679774|NCT03055988|525344082|FG000|Period 1|Adverse Event|0|||
145679775|NCT03055988|525344083|FG001|Period 1|Adverse Event|1|||
145679776|NCT03055988|525344082|FG000|Period 1|Lost to Follow-up|1|||
145679777|NCT03055988|525344083|FG001|Period 1|Lost to Follow-up|0|||
145679778|NCT03055988|525344082|FG000|Period 1|Withdrawal by Subject|0|||
145679779|NCT03055988|525344083|FG001|Period 1|Withdrawal by Subject|4|||
145679780|NCT03055988|525344082|FG000|Period 2|Adverse Event|0|||
145679781|NCT03055988|525344083|FG001|Period 2|Adverse Event|1|||
145679782|NCT03055988|525344082|FG000|Period 2|Other than listed|1|||
145679783|NCT03055988|525344083|FG001|Period 2|Other than listed|1|||
145679784|NCT02326220|525344089|FG000|Double-blind Treatment Period|Adverse Event|1|||
145679785|NCT02326220|525344090|FG001|Double-blind Treatment Period|Adverse Event|2|||
145679786|NCT02326220|525344091|FG002|Double-blind Treatment Period|Adverse Event|0|||
145679787|NCT02326220|525344089|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145679788|NCT02326220|525344090|FG001|Double-blind Treatment Period|Protocol Violation|1|||
145679789|NCT02326220|525344091|FG002|Double-blind Treatment Period|Protocol Violation|0|||
145679790|NCT02326220|525344089|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145679791|NCT02326220|525344090|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
145679792|NCT02326220|525344091|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145679793|NCT02326220|525344089|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
145679794|NCT02326220|525344090|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
145679795|NCT02326220|525344091|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
145679796|NCT02326220|525344089|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145679797|NCT02326220|525344090|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
145679798|NCT02326220|525344091|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
145679799|NCT02699099|525344092|FG000|Overall Study|Adverse Event|1|||
145679800|NCT02699099|525344093|FG001|Overall Study|Adverse Event|0|||
145679801|NCT02699099|525344094|FG002|Overall Study|Adverse Event|2|||
145679802|NCT02699099|525344092|FG000|Overall Study|Lost to Follow-up|0|||
145679803|NCT02699099|525344093|FG001|Overall Study|Lost to Follow-up|1|||
145679804|NCT02699099|525344094|FG002|Overall Study|Lost to Follow-up|0|||
145679805|NCT02699099|525344092|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
145679806|NCT02699099|525344093|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
145679807|NCT02699099|525344094|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
145679808|NCT02659540|525344095|FG000|Overall Study|Adverse Event|3|||
145679809|NCT02659540|525344096|FG001|Overall Study|Adverse Event|2|||
145679810|NCT02659540|525344095|FG000|Overall Study|Death|1|||
145679811|NCT02659540|525344096|FG001|Overall Study|Death|0|||
145679812|NCT02659540|525344095|FG000|Overall Study|Progressive disease|2|||
145679813|NCT02659540|525344096|FG001|Overall Study|Progressive disease|6|||
145679814|NCT02489799|525345577|FG000|Overall Study|Lost to Follow-up|4|||
145679815|NCT02489799|525345578|FG001|Overall Study|Lost to Follow-up|1|||
145679816|NCT02489799|525345577|FG000|Overall Study|Failure to Maintain Eligibility|4|||
145679817|NCT02489799|525345578|FG001|Overall Study|Failure to Maintain Eligibility|6|||
145679818|NCT02489799|525345577|FG000|Overall Study|Withdrawal by Subject|1|||
145679819|NCT02489799|525345578|FG001|Overall Study|Withdrawal by Subject|1|||
145679820|NCT02489799|525345577|FG000|Overall Study|Death|0|||
145679821|NCT02489799|525345578|FG001|Overall Study|Death|1|||
145679822|NCT01655498|525345579|FG000|Overall Study|Unrelated health issue|2|||
145679823|NCT01655498|525345579|FG000|Overall Study|Protocol Violation|2|||
145679824|NCT01655498|525345579|FG000|Overall Study|Withdrawal by Subject|1|||
145679825|NCT01072149|525345581|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679826|NCT01072149|525345582|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679827|NCT01072149|525345583|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
145679828|NCT01072149|525345584|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679829|NCT01072149|525345585|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679830|NCT01072149|525345586|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679831|NCT01072149|525345587|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679832|NCT01072149|525345588|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679833|NCT01072149|525345589|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679834|NCT01072149|525345590|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679835|NCT01072149|525345591|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679836|NCT01072149|525345592|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679837|NCT01072149|525345593|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679838|NCT01072149|525345594|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679839|NCT01072149|525345595|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679840|NCT01072149|525345596|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679841|NCT01072149|525345597|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679842|NCT01072149|525345598|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
145679843|NCT01072149|525345581|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679844|NCT01072149|525345582|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679845|NCT01072149|525345583|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679846|NCT01072149|525345584|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679847|NCT01072149|525345585|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679848|NCT01072149|525345586|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679849|NCT01072149|525345587|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679850|NCT01072149|525345588|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679851|NCT01072149|525345589|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679852|NCT01072149|525345590|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679853|NCT01072149|525345591|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679854|NCT01072149|525345592|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679855|NCT01072149|525345593|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679856|NCT01072149|525345594|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679857|NCT01072149|525345595|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679858|NCT01072149|525345596|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679859|NCT01072149|525345597|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
145679860|NCT01072149|525345598|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
145679861|NCT01072149|525345581|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679862|NCT01072149|525345582|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679863|NCT01072149|525345583|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679864|NCT01072149|525345584|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679865|NCT01072149|525345585|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679866|NCT01072149|525345586|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679867|NCT01072149|525345587|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679868|NCT01072149|525345588|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679869|NCT01072149|525345589|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679870|NCT01072149|525345590|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679871|NCT01072149|525345591|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
145679872|NCT01072149|525345592|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679873|NCT01072149|525345593|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679874|NCT01072149|525345594|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679875|NCT01072149|525345595|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679876|NCT01072149|525345596|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679877|NCT01072149|525345597|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679878|NCT01072149|525345598|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
145679879|NCT01072149|525345581|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679880|NCT01072149|525345582|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
145679881|NCT01072149|525345583|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679882|NCT01072149|525345584|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679883|NCT01072149|525345585|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679884|NCT01072149|525345586|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679885|NCT01072149|525345587|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679886|NCT01072149|525345588|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679887|NCT01072149|525345589|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679888|NCT01072149|525345590|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679889|NCT01072149|525345591|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679890|NCT01072149|525345592|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679891|NCT01072149|525345593|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679892|NCT01072149|525345594|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679893|NCT01072149|525345595|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679894|NCT01072149|525345596|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679895|NCT01072149|525345597|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679896|NCT01072149|525345598|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
145679897|NCT01072149|525345581|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679898|NCT01072149|525345582|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679899|NCT01072149|525345583|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
145679900|NCT01072149|525345584|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679901|NCT01072149|525345585|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679902|NCT01072149|525345586|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679903|NCT01072149|525345587|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679904|NCT01072149|525345588|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679905|NCT01072149|525345589|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679906|NCT01072149|525345590|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679907|NCT01072149|525345591|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679908|NCT01072149|525345592|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679909|NCT01072149|525345593|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679910|NCT01072149|525345594|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679911|NCT01072149|525345595|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679912|NCT01072149|525345596|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679913|NCT01072149|525345597|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679914|NCT01072149|525345598|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
145679915|NCT01072149|525345581|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679916|NCT01072149|525345582|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679917|NCT01072149|525345583|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679918|NCT01072149|525345584|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679919|NCT01072149|525345585|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679920|NCT01072149|525345586|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679921|NCT01072149|525345587|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679922|NCT01072149|525345588|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
145679923|NCT01072149|525345589|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679924|NCT01072149|525345590|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679925|NCT01072149|525345591|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679926|NCT01072149|525345592|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679927|NCT01072149|525345593|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679928|NCT01072149|525345594|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679929|NCT01072149|525345595|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679930|NCT01072149|525345596|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679931|NCT01072149|525345597|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679932|NCT01072149|525345598|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
145679933|NCT01072149|525345581|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
145679934|NCT01072149|525345582|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
145679935|NCT01072149|525345583|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
145679936|NCT01072149|525345584|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
145679937|NCT01072149|525345585|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
145679938|NCT01072149|525345586|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
145679939|NCT01072149|525345587|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
145679940|NCT01072149|525345588|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
145679941|NCT01072149|525345589|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
145679942|NCT01072149|525345590|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
145679943|NCT01072149|525345591|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
145679944|NCT01072149|525345592|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
145679945|NCT01072149|525345593|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
145679946|NCT01072149|525345594|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
145679947|NCT01072149|525345595|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
145679948|NCT01072149|525345596|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
145679949|NCT01072149|525345597|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
145679950|NCT01072149|525345598|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
145679951|NCT01072149|525345581|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679952|NCT01072149|525345582|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679953|NCT01072149|525345583|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679954|NCT01072149|525345584|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679955|NCT01072149|525345585|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679956|NCT01072149|525345586|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679957|NCT01072149|525345587|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679958|NCT01072149|525345588|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679959|NCT01072149|525345589|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679960|NCT01072149|525345590|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679961|NCT01072149|525345591|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679962|NCT01072149|525345592|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679963|NCT01072149|525345593|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679964|NCT01072149|525345594|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679965|NCT01072149|525345595|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679966|NCT01072149|525345596|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
145679967|NCT01072149|525345597|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679968|NCT01072149|525345598|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
145679969|NCT01072149|525345581|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
145679970|NCT01072149|525345582|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
145679971|NCT01072149|525345583|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
145679972|NCT01072149|525345584|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
145679973|NCT01072149|525345585|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
145679974|NCT01072149|525345586|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
145679975|NCT01072149|525345587|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
145679976|NCT01072149|525345588|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
145679977|NCT01072149|525345589|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
145679978|NCT01072149|525345590|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
145679979|NCT01072149|525345591|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
145679980|NCT01072149|525345592|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
145679981|NCT01072149|525345593|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
145679982|NCT01072149|525345594|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
145679983|NCT01072149|525345595|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
145679984|NCT01072149|525345596|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
145679985|NCT01072149|525345597|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
145679986|NCT01072149|525345598|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
145679987|NCT01072149|525345581|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679988|NCT01072149|525345582|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679989|NCT01072149|525345583|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679990|NCT01072149|525345584|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679991|NCT01072149|525345585|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679992|NCT01072149|525345586|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679993|NCT01072149|525345587|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679994|NCT01072149|525345588|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679995|NCT01072149|525345589|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679996|NCT01072149|525345590|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679997|NCT01072149|525345591|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679998|NCT01072149|525345592|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145679999|NCT01072149|525345593|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
145680000|NCT01072149|525345594|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145680001|NCT01072149|525345595|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145680002|NCT01072149|525345596|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145680003|NCT01072149|525345597|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145680004|NCT01072149|525345598|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
145680005|NCT01072149|525345581|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680006|NCT01072149|525345582|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680007|NCT01072149|525345583|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
145680008|NCT01072149|525345584|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680009|NCT01072149|525345585|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680010|NCT01072149|525345586|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680011|NCT01072149|525345587|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680012|NCT01072149|525345588|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680013|NCT01072149|525345589|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680014|NCT01072149|525345590|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680015|NCT01072149|525345591|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680016|NCT01072149|525345592|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680017|NCT01072149|525345593|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680018|NCT01072149|525345594|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
145680019|NCT01072149|525345595|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680020|NCT01072149|525345596|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680021|NCT01072149|525345597|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680022|NCT01072149|525345598|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
145680023|NCT00871494|525345603|FG000|Overall Study|Protocol Violation|5|||
145680024|NCT00871494|525345603|FG000|Overall Study|Lack of Efficacy|4|||
145680025|NCT00871494|525345603|FG000|Overall Study|Adverse Event|4|||
145680026|NCT00871494|525345603|FG000|Overall Study|Lost to Follow-up|1|||
145680027|NCT00889863|525345607|FG000|Part I: Open Label|Death|1|||
145680028|NCT00889863|525345608|FG001|Part I: Open Label|Death|0|||
145680029|NCT00889863|525345607|FG000|Part I: Open Label|Adverse Event|4|||
145680030|NCT00889863|525345608|FG001|Part I: Open Label|Adverse Event|0|||
145680031|NCT00889863|525345607|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
145680032|NCT00889863|525345608|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
145680033|NCT00889863|525345607|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
145680034|NCT00889863|525345608|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
145680035|NCT00889863|525345607|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
145680036|NCT00889863|525345608|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
145680037|NCT00889863|525345607|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
145680038|NCT00889863|525345608|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
145680039|NCT00889863|525345607|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
145680040|NCT00889863|525345608|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
145680041|NCT01090739|525345609|FG000|Enrollment|Withdrawal by Subject|24|||
145680042|NCT01090739|525345609|FG000|Enrollment|Protocol Violation|14|||
145680043|NCT01090739|525345609|FG000|Enrollment|Lost to Follow-up|5|||
145680044|NCT01090739|525345609|FG000|Enrollment|Physician Decision|5|||
145680045|NCT01090739|525345609|FG000|Enrollment|Sponsor termination of site|4|||
145680046|NCT01090739|525345609|FG000|Enrollment|Study implant limit reached|2|||
145680047|NCT01090739|525345609|FG000|Enrollment|Adverse Event|1|||
145680048|NCT01090739|525345609|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
145680049|NCT01090739|525345609|FG000|12 Month Follow-up|Lost to Follow-up|1|||
145680050|NCT01090739|525345609|FG000|12 Month Follow-up|Physician Decision|1|||
145680051|NCT01090739|525345609|FG000|12 Month Follow-up|Death|1|||
145680052|NCT01090739|525345609|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
145680053|NCT01090739|525345609|FG000|24 Month Follow-up|Lost to Follow-up|1|||
145680054|NCT01090739|525345609|FG000|24 Month Follow-up|Death|1|||
145680055|NCT01090739|525345609|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
145680056|NCT01090739|525345609|FG000|36 Month Follow-up|Visit still pending|17|||
145680057|NCT00988429|525345610|FG000|Overall Study|Adverse Event|9|||
145680058|NCT00988429|525345611|FG001|Overall Study|Adverse Event|21|||
145680059|NCT00988429|525345612|FG002|Overall Study|Adverse Event|45|||
145680060|NCT00988429|525345610|FG000|Overall Study|Lack of Efficacy|0|||
145680061|NCT00988429|525345611|FG001|Overall Study|Lack of Efficacy|0|||
145680062|NCT00988429|525345612|FG002|Overall Study|Lack of Efficacy|1|||
145680063|NCT00988429|525345610|FG000|Overall Study|Non-Compliance with Study Drug|5|||
145680064|NCT00988429|525345611|FG001|Overall Study|Non-Compliance with Study Drug|1|||
145680065|NCT00988429|525345612|FG002|Overall Study|Non-Compliance with Study Drug|3|||
145680066|NCT00988429|525345610|FG000|Overall Study|Physician Decision|1|||
145680067|NCT00988429|525345611|FG001|Overall Study|Physician Decision|0|||
145680068|NCT00988429|525345612|FG002|Overall Study|Physician Decision|3|||
145680069|NCT00988429|525345610|FG000|Overall Study|Pregnancy|2|||
145680070|NCT00988429|525345611|FG001|Overall Study|Pregnancy|1|||
145680071|NCT00988429|525345612|FG002|Overall Study|Pregnancy|0|||
145680072|NCT00988429|525345610|FG000|Overall Study|Protocol Violation|4|||
145680073|NCT00988429|525345611|FG001|Overall Study|Protocol Violation|3|||
145680074|NCT00988429|525345612|FG002|Overall Study|Protocol Violation|3|||
145680075|NCT00988429|525345610|FG000|Overall Study|Withdrawal by Subject|7|||
145680076|NCT00988429|525345611|FG001|Overall Study|Withdrawal by Subject|7|||
145680077|NCT00988429|525345612|FG002|Overall Study|Withdrawal by Subject|12|||
145680078|NCT00988429|525345610|FG000|Overall Study|Administrative Reasons|1|||
145491071|NCT01384734|524652351|FG003|Overall Study|Sponsor terminated|0|||
145491072|NCT01384734|524652352|FG004|Overall Study|Sponsor terminated|1|||
145491073|NCT01384734|524652348|FG000|Overall Study|Withdrawal by Subject|5|||
145680079|NCT00988429|525345611|FG001|Overall Study|Administrative Reasons|2|||
145680080|NCT00988429|525345612|FG002|Overall Study|Administrative Reasons|1|||
145680081|NCT00988429|525345610|FG000|Overall Study|other reasons|8|||
145680082|NCT00988429|525345611|FG001|Overall Study|other reasons|8|||
145680083|NCT00988429|525345612|FG002|Overall Study|other reasons|1|||
145680084|NCT00441168|525345613|FG000|Treatment Period|Death|3|||
145680085|NCT00441168|525345614|FG001|Treatment Period|Death|0|||
145680086|NCT00441168|525345613|FG000|Treatment Period|Adverse Event|1|||
145680087|NCT00441168|525345614|FG001|Treatment Period|Adverse Event|2|||
145680088|NCT00441168|525345613|FG000|Treatment Period|Progressive Disease|0|||
145680089|NCT00441168|525345614|FG001|Treatment Period|Progressive Disease|2|||
145680090|NCT00441168|525345613|FG000|Treatment Period|Protocol Violation|0|||
145680091|NCT00441168|525345614|FG001|Treatment Period|Protocol Violation|1|||
145680092|NCT00441168|525345613|FG000|Treatment Period|Lost to Follow-up|0|||
145680093|NCT00441168|525345614|FG001|Treatment Period|Lost to Follow-up|1|||
145680094|NCT00441168|525345613|FG000|Treatment Period|Withdrawal by Subject|3|||
145680095|NCT00441168|525345614|FG001|Treatment Period|Withdrawal by Subject|0|||
145680096|NCT00441168|525345613|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
145680097|NCT00441168|525345614|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
145680098|NCT00441168|525345613|FG000|Treatment Period|refractory disease|1|||
145680099|NCT00441168|525345614|FG001|Treatment Period|refractory disease|0|||
145680100|NCT00441168|525345613|FG000|Follow-up Period|Death|3|||
145680101|NCT00441168|525345614|FG001|Follow-up Period|Death|0|||
145680102|NCT00441168|525345613|FG000|Follow-up Period|Lost to Follow-up|5|||
145680103|NCT00441168|525345614|FG001|Follow-up Period|Lost to Follow-up|6|||
145680104|NCT00441168|525345613|FG000|Follow-up Period|Withdrawal by Subject|3|||
145680105|NCT00441168|525345614|FG001|Follow-up Period|Withdrawal by Subject|0|||
145680106|NCT00441168|525345613|FG000|Follow-up Period|Other|1|||
145680107|NCT00441168|525345614|FG001|Follow-up Period|Other|3|||
145680108|NCT02964234|525345615|FG000|Overall Study|Lost to Follow-up|22|||
145680109|NCT02964234|525345616|FG001|Overall Study|Lost to Follow-up|13|||
145680110|NCT01799993|525345618|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
145680111|NCT01799993|525345619|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
145680112|NCT01799993|525345618|FG000|Overall Study|Death|61|||
145680113|NCT01799993|525345619|FG001|Overall Study|Death|45|||
145680114|NCT01799993|525345618|FG000|Overall Study|Withdrawal by Subject|23|||
145680115|NCT01799993|525345619|FG001|Overall Study|Withdrawal by Subject|24|||
145680116|NCT01799993|525345618|FG000|Overall Study|Lost to Follow-up|5|||
145680117|NCT01799993|525345619|FG001|Overall Study|Lost to Follow-up|8|||
145680118|NCT01799993|525345618|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
145680119|NCT01799993|525345619|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
145680120|NCT01799993|525345618|FG000|Overall Study|Protocol driven decision point|0|||
145680121|NCT01799993|525345619|FG001|Overall Study|Protocol driven decision point|3|||
145680122|NCT01799993|525345618|FG000|Overall Study|Protocol Violation|1|||
145680123|NCT01799993|525345619|FG001|Overall Study|Protocol Violation|1|||
145680124|NCT01799993|525345618|FG000|Overall Study|Deterioration of general conditions|2|||
145680125|NCT01799993|525345619|FG001|Overall Study|Deterioration of general conditions|0|||
145680126|NCT01799993|525345618|FG000|Overall Study|Screen failure|0|||
145680127|NCT01799993|525345619|FG001|Overall Study|Screen failure|1|||
145680128|NCT01799993|525345618|FG000|Overall Study|Adverse Event|1|||
145680129|NCT01799993|525345619|FG001|Overall Study|Adverse Event|0|||
145680130|NCT01799993|525345618|FG000|Overall Study|Lack of Efficacy|1|||
145680131|NCT01799993|525345619|FG001|Overall Study|Lack of Efficacy|0|||
145680132|NCT01799993|525345618|FG000|Overall Study|Recovery|0|||
145680133|NCT01799993|525345619|FG001|Overall Study|Recovery|1|||
145680134|NCT01799993|525345618|FG000|Overall Study|Logistical difficulties|1|||
145680135|NCT01799993|525345619|FG001|Overall Study|Logistical difficulties|0|||
145680136|NCT01799993|525345618|FG000|Overall Study|Protocol deviation|1|||
145680137|NCT01799993|525345619|FG001|Overall Study|Protocol deviation|0|||
145680138|NCT01799993|525345618|FG000|Overall Study|Non-compliance with medical device|1|||
145680139|NCT01799993|525345619|FG001|Overall Study|Non-compliance with medical device|0|||
145680140|NCT01799993|525345618|FG000|Overall Study|Withdrawal by parent/guardian|0|||
145680141|NCT01799993|525345619|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145680142|NCT01799993|525345618|FG000|Overall Study|Other|1|||
145680143|NCT01799993|525345619|FG001|Overall Study|Other|0|||
145680144|NCT01799993|525345618|FG000|Overall Study|Subject didn't return for follow-up|0|||
145680145|NCT01799993|525345619|FG001|Overall Study|Subject didn't return for follow-up|1|||
145680146|NCT04410445|525345620|FG000|Overall Study|Lost to Follow-up|3|||
145680147|NCT04410445|525345621|FG001|Overall Study|Lost to Follow-up|9|||
145680148|NCT04410445|525345620|FG000|Overall Study|Withdrawal by Subject|27|||
145680149|NCT04410445|525345621|FG001|Overall Study|Withdrawal by Subject|15|||
145680150|NCT01320683|525345622|FG000|Overall Study|Positive antibody response|1|||
145680151|NCT02291861|525345623|FG000|Overall Study|Adverse Event|2|||
145680152|NCT02291861|525345624|FG001|Overall Study|Adverse Event|4|||
145680153|NCT02291861|525345625|FG002|Overall Study|Adverse Event|1|||
145680154|NCT02291861|525345626|FG003|Overall Study|Adverse Event|2|||
145680155|NCT02291861|525345623|FG000|Overall Study|Death|0|||
145680156|NCT02291861|525345624|FG001|Overall Study|Death|0|||
145680157|NCT02291861|525345625|FG002|Overall Study|Death|1|||
145680158|NCT02291861|525345626|FG003|Overall Study|Death|1|||
145680159|NCT02291861|525345623|FG000|Overall Study|Protocol Violation|1|||
145680160|NCT02291861|525345624|FG001|Overall Study|Protocol Violation|0|||
145680161|NCT02291861|525345625|FG002|Overall Study|Protocol Violation|0|||
145680162|NCT02291861|525345626|FG003|Overall Study|Protocol Violation|1|||
145680163|NCT02291861|525345623|FG000|Overall Study|Withdrawal by Subject|1|||
145680164|NCT02291861|525345624|FG001|Overall Study|Withdrawal by Subject|2|||
145680165|NCT02291861|525345625|FG002|Overall Study|Withdrawal by Subject|1|||
145680166|NCT02291861|525345626|FG003|Overall Study|Withdrawal by Subject|4|||
145680167|NCT02291861|525345623|FG000|Overall Study|Noncompliance|1|||
145680168|NCT02291861|525345624|FG001|Overall Study|Noncompliance|1|||
145680169|NCT02291861|525345625|FG002|Overall Study|Noncompliance|2|||
145680170|NCT02291861|525345626|FG003|Overall Study|Noncompliance|1|||
145680171|NCT02291861|525345623|FG000|Overall Study|Lost to Follow-up|2|||
145680172|NCT02291861|525345624|FG001|Overall Study|Lost to Follow-up|1|||
145680173|NCT02291861|525345625|FG002|Overall Study|Lost to Follow-up|4|||
145680174|NCT02291861|525345626|FG003|Overall Study|Lost to Follow-up|0|||
145680175|NCT02291861|525345623|FG000|Overall Study|Other|0|||
145680176|NCT02291861|525345624|FG001|Overall Study|Other|0|||
145680177|NCT02291861|525345625|FG002|Overall Study|Other|0|||
145680178|NCT02291861|525345626|FG003|Overall Study|Other|1|||
145680179|NCT03547154|525345631|FG000|Overall Study|Disease Progression/Recurrence|6|||
145680180|NCT03547154|525345632|FG001|Overall Study|Disease Progression/Recurrence|14|||
145680181|NCT03547154|525345631|FG000|Overall Study|Adverse Event|26|||
145680182|NCT03547154|525345632|FG001|Overall Study|Adverse Event|31|||
145680183|NCT03547154|525345631|FG000|Overall Study|Protocol Violation|6|||
145680184|NCT03547154|525345632|FG001|Overall Study|Protocol Violation|1|||
145680185|NCT03547154|525345631|FG000|Overall Study|Physician Decision|4|||
145680186|NCT03547154|525345632|FG001|Overall Study|Physician Decision|3|||
145680187|NCT03547154|525345631|FG000|Overall Study|Insufficient Therapeutic Response|13|||
145680188|NCT03547154|525345632|FG001|Overall Study|Insufficient Therapeutic Response|10|||
145680189|NCT03547154|525345631|FG000|Overall Study|Withdrawal by Subject|10|||
145680190|NCT03547154|525345632|FG001|Overall Study|Withdrawal by Subject|6|||
145680191|NCT03547154|525345631|FG000|Overall Study|Not Selected|0|||
145680192|NCT03547154|525345632|FG001|Overall Study|Not Selected|1|||
145680193|NCT03547154|525345631|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
145680194|NCT03547154|525345632|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
145680195|NCT00088166|525345637|FG000|Overall Study|Adverse Event|11|||
145680196|NCT00088166|525345638|FG001|Overall Study|Adverse Event|9|||
145680197|NCT00088166|525345637|FG000|Overall Study|Death|3|||
145680198|NCT00088166|525345638|FG001|Overall Study|Death|1|||
145680199|NCT00088166|525345637|FG000|Overall Study|Lost to Follow-up|0|||
145680200|NCT00088166|525345638|FG001|Overall Study|Lost to Follow-up|1|||
145680201|NCT00088166|525345637|FG000|Overall Study|Physician Decision|4|||
145680202|NCT00088166|525345638|FG001|Overall Study|Physician Decision|1|||
145680203|NCT00088166|525345637|FG000|Overall Study|Protocol Violation|1|||
145680204|NCT00088166|525345638|FG001|Overall Study|Protocol Violation|5|||
145680205|NCT00088166|525345637|FG000|Overall Study|Patient deterioration|29|||
145680206|NCT00088166|525345638|FG001|Overall Study|Patient deterioration|39|||
145680207|NCT00088166|525345637|FG000|Overall Study|Withdrawal by Subject|5|||
145680208|NCT00088166|525345638|FG001|Overall Study|Withdrawal by Subject|5|||
145680209|NCT02671266|525345639|FG000|Overall Study|Withdrawal by Subject|1|||
145680210|NCT02671266|525345640|FG001|Overall Study|Withdrawal by Subject|1|||
145680211|NCT00666705|525345646|FG000|Overall Study|Withdrawal by Subject|1|||
145680212|NCT01029704|525345647|FG000|Overall Study|Adverse Event|0|||
145680213|NCT01029704|525345648|FG001|Overall Study|Adverse Event|0|||
145680214|NCT01029704|525345649|FG002|Overall Study|Adverse Event|0|||
145680215|NCT01029704|525345650|FG003|Overall Study|Adverse Event|0|||
145680216|NCT01029704|525345651|FG004|Overall Study|Adverse Event|0|||
145680217|NCT01029704|525345652|FG005|Overall Study|Adverse Event|0|||
145680218|NCT01029704|525345653|FG006|Overall Study|Adverse Event|1|||
145680219|NCT01029704|525345654|FG007|Overall Study|Adverse Event|1|||
145680220|NCT01029704|525345655|FG008|Overall Study|Adverse Event|0|||
145680221|NCT01029704|525345647|FG000|Overall Study|Withdrawal by Subject|0|||
145680222|NCT01029704|525345648|FG001|Overall Study|Withdrawal by Subject|0|||
145680223|NCT01029704|525345649|FG002|Overall Study|Withdrawal by Subject|0|||
145680224|NCT01029704|525345650|FG003|Overall Study|Withdrawal by Subject|0|||
145680225|NCT01029704|525345651|FG004|Overall Study|Withdrawal by Subject|2|||
145680226|NCT01029704|525345652|FG005|Overall Study|Withdrawal by Subject|1|||
145680227|NCT01029704|525345653|FG006|Overall Study|Withdrawal by Subject|1|||
145680228|NCT01029704|525345654|FG007|Overall Study|Withdrawal by Subject|1|||
145680229|NCT01029704|525345655|FG008|Overall Study|Withdrawal by Subject|0|||
145680230|NCT01029704|525345647|FG000|Overall Study|Lost to Follow-up|0|||
145680231|NCT01029704|525345648|FG001|Overall Study|Lost to Follow-up|0|||
145491074|NCT01384734|524652349|FG001|Overall Study|Withdrawal by Subject|5|||
145680232|NCT01029704|525345649|FG002|Overall Study|Lost to Follow-up|0|||
145680233|NCT01029704|525345650|FG003|Overall Study|Lost to Follow-up|0|||
145680234|NCT01029704|525345651|FG004|Overall Study|Lost to Follow-up|0|||
145680235|NCT01029704|525345652|FG005|Overall Study|Lost to Follow-up|0|||
145680236|NCT01029704|525345653|FG006|Overall Study|Lost to Follow-up|1|||
145680237|NCT01029704|525345654|FG007|Overall Study|Lost to Follow-up|1|||
145680238|NCT01029704|525345655|FG008|Overall Study|Lost to Follow-up|1|||
145680239|NCT01029704|525345647|FG000|Overall Study|Lack of Efficacy|0|||
145680240|NCT01029704|525345648|FG001|Overall Study|Lack of Efficacy|0|||
145680241|NCT01029704|525345649|FG002|Overall Study|Lack of Efficacy|0|||
145680242|NCT01029704|525345650|FG003|Overall Study|Lack of Efficacy|0|||
145680243|NCT01029704|525345651|FG004|Overall Study|Lack of Efficacy|2|||
145680244|NCT01029704|525345652|FG005|Overall Study|Lack of Efficacy|3|||
145680245|NCT01029704|525345653|FG006|Overall Study|Lack of Efficacy|1|||
145680246|NCT01029704|525345654|FG007|Overall Study|Lack of Efficacy|2|||
145680247|NCT01029704|525345655|FG008|Overall Study|Lack of Efficacy|0|||
145680248|NCT01029704|525345647|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
145680249|NCT01029704|525345648|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
145680250|NCT01029704|525345649|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
145680251|NCT01029704|525345650|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
145680252|NCT01029704|525345651|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
145680253|NCT01029704|525345652|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
145680254|NCT01029704|525345653|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
145680255|NCT01029704|525345654|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
145680256|NCT01029704|525345655|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
145680257|NCT00687297|525345656|FG000|Randomization|Withdrawal by Subject|2|||
145680258|NCT00687297|525345657|FG001|Randomization|Withdrawal by Subject|0|||
145680259|NCT00687297|525345656|FG000|Randomization|Withdrew before treatment, ineligible|1|||
145680260|NCT00687297|525345657|FG001|Randomization|Withdrew before treatment, ineligible|1|||
145680261|NCT00687297|525345656|FG000|Induction|Withdrawal by Subject|4|||
145680262|NCT00687297|525345657|FG001|Induction|Withdrawal by Subject|4|||
145680263|NCT00687297|525345656|FG000|Induction|Adverse Event|16|||
145680264|NCT00687297|525345657|FG001|Induction|Adverse Event|15|||
145680265|NCT00687297|525345656|FG000|Induction|Death|7|||
145680266|NCT00687297|525345657|FG001|Induction|Death|11|||
145680267|NCT00687297|525345656|FG000|Induction|Lack of Efficacy|17|||
145680268|NCT00687297|525345657|FG001|Induction|Lack of Efficacy|21|||
145680269|NCT00687297|525345656|FG000|Induction|Ineligible|0|||
145680270|NCT00687297|525345657|FG001|Induction|Ineligible|1|||
145680271|NCT00687297|525345656|FG000|Induction|Patient Noncompliance|1|||
145680272|NCT00687297|525345657|FG001|Induction|Patient Noncompliance|0|||
145680273|NCT00687297|525345656|FG000|Induction|Physician Decision|0|||
145680274|NCT00687297|525345657|FG001|Induction|Physician Decision|2|||
145680275|NCT00687297|525345656|FG000|Induction|Other|0|||
145680276|NCT00687297|525345657|FG001|Induction|Other|1|||
145680277|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
145680278|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
145680279|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
145680280|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
145680281|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Death|0|||
145680282|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Death|0|||
145680283|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Death|1|||
145680284|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Death|0|||
145680285|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
145680286|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
145680287|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
145680288|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
145680289|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
145680290|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
145680291|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
145680292|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
145680293|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
145680294|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
145680295|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
145680296|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
145680297|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
145680298|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
145680299|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
145680300|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
145680301|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
145680302|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
145680303|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
145680304|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
145680305|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Other|2|||
145680306|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Other|0|||
145680307|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Other|0|||
145680308|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Other|0|||
145680309|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
145680310|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
145680311|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
145680312|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
145680313|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
145680314|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
145680315|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
145680316|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
145680317|NCT03845517|525345658|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
145680318|NCT03845517|525345659|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
145680319|NCT03845517|525345660|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
145680320|NCT03845517|525345661|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
145680321|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
145680322|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
145680323|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
145680324|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
145680325|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Death|0|||
145680326|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Death|0|||
145680327|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Death|1|||
145680328|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Death|1|||
145680329|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
145680330|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
145680331|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
145680332|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
145680333|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
145680334|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
145680335|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
145680336|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
145680337|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
145680338|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
145680339|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
145680340|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
145680341|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Other|1|||
145680342|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Other|0|||
145680343|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Other|1|||
145680344|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Other|0|||
145680345|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
145680346|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
145680347|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
145680348|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
145680349|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
145680350|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
145680351|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
145680352|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
145680353|NCT03845517|525345658|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
145680354|NCT03845517|525345659|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
145680355|NCT03845517|525345660|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
145680356|NCT03845517|525345661|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
145680357|NCT01109979|525345662|FG000|Overall Study|Physician Decision|2|||
145680358|NCT01109979|525345663|FG001|Overall Study|Physician Decision|0|||
145680359|NCT01109979|525345662|FG000|Overall Study|Withdrawal by Subject|0|||
145680360|NCT01109979|525345663|FG001|Overall Study|Withdrawal by Subject|1|||
145680361|NCT00807599|525345666|FG000|Overall Study|Not treated on protocol study|0|||
145680362|NCT00807599|525345667|FG001|Overall Study|Not treated on protocol study|0|||
145680363|NCT00807599|525345668|FG002|Overall Study|Not treated on protocol study|2|||
145680364|NCT00807599|525345666|FG000|Overall Study|Adverse Event|0|||
145680365|NCT00807599|525345667|FG001|Overall Study|Adverse Event|0|||
145680366|NCT00807599|525345668|FG002|Overall Study|Adverse Event|5|||
145680367|NCT00807599|525345666|FG000|Overall Study|Inadequate response to induction|0|||
145680368|NCT00807599|525345667|FG001|Overall Study|Inadequate response to induction|0|||
145680369|NCT00807599|525345668|FG002|Overall Study|Inadequate response to induction|9|||
145680370|NCT00807599|525345666|FG000|Overall Study|Withdrawal by Subject|0|||
145680371|NCT00807599|525345667|FG001|Overall Study|Withdrawal by Subject|0|||
145680372|NCT00807599|525345668|FG002|Overall Study|Withdrawal by Subject|1|||
145680373|NCT05376397|525345672|FG000|Overall Study|Lost to Follow-up|1|||
145680374|NCT01535261|525345673|FG000|Overall Study|Physician Decision|8|||
145680375|NCT01535261|525345673|FG000|Overall Study|Protocol Violation|3|||
145680376|NCT01535261|525345673|FG000|Overall Study|Death|5|||
145680377|NCT01535261|525345673|FG000|Overall Study|Lost to Follow-up|8|||
145680378|NCT01535261|525345673|FG000|Overall Study|Withdrawal by Subject|14|||
145680379|NCT01535261|525345673|FG000|Overall Study|Adverse Event|12|||
145680380|NCT02525744|525345677|FG000|Period 1|Physician Decision|0|||
145680381|NCT02525744|525345678|FG001|Period 1|Physician Decision|0|||
145680382|NCT02525744|525345679|FG002|Period 1|Physician Decision|1|||
145680383|NCT02525744|525345680|FG003|Period 1|Physician Decision|0|||
145680384|NCT02525744|525345677|FG000|Period 3|Adverse Event|0|||
145680385|NCT02525744|525345678|FG001|Period 3|Adverse Event|1|||
145680386|NCT02525744|525345679|FG002|Period 3|Adverse Event|0|||
145680387|NCT02525744|525345680|FG003|Period 3|Adverse Event|0|||
145680388|NCT02525744|525345677|FG000|Period 4|Withdrawal by Subject|1|||
145680389|NCT02525744|525345678|FG001|Period 4|Withdrawal by Subject|0|||
145680390|NCT02525744|525345679|FG002|Period 4|Withdrawal by Subject|0|||
145680391|NCT02525744|525345680|FG003|Period 4|Withdrawal by Subject|0|||
145680392|NCT02525744|525345677|FG000|Period 5|Physician Decision|1|||
145680393|NCT02525744|525345678|FG001|Period 5|Physician Decision|0|||
145680394|NCT02525744|525345679|FG002|Period 5|Physician Decision|0|||
145680395|NCT02525744|525345680|FG003|Period 5|Physician Decision|0|||
145680396|NCT00472082|525345681|FG000|Overall Study|Study prematurely terminated|5|||
145680397|NCT02069379|525345682|FG000|Baseline Measurements|Lost to Follow-up|1|||
145680398|NCT02069379|525345683|FG001|Baseline Measurements|Lost to Follow-up|0|||
145680399|NCT02069379|525345684|FG002|Baseline Measurements|Lost to Follow-up|0|||
145680400|NCT02069379|525345685|FG003|Baseline Measurements|Lost to Follow-up|0|||
145680401|NCT02069379|525345682|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
145680402|NCT02069379|525345683|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
145680403|NCT02069379|525345684|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
145680404|NCT02069379|525345685|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
145680405|NCT02069379|525345682|FG000|First Treatment Arm|Lost to Follow-up|0|||
145680406|NCT02069379|525345683|FG001|First Treatment Arm|Lost to Follow-up|1|||
145680407|NCT02069379|525345684|FG002|First Treatment Arm|Lost to Follow-up|1|||
145680408|NCT02069379|525345685|FG003|First Treatment Arm|Lost to Follow-up|0|||
145680409|NCT02069379|525345682|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
145680410|NCT02069379|525345683|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
145680411|NCT02069379|525345684|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
145680412|NCT02069379|525345685|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
145680413|NCT02069379|525345682|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
145680414|NCT02069379|525345683|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
145680415|NCT02069379|525345684|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
145680416|NCT02069379|525345685|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
145680417|NCT02069379|525345682|FG000|Second Treatment Arm|Lost to Follow-up|0|||
145680418|NCT02069379|525345683|FG001|Second Treatment Arm|Lost to Follow-up|0|||
145680419|NCT02069379|525345684|FG002|Second Treatment Arm|Lost to Follow-up|1|||
145680420|NCT02069379|525345685|FG003|Second Treatment Arm|Lost to Follow-up|0|||
145680421|NCT04421456|525345686|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
145680422|NCT04421456|525345687|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
145680423|NCT04421456|525345688|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
145680424|NCT04421456|525345686|FG000|Randomized Treatment Period|Adverse Event|0|||
145680425|NCT04421456|525345687|FG001|Randomized Treatment Period|Adverse Event|1|||
145680426|NCT04421456|525345688|FG002|Randomized Treatment Period|Adverse Event|0|||
145680427|NCT04421456|525345686|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
145680428|NCT04421456|525345687|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
145680429|NCT04421456|525345688|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
145680430|NCT04421456|525345686|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
145680431|NCT04421456|525345687|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
145680432|NCT04421456|525345688|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
145680433|NCT04421456|525345686|FG000|Randomized Treatment Period|Participant non-compliance|1|||
145680434|NCT04421456|525345687|FG001|Randomized Treatment Period|Participant non-compliance|1|||
145680435|NCT04421456|525345688|FG002|Randomized Treatment Period|Participant non-compliance|2|||
145680436|NCT04421456|525345686|FG000|Randomized Treatment Period|Other|0|||
145680437|NCT04421456|525345687|FG001|Randomized Treatment Period|Other|1|||
145680438|NCT04421456|525345688|FG002|Randomized Treatment Period|Other|3|||
145680439|NCT04617847|525345689|FG000|Overall Study|Withdrawal by Subject|1|||
145680440|NCT04617847|525345690|FG001|Overall Study|Withdrawal by Subject|0|||
145680441|NCT04617847|525345689|FG000|Overall Study|Adverse Event|0|||
145680442|NCT04617847|525345690|FG001|Overall Study|Adverse Event|2|||
145680443|NCT04617847|525345689|FG000|Overall Study|Death|0|||
145680444|NCT04617847|525345690|FG001|Overall Study|Death|1|||
145680445|NCT04617847|525345689|FG000|Overall Study|Termination of Study by Sponsor|2|||
145680446|NCT04617847|525345690|FG001|Overall Study|Termination of Study by Sponsor|21|||
145680447|NCT02206607|525345691|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
145680448|NCT02206607|525345692|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
145680449|NCT02206607|525345693|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
145680450|NCT02206607|525345694|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
145680451|NCT02206607|525345695|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
145680452|NCT02206607|525345691|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
145680453|NCT02206607|525345692|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
145680454|NCT02206607|525345693|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
145680455|NCT02206607|525345694|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
145680456|NCT02206607|525345695|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
145680457|NCT04183491|525345700|FG000|Overall Study|Withdrawal by Subject|0|||
145680458|NCT04183491|525345701|FG001|Overall Study|Withdrawal by Subject|0|||
145680459|NCT04183491|525345702|FG002|Overall Study|Withdrawal by Subject|1|||
145680460|NCT04183491|525345703|FG003|Overall Study|Withdrawal by Subject|0|||
145680461|NCT04183491|525345704|FG004|Overall Study|Withdrawal by Subject|0|||
145680462|NCT04183491|525345705|FG005|Overall Study|Withdrawal by Subject|1|||
145680463|NCT04183491|525345706|FG006|Overall Study|Withdrawal by Subject|0|||
145680464|NCT03989232|525345709|FG000|Overall Study|Lost to Follow-up|3|||
145680465|NCT03989232|525345710|FG001|Overall Study|Lost to Follow-up|10|||
145680466|NCT03989232|525345709|FG000|Overall Study|Withdrawal by Subject|6|||
145680467|NCT03989232|525345710|FG001|Overall Study|Withdrawal by Subject|6|||
145680468|NCT03989232|525345709|FG000|Overall Study|Death|1|||
145680469|NCT03989232|525345710|FG001|Overall Study|Death|2|||
145680470|NCT01930188|525345711|FG000|Overall Study|unclassified|4|||
145680471|NCT01930188|525345712|FG001|Overall Study|unclassified|5|||
145680472|NCT01930188|525345713|FG002|Overall Study|unclassified|3|||
145680473|NCT01930188|525345711|FG000|Overall Study|Missing follow-up information|2|||
145680474|NCT01930188|525345712|FG001|Overall Study|Missing follow-up information|2|||
145680475|NCT01930188|525345713|FG002|Overall Study|Missing follow-up information|3|||
145680476|NCT01930188|525345711|FG000|Overall Study|Lost to Follow-up|5|||
145680477|NCT01930188|525345712|FG001|Overall Study|Lost to Follow-up|2|||
145680478|NCT01930188|525345713|FG002|Overall Study|Lost to Follow-up|2|||
145680479|NCT01930188|525345711|FG000|Overall Study|Death|2|||
145680480|NCT01930188|525345712|FG001|Overall Study|Death|1|||
145680481|NCT01930188|525345713|FG002|Overall Study|Death|3|||
145680482|NCT01930188|525345711|FG000|Overall Study|Withdrawal by Subject|9|||
145680483|NCT01930188|525345712|FG001|Overall Study|Withdrawal by Subject|11|||
145680484|NCT01930188|525345713|FG002|Overall Study|Withdrawal by Subject|8|||
145680485|NCT00337610|525345716|FG000|Overall Study|Adverse Event|2|||
145680486|NCT00337610|525345717|FG001|Overall Study|Adverse Event|2|||
145680487|NCT00337610|525345716|FG000|Overall Study|Death|0|||
145680488|NCT00337610|525345717|FG001|Overall Study|Death|1|||
145680489|NCT00337610|525345716|FG000|Overall Study|Lack of Efficacy|6|||
145680490|NCT00337610|525345717|FG001|Overall Study|Lack of Efficacy|3|||
145680491|NCT00337610|525345716|FG000|Overall Study|Lost to Follow-up|3|||
145680492|NCT00337610|525345717|FG001|Overall Study|Lost to Follow-up|3|||
145680493|NCT00337610|525345716|FG000|Overall Study|Withdrawal by Subject|6|||
145680494|NCT00337610|525345717|FG001|Overall Study|Withdrawal by Subject|5|||
145680495|NCT01681511|525345720|FG000|Overall Study|No Treatment Received|1|||
145680496|NCT01681511|525345721|FG001|Overall Study|No Treatment Received|3|||
145680497|NCT01681511|525345720|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
145680498|NCT01681511|525345721|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
145680499|NCT01681511|525345720|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
145680500|NCT01681511|525345721|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
145680501|NCT01681511|525345720|FG000|Overall Study|No Daily Urine Sample Collected|0|||
145680502|NCT01681511|525345721|FG001|Overall Study|No Daily Urine Sample Collected|1|||
145680503|NCT01681511|525345720|FG000|Overall Study|No post-catheter sample collected|11|||
145680504|NCT01681511|525345721|FG001|Overall Study|No post-catheter sample collected|4|||
145680505|NCT01156675|525345722|FG000|Overall Study|Death|5|||
145680506|NCT01156675|525345723|FG001|Overall Study|Death|3|||
145680507|NCT01156675|525345724|FG002|Overall Study|Death|0|||
145680508|NCT01156675|525345722|FG000|Overall Study|No data|29|||
145680509|NCT01156675|525345723|FG001|Overall Study|No data|22|||
145680510|NCT01156675|525345724|FG002|Overall Study|No data|2|||
145680511|NCT02807857|525345725|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
145680512|NCT02807857|525345725|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
145680513|NCT02807857|525345725|FG000|Follow-Up Set|Withdrawal by Subject|8|||
145680514|NCT02807857|525345725|FG000|Follow-Up Set|Lost to Follow-up|7|||
145680515|NCT02807857|525345725|FG000|Follow-Up Set|Physician Decision|6|||
145680516|NCT02807857|525345725|FG000|Follow-Up Set|Adverse Event|3|||
145680517|NCT02807857|525345725|FG000|Follow-Up Set|Death|27|||
145680518|NCT02807857|525345725|FG000|Follow-Up Set|Relocation|2|||
145680519|NCT01240590|525345726|FG000|Phase I|Refused further treatment|0|||
145680520|NCT01240590|525345727|FG001|Phase I|Refused further treatment|0|||
145680521|NCT01240590|525345728|FG002|Phase I|Refused further treatment|3|||
145680522|NCT01240590|525345729|FG003|Phase I|Refused further treatment|0|||
145680523|NCT01240590|525345730|FG004|Phase I|Refused further treatment|0|||
145680524|NCT01240590|525345726|FG000|Phase II|Refused further treatment|0|||
145680525|NCT01240590|525345727|FG001|Phase II|Refused further treatment|0|||
145680526|NCT01240590|525345728|FG002|Phase II|Refused further treatment|0|||
145680527|NCT01240590|525345729|FG003|Phase II|Refused further treatment|2|||
145680528|NCT01240590|525345730|FG004|Phase II|Refused further treatment|1|||
145680529|NCT01075152|525345732|FG000|Overall Study|Withdrawal by Subject|1|||
145680530|NCT01075152|525345733|FG001|Overall Study|Withdrawal by Subject|0|||
145680531|NCT01079949|525345734|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
145680532|NCT01079949|525345735|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
145680533|NCT01079949|525345734|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
145680534|NCT01079949|525345735|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
145680535|NCT01079949|525345734|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
145680536|NCT01079949|525345735|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
145680537|NCT01079949|525345734|FG000|Overall Study|Randomized but not treated|1|||
145680538|NCT01079949|525345735|FG001|Overall Study|Randomized but not treated|0|||
145680539|NCT02144285|525345736|FG000|Overall Study|Withdrawal by Subject|0|||
145680540|NCT02144285|525345737|FG001|Overall Study|Withdrawal by Subject|0|||
145680541|NCT02144285|525345738|FG002|Overall Study|Withdrawal by Subject|0|||
145680542|NCT02144285|525345739|FG003|Overall Study|Withdrawal by Subject|0|||
145680543|NCT02144285|525345740|FG004|Overall Study|Withdrawal by Subject|1|||
145680544|NCT02144285|525345741|FG005|Overall Study|Withdrawal by Subject|0|||
145680545|NCT02144285|525345742|FG006|Overall Study|Withdrawal by Subject|0|||
145680546|NCT02144285|525345743|FG007|Overall Study|Withdrawal by Subject|0|||
145680547|NCT02144285|525345744|FG008|Overall Study|Withdrawal by Subject|0|||
145680548|NCT02144285|525345745|FG009|Overall Study|Withdrawal by Subject|0|||
145680549|NCT01529632|525345746|FG000|Overall Study|Administrative problem|2|||
145680550|NCT01529632|525345747|FG001|Overall Study|Administrative problem|1|||
145680551|NCT01529632|525345746|FG000|Overall Study|Protocol Violation|0|||
145680552|NCT01529632|525345747|FG001|Overall Study|Protocol Violation|1|||
145680553|NCT01529632|525345746|FG000|Overall Study|Adverse Event|1|||
145680554|NCT01529632|525345747|FG001|Overall Study|Adverse Event|1|||
145680555|NCT00452452|525345748|FG000|Overall Study|Protocol Violation|0|||
145680556|NCT00452452|525345749|FG001|Overall Study|Protocol Violation|0|||
145680557|NCT00452452|525345750|FG002|Overall Study|Protocol Violation|1|||
145680558|NCT00452452|525345748|FG000|Overall Study|Withdrawal by Subject|1|||
145680559|NCT00452452|525345749|FG001|Overall Study|Withdrawal by Subject|0|||
145680560|NCT00452452|525345750|FG002|Overall Study|Withdrawal by Subject|0|||
145680561|NCT00452452|525345748|FG000|Overall Study|Lost to Follow-up|1|||
145680562|NCT00452452|525345749|FG001|Overall Study|Lost to Follow-up|0|||
145680563|NCT00452452|525345750|FG002|Overall Study|Lost to Follow-up|0|||
145680564|NCT05184062|525345751|FG000|Overall Study|Lost to Follow-up|5|||
145680565|NCT05184062|525345752|FG001|Overall Study|Lost to Follow-up|1|||
145680566|NCT05184062|525345751|FG000|Overall Study|Withdrawal by Subject|1|||
145680567|NCT05184062|525345752|FG001|Overall Study|Withdrawal by Subject|0|||
145680568|NCT05522777|525347244|FG000|Overall Study|Lack of Efficacy|1|||
145680569|NCT05522777|525347244|FG000|Overall Study|Withdrawal by Subject|1|||
145680570|NCT02196259|525347247|FG000|Overall Study|Researcher choice|0|||
145680571|NCT02196259|525347248|FG001|Overall Study|Researcher choice|0|||
145680572|NCT02196259|525347249|FG002|Overall Study|Researcher choice|1|||
145680573|NCT02196259|525347247|FG000|Overall Study|Partial data analysis|0|||
145680574|NCT02196259|525347248|FG001|Overall Study|Partial data analysis|3|||
145680575|NCT02196259|525347249|FG002|Overall Study|Partial data analysis|0|||
145680576|NCT02164578|525347250|FG000|Treatment Period|Withdrawal by Subject|3|||
145680577|NCT02164578|525347251|FG001|Treatment Period|Withdrawal by Subject|3|||
145680578|NCT02164578|525347250|FG000|Treatment Period|Adverse Event|13|||
145680579|NCT02164578|525347251|FG001|Treatment Period|Adverse Event|6|||
145680580|NCT02164578|525347250|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
145680581|NCT02164578|525347251|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
145680582|NCT02164578|525347250|FG000|Treatment Period|Protocol Violation|0|||
145680583|NCT02164578|525347251|FG001|Treatment Period|Protocol Violation|2|||
145680584|NCT02164578|525347250|FG000|Extension Period|Withdrawal by Subject|2|||
145680585|NCT02164578|525347251|FG001|Extension Period|Withdrawal by Subject|0|||
145680586|NCT02164578|525347250|FG000|Extension Period|Adverse Event|4|||
145680587|NCT02164578|525347251|FG001|Extension Period|Adverse Event|0|||
145680588|NCT02164578|525347250|FG000|Extension Period|Expiry of study medication|1|||
145680589|NCT02164578|525347251|FG001|Extension Period|Expiry of study medication|0|||
145680590|NCT02164578|525347250|FG000|Extension Period|Protocol Violation|0|||
145680591|NCT02164578|525347251|FG001|Extension Period|Protocol Violation|1|||
145680592|NCT01241448|525347252|FG000|Overall Study|Adverse Event|1|||
145680593|NCT01241448|525347253|FG001|Overall Study|Adverse Event|0|||
145680594|NCT01241448|525347254|FG002|Overall Study|Adverse Event|2|||
145680595|NCT01241448|525347255|FG003|Overall Study|Adverse Event|2|||
145680596|NCT01241448|525347252|FG000|Overall Study|Lost to Follow-up|2|||
145680597|NCT01241448|525347253|FG001|Overall Study|Lost to Follow-up|1|||
145680598|NCT01241448|525347254|FG002|Overall Study|Lost to Follow-up|1|||
145680599|NCT01241448|525347255|FG003|Overall Study|Lost to Follow-up|1|||
145680600|NCT01241448|525347252|FG000|Overall Study|Physician Decision|0|||
145680601|NCT01241448|525347253|FG001|Overall Study|Physician Decision|2|||
145680602|NCT01241448|525347254|FG002|Overall Study|Physician Decision|0|||
145680603|NCT01241448|525347255|FG003|Overall Study|Physician Decision|0|||
145680604|NCT01241448|525347252|FG000|Overall Study|Protocol Violation|10|||
145680605|NCT01241448|525347253|FG001|Overall Study|Protocol Violation|5|||
145680606|NCT01241448|525347254|FG002|Overall Study|Protocol Violation|3|||
145680607|NCT01241448|525347255|FG003|Overall Study|Protocol Violation|6|||
145680608|NCT01241448|525347252|FG000|Overall Study|Sponsor Decision|17|||
145680609|NCT01241448|525347253|FG001|Overall Study|Sponsor Decision|14|||
145680610|NCT01241448|525347254|FG002|Overall Study|Sponsor Decision|12|||
145680611|NCT01241448|525347255|FG003|Overall Study|Sponsor Decision|6|||
145680612|NCT01241448|525347252|FG000|Overall Study|Withdrawal by Subject|4|||
145680613|NCT01241448|525347253|FG001|Overall Study|Withdrawal by Subject|5|||
145680614|NCT01241448|525347254|FG002|Overall Study|Withdrawal by Subject|3|||
145680615|NCT01241448|525347255|FG003|Overall Study|Withdrawal by Subject|6|||
145680616|NCT01241448|525347252|FG000|Overall Study|Excluded due to data integrity issues|3|||
145680617|NCT01241448|525347253|FG001|Overall Study|Excluded due to data integrity issues|2|||
145680618|NCT01241448|525347254|FG002|Overall Study|Excluded due to data integrity issues|2|||
145680619|NCT01241448|525347255|FG003|Overall Study|Excluded due to data integrity issues|2|||
145680620|NCT03340961|525347256|FG000|Overall Study|Adverse Event|1|||
145680621|NCT03340961|525347257|FG001|Overall Study|Adverse Event|3|||
145680622|NCT03340961|525347258|FG002|Overall Study|Adverse Event|2|||
145680623|NCT03340961|525347259|FG003|Overall Study|Adverse Event|4|||
145680624|NCT03340961|525347256|FG000|Overall Study|Lost to Follow-up|0|||
145680625|NCT03340961|525347257|FG001|Overall Study|Lost to Follow-up|1|||
145680626|NCT03340961|525347258|FG002|Overall Study|Lost to Follow-up|0|||
145680627|NCT03340961|525347259|FG003|Overall Study|Lost to Follow-up|1|||
145680628|NCT03340961|525347256|FG000|Overall Study|Withdrawal by Subject|3|||
145680629|NCT03340961|525347257|FG001|Overall Study|Withdrawal by Subject|2|||
145680630|NCT03340961|525347258|FG002|Overall Study|Withdrawal by Subject|4|||
145680631|NCT03340961|525347259|FG003|Overall Study|Withdrawal by Subject|7|||
145680632|NCT03340961|525347256|FG000|Overall Study|Use of prohibited treatment|0|||
145680633|NCT03340961|525347257|FG001|Overall Study|Use of prohibited treatment|3|||
145680634|NCT03340961|525347258|FG002|Overall Study|Use of prohibited treatment|2|||
145680635|NCT03340961|525347259|FG003|Overall Study|Use of prohibited treatment|4|||
145680636|NCT03340961|525347256|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
145680637|NCT03340961|525347257|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
145680638|NCT03340961|525347258|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
145680639|NCT03340961|525347259|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
145680640|NCT03340961|525347256|FG000|Overall Study|Subject developed an exclusion criterion|0|||
145680641|NCT03340961|525347257|FG001|Overall Study|Subject developed an exclusion criterion|1|||
145680642|NCT03340961|525347258|FG002|Overall Study|Subject developed an exclusion criterion|0|||
145680643|NCT03340961|525347259|FG003|Overall Study|Subject developed an exclusion criterion|0|||
145680644|NCT03340961|525347256|FG000|Overall Study|Protocol Violation|1|||
145680645|NCT03340961|525347257|FG001|Overall Study|Protocol Violation|0|||
145680646|NCT03340961|525347258|FG002|Overall Study|Protocol Violation|1|||
145680647|NCT03340961|525347259|FG003|Overall Study|Protocol Violation|0|||
145680648|NCT03340961|525347256|FG000|Overall Study|Adverse Event|1|||
145680649|NCT03340961|525347257|FG001|Overall Study|Adverse Event|1|||
145680650|NCT03340961|525347258|FG002|Overall Study|Adverse Event|0|||
145680651|NCT03340961|525347259|FG003|Overall Study|Adverse Event|0|||
145680652|NCT03340961|525347256|FG000|Overall Study|Lack of Efficacy|0|||
145680653|NCT03340961|525347257|FG001|Overall Study|Lack of Efficacy|0|||
145680654|NCT03340961|525347258|FG002|Overall Study|Lack of Efficacy|0|||
145680655|NCT03340961|525347259|FG003|Overall Study|Lack of Efficacy|1|||
145680656|NCT04311983|525347260|FG000|Overall Study|Lost to Follow-up|421|||
145680657|NCT04311983|525347261|FG001|Overall Study|Lost to Follow-up|456|||
145680658|NCT04311983|525347260|FG000|Overall Study|Incomplete survey|7|||
145680659|NCT04311983|525347261|FG001|Overall Study|Incomplete survey|9|||
145680660|NCT04311983|525347260|FG000|Overall Study|Death|1|||
145680661|NCT04311983|525347261|FG001|Overall Study|Death|0|||
145680662|NCT02165202|525347267|FG000|Oral Phase|Refused further participation|5|||
145680663|NCT02165202|525347268|FG001|Oral Phase|Refused further participation|1|||
145680664|NCT02165202|525347267|FG000|Oral Phase|Study product Related Toxicity|1|||
145680665|NCT02165202|525347268|FG001|Oral Phase|Study product Related Toxicity|0|||
145680666|NCT02165202|525347267|FG000|Oral Phase|Unable to contact Participant|1|||
145680667|NCT02165202|525347268|FG001|Oral Phase|Unable to contact Participant|1|||
145680668|NCT02165202|525347267|FG000|Oral Phase|Clinical reasons|1|||
145680669|NCT02165202|525347268|FG001|Oral Phase|Clinical reasons|0|||
145680670|NCT02165202|525347267|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
145680671|NCT02165202|525347268|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
145680672|NCT02165202|525347267|FG000|Oral Phase|CMC advised termination|1|||
145680673|NCT02165202|525347268|FG001|Oral Phase|CMC advised termination|0|||
145680674|NCT02165202|525347267|FG000|Oral Phase|Relocated, no follow-up planned|1|||
145680675|NCT02165202|525347268|FG001|Oral Phase|Relocated, no follow-up planned|0|||
145680676|NCT02165202|525347267|FG000|Oral Phase|Abnormal EKG|0|||
145680677|NCT02165202|525347268|FG001|Oral Phase|Abnormal EKG|1|||
145680678|NCT02165202|525347267|FG000|Injection Phase|Abnormal Lab Value|5|||
145680679|NCT02165202|525347268|FG001|Injection Phase|Abnormal Lab Value|1|||
145680680|NCT02165202|525347267|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
145680681|NCT02165202|525347268|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
145680682|NCT02165202|525347267|FG000|Injection Phase|Unable to attend within Visit Window|1|||
145680683|NCT02165202|525347268|FG001|Injection Phase|Unable to attend within Visit Window|0|||
145680684|NCT02165202|525347267|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
145680685|NCT02165202|525347268|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
145680686|NCT02165202|525347267|FG000|Injection Phase|End of Study|2|||
145680687|NCT02165202|525347268|FG001|Injection Phase|End of Study|1|||
145680688|NCT02165202|525347267|FG000|Injection Phase|Study Product related Toxicity|1|||
145680689|NCT02165202|525347268|FG001|Injection Phase|Study Product related Toxicity|0|||
145680690|NCT02165202|525347267|FG000|Injection Phase|No longer interested|0|||
145680691|NCT02165202|525347268|FG001|Injection Phase|No longer interested|1|||
145680692|NCT02165202|525347267|FG000|Injection Phase|Participant unwilling to comply|1|||
145680693|NCT02165202|525347268|FG001|Injection Phase|Participant unwilling to comply|0|||
145680694|NCT00990184|525347274|FG000|Overall Study|Physician Decision|1|||
145680695|NCT01975701|525347277|FG000|Overall Study|Lost to Follow-up|1|||
145680696|NCT01975701|525347277|FG000|Overall Study|Death|23|||
145680697|NCT01975701|525347277|FG000|Overall Study|Physician Decision|1|||
145680698|NCT02753075|525347278|FG000|Overall Study|Adverse Event|2|||
145680699|NCT02753075|525347279|FG001|Overall Study|Adverse Event|1|||
145680700|NCT02753075|525347280|FG002|Overall Study|Adverse Event|0|||
145680701|NCT02753075|525347278|FG000|Overall Study|Lost to Follow-up|2|||
145680702|NCT02753075|525347279|FG001|Overall Study|Lost to Follow-up|0|||
145680703|NCT02753075|525347280|FG002|Overall Study|Lost to Follow-up|0|||
145680704|NCT02753075|525347278|FG000|Overall Study|Withdrawal of Consent|1|||
145680705|NCT02753075|525347279|FG001|Overall Study|Withdrawal of Consent|1|||
145680706|NCT02753075|525347280|FG002|Overall Study|Withdrawal of Consent|3|||
145680707|NCT02753075|525347278|FG000|Overall Study|Physician Decision|3|||
145680708|NCT02753075|525347279|FG001|Overall Study|Physician Decision|1|||
145680709|NCT02753075|525347280|FG002|Overall Study|Physician Decision|0|||
145680710|NCT02152384|525347283|FG000|Period 1|Withdrawal by Subject|0|||
145680711|NCT02152384|525347284|FG001|Period 1|Withdrawal by Subject|1|||
145680712|NCT02152384|525347283|FG000|Period 1|Adverse Event|1|||
145680713|NCT02152384|525347284|FG001|Period 1|Adverse Event|1|||
145680714|NCT02446015|525347285|FG000|Overall Study|Adverse Event|0|||
145680715|NCT02446015|525347286|FG001|Overall Study|Adverse Event|1|||
145680716|NCT02446015|525347285|FG000|Overall Study|Withdrawal by Subject|1|||
145680717|NCT02446015|525347286|FG001|Overall Study|Withdrawal by Subject|0|||
145680718|NCT00603798|525347287|FG000|Overall Study|Adverse Event|4|||
145680719|NCT00603798|525347288|FG001|Overall Study|Adverse Event|2|||
145680720|NCT00603798|525347289|FG002|Overall Study|Adverse Event|1|||
145680721|NCT00603798|525347287|FG000|Overall Study|Withdrawal by Subject|4|||
145680722|NCT00603798|525347288|FG001|Overall Study|Withdrawal by Subject|3|||
145680723|NCT00603798|525347289|FG002|Overall Study|Withdrawal by Subject|4|||
145680724|NCT00603798|525347287|FG000|Overall Study|Lost to Follow-up|1|||
145680725|NCT00603798|525347288|FG001|Overall Study|Lost to Follow-up|0|||
145680726|NCT00603798|525347289|FG002|Overall Study|Lost to Follow-up|1|||
145680727|NCT00603798|525347287|FG000|Overall Study|Non-compliance with study procedures|0|||
145680728|NCT00603798|525347288|FG001|Overall Study|Non-compliance with study procedures|1|||
145680729|NCT00603798|525347289|FG002|Overall Study|Non-compliance with study procedures|0|||
145680730|NCT00603798|525347287|FG000|Overall Study|Not due to AE|1|||
145680731|NCT00603798|525347288|FG001|Overall Study|Not due to AE|1|||
145680732|NCT00603798|525347289|FG002|Overall Study|Not due to AE|4|||
145680733|NCT03695185|525347294|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
145680734|NCT03695185|525347294|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
145680735|NCT03695185|525347294|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
145680736|NCT03695185|525347294|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
145680737|NCT03695185|525347294|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
145680738|NCT03695185|525347294|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
145680739|NCT01670877|525347295|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
145680740|NCT01670877|525347296|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
145680741|NCT01670877|525347297|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
145680742|NCT01670877|525347298|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
145680743|NCT01670877|525347299|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
145680744|NCT01670877|525347300|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
145680745|NCT01670877|525347295|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
145680746|NCT01670877|525347296|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
145680747|NCT01670877|525347297|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
145680748|NCT01670877|525347298|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
145680749|NCT01670877|525347299|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
145680750|NCT01670877|525347300|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
145680751|NCT01670877|525347295|FG000|Part I and Part 2|Grade 2 vomiting|0|||
145680752|NCT01670877|525347296|FG001|Part I and Part 2|Grade 2 vomiting|0|||
145680753|NCT01670877|525347297|FG002|Part I and Part 2|Grade 2 vomiting|0|||
145680754|NCT01670877|525347298|FG003|Part I and Part 2|Grade 2 vomiting|1|||
145680755|NCT01670877|525347299|FG004|Part I and Part 2|Grade 2 vomiting|0|||
145680756|NCT01670877|525347300|FG005|Part I and Part 2|Grade 2 vomiting|0|||
145680757|NCT01670877|525347295|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145680758|NCT01670877|525347296|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145680759|NCT01670877|525347297|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145680760|NCT01670877|525347298|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
145680761|NCT01670877|525347299|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145680762|NCT01670877|525347300|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
145680763|NCT01670877|525347295|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145680764|NCT01670877|525347296|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145680765|NCT01670877|525347297|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145491075|NCT01384734|524652350|FG002|Overall Study|Withdrawal by Subject|6|||
145680766|NCT01670877|525347298|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
145680767|NCT01670877|525347299|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145680768|NCT01670877|525347300|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
145680769|NCT00417885|525347301|FG000|Overall Study|Adverse Event|1|||
145680770|NCT00417885|525347301|FG000|Overall Study|Objective Progression or Relapse|3|||
145680771|NCT00417885|525347301|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
145680772|NCT01137682|525347304|FG000|Overall Study|Adverse Event-CORE|2|||
145680773|NCT01137682|525347305|FG001|Overall Study|Adverse Event-CORE|4|||
145680774|NCT01137682|525347306|FG002|Overall Study|Adverse Event-CORE|0|||
145680775|NCT01137682|525347304|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
145680776|NCT01137682|525347305|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
145680777|NCT01137682|525347306|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
145680778|NCT01137682|525347304|FG000|Overall Study|Administrative problems-CORE|2|||
145680779|NCT01137682|525347305|FG001|Overall Study|Administrative problems-CORE|1|||
145680780|NCT01137682|525347306|FG002|Overall Study|Administrative problems-CORE|0|||
145680781|NCT01137682|525347304|FG000|Overall Study|Protocol Violation-CORE|0|||
145680782|NCT01137682|525347305|FG001|Overall Study|Protocol Violation-CORE|1|||
145680783|NCT01137682|525347306|FG002|Overall Study|Protocol Violation-CORE|1|||
145680784|NCT01137682|525347304|FG000|Overall Study|Adverse Event-Extension|4|||
145680785|NCT01137682|525347305|FG001|Overall Study|Adverse Event-Extension|8|||
145680786|NCT01137682|525347306|FG002|Overall Study|Adverse Event-Extension|7|||
145680787|NCT01137682|525347304|FG000|Overall Study|Lack of Efficacy-Extension|15|||
145680788|NCT01137682|525347305|FG001|Overall Study|Lack of Efficacy-Extension|9|||
145680789|NCT01137682|525347306|FG002|Overall Study|Lack of Efficacy-Extension|13|||
145680790|NCT01137682|525347304|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
145680791|NCT01137682|525347305|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
145680792|NCT01137682|525347306|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
145680793|NCT01137682|525347304|FG000|Overall Study|Lost to Follow Up-Extension|0|||
145680794|NCT01137682|525347305|FG001|Overall Study|Lost to Follow Up-Extension|1|||
145680795|NCT01137682|525347306|FG002|Overall Study|Lost to Follow Up-Extension|0|||
145680796|NCT01137682|525347304|FG000|Overall Study|Administrative problems-Extension|0|||
145680797|NCT01137682|525347305|FG001|Overall Study|Administrative problems-Extension|2|||
145680798|NCT01137682|525347306|FG002|Overall Study|Administrative problems-Extension|0|||
145680799|NCT01137682|525347304|FG000|Overall Study|Death-Extension|2|||
145680800|NCT01137682|525347305|FG001|Overall Study|Death-Extension|0|||
145680801|NCT01137682|525347306|FG002|Overall Study|Death-Extension|0|||
145680802|NCT01137682|525347304|FG000|Overall Study|Protocol Violation-Extension|2|||
145680803|NCT01137682|525347305|FG001|Overall Study|Protocol Violation-Extension|1|||
145680804|NCT01137682|525347306|FG002|Overall Study|Protocol Violation-Extension|0|||
145680805|NCT01137682|525347304|FG000|Overall Study|Did not enter extension|2|||
145680806|NCT01137682|525347305|FG001|Overall Study|Did not enter extension|3|||
145680807|NCT01137682|525347306|FG002|Overall Study|Did not enter extension|2|||
145680808|NCT01137682|525347304|FG000|Overall Study|Did not receive treatment in extension|0|||
145680809|NCT01137682|525347305|FG001|Overall Study|Did not receive treatment in extension|0|||
145680810|NCT01137682|525347306|FG002|Overall Study|Did not receive treatment in extension|1|||
145680811|NCT02009332|525347309|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
145680812|NCT02009332|525347310|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
145680813|NCT02009332|525347311|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
145680814|NCT02009332|525347312|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
145680815|NCT02009332|525347313|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
145680816|NCT02009332|525347314|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
145680817|NCT02009332|525347309|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
145680818|NCT02009332|525347310|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
145680819|NCT02009332|525347311|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
145680820|NCT02009332|525347312|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
145680821|NCT02009332|525347313|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
145680822|NCT02009332|525347314|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
145680823|NCT02009332|525347309|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
145680824|NCT02009332|525347310|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
145680825|NCT02009332|525347311|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
145680826|NCT02009332|525347312|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
145680827|NCT02009332|525347313|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
145680828|NCT02009332|525347314|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
145680829|NCT01912599|525347316|FG000|Overall Study|Withdrawal by Subject|0|||
145680830|NCT01912599|525347317|FG001|Overall Study|Withdrawal by Subject|1|||
145680831|NCT03449979|525347324|FG000|Overall Study|Technical difficulty|0|||
145491076|NCT01384734|524652351|FG003|Overall Study|Withdrawal by Subject|7|||
145680832|NCT03449979|525347325|FG001|Overall Study|Technical difficulty|0|||
145680833|NCT03449979|525347326|FG002|Overall Study|Technical difficulty|0|||
145680834|NCT03449979|525347327|FG003|Overall Study|Technical difficulty|1|||
145680835|NCT00068107|525347329|FG000|Overall Study|end-stage renal disease|6|||
145680836|NCT00068107|525347329|FG000|Overall Study|Death|2|||
145680837|NCT00068107|525347329|FG000|Overall Study|Withdrawal by Subject|1|||
145680838|NCT03288506|525347330|FG000|Overall Study|Withdrawal by Subject|52|||
145680839|NCT02644122|525347334|FG000|Overall Study|Withdrawal by Subject|1|||
145680840|NCT04867382|525347337|FG000|Overall Study|Did not complete the survey|2|||
145680841|NCT04867382|525347338|FG001|Overall Study|Did not complete the survey|1|||
145680842|NCT02102724|525347343|FG000|Overall Study|Lost to Follow-up|1|||
145680843|NCT02102724|525347344|FG001|Overall Study|Lost to Follow-up|0|||
145680844|NCT02102724|525347343|FG000|Overall Study|surgery for brain aneurysm|1|||
145680845|NCT02102724|525347344|FG001|Overall Study|surgery for brain aneurysm|1|||
145680846|NCT02203513|525347348|FG000|Overall Study|Refused further treatment|2|||
145680847|NCT02203513|525347349|FG001|Overall Study|Refused further treatment|0|||
145680848|NCT02203513|525347350|FG002|Overall Study|Refused further treatment|1|||
145680849|NCT02203513|525347351|FG003|Overall Study|Refused further treatment|0|||
145680850|NCT02203513|525347352|FG004|Overall Study|Refused further treatment|0|||
145680851|NCT02203513|525347348|FG000|Overall Study|Switched to alternative treatment|3|||
145680852|NCT02203513|525347349|FG001|Overall Study|Switched to alternative treatment|4|||
145680853|NCT02203513|525347350|FG002|Overall Study|Switched to alternative treatment|0|||
145680854|NCT02203513|525347351|FG003|Overall Study|Switched to alternative treatment|0|||
145680855|NCT02203513|525347352|FG004|Overall Study|Switched to alternative treatment|4|||
145680856|NCT02203513|525347348|FG000|Overall Study|Did not receive investigational product (IP)|0|||
145680857|NCT02203513|525347349|FG001|Overall Study|Did not receive investigational product (IP)|1|||
145680858|NCT02203513|525347350|FG002|Overall Study|Did not receive investigational product (IP)|0|||
145680859|NCT02203513|525347351|FG003|Overall Study|Did not receive investigational product (IP)|0|||
145680860|NCT02203513|525347352|FG004|Overall Study|Did not receive investigational product (IP)|0|||
145680861|NCT02203513|525347348|FG000|Overall Study|Death (unrelated to study therapy)|1|||
145680862|NCT02203513|525347349|FG001|Overall Study|Death (unrelated to study therapy)|3|||
145680863|NCT02203513|525347350|FG002|Overall Study|Death (unrelated to study therapy)|1|||
145680864|NCT02203513|525347351|FG003|Overall Study|Death (unrelated to study therapy)|0|||
145680865|NCT02203513|525347352|FG004|Overall Study|Death (unrelated to study therapy)|2|||
145680866|NCT02203513|525347348|FG000|Overall Study|Lost to Follow-up|0|||
145680867|NCT02203513|525347349|FG001|Overall Study|Lost to Follow-up|0|||
145680868|NCT02203513|525347350|FG002|Overall Study|Lost to Follow-up|1|||
145680869|NCT02203513|525347351|FG003|Overall Study|Lost to Follow-up|1|||
145680870|NCT02203513|525347352|FG004|Overall Study|Lost to Follow-up|0|||
145680871|NCT01441596|525347353|FG000|Overall Study|Other reason not defined below|0|||
145680872|NCT01441596|525347354|FG001|Overall Study|Other reason not defined below|2|||
145680873|NCT01441596|525347355|FG002|Overall Study|Other reason not defined below|1|||
145680874|NCT01441596|525347353|FG000|Overall Study|Withdrawal by Subject|4|||
145680875|NCT01441596|525347354|FG001|Overall Study|Withdrawal by Subject|0|||
145680876|NCT01441596|525347355|FG002|Overall Study|Withdrawal by Subject|2|||
145680877|NCT01441596|525347353|FG000|Overall Study|Not treated|0|||
145680878|NCT01441596|525347354|FG001|Overall Study|Not treated|1|||
145680879|NCT01441596|525347355|FG002|Overall Study|Not treated|1|||
145680880|NCT02008916|525347356|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
145680881|NCT02008916|525347357|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
145680882|NCT02008916|525347358|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
145680883|NCT02008916|525347356|FG000|Week 16 - 156|Adverse Event|4|||
145680884|NCT02008916|525347357|FG001|Week 16 - 156|Adverse Event|2|||
145680885|NCT02008916|525347358|FG002|Week 16 - 156|Adverse Event|3|||
145680886|NCT02008916|525347356|FG000|Week 16 - 156|Withdrawal by Subject|7|||
145680887|NCT02008916|525347357|FG001|Week 16 - 156|Withdrawal by Subject|3|||
145680888|NCT02008916|525347358|FG002|Week 16 - 156|Withdrawal by Subject|5|||
145680889|NCT02008916|525347356|FG000|Week 16 - 156|No longer requires treatment|0|||
145680890|NCT02008916|525347357|FG001|Week 16 - 156|No longer requires treatment|1|||
145680891|NCT02008916|525347358|FG002|Week 16 - 156|No longer requires treatment|0|||
145680892|NCT02008916|525347356|FG000|Week 16 - 156|Lost to Follow-up|5|||
145680893|NCT02008916|525347357|FG001|Week 16 - 156|Lost to Follow-up|0|||
145680894|NCT02008916|525347358|FG002|Week 16 - 156|Lost to Follow-up|0|||
145680895|NCT02008916|525347356|FG000|Week 16 - 156|Lack of Efficacy|3|||
145680896|NCT02008916|525347357|FG001|Week 16 - 156|Lack of Efficacy|5|||
145680897|NCT02008916|525347358|FG002|Week 16 - 156|Lack of Efficacy|2|||
145680898|NCT02008916|525347356|FG000|Week 16 - 156|Pregnancy|0|||
145680899|NCT02008916|525347357|FG001|Week 16 - 156|Pregnancy|1|||
145680900|NCT02008916|525347358|FG002|Week 16 - 156|Pregnancy|0|||
145680901|NCT02008916|525347356|FG000|Week 16 - 156|Physician Decision|0|||
145680902|NCT02008916|525347357|FG001|Week 16 - 156|Physician Decision|1|||
145680903|NCT02008916|525347358|FG002|Week 16 - 156|Physician Decision|0|||
145680904|NCT01528605|525347359|FG000|Overall Study|Lost to Follow-up|1|||
145680905|NCT01528605|525347360|FG001|Overall Study|Lost to Follow-up|0|||
145680906|NCT01528605|525347361|FG002|Overall Study|Lost to Follow-up|1|||
145680907|NCT01528605|525347362|FG003|Overall Study|Lost to Follow-up|1|||
145680908|NCT01528605|525347363|FG004|Overall Study|Lost to Follow-up|0|||
145680909|NCT01528605|525347364|FG005|Overall Study|Lost to Follow-up|0|||
145680910|NCT01528605|525347359|FG000|Overall Study|Death|1|||
145680911|NCT01528605|525347360|FG001|Overall Study|Death|0|||
145680912|NCT01528605|525347361|FG002|Overall Study|Death|0|||
145680913|NCT01528605|525347362|FG003|Overall Study|Death|0|||
145680914|NCT01528605|525347363|FG004|Overall Study|Death|0|||
145680915|NCT01528605|525347364|FG005|Overall Study|Death|0|||
145680916|NCT02432274|525347378|FG000|Overall Study|Death|2|||
145680917|NCT02432274|525347379|FG001|Overall Study|Death|6|||
145680918|NCT02432274|525347380|FG002|Overall Study|Death|7|||
145680919|NCT02432274|525347381|FG003|Overall Study|Death|0|||
145680920|NCT02432274|525347382|FG004|Overall Study|Death|27|||
145680921|NCT02432274|525347383|FG005|Overall Study|Death|7|||
145680922|NCT02432274|525347384|FG006|Overall Study|Death|9|||
145680923|NCT02432274|525347385|FG007|Overall Study|Death|14|||
145680924|NCT02432274|525347378|FG000|Overall Study|Withdrawal of Consent|0|||
145680925|NCT02432274|525347379|FG001|Overall Study|Withdrawal of Consent|0|||
145680926|NCT02432274|525347380|FG002|Overall Study|Withdrawal of Consent|0|||
145680927|NCT02432274|525347381|FG003|Overall Study|Withdrawal of Consent|0|||
145680928|NCT02432274|525347382|FG004|Overall Study|Withdrawal of Consent|2|||
145680929|NCT02432274|525347383|FG005|Overall Study|Withdrawal of Consent|0|||
145680930|NCT02432274|525347384|FG006|Overall Study|Withdrawal of Consent|1|||
145680931|NCT02432274|525347385|FG007|Overall Study|Withdrawal of Consent|2|||
145680932|NCT00090519|525347386|FG000|Overall Study|Adverse Event|5|||
145680933|NCT00090519|525347387|FG001|Overall Study|Adverse Event|4|||
145680934|NCT00090519|525347386|FG000|Overall Study|Death|9|||
145680935|NCT00090519|525347387|FG001|Overall Study|Death|9|||
145680936|NCT00090519|525347386|FG000|Overall Study|Lost to Follow-up|26|||
145680937|NCT00090519|525347387|FG001|Overall Study|Lost to Follow-up|29|||
145680938|NCT00090519|525347386|FG000|Overall Study|Withdrawal by Subject|28|||
145680939|NCT00090519|525347387|FG001|Overall Study|Withdrawal by Subject|29|||
145680940|NCT00090519|525347386|FG000|Overall Study|Physician Decision|2|||
145680941|NCT00090519|525347387|FG001|Overall Study|Physician Decision|3|||
145680942|NCT00090519|525347386|FG000|Overall Study|Sponsor Decision|3|||
145680943|NCT00090519|525347387|FG001|Overall Study|Sponsor Decision|1|||
145680944|NCT00116649|525347388|FG000|Overall Study|Adverse Event|20|||
145680945|NCT00116649|525347388|FG000|Overall Study|Lack of Efficacy|1|||
145680946|NCT00116649|525347388|FG000|Overall Study|Lost to Follow-up|32|||
145680947|NCT00116649|525347388|FG000|Overall Study|Withdrawal by Subject|68|||
145680948|NCT00116649|525347388|FG000|Overall Study|Local Skin Reaction|9|||
145680949|NCT00116649|525347388|FG000|Overall Study|Various Reasons|18|||
145680950|NCT00116649|525347388|FG000|Overall Study|Protocol Specified|7|||
145680951|NCT02161146|525347389|FG000|Overall Study|Adverse Event|1|||
145680952|NCT02161146|525347390|FG001|Overall Study|Adverse Event|1|||
145680953|NCT02161146|525347391|FG002|Overall Study|Adverse Event|0|||
145680954|NCT02161146|525347392|FG003|Overall Study|Adverse Event|1|||
145680955|NCT02161146|525347393|FG004|Overall Study|Adverse Event|0|||
145680956|NCT02161146|525347389|FG000|Overall Study|Lost to Follow-up|0|||
145680957|NCT02161146|525347390|FG001|Overall Study|Lost to Follow-up|1|||
145680958|NCT02161146|525347391|FG002|Overall Study|Lost to Follow-up|0|||
145680959|NCT02161146|525347392|FG003|Overall Study|Lost to Follow-up|0|||
145680960|NCT02161146|525347393|FG004|Overall Study|Lost to Follow-up|0|||
145680961|NCT02161146|525347389|FG000|Overall Study|Personal Reasons|0|||
145680962|NCT02161146|525347390|FG001|Overall Study|Personal Reasons|1|||
145680963|NCT02161146|525347391|FG002|Overall Study|Personal Reasons|0|||
145680964|NCT02161146|525347392|FG003|Overall Study|Personal Reasons|2|||
145680965|NCT02161146|525347393|FG004|Overall Study|Personal Reasons|1|||
145680966|NCT02161146|525347389|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145680967|NCT02161146|525347390|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145680968|NCT02161146|525347391|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145680969|NCT02161146|525347392|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145680970|NCT02161146|525347393|FG004|Overall Study|Other Miscellaneous Reasons|0|||
145680971|NCT00845520|525347394|FG000|Overall Study|Death|1|||
145680972|NCT00845520|525347395|FG001|Overall Study|Death|2|||
145680973|NCT00845520|525347396|FG002|Overall Study|Death|0|||
145680974|NCT00845520|525347394|FG000|Overall Study|Lost to Follow-up|1|||
145680975|NCT00845520|525347395|FG001|Overall Study|Lost to Follow-up|0|||
145680976|NCT00845520|525347396|FG002|Overall Study|Lost to Follow-up|0|||
145680977|NCT00845520|525347394|FG000|Overall Study|Adverse Event|0|||
145680978|NCT00845520|525347395|FG001|Overall Study|Adverse Event|0|||
145680979|NCT00845520|525347396|FG002|Overall Study|Adverse Event|1|||
145680980|NCT02613403|525347397|FG000|Overall Study|Lost to Follow-up|0|||
145680981|NCT02613403|525347398|FG001|Overall Study|Lost to Follow-up|1|||
145680982|NCT02613403|525347399|FG002|Overall Study|Lost to Follow-up|0|||
145680983|NCT02613403|525347400|FG003|Overall Study|Lost to Follow-up|0|||
145680984|NCT02613403|525347401|FG004|Overall Study|Lost to Follow-up|0|||
145680985|NCT02613403|525347397|FG000|Overall Study|Withdrawal by Subject|2|||
145680986|NCT02613403|525347398|FG001|Overall Study|Withdrawal by Subject|0|||
145680987|NCT02613403|525347399|FG002|Overall Study|Withdrawal by Subject|0|||
145680988|NCT02613403|525347400|FG003|Overall Study|Withdrawal by Subject|0|||
145680989|NCT02613403|525347401|FG004|Overall Study|Withdrawal by Subject|0|||
145680990|NCT00800176|525347402|FG000|Overall Study|Adverse Event|2|||
145680991|NCT00800176|525347403|FG001|Overall Study|Adverse Event|1|||
145680992|NCT00800176|525347404|FG002|Overall Study|Adverse Event|0|||
145680993|NCT00800176|525347405|FG003|Overall Study|Adverse Event|2|||
145680994|NCT00800176|525347406|FG004|Overall Study|Adverse Event|1|||
145680995|NCT00800176|525347407|FG005|Overall Study|Adverse Event|1|||
145680996|NCT00800176|525347402|FG000|Overall Study|Refused treatment|3|||
145680997|NCT00800176|525347403|FG001|Overall Study|Refused treatment|2|||
145680998|NCT00800176|525347404|FG002|Overall Study|Refused treatment|0|||
145680999|NCT00800176|525347405|FG003|Overall Study|Refused treatment|0|||
145681000|NCT00800176|525347406|FG004|Overall Study|Refused treatment|1|||
145681001|NCT00800176|525347407|FG005|Overall Study|Refused treatment|4|||
145491077|NCT01384734|524652352|FG004|Overall Study|Withdrawal by Subject|9|||
145491078|NCT01384734|524652348|FG000|Overall Study|Investigator relocating|0|||
145491079|NCT01384734|524652349|FG001|Overall Study|Investigator relocating|2|||
145491080|NCT01384734|524652350|FG002|Overall Study|Investigator relocating|0|||
145491081|NCT01384734|524652351|FG003|Overall Study|Investigator relocating|3|||
145491082|NCT01384734|524652352|FG004|Overall Study|Investigator relocating|1|||
145491083|NCT01384734|524652348|FG000|Overall Study|Unable to come back for visit|1|||
145491084|NCT01384734|524652349|FG001|Overall Study|Unable to come back for visit|0|||
145491085|NCT01384734|524652350|FG002|Overall Study|Unable to come back for visit|1|||
145491086|NCT01384734|524652351|FG003|Overall Study|Unable to come back for visit|1|||
145681002|NCT00800176|525347402|FG000|Overall Study|Failure to return|3|||
145681003|NCT00800176|525347403|FG001|Overall Study|Failure to return|3|||
145681004|NCT00800176|525347404|FG002|Overall Study|Failure to return|0|||
145681005|NCT00800176|525347405|FG003|Overall Study|Failure to return|2|||
145681006|NCT00800176|525347406|FG004|Overall Study|Failure to return|0|||
145681007|NCT00800176|525347407|FG005|Overall Study|Failure to return|0|||
145681008|NCT00800176|525347402|FG000|Overall Study|Other|1|||
145681009|NCT00800176|525347403|FG001|Overall Study|Other|0|||
145681010|NCT00800176|525347404|FG002|Overall Study|Other|0|||
145681011|NCT00800176|525347405|FG003|Overall Study|Other|0|||
145681012|NCT00800176|525347406|FG004|Overall Study|Other|2|||
145681013|NCT00800176|525347407|FG005|Overall Study|Other|0|||
145681014|NCT00805441|525347410|FG000|Overall Study|Adverse Event|5|||
145681015|NCT00805441|525347411|FG001|Overall Study|Adverse Event|2|||
145681016|NCT00805441|525347410|FG000|Overall Study|Lack of Efficacy|0|||
145681017|NCT00805441|525347411|FG001|Overall Study|Lack of Efficacy|2|||
145681018|NCT00805441|525347410|FG000|Overall Study|Protocol Violation|4|||
145681019|NCT00805441|525347411|FG001|Overall Study|Protocol Violation|8|||
145681020|NCT00805441|525347410|FG000|Overall Study|Lost to Follow-up|10|||
145681021|NCT00805441|525347411|FG001|Overall Study|Lost to Follow-up|13|||
145681022|NCT00805441|525347410|FG000|Overall Study|Withdrawal by Subject|15|||
145681023|NCT00805441|525347411|FG001|Overall Study|Withdrawal by Subject|9|||
145681024|NCT00805441|525347410|FG000|Overall Study|Physician Decision|0|||
145681025|NCT00805441|525347411|FG001|Overall Study|Physician Decision|1|||
145681026|NCT00805441|525347410|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
145681027|NCT00805441|525347411|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
145681028|NCT02935894|525347413|FG000|Overall Study|Subject dismissed|1|||
145681029|NCT03786471|525347416|FG000|Overall Study|Death|254|||
145681030|NCT03786471|525347417|FG001|Overall Study|Death|223|||
145681031|NCT03786471|525347418|FG002|Overall Study|Death|37|||
145681032|NCT03786471|525347416|FG000|Overall Study|Lost to Follow-up|63|||
145681033|NCT03786471|525347417|FG001|Overall Study|Lost to Follow-up|50|||
145681034|NCT03786471|525347418|FG002|Overall Study|Lost to Follow-up|15|||
145681035|NCT03786471|525347416|FG000|Overall Study|Withdrawal by Subject|99|||
145681036|NCT03786471|525347417|FG001|Overall Study|Withdrawal by Subject|81|||
145681037|NCT03786471|525347418|FG002|Overall Study|Withdrawal by Subject|11|||
145681038|NCT00747149|525348992|FG000|Overall Study|Adverse Event|0|||
145681039|NCT00747149|525348993|FG001|Overall Study|Adverse Event|15|||
145681040|NCT00747149|525348992|FG000|Overall Study|Lost to Follow-up|0|||
145681041|NCT00747149|525348993|FG001|Overall Study|Lost to Follow-up|10|||
145681042|NCT00747149|525348992|FG000|Overall Study|Withdrawal by Subject|0|||
145681043|NCT00747149|525348993|FG001|Overall Study|Withdrawal by Subject|6|||
145681044|NCT00747149|525348992|FG000|Overall Study|Did not receive treatment|0|||
145681045|NCT00747149|525348993|FG001|Overall Study|Did not receive treatment|1|||
145681046|NCT00747149|525348992|FG000|Overall Study|Incorrect enrollment|0|||
145681047|NCT00747149|525348993|FG001|Overall Study|Incorrect enrollment|6|||
145681048|NCT00747149|525348992|FG000|Overall Study|Severe non-compliance to protocol|0|||
145681049|NCT00747149|525348993|FG001|Overall Study|Severe non-compliance to protocol|1|||
145681050|NCT00747149|525348992|FG000|Overall Study|Not reported|1|||
145681051|NCT00747149|525348993|FG001|Overall Study|Not reported|4|||
145681052|NCT03840200|525348994|FG000|Overall Study|Death|6|||
145681053|NCT03840200|525348995|FG001|Overall Study|Death|3|||
145681054|NCT03840200|525348996|FG002|Overall Study|Death|6|||
145681055|NCT03840200|525348997|FG003|Overall Study|Death|10|||
145681056|NCT03840200|525348994|FG000|Overall Study|Reason Not Specified|2|||
145681057|NCT03840200|525348995|FG001|Overall Study|Reason Not Specified|2|||
145681058|NCT03840200|525348996|FG002|Overall Study|Reason Not Specified|1|||
145681059|NCT03840200|525348997|FG003|Overall Study|Reason Not Specified|15|||
145681060|NCT03840200|525348994|FG000|Overall Study|Physician Decision|0|||
145681061|NCT03840200|525348995|FG001|Overall Study|Physician Decision|0|||
145681062|NCT03840200|525348996|FG002|Overall Study|Physician Decision|0|||
145681063|NCT03840200|525348997|FG003|Overall Study|Physician Decision|2|||
145681064|NCT03840200|525348994|FG000|Overall Study|Progressive Disease|0|||
145681065|NCT03840200|525348995|FG001|Overall Study|Progressive Disease|0|||
145681066|NCT03840200|525348996|FG002|Overall Study|Progressive Disease|0|||
145681067|NCT03840200|525348997|FG003|Overall Study|Progressive Disease|1|||
145681068|NCT03840200|525348994|FG000|Overall Study|Withdrawal by Subject|0|||
145681069|NCT03840200|525348995|FG001|Overall Study|Withdrawal by Subject|1|||
145681070|NCT03840200|525348996|FG002|Overall Study|Withdrawal by Subject|0|||
145681071|NCT03840200|525348997|FG003|Overall Study|Withdrawal by Subject|2|||
145681072|NCT05006703|525348998|FG000|Overall Study|Withdrawal by Subject|1|||
145681073|NCT05006703|525348999|FG001|Overall Study|Withdrawal by Subject|0|||
145681074|NCT05006703|525348998|FG000|Overall Study|Lost to Follow-up|13|||
145681075|NCT05006703|525348999|FG001|Overall Study|Lost to Follow-up|5|||
145681076|NCT04620733|525349000|FG000|Overall Study|Adverse Event|4|||
145681077|NCT04620733|525349001|FG001|Overall Study|Adverse Event|3|||
145681078|NCT04620733|525349000|FG000|Overall Study|Withdrawal by Subject|2|||
145681079|NCT04620733|525349001|FG001|Overall Study|Withdrawal by Subject|5|||
145681080|NCT04620733|525349000|FG000|Overall Study|Lost to Follow-up|1|||
145681081|NCT04620733|525349001|FG001|Overall Study|Lost to Follow-up|1|||
145681082|NCT04620733|525349000|FG000|Overall Study|Protocol Deviation|1|||
145681083|NCT04620733|525349001|FG001|Overall Study|Protocol Deviation|1|||
145681084|NCT04620733|525349000|FG000|Overall Study|Reason Not Specified|0|||
145681085|NCT04620733|525349001|FG001|Overall Study|Reason Not Specified|1|||
145681086|NCT00264576|525349006|FG000|Overall Study|Lost to Follow-up|1|||
145681087|NCT00264576|525349007|FG001|Overall Study|Lost to Follow-up|1|||
145681088|NCT02659059|525349010|FG000|Overall Study|Other reasons|6|||
145681089|NCT02659059|525349011|FG001|Overall Study|Other reasons|1|||
145681090|NCT02659059|525349010|FG000|Overall Study|Disease Progression|143|||
145681091|NCT02659059|525349011|FG001|Overall Study|Disease Progression|16|||
145681092|NCT02659059|525349010|FG000|Overall Study|Study Drug toxicity|56|||
145681093|NCT02659059|525349011|FG001|Overall Study|Study Drug toxicity|9|||
145681094|NCT02659059|525349010|FG000|Overall Study|Death|3|||
145681095|NCT02659059|525349011|FG001|Overall Study|Death|1|||
145681096|NCT02659059|525349010|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
145681097|NCT02659059|525349011|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
145681098|NCT02659059|525349010|FG000|Overall Study|Participant request to discontinue study treatment|5|||
145681099|NCT02659059|525349011|FG001|Overall Study|Participant request to discontinue study treatment|0|||
145681100|NCT02659059|525349010|FG000|Overall Study|Participant withdrew consent|6|||
145681101|NCT02659059|525349011|FG001|Overall Study|Participant withdrew consent|1|||
145681102|NCT00092456|525349017|FG000|Overall Study|Adverse Event|0|||
145681103|NCT00092456|525349018|FG001|Overall Study|Adverse Event|0|||
145681104|NCT00092456|525349019|FG002|Overall Study|Adverse Event|1|||
145681105|NCT00092456|525349020|FG003|Overall Study|Adverse Event|1|||
145681106|NCT00092456|525349017|FG000|Overall Study|Lost to Follow-up|2|||
145681107|NCT00092456|525349018|FG001|Overall Study|Lost to Follow-up|2|||
145681108|NCT00092456|525349019|FG002|Overall Study|Lost to Follow-up|1|||
145681109|NCT00092456|525349020|FG003|Overall Study|Lost to Follow-up|2|||
145681110|NCT00092456|525349017|FG000|Overall Study|Protocol Violation|5|||
145681111|NCT00092456|525349018|FG001|Overall Study|Protocol Violation|7|||
145681112|NCT00092456|525349019|FG002|Overall Study|Protocol Violation|8|||
145681113|NCT00092456|525349020|FG003|Overall Study|Protocol Violation|6|||
145681114|NCT00092456|525349017|FG000|Overall Study|Withdrawal by Subject|13|||
145681115|NCT00092456|525349018|FG001|Overall Study|Withdrawal by Subject|5|||
145681116|NCT00092456|525349019|FG002|Overall Study|Withdrawal by Subject|16|||
145681117|NCT00092456|525349020|FG003|Overall Study|Withdrawal by Subject|6|||
145681118|NCT00092456|525349017|FG000|Overall Study|Moved|1|||
145681119|NCT00092456|525349018|FG001|Overall Study|Moved|1|||
145681120|NCT00092456|525349019|FG002|Overall Study|Moved|0|||
145681121|NCT00092456|525349020|FG003|Overall Study|Moved|1|||
145681122|NCT00092456|525349017|FG000|Overall Study|Other|4|||
145681123|NCT00092456|525349018|FG001|Overall Study|Other|2|||
145681124|NCT00092456|525349019|FG002|Overall Study|Other|3|||
145681125|NCT00092456|525349020|FG003|Overall Study|Other|0|||
145681126|NCT04783389|525349021|FG000|Overall Study|Withdrawal by Subject|2|||
145681127|NCT04783389|525349022|FG001|Overall Study|Withdrawal by Subject|0|||
145681128|NCT04783389|525349023|FG002|Overall Study|Withdrawal by Subject|0|||
145681129|NCT04783389|525349021|FG000|Overall Study|Termination of Study by Sponsor|10|||
145681130|NCT04783389|525349022|FG001|Overall Study|Termination of Study by Sponsor|12|||
145681131|NCT04783389|525349023|FG002|Overall Study|Termination of Study by Sponsor|14|||
145681132|NCT00451906|525349024|FG000|Overall Study|Adverse Event|515|||
145681133|NCT00451906|525349024|FG000|Overall Study|Lost to Follow-up|31|||
145681134|NCT00451906|525349024|FG000|Overall Study|Withdrawal by Subject|111|||
145681135|NCT00451906|525349024|FG000|Overall Study|Protocol Violation|21|||
145681136|NCT00451906|525349024|FG000|Overall Study|Progressive disease|1328|||
145681137|NCT00451906|525349024|FG000|Overall Study|Termination of the study|108|||
145681138|NCT00451906|525349024|FG000|Overall Study|Other Reasons|121|||
145681139|NCT00451906|525349024|FG000|Overall Study|Did not complete final visit|4|||
145681140|NCT02121808|525349030|FG000|Overall Study|Technical problem|3|||
145681141|NCT03924193|525349031|FG000|Overall Study|Adverse Event|10|||
145681142|NCT03924193|525349032|FG001|Overall Study|Adverse Event|0|||
145681143|NCT03924193|525349033|FG002|Overall Study|Adverse Event|10|||
145681144|NCT03924193|525349031|FG000|Overall Study|Withdrawal by Subject|5|||
145681145|NCT03924193|525349032|FG001|Overall Study|Withdrawal by Subject|10|||
145681146|NCT03924193|525349033|FG002|Overall Study|Withdrawal by Subject|2|||
145681147|NCT00647699|525349034|FG000|Overall Study|Lost to Follow-up|5|||
145681148|NCT00647699|525349035|FG001|Overall Study|Lost to Follow-up|4|||
145681149|NCT00647699|525349034|FG000|Overall Study|Withdrawal by Subject|3|||
145681150|NCT00647699|525349035|FG001|Overall Study|Withdrawal by Subject|8|||
145681151|NCT03029585|525349036|FG000|Overall Study|Death|1|||
145681152|NCT03029585|525349037|FG001|Overall Study|Death|1|||
145681153|NCT03029585|525349036|FG000|Overall Study|Withdrawal by Subject|1|||
145681154|NCT03029585|525349037|FG001|Overall Study|Withdrawal by Subject|0|||
145681155|NCT04361617|525349042|FG000|Overall Study|Withdrawal by Subject|0|||
145681156|NCT04361617|525349043|FG001|Overall Study|Withdrawal by Subject|1|||
145681157|NCT02005484|525349045|FG000|Overall Study|Death|1|||
145681158|NCT02005484|525349045|FG000|Overall Study|Disease progression|1|||
145681159|NCT02005484|525349045|FG000|Overall Study|Changed to a Different Study|1|||
145681160|NCT02005484|525349045|FG000|Overall Study|Sponsor decision|1|||
145681161|NCT02137785|525349051|FG000|Overall Study|Lost to Follow-up|1|||
145681162|NCT02137785|525349052|FG001|Overall Study|Lost to Follow-up|0|||
145681163|NCT02137785|525349051|FG000|Overall Study|Withdrawal by Subject|1|||
145681164|NCT02137785|525349052|FG001|Overall Study|Withdrawal by Subject|4|||
145681165|NCT02137785|525349051|FG000|Overall Study|subject moved out of state|1|||
145681166|NCT02137785|525349052|FG001|Overall Study|subject moved out of state|0|||
145681167|NCT02584257|525349053|FG000|Period 1|Withdrawal by Subject|0|||
145681168|NCT02584257|525349054|FG001|Period 1|Withdrawal by Subject|0|||
145681169|NCT02584257|525349055|FG002|Period 1|Withdrawal by Subject|0|||
145681170|NCT02584257|525349056|FG003|Period 1|Withdrawal by Subject|0|||
145681171|NCT02584257|525349057|FG004|Period 1|Withdrawal by Subject|0|||
145681172|NCT02584257|525349058|FG005|Period 1|Withdrawal by Subject|0|||
145681173|NCT02584257|525349059|FG006|Period 1|Withdrawal by Subject|1|||
145681174|NCT02584257|525349060|FG007|Period 1|Withdrawal by Subject|0|||
145681175|NCT02584257|525349061|FG008|Period 1|Withdrawal by Subject|0|||
145681176|NCT02584257|525349053|FG000|Period 2|Physician Decision|1|||
145681177|NCT02584257|525349054|FG001|Period 2|Physician Decision|0|||
145681178|NCT02584257|525349055|FG002|Period 2|Physician Decision|0|||
145681179|NCT02584257|525349056|FG003|Period 2|Physician Decision|0|||
145681180|NCT02584257|525349057|FG004|Period 2|Physician Decision|0|||
145681181|NCT02584257|525349058|FG005|Period 2|Physician Decision|0|||
145681182|NCT02584257|525349059|FG006|Period 2|Physician Decision|0|||
145681183|NCT02584257|525349060|FG007|Period 2|Physician Decision|0|||
145681184|NCT02584257|525349061|FG008|Period 2|Physician Decision|0|||
145681185|NCT02584257|525349053|FG000|Period 2|Adverse Event|0|||
145681186|NCT02584257|525349054|FG001|Period 2|Adverse Event|1|||
145681187|NCT02584257|525349055|FG002|Period 2|Adverse Event|0|||
145681188|NCT02584257|525349056|FG003|Period 2|Adverse Event|0|||
145681189|NCT02584257|525349057|FG004|Period 2|Adverse Event|0|||
145681190|NCT02584257|525349058|FG005|Period 2|Adverse Event|0|||
145681191|NCT02584257|525349059|FG006|Period 2|Adverse Event|0|||
145681192|NCT02584257|525349060|FG007|Period 2|Adverse Event|0|||
145681193|NCT02584257|525349061|FG008|Period 2|Adverse Event|0|||
145681194|NCT02309892|525349062|FG000|Overall Study|Physician Decision|1|||
145681195|NCT02309892|525349063|FG001|Overall Study|Physician Decision|0|||
145681196|NCT02309892|525349064|FG002|Overall Study|Physician Decision|0|||
145681197|NCT02309892|525349065|FG003|Overall Study|Physician Decision|0|||
145681198|NCT02309892|525349066|FG004|Overall Study|Physician Decision|0|||
145681199|NCT02309892|525349067|FG005|Overall Study|Physician Decision|0|||
145681200|NCT02309892|525349068|FG006|Overall Study|Physician Decision|0|||
145681201|NCT02309892|525349062|FG000|Overall Study|Adverse Event|1|||
145681202|NCT02309892|525349063|FG001|Overall Study|Adverse Event|0|||
145681203|NCT02309892|525349064|FG002|Overall Study|Adverse Event|1|||
145681204|NCT02309892|525349065|FG003|Overall Study|Adverse Event|0|||
145681205|NCT02309892|525349066|FG004|Overall Study|Adverse Event|0|||
145681206|NCT02309892|525349067|FG005|Overall Study|Adverse Event|0|||
145681207|NCT02309892|525349068|FG006|Overall Study|Adverse Event|0|||
145681208|NCT02309892|525349062|FG000|Overall Study|Progressive Disease|0|||
145681209|NCT02309892|525349063|FG001|Overall Study|Progressive Disease|1|||
145681210|NCT02309892|525349064|FG002|Overall Study|Progressive Disease|0|||
145681211|NCT02309892|525349065|FG003|Overall Study|Progressive Disease|0|||
145681212|NCT02309892|525349066|FG004|Overall Study|Progressive Disease|1|||
145681213|NCT02309892|525349067|FG005|Overall Study|Progressive Disease|0|||
145681214|NCT02309892|525349068|FG006|Overall Study|Progressive Disease|0|||
145681215|NCT02309892|525349062|FG000|Overall Study|Death|0|||
145681216|NCT02309892|525349063|FG001|Overall Study|Death|0|||
145681217|NCT02309892|525349064|FG002|Overall Study|Death|0|||
145681218|NCT02309892|525349065|FG003|Overall Study|Death|0|||
145681219|NCT02309892|525349066|FG004|Overall Study|Death|0|||
145681220|NCT02309892|525349067|FG005|Overall Study|Death|1|||
145681221|NCT02309892|525349068|FG006|Overall Study|Death|0|||
145681222|NCT01584648|525349069|FG000|Overall Study|Death|136|||
145681223|NCT01584648|525349070|FG001|Overall Study|Death|146|||
145681224|NCT01584648|525349069|FG000|Overall Study|Lost to Follow-up|9|||
145681225|NCT01584648|525349070|FG001|Overall Study|Lost to Follow-up|9|||
145681226|NCT01584648|525349069|FG000|Overall Study|Investigator discretion|3|||
145681227|NCT01584648|525349070|FG001|Overall Study|Investigator discretion|2|||
145681228|NCT01584648|525349069|FG000|Overall Study|Withdrew consent|13|||
145681229|NCT01584648|525349070|FG001|Overall Study|Withdrew consent|4|||
145681230|NCT01584648|525349069|FG000|Overall Study|Study closed/terminated|50|||
145681231|NCT01584648|525349070|FG001|Overall Study|Study closed/terminated|23|||
145681232|NCT01584648|525349069|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
145681233|NCT01584648|525349070|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
145681234|NCT01722097|525349071|FG000|Overall Study|Patient sheets not returned|6|||
145681235|NCT01722097|525349072|FG001|Overall Study|Patient sheets not returned|5|||
145681236|NCT01757288|525349075|FG000|Overall Study|Consent withdrawal|0|||
145681237|NCT01757288|525349076|FG001|Overall Study|Consent withdrawal|4|||
145681238|NCT01757288|525349077|FG002|Overall Study|Consent withdrawal|4|||
145681239|NCT01757288|525349075|FG000|Overall Study|Patient off study, IRB hold.|0|||
145681240|NCT01757288|525349076|FG001|Overall Study|Patient off study, IRB hold.|0|||
145681241|NCT01757288|525349077|FG002|Overall Study|Patient off study, IRB hold.|1|||
145681242|NCT01757288|525349075|FG000|Overall Study|Patient death prior to starting treatment|0|||
145681243|NCT01757288|525349076|FG001|Overall Study|Patient death prior to starting treatment|0|||
145681244|NCT01757288|525349077|FG002|Overall Study|Patient death prior to starting treatment|1|||
145681245|NCT01757288|525349075|FG000|Overall Study|Wrong medication administered|0|||
145681246|NCT01757288|525349076|FG001|Overall Study|Wrong medication administered|1|||
145681247|NCT01757288|525349077|FG002|Overall Study|Wrong medication administered|0|||
145681248|NCT01757288|525349075|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
145681249|NCT01757288|525349076|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
145681250|NCT01757288|525349077|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
145681251|NCT01757288|525349075|FG000|Overall Study|Not meeting protocol constraints|0|||
145681252|NCT01757288|525349076|FG001|Overall Study|Not meeting protocol constraints|1|||
145681253|NCT01757288|525349077|FG002|Overall Study|Not meeting protocol constraints|1|||
145681254|NCT01757288|525349075|FG000|Overall Study|Multiple missed appointments|0|||
145681255|NCT01757288|525349076|FG001|Overall Study|Multiple missed appointments|1|||
145681256|NCT01757288|525349077|FG002|Overall Study|Multiple missed appointments|0|||
145681257|NCT01757288|525349075|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
145681258|NCT01757288|525349076|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
145681259|NCT01757288|525349077|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
145681260|NCT01757288|525349075|FG000|Overall Study|>2 weeks treatment break|0|||
145681261|NCT01757288|525349076|FG001|Overall Study|>2 weeks treatment break|0|||
145681262|NCT01757288|525349077|FG002|Overall Study|>2 weeks treatment break|1|||
145681263|NCT02825550|525349078|FG000|Overall Study|Physician Decision|1|||
145681264|NCT00042939|525349079|FG000|Overall Study|Adverse Event|6|||
145681265|NCT00042939|525349080|FG001|Overall Study|Adverse Event|7|||
145681266|NCT00042939|525349079|FG000|Overall Study|Death|3|||
145681267|NCT00042939|525349080|FG001|Overall Study|Death|2|||
145681268|NCT00042939|525349079|FG000|Overall Study|Withdrawal by Subject|3|||
145681269|NCT00042939|525349080|FG001|Overall Study|Withdrawal by Subject|4|||
145681270|NCT00042939|525349079|FG000|Overall Study|Other disease|1|||
145681271|NCT00042939|525349080|FG001|Overall Study|Other disease|0|||
145681272|NCT00042939|525349079|FG000|Overall Study|Ineligible|2|||
145681273|NCT00042939|525349080|FG001|Overall Study|Ineligible|2|||
145681274|NCT00042939|525349079|FG000|Overall Study|Deterioration of health|3|||
145681275|NCT00042939|525349080|FG001|Overall Study|Deterioration of health|4|||
145681276|NCT00042939|525349079|FG000|Overall Study|QOL diminished|1|||
145681277|NCT00042939|525349080|FG001|Overall Study|QOL diminished|0|||
145681278|NCT00042939|525349079|FG000|Overall Study|Rising ca 19-9|1|||
145681279|NCT00042939|525349080|FG001|Overall Study|Rising ca 19-9|0|||
145681280|NCT00042939|525349079|FG000|Overall Study|Patient non-compliance|1|||
145681281|NCT00042939|525349080|FG001|Overall Study|Patient non-compliance|0|||
145681282|NCT00042939|525349079|FG000|Overall Study|Still on treatment|1|||
145681283|NCT00042939|525349080|FG001|Overall Study|Still on treatment|0|||
145681284|NCT00042939|525349079|FG000|Overall Study|Treatment break > 4 weeks|0|||
145681285|NCT00042939|525349080|FG001|Overall Study|Treatment break > 4 weeks|1|||
145681286|NCT00042939|525349079|FG000|Overall Study|Did not start treatment|2|||
145681287|NCT00042939|525349080|FG001|Overall Study|Did not start treatment|1|||
145681288|NCT00795639|525349081|FG000|Overall Study|Death|1|||
145681289|NCT00795639|525349082|FG001|Overall Study|Death|6|||
145681290|NCT00795639|525349081|FG000|Overall Study|Withdrawal by Subject|1|||
145681291|NCT00795639|525349082|FG001|Overall Study|Withdrawal by Subject|3|||
145681292|NCT00795639|525349081|FG000|Overall Study|Pregnancy|1|||
145681293|NCT00795639|525349082|FG001|Overall Study|Pregnancy|0|||
145681294|NCT00795639|525349081|FG000|Overall Study|Adverse Event|5|||
145681295|NCT00795639|525349082|FG001|Overall Study|Adverse Event|2|||
145681296|NCT00795639|525349081|FG000|Overall Study|Other|0|||
145681297|NCT00795639|525349082|FG001|Overall Study|Other|2|||
145681298|NCT00795639|525349081|FG000|Overall Study|Terminated by sponsor|13|||
145681299|NCT00795639|525349082|FG001|Overall Study|Terminated by sponsor|12|||
145681300|NCT00795639|525349081|FG000|Overall Study|Randomized and not treated|0|||
145681301|NCT00795639|525349082|FG001|Overall Study|Randomized and not treated|1|||
145681302|NCT03349476|525349083|FG000|Overall Study|Physician Decision|3|||
145681303|NCT00248794|525349084|FG000|Overall Study|Lost to Follow-up|6|||
145681304|NCT00248794|525349085|FG001|Overall Study|Lost to Follow-up|8|||
145681305|NCT00248794|525349086|FG002|Overall Study|Lost to Follow-up|3|||
145681306|NCT01762345|525349089|FG000|Overall Study|Adverse Event|5|||
145681307|NCT01762345|525349089|FG000|Overall Study|Protocol Violation|2|||
145681308|NCT00244751|525349090|FG000|Overall Study|Adverse Event|7|||
145681309|NCT00244751|525349091|FG001|Overall Study|Adverse Event|7|||
145681310|NCT00244751|525349092|FG002|Overall Study|Adverse Event|5|||
145681311|NCT00244751|525349090|FG000|Overall Study|Lost to Follow-up|0|||
145681312|NCT00244751|525349091|FG001|Overall Study|Lost to Follow-up|1|||
145681313|NCT00244751|525349092|FG002|Overall Study|Lost to Follow-up|0|||
145681314|NCT00244751|525349090|FG000|Overall Study|Protocol Violation|1|||
145681315|NCT00244751|525349091|FG001|Overall Study|Protocol Violation|0|||
145681316|NCT00244751|525349092|FG002|Overall Study|Protocol Violation|1|||
145681317|NCT00244751|525349090|FG000|Overall Study|Withdrawal by Subject|7|||
145681318|NCT00244751|525349091|FG001|Overall Study|Withdrawal by Subject|5|||
145681319|NCT00244751|525349092|FG002|Overall Study|Withdrawal by Subject|3|||
145681320|NCT00244751|525349090|FG000|Overall Study|Elevated liver enzymes|1|||
145681321|NCT00244751|525349091|FG001|Overall Study|Elevated liver enzymes|0|||
145681322|NCT00244751|525349092|FG002|Overall Study|Elevated liver enzymes|0|||
145681323|NCT00244751|525349090|FG000|Overall Study|Lack of compliance with protocol|0|||
145681324|NCT00244751|525349091|FG001|Overall Study|Lack of compliance with protocol|1|||
145681325|NCT00244751|525349092|FG002|Overall Study|Lack of compliance with protocol|0|||
145681326|NCT00244751|525349090|FG000|Overall Study|Safety reasons|0|||
145681327|NCT00244751|525349091|FG001|Overall Study|Safety reasons|1|||
145681328|NCT00244751|525349092|FG002|Overall Study|Safety reasons|0|||
145681329|NCT00244751|525349090|FG000|Overall Study|Participant randomized by mistake|0|||
145681330|NCT00244751|525349091|FG001|Overall Study|Participant randomized by mistake|0|||
145681331|NCT00244751|525349092|FG002|Overall Study|Participant randomized by mistake|1|||
145681332|NCT00761267|525349097|FG000|Overall Study|Death|1|||
145681333|NCT00761267|525349098|FG001|Overall Study|Death|2|||
145681334|NCT00761267|525349099|FG002|Overall Study|Death|5|||
145681335|NCT00761267|525349097|FG000|Overall Study|Lost to Follow-up|0|||
145681336|NCT00761267|525349098|FG001|Overall Study|Lost to Follow-up|0|||
145681337|NCT00761267|525349099|FG002|Overall Study|Lost to Follow-up|1|||
145681338|NCT00761267|525349097|FG000|Overall Study|Randomized but not treated|1|||
145681339|NCT00761267|525349098|FG001|Overall Study|Randomized but not treated|1|||
145681340|NCT00761267|525349099|FG002|Overall Study|Randomized but not treated|0|||
145681341|NCT00761267|525349097|FG000|Overall Study|Withdrawal by Subject|0|||
145681342|NCT00761267|525349098|FG001|Overall Study|Withdrawal by Subject|1|||
145681343|NCT00761267|525349099|FG002|Overall Study|Withdrawal by Subject|0|||
145681344|NCT01777932|525349100|FG000|Overall Study|Disease progression|136|||
145681345|NCT01777932|525349100|FG000|Overall Study|Death|3|||
145681346|NCT01777932|525349100|FG000|Overall Study|Adverse Event|34|||
145681347|NCT01777932|525349100|FG000|Overall Study|Lost to Follow-up|3|||
145681348|NCT01777932|525349100|FG000|Overall Study|Investigator decision|10|||
145681349|NCT01777932|525349100|FG000|Overall Study|Reimbursement limit|9|||
145681350|NCT01777932|525349100|FG000|Overall Study|Patient refused further treatment|10|||
145681351|NCT01419184|525349104|FG000|Overall Study|Site data not available|3|||
145681352|NCT01419184|525349105|FG001|Overall Study|Site data not available|2|||
145681353|NCT01419184|525349104|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
145681354|NCT01419184|525349105|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
145681355|NCT01419184|525349104|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
145681356|NCT01419184|525349105|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
145681357|NCT01419184|525349104|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
145681358|NCT01419184|525349105|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
145681359|NCT01419184|525349104|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
145681360|NCT01419184|525349105|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
145681361|NCT01419184|525349104|FG000|Overall Study|Participant randomized, not treated|1|||
145681362|NCT01419184|525349105|FG001|Overall Study|Participant randomized, not treated|0|||
145681363|NCT03031782|525349110|FG000|Treatment Period 1|Lack of Efficacy|3|||
145681364|NCT03031782|525349111|FG001|Treatment Period 1|Lack of Efficacy|0|||
145681365|NCT03031782|525349112|FG002|Treatment Period 1|Lack of Efficacy|0|||
145681366|NCT03031782|525349113|FG003|Treatment Period 1|Lack of Efficacy|0|||
145681367|NCT03031782|525349114|FG004|Treatment Period 1|Lack of Efficacy|0|||
145681368|NCT03031782|525349110|FG000|Treatment Period 2|Physician Decision|0|||
145681369|NCT03031782|525349111|FG001|Treatment Period 2|Physician Decision|1|||
145681370|NCT03031782|525349112|FG002|Treatment Period 2|Physician Decision|0|||
145681371|NCT03031782|525349113|FG003|Treatment Period 2|Physician Decision|0|||
145681372|NCT03031782|525349114|FG004|Treatment Period 2|Physician Decision|3|||
145681373|NCT03031782|525349110|FG000|Treatment Period 2|Lack of Efficacy|0|||
145681374|NCT03031782|525349111|FG001|Treatment Period 2|Lack of Efficacy|1|||
145681375|NCT03031782|525349112|FG002|Treatment Period 2|Lack of Efficacy|0|||
145681376|NCT03031782|525349113|FG003|Treatment Period 2|Lack of Efficacy|0|||
145681377|NCT03031782|525349114|FG004|Treatment Period 2|Lack of Efficacy|1|||
145681378|NCT03031782|525349110|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145681379|NCT03031782|525349111|FG001|Treatment Period 2|Withdrawal by Subject|3|||
145681380|NCT03031782|525349112|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145681381|NCT03031782|525349113|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145681382|NCT03031782|525349114|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145681383|NCT03031782|525349110|FG000|Treatment Period 2|Adverse Event|0|||
145681384|NCT03031782|525349111|FG001|Treatment Period 2|Adverse Event|1|||
145681385|NCT03031782|525349112|FG002|Treatment Period 2|Adverse Event|2|||
145681386|NCT03031782|525349113|FG003|Treatment Period 2|Adverse Event|0|||
145681387|NCT03031782|525349114|FG004|Treatment Period 2|Adverse Event|0|||
145681388|NCT03031782|525349110|FG000|Treatment Period 3|Withdrawal by Subject|0|||
145681389|NCT03031782|525349111|FG001|Treatment Period 3|Withdrawal by Subject|0|||
145681390|NCT03031782|525349112|FG002|Treatment Period 3|Withdrawal by Subject|0|||
145681391|NCT03031782|525349113|FG003|Treatment Period 3|Withdrawal by Subject|1|||
145681392|NCT03031782|525349114|FG004|Treatment Period 3|Withdrawal by Subject|0|||
145681393|NCT00424476|525349115|FG000|Overall Study|Withdrawal by Subject|7|||
145681394|NCT00424476|525349116|FG001|Overall Study|Withdrawal by Subject|6|||
145681395|NCT00424476|525349117|FG002|Overall Study|Withdrawal by Subject|3|||
145681396|NCT00424476|525349115|FG000|Overall Study|Adverse Event|19|||
145681397|NCT00424476|525349116|FG001|Overall Study|Adverse Event|16|||
145681398|NCT00424476|525349117|FG002|Overall Study|Adverse Event|15|||
145681399|NCT00424476|525349115|FG000|Overall Study|Lack of Efficacy|16|||
145681400|NCT00424476|525349116|FG001|Overall Study|Lack of Efficacy|12|||
145681401|NCT00424476|525349117|FG002|Overall Study|Lack of Efficacy|12|||
145681402|NCT00424476|525349115|FG000|Overall Study|Lack of Compliance|1|||
145681403|NCT00424476|525349116|FG001|Overall Study|Lack of Compliance|1|||
145681404|NCT00424476|525349117|FG002|Overall Study|Lack of Compliance|1|||
145681405|NCT00424476|525349115|FG000|Overall Study|Lost to Follow-up|4|||
145681406|NCT00424476|525349116|FG001|Overall Study|Lost to Follow-up|6|||
145681407|NCT00424476|525349117|FG002|Overall Study|Lost to Follow-up|3|||
145681408|NCT00424476|525349115|FG000|Overall Study|Protocol Violation|7|||
145681409|NCT00424476|525349116|FG001|Overall Study|Protocol Violation|2|||
145681410|NCT00424476|525349117|FG002|Overall Study|Protocol Violation|3|||
145681411|NCT00424476|525349115|FG000|Overall Study|Physician Decision|3|||
145681412|NCT00424476|525349116|FG001|Overall Study|Physician Decision|2|||
145681413|NCT00424476|525349117|FG002|Overall Study|Physician Decision|3|||
145681414|NCT00424476|525349115|FG000|Overall Study|Other|4|||
145681415|NCT00424476|525349116|FG001|Overall Study|Other|3|||
145681416|NCT00424476|525349117|FG002|Overall Study|Other|9|||
145681417|NCT03979040|525349118|FG000|Overall Study|Withdrawal by Subject|24|||
145681418|NCT03979040|525349119|FG001|Overall Study|Withdrawal by Subject|32|||
145681419|NCT03979040|525349118|FG000|Overall Study|randomized but never started treatment|32|||
145681420|NCT03979040|525349119|FG001|Overall Study|randomized but never started treatment|39|||
145681421|NCT03979040|525349118|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
145681422|NCT03979040|525349119|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
145681423|NCT03541369|525349122|FG000|Overall Study|Death|0|||
145681424|NCT03541369|525349123|FG001|Overall Study|Death|0|||
145681425|NCT03541369|525349124|FG002|Overall Study|Death|0|||
145491087|NCT01384734|524652352|FG004|Overall Study|Unable to come back for visit|0|||
145491088|NCT01384734|524652348|FG000|Overall Study|Prison|0|||
145491089|NCT01384734|524652349|FG001|Overall Study|Prison|0|||
145491090|NCT01384734|524652350|FG002|Overall Study|Prison|1|||
145491091|NCT01384734|524652351|FG003|Overall Study|Prison|0|||
145491092|NCT01384734|524652352|FG004|Overall Study|Prison|0|||
145491093|NCT01384734|524652348|FG000|Overall Study|As per Exclusion criteria|0|||
145491094|NCT01384734|524652349|FG001|Overall Study|As per Exclusion criteria|1|||
145491095|NCT01384734|524652350|FG002|Overall Study|As per Exclusion criteria|0|||
145491096|NCT01384734|524652351|FG003|Overall Study|As per Exclusion criteria|0|||
145491097|NCT01384734|524652352|FG004|Overall Study|As per Exclusion criteria|0|||
145491098|NCT01384734|524652348|FG000|Overall Study|Missed End of treatment visit|0|||
145491099|NCT01384734|524652349|FG001|Overall Study|Missed End of treatment visit|0|||
145491100|NCT01384734|524652350|FG002|Overall Study|Missed End of treatment visit|0|||
145491101|NCT01384734|524652351|FG003|Overall Study|Missed End of treatment visit|1|||
145491102|NCT01384734|524652352|FG004|Overall Study|Missed End of treatment visit|0|||
145681426|NCT03541369|525349125|FG003|Overall Study|Death|0|||
145681427|NCT03541369|525349126|FG004|Overall Study|Death|1|||
145681428|NCT03541369|525349127|FG005|Overall Study|Death|1|||
145681429|NCT03541369|525349128|FG006|Overall Study|Death|0|||
145681430|NCT03541369|525349129|FG007|Overall Study|Death|2|||
145681431|NCT03541369|525349130|FG008|Overall Study|Death|1|||
145681432|NCT03541369|525349131|FG009|Overall Study|Death|2|||
145491103|NCT01384734|524652348|FG000|Overall Study|Adhesion problem|0|||
145681433|NCT03541369|525349132|FG010|Overall Study|Death|1|||
145681434|NCT03541369|525349133|FG011|Overall Study|Death|0|||
145681435|NCT03541369|525349134|FG012|Overall Study|Death|2|||
145681436|NCT03541369|525349135|FG013|Overall Study|Death|1|||
145681437|NCT03541369|525349136|FG014|Overall Study|Death|1|||
145681438|NCT03541369|525349137|FG015|Overall Study|Death|1|||
145681439|NCT03541369|525349138|FG016|Overall Study|Death|0|||
145681440|NCT03541369|525349139|FG017|Overall Study|Death|1|||
145681441|NCT03541369|525349122|FG000|Overall Study|Decision by sponsor|0|||
145681442|NCT03541369|525349123|FG001|Overall Study|Decision by sponsor|0|||
145681443|NCT03541369|525349124|FG002|Overall Study|Decision by sponsor|0|||
145681444|NCT03541369|525349125|FG003|Overall Study|Decision by sponsor|1|||
145681445|NCT03541369|525349126|FG004|Overall Study|Decision by sponsor|0|||
145681446|NCT03541369|525349127|FG005|Overall Study|Decision by sponsor|2|||
145681447|NCT03541369|525349128|FG006|Overall Study|Decision by sponsor|0|||
145681448|NCT03541369|525349129|FG007|Overall Study|Decision by sponsor|1|||
145681449|NCT03541369|525349130|FG008|Overall Study|Decision by sponsor|2|||
145681450|NCT03541369|525349131|FG009|Overall Study|Decision by sponsor|0|||
145681451|NCT03541369|525349132|FG010|Overall Study|Decision by sponsor|0|||
145681452|NCT03541369|525349133|FG011|Overall Study|Decision by sponsor|0|||
145681453|NCT03541369|525349134|FG012|Overall Study|Decision by sponsor|2|||
145681454|NCT03541369|525349135|FG013|Overall Study|Decision by sponsor|2|||
145681455|NCT03541369|525349136|FG014|Overall Study|Decision by sponsor|0|||
145681456|NCT03541369|525349137|FG015|Overall Study|Decision by sponsor|1|||
145681457|NCT03541369|525349138|FG016|Overall Study|Decision by sponsor|1|||
145681458|NCT03541369|525349139|FG017|Overall Study|Decision by sponsor|1|||
145681459|NCT03541369|525349122|FG000|Overall Study|Withdrawal by Subject|0|||
145681460|NCT03541369|525349123|FG001|Overall Study|Withdrawal by Subject|0|||
145681461|NCT03541369|525349124|FG002|Overall Study|Withdrawal by Subject|0|||
145681462|NCT03541369|525349125|FG003|Overall Study|Withdrawal by Subject|0|||
145681463|NCT03541369|525349126|FG004|Overall Study|Withdrawal by Subject|0|||
145681464|NCT03541369|525349127|FG005|Overall Study|Withdrawal by Subject|0|||
145681465|NCT03541369|525349128|FG006|Overall Study|Withdrawal by Subject|1|||
145681466|NCT03541369|525349129|FG007|Overall Study|Withdrawal by Subject|0|||
145681467|NCT03541369|525349130|FG008|Overall Study|Withdrawal by Subject|0|||
145681468|NCT03541369|525349131|FG009|Overall Study|Withdrawal by Subject|0|||
145681469|NCT03541369|525349132|FG010|Overall Study|Withdrawal by Subject|0|||
145681470|NCT03541369|525349133|FG011|Overall Study|Withdrawal by Subject|1|||
145681471|NCT03541369|525349134|FG012|Overall Study|Withdrawal by Subject|0|||
145681472|NCT03541369|525349135|FG013|Overall Study|Withdrawal by Subject|0|||
145681473|NCT03541369|525349136|FG014|Overall Study|Withdrawal by Subject|3|||
145681474|NCT03541369|525349137|FG015|Overall Study|Withdrawal by Subject|0|||
145681475|NCT03541369|525349138|FG016|Overall Study|Withdrawal by Subject|4|||
145681476|NCT03541369|525349139|FG017|Overall Study|Withdrawal by Subject|2|||
145681477|NCT03541369|525349122|FG000|Overall Study|Lost to Follow-up|0|||
145681478|NCT03541369|525349123|FG001|Overall Study|Lost to Follow-up|0|||
145681479|NCT03541369|525349124|FG002|Overall Study|Lost to Follow-up|0|||
145681480|NCT03541369|525349125|FG003|Overall Study|Lost to Follow-up|0|||
145681481|NCT03541369|525349126|FG004|Overall Study|Lost to Follow-up|1|||
145681482|NCT03541369|525349127|FG005|Overall Study|Lost to Follow-up|0|||
145681483|NCT03541369|525349128|FG006|Overall Study|Lost to Follow-up|0|||
145681484|NCT03541369|525349129|FG007|Overall Study|Lost to Follow-up|0|||
145681485|NCT03541369|525349130|FG008|Overall Study|Lost to Follow-up|1|||
145681486|NCT03541369|525349131|FG009|Overall Study|Lost to Follow-up|0|||
145681487|NCT03541369|525349132|FG010|Overall Study|Lost to Follow-up|0|||
145681488|NCT03541369|525349133|FG011|Overall Study|Lost to Follow-up|0|||
145681489|NCT03541369|525349134|FG012|Overall Study|Lost to Follow-up|1|||
145681490|NCT03541369|525349135|FG013|Overall Study|Lost to Follow-up|0|||
145681491|NCT03541369|525349136|FG014|Overall Study|Lost to Follow-up|0|||
145681492|NCT03541369|525349137|FG015|Overall Study|Lost to Follow-up|0|||
145681493|NCT03541369|525349138|FG016|Overall Study|Lost to Follow-up|0|||
145681494|NCT03541369|525349139|FG017|Overall Study|Lost to Follow-up|0|||
145681495|NCT02279732|525349142|FG000|Overall Study|Death|23|||
145681496|NCT02279732|525349143|FG001|Overall Study|Death|20|||
145681497|NCT02279732|525349142|FG000|Overall Study|Disease Progression|13|||
145681498|NCT02279732|525349143|FG001|Overall Study|Disease Progression|3|||
145681499|NCT02279732|525349142|FG000|Overall Study|Withdrawal by Subject|2|||
145681500|NCT02279732|525349143|FG001|Overall Study|Withdrawal by Subject|7|||
145681501|NCT02279732|525349142|FG000|Overall Study|Adverse Event|1|||
145681502|NCT02279732|525349143|FG001|Overall Study|Adverse Event|2|||
145681503|NCT02279732|525349142|FG000|Overall Study|Administrative Reason By Sponsor|0|||
145681504|NCT02279732|525349143|FG001|Overall Study|Administrative Reason By Sponsor|2|||
145681505|NCT02279732|525349142|FG000|Overall Study|Study Drug Toxicity|2|||
145681506|NCT02279732|525349143|FG001|Overall Study|Study Drug Toxicity|0|||
145681507|NCT02279732|525349142|FG000|Overall Study|Lost to Follow-up|0|||
145681508|NCT02279732|525349143|FG001|Overall Study|Lost to Follow-up|1|||
145681509|NCT02279732|525349142|FG000|Overall Study|Maximum Clinical Benefit|1|||
145681510|NCT02279732|525349143|FG001|Overall Study|Maximum Clinical Benefit|0|||
145681511|NCT02279732|525349142|FG000|Overall Study|Subject Requested to Discontinue|0|||
145681512|NCT02279732|525349143|FG001|Overall Study|Subject Requested to Discontinue|1|||
145681513|NCT02279732|525349142|FG000|Overall Study|Other|53|||
145681514|NCT02279732|525349143|FG001|Overall Study|Other|67|||
145491104|NCT01384734|524652349|FG001|Overall Study|Adhesion problem|0|||
145681515|NCT02279732|525349142|FG000|Overall Study|Other|3|||
145681516|NCT02279732|525349143|FG001|Overall Study|Other|3|||
145681517|NCT03072862|525349147|FG000|Overall Study|Withdrawal by Subject|4|||
145681518|NCT03072862|525349147|FG000|Overall Study|Lost to Follow-up|6|||
145681519|NCT03072862|525349147|FG000|Overall Study|Protocol Violation|4|||
145681520|NCT03072862|525349147|FG000|Overall Study|Physician Decision|2|||
145681521|NCT03072862|525349147|FG000|Overall Study|Death|1|||
145681522|NCT03072862|525349147|FG000|Overall Study|Adverse Event|1|||
145681523|NCT02513667|525349148|FG000|Overall Study|Withdrawal by Subject|0|||
145681524|NCT02513667|525349149|FG001|Overall Study|Withdrawal by Subject|1|||
145681525|NCT03347396|525349150|FG000|Part A (26 Weeks)|Adverse Event|1|||
145681526|NCT03347396|525349151|FG001|Part A (26 Weeks)|Adverse Event|0|||
145681527|NCT03347396|525349150|FG000|Part A (26 Weeks)|Death|0|||
145681528|NCT03347396|525349151|FG001|Part A (26 Weeks)|Death|1|||
145681529|NCT03347396|525349150|FG000|Part B (149 Weeks)|Adverse Event|1|||
145681530|NCT03347396|525349151|FG001|Part B (149 Weeks)|Adverse Event|1|||
145681531|NCT03347396|525349150|FG000|Part B (149 Weeks)|Death|1|||
145681532|NCT03347396|525349151|FG001|Part B (149 Weeks)|Death|0|||
145681533|NCT01670526|525349156|FG000|Overall Study|Withdrawal by Subject|3|||
145681534|NCT01670526|525349157|FG001|Overall Study|Withdrawal by Subject|1|||
145681535|NCT01670526|525349156|FG000|Overall Study|Lost to Follow-up|9|||
145681536|NCT01670526|525349157|FG001|Overall Study|Lost to Follow-up|5|||
145681537|NCT03659136|525349164|FG000|Overall Study|Not treated|2|||
145681538|NCT03659136|525349165|FG001|Overall Study|Not treated|0|||
145681539|NCT03659136|525349164|FG000|Overall Study|Covid-19 related|1|||
145681540|NCT03659136|525349165|FG001|Overall Study|Covid-19 related|1|||
145681541|NCT03659136|525349164|FG000|Overall Study|Withdrawal by Subject|1|||
145681542|NCT03659136|525349165|FG001|Overall Study|Withdrawal by Subject|6|||
145681543|NCT03659136|525349164|FG000|Overall Study|Adverse Event|4|||
145681544|NCT03659136|525349165|FG001|Overall Study|Adverse Event|6|||
145681545|NCT03659136|525349164|FG000|Overall Study|Progressive disease|37|||
145681546|NCT03659136|525349165|FG001|Overall Study|Progressive disease|31|||
145681547|NCT03659136|525349164|FG000|Overall Study|Study closure|2|||
145681548|NCT03659136|525349165|FG001|Overall Study|Study closure|2|||
145681549|NCT03659136|525349164|FG000|Overall Study|Sponsor decision/recommendation|3|||
145681550|NCT03659136|525349165|FG001|Overall Study|Sponsor decision/recommendation|2|||
145681551|NCT03659136|525349164|FG000|Overall Study|Switched to other drug/therapy|2|||
145681552|NCT03659136|525349165|FG001|Overall Study|Switched to other drug/therapy|2|||
145681553|NCT03659136|525349164|FG000|Overall Study|Lack of clinical benefit|0|||
145681554|NCT03659136|525349165|FG001|Overall Study|Lack of clinical benefit|1|||
145681555|NCT05487300|525351026|FG000|Overall Study|Withdrawal by Subject|1|||
145681556|NCT05487300|525351027|FG001|Overall Study|Withdrawal by Subject|0|||
145681557|NCT03141177|525351028|FG000|Overall Study|Death|62|||
145681558|NCT03141177|525351029|FG001|Overall Study|Death|13|||
145681559|NCT03141177|525351030|FG002|Overall Study|Death|84|||
145681560|NCT03141177|525351028|FG000|Overall Study|Participant withdrew consent|9|||
145681561|NCT03141177|525351029|FG001|Overall Study|Participant withdrew consent|2|||
145681562|NCT03141177|525351030|FG002|Overall Study|Participant withdrew consent|13|||
145681563|NCT03141177|525351028|FG000|Overall Study|Not reported|1|||
145681564|NCT03141177|525351029|FG001|Overall Study|Not reported|0|||
145681565|NCT03141177|525351030|FG002|Overall Study|Not reported|1|||
145681566|NCT03141177|525351028|FG000|Overall Study|Lost to Follow-up|2|||
145681567|NCT03141177|525351029|FG001|Overall Study|Lost to Follow-up|1|||
145681568|NCT03141177|525351030|FG002|Overall Study|Lost to Follow-up|1|||
145681569|NCT03141177|525351028|FG000|Overall Study|Other reasons|4|||
145681570|NCT03141177|525351029|FG001|Overall Study|Other reasons|0|||
145681571|NCT03141177|525351030|FG002|Overall Study|Other reasons|11|||
145681572|NCT03141177|525351028|FG000|Overall Study|Participants did not start treatment period|3|||
145681573|NCT03141177|525351029|FG001|Overall Study|Participants did not start treatment period|0|||
145681574|NCT03141177|525351030|FG002|Overall Study|Participants did not start treatment period|8|||
145681575|NCT03976102|525351036|FG000|Overall Study|Withdrawal by Subject|4|||
145681576|NCT03976102|525351037|FG001|Overall Study|Withdrawal by Subject|4|||
145681577|NCT03976102|525351036|FG000|Overall Study|Adverse Event|2|||
145681578|NCT03976102|525351037|FG001|Overall Study|Adverse Event|4|||
145681579|NCT03976102|525351036|FG000|Overall Study|Not related to Covid-19|9|||
145681580|NCT03976102|525351037|FG001|Overall Study|Not related to Covid-19|13|||
145681581|NCT03976102|525351036|FG000|Overall Study|Lost to Follow-up|0|||
145681582|NCT03976102|525351037|FG001|Overall Study|Lost to Follow-up|2|||
145681583|NCT03976102|525351036|FG000|Overall Study|Death|3|||
145681584|NCT03976102|525351037|FG001|Overall Study|Death|2|||
145681585|NCT03976102|525351036|FG000|Overall Study|Physician Decision|1|||
145681586|NCT03976102|525351037|FG001|Overall Study|Physician Decision|1|||
145681587|NCT05066230|525351040|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
145681588|NCT05066230|525351041|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
145681589|NCT05066230|525351040|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
145681590|NCT05066230|525351041|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
145681591|NCT05066230|525351040|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
145681592|NCT05066230|525351041|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
145681593|NCT05066230|525351040|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
145681594|NCT05066230|525351041|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
145681595|NCT05066230|525351040|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
145681596|NCT05066230|525351041|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
145681597|NCT05066230|525351040|FG000|After Week 48|Adverse Event|1|||
145681598|NCT05066230|525351041|FG001|After Week 48|Adverse Event|0|||
145681599|NCT05066230|525351040|FG000|After Week 48|Non-compliance with study schedule|1|||
145681600|NCT05066230|525351041|FG001|After Week 48|Non-compliance with study schedule|0|||
145681601|NCT05066230|525351040|FG000|After Week 48|Withdrawal by Subject|0|||
145681602|NCT05066230|525351041|FG001|After Week 48|Withdrawal by Subject|1|||
145681603|NCT05066230|525351040|FG000|After Week 48|Lost to Follow-up|3|||
145681604|NCT05066230|525351041|FG001|After Week 48|Lost to Follow-up|3|||
145681605|NCT05066230|525351040|FG000|After Week 48|Sponsor Request|115|||
145681606|NCT05066230|525351041|FG001|After Week 48|Sponsor Request|111|||
145681607|NCT03072238|525351042|FG000|Overall Study|Withdrawal by Subject|44|||
145681608|NCT03072238|525351043|FG001|Overall Study|Withdrawal by Subject|64|||
145681609|NCT03072238|525351042|FG000|Overall Study|Lost to Follow-up|14|||
145681610|NCT03072238|525351043|FG001|Overall Study|Lost to Follow-up|5|||
145681611|NCT03072238|525351042|FG000|Overall Study|Physician Decision|4|||
145681612|NCT03072238|525351043|FG001|Overall Study|Physician Decision|6|||
145681613|NCT03072238|525351042|FG000|Overall Study|Death|351|||
145681614|NCT03072238|525351043|FG001|Overall Study|Death|318|||
145681615|NCT03072238|525351042|FG000|Overall Study|Progressive Disease|3|||
145681616|NCT03072238|525351043|FG001|Overall Study|Progressive Disease|4|||
145681617|NCT03072238|525351042|FG000|Overall Study|Reason Not Specified|138|||
145681618|NCT03072238|525351043|FG001|Overall Study|Reason Not Specified|150|||
145681619|NCT01562275|525351049|FG000|Stage 1|Adverse Event|0|||
145681620|NCT01562275|525351050|FG001|Stage 1|Adverse Event|0|||
145681621|NCT01562275|525351051|FG002|Stage 1|Adverse Event|0|||
145681622|NCT01562275|525351052|FG003|Stage 1|Adverse Event|1|||
145681623|NCT01562275|525351053|FG004|Stage 1|Adverse Event|1|||
145681624|NCT01562275|525351054|FG005|Stage 1|Adverse Event|0|||
145681625|NCT01562275|525351055|FG006|Stage 1|Adverse Event|0|||
145681626|NCT01562275|525351056|FG007|Stage 1|Adverse Event|0|||
145681627|NCT01562275|525351057|FG008|Stage 1|Adverse Event|0|||
145681628|NCT01562275|525351058|FG009|Stage 1|Adverse Event|1|||
145681629|NCT01562275|525351059|FG010|Stage 1|Adverse Event|0|||
145681630|NCT01562275|525351060|FG011|Stage 1|Adverse Event|0|||
145681631|NCT01562275|525351061|FG012|Stage 1|Adverse Event|0|||
145681632|NCT01562275|525351049|FG000|Stage 1|Death|1|||
145681633|NCT01562275|525351050|FG001|Stage 1|Death|0|||
145681634|NCT01562275|525351051|FG002|Stage 1|Death|0|||
145681635|NCT01562275|525351052|FG003|Stage 1|Death|0|||
145681636|NCT01562275|525351053|FG004|Stage 1|Death|0|||
145681637|NCT01562275|525351054|FG005|Stage 1|Death|0|||
145681638|NCT01562275|525351055|FG006|Stage 1|Death|0|||
145681639|NCT01562275|525351056|FG007|Stage 1|Death|0|||
145681640|NCT01562275|525351057|FG008|Stage 1|Death|0|||
145681641|NCT01562275|525351058|FG009|Stage 1|Death|0|||
145681642|NCT01562275|525351059|FG010|Stage 1|Death|0|||
145681643|NCT01562275|525351060|FG011|Stage 1|Death|0|||
145681644|NCT01562275|525351061|FG012|Stage 1|Death|0|||
145681645|NCT01562275|525351049|FG000|Stage 1|Non Compliance|0|||
145681646|NCT01562275|525351050|FG001|Stage 1|Non Compliance|0|||
145681647|NCT01562275|525351051|FG002|Stage 1|Non Compliance|1|||
145681648|NCT01562275|525351052|FG003|Stage 1|Non Compliance|0|||
145681649|NCT01562275|525351053|FG004|Stage 1|Non Compliance|0|||
145681650|NCT01562275|525351054|FG005|Stage 1|Non Compliance|0|||
145681651|NCT01562275|525351055|FG006|Stage 1|Non Compliance|0|||
145681652|NCT01562275|525351056|FG007|Stage 1|Non Compliance|0|||
145681653|NCT01562275|525351057|FG008|Stage 1|Non Compliance|0|||
145681654|NCT01562275|525351058|FG009|Stage 1|Non Compliance|0|||
145681655|NCT01562275|525351059|FG010|Stage 1|Non Compliance|0|||
145681656|NCT01562275|525351060|FG011|Stage 1|Non Compliance|0|||
145681657|NCT01562275|525351061|FG012|Stage 1|Non Compliance|0|||
145681658|NCT01562275|525351049|FG000|Stage 1|Physician Decision|0|||
145681659|NCT01562275|525351050|FG001|Stage 1|Physician Decision|0|||
145681660|NCT01562275|525351051|FG002|Stage 1|Physician Decision|0|||
145681661|NCT01562275|525351052|FG003|Stage 1|Physician Decision|0|||
145681662|NCT01562275|525351053|FG004|Stage 1|Physician Decision|1|||
145681663|NCT01562275|525351054|FG005|Stage 1|Physician Decision|0|||
145681664|NCT01562275|525351055|FG006|Stage 1|Physician Decision|1|||
145681665|NCT01562275|525351056|FG007|Stage 1|Physician Decision|0|||
145681666|NCT01562275|525351057|FG008|Stage 1|Physician Decision|1|||
145681667|NCT01562275|525351058|FG009|Stage 1|Physician Decision|0|||
145681668|NCT01562275|525351059|FG010|Stage 1|Physician Decision|0|||
145681669|NCT01562275|525351060|FG011|Stage 1|Physician Decision|0|||
145681670|NCT01562275|525351061|FG012|Stage 1|Physician Decision|0|||
145681671|NCT01562275|525351049|FG000|Stage 1|Progression of Disease|2|||
145681672|NCT01562275|525351050|FG001|Stage 1|Progression of Disease|6|||
145681673|NCT01562275|525351051|FG002|Stage 1|Progression of Disease|2|||
145681674|NCT01562275|525351052|FG003|Stage 1|Progression of Disease|1|||
145681675|NCT01562275|525351053|FG004|Stage 1|Progression of Disease|2|||
145681676|NCT01562275|525351054|FG005|Stage 1|Progression of Disease|4|||
145681677|NCT01562275|525351055|FG006|Stage 1|Progression of Disease|1|||
145681678|NCT01562275|525351056|FG007|Stage 1|Progression of Disease|7|||
145681679|NCT01562275|525351057|FG008|Stage 1|Progression of Disease|2|||
145681680|NCT01562275|525351058|FG009|Stage 1|Progression of Disease|5|||
145681681|NCT01562275|525351059|FG010|Stage 1|Progression of Disease|3|||
145681682|NCT01562275|525351060|FG011|Stage 1|Progression of Disease|0|||
145681683|NCT01562275|525351061|FG012|Stage 1|Progression of Disease|0|||
145681684|NCT01562275|525351049|FG000|Stage 1|Withdrawal by Subject|0|||
145681685|NCT01562275|525351050|FG001|Stage 1|Withdrawal by Subject|1|||
145681686|NCT01562275|525351051|FG002|Stage 1|Withdrawal by Subject|0|||
145681687|NCT01562275|525351052|FG003|Stage 1|Withdrawal by Subject|2|||
145681688|NCT01562275|525351053|FG004|Stage 1|Withdrawal by Subject|0|||
145681689|NCT01562275|525351054|FG005|Stage 1|Withdrawal by Subject|0|||
145681690|NCT01562275|525351055|FG006|Stage 1|Withdrawal by Subject|1|||
145681691|NCT01562275|525351056|FG007|Stage 1|Withdrawal by Subject|0|||
145681692|NCT01562275|525351057|FG008|Stage 1|Withdrawal by Subject|0|||
145681693|NCT01562275|525351058|FG009|Stage 1|Withdrawal by Subject|1|||
145681694|NCT01562275|525351059|FG010|Stage 1|Withdrawal by Subject|0|||
145681695|NCT01562275|525351060|FG011|Stage 1|Withdrawal by Subject|0|||
145681696|NCT01562275|525351061|FG012|Stage 1|Withdrawal by Subject|0|||
145681697|NCT01562275|525351049|FG000|Stage 2|Death|0|||
145681698|NCT01562275|525351050|FG001|Stage 2|Death|0|||
145681699|NCT01562275|525351051|FG002|Stage 2|Death|0|||
145681700|NCT01562275|525351052|FG003|Stage 2|Death|0|||
145681701|NCT01562275|525351053|FG004|Stage 2|Death|0|||
145681702|NCT01562275|525351054|FG005|Stage 2|Death|0|||
145681703|NCT01562275|525351055|FG006|Stage 2|Death|0|||
145681704|NCT01562275|525351056|FG007|Stage 2|Death|0|||
145681705|NCT01562275|525351057|FG008|Stage 2|Death|0|||
145681706|NCT01562275|525351058|FG009|Stage 2|Death|0|||
145681707|NCT01562275|525351059|FG010|Stage 2|Death|0|||
145681708|NCT01562275|525351060|FG011|Stage 2|Death|2|||
145681709|NCT01562275|525351061|FG012|Stage 2|Death|1|||
145681710|NCT01562275|525351049|FG000|Stage 2|Progression of Disease|0|||
145681711|NCT01562275|525351050|FG001|Stage 2|Progression of Disease|0|||
145681712|NCT01562275|525351051|FG002|Stage 2|Progression of Disease|0|||
145681713|NCT01562275|525351052|FG003|Stage 2|Progression of Disease|0|||
145681714|NCT01562275|525351053|FG004|Stage 2|Progression of Disease|0|||
145681715|NCT01562275|525351054|FG005|Stage 2|Progression of Disease|0|||
145681716|NCT01562275|525351055|FG006|Stage 2|Progression of Disease|0|||
145681717|NCT01562275|525351056|FG007|Stage 2|Progression of Disease|0|||
145681718|NCT01562275|525351057|FG008|Stage 2|Progression of Disease|0|||
145681719|NCT01562275|525351058|FG009|Stage 2|Progression of Disease|0|||
145681720|NCT01562275|525351059|FG010|Stage 2|Progression of Disease|0|||
145681721|NCT01562275|525351060|FG011|Stage 2|Progression of Disease|12|||
145681722|NCT01562275|525351061|FG012|Stage 2|Progression of Disease|4|||
145681723|NCT01863368|525351062|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
145681724|NCT01863368|525351063|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
145681725|NCT01863368|525351062|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
145681726|NCT01863368|525351063|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
145681727|NCT01863368|525351062|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
145681728|NCT01863368|525351063|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
145681729|NCT01863368|525351062|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
145681730|NCT01863368|525351063|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
145681731|NCT01863368|525351062|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
145681732|NCT01863368|525351063|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
145681733|NCT01863368|525351062|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
145681734|NCT01863368|525351063|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
145681735|NCT00515112|525351065|FG000|Overall Study|Death|0|||
145681736|NCT00515112|525351066|FG001|Overall Study|Death|1|||
145681737|NCT00515112|525351065|FG000|Overall Study|The study was terminated|3|||
145681738|NCT00515112|525351066|FG001|Overall Study|The study was terminated|2|||
145681739|NCT00307489|525351069|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
145681740|NCT00307489|525351070|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
145681741|NCT00307489|525351069|FG000|Baseline Through Week 48|Physician Decision|1|||
145681742|NCT00307489|525351070|FG001|Baseline Through Week 48|Physician Decision|0|||
145681743|NCT00307489|525351069|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
145681744|NCT00307489|525351070|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
145681745|NCT00307489|525351069|FG000|Week 48 Through Week 168|Adverse Event|1|||
145681746|NCT00307489|525351070|FG001|Week 48 Through Week 168|Adverse Event|0|||
145681747|NCT00307489|525351069|FG000|Week 48 Through Week 168|Physician Decision|1|||
145681748|NCT00307489|525351070|FG001|Week 48 Through Week 168|Physician Decision|0|||
145681749|NCT00307489|525351069|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
145681750|NCT00307489|525351070|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
145681751|NCT00307489|525351069|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
145681752|NCT00307489|525351070|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
145681753|NCT00307489|525351069|FG000|Week 48 Through Week 168|Death|0|||
145681754|NCT00307489|525351070|FG001|Week 48 Through Week 168|Death|1|||
145681755|NCT00307489|525351069|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
145681756|NCT00307489|525351070|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
145681757|NCT00307489|525351069|FG000|Week 48 Through Week 168|Seroconversion|1|||
145681758|NCT00307489|525351070|FG001|Week 48 Through Week 168|Seroconversion|0|||
145681759|NCT00304278|525351072|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
145681760|NCT00304278|525351072|FG000|Overall Study|PT had medical condition preventing TX|1|||
145681761|NCT04025762|525351075|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
145681762|NCT04025762|525351076|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
145681763|NCT01286311|525351078|FG000|Overall Study|Physician did not want outreach sent|14|||
145681764|NCT01286311|525351079|FG001|Overall Study|Physician did not want outreach sent|0|||
145681765|NCT01381549|525351082|FG000|Overall Study|Ineligible: No organisms isolated|0|||
145681766|NCT01381549|525351083|FG001|Overall Study|Ineligible: No organisms isolated|0|||
145681767|NCT01381549|525351084|FG002|Overall Study|Ineligible: No organisms isolated|1|||
145681768|NCT02981953|525351085|FG000|Overall Study|Death|9|||
145681769|NCT02981953|525351085|FG000|Overall Study|Withdrawal by Subject|1|||
145681770|NCT02981953|525351085|FG000|Overall Study|Withdrawal to non-compliance|1|||
145681771|NCT02889900|525351086|FG000|Overall Study|Adverse Event|11|||
145681772|NCT02889900|525351086|FG000|Overall Study|Condition under investigation worsened|32|||
145681773|NCT02889900|525351086|FG000|Overall Study|Other|5|||
145681774|NCT02889900|525351086|FG000|Overall Study|Withdrawal by Subject|7|||
145681775|NCT02889900|525351086|FG000|Overall Study|Not treated|2|||
145681776|NCT00813709|525351097|FG000|Double Blind Period|Adverse Event|4|||
145681777|NCT00813709|525351098|FG001|Double Blind Period|Adverse Event|1|||
145681778|NCT00813709|525351099|FG002|Double Blind Period|Adverse Event|4|||
145681779|NCT00813709|525351100|FG003|Double Blind Period|Adverse Event|0|||
145681780|NCT00813709|525351101|FG004|Double Blind Period|Adverse Event|0|||
145681781|NCT00813709|525351102|FG005|Double Blind Period|Adverse Event|0|||
145681782|NCT00813709|525351097|FG000|Double Blind Period|Lost to Follow-up|3|||
145681783|NCT00813709|525351098|FG001|Double Blind Period|Lost to Follow-up|2|||
145681784|NCT00813709|525351099|FG002|Double Blind Period|Lost to Follow-up|2|||
145681785|NCT00813709|525351100|FG003|Double Blind Period|Lost to Follow-up|0|||
145681786|NCT00813709|525351101|FG004|Double Blind Period|Lost to Follow-up|0|||
145681787|NCT00813709|525351102|FG005|Double Blind Period|Lost to Follow-up|0|||
145681788|NCT00813709|525351097|FG000|Double Blind Period|Switched to open label phase|9|||
145681789|NCT00813709|525351098|FG001|Double Blind Period|Switched to open label phase|26|||
145681790|NCT00813709|525351099|FG002|Double Blind Period|Switched to open label phase|18|||
145681791|NCT00813709|525351100|FG003|Double Blind Period|Switched to open label phase|0|||
145681792|NCT00813709|525351101|FG004|Double Blind Period|Switched to open label phase|0|||
145681793|NCT00813709|525351102|FG005|Double Blind Period|Switched to open label phase|0|||
145681794|NCT00813709|525351097|FG000|Double Blind Period|Randomized but not treated|1|||
145681795|NCT00813709|525351098|FG001|Double Blind Period|Randomized but not treated|3|||
145681796|NCT00813709|525351099|FG002|Double Blind Period|Randomized but not treated|1|||
145681797|NCT00813709|525351100|FG003|Double Blind Period|Randomized but not treated|0|||
145681798|NCT00813709|525351101|FG004|Double Blind Period|Randomized but not treated|0|||
145681799|NCT00813709|525351102|FG005|Double Blind Period|Randomized but not treated|0|||
145681800|NCT00813709|525351097|FG000|Double Blind Period|Other|14|||
145681801|NCT00813709|525351098|FG001|Double Blind Period|Other|9|||
145681802|NCT00813709|525351099|FG002|Double Blind Period|Other|6|||
145681803|NCT00813709|525351100|FG003|Double Blind Period|Other|0|||
145681804|NCT00813709|525351101|FG004|Double Blind Period|Other|0|||
145681805|NCT00813709|525351102|FG005|Double Blind Period|Other|0|||
145681806|NCT00813709|525351097|FG000|Open Label Period|Adverse Event|0|||
145681807|NCT00813709|525351098|FG001|Open Label Period|Adverse Event|0|||
145681808|NCT00813709|525351099|FG002|Open Label Period|Adverse Event|0|||
145681809|NCT00813709|525351100|FG003|Open Label Period|Adverse Event|5|||
145681810|NCT00813709|525351101|FG004|Open Label Period|Adverse Event|4|||
145681811|NCT00813709|525351102|FG005|Open Label Period|Adverse Event|3|||
145681812|NCT00813709|525351097|FG000|Open Label Period|Lack of Efficacy|0|||
145681813|NCT00813709|525351098|FG001|Open Label Period|Lack of Efficacy|0|||
145681814|NCT00813709|525351099|FG002|Open Label Period|Lack of Efficacy|0|||
145681815|NCT00813709|525351100|FG003|Open Label Period|Lack of Efficacy|3|||
145681816|NCT00813709|525351101|FG004|Open Label Period|Lack of Efficacy|1|||
145681817|NCT00813709|525351102|FG005|Open Label Period|Lack of Efficacy|1|||
145681818|NCT00813709|525351097|FG000|Open Label Period|Randomized but not treated|0|||
145681819|NCT00813709|525351098|FG001|Open Label Period|Randomized but not treated|0|||
145681820|NCT00813709|525351099|FG002|Open Label Period|Randomized but not treated|0|||
145681821|NCT00813709|525351100|FG003|Open Label Period|Randomized but not treated|1|||
145681822|NCT00813709|525351101|FG004|Open Label Period|Randomized but not treated|0|||
145681823|NCT00813709|525351102|FG005|Open Label Period|Randomized but not treated|1|||
145681824|NCT00813709|525351097|FG000|Open Label Period|Other|0|||
145681825|NCT00813709|525351098|FG001|Open Label Period|Other|0|||
145681826|NCT00813709|525351099|FG002|Open Label Period|Other|0|||
145681827|NCT00813709|525351100|FG003|Open Label Period|Other|11|||
145681828|NCT00813709|525351101|FG004|Open Label Period|Other|5|||
145681829|NCT00813709|525351102|FG005|Open Label Period|Other|6|||
145681830|NCT00759681|525351103|FG000|Overall Study|Death|2|||
145681831|NCT00759681|525351104|FG001|Overall Study|Death|5|||
145265414|NCT00764465|523819352|FG000|Overall Study|Withdrawal by Subject|0|||
145681832|NCT00759681|525351103|FG000|Overall Study|Lost to Follow-up|8|||
145681833|NCT00759681|525351104|FG001|Overall Study|Lost to Follow-up|5|||
145681834|NCT03146845|525351106|FG000|Overall Study|Reference ulcer healed|1|||
145681835|NCT03146845|525351107|FG001|Overall Study|Reference ulcer healed|0|||
145681836|NCT03146845|525351106|FG000|Overall Study|Physician Decision|1|||
145681837|NCT03146845|525351107|FG001|Overall Study|Physician Decision|0|||
145681838|NCT03146845|525351106|FG000|Overall Study|Adverse Event|1|||
145681839|NCT03146845|525351107|FG001|Overall Study|Adverse Event|0|||
145681840|NCT03146845|525351106|FG000|Overall Study|Withdrawal by Subject|2|||
145681841|NCT03146845|525351107|FG001|Overall Study|Withdrawal by Subject|0|||
145681842|NCT03146845|525351106|FG000|Overall Study|Noncompliance|0|||
145681843|NCT03146845|525351107|FG001|Overall Study|Noncompliance|1|||
145681844|NCT03146845|525351106|FG000|Overall Study|Protocol Violation|0|||
145681845|NCT03146845|525351107|FG001|Overall Study|Protocol Violation|2|||
145681846|NCT03146845|525351106|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
145681847|NCT03146845|525351107|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
145681848|NCT02721147|525351110|FG000|Overall Study|Lost to Follow-up|2|||
145681849|NCT02721147|525351111|FG001|Overall Study|Lost to Follow-up|0|||
145681850|NCT02721147|525351112|FG002|Overall Study|Lost to Follow-up|0|||
145681851|NCT03209492|525351115|FG000|Overall Study|Case Report Forms Uncollected|5|||
145681852|NCT01133678|525351116|FG000|Overall Study|Death|1|||
145681853|NCT01133678|525351117|FG001|Overall Study|Death|1|||
145681854|NCT00879710|525351118|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
145681855|NCT00879710|525351119|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
145681856|NCT00879710|525351120|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
145681857|NCT00879710|525351121|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
145681858|NCT00879710|525351118|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
145681859|NCT00879710|525351119|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
145681860|NCT00879710|525351120|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
145681861|NCT00879710|525351121|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
145681862|NCT01864200|525351122|FG000|Overall Study|Lost to Follow-up|1|||
145681863|NCT01864200|525351123|FG001|Overall Study|Lost to Follow-up|3|||
145681864|NCT01864200|525351122|FG000|Overall Study|Protocol Violation|1|||
145681865|NCT01864200|525351123|FG001|Overall Study|Protocol Violation|0|||
145681866|NCT02514824|525351131|FG000|Overall Study|Withdrawal by Subject|1|||
145681867|NCT02514824|525351132|FG001|Overall Study|Withdrawal by Subject|0|||
145681868|NCT02514824|525351133|FG002|Overall Study|Withdrawal by Subject|0|||
145681869|NCT02514824|525351134|FG003|Overall Study|Withdrawal by Subject|0|||
145681870|NCT02514824|525351131|FG000|Overall Study|Dose-Limiting Toxicity|0|||
145681871|NCT02514824|525351132|FG001|Overall Study|Dose-Limiting Toxicity|1|||
145681872|NCT02514824|525351133|FG002|Overall Study|Dose-Limiting Toxicity|0|||
145681873|NCT02514824|525351134|FG003|Overall Study|Dose-Limiting Toxicity|0|||
145681874|NCT02170207|525351137|FG000|Overall Study|Case report forms unavailable|5|||
145681875|NCT03122860|525351138|FG000|Overall Study|Discontinued Before Treatment|1|||
145681876|NCT03122860|525351139|FG001|Overall Study|Discontinued Before Treatment|1|||
145681877|NCT03122860|525351140|FG002|Overall Study|Discontinued Before Treatment|2|||
145681878|NCT03122860|525351141|FG003|Overall Study|Discontinued Before Treatment|0|||
145681879|NCT03122860|525351142|FG004|Overall Study|Discontinued Before Treatment|1|||
145681880|NCT03122860|525351143|FG005|Overall Study|Discontinued Before Treatment|0|||
145681881|NCT03122860|525351138|FG000|Overall Study|Adverse Event|1|||
145681882|NCT03122860|525351139|FG001|Overall Study|Adverse Event|0|||
145681883|NCT03122860|525351140|FG002|Overall Study|Adverse Event|1|||
145681884|NCT03122860|525351141|FG003|Overall Study|Adverse Event|1|||
145681885|NCT03122860|525351142|FG004|Overall Study|Adverse Event|0|||
145681886|NCT03122860|525351143|FG005|Overall Study|Adverse Event|0|||
145681887|NCT03122860|525351138|FG000|Overall Study|Lost to Follow-up|5|||
145681888|NCT03122860|525351139|FG001|Overall Study|Lost to Follow-up|2|||
145681889|NCT03122860|525351140|FG002|Overall Study|Lost to Follow-up|3|||
145681890|NCT03122860|525351141|FG003|Overall Study|Lost to Follow-up|3|||
145681891|NCT03122860|525351142|FG004|Overall Study|Lost to Follow-up|5|||
145681892|NCT03122860|525351143|FG005|Overall Study|Lost to Follow-up|4|||
145681893|NCT03122860|525351138|FG000|Overall Study|Subject Non-Compliance|0|||
145681894|NCT03122860|525351139|FG001|Overall Study|Subject Non-Compliance|0|||
145681895|NCT03122860|525351140|FG002|Overall Study|Subject Non-Compliance|1|||
145681896|NCT03122860|525351141|FG003|Overall Study|Subject Non-Compliance|0|||
145681897|NCT03122860|525351142|FG004|Overall Study|Subject Non-Compliance|0|||
145681898|NCT03122860|525351143|FG005|Overall Study|Subject Non-Compliance|0|||
145491105|NCT01384734|524652350|FG002|Overall Study|Adhesion problem|0|||
145681899|NCT03122860|525351138|FG000|Overall Study|Withdrawal by Subject|3|||
145681900|NCT03122860|525351139|FG001|Overall Study|Withdrawal by Subject|2|||
145681901|NCT03122860|525351140|FG002|Overall Study|Withdrawal by Subject|5|||
145681902|NCT03122860|525351141|FG003|Overall Study|Withdrawal by Subject|7|||
145681903|NCT03122860|525351142|FG004|Overall Study|Withdrawal by Subject|9|||
145681904|NCT03122860|525351143|FG005|Overall Study|Withdrawal by Subject|8|||
145681905|NCT01138657|525351144|FG000|Overall Study|Adverse Event|3|||
145681906|NCT01138657|525351145|FG001|Overall Study|Adverse Event|10|||
145681907|NCT01138657|525351144|FG000|Overall Study|Lack of Efficacy|2|||
145681908|NCT01138657|525351145|FG001|Overall Study|Lack of Efficacy|1|||
145681909|NCT01138657|525351144|FG000|Overall Study|Lost to Follow-up|0|||
145681910|NCT01138657|525351145|FG001|Overall Study|Lost to Follow-up|3|||
145681911|NCT01138657|525351144|FG000|Overall Study|Miscellaneous Reasons|3|||
145681912|NCT01138657|525351145|FG001|Overall Study|Miscellaneous Reasons|4|||
145681913|NCT01916109|525351146|FG000|Overall Study|Withdrawal by Subject|1|||
145681914|NCT00103857|525351149|FG000|54-Week Base Study|Adverse Event|12|||
145681915|NCT00103857|525351150|FG001|54-Week Base Study|Adverse Event|9|||
145681916|NCT00103857|525351151|FG002|54-Week Base Study|Adverse Event|11|||
145681917|NCT00103857|525351152|FG003|54-Week Base Study|Adverse Event|6|||
145681918|NCT00103857|525351153|FG004|54-Week Base Study|Adverse Event|5|||
145681919|NCT00103857|525351154|FG005|54-Week Base Study|Adverse Event|11|||
145681920|NCT00103857|525351155|FG006|54-Week Base Study|Adverse Event|3|||
145681921|NCT00103857|525351149|FG000|54-Week Base Study|Death|0|||
145681922|NCT00103857|525351150|FG001|54-Week Base Study|Death|0|||
145681923|NCT00103857|525351151|FG002|54-Week Base Study|Death|0|||
145681924|NCT00103857|525351152|FG003|54-Week Base Study|Death|0|||
145681925|NCT00103857|525351153|FG004|54-Week Base Study|Death|1|||
145681926|NCT00103857|525351154|FG005|54-Week Base Study|Death|1|||
145681927|NCT00103857|525351155|FG006|54-Week Base Study|Death|0|||
145681928|NCT00103857|525351149|FG000|54-Week Base Study|Lack of Efficacy|11|||
145681929|NCT00103857|525351150|FG001|54-Week Base Study|Lack of Efficacy|14|||
145681930|NCT00103857|525351151|FG002|54-Week Base Study|Lack of Efficacy|8|||
145681931|NCT00103857|525351152|FG003|54-Week Base Study|Lack of Efficacy|4|||
145681932|NCT00103857|525351153|FG004|54-Week Base Study|Lack of Efficacy|3|||
145681933|NCT00103857|525351154|FG005|54-Week Base Study|Lack of Efficacy|14|||
145681934|NCT00103857|525351155|FG006|54-Week Base Study|Lack of Efficacy|19|||
145681935|NCT00103857|525351149|FG000|54-Week Base Study|Lost to Follow-up|5|||
145681936|NCT00103857|525351150|FG001|54-Week Base Study|Lost to Follow-up|4|||
145681937|NCT00103857|525351151|FG002|54-Week Base Study|Lost to Follow-up|7|||
145681938|NCT00103857|525351152|FG003|54-Week Base Study|Lost to Follow-up|5|||
145681939|NCT00103857|525351153|FG004|54-Week Base Study|Lost to Follow-up|10|||
145681940|NCT00103857|525351154|FG005|54-Week Base Study|Lost to Follow-up|9|||
145681941|NCT00103857|525351155|FG006|54-Week Base Study|Lost to Follow-up|3|||
145681942|NCT00103857|525351149|FG000|54-Week Base Study|Physician Decision|1|||
145681943|NCT00103857|525351150|FG001|54-Week Base Study|Physician Decision|1|||
145681944|NCT00103857|525351151|FG002|54-Week Base Study|Physician Decision|0|||
145681945|NCT00103857|525351152|FG003|54-Week Base Study|Physician Decision|0|||
145681946|NCT00103857|525351153|FG004|54-Week Base Study|Physician Decision|1|||
145681947|NCT00103857|525351154|FG005|54-Week Base Study|Physician Decision|0|||
145681948|NCT00103857|525351155|FG006|54-Week Base Study|Physician Decision|0|||
145681949|NCT00103857|525351149|FG000|54-Week Base Study|Pregnancy|1|||
145681950|NCT00103857|525351150|FG001|54-Week Base Study|Pregnancy|0|||
145681951|NCT00103857|525351151|FG002|54-Week Base Study|Pregnancy|0|||
145681952|NCT00103857|525351152|FG003|54-Week Base Study|Pregnancy|0|||
145681953|NCT00103857|525351153|FG004|54-Week Base Study|Pregnancy|1|||
145681954|NCT00103857|525351154|FG005|54-Week Base Study|Pregnancy|0|||
145681955|NCT00103857|525351155|FG006|54-Week Base Study|Pregnancy|1|||
145681956|NCT00103857|525351149|FG000|54-Week Base Study|Protocol Violation|6|||
145681957|NCT00103857|525351150|FG001|54-Week Base Study|Protocol Violation|4|||
145681958|NCT00103857|525351151|FG002|54-Week Base Study|Protocol Violation|2|||
145681959|NCT00103857|525351152|FG003|54-Week Base Study|Protocol Violation|4|||
145681960|NCT00103857|525351153|FG004|54-Week Base Study|Protocol Violation|0|||
145681961|NCT00103857|525351154|FG005|54-Week Base Study|Protocol Violation|3|||
145681962|NCT00103857|525351155|FG006|54-Week Base Study|Protocol Violation|3|||
145681963|NCT00103857|525351149|FG000|54-Week Base Study|Withdrawal by Subject|17|||
145681964|NCT00103857|525351150|FG001|54-Week Base Study|Withdrawal by Subject|16|||
145681965|NCT00103857|525351151|FG002|54-Week Base Study|Withdrawal by Subject|16|||
145681966|NCT00103857|525351152|FG003|54-Week Base Study|Withdrawal by Subject|15|||
145681967|NCT00103857|525351153|FG004|54-Week Base Study|Withdrawal by Subject|10|||
145681968|NCT00103857|525351154|FG005|54-Week Base Study|Withdrawal by Subject|15|||
145681969|NCT00103857|525351155|FG006|54-Week Base Study|Withdrawal by Subject|4|||
145681970|NCT00103857|525351149|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
145681971|NCT00103857|525351150|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
145681972|NCT00103857|525351151|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
145681973|NCT00103857|525351152|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
145681974|NCT00103857|525351153|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
145681975|NCT00103857|525351154|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
145681976|NCT00103857|525351155|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
145681977|NCT00103857|525351149|FG000|54-Week Base Study|patient moved|0|||
145681978|NCT00103857|525351150|FG001|54-Week Base Study|patient moved|1|||
145681979|NCT00103857|525351151|FG002|54-Week Base Study|patient moved|1|||
145681980|NCT00103857|525351152|FG003|54-Week Base Study|patient moved|2|||
145681981|NCT00103857|525351153|FG004|54-Week Base Study|patient moved|3|||
145681982|NCT00103857|525351154|FG005|54-Week Base Study|patient moved|1|||
145681983|NCT00103857|525351155|FG006|54-Week Base Study|patient moved|0|||
145681984|NCT00103857|525351149|FG000|54-Week Base Study|non-compliance with study procedures|1|||
145681985|NCT00103857|525351150|FG001|54-Week Base Study|non-compliance with study procedures|2|||
145681986|NCT00103857|525351151|FG002|54-Week Base Study|non-compliance with study procedures|0|||
145681987|NCT00103857|525351152|FG003|54-Week Base Study|non-compliance with study procedures|0|||
145681988|NCT00103857|525351153|FG004|54-Week Base Study|non-compliance with study procedures|0|||
145681989|NCT00103857|525351154|FG005|54-Week Base Study|non-compliance with study procedures|2|||
145681990|NCT00103857|525351155|FG006|54-Week Base Study|non-compliance with study procedures|0|||
145681991|NCT00103857|525351149|FG000|54-Week Base Study|patient incarcerated|0|||
145681992|NCT00103857|525351150|FG001|54-Week Base Study|patient incarcerated|0|||
145681993|NCT00103857|525351151|FG002|54-Week Base Study|patient incarcerated|0|||
145681994|NCT00103857|525351152|FG003|54-Week Base Study|patient incarcerated|0|||
145681995|NCT00103857|525351153|FG004|54-Week Base Study|patient incarcerated|1|||
145681996|NCT00103857|525351154|FG005|54-Week Base Study|patient incarcerated|1|||
145681997|NCT00103857|525351155|FG006|54-Week Base Study|patient incarcerated|0|||
145681998|NCT00103857|525351149|FG000|54-Week Base Study|laboratory reporting error|0|||
145681999|NCT00103857|525351150|FG001|54-Week Base Study|laboratory reporting error|0|||
145682000|NCT00103857|525351151|FG002|54-Week Base Study|laboratory reporting error|0|||
145682001|NCT00103857|525351152|FG003|54-Week Base Study|laboratory reporting error|0|||
145682002|NCT00103857|525351153|FG004|54-Week Base Study|laboratory reporting error|1|||
145682003|NCT00103857|525351154|FG005|54-Week Base Study|laboratory reporting error|0|||
145682004|NCT00103857|525351155|FG006|54-Week Base Study|laboratory reporting error|0|||
145682005|NCT00103857|525351149|FG000|54-Week Base Study|site error|0|||
145682006|NCT00103857|525351150|FG001|54-Week Base Study|site error|0|||
145682007|NCT00103857|525351151|FG002|54-Week Base Study|site error|0|||
145682008|NCT00103857|525351152|FG003|54-Week Base Study|site error|0|||
145682009|NCT00103857|525351153|FG004|54-Week Base Study|site error|0|||
145682010|NCT00103857|525351154|FG005|54-Week Base Study|site error|1|||
145682011|NCT00103857|525351155|FG006|54-Week Base Study|site error|0|||
145682012|NCT00103857|525351149|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
145682013|NCT00103857|525351150|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682014|NCT00103857|525351151|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682015|NCT00103857|525351152|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682016|NCT00103857|525351153|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682017|NCT00103857|525351154|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682018|NCT00103857|525351155|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
145682019|NCT00103857|525351149|FG000|50-Week Extension Study|Adverse Event|2|||
145682020|NCT00103857|525351150|FG001|50-Week Extension Study|Adverse Event|3|||
145682021|NCT00103857|525351151|FG002|50-Week Extension Study|Adverse Event|2|||
145682022|NCT00103857|525351152|FG003|50-Week Extension Study|Adverse Event|0|||
145682023|NCT00103857|525351153|FG004|50-Week Extension Study|Adverse Event|1|||
145682024|NCT00103857|525351154|FG005|50-Week Extension Study|Adverse Event|1|||
145682025|NCT00103857|525351155|FG006|50-Week Extension Study|Adverse Event|0|||
145682026|NCT00103857|525351149|FG000|50-Week Extension Study|Death|0|||
145682027|NCT00103857|525351150|FG001|50-Week Extension Study|Death|0|||
145682028|NCT00103857|525351151|FG002|50-Week Extension Study|Death|0|||
145682029|NCT00103857|525351152|FG003|50-Week Extension Study|Death|1|||
145682030|NCT00103857|525351153|FG004|50-Week Extension Study|Death|0|||
145682031|NCT00103857|525351154|FG005|50-Week Extension Study|Death|1|||
145682032|NCT00103857|525351155|FG006|50-Week Extension Study|Death|0|||
145682033|NCT00103857|525351149|FG000|50-Week Extension Study|Lack of Efficacy|26|||
145682034|NCT00103857|525351150|FG001|50-Week Extension Study|Lack of Efficacy|15|||
145682035|NCT00103857|525351151|FG002|50-Week Extension Study|Lack of Efficacy|13|||
145682036|NCT00103857|525351152|FG003|50-Week Extension Study|Lack of Efficacy|16|||
145682037|NCT00103857|525351153|FG004|50-Week Extension Study|Lack of Efficacy|8|||
145682038|NCT00103857|525351154|FG005|50-Week Extension Study|Lack of Efficacy|8|||
145682039|NCT00103857|525351155|FG006|50-Week Extension Study|Lack of Efficacy|0|||
145682040|NCT00103857|525351149|FG000|50-Week Extension Study|Lost to Follow-up|4|||
145682041|NCT00103857|525351150|FG001|50-Week Extension Study|Lost to Follow-up|0|||
145682042|NCT00103857|525351151|FG002|50-Week Extension Study|Lost to Follow-up|1|||
145682043|NCT00103857|525351152|FG003|50-Week Extension Study|Lost to Follow-up|4|||
145682044|NCT00103857|525351153|FG004|50-Week Extension Study|Lost to Follow-up|3|||
145682045|NCT00103857|525351154|FG005|50-Week Extension Study|Lost to Follow-up|3|||
145682046|NCT00103857|525351155|FG006|50-Week Extension Study|Lost to Follow-up|0|||
145682047|NCT00103857|525351149|FG000|50-Week Extension Study|Physician Decision|0|||
145682048|NCT00103857|525351150|FG001|50-Week Extension Study|Physician Decision|1|||
145682049|NCT00103857|525351151|FG002|50-Week Extension Study|Physician Decision|1|||
145682050|NCT00103857|525351152|FG003|50-Week Extension Study|Physician Decision|0|||
145682051|NCT00103857|525351153|FG004|50-Week Extension Study|Physician Decision|0|||
145682052|NCT00103857|525351154|FG005|50-Week Extension Study|Physician Decision|0|||
145682053|NCT00103857|525351155|FG006|50-Week Extension Study|Physician Decision|0|||
145491106|NCT01384734|524652351|FG003|Overall Study|Adhesion problem|1|||
145682054|NCT00103857|525351149|FG000|50-Week Extension Study|Pregnancy|0|||
145682055|NCT00103857|525351150|FG001|50-Week Extension Study|Pregnancy|0|||
145491107|NCT01384734|524652352|FG004|Overall Study|Adhesion problem|0|||
145682056|NCT00103857|525351151|FG002|50-Week Extension Study|Pregnancy|1|||
145682057|NCT00103857|525351152|FG003|50-Week Extension Study|Pregnancy|0|||
145682058|NCT00103857|525351153|FG004|50-Week Extension Study|Pregnancy|1|||
145682059|NCT00103857|525351154|FG005|50-Week Extension Study|Pregnancy|0|||
145682060|NCT00103857|525351155|FG006|50-Week Extension Study|Pregnancy|0|||
145682061|NCT00103857|525351149|FG000|50-Week Extension Study|Protocol Violation|1|||
145682062|NCT00103857|525351150|FG001|50-Week Extension Study|Protocol Violation|1|||
145682063|NCT00103857|525351151|FG002|50-Week Extension Study|Protocol Violation|1|||
145682064|NCT00103857|525351152|FG003|50-Week Extension Study|Protocol Violation|2|||
145682065|NCT00103857|525351153|FG004|50-Week Extension Study|Protocol Violation|0|||
145682066|NCT00103857|525351154|FG005|50-Week Extension Study|Protocol Violation|1|||
145682067|NCT00103857|525351155|FG006|50-Week Extension Study|Protocol Violation|0|||
145682068|NCT00103857|525351149|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
145682069|NCT00103857|525351150|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
145682070|NCT00103857|525351151|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
145682071|NCT00103857|525351152|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
145682072|NCT00103857|525351153|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
145682073|NCT00103857|525351154|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
145682074|NCT00103857|525351155|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
145682075|NCT00103857|525351149|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
145682076|NCT00103857|525351150|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
145682077|NCT00103857|525351151|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
145682078|NCT00103857|525351152|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
145682079|NCT00103857|525351153|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
145682080|NCT00103857|525351154|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
145682081|NCT00103857|525351155|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
145682082|NCT00103857|525351149|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
145682083|NCT00103857|525351150|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
145682084|NCT00103857|525351151|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
145682085|NCT00103857|525351152|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
145682086|NCT00103857|525351153|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
145682087|NCT00103857|525351154|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
145682088|NCT00103857|525351155|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
145682089|NCT00103857|525351149|FG000|50-Week Extension Study|patient moved|0|||
145682090|NCT00103857|525351150|FG001|50-Week Extension Study|patient moved|0|||
145682091|NCT00103857|525351151|FG002|50-Week Extension Study|patient moved|1|||
145682092|NCT00103857|525351152|FG003|50-Week Extension Study|patient moved|2|||
145682093|NCT00103857|525351153|FG004|50-Week Extension Study|patient moved|0|||
145682094|NCT00103857|525351154|FG005|50-Week Extension Study|patient moved|0|||
145682095|NCT00103857|525351155|FG006|50-Week Extension Study|patient moved|0|||
145682096|NCT00103857|525351149|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682097|NCT00103857|525351150|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682098|NCT00103857|525351151|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
145682099|NCT00103857|525351152|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682100|NCT00103857|525351153|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682101|NCT00103857|525351154|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682102|NCT00103857|525351155|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
145682103|NCT00103857|525351149|FG000|50-Week Extension Study|reason unspecified|0|||
145682104|NCT00103857|525351150|FG001|50-Week Extension Study|reason unspecified|0|||
145682105|NCT00103857|525351151|FG002|50-Week Extension Study|reason unspecified|0|||
145682106|NCT00103857|525351152|FG003|50-Week Extension Study|reason unspecified|0|||
145682107|NCT00103857|525351153|FG004|50-Week Extension Study|reason unspecified|1|||
145682108|NCT00103857|525351154|FG005|50-Week Extension Study|reason unspecified|0|||
145682109|NCT00103857|525351155|FG006|50-Week Extension Study|reason unspecified|0|||
145682110|NCT01856569|525351156|FG000|Overall Study|Other|1|||
145682111|NCT01856569|525351156|FG000|Overall Study|Changed Site/Structure|1|||
145682112|NCT01856569|525351156|FG000|Overall Study|Lost to Follow-up|3|||
145682113|NCT01856569|525351156|FG000|Overall Study|Did not met inclusion criteria|8|||
145682114|NCT00696241|525351157|FG000|Overall Study|Adverse Event|11|||
145491108|NCT01384734|524652348|FG000|Overall Study|Early termination|0|||
145491109|NCT01384734|524652349|FG001|Overall Study|Early termination|0|||
145682115|NCT00696241|525351158|FG001|Overall Study|Adverse Event|3|||
145682116|NCT00696241|525351159|FG002|Overall Study|Adverse Event|6|||
145682117|NCT00696241|525351160|FG003|Overall Study|Adverse Event|4|||
145682118|NCT00696241|525351161|FG004|Overall Study|Adverse Event|5|||
145682119|NCT00696241|525351157|FG000|Overall Study|Protocol Violation|1|||
145682120|NCT00696241|525351158|FG001|Overall Study|Protocol Violation|1|||
145682121|NCT00696241|525351159|FG002|Overall Study|Protocol Violation|2|||
145682122|NCT00696241|525351160|FG003|Overall Study|Protocol Violation|0|||
145682123|NCT00696241|525351161|FG004|Overall Study|Protocol Violation|3|||
145682124|NCT00696241|525351157|FG000|Overall Study|Lost to Follow-up|1|||
145682125|NCT00696241|525351158|FG001|Overall Study|Lost to Follow-up|4|||
145682126|NCT00696241|525351159|FG002|Overall Study|Lost to Follow-up|1|||
145682127|NCT00696241|525351160|FG003|Overall Study|Lost to Follow-up|2|||
145682128|NCT00696241|525351161|FG004|Overall Study|Lost to Follow-up|0|||
145682129|NCT00696241|525351157|FG000|Overall Study|Withdrawal by Subject|4|||
145682130|NCT00696241|525351158|FG001|Overall Study|Withdrawal by Subject|8|||
145682131|NCT00696241|525351159|FG002|Overall Study|Withdrawal by Subject|6|||
145682132|NCT00696241|525351160|FG003|Overall Study|Withdrawal by Subject|1|||
145682133|NCT00696241|525351161|FG004|Overall Study|Withdrawal by Subject|0|||
145682134|NCT00696241|525351157|FG000|Overall Study|Lack of Efficacy|1|||
145682135|NCT00696241|525351158|FG001|Overall Study|Lack of Efficacy|5|||
145682136|NCT00696241|525351159|FG002|Overall Study|Lack of Efficacy|4|||
145682137|NCT00696241|525351160|FG003|Overall Study|Lack of Efficacy|5|||
145682138|NCT00696241|525351161|FG004|Overall Study|Lack of Efficacy|3|||
145682139|NCT00696241|525351157|FG000|Overall Study|Other|6|||
145682140|NCT00696241|525351158|FG001|Overall Study|Other|1|||
145682141|NCT00696241|525351159|FG002|Overall Study|Other|5|||
145682142|NCT00696241|525351160|FG003|Overall Study|Other|2|||
145682143|NCT00696241|525351161|FG004|Overall Study|Other|1|||
145682144|NCT03065400|525351162|FG000|Overall Study|Adverse Event|1|||
145682145|NCT03065400|525351162|FG000|Overall Study|Physician Decision|3|||
145682146|NCT03065400|525351162|FG000|Overall Study|Withdrawal by Subject|1|||
145682147|NCT03065400|525351162|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
145682148|NCT00392197|525351165|FG000|Overall Study|Adverse Event|4|||
145682149|NCT00392197|525351166|FG001|Overall Study|Adverse Event|12|||
145682150|NCT00392197|525351165|FG000|Overall Study|Lack of Efficacy|3|||
145682151|NCT00392197|525351166|FG001|Overall Study|Lack of Efficacy|4|||
145682152|NCT00392197|525351165|FG000|Overall Study|Lost to Follow-up|0|||
145682153|NCT00392197|525351166|FG001|Overall Study|Lost to Follow-up|1|||
145682154|NCT00392197|525351165|FG000|Overall Study|Physician Decision|3|||
145682155|NCT00392197|525351166|FG001|Overall Study|Physician Decision|2|||
145682156|NCT00392197|525351165|FG000|Overall Study|Protocol Violation|7|||
145682157|NCT00392197|525351166|FG001|Overall Study|Protocol Violation|5|||
145682158|NCT00392197|525351165|FG000|Overall Study|Withdrawal by Subject|4|||
145682159|NCT00392197|525351166|FG001|Overall Study|Withdrawal by Subject|6|||
145682160|NCT01970527|525351168|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
145682161|NCT01970527|525351169|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
145682162|NCT01970527|525351168|FG000|Treatment|Disease progression|0|||
145682163|NCT01970527|525351169|FG001|Treatment|Disease progression|1|||
145682164|NCT01970527|525351168|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
145682165|NCT01970527|525351169|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
145682166|NCT01970527|525351168|FG000|Treatment|Death|0|||
145682167|NCT01970527|525351169|FG001|Treatment|Death|1|||
145682168|NCT01970527|525351168|FG000|Follow-up Clinic Visit|Disease progression|1|||
145682169|NCT01970527|525351169|FG001|Follow-up Clinic Visit|Disease progression|1|||
145682170|NCT01970527|525351168|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
145682171|NCT01970527|525351169|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
145682172|NCT01970527|525351168|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
145682173|NCT01970527|525351169|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
145682174|NCT03060525|525351170|FG000|Overall Study|moved out of state|1|||
145682175|NCT03060525|525351171|FG001|Overall Study|moved out of state|1|||
145682176|NCT03060525|525351172|FG002|Overall Study|moved out of state|1|||
145682177|NCT03060525|525351173|FG003|Overall Study|moved out of state|1|||
145682178|NCT03060525|525351170|FG000|Overall Study|unable to meet time commitment required of study|2|||
145682179|NCT03060525|525351171|FG001|Overall Study|unable to meet time commitment required of study|3|||
145682180|NCT03060525|525351172|FG002|Overall Study|unable to meet time commitment required of study|3|||
145682181|NCT03060525|525351173|FG003|Overall Study|unable to meet time commitment required of study|1|||
145682182|NCT03060525|525351170|FG000|Overall Study|no longer interested in doing intervention|0|||
145682183|NCT03060525|525351171|FG001|Overall Study|no longer interested in doing intervention|0|||
145682184|NCT03060525|525351172|FG002|Overall Study|no longer interested in doing intervention|0|||
145682185|NCT03060525|525351173|FG003|Overall Study|no longer interested in doing intervention|1|||
145682186|NCT02147093|525351174|FG000|Period 1|Lost to Follow-up|0|||
145682187|NCT02147093|525351175|FG001|Period 1|Lost to Follow-up|1|||
145682188|NCT02147093|525351174|FG000|Period 2|Protocol Violation|2|||
145682189|NCT02147093|525351175|FG001|Period 2|Protocol Violation|0|||
145682190|NCT02189759|525351181|FG000|Overall Study|Lost to Follow-up|0|||
145682191|NCT02189759|525351182|FG001|Overall Study|Lost to Follow-up|0|||
145682192|NCT02189759|525351183|FG002|Overall Study|Lost to Follow-up|2|||
145682193|NCT02189759|525351184|FG003|Overall Study|Lost to Follow-up|5|||
145682194|NCT01147471|525351185|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
145682195|NCT01147471|525351186|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
145682196|NCT01147471|525351185|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
145682197|NCT01147471|525351186|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
145682198|NCT01147471|525351185|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
145682199|NCT01147471|525351186|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
145682200|NCT01147471|525351185|FG000|3 Month Follow Up|Lost to Follow-up|1|||
145682201|NCT01147471|525351186|FG001|3 Month Follow Up|Lost to Follow-up|1|||
145682202|NCT01147471|525351185|FG000|3 Month Follow Up|Physician Decision|0|||
145682203|NCT01147471|525351186|FG001|3 Month Follow Up|Physician Decision|1|||
145682204|NCT01147471|525351185|FG000|6 Month Follow Up|Lost to Follow-up|4|||
145682205|NCT01147471|525351186|FG001|6 Month Follow Up|Lost to Follow-up|2|||
145682206|NCT03890484|525351192|FG000|Overall Study|Lost to Follow-up|1|||
145682207|NCT03890484|525351193|FG001|Overall Study|Lost to Follow-up|1|||
145682208|NCT00518206|525351194|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
145682209|NCT00518206|525351195|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
145682210|NCT00518206|525351194|FG000|Overall Study|Withdrawal by Subject|2|||
145682211|NCT00518206|525351195|FG001|Overall Study|Withdrawal by Subject|0|||
145682212|NCT00518206|525351194|FG000|Overall Study|Drug Supply Issue|1|||
145682213|NCT00518206|525351195|FG001|Overall Study|Drug Supply Issue|0|||
145682214|NCT00518206|525351194|FG000|Overall Study|Reason Unknown|1|||
145682215|NCT00518206|525351195|FG001|Overall Study|Reason Unknown|0|||
145682216|NCT00518206|525351194|FG000|Overall Study|Completion Status Unknown|1|||
145682217|NCT00518206|525351195|FG001|Overall Study|Completion Status Unknown|0|||
145682218|NCT01294644|525351196|FG000|Overall Study|Adverse Event|2|||
145682219|NCT01294644|525351197|FG001|Overall Study|Adverse Event|0|||
145682220|NCT01294644|525351198|FG002|Overall Study|Adverse Event|1|||
145682221|NCT01294644|525351196|FG000|Overall Study|Withdrawal by Subject|3|||
145682222|NCT01294644|525351197|FG001|Overall Study|Withdrawal by Subject|7|||
145682223|NCT01294644|525351198|FG002|Overall Study|Withdrawal by Subject|4|||
145682224|NCT01294644|525351196|FG000|Overall Study|Lost to Follow-up|3|||
145682225|NCT01294644|525351197|FG001|Overall Study|Lost to Follow-up|2|||
145682226|NCT01294644|525351198|FG002|Overall Study|Lost to Follow-up|5|||
145682227|NCT01294644|525351196|FG000|Overall Study|Miscellaneous Reason|2|||
145682228|NCT01294644|525351197|FG001|Overall Study|Miscellaneous Reason|1|||
145682229|NCT01294644|525351198|FG002|Overall Study|Miscellaneous Reason|4|||
145682230|NCT02188459|525351199|FG000|Overall Study|Lost to Follow-up|3|||
145682231|NCT02188459|525351200|FG001|Overall Study|Lost to Follow-up|4|||
145682232|NCT02188459|525351199|FG000|Overall Study|Early Termination|0|||
145682233|NCT02188459|525351200|FG001|Overall Study|Early Termination|3|||
145682234|NCT02548585|525351201|FG000|Overall Study|Withdrawal by Subject|0|||
145682235|NCT02548585|525351202|FG001|Overall Study|Withdrawal by Subject|0|||
145682236|NCT02548585|525351203|FG002|Overall Study|Withdrawal by Subject|0|||
145682237|NCT02548585|525351204|FG003|Overall Study|Withdrawal by Subject|0|||
145682238|NCT02548585|525351205|FG004|Overall Study|Withdrawal by Subject|0|||
145682239|NCT02548585|525351206|FG005|Overall Study|Withdrawal by Subject|1|||
145682240|NCT02548585|525351207|FG006|Overall Study|Withdrawal by Subject|0|||
145682241|NCT02548585|525351201|FG000|Overall Study|Lost to Follow-up|1|||
145682242|NCT02548585|525351202|FG001|Overall Study|Lost to Follow-up|0|||
145682243|NCT02548585|525351203|FG002|Overall Study|Lost to Follow-up|0|||
145682244|NCT02548585|525351204|FG003|Overall Study|Lost to Follow-up|0|||
145682245|NCT02548585|525351205|FG004|Overall Study|Lost to Follow-up|0|||
145682246|NCT02548585|525351206|FG005|Overall Study|Lost to Follow-up|0|||
145682247|NCT02548585|525351207|FG006|Overall Study|Lost to Follow-up|0|||
145682248|NCT02548585|525351201|FG000|Overall Study|Other|1|||
145682249|NCT02548585|525351202|FG001|Overall Study|Other|0|||
145682250|NCT02548585|525351203|FG002|Overall Study|Other|0|||
145682251|NCT02548585|525351204|FG003|Overall Study|Other|2|||
145682252|NCT02548585|525351205|FG004|Overall Study|Other|3|||
145682253|NCT02548585|525351206|FG005|Overall Study|Other|0|||
145682254|NCT02548585|525351207|FG006|Overall Study|Other|1|||
145682255|NCT02548585|525351201|FG000|Overall Study|Randomized but not treated|0|||
145682256|NCT02548585|525351202|FG001|Overall Study|Randomized but not treated|0|||
145682257|NCT02548585|525351203|FG002|Overall Study|Randomized but not treated|0|||
145682258|NCT02548585|525351204|FG003|Overall Study|Randomized but not treated|0|||
145682259|NCT02548585|525351205|FG004|Overall Study|Randomized but not treated|0|||
145682260|NCT02548585|525351206|FG005|Overall Study|Randomized but not treated|1|||
145682261|NCT02548585|525351207|FG006|Overall Study|Randomized but not treated|0|||
145682262|NCT00853957|525351212|FG000|Overall Study|Adverse Event|9|||
145682263|NCT00853957|525351213|FG001|Overall Study|Adverse Event|3|||
145682264|NCT00853957|525351212|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145682265|NCT00853957|525351213|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145682266|NCT00853957|525351212|FG000|Overall Study|Subject withdrew consent|4|||
145682267|NCT00853957|525351213|FG001|Overall Study|Subject withdrew consent|5|||
145682268|NCT00853957|525351212|FG000|Overall Study|Lost to Follow-up|1|||
145682269|NCT00853957|525351213|FG001|Overall Study|Lost to Follow-up|6|||
145682270|NCT00853957|525351212|FG000|Overall Study|Protocol deviation|0|||
145682271|NCT00853957|525351213|FG001|Overall Study|Protocol deviation|3|||
145682272|NCT02942771|525351214|FG000|Overall Study|Adverse Event|1|||
145682273|NCT02942771|525351215|FG001|Overall Study|Adverse Event|0|||
145682274|NCT02942771|525351216|FG002|Overall Study|Adverse Event|0|||
145682275|NCT02942771|525351217|FG003|Overall Study|Adverse Event|0|||
145682276|NCT02942771|525351218|FG004|Overall Study|Adverse Event|2|||
145682277|NCT02942771|525351214|FG000|Overall Study|Lost to Follow-up|1|||
145682278|NCT02942771|525351215|FG001|Overall Study|Lost to Follow-up|0|||
145682279|NCT02942771|525351216|FG002|Overall Study|Lost to Follow-up|0|||
145682280|NCT02942771|525351217|FG003|Overall Study|Lost to Follow-up|0|||
145682281|NCT02942771|525351218|FG004|Overall Study|Lost to Follow-up|0|||
145682282|NCT02942771|525351214|FG000|Overall Study|Withdrawal by Subject|1|||
145682283|NCT02942771|525351215|FG001|Overall Study|Withdrawal by Subject|0|||
145682284|NCT02942771|525351216|FG002|Overall Study|Withdrawal by Subject|0|||
145682285|NCT02942771|525351217|FG003|Overall Study|Withdrawal by Subject|0|||
145682286|NCT02942771|525351218|FG004|Overall Study|Withdrawal by Subject|2|||
145682287|NCT04914897|525353136|FG000|Overall Study|Withdrawal by Subject|3|||
145682288|NCT04914897|525353137|FG001|Overall Study|Withdrawal by Subject|1|||
145682289|NCT04914897|525353138|FG002|Overall Study|Withdrawal by Subject|1|||
145682290|NCT04914897|525353139|FG003|Overall Study|Withdrawal by Subject|1|||
145682291|NCT04914897|525353136|FG000|Overall Study|Poor compliance to protocol|0|||
145682292|NCT04914897|525353137|FG001|Overall Study|Poor compliance to protocol|0|||
145682293|NCT04914897|525353138|FG002|Overall Study|Poor compliance to protocol|1|||
145682294|NCT04914897|525353139|FG003|Overall Study|Poor compliance to protocol|0|||
145682295|NCT04914897|525353136|FG000|Overall Study|Progressive disease|5|||
145682296|NCT04914897|525353137|FG001|Overall Study|Progressive disease|14|||
145682297|NCT04914897|525353138|FG002|Overall Study|Progressive disease|30|||
145682298|NCT04914897|525353139|FG003|Overall Study|Progressive disease|21|||
145682299|NCT04914897|525353136|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145682300|NCT04914897|525353137|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
145682301|NCT04914897|525353138|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
145682302|NCT04914897|525353139|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
145682303|NCT04914897|525353136|FG000|Overall Study|Other|1|||
145682304|NCT04914897|525353137|FG001|Overall Study|Other|0|||
145682305|NCT04914897|525353138|FG002|Overall Study|Other|0|||
145682306|NCT04914897|525353139|FG003|Overall Study|Other|1|||
145682307|NCT03020914|525353140|FG000|Overall Study|Surgery Cancelled|1|||
145682308|NCT03020914|525353141|FG001|Overall Study|Surgery Cancelled|0|||
145682309|NCT04425252|525353143|FG000|Overall Study|Withdrawal by Subject|2|||
145682310|NCT04425252|525353144|FG001|Overall Study|Withdrawal by Subject|1|||
145682311|NCT04425252|525353143|FG000|Overall Study|Lost to Follow-up|1|||
145682312|NCT04425252|525353144|FG001|Overall Study|Lost to Follow-up|0|||
145682313|NCT04425252|525353143|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
145682314|NCT04425252|525353144|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
145682315|NCT01215253|525353145|FG000|Overall Study|Withdrawal by Subject|57|||
145682316|NCT01215253|525353146|FG001|Overall Study|Withdrawal by Subject|35|||
145682317|NCT01215253|525353145|FG000|Overall Study|Physician Decision|9|||
145682318|NCT01215253|525353146|FG001|Overall Study|Physician Decision|12|||
145682319|NCT01215253|525353145|FG000|Overall Study|Lost to Follow-up|6|||
145682320|NCT01215253|525353146|FG001|Overall Study|Lost to Follow-up|4|||
145682321|NCT01215253|525353145|FG000|Overall Study|Other|14|||
145682322|NCT01215253|525353146|FG001|Overall Study|Other|12|||
145682323|NCT03761849|525353147|FG000|Overall Study|transferred to OpenLabelExtension|35|||
145682324|NCT03761849|525353148|FG001|Overall Study|transferred to OpenLabelExtension|34|||
145682325|NCT03761849|525353149|FG002|Overall Study|transferred to OpenLabelExtension|36|||
145682326|NCT03761849|525353150|FG003|Overall Study|transferred to OpenLabelExtension|0|||
145682327|NCT03761849|525353151|FG004|Overall Study|transferred to OpenLabelExtension|0|||
145682328|NCT03761849|525353152|FG005|Overall Study|transferred to OpenLabelExtension|0|||
145682329|NCT03761849|525353147|FG000|Overall Study|Adverse Event|1|||
145682330|NCT03761849|525353148|FG001|Overall Study|Adverse Event|0|||
145682331|NCT03761849|525353149|FG002|Overall Study|Adverse Event|0|||
145682332|NCT03761849|525353150|FG003|Overall Study|Adverse Event|0|||
145682333|NCT03761849|525353151|FG004|Overall Study|Adverse Event|2|||
145682334|NCT03761849|525353152|FG005|Overall Study|Adverse Event|3|||
145682335|NCT03761849|525353147|FG000|Overall Study|Withdrawal by Subject|0|||
145682336|NCT03761849|525353148|FG001|Overall Study|Withdrawal by Subject|0|||
145682337|NCT03761849|525353149|FG002|Overall Study|Withdrawal by Subject|0|||
145682338|NCT03761849|525353150|FG003|Overall Study|Withdrawal by Subject|41|||
145682339|NCT03761849|525353151|FG004|Overall Study|Withdrawal by Subject|43|||
145682340|NCT03761849|525353152|FG005|Overall Study|Withdrawal by Subject|35|||
145682341|NCT03761849|525353147|FG000|Overall Study|Lost to Follow-up|0|||
145682342|NCT03761849|525353148|FG001|Overall Study|Lost to Follow-up|1|||
145682343|NCT03761849|525353149|FG002|Overall Study|Lost to Follow-up|0|||
145682344|NCT03761849|525353150|FG003|Overall Study|Lost to Follow-up|2|||
145682345|NCT03761849|525353151|FG004|Overall Study|Lost to Follow-up|4|||
145682346|NCT03761849|525353152|FG005|Overall Study|Lost to Follow-up|5|||
145682347|NCT03761849|525353147|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
145682348|NCT03761849|525353148|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
145682349|NCT03761849|525353149|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
145682350|NCT03761849|525353150|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
145682351|NCT03761849|525353151|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
145682352|NCT03761849|525353152|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
145682353|NCT03761849|525353147|FG000|Overall Study|Physician Decision|0|||
145682354|NCT03761849|525353148|FG001|Overall Study|Physician Decision|0|||
145682355|NCT03761849|525353149|FG002|Overall Study|Physician Decision|0|||
145682356|NCT03761849|525353150|FG003|Overall Study|Physician Decision|1|||
145682357|NCT03761849|525353151|FG004|Overall Study|Physician Decision|4|||
145682358|NCT03761849|525353152|FG005|Overall Study|Physician Decision|4|||
145682359|NCT03761849|525353147|FG000|Overall Study|Death|0|||
145682360|NCT03761849|525353148|FG001|Overall Study|Death|0|||
145682361|NCT03761849|525353149|FG002|Overall Study|Death|0|||
145682362|NCT03761849|525353150|FG003|Overall Study|Death|1|||
145682363|NCT03761849|525353151|FG004|Overall Study|Death|1|||
145682364|NCT03761849|525353152|FG005|Overall Study|Death|3|||
145682365|NCT03761849|525353147|FG000|Overall Study|Protocol Violation|0|||
145682366|NCT03761849|525353148|FG001|Overall Study|Protocol Violation|0|||
145682367|NCT03761849|525353149|FG002|Overall Study|Protocol Violation|0|||
145682368|NCT03761849|525353150|FG003|Overall Study|Protocol Violation|2|||
145682369|NCT03761849|525353151|FG004|Overall Study|Protocol Violation|2|||
145682370|NCT03761849|525353152|FG005|Overall Study|Protocol Violation|1|||
145682371|NCT03761849|525353147|FG000|Overall Study|Participant could not come to site|0|||
145682372|NCT03761849|525353148|FG001|Overall Study|Participant could not come to site|0|||
145682373|NCT03761849|525353149|FG002|Overall Study|Participant could not come to site|0|||
145682374|NCT03761849|525353150|FG003|Overall Study|Participant could not come to site|0|||
145682375|NCT03761849|525353151|FG004|Overall Study|Participant could not come to site|1|||
145682376|NCT03761849|525353152|FG005|Overall Study|Participant could not come to site|0|||
145682377|NCT03761849|525353147|FG000|Overall Study|SF- safety Finding|0|||
145682378|NCT03761849|525353148|FG001|Overall Study|SF- safety Finding|0|||
145682379|NCT03761849|525353149|FG002|Overall Study|SF- safety Finding|0|||
145682380|NCT03761849|525353150|FG003|Overall Study|SF- safety Finding|0|||
145682381|NCT03761849|525353151|FG004|Overall Study|SF- safety Finding|0|||
145682382|NCT03761849|525353152|FG005|Overall Study|SF- safety Finding|1|||
145682383|NCT03761849|525353147|FG000|Overall Study|Patient did not attend visit|0|||
145682384|NCT03761849|525353148|FG001|Overall Study|Patient did not attend visit|0|||
145682385|NCT03761849|525353149|FG002|Overall Study|Patient did not attend visit|0|||
145682386|NCT03761849|525353150|FG003|Overall Study|Patient did not attend visit|0|||
145682387|NCT03761849|525353151|FG004|Overall Study|Patient did not attend visit|0|||
145682388|NCT03761849|525353152|FG005|Overall Study|Patient did not attend visit|1|||
145682389|NCT01131325|525353153|FG000|Overall Study|Adverse Event|1|||
145682390|NCT01131325|525353153|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
145682391|NCT03840993|525353154|FG000|Overall Study|Adverse Event|1|||
145682392|NCT03840993|525353155|FG001|Overall Study|Adverse Event|0|||
145682393|NCT03840993|525353154|FG000|Overall Study|Lost to Follow-up|4|||
145682394|NCT03840993|525353155|FG001|Overall Study|Lost to Follow-up|0|||
145682395|NCT03840993|525353154|FG000|Overall Study|Physician Decision|0|||
145682396|NCT03840993|525353155|FG001|Overall Study|Physician Decision|1|||
145682397|NCT03840993|525353154|FG000|Overall Study|Pregnancy|0|||
145682398|NCT03840993|525353155|FG001|Overall Study|Pregnancy|1|||
145682399|NCT03840993|525353154|FG000|Overall Study|Withdrawal by Subject|1|||
145682400|NCT03840993|525353155|FG001|Overall Study|Withdrawal by Subject|3|||
145682401|NCT03840993|525353154|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
145682402|NCT03840993|525353155|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
145682403|NCT00828139|525353156|FG000|Overall Study|Adverse Event|8|||
145682404|NCT00828139|525353157|FG001|Overall Study|Adverse Event|1|||
145682405|NCT00828139|525353158|FG002|Overall Study|Adverse Event|10|||
145682406|NCT00828139|525353159|FG003|Overall Study|Adverse Event|5|||
145682407|NCT00828139|525353156|FG000|Overall Study|Death|2|||
145682408|NCT00828139|525353157|FG001|Overall Study|Death|1|||
145682409|NCT00828139|525353158|FG002|Overall Study|Death|0|||
145682410|NCT00828139|525353159|FG003|Overall Study|Death|2|||
145682411|NCT00828139|525353156|FG000|Overall Study|Refusal unrelated to toxicity|3|||
145682412|NCT00828139|525353157|FG001|Overall Study|Refusal unrelated to toxicity|4|||
145682413|NCT00828139|525353158|FG002|Overall Study|Refusal unrelated to toxicity|5|||
145682414|NCT00828139|525353159|FG003|Overall Study|Refusal unrelated to toxicity|3|||
145682415|NCT00828139|525353156|FG000|Overall Study|Disease Progression|24|||
145682416|NCT00828139|525353157|FG001|Overall Study|Disease Progression|33|||
145682417|NCT00828139|525353158|FG002|Overall Study|Disease Progression|35|||
145491110|NCT01384734|524652350|FG002|Overall Study|Early termination|0|||
145491111|NCT01384734|524652351|FG003|Overall Study|Early termination|0|||
145491112|NCT01384734|524652352|FG004|Overall Study|Early termination|1|||
145491113|NCT01384734|524652348|FG000|Overall Study|Physician Decision|1|||
145491114|NCT01384734|524652349|FG001|Overall Study|Physician Decision|0|||
145491115|NCT01384734|524652350|FG002|Overall Study|Physician Decision|0|||
145491116|NCT01384734|524652351|FG003|Overall Study|Physician Decision|0|||
145491117|NCT01384734|524652352|FG004|Overall Study|Physician Decision|0|||
145491118|NCT01300234|524652353|FG000|Overall Study|Adverse Event|1|||
145491119|NCT01300234|524652354|FG001|Overall Study|Adverse Event|1|||
145682418|NCT00828139|525353159|FG003|Overall Study|Disease Progression|39|||
145491120|NCT01300234|524652353|FG000|Overall Study|Protocol Violation|2|||
145682419|NCT00828139|525353156|FG000|Overall Study|Other|4|||
145682420|NCT00828139|525353157|FG001|Overall Study|Other|2|||
145682421|NCT00828139|525353158|FG002|Overall Study|Other|5|||
145682422|NCT00828139|525353159|FG003|Overall Study|Other|2|||
145682423|NCT01714947|525353160|FG000|Part B|Progressive Disease|3|||
145682424|NCT04271254|525353161|FG000|Overall Study|Withdrawal by Subject|3|||
145682425|NCT04751929|525353162|FG000|Overall Study|Withdrawal by Subject|2|||
145682426|NCT04751929|525353163|FG001|Overall Study|Withdrawal by Subject|0|||
145682427|NCT04751929|525353164|FG002|Overall Study|Withdrawal by Subject|0|||
145682428|NCT04751929|525353165|FG003|Overall Study|Withdrawal by Subject|0|||
145682429|NCT04751929|525353162|FG000|Overall Study|Rising PSA|0|||
145682430|NCT04751929|525353163|FG001|Overall Study|Rising PSA|1|||
145682431|NCT04751929|525353164|FG002|Overall Study|Rising PSA|0|||
145682432|NCT04751929|525353165|FG003|Overall Study|Rising PSA|0|||
145682433|NCT04751929|525353162|FG000|Overall Study|Adverse Event|1|||
145682434|NCT04751929|525353163|FG001|Overall Study|Adverse Event|2|||
145682435|NCT04751929|525353164|FG002|Overall Study|Adverse Event|0|||
145682436|NCT04751929|525353165|FG003|Overall Study|Adverse Event|0|||
145682437|NCT04751929|525353162|FG000|Overall Study|Progressive Disease|3|||
145682438|NCT04751929|525353163|FG001|Overall Study|Progressive Disease|4|||
145682439|NCT04751929|525353164|FG002|Overall Study|Progressive Disease|4|||
145682440|NCT04751929|525353165|FG003|Overall Study|Progressive Disease|0|||
145682441|NCT04751929|525353162|FG000|Overall Study|Death|1|||
145682442|NCT04751929|525353163|FG001|Overall Study|Death|1|||
145682443|NCT04751929|525353164|FG002|Overall Study|Death|0|||
145682444|NCT04751929|525353165|FG003|Overall Study|Death|0|||
145682445|NCT01123356|525353166|FG000|Overall Study|Adverse Event|2|||
145682446|NCT01123356|525353166|FG000|Overall Study|Lack of Efficacy|4|||
145682447|NCT01123356|525353166|FG000|Overall Study|Withdrawal by Subject|1|||
145682448|NCT00376259|525353169|FG000|Overall Study|Sponsor request - study termination|21|||
145682449|NCT00376259|525353170|FG001|Overall Study|Sponsor request - study termination|21|||
145682450|NCT00376259|525353169|FG000|Overall Study|Patient request|1|||
145682451|NCT00376259|525353170|FG001|Overall Study|Patient request|0|||
145682452|NCT00930644|525353171|FG000|Overall Study|Withdrawal by Subject|4|||
145682453|NCT00930644|525353171|FG000|Overall Study|Physician Decision|2|||
145682454|NCT00930644|525353171|FG000|Overall Study|Death|1|||
145682455|NCT00930644|525353171|FG000|Overall Study|Adverse Event|16|||
145682456|NCT01877720|525353172|FG000|Overall Study|Adverse Event|1|||
145682457|NCT01877720|525353173|FG001|Overall Study|Adverse Event|0|||
145682458|NCT02068352|525353176|FG000|Overall Study|Lost to Follow-up|0|||
145682459|NCT02068352|525353177|FG001|Overall Study|Lost to Follow-up|2|||
145682460|NCT02068352|525353178|FG002|Overall Study|Lost to Follow-up|0|||
145682461|NCT02068352|525353176|FG000|Overall Study|Adverse Event|4|||
145682462|NCT02068352|525353177|FG001|Overall Study|Adverse Event|2|||
145682463|NCT02068352|525353178|FG002|Overall Study|Adverse Event|7|||
145682464|NCT02068352|525353176|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
145682465|NCT02068352|525353177|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
145682466|NCT02068352|525353178|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
145682467|NCT02068352|525353176|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
145682468|NCT02068352|525353177|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
145682469|NCT02068352|525353178|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
145682470|NCT02068352|525353176|FG000|Overall Study|Protocol Deviation|0|||
145682471|NCT02068352|525353177|FG001|Overall Study|Protocol Deviation|0|||
145682472|NCT02068352|525353178|FG002|Overall Study|Protocol Deviation|1|||
145682473|NCT00473512|525353184|FG000|Period 1 (Phase 1)|Adverse Event|0|||
145682474|NCT00473512|525353185|FG001|Period 1 (Phase 1)|Adverse Event|0|||
145682475|NCT00473512|525353186|FG002|Period 1 (Phase 1)|Adverse Event|0|||
145682476|NCT00473512|525353187|FG003|Period 1 (Phase 1)|Adverse Event|5|||
145682477|NCT00473512|525353188|FG004|Period 1 (Phase 1)|Adverse Event|0|||
145682478|NCT00473512|525353184|FG000|Period 1 (Phase 1)|Death|0|||
145682479|NCT00473512|525353185|FG001|Period 1 (Phase 1)|Death|0|||
145682480|NCT00473512|525353186|FG002|Period 1 (Phase 1)|Death|0|||
145682481|NCT00473512|525353187|FG003|Period 1 (Phase 1)|Death|1|||
145682482|NCT00473512|525353188|FG004|Period 1 (Phase 1)|Death|0|||
145682483|NCT00473512|525353184|FG000|Period 1 (Phase 1)|Disease Progression|1|||
145682484|NCT00473512|525353185|FG001|Period 1 (Phase 1)|Disease Progression|1|||
145682485|NCT00473512|525353186|FG002|Period 1 (Phase 1)|Disease Progression|0|||
145682486|NCT00473512|525353187|FG003|Period 1 (Phase 1)|Disease Progression|10|||
145682487|NCT00473512|525353188|FG004|Period 1 (Phase 1)|Disease Progression|1|||
145682488|NCT00473512|525353184|FG000|Period 1 (Phase 1)|Other|0|||
145682489|NCT00473512|525353185|FG001|Period 1 (Phase 1)|Other|0|||
145682490|NCT00473512|525353186|FG002|Period 1 (Phase 1)|Other|0|||
145682491|NCT00473512|525353187|FG003|Period 1 (Phase 1)|Other|1|||
145682492|NCT00473512|525353188|FG004|Period 1 (Phase 1)|Other|0|||
145682493|NCT00473512|525353184|FG000|Period 2 (Phase 2)|Adverse Event|0|||
145682494|NCT00473512|525353185|FG001|Period 2 (Phase 2)|Adverse Event|0|||
145682495|NCT00473512|525353186|FG002|Period 2 (Phase 2)|Adverse Event|0|||
145682496|NCT00473512|525353187|FG003|Period 2 (Phase 2)|Adverse Event|1|||
145682497|NCT00473512|525353188|FG004|Period 2 (Phase 2)|Adverse Event|0|||
145682498|NCT00473512|525353184|FG000|Period 2 (Phase 2)|Death|0|||
145682499|NCT00473512|525353185|FG001|Period 2 (Phase 2)|Death|0|||
145682500|NCT00473512|525353186|FG002|Period 2 (Phase 2)|Death|0|||
145682501|NCT00473512|525353187|FG003|Period 2 (Phase 2)|Death|1|||
145682502|NCT00473512|525353188|FG004|Period 2 (Phase 2)|Death|1|||
145682503|NCT00473512|525353184|FG000|Period 2 (Phase 2)|Disease Progression|0|||
145682504|NCT00473512|525353185|FG001|Period 2 (Phase 2)|Disease Progression|2|||
145682505|NCT00473512|525353186|FG002|Period 2 (Phase 2)|Disease Progression|2|||
145682506|NCT00473512|525353187|FG003|Period 2 (Phase 2)|Disease Progression|17|||
145682507|NCT00473512|525353188|FG004|Period 2 (Phase 2)|Disease Progression|1|||
145682508|NCT00473512|525353184|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
145682509|NCT00473512|525353185|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
145682510|NCT00473512|525353186|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
145682511|NCT00473512|525353187|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
145682512|NCT00473512|525353188|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
145682513|NCT00473512|525353184|FG000|Period 2 (Phase 2)|Other|1|||
145682514|NCT00473512|525353185|FG001|Period 2 (Phase 2)|Other|0|||
145682515|NCT00473512|525353186|FG002|Period 2 (Phase 2)|Other|0|||
145682516|NCT00473512|525353187|FG003|Period 2 (Phase 2)|Other|3|||
145682517|NCT00473512|525353188|FG004|Period 2 (Phase 2)|Other|0|||
145682518|NCT00267956|525353193|FG000|Controlled Period|Adverse Event|4|||
145682519|NCT00267956|525353194|FG001|Controlled Period|Adverse Event|1|||
145682520|NCT00267956|525353195|FG002|Controlled Period|Adverse Event|0|||
145682521|NCT00267956|525353196|FG003|Controlled Period|Adverse Event|0|||
145682522|NCT00267956|525353193|FG000|Controlled Period|Lack of Efficacy|4|||
145682523|NCT00267956|525353194|FG001|Controlled Period|Lack of Efficacy|2|||
145682524|NCT00267956|525353195|FG002|Controlled Period|Lack of Efficacy|0|||
145682525|NCT00267956|525353196|FG003|Controlled Period|Lack of Efficacy|0|||
145682526|NCT00267956|525353193|FG000|Controlled Period|Lost to Follow-up|2|||
145682527|NCT00267956|525353194|FG001|Controlled Period|Lost to Follow-up|0|||
145682528|NCT00267956|525353195|FG002|Controlled Period|Lost to Follow-up|0|||
145682529|NCT00267956|525353196|FG003|Controlled Period|Lost to Follow-up|0|||
145682530|NCT00267956|525353193|FG000|Controlled Period|Withdrew consent|3|||
145682531|NCT00267956|525353194|FG001|Controlled Period|Withdrew consent|1|||
145682532|NCT00267956|525353195|FG002|Controlled Period|Withdrew consent|0|||
145682533|NCT00267956|525353196|FG003|Controlled Period|Withdrew consent|0|||
145682534|NCT00267956|525353193|FG000|After Controlled Period|Adverse Event|0|||
145682535|NCT00267956|525353194|FG001|After Controlled Period|Adverse Event|0|||
145682536|NCT00267956|525353195|FG002|After Controlled Period|Adverse Event|2|||
145682537|NCT00267956|525353196|FG003|After Controlled Period|Adverse Event|1|||
145682538|NCT00267956|525353193|FG000|After Controlled Period|Lack of Efficacy|0|||
145682539|NCT00267956|525353194|FG001|After Controlled Period|Lack of Efficacy|0|||
145682540|NCT00267956|525353195|FG002|After Controlled Period|Lack of Efficacy|1|||
145682541|NCT00267956|525353196|FG003|After Controlled Period|Lack of Efficacy|1|||
145682542|NCT00267956|525353193|FG000|After Controlled Period|Lost to Follow-up|0|||
145682543|NCT00267956|525353194|FG001|After Controlled Period|Lost to Follow-up|0|||
145682544|NCT00267956|525353195|FG002|After Controlled Period|Lost to Follow-up|1|||
145682545|NCT00267956|525353196|FG003|After Controlled Period|Lost to Follow-up|0|||
145682546|NCT00267956|525353193|FG000|After Controlled Period|Withdrew consent|0|||
145682547|NCT00267956|525353194|FG001|After Controlled Period|Withdrew consent|0|||
145682548|NCT00267956|525353195|FG002|After Controlled Period|Withdrew consent|1|||
145682549|NCT00267956|525353196|FG003|After Controlled Period|Withdrew consent|0|||
145682550|NCT01263223|525353197|FG000|Period 2|Withdrawal by Subject|0|||
145682551|NCT01263223|525353198|FG001|Period 2|Withdrawal by Subject|1|||
145682552|NCT01263223|525353197|FG000|7-day Follow-up|Withdrawal by Subject|0|||
145682553|NCT01263223|525353198|FG001|7-day Follow-up|Withdrawal by Subject|1|||
145682554|NCT01263223|525353197|FG000|7-day Follow-up|Lost to Follow-up|1|||
145682555|NCT01263223|525353198|FG001|7-day Follow-up|Lost to Follow-up|0|||
145682556|NCT01129011|525353199|FG000|Overall Study|Adverse Event|20|||
145682557|NCT01129011|525353200|FG001|Overall Study|Adverse Event|30|||
145682558|NCT01129011|525353199|FG000|Overall Study|Withdrawal by Subject|24|||
145682559|NCT01129011|525353200|FG001|Overall Study|Withdrawal by Subject|8|||
145682560|NCT01129011|525353199|FG000|Overall Study|Lost to Follow-up|6|||
145682561|NCT01129011|525353200|FG001|Overall Study|Lost to Follow-up|7|||
145682562|NCT01129011|525353199|FG000|Overall Study|Duodenal Ulcer|2|||
145682563|NCT01129011|525353200|FG001|Overall Study|Duodenal Ulcer|8|||
145682564|NCT01129011|525353199|FG000|Overall Study|misc|7|||
145682565|NCT01129011|525353200|FG001|Overall Study|misc|4|||
145491121|NCT01300234|524652354|FG001|Overall Study|Protocol Violation|3|||
145682566|NCT02246647|525353201|FG000|Overall Study|Withdrawal by Subject|1|||
145682567|NCT02246647|525353202|FG001|Overall Study|Withdrawal by Subject|1|||
145491122|NCT01300234|524652353|FG000|Overall Study|Withdrawal by Subject|5|||
145491123|NCT01300234|524652354|FG001|Overall Study|Withdrawal by Subject|9|||
145682568|NCT01113541|525353206|FG000|Overall Study|Withdrawal by Subject|1|||
145491124|NCT01300234|524652353|FG000|Overall Study|Lost to Follow-up|14|||
145682569|NCT01113541|525353206|FG000|Overall Study|Protocol Violation|1|||
145682570|NCT01113541|525353206|FG000|Overall Study|Study Terminated by Sponsor|7|||
145682571|NCT01113541|525353206|FG000|Overall Study|Adverse Event|4|||
145682572|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
145682573|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
145682574|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145682575|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145682576|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145682577|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145682578|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
145682579|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
145682580|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
145682581|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
145682582|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145682583|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145682584|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145682585|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
145682586|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
145682587|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145682588|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
145682589|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145682590|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145682591|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145682592|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
145682593|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682594|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
145682595|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682596|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682597|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682598|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682599|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
145682600|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
145682601|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
145682602|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
145682603|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145682604|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145682605|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145682606|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
145682607|NCT03745651|525353207|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
145682608|NCT03745651|525353208|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
145682609|NCT03745651|525353209|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
145682610|NCT03745651|525353210|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
145682611|NCT03745651|525353211|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
145682612|NCT03745651|525353212|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
145682613|NCT03745651|525353213|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
145682614|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682615|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682616|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682617|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682618|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682619|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
145682620|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
145682621|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145682622|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145682623|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145682624|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
145682625|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
145682626|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
145682627|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
145682628|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145682629|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145682630|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
145682631|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
145682632|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
145682633|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
145682634|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
145682635|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145682636|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145682637|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145682638|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
145682639|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
145682640|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
145682641|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
145682642|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
145682643|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
145682644|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
145682645|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
145682646|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
145682647|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
145682648|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
145682649|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682650|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682651|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682652|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682653|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682654|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
145682655|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
145682656|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145682657|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145682658|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
145682659|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
145682660|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
145682661|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
145682662|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
145682663|NCT03745651|525353207|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
145682664|NCT03745651|525353208|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
145682665|NCT03745651|525353209|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
145682666|NCT03745651|525353210|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
145682667|NCT03745651|525353211|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
145682668|NCT03745651|525353212|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
145682669|NCT03745651|525353213|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
145682670|NCT04175834|525353214|FG000|Overall Study|Withdrawal by Subject|1|||
145682671|NCT04175834|525353215|FG001|Overall Study|Withdrawal by Subject|0|||
145682672|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
145682673|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
145682674|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
145682675|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
145682676|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
145682677|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
145682678|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
145682679|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
145682680|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
145682681|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
145682682|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
145682683|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
145682684|NCT01494467|525353224|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
145682685|NCT01494467|525353225|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
145682686|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
145682687|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
145682688|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
145682689|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
145682690|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
145682691|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
145682692|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
145682693|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
145682694|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
145682695|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
145682696|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
145682697|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
145682698|NCT01494467|525353224|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
145682699|NCT01494467|525353225|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
145491125|NCT01300234|524652354|FG001|Overall Study|Lost to Follow-up|12|||
145491126|NCT01300234|524652353|FG000|Overall Study|Pregnancy|2|||
145491127|NCT01300234|524652354|FG001|Overall Study|Pregnancy|1|||
145682700|NCT03693989|525353228|FG000|Overall Study|Protocol Violation|3|||
145682701|NCT03693989|525353229|FG001|Overall Study|Protocol Violation|4|||
145682702|NCT01190436|525353230|FG000|Overall Study|Lost to Follow-up|35|||
145682703|NCT01190436|525353230|FG000|Overall Study|Other|4|||
145682704|NCT00113529|525353231|FG000|Overall Study|Adverse Event|4|||
145682705|NCT00113529|525353231|FG000|Overall Study|Lack of Efficacy|20|||
145682706|NCT00113529|525353231|FG000|Overall Study|Decision of sponsor|6|||
145682707|NCT00113529|525353231|FG000|Overall Study|Withdrawal by Subject|4|||
145682708|NCT00648895|525353234|FG000|Overall Study|Lack of Efficacy|0|||
145682709|NCT00648895|525353235|FG001|Overall Study|Lack of Efficacy|1|||
145682710|NCT03386344|525353236|FG000|Overall Study|Adverse Event|6|||
145682711|NCT03386344|525353237|FG001|Overall Study|Adverse Event|3|||
145682712|NCT03386344|525353238|FG002|Overall Study|Adverse Event|1|||
145682713|NCT03386344|525353236|FG000|Overall Study|Poor Compliance to Protocol|0|||
145682714|NCT03386344|525353237|FG001|Overall Study|Poor Compliance to Protocol|1|||
145682715|NCT03386344|525353238|FG002|Overall Study|Poor Compliance to Protocol|0|||
145682716|NCT03386344|525353236|FG000|Overall Study|Study Terminated by Sponsor|101|||
145682717|NCT03386344|525353237|FG001|Overall Study|Study Terminated by Sponsor|102|||
145682718|NCT03386344|525353238|FG002|Overall Study|Study Terminated by Sponsor|106|||
145682719|NCT03386344|525353236|FG000|Overall Study|Lost to Follow-up|3|||
145682720|NCT03386344|525353237|FG001|Overall Study|Lost to Follow-up|2|||
145682721|NCT03386344|525353238|FG002|Overall Study|Lost to Follow-up|1|||
145682722|NCT03386344|525353236|FG000|Overall Study|At the Participant's own Request|7|||
145682723|NCT03386344|525353237|FG001|Overall Study|At the Participant's own Request|7|||
145682724|NCT03386344|525353238|FG002|Overall Study|At the Participant's own Request|8|||
145682725|NCT03386344|525353236|FG000|Overall Study|Reason not Specified|0|||
145682726|NCT03386344|525353237|FG001|Overall Study|Reason not Specified|1|||
145682727|NCT03386344|525353238|FG002|Overall Study|Reason not Specified|0|||
145682728|NCT01077284|525353241|FG000|Overall Study|Adverse Event|2|||
145682729|NCT01077284|525353242|FG001|Overall Study|Adverse Event|0|||
145682730|NCT01077284|525353243|FG002|Overall Study|Adverse Event|1|||
145682731|NCT01077284|525353241|FG000|Overall Study|Lost to Follow-up|1|||
145682732|NCT01077284|525353242|FG001|Overall Study|Lost to Follow-up|2|||
145682733|NCT01077284|525353243|FG002|Overall Study|Lost to Follow-up|0|||
145682734|NCT01077284|525353241|FG000|Overall Study|Withdrawal by Subject|2|||
145682735|NCT01077284|525353242|FG001|Overall Study|Withdrawal by Subject|3|||
145682736|NCT01077284|525353243|FG002|Overall Study|Withdrawal by Subject|1|||
145682737|NCT01077284|525353241|FG000|Overall Study|Other|0|||
145682738|NCT01077284|525353242|FG001|Overall Study|Other|0|||
145682739|NCT01077284|525353243|FG002|Overall Study|Other|1|||
145682740|NCT01280721|525353244|FG000|Overall Study|Adverse Event|4|||
145682741|NCT01280721|525353244|FG000|Overall Study|Physician Decision|3|||
145682742|NCT01280721|525353244|FG000|Overall Study|Withdrawal by Subject|6|||
145682743|NCT01280721|525353244|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
145682744|NCT01280721|525353244|FG000|Overall Study|No tolerability for the lowest dose|2|||
145682745|NCT01180400|525353245|FG000|Overall Study|Withdrawal by Subject|5|||
145682746|NCT01180400|525353246|FG001|Overall Study|Withdrawal by Subject|6|||
145682747|NCT01180400|525353245|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145682748|NCT01180400|525353246|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
145682749|NCT01180400|525353245|FG000|Overall Study|Adverse Event|12|||
145682750|NCT01180400|525353246|FG001|Overall Study|Adverse Event|10|||
145682751|NCT01180400|525353245|FG000|Overall Study|Severe non-compliance to protocol|1|||
145682752|NCT01180400|525353246|FG001|Overall Study|Severe non-compliance to protocol|2|||
145682753|NCT01180400|525353245|FG000|Overall Study|Condition under investigation worsened|2|||
145682754|NCT01180400|525353246|FG001|Overall Study|Condition under investigation worsened|1|||
145682755|NCT01180400|525353245|FG000|Overall Study|Lack of Efficacy|2|||
145682756|NCT01180400|525353246|FG001|Overall Study|Lack of Efficacy|0|||
145682757|NCT01180400|525353245|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145682758|NCT01180400|525353246|FG001|Overall Study|Study-specific withdrawal criteria|2|||
145682759|NCT01180400|525353245|FG000|Overall Study|Lost to Follow-up|2|||
145682760|NCT01180400|525353246|FG001|Overall Study|Lost to Follow-up|3|||
145682761|NCT01180400|525353245|FG000|Overall Study|Other|0|||
145682762|NCT01180400|525353246|FG001|Overall Study|Other|1|||
145682763|NCT01182285|525353247|FG000|First Intervention Week 1-10|Disease progression|1|||
145491128|NCT01300234|524652353|FG000|Overall Study|Participant reached stopping critera|2|||
145491129|NCT01300234|524652354|FG001|Overall Study|Participant reached stopping critera|0|||
145682764|NCT01182285|525353248|FG001|First Intervention Week 1-10|Disease progression|0|||
145682765|NCT01182285|525353249|FG002|First Intervention Week 1-10|Disease progression|0|||
145682766|NCT01182285|525353247|FG000|First Intervention Week 1-10|Adverse Event|1|||
145682767|NCT01182285|525353248|FG001|First Intervention Week 1-10|Adverse Event|0|||
145682768|NCT01182285|525353249|FG002|First Intervention Week 1-10|Adverse Event|0|||
145682769|NCT01182285|525353247|FG000|First Intervention Week 1-10|Non-compliance|1|||
145682770|NCT01182285|525353248|FG001|First Intervention Week 1-10|Non-compliance|0|||
145682771|NCT01182285|525353249|FG002|First Intervention Week 1-10|Non-compliance|0|||
145682772|NCT01182285|525353247|FG000|Third Intervention Week 11-52|Disease Progression|0|||
145682773|NCT01182285|525353248|FG001|Third Intervention Week 11-52|Disease Progression|0|||
145682774|NCT01182285|525353249|FG002|Third Intervention Week 11-52|Disease Progression|6|||
145682775|NCT01182285|525353247|FG000|Third Intervention Week 11-52|Other|0|||
145682776|NCT01182285|525353248|FG001|Third Intervention Week 11-52|Other|0|||
145682777|NCT01182285|525353249|FG002|Third Intervention Week 11-52|Other|2|||
145682778|NCT02632747|525353250|FG000|Wash-out Period|Adverse Event|1|||
145682779|NCT02632747|525353251|FG001|Wash-out Period|Adverse Event|0|||
145682780|NCT01525875|525353252|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
145682781|NCT01525875|525353253|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
145682782|NCT01525875|525353252|FG000|Open-label Period|Lost to Follow-up|0|||
145682783|NCT01525875|525353253|FG001|Open-label Period|Lost to Follow-up|2|||
145682784|NCT00700999|525353254|FG000|Overall Study|Lost to Follow-up|7|||
145682785|NCT00700999|525353255|FG001|Overall Study|Lost to Follow-up|7|||
145682786|NCT00700999|525353254|FG000|Overall Study|Excluded - did not meet study criteria|0|||
145682787|NCT00700999|525353255|FG001|Overall Study|Excluded - did not meet study criteria|1|||
145682788|NCT00700999|525353254|FG000|Overall Study|Withdrawal by Subject|8|||
145682789|NCT00700999|525353255|FG001|Overall Study|Withdrawal by Subject|1|||
145682790|NCT02379078|525353256|FG000|Overall Study|Lost to Follow-up|33|||
145682791|NCT02379078|525353257|FG001|Overall Study|Lost to Follow-up|30|||
145682792|NCT02379078|525353256|FG000|Overall Study|Withdrawal by Subject|6|||
145682793|NCT02379078|525353257|FG001|Overall Study|Withdrawal by Subject|5|||
145682794|NCT03481725|525353258|FG000|Overall Study|Withdrawal by Subject|1|||
145682795|NCT03481725|525353259|FG001|Overall Study|Withdrawal by Subject|0|||
145682796|NCT01894620|525353260|FG000|Overall Study|Withdrawal by Subject|0|||
145682797|NCT01894620|525353261|FG001|Overall Study|Withdrawal by Subject|1|||
145682798|NCT03875729|525353268|FG000|Overall Study|Adverse Event|0|||
145682799|NCT03875729|525353269|FG001|Overall Study|Adverse Event|5|||
145682800|NCT03875729|525353268|FG000|Overall Study|Withdrawal by Subject|8|||
145682801|NCT03875729|525353269|FG001|Overall Study|Withdrawal by Subject|11|||
145682802|NCT03875729|525353268|FG000|Overall Study|Pregnancy|0|||
145682803|NCT03875729|525353269|FG001|Overall Study|Pregnancy|1|||
145682804|NCT03875729|525353268|FG000|Overall Study|Lost to Follow-up|0|||
145682805|NCT03875729|525353269|FG001|Overall Study|Lost to Follow-up|5|||
145682806|NCT03875729|525353268|FG000|Overall Study|Personal reasons|2|||
145682807|NCT03875729|525353269|FG001|Overall Study|Personal reasons|0|||
145682808|NCT02399449|525353272|FG000|Overall Study|Withdrawal by Subject|3|||
145682809|NCT02399449|525353273|FG001|Overall Study|Withdrawal by Subject|9|||
145682810|NCT02399449|525353272|FG000|Overall Study|Physician Decision|0|||
145682811|NCT02399449|525353273|FG001|Overall Study|Physician Decision|1|||
145682812|NCT02516202|525353274|FG000|Overall Study|Withdrawal by Subject|1|||
145682813|NCT02516202|525353275|FG001|Overall Study|Withdrawal by Subject|0|||
145682814|NCT02516202|525353276|FG002|Overall Study|Withdrawal by Subject|1|||
145682815|NCT02516202|525353274|FG000|Overall Study|Lost to Follow-up|1|||
145682816|NCT02516202|525353275|FG001|Overall Study|Lost to Follow-up|1|||
145491130|NCT01300234|524652353|FG000|Overall Study|Participant stopped medication|1|||
145491131|NCT01300234|524652354|FG001|Overall Study|Participant stopped medication|1|||
145491132|NCT01300234|524652353|FG000|Overall Study|Participant refused return to hospital|1|||
145491133|NCT01300234|524652354|FG001|Overall Study|Participant refused return to hospital|0|||
145491134|NCT04158583|524652355|FG000|Overall Study|Withdrawal by Subject|1|||
145491135|NCT04158583|524652356|FG001|Overall Study|Withdrawal by Subject|1|||
145491136|NCT04158583|524652357|FG002|Overall Study|Withdrawal by Subject|0|||
145491137|NCT04158583|524652358|FG003|Overall Study|Withdrawal by Subject|0|||
145491138|NCT04158583|524652359|FG004|Overall Study|Withdrawal by Subject|1|||
145491139|NCT04158583|524652360|FG005|Overall Study|Withdrawal by Subject|0|||
145491140|NCT04158583|524652361|FG006|Overall Study|Withdrawal by Subject|0|||
145491141|NCT04158583|524652362|FG007|Overall Study|Withdrawal by Subject|0|||
145491142|NCT04158583|524652363|FG008|Overall Study|Withdrawal by Subject|2|||
145491143|NCT04158583|524652364|FG009|Overall Study|Withdrawal by Subject|0|||
145491144|NCT04158583|524652355|FG000|Overall Study|Study Terminated by Sponsor|0|||
145491145|NCT04158583|524652356|FG001|Overall Study|Study Terminated by Sponsor|0|||
145682817|NCT02516202|525353276|FG002|Overall Study|Lost to Follow-up|1|||
145682818|NCT02516202|525353274|FG000|Overall Study|Stopped Follow-up|0|||
145682819|NCT02516202|525353275|FG001|Overall Study|Stopped Follow-up|0|||
145682820|NCT02516202|525353276|FG002|Overall Study|Stopped Follow-up|1|||
145682821|NCT02159352|525353279|FG000|Overall Study|Adverse Event|3|||
145682822|NCT02159352|525353280|FG001|Overall Study|Adverse Event|1|||
145682823|NCT02159352|525353279|FG000|Overall Study|Withdrawal by Subject|0|||
145491146|NCT04158583|524652357|FG002|Overall Study|Study Terminated by Sponsor|0|||
145491147|NCT04158583|524652358|FG003|Overall Study|Study Terminated by Sponsor|1|||
145491148|NCT04158583|524652359|FG004|Overall Study|Study Terminated by Sponsor|0|||
145682824|NCT02159352|525353280|FG001|Overall Study|Withdrawal by Subject|1|||
145682825|NCT00529529|525353285|FG000|Overall Study|Adverse Event|12|||
145682826|NCT00529529|525353286|FG001|Overall Study|Adverse Event|17|||
145682827|NCT00529529|525353287|FG002|Overall Study|Adverse Event|8|||
145682828|NCT00529529|525353285|FG000|Overall Study|Subject withdrew consent|12|||
145682829|NCT00529529|525353286|FG001|Overall Study|Subject withdrew consent|9|||
145682830|NCT00529529|525353287|FG002|Overall Study|Subject withdrew consent|12|||
145682831|NCT00529529|525353285|FG000|Overall Study|Protocol deviation|8|||
145682832|NCT00529529|525353286|FG001|Overall Study|Protocol deviation|12|||
145682833|NCT00529529|525353287|FG002|Overall Study|Protocol deviation|5|||
145682834|NCT00529529|525353285|FG000|Overall Study|Lost to Follow-up|5|||
145682835|NCT00529529|525353286|FG001|Overall Study|Lost to Follow-up|3|||
145682836|NCT00529529|525353287|FG002|Overall Study|Lost to Follow-up|1|||
145682837|NCT00529529|525353285|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
145682838|NCT00529529|525353286|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145682839|NCT00529529|525353287|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
145682840|NCT00529529|525353285|FG000|Overall Study|Death|2|||
145682841|NCT00529529|525353286|FG001|Overall Study|Death|0|||
145682842|NCT00529529|525353287|FG002|Overall Study|Death|0|||
145682843|NCT00529529|525353285|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145682844|NCT00529529|525353286|FG001|Overall Study|Abnormal test procedure result(s)|0|||
145682845|NCT00529529|525353287|FG002|Overall Study|Abnormal test procedure result(s)|0|||
145682846|NCT00529529|525353285|FG000|Overall Study|Administrative problems|1|||
145682847|NCT00529529|525353286|FG001|Overall Study|Administrative problems|0|||
145682848|NCT00529529|525353287|FG002|Overall Study|Administrative problems|3|||
145682849|NCT01020435|525353288|FG000|Overall Study|Lost to Follow-up|0|||
145682850|NCT01020435|525353289|FG001|Overall Study|Lost to Follow-up|1|||
145682851|NCT01000649|525353292|FG000|Overall Study|Adverse Event|5|||
145682852|NCT01000649|525353293|FG001|Overall Study|Adverse Event|1|||
145682853|NCT01000649|525353294|FG002|Overall Study|Adverse Event|2|||
145682854|NCT01000649|525353295|FG003|Overall Study|Adverse Event|4|||
145682855|NCT01000649|525353292|FG000|Overall Study|Lost to Follow-up|0|||
145682856|NCT01000649|525353293|FG001|Overall Study|Lost to Follow-up|2|||
145682857|NCT01000649|525353294|FG002|Overall Study|Lost to Follow-up|0|||
145682858|NCT01000649|525353295|FG003|Overall Study|Lost to Follow-up|2|||
145682859|NCT02707952|525353296|FG000|Overall Study|Adverse Event|1|||
145682860|NCT02707952|525353297|FG001|Overall Study|Adverse Event|0|||
145682861|NCT02707952|525353298|FG002|Overall Study|Adverse Event|0|||
145682862|NCT02707952|525353299|FG003|Overall Study|Adverse Event|0|||
145682863|NCT02707952|525353296|FG000|Overall Study|Lost to Follow-up|1|||
145682864|NCT02707952|525353297|FG001|Overall Study|Lost to Follow-up|0|||
145682865|NCT02707952|525353298|FG002|Overall Study|Lost to Follow-up|0|||
145682866|NCT02707952|525353299|FG003|Overall Study|Lost to Follow-up|0|||
145682867|NCT02707952|525353296|FG000|Overall Study|Withdrawal by Subject|0|||
145682868|NCT02707952|525353297|FG001|Overall Study|Withdrawal by Subject|1|||
145682869|NCT02707952|525353298|FG002|Overall Study|Withdrawal by Subject|2|||
145682870|NCT02707952|525353299|FG003|Overall Study|Withdrawal by Subject|0|||
145682871|NCT00871715|525353300|FG000|Overall Study|Withdrawal by Subject|6|||
145682872|NCT00871715|525353301|FG001|Overall Study|Withdrawal by Subject|10|||
145682873|NCT00871715|525353302|FG002|Overall Study|Withdrawal by Subject|15|||
145682874|NCT00871715|525353300|FG000|Overall Study|Physician Decision|6|||
145682875|NCT00871715|525353301|FG001|Overall Study|Physician Decision|0|||
145682876|NCT00871715|525353302|FG002|Overall Study|Physician Decision|2|||
145682877|NCT00871715|525353300|FG000|Overall Study|Lost to Follow-up|3|||
145682878|NCT00871715|525353301|FG001|Overall Study|Lost to Follow-up|6|||
145682879|NCT00871715|525353302|FG002|Overall Study|Lost to Follow-up|9|||
145682880|NCT01794689|525353303|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
145682881|NCT01794689|525353304|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
145682882|NCT01794689|525353305|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
145682883|NCT01794689|525353306|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
145682884|NCT01794689|525353303|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
145682885|NCT01794689|525353304|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
145682886|NCT01794689|525353305|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
145682887|NCT01794689|525353306|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
145491149|NCT04158583|524652360|FG005|Overall Study|Study Terminated by Sponsor|0|||
145682888|NCT01794689|525353303|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
145682889|NCT01794689|525353304|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
145682890|NCT01794689|525353305|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
145682891|NCT01794689|525353306|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
145682892|NCT01794689|525353303|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
145682893|NCT01794689|525353304|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
145682894|NCT01794689|525353305|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
145682895|NCT01794689|525353306|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
145682896|NCT02612285|525353307|FG000|Overall Study|Withdrawal by Subject|1|||
145682897|NCT01986348|525353308|FG000|Overall Study|Death|8|||
145682898|NCT01986348|525353309|FG001|Overall Study|Death|22|||
145682899|NCT01986348|525353310|FG002|Overall Study|Death|10|||
145682900|NCT01986348|525353311|FG003|Overall Study|Death|21|||
145682901|NCT01986348|525353308|FG000|Overall Study|Lost to Follow-up|0|||
145682902|NCT01986348|525353309|FG001|Overall Study|Lost to Follow-up|0|||
145682903|NCT01986348|525353310|FG002|Overall Study|Lost to Follow-up|0|||
145682904|NCT01986348|525353311|FG003|Overall Study|Lost to Follow-up|2|||
145682905|NCT01986348|525353308|FG000|Overall Study|Physician Decision|0|||
145682906|NCT01986348|525353309|FG001|Overall Study|Physician Decision|0|||
145682907|NCT01986348|525353310|FG002|Overall Study|Physician Decision|0|||
145682908|NCT01986348|525353311|FG003|Overall Study|Physician Decision|1|||
145682909|NCT01986348|525353308|FG000|Overall Study|Progressive Disease|0|||
145682910|NCT01986348|525353309|FG001|Overall Study|Progressive Disease|0|||
145682911|NCT01986348|525353310|FG002|Overall Study|Progressive Disease|2|||
145682912|NCT01986348|525353311|FG003|Overall Study|Progressive Disease|0|||
145682913|NCT01986348|525353308|FG000|Overall Study|Withdrawal by Participant|0|||
145682914|NCT01986348|525353309|FG001|Overall Study|Withdrawal by Participant|1|||
145682915|NCT01986348|525353310|FG002|Overall Study|Withdrawal by Participant|2|||
145682916|NCT01986348|525353311|FG003|Overall Study|Withdrawal by Participant|1|||
145682917|NCT01986348|525353308|FG000|Overall Study|Study Terminated by Sponsor|0|||
145682918|NCT01986348|525353309|FG001|Overall Study|Study Terminated by Sponsor|0|||
145682919|NCT01986348|525353310|FG002|Overall Study|Study Terminated by Sponsor|0|||
145682920|NCT01986348|525353311|FG003|Overall Study|Study Terminated by Sponsor|3|||
145682921|NCT01986348|525353308|FG000|Overall Study|Other-unspecified|0|||
145682922|NCT01986348|525353309|FG001|Overall Study|Other-unspecified|1|||
145682923|NCT01986348|525353310|FG002|Overall Study|Other-unspecified|0|||
145682924|NCT01986348|525353311|FG003|Overall Study|Other-unspecified|2|||
145682925|NCT04919499|525353312|FG000|Overall Study|Adverse Event|0|||
145682926|NCT04919499|525353313|FG001|Overall Study|Adverse Event|0|||
145682927|NCT04919499|525353314|FG002|Overall Study|Adverse Event|0|||
145682928|NCT04919499|525353315|FG003|Overall Study|Adverse Event|0|||
145682929|NCT04919499|525353316|FG004|Overall Study|Adverse Event|2|||
145682930|NCT04919499|525353312|FG000|Overall Study|Not treated|0|||
145682931|NCT04919499|525353313|FG001|Overall Study|Not treated|0|||
145682932|NCT04919499|525353314|FG002|Overall Study|Not treated|0|||
145682933|NCT04919499|525353315|FG003|Overall Study|Not treated|1|||
145682934|NCT04919499|525353316|FG004|Overall Study|Not treated|0|||
145682935|NCT04820023|525355265|FG000|Overall Study|Death|0|||
145682936|NCT04820023|525355266|FG001|Overall Study|Death|0|||
145682937|NCT04820023|525355267|FG002|Overall Study|Death|0|||
145682938|NCT04820023|525355268|FG003|Overall Study|Death|0|||
145682939|NCT04820023|525355269|FG004|Overall Study|Death|0|||
145682940|NCT04820023|525355270|FG005|Overall Study|Death|0|||
145682941|NCT04820023|525355271|FG006|Overall Study|Death|1|||
145682942|NCT04820023|525355272|FG007|Overall Study|Death|0|||
145682943|NCT04820023|525355273|FG008|Overall Study|Death|1|||
145682944|NCT04820023|525355265|FG000|Overall Study|Withdrawal by Subject|1|||
145682945|NCT04820023|525355266|FG001|Overall Study|Withdrawal by Subject|2|||
145682946|NCT04820023|525355267|FG002|Overall Study|Withdrawal by Subject|2|||
145682947|NCT04820023|525355268|FG003|Overall Study|Withdrawal by Subject|1|||
145682948|NCT04820023|525355269|FG004|Overall Study|Withdrawal by Subject|4|||
145682949|NCT04820023|525355270|FG005|Overall Study|Withdrawal by Subject|3|||
145682950|NCT04820023|525355271|FG006|Overall Study|Withdrawal by Subject|3|||
145682951|NCT04820023|525355272|FG007|Overall Study|Withdrawal by Subject|6|||
145682952|NCT04820023|525355273|FG008|Overall Study|Withdrawal by Subject|5|||
145682953|NCT04820023|525355265|FG000|Overall Study|Progressive Disease|3|||
145682954|NCT04820023|525355266|FG001|Overall Study|Progressive Disease|0|||
145682955|NCT04820023|525355267|FG002|Overall Study|Progressive Disease|2|||
145682956|NCT04820023|525355268|FG003|Overall Study|Progressive Disease|2|||
145682957|NCT04820023|525355269|FG004|Overall Study|Progressive Disease|2|||
145682958|NCT04820023|525355270|FG005|Overall Study|Progressive Disease|0|||
145682959|NCT04820023|525355271|FG006|Overall Study|Progressive Disease|1|||
145682960|NCT04820023|525355272|FG007|Overall Study|Progressive Disease|1|||
145682961|NCT04820023|525355273|FG008|Overall Study|Progressive Disease|0|||
145682962|NCT04820023|525355265|FG000|Overall Study|New anti-cancer therapy|0|||
145682963|NCT04820023|525355266|FG001|Overall Study|New anti-cancer therapy|0|||
145682964|NCT04820023|525355267|FG002|Overall Study|New anti-cancer therapy|0|||
145682965|NCT04820023|525355268|FG003|Overall Study|New anti-cancer therapy|0|||
145682966|NCT04820023|525355269|FG004|Overall Study|New anti-cancer therapy|2|||
145682967|NCT04820023|525355270|FG005|Overall Study|New anti-cancer therapy|0|||
145682968|NCT04820023|525355271|FG006|Overall Study|New anti-cancer therapy|0|||
145682969|NCT04820023|525355272|FG007|Overall Study|New anti-cancer therapy|0|||
145682970|NCT04820023|525355273|FG008|Overall Study|New anti-cancer therapy|0|||
145682971|NCT04820023|525355265|FG000|Overall Study|Other|0|||
145682972|NCT04820023|525355266|FG001|Overall Study|Other|1|||
145682973|NCT04820023|525355267|FG002|Overall Study|Other|0|||
145682974|NCT04820023|525355268|FG003|Overall Study|Other|0|||
145682975|NCT04820023|525355269|FG004|Overall Study|Other|0|||
145682976|NCT04820023|525355270|FG005|Overall Study|Other|0|||
145682977|NCT04820023|525355271|FG006|Overall Study|Other|0|||
145682978|NCT04820023|525355272|FG007|Overall Study|Other|2|||
145682979|NCT04820023|525355273|FG008|Overall Study|Other|0|||
145682980|NCT01020487|525355274|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
145682981|NCT01020487|525355275|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
145682982|NCT01020487|525355276|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
145682983|NCT01020487|525355274|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
145682984|NCT01020487|525355275|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
145682985|NCT01020487|525355276|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
145682986|NCT01020487|525355274|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
145682987|NCT01020487|525355275|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
145682988|NCT01020487|525355276|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
145682989|NCT01020487|525355274|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
145682990|NCT01020487|525355275|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
145682991|NCT01020487|525355276|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
145682992|NCT01020487|525355274|FG000|Part 2 Open-label Period|Adverse Event|0|||
145682993|NCT01020487|525355275|FG001|Part 2 Open-label Period|Adverse Event|4|||
145682994|NCT01020487|525355276|FG002|Part 2 Open-label Period|Adverse Event|1|||
145682995|NCT01945593|525355277|FG000|Overall Study|Adverse Event|0|||
145682996|NCT01945593|525355278|FG001|Overall Study|Adverse Event|0|||
145682997|NCT01945593|525355279|FG002|Overall Study|Adverse Event|0|||
145682998|NCT01945593|525355280|FG003|Overall Study|Adverse Event|5|||
145682999|NCT01945593|525355277|FG000|Overall Study|Physician Decision|0|||
145683000|NCT01945593|525355278|FG001|Overall Study|Physician Decision|0|||
145683001|NCT01945593|525355279|FG002|Overall Study|Physician Decision|1|||
145683002|NCT01945593|525355280|FG003|Overall Study|Physician Decision|1|||
145683003|NCT01945593|525355277|FG000|Overall Study|Withdrawal by Subject|0|||
145683004|NCT01945593|525355278|FG001|Overall Study|Withdrawal by Subject|2|||
145683005|NCT01945593|525355279|FG002|Overall Study|Withdrawal by Subject|0|||
145683006|NCT01945593|525355280|FG003|Overall Study|Withdrawal by Subject|4|||
145683007|NCT01945593|525355277|FG000|Overall Study|Protocol Violation|0|||
145683008|NCT01945593|525355278|FG001|Overall Study|Protocol Violation|2|||
145683009|NCT01945593|525355279|FG002|Overall Study|Protocol Violation|1|||
145683010|NCT01945593|525355280|FG003|Overall Study|Protocol Violation|3|||
145683011|NCT01945593|525355277|FG000|Overall Study|Death|0|||
145683012|NCT01945593|525355278|FG001|Overall Study|Death|0|||
145683013|NCT01945593|525355279|FG002|Overall Study|Death|1|||
145683014|NCT01945593|525355280|FG003|Overall Study|Death|0|||
145683015|NCT01945593|525355277|FG000|Overall Study|Other: Terminated|0|||
145683016|NCT01945593|525355278|FG001|Overall Study|Other: Terminated|0|||
145683017|NCT01945593|525355279|FG002|Overall Study|Other: Terminated|0|||
145683018|NCT01945593|525355280|FG003|Overall Study|Other: Terminated|1|||
145683019|NCT01945593|525355277|FG000|Overall Study|Other: Surgical Procedure|0|||
145683020|NCT01945593|525355278|FG001|Overall Study|Other: Surgical Procedure|2|||
145683021|NCT01945593|525355279|FG002|Overall Study|Other: Surgical Procedure|0|||
145683022|NCT01945593|525355280|FG003|Overall Study|Other: Surgical Procedure|6|||
145683023|NCT01945593|525355277|FG000|Overall Study|Other: Screen Failure|0|||
145683024|NCT01945593|525355278|FG001|Overall Study|Other: Screen Failure|2|||
145683025|NCT01945593|525355279|FG002|Overall Study|Other: Screen Failure|0|||
145683026|NCT01945593|525355280|FG003|Overall Study|Other: Screen Failure|0|||
145683027|NCT00228813|525355281|FG000|Overall Study|Death|4|||
145683028|NCT00507429|525355282|FG000|Treatment Phase|Disease Progression|12|||
145683029|NCT00507429|525355283|FG001|Treatment Phase|Disease Progression|5|||
145683030|NCT00507429|525355282|FG000|Treatment Phase|Adverse Event|12|||
145683031|NCT00507429|525355283|FG001|Treatment Phase|Adverse Event|5|||
145683032|NCT00507429|525355282|FG000|Treatment Phase|Withdrawal by Subject|3|||
145683033|NCT00507429|525355283|FG001|Treatment Phase|Withdrawal by Subject|3|||
145683034|NCT00507429|525355282|FG000|Treatment Phase|Physician Decision|4|||
145683035|NCT00507429|525355283|FG001|Treatment Phase|Physician Decision|2|||
145683036|NCT00507429|525355282|FG000|Treatment Phase|Other|6|||
145683037|NCT00507429|525355283|FG001|Treatment Phase|Other|3|||
145683038|NCT00507429|525355282|FG000|Maintenance Phase|Progressive Disease|14|||
145683039|NCT00507429|525355283|FG001|Maintenance Phase|Progressive Disease|0|||
145683040|NCT01437540|525355285|FG000|Overall Study|Not listed below|7|||
145683041|NCT01437540|525355286|FG001|Overall Study|Not listed below|6|||
145683042|NCT01437540|525355285|FG000|Overall Study|COPD exacerbation|13|||
145491150|NCT04158583|524652361|FG006|Overall Study|Study Terminated by Sponsor|0|||
145491151|NCT04158583|524652362|FG007|Overall Study|Study Terminated by Sponsor|0|||
145491152|NCT04158583|524652363|FG008|Overall Study|Study Terminated by Sponsor|0|||
145491153|NCT04158583|524652364|FG009|Overall Study|Study Terminated by Sponsor|0|||
145491154|NCT04158583|524652355|FG000|Overall Study|Progressive Disease|1|||
145491155|NCT04158583|524652356|FG001|Overall Study|Progressive Disease|0|||
145491156|NCT04158583|524652357|FG002|Overall Study|Progressive Disease|3|||
145491157|NCT04158583|524652358|FG003|Overall Study|Progressive Disease|5|||
145683043|NCT01437540|525355286|FG001|Overall Study|COPD exacerbation|3|||
145683044|NCT01437540|525355285|FG000|Overall Study|Lost to Follow-up|3|||
145683045|NCT01437540|525355286|FG001|Overall Study|Lost to Follow-up|5|||
145683046|NCT01437540|525355285|FG000|Overall Study|Lack of Efficacy|23|||
145683047|NCT01437540|525355286|FG001|Overall Study|Lack of Efficacy|11|||
145491158|NCT04158583|524652359|FG004|Overall Study|Progressive Disease|0|||
145683048|NCT01437540|525355285|FG000|Overall Study|Protocol Violation|24|||
145683049|NCT01437540|525355286|FG001|Overall Study|Protocol Violation|12|||
145683050|NCT01437540|525355285|FG000|Overall Study|Adverse Event|26|||
145683051|NCT01437540|525355286|FG001|Overall Study|Adverse Event|13|||
145683052|NCT01437540|525355285|FG000|Overall Study|Withdrawal by Subject|31|||
145683053|NCT01437540|525355286|FG001|Overall Study|Withdrawal by Subject|15|||
145683054|NCT00608959|525355290|FG000|Part 1|Did not meet eligibility criteria|1|||
145683055|NCT01416285|525355291|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
145683056|NCT01416285|525355292|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
145683057|NCT01005602|525355294|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
145683058|NCT01005602|525355295|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
145683059|NCT01248715|525355296|FG000|Overall Study|Not influenza positive|501|||
145683060|NCT01248715|525355297|FG001|Overall Study|Not influenza positive|510|||
145683061|NCT01919489|525355301|FG000|Overall Study|Rejected the need of injections|4|||
145683062|NCT01919489|525355302|FG001|Overall Study|Rejected the need of injections|7|||
145683063|NCT01919489|525355301|FG000|Overall Study|Adverse Event|10|||
145683064|NCT01919489|525355302|FG001|Overall Study|Adverse Event|0|||
145683065|NCT01919489|525355301|FG000|Overall Study|Hospital readmission|2|||
145683066|NCT01919489|525355302|FG001|Overall Study|Hospital readmission|9|||
145683067|NCT01919489|525355301|FG000|Overall Study|Death|2|||
145683068|NCT01919489|525355302|FG001|Overall Study|Death|1|||
145683069|NCT01919489|525355301|FG000|Overall Study|Lost to Follow-up|38|||
145683070|NCT01919489|525355302|FG001|Overall Study|Lost to Follow-up|27|||
145683071|NCT03884478|525355303|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
145683072|NCT03884478|525355304|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
145683073|NCT03884478|525355305|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
145683074|NCT03884478|525355303|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
145683075|NCT03884478|525355304|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
145683076|NCT03884478|525355305|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
145683077|NCT03884478|525355303|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
145683078|NCT03884478|525355304|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
145683079|NCT03884478|525355305|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
145683080|NCT03884478|525355303|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
145683081|NCT03884478|525355304|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
145683082|NCT03884478|525355305|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
145683083|NCT01807234|525355306|FG000|Overall Study|Lost to Follow-up|2|||
145683084|NCT01807234|525355307|FG001|Overall Study|Lost to Follow-up|5|||
145683085|NCT01807234|525355308|FG002|Overall Study|Lost to Follow-up|1|||
145683086|NCT01807234|525355309|FG003|Overall Study|Lost to Follow-up|1|||
145683087|NCT01807234|525355310|FG004|Overall Study|Lost to Follow-up|1|||
145683088|NCT01807234|525355311|FG005|Overall Study|Lost to Follow-up|2|||
145683089|NCT01807234|525355306|FG000|Overall Study|Withdrawal by Subject|3|||
145683090|NCT01807234|525355307|FG001|Overall Study|Withdrawal by Subject|1|||
145683091|NCT01807234|525355308|FG002|Overall Study|Withdrawal by Subject|1|||
145683092|NCT01807234|525355309|FG003|Overall Study|Withdrawal by Subject|1|||
145683093|NCT01807234|525355310|FG004|Overall Study|Withdrawal by Subject|2|||
145683094|NCT01807234|525355311|FG005|Overall Study|Withdrawal by Subject|1|||
145683095|NCT01807234|525355306|FG000|Overall Study|Lack of Efficacy|0|||
145683096|NCT01807234|525355307|FG001|Overall Study|Lack of Efficacy|0|||
145683097|NCT01807234|525355308|FG002|Overall Study|Lack of Efficacy|0|||
145683098|NCT01807234|525355309|FG003|Overall Study|Lack of Efficacy|0|||
145683099|NCT01807234|525355310|FG004|Overall Study|Lack of Efficacy|1|||
145683100|NCT01807234|525355311|FG005|Overall Study|Lack of Efficacy|1|||
145683101|NCT01540474|525355312|FG000|Vaccination Period|Lost to Follow-up|0|||
145683102|NCT01540474|525355313|FG001|Vaccination Period|Lost to Follow-up|1|||
145683103|NCT01540474|525355314|FG002|Vaccination Period|Lost to Follow-up|0|||
145683104|NCT01540474|525355315|FG003|Vaccination Period|Lost to Follow-up|0|||
145683105|NCT01587703|525355316|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
145683106|NCT01587703|525355317|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683107|NCT01587703|525355318|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683108|NCT01587703|525355319|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683109|NCT01587703|525355320|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683110|NCT01587703|525355321|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683111|NCT01587703|525355322|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683112|NCT01587703|525355323|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683113|NCT01587703|525355324|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683114|NCT01587703|525355325|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683115|NCT01587703|525355326|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683116|NCT01587703|525355327|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683117|NCT01587703|525355328|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683118|NCT01587703|525355329|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683119|NCT01587703|525355330|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683120|NCT01587703|525355331|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683121|NCT01587703|525355332|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683122|NCT01587703|525355333|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683123|NCT01587703|525355334|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
145683124|NCT01587703|525355316|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683125|NCT01587703|525355317|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683126|NCT01587703|525355318|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683127|NCT01587703|525355319|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683128|NCT01587703|525355320|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683129|NCT01587703|525355321|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
145683130|NCT01587703|525355322|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683131|NCT01587703|525355323|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
145683132|NCT01587703|525355324|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683133|NCT01587703|525355325|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683134|NCT01587703|525355326|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683135|NCT01587703|525355327|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683136|NCT01587703|525355328|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683137|NCT01587703|525355329|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683138|NCT01587703|525355330|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683139|NCT01587703|525355331|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683140|NCT01587703|525355332|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683141|NCT01587703|525355333|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683142|NCT01587703|525355334|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
145683143|NCT01587703|525355316|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683144|NCT01587703|525355317|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683145|NCT01587703|525355318|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683146|NCT01587703|525355319|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683147|NCT01587703|525355320|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683148|NCT01587703|525355321|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683149|NCT01587703|525355322|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
145683150|NCT01587703|525355323|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683151|NCT01587703|525355324|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683152|NCT01587703|525355325|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683153|NCT01587703|525355326|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683154|NCT01587703|525355327|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683155|NCT01587703|525355328|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683156|NCT01587703|525355329|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683157|NCT01587703|525355330|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683158|NCT01587703|525355331|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683159|NCT01587703|525355332|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683160|NCT01587703|525355333|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683161|NCT01587703|525355334|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
145683162|NCT01587703|525355316|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
145683163|NCT01587703|525355317|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
145683164|NCT01587703|525355318|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
145683165|NCT01587703|525355319|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
145683166|NCT01587703|525355320|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
145683167|NCT01587703|525355321|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
145683168|NCT01587703|525355322|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
145683169|NCT01587703|525355323|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
145683170|NCT01587703|525355324|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683171|NCT01587703|525355325|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683172|NCT01587703|525355326|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683173|NCT01587703|525355327|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683174|NCT01587703|525355328|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683175|NCT01587703|525355329|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683176|NCT01587703|525355330|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683177|NCT01587703|525355331|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683178|NCT01587703|525355332|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683179|NCT01587703|525355333|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683180|NCT01587703|525355334|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
145683181|NCT01587703|525355316|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683182|NCT01587703|525355317|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683183|NCT01587703|525355318|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683184|NCT01587703|525355319|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683185|NCT01587703|525355320|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683186|NCT01587703|525355321|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683187|NCT01587703|525355322|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683188|NCT01587703|525355323|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683189|NCT01587703|525355324|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
145683190|NCT01587703|525355325|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
145491159|NCT04158583|524652360|FG005|Overall Study|Progressive Disease|1|||
145683191|NCT01587703|525355326|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
145683192|NCT01587703|525355327|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683193|NCT01587703|525355328|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683194|NCT01587703|525355329|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683195|NCT01587703|525355330|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683196|NCT01587703|525355331|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683197|NCT01587703|525355332|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683198|NCT01587703|525355333|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683199|NCT01587703|525355334|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
145683200|NCT01587703|525355316|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683201|NCT01587703|525355317|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683202|NCT01587703|525355318|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683203|NCT01587703|525355319|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683204|NCT01587703|525355320|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683205|NCT01587703|525355321|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683206|NCT01587703|525355322|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683207|NCT01587703|525355323|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683208|NCT01587703|525355324|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
145683209|NCT01587703|525355325|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683210|NCT01587703|525355326|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
145683211|NCT01587703|525355327|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683212|NCT01587703|525355328|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683213|NCT01587703|525355329|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683214|NCT01587703|525355330|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683215|NCT01587703|525355331|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683216|NCT01587703|525355332|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683217|NCT01587703|525355333|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683218|NCT01587703|525355334|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
145683219|NCT01587703|525355316|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683220|NCT01587703|525355317|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683221|NCT01587703|525355318|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683222|NCT01587703|525355319|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683223|NCT01587703|525355320|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683224|NCT01587703|525355321|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683225|NCT01587703|525355322|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683226|NCT01587703|525355323|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683227|NCT01587703|525355324|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683228|NCT01587703|525355325|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
145683229|NCT01587703|525355326|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
145683230|NCT01587703|525355327|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683231|NCT01587703|525355328|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683232|NCT01587703|525355329|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683233|NCT01587703|525355330|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683234|NCT01587703|525355331|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683235|NCT01587703|525355332|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683236|NCT01587703|525355333|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683237|NCT01587703|525355334|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
145683238|NCT01587703|525355316|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683239|NCT01587703|525355317|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683240|NCT01587703|525355318|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683241|NCT01587703|525355319|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683242|NCT01587703|525355320|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683243|NCT01587703|525355321|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683244|NCT01587703|525355322|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683245|NCT01587703|525355323|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683246|NCT01587703|525355324|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
145683247|NCT01587703|525355325|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145491160|NCT04158583|524652361|FG006|Overall Study|Progressive Disease|6|||
145491161|NCT04158583|524652362|FG007|Overall Study|Progressive Disease|2|||
145491162|NCT04158583|524652363|FG008|Overall Study|Progressive Disease|1|||
145491163|NCT04158583|524652364|FG009|Overall Study|Progressive Disease|2|||
145491164|NCT04158583|524652355|FG000|Overall Study|Lost to Follow-up|0|||
145491165|NCT04158583|524652356|FG001|Overall Study|Lost to Follow-up|0|||
145491166|NCT04158583|524652357|FG002|Overall Study|Lost to Follow-up|1|||
145491167|NCT04158583|524652358|FG003|Overall Study|Lost to Follow-up|1|||
145683248|NCT01587703|525355326|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683249|NCT01587703|525355327|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683250|NCT01587703|525355328|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683251|NCT01587703|525355329|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683252|NCT01587703|525355330|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683253|NCT01587703|525355331|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683254|NCT01587703|525355332|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683255|NCT01587703|525355333|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683256|NCT01587703|525355334|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
145683257|NCT01587703|525355316|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683258|NCT01587703|525355317|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683259|NCT01587703|525355318|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683260|NCT01587703|525355319|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683261|NCT01587703|525355320|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683262|NCT01587703|525355321|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683263|NCT01587703|525355322|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683264|NCT01587703|525355323|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683265|NCT01587703|525355324|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683266|NCT01587703|525355325|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683267|NCT01587703|525355326|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683268|NCT01587703|525355327|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683269|NCT01587703|525355328|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683270|NCT01587703|525355329|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683271|NCT01587703|525355330|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683272|NCT01587703|525355331|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683273|NCT01587703|525355332|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683274|NCT01587703|525355333|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
145683275|NCT01587703|525355334|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
145683276|NCT01587703|525355316|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683277|NCT01587703|525355317|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683278|NCT01587703|525355318|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683279|NCT01587703|525355319|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683280|NCT01587703|525355320|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683281|NCT01587703|525355321|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683282|NCT01587703|525355322|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683283|NCT01587703|525355323|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683284|NCT01587703|525355324|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683285|NCT01587703|525355325|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683286|NCT01587703|525355326|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683287|NCT01587703|525355327|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683288|NCT01587703|525355328|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683289|NCT01587703|525355329|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683290|NCT01587703|525355330|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683291|NCT01587703|525355331|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683292|NCT01587703|525355332|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
145683293|NCT01587703|525355333|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
145683294|NCT01587703|525355334|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
145683295|NCT01587703|525355316|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683296|NCT01587703|525355317|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683297|NCT01587703|525355318|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683298|NCT01587703|525355319|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683299|NCT01587703|525355320|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683300|NCT01587703|525355321|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683301|NCT01587703|525355322|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683302|NCT01587703|525355323|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683303|NCT01587703|525355324|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683304|NCT01587703|525355325|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683305|NCT01587703|525355326|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683306|NCT01587703|525355327|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683307|NCT01587703|525355328|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683308|NCT01587703|525355329|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683309|NCT01587703|525355330|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683310|NCT01587703|525355331|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
145491168|NCT04158583|524652359|FG004|Overall Study|Lost to Follow-up|1|||
145683311|NCT01587703|525355332|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683312|NCT01587703|525355333|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683313|NCT01587703|525355334|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
145683314|NCT01587703|525355316|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683315|NCT01587703|525355317|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683316|NCT01587703|525355318|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683317|NCT01587703|525355319|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683318|NCT01587703|525355320|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683319|NCT01587703|525355321|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683320|NCT01587703|525355322|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683321|NCT01587703|525355323|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683322|NCT01587703|525355324|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683323|NCT01587703|525355325|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683324|NCT01587703|525355326|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683325|NCT01587703|525355327|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
145683326|NCT01587703|525355328|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683327|NCT01587703|525355329|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683328|NCT01587703|525355330|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
145683329|NCT01587703|525355331|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683330|NCT01587703|525355332|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683331|NCT01587703|525355333|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683332|NCT01587703|525355334|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
145683333|NCT01587703|525355316|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683334|NCT01587703|525355317|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683335|NCT01587703|525355318|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683336|NCT01587703|525355319|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683337|NCT01587703|525355320|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683338|NCT01587703|525355321|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683339|NCT01587703|525355322|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683340|NCT01587703|525355323|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683341|NCT01587703|525355324|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683342|NCT01587703|525355325|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683343|NCT01587703|525355326|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683344|NCT01587703|525355327|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
145683345|NCT01587703|525355328|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
145683346|NCT01587703|525355329|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
145683347|NCT01587703|525355330|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
145683348|NCT01587703|525355331|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
145683349|NCT01587703|525355332|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
145683350|NCT01587703|525355333|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683351|NCT01587703|525355334|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
145683352|NCT01587703|525355316|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683353|NCT01587703|525355317|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683354|NCT01587703|525355318|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683355|NCT01587703|525355319|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683356|NCT01587703|525355320|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683357|NCT01587703|525355321|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683358|NCT01587703|525355322|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683359|NCT01587703|525355323|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683360|NCT01587703|525355324|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683361|NCT01587703|525355325|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683362|NCT01587703|525355326|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683363|NCT01587703|525355327|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
145683364|NCT01587703|525355328|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
145683365|NCT01587703|525355329|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
145683366|NCT01587703|525355330|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
145683367|NCT01587703|525355331|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
145683368|NCT01587703|525355332|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
145683369|NCT01587703|525355333|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683370|NCT01587703|525355334|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
145683371|NCT01587703|525355316|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683372|NCT01587703|525355317|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683373|NCT01587703|525355318|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683374|NCT01587703|525355319|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683375|NCT01587703|525355320|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683376|NCT01587703|525355321|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683377|NCT01587703|525355322|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145491169|NCT04158583|524652360|FG005|Overall Study|Lost to Follow-up|0|||
145683378|NCT01587703|525355323|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683379|NCT01587703|525355324|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683380|NCT01587703|525355325|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683381|NCT01587703|525355326|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683382|NCT01587703|525355327|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
145683383|NCT01587703|525355328|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683384|NCT01587703|525355329|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683385|NCT01587703|525355330|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683386|NCT01587703|525355331|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683387|NCT01587703|525355332|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683388|NCT01587703|525355333|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683389|NCT01587703|525355334|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
145683390|NCT02823574|525355335|FG000|Randomization|Disease Progression|0|||
145683391|NCT02823574|525355336|FG001|Randomization|Disease Progression|0|||
145683392|NCT02823574|525355337|FG002|Randomization|Disease Progression|1|||
145683393|NCT02823574|525355338|FG003|Randomization|Disease Progression|0|||
145683394|NCT02823574|525355335|FG000|Randomization|AE unrelated to Study Drug|1|||
145683395|NCT02823574|525355336|FG001|Randomization|AE unrelated to Study Drug|0|||
145683396|NCT02823574|525355337|FG002|Randomization|AE unrelated to Study Drug|0|||
145683397|NCT02823574|525355338|FG003|Randomization|AE unrelated to Study Drug|0|||
145683398|NCT02823574|525355335|FG000|Treatment Period|Poor/Non Compliance|1|||
145683399|NCT02823574|525355336|FG001|Treatment Period|Poor/Non Compliance|0|||
145683400|NCT02823574|525355337|FG002|Treatment Period|Poor/Non Compliance|0|||
145683401|NCT02823574|525355338|FG003|Treatment Period|Poor/Non Compliance|1|||
145683402|NCT02823574|525355335|FG000|Treatment Period|Maximum Clinical Benefit|8|||
145683403|NCT02823574|525355336|FG001|Treatment Period|Maximum Clinical Benefit|4|||
145683404|NCT02823574|525355337|FG002|Treatment Period|Maximum Clinical Benefit|7|||
145683405|NCT02823574|525355338|FG003|Treatment Period|Maximum Clinical Benefit|1|||
145683406|NCT02823574|525355335|FG000|Treatment Period|Lost to Follow-up|1|||
145683407|NCT02823574|525355336|FG001|Treatment Period|Lost to Follow-up|1|||
145683408|NCT02823574|525355337|FG002|Treatment Period|Lost to Follow-up|0|||
145683409|NCT02823574|525355338|FG003|Treatment Period|Lost to Follow-up|0|||
145683410|NCT02823574|525355335|FG000|Treatment Period|Participant withdrew consent|4|||
145683411|NCT02823574|525355336|FG001|Treatment Period|Participant withdrew consent|0|||
145683412|NCT02823574|525355337|FG002|Treatment Period|Participant withdrew consent|0|||
145683413|NCT02823574|525355338|FG003|Treatment Period|Participant withdrew consent|1|||
145683414|NCT02823574|525355335|FG000|Treatment Period|Participant request to discontinue|5|||
145683415|NCT02823574|525355336|FG001|Treatment Period|Participant request to discontinue|0|||
145683416|NCT02823574|525355337|FG002|Treatment Period|Participant request to discontinue|3|||
145683417|NCT02823574|525355338|FG003|Treatment Period|Participant request to discontinue|2|||
145683418|NCT02823574|525355335|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
145683419|NCT02823574|525355336|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
145683420|NCT02823574|525355337|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
145683421|NCT02823574|525355338|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
145683422|NCT02823574|525355335|FG000|Treatment Period|Study Drug Toxicity|11|||
145683423|NCT02823574|525355336|FG001|Treatment Period|Study Drug Toxicity|2|||
145683424|NCT02823574|525355337|FG002|Treatment Period|Study Drug Toxicity|14|||
145683425|NCT02823574|525355338|FG003|Treatment Period|Study Drug Toxicity|4|||
145683426|NCT02823574|525355335|FG000|Treatment Period|Disease Progression|113|||
145683427|NCT02823574|525355336|FG001|Treatment Period|Disease Progression|64|||
145683428|NCT02823574|525355337|FG002|Treatment Period|Disease Progression|82|||
145683429|NCT02823574|525355338|FG003|Treatment Period|Disease Progression|43|||
145683430|NCT02823574|525355335|FG000|Treatment Period|Other reasons|5|||
145683431|NCT02823574|525355336|FG001|Treatment Period|Other reasons|9|||
145683432|NCT02823574|525355337|FG002|Treatment Period|Other reasons|3|||
145683433|NCT02823574|525355338|FG003|Treatment Period|Other reasons|6|||
145683434|NCT02823574|525355335|FG000|Treatment Period|Participant no longer meets study criteria|0|||
145683435|NCT02823574|525355336|FG001|Treatment Period|Participant no longer meets study criteria|0|||
145683436|NCT02823574|525355337|FG002|Treatment Period|Participant no longer meets study criteria|1|||
145683437|NCT02823574|525355338|FG003|Treatment Period|Participant no longer meets study criteria|0|||
145683438|NCT02823574|525355335|FG000|Treatment Period|Death|0|||
145683439|NCT02823574|525355336|FG001|Treatment Period|Death|0|||
145683440|NCT02823574|525355337|FG002|Treatment Period|Death|3|||
145683441|NCT02823574|525355338|FG003|Treatment Period|Death|1|||
145683442|NCT00590759|525355339|FG000|Overall Study|Death|52|||
145683443|NCT00590759|525355339|FG000|Overall Study|Lost to Follow-up|28|||
145683444|NCT02542696|525355340|FG000|Overall Study|Adverse Event|167|||
145683445|NCT02542696|525355340|FG000|Overall Study|Lack of Efficacy|26|||
145683446|NCT02542696|525355340|FG000|Overall Study|Lost to Follow-up|6|||
145683447|NCT02542696|525355340|FG000|Overall Study|Withdrawal by Subject|104|||
145683448|NCT02542696|525355340|FG000|Overall Study|Protocol Violation|5|||
145683449|NCT02542696|525355340|FG000|Overall Study|Death|8|||
145491170|NCT04158583|524652361|FG006|Overall Study|Lost to Follow-up|0|||
145683450|NCT02542696|525355340|FG000|Overall Study|DECREASED OFF TIME|1|||
145683451|NCT02542696|525355340|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
145683452|NCT02542696|525355340|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
145683453|NCT02542696|525355340|FG000|Overall Study|MEDICAL HISTORY|1|||
145683454|NCT02542696|525355340|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
145683455|NCT02542696|525355340|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
145683456|NCT02542696|525355340|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
145683457|NCT02542696|525355340|FG000|Overall Study|SPONSOR DECISION|3|||
145683458|NCT02542696|525355340|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
145683459|NCT02542696|525355340|FG000|Overall Study|SUBJECT DECISION|2|||
145683460|NCT02410278|525355341|FG000|Run-in Period|Adverse Event|5|||
145683461|NCT02410278|525355342|FG001|Run-in Period|Adverse Event|0|||
145683462|NCT02410278|525355343|FG002|Run-in Period|Adverse Event|0|||
145683463|NCT02410278|525355341|FG000|Run-in Period|GSRS Threshold Not Met|30|||
145683464|NCT02410278|525355342|FG001|Run-in Period|GSRS Threshold Not Met|0|||
145683465|NCT02410278|525355343|FG002|Run-in Period|GSRS Threshold Not Met|0|||
145683466|NCT02410278|525355341|FG000|Run-in Period|Lost to Follow-up|1|||
145683467|NCT02410278|525355342|FG001|Run-in Period|Lost to Follow-up|0|||
145683468|NCT02410278|525355343|FG002|Run-in Period|Lost to Follow-up|0|||
145683469|NCT02410278|525355341|FG000|Run-in Period|Withdrawal by Subject|1|||
145683470|NCT02410278|525355342|FG001|Run-in Period|Withdrawal by Subject|0|||
145683471|NCT02410278|525355343|FG002|Run-in Period|Withdrawal by Subject|0|||
145683472|NCT02410278|525355341|FG000|Run-in Period|Pregnancy|1|||
145683473|NCT02410278|525355342|FG001|Run-in Period|Pregnancy|0|||
145683474|NCT02410278|525355343|FG002|Run-in Period|Pregnancy|0|||
145683475|NCT02410278|525355341|FG000|Study Treatment Period|Adverse Event|0|||
145683476|NCT02410278|525355342|FG001|Study Treatment Period|Adverse Event|6|||
145683477|NCT02410278|525355343|FG002|Study Treatment Period|Adverse Event|3|||
145683478|NCT02410278|525355341|FG000|Study Treatment Period|Physician Decision|0|||
145683479|NCT02410278|525355342|FG001|Study Treatment Period|Physician Decision|0|||
145683480|NCT02410278|525355343|FG002|Study Treatment Period|Physician Decision|1|||
145683481|NCT02410278|525355341|FG000|Study Treatment Period|Withdrawal by Subject|0|||
145683482|NCT02410278|525355342|FG001|Study Treatment Period|Withdrawal by Subject|1|||
145683483|NCT02410278|525355343|FG002|Study Treatment Period|Withdrawal by Subject|0|||
145683484|NCT02410278|525355341|FG000|Study Treatment Period|Other|0|||
145683485|NCT02410278|525355342|FG001|Study Treatment Period|Other|3|||
145683486|NCT02410278|525355343|FG002|Study Treatment Period|Other|0|||
145683487|NCT02410278|525355341|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
145683488|NCT02410278|525355342|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
145683489|NCT02410278|525355343|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
145683490|NCT04626128|525355344|FG000|Overall Study|Withdrawal by Subject|0|||
145683491|NCT04626128|525355345|FG001|Overall Study|Withdrawal by Subject|1|||
145683492|NCT04626128|525355346|FG002|Overall Study|Withdrawal by Subject|0|||
145683493|NCT04626128|525355347|FG003|Overall Study|Withdrawal by Subject|0|||
145683494|NCT00841321|525355348|FG000|Overall Study|Lost to Follow-up|1|||
145683495|NCT00841321|525355349|FG001|Overall Study|Lost to Follow-up|1|||
145683496|NCT00841321|525355348|FG000|Overall Study|Adverse Event|0|||
145683497|NCT00841321|525355349|FG001|Overall Study|Adverse Event|2|||
145683498|NCT00379210|525355352|FG000|Overall Study|Withdrawal by Subject|10|||
145683499|NCT00379210|525355353|FG001|Overall Study|Withdrawal by Subject|7|||
145683500|NCT03444155|525355354|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
145683501|NCT03444155|525355355|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
145683502|NCT02877680|525355356|FG000|Overall Study|Lost to Follow-up|1|||
145683503|NCT02877680|525355357|FG001|Overall Study|Lost to Follow-up|1|||
145683504|NCT02077374|525355358|FG000|Overall Study|Withdrawal by Subject|0|||
145683505|NCT02077374|525355359|FG001|Overall Study|Withdrawal by Subject|1|||
145683506|NCT02077374|525355358|FG000|Overall Study|Protocol Violation|0|||
145683507|NCT02077374|525355359|FG001|Overall Study|Protocol Violation|1|||
145683508|NCT00963924|525355360|FG000|Overall Study|Adverse Event|1|||
145683509|NCT00963924|525355361|FG001|Overall Study|Adverse Event|0|||
145683510|NCT00963924|525355360|FG000|Overall Study|Withdrawal by Subject|0|||
145683511|NCT00963924|525355361|FG001|Overall Study|Withdrawal by Subject|1|||
145683512|NCT00963924|525355360|FG000|Overall Study|Changed antipsychotic|0|||
145683513|NCT00963924|525355361|FG001|Overall Study|Changed antipsychotic|1|||
145683514|NCT00963924|525355360|FG000|Overall Study|Lost to Follow-up|0|||
145683515|NCT00963924|525355361|FG001|Overall Study|Lost to Follow-up|1|||
145683516|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
145683517|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
145491171|NCT04158583|524652362|FG007|Overall Study|Lost to Follow-up|0|||
145683518|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
145683519|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
145683520|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
145683521|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Adverse Event|0|||
145683522|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Adverse Event|1|||
145683523|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Adverse Event|1|||
145683524|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Adverse Event|0|||
145683525|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Adverse Event|0|||
145683526|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
145683527|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
145683528|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
145683529|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
145683530|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
145683531|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Physician Decision|1|||
145683532|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Physician Decision|0|||
145683533|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Physician Decision|0|||
145683534|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Physician Decision|0|||
145683535|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Physician Decision|0|||
145683536|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
145683537|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
145683538|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
145683539|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
145683540|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
145683541|NCT00446095|525355362|FG000|Phase II (8 Weeks)|Ongoing|0|||
145683542|NCT00446095|525355363|FG001|Phase II (8 Weeks)|Ongoing|0|||
145683543|NCT00446095|525355364|FG002|Phase II (8 Weeks)|Ongoing|1|||
145683544|NCT00446095|525355365|FG003|Phase II (8 Weeks)|Ongoing|0|||
145683545|NCT00446095|525355366|FG004|Phase II (8 Weeks)|Ongoing|0|||
145683546|NCT00446095|525355362|FG000|Phase I (28 Days)|Adverse Event|0|||
145683547|NCT00446095|525355363|FG001|Phase I (28 Days)|Adverse Event|0|||
145683548|NCT00446095|525355364|FG002|Phase I (28 Days)|Adverse Event|0|||
145683549|NCT00446095|525355365|FG003|Phase I (28 Days)|Adverse Event|1|||
145683550|NCT00446095|525355366|FG004|Phase I (28 Days)|Adverse Event|0|||
145683551|NCT00446095|525355362|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
145683552|NCT00446095|525355363|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
145683553|NCT00446095|525355364|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
145683554|NCT00446095|525355365|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
145683555|NCT00446095|525355366|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
145683556|NCT00886834|525355367|FG000|Overall Study|Protocol Violation|0|||
145683557|NCT00886834|525355368|FG001|Overall Study|Protocol Violation|3|||
145683558|NCT00657709|525355369|FG000|Overall Study|AE or Death|7|||
145683559|NCT00657709|525355370|FG001|Overall Study|AE or Death|7|||
145683560|NCT00657709|525355371|FG002|Overall Study|AE or Death|6|||
145683561|NCT00657709|525355372|FG003|Overall Study|AE or Death|7|||
145683562|NCT00657709|525355373|FG004|Overall Study|AE or Death|1|||
145683563|NCT00657709|525355369|FG000|Overall Study|Withdrawal by Subject|7|||
145683564|NCT00657709|525355370|FG001|Overall Study|Withdrawal by Subject|15|||
145683565|NCT00657709|525355371|FG002|Overall Study|Withdrawal by Subject|15|||
145683566|NCT00657709|525355372|FG003|Overall Study|Withdrawal by Subject|5|||
145683567|NCT00657709|525355373|FG004|Overall Study|Withdrawal by Subject|9|||
145683568|NCT00657709|525355369|FG000|Overall Study|Lost to Follow-up|9|||
145683569|NCT00657709|525355370|FG001|Overall Study|Lost to Follow-up|9|||
145683570|NCT00657709|525355371|FG002|Overall Study|Lost to Follow-up|7|||
145683571|NCT00657709|525355372|FG003|Overall Study|Lost to Follow-up|1|||
145683572|NCT00657709|525355373|FG004|Overall Study|Lost to Follow-up|21|||
145683573|NCT00657709|525355369|FG000|Overall Study|Protocol Violation|0|||
145683574|NCT00657709|525355370|FG001|Overall Study|Protocol Violation|2|||
145683575|NCT00657709|525355371|FG002|Overall Study|Protocol Violation|0|||
145683576|NCT00657709|525355372|FG003|Overall Study|Protocol Violation|1|||
145683577|NCT00657709|525355373|FG004|Overall Study|Protocol Violation|2|||
145683578|NCT02574286|525355374|FG000|Overall Study|Adverse Event|3|||
145683579|NCT02574286|525355374|FG000|Overall Study|Withdrawal by Subject|2|||
145683580|NCT02959866|525355375|FG000|Overall Study|Withdrawal by Subject|1|||
145683581|NCT00952523|525355376|FG000|Overall Study|Withdrawal by Subject|7|||
145683582|NCT04085614|525355377|FG000|Overall Study|Protocol Violation|9|||
145683583|NCT04085614|525355378|FG001|Overall Study|Protocol Violation|6|||
145683584|NCT03150589|525355379|FG000|Overall Study|Withdrawal by Subject|16|||
145683585|NCT03150589|525355380|FG001|Overall Study|Withdrawal by Subject|9|||
145683586|NCT03150589|525355379|FG000|Overall Study|Adverse Event|7|||
145683587|NCT03150589|525355380|FG001|Overall Study|Adverse Event|6|||
145683588|NCT03150589|525355379|FG000|Overall Study|Protocol Violation|4|||
145683589|NCT03150589|525355380|FG001|Overall Study|Protocol Violation|3|||
145683590|NCT03150589|525355379|FG000|Overall Study|Lost to Follow-up|3|||
145683591|NCT03150589|525355380|FG001|Overall Study|Lost to Follow-up|3|||
145683592|NCT03150589|525355379|FG000|Overall Study|Death|2|||
145683593|NCT03150589|525355380|FG001|Overall Study|Death|3|||
145683594|NCT03150589|525355379|FG000|Overall Study|IP non-compliance and other reasons|12|||
145683595|NCT03150589|525355380|FG001|Overall Study|IP non-compliance and other reasons|3|||
145683596|NCT05265247|525355381|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
145683597|NCT05265247|525355382|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
145683598|NCT05265247|525355381|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
145683599|NCT05265247|525355382|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
145683600|NCT05265247|525355381|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
145683601|NCT05265247|525355382|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
145683602|NCT01029925|525355383|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
145683603|NCT01029925|525355383|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
145683604|NCT01029925|525355383|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
145683605|NCT01405508|525355384|FG000|Overall Study|AE, non-serious non-fatal|1|||
145683606|NCT01405508|525355385|FG001|Overall Study|AE, non-serious non-fatal|1|||
145683607|NCT01405508|525355386|FG002|Overall Study|AE, non-serious non-fatal|0|||
145683608|NCT01405508|525355387|FG003|Overall Study|AE, non-serious non-fatal|0|||
145683609|NCT00476957|525355392|FG000|Overall Study|Lost to Follow-up|176|||
145683610|NCT00476957|525355393|FG001|Overall Study|Lost to Follow-up|193|||
145683611|NCT00346398|525355394|FG000|Overall Study|Lost to Follow-up|3|||
145683612|NCT00346398|525355395|FG001|Overall Study|Lost to Follow-up|0|||
145683613|NCT00346398|525355394|FG000|Overall Study|Withdrawal by Subject|0|||
145683614|NCT00346398|525355395|FG001|Overall Study|Withdrawal by Subject|2|||
145683615|NCT02607956|525355396|FG000|Double-Blinded Phase|Withdrew Consent|17|||
145683616|NCT02607956|525355397|FG001|Double-Blinded Phase|Withdrew Consent|19|||
145683617|NCT02607956|525355398|FG002|Double-Blinded Phase|Withdrew Consent|0|||
145683618|NCT02607956|525355399|FG003|Double-Blinded Phase|Withdrew Consent|0|||
145683619|NCT02607956|525355396|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
145683620|NCT02607956|525355397|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
145683621|NCT02607956|525355398|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
145683622|NCT02607956|525355399|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
145683623|NCT02607956|525355396|FG000|Double-Blinded Phase|Randomized but never treated|7|||
145683624|NCT02607956|525355397|FG001|Double-Blinded Phase|Randomized but never treated|5|||
145683625|NCT02607956|525355398|FG002|Double-Blinded Phase|Randomized but never treated|0|||
145683626|NCT02607956|525355399|FG003|Double-Blinded Phase|Randomized but never treated|0|||
145683627|NCT02607956|525355396|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
145683628|NCT02607956|525355397|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
145683629|NCT02607956|525355398|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
145683630|NCT02607956|525355399|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
145683631|NCT02607956|525355396|FG000|Double-Blinded Phase|Death|4|||
145683632|NCT02607956|525355397|FG001|Double-Blinded Phase|Death|4|||
145683633|NCT02607956|525355398|FG002|Double-Blinded Phase|Death|0|||
145683634|NCT02607956|525355399|FG003|Double-Blinded Phase|Death|0|||
145683635|NCT02607956|525355396|FG000|Double-Blinded Phase|Adverse Event|4|||
145683636|NCT02607956|525355397|FG001|Double-Blinded Phase|Adverse Event|3|||
145683637|NCT02607956|525355398|FG002|Double-Blinded Phase|Adverse Event|0|||
145683638|NCT02607956|525355399|FG003|Double-Blinded Phase|Adverse Event|0|||
145683639|NCT02607956|525355396|FG000|Double-Blinded Phase|Protocol Violation|3|||
145683640|NCT02607956|525355397|FG001|Double-Blinded Phase|Protocol Violation|1|||
145683641|NCT02607956|525355398|FG002|Double-Blinded Phase|Protocol Violation|0|||
145683642|NCT02607956|525355399|FG003|Double-Blinded Phase|Protocol Violation|0|||
145683643|NCT02607956|525355396|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
145683644|NCT02607956|525355397|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
145683645|NCT02607956|525355398|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
145683646|NCT02607956|525355399|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
145683647|NCT02607956|525355396|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
145683648|NCT02607956|525355397|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
145683649|NCT02607956|525355398|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
145683650|NCT02607956|525355399|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
145683651|NCT02607956|525355396|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
145683652|NCT02607956|525355397|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
145683653|NCT02607956|525355398|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
145683654|NCT02607956|525355399|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
145683655|NCT02607956|525355396|FG000|Open-Label Extension Phase|Death|0|||
145683656|NCT02607956|525355397|FG001|Open-Label Extension Phase|Death|0|||
145683657|NCT02607956|525355398|FG002|Open-Label Extension Phase|Death|1|||
145683658|NCT02607956|525355399|FG003|Open-Label Extension Phase|Death|3|||
145683659|NCT02607956|525355396|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
145683660|NCT02607956|525355397|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
145683661|NCT02607956|525355398|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
145683662|NCT02607956|525355399|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
145683663|NCT02607956|525355396|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
145683664|NCT02607956|525355397|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
145683665|NCT02607956|525355398|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
145683666|NCT02607956|525355399|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
145683667|NCT02607956|525355396|FG000|Open-Label Extension Phase|Protocol Violation|0|||
145491172|NCT04158583|524652363|FG008|Overall Study|Lost to Follow-up|0|||
145491173|NCT04158583|524652364|FG009|Overall Study|Lost to Follow-up|0|||
145683668|NCT02607956|525355397|FG001|Open-Label Extension Phase|Protocol Violation|0|||
145683669|NCT02607956|525355398|FG002|Open-Label Extension Phase|Protocol Violation|0|||
145683670|NCT02607956|525355399|FG003|Open-Label Extension Phase|Protocol Violation|2|||
145683671|NCT02607956|525355396|FG000|Open-Label Extension Phase|Pregnancy|0|||
145683672|NCT02607956|525355397|FG001|Open-Label Extension Phase|Pregnancy|0|||
145683673|NCT02607956|525355398|FG002|Open-Label Extension Phase|Pregnancy|0|||
145683674|NCT02607956|525355399|FG003|Open-Label Extension Phase|Pregnancy|1|||
145683675|NCT02006641|525355400|FG000|Overall Study|Withdrawal before treatment|2|||
145683676|NCT02006641|525355401|FG001|Overall Study|Withdrawal before treatment|5|||
145683677|NCT02006641|525355402|FG002|Overall Study|Withdrawal before treatment|3|||
145683678|NCT02006641|525355400|FG000|Overall Study|Adverse Event|15|||
145683679|NCT02006641|525355401|FG001|Overall Study|Adverse Event|11|||
145683680|NCT02006641|525355402|FG002|Overall Study|Adverse Event|15|||
145683681|NCT02006641|525355400|FG000|Overall Study|Protocol Violation|0|||
145683682|NCT02006641|525355401|FG001|Overall Study|Protocol Violation|2|||
145683683|NCT02006641|525355402|FG002|Overall Study|Protocol Violation|2|||
145683684|NCT02006641|525355400|FG000|Overall Study|Lost to Follow-up|0|||
145683685|NCT02006641|525355401|FG001|Overall Study|Lost to Follow-up|1|||
145683686|NCT02006641|525355402|FG002|Overall Study|Lost to Follow-up|0|||
145683687|NCT02006641|525355400|FG000|Overall Study|Withdrawal by Subject|7|||
145683688|NCT02006641|525355401|FG001|Overall Study|Withdrawal by Subject|12|||
145683689|NCT02006641|525355402|FG002|Overall Study|Withdrawal by Subject|11|||
145683690|NCT02006641|525355400|FG000|Overall Study|Other reason: patient didn't show up|1|||
145683691|NCT02006641|525355401|FG001|Overall Study|Other reason: patient didn't show up|0|||
145683692|NCT02006641|525355402|FG002|Overall Study|Other reason: patient didn't show up|0|||
145683693|NCT02006641|525355400|FG000|Overall Study|Other reason:patient didn't want to come|0|||
145683694|NCT02006641|525355401|FG001|Overall Study|Other reason:patient didn't want to come|0|||
145683695|NCT02006641|525355402|FG002|Overall Study|Other reason:patient didn't want to come|1|||
145683696|NCT02006641|525355400|FG000|Overall Study|Other reason: patient has moved|1|||
145683697|NCT02006641|525355401|FG001|Overall Study|Other reason: patient has moved|0|||
145683698|NCT02006641|525355402|FG002|Overall Study|Other reason: patient has moved|1|||
145683699|NCT02006641|525355400|FG000|Overall Study|Other reason: caregiver in hospital|0|||
145683700|NCT02006641|525355401|FG001|Overall Study|Other reason: caregiver in hospital|1|||
145683701|NCT02006641|525355402|FG002|Overall Study|Other reason: caregiver in hospital|0|||
145683702|NCT02006641|525355400|FG000|Overall Study|Other reason: patient's wife has died|0|||
145683703|NCT02006641|525355401|FG001|Overall Study|Other reason: patient's wife has died|0|||
145683704|NCT02006641|525355402|FG002|Overall Study|Other reason: patient's wife has died|1|||
145683705|NCT02006641|525355400|FG000|Overall Study|Other reason: hospitalisation|0|||
145683706|NCT02006641|525355401|FG001|Overall Study|Other reason: hospitalisation|1|||
145683707|NCT02006641|525355402|FG002|Overall Study|Other reason: hospitalisation|0|||
145683708|NCT02006641|525355400|FG000|Overall Study|Other reason: caregiver impossibility|0|||
145683709|NCT02006641|525355401|FG001|Overall Study|Other reason: caregiver impossibility|0|||
145683710|NCT02006641|525355402|FG002|Overall Study|Other reason: caregiver impossibility|1|||
145683711|NCT02006641|525355400|FG000|Overall Study|Other reason: protocol non-compliance|0|||
145683712|NCT02006641|525355401|FG001|Overall Study|Other reason: protocol non-compliance|0|||
145683713|NCT02006641|525355402|FG002|Overall Study|Other reason: protocol non-compliance|1|||
145683714|NCT02132195|525355403|FG000|Initial Assignment|Relapsed|14|||
145683715|NCT02132195|525355404|FG001|Initial Assignment|Relapsed|0|||
145683716|NCT02132195|525355405|FG002|Initial Assignment|Relapsed|0|||
145683717|NCT02132195|525355403|FG000|Rescue Therapy|Relapsed|0|||
145683718|NCT02132195|525355404|FG001|Rescue Therapy|Relapsed|0|||
145683719|NCT02132195|525355405|FG002|Rescue Therapy|Relapsed|7|||
145683720|NCT02132195|525355403|FG000|Rescue Therapy|Physician Decision|0|||
145683721|NCT02132195|525355404|FG001|Rescue Therapy|Physician Decision|0|||
145683722|NCT02132195|525355405|FG002|Rescue Therapy|Physician Decision|1|||
145683723|NCT02132195|525355403|FG000|Rescue Therapy|Withdrawal by Subject|0|||
145683724|NCT02132195|525355404|FG001|Rescue Therapy|Withdrawal by Subject|0|||
145683725|NCT02132195|525355405|FG002|Rescue Therapy|Withdrawal by Subject|1|||
145683726|NCT02132195|525355403|FG000|Rescue Therapy|Adverse Event|0|||
145683727|NCT02132195|525355404|FG001|Rescue Therapy|Adverse Event|0|||
145683728|NCT02132195|525355405|FG002|Rescue Therapy|Adverse Event|2|||
145683729|NCT01697956|525355406|FG000|Overall Study|Protocol Violation|1|||
145683730|NCT01697956|525355407|FG001|Overall Study|Protocol Violation|1|||
145683731|NCT01964547|525355408|FG000|Overall Study|Adverse Event|8|||
145683732|NCT01964547|525355409|FG001|Overall Study|Adverse Event|2|||
145683733|NCT01964547|525355408|FG000|Overall Study|Withdrawal by Subject|4|||
145683734|NCT01964547|525355409|FG001|Overall Study|Withdrawal by Subject|7|||
145683735|NCT01964547|525355408|FG000|Overall Study|Lost to Follow-up|0|||
145683736|NCT01964547|525355409|FG001|Overall Study|Lost to Follow-up|1|||
145683737|NCT01964547|525355408|FG000|Overall Study|Withdrawal by Investigator|0|||
145683738|NCT01964547|525355409|FG001|Overall Study|Withdrawal by Investigator|1|||
145683739|NCT01115309|525355410|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
145683740|NCT01115309|525355410|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
145683741|NCT01115309|525355410|FG000|Long-term Follow-up|Lost to Follow-up|6|||
145683742|NCT05700851|525355411|FG000|Overall Study|Received a kidney transplant|1|||
145683743|NCT05700851|525355411|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
145683744|NCT05700851|525355411|FG000|Overall Study|Withdrawal by Subject|1|||
145683745|NCT03246724|525355412|FG000|Overall Study|Withdrawal by Subject|5|||
145683746|NCT03246724|525355413|FG001|Overall Study|Withdrawal by Subject|2|||
145683747|NCT03246724|525355414|FG002|Overall Study|Withdrawal by Subject|4|||
145683748|NCT03246724|525355415|FG003|Overall Study|Withdrawal by Subject|2|||
145683749|NCT03246724|525355412|FG000|Overall Study|Ineligible on day of surgery|7|||
145683750|NCT03246724|525355413|FG001|Overall Study|Ineligible on day of surgery|2|||
145683751|NCT03246724|525355414|FG002|Overall Study|Ineligible on day of surgery|0|||
145683752|NCT03246724|525355415|FG003|Overall Study|Ineligible on day of surgery|3|||
145683753|NCT03246724|525355412|FG000|Overall Study|Study completed before surgical date|2|||
145683754|NCT03246724|525355413|FG001|Overall Study|Study completed before surgical date|1|||
145683755|NCT03246724|525355414|FG002|Overall Study|Study completed before surgical date|8|||
145683756|NCT03246724|525355415|FG003|Overall Study|Study completed before surgical date|1|||
145683757|NCT03246724|525355412|FG000|Overall Study|Transferred to other arm|0|||
145683758|NCT03246724|525355413|FG001|Overall Study|Transferred to other arm|0|||
145683759|NCT03246724|525355414|FG002|Overall Study|Transferred to other arm|1|||
145683760|NCT03246724|525355415|FG003|Overall Study|Transferred to other arm|0|||
145683761|NCT03246724|525355412|FG000|Overall Study|Unable to obtain medication timely|0|||
145683762|NCT03246724|525355413|FG001|Overall Study|Unable to obtain medication timely|2|||
145683763|NCT03246724|525355414|FG002|Overall Study|Unable to obtain medication timely|2|||
145683764|NCT03246724|525355415|FG003|Overall Study|Unable to obtain medication timely|1|||
145683765|NCT03246724|525355412|FG000|Overall Study|Re-consented to participate|0|||
145683766|NCT03246724|525355413|FG001|Overall Study|Re-consented to participate|0|||
145683767|NCT03246724|525355414|FG002|Overall Study|Re-consented to participate|0|||
145683768|NCT03246724|525355415|FG003|Overall Study|Re-consented to participate|1|||
145683769|NCT02978716|525355416|FG000|Overall Study|Death|25|||
145683770|NCT02978716|525355417|FG001|Overall Study|Death|13|||
145683771|NCT02978716|525355418|FG002|Overall Study|Death|20|||
145683772|NCT02978716|525355416|FG000|Overall Study|Lost to Follow-up|0|||
145683773|NCT02978716|525355417|FG001|Overall Study|Lost to Follow-up|0|||
145683774|NCT02978716|525355418|FG002|Overall Study|Lost to Follow-up|1|||
145683775|NCT02978716|525355416|FG000|Overall Study|Withdrawal by Subject|6|||
145683776|NCT02978716|525355417|FG001|Overall Study|Withdrawal by Subject|4|||
145683777|NCT02978716|525355418|FG002|Overall Study|Withdrawal by Subject|5|||
145683778|NCT02978716|525355416|FG000|Overall Study|Sponsor terminated|2|||
145683779|NCT02978716|525355417|FG001|Overall Study|Sponsor terminated|13|||
145683780|NCT02978716|525355418|FG002|Overall Study|Sponsor terminated|9|||
145683781|NCT02978716|525355416|FG000|Overall Study|Other|1|||
145683782|NCT02978716|525355417|FG001|Overall Study|Other|3|||
145683783|NCT02978716|525355418|FG002|Overall Study|Other|0|||
145683784|NCT00589628|525355419|FG000|Overall Study|Lost to Follow-up|0|||
145683785|NCT00589628|525355420|FG001|Overall Study|Lost to Follow-up|1|||
145683786|NCT00689351|525355424|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
145683787|NCT00689351|525355425|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
145683788|NCT00689351|525355424|FG000|Infant Series of Dosing|Adverse Event|1|||
145683789|NCT00689351|525355425|FG001|Infant Series of Dosing|Adverse Event|0|||
145683790|NCT00689351|525355424|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
145683791|NCT00689351|525355425|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
145683792|NCT00689351|525355424|FG000|After Infant Series|Parent/legal guardian request|1|||
145683793|NCT00689351|525355425|FG001|After Infant Series|Parent/legal guardian request|0|||
145683794|NCT01766206|525355426|FG000|Overall Study|Withdrawal by Subject|22|||
145683795|NCT01766206|525355426|FG000|Overall Study|Lost to Follow-up|10|||
145683796|NCT01766206|525355426|FG000|Overall Study|Inappropriate enrollment|18|||
145683797|NCT01766206|525355426|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
145683798|NCT01313663|525355427|FG000|Overall Study|Study Closed/Terminated|2|||
145683799|NCT01313663|525355428|FG001|Overall Study|Study Closed/Terminated|4|||
145683800|NCT01313663|525355427|FG000|Overall Study|Lost to Follow-up|0|||
145683801|NCT01313663|525355428|FG001|Overall Study|Lost to Follow-up|1|||
145683802|NCT01313663|525355427|FG000|Overall Study|Physician Decision|0|||
145683803|NCT01313663|525355428|FG001|Overall Study|Physician Decision|2|||
145683804|NCT01313663|525355427|FG000|Overall Study|Withdrawal by Subject|2|||
145683805|NCT01313663|525355428|FG001|Overall Study|Withdrawal by Subject|1|||
145683806|NCT03075878|525355429|FG000|Overall Study|Physician Decision|1|||
145683807|NCT02158806|525355431|FG000|Overall Study|Death|2|||
145683808|NCT02158806|525355432|FG001|Overall Study|Death|0|||
145683809|NCT02158806|525355431|FG000|Overall Study|Withdrawal by Subject|2|||
145683810|NCT02158806|525355432|FG001|Overall Study|Withdrawal by Subject|0|||
145683811|NCT02158806|525355431|FG000|Overall Study|Lost to Follow-up|0|||
145683812|NCT02158806|525355432|FG001|Overall Study|Lost to Follow-up|3|||
145683813|NCT02158806|525355431|FG000|Overall Study|Moved out of area|0|||
145683814|NCT02158806|525355432|FG001|Overall Study|Moved out of area|1|||
145491174|NCT04158583|524652355|FG000|Overall Study|Due To Patient Status|0|||
145683815|NCT02158806|525355431|FG000|Overall Study|Transferred to palliative care|0|||
145683816|NCT02158806|525355432|FG001|Overall Study|Transferred to palliative care|1|||
145683817|NCT01898299|525355433|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
145683818|NCT01898299|525355434|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
145683819|NCT00760877|525356903|FG000|Overall Study|Protocol Violation|1|||
145683820|NCT00760877|525356904|FG001|Overall Study|Protocol Violation|0|||
145683821|NCT00760877|525356903|FG000|Overall Study|Non-compliance with protocol treatment|2|||
145683822|NCT00760877|525356904|FG001|Overall Study|Non-compliance with protocol treatment|1|||
145683823|NCT00760877|525356903|FG000|Overall Study|Pregnancy|1|||
145683824|NCT00760877|525356904|FG001|Overall Study|Pregnancy|4|||
145683825|NCT00760877|525356903|FG000|Overall Study|Death|2|||
145683826|NCT00760877|525356904|FG001|Overall Study|Death|1|||
145683827|NCT00760877|525356903|FG000|Overall Study|Withdrawal by Subject|7|||
145683828|NCT00760877|525356904|FG001|Overall Study|Withdrawal by Subject|3|||
145683829|NCT00760877|525356903|FG000|Overall Study|Adverse Event|19|||
145683830|NCT00760877|525356904|FG001|Overall Study|Adverse Event|12|||
145683831|NCT00760877|525356903|FG000|Overall Study|Participant diagnosed with AML|0|||
145683832|NCT00760877|525356904|FG001|Overall Study|Participant diagnosed with AML|1|||
145683833|NCT00760877|525356903|FG000|Overall Study|Participant not eligible to cross-over|0|||
145683834|NCT00760877|525356904|FG001|Overall Study|Participant not eligible to cross-over|1|||
145683835|NCT00760877|525356903|FG000|Overall Study|Physician Decision|1|||
145683836|NCT00760877|525356904|FG001|Overall Study|Physician Decision|2|||
145683837|NCT00760877|525356903|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
145683838|NCT00760877|525356904|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
145683839|NCT00760877|525356903|FG000|Overall Study|Treatment failure|1|||
145683840|NCT00760877|525356904|FG001|Overall Study|Treatment failure|0|||
145683841|NCT00711555|525356907|FG000|Overall Study|Adverse Event|3|||
145683842|NCT04049578|525356908|FG000|Overall Study|Physician Decision|1|||
145683843|NCT02400749|525356909|FG000|Week 0 -16|Withdrawal by Subject|5|||
145683844|NCT02400749|525356910|FG001|Week 0 -16|Withdrawal by Subject|5|||
145683845|NCT02400749|525356909|FG000|Week 0 -16|Adverse Event|3|||
145683846|NCT02400749|525356910|FG001|Week 0 -16|Adverse Event|1|||
145683847|NCT02400749|525356909|FG000|Week 0 -16|Lost to Follow-up|2|||
145683848|NCT02400749|525356910|FG001|Week 0 -16|Lost to Follow-up|0|||
145683849|NCT02400749|525356909|FG000|Week 0 -16|Protocol Violation|1|||
145683850|NCT02400749|525356910|FG001|Week 0 -16|Protocol Violation|0|||
145683851|NCT02400749|525356909|FG000|Week 17 - 32|Withdrawal by Subject|3|||
145683852|NCT02400749|525356910|FG001|Week 17 - 32|Withdrawal by Subject|2|||
145683853|NCT02400749|525356909|FG000|Week 17 - 32|Adverse Event|2|||
145683854|NCT02400749|525356910|FG001|Week 17 - 32|Adverse Event|1|||
145683855|NCT02213094|525356915|FG000|Overall Study|Adverse Event|1|||
145683856|NCT02213094|525356916|FG001|Overall Study|Adverse Event|0|||
145683857|NCT01074229|525356917|FG000|Overall Study|Lost to Follow-up|1|||
145683858|NCT01074229|525356918|FG001|Overall Study|Lost to Follow-up|0|||
145683859|NCT01074229|525356919|FG002|Overall Study|Lost to Follow-up|0|||
145683860|NCT01074229|525356917|FG000|Overall Study|Change to open surgical procedure|1|||
145683861|NCT01074229|525356918|FG001|Overall Study|Change to open surgical procedure|3|||
145683862|NCT01074229|525356919|FG002|Overall Study|Change to open surgical procedure|4|||
145683863|NCT02163499|525356920|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
145683864|NCT02163499|525356920|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
145683865|NCT02163499|525356920|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
145683866|NCT02163499|525356920|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
145683867|NCT02163499|525356920|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
145683868|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
145683869|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
145683870|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
145683871|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
145683872|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
145683873|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
145683874|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
145683875|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
145683876|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
145683877|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Death|8|||
145683878|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
145683879|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
145683880|NCT02163499|525356920|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
145683881|NCT00857311|525356921|FG000|Overall Study|Lost to Follow-up|1|||
145683882|NCT00857311|525356922|FG001|Overall Study|Lost to Follow-up|0|||
145683883|NCT00857311|525356923|FG002|Overall Study|Lost to Follow-up|0|||
145683884|NCT00857311|525356924|FG003|Overall Study|Lost to Follow-up|0|||
145683885|NCT01922102|525356925|FG000|Overall Study|Withdrawal by Subject|7|||
145683886|NCT01922102|525356926|FG001|Overall Study|Withdrawal by Subject|3|||
145683887|NCT01922102|525356927|FG002|Overall Study|Withdrawal by Subject|7|||
145683888|NCT01922102|525356925|FG000|Overall Study|Physician Decision|0|||
145683889|NCT01922102|525356926|FG001|Overall Study|Physician Decision|2|||
145683890|NCT01922102|525356927|FG002|Overall Study|Physician Decision|1|||
145683891|NCT01922102|525356925|FG000|Overall Study|Adverse Event|1|||
145683892|NCT01922102|525356926|FG001|Overall Study|Adverse Event|2|||
145683893|NCT01922102|525356927|FG002|Overall Study|Adverse Event|0|||
145683894|NCT01922102|525356925|FG000|Overall Study|Lost to Follow-up|1|||
145683895|NCT01922102|525356926|FG001|Overall Study|Lost to Follow-up|0|||
145683896|NCT01922102|525356927|FG002|Overall Study|Lost to Follow-up|0|||
145683897|NCT01922102|525356925|FG000|Overall Study|Administrative problems|0|||
145683898|NCT01922102|525356926|FG001|Overall Study|Administrative problems|2|||
145683899|NCT01922102|525356927|FG002|Overall Study|Administrative problems|0|||
145683900|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
145683901|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
145683902|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
145683903|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
145683904|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
145683905|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
145683906|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
145683907|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
145683908|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
145683909|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
145683910|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
145683911|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
145683912|NCT01345253|525356932|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
145683913|NCT01345253|525356933|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
145683914|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
145683915|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
145683916|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
145683917|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
145683918|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
145683919|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
145683920|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
145683921|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
145683922|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
145683923|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
145683924|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
145683925|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
145683926|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
145683927|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
145683928|NCT01345253|525356932|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
145683929|NCT01345253|525356933|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
145683930|NCT05361304|525356936|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
145683931|NCT05361304|525356937|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
145683932|NCT05361304|525356936|FG000|Overall Study|COVID-19 Related|1|||
145683933|NCT05361304|525356937|FG001|Overall Study|COVID-19 Related|2|||
145683934|NCT05361304|525356936|FG000|Overall Study|Withdrawal by Subject|1|||
145683935|NCT05361304|525356937|FG001|Overall Study|Withdrawal by Subject|0|||
145683936|NCT00476151|525356939|FG000|Overall Study|Adverse Event|0|||
145683937|NCT00476151|525356940|FG001|Overall Study|Adverse Event|2|||
145683938|NCT00476151|525356939|FG000|Overall Study|Protocol Violation|1|||
145683939|NCT00476151|525356940|FG001|Overall Study|Protocol Violation|3|||
145683940|NCT00476151|525356939|FG000|Overall Study|Withdrawal by Subject|2|||
145683941|NCT00476151|525356940|FG001|Overall Study|Withdrawal by Subject|0|||
145683942|NCT00476151|525356939|FG000|Overall Study|Physician Decision|0|||
145683943|NCT00476151|525356940|FG001|Overall Study|Physician Decision|2|||
145683944|NCT01012999|525356944|FG000|Overall Study|Protocol Violation|1|||
145683945|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
145683946|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
145683947|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
145683948|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
145683949|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
145683950|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
145683951|NCT03557307|525356945|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
145683952|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
145683953|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Death|3|||
145683954|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
145683955|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
145683956|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
145683957|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
145683958|NCT03557307|525356945|FG000|Period 2: Maintenance Phase|other|3|||
145683959|NCT01322347|525356946|FG000|Overall Study|Adverse Event|7|||
145683960|NCT01322347|525356947|FG001|Overall Study|Adverse Event|2|||
145683961|NCT01322347|525356946|FG000|Overall Study|Death|5|||
145683962|NCT01322347|525356947|FG001|Overall Study|Death|3|||
145683963|NCT01322347|525356946|FG000|Overall Study|Physician Decision|2|||
145683964|NCT01322347|525356947|FG001|Overall Study|Physician Decision|1|||
145491175|NCT04158583|524652356|FG001|Overall Study|Due To Patient Status|0|||
145683965|NCT01322347|525356946|FG000|Overall Study|Protocol Violation|5|||
145683966|NCT01322347|525356947|FG001|Overall Study|Protocol Violation|2|||
145683967|NCT01322347|525356946|FG000|Overall Study|Withdrawal by Subject|1|||
145683968|NCT01322347|525356947|FG001|Overall Study|Withdrawal by Subject|4|||
145683969|NCT01322347|525356946|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
145683970|NCT01322347|525356947|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
145683971|NCT01322347|525356946|FG000|Overall Study|blood transfusion|5|||
145683972|NCT01322347|525356947|FG001|Overall Study|blood transfusion|5|||
145683973|NCT01322347|525356946|FG000|Overall Study|sponsor decision|1|||
145683974|NCT01322347|525356947|FG001|Overall Study|sponsor decision|3|||
145683975|NCT01322347|525356946|FG000|Overall Study|ineligible|6|||
145683976|NCT01322347|525356947|FG001|Overall Study|ineligible|3|||
145683977|NCT01322347|525356946|FG000|Overall Study|kidney transplant|3|||
145683978|NCT01322347|525356947|FG001|Overall Study|kidney transplant|1|||
145683979|NCT01322347|525356946|FG000|Overall Study|study drug withheld > 12 wks|0|||
145683980|NCT01322347|525356947|FG001|Overall Study|study drug withheld > 12 wks|1|||
145683981|NCT01322347|525356946|FG000|Overall Study|moved/changed dialysis|2|||
145683982|NCT01322347|525356947|FG001|Overall Study|moved/changed dialysis|4|||
145683983|NCT04883541|525356948|FG000|Overall Study|Not attending regular yoga class|16|||
145683984|NCT04883541|525356949|FG001|Overall Study|Not attending regular yoga class|0|||
145683985|NCT04883541|525356948|FG000|Overall Study|Not attending the pregnancy school|0|||
145683986|NCT04883541|525356949|FG001|Overall Study|Not attending the pregnancy school|9|||
145683987|NCT01369147|525356952|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
145683988|NCT01369147|525356953|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
145683989|NCT01369147|525356954|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
145683990|NCT04239911|525356955|FG000|Overall Study|Lost to Follow-up|2|||
145683991|NCT04239911|525356956|FG001|Overall Study|Lost to Follow-up|1|||
145683992|NCT03456856|525356957|FG000|Overall Study|Lost to Follow-up|2|||
145683993|NCT03456856|525356957|FG000|Overall Study|Withdrawal by Subject|1|||
145683994|NCT03262389|525356960|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
145683995|NCT03262389|525356960|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
145683996|NCT03262389|525356960|FG000|Overall Study|opted out of PET/MR|1|||
145683997|NCT01052272|525356961|FG000|Overall Study|Death|0|||
145683998|NCT01052272|525356962|FG001|Overall Study|Death|0|||
145683999|NCT01052272|525356963|FG002|Overall Study|Death|1|||
145684000|NCT01052272|525356964|FG003|Overall Study|Death|1|||
145684001|NCT01052272|525356961|FG000|Overall Study|Physician Decision|0|||
145684002|NCT01052272|525356962|FG001|Overall Study|Physician Decision|1|||
145684003|NCT01052272|525356963|FG002|Overall Study|Physician Decision|0|||
145684004|NCT01052272|525356964|FG003|Overall Study|Physician Decision|0|||
145684005|NCT01052272|525356961|FG000|Overall Study|patient refuses follow-up|5|||
145684006|NCT01052272|525356962|FG001|Overall Study|patient refuses follow-up|4|||
145684007|NCT01052272|525356963|FG002|Overall Study|patient refuses follow-up|2|||
145684008|NCT01052272|525356964|FG003|Overall Study|patient refuses follow-up|4|||
145684009|NCT01052272|525356961|FG000|Overall Study|Withdrawal by Subject|0|||
145684010|NCT01052272|525356962|FG001|Overall Study|Withdrawal by Subject|2|||
145684011|NCT01052272|525356963|FG002|Overall Study|Withdrawal by Subject|3|||
145684012|NCT01052272|525356964|FG003|Overall Study|Withdrawal by Subject|2|||
145684013|NCT01052272|525356961|FG000|Overall Study|placed in long-term care|0|||
145684014|NCT01052272|525356962|FG001|Overall Study|placed in long-term care|0|||
145684015|NCT01052272|525356963|FG002|Overall Study|placed in long-term care|1|||
145684016|NCT01052272|525356964|FG003|Overall Study|placed in long-term care|0|||
145684017|NCT01052272|525356961|FG000|Overall Study|decline in health|0|||
145684018|NCT01052272|525356962|FG001|Overall Study|decline in health|0|||
145684019|NCT01052272|525356963|FG002|Overall Study|decline in health|1|||
145684020|NCT01052272|525356964|FG003|Overall Study|decline in health|0|||
145684021|NCT00096278|525356965|FG000|Overall Study|No follow-up data|15|||
145684022|NCT00096278|525356966|FG001|Overall Study|No follow-up data|18|||
145684023|NCT00096278|525356965|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
145684024|NCT00096278|525356966|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
145684025|NCT04908488|525356969|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
145684026|NCT04908488|525356970|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
145684027|NCT04908488|525356969|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
145684028|NCT04908488|525356970|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
145684029|NCT01107912|525356971|FG000|Period 1|Adverse Event|0|||
145684030|NCT01107912|525356972|FG001|Period 1|Adverse Event|0|||
145684031|NCT01107912|525356973|FG002|Period 1|Adverse Event|0|||
145684032|NCT01107912|525356974|FG003|Period 1|Adverse Event|0|||
145684033|NCT01107912|525356975|FG004|Period 1|Adverse Event|2|||
145684034|NCT01107912|525356976|FG005|Period 1|Adverse Event|0|||
145684035|NCT01107912|525356971|FG000|Period 1|Physician Decision|0|||
145491176|NCT04158583|524652357|FG002|Overall Study|Due To Patient Status|0|||
145684036|NCT01107912|525356972|FG001|Period 1|Physician Decision|0|||
145684037|NCT01107912|525356973|FG002|Period 1|Physician Decision|0|||
145684038|NCT01107912|525356974|FG003|Period 1|Physician Decision|0|||
145684039|NCT01107912|525356975|FG004|Period 1|Physician Decision|1|||
145684040|NCT01107912|525356976|FG005|Period 1|Physician Decision|0|||
145684041|NCT01107912|525356971|FG000|Period 1|Withdrawal by Subject|1|||
145684042|NCT01107912|525356972|FG001|Period 1|Withdrawal by Subject|0|||
145684043|NCT01107912|525356973|FG002|Period 1|Withdrawal by Subject|0|||
145684044|NCT01107912|525356974|FG003|Period 1|Withdrawal by Subject|0|||
145684045|NCT01107912|525356975|FG004|Period 1|Withdrawal by Subject|0|||
145684046|NCT01107912|525356976|FG005|Period 1|Withdrawal by Subject|0|||
145684047|NCT01107912|525356971|FG000|Period 2|Physician Decision|0|||
145684048|NCT01107912|525356972|FG001|Period 2|Physician Decision|0|||
145684049|NCT01107912|525356973|FG002|Period 2|Physician Decision|1|||
145684050|NCT01107912|525356974|FG003|Period 2|Physician Decision|0|||
145684051|NCT01107912|525356975|FG004|Period 2|Physician Decision|0|||
145684052|NCT01107912|525356976|FG005|Period 2|Physician Decision|0|||
145684053|NCT01107912|525356971|FG000|Period 3|Adverse Event|0|||
145684054|NCT01107912|525356972|FG001|Period 3|Adverse Event|1|||
145684055|NCT01107912|525356973|FG002|Period 3|Adverse Event|1|||
145684056|NCT01107912|525356974|FG003|Period 3|Adverse Event|0|||
145684057|NCT01107912|525356975|FG004|Period 3|Adverse Event|0|||
145684058|NCT01107912|525356976|FG005|Period 3|Adverse Event|0|||
145684059|NCT01107912|525356971|FG000|Period 3|Withdrawal by Subject|0|||
145684060|NCT01107912|525356972|FG001|Period 3|Withdrawal by Subject|0|||
145684061|NCT01107912|525356973|FG002|Period 3|Withdrawal by Subject|0|||
145684062|NCT01107912|525356974|FG003|Period 3|Withdrawal by Subject|1|||
145684063|NCT01107912|525356975|FG004|Period 3|Withdrawal by Subject|0|||
145684064|NCT01107912|525356976|FG005|Period 3|Withdrawal by Subject|0|||
145684065|NCT02991118|525356981|FG000|Overall Study|Death|3|||
145684066|NCT02991118|525356982|FG001|Overall Study|Death|8|||
145684067|NCT02991118|525356981|FG000|Overall Study|Protocol Violation|0|||
145684068|NCT02991118|525356982|FG001|Overall Study|Protocol Violation|3|||
145684069|NCT02991118|525356981|FG000|Overall Study|Physician Decision|0|||
145684070|NCT02991118|525356982|FG001|Overall Study|Physician Decision|1|||
145684071|NCT02991118|525356981|FG000|Overall Study|Moved out of the country|0|||
145684072|NCT02991118|525356982|FG001|Overall Study|Moved out of the country|1|||
145684073|NCT02991118|525356981|FG000|Overall Study|Adverse Event|2|||
145684074|NCT02991118|525356982|FG001|Overall Study|Adverse Event|2|||
145684075|NCT02991118|525356981|FG000|Overall Study|Withdrawal by Subject|1|||
145684076|NCT02991118|525356982|FG001|Overall Study|Withdrawal by Subject|7|||
145684077|NCT02991118|525356981|FG000|Overall Study|Could not attend study visits|0|||
145684078|NCT02991118|525356982|FG001|Overall Study|Could not attend study visits|1|||
145684079|NCT02991118|525356981|FG000|Overall Study|Lost to Follow-up|1|||
145684080|NCT02991118|525356982|FG001|Overall Study|Lost to Follow-up|9|||
145684081|NCT01287832|525356988|FG000|Overall Study|Adverse Event|1|||
145684082|NCT01287832|525356989|FG001|Overall Study|Adverse Event|0|||
145684083|NCT01287832|525356988|FG000|Overall Study|Death|0|||
145684084|NCT01287832|525356989|FG001|Overall Study|Death|1|||
145684085|NCT04749797|525356990|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
145684086|NCT04749797|525356991|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
145684087|NCT04749797|525356992|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
145684088|NCT00537914|525356993|FG000|Overall Study|Death|1|||
145684089|NCT00537914|525356993|FG000|Overall Study|Adverse Event|7|||
145684090|NCT00537914|525356993|FG000|Overall Study|Treatment failure|10|||
145684091|NCT00537914|525356993|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
145684092|NCT00537914|525356993|FG000|Overall Study|Lost to Follow-up|19|||
145684093|NCT00537914|525356993|FG000|Overall Study|Withdrawal of informed consent|59|||
145684094|NCT02312258|525356994|FG000|Overall Study|Lost to Follow-up|8|||
145684095|NCT02312258|525356995|FG001|Overall Study|Lost to Follow-up|8|||
145684096|NCT02312258|525356994|FG000|Overall Study|Withdrawal by Patient|49|||
145684097|NCT02312258|525356995|FG001|Overall Study|Withdrawal by Patient|76|||
145684098|NCT02312258|525356994|FG000|Overall Study|Reason not Specified|107|||
145684099|NCT02312258|525356995|FG001|Overall Study|Reason not Specified|159|||
145684100|NCT02312258|525356994|FG000|Overall Study|Missing|2|||
145684101|NCT02312258|525356995|FG001|Overall Study|Missing|1|||
145684102|NCT02312258|525356994|FG000|Overall Study|Death|115|||
145684103|NCT02312258|525356995|FG001|Overall Study|Death|181|||
145684104|NCT04447287|525356996|FG000|Period 1: Run-in Period|Adverse Event|3|||
145684105|NCT04447287|525356997|FG001|Period 1: Run-in Period|Adverse Event|0|||
145684106|NCT04447287|525356998|FG002|Period 1: Run-in Period|Adverse Event|0|||
145684107|NCT04447287|525356996|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
145684108|NCT04447287|525356997|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
145684109|NCT04447287|525356998|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
145684110|NCT04447287|525356996|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
145684111|NCT04447287|525356997|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
145684112|NCT04447287|525356998|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
145684113|NCT00655824|525357001|FG000|Overall Study|Adverse Event|3|||
145684114|NCT00655824|525357001|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
145684115|NCT00655824|525357001|FG000|Overall Study|Protocol Violation|1|||
145684116|NCT00655824|525357001|FG000|Overall Study|Withdrawal by Subject|4|||
145684117|NCT00655824|525357001|FG000|Overall Study|Deterioration of Trial Disease|2|||
145684118|NCT00960206|525357002|FG000|Overall Study|Death|7|||
145684119|NCT00960206|525357003|FG001|Overall Study|Death|4|||
145684120|NCT00960206|525357004|FG002|Overall Study|Death|1|||
145684121|NCT00960206|525357002|FG000|Overall Study|Unwilling/Unable to return|1|||
145684122|NCT00960206|525357003|FG001|Overall Study|Unwilling/Unable to return|2|||
145684123|NCT00960206|525357004|FG002|Overall Study|Unwilling/Unable to return|0|||
145684124|NCT00960206|525357002|FG000|Overall Study|Lost to Follow-up|8|||
145684125|NCT00960206|525357003|FG001|Overall Study|Lost to Follow-up|14|||
145684126|NCT00960206|525357004|FG002|Overall Study|Lost to Follow-up|8|||
145684127|NCT00960206|525357002|FG000|Overall Study|Withdrawal by Subject|2|||
145684128|NCT00960206|525357003|FG001|Overall Study|Withdrawal by Subject|4|||
145684129|NCT00960206|525357004|FG002|Overall Study|Withdrawal by Subject|0|||
145684130|NCT00960206|525357002|FG000|Overall Study|Revision of study component|2|||
145684131|NCT00960206|525357003|FG001|Overall Study|Revision of study component|2|||
145684132|NCT00960206|525357004|FG002|Overall Study|Revision of study component|2|||
145684133|NCT00960206|525357002|FG000|Overall Study|Missing 10 year data|20|||
145684134|NCT00960206|525357003|FG001|Overall Study|Missing 10 year data|1|||
145684135|NCT00960206|525357004|FG002|Overall Study|Missing 10 year data|1|||
145684136|NCT03032198|525357010|FG000|Overall Study|Screen Fail|1|||
145684137|NCT00866619|525357011|FG000|Overall Study|Adverse Event|112|||
145684138|NCT00866619|525357012|FG001|Overall Study|Adverse Event|106|||
145684139|NCT00866619|525357013|FG002|Overall Study|Adverse Event|47|||
145684140|NCT00866619|525357014|FG003|Overall Study|Adverse Event|44|||
145684141|NCT00866619|525357011|FG000|Overall Study|Protocol Violation|2|||
145684142|NCT00866619|525357012|FG001|Overall Study|Protocol Violation|39|||
145684143|NCT00866619|525357013|FG002|Overall Study|Protocol Violation|2|||
145684144|NCT00866619|525357014|FG003|Overall Study|Protocol Violation|17|||
145684145|NCT00866619|525357011|FG000|Overall Study|Withdrawal by Subject|587|||
145684146|NCT00866619|525357012|FG001|Overall Study|Withdrawal by Subject|295|||
145684147|NCT00866619|525357013|FG002|Overall Study|Withdrawal by Subject|272|||
145684148|NCT00866619|525357014|FG003|Overall Study|Withdrawal by Subject|144|||
145684149|NCT00866619|525357011|FG000|Overall Study|Lost to Follow-up|1145|||
145684150|NCT00866619|525357012|FG001|Overall Study|Lost to Follow-up|830|||
145684151|NCT00866619|525357013|FG002|Overall Study|Lost to Follow-up|568|||
145684152|NCT00866619|525357014|FG003|Overall Study|Lost to Follow-up|425|||
145684153|NCT02892019|525357016|FG000|Overall Study|randomized but not treated|0|||
145684154|NCT02892019|525357017|FG001|Overall Study|randomized but not treated|1|||
145684155|NCT02892019|525357016|FG000|Overall Study|Withdrawal by Subject|0|||
145684156|NCT02892019|525357017|FG001|Overall Study|Withdrawal by Subject|1|||
145684157|NCT02892019|525357016|FG000|Overall Study|Adverse Event|1|||
145684158|NCT02892019|525357017|FG001|Overall Study|Adverse Event|1|||
145684159|NCT01662505|525357018|FG000|Overall Study|Progressive disease|6|||
145684160|NCT01662505|525357019|FG001|Overall Study|Progressive disease|1|||
145684161|NCT01662505|525357020|FG002|Overall Study|Progressive disease|5|||
145684162|NCT01662505|525357018|FG000|Overall Study|Refused cont. medication|0|||
145684163|NCT01662505|525357019|FG001|Overall Study|Refused cont. medication|0|||
145684164|NCT01662505|525357020|FG002|Overall Study|Refused cont. medication|1|||
145684165|NCT01662505|525357018|FG000|Overall Study|Not specified above|1|||
145684166|NCT01662505|525357019|FG001|Overall Study|Not specified above|3|||
145684167|NCT01662505|525357020|FG002|Overall Study|Not specified above|2|||
145684168|NCT02340806|525357023|FG000|Overall Study|Protocol Violation|2|||
145684169|NCT02340806|525357024|FG001|Overall Study|Protocol Violation|0|||
145684170|NCT02340806|525357023|FG000|Overall Study|epidural catheter replaced|2|||
145684171|NCT02340806|525357024|FG001|Overall Study|epidural catheter replaced|1|||
145684172|NCT02340806|525357023|FG000|Overall Study|history of chronic pain medication|1|||
145684173|NCT02340806|525357024|FG001|Overall Study|history of chronic pain medication|0|||
145684174|NCT02340806|525357023|FG000|Overall Study|re-dose < 90 min of CSE|1|||
145684175|NCT02340806|525357024|FG001|Overall Study|re-dose < 90 min of CSE|3|||
145684176|NCT01186809|525357025|FG000|Overall Study|Death|30|||
145684177|NCT04895085|525357026|FG000|Overall Study|Death|1|||
145684178|NCT04895085|525357026|FG000|Overall Study|Withdrawal by Subject|1|||
145684179|NCT04895085|525357026|FG000|Overall Study|No longer eligible: Moved from area|1|||
145684180|NCT05379400|525358268|FG000|Overall Study|Lost to Follow-up|1|||
145684181|NCT05379400|525358269|FG001|Overall Study|Lost to Follow-up|1|||
145684182|NCT01279447|525358275|FG000|Overall Study|Lost to Follow-up|3|||
145684183|NCT01279447|525358276|FG001|Overall Study|Lost to Follow-up|1|||
145684184|NCT00538629|525358282|FG000|Overall Study|At subject's request|1|||
145684185|NCT00538629|525358282|FG000|Overall Study|Adverse Event|2|||
145684186|NCT00538629|525358282|FG000|Overall Study|Lack of Efficacy|12|||
145684187|NCT00538629|525358282|FG000|Overall Study|Lost to Follow-up|6|||
145684188|NCT00538629|525358282|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
145684189|NCT00555620|525358288|FG000|Overall Study|Death|0|||
145684190|NCT00555620|525358289|FG001|Overall Study|Death|1|||
145684191|NCT00555620|525358290|FG002|Overall Study|Death|0|||
145684192|NCT00555620|525358291|FG003|Overall Study|Death|0|||
145684193|NCT00555620|525358292|FG004|Overall Study|Death|0|||
145684194|NCT00555620|525358293|FG005|Overall Study|Death|1|||
145684195|NCT00555620|525358288|FG000|Overall Study|Study terminated by sponsor|0|||
145684196|NCT00555620|525358289|FG001|Overall Study|Study terminated by sponsor|0|||
145684197|NCT00555620|525358290|FG002|Overall Study|Study terminated by sponsor|1|||
145684198|NCT00555620|525358291|FG003|Overall Study|Study terminated by sponsor|0|||
145684199|NCT00555620|525358292|FG004|Overall Study|Study terminated by sponsor|0|||
145684200|NCT00555620|525358293|FG005|Overall Study|Study terminated by sponsor|0|||
145684201|NCT00555620|525358288|FG000|Overall Study|Adverse Event|0|||
145684202|NCT00555620|525358289|FG001|Overall Study|Adverse Event|0|||
145684203|NCT00555620|525358290|FG002|Overall Study|Adverse Event|1|||
145684204|NCT00555620|525358291|FG003|Overall Study|Adverse Event|5|||
145684205|NCT00555620|525358292|FG004|Overall Study|Adverse Event|0|||
145684206|NCT00555620|525358293|FG005|Overall Study|Adverse Event|1|||
145684207|NCT00555620|525358288|FG000|Overall Study|Objective progression or relapse|6|||
145684208|NCT00555620|525358289|FG001|Overall Study|Objective progression or relapse|5|||
145684209|NCT00555620|525358290|FG002|Overall Study|Objective progression or relapse|12|||
145684210|NCT00555620|525358291|FG003|Overall Study|Objective progression or relapse|17|||
145684211|NCT00555620|525358292|FG004|Overall Study|Objective progression or relapse|3|||
145684212|NCT00555620|525358293|FG005|Overall Study|Objective progression or relapse|16|||
145684213|NCT00555620|525358288|FG000|Overall Study|Participant refused treatment|0|||
145684214|NCT00555620|525358289|FG001|Overall Study|Participant refused treatment|1|||
145684215|NCT00555620|525358290|FG002|Overall Study|Participant refused treatment|1|||
145684216|NCT00555620|525358291|FG003|Overall Study|Participant refused treatment|0|||
145684217|NCT00555620|525358292|FG004|Overall Study|Participant refused treatment|0|||
145684218|NCT00555620|525358293|FG005|Overall Study|Participant refused treatment|1|||
145684219|NCT00555620|525358288|FG000|Overall Study|Other|0|||
145684220|NCT00555620|525358289|FG001|Overall Study|Other|0|||
145684221|NCT00555620|525358290|FG002|Overall Study|Other|0|||
145684222|NCT00555620|525358291|FG003|Overall Study|Other|1|||
145684223|NCT00555620|525358292|FG004|Overall Study|Other|0|||
145684224|NCT00555620|525358293|FG005|Overall Study|Other|3|||
145684225|NCT00447499|525358297|FG000|Overall Study|Adverse Event|1|||
145684226|NCT00447499|525358297|FG000|Overall Study|Patient Decision|4|||
145684227|NCT00447499|525358297|FG000|Overall Study|Sponsor Decision|1|||
145684228|NCT00447499|525358297|FG000|Overall Study|Physician Decision|1|||
145684229|NCT01767376|525358298|FG000|Overall Study|Lost to Follow-up|3|||
145684230|NCT01767376|525358299|FG001|Overall Study|Lost to Follow-up|2|||
145684231|NCT01767376|525358300|FG002|Overall Study|Lost to Follow-up|0|||
145684232|NCT01767376|525358298|FG000|Overall Study|Withdrawal by Subject|1|||
145684233|NCT01767376|525358299|FG001|Overall Study|Withdrawal by Subject|1|||
145684234|NCT01767376|525358300|FG002|Overall Study|Withdrawal by Subject|0|||
145684235|NCT03184519|525358301|FG000|Overall Study|Lost to Follow-up|6|||
145684236|NCT03184519|525358301|FG000|Overall Study|Physician Decision|21|||
145684237|NCT02105688|525358304|FG000|Part A: Double-Blind|Adverse Event|1|||
145684238|NCT02105688|525358305|FG001|Part A: Double-Blind|Adverse Event|0|||
145684239|NCT02105688|525358304|FG000|Part A: Double-Blind|Death|0|||
145684240|NCT02105688|525358305|FG001|Part A: Double-Blind|Death|1|||
145684241|NCT02105688|525358304|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
145684242|NCT02105688|525358305|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
145684243|NCT02105688|525358304|FG000|Part A: Double-Blind|Physician Decision|0|||
145684244|NCT02105688|525358305|FG001|Part A: Double-Blind|Physician Decision|1|||
145684245|NCT02105688|525358304|FG000|Part A: Double-Blind|Status Unknown|0|||
145684246|NCT02105688|525358305|FG001|Part A: Double-Blind|Status Unknown|2|||
145684247|NCT02105688|525358304|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
145684248|NCT02105688|525358305|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
145684249|NCT02105688|525358304|FG000|Part B: Observational Follow-up|Death|2|||
145684250|NCT02105688|525358305|FG001|Part B: Observational Follow-up|Death|1|||
145684251|NCT02105688|525358304|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
145684252|NCT02105688|525358305|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
145684253|NCT02105688|525358304|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
145684254|NCT02105688|525358305|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
145684255|NCT02105688|525358304|FG000|Part B: Observational Follow-up|Physician Decision|3|||
145684256|NCT02105688|525358305|FG001|Part B: Observational Follow-up|Physician Decision|1|||
145684257|NCT01358175|525358306|FG000|Overall Study|Death|1|||
145684258|NCT01358175|525358307|FG001|Overall Study|Death|0|||
145684259|NCT01358175|525358308|FG002|Overall Study|Death|1|||
145684260|NCT01358175|525358306|FG000|Overall Study|Withdrawal by Subject|9|||
145684261|NCT01358175|525358307|FG001|Overall Study|Withdrawal by Subject|5|||
145684262|NCT01358175|525358308|FG002|Overall Study|Withdrawal by Subject|10|||
145684263|NCT01358175|525358306|FG000|Overall Study|Technical issues|0|||
145684264|NCT01358175|525358307|FG001|Overall Study|Technical issues|1|||
145684265|NCT01358175|525358308|FG002|Overall Study|Technical issues|0|||
145684266|NCT01358175|525358306|FG000|Overall Study|Pregnancy|0|||
145684267|NCT01358175|525358307|FG001|Overall Study|Pregnancy|1|||
145684268|NCT01358175|525358308|FG002|Overall Study|Pregnancy|0|||
145684269|NCT01358175|525358306|FG000|Overall Study|Physician Decision|1|||
145684270|NCT01358175|525358307|FG001|Overall Study|Physician Decision|0|||
145684271|NCT01358175|525358308|FG002|Overall Study|Physician Decision|0|||
145684272|NCT01358175|525358306|FG000|Overall Study|Non Compliance with Study Treatment|0|||
145684273|NCT01358175|525358307|FG001|Overall Study|Non Compliance with Study Treatment|1|||
145684274|NCT01358175|525358308|FG002|Overall Study|Non Compliance with Study Treatment|1|||
145684275|NCT01358175|525358306|FG000|Overall Study|Lost to Follow-up|1|||
145684276|NCT01358175|525358307|FG001|Overall Study|Lost to Follow-up|1|||
145684277|NCT01358175|525358308|FG002|Overall Study|Lost to Follow-up|3|||
145684278|NCT01358175|525358306|FG000|Overall Study|Lack of Efficacy|3|||
145684279|NCT01358175|525358307|FG001|Overall Study|Lack of Efficacy|8|||
145684280|NCT01358175|525358308|FG002|Overall Study|Lack of Efficacy|6|||
145684281|NCT01358175|525358306|FG000|Overall Study|Adverse Event|6|||
145684282|NCT01358175|525358307|FG001|Overall Study|Adverse Event|11|||
145684283|NCT01358175|525358308|FG002|Overall Study|Adverse Event|11|||
145684284|NCT00595959|525358310|FG000|Overall Study|Withdrawal by Subject|1|||
145684285|NCT00595959|525358310|FG000|Overall Study|Lost to Follow-up|1|||
145684286|NCT00901459|525358313|FG000|Overall Study|Withdrawal by Subject|6|||
145684287|NCT02764320|525358314|FG000|Overall Study|Withdrawal by Subject|35|||
145684288|NCT02764320|525358315|FG001|Overall Study|Withdrawal by Subject|38|||
145684289|NCT02764320|525358314|FG000|Overall Study|Protocol Violation|11|||
145684290|NCT02764320|525358315|FG001|Overall Study|Protocol Violation|6|||
145684291|NCT02764320|525358314|FG000|Overall Study|Adverse Event|2|||
145684292|NCT02764320|525358315|FG001|Overall Study|Adverse Event|0|||
145684293|NCT02764320|525358314|FG000|Overall Study|Health Issues unable to continue|2|||
145684294|NCT02764320|525358315|FG001|Overall Study|Health Issues unable to continue|0|||
145684295|NCT02764320|525358314|FG000|Overall Study|Did not meet inclusion criteria|1|||
145684296|NCT02764320|525358315|FG001|Overall Study|Did not meet inclusion criteria|0|||
145684297|NCT02764320|525358314|FG000|Overall Study|Subject moved|0|||
145684298|NCT02764320|525358315|FG001|Overall Study|Subject moved|2|||
145684299|NCT02764320|525358314|FG000|Overall Study|Overused medication unavailable|0|||
145684300|NCT02764320|525358315|FG001|Overall Study|Overused medication unavailable|1|||
145684301|NCT02764320|525358314|FG000|Overall Study|Seeking care outside site|0|||
145684302|NCT02764320|525358315|FG001|Overall Study|Seeking care outside site|1|||
145684303|NCT02764320|525358314|FG000|Overall Study|Technology barriers|0|||
145684304|NCT02764320|525358315|FG001|Overall Study|Technology barriers|1|||
145684305|NCT00753896|525358316|FG000|Overall Study|Adverse Event|4|||
145684306|NCT00753896|525358316|FG000|Overall Study|Death|1|||
145684307|NCT00753896|525358316|FG000|Overall Study|Lost to Follow-up|2|||
145684308|NCT00753896|525358316|FG000|Overall Study|Protocol Violation|1|||
145684309|NCT00753896|525358316|FG000|Overall Study|Withdrawal by Subject|4|||
145684310|NCT00753896|525358316|FG000|Overall Study|Entry Criteria Not Met|4|||
145684311|NCT01280656|525358317|FG000|Overall Study|Adverse Event|1|||
145684312|NCT01280656|525358318|FG001|Overall Study|Adverse Event|14|||
145684313|NCT01280656|525358319|FG002|Overall Study|Adverse Event|13|||
145684314|NCT01280656|525358317|FG000|Overall Study|Lack of Efficacy|1|||
145684315|NCT01280656|525358318|FG001|Overall Study|Lack of Efficacy|22|||
145684316|NCT01280656|525358319|FG002|Overall Study|Lack of Efficacy|38|||
145684317|NCT01280656|525358317|FG000|Overall Study|Treatment shortening (RGT)|0|||
145684318|NCT01280656|525358318|FG001|Overall Study|Treatment shortening (RGT)|4|||
145684319|NCT01280656|525358319|FG002|Overall Study|Treatment shortening (RGT)|5|||
145684320|NCT01280656|525358317|FG000|Overall Study|Other|1|||
145684321|NCT01280656|525358318|FG001|Overall Study|Other|7|||
145684322|NCT01280656|525358319|FG002|Overall Study|Other|7|||
145684323|NCT03529942|525358320|FG000|Overall Study|Withdrawal by Subject|13|||
145684324|NCT03529942|525358320|FG000|Overall Study|Physician Decision|1|||
145684325|NCT03529942|525358320|FG000|Overall Study|Lost to Follow-up|7|||
145684326|NCT03529942|525358320|FG000|Overall Study|Needle inserted but no drug administered|1|||
145684327|NCT03529942|525358320|FG000|Overall Study|Personal reasons|1|||
145684328|NCT00409747|525358323|FG000|Overall Study|Withdrawal by Subject|1|||
145684329|NCT00636168|525358324|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
145684330|NCT00636168|525358325|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
145684331|NCT00636168|525358324|FG000|Randomized to Study Drug|Adverse Event|1|||
145684332|NCT00636168|525358325|FG001|Randomized to Study Drug|Adverse Event|0|||
145684333|NCT00636168|525358324|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
145684334|NCT00636168|525358325|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
145684335|NCT00636168|525358324|FG000|Treated With Study Drug|Recurrence of disease|135|||
145684336|NCT00636168|525358325|FG001|Treated With Study Drug|Recurrence of disease|282|||
145684337|NCT00636168|525358324|FG000|Treated With Study Drug|Adverse Event|250|||
145684338|NCT00636168|525358325|FG001|Treated With Study Drug|Adverse Event|22|||
145684339|NCT00636168|525358324|FG000|Treated With Study Drug|Participant withdrew consent|16|||
145684340|NCT00636168|525358325|FG001|Treated With Study Drug|Participant withdrew consent|21|||
145684341|NCT00636168|525358324|FG000|Treated With Study Drug|Poor/non-compliance|1|||
145684342|NCT00636168|525358325|FG001|Treated With Study Drug|Poor/non-compliance|3|||
145684343|NCT00636168|525358324|FG000|Treated With Study Drug|Death|3|||
145684344|NCT00636168|525358325|FG001|Treated With Study Drug|Death|0|||
145684345|NCT00636168|525358324|FG000|Treated With Study Drug|Pregnancy|1|||
145684346|NCT00636168|525358325|FG001|Treated With Study Drug|Pregnancy|0|||
145684347|NCT00636168|525358324|FG000|Treated With Study Drug|No longer meets study criteria|1|||
145684348|NCT00636168|525358325|FG001|Treated With Study Drug|No longer meets study criteria|0|||
145684349|NCT00636168|525358324|FG000|Treated With Study Drug|Other reason|1|||
145684350|NCT00636168|525358325|FG001|Treated With Study Drug|Other reason|3|||
145684351|NCT00636168|525358324|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
145684352|NCT00636168|525358325|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
145684353|NCT00636168|525358324|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
145684354|NCT00636168|525358325|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
145684355|NCT00636168|525358324|FG000|Long Term Follow-Up|Death|8|||
145684356|NCT00636168|525358325|FG001|Long Term Follow-Up|Death|9|||
145684357|NCT00632736|525358327|FG000|Overall Study|Adverse Event|104|||
145684358|NCT00632736|525358327|FG000|Overall Study|Lost to Follow-up|15|||
145684359|NCT00632736|525358327|FG000|Overall Study|Protocol Violation|14|||
145684360|NCT00632736|525358327|FG000|Overall Study|Withdrawal by Subject|99|||
145684361|NCT00632736|525358327|FG000|Overall Study|Lack of Efficacy|5|||
145684362|NCT00632736|525358327|FG000|Overall Study|Sponsor terminated study|5|||
145684363|NCT00632736|525358327|FG000|Overall Study|Non-compliance|10|||
145684364|NCT00632736|525358327|FG000|Overall Study|Other|16|||
145684365|NCT03015220|525358328|FG000|Overall Study|Withdrawal by Subject|3|||
145684366|NCT03015220|525358329|FG001|Overall Study|Withdrawal by Subject|2|||
145684367|NCT03015220|525358330|FG002|Overall Study|Withdrawal by Subject|2|||
145684368|NCT03015220|525358331|FG003|Overall Study|Withdrawal by Subject|2|||
145684369|NCT03015220|525358328|FG000|Overall Study|Lost to Follow-up|0|||
145684370|NCT03015220|525358329|FG001|Overall Study|Lost to Follow-up|0|||
145684371|NCT03015220|525358330|FG002|Overall Study|Lost to Follow-up|1|||
145684372|NCT03015220|525358331|FG003|Overall Study|Lost to Follow-up|0|||
145684373|NCT02291549|525358332|FG000|Overall Study|Lost to Follow-up|1|||
145684374|NCT02291549|525358333|FG001|Overall Study|Lost to Follow-up|0|||
145684375|NCT02291549|525358332|FG000|Overall Study|Withdrawal by Subject|0|||
145684376|NCT02291549|525358333|FG001|Overall Study|Withdrawal by Subject|1|||
145684377|NCT01468597|525358335|FG000|Overall Study|Found ineligible|17|||
145684378|NCT01468597|525358335|FG000|Overall Study|concomitant valves|12|||
145684379|NCT01468597|525358335|FG000|Overall Study|off-pump CABG|1|||
145684380|NCT01468597|525358335|FG000|Overall Study|no platelet function data|5|||
145684381|NCT00912964|525358336|FG000|Overall Study|Eligibility criterion not met|1|||
145684382|NCT00912964|525358337|FG001|Overall Study|Eligibility criterion not met|1|||
145684383|NCT00912964|525358338|FG002|Overall Study|Eligibility criterion not met|0|||
145684384|NCT00912964|525358336|FG000|Overall Study|Adverse Event|15|||
145684385|NCT00912964|525358337|FG001|Overall Study|Adverse Event|18|||
145684386|NCT00912964|525358338|FG002|Overall Study|Adverse Event|12|||
145684387|NCT00912964|525358336|FG000|Overall Study|Lack of Efficacy|11|||
145684388|NCT00912964|525358337|FG001|Overall Study|Lack of Efficacy|4|||
145684389|NCT00912964|525358338|FG002|Overall Study|Lack of Efficacy|3|||
145684390|NCT00912964|525358336|FG000|Overall Study|Withdrawal by Subject|20|||
145684391|NCT00912964|525358337|FG001|Overall Study|Withdrawal by Subject|12|||
145684392|NCT00912964|525358338|FG002|Overall Study|Withdrawal by Subject|18|||
145684393|NCT00912964|525358336|FG000|Overall Study|Lost to Follow-up|4|||
145684394|NCT00912964|525358337|FG001|Overall Study|Lost to Follow-up|3|||
145684395|NCT00912964|525358338|FG002|Overall Study|Lost to Follow-up|3|||
145684396|NCT00912964|525358336|FG000|Overall Study|Protocol Violation|5|||
145684397|NCT00912964|525358337|FG001|Overall Study|Protocol Violation|3|||
145684398|NCT00912964|525358338|FG002|Overall Study|Protocol Violation|8|||
145684399|NCT00912964|525358336|FG000|Overall Study|Taking exclusionary medications|7|||
145684400|NCT00912964|525358337|FG001|Overall Study|Taking exclusionary medications|4|||
145684401|NCT00912964|525358338|FG002|Overall Study|Taking exclusionary medications|8|||
145684402|NCT00912964|525358336|FG000|Overall Study|Medical History|1|||
145684403|NCT00912964|525358337|FG001|Overall Study|Medical History|0|||
145684404|NCT00912964|525358338|FG002|Overall Study|Medical History|0|||
145684405|NCT00912964|525358336|FG000|Overall Study|Non-compliance with study procedures|2|||
145684406|NCT00912964|525358337|FG001|Overall Study|Non-compliance with study procedures|0|||
145684407|NCT00912964|525358338|FG002|Overall Study|Non-compliance with study procedures|0|||
145684408|NCT00912964|525358336|FG000|Overall Study|Violation of exclusion criterion|0|||
145684409|NCT00912964|525358337|FG001|Overall Study|Violation of exclusion criterion|0|||
145684410|NCT00912964|525358338|FG002|Overall Study|Violation of exclusion criterion|2|||
145684411|NCT00912964|525358336|FG000|Overall Study|Randomized but never received study drug|0|||
145684412|NCT00912964|525358337|FG001|Overall Study|Randomized but never received study drug|1|||
145684413|NCT00912964|525358338|FG002|Overall Study|Randomized but never received study drug|0|||
145684414|NCT02470806|525358340|FG000|Overall Study|Lost to Follow-up|1|||
145684415|NCT02470806|525358341|FG001|Overall Study|Lost to Follow-up|1|||
145684416|NCT02470806|525358340|FG000|Overall Study|Adverse Event|5|||
145684417|NCT02470806|525358341|FG001|Overall Study|Adverse Event|2|||
145684418|NCT02470806|525358340|FG000|Overall Study|Protocol Violation|4|||
145684419|NCT02470806|525358341|FG001|Overall Study|Protocol Violation|11|||
145684420|NCT02470806|525358340|FG000|Overall Study|Physician Decision|0|||
145684421|NCT02470806|525358341|FG001|Overall Study|Physician Decision|3|||
145684422|NCT02470806|525358340|FG000|Overall Study|Withdrawal by Subject|3|||
145684423|NCT02470806|525358341|FG001|Overall Study|Withdrawal by Subject|10|||
145684424|NCT02470806|525358340|FG000|Overall Study|Lack of Efficacy|5|||
145684425|NCT02470806|525358341|FG001|Overall Study|Lack of Efficacy|15|||
145684426|NCT01229176|525358342|FG000|Overall Study|Withdrawal by Subject|0|||
145684427|NCT01229176|525358343|FG001|Overall Study|Withdrawal by Subject|0|||
145684428|NCT01229176|525358344|FG002|Overall Study|Withdrawal by Subject|0|||
145684429|NCT01229176|525358345|FG003|Overall Study|Withdrawal by Subject|1|||
145684430|NCT01229176|525358346|FG004|Overall Study|Withdrawal by Subject|1|||
145684431|NCT01229176|525358347|FG005|Overall Study|Withdrawal by Subject|1|||
145684432|NCT01229176|525358348|FG006|Overall Study|Withdrawal by Subject|0|||
145684433|NCT01229176|525358349|FG007|Overall Study|Withdrawal by Subject|1|||
145684434|NCT01229176|525358342|FG000|Overall Study|Lost to Follow-up|0|||
145684435|NCT01229176|525358343|FG001|Overall Study|Lost to Follow-up|3|||
145684436|NCT01229176|525358344|FG002|Overall Study|Lost to Follow-up|0|||
145684437|NCT01229176|525358345|FG003|Overall Study|Lost to Follow-up|0|||
145684438|NCT01229176|525358346|FG004|Overall Study|Lost to Follow-up|1|||
145684439|NCT01229176|525358347|FG005|Overall Study|Lost to Follow-up|1|||
145684440|NCT01229176|525358348|FG006|Overall Study|Lost to Follow-up|0|||
145684441|NCT01229176|525358349|FG007|Overall Study|Lost to Follow-up|2|||
145684442|NCT01661972|525358350|FG000|Overall Study|Adverse Event|1|||
145684443|NCT01661972|525358351|FG001|Overall Study|Adverse Event|2|||
145684444|NCT01661972|525358350|FG000|Overall Study|Death during Treatment period|1|||
145684445|NCT01661972|525358351|FG001|Overall Study|Death during Treatment period|1|||
145684446|NCT01661972|525358350|FG000|Overall Study|Withdrawal by Subject|0|||
145684447|NCT01661972|525358351|FG001|Overall Study|Withdrawal by Subject|1|||
145684448|NCT02138838|525358354|FG000|Overall Study|Study Closure|7|||
145684449|NCT02138838|525358355|FG001|Overall Study|Study Closure|6|||
145684450|NCT02138838|525358354|FG000|Overall Study|Withdrawal by Subject|1|||
145684451|NCT02138838|525358355|FG001|Overall Study|Withdrawal by Subject|5|||
145684452|NCT00882050|525358358|FG000|Overall Study|Physician Decision|1|||
145684453|NCT00882050|525358359|FG001|Overall Study|Physician Decision|0|||
145684454|NCT00882050|525358360|FG002|Overall Study|Physician Decision|0|||
145684455|NCT02010684|525358361|FG000|Overall Study|Lost to Follow-up|8|||
145684456|NCT02010684|525358362|FG001|Overall Study|Lost to Follow-up|18|||
145684457|NCT02010684|525358361|FG000|Overall Study|Withdrawal by Subject|4|||
145684458|NCT02010684|525358362|FG001|Overall Study|Withdrawal by Subject|5|||
145684459|NCT01884571|525358367|FG000|Overall Study|Adverse Event|1|||
145684460|NCT01884571|525358367|FG000|Overall Study|Death|2|||
145684461|NCT01884571|525358367|FG000|Overall Study|Withdrawal by Subject|2|||
145684462|NCT01884571|525358367|FG000|Overall Study|Disease progression|3|||
145684463|NCT00091572|525358368|FG000|Overall Study|Lost to Follow-up|1|||
145684464|NCT00091572|525358369|FG001|Overall Study|Lost to Follow-up|1|||
145684465|NCT00091572|525358368|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
145684466|NCT00091572|525358369|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
145684467|NCT00091572|525358368|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
145684468|NCT00091572|525358369|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
145684469|NCT00091572|525358368|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
145684470|NCT00091572|525358369|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
145684471|NCT00091572|525358368|FG000|Overall Study|Other Reason|6|||
145684472|NCT00091572|525358369|FG001|Overall Study|Other Reason|13|||
145684473|NCT00091572|525358368|FG000|Overall Study|Ongoing (still on treatment)|8|||
145684474|NCT00091572|525358369|FG001|Overall Study|Ongoing (still on treatment)|12|||
145684475|NCT00091572|525358368|FG000|Overall Study|Major Protocol Violation|2|||
145684476|NCT00091572|525358369|FG001|Overall Study|Major Protocol Violation|0|||
145684477|NCT00091572|525358368|FG000|Overall Study|Toxicity (Related AE)|53|||
145684478|NCT00091572|525358369|FG001|Overall Study|Toxicity (Related AE)|9|||
145684479|NCT01199302|525358371|FG000|Overall Study|Adverse Event|1|||
145684480|NCT01199302|525358372|FG001|Overall Study|Adverse Event|1|||
145684481|NCT01199302|525358373|FG002|Overall Study|Adverse Event|2|||
145684482|NCT01199302|525358374|FG003|Overall Study|Adverse Event|0|||
145684483|NCT01199302|525358371|FG000|Overall Study|Withdrawal by Subject|2|||
145684484|NCT01199302|525358372|FG001|Overall Study|Withdrawal by Subject|2|||
145684485|NCT01199302|525358373|FG002|Overall Study|Withdrawal by Subject|3|||
145684486|NCT01199302|525358374|FG003|Overall Study|Withdrawal by Subject|0|||
145684487|NCT01199302|525358371|FG000|Overall Study|Disease Progression|3|||
145684488|NCT01199302|525358372|FG001|Overall Study|Disease Progression|4|||
145684489|NCT01199302|525358373|FG002|Overall Study|Disease Progression|4|||
145684490|NCT01199302|525358374|FG003|Overall Study|Disease Progression|2|||
145684491|NCT01199302|525358371|FG000|Overall Study|Study Termination|13|||
145684492|NCT01199302|525358372|FG001|Overall Study|Study Termination|8|||
145265415|NCT00764465|523819353|FG001|Overall Study|Withdrawal by Subject|1|||
145684493|NCT01199302|525358373|FG002|Overall Study|Study Termination|11|||
145684494|NCT01199302|525358374|FG003|Overall Study|Study Termination|9|||
145684495|NCT01199302|525358371|FG000|Overall Study|Lost to Follow-up|0|||
145684496|NCT01199302|525358372|FG001|Overall Study|Lost to Follow-up|1|||
145684497|NCT01199302|525358373|FG002|Overall Study|Lost to Follow-up|0|||
145684498|NCT01199302|525358374|FG003|Overall Study|Lost to Follow-up|0|||
145684499|NCT01199302|525358371|FG000|Overall Study|Other|1|||
145265416|NCT00764465|523819354|FG002|Overall Study|Withdrawal by Subject|1|||
145684500|NCT01199302|525358372|FG001|Overall Study|Other|0|||
145684501|NCT01199302|525358373|FG002|Overall Study|Other|0|||
145684502|NCT01199302|525358374|FG003|Overall Study|Other|0|||
145684503|NCT01159600|525358376|FG000|Overall Study|Not treated|0|||
145684504|NCT01159600|525358377|FG001|Overall Study|Not treated|0|||
145684505|NCT01159600|525358378|FG002|Overall Study|Not treated|1|||
145491177|NCT04158583|524652358|FG003|Overall Study|Due To Patient Status|0|||
145491178|NCT04158583|524652359|FG004|Overall Study|Due To Patient Status|0|||
145491179|NCT04158583|524652360|FG005|Overall Study|Due To Patient Status|0|||
145491180|NCT04158583|524652361|FG006|Overall Study|Due To Patient Status|0|||
145684506|NCT01159600|525358379|FG003|Overall Study|Not treated|0|||
145684507|NCT01159600|525358380|FG004|Overall Study|Not treated|0|||
145684508|NCT01159600|525358381|FG005|Overall Study|Not treated|1|||
145684509|NCT01159600|525358382|FG006|Overall Study|Not treated|2|||
145684510|NCT01159600|525358383|FG007|Overall Study|Not treated|2|||
145684511|NCT01159600|525358376|FG000|Overall Study|Adverse Event|7|||
145684512|NCT01159600|525358377|FG001|Overall Study|Adverse Event|2|||
145684513|NCT01159600|525358378|FG002|Overall Study|Adverse Event|5|||
145684514|NCT01159600|525358379|FG003|Overall Study|Adverse Event|1|||
145684515|NCT01159600|525358380|FG004|Overall Study|Adverse Event|8|||
145684516|NCT01159600|525358381|FG005|Overall Study|Adverse Event|6|||
145684517|NCT01159600|525358382|FG006|Overall Study|Adverse Event|7|||
145684518|NCT01159600|525358383|FG007|Overall Study|Adverse Event|5|||
145684519|NCT01159600|525358376|FG000|Overall Study|Lack of Efficacy|0|||
145684520|NCT01159600|525358377|FG001|Overall Study|Lack of Efficacy|0|||
145684521|NCT01159600|525358378|FG002|Overall Study|Lack of Efficacy|0|||
145684522|NCT01159600|525358379|FG003|Overall Study|Lack of Efficacy|0|||
145684523|NCT01159600|525358380|FG004|Overall Study|Lack of Efficacy|2|||
145684524|NCT01159600|525358381|FG005|Overall Study|Lack of Efficacy|0|||
145684525|NCT01159600|525358382|FG006|Overall Study|Lack of Efficacy|0|||
145684526|NCT01159600|525358383|FG007|Overall Study|Lack of Efficacy|1|||
145684527|NCT01159600|525358376|FG000|Overall Study|Non compliant with protocol|2|||
145684528|NCT01159600|525358377|FG001|Overall Study|Non compliant with protocol|1|||
145684529|NCT01159600|525358378|FG002|Overall Study|Non compliant with protocol|0|||
145684530|NCT01159600|525358379|FG003|Overall Study|Non compliant with protocol|0|||
145684531|NCT01159600|525358380|FG004|Overall Study|Non compliant with protocol|2|||
145684532|NCT01159600|525358381|FG005|Overall Study|Non compliant with protocol|0|||
145684533|NCT01159600|525358382|FG006|Overall Study|Non compliant with protocol|2|||
145684534|NCT01159600|525358383|FG007|Overall Study|Non compliant with protocol|0|||
145684535|NCT01159600|525358376|FG000|Overall Study|Lost to Follow-up|2|||
145684536|NCT01159600|525358377|FG001|Overall Study|Lost to Follow-up|3|||
145684537|NCT01159600|525358378|FG002|Overall Study|Lost to Follow-up|4|||
145684538|NCT01159600|525358379|FG003|Overall Study|Lost to Follow-up|3|||
145684539|NCT01159600|525358380|FG004|Overall Study|Lost to Follow-up|3|||
145684540|NCT01159600|525358381|FG005|Overall Study|Lost to Follow-up|0|||
145684541|NCT01159600|525358382|FG006|Overall Study|Lost to Follow-up|3|||
145684542|NCT01159600|525358383|FG007|Overall Study|Lost to Follow-up|2|||
145684543|NCT01159600|525358376|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
145684544|NCT01159600|525358377|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
145684545|NCT01159600|525358378|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
145684546|NCT01159600|525358379|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
145684547|NCT01159600|525358380|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
145684548|NCT01159600|525358381|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
145684549|NCT01159600|525358382|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
145684550|NCT01159600|525358383|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
145491181|NCT04158583|524652362|FG007|Overall Study|Due To Patient Status|0|||
145491182|NCT04158583|524652363|FG008|Overall Study|Due To Patient Status|1|||
145684551|NCT01159600|525358376|FG000|Overall Study|Other reason not defined above|3|||
145684552|NCT01159600|525358377|FG001|Overall Study|Other reason not defined above|0|||
145684553|NCT01159600|525358378|FG002|Overall Study|Other reason not defined above|4|||
145684554|NCT01159600|525358379|FG003|Overall Study|Other reason not defined above|2|||
145684555|NCT01159600|525358380|FG004|Overall Study|Other reason not defined above|5|||
145684556|NCT01159600|525358381|FG005|Overall Study|Other reason not defined above|7|||
145684557|NCT01159600|525358382|FG006|Overall Study|Other reason not defined above|3|||
145684558|NCT01159600|525358383|FG007|Overall Study|Other reason not defined above|3|||
145684559|NCT04433091|525358384|FG000|Overall Study|Lost to Follow-up|1|||
145684560|NCT04433091|525358385|FG001|Overall Study|Lost to Follow-up|0|||
145684561|NCT04433091|525358384|FG000|Overall Study|Withdrawn .|2|||
145684562|NCT04433091|525358385|FG001|Overall Study|Withdrawn .|4|||
145684563|NCT00946998|525359902|FG000|Overall Study|Exited prior to first outcome assessment|5|||
145684564|NCT00946998|525359903|FG001|Overall Study|Exited prior to first outcome assessment|3|||
145684565|NCT05356130|525359907|FG000|Overall Study|Withdrawal by Subject|0|||
145684566|NCT05356130|525359908|FG001|Overall Study|Withdrawal by Subject|0|||
145684567|NCT05356130|525359909|FG002|Overall Study|Withdrawal by Subject|3|||
145684568|NCT02880293|525359910|FG000|Overall Study|Inevaluable|5|||
145684569|NCT02109172|525359911|FG000|Overall Study|Withdrawal by Subject|1|||
145684570|NCT02109172|525359912|FG001|Overall Study|Withdrawal by Subject|0|||
145684571|NCT02109172|525359913|FG002|Overall Study|Withdrawal by Subject|0|||
145684572|NCT02109172|525359914|FG003|Overall Study|Withdrawal by Subject|1|||
145684573|NCT02109172|525359915|FG004|Overall Study|Withdrawal by Subject|0|||
145684574|NCT02109172|525359916|FG005|Overall Study|Withdrawal by Subject|0|||
145684575|NCT02109172|525359911|FG000|Overall Study|Adverse Event|0|||
145684576|NCT02109172|525359912|FG001|Overall Study|Adverse Event|0|||
145684577|NCT02109172|525359913|FG002|Overall Study|Adverse Event|1|||
145684578|NCT02109172|525359914|FG003|Overall Study|Adverse Event|0|||
145684579|NCT02109172|525359915|FG004|Overall Study|Adverse Event|0|||
145684580|NCT02109172|525359916|FG005|Overall Study|Adverse Event|1|||
145684581|NCT02109172|525359911|FG000|Overall Study|Death|0|||
145684582|NCT02109172|525359912|FG001|Overall Study|Death|0|||
145684583|NCT02109172|525359913|FG002|Overall Study|Death|0|||
145684584|NCT02109172|525359914|FG003|Overall Study|Death|0|||
145684585|NCT02109172|525359915|FG004|Overall Study|Death|1|||
145684586|NCT02109172|525359916|FG005|Overall Study|Death|0|||
145684587|NCT03409276|525359917|FG000|Overall Study|Withdrawal by Subject|0|||
145684588|NCT03409276|525359918|FG001|Overall Study|Withdrawal by Subject|0|||
145684589|NCT03409276|525359919|FG002|Overall Study|Withdrawal by Subject|0|||
145684590|NCT03409276|525359920|FG003|Overall Study|Withdrawal by Subject|0|||
145684591|NCT03409276|525359921|FG004|Overall Study|Withdrawal by Subject|1|||
145684592|NCT03409276|525359917|FG000|Overall Study|Lost to Follow-up|0|||
145684593|NCT03409276|525359918|FG001|Overall Study|Lost to Follow-up|0|||
145684594|NCT03409276|525359919|FG002|Overall Study|Lost to Follow-up|0|||
145684595|NCT03409276|525359920|FG003|Overall Study|Lost to Follow-up|2|||
145684596|NCT03409276|525359921|FG004|Overall Study|Lost to Follow-up|2|||
145684597|NCT05203822|525359922|FG000|Overall Study|Adverse Event|1|||
145684598|NCT05203822|525359922|FG000|Overall Study|Withdrawal by Subject|1|||
145684599|NCT03320941|525359923|FG000|Overall Study|subject/guardian decision|0|||
145684600|NCT03320941|525359924|FG001|Overall Study|subject/guardian decision|0|||
145684601|NCT03320941|525359925|FG002|Overall Study|subject/guardian decision|0|||
145684602|NCT03320941|525359926|FG003|Overall Study|subject/guardian decision|1|||
145684603|NCT03320941|525359927|FG004|Overall Study|subject/guardian decision|0|||
145684604|NCT00946088|525359929|FG000|Overall Study|Withdrawal by Subject|0|||
145684605|NCT00946088|525359930|FG001|Overall Study|Withdrawal by Subject|1|||
145684606|NCT00584909|525359932|FG000|Overall Study|Adverse Event|4|||
145684607|NCT03345407|525359933|FG000|Overall Study|Withdrawal by Subject|11|||
145684608|NCT03345407|525359934|FG001|Overall Study|Withdrawal by Subject|1|||
145684609|NCT03345407|525359935|FG002|Overall Study|Withdrawal by Subject|5|||
145684610|NCT03345407|525359936|FG003|Overall Study|Withdrawal by Subject|6|||
145684611|NCT03345407|525359937|FG004|Overall Study|Withdrawal by Subject|3|||
145684612|NCT03345407|525359938|FG005|Overall Study|Withdrawal by Subject|6|||
145684613|NCT03345407|525359939|FG006|Overall Study|Withdrawal by Subject|16|||
145684614|NCT03345407|525359933|FG000|Overall Study|Physician Decision|3|||
145684615|NCT03345407|525359934|FG001|Overall Study|Physician Decision|1|||
145684616|NCT03345407|525359935|FG002|Overall Study|Physician Decision|0|||
145684617|NCT03345407|525359936|FG003|Overall Study|Physician Decision|0|||
145684618|NCT03345407|525359937|FG004|Overall Study|Physician Decision|1|||
145684619|NCT03345407|525359938|FG005|Overall Study|Physician Decision|2|||
145684620|NCT03345407|525359939|FG006|Overall Study|Physician Decision|3|||
145684621|NCT03345407|525359933|FG000|Overall Study|Lost to Follow-up|2|||
145684622|NCT03345407|525359934|FG001|Overall Study|Lost to Follow-up|0|||
145684623|NCT03345407|525359935|FG002|Overall Study|Lost to Follow-up|1|||
145684624|NCT03345407|525359936|FG003|Overall Study|Lost to Follow-up|0|||
145684625|NCT03345407|525359937|FG004|Overall Study|Lost to Follow-up|1|||
145491183|NCT04158583|524652364|FG009|Overall Study|Due To Patient Status|0|||
145684626|NCT03345407|525359938|FG005|Overall Study|Lost to Follow-up|2|||
145684627|NCT03345407|525359939|FG006|Overall Study|Lost to Follow-up|3|||
145684628|NCT03345407|525359933|FG000|Overall Study|Protocol-defined stopping criteria|9|||
145684629|NCT03345407|525359934|FG001|Overall Study|Protocol-defined stopping criteria|0|||
145684630|NCT03345407|525359935|FG002|Overall Study|Protocol-defined stopping criteria|0|||
145684631|NCT03345407|525359936|FG003|Overall Study|Protocol-defined stopping criteria|0|||
145684632|NCT03345407|525359937|FG004|Overall Study|Protocol-defined stopping criteria|2|||
145684633|NCT03345407|525359938|FG005|Overall Study|Protocol-defined stopping criteria|1|||
145684634|NCT03345407|525359939|FG006|Overall Study|Protocol-defined stopping criteria|1|||
145684635|NCT03345407|525359933|FG000|Overall Study|Protocol Violation|2|||
145684636|NCT03345407|525359934|FG001|Overall Study|Protocol Violation|0|||
145684637|NCT03345407|525359935|FG002|Overall Study|Protocol Violation|0|||
145684638|NCT03345407|525359936|FG003|Overall Study|Protocol Violation|0|||
145684639|NCT03345407|525359937|FG004|Overall Study|Protocol Violation|1|||
145684640|NCT03345407|525359938|FG005|Overall Study|Protocol Violation|0|||
145684641|NCT03345407|525359939|FG006|Overall Study|Protocol Violation|3|||
145684642|NCT03345407|525359933|FG000|Overall Study|Lack of Efficacy|1|||
145684643|NCT03345407|525359934|FG001|Overall Study|Lack of Efficacy|1|||
145684644|NCT03345407|525359935|FG002|Overall Study|Lack of Efficacy|1|||
145684645|NCT03345407|525359936|FG003|Overall Study|Lack of Efficacy|1|||
145684646|NCT03345407|525359937|FG004|Overall Study|Lack of Efficacy|1|||
145684647|NCT03345407|525359938|FG005|Overall Study|Lack of Efficacy|0|||
145684648|NCT03345407|525359939|FG006|Overall Study|Lack of Efficacy|3|||
145684649|NCT03345407|525359933|FG000|Overall Study|Adverse Event|4|||
145684650|NCT03345407|525359934|FG001|Overall Study|Adverse Event|0|||
145684651|NCT03345407|525359935|FG002|Overall Study|Adverse Event|5|||
145684652|NCT03345407|525359936|FG003|Overall Study|Adverse Event|4|||
145684653|NCT03345407|525359937|FG004|Overall Study|Adverse Event|6|||
145684654|NCT03345407|525359938|FG005|Overall Study|Adverse Event|5|||
145684655|NCT03345407|525359939|FG006|Overall Study|Adverse Event|16|||
145684656|NCT02092909|525359942|FG000|Overall Study|Adverse Event|0|||
145684657|NCT02092909|525359943|FG001|Overall Study|Adverse Event|0|||
145684658|NCT02092909|525359944|FG002|Overall Study|Adverse Event|4|||
145684659|NCT02092909|525359945|FG003|Overall Study|Adverse Event|2|||
145684660|NCT02092909|525359942|FG000|Overall Study|Lack of Efficacy|0|||
145684661|NCT02092909|525359943|FG001|Overall Study|Lack of Efficacy|2|||
145684662|NCT02092909|525359944|FG002|Overall Study|Lack of Efficacy|1|||
145684663|NCT02092909|525359945|FG003|Overall Study|Lack of Efficacy|0|||
145684664|NCT02092909|525359942|FG000|Overall Study|Withdrawal by Subject|0|||
145684665|NCT02092909|525359943|FG001|Overall Study|Withdrawal by Subject|0|||
145684666|NCT02092909|525359944|FG002|Overall Study|Withdrawal by Subject|2|||
145684667|NCT02092909|525359945|FG003|Overall Study|Withdrawal by Subject|1|||
145684668|NCT02092909|525359942|FG000|Overall Study|Study terminated by Sponsor|0|||
145684669|NCT02092909|525359943|FG001|Overall Study|Study terminated by Sponsor|0|||
145684670|NCT02092909|525359944|FG002|Overall Study|Study terminated by Sponsor|0|||
145684671|NCT02092909|525359945|FG003|Overall Study|Study terminated by Sponsor|2|||
145684672|NCT02092909|525359942|FG000|Overall Study|Miscellaneous|1|||
145684673|NCT02092909|525359943|FG001|Overall Study|Miscellaneous|1|||
145684674|NCT02092909|525359944|FG002|Overall Study|Miscellaneous|2|||
145684675|NCT02092909|525359945|FG003|Overall Study|Miscellaneous|1|||
145684676|NCT03436797|525359946|FG000|Main Study|Withdrawal by Subject|2|||
145684677|NCT03436797|525359946|FG000|Main Study|Adverse Event|4|||
145684678|NCT03436797|525359946|FG000|Main Study|Lost to Follow-up|1|||
145684679|NCT03436797|525359946|FG000|Main Study|Death|1|||
145684680|NCT03436797|525359946|FG000|Main Study|Non-Specific|2|||
145684681|NCT03436797|525359946|FG000|Extended Dosing|Patient decision|1|||
145684682|NCT02865083|525359949|FG000|Overall Study|Early Termination|3|||
145684683|NCT02865083|525359950|FG001|Overall Study|Early Termination|1|||
145684684|NCT02727998|525359951|FG000|Overall Study|Lost to Follow-up|3|||
145684685|NCT02727998|525359952|FG001|Overall Study|Lost to Follow-up|3|||
145684686|NCT02727998|525359951|FG000|Overall Study|Withdrawal by Subject|0|||
145684687|NCT02727998|525359952|FG001|Overall Study|Withdrawal by Subject|1|||
145684688|NCT05072795|525359953|FG000|Overall Study|Lost to Follow-up|5|||
145684689|NCT03651271|525359954|FG000|Overall Study|Death|4|||
145684690|NCT03651271|525359955|FG001|Overall Study|Death|37|||
145684691|NCT03651271|525359956|FG002|Overall Study|Death|0|||
145684692|NCT03651271|525359957|FG003|Overall Study|Death|2|||
145684693|NCT03651271|525359958|FG004|Overall Study|Death|6|||
145684694|NCT03651271|525359954|FG000|Overall Study|Lost to Follow-up|1|||
145684695|NCT03651271|525359955|FG001|Overall Study|Lost to Follow-up|5|||
145684696|NCT03651271|525359956|FG002|Overall Study|Lost to Follow-up|0|||
145684697|NCT03651271|525359957|FG003|Overall Study|Lost to Follow-up|1|||
145684698|NCT03651271|525359958|FG004|Overall Study|Lost to Follow-up|0|||
145684699|NCT03651271|525359954|FG000|Overall Study|Physician Decision|0|||
145684700|NCT03651271|525359955|FG001|Overall Study|Physician Decision|2|||
145684701|NCT03651271|525359956|FG002|Overall Study|Physician Decision|0|||
145684702|NCT03651271|525359957|FG003|Overall Study|Physician Decision|0|||
145684703|NCT03651271|525359958|FG004|Overall Study|Physician Decision|0|||
145684704|NCT03651271|525359954|FG000|Overall Study|Withdrawal by Subject|1|||
145684705|NCT03651271|525359955|FG001|Overall Study|Withdrawal by Subject|15|||
145684706|NCT03651271|525359956|FG002|Overall Study|Withdrawal by Subject|0|||
145491184|NCT04158583|524652355|FG000|Overall Study|Death|3|||
145684707|NCT03651271|525359957|FG003|Overall Study|Withdrawal by Subject|0|||
145684708|NCT03651271|525359958|FG004|Overall Study|Withdrawal by Subject|1|||
145684709|NCT03651271|525359954|FG000|Overall Study|Patient medically unable to continue|0|||
145491185|NCT04158583|524652356|FG001|Overall Study|Death|4|||
145491186|NCT04158583|524652357|FG002|Overall Study|Death|2|||
145684710|NCT03651271|525359955|FG001|Overall Study|Patient medically unable to continue|0|||
145684711|NCT03651271|525359956|FG002|Overall Study|Patient medically unable to continue|0|||
145684712|NCT03651271|525359957|FG003|Overall Study|Patient medically unable to continue|1|||
145684713|NCT03651271|525359958|FG004|Overall Study|Patient medically unable to continue|0|||
145684714|NCT00821093|525359961|FG000|Overall Study|Adverse Event|20|||
145684715|NCT00821093|525359962|FG001|Overall Study|Adverse Event|12|||
145684716|NCT00821093|525359961|FG000|Overall Study|Withdrawal by Subject|9|||
145684717|NCT00821093|525359962|FG001|Overall Study|Withdrawal by Subject|13|||
145684718|NCT00821093|525359961|FG000|Overall Study|Lost to Follow-up|9|||
145684719|NCT00821093|525359962|FG001|Overall Study|Lost to Follow-up|3|||
145684720|NCT00821093|525359961|FG000|Overall Study|Protocol deviation|3|||
145684721|NCT00821093|525359962|FG001|Overall Study|Protocol deviation|6|||
145684722|NCT00821093|525359961|FG000|Overall Study|Abnormal laboratory value(s)|2|||
145684723|NCT00821093|525359962|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145684724|NCT00821093|525359961|FG000|Overall Study|Lack of Efficacy|2|||
145684725|NCT00821093|525359962|FG001|Overall Study|Lack of Efficacy|2|||
145684726|NCT00821093|525359961|FG000|Overall Study|Death|2|||
145684727|NCT00821093|525359962|FG001|Overall Study|Death|1|||
145684728|NCT00821093|525359961|FG000|Overall Study|Abnormal test procedure result(s)|1|||
145684729|NCT00821093|525359962|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145684730|NCT00821093|525359961|FG000|Overall Study|Administrative problems|1|||
145684731|NCT00821093|525359962|FG001|Overall Study|Administrative problems|2|||
145684732|NCT01601821|525359963|FG000|Overall Study|Death|2|||
145684733|NCT01601821|525359964|FG001|Overall Study|Death|5|||
145684734|NCT01601821|525359963|FG000|Overall Study|Protocol Violation|2|||
145684735|NCT01601821|525359964|FG001|Overall Study|Protocol Violation|2|||
145684736|NCT01601821|525359963|FG000|Overall Study|Lost to Follow-up|6|||
145684737|NCT01601821|525359964|FG001|Overall Study|Lost to Follow-up|14|||
145684738|NCT01601821|525359963|FG000|Overall Study|Withdrawal by Subject|1|||
145684739|NCT01601821|525359964|FG001|Overall Study|Withdrawal by Subject|0|||
145684740|NCT01601821|525359963|FG000|Overall Study|Graft Loss|6|||
145684741|NCT01601821|525359964|FG001|Overall Study|Graft Loss|6|||
145684742|NCT01601821|525359963|FG000|Overall Study|Study Events|7|||
145684743|NCT01601821|525359964|FG001|Overall Study|Study Events|1|||
145684744|NCT01601821|525359963|FG000|Overall Study|Other|5|||
145684745|NCT01601821|525359964|FG001|Overall Study|Other|1|||
145684746|NCT01124916|525359968|FG000|Overall Study|Lost to Follow-up|3|||
145684747|NCT01124916|525359969|FG001|Overall Study|Lost to Follow-up|2|||
145684748|NCT01901302|525359970|FG000|Overall Study|Adverse Event|2|||
145684749|NCT01901302|525359971|FG001|Overall Study|Adverse Event|1|||
145684750|NCT01901302|525359970|FG000|Overall Study|Lack of Efficacy|0|||
145684751|NCT01901302|525359971|FG001|Overall Study|Lack of Efficacy|2|||
145684752|NCT01901302|525359970|FG000|Overall Study|Study Terminated by Sponsor|23|||
145684753|NCT01901302|525359971|FG001|Overall Study|Study Terminated by Sponsor|20|||
145684754|NCT01901302|525359970|FG000|Overall Study|Withdrawal by Subject|2|||
145684755|NCT01901302|525359971|FG001|Overall Study|Withdrawal by Subject|0|||
145684756|NCT05104242|525359978|FG000|Overall Study|Withdrawal by Subject|1|||
145684757|NCT05104242|525359979|FG001|Overall Study|Withdrawal by Subject|5|||
145684758|NCT05104242|525359978|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
145684759|NCT05104242|525359979|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
145684760|NCT02469155|525359984|FG000|Overall Study|Adverse Event|6|||
145684761|NCT02469155|525359985|FG001|Overall Study|Adverse Event|0|||
145684762|NCT02469155|525359986|FG002|Overall Study|Adverse Event|1|||
145684763|NCT02469155|525359987|FG003|Overall Study|Adverse Event|10|||
145684764|NCT02469155|525359984|FG000|Overall Study|Lack of Efficacy|13|||
145684765|NCT02469155|525359985|FG001|Overall Study|Lack of Efficacy|10|||
145684766|NCT02469155|525359986|FG002|Overall Study|Lack of Efficacy|10|||
145684767|NCT02469155|525359987|FG003|Overall Study|Lack of Efficacy|8|||
145684768|NCT02469155|525359984|FG000|Overall Study|Death|0|||
145684769|NCT02469155|525359985|FG001|Overall Study|Death|0|||
145684770|NCT02469155|525359986|FG002|Overall Study|Death|0|||
145684771|NCT02469155|525359987|FG003|Overall Study|Death|1|||
145684772|NCT02469155|525359984|FG000|Overall Study|Lost to Follow-up|5|||
145684773|NCT02469155|525359985|FG001|Overall Study|Lost to Follow-up|2|||
145684774|NCT02469155|525359986|FG002|Overall Study|Lost to Follow-up|7|||
145684775|NCT02469155|525359987|FG003|Overall Study|Lost to Follow-up|2|||
145684776|NCT02469155|525359984|FG000|Overall Study|Physician Decision|0|||
145684777|NCT02469155|525359985|FG001|Overall Study|Physician Decision|0|||
145684778|NCT02469155|525359986|FG002|Overall Study|Physician Decision|1|||
145684779|NCT02469155|525359987|FG003|Overall Study|Physician Decision|0|||
145684780|NCT02469155|525359984|FG000|Overall Study|Withdrawal by Subject|34|||
145491187|NCT04158583|524652358|FG003|Overall Study|Death|2|||
145491188|NCT04158583|524652359|FG004|Overall Study|Death|4|||
145684781|NCT02469155|525359985|FG001|Overall Study|Withdrawal by Subject|30|||
145684782|NCT02469155|525359986|FG002|Overall Study|Withdrawal by Subject|20|||
145684783|NCT02469155|525359987|FG003|Overall Study|Withdrawal by Subject|37|||
145684784|NCT02469155|525359984|FG000|Overall Study|Other|3|||
145684785|NCT02469155|525359985|FG001|Overall Study|Other|3|||
145684786|NCT02469155|525359986|FG002|Overall Study|Other|2|||
145684787|NCT02469155|525359987|FG003|Overall Study|Other|10|||
145684788|NCT02469155|525359984|FG000|Overall Study|Protocol Violation|0|||
145684789|NCT02469155|525359985|FG001|Overall Study|Protocol Violation|1|||
145684790|NCT02469155|525359986|FG002|Overall Study|Protocol Violation|0|||
145684791|NCT02469155|525359987|FG003|Overall Study|Protocol Violation|1|||
145684792|NCT04765046|525359989|FG000|Overall Study|Screen Failure|2|||
145684793|NCT04765046|525359989|FG000|Overall Study|Withdrawal by Subject|4|||
145684794|NCT04765046|525359989|FG000|Overall Study|Physician Decision|4|||
145684795|NCT04765046|525359989|FG000|Overall Study|Surgery Cancelled|8|||
145684796|NCT04930263|525359997|FG000|Overall Study|Withdrawal by Subject|3|||
145684797|NCT04930263|525359998|FG001|Overall Study|Withdrawal by Subject|5|||
145684798|NCT01989156|525359999|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
145684799|NCT01989156|525360000|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
145684800|NCT01989156|525360001|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
145684801|NCT01989156|525359999|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
145684802|NCT01989156|525360000|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
145684803|NCT01989156|525360001|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
145684804|NCT01989156|525359999|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
145684805|NCT01989156|525360000|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
145684806|NCT01989156|525360001|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
145684807|NCT01989156|525359999|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
145684808|NCT01989156|525360000|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
145684809|NCT01989156|525360001|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
145684810|NCT01989156|525359999|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
145684811|NCT01989156|525360000|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
145684812|NCT01989156|525360001|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
145684813|NCT01989156|525359999|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
145684814|NCT01989156|525360000|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
145684815|NCT01989156|525360001|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
145684816|NCT01989156|525359999|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
145684817|NCT01989156|525360000|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
145684818|NCT01989156|525360001|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
145684819|NCT01989156|525359999|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
145684820|NCT01989156|525360000|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
145684821|NCT01989156|525360001|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
145684822|NCT00850993|525360002|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
145684823|NCT00850993|525360003|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
145684824|NCT00850993|525360004|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
145684825|NCT00850993|525360005|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
145684826|NCT03839355|525360006|FG000|Overall Study|Withdrawal by Subject|1|||
145684827|NCT03839355|525360007|FG001|Overall Study|Withdrawal by Subject|0|||
145684828|NCT04501614|525360013|FG000|Overall Study|Study Terminated by Sponsor|6|||
145684829|NCT04501614|525360014|FG001|Overall Study|Study Terminated by Sponsor|3|||
145684830|NCT04501614|525360013|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
145684831|NCT04501614|525360014|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
145684832|NCT02555397|525360015|FG000|Overall Study|Withdrawal by Subject|1|||
145684833|NCT02555397|525360016|FG001|Overall Study|Withdrawal by Subject|0|||
145684834|NCT02555397|525360017|FG002|Overall Study|Withdrawal by Subject|0|||
145684835|NCT02555397|525360018|FG003|Overall Study|Withdrawal by Subject|0|||
145684836|NCT02555397|525360019|FG004|Overall Study|Withdrawal by Subject|0|||
145684837|NCT01005914|525360020|FG000|Overall Study|Adverse Event|4|||
145684838|NCT01005914|525360020|FG000|Overall Study|Death|4|||
145684839|NCT01005914|525360020|FG000|Overall Study|Lack of Efficacy|1|||
145684840|NCT01005914|525360020|FG000|Overall Study|Withdrawal by Subject|1|||
145684841|NCT01240785|525360021|FG000|Overall Study|Lost to Follow-up|1|||
145684842|NCT01240785|525360022|FG001|Overall Study|Lost to Follow-up|0|||
145684843|NCT01240785|525360021|FG000|Overall Study|Protocol Violation|0|||
145684844|NCT01240785|525360022|FG001|Overall Study|Protocol Violation|3|||
145684845|NCT00237809|525360023|FG000|Overall Study|Lost to Follow-up|11|||
145684846|NCT00237809|525360024|FG001|Overall Study|Lost to Follow-up|10|||
145684847|NCT00237809|525360025|FG002|Overall Study|Lost to Follow-up|9|||
145684848|NCT00237809|525360026|FG003|Overall Study|Lost to Follow-up|9|||
145684849|NCT01755598|525360031|FG000|Overall Study|Other|109|||
145684850|NCT01755598|525360032|FG001|Overall Study|Other|109|||
145684851|NCT01755598|525360031|FG000|Overall Study|Lost to Follow-up|32|||
145684852|NCT01755598|525360032|FG001|Overall Study|Lost to Follow-up|43|||
145684853|NCT01755598|525360031|FG000|Overall Study|Migrated/moved from study area|76|||
145684854|NCT01755598|525360032|FG001|Overall Study|Migrated/moved from study area|65|||
145684855|NCT01755598|525360031|FG000|Overall Study|Withdrawal by Subject|22|||
145684856|NCT01755598|525360032|FG001|Overall Study|Withdrawal by Subject|31|||
145684857|NCT01755598|525360031|FG000|Overall Study|Protocol Violation|7|||
145491189|NCT04158583|524652360|FG005|Overall Study|Death|3|||
145684858|NCT01755598|525360032|FG001|Overall Study|Protocol Violation|7|||
145684859|NCT01755598|525360031|FG000|Overall Study|Adverse Event|19|||
145684860|NCT01755598|525360032|FG001|Overall Study|Adverse Event|28|||
145491190|NCT04158583|524652361|FG006|Overall Study|Death|5|||
145491191|NCT04158583|524652362|FG007|Overall Study|Death|2|||
145684861|NCT02260154|525360041|FG000|Overall Study|Screening failure|2|||
145684862|NCT03547167|525360042|FG000|Overall Study|Withdrawal by Subject|34|||
145684863|NCT03547167|525360043|FG001|Overall Study|Withdrawal by Subject|12|||
145684864|NCT03547167|525360042|FG000|Overall Study|Screen Failure|0|||
145684865|NCT03547167|525360043|FG001|Overall Study|Screen Failure|1|||
145684866|NCT03547167|525360042|FG000|Overall Study|Lost to Follow-up|59|||
145684867|NCT03547167|525360043|FG001|Overall Study|Lost to Follow-up|15|||
145684868|NCT03547167|525360042|FG000|Overall Study|Death|4|||
145684869|NCT03547167|525360043|FG001|Overall Study|Death|2|||
145684870|NCT00736502|525360044|FG000|Overall Study|Adverse Event|22|||
145684871|NCT00736502|525360044|FG000|Overall Study|Lack of Efficacy|16|||
145684872|NCT00736502|525360044|FG000|Overall Study|Lost to Follow-up|27|||
145684873|NCT00645411|525360045|FG000|Overall Study|Adverse Event|0|||
145684874|NCT00645411|525360046|FG001|Overall Study|Adverse Event|0|||
145684875|NCT00645411|525360047|FG002|Overall Study|Adverse Event|0|||
145684876|NCT00645411|525360048|FG003|Overall Study|Adverse Event|2|||
145684877|NCT00645411|525360045|FG000|Overall Study|Withdrawal by Subject|2|||
145684878|NCT00645411|525360046|FG001|Overall Study|Withdrawal by Subject|1|||
145684879|NCT00645411|525360047|FG002|Overall Study|Withdrawal by Subject|19|||
145684880|NCT00645411|525360048|FG003|Overall Study|Withdrawal by Subject|21|||
145684881|NCT00645411|525360045|FG000|Overall Study|Lost to Follow-up|10|||
145684882|NCT00645411|525360046|FG001|Overall Study|Lost to Follow-up|5|||
145684883|NCT00645411|525360047|FG002|Overall Study|Lost to Follow-up|124|||
145684884|NCT00645411|525360048|FG003|Overall Study|Lost to Follow-up|75|||
145684885|NCT00645411|525360045|FG000|Overall Study|Protocol Violation|1|||
145684886|NCT00645411|525360046|FG001|Overall Study|Protocol Violation|0|||
145684887|NCT00645411|525360047|FG002|Overall Study|Protocol Violation|1|||
145684888|NCT00645411|525360048|FG003|Overall Study|Protocol Violation|0|||
145684889|NCT00645411|525360045|FG000|Overall Study|Inappropriate enrollment|0|||
145684890|NCT00645411|525360046|FG001|Overall Study|Inappropriate enrollment|0|||
145684891|NCT00645411|525360047|FG002|Overall Study|Inappropriate enrollment|4|||
145684892|NCT00645411|525360048|FG003|Overall Study|Inappropriate enrollment|1|||
145684893|NCT00645411|525360045|FG000|Overall Study|Unable to classify|0|||
145684894|NCT00645411|525360046|FG001|Overall Study|Unable to classify|0|||
145684895|NCT00645411|525360047|FG002|Overall Study|Unable to classify|3|||
145684896|NCT00645411|525360048|FG003|Overall Study|Unable to classify|4|||
145684897|NCT01307800|525360049|FG000|Overall Study|Adverse Event|9|||
145684898|NCT01307800|525360050|FG001|Overall Study|Adverse Event|8|||
145684899|NCT01307800|525360051|FG002|Overall Study|Adverse Event|10|||
145684900|NCT01307800|525360052|FG003|Overall Study|Adverse Event|14|||
145684901|NCT01307800|525360049|FG000|Overall Study|Entry Criteria Not Met|0|||
145684902|NCT01307800|525360050|FG001|Overall Study|Entry Criteria Not Met|0|||
145684903|NCT01307800|525360051|FG002|Overall Study|Entry Criteria Not Met|0|||
145684904|NCT01307800|525360052|FG003|Overall Study|Entry Criteria Not Met|2|||
145684905|NCT01307800|525360049|FG000|Overall Study|Lost to Follow-up|5|||
145684906|NCT01307800|525360050|FG001|Overall Study|Lost to Follow-up|6|||
145684907|NCT01307800|525360051|FG002|Overall Study|Lost to Follow-up|2|||
145684908|NCT01307800|525360052|FG003|Overall Study|Lost to Follow-up|8|||
145684909|NCT01307800|525360049|FG000|Overall Study|Perceived Lack of Efficacy|24|||
145684910|NCT01307800|525360050|FG001|Overall Study|Perceived Lack of Efficacy|23|||
145684911|NCT01307800|525360051|FG002|Overall Study|Perceived Lack of Efficacy|20|||
145684912|NCT01307800|525360052|FG003|Overall Study|Perceived Lack of Efficacy|33|||
145684913|NCT01307800|525360049|FG000|Overall Study|Protocol Violation|0|||
145684914|NCT01307800|525360050|FG001|Overall Study|Protocol Violation|3|||
145684915|NCT01307800|525360051|FG002|Overall Study|Protocol Violation|4|||
145684916|NCT01307800|525360052|FG003|Overall Study|Protocol Violation|5|||
145684917|NCT01307800|525360049|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
145684918|NCT01307800|525360050|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
145684919|NCT01307800|525360051|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
145684920|NCT01307800|525360052|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
145684921|NCT01307800|525360049|FG000|Overall Study|Sponsor Decision|6|||
145684922|NCT01307800|525360050|FG001|Overall Study|Sponsor Decision|9|||
145684923|NCT01307800|525360051|FG002|Overall Study|Sponsor Decision|12|||
145684924|NCT01307800|525360052|FG003|Overall Study|Sponsor Decision|28|||
145684925|NCT01307800|525360049|FG000|Overall Study|Withdrawal by Subject|10|||
145491192|NCT04158583|524652363|FG008|Overall Study|Death|0|||
145491193|NCT04158583|524652364|FG009|Overall Study|Death|1|||
145491194|NCT04158583|524652355|FG000|Overall Study|Clinical Progression Disease|0|||
145491195|NCT04158583|524652356|FG001|Overall Study|Clinical Progression Disease|0|||
145684926|NCT01307800|525360050|FG001|Overall Study|Withdrawal by Subject|11|||
145684927|NCT01307800|525360051|FG002|Overall Study|Withdrawal by Subject|8|||
145684928|NCT01307800|525360052|FG003|Overall Study|Withdrawal by Subject|15|||
145684929|NCT01307800|525360049|FG000|Overall Study|Participant Moved|0|||
145684930|NCT01307800|525360050|FG001|Overall Study|Participant Moved|2|||
145684931|NCT01307800|525360051|FG002|Overall Study|Participant Moved|1|||
145684932|NCT01307800|525360052|FG003|Overall Study|Participant Moved|3|||
145684933|NCT02674399|525360053|FG000|Overall Study|Lost to Follow-up|2|||
145684934|NCT02674399|525360054|FG001|Overall Study|Lost to Follow-up|0|||
145684935|NCT02255474|525360055|FG000|Overall Study|Lost to Follow-up|1|||
145684936|NCT02255474|525360056|FG001|Overall Study|Lost to Follow-up|1|||
145684937|NCT02255474|525360057|FG002|Overall Study|Lost to Follow-up|3|||
145684938|NCT02255474|525360055|FG000|Overall Study|Withdrawal by Subject|1|||
145684939|NCT02255474|525360056|FG001|Overall Study|Withdrawal by Subject|1|||
145684940|NCT02255474|525360057|FG002|Overall Study|Withdrawal by Subject|0|||
145684941|NCT02367794|525360063|FG000|Overall Study|Death|252|||
145684942|NCT02367794|525360064|FG001|Overall Study|Death|245|||
145684943|NCT02367794|525360065|FG002|Overall Study|Death|243|||
145684944|NCT02367794|525360063|FG000|Overall Study|Lost to Follow-up|1|||
145684945|NCT02367794|525360064|FG001|Overall Study|Lost to Follow-up|2|||
145684946|NCT02367794|525360065|FG002|Overall Study|Lost to Follow-up|2|||
145684947|NCT02367794|525360063|FG000|Overall Study|Physician Decision|0|||
145684948|NCT02367794|525360064|FG001|Overall Study|Physician Decision|5|||
145684949|NCT02367794|525360065|FG002|Overall Study|Physician Decision|3|||
145684950|NCT02367794|525360063|FG000|Overall Study|Protocol Violation|1|||
145684951|NCT02367794|525360064|FG001|Overall Study|Protocol Violation|0|||
145684952|NCT02367794|525360065|FG002|Overall Study|Protocol Violation|1|||
145684953|NCT02367794|525360063|FG000|Overall Study|Withdrawal by Subject|25|||
145684954|NCT02367794|525360064|FG001|Overall Study|Withdrawal by Subject|12|||
145684955|NCT02367794|525360065|FG002|Overall Study|Withdrawal by Subject|20|||
145684956|NCT02367794|525360063|FG000|Overall Study|Brain metastasis|1|||
145684957|NCT02367794|525360064|FG001|Overall Study|Brain metastasis|0|||
145684958|NCT02367794|525360065|FG002|Overall Study|Brain metastasis|0|||
145684959|NCT02367794|525360063|FG000|Overall Study|Randomized in error|0|||
145684960|NCT02367794|525360064|FG001|Overall Study|Randomized in error|0|||
145684961|NCT02367794|525360065|FG002|Overall Study|Randomized in error|1|||
145684962|NCT02367794|525360063|FG000|Overall Study|Patient unable to receive carboplatin|0|||
145684963|NCT02367794|525360064|FG001|Overall Study|Patient unable to receive carboplatin|0|||
145684964|NCT02367794|525360065|FG002|Overall Study|Patient unable to receive carboplatin|1|||
145684965|NCT02367794|525360063|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
145684966|NCT02367794|525360064|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
145684967|NCT02367794|525360065|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
145684968|NCT02367794|525360063|FG000|Overall Study|Adverse Event|0|||
145684969|NCT02367794|525360064|FG001|Overall Study|Adverse Event|0|||
145684970|NCT02367794|525360065|FG002|Overall Study|Adverse Event|2|||
145684971|NCT02367794|525360063|FG000|Overall Study|Study Terminated By Sponsor|0|||
145684972|NCT02367794|525360064|FG001|Overall Study|Study Terminated By Sponsor|1|||
145684973|NCT02367794|525360065|FG002|Overall Study|Study Terminated By Sponsor|1|||
145684974|NCT02367794|525360063|FG000|Overall Study|Moved to Roll-Over Study|0|||
145684975|NCT02367794|525360064|FG001|Overall Study|Moved to Roll-Over Study|15|||
145684976|NCT02367794|525360065|FG002|Overall Study|Moved to Roll-Over Study|13|||
145684977|NCT02367794|525360063|FG000|Overall Study|Sponsor Request|60|||
145684978|NCT02367794|525360064|FG001|Overall Study|Sponsor Request|57|||
145684979|NCT02367794|525360065|FG002|Overall Study|Sponsor Request|45|||
145684980|NCT02367794|525360063|FG000|Overall Study|Moved into PTAP Study|0|||
145684981|NCT02367794|525360064|FG001|Overall Study|Moved into PTAP Study|2|||
145684982|NCT02367794|525360065|FG002|Overall Study|Moved into PTAP Study|3|||
145684983|NCT02367794|525360063|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
145684984|NCT02367794|525360064|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
145684985|NCT02367794|525360065|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
145684986|NCT02367794|525360063|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
145684987|NCT02367794|525360064|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
145684988|NCT02367794|525360065|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
145684989|NCT02367794|525360063|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
145684990|NCT02367794|525360064|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
145684991|NCT02367794|525360065|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
145684992|NCT02367794|525360063|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
145684993|NCT02367794|525360064|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
145684994|NCT02367794|525360065|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
145684995|NCT01730118|525360976|FG000|Dose Escalation|Death on study|5|||
145684996|NCT01730118|525360977|FG001|Dose Escalation|Death on study|7|||
145684997|NCT01730118|525360978|FG002|Dose Escalation|Death on study|2|||
145684998|NCT01730118|525360979|FG003|Dose Escalation|Death on study|6|||
145684999|NCT01730118|525360980|FG004|Dose Escalation|Death on study|0|||
145685000|NCT01730118|525360981|FG005|Dose Escalation|Death on study|0|||
145685001|NCT01730118|525360982|FG006|Dose Escalation|Death on study|0|||
145685002|NCT01730118|525360976|FG000|Dose Escalation|Died before treatment|0|||
145685003|NCT01730118|525360977|FG001|Dose Escalation|Died before treatment|0|||
145685004|NCT01730118|525360978|FG002|Dose Escalation|Died before treatment|0|||
145685005|NCT01730118|525360979|FG003|Dose Escalation|Died before treatment|0|||
145685006|NCT01730118|525360980|FG004|Dose Escalation|Died before treatment|0|||
145685007|NCT01730118|525360981|FG005|Dose Escalation|Died before treatment|0|||
145685008|NCT01730118|525360982|FG006|Dose Escalation|Died before treatment|1|||
145685009|NCT01730118|525360976|FG000|Dose Escalation|Chose to start a different treatment|1|||
145685010|NCT01730118|525360977|FG001|Dose Escalation|Chose to start a different treatment|0|||
145685011|NCT01730118|525360978|FG002|Dose Escalation|Chose to start a different treatment|0|||
145685012|NCT01730118|525360979|FG003|Dose Escalation|Chose to start a different treatment|0|||
145685013|NCT01730118|525360980|FG004|Dose Escalation|Chose to start a different treatment|0|||
145685014|NCT01730118|525360981|FG005|Dose Escalation|Chose to start a different treatment|0|||
145685015|NCT01730118|525360982|FG006|Dose Escalation|Chose to start a different treatment|0|||
145685016|NCT01730118|525360976|FG000|Dose Escalation|Withdrawal by Subject|0|||
145685017|NCT01730118|525360977|FG001|Dose Escalation|Withdrawal by Subject|0|||
145685018|NCT01730118|525360978|FG002|Dose Escalation|Withdrawal by Subject|1|||
145685019|NCT01730118|525360979|FG003|Dose Escalation|Withdrawal by Subject|0|||
145685020|NCT01730118|525360980|FG004|Dose Escalation|Withdrawal by Subject|0|||
145685021|NCT01730118|525360981|FG005|Dose Escalation|Withdrawal by Subject|0|||
145685022|NCT01730118|525360982|FG006|Dose Escalation|Withdrawal by Subject|0|||
145685023|NCT01730118|525360976|FG000|Dose Escalation|Disease progression prior to treatment|0|||
145685024|NCT01730118|525360977|FG001|Dose Escalation|Disease progression prior to treatment|0|||
145685025|NCT01730118|525360978|FG002|Dose Escalation|Disease progression prior to treatment|0|||
145685026|NCT01730118|525360979|FG003|Dose Escalation|Disease progression prior to treatment|0|||
145685027|NCT01730118|525360980|FG004|Dose Escalation|Disease progression prior to treatment|0|||
145685028|NCT01730118|525360981|FG005|Dose Escalation|Disease progression prior to treatment|0|||
145685029|NCT01730118|525360982|FG006|Dose Escalation|Disease progression prior to treatment|1|||
145685030|NCT01730118|525360976|FG000|Dose Expansion|Death|0|||
145685031|NCT01730118|525360977|FG001|Dose Expansion|Death|0|||
145685032|NCT01730118|525360978|FG002|Dose Expansion|Death|0|||
145685033|NCT01730118|525360979|FG003|Dose Expansion|Death|0|||
145685034|NCT01730118|525360980|FG004|Dose Expansion|Death|1|||
145685035|NCT01730118|525360981|FG005|Dose Expansion|Death|0|||
145685036|NCT01730118|525360982|FG006|Dose Expansion|Death|0|||
145685037|NCT01730118|525360976|FG000|Dose Expansion|Other medical condition|0|||
145685038|NCT01730118|525360977|FG001|Dose Expansion|Other medical condition|0|||
145685039|NCT01730118|525360978|FG002|Dose Expansion|Other medical condition|0|||
145685040|NCT01730118|525360979|FG003|Dose Expansion|Other medical condition|0|||
145685041|NCT01730118|525360980|FG004|Dose Expansion|Other medical condition|1|||
145685042|NCT01730118|525360981|FG005|Dose Expansion|Other medical condition|0|||
145685043|NCT01730118|525360982|FG006|Dose Expansion|Other medical condition|0|||
145685044|NCT01730118|525360976|FG000|Dose Expansion|Withdrawal by Subject|0|||
145685045|NCT01730118|525360977|FG001|Dose Expansion|Withdrawal by Subject|0|||
145685046|NCT01730118|525360978|FG002|Dose Expansion|Withdrawal by Subject|0|||
145685047|NCT01730118|525360979|FG003|Dose Expansion|Withdrawal by Subject|0|||
145685048|NCT01730118|525360980|FG004|Dose Expansion|Withdrawal by Subject|1|||
145685049|NCT01730118|525360981|FG005|Dose Expansion|Withdrawal by Subject|0|||
145685050|NCT01730118|525360982|FG006|Dose Expansion|Withdrawal by Subject|0|||
145685051|NCT01730118|525360976|FG000|Dose Expansion|Disease progression|0|||
145685052|NCT01730118|525360977|FG001|Dose Expansion|Disease progression|0|||
145685053|NCT01730118|525360978|FG002|Dose Expansion|Disease progression|0|||
145685054|NCT01730118|525360979|FG003|Dose Expansion|Disease progression|0|||
145685055|NCT01730118|525360980|FG004|Dose Expansion|Disease progression|0|||
145685056|NCT01730118|525360981|FG005|Dose Expansion|Disease progression|1|||
145685057|NCT01730118|525360982|FG006|Dose Expansion|Disease progression|0|||
145685058|NCT01730118|525360976|FG000|Dose Expansion|Inability to return|0|||
145685059|NCT01730118|525360977|FG001|Dose Expansion|Inability to return|0|||
145685060|NCT01730118|525360978|FG002|Dose Expansion|Inability to return|0|||
145685061|NCT01730118|525360979|FG003|Dose Expansion|Inability to return|0|||
145685062|NCT01730118|525360980|FG004|Dose Expansion|Inability to return|0|||
145685063|NCT01730118|525360981|FG005|Dose Expansion|Inability to return|1|||
145685064|NCT01730118|525360982|FG006|Dose Expansion|Inability to return|0|||
145685065|NCT01730118|525360976|FG000|Dose Expansion|Physician Decision|0|||
145685066|NCT01730118|525360977|FG001|Dose Expansion|Physician Decision|0|||
145685067|NCT01730118|525360978|FG002|Dose Expansion|Physician Decision|0|||
145685068|NCT01730118|525360979|FG003|Dose Expansion|Physician Decision|0|||
145685069|NCT01730118|525360980|FG004|Dose Expansion|Physician Decision|0|||
145685070|NCT01730118|525360981|FG005|Dose Expansion|Physician Decision|1|||
145685071|NCT01730118|525360982|FG006|Dose Expansion|Physician Decision|0|||
145685072|NCT04851587|525360986|FG000|Overall Study|Lost to Follow-up|18|||
145685073|NCT00668746|525360990|FG000|Overall Study|Lost to Follow-up|2|||
145685074|NCT00668746|525360991|FG001|Overall Study|Lost to Follow-up|1|||
145491196|NCT04158583|524652357|FG002|Overall Study|Clinical Progression Disease|0|||
145491197|NCT04158583|524652358|FG003|Overall Study|Clinical Progression Disease|1|||
145491198|NCT04158583|524652359|FG004|Overall Study|Clinical Progression Disease|0|||
145685075|NCT03605745|525360993|FG000|Overall Study|Study was terminated for business reasons|47|||
145685076|NCT04454125|525360999|FG000|Overall Study|Lost to Follow-up|0|||
145685077|NCT04454125|525361000|FG001|Overall Study|Lost to Follow-up|1|||
145685078|NCT03360071|525361004|FG000|Overall Study|Lost to Follow-up|1|||
145685079|NCT03360071|525361005|FG001|Overall Study|Lost to Follow-up|0|||
145685080|NCT01193283|525361006|FG000|Overall Study|Death|1|||
145685081|NCT01183013|525361008|FG000|Overall Study|Adverse Event|6|||
145685082|NCT01183013|525361009|FG001|Overall Study|Adverse Event|8|||
145685083|NCT01183013|525361010|FG002|Overall Study|Adverse Event|5|||
145685084|NCT01183013|525361011|FG003|Overall Study|Adverse Event|5|||
145685085|NCT01183013|525361012|FG004|Overall Study|Adverse Event|10|||
145685086|NCT01183013|525361013|FG005|Overall Study|Adverse Event|10|||
145685087|NCT01183013|525361014|FG006|Overall Study|Adverse Event|6|||
145685088|NCT01183013|525361008|FG000|Overall Study|Lack of Efficacy|3|||
145685089|NCT01183013|525361009|FG001|Overall Study|Lack of Efficacy|2|||
145685090|NCT01183013|525361010|FG002|Overall Study|Lack of Efficacy|1|||
145685091|NCT01183013|525361011|FG003|Overall Study|Lack of Efficacy|2|||
145685092|NCT01183013|525361012|FG004|Overall Study|Lack of Efficacy|1|||
145685093|NCT01183013|525361013|FG005|Overall Study|Lack of Efficacy|2|||
145685094|NCT01183013|525361014|FG006|Overall Study|Lack of Efficacy|0|||
145685095|NCT01183013|525361008|FG000|Overall Study|Protocol Violation|5|||
145685096|NCT01183013|525361009|FG001|Overall Study|Protocol Violation|2|||
145685097|NCT01183013|525361010|FG002|Overall Study|Protocol Violation|4|||
145685098|NCT01183013|525361011|FG003|Overall Study|Protocol Violation|0|||
145685099|NCT01183013|525361012|FG004|Overall Study|Protocol Violation|4|||
145685100|NCT01183013|525361013|FG005|Overall Study|Protocol Violation|3|||
145685101|NCT01183013|525361014|FG006|Overall Study|Protocol Violation|3|||
145685102|NCT01183013|525361008|FG000|Overall Study|Lost to Follow-up|7|||
145685103|NCT01183013|525361009|FG001|Overall Study|Lost to Follow-up|3|||
145685104|NCT01183013|525361010|FG002|Overall Study|Lost to Follow-up|4|||
145685105|NCT01183013|525361011|FG003|Overall Study|Lost to Follow-up|3|||
145685106|NCT01183013|525361012|FG004|Overall Study|Lost to Follow-up|2|||
145685107|NCT01183013|525361013|FG005|Overall Study|Lost to Follow-up|6|||
145685108|NCT01183013|525361014|FG006|Overall Study|Lost to Follow-up|5|||
145685109|NCT01183013|525361008|FG000|Overall Study|Withdrawal by Subject|9|||
145685110|NCT01183013|525361009|FG001|Overall Study|Withdrawal by Subject|13|||
145685111|NCT01183013|525361010|FG002|Overall Study|Withdrawal by Subject|10|||
145685112|NCT01183013|525361011|FG003|Overall Study|Withdrawal by Subject|8|||
145685113|NCT01183013|525361012|FG004|Overall Study|Withdrawal by Subject|7|||
145685114|NCT01183013|525361013|FG005|Overall Study|Withdrawal by Subject|9|||
145685115|NCT01183013|525361014|FG006|Overall Study|Withdrawal by Subject|10|||
145685116|NCT01183013|525361008|FG000|Overall Study|Reasons other than stated above|15|||
145685117|NCT01183013|525361009|FG001|Overall Study|Reasons other than stated above|11|||
145685118|NCT01183013|525361010|FG002|Overall Study|Reasons other than stated above|17|||
145685119|NCT01183013|525361011|FG003|Overall Study|Reasons other than stated above|12|||
145685120|NCT01183013|525361012|FG004|Overall Study|Reasons other than stated above|12|||
145685121|NCT01183013|525361013|FG005|Overall Study|Reasons other than stated above|15|||
145685122|NCT01183013|525361014|FG006|Overall Study|Reasons other than stated above|13|||
145685123|NCT02256553|525361019|FG000|Period I|Adverse Event|5|||
145685124|NCT02256553|525361019|FG000|Period I|Protocol Violation|1|||
145685125|NCT02256553|525361019|FG000|Period II|Adverse Event|1|||
145685126|NCT02256553|525361019|FG000|Period II|Subject Moved|1|||
145685127|NCT02256553|525361019|FG000|Period III|Adverse Event|3|||
145685128|NCT04739306|525361020|FG000|Main Study Period|Adverse Event|6|||
145685129|NCT04739306|525361021|FG001|Main Study Period|Adverse Event|7|||
145685130|NCT04739306|525361020|FG000|Main Study Period|Lost to Follow-up|4|||
145685131|NCT04739306|525361021|FG001|Main Study Period|Lost to Follow-up|6|||
145685132|NCT04739306|525361020|FG000|Main Study Period|Physician Decision|1|||
145685133|NCT04739306|525361021|FG001|Main Study Period|Physician Decision|1|||
145685134|NCT04739306|525361020|FG000|Main Study Period|Withdrawal by Subject|8|||
145685135|NCT04739306|525361021|FG001|Main Study Period|Withdrawal by Subject|6|||
145685136|NCT04739306|525361020|FG000|Main Study Period|Protocol Violation|0|||
145685137|NCT04739306|525361021|FG001|Main Study Period|Protocol Violation|1|||
145685138|NCT04739306|525361020|FG000|Main Study Period|War in Ukraine|1|||
145685139|NCT04739306|525361021|FG001|Main Study Period|War in Ukraine|1|||
145685140|NCT01951105|525361022|FG000|Overall Study|Adverse Event|0|||
145685141|NCT01951105|525361023|FG001|Overall Study|Adverse Event|5|||
145685142|NCT01951105|525361024|FG002|Overall Study|Adverse Event|0|||
145685143|NCT01951105|525361022|FG000|Overall Study|Lost to Follow-up|0|||
145685144|NCT01951105|525361023|FG001|Overall Study|Lost to Follow-up|1|||
145685145|NCT01951105|525361024|FG002|Overall Study|Lost to Follow-up|0|||
145685146|NCT01951105|525361022|FG000|Overall Study|Protocol Violation|1|||
145685147|NCT01951105|525361023|FG001|Overall Study|Protocol Violation|1|||
145491199|NCT04158583|524652360|FG005|Overall Study|Clinical Progression Disease|0|||
145491200|NCT04158583|524652361|FG006|Overall Study|Clinical Progression Disease|0|||
145491201|NCT04158583|524652362|FG007|Overall Study|Clinical Progression Disease|0|||
145491202|NCT04158583|524652363|FG008|Overall Study|Clinical Progression Disease|0|||
145491203|NCT04158583|524652364|FG009|Overall Study|Clinical Progression Disease|0|||
145491204|NCT04158583|524652355|FG000|Overall Study|Clinical Progression|0|||
145491205|NCT04158583|524652356|FG001|Overall Study|Clinical Progression|0|||
145491206|NCT04158583|524652357|FG002|Overall Study|Clinical Progression|0|||
145491207|NCT04158583|524652358|FG003|Overall Study|Clinical Progression|0|||
145491208|NCT04158583|524652359|FG004|Overall Study|Clinical Progression|1|||
145491209|NCT04158583|524652360|FG005|Overall Study|Clinical Progression|0|||
145491210|NCT04158583|524652361|FG006|Overall Study|Clinical Progression|2|||
145491211|NCT04158583|524652362|FG007|Overall Study|Clinical Progression|0|||
145685148|NCT01951105|525361024|FG002|Overall Study|Protocol Violation|1|||
145685149|NCT01951105|525361022|FG000|Overall Study|Withdrawal by Subject|0|||
145685150|NCT01951105|525361023|FG001|Overall Study|Withdrawal by Subject|3|||
145685151|NCT01951105|525361024|FG002|Overall Study|Withdrawal by Subject|1|||
145685152|NCT04175392|525361025|FG000|Overall Study|Withdrawal by Subject|3|||
145685153|NCT04175392|525361026|FG001|Overall Study|Withdrawal by Subject|2|||
145685154|NCT02812706|525361027|FG000|Phase 1|Adverse Event|0|||
145685155|NCT02812706|525361028|FG001|Phase 1|Adverse Event|2|||
145685156|NCT02812706|525361029|FG002|Phase 1|Adverse Event|0|||
145685157|NCT02812706|525361027|FG000|Phase 1|Progressive disease|3|||
145685158|NCT02812706|525361028|FG001|Phase 1|Progressive disease|3|||
145685159|NCT02812706|525361029|FG002|Phase 1|Progressive disease|0|||
145685160|NCT02812706|525361027|FG000|Phase 2|Adverse Event|0|||
145685161|NCT02812706|525361028|FG001|Phase 2|Adverse Event|0|||
145685162|NCT02812706|525361029|FG002|Phase 2|Adverse Event|2|||
145685163|NCT02812706|525361027|FG000|Phase 2|Progressive disease|0|||
145685164|NCT02812706|525361028|FG001|Phase 2|Progressive disease|0|||
145685165|NCT02812706|525361029|FG002|Phase 2|Progressive disease|22|||
145685166|NCT02812706|525361027|FG000|Phase 2|Other-Unspecified|0|||
145685167|NCT02812706|525361028|FG001|Phase 2|Other-Unspecified|0|||
145685168|NCT02812706|525361029|FG002|Phase 2|Other-Unspecified|4|||
145685169|NCT00910871|525361035|FG000|Overall Study|Adverse Event|5|||
145685170|NCT00910871|525361035|FG000|Overall Study|Death|12|||
145685171|NCT00910871|525361035|FG000|Overall Study|Lost to Follow-up|8|||
145685172|NCT00910871|525361035|FG000|Overall Study|Protocol Violation|11|||
145685173|NCT00910871|525361035|FG000|Overall Study|Withdrawal by Subject|12|||
145685174|NCT00910871|525361035|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
145685175|NCT00910871|525361035|FG000|Overall Study|Undefined|1|||
145685176|NCT04529941|525361039|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
145685177|NCT04529941|525361040|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
145685178|NCT03905512|525361041|FG000|Overall Study|Withdrawal by Subject|9|||
145685179|NCT03905512|525361042|FG001|Overall Study|Withdrawal by Subject|8|||
145685180|NCT03905512|525361041|FG000|Overall Study|Adverse Event|1|||
145685181|NCT03905512|525361042|FG001|Overall Study|Adverse Event|2|||
145685182|NCT03905512|525361041|FG000|Overall Study|Lost to Follow-up|4|||
145685183|NCT03905512|525361042|FG001|Overall Study|Lost to Follow-up|3|||
145685184|NCT03905512|525361041|FG000|Overall Study|Other than Specified|7|||
145491212|NCT04158583|524652363|FG008|Overall Study|Clinical Progression|0|||
145491213|NCT04158583|524652364|FG009|Overall Study|Clinical Progression|0|||
145491214|NCT04158583|524652355|FG000|Overall Study|Clinical Deterioration|0|||
145491215|NCT04158583|524652356|FG001|Overall Study|Clinical Deterioration|0|||
145491216|NCT04158583|524652357|FG002|Overall Study|Clinical Deterioration|0|||
145491217|NCT04158583|524652358|FG003|Overall Study|Clinical Deterioration|1|||
145491218|NCT04158583|524652359|FG004|Overall Study|Clinical Deterioration|0|||
145491219|NCT04158583|524652360|FG005|Overall Study|Clinical Deterioration|0|||
145491220|NCT04158583|524652361|FG006|Overall Study|Clinical Deterioration|0|||
145491221|NCT04158583|524652362|FG007|Overall Study|Clinical Deterioration|0|||
145491222|NCT04158583|524652363|FG008|Overall Study|Clinical Deterioration|0|||
145491223|NCT04158583|524652364|FG009|Overall Study|Clinical Deterioration|1|||
145491224|NCT00948064|524653717|FG000|Phase I|No treatment received|1|||
145491225|NCT00948064|524653718|FG001|Phase I|No treatment received|0|||
145491226|NCT00948064|524653719|FG002|Phase I|No treatment received|0|||
145491227|NCT00948064|524653717|FG000|Phase II|Physician Decision|0|||
145491228|NCT00948064|524653718|FG001|Phase II|Physician Decision|0|||
145491229|NCT00948064|524653719|FG002|Phase II|Physician Decision|1|||
145491230|NCT00948064|524653717|FG000|Phase II|Withdrawal by Subject|0|||
145491231|NCT00948064|524653718|FG001|Phase II|Withdrawal by Subject|1|||
145491232|NCT00948064|524653719|FG002|Phase II|Withdrawal by Subject|0|||
145491233|NCT00644423|524653720|FG000|Overall Study|Lost to Follow-up|1|||
145491234|NCT00644423|524653721|FG001|Overall Study|Lost to Follow-up|1|||
145491235|NCT03096834|524653722|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
145491236|NCT03096834|524653723|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
145491237|NCT03096834|524653724|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
145491238|NCT03096834|524653725|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
145491239|NCT03096834|524653722|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
145491240|NCT03096834|524653723|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
145491241|NCT03096834|524653724|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
145491242|NCT03096834|524653725|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
145491243|NCT03096834|524653722|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
145491244|NCT03096834|524653723|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
145491245|NCT03096834|524653724|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
145491246|NCT03096834|524653725|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
145491247|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
145491248|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
145491249|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
145491250|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
145491251|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
145491252|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
145491253|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
145491254|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
145685185|NCT03905512|525361042|FG001|Overall Study|Other than Specified|4|||
145685186|NCT00070317|525361043|FG000|Overall Study|Inevaluable (Never Treated)|1|||
145685187|NCT00070317|525361043|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
145685188|NCT00070317|525361043|FG000|Overall Study|Ineligible required test not done|1|||
145685189|NCT00070317|525361043|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
145685190|NCT00070317|525361043|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
145685191|NCT00508144|525361044|FG000|Overall Study|Not eligible|6|||
145685192|NCT00508144|525361044|FG000|Overall Study|Death|5|||
145685193|NCT01084772|525361046|FG000|Baseline|Withdrawal by Subject|7|||
145685194|NCT01084772|525361047|FG001|Baseline|Withdrawal by Subject|6|||
145685195|NCT01084772|525361046|FG000|3 Months|Death|1|||
145685196|NCT01084772|525361047|FG001|3 Months|Death|0|||
145685197|NCT01084772|525361046|FG000|3 Months|Study Termination|2|||
145685198|NCT01084772|525361047|FG001|3 Months|Study Termination|2|||
145685199|NCT01084772|525361046|FG000|1 Year|Withdrawal by Subject|0|||
145685200|NCT01084772|525361047|FG001|1 Year|Withdrawal by Subject|1|||
145685201|NCT01084772|525361046|FG000|1 Year|Lost to Follow-up|3|||
145685202|NCT01084772|525361047|FG001|1 Year|Lost to Follow-up|0|||
145685203|NCT01084772|525361046|FG000|1 Year|Study Termination|0|||
145685204|NCT01084772|525361047|FG001|1 Year|Study Termination|7|||
145685205|NCT01084772|525361046|FG000|2 Years|Withdrawal by Subject|1|||
145685206|NCT01084772|525361047|FG001|2 Years|Withdrawal by Subject|0|||
145685207|NCT01084772|525361046|FG000|2 Years|Lost to Follow-up|5|||
145685208|NCT01084772|525361047|FG001|2 Years|Lost to Follow-up|2|||
145685209|NCT01084772|525361046|FG000|2 Years|Study Termination|3|||
145685210|NCT01084772|525361047|FG001|2 Years|Study Termination|2|||
145685211|NCT00525915|525361049|FG000|Overall Study|Non-Compliance|0|||
145685212|NCT00525915|525361050|FG001|Overall Study|Non-Compliance|1|||
145685213|NCT00525915|525361049|FG000|Overall Study|Disease Progression|5|||
145685214|NCT00525915|525361050|FG001|Overall Study|Disease Progression|6|||
145685215|NCT00525915|525361049|FG000|Overall Study|Withdrawal by Subject|1|||
145685216|NCT00525915|525361050|FG001|Overall Study|Withdrawal by Subject|0|||
145685217|NCT00525915|525361049|FG000|Overall Study|Refused Surgery|1|||
145685218|NCT00525915|525361050|FG001|Overall Study|Refused Surgery|2|||
145685219|NCT00525915|525361049|FG000|Overall Study|Unrelated illness|1|||
145685220|NCT00525915|525361050|FG001|Overall Study|Unrelated illness|0|||
145685221|NCT02332889|525361061|FG000|Overall Study|Physician Decision|1|||
145685222|NCT04097535|525361065|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
145685223|NCT04520256|525361067|FG000|Overall Study|Lost to Follow-up|6|||
145685224|NCT04520256|525361068|FG001|Overall Study|Lost to Follow-up|4|||
145685225|NCT04520256|525361069|FG002|Overall Study|Lost to Follow-up|2|||
145685226|NCT04520256|525361070|FG003|Overall Study|Lost to Follow-up|3|||
145685227|NCT04520256|525361071|FG004|Overall Study|Lost to Follow-up|6|||
145685228|NCT04520256|525361072|FG005|Overall Study|Lost to Follow-up|6|||
145685229|NCT04520256|525361073|FG006|Overall Study|Lost to Follow-up|4|||
145685230|NCT04520256|525361074|FG007|Overall Study|Lost to Follow-up|6|||
145685231|NCT04520256|525361075|FG008|Overall Study|Lost to Follow-up|1|||
145685232|NCT04520256|525361076|FG009|Overall Study|Lost to Follow-up|3|||
145685233|NCT04520256|525361077|FG010|Overall Study|Lost to Follow-up|3|||
145685234|NCT04520256|525361078|FG011|Overall Study|Lost to Follow-up|2|||
145685235|NCT04520256|525361079|FG012|Overall Study|Lost to Follow-up|5|||
145685236|NCT04520256|525361080|FG013|Overall Study|Lost to Follow-up|3|||
145685237|NCT04520256|525361081|FG014|Overall Study|Lost to Follow-up|3|||
145685238|NCT04520256|525361082|FG015|Overall Study|Lost to Follow-up|6|||
145685239|NCT04520256|525361083|FG016|Overall Study|Lost to Follow-up|6|||
145685240|NCT04520256|525361084|FG017|Overall Study|Lost to Follow-up|4|||
145685241|NCT04520256|525361085|FG018|Overall Study|Lost to Follow-up|3|||
145685242|NCT04520256|525361086|FG019|Overall Study|Lost to Follow-up|3|||
145685243|NCT04520256|525361087|FG020|Overall Study|Lost to Follow-up|7|||
145685244|NCT04520256|525361088|FG021|Overall Study|Lost to Follow-up|3|||
145685245|NCT04520256|525361089|FG022|Overall Study|Lost to Follow-up|3|||
145685246|NCT04520256|525361090|FG023|Overall Study|Lost to Follow-up|8|||
145685247|NCT04520256|525361091|FG024|Overall Study|Lost to Follow-up|5|||
145685248|NCT04520256|525361092|FG025|Overall Study|Lost to Follow-up|4|||
145685249|NCT04520256|525361093|FG026|Overall Study|Lost to Follow-up|3|||
145685250|NCT04520256|525361094|FG027|Overall Study|Lost to Follow-up|4|||
145685251|NCT04520256|525361095|FG028|Overall Study|Lost to Follow-up|3|||
145685252|NCT04520256|525361096|FG029|Overall Study|Lost to Follow-up|4|||
145685253|NCT04520256|525361097|FG030|Overall Study|Lost to Follow-up|4|||
145685254|NCT04520256|525361098|FG031|Overall Study|Lost to Follow-up|4|||
145685255|NCT03556891|525361099|FG000|Initial Pivotal Study|Adverse Event|4|||
145685256|NCT03556891|525361099|FG000|Initial Pivotal Study|MRI Need|3|||
145685257|NCT03556891|525361099|FG000|Initial Pivotal Study|Device Failure|1|||
145685258|NCT03556891|525361099|FG000|Initial Pivotal Study|Death|1|||
145685259|NCT03556891|525361099|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
145685260|NCT03556891|525361099|FG000|Initial Pivotal Study|Missing at random|1|||
145685261|NCT03556891|525361099|FG000|Initial Pivotal Study|Missing due to COVID|1|||
145685262|NCT03556891|525361099|FG000|Initial Pivotal Study|Protocol Violation|1|||
145685263|NCT00489489|525361996|FG000|Overall Study|Not treated due to protocol violation|0|||
145685264|NCT00489489|525361997|FG001|Overall Study|Not treated due to protocol violation|1|||
145685265|NCT00489489|525361998|FG002|Overall Study|Not treated due to protocol violation|1|||
145685266|NCT00489489|525361996|FG000|Overall Study|Adverse Event|1|||
145685267|NCT00489489|525361997|FG001|Overall Study|Adverse Event|1|||
145685268|NCT00489489|525361998|FG002|Overall Study|Adverse Event|1|||
145685269|NCT00489489|525361996|FG000|Overall Study|Protocol Violation|1|||
145685270|NCT00489489|525361997|FG001|Overall Study|Protocol Violation|0|||
145685271|NCT00489489|525361998|FG002|Overall Study|Protocol Violation|1|||
145685272|NCT00489489|525361996|FG000|Overall Study|Progressive disease|0|||
145685273|NCT00489489|525361997|FG001|Overall Study|Progressive disease|1|||
145685274|NCT00489489|525361998|FG002|Overall Study|Progressive disease|0|||
145685275|NCT00489489|525361996|FG000|Overall Study|Participant did not wish to continue|1|||
145685276|NCT00489489|525361997|FG001|Overall Study|Participant did not wish to continue|1|||
145685277|NCT00489489|525361998|FG002|Overall Study|Participant did not wish to continue|0|||
145685278|NCT00489489|525361996|FG000|Overall Study|Other than above|0|||
145685279|NCT00489489|525361997|FG001|Overall Study|Other than above|1|||
145685280|NCT00489489|525361998|FG002|Overall Study|Other than above|0|||
145685281|NCT03978130|525362001|FG000|Overall Study|Lost to Follow-up|13|||
145685282|NCT03978130|525362002|FG001|Overall Study|Lost to Follow-up|14|||
145685283|NCT03978130|525362001|FG000|Overall Study|Withdrawal by Subject|12|||
145685284|NCT03978130|525362002|FG001|Overall Study|Withdrawal by Subject|2|||
145685285|NCT03978130|525362001|FG000|Overall Study|Adverse Event|2|||
145685286|NCT03978130|525362002|FG001|Overall Study|Adverse Event|1|||
145685287|NCT03614923|525362007|FG000|Overall Study|Withdrawal by Subject|2|||
145685288|NCT03614923|525362008|FG001|Overall Study|Withdrawal by Subject|1|||
145685289|NCT03614923|525362009|FG002|Overall Study|Withdrawal by Subject|1|||
145685290|NCT03614923|525362007|FG000|Overall Study|Adverse Event|0|||
145685291|NCT03614923|525362008|FG001|Overall Study|Adverse Event|2|||
145685292|NCT03614923|525362009|FG002|Overall Study|Adverse Event|1|||
145685293|NCT03614923|525362007|FG000|Overall Study|Lost to Follow-up|1|||
145685294|NCT03614923|525362008|FG001|Overall Study|Lost to Follow-up|0|||
145685295|NCT03614923|525362009|FG002|Overall Study|Lost to Follow-up|1|||
145685296|NCT03614923|525362007|FG000|Overall Study|Lack of Efficacy|2|||
145685297|NCT03614923|525362008|FG001|Overall Study|Lack of Efficacy|0|||
145685298|NCT03614923|525362009|FG002|Overall Study|Lack of Efficacy|1|||
145685299|NCT03614923|525362007|FG000|Overall Study|Non-compliance|0|||
145685300|NCT03614923|525362008|FG001|Overall Study|Non-compliance|1|||
145685301|NCT03614923|525362009|FG002|Overall Study|Non-compliance|0|||
145685302|NCT03614923|525362007|FG000|Overall Study|Other|0|||
145685303|NCT03614923|525362008|FG001|Overall Study|Other|1|||
145685304|NCT03614923|525362009|FG002|Overall Study|Other|1|||
145685305|NCT01882088|525362010|FG000|Overall Study|Intolerance of esophageal manometry|1|||
145685306|NCT01882088|525362010|FG000|Overall Study|no possibility to place the catheter|1|||
145685307|NCT01882088|525362010|FG000|Overall Study|Protocol Violation|1|||
145685308|NCT01882088|525362010|FG000|Overall Study|inadequate pH-impedance tracings|2|||
145685309|NCT02062827|525362019|FG000|Overall Study|Death|1|||
145685310|NCT02062827|525362020|FG001|Overall Study|Death|0|||
145685311|NCT02062827|525362021|FG002|Overall Study|Death|0|||
145685312|NCT02062827|525362022|FG003|Overall Study|Death|0|||
145685313|NCT02062827|525362023|FG004|Overall Study|Death|0|||
145685314|NCT02062827|525362024|FG005|Overall Study|Death|0|||
145685315|NCT02062827|525362025|FG006|Overall Study|Death|0|||
145685316|NCT02062827|525362026|FG007|Overall Study|Death|0|||
145685317|NCT02062827|525362019|FG000|Overall Study|Withdrawal by Subject|3|||
145685318|NCT02062827|525362020|FG001|Overall Study|Withdrawal by Subject|1|||
145685319|NCT02062827|525362021|FG002|Overall Study|Withdrawal by Subject|1|||
145685320|NCT02062827|525362022|FG003|Overall Study|Withdrawal by Subject|2|||
145685321|NCT02062827|525362023|FG004|Overall Study|Withdrawal by Subject|6|||
145685322|NCT02062827|525362024|FG005|Overall Study|Withdrawal by Subject|0|||
145685323|NCT02062827|525362025|FG006|Overall Study|Withdrawal by Subject|5|||
145685324|NCT02062827|525362026|FG007|Overall Study|Withdrawal by Subject|0|||
145685325|NCT02062827|525362019|FG000|Overall Study|Screen Fail|0|||
145685326|NCT02062827|525362020|FG001|Overall Study|Screen Fail|0|||
145685327|NCT02062827|525362021|FG002|Overall Study|Screen Fail|0|||
145685328|NCT02062827|525362022|FG003|Overall Study|Screen Fail|0|||
145685329|NCT02062827|525362023|FG004|Overall Study|Screen Fail|0|||
145685330|NCT02062827|525362024|FG005|Overall Study|Screen Fail|0|||
145685331|NCT02062827|525362025|FG006|Overall Study|Screen Fail|0|||
145685332|NCT02062827|525362026|FG007|Overall Study|Screen Fail|8|||
145685333|NCT01721109|525362029|FG000|Overall Study|Lack of Efficacy|1|||
145685334|NCT01721109|525362029|FG000|Overall Study|Non- Compliance with Study Drug|3|||
145685335|NCT01721109|525362029|FG000|Overall Study|Withdrew Consent|1|||
145685336|NCT01721109|525362029|FG000|Overall Study|Lost to Follow-up|2|||
145685337|NCT05740371|525362030|FG000|Overall Study|Death|1|||
145685338|NCT01613599|525362032|FG000|Overall Study|Death|9|||
145685339|NCT01613599|525362032|FG000|Overall Study|Lost to Follow-up|5|||
145685340|NCT01613599|525362032|FG000|Overall Study|Withdrawal by Subject|8|||
145685341|NCT01613599|525362032|FG000|Overall Study|Reason not specified|3|||
145685342|NCT02991456|525362033|FG000|Overall Study|Adverse Event|2|||
145685343|NCT02991456|525362034|FG001|Overall Study|Adverse Event|0|||
145685344|NCT02991456|525362033|FG000|Overall Study|Lost to Follow-up|0|||
145685345|NCT02991456|525362034|FG001|Overall Study|Lost to Follow-up|2|||
145685346|NCT02991456|525362033|FG000|Overall Study|Withdrawal by Subject|1|||
145685347|NCT02991456|525362034|FG001|Overall Study|Withdrawal by Subject|0|||
145685348|NCT03503188|525362035|FG000|Overall Study|Non eligible in the sub study|0|||
145685349|NCT03503188|525362036|FG001|Overall Study|Non eligible in the sub study|1|||
145685350|NCT01699178|525362037|FG000|Overall Study|Adverse Event|1|||
145685351|NCT01699178|525362038|FG001|Overall Study|Adverse Event|5|||
145685352|NCT01699178|525362037|FG000|Overall Study|Lost to Follow-up|1|||
145685353|NCT01699178|525362038|FG001|Overall Study|Lost to Follow-up|6|||
145685354|NCT01699178|525362037|FG000|Overall Study|Non-compliance with Study Drug|3|||
145685355|NCT01699178|525362038|FG001|Overall Study|Non-compliance with Study Drug|1|||
145685356|NCT01699178|525362037|FG000|Overall Study|Physician Decision|1|||
145685357|NCT01699178|525362038|FG001|Overall Study|Physician Decision|0|||
145685358|NCT01699178|525362037|FG000|Overall Study|Withdrawal by Subject|4|||
145685359|NCT01699178|525362038|FG001|Overall Study|Withdrawal by Subject|12|||
145685360|NCT01699178|525362037|FG000|Overall Study|Hematocrit >54%|1|||
145685361|NCT01699178|525362038|FG001|Overall Study|Hematocrit >54%|1|||
145685362|NCT01699178|525362037|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
145685363|NCT01699178|525362038|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
145685364|NCT01699178|525362037|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
145685365|NCT01699178|525362038|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
145685366|NCT00321555|525362039|FG000|Overall Study|Developed antibodies|1|||
145685367|NCT00321555|525362039|FG000|Overall Study|Switched to alternative treatment|3|||
145685368|NCT00321555|525362039|FG000|Overall Study|Physician Decision|1|||
145685369|NCT00321555|525362039|FG000|Overall Study|Disease progression on study|1|||
145685370|NCT02066389|525362041|FG000|Overall Study|Adverse Event|1|||
145685371|NCT02066389|525362042|FG001|Overall Study|Adverse Event|1|||
145685372|NCT02066389|525362043|FG002|Overall Study|Adverse Event|1|||
145685373|NCT02066389|525362044|FG003|Overall Study|Adverse Event|1|||
145685374|NCT02066389|525362045|FG004|Overall Study|Adverse Event|5|||
145685375|NCT02066389|525362046|FG005|Overall Study|Adverse Event|1|||
145685376|NCT02066389|525362041|FG000|Overall Study|Withdrawal by Subject|4|||
145685377|NCT02066389|525362042|FG001|Overall Study|Withdrawal by Subject|0|||
145685378|NCT02066389|525362043|FG002|Overall Study|Withdrawal by Subject|5|||
145685379|NCT02066389|525362044|FG003|Overall Study|Withdrawal by Subject|1|||
145685380|NCT02066389|525362045|FG004|Overall Study|Withdrawal by Subject|1|||
145685381|NCT02066389|525362046|FG005|Overall Study|Withdrawal by Subject|2|||
145685382|NCT02066389|525362041|FG000|Overall Study|Lost to Follow-up|0|||
145685383|NCT02066389|525362042|FG001|Overall Study|Lost to Follow-up|0|||
145685384|NCT02066389|525362043|FG002|Overall Study|Lost to Follow-up|0|||
145685385|NCT02066389|525362044|FG003|Overall Study|Lost to Follow-up|1|||
145685386|NCT02066389|525362045|FG004|Overall Study|Lost to Follow-up|1|||
145685387|NCT02066389|525362046|FG005|Overall Study|Lost to Follow-up|1|||
145685388|NCT02066389|525362041|FG000|Overall Study|Randomized in Error|0|||
145685389|NCT02066389|525362042|FG001|Overall Study|Randomized in Error|0|||
145685390|NCT02066389|525362043|FG002|Overall Study|Randomized in Error|0|||
145685391|NCT02066389|525362044|FG003|Overall Study|Randomized in Error|0|||
145685392|NCT02066389|525362045|FG004|Overall Study|Randomized in Error|0|||
145685393|NCT02066389|525362046|FG005|Overall Study|Randomized in Error|1|||
145685394|NCT04016415|525362049|FG000|Overall Study|Adverse Event|2|||
145685395|NCT04016415|525362050|FG001|Overall Study|Adverse Event|1|||
145685396|NCT04016415|525362049|FG000|Overall Study|Lost to Follow-up|6|||
145685397|NCT04016415|525362050|FG001|Overall Study|Lost to Follow-up|2|||
145685398|NCT04016415|525362049|FG000|Overall Study|Physician Decision|5|||
145685399|NCT04016415|525362050|FG001|Overall Study|Physician Decision|1|||
145685400|NCT04016415|525362049|FG000|Overall Study|Pregnancy|0|||
145685401|NCT04016415|525362050|FG001|Overall Study|Pregnancy|1|||
145685402|NCT04016415|525362049|FG000|Overall Study|Withdrawal by Subject|24|||
145685403|NCT04016415|525362050|FG001|Overall Study|Withdrawal by Subject|27|||
145685404|NCT04016415|525362049|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
145685405|NCT04016415|525362050|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
145685406|NCT01885559|525362060|FG000|Overall Study|Lost to Follow-up|15|||
145685407|NCT01885559|525362061|FG001|Overall Study|Lost to Follow-up|16|||
145685408|NCT01885559|525362060|FG000|Overall Study|Less than full participation|9|||
145685409|NCT01885559|525362061|FG001|Overall Study|Less than full participation|19|||
145685410|NCT01885559|525362060|FG000|Overall Study|Protocol Violation|0|||
145685411|NCT01885559|525362061|FG001|Overall Study|Protocol Violation|1|||
145685412|NCT03560206|525362063|FG000|Overall Study|Lost to Follow-up|19|||
145685413|NCT03560206|525362064|FG001|Overall Study|Lost to Follow-up|11|||
145685414|NCT03560206|525362063|FG000|Overall Study|Withdrawal by Subject|2|||
145685415|NCT03560206|525362064|FG001|Overall Study|Withdrawal by Subject|4|||
145685416|NCT03560206|525362063|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
145685417|NCT03560206|525362064|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
145685418|NCT03560206|525362063|FG000|Overall Study|Busy schedule|14|||
145685419|NCT03560206|525362064|FG001|Overall Study|Busy schedule|2|||
145685420|NCT03560206|525362063|FG000|Overall Study|patients' new health condition such as cancer|10|||
145685421|NCT03560206|525362064|FG001|Overall Study|patients' new health condition such as cancer|1|||
145685422|NCT03987074|525362065|FG000|Overall Study|Withdrew Consent|1|||
145685423|NCT03987074|525362066|FG001|Overall Study|Withdrew Consent|1|||
145685424|NCT03987074|525362067|FG002|Overall Study|Withdrew Consent|0|||
145685425|NCT03987074|525362068|FG003|Overall Study|Withdrew Consent|2|||
145685426|NCT03987074|525362069|FG004|Overall Study|Withdrew Consent|1|||
145685427|NCT03987074|525362065|FG000|Overall Study|Adverse Event|2|||
145685428|NCT03987074|525362066|FG001|Overall Study|Adverse Event|1|||
145685429|NCT03987074|525362067|FG002|Overall Study|Adverse Event|0|||
145685430|NCT03987074|525362068|FG003|Overall Study|Adverse Event|0|||
145685431|NCT03987074|525362069|FG004|Overall Study|Adverse Event|1|||
145685432|NCT03987074|525362065|FG000|Overall Study|Lost to Follow-up|0|||
145685433|NCT03987074|525362066|FG001|Overall Study|Lost to Follow-up|0|||
145685434|NCT03987074|525362067|FG002|Overall Study|Lost to Follow-up|1|||
145685435|NCT03987074|525362068|FG003|Overall Study|Lost to Follow-up|1|||
145685436|NCT03987074|525362069|FG004|Overall Study|Lost to Follow-up|0|||
145685437|NCT03987074|525362065|FG000|Overall Study|Investigator's Discretion|0|||
145685438|NCT03987074|525362066|FG001|Overall Study|Investigator's Discretion|0|||
145685439|NCT03987074|525362067|FG002|Overall Study|Investigator's Discretion|0|||
145685440|NCT03987074|525362068|FG003|Overall Study|Investigator's Discretion|1|||
145685441|NCT03987074|525362069|FG004|Overall Study|Investigator's Discretion|0|||
145685442|NCT03100370|525362070|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145685443|NCT03100370|525362071|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145685444|NCT03100370|525362072|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145685445|NCT03100370|525362073|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
145685446|NCT03100370|525362074|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145685447|NCT03100370|525362075|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
145685448|NCT01867307|525362081|FG000|Overall Study|Protocol Violation|2|||
145685449|NCT01867307|525362082|FG001|Overall Study|Protocol Violation|0|||
145685450|NCT01867307|525362081|FG000|Overall Study|Other Adverse Event|1|||
145685451|NCT01867307|525362082|FG001|Overall Study|Other Adverse Event|3|||
145685452|NCT02009865|525362087|FG000|Overall Study|Adverse Event|0|||
145685453|NCT02009865|525362088|FG001|Overall Study|Adverse Event|2|||
145685454|NCT02009865|525362087|FG000|Overall Study|Protocol Violation|0|||
145685455|NCT02009865|525362088|FG001|Overall Study|Protocol Violation|2|||
145685456|NCT02009865|525362087|FG000|Overall Study|Withdrawal by Subject|1|||
145685457|NCT02009865|525362088|FG001|Overall Study|Withdrawal by Subject|1|||
145685458|NCT01517282|525362089|FG000|Overall Study|Consent withdrawn|0|||
145685459|NCT01517282|525362090|FG001|Overall Study|Consent withdrawn|1|||
145685460|NCT01517282|525362091|FG002|Overall Study|Consent withdrawn|1|||
145685461|NCT01517282|525362092|FG003|Overall Study|Consent withdrawn|1|||
145685462|NCT01517282|525362089|FG000|Overall Study|Physician Decision|1|||
145685463|NCT01517282|525362090|FG001|Overall Study|Physician Decision|0|||
145685464|NCT01517282|525362091|FG002|Overall Study|Physician Decision|0|||
145685465|NCT01517282|525362092|FG003|Overall Study|Physician Decision|0|||
145685466|NCT01634165|525362095|FG000|Period 2|Adverse Event|0|||
145685467|NCT01634165|525362096|FG001|Period 2|Adverse Event|1|||
145685468|NCT01634165|525362097|FG002|Period 2|Adverse Event|0|||
145685469|NCT01634165|525362098|FG003|Period 2|Adverse Event|0|||
145685470|NCT02135445|525362099|FG000|Overall Study|Lost to Follow-up|1|||
145685471|NCT02135445|525362100|FG001|Overall Study|Lost to Follow-up|0|||
145685472|NCT02135445|525362099|FG000|Overall Study|Withdrawal by Subject|1|||
145685473|NCT02135445|525362100|FG001|Overall Study|Withdrawal by Subject|0|||
145685474|NCT03070301|525362101|FG000|Overall Study|Progression of disease|16|||
145685475|NCT03070301|525362101|FG000|Overall Study|Physician Decision|3|||
145685476|NCT03070301|525362101|FG000|Overall Study|Withdrawal by Subject|1|||
145685477|NCT05927753|525363214|FG000|Overall Study|Withdrawal by Subject|0|||
145685478|NCT05927753|525363215|FG001|Overall Study|Withdrawal by Subject|2|||
145685479|NCT05927753|525363214|FG000|Overall Study|Physician Decision|0|||
145685480|NCT05927753|525363215|FG001|Overall Study|Physician Decision|1|||
145685481|NCT02136797|525363219|FG000|Overall Study|Not Treated|8|||
145685482|NCT04523571|525363220|FG000|Received 2 Doses|Withdrawal by Subject|0|||
145685483|NCT04523571|525363221|FG001|Received 2 Doses|Withdrawal by Subject|0|||
145685484|NCT04523571|525363222|FG002|Received 2 Doses|Withdrawal by Subject|0|||
145685485|NCT04523571|525363223|FG003|Received 2 Doses|Withdrawal by Subject|1|||
145685486|NCT04523571|525363224|FG004|Received 2 Doses|Withdrawal by Subject|1|||
145685487|NCT04523571|525363225|FG005|Received 2 Doses|Withdrawal by Subject|0|||
145685488|NCT04523571|525363220|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
145685489|NCT04523571|525363221|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
145685490|NCT04523571|525363222|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
145685491|NCT04523571|525363223|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
145685492|NCT04523571|525363224|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
145685493|NCT04523571|525363225|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
145685494|NCT04523571|525363220|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
145685495|NCT04523571|525363221|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
145685496|NCT04523571|525363222|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
145685497|NCT04523571|525363223|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
145685498|NCT04523571|525363224|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
145685499|NCT04523571|525363225|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
145685500|NCT04523571|525363220|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
145685501|NCT04523571|525363221|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
145685502|NCT04523571|525363222|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
145685503|NCT04523571|525363223|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
145685504|NCT04523571|525363224|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
145685505|NCT04523571|525363225|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
145685506|NCT04198428|525363226|FG000|Overall Study|Withdrawal by Subject|150|||
145685507|NCT04198428|525363227|FG001|Overall Study|Withdrawal by Subject|156|||
145685508|NCT03344458|525363230|FG000|Overall Study|Physician Decision|1|||
145685509|NCT03344458|525363230|FG000|Overall Study|Withdrawal by Subject|16|||
145685510|NCT03344458|525363230|FG000|Overall Study|Other reasons|10|||
145685511|NCT03344458|525363230|FG000|Overall Study|Lost to Follow-up|9|||
145685512|NCT03344458|525363230|FG000|Overall Study|Protocol Violation|3|||
145685513|NCT03696342|525363233|FG000|Overall Study|Lost to Follow-up|1|||
145685514|NCT03696342|525363234|FG001|Overall Study|Lost to Follow-up|0|||
145685515|NCT01816165|525363237|FG000|Overall Study|Adverse Event|1|||
145685516|NCT01816165|525363238|FG001|Overall Study|Adverse Event|0|||
145685517|NCT01816165|525363239|FG002|Overall Study|Adverse Event|0|||
145685518|NCT01816165|525363240|FG003|Overall Study|Adverse Event|0|||
145685519|NCT02409732|525363241|FG000|Overall Study|Withdrawal by Subject|4|||
145685520|NCT02409732|525363241|FG000|Overall Study|Lost to Follow-up|2|||
145685521|NCT03960437|525363243|FG000|Overall Study|Removed by PI|4|||
145685522|NCT03960437|525363243|FG000|Overall Study|Lost to Follow-up|2|||
145685523|NCT03960437|525363243|FG000|Overall Study|Withdrawal by Subject|1|||
145685524|NCT03960437|525363243|FG000|Overall Study|Death|2|||
145685525|NCT01838499|525363244|FG000|Overall Study|Protocol Violation|0|||
145685526|NCT01838499|525363245|FG001|Overall Study|Protocol Violation|1|||
145685527|NCT01838499|525363244|FG000|Overall Study|Lost to Follow-up|2|||
145685528|NCT01838499|525363245|FG001|Overall Study|Lost to Follow-up|4|||
145685529|NCT01838499|525363244|FG000|Overall Study|Lack of Efficacy|1|||
145685530|NCT01838499|525363245|FG001|Overall Study|Lack of Efficacy|2|||
145685531|NCT01838499|525363244|FG000|Overall Study|Adverse Event|2|||
145685532|NCT01838499|525363245|FG001|Overall Study|Adverse Event|1|||
145685533|NCT01838499|525363244|FG000|Overall Study|Withdrawal by Subject|19|||
145685534|NCT01838499|525363245|FG001|Overall Study|Withdrawal by Subject|9|||
145685535|NCT02030847|525363249|FG000|Overall Study|Death|10|||
145685536|NCT02030847|525363249|FG000|Overall Study|Disease Progression|15|||
145685537|NCT02030847|525363249|FG000|Overall Study|New Cancer Therapy|8|||
145685538|NCT02030847|525363249|FG000|Overall Study|Physician Decision|3|||
145685539|NCT02030847|525363249|FG000|Overall Study|Withdrawal by Subject|1|||
145685540|NCT00168805|525363250|FG000|Overall Study|Adverse Event|7|||
145685541|NCT00168805|525363251|FG001|Overall Study|Adverse Event|11|||
145685542|NCT00168805|525363252|FG002|Overall Study|Adverse Event|16|||
145685543|NCT00168805|525363250|FG000|Overall Study|Protocol Violation|12|||
145685544|NCT00168805|525363251|FG001|Overall Study|Protocol Violation|11|||
145685545|NCT00168805|525363252|FG002|Overall Study|Protocol Violation|8|||
145685546|NCT00168805|525363250|FG000|Overall Study|Lost to Follow-up|12|||
145685547|NCT00168805|525363251|FG001|Overall Study|Lost to Follow-up|17|||
145685548|NCT00168805|525363252|FG002|Overall Study|Lost to Follow-up|11|||
145685549|NCT00168805|525363250|FG000|Overall Study|Withdrawal by Subject|16|||
145685550|NCT00168805|525363251|FG001|Overall Study|Withdrawal by Subject|18|||
145685551|NCT00168805|525363252|FG002|Overall Study|Withdrawal by Subject|21|||
145685552|NCT00168805|525363250|FG000|Overall Study|Other|24|||
145685553|NCT00168805|525363251|FG001|Overall Study|Other|21|||
145685554|NCT00168805|525363252|FG002|Overall Study|Other|22|||
145685555|NCT00168805|525363250|FG000|Treatment|Adverse Event|25|||
145685556|NCT00168805|525363251|FG001|Treatment|Adverse Event|26|||
145685557|NCT00168805|525363252|FG002|Treatment|Adverse Event|32|||
145685558|NCT00168805|525363250|FG000|Treatment|Protocol Violation|3|||
145685559|NCT00168805|525363251|FG001|Treatment|Protocol Violation|5|||
145685560|NCT00168805|525363252|FG002|Treatment|Protocol Violation|5|||
145685561|NCT00168805|525363250|FG000|Treatment|Withdrawal by Subject|3|||
145685562|NCT00168805|525363251|FG001|Treatment|Withdrawal by Subject|7|||
145685563|NCT00168805|525363252|FG002|Treatment|Withdrawal by Subject|8|||
145685564|NCT00168805|525363250|FG000|Treatment|Other|18|||
145685565|NCT00168805|525363251|FG001|Treatment|Other|18|||
145685566|NCT00168805|525363252|FG002|Treatment|Other|17|||
145685567|NCT01114217|525363255|FG000|Overall Study|Adverse Event|5|||
145685568|NCT01114217|525363256|FG001|Overall Study|Adverse Event|3|||
145685569|NCT01114217|525363255|FG000|Overall Study|Lost to Follow-up|17|||
145685570|NCT01114217|525363256|FG001|Overall Study|Lost to Follow-up|33|||
145685571|NCT01114217|525363255|FG000|Overall Study|Withdrawal by Subject|21|||
145685572|NCT01114217|525363256|FG001|Overall Study|Withdrawal by Subject|28|||
145685573|NCT01114217|525363255|FG000|Overall Study|Other-Clerical Error|3|||
145685574|NCT01114217|525363256|FG001|Overall Study|Other-Clerical Error|0|||
145685575|NCT01114217|525363255|FG000|Overall Study|Other-Early termination|6|||
145685576|NCT01114217|525363256|FG001|Overall Study|Other-Early termination|10|||
145685577|NCT01114217|525363255|FG000|Overall Study|Other-Procedure|1|||
145685578|NCT01114217|525363256|FG001|Overall Study|Other-Procedure|1|||
145685579|NCT01114217|525363255|FG000|Overall Study|Other-Pregnancy|2|||
145685580|NCT01114217|525363256|FG001|Overall Study|Other-Pregnancy|4|||
145685581|NCT01114217|525363255|FG000|Overall Study|Other-Protocol Violation|1|||
145685582|NCT01114217|525363256|FG001|Overall Study|Other-Protocol Violation|3|||
145685583|NCT01114217|525363255|FG000|Overall Study|Other-Lack of Efficacy|1|||
145685584|NCT01114217|525363256|FG001|Overall Study|Other-Lack of Efficacy|0|||
145685585|NCT01114217|525363255|FG000|Overall Study|Other-Non Compliance|2|||
145685586|NCT01114217|525363256|FG001|Overall Study|Other-Non Compliance|0|||
145685587|NCT01114217|525363255|FG000|Overall Study|Other-Physician Decision|1|||
145685588|NCT01114217|525363256|FG001|Overall Study|Other-Physician Decision|1|||
145685589|NCT01114217|525363255|FG000|Overall Study|Other-Sponsor Decision|10|||
145685590|NCT01114217|525363256|FG001|Overall Study|Other-Sponsor Decision|12|||
145685591|NCT01114217|525363255|FG000|Overall Study|Other-Study Termination|0|||
145685592|NCT01114217|525363256|FG001|Overall Study|Other-Study Termination|1|||
145685593|NCT01114217|525363255|FG000|Overall Study|Other-Study Withdrawn|1|||
145685594|NCT01114217|525363256|FG001|Overall Study|Other-Study Withdrawn|1|||
145685595|NCT01114217|525363255|FG000|Overall Study|Other-Site Stopped Communicating|2|||
145685596|NCT01114217|525363256|FG001|Overall Study|Other-Site Stopped Communicating|0|||
145685597|NCT01114217|525363255|FG000|Overall Study|Other-Lost to Follow-up|1|||
145685598|NCT01114217|525363256|FG001|Overall Study|Other-Lost to Follow-up|0|||
145685599|NCT01114217|525363255|FG000|Overall Study|Other-Withdrawal by Subject|1|||
145685600|NCT01114217|525363256|FG001|Overall Study|Other-Withdrawal by Subject|1|||
145685601|NCT06247488|525363257|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
145685602|NCT06247488|525363258|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
145685603|NCT06247488|525363259|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
145685604|NCT06247488|525363260|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
145685605|NCT06247488|525363261|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
145685606|NCT06247488|525363262|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
145685607|NCT06247488|525363257|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
145685608|NCT06247488|525363258|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
145685609|NCT06247488|525363259|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
145685610|NCT06247488|525363260|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
145685611|NCT06247488|525363261|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
145685612|NCT06247488|525363262|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
145685613|NCT06247488|525363257|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
145685614|NCT06247488|525363258|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
145685615|NCT06247488|525363259|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
145685616|NCT06247488|525363260|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
145685617|NCT06247488|525363261|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
145685618|NCT06247488|525363262|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
145685619|NCT06247488|525363257|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
145685620|NCT06247488|525363258|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
145685621|NCT06247488|525363259|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
145685622|NCT06247488|525363260|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
145685623|NCT06247488|525363261|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
145685624|NCT06247488|525363262|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
145685625|NCT06247488|525363257|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
145685626|NCT06247488|525363258|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
145685627|NCT06247488|525363259|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
145685628|NCT06247488|525363260|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
145685629|NCT06247488|525363261|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
145685630|NCT06247488|525363262|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
145685631|NCT06247488|525363257|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
145685632|NCT06247488|525363258|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
145685633|NCT06247488|525363259|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
145685634|NCT06247488|525363260|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
145685635|NCT06247488|525363261|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
145685636|NCT06247488|525363262|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
145685637|NCT06247488|525363257|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
145685638|NCT06247488|525363258|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
145685639|NCT06247488|525363259|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
145685640|NCT06247488|525363260|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
145685641|NCT06247488|525363261|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
145685642|NCT06247488|525363262|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
145685643|NCT03785210|525363263|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
145685644|NCT03785210|525363264|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
145685645|NCT03708744|525363267|FG000|Overall Study|Withdrawal by Subject|0|||
145685646|NCT03708744|525363268|FG001|Overall Study|Withdrawal by Subject|0|||
145685647|NCT03708744|525363269|FG002|Overall Study|Withdrawal by Subject|1|||
145685648|NCT03708744|525363270|FG003|Overall Study|Withdrawal by Subject|0|||
145685649|NCT02604199|525363273|FG000|Overall Study|Pregnancy|0|||
145685650|NCT02604199|525363274|FG001|Overall Study|Pregnancy|0|||
145685651|NCT02604199|525363275|FG002|Overall Study|Pregnancy|0|||
145685652|NCT02604199|525363276|FG003|Overall Study|Pregnancy|1|||
145685653|NCT02604199|525363273|FG000|Overall Study|Study terminated by sponsor|0|||
145685654|NCT02604199|525363274|FG001|Overall Study|Study terminated by sponsor|2|||
145685655|NCT02604199|525363275|FG002|Overall Study|Study terminated by sponsor|0|||
145685656|NCT02604199|525363276|FG003|Overall Study|Study terminated by sponsor|2|||
145685657|NCT02604199|525363273|FG000|Overall Study|Withdrawal by Subject|0|||
145685658|NCT02604199|525363274|FG001|Overall Study|Withdrawal by Subject|1|||
145685659|NCT02604199|525363275|FG002|Overall Study|Withdrawal by Subject|0|||
145685660|NCT02604199|525363276|FG003|Overall Study|Withdrawal by Subject|0|||
145685661|NCT02213458|525363282|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
145685662|NCT02213458|525363283|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
145685663|NCT02213458|525363282|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
145685664|NCT02213458|525363283|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
145685665|NCT02213458|525363282|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
145685666|NCT02213458|525363283|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
145685667|NCT02213458|525363282|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
145685668|NCT02213458|525363283|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
145685669|NCT02213458|525363282|FG000|Overall Study|Refused re-consent|6|||
145685670|NCT02213458|525363283|FG001|Overall Study|Refused re-consent|0|||
145685671|NCT02213458|525363282|FG000|Overall Study|Lost to Follow-up|2|||
145685672|NCT02213458|525363283|FG001|Overall Study|Lost to Follow-up|2|||
145685673|NCT02213458|525363282|FG000|Overall Study|Withdrawal by Subject|26|||
145685674|NCT02213458|525363283|FG001|Overall Study|Withdrawal by Subject|8|||
145685675|NCT02561195|525363286|FG000|Vaccination 1 to 3|Adverse Event|4|||
145685676|NCT02561195|525363287|FG001|Vaccination 1 to 3|Adverse Event|5|||
145685677|NCT02561195|525363288|FG002|Vaccination 1 to 3|Adverse Event|0|||
145685678|NCT02561195|525363289|FG003|Vaccination 1 to 3|Adverse Event|3|||
145685679|NCT02561195|525363290|FG004|Vaccination 1 to 3|Adverse Event|4|||
145685680|NCT02561195|525363291|FG005|Vaccination 1 to 3|Adverse Event|0|||
145685681|NCT02561195|525363292|FG006|Vaccination 1 to 3|Adverse Event|0|||
145685682|NCT02561195|525363293|FG007|Vaccination 1 to 3|Adverse Event|0|||
145685683|NCT02561195|525363294|FG008|Vaccination 1 to 3|Adverse Event|0|||
145685684|NCT02561195|525363295|FG009|Vaccination 1 to 3|Adverse Event|0|||
145685685|NCT02561195|525363296|FG010|Vaccination 1 to 3|Adverse Event|0|||
145685686|NCT02561195|525363297|FG011|Vaccination 1 to 3|Adverse Event|0|||
145685687|NCT02561195|525363298|FG012|Vaccination 1 to 3|Adverse Event|0|||
145685688|NCT02561195|525363299|FG013|Vaccination 1 to 3|Adverse Event|0|||
145685689|NCT02561195|525363286|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
145685690|NCT02561195|525363287|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
145685691|NCT02561195|525363288|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
145685692|NCT02561195|525363289|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
145685693|NCT02561195|525363290|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
145685694|NCT02561195|525363291|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
145685695|NCT02561195|525363292|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
145685696|NCT02561195|525363293|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
145685697|NCT02561195|525363294|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
145685698|NCT02561195|525363295|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
145685699|NCT02561195|525363296|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
145685700|NCT02561195|525363297|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
145685701|NCT02561195|525363298|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
145685702|NCT02561195|525363299|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
145685703|NCT02561195|525363286|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685704|NCT02561195|525363287|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
145685705|NCT02561195|525363288|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685706|NCT02561195|525363289|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
145685707|NCT02561195|525363290|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
145685708|NCT02561195|525363291|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
145685709|NCT02561195|525363292|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685710|NCT02561195|525363293|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685711|NCT02561195|525363294|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685712|NCT02561195|525363295|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685713|NCT02561195|525363296|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685714|NCT02561195|525363297|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685715|NCT02561195|525363298|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685716|NCT02561195|525363299|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
145685717|NCT02561195|525363286|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
145685718|NCT02561195|525363287|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
145685719|NCT02561195|525363288|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
145685720|NCT02561195|525363289|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
145685721|NCT02561195|525363290|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
145685722|NCT02561195|525363291|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
145685723|NCT02561195|525363292|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
145685724|NCT02561195|525363293|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
145685725|NCT02561195|525363294|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
145685726|NCT02561195|525363295|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
145685727|NCT02561195|525363296|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
145685728|NCT02561195|525363297|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
145685729|NCT02561195|525363298|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
145685730|NCT02561195|525363299|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
145685731|NCT02561195|525363286|FG000|Vaccination 1 to 3|Other|7|||
145685732|NCT02561195|525363287|FG001|Vaccination 1 to 3|Other|3|||
145685733|NCT02561195|525363288|FG002|Vaccination 1 to 3|Other|1|||
145685734|NCT02561195|525363289|FG003|Vaccination 1 to 3|Other|7|||
145685735|NCT02561195|525363290|FG004|Vaccination 1 to 3|Other|5|||
145685736|NCT02561195|525363291|FG005|Vaccination 1 to 3|Other|1|||
145685737|NCT02561195|525363292|FG006|Vaccination 1 to 3|Other|0|||
145685738|NCT02561195|525363293|FG007|Vaccination 1 to 3|Other|0|||
145685739|NCT02561195|525363294|FG008|Vaccination 1 to 3|Other|0|||
145685740|NCT02561195|525363295|FG009|Vaccination 1 to 3|Other|0|||
145685741|NCT02561195|525363296|FG010|Vaccination 1 to 3|Other|0|||
145685742|NCT02561195|525363297|FG011|Vaccination 1 to 3|Other|0|||
145685743|NCT02561195|525363298|FG012|Vaccination 1 to 3|Other|0|||
145685744|NCT02561195|525363299|FG013|Vaccination 1 to 3|Other|0|||
145685745|NCT02561195|525363286|FG000|Vaccination 1 to 3|Protocol Violation|1|||
145685746|NCT02561195|525363287|FG001|Vaccination 1 to 3|Protocol Violation|0|||
145685747|NCT02561195|525363288|FG002|Vaccination 1 to 3|Protocol Violation|1|||
145685748|NCT02561195|525363289|FG003|Vaccination 1 to 3|Protocol Violation|2|||
145685749|NCT02561195|525363290|FG004|Vaccination 1 to 3|Protocol Violation|5|||
145685750|NCT02561195|525363291|FG005|Vaccination 1 to 3|Protocol Violation|2|||
145685751|NCT02561195|525363292|FG006|Vaccination 1 to 3|Protocol Violation|0|||
145685752|NCT02561195|525363293|FG007|Vaccination 1 to 3|Protocol Violation|0|||
145685753|NCT02561195|525363294|FG008|Vaccination 1 to 3|Protocol Violation|0|||
145685754|NCT02561195|525363295|FG009|Vaccination 1 to 3|Protocol Violation|0|||
145685755|NCT02561195|525363296|FG010|Vaccination 1 to 3|Protocol Violation|0|||
145685756|NCT02561195|525363297|FG011|Vaccination 1 to 3|Protocol Violation|0|||
145685757|NCT02561195|525363298|FG012|Vaccination 1 to 3|Protocol Violation|0|||
145685758|NCT02561195|525363299|FG013|Vaccination 1 to 3|Protocol Violation|0|||
145685759|NCT02561195|525363286|FG000|Vaccination 1 to 3|Death|2|||
145685760|NCT02561195|525363287|FG001|Vaccination 1 to 3|Death|1|||
145685761|NCT02561195|525363288|FG002|Vaccination 1 to 3|Death|0|||
145685762|NCT02561195|525363289|FG003|Vaccination 1 to 3|Death|2|||
145685763|NCT02561195|525363290|FG004|Vaccination 1 to 3|Death|0|||
145685764|NCT02561195|525363291|FG005|Vaccination 1 to 3|Death|0|||
145685765|NCT02561195|525363292|FG006|Vaccination 1 to 3|Death|0|||
145685766|NCT02561195|525363293|FG007|Vaccination 1 to 3|Death|0|||
145685767|NCT02561195|525363294|FG008|Vaccination 1 to 3|Death|0|||
145685768|NCT02561195|525363295|FG009|Vaccination 1 to 3|Death|0|||
145685769|NCT02561195|525363296|FG010|Vaccination 1 to 3|Death|0|||
145685770|NCT02561195|525363297|FG011|Vaccination 1 to 3|Death|0|||
145685771|NCT02561195|525363298|FG012|Vaccination 1 to 3|Death|0|||
145685772|NCT02561195|525363299|FG013|Vaccination 1 to 3|Death|0|||
145685773|NCT02561195|525363286|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
145685774|NCT02561195|525363287|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
145685775|NCT02561195|525363288|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
145685776|NCT02561195|525363289|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
145685777|NCT02561195|525363290|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
145685778|NCT02561195|525363291|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685779|NCT02561195|525363292|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685780|NCT02561195|525363293|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685781|NCT02561195|525363294|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685782|NCT02561195|525363295|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685783|NCT02561195|525363296|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685784|NCT02561195|525363297|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685785|NCT02561195|525363298|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685786|NCT02561195|525363299|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
145685787|NCT02561195|525363286|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
145685788|NCT02561195|525363287|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
145685789|NCT02561195|525363288|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
145685790|NCT02561195|525363289|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
145685791|NCT02561195|525363290|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
145685792|NCT02561195|525363291|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
145685793|NCT02561195|525363292|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
145685794|NCT02561195|525363293|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
145685795|NCT02561195|525363294|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
145685796|NCT02561195|525363295|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
145685797|NCT02561195|525363296|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
145685798|NCT02561195|525363297|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
145685799|NCT02561195|525363298|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
145685800|NCT02561195|525363299|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
145685801|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685802|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685803|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685804|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685805|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685806|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685807|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685808|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685809|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
145685810|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
145685811|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
145685812|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
145685813|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
145685814|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
145685815|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685816|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685817|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685818|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685819|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685820|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685821|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685822|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685823|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685824|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685825|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685826|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685827|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
145685828|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
145685829|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Death|0|||
145685830|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Death|0|||
145685831|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Death|0|||
145685832|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Death|0|||
145685833|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Death|0|||
145685834|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Death|0|||
145685835|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Death|0|||
145685836|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Death|0|||
145685837|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Death|0|||
145685838|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Death|1|||
145685839|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Death|0|||
145685840|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Death|0|||
145685841|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Death|0|||
145685842|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Death|0|||
145685843|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685844|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685845|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685846|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685847|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685848|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685849|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
145685850|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
145685851|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685852|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
145685853|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
145685854|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
145685855|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
145685856|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
145685857|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685858|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685859|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685860|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685861|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685862|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685863|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685864|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685865|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685866|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685867|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
145685868|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
145685869|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
145685870|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
145685871|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Other|0|||
145685872|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Other|0|||
145685873|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Other|0|||
145685874|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Other|0|||
145685875|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Other|0|||
145685876|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Other|0|||
145685877|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Other|0|||
145685878|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Other|0|||
145685879|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Other|0|||
145685880|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Other|0|||
145685881|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Other|2|||
145685882|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Other|2|||
145685883|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Other|1|||
145685884|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Other|0|||
145685885|NCT02561195|525363286|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685886|NCT02561195|525363287|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685887|NCT02561195|525363288|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685888|NCT02561195|525363289|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685889|NCT02561195|525363290|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685890|NCT02561195|525363291|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685891|NCT02561195|525363292|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
145685892|NCT02561195|525363293|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685893|NCT02561195|525363294|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685894|NCT02561195|525363295|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685895|NCT02561195|525363296|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
145685896|NCT02561195|525363297|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
145685897|NCT02561195|525363298|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
145685898|NCT02561195|525363299|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
145685899|NCT02993926|525363307|FG000|Enantone Treatment Phase|Adverse Event|1|||
145685900|NCT02993926|525363308|FG001|Enantone Treatment Phase|Adverse Event|0|||
145685901|NCT02993926|525363309|FG002|Enantone Treatment Phase|Adverse Event|0|||
145685902|NCT02993926|525363307|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
145685903|NCT02993926|525363308|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
145685904|NCT02993926|525363309|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
145685905|NCT02993926|525363307|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
145685906|NCT02993926|525363308|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
145685907|NCT02993926|525363309|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
145685908|NCT02993926|525363307|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
145685909|NCT02993926|525363308|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
145685910|NCT02993926|525363309|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
145685911|NCT03394508|525363313|FG000|Overall Study|Protocol Violation|0|||
145685912|NCT03394508|525363314|FG001|Overall Study|Protocol Violation|3|||
145685913|NCT03394508|525363313|FG000|Overall Study|Lost to Follow-up|1|||
145685914|NCT03394508|525363314|FG001|Overall Study|Lost to Follow-up|0|||
145685915|NCT03122548|525363318|FG000|Overall Study|Death|2|||
145685916|NCT03122548|525363318|FG000|Overall Study|Progression - subject went into hospice|1|||
145685917|NCT03122548|525363318|FG000|Overall Study|Study Terminated by Sponsor|2|||
145685918|NCT02819141|525363319|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
145685919|NCT02819141|525363320|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
145685920|NCT03820024|525363321|FG000|Overall Study|Physician Decision|1|||
145685921|NCT03820024|525363322|FG001|Overall Study|Physician Decision|2|||
145685922|NCT00676195|525364874|FG000|Overall Study|Lost to Follow-up|1|||
145685923|NCT00676195|525364874|FG000|Overall Study|Adverse Event|1|||
145685924|NCT00676195|525364874|FG000|Overall Study|Physician Decision|1|||
145685925|NCT02101554|525364875|FG000|Overall Study|Protocol Violation|0|||
145685926|NCT02101554|525364876|FG001|Overall Study|Protocol Violation|1|||
145685927|NCT02101554|525364877|FG002|Overall Study|Protocol Violation|0|||
145685928|NCT02101554|525364875|FG000|Overall Study|Insufficient Clinical Response|0|||
145685929|NCT02101554|525364876|FG001|Overall Study|Insufficient Clinical Response|2|||
145685930|NCT02101554|525364877|FG002|Overall Study|Insufficient Clinical Response|0|||
145685931|NCT02101554|525364875|FG000|Overall Study|Adverse Event|2|||
145685932|NCT02101554|525364876|FG001|Overall Study|Adverse Event|1|||
145685933|NCT02101554|525364877|FG002|Overall Study|Adverse Event|1|||
145685934|NCT02101554|525364875|FG000|Overall Study|Lost to Follow-up|0|||
145685935|NCT02101554|525364876|FG001|Overall Study|Lost to Follow-up|1|||
145685936|NCT02101554|525364877|FG002|Overall Study|Lost to Follow-up|0|||
145685937|NCT02101554|525364875|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
145685938|NCT02101554|525364876|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
145685939|NCT02101554|525364877|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
145685940|NCT00409006|525364880|FG000|Overall Study|Death|15|||
145685941|NCT00409006|525364881|FG001|Overall Study|Death|6|||
145685942|NCT00409006|525364880|FG000|Overall Study|Lost to Follow-up|1|||
145685943|NCT00409006|525364881|FG001|Overall Study|Lost to Follow-up|2|||
145685944|NCT00409006|525364880|FG000|Overall Study|Withdrawal by Subject|3|||
145685945|NCT00409006|525364881|FG001|Overall Study|Withdrawal by Subject|2|||
145685946|NCT00409006|525364880|FG000|Overall Study|Physician Decision|1|||
145685947|NCT00409006|525364881|FG001|Overall Study|Physician Decision|2|||
145685948|NCT02011568|525364884|FG000|Overall Study|Withdrawal by Subject|8|||
145685949|NCT02011568|525364885|FG001|Overall Study|Withdrawal by Subject|10|||
145685950|NCT02011568|525364884|FG000|Overall Study|Physician Decision|1|||
145685951|NCT02011568|525364885|FG001|Overall Study|Physician Decision|3|||
145685952|NCT01107353|525364886|FG000|Overall Study|Positive Drug Screen|1|||
145685953|NCT01107353|525364887|FG001|Overall Study|Positive Drug Screen|0|||
145685954|NCT03034772|525364888|FG000|Overall Study|Adverse Event|0|||
145685955|NCT03034772|525364889|FG001|Overall Study|Adverse Event|1|||
145685956|NCT03034772|525364888|FG000|Overall Study|Withdrawal by Subject|0|||
145685957|NCT03034772|525364889|FG001|Overall Study|Withdrawal by Subject|1|||
145685958|NCT01136733|525364890|FG000|Phase 1b|Adverse Event|0|||
145685959|NCT01136733|525364891|FG001|Phase 1b|Adverse Event|3|||
145685960|NCT01136733|525364892|FG002|Phase 1b|Adverse Event|1|||
145685961|NCT01136733|525364893|FG003|Phase 1b|Adverse Event|0|||
145685962|NCT01136733|525364894|FG004|Phase 1b|Adverse Event|0|||
145685963|NCT01136733|525364895|FG005|Phase 1b|Adverse Event|0|||
145685964|NCT01136733|525364896|FG006|Phase 1b|Adverse Event|0|||
145685965|NCT01136733|525364890|FG000|Phase 1b|Participant Choice|0|||
145685966|NCT01136733|525364891|FG001|Phase 1b|Participant Choice|0|||
145685967|NCT01136733|525364892|FG002|Phase 1b|Participant Choice|1|||
145685968|NCT01136733|525364893|FG003|Phase 1b|Participant Choice|0|||
145685969|NCT01136733|525364894|FG004|Phase 1b|Participant Choice|0|||
145685970|NCT01136733|525364895|FG005|Phase 1b|Participant Choice|0|||
145685971|NCT01136733|525364896|FG006|Phase 1b|Participant Choice|0|||
145685972|NCT01136733|525364890|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
145685973|NCT01136733|525364891|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
145685974|NCT01136733|525364892|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
145685975|NCT01136733|525364893|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
145685976|NCT01136733|525364894|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
145685977|NCT01136733|525364895|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
145685978|NCT01136733|525364896|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
145685979|NCT01136733|525364890|FG000|Phase 1b|Clinical Progression|1|||
145685980|NCT01136733|525364891|FG001|Phase 1b|Clinical Progression|1|||
145685981|NCT01136733|525364892|FG002|Phase 1b|Clinical Progression|0|||
145685982|NCT01136733|525364893|FG003|Phase 1b|Clinical Progression|0|||
145685983|NCT01136733|525364894|FG004|Phase 1b|Clinical Progression|0|||
145685984|NCT01136733|525364895|FG005|Phase 1b|Clinical Progression|0|||
145685985|NCT01136733|525364896|FG006|Phase 1b|Clinical Progression|0|||
145685986|NCT01136733|525364890|FG000|Phase 2|Disease Progression|0|||
145685987|NCT01136733|525364891|FG001|Phase 2|Disease Progression|0|||
145685988|NCT01136733|525364892|FG002|Phase 2|Disease Progression|0|||
145685989|NCT01136733|525364893|FG003|Phase 2|Disease Progression|0|||
145685990|NCT01136733|525364894|FG004|Phase 2|Disease Progression|30|||
145685991|NCT01136733|525364895|FG005|Phase 2|Disease Progression|32|||
145685992|NCT01136733|525364896|FG006|Phase 2|Disease Progression|38|||
145685993|NCT01136733|525364890|FG000|Phase 2|Adverse Event|0|||
145685994|NCT01136733|525364891|FG001|Phase 2|Adverse Event|0|||
145685995|NCT01136733|525364892|FG002|Phase 2|Adverse Event|0|||
145685996|NCT01136733|525364893|FG003|Phase 2|Adverse Event|0|||
145685997|NCT01136733|525364894|FG004|Phase 2|Adverse Event|11|||
145685998|NCT01136733|525364895|FG005|Phase 2|Adverse Event|13|||
145685999|NCT01136733|525364896|FG006|Phase 2|Adverse Event|5|||
145686000|NCT01136733|525364890|FG000|Phase 2|Participant Choice|0|||
145686001|NCT01136733|525364891|FG001|Phase 2|Participant Choice|0|||
145686002|NCT01136733|525364892|FG002|Phase 2|Participant Choice|0|||
145686003|NCT01136733|525364893|FG003|Phase 2|Participant Choice|0|||
145686004|NCT01136733|525364894|FG004|Phase 2|Participant Choice|3|||
145686005|NCT01136733|525364895|FG005|Phase 2|Participant Choice|0|||
145686006|NCT01136733|525364896|FG006|Phase 2|Participant Choice|1|||
145686007|NCT01136733|525364890|FG000|Phase 2|Administrative-Withdrew Consent|0|||
145686008|NCT01136733|525364891|FG001|Phase 2|Administrative-Withdrew Consent|0|||
145686009|NCT01136733|525364892|FG002|Phase 2|Administrative-Withdrew Consent|0|||
145686010|NCT01136733|525364893|FG003|Phase 2|Administrative-Withdrew Consent|0|||
145686011|NCT01136733|525364894|FG004|Phase 2|Administrative-Withdrew Consent|1|||
145686012|NCT01136733|525364895|FG005|Phase 2|Administrative-Withdrew Consent|0|||
145686013|NCT01136733|525364896|FG006|Phase 2|Administrative-Withdrew Consent|0|||
145686014|NCT01136733|525364890|FG000|Phase 2|Other|0|||
145686015|NCT01136733|525364891|FG001|Phase 2|Other|0|||
145686016|NCT01136733|525364892|FG002|Phase 2|Other|0|||
145686017|NCT01136733|525364893|FG003|Phase 2|Other|0|||
145686018|NCT01136733|525364894|FG004|Phase 2|Other|6|||
145686019|NCT01136733|525364895|FG005|Phase 2|Other|7|||
145686020|NCT01136733|525364896|FG006|Phase 2|Other|6|||
145686021|NCT01745380|525364897|FG000|Overall Study|Lost to Follow-up|1|||
145686022|NCT01745380|525364898|FG001|Overall Study|Lost to Follow-up|0|||
145686023|NCT01745380|525364897|FG000|Overall Study|Lack of Efficacy|0|||
145686024|NCT01745380|525364898|FG001|Overall Study|Lack of Efficacy|1|||
145686025|NCT02368691|525364899|FG000|Overall Study|Death|13|||
145686026|NCT02368691|525364899|FG000|Overall Study|Lack of Efficacy|15|||
145686027|NCT02368691|525364899|FG000|Overall Study|Physician Decision|4|||
145686028|NCT02660034|525364900|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
145686029|NCT02660034|525364901|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
145686030|NCT02660034|525364902|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
145686031|NCT02660034|525364903|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
145686032|NCT02660034|525364904|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
145686033|NCT02660034|525364905|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
145686034|NCT02660034|525364906|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
145686035|NCT02660034|525364907|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
145686036|NCT02660034|525364908|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
145686037|NCT02660034|525364909|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
145686038|NCT02660034|525364910|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
145686039|NCT02660034|525364911|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
145686040|NCT02660034|525364912|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
145686041|NCT02660034|525364913|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
145686042|NCT02660034|525364900|FG000|Overall Study|Progressive Disease (Clinical)|7|||
145686043|NCT02660034|525364901|FG001|Overall Study|Progressive Disease (Clinical)|8|||
145686044|NCT02660034|525364902|FG002|Overall Study|Progressive Disease (Clinical)|3|||
145686045|NCT02660034|525364903|FG003|Overall Study|Progressive Disease (Clinical)|9|||
145686046|NCT02660034|525364904|FG004|Overall Study|Progressive Disease (Clinical)|3|||
145686047|NCT02660034|525364905|FG005|Overall Study|Progressive Disease (Clinical)|0|||
145686048|NCT02660034|525364906|FG006|Overall Study|Progressive Disease (Clinical)|0|||
145686049|NCT02660034|525364907|FG007|Overall Study|Progressive Disease (Clinical)|0|||
145686050|NCT02660034|525364908|FG008|Overall Study|Progressive Disease (Clinical)|0|||
145686051|NCT02660034|525364909|FG009|Overall Study|Progressive Disease (Clinical)|0|||
145686052|NCT02660034|525364910|FG010|Overall Study|Progressive Disease (Clinical)|0|||
145686053|NCT02660034|525364911|FG011|Overall Study|Progressive Disease (Clinical)|0|||
145686054|NCT02660034|525364912|FG012|Overall Study|Progressive Disease (Clinical)|0|||
145686055|NCT02660034|525364913|FG013|Overall Study|Progressive Disease (Clinical)|0|||
145686056|NCT02660034|525364900|FG000|Overall Study|Lost to Follow-up|0|||
145686057|NCT02660034|525364901|FG001|Overall Study|Lost to Follow-up|0|||
145686058|NCT02660034|525364902|FG002|Overall Study|Lost to Follow-up|1|||
145686059|NCT02660034|525364903|FG003|Overall Study|Lost to Follow-up|1|||
145686060|NCT02660034|525364904|FG004|Overall Study|Lost to Follow-up|0|||
145686061|NCT02660034|525364905|FG005|Overall Study|Lost to Follow-up|0|||
145686062|NCT02660034|525364906|FG006|Overall Study|Lost to Follow-up|0|||
145686063|NCT02660034|525364907|FG007|Overall Study|Lost to Follow-up|0|||
145686064|NCT02660034|525364908|FG008|Overall Study|Lost to Follow-up|0|||
145686065|NCT02660034|525364909|FG009|Overall Study|Lost to Follow-up|1|||
145686066|NCT02660034|525364910|FG010|Overall Study|Lost to Follow-up|1|||
145686067|NCT02660034|525364911|FG011|Overall Study|Lost to Follow-up|1|||
145686068|NCT02660034|525364912|FG012|Overall Study|Lost to Follow-up|0|||
145686069|NCT02660034|525364913|FG013|Overall Study|Lost to Follow-up|0|||
145686070|NCT02660034|525364900|FG000|Overall Study|Participant moved into special access scheme|1|||
145686071|NCT02660034|525364901|FG001|Overall Study|Participant moved into special access scheme|2|||
145686072|NCT02660034|525364902|FG002|Overall Study|Participant moved into special access scheme|0|||
145686073|NCT02660034|525364903|FG003|Overall Study|Participant moved into special access scheme|0|||
145686074|NCT02660034|525364904|FG004|Overall Study|Participant moved into special access scheme|0|||
145686075|NCT02660034|525364905|FG005|Overall Study|Participant moved into special access scheme|0|||
145686076|NCT02660034|525364906|FG006|Overall Study|Participant moved into special access scheme|0|||
145686077|NCT02660034|525364907|FG007|Overall Study|Participant moved into special access scheme|0|||
145686078|NCT02660034|525364908|FG008|Overall Study|Participant moved into special access scheme|0|||
145686079|NCT02660034|525364909|FG009|Overall Study|Participant moved into special access scheme|0|||
145686080|NCT02660034|525364910|FG010|Overall Study|Participant moved into special access scheme|0|||
145686081|NCT02660034|525364911|FG011|Overall Study|Participant moved into special access scheme|0|||
145686082|NCT02660034|525364912|FG012|Overall Study|Participant moved into special access scheme|0|||
145686083|NCT02660034|525364913|FG013|Overall Study|Participant moved into special access scheme|0|||
145686084|NCT02660034|525364900|FG000|Overall Study|Adverse Event|1|||
145686085|NCT02660034|525364901|FG001|Overall Study|Adverse Event|0|||
145686086|NCT02660034|525364902|FG002|Overall Study|Adverse Event|0|||
145686087|NCT02660034|525364903|FG003|Overall Study|Adverse Event|0|||
145686088|NCT02660034|525364904|FG004|Overall Study|Adverse Event|0|||
145686089|NCT02660034|525364905|FG005|Overall Study|Adverse Event|0|||
145686090|NCT02660034|525364906|FG006|Overall Study|Adverse Event|0|||
145686091|NCT02660034|525364907|FG007|Overall Study|Adverse Event|0|||
145686092|NCT02660034|525364908|FG008|Overall Study|Adverse Event|0|||
145686093|NCT02660034|525364909|FG009|Overall Study|Adverse Event|0|||
145686094|NCT02660034|525364910|FG010|Overall Study|Adverse Event|0|||
145686095|NCT02660034|525364911|FG011|Overall Study|Adverse Event|0|||
145686096|NCT02660034|525364912|FG012|Overall Study|Adverse Event|0|||
145686097|NCT02660034|525364913|FG013|Overall Study|Adverse Event|0|||
145686098|NCT02660034|525364900|FG000|Overall Study|Sponsor Decision|0|||
145686099|NCT02660034|525364901|FG001|Overall Study|Sponsor Decision|1|||
145686100|NCT02660034|525364902|FG002|Overall Study|Sponsor Decision|2|||
145686101|NCT02660034|525364903|FG003|Overall Study|Sponsor Decision|2|||
145686102|NCT02660034|525364904|FG004|Overall Study|Sponsor Decision|3|||
145686103|NCT02660034|525364905|FG005|Overall Study|Sponsor Decision|0|||
145686104|NCT02660034|525364906|FG006|Overall Study|Sponsor Decision|0|||
145686105|NCT02660034|525364907|FG007|Overall Study|Sponsor Decision|0|||
145686106|NCT02660034|525364908|FG008|Overall Study|Sponsor Decision|0|||
145686107|NCT02660034|525364909|FG009|Overall Study|Sponsor Decision|0|||
145686108|NCT02660034|525364910|FG010|Overall Study|Sponsor Decision|0|||
145686109|NCT02660034|525364911|FG011|Overall Study|Sponsor Decision|0|||
145686110|NCT02660034|525364912|FG012|Overall Study|Sponsor Decision|0|||
145686111|NCT02660034|525364913|FG013|Overall Study|Sponsor Decision|1|||
145686112|NCT02660034|525364900|FG000|Overall Study|Withdrawal by Subject|0|||
145686113|NCT02660034|525364901|FG001|Overall Study|Withdrawal by Subject|0|||
145686114|NCT02660034|525364902|FG002|Overall Study|Withdrawal by Subject|0|||
145686115|NCT02660034|525364903|FG003|Overall Study|Withdrawal by Subject|0|||
145686116|NCT02660034|525364904|FG004|Overall Study|Withdrawal by Subject|0|||
145686117|NCT02660034|525364905|FG005|Overall Study|Withdrawal by Subject|0|||
145686118|NCT02660034|525364906|FG006|Overall Study|Withdrawal by Subject|1|||
145686119|NCT02660034|525364907|FG007|Overall Study|Withdrawal by Subject|1|||
145686120|NCT02660034|525364908|FG008|Overall Study|Withdrawal by Subject|1|||
145686121|NCT02660034|525364909|FG009|Overall Study|Withdrawal by Subject|0|||
145686122|NCT02660034|525364910|FG010|Overall Study|Withdrawal by Subject|0|||
145686123|NCT02660034|525364911|FG011|Overall Study|Withdrawal by Subject|1|||
145686124|NCT02660034|525364912|FG012|Overall Study|Withdrawal by Subject|2|||
145686125|NCT02660034|525364913|FG013|Overall Study|Withdrawal by Subject|0|||
145686126|NCT02660034|525364900|FG000|Overall Study|Death|0|||
145686127|NCT02660034|525364901|FG001|Overall Study|Death|0|||
145686128|NCT02660034|525364902|FG002|Overall Study|Death|0|||
145686129|NCT02660034|525364903|FG003|Overall Study|Death|0|||
145686130|NCT02660034|525364904|FG004|Overall Study|Death|0|||
145686131|NCT02660034|525364905|FG005|Overall Study|Death|13|||
145686132|NCT02660034|525364906|FG006|Overall Study|Death|14|||
145686133|NCT02660034|525364907|FG007|Overall Study|Death|10|||
145686134|NCT02660034|525364908|FG008|Overall Study|Death|9|||
145686135|NCT02660034|525364909|FG009|Overall Study|Death|21|||
145686136|NCT02660034|525364910|FG010|Overall Study|Death|17|||
145686137|NCT02660034|525364911|FG011|Overall Study|Death|15|||
145686138|NCT02660034|525364912|FG012|Overall Study|Death|18|||
145686139|NCT02660034|525364913|FG013|Overall Study|Death|7|||
145686140|NCT02660034|525364900|FG000|Overall Study|Physician Decision|0|||
145686141|NCT02660034|525364901|FG001|Overall Study|Physician Decision|0|||
145686142|NCT02660034|525364902|FG002|Overall Study|Physician Decision|0|||
145686143|NCT02660034|525364903|FG003|Overall Study|Physician Decision|0|||
145686144|NCT02660034|525364904|FG004|Overall Study|Physician Decision|0|||
145686145|NCT02660034|525364905|FG005|Overall Study|Physician Decision|0|||
145686146|NCT02660034|525364906|FG006|Overall Study|Physician Decision|0|||
145686147|NCT02660034|525364907|FG007|Overall Study|Physician Decision|0|||
145686148|NCT02660034|525364908|FG008|Overall Study|Physician Decision|0|||
145686149|NCT02660034|525364909|FG009|Overall Study|Physician Decision|0|||
145686150|NCT02660034|525364910|FG010|Overall Study|Physician Decision|0|||
145686151|NCT02660034|525364911|FG011|Overall Study|Physician Decision|0|||
145686152|NCT02660034|525364912|FG012|Overall Study|Physician Decision|0|||
145686153|NCT02660034|525364913|FG013|Overall Study|Physician Decision|1|||
145686154|NCT02660034|525364900|FG000|Overall Study|Participants transferred to LTE|0|||
145686155|NCT02660034|525364901|FG001|Overall Study|Participants transferred to LTE|0|||
145686156|NCT02660034|525364902|FG002|Overall Study|Participants transferred to LTE|0|||
145686157|NCT02660034|525364903|FG003|Overall Study|Participants transferred to LTE|0|||
145686158|NCT02660034|525364904|FG004|Overall Study|Participants transferred to LTE|0|||
145686159|NCT02660034|525364905|FG005|Overall Study|Participants transferred to LTE|10|||
145686160|NCT02660034|525364906|FG006|Overall Study|Participants transferred to LTE|8|||
145686161|NCT02660034|525364907|FG007|Overall Study|Participants transferred to LTE|8|||
145686162|NCT02660034|525364908|FG008|Overall Study|Participants transferred to LTE|10|||
145686163|NCT02660034|525364909|FG009|Overall Study|Participants transferred to LTE|1|||
145686164|NCT02660034|525364910|FG010|Overall Study|Participants transferred to LTE|2|||
145686165|NCT02660034|525364911|FG011|Overall Study|Participants transferred to LTE|4|||
145686166|NCT02660034|525364912|FG012|Overall Study|Participants transferred to LTE|1|||
145686167|NCT02660034|525364913|FG013|Overall Study|Participants transferred to LTE|1|||
145686168|NCT02069366|525364916|FG000|Overall Study|Lost to Follow-up|0|||
145686169|NCT02069366|525364917|FG001|Overall Study|Lost to Follow-up|0|||
145686170|NCT02069366|525364918|FG002|Overall Study|Lost to Follow-up|1|||
145686171|NCT02069366|525364919|FG003|Overall Study|Lost to Follow-up|0|||
145686172|NCT02069366|525364920|FG004|Overall Study|Lost to Follow-up|0|||
145686173|NCT02069366|525364921|FG005|Overall Study|Lost to Follow-up|2|||
145686174|NCT02069366|525364916|FG000|Overall Study|Protocol Violation|0|||
145686175|NCT02069366|525364917|FG001|Overall Study|Protocol Violation|0|||
145686176|NCT02069366|525364918|FG002|Overall Study|Protocol Violation|1|||
145686177|NCT02069366|525364919|FG003|Overall Study|Protocol Violation|0|||
145686178|NCT02069366|525364920|FG004|Overall Study|Protocol Violation|0|||
145686179|NCT02069366|525364921|FG005|Overall Study|Protocol Violation|0|||
145686180|NCT02069366|525364916|FG000|Overall Study|Withdrawal by Subject|1|||
145686181|NCT02069366|525364917|FG001|Overall Study|Withdrawal by Subject|0|||
145686182|NCT02069366|525364918|FG002|Overall Study|Withdrawal by Subject|1|||
145686183|NCT02069366|525364919|FG003|Overall Study|Withdrawal by Subject|2|||
145686184|NCT02069366|525364920|FG004|Overall Study|Withdrawal by Subject|0|||
145686185|NCT02069366|525364921|FG005|Overall Study|Withdrawal by Subject|0|||
145686186|NCT03314233|525364923|FG000|Overall Study|No longer eligible at time of delivery|1|||
145686187|NCT01797705|525364924|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
145686188|NCT01797705|525364924|FG000|Overall Study|Withdrawal by Subject|1|||
145686189|NCT01838447|525364925|FG000|Overall Study|Change in surgical plan|1|||
145686190|NCT01838447|525364926|FG001|Overall Study|Change in surgical plan|2|||
145686191|NCT01838447|525364925|FG000|Overall Study|Withdrawal by Subject|1|||
145686192|NCT01838447|525364926|FG001|Overall Study|Withdrawal by Subject|1|||
145686193|NCT00460434|525364929|FG000|Overall Study|Lost to Follow-up|3|||
145686194|NCT00460434|525364930|FG001|Overall Study|Lost to Follow-up|7|||
145686195|NCT02722278|525364933|FG000|Overall Study|Withdrawal by Subject|5|||
145686196|NCT02722278|525364934|FG001|Overall Study|Withdrawal by Subject|3|||
145686197|NCT02722278|525364933|FG000|Overall Study|Adverse Event|4|||
145686198|NCT02722278|525364934|FG001|Overall Study|Adverse Event|1|||
145686199|NCT02722278|525364933|FG000|Overall Study|Lost to Follow-up|2|||
145686200|NCT02722278|525364934|FG001|Overall Study|Lost to Follow-up|0|||
145686201|NCT02722278|525364933|FG000|Overall Study|Protocol Violation|1|||
145686202|NCT02722278|525364934|FG001|Overall Study|Protocol Violation|0|||
145686203|NCT02722278|525364933|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
145686204|NCT02722278|525364934|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
145686205|NCT02722278|525364933|FG000|Overall Study|Subject declined after tx assignment|0|||
145686206|NCT02722278|525364934|FG001|Overall Study|Subject declined after tx assignment|1|||
145686207|NCT02722278|525364933|FG000|Overall Study|Site closure not study related|0|||
145686208|NCT02722278|525364934|FG001|Overall Study|Site closure not study related|1|||
145686209|NCT00561678|525364935|FG000|Overall Study|Withdrawal by Subject|4|||
145686210|NCT00561678|525364936|FG001|Overall Study|Withdrawal by Subject|3|||
145686211|NCT00561678|525364935|FG000|Overall Study|surgery cancelled|1|||
145686212|NCT00561678|525364936|FG001|Overall Study|surgery cancelled|1|||
145686213|NCT00561678|525364935|FG000|Overall Study|surgery rescheduled to different site|2|||
145686214|NCT00561678|525364936|FG001|Overall Study|surgery rescheduled to different site|2|||
145686215|NCT00561678|525364935|FG000|Overall Study|anesthesia provider refusal|1|||
145686216|NCT00561678|525364936|FG001|Overall Study|anesthesia provider refusal|0|||
145686217|NCT01103141|525364937|FG000|Overall Study|Death|0|||
145686218|NCT01103141|525364938|FG001|Overall Study|Death|1|||
145686219|NCT01103141|525364937|FG000|Overall Study|Lost to Follow-up|2|||
145686220|NCT01103141|525364938|FG001|Overall Study|Lost to Follow-up|1|||
145686221|NCT00422162|525364939|FG000|Overall Study|Adverse Event|11|||
145686222|NCT00422162|525364940|FG001|Overall Study|Adverse Event|9|||
145686223|NCT00422162|525364939|FG000|Overall Study|Lack of Efficacy|4|||
145686224|NCT00422162|525364940|FG001|Overall Study|Lack of Efficacy|10|||
145686225|NCT00422162|525364939|FG000|Overall Study|Withdrawal by Subject|7|||
145686226|NCT00422162|525364940|FG001|Overall Study|Withdrawal by Subject|6|||
145686227|NCT00422162|525364939|FG000|Overall Study|Lost to Follow-up|1|||
145686228|NCT00422162|525364940|FG001|Overall Study|Lost to Follow-up|2|||
145686229|NCT00422162|525364939|FG000|Overall Study|Non-Compliant with Protocol|1|||
145686230|NCT00422162|525364940|FG001|Overall Study|Non-Compliant with Protocol|1|||
145686231|NCT00422162|525364939|FG000|Overall Study|Other|0|||
145686232|NCT00422162|525364940|FG001|Overall Study|Other|1|||
145686233|NCT00422162|525364939|FG000|Overall Study|Didn't Receive Treatment|0|||
145686234|NCT00422162|525364940|FG001|Overall Study|Didn't Receive Treatment|1|||
145686235|NCT05274906|525364942|FG000|Overall Study|Withdrawal by Subject|2|||
145686236|NCT05274906|525364943|FG001|Overall Study|Withdrawal by Subject|1|||
145686237|NCT00848198|525364944|FG000|Overall Study|Incomplete Case Report Forms|15|||
145686238|NCT00460577|525364945|FG000|Overall Study|Protocol Violation|2|||
145686239|NCT00460577|525364946|FG001|Overall Study|Protocol Violation|6|||
145686240|NCT04043806|525364947|FG000|Overall Study|Commercial drug is available for participants|13|||
145686241|NCT04043806|525364947|FG000|Overall Study|Physician Decision|2|||
145686242|NCT04043806|525364947|FG000|Overall Study|Other|12|||
145686243|NCT04043806|525364947|FG000|Overall Study|Adverse Event|2|||
145686244|NCT04043806|525364947|FG000|Overall Study|Lost to Follow-up|6|||
145686245|NCT04043806|525364947|FG000|Overall Study|Other non-compliance|2|||
145686246|NCT04043806|525364947|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
145686247|NCT04043806|525364947|FG000|Overall Study|Never Dosed|1|||
145686248|NCT01622088|525364950|FG000|Overall Study|Adverse Event|20|||
145686249|NCT01622088|525364950|FG000|Overall Study|Lost to Follow-up|1|||
145686250|NCT01622088|525364950|FG000|Overall Study|Withdrawal by Subject|20|||
145686251|NCT01622088|525364950|FG000|Overall Study|Investigator Decision|1|||
145686252|NCT01622088|525364950|FG000|Overall Study|Death|53|||
145686253|NCT01622088|525364950|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
145686254|NCT03045302|525364955|FG000|Overall Study|Pre-treatment adverse event|1|||
145686255|NCT00134056|525364956|FG000|Randomization|Not eligible for assigned treatment|22|||
145686256|NCT00134056|525364957|FG001|Randomization|Not eligible for assigned treatment|20|||
145686257|NCT00134056|525364956|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
145686258|NCT00134056|525364957|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
145686259|NCT00134056|525364956|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
145686260|NCT00134056|525364957|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
145686261|NCT00134056|525364956|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
145686262|NCT00134056|525364957|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
145686263|NCT00134056|525364956|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
145686264|NCT00134056|525364957|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
145686265|NCT03166215|525364958|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
145686266|NCT03166215|525364959|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
145686267|NCT03166215|525364960|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
145686268|NCT03166215|525364958|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
145686269|NCT03166215|525364959|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
145686270|NCT03166215|525364960|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
145686271|NCT04362176|525364964|FG000|Overall Study|Lost to Follow-up|5|||
145686272|NCT04362176|525364965|FG001|Overall Study|Lost to Follow-up|8|||
145686273|NCT04362176|525364964|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
145686274|NCT04362176|525364965|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
145686275|NCT00742560|525364966|FG000|Overall Study|Adverse Event|0|||
145686276|NCT00742560|525364967|FG001|Overall Study|Adverse Event|0|||
145686277|NCT00742560|525364968|FG002|Overall Study|Adverse Event|1|||
145686278|NCT00742560|525364969|FG003|Overall Study|Adverse Event|1|||
145686279|NCT00742560|525364970|FG004|Overall Study|Adverse Event|1|||
145686280|NCT00742560|525364966|FG000|Overall Study|Death|0|||
145686281|NCT00742560|525364967|FG001|Overall Study|Death|2|||
145686282|NCT00742560|525364968|FG002|Overall Study|Death|0|||
145686283|NCT00742560|525364969|FG003|Overall Study|Death|2|||
145686284|NCT00742560|525364970|FG004|Overall Study|Death|3|||
145686285|NCT00742560|525364966|FG000|Overall Study|Subject's Decision|1|||
145686286|NCT00742560|525364967|FG001|Overall Study|Subject's Decision|0|||
145686287|NCT00742560|525364968|FG002|Overall Study|Subject's Decision|2|||
145686288|NCT00742560|525364969|FG003|Overall Study|Subject's Decision|3|||
145686289|NCT00742560|525364970|FG004|Overall Study|Subject's Decision|3|||
145686290|NCT00742560|525364966|FG000|Overall Study|Investigator's Decision|0|||
145686291|NCT00742560|525364967|FG001|Overall Study|Investigator's Decision|0|||
145686292|NCT00742560|525364968|FG002|Overall Study|Investigator's Decision|4|||
145686293|NCT00742560|525364969|FG003|Overall Study|Investigator's Decision|1|||
145686294|NCT00742560|525364970|FG004|Overall Study|Investigator's Decision|0|||
145686295|NCT00742560|525364966|FG000|Overall Study|Disease Progression|1|||
145686296|NCT00742560|525364967|FG001|Overall Study|Disease Progression|0|||
145686297|NCT00742560|525364968|FG002|Overall Study|Disease Progression|5|||
145686298|NCT00742560|525364969|FG003|Overall Study|Disease Progression|17|||
145686299|NCT00742560|525364970|FG004|Overall Study|Disease Progression|16|||
145686300|NCT00742560|525364966|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
145686301|NCT00742560|525364967|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
145686302|NCT00742560|525364968|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
145686303|NCT00742560|525364969|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
145686304|NCT00742560|525364970|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
145686305|NCT00742560|525364966|FG000|Overall Study|Other|0|||
145686306|NCT00742560|525364967|FG001|Overall Study|Other|1|||
145686307|NCT00742560|525364968|FG002|Overall Study|Other|8|||
145686308|NCT00742560|525364969|FG003|Overall Study|Other|9|||
145686309|NCT00742560|525364970|FG004|Overall Study|Other|9|||
145686310|NCT00742560|525364966|FG000|Overall Study|MIssing|0|||
145686311|NCT00742560|525364967|FG001|Overall Study|MIssing|0|||
145686312|NCT00742560|525364968|FG002|Overall Study|MIssing|0|||
145686313|NCT00742560|525364969|FG003|Overall Study|MIssing|0|||
145686314|NCT00742560|525364970|FG004|Overall Study|MIssing|1|||
145686315|NCT01536795|525364972|FG000|Overall Study|Lost to Follow-up|0|||
145686316|NCT01536795|525364973|FG001|Overall Study|Lost to Follow-up|2|||
145686317|NCT01536795|525364972|FG000|Overall Study|Lack of Efficacy|1|||
145491255|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
145686318|NCT01536795|525364973|FG001|Overall Study|Lack of Efficacy|0|||
145686319|NCT00658632|525364976|FG000|Overall Study|Adverse Event|13|||
145686320|NCT00658632|525364977|FG001|Overall Study|Adverse Event|11|||
145686321|NCT00658632|525364976|FG000|Overall Study|Lost to Follow-up|25|||
145686322|NCT00658632|525364977|FG001|Overall Study|Lost to Follow-up|23|||
145686323|NCT00658632|525364976|FG000|Overall Study|Withdrawal by Subject|10|||
145686324|NCT00658632|525364977|FG001|Overall Study|Withdrawal by Subject|7|||
145686325|NCT00658632|525364976|FG000|Overall Study|Lack of Efficacy|0|||
145686326|NCT00658632|525364977|FG001|Overall Study|Lack of Efficacy|1|||
145686327|NCT00658632|525364976|FG000|Overall Study|Withdrawal of consent|8|||
145686328|NCT00658632|525364977|FG001|Overall Study|Withdrawal of consent|14|||
145686329|NCT00658632|525364976|FG000|Overall Study|Pregnancy|1|||
145686330|NCT00658632|525364977|FG001|Overall Study|Pregnancy|1|||
145686331|NCT00658632|525364976|FG000|Overall Study|Other|7|||
145686332|NCT00658632|525364977|FG001|Overall Study|Other|8|||
145686333|NCT02632045|525364982|FG000|Overall Study|Withdrawal by Subject|1|||
145686334|NCT02632045|525364983|FG001|Overall Study|Withdrawal by Subject|2|||
145686335|NCT05878522|525364984|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686336|NCT05878522|525364985|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686337|NCT05878522|525364986|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686338|NCT05878522|525364987|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686339|NCT05878522|525364988|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686340|NCT05878522|525364989|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686341|NCT05878522|525364990|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686342|NCT05878522|525364991|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686343|NCT05878522|525364992|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
145686344|NCT05878522|525364993|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686345|NCT05878522|525364994|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686346|NCT05878522|525364995|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
145686347|NCT05878522|525364984|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
145686348|NCT05878522|525364985|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686349|NCT05878522|525364986|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686350|NCT05878522|525364987|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686351|NCT05878522|525364988|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686352|NCT05878522|525364989|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686353|NCT05878522|525364990|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686354|NCT05878522|525364991|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686355|NCT05878522|525364992|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686356|NCT05878522|525364993|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
145686357|NCT05878522|525364994|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686358|NCT05878522|525364995|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
145686359|NCT05878522|525364984|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686360|NCT05878522|525364985|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
145686361|NCT05878522|525364986|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686362|NCT05878522|525364987|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
145686363|NCT05878522|525364988|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686364|NCT05878522|525364989|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686365|NCT05878522|525364990|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686366|NCT05878522|525364991|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686367|NCT05878522|525364992|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686368|NCT05878522|525364993|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686369|NCT05878522|525364994|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686370|NCT05878522|525364995|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
145686371|NCT05878522|525364984|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686372|NCT05878522|525364985|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686373|NCT05878522|525364986|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686374|NCT05878522|525364987|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686375|NCT05878522|525364988|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
145686376|NCT05878522|525364989|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686377|NCT05878522|525364990|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686378|NCT05878522|525364991|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686379|NCT05878522|525364992|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686380|NCT05878522|525364993|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686381|NCT05878522|525364994|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686382|NCT05878522|525364995|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
145686383|NCT00617708|525364999|FG000|Overall Study|Adverse Event|0|||
145686384|NCT00617708|525365000|FG001|Overall Study|Adverse Event|6|||
145686385|NCT00617708|525365001|FG002|Overall Study|Adverse Event|9|||
145686386|NCT00617708|525364999|FG000|Overall Study|Withdrawal by Subject|1|||
145686387|NCT00617708|525365000|FG001|Overall Study|Withdrawal by Subject|1|||
145686388|NCT00617708|525365001|FG002|Overall Study|Withdrawal by Subject|7|||
145686389|NCT00617708|525364999|FG000|Overall Study|Death|0|||
145491256|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
145491257|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
145491258|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
145686390|NCT00617708|525365000|FG001|Overall Study|Death|6|||
145686391|NCT00617708|525365001|FG002|Overall Study|Death|5|||
145686392|NCT00617708|525364999|FG000|Overall Study|Progression/Relapse|7|||
145686393|NCT00617708|525365000|FG001|Overall Study|Progression/Relapse|40|||
145686394|NCT00617708|525365001|FG002|Overall Study|Progression/Relapse|36|||
145686395|NCT00617708|525364999|FG000|Overall Study|Not protocol specified|1|||
145686396|NCT00617708|525365000|FG001|Overall Study|Not protocol specified|4|||
145686397|NCT00617708|525365001|FG002|Overall Study|Not protocol specified|2|||
145686398|NCT00617708|525364999|FG000|Overall Study|Not eligible|1|||
145686399|NCT00617708|525365000|FG001|Overall Study|Not eligible|3|||
145686400|NCT00617708|525365001|FG002|Overall Study|Not eligible|5|||
145686401|NCT05615870|525365002|FG000|Overall Study|Lost to Follow-up|10|||
145686402|NCT05615870|525365003|FG001|Overall Study|Lost to Follow-up|13|||
145686403|NCT05615870|525365002|FG000|Overall Study|Physician Decision|2|||
145686404|NCT05615870|525365003|FG001|Overall Study|Physician Decision|0|||
145686405|NCT05615870|525365002|FG000|Overall Study|Withdrawal by Subject|0|||
145686406|NCT05615870|525365003|FG001|Overall Study|Withdrawal by Subject|2|||
145686407|NCT05615870|525365002|FG000|Overall Study|Protocol Violation|0|||
145686408|NCT05615870|525365003|FG001|Overall Study|Protocol Violation|3|||
145686409|NCT05615870|525365002|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
145686410|NCT05615870|525365003|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
145686411|NCT05615870|525365002|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
145686412|NCT05615870|525365003|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
145686413|NCT05615870|525365002|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
145686414|NCT05615870|525365003|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
145686415|NCT01760876|525365004|FG000|Overall Study|Non-cardiac death (head injury)|1|||
145686416|NCT01760876|525365004|FG000|Overall Study|Carcinoma of prostate|1|||
145686417|NCT01760876|525365004|FG000|Overall Study|Impaired renal function|1|||
145686418|NCT01760876|525365004|FG000|Overall Study|Major depression|1|||
145686419|NCT01760876|525365004|FG000|Overall Study|Very poor baseline OCT quality|2|||
145686420|NCT00732498|525365005|FG000|Overall Study|Ineligible|1|||
145686421|NCT00732498|525365005|FG000|Overall Study|Adverse Event|2|||
145686422|NCT00732498|525365005|FG000|Overall Study|Physician Decision|3|||
145686423|NCT00267865|525365010|FG000|Induction Treatment|Died before completing.|2|||
145686424|NCT00267865|525365010|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
145686425|NCT03686176|525365011|FG000|Overall Study|Procedure cancelled|1|||
145686426|NCT03686176|525365012|FG001|Overall Study|Procedure cancelled|0|||
145686427|NCT03686176|525365013|FG002|Overall Study|Procedure cancelled|0|||
145686428|NCT03686176|525365011|FG000|Overall Study|VR Malfunction|1|||
145686429|NCT03686176|525365012|FG001|Overall Study|VR Malfunction|0|||
145686430|NCT03686176|525365013|FG002|Overall Study|VR Malfunction|0|||
145686431|NCT04295499|525365018|FG000|Overall Study|moving out of state|1|||
145686432|NCT04295499|525365019|FG001|Overall Study|moving out of state|0|||
145686433|NCT04295499|525365018|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
145686434|NCT04295499|525365019|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
145686435|NCT00308113|525365022|FG000|Overall Study|Protocol closure|0|||
145686436|NCT00308113|525365023|FG001|Overall Study|Protocol closure|0|||
145686437|NCT00308113|525365024|FG002|Overall Study|Protocol closure|0|||
145686438|NCT00308113|525365025|FG003|Overall Study|Protocol closure|1|||
145686439|NCT04448561|525365026|FG000|Overall Study|Noncompliance|1|||
145686440|NCT04448561|525365027|FG001|Overall Study|Noncompliance|0|||
145686441|NCT02878590|525366594|FG000|Overall Study|Withdrawal by Subject|2|||
145686442|NCT03050372|525366596|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
145686443|NCT03050372|525366597|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
145686444|NCT03050372|525366596|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
145686445|NCT03050372|525366597|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
145686446|NCT02123797|525366600|FG000|Baseline Intervention|Death|9|||
145686447|NCT02123797|525366601|FG001|Baseline Intervention|Death|16|||
145686448|NCT02123797|525366602|FG002|Baseline Intervention|Death|0|||
145686449|NCT02123797|525366603|FG003|Baseline Intervention|Death|0|||
145686450|NCT02123797|525366604|FG004|Baseline Intervention|Death|0|||
145686451|NCT02123797|525366600|FG000|Baseline Intervention|Withdrawal by Subject|2|||
145686452|NCT02123797|525366601|FG001|Baseline Intervention|Withdrawal by Subject|8|||
145686453|NCT02123797|525366602|FG002|Baseline Intervention|Withdrawal by Subject|0|||
145686454|NCT02123797|525366603|FG003|Baseline Intervention|Withdrawal by Subject|0|||
145686455|NCT02123797|525366604|FG004|Baseline Intervention|Withdrawal by Subject|0|||
145686456|NCT02123797|525366600|FG000|Baseline Intervention|Relocation|2|||
145686457|NCT02123797|525366601|FG001|Baseline Intervention|Relocation|0|||
145686458|NCT02123797|525366602|FG002|Baseline Intervention|Relocation|0|||
145686459|NCT02123797|525366603|FG003|Baseline Intervention|Relocation|0|||
145686460|NCT02123797|525366604|FG004|Baseline Intervention|Relocation|0|||
145686461|NCT02123797|525366600|FG000|Baseline Intervention|Out of window for initial survey|6|||
145686462|NCT02123797|525366601|FG001|Baseline Intervention|Out of window for initial survey|13|||
145686463|NCT02123797|525366602|FG002|Baseline Intervention|Out of window for initial survey|0|||
145686464|NCT02123797|525366603|FG003|Baseline Intervention|Out of window for initial survey|0|||
145686465|NCT02123797|525366604|FG004|Baseline Intervention|Out of window for initial survey|0|||
145686466|NCT02123797|525366600|FG000|Baseline Intervention|Lost to Follow-up|0|||
145686467|NCT02123797|525366601|FG001|Baseline Intervention|Lost to Follow-up|5|||
145686468|NCT02123797|525366602|FG002|Baseline Intervention|Lost to Follow-up|0|||
145686469|NCT02123797|525366603|FG003|Baseline Intervention|Lost to Follow-up|0|||
145686470|NCT02123797|525366604|FG004|Baseline Intervention|Lost to Follow-up|0|||
145686471|NCT02123797|525366600|FG000|Baseline Intervention|Other Disease|3|||
145686472|NCT02123797|525366601|FG001|Baseline Intervention|Other Disease|0|||
145686473|NCT02123797|525366602|FG002|Baseline Intervention|Other Disease|0|||
145686474|NCT02123797|525366603|FG003|Baseline Intervention|Other Disease|0|||
145686475|NCT02123797|525366604|FG004|Baseline Intervention|Other Disease|0|||
145686476|NCT02123797|525366600|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
145686477|NCT02123797|525366601|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
145686478|NCT02123797|525366602|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
145686479|NCT02123797|525366603|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
145686480|NCT02123797|525366604|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
145686481|NCT02123797|525366600|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
145686482|NCT02123797|525366601|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
145686483|NCT02123797|525366602|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
145686484|NCT02123797|525366603|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
145686485|NCT02123797|525366604|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
145686486|NCT02123797|525366600|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
145686487|NCT02123797|525366601|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
145686488|NCT02123797|525366602|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686489|NCT02123797|525366603|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686490|NCT02123797|525366604|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686491|NCT02123797|525366600|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
145686492|NCT02123797|525366601|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
145686493|NCT02123797|525366602|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
145686494|NCT02123797|525366603|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
145686495|NCT02123797|525366604|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
145686496|NCT02123797|525366600|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
145686497|NCT02123797|525366601|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
145686498|NCT02123797|525366602|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
145686499|NCT02123797|525366603|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
145686500|NCT02123797|525366604|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
145686501|NCT02123797|525366600|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
145686502|NCT02123797|525366601|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
145686503|NCT02123797|525366602|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
145686504|NCT02123797|525366603|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
145686505|NCT02123797|525366604|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
145686506|NCT02123797|525366600|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
145686507|NCT02123797|525366601|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
145686508|NCT02123797|525366602|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
145686509|NCT02123797|525366603|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
145686510|NCT02123797|525366604|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
145686511|NCT02123797|525366600|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
145686512|NCT02123797|525366601|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
145686513|NCT02123797|525366602|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686514|NCT02123797|525366603|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686515|NCT02123797|525366604|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
145686516|NCT02123797|525366600|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
145686517|NCT02123797|525366601|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
145686518|NCT02123797|525366602|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
145686519|NCT02123797|525366603|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
145686520|NCT02123797|525366604|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
145686521|NCT05878990|525366605|FG000|Overall Study|Lost to Follow-up|7|||
145686522|NCT05878990|525366605|FG000|Overall Study|Withdrawal by Subject|1|||
145686523|NCT00396409|525366613|FG000|Period 1 - 2007|Adverse Event|0|||
145686524|NCT00396409|525366614|FG001|Period 1 - 2007|Adverse Event|1|||
145686525|NCT00396409|525366613|FG000|Period 1 - 2007|Lack of Efficacy|0|||
145686526|NCT00396409|525366614|FG001|Period 1 - 2007|Lack of Efficacy|1|||
145686527|NCT00396409|525366613|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
145686528|NCT00396409|525366614|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
145686529|NCT00396409|525366613|FG000|Period 1 - 2007|Lost to Follow-up|2|||
145686530|NCT00396409|525366614|FG001|Period 1 - 2007|Lost to Follow-up|3|||
145686531|NCT00396409|525366613|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
145686532|NCT00396409|525366614|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
145686533|NCT00396409|525366613|FG000|Period 2 - 2008|Protocol Violation|1|||
145686534|NCT00396409|525366614|FG001|Period 2 - 2008|Protocol Violation|0|||
145686535|NCT00396409|525366613|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
145686536|NCT00396409|525366614|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
145686537|NCT00396409|525366613|FG000|Period 2 - 2008|Lost to Follow-up|3|||
145686538|NCT00396409|525366614|FG001|Period 2 - 2008|Lost to Follow-up|1|||
145686539|NCT00331799|525366615|FG000|Overall Study|Withdrawal by Subject|2|||
145686540|NCT00331799|525366615|FG000|Overall Study|Sedation|1|||
145686541|NCT02889809|525366616|FG000|Overall Study|Withdrawal by Subject|30|||
145686542|NCT02889809|525366617|FG001|Overall Study|Withdrawal by Subject|21|||
145686543|NCT02889809|525366616|FG000|Overall Study|Lost to Follow-up|1|||
145686544|NCT02889809|525366617|FG001|Overall Study|Lost to Follow-up|1|||
145686545|NCT02889809|525366616|FG000|Overall Study|Site Closed|12|||
145686546|NCT02889809|525366617|FG001|Overall Study|Site Closed|11|||
145686547|NCT04203199|525366620|FG000|First Intervention Period|Lost to Follow-up|0|||
145686548|NCT04203199|525366621|FG001|First Intervention Period|Lost to Follow-up|1|||
145686549|NCT04203199|525366620|FG000|Second Intervention Period|Medication change|1|||
145686550|NCT04203199|525366621|FG001|Second Intervention Period|Medication change|0|||
145686551|NCT02186015|525366630|FG000|Overall Study|Physician Decision|1|||
145686552|NCT02186015|525366631|FG001|Overall Study|Physician Decision|0|||
145686553|NCT01837719|525366634|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
145686554|NCT01837719|525366634|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
145686555|NCT01703988|525366635|FG000|Overall Study|Investigator Judgment|0|||
145686556|NCT01703988|525366636|FG001|Overall Study|Investigator Judgment|0|||
145686557|NCT01703988|525366637|FG002|Overall Study|Investigator Judgment|0|||
145686558|NCT01703988|525366638|FG003|Overall Study|Investigator Judgment|1|||
145686559|NCT02995733|525366639|FG000|Overall Study|Study site closed|9|||
145686560|NCT02995733|525366640|FG001|Overall Study|Study site closed|10|||
145686561|NCT02995733|525366639|FG000|Overall Study|Death|3|||
145686562|NCT02995733|525366640|FG001|Overall Study|Death|4|||
145686563|NCT02995733|525366639|FG000|Overall Study|Withdrawal by Subject|6|||
145686564|NCT02995733|525366640|FG001|Overall Study|Withdrawal by Subject|2|||
145686565|NCT02995733|525366639|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
145686566|NCT02995733|525366640|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
145686567|NCT02995733|525366639|FG000|Overall Study|Lost to Follow-up|48|||
145686568|NCT02995733|525366640|FG001|Overall Study|Lost to Follow-up|37|||
145686569|NCT02995733|525366639|FG000|Overall Study|Other|0|||
145686570|NCT02995733|525366640|FG001|Overall Study|Other|1|||
145686571|NCT02720198|525366641|FG000|Overall Study|Withdrawal by Subject|0|||
145686572|NCT02720198|525366642|FG001|Overall Study|Withdrawal by Subject|1|||
145686573|NCT01403805|525366645|FG000|Overall Study|Withdrawal by Subject|0|||
145686574|NCT01403805|525366646|FG001|Overall Study|Withdrawal by Subject|4|||
145686575|NCT01403805|525366645|FG000|Overall Study|Lost to Follow-up|0|||
145686576|NCT01403805|525366646|FG001|Overall Study|Lost to Follow-up|2|||
145686577|NCT01403805|525366645|FG000|Overall Study|Death|0|||
145686578|NCT01403805|525366646|FG001|Overall Study|Death|1|||
145686579|NCT00147745|525366647|FG000|Overall Study|Withdrawal by Subject|1|||
145686580|NCT00147745|525366648|FG001|Overall Study|Withdrawal by Subject|0|||
145686581|NCT00147745|525366649|FG002|Overall Study|Withdrawal by Subject|0|||
145686582|NCT00316121|525366653|FG000|Overall Study|Death|1|||
145686583|NCT00316121|525366654|FG001|Overall Study|Death|0|||
145686584|NCT00316121|525366653|FG000|Overall Study|Lost to Follow-up|14|||
145686585|NCT00316121|525366654|FG001|Overall Study|Lost to Follow-up|8|||
145686586|NCT00316121|525366653|FG000|Overall Study|Withdrawal by Subject|2|||
145686587|NCT00316121|525366654|FG001|Overall Study|Withdrawal by Subject|0|||
145686588|NCT00316121|525366653|FG000|Overall Study|Reason is missing|1|||
145686589|NCT00316121|525366654|FG001|Overall Study|Reason is missing|0|||
145686590|NCT00316121|525366653|FG000|Overall Study|Subject relocated|1|||
145686591|NCT00316121|525366654|FG001|Overall Study|Subject relocated|1|||
145686592|NCT00316121|525366653|FG000|Overall Study|Subject refused to return|1|||
145686593|NCT00316121|525366654|FG001|Overall Study|Subject refused to return|0|||
145686594|NCT00316121|525366653|FG000|Overall Study|Subject no show for visit x 3|1|||
145686595|NCT00316121|525366654|FG001|Overall Study|Subject no show for visit x 3|0|||
145686596|NCT00316121|525366653|FG000|Overall Study|Subject did not have 24 month visit|1|||
145686597|NCT00316121|525366654|FG001|Overall Study|Subject did not have 24 month visit|0|||
145686598|NCT00442559|525366655|FG000|Overall Study|Lost to Follow-up|32|||
145686599|NCT00442559|525366656|FG001|Overall Study|Lost to Follow-up|34|||
145686600|NCT00442559|525366655|FG000|Overall Study|Protocol Violation|1|||
145686601|NCT00442559|525366656|FG001|Overall Study|Protocol Violation|1|||
145686602|NCT00442559|525366655|FG000|Overall Study|Withdrawal by Subject|1|||
145686603|NCT00442559|525366656|FG001|Overall Study|Withdrawal by Subject|0|||
145686604|NCT01812837|525366664|FG000|Overall Study|Lost to Follow-up|1|||
145686605|NCT01812837|525366665|FG001|Overall Study|Lost to Follow-up|1|||
145686606|NCT01812837|525366666|FG002|Overall Study|Lost to Follow-up|0|||
145686607|NCT01812837|525366664|FG000|Overall Study|Protocol Violation|1|||
145686608|NCT01812837|525366665|FG001|Overall Study|Protocol Violation|0|||
145686609|NCT01812837|525366666|FG002|Overall Study|Protocol Violation|0|||
145686610|NCT05234632|525366667|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
145686611|NCT05234632|525366668|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
145686612|NCT05234632|525366667|FG000|Overall Study|Withdrawal by Subject|2|||
145686613|NCT05234632|525366668|FG001|Overall Study|Withdrawal by Subject|0|||
145686614|NCT05234632|525366667|FG000|Overall Study|Adverse Event|0|||
145686615|NCT05234632|525366668|FG001|Overall Study|Adverse Event|4|||
145686616|NCT05234632|525366667|FG000|Overall Study|Physician Decision|1|||
145686617|NCT05234632|525366668|FG001|Overall Study|Physician Decision|1|||
145686618|NCT05234632|525366667|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
145686619|NCT05234632|525366668|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
145686620|NCT05234632|525366667|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
145686621|NCT05234632|525366668|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
145686622|NCT04799587|525366669|FG000|Overall Study|Withdrawal by Subject|0|||
145686623|NCT04799587|525366670|FG001|Overall Study|Withdrawal by Subject|1|||
145686624|NCT04985604|525366671|FG000|Overall Study|Death|4|||
145686625|NCT04985604|525366672|FG001|Overall Study|Death|6|||
145686626|NCT04985604|525366671|FG000|Overall Study|Withdrawal by Subject|0|||
145686627|NCT04985604|525366672|FG001|Overall Study|Withdrawal by Subject|1|||
145686628|NCT04598776|525366673|FG000|Overall Study|Protocol Violation|5|||
145686629|NCT04598776|525366673|FG000|Overall Study|Physician Decision|4|||
145686630|NCT00348283|525366674|FG000|Induction|Adverse Event|0|||
145686631|NCT00348283|525366675|FG001|Induction|Adverse Event|2|||
145686632|NCT00348283|525366674|FG000|Induction|Protocol Violation|0|||
145686633|NCT00348283|525366675|FG001|Induction|Protocol Violation|4|||
145686634|NCT00348283|525366674|FG000|Double Blind|Adverse Event|2|||
145686635|NCT00348283|525366675|FG001|Double Blind|Adverse Event|5|||
145686636|NCT00348283|525366674|FG000|Double Blind|Withdrawal by Subject|1|||
145686637|NCT00348283|525366675|FG001|Double Blind|Withdrawal by Subject|1|||
145686638|NCT00348283|525366674|FG000|Double Blind|Protocol Violation|0|||
145686639|NCT00348283|525366675|FG001|Double Blind|Protocol Violation|1|||
145686640|NCT00348283|525366674|FG000|Double Blind|Lack of Efficacy|2|||
145686641|NCT00348283|525366675|FG001|Double Blind|Lack of Efficacy|2|||
145686642|NCT00348283|525366674|FG000|Double Blind|Pregnancy|0|||
145686643|NCT00348283|525366675|FG001|Double Blind|Pregnancy|1|||
145686644|NCT00348283|525366674|FG000|Open Label|Adverse Event|0|||
145686645|NCT00348283|525366675|FG001|Open Label|Adverse Event|8|||
145686646|NCT00348283|525366674|FG000|Open Label|Withdrawal by Subject|0|||
145686647|NCT00348283|525366675|FG001|Open Label|Withdrawal by Subject|4|||
145686648|NCT00348283|525366674|FG000|Open Label|Lost to Follow-up|0|||
145686649|NCT00348283|525366675|FG001|Open Label|Lost to Follow-up|1|||
145686650|NCT00348283|525366674|FG000|Open Label|Lack of Efficacy|0|||
145686651|NCT00348283|525366675|FG001|Open Label|Lack of Efficacy|13|||
145686652|NCT00348283|525366674|FG000|Open Label|Administrative reasons|0|||
145686653|NCT00348283|525366675|FG001|Open Label|Administrative reasons|5|||
145686654|NCT00348283|525366674|FG000|Open Label|Subject moved to the United States|0|||
145686655|NCT00348283|525366675|FG001|Open Label|Subject moved to the United States|1|||
145686656|NCT00348283|525366674|FG000|Open Label|Pregnancy|0|||
145686657|NCT00348283|525366675|FG001|Open Label|Pregnancy|1|||
145686658|NCT00348283|525366674|FG000|Open Label|Sponsor decision|0|||
145686659|NCT00348283|525366675|FG001|Open Label|Sponsor decision|1|||
145686660|NCT02282761|525366678|FG000|Overall Study|Death|0|||
145686661|NCT02282761|525366679|FG001|Overall Study|Death|0|||
145686662|NCT02282761|525366680|FG002|Overall Study|Death|1|||
145686663|NCT02282761|525366678|FG000|Overall Study|Adverse Event|6|||
145686664|NCT02282761|525366679|FG001|Overall Study|Adverse Event|2|||
145686665|NCT02282761|525366680|FG002|Overall Study|Adverse Event|0|||
145686666|NCT02282761|525366678|FG000|Overall Study|Lack of Efficacy|11|||
145686667|NCT02282761|525366679|FG001|Overall Study|Lack of Efficacy|6|||
145686668|NCT02282761|525366680|FG002|Overall Study|Lack of Efficacy|17|||
145686669|NCT02282761|525366678|FG000|Overall Study|Lost to Follow-up|2|||
145686670|NCT02282761|525366679|FG001|Overall Study|Lost to Follow-up|2|||
145686671|NCT02282761|525366680|FG002|Overall Study|Lost to Follow-up|1|||
145686672|NCT02282761|525366678|FG000|Overall Study|Physician Decision|0|||
145686673|NCT02282761|525366679|FG001|Overall Study|Physician Decision|0|||
145686674|NCT02282761|525366680|FG002|Overall Study|Physician Decision|2|||
145686675|NCT02282761|525366678|FG000|Overall Study|Withdrawal by Subject|8|||
145686676|NCT02282761|525366679|FG001|Overall Study|Withdrawal by Subject|10|||
145686677|NCT02282761|525366680|FG002|Overall Study|Withdrawal by Subject|16|||
145686678|NCT02282761|525366678|FG000|Overall Study|Other|3|||
145686679|NCT02282761|525366679|FG001|Overall Study|Other|2|||
145686680|NCT02282761|525366680|FG002|Overall Study|Other|1|||
145686681|NCT06312566|525366681|FG000|Overall Study|Protocol Violation|0|||
145686682|NCT06312566|525366682|FG001|Overall Study|Protocol Violation|1|||
145686683|NCT04551053|525366683|FG000|Overall Study|Death|10|||
145686684|NCT04551053|525366684|FG001|Overall Study|Death|9|||
145686685|NCT04551053|525366683|FG000|Overall Study|Lost to Follow-up|0|||
145686686|NCT04551053|525366684|FG001|Overall Study|Lost to Follow-up|2|||
145686687|NCT04551053|525366683|FG000|Overall Study|Study Terminated by Sponsor|57|||
145686688|NCT04551053|525366684|FG001|Overall Study|Study Terminated by Sponsor|65|||
145686689|NCT04551053|525366683|FG000|Overall Study|Withdrawal by Subject|12|||
145686690|NCT04551053|525366684|FG001|Overall Study|Withdrawal by Subject|5|||
145686691|NCT04551053|525366683|FG000|Overall Study|Adverse Event|2|||
145686692|NCT04551053|525366684|FG001|Overall Study|Adverse Event|0|||
145686693|NCT04551053|525366683|FG000|Overall Study|Lack of Efficacy|2|||
145686694|NCT04551053|525366684|FG001|Overall Study|Lack of Efficacy|1|||
145686695|NCT04551053|525366683|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
145686696|NCT04551053|525366684|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
145686697|NCT04551053|525366683|FG000|Overall Study|Splenapendectomi|1|||
145686698|NCT04551053|525366684|FG001|Overall Study|Splenapendectomi|0|||
145686699|NCT04551053|525366683|FG000|Overall Study|Medical Decision|1|||
145686700|NCT04551053|525366684|FG001|Overall Study|Medical Decision|1|||
145686701|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
145686702|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
145686703|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
145686704|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
145686705|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
145686706|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
145686707|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
145686708|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
145686709|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
145686710|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
145686711|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
145686712|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
145686713|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
145686714|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
145686715|NCT02971683|525366685|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
145686716|NCT02971683|525366686|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
145686717|NCT02971683|525366685|FG000|Open-Label|Lost to Follow-up|1|||
145686718|NCT02971683|525366686|FG001|Open-Label|Lost to Follow-up|0|||
145686719|NCT02971683|525366685|FG000|Open-Label|Participants withdrew consent|0|||
145686720|NCT02971683|525366686|FG001|Open-Label|Participants withdrew consent|2|||
145686721|NCT02971683|525366685|FG000|Open-Label|Participant request to discontinue study treatment|1|||
145686722|NCT02971683|525366686|FG001|Open-Label|Participant request to discontinue study treatment|0|||
145686723|NCT02971683|525366685|FG000|Open-Label|Lack of Efficacy|2|||
145686724|NCT02971683|525366686|FG001|Open-Label|Lack of Efficacy|0|||
145686725|NCT02971683|525366685|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
145686726|NCT02971683|525366686|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
145686727|NCT02971683|525366685|FG000|Long-Term Open Label|Participant withdrew consent|1|||
145686728|NCT02971683|525366686|FG001|Long-Term Open Label|Participant withdrew consent|0|||
145686729|NCT02971683|525366685|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
145686730|NCT02971683|525366686|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
145686731|NCT02971683|525366685|FG000|Long-Term Open Label|Adverse Event|1|||
145686732|NCT02971683|525366686|FG001|Long-Term Open Label|Adverse Event|2|||
145686733|NCT02971683|525366685|FG000|Long-Term Open Label|Lack of Efficacy|1|||
145686734|NCT02971683|525366686|FG001|Long-Term Open Label|Lack of Efficacy|1|||
145686735|NCT03747575|525366692|FG000|Overall Study|Withdrawal by Subject|6|||
145686736|NCT03747575|525366693|FG001|Overall Study|Withdrawal by Subject|3|||
145686737|NCT03747575|525366692|FG000|Overall Study|Lost to Follow-up|3|||
145686738|NCT03747575|525366693|FG001|Overall Study|Lost to Follow-up|3|||
145686739|NCT03747575|525366692|FG000|Overall Study|Adverse Event|0|||
145686740|NCT03747575|525366693|FG001|Overall Study|Adverse Event|1|||
145686741|NCT02924051|525366698|FG000|Overall Study|Withdrawal by Subject|1|||
145686742|NCT02924051|525366699|FG001|Overall Study|Withdrawal by Subject|9|||
145686743|NCT03005106|525366703|FG000|Overall Study|Lost to Follow-up|16|||
145686744|NCT03005106|525366703|FG000|Overall Study|Adverse Event|1|||
145686745|NCT03005106|525366703|FG000|Overall Study|Physician Decision|1|||
145686746|NCT03005106|525366703|FG000|Overall Study|Death|2|||
145686747|NCT00936065|525366704|FG000|Overall Study|Adverse Event|1|||
145686748|NCT00936065|525366705|FG001|Overall Study|Adverse Event|0|||
145686749|NCT00936065|525366706|FG002|Overall Study|Adverse Event|1|||
145686750|NCT00936065|525366704|FG000|Overall Study|Lack of Efficacy|1|||
145686751|NCT00936065|525366705|FG001|Overall Study|Lack of Efficacy|0|||
145686752|NCT00936065|525366706|FG002|Overall Study|Lack of Efficacy|1|||
145686753|NCT00936065|525366704|FG000|Overall Study|Lost to Follow-up|1|||
145686754|NCT00936065|525366705|FG001|Overall Study|Lost to Follow-up|0|||
145686755|NCT00936065|525366706|FG002|Overall Study|Lost to Follow-up|0|||
145686756|NCT00936065|525366704|FG000|Overall Study|Protocol Violation|1|||
145686757|NCT00936065|525366705|FG001|Overall Study|Protocol Violation|2|||
145686758|NCT00936065|525366706|FG002|Overall Study|Protocol Violation|1|||
145686759|NCT00936065|525366704|FG000|Overall Study|Withdrawal by Subject|0|||
145686760|NCT00936065|525366705|FG001|Overall Study|Withdrawal by Subject|2|||
145686761|NCT00936065|525366706|FG002|Overall Study|Withdrawal by Subject|4|||
145686762|NCT02389894|525366707|FG000|Overall Study|Death|4|||
145686763|NCT02389894|525366708|FG001|Overall Study|Death|5|||
145686764|NCT02389894|525366709|FG002|Overall Study|Death|3|||
145686765|NCT02389894|525366707|FG000|Overall Study|Withdrawal by Subject|2|||
145686766|NCT02389894|525366708|FG001|Overall Study|Withdrawal by Subject|4|||
145686767|NCT02389894|525366709|FG002|Overall Study|Withdrawal by Subject|5|||
145686768|NCT02389894|525366707|FG000|Overall Study|Lost to Follow-up|2|||
145686769|NCT02389894|525366708|FG001|Overall Study|Lost to Follow-up|1|||
145686770|NCT02389894|525366709|FG002|Overall Study|Lost to Follow-up|1|||
145686771|NCT01429285|525366712|FG000|Overall Study|Protocol Violation|9|||
145686772|NCT01429285|525366713|FG001|Overall Study|Protocol Violation|4|||
145686773|NCT01429285|525366712|FG000|Overall Study|Missing Data|5|||
145686774|NCT01429285|525366713|FG001|Overall Study|Missing Data|3|||
145686775|NCT01429285|525366712|FG000|Overall Study|Erroneously Enrolled Twice|8|||
145686776|NCT01429285|525366713|FG001|Overall Study|Erroneously Enrolled Twice|2|||
145686777|NCT01549951|525366714|FG000|Overall Study|Adverse Event|15|||
145686778|NCT01549951|525366714|FG000|Overall Study|Withdrawal by Subject|2|||
145686779|NCT01549951|525366714|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
145686780|NCT01549951|525366714|FG000|Overall Study|Progressive disease|29|||
145686781|NCT01549951|525366714|FG000|Overall Study|Symptomatic deterioration|1|||
145686782|NCT01549951|525366714|FG000|Overall Study|Other|2|||
145686783|NCT00738400|525366715|FG000|Overall Study|Adverse Event|3|||
145686784|NCT00738400|525366716|FG001|Overall Study|Adverse Event|1|||
145686785|NCT00738400|525366715|FG000|Overall Study|Withdrawal by Subject|0|||
145686786|NCT00738400|525366716|FG001|Overall Study|Withdrawal by Subject|1|||
145686787|NCT00738400|525366715|FG000|Overall Study|Lack of Efficacy|0|||
145686788|NCT00738400|525366716|FG001|Overall Study|Lack of Efficacy|1|||
145686789|NCT00738400|525366715|FG000|Overall Study|Lost to Follow-up|0|||
145686790|NCT00738400|525366716|FG001|Overall Study|Lost to Follow-up|3|||
145686791|NCT00738400|525366715|FG000|Overall Study|Protocol Violation|1|||
145686792|NCT00738400|525366716|FG001|Overall Study|Protocol Violation|0|||
145686793|NCT00738400|525366715|FG000|Overall Study|Non-compliant with study medication|0|||
145686794|NCT00738400|525366716|FG001|Overall Study|Non-compliant with study medication|1|||
145686795|NCT01052714|525366723|FG000|Overall Study|Adverse Event|6|||
145686796|NCT01052714|525366724|FG001|Overall Study|Adverse Event|3|||
145686797|NCT01052714|525366725|FG002|Overall Study|Adverse Event|0|||
145686798|NCT01052714|525366723|FG000|Overall Study|Death|1|||
145686799|NCT01052714|525366724|FG001|Overall Study|Death|2|||
145686800|NCT01052714|525366725|FG002|Overall Study|Death|0|||
145686801|NCT01052714|525366723|FG000|Overall Study|Lost to Follow-up|2|||
145686802|NCT01052714|525366724|FG001|Overall Study|Lost to Follow-up|3|||
145686803|NCT01052714|525366725|FG002|Overall Study|Lost to Follow-up|0|||
145686804|NCT01052714|525366723|FG000|Overall Study|Physician Decision|9|||
145686805|NCT01052714|525366724|FG001|Overall Study|Physician Decision|9|||
145686806|NCT01052714|525366725|FG002|Overall Study|Physician Decision|1|||
145686807|NCT01052714|525366723|FG000|Overall Study|Withdrawal by Subject|7|||
145686808|NCT01052714|525366724|FG001|Overall Study|Withdrawal by Subject|12|||
145686809|NCT01052714|525366725|FG002|Overall Study|Withdrawal by Subject|1|||
145686810|NCT03689452|525366732|FG000|Overall Study|Lost to Follow-up|1|||
145686811|NCT03689452|525366733|FG001|Overall Study|Lost to Follow-up|1|||
145686812|NCT02676778|525366734|FG000|Overall Study|Disease Progression|7|||
145686813|NCT02676778|525366735|FG001|Overall Study|Disease Progression|3|||
145686814|NCT02676778|525366736|FG002|Overall Study|Disease Progression|1|||
145686815|NCT02676778|525366734|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
145491259|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
145491260|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
145686816|NCT02676778|525366735|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
145686817|NCT02676778|525366736|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
145686818|NCT02676778|525366734|FG000|Overall Study|Withdrawal by Subject|3|||
145686819|NCT02676778|525366735|FG001|Overall Study|Withdrawal by Subject|2|||
145686820|NCT02676778|525366736|FG002|Overall Study|Withdrawal by Subject|0|||
145686821|NCT02676778|525366734|FG000|Overall Study|Other|4|||
145686822|NCT02676778|525366735|FG001|Overall Study|Other|3|||
145686823|NCT02676778|525366736|FG002|Overall Study|Other|0|||
145686824|NCT02676778|525366734|FG000|Overall Study|Adverse Event|2|||
145686825|NCT02676778|525366735|FG001|Overall Study|Adverse Event|3|||
145686826|NCT02676778|525366736|FG002|Overall Study|Adverse Event|0|||
145686827|NCT03214198|525366742|FG000|Overall Study|Case Report Forms Uncollected|18|||
145686828|NCT03214198|525366742|FG000|Overall Study|Protocol Deviation|18|||
145686829|NCT04413149|525368325|FG000|Overall Study|Death|10|||
145686830|NCT04413149|525368326|FG001|Overall Study|Death|5|||
145686831|NCT04413149|525368325|FG000|Overall Study|Lung transplantation|1|||
145686832|NCT04413149|525368326|FG001|Overall Study|Lung transplantation|0|||
145686833|NCT02661490|525368329|FG000|Overall Study|Lost to Follow-up|0|||
145686834|NCT02661490|525368330|FG001|Overall Study|Lost to Follow-up|1|||
145686835|NCT02661490|525368331|FG002|Overall Study|Lost to Follow-up|0|||
145686836|NCT02661490|525368332|FG003|Overall Study|Lost to Follow-up|0|||
145686837|NCT02661490|525368333|FG004|Overall Study|Lost to Follow-up|2|||
145686838|NCT02661490|525368329|FG000|Overall Study|Withdrawal by Subject|2|||
145686839|NCT02661490|525368330|FG001|Overall Study|Withdrawal by Subject|0|||
145686840|NCT02661490|525368331|FG002|Overall Study|Withdrawal by Subject|2|||
145686841|NCT02661490|525368332|FG003|Overall Study|Withdrawal by Subject|0|||
145686842|NCT02661490|525368333|FG004|Overall Study|Withdrawal by Subject|0|||
145686843|NCT02661490|525368329|FG000|Overall Study|Death|1|||
145686844|NCT02661490|525368330|FG001|Overall Study|Death|1|||
145686845|NCT02661490|525368331|FG002|Overall Study|Death|0|||
145686846|NCT02661490|525368332|FG003|Overall Study|Death|1|||
145686847|NCT02661490|525368333|FG004|Overall Study|Death|0|||
145686848|NCT02661490|525368329|FG000|Overall Study|Reason not Specified|0|||
145686849|NCT02661490|525368330|FG001|Overall Study|Reason not Specified|0|||
145686850|NCT02661490|525368331|FG002|Overall Study|Reason not Specified|0|||
145686851|NCT02661490|525368332|FG003|Overall Study|Reason not Specified|0|||
145686852|NCT02661490|525368333|FG004|Overall Study|Reason not Specified|1|||
145686853|NCT03322514|525368334|FG000|Overall Study|Withdrawal by Subject|1|||
145686854|NCT03322514|525368335|FG001|Overall Study|Withdrawal by Subject|1|||
145686855|NCT01184859|525368336|FG000|Period 1: Single Dose|Insufficient urine production|0|||
145686856|NCT01184859|525368337|FG001|Period 1: Single Dose|Insufficient urine production|1|||
145686857|NCT01184859|525368338|FG002|Period 1: Single Dose|Insufficient urine production|0|||
145686858|NCT01184859|525368339|FG003|Period 1: Single Dose|Insufficient urine production|0|||
145686859|NCT01184859|525368340|FG004|Period 1: Single Dose|Insufficient urine production|0|||
145686860|NCT01184859|525368336|FG000|Period 1: Single Dose|Protocol Violation|0|||
145686861|NCT01184859|525368337|FG001|Period 1: Single Dose|Protocol Violation|1|||
145686862|NCT01184859|525368338|FG002|Period 1: Single Dose|Protocol Violation|0|||
145686863|NCT01184859|525368339|FG003|Period 1: Single Dose|Protocol Violation|0|||
145686864|NCT01184859|525368340|FG004|Period 1: Single Dose|Protocol Violation|0|||
145686865|NCT01184859|525368336|FG000|Period 1: Single Dose|Adverse Event|0|||
145686866|NCT01184859|525368337|FG001|Period 1: Single Dose|Adverse Event|0|||
145686867|NCT01184859|525368338|FG002|Period 1: Single Dose|Adverse Event|0|||
145686868|NCT01184859|525368339|FG003|Period 1: Single Dose|Adverse Event|0|||
145686869|NCT01184859|525368340|FG004|Period 1: Single Dose|Adverse Event|1|||
145686870|NCT01184859|525368336|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
145686871|NCT01184859|525368337|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
145686872|NCT01184859|525368338|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
145686873|NCT01184859|525368339|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
145686874|NCT01184859|525368340|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
145686875|NCT01184859|525368336|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
145686876|NCT01184859|525368337|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
145686877|NCT01184859|525368338|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
145686878|NCT01184859|525368339|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
145686879|NCT01184859|525368340|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
145686880|NCT00961298|525368341|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
145686881|NCT00961298|525368341|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
145686882|NCT00961298|525368341|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
145686883|NCT00814632|525368342|FG000|Overall Study|Lack of Efficacy|2|||
145686884|NCT02514577|525368346|FG000|Overall Study|Lost to Follow-up|6|||
145686885|NCT02514577|525368347|FG001|Overall Study|Lost to Follow-up|6|||
145686886|NCT02514577|525368346|FG000|Overall Study|Protocol Violation|1|||
145686887|NCT02514577|525368347|FG001|Overall Study|Protocol Violation|0|||
145686888|NCT02514577|525368346|FG000|Overall Study|Withdrawal by Subject|6|||
145686889|NCT02514577|525368347|FG001|Overall Study|Withdrawal by Subject|6|||
145686890|NCT02514577|525368346|FG000|Overall Study|Adverse Event|1|||
145686891|NCT02514577|525368347|FG001|Overall Study|Adverse Event|1|||
145686892|NCT02388932|525368348|FG000|Overall Study|Death|1|||
145686893|NCT01234675|525368355|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
145686894|NCT01234675|525368356|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
145686895|NCT01234675|525368355|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145686896|NCT01234675|525368356|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
145686897|NCT01533181|525368367|FG000|Overall Study|Disease progression pre-active treatment|0|||
145686898|NCT01533181|525368368|FG001|Overall Study|Disease progression pre-active treatment|1|||
145686899|NCT01533181|525368367|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
145686900|NCT01533181|525368368|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
145686901|NCT01498445|525368371|FG000|Overall Study|Lack of Efficacy|0|||
145686902|NCT01498445|525368372|FG001|Overall Study|Lack of Efficacy|0|||
145686903|NCT01498445|525368373|FG002|Overall Study|Lack of Efficacy|1|||
145686904|NCT01498445|525368374|FG003|Overall Study|Lack of Efficacy|2|||
145686905|NCT01498445|525368375|FG004|Overall Study|Lack of Efficacy|0|||
145686906|NCT01498445|525368376|FG005|Overall Study|Lack of Efficacy|0|||
145686907|NCT01498445|525368371|FG000|Overall Study|Screen Failure|0|||
145686908|NCT01498445|525368372|FG001|Overall Study|Screen Failure|0|||
145686909|NCT01498445|525368373|FG002|Overall Study|Screen Failure|0|||
145686910|NCT01498445|525368374|FG003|Overall Study|Screen Failure|0|||
145686911|NCT01498445|525368375|FG004|Overall Study|Screen Failure|1|||
145686912|NCT01498445|525368376|FG005|Overall Study|Screen Failure|1|||
145686913|NCT02023099|525368377|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
145686914|NCT02023099|525368378|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
145686915|NCT02023099|525368379|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
145686916|NCT02023099|525368377|FG000|Overall Study|Withdrawn Consent|3|||
145686917|NCT02023099|525368378|FG001|Overall Study|Withdrawn Consent|0|||
145686918|NCT02023099|525368379|FG002|Overall Study|Withdrawn Consent|1|||
145686919|NCT02023099|525368377|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
145686920|NCT02023099|525368378|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
145686921|NCT02023099|525368379|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
145686922|NCT00203502|525368380|FG000|Overall Study|Death|1|||
145686923|NCT00105521|525368403|FG000|Overall Study|Other|1|||
145686924|NCT00105521|525368404|FG001|Overall Study|Other|1|||
145686925|NCT00105521|525368405|FG002|Overall Study|Other|2|||
145686926|NCT00105521|525368406|FG003|Overall Study|Other|0|||
145686927|NCT00105521|525368403|FG000|Overall Study|Adverse Event|10|||
145686928|NCT00105521|525368404|FG001|Overall Study|Adverse Event|4|||
145686929|NCT00105521|525368405|FG002|Overall Study|Adverse Event|10|||
145686930|NCT00105521|525368406|FG003|Overall Study|Adverse Event|8|||
145686931|NCT00105521|525368403|FG000|Overall Study|Withdrawal by Subject|1|||
145686932|NCT00105521|525368404|FG001|Overall Study|Withdrawal by Subject|0|||
145686933|NCT00105521|525368405|FG002|Overall Study|Withdrawal by Subject|1|||
145686934|NCT00105521|525368406|FG003|Overall Study|Withdrawal by Subject|4|||
145686935|NCT00105521|525368403|FG000|Overall Study|Lack of Efficacy|0|||
145686936|NCT00105521|525368404|FG001|Overall Study|Lack of Efficacy|0|||
145686937|NCT00105521|525368405|FG002|Overall Study|Lack of Efficacy|0|||
145686938|NCT00105521|525368406|FG003|Overall Study|Lack of Efficacy|1|||
145686939|NCT00105521|525368403|FG000|Overall Study|Protocol Violation|3|||
145686940|NCT00105521|525368404|FG001|Overall Study|Protocol Violation|5|||
145686941|NCT00105521|525368405|FG002|Overall Study|Protocol Violation|4|||
145686942|NCT00105521|525368406|FG003|Overall Study|Protocol Violation|4|||
145686943|NCT00105521|525368403|FG000|Overall Study|Lost to Follow-up|0|||
145686944|NCT00105521|525368404|FG001|Overall Study|Lost to Follow-up|1|||
145686945|NCT00105521|525368405|FG002|Overall Study|Lost to Follow-up|0|||
145686946|NCT00105521|525368406|FG003|Overall Study|Lost to Follow-up|0|||
145686947|NCT00385697|525368407|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
145686948|NCT00385697|525368408|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
145686949|NCT00385697|525368409|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
145686950|NCT00385697|525368410|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
145686951|NCT00385697|525368411|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
145686952|NCT00385697|525368407|FG000|Open-label Segment 1|Lost to Follow-up|1|||
145686953|NCT00385697|525368408|FG001|Open-label Segment 1|Lost to Follow-up|0|||
145686954|NCT00385697|525368409|FG002|Open-label Segment 1|Lost to Follow-up|0|||
145686955|NCT00385697|525368410|FG003|Open-label Segment 1|Lost to Follow-up|0|||
145686956|NCT00385697|525368411|FG004|Open-label Segment 1|Lost to Follow-up|0|||
145686957|NCT00385697|525368407|FG000|Double-blind Segment 2|Adverse Event|0|||
145686958|NCT00385697|525368408|FG001|Double-blind Segment 2|Adverse Event|3|||
145686959|NCT00385697|525368409|FG002|Double-blind Segment 2|Adverse Event|1|||
145686960|NCT00385697|525368410|FG003|Double-blind Segment 2|Adverse Event|0|||
145686961|NCT00385697|525368411|FG004|Double-blind Segment 2|Adverse Event|0|||
145686962|NCT00385697|525368407|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
145686963|NCT00385697|525368408|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
145686964|NCT00385697|525368409|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
145686965|NCT00385697|525368410|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
145686966|NCT00385697|525368411|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
145686967|NCT00385697|525368407|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
145686968|NCT00385697|525368408|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
145686969|NCT00385697|525368409|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
145686970|NCT00385697|525368410|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
145686971|NCT00385697|525368411|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
145686972|NCT00385697|525368407|FG000|Double-blind Segment 2|Other|0|||
145686973|NCT00385697|525368408|FG001|Double-blind Segment 2|Other|2|||
145686974|NCT00385697|525368409|FG002|Double-blind Segment 2|Other|0|||
145686975|NCT00385697|525368410|FG003|Double-blind Segment 2|Other|0|||
145686976|NCT00385697|525368411|FG004|Double-blind Segment 2|Other|0|||
145686977|NCT00510783|525368414|FG000|Overall Study|Lost to Follow-up|29|||
145686978|NCT00510783|525368415|FG001|Overall Study|Lost to Follow-up|25|||
145686979|NCT00510783|525368414|FG000|Overall Study|Withdrawal by Subject|2|||
145686980|NCT00510783|525368415|FG001|Overall Study|Withdrawal by Subject|3|||
145686981|NCT00510783|525368414|FG000|Overall Study|Protocol Violation|0|||
145686982|NCT00510783|525368415|FG001|Overall Study|Protocol Violation|1|||
145686983|NCT03508830|525368416|FG000|Overall Study|Withdrawal by Subject|3|||
145686984|NCT03508830|525368417|FG001|Overall Study|Withdrawal by Subject|4|||
145686985|NCT03508830|525368416|FG000|Overall Study|Physician Decision|2|||
145686986|NCT03508830|525368417|FG001|Overall Study|Physician Decision|2|||
145686987|NCT05287178|525368421|FG000|Overall Study|Lost to Follow-up|2|||
145686988|NCT01426217|525368422|FG000|Overall Study|lost sample|8|||
145686989|NCT01426217|525368423|FG001|Overall Study|lost sample|14|||
145686990|NCT01648699|525368424|FG000|Overall Study|Death|1|||
145686991|NCT01648699|525368424|FG000|Overall Study|Lost to Follow-up|2|||
145686992|NCT01648699|525368424|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
145686993|NCT02267746|525368425|FG000|Overall Study|Adverse Event|0|||
145686994|NCT02267746|525368426|FG001|Overall Study|Adverse Event|2|||
145686995|NCT02267746|525368427|FG002|Overall Study|Adverse Event|1|||
145686996|NCT02267746|525368425|FG000|Overall Study|Protocol Violation|8|||
145686997|NCT02267746|525368426|FG001|Overall Study|Protocol Violation|7|||
145686998|NCT02267746|525368427|FG002|Overall Study|Protocol Violation|3|||
145686999|NCT02267746|525368425|FG000|Overall Study|Lack of Efficacy|11|||
145687000|NCT02267746|525368426|FG001|Overall Study|Lack of Efficacy|11|||
145687001|NCT02267746|525368427|FG002|Overall Study|Lack of Efficacy|15|||
145687002|NCT02267746|525368425|FG000|Overall Study|Protocol Violation|1|||
145687003|NCT02267746|525368426|FG001|Overall Study|Protocol Violation|2|||
145687004|NCT02267746|525368427|FG002|Overall Study|Protocol Violation|1|||
145687005|NCT02267746|525368425|FG000|Overall Study|Miscellaneous|1|||
145687006|NCT02267746|525368426|FG001|Overall Study|Miscellaneous|0|||
145687007|NCT02267746|525368427|FG002|Overall Study|Miscellaneous|1|||
145687008|NCT00288353|525368432|FG000|Overall Study|Lack of Efficacy|2|||
145687009|NCT00288353|525368433|FG001|Overall Study|Lack of Efficacy|2|||
145687010|NCT00288353|525368432|FG000|Overall Study|Withdrawal by Subject|5|||
145687011|NCT00288353|525368433|FG001|Overall Study|Withdrawal by Subject|5|||
145687012|NCT05008224|525368434|FG000|Overall Study|Death|3|||
145687013|NCT05008224|525368434|FG000|Overall Study|Lost to Follow-up|2|||
145687014|NCT05008224|525368434|FG000|Overall Study|Did Not Continue on Extension Study|39|||
145687015|NCT05008224|525368434|FG000|Overall Study|Transferred to Extension Study|100|||
145687016|NCT05008224|525368434|FG000|Overall Study|Withdrawal by Subject|2|||
145687017|NCT00728884|525368435|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
145687018|NCT00728884|525368435|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
145687019|NCT05263492|525368436|FG000|Overall Study|Adverse Event|1|||
145687020|NCT05263492|525368436|FG000|Overall Study|Disease progression during active treatment|3|||
145687021|NCT03345420|525368439|FG000|Overall Study|Withdrawal by Subject|1|||
145687022|NCT05216835|525368440|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
145687023|NCT05216835|525368441|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
145687024|NCT05216835|525368442|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
145687025|NCT05216835|525368443|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
145687026|NCT05216835|525368444|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
145687027|NCT05216835|525368445|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
145687028|NCT05216835|525368446|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
145687029|NCT05216835|525368447|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
145687030|NCT05216835|525368440|FG000|Overall Study|Death|0|||
145687031|NCT05216835|525368441|FG001|Overall Study|Death|0|||
145687032|NCT05216835|525368442|FG002|Overall Study|Death|0|||
145687033|NCT05216835|525368443|FG003|Overall Study|Death|1|||
145687034|NCT05216835|525368444|FG004|Overall Study|Death|1|||
145687035|NCT05216835|525368445|FG005|Overall Study|Death|1|||
145687036|NCT05216835|525368446|FG006|Overall Study|Death|1|||
145687037|NCT05216835|525368447|FG007|Overall Study|Death|1|||
145687038|NCT05216835|525368440|FG000|Overall Study|Physician Decision|0|||
145687039|NCT05216835|525368441|FG001|Overall Study|Physician Decision|0|||
145687040|NCT05216835|525368442|FG002|Overall Study|Physician Decision|0|||
145687041|NCT05216835|525368443|FG003|Overall Study|Physician Decision|0|||
145687042|NCT05216835|525368444|FG004|Overall Study|Physician Decision|0|||
145687043|NCT05216835|525368445|FG005|Overall Study|Physician Decision|1|||
145687044|NCT05216835|525368446|FG006|Overall Study|Physician Decision|1|||
145687045|NCT05216835|525368447|FG007|Overall Study|Physician Decision|0|||
145687046|NCT05216835|525368440|FG000|Overall Study|Study terminated by Sponsor|0|||
145687047|NCT05216835|525368441|FG001|Overall Study|Study terminated by Sponsor|0|||
145687048|NCT05216835|525368442|FG002|Overall Study|Study terminated by Sponsor|0|||
145687049|NCT05216835|525368443|FG003|Overall Study|Study terminated by Sponsor|0|||
145687050|NCT05216835|525368444|FG004|Overall Study|Study terminated by Sponsor|0|||
145687051|NCT05216835|525368445|FG005|Overall Study|Study terminated by Sponsor|0|||
145687052|NCT05216835|525368446|FG006|Overall Study|Study terminated by Sponsor|0|||
145687053|NCT05216835|525368447|FG007|Overall Study|Study terminated by Sponsor|1|||
145687054|NCT05216835|525368440|FG000|Overall Study|Withdrawal by Subject|1|||
145687055|NCT05216835|525368441|FG001|Overall Study|Withdrawal by Subject|0|||
145687056|NCT05216835|525368442|FG002|Overall Study|Withdrawal by Subject|1|||
145687057|NCT05216835|525368443|FG003|Overall Study|Withdrawal by Subject|0|||
145687058|NCT05216835|525368444|FG004|Overall Study|Withdrawal by Subject|1|||
145687059|NCT05216835|525368445|FG005|Overall Study|Withdrawal by Subject|0|||
145687060|NCT05216835|525368446|FG006|Overall Study|Withdrawal by Subject|0|||
145687061|NCT05216835|525368447|FG007|Overall Study|Withdrawal by Subject|1|||
145687062|NCT05216835|525368440|FG000|Overall Study|Other|0|||
145687063|NCT05216835|525368441|FG001|Overall Study|Other|1|||
145687064|NCT05216835|525368442|FG002|Overall Study|Other|0|||
145687065|NCT05216835|525368443|FG003|Overall Study|Other|0|||
145687066|NCT05216835|525368444|FG004|Overall Study|Other|0|||
145687067|NCT05216835|525368445|FG005|Overall Study|Other|0|||
145687068|NCT05216835|525368446|FG006|Overall Study|Other|0|||
145687069|NCT05216835|525368447|FG007|Overall Study|Other|0|||
145687070|NCT05179603|525368448|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
145687071|NCT05179603|525368448|FG000|Overall Study|Withdrawal by Subject|1|||
145687072|NCT05179603|525368448|FG000|Overall Study|Progressive disease|4|||
145687073|NCT05179603|525368448|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
145687074|NCT03861078|525368449|FG000|Overall Study|COVID-19 shut down|4|||
145687075|NCT03861078|525368449|FG000|Overall Study|Lost to Follow-up|1|||
145687076|NCT03861078|525368449|FG000|Overall Study|Protocol Violation|2|||
145687077|NCT03861078|525368449|FG000|Overall Study|lack of venous access|1|||
145687078|NCT00596960|525368450|FG000|Overall Study|Death|1|||
145687079|NCT00596960|525368451|FG001|Overall Study|Death|2|||
145687080|NCT00596960|525368450|FG000|Overall Study|Lost to Follow-up|6|||
145687081|NCT00596960|525368451|FG001|Overall Study|Lost to Follow-up|5|||
145687082|NCT00596960|525368450|FG000|Overall Study|Withdrawal by Subject|1|||
145687083|NCT00596960|525368451|FG001|Overall Study|Withdrawal by Subject|0|||
145687084|NCT00596960|525368450|FG000|Overall Study|Incarcerated|2|||
145687085|NCT00596960|525368451|FG001|Overall Study|Incarcerated|0|||
145687086|NCT00596960|525368450|FG000|Overall Study|Physician Decision|1|||
145687087|NCT00596960|525368451|FG001|Overall Study|Physician Decision|0|||
145687088|NCT00596960|525368450|FG000|Overall Study|Protocol Violation|0|||
145687089|NCT00596960|525368451|FG001|Overall Study|Protocol Violation|1|||
145687090|NCT00596960|525368450|FG000|Overall Study|No alcohol use data|0|||
145687091|NCT00596960|525368451|FG001|Overall Study|No alcohol use data|1|||
145687092|NCT01075815|525368452|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
145687093|NCT01075815|525368453|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
145687094|NCT01075815|525368452|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
145687095|NCT01075815|525368453|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
145687096|NCT01075815|525368452|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
145687097|NCT01075815|525368453|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
145687098|NCT02058992|525368454|FG000|Overall Study|Lost to Follow-up|4|||
145687099|NCT02058992|525368454|FG000|Overall Study|Protocol Violation|92|||
145687100|NCT02058992|525368454|FG000|Overall Study|CRF Uncollected|20|||
145687101|NCT00914732|525368458|FG000|Overall Study|Lost to Follow-up|6|||
145687102|NCT00914732|525368459|FG001|Overall Study|Lost to Follow-up|7|||
145687103|NCT00914732|525368460|FG002|Overall Study|Lost to Follow-up|9|||
145687104|NCT00914732|525368458|FG000|Overall Study|Withdrawal by Subject|3|||
145687105|NCT00914732|525368459|FG001|Overall Study|Withdrawal by Subject|0|||
145687106|NCT00914732|525368460|FG002|Overall Study|Withdrawal by Subject|2|||
145687107|NCT00914732|525368458|FG000|Overall Study|Adverse Event|1|||
145687108|NCT00914732|525368459|FG001|Overall Study|Adverse Event|0|||
145687109|NCT00914732|525368460|FG002|Overall Study|Adverse Event|0|||
145687110|NCT02130401|525368461|FG000|Overall Study|Poor enrollment|6|||
145687111|NCT01855399|525368462|FG000|6 Month|Lost to Follow-up|12|||
145687112|NCT01855399|525368463|FG001|6 Month|Lost to Follow-up|9|||
145687113|NCT01855399|525368462|FG000|6 Month|Withdrawal by Subject|8|||
145687114|NCT01855399|525368463|FG001|6 Month|Withdrawal by Subject|6|||
145687115|NCT01855399|525368462|FG000|12 Month|Lost to Follow-up|7|||
145687116|NCT01855399|525368463|FG001|12 Month|Lost to Follow-up|11|||
145687117|NCT00321672|525368466|FG000|Overall Study|Withdrawal by Subject|5|||
145687118|NCT00321672|525368467|FG001|Overall Study|Withdrawal by Subject|1|||
145687119|NCT00321672|525368468|FG002|Overall Study|Withdrawal by Subject|2|||
145687120|NCT00321672|525368469|FG003|Overall Study|Withdrawal by Subject|0|||
145687121|NCT00321672|525368466|FG000|Overall Study|Noncompliance|1|||
145687122|NCT00321672|525368467|FG001|Overall Study|Noncompliance|2|||
145687123|NCT00321672|525368468|FG002|Overall Study|Noncompliance|1|||
145687124|NCT00321672|525368469|FG003|Overall Study|Noncompliance|0|||
145687125|NCT00321672|525368466|FG000|Overall Study|Adverse Event|1|||
145687126|NCT00321672|525368467|FG001|Overall Study|Adverse Event|1|||
145687127|NCT00321672|525368468|FG002|Overall Study|Adverse Event|0|||
145687128|NCT00321672|525368469|FG003|Overall Study|Adverse Event|0|||
145687129|NCT00321672|525368466|FG000|Overall Study|Lack of Efficacy|1|||
145687130|NCT00321672|525368467|FG001|Overall Study|Lack of Efficacy|1|||
145687131|NCT00321672|525368468|FG002|Overall Study|Lack of Efficacy|0|||
145687132|NCT00321672|525368469|FG003|Overall Study|Lack of Efficacy|0|||
145687133|NCT00321672|525368466|FG000|Overall Study|Lost to Follow-up|2|||
145687134|NCT00321672|525368467|FG001|Overall Study|Lost to Follow-up|0|||
145687135|NCT00321672|525368468|FG002|Overall Study|Lost to Follow-up|4|||
145687136|NCT00321672|525368469|FG003|Overall Study|Lost to Follow-up|2|||
145687137|NCT00321672|525368466|FG000|Overall Study|Death|1|||
145687138|NCT00321672|525368467|FG001|Overall Study|Death|0|||
145687139|NCT00321672|525368468|FG002|Overall Study|Death|0|||
145687140|NCT00321672|525368469|FG003|Overall Study|Death|0|||
145687141|NCT00321672|525368466|FG000|Overall Study|Too far to travel for visits|1|||
145687142|NCT00321672|525368467|FG001|Overall Study|Too far to travel for visits|0|||
145687143|NCT00321672|525368468|FG002|Overall Study|Too far to travel for visits|0|||
145687144|NCT00321672|525368469|FG003|Overall Study|Too far to travel for visits|0|||
145687145|NCT00321672|525368466|FG000|Overall Study|Incarcerated|0|||
145687146|NCT00321672|525368467|FG001|Overall Study|Incarcerated|0|||
145687147|NCT00321672|525368468|FG002|Overall Study|Incarcerated|2|||
145687148|NCT00321672|525368469|FG003|Overall Study|Incarcerated|0|||
145687149|NCT00321672|525368466|FG000|Overall Study|Moved out of state|0|||
145687150|NCT00321672|525368467|FG001|Overall Study|Moved out of state|1|||
145687151|NCT00321672|525368468|FG002|Overall Study|Moved out of state|1|||
145687152|NCT00321672|525368469|FG003|Overall Study|Moved out of state|0|||
145687153|NCT00321672|525368466|FG000|Overall Study|Protocol Violation|0|||
145687154|NCT00321672|525368467|FG001|Overall Study|Protocol Violation|0|||
145687155|NCT00321672|525368468|FG002|Overall Study|Protocol Violation|1|||
145687156|NCT00321672|525368469|FG003|Overall Study|Protocol Violation|0|||
145687157|NCT00321672|525368466|FG000|Overall Study|Diagnosis of testicular cancer|0|||
145687158|NCT00321672|525368467|FG001|Overall Study|Diagnosis of testicular cancer|1|||
145687159|NCT00321672|525368468|FG002|Overall Study|Diagnosis of testicular cancer|0|||
145687160|NCT00321672|525368469|FG003|Overall Study|Diagnosis of testicular cancer|0|||
145687161|NCT00321672|525368466|FG000|Overall Study|Extensive travel required for new job|0|||
145687162|NCT00321672|525368467|FG001|Overall Study|Extensive travel required for new job|1|||
145687163|NCT00321672|525368468|FG002|Overall Study|Extensive travel required for new job|0|||
145687164|NCT00321672|525368469|FG003|Overall Study|Extensive travel required for new job|0|||
145687165|NCT00512902|525368470|FG000|Overall Study|Adverse Event|7|||
145687166|NCT00512902|525368470|FG000|Overall Study|Lost to Follow-up|1|||
145687167|NCT03019289|525368471|FG000|Overall Study|Adverse Event|1|||
145687168|NCT03019289|525368472|FG001|Overall Study|Adverse Event|0|||
145687169|NCT03019289|525368473|FG002|Overall Study|Adverse Event|0|||
145687170|NCT03019289|525368474|FG003|Overall Study|Adverse Event|0|||
145687171|NCT03019289|525368475|FG004|Overall Study|Adverse Event|0|||
145687172|NCT03019289|525368476|FG005|Overall Study|Adverse Event|0|||
145687173|NCT03019289|525368477|FG006|Overall Study|Adverse Event|0|||
145687174|NCT03019289|525368478|FG007|Overall Study|Adverse Event|0|||
145687175|NCT03019289|525368479|FG008|Overall Study|Adverse Event|1|||
145687176|NCT03019289|525368471|FG000|Overall Study|Other|1|||
145687177|NCT03019289|525368472|FG001|Overall Study|Other|0|||
145687178|NCT03019289|525368473|FG002|Overall Study|Other|0|||
145687179|NCT03019289|525368474|FG003|Overall Study|Other|0|||
145687180|NCT03019289|525368475|FG004|Overall Study|Other|0|||
145687181|NCT03019289|525368476|FG005|Overall Study|Other|0|||
145687182|NCT03019289|525368477|FG006|Overall Study|Other|0|||
145687183|NCT03019289|525368478|FG007|Overall Study|Other|0|||
145687184|NCT03019289|525368479|FG008|Overall Study|Other|0|||
145687185|NCT00145496|525368480|FG000|Overall Study|Adverse Event|42|||
145687186|NCT00145496|525368481|FG001|Overall Study|Adverse Event|30|||
145687187|NCT00145496|525368480|FG000|Overall Study|Lack of Efficacy|12|||
145687188|NCT00145496|525368481|FG001|Overall Study|Lack of Efficacy|7|||
145687189|NCT00145496|525368480|FG000|Overall Study|Withdrawal by Subject|32|||
145687190|NCT00145496|525368481|FG001|Overall Study|Withdrawal by Subject|26|||
145687191|NCT00145496|525368480|FG000|Overall Study|Lost to Follow-up|12|||
145687192|NCT00145496|525368481|FG001|Overall Study|Lost to Follow-up|5|||
145687193|NCT00145496|525368480|FG000|Overall Study|Other|25|||
145687194|NCT00145496|525368481|FG001|Overall Study|Other|13|||
145687195|NCT03138499|525368485|FG000|Overall Study|Lost to Follow-up|1|||
145687196|NCT03138499|525368486|FG001|Overall Study|Lost to Follow-up|0|||
145687197|NCT03138499|525368485|FG000|Overall Study|Participants withdrew consent|1|||
145687198|NCT03138499|525368486|FG001|Overall Study|Participants withdrew consent|0|||
145687199|NCT03138499|525368485|FG000|Overall Study|Participant discontinued study before treatment|0|||
145687200|NCT03138499|525368486|FG001|Overall Study|Participant discontinued study before treatment|1|||
145687201|NCT03138499|525368485|FG000|Overall Study|Disease Progression|2|||
145687202|NCT03138499|525368486|FG001|Overall Study|Disease Progression|6|||
145687203|NCT03138499|525368485|FG000|Overall Study|Study drug toxicity|2|||
145687204|NCT03138499|525368486|FG001|Overall Study|Study drug toxicity|2|||
145687205|NCT03138499|525368485|FG000|Overall Study|Participant request to discontinue study treatment|1|||
145687206|NCT03138499|525368486|FG001|Overall Study|Participant request to discontinue study treatment|1|||
145687207|NCT03138499|525368485|FG000|Overall Study|Other reasons|2|||
145687208|NCT03138499|525368486|FG001|Overall Study|Other reasons|0|||
145687209|NCT01334606|525368487|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
145687210|NCT02312245|525368488|FG000|Overall Study|Death|0|||
145687211|NCT02312245|525368489|FG001|Overall Study|Death|0|||
145687212|NCT02312245|525368490|FG002|Overall Study|Death|0|||
145687213|NCT02312245|525368491|FG003|Overall Study|Death|1|||
145687214|NCT02312245|525368488|FG000|Overall Study|Withdrawal by Subject|1|||
145687215|NCT02312245|525368489|FG001|Overall Study|Withdrawal by Subject|1|||
145687216|NCT02312245|525368490|FG002|Overall Study|Withdrawal by Subject|0|||
145687217|NCT02312245|525368491|FG003|Overall Study|Withdrawal by Subject|2|||
145687218|NCT02312245|525368488|FG000|Overall Study|Alternative Therapy|1|||
145687219|NCT02312245|525368489|FG001|Overall Study|Alternative Therapy|0|||
145687220|NCT02312245|525368490|FG002|Overall Study|Alternative Therapy|0|||
145687221|NCT02312245|525368491|FG003|Overall Study|Alternative Therapy|0|||
145687222|NCT02312245|525368488|FG000|Overall Study|Progression|0|||
145687223|NCT02312245|525368489|FG001|Overall Study|Progression|0|||
145687224|NCT02312245|525368490|FG002|Overall Study|Progression|0|||
145687225|NCT02312245|525368491|FG003|Overall Study|Progression|5|||
145687226|NCT02312245|525368488|FG000|Overall Study|Patient went to hospice|0|||
145687227|NCT02312245|525368489|FG001|Overall Study|Patient went to hospice|0|||
145687228|NCT02312245|525368490|FG002|Overall Study|Patient went to hospice|0|||
145687229|NCT02312245|525368491|FG003|Overall Study|Patient went to hospice|1|||
145687230|NCT02312245|525368488|FG000|Overall Study|Ineligible|1|||
145687231|NCT02312245|525368489|FG001|Overall Study|Ineligible|0|||
145687232|NCT02312245|525368490|FG002|Overall Study|Ineligible|0|||
145687233|NCT02312245|525368491|FG003|Overall Study|Ineligible|0|||
145687234|NCT00448344|525368492|FG000|Overall Study|Lost to Follow-up|20|||
145687235|NCT00448344|525368493|FG001|Overall Study|Lost to Follow-up|22|||
145687236|NCT00448344|525368492|FG000|Overall Study|Withdrawal by Subject|6|||
145687237|NCT00448344|525368493|FG001|Overall Study|Withdrawal by Subject|8|||
145687238|NCT00448344|525368492|FG000|Overall Study|Death|3|||
145687239|NCT00448344|525368493|FG001|Overall Study|Death|4|||
145687240|NCT00448344|525368492|FG000|Overall Study|Physician Decision|1|||
145687241|NCT00448344|525368493|FG001|Overall Study|Physician Decision|2|||
145687242|NCT01123200|525368497|FG000|Overall Study|Withdrawal by Subject|1|||
145687243|NCT00990314|525368498|FG000|Overall Study|Death|2|||
145687244|NCT00990314|525368498|FG000|Overall Study|Adverse Event|2|||
145687245|NCT00990314|525368498|FG000|Overall Study|Withdrawal by Subject|3|||
145687246|NCT00990314|525368498|FG000|Overall Study|Non-Compliance|1|||
145687247|NCT00990314|525368498|FG000|Overall Study|Physician Decision|3|||
145687248|NCT00990314|525368498|FG000|Overall Study|Lack of Efficacy|1|||
145687249|NCT01288729|525368502|FG000|Overall Study|Withdrawal by Subject|1|||
145687250|NCT01288729|525368503|FG001|Overall Study|Withdrawal by Subject|0|||
145687251|NCT01232569|525370285|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
145687252|NCT01232569|525370286|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
145687253|NCT01232569|525370287|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145687254|NCT01232569|525370288|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
145687255|NCT01232569|525370285|FG000|Double-blind Treatment Period|Escape|2|||
145687256|NCT01232569|525370286|FG001|Double-blind Treatment Period|Escape|2|||
145687257|NCT01232569|525370287|FG002|Double-blind Treatment Period|Escape|0|||
145687258|NCT01232569|525370288|FG003|Double-blind Treatment Period|Escape|0|||
145687259|NCT01232569|525370285|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
145687260|NCT01232569|525370286|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
145687261|NCT01232569|525370287|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
145687262|NCT01232569|525370288|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
145687263|NCT01232569|525370285|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
145687264|NCT01232569|525370286|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
145687265|NCT01232569|525370287|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
145687266|NCT01232569|525370288|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
145687267|NCT01232569|525370285|FG000|Double-blind Treatment Period|Physician Decision|1|||
145687268|NCT01232569|525370286|FG001|Double-blind Treatment Period|Physician Decision|0|||
145687269|NCT01232569|525370287|FG002|Double-blind Treatment Period|Physician Decision|0|||
145687270|NCT01232569|525370288|FG003|Double-blind Treatment Period|Physician Decision|0|||
145687271|NCT01232569|525370285|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
145687272|NCT01232569|525370286|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
145687273|NCT01232569|525370287|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
145687274|NCT01232569|525370288|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
145687275|NCT01232569|525370285|FG000|Double-blind Treatment Period|Death|2|||
145687276|NCT01232569|525370286|FG001|Double-blind Treatment Period|Death|0|||
145687277|NCT01232569|525370287|FG002|Double-blind Treatment Period|Death|0|||
145687278|NCT01232569|525370288|FG003|Double-blind Treatment Period|Death|0|||
145687279|NCT01537120|525370296|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
145687280|NCT01537120|525370296|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
145687281|NCT05335005|525370298|FG000|Overall Study|Lost to Follow-up|1|||
145687282|NCT00627523|525370301|FG000|Overall Study|Lack of Efficacy|1|||
145687283|NCT00627523|525370302|FG001|Overall Study|Lack of Efficacy|0|||
145687284|NCT00627523|525370301|FG000|Overall Study|Withdrawal by Subject|0|||
145687285|NCT00627523|525370302|FG001|Overall Study|Withdrawal by Subject|2|||
145687286|NCT00627523|525370301|FG000|Overall Study|Other|1|||
145687287|NCT00627523|525370302|FG001|Overall Study|Other|0|||
145687288|NCT03451292|525370303|FG000|Overall Study|Death|44|||
145687289|NCT03451292|525370304|FG001|Overall Study|Death|59|||
145687290|NCT03451292|525370303|FG000|Overall Study|Withdrawal by Subject|18|||
145687291|NCT03451292|525370304|FG001|Overall Study|Withdrawal by Subject|13|||
145687292|NCT03451292|525370303|FG000|Overall Study|Transplantation|18|||
145687293|NCT03451292|525370304|FG001|Overall Study|Transplantation|12|||
145687294|NCT03451292|525370303|FG000|Overall Study|Lost to Follow-up|4|||
145687295|NCT03451292|525370304|FG001|Overall Study|Lost to Follow-up|12|||
145687296|NCT03451292|525370303|FG000|Overall Study|Physician Decision|4|||
145687297|NCT03451292|525370304|FG001|Overall Study|Physician Decision|3|||
145687298|NCT03451292|525370303|FG000|Overall Study|Adverse Event|3|||
145687299|NCT03451292|525370304|FG001|Overall Study|Adverse Event|3|||
145687300|NCT03451292|525370303|FG000|Overall Study|Non-compliance with Study Drug|2|||
145687301|NCT03451292|525370304|FG001|Overall Study|Non-compliance with Study Drug|0|||
145687302|NCT03602053|525370311|FG000|Overall Study|Withdrawal by Subject|7|||
145687303|NCT03602053|525370312|FG001|Overall Study|Withdrawal by Subject|9|||
145687304|NCT03602053|525370313|FG002|Overall Study|Withdrawal by Subject|7|||
145687305|NCT03602053|525370311|FG000|Overall Study|Lost to Follow-up|5|||
145687306|NCT03602053|525370312|FG001|Overall Study|Lost to Follow-up|6|||
145687307|NCT03602053|525370313|FG002|Overall Study|Lost to Follow-up|0|||
145687308|NCT03602053|525370311|FG000|Overall Study|Protocol Violation|3|||
145687309|NCT03602053|525370312|FG001|Overall Study|Protocol Violation|0|||
145687310|NCT03602053|525370313|FG002|Overall Study|Protocol Violation|4|||
145687311|NCT03602053|525370311|FG000|Overall Study|Physician Decision|1|||
145687312|NCT03602053|525370312|FG001|Overall Study|Physician Decision|0|||
145687313|NCT03602053|525370313|FG002|Overall Study|Physician Decision|0|||
145687314|NCT03602053|525370311|FG000|Overall Study|migration|2|||
145687315|NCT03602053|525370312|FG001|Overall Study|migration|3|||
145687316|NCT03602053|525370313|FG002|Overall Study|migration|0|||
145687317|NCT03602053|525370311|FG000|Overall Study|Other|1|||
145687318|NCT03602053|525370312|FG001|Overall Study|Other|0|||
145687319|NCT03602053|525370313|FG002|Overall Study|Other|0|||
145687320|NCT01038128|525370314|FG000|Overall Study|Lack of Efficacy|1|||
145687321|NCT01038128|525370314|FG000|Overall Study|Lost to Follow-up|1|||
145687322|NCT01038128|525370314|FG000|Overall Study|Withdrawal by Subject|2|||
145687323|NCT01753323|525370319|FG000|Overall Study|Lack of Efficacy|0|||
145687324|NCT01753323|525370320|FG001|Overall Study|Lack of Efficacy|0|||
145687325|NCT01753323|525370321|FG002|Overall Study|Lack of Efficacy|8|||
145687326|NCT01753323|525370319|FG000|Overall Study|Protocol deviation|1|||
145687327|NCT01753323|525370320|FG001|Overall Study|Protocol deviation|0|||
145687328|NCT01753323|525370321|FG002|Overall Study|Protocol deviation|0|||
145687329|NCT01753323|525370319|FG000|Overall Study|Adverse Event|0|||
145687330|NCT01753323|525370320|FG001|Overall Study|Adverse Event|0|||
145687331|NCT01753323|525370321|FG002|Overall Study|Adverse Event|1|||
145687332|NCT01870999|525370323|FG000|Overall Study|Adverse Event|0|||
145687333|NCT01870999|525370324|FG001|Overall Study|Adverse Event|4|||
145687334|NCT01870999|525370325|FG002|Overall Study|Adverse Event|1|||
145687335|NCT01870999|525370323|FG000|Overall Study|Subject met withdrawal criteria|3|||
145687336|NCT01870999|525370324|FG001|Overall Study|Subject met withdrawal criteria|2|||
145687337|NCT01870999|525370325|FG002|Overall Study|Subject met withdrawal criteria|0|||
145687338|NCT01870999|525370323|FG000|Overall Study|Subject withdrawn by Investigator|1|||
145687339|NCT01870999|525370324|FG001|Overall Study|Subject withdrawn by Investigator|0|||
145687340|NCT01870999|525370325|FG002|Overall Study|Subject withdrawn by Investigator|0|||
145687341|NCT01870999|525370323|FG000|Overall Study|Withdrawal by Subject|0|||
145687342|NCT01870999|525370324|FG001|Overall Study|Withdrawal by Subject|2|||
145687343|NCT01870999|525370325|FG002|Overall Study|Withdrawal by Subject|5|||
145687344|NCT01870999|525370323|FG000|Overall Study|Protocol Violation|0|||
145687345|NCT01870999|525370324|FG001|Overall Study|Protocol Violation|0|||
145687346|NCT01870999|525370325|FG002|Overall Study|Protocol Violation|1|||
145687347|NCT01636258|525370326|FG000|Overall Study|Lost to Follow-up|1|||
145687348|NCT01636258|525370327|FG001|Overall Study|Lost to Follow-up|0|||
145687349|NCT00116584|525370328|FG000|Overall Study|Withdrawal by Subject|1|||
145687350|NCT00116584|525370329|FG001|Overall Study|Withdrawal by Subject|0|||
145687351|NCT00116584|525370328|FG000|Overall Study|Protocol Violation|1|||
145687352|NCT00116584|525370329|FG001|Overall Study|Protocol Violation|1|||
145687353|NCT02798861|525370332|FG000|Overall Study|Lost to Follow-up|22|||
145687354|NCT02798861|525370332|FG000|Overall Study|Withdrawal by Subject|1|||
145687355|NCT04879823|525370340|FG000|Overall Study|Physician Decision|3|||
145687356|NCT04879823|525370341|FG001|Overall Study|Physician Decision|1|||
145687357|NCT04879823|525370340|FG000|Overall Study|Protocol Violation|2|||
145687358|NCT04879823|525370341|FG001|Overall Study|Protocol Violation|3|||
145687359|NCT04879823|525370340|FG000|Overall Study|Lost to Follow-up|43|||
145687360|NCT04879823|525370341|FG001|Overall Study|Lost to Follow-up|35|||
145687361|NCT04468633|525370342|FG000|Overall Study|Withdrawal by Subject|4|||
145687362|NCT04468633|525370343|FG001|Overall Study|Withdrawal by Subject|0|||
145687363|NCT02465866|525370344|FG000|Period 3|Withdrawal by Subject|0|||
145687364|NCT02465866|525370345|FG001|Period 3|Withdrawal by Subject|1|||
145687365|NCT02465866|525370346|FG002|Period 3|Withdrawal by Subject|0|||
145687366|NCT02465866|525370347|FG003|Period 3|Withdrawal by Subject|0|||
145687367|NCT02592434|525370348|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
145687368|NCT02592434|525370349|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
145687369|NCT02592434|525370350|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
145687370|NCT02592434|525370348|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
145687371|NCT02592434|525370349|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
145687372|NCT02592434|525370350|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
145687373|NCT02592434|525370348|FG000|Open-Label Phase (18 Weeks)|Other|3|||
145687374|NCT02592434|525370349|FG001|Open-Label Phase (18 Weeks)|Other|0|||
145687375|NCT02592434|525370350|FG002|Open-Label Phase (18 Weeks)|Other|0|||
145687376|NCT02592434|525370348|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
145687377|NCT02592434|525370349|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
145687378|NCT02592434|525370350|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
145687379|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
145687380|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
145687381|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
145687382|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
145687383|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
145687384|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
145687385|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Other|0|||
145687386|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Other|1|||
145687387|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Other|0|||
145687388|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
145687389|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
145687390|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
145687391|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
145687392|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
145687393|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
145687394|NCT02592434|525370348|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
145687395|NCT02592434|525370349|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
145687396|NCT02592434|525370350|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
145687397|NCT01469819|525370351|FG000|Overall Study|Withdrawal by Subject|1|||
145687398|NCT01469819|525370351|FG000|Overall Study|Did not meet inclusionary criteria|2|||
145491261|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
145687399|NCT01469819|525370351|FG000|Overall Study|Could not swallow SmartPill|2|||
145687400|NCT01469819|525370351|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
145687401|NCT01695993|525370354|FG000|Overall Study|Lost to Follow-up|2|||
145687402|NCT01695993|525370355|FG001|Overall Study|Lost to Follow-up|1|||
145687403|NCT01695993|525370356|FG002|Overall Study|Lost to Follow-up|3|||
145687404|NCT01695993|525370354|FG000|Overall Study|Withdrawal by Subject|2|||
145687405|NCT01695993|525370355|FG001|Overall Study|Withdrawal by Subject|2|||
145687406|NCT01695993|525370356|FG002|Overall Study|Withdrawal by Subject|2|||
145687407|NCT01695993|525370354|FG000|Overall Study|To ill to continue|1|||
145687408|NCT01695993|525370355|FG001|Overall Study|To ill to continue|2|||
145687409|NCT01695993|525370356|FG002|Overall Study|To ill to continue|0|||
145687410|NCT01695993|525370354|FG000|Overall Study|Changed Medical Facility|0|||
145491262|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
145491263|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
145491264|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
145491265|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
145491266|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
145491267|NCT03096834|524653722|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
145491268|NCT03096834|524653723|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
145491269|NCT03096834|524653724|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
145491270|NCT03096834|524653725|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
145491271|NCT03096834|524653722|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
145491272|NCT03096834|524653723|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
145491273|NCT03096834|524653724|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
145491274|NCT03096834|524653725|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
145491275|NCT03096834|524653722|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
145687411|NCT01695993|525370355|FG001|Overall Study|Changed Medical Facility|0|||
145687412|NCT01695993|525370356|FG002|Overall Study|Changed Medical Facility|1|||
145687413|NCT04057937|525370357|FG000|Placebo-controlled Phase|Adverse Event|3|||
145687414|NCT04057937|525370358|FG001|Placebo-controlled Phase|Adverse Event|0|||
145687415|NCT04057937|525370357|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
145687416|NCT04057937|525370358|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
145687417|NCT04057937|525370357|FG000|Active-treatment Phase|Pregnancy|0|||
145687418|NCT04057937|525370358|FG001|Active-treatment Phase|Pregnancy|1|||
145687419|NCT04057937|525370357|FG000|Active-treatment Phase|Physician Decision|0|||
145687420|NCT04057937|525370358|FG001|Active-treatment Phase|Physician Decision|1|||
145687421|NCT01072396|525370359|FG000|Period One|Adverse Event|1|||
145687422|NCT01072396|525370360|FG001|Period One|Adverse Event|1|||
145687423|NCT01072396|525370359|FG000|Period One|Protocol Violation|2|||
145687424|NCT01072396|525370360|FG001|Period One|Protocol Violation|1|||
145687425|NCT01072396|525370359|FG000|Period One|Withdrawal by Subject|2|||
145687426|NCT01072396|525370360|FG001|Period One|Withdrawal by Subject|0|||
145687427|NCT01072396|525370359|FG000|Washout Period|Missing termination information|0|||
145687428|NCT01072396|525370360|FG001|Washout Period|Missing termination information|1|||
145687429|NCT01072396|525370359|FG000|Period Two|Adverse Event|0|||
145687430|NCT01072396|525370360|FG001|Period Two|Adverse Event|3|||
145687431|NCT01072396|525370359|FG000|Period Two|Lost to Follow-up|1|||
145687432|NCT01072396|525370360|FG001|Period Two|Lost to Follow-up|0|||
145687433|NCT00472199|525370361|FG000|Overall Study|Adverse Event|19|||
145687434|NCT00472199|525370362|FG001|Overall Study|Adverse Event|23|||
145687435|NCT00472199|525370361|FG000|Overall Study|Lack of Efficacy|4|||
145687436|NCT00472199|525370362|FG001|Overall Study|Lack of Efficacy|25|||
145687437|NCT00472199|525370361|FG000|Overall Study|Lost to Follow-up|2|||
145687438|NCT00472199|525370362|FG001|Overall Study|Lost to Follow-up|4|||
145687439|NCT00472199|525370361|FG000|Overall Study|Protocol Violation|3|||
145265417|NCT00764465|523819355|FG003|Overall Study|Withdrawal by Subject|0|||
145687440|NCT00472199|525370362|FG001|Overall Study|Protocol Violation|2|||
145687441|NCT00472199|525370361|FG000|Overall Study|Withdrawal by Subject|6|||
145687442|NCT00472199|525370362|FG001|Overall Study|Withdrawal by Subject|5|||
145687443|NCT00472199|525370361|FG000|Overall Study|personal reason|0|||
145687444|NCT00472199|525370362|FG001|Overall Study|personal reason|1|||
145687445|NCT00472199|525370361|FG000|Overall Study|patient was asymptomatic|1|||
145687446|NCT00472199|525370362|FG001|Overall Study|patient was asymptomatic|0|||
145687447|NCT01268488|525370364|FG000|Overall Study|Adverse Event|3|||
145687448|NCT01268488|525370364|FG000|Overall Study|Physician Decision|2|||
145687449|NCT02475733|525370367|FG000|Overall Study|Withdrawal by Subject|1|||
145687450|NCT02475733|525370368|FG001|Overall Study|Withdrawal by Subject|0|||
145687451|NCT02475733|525370367|FG000|Overall Study|Physician Decision|1|||
145687452|NCT02475733|525370368|FG001|Overall Study|Physician Decision|0|||
145687453|NCT00475735|525370372|FG000|Treatment Period 1|Adverse Event|2|||
145687454|NCT00475735|525370373|FG001|Treatment Period 1|Adverse Event|0|||
145687455|NCT00475735|525370374|FG002|Treatment Period 1|Adverse Event|0|||
145687456|NCT00475735|525370375|FG003|Treatment Period 1|Adverse Event|0|||
145687457|NCT00475735|525370376|FG004|Treatment Period 1|Adverse Event|0|||
145687458|NCT00475735|525370377|FG005|Treatment Period 1|Adverse Event|0|||
145687459|NCT00475735|525370372|FG000|Treatment Period 1|Lack of Efficacy|1|||
145687460|NCT00475735|525370373|FG001|Treatment Period 1|Lack of Efficacy|0|||
145687461|NCT00475735|525370374|FG002|Treatment Period 1|Lack of Efficacy|0|||
145687462|NCT00475735|525370375|FG003|Treatment Period 1|Lack of Efficacy|0|||
145687463|NCT00475735|525370376|FG004|Treatment Period 1|Lack of Efficacy|0|||
145687464|NCT00475735|525370377|FG005|Treatment Period 1|Lack of Efficacy|0|||
145687465|NCT00475735|525370372|FG000|Treatment Period 1|Lost to Follow-up|0|||
145687466|NCT00475735|525370373|FG001|Treatment Period 1|Lost to Follow-up|0|||
145687467|NCT00475735|525370374|FG002|Treatment Period 1|Lost to Follow-up|0|||
145687468|NCT00475735|525370375|FG003|Treatment Period 1|Lost to Follow-up|0|||
145687469|NCT00475735|525370376|FG004|Treatment Period 1|Lost to Follow-up|0|||
145687470|NCT00475735|525370377|FG005|Treatment Period 1|Lost to Follow-up|1|||
145687471|NCT00475735|525370372|FG000|Treatment Period 1|Protocol Violation|0|||
145687472|NCT00475735|525370373|FG001|Treatment Period 1|Protocol Violation|0|||
145687473|NCT00475735|525370374|FG002|Treatment Period 1|Protocol Violation|0|||
145687474|NCT00475735|525370375|FG003|Treatment Period 1|Protocol Violation|1|||
145687475|NCT00475735|525370376|FG004|Treatment Period 1|Protocol Violation|0|||
145687476|NCT00475735|525370377|FG005|Treatment Period 1|Protocol Violation|0|||
145687477|NCT00475735|525370372|FG000|Treatment Period 1|Withdrawal by Subject|1|||
145687478|NCT00475735|525370373|FG001|Treatment Period 1|Withdrawal by Subject|1|||
145687479|NCT00475735|525370374|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145687480|NCT00475735|525370375|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145687481|NCT00475735|525370376|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145687482|NCT00475735|525370377|FG005|Treatment Period 1|Withdrawal by Subject|0|||
145687483|NCT00475735|525370372|FG000|Treatment Period 1|DC due to AE but continuing|0|||
145687484|NCT00475735|525370373|FG001|Treatment Period 1|DC due to AE but continuing|0|||
145687485|NCT00475735|525370374|FG002|Treatment Period 1|DC due to AE but continuing|0|||
145687486|NCT00475735|525370375|FG003|Treatment Period 1|DC due to AE but continuing|1|||
145687487|NCT00475735|525370376|FG004|Treatment Period 1|DC due to AE but continuing|2|||
145687488|NCT00475735|525370377|FG005|Treatment Period 1|DC due to AE but continuing|2|||
145687489|NCT00475735|525370372|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
145687490|NCT00475735|525370373|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
145687491|NCT00475735|525370374|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
145687492|NCT00475735|525370375|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
145687493|NCT00475735|525370376|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
145687494|NCT00475735|525370377|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
145687495|NCT00475735|525370372|FG000|Treatment Washout|Lost to Follow-up|0|||
145687496|NCT00475735|525370373|FG001|Treatment Washout|Lost to Follow-up|1|||
145687497|NCT00475735|525370374|FG002|Treatment Washout|Lost to Follow-up|0|||
145687498|NCT00475735|525370375|FG003|Treatment Washout|Lost to Follow-up|0|||
145687499|NCT00475735|525370376|FG004|Treatment Washout|Lost to Follow-up|0|||
145687500|NCT00475735|525370377|FG005|Treatment Washout|Lost to Follow-up|0|||
145687501|NCT00475735|525370372|FG000|Treatment Washout|Protocol Violation|0|||
145687502|NCT00475735|525370373|FG001|Treatment Washout|Protocol Violation|1|||
145687503|NCT00475735|525370374|FG002|Treatment Washout|Protocol Violation|0|||
145687504|NCT00475735|525370375|FG003|Treatment Washout|Protocol Violation|0|||
145687505|NCT00475735|525370376|FG004|Treatment Washout|Protocol Violation|0|||
145687506|NCT00475735|525370377|FG005|Treatment Washout|Protocol Violation|0|||
145687507|NCT00475735|525370372|FG000|Treatment Period 2|Adverse Event|0|||
145687508|NCT00475735|525370373|FG001|Treatment Period 2|Adverse Event|1|||
145687509|NCT00475735|525370374|FG002|Treatment Period 2|Adverse Event|0|||
145687510|NCT00475735|525370375|FG003|Treatment Period 2|Adverse Event|2|||
145687511|NCT00475735|525370376|FG004|Treatment Period 2|Adverse Event|0|||
145687512|NCT00475735|525370377|FG005|Treatment Period 2|Adverse Event|0|||
145687513|NCT00475735|525370372|FG000|Treatment Period 2|Lack of Efficacy|0|||
145687514|NCT00475735|525370373|FG001|Treatment Period 2|Lack of Efficacy|0|||
145687515|NCT00475735|525370374|FG002|Treatment Period 2|Lack of Efficacy|0|||
145687516|NCT00475735|525370375|FG003|Treatment Period 2|Lack of Efficacy|0|||
145687517|NCT00475735|525370376|FG004|Treatment Period 2|Lack of Efficacy|0|||
145687518|NCT00475735|525370377|FG005|Treatment Period 2|Lack of Efficacy|1|||
145687519|NCT00475735|525370372|FG000|Treatment Period 2|Withdrawal by Subject|0|||
145687520|NCT00475735|525370373|FG001|Treatment Period 2|Withdrawal by Subject|0|||
145687521|NCT00475735|525370374|FG002|Treatment Period 2|Withdrawal by Subject|0|||
145687522|NCT00475735|525370375|FG003|Treatment Period 2|Withdrawal by Subject|0|||
145687523|NCT00475735|525370376|FG004|Treatment Period 2|Withdrawal by Subject|1|||
145687524|NCT00475735|525370377|FG005|Treatment Period 2|Withdrawal by Subject|0|||
145687525|NCT01014013|525370378|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
145687526|NCT01014013|525370379|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
145687527|NCT01014013|525370378|FG000|Overall Study|Clinical adverse experience|4|||
145687528|NCT01014013|525370379|FG001|Overall Study|Clinical adverse experience|2|||
145687529|NCT01014013|525370378|FG000|Overall Study|Laboratory adverse experience|1|||
145687530|NCT01014013|525370379|FG001|Overall Study|Laboratory adverse experience|1|||
145687531|NCT01014013|525370378|FG000|Overall Study|Protocol Violation|1|||
145687532|NCT01014013|525370379|FG001|Overall Study|Protocol Violation|3|||
145687533|NCT01014013|525370378|FG000|Overall Study|Withdrawal by Subject|7|||
145687534|NCT01014013|525370379|FG001|Overall Study|Withdrawal by Subject|4|||
145687535|NCT01014013|525370378|FG000|Overall Study|Clinical/microbiologic failure|1|||
145687536|NCT01014013|525370379|FG001|Overall Study|Clinical/microbiologic failure|2|||
145687537|NCT01014013|525370378|FG000|Overall Study|Pathogen culture = no growth|26|||
145687538|NCT01014013|525370379|FG001|Overall Study|Pathogen culture = no growth|34|||
145687539|NCT01014013|525370378|FG000|Overall Study|Negative urine culture|2|||
145687540|NCT01014013|525370379|FG001|Overall Study|Negative urine culture|0|||
145687541|NCT01014013|525370378|FG000|Overall Study|Pathogen resistant|7|||
145687542|NCT01014013|525370379|FG001|Overall Study|Pathogen resistant|4|||
145687543|NCT01014013|525370378|FG000|Overall Study|Physician Decision|0|||
145687544|NCT01014013|525370379|FG001|Overall Study|Physician Decision|1|||
145687545|NCT01014013|525370378|FG000|Overall Study|Another antibiotic therapy required|0|||
145687546|NCT01014013|525370379|FG001|Overall Study|Another antibiotic therapy required|1|||
145687547|NCT01014013|525370378|FG000|Overall Study|Appendectomy|1|||
145687548|NCT01014013|525370379|FG001|Overall Study|Appendectomy|0|||
145687549|NCT01014013|525370378|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
145687550|NCT01014013|525370379|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
145687551|NCT02305797|525370386|FG000|Overall Study|Adverse Event|11|||
145687552|NCT02305797|525370387|FG001|Overall Study|Adverse Event|2|||
145687553|NCT02305797|525370386|FG000|Overall Study|Withdrawal by Subject|9|||
145687554|NCT02305797|525370387|FG001|Overall Study|Withdrawal by Subject|10|||
145687555|NCT02305797|525370386|FG000|Overall Study|Lack of Efficacy|6|||
145687556|NCT02305797|525370387|FG001|Overall Study|Lack of Efficacy|0|||
145687557|NCT02305797|525370386|FG000|Overall Study|Lost to Follow-up|5|||
145687558|NCT02305797|525370387|FG001|Overall Study|Lost to Follow-up|11|||
145687559|NCT02305797|525370386|FG000|Overall Study|Pregnancy|0|||
145687560|NCT02305797|525370387|FG001|Overall Study|Pregnancy|2|||
145687561|NCT02305797|525370386|FG000|Overall Study|Noncompliance|14|||
145687562|NCT02305797|525370387|FG001|Overall Study|Noncompliance|12|||
145687563|NCT02305797|525370386|FG000|Overall Study|Reason not collected|0|||
145687564|NCT02305797|525370387|FG001|Overall Study|Reason not collected|1|||
145687565|NCT02097056|525370388|FG000|Overall Study|Protocol Violation|2|||
145687566|NCT02097056|525370388|FG000|Overall Study|Withdrawal by Subject|15|||
145687567|NCT02097056|525370388|FG000|Overall Study|Lost to Follow-up|2|||
145687568|NCT02097056|525370388|FG000|Overall Study|Adverse Event|37|||
145687569|NCT02097056|525370388|FG000|Overall Study|Other|2|||
145687570|NCT03906240|525370391|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
145687571|NCT03906240|525370392|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
145687572|NCT03906240|525370391|FG000|Overall Study|Lost to Follow-up|1|||
145687573|NCT03906240|525370392|FG001|Overall Study|Lost to Follow-up|0|||
145687574|NCT03906240|525370391|FG000|Overall Study|Withdrawal by Subject|0|||
145687575|NCT03906240|525370392|FG001|Overall Study|Withdrawal by Subject|1|||
145687576|NCT01446042|525370393|FG000|Overall Study|Withdrawal by Subject|12|||
145687577|NCT01446042|525370394|FG001|Overall Study|Withdrawal by Subject|2|||
145687578|NCT01446042|525370395|FG002|Overall Study|Withdrawal by Subject|4|||
145687579|NCT01446042|525370393|FG000|Overall Study|Adverse Event|1|||
145491276|NCT03096834|524653723|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
145491277|NCT03096834|524653724|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
145687580|NCT01446042|525370394|FG001|Overall Study|Adverse Event|0|||
145687581|NCT01446042|525370395|FG002|Overall Study|Adverse Event|4|||
145687582|NCT01446042|525370393|FG000|Overall Study|Lost to Follow-up|5|||
145687583|NCT01446042|525370394|FG001|Overall Study|Lost to Follow-up|0|||
145687584|NCT01446042|525370395|FG002|Overall Study|Lost to Follow-up|0|||
145687585|NCT01446042|525370393|FG000|Overall Study|Other reasons|2|||
145687586|NCT01446042|525370394|FG001|Overall Study|Other reasons|1|||
145687587|NCT01446042|525370395|FG002|Overall Study|Other reasons|1|||
145687588|NCT01078571|525370406|FG000|Overall Study|Adverse Event|36|||
145687589|NCT01078571|525370406|FG000|Overall Study|Lack of effectiveness|36|||
145687590|NCT01078571|525370406|FG000|Overall Study|Reason not reported|21|||
145687591|NCT01078571|525370406|FG000|Overall Study|Withdrawal by Subject|12|||
145687592|NCT01078571|525370406|FG000|Overall Study|Lost to Follow-up|8|||
145687593|NCT01078571|525370406|FG000|Overall Study|Protocol Violation|2|||
145687594|NCT01047306|525370410|FG000|Overall Study|Withdrawal by Subject|2|||
145687595|NCT01047306|525370411|FG001|Overall Study|Withdrawal by Subject|0|||
145687596|NCT01047306|525370410|FG000|Overall Study|Lost to Follow-up|1|||
145687597|NCT01047306|525370411|FG001|Overall Study|Lost to Follow-up|0|||
145687598|NCT01878253|525370413|FG000|Overall Study|Death|1|||
145687599|NCT01878253|525370413|FG000|Overall Study|SIdus System Removal|3|||
145687600|NCT01878253|525370413|FG000|Overall Study|Withdrawal by Subject|1|||
145687601|NCT01878253|525370413|FG000|Overall Study|Lost to Follow-up|2|||
145687602|NCT01878253|525370413|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
145687603|NCT02374476|525370422|FG000|VT Induced Ablation|Screening Failures|36|||
145687604|NCT02374476|525370423|FG001|VT Induced Ablation|Screening Failures|0|||
145687605|NCT02374476|525370424|FG002|VT Induced Ablation|Screening Failures|0|||
145687606|NCT02374476|525370422|FG000|Arm Assignment|Withdrawal by Subject|0|||
145687607|NCT02374476|525370423|FG001|Arm Assignment|Withdrawal by Subject|0|||
145687608|NCT02374476|525370424|FG002|Arm Assignment|Withdrawal by Subject|1|||
145687609|NCT05431543|525370425|FG000|Overall Study|Medical History|1|||
145687610|NCT05431543|525370426|FG001|Overall Study|Medical History|0|||
145687611|NCT05431543|525370427|FG002|Overall Study|Medical History|0|||
145687612|NCT01945086|525370430|FG000|Overall Study|Withdrawal by Subject|1|||
145687613|NCT01945086|525370431|FG001|Overall Study|Withdrawal by Subject|0|||
145687614|NCT01945086|525370432|FG002|Overall Study|Withdrawal by Subject|1|||
145687615|NCT01945086|525370430|FG000|Overall Study|Adverse Event|0|||
145687616|NCT01945086|525370431|FG001|Overall Study|Adverse Event|0|||
145687617|NCT01945086|525370432|FG002|Overall Study|Adverse Event|1|||
145687618|NCT04853394|525370434|FG000|Follow-up Interviews|Lost to Follow-up|22|||
145687619|NCT04853394|525370435|FG001|Follow-up Interviews|Lost to Follow-up|15|||
145687620|NCT00748098|525370438|FG000|First Treatment Intervention Period|Adverse Event|1|||
145687621|NCT00748098|525370439|FG001|First Treatment Intervention Period|Adverse Event|1|||
145687622|NCT00748098|525370438|FG000|First Treatment Intervention Period|Protocol Violation|1|||
145687623|NCT00748098|525370439|FG001|First Treatment Intervention Period|Protocol Violation|0|||
145687624|NCT00748098|525370438|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
145687625|NCT00748098|525370439|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
145687626|NCT00748098|525370438|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
145687627|NCT00748098|525370439|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
145687628|NCT00748098|525370438|FG000|First Taper Period|Protocol Violation|1|||
145687629|NCT00748098|525370439|FG001|First Taper Period|Protocol Violation|0|||
145687630|NCT00748098|525370438|FG000|First Taper Period|Withdrawal by Subject|2|||
145687631|NCT00748098|525370439|FG001|First Taper Period|Withdrawal by Subject|0|||
145687632|NCT00748098|525370438|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
145687633|NCT00748098|525370439|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
145687634|NCT00748098|525370438|FG000|1-Week Washout Period|Adverse Event|0|||
145687635|NCT00748098|525370439|FG001|1-Week Washout Period|Adverse Event|1|||
145687636|NCT00748098|525370438|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
145687637|NCT00748098|525370439|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
145687638|NCT00748098|525370438|FG000|Second Treatment Intervention Period|Adverse Event|4|||
145687639|NCT00748098|525370439|FG001|Second Treatment Intervention Period|Adverse Event|1|||
145687640|NCT00748098|525370438|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
145687641|NCT00748098|525370439|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
145687642|NCT00748098|525370438|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
145687643|NCT00748098|525370439|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
145687644|NCT04212299|525370440|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
145687645|NCT00644332|525372247|FG000|Overall Study|Adverse Event|11|||
145687646|NCT00644332|525372247|FG000|Overall Study|Withdrawal by Subject|6|||
145687647|NCT00644332|525372247|FG000|Overall Study|Completion Status Unknown|2|||
145687648|NCT00644332|525372247|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
145687649|NCT00644332|525372247|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
145687650|NCT03694210|525372248|FG000|Overall Study|Death|1|||
145687651|NCT03694210|525372248|FG000|Overall Study|Screen Failure|7|||
145687652|NCT00443755|525372249|FG000|Overall Study|Withdrawal by Subject|2|||
145687653|NCT00443755|525372250|FG001|Overall Study|Withdrawal by Subject|1|||
145687654|NCT02706834|525372254|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145687655|NCT02706834|525372255|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
145687656|NCT02706834|525372256|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145687657|NCT02706834|525372257|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
145687658|NCT02706834|525372258|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
145687659|NCT02706834|525372259|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
145687660|NCT02706834|525372260|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
145491278|NCT03096834|524653725|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
145687661|NCT02706834|525372261|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
145687662|NCT02706834|525372262|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
145687663|NCT02706834|525372263|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
145687664|NCT02706834|525372264|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
145687665|NCT02706834|525372254|FG000|Overall Study|Lost to Follow-up|0|||
145687666|NCT02706834|525372255|FG001|Overall Study|Lost to Follow-up|0|||
145687667|NCT02706834|525372256|FG002|Overall Study|Lost to Follow-up|1|||
145687668|NCT02706834|525372257|FG003|Overall Study|Lost to Follow-up|0|||
145687669|NCT02706834|525372258|FG004|Overall Study|Lost to Follow-up|0|||
145687670|NCT02706834|525372259|FG005|Overall Study|Lost to Follow-up|0|||
145687671|NCT02706834|525372260|FG006|Overall Study|Lost to Follow-up|0|||
145687672|NCT02706834|525372261|FG007|Overall Study|Lost to Follow-up|0|||
145687673|NCT02706834|525372262|FG008|Overall Study|Lost to Follow-up|0|||
145687674|NCT02706834|525372263|FG009|Overall Study|Lost to Follow-up|0|||
145687675|NCT02706834|525372264|FG010|Overall Study|Lost to Follow-up|0|||
145687676|NCT02706834|525372254|FG000|Overall Study|Voluntary Withdrawal|1|||
145687677|NCT02706834|525372255|FG001|Overall Study|Voluntary Withdrawal|0|||
145687678|NCT02706834|525372256|FG002|Overall Study|Voluntary Withdrawal|0|||
145687679|NCT02706834|525372257|FG003|Overall Study|Voluntary Withdrawal|0|||
145687680|NCT02706834|525372258|FG004|Overall Study|Voluntary Withdrawal|0|||
145687681|NCT02706834|525372259|FG005|Overall Study|Voluntary Withdrawal|0|||
145687682|NCT02706834|525372260|FG006|Overall Study|Voluntary Withdrawal|0|||
145687683|NCT02706834|525372261|FG007|Overall Study|Voluntary Withdrawal|0|||
145687684|NCT02706834|525372262|FG008|Overall Study|Voluntary Withdrawal|0|||
145687685|NCT02706834|525372263|FG009|Overall Study|Voluntary Withdrawal|1|||
145687686|NCT02706834|525372264|FG010|Overall Study|Voluntary Withdrawal|0|||
145687687|NCT02706834|525372254|FG000|Overall Study|Other Reason Not Specified|1|||
145687688|NCT02706834|525372255|FG001|Overall Study|Other Reason Not Specified|0|||
145687689|NCT02706834|525372256|FG002|Overall Study|Other Reason Not Specified|0|||
145687690|NCT02706834|525372257|FG003|Overall Study|Other Reason Not Specified|0|||
145687691|NCT02706834|525372258|FG004|Overall Study|Other Reason Not Specified|1|||
145687692|NCT02706834|525372259|FG005|Overall Study|Other Reason Not Specified|0|||
145687693|NCT02706834|525372260|FG006|Overall Study|Other Reason Not Specified|0|||
145687694|NCT02706834|525372261|FG007|Overall Study|Other Reason Not Specified|0|||
145687695|NCT02706834|525372262|FG008|Overall Study|Other Reason Not Specified|0|||
145687696|NCT02706834|525372263|FG009|Overall Study|Other Reason Not Specified|0|||
145687697|NCT02706834|525372264|FG010|Overall Study|Other Reason Not Specified|0|||
145687698|NCT00678899|525372269|FG000|Overall Study|Adverse Event|1|||
145687699|NCT04385849|525372270|FG000|Overall Study|Lost to Follow-up|1|||
145687700|NCT04385849|525372271|FG001|Overall Study|Lost to Follow-up|0|||
145687701|NCT01375777|525372272|FG000|Overall Study|Withdrawal by Subject|0|||
145687702|NCT01375777|525372273|FG001|Overall Study|Withdrawal by Subject|2|||
145687703|NCT01375777|525372274|FG002|Overall Study|Withdrawal by Subject|1|||
145687704|NCT01375777|525372275|FG003|Overall Study|Withdrawal by Subject|0|||
145687705|NCT01375777|525372276|FG004|Overall Study|Withdrawal by Subject|1|||
145687706|NCT01375777|525372277|FG005|Overall Study|Withdrawal by Subject|1|||
145687707|NCT01375777|525372278|FG006|Overall Study|Withdrawal by Subject|1|||
145687708|NCT01375777|525372279|FG007|Overall Study|Withdrawal by Subject|2|||
145687709|NCT01375777|525372280|FG008|Overall Study|Withdrawal by Subject|1|||
145687710|NCT01375777|525372272|FG000|Overall Study|Lost to Follow-up|1|||
145687711|NCT01375777|525372273|FG001|Overall Study|Lost to Follow-up|0|||
145687712|NCT01375777|525372274|FG002|Overall Study|Lost to Follow-up|0|||
145687713|NCT01375777|525372275|FG003|Overall Study|Lost to Follow-up|0|||
145687714|NCT01375777|525372276|FG004|Overall Study|Lost to Follow-up|0|||
145687715|NCT01375777|525372277|FG005|Overall Study|Lost to Follow-up|0|||
145687716|NCT01375777|525372278|FG006|Overall Study|Lost to Follow-up|1|||
145687717|NCT01375777|525372279|FG007|Overall Study|Lost to Follow-up|0|||
145687718|NCT01375777|525372280|FG008|Overall Study|Lost to Follow-up|0|||
145687719|NCT01375777|525372272|FG000|Overall Study|Other|1|||
145687720|NCT01375777|525372273|FG001|Overall Study|Other|1|||
145687721|NCT01375777|525372274|FG002|Overall Study|Other|0|||
145687722|NCT01375777|525372275|FG003|Overall Study|Other|0|||
145687723|NCT01375777|525372276|FG004|Overall Study|Other|0|||
145687724|NCT01375777|525372277|FG005|Overall Study|Other|0|||
145687725|NCT01375777|525372278|FG006|Overall Study|Other|0|||
145687726|NCT01375777|525372279|FG007|Overall Study|Other|0|||
145687727|NCT01375777|525372280|FG008|Overall Study|Other|1|||
145687728|NCT00355784|525372281|FG000|Overall Study|Withdrawal by Subject|0|||
145687729|NCT00355784|525372282|FG001|Overall Study|Withdrawal by Subject|0|||
145687730|NCT00355784|525372283|FG002|Overall Study|Withdrawal by Subject|2|||
145687731|NCT02543294|525372284|FG000|Overall Study|Lost to Follow-up|3|||
145687732|NCT02543294|525372284|FG000|Overall Study|Physician Decision|2|||
145687733|NCT02543294|525372284|FG000|Overall Study|Withdrawal by Subject|7|||
145687734|NCT02339506|525372285|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
145687735|NCT02339506|525372286|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
145687736|NCT02339506|525372285|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
145687737|NCT02339506|525372286|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
145687738|NCT03672188|525372287|FG000|Overall Study|Withdrawal by Subject|0|||
145687739|NCT03672188|525372288|FG001|Overall Study|Withdrawal by Subject|0|||
145687740|NCT03672188|525372289|FG002|Overall Study|Withdrawal by Subject|0|||
145687741|NCT03672188|525372290|FG003|Overall Study|Withdrawal by Subject|3|||
145687742|NCT03672188|525372291|FG004|Overall Study|Withdrawal by Subject|0|||
145687743|NCT03672188|525372292|FG005|Overall Study|Withdrawal by Subject|0|||
145687744|NCT03672188|525372293|FG006|Overall Study|Withdrawal by Subject|0|||
145687745|NCT03672188|525372294|FG007|Overall Study|Withdrawal by Subject|0|||
145687746|NCT03672188|525372295|FG008|Overall Study|Withdrawal by Subject|0|||
145687747|NCT03672188|525372296|FG009|Overall Study|Withdrawal by Subject|0|||
145687748|NCT03672188|525372297|FG010|Overall Study|Withdrawal by Subject|0|||
145687749|NCT03672188|525372298|FG011|Overall Study|Withdrawal by Subject|0|||
145687750|NCT03672188|525372299|FG012|Overall Study|Withdrawal by Subject|0|||
145687751|NCT03672188|525372300|FG013|Overall Study|Withdrawal by Subject|0|||
145687752|NCT03672188|525372301|FG014|Overall Study|Withdrawal by Subject|0|||
145687753|NCT03672188|525372287|FG000|Overall Study|Death|0|||
145687754|NCT03672188|525372288|FG001|Overall Study|Death|0|||
145687755|NCT03672188|525372289|FG002|Overall Study|Death|0|||
145687756|NCT03672188|525372290|FG003|Overall Study|Death|0|||
145687757|NCT03672188|525372291|FG004|Overall Study|Death|0|||
145687758|NCT03672188|525372292|FG005|Overall Study|Death|0|||
145687759|NCT03672188|525372293|FG006|Overall Study|Death|0|||
145687760|NCT03672188|525372294|FG007|Overall Study|Death|0|||
145687761|NCT03672188|525372295|FG008|Overall Study|Death|0|||
145687762|NCT03672188|525372296|FG009|Overall Study|Death|0|||
145687763|NCT03672188|525372297|FG010|Overall Study|Death|0|||
145687764|NCT03672188|525372298|FG011|Overall Study|Death|0|||
145687765|NCT03672188|525372299|FG012|Overall Study|Death|1|||
145687766|NCT03672188|525372300|FG013|Overall Study|Death|0|||
145687767|NCT03672188|525372301|FG014|Overall Study|Death|0|||
145687768|NCT03672188|525372287|FG000|Overall Study|Lost to Follow-up|0|||
145687769|NCT03672188|525372288|FG001|Overall Study|Lost to Follow-up|0|||
145687770|NCT03672188|525372289|FG002|Overall Study|Lost to Follow-up|1|||
145687771|NCT03672188|525372290|FG003|Overall Study|Lost to Follow-up|0|||
145687772|NCT03672188|525372291|FG004|Overall Study|Lost to Follow-up|0|||
145687773|NCT03672188|525372292|FG005|Overall Study|Lost to Follow-up|0|||
145687774|NCT03672188|525372293|FG006|Overall Study|Lost to Follow-up|0|||
145687775|NCT03672188|525372294|FG007|Overall Study|Lost to Follow-up|0|||
145687776|NCT03672188|525372295|FG008|Overall Study|Lost to Follow-up|0|||
145687777|NCT03672188|525372296|FG009|Overall Study|Lost to Follow-up|0|||
145687778|NCT03672188|525372297|FG010|Overall Study|Lost to Follow-up|0|||
145687779|NCT03672188|525372298|FG011|Overall Study|Lost to Follow-up|0|||
145687780|NCT03672188|525372299|FG012|Overall Study|Lost to Follow-up|0|||
145687781|NCT03672188|525372300|FG013|Overall Study|Lost to Follow-up|0|||
145687782|NCT03672188|525372301|FG014|Overall Study|Lost to Follow-up|0|||
145687783|NCT03997409|525372302|FG000|Overall Study|Protocol Violation|1|||
145687784|NCT03997409|525372303|FG001|Overall Study|Protocol Violation|1|||
145687785|NCT03997409|525372304|FG002|Overall Study|Protocol Violation|0|||
145687786|NCT03997409|525372302|FG000|Overall Study|Withdrawal by Subject|3|||
145687787|NCT03997409|525372303|FG001|Overall Study|Withdrawal by Subject|0|||
145687788|NCT03997409|525372304|FG002|Overall Study|Withdrawal by Subject|0|||
145687789|NCT03997409|525372302|FG000|Overall Study|Lost to Follow-up|0|||
145687790|NCT03997409|525372303|FG001|Overall Study|Lost to Follow-up|0|||
145687791|NCT03997409|525372304|FG002|Overall Study|Lost to Follow-up|1|||
145687792|NCT00907517|525372305|FG000|Overall Study|Progressive Disease|3|||
145687793|NCT00907517|525372306|FG001|Overall Study|Progressive Disease|3|||
145687794|NCT00907517|525372307|FG002|Overall Study|Progressive Disease|4|||
145687795|NCT00907517|525372308|FG003|Overall Study|Progressive Disease|4|||
145687796|NCT00907517|525372309|FG004|Overall Study|Progressive Disease|4|||
145687797|NCT00907517|525372305|FG000|Overall Study|Symptomatic Deterioration|0|||
145687798|NCT00907517|525372306|FG001|Overall Study|Symptomatic Deterioration|0|||
145687799|NCT00907517|525372307|FG002|Overall Study|Symptomatic Deterioration|0|||
145687800|NCT00907517|525372308|FG003|Overall Study|Symptomatic Deterioration|0|||
145687801|NCT00907517|525372309|FG004|Overall Study|Symptomatic Deterioration|1|||
145687802|NCT02029521|525372311|FG000|Overall Study|Protocol Violation|1|||
145687803|NCT02029521|525372312|FG001|Overall Study|Protocol Violation|0|||
145687804|NCT02029521|525372311|FG000|Overall Study|Withdrawal by Subject|1|||
145687805|NCT02029521|525372312|FG001|Overall Study|Withdrawal by Subject|1|||
145687806|NCT02446912|525372313|FG000|Overall Study|Adverse Event|3|||
145687807|NCT02446912|525372314|FG001|Overall Study|Adverse Event|13|||
145687808|NCT02446912|525372315|FG002|Overall Study|Adverse Event|5|||
145687809|NCT02446912|525372313|FG000|Overall Study|Condition under investigation worsened|0|||
145687810|NCT02446912|525372314|FG001|Overall Study|Condition under investigation worsened|1|||
145687811|NCT02446912|525372315|FG002|Overall Study|Condition under investigation worsened|1|||
145687812|NCT02446912|525372313|FG000|Overall Study|Study-specific withdrawal criteria|1|||
145687813|NCT02446912|525372314|FG001|Overall Study|Study-specific withdrawal criteria|0|||
145687814|NCT02446912|525372315|FG002|Overall Study|Study-specific withdrawal criteria|0|||
145687815|NCT02446912|525372313|FG000|Overall Study|Lack of Efficacy|1|||
145687816|NCT02446912|525372314|FG001|Overall Study|Lack of Efficacy|4|||
145687817|NCT02446912|525372315|FG002|Overall Study|Lack of Efficacy|7|||
145687818|NCT02446912|525372313|FG000|Overall Study|Lost to Follow-up|0|||
145687819|NCT02446912|525372314|FG001|Overall Study|Lost to Follow-up|0|||
145687820|NCT02446912|525372315|FG002|Overall Study|Lost to Follow-up|2|||
145687821|NCT02446912|525372313|FG000|Overall Study|Severe non-compliance to protocol|1|||
145687822|NCT02446912|525372314|FG001|Overall Study|Severe non-compliance to protocol|0|||
145687823|NCT02446912|525372315|FG002|Overall Study|Severe non-compliance to protocol|1|||
145687824|NCT02446912|525372313|FG000|Overall Study|Withdrawal by Subject|10|||
145687825|NCT02446912|525372314|FG001|Overall Study|Withdrawal by Subject|15|||
145687826|NCT02446912|525372315|FG002|Overall Study|Withdrawal by Subject|15|||
145687827|NCT02446912|525372313|FG000|Overall Study|Miscellaneous|2|||
145687828|NCT02446912|525372314|FG001|Overall Study|Miscellaneous|2|||
145687829|NCT02446912|525372315|FG002|Overall Study|Miscellaneous|4|||
145687830|NCT01106586|525372318|FG000|Overall Study|Adverse Event|9|||
145687831|NCT01106586|525372319|FG001|Overall Study|Adverse Event|15|||
145687832|NCT01106586|525372318|FG000|Overall Study|Death|1|||
145687833|NCT01106586|525372319|FG001|Overall Study|Death|3|||
145687834|NCT01106586|525372318|FG000|Overall Study|Pregnancy|2|||
145687835|NCT01106586|525372319|FG001|Overall Study|Pregnancy|2|||
145687836|NCT01106586|525372318|FG000|Overall Study|Lack of Efficacy|1|||
145687837|NCT01106586|525372319|FG001|Overall Study|Lack of Efficacy|0|||
145687838|NCT01106586|525372318|FG000|Overall Study|Investigator's Discretion|5|||
145687839|NCT01106586|525372319|FG001|Overall Study|Investigator's Discretion|8|||
145687840|NCT01106586|525372318|FG000|Overall Study|Withdrew Consent|18|||
145687841|NCT01106586|525372319|FG001|Overall Study|Withdrew Consent|30|||
145687842|NCT01106586|525372318|FG000|Overall Study|Lost to Follow-up|24|||
145687843|NCT01106586|525372319|FG001|Overall Study|Lost to Follow-up|20|||
145687844|NCT01106586|525372318|FG000|Overall Study|Participant Noncompliance|12|||
145687845|NCT01106586|525372319|FG001|Overall Study|Participant Noncompliance|10|||
145687846|NCT01106586|525372318|FG000|Overall Study|Protocol Violation|1|||
145687847|NCT01106586|525372319|FG001|Overall Study|Protocol Violation|0|||
145687848|NCT01106586|525372318|FG000|Overall Study|Participant Transferred to Another Study|212|||
145687849|NCT01106586|525372319|FG001|Overall Study|Participant Transferred to Another Study|197|||
145687850|NCT01757171|525372320|FG000|Overall Study|Adverse Event|5|||
145687851|NCT01757171|525372321|FG001|Overall Study|Adverse Event|1|||
145687852|NCT01757171|525372320|FG000|Overall Study|Disease Progression|1|||
145687853|NCT01757171|525372321|FG001|Overall Study|Disease Progression|0|||
145687854|NCT01757171|525372320|FG000|Overall Study|Hospitalization|1|||
145687855|NCT01757171|525372321|FG001|Overall Study|Hospitalization|0|||
145687856|NCT01757171|525372320|FG000|Overall Study|ECOG decline|1|||
145687857|NCT01757171|525372321|FG001|Overall Study|ECOG decline|0|||
145687858|NCT02504502|525372322|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
145687859|NCT02504502|525372323|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
145687860|NCT02504502|525372322|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
145687861|NCT02504502|525372323|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
145687862|NCT00428441|525372324|FG000|Overall Study|Lost to Follow-up|1|||
145687863|NCT02131155|525372327|FG000|Overall Study|Adverse Event|1|||
145687864|NCT02131155|525372328|FG001|Overall Study|Adverse Event|0|||
145687865|NCT02131155|525372327|FG000|Overall Study|Treatment completed|1|||
145687866|NCT02131155|525372328|FG001|Overall Study|Treatment completed|0|||
145687867|NCT02131155|525372327|FG000|Overall Study|Primary tumour recurrence|2|||
145687868|NCT02131155|525372328|FG001|Overall Study|Primary tumour recurrence|1|||
145687869|NCT02131155|525372327|FG000|Overall Study|Refused to continue study medication|1|||
145687870|NCT02131155|525372328|FG001|Overall Study|Refused to continue study medication|0|||
145687871|NCT02131155|525372327|FG000|Overall Study|Study early termination|20|||
145687872|NCT02131155|525372328|FG001|Overall Study|Study early termination|10|||
145687873|NCT01887418|525372329|FG000|Overall Study|Travelling difficulties|0|||
145687874|NCT01887418|525372330|FG001|Overall Study|Travelling difficulties|0|||
145687875|NCT01887418|525372331|FG002|Overall Study|Travelling difficulties|1|||
145687876|NCT03132753|525372332|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
145687877|NCT03132753|525372333|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
145687878|NCT03132753|525372332|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
145687879|NCT03132753|525372333|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
145687880|NCT00084747|525372334|FG000|Overall Study|Relapsed|8|||
145687881|NCT00084747|525372334|FG000|Overall Study|Death|3|||
145687882|NCT00084747|525372334|FG000|Overall Study|Withdrawal by Subject|2|||
145687883|NCT02744898|525372336|FG000|Overall Study|Progressive Disease|2|||
145687884|NCT02744898|525372336|FG000|Overall Study|Physician Decision|1|||
145687885|NCT02744898|525372336|FG000|Overall Study|Toxicity|1|||
145687886|NCT03751280|525372338|FG000|Overall Study|Adverse Event|0|||
145687887|NCT03751280|525372339|FG001|Overall Study|Adverse Event|1|||
145687888|NCT03751280|525372338|FG000|Overall Study|Lost to Follow-up|3|||
145687889|NCT03751280|525372339|FG001|Overall Study|Lost to Follow-up|5|||
145687890|NCT03751280|525372338|FG000|Overall Study|Physician Decision|0|||
145687891|NCT03751280|525372339|FG001|Overall Study|Physician Decision|2|||
145687892|NCT03751280|525372338|FG000|Overall Study|Protocol Violation|0|||
145687893|NCT03751280|525372339|FG001|Overall Study|Protocol Violation|2|||
145687894|NCT03751280|525372338|FG000|Overall Study|Withdrawal by Subject|5|||
145687895|NCT03751280|525372339|FG001|Overall Study|Withdrawal by Subject|2|||
145687896|NCT00296504|525372340|FG000|Interim Analysis|Withdrawal by Subject|8|||
145687897|NCT00296504|525372341|FG001|Interim Analysis|Withdrawal by Subject|0|||
145687898|NCT00296504|525372342|FG002|Interim Analysis|Withdrawal by Subject|12|||
145687899|NCT00296504|525372343|FG003|Interim Analysis|Withdrawal by Subject|0|||
145687900|NCT00296504|525372344|FG004|Interim Analysis|Withdrawal by Subject|5|||
145687901|NCT00296504|525372345|FG005|Interim Analysis|Withdrawal by Subject|5|||
145687902|NCT00296504|525372346|FG006|Interim Analysis|Withdrawal by Subject|9|||
145687903|NCT00296504|525372347|FG007|Interim Analysis|Withdrawal by Subject|3|||
145687904|NCT00296504|525372348|FG008|Interim Analysis|Withdrawal by Subject|0|||
145687905|NCT00296504|525372340|FG000|Interim Analysis|Lost to Follow-up|13|||
145687906|NCT00296504|525372341|FG001|Interim Analysis|Lost to Follow-up|3|||
145687907|NCT00296504|525372342|FG002|Interim Analysis|Lost to Follow-up|26|||
145687908|NCT00296504|525372343|FG003|Interim Analysis|Lost to Follow-up|8|||
145687909|NCT00296504|525372344|FG004|Interim Analysis|Lost to Follow-up|14|||
145687910|NCT00296504|525372345|FG005|Interim Analysis|Lost to Follow-up|4|||
145687911|NCT00296504|525372346|FG006|Interim Analysis|Lost to Follow-up|11|||
145687912|NCT00296504|525372347|FG007|Interim Analysis|Lost to Follow-up|4|||
145687913|NCT00296504|525372348|FG008|Interim Analysis|Lost to Follow-up|0|||
145687914|NCT00296504|525372340|FG000|Interim Analysis|Clinical Progression|1|||
145687915|NCT00296504|525372341|FG001|Interim Analysis|Clinical Progression|0|||
145687916|NCT00296504|525372342|FG002|Interim Analysis|Clinical Progression|1|||
145687917|NCT00296504|525372343|FG003|Interim Analysis|Clinical Progression|1|||
145687918|NCT00296504|525372344|FG004|Interim Analysis|Clinical Progression|0|||
145687919|NCT00296504|525372345|FG005|Interim Analysis|Clinical Progression|2|||
145687920|NCT00296504|525372346|FG006|Interim Analysis|Clinical Progression|1|||
145687921|NCT00296504|525372347|FG007|Interim Analysis|Clinical Progression|2|||
145687922|NCT00296504|525372348|FG008|Interim Analysis|Clinical Progression|0|||
145687923|NCT00296504|525372340|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
145687924|NCT00296504|525372341|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
145687925|NCT00296504|525372342|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
145687926|NCT00296504|525372343|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
145687927|NCT00296504|525372344|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
145687928|NCT00296504|525372345|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
145687929|NCT00296504|525372346|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
145687930|NCT00296504|525372347|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
145687931|NCT00296504|525372348|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
145687932|NCT00296504|525372340|FG000|Interim Analysis|Adverse Event|0|||
145687933|NCT00296504|525372341|FG001|Interim Analysis|Adverse Event|0|||
145687934|NCT00296504|525372342|FG002|Interim Analysis|Adverse Event|13|||
145687935|NCT00296504|525372343|FG003|Interim Analysis|Adverse Event|4|||
145687936|NCT00296504|525372344|FG004|Interim Analysis|Adverse Event|6|||
145687937|NCT00296504|525372345|FG005|Interim Analysis|Adverse Event|3|||
145687938|NCT00296504|525372346|FG006|Interim Analysis|Adverse Event|4|||
145687939|NCT00296504|525372347|FG007|Interim Analysis|Adverse Event|5|||
145687940|NCT00296504|525372348|FG008|Interim Analysis|Adverse Event|0|||
145687941|NCT00296504|525372340|FG000|Interim Analysis|Protocol Violation|0|||
145687942|NCT00296504|525372341|FG001|Interim Analysis|Protocol Violation|0|||
145687943|NCT00296504|525372342|FG002|Interim Analysis|Protocol Violation|2|||
145687944|NCT00296504|525372343|FG003|Interim Analysis|Protocol Violation|0|||
145687945|NCT00296504|525372344|FG004|Interim Analysis|Protocol Violation|1|||
145687946|NCT00296504|525372345|FG005|Interim Analysis|Protocol Violation|0|||
145687947|NCT00296504|525372346|FG006|Interim Analysis|Protocol Violation|0|||
145687948|NCT00296504|525372347|FG007|Interim Analysis|Protocol Violation|1|||
145687949|NCT00296504|525372348|FG008|Interim Analysis|Protocol Violation|0|||
145687950|NCT00296504|525372340|FG000|Interim Analysis|Insufficient CD4 Response|0|||
145687951|NCT00296504|525372341|FG001|Interim Analysis|Insufficient CD4 Response|0|||
145687952|NCT00296504|525372342|FG002|Interim Analysis|Insufficient CD4 Response|0|||
145687953|NCT00296504|525372343|FG003|Interim Analysis|Insufficient CD4 Response|0|||
145687954|NCT00296504|525372344|FG004|Interim Analysis|Insufficient CD4 Response|1|||
145687955|NCT00296504|525372345|FG005|Interim Analysis|Insufficient CD4 Response|1|||
145687956|NCT00296504|525372346|FG006|Interim Analysis|Insufficient CD4 Response|0|||
145687957|NCT00296504|525372347|FG007|Interim Analysis|Insufficient CD4 Response|0|||
145687958|NCT00296504|525372348|FG008|Interim Analysis|Insufficient CD4 Response|0|||
145687959|NCT00296504|525372340|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
145687960|NCT00296504|525372341|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
145687961|NCT00296504|525372342|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
145687962|NCT00296504|525372343|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
145687963|NCT00296504|525372344|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
145687964|NCT00296504|525372345|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
145687965|NCT00296504|525372346|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
145687966|NCT00296504|525372347|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
145687967|NCT00296504|525372348|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
145687968|NCT00296504|525372340|FG000|Interim Analysis|Pregnancy|4|||
145687969|NCT00296504|525372341|FG001|Interim Analysis|Pregnancy|1|||
145687970|NCT00296504|525372342|FG002|Interim Analysis|Pregnancy|4|||
145687971|NCT00296504|525372343|FG003|Interim Analysis|Pregnancy|2|||
145687972|NCT00296504|525372344|FG004|Interim Analysis|Pregnancy|0|||
145687973|NCT00296504|525372345|FG005|Interim Analysis|Pregnancy|1|||
145687974|NCT00296504|525372346|FG006|Interim Analysis|Pregnancy|1|||
145687975|NCT00296504|525372347|FG007|Interim Analysis|Pregnancy|1|||
145687976|NCT00296504|525372348|FG008|Interim Analysis|Pregnancy|0|||
145687977|NCT00296504|525372340|FG000|Interim Analysis|Death|1|||
145687978|NCT00296504|525372341|FG001|Interim Analysis|Death|0|||
145687979|NCT00296504|525372342|FG002|Interim Analysis|Death|3|||
145687980|NCT00296504|525372343|FG003|Interim Analysis|Death|0|||
145687981|NCT00296504|525372344|FG004|Interim Analysis|Death|0|||
145687982|NCT00296504|525372345|FG005|Interim Analysis|Death|0|||
145687983|NCT00296504|525372346|FG006|Interim Analysis|Death|0|||
145687984|NCT00296504|525372347|FG007|Interim Analysis|Death|0|||
145687985|NCT00296504|525372348|FG008|Interim Analysis|Death|0|||
145687986|NCT00296504|525372340|FG000|Interim Analysis|Participant Non-compliant|0|||
145687987|NCT00296504|525372341|FG001|Interim Analysis|Participant Non-compliant|1|||
145687988|NCT00296504|525372342|FG002|Interim Analysis|Participant Non-compliant|2|||
145687989|NCT00296504|525372343|FG003|Interim Analysis|Participant Non-compliant|1|||
145687990|NCT00296504|525372344|FG004|Interim Analysis|Participant Non-compliant|1|||
145687991|NCT00296504|525372345|FG005|Interim Analysis|Participant Non-compliant|3|||
145687992|NCT00296504|525372346|FG006|Interim Analysis|Participant Non-compliant|6|||
145687993|NCT00296504|525372347|FG007|Interim Analysis|Participant Non-compliant|2|||
145687994|NCT00296504|525372348|FG008|Interim Analysis|Participant Non-compliant|0|||
145687995|NCT00296504|525372340|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145687996|NCT00296504|525372341|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145687997|NCT00296504|525372342|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
145687998|NCT00296504|525372343|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145687999|NCT00296504|525372344|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145688000|NCT00296504|525372345|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
145688001|NCT00296504|525372346|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145688002|NCT00296504|525372347|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145688003|NCT00296504|525372348|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
145688004|NCT00296504|525372340|FG000|Interim Analysis|To Simplify Treatment|0|||
145688005|NCT00296504|525372341|FG001|Interim Analysis|To Simplify Treatment|0|||
145688006|NCT00296504|525372342|FG002|Interim Analysis|To Simplify Treatment|1|||
145688007|NCT00296504|525372343|FG003|Interim Analysis|To Simplify Treatment|0|||
145688008|NCT00296504|525372344|FG004|Interim Analysis|To Simplify Treatment|0|||
145688009|NCT00296504|525372345|FG005|Interim Analysis|To Simplify Treatment|0|||
145688010|NCT00296504|525372346|FG006|Interim Analysis|To Simplify Treatment|2|||
145688011|NCT00296504|525372347|FG007|Interim Analysis|To Simplify Treatment|0|||
145688012|NCT00296504|525372348|FG008|Interim Analysis|To Simplify Treatment|0|||
145688013|NCT00296504|525372340|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688014|NCT00296504|525372341|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688015|NCT00296504|525372342|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
145688016|NCT00296504|525372343|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688017|NCT00296504|525372344|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688018|NCT00296504|525372345|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688019|NCT00296504|525372346|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688020|NCT00296504|525372347|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688021|NCT00296504|525372348|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
145688022|NCT00296504|525372340|FG000|Interim Analysis|Participant Moved|1|||
145688023|NCT00296504|525372341|FG001|Interim Analysis|Participant Moved|0|||
145688024|NCT00296504|525372342|FG002|Interim Analysis|Participant Moved|1|||
145688025|NCT00296504|525372343|FG003|Interim Analysis|Participant Moved|0|||
145688026|NCT00296504|525372344|FG004|Interim Analysis|Participant Moved|0|||
145688027|NCT00296504|525372345|FG005|Interim Analysis|Participant Moved|1|||
145688028|NCT00296504|525372346|FG006|Interim Analysis|Participant Moved|1|||
145688029|NCT00296504|525372347|FG007|Interim Analysis|Participant Moved|0|||
145688030|NCT00296504|525372348|FG008|Interim Analysis|Participant Moved|0|||
145688031|NCT00296504|525372340|FG000|Interim Analysis|Participant Was Incarcerated|2|||
145688032|NCT00296504|525372341|FG001|Interim Analysis|Participant Was Incarcerated|0|||
145688033|NCT00296504|525372342|FG002|Interim Analysis|Participant Was Incarcerated|1|||
145688034|NCT00296504|525372343|FG003|Interim Analysis|Participant Was Incarcerated|0|||
145688035|NCT00296504|525372344|FG004|Interim Analysis|Participant Was Incarcerated|0|||
145688036|NCT00296504|525372345|FG005|Interim Analysis|Participant Was Incarcerated|0|||
145688037|NCT00296504|525372346|FG006|Interim Analysis|Participant Was Incarcerated|0|||
145688038|NCT00296504|525372347|FG007|Interim Analysis|Participant Was Incarcerated|0|||
145688039|NCT00296504|525372348|FG008|Interim Analysis|Participant Was Incarcerated|0|||
145688040|NCT00296504|525372340|FG000|Interim Analysis|Resistance to FPV|0|||
145688041|NCT00296504|525372341|FG001|Interim Analysis|Resistance to FPV|0|||
145688042|NCT00296504|525372342|FG002|Interim Analysis|Resistance to FPV|1|||
145688043|NCT00296504|525372343|FG003|Interim Analysis|Resistance to FPV|0|||
145688044|NCT00296504|525372344|FG004|Interim Analysis|Resistance to FPV|0|||
145688045|NCT00296504|525372345|FG005|Interim Analysis|Resistance to FPV|0|||
145688046|NCT00296504|525372346|FG006|Interim Analysis|Resistance to FPV|0|||
145688047|NCT00296504|525372347|FG007|Interim Analysis|Resistance to FPV|0|||
145688048|NCT00296504|525372348|FG008|Interim Analysis|Resistance to FPV|0|||
145688049|NCT00296504|525372340|FG000|Interim Analysis|Physician Decision|0|||
145688050|NCT00296504|525372341|FG001|Interim Analysis|Physician Decision|0|||
145688051|NCT00296504|525372342|FG002|Interim Analysis|Physician Decision|1|||
145688052|NCT00296504|525372343|FG003|Interim Analysis|Physician Decision|0|||
145688053|NCT00296504|525372344|FG004|Interim Analysis|Physician Decision|0|||
145688054|NCT00296504|525372345|FG005|Interim Analysis|Physician Decision|0|||
145688055|NCT00296504|525372346|FG006|Interim Analysis|Physician Decision|0|||
145688056|NCT00296504|525372347|FG007|Interim Analysis|Physician Decision|0|||
145688057|NCT00296504|525372348|FG008|Interim Analysis|Physician Decision|0|||
145688058|NCT00296504|525372340|FG000|Interim Analysis|Principle Investigator Discretion|2|||
145688059|NCT00296504|525372341|FG001|Interim Analysis|Principle Investigator Discretion|0|||
145688060|NCT00296504|525372342|FG002|Interim Analysis|Principle Investigator Discretion|1|||
145688061|NCT00296504|525372343|FG003|Interim Analysis|Principle Investigator Discretion|1|||
145688062|NCT00296504|525372344|FG004|Interim Analysis|Principle Investigator Discretion|0|||
145688063|NCT00296504|525372345|FG005|Interim Analysis|Principle Investigator Discretion|0|||
145688064|NCT00296504|525372346|FG006|Interim Analysis|Principle Investigator Discretion|0|||
145688065|NCT00296504|525372347|FG007|Interim Analysis|Principle Investigator Discretion|0|||
145688066|NCT00296504|525372348|FG008|Interim Analysis|Principle Investigator Discretion|0|||
145688067|NCT00296504|525372340|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
145688068|NCT00296504|525372341|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
145688069|NCT00296504|525372342|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
145688070|NCT00296504|525372343|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
145688071|NCT00296504|525372344|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
145688072|NCT00296504|525372345|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
145688073|NCT00296504|525372346|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
145688074|NCT00296504|525372347|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
145688075|NCT00296504|525372348|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
145688076|NCT00296504|525372340|FG000|Interim Analysis|Non-adherence|2|||
145688077|NCT00296504|525372341|FG001|Interim Analysis|Non-adherence|0|||
145688078|NCT00296504|525372342|FG002|Interim Analysis|Non-adherence|0|||
145688079|NCT00296504|525372343|FG003|Interim Analysis|Non-adherence|0|||
145688080|NCT00296504|525372344|FG004|Interim Analysis|Non-adherence|1|||
145688081|NCT00296504|525372345|FG005|Interim Analysis|Non-adherence|0|||
145688082|NCT00296504|525372346|FG006|Interim Analysis|Non-adherence|0|||
145688083|NCT00296504|525372347|FG007|Interim Analysis|Non-adherence|1|||
145688084|NCT00296504|525372348|FG008|Interim Analysis|Non-adherence|0|||
145688085|NCT00296504|525372340|FG000|Interim Analysis|Site Closing|1|||
145688086|NCT00296504|525372341|FG001|Interim Analysis|Site Closing|0|||
145688087|NCT00296504|525372342|FG002|Interim Analysis|Site Closing|0|||
145688088|NCT00296504|525372343|FG003|Interim Analysis|Site Closing|0|||
145688089|NCT00296504|525372344|FG004|Interim Analysis|Site Closing|0|||
145688090|NCT00296504|525372345|FG005|Interim Analysis|Site Closing|1|||
145688091|NCT00296504|525372346|FG006|Interim Analysis|Site Closing|2|||
145688092|NCT00296504|525372347|FG007|Interim Analysis|Site Closing|0|||
145688093|NCT00296504|525372348|FG008|Interim Analysis|Site Closing|0|||
145688094|NCT00296504|525372340|FG000|Interim Analysis|Lack of Personnel at Site|1|||
145688095|NCT00296504|525372341|FG001|Interim Analysis|Lack of Personnel at Site|0|||
145688096|NCT00296504|525372342|FG002|Interim Analysis|Lack of Personnel at Site|0|||
145688097|NCT00296504|525372343|FG003|Interim Analysis|Lack of Personnel at Site|0|||
145688098|NCT00296504|525372344|FG004|Interim Analysis|Lack of Personnel at Site|0|||
145688099|NCT00296504|525372345|FG005|Interim Analysis|Lack of Personnel at Site|0|||
145688100|NCT00296504|525372346|FG006|Interim Analysis|Lack of Personnel at Site|0|||
145688101|NCT00296504|525372347|FG007|Interim Analysis|Lack of Personnel at Site|0|||
145688102|NCT00296504|525372348|FG008|Interim Analysis|Lack of Personnel at Site|0|||
145688103|NCT00296504|525372340|FG000|Interim Analysis|Missed Schedule Date|1|||
145688104|NCT00296504|525372341|FG001|Interim Analysis|Missed Schedule Date|0|||
145688105|NCT00296504|525372342|FG002|Interim Analysis|Missed Schedule Date|0|||
145688106|NCT00296504|525372343|FG003|Interim Analysis|Missed Schedule Date|0|||
145688107|NCT00296504|525372344|FG004|Interim Analysis|Missed Schedule Date|0|||
145688108|NCT00296504|525372345|FG005|Interim Analysis|Missed Schedule Date|0|||
145688109|NCT00296504|525372346|FG006|Interim Analysis|Missed Schedule Date|0|||
145688110|NCT00296504|525372347|FG007|Interim Analysis|Missed Schedule Date|0|||
145688111|NCT00296504|525372348|FG008|Interim Analysis|Missed Schedule Date|0|||
145688112|NCT00296504|525372340|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
145688113|NCT00296504|525372341|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
145688114|NCT00296504|525372342|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
145688115|NCT00296504|525372343|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
145688116|NCT00296504|525372344|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
145688117|NCT00296504|525372345|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
145688118|NCT00296504|525372346|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
145688119|NCT00296504|525372347|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
145688120|NCT00296504|525372348|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
145688121|NCT00296504|525372340|FG000|Interim Analysis|Participant Stopped|0|||
145688122|NCT00296504|525372341|FG001|Interim Analysis|Participant Stopped|0|||
145688123|NCT00296504|525372342|FG002|Interim Analysis|Participant Stopped|0|||
145688124|NCT00296504|525372343|FG003|Interim Analysis|Participant Stopped|0|||
145688125|NCT00296504|525372344|FG004|Interim Analysis|Participant Stopped|1|||
145688126|NCT00296504|525372345|FG005|Interim Analysis|Participant Stopped|0|||
145688127|NCT00296504|525372346|FG006|Interim Analysis|Participant Stopped|0|||
145688128|NCT00296504|525372347|FG007|Interim Analysis|Participant Stopped|0|||
145688129|NCT00296504|525372348|FG008|Interim Analysis|Participant Stopped|0|||
145688130|NCT00296504|525372340|FG000|Interim Analysis|Physician and Participant Decision|0|||
145688131|NCT00296504|525372341|FG001|Interim Analysis|Physician and Participant Decision|0|||
145688132|NCT00296504|525372342|FG002|Interim Analysis|Physician and Participant Decision|0|||
145688133|NCT00296504|525372343|FG003|Interim Analysis|Physician and Participant Decision|0|||
145688134|NCT00296504|525372344|FG004|Interim Analysis|Physician and Participant Decision|0|||
145688135|NCT00296504|525372345|FG005|Interim Analysis|Physician and Participant Decision|1|||
145688136|NCT00296504|525372346|FG006|Interim Analysis|Physician and Participant Decision|0|||
145688137|NCT00296504|525372347|FG007|Interim Analysis|Physician and Participant Decision|0|||
145688138|NCT00296504|525372348|FG008|Interim Analysis|Physician and Participant Decision|0|||
145688139|NCT00296504|525372340|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
145688140|NCT00296504|525372341|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
145688141|NCT00296504|525372342|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
145688142|NCT00296504|525372343|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
145688143|NCT00296504|525372344|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
145688144|NCT00296504|525372345|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
145688145|NCT00296504|525372346|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
145688146|NCT00296504|525372347|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
145688147|NCT00296504|525372348|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
145688148|NCT00296504|525372340|FG000|Interim Analysis|Study Ended|0|||
145688149|NCT00296504|525372341|FG001|Interim Analysis|Study Ended|0|||
145688150|NCT00296504|525372342|FG002|Interim Analysis|Study Ended|0|||
145688151|NCT00296504|525372343|FG003|Interim Analysis|Study Ended|0|||
145688152|NCT00296504|525372344|FG004|Interim Analysis|Study Ended|0|||
145688153|NCT00296504|525372345|FG005|Interim Analysis|Study Ended|0|||
145688154|NCT00296504|525372346|FG006|Interim Analysis|Study Ended|1|||
145688155|NCT00296504|525372347|FG007|Interim Analysis|Study Ended|0|||
145688156|NCT00296504|525372348|FG008|Interim Analysis|Study Ended|0|||
145688157|NCT00296504|525372340|FG000|Interim Analysis|Participant Needed Interferon|0|||
145688158|NCT00296504|525372341|FG001|Interim Analysis|Participant Needed Interferon|0|||
145688159|NCT00296504|525372342|FG002|Interim Analysis|Participant Needed Interferon|0|||
145688160|NCT00296504|525372343|FG003|Interim Analysis|Participant Needed Interferon|0|||
145688161|NCT00296504|525372344|FG004|Interim Analysis|Participant Needed Interferon|0|||
145688162|NCT00296504|525372345|FG005|Interim Analysis|Participant Needed Interferon|0|||
145688163|NCT00296504|525372346|FG006|Interim Analysis|Participant Needed Interferon|0|||
145688164|NCT00296504|525372347|FG007|Interim Analysis|Participant Needed Interferon|1|||
145688165|NCT00296504|525372348|FG008|Interim Analysis|Participant Needed Interferon|0|||
145688166|NCT00296504|525372340|FG000|Interim Analysis|Ongoing|32|||
145688167|NCT00296504|525372341|FG001|Interim Analysis|Ongoing|12|||
145688168|NCT00296504|525372342|FG002|Interim Analysis|Ongoing|16|||
145688169|NCT00296504|525372343|FG003|Interim Analysis|Ongoing|22|||
145688170|NCT00296504|525372344|FG004|Interim Analysis|Ongoing|0|||
145688171|NCT00296504|525372345|FG005|Interim Analysis|Ongoing|0|||
145688172|NCT00296504|525372346|FG006|Interim Analysis|Ongoing|30|||
145688173|NCT00296504|525372347|FG007|Interim Analysis|Ongoing|1|||
145688174|NCT00296504|525372348|FG008|Interim Analysis|Ongoing|0|||
145688175|NCT00296504|525372340|FG000|Final Analysis|Withdrawal by Subject|0|||
145688176|NCT00296504|525372341|FG001|Final Analysis|Withdrawal by Subject|0|||
145688177|NCT00296504|525372342|FG002|Final Analysis|Withdrawal by Subject|0|||
145688178|NCT00296504|525372343|FG003|Final Analysis|Withdrawal by Subject|0|||
145688179|NCT00296504|525372344|FG004|Final Analysis|Withdrawal by Subject|0|||
145688180|NCT00296504|525372345|FG005|Final Analysis|Withdrawal by Subject|0|||
145688181|NCT00296504|525372346|FG006|Final Analysis|Withdrawal by Subject|0|||
145688182|NCT00296504|525372347|FG007|Final Analysis|Withdrawal by Subject|0|||
145688183|NCT00296504|525372348|FG008|Final Analysis|Withdrawal by Subject|1|||
145688184|NCT00296504|525372340|FG000|Final Analysis|Lost to Follow-up|0|||
145688185|NCT00296504|525372341|FG001|Final Analysis|Lost to Follow-up|0|||
145688186|NCT00296504|525372342|FG002|Final Analysis|Lost to Follow-up|0|||
145688187|NCT00296504|525372343|FG003|Final Analysis|Lost to Follow-up|0|||
145688188|NCT00296504|525372344|FG004|Final Analysis|Lost to Follow-up|0|||
145688189|NCT00296504|525372345|FG005|Final Analysis|Lost to Follow-up|0|||
145688190|NCT00296504|525372346|FG006|Final Analysis|Lost to Follow-up|0|||
145688191|NCT00296504|525372347|FG007|Final Analysis|Lost to Follow-up|0|||
145688192|NCT00296504|525372348|FG008|Final Analysis|Lost to Follow-up|5|||
145688193|NCT00296504|525372340|FG000|Final Analysis|Insufficient Viral Load Response|0|||
145688194|NCT00296504|525372341|FG001|Final Analysis|Insufficient Viral Load Response|0|||
145688195|NCT00296504|525372342|FG002|Final Analysis|Insufficient Viral Load Response|0|||
145688196|NCT00296504|525372343|FG003|Final Analysis|Insufficient Viral Load Response|0|||
145688197|NCT00296504|525372344|FG004|Final Analysis|Insufficient Viral Load Response|0|||
145688198|NCT00296504|525372345|FG005|Final Analysis|Insufficient Viral Load Response|0|||
145688199|NCT00296504|525372346|FG006|Final Analysis|Insufficient Viral Load Response|0|||
145688200|NCT00296504|525372347|FG007|Final Analysis|Insufficient Viral Load Response|0|||
145688201|NCT00296504|525372348|FG008|Final Analysis|Insufficient Viral Load Response|6|||
145688202|NCT00296504|525372340|FG000|Final Analysis|Adverse Event|0|||
145688203|NCT00296504|525372341|FG001|Final Analysis|Adverse Event|0|||
145688204|NCT00296504|525372342|FG002|Final Analysis|Adverse Event|0|||
145688205|NCT00296504|525372343|FG003|Final Analysis|Adverse Event|0|||
145688206|NCT00296504|525372344|FG004|Final Analysis|Adverse Event|0|||
145688207|NCT00296504|525372345|FG005|Final Analysis|Adverse Event|0|||
145688208|NCT00296504|525372346|FG006|Final Analysis|Adverse Event|0|||
145688209|NCT00296504|525372347|FG007|Final Analysis|Adverse Event|0|||
145688210|NCT00296504|525372348|FG008|Final Analysis|Adverse Event|2|||
145688211|NCT00296504|525372340|FG000|Final Analysis|Pregnancy|0|||
145688212|NCT00296504|525372341|FG001|Final Analysis|Pregnancy|0|||
145688213|NCT00296504|525372342|FG002|Final Analysis|Pregnancy|0|||
145688214|NCT00296504|525372343|FG003|Final Analysis|Pregnancy|0|||
145688215|NCT00296504|525372344|FG004|Final Analysis|Pregnancy|0|||
145688216|NCT00296504|525372345|FG005|Final Analysis|Pregnancy|0|||
145688217|NCT00296504|525372346|FG006|Final Analysis|Pregnancy|0|||
145688218|NCT00296504|525372347|FG007|Final Analysis|Pregnancy|0|||
145688219|NCT00296504|525372348|FG008|Final Analysis|Pregnancy|4|||
145688220|NCT00296504|525372340|FG000|Final Analysis|Tuberculosis|0|||
145688221|NCT00296504|525372341|FG001|Final Analysis|Tuberculosis|0|||
145688222|NCT00296504|525372342|FG002|Final Analysis|Tuberculosis|0|||
145688223|NCT00296504|525372343|FG003|Final Analysis|Tuberculosis|0|||
145688224|NCT00296504|525372344|FG004|Final Analysis|Tuberculosis|0|||
145688225|NCT00296504|525372345|FG005|Final Analysis|Tuberculosis|0|||
145688226|NCT00296504|525372346|FG006|Final Analysis|Tuberculosis|0|||
145688227|NCT00296504|525372347|FG007|Final Analysis|Tuberculosis|0|||
145688228|NCT00296504|525372348|FG008|Final Analysis|Tuberculosis|1|||
145688229|NCT00296504|525372340|FG000|Final Analysis|Participant Moved to Another Country|0|||
145688230|NCT00296504|525372341|FG001|Final Analysis|Participant Moved to Another Country|0|||
145688231|NCT00296504|525372342|FG002|Final Analysis|Participant Moved to Another Country|0|||
145688232|NCT00296504|525372343|FG003|Final Analysis|Participant Moved to Another Country|0|||
145688233|NCT00296504|525372344|FG004|Final Analysis|Participant Moved to Another Country|0|||
145688234|NCT00296504|525372345|FG005|Final Analysis|Participant Moved to Another Country|0|||
145688235|NCT00296504|525372346|FG006|Final Analysis|Participant Moved to Another Country|0|||
145688236|NCT00296504|525372347|FG007|Final Analysis|Participant Moved to Another Country|0|||
145688237|NCT00296504|525372348|FG008|Final Analysis|Participant Moved to Another Country|1|||
145688238|NCT00296504|525372340|FG000|Final Analysis|Poor Adherence|0|||
145688239|NCT00296504|525372341|FG001|Final Analysis|Poor Adherence|0|||
145688240|NCT00296504|525372342|FG002|Final Analysis|Poor Adherence|0|||
145688241|NCT00296504|525372343|FG003|Final Analysis|Poor Adherence|0|||
145688242|NCT00296504|525372344|FG004|Final Analysis|Poor Adherence|0|||
145688243|NCT00296504|525372345|FG005|Final Analysis|Poor Adherence|0|||
145688244|NCT00296504|525372346|FG006|Final Analysis|Poor Adherence|0|||
145688245|NCT00296504|525372347|FG007|Final Analysis|Poor Adherence|0|||
145688246|NCT00296504|525372348|FG008|Final Analysis|Poor Adherence|1|||
145688247|NCT02162771|525372349|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
145688248|NCT02162771|525372350|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
145688249|NCT02162771|525372349|FG000|Core Study Period (Part 2)|Adverse Event|4|||
145688250|NCT02162771|525372350|FG001|Core Study Period (Part 2)|Adverse Event|1|||
145688251|NCT02162771|525372349|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
145688252|NCT02162771|525372350|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
145688253|NCT02162771|525372349|FG000|Core Study Period (Part 2)|Physician Decision|0|||
145491279|NCT03096834|524653722|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
145688254|NCT02162771|525372350|FG001|Core Study Period (Part 2)|Physician Decision|2|||
145688255|NCT02162771|525372349|FG000|Core Study Period (Part 2)|Death|1|||
145688256|NCT02162771|525372350|FG001|Core Study Period (Part 2)|Death|0|||
145688257|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
145688258|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
145688259|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
145688260|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
145688261|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Death|2|||
145688262|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Death|1|||
145688263|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
145688264|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
145688265|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
145688266|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
145688267|NCT02162771|525372349|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
145688268|NCT02162771|525372350|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
145688269|NCT00274846|525372353|FG000|Overall Study|Did not receive adequate NK cells|1|||
145688270|NCT01920178|525372356|FG000|Overall Study|Lost to Follow-up|2|||
145688271|NCT01920178|525372357|FG001|Overall Study|Lost to Follow-up|1|||
145688272|NCT02849509|525372358|FG000|Overall Study|Worsening of disease under study|1|||
145688273|NCT02849509|525372359|FG001|Overall Study|Worsening of disease under study|1|||
145688274|NCT02849509|525372360|FG002|Overall Study|Worsening of disease under study|1|||
145688275|NCT02849509|525372358|FG000|Overall Study|Worsening of other pre-existing disease|0|||
145688276|NCT02849509|525372359|FG001|Overall Study|Worsening of other pre-existing disease|1|||
145688277|NCT02849509|525372360|FG002|Overall Study|Worsening of other pre-existing disease|2|||
145688278|NCT02849509|525372358|FG000|Overall Study|Other adverse event|36|||
145688279|NCT02849509|525372359|FG001|Overall Study|Other adverse event|41|||
145688280|NCT02849509|525372360|FG002|Overall Study|Other adverse event|8|||
145688281|NCT02849509|525372358|FG000|Overall Study|Withdrawal by Subject|6|||
145688282|NCT02849509|525372359|FG001|Overall Study|Withdrawal by Subject|17|||
145688283|NCT02849509|525372360|FG002|Overall Study|Withdrawal by Subject|12|||
145688284|NCT02849509|525372358|FG000|Overall Study|Lost to Follow-up|27|||
145688285|NCT02849509|525372359|FG001|Overall Study|Lost to Follow-up|67|||
145688286|NCT02849509|525372360|FG002|Overall Study|Lost to Follow-up|36|||
145688287|NCT02849509|525372358|FG000|Overall Study|Other, reason not specified|14|||
145688288|NCT02849509|525372359|FG001|Overall Study|Other, reason not specified|29|||
145688289|NCT02849509|525372360|FG002|Overall Study|Other, reason not specified|25|||
145688290|NCT02849509|525372358|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
145688291|NCT02849509|525372359|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
145688292|NCT02849509|525372360|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
145688293|NCT00440037|525372361|FG000|Overall Study|Withdrawal by Subject|6|||
145688294|NCT00440037|525372361|FG000|Overall Study|Administrative decision|3|||
145688295|NCT03928821|525372362|FG000|Overall Study|Death|0|||
145688296|NCT03928821|525372363|FG001|Overall Study|Death|1|||
145688297|NCT03928821|525372364|FG002|Overall Study|Death|0|||
145688298|NCT03928821|525372365|FG003|Overall Study|Death|0|||
145688299|NCT03928821|525372362|FG000|Overall Study|Lost to Follow-up|0|||
145688300|NCT03928821|525372363|FG001|Overall Study|Lost to Follow-up|2|||
145688301|NCT03928821|525372364|FG002|Overall Study|Lost to Follow-up|3|||
145688302|NCT03928821|525372365|FG003|Overall Study|Lost to Follow-up|0|||
145688303|NCT03928821|525372362|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
145688304|NCT03928821|525372363|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
145688305|NCT03928821|525372364|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
145688306|NCT03928821|525372365|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
145688307|NCT00985621|525372366|FG000|Overall Study|Adverse Event|2|||
145688308|NCT00985621|525372367|FG001|Overall Study|Adverse Event|3|||
145688309|NCT00985621|525372368|FG002|Overall Study|Adverse Event|4|||
145688310|NCT00985621|525372369|FG003|Overall Study|Adverse Event|16|||
145688311|NCT00985621|525372366|FG000|Overall Study|Lack of Efficacy|10|||
145688312|NCT00985621|525372367|FG001|Overall Study|Lack of Efficacy|6|||
145688313|NCT00985621|525372368|FG002|Overall Study|Lack of Efficacy|5|||
145688314|NCT00985621|525372369|FG003|Overall Study|Lack of Efficacy|12|||
145688315|NCT00985621|525372366|FG000|Overall Study|Lost to Follow-up|2|||
145688316|NCT00985621|525372367|FG001|Overall Study|Lost to Follow-up|3|||
145688317|NCT00985621|525372368|FG002|Overall Study|Lost to Follow-up|4|||
145688318|NCT00985621|525372369|FG003|Overall Study|Lost to Follow-up|4|||
145688319|NCT00985621|525372366|FG000|Overall Study|Study Terminated by Sponsor|89|||
145688320|NCT00985621|525372367|FG001|Overall Study|Study Terminated by Sponsor|108|||
145688321|NCT00985621|525372368|FG002|Overall Study|Study Terminated by Sponsor|99|||
145688322|NCT00985621|525372369|FG003|Overall Study|Study Terminated by Sponsor|92|||
145688323|NCT00985621|525372366|FG000|Overall Study|Protocol Violation|1|||
145688324|NCT00985621|525372367|FG001|Overall Study|Protocol Violation|1|||
145688325|NCT00985621|525372368|FG002|Overall Study|Protocol Violation|1|||
145688326|NCT00985621|525372369|FG003|Overall Study|Protocol Violation|0|||
145688327|NCT00985621|525372366|FG000|Overall Study|Withdrawal by Subject|8|||
145688328|NCT00985621|525372367|FG001|Overall Study|Withdrawal by Subject|10|||
145688329|NCT00985621|525372368|FG002|Overall Study|Withdrawal by Subject|8|||
145688330|NCT00985621|525372369|FG003|Overall Study|Withdrawal by Subject|12|||
145688331|NCT00985621|525372366|FG000|Overall Study|Other|1|||
145688332|NCT00985621|525372367|FG001|Overall Study|Other|0|||
145688333|NCT00985621|525372368|FG002|Overall Study|Other|0|||
145688334|NCT00985621|525372369|FG003|Overall Study|Other|0|||
145688335|NCT00985621|525372366|FG000|Overall Study|Randomized but not Treated|1|||
145688336|NCT00985621|525372367|FG001|Overall Study|Randomized but not Treated|0|||
145688337|NCT00985621|525372368|FG002|Overall Study|Randomized but not Treated|2|||
145688338|NCT00985621|525372369|FG003|Overall Study|Randomized but not Treated|1|||
145688339|NCT00417989|525372379|FG000|Overall Study|Withdrawal by Subject|13|||
145688340|NCT00417989|525372380|FG001|Overall Study|Withdrawal by Subject|13|||
145688341|NCT00417989|525372379|FG000|Overall Study|Lost to Follow-up|1|||
145688342|NCT00417989|525372380|FG001|Overall Study|Lost to Follow-up|6|||
145688343|NCT00417989|525372379|FG000|Overall Study|Protocol Violation|1|||
145688344|NCT00417989|525372380|FG001|Overall Study|Protocol Violation|0|||
145688345|NCT00417989|525372379|FG000|Overall Study|Death|0|||
145688346|NCT00417989|525372380|FG001|Overall Study|Death|1|||
145688347|NCT00417989|525372379|FG000|Overall Study|Physician Decision|5|||
145688348|NCT00417989|525372380|FG001|Overall Study|Physician Decision|2|||
145688349|NCT01636778|525372383|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
145688350|NCT01636778|525372384|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
145688351|NCT01636778|525372385|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
145688352|NCT01636778|525372383|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
145688353|NCT01636778|525372384|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
145688354|NCT01636778|525372385|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
145688355|NCT01636778|525372383|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
145688356|NCT01636778|525372384|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
145688357|NCT01636778|525372385|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
145688358|NCT01636778|525372383|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
145688359|NCT01636778|525372384|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
145688360|NCT01636778|525372385|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
145688361|NCT01636778|525372383|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
145688362|NCT01636778|525372384|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
145688363|NCT01636778|525372385|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
145688364|NCT01636778|525372383|FG000|Follow-up Period After Part 2|Other|0|||
145688365|NCT01636778|525372384|FG001|Follow-up Period After Part 2|Other|0|||
145688366|NCT01636778|525372385|FG002|Follow-up Period After Part 2|Other|1|||
145688367|NCT01636778|525372383|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
145688368|NCT01636778|525372384|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
145688369|NCT01636778|525372385|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
145688370|NCT01636778|525372383|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
145688371|NCT01636778|525372384|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
145688372|NCT01636778|525372385|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
145688373|NCT03530345|525372386|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
145688374|NCT03530345|525372387|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
145688375|NCT03530345|525372386|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
145688376|NCT03530345|525372387|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
145688377|NCT03530345|525372386|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
145688378|NCT03530345|525372387|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
145688379|NCT03530345|525372386|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
145688380|NCT03530345|525372387|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
145688381|NCT04150250|525372388|FG000|Overall Study|Lost to Follow-up|0|||
145688382|NCT04150250|525372389|FG001|Overall Study|Lost to Follow-up|2|||
145688383|NCT00383500|525372390|FG000|Overall Study|Withdrawal by Subject|8|||
145688384|NCT00383500|525372391|FG001|Overall Study|Withdrawal by Subject|3|||
145688385|NCT00383500|525372392|FG002|Overall Study|Withdrawal by Subject|0|||
145688386|NCT00383500|525372390|FG000|Overall Study|Lost to Follow-up|0|||
145688387|NCT00383500|525372391|FG001|Overall Study|Lost to Follow-up|0|||
145688388|NCT00383500|525372392|FG002|Overall Study|Lost to Follow-up|2|||
145688389|NCT00088452|525374199|FG000|Overall Study|Did not receive intervention|1|||
145688390|NCT00088452|525374200|FG001|Overall Study|Did not receive intervention|0|||
145688391|NCT00088452|525374201|FG002|Overall Study|Did not receive intervention|1|||
145688392|NCT04044352|525374207|FG000|Overall Study|Lost to Follow-up|9|||
145688393|NCT04044352|525374207|FG000|Overall Study|Withdrawal by Subject|2|||
145688394|NCT02176356|525374209|FG000|Overall Study|Screen Failure|14|||
145688395|NCT02176356|525374209|FG000|Overall Study|Lost to Follow-up|4|||
145688396|NCT02176356|525374209|FG000|Overall Study|Personal Reasons|3|||
145688397|NCT02176356|525374209|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145688398|NCT04816708|525374212|FG000|Overall Study|Lost to Follow-up|10|||
145688399|NCT04816708|525374213|FG001|Overall Study|Lost to Follow-up|4|||
145688400|NCT01503515|525374215|FG000|Overall Study|Adverse Event|4|||
145688401|NCT01503515|525374216|FG001|Overall Study|Adverse Event|5|||
145688402|NCT01503515|525374215|FG000|Overall Study|Death|0|||
145688403|NCT01503515|525374216|FG001|Overall Study|Death|1|||
145688404|NCT01503515|525374215|FG000|Overall Study|Physician Decision|14|||
145688405|NCT01503515|525374216|FG001|Overall Study|Physician Decision|23|||
145688406|NCT01503515|525374215|FG000|Overall Study|Withdrawal by Subject|0|||
145688407|NCT01503515|525374216|FG001|Overall Study|Withdrawal by Subject|1|||
145688408|NCT01503515|525374215|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
145688409|NCT01503515|525374216|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
145688410|NCT01503515|525374215|FG000|Overall Study|Ineligible|1|||
145688411|NCT01503515|525374216|FG001|Overall Study|Ineligible|1|||
145688412|NCT04050722|525374217|FG000|Overall Study|Withdrawal by Subject|1|||
145688413|NCT04050722|525374218|FG001|Overall Study|Withdrawal by Subject|0|||
145688414|NCT01350102|525374219|FG000|Overall Study|Adverse Event|0|||
145688415|NCT01350102|525374220|FG001|Overall Study|Adverse Event|0|||
145688416|NCT01350102|525374221|FG002|Overall Study|Adverse Event|1|||
145688417|NCT01350102|525374222|FG003|Overall Study|Adverse Event|0|||
145688418|NCT03087851|525374226|FG000|Overall Study|Withdraw on medical grounds|0|||
145688419|NCT03087851|525374227|FG001|Overall Study|Withdraw on medical grounds|1|||
145688420|NCT03087851|525374228|FG002|Overall Study|Withdraw on medical grounds|2|||
145688421|NCT00377312|525374231|FG000|Overall Study|Adverse Event|1|||
145688422|NCT00377312|525374232|FG001|Overall Study|Adverse Event|1|||
145688423|NCT01572493|525374237|FG000|Overall Study|Physician Decision|1|||
145688424|NCT01572493|525374238|FG001|Overall Study|Physician Decision|0|||
145688425|NCT01572493|525374239|FG002|Overall Study|Physician Decision|0|||
145688426|NCT01572493|525374240|FG003|Overall Study|Physician Decision|0|||
145688427|NCT01572493|525374241|FG004|Overall Study|Physician Decision|0|||
145688428|NCT01572493|525374242|FG005|Overall Study|Physician Decision|0|||
145688429|NCT01572493|525374243|FG006|Overall Study|Physician Decision|0|||
145688430|NCT01572493|525374244|FG007|Overall Study|Physician Decision|0|||
145688431|NCT01572493|525374245|FG008|Overall Study|Physician Decision|0|||
145688432|NCT01572493|525374237|FG000|Overall Study|Switched to alternative treatment|0|||
145688433|NCT01572493|525374238|FG001|Overall Study|Switched to alternative treatment|1|||
145688434|NCT01572493|525374239|FG002|Overall Study|Switched to alternative treatment|2|||
145688435|NCT01572493|525374240|FG003|Overall Study|Switched to alternative treatment|1|||
145688436|NCT01572493|525374241|FG004|Overall Study|Switched to alternative treatment|2|||
145688437|NCT01572493|525374242|FG005|Overall Study|Switched to alternative treatment|0|||
145688438|NCT01572493|525374243|FG006|Overall Study|Switched to alternative treatment|2|||
145688439|NCT01572493|525374244|FG007|Overall Study|Switched to alternative treatment|0|||
145688440|NCT01572493|525374245|FG008|Overall Study|Switched to alternative treatment|2|||
145688441|NCT01572493|525374237|FG000|Overall Study|Death|0|||
145688442|NCT01572493|525374238|FG001|Overall Study|Death|0|||
145688443|NCT01572493|525374239|FG002|Overall Study|Death|0|||
145688444|NCT01572493|525374240|FG003|Overall Study|Death|1|||
145688445|NCT01572493|525374241|FG004|Overall Study|Death|0|||
145688446|NCT01572493|525374242|FG005|Overall Study|Death|1|||
145688447|NCT01572493|525374243|FG006|Overall Study|Death|0|||
145688448|NCT01572493|525374244|FG007|Overall Study|Death|0|||
145688449|NCT01572493|525374245|FG008|Overall Study|Death|0|||
145688450|NCT01572493|525374237|FG000|Overall Study|Adverse Event|0|||
145688451|NCT01572493|525374238|FG001|Overall Study|Adverse Event|0|||
145688452|NCT01572493|525374239|FG002|Overall Study|Adverse Event|0|||
145688453|NCT01572493|525374240|FG003|Overall Study|Adverse Event|0|||
145688454|NCT01572493|525374241|FG004|Overall Study|Adverse Event|0|||
145688455|NCT01572493|525374242|FG005|Overall Study|Adverse Event|0|||
145688456|NCT01572493|525374243|FG006|Overall Study|Adverse Event|1|||
145688457|NCT01572493|525374244|FG007|Overall Study|Adverse Event|0|||
145688458|NCT01572493|525374245|FG008|Overall Study|Adverse Event|0|||
145688459|NCT00609245|525374246|FG000|Overall Study|Adverse Event|1|||
145688460|NCT01090076|525374247|FG000|Overall Study|Death|1|||
145688461|NCT01090076|525374248|FG001|Overall Study|Death|1|||
145688462|NCT01090076|525374247|FG000|Overall Study|Withdrawal by Subject|0|||
145688463|NCT01090076|525374248|FG001|Overall Study|Withdrawal by Subject|1|||
145688464|NCT01116440|525374249|FG000|Treatment|Withdrawal by Subject|2|||
145688465|NCT01116440|525374250|FG001|Treatment|Withdrawal by Subject|2|||
145688466|NCT01116440|525374249|FG000|Treatment|Lost to Follow-up|1|||
145688467|NCT01116440|525374250|FG001|Treatment|Lost to Follow-up|1|||
145688468|NCT01116440|525374249|FG000|Treatment|Protocol Violation|0|||
145688469|NCT01116440|525374250|FG001|Treatment|Protocol Violation|2|||
145688470|NCT01116440|525374249|FG000|Treatment|Lack of Efficacy|0|||
145688471|NCT01116440|525374250|FG001|Treatment|Lack of Efficacy|1|||
145688472|NCT01116440|525374249|FG000|Treatment|Adverse Event|0|||
145688473|NCT01116440|525374250|FG001|Treatment|Adverse Event|1|||
145688474|NCT01116440|525374249|FG000|Withdrawal|Withdrawal by Subject|0|||
145688475|NCT01116440|525374250|FG001|Withdrawal|Withdrawal by Subject|1|||
145688476|NCT01116440|525374249|FG000|Withdrawal|Lost to Follow-up|0|||
145688477|NCT01116440|525374250|FG001|Withdrawal|Lost to Follow-up|1|||
145688478|NCT01116440|525374249|FG000|Follow-up|Lost to Follow-up|0|||
145688479|NCT01116440|525374250|FG001|Follow-up|Lost to Follow-up|1|||
145688480|NCT01116440|525374249|FG000|Follow-up|Withdrawal by Subject|0|||
145688481|NCT01116440|525374250|FG001|Follow-up|Withdrawal by Subject|1|||
145688482|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Adverse Event|3|||
145688483|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Adverse Event|0|||
145688484|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
145688485|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
145688486|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Disease Progression|23|||
145688487|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Disease Progression|22|||
145688488|NCT01379521|525374259|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
145688489|NCT01379521|525374260|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
145688490|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
145688491|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
145688492|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
145688493|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
145688494|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
145688495|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
145688496|NCT01379521|525374259|FG000|Overall Study -Treatment Period|Death|2|||
145688497|NCT01379521|525374260|FG001|Overall Study -Treatment Period|Death|1|||
145688498|NCT01379521|525374259|FG000|Post-Treatment Evaluations|Disease Progression|22|||
145688499|NCT01379521|525374260|FG001|Post-Treatment Evaluations|Disease Progression|20|||
145688500|NCT01379521|525374259|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
145688501|NCT01379521|525374260|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
145688502|NCT01379521|525374259|FG000|Post-Treatment Evaluations|Death|1|||
145688503|NCT01379521|525374260|FG001|Post-Treatment Evaluations|Death|0|||
145688504|NCT01536535|525374263|FG000|Overall Study|Withdrawal by Subject|10|||
145688505|NCT01536535|525374264|FG001|Overall Study|Withdrawal by Subject|5|||
145688506|NCT01536535|525374263|FG000|Overall Study|Lost to Follow-up|4|||
145688507|NCT01536535|525374264|FG001|Overall Study|Lost to Follow-up|6|||
145688508|NCT01536535|525374263|FG000|Overall Study|Physician Decision|1|||
145688509|NCT01536535|525374264|FG001|Overall Study|Physician Decision|1|||
145688510|NCT01536535|525374263|FG000|Overall Study|Participant moved|0|||
145688511|NCT01536535|525374264|FG001|Overall Study|Participant moved|1|||
145688512|NCT01485991|525374268|FG000|Overall Study|Adverse Event|0|||
145688513|NCT01485991|525374269|FG001|Overall Study|Adverse Event|4|||
145688514|NCT01485991|525374268|FG000|Overall Study|Lost to Follow-up|13|||
145688515|NCT01485991|525374269|FG001|Overall Study|Lost to Follow-up|10|||
145688516|NCT01485991|525374268|FG000|Overall Study|Withdrawal by Subject|13|||
145688517|NCT01485991|525374269|FG001|Overall Study|Withdrawal by Subject|20|||
145688518|NCT01485991|525374268|FG000|Overall Study|randomized but not treated|6|||
145688519|NCT01485991|525374269|FG001|Overall Study|randomized but not treated|2|||
145688520|NCT02538471|525374270|FG000|Overall Study|Progression of disease|2|||
145688521|NCT01475370|525374271|FG000|Overall Study|Exacerbation of primary disease|2|||
145688522|NCT01475370|525374272|FG001|Overall Study|Exacerbation of primary disease|2|||
145688523|NCT01475370|525374273|FG002|Overall Study|Exacerbation of primary disease|2|||
145688524|NCT01475370|525374271|FG000|Overall Study|Study drug administration difficult|0|||
145688525|NCT01475370|525374272|FG001|Overall Study|Study drug administration difficult|1|||
145688526|NCT01475370|525374273|FG002|Overall Study|Study drug administration difficult|1|||
145688527|NCT01475370|525374271|FG000|Overall Study|Other than specified|1|||
145688528|NCT01475370|525374272|FG001|Overall Study|Other than specified|0|||
145688529|NCT01475370|525374273|FG002|Overall Study|Other than specified|0|||
145688530|NCT00125853|525374274|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
145688531|NCT00125853|525374275|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
145688532|NCT02522299|525374276|FG000|Overall Study|Adverse Event|2|||
145688533|NCT02522299|525374277|FG001|Overall Study|Adverse Event|0|||
145688534|NCT02522299|525374276|FG000|Overall Study|Physician Decision|0|||
145688535|NCT02522299|525374277|FG001|Overall Study|Physician Decision|1|||
145688536|NCT02522299|525374276|FG000|Overall Study|Withdrawal by Subject|2|||
145688537|NCT02522299|525374277|FG001|Overall Study|Withdrawal by Subject|0|||
145688538|NCT04908800|525374278|FG000|Overall Study|Adverse Event|0|||
145688539|NCT04908800|525374279|FG001|Overall Study|Adverse Event|0|||
145688540|NCT04908800|525374280|FG002|Overall Study|Adverse Event|0|||
145688541|NCT04908800|525374281|FG003|Overall Study|Adverse Event|0|||
145688542|NCT04908800|525374282|FG004|Overall Study|Adverse Event|0|||
145688543|NCT04908800|525374283|FG005|Overall Study|Adverse Event|0|||
145688544|NCT04908800|525374284|FG006|Overall Study|Adverse Event|0|||
145688545|NCT04908800|525374285|FG007|Overall Study|Adverse Event|0|||
145688546|NCT04908800|525374286|FG008|Overall Study|Adverse Event|0|||
145688547|NCT04908800|525374287|FG009|Overall Study|Adverse Event|0|||
145688548|NCT04908800|525374288|FG010|Overall Study|Adverse Event|1|||
145688549|NCT04908800|525374289|FG011|Overall Study|Adverse Event|0|||
145688550|NCT04908800|525374290|FG012|Overall Study|Adverse Event|0|||
145688551|NCT00157209|525374291|FG000|Overall Study|Ongoing at data cut-off|10|||
145688552|NCT00157209|525374292|FG001|Overall Study|Ongoing at data cut-off|0|||
145688553|NCT04474691|525374293|FG000|Overall Study|Withdrawal by Subject|9|||
145688554|NCT01323309|525374294|FG000|Overall Study|Death|9|||
145688555|NCT01323309|525374295|FG001|Overall Study|Death|15|||
145688556|NCT01323309|525374296|FG002|Overall Study|Death|5|||
145688557|NCT01323309|525374294|FG000|Overall Study|Lost to Follow-up|11|||
145688558|NCT01323309|525374295|FG001|Overall Study|Lost to Follow-up|14|||
145688559|NCT01323309|525374296|FG002|Overall Study|Lost to Follow-up|24|||
145688560|NCT01323309|525374294|FG000|Overall Study|Withdrawal by Subject|14|||
145688561|NCT01323309|525374295|FG001|Overall Study|Withdrawal by Subject|14|||
145688562|NCT01323309|525374296|FG002|Overall Study|Withdrawal by Subject|18|||
145688563|NCT01323309|525374294|FG000|Overall Study|Disease progression|5|||
145688564|NCT01323309|525374295|FG001|Overall Study|Disease progression|11|||
145688565|NCT01323309|525374296|FG002|Overall Study|Disease progression|4|||
145688566|NCT01348763|525374301|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
145688567|NCT01348763|525374301|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
145688568|NCT03647709|525374314|FG000|Overall Study|Lost to Follow-up|5|||
145688569|NCT03647709|525374314|FG000|Overall Study|Physician Decision|6|||
145688570|NCT03647709|525374314|FG000|Overall Study|Withdrawal by Subject|3|||
145688571|NCT00449033|525374319|FG000|Treatment Period|Adverse Event|117|||
145688572|NCT00449033|525374320|FG001|Treatment Period|Adverse Event|83|||
145688573|NCT00449033|525374319|FG000|Treatment Period|Death|21|||
145688574|NCT00449033|525374320|FG001|Treatment Period|Death|12|||
145688575|NCT00449033|525374319|FG000|Treatment Period|Lost to Follow-up|0|||
145688576|NCT00449033|525374320|FG001|Treatment Period|Lost to Follow-up|2|||
145688577|NCT00449033|525374319|FG000|Treatment Period|Physician Decision|4|||
145688578|NCT00449033|525374320|FG001|Treatment Period|Physician Decision|5|||
145688579|NCT00449033|525374319|FG000|Treatment Period|Protocol Violation|8|||
145688580|NCT00449033|525374320|FG001|Treatment Period|Protocol Violation|7|||
145688581|NCT00449033|525374319|FG000|Treatment Period|Disease Progression|231|||
145688582|NCT00449033|525374320|FG001|Treatment Period|Disease Progression|288|||
145688583|NCT00449033|525374319|FG000|Treatment Period|Consent Withdrawn|36|||
145688584|NCT00449033|525374320|FG001|Treatment Period|Consent Withdrawn|20|||
145688585|NCT00449033|525374319|FG000|Treatment Period|Amended Protocol Criteria|22|||
145688586|NCT00449033|525374320|FG001|Treatment Period|Amended Protocol Criteria|18|||
145688587|NCT00449033|525374319|FG000|Treatment Period|Non-compliance|7|||
145688588|NCT00449033|525374320|FG001|Treatment Period|Non-compliance|8|||
145688589|NCT00449033|525374319|FG000|Treatment Period|Second Malignancy|0|||
145688590|NCT00449033|525374320|FG001|Treatment Period|Second Malignancy|1|||
145688591|NCT00449033|525374319|FG000|Treatment Period|Reason Missing|0|||
145688592|NCT00449033|525374320|FG001|Treatment Period|Reason Missing|4|||
145688593|NCT00449033|525374319|FG000|Treatment Period|Treatment Ongoing|6|||
145688594|NCT00449033|525374320|FG001|Treatment Period|Treatment Ongoing|4|||
145688595|NCT00449033|525374319|FG000|Follow-up Period|Death|299|||
145688596|NCT00449033|525374320|FG001|Follow-up Period|Death|311|||
145688597|NCT00449033|525374319|FG000|Follow-up Period|Lost to Follow-up|6|||
145688598|NCT00449033|525374320|FG001|Follow-up Period|Lost to Follow-up|10|||
145688599|NCT00449033|525374319|FG000|Follow-up Period|Reason Missing|120|||
145688600|NCT00449033|525374320|FG001|Follow-up Period|Reason Missing|113|||
145688601|NCT04393779|525374321|FG000|Overall Study|Death|1|||
145688602|NCT04393779|525374321|FG000|Overall Study|Device reintervention or explant|4|||
145688603|NCT03802513|525374323|FG000|Overall Study|Lost to Follow-up|1|||
145688604|NCT01190228|525374331|FG000|Overall Study|Protocol Violation|4|||
145688605|NCT01190228|525374332|FG001|Overall Study|Protocol Violation|0|||
145688606|NCT01190228|525374333|FG002|Overall Study|Protocol Violation|0|||
145688607|NCT01190228|525374331|FG000|Overall Study|Withdrawal by Subject|1|||
145688608|NCT01190228|525374332|FG001|Overall Study|Withdrawal by Subject|0|||
145688609|NCT01190228|525374333|FG002|Overall Study|Withdrawal by Subject|0|||
145688610|NCT01395914|525374334|FG000|Overall Study|Unrelated to study drug AE|6|||
145688611|NCT01395914|525374335|FG001|Overall Study|Unrelated to study drug AE|1|||
145688612|NCT01395914|525374334|FG000|Overall Study|Death|23|||
145688613|NCT01395914|525374335|FG001|Overall Study|Death|17|||
145688614|NCT01395914|525374334|FG000|Overall Study|Other|9|||
145688615|NCT01395914|525374335|FG001|Overall Study|Other|3|||
145688616|NCT01395914|525374334|FG000|Overall Study|Withdrawal by patient|27|||
145688617|NCT01395914|525374335|FG001|Overall Study|Withdrawal by patient|14|||
145688618|NCT01395914|525374334|FG000|Overall Study|Study drug-related AE|1|||
145688619|NCT01395914|525374335|FG001|Overall Study|Study drug-related AE|0|||
145688620|NCT01395914|525374334|FG000|Overall Study|Lost to Follow-up|6|||
145688621|NCT01395914|525374335|FG001|Overall Study|Lost to Follow-up|2|||
145688622|NCT03023878|525374336|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
145688623|NCT03023878|525374336|FG000|Pre-Study Run-In Period|Death|1|||
145688624|NCT03023878|525374336|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
145688625|NCT03023878|525374336|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
145688626|NCT03023878|525374336|FG000|Treatment Period|Disease Progression|1|||
145688627|NCT03023878|525374336|FG000|Treatment Period|Withdrawal by Subject|1|||
145688628|NCT03023878|525374336|FG000|Treatment Period|Adverse Event|1|||
145688629|NCT03023878|525374336|FG000|Long Term Follow-Up Period|Death|2|||
145688630|NCT00832650|525374340|FG000|Overall Study|Randomized but not treated|0|||
145688631|NCT00832650|525374341|FG001|Overall Study|Randomized but not treated|0|||
145688632|NCT00832650|525374342|FG002|Overall Study|Randomized but not treated|1|||
145688633|NCT03219216|525374343|FG000|Overall Study|Lost to Follow-up|0|||
145688634|NCT03219216|525374344|FG001|Overall Study|Lost to Follow-up|1|||
145688635|NCT02332824|525374345|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
145688636|NCT02332824|525374346|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
145688637|NCT02332824|525374347|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
145688638|NCT02332824|525374348|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
145688639|NCT02332824|525374349|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
145491280|NCT03096834|524653723|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
145688640|NCT02332824|525374350|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
145688641|NCT02332824|525374345|FG000|Overall Study|Voluntary Withdrawal|1|||
145688642|NCT02332824|525374346|FG001|Overall Study|Voluntary Withdrawal|0|||
145688643|NCT02332824|525374347|FG002|Overall Study|Voluntary Withdrawal|0|||
145688644|NCT02332824|525374348|FG003|Overall Study|Voluntary Withdrawal|0|||
145688645|NCT02332824|525374349|FG004|Overall Study|Voluntary Withdrawal|0|||
145688646|NCT02332824|525374350|FG005|Overall Study|Voluntary Withdrawal|0|||
145688647|NCT02332824|525374345|FG000|Overall Study|Inconvenient schedule|1|||
145688648|NCT02332824|525374346|FG001|Overall Study|Inconvenient schedule|1|||
145688649|NCT02332824|525374347|FG002|Overall Study|Inconvenient schedule|0|||
145688650|NCT02332824|525374348|FG003|Overall Study|Inconvenient schedule|0|||
145688651|NCT02332824|525374349|FG004|Overall Study|Inconvenient schedule|0|||
145688652|NCT02332824|525374350|FG005|Overall Study|Inconvenient schedule|0|||
145688653|NCT02332824|525374345|FG000|Overall Study|Transfer|0|||
145688654|NCT02332824|525374346|FG001|Overall Study|Transfer|0|||
145688655|NCT02332824|525374347|FG002|Overall Study|Transfer|1|||
145688656|NCT02332824|525374348|FG003|Overall Study|Transfer|1|||
145688657|NCT02332824|525374349|FG004|Overall Study|Transfer|0|||
145688658|NCT02332824|525374350|FG005|Overall Study|Transfer|0|||
145688659|NCT00498797|525374351|FG000|Overall Study|Withdrawal by Subject|4|||
145688660|NCT00498797|525374352|FG001|Overall Study|Withdrawal by Subject|2|||
145688661|NCT00498797|525374351|FG000|Overall Study|Adverse Event|12|||
145688662|NCT00498797|525374352|FG001|Overall Study|Adverse Event|5|||
145688663|NCT00498797|525374351|FG000|Overall Study|Condition under investigation worsened|19|||
145688664|NCT00498797|525374352|FG001|Overall Study|Condition under investigation worsened|21|||
145688665|NCT00498797|525374351|FG000|Overall Study|Other|3|||
145688666|NCT00498797|525374352|FG001|Overall Study|Other|1|||
145688667|NCT02784535|525374353|FG000|Overall Study|Adverse Event|1|||
145688668|NCT02784535|525374354|FG001|Overall Study|Adverse Event|0|||
145688669|NCT02784535|525374353|FG000|Overall Study|Withdrawal by Subject|0|||
145688670|NCT02784535|525374354|FG001|Overall Study|Withdrawal by Subject|1|||
145688671|NCT02784535|525374353|FG000|Overall Study|Physician Decision|0|||
145688672|NCT02784535|525374354|FG001|Overall Study|Physician Decision|1|||
145688673|NCT03740919|525374355|FG000|Lead-in Period|Lost to Follow-up|1|||
145688674|NCT03740919|525374356|FG001|Lead-in Period|Lost to Follow-up|0|||
145688675|NCT03740919|525374357|FG002|Lead-in Period|Lost to Follow-up|0|||
145688676|NCT03740919|525374358|FG003|Lead-in Period|Lost to Follow-up|0|||
145688677|NCT03740919|525374355|FG000|Lead-in Period|Physician Decision|2|||
145688678|NCT03740919|525374356|FG001|Lead-in Period|Physician Decision|0|||
145688679|NCT03740919|525374357|FG002|Lead-in Period|Physician Decision|0|||
145688680|NCT03740919|525374358|FG003|Lead-in Period|Physician Decision|0|||
145688681|NCT03740919|525374355|FG000|Lead-in Period|Protocol Violation|1|||
145688682|NCT03740919|525374356|FG001|Lead-in Period|Protocol Violation|0|||
145688683|NCT03740919|525374357|FG002|Lead-in Period|Protocol Violation|0|||
145688684|NCT03740919|525374358|FG003|Lead-in Period|Protocol Violation|0|||
145688685|NCT03740919|525374355|FG000|Lead-in Period|Withdrawal by Subject|10|||
145688686|NCT03740919|525374356|FG001|Lead-in Period|Withdrawal by Subject|0|||
145688687|NCT03740919|525374357|FG002|Lead-in Period|Withdrawal by Subject|0|||
145688688|NCT03740919|525374358|FG003|Lead-in Period|Withdrawal by Subject|0|||
145688689|NCT03740919|525374355|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
145688690|NCT03740919|525374356|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
145688691|NCT03740919|525374357|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
145688692|NCT03740919|525374358|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
145688693|NCT03740919|525374355|FG000|Lead-in Period|Study Task Too Burdensome|1|||
145688694|NCT03740919|525374356|FG001|Lead-in Period|Study Task Too Burdensome|0|||
145688695|NCT03740919|525374357|FG002|Lead-in Period|Study Task Too Burdensome|0|||
145688696|NCT03740919|525374358|FG003|Lead-in Period|Study Task Too Burdensome|0|||
145688697|NCT03740919|525374355|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
145688698|NCT03740919|525374356|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
145688699|NCT03740919|525374357|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
145688700|NCT03740919|525374358|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
145688701|NCT03740919|525374355|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
145688702|NCT03740919|525374356|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
145688703|NCT03740919|525374357|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
145688704|NCT03740919|525374358|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
145688705|NCT03740919|525374355|FG000|Treatment Period|Adverse Event|0|||
145688706|NCT03740919|525374356|FG001|Treatment Period|Adverse Event|0|||
145688707|NCT03740919|525374357|FG002|Treatment Period|Adverse Event|2|||
145688708|NCT03740919|525374358|FG003|Treatment Period|Adverse Event|0|||
145688709|NCT03740919|525374355|FG000|Treatment Period|Protocol Violation|0|||
145688710|NCT03740919|525374356|FG001|Treatment Period|Protocol Violation|1|||
145688711|NCT03740919|525374357|FG002|Treatment Period|Protocol Violation|0|||
145688712|NCT03740919|525374358|FG003|Treatment Period|Protocol Violation|0|||
145688713|NCT03740919|525374355|FG000|Treatment Period|Withdrawal by Subject|0|||
145688714|NCT03740919|525374356|FG001|Treatment Period|Withdrawal by Subject|7|||
145688715|NCT03740919|525374357|FG002|Treatment Period|Withdrawal by Subject|6|||
145688716|NCT03740919|525374358|FG003|Treatment Period|Withdrawal by Subject|2|||
145688717|NCT03740919|525374355|FG000|Treatment Period|Terminated by Sponsor|0|||
145688718|NCT03740919|525374356|FG001|Treatment Period|Terminated by Sponsor|1|||
145688719|NCT03740919|525374357|FG002|Treatment Period|Terminated by Sponsor|0|||
145688720|NCT03740919|525374358|FG003|Treatment Period|Terminated by Sponsor|0|||
145688721|NCT03740919|525374355|FG000|Treatment Period|Issue with Insulin Pump|0|||
145688722|NCT03740919|525374356|FG001|Treatment Period|Issue with Insulin Pump|1|||
145688723|NCT03740919|525374357|FG002|Treatment Period|Issue with Insulin Pump|0|||
145688724|NCT03740919|525374358|FG003|Treatment Period|Issue with Insulin Pump|0|||
145688725|NCT03740919|525374355|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
145688726|NCT03740919|525374356|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
145688727|NCT03740919|525374357|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
145688728|NCT03740919|525374358|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
145688729|NCT03740919|525374355|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
145688730|NCT03740919|525374356|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
145688731|NCT03740919|525374357|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
145688732|NCT03740919|525374358|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
145688733|NCT03740919|525374355|FG000|Treatment Period|Not Completing Diary|0|||
145688734|NCT03740919|525374356|FG001|Treatment Period|Not Completing Diary|0|||
145688735|NCT03740919|525374357|FG002|Treatment Period|Not Completing Diary|1|||
145688736|NCT03740919|525374358|FG003|Treatment Period|Not Completing Diary|0|||
145688737|NCT03740919|525374355|FG000|Treatment Period|Insulin Painful to Participant|0|||
145688738|NCT03740919|525374356|FG001|Treatment Period|Insulin Painful to Participant|0|||
145688739|NCT03740919|525374357|FG002|Treatment Period|Insulin Painful to Participant|1|||
145688740|NCT03740919|525374358|FG003|Treatment Period|Insulin Painful to Participant|0|||
145688741|NCT01911819|525374361|FG000|Overall Study|Adverse Event|0|||
145688742|NCT01911819|525374362|FG001|Overall Study|Adverse Event|1|||
145688743|NCT01911819|525374363|FG002|Overall Study|Adverse Event|0|||
145688744|NCT01911819|525374361|FG000|Overall Study|Withdrawal by Subject|1|||
145688745|NCT01911819|525374362|FG001|Overall Study|Withdrawal by Subject|1|||
145688746|NCT01911819|525374363|FG002|Overall Study|Withdrawal by Subject|0|||
145688747|NCT03953079|525374364|FG000|Core Study|Withdrawal by Subject|1|||
145688748|NCT03953079|525374365|FG001|Core Study|Withdrawal by Subject|2|||
145688749|NCT03953079|525374366|FG002|Core Study|Withdrawal by Subject|1|||
145688750|NCT03953079|525374364|FG000|Core Study|COVID-19|0|||
145688751|NCT03953079|525374365|FG001|Core Study|COVID-19|1|||
145688752|NCT03953079|525374366|FG002|Core Study|COVID-19|0|||
145688753|NCT03953079|525374364|FG000|Core Study|Difficulties leaving the house|0|||
145688754|NCT03953079|525374365|FG001|Core Study|Difficulties leaving the house|1|||
145688755|NCT03953079|525374366|FG002|Core Study|Difficulties leaving the house|0|||
145688756|NCT03953079|525374364|FG000|Extension Study|Withdrawal by Subject|1|||
145688757|NCT03953079|525374365|FG001|Extension Study|Withdrawal by Subject|0|||
145688758|NCT03953079|525374366|FG002|Extension Study|Withdrawal by Subject|0|||
145688759|NCT03953079|525374364|FG000|Extension Study|Received Rescue Treatment|5|||
145688760|NCT03953079|525374365|FG001|Extension Study|Received Rescue Treatment|6|||
145688761|NCT03953079|525374366|FG002|Extension Study|Received Rescue Treatment|5|||
145688762|NCT04394624|525374367|FG000|Overall Study|Adverse Event|6|||
145688763|NCT04394624|525374368|FG001|Overall Study|Adverse Event|0|||
145688764|NCT04394624|525374367|FG000|Overall Study|Progressive disease|24|||
145688765|NCT04394624|525374368|FG001|Overall Study|Progressive disease|0|||
145688766|NCT04394624|525374367|FG000|Overall Study|Not related to COVID-19|1|||
145688767|NCT04394624|525374368|FG001|Overall Study|Not related to COVID-19|0|||
145688768|NCT00603278|525374370|FG000|Overall Study|Lack of Efficacy|35|||
145688769|NCT00603278|525374371|FG001|Overall Study|Lack of Efficacy|10|||
145688770|NCT00603278|525374372|FG002|Overall Study|Lack of Efficacy|11|||
145688771|NCT00603278|525374373|FG003|Overall Study|Lack of Efficacy|8|||
145688772|NCT00603278|525374374|FG004|Overall Study|Lack of Efficacy|7|||
145688773|NCT00603278|525374375|FG005|Overall Study|Lack of Efficacy|14|||
145688774|NCT00603278|525374370|FG000|Overall Study|Adverse Event|0|||
145688775|NCT00603278|525374371|FG001|Overall Study|Adverse Event|3|||
145688776|NCT00603278|525374372|FG002|Overall Study|Adverse Event|1|||
145688777|NCT00603278|525374373|FG003|Overall Study|Adverse Event|0|||
145688778|NCT00603278|525374374|FG004|Overall Study|Adverse Event|2|||
145688779|NCT00603278|525374375|FG005|Overall Study|Adverse Event|1|||
145688780|NCT00603278|525374370|FG000|Overall Study|Withdrawal by Subject|2|||
145688781|NCT00603278|525374371|FG001|Overall Study|Withdrawal by Subject|3|||
145688782|NCT00603278|525374372|FG002|Overall Study|Withdrawal by Subject|1|||
145688783|NCT00603278|525374373|FG003|Overall Study|Withdrawal by Subject|2|||
145688784|NCT00603278|525374374|FG004|Overall Study|Withdrawal by Subject|1|||
145688785|NCT00603278|525374375|FG005|Overall Study|Withdrawal by Subject|2|||
145688786|NCT00603278|525374370|FG000|Overall Study|Protocol Violation|3|||
145688787|NCT00603278|525374371|FG001|Overall Study|Protocol Violation|0|||
145688788|NCT00603278|525374372|FG002|Overall Study|Protocol Violation|1|||
145688789|NCT00603278|525374373|FG003|Overall Study|Protocol Violation|1|||
145688790|NCT00603278|525374374|FG004|Overall Study|Protocol Violation|0|||
145688791|NCT00603278|525374375|FG005|Overall Study|Protocol Violation|1|||
145688792|NCT00603278|525374370|FG000|Overall Study|Physician Decision|0|||
145688793|NCT00603278|525374371|FG001|Overall Study|Physician Decision|1|||
145688794|NCT00603278|525374372|FG002|Overall Study|Physician Decision|0|||
145688795|NCT00603278|525374373|FG003|Overall Study|Physician Decision|0|||
145688796|NCT00603278|525374374|FG004|Overall Study|Physician Decision|2|||
145688797|NCT00603278|525374375|FG005|Overall Study|Physician Decision|1|||
145688798|NCT00603278|525374370|FG000|Overall Study|Lost to Follow-up|1|||
145688799|NCT00603278|525374371|FG001|Overall Study|Lost to Follow-up|0|||
145688800|NCT00603278|525374372|FG002|Overall Study|Lost to Follow-up|0|||
145688801|NCT00603278|525374373|FG003|Overall Study|Lost to Follow-up|0|||
145688802|NCT00603278|525374374|FG004|Overall Study|Lost to Follow-up|1|||
145688803|NCT00603278|525374375|FG005|Overall Study|Lost to Follow-up|0|||
145688804|NCT04743999|525374377|FG000|3-month Questionnaire|Death|1|||
145688805|NCT04743999|525374377|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
145688806|NCT04743999|525374377|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
145688807|NCT04743999|525374377|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
145688808|NCT01721759|525374378|FG000|Treatment Period|Disease Progression|85|||
145688809|NCT01721759|525374378|FG000|Treatment Period|Study drug toxicity|14|||
145688810|NCT01721759|525374378|FG000|Treatment Period|Death|1|||
145688811|NCT01721759|525374378|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
145688812|NCT01721759|525374378|FG000|Treatment Period|Participant request to withdraw|3|||
145688813|NCT01721759|525374378|FG000|Treatment Period|Other Reasons|3|||
145688814|NCT01721759|525374378|FG000|End of Study Period|Participant Withdrew Consent|5|||
145688815|NCT01721759|525374378|FG000|End of Study Period|Death|101|||
145688816|NCT01721759|525374378|FG000|End of Study Period|Lost to Follow-up|1|||
145688817|NCT01721759|525374378|FG000|End of Study Period|Other Reasons|10|||
145688818|NCT02577315|525374379|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
145688819|NCT02577315|525374380|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
145688820|NCT00990821|525374384|FG000|Overall Study|Withdrawal by Subject|0|||
145688821|NCT00990821|525374385|FG001|Overall Study|Withdrawal by Subject|2|||
145688822|NCT00990821|525374386|FG002|Overall Study|Withdrawal by Subject|0|||
145688823|NCT00990821|525374387|FG003|Overall Study|Withdrawal by Subject|0|||
145688824|NCT00990821|525374388|FG004|Overall Study|Withdrawal by Subject|3|||
145688825|NCT00990821|525374389|FG005|Overall Study|Withdrawal by Subject|3|||
145688826|NCT00990821|525374390|FG006|Overall Study|Withdrawal by Subject|1|||
145688827|NCT00990821|525374391|FG007|Overall Study|Withdrawal by Subject|0|||
145688828|NCT00990821|525374392|FG008|Overall Study|Withdrawal by Subject|0|||
145688829|NCT00990821|525374393|FG009|Overall Study|Withdrawal by Subject|1|||
145688830|NCT00990821|525374394|FG010|Overall Study|Withdrawal by Subject|3|||
145688831|NCT00990821|525374395|FG011|Overall Study|Withdrawal by Subject|5|||
145688832|NCT00990821|525374396|FG012|Overall Study|Withdrawal by Subject|2|||
145688833|NCT00990821|525374397|FG013|Overall Study|Withdrawal by Subject|1|||
145688834|NCT02442622|525374403|FG000|Overall Study|Withdrawal by Subject|3|||
145688835|NCT02442622|525374404|FG001|Overall Study|Withdrawal by Subject|1|||
145688836|NCT01002547|525375976|FG000|Overall Study|Withdrawal by Subject|4|||
145688837|NCT01002547|525375977|FG001|Overall Study|Withdrawal by Subject|0|||
145688838|NCT01002547|525375978|FG002|Overall Study|Withdrawal by Subject|5|||
145688839|NCT01002547|525375976|FG000|Overall Study|Lost to Follow-up|2|||
145688840|NCT01002547|525375977|FG001|Overall Study|Lost to Follow-up|1|||
145688841|NCT01002547|525375978|FG002|Overall Study|Lost to Follow-up|1|||
145688842|NCT01002547|525375976|FG000|Overall Study|Physician Decision|1|||
145688843|NCT01002547|525375977|FG001|Overall Study|Physician Decision|0|||
145688844|NCT01002547|525375978|FG002|Overall Study|Physician Decision|0|||
145688845|NCT01002547|525375976|FG000|Overall Study|Death|0|||
145688846|NCT01002547|525375977|FG001|Overall Study|Death|2|||
145688847|NCT01002547|525375978|FG002|Overall Study|Death|2|||
145688848|NCT01002547|525375976|FG000|Overall Study|Adverse Event|1|||
145688849|NCT01002547|525375977|FG001|Overall Study|Adverse Event|0|||
145688850|NCT01002547|525375978|FG002|Overall Study|Adverse Event|0|||
145688851|NCT00705614|525375983|FG000|Initial Intervention|Adverse Event|40|||
145688852|NCT00705614|525375984|FG001|Initial Intervention|Adverse Event|21|||
145688853|NCT00705614|525375983|FG000|Initial Intervention|Lost to Follow-up|310|||
145688854|NCT00705614|525375984|FG001|Initial Intervention|Lost to Follow-up|191|||
145688855|NCT00705614|525375983|FG000|Initial Intervention|Withdrawal by Subject|114|||
145688856|NCT00705614|525375984|FG001|Initial Intervention|Withdrawal by Subject|71|||
145688857|NCT00705614|525375983|FG000|Initial Intervention|Administrative Reason|51|||
145688858|NCT00705614|525375984|FG001|Initial Intervention|Administrative Reason|38|||
145688859|NCT00705614|525375983|FG000|Initial Intervention|Status completion unknown|3|||
145491281|NCT03096834|524653724|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
145688860|NCT00705614|525375984|FG001|Initial Intervention|Status completion unknown|0|||
145688861|NCT00705614|525375983|FG000|Switch to Remicade|Adverse Event|0|||
145688862|NCT00705614|525375984|FG001|Switch to Remicade|Adverse Event|5|||
145688863|NCT00705614|525375983|FG000|Switch to Remicade|Lost to Follow-up|0|||
145688864|NCT00705614|525375984|FG001|Switch to Remicade|Lost to Follow-up|23|||
145688865|NCT00705614|525375983|FG000|Switch to Remicade|Withdrawal by Subject|0|||
145688866|NCT00705614|525375984|FG001|Switch to Remicade|Withdrawal by Subject|12|||
145688867|NCT00705614|525375983|FG000|Switch to Remicade|Administrative Reason|0|||
145688868|NCT00705614|525375984|FG001|Switch to Remicade|Administrative Reason|9|||
145688869|NCT00925288|525375985|FG000|Overall Study|Lost to Follow-up|9|||
145688870|NCT00925288|525375986|FG001|Overall Study|Lost to Follow-up|7|||
145688871|NCT02081196|525375987|FG000|Overall Study|Lost to Follow-up|1|||
145688872|NCT00434577|525375988|FG000|Months 0-3|Serious Adverse Event|0|||
145688873|NCT00434577|525375989|FG001|Months 0-3|Serious Adverse Event|0|||
145688874|NCT00434577|525375990|FG002|Months 0-3|Serious Adverse Event|1|||
145688875|NCT00434577|525375991|FG003|Months 0-3|Serious Adverse Event|0|||
145688876|NCT00434577|525375992|FG004|Months 0-3|Serious Adverse Event|0|||
145688877|NCT00434577|525375988|FG000|Months 0-3|Adverse Event|0|||
145688878|NCT00434577|525375989|FG001|Months 0-3|Adverse Event|1|||
145688879|NCT00434577|525375990|FG002|Months 0-3|Adverse Event|1|||
145688880|NCT00434577|525375991|FG003|Months 0-3|Adverse Event|0|||
145688881|NCT00434577|525375992|FG004|Months 0-3|Adverse Event|0|||
145688882|NCT00434577|525375988|FG000|Months 0-3|Lost to Follow-up|0|||
145688883|NCT00434577|525375989|FG001|Months 0-3|Lost to Follow-up|0|||
145688884|NCT00434577|525375990|FG002|Months 0-3|Lost to Follow-up|0|||
145688885|NCT00434577|525375991|FG003|Months 0-3|Lost to Follow-up|0|||
145688886|NCT00434577|525375992|FG004|Months 0-3|Lost to Follow-up|2|||
145688887|NCT00434577|525375988|FG000|Months 0-3|Protocol Violation|1|||
145688888|NCT00434577|525375989|FG001|Months 0-3|Protocol Violation|0|||
145688889|NCT00434577|525375990|FG002|Months 0-3|Protocol Violation|1|||
145688890|NCT00434577|525375991|FG003|Months 0-3|Protocol Violation|0|||
145688891|NCT00434577|525375992|FG004|Months 0-3|Protocol Violation|0|||
145688892|NCT00434577|525375988|FG000|Months 0-3|Withdrawal by Subject|2|||
145688893|NCT00434577|525375989|FG001|Months 0-3|Withdrawal by Subject|1|||
145688894|NCT00434577|525375990|FG002|Months 0-3|Withdrawal by Subject|1|||
145688895|NCT00434577|525375991|FG003|Months 0-3|Withdrawal by Subject|1|||
145688896|NCT00434577|525375992|FG004|Months 0-3|Withdrawal by Subject|1|||
145688897|NCT01904019|525375993|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
145688898|NCT01904019|525375993|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
145688899|NCT01904019|525375993|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
145688900|NCT01904019|525375993|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
145688901|NCT01904019|525375993|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
145688902|NCT01904019|525375993|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
145688903|NCT00635570|525375994|FG000|Overall Study|Lost to Follow-up|8|||
145688904|NCT00635570|525375995|FG001|Overall Study|Lost to Follow-up|8|||
145688905|NCT00635570|525375994|FG000|Overall Study|Withdrawal by Subject|1|||
145688906|NCT00635570|525375995|FG001|Overall Study|Withdrawal by Subject|1|||
145688907|NCT00635570|525375994|FG000|Overall Study|Adverse Event|2|||
145688908|NCT00635570|525375995|FG001|Overall Study|Adverse Event|0|||
145688909|NCT00635570|525375994|FG000|Overall Study|Physician Decision|1|||
145688910|NCT00635570|525375995|FG001|Overall Study|Physician Decision|0|||
145688911|NCT00635570|525375994|FG000|Overall Study|Did not complete survey|2|||
145688912|NCT00635570|525375995|FG001|Overall Study|Did not complete survey|1|||
145688913|NCT00635570|525375994|FG000|Overall Study|Early termination(No sexual activity)|1|||
145688914|NCT00635570|525375995|FG001|Overall Study|Early termination(No sexual activity)|1|||
145688915|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
145688916|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
145688917|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
145688918|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
145688919|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
145688920|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
145688921|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
145688922|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
145688923|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
145688924|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
145688925|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
145688926|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
145688927|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
145688928|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
145688929|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
145688930|NCT00332488|525375999|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
145688931|NCT00332488|525376000|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
145688932|NCT00332488|525376001|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
145688933|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
145688934|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
145688935|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
145688936|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
145688937|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
145688938|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
145688939|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
145688940|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
145688941|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
145688942|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
145688943|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
145688944|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
145688945|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
145688946|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
145688947|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
145688948|NCT00332488|525375999|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
145688949|NCT00332488|525376000|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
145688950|NCT00332488|525376001|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
145688951|NCT02775214|525376004|FG000|Overall Study|Withdrawal by Subject|2|||
145688952|NCT02775214|525376005|FG001|Overall Study|Withdrawal by Subject|0|||
145688953|NCT00762723|525376006|FG000|Overall Study|Study Terminated slow enrollement|5|||
145688954|NCT00762723|525376007|FG001|Overall Study|Study Terminated slow enrollement|5|||
145688955|NCT00762723|525376008|FG002|Overall Study|Study Terminated slow enrollement|3|||
145688956|NCT02402465|525376014|FG000|Overall Study|Withdrawal by Subject|0|||
145688957|NCT02402465|525376015|FG001|Overall Study|Withdrawal by Subject|0|||
145688958|NCT02402465|525376016|FG002|Overall Study|Withdrawal by Subject|0|||
145688959|NCT02402465|525376017|FG003|Overall Study|Withdrawal by Subject|0|||
145688960|NCT02402465|525376018|FG004|Overall Study|Withdrawal by Subject|0|||
145688961|NCT02402465|525376019|FG005|Overall Study|Withdrawal by Subject|1|||
145688962|NCT02402465|525376014|FG000|Overall Study|Lost to Follow-up|0|||
145688963|NCT02402465|525376015|FG001|Overall Study|Lost to Follow-up|1|||
145688964|NCT02402465|525376016|FG002|Overall Study|Lost to Follow-up|0|||
145688965|NCT02402465|525376017|FG003|Overall Study|Lost to Follow-up|0|||
145688966|NCT02402465|525376018|FG004|Overall Study|Lost to Follow-up|1|||
145688967|NCT02402465|525376019|FG005|Overall Study|Lost to Follow-up|0|||
145688968|NCT01284634|525376020|FG000|Overall Study|Adverse Event|1|||
145688969|NCT01284634|525376021|FG001|Overall Study|Adverse Event|0|||
145688970|NCT01284634|525376022|FG002|Overall Study|Adverse Event|2|||
145688971|NCT01284634|525376023|FG003|Overall Study|Adverse Event|1|||
145688972|NCT02236598|525376024|FG000|Overall Study|Adverse Event|0|||
145688973|NCT02236598|525376025|FG001|Overall Study|Adverse Event|1|||
145688974|NCT02236598|525376024|FG000|Overall Study|Withdrawal by Subject|0|||
145688975|NCT02236598|525376025|FG001|Overall Study|Withdrawal by Subject|1|||
145688976|NCT00730925|525376029|FG000|Overall Study|Progressive Disease|21|||
145688977|NCT00730925|525376029|FG000|Overall Study|Dose reducing Event|2|||
145688978|NCT00730925|525376029|FG000|Overall Study|Other Averse Event|7|||
145688979|NCT00730925|525376029|FG000|Overall Study|Protocol Violation|1|||
145688980|NCT00730925|525376029|FG000|Overall Study|Withdrawal by Subject|1|||
145688981|NCT00730925|525376029|FG000|Overall Study|Switch to combination therapy|8|||
145688982|NCT00730925|525376029|FG000|Overall Study|Other|1|||
145688983|NCT03334747|525376030|FG000|Treatment Phase|Technical problems|0|||
145688984|NCT03334747|525376031|FG001|Treatment Phase|Technical problems|0|||
145688985|NCT03334747|525376032|FG002|Treatment Phase|Technical problems|0|||
145688986|NCT03334747|525376033|FG003|Treatment Phase|Technical problems|0|||
145688987|NCT03334747|525376034|FG004|Treatment Phase|Technical problems|1|||
145688988|NCT03334747|525376035|FG005|Treatment Phase|Technical problems|0|||
145688989|NCT03334747|525376036|FG006|Treatment Phase|Technical problems|0|||
145688990|NCT03334747|525376037|FG007|Treatment Phase|Technical problems|0|||
145688991|NCT03334747|525376038|FG008|Treatment Phase|Technical problems|0|||
145688992|NCT03334747|525376030|FG000|Treatment Phase|Subject/guardian decision|1|||
145688993|NCT03334747|525376031|FG001|Treatment Phase|Subject/guardian decision|0|||
145688994|NCT03334747|525376032|FG002|Treatment Phase|Subject/guardian decision|0|||
145688995|NCT03334747|525376033|FG003|Treatment Phase|Subject/guardian decision|0|||
145688996|NCT03334747|525376034|FG004|Treatment Phase|Subject/guardian decision|0|||
145688997|NCT03334747|525376035|FG005|Treatment Phase|Subject/guardian decision|1|||
145688998|NCT03334747|525376036|FG006|Treatment Phase|Subject/guardian decision|0|||
145688999|NCT03334747|525376037|FG007|Treatment Phase|Subject/guardian decision|0|||
145689000|NCT03334747|525376038|FG008|Treatment Phase|Subject/guardian decision|0|||
145689001|NCT03334747|525376030|FG000|Follow-Up Phase|Subject/guardian decision|0|||
145689002|NCT03334747|525376031|FG001|Follow-Up Phase|Subject/guardian decision|0|||
145689003|NCT03334747|525376032|FG002|Follow-Up Phase|Subject/guardian decision|0|||
145689004|NCT03334747|525376033|FG003|Follow-Up Phase|Subject/guardian decision|0|||
145689005|NCT03334747|525376034|FG004|Follow-Up Phase|Subject/guardian decision|0|||
145689006|NCT03334747|525376035|FG005|Follow-Up Phase|Subject/guardian decision|0|||
145689007|NCT03334747|525376036|FG006|Follow-Up Phase|Subject/guardian decision|1|||
145689008|NCT03334747|525376037|FG007|Follow-Up Phase|Subject/guardian decision|0|||
145689009|NCT03334747|525376038|FG008|Follow-Up Phase|Subject/guardian decision|1|||
145689010|NCT03303521|525376045|FG000|Overall Study|Withdrawal by Subject|2|||
145689011|NCT03303521|525376046|FG001|Overall Study|Withdrawal by Subject|0|||
145689012|NCT03303521|525376045|FG000|Overall Study|Death|1|||
145689013|NCT03303521|525376046|FG001|Overall Study|Death|0|||
145689014|NCT03303521|525376045|FG000|Overall Study|Kidney transplantation|0|||
145689015|NCT03303521|525376046|FG001|Overall Study|Kidney transplantation|1|||
145689016|NCT03303521|525376045|FG000|Overall Study|Investigational product discontinuation|0|||
145689017|NCT03303521|525376046|FG001|Overall Study|Investigational product discontinuation|1|||
145689018|NCT03303521|525376045|FG000|Overall Study|Transferred to non-study dialysis center|1|||
145689019|NCT03303521|525376046|FG001|Overall Study|Transferred to non-study dialysis center|0|||
145689020|NCT03303521|525376045|FG000|Overall Study|Non-comliance to study protocol|0|||
145689021|NCT03303521|525376046|FG001|Overall Study|Non-comliance to study protocol|1|||
145689022|NCT03303521|525376045|FG000|Overall Study|Adverse Event|1|||
145689023|NCT03303521|525376046|FG001|Overall Study|Adverse Event|0|||
145689024|NCT00191984|525376047|FG000|Overall Study|Disease Progression|21|||
145689025|NCT00191984|525376047|FG000|Overall Study|Adverse Event|4|||
145689026|NCT00191984|525376047|FG000|Overall Study|Death|2|||
145689027|NCT00191984|525376047|FG000|Overall Study|Entry Criteria Exclusion|1|||
145689028|NCT00191984|525376047|FG000|Overall Study|Withdrawal by Subject|7|||
145689029|NCT00191984|525376047|FG000|Overall Study|Physician Decision|4|||
145689030|NCT01654289|525376048|FG000|Overall Study|Withdrawal by Subject|10|||
145689031|NCT01654289|525376049|FG001|Overall Study|Withdrawal by Subject|8|||
145689032|NCT01654289|525376050|FG002|Overall Study|Withdrawal by Subject|5|||
145689033|NCT01654289|525376048|FG000|Overall Study|Withdrew from intervention only|17|||
145689034|NCT01654289|525376049|FG001|Overall Study|Withdrew from intervention only|20|||
145689035|NCT01654289|525376050|FG002|Overall Study|Withdrew from intervention only|0|||
145689036|NCT01732627|525376051|FG000|Overall Study|Withdrawal by Subject|1|||
145689037|NCT01732627|525376052|FG001|Overall Study|Withdrawal by Subject|0|||
145689038|NCT02137239|525376053|FG000|Overall Study|Discontinued Study Treatment|0|||
145689039|NCT02137239|525376054|FG001|Overall Study|Discontinued Study Treatment|3|||
145689040|NCT02137239|525376053|FG000|Overall Study|Withdrew Consent|1|||
145689041|NCT02137239|525376054|FG001|Overall Study|Withdrew Consent|1|||
145689042|NCT02137239|525376053|FG000|Overall Study|Adverse Event|2|||
145689043|NCT02137239|525376054|FG001|Overall Study|Adverse Event|2|||
145689044|NCT00005908|525376055|FG000|Overall Study|Withdrawal by Subject|1|||
145689045|NCT00005908|525376056|FG001|Overall Study|Withdrawal by Subject|0|||
145689046|NCT00938041|525376063|FG000|Overall Study|Lost to Follow-up|6|||
145689047|NCT00938041|525376063|FG000|Overall Study|Received Alternative Therapy|1|||
145689048|NCT00938041|525376063|FG000|Overall Study|Progressive Disease|5|||
145689049|NCT00938041|525376063|FG000|Overall Study|Death|12|||
145689050|NCT00938041|525376063|FG000|Overall Study|Adrenal Insufficiency|3|||
145689051|NCT03042559|525376067|FG000|Overall Study|drop out|1|||
145689052|NCT03042559|525376068|FG001|Overall Study|drop out|1|||
145689053|NCT00404547|525376070|FG000|Overall Study|Adverse Event|39|||
145689054|NCT00404547|525376071|FG001|Overall Study|Adverse Event|6|||
145689055|NCT00404547|525376070|FG000|Overall Study|Withdrawal by Subject|19|||
145689056|NCT00404547|525376071|FG001|Overall Study|Withdrawal by Subject|2|||
145689057|NCT00404547|525376070|FG000|Overall Study|Protocol Violation|0|||
145491282|NCT03096834|524653725|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
145491283|NCT00966654|524653726|FG000|Overall Study|Study was terminated,PI left institution|12|||
145491284|NCT01600326|524653731|FG000|Overall Study|Lost to Follow-up|1|||
145491285|NCT01600326|524653732|FG001|Overall Study|Lost to Follow-up|1|||
145491286|NCT04456504|524653733|FG000|Overall Study|Lost to Follow-up|2|||
145491287|NCT04233801|524653734|FG000|Overall Study|Other than listed|0|||
145491288|NCT04233801|524653735|FG001|Overall Study|Other than listed|0|||
145491289|NCT04233801|524653736|FG002|Overall Study|Other than listed|1|||
145491290|NCT04233801|524653734|FG000|Overall Study|Withdrawal by Subject|0|||
145491291|NCT04233801|524653735|FG001|Overall Study|Withdrawal by Subject|2|||
145491292|NCT04233801|524653736|FG002|Overall Study|Withdrawal by Subject|3|||
145491293|NCT00762359|524653737|FG000|Overall Study|Adverse Event|20|||
145491294|NCT00762359|524653738|FG001|Overall Study|Adverse Event|23|||
145491295|NCT00762359|524653737|FG000|Overall Study|Protocol Violation|21|||
145491296|NCT00762359|524653738|FG001|Overall Study|Protocol Violation|13|||
145491297|NCT00762359|524653737|FG000|Overall Study|Withdrawal by Subject|13|||
145491298|NCT00762359|524653738|FG001|Overall Study|Withdrawal by Subject|10|||
145491299|NCT00762359|524653737|FG000|Overall Study|Lack of Efficacy|0|||
145491300|NCT00762359|524653738|FG001|Overall Study|Lack of Efficacy|4|||
145491301|NCT00762359|524653737|FG000|Overall Study|Institution closed|2|||
145491302|NCT00762359|524653738|FG001|Overall Study|Institution closed|3|||
145491303|NCT00762359|524653737|FG000|Overall Study|Physician Decision|2|||
145689058|NCT00404547|525376071|FG001|Overall Study|Protocol Violation|1|||
145491304|NCT00762359|524653738|FG001|Overall Study|Physician Decision|3|||
145491305|NCT00762359|524653737|FG000|Overall Study|Removal|0|||
145491306|NCT00762359|524653738|FG001|Overall Study|Removal|1|||
145491307|NCT00762359|524653737|FG000|Overall Study|Withdrew consent|1|||
145491308|NCT00762359|524653738|FG001|Overall Study|Withdrew consent|0|||
145491309|NCT01690052|524653743|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
145491310|NCT01690052|524653744|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
145491311|NCT02421172|524653745|FG000|Period 1|Adverse Event|1|||
145689059|NCT00404547|525376070|FG000|Overall Study|Lost to Follow-up|20|||
145689060|NCT00404547|525376071|FG001|Overall Study|Lost to Follow-up|9|||
145689061|NCT00404547|525376070|FG000|Overall Study|Lack of compliance|5|||
145491312|NCT02421172|524653746|FG001|Period 1|Adverse Event|0|||
145491313|NCT02421172|524653747|FG002|Period 1|Adverse Event|0|||
145689062|NCT00404547|525376071|FG001|Overall Study|Lack of compliance|1|||
145689063|NCT00404547|525376070|FG000|Overall Study|Other|4|||
145689064|NCT00404547|525376071|FG001|Overall Study|Other|0|||
145689065|NCT00404547|525376070|FG000|Overall Study|Reason not stated|3|||
145689066|NCT00404547|525376071|FG001|Overall Study|Reason not stated|6|||
145689067|NCT02350127|525376077|FG000|4-Month Assessment|Withdrawal by Subject|10|||
145689068|NCT02350127|525376078|FG001|4-Month Assessment|Withdrawal by Subject|9|||
145689069|NCT02350127|525376077|FG000|4-Month Assessment|Death|1|||
145689070|NCT02350127|525376078|FG001|4-Month Assessment|Death|0|||
145689071|NCT02350127|525376077|FG000|8-Month Assessment|Death|1|||
145689072|NCT02350127|525376078|FG001|8-Month Assessment|Death|1|||
145689073|NCT02350127|525376077|FG000|8-Month Assessment|Withdrawal by Subject|5|||
145689074|NCT02350127|525376078|FG001|8-Month Assessment|Withdrawal by Subject|8|||
145689075|NCT03575572|525376081|FG000|Overall Study|Withdrawal by Subject|2|||
145689076|NCT03575572|525376081|FG000|Overall Study|Physician Decision|2|||
145689077|NCT02268526|525376084|FG000|Overall Study|Adverse Event|0|||
145689078|NCT02268526|525376085|FG001|Overall Study|Adverse Event|2|||
145689079|NCT02268526|525376086|FG002|Overall Study|Adverse Event|1|||
145689080|NCT02268526|525376084|FG000|Overall Study|Death|1|||
145689081|NCT02268526|525376085|FG001|Overall Study|Death|11|||
145689082|NCT02268526|525376086|FG002|Overall Study|Death|0|||
145689083|NCT02268526|525376084|FG000|Overall Study|protocol deviation|0|||
145689084|NCT02268526|525376085|FG001|Overall Study|protocol deviation|1|||
145689085|NCT02268526|525376086|FG002|Overall Study|protocol deviation|0|||
145689086|NCT02268526|525376084|FG000|Overall Study|Physician Decision|0|||
145689087|NCT02268526|525376085|FG001|Overall Study|Physician Decision|0|||
145689088|NCT02268526|525376086|FG002|Overall Study|Physician Decision|1|||
145689089|NCT02268526|525376084|FG000|Overall Study|Subject/guardian decision|0|||
145689090|NCT02268526|525376085|FG001|Overall Study|Subject/guardian decision|7|||
145689091|NCT02268526|525376086|FG002|Overall Study|Subject/guardian decision|3|||
145689092|NCT02418819|525376087|FG000|Overall Study|Adverse Event|0|||
145689093|NCT02418819|525376088|FG001|Overall Study|Adverse Event|0|||
145689094|NCT02418819|525376089|FG002|Overall Study|Adverse Event|1|||
145689095|NCT02418819|525376090|FG003|Overall Study|Adverse Event|0|||
145689096|NCT02418819|525376087|FG000|Overall Study|Lost to Follow-up|1|||
145689097|NCT02418819|525376088|FG001|Overall Study|Lost to Follow-up|0|||
145689098|NCT02418819|525376089|FG002|Overall Study|Lost to Follow-up|0|||
145689099|NCT02418819|525376090|FG003|Overall Study|Lost to Follow-up|0|||
145689100|NCT02418819|525376087|FG000|Overall Study|No longer meets eligibility criteria|0|||
145689101|NCT02418819|525376088|FG001|Overall Study|No longer meets eligibility criteria|0|||
145689102|NCT02418819|525376089|FG002|Overall Study|No longer meets eligibility criteria|1|||
145689103|NCT02418819|525376090|FG003|Overall Study|No longer meets eligibility criteria|0|||
145689104|NCT02418819|525376087|FG000|Overall Study|No longer willing to participate|0|||
145689105|NCT02418819|525376088|FG001|Overall Study|No longer willing to participate|0|||
145689106|NCT02418819|525376089|FG002|Overall Study|No longer willing to participate|2|||
145689107|NCT02418819|525376090|FG003|Overall Study|No longer willing to participate|1|||
145689108|NCT04374253|525376094|FG000|Overall Study|Adverse Event|0|||
145689109|NCT04374253|525376095|FG001|Overall Study|Adverse Event|26|||
145689110|NCT04374253|525376096|FG002|Overall Study|Adverse Event|2|||
145689111|NCT04374253|525376097|FG003|Overall Study|Adverse Event|12|||
145689112|NCT04374253|525376094|FG000|Overall Study|Study terminated by sponsor|13|||
145689113|NCT04374253|525376095|FG001|Overall Study|Study terminated by sponsor|593|||
145689114|NCT04374253|525376096|FG002|Overall Study|Study terminated by sponsor|21|||
145689115|NCT04374253|525376097|FG003|Overall Study|Study terminated by sponsor|567|||
145689116|NCT04374253|525376094|FG000|Overall Study|Withdrawal by Subject|0|||
145689117|NCT04374253|525376095|FG001|Overall Study|Withdrawal by Subject|55|||
145689118|NCT04374253|525376096|FG002|Overall Study|Withdrawal by Subject|3|||
145689119|NCT04374253|525376097|FG003|Overall Study|Withdrawal by Subject|40|||
145689120|NCT04374253|525376094|FG000|Overall Study|Physician Decision|1|||
145689121|NCT04374253|525376095|FG001|Overall Study|Physician Decision|10|||
145689122|NCT04374253|525376096|FG002|Overall Study|Physician Decision|1|||
145689123|NCT04374253|525376097|FG003|Overall Study|Physician Decision|10|||
145689124|NCT04374253|525376094|FG000|Overall Study|Protocol Violation|0|||
145689125|NCT04374253|525376095|FG001|Overall Study|Protocol Violation|0|||
145689126|NCT04374253|525376096|FG002|Overall Study|Protocol Violation|0|||
145689127|NCT04374253|525376097|FG003|Overall Study|Protocol Violation|2|||
145689128|NCT04374253|525376094|FG000|Overall Study|Death|0|||
145689129|NCT04374253|525376095|FG001|Overall Study|Death|3|||
145689130|NCT04374253|525376096|FG002|Overall Study|Death|1|||
145689131|NCT04374253|525376097|FG003|Overall Study|Death|1|||
145689132|NCT04374253|525376094|FG000|Overall Study|Lack of Efficacy|0|||
145689133|NCT04374253|525376095|FG001|Overall Study|Lack of Efficacy|0|||
145689134|NCT04374253|525376096|FG002|Overall Study|Lack of Efficacy|0|||
145689135|NCT04374253|525376097|FG003|Overall Study|Lack of Efficacy|1|||
145689136|NCT04374253|525376094|FG000|Overall Study|Lost to Follow-up|1|||
145689137|NCT04374253|525376095|FG001|Overall Study|Lost to Follow-up|1|||
145689138|NCT04374253|525376096|FG002|Overall Study|Lost to Follow-up|0|||
145689139|NCT04374253|525376097|FG003|Overall Study|Lost to Follow-up|2|||
145689140|NCT04374253|525376094|FG000|Overall Study|Reason Not Specified|0|||
145689141|NCT04374253|525376095|FG001|Overall Study|Reason Not Specified|8|||
145689142|NCT04374253|525376096|FG002|Overall Study|Reason Not Specified|0|||
145689143|NCT04374253|525376097|FG003|Overall Study|Reason Not Specified|8|||
145689144|NCT04382053|525376103|FG000|Overall Study|Death|6|||
145689145|NCT04382053|525376104|FG001|Overall Study|Death|8|||
145689146|NCT04382053|525376103|FG000|Overall Study|Lost to Follow-up|0|||
145689147|NCT04382053|525376104|FG001|Overall Study|Lost to Follow-up|2|||
145689148|NCT04382053|525376103|FG000|Overall Study|Protocol Deviation|1|||
145689149|NCT04382053|525376104|FG001|Overall Study|Protocol Deviation|2|||
145689150|NCT04382053|525376103|FG000|Overall Study|Withdrawal by Subject|2|||
145689151|NCT04382053|525376104|FG001|Overall Study|Withdrawal by Subject|1|||
145689152|NCT01786551|525376109|FG000|Overall Study|Participant withdrew consent|2|||
145689153|NCT01123642|525376112|FG000|Overall Study|Lost to Follow-up|23|||
145689154|NCT01123642|525376112|FG000|Overall Study|Withdrawal by Subject|9|||
145689155|NCT01123642|525376112|FG000|Overall Study|ineligible at baseline assessment|36|||
145689156|NCT00651937|525377680|FG000|Overall Study|Withdrawal by Subject|4|||
145689157|NCT00651937|525377681|FG001|Overall Study|Withdrawal by Subject|1|||
145689158|NCT04357964|525377689|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
145689159|NCT04357964|525377690|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
145689160|NCT04357964|525377689|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
145689161|NCT04357964|525377690|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
145689162|NCT04357964|525377689|FG000|Overall Study|Adipose sample was insufficient quality|0|||
145689163|NCT04357964|525377690|FG001|Overall Study|Adipose sample was insufficient quality|1|||
145689164|NCT00733226|525377691|FG000|Overall Study|Withdrawal by Subject|1|||
145689165|NCT00733226|525377692|FG001|Overall Study|Withdrawal by Subject|0|||
145689166|NCT00733226|525377691|FG000|Overall Study|Lost to Follow-up|2|||
145689167|NCT00733226|525377692|FG001|Overall Study|Lost to Follow-up|0|||
145689168|NCT00733226|525377691|FG000|Overall Study|moved to another place|2|||
145689169|NCT00733226|525377692|FG001|Overall Study|moved to another place|0|||
145689170|NCT00848393|525377697|FG000|Overall Study|Protocol Violation|0|||
145689171|NCT00848393|525377698|FG001|Overall Study|Protocol Violation|0|||
145689172|NCT00848393|525377699|FG002|Overall Study|Protocol Violation|1|||
145689173|NCT00848393|525377697|FG000|Overall Study|surgical complications unrelated to stud|0|||
145689174|NCT00848393|525377698|FG001|Overall Study|surgical complications unrelated to stud|0|||
145689175|NCT00848393|525377699|FG002|Overall Study|surgical complications unrelated to stud|2|||
145689176|NCT02561078|525377700|FG000|Overall Study|Adverse Event|5|||
145689177|NCT02561078|525377701|FG001|Overall Study|Adverse Event|2|||
145689178|NCT02561078|525377700|FG000|Overall Study|Death|2|||
145689179|NCT02561078|525377701|FG001|Overall Study|Death|1|||
145689180|NCT02561078|525377700|FG000|Overall Study|Lost to Follow-up|2|||
145689181|NCT02561078|525377701|FG001|Overall Study|Lost to Follow-up|6|||
145689182|NCT02561078|525377700|FG000|Overall Study|Non-Compliance with Study Drug|6|||
145689183|NCT02561078|525377701|FG001|Overall Study|Non-Compliance with Study Drug|3|||
145689184|NCT02561078|525377700|FG000|Overall Study|Physician Decision|2|||
145689185|NCT02561078|525377701|FG001|Overall Study|Physician Decision|3|||
145689186|NCT02561078|525377700|FG000|Overall Study|Withdrawal by Subject|13|||
145689187|NCT02561078|525377701|FG001|Overall Study|Withdrawal by Subject|10|||
145689188|NCT00755716|525377704|FG000|Overall Study|Adverse Event|1|||
145689189|NCT00755716|525377705|FG001|Overall Study|Adverse Event|4|||
145689190|NCT00755716|525377706|FG002|Overall Study|Adverse Event|1|||
145689191|NCT00755716|525377704|FG000|Overall Study|Lack of Efficacy|2|||
145689192|NCT00755716|525377705|FG001|Overall Study|Lack of Efficacy|0|||
145689193|NCT00755716|525377706|FG002|Overall Study|Lack of Efficacy|0|||
145689194|NCT00755716|525377704|FG000|Overall Study|Lost to Follow-up|5|||
145689195|NCT00755716|525377705|FG001|Overall Study|Lost to Follow-up|3|||
145689196|NCT00755716|525377706|FG002|Overall Study|Lost to Follow-up|1|||
145689197|NCT00755716|525377704|FG000|Overall Study|work schedule issues|0|||
145689198|NCT00755716|525377705|FG001|Overall Study|work schedule issues|1|||
145689199|NCT00755716|525377706|FG002|Overall Study|work schedule issues|1|||
145689200|NCT00726388|525377712|FG000|Overall Study|Withdrawal by Subject|5|||
145689201|NCT00726388|525377712|FG000|Overall Study|Adverse Event|3|||
145689202|NCT00726388|525377712|FG000|Overall Study|Lost to Follow-up|10|||
145689203|NCT00726388|525377712|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
145689204|NCT00726388|525377712|FG000|Overall Study|Other|5|||
145689205|NCT00726388|525377712|FG000|Overall Study|Enrolled, Not Treated|79|||
145689206|NCT03568708|525377718|FG000|Overall Study|Withdrawal by Subject|1|||
145689207|NCT03568708|525377719|FG001|Overall Study|Withdrawal by Subject|1|||
145689208|NCT03568708|525377718|FG000|Overall Study|Lost to Follow-up|0|||
145689209|NCT03568708|525377719|FG001|Overall Study|Lost to Follow-up|1|||
145689210|NCT01732588|525377720|FG000|First Intervention (7 Days)|Adverse Event|0|||
145689211|NCT01732588|525377721|FG001|First Intervention (7 Days)|Adverse Event|1|||
145689212|NCT01732588|525377722|FG002|First Intervention (7 Days)|Adverse Event|0|||
145689213|NCT05012397|525377723|FG000|Overall Study|Death|10|||
145689214|NCT05012397|525377723|FG000|Overall Study|Physician Decision|9|||
145689215|NCT05012397|525377723|FG000|Overall Study|Withdrawal by Subject|5|||
145689216|NCT05012397|525377723|FG000|Overall Study|Lost to Follow-up|2|||
145689217|NCT04748445|525377724|FG000|Overall Study|No longer met eligibility criteria|12|||
145689218|NCT04748445|525377724|FG000|Overall Study|Other|36|||
145689219|NCT04748445|525377724|FG000|Overall Study|Withdrawal by Subject|553|||
145689220|NCT04748445|525377724|FG000|Overall Study|Lost to Follow-up|30|||
145689221|NCT04736602|525377725|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
145689222|NCT04736602|525377725|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
145689223|NCT00679549|525377728|FG000|Overall Study|dropout|2|||
145689224|NCT00679549|525377729|FG001|Overall Study|dropout|4|||
145689225|NCT00679549|525377728|FG000|Overall Study|missing outcome echocardiograms|4|||
145689226|NCT00679549|525377729|FG001|Overall Study|missing outcome echocardiograms|5|||
145689227|NCT03048058|525377732|FG000|Overall Study|Lost to Follow-up|4|||
145689228|NCT03048058|525377733|FG001|Overall Study|Lost to Follow-up|0|||
145689229|NCT03048058|525377732|FG000|Overall Study|Withdrawal by Subject|0|||
145689230|NCT03048058|525377733|FG001|Overall Study|Withdrawal by Subject|4|||
145689231|NCT01257698|525377738|FG000|Overall Study|Protocol Violation|4|||
145689232|NCT01257698|525377739|FG001|Overall Study|Protocol Violation|0|||
145689233|NCT00050167|525377761|FG000|Overall Study|not eligible not invasive|1|||
145689234|NCT00050167|525377762|FG001|Overall Study|not eligible not invasive|1|||
145689235|NCT02038803|525377766|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
145689236|NCT02038803|525377766|FG000|Overall Study|Lost to Follow-up|1|||
145689237|NCT04754594|525377767|FG000|Blinded Period|Withdrawal by Subject|4|||
145689238|NCT04754594|525377768|FG001|Blinded Period|Withdrawal by Subject|9|||
145689239|NCT04754594|525377769|FG002|Blinded Period|Withdrawal by Subject|0|||
145689240|NCT04754594|525377770|FG003|Blinded Period|Withdrawal by Subject|0|||
145689241|NCT04754594|525377767|FG000|Blinded Period|Protocol Violation|2|||
145689242|NCT04754594|525377768|FG001|Blinded Period|Protocol Violation|2|||
145689243|NCT04754594|525377769|FG002|Blinded Period|Protocol Violation|0|||
145689244|NCT04754594|525377770|FG003|Blinded Period|Protocol Violation|0|||
145689245|NCT04754594|525377767|FG000|Blinded Period|Lost to Follow-up|1|||
145689246|NCT04754594|525377768|FG001|Blinded Period|Lost to Follow-up|1|||
145689247|NCT04754594|525377769|FG002|Blinded Period|Lost to Follow-up|0|||
145689248|NCT04754594|525377770|FG003|Blinded Period|Lost to Follow-up|0|||
145689249|NCT04754594|525377767|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
145689250|NCT04754594|525377768|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
145689251|NCT04754594|525377769|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
145689252|NCT04754594|525377770|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
145689253|NCT04754594|525377767|FG000|Unblinded Period|Withdrawal by Subject|6|||
145689254|NCT04754594|525377768|FG001|Unblinded Period|Withdrawal by Subject|8|||
145689255|NCT04754594|525377769|FG002|Unblinded Period|Withdrawal by Subject|0|||
145689256|NCT04754594|525377770|FG003|Unblinded Period|Withdrawal by Subject|0|||
145689257|NCT04754594|525377767|FG000|Unblinded Period|Lost to Follow-up|5|||
145689258|NCT04754594|525377768|FG001|Unblinded Period|Lost to Follow-up|3|||
145689259|NCT04754594|525377769|FG002|Unblinded Period|Lost to Follow-up|0|||
145689260|NCT04754594|525377770|FG003|Unblinded Period|Lost to Follow-up|0|||
145689261|NCT04754594|525377767|FG000|Unblinded Period|Protocol Violation|2|||
145689262|NCT04754594|525377768|FG001|Unblinded Period|Protocol Violation|4|||
145689263|NCT04754594|525377769|FG002|Unblinded Period|Protocol Violation|0|||
145689264|NCT04754594|525377770|FG003|Unblinded Period|Protocol Violation|0|||
145689265|NCT04754594|525377767|FG000|Unblinded Period|Other|3|||
145689266|NCT04754594|525377768|FG001|Unblinded Period|Other|0|||
145689267|NCT04754594|525377769|FG002|Unblinded Period|Other|0|||
145689268|NCT04754594|525377770|FG003|Unblinded Period|Other|0|||
145689269|NCT04754594|525377767|FG000|Infant Participants|Withdrawal by Subject|0|||
145689270|NCT04754594|525377768|FG001|Infant Participants|Withdrawal by Subject|0|||
145689271|NCT04754594|525377769|FG002|Infant Participants|Withdrawal by Subject|9|||
145689272|NCT04754594|525377770|FG003|Infant Participants|Withdrawal by Subject|17|||
145689273|NCT04754594|525377767|FG000|Infant Participants|Lost to Follow-up|0|||
145689274|NCT04754594|525377768|FG001|Infant Participants|Lost to Follow-up|0|||
145689275|NCT04754594|525377769|FG002|Infant Participants|Lost to Follow-up|4|||
145689276|NCT04754594|525377770|FG003|Infant Participants|Lost to Follow-up|10|||
145689277|NCT04754594|525377767|FG000|Infant Participants|Death|0|||
145689278|NCT04754594|525377768|FG001|Infant Participants|Death|0|||
145689279|NCT04754594|525377769|FG002|Infant Participants|Death|1|||
145689280|NCT04754594|525377770|FG003|Infant Participants|Death|1|||
145689281|NCT04754594|525377767|FG000|Infant Participants|Other|0|||
145689282|NCT04754594|525377768|FG001|Infant Participants|Other|0|||
145689283|NCT04754594|525377769|FG002|Infant Participants|Other|1|||
145689284|NCT04754594|525377770|FG003|Infant Participants|Other|1|||
145689285|NCT01247922|525377771|FG000|Overall Study|Disease progression|4|||
145689286|NCT02588027|525377772|FG000|Overall Study|Withdrawal by Subject|1|||
145689287|NCT02588027|525377773|FG001|Overall Study|Withdrawal by Subject|3|||
145689288|NCT02588027|525377772|FG000|Overall Study|Protocol Violation|4|||
145689289|NCT02588027|525377773|FG001|Overall Study|Protocol Violation|1|||
145689290|NCT04372186|525377774|FG000|Overall Study|Death|24|||
145689291|NCT04372186|525377775|FG001|Overall Study|Death|11|||
145689292|NCT04372186|525377774|FG000|Overall Study|Transferred to a different facility for care|0|||
145689293|NCT04372186|525377775|FG001|Overall Study|Transferred to a different facility for care|2|||
145689294|NCT04736472|525377776|FG000|Overall Study|Lost to Follow-up|1|||
145689295|NCT04736472|525377777|FG001|Overall Study|Lost to Follow-up|0|||
145689296|NCT04736472|525377778|FG002|Overall Study|Lost to Follow-up|0|||
145689297|NCT04736472|525377776|FG000|Overall Study|Withdrawal by Subject|2|||
145689298|NCT04736472|525377777|FG001|Overall Study|Withdrawal by Subject|0|||
145689299|NCT04736472|525377778|FG002|Overall Study|Withdrawal by Subject|0|||
145689300|NCT04736472|525377776|FG000|Overall Study|Protocol Violation|48|||
145689301|NCT04736472|525377777|FG001|Overall Study|Protocol Violation|0|||
145689302|NCT04736472|525377778|FG002|Overall Study|Protocol Violation|6|||
145689303|NCT02116582|525377779|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
145689304|NCT02116582|525377779|FG000|Overall Study|Adverse Event|22|||
145689305|NCT02116582|525377779|FG000|Overall Study|Death|9|||
145689306|NCT02116582|525377779|FG000|Overall Study|Progressive Disease|148|||
145689307|NCT02116582|525377779|FG000|Overall Study|Protocol Violation|3|||
145689308|NCT02116582|525377779|FG000|Overall Study|Withdrawal by Subject|8|||
145689309|NCT02116582|525377779|FG000|Overall Study|Other: Miscellaneous|11|||
145689310|NCT02116582|525377779|FG000|Overall Study|Lost to Follow-up|1|||
145689311|NCT02116582|525377779|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
145689312|NCT01876823|525377780|FG000|Overall Study|Withdrawal by Subject|5|||
145689313|NCT01876823|525377780|FG000|Overall Study|Physician Decision|2|||
145689314|NCT01876823|525377780|FG000|Overall Study|Patients moved|2|||
145689315|NCT02256488|525377783|FG000|Overall Study|Lost to Follow-up|6|||
145689316|NCT02256488|525377784|FG001|Overall Study|Lost to Follow-up|6|||
145689317|NCT02256488|525377785|FG002|Overall Study|Lost to Follow-up|9|||
145689318|NCT02256488|525377786|FG003|Overall Study|Lost to Follow-up|3|||
145689319|NCT02256488|525377783|FG000|Overall Study|OTHER|1|||
145689320|NCT02256488|525377784|FG001|Overall Study|OTHER|0|||
145689321|NCT02256488|525377785|FG002|Overall Study|OTHER|1|||
145689322|NCT02256488|525377786|FG003|Overall Study|OTHER|1|||
145689323|NCT02256488|525377783|FG000|Overall Study|Withdrawal by Subject|1|||
145689324|NCT02256488|525377784|FG001|Overall Study|Withdrawal by Subject|0|||
145689325|NCT02256488|525377785|FG002|Overall Study|Withdrawal by Subject|0|||
145689326|NCT02256488|525377786|FG003|Overall Study|Withdrawal by Subject|2|||
145689327|NCT00975130|525377787|FG000|Study Part 1|Adverse Event|150|||
145689328|NCT00975130|525377788|FG001|Study Part 1|Adverse Event|0|||
145689329|NCT00975130|525377789|FG002|Study Part 1|Adverse Event|0|||
145689330|NCT00975130|525377787|FG000|Study Part 1|Lost to Follow-up|19|||
145689331|NCT00975130|525377788|FG001|Study Part 1|Lost to Follow-up|0|||
145689332|NCT00975130|525377789|FG002|Study Part 1|Lost to Follow-up|0|||
145689333|NCT00975130|525377787|FG000|Study Part 1|Withdrawal by Subject|61|||
145689334|NCT00975130|525377788|FG001|Study Part 1|Withdrawal by Subject|0|||
145689335|NCT00975130|525377789|FG002|Study Part 1|Withdrawal by Subject|0|||
145689336|NCT00975130|525377787|FG000|Study Part 1|Protocol Violation|13|||
145689337|NCT00975130|525377788|FG001|Study Part 1|Protocol Violation|0|||
145689338|NCT00975130|525377789|FG002|Study Part 1|Protocol Violation|0|||
145689339|NCT00975130|525377787|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
145689340|NCT00975130|525377788|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
145689341|NCT00975130|525377789|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
145689342|NCT00975130|525377787|FG000|Study Part 1|Administrative|4|||
145689343|NCT00975130|525377788|FG001|Study Part 1|Administrative|0|||
145689344|NCT00975130|525377789|FG002|Study Part 1|Administrative|0|||
145689345|NCT00975130|525377787|FG000|Study Part 1|Withdrew Consent|24|||
145689346|NCT00975130|525377788|FG001|Study Part 1|Withdrew Consent|0|||
145689347|NCT00975130|525377789|FG002|Study Part 1|Withdrew Consent|0|||
145689348|NCT00975130|525377787|FG000|Study Part 2|Adverse Event|0|||
145689349|NCT00975130|525377788|FG001|Study Part 2|Adverse Event|14|||
145689350|NCT00975130|525377789|FG002|Study Part 2|Adverse Event|7|||
145689351|NCT00975130|525377787|FG000|Study Part 2|Lost to Follow-up|0|||
145689352|NCT00975130|525377788|FG001|Study Part 2|Lost to Follow-up|0|||
145689353|NCT00975130|525377789|FG002|Study Part 2|Lost to Follow-up|1|||
145689354|NCT00975130|525377787|FG000|Study Part 2|Withdrawal by Subject|0|||
145689355|NCT00975130|525377788|FG001|Study Part 2|Withdrawal by Subject|13|||
145689356|NCT00975130|525377789|FG002|Study Part 2|Withdrawal by Subject|5|||
145689357|NCT00975130|525377787|FG000|Study Part 2|Withdrew Consent|0|||
145689358|NCT00975130|525377788|FG001|Study Part 2|Withdrew Consent|6|||
145689359|NCT00975130|525377789|FG002|Study Part 2|Withdrew Consent|2|||
145689360|NCT00975130|525377787|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
145491314|NCT02421172|524653748|FG003|Period 1|Adverse Event|0|||
145491315|NCT02421172|524653749|FG004|Period 1|Adverse Event|0|||
145491316|NCT02421172|524653745|FG000|Period 1|Lost to Follow-up|3|||
145491317|NCT02421172|524653746|FG001|Period 1|Lost to Follow-up|1|||
145491318|NCT02421172|524653747|FG002|Period 1|Lost to Follow-up|0|||
145689361|NCT00975130|525377788|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
145689362|NCT00975130|525377789|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
145689363|NCT00975130|525377787|FG000|Study Part 2|Administrative|0|||
145689364|NCT00975130|525377788|FG001|Study Part 2|Administrative|1|||
145491319|NCT02421172|524653748|FG003|Period 1|Lost to Follow-up|0|||
145689365|NCT00975130|525377789|FG002|Study Part 2|Administrative|0|||
145689366|NCT00975130|525377787|FG000|Study Part 2|Protocol Violation|0|||
145689367|NCT00975130|525377788|FG001|Study Part 2|Protocol Violation|0|||
145689368|NCT00975130|525377789|FG002|Study Part 2|Protocol Violation|1|||
145689369|NCT01261793|525377790|FG000|Overall Study|Lack of Efficacy|44|||
145689370|NCT01261793|525377791|FG001|Overall Study|Lack of Efficacy|37|||
145689371|NCT01261793|525377792|FG002|Overall Study|Lack of Efficacy|32|||
145689372|NCT01261793|525377790|FG000|Overall Study|Protocol Violation|3|||
145689373|NCT01261793|525377791|FG001|Overall Study|Protocol Violation|5|||
145689374|NCT01261793|525377792|FG002|Overall Study|Protocol Violation|6|||
145689375|NCT01261793|525377790|FG000|Overall Study|Lost to Follow-up|10|||
145689376|NCT01261793|525377791|FG001|Overall Study|Lost to Follow-up|3|||
145689377|NCT01261793|525377792|FG002|Overall Study|Lost to Follow-up|7|||
145689378|NCT01261793|525377790|FG000|Overall Study|Withdrawal by Subject|12|||
145689379|NCT01261793|525377791|FG001|Overall Study|Withdrawal by Subject|14|||
145689380|NCT01261793|525377792|FG002|Overall Study|Withdrawal by Subject|14|||
145689381|NCT01261793|525377790|FG000|Overall Study|Death|3|||
145689382|NCT01261793|525377791|FG001|Overall Study|Death|1|||
145689383|NCT01261793|525377792|FG002|Overall Study|Death|0|||
145689384|NCT01261793|525377790|FG000|Overall Study|Adverse Event|9|||
145689385|NCT01261793|525377791|FG001|Overall Study|Adverse Event|24|||
145689386|NCT01261793|525377792|FG002|Overall Study|Adverse Event|19|||
145689387|NCT01261793|525377790|FG000|Overall Study|Patient non-availability|1|||
145689388|NCT01261793|525377791|FG001|Overall Study|Patient non-availability|1|||
145689389|NCT01261793|525377792|FG002|Overall Study|Patient non-availability|1|||
145689390|NCT01261793|525377790|FG000|Overall Study|Suspected pregnancy|1|||
145689391|NCT01261793|525377791|FG001|Overall Study|Suspected pregnancy|1|||
145689392|NCT01261793|525377792|FG002|Overall Study|Suspected pregnancy|0|||
145689393|NCT01261793|525377790|FG000|Overall Study|Patient non-compliance|1|||
145689394|NCT01261793|525377791|FG001|Overall Study|Patient non-compliance|0|||
145689395|NCT01261793|525377792|FG002|Overall Study|Patient non-compliance|1|||
145689396|NCT01261793|525377790|FG000|Overall Study|Patient pregnant|1|||
145689397|NCT01261793|525377791|FG001|Overall Study|Patient pregnant|0|||
145689398|NCT01261793|525377792|FG002|Overall Study|Patient pregnant|0|||
145689399|NCT01261793|525377790|FG000|Overall Study|Outside the study area|0|||
145689400|NCT01261793|525377791|FG001|Overall Study|Outside the study area|2|||
145689401|NCT01261793|525377792|FG002|Overall Study|Outside the study area|1|||
145689402|NCT01261793|525377790|FG000|Overall Study|Lack of efficacy & patient not available|0|||
145689403|NCT01261793|525377791|FG001|Overall Study|Lack of efficacy & patient not available|1|||
145689404|NCT01261793|525377792|FG002|Overall Study|Lack of efficacy & patient not available|0|||
145689405|NCT01261793|525377790|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
145689406|NCT01261793|525377791|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
145689407|NCT01261793|525377792|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
145689408|NCT01261793|525377790|FG000|Overall Study|Randomization error|0|||
145689409|NCT01261793|525377791|FG001|Overall Study|Randomization error|1|||
145689410|NCT01261793|525377792|FG002|Overall Study|Randomization error|0|||
145689411|NCT01261793|525377790|FG000|Overall Study|Patient unable to start IV line|0|||
145689412|NCT01261793|525377791|FG001|Overall Study|Patient unable to start IV line|0|||
145689413|NCT01261793|525377792|FG002|Overall Study|Patient unable to start IV line|1|||
145689414|NCT00577096|525377793|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
145689415|NCT00577096|525377794|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
145689416|NCT00577096|525377793|FG000|Short Term Participation|Withdrawal by Subject|3|||
145689417|NCT00577096|525377794|FG001|Short Term Participation|Withdrawal by Subject|5|||
145689418|NCT00577096|525377793|FG000|Short Term Participation|Death|1|||
145689419|NCT00577096|525377794|FG001|Short Term Participation|Death|1|||
145689420|NCT03305458|525377795|FG000|Overall Study|Withdrawal by Subject|50|||
145689421|NCT03305458|525377796|FG001|Overall Study|Withdrawal by Subject|46|||
145689422|NCT03305458|525377797|FG002|Overall Study|Withdrawal by Subject|93|||
145689423|NCT03305458|525377795|FG000|Overall Study|Lost to Follow-up|85|||
145689424|NCT03305458|525377796|FG001|Overall Study|Lost to Follow-up|85|||
145689425|NCT03305458|525377797|FG002|Overall Study|Lost to Follow-up|35|||
145689426|NCT03562117|525377799|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
145689427|NCT03562117|525377800|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
145689428|NCT03562117|525377801|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
145689429|NCT01207453|525377810|FG000|First Intervention|Adverse Event|2|||
145689430|NCT01207453|525377811|FG001|First Intervention|Adverse Event|1|||
145689431|NCT01207453|525377810|FG000|Washout|Adverse Event|1|||
145689432|NCT01207453|525377811|FG001|Washout|Adverse Event|0|||
145689433|NCT01207453|525377810|FG000|Washout|Lost to Follow-up|1|||
145689434|NCT01207453|525377811|FG001|Washout|Lost to Follow-up|0|||
145689435|NCT01207453|525377810|FG000|2nd Intervention|Adverse Event|1|||
145689436|NCT01207453|525377811|FG001|2nd Intervention|Adverse Event|2|||
145689437|NCT01207453|525377810|FG000|2nd Intervention|Lost to Follow-up|1|||
145689438|NCT01207453|525377811|FG001|2nd Intervention|Lost to Follow-up|0|||
145689439|NCT00676663|525377814|FG000|Overall Study|Death|43|||
145689440|NCT00676663|525377815|FG001|Overall Study|Death|27|||
145689441|NCT00676663|525377814|FG000|Overall Study|Withdrew Consent|1|||
145689442|NCT00676663|525377815|FG001|Overall Study|Withdrew Consent|8|||
145689443|NCT00676663|525377814|FG000|Overall Study|Lost to Follow-up|1|||
145689444|NCT00676663|525377815|FG001|Overall Study|Lost to Follow-up|3|||
145689445|NCT01399905|525377816|FG000|Overall Study|Withdrawal by Subject|1|||
145689446|NCT01399905|525377817|FG001|Overall Study|Withdrawal by Subject|1|||
145689447|NCT00714688|525377823|FG000|Overall Study|Lack of Efficacy|14|||
145689448|NCT00714688|525377824|FG001|Overall Study|Lack of Efficacy|1|||
145689449|NCT00714688|525377825|FG002|Overall Study|Lack of Efficacy|4|||
145689450|NCT00714688|525377823|FG000|Overall Study|Withdrawal by Subject|4|||
145689451|NCT00714688|525377824|FG001|Overall Study|Withdrawal by Subject|3|||
145689452|NCT00714688|525377825|FG002|Overall Study|Withdrawal by Subject|3|||
145689453|NCT00714688|525377823|FG000|Overall Study|Lost to Follow-up|5|||
145689454|NCT00714688|525377824|FG001|Overall Study|Lost to Follow-up|2|||
145689455|NCT00714688|525377825|FG002|Overall Study|Lost to Follow-up|0|||
145689456|NCT00714688|525377823|FG000|Overall Study|Adverse Event|2|||
145689457|NCT00714688|525377824|FG001|Overall Study|Adverse Event|15|||
145689458|NCT00714688|525377825|FG002|Overall Study|Adverse Event|19|||
145689459|NCT00714688|525377823|FG000|Overall Study|Subject Non-compliant|3|||
145689460|NCT00714688|525377824|FG001|Overall Study|Subject Non-compliant|5|||
145689461|NCT00714688|525377825|FG002|Overall Study|Subject Non-compliant|5|||
145689462|NCT00714688|525377823|FG000|Overall Study|Ineligible to Continue the Study|0|||
145689463|NCT00714688|525377824|FG001|Overall Study|Ineligible to Continue the Study|1|||
145689464|NCT00714688|525377825|FG002|Overall Study|Ineligible to Continue the Study|1|||
145689465|NCT00714688|525377823|FG000|Overall Study|Sponsor's Decision|0|||
145689466|NCT00714688|525377824|FG001|Overall Study|Sponsor's Decision|2|||
145689467|NCT00714688|525377825|FG002|Overall Study|Sponsor's Decision|0|||
145689468|NCT00714688|525377823|FG000|Overall Study|Other|1|||
145689469|NCT00714688|525377824|FG001|Overall Study|Other|6|||
145689470|NCT00714688|525377825|FG002|Overall Study|Other|5|||
145689471|NCT00170950|525377826|FG000|Overall Study|Death|236|||
145689472|NCT00170950|525377827|FG001|Overall Study|Death|274|||
145689473|NCT00170950|525377826|FG000|Overall Study|Withdrawal by Subject|496|||
145689474|NCT00170950|525377827|FG001|Overall Study|Withdrawal by Subject|498|||
145689475|NCT00170950|525377826|FG000|Overall Study|Lost to Follow-up|134|||
145689476|NCT00170950|525377827|FG001|Overall Study|Lost to Follow-up|115|||
145689477|NCT00170950|525377826|FG000|Overall Study|Missing|2|||
145689478|NCT00170950|525377827|FG001|Overall Study|Missing|1|||
145689479|NCT00170950|525377826|FG000|Overall Study|Termination Data Not Recorded|17|||
145689480|NCT00170950|525377827|FG001|Overall Study|Termination Data Not Recorded|22|||
145689481|NCT00381888|525379599|FG000|Overall Study|Death|1|||
145689482|NCT00381888|525379599|FG000|Overall Study|Withdrawal by Subject|1|||
145689483|NCT00381888|525379599|FG000|Overall Study|Physician Decision|1|||
145689484|NCT00381888|525379599|FG000|Overall Study|Protocol Violation|9|||
145689485|NCT00381888|525379599|FG000|Overall Study|Had laparoscopic surgery|2|||
145689486|NCT00381888|525379599|FG000|Overall Study|Surgery was cancelled|2|||
145689487|NCT00381888|525379599|FG000|Overall Study|Adverse Event|1|||
145689488|NCT01589523|525379602|FG000|Overall Study|Withdrawal by Subject|1|||
145689489|NCT00961896|525379603|FG000|Overall Study|Abnormal laboratory value|0|||
145689490|NCT00961896|525379604|FG001|Overall Study|Abnormal laboratory value|0|||
145689491|NCT00961896|525379605|FG002|Overall Study|Abnormal laboratory value|1|||
145689492|NCT00506922|525379606|FG000|Overall Study|Physician Decision|0|||
145689493|NCT00506922|525379607|FG001|Overall Study|Physician Decision|0|||
145689494|NCT00506922|525379608|FG002|Overall Study|Physician Decision|0|||
145689495|NCT00506922|525379609|FG003|Overall Study|Physician Decision|2|||
145689496|NCT00506922|525379610|FG004|Overall Study|Physician Decision|0|||
145689497|NCT00506922|525379606|FG000|Overall Study|Withdrawal by Subject|0|||
145689498|NCT00506922|525379607|FG001|Overall Study|Withdrawal by Subject|0|||
145689499|NCT00506922|525379608|FG002|Overall Study|Withdrawal by Subject|0|||
145689500|NCT00506922|525379609|FG003|Overall Study|Withdrawal by Subject|0|||
145689501|NCT00506922|525379610|FG004|Overall Study|Withdrawal by Subject|1|||
145689502|NCT00792259|525379611|FG000|Overall Study|Poor Quality Scans|1|||
145689503|NCT00792259|525379612|FG001|Overall Study|Poor Quality Scans|0|||
145689504|NCT00792259|525379613|FG002|Overall Study|Poor Quality Scans|0|||
145689505|NCT03721978|525379614|FG000|Overall Study|Withdrawal by Subject|6|||
145689506|NCT03721978|525379615|FG001|Overall Study|Withdrawal by Subject|1|||
145689507|NCT03721978|525379614|FG000|Overall Study|Adverse Event|1|||
145689508|NCT03721978|525379615|FG001|Overall Study|Adverse Event|1|||
145689509|NCT03721978|525379614|FG000|Overall Study|Progressive Disease|1|||
145689510|NCT03721978|525379615|FG001|Overall Study|Progressive Disease|0|||
145689511|NCT03721978|525379614|FG000|Overall Study|Lost to Follow-up|5|||
145689512|NCT03721978|525379615|FG001|Overall Study|Lost to Follow-up|1|||
145689513|NCT03721978|525379614|FG000|Overall Study|Reason not Specified|0|||
145689514|NCT03721978|525379615|FG001|Overall Study|Reason not Specified|2|||
145689515|NCT05244226|525379616|FG000|Overall Study|Adverse Event|1|||
145689516|NCT05244226|525379617|FG001|Overall Study|Adverse Event|0|||
145689517|NCT05244226|525379618|FG002|Overall Study|Adverse Event|0|||
145689518|NCT05244226|525379616|FG000|Overall Study|Lost to Follow-up|0|||
145689519|NCT05244226|525379617|FG001|Overall Study|Lost to Follow-up|0|||
145689520|NCT05244226|525379618|FG002|Overall Study|Lost to Follow-up|1|||
145689521|NCT05244226|525379616|FG000|Overall Study|Protocol Violation|0|||
145689522|NCT05244226|525379617|FG001|Overall Study|Protocol Violation|2|||
145689523|NCT05244226|525379618|FG002|Overall Study|Protocol Violation|2|||
145689524|NCT02507687|525379625|FG000|Overall Study|Adverse Event|3|||
145689525|NCT02507687|525379626|FG001|Overall Study|Adverse Event|2|||
145689526|NCT02507687|525379627|FG002|Overall Study|Adverse Event|2|||
145689527|NCT02507687|525379628|FG003|Overall Study|Adverse Event|2|||
145689528|NCT02507687|525379625|FG000|Overall Study|Withdrawal by Subject|1|||
145689529|NCT02507687|525379626|FG001|Overall Study|Withdrawal by Subject|4|||
145689530|NCT02507687|525379627|FG002|Overall Study|Withdrawal by Subject|6|||
145689531|NCT02507687|525379628|FG003|Overall Study|Withdrawal by Subject|6|||
145689532|NCT02507687|525379625|FG000|Overall Study|Protocol Violation|1|||
145689533|NCT02507687|525379626|FG001|Overall Study|Protocol Violation|0|||
145689534|NCT02507687|525379627|FG002|Overall Study|Protocol Violation|2|||
145689535|NCT02507687|525379628|FG003|Overall Study|Protocol Violation|0|||
145689536|NCT02507687|525379625|FG000|Overall Study|Lost to Follow-up|0|||
145689537|NCT02507687|525379626|FG001|Overall Study|Lost to Follow-up|0|||
145689538|NCT02507687|525379627|FG002|Overall Study|Lost to Follow-up|2|||
145689539|NCT02507687|525379628|FG003|Overall Study|Lost to Follow-up|1|||
145689540|NCT02507687|525379625|FG000|Overall Study|Screen Failure|0|||
145689541|NCT02507687|525379626|FG001|Overall Study|Screen Failure|0|||
145689542|NCT02507687|525379627|FG002|Overall Study|Screen Failure|1|||
145689543|NCT02507687|525379628|FG003|Overall Study|Screen Failure|0|||
145689544|NCT02507687|525379625|FG000|Overall Study|Other, Not Specified|0|||
145689545|NCT02507687|525379626|FG001|Overall Study|Other, Not Specified|0|||
145689546|NCT02507687|525379627|FG002|Overall Study|Other, Not Specified|2|||
145689547|NCT02507687|525379628|FG003|Overall Study|Other, Not Specified|4|||
145689548|NCT02675998|525379629|FG000|8-Week Treatment Period|Adverse Event|6|||
145689549|NCT02675998|525379630|FG001|8-Week Treatment Period|Adverse Event|5|||
145689550|NCT02675998|525379631|FG002|8-Week Treatment Period|Adverse Event|6|||
145689551|NCT02675998|525379632|FG003|8-Week Treatment Period|Adverse Event|0|||
145689552|NCT02675998|525379629|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
145689553|NCT02675998|525379630|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
145689554|NCT02675998|525379631|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
145689555|NCT02675998|525379632|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
145689556|NCT02675998|525379629|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
145689557|NCT02675998|525379630|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
145689558|NCT02675998|525379631|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
145689559|NCT02675998|525379632|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
145689560|NCT02675998|525379629|FG000|8-Week Treatment Period|Physician Decision|1|||
145689561|NCT02675998|525379630|FG001|8-Week Treatment Period|Physician Decision|0|||
145689562|NCT02675998|525379631|FG002|8-Week Treatment Period|Physician Decision|2|||
145689563|NCT02675998|525379632|FG003|8-Week Treatment Period|Physician Decision|0|||
145689564|NCT02675998|525379629|FG000|8-Week Treatment Period|GI side Effects|1|||
145689565|NCT02675998|525379630|FG001|8-Week Treatment Period|GI side Effects|4|||
145689566|NCT02675998|525379631|FG002|8-Week Treatment Period|GI side Effects|2|||
145689567|NCT02675998|525379632|FG003|8-Week Treatment Period|GI side Effects|0|||
145689568|NCT02675998|525379629|FG000|8-Week Treatment Period|Protocol Violation|1|||
145689569|NCT02675998|525379630|FG001|8-Week Treatment Period|Protocol Violation|1|||
145689570|NCT02675998|525379631|FG002|8-Week Treatment Period|Protocol Violation|1|||
145689571|NCT02675998|525379632|FG003|8-Week Treatment Period|Protocol Violation|0|||
145689572|NCT02675998|525379629|FG000|8-Week Treatment Period|Other|3|||
145689573|NCT02675998|525379630|FG001|8-Week Treatment Period|Other|1|||
145689574|NCT02675998|525379631|FG002|8-Week Treatment Period|Other|2|||
145689575|NCT02675998|525379632|FG003|8-Week Treatment Period|Other|0|||
145689576|NCT02675998|525379629|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
145689577|NCT02675998|525379630|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
145689578|NCT02675998|525379631|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
145689579|NCT02675998|525379632|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
145689580|NCT02675998|525379629|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
145689581|NCT02675998|525379630|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
145689582|NCT02675998|525379631|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
145689583|NCT02675998|525379632|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
145689584|NCT02675998|525379629|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
145689585|NCT02675998|525379630|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
145689586|NCT02675998|525379631|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
145689587|NCT02675998|525379632|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
145689588|NCT02675998|525379629|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
145689589|NCT02675998|525379630|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
145689590|NCT02675998|525379631|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
145689591|NCT02675998|525379632|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
145689592|NCT02675998|525379629|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
145689593|NCT02675998|525379630|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
145689594|NCT02675998|525379631|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
145689595|NCT02675998|525379632|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
145689596|NCT00275301|525379633|FG000|Overall Study|Adverse Event|5|||
145689597|NCT00598871|525379634|FG000|Overall Study|Adverse Event|0|||
145689598|NCT00598871|525379635|FG001|Overall Study|Adverse Event|1|||
145689599|NCT01194271|525379636|FG000|Overall Study|Withdrawal by Subject|1|||
145689600|NCT01194271|525379636|FG000|Overall Study|Ineligible, Screen Failure|1|||
145689601|NCT01194271|525379636|FG000|Overall Study|Death|1|||
145689602|NCT01983462|525379639|FG000|Overall Study|Adverse Event|1|||
145689603|NCT01983462|525379640|FG001|Overall Study|Adverse Event|0|||
145689604|NCT01983462|525379641|FG002|Overall Study|Adverse Event|0|||
145689605|NCT00443898|525379644|FG000|Overall Study|Adverse Event|0|||
145689606|NCT00443898|525379645|FG001|Overall Study|Adverse Event|0|||
145689607|NCT00443898|525379646|FG002|Overall Study|Adverse Event|1|||
145689608|NCT00443898|525379647|FG003|Overall Study|Adverse Event|1|||
145689609|NCT00443898|525379644|FG000|Overall Study|Lack of Efficacy|2|||
145689610|NCT00443898|525379645|FG001|Overall Study|Lack of Efficacy|3|||
145689611|NCT00443898|525379646|FG002|Overall Study|Lack of Efficacy|3|||
145689612|NCT00443898|525379647|FG003|Overall Study|Lack of Efficacy|1|||
145689613|NCT00443898|525379644|FG000|Overall Study|Protocol Violation|1|||
145689614|NCT00443898|525379645|FG001|Overall Study|Protocol Violation|1|||
145689615|NCT00443898|525379646|FG002|Overall Study|Protocol Violation|1|||
145689616|NCT00443898|525379647|FG003|Overall Study|Protocol Violation|0|||
145689617|NCT00443898|525379644|FG000|Overall Study|Withdrawal by Subject|11|||
145689618|NCT00443898|525379645|FG001|Overall Study|Withdrawal by Subject|10|||
145689619|NCT00443898|525379646|FG002|Overall Study|Withdrawal by Subject|10|||
145689620|NCT00443898|525379647|FG003|Overall Study|Withdrawal by Subject|6|||
145689621|NCT00443898|525379644|FG000|Overall Study|Lost to Follow-up|10|||
145689622|NCT00443898|525379645|FG001|Overall Study|Lost to Follow-up|10|||
145689623|NCT00443898|525379646|FG002|Overall Study|Lost to Follow-up|14|||
145689624|NCT00443898|525379647|FG003|Overall Study|Lost to Follow-up|10|||
145689625|NCT00443898|525379644|FG000|Overall Study|Death|0|||
145689626|NCT00443898|525379645|FG001|Overall Study|Death|1|||
145689627|NCT00443898|525379646|FG002|Overall Study|Death|0|||
145689628|NCT00443898|525379647|FG003|Overall Study|Death|0|||
145689629|NCT00043186|525379648|FG000|Overall Study|Physician Decision|0|||
145689630|NCT00043186|525379649|FG001|Overall Study|Physician Decision|0|||
145689631|NCT00043186|525379650|FG002|Overall Study|Physician Decision|3|||
145689632|NCT00043186|525379651|FG003|Overall Study|Physician Decision|0|||
145689633|NCT00043186|525379652|FG004|Overall Study|Physician Decision|1|||
145689634|NCT00043186|525379653|FG005|Overall Study|Physician Decision|0|||
145689635|NCT00043186|525379654|FG006|Overall Study|Physician Decision|0|||
145689636|NCT00043186|525379655|FG007|Overall Study|Physician Decision|1|||
145689637|NCT00043186|525379656|FG008|Overall Study|Physician Decision|1|||
145689638|NCT00043186|525379648|FG000|Overall Study|Adverse Event|2|||
145689639|NCT00043186|525379649|FG001|Overall Study|Adverse Event|2|||
145689640|NCT00043186|525379650|FG002|Overall Study|Adverse Event|2|||
145689641|NCT00043186|525379651|FG003|Overall Study|Adverse Event|3|||
145689642|NCT00043186|525379652|FG004|Overall Study|Adverse Event|2|||
145689643|NCT00043186|525379653|FG005|Overall Study|Adverse Event|1|||
145689644|NCT00043186|525379654|FG006|Overall Study|Adverse Event|2|||
145689645|NCT00043186|525379655|FG007|Overall Study|Adverse Event|1|||
145689646|NCT00043186|525379656|FG008|Overall Study|Adverse Event|3|||
145689647|NCT00043186|525379648|FG000|Overall Study|Withdrawal by Subject|11|||
145689648|NCT00043186|525379649|FG001|Overall Study|Withdrawal by Subject|8|||
145689649|NCT00043186|525379650|FG002|Overall Study|Withdrawal by Subject|11|||
145689650|NCT00043186|525379651|FG003|Overall Study|Withdrawal by Subject|13|||
145689651|NCT00043186|525379652|FG004|Overall Study|Withdrawal by Subject|14|||
145689652|NCT00043186|525379653|FG005|Overall Study|Withdrawal by Subject|6|||
145689653|NCT00043186|525379654|FG006|Overall Study|Withdrawal by Subject|12|||
145689654|NCT00043186|525379655|FG007|Overall Study|Withdrawal by Subject|9|||
145689655|NCT00043186|525379656|FG008|Overall Study|Withdrawal by Subject|10|||
145689656|NCT00043186|525379648|FG000|Overall Study|Death|0|||
145689657|NCT00043186|525379649|FG001|Overall Study|Death|0|||
145689658|NCT00043186|525379650|FG002|Overall Study|Death|1|||
145689659|NCT00043186|525379651|FG003|Overall Study|Death|0|||
145689660|NCT00043186|525379652|FG004|Overall Study|Death|0|||
145689661|NCT00043186|525379653|FG005|Overall Study|Death|0|||
145689662|NCT00043186|525379654|FG006|Overall Study|Death|2|||
145689663|NCT00043186|525379655|FG007|Overall Study|Death|0|||
145689664|NCT00043186|525379656|FG008|Overall Study|Death|0|||
145689665|NCT00043186|525379648|FG000|Overall Study|Disease progression|1|||
145689666|NCT00043186|525379649|FG001|Overall Study|Disease progression|0|||
145689667|NCT00043186|525379650|FG002|Overall Study|Disease progression|0|||
145689668|NCT00043186|525379651|FG003|Overall Study|Disease progression|3|||
145689669|NCT00043186|525379652|FG004|Overall Study|Disease progression|0|||
145689670|NCT00043186|525379653|FG005|Overall Study|Disease progression|0|||
145689671|NCT00043186|525379654|FG006|Overall Study|Disease progression|0|||
145689672|NCT00043186|525379655|FG007|Overall Study|Disease progression|4|||
145689673|NCT00043186|525379656|FG008|Overall Study|Disease progression|0|||
145689674|NCT00043186|525379648|FG000|Overall Study|Ineligibility determined|0|||
145689675|NCT00043186|525379649|FG001|Overall Study|Ineligibility determined|0|||
145689676|NCT00043186|525379650|FG002|Overall Study|Ineligibility determined|0|||
145689677|NCT00043186|525379651|FG003|Overall Study|Ineligibility determined|0|||
145689678|NCT00043186|525379652|FG004|Overall Study|Ineligibility determined|0|||
145689679|NCT00043186|525379653|FG005|Overall Study|Ineligibility determined|0|||
145689680|NCT00043186|525379654|FG006|Overall Study|Ineligibility determined|0|||
145689681|NCT00043186|525379655|FG007|Overall Study|Ineligibility determined|0|||
145689682|NCT00043186|525379656|FG008|Overall Study|Ineligibility determined|1|||
145689683|NCT00043186|525379648|FG000|Overall Study|Lost to Follow-up|3|||
145689684|NCT00043186|525379649|FG001|Overall Study|Lost to Follow-up|5|||
145689685|NCT00043186|525379650|FG002|Overall Study|Lost to Follow-up|1|||
145689686|NCT00043186|525379651|FG003|Overall Study|Lost to Follow-up|1|||
145689687|NCT00043186|525379652|FG004|Overall Study|Lost to Follow-up|1|||
145689688|NCT00043186|525379653|FG005|Overall Study|Lost to Follow-up|1|||
145689689|NCT00043186|525379654|FG006|Overall Study|Lost to Follow-up|1|||
145689690|NCT00043186|525379655|FG007|Overall Study|Lost to Follow-up|1|||
145689691|NCT00043186|525379656|FG008|Overall Study|Lost to Follow-up|2|||
145689692|NCT00043186|525379648|FG000|Overall Study|Noncompliance|0|||
145689693|NCT00043186|525379649|FG001|Overall Study|Noncompliance|0|||
145689694|NCT00043186|525379650|FG002|Overall Study|Noncompliance|1|||
145689695|NCT00043186|525379651|FG003|Overall Study|Noncompliance|1|||
145689696|NCT00043186|525379652|FG004|Overall Study|Noncompliance|0|||
145689697|NCT00043186|525379653|FG005|Overall Study|Noncompliance|0|||
145689698|NCT00043186|525379654|FG006|Overall Study|Noncompliance|0|||
145689699|NCT00043186|525379655|FG007|Overall Study|Noncompliance|0|||
145689700|NCT00043186|525379656|FG008|Overall Study|Noncompliance|0|||
145689701|NCT00043186|525379648|FG000|Overall Study|Other|0|||
145689702|NCT00043186|525379649|FG001|Overall Study|Other|0|||
145689703|NCT00043186|525379650|FG002|Overall Study|Other|1|||
145689704|NCT00043186|525379651|FG003|Overall Study|Other|1|||
145689705|NCT00043186|525379652|FG004|Overall Study|Other|0|||
145689706|NCT00043186|525379653|FG005|Overall Study|Other|0|||
145689707|NCT00043186|525379654|FG006|Overall Study|Other|0|||
145689708|NCT00043186|525379655|FG007|Overall Study|Other|0|||
145689709|NCT00043186|525379656|FG008|Overall Study|Other|0|||
145689710|NCT00958711|525379657|FG000|Overall Study|Withdrawal by Subject|0|||
145689711|NCT00958711|525379658|FG001|Overall Study|Withdrawal by Subject|4|||
145689712|NCT00958711|525379657|FG000|Overall Study|Physician Decision|5|||
145689713|NCT00958711|525379658|FG001|Overall Study|Physician Decision|7|||
145689714|NCT00958711|525379657|FG000|Overall Study|Lost to Follow-up|4|||
145689715|NCT00958711|525379658|FG001|Overall Study|Lost to Follow-up|1|||
145689716|NCT00958711|525379657|FG000|Overall Study|Other|2|||
145689717|NCT00958711|525379658|FG001|Overall Study|Other|5|||
145689718|NCT00958711|525379657|FG000|Overall Study|Death|1|||
145689719|NCT00958711|525379658|FG001|Overall Study|Death|2|||
145689720|NCT00958711|525379657|FG000|Overall Study|Adverse Event|1|||
145689721|NCT00958711|525379658|FG001|Overall Study|Adverse Event|2|||
145689722|NCT03722485|525379659|FG000|Overall Study|Withdrawal by Subject|1|||
145689723|NCT03722485|525379660|FG001|Overall Study|Withdrawal by Subject|0|||
145689724|NCT03722485|525379659|FG000|Overall Study|Adverse Event|0|||
145689725|NCT03722485|525379660|FG001|Overall Study|Adverse Event|2|||
145689726|NCT03722485|525379659|FG000|Overall Study|subject discharged prior to study completion|1|||
145689727|NCT03722485|525379660|FG001|Overall Study|subject discharged prior to study completion|5|||
145689728|NCT03722485|525379659|FG000|Overall Study|eligibility criteria not met|2|||
145689729|NCT03722485|525379660|FG001|Overall Study|eligibility criteria not met|0|||
145689730|NCT02151643|525379661|FG000|Overall Study|Adverse Event|2|||
145689731|NCT02151643|525379662|FG001|Overall Study|Adverse Event|0|||
145689732|NCT02151643|525379663|FG002|Overall Study|Adverse Event|1|||
145689733|NCT02151643|525379664|FG003|Overall Study|Adverse Event|4|||
145689734|NCT02151643|525379665|FG004|Overall Study|Adverse Event|0|||
145689735|NCT02151643|525379661|FG000|Overall Study|Withdrawal by Subject|0|||
145689736|NCT02151643|525379662|FG001|Overall Study|Withdrawal by Subject|1|||
145689737|NCT02151643|525379663|FG002|Overall Study|Withdrawal by Subject|1|||
145689738|NCT02151643|525379664|FG003|Overall Study|Withdrawal by Subject|1|||
145689739|NCT02151643|525379665|FG004|Overall Study|Withdrawal by Subject|1|||
145689740|NCT02151643|525379661|FG000|Overall Study|Hyperphosphataemia|1|||
145689741|NCT02151643|525379662|FG001|Overall Study|Hyperphosphataemia|0|||
145689742|NCT02151643|525379663|FG002|Overall Study|Hyperphosphataemia|0|||
145689743|NCT02151643|525379664|FG003|Overall Study|Hyperphosphataemia|0|||
145689744|NCT02151643|525379665|FG004|Overall Study|Hyperphosphataemia|1|||
145689745|NCT02151643|525379661|FG000|Overall Study|High Ferritin levels|3|||
145689746|NCT02151643|525379662|FG001|Overall Study|High Ferritin levels|3|||
145689747|NCT02151643|525379663|FG002|Overall Study|High Ferritin levels|2|||
145491320|NCT02421172|524653749|FG004|Period 1|Lost to Follow-up|0|||
145689748|NCT02151643|525379664|FG003|Overall Study|High Ferritin levels|2|||
145689749|NCT02151643|525379665|FG004|Overall Study|High Ferritin levels|1|||
145689750|NCT00197106|525379668|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
145689751|NCT00197106|525379669|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
145689752|NCT00197106|525379670|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
145689753|NCT00197106|525379668|FG000|Overall Treatment Period|Lack of Efficacy|0|||
145689754|NCT00197106|525379669|FG001|Overall Treatment Period|Lack of Efficacy|1|||
145689755|NCT00197106|525379670|FG002|Overall Treatment Period|Lack of Efficacy|0|||
145689756|NCT00197106|525379668|FG000|Overall Treatment Period|Lost to Follow-up|0|||
145689757|NCT00197106|525379669|FG001|Overall Treatment Period|Lost to Follow-up|0|||
145689758|NCT00197106|525379670|FG002|Overall Treatment Period|Lost to Follow-up|2|||
145689759|NCT00197106|525379668|FG000|Overall Treatment Period|Protocol Violation|0|||
145689760|NCT00197106|525379669|FG001|Overall Treatment Period|Protocol Violation|0|||
145689761|NCT00197106|525379670|FG002|Overall Treatment Period|Protocol Violation|2|||
145689762|NCT00197106|525379668|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
145689763|NCT00197106|525379669|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
145689764|NCT00197106|525379670|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
145689765|NCT00550771|525379672|FG000|Overall Study|Adverse Event|11|||
145689766|NCT00550771|525379673|FG001|Overall Study|Adverse Event|3|||
145689767|NCT00550771|525379672|FG000|Overall Study|Discontinued for study-related reasons|0|||
145689768|NCT00550771|525379673|FG001|Overall Study|Discontinued for study-related reasons|1|||
145689769|NCT00550771|525379672|FG000|Overall Study|Physician Decision|2|||
145689770|NCT00550771|525379673|FG001|Overall Study|Physician Decision|0|||
145689771|NCT00550771|525379672|FG000|Overall Study|Withdrawal by Subject|0|||
145689772|NCT00550771|525379673|FG001|Overall Study|Withdrawal by Subject|1|||
145689773|NCT00550771|525379672|FG000|Overall Study|Protocol Violation|4|||
145689774|NCT00550771|525379673|FG001|Overall Study|Protocol Violation|5|||
145689775|NCT03022578|525379674|FG000|Overall Study|Adverse Event|1|||
145689776|NCT03022578|525379674|FG000|Overall Study|Lack of Efficacy|2|||
145689777|NCT03022578|525379674|FG000|Overall Study|Withdrawal by Subject|1|||
145689778|NCT03681353|525379675|FG000|Overall Study|Lost to Follow-up|2|||
145689779|NCT03681353|525379675|FG000|Overall Study|Withdrawal by Subject|3|||
145689780|NCT03681353|525379675|FG000|Overall Study|withdrawn by PI|2|||
145689781|NCT00382408|525379679|FG000|Overall Study|Did not meet protocol requirement|3|||
145689782|NCT00382408|525379680|FG001|Overall Study|Did not meet protocol requirement|3|||
145689783|NCT00382408|525379679|FG000|Overall Study|Protocol Violation|2|||
145689784|NCT00382408|525379680|FG001|Overall Study|Protocol Violation|2|||
145689785|NCT00382408|525379679|FG000|Overall Study|Physician Decision|1|||
145689786|NCT00382408|525379680|FG001|Overall Study|Physician Decision|0|||
145689787|NCT00382408|525379679|FG000|Overall Study|Withdrawal by Subject|17|||
145689788|NCT00382408|525379680|FG001|Overall Study|Withdrawal by Subject|6|||
145689789|NCT00382408|525379679|FG000|Overall Study|Pregnancy|2|||
145689790|NCT00382408|525379680|FG001|Overall Study|Pregnancy|0|||
145689791|NCT00382408|525379679|FG000|Overall Study|Lost to Follow-up|19|||
145689792|NCT00382408|525379680|FG001|Overall Study|Lost to Follow-up|8|||
145689793|NCT00382408|525379679|FG000|Overall Study|Other|100|||
145689794|NCT00382408|525379680|FG001|Overall Study|Other|35|||
145689795|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
145689796|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
145689797|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
145689798|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
145689799|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
145689800|NCT00520403|525379681|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
145689801|NCT00520403|525379681|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
145689802|NCT00520403|525379681|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
145689803|NCT01145417|525379682|FG000|Overall Study|Death|1|||
145689804|NCT01145417|525379683|FG001|Overall Study|Death|0|||
145689805|NCT01145417|525379682|FG000|Overall Study|Lost to Follow-up|2|||
145689806|NCT01145417|525379683|FG001|Overall Study|Lost to Follow-up|1|||
145689807|NCT01145417|525379682|FG000|Overall Study|Withdrawal by Subject|1|||
145689808|NCT01145417|525379683|FG001|Overall Study|Withdrawal by Subject|2|||
145689809|NCT01145417|525379682|FG000|Overall Study|Pregnancy|1|||
145689810|NCT01145417|525379683|FG001|Overall Study|Pregnancy|0|||
145689811|NCT01145417|525379682|FG000|Overall Study|Adverse Event|0|||
145689812|NCT01145417|525379683|FG001|Overall Study|Adverse Event|1|||
145689813|NCT01145417|525379682|FG000|Overall Study|Study terminated by sponsor|35|||
145689814|NCT01145417|525379683|FG001|Overall Study|Study terminated by sponsor|43|||
145689815|NCT01145417|525379682|FG000|Overall Study|Other|1|||
145689816|NCT01145417|525379683|FG001|Overall Study|Other|0|||
145689817|NCT01797562|525379684|FG000|Overall Study|Protocol Violation|5|||
145689818|NCT00917462|525379685|FG000|Overall Study|Clinical Deterioration|1|||
145689819|NCT03341312|525379689|FG000|Period 1|Withdrawal by Subject|0|||
145689820|NCT03341312|525379690|FG001|Period 1|Withdrawal by Subject|1|||
145689821|NCT03341312|525379691|FG002|Period 1|Withdrawal by Subject|0|||
145689822|NCT03341312|525379692|FG003|Period 1|Withdrawal by Subject|0|||
145689823|NCT01631825|525379693|FG000|Overall Study|Adverse Event|42|||
145689824|NCT01631825|525379693|FG000|Overall Study|Lack of Efficacy|7|||
145689825|NCT01631825|525379693|FG000|Overall Study|Withdrawal by Subject|9|||
145689826|NCT01631825|525379693|FG000|Overall Study|Protocol Violation|4|||
145689827|NCT01631825|525379693|FG000|Overall Study|Discontinuation criteria|1|||
145689828|NCT01631825|525379693|FG000|Overall Study|Physician Decision|2|||
145689829|NCT00511147|525379695|FG000|Overall Study|Withdrawal by Subject|1|||
145689830|NCT00511147|525379695|FG000|Overall Study|Disease progression|5|||
145689831|NCT00511147|525379695|FG000|Overall Study|Required platelet transfusion|1|||
145689832|NCT05372913|525379702|FG000|Overall Study|Withdrawal by Subject|0|||
145689833|NCT05372913|525379703|FG001|Overall Study|Withdrawal by Subject|2|||
145689834|NCT05372913|525379702|FG000|Overall Study|Protocol Violation|2|||
145689835|NCT05372913|525379703|FG001|Overall Study|Protocol Violation|2|||
145689836|NCT05372913|525379702|FG000|Overall Study|Adverse Event|0|||
145689837|NCT05372913|525379703|FG001|Overall Study|Adverse Event|1|||
145689838|NCT03275402|525379704|FG000|Overall Study|Death|17|||
145689839|NCT03275402|525379704|FG000|Overall Study|Study terminated by sponsor|21|||
145689840|NCT03275402|525379704|FG000|Overall Study|Withdrawal by Subject|1|||
145689841|NCT03193216|525379705|FG000|Overall Study|Lost to Follow-up|1|||
145689842|NCT03193216|525379706|FG001|Overall Study|Lost to Follow-up|0|||
145689843|NCT03193216|525379705|FG000|Overall Study|Withdrawal by Subject|5|||
145689844|NCT03193216|525379706|FG001|Overall Study|Withdrawal by Subject|0|||
145689845|NCT03193216|525379705|FG000|Overall Study|Physician Decision|4|||
145689846|NCT03193216|525379706|FG001|Overall Study|Physician Decision|0|||
145689847|NCT01514864|525379707|FG000|Overall Study|Disease progression|7|||
145689848|NCT01514864|525379708|FG001|Overall Study|Disease progression|5|||
145689849|NCT01514864|525379707|FG000|Overall Study|Study drug toxicity|2|||
145689850|NCT01514864|525379708|FG001|Overall Study|Study drug toxicity|0|||
145689851|NCT02986659|525379709|FG000|First Intervention Period|Adverse Event|3|||
145689852|NCT02986659|525379710|FG001|First Intervention Period|Adverse Event|1|||
145689853|NCT02986659|525379709|FG000|First Intervention Period|Lost to Follow-up|1|||
145689854|NCT02986659|525379710|FG001|First Intervention Period|Lost to Follow-up|0|||
145689855|NCT02986659|525379709|FG000|First Intervention Period|Withdrawal by Subject|0|||
145689856|NCT02986659|525379710|FG001|First Intervention Period|Withdrawal by Subject|1|||
145689857|NCT02986659|525379709|FG000|Second Intervention Period|Adverse Event|0|||
145689858|NCT02986659|525379710|FG001|Second Intervention Period|Adverse Event|6|||
145689859|NCT02254681|525379716|FG000|Overall Study|Lack of Efficacy|6|||
145689860|NCT02469077|525379717|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
145689861|NCT02469077|525379718|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
145689862|NCT02469077|525379717|FG000|Post Randomization/Intervention Period|Relocated|1|||
145689863|NCT02469077|525379718|FG001|Post Randomization/Intervention Period|Relocated|1|||
145689864|NCT02469077|525379717|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
145689865|NCT02469077|525379718|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
145689866|NCT02469077|525379717|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
145689867|NCT02469077|525379718|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
145689868|NCT01059526|525379719|FG000|Overall Study|Patient enrolled but not treated|20|||
145689869|NCT01059526|525379720|FG001|Overall Study|Patient enrolled but not treated|17|||
145689870|NCT01059526|525379719|FG000|Overall Study|Adverse Event|2|||
145689871|NCT01059526|525379720|FG001|Overall Study|Adverse Event|2|||
145689872|NCT01059526|525379719|FG000|Overall Study|Protocol Violation|0|||
145689873|NCT01059526|525379720|FG001|Overall Study|Protocol Violation|1|||
145689874|NCT01059526|525379719|FG000|Overall Study|Withdrawal by Subject|3|||
145689875|NCT01059526|525379720|FG001|Overall Study|Withdrawal by Subject|1|||
145689876|NCT01059526|525379719|FG000|Overall Study|Lost to Follow-up|4|||
145689877|NCT01059526|525379720|FG001|Overall Study|Lost to Follow-up|1|||
145689878|NCT01059526|525379719|FG000|Overall Study|Patient found to be dermatographic|1|||
145689879|NCT01059526|525379720|FG001|Overall Study|Patient found to be dermatographic|0|||
145689880|NCT02005029|525379721|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
145689881|NCT02005029|525379722|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
145689882|NCT02621047|525379723|FG000|Overall Study|Adverse Event|0|||
145689883|NCT02621047|525379724|FG001|Overall Study|Adverse Event|0|||
145689884|NCT02621047|525379725|FG002|Overall Study|Adverse Event|1|||
145689885|NCT01370018|525379726|FG000|Overall Study|Did not meet criteria for analysis|1|||
145689886|NCT03772041|525379729|FG000|Overall Study|Adverse Event|8|||
145689887|NCT03772041|525379730|FG001|Overall Study|Adverse Event|3|||
145689888|NCT03772041|525379729|FG000|Overall Study|Withdrawal by Subject|0|||
145689889|NCT03772041|525379730|FG001|Overall Study|Withdrawal by Subject|2|||
145689890|NCT03772041|525379729|FG000|Overall Study|Protocol Violation|4|||
145689891|NCT03772041|525379730|FG001|Overall Study|Protocol Violation|2|||
145689892|NCT03772041|525379729|FG000|Overall Study|Physician Decision|2|||
145689893|NCT03772041|525379730|FG001|Overall Study|Physician Decision|3|||
145689894|NCT01525641|525379731|FG000|Overall Study|Case report form not collected|25|||
145689895|NCT01525641|525379731|FG000|Overall Study|No visit since the first visit|16|||
145689896|NCT01525641|525379731|FG000|Overall Study|Adverse Event|73|||
145689897|NCT01525641|525379731|FG000|Overall Study|Lack of Efficacy|24|||
145689898|NCT01525641|525379731|FG000|Overall Study|Improvement|5|||
145491321|NCT02421172|524653745|FG000|Period 1|Patient/guardian decision|0|||
145689899|NCT01525641|525379731|FG000|Overall Study|Lost to follow-up (relocation)|1|||
145689900|NCT01525641|525379731|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
145689901|NCT01525641|525379731|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
145689902|NCT01525641|525379731|FG000|Overall Study|Other than stated above|7|||
145689903|NCT02204319|525379732|FG000|Overall Study|Pregnancy|1|||
145689904|NCT02204319|525379732|FG000|Overall Study|Withdrawal by Subject|2|||
145689905|NCT03544229|525379737|FG000|Overall Study|Adverse Event|1|||
145689906|NCT03544229|525379738|FG001|Overall Study|Adverse Event|0|||
145689907|NCT03544229|525379739|FG002|Overall Study|Adverse Event|1|||
145689908|NCT03544229|525379740|FG003|Overall Study|Adverse Event|0|||
145689909|NCT03544229|525379737|FG000|Overall Study|Protocol Deviation|0|||
145689910|NCT03544229|525379738|FG001|Overall Study|Protocol Deviation|0|||
145689911|NCT03544229|525379739|FG002|Overall Study|Protocol Deviation|1|||
145689912|NCT03544229|525379740|FG003|Overall Study|Protocol Deviation|0|||
145689913|NCT03544229|525379737|FG000|Overall Study|Lost to Follow-up|3|||
145689914|NCT03544229|525379738|FG001|Overall Study|Lost to Follow-up|0|||
145689915|NCT03544229|525379739|FG002|Overall Study|Lost to Follow-up|0|||
145689916|NCT03544229|525379740|FG003|Overall Study|Lost to Follow-up|2|||
145689917|NCT03544229|525379737|FG000|Overall Study|Voluntary Withdrawal|2|||
145689918|NCT03544229|525379738|FG001|Overall Study|Voluntary Withdrawal|1|||
145689919|NCT03544229|525379739|FG002|Overall Study|Voluntary Withdrawal|3|||
145689920|NCT03544229|525379740|FG003|Overall Study|Voluntary Withdrawal|0|||
145689921|NCT03544229|525379737|FG000|Overall Study|Lack of Efficacy|0|||
145689922|NCT03544229|525379738|FG001|Overall Study|Lack of Efficacy|1|||
145689923|NCT03544229|525379739|FG002|Overall Study|Lack of Efficacy|0|||
145689924|NCT03544229|525379740|FG003|Overall Study|Lack of Efficacy|0|||
145689925|NCT03794609|525379745|FG000|Overall Study|Other|10|||
145689926|NCT03794609|525379745|FG000|Overall Study|Withdrawal by Subject|66|||
145689927|NCT03794609|525379745|FG000|Overall Study|The child is enrolled in an interventional study|70|||
145689928|NCT03794609|525379745|FG000|Overall Study|Inclusion/exclusion criteria|8|||
145689929|NCT03794609|525379745|FG000|Overall Study|At sponsor's request|151|||
145689930|NCT03794609|525379745|FG000|Overall Study|Physician Decision|1|||
145689931|NCT03794609|525379745|FG000|Overall Study|Lost to Follow-up|5|||
145689932|NCT02205476|525379746|FG000|Overall Study|Study termination by Sponsor|7|||
145689933|NCT02205476|525379747|FG001|Overall Study|Study termination by Sponsor|3|||
145689934|NCT00139659|525379752|FG000|Overall Study|Adverse Event|12|||
145689935|NCT00139659|525379753|FG001|Overall Study|Adverse Event|1|||
145689936|NCT00139659|525379752|FG000|Overall Study|Lack of Efficacy|1|||
145689937|NCT00139659|525379753|FG001|Overall Study|Lack of Efficacy|1|||
145689938|NCT00139659|525379752|FG000|Overall Study|Lost to Follow-up|7|||
145689939|NCT00139659|525379753|FG001|Overall Study|Lost to Follow-up|3|||
145689940|NCT00139659|525379752|FG000|Overall Study|Reason not Specified|6|||
145689941|NCT00139659|525379753|FG001|Overall Study|Reason not Specified|3|||
145689942|NCT00139659|525379752|FG000|Overall Study|Withdrawal by Subject|14|||
145689943|NCT00139659|525379753|FG001|Overall Study|Withdrawal by Subject|10|||
145689944|NCT04089332|525379759|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
145689945|NCT04089332|525379759|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
145689946|NCT04089332|525379759|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
145689947|NCT06016127|525379764|FG000|Overall Study|Withdrawal by Subject|4|||
145689948|NCT06016127|525379765|FG001|Overall Study|Withdrawal by Subject|3|||
145689949|NCT00734851|525379768|FG000|Overall Study|Withdrawal by Subject|2|||
145689950|NCT00734851|525379768|FG000|Overall Study|Lost to Follow-up|1|||
145689951|NCT00734851|525379768|FG000|Overall Study|Physician Decision|18|||
145689952|NCT01770509|525379769|FG000|Overall Study|Injury|0|||
145689953|NCT01770509|525379770|FG001|Overall Study|Injury|1|||
145689954|NCT01770509|525379769|FG000|Overall Study|Lost to Follow-up|1|||
145689955|NCT01770509|525379770|FG001|Overall Study|Lost to Follow-up|2|||
145689956|NCT00508274|525381761|FG000|Overall Study|Adverse Event|5|||
145689957|NCT00508274|525381761|FG000|Overall Study|Death|7|||
145689958|NCT00508274|525381761|FG000|Overall Study|Disease progression|32|||
145689959|NCT00508274|525381761|FG000|Overall Study|Withdrawal by Subject|1|||
145689960|NCT00508274|525381761|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
145689961|NCT00508274|525381761|FG000|Overall Study|Missing|3|||
145689962|NCT03296566|525381762|FG000|Overall Study|Lost to Follow-up|19|||
145689963|NCT03296566|525381763|FG001|Overall Study|Lost to Follow-up|46|||
145689964|NCT03296566|525381762|FG000|Overall Study|Withdrawal by Subject|0|||
145689965|NCT03296566|525381763|FG001|Overall Study|Withdrawal by Subject|3|||
145689966|NCT02110225|525381766|FG000|Overall Study|Lost to Follow-up|0|||
145689967|NCT02110225|525381767|FG001|Overall Study|Lost to Follow-up|1|||
145689968|NCT02110225|525381768|FG002|Overall Study|Lost to Follow-up|0|||
145689969|NCT02176018|525381769|FG000|Overall Study|Adverse Event|0|||
145689970|NCT02176018|525381770|FG001|Overall Study|Adverse Event|2|||
145689971|NCT02176018|525381769|FG000|Overall Study|Lost to Follow-up|3|||
145689972|NCT02176018|525381770|FG001|Overall Study|Lost to Follow-up|1|||
145689973|NCT02176018|525381769|FG000|Overall Study|Protocol Violation|1|||
145689974|NCT02176018|525381770|FG001|Overall Study|Protocol Violation|1|||
145689975|NCT02176018|525381769|FG000|Overall Study|Withdrawal by Subject|1|||
145689976|NCT02176018|525381770|FG001|Overall Study|Withdrawal by Subject|2|||
145689977|NCT00265096|525381771|FG000|Overall Study|Adverse Event|14|||
145689978|NCT00265096|525381772|FG001|Overall Study|Adverse Event|18|||
145689979|NCT00265096|525381773|FG002|Overall Study|Adverse Event|18|||
145689980|NCT00265096|525381771|FG000|Overall Study|Lost to Follow-up|2|||
145689981|NCT00265096|525381772|FG001|Overall Study|Lost to Follow-up|5|||
145689982|NCT00265096|525381773|FG002|Overall Study|Lost to Follow-up|3|||
145689983|NCT00265096|525381771|FG000|Overall Study|Death|0|||
145689984|NCT00265096|525381772|FG001|Overall Study|Death|1|||
145689985|NCT00265096|525381773|FG002|Overall Study|Death|2|||
145689986|NCT00265096|525381771|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
145689987|NCT00265096|525381772|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
145689988|NCT00265096|525381773|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
145689989|NCT00265096|525381771|FG000|Overall Study|Other|11|||
145689990|NCT00265096|525381772|FG001|Overall Study|Other|19|||
145689991|NCT00265096|525381773|FG002|Overall Study|Other|10|||
145689992|NCT00774306|525381774|FG000|Overall Study|Adverse Event|3|||
145689993|NCT00774306|525381775|FG001|Overall Study|Adverse Event|0|||
145689994|NCT00774306|525381776|FG002|Overall Study|Adverse Event|0|||
145689995|NCT00774306|525381777|FG003|Overall Study|Adverse Event|0|||
145689996|NCT00774306|525381774|FG000|Overall Study|Protocol Violation|2|||
145689997|NCT00774306|525381775|FG001|Overall Study|Protocol Violation|0|||
145689998|NCT00774306|525381776|FG002|Overall Study|Protocol Violation|3|||
145689999|NCT00774306|525381777|FG003|Overall Study|Protocol Violation|0|||
145690000|NCT00774306|525381774|FG000|Overall Study|Withdrawal by Subject|6|||
145690001|NCT00774306|525381775|FG001|Overall Study|Withdrawal by Subject|1|||
145690002|NCT00774306|525381776|FG002|Overall Study|Withdrawal by Subject|1|||
145690003|NCT00774306|525381777|FG003|Overall Study|Withdrawal by Subject|0|||
145690004|NCT00774306|525381774|FG000|Overall Study|Lost to Follow-up|6|||
145690005|NCT00774306|525381775|FG001|Overall Study|Lost to Follow-up|0|||
145690006|NCT00774306|525381776|FG002|Overall Study|Lost to Follow-up|4|||
145690007|NCT00774306|525381777|FG003|Overall Study|Lost to Follow-up|5|||
145690008|NCT00774306|525381774|FG000|Overall Study|Death|1|||
145690009|NCT00774306|525381775|FG001|Overall Study|Death|1|||
145690010|NCT00774306|525381776|FG002|Overall Study|Death|0|||
145690011|NCT00774306|525381777|FG003|Overall Study|Death|0|||
145690012|NCT00809783|525381783|FG000|Overall Study|Death|1|||
145690013|NCT00809783|525381784|FG001|Overall Study|Death|0|||
145690014|NCT00809783|525381785|FG002|Overall Study|Death|0|||
145690015|NCT00809783|525381783|FG000|Overall Study|Adverse Event|34|||
145690016|NCT00809783|525381784|FG001|Overall Study|Adverse Event|52|||
145690017|NCT00809783|525381785|FG002|Overall Study|Adverse Event|71|||
145690018|NCT00809783|525381783|FG000|Overall Study|Lack of Efficacy|39|||
145690019|NCT00809783|525381784|FG001|Overall Study|Lack of Efficacy|52|||
145690020|NCT00809783|525381785|FG002|Overall Study|Lack of Efficacy|63|||
145690021|NCT00809783|525381783|FG000|Overall Study|Lost to Follow-up|0|||
145690022|NCT00809783|525381784|FG001|Overall Study|Lost to Follow-up|3|||
145690023|NCT00809783|525381785|FG002|Overall Study|Lost to Follow-up|4|||
145690024|NCT00809783|525381783|FG000|Overall Study|Withdrawal by Subject|47|||
145690025|NCT00809783|525381784|FG001|Overall Study|Withdrawal by Subject|72|||
145690026|NCT00809783|525381785|FG002|Overall Study|Withdrawal by Subject|64|||
145690027|NCT00809783|525381783|FG000|Overall Study|Protocol Violation|2|||
145690028|NCT00809783|525381784|FG001|Overall Study|Protocol Violation|6|||
145690029|NCT00809783|525381785|FG002|Overall Study|Protocol Violation|5|||
145690030|NCT00809783|525381783|FG000|Overall Study|Randomized, but not treated|3|||
145690031|NCT00809783|525381784|FG001|Overall Study|Randomized, but not treated|0|||
145690032|NCT00809783|525381785|FG002|Overall Study|Randomized, but not treated|2|||
145690033|NCT00809783|525381783|FG000|Overall Study|Study Terminated by Sponsor|378|||
145690034|NCT00809783|525381784|FG001|Overall Study|Study Terminated by Sponsor|626|||
145690035|NCT00809783|525381785|FG002|Overall Study|Study Terminated by Sponsor|565|||
145690036|NCT00809783|525381783|FG000|Overall Study|Other|21|||
145690037|NCT00809783|525381784|FG001|Overall Study|Other|21|||
145690038|NCT00809783|525381785|FG002|Overall Study|Other|16|||
145690039|NCT00126555|525381786|FG000|Overall Study|Withdrawal by Subject|1|||
145690040|NCT00126555|525381786|FG000|Overall Study|Adverse Event|2|||
145690041|NCT00126555|525381786|FG000|Overall Study|Progressive Disease|3|||
145690042|NCT01780545|525381790|FG000|Overall Study|Withdrawal by Subject|3|||
145690043|NCT01780545|525381791|FG001|Overall Study|Withdrawal by Subject|1|||
145690044|NCT01780545|525381790|FG000|Overall Study|Lost to Follow-up|1|||
145690045|NCT01780545|525381791|FG001|Overall Study|Lost to Follow-up|1|||
145690046|NCT05135156|525381798|FG000|Overall Study|Lost to Follow-up|0|||
145690047|NCT05135156|525381799|FG001|Overall Study|Lost to Follow-up|0|||
145690048|NCT05135156|525381800|FG002|Overall Study|Lost to Follow-up|2|||
145690049|NCT00396097|525381803|FG000|Overall Study|Withdrawal by Subject|17|||
145690050|NCT00396097|525381804|FG001|Overall Study|Withdrawal by Subject|17|||
145690051|NCT00396097|525381803|FG000|Overall Study|Lost to Follow-up|4|||
145690052|NCT00396097|525381804|FG001|Overall Study|Lost to Follow-up|9|||
145690053|NCT00396097|525381803|FG000|Overall Study|Other|3|||
145690054|NCT00396097|525381804|FG001|Overall Study|Other|5|||
145690055|NCT00396097|525381803|FG000|Overall Study|Protocol Violation|0|||
145690056|NCT00396097|525381804|FG001|Overall Study|Protocol Violation|6|||
145690057|NCT00396097|525381803|FG000|Overall Study|Adverse Event|1|||
145690058|NCT00396097|525381804|FG001|Overall Study|Adverse Event|5|||
145690059|NCT00396097|525381803|FG000|Overall Study|Insufficient Clinical Response|1|||
145690060|NCT00396097|525381804|FG001|Overall Study|Insufficient Clinical Response|4|||
145690061|NCT03461211|525381805|FG000|Overall Study|Adverse Event|1|||
145690062|NCT03461211|525381806|FG001|Overall Study|Adverse Event|1|||
145690063|NCT03461211|525381805|FG000|Overall Study|Lack of Efficacy|0|||
145690064|NCT03461211|525381806|FG001|Overall Study|Lack of Efficacy|1|||
145690065|NCT03807700|525381807|FG000|Overall Study|Withdrawal by Subject|2|||
145690066|NCT03807700|525381808|FG001|Overall Study|Withdrawal by Subject|1|||
145690067|NCT02720081|525381809|FG000|Overall Study|Adverse Event|0|||
145690068|NCT02720081|525381810|FG001|Overall Study|Adverse Event|3|||
145690069|NCT02720081|525381809|FG000|Overall Study|Protocol Violation|4|||
145690070|NCT02720081|525381810|FG001|Overall Study|Protocol Violation|1|||
145690071|NCT02316847|525381812|FG000|Overall Study|Adverse Event|0|||
145690072|NCT02316847|525381813|FG001|Overall Study|Adverse Event|3|||
145690073|NCT02316847|525381812|FG000|Overall Study|Lost to Follow-up|0|||
145690074|NCT02316847|525381813|FG001|Overall Study|Lost to Follow-up|2|||
145690075|NCT02316847|525381812|FG000|Overall Study|Physician Decision|0|||
145690076|NCT02316847|525381813|FG001|Overall Study|Physician Decision|1|||
145690077|NCT02316847|525381812|FG000|Overall Study|Pregnancy|0|||
145690078|NCT02316847|525381813|FG001|Overall Study|Pregnancy|1|||
145690079|NCT02316847|525381812|FG000|Overall Study|Withdrawal by Subject|2|||
145690080|NCT02316847|525381813|FG001|Overall Study|Withdrawal by Subject|9|||
145690081|NCT02316847|525381812|FG000|Overall Study|Noncompliance with study drug|0|||
145690082|NCT02316847|525381813|FG001|Overall Study|Noncompliance with study drug|3|||
145690083|NCT02316847|525381812|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
145690084|NCT02316847|525381813|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
145690085|NCT03371485|525381816|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
145690086|NCT03371485|525381816|FG000|2-year Follow-up|Death|5|||
145690087|NCT01264887|525381820|FG000|Overall Study|Adverse Event|5|||
145690088|NCT01264887|525381820|FG000|Overall Study|Death|7|||
145690089|NCT01264887|525381820|FG000|Overall Study|Lack of Efficacy|5|||
145690090|NCT01264887|525381820|FG000|Overall Study|Physician Decision|4|||
145690091|NCT01264887|525381820|FG000|Overall Study|Withdrawal by Subject|6|||
145690092|NCT01264887|525381820|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
145690093|NCT01264887|525381820|FG000|Overall Study|Other|2|||
145690094|NCT00591409|525381821|FG000|Overall Study|Not Treated|0|||
145690095|NCT00591409|525381822|FG001|Overall Study|Not Treated|0|||
145690096|NCT00591409|525381823|FG002|Overall Study|Not Treated|0|||
145690097|NCT00591409|525381824|FG003|Overall Study|Not Treated|0|||
145690098|NCT00591409|525381825|FG004|Overall Study|Not Treated|1|||
145690099|NCT00591409|525381826|FG005|Overall Study|Not Treated|0|||
145690100|NCT00591409|525381827|FG006|Overall Study|Not Treated|0|||
145690101|NCT00591409|525381828|FG007|Overall Study|Not Treated|0|||
145690102|NCT00591409|525381829|FG008|Overall Study|Not Treated|0|||
145690103|NCT00591409|525381830|FG009|Overall Study|Not Treated|1|||
145690104|NCT02171130|525381831|FG000|Overall Study|Death|1|||
145690105|NCT02171130|525381831|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
145690106|NCT02171130|525381831|FG000|Overall Study|Discontinued; Site Termination|5|||
145690107|NCT02171130|525381831|FG000|Overall Study|Withdrawal by Subject|3|||
145690108|NCT02171130|525381831|FG000|Overall Study|Physician Decision|1|||
145690109|NCT02171130|525381831|FG000|Overall Study|Lost to Follow-up|1|||
145690110|NCT02171130|525381831|FG000|Overall Study|Met Exclusion Criteria|1|||
145690111|NCT04531813|525381832|FG000|Overall Study|Protocol Violation|1|||
145690112|NCT04531813|525381832|FG000|Overall Study|Withdrawal by Subject|1|||
145690113|NCT02853305|525381835|FG000|Overall Study|Death|287|||
145690114|NCT02853305|525381836|FG001|Overall Study|Death|249|||
145690115|NCT02853305|525381837|FG002|Overall Study|Death|300|||
145690116|NCT02853305|525381835|FG000|Overall Study|Withdrawal by Subject|2|||
145690117|NCT02853305|525381836|FG001|Overall Study|Withdrawal by Subject|8|||
145690118|NCT02853305|525381837|FG002|Overall Study|Withdrawal by Subject|3|||
145690119|NCT02853305|525381835|FG000|Overall Study|Transferred to Extension Study|46|||
145690120|NCT02853305|525381836|FG001|Overall Study|Transferred to Extension Study|30|||
145690121|NCT02853305|525381837|FG002|Overall Study|Transferred to Extension Study|25|||
145690122|NCT02853305|525381835|FG000|Overall Study|Did Not Continue on Extension Study|16|||
145690123|NCT02853305|525381836|FG001|Overall Study|Did Not Continue on Extension Study|20|||
145690124|NCT02853305|525381837|FG002|Overall Study|Did Not Continue on Extension Study|24|||
145690125|NCT04772313|525381838|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
145690126|NCT04772313|525381838|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
145690127|NCT01836198|525381839|FG000|Part A, Period 2|Protocol Violation|0|||
145690128|NCT01836198|525381840|FG001|Part A, Period 2|Protocol Violation|1|||
145690129|NCT01836198|525381841|FG002|Part A, Period 2|Protocol Violation|0|||
145690130|NCT03187353|525381842|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
145690131|NCT03187353|525381843|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
145690132|NCT03187353|525381842|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
145690133|NCT03187353|525381843|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
145690134|NCT03187353|525381842|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
145690135|NCT03187353|525381843|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
145690136|NCT03187353|525381842|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
145690137|NCT03187353|525381843|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
145690138|NCT03187353|525381842|FG000|Washout (2 Weeks)|Adverse Event|2|||
145690139|NCT03187353|525381843|FG001|Washout (2 Weeks)|Adverse Event|0|||
145690140|NCT03187353|525381842|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
145690141|NCT03187353|525381843|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
145690142|NCT01061775|525381846|FG000|Overall Study|Physician Decision|2|||
145690143|NCT01061775|525381846|FG000|Overall Study|Lost to Follow-up|1|||
145690144|NCT02567227|525381847|FG000|9 Weeks|Adverse Event|5|||
145690145|NCT02567227|525381848|FG001|9 Weeks|Adverse Event|5|||
145690146|NCT02567227|525381847|FG000|9 Weeks|Withdrawal by Subject|18|||
145690147|NCT02567227|525381848|FG001|9 Weeks|Withdrawal by Subject|8|||
145690148|NCT02567227|525381847|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
145690149|NCT02567227|525381848|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
145690150|NCT02567227|525381847|FG000|6 Month|Death|2|||
145690151|NCT02567227|525381848|FG001|6 Month|Death|0|||
145690152|NCT02567227|525381847|FG000|6 Month|Lost to Follow-up|43|||
145690153|NCT02567227|525381848|FG001|6 Month|Lost to Follow-up|40|||
145690154|NCT02567227|525381847|FG000|12 Months|Lost to Follow-up|31|||
145690155|NCT02567227|525381848|FG001|12 Months|Lost to Follow-up|32|||
145690156|NCT02567227|525381847|FG000|12 Months|Death|0|||
145690157|NCT02567227|525381848|FG001|12 Months|Death|2|||
145690158|NCT01026103|525381850|FG000|Overall Study|Physician Decision|1|||
145690159|NCT01026103|525381850|FG000|Overall Study|did not receive study device bc of error|1|||
145690160|NCT02498418|525381851|FG000|Overall Study|Lack of Efficacy|0|||
145690161|NCT02498418|525381852|FG001|Overall Study|Lack of Efficacy|0|||
145690162|NCT02498418|525381853|FG002|Overall Study|Lack of Efficacy|1|||
145690163|NCT02498418|525381851|FG000|Overall Study|Withdrawal by Subject|2|||
145690164|NCT02498418|525381852|FG001|Overall Study|Withdrawal by Subject|0|||
145690165|NCT02498418|525381853|FG002|Overall Study|Withdrawal by Subject|3|||
145690166|NCT02498418|525381851|FG000|Overall Study|Lost to Follow-up|0|||
145491322|NCT02421172|524653746|FG001|Period 1|Patient/guardian decision|1|||
145491323|NCT02421172|524653747|FG002|Period 1|Patient/guardian decision|0|||
145491324|NCT02421172|524653748|FG003|Period 1|Patient/guardian decision|0|||
145491325|NCT02421172|524653749|FG004|Period 1|Patient/guardian decision|0|||
145491326|NCT02421172|524653745|FG000|Period 2|Adverse Event|0|||
145491327|NCT02421172|524653746|FG001|Period 2|Adverse Event|0|||
145491328|NCT02421172|524653747|FG002|Period 2|Adverse Event|4|||
145491329|NCT02421172|524653748|FG003|Period 2|Adverse Event|0|||
145491330|NCT02421172|524653749|FG004|Period 2|Adverse Event|0|||
145491331|NCT02421172|524653745|FG000|Period 2|Lost to Follow-up|0|||
145491332|NCT02421172|524653746|FG001|Period 2|Lost to Follow-up|0|||
145491333|NCT02421172|524653747|FG002|Period 2|Lost to Follow-up|0|||
145491334|NCT02421172|524653748|FG003|Period 2|Lost to Follow-up|1|||
145491335|NCT02421172|524653749|FG004|Period 2|Lost to Follow-up|0|||
145491336|NCT02421172|524653745|FG000|Period 2|Patient/guardian decision|0|||
145491337|NCT02421172|524653746|FG001|Period 2|Patient/guardian decision|0|||
145491338|NCT02421172|524653747|FG002|Period 2|Patient/guardian decision|3|||
145491339|NCT02421172|524653748|FG003|Period 2|Patient/guardian decision|2|||
145491340|NCT02421172|524653749|FG004|Period 2|Patient/guardian decision|1|||
145491341|NCT00928486|524653750|FG000|Overall Study|Adverse Event|2|||
145491342|NCT00928486|524653750|FG000|Overall Study|Disease Progression|7|||
145491343|NCT00928486|524653750|FG000|Overall Study|Withdrawal by Subject|1|||
145491344|NCT00683878|524653755|FG000|Overall Study|Lack of Efficacy|3|||
145491345|NCT00683878|524653756|FG001|Overall Study|Lack of Efficacy|0|||
145491346|NCT00683878|524653757|FG002|Overall Study|Lack of Efficacy|1|||
145491347|NCT00683878|524653755|FG000|Overall Study|Adverse Event|4|||
145491348|NCT00683878|524653756|FG001|Overall Study|Adverse Event|3|||
145491349|NCT00683878|524653757|FG002|Overall Study|Adverse Event|3|||
145491350|NCT00683878|524653755|FG000|Overall Study|Withdrawal by Subject|9|||
145491351|NCT00683878|524653756|FG001|Overall Study|Withdrawal by Subject|8|||
145491352|NCT00683878|524653757|FG002|Overall Study|Withdrawal by Subject|6|||
145491353|NCT00683878|524653755|FG000|Overall Study|Death|0|||
145491354|NCT00683878|524653756|FG001|Overall Study|Death|1|||
145491355|NCT00683878|524653757|FG002|Overall Study|Death|0|||
145491356|NCT00683878|524653755|FG000|Overall Study|Lost to Follow-up|4|||
145491357|NCT00683878|524653756|FG001|Overall Study|Lost to Follow-up|2|||
145491358|NCT00683878|524653757|FG002|Overall Study|Lost to Follow-up|4|||
145491359|NCT00683878|524653755|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
145491360|NCT00683878|524653756|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
145491361|NCT00683878|524653757|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
145491362|NCT02210000|524653774|FG000|Overall Study|Study Terminated|11|||
145491363|NCT02210000|524653775|FG001|Overall Study|Study Terminated|12|||
145690167|NCT02498418|525381852|FG001|Overall Study|Lost to Follow-up|1|||
145690168|NCT02498418|525381853|FG002|Overall Study|Lost to Follow-up|1|||
145690169|NCT02498418|525381851|FG000|Overall Study|Participant taken prohibited medication|0|||
145690170|NCT02498418|525381852|FG001|Overall Study|Participant taken prohibited medication|1|||
145491364|NCT02210000|524653774|FG000|Overall Study|Withdrawal by Subject|7|||
145491365|NCT02210000|524653775|FG001|Overall Study|Withdrawal by Subject|1|||
145491366|NCT02210000|524653774|FG000|Overall Study|Adverse Event|1|||
145491367|NCT02210000|524653775|FG001|Overall Study|Adverse Event|5|||
145491368|NCT02210000|524653774|FG000|Overall Study|Lost to Follow-up|0|||
145690171|NCT02498418|525381853|FG002|Overall Study|Participant taken prohibited medication|1|||
145690172|NCT00762502|525381854|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
145690173|NCT00762502|525381855|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
145690174|NCT00762502|525381856|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
145690175|NCT00762502|525381854|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
145690176|NCT00762502|525381855|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
145690177|NCT00762502|525381856|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
145690178|NCT00762502|525381854|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
145690179|NCT00762502|525381855|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
145690180|NCT00762502|525381856|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
145690181|NCT02625922|525381858|FG000|Overall Study|Non-availability of IMP|1|||
145690182|NCT02625922|525381859|FG001|Overall Study|Non-availability of IMP|1|||
145690183|NCT02625922|525381858|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
145690184|NCT02625922|525381859|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
145690185|NCT02359552|525381860|FG000|Overall Study|Lost to Follow-up|3|||
145690186|NCT02359552|525381861|FG001|Overall Study|Lost to Follow-up|4|||
145690187|NCT02391116|525381862|FG000|Treatment|Withdrawal by Subject|1|||
145690188|NCT02391116|525381862|FG000|Treatment|Protocol Violation|1|||
145690189|NCT02391116|525381862|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
145690190|NCT02391116|525381862|FG000|Treatment|AE with Clinical PD|3|||
145690191|NCT02391116|525381862|FG000|Safety Follow-up|Adverse Event|1|||
145690192|NCT02391116|525381862|FG000|Safety Follow-up|Withdrawal by Subject|4|||
145690193|NCT02391116|525381862|FG000|Safety Follow-up|Switching to Other Therapy|4|||
145690194|NCT02391116|525381862|FG000|Safety Follow-up|No Follow Up|1|||
145690195|NCT02391116|525381862|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
145690196|NCT02391116|525381862|FG000|Active Follow-up|Withdrawal by Subject|1|||
145690197|NCT02391116|525381862|FG000|Active Follow-up|Switching to Other Therapy|2|||
145690198|NCT02391116|525381862|FG000|Survival Follow-up|Withdrawal by Subject|3|||
145690199|NCT02391116|525381862|FG000|Survival Follow-up|Switching to Other Therapy|1|||
145690200|NCT02282917|525381863|FG000|Overall Study|Withdrawal by Subject|1|||
145690201|NCT02282917|525381863|FG000|Overall Study|Screen Failure/Not Eligible|1|||
145690202|NCT01747629|525381864|FG000|Overall Study|Adverse Event|1|||
145690203|NCT01747629|525381865|FG001|Overall Study|Adverse Event|2|||
145690204|NCT01747629|525381864|FG000|Overall Study|Withdrawal by Subject|2|||
145690205|NCT01747629|525381865|FG001|Overall Study|Withdrawal by Subject|2|||
145690206|NCT01747629|525381864|FG000|Overall Study|Noncompliance|1|||
145690207|NCT01747629|525381865|FG001|Overall Study|Noncompliance|1|||
145690208|NCT01747629|525381864|FG000|Overall Study|Inclusion criteria not met|1|||
145690209|NCT01747629|525381865|FG001|Overall Study|Inclusion criteria not met|0|||
145690210|NCT01747629|525381864|FG000|Overall Study|Not treated|1|||
145690211|NCT01747629|525381865|FG001|Overall Study|Not treated|0|||
145690212|NCT01747629|525381864|FG000|Overall Study|Other|2|||
145690213|NCT01747629|525381865|FG001|Overall Study|Other|1|||
145690214|NCT00794573|525381875|FG000|Overall Study|Death|3|||
145690215|NCT00794573|525381876|FG001|Overall Study|Death|0|||
145690216|NCT00794573|525381875|FG000|Overall Study|Withdrawal by Subject|9|||
145690217|NCT00794573|525381876|FG001|Overall Study|Withdrawal by Subject|12|||
145690218|NCT00794573|525381875|FG000|Overall Study|Lost to Follow-up|26|||
145690219|NCT00794573|525381876|FG001|Overall Study|Lost to Follow-up|33|||
145690220|NCT01294358|525381877|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
145690221|NCT01294358|525381878|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
145690222|NCT01294358|525381879|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
145690223|NCT01294358|525381880|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
145690224|NCT01294358|525381881|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
145690225|NCT01294358|525381877|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
145690226|NCT01294358|525381878|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
145690227|NCT01294358|525381879|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
145690228|NCT01294358|525381880|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
145690229|NCT01294358|525381881|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
145690230|NCT01294358|525381877|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
145690231|NCT01294358|525381878|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
145690232|NCT01294358|525381879|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
145690233|NCT01294358|525381880|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
145690234|NCT01294358|525381881|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
145690235|NCT01294358|525381877|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
145690236|NCT01294358|525381878|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
145690237|NCT01294358|525381879|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
145690238|NCT01294358|525381880|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
145690239|NCT01294358|525381881|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
145690240|NCT03356145|525381882|FG000|Overall Study|Withdrawal by Subject|2|||
145690241|NCT03356145|525381883|FG001|Overall Study|Withdrawal by Subject|1|||
145690242|NCT03356145|525381882|FG000|Overall Study|Did not meet inclusion criteria|1|||
145690243|NCT03356145|525381883|FG001|Overall Study|Did not meet inclusion criteria|0|||
145690244|NCT02963922|525381884|FG000|Overall Study|Adverse Event|15|||
145690245|NCT02963922|525381885|FG001|Overall Study|Adverse Event|6|||
145690246|NCT02963922|525381884|FG000|Overall Study|Protocol deviation|6|||
145690247|NCT02963922|525381885|FG001|Overall Study|Protocol deviation|6|||
145690248|NCT02963922|525381884|FG000|Overall Study|Lack of Efficacy|1|||
145690249|NCT02963922|525381885|FG001|Overall Study|Lack of Efficacy|1|||
145690250|NCT02963922|525381884|FG000|Overall Study|Lost to Follow-up|2|||
145690251|NCT02963922|525381885|FG001|Overall Study|Lost to Follow-up|3|||
145690252|NCT02963922|525381884|FG000|Overall Study|Other|8|||
145690253|NCT02963922|525381885|FG001|Overall Study|Other|14|||
145690254|NCT03840148|525381893|FG000|Study Drug Disposition|Adverse Event|13|||
145690255|NCT03840148|525381894|FG001|Study Drug Disposition|Adverse Event|2|||
145690256|NCT03840148|525381893|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
145690257|NCT03840148|525381894|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
145690258|NCT03840148|525381893|FG000|Study Drug Disposition|Lack of Efficacy|3|||
145690259|NCT03840148|525381894|FG001|Study Drug Disposition|Lack of Efficacy|0|||
145690260|NCT03840148|525381893|FG000|Study Drug Disposition|Physician Decision|2|||
145690261|NCT03840148|525381894|FG001|Study Drug Disposition|Physician Decision|0|||
145690262|NCT03840148|525381893|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
145690263|NCT03840148|525381894|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
145690264|NCT03840148|525381893|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
145690265|NCT03840148|525381894|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
145690266|NCT03840148|525381893|FG000|Study Completion Disposition|Physician Decision|2|||
145690267|NCT03840148|525381894|FG001|Study Completion Disposition|Physician Decision|0|||
145690268|NCT03840148|525381893|FG000|Study Completion Disposition|Covid-19 related|2|||
145690269|NCT03840148|525381894|FG001|Study Completion Disposition|Covid-19 related|0|||
145690270|NCT03840148|525381893|FG000|Study Completion Disposition|Lost to Follow-up|1|||
145690271|NCT03840148|525381894|FG001|Study Completion Disposition|Lost to Follow-up|1|||
145690272|NCT03840148|525381893|FG000|Study Completion Disposition|Death|1|||
145690273|NCT03840148|525381894|FG001|Study Completion Disposition|Death|0|||
145690274|NCT03840148|525381893|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
145690275|NCT03840148|525381894|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
145690276|NCT03615404|525381895|FG000|Overall Study|Death|1|||
145690277|NCT03615404|525381895|FG000|Overall Study|vaccine did not pass quality assurance|1|||
145690278|NCT00257556|525381896|FG000|Overall Study|Adverse Event|1|||
145690279|NCT00257556|525381897|FG001|Overall Study|Adverse Event|4|||
145690280|NCT00257556|525381896|FG000|Overall Study|Physician Decision|6|||
145690281|NCT00257556|525381897|FG001|Overall Study|Physician Decision|0|||
145690282|NCT00257556|525381896|FG000|Overall Study|Did not meet hCG criterion|3|||
145690283|NCT00257556|525381897|FG001|Overall Study|Did not meet hCG criterion|0|||
145690284|NCT00257556|525381896|FG000|Overall Study|other reason|4|||
145690285|NCT00257556|525381897|FG001|Overall Study|other reason|6|||
145690286|NCT00905255|525381899|FG000|Overall Study|Adverse Event|7|||
145690287|NCT00905255|525381900|FG001|Overall Study|Adverse Event|5|||
145690288|NCT00905255|525381899|FG000|Overall Study|Withdrawal by Subject|5|||
145690289|NCT00905255|525381900|FG001|Overall Study|Withdrawal by Subject|4|||
145690290|NCT00905255|525381899|FG000|Overall Study|Familial and Personal Reasons|1|||
145690291|NCT00905255|525381900|FG001|Overall Study|Familial and Personal Reasons|0|||
145690292|NCT03849300|525381901|FG000|Overall Study|move out to different area|1|||
145690293|NCT03849300|525381902|FG001|Overall Study|move out to different area|3|||
145690294|NCT03849300|525381903|FG002|Overall Study|move out to different area|1|||
145690295|NCT03849300|525381904|FG003|Overall Study|move out to different area|4|||
145690296|NCT03849300|525381901|FG000|Overall Study|scheduling/transportation conflict|4|||
145690297|NCT03849300|525381902|FG001|Overall Study|scheduling/transportation conflict|4|||
145690298|NCT03849300|525381903|FG002|Overall Study|scheduling/transportation conflict|3|||
145690299|NCT03849300|525381904|FG003|Overall Study|scheduling/transportation conflict|2|||
145690300|NCT01774929|525381905|FG000|Overall Study|Adverse Event|3|||
145690301|NCT04839289|525381906|FG000|Overall Study|Withdrawal by Subject|1|||
145690302|NCT04839289|525381907|FG001|Overall Study|Withdrawal by Subject|0|||
145690303|NCT01332318|525381908|FG000|Overall Study|Adverse Event|0|||
145690304|NCT01332318|525381909|FG001|Overall Study|Adverse Event|3|||
145690305|NCT01332318|525381910|FG002|Overall Study|Adverse Event|0|||
145690306|NCT01332318|525381911|FG003|Overall Study|Adverse Event|0|||
145690307|NCT01332318|525381908|FG000|Overall Study|Withdrawal by Subject|1|||
145690308|NCT01332318|525381909|FG001|Overall Study|Withdrawal by Subject|1|||
145690309|NCT01332318|525381910|FG002|Overall Study|Withdrawal by Subject|0|||
145690310|NCT01332318|525381911|FG003|Overall Study|Withdrawal by Subject|1|||
145690311|NCT01332318|525381908|FG000|Overall Study|Protocol Violation|1|||
145690312|NCT01332318|525381909|FG001|Overall Study|Protocol Violation|0|||
145690313|NCT01332318|525381910|FG002|Overall Study|Protocol Violation|1|||
145690314|NCT01332318|525381911|FG003|Overall Study|Protocol Violation|1|||
145690315|NCT02040532|525381912|FG000|Overall Study|Lost to Follow-up|1|||
145690316|NCT02040532|525381912|FG000|Overall Study|Physician Decision|4|||
145690317|NCT02040532|525381912|FG000|Overall Study|Adverse Event|4|||
145690318|NCT02040532|525381912|FG000|Overall Study|Withdrawal by Subject|3|||
145690319|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
145690320|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
145690321|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
145690322|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
145690323|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
145690324|NCT00500539|525381914|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
145690325|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
145690326|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
145690327|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
145690328|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
145690329|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Death|1|||
145690330|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
145690331|NCT00500539|525381914|FG000|Follow-up Period (16 Weeks)|Missing|3|||
145690332|NCT01524887|525381915|FG000|Overall Study|Withdrawal by Subject|6|||
145690333|NCT01524887|525381916|FG001|Overall Study|Withdrawal by Subject|2|||
145690334|NCT01524887|525381917|FG002|Overall Study|Withdrawal by Subject|3|||
145690335|NCT01524887|525381915|FG000|Overall Study|Adverse Event|5|||
145690336|NCT01524887|525381916|FG001|Overall Study|Adverse Event|1|||
145690337|NCT01524887|525381917|FG002|Overall Study|Adverse Event|1|||
145690338|NCT01524887|525381915|FG000|Overall Study|Protocol Violation|0|||
145690339|NCT01524887|525381916|FG001|Overall Study|Protocol Violation|0|||
145690340|NCT01524887|525381917|FG002|Overall Study|Protocol Violation|1|||
145690341|NCT01524887|525381915|FG000|Overall Study|Study termination|73|||
145690342|NCT01524887|525381916|FG001|Overall Study|Study termination|87|||
145690343|NCT01524887|525381917|FG002|Overall Study|Study termination|79|||
145690344|NCT01524887|525381915|FG000|Overall Study|Withdrawal by Caregiver|0|||
145690345|NCT01524887|525381916|FG001|Overall Study|Withdrawal by Caregiver|0|||
145690346|NCT01524887|525381917|FG002|Overall Study|Withdrawal by Caregiver|2|||
145690347|NCT01524887|525381915|FG000|Overall Study|Use of prohibited medication|1|||
145690348|NCT01524887|525381916|FG001|Overall Study|Use of prohibited medication|0|||
145690349|NCT01524887|525381917|FG002|Overall Study|Use of prohibited medication|0|||
145690350|NCT01808144|525381918|FG000|Overall Study|Death|1|||
145690351|NCT01808144|525381919|FG001|Overall Study|Death|0|||
145690352|NCT01808144|525381918|FG000|Overall Study|Withdrawal by Subject|16|||
145690353|NCT01808144|525381919|FG001|Overall Study|Withdrawal by Subject|23|||
145690354|NCT01808144|525381918|FG000|Overall Study|Lost to Follow-up|6|||
145690355|NCT01808144|525381919|FG001|Overall Study|Lost to Follow-up|3|||
145690356|NCT01808144|525381918|FG000|Overall Study|Protocol Violation|6|||
145690357|NCT01808144|525381919|FG001|Overall Study|Protocol Violation|6|||
145690358|NCT01808144|525381918|FG000|Overall Study|Gout flare|0|||
145690359|NCT01808144|525381919|FG001|Overall Study|Gout flare|1|||
145690360|NCT01808144|525381918|FG000|Overall Study|Adverse Event|11|||
145690361|NCT01808144|525381919|FG001|Overall Study|Adverse Event|15|||
145690362|NCT03993054|525381920|FG000|Overall Study|PI Decision|1|||
145690363|NCT04341584|525381921|FG000|Overall Study|Withdrew consent|0|||
145690364|NCT04341584|525381922|FG001|Overall Study|Withdrew consent|2|||
145690365|NCT04341584|525381923|FG002|Overall Study|Withdrew consent|2|||
145690366|NCT04341584|525381924|FG003|Overall Study|Withdrew consent|1|||
145690367|NCT00497198|525381926|FG000|Overall Study|Adverse Event|4|||
145690368|NCT00497198|525381927|FG001|Overall Study|Adverse Event|2|||
145690369|NCT00497198|525381926|FG000|Overall Study|Physician Decision|1|||
145690370|NCT00497198|525381927|FG001|Overall Study|Physician Decision|2|||
145690371|NCT00497198|525381926|FG000|Overall Study|Withdrawal by Subject|0|||
145690372|NCT00497198|525381927|FG001|Overall Study|Withdrawal by Subject|1|||
145690373|NCT04853238|525381928|FG000|Overall Study|Death|4|||
145690374|NCT04853238|525381929|FG001|Overall Study|Death|0|||
145690375|NCT04853238|525381930|FG002|Overall Study|Death|2|||
145690376|NCT04853238|525381928|FG000|Overall Study|Lost to Follow-up|16|||
145690377|NCT04853238|525381929|FG001|Overall Study|Lost to Follow-up|2|||
145690378|NCT04853238|525381930|FG002|Overall Study|Lost to Follow-up|37|||
145690379|NCT04853238|525381928|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
145690380|NCT04853238|525381929|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
145690381|NCT04853238|525381930|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
145690382|NCT04853238|525381928|FG000|Overall Study|Withdrawal by Subject|6|||
145690383|NCT04853238|525381929|FG001|Overall Study|Withdrawal by Subject|0|||
145690384|NCT04853238|525381930|FG002|Overall Study|Withdrawal by Subject|21|||
145690385|NCT04853238|525381928|FG000|Overall Study|Physician Decision|0|||
145690386|NCT04853238|525381929|FG001|Overall Study|Physician Decision|0|||
145690387|NCT04853238|525381930|FG002|Overall Study|Physician Decision|2|||
145690388|NCT04853238|525381928|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
145690389|NCT04853238|525381929|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
145690390|NCT04853238|525381930|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
145690391|NCT02972242|525383825|FG000|Overall Study|Withdrawal by Subject|1|||
145690392|NCT02972242|525383826|FG001|Overall Study|Withdrawal by Subject|0|||
145690393|NCT03098797|525383827|FG000|Part 2 Open Label Extension|Adverse Event|2|||
145690394|NCT03098797|525383828|FG001|Part 2 Open Label Extension|Adverse Event|0|||
145690395|NCT00509821|525383829|FG000|Study Period 1 (Induction)|Death|0|||
145690396|NCT00509821|525383830|FG001|Study Period 1 (Induction)|Death|1|||
145690397|NCT00509821|525383829|FG000|Study Period 1 (Induction)|Adverse Event|0|||
145690398|NCT00509821|525383830|FG001|Study Period 1 (Induction)|Adverse Event|2|||
145690399|NCT00509821|525383829|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
145690400|NCT00509821|525383830|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
145690401|NCT00552513|525383833|FG000|Overall Study|Lost to Follow-up|5|||
145690402|NCT00552513|525383834|FG001|Overall Study|Lost to Follow-up|1|||
145690403|NCT01816685|525383835|FG000|Overall Study|Lost to Follow-up|7|||
145690404|NCT01816685|525383836|FG001|Overall Study|Lost to Follow-up|9|||
145690405|NCT01816685|525383835|FG000|Overall Study|Surgery Cancelled|3|||
145690406|NCT01816685|525383836|FG001|Overall Study|Surgery Cancelled|2|||
145690407|NCT02720185|525383837|FG000|Overall Study|Lost to Follow-up|1|||
145690408|NCT00371462|525383838|FG000|Overall Study|Withdrawal by Subject|1|||
145690409|NCT00371462|525383839|FG001|Overall Study|Withdrawal by Subject|0|||
145690410|NCT00371462|525383838|FG000|Overall Study|Other|7|||
145690411|NCT00371462|525383839|FG001|Overall Study|Other|8|||
145690412|NCT00349622|525383845|FG000|Overall Study|Death|168|||
145690413|NCT00349622|525383846|FG001|Overall Study|Death|86|||
145690414|NCT00349622|525383845|FG000|Overall Study|Lost to Follow-up|5|||
145690415|NCT00349622|525383846|FG001|Overall Study|Lost to Follow-up|1|||
145690416|NCT00349622|525383845|FG000|Overall Study|Withdrawal by Subject|5|||
145690417|NCT00349622|525383846|FG001|Overall Study|Withdrawal by Subject|9|||
145690418|NCT02229396|525383851|FG000|Overall Study|Adverse Event|6|||
145690419|NCT02229396|525383852|FG001|Overall Study|Adverse Event|12|||
145690420|NCT02229396|525383853|FG002|Overall Study|Adverse Event|12|||
145690421|NCT02229396|525383851|FG000|Overall Study|Death|2|||
145690422|NCT02229396|525383852|FG001|Overall Study|Death|3|||
145690423|NCT02229396|525383853|FG002|Overall Study|Death|1|||
145690424|NCT02229396|525383851|FG000|Overall Study|Lost to Follow-up|14|||
145690425|NCT02229396|525383852|FG001|Overall Study|Lost to Follow-up|14|||
145690426|NCT02229396|525383853|FG002|Overall Study|Lost to Follow-up|21|||
145690427|NCT02229396|525383851|FG000|Overall Study|Protocol Violation|2|||
145690428|NCT02229396|525383852|FG001|Overall Study|Protocol Violation|1|||
145690429|NCT02229396|525383853|FG002|Overall Study|Protocol Violation|0|||
145690430|NCT02229396|525383851|FG000|Overall Study|Patient Incorrectly Randomized|0|||
145690431|NCT02229396|525383852|FG001|Overall Study|Patient Incorrectly Randomized|0|||
145690432|NCT02229396|525383853|FG002|Overall Study|Patient Incorrectly Randomized|1|||
145690433|NCT02229396|525383851|FG000|Overall Study|Other|10|||
145690434|NCT02229396|525383852|FG001|Overall Study|Other|18|||
145690435|NCT02229396|525383853|FG002|Overall Study|Other|15|||
145690436|NCT02229396|525383851|FG000|Overall Study|Withdrawal by Subject|42|||
145690437|NCT02229396|525383852|FG001|Overall Study|Withdrawal by Subject|28|||
145690438|NCT02229396|525383853|FG002|Overall Study|Withdrawal by Subject|41|||
145690439|NCT02229396|525383851|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
145690440|NCT02229396|525383852|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
145690441|NCT02229396|525383853|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
145690442|NCT02229396|525383851|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
145690443|NCT02229396|525383852|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
145690444|NCT02229396|525383853|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
145690445|NCT01243411|525383854|FG000|Overall Study|Withdrawal by Subject|18|||
145690446|NCT01243411|525383854|FG000|Overall Study|Lost to Follow-up|10|||
145690447|NCT01243411|525383854|FG000|Overall Study|Adverse Event|5|||
145690448|NCT01243411|525383854|FG000|Overall Study|Other|8|||
145690449|NCT00805285|525383857|FG000|Overall Study|Lack of Efficacy|1|||
145690450|NCT00839306|525383858|FG000|Overall Study|Adverse Event|3|||
145690451|NCT00839306|525383859|FG001|Overall Study|Adverse Event|5|||
145690452|NCT00839306|525383858|FG000|Overall Study|Lost to Follow-up|6|||
145690453|NCT00839306|525383859|FG001|Overall Study|Lost to Follow-up|9|||
145690454|NCT00839306|525383858|FG000|Overall Study|Withdrawal by Subject|5|||
145690455|NCT00839306|525383859|FG001|Overall Study|Withdrawal by Subject|7|||
145690456|NCT00839306|525383858|FG000|Overall Study|Lack of Efficacy|5|||
145690457|NCT00839306|525383859|FG001|Overall Study|Lack of Efficacy|4|||
145690458|NCT00839306|525383858|FG000|Overall Study|Other|6|||
145690459|NCT00839306|525383859|FG001|Overall Study|Other|18|||
145690460|NCT01812707|525383860|FG000|Overall Study|Adverse Event|0|||
145690461|NCT01812707|525383861|FG001|Overall Study|Adverse Event|0|||
145690462|NCT01812707|525383862|FG002|Overall Study|Adverse Event|0|||
145690463|NCT01812707|525383863|FG003|Overall Study|Adverse Event|2|||
145491369|NCT02210000|524653775|FG001|Overall Study|Lost to Follow-up|2|||
145690464|NCT01812707|525383860|FG000|Overall Study|Poor compliance to protocol|1|||
145690465|NCT01812707|525383861|FG001|Overall Study|Poor compliance to protocol|0|||
145690466|NCT01812707|525383862|FG002|Overall Study|Poor compliance to protocol|0|||
145690467|NCT01812707|525383863|FG003|Overall Study|Poor compliance to protocol|0|||
145690468|NCT01812707|525383860|FG000|Overall Study|Consent withdrawn by participant|1|||
145690469|NCT01812707|525383861|FG001|Overall Study|Consent withdrawn by participant|0|||
145690470|NCT01812707|525383862|FG002|Overall Study|Consent withdrawn by participant|0|||
145690471|NCT01812707|525383863|FG003|Overall Study|Consent withdrawn by participant|0|||
145690472|NCT01066897|525383864|FG000|Overall Study|Withdrawal by Subject|1|||
145690473|NCT01066897|525383865|FG001|Overall Study|Withdrawal by Subject|0|||
145690474|NCT01066897|525383864|FG000|Overall Study|stopped study after developing the flu.|1|||
145690475|NCT01066897|525383865|FG001|Overall Study|stopped study after developing the flu.|0|||
145690476|NCT02396758|525383868|FG000|Overall Study|Withdrawal by Subject|2|||
145690477|NCT02396758|525383869|FG001|Overall Study|Withdrawal by Subject|0|||
145690478|NCT02396758|525383870|FG002|Overall Study|Withdrawal by Subject|0|||
145690479|NCT02396758|525383871|FG003|Overall Study|Withdrawal by Subject|1|||
145690480|NCT02396758|525383868|FG000|Overall Study|Lost to Follow-up|8|||
145690481|NCT02396758|525383869|FG001|Overall Study|Lost to Follow-up|5|||
145690482|NCT02396758|525383870|FG002|Overall Study|Lost to Follow-up|3|||
145690483|NCT02396758|525383871|FG003|Overall Study|Lost to Follow-up|3|||
145690484|NCT02396758|525383868|FG000|Overall Study|Death|1|||
145690485|NCT02396758|525383869|FG001|Overall Study|Death|1|||
145690486|NCT02396758|525383870|FG002|Overall Study|Death|0|||
145690487|NCT02396758|525383871|FG003|Overall Study|Death|1|||
145690488|NCT02396758|525383868|FG000|Overall Study|Randomized but not treated|1|||
145690489|NCT02396758|525383869|FG001|Overall Study|Randomized but not treated|0|||
145690490|NCT02396758|525383870|FG002|Overall Study|Randomized but not treated|1|||
145690491|NCT02396758|525383871|FG003|Overall Study|Randomized but not treated|0|||
145690492|NCT03022045|525383872|FG000|Overall Study|Adverse Event|0|||
145690493|NCT03022045|525383873|FG001|Overall Study|Adverse Event|1|||
145690494|NCT03022045|525383872|FG000|Overall Study|Withdrawal by Subject|1|||
145690495|NCT03022045|525383873|FG001|Overall Study|Withdrawal by Subject|1|||
145690496|NCT01126879|525383874|FG000|Overall Study|Progressive Disease|3|||
145690497|NCT01126879|525383875|FG001|Overall Study|Progressive Disease|1|||
145690498|NCT01126879|525383874|FG000|Overall Study|Withdrawal by Subject|1|||
145690499|NCT01126879|525383875|FG001|Overall Study|Withdrawal by Subject|0|||
145690500|NCT01126879|525383874|FG000|Overall Study|Adverse Event|0|||
145690501|NCT01126879|525383875|FG001|Overall Study|Adverse Event|1|||
145690502|NCT01126879|525383874|FG000|Overall Study|Physician Decision|1|||
145690503|NCT01126879|525383875|FG001|Overall Study|Physician Decision|0|||
145690504|NCT00666835|525383876|FG000|Overall Study|Withdrawal by Subject|5|||
145690505|NCT00666835|525383877|FG001|Overall Study|Withdrawal by Subject|2|||
145690506|NCT00666835|525383876|FG000|Overall Study|Lack of Efficacy|0|||
145690507|NCT00666835|525383877|FG001|Overall Study|Lack of Efficacy|1|||
145690508|NCT00666835|525383876|FG000|Overall Study|Incl./excl. not fulfilled|7|||
145690509|NCT00666835|525383877|FG001|Overall Study|Incl./excl. not fulfilled|2|||
145690510|NCT00666835|525383876|FG000|Overall Study|Adverse Event|7|||
145690511|NCT00666835|525383877|FG001|Overall Study|Adverse Event|6|||
145690512|NCT00666835|525383876|FG000|Overall Study|Protocol Violation|2|||
145690513|NCT00666835|525383877|FG001|Overall Study|Protocol Violation|0|||
145690514|NCT00666835|525383876|FG000|Overall Study|Death|15|||
145690515|NCT00666835|525383877|FG001|Overall Study|Death|4|||
145690516|NCT00666835|525383876|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
145690517|NCT00666835|525383877|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
145690518|NCT00666835|525383876|FG000|Overall Study|Hemoglobulin concentration|4|||
145690519|NCT00666835|525383877|FG001|Overall Study|Hemoglobulin concentration|3|||
145690520|NCT00666835|525383876|FG000|Overall Study|Planned operation|2|||
145690521|NCT00666835|525383877|FG001|Overall Study|Planned operation|0|||
145690522|NCT00666835|525383876|FG000|Overall Study|Physician Decision|1|||
145690523|NCT00666835|525383877|FG001|Overall Study|Physician Decision|2|||
145690524|NCT00899379|525383878|FG000|Overall Study|Adverse Event|2|||
145690525|NCT00899379|525383879|FG001|Overall Study|Adverse Event|2|||
145690526|NCT00899379|525383880|FG002|Overall Study|Adverse Event|1|||
145690527|NCT00899379|525383881|FG003|Overall Study|Adverse Event|1|||
145690528|NCT00899379|525383882|FG004|Overall Study|Adverse Event|2|||
145690529|NCT00899379|525383878|FG000|Overall Study|Lack of Efficacy|0|||
145690530|NCT00899379|525383879|FG001|Overall Study|Lack of Efficacy|4|||
145690531|NCT00899379|525383880|FG002|Overall Study|Lack of Efficacy|3|||
145690532|NCT00899379|525383881|FG003|Overall Study|Lack of Efficacy|0|||
145690533|NCT00899379|525383882|FG004|Overall Study|Lack of Efficacy|1|||
145690534|NCT00899379|525383878|FG000|Overall Study|Lost to Follow-up|9|||
145690535|NCT00899379|525383879|FG001|Overall Study|Lost to Follow-up|3|||
145690536|NCT00899379|525383880|FG002|Overall Study|Lost to Follow-up|0|||
145690537|NCT00899379|525383881|FG003|Overall Study|Lost to Follow-up|6|||
145690538|NCT00899379|525383882|FG004|Overall Study|Lost to Follow-up|2|||
145690539|NCT00899379|525383878|FG000|Overall Study|Protocol Violation|0|||
145690540|NCT00899379|525383879|FG001|Overall Study|Protocol Violation|0|||
145690541|NCT00899379|525383880|FG002|Overall Study|Protocol Violation|1|||
145690542|NCT00899379|525383881|FG003|Overall Study|Protocol Violation|1|||
145690543|NCT00899379|525383882|FG004|Overall Study|Protocol Violation|0|||
145690544|NCT00899379|525383878|FG000|Overall Study|Withdrawal by Subject|2|||
145690545|NCT00899379|525383879|FG001|Overall Study|Withdrawal by Subject|4|||
145690546|NCT00899379|525383880|FG002|Overall Study|Withdrawal by Subject|2|||
145690547|NCT00899379|525383881|FG003|Overall Study|Withdrawal by Subject|3|||
145690548|NCT00899379|525383882|FG004|Overall Study|Withdrawal by Subject|6|||
145690549|NCT00899379|525383878|FG000|Overall Study|Pregnancy|0|||
145690550|NCT00899379|525383879|FG001|Overall Study|Pregnancy|0|||
145690551|NCT00899379|525383880|FG002|Overall Study|Pregnancy|1|||
145690552|NCT00899379|525383881|FG003|Overall Study|Pregnancy|0|||
145690553|NCT00899379|525383882|FG004|Overall Study|Pregnancy|1|||
145690554|NCT00899379|525383878|FG000|Overall Study|Patient Uncooperative|0|||
145690555|NCT00899379|525383879|FG001|Overall Study|Patient Uncooperative|1|||
145690556|NCT00899379|525383880|FG002|Overall Study|Patient Uncooperative|0|||
145690557|NCT00899379|525383881|FG003|Overall Study|Patient Uncooperative|1|||
145690558|NCT00899379|525383882|FG004|Overall Study|Patient Uncooperative|2|||
145690559|NCT00899379|525383878|FG000|Overall Study|Abnormal Baseline ECG|0|||
145690560|NCT00899379|525383879|FG001|Overall Study|Abnormal Baseline ECG|0|||
145690561|NCT00899379|525383880|FG002|Overall Study|Abnormal Baseline ECG|0|||
145690562|NCT00899379|525383881|FG003|Overall Study|Abnormal Baseline ECG|1|||
145690563|NCT00899379|525383882|FG004|Overall Study|Abnormal Baseline ECG|0|||
145690564|NCT00899379|525383878|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
145690565|NCT00899379|525383879|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
145690566|NCT00899379|525383880|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
145690567|NCT00899379|525383881|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690568|NCT00899379|525383882|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690569|NCT00899379|525383878|FG000|Overall Study|Not Completed/Entered Extn|5|||
145690570|NCT00899379|525383879|FG001|Overall Study|Not Completed/Entered Extn|1|||
145690571|NCT00899379|525383880|FG002|Overall Study|Not Completed/Entered Extn|6|||
145690572|NCT00899379|525383881|FG003|Overall Study|Not Completed/Entered Extn|4|||
145690573|NCT00899379|525383882|FG004|Overall Study|Not Completed/Entered Extn|3|||
145690574|NCT00899379|525383878|FG000|Overall Study|Study Terminated|3|||
145690575|NCT00899379|525383879|FG001|Overall Study|Study Terminated|0|||
145690576|NCT00899379|525383880|FG002|Overall Study|Study Terminated|3|||
145690577|NCT00899379|525383881|FG003|Overall Study|Study Terminated|3|||
145690578|NCT00899379|525383882|FG004|Overall Study|Study Terminated|1|||
145690579|NCT00899379|525383878|FG000|Overall Study|Lost to Follow-up|3|||
145690580|NCT00899379|525383879|FG001|Overall Study|Lost to Follow-up|1|||
145690581|NCT00899379|525383880|FG002|Overall Study|Lost to Follow-up|0|||
145690582|NCT00899379|525383881|FG003|Overall Study|Lost to Follow-up|2|||
145690583|NCT00899379|525383882|FG004|Overall Study|Lost to Follow-up|5|||
145690584|NCT00899379|525383878|FG000|Overall Study|Withdrawal by Subject|4|||
145690585|NCT00899379|525383879|FG001|Overall Study|Withdrawal by Subject|7|||
145690586|NCT00899379|525383880|FG002|Overall Study|Withdrawal by Subject|4|||
145690587|NCT00899379|525383881|FG003|Overall Study|Withdrawal by Subject|7|||
145690588|NCT00899379|525383882|FG004|Overall Study|Withdrawal by Subject|2|||
145690589|NCT00899379|525383878|FG000|Overall Study|Pregnancy|1|||
145690590|NCT00899379|525383879|FG001|Overall Study|Pregnancy|0|||
145690591|NCT00899379|525383880|FG002|Overall Study|Pregnancy|0|||
145690592|NCT00899379|525383881|FG003|Overall Study|Pregnancy|0|||
145690593|NCT00899379|525383882|FG004|Overall Study|Pregnancy|0|||
145690594|NCT00899379|525383878|FG000|Overall Study|Patient Uncooperative|0|||
145690595|NCT00899379|525383879|FG001|Overall Study|Patient Uncooperative|0|||
145690596|NCT00899379|525383880|FG002|Overall Study|Patient Uncooperative|0|||
145690597|NCT00899379|525383881|FG003|Overall Study|Patient Uncooperative|1|||
145690598|NCT00899379|525383882|FG004|Overall Study|Patient Uncooperative|0|||
145690599|NCT00899379|525383878|FG000|Overall Study|Abnormal Prestudy Labs|0|||
145690600|NCT00899379|525383879|FG001|Overall Study|Abnormal Prestudy Labs|0|||
145690601|NCT00899379|525383880|FG002|Overall Study|Abnormal Prestudy Labs|0|||
145690602|NCT00899379|525383881|FG003|Overall Study|Abnormal Prestudy Labs|0|||
145690603|NCT00899379|525383882|FG004|Overall Study|Abnormal Prestudy Labs|2|||
145690604|NCT00899379|525383878|FG000|Overall Study|Abnormal Baseline ECG|0|||
145690605|NCT00899379|525383879|FG001|Overall Study|Abnormal Baseline ECG|0|||
145690606|NCT00899379|525383880|FG002|Overall Study|Abnormal Baseline ECG|1|||
145690607|NCT00899379|525383881|FG003|Overall Study|Abnormal Baseline ECG|1|||
145690608|NCT00899379|525383882|FG004|Overall Study|Abnormal Baseline ECG|0|||
145690609|NCT00899379|525383878|FG000|Overall Study|No Attack Pretreatment|3|||
145690610|NCT00899379|525383879|FG001|Overall Study|No Attack Pretreatment|5|||
145690611|NCT00899379|525383880|FG002|Overall Study|No Attack Pretreatment|5|||
145491370|NCT02210000|524653774|FG000|Overall Study|Physician Decision|0|||
145690612|NCT00899379|525383881|FG003|Overall Study|No Attack Pretreatment|6|||
145690613|NCT00899379|525383882|FG004|Overall Study|No Attack Pretreatment|4|||
145690614|NCT00899379|525383878|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
145690615|NCT00899379|525383879|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690616|NCT00899379|525383880|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690617|NCT00899379|525383881|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690618|NCT00899379|525383882|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
145690619|NCT00899379|525383878|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
145690620|NCT00899379|525383879|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
145491371|NCT02210000|524653775|FG001|Overall Study|Physician Decision|1|||
145690621|NCT00899379|525383880|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
145690622|NCT00899379|525383881|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
145690623|NCT00899379|525383882|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
145690624|NCT00498433|525383887|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
145690625|NCT00498433|525383888|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
145690626|NCT00498433|525383889|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
145690627|NCT00498433|525383887|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
145690628|NCT00498433|525383888|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
145690629|NCT00498433|525383889|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
145690630|NCT00498433|525383887|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
145690631|NCT00498433|525383888|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
145690632|NCT00498433|525383889|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
145690633|NCT00498433|525383887|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
145690634|NCT00498433|525383888|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
145690635|NCT00498433|525383889|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
145690636|NCT02581189|525383890|FG000|Overall Study|Failure to return|36|||
145690637|NCT02581189|525383890|FG000|Overall Study|Withdrew consent|5|||
145690638|NCT02581189|525383890|FG000|Overall Study|Death|3|||
145690639|NCT02581189|525383890|FG000|Overall Study|Insufficient virological response|2|||
145690640|NCT02581189|525383890|FG000|Overall Study|Other, not specified|7|||
145690641|NCT02253147|525383891|FG000|Overall Study|Protocol Violation|30|||
145690642|NCT02253147|525383891|FG000|Overall Study|Did not consent to study extension|9|||
145690643|NCT02253147|525383891|FG000|Overall Study|Conditional re-treatment at W52|5|||
145690644|NCT02253147|525383891|FG000|Overall Study|Lost to Follow-up|2|||
145690645|NCT02253147|525383891|FG000|Overall Study|Withdrawal by Subject|1|||
145690646|NCT02973477|525383892|FG000|First Intervention|Lost to Follow-up|0|||
145690647|NCT02973477|525383893|FG001|First Intervention|Lost to Follow-up|2|||
145690648|NCT02973477|525383892|FG000|Washout|Withdrawal by Subject|1|||
145690649|NCT02973477|525383893|FG001|Washout|Withdrawal by Subject|0|||
145690650|NCT02973477|525383892|FG000|Second Intervention|Lost to Follow-up|1|||
145690651|NCT02973477|525383893|FG001|Second Intervention|Lost to Follow-up|0|||
145690652|NCT02381652|525383902|FG000|Overall Study|Withdrawal by Subject|0|||
145690653|NCT02381652|525383903|FG001|Overall Study|Withdrawal by Subject|0|||
145690654|NCT02381652|525383904|FG002|Overall Study|Withdrawal by Subject|1|||
145690655|NCT03746483|525383905|FG000|Overall Study|Adverse Event|0|||
145690656|NCT03746483|525383906|FG001|Overall Study|Adverse Event|1|||
145690657|NCT03746483|525383905|FG000|Overall Study|Lack of Efficacy|3|||
145690658|NCT03746483|525383906|FG001|Overall Study|Lack of Efficacy|2|||
145690659|NCT03746483|525383905|FG000|Overall Study|Lost to Follow-up|1|||
145690660|NCT03746483|525383906|FG001|Overall Study|Lost to Follow-up|0|||
145690661|NCT03746483|525383905|FG000|Overall Study|Protocol Violation|2|||
145690662|NCT03746483|525383906|FG001|Overall Study|Protocol Violation|0|||
145690663|NCT01954771|525383907|FG000|Overall Study|Missing HbA1c of end-point|1|||
145690664|NCT01954771|525383908|FG001|Overall Study|Missing HbA1c of end-point|1|||
145690665|NCT01954771|525383909|FG002|Overall Study|Missing HbA1c of end-point|0|||
145690666|NCT01954771|525383907|FG000|Overall Study|Missing CGMS of end-point|1|||
145690667|NCT01954771|525383908|FG001|Overall Study|Missing CGMS of end-point|1|||
145690668|NCT01954771|525383909|FG002|Overall Study|Missing CGMS of end-point|0|||
145690669|NCT01954771|525383907|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
145690670|NCT01954771|525383908|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
145690671|NCT01954771|525383909|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
145690672|NCT01675050|525383913|FG000|Period One Treatment|Withdrawal by Subject|1|||
145690673|NCT01675050|525383914|FG001|Period One Treatment|Withdrawal by Subject|0|||
145690674|NCT02382406|525383915|FG000|Study Treatment|Disease Progression|8|||
145690675|NCT02382406|525383916|FG001|Study Treatment|Disease Progression|0|||
145491372|NCT01421017|524653776|FG000|Overall Study|Withdrawal by Subject|2|||
145491373|NCT01421017|524653777|FG001|Overall Study|Withdrawal by Subject|0|||
145491374|NCT01421017|524653778|FG002|Overall Study|Withdrawal by Subject|0|||
145491375|NCT01421017|524653776|FG000|Overall Study|POD|0|||
145491376|NCT01421017|524653777|FG001|Overall Study|POD|6|||
145491377|NCT01421017|524653778|FG002|Overall Study|POD|3|||
145491378|NCT02356159|524653779|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
145491379|NCT02356159|524653780|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
145491380|NCT02356159|524653781|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
145491381|NCT02356159|524653782|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
145491382|NCT02356159|524653783|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
145491383|NCT02356159|524653784|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
145491384|NCT00861705|524653785|FG000|Overall Study|Never Began Treatment|7|||
145491385|NCT00861705|524653786|FG001|Overall Study|Never Began Treatment|3|||
145491386|NCT00861705|524653787|FG002|Overall Study|Never Began Treatment|0|||
145491387|NCT00861705|524653788|FG003|Overall Study|Never Began Treatment|1|||
145491388|NCT00472108|524653790|FG000|Overall Study|Lost to Follow-up|0|||
145491389|NCT00472108|524653791|FG001|Overall Study|Lost to Follow-up|1|||
145491390|NCT04551989|524653792|FG000|Overall Study|Adverse Event|4|||
145491391|NCT04551989|524653792|FG000|Overall Study|Protocol Violation|3|||
145690676|NCT02382406|525383917|FG002|Study Treatment|Disease Progression|20|||
145690677|NCT02382406|525383915|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
145690678|NCT02382406|525383916|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
145690679|NCT02382406|525383917|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
145690680|NCT02382406|525383915|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
145690681|NCT02382406|525383916|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
145690682|NCT02382406|525383917|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
145690683|NCT02382406|525383915|FG000|Study Treatment|symptomatic deterioration|1|||
145690684|NCT02382406|525383916|FG001|Study Treatment|symptomatic deterioration|0|||
145690685|NCT02382406|525383917|FG002|Study Treatment|symptomatic deterioration|1|||
145690686|NCT02382406|525383915|FG000|Study Treatment|Death|0|||
145690687|NCT02382406|525383916|FG001|Study Treatment|Death|0|||
145690688|NCT02382406|525383917|FG002|Study Treatment|Death|2|||
145690689|NCT02382406|525383915|FG000|Follow up|Death|11|||
145690690|NCT02382406|525383916|FG001|Follow up|Death|0|||
145690691|NCT02382406|525383917|FG002|Follow up|Death|19|||
145690692|NCT02382406|525383915|FG000|Follow up|Symptomatic deterioration|1|||
145690693|NCT02382406|525383916|FG001|Follow up|Symptomatic deterioration|0|||
145690694|NCT02382406|525383917|FG002|Follow up|Symptomatic deterioration|1|||
145690695|NCT02382406|525383915|FG000|Follow up|Patient Refused Follow-up|1|||
145690696|NCT02382406|525383916|FG001|Follow up|Patient Refused Follow-up|0|||
145690697|NCT02382406|525383917|FG002|Follow up|Patient Refused Follow-up|0|||
145690698|NCT02382406|525383915|FG000|Follow up|Study Terminated|1|||
145690699|NCT02382406|525383916|FG001|Follow up|Study Terminated|0|||
145690700|NCT02382406|525383917|FG002|Follow up|Study Terminated|8|||
145690701|NCT02382406|525383915|FG000|Follow up|Withdrawal by Subject|0|||
145690702|NCT02382406|525383916|FG001|Follow up|Withdrawal by Subject|0|||
145690703|NCT02382406|525383917|FG002|Follow up|Withdrawal by Subject|2|||
145690704|NCT04543942|525383918|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
145690705|NCT04543942|525383919|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
145690706|NCT04543942|525383918|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
145690707|NCT04543942|525383919|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
145690708|NCT02506881|525383925|FG000|First Intervention (Day 1)|Protocol Violation|0|||
145690709|NCT02506881|525383926|FG001|First Intervention (Day 1)|Protocol Violation|0|||
145690710|NCT02506881|525383927|FG002|First Intervention (Day 1)|Protocol Violation|1|||
145690711|NCT02506881|525383928|FG003|First Intervention (Day 1)|Protocol Violation|0|||
145690712|NCT02506881|525383925|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
145690713|NCT02506881|525383926|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
145690714|NCT02506881|525383927|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145690715|NCT02506881|525383928|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
145690716|NCT02506881|525383925|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
145690717|NCT02506881|525383926|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
145690718|NCT02506881|525383927|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
145690719|NCT02506881|525383928|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
145690720|NCT02391545|525383929|FG000|Overall Study|Death|0|||
145690721|NCT02391545|525383930|FG001|Overall Study|Death|2|||
145690722|NCT02391545|525383929|FG000|Overall Study|Lost to Follow-up|0|||
145690723|NCT02391545|525383930|FG001|Overall Study|Lost to Follow-up|1|||
145690724|NCT02391545|525383929|FG000|Overall Study|Termination of study by sponsor|20|||
145690725|NCT02391545|525383930|FG001|Overall Study|Termination of study by sponsor|20|||
145690726|NCT02391545|525383929|FG000|Overall Study|Withdrawal by Subject|0|||
145690727|NCT02391545|525383930|FG001|Overall Study|Withdrawal by Subject|1|||
145690728|NCT02391545|525383929|FG000|Overall Study|Other Reasons|6|||
145690729|NCT02391545|525383930|FG001|Overall Study|Other Reasons|4|||
145690730|NCT02016690|525383931|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
145690731|NCT02016690|525383931|FG000|Overall Study|Excluded from SAS: Duplication|2|||
145690732|NCT02016690|525383931|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
145690733|NCT02016690|525383931|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
145690734|NCT02016690|525383931|FG000|Overall Study|Did not meet inclusion criteria|13|||
145690735|NCT02016690|525383931|FG000|Overall Study|Hospitalized for RSV at study start|3|||
145690736|NCT01363297|525383932|FG000|Overall Study|Other|0|||
145690737|NCT01363297|525383933|FG001|Overall Study|Other|0|||
145690738|NCT01363297|525383934|FG002|Overall Study|Other|0|||
145690739|NCT01363297|525383935|FG003|Overall Study|Other|0|||
145690740|NCT01363297|525383936|FG004|Overall Study|Other|1|||
145690741|NCT01363297|525383932|FG000|Overall Study|Death|3|||
145690742|NCT01363297|525383933|FG001|Overall Study|Death|6|||
145690743|NCT01363297|525383934|FG002|Overall Study|Death|6|||
145690744|NCT01363297|525383935|FG003|Overall Study|Death|10|||
145690745|NCT01363297|525383936|FG004|Overall Study|Death|30|||
145690746|NCT00495612|525383937|FG000|Overall Study|Lost to Follow-up|1|||
145690747|NCT00495612|525383938|FG001|Overall Study|Lost to Follow-up|0|||
145690748|NCT00495612|525383937|FG000|Overall Study|Subject's Decision to Withdraw|3|||
145690749|NCT00495612|525383938|FG001|Overall Study|Subject's Decision to Withdraw|0|||
145690750|NCT00818519|525383943|FG000|Overall Study|Adverse Event|2|||
145690751|NCT00818519|525383944|FG001|Overall Study|Adverse Event|2|||
145690752|NCT00818519|525383943|FG000|Overall Study|Lost to Follow-up|4|||
145690753|NCT00818519|525383944|FG001|Overall Study|Lost to Follow-up|6|||
145690754|NCT00818519|525383943|FG000|Overall Study|Protocol Violation|2|||
145690755|NCT00818519|525383944|FG001|Overall Study|Protocol Violation|1|||
145690756|NCT00818519|525383943|FG000|Overall Study|Pregnancy|0|||
145690757|NCT00818519|525383944|FG001|Overall Study|Pregnancy|1|||
145690758|NCT00818519|525383943|FG000|Overall Study|Withdrawal by Subject|4|||
145690759|NCT00818519|525383944|FG001|Overall Study|Withdrawal by Subject|9|||
145690760|NCT00818519|525383943|FG000|Overall Study|participant recovered completely|1|||
145690761|NCT00818519|525383944|FG001|Overall Study|participant recovered completely|0|||
145690762|NCT00818519|525383943|FG000|Overall Study|participant will leave for long tme|1|||
145690763|NCT00818519|525383944|FG001|Overall Study|participant will leave for long tme|0|||
145690764|NCT00655668|525383954|FG000|Overall Study|Adverse Event|6|||
145690765|NCT00655668|525383954|FG000|Overall Study|Death|5|||
145690766|NCT00655668|525383954|FG000|Overall Study|Disease Progression|27|||
145690767|NCT00655668|525383954|FG000|Overall Study|Study Terminated|9|||
145690768|NCT00655668|525383954|FG000|Overall Study|Other|1|||
145690769|NCT00655668|525383954|FG000|Overall Study|New Lymphoma Treatment Started|4|||
145690770|NCT00655668|525383954|FG000|Overall Study|Withdrawal by Subject|2|||
145690771|NCT03873038|525383955|FG000|Part 2|Withdrawal by Subject|0|||
145690772|NCT03873038|525383956|FG001|Part 2|Withdrawal by Subject|0|||
145690773|NCT03873038|525383957|FG002|Part 2|Withdrawal by Subject|0|||
145690774|NCT03873038|525383958|FG003|Part 2|Withdrawal by Subject|0|||
145690775|NCT03873038|525383959|FG004|Part 2|Withdrawal by Subject|0|||
145690776|NCT03873038|525383960|FG005|Part 2|Withdrawal by Subject|1|||
145690777|NCT03873038|525383955|FG000|Part 2|Unknon|0|||
145690778|NCT03873038|525383956|FG001|Part 2|Unknon|0|||
145690779|NCT03873038|525383957|FG002|Part 2|Unknon|0|||
145690780|NCT03873038|525383958|FG003|Part 2|Unknon|0|||
145690781|NCT03873038|525383959|FG004|Part 2|Unknon|1|||
145690782|NCT03873038|525383960|FG005|Part 2|Unknon|0|||
145690783|NCT00464737|525383961|FG000|Overall Study|Adverse Event|12|||
145690784|NCT00464737|525383962|FG001|Overall Study|Adverse Event|17|||
145690785|NCT00464737|525383963|FG002|Overall Study|Adverse Event|33|||
145690786|NCT00464737|525383961|FG000|Overall Study|Lack of Efficacy|7|||
145690787|NCT00464737|525383962|FG001|Overall Study|Lack of Efficacy|7|||
145690788|NCT00464737|525383963|FG002|Overall Study|Lack of Efficacy|4|||
145690789|NCT00464737|525383961|FG000|Overall Study|Withdrawal by Subject|5|||
145690790|NCT00464737|525383962|FG001|Overall Study|Withdrawal by Subject|3|||
145690791|NCT00464737|525383963|FG002|Overall Study|Withdrawal by Subject|5|||
145690792|NCT00464737|525383961|FG000|Overall Study|Protocol Violation|1|||
145690793|NCT00464737|525383962|FG001|Overall Study|Protocol Violation|1|||
145690794|NCT00464737|525383963|FG002|Overall Study|Protocol Violation|5|||
145690795|NCT00464737|525383961|FG000|Overall Study|Non-compliance|0|||
145690796|NCT00464737|525383962|FG001|Overall Study|Non-compliance|1|||
145690797|NCT00464737|525383963|FG002|Overall Study|Non-compliance|1|||
145690798|NCT00464737|525383961|FG000|Overall Study|Lost to Follow-up|5|||
145690799|NCT00464737|525383962|FG001|Overall Study|Lost to Follow-up|2|||
145690800|NCT00464737|525383963|FG002|Overall Study|Lost to Follow-up|5|||
145690801|NCT00464737|525383961|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
145690802|NCT00464737|525383962|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
145690803|NCT00464737|525383963|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
145690804|NCT00464737|525383961|FG000|Overall Study|Other: Subject left town; family illness|1|||
145690805|NCT00464737|525383962|FG001|Overall Study|Other: Subject left town; family illness|0|||
145690806|NCT00464737|525383963|FG002|Overall Study|Other: Subject left town; family illness|0|||
145690807|NCT00464737|525383961|FG000|Overall Study|Other: Study demands too great|0|||
145690808|NCT00464737|525383962|FG001|Overall Study|Other: Study demands too great|1|||
145690809|NCT00464737|525383963|FG002|Overall Study|Other: Study demands too great|0|||
145690810|NCT00464737|525383961|FG000|Overall Study|Other: Personal family reasons|0|||
145690811|NCT00464737|525383962|FG001|Overall Study|Other: Personal family reasons|0|||
145690812|NCT00464737|525383963|FG002|Overall Study|Other: Personal family reasons|1|||
145690813|NCT00464737|525383961|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
145690814|NCT00464737|525383962|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
145690815|NCT00464737|525383963|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
145690816|NCT00141271|525383966|FG000|Overall Study|Adverse Event|31|||
145690817|NCT00141271|525383967|FG001|Overall Study|Adverse Event|19|||
145690818|NCT00141271|525383968|FG002|Overall Study|Adverse Event|17|||
145690819|NCT00141271|525383966|FG000|Overall Study|Laboratory Abnormality|2|||
145491392|NCT04551989|524653792|FG000|Overall Study|Lost to Follow-up|1|||
145690820|NCT00141271|525383967|FG001|Overall Study|Laboratory Abnormality|1|||
145690821|NCT00141271|525383968|FG002|Overall Study|Laboratory Abnormality|1|||
145690822|NCT00141271|525383966|FG000|Overall Study|Lack of Efficacy|7|||
145690823|NCT00141271|525383967|FG001|Overall Study|Lack of Efficacy|7|||
145690824|NCT00141271|525383968|FG002|Overall Study|Lack of Efficacy|3|||
145690825|NCT00141271|525383966|FG000|Overall Study|Lost to Follow-up|15|||
145690826|NCT00141271|525383967|FG001|Overall Study|Lost to Follow-up|15|||
145690827|NCT00141271|525383968|FG002|Overall Study|Lost to Follow-up|21|||
145690828|NCT00141271|525383966|FG000|Overall Study|Withdrawal by Subject|14|||
145690829|NCT00141271|525383967|FG001|Overall Study|Withdrawal by Subject|9|||
145690830|NCT00141271|525383968|FG002|Overall Study|Withdrawal by Subject|10|||
145690831|NCT00141271|525383966|FG000|Overall Study|Other|11|||
145690832|NCT00141271|525383967|FG001|Overall Study|Other|12|||
145690833|NCT00141271|525383968|FG002|Overall Study|Other|5|||
145491393|NCT04551989|524653792|FG000|Overall Study|Physician Decision|3|||
145690834|NCT02133131|525383969|FG000|Overall Study|Adverse Event|0|||
145690835|NCT02133131|525383970|FG001|Overall Study|Adverse Event|0|||
145690836|NCT02133131|525383971|FG002|Overall Study|Adverse Event|0|||
145690837|NCT02133131|525383972|FG003|Overall Study|Adverse Event|1|||
145690838|NCT02133131|525383973|FG004|Overall Study|Adverse Event|0|||
145690839|NCT02133131|525383974|FG005|Overall Study|Adverse Event|0|||
145690840|NCT02133131|525383975|FG006|Overall Study|Adverse Event|0|||
145690841|NCT02133131|525383969|FG000|Overall Study|Lost to Follow-up|1|||
145690842|NCT02133131|525383970|FG001|Overall Study|Lost to Follow-up|0|||
145690843|NCT02133131|525383971|FG002|Overall Study|Lost to Follow-up|0|||
145690844|NCT02133131|525383972|FG003|Overall Study|Lost to Follow-up|1|||
145690845|NCT02133131|525383973|FG004|Overall Study|Lost to Follow-up|0|||
145690846|NCT02133131|525383974|FG005|Overall Study|Lost to Follow-up|0|||
145690847|NCT02133131|525383975|FG006|Overall Study|Lost to Follow-up|0|||
145690848|NCT02133131|525383969|FG000|Overall Study|Status not recorded|4|||
145690849|NCT02133131|525383970|FG001|Overall Study|Status not recorded|5|||
145690850|NCT02133131|525383971|FG002|Overall Study|Status not recorded|1|||
145690851|NCT02133131|525383972|FG003|Overall Study|Status not recorded|4|||
145690852|NCT02133131|525383973|FG004|Overall Study|Status not recorded|0|||
145690853|NCT02133131|525383974|FG005|Overall Study|Status not recorded|0|||
145690854|NCT02133131|525383975|FG006|Overall Study|Status not recorded|0|||
145690855|NCT02133131|525383969|FG000|Overall Study|Ongoing in study|0|||
145690856|NCT02133131|525383970|FG001|Overall Study|Ongoing in study|0|||
145690857|NCT02133131|525383971|FG002|Overall Study|Ongoing in study|0|||
145690858|NCT02133131|525383972|FG003|Overall Study|Ongoing in study|0|||
145690859|NCT02133131|525383973|FG004|Overall Study|Ongoing in study|15|||
145690860|NCT02133131|525383974|FG005|Overall Study|Ongoing in study|14|||
145690861|NCT02133131|525383975|FG006|Overall Study|Ongoing in study|11|||
145690862|NCT02133131|525383969|FG000|Overall Study|Protocol Violation|0|||
145690863|NCT02133131|525383970|FG001|Overall Study|Protocol Violation|0|||
145690864|NCT02133131|525383971|FG002|Overall Study|Protocol Violation|0|||
145690865|NCT02133131|525383972|FG003|Overall Study|Protocol Violation|0|||
145690866|NCT02133131|525383973|FG004|Overall Study|Protocol Violation|0|||
145690867|NCT02133131|525383974|FG005|Overall Study|Protocol Violation|0|||
145690868|NCT02133131|525383975|FG006|Overall Study|Protocol Violation|1|||
145690869|NCT01544153|525383976|FG000|Overall Study|Under 18|0|||
145690870|NCT01544153|525383977|FG001|Overall Study|Under 18|1|||
145690871|NCT01544153|525383978|FG002|Overall Study|Under 18|0|||
145690872|NCT01544153|525383979|FG003|Overall Study|Under 18|0|||
145690873|NCT01544153|525383976|FG000|Overall Study|Non-smoker|0|||
145690874|NCT01544153|525383977|FG001|Overall Study|Non-smoker|0|||
145690875|NCT01544153|525383978|FG002|Overall Study|Non-smoker|1|||
145690876|NCT01544153|525383979|FG003|Overall Study|Non-smoker|0|||
145690877|NCT00390806|525383984|FG000|Overall Study|Lost to Follow-up|7|||
145690878|NCT00390806|525383985|FG001|Overall Study|Lost to Follow-up|6|||
145690879|NCT00390806|525383984|FG000|Overall Study|Protocol Violation|2|||
145690880|NCT00390806|525383985|FG001|Overall Study|Protocol Violation|2|||
145690881|NCT00390806|525383984|FG000|Overall Study|Withdrawal by Subject|12|||
145690882|NCT00390806|525383985|FG001|Overall Study|Withdrawal by Subject|15|||
145690883|NCT00390806|525383984|FG000|Overall Study|Investigator Decision|4|||
145690884|NCT00390806|525383985|FG001|Overall Study|Investigator Decision|6|||
145690885|NCT00390806|525383984|FG000|Overall Study|Death|1|||
145690886|NCT00390806|525383985|FG001|Overall Study|Death|0|||
145690887|NCT00390806|525383984|FG000|Overall Study|Physician Decision|0|||
145690888|NCT00390806|525383985|FG001|Overall Study|Physician Decision|1|||
145690889|NCT00390806|525383984|FG000|Overall Study|Ongoing|4|||
145690890|NCT00390806|525383985|FG001|Overall Study|Ongoing|2|||
145690891|NCT03169530|525383988|FG000|Overall Study|Study ended by NIH|15|||
145690892|NCT03169530|525383989|FG001|Overall Study|Study ended by NIH|17|||
145690893|NCT00884793|525383990|FG000|Overall Study|Withdrawal by Subject|1|||
145690894|NCT01032200|525383991|FG000|Overall Study|Death|1|||
145491394|NCT00088530|524653793|FG000|Overall Study|Progressive/Relapsed Disease|28|||
145491395|NCT00088530|524653794|FG001|Overall Study|Progressive/Relapsed Disease|39|||
145491396|NCT00088530|524653793|FG000|Overall Study|Adverse Event|15|||
145491397|NCT00088530|524653794|FG001|Overall Study|Adverse Event|9|||
145491398|NCT00088530|524653793|FG000|Overall Study|Withdrawal by Subject|2|||
145491399|NCT00088530|524653794|FG001|Overall Study|Withdrawal by Subject|5|||
145491400|NCT00088530|524653793|FG000|Overall Study|Lost to Follow-up|2|||
145491401|NCT00088530|524653794|FG001|Overall Study|Lost to Follow-up|0|||
145491402|NCT00088530|524653793|FG000|Overall Study|Physician Decision|2|||
145491403|NCT00088530|524653794|FG001|Overall Study|Physician Decision|0|||
145491404|NCT00088530|524653793|FG000|Overall Study|Sponsor decision|0|||
145690895|NCT01032200|525383992|FG001|Overall Study|Death|1|||
145690896|NCT01032200|525383991|FG000|Overall Study|Withdrawal by Subject|1|||
145690897|NCT01032200|525383992|FG001|Overall Study|Withdrawal by Subject|3|||
145690898|NCT01032200|525383991|FG000|Overall Study|Toxicity|0|||
145690899|NCT01032200|525383992|FG001|Overall Study|Toxicity|2|||
145690900|NCT01032200|525383991|FG000|Overall Study|Progression|1|||
145690901|NCT01032200|525383992|FG001|Overall Study|Progression|0|||
145690902|NCT01032200|525383991|FG000|Overall Study|Multiple|1|||
145690903|NCT01032200|525383992|FG001|Overall Study|Multiple|1|||
145690904|NCT00727259|525383996|FG000|Overall Study|Not all questionnaires completed|1055|||
145690905|NCT01021683|525383997|FG000|Overall Study|Lack of Efficacy|12|||
145690906|NCT01021683|525383997|FG000|Overall Study|Recovery of neutrophil count|51|||
145690907|NCT01021683|525383997|FG000|Overall Study|Other|8|||
145690908|NCT00663923|525383998|FG000|Overall Study|Lost to Follow-up|2|||
145690909|NCT01804140|525384000|FG000|Overall Study|No sampling or biopsy procedures done|114|||
145690910|NCT00547300|525384001|FG000|Overall Study|Study was Administratively Terminated|25|||
145690911|NCT00547300|525384002|FG001|Overall Study|Study was Administratively Terminated|24|||
145690912|NCT00547300|525384001|FG000|Overall Study|Did not Meet Entry Criteria|0|||
145690913|NCT00547300|525384002|FG001|Overall Study|Did not Meet Entry Criteria|2|||
145690914|NCT02785900|525384003|FG000|Overall Study|Study Termination by Sponsor|64|||
145690915|NCT02785900|525384004|FG001|Overall Study|Study Termination by Sponsor|81|||
145690916|NCT02785900|525384003|FG000|Overall Study|Death|46|||
145690917|NCT02785900|525384004|FG001|Overall Study|Death|32|||
145690918|NCT02785900|525384003|FG000|Overall Study|Withdrawal by Subject|4|||
145690919|NCT02785900|525384004|FG001|Overall Study|Withdrawal by Subject|8|||
145690920|NCT02785900|525384003|FG000|Overall Study|Physician Decision|3|||
145690921|NCT02785900|525384004|FG001|Overall Study|Physician Decision|2|||
145690922|NCT04130061|525384007|FG000|Overall Study|OR team forgot to request membrane|1|||
145690923|NCT04130061|525384008|FG001|Overall Study|OR team forgot to request membrane|0|||
145690924|NCT02093897|525385730|FG000|Overall Study|Physician Decision|1|||
145690925|NCT02093897|525385730|FG000|Overall Study|Planned age group closure - no's reached|17|||
145690926|NCT02093897|525385730|FG000|Overall Study|Adverse event, non-fatal|1|||
145690927|NCT00796614|525385731|FG000|Overall Study|Adverse Event|1|||
145690928|NCT00796614|525385732|FG001|Overall Study|Adverse Event|2|||
145690929|NCT00796614|525385733|FG002|Overall Study|Adverse Event|0|||
145690930|NCT00796614|525385734|FG003|Overall Study|Adverse Event|0|||
145690931|NCT00796614|525385731|FG000|Overall Study|Protocol Violation|0|||
145690932|NCT00796614|525385732|FG001|Overall Study|Protocol Violation|0|||
145690933|NCT00796614|525385733|FG002|Overall Study|Protocol Violation|2|||
145690934|NCT00796614|525385734|FG003|Overall Study|Protocol Violation|0|||
145690935|NCT00796614|525385731|FG000|Overall Study|Lost to Follow-up|2|||
145690936|NCT00796614|525385732|FG001|Overall Study|Lost to Follow-up|2|||
145690937|NCT00796614|525385733|FG002|Overall Study|Lost to Follow-up|1|||
145690938|NCT00796614|525385734|FG003|Overall Study|Lost to Follow-up|0|||
145690939|NCT00796614|525385731|FG000|Overall Study|Withdrawal by Subject|1|||
145690940|NCT00796614|525385732|FG001|Overall Study|Withdrawal by Subject|0|||
145690941|NCT00796614|525385733|FG002|Overall Study|Withdrawal by Subject|0|||
145690942|NCT00796614|525385734|FG003|Overall Study|Withdrawal by Subject|1|||
145690943|NCT00796614|525385731|FG000|Overall Study|Other than stated|1|||
145690944|NCT00796614|525385732|FG001|Overall Study|Other than stated|0|||
145690945|NCT00796614|525385733|FG002|Overall Study|Other than stated|0|||
145690946|NCT00796614|525385734|FG003|Overall Study|Other than stated|0|||
145690947|NCT00746785|525385737|FG000|Overall Study|Lost to Follow-up|29|||
145690948|NCT00746785|525385738|FG001|Overall Study|Lost to Follow-up|25|||
145690949|NCT00746785|525385739|FG002|Overall Study|Lost to Follow-up|27|||
145690950|NCT01960348|525385744|FG000|Overall Study|Adverse event, not serious|2|||
145690951|NCT01960348|525385745|FG001|Overall Study|Adverse event, not serious|2|||
145690952|NCT01960348|525385744|FG000|Overall Study|Adverse event, serious fatal|6|||
145690953|NCT01960348|525385745|FG001|Overall Study|Adverse event, serious fatal|5|||
145690954|NCT01960348|525385744|FG000|Overall Study|Adverse event, serious non-fatal|0|||
145690955|NCT01960348|525385745|FG001|Overall Study|Adverse event, serious non-fatal|3|||
145690956|NCT01960348|525385744|FG000|Overall Study|Withdrawal by Subject|1|||
145690957|NCT01960348|525385745|FG001|Overall Study|Withdrawal by Subject|11|||
145690958|NCT01960348|525385744|FG000|Overall Study|Physician Decision|0|||
145690959|NCT01960348|525385745|FG001|Overall Study|Physician Decision|1|||
145690960|NCT01960348|525385744|FG000|Overall Study|Protocol Violation|1|||
145690961|NCT01960348|525385745|FG001|Overall Study|Protocol Violation|0|||
145690962|NCT01580995|525385746|FG000|Overall Study|Lost to Follow-up|2|||
145690963|NCT01580995|525385747|FG001|Overall Study|Lost to Follow-up|2|||
145690964|NCT02916706|525385748|FG000|Overall Study|Adverse Event|0|||
145690965|NCT02916706|525385749|FG001|Overall Study|Adverse Event|1|||
145690966|NCT02916706|525385748|FG000|Overall Study|Lost to Follow-up|0|||
145690967|NCT02916706|525385749|FG001|Overall Study|Lost to Follow-up|1|||
145690968|NCT02916706|525385748|FG000|Overall Study|Physician Decision|1|||
145690969|NCT02916706|525385749|FG001|Overall Study|Physician Decision|0|||
145690970|NCT02916706|525385748|FG000|Overall Study|Protocol Violation|3|||
145690971|NCT02916706|525385749|FG001|Overall Study|Protocol Violation|1|||
145690972|NCT02916706|525385748|FG000|Overall Study|Withdrawal by Subject|6|||
145690973|NCT02916706|525385749|FG001|Overall Study|Withdrawal by Subject|9|||
145690974|NCT02916706|525385748|FG000|Overall Study|Other|5|||
145690975|NCT02916706|525385749|FG001|Overall Study|Other|19|||
145690976|NCT01902381|525385752|FG000|Overall Study|Withdrawal by Subject|1|||
145690977|NCT04140266|525385753|FG000|Overall Study|Physician Decision|2|||
145690978|NCT04140266|525385754|FG001|Overall Study|Physician Decision|0|||
145690979|NCT04140266|525385753|FG000|Overall Study|Withdrawal by Subject|4|||
145690980|NCT04140266|525385754|FG001|Overall Study|Withdrawal by Subject|2|||
145690981|NCT03511378|525385757|FG000|Overall Study|Withdrawal by Subject|2|||
145690982|NCT03511378|525385758|FG001|Overall Study|Withdrawal by Subject|2|||
145690983|NCT03511378|525385757|FG000|Overall Study|Patient not coming or schedule visit|1|||
145690984|NCT03511378|525385758|FG001|Overall Study|Patient not coming or schedule visit|0|||
145690985|NCT02762500|525385759|FG000|Overall Study|Lack of Efficacy|1|||
145690986|NCT02762500|525385760|FG001|Overall Study|Lack of Efficacy|0|||
145690987|NCT02762500|525385759|FG000|Overall Study|Withdrawal by Subject|1|||
145690988|NCT02762500|525385760|FG001|Overall Study|Withdrawal by Subject|1|||
145690989|NCT02762500|525385759|FG000|Overall Study|Adverse Event|0|||
145690990|NCT02762500|525385760|FG001|Overall Study|Adverse Event|2|||
145690991|NCT00730847|525385762|FG000|Overall Study|Adverse Event|1|||
145690992|NCT00730847|525385762|FG000|Overall Study|Protocol Violation|2|||
145690993|NCT00730847|525385762|FG000|Overall Study|Withdrawal by Subject|16|||
145690994|NCT00730847|525385762|FG000|Overall Study|Lost to Follow-up|67|||
145690995|NCT00730847|525385762|FG000|Overall Study|Unknown completion status|21|||
145690996|NCT00730847|525385762|FG000|Overall Study|Other|24|||
145690997|NCT00280683|525385763|FG000|Overall Study|Withdrawal by Subject|1|||
145690998|NCT00280683|525385764|FG001|Overall Study|Withdrawal by Subject|2|||
145690999|NCT00280683|525385763|FG000|Overall Study|Adverse Event|1|||
145691000|NCT00280683|525385764|FG001|Overall Study|Adverse Event|1|||
145691001|NCT00329550|525385770|FG000|Overall Study|Adverse Event|3|||
145691002|NCT00329550|525385771|FG001|Overall Study|Adverse Event|4|||
145691003|NCT00329550|525385772|FG002|Overall Study|Adverse Event|2|||
145691004|NCT00329550|525385770|FG000|Overall Study|Withdrawal of Consent|1|||
145691005|NCT00329550|525385771|FG001|Overall Study|Withdrawal of Consent|0|||
145691006|NCT00329550|525385772|FG002|Overall Study|Withdrawal of Consent|1|||
145691007|NCT00329550|525385770|FG000|Overall Study|Due to Relocation|0|||
145691008|NCT00329550|525385771|FG001|Overall Study|Due to Relocation|0|||
145691009|NCT00329550|525385772|FG002|Overall Study|Due to Relocation|1|||
145691010|NCT02679079|525385778|FG000|Overall Study|Adverse Event|2|||
145691011|NCT02679079|525385779|FG001|Overall Study|Adverse Event|0|||
145691012|NCT02679079|525385780|FG002|Overall Study|Adverse Event|2|||
145691013|NCT02679079|525385778|FG000|Overall Study|Protocol Violation|0|||
145691014|NCT02679079|525385779|FG001|Overall Study|Protocol Violation|1|||
145691015|NCT02679079|525385780|FG002|Overall Study|Protocol Violation|0|||
145691016|NCT02679079|525385778|FG000|Overall Study|Withdrawal by Subject|2|||
145691017|NCT02679079|525385779|FG001|Overall Study|Withdrawal by Subject|1|||
145691018|NCT02679079|525385780|FG002|Overall Study|Withdrawal by Subject|0|||
145691019|NCT00111839|525385781|FG000|Overall Study|Disease Progression|30|||
145691020|NCT00111839|525385782|FG001|Overall Study|Disease Progression|33|||
145691021|NCT00111839|525385783|FG002|Overall Study|Disease Progression|33|||
145691022|NCT00111839|525385781|FG000|Overall Study|Adverse Event|5|||
145691023|NCT00111839|525385782|FG001|Overall Study|Adverse Event|3|||
145691024|NCT00111839|525385783|FG002|Overall Study|Adverse Event|1|||
145691025|NCT00111839|525385781|FG000|Overall Study|Protocol Violation|2|||
145691026|NCT00111839|525385782|FG001|Overall Study|Protocol Violation|4|||
145691027|NCT00111839|525385783|FG002|Overall Study|Protocol Violation|2|||
145691028|NCT00111839|525385781|FG000|Overall Study|Death|1|||
145691029|NCT00111839|525385782|FG001|Overall Study|Death|1|||
145691030|NCT00111839|525385783|FG002|Overall Study|Death|6|||
145691031|NCT00111839|525385781|FG000|Overall Study|Withdrawal by Subject|2|||
145691032|NCT00111839|525385782|FG001|Overall Study|Withdrawal by Subject|2|||
145691033|NCT00111839|525385783|FG002|Overall Study|Withdrawal by Subject|2|||
145691034|NCT00111839|525385781|FG000|Overall Study|Lost to Follow-up|1|||
145691035|NCT00111839|525385782|FG001|Overall Study|Lost to Follow-up|0|||
145691036|NCT00111839|525385783|FG002|Overall Study|Lost to Follow-up|0|||
145691037|NCT00111839|525385781|FG000|Overall Study|Logistical Constraint|1|||
145691038|NCT00111839|525385782|FG001|Overall Study|Logistical Constraint|0|||
145691039|NCT00111839|525385783|FG002|Overall Study|Logistical Constraint|0|||
145691040|NCT00111839|525385781|FG000|Overall Study|Other|6|||
145691041|NCT00111839|525385782|FG001|Overall Study|Other|3|||
145691042|NCT00111839|525385783|FG002|Overall Study|Other|3|||
145691043|NCT00111839|525385781|FG000|Overall Study|Randomized but Not Treated|0|||
145691044|NCT00111839|525385782|FG001|Overall Study|Randomized but Not Treated|0|||
145691045|NCT00111839|525385783|FG002|Overall Study|Randomized but Not Treated|2|||
145691046|NCT03924947|525385789|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
145691047|NCT03924947|525385790|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
145691048|NCT03924947|525385791|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
145691049|NCT03924947|525385792|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
145691050|NCT03924947|525385793|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
145691051|NCT03924947|525385794|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
145691052|NCT01441583|525385797|FG000|Overall Study|Withdrawal by Subject|1|||
145691053|NCT01441583|525385798|FG001|Overall Study|Withdrawal by Subject|1|||
145691054|NCT01441583|525385799|FG002|Overall Study|Withdrawal by Subject|1|||
145691055|NCT01441583|525385797|FG000|Overall Study|Death|1|||
145691056|NCT01441583|525385798|FG001|Overall Study|Death|0|||
145691057|NCT01441583|525385799|FG002|Overall Study|Death|4|||
145691058|NCT01441583|525385797|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
145691059|NCT01441583|525385798|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
145691060|NCT01441583|525385799|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
145691061|NCT05060237|525385801|FG000|Overall Study|Withdrawal by Subject|4|||
145691062|NCT05060237|525385801|FG000|Overall Study|Screening failure|8|||
145691063|NCT01697592|525385805|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
145691064|NCT01697592|525385806|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691065|NCT01697592|525385807|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691066|NCT01697592|525385808|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691067|NCT01697592|525385809|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691068|NCT01697592|525385810|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691069|NCT01697592|525385811|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691070|NCT01697592|525385812|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691071|NCT01697592|525385813|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691072|NCT01697592|525385814|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
145691073|NCT01697592|525385805|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691074|NCT01697592|525385806|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691075|NCT01697592|525385807|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691076|NCT01697592|525385808|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691077|NCT01697592|525385809|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691078|NCT01697592|525385810|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
145691079|NCT01697592|525385811|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691080|NCT01697592|525385812|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691081|NCT01697592|525385813|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691082|NCT01697592|525385814|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
145691083|NCT01697592|525385805|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
145691084|NCT01697592|525385806|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691085|NCT01697592|525385807|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691086|NCT01697592|525385808|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691087|NCT01697592|525385809|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691088|NCT01697592|525385810|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691089|NCT01697592|525385811|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691090|NCT01697592|525385812|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691091|NCT01697592|525385813|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691092|NCT01697592|525385814|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
145691093|NCT01697592|525385805|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145691094|NCT01697592|525385806|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145691095|NCT01697592|525385807|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691096|NCT01697592|525385808|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691097|NCT01697592|525385809|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691098|NCT01697592|525385810|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691099|NCT01697592|525385811|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145691100|NCT01697592|525385812|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691101|NCT01697592|525385813|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
145691102|NCT01697592|525385814|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
145691103|NCT01697592|525385805|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145691104|NCT01697592|525385806|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
145691105|NCT01697592|525385807|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
145691106|NCT01697592|525385808|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
145691107|NCT01697592|525385809|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145691108|NCT01697592|525385810|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145691109|NCT01697592|525385811|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
145691110|NCT01697592|525385812|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145691111|NCT01697592|525385813|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
145691112|NCT01697592|525385814|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
145691113|NCT01697592|525385805|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
145691114|NCT01697592|525385806|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691115|NCT01697592|525385807|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691116|NCT01697592|525385808|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
145691117|NCT01697592|525385809|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691118|NCT01697592|525385810|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691119|NCT01697592|525385811|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691120|NCT01697592|525385812|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691121|NCT01697592|525385813|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691122|NCT01697592|525385814|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
145691123|NCT01697592|525385805|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
145691124|NCT01697592|525385806|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691125|NCT01697592|525385807|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145491405|NCT00088530|524653794|FG001|Overall Study|Sponsor decision|1|||
145691126|NCT01697592|525385808|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691127|NCT01697592|525385809|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691128|NCT01697592|525385810|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
145691129|NCT01697592|525385811|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691130|NCT01697592|525385812|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
145691131|NCT01697592|525385813|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691132|NCT01697592|525385814|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
145691133|NCT01697592|525385805|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
145691134|NCT01697592|525385806|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
145691135|NCT01697592|525385807|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
145691136|NCT01697592|525385808|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
145691137|NCT01697592|525385809|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
145691138|NCT01697592|525385810|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
145691139|NCT01697592|525385811|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
145691140|NCT01697592|525385812|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
145691141|NCT01697592|525385813|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
145691142|NCT01697592|525385814|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
145691143|NCT05109117|525385815|FG000|Overall Study|Lost to Follow-up|1|||
145691144|NCT05109117|525385815|FG000|Overall Study|Discontinued for non-compliance|1|||
145691145|NCT02499835|525385816|FG000|Overall Study|Withdrawal by Subject|1|||
145691146|NCT02499835|525385817|FG001|Overall Study|Withdrawal by Subject|0|||
145691147|NCT02499835|525385818|FG002|Overall Study|Withdrawal by Subject|0|||
145691148|NCT02499835|525385819|FG003|Overall Study|Withdrawal by Subject|1|||
145691149|NCT02499835|525385816|FG000|Overall Study|Physician Decision|0|||
145691150|NCT02499835|525385817|FG001|Overall Study|Physician Decision|3|||
145691151|NCT02499835|525385818|FG002|Overall Study|Physician Decision|18|||
145691152|NCT02499835|525385819|FG003|Overall Study|Physician Decision|7|||
145691153|NCT02499835|525385816|FG000|Overall Study|Adverse Event|0|||
145691154|NCT02499835|525385817|FG001|Overall Study|Adverse Event|0|||
145691155|NCT02499835|525385818|FG002|Overall Study|Adverse Event|0|||
145691156|NCT02499835|525385819|FG003|Overall Study|Adverse Event|1|||
145691157|NCT02499835|525385816|FG000|Overall Study|Disease progression|2|||
145691158|NCT02499835|525385817|FG001|Overall Study|Disease progression|1|||
145691159|NCT02499835|525385818|FG002|Overall Study|Disease progression|0|||
145691160|NCT02499835|525385819|FG003|Overall Study|Disease progression|7|||
145691161|NCT03972137|525385820|FG000|Overall Study|Lost to Follow-up|2|||
145691162|NCT03972137|525385820|FG000|Overall Study|Withdrawal by Subject|4|||
145691163|NCT03319719|525385825|FG000|Overall Study|Lost to Follow-up|1|||
145691164|NCT00744796|525385826|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
145691165|NCT01340300|525385828|FG000|Overall Study|Lost to Follow-up|3|||
145265418|NCT00764465|523819356|FG004|Overall Study|Withdrawal by Subject|0|||
145265419|NCT00764465|523819357|FG005|Overall Study|Withdrawal by Subject|0|||
145265420|NCT01195662|523819359|FG000|Double Blind Treatment Period|Adverse Event|4|||
145265421|NCT01195662|523819360|FG001|Double Blind Treatment Period|Adverse Event|1|||
145265422|NCT01195662|523819361|FG002|Double Blind Treatment Period|Adverse Event|2|||
145265423|NCT01195662|523819359|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
145265424|NCT01195662|523819360|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
145265425|NCT01195662|523819361|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
145265426|NCT01195662|523819359|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
145265427|NCT01195662|523819360|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
145265428|NCT01195662|523819361|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
145265429|NCT01195662|523819359|FG000|Double Blind Treatment Period|Administrative reason|2|||
145265430|NCT01195662|523819360|FG001|Double Blind Treatment Period|Administrative reason|1|||
145265431|NCT01195662|523819361|FG002|Double Blind Treatment Period|Administrative reason|1|||
145265432|NCT01195662|523819359|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
145265433|NCT01195662|523819360|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
145265434|NCT01195662|523819361|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
145265435|NCT01195662|523819359|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
145265436|NCT01195662|523819360|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
145265437|NCT01195662|523819361|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
145265438|NCT01195662|523819359|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
145265439|NCT01195662|523819360|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
145265440|NCT01195662|523819361|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
145265441|NCT01195662|523819359|FG000|Double Blind Treatment Period|Non-specified|3|||
145691166|NCT01340300|525385829|FG001|Overall Study|Lost to Follow-up|0|||
145691167|NCT01340300|525385830|FG002|Overall Study|Lost to Follow-up|5|||
145691168|NCT01340300|525385831|FG003|Overall Study|Lost to Follow-up|10|||
145691169|NCT01340300|525385828|FG000|Overall Study|Withdrawal by Subject|5|||
145691170|NCT01340300|525385829|FG001|Overall Study|Withdrawal by Subject|6|||
145691171|NCT01340300|525385830|FG002|Overall Study|Withdrawal by Subject|6|||
145691172|NCT01340300|525385831|FG003|Overall Study|Withdrawal by Subject|3|||
145691173|NCT01340300|525385828|FG000|Overall Study|Adverse Event|1|||
145691174|NCT01340300|525385829|FG001|Overall Study|Adverse Event|0|||
145691175|NCT01340300|525385830|FG002|Overall Study|Adverse Event|4|||
145691176|NCT01340300|525385831|FG003|Overall Study|Adverse Event|0|||
145691177|NCT01340300|525385828|FG000|Overall Study|Physician Decision|0|||
145691178|NCT01340300|525385829|FG001|Overall Study|Physician Decision|1|||
145691179|NCT01340300|525385830|FG002|Overall Study|Physician Decision|0|||
145691180|NCT01340300|525385831|FG003|Overall Study|Physician Decision|0|||
145691181|NCT01340300|525385828|FG000|Overall Study|Unrelated sickness|0|||
145691182|NCT01340300|525385829|FG001|Overall Study|Unrelated sickness|2|||
145691183|NCT01340300|525385830|FG002|Overall Study|Unrelated sickness|0|||
145691184|NCT01340300|525385831|FG003|Overall Study|Unrelated sickness|1|||
145691185|NCT04194541|525385833|FG000|Day 1 Through 13|Lost to Follow-up|3|||
145691186|NCT04194541|525385833|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
145691187|NCT04194541|525385833|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
145691188|NCT02642159|525385834|FG000|Overall Study|Randomized but not treated|1|||
145691189|NCT02642159|525385835|FG001|Overall Study|Randomized but not treated|0|||
145691190|NCT02642159|525385834|FG000|Overall Study|Adverse Event|10|||
145691191|NCT02642159|525385835|FG001|Overall Study|Adverse Event|4|||
145691192|NCT02642159|525385834|FG000|Overall Study|Withdrawal by Subject|9|||
145691193|NCT02642159|525385835|FG001|Overall Study|Withdrawal by Subject|1|||
145691194|NCT02642159|525385834|FG000|Overall Study|Poor compliance to study protocol|1|||
145691195|NCT02642159|525385835|FG001|Overall Study|Poor compliance to study protocol|0|||
145691196|NCT02642159|525385834|FG000|Overall Study|Other than specified above|10|||
145691197|NCT02642159|525385835|FG001|Overall Study|Other than specified above|3|||
145691198|NCT03635775|525385838|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
145691199|NCT03635775|525385839|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
145691200|NCT03635775|525385840|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
145691201|NCT03635775|525385841|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
145691202|NCT01820637|525385843|FG000|Overall Study|Death|2|||
145691203|NCT01820637|525385843|FG000|Overall Study|Withdrawal by Subject|1|||
145691204|NCT00264498|525385844|FG000|Randomized Treatment|Death|0|||
145691205|NCT00264498|525385845|FG001|Randomized Treatment|Death|3|||
145691206|NCT00264498|525385844|FG000|Randomized Treatment|Withdrawal by Subject|0|||
145691207|NCT00264498|525385845|FG001|Randomized Treatment|Withdrawal by Subject|1|||
145691208|NCT00264498|525385844|FG000|Randomized Treatment|Objective disease Progression|13|||
145691209|NCT00264498|525385845|FG001|Randomized Treatment|Objective disease Progression|14|||
145691210|NCT00264498|525385844|FG000|Randomized Treatment|Physician Decision|1|||
145691211|NCT00264498|525385845|FG001|Randomized Treatment|Physician Decision|0|||
145691212|NCT00264498|525385844|FG000|Randomized Treatment|Incorrectly randomized|1|||
145691213|NCT00264498|525385845|FG001|Randomized Treatment|Incorrectly randomized|0|||
145691214|NCT00264498|525385844|FG000|Randomized Treatment|Study Closure|1|||
145691215|NCT00264498|525385845|FG001|Randomized Treatment|Study Closure|0|||
145691216|NCT00264498|525385844|FG000|Randomized Treatment|Protocol Violation|1|||
145691217|NCT00264498|525385845|FG001|Randomized Treatment|Protocol Violation|0|||
145691218|NCT00264498|525385844|FG000|Crossover Treatment|Death|1|||
145691219|NCT00264498|525385845|FG001|Crossover Treatment|Death|3|||
145691220|NCT00264498|525385844|FG000|Crossover Treatment|Objective disease progression|4|||
145691221|NCT00264498|525385845|FG001|Crossover Treatment|Objective disease progression|5|||
145691222|NCT00264498|525385844|FG000|Crossover Treatment|Study closure|0|||
145691223|NCT00264498|525385845|FG001|Crossover Treatment|Study closure|1|||
145691224|NCT00264498|525385844|FG000|Crossover Treatment|Withdrawal by Subject|1|||
145691225|NCT00264498|525385845|FG001|Crossover Treatment|Withdrawal by Subject|0|||
145691226|NCT00583115|525385846|FG000|Overall Study|Death|1|||
145691227|NCT03340766|525385850|FG000|Overall Study|Withdrawal by Subject|2|||
145691228|NCT03340766|525385851|FG001|Overall Study|Withdrawal by Subject|1|||
145691229|NCT03340766|525385852|FG002|Overall Study|Withdrawal by Subject|3|||
145691230|NCT03340766|525385850|FG000|Overall Study|Lost to Follow-up|0|||
145691231|NCT03340766|525385851|FG001|Overall Study|Lost to Follow-up|0|||
145691232|NCT03340766|525385852|FG002|Overall Study|Lost to Follow-up|1|||
145691233|NCT03340766|525385850|FG000|Overall Study|Death|6|||
145691234|NCT03340766|525385851|FG001|Overall Study|Death|7|||
145691235|NCT03340766|525385852|FG002|Overall Study|Death|4|||
145691236|NCT02864147|525385856|FG000|Overall Study|Withdrawal by Subject|3|||
145691237|NCT02864147|525385857|FG001|Overall Study|Withdrawal by Subject|2|||
145691238|NCT02864147|525385858|FG002|Overall Study|Withdrawal by Subject|1|||
145691239|NCT02864147|525385856|FG000|Overall Study|Lost to Follow-up|0|||
145691240|NCT02864147|525385857|FG001|Overall Study|Lost to Follow-up|4|||
145691241|NCT02864147|525385858|FG002|Overall Study|Lost to Follow-up|0|||
145691242|NCT02864147|525385856|FG000|Overall Study|Adverse Event|0|||
145691243|NCT02864147|525385857|FG001|Overall Study|Adverse Event|1|||
145691244|NCT02864147|525385858|FG002|Overall Study|Adverse Event|0|||
145691245|NCT02864147|525385856|FG000|Overall Study|Pregnancy|4|||
145691246|NCT02864147|525385857|FG001|Overall Study|Pregnancy|0|||
145691247|NCT02864147|525385858|FG002|Overall Study|Pregnancy|0|||
145691248|NCT02864147|525385856|FG000|Overall Study|Physician Decision|0|||
145691249|NCT02864147|525385857|FG001|Overall Study|Physician Decision|0|||
145691250|NCT02864147|525385858|FG002|Overall Study|Physician Decision|1|||
145691251|NCT02864147|525385856|FG000|Overall Study|Opted for excisional procedures|0|||
145691252|NCT02864147|525385857|FG001|Overall Study|Opted for excisional procedures|0|||
145691253|NCT02864147|525385858|FG002|Overall Study|Opted for excisional procedures|3|||
145691254|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
145691255|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
145691256|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
145691257|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
145691258|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
145691259|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
145691260|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
145691261|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
145691262|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
145691263|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
145691264|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
145691265|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
145691266|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
145691267|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
145691268|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
145691269|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
145691270|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
145691271|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
145691272|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
145691273|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
145691274|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
145691275|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
145691276|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
145691277|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
145691278|NCT02269917|525385859|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
145691279|NCT02269917|525385860|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
145691280|NCT02269917|525385861|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
145691281|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
145691282|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
145691283|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
145691284|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
145691285|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
145691286|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
145691287|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
145691288|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
145691289|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
145691290|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
145691291|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
145691292|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
145691293|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
145691294|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
145691295|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
145691296|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
145691297|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
145691298|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
145691299|NCT02269917|525385859|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
145691300|NCT02269917|525385860|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
145691301|NCT02269917|525385861|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
145691302|NCT00240097|525385862|FG000|Part I|Adverse Event|1|||
145691303|NCT00240097|525385862|FG000|Part I|Death|1|||
145691304|NCT00240097|525385862|FG000|Part I|histology|1|||
145691305|NCT00240097|525385862|FG000|Part I|unevaluable|1|||
145691306|NCT00240097|525385862|FG000|Part II|did not continue from Part I|23|||
145691307|NCT02335242|525385863|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
145691308|NCT02335242|525385864|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
145691309|NCT02335242|525385863|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
145691310|NCT02335242|525385864|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
145691311|NCT02335242|525385863|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
145691312|NCT02335242|525385864|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
145691313|NCT04222088|525385865|FG000|Overall Study|Lost to Follow-up|5|||
145691314|NCT04222088|525385866|FG001|Overall Study|Lost to Follow-up|1|||
145691315|NCT04222088|525385865|FG000|Overall Study|Withdrawal by Subject|4|||
145491406|NCT00088530|524653793|FG000|Overall Study|Patient never treated|1|||
145491407|NCT00088530|524653794|FG001|Overall Study|Patient never treated|0|||
145491408|NCT00686777|524653798|FG000|Overall Study|Adverse Event|2|||
145691316|NCT04222088|525385866|FG001|Overall Study|Withdrawal by Subject|0|||
145691317|NCT00595764|525385867|FG000|Overall Study|Protocol Violation|24|||
145691318|NCT00595764|525385868|FG001|Overall Study|Protocol Violation|19|||
145691319|NCT00595764|525385867|FG000|Overall Study|Missed Medication >1 week|10|||
145691320|NCT00595764|525385868|FG001|Overall Study|Missed Medication >1 week|17|||
145691321|NCT00595764|525385867|FG000|Overall Study|Missed 3 PM visits|1|||
145691322|NCT00595764|525385868|FG001|Overall Study|Missed 3 PM visits|7|||
145691323|NCT00595764|525385867|FG000|Overall Study|Withdrawal by Subject|4|||
145691324|NCT00595764|525385868|FG001|Overall Study|Withdrawal by Subject|0|||
145691325|NCT00580047|525385875|FG000|Overall Study|Lost to Follow-up|1|||
145691326|NCT00580047|525385876|FG001|Overall Study|Lost to Follow-up|1|||
145691327|NCT00580047|525385877|FG002|Overall Study|Lost to Follow-up|0|||
145691328|NCT00580047|525385875|FG000|Overall Study|Withdrawal by Subject|1|||
145691329|NCT00580047|525385876|FG001|Overall Study|Withdrawal by Subject|1|||
145691330|NCT00580047|525385877|FG002|Overall Study|Withdrawal by Subject|2|||
145691331|NCT00580047|525385875|FG000|Overall Study|Withdrawal by Subject|1|||
145691332|NCT00580047|525385876|FG001|Overall Study|Withdrawal by Subject|0|||
145691333|NCT00580047|525385877|FG002|Overall Study|Withdrawal by Subject|0|||
145691334|NCT02820298|525385878|FG000|Overall Study|Withdrawal by Subject|0|||
145691335|NCT02820298|525385879|FG001|Overall Study|Withdrawal by Subject|1|||
145691336|NCT02820298|525385878|FG000|Overall Study|Physician Decision|1|||
145691337|NCT02820298|525385879|FG001|Overall Study|Physician Decision|0|||
145691338|NCT02820298|525385878|FG000|Overall Study|Protocol Violation|0|||
145691339|NCT02820298|525385879|FG001|Overall Study|Protocol Violation|1|||
145691340|NCT01894256|525385880|FG000|Part A|Adverse Event|0|||
145691341|NCT01894256|525385881|FG001|Part A|Adverse Event|1|||
145691342|NCT01894256|525385882|FG002|Part A|Adverse Event|0|||
145691343|NCT01894256|525385880|FG000|Part B|Death|0|||
145691344|NCT01894256|525385881|FG001|Part B|Death|1|||
145691345|NCT01894256|525385882|FG002|Part B|Death|1|||
145691346|NCT01894256|525385880|FG000|Part B|Withdrawal by Subject|0|||
145691347|NCT01894256|525385881|FG001|Part B|Withdrawal by Subject|1|||
145691348|NCT01894256|525385882|FG002|Part B|Withdrawal by Subject|0|||
145691349|NCT01894256|525385880|FG000|Part B|Lack of Efficacy|15|||
145691350|NCT01894256|525385881|FG001|Part B|Lack of Efficacy|12|||
145691351|NCT01894256|525385882|FG002|Part B|Lack of Efficacy|13|||
145691352|NCT01780584|525385883|FG000|Overall Study|Death|1|||
145691353|NCT01780584|525385884|FG001|Overall Study|Death|0|||
145691354|NCT01780584|525385885|FG002|Overall Study|Death|1|||
145691355|NCT01780584|525385883|FG000|Overall Study|Adverse Event|0|||
145691356|NCT01780584|525385884|FG001|Overall Study|Adverse Event|1|||
145691357|NCT01780584|525385885|FG002|Overall Study|Adverse Event|0|||
145691358|NCT01780584|525385883|FG000|Overall Study|Protocol Violation|0|||
145691359|NCT01780584|525385884|FG001|Overall Study|Protocol Violation|0|||
145691360|NCT01780584|525385885|FG002|Overall Study|Protocol Violation|1|||
145691361|NCT03406507|525385886|FG000|Extension Period|Lack of Efficacy|0|||
145691362|NCT03406507|525385887|FG001|Extension Period|Lack of Efficacy|1|||
145691363|NCT02316171|525385888|FG000|Overall Study|difficulties with urinary catheter|1|||
145691364|NCT02316171|525385889|FG001|Overall Study|difficulties with urinary catheter|0|||
145691365|NCT02316171|525385890|FG002|Overall Study|difficulties with urinary catheter|0|||
145691366|NCT02316171|525385891|FG003|Overall Study|difficulties with urinary catheter|0|||
145691367|NCT01772147|525387951|FG000|Overall Study|Adverse Event|13|||
145691368|NCT01772147|525387952|FG001|Overall Study|Adverse Event|10|||
145691369|NCT01772147|525387953|FG002|Overall Study|Adverse Event|6|||
145691370|NCT01772147|525387951|FG000|Overall Study|Withdrew Consent|7|||
145691371|NCT01772147|525387952|FG001|Overall Study|Withdrew Consent|8|||
145691372|NCT01772147|525387953|FG002|Overall Study|Withdrew Consent|4|||
145691373|NCT01772147|525387951|FG000|Overall Study|Lost to Follow-up|1|||
145691374|NCT01772147|525387952|FG001|Overall Study|Lost to Follow-up|0|||
145691375|NCT01772147|525387953|FG002|Overall Study|Lost to Follow-up|1|||
145691376|NCT01772147|525387951|FG000|Overall Study|Protocol Deviation|2|||
145691377|NCT01772147|525387952|FG001|Overall Study|Protocol Deviation|1|||
145691378|NCT01772147|525387953|FG002|Overall Study|Protocol Deviation|1|||
145691379|NCT01772147|525387951|FG000|Overall Study|Lack of Efficacy|8|||
145691380|NCT01772147|525387952|FG001|Overall Study|Lack of Efficacy|6|||
145691381|NCT01772147|525387953|FG002|Overall Study|Lack of Efficacy|6|||
145691382|NCT04572997|525387958|FG000|Overall Study|Adverse Event|1|||
145691383|NCT02956278|525387959|FG000|Overall Study|Withdrawal by Subject|6|||
145691384|NCT02956278|525387960|FG001|Overall Study|Withdrawal by Subject|2|||
145691385|NCT02956278|525387961|FG002|Overall Study|Withdrawal by Subject|0|||
145691386|NCT01967719|525387962|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
145691387|NCT01967719|525387963|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
145691388|NCT01967719|525387964|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
145691389|NCT01967719|525387965|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
145691390|NCT01967719|525387962|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
145691391|NCT01967719|525387963|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
145691392|NCT01967719|525387964|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
145691393|NCT01967719|525387965|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
145691394|NCT00740597|525387967|FG000|Overall Study|insurance would not cover treatment|1|||
145691395|NCT01157351|525387969|FG000|Overall Study|Adverse Event|5|||
145691396|NCT01157351|525387970|FG001|Overall Study|Adverse Event|4|||
145691397|NCT01157351|525387969|FG000|Overall Study|Death|1|||
145691398|NCT01157351|525387970|FG001|Overall Study|Death|0|||
145691399|NCT01157351|525387969|FG000|Overall Study|Lost to Follow-up|53|||
145691400|NCT01157351|525387970|FG001|Overall Study|Lost to Follow-up|55|||
145691401|NCT01157351|525387969|FG000|Overall Study|Withdrawal by Subject|37|||
145691402|NCT01157351|525387970|FG001|Overall Study|Withdrawal by Subject|27|||
145691403|NCT01157351|525387969|FG000|Overall Study|Physician Decision|5|||
145691404|NCT01157351|525387970|FG001|Overall Study|Physician Decision|4|||
145691405|NCT01157351|525387969|FG000|Overall Study|Protocol Violation|0|||
145691406|NCT01157351|525387970|FG001|Overall Study|Protocol Violation|1|||
145691407|NCT01157351|525387969|FG000|Overall Study|Other|32|||
145691408|NCT01157351|525387970|FG001|Overall Study|Other|36|||
145691409|NCT01157351|525387969|FG000|Overall Study|Noncompliance with Study Drug|0|||
145691410|NCT01157351|525387970|FG001|Overall Study|Noncompliance with Study Drug|3|||
145691411|NCT01157351|525387969|FG000|Overall Study|Randomized but not Treated|4|||
145691412|NCT01157351|525387970|FG001|Overall Study|Randomized but not Treated|2|||
145691413|NCT01231464|525387971|FG000|Overall Study|Adverse Event|0|||
145691414|NCT01231464|525387972|FG001|Overall Study|Adverse Event|1|||
145691415|NCT01231464|525387971|FG000|Overall Study|Protocol Violation|1|||
145691416|NCT01231464|525387972|FG001|Overall Study|Protocol Violation|2|||
145691417|NCT01231464|525387971|FG000|Overall Study|Lost to Follow-up|1|||
145691418|NCT01231464|525387972|FG001|Overall Study|Lost to Follow-up|2|||
145691419|NCT01231464|525387971|FG000|Overall Study|Withdrawal by Subject|3|||
145691420|NCT01231464|525387972|FG001|Overall Study|Withdrawal by Subject|2|||
145691421|NCT03449134|525387973|FG000|52-Week Treatment Period|Death|2|||
145691422|NCT03449134|525387974|FG001|52-Week Treatment Period|Death|1|||
145691423|NCT03449134|525387975|FG002|52-Week Treatment Period|Death|0|||
145691424|NCT03449134|525387973|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
145691425|NCT03449134|525387974|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
145691426|NCT03449134|525387975|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
145691427|NCT03449134|525387973|FG000|52-Week Treatment Period|Physician Decision|2|||
145691428|NCT03449134|525387974|FG001|52-Week Treatment Period|Physician Decision|3|||
145691429|NCT03449134|525387975|FG002|52-Week Treatment Period|Physician Decision|3|||
145691430|NCT03449134|525387973|FG000|52-Week Treatment Period|Screen Failure|1|||
145691431|NCT03449134|525387974|FG001|52-Week Treatment Period|Screen Failure|0|||
145691432|NCT03449134|525387975|FG002|52-Week Treatment Period|Screen Failure|1|||
145691433|NCT03449134|525387973|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
145691434|NCT03449134|525387974|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
145691435|NCT03449134|525387975|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
145691436|NCT03449134|525387973|FG000|52-Week Treatment Period|Site Closure|1|||
145691437|NCT03449134|525387974|FG001|52-Week Treatment Period|Site Closure|0|||
145691438|NCT03449134|525387975|FG002|52-Week Treatment Period|Site Closure|0|||
145691439|NCT00957996|525387981|FG000|Overall Study|Death|4|||
145691440|NCT00957996|525387982|FG001|Overall Study|Death|10|||
145691441|NCT00957996|525387981|FG000|Overall Study|Lost to Follow-up|4|||
145691442|NCT00957996|525387982|FG001|Overall Study|Lost to Follow-up|7|||
145691443|NCT00957996|525387981|FG000|Overall Study|Withdrawal by Subject|9|||
145691444|NCT00957996|525387982|FG001|Overall Study|Withdrawal by Subject|2|||
145691445|NCT00957996|525387981|FG000|Overall Study|Adverse Event|2|||
145691446|NCT00957996|525387982|FG001|Overall Study|Adverse Event|1|||
145691447|NCT00957996|525387981|FG000|Overall Study|Physician Decision|1|||
145691448|NCT00957996|525387982|FG001|Overall Study|Physician Decision|1|||
145691449|NCT00957996|525387981|FG000|Overall Study|Influenza-related complication|0|||
145691450|NCT00957996|525387982|FG001|Overall Study|Influenza-related complication|1|||
145691451|NCT00957996|525387981|FG000|Overall Study|Missing|1|||
145691452|NCT00957996|525387982|FG001|Overall Study|Missing|0|||
145691453|NCT00957996|525387981|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
145691454|NCT00957996|525387982|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
145691455|NCT01821729|525387984|FG000|Overall Study|Withdrawal by Subject|1|||
145491409|NCT00686777|524653798|FG000|Overall Study|Pregnancy|1|||
145491410|NCT00686777|524653798|FG000|Overall Study|Withdrawal by Subject|2|||
145691456|NCT00381797|525387990|FG000|Overall Study|Withdrawal by Subject|1|||
145691457|NCT00381797|525387991|FG001|Overall Study|Withdrawal by Subject|1|||
145691458|NCT00381797|525387992|FG002|Overall Study|Withdrawal by Subject|0|||
145691459|NCT00381797|525387993|FG003|Overall Study|Withdrawal by Subject|0|||
145691460|NCT00381797|525387994|FG004|Overall Study|Withdrawal by Subject|2|||
145691461|NCT00381797|525387990|FG000|Overall Study|Ineligible|0|||
145691462|NCT00381797|525387991|FG001|Overall Study|Ineligible|0|||
145691463|NCT00381797|525387992|FG002|Overall Study|Ineligible|0|||
145691464|NCT00381797|525387993|FG003|Overall Study|Ineligible|1|||
145691465|NCT00381797|525387994|FG004|Overall Study|Ineligible|0|||
145691466|NCT00684203|525387995|FG000|Overall Study|Adverse Event|6|||
145691467|NCT00684203|525387996|FG001|Overall Study|Adverse Event|4|||
145691468|NCT00684203|525387997|FG002|Overall Study|Adverse Event|8|||
145691469|NCT00684203|525387998|FG003|Overall Study|Adverse Event|0|||
145691470|NCT00684203|525387999|FG004|Overall Study|Adverse Event|0|||
145691471|NCT00684203|525388000|FG005|Overall Study|Adverse Event|0|||
145691472|NCT00684203|525387995|FG000|Overall Study|Protocol-defined clinical event|3|||
145691473|NCT00684203|525387996|FG001|Overall Study|Protocol-defined clinical event|1|||
145691474|NCT00684203|525387997|FG002|Overall Study|Protocol-defined clinical event|0|||
145691475|NCT00684203|525387998|FG003|Overall Study|Protocol-defined clinical event|0|||
145691476|NCT00684203|525387999|FG004|Overall Study|Protocol-defined clinical event|0|||
145691477|NCT00684203|525388000|FG005|Overall Study|Protocol-defined clinical event|0|||
145691478|NCT00684203|525387995|FG000|Overall Study|Withdrawal by Subject|0|||
145691479|NCT00684203|525387996|FG001|Overall Study|Withdrawal by Subject|2|||
145691480|NCT00684203|525387997|FG002|Overall Study|Withdrawal by Subject|1|||
145691481|NCT00684203|525387998|FG003|Overall Study|Withdrawal by Subject|0|||
145691482|NCT00684203|525387999|FG004|Overall Study|Withdrawal by Subject|0|||
145691483|NCT00684203|525388000|FG005|Overall Study|Withdrawal by Subject|0|||
145691484|NCT00684203|525387995|FG000|Overall Study|Did not meet protocol eligibility|0|||
145691485|NCT00684203|525387996|FG001|Overall Study|Did not meet protocol eligibility|1|||
145691486|NCT00684203|525387997|FG002|Overall Study|Did not meet protocol eligibility|0|||
145691487|NCT00684203|525387998|FG003|Overall Study|Did not meet protocol eligibility|0|||
145691488|NCT00684203|525387999|FG004|Overall Study|Did not meet protocol eligibility|0|||
145691489|NCT00684203|525388000|FG005|Overall Study|Did not meet protocol eligibility|0|||
145691490|NCT00719212|525388003|FG000|Overall Study|Death|41|||
145691491|NCT00719212|525388003|FG000|Overall Study|Lost to Follow-up|2|||
145691492|NCT00719212|525388003|FG000|Overall Study|Withdrawal by Subject|1|||
145691493|NCT00837096|525388004|FG000|Overall Study|Physician Decision|1|||
145691494|NCT00837096|525388005|FG001|Overall Study|Physician Decision|1|||
145691495|NCT00837096|525388004|FG000|Overall Study|Not reported|9|||
145691496|NCT00837096|525388005|FG001|Overall Study|Not reported|8|||
145691497|NCT01011049|525388006|FG000|Overall Study|Protocol Violation|0|||
145691498|NCT01011049|525388007|FG001|Overall Study|Protocol Violation|0|||
145691499|NCT01011049|525388008|FG002|Overall Study|Protocol Violation|2|||
145691500|NCT01011049|525388009|FG003|Overall Study|Protocol Violation|0|||
145691501|NCT01011049|525388006|FG000|Overall Study|Lost to Follow-up|1|||
145691502|NCT01011049|525388007|FG001|Overall Study|Lost to Follow-up|2|||
145691503|NCT01011049|525388008|FG002|Overall Study|Lost to Follow-up|1|||
145691504|NCT01011049|525388009|FG003|Overall Study|Lost to Follow-up|0|||
145691505|NCT01011049|525388006|FG000|Overall Study|Withdrawal by Subject|0|||
145691506|NCT01011049|525388007|FG001|Overall Study|Withdrawal by Subject|0|||
145691507|NCT01011049|525388008|FG002|Overall Study|Withdrawal by Subject|1|||
145691508|NCT01011049|525388009|FG003|Overall Study|Withdrawal by Subject|0|||
145691509|NCT00352053|525388010|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
145691510|NCT00352053|525388011|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
145691511|NCT00352053|525388010|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
145691512|NCT00352053|525388011|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
145691513|NCT00352053|525388010|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
145691514|NCT00352053|525388011|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
145691515|NCT00352053|525388010|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
145691516|NCT00352053|525388011|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
145691517|NCT00352053|525388010|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
145691518|NCT00352053|525388011|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
145691519|NCT00352053|525388010|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
145691520|NCT00352053|525388011|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
145691521|NCT00352053|525388010|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
145691522|NCT00352053|525388011|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
145691523|NCT00352053|525388010|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
145691524|NCT00352053|525388011|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
145691525|NCT00352053|525388010|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
145691526|NCT00352053|525388011|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
145691527|NCT00352053|525388010|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
145691528|NCT00352053|525388011|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
145691529|NCT00352053|525388010|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
145691530|NCT00352053|525388011|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
145691531|NCT00352053|525388010|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
145691532|NCT00352053|525388011|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
145691533|NCT00352053|525388010|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
145691534|NCT00352053|525388011|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
145691535|NCT02435381|525388012|FG000|Overall Study|Lost to Follow-up|2|||
145691536|NCT02435381|525388013|FG001|Overall Study|Lost to Follow-up|1|||
145691537|NCT00833898|525388019|FG000|Overall Study|Withdrawal by Subject|33|||
145691538|NCT00833898|525388020|FG001|Overall Study|Withdrawal by Subject|27|||
145691539|NCT00833898|525388019|FG000|Overall Study|Lost to Follow-up|7|||
145691540|NCT00833898|525388020|FG001|Overall Study|Lost to Follow-up|7|||
145691541|NCT00833898|525388019|FG000|Overall Study|Patient did not receive transplant|0|||
145691542|NCT00833898|525388020|FG001|Overall Study|Patient did not receive transplant|2|||
145691543|NCT00666198|525388021|FG000|Overall Study|Protocol Violation|10|||
145691544|NCT00666198|525388021|FG000|Overall Study|No Visit After First Day of Treatment|13|||
145691545|NCT00666198|525388021|FG000|Overall Study|Safety Not Assessable|6|||
145691546|NCT00666198|525388021|FG000|Overall Study|No Drug Administration|4|||
145691547|NCT03220776|525388027|FG000|Overall Study|Claustrophobia|0|||
145691548|NCT03220776|525388028|FG001|Overall Study|Claustrophobia|1|||
145691549|NCT03220776|525388029|FG002|Overall Study|Claustrophobia|1|||
145691550|NCT03220776|525388030|FG003|Overall Study|Claustrophobia|0|||
145691551|NCT03220776|525388031|FG004|Overall Study|Claustrophobia|1|||
145691552|NCT03220776|525388032|FG005|Overall Study|Claustrophobia|0|||
145691553|NCT03220776|525388027|FG000|Overall Study|MRI Equipment Failure|1|||
145691554|NCT03220776|525388028|FG001|Overall Study|MRI Equipment Failure|0|||
145691555|NCT03220776|525388029|FG002|Overall Study|MRI Equipment Failure|0|||
145691556|NCT03220776|525388030|FG003|Overall Study|MRI Equipment Failure|0|||
145691557|NCT03220776|525388031|FG004|Overall Study|MRI Equipment Failure|0|||
145691558|NCT03220776|525388032|FG005|Overall Study|MRI Equipment Failure|0|||
145691559|NCT03220776|525388027|FG000|Overall Study|Inclimate Weather|0|||
145691560|NCT03220776|525388028|FG001|Overall Study|Inclimate Weather|0|||
145691561|NCT03220776|525388029|FG002|Overall Study|Inclimate Weather|0|||
145691562|NCT03220776|525388030|FG003|Overall Study|Inclimate Weather|0|||
145691563|NCT03220776|525388031|FG004|Overall Study|Inclimate Weather|0|||
145691564|NCT03220776|525388032|FG005|Overall Study|Inclimate Weather|1|||
145691565|NCT03220776|525388027|FG000|Overall Study|Physician Decision|0|||
145691566|NCT03220776|525388028|FG001|Overall Study|Physician Decision|0|||
145691567|NCT03220776|525388029|FG002|Overall Study|Physician Decision|0|||
145691568|NCT03220776|525388030|FG003|Overall Study|Physician Decision|1|||
145691569|NCT03220776|525388031|FG004|Overall Study|Physician Decision|0|||
145691570|NCT03220776|525388032|FG005|Overall Study|Physician Decision|0|||
145691571|NCT03220776|525388027|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
145691572|NCT03220776|525388028|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
145691573|NCT03220776|525388029|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
145691574|NCT03220776|525388030|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
145691575|NCT03220776|525388031|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
145691576|NCT03220776|525388032|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
145691577|NCT03220776|525388027|FG000|Overall Study|Protocol Violation|0|||
145691578|NCT03220776|525388028|FG001|Overall Study|Protocol Violation|0|||
145691579|NCT03220776|525388029|FG002|Overall Study|Protocol Violation|0|||
145691580|NCT03220776|525388030|FG003|Overall Study|Protocol Violation|2|||
145691581|NCT03220776|525388031|FG004|Overall Study|Protocol Violation|0|||
145691582|NCT03220776|525388032|FG005|Overall Study|Protocol Violation|1|||
145691583|NCT03220776|525388027|FG000|Overall Study|Withdrawal by Subject|1|||
145691584|NCT03220776|525388028|FG001|Overall Study|Withdrawal by Subject|0|||
145691585|NCT03220776|525388029|FG002|Overall Study|Withdrawal by Subject|0|||
145691586|NCT03220776|525388030|FG003|Overall Study|Withdrawal by Subject|0|||
145691587|NCT03220776|525388031|FG004|Overall Study|Withdrawal by Subject|0|||
145691588|NCT03220776|525388032|FG005|Overall Study|Withdrawal by Subject|0|||
145691589|NCT03226353|525388033|FG000|Overall Study|Withdrawal by Subject|1|||
145691590|NCT03226353|525388033|FG000|Overall Study|Screen Failure|5|||
145691591|NCT03441789|525388034|FG000|Overall Study|Withdrawal by Subject|1|||
145691592|NCT03441789|525388035|FG001|Overall Study|Withdrawal by Subject|1|||
145691593|NCT03441789|525388034|FG000|Overall Study|Adverse Event|0|||
145691594|NCT03441789|525388035|FG001|Overall Study|Adverse Event|1|||
145691595|NCT03441789|525388034|FG000|Overall Study|Protocol Violation|0|||
145691596|NCT03441789|525388035|FG001|Overall Study|Protocol Violation|1|||
145691597|NCT03441789|525388034|FG000|Overall Study|Lost to Follow-up|0|||
145691598|NCT03441789|525388035|FG001|Overall Study|Lost to Follow-up|1|||
145691599|NCT02166047|525388038|FG000|Overall Study|Withdrawal by Participant|0|||
145691600|NCT02166047|525388039|FG001|Overall Study|Withdrawal by Participant|1|||
145691601|NCT02166047|525388040|FG002|Overall Study|Withdrawal by Participant|2|||
145691602|NCT02166047|525388041|FG003|Overall Study|Withdrawal by Participant|0|||
145691603|NCT02166047|525388042|FG004|Overall Study|Withdrawal by Participant|0|||
145691604|NCT02166047|525388043|FG005|Overall Study|Withdrawal by Participant|0|||
145691605|NCT02166047|525388044|FG006|Overall Study|Withdrawal by Participant|1|||
145691606|NCT02166047|525388045|FG007|Overall Study|Withdrawal by Participant|0|||
145691607|NCT02166047|525388046|FG008|Overall Study|Withdrawal by Participant|0|||
145691608|NCT02166047|525388047|FG009|Overall Study|Withdrawal by Participant|0|||
145691609|NCT02166047|525388048|FG010|Overall Study|Withdrawal by Participant|0|||
145691610|NCT02166047|525388049|FG011|Overall Study|Withdrawal by Participant|0|||
145691611|NCT02166047|525388038|FG000|Overall Study|Adverse Event|0|||
145691612|NCT02166047|525388039|FG001|Overall Study|Adverse Event|0|||
145691613|NCT02166047|525388040|FG002|Overall Study|Adverse Event|0|||
145691614|NCT02166047|525388041|FG003|Overall Study|Adverse Event|0|||
145691615|NCT02166047|525388042|FG004|Overall Study|Adverse Event|1|||
145691616|NCT02166047|525388043|FG005|Overall Study|Adverse Event|0|||
145691617|NCT02166047|525388044|FG006|Overall Study|Adverse Event|1|||
145691618|NCT02166047|525388045|FG007|Overall Study|Adverse Event|0|||
145691619|NCT02166047|525388046|FG008|Overall Study|Adverse Event|0|||
145691620|NCT02166047|525388047|FG009|Overall Study|Adverse Event|0|||
145691621|NCT02166047|525388048|FG010|Overall Study|Adverse Event|2|||
145691622|NCT02166047|525388049|FG011|Overall Study|Adverse Event|0|||
145691623|NCT02845375|525388051|FG000|Overall Study|upper airway obstruction|1|||
145691624|NCT02845375|525388052|FG001|Overall Study|upper airway obstruction|2|||
145691625|NCT02845375|525388053|FG002|Overall Study|upper airway obstruction|1|||
145691626|NCT01177137|525388054|FG000|Overall Study|Withdrawal by Subject|10|||
145691627|NCT01177137|525388055|FG001|Overall Study|Withdrawal by Subject|10|||
145691628|NCT01177137|525388056|FG002|Overall Study|Withdrawal by Subject|2|||
145691629|NCT02215954|525388058|FG000|Overall Study|Adverse Event|0|||
145691630|NCT02215954|525388059|FG001|Overall Study|Adverse Event|0|||
145691631|NCT02215954|525388060|FG002|Overall Study|Adverse Event|1|||
145691632|NCT02215954|525388058|FG000|Overall Study|Withdrawal by Subject|0|||
145691633|NCT02215954|525388059|FG001|Overall Study|Withdrawal by Subject|0|||
145691634|NCT02215954|525388060|FG002|Overall Study|Withdrawal by Subject|2|||
145691635|NCT02215954|525388058|FG000|Overall Study|Not exposed|1|||
145691636|NCT02215954|525388059|FG001|Overall Study|Not exposed|1|||
145691637|NCT02215954|525388060|FG002|Overall Study|Not exposed|3|||
145691638|NCT02460562|525388061|FG000|Overall Study|Lost to Follow-up|15|||
145691639|NCT02460562|525388062|FG001|Overall Study|Lost to Follow-up|16|||
145691640|NCT00588341|525388063|FG000|Overall Study|Withdrawal by Subject|3|||
145691641|NCT00588341|525388063|FG000|Overall Study|Not treated due to metastatic disease|1|||
145691642|NCT00588341|525388063|FG000|Overall Study|Patient ineligible|1|||
145691643|NCT01951261|525388064|FG000|Overall Study|Death|1|||
145691644|NCT01951261|525388065|FG001|Overall Study|Death|0|||
145691645|NCT01951261|525388064|FG000|Overall Study|Lost to Follow-up|4|||
145691646|NCT01951261|525388065|FG001|Overall Study|Lost to Follow-up|3|||
145691647|NCT01951261|525388064|FG000|Overall Study|Protocol Violation|4|||
145691648|NCT01951261|525388065|FG001|Overall Study|Protocol Violation|3|||
145691649|NCT01924806|525388066|FG000|Overall Study|Physician Decision|2|||
145691650|NCT01924806|525388067|FG001|Overall Study|Physician Decision|1|||
145691651|NCT00297778|525388075|FG000|Overall Study|Adverse Event|16|||
145691652|NCT00297778|525388076|FG001|Overall Study|Adverse Event|10|||
145691653|NCT00297778|525388075|FG000|Overall Study|Withdrawal by Subject|1|||
145691654|NCT00297778|525388076|FG001|Overall Study|Withdrawal by Subject|5|||
145691655|NCT00297778|525388075|FG000|Overall Study|Lack of Efficacy|2|||
145691656|NCT00297778|525388076|FG001|Overall Study|Lack of Efficacy|1|||
145691657|NCT00297778|525388075|FG000|Overall Study|Non-compliant with trial protocol|0|||
145691658|NCT00297778|525388076|FG001|Overall Study|Non-compliant with trial protocol|3|||
145691659|NCT00297778|525388075|FG000|Overall Study|Other|0|||
145691660|NCT00297778|525388076|FG001|Overall Study|Other|1|||
145691661|NCT03280108|525388077|FG000|Overall Study|Lost to Follow-up|2|||
145691662|NCT03280108|525388078|FG001|Overall Study|Lost to Follow-up|0|||
145691663|NCT02996097|525388079|FG000|Overall Study|Lost to Follow-up|11|||
145691664|NCT02996097|525388080|FG001|Overall Study|Lost to Follow-up|11|||
145691665|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
145691666|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145691667|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145691668|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145691669|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
145691670|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
145691671|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145691672|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145691673|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145691674|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
145691675|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
145691676|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145691677|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145691678|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145691679|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
145691680|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
145691681|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145691682|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145691683|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145691684|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
145691685|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
145691686|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145691687|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145691688|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145691689|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
145691690|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
145691691|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145691692|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145691693|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145691694|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
145691695|NCT01187407|525388081|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
145691696|NCT01187407|525388082|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145691697|NCT01187407|525388083|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145691698|NCT01187407|525388084|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145691699|NCT01187407|525388085|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
145691700|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
145691701|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
145691702|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
145691703|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
145691704|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
145691705|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
145691706|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
145691707|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
145691708|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
145691709|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
145691710|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
145691711|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
145691712|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
145691713|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
145691714|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
145691715|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145691716|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145691717|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
145691718|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
145691719|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
145691720|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
145691721|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
145691722|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
145691723|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
145691724|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
145691725|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
145691726|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
145691727|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
145691728|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
145691729|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
145691730|NCT01187407|525388081|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
145691731|NCT01187407|525388082|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
145691732|NCT01187407|525388083|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
145691733|NCT01187407|525388084|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
145691734|NCT01187407|525388085|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
145691735|NCT02201771|525388086|FG000|Overall Study|Death|3|||
145691736|NCT02201771|525388087|FG001|Overall Study|Death|2|||
145691737|NCT02201771|525388088|FG002|Overall Study|Death|0|||
145691738|NCT02201771|525388086|FG000|Overall Study|Protocol Violation|10|||
145691739|NCT02201771|525388087|FG001|Overall Study|Protocol Violation|8|||
145691740|NCT02201771|525388088|FG002|Overall Study|Protocol Violation|10|||
145691741|NCT01713998|525388089|FG000|Overall Study|Lost to Follow-up|2|||
145691742|NCT01713998|525388090|FG001|Overall Study|Lost to Follow-up|0|||
145691743|NCT01713998|525388091|FG002|Overall Study|Lost to Follow-up|2|||
145691744|NCT01713998|525388089|FG000|Overall Study|Withdrawal by Subject|1|||
145691745|NCT01713998|525388090|FG001|Overall Study|Withdrawal by Subject|0|||
145691746|NCT01713998|525388091|FG002|Overall Study|Withdrawal by Subject|0|||
145691747|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
145691748|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
145691749|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
145691750|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
145691751|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
145691752|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
145691753|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
145691754|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
145691755|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
145691756|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
145691757|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
145691758|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
145691759|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
145691760|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
145691761|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
145691762|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
145691763|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
145691764|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
145691765|NCT03569475|525388092|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
145691766|NCT03569475|525388093|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
145691767|NCT03569475|525388094|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
145691768|NCT03569475|525388092|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
145691769|NCT03569475|525388093|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
145691770|NCT03569475|525388094|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
145691771|NCT03569475|525388092|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
145691772|NCT03569475|525388093|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
145691773|NCT03569475|525388094|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
145691774|NCT03638258|525388095|FG000|Overall Study|Adverse Event|1|||
145691775|NCT03638258|525388096|FG001|Overall Study|Adverse Event|0|||
145691776|NCT03638258|525388097|FG002|Overall Study|Adverse Event|2|||
145691777|NCT03638258|525388095|FG000|Overall Study|Lost to Follow-up|2|||
145691778|NCT03638258|525388096|FG001|Overall Study|Lost to Follow-up|4|||
145691779|NCT03638258|525388097|FG002|Overall Study|Lost to Follow-up|5|||
145691780|NCT03638258|525388095|FG000|Overall Study|Pregnancy|0|||
145691781|NCT03638258|525388096|FG001|Overall Study|Pregnancy|0|||
145691782|NCT03638258|525388097|FG002|Overall Study|Pregnancy|1|||
145691783|NCT03638258|525388095|FG000|Overall Study|Protocol Violation|0|||
145691784|NCT03638258|525388096|FG001|Overall Study|Protocol Violation|0|||
145691785|NCT03638258|525388097|FG002|Overall Study|Protocol Violation|1|||
145691786|NCT03638258|525388095|FG000|Overall Study|Withdrawal by Subject|4|||
145691787|NCT03638258|525388096|FG001|Overall Study|Withdrawal by Subject|5|||
145691788|NCT03638258|525388097|FG002|Overall Study|Withdrawal by Subject|12|||
145691789|NCT03638258|525388095|FG000|Overall Study|Lack of Efficacy|0|||
145691790|NCT03638258|525388096|FG001|Overall Study|Lack of Efficacy|0|||
145691791|NCT03638258|525388097|FG002|Overall Study|Lack of Efficacy|2|||
145691792|NCT01287416|525388098|FG000|Pre-post Training|Withdrawal by Subject|17|||
145691793|NCT01287416|525388099|FG001|Pre-post Training|Withdrawal by Subject|24|||
145691794|NCT01287416|525388098|FG000|Pre-post Training|Lost to Follow-up|5|||
145691795|NCT01287416|525388099|FG001|Pre-post Training|Lost to Follow-up|1|||
145691796|NCT01287416|525388098|FG000|6 Month Follow-up|Lost to Follow-up|3|||
145691797|NCT01287416|525388099|FG001|6 Month Follow-up|Lost to Follow-up|2|||
145691798|NCT02109107|525388100|FG000|Overall Study|Lost to Follow-up|2|||
145691799|NCT03078751|525388101|FG000|Overall Study|Adverse Event|4|||
145691800|NCT03078751|525388102|FG001|Overall Study|Adverse Event|0|||
145691801|NCT03078751|525388101|FG000|Overall Study|Physician Decision|1|||
145691802|NCT03078751|525388102|FG001|Overall Study|Physician Decision|0|||
145691803|NCT03078751|525388101|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
145691804|NCT03078751|525388102|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
145691805|NCT03078751|525388101|FG000|Overall Study|Subject/guardian decision|8|||
145691806|NCT03078751|525388102|FG001|Overall Study|Subject/guardian decision|1|||
145691807|NCT03078751|525388101|FG000|Overall Study|Untreated|0|||
145691808|NCT03078751|525388102|FG001|Overall Study|Untreated|4|||
145691809|NCT00607789|525388104|FG000|Overall Study|Adverse Event|3|||
145691810|NCT00607789|525388105|FG001|Overall Study|Adverse Event|0|||
145691811|NCT00607789|525388104|FG000|Overall Study|Lack of Efficacy|0|||
145691812|NCT00607789|525388105|FG001|Overall Study|Lack of Efficacy|1|||
145691813|NCT00607789|525388104|FG000|Overall Study|Inadequate adherence|3|||
145691814|NCT00607789|525388105|FG001|Overall Study|Inadequate adherence|0|||
145691815|NCT00607789|525388104|FG000|Overall Study|Lost to Follow-up|0|||
145691816|NCT00607789|525388105|FG001|Overall Study|Lost to Follow-up|5|||
145691817|NCT00607789|525388104|FG000|Overall Study|Withdrawal by Subject|1|||
145691818|NCT00607789|525388105|FG001|Overall Study|Withdrawal by Subject|0|||
145691819|NCT01313299|525388106|FG000|Overall Study|Adverse Event|3|||
145691820|NCT01313299|525388107|FG001|Overall Study|Adverse Event|1|||
145691821|NCT01313299|525388108|FG002|Overall Study|Adverse Event|1|||
145691822|NCT01313299|525388106|FG000|Overall Study|Lost to Follow-up|1|||
145691823|NCT01313299|525388107|FG001|Overall Study|Lost to Follow-up|0|||
145691824|NCT01313299|525388108|FG002|Overall Study|Lost to Follow-up|0|||
145691825|NCT01313299|525388106|FG000|Overall Study|Protocol Violation|2|||
145491411|NCT00686777|524653798|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
145691826|NCT01313299|525388107|FG001|Overall Study|Protocol Violation|0|||
145691827|NCT01313299|525388108|FG002|Overall Study|Protocol Violation|0|||
145691828|NCT01313299|525388106|FG000|Overall Study|Withdrawal by Subject|1|||
145691829|NCT01313299|525388107|FG001|Overall Study|Withdrawal by Subject|0|||
145691830|NCT01313299|525388108|FG002|Overall Study|Withdrawal by Subject|2|||
145691831|NCT01313299|525388106|FG000|Overall Study|Family reason and moved out of state|0|||
145691832|NCT01313299|525388107|FG001|Overall Study|Family reason and moved out of state|2|||
145691833|NCT01313299|525388108|FG002|Overall Study|Family reason and moved out of state|0|||
145691834|NCT01313299|525388106|FG000|Overall Study|Lack of subject compliance|0|||
145691835|NCT01313299|525388107|FG001|Overall Study|Lack of subject compliance|0|||
145691836|NCT01313299|525388108|FG002|Overall Study|Lack of subject compliance|1|||
145691837|NCT01919398|525388109|FG000|Overall Study|Progressive Disease|0|||
145691838|NCT01919398|525388110|FG001|Overall Study|Progressive Disease|0|||
145691839|NCT01919398|525388111|FG002|Overall Study|Progressive Disease|4|||
145691840|NCT01222078|525388114|FG000|Overall Study|Early termination of the study|1|||
145691841|NCT02383927|525388116|FG000|Overall Study|Disease Progression|8|||
145691842|NCT02383927|525388117|FG001|Overall Study|Disease Progression|8|||
145691843|NCT02383927|525388118|FG002|Overall Study|Disease Progression|15|||
145691844|NCT02383927|525388119|FG003|Overall Study|Disease Progression|4|||
145691845|NCT02383927|525388116|FG000|Overall Study|Physician Decision|0|||
145691846|NCT02383927|525388117|FG001|Overall Study|Physician Decision|0|||
145691847|NCT02383927|525388118|FG002|Overall Study|Physician Decision|2|||
145691848|NCT02383927|525388119|FG003|Overall Study|Physician Decision|0|||
145691849|NCT02383927|525388116|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
145691850|NCT02383927|525388117|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
145691851|NCT02383927|525388118|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
145691852|NCT02383927|525388119|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
145691853|NCT02383927|525388116|FG000|Overall Study|Adverse Event|4|||
145691854|NCT02383927|525388117|FG001|Overall Study|Adverse Event|1|||
145691855|NCT02383927|525388118|FG002|Overall Study|Adverse Event|3|||
145691856|NCT02383927|525388119|FG003|Overall Study|Adverse Event|5|||
145691857|NCT02383927|525388116|FG000|Overall Study|Miscellaneous|1|||
145691858|NCT02383927|525388117|FG001|Overall Study|Miscellaneous|0|||
145691859|NCT02383927|525388118|FG002|Overall Study|Miscellaneous|0|||
145691860|NCT02383927|525388119|FG003|Overall Study|Miscellaneous|1|||
145691861|NCT02383927|525388116|FG000|Overall Study|Withdrawal by Subject|0|||
145691862|NCT02383927|525388117|FG001|Overall Study|Withdrawal by Subject|1|||
145691863|NCT02383927|525388118|FG002|Overall Study|Withdrawal by Subject|4|||
145691864|NCT02383927|525388119|FG003|Overall Study|Withdrawal by Subject|0|||
145691865|NCT00981578|525388120|FG000|Overall Study|Death|1|||
145691866|NCT00981578|525388120|FG000|Overall Study|Withdrawal by Subject|2|||
145691867|NCT02865135|525388121|FG000|Overall Study|Death|0|||
145691868|NCT02865135|525388122|FG001|Overall Study|Death|1|||
145691869|NCT02865135|525388123|FG002|Overall Study|Death|0|||
145691870|NCT02865135|525388121|FG000|Overall Study|Progression|6|||
145691871|NCT02865135|525388122|FG001|Overall Study|Progression|2|||
145691872|NCT02865135|525388123|FG002|Overall Study|Progression|2|||
145691873|NCT01180790|525388126|FG000|Overall Study|Adverse Event|1|||
145691874|NCT01180790|525388127|FG001|Overall Study|Adverse Event|1|||
145691875|NCT01180790|525388128|FG002|Overall Study|Adverse Event|2|||
145691876|NCT01180790|525388129|FG003|Overall Study|Adverse Event|0|||
145691877|NCT01180790|525388130|FG004|Overall Study|Adverse Event|1|||
145691878|NCT01180790|525388131|FG005|Overall Study|Adverse Event|3|||
145691879|NCT01180790|525388132|FG006|Overall Study|Adverse Event|0|||
145691880|NCT01180790|525388126|FG000|Overall Study|Withdrawal by Subject|3|||
145691881|NCT01180790|525388127|FG001|Overall Study|Withdrawal by Subject|0|||
145691882|NCT01180790|525388128|FG002|Overall Study|Withdrawal by Subject|5|||
145691883|NCT01180790|525388129|FG003|Overall Study|Withdrawal by Subject|0|||
145691884|NCT01180790|525388130|FG004|Overall Study|Withdrawal by Subject|2|||
145691885|NCT01180790|525388131|FG005|Overall Study|Withdrawal by Subject|1|||
145691886|NCT01180790|525388132|FG006|Overall Study|Withdrawal by Subject|0|||
145691887|NCT01180790|525388126|FG000|Overall Study|Lost to Follow-up|3|||
145691888|NCT01180790|525388127|FG001|Overall Study|Lost to Follow-up|1|||
145691889|NCT01180790|525388128|FG002|Overall Study|Lost to Follow-up|0|||
145691890|NCT01180790|525388129|FG003|Overall Study|Lost to Follow-up|2|||
145691891|NCT01180790|525388130|FG004|Overall Study|Lost to Follow-up|1|||
145691892|NCT01180790|525388131|FG005|Overall Study|Lost to Follow-up|0|||
145691893|NCT01180790|525388132|FG006|Overall Study|Lost to Follow-up|1|||
145691894|NCT01180790|525388126|FG000|Overall Study|Physician Decision|1|||
145691895|NCT01180790|525388127|FG001|Overall Study|Physician Decision|0|||
145691896|NCT01180790|525388128|FG002|Overall Study|Physician Decision|0|||
145691897|NCT01180790|525388129|FG003|Overall Study|Physician Decision|1|||
145691898|NCT01180790|525388130|FG004|Overall Study|Physician Decision|0|||
145691899|NCT01180790|525388131|FG005|Overall Study|Physician Decision|0|||
145691900|NCT01180790|525388132|FG006|Overall Study|Physician Decision|0|||
145691901|NCT01180790|525388126|FG000|Overall Study|Lack of Efficacy|1|||
145691902|NCT01180790|525388127|FG001|Overall Study|Lack of Efficacy|2|||
145691903|NCT01180790|525388128|FG002|Overall Study|Lack of Efficacy|5|||
145691904|NCT01180790|525388129|FG003|Overall Study|Lack of Efficacy|6|||
145691905|NCT01180790|525388130|FG004|Overall Study|Lack of Efficacy|1|||
145691906|NCT01180790|525388131|FG005|Overall Study|Lack of Efficacy|3|||
145691907|NCT01180790|525388132|FG006|Overall Study|Lack of Efficacy|0|||
145691908|NCT01180790|525388126|FG000|Overall Study|compliance|0|||
145691909|NCT01180790|525388127|FG001|Overall Study|compliance|1|||
145691910|NCT01180790|525388128|FG002|Overall Study|compliance|0|||
145691911|NCT01180790|525388129|FG003|Overall Study|compliance|0|||
145691912|NCT01180790|525388130|FG004|Overall Study|compliance|0|||
145691913|NCT01180790|525388131|FG005|Overall Study|compliance|0|||
145691914|NCT01180790|525388132|FG006|Overall Study|compliance|0|||
145691915|NCT01180790|525388126|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691916|NCT01180790|525388127|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691917|NCT01180790|525388128|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
145691918|NCT01180790|525388129|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691919|NCT01180790|525388130|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691920|NCT01180790|525388131|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691921|NCT01180790|525388132|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
145691922|NCT01064856|525388136|FG000|Double-blind (DB) Period|Adverse Event|1|||
145691923|NCT01064856|525388137|FG001|Double-blind (DB) Period|Adverse Event|0|||
145691924|NCT01064856|525388138|FG002|Double-blind (DB) Period|Adverse Event|0|||
145691925|NCT01064856|525388139|FG003|Double-blind (DB) Period|Adverse Event|0|||
145691926|NCT01064856|525388136|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
145691927|NCT01064856|525388137|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
145691928|NCT01064856|525388138|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
145691929|NCT01064856|525388139|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
145691930|NCT01064856|525388136|FG000|Open-label (OL) Period|Adverse Event|0|||
145691931|NCT01064856|525388137|FG001|Open-label (OL) Period|Adverse Event|0|||
145691932|NCT01064856|525388138|FG002|Open-label (OL) Period|Adverse Event|12|||
145691933|NCT01064856|525388139|FG003|Open-label (OL) Period|Adverse Event|6|||
145691934|NCT01064856|525388136|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
145691935|NCT01064856|525388137|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
145691936|NCT01064856|525388138|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
145691937|NCT01064856|525388139|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
145691938|NCT01064856|525388136|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
145691939|NCT01064856|525388137|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
145691940|NCT01064856|525388138|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
145691941|NCT01064856|525388139|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
145691942|NCT01064856|525388136|FG000|Open-label (OL) Period|Other|0|||
145691943|NCT01064856|525388137|FG001|Open-label (OL) Period|Other|0|||
145691944|NCT01064856|525388138|FG002|Open-label (OL) Period|Other|7|||
145691945|NCT01064856|525388139|FG003|Open-label (OL) Period|Other|7|||
145691946|NCT04783519|525388140|FG000|Overall Study|Withdrawal by Subject|2|||
145691947|NCT04783519|525388141|FG001|Overall Study|Withdrawal by Subject|7|||
145691948|NCT04783519|525388142|FG002|Overall Study|Withdrawal by Subject|3|||
145691949|NCT04783519|525388140|FG000|Overall Study|Lost to Follow-up|9|||
145691950|NCT04783519|525388141|FG001|Overall Study|Lost to Follow-up|7|||
145691951|NCT04783519|525388142|FG002|Overall Study|Lost to Follow-up|6|||
145691952|NCT00645099|525388143|FG000|Overall Study|Lack of Efficacy|15|||
145691953|NCT00645099|525388144|FG001|Overall Study|Lack of Efficacy|6|||
145691954|NCT00645099|525388143|FG000|Overall Study|Withdrawal by Subject|30|||
145691955|NCT00645099|525388144|FG001|Overall Study|Withdrawal by Subject|22|||
145691956|NCT00645099|525388143|FG000|Overall Study|Lost to Follow-up|6|||
145691957|NCT00645099|525388144|FG001|Overall Study|Lost to Follow-up|4|||
145691958|NCT00645099|525388143|FG000|Overall Study|Adverse Event|11|||
145691959|NCT00645099|525388144|FG001|Overall Study|Adverse Event|5|||
145691960|NCT00645099|525388143|FG000|Overall Study|Other|9|||
145691961|NCT00645099|525388144|FG001|Overall Study|Other|5|||
145691962|NCT01201915|525388145|FG000|Overall Study|Adverse Event|2|||
145691963|NCT01201915|525388146|FG001|Overall Study|Adverse Event|1|||
145691964|NCT01201915|525388147|FG002|Overall Study|Adverse Event|1|||
145691965|NCT01201915|525388145|FG000|Overall Study|Lost to Follow-up|0|||
145691966|NCT01201915|525388146|FG001|Overall Study|Lost to Follow-up|4|||
145691967|NCT01201915|525388147|FG002|Overall Study|Lost to Follow-up|0|||
145691968|NCT01201915|525388145|FG000|Overall Study|Physician Decision|3|||
145691969|NCT01201915|525388146|FG001|Overall Study|Physician Decision|0|||
145691970|NCT01201915|525388147|FG002|Overall Study|Physician Decision|0|||
145691971|NCT01201915|525388145|FG000|Overall Study|Subject Decision|3|||
145691972|NCT01201915|525388146|FG001|Overall Study|Subject Decision|3|||
145691973|NCT01201915|525388147|FG002|Overall Study|Subject Decision|5|||
145691974|NCT01201915|525388145|FG000|Overall Study|Target Lesion Progression|0|||
145691975|NCT01201915|525388146|FG001|Overall Study|Target Lesion Progression|3|||
145691976|NCT01201915|525388147|FG002|Overall Study|Target Lesion Progression|0|||
145691977|NCT02329223|525389374|FG000|Overall Study|Withdrawal by Subject|1|||
145691978|NCT02329223|525389375|FG001|Overall Study|Withdrawal by Subject|2|||
145691979|NCT02329223|525389376|FG002|Overall Study|Withdrawal by Subject|5|||
145691980|NCT02329223|525389374|FG000|Overall Study|Physician Decision|0|||
145691981|NCT02329223|525389375|FG001|Overall Study|Physician Decision|0|||
145691982|NCT02329223|525389376|FG002|Overall Study|Physician Decision|1|||
145691983|NCT02329223|525389374|FG000|Overall Study|Adverse Event|0|||
145691984|NCT02329223|525389375|FG001|Overall Study|Adverse Event|1|||
145691985|NCT02329223|525389376|FG002|Overall Study|Adverse Event|0|||
145691986|NCT04150341|525389389|FG000|Overall Study|Physician Decision|0|||
145691987|NCT04150341|525389390|FG001|Overall Study|Physician Decision|0|||
145691988|NCT04150341|525389391|FG002|Overall Study|Physician Decision|1|||
145691989|NCT04150341|525389392|FG003|Overall Study|Physician Decision|0|||
145691990|NCT04150341|525389393|FG004|Overall Study|Physician Decision|0|||
145691991|NCT04150341|525389394|FG005|Overall Study|Physician Decision|0|||
145691992|NCT04150341|525389389|FG000|Overall Study|Adverse Event|0|||
145691993|NCT04150341|525389390|FG001|Overall Study|Adverse Event|0|||
145691994|NCT04150341|525389391|FG002|Overall Study|Adverse Event|0|||
145691995|NCT04150341|525389392|FG003|Overall Study|Adverse Event|0|||
145691996|NCT04150341|525389393|FG004|Overall Study|Adverse Event|1|||
145691997|NCT04150341|525389394|FG005|Overall Study|Adverse Event|0|||
145691998|NCT00875615|525389395|FG000|Overall Study|Withdrawal by Subject|1|||
145691999|NCT00405912|525389397|FG000|Overall Study|Withdrawal by Subject|12|||
145692000|NCT00405912|525389398|FG001|Overall Study|Withdrawal by Subject|11|||
145692001|NCT00405912|525389399|FG002|Overall Study|Withdrawal by Subject|12|||
145692002|NCT00405912|525389397|FG000|Overall Study|Lost to Follow-up|4|||
145692003|NCT00405912|525389398|FG001|Overall Study|Lost to Follow-up|8|||
145692004|NCT00405912|525389399|FG002|Overall Study|Lost to Follow-up|4|||
145692005|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
145692006|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
145692007|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
145692008|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
145692009|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
145692010|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
145692011|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
145692012|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
145692013|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Death|6|||
145692014|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Death|2|||
145692015|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Death|2|||
145692016|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Death|9|||
145692017|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
145692018|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
145692019|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
145692020|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
145692021|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
145692022|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
145692023|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
145692024|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
145692025|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
145692026|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
145692027|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
145692028|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
145692029|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
145692030|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
145692031|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
145692032|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
145692033|NCT03730662|525389400|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
145692034|NCT03730662|525389401|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
145692035|NCT03730662|525389402|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
145692036|NCT03730662|525389403|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
145692037|NCT03730662|525389400|FG000|Variable Treatment Period|Adverse Event|1|||
145692038|NCT03730662|525389401|FG001|Variable Treatment Period|Adverse Event|2|||
145692039|NCT03730662|525389402|FG002|Variable Treatment Period|Adverse Event|0|||
145692040|NCT03730662|525389403|FG003|Variable Treatment Period|Adverse Event|7|||
145692041|NCT03730662|525389400|FG000|Variable Treatment Period|Death|9|||
145692042|NCT03730662|525389401|FG001|Variable Treatment Period|Death|0|||
145692043|NCT03730662|525389402|FG002|Variable Treatment Period|Death|6|||
145692044|NCT03730662|525389403|FG003|Variable Treatment Period|Death|26|||
145692045|NCT03730662|525389400|FG000|Variable Treatment Period|Lost to Follow-up|2|||
145692046|NCT03730662|525389401|FG001|Variable Treatment Period|Lost to Follow-up|1|||
145692047|NCT03730662|525389402|FG002|Variable Treatment Period|Lost to Follow-up|4|||
145692048|NCT03730662|525389403|FG003|Variable Treatment Period|Lost to Follow-up|11|||
145692049|NCT03730662|525389400|FG000|Variable Treatment Period|Personal Reason|0|||
145692050|NCT03730662|525389401|FG001|Variable Treatment Period|Personal Reason|2|||
145692051|NCT03730662|525389402|FG002|Variable Treatment Period|Personal Reason|1|||
145692052|NCT03730662|525389403|FG003|Variable Treatment Period|Personal Reason|6|||
145692053|NCT03730662|525389400|FG000|Variable Treatment Period|Physician Decision|0|||
145692054|NCT03730662|525389401|FG001|Variable Treatment Period|Physician Decision|0|||
145692055|NCT03730662|525389402|FG002|Variable Treatment Period|Physician Decision|0|||
145692056|NCT03730662|525389403|FG003|Variable Treatment Period|Physician Decision|3|||
145692057|NCT03730662|525389400|FG000|Variable Treatment Period|Protocol Violation|0|||
145692058|NCT03730662|525389401|FG001|Variable Treatment Period|Protocol Violation|1|||
145692059|NCT03730662|525389402|FG002|Variable Treatment Period|Protocol Violation|1|||
145692060|NCT03730662|525389403|FG003|Variable Treatment Period|Protocol Violation|1|||
145692061|NCT03730662|525389400|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
145692062|NCT03730662|525389401|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
145692063|NCT03730662|525389402|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
145692064|NCT03730662|525389403|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
145692065|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
145692066|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
145692067|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
145692068|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
145692069|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Death|0|||
145692070|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Death|1|||
145692071|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
145692072|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
145692073|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
145692074|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
145692075|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
145692076|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
145692077|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
145692078|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
145692079|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
145692080|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
145692081|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
145692082|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
145692083|NCT01309243|525389404|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
145692084|NCT01309243|525389405|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
145692085|NCT01309243|525389404|FG000|Extension Phase|Lost to Follow-up|6|||
145692086|NCT01309243|525389405|FG001|Extension Phase|Lost to Follow-up|0|||
145692087|NCT03712449|525389411|FG000|Overall Study|Withdraw Consent|0|||
145692088|NCT03712449|525389412|FG001|Overall Study|Withdraw Consent|1|||
145692089|NCT05153499|525389413|FG000|Overall Study|Withdrawal by Subject|1|||
145692090|NCT05153499|525389414|FG001|Overall Study|Withdrawal by Subject|0|||
145692091|NCT05153499|525389413|FG000|Overall Study|Clinical Hold|1|||
145692092|NCT05153499|525389414|FG001|Overall Study|Clinical Hold|0|||
145692093|NCT05153499|525389413|FG000|Overall Study|Study Termination|6|||
145692094|NCT05153499|525389414|FG001|Overall Study|Study Termination|5|||
145692095|NCT03168425|525389415|FG000|Overall Study|Lost to Follow-up|5|||
145692096|NCT03168425|525389416|FG001|Overall Study|Lost to Follow-up|8|||
145692097|NCT03168425|525389415|FG000|Overall Study|unable to confirm post op opioids|2|||
145692098|NCT03168425|525389416|FG001|Overall Study|unable to confirm post op opioids|3|||
145692099|NCT04491006|525389417|FG000|Overall Study|Adverse Event|0|||
145692100|NCT04491006|525389418|FG001|Overall Study|Adverse Event|3|||
145692101|NCT04491006|525389419|FG002|Overall Study|Adverse Event|5|||
145692102|NCT04491006|525389417|FG000|Overall Study|Withdrawal by Subject|1|||
145692103|NCT04491006|525389418|FG001|Overall Study|Withdrawal by Subject|0|||
145692104|NCT04491006|525389419|FG002|Overall Study|Withdrawal by Subject|2|||
145692105|NCT01960114|525389424|FG000|Overall Study|Adverse Event|1|||
145692106|NCT01960114|525389425|FG001|Overall Study|Adverse Event|0|||
145692107|NCT01960114|525389424|FG000|Overall Study|Could not swallow study medication|0|||
145692108|NCT01960114|525389425|FG001|Overall Study|Could not swallow study medication|1|||
145692109|NCT02490878|525389429|FG000|Overall Study|deemed ineligible|0|||
145692110|NCT02490878|525389430|FG001|Overall Study|deemed ineligible|1|||
145692111|NCT02490878|525389429|FG000|Overall Study|progression prior to treatment|0|||
145692112|NCT02490878|525389430|FG001|Overall Study|progression prior to treatment|1|||
145692113|NCT02490878|525389429|FG000|Overall Study|only submitted baseline QOL|0|||
145692114|NCT02490878|525389430|FG001|Overall Study|only submitted baseline QOL|1|||
145692115|NCT00451555|525389431|FG000|Overall Study|Protocol Violation|2|||
145692116|NCT00451555|525389432|FG001|Overall Study|Protocol Violation|2|||
145692117|NCT00451555|525389431|FG000|Overall Study|Adverse Event|3|||
145692118|NCT00451555|525389432|FG001|Overall Study|Adverse Event|1|||
145692119|NCT00451555|525389431|FG000|Overall Study|Withdrawal by Subject|6|||
145692120|NCT00451555|525389432|FG001|Overall Study|Withdrawal by Subject|0|||
145692121|NCT00451555|525389431|FG000|Overall Study|Physician Decision|2|||
145692122|NCT00451555|525389432|FG001|Overall Study|Physician Decision|1|||
145692123|NCT00922441|525389433|FG000|Overall Study|Protocol Violation|0|||
145692124|NCT00922441|525389434|FG001|Overall Study|Protocol Violation|0|||
145692125|NCT00922441|525389435|FG002|Overall Study|Protocol Violation|2|||
145692126|NCT00922441|525389433|FG000|Overall Study|Withdrawal by Subject|0|||
145692127|NCT00922441|525389434|FG001|Overall Study|Withdrawal by Subject|0|||
145692128|NCT00922441|525389435|FG002|Overall Study|Withdrawal by Subject|1|||
145692129|NCT00317603|525389436|FG000|Overall Study|Progressive Disease|3|||
145692130|NCT00523549|525389437|FG000|Overall Study|Adverse Event|6|||
145692131|NCT00523549|525389438|FG001|Overall Study|Adverse Event|3|||
145692132|NCT00523549|525389437|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145692133|NCT00523549|525389438|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145692134|NCT00523549|525389437|FG000|Overall Study|Protocol Deviation|3|||
145692135|NCT00523549|525389438|FG001|Overall Study|Protocol Deviation|1|||
145692136|NCT00523549|525389437|FG000|Overall Study|Patient withdrew consent|7|||
145692137|NCT00523549|525389438|FG001|Overall Study|Patient withdrew consent|6|||
145692138|NCT00523549|525389437|FG000|Overall Study|Lost to Follow-up|3|||
145692139|NCT00523549|525389438|FG001|Overall Study|Lost to Follow-up|5|||
145692140|NCT00427778|525389443|FG000|First Intervention (4 Weeks)|no longer interested|1|||
145692141|NCT00427778|525389444|FG001|First Intervention (4 Weeks)|no longer interested|0|||
145692142|NCT00427778|525389443|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
145692143|NCT00427778|525389444|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
145692144|NCT00427778|525389443|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
145692145|NCT00427778|525389444|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
145692146|NCT00427778|525389443|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
145692147|NCT00427778|525389444|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
145692148|NCT00439647|525389445|FG000|Overall Study|Withdrawal by Subject|25|||
145692149|NCT00439647|525389446|FG001|Overall Study|Withdrawal by Subject|22|||
145692150|NCT00439647|525389445|FG000|Overall Study|Death|15|||
145692151|NCT00439647|525389446|FG001|Overall Study|Death|18|||
145692152|NCT00439647|525389445|FG000|Overall Study|Adverse Event|11|||
145692153|NCT00439647|525389446|FG001|Overall Study|Adverse Event|11|||
145692154|NCT00439647|525389445|FG000|Overall Study|Lost to Follow-up|4|||
145692155|NCT00439647|525389446|FG001|Overall Study|Lost to Follow-up|12|||
145692156|NCT00439647|525389445|FG000|Overall Study|Protocol Violation|3|||
145692157|NCT00439647|525389446|FG001|Overall Study|Protocol Violation|4|||
145692158|NCT00439647|525389445|FG000|Overall Study|Lack of Efficacy|0|||
145692159|NCT00439647|525389446|FG001|Overall Study|Lack of Efficacy|4|||
145692160|NCT00843115|525389447|FG000|Overall Study|Death|4|||
145692161|NCT00843115|525389447|FG000|Overall Study|Adverse Event|30|||
145692162|NCT00843115|525389447|FG000|Overall Study|Lost to Follow-up|4|||
145692163|NCT00843115|525389447|FG000|Overall Study|Withdrawal by Subject|17|||
145692164|NCT00843115|525389447|FG000|Overall Study|Family wanted meds stopped|1|||
145692165|NCT00843115|525389447|FG000|Overall Study|Family does not want continuation|1|||
145692166|NCT00843115|525389447|FG000|Overall Study|Patient forgot to take meds|1|||
145692167|NCT00843115|525389447|FG000|Overall Study|Does not meet entrance criteria|1|||
145692168|NCT00843115|525389447|FG000|Overall Study|Physician Decision|1|||
145692169|NCT00843115|525389447|FG000|Overall Study|Family discontinued meds|1|||
145692170|NCT00843115|525389447|FG000|Overall Study|patient took for 2 days then stopped|1|||
145692171|NCT00843115|525389447|FG000|Overall Study|patient never took the medication|1|||
145692172|NCT00843115|525389447|FG000|Overall Study|hospitalized due to deterioration|1|||
145692173|NCT00843115|525389447|FG000|Overall Study|week 12 not done|1|||
145692174|NCT00843115|525389447|FG000|Overall Study|Syndrome De Glissement|1|||
145692175|NCT00225277|525389448|FG000|Overall Study|Adverse Event|30|||
145692176|NCT00225277|525389449|FG001|Overall Study|Adverse Event|34|||
145692177|NCT00225277|525389448|FG000|Overall Study|Lack of Efficacy|4|||
145692178|NCT00225277|525389449|FG001|Overall Study|Lack of Efficacy|1|||
145692179|NCT00225277|525389448|FG000|Overall Study|Lost to Follow-up|4|||
145692180|NCT00225277|525389449|FG001|Overall Study|Lost to Follow-up|6|||
145692181|NCT00225277|525389448|FG000|Overall Study|Physician Decision|6|||
145692182|NCT00225277|525389449|FG001|Overall Study|Physician Decision|8|||
145692183|NCT00225277|525389448|FG000|Overall Study|Protocol Violation|6|||
145692184|NCT00225277|525389449|FG001|Overall Study|Protocol Violation|3|||
145692185|NCT00225277|525389448|FG000|Overall Study|Withdrawal by Subject|40|||
145692186|NCT00225277|525389449|FG001|Overall Study|Withdrawal by Subject|34|||
145692187|NCT00225277|525389448|FG000|Overall Study|Other|7|||
145692188|NCT00225277|525389449|FG001|Overall Study|Other|9|||
145692189|NCT02959177|525389452|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
145692190|NCT02959177|525389453|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
145692191|NCT02959177|525389454|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
145692192|NCT02959177|525389452|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
145692193|NCT02959177|525389453|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
145692194|NCT02959177|525389454|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
145692195|NCT02959177|525389452|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
145692196|NCT02959177|525389453|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
145692197|NCT02959177|525389454|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
145692198|NCT02959177|525389452|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
145692199|NCT02959177|525389453|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
145692200|NCT02959177|525389454|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
145692201|NCT02959177|525389452|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
145692202|NCT02959177|525389453|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
145692203|NCT02959177|525389454|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
145692204|NCT02959177|525389452|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
145692205|NCT02959177|525389453|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
145692206|NCT02959177|525389454|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
145692207|NCT02959177|525389452|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
145692208|NCT02959177|525389453|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
145692209|NCT02959177|525389454|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
145692210|NCT00677092|525389456|FG000|Overall Study|Adverse Event|1|||
145692211|NCT00677092|525389456|FG000|Overall Study|Lost to Follow-up|1|||
145692212|NCT00677092|525389456|FG000|Overall Study|Withdrawal by Subject|3|||
145692213|NCT00677092|525389456|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
145692214|NCT00784277|525389457|FG000|IR Treatment|Adverse Event|4|||
145692215|NCT00784277|525389458|FG001|IR Treatment|Adverse Event|8|||
145692216|NCT00784277|525389459|FG002|IR Treatment|Adverse Event|19|||
145692217|NCT00784277|525389460|FG003|IR Treatment|Adverse Event|35|||
145692218|NCT00784277|525389461|FG004|IR Treatment|Adverse Event|0|||
145692219|NCT00784277|525389462|FG005|IR Treatment|Adverse Event|0|||
145692220|NCT00784277|525389463|FG006|IR Treatment|Adverse Event|0|||
145692221|NCT00784277|525389457|FG000|IR Treatment|Lack of Efficacy|4|||
145692222|NCT00784277|525389458|FG001|IR Treatment|Lack of Efficacy|4|||
145692223|NCT00784277|525389459|FG002|IR Treatment|Lack of Efficacy|1|||
145692224|NCT00784277|525389460|FG003|IR Treatment|Lack of Efficacy|0|||
145692225|NCT00784277|525389461|FG004|IR Treatment|Lack of Efficacy|0|||
145692226|NCT00784277|525389462|FG005|IR Treatment|Lack of Efficacy|0|||
145692227|NCT00784277|525389463|FG006|IR Treatment|Lack of Efficacy|0|||
145692228|NCT00784277|525389457|FG000|IR Treatment|Lost to Follow-up|1|||
145692229|NCT00784277|525389458|FG001|IR Treatment|Lost to Follow-up|0|||
145692230|NCT00784277|525389459|FG002|IR Treatment|Lost to Follow-up|1|||
145692231|NCT00784277|525389460|FG003|IR Treatment|Lost to Follow-up|0|||
145692232|NCT00784277|525389461|FG004|IR Treatment|Lost to Follow-up|0|||
145692233|NCT00784277|525389462|FG005|IR Treatment|Lost to Follow-up|0|||
145692234|NCT00784277|525389463|FG006|IR Treatment|Lost to Follow-up|0|||
145692235|NCT00784277|525389457|FG000|IR Treatment|Withdrawal by Subject|5|||
145692236|NCT00784277|525389458|FG001|IR Treatment|Withdrawal by Subject|1|||
145692237|NCT00784277|525389459|FG002|IR Treatment|Withdrawal by Subject|4|||
145692238|NCT00784277|525389460|FG003|IR Treatment|Withdrawal by Subject|6|||
145692239|NCT00784277|525389461|FG004|IR Treatment|Withdrawal by Subject|0|||
145692240|NCT00784277|525389462|FG005|IR Treatment|Withdrawal by Subject|0|||
145692241|NCT00784277|525389463|FG006|IR Treatment|Withdrawal by Subject|0|||
145692242|NCT00784277|525389457|FG000|IR Treatment|Resolution Of Pain|0|||
145692243|NCT00784277|525389458|FG001|IR Treatment|Resolution Of Pain|1|||
145692244|NCT00784277|525389459|FG002|IR Treatment|Resolution Of Pain|0|||
145692245|NCT00784277|525389460|FG003|IR Treatment|Resolution Of Pain|0|||
145692246|NCT00784277|525389461|FG004|IR Treatment|Resolution Of Pain|0|||
145692247|NCT00784277|525389462|FG005|IR Treatment|Resolution Of Pain|0|||
145692248|NCT00784277|525389463|FG006|IR Treatment|Resolution Of Pain|0|||
145692249|NCT00784277|525389457|FG000|IR Treatment|Other|2|||
145692250|NCT00784277|525389458|FG001|IR Treatment|Other|3|||
145692251|NCT00784277|525389459|FG002|IR Treatment|Other|3|||
145692252|NCT00784277|525389460|FG003|IR Treatment|Other|2|||
145692253|NCT00784277|525389461|FG004|IR Treatment|Other|0|||
145692254|NCT00784277|525389462|FG005|IR Treatment|Other|0|||
145692255|NCT00784277|525389463|FG006|IR Treatment|Other|0|||
145692256|NCT00784277|525389457|FG000|ER Treatment|Adverse Event|0|||
145692257|NCT00784277|525389458|FG001|ER Treatment|Adverse Event|0|||
145692258|NCT00784277|525389459|FG002|ER Treatment|Adverse Event|0|||
145692259|NCT00784277|525389460|FG003|ER Treatment|Adverse Event|0|||
145692260|NCT00784277|525389461|FG004|ER Treatment|Adverse Event|1|||
145692261|NCT00784277|525389462|FG005|ER Treatment|Adverse Event|7|||
145692262|NCT00784277|525389463|FG006|ER Treatment|Adverse Event|7|||
145692263|NCT00784277|525389457|FG000|ER Treatment|Lack of Efficacy|0|||
145692264|NCT00784277|525389458|FG001|ER Treatment|Lack of Efficacy|0|||
145692265|NCT00784277|525389459|FG002|ER Treatment|Lack of Efficacy|0|||
145692266|NCT00784277|525389460|FG003|ER Treatment|Lack of Efficacy|0|||
145692267|NCT00784277|525389461|FG004|ER Treatment|Lack of Efficacy|3|||
145692268|NCT00784277|525389462|FG005|ER Treatment|Lack of Efficacy|4|||
145692269|NCT00784277|525389463|FG006|ER Treatment|Lack of Efficacy|0|||
145692270|NCT00784277|525389457|FG000|ER Treatment|Lost to Follow-up|0|||
145692271|NCT00784277|525389458|FG001|ER Treatment|Lost to Follow-up|0|||
145692272|NCT00784277|525389459|FG002|ER Treatment|Lost to Follow-up|0|||
145692273|NCT00784277|525389460|FG003|ER Treatment|Lost to Follow-up|0|||
145692274|NCT00784277|525389461|FG004|ER Treatment|Lost to Follow-up|0|||
145692275|NCT00784277|525389462|FG005|ER Treatment|Lost to Follow-up|2|||
145692276|NCT00784277|525389463|FG006|ER Treatment|Lost to Follow-up|0|||
145692277|NCT00784277|525389457|FG000|ER Treatment|Withdrawal by Subject|0|||
145692278|NCT00784277|525389458|FG001|ER Treatment|Withdrawal by Subject|0|||
145692279|NCT00784277|525389459|FG002|ER Treatment|Withdrawal by Subject|0|||
145692280|NCT00784277|525389460|FG003|ER Treatment|Withdrawal by Subject|0|||
145692281|NCT00784277|525389461|FG004|ER Treatment|Withdrawal by Subject|2|||
145692282|NCT00784277|525389462|FG005|ER Treatment|Withdrawal by Subject|5|||
145692283|NCT00784277|525389463|FG006|ER Treatment|Withdrawal by Subject|3|||
145692284|NCT00784277|525389457|FG000|ER Treatment|Study Medication Non-Compliant|0|||
145692285|NCT00784277|525389458|FG001|ER Treatment|Study Medication Non-Compliant|0|||
145692286|NCT00784277|525389459|FG002|ER Treatment|Study Medication Non-Compliant|0|||
145692287|NCT00784277|525389460|FG003|ER Treatment|Study Medication Non-Compliant|0|||
145692288|NCT00784277|525389461|FG004|ER Treatment|Study Medication Non-Compliant|2|||
145692289|NCT00784277|525389462|FG005|ER Treatment|Study Medication Non-Compliant|3|||
145692290|NCT00784277|525389463|FG006|ER Treatment|Study Medication Non-Compliant|3|||
145692291|NCT00784277|525389457|FG000|ER Treatment|Other|0|||
145692292|NCT00784277|525389458|FG001|ER Treatment|Other|0|||
145692293|NCT00784277|525389459|FG002|ER Treatment|Other|0|||
145692294|NCT00784277|525389460|FG003|ER Treatment|Other|0|||
145692295|NCT00784277|525389461|FG004|ER Treatment|Other|1|||
145692296|NCT00784277|525389462|FG005|ER Treatment|Other|3|||
145692297|NCT00784277|525389463|FG006|ER Treatment|Other|2|||
145692298|NCT01093222|525389464|FG000|Overall Study|Ineligible|6|||
145692299|NCT01093222|525389464|FG000|Overall Study|Adverse Event|7|||
145692300|NCT01093222|525389464|FG000|Overall Study|Progression/relapse|24|||
145692301|NCT01093222|525389464|FG000|Overall Study|Death|2|||
145692302|NCT01093222|525389464|FG000|Overall Study|Not protocol specified|1|||
145692303|NCT00187135|525389465|FG000|Visit One|Withdrawal by Subject|1|||
145692304|NCT00187135|525389466|FG001|Visit One|Withdrawal by Subject|0|||
145692305|NCT00187135|525389467|FG002|Visit One|Withdrawal by Subject|0|||
145692306|NCT00187135|525389468|FG003|Visit One|Withdrawal by Subject|0|||
145692307|NCT00187135|525389469|FG004|Visit One|Withdrawal by Subject|0|||
145692308|NCT00187135|525389470|FG005|Visit One|Withdrawal by Subject|1|||
145692309|NCT00187135|525389465|FG000|Visit One|Physician Decision|3|||
145692310|NCT00187135|525389466|FG001|Visit One|Physician Decision|1|||
145692311|NCT00187135|525389467|FG002|Visit One|Physician Decision|0|||
145692312|NCT00187135|525389468|FG003|Visit One|Physician Decision|0|||
145692313|NCT00187135|525389469|FG004|Visit One|Physician Decision|0|||
145692314|NCT00187135|525389470|FG005|Visit One|Physician Decision|1|||
145692315|NCT00187135|525389465|FG000|Visit Two|Death|0|||
145692316|NCT00187135|525389466|FG001|Visit Two|Death|0|||
145692317|NCT00187135|525389467|FG002|Visit Two|Death|0|||
145692318|NCT00187135|525389468|FG003|Visit Two|Death|1|||
145692319|NCT00187135|525389469|FG004|Visit Two|Death|0|||
145692320|NCT00187135|525389470|FG005|Visit Two|Death|1|||
145692321|NCT00187135|525389465|FG000|Visit Two|Physician Decision|1|||
145692322|NCT00187135|525389466|FG001|Visit Two|Physician Decision|0|||
145692323|NCT00187135|525389467|FG002|Visit Two|Physician Decision|0|||
145692324|NCT00187135|525389468|FG003|Visit Two|Physician Decision|0|||
145692325|NCT00187135|525389469|FG004|Visit Two|Physician Decision|0|||
145692326|NCT00187135|525389470|FG005|Visit Two|Physician Decision|0|||
145692327|NCT00187135|525389465|FG000|Visit Two|Withdrawal by Subject|1|||
145692328|NCT00187135|525389466|FG001|Visit Two|Withdrawal by Subject|1|||
145692329|NCT00187135|525389467|FG002|Visit Two|Withdrawal by Subject|1|||
145692330|NCT00187135|525389468|FG003|Visit Two|Withdrawal by Subject|0|||
145692331|NCT00187135|525389469|FG004|Visit Two|Withdrawal by Subject|1|||
145692332|NCT00187135|525389470|FG005|Visit Two|Withdrawal by Subject|1|||
145692333|NCT00187135|525389465|FG000|Visit Two|Study Discontinued|3|||
145692334|NCT00187135|525389466|FG001|Visit Two|Study Discontinued|2|||
145692335|NCT00187135|525389467|FG002|Visit Two|Study Discontinued|1|||
145692336|NCT00187135|525389468|FG003|Visit Two|Study Discontinued|7|||
145692337|NCT00187135|525389469|FG004|Visit Two|Study Discontinued|5|||
145692338|NCT00187135|525389470|FG005|Visit Two|Study Discontinued|6|||
145692339|NCT00187135|525389465|FG000|Visit Three|Death|0|||
145692340|NCT00187135|525389466|FG001|Visit Three|Death|0|||
145692341|NCT00187135|525389467|FG002|Visit Three|Death|1|||
145692342|NCT00187135|525389468|FG003|Visit Three|Death|0|||
145692343|NCT00187135|525389469|FG004|Visit Three|Death|1|||
145692344|NCT00187135|525389470|FG005|Visit Three|Death|0|||
145692345|NCT00187135|525389465|FG000|Visit Three|Withdrawal by Subject|0|||
145692346|NCT00187135|525389466|FG001|Visit Three|Withdrawal by Subject|1|||
145692347|NCT00187135|525389467|FG002|Visit Three|Withdrawal by Subject|1|||
145692348|NCT00187135|525389468|FG003|Visit Three|Withdrawal by Subject|2|||
145692349|NCT00187135|525389469|FG004|Visit Three|Withdrawal by Subject|0|||
145692350|NCT00187135|525389470|FG005|Visit Three|Withdrawal by Subject|0|||
145692351|NCT00187135|525389465|FG000|Visit Three|Study Discontinued|7|||
145692352|NCT00187135|525389466|FG001|Visit Three|Study Discontinued|6|||
145692353|NCT00187135|525389467|FG002|Visit Three|Study Discontinued|7|||
145692354|NCT00187135|525389468|FG003|Visit Three|Study Discontinued|7|||
145692355|NCT00187135|525389469|FG004|Visit Three|Study Discontinued|7|||
145692356|NCT00187135|525389470|FG005|Visit Three|Study Discontinued|6|||
145692357|NCT02515097|525389477|FG000|Overall Study|Lost to Follow-up|4|||
145692358|NCT02515097|525389478|FG001|Overall Study|Lost to Follow-up|2|||
145692359|NCT02515097|525389477|FG000|Overall Study|Withdrawal by Subject|1|||
145692360|NCT02515097|525389478|FG001|Overall Study|Withdrawal by Subject|3|||
145692361|NCT02515097|525389477|FG000|Overall Study|Adverse Event|2|||
145692362|NCT02515097|525389478|FG001|Overall Study|Adverse Event|1|||
145692363|NCT00853021|525389479|FG000|Overall Study|Adverse Event|2|||
145692364|NCT00853021|525389479|FG000|Overall Study|Withdrawal by Subject|2|||
145692365|NCT00853021|525389479|FG000|Overall Study|Death|1|||
145692366|NCT03613454|525389480|FG000|Overall Study|Protocol Violation|1|||
145692367|NCT03613454|525389481|FG001|Overall Study|Protocol Violation|0|||
145692368|NCT03613454|525389480|FG000|Overall Study|Protocol Violation|0|||
145692369|NCT03613454|525389481|FG001|Overall Study|Protocol Violation|1|||
145692370|NCT02273180|525389485|FG000|Overall Study|Adverse Event|2|||
145692371|NCT02273180|525389486|FG001|Overall Study|Adverse Event|2|||
145692372|NCT02273180|525389485|FG000|Overall Study|Lack of Efficacy|1|||
145692373|NCT02273180|525389486|FG001|Overall Study|Lack of Efficacy|0|||
145692374|NCT02273180|525389485|FG000|Overall Study|Protocol Violation|1|||
145692375|NCT02273180|525389486|FG001|Overall Study|Protocol Violation|7|||
145692376|NCT02273180|525389485|FG000|Overall Study|Randomized but not treated|1|||
145692377|NCT02273180|525389486|FG001|Overall Study|Randomized but not treated|0|||
145692378|NCT02273180|525389485|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
145692379|NCT02273180|525389486|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
145692380|NCT02273180|525389485|FG000|Overall Study|Other than specified above|21|||
145692381|NCT02273180|525389486|FG001|Overall Study|Other than specified above|10|||
145692382|NCT02154516|525389487|FG000|Overall Study|Withdrawal by Subject|0|||
145692383|NCT02154516|525389488|FG001|Overall Study|Withdrawal by Subject|1|||
145692384|NCT02154516|525389487|FG000|Overall Study|Lost to Follow-up|1|||
145692385|NCT02154516|525389488|FG001|Overall Study|Lost to Follow-up|0|||
145692386|NCT02154516|525389487|FG000|Overall Study|Removal/revision of device|1|||
145692387|NCT02154516|525389488|FG001|Overall Study|Removal/revision of device|0|||
145692388|NCT02154516|525389487|FG000|Overall Study|Death|2|||
145692389|NCT02154516|525389488|FG001|Overall Study|Death|1|||
145692390|NCT02965599|525389492|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
145692391|NCT02965599|525389493|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
145692392|NCT04435522|525389497|FG000|Overall Study|Withdrawal by Subject|2|||
145692393|NCT02799745|525389500|FG000|Overall Study|Participant moved out of state|1|||
145692394|NCT02799745|525389501|FG001|Overall Study|Participant moved out of state|0|||
145692395|NCT02799745|525389500|FG000|Overall Study|Discontinued due to planned surgery|1|||
145692396|NCT02799745|525389501|FG001|Overall Study|Discontinued due to planned surgery|0|||
145692397|NCT02799745|525389500|FG000|Overall Study|Withdrawal by Subject|16|||
145692398|NCT02799745|525389501|FG001|Overall Study|Withdrawal by Subject|25|||
145692399|NCT02799745|525389500|FG000|Overall Study|Protocol Deviation|4|||
145692400|NCT02799745|525389501|FG001|Overall Study|Protocol Deviation|5|||
145692401|NCT02799745|525389500|FG000|Overall Study|Progressive Disease|28|||
145692402|NCT02799745|525389501|FG001|Overall Study|Progressive Disease|38|||
145692403|NCT02799745|525389500|FG000|Overall Study|Lost to Follow-up|3|||
145692404|NCT02799745|525389501|FG001|Overall Study|Lost to Follow-up|2|||
145692405|NCT02799745|525389500|FG000|Overall Study|Death|3|||
145692406|NCT02799745|525389501|FG001|Overall Study|Death|0|||
145692407|NCT02799745|525389500|FG000|Overall Study|Adverse Event|0|||
145692408|NCT02799745|525389501|FG001|Overall Study|Adverse Event|1|||
145692409|NCT00853372|525390726|FG000|Overall Study|Death|30|||
145692410|NCT00853372|525390727|FG001|Overall Study|Death|26|||
145692411|NCT00853372|525390726|FG000|Overall Study|Lost to Follow-up|1|||
145692412|NCT00853372|525390727|FG001|Overall Study|Lost to Follow-up|2|||
145692413|NCT00853372|525390726|FG000|Overall Study|Full Consent Withdrawn|1|||
145692414|NCT00853372|525390727|FG001|Overall Study|Full Consent Withdrawn|1|||
145692415|NCT02517528|525390728|FG000|Overall Study|Withdrawal by Subject|1|||
145692416|NCT01093599|525390731|FG000|Overall Study|Lost to Follow-up|32|||
145692417|NCT01093599|525390732|FG001|Overall Study|Lost to Follow-up|46|||
145692418|NCT01703845|525390733|FG000|Overall Study|Adverse Event|1|||
145692419|NCT01703845|525390734|FG001|Overall Study|Adverse Event|0|||
145692420|NCT01703845|525390733|FG000|Overall Study|Protocol Violation|1|||
145692421|NCT01703845|525390734|FG001|Overall Study|Protocol Violation|0|||
145692422|NCT01703845|525390733|FG000|Overall Study|other than stated above|1|||
145692423|NCT01703845|525390734|FG001|Overall Study|other than stated above|0|||
145692424|NCT01644188|525390735|FG000|Overall Study|Adverse Event|44|||
145692425|NCT01644188|525390736|FG001|Overall Study|Adverse Event|20|||
145692426|NCT01644188|525390735|FG000|Overall Study|Poor compliance to protocol|26|||
145692427|NCT01644188|525390736|FG001|Overall Study|Poor compliance to protocol|14|||
145692428|NCT01644188|525390735|FG000|Overall Study|Physician Decision|1|||
145692429|NCT01644188|525390736|FG001|Overall Study|Physician Decision|3|||
145692430|NCT01644188|525390735|FG000|Overall Study|Participant moved|7|||
145692431|NCT01644188|525390736|FG001|Overall Study|Participant moved|2|||
145692432|NCT01644188|525390735|FG000|Overall Study|Related to auto-injector administration|2|||
145692433|NCT01644188|525390736|FG001|Overall Study|Related to auto-injector administration|2|||
145692434|NCT01644188|525390735|FG000|Overall Study|Consent withdrawn by participant|14|||
145692435|NCT01644188|525390736|FG001|Overall Study|Consent withdrawn by participant|7|||
145692436|NCT01644188|525390735|FG000|Overall Study|Selection criteria finally not met|2|||
145692437|NCT01644188|525390736|FG001|Overall Study|Selection criteria finally not met|0|||
145692438|NCT01644188|525390735|FG000|Overall Study|Lost to Follow-up|1|||
145692439|NCT01644188|525390736|FG001|Overall Study|Lost to Follow-up|0|||
145692440|NCT01644188|525390735|FG000|Overall Study|Death|4|||
145692441|NCT01644188|525390736|FG001|Overall Study|Death|3|||
145692442|NCT01644188|525390735|FG000|Overall Study|Last visit outside protocol visit window|14|||
145692443|NCT01644188|525390736|FG001|Overall Study|Last visit outside protocol visit window|16|||
145692444|NCT01644188|525390735|FG000|Overall Study|Site closure|1|||
145692445|NCT01644188|525390736|FG001|Overall Study|Site closure|1|||
145692446|NCT01644188|525390735|FG000|Overall Study|Other than specified above|6|||
145692447|NCT01644188|525390736|FG001|Overall Study|Other than specified above|7|||
145692448|NCT03991988|525390739|FG000|Overall Study|Withdrawal by Subject|2|||
145692449|NCT03991988|525390740|FG001|Overall Study|Withdrawal by Subject|2|||
145692450|NCT00966979|525390741|FG000|Overall Study|Death|1|||
145692451|NCT00966979|525390741|FG000|Overall Study|Lost to Follow-up|6|||
145692452|NCT00966979|525390741|FG000|Overall Study|Withdrawal by Subject|14|||
145692453|NCT00966979|525390741|FG000|Overall Study|Adverse Event|5|||
145692454|NCT00966979|525390741|FG000|Overall Study|Sponsor terminated early|49|||
145692455|NCT00966979|525390741|FG000|Overall Study|Censored because surgery not done|2|||
145692456|NCT00966979|525390741|FG000|Overall Study|Censored because study device was not implanted|14|||
145692457|NCT00966979|525390741|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
145692458|NCT00630552|525390745|FG000|Overall Study|Adverse Event|0|||
145692459|NCT00630552|525390746|FG001|Overall Study|Adverse Event|1|||
145692460|NCT00630552|525390747|FG002|Overall Study|Adverse Event|5|||
145692461|NCT00630552|525390748|FG003|Overall Study|Adverse Event|4|||
145692462|NCT00630552|525390749|FG004|Overall Study|Adverse Event|2|||
145692463|NCT00630552|525390745|FG000|Overall Study|Disease progression|5|||
145692464|NCT00630552|525390746|FG001|Overall Study|Disease progression|6|||
145692465|NCT00630552|525390747|FG002|Overall Study|Disease progression|27|||
145692466|NCT00630552|525390748|FG003|Overall Study|Disease progression|22|||
145692467|NCT00630552|525390749|FG004|Overall Study|Disease progression|31|||
145692468|NCT00630552|525390745|FG000|Overall Study|Never received IP|0|||
145692469|NCT00630552|525390746|FG001|Overall Study|Never received IP|0|||
145692470|NCT00630552|525390747|FG002|Overall Study|Never received IP|0|||
145692471|NCT00630552|525390748|FG003|Overall Study|Never received IP|2|||
145692472|NCT00630552|525390749|FG004|Overall Study|Never received IP|2|||
145692473|NCT00630552|525390745|FG000|Overall Study|Ineligibility determined|0|||
145692474|NCT00630552|525390746|FG001|Overall Study|Ineligibility determined|0|||
145692475|NCT00630552|525390747|FG002|Overall Study|Ineligibility determined|0|||
145692476|NCT00630552|525390748|FG003|Overall Study|Ineligibility determined|0|||
145692477|NCT00630552|525390749|FG004|Overall Study|Ineligibility determined|1|||
145692478|NCT00630552|525390745|FG000|Overall Study|Protocol Violation|0|||
145692479|NCT00630552|525390746|FG001|Overall Study|Protocol Violation|0|||
145692480|NCT00630552|525390747|FG002|Overall Study|Protocol Violation|0|||
145692481|NCT00630552|525390748|FG003|Overall Study|Protocol Violation|1|||
145692482|NCT00630552|525390749|FG004|Overall Study|Protocol Violation|0|||
145692483|NCT00630552|525390745|FG000|Overall Study|Physician Decision|0|||
145692484|NCT00630552|525390746|FG001|Overall Study|Physician Decision|0|||
145692485|NCT00630552|525390747|FG002|Overall Study|Physician Decision|0|||
145692486|NCT00630552|525390748|FG003|Overall Study|Physician Decision|0|||
145692487|NCT00630552|525390749|FG004|Overall Study|Physician Decision|1|||
145692488|NCT00630552|525390745|FG000|Overall Study|Death|0|||
145692489|NCT00630552|525390746|FG001|Overall Study|Death|0|||
145692490|NCT00630552|525390747|FG002|Overall Study|Death|1|||
145692491|NCT00630552|525390748|FG003|Overall Study|Death|2|||
145692492|NCT00630552|525390749|FG004|Overall Study|Death|2|||
145692493|NCT00630552|525390745|FG000|Overall Study|Withdrawal by Subject|0|||
145692494|NCT00630552|525390746|FG001|Overall Study|Withdrawal by Subject|0|||
145692495|NCT00630552|525390747|FG002|Overall Study|Withdrawal by Subject|0|||
145692496|NCT00630552|525390748|FG003|Overall Study|Withdrawal by Subject|1|||
145692497|NCT00630552|525390749|FG004|Overall Study|Withdrawal by Subject|0|||
145692498|NCT00630552|525390745|FG000|Overall Study|Other|0|||
145692499|NCT00630552|525390746|FG001|Overall Study|Other|0|||
145692500|NCT00630552|525390747|FG002|Overall Study|Other|4|||
145692501|NCT00630552|525390748|FG003|Overall Study|Other|2|||
145692502|NCT00630552|525390749|FG004|Overall Study|Other|0|||
145692503|NCT03226106|525390750|FG000|Overall Study|Withdrawal by Subject|2|||
145692504|NCT03226106|525390751|FG001|Overall Study|Withdrawal by Subject|0|||
145692505|NCT03226106|525390750|FG000|Overall Study|Adverse Event|1|||
145692506|NCT03226106|525390751|FG001|Overall Study|Adverse Event|0|||
145692507|NCT03226106|525390750|FG000|Overall Study|Lost to Follow-up|2|||
145692508|NCT03226106|525390751|FG001|Overall Study|Lost to Follow-up|0|||
145692509|NCT01084239|525390752|FG000|28-Day Follow-up|Lost to Follow-up|4|||
145692510|NCT01084239|525390753|FG001|28-Day Follow-up|Lost to Follow-up|9|||
145692511|NCT00721214|525390754|FG000|Overall Study|Chose another center for transplant|1|||
145692512|NCT00721214|525390754|FG000|Overall Study|Death|3|||
145692513|NCT00983905|525390755|FG000|Theophylline Alone|Adverse Event|1|||
145692514|NCT00983905|525390755|FG000|Colchicine Alone|Adverse Event|2|||
145692515|NCT02396953|525390756|FG000|Overall Study|Withdrawal by Subject|0|||
145692516|NCT02396953|525390757|FG001|Overall Study|Withdrawal by Subject|0|||
145692517|NCT02396953|525390758|FG002|Overall Study|Withdrawal by Subject|1|||
145692518|NCT02396953|525390756|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
145692519|NCT02396953|525390757|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
145692520|NCT02396953|525390758|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
145692521|NCT02396953|525390756|FG000|Overall Study|Personal Reasons|1|||
145692522|NCT02396953|525390757|FG001|Overall Study|Personal Reasons|1|||
145692523|NCT02396953|525390758|FG002|Overall Study|Personal Reasons|0|||
145692524|NCT00488319|525390759|FG000|Overall Study|Adverse Event|1|||
145692525|NCT00488319|525390760|FG001|Overall Study|Adverse Event|2|||
145692526|NCT00488319|525390761|FG002|Overall Study|Adverse Event|23|||
145692527|NCT00488319|525390759|FG000|Overall Study|Lack of Efficacy|6|||
145692528|NCT00488319|525390760|FG001|Overall Study|Lack of Efficacy|12|||
145692529|NCT00488319|525390761|FG002|Overall Study|Lack of Efficacy|27|||
145692530|NCT00488319|525390759|FG000|Overall Study|Lost to Follow-up|3|||
145692531|NCT00488319|525390760|FG001|Overall Study|Lost to Follow-up|5|||
145692532|NCT00488319|525390761|FG002|Overall Study|Lost to Follow-up|16|||
145692533|NCT00488319|525390759|FG000|Overall Study|Withdrawal by Subject|5|||
145692534|NCT00488319|525390760|FG001|Overall Study|Withdrawal by Subject|20|||
145692535|NCT00488319|525390761|FG002|Overall Study|Withdrawal by Subject|44|||
145692536|NCT00488319|525390759|FG000|Overall Study|Other reasons for withdrawal|0|||
145692537|NCT00488319|525390760|FG001|Overall Study|Other reasons for withdrawal|4|||
145692538|NCT00488319|525390761|FG002|Overall Study|Other reasons for withdrawal|12|||
145692539|NCT00632931|525390764|FG000|Part 1, Period 1|Protocol Violation|1|||
145692540|NCT00632931|525390765|FG001|Part 1, Period 1|Protocol Violation|0|||
145692541|NCT00632931|525390766|FG002|Part 1, Period 1|Protocol Violation|0|||
145692542|NCT00632931|525390764|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
145692543|NCT00632931|525390765|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
145692544|NCT00632931|525390766|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
145692545|NCT00632931|525390764|FG000|Part 2|Adverse Event|0|||
145692546|NCT00632931|525390765|FG001|Part 2|Adverse Event|0|||
145692547|NCT00632931|525390766|FG002|Part 2|Adverse Event|3|||
145692548|NCT00632931|525390764|FG000|Part 2|Death|0|||
145692549|NCT00632931|525390765|FG001|Part 2|Death|0|||
145692550|NCT00632931|525390766|FG002|Part 2|Death|1|||
145692551|NCT00632931|525390764|FG000|Part 2|Lack of Efficacy|0|||
145692552|NCT00632931|525390765|FG001|Part 2|Lack of Efficacy|0|||
145692553|NCT00632931|525390766|FG002|Part 2|Lack of Efficacy|17|||
145692554|NCT00632931|525390764|FG000|Part 2|Withdrawal by Subject|0|||
145692555|NCT00632931|525390765|FG001|Part 2|Withdrawal by Subject|0|||
145692556|NCT00632931|525390766|FG002|Part 2|Withdrawal by Subject|3|||
145692557|NCT01402063|525390767|FG000|Overall Study|Withdrawal by Subject|3|||
145692558|NCT01402063|525390768|FG001|Overall Study|Withdrawal by Subject|3|||
145692559|NCT00468858|525390778|FG000|Overall Study|Adverse Event|0|||
145692560|NCT00468858|525390779|FG001|Overall Study|Adverse Event|1|||
145692561|NCT00468858|525390780|FG002|Overall Study|Adverse Event|0|||
145692562|NCT00468858|525390778|FG000|Overall Study|Withdrawal by Subject|7|||
145692563|NCT00468858|525390779|FG001|Overall Study|Withdrawal by Subject|4|||
145692564|NCT00468858|525390780|FG002|Overall Study|Withdrawal by Subject|5|||
145692565|NCT00468858|525390778|FG000|Overall Study|Relocation|1|||
145692566|NCT00468858|525390779|FG001|Overall Study|Relocation|3|||
145692567|NCT00468858|525390780|FG002|Overall Study|Relocation|3|||
145692568|NCT00468858|525390778|FG000|Overall Study|Lost to Follow-up|1|||
145692569|NCT00468858|525390779|FG001|Overall Study|Lost to Follow-up|2|||
145692570|NCT00468858|525390780|FG002|Overall Study|Lost to Follow-up|5|||
145692571|NCT00468858|525390778|FG000|Overall Study|Other|0|||
145692572|NCT00468858|525390779|FG001|Overall Study|Other|0|||
145692573|NCT00468858|525390780|FG002|Overall Study|Other|1|||
145692574|NCT01885936|525390783|FG000|Overall Study|Withdrawal by Subject|1|||
145692575|NCT01885936|525390784|FG001|Overall Study|Withdrawal by Subject|0|||
145692576|NCT03891641|525390790|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
145692577|NCT03891641|525390791|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
145692578|NCT03927222|525390797|FG000|Overall Study|Progression|3|||
145692579|NCT03927222|525390797|FG000|Overall Study|CMV testing results inconclusive|1|||
145692580|NCT03927222|525390797|FG000|Overall Study|Unable to generate enough vaccines|1|||
145692581|NCT03927222|525390797|FG000|Overall Study|Early study termination|1|||
145692582|NCT00640042|525390798|FG000|Enrollment|Did not receive study drug|83|||
145692583|NCT04414397|525390808|FG000|Control Period|Withdrawal by Subject|2|||
145692584|NCT04414397|525390809|FG001|Control Period|Withdrawal by Subject|2|||
145692585|NCT04414397|525390808|FG000|Control Period|Lost to Follow-up|0|||
145692586|NCT04414397|525390809|FG001|Control Period|Lost to Follow-up|4|||
145692587|NCT04414397|525390808|FG000|Control Period|Protocol deviation|0|||
145692588|NCT04414397|525390809|FG001|Control Period|Protocol deviation|1|||
145692589|NCT04414397|525390808|FG000|Post-Control Period|Withdrawal by Subject|3|||
145692590|NCT04414397|525390809|FG001|Post-Control Period|Withdrawal by Subject|6|||
145692591|NCT04414397|525390808|FG000|Post-Control Period|Lost to Follow-up|4|||
145692592|NCT04414397|525390809|FG001|Post-Control Period|Lost to Follow-up|9|||
145692593|NCT04414397|525390808|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
145692594|NCT04414397|525390809|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
145692595|NCT04414397|525390808|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
145692596|NCT04414397|525390809|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
145692597|NCT01592383|525390815|FG000|Overall Study|Adverse Event|1|||
145692598|NCT04167085|525390816|FG000|Baseline|Withdrawal by Subject|2|||
145692599|NCT04167085|525390817|FG001|Baseline|Withdrawal by Subject|1|||
145692600|NCT04167085|525390816|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
145692601|NCT04167085|525390817|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
145692602|NCT03640754|525390818|FG000|Overall Study|Withdrawal by Subject|1|||
145692603|NCT03640754|525390819|FG001|Overall Study|Withdrawal by Subject|0|||
145692604|NCT03640754|525390818|FG000|Overall Study|Lost to Follow-up|0|||
145692605|NCT03640754|525390819|FG001|Overall Study|Lost to Follow-up|1|||
145692606|NCT01204775|525390824|FG000|Overall Study|Poor/non-compliance|0|||
145692607|NCT01204775|525390825|FG001|Overall Study|Poor/non-compliance|1|||
145692608|NCT01204775|525390824|FG000|Overall Study|Withdrawal by Subject|1|||
145692609|NCT01204775|525390825|FG001|Overall Study|Withdrawal by Subject|0|||
145692610|NCT00276016|525390826|FG000|Intervention 1|Withdrawal by Subject|0|||
145692611|NCT00276016|525390827|FG001|Intervention 1|Withdrawal by Subject|1|||
145692612|NCT00276016|525390828|FG002|Intervention 1|Withdrawal by Subject|0|||
145692613|NCT00276016|525390829|FG003|Intervention 1|Withdrawal by Subject|0|||
145692614|NCT00276016|525390830|FG004|Intervention 1|Withdrawal by Subject|0|||
145692615|NCT00276016|525390831|FG005|Intervention 1|Withdrawal by Subject|0|||
145692616|NCT01679613|525390832|FG000|Overall Study|other than stated above|0|||
145692617|NCT01679613|525390833|FG001|Overall Study|other than stated above|1|||
145692618|NCT01679613|525390834|FG002|Overall Study|other than stated above|2|||
145692619|NCT01679613|525390835|FG003|Overall Study|other than stated above|2|||
145692620|NCT01374971|525390836|FG000|Overall Study|Withdrawal by Subject|1|||
145692621|NCT00509925|525390838|FG000|Overall Study|Personal reasons|0|||
145692622|NCT00509925|525390839|FG001|Overall Study|Personal reasons|1|||
145692623|NCT00951171|525390840|FG000|Overall Study|Adverse Event|2|||
145692624|NCT00951171|525390841|FG001|Overall Study|Adverse Event|0|||
145692625|NCT00919061|525390842|FG000|Overall Study|Adverse Event|1|||
145692626|NCT00919061|525390842|FG000|Overall Study|Withdrawal by Subject|1|||
145692627|NCT00560313|525392470|FG000|Overall Study|Adverse Events or Death|2|||
145692628|NCT00560313|525392470|FG000|Overall Study|Withdrawal by Subject|2|||
145692629|NCT00560313|525392470|FG000|Overall Study|Lost to Follow-up|1|||
145692630|NCT00560313|525392470|FG000|Overall Study|Protocol Violation|1|||
145692631|NCT00113269|525392471|FG000|Overall Study|Not transplanted, donor issues|4|||
145692632|NCT00113269|525392472|FG001|Overall Study|Not transplanted, donor issues|0|||
145692633|NCT00113269|525392473|FG002|Overall Study|Not transplanted, donor issues|2|||
145692634|NCT00113269|525392474|FG003|Overall Study|Not transplanted, donor issues|2|||
145692635|NCT00113269|525392471|FG000|Overall Study|Not transplanted, recipient issues|2|||
145692636|NCT00113269|525392472|FG001|Overall Study|Not transplanted, recipient issues|1|||
145692637|NCT00113269|525392473|FG002|Overall Study|Not transplanted, recipient issues|7|||
145692638|NCT00113269|525392474|FG003|Overall Study|Not transplanted, recipient issues|4|||
145692639|NCT00113269|525392471|FG000|Overall Study|Early graft loss, technical|0|||
145692640|NCT00113269|525392472|FG001|Overall Study|Early graft loss, technical|0|||
145692641|NCT00113269|525392473|FG002|Overall Study|Early graft loss, technical|2|||
145692642|NCT00113269|525392474|FG003|Overall Study|Early graft loss, technical|0|||
145692643|NCT00113269|525392471|FG000|Overall Study|Death in operating room|0|||
145692644|NCT00113269|525392472|FG001|Overall Study|Death in operating room|0|||
145692645|NCT00113269|525392473|FG002|Overall Study|Death in operating room|0|||
145692646|NCT00113269|525392474|FG003|Overall Study|Death in operating room|1|||
145692647|NCT00113269|525392471|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
145692648|NCT00113269|525392472|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
145692649|NCT00113269|525392473|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
145692650|NCT00113269|525392474|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
145692651|NCT00113269|525392471|FG000|Overall Study|Adverse Event|2|||
145692652|NCT00113269|525392472|FG001|Overall Study|Adverse Event|7|||
145692653|NCT00113269|525392473|FG002|Overall Study|Adverse Event|11|||
145692654|NCT00113269|525392474|FG003|Overall Study|Adverse Event|7|||
145692655|NCT00113269|525392471|FG000|Overall Study|Withdrawal by Subject|4|||
145692656|NCT00113269|525392472|FG001|Overall Study|Withdrawal by Subject|3|||
145692657|NCT00113269|525392473|FG002|Overall Study|Withdrawal by Subject|4|||
145692658|NCT00113269|525392474|FG003|Overall Study|Withdrawal by Subject|2|||
145692659|NCT00113269|525392471|FG000|Overall Study|Graft loss|6|||
145692660|NCT00113269|525392472|FG001|Overall Study|Graft loss|6|||
145692661|NCT00113269|525392473|FG002|Overall Study|Graft loss|4|||
145692662|NCT00113269|525392474|FG003|Overall Study|Graft loss|9|||
145692663|NCT00113269|525392471|FG000|Overall Study|Protocol Violation|1|||
145692664|NCT00113269|525392472|FG001|Overall Study|Protocol Violation|0|||
145692665|NCT00113269|525392473|FG002|Overall Study|Protocol Violation|4|||
145692666|NCT00113269|525392474|FG003|Overall Study|Protocol Violation|2|||
145692667|NCT00113269|525392471|FG000|Overall Study|Lost to Follow-up|2|||
145692668|NCT00113269|525392472|FG001|Overall Study|Lost to Follow-up|3|||
145692669|NCT00113269|525392473|FG002|Overall Study|Lost to Follow-up|6|||
145692670|NCT00113269|525392474|FG003|Overall Study|Lost to Follow-up|3|||
145692671|NCT00113269|525392471|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
145692672|NCT00113269|525392472|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
145692673|NCT00113269|525392473|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
145692674|NCT00113269|525392474|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
145692675|NCT00113269|525392471|FG000|Overall Study|Discontinued due to rejection|0|||
145692676|NCT00113269|525392472|FG001|Overall Study|Discontinued due to rejection|0|||
145692677|NCT00113269|525392473|FG002|Overall Study|Discontinued due to rejection|1|||
145692678|NCT00113269|525392474|FG003|Overall Study|Discontinued due to rejection|0|||
145692679|NCT00113269|525392471|FG000|Overall Study|Moved|0|||
145692680|NCT00113269|525392472|FG001|Overall Study|Moved|1|||
145692681|NCT00113269|525392473|FG002|Overall Study|Moved|0|||
145692682|NCT00113269|525392474|FG003|Overall Study|Moved|3|||
145692683|NCT00113269|525392471|FG000|Overall Study|Received pancreas transplant|0|||
145692684|NCT00113269|525392472|FG001|Overall Study|Received pancreas transplant|0|||
145692685|NCT00113269|525392473|FG002|Overall Study|Received pancreas transplant|0|||
145692686|NCT00113269|525392474|FG003|Overall Study|Received pancreas transplant|2|||
145692687|NCT00113269|525392471|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
145692688|NCT00113269|525392472|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
145692689|NCT00113269|525392473|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
145692690|NCT00113269|525392474|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
145692691|NCT00113269|525392471|FG000|Overall Study|Did not meet eligibility criteria|1|||
145692692|NCT00113269|525392472|FG001|Overall Study|Did not meet eligibility criteria|0|||
145692693|NCT00113269|525392473|FG002|Overall Study|Did not meet eligibility criteria|0|||
145692694|NCT00113269|525392474|FG003|Overall Study|Did not meet eligibility criteria|1|||
145692695|NCT00113269|525392471|FG000|Overall Study|Unable to return for follow up|2|||
145692696|NCT00113269|525392472|FG001|Overall Study|Unable to return for follow up|1|||
145692697|NCT00113269|525392473|FG002|Overall Study|Unable to return for follow up|0|||
145692698|NCT00113269|525392474|FG003|Overall Study|Unable to return for follow up|0|||
145692699|NCT01268098|525392481|FG000|Overall Study|Adverse Event|1|||
145692700|NCT01268098|525392482|FG001|Overall Study|Adverse Event|0|||
145692701|NCT01929876|525392485|FG000|Period 2|Non-Compliance|1|||
145692702|NCT01845649|525392488|FG000|Overall Study|Adverse Event|7|||
145692703|NCT01845649|525392489|FG001|Overall Study|Adverse Event|10|||
145692704|NCT01845649|525392488|FG000|Overall Study|Lack of Efficacy|1|||
145692705|NCT01845649|525392489|FG001|Overall Study|Lack of Efficacy|1|||
145692706|NCT01845649|525392488|FG000|Overall Study|Lost to Follow-up|2|||
145692707|NCT01845649|525392489|FG001|Overall Study|Lost to Follow-up|2|||
145692708|NCT01845649|525392488|FG000|Overall Study|Withdrew Consent|12|||
145692709|NCT01845649|525392489|FG001|Overall Study|Withdrew Consent|4|||
145692710|NCT01845649|525392488|FG000|Overall Study|Protocol Deviation|7|||
145692711|NCT01845649|525392489|FG001|Overall Study|Protocol Deviation|4|||
145692712|NCT01845649|525392488|FG000|Overall Study|Reason not Specified|2|||
145692713|NCT01845649|525392489|FG001|Overall Study|Reason not Specified|1|||
145692714|NCT01222533|525392491|FG000|Overall Study|Adverse Event|5|||
145692715|NCT01222533|525392491|FG000|Overall Study|Withdrawal by Subject|5|||
145692716|NCT01222533|525392491|FG000|Overall Study|Other|4|||
145692717|NCT01947517|525392492|FG000|Overall Study|Withdrawal by Subject|1|||
145692718|NCT01947517|525392493|FG001|Overall Study|Withdrawal by Subject|1|||
145692719|NCT03418493|525392494|FG000|Overall Study|Adverse Event|1|||
145692720|NCT03418493|525392495|FG001|Overall Study|Adverse Event|0|||
145692721|NCT03418493|525392496|FG002|Overall Study|Adverse Event|0|||
145692722|NCT03418493|525392497|FG003|Overall Study|Adverse Event|0|||
145692723|NCT03418493|525392498|FG004|Overall Study|Adverse Event|0|||
145692724|NCT03418493|525392499|FG005|Overall Study|Adverse Event|0|||
145692725|NCT03418493|525392500|FG006|Overall Study|Adverse Event|0|||
145692726|NCT03418493|525392501|FG007|Overall Study|Adverse Event|0|||
145692727|NCT03418493|525392502|FG008|Overall Study|Adverse Event|0|||
145692728|NCT03418493|525392503|FG009|Overall Study|Adverse Event|0|||
145692729|NCT03418493|525392504|FG010|Overall Study|Adverse Event|0|||
145692730|NCT03418493|525392494|FG000|Overall Study|Protocol Violation|0|||
145692731|NCT03418493|525392495|FG001|Overall Study|Protocol Violation|0|||
145692732|NCT03418493|525392496|FG002|Overall Study|Protocol Violation|0|||
145692733|NCT03418493|525392497|FG003|Overall Study|Protocol Violation|0|||
145692734|NCT03418493|525392498|FG004|Overall Study|Protocol Violation|0|||
145692735|NCT03418493|525392499|FG005|Overall Study|Protocol Violation|0|||
145692736|NCT03418493|525392500|FG006|Overall Study|Protocol Violation|0|||
145692737|NCT03418493|525392501|FG007|Overall Study|Protocol Violation|0|||
145692738|NCT03418493|525392502|FG008|Overall Study|Protocol Violation|0|||
145692739|NCT03418493|525392503|FG009|Overall Study|Protocol Violation|1|||
145692740|NCT03418493|525392504|FG010|Overall Study|Protocol Violation|0|||
145692741|NCT05446714|525392508|FG000|Overall Study|Lost to Follow-up|1|||
145692742|NCT05446714|525392509|FG001|Overall Study|Lost to Follow-up|3|||
145692743|NCT05446714|525392510|FG002|Overall Study|Lost to Follow-up|2|||
145692744|NCT05446714|525392508|FG000|Overall Study|Protocol Violation|2|||
145692745|NCT05446714|525392509|FG001|Overall Study|Protocol Violation|0|||
145692746|NCT05446714|525392510|FG002|Overall Study|Protocol Violation|0|||
145692747|NCT00526097|525392516|FG000|Overall Study|Adverse Event|6|||
145692748|NCT00526097|525392517|FG001|Overall Study|Adverse Event|44|||
145692749|NCT00526097|525392516|FG000|Overall Study|Protocol Violation|4|||
145692750|NCT00526097|525392517|FG001|Overall Study|Protocol Violation|10|||
145692751|NCT00526097|525392516|FG000|Overall Study|Withdrawal by Subject|3|||
145692752|NCT00526097|525392517|FG001|Overall Study|Withdrawal by Subject|1|||
145692753|NCT00526097|525392516|FG000|Overall Study|Other|2|||
145692754|NCT00526097|525392517|FG001|Overall Study|Other|1|||
145692755|NCT00943618|525392518|FG000|Overall Study|Lost to Follow-up|38|||
145692756|NCT00943618|525392519|FG001|Overall Study|Lost to Follow-up|48|||
145692757|NCT00943618|525392520|FG002|Overall Study|Lost to Follow-up|20|||
145692758|NCT00943618|525392518|FG000|Overall Study|Discontinued Medication|17|||
145692759|NCT00943618|525392519|FG001|Overall Study|Discontinued Medication|29|||
145692760|NCT00943618|525392520|FG002|Overall Study|Discontinued Medication|11|||
145692761|NCT03713281|525392525|FG000|Overall Study|Lens handling difficuluties|2|||
145692762|NCT03713281|525392525|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
145692763|NCT02412111|525392527|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
145692764|NCT02412111|525392528|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
145692765|NCT02412111|525392529|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
145692766|NCT02412111|525392527|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
145692767|NCT02412111|525392528|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
145692768|NCT02412111|525392529|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
145692769|NCT02412111|525392527|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
145692770|NCT02412111|525392528|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
145692771|NCT02412111|525392529|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
145692772|NCT02412111|525392527|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
145692773|NCT02412111|525392528|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
145692774|NCT02412111|525392529|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
145692775|NCT02412111|525392527|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
145692776|NCT02412111|525392528|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
145692777|NCT02412111|525392529|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
145692778|NCT02412111|525392527|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
145692779|NCT02412111|525392528|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
145692780|NCT02412111|525392529|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
145692781|NCT02412111|525392527|FG000|Active Comparator Period (8 Weeks)|Other|0|||
145692782|NCT02412111|525392528|FG001|Active Comparator Period (8 Weeks)|Other|0|||
145692783|NCT02412111|525392529|FG002|Active Comparator Period (8 Weeks)|Other|2|||
145692784|NCT00487552|525392530|FG000|Overall Study|Unsuccessful magnet placements|3|||
145692785|NCT00487552|525392530|FG000|Overall Study|Death due to progressive malignancy|2|||
145692786|NCT00487552|525392530|FG000|Overall Study|Stent not placed|1|||
145692787|NCT04349644|525392532|FG000|Allocation/Pretest|Lost to pretest|0|||
145692788|NCT04349644|525392533|FG001|Allocation/Pretest|Lost to pretest|3|||
145692789|NCT04349644|525392532|FG000|Posttest|Lost to posttest|0|||
145692790|NCT04349644|525392533|FG001|Posttest|Lost to posttest|8|||
145692791|NCT04349644|525392532|FG000|Posttest|Discontinued intervention|6|||
145692792|NCT04349644|525392533|FG001|Posttest|Discontinued intervention|0|||
145692793|NCT04349644|525392532|FG000|Follow-up|Lost to Follow-up|0|||
145692794|NCT04349644|525392533|FG001|Follow-up|Lost to Follow-up|2|||
145692795|NCT05006417|525392534|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
145692796|NCT01169636|525392535|FG000|Overall Study|Adverse Event|0|||
145692797|NCT01169636|525392536|FG001|Overall Study|Adverse Event|0|||
145692798|NCT01169636|525392537|FG002|Overall Study|Adverse Event|1|||
145692799|NCT01169636|525392538|FG003|Overall Study|Adverse Event|1|||
145692800|NCT01169636|525392539|FG004|Overall Study|Adverse Event|0|||
145692801|NCT01169636|525392535|FG000|Overall Study|Screen failure|0|||
145692802|NCT01169636|525392536|FG001|Overall Study|Screen failure|0|||
145692803|NCT01169636|525392537|FG002|Overall Study|Screen failure|2|||
145692804|NCT01169636|525392538|FG003|Overall Study|Screen failure|0|||
145692805|NCT01169636|525392539|FG004|Overall Study|Screen failure|0|||
145692806|NCT01169636|525392535|FG000|Overall Study|Withdrawal by Subject|0|||
145692807|NCT01169636|525392536|FG001|Overall Study|Withdrawal by Subject|0|||
145692808|NCT01169636|525392537|FG002|Overall Study|Withdrawal by Subject|0|||
145692809|NCT01169636|525392538|FG003|Overall Study|Withdrawal by Subject|0|||
145692810|NCT01169636|525392539|FG004|Overall Study|Withdrawal by Subject|3|||
145692811|NCT00510198|525392540|FG000|Overall Study|Withdrawal by Subject|5|||
145692812|NCT00510198|525392541|FG001|Overall Study|Withdrawal by Subject|4|||
145692813|NCT02994784|525392542|FG000|6 Months Follow-up|Lost to Follow-up|3|||
145692814|NCT00494026|525392543|FG000|Overall Study|Sponsor Decision|4|||
145692815|NCT02466243|525392544|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
145692816|NCT02466243|525392545|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
145692817|NCT02466243|525392544|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
145692818|NCT02466243|525392545|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
145692819|NCT02466243|525392544|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
145692820|NCT02466243|525392545|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
145692821|NCT02466243|525392544|FG000|Part B Open-label Treatment Period|Missing|2|||
145692822|NCT02466243|525392545|FG001|Part B Open-label Treatment Period|Missing|2|||
145692823|NCT01649557|525392549|FG000|Overall Study|Lost to Follow-up|5|||
145692824|NCT01649557|525392550|FG001|Overall Study|Lost to Follow-up|0|||
145692825|NCT01649557|525392551|FG002|Overall Study|Lost to Follow-up|3|||
145692826|NCT01649557|525392549|FG000|Overall Study|Adverse Event|7|||
145692827|NCT01649557|525392550|FG001|Overall Study|Adverse Event|5|||
145692828|NCT01649557|525392551|FG002|Overall Study|Adverse Event|1|||
145692829|NCT01649557|525392549|FG000|Overall Study|Met withdrawal criteria|4|||
145692830|NCT01649557|525392550|FG001|Overall Study|Met withdrawal criteria|0|||
145692831|NCT01649557|525392551|FG002|Overall Study|Met withdrawal criteria|0|||
145692832|NCT01649557|525392549|FG000|Overall Study|Physician Decision|8|||
145692833|NCT01649557|525392550|FG001|Overall Study|Physician Decision|2|||
145692834|NCT01649557|525392551|FG002|Overall Study|Physician Decision|1|||
145692835|NCT01649557|525392549|FG000|Overall Study|Withdrawal by Subject|15|||
145692836|NCT01649557|525392550|FG001|Overall Study|Withdrawal by Subject|5|||
145692837|NCT01649557|525392551|FG002|Overall Study|Withdrawal by Subject|4|||
145692838|NCT01649557|525392549|FG000|Overall Study|Protocol deviation|0|||
145692839|NCT01649557|525392550|FG001|Overall Study|Protocol deviation|2|||
145692840|NCT01649557|525392551|FG002|Overall Study|Protocol deviation|0|||
145692841|NCT01649557|525392549|FG000|Overall Study|Lack of Efficacy|5|||
145692842|NCT01649557|525392550|FG001|Overall Study|Lack of Efficacy|0|||
145692843|NCT01649557|525392551|FG002|Overall Study|Lack of Efficacy|0|||
145692844|NCT03029234|525392552|FG000|Overall Study|Sponsor Decision|1|||
145692845|NCT03029234|525392552|FG000|Overall Study|Withdrawal by Subject|5|||
145692846|NCT03029234|525392552|FG000|Overall Study|Death|91|||
145692847|NCT03029234|525392552|FG000|Overall Study|Lost to Follow-up|2|||
145692848|NCT02544113|525392553|FG000|Overall Study|Death|3|||
145692849|NCT02544113|525392554|FG001|Overall Study|Death|4|||
145692850|NCT00053352|525392555|FG000|Overall Study|Lost to Follow-up|0|||
145692851|NCT00053352|525392556|FG001|Overall Study|Lost to Follow-up|1|||
145692852|NCT00053352|525392555|FG000|Overall Study|Physician Decision|11|||
145692853|NCT00053352|525392556|FG001|Overall Study|Physician Decision|1|||
145692854|NCT00053352|525392555|FG000|Overall Study|Withdrawal by Subject|1|||
145692855|NCT00053352|525392556|FG001|Overall Study|Withdrawal by Subject|0|||
145692856|NCT00053352|525392555|FG000|Overall Study|Ineligible|8|||
145692857|NCT00053352|525392556|FG001|Overall Study|Ineligible|8|||
145692858|NCT00053352|525392555|FG000|Overall Study|Disease at new site|1|||
145692859|NCT00053352|525392556|FG001|Overall Study|Disease at new site|0|||
145692860|NCT01388478|525392557|FG000|Overall Study|Adverse Event|4|||
145692861|NCT01388478|525392557|FG000|Overall Study|Withdrawal by Subject|1|||
145692862|NCT01990664|525392558|FG000|Overall Study|Lost to Follow-up|2|||
145692863|NCT01990664|525392559|FG001|Overall Study|Lost to Follow-up|6|||
145491412|NCT00686777|524653798|FG000|Overall Study|No Visit|1|||
145491413|NCT01945021|524653799|FG000|Overall Study|Adverse Event|1|||
145692864|NCT01990664|525392558|FG000|Overall Study|Withdrawal by Subject|2|||
145692865|NCT01990664|525392559|FG001|Overall Study|Withdrawal by Subject|3|||
145692866|NCT01990664|525392558|FG000|Overall Study|Protocol Violation|1|||
145692867|NCT01990664|525392559|FG001|Overall Study|Protocol Violation|0|||
145692868|NCT01990664|525392558|FG000|Overall Study|Lens Discomfort|1|||
145692869|NCT01990664|525392559|FG001|Overall Study|Lens Discomfort|1|||
145692870|NCT01990664|525392558|FG000|Overall Study|Lens Handling Difficulties|1|||
145692871|NCT01990664|525392559|FG001|Overall Study|Lens Handling Difficulties|0|||
145692872|NCT01990664|525392558|FG000|Overall Study|Unsatisfactory Visual Response|0|||
145692873|NCT01990664|525392559|FG001|Overall Study|Unsatisfactory Visual Response|1|||
145692874|NCT01037413|525392560|FG000|Part A: Skin Testing|Adverse Event|1|||
145692875|NCT01037413|525392561|FG001|Part A: Skin Testing|Adverse Event|0|||
145692876|NCT01037413|525392560|FG000|Part A: Skin Testing|Protocol Violation|1|||
145692877|NCT01037413|525392561|FG001|Part A: Skin Testing|Protocol Violation|0|||
145692878|NCT01037413|525392560|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
145692879|NCT01037413|525392561|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
145692880|NCT01037413|525392560|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
145692881|NCT01037413|525392561|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
145692882|NCT00931918|525392565|FG000|Overall Study|Adverse Event|4|||
145692883|NCT00931918|525392566|FG001|Overall Study|Adverse Event|6|||
145692884|NCT00931918|525392565|FG000|Overall Study|Progressive Disease|2|||
145692885|NCT00931918|525392566|FG001|Overall Study|Progressive Disease|1|||
145692886|NCT00931918|525392565|FG000|Overall Study|Symptomatic Deterioration|1|||
145692887|NCT00931918|525392566|FG001|Overall Study|Symptomatic Deterioration|0|||
145692888|NCT00931918|525392565|FG000|Overall Study|Withdrawal by Patient|3|||
145692889|NCT00931918|525392566|FG001|Overall Study|Withdrawal by Patient|4|||
145692890|NCT00931918|525392565|FG000|Overall Study|Other Reason not Specified|4|||
145692891|NCT00931918|525392566|FG001|Overall Study|Other Reason not Specified|4|||
145692892|NCT00931918|525392565|FG000|Overall Study|Did not receive study drug|3|||
145692893|NCT00931918|525392566|FG001|Overall Study|Did not receive study drug|2|||
145692894|NCT00809341|525392567|FG000|Overall Study|Physician Decision|0|||
145692895|NCT00809341|525392568|FG001|Overall Study|Physician Decision|1|||
145692896|NCT00745121|525392579|FG000|Overall Study|Death|3|||
145692897|NCT00745121|525392580|FG001|Overall Study|Death|0|||
145692898|NCT00745121|525392579|FG000|Overall Study|Adverse Event|1|||
145692899|NCT00745121|525392580|FG001|Overall Study|Adverse Event|0|||
145692900|NCT00745121|525392579|FG000|Overall Study|Lost to Follow-up|1|||
145692901|NCT00745121|525392580|FG001|Overall Study|Lost to Follow-up|0|||
145692902|NCT00745121|525392579|FG000|Overall Study|Withdrawal by Subject|4|||
145692903|NCT00745121|525392580|FG001|Overall Study|Withdrawal by Subject|2|||
145692904|NCT03723915|525392590|FG000|Screening|Failed to meet screening requirements.|2|||
145692905|NCT03723915|525392590|FG000|On Treatment|Failed to meet treatment requirements|2|||
145692906|NCT01281917|525392593|FG000|Overall Study|Withdrawal by Subject|1|||
145692907|NCT04016805|525392594|FG000|Overall Study|Sponsor's Discretion|30|||
145692908|NCT04016805|525392595|FG001|Overall Study|Sponsor's Discretion|6|||
145265442|NCT01195662|523819360|FG001|Double Blind Treatment Period|Non-specified|0|||
145265443|NCT01195662|523819361|FG002|Double Blind Treatment Period|Non-specified|0|||
145265444|NCT01195662|523819359|FG000|Double Blind Treatment Period|Missing disposition information|0|||
145265445|NCT01195662|523819360|FG001|Double Blind Treatment Period|Missing disposition information|1|||
145265446|NCT01195662|523819361|FG002|Double Blind Treatment Period|Missing disposition information|1|||
145265447|NCT01195662|523819359|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
145265448|NCT01195662|523819360|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
145265449|NCT01195662|523819361|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
145265450|NCT01195662|523819359|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
145265451|NCT01195662|523819360|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
145265452|NCT01195662|523819361|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
145265453|NCT01463631|523819365|FG000|Overall Study|Withdrawal by Subject|0|||
145265454|NCT01463631|523819366|FG001|Overall Study|Withdrawal by Subject|0|||
145265455|NCT01463631|523819367|FG002|Overall Study|Withdrawal by Subject|0|||
145265456|NCT01463631|523819368|FG003|Overall Study|Withdrawal by Subject|1|||
145265457|NCT01463631|523819365|FG000|Overall Study|Death|0|||
145265458|NCT01463631|523819366|FG001|Overall Study|Death|0|||
145265459|NCT01463631|523819367|FG002|Overall Study|Death|1|||
145265460|NCT01463631|523819368|FG003|Overall Study|Death|0|||
145265461|NCT01463631|523819365|FG000|Overall Study|Progressive Disease|0|||
145265462|NCT01463631|523819366|FG001|Overall Study|Progressive Disease|0|||
145265463|NCT01463631|523819367|FG002|Overall Study|Progressive Disease|0|||
145265464|NCT01463631|523819368|FG003|Overall Study|Progressive Disease|5|||
145265465|NCT01298323|523819369|FG000|Overall Study|Adverse Event|2|||
145265466|NCT01298323|523819370|FG001|Overall Study|Adverse Event|4|||
145265467|NCT01298323|523819369|FG000|Overall Study|Death|11|||
145491414|NCT01945021|524653799|FG000|Overall Study|Withdrawal of consent|12|||
145265468|NCT01298323|523819370|FG001|Overall Study|Death|16|||
145265469|NCT01298323|523819369|FG000|Overall Study|Lost to Follow-up|1|||
145265470|NCT01298323|523819370|FG001|Overall Study|Lost to Follow-up|0|||
145265471|NCT01298323|523819369|FG000|Overall Study|Withdrawal by Subject|6|||
145265472|NCT01298323|523819370|FG001|Overall Study|Withdrawal by Subject|3|||
145491415|NCT01945021|524653799|FG000|Overall Study|Lost to Follow-up|5|||
145265473|NCT01298323|523819369|FG000|Overall Study|Protocol Violation|1|||
145491416|NCT01945021|524653799|FG000|Overall Study|Death|65|||
145692909|NCT04016805|525392596|FG002|Overall Study|Sponsor's Discretion|5|||
145692910|NCT00740870|525392599|FG000|Overall Study|Not Catheterized|4|||
145692911|NCT00740870|525392599|FG000|Overall Study|Further testing contraindicated implant|17|||
145692912|NCT00819013|525392600|FG000|Overall Study|Not meeting continuing study eligibility|2|||
145692913|NCT00819013|525392601|FG001|Overall Study|Not meeting continuing study eligibility|1|||
145692914|NCT00819013|525392602|FG002|Overall Study|Not meeting continuing study eligibility|2|||
145692915|NCT00819013|525392603|FG003|Overall Study|Not meeting continuing study eligibility|1|||
145692916|NCT00819013|525392600|FG000|Overall Study|Adverse Event|0|||
145692917|NCT00819013|525392601|FG001|Overall Study|Adverse Event|0|||
145692918|NCT00819013|525392602|FG002|Overall Study|Adverse Event|1|||
145692919|NCT00819013|525392603|FG003|Overall Study|Adverse Event|0|||
145692920|NCT00819013|525392600|FG000|Overall Study|Withdrawal by Subject|1|||
145692921|NCT00819013|525392601|FG001|Overall Study|Withdrawal by Subject|0|||
145692922|NCT00819013|525392602|FG002|Overall Study|Withdrawal by Subject|1|||
145692923|NCT00819013|525392603|FG003|Overall Study|Withdrawal by Subject|0|||
145692924|NCT00819013|525392600|FG000|Overall Study|Lost to Follow-up|0|||
145692925|NCT00819013|525392601|FG001|Overall Study|Lost to Follow-up|0|||
145692926|NCT00819013|525392602|FG002|Overall Study|Lost to Follow-up|1|||
145692927|NCT00819013|525392603|FG003|Overall Study|Lost to Follow-up|2|||
145692928|NCT00819013|525392600|FG000|Overall Study|Death|0|||
145692929|NCT00819013|525392601|FG001|Overall Study|Death|0|||
145692930|NCT00819013|525392602|FG002|Overall Study|Death|0|||
145692931|NCT00819013|525392603|FG003|Overall Study|Death|1|||
145692932|NCT00607997|525392604|FG000|Overall Study|Lack of Efficacy|6|||
145692933|NCT00607997|525392605|FG001|Overall Study|Lack of Efficacy|20|||
145692934|NCT00607997|525392606|FG002|Overall Study|Lack of Efficacy|14|||
145692935|NCT00607997|525392607|FG003|Overall Study|Lack of Efficacy|10|||
145692936|NCT00607997|525392604|FG000|Overall Study|Death|8|||
145692937|NCT00607997|525392605|FG001|Overall Study|Death|5|||
145692938|NCT00607997|525392606|FG002|Overall Study|Death|2|||
145692939|NCT00607997|525392607|FG003|Overall Study|Death|5|||
145692940|NCT00607997|525392604|FG000|Overall Study|Adverse Event|3|||
145692941|NCT00607997|525392605|FG001|Overall Study|Adverse Event|1|||
145692942|NCT00607997|525392606|FG002|Overall Study|Adverse Event|2|||
145692943|NCT00607997|525392607|FG003|Overall Study|Adverse Event|0|||
145692944|NCT00607997|525392604|FG000|Overall Study|Physician Decision|4|||
145692945|NCT00607997|525392605|FG001|Overall Study|Physician Decision|1|||
145692946|NCT00607997|525392606|FG002|Overall Study|Physician Decision|0|||
145692947|NCT00607997|525392607|FG003|Overall Study|Physician Decision|0|||
145692948|NCT00607997|525392604|FG000|Overall Study|Relapse, recurrent illness|4|||
145692949|NCT00607997|525392605|FG001|Overall Study|Relapse, recurrent illness|0|||
145692950|NCT00607997|525392606|FG002|Overall Study|Relapse, recurrent illness|2|||
145692951|NCT00607997|525392607|FG003|Overall Study|Relapse, recurrent illness|0|||
145692952|NCT00607997|525392604|FG000|Overall Study|Other without explanation|2|||
145692953|NCT00607997|525392605|FG001|Overall Study|Other without explanation|0|||
145692954|NCT00607997|525392606|FG002|Overall Study|Other without explanation|4|||
145692955|NCT00607997|525392607|FG003|Overall Study|Other without explanation|1|||
145692956|NCT00839332|525392611|FG000|Phase 1|Disease Progression|38|||
145692957|NCT00839332|525392612|FG001|Phase 1|Disease Progression|0|||
145692958|NCT00839332|525392613|FG002|Phase 1|Disease Progression|0|||
145692959|NCT00839332|525392611|FG000|Phase 1|Adverse Event|6|||
145692960|NCT00839332|525392612|FG001|Phase 1|Adverse Event|0|||
145692961|NCT00839332|525392613|FG002|Phase 1|Adverse Event|0|||
145692962|NCT00839332|525392611|FG000|Phase 1|Withdrawal by Subject|4|||
145692963|NCT00839332|525392612|FG001|Phase 1|Withdrawal by Subject|0|||
145692964|NCT00839332|525392613|FG002|Phase 1|Withdrawal by Subject|0|||
145692965|NCT00839332|525392611|FG000|Phase 1|Physician Decision|2|||
145692966|NCT00839332|525392612|FG001|Phase 1|Physician Decision|0|||
145692967|NCT00839332|525392613|FG002|Phase 1|Physician Decision|0|||
145692968|NCT00839332|525392611|FG000|Phase 2|Protocol Violation|0|||
145692969|NCT00839332|525392612|FG001|Phase 2|Protocol Violation|1|||
145491417|NCT02163902|524653800|FG000|Overall Study|Subject's Request|3|||
145692970|NCT00839332|525392613|FG002|Phase 2|Protocol Violation|0|||
145692971|NCT00839332|525392611|FG000|Phase 2|Disease Progression|0|||
145692972|NCT00839332|525392612|FG001|Phase 2|Disease Progression|46|||
145692973|NCT00839332|525392613|FG002|Phase 2|Disease Progression|21|||
145692974|NCT00839332|525392611|FG000|Phase 2|Adverse Event|0|||
145692975|NCT00839332|525392612|FG001|Phase 2|Adverse Event|8|||
145692976|NCT00839332|525392613|FG002|Phase 2|Adverse Event|6|||
145692977|NCT00839332|525392611|FG000|Phase 2|Death|0|||
145692978|NCT00839332|525392612|FG001|Phase 2|Death|4|||
145692979|NCT00839332|525392613|FG002|Phase 2|Death|2|||
145692980|NCT00839332|525392611|FG000|Phase 2|Withdrawal by Subject|0|||
145692981|NCT00839332|525392612|FG001|Phase 2|Withdrawal by Subject|5|||
145692982|NCT00839332|525392613|FG002|Phase 2|Withdrawal by Subject|8|||
145692983|NCT00839332|525392611|FG000|Phase 2|Physician Decision|0|||
145692984|NCT00839332|525392612|FG001|Phase 2|Physician Decision|4|||
145692985|NCT00839332|525392613|FG002|Phase 2|Physician Decision|1|||
145692986|NCT00839332|525392611|FG000|Phase 2|Lost to Follow-up|0|||
145692987|NCT00839332|525392612|FG001|Phase 2|Lost to Follow-up|0|||
145692988|NCT00839332|525392613|FG002|Phase 2|Lost to Follow-up|1|||
145692989|NCT01200485|525392614|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
145692990|NCT01200485|525392615|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
145692991|NCT01200485|525392616|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
145692992|NCT01200485|525392614|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
145692993|NCT01200485|525392615|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
145692994|NCT01200485|525392616|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
145692995|NCT06080438|525392618|FG000|Overall Study|Lost to Follow-up|2|||
145692996|NCT03589300|525392620|FG000|Overall Study|Adverse Event|2|||
145692997|NCT03589300|525392620|FG000|Overall Study|Death|4|||
145692998|NCT03589300|525392620|FG000|Overall Study|Lost to Follow-up|12|||
145692999|NCT03589300|525392620|FG000|Overall Study|Withdrawal by Subject|5|||
145693000|NCT01678898|525392625|FG000|PB-102-F01|Adverse Event|0|||
145693001|NCT01678898|525392626|FG001|PB-102-F01|Adverse Event|1|||
145693002|NCT01678898|525392627|FG002|PB-102-F01|Adverse Event|0|||
145693003|NCT01678898|525392625|FG000|PB-102-F01|Physician Decision|0|||
145693004|NCT01678898|525392626|FG001|PB-102-F01|Physician Decision|1|||
145693005|NCT01678898|525392627|FG002|PB-102-F01|Physician Decision|0|||
145693006|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
145693007|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
145693008|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
145693009|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Other|1|||
145693010|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Other|0|||
145693011|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Other|0|||
145693012|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Physician Decision|3|||
145693013|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Physician Decision|0|||
145693014|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Physician Decision|0|||
145693015|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
145693016|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
145693017|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
145693018|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
145693019|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
145693020|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
145693021|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Adverse Event|18|||
145693022|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Adverse Event|0|||
145693023|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Adverse Event|0|||
145693024|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
145693025|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
145693026|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
145693027|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
145693028|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
145693029|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
145693030|NCT03030599|525392628|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
145693031|NCT03030599|525392629|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
145693032|NCT03030599|525392630|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
145693033|NCT03030599|525392628|FG000|Stable Dose|Protocol deviation|3|||
145693034|NCT03030599|525392629|FG001|Stable Dose|Protocol deviation|0|||
145693035|NCT03030599|525392630|FG002|Stable Dose|Protocol deviation|0|||
145693036|NCT03030599|525392628|FG000|Stable Dose|Adverse Event|1|||
145693037|NCT03030599|525392629|FG001|Stable Dose|Adverse Event|0|||
145693038|NCT03030599|525392630|FG002|Stable Dose|Adverse Event|0|||
145693039|NCT03030599|525392628|FG000|Stable Dose|Lost to Follow-up|1|||
145693040|NCT03030599|525392629|FG001|Stable Dose|Lost to Follow-up|0|||
145693041|NCT03030599|525392630|FG002|Stable Dose|Lost to Follow-up|0|||
145693042|NCT03030599|525392628|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
145693043|NCT03030599|525392629|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
145693044|NCT03030599|525392630|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
145693045|NCT03030599|525392628|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
145693046|NCT03030599|525392629|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
145693047|NCT03030599|525392630|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
145693048|NCT03030599|525392628|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
145693049|NCT03030599|525392629|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
145693050|NCT03030599|525392630|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
145693051|NCT03030599|525392628|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
145693052|NCT03030599|525392629|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
145693053|NCT03030599|525392630|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
145693054|NCT03030599|525392628|FG000|Open-label Extension|Adverse Event|3|||
145693055|NCT03030599|525392629|FG001|Open-label Extension|Adverse Event|0|||
145693056|NCT03030599|525392630|FG002|Open-label Extension|Adverse Event|0|||
145693057|NCT03030599|525392628|FG000|Open-label Extension|Lost to Follow-up|2|||
145693058|NCT03030599|525392629|FG001|Open-label Extension|Lost to Follow-up|0|||
145693059|NCT03030599|525392630|FG002|Open-label Extension|Lost to Follow-up|0|||
145693060|NCT03030599|525392628|FG000|Open-label Extension|Lack of Efficacy|1|||
145693061|NCT03030599|525392629|FG001|Open-label Extension|Lack of Efficacy|0|||
145693062|NCT03030599|525392630|FG002|Open-label Extension|Lack of Efficacy|0|||
145693063|NCT03030599|525392628|FG000|Open-label Extension|Other Reason|1|||
145693064|NCT03030599|525392629|FG001|Open-label Extension|Other Reason|0|||
145693065|NCT03030599|525392630|FG002|Open-label Extension|Other Reason|0|||
145693066|NCT00230971|525392632|FG000|Randomization|No study drug administered|3|||
145693067|NCT00230971|525392633|FG001|Randomization|No study drug administered|3|||
145693068|NCT00230971|525392632|FG000|Baseline Participants|Lost to Follow-up|5|||
145693069|NCT00230971|525392633|FG001|Baseline Participants|Lost to Follow-up|12|||
145693070|NCT00230971|525392632|FG000|Baseline Participants|Death|6|||
145693071|NCT00230971|525392633|FG001|Baseline Participants|Death|5|||
145693072|NCT00230971|525392632|FG000|Baseline Participants|Withdrawal by Subject|7|||
145693073|NCT00230971|525392633|FG001|Baseline Participants|Withdrawal by Subject|1|||
145693074|NCT00230971|525392632|FG000|Baseline Participants|Adverse Event|1|||
145693075|NCT00230971|525392633|FG001|Baseline Participants|Adverse Event|0|||
145693076|NCT00230971|525392632|FG000|Baseline Participants|No bacteria observed|1|||
145693077|NCT00230971|525392633|FG001|Baseline Participants|No bacteria observed|0|||
145693078|NCT00230971|525392632|FG000|Baseline Participants|Failure to return|1|||
145693079|NCT00230971|525392633|FG001|Baseline Participants|Failure to return|1|||
145693080|NCT00230971|525392632|FG000|Baseline Participants|Reintervention|1|||
145693081|NCT00230971|525392633|FG001|Baseline Participants|Reintervention|0|||
145693082|NCT04380688|525392634|FG000|Overall Study|Death|2|||
145693083|NCT04380688|525392635|FG001|Overall Study|Death|2|||
145693084|NCT04380688|525392634|FG000|Overall Study|Lost to Follow-up|2|||
145693085|NCT04380688|525392635|FG001|Overall Study|Lost to Follow-up|4|||
145693086|NCT04380688|525392634|FG000|Overall Study|Withdrawal by Subject|3|||
145693087|NCT04380688|525392635|FG001|Overall Study|Withdrawal by Subject|3|||
145693088|NCT05294328|525392641|FG000|Overall Study|Adverse Event|1|||
145693089|NCT05294328|525392642|FG001|Overall Study|Adverse Event|0|||
145693090|NCT05294328|525392643|FG002|Overall Study|Adverse Event|0|||
145693091|NCT05294328|525392641|FG000|Overall Study|Physician Decision|1|||
145693092|NCT05294328|525392642|FG001|Overall Study|Physician Decision|1|||
145693093|NCT05294328|525392643|FG002|Overall Study|Physician Decision|0|||
145693094|NCT05294328|525392641|FG000|Overall Study|Withdrawal by Subject|0|||
145693095|NCT05294328|525392642|FG001|Overall Study|Withdrawal by Subject|2|||
145693096|NCT05294328|525392643|FG002|Overall Study|Withdrawal by Subject|1|||
145693097|NCT05294328|525392641|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
145693098|NCT05294328|525392642|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
145693099|NCT05294328|525392643|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
145693100|NCT04267393|525392644|FG000|Randomization|Adverse Event|1|||
145693101|NCT04267393|525392645|FG001|Randomization|Adverse Event|0|||
145693102|NCT04267393|525392646|FG002|Randomization|Adverse Event|0|||
145693103|NCT04267393|525392644|FG000|Randomization|Administrative Reasons by Sponsor|0|||
145693104|NCT04267393|525392645|FG001|Randomization|Administrative Reasons by Sponsor|1|||
145693105|NCT04267393|525392646|FG002|Randomization|Administrative Reasons by Sponsor|0|||
145693106|NCT04267393|525392644|FG000|Treatment Period|Adverse Event|0|||
145693107|NCT04267393|525392645|FG001|Treatment Period|Adverse Event|2|||
145693108|NCT04267393|525392646|FG002|Treatment Period|Adverse Event|3|||
145693109|NCT04267393|525392644|FG000|Treatment Period|Participant Withdrew Consent|0|||
145693110|NCT04267393|525392645|FG001|Treatment Period|Participant Withdrew Consent|0|||
145693111|NCT04267393|525392646|FG002|Treatment Period|Participant Withdrew Consent|1|||
145693112|NCT04267393|525392644|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
145693113|NCT04267393|525392645|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
145693114|NCT04267393|525392646|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
145693115|NCT02056873|525392647|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
145693116|NCT01917006|525394672|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
145693117|NCT01917006|525394673|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
145693118|NCT01917006|525394674|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
145693119|NCT01917006|525394675|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
145693120|NCT01917006|525394676|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
145693121|NCT01917006|525394677|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
145693122|NCT01917006|525394678|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
145693123|NCT01917006|525394679|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
145693124|NCT01917006|525394672|FG000|Randomized-treatment Period|Personal Reasons|0|||
145693125|NCT01917006|525394673|FG001|Randomized-treatment Period|Personal Reasons|0|||
145693126|NCT01917006|525394674|FG002|Randomized-treatment Period|Personal Reasons|0|||
145693127|NCT01917006|525394675|FG003|Randomized-treatment Period|Personal Reasons|0|||
145693128|NCT01917006|525394676|FG004|Randomized-treatment Period|Personal Reasons|0|||
145693129|NCT01917006|525394677|FG005|Randomized-treatment Period|Personal Reasons|1|||
145693130|NCT01917006|525394678|FG006|Randomized-treatment Period|Personal Reasons|0|||
145693131|NCT01917006|525394679|FG007|Randomized-treatment Period|Personal Reasons|0|||
145693132|NCT01917006|525394672|FG000|Randomized-treatment Period|Protocol Violation|1|||
145693133|NCT01917006|525394673|FG001|Randomized-treatment Period|Protocol Violation|0|||
145693134|NCT01917006|525394674|FG002|Randomized-treatment Period|Protocol Violation|0|||
145693135|NCT01917006|525394675|FG003|Randomized-treatment Period|Protocol Violation|0|||
145693136|NCT01917006|525394676|FG004|Randomized-treatment Period|Protocol Violation|0|||
145693137|NCT01917006|525394677|FG005|Randomized-treatment Period|Protocol Violation|0|||
145693138|NCT01917006|525394678|FG006|Randomized-treatment Period|Protocol Violation|0|||
145693139|NCT01917006|525394679|FG007|Randomized-treatment Period|Protocol Violation|0|||
145693140|NCT01917006|525394672|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693141|NCT01917006|525394673|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693142|NCT01917006|525394674|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693143|NCT01917006|525394675|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693144|NCT01917006|525394676|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693145|NCT01917006|525394677|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693146|NCT01917006|525394678|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
145693147|NCT01917006|525394679|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
145693148|NCT01917006|525394672|FG000|Open-label Period|Adverse Event|0|||
145693149|NCT01917006|525394673|FG001|Open-label Period|Adverse Event|0|||
145693150|NCT01917006|525394674|FG002|Open-label Period|Adverse Event|0|||
145693151|NCT01917006|525394675|FG003|Open-label Period|Adverse Event|0|||
145693152|NCT01917006|525394676|FG004|Open-label Period|Adverse Event|0|||
145693153|NCT01917006|525394677|FG005|Open-label Period|Adverse Event|0|||
145693154|NCT01917006|525394678|FG006|Open-label Period|Adverse Event|0|||
145693155|NCT01917006|525394679|FG007|Open-label Period|Adverse Event|1|||
145693156|NCT01917006|525394672|FG000|Open-label Period|Lost to Follow-up|0|||
145693157|NCT01917006|525394673|FG001|Open-label Period|Lost to Follow-up|0|||
145693158|NCT01917006|525394674|FG002|Open-label Period|Lost to Follow-up|0|||
145693159|NCT01917006|525394675|FG003|Open-label Period|Lost to Follow-up|0|||
145693160|NCT01917006|525394676|FG004|Open-label Period|Lost to Follow-up|0|||
145693161|NCT01917006|525394677|FG005|Open-label Period|Lost to Follow-up|0|||
145693162|NCT01917006|525394678|FG006|Open-label Period|Lost to Follow-up|0|||
145693163|NCT01917006|525394679|FG007|Open-label Period|Lost to Follow-up|1|||
145693164|NCT02158247|525394680|FG000|Overall Study|Invisible vocal cords|5|||
145693165|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
145693166|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
145693167|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
145693168|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
145693169|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
145693170|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
145693171|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
145693172|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
145693173|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
145693174|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
145693175|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
145693176|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
145693177|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
145693178|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
145693179|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
145693180|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
145693181|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
145693182|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
145693183|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
145693184|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
145693185|NCT02637856|525394688|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
145693186|NCT02637856|525394689|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
145693187|NCT02637856|525394688|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
145693188|NCT02637856|525394689|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
145693189|NCT02637856|525394688|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
145693190|NCT02637856|525394689|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
145693191|NCT02509312|525394690|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
145693192|NCT02509312|525394691|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
145693193|NCT02509312|525394690|FG000|Overall Study|Obstetrician refusal|0|||
145693194|NCT02509312|525394691|FG001|Overall Study|Obstetrician refusal|1|||
145693195|NCT02509312|525394690|FG000|Overall Study|Patient elected for TOLAC|1|||
145693196|NCT02509312|525394691|FG001|Overall Study|Patient elected for TOLAC|0|||
145693197|NCT02509312|525394690|FG000|Overall Study|Cesarean deemed stat|1|||
145693198|NCT02509312|525394691|FG001|Overall Study|Cesarean deemed stat|0|||
145693199|NCT02509312|525394690|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
145693200|NCT02509312|525394691|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
145693201|NCT02815735|525394694|FG000|First Intervention (4 Weeks)|Discomfort|1|||
145693202|NCT02815735|525394695|FG001|First Intervention (4 Weeks)|Discomfort|0|||
145693203|NCT02815735|525394694|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
145693204|NCT02815735|525394695|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
145693205|NCT02815735|525394694|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
145693206|NCT02815735|525394695|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
145693207|NCT02815735|525394694|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
145693208|NCT02815735|525394695|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
145693209|NCT00702650|525394697|FG000|Overall Study|Withdrawal by Subject|9|||
145693210|NCT00702650|525394697|FG000|Overall Study|Non-Compliance of Study Drug|3|||
145693211|NCT00702650|525394697|FG000|Overall Study|Lost to Follow-up|2|||
145693212|NCT00702650|525394697|FG000|Overall Study|Non-Compliance with Site Directives|1|||
145693213|NCT00702650|525394697|FG000|Overall Study|Sponsor Request|1|||
145693214|NCT00702650|525394697|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
145693215|NCT00702650|525394697|FG000|Overall Study|Adverse Event|3|||
145693216|NCT00988533|525394698|FG000|Overall Study|Lost to Follow-up|3|||
145693217|NCT00943722|525394700|FG000|Base Study|Adverse Event|0|||
145693218|NCT00943722|525394701|FG001|Base Study|Adverse Event|0|||
145693219|NCT00943722|525394702|FG002|Base Study|Adverse Event|0|||
145693220|NCT00943722|525394703|FG003|Base Study|Adverse Event|1|||
145693221|NCT00943722|525394704|FG004|Base Study|Adverse Event|0|||
145693222|NCT00943722|525394705|FG005|Base Study|Adverse Event|0|||
145693223|NCT00943722|525394706|FG006|Base Study|Adverse Event|0|||
145693224|NCT00943722|525394700|FG000|Base Study|Lost to Follow-up|12|||
145693225|NCT00943722|525394701|FG001|Base Study|Lost to Follow-up|8|||
145693226|NCT00943722|525394702|FG002|Base Study|Lost to Follow-up|10|||
145693227|NCT00943722|525394703|FG003|Base Study|Lost to Follow-up|8|||
145693228|NCT00943722|525394704|FG004|Base Study|Lost to Follow-up|11|||
145693229|NCT00943722|525394705|FG005|Base Study|Lost to Follow-up|0|||
145693230|NCT00943722|525394706|FG006|Base Study|Lost to Follow-up|0|||
145693231|NCT00943722|525394700|FG000|Base Study|Physician Decision|1|||
145693232|NCT00943722|525394701|FG001|Base Study|Physician Decision|0|||
145693233|NCT00943722|525394702|FG002|Base Study|Physician Decision|0|||
145693234|NCT00943722|525394703|FG003|Base Study|Physician Decision|0|||
145693235|NCT00943722|525394704|FG004|Base Study|Physician Decision|1|||
145693236|NCT00943722|525394705|FG005|Base Study|Physician Decision|0|||
145693237|NCT00943722|525394706|FG006|Base Study|Physician Decision|0|||
145693238|NCT00943722|525394700|FG000|Base Study|Pregnancy|0|||
145693239|NCT00943722|525394701|FG001|Base Study|Pregnancy|0|||
145693240|NCT00943722|525394702|FG002|Base Study|Pregnancy|1|||
145693241|NCT00943722|525394703|FG003|Base Study|Pregnancy|0|||
145693242|NCT00943722|525394704|FG004|Base Study|Pregnancy|2|||
145693243|NCT00943722|525394705|FG005|Base Study|Pregnancy|0|||
145693244|NCT00943722|525394706|FG006|Base Study|Pregnancy|0|||
145693245|NCT00943722|525394700|FG000|Base Study|Protocol Violation|0|||
145693246|NCT00943722|525394701|FG001|Base Study|Protocol Violation|1|||
145693247|NCT00943722|525394702|FG002|Base Study|Protocol Violation|0|||
145693248|NCT00943722|525394703|FG003|Base Study|Protocol Violation|0|||
145693249|NCT00943722|525394704|FG004|Base Study|Protocol Violation|2|||
145693250|NCT00943722|525394705|FG005|Base Study|Protocol Violation|0|||
145693251|NCT00943722|525394706|FG006|Base Study|Protocol Violation|0|||
145693252|NCT00943722|525394700|FG000|Base Study|Withdrawal by Subject|12|||
145693253|NCT00943722|525394701|FG001|Base Study|Withdrawal by Subject|13|||
145693254|NCT00943722|525394702|FG002|Base Study|Withdrawal by Subject|2|||
145693255|NCT00943722|525394703|FG003|Base Study|Withdrawal by Subject|13|||
145693256|NCT00943722|525394704|FG004|Base Study|Withdrawal by Subject|8|||
145693257|NCT00943722|525394705|FG005|Base Study|Withdrawal by Subject|0|||
145693258|NCT00943722|525394706|FG006|Base Study|Withdrawal by Subject|0|||
145693259|NCT00943722|525394700|FG000|Base Study|Month 12 visit not completed|0|||
145693260|NCT00943722|525394701|FG001|Base Study|Month 12 visit not completed|0|||
145693261|NCT00943722|525394702|FG002|Base Study|Month 12 visit not completed|0|||
145693262|NCT00943722|525394703|FG003|Base Study|Month 12 visit not completed|0|||
145693263|NCT00943722|525394704|FG004|Base Study|Month 12 visit not completed|2|||
145693264|NCT00943722|525394705|FG005|Base Study|Month 12 visit not completed|0|||
145693265|NCT00943722|525394706|FG006|Base Study|Month 12 visit not completed|0|||
145693266|NCT00943722|525394700|FG000|First Extension Study: EXT 1|Adverse Event|0|||
145693267|NCT00943722|525394701|FG001|First Extension Study: EXT 1|Adverse Event|0|||
145693268|NCT00943722|525394702|FG002|First Extension Study: EXT 1|Adverse Event|0|||
145693269|NCT00943722|525394703|FG003|First Extension Study: EXT 1|Adverse Event|0|||
145693270|NCT00943722|525394704|FG004|First Extension Study: EXT 1|Adverse Event|0|||
145693271|NCT00943722|525394705|FG005|First Extension Study: EXT 1|Adverse Event|1|||
145693272|NCT00943722|525394706|FG006|First Extension Study: EXT 1|Adverse Event|0|||
145693273|NCT00943722|525394700|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
145693274|NCT00943722|525394701|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
145693275|NCT00943722|525394702|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
145693276|NCT00943722|525394703|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
145693277|NCT00943722|525394704|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
145693278|NCT00943722|525394705|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
145693279|NCT00943722|525394706|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
145693280|NCT00943722|525394700|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
145693281|NCT00943722|525394701|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
145693282|NCT00943722|525394702|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
145693283|NCT00943722|525394703|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
145693284|NCT00943722|525394704|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
145693285|NCT00943722|525394705|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
145693286|NCT00943722|525394706|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
145693287|NCT00943722|525394700|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
145693288|NCT00943722|525394701|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
145693289|NCT00943722|525394702|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
145693290|NCT00943722|525394703|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
145693291|NCT00943722|525394704|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
145693292|NCT00943722|525394705|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
145693293|NCT00943722|525394706|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
145693294|NCT00943722|525394700|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
145693295|NCT00943722|525394701|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
145693296|NCT00943722|525394702|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
145693297|NCT00943722|525394703|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
145693298|NCT00943722|525394704|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
145693299|NCT00943722|525394705|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
145693300|NCT00943722|525394706|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
145693301|NCT00943722|525394700|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
145693302|NCT00943722|525394701|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
145693303|NCT00943722|525394702|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
145693304|NCT00943722|525394703|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
145693305|NCT00943722|525394704|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
145693306|NCT00943722|525394705|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
145693307|NCT00943722|525394706|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
145693308|NCT00943722|525394700|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
145693309|NCT00943722|525394701|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
145693310|NCT00943722|525394702|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
145693311|NCT00943722|525394703|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
145693312|NCT00943722|525394704|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
145693313|NCT00943722|525394705|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
145693314|NCT00943722|525394706|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
145693315|NCT00943722|525394700|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
145693316|NCT00943722|525394701|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
145693317|NCT00943722|525394702|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
145693318|NCT00943722|525394703|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
145693319|NCT00943722|525394704|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
145693320|NCT00943722|525394705|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
145693321|NCT00943722|525394706|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
145693322|NCT00943722|525394700|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
145693323|NCT00943722|525394701|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
145693324|NCT00943722|525394702|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
145693325|NCT00943722|525394703|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
145693326|NCT00943722|525394704|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
145693327|NCT00943722|525394705|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
145693328|NCT00943722|525394706|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
145693329|NCT01036165|525394707|FG000|Overall Study|Adverse Event|6|||
145693330|NCT01036165|525394707|FG000|Overall Study|Lost to Follow-up|2|||
145693331|NCT01036165|525394707|FG000|Overall Study|Withdrawal by Subject|3|||
145693332|NCT01036165|525394707|FG000|Overall Study|Device Related Issues|3|||
145693333|NCT01036165|525394707|FG000|Overall Study|Problems finding proper area to inject|1|||
145693334|NCT00307164|525394712|FG000|Overall Study|Death|1|||
145693335|NCT00307164|525394713|FG001|Overall Study|Death|0|||
145693336|NCT00307164|525394712|FG000|Overall Study|Severe debilitation, unable to continue|1|||
145693337|NCT00307164|525394713|FG001|Overall Study|Severe debilitation, unable to continue|0|||
145693338|NCT00307164|525394712|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
145693339|NCT00307164|525394713|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
145693340|NCT00307164|525394712|FG000|Overall Study|Withdrawal by Subject|1|||
145693341|NCT00307164|525394713|FG001|Overall Study|Withdrawal by Subject|8|||
145693342|NCT00307164|525394712|FG000|Overall Study|Not compliant with requirements|4|||
145693343|NCT00307164|525394713|FG001|Overall Study|Not compliant with requirements|4|||
145693344|NCT00307164|525394712|FG000|Overall Study|Lost to Follow-up|6|||
145693345|NCT00307164|525394713|FG001|Overall Study|Lost to Follow-up|1|||
145693346|NCT02847637|525394718|FG000|Overall Study|Withdrawal by Subject|0|||
145693347|NCT02847637|525394719|FG001|Overall Study|Withdrawal by Subject|1|||
145693348|NCT02847637|525394720|FG002|Overall Study|Withdrawal by Subject|1|||
145693349|NCT02847637|525394721|FG003|Overall Study|Withdrawal by Subject|0|||
145693350|NCT02847637|525394718|FG000|Overall Study|Lost to Follow-up|1|||
145693351|NCT02847637|525394719|FG001|Overall Study|Lost to Follow-up|1|||
145693352|NCT02847637|525394720|FG002|Overall Study|Lost to Follow-up|0|||
145693353|NCT02847637|525394721|FG003|Overall Study|Lost to Follow-up|0|||
145693354|NCT01746108|525394726|FG000|Overall Study|Migrated /moved from study area|0|||
145693355|NCT01746108|525394727|FG001|Overall Study|Migrated /moved from study area|1|||
145693356|NCT01746108|525394728|FG002|Overall Study|Migrated /moved from study area|0|||
145693357|NCT01746108|525394726|FG000|Overall Study|Adverse event, non-fatal|0|||
145693358|NCT01746108|525394727|FG001|Overall Study|Adverse event, non-fatal|1|||
145693359|NCT01746108|525394728|FG002|Overall Study|Adverse event, non-fatal|0|||
145693360|NCT01746108|525394726|FG000|Overall Study|Withdrawal by Subject|0|||
145693361|NCT01746108|525394727|FG001|Overall Study|Withdrawal by Subject|1|||
145693362|NCT01746108|525394728|FG002|Overall Study|Withdrawal by Subject|0|||
145693363|NCT01746108|525394726|FG000|Overall Study|Lost to Follow-up|0|||
145693364|NCT01746108|525394727|FG001|Overall Study|Lost to Follow-up|1|||
145693365|NCT01746108|525394728|FG002|Overall Study|Lost to Follow-up|0|||
145693366|NCT01040403|525394730|FG000|Overall Study|Adverse Event|10|||
145693367|NCT01040403|525394730|FG000|Overall Study|Protocol Violation|2|||
145693368|NCT01040403|525394730|FG000|Overall Study|Lost to Follow-up|1|||
145693369|NCT01040403|525394730|FG000|Overall Study|Not treated|1|||
145693370|NCT01040403|525394730|FG000|Overall Study|Other reason not defined above|6|||
145693371|NCT00797511|525394731|FG000|Overall Study|Withdrawal by Subject|1|||
145693372|NCT03036150|525394732|FG000|Overall Study|Withdrawal by Subject|8|||
145693373|NCT03036150|525394733|FG001|Overall Study|Withdrawal by Subject|3|||
145693374|NCT03036150|525394732|FG000|Overall Study|Lost to Follow-up|2|||
145693375|NCT03036150|525394733|FG001|Overall Study|Lost to Follow-up|2|||
145693376|NCT02741713|525394739|FG000|Overall Study|Surgery type changed intra-operatively|2|||
145693377|NCT02741713|525394740|FG001|Overall Study|Surgery type changed intra-operatively|1|||
145693378|NCT00619983|525394743|FG000|Test Drug Alone|Withdrawal by Subject|1|||
145693379|NCT00619983|525394744|FG001|Test Drug Alone|Withdrawal by Subject|0|||
145693380|NCT00619983|525394745|FG002|Test Drug Alone|Withdrawal by Subject|0|||
145693381|NCT00619983|525394746|FG003|Test Drug Alone|Withdrawal by Subject|1|||
145693382|NCT00619983|525394743|FG000|Test Drug Alone|Failure of daily diary device|1|||
145693383|NCT00619983|525394744|FG001|Test Drug Alone|Failure of daily diary device|1|||
145693384|NCT00619983|525394745|FG002|Test Drug Alone|Failure of daily diary device|2|||
145693385|NCT00619983|525394746|FG003|Test Drug Alone|Failure of daily diary device|2|||
145693386|NCT00570921|525394748|FG000|Overall Study|Protocol Violation|1|||
145693387|NCT00570921|525394748|FG000|Overall Study|Physician Decision|1|||
145693388|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
145693389|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
145693390|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
145693391|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
145693392|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
145693393|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
145693394|NCT03201900|525394751|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
145693395|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
145693396|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
145693397|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
145693398|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
145693399|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
145693400|NCT03201900|525394751|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
145693401|NCT02971228|525394752|FG000|Overall Study|Withdrawal by Subject|1|||
145693402|NCT02971228|525394753|FG001|Overall Study|Withdrawal by Subject|1|||
145693403|NCT02971228|525394754|FG002|Overall Study|Withdrawal by Subject|0|||
145693404|NCT02971228|525394755|FG003|Overall Study|Withdrawal by Subject|0|||
145693405|NCT02971228|525394756|FG004|Overall Study|Withdrawal by Subject|0|||
145693406|NCT02971228|525394752|FG000|Overall Study|Logistical challenges|0|||
145693407|NCT02971228|525394753|FG001|Overall Study|Logistical challenges|1|||
145693408|NCT02971228|525394754|FG002|Overall Study|Logistical challenges|0|||
145693409|NCT02971228|525394755|FG003|Overall Study|Logistical challenges|0|||
145693410|NCT02971228|525394756|FG004|Overall Study|Logistical challenges|0|||
145693411|NCT02560389|525394757|FG000|Overall Study|Lost to Follow-up|1|||
145693412|NCT02560389|525394758|FG001|Overall Study|Lost to Follow-up|2|||
145693413|NCT02560389|525394759|FG002|Overall Study|Lost to Follow-up|2|||
145693414|NCT02560389|525394757|FG000|Overall Study|Tested positive for illicit substance|0|||
145693415|NCT02560389|525394758|FG001|Overall Study|Tested positive for illicit substance|1|||
145693416|NCT02560389|525394759|FG002|Overall Study|Tested positive for illicit substance|0|||
145693417|NCT02716298|525394760|FG000|First Intervention (1 Month)|Lens discomfort|1|||
145693418|NCT02716298|525394761|FG001|First Intervention (1 Month)|Lens discomfort|1|||
145693419|NCT00550446|525394762|FG000|Up To Week 12|Adverse Event|2|||
145693420|NCT00550446|525394763|FG001|Up To Week 12|Adverse Event|2|||
145491418|NCT02163902|524653801|FG001|Overall Study|Subject's Request|4|||
145693421|NCT00550446|525394764|FG002|Up To Week 12|Adverse Event|0|||
145693422|NCT00550446|525394765|FG003|Up To Week 12|Adverse Event|0|||
145693423|NCT00550446|525394766|FG004|Up To Week 12|Adverse Event|2|||
145693424|NCT00550446|525394767|FG005|Up To Week 12|Adverse Event|2|||
145693425|NCT00550446|525394768|FG006|Up To Week 12|Adverse Event|1|||
145693426|NCT00550446|525394769|FG007|Up To Week 12|Adverse Event|0|||
145693427|NCT00550446|525394770|FG008|Up To Week 12|Adverse Event|0|||
145693428|NCT00550446|525394771|FG009|Up To Week 12|Adverse Event|0|||
145693429|NCT00550446|525394772|FG010|Up To Week 12|Adverse Event|0|||
145693430|NCT00550446|525394762|FG000|Up To Week 12|Lack of Efficacy|3|||
145693431|NCT00550446|525394763|FG001|Up To Week 12|Lack of Efficacy|1|||
145693432|NCT00550446|525394764|FG002|Up To Week 12|Lack of Efficacy|0|||
145693433|NCT00550446|525394765|FG003|Up To Week 12|Lack of Efficacy|1|||
145693434|NCT00550446|525394766|FG004|Up To Week 12|Lack of Efficacy|0|||
145693435|NCT00550446|525394767|FG005|Up To Week 12|Lack of Efficacy|3|||
145693436|NCT00550446|525394768|FG006|Up To Week 12|Lack of Efficacy|3|||
145693437|NCT00550446|525394769|FG007|Up To Week 12|Lack of Efficacy|0|||
145693438|NCT00550446|525394770|FG008|Up To Week 12|Lack of Efficacy|0|||
145693439|NCT00550446|525394771|FG009|Up To Week 12|Lack of Efficacy|0|||
145693440|NCT00550446|525394772|FG010|Up To Week 12|Lack of Efficacy|0|||
145693441|NCT00550446|525394762|FG000|Up To Week 12|Lost to Follow-up|0|||
145693442|NCT00550446|525394763|FG001|Up To Week 12|Lost to Follow-up|1|||
145693443|NCT00550446|525394764|FG002|Up To Week 12|Lost to Follow-up|0|||
145693444|NCT00550446|525394765|FG003|Up To Week 12|Lost to Follow-up|0|||
145693445|NCT00550446|525394766|FG004|Up To Week 12|Lost to Follow-up|1|||
145693446|NCT00550446|525394767|FG005|Up To Week 12|Lost to Follow-up|1|||
145693447|NCT00550446|525394768|FG006|Up To Week 12|Lost to Follow-up|2|||
145693448|NCT00550446|525394769|FG007|Up To Week 12|Lost to Follow-up|0|||
145693449|NCT00550446|525394770|FG008|Up To Week 12|Lost to Follow-up|0|||
145693450|NCT00550446|525394771|FG009|Up To Week 12|Lost to Follow-up|0|||
145693451|NCT00550446|525394772|FG010|Up To Week 12|Lost to Follow-up|0|||
145693452|NCT00550446|525394762|FG000|Up To Week 12|Withdrawal by Subject|2|||
145693453|NCT00550446|525394763|FG001|Up To Week 12|Withdrawal by Subject|0|||
145693454|NCT00550446|525394764|FG002|Up To Week 12|Withdrawal by Subject|3|||
145693455|NCT00550446|525394765|FG003|Up To Week 12|Withdrawal by Subject|2|||
145693456|NCT00550446|525394766|FG004|Up To Week 12|Withdrawal by Subject|0|||
145693457|NCT00550446|525394767|FG005|Up To Week 12|Withdrawal by Subject|1|||
145693458|NCT00550446|525394768|FG006|Up To Week 12|Withdrawal by Subject|3|||
145693459|NCT00550446|525394769|FG007|Up To Week 12|Withdrawal by Subject|0|||
145693460|NCT00550446|525394770|FG008|Up To Week 12|Withdrawal by Subject|0|||
145693461|NCT00550446|525394771|FG009|Up To Week 12|Withdrawal by Subject|0|||
145693462|NCT00550446|525394772|FG010|Up To Week 12|Withdrawal by Subject|0|||
145693463|NCT00550446|525394762|FG000|Up To Week 12|Other|3|||
145693464|NCT00550446|525394763|FG001|Up To Week 12|Other|0|||
145693465|NCT00550446|525394764|FG002|Up To Week 12|Other|0|||
145693466|NCT00550446|525394765|FG003|Up To Week 12|Other|0|||
145693467|NCT00550446|525394766|FG004|Up To Week 12|Other|0|||
145693468|NCT00550446|525394767|FG005|Up To Week 12|Other|1|||
145693469|NCT00550446|525394768|FG006|Up To Week 12|Other|4|||
145693470|NCT00550446|525394769|FG007|Up To Week 12|Other|0|||
145693471|NCT00550446|525394770|FG008|Up To Week 12|Other|0|||
145693472|NCT00550446|525394771|FG009|Up To Week 12|Other|0|||
145693473|NCT00550446|525394772|FG010|Up To Week 12|Other|0|||
145693474|NCT00550446|525394762|FG000|Up To Week 12|Randomized not treated|0|||
145693475|NCT00550446|525394763|FG001|Up To Week 12|Randomized not treated|1|||
145693476|NCT00550446|525394764|FG002|Up To Week 12|Randomized not treated|1|||
145693477|NCT00550446|525394765|FG003|Up To Week 12|Randomized not treated|0|||
145693478|NCT00550446|525394766|FG004|Up To Week 12|Randomized not treated|0|||
145693479|NCT00550446|525394767|FG005|Up To Week 12|Randomized not treated|0|||
145693480|NCT00550446|525394768|FG006|Up To Week 12|Randomized not treated|0|||
145693481|NCT00550446|525394769|FG007|Up To Week 12|Randomized not treated|0|||
145693482|NCT00550446|525394770|FG008|Up To Week 12|Randomized not treated|0|||
145693483|NCT00550446|525394771|FG009|Up To Week 12|Randomized not treated|0|||
145693484|NCT00550446|525394772|FG010|Up To Week 12|Randomized not treated|0|||
145693485|NCT00550446|525394762|FG000|Post Week 12|Adverse Event|2|||
145693486|NCT00550446|525394763|FG001|Post Week 12|Adverse Event|1|||
145693487|NCT00550446|525394764|FG002|Post Week 12|Adverse Event|1|||
145693488|NCT00550446|525394765|FG003|Post Week 12|Adverse Event|1|||
145693489|NCT00550446|525394766|FG004|Post Week 12|Adverse Event|1|||
145693490|NCT00550446|525394767|FG005|Post Week 12|Adverse Event|1|||
145693491|NCT00550446|525394768|FG006|Post Week 12|Adverse Event|0|||
145693492|NCT00550446|525394769|FG007|Post Week 12|Adverse Event|0|||
145693493|NCT00550446|525394770|FG008|Post Week 12|Adverse Event|0|||
145693494|NCT00550446|525394771|FG009|Post Week 12|Adverse Event|4|||
145693495|NCT00550446|525394772|FG010|Post Week 12|Adverse Event|0|||
145693496|NCT00550446|525394762|FG000|Post Week 12|Lack of Efficacy|0|||
145693497|NCT00550446|525394763|FG001|Post Week 12|Lack of Efficacy|0|||
145693498|NCT00550446|525394764|FG002|Post Week 12|Lack of Efficacy|1|||
145693499|NCT00550446|525394765|FG003|Post Week 12|Lack of Efficacy|0|||
145693500|NCT00550446|525394766|FG004|Post Week 12|Lack of Efficacy|0|||
145693501|NCT00550446|525394767|FG005|Post Week 12|Lack of Efficacy|0|||
145693502|NCT00550446|525394768|FG006|Post Week 12|Lack of Efficacy|0|||
145693503|NCT00550446|525394769|FG007|Post Week 12|Lack of Efficacy|1|||
145693504|NCT00550446|525394770|FG008|Post Week 12|Lack of Efficacy|1|||
145693505|NCT00550446|525394771|FG009|Post Week 12|Lack of Efficacy|2|||
145693506|NCT00550446|525394772|FG010|Post Week 12|Lack of Efficacy|1|||
145693507|NCT00550446|525394762|FG000|Post Week 12|Lost to Follow-up|0|||
145693508|NCT00550446|525394763|FG001|Post Week 12|Lost to Follow-up|0|||
145693509|NCT00550446|525394764|FG002|Post Week 12|Lost to Follow-up|1|||
145693510|NCT00550446|525394765|FG003|Post Week 12|Lost to Follow-up|1|||
145693511|NCT00550446|525394766|FG004|Post Week 12|Lost to Follow-up|0|||
145693512|NCT00550446|525394767|FG005|Post Week 12|Lost to Follow-up|0|||
145693513|NCT00550446|525394768|FG006|Post Week 12|Lost to Follow-up|1|||
145693514|NCT00550446|525394769|FG007|Post Week 12|Lost to Follow-up|0|||
145693515|NCT00550446|525394770|FG008|Post Week 12|Lost to Follow-up|0|||
145693516|NCT00550446|525394771|FG009|Post Week 12|Lost to Follow-up|0|||
145693517|NCT00550446|525394772|FG010|Post Week 12|Lost to Follow-up|0|||
145693518|NCT00550446|525394762|FG000|Post Week 12|Withdrawal by Subject|0|||
145693519|NCT00550446|525394763|FG001|Post Week 12|Withdrawal by Subject|0|||
145693520|NCT00550446|525394764|FG002|Post Week 12|Withdrawal by Subject|0|||
145693521|NCT00550446|525394765|FG003|Post Week 12|Withdrawal by Subject|0|||
145693522|NCT00550446|525394766|FG004|Post Week 12|Withdrawal by Subject|1|||
145693523|NCT00550446|525394767|FG005|Post Week 12|Withdrawal by Subject|0|||
145693524|NCT00550446|525394768|FG006|Post Week 12|Withdrawal by Subject|0|||
145693525|NCT00550446|525394769|FG007|Post Week 12|Withdrawal by Subject|0|||
145693526|NCT00550446|525394770|FG008|Post Week 12|Withdrawal by Subject|0|||
145693527|NCT00550446|525394771|FG009|Post Week 12|Withdrawal by Subject|0|||
145693528|NCT00550446|525394772|FG010|Post Week 12|Withdrawal by Subject|0|||
145693529|NCT00550446|525394762|FG000|Post Week 12|Other|1|||
145693530|NCT00550446|525394763|FG001|Post Week 12|Other|1|||
145693531|NCT00550446|525394764|FG002|Post Week 12|Other|0|||
145693532|NCT00550446|525394765|FG003|Post Week 12|Other|1|||
145693533|NCT00550446|525394766|FG004|Post Week 12|Other|0|||
145693534|NCT00550446|525394767|FG005|Post Week 12|Other|0|||
145693535|NCT00550446|525394768|FG006|Post Week 12|Other|1|||
145693536|NCT00550446|525394769|FG007|Post Week 12|Other|0|||
145693537|NCT00550446|525394770|FG008|Post Week 12|Other|1|||
145693538|NCT00550446|525394771|FG009|Post Week 12|Other|1|||
145693539|NCT00550446|525394772|FG010|Post Week 12|Other|0|||
145693540|NCT04081389|525394774|FG000|Overall Study|Withdrawal by Subject|0|||
145693541|NCT04081389|525394775|FG001|Overall Study|Withdrawal by Subject|0|||
145693542|NCT04081389|525394776|FG002|Overall Study|Withdrawal by Subject|1|||
145693543|NCT04081389|525394777|FG003|Overall Study|Withdrawal by Subject|0|||
145693544|NCT01670188|525394786|FG000|Overall Study|Death|0|||
145693545|NCT01670188|525394787|FG001|Overall Study|Death|1|||
145693546|NCT00866918|525394790|FG000|Overall Study|Death|1|||
145693547|NCT00866918|525394791|FG001|Overall Study|Death|5|||
145693548|NCT00866918|525394790|FG000|Overall Study|Lack of Efficacy|1|||
145693549|NCT00866918|525394791|FG001|Overall Study|Lack of Efficacy|1|||
145693550|NCT00866918|525394790|FG000|Overall Study|Physician Decision|10|||
145693551|NCT00866918|525394791|FG001|Overall Study|Physician Decision|2|||
145693552|NCT00866918|525394790|FG000|Overall Study|Ineligible|2|||
145693553|NCT00866918|525394791|FG001|Overall Study|Ineligible|4|||
145693554|NCT00866918|525394790|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
145693555|NCT00866918|525394791|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
145693556|NCT00866918|525394790|FG000|Overall Study|Secondary malignancy|1|||
145693557|NCT00866918|525394791|FG001|Overall Study|Secondary malignancy|0|||
145693558|NCT00802438|525394792|FG000|Overall Study|Screen Failure|20|||
145693559|NCT00802438|525394792|FG000|Overall Study|Withdrawal by Subject|7|||
145693560|NCT00802438|525394792|FG000|Overall Study|Physician Decision|1|||
145693561|NCT03175198|525394794|FG000|Overall Study|Adverse Event|480|||
145693562|NCT03175198|525394794|FG000|Overall Study|No actual visit|120|||
145693563|NCT03175198|525394794|FG000|Overall Study|Registration rule not followed|4|||
145693564|NCT03175198|525394794|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
145693565|NCT03175198|525394794|FG000|Overall Study|Other personal reason|509|||
145693566|NCT03175198|525394794|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
145693567|NCT03175198|525394794|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
145693568|NCT03175198|525394794|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
145693569|NCT03175198|525394794|FG000|Overall Study|To conduct invasive treatment of operation|53|||
145693570|NCT03175198|525394794|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
145693571|NCT02101268|525394796|FG000|Randomized Treatment Phase|Subject Decision|8|||
145693572|NCT02101268|525394797|FG001|Randomized Treatment Phase|Subject Decision|4|||
145693573|NCT02101268|525394798|FG002|Randomized Treatment Phase|Subject Decision|0|||
145693574|NCT02101268|525394799|FG003|Randomized Treatment Phase|Subject Decision|0|||
145693575|NCT02101268|525394796|FG000|Randomized Treatment Phase|Physician Decision|4|||
145693576|NCT02101268|525394797|FG001|Randomized Treatment Phase|Physician Decision|1|||
145693577|NCT02101268|525394798|FG002|Randomized Treatment Phase|Physician Decision|0|||
145693578|NCT02101268|525394799|FG003|Randomized Treatment Phase|Physician Decision|0|||
145693579|NCT02101268|525394796|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
145693580|NCT02101268|525394797|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
145491419|NCT02163902|524653800|FG000|Overall Study|Lost to Follow-up|6|||
145693581|NCT02101268|525394798|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
145693582|NCT02101268|525394799|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
145693583|NCT02101268|525394796|FG000|Randomized Treatment Phase|Adverse Event|6|||
145693584|NCT02101268|525394797|FG001|Randomized Treatment Phase|Adverse Event|0|||
145693585|NCT02101268|525394798|FG002|Randomized Treatment Phase|Adverse Event|0|||
145693586|NCT02101268|525394799|FG003|Randomized Treatment Phase|Adverse Event|0|||
145693587|NCT02101268|525394796|FG000|Randomized Treatment Phase|Death|5|||
145693588|NCT02101268|525394797|FG001|Randomized Treatment Phase|Death|4|||
145693589|NCT02101268|525394798|FG002|Randomized Treatment Phase|Death|0|||
145693590|NCT02101268|525394799|FG003|Randomized Treatment Phase|Death|0|||
145693591|NCT02101268|525394796|FG000|Randomized Treatment Phase|Disease Progression|4|||
145693592|NCT02101268|525394797|FG001|Randomized Treatment Phase|Disease Progression|1|||
145693593|NCT02101268|525394798|FG002|Randomized Treatment Phase|Disease Progression|0|||
145693594|NCT02101268|525394799|FG003|Randomized Treatment Phase|Disease Progression|0|||
145693595|NCT02101268|525394796|FG000|Extended Treatment Phase|Subject Decision|0|||
145693596|NCT02101268|525394797|FG001|Extended Treatment Phase|Subject Decision|0|||
145693597|NCT02101268|525394798|FG002|Extended Treatment Phase|Subject Decision|3|||
145693598|NCT02101268|525394799|FG003|Extended Treatment Phase|Subject Decision|2|||
145693599|NCT02101268|525394796|FG000|Extended Treatment Phase|Physician Decision|0|||
145693600|NCT02101268|525394797|FG001|Extended Treatment Phase|Physician Decision|0|||
145693601|NCT02101268|525394798|FG002|Extended Treatment Phase|Physician Decision|5|||
145693602|NCT02101268|525394799|FG003|Extended Treatment Phase|Physician Decision|2|||
145693603|NCT02101268|525394796|FG000|Extended Treatment Phase|Adverse Event|0|||
145693604|NCT02101268|525394797|FG001|Extended Treatment Phase|Adverse Event|0|||
145693605|NCT02101268|525394798|FG002|Extended Treatment Phase|Adverse Event|14|||
145693606|NCT02101268|525394799|FG003|Extended Treatment Phase|Adverse Event|18|||
145693607|NCT02101268|525394796|FG000|Extended Treatment Phase|Death|0|||
145693608|NCT02101268|525394797|FG001|Extended Treatment Phase|Death|0|||
145693609|NCT02101268|525394798|FG002|Extended Treatment Phase|Death|5|||
145693610|NCT02101268|525394799|FG003|Extended Treatment Phase|Death|1|||
145693611|NCT02101268|525394796|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
145693612|NCT02101268|525394797|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
145693613|NCT02101268|525394798|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
145693614|NCT02101268|525394799|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
145693615|NCT02101268|525394796|FG000|Extended Treatment Phase|Disease Progression|0|||
145693616|NCT02101268|525394797|FG001|Extended Treatment Phase|Disease Progression|0|||
145693617|NCT02101268|525394798|FG002|Extended Treatment Phase|Disease Progression|13|||
145693618|NCT02101268|525394799|FG003|Extended Treatment Phase|Disease Progression|6|||
145693619|NCT02101268|525394796|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
145693620|NCT02101268|525394797|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
145693621|NCT02101268|525394798|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
145693622|NCT02101268|525394799|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
145693623|NCT02630706|525394801|FG000|Overall Study|Adverse Event|2|||
145693624|NCT02630706|525394802|FG001|Overall Study|Adverse Event|1|||
145693625|NCT02630706|525394803|FG002|Overall Study|Adverse Event|1|||
145693626|NCT02630706|525394801|FG000|Overall Study|Lost to Follow-up|0|||
145693627|NCT02630706|525394802|FG001|Overall Study|Lost to Follow-up|1|||
145693628|NCT02630706|525394803|FG002|Overall Study|Lost to Follow-up|2|||
145693629|NCT02630706|525394801|FG000|Overall Study|Physician Decision|1|||
145693630|NCT02630706|525394802|FG001|Overall Study|Physician Decision|1|||
145693631|NCT02630706|525394803|FG002|Overall Study|Physician Decision|0|||
145693632|NCT02630706|525394801|FG000|Overall Study|Pregnancy|0|||
145693633|NCT02630706|525394802|FG001|Overall Study|Pregnancy|1|||
145693634|NCT02630706|525394803|FG002|Overall Study|Pregnancy|0|||
145693635|NCT02630706|525394801|FG000|Overall Study|Withdrawal by Subject|4|||
145693636|NCT02630706|525394802|FG001|Overall Study|Withdrawal by Subject|5|||
145693637|NCT02630706|525394803|FG002|Overall Study|Withdrawal by Subject|7|||
145693638|NCT00776984|525394804|FG000|Overall Study|Adverse Event|8|||
145693639|NCT00776984|525394805|FG001|Overall Study|Adverse Event|2|||
145693640|NCT00776984|525394804|FG000|Overall Study|Protocol Violation|4|||
145693641|NCT00776984|525394805|FG001|Overall Study|Protocol Violation|2|||
145693642|NCT00776984|525394804|FG000|Overall Study|Lost to Follow-up|2|||
145693643|NCT00776984|525394805|FG001|Overall Study|Lost to Follow-up|0|||
145693644|NCT00776984|525394804|FG000|Overall Study|Withdrawal by Subject|12|||
145693645|NCT00776984|525394805|FG001|Overall Study|Withdrawal by Subject|7|||
145693646|NCT00776984|525394804|FG000|Overall Study|Lack of Efficacy|0|||
145693647|NCT00776984|525394805|FG001|Overall Study|Lack of Efficacy|1|||
145693648|NCT00776984|525394804|FG000|Overall Study|Other|5|||
145693649|NCT00776984|525394805|FG001|Overall Study|Other|9|||
145693650|NCT01544309|525394810|FG000|Overall Study|Withdrawal by Subject|12|||
145693651|NCT01544309|525394811|FG001|Overall Study|Withdrawal by Subject|7|||
145693652|NCT01544309|525394810|FG000|Overall Study|Protocol Violation|2|||
145693653|NCT01544309|525394811|FG001|Overall Study|Protocol Violation|1|||
145693654|NCT01544309|525394810|FG000|Overall Study|Physician Decision|4|||
145693655|NCT01544309|525394811|FG001|Overall Study|Physician Decision|1|||
145693656|NCT01544309|525394810|FG000|Overall Study|Not performed pre-dose examination|1|||
145693657|NCT01544309|525394811|FG001|Overall Study|Not performed pre-dose examination|2|||
145693658|NCT01544309|525394810|FG000|Overall Study|Administered prohibit prior medication|1|||
145693659|NCT01544309|525394811|FG001|Overall Study|Administered prohibit prior medication|0|||
145693660|NCT02551692|525394816|FG000|Overall Study|Lost to Follow-up|0|||
145693661|NCT02551692|525394817|FG001|Overall Study|Lost to Follow-up|1|||
145693662|NCT02551692|525394818|FG002|Overall Study|Lost to Follow-up|4|||
145693663|NCT02551692|525394816|FG000|Overall Study|Withdrawal by Subject|1|||
145693664|NCT02551692|525394817|FG001|Overall Study|Withdrawal by Subject|0|||
145693665|NCT02551692|525394818|FG002|Overall Study|Withdrawal by Subject|1|||
145693666|NCT01091519|525394819|FG000|Overall Study|Adverse Event|12|||
145693667|NCT01091519|525394820|FG001|Overall Study|Adverse Event|16|||
145693668|NCT01091519|525394819|FG000|Overall Study|Death|1|||
145693669|NCT01091519|525394820|FG001|Overall Study|Death|0|||
145693670|NCT01091519|525394819|FG000|Overall Study|Lack of Efficacy|16|||
145693671|NCT01091519|525394820|FG001|Overall Study|Lack of Efficacy|19|||
145693672|NCT01091519|525394819|FG000|Overall Study|Lost to Follow-up|14|||
145693673|NCT01091519|525394820|FG001|Overall Study|Lost to Follow-up|24|||
145693674|NCT01091519|525394819|FG000|Overall Study|Withdrawal by Subject|2|||
145693675|NCT01091519|525394820|FG001|Overall Study|Withdrawal by Subject|2|||
145693676|NCT01091519|525394819|FG000|Overall Study|Other|6|||
145693677|NCT01091519|525394820|FG001|Overall Study|Other|8|||
145693678|NCT01091519|525394819|FG000|Overall Study|Randomized not treated|4|||
145693679|NCT01091519|525394820|FG001|Overall Study|Randomized not treated|4|||
145693680|NCT01196741|525394823|FG000|Overall Study|Disease progression|34|||
145693681|NCT01196741|525394824|FG001|Overall Study|Disease progression|14|||
145693682|NCT01196741|525394823|FG000|Overall Study|Adverse Event|10|||
145693683|NCT01196741|525394824|FG001|Overall Study|Adverse Event|6|||
145693684|NCT01196741|525394823|FG000|Overall Study|Serious Adverse Event|3|||
145693685|NCT01196741|525394824|FG001|Overall Study|Serious Adverse Event|1|||
145693686|NCT01196741|525394823|FG000|Overall Study|Dose limiting Adverse Event|2|||
145693687|NCT01196741|525394824|FG001|Overall Study|Dose limiting Adverse Event|1|||
145693688|NCT01196741|525394823|FG000|Overall Study|Withdrawal by Subject|3|||
145693689|NCT01196741|525394824|FG001|Overall Study|Withdrawal by Subject|0|||
145693690|NCT01196741|525394823|FG000|Overall Study|Other reason|3|||
145693691|NCT01196741|525394824|FG001|Overall Study|Other reason|3|||
145693692|NCT01196741|525394823|FG000|Overall Study|Other|3|||
145693693|NCT01196741|525394824|FG001|Overall Study|Other|2|||
145693694|NCT01196741|525394823|FG000|Overall Study|Protocol Violation|2|||
145693695|NCT01196741|525394824|FG001|Overall Study|Protocol Violation|1|||
145693696|NCT01227928|525394825|FG000|Overall Study|Lost to Follow-up|4|||
145693697|NCT01227928|525394826|FG001|Overall Study|Lost to Follow-up|2|||
145693698|NCT01227928|525394825|FG000|Overall Study|Withdrawal by Subject|4|||
145693699|NCT01227928|525394826|FG001|Overall Study|Withdrawal by Subject|3|||
145693700|NCT01227928|525394825|FG000|Overall Study|Death|14|||
145693701|NCT01227928|525394826|FG001|Overall Study|Death|12|||
145693702|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
145693703|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
145693704|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
145693705|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
145693706|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
145693707|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
145693708|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
145693709|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
145693710|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
145693711|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
145693712|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
145693713|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
145693714|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
145693715|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
145693716|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
145693717|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
145693718|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
145693719|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
145693720|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
145693721|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
145693722|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
145693723|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
145693724|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
145693725|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
145693726|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
145693727|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
145693728|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
145693729|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
145693730|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
145693731|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
145693732|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
145693733|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
145693734|NCT00092521|525396361|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
145693735|NCT00092521|525396362|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
145693736|NCT00092521|525396363|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
145693737|NCT00092521|525396364|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
145693738|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
145693739|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
145693740|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
145693741|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
145693742|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
145693743|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
145693744|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
145693745|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
145693746|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
145693747|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
145693748|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
145693749|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
145693750|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Death|2|||
145693751|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Death|0|||
145693752|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Death|1|||
145693753|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Death|0|||
145693754|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
145693755|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
145693756|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
145693757|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
145693758|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
145693759|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
145693760|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
145693761|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
145693762|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
145693763|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
145693764|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
145693765|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
145693766|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Moved|32|||
145693767|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Moved|2|||
145693768|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Moved|28|||
145693769|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Moved|0|||
145693770|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
145693771|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
145693772|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
145693773|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
145693774|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Travel|2|||
145693775|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Travel|0|||
145693776|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Travel|0|||
145693777|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Travel|0|||
145693778|NCT00092521|525396361|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
145693779|NCT00092521|525396362|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
145693780|NCT00092521|525396363|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
145693781|NCT00092521|525396364|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
145693782|NCT00092521|525396361|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
145693783|NCT00092521|525396362|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
145693784|NCT00092521|525396363|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
145693785|NCT00092521|525396364|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
145693786|NCT00092521|525396361|FG000|Extension Study (Group 4)|Adverse Event|0|||
145693787|NCT00092521|525396362|FG001|Extension Study (Group 4)|Adverse Event|0|||
145693788|NCT00092521|525396363|FG002|Extension Study (Group 4)|Adverse Event|0|||
145693789|NCT00092521|525396364|FG003|Extension Study (Group 4)|Adverse Event|2|||
145693790|NCT00092521|525396361|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
145693791|NCT00092521|525396362|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
145693792|NCT00092521|525396363|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
145693793|NCT00092521|525396364|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
145693794|NCT00092521|525396361|FG000|Extension Study (Group 4)|Pregnancy|0|||
145693795|NCT00092521|525396362|FG001|Extension Study (Group 4)|Pregnancy|0|||
145693796|NCT00092521|525396363|FG002|Extension Study (Group 4)|Pregnancy|0|||
145693797|NCT00092521|525396364|FG003|Extension Study (Group 4)|Pregnancy|4|||
145693798|NCT00092521|525396361|FG000|Extension Study (Group 4)|Protocol Violation|0|||
145693799|NCT00092521|525396362|FG001|Extension Study (Group 4)|Protocol Violation|0|||
145693800|NCT00092521|525396363|FG002|Extension Study (Group 4)|Protocol Violation|0|||
145693801|NCT00092521|525396364|FG003|Extension Study (Group 4)|Protocol Violation|2|||
145693802|NCT00092521|525396361|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
145693803|NCT00092521|525396362|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
145693804|NCT00092521|525396363|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
145693805|NCT00092521|525396364|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
145693806|NCT00092521|525396361|FG000|Extension Study (Group 4)|Moved|0|||
145693807|NCT00092521|525396362|FG001|Extension Study (Group 4)|Moved|0|||
145693808|NCT00092521|525396363|FG002|Extension Study (Group 4)|Moved|0|||
145693809|NCT00092521|525396364|FG003|Extension Study (Group 4)|Moved|16|||
145693810|NCT00092521|525396361|FG000|Extension Study (Group 4)|Site Terminated|0|||
145693811|NCT00092521|525396362|FG001|Extension Study (Group 4)|Site Terminated|0|||
145693812|NCT00092521|525396363|FG002|Extension Study (Group 4)|Site Terminated|0|||
145693813|NCT00092521|525396364|FG003|Extension Study (Group 4)|Site Terminated|4|||
145693814|NCT00092521|525396361|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
145693815|NCT00092521|525396362|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
145693816|NCT00092521|525396363|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
145693817|NCT00092521|525396364|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
145693818|NCT01878383|525396365|FG000|Overall Study|Lost to Follow-up|0|||
145693819|NCT01878383|525396366|FG001|Overall Study|Lost to Follow-up|1499|||
145693820|NCT03464383|525396367|FG000|Overall Study|Lost to Follow-up|1|||
145693821|NCT03464383|525396368|FG001|Overall Study|Lost to Follow-up|0|||
145693822|NCT03464383|525396369|FG002|Overall Study|Lost to Follow-up|0|||
145693823|NCT03464383|525396367|FG000|Overall Study|Withdrawal by Subject|0|||
145693824|NCT03464383|525396368|FG001|Overall Study|Withdrawal by Subject|1|||
145693825|NCT03464383|525396369|FG002|Overall Study|Withdrawal by Subject|0|||
145693826|NCT03475056|525396370|FG000|Overall Study|Lost to Follow-up|0|||
145693827|NCT03475056|525396371|FG001|Overall Study|Lost to Follow-up|1|||
145693828|NCT03475056|525396370|FG000|Overall Study|Moved from Area|0|||
145693829|NCT03475056|525396371|FG001|Overall Study|Moved from Area|2|||
145693830|NCT01904136|525396375|FG000|Overall Study|Physician Decision|0|||
145693831|NCT01904136|525396376|FG001|Overall Study|Physician Decision|0|||
145693832|NCT01904136|525396377|FG002|Overall Study|Physician Decision|0|||
145693833|NCT01904136|525396378|FG003|Overall Study|Physician Decision|0|||
145693834|NCT01904136|525396379|FG004|Overall Study|Physician Decision|0|||
145693835|NCT01904136|525396380|FG005|Overall Study|Physician Decision|1|||
145693836|NCT01904136|525396381|FG006|Overall Study|Physician Decision|0|||
145693837|NCT01904136|525396382|FG007|Overall Study|Physician Decision|0|||
145693838|NCT01904136|525396383|FG008|Overall Study|Physician Decision|0|||
145693839|NCT02418845|525396386|FG000|Overall Study|Lost to Follow-up|7|||
145693840|NCT02418845|525396387|FG001|Overall Study|Lost to Follow-up|2|||
145693841|NCT02418845|525396386|FG000|Overall Study|Lack of Efficacy|0|||
145693842|NCT02418845|525396387|FG001|Overall Study|Lack of Efficacy|3|||
145693843|NCT02418845|525396386|FG000|Overall Study|Physician Decision|5|||
145693844|NCT02418845|525396387|FG001|Overall Study|Physician Decision|5|||
145693845|NCT02418845|525396386|FG000|Overall Study|Protocol Violation|1|||
145693846|NCT02418845|525396387|FG001|Overall Study|Protocol Violation|0|||
145693847|NCT02418845|525396386|FG000|Overall Study|Withdrawal by Subject|3|||
145693848|NCT02418845|525396387|FG001|Overall Study|Withdrawal by Subject|2|||
145693849|NCT00460564|525396388|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
145693850|NCT00460564|525396389|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
145693851|NCT00460564|525396390|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693852|NCT00460564|525396391|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693853|NCT00460564|525396392|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693854|NCT00460564|525396393|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693855|NCT00460564|525396394|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693856|NCT00460564|525396395|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
145693857|NCT00460564|525396388|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
145693858|NCT00460564|525396389|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693859|NCT00460564|525396390|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693860|NCT00460564|525396391|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693861|NCT00460564|525396392|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693862|NCT00460564|525396393|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693863|NCT00460564|525396394|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693864|NCT00460564|525396395|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
145693865|NCT00460564|525396388|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145693866|NCT00460564|525396389|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145693867|NCT00460564|525396390|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145693868|NCT00460564|525396391|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145693869|NCT00460564|525396392|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
145693870|NCT00460564|525396393|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
145693871|NCT00460564|525396394|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
145693872|NCT00460564|525396395|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
145693873|NCT00460564|525396388|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145491420|NCT02163902|524653801|FG001|Overall Study|Lost to Follow-up|7|||
145693874|NCT00460564|525396389|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145693875|NCT00460564|525396390|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145693876|NCT00460564|525396391|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145693877|NCT00460564|525396392|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
145693878|NCT00460564|525396393|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
145693879|NCT00460564|525396394|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145693880|NCT00460564|525396395|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
145693881|NCT00460564|525396388|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693882|NCT00460564|525396389|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693883|NCT00460564|525396390|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693884|NCT00460564|525396391|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693885|NCT00460564|525396392|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
145693886|NCT00460564|525396393|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693887|NCT00460564|525396394|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693888|NCT00460564|525396395|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
145693889|NCT01990313|525396401|FG000|Overall Study|Lost to Follow-up|1|||
145693890|NCT03119688|525396402|FG000|Overall Study|Adverse Event|4|||
145693891|NCT02624869|525396403|FG000|Overall Study|Lost to Follow-up|0|||
145693892|NCT02624869|525396404|FG001|Overall Study|Lost to Follow-up|0|||
145693893|NCT02624869|525396405|FG002|Overall Study|Lost to Follow-up|1|||
145693894|NCT02624869|525396403|FG000|Overall Study|Withdrawal by Subject|1|||
145693895|NCT02624869|525396404|FG001|Overall Study|Withdrawal by Subject|3|||
145693896|NCT02624869|525396405|FG002|Overall Study|Withdrawal by Subject|1|||
145693897|NCT02705625|525396406|FG000|Overall Study|Protocol Violation|1|||
145693898|NCT02705625|525396407|FG001|Overall Study|Protocol Violation|0|||
145693899|NCT02705625|525396408|FG002|Overall Study|Protocol Violation|0|||
145693900|NCT02705625|525396406|FG000|Overall Study|Adverse Event|6|||
145693901|NCT02705625|525396407|FG001|Overall Study|Adverse Event|5|||
145693902|NCT02705625|525396408|FG002|Overall Study|Adverse Event|2|||
145693903|NCT02705625|525396406|FG000|Overall Study|Death|0|||
145693904|NCT02705625|525396407|FG001|Overall Study|Death|0|||
145693905|NCT02705625|525396408|FG002|Overall Study|Death|1|||
145693906|NCT02705625|525396406|FG000|Overall Study|Withdrawal by Subject|1|||
145693907|NCT02705625|525396407|FG001|Overall Study|Withdrawal by Subject|4|||
145693908|NCT02705625|525396408|FG002|Overall Study|Withdrawal by Subject|5|||
145693909|NCT02705625|525396406|FG000|Overall Study|Lost to Follow-up|0|||
145693910|NCT02705625|525396407|FG001|Overall Study|Lost to Follow-up|0|||
145693911|NCT02705625|525396408|FG002|Overall Study|Lost to Follow-up|1|||
145693912|NCT02705625|525396406|FG000|Overall Study|Non-compliance|0|||
145693913|NCT02705625|525396407|FG001|Overall Study|Non-compliance|1|||
145693914|NCT02705625|525396408|FG002|Overall Study|Non-compliance|1|||
145693915|NCT02705625|525396406|FG000|Overall Study|Overdosing|0|||
145693916|NCT02705625|525396407|FG001|Overall Study|Overdosing|0|||
145693917|NCT02705625|525396408|FG002|Overall Study|Overdosing|1|||
145693918|NCT00863798|525396409|FG000|Overall Study|Adverse Event|5|||
145693919|NCT00863798|525396410|FG001|Overall Study|Adverse Event|2|||
145693920|NCT00863798|525396411|FG002|Overall Study|Adverse Event|4|||
145693921|NCT00863798|525396409|FG000|Overall Study|Participant failed to return|2|||
145693922|NCT00863798|525396410|FG001|Overall Study|Participant failed to return|1|||
145693923|NCT00863798|525396411|FG002|Overall Study|Participant failed to return|0|||
145693924|NCT00863798|525396409|FG000|Overall Study|Investigator request|1|||
145693925|NCT00863798|525396410|FG001|Overall Study|Investigator request|2|||
145693926|NCT00863798|525396411|FG002|Overall Study|Investigator request|1|||
145693927|NCT00863798|525396409|FG000|Overall Study|Lack of Efficacy|4|||
145693928|NCT00863798|525396410|FG001|Overall Study|Lack of Efficacy|3|||
145693929|NCT00863798|525396411|FG002|Overall Study|Lack of Efficacy|6|||
145693930|NCT00863798|525396409|FG000|Overall Study|Lost to Follow-up|6|||
145693931|NCT00863798|525396410|FG001|Overall Study|Lost to Follow-up|9|||
145693932|NCT00863798|525396411|FG002|Overall Study|Lost to Follow-up|5|||
145693933|NCT00863798|525396409|FG000|Overall Study|Other|2|||
145693934|NCT00863798|525396410|FG001|Overall Study|Other|3|||
145693935|NCT00863798|525396411|FG002|Overall Study|Other|1|||
145693936|NCT00863798|525396409|FG000|Overall Study|Protocol Violation|0|||
145693937|NCT00863798|525396410|FG001|Overall Study|Protocol Violation|1|||
145693938|NCT00863798|525396411|FG002|Overall Study|Protocol Violation|1|||
145693939|NCT00863798|525396409|FG000|Overall Study|Withdrawal by Subject|8|||
145693940|NCT00863798|525396410|FG001|Overall Study|Withdrawal by Subject|7|||
145693941|NCT00863798|525396411|FG002|Overall Study|Withdrawal by Subject|4|||
145693942|NCT00863798|525396409|FG000|Overall Study|Randomized not treated|4|||
145693943|NCT00863798|525396410|FG001|Overall Study|Randomized not treated|2|||
145693944|NCT00863798|525396411|FG002|Overall Study|Randomized not treated|3|||
145693945|NCT04238520|525396413|FG000|Overall Study|Withdrawal by Subject|1|||
145693946|NCT04238520|525396414|FG001|Overall Study|Withdrawal by Subject|1|||
145693947|NCT04238520|525396413|FG000|Overall Study|Lost to Follow-up|1|||
145693948|NCT04238520|525396414|FG001|Overall Study|Lost to Follow-up|2|||
145693949|NCT04238520|525396413|FG000|Overall Study|Death|0|||
145693950|NCT04238520|525396414|FG001|Overall Study|Death|2|||
145693951|NCT04238520|525396413|FG000|Overall Study|Unsafe home environment for research staff|0|||
145693952|NCT04238520|525396414|FG001|Overall Study|Unsafe home environment for research staff|1|||
145693953|NCT01470599|525396415|FG000|Overall Study|Did not meet entrance criteria|1|||
145693954|NCT01470599|525396416|FG001|Overall Study|Did not meet entrance criteria|0|||
145693955|NCT01470599|525396415|FG000|Overall Study|Lost to Follow-up|2|||
145693956|NCT01470599|525396416|FG001|Overall Study|Lost to Follow-up|1|||
145693957|NCT01470599|525396415|FG000|Overall Study|Withdrawal by Subject|3|||
145693958|NCT01470599|525396416|FG001|Overall Study|Withdrawal by Subject|4|||
145693959|NCT01470599|525396415|FG000|Overall Study|Other|1|||
145693960|NCT01470599|525396416|FG001|Overall Study|Other|0|||
145693961|NCT01470599|525396415|FG000|Overall Study|Protocol Violation|3|||
145693962|NCT01470599|525396416|FG001|Overall Study|Protocol Violation|1|||
145693963|NCT01470599|525396415|FG000|Overall Study|Adverse event related to study drug|2|||
145693964|NCT01470599|525396416|FG001|Overall Study|Adverse event related to study drug|5|||
145693965|NCT01470599|525396415|FG000|Overall Study|Insufficient clinical response|6|||
145693966|NCT01470599|525396416|FG001|Overall Study|Insufficient clinical response|27|||
145693967|NCT01470599|525396415|FG000|Overall Study|Adverse event not related to study drug|1|||
145693968|NCT01470599|525396416|FG001|Overall Study|Adverse event not related to study drug|5|||
145693969|NCT00195442|525396417|FG000|Overall Study|Less than expected therapeutic effect|38|||
145693970|NCT00195442|525396417|FG000|Overall Study|Lost to Follow-up|27|||
145693971|NCT00195442|525396417|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
145693972|NCT00195442|525396417|FG000|Overall Study|Intermittent product shortage|21|||
145693973|NCT00195442|525396417|FG000|Overall Study|Death|7|||
145693974|NCT00195442|525396417|FG000|Overall Study|No reason specified|4|||
145693975|NCT00195442|525396417|FG000|Overall Study|Poor cooperation|2|||
145693976|NCT00195442|525396417|FG000|Overall Study|Other|14|||
145693977|NCT01649297|525396418|FG000|Overall Study|Adverse Event|5|||
145693978|NCT01649297|525396419|FG001|Overall Study|Adverse Event|5|||
145693979|NCT01649297|525396420|FG002|Overall Study|Adverse Event|4|||
145693980|NCT01649297|525396421|FG003|Overall Study|Adverse Event|13|||
145693981|NCT01649297|525396422|FG004|Overall Study|Adverse Event|1|||
145693982|NCT01649297|525396418|FG000|Overall Study|Lack of Efficacy|0|||
145693983|NCT01649297|525396419|FG001|Overall Study|Lack of Efficacy|0|||
145693984|NCT01649297|525396420|FG002|Overall Study|Lack of Efficacy|0|||
145693985|NCT01649297|525396421|FG003|Overall Study|Lack of Efficacy|0|||
145693986|NCT01649297|525396422|FG004|Overall Study|Lack of Efficacy|1|||
145693987|NCT01649297|525396418|FG000|Overall Study|Non compliant with Protocol|1|||
145693988|NCT01649297|525396419|FG001|Overall Study|Non compliant with Protocol|0|||
145693989|NCT01649297|525396420|FG002|Overall Study|Non compliant with Protocol|3|||
145693990|NCT01649297|525396421|FG003|Overall Study|Non compliant with Protocol|2|||
145693991|NCT01649297|525396422|FG004|Overall Study|Non compliant with Protocol|1|||
145693992|NCT01649297|525396418|FG000|Overall Study|Lost to Follow-up|1|||
145693993|NCT01649297|525396419|FG001|Overall Study|Lost to Follow-up|1|||
145693994|NCT01649297|525396420|FG002|Overall Study|Lost to Follow-up|4|||
145693995|NCT01649297|525396421|FG003|Overall Study|Lost to Follow-up|3|||
145693996|NCT01649297|525396422|FG004|Overall Study|Lost to Follow-up|0|||
145693997|NCT01649297|525396418|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
145693998|NCT01649297|525396419|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
145693999|NCT01649297|525396420|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
145694000|NCT01649297|525396421|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
145694001|NCT01649297|525396422|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
145694002|NCT01649297|525396418|FG000|Overall Study|For other reason|4|||
145694003|NCT01649297|525396419|FG001|Overall Study|For other reason|1|||
145694004|NCT01649297|525396420|FG002|Overall Study|For other reason|2|||
145694005|NCT01649297|525396421|FG003|Overall Study|For other reason|0|||
145694006|NCT01649297|525396422|FG004|Overall Study|For other reason|0|||
145694007|NCT01685047|525396423|FG000|Overall Study|Withdrawal by Subject|20|||
145694008|NCT01685047|525396423|FG000|Overall Study|Death|26|||
145694009|NCT01685047|525396423|FG000|Overall Study|Lost to Follow-up|8|||
145694010|NCT01685047|525396423|FG000|Overall Study|Physician Decision|25|||
145694011|NCT01685047|525396423|FG000|Overall Study|Adverse Event|5|||
145694012|NCT01685047|525396423|FG000|Overall Study|patient withdrawn by sponsor|1|||
145694013|NCT01049984|525396424|FG000|Overall Study|Withdrawal by Subject|1|||
145694014|NCT01049984|525396425|FG001|Overall Study|Withdrawal by Subject|5|||
145694015|NCT01049984|525396424|FG000|Overall Study|Protocol Violation|3|||
145694016|NCT01049984|525396425|FG001|Overall Study|Protocol Violation|4|||
145694017|NCT01049984|525396424|FG000|Overall Study|Lost to Follow-up|2|||
145694018|NCT01049984|525396425|FG001|Overall Study|Lost to Follow-up|1|||
145694019|NCT01049984|525396424|FG000|Overall Study|Adverse Event|13|||
145694020|NCT01049984|525396425|FG001|Overall Study|Adverse Event|7|||
145694021|NCT01049984|525396424|FG000|Overall Study|Treatment failure|0|||
145694022|NCT01049984|525396425|FG001|Overall Study|Treatment failure|2|||
145694023|NCT01233999|525396428|FG000|Overall Study|Withdrawal by Subject|1|||
145694024|NCT01233999|525396428|FG000|Overall Study|Lost to Follow-up|1|||
145694025|NCT01321723|525396429|FG000|Overall Study|Adverse Event|3|||
145694026|NCT01321723|525396430|FG001|Overall Study|Adverse Event|5|||
145694027|NCT01321723|525396431|FG002|Overall Study|Adverse Event|2|||
145694028|NCT01321723|525396429|FG000|Overall Study|Withdrawal by Subject|2|||
145694029|NCT01321723|525396430|FG001|Overall Study|Withdrawal by Subject|0|||
145694030|NCT01321723|525396431|FG002|Overall Study|Withdrawal by Subject|2|||
145694031|NCT02246218|525396432|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
145694032|NCT02246218|525396433|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
145694033|NCT02246218|525396432|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
145694034|NCT02246218|525396433|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
145694035|NCT02246218|525396432|FG000|Overall Study|Adverse Event|1|||
145694036|NCT02246218|525396433|FG001|Overall Study|Adverse Event|1|||
145694037|NCT02246218|525396432|FG000|Overall Study|Lost to Follow-up|1|||
145694038|NCT02246218|525396433|FG001|Overall Study|Lost to Follow-up|0|||
145694039|NCT04952701|525396434|FG000|Control Lens|Physician Decision|4|||
145694040|NCT04952701|525396434|FG000|Test Lens|Physician Decision|1|||
145694041|NCT00827775|525396435|FG000|Overall Study|Withdrawal by Subject|0|||
145694042|NCT00827775|525396436|FG001|Overall Study|Withdrawal by Subject|5|||
145694043|NCT02212301|525396437|FG000|Period 1|Lost to Follow-up|0|||
145694044|NCT02212301|525396438|FG001|Period 1|Lost to Follow-up|1|||
145694045|NCT00578318|525396441|FG000|Overall Study|Lost to Follow-up|2|||
145694046|NCT00578318|525396442|FG001|Overall Study|Lost to Follow-up|0|||
145694047|NCT00578318|525396441|FG000|Overall Study|Physician Decision|1|||
145694048|NCT00578318|525396442|FG001|Overall Study|Physician Decision|0|||
145694049|NCT02025985|525396443|FG000|Overall Study|Consent withdrawn|0|||
145694050|NCT02025985|525396444|FG001|Overall Study|Consent withdrawn|0|||
145694051|NCT02025985|525396445|FG002|Overall Study|Consent withdrawn|1|||
145694052|NCT02025985|525396446|FG003|Overall Study|Consent withdrawn|0|||
145694053|NCT02025985|525396447|FG004|Overall Study|Consent withdrawn|0|||
145694054|NCT02025985|525396443|FG000|Overall Study|Termination of study by Sponsor|4|||
145694055|NCT02025985|525396444|FG001|Overall Study|Termination of study by Sponsor|3|||
145694056|NCT02025985|525396445|FG002|Overall Study|Termination of study by Sponsor|1|||
145694057|NCT02025985|525396446|FG003|Overall Study|Termination of study by Sponsor|1|||
145694058|NCT02025985|525396447|FG004|Overall Study|Termination of study by Sponsor|3|||
145694059|NCT02025985|525396443|FG000|Overall Study|Death|21|||
145694060|NCT02025985|525396444|FG001|Overall Study|Death|20|||
145694061|NCT02025985|525396445|FG002|Overall Study|Death|23|||
145694062|NCT02025985|525396446|FG003|Overall Study|Death|20|||
145694063|NCT02025985|525396447|FG004|Overall Study|Death|17|||
145694064|NCT03041701|525396448|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
145694065|NCT03041701|525396449|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
145694066|NCT03041701|525396450|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
145694067|NCT03041701|525396448|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
145694068|NCT03041701|525396449|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
145694069|NCT03041701|525396450|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
145694070|NCT00527514|525396451|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
145694071|NCT00527514|525396451|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
145694072|NCT00527514|525396451|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
145694073|NCT00527514|525396451|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
145694074|NCT00527514|525396451|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
145694075|NCT00527514|525396451|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
145694076|NCT00527514|525396451|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
145694077|NCT00920699|525396454|FG000|Overall Study|Withdrawal by Subject|2|||
145694078|NCT00920699|525396455|FG001|Overall Study|Withdrawal by Subject|0|||
145694079|NCT00920699|525396456|FG002|Overall Study|Withdrawal by Subject|2|||
145694080|NCT00920699|525396454|FG000|Overall Study|no longer met eligibility|0|||
145694081|NCT00920699|525396455|FG001|Overall Study|no longer met eligibility|1|||
145694082|NCT00920699|525396456|FG002|Overall Study|no longer met eligibility|0|||
145694083|NCT00920699|525396454|FG000|Overall Study|Lost to Follow-up|0|||
145694084|NCT00920699|525396455|FG001|Overall Study|Lost to Follow-up|0|||
145694085|NCT00920699|525396456|FG002|Overall Study|Lost to Follow-up|2|||
145694086|NCT00001941|525396457|FG000|Overall Study|not treated- rapidly progressing disease|0|||
145694087|NCT00001941|525396458|FG001|Overall Study|not treated- rapidly progressing disease|0|||
145694088|NCT00001941|525396459|FG002|Overall Study|not treated- rapidly progressing disease|0|||
145694089|NCT00001941|525396460|FG003|Overall Study|not treated- rapidly progressing disease|0|||
145694090|NCT00001941|525396461|FG004|Overall Study|not treated- rapidly progressing disease|1|||
145694091|NCT01527500|525396463|FG000|Part A|Administrative|11|||
145694092|NCT01527500|525396464|FG001|Part A|Administrative|7|||
145694093|NCT01527500|525396463|FG000|Part A|Adverse Event|4|||
145694094|NCT01527500|525396464|FG001|Part A|Adverse Event|2|||
145694095|NCT01527500|525396463|FG000|Part A|Death|4|||
145694096|NCT01527500|525396464|FG001|Part A|Death|1|||
145694097|NCT01527500|525396463|FG000|Part A|Lost to Follow-up|0|||
145694098|NCT01527500|525396464|FG001|Part A|Lost to Follow-up|1|||
145694099|NCT01527500|525396463|FG000|Part A|Protocol Deviation|9|||
145694100|NCT01527500|525396464|FG001|Part A|Protocol Deviation|2|||
145694101|NCT01527500|525396463|FG000|Part A|Withdrawal by Subject|2|||
145694102|NCT01527500|525396464|FG001|Part A|Withdrawal by Subject|0|||
145694103|NCT01527500|525396463|FG000|Part B|Adverse Event|1|||
145694104|NCT01527500|525396464|FG001|Part B|Adverse Event|0|||
145694105|NCT02864342|525396465|FG000|Overall Study|Eligibility Criteria Deviation|2|||
145694106|NCT02864342|525396466|FG001|Overall Study|Eligibility Criteria Deviation|3|||
145694107|NCT02864342|525396465|FG000|Overall Study|Withdrawal by Subject|4|||
145694108|NCT02864342|525396466|FG001|Overall Study|Withdrawal by Subject|2|||
145694109|NCT02864342|525396465|FG000|Overall Study|Device Technology Issue|6|||
145694110|NCT02864342|525396466|FG001|Overall Study|Device Technology Issue|7|||
145694111|NCT02864342|525396465|FG000|Overall Study|Death|0|||
145694112|NCT02864342|525396466|FG001|Overall Study|Death|1|||
145694113|NCT02864342|525396465|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
145694114|NCT02864342|525396466|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
145694115|NCT02864342|525396465|FG000|Overall Study|Lost to Follow-up|1|||
145694116|NCT02864342|525396466|FG001|Overall Study|Lost to Follow-up|5|||
145694117|NCT02864342|525396465|FG000|Overall Study|Lost Device|1|||
145694118|NCT02864342|525396466|FG001|Overall Study|Lost Device|0|||
145694119|NCT02864342|525396465|FG000|Overall Study|Adverse Event|1|||
145694120|NCT02864342|525396466|FG001|Overall Study|Adverse Event|0|||
145694121|NCT02573883|525396467|FG000|Six Month Follow Up|Lost to Follow-up|1|||
145694122|NCT02573883|525396468|FG001|Six Month Follow Up|Lost to Follow-up|0|||
145694123|NCT02573883|525396469|FG002|Six Month Follow Up|Lost to Follow-up|0|||
145694124|NCT02573883|525396470|FG003|Six Month Follow Up|Lost to Follow-up|0|||
145694125|NCT02573883|525396467|FG000|One Year Follow Up|Lost to Follow-up|2|||
145694126|NCT02573883|525396468|FG001|One Year Follow Up|Lost to Follow-up|1|||
145694127|NCT02573883|525396469|FG002|One Year Follow Up|Lost to Follow-up|0|||
145694128|NCT02573883|525396470|FG003|One Year Follow Up|Lost to Follow-up|0|||
145694129|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
145694130|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
145694131|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
145694132|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
145694133|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
145694134|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
145694135|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
145694136|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
145694137|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
145694138|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
145694139|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
145694140|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
145694141|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
145694142|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
145694143|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
145694144|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
145694145|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
145694146|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
145694147|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
145694148|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
145694149|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
145694150|NCT01125566|525396476|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
145694151|NCT01125566|525396477|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
145694152|NCT01125566|525396478|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
145694153|NCT01125566|525396476|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
145694154|NCT01125566|525396477|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
145694155|NCT01125566|525396478|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
145694156|NCT01125566|525396476|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
145694157|NCT01125566|525396477|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
145694158|NCT01125566|525396478|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
145694159|NCT01125566|525396476|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
145694160|NCT01125566|525396477|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
145694161|NCT01125566|525396478|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
145694162|NCT01125566|525396476|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
145694163|NCT01125566|525396477|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
145694164|NCT01125566|525396478|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
145694165|NCT01560585|525396479|FG000|Overall Study|Physician Decision|3|||
145694166|NCT00519285|525396480|FG000|Overall Study|Adverse Event|127|||
145694167|NCT00519285|525396481|FG001|Overall Study|Adverse Event|266|||
145694168|NCT00519285|525396480|FG000|Overall Study|Disease progression|334|||
145694169|NCT00519285|525396481|FG001|Overall Study|Disease progression|186|||
145694170|NCT00519285|525396480|FG000|Overall Study|Physician Decision|75|||
145694171|NCT00519285|525396481|FG001|Overall Study|Physician Decision|47|||
145694172|NCT00519285|525396480|FG000|Overall Study|Participant's request|53|||
145694173|NCT00519285|525396481|FG001|Overall Study|Participant's request|84|||
145694174|NCT00519285|525396480|FG000|Overall Study|Consent withdrawn|4|||
145694175|NCT00519285|525396481|FG001|Overall Study|Consent withdrawn|5|||
145694176|NCT00519285|525396480|FG000|Overall Study|Poor compliance to protocol|5|||
145694177|NCT00519285|525396481|FG001|Overall Study|Poor compliance to protocol|7|||
145694178|NCT00519285|525396480|FG000|Overall Study|Reason unspecified|5|||
145694179|NCT00519285|525396481|FG001|Overall Study|Reason unspecified|8|||
145694180|NCT00519285|525396480|FG000|Overall Study|Not treated|8|||
145694181|NCT00519285|525396481|FG001|Overall Study|Not treated|7|||
145694182|NCT00519285|525396480|FG000|Overall Study|Treatment ongoing|1|||
145694183|NCT00519285|525396481|FG001|Overall Study|Treatment ongoing|2|||
145694184|NCT01813305|525396483|FG000|Overall Study|Withdrawal by Subject|12|||
145694185|NCT01813305|525396484|FG001|Overall Study|Withdrawal by Subject|5|||
145694186|NCT01813305|525396483|FG000|Overall Study|Safety Concern|4|||
145694187|NCT01813305|525396484|FG001|Overall Study|Safety Concern|0|||
145694188|NCT01813305|525396483|FG000|Overall Study|Ulcer became worse|4|||
145694189|NCT01813305|525396484|FG001|Overall Study|Ulcer became worse|0|||
145694190|NCT01813305|525396483|FG000|Overall Study|Physician Decision|4|||
145694191|NCT01813305|525396484|FG001|Overall Study|Physician Decision|0|||
145694192|NCT01813305|525396483|FG000|Overall Study|Lost to Follow-up|3|||
145694193|NCT01813305|525396484|FG001|Overall Study|Lost to Follow-up|1|||
145694194|NCT01813305|525396483|FG000|Overall Study|Protocol Violation|1|||
145694195|NCT01813305|525396484|FG001|Overall Study|Protocol Violation|0|||
145694196|NCT01813305|525396483|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
145694197|NCT01813305|525396484|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
145694198|NCT00988117|525396485|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
145694199|NCT00988117|525396485|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
145694200|NCT04088500|525396486|FG000|Overall Study|Reason unknown|1|||
145694201|NCT04088500|525396486|FG000|Overall Study|Participant withdrew consent|1|||
145694202|NCT04088500|525396486|FG000|Overall Study|Disease progression|3|||
145694203|NCT02930837|525396490|FG000|Overall Study|Adverse Event|6|||
145694204|NCT02930837|525396490|FG000|Overall Study|Lost to Follow-up|5|||
145694205|NCT02930837|525396490|FG000|Overall Study|Withdrawal by Subject|1|||
145694206|NCT04582864|525396491|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
145694207|NCT04582864|525396491|FG000|Overall Study|Death|1|||
145694208|NCT00006436|525396492|FG000|Overall Study|Refused further treatment|2|||
145694209|NCT00006436|525396492|FG000|Overall Study|Declined to participate (before treatment started)|1|||
145694210|NCT01071317|525396493|FG000|Overall Study|Lost to Follow-up|2|||
145694211|NCT01071317|525396494|FG001|Overall Study|Lost to Follow-up|2|||
145694212|NCT01502371|525396501|FG000|Overall Study|Withdrawal by Subject|1|||
145694213|NCT01502371|525396502|FG001|Overall Study|Withdrawal by Subject|2|||
145694214|NCT01502371|525396503|FG002|Overall Study|Withdrawal by Subject|1|||
145694215|NCT01502371|525396504|FG003|Overall Study|Withdrawal by Subject|1|||
145694216|NCT01502371|525396505|FG004|Overall Study|Withdrawal by Subject|1|||
145694217|NCT01502371|525396501|FG000|Overall Study|Adverse Event|2|||
145694218|NCT01502371|525396502|FG001|Overall Study|Adverse Event|1|||
145694219|NCT01502371|525396503|FG002|Overall Study|Adverse Event|0|||
145694220|NCT01502371|525396504|FG003|Overall Study|Adverse Event|4|||
145694221|NCT01502371|525396505|FG004|Overall Study|Adverse Event|3|||
145694222|NCT01502371|525396501|FG000|Overall Study|Treatment Failure|22|||
145694223|NCT01502371|525396502|FG001|Overall Study|Treatment Failure|20|||
145694224|NCT01502371|525396503|FG002|Overall Study|Treatment Failure|12|||
145694225|NCT01502371|525396504|FG003|Overall Study|Treatment Failure|19|||
145694226|NCT01502371|525396505|FG004|Overall Study|Treatment Failure|30|||
145694227|NCT01502371|525396501|FG000|Overall Study|Lack of Efficacy|3|||
145694228|NCT01502371|525396502|FG001|Overall Study|Lack of Efficacy|3|||
145694229|NCT01502371|525396503|FG002|Overall Study|Lack of Efficacy|2|||
145694230|NCT01502371|525396504|FG003|Overall Study|Lack of Efficacy|2|||
145694231|NCT01502371|525396505|FG004|Overall Study|Lack of Efficacy|4|||
145694232|NCT01502371|525396501|FG000|Overall Study|Physician Decision|3|||
145694233|NCT01502371|525396502|FG001|Overall Study|Physician Decision|0|||
145694234|NCT01502371|525396503|FG002|Overall Study|Physician Decision|0|||
145694235|NCT01502371|525396504|FG003|Overall Study|Physician Decision|0|||
145694236|NCT01502371|525396505|FG004|Overall Study|Physician Decision|1|||
145694237|NCT01502371|525396501|FG000|Overall Study|Noncompliance with Study Drug|0|||
145694238|NCT01502371|525396502|FG001|Overall Study|Noncompliance with Study Drug|0|||
145694239|NCT01502371|525396503|FG002|Overall Study|Noncompliance with Study Drug|1|||
145694240|NCT01502371|525396504|FG003|Overall Study|Noncompliance with Study Drug|2|||
145694241|NCT01502371|525396505|FG004|Overall Study|Noncompliance with Study Drug|1|||
145694242|NCT01502371|525396501|FG000|Overall Study|Technical Problems|1|||
145694243|NCT01502371|525396502|FG001|Overall Study|Technical Problems|0|||
145694244|NCT01502371|525396503|FG002|Overall Study|Technical Problems|2|||
145694245|NCT01502371|525396504|FG003|Overall Study|Technical Problems|4|||
145694246|NCT01502371|525396505|FG004|Overall Study|Technical Problems|1|||
145694247|NCT01502371|525396501|FG000|Overall Study|Protocol Violation|9|||
145694248|NCT01502371|525396502|FG001|Overall Study|Protocol Violation|5|||
145694249|NCT01502371|525396503|FG002|Overall Study|Protocol Violation|6|||
145694250|NCT01502371|525396504|FG003|Overall Study|Protocol Violation|5|||
145694251|NCT01502371|525396505|FG004|Overall Study|Protocol Violation|10|||
145694252|NCT01502371|525396501|FG000|Overall Study|Excluded Medication|0|||
145694253|NCT01502371|525396502|FG001|Overall Study|Excluded Medication|1|||
145694254|NCT01502371|525396503|FG002|Overall Study|Excluded Medication|1|||
145694255|NCT01502371|525396504|FG003|Overall Study|Excluded Medication|0|||
145694256|NCT01502371|525396505|FG004|Overall Study|Excluded Medication|1|||
145694257|NCT02598934|525396510|FG000|Overall Study|Adverse Event|11|||
145694258|NCT02598934|525396511|FG001|Overall Study|Adverse Event|13|||
145694259|NCT02598934|525396510|FG000|Overall Study|Failure to Return|3|||
145694260|NCT02598934|525396511|FG001|Overall Study|Failure to Return|3|||
145694261|NCT02598934|525396510|FG000|Overall Study|Withdrawal by Subject|2|||
145694262|NCT02598934|525396511|FG001|Overall Study|Withdrawal by Subject|3|||
145694263|NCT02598934|525396510|FG000|Overall Study|Administrative|2|||
145694264|NCT02598934|525396511|FG001|Overall Study|Administrative|1|||
145694265|NCT02598934|525396510|FG000|Overall Study|Protocol Violation|1|||
145694266|NCT02598934|525396511|FG001|Overall Study|Protocol Violation|2|||
145694267|NCT02481934|525396513|FG000|Overall Study|Death|2|||
145694268|NCT03749616|525396517|FG000|Overall Study|Lost to Follow-up|4|||
145694269|NCT03749616|525396518|FG001|Overall Study|Lost to Follow-up|7|||
145694270|NCT03749616|525396517|FG000|Overall Study|Screen Failure|1|||
145694271|NCT03749616|525396518|FG001|Overall Study|Screen Failure|1|||
145694272|NCT03749616|525396517|FG000|Overall Study|Withdrawal by Subject|2|||
145694273|NCT03749616|525396518|FG001|Overall Study|Withdrawal by Subject|0|||
145694274|NCT03302559|525396521|FG000|Overall Study|Adverse Event|2|||
145694275|NCT03302559|525396521|FG000|Overall Study|Lost to Follow-up|1|||
145694276|NCT03302559|525396521|FG000|Overall Study|Withdrew Consent|3|||
145694277|NCT00320398|525398356|FG000|Overall Study|Adverse Event|1|||
145694278|NCT00320398|525398357|FG001|Overall Study|Adverse Event|4|||
145694279|NCT00320398|525398356|FG000|Overall Study|Other|1|||
145694280|NCT00320398|525398357|FG001|Overall Study|Other|0|||
145694281|NCT04190225|525398358|FG000|Overall Study|Lost to Follow-up|2|||
145694282|NCT04190225|525398359|FG001|Overall Study|Lost to Follow-up|3|||
145694283|NCT04190225|525398358|FG000|Overall Study|Withdrawal by Subject|3|||
145694284|NCT04190225|525398359|FG001|Overall Study|Withdrawal by Subject|2|||
145694285|NCT04190225|525398358|FG000|Overall Study|Unrelated health condition|2|||
145694286|NCT04190225|525398359|FG001|Overall Study|Unrelated health condition|0|||
145694287|NCT04544865|525398360|FG000|Overall Study|Death|0|||
145694288|NCT04544865|525398361|FG001|Overall Study|Death|2|||
145694289|NCT04544865|525398360|FG000|Overall Study|Lost to Follow-up|11|||
145694290|NCT04544865|525398361|FG001|Overall Study|Lost to Follow-up|7|||
145694291|NCT04544865|525398360|FG000|Overall Study|Withdrawal by Subject|0|||
145694292|NCT04544865|525398361|FG001|Overall Study|Withdrawal by Subject|1|||
145694293|NCT04544865|525398360|FG000|Overall Study|Other|0|||
145694294|NCT04544865|525398361|FG001|Overall Study|Other|1|||
145694295|NCT02973802|525398362|FG000|Overall Study|Lost to Follow-up|1|||
145694296|NCT02973802|525398362|FG000|Overall Study|Withdrawal by Subject|1|||
145694297|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
145694298|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
145694299|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
145694300|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
145694301|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
145694302|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
145694303|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
145694304|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
145694305|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
145694306|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
145694307|NCT01772823|525398367|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
145694308|NCT01772823|525398368|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
145694309|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
145694310|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
145694311|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
145694312|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
145694313|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
145694314|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
145694315|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
145694316|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
145694317|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
145694318|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
145694319|NCT01772823|525398367|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
145694320|NCT01772823|525398368|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
145694321|NCT01772823|525398367|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
145694322|NCT01772823|525398368|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
145694323|NCT01772823|525398367|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
145694324|NCT01772823|525398368|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
145694325|NCT01772823|525398367|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
145694326|NCT01772823|525398368|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
145694327|NCT01772823|525398367|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
145694328|NCT01772823|525398368|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
145694329|NCT02895360|525398369|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
145694330|NCT02895360|525398370|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
145694331|NCT02895360|525398371|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
145694332|NCT02895360|525398372|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
145694333|NCT02895360|525398373|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
145694334|NCT02895360|525398374|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
145694335|NCT02895360|525398369|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
145694336|NCT02895360|525398370|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
145694337|NCT02895360|525398371|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
145694338|NCT02895360|525398372|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
145694339|NCT02895360|525398373|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
145694340|NCT02895360|525398374|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
145694341|NCT02895360|525398369|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
145694342|NCT02895360|525398370|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
145694343|NCT02895360|525398371|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
145694344|NCT02895360|525398372|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
145694345|NCT02895360|525398373|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
145694346|NCT02895360|525398374|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
145694347|NCT02895360|525398369|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
145694348|NCT02895360|525398370|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
145694349|NCT02895360|525398371|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
145694350|NCT02895360|525398372|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
145694351|NCT02895360|525398373|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
145694352|NCT02895360|525398374|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
145694353|NCT02895360|525398369|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
145694354|NCT02895360|525398370|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
145694355|NCT02895360|525398371|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
145694356|NCT02895360|525398372|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
145694357|NCT02895360|525398373|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
145694358|NCT02895360|525398374|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
145694359|NCT02895360|525398369|FG000|Phase 2a|Adverse Event|0|||
145694360|NCT02895360|525398370|FG001|Phase 2a|Adverse Event|0|||
145694361|NCT02895360|525398371|FG002|Phase 2a|Adverse Event|0|||
145694362|NCT02895360|525398372|FG003|Phase 2a|Adverse Event|0|||
145694363|NCT02895360|525398373|FG004|Phase 2a|Adverse Event|0|||
145694364|NCT02895360|525398374|FG005|Phase 2a|Adverse Event|1|||
145694365|NCT02895360|525398369|FG000|Phase 2a|Progressive disease|0|||
145694366|NCT02895360|525398370|FG001|Phase 2a|Progressive disease|0|||
145694367|NCT02895360|525398371|FG002|Phase 2a|Progressive disease|0|||
145694368|NCT02895360|525398372|FG003|Phase 2a|Progressive disease|0|||
145694369|NCT02895360|525398373|FG004|Phase 2a|Progressive disease|11|||
145694370|NCT02895360|525398374|FG005|Phase 2a|Progressive disease|11|||
145694371|NCT01732926|525398376|FG000|Overall Study|Study Terminated by Sponsor|168|||
145694372|NCT01732926|525398377|FG001|Overall Study|Study Terminated by Sponsor|80|||
145694373|NCT01732926|525398376|FG000|Overall Study|Withdrawal by Subject|46|||
145694374|NCT01732926|525398377|FG001|Overall Study|Withdrawal by Subject|8|||
145694375|NCT01732926|525398376|FG000|Overall Study|Physician Decision|24|||
145694376|NCT01732926|525398377|FG001|Overall Study|Physician Decision|11|||
145694377|NCT01732926|525398376|FG000|Overall Study|Other Reason|21|||
145694378|NCT01732926|525398377|FG001|Overall Study|Other Reason|4|||
145694379|NCT01732926|525398376|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
145694380|NCT01732926|525398377|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
145694381|NCT01732926|525398376|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
145694382|NCT01732926|525398377|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
145694383|NCT02262364|525398382|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
145694384|NCT00337285|525398385|FG000|Overall Study|Withdrawal by Subject|42|||
145694385|NCT00337285|525398385|FG000|Overall Study|Lost to Follow-up|41|||
145694386|NCT00337285|525398385|FG000|Overall Study|Adverse Event|28|||
145694387|NCT00337285|525398385|FG000|Overall Study|Protocol Violation|27|||
145694388|NCT00337285|525398385|FG000|Overall Study|Lack of Efficacy|11|||
145694389|NCT00337285|525398385|FG000|Overall Study|Death|1|||
145694390|NCT00337285|525398385|FG000|Overall Study|Physician Decision|1|||
145694391|NCT00337285|525398385|FG000|Overall Study|Lack of protocol compliance|7|||
145694392|NCT00553605|525398386|FG000|Overall Study|Did not meet entrance criteria|1|||
145694393|NCT00553605|525398387|FG001|Overall Study|Did not meet entrance criteria|3|||
145694394|NCT00553605|525398386|FG000|Overall Study|Did not receive full dose|1|||
145694395|NCT00553605|525398387|FG001|Overall Study|Did not receive full dose|0|||
145694396|NCT00553605|525398386|FG000|Overall Study|Randomized but not treated|2|||
145694397|NCT00553605|525398387|FG001|Overall Study|Randomized but not treated|0|||
145694398|NCT01004185|525398389|FG000|Overall Study|Adverse Event|1|||
145694399|NCT01004185|525398390|FG001|Overall Study|Adverse Event|1|||
145694400|NCT01004185|525398389|FG000|Overall Study|Lost to Follow-up|0|||
145694401|NCT01004185|525398390|FG001|Overall Study|Lost to Follow-up|1|||
145694402|NCT01004185|525398389|FG000|Overall Study|Lack of Efficacy|2|||
145694403|NCT01004185|525398390|FG001|Overall Study|Lack of Efficacy|1|||
145694404|NCT01004185|525398389|FG000|Overall Study|Sponsor Terminated Study|4|||
145694405|NCT01004185|525398390|FG001|Overall Study|Sponsor Terminated Study|5|||
145694406|NCT01004185|525398389|FG000|Overall Study|Withdrawal by Subject|2|||
145694407|NCT01004185|525398390|FG001|Overall Study|Withdrawal by Subject|1|||
145694408|NCT03214250|525398391|FG000|Overall Study|Death|5|||
145694409|NCT03214250|525398392|FG001|Overall Study|Death|5|||
145694410|NCT03214250|525398393|FG002|Overall Study|Death|7|||
145694411|NCT03214250|525398394|FG003|Overall Study|Death|4|||
145694412|NCT03214250|525398395|FG004|Overall Study|Death|23|||
145694413|NCT03214250|525398396|FG005|Overall Study|Death|23|||
145694414|NCT03214250|525398397|FG006|Overall Study|Death|24|||
145694415|NCT03214250|525398391|FG000|Overall Study|Lost to Follow-up|0|||
145694416|NCT03214250|525398392|FG001|Overall Study|Lost to Follow-up|0|||
145694417|NCT03214250|525398393|FG002|Overall Study|Lost to Follow-up|0|||
145694418|NCT03214250|525398394|FG003|Overall Study|Lost to Follow-up|1|||
145694419|NCT03214250|525398395|FG004|Overall Study|Lost to Follow-up|1|||
145694420|NCT03214250|525398396|FG005|Overall Study|Lost to Follow-up|2|||
145694421|NCT03214250|525398397|FG006|Overall Study|Lost to Follow-up|0|||
145694422|NCT03214250|525398391|FG000|Overall Study|Other|0|||
145694423|NCT03214250|525398392|FG001|Overall Study|Other|0|||
145694424|NCT03214250|525398393|FG002|Overall Study|Other|0|||
145694425|NCT03214250|525398394|FG003|Overall Study|Other|0|||
145694426|NCT03214250|525398395|FG004|Overall Study|Other|1|||
145694427|NCT03214250|525398396|FG005|Overall Study|Other|1|||
145694428|NCT03214250|525398397|FG006|Overall Study|Other|2|||
145694429|NCT03214250|525398391|FG000|Overall Study|Remains on Study|2|||
145694430|NCT03214250|525398392|FG001|Overall Study|Remains on Study|2|||
145694431|NCT03214250|525398393|FG002|Overall Study|Remains on Study|0|||
145694432|NCT03214250|525398394|FG003|Overall Study|Remains on Study|1|||
145694433|NCT03214250|525398395|FG004|Overall Study|Remains on Study|7|||
145694434|NCT03214250|525398396|FG005|Overall Study|Remains on Study|5|||
145694435|NCT03214250|525398397|FG006|Overall Study|Remains on Study|3|||
145694436|NCT03214250|525398391|FG000|Overall Study|Withdrawal by Subject|0|||
145694437|NCT03214250|525398392|FG001|Overall Study|Withdrawal by Subject|0|||
145694438|NCT03214250|525398393|FG002|Overall Study|Withdrawal by Subject|1|||
145694439|NCT03214250|525398394|FG003|Overall Study|Withdrawal by Subject|2|||
145694440|NCT03214250|525398395|FG004|Overall Study|Withdrawal by Subject|5|||
145694441|NCT03214250|525398396|FG005|Overall Study|Withdrawal by Subject|0|||
145694442|NCT03214250|525398397|FG006|Overall Study|Withdrawal by Subject|2|||
145694443|NCT00292981|525398406|FG000|Overall Study|Adverse Event|1|||
145694444|NCT00292981|525398406|FG000|Overall Study|Lost to Follow-up|13|||
145694445|NCT00292981|525398406|FG000|Overall Study|Withdrawal by Subject|22|||
145694446|NCT00292981|525398406|FG000|Overall Study|Other|3|||
145694447|NCT01085812|525398407|FG000|Open-Label Period|Adverse Event|0|||
145694448|NCT01085812|525398408|FG001|Open-Label Period|Adverse Event|80|||
145694449|NCT01085812|525398407|FG000|Open-Label Period|Lack of Efficacy|0|||
145694450|NCT01085812|525398408|FG001|Open-Label Period|Lack of Efficacy|26|||
145694451|NCT01085812|525398407|FG000|Open-Label Period|Protocol Violation|0|||
145694452|NCT01085812|525398408|FG001|Open-Label Period|Protocol Violation|39|||
145694453|NCT01085812|525398407|FG000|Open-Label Period|Withdrawal by Subject|0|||
145694454|NCT01085812|525398408|FG001|Open-Label Period|Withdrawal by Subject|53|||
145694455|NCT01085812|525398407|FG000|Open-Label Period|Lost to Follow-up|0|||
145694456|NCT01085812|525398408|FG001|Open-Label Period|Lost to Follow-up|42|||
145694457|NCT01085812|525398407|FG000|Double-Blind Period|Adverse Event|3|||
145694458|NCT01085812|525398408|FG001|Double-Blind Period|Adverse Event|8|||
145694459|NCT01085812|525398407|FG000|Double-Blind Period|Protocol Violation|2|||
145265474|NCT01298323|523819370|FG001|Overall Study|Protocol Violation|0|||
145694460|NCT01085812|525398408|FG001|Double-Blind Period|Protocol Violation|7|||
145694461|NCT01085812|525398407|FG000|Double-Blind Period|Withdrawal by Subject|11|||
145694462|NCT01085812|525398408|FG001|Double-Blind Period|Withdrawal by Subject|24|||
145694463|NCT01085812|525398407|FG000|Double-Blind Period|Lost to Follow-up|5|||
145694464|NCT01085812|525398408|FG001|Double-Blind Period|Lost to Follow-up|17|||
145694465|NCT01085812|525398407|FG000|Double-Blind Period|Other Reasons|0|||
145694466|NCT01085812|525398408|FG001|Double-Blind Period|Other Reasons|2|||
145694467|NCT01085812|525398407|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
145694468|NCT01085812|525398408|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
145694469|NCT01085812|525398407|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
145694470|NCT01085812|525398408|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
145694471|NCT01085812|525398407|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
145694472|NCT01085812|525398408|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
145694473|NCT01085812|525398407|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
145694474|NCT01085812|525398408|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
145694475|NCT01085812|525398407|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
145694476|NCT01085812|525398408|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
145694477|NCT00594178|525398411|FG000|Overall Study|Physician Decision|5|||
145694478|NCT04191148|525398417|FG000|Overall Study|Withdrawal by Subject|1|||
145694479|NCT04191148|525398418|FG001|Overall Study|Withdrawal by Subject|0|||
145694480|NCT04191148|525398417|FG000|Overall Study|Adverse Event|1|||
145694481|NCT04191148|525398418|FG001|Overall Study|Adverse Event|0|||
145694482|NCT01874665|525398419|FG000|Overall Study|Adverse Event|6|||
145694483|NCT01874665|525398420|FG001|Overall Study|Adverse Event|2|||
145694484|NCT01874665|525398419|FG000|Overall Study|Withdrawal by Subject|4|||
145694485|NCT01874665|525398420|FG001|Overall Study|Withdrawal by Subject|1|||
145694486|NCT01874665|525398419|FG000|Overall Study|Physician Decision|3|||
145694487|NCT01874665|525398420|FG001|Overall Study|Physician Decision|0|||
145694488|NCT01874665|525398419|FG000|Overall Study|Clinical Progressive Disease|4|||
145694489|NCT01874665|525398420|FG001|Overall Study|Clinical Progressive Disease|3|||
145694490|NCT01874665|525398419|FG000|Overall Study|Study Terminated by Sponsor|0|||
145694491|NCT01874665|525398420|FG001|Overall Study|Study Terminated by Sponsor|2|||
145694492|NCT01874665|525398419|FG000|Overall Study|Documented Progressive Disease|11|||
145694493|NCT01874665|525398420|FG001|Overall Study|Documented Progressive Disease|7|||
145694494|NCT01874665|525398419|FG000|Overall Study|Other|2|||
145694495|NCT01874665|525398420|FG001|Overall Study|Other|0|||
145694496|NCT04582669|525398421|FG000|Overall Study|Subject missed appointment(s).|1|||
145694497|NCT04582669|525398422|FG001|Overall Study|Subject missed appointment(s).|0|||
145694498|NCT04582669|525398423|FG002|Overall Study|Subject missed appointment(s).|1|||
145694499|NCT04582669|525398424|FG003|Overall Study|Subject missed appointment(s).|2|||
145694500|NCT04582669|525398421|FG000|Overall Study|Protocol Violation|0|||
145694501|NCT04582669|525398422|FG001|Overall Study|Protocol Violation|1|||
145694502|NCT04582669|525398423|FG002|Overall Study|Protocol Violation|1|||
145694503|NCT04582669|525398424|FG003|Overall Study|Protocol Violation|0|||
145694504|NCT02647788|525398427|FG000|Overall Study|Lost to Follow-up|13|||
145694505|NCT02647788|525398428|FG001|Overall Study|Lost to Follow-up|11|||
145694506|NCT02647788|525398427|FG000|Overall Study|Did not want opiate|0|||
145694507|NCT02647788|525398428|FG001|Overall Study|Did not want opiate|1|||
145694508|NCT02647788|525398427|FG000|Overall Study|Withdrawal by Subject|1|||
145694509|NCT02647788|525398428|FG001|Overall Study|Withdrawal by Subject|0|||
145694510|NCT02647788|525398427|FG000|Overall Study|Felt itchy with assigned medication|1|||
145694511|NCT02647788|525398428|FG001|Overall Study|Felt itchy with assigned medication|0|||
145694512|NCT02647788|525398427|FG000|Overall Study|Felt nauseous with assigned medication|1|||
145694513|NCT02647788|525398428|FG001|Overall Study|Felt nauseous with assigned medication|1|||
145694514|NCT01274559|525398429|FG000|Overall Study|Adverse Event|57|||
145694515|NCT01274559|525398430|FG001|Overall Study|Adverse Event|13|||
145694516|NCT01274559|525398429|FG000|Overall Study|Death|1|||
145694517|NCT01274559|525398430|FG001|Overall Study|Death|1|||
145694518|NCT01274559|525398429|FG000|Overall Study|Lost to Follow-up|3|||
145694519|NCT01274559|525398430|FG001|Overall Study|Lost to Follow-up|3|||
145694520|NCT01274559|525398429|FG000|Overall Study|Non-compliance with Study Drug|2|||
145694521|NCT01274559|525398430|FG001|Overall Study|Non-compliance with Study Drug|4|||
145694522|NCT01274559|525398429|FG000|Overall Study|Physician Decision|2|||
145694523|NCT01274559|525398430|FG001|Overall Study|Physician Decision|1|||
145694524|NCT01274559|525398429|FG000|Overall Study|Protocol Violation|28|||
145694525|NCT01274559|525398430|FG001|Overall Study|Protocol Violation|23|||
145694526|NCT01274559|525398429|FG000|Overall Study|Study Terminated by Sponsor|79|||
145694527|NCT01274559|525398430|FG001|Overall Study|Study Terminated by Sponsor|87|||
145694528|NCT01274559|525398429|FG000|Overall Study|Withdrawal by Subject|25|||
145694529|NCT01274559|525398430|FG001|Overall Study|Withdrawal by Subject|13|||
145694530|NCT03245619|525398432|FG000|Part A (Up to Day 22)|Physician Decision|4|||
145694531|NCT03245619|525398433|FG001|Part A (Up to Day 22)|Physician Decision|6|||
145694532|NCT03245619|525398434|FG002|Part A (Up to Day 22)|Physician Decision|6|||
145694533|NCT03245619|525398435|FG003|Part A (Up to Day 22)|Physician Decision|0|||
145694534|NCT03245619|525398436|FG004|Part A (Up to Day 22)|Physician Decision|0|||
145694535|NCT03245619|525398437|FG005|Part A (Up to Day 22)|Physician Decision|0|||
145694536|NCT03245619|525398438|FG006|Part A (Up to Day 22)|Physician Decision|0|||
145694537|NCT03245619|525398439|FG007|Part A (Up to Day 22)|Physician Decision|0|||
145694538|NCT03245619|525398440|FG008|Part A (Up to Day 22)|Physician Decision|0|||
145694539|NCT03245619|525398441|FG009|Part A (Up to Day 22)|Physician Decision|0|||
145694540|NCT03245619|525398442|FG010|Part A (Up to Day 22)|Physician Decision|0|||
145694541|NCT03245619|525398443|FG011|Part A (Up to Day 22)|Physician Decision|0|||
145694542|NCT03245619|525398444|FG012|Part A (Up to Day 22)|Physician Decision|0|||
145694543|NCT03245619|525398445|FG013|Part A (Up to Day 22)|Physician Decision|0|||
145694544|NCT03245619|525398446|FG014|Part A (Up to Day 22)|Physician Decision|0|||
145694545|NCT03245619|525398447|FG015|Part A (Up to Day 22)|Physician Decision|0|||
145694546|NCT03245619|525398448|FG016|Part A (Up to Day 22)|Physician Decision|0|||
145694547|NCT00776659|525398464|FG000|Overall Study|Lost to Follow-up|15|||
145694548|NCT00776659|525398464|FG000|Overall Study|Withdrawal by Subject|10|||
145694549|NCT00776659|525398464|FG000|Overall Study|Study Terminated by Sponsor|1|||
145694550|NCT01167192|525398467|FG000|Overall Study|Adverse Event|1|||
145694551|NCT01167192|525398467|FG000|Overall Study|Death|1|||
145694552|NCT01167192|525398467|FG000|Overall Study|Withdrawal by Subject|1|||
145694553|NCT01167192|525398467|FG000|Overall Study|Insurance denial|1|||
145694554|NCT01336205|525398468|FG000|Overall Study|Other|22|||
145694555|NCT01336205|525398469|FG001|Overall Study|Other|9|||
145694556|NCT01336205|525398468|FG000|Overall Study|Lost to Follow-up|40|||
145694557|NCT01336205|525398469|FG001|Overall Study|Lost to Follow-up|20|||
145694558|NCT01336205|525398468|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
145694559|NCT01336205|525398469|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
145694560|NCT01336205|525398468|FG000|Overall Study|Lack of Efficacy|4|||
145694561|NCT01336205|525398469|FG001|Overall Study|Lack of Efficacy|0|||
145694562|NCT01336205|525398468|FG000|Overall Study|Severe noncompliance with protocol|9|||
145694563|NCT01336205|525398469|FG001|Overall Study|Severe noncompliance with protocol|2|||
145694564|NCT01336205|525398468|FG000|Overall Study|Adverse Event|56|||
145694565|NCT01336205|525398469|FG001|Overall Study|Adverse Event|6|||
145694566|NCT01336205|525398468|FG000|Overall Study|Death|1|||
145694567|NCT01336205|525398469|FG001|Overall Study|Death|1|||
145694568|NCT01336205|525398468|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
145694569|NCT01336205|525398469|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
145694570|NCT01336205|525398468|FG000|Overall Study|Withdrawal by Subject|72|||
145694571|NCT01336205|525398469|FG001|Overall Study|Withdrawal by Subject|38|||
145694572|NCT01336205|525398468|FG000|Overall Study|Did not receive treatment|4|||
145694573|NCT01336205|525398469|FG001|Overall Study|Did not receive treatment|0|||
145694574|NCT00129649|525398485|FG000|Overall Study|Withdrawal by Subject|76|||
145694575|NCT00129649|525398486|FG001|Overall Study|Withdrawal by Subject|65|||
145694576|NCT02482935|525398487|FG000|Period 1|Withdrawal by Subject|1|||
145694577|NCT02482935|525398488|FG001|Period 1|Withdrawal by Subject|0|||
145694578|NCT03503162|525398489|FG000|Overall Study|did not meet eligibility|1|||
145694579|NCT02835092|525398490|FG000|Overall Study|Withdrawal by Subject|3|||
145694580|NCT02835092|525398491|FG001|Overall Study|Withdrawal by Subject|6|||
145694581|NCT02835092|525398492|FG002|Overall Study|Withdrawal by Subject|3|||
145694582|NCT02835092|525398490|FG000|Overall Study|Lost to Follow-up|0|||
145694583|NCT02835092|525398491|FG001|Overall Study|Lost to Follow-up|2|||
145694584|NCT02835092|525398492|FG002|Overall Study|Lost to Follow-up|0|||
145694585|NCT00025506|525398493|FG000|Overall Study|Ineligible: clerical error|1|||
145694586|NCT00025506|525398493|FG000|Overall Study|Ineligible: wrong cell type|5|||
145694587|NCT00025506|525398493|FG000|Overall Study|Ineligible: inadequate pathology|2|||
145694588|NCT00025506|525398493|FG000|Overall Study|Never Treated|2|||
145694589|NCT00713206|525398494|FG000|Overall Study|Lost to Follow-up|4|||
145694590|NCT00713206|525398495|FG001|Overall Study|Lost to Follow-up|4|||
145694591|NCT00713206|525398494|FG000|Overall Study|Death|1|||
145694592|NCT00713206|525398495|FG001|Overall Study|Death|0|||
145694593|NCT02561806|525398496|FG000|Induction Period|Adverse Event|0|||
145694594|NCT02561806|525398497|FG001|Induction Period|Adverse Event|2|||
145694595|NCT02561806|525398496|FG000|Induction Period|Lack of Efficacy|1|||
145694596|NCT02561806|525398497|FG001|Induction Period|Lack of Efficacy|0|||
145694597|NCT02561806|525398496|FG000|Induction Period|Withdrawal by Subject|0|||
145694598|NCT02561806|525398497|FG001|Induction Period|Withdrawal by Subject|2|||
145694599|NCT02561806|525398496|FG000|Induction Period|Site staff became unblinded|1|||
145694600|NCT02561806|525398497|FG001|Induction Period|Site staff became unblinded|0|||
145694601|NCT02561806|525398496|FG000|Induction Period|Randomized but not treated|0|||
145694602|NCT02561806|525398497|FG001|Induction Period|Randomized but not treated|1|||
145694603|NCT02561806|525398496|FG000|Maintenance Period|Adverse Event|2|||
145694604|NCT02561806|525398497|FG001|Maintenance Period|Adverse Event|1|||
145694605|NCT02561806|525398496|FG000|Maintenance Period|Lack of Efficacy|3|||
145694606|NCT02561806|525398497|FG001|Maintenance Period|Lack of Efficacy|1|||
145694607|NCT02561806|525398496|FG000|Maintenance Period|Lost to Follow-up|2|||
145694608|NCT02561806|525398497|FG001|Maintenance Period|Lost to Follow-up|2|||
145694609|NCT02561806|525398496|FG000|Maintenance Period|Protocol Violation|1|||
145694610|NCT02561806|525398497|FG001|Maintenance Period|Protocol Violation|0|||
145694611|NCT02561806|525398496|FG000|Maintenance Period|Withdrawal by Subject|5|||
145694612|NCT02561806|525398497|FG001|Maintenance Period|Withdrawal by Subject|3|||
145694613|NCT02561806|525398496|FG000|Maintenance Period|Site staff became unblinded|0|||
145694614|NCT02561806|525398497|FG001|Maintenance Period|Site staff became unblinded|1|||
145491421|NCT02163902|524653800|FG000|Overall Study|Administrative Decision|2|||
145491422|NCT02163902|524653801|FG001|Overall Study|Administrative Decision|2|||
145694615|NCT02561806|525398496|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
145694616|NCT02561806|525398497|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
145694617|NCT02561806|525398496|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
145694618|NCT02561806|525398497|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
145694619|NCT02547441|525398498|FG000|Double-Blind Study Period|Adverse Event|4|||
145694620|NCT02547441|525398499|FG001|Double-Blind Study Period|Adverse Event|9|||
145694621|NCT02547441|525398498|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
145694622|NCT02547441|525398499|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
145694623|NCT02547441|525398498|FG000|Double-Blind Study Period|Physician Decision|1|||
145694624|NCT02547441|525398499|FG001|Double-Blind Study Period|Physician Decision|0|||
145694625|NCT02547441|525398498|FG000|Double-Blind Study Period|Protocol Violation|1|||
145694626|NCT02547441|525398499|FG001|Double-Blind Study Period|Protocol Violation|2|||
145694627|NCT02547441|525398498|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
145694628|NCT02547441|525398499|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
145694629|NCT02547441|525398498|FG000|Double-Blind Study Period|Sponsor Decision|1|||
145694630|NCT02547441|525398499|FG001|Double-Blind Study Period|Sponsor Decision|0|||
145694631|NCT02547441|525398498|FG000|Open-Label Study Period|Adverse Event|10|||
145694632|NCT02547441|525398499|FG001|Open-Label Study Period|Adverse Event|11|||
145694633|NCT02547441|525398498|FG000|Open-Label Study Period|Lack of Efficacy|3|||
145694634|NCT02547441|525398499|FG001|Open-Label Study Period|Lack of Efficacy|2|||
145694635|NCT02547441|525398498|FG000|Open-Label Study Period|Lost to Follow-up|7|||
145694636|NCT02547441|525398499|FG001|Open-Label Study Period|Lost to Follow-up|8|||
145694637|NCT02547441|525398498|FG000|Open-Label Study Period|Physician Decision|1|||
145694638|NCT02547441|525398499|FG001|Open-Label Study Period|Physician Decision|0|||
145694639|NCT02547441|525398498|FG000|Open-Label Study Period|Protocol Violation|2|||
145694640|NCT02547441|525398499|FG001|Open-Label Study Period|Protocol Violation|0|||
145694641|NCT02547441|525398498|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
145694642|NCT02547441|525398499|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
145694643|NCT02547441|525398498|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
145694644|NCT02547441|525398499|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
145694645|NCT01322009|525398500|FG000|Overall Study|Death|0|||
145694646|NCT01322009|525398501|FG001|Overall Study|Death|1|||
145694647|NCT01322009|525398500|FG000|Overall Study|Adverse Event|0|||
145694648|NCT01322009|525398501|FG001|Overall Study|Adverse Event|1|||
145694649|NCT01322009|525398500|FG000|Overall Study|ng tube discontinued|0|||
145694650|NCT01322009|525398501|FG001|Overall Study|ng tube discontinued|1|||
145694651|NCT01657877|525398502|FG000|Overall Study|Withdrawal by Subject|4|||
145694652|NCT01657877|525398502|FG000|Overall Study|Protocol Violation|6|||
145694653|NCT01657877|525398502|FG000|Overall Study|Adverse Event|2|||
145694654|NCT01657877|525398502|FG000|Overall Study|Other Reason|2|||
145694655|NCT00905034|525398504|FG000|Overall Study|Withdrawal by Subject|1|||
145694656|NCT00394589|525398505|FG000|Overall Study|Adverse Event|2|||
145694657|NCT00394589|525398506|FG001|Overall Study|Adverse Event|1|||
145694658|NCT00394589|525398507|FG002|Overall Study|Adverse Event|2|||
145694659|NCT00394589|525398505|FG000|Overall Study|Lack of Efficacy|2|||
145694660|NCT00394589|525398506|FG001|Overall Study|Lack of Efficacy|2|||
145694661|NCT00394589|525398507|FG002|Overall Study|Lack of Efficacy|3|||
145694662|NCT00394589|525398505|FG000|Overall Study|Protocol Violation|4|||
145694663|NCT00394589|525398506|FG001|Overall Study|Protocol Violation|0|||
145694664|NCT00394589|525398507|FG002|Overall Study|Protocol Violation|2|||
145694665|NCT03409731|525398509|FG000|Overall Study|Withdrawal by Subject|17|||
145694666|NCT03409731|525398509|FG000|Overall Study|Death|4|||
145694667|NCT01114672|525398510|FG000|Overall Study|Death|0|||
145694668|NCT01114672|525398511|FG001|Overall Study|Death|1|||
145694669|NCT01114672|525398510|FG000|Overall Study|Withdrawal by Subject|2|||
145694670|NCT01114672|525398511|FG001|Overall Study|Withdrawal by Subject|1|||
145694671|NCT01114672|525398510|FG000|Overall Study|Lost to Follow-up|1|||
145694672|NCT01114672|525398511|FG001|Overall Study|Lost to Follow-up|0|||
145694673|NCT01114672|525398510|FG000|Overall Study|transplanted|1|||
145694674|NCT01114672|525398511|FG001|Overall Study|transplanted|0|||
145694675|NCT01710800|525398514|FG000|Overall Study|Withdrawal by Subject|21|||
145694676|NCT01710800|525398514|FG000|Overall Study|Protocol Violation|1|||
145694677|NCT02427958|525398515|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
145694678|NCT02427958|525398515|FG000|Overall Study|Lost to Follow-up|6|||
145694679|NCT02427958|525398515|FG000|Overall Study|Withdrawal by Subject|14|||
145694680|NCT02427958|525398515|FG000|Overall Study|Lack of Efficacy|1|||
145694681|NCT02287883|525398521|FG000|Overall Study|Death|8|||
145694682|NCT02287883|525398522|FG001|Overall Study|Death|7|||
145694683|NCT02287883|525398521|FG000|Overall Study|No longer eligible|222|||
145694684|NCT02287883|525398522|FG001|Overall Study|No longer eligible|182|||
145694685|NCT02287883|525398521|FG000|Overall Study|Non-response to survey|229|||
145694686|NCT02287883|525398522|FG001|Overall Study|Non-response to survey|237|||
145694687|NCT00545571|525398526|FG000|Overall Study|Administrative Reasons|1|||
145694688|NCT00545571|525398526|FG000|Overall Study|Adverse Event|2|||
145694689|NCT00545571|525398526|FG000|Overall Study|Death|5|||
145694690|NCT00545571|525398526|FG000|Overall Study|Lack of Efficacy|1|||
145694691|NCT00545571|525398526|FG000|Overall Study|Protocol Violation|2|||
145694692|NCT00545571|525398526|FG000|Overall Study|Refused Treatment|1|||
145694693|NCT00545571|525398526|FG000|Overall Study|Screen Failure|16|||
145694694|NCT00545571|525398526|FG000|Overall Study|Transfusion|12|||
145694695|NCT00545571|525398526|FG000|Overall Study|Early Termination of Study|24|||
145694696|NCT00545571|525398526|FG000|Overall Study|Kidney Transplantation|3|||
145694697|NCT01978236|525398527|FG000|Overall Study|Discontinued due to study close|2|||
145265475|NCT01298323|523819369|FG000|Overall Study|Other|10|||
145694698|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
145694699|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
145694700|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
145694701|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
145694702|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
145694703|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
145694704|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Rejections|0|||
145694705|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Rejections|0|||
145694706|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Rejections|55|||
145694707|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
145694708|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
145694709|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
145694710|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
145694711|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
145694712|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
145694713|NCT00634920|525398529|FG000|Period 1 - Pre-Randomization|Other issues|0|||
145694714|NCT00634920|525398530|FG001|Period 1 - Pre-Randomization|Other issues|0|||
145694715|NCT00634920|525398531|FG002|Period 1 - Pre-Randomization|Other issues|6|||
145694716|NCT00634920|525398529|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
145694717|NCT00634920|525398530|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
145694718|NCT00634920|525398531|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
145694719|NCT00634920|525398529|FG000|Period 2 - Post-Randomization|Rejection|11|||
145694720|NCT00634920|525398530|FG001|Period 2 - Post-Randomization|Rejection|5|||
145694721|NCT00634920|525398531|FG002|Period 2 - Post-Randomization|Rejection|0|||
145694722|NCT00634920|525398529|FG000|Period 2 - Post-Randomization|Death|2|||
145694723|NCT00634920|525398530|FG001|Period 2 - Post-Randomization|Death|5|||
145694724|NCT00634920|525398531|FG002|Period 2 - Post-Randomization|Death|0|||
145694725|NCT00634920|525398529|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
145694726|NCT00634920|525398530|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
145694727|NCT00634920|525398531|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
145694728|NCT00634920|525398529|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
145694729|NCT00634920|525398530|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
145694730|NCT00634920|525398531|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
145694731|NCT01193218|525398532|FG000|0-12 Weeks|Adverse Event|6|||
145694732|NCT01193218|525398533|FG001|0-12 Weeks|Adverse Event|0|||
145694733|NCT01193218|525398534|FG002|0-12 Weeks|Adverse Event|1|||
145694734|NCT01193218|525398535|FG003|0-12 Weeks|Adverse Event|0|||
145694735|NCT01193218|525398536|FG004|0-12 Weeks|Adverse Event|0|||
145694736|NCT01193218|525398537|FG005|0-12 Weeks|Adverse Event|2|||
145694737|NCT01193218|525398538|FG006|0-12 Weeks|Adverse Event|2|||
145694738|NCT01193218|525398539|FG007|0-12 Weeks|Adverse Event|0|||
145694739|NCT01193218|525398532|FG000|0-12 Weeks|Protocol Violation|0|||
145694740|NCT01193218|525398533|FG001|0-12 Weeks|Protocol Violation|0|||
145694741|NCT01193218|525398534|FG002|0-12 Weeks|Protocol Violation|0|||
145694742|NCT01193218|525398535|FG003|0-12 Weeks|Protocol Violation|0|||
145694743|NCT01193218|525398536|FG004|0-12 Weeks|Protocol Violation|1|||
145694744|NCT01193218|525398537|FG005|0-12 Weeks|Protocol Violation|1|||
145694745|NCT01193218|525398538|FG006|0-12 Weeks|Protocol Violation|0|||
145694746|NCT01193218|525398539|FG007|0-12 Weeks|Protocol Violation|0|||
145694747|NCT01193218|525398532|FG000|0-12 Weeks|Withdrawal by Subject|3|||
145694748|NCT01193218|525398533|FG001|0-12 Weeks|Withdrawal by Subject|0|||
145694749|NCT01193218|525398534|FG002|0-12 Weeks|Withdrawal by Subject|2|||
145694750|NCT01193218|525398535|FG003|0-12 Weeks|Withdrawal by Subject|0|||
145694751|NCT01193218|525398536|FG004|0-12 Weeks|Withdrawal by Subject|0|||
145694752|NCT01193218|525398537|FG005|0-12 Weeks|Withdrawal by Subject|0|||
145694753|NCT01193218|525398538|FG006|0-12 Weeks|Withdrawal by Subject|1|||
145694754|NCT01193218|525398539|FG007|0-12 Weeks|Withdrawal by Subject|0|||
145694755|NCT01193218|525398532|FG000|12-52 Weeks|Adverse Event|1|||
145694756|NCT01193218|525398533|FG001|12-52 Weeks|Adverse Event|0|||
145694757|NCT01193218|525398534|FG002|12-52 Weeks|Adverse Event|1|||
145694758|NCT01193218|525398535|FG003|12-52 Weeks|Adverse Event|2|||
145694759|NCT01193218|525398536|FG004|12-52 Weeks|Adverse Event|3|||
145694760|NCT01193218|525398537|FG005|12-52 Weeks|Adverse Event|3|||
145694761|NCT01193218|525398538|FG006|12-52 Weeks|Adverse Event|1|||
145694762|NCT01193218|525398539|FG007|12-52 Weeks|Adverse Event|2|||
145694763|NCT01193218|525398532|FG000|12-52 Weeks|Lack of Efficacy|0|||
145694764|NCT01193218|525398533|FG001|12-52 Weeks|Lack of Efficacy|0|||
145694765|NCT01193218|525398534|FG002|12-52 Weeks|Lack of Efficacy|0|||
145694766|NCT01193218|525398535|FG003|12-52 Weeks|Lack of Efficacy|0|||
145694767|NCT01193218|525398536|FG004|12-52 Weeks|Lack of Efficacy|0|||
145694768|NCT01193218|525398537|FG005|12-52 Weeks|Lack of Efficacy|0|||
145694769|NCT01193218|525398538|FG006|12-52 Weeks|Lack of Efficacy|1|||
145694770|NCT01193218|525398539|FG007|12-52 Weeks|Lack of Efficacy|0|||
145694771|NCT01193218|525398532|FG000|12-52 Weeks|Withdrawal by Subject|3|||
145694772|NCT01193218|525398533|FG001|12-52 Weeks|Withdrawal by Subject|0|||
145694773|NCT01193218|525398534|FG002|12-52 Weeks|Withdrawal by Subject|3|||
145694774|NCT01193218|525398535|FG003|12-52 Weeks|Withdrawal by Subject|0|||
145694775|NCT01193218|525398536|FG004|12-52 Weeks|Withdrawal by Subject|0|||
145694776|NCT01193218|525398537|FG005|12-52 Weeks|Withdrawal by Subject|2|||
145694777|NCT01193218|525398538|FG006|12-52 Weeks|Withdrawal by Subject|1|||
145694778|NCT01193218|525398539|FG007|12-52 Weeks|Withdrawal by Subject|2|||
145694779|NCT01193218|525398532|FG000|12-52 Weeks|Other reason than above|1|||
145694780|NCT01193218|525398533|FG001|12-52 Weeks|Other reason than above|0|||
145694781|NCT01193218|525398534|FG002|12-52 Weeks|Other reason than above|0|||
145694782|NCT01193218|525398535|FG003|12-52 Weeks|Other reason than above|1|||
145694783|NCT01193218|525398536|FG004|12-52 Weeks|Other reason than above|1|||
145694784|NCT01193218|525398537|FG005|12-52 Weeks|Other reason than above|0|||
145694785|NCT01193218|525398538|FG006|12-52 Weeks|Other reason than above|0|||
145694786|NCT01193218|525398539|FG007|12-52 Weeks|Other reason than above|0|||
145694787|NCT00363649|525398540|FG000|Overall Study|Withdrawal by Subject|1|||
145694788|NCT00363649|525398541|FG001|Overall Study|Withdrawal by Subject|1|||
145694789|NCT00363649|525398540|FG000|Overall Study|Adverse Event|6|||
145694790|NCT00363649|525398541|FG001|Overall Study|Adverse Event|0|||
145694791|NCT01013740|525398542|FG000|Overall Study|Lost to Follow-up|3|||
145694792|NCT01013740|525398543|FG001|Overall Study|Lost to Follow-up|5|||
145694793|NCT01013740|525398542|FG000|Overall Study|Physician Decision|2|||
145694794|NCT01013740|525398543|FG001|Overall Study|Physician Decision|0|||
145694795|NCT01013740|525398542|FG000|Overall Study|Withdrawal by Subject|2|||
145694796|NCT01013740|525398543|FG001|Overall Study|Withdrawal by Subject|10|||
145694797|NCT01013740|525398542|FG000|Overall Study|study close / terminated : done in error|2|||
145694798|NCT01013740|525398543|FG001|Overall Study|study close / terminated : done in error|1|||
145694799|NCT01013740|525398542|FG000|Overall Study|Missing|2|||
145694800|NCT01013740|525398543|FG001|Overall Study|Missing|1|||
145694801|NCT01013740|525398542|FG000|Overall Study|Ongoing: Study records not completed|0|||
145694802|NCT01013740|525398543|FG001|Overall Study|Ongoing: Study records not completed|2|||
145694803|NCT03811834|525398546|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
145694804|NCT01215032|525398547|FG000|Overall Study|Adverse Event|3|||
145694805|NCT01215032|525398547|FG000|Overall Study|Lack of Efficacy|17|||
145694806|NCT02970305|525398548|FG000|Overall Study|Adverse Event|10|||
145694807|NCT02970305|525398549|FG001|Overall Study|Adverse Event|6|||
145694808|NCT02970305|525398548|FG000|Overall Study|Lack of Efficacy|1|||
145694809|NCT02970305|525398549|FG001|Overall Study|Lack of Efficacy|1|||
145694810|NCT02970305|525398548|FG000|Overall Study|Noncompliance with study drug|2|||
145694811|NCT02970305|525398549|FG001|Overall Study|Noncompliance with study drug|4|||
145694812|NCT02970305|525398548|FG000|Overall Study|Protocol Violation|2|||
145694813|NCT02970305|525398549|FG001|Overall Study|Protocol Violation|2|||
145694814|NCT02970305|525398548|FG000|Overall Study|Withdrawal by Subject|12|||
145694815|NCT02970305|525398549|FG001|Overall Study|Withdrawal by Subject|11|||
145694816|NCT02970305|525398548|FG000|Overall Study|Not further specified|1|||
145694817|NCT02970305|525398549|FG001|Overall Study|Not further specified|2|||
145694818|NCT02970305|525398548|FG000|Overall Study|Lost to Follow-up|1|||
145694819|NCT02970305|525398549|FG001|Overall Study|Lost to Follow-up|2|||
145694820|NCT00605566|525400308|FG000|Overall Study|Adverse Event|1|||
145694821|NCT00605566|525400308|FG000|Overall Study|Clinical deterioration|1|||
145694822|NCT00605566|525400308|FG000|Overall Study|Poor compliance in run-in period|1|||
145694823|NCT03864341|525400311|FG000|Overall Study|Withdrawal by Subject|1|||
145694824|NCT01066936|525400312|FG000|Overall Study|Death|2|||
145694825|NCT01066936|525400312|FG000|Overall Study|Device revised/removed|1|||
145694826|NCT01066936|525400312|FG000|Overall Study|Lost to Follow-up|3|||
145694827|NCT01066936|525400312|FG000|Overall Study|Withdrawal by Subject|4|||
145694828|NCT00695136|525400313|FG000|Overall Study|Withdrawal by Subject|1|||
145694829|NCT00695136|525400313|FG000|Overall Study|unrelated adverse event|1|||
145694830|NCT01726049|525400315|FG000|Overall Study|Death|1|||
145694831|NCT01726049|525400316|FG001|Overall Study|Death|1|||
145694832|NCT01726049|525400315|FG000|Overall Study|Adverse Event|4|||
145694833|NCT01726049|525400316|FG001|Overall Study|Adverse Event|1|||
145694834|NCT01726049|525400315|FG000|Overall Study|refused second HC|0|||
145694835|NCT01726049|525400316|FG001|Overall Study|refused second HC|2|||
145694836|NCT02202109|525400319|FG000|Overall Study|Lost to Follow-up|88|||
145694837|NCT02202109|525400320|FG001|Overall Study|Lost to Follow-up|87|||
145694838|NCT02202109|525400319|FG000|Overall Study|Withdrawal by Subject|2|||
145694839|NCT02202109|525400320|FG001|Overall Study|Withdrawal by Subject|0|||
145694840|NCT04156399|525400327|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
145694841|NCT04156399|525400327|FG000|Overall Study|study suspension due to COVID pandemic|3|||
145694842|NCT01333111|525400330|FG000|Overall Study|patient undergoing major surgery|0|||
145694843|NCT01333111|525400331|FG001|Overall Study|patient undergoing major surgery|2|||
145694844|NCT01333111|525400332|FG002|Overall Study|patient undergoing major surgery|0|||
145694845|NCT01333111|525400330|FG000|Overall Study|personal reasons|0|||
145694846|NCT01333111|525400331|FG001|Overall Study|personal reasons|0|||
145694847|NCT01333111|525400332|FG002|Overall Study|personal reasons|1|||
145694848|NCT01333111|525400330|FG000|Overall Study|unclassified|1|||
145694849|NCT01333111|525400331|FG001|Overall Study|unclassified|0|||
145694850|NCT01333111|525400332|FG002|Overall Study|unclassified|0|||
145694851|NCT01333111|525400330|FG000|Overall Study|withdrawal criteria|0|||
145694852|NCT01333111|525400331|FG001|Overall Study|withdrawal criteria|1|||
145694853|NCT01333111|525400332|FG002|Overall Study|withdrawal criteria|0|||
145694854|NCT01333111|525400330|FG000|Overall Study|Non-compliance|1|||
145694855|NCT01333111|525400331|FG001|Overall Study|Non-compliance|0|||
145694856|NCT01333111|525400332|FG002|Overall Study|Non-compliance|0|||
145694857|NCT01333111|525400330|FG000|Overall Study|Ineffective therapy|0|||
145694858|NCT01333111|525400331|FG001|Overall Study|Ineffective therapy|0|||
145694859|NCT01333111|525400332|FG002|Overall Study|Ineffective therapy|1|||
145694860|NCT00847132|525400335|FG000|Overall Study|Death|1|||
145694861|NCT00847132|525400336|FG001|Overall Study|Death|1|||
145694862|NCT01057251|525400337|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
145694863|NCT01057251|525400338|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
145694864|NCT01057251|525400337|FG000|Overall Study|Adverse Event|4|||
145694865|NCT01057251|525400338|FG001|Overall Study|Adverse Event|2|||
145694866|NCT01057251|525400337|FG000|Overall Study|Lack of Efficacy|2|||
145694867|NCT01057251|525400338|FG001|Overall Study|Lack of Efficacy|11|||
145694868|NCT01057251|525400337|FG000|Overall Study|Protocol Violation|6|||
145694869|NCT01057251|525400338|FG001|Overall Study|Protocol Violation|2|||
145694870|NCT01057251|525400337|FG000|Overall Study|Withdrawal by Subject|4|||
145694871|NCT01057251|525400338|FG001|Overall Study|Withdrawal by Subject|5|||
145694872|NCT01057251|525400337|FG000|Overall Study|Lost to Follow-up|7|||
145694873|NCT01057251|525400338|FG001|Overall Study|Lost to Follow-up|6|||
145694874|NCT01057251|525400337|FG000|Overall Study|Other Reason|1|||
145694875|NCT01057251|525400338|FG001|Overall Study|Other Reason|1|||
145694876|NCT01850823|525400339|FG000|Overall Study|Early Visit Window|0|||
145694877|NCT01850823|525400340|FG001|Overall Study|Early Visit Window|1|||
145694878|NCT01850823|525400341|FG002|Overall Study|Early Visit Window|4|||
145694879|NCT01850823|525400339|FG000|Overall Study|Enrolled in Error|0|||
145694880|NCT01850823|525400340|FG001|Overall Study|Enrolled in Error|1|||
145694881|NCT01850823|525400341|FG002|Overall Study|Enrolled in Error|2|||
145694882|NCT01850823|525400339|FG000|Overall Study|Lack of Efficacy|1|||
145694883|NCT01850823|525400340|FG001|Overall Study|Lack of Efficacy|0|||
145694884|NCT01850823|525400341|FG002|Overall Study|Lack of Efficacy|0|||
145694885|NCT01850823|525400339|FG000|Overall Study|Lost to Follow-up|0|||
145694886|NCT01850823|525400340|FG001|Overall Study|Lost to Follow-up|0|||
145694887|NCT01850823|525400341|FG002|Overall Study|Lost to Follow-up|1|||
145694888|NCT01850823|525400339|FG000|Overall Study|Restricted Medication|0|||
145694889|NCT01850823|525400340|FG001|Overall Study|Restricted Medication|0|||
145694890|NCT01850823|525400341|FG002|Overall Study|Restricted Medication|2|||
145694891|NCT01850823|525400339|FG000|Overall Study|Significant worstening of SAR|0|||
145694892|NCT01850823|525400340|FG001|Overall Study|Significant worstening of SAR|1|||
145694893|NCT01850823|525400341|FG002|Overall Study|Significant worstening of SAR|0|||
145694894|NCT01850823|525400339|FG000|Overall Study|Withdrawal by Subject|2|||
145694895|NCT01850823|525400340|FG001|Overall Study|Withdrawal by Subject|0|||
145694896|NCT01850823|525400341|FG002|Overall Study|Withdrawal by Subject|1|||
145694897|NCT01751165|525400342|FG000|Overall Study|Adverse event, serious fatal|1|||
145694898|NCT01751165|525400343|FG001|Overall Study|Adverse event, serious fatal|0|||
145694899|NCT01751165|525400344|FG002|Overall Study|Adverse event, serious fatal|1|||
145694900|NCT01751165|525400342|FG000|Overall Study|Withdrawal by Subject|0|||
145694901|NCT01751165|525400343|FG001|Overall Study|Withdrawal by Subject|0|||
145694902|NCT01751165|525400344|FG002|Overall Study|Withdrawal by Subject|1|||
145694903|NCT01751165|525400342|FG000|Overall Study|Serious adverse event|0|||
145694904|NCT01751165|525400343|FG001|Overall Study|Serious adverse event|2|||
145694905|NCT01751165|525400344|FG002|Overall Study|Serious adverse event|0|||
145694906|NCT01751165|525400342|FG000|Overall Study|Lost to Follow-up|1|||
145694907|NCT01751165|525400343|FG001|Overall Study|Lost to Follow-up|1|||
145694908|NCT01751165|525400344|FG002|Overall Study|Lost to Follow-up|1|||
145694909|NCT00913523|525400348|FG000|Overall Study|Withdrawal by Subject|3|||
145694910|NCT00913523|525400349|FG001|Overall Study|Withdrawal by Subject|2|||
145694911|NCT00913523|525400350|FG002|Overall Study|Withdrawal by Subject|2|||
145694912|NCT00913523|525400348|FG000|Overall Study|Lost to Follow-up|1|||
145694913|NCT00913523|525400349|FG001|Overall Study|Lost to Follow-up|1|||
145694914|NCT00913523|525400350|FG002|Overall Study|Lost to Follow-up|1|||
145694915|NCT00913523|525400348|FG000|Overall Study|Adverse Event|1|||
145694916|NCT00913523|525400349|FG001|Overall Study|Adverse Event|0|||
145694917|NCT00913523|525400350|FG002|Overall Study|Adverse Event|0|||
145694918|NCT00913523|525400348|FG000|Overall Study|Protocol Violation|5|||
145694919|NCT00913523|525400349|FG001|Overall Study|Protocol Violation|8|||
145694920|NCT00913523|525400350|FG002|Overall Study|Protocol Violation|8|||
145694921|NCT00913523|525400348|FG000|Overall Study|Pregnancy|1|||
145694922|NCT00913523|525400349|FG001|Overall Study|Pregnancy|3|||
145694923|NCT00913523|525400350|FG002|Overall Study|Pregnancy|0|||
145694924|NCT00913523|525400348|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
145694925|NCT00913523|525400349|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
145694926|NCT00913523|525400350|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
145694927|NCT01202409|525400351|FG000|Overall Study|Adverse Event|1|||
145694928|NCT01202409|525400351|FG000|Overall Study|Ineligible - KRAS mutants|7|||
145694929|NCT01774019|525400352|FG000|Overall Study|No longer meets protocol criteria|2|||
145694930|NCT01774019|525400353|FG001|Overall Study|No longer meets protocol criteria|0|||
145694931|NCT01774019|525400352|FG000|Overall Study|Withdrawal by Subject|1|||
145694932|NCT01774019|525400353|FG001|Overall Study|Withdrawal by Subject|0|||
145694933|NCT01774019|525400352|FG000|Overall Study|Surgery delayed > 120 days|1|||
145694934|NCT01774019|525400353|FG001|Overall Study|Surgery delayed > 120 days|0|||
145694935|NCT01774019|525400352|FG000|Overall Study|Patient refused surgery|1|||
145694936|NCT01774019|525400353|FG001|Overall Study|Patient refused surgery|1|||
145694937|NCT01774019|525400352|FG000|Overall Study|Unable to implant study device|1|||
145694938|NCT01774019|525400353|FG001|Overall Study|Unable to implant study device|0|||
145694939|NCT01774019|525400352|FG000|Overall Study|Lost to Follow-up|0|||
145694940|NCT01774019|525400353|FG001|Overall Study|Lost to Follow-up|3|||
145694941|NCT00496626|525400356|FG000|Overall Study|Lost to Follow-up|0|||
145694942|NCT00496626|525400357|FG001|Overall Study|Lost to Follow-up|1|||
145694943|NCT00496626|525400356|FG000|Overall Study|Protocol Violation|1|||
145694944|NCT00496626|525400357|FG001|Overall Study|Protocol Violation|0|||
145694945|NCT00496626|525400356|FG000|Overall Study|Withdrawal by Subject|5|||
145694946|NCT00496626|525400357|FG001|Overall Study|Withdrawal by Subject|4|||
145694947|NCT00496626|525400356|FG000|Overall Study|Relocated|0|||
145694948|NCT00496626|525400357|FG001|Overall Study|Relocated|1|||
145694949|NCT00576823|525400358|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
145694950|NCT00576823|525400359|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
145694951|NCT00576823|525400360|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
145694952|NCT00576823|525400358|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
145694953|NCT00576823|525400359|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
145694954|NCT00576823|525400360|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
145694955|NCT01242371|525400361|FG000|Overall Study|Withdrawal by Subject|2|||
145694956|NCT01242371|525400362|FG001|Overall Study|Withdrawal by Subject|2|||
145694957|NCT01242371|525400361|FG000|Overall Study|Protocol Violation|0|||
145694958|NCT01242371|525400362|FG001|Overall Study|Protocol Violation|3|||
145694959|NCT00510146|525400363|FG000|Double-Blind Treatment|Adverse Event|30|||
145694960|NCT00510146|525400364|FG001|Double-Blind Treatment|Adverse Event|13|||
145694961|NCT00510146|525400363|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
145694962|NCT00510146|525400364|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
145694963|NCT00510146|525400363|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
145694964|NCT00510146|525400364|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
145694965|NCT00510146|525400363|FG000|Double-Blind Treatment|Physician Decision|6|||
145694966|NCT00510146|525400364|FG001|Double-Blind Treatment|Physician Decision|0|||
145694967|NCT00510146|525400363|FG000|Double-Blind Treatment|Protocol Violation|1|||
145694968|NCT00510146|525400364|FG001|Double-Blind Treatment|Protocol Violation|2|||
145694969|NCT00510146|525400363|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
145694970|NCT00510146|525400364|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
145694971|NCT00510146|525400363|FG000|Double-Blind Treatment|Clinical Relapse|0|||
145694972|NCT00510146|525400364|FG001|Double-Blind Treatment|Clinical Relapse|1|||
145694973|NCT00510146|525400363|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
145694974|NCT00510146|525400364|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
145694975|NCT00510146|525400363|FG000|Open-Label Treatment|Adverse Event|22|||
145694976|NCT00510146|525400364|FG001|Open-Label Treatment|Adverse Event|8|||
145694977|NCT00510146|525400363|FG000|Open-Label Treatment|Death|1|||
145694978|NCT00510146|525400364|FG001|Open-Label Treatment|Death|1|||
145694979|NCT00510146|525400363|FG000|Open-Label Treatment|Lack of Efficacy|4|||
145694980|NCT00510146|525400364|FG001|Open-Label Treatment|Lack of Efficacy|0|||
145694981|NCT00510146|525400363|FG000|Open-Label Treatment|Lost to Follow-up|10|||
145694982|NCT00510146|525400364|FG001|Open-Label Treatment|Lost to Follow-up|1|||
145694983|NCT00510146|525400363|FG000|Open-Label Treatment|Physician Decision|3|||
145694984|NCT00510146|525400364|FG001|Open-Label Treatment|Physician Decision|1|||
145694985|NCT00510146|525400363|FG000|Open-Label Treatment|Protocol Violation|4|||
145694986|NCT00510146|525400364|FG001|Open-Label Treatment|Protocol Violation|2|||
145694987|NCT00510146|525400363|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
145694988|NCT00510146|525400364|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
145694989|NCT00510146|525400363|FG000|Open-Label Treatment|Clinical Relapse|1|||
145694990|NCT00510146|525400364|FG001|Open-Label Treatment|Clinical Relapse|1|||
145694991|NCT00510146|525400363|FG000|Open-Label Treatment|Sponsor Decision|2|||
145694992|NCT00510146|525400364|FG001|Open-Label Treatment|Sponsor Decision|0|||
145694993|NCT03188536|525400367|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
145694994|NCT03188536|525400367|FG000|Overall Study|Not participated/met inclusion criteria|1|||
145694995|NCT01930214|525400368|FG000|Overall Study|Death|4|||
145694996|NCT01930214|525400369|FG001|Overall Study|Death|4|||
145694997|NCT01930214|525400370|FG002|Overall Study|Death|11|||
145694998|NCT01930214|525400368|FG000|Overall Study|Lost to Follow-up|12|||
145694999|NCT01930214|525400369|FG001|Overall Study|Lost to Follow-up|13|||
145695000|NCT01930214|525400370|FG002|Overall Study|Lost to Follow-up|12|||
145695001|NCT01930214|525400368|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
145695002|NCT01930214|525400369|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
145695003|NCT01930214|525400370|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
145695004|NCT01930214|525400368|FG000|Overall Study|Physician Decision|2|||
145695005|NCT01930214|525400369|FG001|Overall Study|Physician Decision|0|||
145695006|NCT01930214|525400370|FG002|Overall Study|Physician Decision|0|||
145695007|NCT00025662|525400371|FG000|Overall Study|Withdrawal by Subject|2|||
145695008|NCT00025662|525400371|FG000|Overall Study|Technical failure of manipulation|1|||
145695009|NCT02132117|525400374|FG000|Overall Study|Adverse Event|6|||
145695010|NCT02132117|525400375|FG001|Overall Study|Adverse Event|1|||
145695011|NCT02132117|525400374|FG000|Overall Study|Lost to Follow-up|2|||
145695012|NCT02132117|525400375|FG001|Overall Study|Lost to Follow-up|2|||
145695013|NCT02132117|525400374|FG000|Overall Study|Personal Reasons|1|||
145695014|NCT02132117|525400375|FG001|Overall Study|Personal Reasons|2|||
145695015|NCT02132117|525400374|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145695016|NCT02132117|525400375|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145695017|NCT04947436|525400376|FG000|Overall Study|Lost to Follow-up|3|||
145695018|NCT04947436|525400377|FG001|Overall Study|Lost to Follow-up|7|||
145695019|NCT04947436|525400378|FG002|Overall Study|Lost to Follow-up|5|||
145695020|NCT04947436|525400376|FG000|Overall Study|Death|1|||
145695021|NCT04947436|525400377|FG001|Overall Study|Death|1|||
145695022|NCT04947436|525400378|FG002|Overall Study|Death|1|||
145695023|NCT02161185|525400382|FG000|Treatment Phase|Administrative/Other|7|||
145695024|NCT00372255|525400383|FG000|Overall Study|Withdrawn for other reasons|2|||
145695025|NCT00372255|525400384|FG001|Overall Study|Withdrawn for other reasons|1|||
145695026|NCT00582114|525400388|FG000|Overall Study|Death|4|||
145695027|NCT00582114|525400389|FG001|Overall Study|Death|4|||
145695028|NCT00582114|525400388|FG000|Overall Study|Kidney Transplant|3|||
145695029|NCT00582114|525400389|FG001|Overall Study|Kidney Transplant|1|||
145695030|NCT00582114|525400388|FG000|Overall Study|Lost to Follow-up|7|||
145695031|NCT00582114|525400389|FG001|Overall Study|Lost to Follow-up|6|||
145695032|NCT00582114|525400388|FG000|Overall Study|Withdrawal by Subject|8|||
145695033|NCT00582114|525400389|FG001|Overall Study|Withdrawal by Subject|16|||
145695034|NCT00582114|525400388|FG000|Overall Study|Adverse Event|1|||
145695035|NCT00582114|525400389|FG001|Overall Study|Adverse Event|1|||
145695036|NCT00582114|525400388|FG000|Overall Study|Physician Decision|0|||
145695037|NCT00582114|525400389|FG001|Overall Study|Physician Decision|6|||
145695038|NCT00582114|525400388|FG000|Overall Study|Stopped by data safety monitoring board|19|||
145695039|NCT00582114|525400389|FG001|Overall Study|Stopped by data safety monitoring board|20|||
145695040|NCT00118703|525400390|FG000|Overall Study|Protocol Violation|1|||
145695041|NCT00118703|525400391|FG001|Overall Study|Protocol Violation|0|||
145695042|NCT00118703|525400390|FG000|Overall Study|Adverse Event|1|||
145695043|NCT00118703|525400391|FG001|Overall Study|Adverse Event|1|||
145695044|NCT00118703|525400390|FG000|Overall Study|Participant took two different treatment|0|||
145695045|NCT00118703|525400391|FG001|Overall Study|Participant took two different treatment|1|||
145695046|NCT00118703|525400390|FG000|Overall Study|Withdrawal by Subject|2|||
145695047|NCT00118703|525400391|FG001|Overall Study|Withdrawal by Subject|5|||
145695048|NCT00118703|525400390|FG000|Overall Study|Lost to Follow-up|1|||
145695049|NCT00118703|525400391|FG001|Overall Study|Lost to Follow-up|2|||
145695050|NCT00130728|525400396|FG000|Overall Study|Death|258|||
145695051|NCT00130728|525400397|FG001|Overall Study|Death|258|||
145695052|NCT00130728|525400396|FG000|Overall Study|Lost to Follow-up|4|||
145695053|NCT00130728|525400397|FG001|Overall Study|Lost to Follow-up|0|||
145695054|NCT00130728|525400396|FG000|Overall Study|Withdrawal by Subject|0|||
145695055|NCT00130728|525400397|FG001|Overall Study|Withdrawal by Subject|2|||
145695056|NCT01209286|525400398|FG000|Overall Study|Adverse Event|4|||
145695057|NCT01209286|525400399|FG001|Overall Study|Adverse Event|3|||
145695058|NCT01209286|525400400|FG002|Overall Study|Adverse Event|1|||
145695059|NCT01209286|525400398|FG000|Overall Study|Hematological Relapse After Remission|0|||
145695060|NCT01209286|525400399|FG001|Overall Study|Hematological Relapse After Remission|1|||
145695061|NCT01209286|525400400|FG002|Overall Study|Hematological Relapse After Remission|1|||
145695062|NCT01209286|525400398|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
145695063|NCT01209286|525400399|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
145695064|NCT01209286|525400400|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
145695065|NCT01209286|525400398|FG000|Overall Study|Physician Decision|0|||
145695066|NCT01209286|525400399|FG001|Overall Study|Physician Decision|2|||
145695067|NCT01209286|525400400|FG002|Overall Study|Physician Decision|0|||
145695068|NCT01209286|525400398|FG000|Overall Study|Other|0|||
145695069|NCT01209286|525400399|FG001|Overall Study|Other|1|||
145695070|NCT01209286|525400400|FG002|Overall Study|Other|0|||
145695071|NCT01349036|525400401|FG000|Overall Study|Disease progression|13|||
145695072|NCT01349036|525400402|FG001|Overall Study|Disease progression|22|||
145695073|NCT01349036|525400401|FG000|Overall Study|Other|1|||
145695074|NCT01349036|525400402|FG001|Overall Study|Other|0|||
145695075|NCT01349036|525400401|FG000|Overall Study|Withdrawal by Subject|0|||
145695076|NCT01349036|525400402|FG001|Overall Study|Withdrawal by Subject|2|||
145695077|NCT03796208|525400403|FG000|Overall Study|Withdrawal by Subject|3|||
145695078|NCT03796208|525400404|FG001|Overall Study|Withdrawal by Subject|0|||
145695079|NCT03796208|525400403|FG000|Overall Study|Loss of pregnancy|1|||
145695080|NCT03796208|525400404|FG001|Overall Study|Loss of pregnancy|1|||
145265476|NCT01298323|523819370|FG001|Overall Study|Other|9|||
145695081|NCT03796208|525400403|FG000|Overall Study|Changed prenatal clinics|0|||
145695082|NCT03796208|525400404|FG001|Overall Study|Changed prenatal clinics|5|||
145695083|NCT03796208|525400403|FG000|Overall Study|Lost to Follow-up|20|||
145695084|NCT03796208|525400404|FG001|Overall Study|Lost to Follow-up|16|||
145695085|NCT02725008|525400406|FG000|Overall Study|Lost to Follow-up|7|||
145695086|NCT02725008|525400407|FG001|Overall Study|Lost to Follow-up|9|||
145695087|NCT02725008|525400406|FG000|Overall Study|Withdrawal by Subject|2|||
145695088|NCT02725008|525400407|FG001|Overall Study|Withdrawal by Subject|2|||
145695089|NCT02725008|525400406|FG000|Overall Study|Admitted to hospital|0|||
145695090|NCT02725008|525400407|FG001|Overall Study|Admitted to hospital|1|||
145695091|NCT03028012|525400410|FG000|Overall Study|Lost to Follow-up|2|||
145695092|NCT03028012|525400411|FG001|Overall Study|Lost to Follow-up|3|||
145695093|NCT03028012|525400412|FG002|Overall Study|Lost to Follow-up|3|||
145695094|NCT01424189|525400424|FG000|Overall Study|Adverse Event|1|||
145695095|NCT01424189|525400425|FG001|Overall Study|Adverse Event|0|||
145695096|NCT01424189|525400424|FG000|Overall Study|Lost to Follow-up|4|||
145695097|NCT01424189|525400425|FG001|Overall Study|Lost to Follow-up|1|||
145695098|NCT01424189|525400424|FG000|Overall Study|Withdrawal by Subject|4|||
145695099|NCT01424189|525400425|FG001|Overall Study|Withdrawal by Subject|4|||
145695100|NCT01424189|525400424|FG000|Overall Study|Subject moved|1|||
145695101|NCT01424189|525400425|FG001|Overall Study|Subject moved|0|||
145695102|NCT01424189|525400424|FG000|Overall Study|Death|3|||
145695103|NCT01424189|525400425|FG001|Overall Study|Death|1|||
145695104|NCT04688086|525400426|FG000|Overall Study|Lost to Follow-up|164|||
145695105|NCT04688086|525400426|FG000|Overall Study|Imaging error;|64|||
145695106|NCT03120949|525400427|FG000|Overall Study|randomized in error|1|||
145695107|NCT03120949|525400428|FG001|Overall Study|randomized in error|0|||
145695108|NCT03120949|525400427|FG000|Overall Study|Death|13|||
145695109|NCT03120949|525400428|FG001|Overall Study|Death|13|||
145695110|NCT03120949|525400427|FG000|Overall Study|Lost to Follow-up|23|||
145695111|NCT03120949|525400428|FG001|Overall Study|Lost to Follow-up|13|||
145695112|NCT03120949|525400427|FG000|Overall Study|Withdrawal by Subject|139|||
145695113|NCT03120949|525400428|FG001|Overall Study|Withdrawal by Subject|124|||
145695114|NCT03120949|525400427|FG000|Overall Study|Covid-19|43|||
145695115|NCT03120949|525400428|FG001|Overall Study|Covid-19|34|||
145695116|NCT03120949|525400427|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
145695117|NCT03120949|525400428|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
145695118|NCT03120949|525400427|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
145695119|NCT03120949|525400428|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
145695120|NCT03120949|525400427|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
145695121|NCT03120949|525400428|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
145695122|NCT03120949|525400427|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
145695123|NCT03120949|525400428|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
145695124|NCT03120949|525400427|FG000|Overall Study|Site was closed|2|||
145695125|NCT03120949|525400428|FG001|Overall Study|Site was closed|3|||
145695126|NCT03120949|525400427|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
145695127|NCT03120949|525400428|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
145695128|NCT03120949|525400427|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
145695129|NCT03120949|525400428|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
145695130|NCT03120949|525400427|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
145695131|NCT03120949|525400428|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
145695132|NCT03120949|525400427|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
145695133|NCT03120949|525400428|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
145695134|NCT03120949|525400427|FG000|Overall Study|Other: Adverse Event|0|||
145695135|NCT03120949|525400428|FG001|Overall Study|Other: Adverse Event|1|||
145695136|NCT03120949|525400427|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
145695137|NCT03120949|525400428|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
145695138|NCT03120949|525400427|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
145695139|NCT03120949|525400428|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
145695140|NCT03120949|525400427|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
145695141|NCT03120949|525400428|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
145695142|NCT03120949|525400427|FG000|Overall Study|Personal Reasons|0|||
145695143|NCT03120949|525400428|FG001|Overall Study|Personal Reasons|1|||
145695144|NCT03120949|525400427|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
145695145|NCT03120949|525400428|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
145695146|NCT03120949|525400427|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
145695147|NCT03120949|525400428|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
145695148|NCT03120949|525400427|FG000|Overall Study|Compliance With Medication|0|||
145695149|NCT03120949|525400428|FG001|Overall Study|Compliance With Medication|1|||
145695150|NCT03120949|525400427|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
145695151|NCT03120949|525400428|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
145695152|NCT03120949|525400427|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
145695153|NCT03120949|525400428|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
145695154|NCT03120949|525400427|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
145695155|NCT03120949|525400428|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
145695156|NCT01329419|525400431|FG000|Overall Study|Protocol Violation|235|||
145695157|NCT00069277|525400432|FG000|Overall Study|Adverse Event|3|||
145695158|NCT00069277|525400432|FG000|Overall Study|Withdrawal by Subject|1|||
145695159|NCT00069277|525400432|FG000|Overall Study|Progressive Disease|15|||
145695160|NCT00069277|525400432|FG000|Overall Study|Physician Decision|2|||
145695161|NCT03512288|525400434|FG000|Overall Study|Adverse Event|1|||
145695162|NCT03512288|525400435|FG001|Overall Study|Adverse Event|0|||
145695163|NCT03512288|525400434|FG000|Overall Study|Lost to Follow-up|12|||
145695164|NCT03512288|525400435|FG001|Overall Study|Lost to Follow-up|15|||
145695165|NCT03512288|525400434|FG000|Overall Study|Physician Decision|0|||
145695166|NCT03512288|525400435|FG001|Overall Study|Physician Decision|2|||
145695167|NCT03512288|525400434|FG000|Overall Study|Protocol Violation|6|||
145695168|NCT03512288|525400435|FG001|Overall Study|Protocol Violation|4|||
145695169|NCT03512288|525400434|FG000|Overall Study|Medication error without associated adverse event|1|||
145695170|NCT03512288|525400435|FG001|Overall Study|Medication error without associated adverse event|0|||
145695171|NCT03512288|525400434|FG000|Overall Study|No longer met eligibility criteria|5|||
145695172|NCT03512288|525400435|FG001|Overall Study|No longer met eligibility criteria|2|||
145695173|NCT03512288|525400434|FG000|Overall Study|Withdrawal by parent/guardian|14|||
145695174|NCT03512288|525400435|FG001|Overall Study|Withdrawal by parent/guardian|18|||
145695175|NCT03512288|525400434|FG000|Overall Study|Other|1|||
145695176|NCT03512288|525400435|FG001|Overall Study|Other|1|||
145695177|NCT03512288|525400434|FG000|Overall Study|Randomized but not treated|1|||
145695178|NCT03512288|525400435|FG001|Overall Study|Randomized but not treated|1|||
145695179|NCT01078584|525400436|FG000|Overall Study|Final Status Unknown|1073|||
145695180|NCT01078584|525400436|FG000|Overall Study|Lost to Follow-up|670|||
145695181|NCT01078584|525400436|FG000|Overall Study|Non-serious Adverse Event|577|||
145695182|NCT01078584|525400436|FG000|Overall Study|Withdrawal of Consent|244|||
145695183|NCT01078584|525400436|FG000|Overall Study|Physician Withdrew from Study|90|||
145695184|NCT01078584|525400436|FG000|Overall Study|Non-compliance|67|||
145695185|NCT01078584|525400436|FG000|Overall Study|Blood Pressure Controlled|49|||
145695186|NCT01078584|525400436|FG000|Overall Study|Physician Switched Medication|26|||
145695187|NCT01078584|525400436|FG000|Overall Study|Physician Discontinued Patient|12|||
145695188|NCT01078584|525400436|FG000|Overall Study|Lack of Efficacy|98|||
145695189|NCT01078584|525400436|FG000|Overall Study|Protocol Violation|75|||
145695190|NCT01078584|525400436|FG000|Overall Study|Serious Adverse Event|27|||
145695191|NCT01078584|525400436|FG000|Overall Study|Multiple Reasons|2|||
145695192|NCT01208870|525400437|FG000|Overall Study|Lost to Follow-up|2|||
145695193|NCT01208870|525400438|FG001|Overall Study|Lost to Follow-up|8|||
145695194|NCT01121185|525400439|FG000|Overall Study|Not infused|0|||
145695195|NCT01121185|525400440|FG001|Overall Study|Not infused|1|||
145695196|NCT01121185|525400439|FG000|Overall Study|Not transplanted|1|||
145695197|NCT01121185|525400440|FG001|Overall Study|Not transplanted|0|||
145695198|NCT00424177|525400441|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
145695199|NCT00424177|525400441|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
145695200|NCT00424177|525400441|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
145695201|NCT00424177|525400441|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
145695202|NCT00424177|525400441|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
145695203|NCT00424177|525400441|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
145695204|NCT00424177|525400441|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
145695205|NCT00424177|525400441|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
145695206|NCT00424177|525400441|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
145695207|NCT00424177|525400441|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
145695208|NCT00316589|525400442|FG000|Overall Study|Withdrawal by Subject|0|||
145695209|NCT00316589|525400443|FG001|Overall Study|Withdrawal by Subject|5|||
145695210|NCT00316589|525400444|FG002|Overall Study|Withdrawal by Subject|0|||
145695211|NCT00316589|525400445|FG003|Overall Study|Withdrawal by Subject|1|||
145695212|NCT00316589|525400442|FG000|Overall Study|Subject unwilling/unable to comply|0|||
145695213|NCT00316589|525400443|FG001|Overall Study|Subject unwilling/unable to comply|6|||
145695214|NCT00316589|525400444|FG002|Overall Study|Subject unwilling/unable to comply|0|||
145695215|NCT00316589|525400445|FG003|Overall Study|Subject unwilling/unable to comply|2|||
145695216|NCT00316589|525400442|FG000|Overall Study|Adverse Event|1|||
145265477|NCT01298323|523819369|FG000|Overall Study|Ongoing|55|||
145695217|NCT00316589|525400443|FG001|Overall Study|Adverse Event|0|||
145695218|NCT00316589|525400444|FG002|Overall Study|Adverse Event|0|||
145695219|NCT00316589|525400445|FG003|Overall Study|Adverse Event|1|||
145695220|NCT00316589|525400442|FG000|Overall Study|Physician Decision|0|||
145695221|NCT00316589|525400443|FG001|Overall Study|Physician Decision|1|||
145695222|NCT00316589|525400444|FG002|Overall Study|Physician Decision|0|||
145695223|NCT00316589|525400445|FG003|Overall Study|Physician Decision|0|||
145695224|NCT00316589|525400442|FG000|Overall Study|Other reason|0|||
145695225|NCT00316589|525400443|FG001|Overall Study|Other reason|12|||
145695226|NCT00316589|525400444|FG002|Overall Study|Other reason|1|||
145695227|NCT00316589|525400445|FG003|Overall Study|Other reason|1|||
145695228|NCT01283971|525400448|FG000|Overall Study|Adverse Event|3|||
145695229|NCT01283971|525400449|FG001|Overall Study|Adverse Event|5|||
145695230|NCT01283971|525400448|FG000|Overall Study|Insufficient therapeutic responses|3|||
145695231|NCT01283971|525400449|FG001|Overall Study|Insufficient therapeutic responses|3|||
145695232|NCT01283971|525400448|FG000|Overall Study|Protocol Violation|5|||
145695233|NCT01283971|525400449|FG001|Overall Study|Protocol Violation|1|||
145695234|NCT01283971|525400448|FG000|Overall Study|Refused treatment|3|||
145695235|NCT01283971|525400449|FG001|Overall Study|Refused treatment|1|||
145695236|NCT01283971|525400448|FG000|Overall Study|Failure to return|0|||
145695237|NCT01283971|525400449|FG001|Overall Study|Failure to return|1|||
145695238|NCT01283971|525400448|FG000|Overall Study|Administrative reasons|1|||
145695239|NCT01283971|525400449|FG001|Overall Study|Administrative reasons|1|||
145695240|NCT01932762|525402109|FG000|Overall Study|Withdrawal by Subject|1|||
145695241|NCT01932762|525402110|FG001|Overall Study|Withdrawal by Subject|2|||
145695242|NCT01932762|525402111|FG002|Overall Study|Withdrawal by Subject|0|||
145695243|NCT01932762|525402112|FG003|Overall Study|Withdrawal by Subject|0|||
145695244|NCT01932762|525402109|FG000|Overall Study|Lost to Follow-up|4|||
145695245|NCT01932762|525402110|FG001|Overall Study|Lost to Follow-up|0|||
145695246|NCT01932762|525402111|FG002|Overall Study|Lost to Follow-up|0|||
145695247|NCT01932762|525402112|FG003|Overall Study|Lost to Follow-up|1|||
145695248|NCT01932762|525402109|FG000|Overall Study|Physician Decision|1|||
145695249|NCT01932762|525402110|FG001|Overall Study|Physician Decision|0|||
145695250|NCT01932762|525402111|FG002|Overall Study|Physician Decision|0|||
145695251|NCT01932762|525402112|FG003|Overall Study|Physician Decision|0|||
145695252|NCT00664105|525402113|FG000|Overall Study|Death|3|||
145695253|NCT00664105|525402113|FG000|Overall Study|Withdrawal by Subject|5|||
145695254|NCT00664105|525402113|FG000|Overall Study|Adverse Event|9|||
145695255|NCT00664105|525402113|FG000|Overall Study|Disease progression|7|||
145695256|NCT01468077|525402120|FG000|Overall Study|Adverse Event|2|||
145695257|NCT01468077|525402121|FG001|Overall Study|Adverse Event|2|||
145695258|NCT01468077|525402120|FG000|Overall Study|Lack of Efficacy|1|||
145695259|NCT01468077|525402121|FG001|Overall Study|Lack of Efficacy|1|||
145695260|NCT01468077|525402120|FG000|Overall Study|Physician Decision|1|||
145695261|NCT01468077|525402121|FG001|Overall Study|Physician Decision|0|||
145695262|NCT04843579|525402122|FG000|Overall Study|Adverse Event|1|||
145695263|NCT04843579|525402122|FG000|Overall Study|Disease Progression|1|||
145695264|NCT03834623|525402123|FG000|Overall Study|Progression|0|||
145695265|NCT03834623|525402124|FG001|Overall Study|Progression|1|||
145695266|NCT03024996|525402126|FG000|Overall Study|Death|57|||
145695267|NCT03024996|525402127|FG001|Overall Study|Death|55|||
145695268|NCT03024996|525402126|FG000|Overall Study|Disease relapse|1|||
145695269|NCT03024996|525402127|FG001|Overall Study|Disease relapse|0|||
145695270|NCT03024996|525402126|FG000|Overall Study|Lost to Follow-up|5|||
145695271|NCT03024996|525402127|FG001|Overall Study|Lost to Follow-up|10|||
145695272|NCT03024996|525402126|FG000|Overall Study|Other|3|||
145695273|NCT03024996|525402127|FG001|Overall Study|Other|3|||
145695274|NCT03024996|525402126|FG000|Overall Study|Physician Decision|0|||
145695275|NCT03024996|525402127|FG001|Overall Study|Physician Decision|1|||
145695276|NCT03024996|525402126|FG000|Overall Study|Study terminated by sponsor|303|||
145695277|NCT03024996|525402127|FG001|Overall Study|Study terminated by sponsor|283|||
145695278|NCT03024996|525402126|FG000|Overall Study|Withdrawal by Subject|21|||
145695279|NCT03024996|525402127|FG001|Overall Study|Withdrawal by Subject|36|||
145695280|NCT00478647|525402128|FG000|Overall Study|Adverse Event|1|||
145695281|NCT00478647|525402128|FG000|Overall Study|Withdrawal by Subject|1|||
145695282|NCT00477464|525402132|FG000|Overall Study|Lost to Follow-up|1|||
145265478|NCT01298323|523819370|FG001|Overall Study|Ongoing|55|||
145695283|NCT00477464|525402132|FG000|Overall Study|Death|36|||
145695284|NCT00477464|525402132|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
145695285|NCT00639769|525402133|FG000|Overall Study|Death|2|||
145695286|NCT00639769|525402133|FG000|Overall Study|Adverse Event|7|||
145695287|NCT00639769|525402133|FG000|Overall Study|Lack of Efficacy|1|||
145695288|NCT00639769|525402133|FG000|Overall Study|Disease progression|26|||
145695289|NCT00639769|525402133|FG000|Overall Study|Withdrawal by Subject|4|||
145695290|NCT00784147|525402134|FG000|Overall Study|Lost to Follow-up|2|||
145695291|NCT00784147|525402135|FG001|Overall Study|Lost to Follow-up|4|||
145695292|NCT00784147|525402134|FG000|Overall Study|Withdrawal by Subject|1|||
145695293|NCT00784147|525402135|FG001|Overall Study|Withdrawal by Subject|3|||
145491423|NCT00499681|524653802|FG000|Overall Study|toxicity|0|||
145695294|NCT00784147|525402134|FG000|Overall Study|Physician Decision|2|||
145695295|NCT00784147|525402135|FG001|Overall Study|Physician Decision|1|||
145695296|NCT00784147|525402134|FG000|Overall Study|Protocol Violation|1|||
145695297|NCT00784147|525402135|FG001|Overall Study|Protocol Violation|1|||
145695298|NCT00784147|525402134|FG000|Overall Study|Death|2|||
145695299|NCT00784147|525402135|FG001|Overall Study|Death|0|||
145695300|NCT01475461|525402140|FG000|Run-in Period|Not meet eligibility criteria|16|||
145695301|NCT01475461|525402141|FG001|Run-in Period|Not meet eligibility criteria|0|||
145695302|NCT01475461|525402142|FG002|Run-in Period|Not meet eligibility criteria|0|||
145695303|NCT01475461|525402143|FG003|Run-in Period|Not meet eligibility criteria|0|||
145695304|NCT01475461|525402144|FG004|Run-in Period|Not meet eligibility criteria|0|||
145695305|NCT01475461|525402145|FG005|Run-in Period|Not meet eligibility criteria|0|||
145695306|NCT01475461|525402146|FG006|Run-in Period|Not meet eligibility criteria|0|||
145695307|NCT01475461|525402140|FG000|Run-in Period|Lost to Follow-up|7|||
145695308|NCT01475461|525402141|FG001|Run-in Period|Lost to Follow-up|0|||
145695309|NCT01475461|525402142|FG002|Run-in Period|Lost to Follow-up|0|||
145695310|NCT01475461|525402143|FG003|Run-in Period|Lost to Follow-up|0|||
145695311|NCT01475461|525402144|FG004|Run-in Period|Lost to Follow-up|0|||
145695312|NCT01475461|525402145|FG005|Run-in Period|Lost to Follow-up|0|||
145695313|NCT01475461|525402146|FG006|Run-in Period|Lost to Follow-up|0|||
145695314|NCT01475461|525402140|FG000|Run-in Period|Withdrawal by Subject|11|||
145695315|NCT01475461|525402141|FG001|Run-in Period|Withdrawal by Subject|0|||
145695316|NCT01475461|525402142|FG002|Run-in Period|Withdrawal by Subject|0|||
145695317|NCT01475461|525402143|FG003|Run-in Period|Withdrawal by Subject|0|||
145695318|NCT01475461|525402144|FG004|Run-in Period|Withdrawal by Subject|0|||
145695319|NCT01475461|525402145|FG005|Run-in Period|Withdrawal by Subject|0|||
145695320|NCT01475461|525402146|FG006|Run-in Period|Withdrawal by Subject|0|||
145695321|NCT01475461|525402140|FG000|Run-in Period|Other|3|||
145695322|NCT01475461|525402141|FG001|Run-in Period|Other|0|||
145695323|NCT01475461|525402142|FG002|Run-in Period|Other|0|||
145695324|NCT01475461|525402143|FG003|Run-in Period|Other|0|||
145695325|NCT01475461|525402144|FG004|Run-in Period|Other|0|||
145695326|NCT01475461|525402145|FG005|Run-in Period|Other|0|||
145695327|NCT01475461|525402146|FG006|Run-in Period|Other|0|||
145695328|NCT01475461|525402140|FG000|Run-in Period|Protocol Violation|4|||
145695329|NCT01475461|525402141|FG001|Run-in Period|Protocol Violation|0|||
145695330|NCT01475461|525402142|FG002|Run-in Period|Protocol Violation|0|||
145695331|NCT01475461|525402143|FG003|Run-in Period|Protocol Violation|0|||
145695332|NCT01475461|525402144|FG004|Run-in Period|Protocol Violation|0|||
145695333|NCT01475461|525402145|FG005|Run-in Period|Protocol Violation|0|||
145695334|NCT01475461|525402146|FG006|Run-in Period|Protocol Violation|0|||
145695335|NCT01475461|525402140|FG000|Treatment Period|Death|0|||
145695336|NCT01475461|525402141|FG001|Treatment Period|Death|0|||
145695337|NCT01475461|525402142|FG002|Treatment Period|Death|0|||
145695338|NCT01475461|525402143|FG003|Treatment Period|Death|1|||
145695339|NCT01475461|525402144|FG004|Treatment Period|Death|0|||
145695340|NCT01475461|525402145|FG005|Treatment Period|Death|0|||
145695341|NCT01475461|525402146|FG006|Treatment Period|Death|0|||
145695342|NCT01475461|525402140|FG000|Treatment Period|Lost to Follow-up|0|||
145695343|NCT01475461|525402141|FG001|Treatment Period|Lost to Follow-up|3|||
145695344|NCT01475461|525402142|FG002|Treatment Period|Lost to Follow-up|2|||
145695345|NCT01475461|525402143|FG003|Treatment Period|Lost to Follow-up|3|||
145695346|NCT01475461|525402144|FG004|Treatment Period|Lost to Follow-up|1|||
145695347|NCT01475461|525402145|FG005|Treatment Period|Lost to Follow-up|2|||
145695348|NCT01475461|525402146|FG006|Treatment Period|Lost to Follow-up|1|||
145695349|NCT01475461|525402140|FG000|Treatment Period|Withdrawal by Subject|0|||
145695350|NCT01475461|525402141|FG001|Treatment Period|Withdrawal by Subject|2|||
145695351|NCT01475461|525402142|FG002|Treatment Period|Withdrawal by Subject|2|||
145695352|NCT01475461|525402143|FG003|Treatment Period|Withdrawal by Subject|0|||
145695353|NCT01475461|525402144|FG004|Treatment Period|Withdrawal by Subject|2|||
145695354|NCT01475461|525402145|FG005|Treatment Period|Withdrawal by Subject|2|||
145695355|NCT01475461|525402146|FG006|Treatment Period|Withdrawal by Subject|0|||
145695356|NCT01475461|525402140|FG000|Treatment Period|Other|0|||
145695357|NCT01475461|525402141|FG001|Treatment Period|Other|1|||
145695358|NCT01475461|525402142|FG002|Treatment Period|Other|0|||
145695359|NCT01475461|525402143|FG003|Treatment Period|Other|0|||
145695360|NCT01475461|525402144|FG004|Treatment Period|Other|0|||
145695361|NCT01475461|525402145|FG005|Treatment Period|Other|0|||
145695362|NCT01475461|525402146|FG006|Treatment Period|Other|0|||
145695363|NCT01475461|525402140|FG000|Treatment Period|Protocol Violation|0|||
145695364|NCT01475461|525402141|FG001|Treatment Period|Protocol Violation|1|||
145695365|NCT01475461|525402142|FG002|Treatment Period|Protocol Violation|0|||
145695366|NCT01475461|525402143|FG003|Treatment Period|Protocol Violation|0|||
145695367|NCT01475461|525402144|FG004|Treatment Period|Protocol Violation|0|||
145695368|NCT01475461|525402145|FG005|Treatment Period|Protocol Violation|0|||
145695369|NCT01475461|525402146|FG006|Treatment Period|Protocol Violation|1|||
145695370|NCT01475461|525402140|FG000|Treatment Period|Lack of Efficacy|0|||
145695371|NCT01475461|525402141|FG001|Treatment Period|Lack of Efficacy|2|||
145695372|NCT01475461|525402142|FG002|Treatment Period|Lack of Efficacy|0|||
145695373|NCT01475461|525402143|FG003|Treatment Period|Lack of Efficacy|2|||
145695374|NCT01475461|525402144|FG004|Treatment Period|Lack of Efficacy|1|||
145695375|NCT01475461|525402145|FG005|Treatment Period|Lack of Efficacy|1|||
145695376|NCT01475461|525402146|FG006|Treatment Period|Lack of Efficacy|0|||
145695377|NCT01475461|525402140|FG000|Treatment Period|Medication Error|0|||
145695378|NCT01475461|525402141|FG001|Treatment Period|Medication Error|0|||
145695379|NCT01475461|525402142|FG002|Treatment Period|Medication Error|0|||
145695380|NCT01475461|525402143|FG003|Treatment Period|Medication Error|1|||
145695381|NCT01475461|525402144|FG004|Treatment Period|Medication Error|0|||
145695382|NCT01475461|525402145|FG005|Treatment Period|Medication Error|0|||
145695383|NCT01475461|525402146|FG006|Treatment Period|Medication Error|0|||
145695384|NCT01475461|525402140|FG000|Treatment Period|Adverse Event|0|||
145695385|NCT01475461|525402141|FG001|Treatment Period|Adverse Event|0|||
145695386|NCT01475461|525402142|FG002|Treatment Period|Adverse Event|0|||
145695387|NCT01475461|525402143|FG003|Treatment Period|Adverse Event|1|||
145695388|NCT01475461|525402144|FG004|Treatment Period|Adverse Event|0|||
145695389|NCT01475461|525402145|FG005|Treatment Period|Adverse Event|0|||
145695390|NCT01475461|525402146|FG006|Treatment Period|Adverse Event|0|||
145695391|NCT04051242|525402149|FG000|Overall Study|Withdrawal by Subject|1|||
145695392|NCT04051242|525402149|FG000|Overall Study|Physician Decision|1|||
145695393|NCT00846768|525402152|FG000|Overall Study|Adverse Event|0|||
145695394|NCT00846768|525402153|FG001|Overall Study|Adverse Event|1|||
145695395|NCT00846768|525402154|FG002|Overall Study|Adverse Event|0|||
145695396|NCT00846768|525402155|FG003|Overall Study|Adverse Event|0|||
145695397|NCT04353817|525402156|FG000|Overall Study|Adverse Event|0|||
145695398|NCT04353817|525402157|FG001|Overall Study|Adverse Event|1|||
145695399|NCT04358068|525402158|FG000|Overall Study|Did not initiate study treatment|2|||
145695400|NCT04358068|525402159|FG001|Overall Study|Did not initiate study treatment|2|||
145695401|NCT00338949|525402160|FG000|Subject Screening|Screen failures|11|||
145695402|NCT00338949|525402161|FG001|Subject Screening|Screen failures|11|||
145695403|NCT00338949|525402160|FG000|Randomization|Withdrawal by Subject|1|||
145695404|NCT00338949|525402161|FG001|Randomization|Withdrawal by Subject|0|||
145695405|NCT00338949|525402160|FG000|Randomization|Adverse Event|0|||
145695406|NCT00338949|525402161|FG001|Randomization|Adverse Event|5|||
145695407|NCT03029819|525402164|FG000|Overall Study|Lost to Follow-up|3|||
145695408|NCT03029819|525402165|FG001|Overall Study|Lost to Follow-up|5|||
145695409|NCT03029819|525402164|FG000|Overall Study|Removed due to disruptive behavior|0|||
145695410|NCT03029819|525402165|FG001|Overall Study|Removed due to disruptive behavior|1|||
145695411|NCT01020747|525402172|FG000|Overall Study|Withdrawal by Subject|1|||
145695412|NCT02175745|525402173|FG000|Overall Study|Not Eligible|1|||
145695413|NCT00983892|525402174|FG000|Overall Study|Withdrawal by Subject|10|||
145695414|NCT00983892|525402175|FG001|Overall Study|Withdrawal by Subject|12|||
145695415|NCT00808899|525402176|FG000|Overall Study|Death|1|||
145695416|NCT00808899|525402176|FG000|Overall Study|Physician Decision|3|||
145695417|NCT01705145|525402177|FG000|Part B|Adverse Event|1|||
145695418|NCT01203956|525402180|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
145695419|NCT01203956|525402181|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
145695420|NCT04522778|525402184|FG000|Overall Study|Patient did not want to wear the device|1|||
145695421|NCT04522778|525402185|FG001|Overall Study|Patient did not want to wear the device|0|||
145695422|NCT04522778|525402184|FG000|Overall Study|Lost to Follow-up|0|||
145695423|NCT04522778|525402185|FG001|Overall Study|Lost to Follow-up|1|||
145695424|NCT01225159|525402186|FG000|Overall Study|Change operation|1|||
145695425|NCT01225159|525402187|FG001|Overall Study|Change operation|0|||
145695426|NCT02230306|525402188|FG000|Overall Study|Did not receive study treatment|1|||
145695427|NCT00312845|525402191|FG000|Overall Study|Adverse Event|19|||
145695428|NCT00312845|525402192|FG001|Overall Study|Adverse Event|5|||
145695429|NCT00312845|525402191|FG000|Overall Study|Death|2|||
145695430|NCT00312845|525402192|FG001|Overall Study|Death|2|||
145695431|NCT00312845|525402191|FG000|Overall Study|Withdrawal by Subject|14|||
145695432|NCT00312845|525402192|FG001|Overall Study|Withdrawal by Subject|6|||
145695433|NCT00312845|525402191|FG000|Overall Study|Disease Progression|56|||
145695434|NCT00312845|525402192|FG001|Overall Study|Disease Progression|77|||
145695435|NCT00312845|525402191|FG000|Overall Study|Lost to Follow-up|2|||
145695436|NCT00312845|525402192|FG001|Overall Study|Lost to Follow-up|0|||
145695437|NCT00312845|525402191|FG000|Overall Study|Other|6|||
145695438|NCT00312845|525402192|FG001|Overall Study|Other|5|||
145695439|NCT01220856|525402195|FG000|Overall Study|graft loss|3|||
145695440|NCT01220856|525402196|FG001|Overall Study|graft loss|3|||
145491424|NCT00499681|524653803|FG001|Overall Study|toxicity|1|||
145695441|NCT01220856|525402195|FG000|Overall Study|Lost to Follow-up|1|||
145695442|NCT01220856|525402196|FG001|Overall Study|Lost to Follow-up|0|||
145695443|NCT00361842|525402197|FG000|Overall Study|Withdrawal by Subject|2|||
145695444|NCT00361842|525402198|FG001|Overall Study|Withdrawal by Subject|3|||
145695445|NCT00361842|525402197|FG000|Overall Study|Death|2|||
145695446|NCT00361842|525402198|FG001|Overall Study|Death|1|||
145695447|NCT00361842|525402197|FG000|Overall Study|Disease progression|19|||
145695448|NCT00361842|525402198|FG001|Overall Study|Disease progression|20|||
145695449|NCT00361842|525402197|FG000|Overall Study|Adverse Event|2|||
145695450|NCT00361842|525402198|FG001|Overall Study|Adverse Event|3|||
145695451|NCT00361842|525402197|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
145695452|NCT00361842|525402198|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
145695453|NCT00361842|525402197|FG000|Overall Study|Other|1|||
145695454|NCT00361842|525402198|FG001|Overall Study|Other|0|||
145695455|NCT00361842|525402197|FG000|Overall Study|Other|0|||
145695456|NCT00361842|525402198|FG001|Overall Study|Other|2|||
145695457|NCT04206384|525402199|FG000|Overall Study|Withdrawal by Subject|8|||
145695458|NCT04206384|525402199|FG000|Overall Study|Adverse Event|2|||
145695459|NCT02212197|525402200|FG000|Overall Study|Need for radiotherapy|1|||
145695460|NCT02212197|525402201|FG001|Overall Study|Need for radiotherapy|0|||
145695461|NCT02212197|525402202|FG002|Overall Study|Need for radiotherapy|0|||
145695462|NCT03015181|525402204|FG000|Overall Study|Enrolled, but product never administered|1|||
145695463|NCT03015181|525402205|FG001|Overall Study|Enrolled, but product never administered|0|||
145695464|NCT03015181|525402206|FG002|Overall Study|Enrolled, but product never administered|0|||
145695465|NCT03015181|525402207|FG003|Overall Study|Enrolled, but product never administered|0|||
145695466|NCT03015181|525402208|FG004|Overall Study|Enrolled, but product never administered|0|||
145695467|NCT03015181|525402209|FG005|Overall Study|Enrolled, but product never administered|0|||
145695468|NCT03015181|525402210|FG006|Overall Study|Enrolled, but product never administered|0|||
145695469|NCT03015181|525402204|FG000|Overall Study|Withdrawal by Subject|0|||
145695470|NCT03015181|525402205|FG001|Overall Study|Withdrawal by Subject|0|||
145695471|NCT03015181|525402206|FG002|Overall Study|Withdrawal by Subject|0|||
145695472|NCT03015181|525402207|FG003|Overall Study|Withdrawal by Subject|0|||
145695473|NCT03015181|525402208|FG004|Overall Study|Withdrawal by Subject|0|||
145695474|NCT03015181|525402209|FG005|Overall Study|Withdrawal by Subject|1|||
145695475|NCT03015181|525402210|FG006|Overall Study|Withdrawal by Subject|0|||
145695476|NCT03015181|525402204|FG000|Overall Study|Physician Decision|0|||
145695477|NCT03015181|525402205|FG001|Overall Study|Physician Decision|0|||
145695478|NCT03015181|525402206|FG002|Overall Study|Physician Decision|0|||
145695479|NCT03015181|525402207|FG003|Overall Study|Physician Decision|0|||
145695480|NCT03015181|525402208|FG004|Overall Study|Physician Decision|0|||
145695481|NCT03015181|525402209|FG005|Overall Study|Physician Decision|0|||
145695482|NCT03015181|525402210|FG006|Overall Study|Physician Decision|1|||
145695483|NCT01077622|525402211|FG000|Overall Study|Physician Decision|2|||
145695484|NCT01077622|525402211|FG000|Overall Study|Withdrawal by Subject|1|||
145695485|NCT01260142|525402212|FG000|Treatment Period 1|Study on hold|1|||
145695486|NCT01260142|525402213|FG001|Treatment Period 1|Study on hold|1|||
145695487|NCT01260142|525402214|FG002|Treatment Period 1|Study on hold|0|||
145695488|NCT01260142|525402215|FG003|Treatment Period 1|Study on hold|0|||
145695489|NCT01260142|525402216|FG004|Treatment Period 1|Study on hold|1|||
145695490|NCT01260142|525402217|FG005|Treatment Period 1|Study on hold|2|||
145695491|NCT01260142|525402212|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
145695492|NCT01260142|525402213|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
145695493|NCT01260142|525402214|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
145695494|NCT01260142|525402215|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
145695495|NCT01260142|525402216|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
145695496|NCT01260142|525402217|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
145695497|NCT01260142|525402212|FG000|Treatment Period 1|Withdrawal by Subject|0|||
145695498|NCT01260142|525402213|FG001|Treatment Period 1|Withdrawal by Subject|0|||
145695499|NCT01260142|525402214|FG002|Treatment Period 1|Withdrawal by Subject|0|||
145695500|NCT01260142|525402215|FG003|Treatment Period 1|Withdrawal by Subject|0|||
145695501|NCT01260142|525402216|FG004|Treatment Period 1|Withdrawal by Subject|0|||
145695502|NCT01260142|525402217|FG005|Treatment Period 1|Withdrawal by Subject|1|||
145695503|NCT00496834|525402226|FG000|Overall Study|Withdrawal by Subject|4|||
145695504|NCT00496834|525402227|FG001|Overall Study|Withdrawal by Subject|6|||
145695505|NCT00496834|525402226|FG000|Overall Study|Contraindicated medication administered|0|||
145695506|NCT00496834|525402227|FG001|Overall Study|Contraindicated medication administered|1|||
145695507|NCT00496834|525402226|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
145695508|NCT00496834|525402227|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
145695509|NCT00496834|525402226|FG000|Overall Study|Adverse Event|5|||
145695510|NCT00496834|525402227|FG001|Overall Study|Adverse Event|3|||
145695511|NCT00496834|525402226|FG000|Overall Study|IP administration violation|2|||
145695512|NCT00496834|525402227|FG001|Overall Study|IP administration violation|0|||
145695513|NCT00496834|525402226|FG000|Overall Study|Lost to Follow-up|2|||
145695514|NCT00496834|525402227|FG001|Overall Study|Lost to Follow-up|0|||
145695515|NCT00496834|525402226|FG000|Overall Study|Blood Pressure control failure|2|||
145695516|NCT00496834|525402227|FG001|Overall Study|Blood Pressure control failure|1|||
145265479|NCT01298323|523819369|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
145491425|NCT00499681|524653802|FG000|Overall Study|disease progression|0|||
145695517|NCT01503164|525402228|FG000|Overall Study|Withdrawal by Subject|2|||
145695518|NCT01503164|525402229|FG001|Overall Study|Withdrawal by Subject|1|||
145695519|NCT01177228|525402230|FG000|Overall Study|Positive tuberculosis test|0|||
145695520|NCT01177228|525402231|FG001|Overall Study|Positive tuberculosis test|1|||
145695521|NCT01177228|525402232|FG002|Overall Study|Positive tuberculosis test|0|||
145695522|NCT01177228|525402233|FG003|Overall Study|Positive tuberculosis test|0|||
145695523|NCT01177228|525402230|FG000|Overall Study|Worsening disease activity|1|||
145695524|NCT01177228|525402231|FG001|Overall Study|Worsening disease activity|0|||
145695525|NCT01177228|525402232|FG002|Overall Study|Worsening disease activity|0|||
145695526|NCT01177228|525402233|FG003|Overall Study|Worsening disease activity|0|||
145695527|NCT01177228|525402230|FG000|Overall Study|Withdrawal by Subject|0|||
145695528|NCT01177228|525402231|FG001|Overall Study|Withdrawal by Subject|1|||
145695529|NCT01177228|525402232|FG002|Overall Study|Withdrawal by Subject|0|||
145695530|NCT01177228|525402233|FG003|Overall Study|Withdrawal by Subject|0|||
145695531|NCT00356759|525402234|FG000|Overall Study|Death|5|||
145695532|NCT00356759|525402235|FG001|Overall Study|Death|2|||
145695533|NCT00356759|525402234|FG000|Overall Study|Withdrawal by Subject|2|||
145695534|NCT00356759|525402235|FG001|Overall Study|Withdrawal by Subject|2|||
145695535|NCT00356759|525402234|FG000|Overall Study|Adverse Event|1|||
145695536|NCT00356759|525402235|FG001|Overall Study|Adverse Event|3|||
145695537|NCT00356759|525402234|FG000|Overall Study|Lost to Follow-up|1|||
145695538|NCT00356759|525402235|FG001|Overall Study|Lost to Follow-up|1|||
145695539|NCT00356759|525402234|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
145695540|NCT00356759|525402235|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
145695541|NCT03821064|525402238|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
145695542|NCT00474383|525402243|FG000|Main Study|Adverse Event|11|||
145695543|NCT00474383|525402244|FG001|Main Study|Adverse Event|0|||
145695544|NCT00474383|525402243|FG000|Main Study|Symptomatic Deterioration|1|||
145695545|NCT00474383|525402244|FG001|Main Study|Symptomatic Deterioration|0|||
145695546|NCT00474383|525402243|FG000|Main Study|Progressive Disease|23|||
145695547|NCT00474383|525402244|FG001|Main Study|Progressive Disease|0|||
145695548|NCT00474383|525402243|FG000|Main Study|Other|1|||
145695549|NCT00474383|525402244|FG001|Main Study|Other|0|||
145695550|NCT00474383|525402243|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
145695551|NCT00474383|525402244|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
145695552|NCT00474383|525402243|FG000|Extension|Progressive Disease|0|||
145695553|NCT00474383|525402244|FG001|Extension|Progressive Disease|5|||
145695554|NCT02998918|525402245|FG000|Overall Study|Withdrawal by Subject|1|||
145695555|NCT02998918|525402246|FG001|Overall Study|Withdrawal by Subject|0|||
145695556|NCT01482819|525402247|FG000|Overall Study|Lost to Follow-up|2|||
145695557|NCT00562484|525402250|FG000|Overall Study|Adverse Event|6|||
145695558|NCT00562484|525402251|FG001|Overall Study|Adverse Event|1|||
145695559|NCT00562484|525402250|FG000|Overall Study|Protocol Violation|11|||
145695560|NCT00562484|525402251|FG001|Overall Study|Protocol Violation|2|||
145695561|NCT00562484|525402250|FG000|Overall Study|Withdrawal by Subject|12|||
145695562|NCT00562484|525402251|FG001|Overall Study|Withdrawal by Subject|9|||
145695563|NCT00562484|525402250|FG000|Overall Study|Moved away from the study area|20|||
145695564|NCT00562484|525402251|FG001|Overall Study|Moved away from the study area|9|||
145695565|NCT00562484|525402250|FG000|Overall Study|Lost to Follow-up|132|||
145695566|NCT00562484|525402251|FG001|Overall Study|Lost to Follow-up|71|||
145695567|NCT00562484|525402250|FG000|Overall Study|Reason not provided or not specified|25|||
145695568|NCT00562484|525402251|FG001|Overall Study|Reason not provided or not specified|12|||
145695569|NCT03325608|525402252|FG000|Overall Study|Lost to Follow-up|23|||
145695570|NCT03325608|525402253|FG001|Overall Study|Lost to Follow-up|23|||
145695571|NCT03325608|525402254|FG002|Overall Study|Lost to Follow-up|30|||
145695572|NCT03325608|525402255|FG003|Overall Study|Lost to Follow-up|30|||
145695573|NCT03325608|525402252|FG000|Overall Study|Death of Caregiver|0|||
145695574|NCT03325608|525402253|FG001|Overall Study|Death of Caregiver|0|||
145695575|NCT03325608|525402254|FG002|Overall Study|Death of Caregiver|2|||
145695576|NCT03325608|525402255|FG003|Overall Study|Death of Caregiver|2|||
145695577|NCT03325608|525402252|FG000|Overall Study|Death of Care Recipient|34|||
145695578|NCT03325608|525402253|FG001|Overall Study|Death of Care Recipient|34|||
145695579|NCT03325608|525402254|FG002|Overall Study|Death of Care Recipient|28|||
145695580|NCT03325608|525402255|FG003|Overall Study|Death of Care Recipient|28|||
145695581|NCT03325608|525402252|FG000|Overall Study|Withdrawal by Subject|49|||
145695582|NCT03325608|525402253|FG001|Overall Study|Withdrawal by Subject|49|||
145695583|NCT03325608|525402254|FG002|Overall Study|Withdrawal by Subject|35|||
145695584|NCT03325608|525402255|FG003|Overall Study|Withdrawal by Subject|35|||
145695585|NCT03325608|525402252|FG000|Overall Study|Ineligible|7|||
145695586|NCT03325608|525402253|FG001|Overall Study|Ineligible|7|||
145695587|NCT03325608|525402254|FG002|Overall Study|Ineligible|5|||
145695588|NCT03325608|525402255|FG003|Overall Study|Ineligible|5|||
145695589|NCT02154347|525402256|FG000|Double-blind Period|Adverse Event|1|||
145695590|NCT02154347|525402257|FG001|Double-blind Period|Adverse Event|2|||
145695591|NCT02154347|525402256|FG000|Double-blind Period|Lack of Efficacy|1|||
145695592|NCT02154347|525402257|FG001|Double-blind Period|Lack of Efficacy|0|||
145695593|NCT02154347|525402256|FG000|Double-blind Period|Physician Decision|0|||
145695594|NCT02154347|525402257|FG001|Double-blind Period|Physician Decision|1|||
145695595|NCT02154347|525402256|FG000|Double-blind Period|Withdrawal by Subject|1|||
145695596|NCT02154347|525402257|FG001|Double-blind Period|Withdrawal by Subject|1|||
145695597|NCT02154347|525402256|FG000|Open-label Period|Adverse Event|3|||
145695598|NCT02154347|525402257|FG001|Open-label Period|Adverse Event|4|||
145695599|NCT02154347|525402256|FG000|Open-label Period|Lack of Efficacy|4|||
145695600|NCT02154347|525402257|FG001|Open-label Period|Lack of Efficacy|19|||
145695601|NCT02154347|525402256|FG000|Open-label Period|Protocol Violation|0|||
145695602|NCT02154347|525402257|FG001|Open-label Period|Protocol Violation|1|||
145695603|NCT02154347|525402256|FG000|Open-label Period|Withdrawal by Subject|0|||
145695604|NCT02154347|525402257|FG001|Open-label Period|Withdrawal by Subject|1|||
145695605|NCT02188784|525402258|FG000|Overall Study|Death|3|||
145695606|NCT02188784|525402259|FG001|Overall Study|Death|1|||
145695607|NCT02188784|525402258|FG000|Overall Study|Lost to Follow-up|1|||
145695608|NCT02188784|525402259|FG001|Overall Study|Lost to Follow-up|0|||
145695609|NCT02188784|525402258|FG000|Overall Study|Withdrawal by Subject|3|||
145695610|NCT02188784|525402259|FG001|Overall Study|Withdrawal by Subject|9|||
145695611|NCT02188784|525402258|FG000|Overall Study|Physician Decision|2|||
145695612|NCT02188784|525402259|FG001|Overall Study|Physician Decision|3|||
145695613|NCT05041439|525402260|FG000|Overall Study|Withdrawal by Subject|1|||
145695614|NCT05041439|525402261|FG001|Overall Study|Withdrawal by Subject|1|||
145695615|NCT05041439|525402260|FG000|Overall Study|Death|1|||
145695616|NCT05041439|525402261|FG001|Overall Study|Death|0|||
145695617|NCT02250183|525402262|FG000|Overall Study|Withdrawal by Subject|2|||
145695618|NCT02250183|525402262|FG000|Overall Study|Adverse Event|5|||
145695619|NCT02250183|525402262|FG000|Overall Study|Lost to Follow-up|1|||
145695620|NCT03282799|525402263|FG000|Overall Study|Pregnancy|1|||
145695621|NCT03282799|525402264|FG001|Overall Study|Pregnancy|0|||
145695622|NCT03282799|525402263|FG000|Overall Study|Physician Decision|1|||
145695623|NCT03282799|525402264|FG001|Overall Study|Physician Decision|0|||
145695624|NCT03614676|525404037|FG000|Overall Study|Delivery before planned visit|2|||
145695625|NCT03614676|525404038|FG001|Overall Study|Delivery before planned visit|0|||
145695626|NCT03614676|525404037|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
145695627|NCT03614676|525404038|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
145695628|NCT03614676|525404037|FG000|Overall Study|Migrated / moved from the study area|30|||
145695629|NCT03614676|525404038|FG001|Overall Study|Migrated / moved from the study area|22|||
145695630|NCT03614676|525404037|FG000|Overall Study|Lost to Follow-up|17|||
145695631|NCT03614676|525404038|FG001|Overall Study|Lost to Follow-up|42|||
145695632|NCT03614676|525404037|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
145695633|NCT03614676|525404038|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
145695634|NCT03614676|525404037|FG000|Overall Study|Other|16|||
145695635|NCT03614676|525404038|FG001|Overall Study|Other|47|||
145695636|NCT03614676|525404037|FG000|Overall Study|Protocol Violation|0|||
145695637|NCT03614676|525404038|FG001|Overall Study|Protocol Violation|2|||
145695638|NCT03614676|525404037|FG000|Overall Study|Neonatal event of interest|0|||
145695639|NCT03614676|525404038|FG001|Overall Study|Neonatal event of interest|6|||
145695640|NCT03614676|525404037|FG000|Overall Study|Death in infant greater than 28 days old|0|||
145695641|NCT03614676|525404038|FG001|Overall Study|Death in infant greater than 28 days old|12|||
145695642|NCT03614676|525404037|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
145695643|NCT03614676|525404038|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
145695644|NCT02080403|525404039|FG000|Overall Study|Adverse Event|5|||
145695645|NCT02080403|525404040|FG001|Overall Study|Adverse Event|1|||
145695646|NCT02080403|525404039|FG000|Overall Study|Death|0|||
145695647|NCT02080403|525404040|FG001|Overall Study|Death|2|||
145695648|NCT02080403|525404039|FG000|Overall Study|Lost to Follow-up|2|||
145695649|NCT02080403|525404040|FG001|Overall Study|Lost to Follow-up|0|||
145695650|NCT02080403|525404039|FG000|Overall Study|Pregnancy|0|||
145695651|NCT02080403|525404040|FG001|Overall Study|Pregnancy|1|||
145695652|NCT02080403|525404039|FG000|Overall Study|Protocol Violation|3|||
145695653|NCT02080403|525404040|FG001|Overall Study|Protocol Violation|7|||
145695654|NCT02080403|525404039|FG000|Overall Study|Withdrawal by Subject|5|||
145695655|NCT02080403|525404040|FG001|Overall Study|Withdrawal by Subject|1|||
145695656|NCT01999972|525404041|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
145695657|NCT01999972|525404042|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
145695658|NCT01999972|525404043|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
145695659|NCT01999972|525404044|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
145695660|NCT01999972|525404045|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
145695661|NCT01999972|525404046|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
145695662|NCT01999972|525404041|FG000|Dose Escalation Part|Death|0|||
145695663|NCT01999972|525404042|FG001|Dose Escalation Part|Death|1|||
145695664|NCT01999972|525404043|FG002|Dose Escalation Part|Death|0|||
145695665|NCT01999972|525404044|FG003|Dose Escalation Part|Death|0|||
145695666|NCT01999972|525404045|FG004|Dose Escalation Part|Death|0|||
145695667|NCT01999972|525404046|FG005|Dose Escalation Part|Death|0|||
145695668|NCT01999972|525404041|FG000|Dose Escalation Part|Enrolled but not treated|0|||
145695669|NCT01999972|525404042|FG001|Dose Escalation Part|Enrolled but not treated|0|||
145695670|NCT01999972|525404043|FG002|Dose Escalation Part|Enrolled but not treated|1|||
145695671|NCT01999972|525404044|FG003|Dose Escalation Part|Enrolled but not treated|1|||
145695672|NCT01999972|525404045|FG004|Dose Escalation Part|Enrolled but not treated|0|||
145695673|NCT01999972|525404046|FG005|Dose Escalation Part|Enrolled but not treated|0|||
145695674|NCT01999972|525404041|FG000|Dose Escalation Part|Disease progression|3|||
145695675|NCT01999972|525404042|FG001|Dose Escalation Part|Disease progression|2|||
145695676|NCT01999972|525404043|FG002|Dose Escalation Part|Disease progression|3|||
145695677|NCT01999972|525404044|FG003|Dose Escalation Part|Disease progression|6|||
145695678|NCT01999972|525404045|FG004|Dose Escalation Part|Disease progression|0|||
145695679|NCT01999972|525404046|FG005|Dose Escalation Part|Disease progression|0|||
145695680|NCT01999972|525404041|FG000|Dose Escalation Part|Adverse Event|0|||
145695681|NCT01999972|525404042|FG001|Dose Escalation Part|Adverse Event|0|||
145695682|NCT01999972|525404043|FG002|Dose Escalation Part|Adverse Event|0|||
145695683|NCT01999972|525404044|FG003|Dose Escalation Part|Adverse Event|2|||
145695684|NCT01999972|525404045|FG004|Dose Escalation Part|Adverse Event|0|||
145695685|NCT01999972|525404046|FG005|Dose Escalation Part|Adverse Event|0|||
145695686|NCT01999972|525404041|FG000|Dose Escalation Part|Global deterioration of health status|1|||
145695687|NCT01999972|525404042|FG001|Dose Escalation Part|Global deterioration of health status|0|||
145695688|NCT01999972|525404043|FG002|Dose Escalation Part|Global deterioration of health status|0|||
145695689|NCT01999972|525404044|FG003|Dose Escalation Part|Global deterioration of health status|1|||
145695690|NCT01999972|525404045|FG004|Dose Escalation Part|Global deterioration of health status|0|||
145695691|NCT01999972|525404046|FG005|Dose Escalation Part|Global deterioration of health status|0|||
145695692|NCT01999972|525404041|FG000|Dose Expansion Part|Death|0|||
145695693|NCT01999972|525404042|FG001|Dose Expansion Part|Death|0|||
145695694|NCT01999972|525404043|FG002|Dose Expansion Part|Death|0|||
145695695|NCT01999972|525404044|FG003|Dose Expansion Part|Death|0|||
145695696|NCT01999972|525404045|FG004|Dose Expansion Part|Death|2|||
145695697|NCT01999972|525404046|FG005|Dose Expansion Part|Death|1|||
145695698|NCT01999972|525404041|FG000|Dose Expansion Part|Disease progression|0|||
145695699|NCT01999972|525404042|FG001|Dose Expansion Part|Disease progression|0|||
145695700|NCT01999972|525404043|FG002|Dose Expansion Part|Disease progression|0|||
145695701|NCT01999972|525404044|FG003|Dose Expansion Part|Disease progression|0|||
145695702|NCT01999972|525404045|FG004|Dose Expansion Part|Disease progression|9|||
145695703|NCT01999972|525404046|FG005|Dose Expansion Part|Disease progression|3|||
145695704|NCT01999972|525404041|FG000|Dose Expansion Part|Sponsor decision|0|||
145695705|NCT01999972|525404042|FG001|Dose Expansion Part|Sponsor decision|0|||
145695706|NCT01999972|525404043|FG002|Dose Expansion Part|Sponsor decision|0|||
145695707|NCT01999972|525404044|FG003|Dose Expansion Part|Sponsor decision|0|||
145695708|NCT01999972|525404045|FG004|Dose Expansion Part|Sponsor decision|1|||
145695709|NCT01999972|525404046|FG005|Dose Expansion Part|Sponsor decision|0|||
145695710|NCT01999972|525404041|FG000|Dose Expansion Part|Adverse Event|0|||
145695711|NCT01999972|525404042|FG001|Dose Expansion Part|Adverse Event|0|||
145695712|NCT01999972|525404043|FG002|Dose Expansion Part|Adverse Event|0|||
145695713|NCT01999972|525404044|FG003|Dose Expansion Part|Adverse Event|0|||
145695714|NCT01999972|525404045|FG004|Dose Expansion Part|Adverse Event|4|||
145695715|NCT01999972|525404046|FG005|Dose Expansion Part|Adverse Event|2|||
145695716|NCT01999972|525404041|FG000|Dose Expansion Part|Participant's non-compliance|0|||
145695717|NCT01999972|525404042|FG001|Dose Expansion Part|Participant's non-compliance|0|||
145695718|NCT01999972|525404043|FG002|Dose Expansion Part|Participant's non-compliance|0|||
145695719|NCT01999972|525404044|FG003|Dose Expansion Part|Participant's non-compliance|0|||
145695720|NCT01999972|525404045|FG004|Dose Expansion Part|Participant's non-compliance|0|||
145695721|NCT01999972|525404046|FG005|Dose Expansion Part|Participant's non-compliance|1|||
145695722|NCT01999972|525404041|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
145695723|NCT01999972|525404042|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
145695724|NCT01999972|525404043|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
145695725|NCT01999972|525404044|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
145695726|NCT01999972|525404045|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
145695727|NCT01999972|525404046|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
145695728|NCT01999972|525404041|FG000|Dose Expansion Part|Changed to standard of care|0|||
145695729|NCT01999972|525404042|FG001|Dose Expansion Part|Changed to standard of care|0|||
145695730|NCT01999972|525404043|FG002|Dose Expansion Part|Changed to standard of care|0|||
145695731|NCT01999972|525404044|FG003|Dose Expansion Part|Changed to standard of care|0|||
145695732|NCT01999972|525404045|FG004|Dose Expansion Part|Changed to standard of care|1|||
145695733|NCT01999972|525404046|FG005|Dose Expansion Part|Changed to standard of care|0|||
145695734|NCT02210208|525404047|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
145695735|NCT02210208|525404047|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
145695736|NCT02210208|525404047|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
145695737|NCT01171183|525404048|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
145695738|NCT01171183|525404049|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
145695739|NCT01171183|525404048|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
145695740|NCT01171183|525404049|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
145695741|NCT01171183|525404048|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
145695742|NCT01171183|525404049|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
145695743|NCT01171183|525404048|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
145695744|NCT01171183|525404049|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
145695745|NCT01171183|525404048|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
145695746|NCT01171183|525404049|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
145695747|NCT01171183|525404048|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
145695748|NCT01171183|525404049|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
145695749|NCT01101334|525404050|FG000|Overall Study|Adverse Event|9|||
145695750|NCT01101334|525404051|FG001|Overall Study|Adverse Event|4|||
145695751|NCT01101334|525404050|FG000|Overall Study|Death|7|||
145695752|NCT01101334|525404051|FG001|Overall Study|Death|1|||
145695753|NCT01101334|525404050|FG000|Overall Study|Withdrawal by Subject|4|||
145695754|NCT01101334|525404051|FG001|Overall Study|Withdrawal by Subject|3|||
145695755|NCT01101334|525404050|FG000|Overall Study|Withdrawal by Sponsor|1|||
145695756|NCT01101334|525404051|FG001|Overall Study|Withdrawal by Sponsor|1|||
145695757|NCT01101334|525404050|FG000|Overall Study|Progressive Disease|22|||
145695758|NCT01101334|525404051|FG001|Overall Study|Progressive Disease|35|||
145695759|NCT01101334|525404050|FG000|Overall Study|Other|2|||
145695760|NCT01101334|525404051|FG001|Overall Study|Other|1|||
145695761|NCT02826798|525404058|FG000|Overall Study|Withdrawal by Subject|0|||
145695762|NCT02826798|525404059|FG001|Overall Study|Withdrawal by Subject|1|||
145695763|NCT02826798|525404060|FG002|Overall Study|Withdrawal by Subject|0|||
145695764|NCT02826798|525404061|FG003|Overall Study|Withdrawal by Subject|1|||
145695765|NCT02826798|525404062|FG004|Overall Study|Withdrawal by Subject|0|||
145695766|NCT02806505|525404063|FG000|Overall Study|Adverse event/intercurrent illness|1|||
145695767|NCT02806505|525404064|FG001|Overall Study|Adverse event/intercurrent illness|3|||
145695768|NCT02806505|525404063|FG000|Overall Study|Death|4|||
145695769|NCT02806505|525404064|FG001|Overall Study|Death|0|||
145695770|NCT02806505|525404063|FG000|Overall Study|Did not cooperate/refused treatment|3|||
145695771|NCT02806505|525404064|FG001|Overall Study|Did not cooperate/refused treatment|3|||
145695772|NCT02806505|525404063|FG000|Overall Study|Failure to return|0|||
145695773|NCT02806505|525404064|FG001|Overall Study|Failure to return|1|||
145695774|NCT02806505|525404063|FG000|Overall Study|Insufficient therapeutic response|2|||
145695775|NCT02806505|525404064|FG001|Overall Study|Insufficient therapeutic response|4|||
145695776|NCT03440047|525404066|FG000|Overall Study|Withdrawal by Subject|2|||
145695777|NCT01181609|525404067|FG000|Overall Study|Adverse Event|1|||
145695778|NCT01181609|525404067|FG000|Overall Study|Withdrawal by Subject|1|||
145695779|NCT01181609|525404067|FG000|Overall Study|Lost to Follow-up|1|||
145695780|NCT01181609|525404067|FG000|Overall Study|Death|50|||
145695781|NCT01722045|525404068|FG000|Overall Study|Adverse Event|8|||
145695782|NCT01722045|525404068|FG000|Overall Study|Death|3|||
145695783|NCT01722045|525404068|FG000|Overall Study|Withdrawal by Subject|8|||
145695784|NCT01722045|525404068|FG000|Overall Study|Lost to Follow-up|4|||
145695785|NCT01722045|525404068|FG000|Overall Study|Protocol Deviation|1|||
145695786|NCT01722045|525404068|FG000|Overall Study|Physician Decision|3|||
145695787|NCT01722045|525404068|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
145695788|NCT00612352|525404069|FG000|Overall Study|Adverse Event|1|||
145695789|NCT00612352|525404070|FG001|Overall Study|Adverse Event|0|||
145695790|NCT00612352|525404069|FG000|Overall Study|Withdrawal by Subject|3|||
145695791|NCT00612352|525404070|FG001|Overall Study|Withdrawal by Subject|5|||
145695792|NCT00612352|525404069|FG000|Overall Study|moved out of state|1|||
145695793|NCT00612352|525404070|FG001|Overall Study|moved out of state|0|||
145695794|NCT00612352|525404069|FG000|Overall Study|didn't return calls/show up on test date|4|||
145695795|NCT00612352|525404070|FG001|Overall Study|didn't return calls/show up on test date|1|||
145695796|NCT02161406|525404071|FG000|Overall Study|Death|2|||
145695797|NCT02161406|525404072|FG001|Overall Study|Death|1|||
145695798|NCT02161406|525404071|FG000|Overall Study|Lost to Follow-up|2|||
145695799|NCT02161406|525404072|FG001|Overall Study|Lost to Follow-up|1|||
145695800|NCT02161406|525404071|FG000|Overall Study|Withdrawal by Subject|2|||
145695801|NCT02161406|525404072|FG001|Overall Study|Withdrawal by Subject|4|||
145695802|NCT02161406|525404071|FG000|Overall Study|investigator withdrew subject|3|||
145695803|NCT02161406|525404072|FG001|Overall Study|investigator withdrew subject|1|||
145695804|NCT02161406|525404071|FG000|Overall Study|Lack of Efficacy|1|||
145695805|NCT02161406|525404072|FG001|Overall Study|Lack of Efficacy|1|||
145695806|NCT02161406|525404071|FG000|Overall Study|relocation|0|||
145695807|NCT02161406|525404072|FG001|Overall Study|relocation|1|||
145695808|NCT04732871|525404075|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
145695809|NCT04732871|525404076|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
145695810|NCT04732871|525404077|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
145695811|NCT04732871|525404075|FG000|Overall Study|Lost to Follow-up|7|||
145695812|NCT04732871|525404076|FG001|Overall Study|Lost to Follow-up|4|||
145695813|NCT04732871|525404077|FG002|Overall Study|Lost to Follow-up|3|||
145695814|NCT04732871|525404075|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
145695815|NCT04732871|525404076|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
145695816|NCT04732871|525404077|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
145695817|NCT04732871|525404075|FG000|Overall Study|Migrated / moved from the study area|5|||
145695818|NCT04732871|525404076|FG001|Overall Study|Migrated / moved from the study area|0|||
145695819|NCT04732871|525404077|FG002|Overall Study|Migrated / moved from the study area|0|||
145695820|NCT04732871|525404075|FG000|Overall Study|Other|1|||
145695821|NCT04732871|525404076|FG001|Overall Study|Other|0|||
145695822|NCT04732871|525404077|FG002|Overall Study|Other|1|||
145491426|NCT00499681|524653803|FG001|Overall Study|disease progression|1|||
145695823|NCT04732871|525404075|FG000|Overall Study|Ongoing|6|||
145695824|NCT04732871|525404076|FG001|Overall Study|Ongoing|0|||
145695825|NCT04732871|525404077|FG002|Overall Study|Ongoing|1|||
145695826|NCT04732871|525404075|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
145695827|NCT04732871|525404076|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
145695828|NCT04732871|525404077|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
145695829|NCT00263211|525404078|FG000|Overall Study|Death|1|||
145695830|NCT00263211|525404079|FG001|Overall Study|Death|0|||
145695831|NCT00263211|525404078|FG000|Overall Study|Withdrawal by Subject|3|||
145695832|NCT00263211|525404079|FG001|Overall Study|Withdrawal by Subject|0|||
145695833|NCT00263211|525404078|FG000|Overall Study|Protocol Violation|1|||
145695834|NCT00263211|525404079|FG001|Overall Study|Protocol Violation|0|||
145695835|NCT00263211|525404078|FG000|Overall Study|Disease Progression|0|||
145695836|NCT00263211|525404079|FG001|Overall Study|Disease Progression|1|||
145695837|NCT02034162|525404080|FG000|Double-blind|Lost to Follow-up|3|||
145695838|NCT02034162|525404081|FG001|Double-blind|Lost to Follow-up|0|||
145695839|NCT02034162|525404082|FG002|Double-blind|Lost to Follow-up|0|||
145695840|NCT02034162|525404080|FG000|Double-blind|Physician Decision|1|||
145695841|NCT02034162|525404081|FG001|Double-blind|Physician Decision|0|||
145695842|NCT02034162|525404082|FG002|Double-blind|Physician Decision|0|||
145695843|NCT02034162|525404080|FG000|Double-blind|Protocol Violation|0|||
145695844|NCT02034162|525404081|FG001|Double-blind|Protocol Violation|1|||
145695845|NCT02034162|525404082|FG002|Double-blind|Protocol Violation|0|||
145695846|NCT02034162|525404080|FG000|Double-blind|Withdrawal by Subject|5|||
145695847|NCT02034162|525404081|FG001|Double-blind|Withdrawal by Subject|7|||
145695848|NCT02034162|525404082|FG002|Double-blind|Withdrawal by Subject|0|||
145695849|NCT00760513|525404083|FG000|Overall Study|Withdrawal by Subject|5|||
145695850|NCT00760513|525404084|FG001|Overall Study|Withdrawal by Subject|7|||
145695851|NCT04606199|525404085|FG000|Overall Study|Withdrawal by Subject|2|||
145695852|NCT03596242|525404086|FG000|Overall Study|Lost to Follow-up|2|||
145695853|NCT03596242|525404087|FG001|Overall Study|Lost to Follow-up|2|||
145695854|NCT03357471|525404088|FG000|Overall Study|Adverse Event|1|||
145695855|NCT03357471|525404089|FG001|Overall Study|Adverse Event|0|||
145695856|NCT03357471|525404088|FG000|Overall Study|Lost to Follow-up|1|||
145695857|NCT03357471|525404089|FG001|Overall Study|Lost to Follow-up|0|||
145695858|NCT03294941|525404090|FG000|Overall Study|Withdrawal by Subject|0|||
145695859|NCT03294941|525404091|FG001|Overall Study|Withdrawal by Subject|2|||
145695860|NCT04629443|525404092|FG000|Overall Study|Adverse Event|2|||
145695861|NCT04629443|525404093|FG001|Overall Study|Adverse Event|1|||
145695862|NCT04629443|525404094|FG002|Overall Study|Adverse Event|2|||
145695863|NCT04629443|525404092|FG000|Overall Study|Progressive Disease|2|||
145695864|NCT04629443|525404093|FG001|Overall Study|Progressive Disease|3|||
145695865|NCT04629443|525404094|FG002|Overall Study|Progressive Disease|3|||
145695866|NCT04629443|525404092|FG000|Overall Study|Physician Decision|1|||
145695867|NCT04629443|525404093|FG001|Overall Study|Physician Decision|3|||
145695868|NCT04629443|525404094|FG002|Overall Study|Physician Decision|0|||
145695869|NCT00916305|525404095|FG000|Overall Study|Lost to Follow-up|21|||
145695870|NCT00916305|525404096|FG001|Overall Study|Lost to Follow-up|27|||
145695871|NCT00916305|525404095|FG000|Overall Study|Withdrawal by Subject|0|||
145695872|NCT00916305|525404096|FG001|Overall Study|Withdrawal by Subject|1|||
145695873|NCT02512861|525404099|FG000|Overall Study|Protocol Violation|3|||
145695874|NCT02512861|525404100|FG001|Overall Study|Protocol Violation|7|||
145695875|NCT02512861|525404099|FG000|Overall Study|Physician Decision|3|||
145695876|NCT02512861|525404100|FG001|Overall Study|Physician Decision|1|||
145695877|NCT02512861|525404099|FG000|Overall Study|Withdrawal by Subject|0|||
145695878|NCT02512861|525404100|FG001|Overall Study|Withdrawal by Subject|1|||
145695879|NCT01585298|525404103|FG000|Overall Study|Study completion was not documented.|1|||
145695880|NCT01585298|525404103|FG000|Overall Study|Protocol deviation|1|||
145695881|NCT01585298|525404103|FG000|Overall Study|Administrative problems|4|||
145695882|NCT01585298|525404103|FG000|Overall Study|Lost to Follow-up|2|||
145695883|NCT01585298|525404103|FG000|Overall Study|Withdrawal by Subject|4|||
145695884|NCT01585298|525404103|FG000|Overall Study|Abnormal test procedure results|1|||
145695885|NCT01585298|525404103|FG000|Overall Study|Adverse Event|24|||
145695886|NCT04545476|525404104|FG000|Overall Study|Lost to Follow-up|1|||
145695887|NCT04545476|525404105|FG001|Overall Study|Lost to Follow-up|1|||
145695888|NCT04545476|525404106|FG002|Overall Study|Lost to Follow-up|0|||
145695889|NCT04545476|525404107|FG003|Overall Study|Lost to Follow-up|0|||
145695890|NCT04035577|525404121|FG000|Overall Study|Lost to Follow-up|1|||
145695891|NCT04035577|525404121|FG000|Overall Study|Withdrawal by Subject|1|||
145695892|NCT00505414|525404123|FG000|Titration Phase|Adverse Event|0|||
145695893|NCT00505414|525404124|FG001|Titration Phase|Adverse Event|0|||
145695894|NCT00505414|525404125|FG002|Titration Phase|Adverse Event|0|||
145695895|NCT00505414|525404126|FG003|Titration Phase|Adverse Event|8|||
145695896|NCT00505414|525404127|FG004|Titration Phase|Adverse Event|3|||
145695897|NCT00505414|525404123|FG000|Titration Phase|Death|0|||
145695898|NCT00505414|525404124|FG001|Titration Phase|Death|0|||
145695899|NCT00505414|525404125|FG002|Titration Phase|Death|0|||
145695900|NCT00505414|525404126|FG003|Titration Phase|Death|2|||
145695901|NCT00505414|525404127|FG004|Titration Phase|Death|0|||
145695902|NCT00505414|525404123|FG000|Titration Phase|Lack of Efficacy|0|||
145695903|NCT00505414|525404124|FG001|Titration Phase|Lack of Efficacy|0|||
145695904|NCT00505414|525404125|FG002|Titration Phase|Lack of Efficacy|0|||
145695905|NCT00505414|525404126|FG003|Titration Phase|Lack of Efficacy|10|||
145695906|NCT00505414|525404127|FG004|Titration Phase|Lack of Efficacy|1|||
145695907|NCT00505414|525404123|FG000|Titration Phase|Protocol Violation|0|||
145695908|NCT00505414|525404124|FG001|Titration Phase|Protocol Violation|0|||
145695909|NCT00505414|525404125|FG002|Titration Phase|Protocol Violation|0|||
145695910|NCT00505414|525404126|FG003|Titration Phase|Protocol Violation|0|||
145695911|NCT00505414|525404127|FG004|Titration Phase|Protocol Violation|1|||
145695912|NCT00505414|525404123|FG000|Titration Phase|Withdrawal by Subject|0|||
145695913|NCT00505414|525404124|FG001|Titration Phase|Withdrawal by Subject|0|||
145695914|NCT00505414|525404125|FG002|Titration Phase|Withdrawal by Subject|0|||
145695915|NCT00505414|525404126|FG003|Titration Phase|Withdrawal by Subject|3|||
145695916|NCT00505414|525404127|FG004|Titration Phase|Withdrawal by Subject|4|||
145695917|NCT00505414|525404123|FG000|Titration Phase|Underlying disease and therapy required|0|||
145695918|NCT00505414|525404124|FG001|Titration Phase|Underlying disease and therapy required|0|||
145695919|NCT00505414|525404125|FG002|Titration Phase|Underlying disease and therapy required|0|||
145695920|NCT00505414|525404126|FG003|Titration Phase|Underlying disease and therapy required|7|||
145695921|NCT00505414|525404127|FG004|Titration Phase|Underlying disease and therapy required|3|||
145695922|NCT00505414|525404123|FG000|Maintenance Phase|Adverse Event|2|||
145695923|NCT00505414|525404124|FG001|Maintenance Phase|Adverse Event|2|||
145695924|NCT00505414|525404125|FG002|Maintenance Phase|Adverse Event|3|||
145695925|NCT00505414|525404126|FG003|Maintenance Phase|Adverse Event|0|||
145695926|NCT00505414|525404127|FG004|Maintenance Phase|Adverse Event|0|||
145695927|NCT00505414|525404123|FG000|Maintenance Phase|Death|2|||
145695928|NCT00505414|525404124|FG001|Maintenance Phase|Death|0|||
145695929|NCT00505414|525404125|FG002|Maintenance Phase|Death|1|||
145695930|NCT00505414|525404126|FG003|Maintenance Phase|Death|0|||
145695931|NCT00505414|525404127|FG004|Maintenance Phase|Death|0|||
145695932|NCT00505414|525404123|FG000|Maintenance Phase|Lack of Efficacy|2|||
145695933|NCT00505414|525404124|FG001|Maintenance Phase|Lack of Efficacy|1|||
145695934|NCT00505414|525404125|FG002|Maintenance Phase|Lack of Efficacy|1|||
145695935|NCT00505414|525404126|FG003|Maintenance Phase|Lack of Efficacy|0|||
145695936|NCT00505414|525404127|FG004|Maintenance Phase|Lack of Efficacy|0|||
145695937|NCT00505414|525404123|FG000|Maintenance Phase|Withdrawal by Subject|0|||
145695938|NCT00505414|525404124|FG001|Maintenance Phase|Withdrawal by Subject|0|||
145695939|NCT00505414|525404125|FG002|Maintenance Phase|Withdrawal by Subject|1|||
145695940|NCT00505414|525404126|FG003|Maintenance Phase|Withdrawal by Subject|0|||
145695941|NCT00505414|525404127|FG004|Maintenance Phase|Withdrawal by Subject|0|||
145695942|NCT00505414|525404123|FG000|Maintenance Phase|underlying disease and therapy required|0|||
145695943|NCT00505414|525404124|FG001|Maintenance Phase|underlying disease and therapy required|2|||
145695944|NCT00505414|525404125|FG002|Maintenance Phase|underlying disease and therapy required|2|||
145695945|NCT00505414|525404126|FG003|Maintenance Phase|underlying disease and therapy required|0|||
145695946|NCT00505414|525404127|FG004|Maintenance Phase|underlying disease and therapy required|0|||
145695947|NCT00644878|525404128|FG000|Overall Study|Adverse Event|2|||
145695948|NCT00644878|525404128|FG000|Overall Study|Abnormal laboratory value|3|||
145695949|NCT00644878|525404128|FG000|Overall Study|Protocol deviation|2|||
145695950|NCT00644878|525404128|FG000|Overall Study|Treatment duration completed as per protocol|11|||
145695951|NCT00770588|525404129|FG000|Overall Study|Adverse Event|9|||
145695952|NCT00770588|525404130|FG001|Overall Study|Adverse Event|2|||
145695953|NCT00770588|525404129|FG000|Overall Study|Death caused by progression of disease|70|||
145695954|NCT00770588|525404130|FG001|Overall Study|Death caused by progression of disease|91|||
145695955|NCT00770588|525404129|FG000|Overall Study|Lost to Follow-up|1|||
145695956|NCT00770588|525404130|FG001|Overall Study|Lost to Follow-up|1|||
145695957|NCT00770588|525404129|FG000|Overall Study|Withdrawal by Subject|1|||
145695958|NCT00770588|525404130|FG001|Overall Study|Withdrawal by Subject|1|||
145695959|NCT01841112|525404132|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
145695960|NCT01841112|525404133|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
145695961|NCT01841112|525404134|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
145695962|NCT01841112|525404135|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
145695963|NCT01841112|525404136|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
145695964|NCT00878553|525404137|FG000|Sleep Study|Withdrawal by Subject|2|||
145695965|NCT00878553|525404138|FG001|Sleep Study|Withdrawal by Subject|0|||
145695966|NCT00878553|525404139|FG002|Sleep Study|Withdrawal by Subject|0|||
145695967|NCT00878553|525404140|FG003|Sleep Study|Withdrawal by Subject|0|||
145695968|NCT00878553|525404141|FG004|Sleep Study|Withdrawal by Subject|0|||
145695969|NCT00878553|525404137|FG000|Sleep Study|Lost to Follow-up|1|||
145695970|NCT00878553|525404138|FG001|Sleep Study|Lost to Follow-up|0|||
145695971|NCT00878553|525404139|FG002|Sleep Study|Lost to Follow-up|0|||
145695972|NCT00878553|525404140|FG003|Sleep Study|Lost to Follow-up|0|||
145695973|NCT00878553|525404141|FG004|Sleep Study|Lost to Follow-up|0|||
145695974|NCT00878553|525404137|FG000|Sleep Study|car accident|1|||
145695975|NCT00878553|525404138|FG001|Sleep Study|car accident|0|||
145695976|NCT00878553|525404139|FG002|Sleep Study|car accident|0|||
145695977|NCT00878553|525404140|FG003|Sleep Study|car accident|0|||
145695978|NCT00878553|525404141|FG004|Sleep Study|car accident|0|||
145695979|NCT00878553|525404137|FG000|Sleep Study|family emergency|1|||
145695980|NCT00878553|525404138|FG001|Sleep Study|family emergency|0|||
145695981|NCT00878553|525404139|FG002|Sleep Study|family emergency|0|||
145695982|NCT00878553|525404140|FG003|Sleep Study|family emergency|0|||
145695983|NCT00878553|525404141|FG004|Sleep Study|family emergency|0|||
145695984|NCT00878553|525404137|FG000|PK Study|Withdrawal by Subject|0|||
145695985|NCT00878553|525404138|FG001|PK Study|Withdrawal by Subject|0|||
145695986|NCT00878553|525404139|FG002|PK Study|Withdrawal by Subject|0|||
145695987|NCT00878553|525404140|FG003|PK Study|Withdrawal by Subject|1|||
145695988|NCT00878553|525404141|FG004|PK Study|Withdrawal by Subject|0|||
145695989|NCT02143063|525404142|FG000|Overall Study|Lost to Follow-up|16|||
145695990|NCT02143063|525404143|FG001|Overall Study|Lost to Follow-up|28|||
145695991|NCT02143063|525404144|FG002|Overall Study|Lost to Follow-up|29|||
145695992|NCT02143063|525404142|FG000|Overall Study|Withdrawal by Subject|0|||
145695993|NCT02143063|525404143|FG001|Overall Study|Withdrawal by Subject|1|||
145695994|NCT02143063|525404144|FG002|Overall Study|Withdrawal by Subject|0|||
145695995|NCT02143063|525404142|FG000|Overall Study|Death|0|||
145695996|NCT02143063|525404143|FG001|Overall Study|Death|1|||
145695997|NCT02143063|525404144|FG002|Overall Study|Death|1|||
145695998|NCT00912223|525404145|FG000|Overall Study|Withdrawal by Subject|1|||
145695999|NCT00912223|525404145|FG000|Overall Study|Not transplanted|1|||
145696000|NCT00912223|525404145|FG000|Overall Study|Transformed disease|1|||
145696001|NCT00461123|525404146|FG000|Overall Study|Adverse Event|1|||
145696002|NCT00461123|525404147|FG001|Overall Study|Adverse Event|0|||
145696003|NCT00461123|525404146|FG000|Overall Study|Lost to Follow-up|1|||
145696004|NCT00461123|525404147|FG001|Overall Study|Lost to Follow-up|1|||
145696005|NCT00461123|525404146|FG000|Overall Study|Protocol Violation|3|||
145696006|NCT00461123|525404147|FG001|Overall Study|Protocol Violation|2|||
145696007|NCT00461123|525404146|FG000|Overall Study|Withdrawal by Subject|1|||
145696008|NCT00461123|525404147|FG001|Overall Study|Withdrawal by Subject|3|||
145696009|NCT02604342|525404148|FG000|Overall Study|Death|32|||
145696010|NCT02604342|525404149|FG001|Overall Study|Death|16|||
145696011|NCT02604342|525404148|FG000|Overall Study|Progression of disease|1|||
145696012|NCT02604342|525404149|FG001|Overall Study|Progression of disease|0|||
145696013|NCT02604342|525404148|FG000|Overall Study|Withdrawal by Subject|5|||
145696014|NCT02604342|525404149|FG001|Overall Study|Withdrawal by Subject|6|||
145696015|NCT02604342|525404148|FG000|Overall Study|Other|1|||
145696016|NCT02604342|525404149|FG001|Overall Study|Other|0|||
145696017|NCT02604342|525404148|FG000|Overall Study|Study Termination by Sponsor|1|||
145696018|NCT02604342|525404149|FG001|Overall Study|Study Termination by Sponsor|0|||
145696019|NCT02604342|525404148|FG000|Overall Study|Lost to Follow-up|1|||
145696020|NCT02604342|525404149|FG001|Overall Study|Lost to Follow-up|1|||
145696021|NCT02604342|525404148|FG000|Overall Study|Physician Decision|2|||
145696022|NCT02604342|525404149|FG001|Overall Study|Physician Decision|0|||
145696023|NCT02024750|525404150|FG000|Overall Study|Withdrawal by Subject|2|||
145696024|NCT02024750|525404151|FG001|Overall Study|Withdrawal by Subject|1|||
145696025|NCT02261285|525404152|FG000|Overall Study|Disease progression|0|||
145696026|NCT02261285|525404153|FG001|Overall Study|Disease progression|0|||
145696027|NCT02261285|525404154|FG002|Overall Study|Disease progression|1|||
145696028|NCT01702519|525404155|FG000|Washout Period|Lost to Follow-up|1|||
145696029|NCT01702519|525404156|FG001|Washout Period|Lost to Follow-up|0|||
145696030|NCT01702519|525404155|FG000|Washout Period|Withdrawal by Subject|0|||
145696031|NCT01702519|525404156|FG001|Washout Period|Withdrawal by Subject|2|||
145696032|NCT00746356|525404163|FG000|Overall Study|Withdrawal by Subject|2|||
145696033|NCT00746356|525404164|FG001|Overall Study|Withdrawal by Subject|3|||
145696034|NCT00746356|525404163|FG000|Overall Study|Death|7|||
145696035|NCT00746356|525404164|FG001|Overall Study|Death|3|||
145696036|NCT00746356|525404163|FG000|Overall Study|Lost to Follow-up|1|||
145696037|NCT00746356|525404164|FG001|Overall Study|Lost to Follow-up|0|||
145696038|NCT00746356|525404163|FG000|Overall Study|Removal of Device|0|||
145696039|NCT00746356|525404164|FG001|Overall Study|Removal of Device|1|||
145696040|NCT00746356|525404163|FG000|Overall Study|Patient relocated|1|||
145696041|NCT00746356|525404164|FG001|Overall Study|Patient relocated|0|||
145696042|NCT01263925|525404165|FG000|Overall Study|Protocol Violation|1|||
145696043|NCT01263925|525404166|FG001|Overall Study|Protocol Violation|0|||
145696044|NCT01263925|525404165|FG000|Overall Study|Lack of Efficacy|0|||
145696045|NCT01263925|525404166|FG001|Overall Study|Lack of Efficacy|1|||
145696046|NCT01263925|525404165|FG000|Overall Study|Adverse Event|23|||
145696047|NCT01263925|525404166|FG001|Overall Study|Adverse Event|22|||
145696048|NCT01263925|525404165|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
145696049|NCT01263925|525404166|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
145696050|NCT01263925|525404165|FG000|Overall Study|Withdrawal by Subject|6|||
145696051|NCT01263925|525404166|FG001|Overall Study|Withdrawal by Subject|8|||
145696052|NCT01263925|525404165|FG000|Overall Study|Other|4|||
145696053|NCT01263925|525404166|FG001|Overall Study|Other|4|||
145696054|NCT01263925|525404165|FG000|Overall Study|Lost to Follow-up|3|||
145696055|NCT01263925|525404166|FG001|Overall Study|Lost to Follow-up|1|||
145696056|NCT01263925|525404165|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
145696057|NCT01263925|525404166|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
145696058|NCT01263925|525404165|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
145696059|NCT01263925|525404166|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
145696060|NCT01263925|525404165|FG000|Overall Study|AE/ Withdrawal|1|||
145696061|NCT01263925|525404166|FG001|Overall Study|AE/ Withdrawal|4|||
145696062|NCT01263925|525404165|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
145696063|NCT01263925|525404166|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
145696064|NCT01263925|525404165|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
145696065|NCT01263925|525404166|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
145696066|NCT01263925|525404165|FG000|Overall Study|Withdrawal/ Not specified|0|||
145696067|NCT01263925|525404166|FG001|Overall Study|Withdrawal/ Not specified|1|||
145696068|NCT02484547|525404167|FG000|Placebo-Controlled Period|Adverse Event|10|||
145696069|NCT02484547|525404168|FG001|Placebo-Controlled Period|Adverse Event|13|||
145696070|NCT02484547|525404169|FG002|Placebo-Controlled Period|Adverse Event|20|||
145696071|NCT02484547|525404170|FG003|Placebo-Controlled Period|Adverse Event|0|||
145696072|NCT02484547|525404171|FG004|Placebo-Controlled Period|Adverse Event|0|||
145696073|NCT02484547|525404172|FG005|Placebo-Controlled Period|Adverse Event|0|||
145696074|NCT02484547|525404173|FG006|Placebo-Controlled Period|Adverse Event|0|||
145696075|NCT02484547|525404167|FG000|Placebo-Controlled Period|Change of Treatment|0|||
145696076|NCT02484547|525404168|FG001|Placebo-Controlled Period|Change of Treatment|0|||
145696077|NCT02484547|525404169|FG002|Placebo-Controlled Period|Change of Treatment|1|||
145696078|NCT02484547|525404170|FG003|Placebo-Controlled Period|Change of Treatment|0|||
145696079|NCT02484547|525404171|FG004|Placebo-Controlled Period|Change of Treatment|0|||
145696080|NCT02484547|525404172|FG005|Placebo-Controlled Period|Change of Treatment|0|||
145696081|NCT02484547|525404173|FG006|Placebo-Controlled Period|Change of Treatment|0|||
145696082|NCT02484547|525404167|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
145696083|NCT02484547|525404168|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
145696084|NCT02484547|525404169|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
145696085|NCT02484547|525404170|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
145696086|NCT02484547|525404171|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
145696087|NCT02484547|525404172|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
145696088|NCT02484547|525404173|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
145696089|NCT02484547|525404167|FG000|Placebo-Controlled Period|Death|5|||
145696090|NCT02484547|525404168|FG001|Placebo-Controlled Period|Death|0|||
145696091|NCT02484547|525404169|FG002|Placebo-Controlled Period|Death|6|||
145696092|NCT02484547|525404170|FG003|Placebo-Controlled Period|Death|0|||
145696093|NCT02484547|525404171|FG004|Placebo-Controlled Period|Death|0|||
145696094|NCT02484547|525404172|FG005|Placebo-Controlled Period|Death|0|||
145696095|NCT02484547|525404173|FG006|Placebo-Controlled Period|Death|0|||
145696096|NCT02484547|525404167|FG000|Placebo-Controlled Period|Disease Progression|2|||
145696097|NCT02484547|525404168|FG001|Placebo-Controlled Period|Disease Progression|0|||
145696098|NCT02484547|525404169|FG002|Placebo-Controlled Period|Disease Progression|1|||
145696099|NCT02484547|525404170|FG003|Placebo-Controlled Period|Disease Progression|0|||
145696100|NCT02484547|525404171|FG004|Placebo-Controlled Period|Disease Progression|0|||
145696101|NCT02484547|525404172|FG005|Placebo-Controlled Period|Disease Progression|0|||
145696102|NCT02484547|525404173|FG006|Placebo-Controlled Period|Disease Progression|0|||
145696103|NCT02484547|525404167|FG000|Placebo-Controlled Period|Investigator Decision|2|||
145696104|NCT02484547|525404168|FG001|Placebo-Controlled Period|Investigator Decision|2|||
145696105|NCT02484547|525404169|FG002|Placebo-Controlled Period|Investigator Decision|5|||
145696106|NCT02484547|525404170|FG003|Placebo-Controlled Period|Investigator Decision|0|||
145696107|NCT02484547|525404171|FG004|Placebo-Controlled Period|Investigator Decision|0|||
145696108|NCT02484547|525404172|FG005|Placebo-Controlled Period|Investigator Decision|0|||
145696109|NCT02484547|525404173|FG006|Placebo-Controlled Period|Investigator Decision|0|||
145696110|NCT02484547|525404167|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
145696111|NCT02484547|525404168|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
145696112|NCT02484547|525404169|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
145696113|NCT02484547|525404170|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
145696114|NCT02484547|525404171|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
145696115|NCT02484547|525404172|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
145696116|NCT02484547|525404173|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
145696117|NCT02484547|525404167|FG000|Placebo-Controlled Period|Relocation|1|||
145696118|NCT02484547|525404168|FG001|Placebo-Controlled Period|Relocation|1|||
145696119|NCT02484547|525404169|FG002|Placebo-Controlled Period|Relocation|1|||
145696120|NCT02484547|525404170|FG003|Placebo-Controlled Period|Relocation|0|||
145696121|NCT02484547|525404171|FG004|Placebo-Controlled Period|Relocation|0|||
145696122|NCT02484547|525404172|FG005|Placebo-Controlled Period|Relocation|0|||
145696123|NCT02484547|525404173|FG006|Placebo-Controlled Period|Relocation|0|||
145696124|NCT02484547|525404167|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
145696125|NCT02484547|525404168|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
145696126|NCT02484547|525404169|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
145696127|NCT02484547|525404170|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
145696128|NCT02484547|525404171|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
145696129|NCT02484547|525404172|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
145696130|NCT02484547|525404173|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
145696131|NCT02484547|525404167|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
145696132|NCT02484547|525404168|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
145696133|NCT02484547|525404169|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
145696134|NCT02484547|525404170|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145696135|NCT02484547|525404171|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145696136|NCT02484547|525404172|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145696137|NCT02484547|525404173|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
145696138|NCT02484547|525404167|FG000|Placebo-Controlled Period|Reason not Specified|216|||
145696139|NCT02484547|525404168|FG001|Placebo-Controlled Period|Reason not Specified|194|||
145696140|NCT02484547|525404169|FG002|Placebo-Controlled Period|Reason not Specified|183|||
145696141|NCT02484547|525404170|FG003|Placebo-Controlled Period|Reason not Specified|0|||
145696142|NCT02484547|525404171|FG004|Placebo-Controlled Period|Reason not Specified|0|||
145696143|NCT02484547|525404172|FG005|Placebo-Controlled Period|Reason not Specified|0|||
145696144|NCT02484547|525404173|FG006|Placebo-Controlled Period|Reason not Specified|0|||
145696145|NCT02484547|525404167|FG000|Long-Term Extension Period|Adverse Event|0|||
145696146|NCT02484547|525404168|FG001|Long-Term Extension Period|Adverse Event|0|||
145696147|NCT02484547|525404169|FG002|Long-Term Extension Period|Adverse Event|0|||
145696148|NCT02484547|525404170|FG003|Long-Term Extension Period|Adverse Event|0|||
145696149|NCT02484547|525404171|FG004|Long-Term Extension Period|Adverse Event|1|||
145696150|NCT02484547|525404172|FG005|Long-Term Extension Period|Adverse Event|3|||
145696151|NCT02484547|525404173|FG006|Long-Term Extension Period|Adverse Event|2|||
145696152|NCT02484547|525404167|FG000|Long-Term Extension Period|Death|0|||
145696153|NCT02484547|525404168|FG001|Long-Term Extension Period|Death|0|||
145696154|NCT02484547|525404169|FG002|Long-Term Extension Period|Death|0|||
145696155|NCT02484547|525404170|FG003|Long-Term Extension Period|Death|0|||
145696156|NCT02484547|525404171|FG004|Long-Term Extension Period|Death|0|||
145696157|NCT02484547|525404172|FG005|Long-Term Extension Period|Death|3|||
145696158|NCT02484547|525404173|FG006|Long-Term Extension Period|Death|0|||
145696159|NCT02484547|525404167|FG000|Long-Term Extension Period|Disease Progression|0|||
145696160|NCT02484547|525404168|FG001|Long-Term Extension Period|Disease Progression|0|||
145696161|NCT02484547|525404169|FG002|Long-Term Extension Period|Disease Progression|0|||
145696162|NCT02484547|525404170|FG003|Long-Term Extension Period|Disease Progression|0|||
145696163|NCT02484547|525404171|FG004|Long-Term Extension Period|Disease Progression|2|||
145696164|NCT02484547|525404172|FG005|Long-Term Extension Period|Disease Progression|4|||
145696165|NCT02484547|525404173|FG006|Long-Term Extension Period|Disease Progression|0|||
145696166|NCT02484547|525404167|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
145696167|NCT02484547|525404168|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
145696168|NCT02484547|525404169|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
145696169|NCT02484547|525404170|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
145696170|NCT02484547|525404171|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
145696171|NCT02484547|525404172|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
145696172|NCT02484547|525404173|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
145696173|NCT02484547|525404167|FG000|Long-Term Extension Period|Loss of Capacity|0|||
145696174|NCT02484547|525404168|FG001|Long-Term Extension Period|Loss of Capacity|0|||
145696175|NCT02484547|525404169|FG002|Long-Term Extension Period|Loss of Capacity|0|||
145696176|NCT02484547|525404170|FG003|Long-Term Extension Period|Loss of Capacity|0|||
145696177|NCT02484547|525404171|FG004|Long-Term Extension Period|Loss of Capacity|1|||
145696178|NCT02484547|525404172|FG005|Long-Term Extension Period|Loss of Capacity|0|||
145696179|NCT02484547|525404173|FG006|Long-Term Extension Period|Loss of Capacity|0|||
145696180|NCT02484547|525404167|FG000|Long-Term Extension Period|Change of Treatment|0|||
145696181|NCT02484547|525404168|FG001|Long-Term Extension Period|Change of Treatment|0|||
145696182|NCT02484547|525404169|FG002|Long-Term Extension Period|Change of Treatment|0|||
145696183|NCT02484547|525404170|FG003|Long-Term Extension Period|Change of Treatment|0|||
145696184|NCT02484547|525404171|FG004|Long-Term Extension Period|Change of Treatment|0|||
145696185|NCT02484547|525404172|FG005|Long-Term Extension Period|Change of Treatment|0|||
145696186|NCT02484547|525404173|FG006|Long-Term Extension Period|Change of Treatment|1|||
145696187|NCT02484547|525404167|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
145696188|NCT02484547|525404168|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
145696189|NCT02484547|525404169|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
145696190|NCT02484547|525404170|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
145696191|NCT02484547|525404171|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
145696192|NCT02484547|525404172|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
145696193|NCT02484547|525404173|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
145696194|NCT02484547|525404167|FG000|Long-Term Extension Period|Investigator Decision|0|||
145696195|NCT02484547|525404168|FG001|Long-Term Extension Period|Investigator Decision|0|||
145696196|NCT02484547|525404169|FG002|Long-Term Extension Period|Investigator Decision|0|||
145696197|NCT02484547|525404170|FG003|Long-Term Extension Period|Investigator Decision|2|||
145696198|NCT02484547|525404171|FG004|Long-Term Extension Period|Investigator Decision|1|||
145696199|NCT02484547|525404172|FG005|Long-Term Extension Period|Investigator Decision|0|||
145696200|NCT02484547|525404173|FG006|Long-Term Extension Period|Investigator Decision|1|||
145696201|NCT02484547|525404167|FG000|Long-Term Extension Period|Relocation|0|||
145696202|NCT02484547|525404168|FG001|Long-Term Extension Period|Relocation|0|||
145696203|NCT02484547|525404169|FG002|Long-Term Extension Period|Relocation|0|||
145696204|NCT02484547|525404170|FG003|Long-Term Extension Period|Relocation|1|||
145696205|NCT02484547|525404171|FG004|Long-Term Extension Period|Relocation|1|||
145696206|NCT02484547|525404172|FG005|Long-Term Extension Period|Relocation|0|||
145696207|NCT02484547|525404173|FG006|Long-Term Extension Period|Relocation|0|||
145696208|NCT02484547|525404167|FG000|Long-Term Extension Period|Study Visit Burden|0|||
145696209|NCT02484547|525404168|FG001|Long-Term Extension Period|Study Visit Burden|0|||
145696210|NCT02484547|525404169|FG002|Long-Term Extension Period|Study Visit Burden|0|||
145696211|NCT02484547|525404170|FG003|Long-Term Extension Period|Study Visit Burden|2|||
145696212|NCT02484547|525404171|FG004|Long-Term Extension Period|Study Visit Burden|0|||
145696213|NCT02484547|525404172|FG005|Long-Term Extension Period|Study Visit Burden|0|||
145696214|NCT02484547|525404173|FG006|Long-Term Extension Period|Study Visit Burden|3|||
145696215|NCT02484547|525404167|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
145696216|NCT02484547|525404168|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
145696217|NCT02484547|525404169|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
145696218|NCT02484547|525404170|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
145696219|NCT02484547|525404171|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
145696220|NCT02484547|525404172|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
145696221|NCT02484547|525404173|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
145696222|NCT02484547|525404167|FG000|Long-Term Extension Period|Reason not Specified|0|||
145696223|NCT02484547|525404168|FG001|Long-Term Extension Period|Reason not Specified|0|||
145696224|NCT02484547|525404169|FG002|Long-Term Extension Period|Reason not Specified|0|||
145696225|NCT02484547|525404170|FG003|Long-Term Extension Period|Reason not Specified|119|||
145696226|NCT02484547|525404171|FG004|Long-Term Extension Period|Reason not Specified|117|||
145696227|NCT02484547|525404172|FG005|Long-Term Extension Period|Reason not Specified|223|||
145696228|NCT02484547|525404173|FG006|Long-Term Extension Period|Reason not Specified|231|||
145696229|NCT01665599|525404174|FG000|Overall Study|Adverse Event|1|||
145696230|NCT01665599|525404174|FG000|Overall Study|Consent Withdrawn|1|||
145696231|NCT01665599|525404174|FG000|Overall Study|Investigator/Sponsor decision|1|||
145696232|NCT01665599|525404174|FG000|Overall Study|Death|1|||
145696233|NCT01665599|525404174|FG000|Overall Study|Lost to Follow-up|2|||
145696234|NCT01665599|525404174|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
145696235|NCT01665599|525404174|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
145696236|NCT04088136|525404177|FG000|Overall Study|Withdrawal by Subject|5|||
145696237|NCT04088136|525404178|FG001|Overall Study|Withdrawal by Subject|0|||
145696238|NCT04088136|525404177|FG000|Overall Study|Lack of Efficacy|0|||
145696239|NCT04088136|525404178|FG001|Overall Study|Lack of Efficacy|1|||
145696240|NCT01494298|525404179|FG000|Overall Study|Protocol Violation|2|||
145696241|NCT01494298|525404180|FG001|Overall Study|Protocol Violation|8|||
145696242|NCT04159805|525404181|FG000|Overall Study|Withdrawal by Subject|0|||
145696243|NCT04159805|525404182|FG001|Overall Study|Withdrawal by Subject|2|||
145696244|NCT04159805|525404183|FG002|Overall Study|Withdrawal by Subject|2|||
145696245|NCT01393613|525404184|FG000|Overall Study|Adverse Event|11|||
145696246|NCT01393613|525404185|FG001|Overall Study|Adverse Event|11|||
145696247|NCT01393613|525404186|FG002|Overall Study|Adverse Event|13|||
145696248|NCT01393613|525404187|FG003|Overall Study|Adverse Event|22|||
145696249|NCT01393613|525404184|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
145696250|NCT01393613|525404185|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
145696251|NCT01393613|525404186|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
145696252|NCT01393613|525404187|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
145696253|NCT01393613|525404184|FG000|Overall Study|Physician Decision|2|||
145696254|NCT01393613|525404185|FG001|Overall Study|Physician Decision|0|||
145696255|NCT01393613|525404186|FG002|Overall Study|Physician Decision|0|||
145696256|NCT01393613|525404187|FG003|Overall Study|Physician Decision|1|||
145696257|NCT01393613|525404184|FG000|Overall Study|Withdrawal by Subject|15|||
145696258|NCT01393613|525404185|FG001|Overall Study|Withdrawal by Subject|25|||
145696259|NCT01393613|525404186|FG002|Overall Study|Withdrawal by Subject|23|||
145696260|NCT01393613|525404187|FG003|Overall Study|Withdrawal by Subject|21|||
145696261|NCT01393613|525404184|FG000|Overall Study|Protocol Deviation|2|||
145696262|NCT01393613|525404185|FG001|Overall Study|Protocol Deviation|1|||
145696263|NCT01393613|525404186|FG002|Overall Study|Protocol Deviation|0|||
145696264|NCT01393613|525404187|FG003|Overall Study|Protocol Deviation|0|||
145696265|NCT01393613|525404184|FG000|Overall Study|Lack of Efficacy|9|||
145696266|NCT01393613|525404185|FG001|Overall Study|Lack of Efficacy|20|||
145696267|NCT01393613|525404186|FG002|Overall Study|Lack of Efficacy|16|||
145696268|NCT01393613|525404187|FG003|Overall Study|Lack of Efficacy|21|||
145696269|NCT00702520|525404190|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
145696270|NCT00702520|525404191|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
145696271|NCT00702520|525404192|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
145696272|NCT00702520|525404193|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
145696273|NCT00702520|525404190|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
145696274|NCT00702520|525404191|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
145696275|NCT00702520|525404192|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
145696276|NCT00702520|525404193|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
145696277|NCT00702520|525404190|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
145696278|NCT00702520|525404191|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
145696279|NCT00702520|525404192|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
145696280|NCT00702520|525404193|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
145696281|NCT00942188|525404194|FG000|Overall Study|Adverse Event|0|||
145696282|NCT00942188|525404195|FG001|Overall Study|Adverse Event|3|||
145696283|NCT00942188|525404196|FG002|Overall Study|Adverse Event|2|||
145696284|NCT00942188|525404197|FG003|Overall Study|Adverse Event|0|||
145696285|NCT00942188|525404194|FG000|Overall Study|Lack of Efficacy|0|||
145696286|NCT00942188|525404195|FG001|Overall Study|Lack of Efficacy|0|||
145696287|NCT00942188|525404196|FG002|Overall Study|Lack of Efficacy|0|||
145696288|NCT00942188|525404197|FG003|Overall Study|Lack of Efficacy|1|||
145696289|NCT00942188|525404194|FG000|Overall Study|Protocol Violation|1|||
145696290|NCT00942188|525404195|FG001|Overall Study|Protocol Violation|1|||
145696291|NCT00942188|525404196|FG002|Overall Study|Protocol Violation|0|||
145696292|NCT00942188|525404197|FG003|Overall Study|Protocol Violation|0|||
145696293|NCT00942188|525404194|FG000|Overall Study|Lost to Follow-up|2|||
145696294|NCT00942188|525404195|FG001|Overall Study|Lost to Follow-up|1|||
145696295|NCT00942188|525404196|FG002|Overall Study|Lost to Follow-up|2|||
145696296|NCT00942188|525404197|FG003|Overall Study|Lost to Follow-up|0|||
145696297|NCT00942188|525404194|FG000|Overall Study|Withdrawal by Subject|1|||
145696298|NCT00942188|525404195|FG001|Overall Study|Withdrawal by Subject|3|||
145696299|NCT00942188|525404196|FG002|Overall Study|Withdrawal by Subject|4|||
145696300|NCT00942188|525404197|FG003|Overall Study|Withdrawal by Subject|2|||
145696301|NCT00942188|525404194|FG000|Overall Study|Physician Decision|0|||
145696302|NCT00942188|525404195|FG001|Overall Study|Physician Decision|0|||
145696303|NCT00942188|525404196|FG002|Overall Study|Physician Decision|1|||
145696304|NCT00942188|525404197|FG003|Overall Study|Physician Decision|0|||
145696305|NCT00942188|525404194|FG000|Overall Study|Sponsor Decision|0|||
145696306|NCT00942188|525404195|FG001|Overall Study|Sponsor Decision|2|||
145696307|NCT00942188|525404196|FG002|Overall Study|Sponsor Decision|0|||
145696308|NCT00942188|525404197|FG003|Overall Study|Sponsor Decision|1|||
145696309|NCT02473913|525404199|FG000|Overall Study|Lost to Follow-up|3|||
145696310|NCT02473913|525404200|FG001|Overall Study|Lost to Follow-up|3|||
145696311|NCT03458728|525405827|FG000|Overall Study|Adverse Event|1|||
145696312|NCT03458728|525405828|FG001|Overall Study|Adverse Event|0|||
145696313|NCT03458728|525405827|FG000|Overall Study|Physician Decision|1|||
145696314|NCT03458728|525405828|FG001|Overall Study|Physician Decision|0|||
145696315|NCT03458728|525405827|FG000|Overall Study|Progressive disease - clinical assessment|1|||
145696316|NCT03458728|525405828|FG001|Overall Study|Progressive disease - clinical assessment|0|||
145696317|NCT03458728|525405827|FG000|Overall Study|Progressive disease - radiological progression|21|||
145696318|NCT03458728|525405828|FG001|Overall Study|Progressive disease - radiological progression|6|||
145696319|NCT03458728|525405827|FG000|Overall Study|Withdrawal by Subject|0|||
145696320|NCT03458728|525405828|FG001|Overall Study|Withdrawal by Subject|1|||
145696321|NCT00908349|525405834|FG000|Overall Study|Adverse Event|10|||
145696322|NCT00908349|525405834|FG000|Overall Study|Withdrawal by Subject|9|||
145696323|NCT00908349|525405834|FG000|Overall Study|Physician Decision|5|||
145696324|NCT00908349|525405834|FG000|Overall Study|Lost to Follow-up|5|||
145696325|NCT00908349|525405834|FG000|Overall Study|Various|6|||
145696326|NCT00511836|525405840|FG000|Double-blind Period|Lost to Follow-up|1|||
145696327|NCT00511836|525405841|FG001|Double-blind Period|Lost to Follow-up|0|||
145696328|NCT01755546|525405842|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
145696329|NCT01755546|525405842|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
145696330|NCT01755546|525405842|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
145696331|NCT01755546|525405842|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
145696332|NCT01755546|525405842|FG000|Titration Phase|Adverse Event|11|||
145696333|NCT01755546|525405842|FG000|Titration Phase|Lack of Efficacy|18|||
145696334|NCT01755546|525405842|FG000|Titration Phase|Protocol Violation|9|||
145696335|NCT01755546|525405842|FG000|Titration Phase|Lost to Follow-up|2|||
145696336|NCT01755546|525405842|FG000|Titration Phase|Other and Continuing|22|||
145696337|NCT01755546|525405842|FG000|Titration Phase|Withdrawal by Subject|8|||
145696338|NCT01755546|525405842|FG000|Long Term Treatment|Adverse Event|12|||
145696339|NCT01755546|525405842|FG000|Long Term Treatment|Lack of Efficacy|6|||
145696340|NCT01755546|525405842|FG000|Long Term Treatment|Protocol Violation|10|||
145696341|NCT01755546|525405842|FG000|Long Term Treatment|Withdrawal by Subject|35|||
145265480|NCT01298323|523819370|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
145696342|NCT01755546|525405842|FG000|Long Term Treatment|Lost to Follow-up|17|||
145696343|NCT01755546|525405842|FG000|Long Term Treatment|other and ongoing|41|||
145696344|NCT00891046|525405847|FG000|Overall Study|Protocol Violation|1|||
145696345|NCT00891046|525405848|FG001|Overall Study|Protocol Violation|1|||
145696346|NCT00891046|525405849|FG002|Overall Study|Protocol Violation|0|||
145696347|NCT00891046|525405850|FG003|Overall Study|Protocol Violation|0|||
145696348|NCT00891046|525405851|FG004|Overall Study|Protocol Violation|1|||
145696349|NCT00891046|525405847|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
145696350|NCT00891046|525405848|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
145696351|NCT00891046|525405849|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
145696352|NCT00891046|525405850|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
145696353|NCT00891046|525405851|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
145696354|NCT00891046|525405847|FG000|Overall Study|Administrative problems|0|||
145696355|NCT00891046|525405848|FG001|Overall Study|Administrative problems|0|||
145696356|NCT00891046|525405849|FG002|Overall Study|Administrative problems|0|||
145696357|NCT00891046|525405850|FG003|Overall Study|Administrative problems|0|||
145696358|NCT00891046|525405851|FG004|Overall Study|Administrative problems|1|||
145696359|NCT00891046|525405847|FG000|Overall Study|Participant no longer required drug|0|||
145696360|NCT00891046|525405848|FG001|Overall Study|Participant no longer required drug|2|||
145696361|NCT00891046|525405849|FG002|Overall Study|Participant no longer required drug|0|||
145696362|NCT00891046|525405850|FG003|Overall Study|Participant no longer required drug|0|||
145696363|NCT00891046|525405851|FG004|Overall Study|Participant no longer required drug|1|||
145696364|NCT00891046|525405847|FG000|Overall Study|Adverse Event|4|||
145696365|NCT00891046|525405848|FG001|Overall Study|Adverse Event|3|||
145696366|NCT00891046|525405849|FG002|Overall Study|Adverse Event|2|||
145696367|NCT00891046|525405850|FG003|Overall Study|Adverse Event|0|||
145696368|NCT00891046|525405851|FG004|Overall Study|Adverse Event|14|||
145696369|NCT00891046|525405847|FG000|Overall Study|Withdrawal by Subject|2|||
145696370|NCT00891046|525405848|FG001|Overall Study|Withdrawal by Subject|1|||
145696371|NCT00891046|525405849|FG002|Overall Study|Withdrawal by Subject|2|||
145696372|NCT00891046|525405850|FG003|Overall Study|Withdrawal by Subject|1|||
145696373|NCT00891046|525405851|FG004|Overall Study|Withdrawal by Subject|1|||
145696374|NCT00891046|525405847|FG000|Overall Study|Lost to Follow-up|0|||
145696375|NCT00891046|525405848|FG001|Overall Study|Lost to Follow-up|0|||
145696376|NCT00891046|525405849|FG002|Overall Study|Lost to Follow-up|0|||
145696377|NCT00891046|525405850|FG003|Overall Study|Lost to Follow-up|0|||
145696378|NCT00891046|525405851|FG004|Overall Study|Lost to Follow-up|1|||
145696379|NCT04333147|525405852|FG000|Overall Study|Adverse Event|43|||
145696380|NCT04333147|525405853|FG001|Overall Study|Adverse Event|40|||
145696381|NCT04333147|525405852|FG000|Overall Study|Lack of Efficacy|49|||
145696382|NCT04333147|525405853|FG001|Overall Study|Lack of Efficacy|48|||
145696383|NCT04333147|525405852|FG000|Overall Study|Lost to Follow-up|19|||
145696384|NCT04333147|525405853|FG001|Overall Study|Lost to Follow-up|16|||
145696385|NCT04333147|525405852|FG000|Overall Study|Physician Decision|17|||
145696386|NCT04333147|525405853|FG001|Overall Study|Physician Decision|20|||
145696387|NCT04333147|525405852|FG000|Overall Study|Withdrawal by Subject|65|||
145696388|NCT04333147|525405853|FG001|Overall Study|Withdrawal by Subject|68|||
145696389|NCT04333147|525405852|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
145696390|NCT04333147|525405853|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
145696391|NCT04333147|525405852|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
145696392|NCT04333147|525405853|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
145696393|NCT04333147|525405852|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
145696394|NCT04333147|525405853|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
145696395|NCT00362375|525405854|FG000|Overall Study|Lost to Follow-up|40|||
145696396|NCT00362375|525405855|FG001|Overall Study|Lost to Follow-up|35|||
145696397|NCT04984239|525405856|FG000|Overall Study|Lost to Follow-up|1|||
145696398|NCT01114139|525405859|FG000|Overall Study|Adverse Event|3|||
145696399|NCT01114139|525405860|FG001|Overall Study|Adverse Event|2|||
145696400|NCT01114139|525405859|FG000|Overall Study|Lost to Follow-up|15|||
145696401|NCT01114139|525405860|FG001|Overall Study|Lost to Follow-up|3|||
145696402|NCT01114139|525405859|FG000|Overall Study|Withdrawal by Subject|17|||
145696403|NCT01114139|525405860|FG001|Overall Study|Withdrawal by Subject|6|||
145696404|NCT01114139|525405859|FG000|Overall Study|Other-Missed 1 visit|1|||
145696405|NCT01114139|525405860|FG001|Overall Study|Other-Missed 1 visit|0|||
145696406|NCT01114139|525405859|FG000|Overall Study|Other-Protocol Violation|1|||
145696407|NCT01114139|525405860|FG001|Overall Study|Other-Protocol Violation|0|||
145696408|NCT01114139|525405859|FG000|Overall Study|Other-Out of window for study drug dose|1|||
145696409|NCT01114139|525405860|FG001|Overall Study|Other-Out of window for study drug dose|0|||
145696410|NCT01114139|525405859|FG000|Overall Study|Other-Participant falsified records|0|||
145696411|NCT01114139|525405860|FG001|Overall Study|Other-Participant falsified records|1|||
145696412|NCT01114139|525405859|FG000|Overall Study|Other-Participant went on hospice|0|||
145696413|NCT01114139|525405860|FG001|Overall Study|Other-Participant went on hospice|1|||
145696414|NCT01114139|525405859|FG000|Overall Study|Other-Physician changed treatment|1|||
145696415|NCT01114139|525405860|FG001|Overall Study|Other-Physician changed treatment|0|||
145696416|NCT01114139|525405859|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
145696417|NCT01114139|525405860|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
145696418|NCT02536742|525405862|FG000|Overall Study|Did not start protocol therapy|1|||
145696419|NCT02536742|525405862|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
145696420|NCT00706914|525405863|FG000|Overall Study|Lack of Efficacy|0|||
145696421|NCT00706914|525405864|FG001|Overall Study|Lack of Efficacy|1|||
145696422|NCT00706914|525405865|FG002|Overall Study|Lack of Efficacy|0|||
145696423|NCT00706914|525405863|FG000|Overall Study|Lost to Follow-up|1|||
145696424|NCT00706914|525405864|FG001|Overall Study|Lost to Follow-up|0|||
145696425|NCT00706914|525405865|FG002|Overall Study|Lost to Follow-up|0|||
145696426|NCT00706914|525405863|FG000|Overall Study|Adverse Event|2|||
145696427|NCT00706914|525405864|FG001|Overall Study|Adverse Event|2|||
145696428|NCT00706914|525405865|FG002|Overall Study|Adverse Event|0|||
145696429|NCT00706914|525405863|FG000|Overall Study|Protocol Violation|3|||
145696430|NCT00706914|525405864|FG001|Overall Study|Protocol Violation|1|||
145696431|NCT00706914|525405865|FG002|Overall Study|Protocol Violation|1|||
145696432|NCT00858247|525405872|FG000|Baseline Assessment|Withdrawal by Subject|1|||
145696433|NCT00858247|525405873|FG001|Baseline Assessment|Withdrawal by Subject|1|||
145696434|NCT00858247|525405872|FG000|Baseline Assessment|Poor IV access|1|||
145696435|NCT00858247|525405873|FG001|Baseline Assessment|Poor IV access|0|||
145696436|NCT00858247|525405872|FG000|Baseline Assessment|Protocol Violation|0|||
145696437|NCT00858247|525405873|FG001|Baseline Assessment|Protocol Violation|1|||
145696438|NCT00858247|525405872|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
145696439|NCT00858247|525405873|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
145696440|NCT01172639|525405874|FG000|Overall Study|Death|1|||
145696441|NCT01172639|525405875|FG001|Overall Study|Death|1|||
145696442|NCT01172639|525405876|FG002|Overall Study|Death|0|||
145696443|NCT01172639|525405877|FG003|Overall Study|Death|0|||
145696444|NCT01172639|525405878|FG004|Overall Study|Death|0|||
145696445|NCT01172639|525405874|FG000|Overall Study|Lost to Follow-up|9|||
145696446|NCT01172639|525405875|FG001|Overall Study|Lost to Follow-up|7|||
145696447|NCT01172639|525405876|FG002|Overall Study|Lost to Follow-up|11|||
145696448|NCT01172639|525405877|FG003|Overall Study|Lost to Follow-up|6|||
145696449|NCT01172639|525405878|FG004|Overall Study|Lost to Follow-up|6|||
145696450|NCT01172639|525405874|FG000|Overall Study|Withdrawal by Subject|3|||
145696451|NCT01172639|525405875|FG001|Overall Study|Withdrawal by Subject|3|||
145696452|NCT01172639|525405876|FG002|Overall Study|Withdrawal by Subject|5|||
145696453|NCT01172639|525405877|FG003|Overall Study|Withdrawal by Subject|5|||
145696454|NCT01172639|525405878|FG004|Overall Study|Withdrawal by Subject|0|||
145696455|NCT02447432|525405879|FG000|Epoch 001|Adverse Event|1|||
145696456|NCT02447432|525405880|FG001|Epoch 001|Adverse Event|1|||
145696457|NCT02447432|525405879|FG000|Epoch 001|Withdrawal by Subject|0|||
145696458|NCT02447432|525405880|FG001|Epoch 001|Withdrawal by Subject|4|||
145696459|NCT02447432|525405879|FG000|Epoch 001|Migrated/moved from study area|3|||
145696460|NCT02447432|525405880|FG001|Epoch 001|Migrated/moved from study area|5|||
145696461|NCT02447432|525405879|FG000|Epoch 001|Lost to Follow-up|1|||
145696462|NCT02447432|525405880|FG001|Epoch 001|Lost to Follow-up|3|||
145696463|NCT01898442|525405881|FG000|Overall Study|Hemolysis/technical problems|1|||
145696464|NCT01898442|525405882|FG001|Overall Study|Hemolysis/technical problems|2|||
145696465|NCT01898442|525405883|FG002|Overall Study|Hemolysis/technical problems|2|||
145696466|NCT01898442|525405881|FG000|Overall Study|Patient vomited pills|0|||
145696467|NCT01898442|525405882|FG001|Overall Study|Patient vomited pills|0|||
145696468|NCT01898442|525405883|FG002|Overall Study|Patient vomited pills|1|||
145696469|NCT00874497|525405884|FG000|Overall Study|Lost to Follow-up|2|||
145696470|NCT00874497|525405885|FG001|Overall Study|Lost to Follow-up|4|||
145696471|NCT00874497|525405884|FG000|Overall Study|Adverse Event|9|||
145696472|NCT00874497|525405885|FG001|Overall Study|Adverse Event|4|||
145696473|NCT00874497|525405884|FG000|Overall Study|Sponsor Discontinued Trial|7|||
145696474|NCT00874497|525405885|FG001|Overall Study|Sponsor Discontinued Trial|3|||
145696475|NCT00874497|525405884|FG000|Overall Study|Met Withdrawal Criteria|4|||
145696476|NCT00874497|525405885|FG001|Overall Study|Met Withdrawal Criteria|2|||
145696477|NCT00874497|525405884|FG000|Overall Study|Physician Decision|1|||
145696478|NCT00874497|525405885|FG001|Overall Study|Physician Decision|1|||
145696479|NCT00874497|525405884|FG000|Overall Study|Withdrawal by Subject|5|||
145696480|NCT00874497|525405885|FG001|Overall Study|Withdrawal by Subject|4|||
145696481|NCT00665223|525405888|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
145696482|NCT00665223|525405889|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
145696483|NCT00665223|525405890|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
145696484|NCT00665223|525405888|FG000|Randomized Phase (26 Weeks)|Death|0|||
145696485|NCT00665223|525405889|FG001|Randomized Phase (26 Weeks)|Death|0|||
145696486|NCT00665223|525405890|FG002|Randomized Phase (26 Weeks)|Death|1|||
145696487|NCT00665223|525405888|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
145696488|NCT00665223|525405889|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
145696489|NCT00665223|525405890|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
145696490|NCT00665223|525405888|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
145696491|NCT00665223|525405889|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
145696492|NCT00665223|525405890|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
145696493|NCT00665223|525405888|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
145696494|NCT00665223|525405889|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
145696495|NCT00665223|525405890|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
145696496|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
145696497|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
145696498|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
145696499|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Death|0|||
145696500|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Death|1|||
145696501|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Death|0|||
145696502|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
145696503|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
145696504|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
145696505|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
145696506|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
145696507|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
145696508|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
145696509|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
145696510|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
145696511|NCT00665223|525405888|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
145696512|NCT00665223|525405889|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
145696513|NCT00665223|525405890|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
145696514|NCT00591591|525405891|FG000|Overall Study|Withdrawal by Subject|1|||
145696515|NCT00591591|525405892|FG001|Overall Study|Withdrawal by Subject|37|||
145696516|NCT00591591|525405891|FG000|Overall Study|Lack of Efficacy|10|||
145696517|NCT00591591|525405892|FG001|Overall Study|Lack of Efficacy|2|||
145696518|NCT00002597|525405893|FG000|Overall Study|Protocol Violation|19|||
145696519|NCT00002597|525405894|FG001|Overall Study|Protocol Violation|17|||
145696520|NCT00002597|525405893|FG000|Overall Study|Withdrawal by Subject|7|||
145696521|NCT00002597|525405894|FG001|Overall Study|Withdrawal by Subject|6|||
145696522|NCT01426113|525405897|FG000|Overall Study|Study Discontinued|1|||
145696523|NCT01426113|525405898|FG001|Overall Study|Study Discontinued|1|||
145696524|NCT01426113|525405897|FG000|Overall Study|Adverse Event|0|||
145696525|NCT01426113|525405898|FG001|Overall Study|Adverse Event|1|||
145696526|NCT00468130|525405901|FG000|Overall Study|Adverse Event|2|||
145696527|NCT00468130|525405902|FG001|Overall Study|Adverse Event|1|||
145696528|NCT00468130|525405901|FG000|Overall Study|Withdrawal by Subject|0|||
145696529|NCT00468130|525405902|FG001|Overall Study|Withdrawal by Subject|1|||
145696530|NCT00436956|525405903|FG000|Overall Study|Not evaluable|1|||
145696531|NCT00436956|525405904|FG001|Overall Study|Not evaluable|0|||
145696532|NCT02485899|525405905|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
145696533|NCT02485899|525405906|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
145696534|NCT02485899|525405905|FG000|Overall Study|Withdrawal by Subject|1|||
145696535|NCT02485899|525405906|FG001|Overall Study|Withdrawal by Subject|0|||
145696536|NCT02485899|525405905|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
145696537|NCT02485899|525405906|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
145696538|NCT03517111|525405909|FG000|Enrolled|Withdrawal by Subject|0|||
145696539|NCT03517111|525405910|FG001|Enrolled|Withdrawal by Subject|1|||
145696540|NCT03517111|525405911|FG002|Enrolled|Withdrawal by Subject|0|||
145696541|NCT03517111|525405909|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
145696542|NCT03517111|525405910|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
145696543|NCT03517111|525405911|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
145696544|NCT03517111|525405909|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
145696545|NCT03517111|525405910|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
145696546|NCT03517111|525405911|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
145696547|NCT03517111|525405909|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
145696548|NCT03517111|525405910|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
145696549|NCT03517111|525405911|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
145696550|NCT03517111|525405909|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
145696551|NCT03517111|525405910|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
145696552|NCT03517111|525405911|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
145696553|NCT00623363|525405912|FG000|Overall Study|Adverse Event|2|||
145696554|NCT00623363|525405913|FG001|Overall Study|Adverse Event|2|||
145696555|NCT02719743|525405914|FG000|Overall Study|Consent withdrawal|0|||
145696556|NCT02719743|525405915|FG001|Overall Study|Consent withdrawal|2|||
145696557|NCT02719743|525405916|FG002|Overall Study|Consent withdrawal|0|||
145696558|NCT02719743|525405917|FG003|Overall Study|Consent withdrawal|1|||
145696559|NCT02719743|525405918|FG004|Overall Study|Consent withdrawal|0|||
145696560|NCT02719743|525405914|FG000|Overall Study|Migrated/moved from study area|0|||
145696561|NCT02719743|525405915|FG001|Overall Study|Migrated/moved from study area|0|||
145696562|NCT02719743|525405916|FG002|Overall Study|Migrated/moved from study area|0|||
145696563|NCT02719743|525405917|FG003|Overall Study|Migrated/moved from study area|0|||
145696564|NCT02719743|525405918|FG004|Overall Study|Migrated/moved from study area|2|||
145696565|NCT02719743|525405914|FG000|Overall Study|Lost to Follow-up|1|||
145696566|NCT02719743|525405915|FG001|Overall Study|Lost to Follow-up|1|||
145696567|NCT02719743|525405916|FG002|Overall Study|Lost to Follow-up|0|||
145696568|NCT02719743|525405917|FG003|Overall Study|Lost to Follow-up|0|||
145696569|NCT02719743|525405918|FG004|Overall Study|Lost to Follow-up|0|||
145696570|NCT01438840|525405920|FG000|Core Study|Adverse Event|0|||
145696571|NCT01438840|525405921|FG001|Core Study|Adverse Event|3|||
145696572|NCT01438840|525405922|FG002|Core Study|Adverse Event|0|||
145696573|NCT01438840|525405920|FG000|Core Study|Lack of Efficacy|15|||
145696574|NCT01438840|525405921|FG001|Core Study|Lack of Efficacy|7|||
145696575|NCT01438840|525405922|FG002|Core Study|Lack of Efficacy|0|||
145696576|NCT01438840|525405920|FG000|Core Study|Withdrawal of consent|1|||
145696577|NCT01438840|525405921|FG001|Core Study|Withdrawal of consent|0|||
145696578|NCT01438840|525405922|FG002|Core Study|Withdrawal of consent|0|||
145696579|NCT01438840|525405920|FG000|Extension Phase|Adverse Event|0|||
145696580|NCT01438840|525405921|FG001|Extension Phase|Adverse Event|0|||
145696581|NCT01438840|525405922|FG002|Extension Phase|Adverse Event|3|||
145696582|NCT01438840|525405920|FG000|Extension Phase|Lost to Follow-up|0|||
145696583|NCT01438840|525405921|FG001|Extension Phase|Lost to Follow-up|0|||
145696584|NCT01438840|525405922|FG002|Extension Phase|Lost to Follow-up|1|||
145696585|NCT01438840|525405920|FG000|Extension Phase|Withdrawal by Subject|0|||
145696586|NCT01438840|525405921|FG001|Extension Phase|Withdrawal by Subject|0|||
145696587|NCT01438840|525405922|FG002|Extension Phase|Withdrawal by Subject|3|||
145696588|NCT01438840|525405920|FG000|Extension Phase|Lack of Efficacy|0|||
145696589|NCT01438840|525405921|FG001|Extension Phase|Lack of Efficacy|0|||
145696590|NCT01438840|525405922|FG002|Extension Phase|Lack of Efficacy|2|||
145696591|NCT01438840|525405920|FG000|Extension Phase|Other|0|||
145696592|NCT01438840|525405921|FG001|Extension Phase|Other|0|||
145696593|NCT01438840|525405922|FG002|Extension Phase|Other|1|||
145696594|NCT02062645|525405925|FG000|Overall Study|Adverse Event|2|||
145696595|NCT02062645|525405925|FG000|Overall Study|Protocol Violation|8|||
145696596|NCT02062645|525405925|FG000|Overall Study|Lost to Follow-up|5|||
145696597|NCT01891890|525405926|FG000|Overall Study|Lost to Follow-up|0|||
145696598|NCT01891890|525405927|FG001|Overall Study|Lost to Follow-up|0|||
145696599|NCT01891890|525405928|FG002|Overall Study|Lost to Follow-up|1|||
145696600|NCT01891890|525405926|FG000|Overall Study|Study ended before endpoint reached|7|||
145696601|NCT01891890|525405927|FG001|Overall Study|Study ended before endpoint reached|3|||
145696602|NCT01891890|525405928|FG002|Overall Study|Study ended before endpoint reached|6|||
145696603|NCT01161628|525405929|FG000|Overall Study|Death|6|||
145696604|NCT01161628|525405929|FG000|Overall Study|Lack of Efficacy|2|||
145696605|NCT03605368|525405935|FG000|Overall Study|Lost to Follow-up|2|||
145696606|NCT03605368|525405936|FG001|Overall Study|Lost to Follow-up|1|||
145696607|NCT03605368|525405937|FG002|Overall Study|Lost to Follow-up|3|||
145696608|NCT03605368|525405938|FG003|Overall Study|Lost to Follow-up|2|||
145696609|NCT03605368|525405935|FG000|Overall Study|Withdrawal by Subject|0|||
145696610|NCT03605368|525405936|FG001|Overall Study|Withdrawal by Subject|0|||
145696611|NCT03605368|525405937|FG002|Overall Study|Withdrawal by Subject|4|||
145696612|NCT03605368|525405938|FG003|Overall Study|Withdrawal by Subject|3|||
145696613|NCT01726517|525405939|FG000|Overall Study|Withdrawal by Subject|0|||
145696614|NCT01726517|525405940|FG001|Overall Study|Withdrawal by Subject|0|||
145696615|NCT01726517|525405941|FG002|Overall Study|Withdrawal by Subject|1|||
145696616|NCT01726517|525405942|FG003|Overall Study|Withdrawal by Subject|0|||
145696617|NCT01726517|525405943|FG004|Overall Study|Withdrawal by Subject|0|||
145696618|NCT03765164|525405944|FG000|Pre-intervention|Withdrawal by Subject|5|||
145696619|NCT03765164|525405945|FG001|Pre-intervention|Withdrawal by Subject|6|||
145696620|NCT03448536|525405946|FG000|Overall Study|Protocol Violation|2|||
145696621|NCT03448536|525405947|FG001|Overall Study|Protocol Violation|0|||
145696622|NCT03448536|525405946|FG000|Overall Study|Pregnancy|1|||
145696623|NCT03448536|525405947|FG001|Overall Study|Pregnancy|0|||
145696624|NCT03448536|525405946|FG000|Overall Study|Withdrawal by Subject|1|||
145696625|NCT03448536|525405947|FG001|Overall Study|Withdrawal by Subject|2|||
145696626|NCT03448536|525405946|FG000|Overall Study|Lost to Follow-up|3|||
145696627|NCT03448536|525405947|FG001|Overall Study|Lost to Follow-up|2|||
145696628|NCT03448536|525405946|FG000|Overall Study|Inadequate pain reporter|1|||
145696629|NCT03448536|525405947|FG001|Overall Study|Inadequate pain reporter|0|||
145696630|NCT03448536|525405946|FG000|Overall Study|Other|3|||
145696631|NCT03448536|525405947|FG001|Overall Study|Other|0|||
145696632|NCT03448536|525405946|FG000|Overall Study|Physician Decision|1|||
145696633|NCT03448536|525405947|FG001|Overall Study|Physician Decision|0|||
145696634|NCT04814992|525405951|FG000|Overall Study|Withdrawal by Subject|6|||
145696635|NCT04814992|525405952|FG001|Overall Study|Withdrawal by Subject|3|||
145696636|NCT04814992|525405951|FG000|Overall Study|Lost to Follow-up|1|||
145696637|NCT04814992|525405952|FG001|Overall Study|Lost to Follow-up|4|||
145696638|NCT01831726|525405955|FG000|Overall Study|Adverse Event|16|||
145696639|NCT01831726|525405955|FG000|Overall Study|Death|7|||
145696640|NCT01831726|525405955|FG000|Overall Study|Disease Progression|49|||
145696641|NCT01831726|525405955|FG000|Overall Study|Physician Decision|1|||
145696642|NCT01831726|525405955|FG000|Overall Study|Subject/guardian decision|7|||
145696643|NCT04944784|525405958|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
145696644|NCT04944784|525405959|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
145696645|NCT04944784|525405960|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
145696646|NCT04944784|525405961|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
145696647|NCT04944784|525405958|FG000|Double-blind Period|Adverse Event|20|||
145696648|NCT04944784|525405959|FG001|Double-blind Period|Adverse Event|4|||
145696649|NCT04944784|525405960|FG002|Double-blind Period|Adverse Event|0|||
145696650|NCT04944784|525405961|FG003|Double-blind Period|Adverse Event|0|||
145696651|NCT04944784|525405958|FG000|Double-blind Period|Withdrawal by Subject|15|||
145696652|NCT04944784|525405959|FG001|Double-blind Period|Withdrawal by Subject|4|||
145696653|NCT04944784|525405960|FG002|Double-blind Period|Withdrawal by Subject|0|||
145696654|NCT04944784|525405961|FG003|Double-blind Period|Withdrawal by Subject|0|||
145696655|NCT04944784|525405958|FG000|Double-blind Period|Death|7|||
145696656|NCT04944784|525405959|FG001|Double-blind Period|Death|2|||
145696657|NCT04944784|525405960|FG002|Double-blind Period|Death|0|||
145696658|NCT04944784|525405961|FG003|Double-blind Period|Death|0|||
145696659|NCT04944784|525405958|FG000|Double-blind Period|Physician Decision|2|||
145696660|NCT04944784|525405959|FG001|Double-blind Period|Physician Decision|1|||
145696661|NCT04944784|525405960|FG002|Double-blind Period|Physician Decision|0|||
145696662|NCT04944784|525405961|FG003|Double-blind Period|Physician Decision|0|||
145696663|NCT04944784|525405958|FG000|Double-blind Period|Lack of Efficacy|0|||
145696664|NCT04944784|525405959|FG001|Double-blind Period|Lack of Efficacy|1|||
145696665|NCT04944784|525405960|FG002|Double-blind Period|Lack of Efficacy|0|||
145696666|NCT04944784|525405961|FG003|Double-blind Period|Lack of Efficacy|0|||
145696667|NCT04944784|525405958|FG000|Double-blind Period|Sponsor Request|2|||
145696668|NCT04944784|525405959|FG001|Double-blind Period|Sponsor Request|1|||
145696669|NCT04944784|525405960|FG002|Double-blind Period|Sponsor Request|0|||
145696670|NCT04944784|525405961|FG003|Double-blind Period|Sponsor Request|0|||
145696671|NCT04944784|525405958|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
145696672|NCT04944784|525405959|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
145696673|NCT04944784|525405960|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
145696674|NCT04944784|525405961|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
145696675|NCT04944784|525405958|FG000|Double-blind Period|Participant Choice|1|||
145696676|NCT04944784|525405959|FG001|Double-blind Period|Participant Choice|1|||
145696677|NCT04944784|525405960|FG002|Double-blind Period|Participant Choice|0|||
145696678|NCT04944784|525405961|FG003|Double-blind Period|Participant Choice|0|||
145696679|NCT04944784|525405958|FG000|Double-blind Period|Progressive Disease|2|||
145696680|NCT04944784|525405959|FG001|Double-blind Period|Progressive Disease|2|||
145696681|NCT04944784|525405960|FG002|Double-blind Period|Progressive Disease|0|||
145696682|NCT04944784|525405961|FG003|Double-blind Period|Progressive Disease|0|||
145696683|NCT04944784|525405958|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
145696684|NCT04944784|525405959|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
145696685|NCT04944784|525405960|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
145696686|NCT04944784|525405961|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
145696687|NCT04944784|525405958|FG000|Active Drug Period|Adverse Event|0|||
145696688|NCT04944784|525405959|FG001|Active Drug Period|Adverse Event|0|||
145696689|NCT04944784|525405960|FG002|Active Drug Period|Adverse Event|3|||
145696690|NCT04944784|525405961|FG003|Active Drug Period|Adverse Event|6|||
145696691|NCT04944784|525405958|FG000|Active Drug Period|Withdrawal by Subject|0|||
145696692|NCT04944784|525405959|FG001|Active Drug Period|Withdrawal by Subject|0|||
145696693|NCT04944784|525405960|FG002|Active Drug Period|Withdrawal by Subject|4|||
145696694|NCT04944784|525405961|FG003|Active Drug Period|Withdrawal by Subject|7|||
145696695|NCT04944784|525405958|FG000|Active Drug Period|Death|0|||
145696696|NCT04944784|525405959|FG001|Active Drug Period|Death|0|||
145696697|NCT04944784|525405960|FG002|Active Drug Period|Death|3|||
145696698|NCT04944784|525405961|FG003|Active Drug Period|Death|4|||
145696699|NCT04944784|525405958|FG000|Active Drug Period|Lack of Efficacy|0|||
145696700|NCT04944784|525405959|FG001|Active Drug Period|Lack of Efficacy|0|||
145696701|NCT04944784|525405960|FG002|Active Drug Period|Lack of Efficacy|2|||
145696702|NCT04944784|525405961|FG003|Active Drug Period|Lack of Efficacy|2|||
145696703|NCT04944784|525405958|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
145696704|NCT04944784|525405959|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
145696705|NCT04944784|525405960|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
145696706|NCT04944784|525405961|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
145696707|NCT04944784|525405958|FG000|Active Drug Period|Participant Choice|0|||
145696708|NCT04944784|525405959|FG001|Active Drug Period|Participant Choice|0|||
145696709|NCT04944784|525405960|FG002|Active Drug Period|Participant Choice|0|||
145696710|NCT04944784|525405961|FG003|Active Drug Period|Participant Choice|1|||
145696711|NCT04944784|525405958|FG000|Active Drug Period|Progressive Disease|0|||
145696712|NCT04944784|525405959|FG001|Active Drug Period|Progressive Disease|0|||
145696713|NCT04944784|525405960|FG002|Active Drug Period|Progressive Disease|4|||
145696714|NCT04944784|525405961|FG003|Active Drug Period|Progressive Disease|4|||
145696715|NCT04944784|525405958|FG000|Active Drug Period|Lost to Follow-up|0|||
145696716|NCT04944784|525405959|FG001|Active Drug Period|Lost to Follow-up|0|||
145696717|NCT04944784|525405960|FG002|Active Drug Period|Lost to Follow-up|0|||
145696718|NCT04944784|525405961|FG003|Active Drug Period|Lost to Follow-up|1|||
145696719|NCT00497874|525407352|FG000|Overall Study|Withdrawal by Subject|48|||
145696720|NCT00497874|525407353|FG001|Overall Study|Withdrawal by Subject|17|||
145696721|NCT00497874|525407352|FG000|Overall Study|Illness|8|||
145696722|NCT00497874|525407353|FG001|Overall Study|Illness|4|||
145696723|NCT00497874|525407352|FG000|Overall Study|Death|2|||
145696724|NCT00497874|525407353|FG001|Overall Study|Death|4|||
145696725|NCT00497874|525407352|FG000|Overall Study|Unable to contact|52|||
145696726|NCT00497874|525407353|FG001|Overall Study|Unable to contact|67|||
145696727|NCT00497874|525407352|FG000|Overall Study|Unable to schedule|37|||
145696728|NCT00497874|525407353|FG001|Overall Study|Unable to schedule|24|||
145696729|NCT00701909|525407356|FG000|Overall Study|Withdrawal by Subject|0|||
145696730|NCT00701909|525407357|FG001|Overall Study|Withdrawal by Subject|1|||
145696731|NCT00971997|525407358|FG000|Overall Study|Adverse Event|2|||
145696732|NCT00971997|525407358|FG000|Overall Study|Death|1|||
145696733|NCT00971997|525407358|FG000|Overall Study|Protocol Violation|4|||
145696734|NCT00971997|525407358|FG000|Overall Study|Withdrawal by Subject|5|||
145696735|NCT00971997|525407358|FG000|Overall Study|Physician Decision|7|||
145696736|NCT04009629|525407359|FG000|Overall Study|Withdrawal by Subject|2|||
145696737|NCT04009629|525407360|FG001|Overall Study|Withdrawal by Subject|0|||
145696738|NCT00761956|525407361|FG000|Overall Study|Lost to Follow-up|6|||
145696739|NCT00761956|525407362|FG001|Overall Study|Lost to Follow-up|11|||
145696740|NCT00761956|525407361|FG000|Overall Study|Withdrawal by Subject|3|||
145696741|NCT00761956|525407362|FG001|Overall Study|Withdrawal by Subject|8|||
145696742|NCT00761956|525407361|FG000|Overall Study|Death|0|||
145696743|NCT00761956|525407362|FG001|Overall Study|Death|1|||
145696744|NCT00761956|525407361|FG000|Overall Study|Adverse Event|26|||
145696745|NCT00761956|525407362|FG001|Overall Study|Adverse Event|34|||
145696746|NCT02808975|525407366|FG000|Overall Study|Adverse Event|3|||
145696747|NCT02808975|525407367|FG001|Overall Study|Adverse Event|4|||
145696748|NCT02808975|525407366|FG000|Overall Study|Withdrew consent|9|||
145696749|NCT02808975|525407367|FG001|Overall Study|Withdrew consent|8|||
145696750|NCT02808975|525407366|FG000|Overall Study|Lost to Follow-up|4|||
145696751|NCT02808975|525407367|FG001|Overall Study|Lost to Follow-up|6|||
145696752|NCT02808975|525407366|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
145696753|NCT02808975|525407367|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
145696754|NCT02808975|525407366|FG000|Overall Study|Other, not specified|5|||
145696755|NCT02808975|525407367|FG001|Overall Study|Other, not specified|1|||
145696756|NCT03602586|525407368|FG000|Overall Study|Withdrawal by Subject|3|||
145696757|NCT00030823|525407369|FG000|Overall Study|Withdrawal by Subject|1|||
145696758|NCT02106195|525407371|FG000|Overall Study|Adverse Event|2|||
145696759|NCT02106195|525407371|FG000|Overall Study|Protocol Violation|1|||
145696760|NCT04523207|525407374|FG000|Overall Study|Adverse Event|5|||
145696761|NCT04523207|525407375|FG001|Overall Study|Adverse Event|1|||
145696762|NCT04523207|525407374|FG000|Overall Study|Lost to Follow-up|2|||
145696763|NCT04523207|525407375|FG001|Overall Study|Lost to Follow-up|0|||
145696764|NCT04523207|525407374|FG000|Overall Study|Withdrawal by Subject|2|||
145696765|NCT04523207|525407375|FG001|Overall Study|Withdrawal by Subject|0|||
145696766|NCT04523207|525407374|FG000|Overall Study|Progressive Disease|2|||
145696767|NCT04523207|525407375|FG001|Overall Study|Progressive Disease|1|||
145696768|NCT04523207|525407374|FG000|Overall Study|Other|7|||
145696769|NCT04523207|525407375|FG001|Overall Study|Other|1|||
145696770|NCT03113383|525407376|FG000|Overall Study|Death|4|||
145696771|NCT03113383|525407377|FG001|Overall Study|Death|0|||
145696772|NCT03062449|525407378|FG000|Overall Study|Withdrawal by Subject|7|||
145696773|NCT03062449|525407379|FG001|Overall Study|Withdrawal by Subject|1|||
145696774|NCT04702893|525407381|FG000|Overall Study|Other reasons than listed|11|||
145696775|NCT04702893|525407381|FG000|Overall Study|Withdrawal by Subject|3|||
145696776|NCT04702893|525407381|FG000|Overall Study|Lost to Follow-up|7|||
145696777|NCT04702893|525407381|FG000|Overall Study|Death|10|||
145696778|NCT04702893|525407381|FG000|Overall Study|Not treated|6|||
145696779|NCT00408928|525407382|FG000|Overall Study|Withdrawal by Subject|1|||
145696780|NCT00408928|525407382|FG000|Overall Study|Death|1|||
145696781|NCT00408928|525407382|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
145696782|NCT01951378|525407384|FG000|Overall Study|Study Terminated-Not completed|23|||
145696783|NCT01951378|525407385|FG001|Overall Study|Study Terminated-Not completed|17|||
145696784|NCT00543062|525407386|FG000|Overall Study|Withdrawal by Subject|1|||
145696785|NCT00543062|525407387|FG001|Overall Study|Withdrawal by Subject|0|||
145696786|NCT00543062|525407388|FG002|Overall Study|Withdrawal by Subject|2|||
145696787|NCT00543062|525407389|FG003|Overall Study|Withdrawal by Subject|0|||
145696788|NCT00543062|525407386|FG000|Overall Study|Adverse Event|0|||
145696789|NCT00543062|525407387|FG001|Overall Study|Adverse Event|1|||
145696790|NCT00543062|525407388|FG002|Overall Study|Adverse Event|1|||
145696791|NCT00543062|525407389|FG003|Overall Study|Adverse Event|1|||
145696792|NCT00543062|525407386|FG000|Overall Study|Protocol Violation|1|||
145696793|NCT00543062|525407387|FG001|Overall Study|Protocol Violation|0|||
145696794|NCT00543062|525407388|FG002|Overall Study|Protocol Violation|0|||
145696795|NCT00543062|525407389|FG003|Overall Study|Protocol Violation|0|||
145696796|NCT03927690|525407392|FG000|Overall Study|Withdrawal by Subject|3|||
145696797|NCT03927690|525407393|FG001|Overall Study|Withdrawal by Subject|1|||
145696798|NCT03927690|525407394|FG002|Overall Study|Withdrawal by Subject|1|||
145696799|NCT03927690|525407392|FG000|Overall Study|Adverse Event|1|||
145696800|NCT03927690|525407393|FG001|Overall Study|Adverse Event|0|||
145696801|NCT03927690|525407394|FG002|Overall Study|Adverse Event|0|||
145696802|NCT03927690|525407392|FG000|Overall Study|Death|1|||
145696803|NCT03927690|525407393|FG001|Overall Study|Death|0|||
145696804|NCT03927690|525407394|FG002|Overall Study|Death|0|||
145696805|NCT03927690|525407392|FG000|Overall Study|Lost to Follow-up|2|||
145696806|NCT03927690|525407393|FG001|Overall Study|Lost to Follow-up|2|||
145696807|NCT03927690|525407394|FG002|Overall Study|Lost to Follow-up|1|||
145696808|NCT01844726|525407401|FG000|Overall Study|Withdrawal by Subject|0|||
145696809|NCT01844726|525407402|FG001|Overall Study|Withdrawal by Subject|1|||
145696810|NCT01844726|525407401|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
145696811|NCT01844726|525407402|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
145696812|NCT03898960|525407405|FG000|Overall Study|Death|10|||
145696813|NCT00548847|525407406|FG000|Overall Study|Disease progression|7|||
145696814|NCT01772563|525407416|FG000|Cycle 1|Dose limiting toxicity|2|||
145696815|NCT01772563|525407416|FG000|Cycle 1|Progressive disease|2|||
145696816|NCT01772563|525407416|FG000|Cycle 2 and Beyond|Progressive disease|17|||
145696817|NCT01772563|525407416|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
145696818|NCT01772563|525407416|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
145696819|NCT01086384|525407417|FG000|2-week Run-in Period|Adverse Event|1|||
145696820|NCT01086384|525407418|FG001|2-week Run-in Period|Adverse Event|0|||
145696821|NCT01086384|525407419|FG002|2-week Run-in Period|Adverse Event|0|||
145696822|NCT01086384|525407417|FG000|2-week Run-in Period|Protocol Violation|1|||
145696823|NCT01086384|525407418|FG001|2-week Run-in Period|Protocol Violation|0|||
145696824|NCT01086384|525407419|FG002|2-week Run-in Period|Protocol Violation|0|||
145696825|NCT01086384|525407417|FG000|2-week Run-in Period|Lost to Follow-up|1|||
145696826|NCT01086384|525407418|FG001|2-week Run-in Period|Lost to Follow-up|0|||
145696827|NCT01086384|525407419|FG002|2-week Run-in Period|Lost to Follow-up|0|||
145696828|NCT01086384|525407417|FG000|2-week Run-in Period|Physician Decision|6|||
145696829|NCT01086384|525407418|FG001|2-week Run-in Period|Physician Decision|0|||
145696830|NCT01086384|525407419|FG002|2-week Run-in Period|Physician Decision|0|||
145696831|NCT01086384|525407417|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
145696832|NCT01086384|525407418|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
145696833|NCT01086384|525407419|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
145696834|NCT01086384|525407417|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
145696835|NCT01086384|525407418|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
145696836|NCT01086384|525407419|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
145696837|NCT01086384|525407417|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
145696838|NCT01086384|525407418|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
145696839|NCT01086384|525407419|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
145696840|NCT01086384|525407417|FG000|2-week Run-in Period|Randomized in Error|1|||
145696841|NCT01086384|525407418|FG001|2-week Run-in Period|Randomized in Error|0|||
145696842|NCT01086384|525407419|FG002|2-week Run-in Period|Randomized in Error|0|||
145696843|NCT01086384|525407417|FG000|Treatment Period|Withdrawal by Subject|0|||
145696844|NCT01086384|525407418|FG001|Treatment Period|Withdrawal by Subject|53|||
145696845|NCT01086384|525407419|FG002|Treatment Period|Withdrawal by Subject|55|||
145696846|NCT01086384|525407417|FG000|Treatment Period|Protocol Violation|0|||
145696847|NCT01086384|525407418|FG001|Treatment Period|Protocol Violation|26|||
145696848|NCT01086384|525407419|FG002|Treatment Period|Protocol Violation|17|||
145696849|NCT01086384|525407417|FG000|Treatment Period|Lack of Efficacy|0|||
145696850|NCT01086384|525407418|FG001|Treatment Period|Lack of Efficacy|22|||
145696851|NCT01086384|525407419|FG002|Treatment Period|Lack of Efficacy|13|||
145696852|NCT01086384|525407417|FG000|Treatment Period|Adverse Event|0|||
145696853|NCT01086384|525407418|FG001|Treatment Period|Adverse Event|19|||
145696854|NCT01086384|525407419|FG002|Treatment Period|Adverse Event|15|||
145696855|NCT01086384|525407417|FG000|Treatment Period|Lost to Follow-up|0|||
145696856|NCT01086384|525407418|FG001|Treatment Period|Lost to Follow-up|11|||
145696857|NCT01086384|525407419|FG002|Treatment Period|Lost to Follow-up|9|||
145696858|NCT01086384|525407417|FG000|Treatment Period|Physician Decision|0|||
145696859|NCT01086384|525407418|FG001|Treatment Period|Physician Decision|9|||
145696860|NCT01086384|525407419|FG002|Treatment Period|Physician Decision|6|||
145696861|NCT01086384|525407417|FG000|Treatment Period|Study Closed/Terminated|0|||
145696862|NCT01086384|525407418|FG001|Treatment Period|Study Closed/Terminated|7|||
145696863|NCT01086384|525407419|FG002|Treatment Period|Study Closed/Terminated|8|||
145696864|NCT01086384|525407417|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
145696865|NCT01086384|525407418|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
145696866|NCT01086384|525407419|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
145696867|NCT01086384|525407417|FG000|Treatment Period|Received Treatment in Error|0|||
145696868|NCT01086384|525407418|FG001|Treatment Period|Received Treatment in Error|1|||
145696869|NCT01086384|525407419|FG002|Treatment Period|Received Treatment in Error|0|||
145696870|NCT00832000|525407426|FG000|Overall Study|Adverse Event|2|||
145696871|NCT00832000|525407427|FG001|Overall Study|Adverse Event|0|||
145696872|NCT00832000|525407426|FG000|Overall Study|Withdrawal by Subject|1|||
145696873|NCT00832000|525407427|FG001|Overall Study|Withdrawal by Subject|0|||
145696874|NCT00832000|525407426|FG000|Overall Study|No calls to IVR in either period|1|||
145696875|NCT00832000|525407427|FG001|Overall Study|No calls to IVR in either period|1|||
145696876|NCT00832000|525407426|FG000|Overall Study|No calls to IVR in period 2|2|||
145696877|NCT00832000|525407427|FG001|Overall Study|No calls to IVR in period 2|0|||
145696878|NCT02872311|525407428|FG000|Overall Study|Death|2|||
145696879|NCT02872311|525407429|FG001|Overall Study|Death|0|||
145696880|NCT02872311|525407430|FG002|Overall Study|Death|0|||
145696881|NCT02872311|525407431|FG003|Overall Study|Death|0|||
145696882|NCT02872311|525407432|FG004|Overall Study|Death|0|||
145696883|NCT02872311|525407428|FG000|Overall Study|Lost to Follow-up|2|||
145696884|NCT02872311|525407429|FG001|Overall Study|Lost to Follow-up|0|||
145696885|NCT02872311|525407430|FG002|Overall Study|Lost to Follow-up|0|||
145696886|NCT02872311|525407431|FG003|Overall Study|Lost to Follow-up|0|||
145696887|NCT02872311|525407432|FG004|Overall Study|Lost to Follow-up|0|||
145696888|NCT02872311|525407428|FG000|Overall Study|Protocol Violation|0|||
145696889|NCT02872311|525407429|FG001|Overall Study|Protocol Violation|2|||
145696890|NCT02872311|525407430|FG002|Overall Study|Protocol Violation|1|||
145696891|NCT02872311|525407431|FG003|Overall Study|Protocol Violation|0|||
145696892|NCT02872311|525407432|FG004|Overall Study|Protocol Violation|0|||
145696893|NCT02725567|525407434|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
145696894|NCT02725567|525407435|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
145696895|NCT02725567|525407434|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
145696896|NCT02725567|525407435|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
145696897|NCT02725567|525407434|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
145696898|NCT02725567|525407435|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
145696899|NCT01747837|525407436|FG000|Overall Study|Lost to Follow-up|5|||
145696900|NCT01747837|525407437|FG001|Overall Study|Lost to Follow-up|2|||
145696901|NCT01747837|525407436|FG000|Overall Study|Death|4|||
145696902|NCT01747837|525407437|FG001|Overall Study|Death|4|||
145696903|NCT03974100|525407438|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
145696904|NCT03974100|525407439|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
145696905|NCT03974100|525407440|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
145696906|NCT03974100|525407441|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
145696907|NCT03974100|525407442|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
145696908|NCT03974100|525407438|FG000|TP1 - Day 1 to Week 52|Death|1|||
145696909|NCT03974100|525407439|FG001|TP1 - Day 1 to Week 52|Death|0|||
145696910|NCT03974100|525407440|FG002|TP1 - Day 1 to Week 52|Death|0|||
145696911|NCT03974100|525407441|FG003|TP1 - Day 1 to Week 52|Death|0|||
145696912|NCT03974100|525407442|FG004|TP1 - Day 1 to Week 52|Death|0|||
145696913|NCT03974100|525407438|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
145696914|NCT03974100|525407439|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
145696915|NCT03974100|525407440|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
145696916|NCT03974100|525407441|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
145696917|NCT03974100|525407442|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
145696918|NCT03974100|525407438|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
145696919|NCT03974100|525407439|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
145696920|NCT03974100|525407440|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
145696921|NCT03974100|525407441|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
145696922|NCT03974100|525407442|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
145696923|NCT03974100|525407438|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
145696924|NCT03974100|525407439|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
145696925|NCT03974100|525407440|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
145696926|NCT03974100|525407441|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
145696927|NCT03974100|525407442|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
145696928|NCT03974100|525407438|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
145696929|NCT03974100|525407439|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
145696930|NCT03974100|525407440|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
145696931|NCT03974100|525407441|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
145696932|NCT03974100|525407442|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
145696933|NCT03974100|525407438|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
145696934|NCT03974100|525407439|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
145696935|NCT03974100|525407440|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
145696936|NCT03974100|525407441|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
145696937|NCT03974100|525407442|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
145696938|NCT01721746|525407443|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
145696939|NCT01721746|525407444|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
145696940|NCT01721746|525407443|FG000|Pre-Treatment|Withdrawal by Subject|1|||
145696941|NCT01721746|525407444|FG001|Pre-Treatment|Withdrawal by Subject|16|||
145696942|NCT01721746|525407443|FG000|Pre-Treatment|Poor/Non-compliance|1|||
145696943|NCT01721746|525407444|FG001|Pre-Treatment|Poor/Non-compliance|0|||
145696944|NCT01721746|525407443|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
145696945|NCT01721746|525407444|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
145696946|NCT01721746|525407443|FG000|Treatment|Disease Progression|192|||
145696947|NCT01721746|525407444|FG001|Treatment|Disease Progression|74|||
145696948|NCT01721746|525407443|FG000|Treatment|Study Drug Toxicity|19|||
145696949|NCT01721746|525407444|FG001|Treatment|Study Drug Toxicity|11|||
145696950|NCT01721746|525407443|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
145696951|NCT01721746|525407444|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
145696952|NCT01721746|525407443|FG000|Treatment|Participant request to discontinue Study treatment|26|||
145696953|NCT01721746|525407444|FG001|Treatment|Participant request to discontinue Study treatment|7|||
145696954|NCT01721746|525407443|FG000|Treatment|Participant withdrew consent|4|||
145265481|NCT00945815|523819373|FG000|Overall Study|Death|3|||
145696955|NCT01721746|525407444|FG001|Treatment|Participant withdrew consent|2|||
145696956|NCT01721746|525407443|FG000|Treatment|Maximum Clinical Benefit|9|||
145696957|NCT01721746|525407444|FG001|Treatment|Maximum Clinical Benefit|3|||
145696958|NCT01721746|525407443|FG000|Treatment|Poor/Non-compliance|2|||
145696959|NCT01721746|525407444|FG001|Treatment|Poor/Non-compliance|0|||
145696960|NCT01721746|525407443|FG000|Treatment|Participant no longer met Study criteria|4|||
145696961|NCT01721746|525407444|FG001|Treatment|Participant no longer met Study criteria|0|||
145696962|NCT01721746|525407443|FG000|Treatment|Other reasons|6|||
145696963|NCT01721746|525407444|FG001|Treatment|Other reasons|2|||
145696964|NCT00927901|525407449|FG000|Treatment Period 1|Subject withdrew consent|0|||
145696965|NCT00927901|525407450|FG001|Treatment Period 1|Subject withdrew consent|0|||
145696966|NCT00927901|525407451|FG002|Treatment Period 1|Subject withdrew consent|1|||
145696967|NCT00927901|525407452|FG003|Treatment Period 1|Subject withdrew consent|0|||
145696968|NCT00927901|525407449|FG000|Treatment Period 4|Adverse Event|0|||
145696969|NCT00927901|525407450|FG001|Treatment Period 4|Adverse Event|0|||
145696970|NCT00927901|525407451|FG002|Treatment Period 4|Adverse Event|0|||
145696971|NCT00927901|525407452|FG003|Treatment Period 4|Adverse Event|1|||
145696972|NCT00927901|525407449|FG000|Treatment Period 4|Subject withdrew consent|0|||
145696973|NCT00927901|525407450|FG001|Treatment Period 4|Subject withdrew consent|0|||
145696974|NCT00927901|525407451|FG002|Treatment Period 4|Subject withdrew consent|1|||
145696975|NCT00927901|525407452|FG003|Treatment Period 4|Subject withdrew consent|0|||
145696976|NCT02344173|525407453|FG000|Procedure|Ablation Procedure Not Performed|7|||
145696977|NCT02344173|525407453|FG000|12-month Visit|Death|8|||
145696978|NCT02344173|525407453|FG000|12-month Visit|Withdrawal by Subject|30|||
145696979|NCT02344173|525407453|FG000|12-month Visit|Lost to Follow-up|58|||
145696980|NCT03738397|525407454|FG000|Overall Study|Adverse Event|3|||
145696981|NCT03738397|525407455|FG001|Overall Study|Adverse Event|7|||
145696982|NCT03738397|525407454|FG000|Overall Study|Withdrawal by Subject|8|||
145696983|NCT03738397|525407455|FG001|Overall Study|Withdrawal by Subject|11|||
145696984|NCT03738397|525407454|FG000|Overall Study|Lost to Follow-up|7|||
145696985|NCT03738397|525407455|FG001|Overall Study|Lost to Follow-up|5|||
145696986|NCT03738397|525407454|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
145696987|NCT03738397|525407455|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
145696988|NCT03738397|525407454|FG000|Overall Study|Other|4|||
145696989|NCT03738397|525407455|FG001|Overall Study|Other|6|||
145696990|NCT01185171|525407456|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
145696991|NCT01185171|525407456|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
145696992|NCT01185171|525407456|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
145696993|NCT01185171|525407456|FG000|Maintenance|Elevated liver transaminases|3|||
145696994|NCT01185171|525407456|FG000|Maintenance|Rush|2|||
145696995|NCT01185171|525407456|FG000|Maintenance|Diarrhea|1|||
145696996|NCT01185171|525407456|FG000|Maintenance|Xerostomia|1|||
145696997|NCT01185171|525407456|FG000|Maintenance|Nausea|1|||
145696998|NCT01185171|525407456|FG000|Maintenance|Comorbid Illness|2|||
145696999|NCT01185171|525407456|FG000|Maintenance|Withdrawal by Subject|1|||
145697000|NCT01185171|525407456|FG000|Maintenance|Disease Recurrence|1|||
145697001|NCT02881047|525407457|FG000|Overall Study|Adverse Event|1|||
145697002|NCT02881047|525407457|FG000|Overall Study|Withdrawal by Subject|1|||
145697003|NCT00573651|525407461|FG000|Overall Study|Lost to Follow-up|3|||
145697004|NCT00573651|525407461|FG000|Overall Study|Withdrawal by Subject|1|||
145697005|NCT01837797|525407464|FG000|Period 1|Adverse Event|9|||
145697006|NCT01837797|525407465|FG001|Period 1|Adverse Event|0|||
145697007|NCT01837797|525407466|FG002|Period 1|Adverse Event|0|||
145697008|NCT01837797|525407467|FG003|Period 1|Adverse Event|0|||
145697009|NCT01837797|525407468|FG004|Period 1|Adverse Event|0|||
145697010|NCT01837797|525407464|FG000|Period 1|Withdrawal by Subject|6|||
145697011|NCT01837797|525407465|FG001|Period 1|Withdrawal by Subject|0|||
145697012|NCT01837797|525407466|FG002|Period 1|Withdrawal by Subject|0|||
145697013|NCT01837797|525407467|FG003|Period 1|Withdrawal by Subject|0|||
145697014|NCT01837797|525407468|FG004|Period 1|Withdrawal by Subject|0|||
145697015|NCT01837797|525407464|FG000|Period 1|Administrative reasons|76|||
145697016|NCT01837797|525407465|FG001|Period 1|Administrative reasons|0|||
145697017|NCT01837797|525407466|FG002|Period 1|Administrative reasons|0|||
145697018|NCT01837797|525407467|FG003|Period 1|Administrative reasons|0|||
145697019|NCT01837797|525407468|FG004|Period 1|Administrative reasons|0|||
145697020|NCT01837797|525407464|FG000|Period 1|Withdrawal of consent before treatment|1|||
145697021|NCT01837797|525407465|FG001|Period 1|Withdrawal of consent before treatment|0|||
145697022|NCT01837797|525407466|FG002|Period 1|Withdrawal of consent before treatment|0|||
145697023|NCT01837797|525407467|FG003|Period 1|Withdrawal of consent before treatment|0|||
145697024|NCT01837797|525407468|FG004|Period 1|Withdrawal of consent before treatment|0|||
145697025|NCT01837797|525407464|FG000|Period 1|Other|10|||
145697026|NCT01837797|525407465|FG001|Period 1|Other|0|||
145697027|NCT01837797|525407466|FG002|Period 1|Other|0|||
145697028|NCT01837797|525407467|FG003|Period 1|Other|0|||
145697029|NCT01837797|525407468|FG004|Period 1|Other|0|||
145697030|NCT01837797|525407464|FG000|Period 2|Administrative or other reasons|0|||
145697031|NCT01837797|525407465|FG001|Period 2|Administrative or other reasons|5|||
145697032|NCT01837797|525407466|FG002|Period 2|Administrative or other reasons|2|||
145697033|NCT01837797|525407467|FG003|Period 2|Administrative or other reasons|4|||
145697034|NCT01837797|525407468|FG004|Period 2|Administrative or other reasons|0|||
145697035|NCT01837797|525407464|FG000|Period 2|Adverse Event|0|||
145697036|NCT01837797|525407465|FG001|Period 2|Adverse Event|0|||
145697037|NCT01837797|525407466|FG002|Period 2|Adverse Event|0|||
145697038|NCT01837797|525407467|FG003|Period 2|Adverse Event|1|||
145697039|NCT01837797|525407468|FG004|Period 2|Adverse Event|0|||
145697040|NCT01837797|525407464|FG000|Period 3|Adverse Event|0|||
145697041|NCT01837797|525407465|FG001|Period 3|Adverse Event|0|||
145697042|NCT01837797|525407466|FG002|Period 3|Adverse Event|0|||
145697043|NCT01837797|525407467|FG003|Period 3|Adverse Event|0|||
145697044|NCT01837797|525407468|FG004|Period 3|Adverse Event|1|||
145697045|NCT01837797|525407464|FG000|Period 3|Administrative reasons|0|||
145697046|NCT01837797|525407465|FG001|Period 3|Administrative reasons|0|||
145697047|NCT01837797|525407466|FG002|Period 3|Administrative reasons|0|||
145697048|NCT01837797|525407467|FG003|Period 3|Administrative reasons|0|||
145697049|NCT01837797|525407468|FG004|Period 3|Administrative reasons|20|||
145697050|NCT01837797|525407464|FG000|Period 3|Other|0|||
145697051|NCT01837797|525407465|FG001|Period 3|Other|0|||
145697052|NCT01837797|525407466|FG002|Period 3|Other|0|||
145697053|NCT01837797|525407467|FG003|Period 3|Other|0|||
145697054|NCT01837797|525407468|FG004|Period 3|Other|2|||
145697055|NCT03797989|525407469|FG000|VAC069A|Withdrawal by Subject|0|||
145697056|NCT03797989|525407470|FG001|VAC069A|Withdrawal by Subject|0|||
145697057|NCT03797989|525407471|FG002|VAC069A|Withdrawal by Subject|1|||
145697058|NCT03797989|525407472|FG003|VAC069A|Withdrawal by Subject|0|||
145697059|NCT03797989|525407473|FG004|VAC069A|Withdrawal by Subject|0|||
145697060|NCT03797989|525407474|FG005|VAC069A|Withdrawal by Subject|0|||
145697061|NCT03797989|525407475|FG006|VAC069A|Withdrawal by Subject|0|||
145697062|NCT03797989|525407476|FG007|VAC069A|Withdrawal by Subject|0|||
145697063|NCT03797989|525407477|FG008|VAC069A|Withdrawal by Subject|0|||
145697064|NCT03797989|525407478|FG009|VAC069A|Withdrawal by Subject|0|||
145697065|NCT03797989|525407479|FG010|VAC069A|Withdrawal by Subject|0|||
145697066|NCT03797989|525407480|FG011|VAC069A|Withdrawal by Subject|0|||
145697067|NCT04052997|525407481|FG000|Overall Study|Withdrawal by Subject|17|||
145697068|NCT04052997|525407481|FG000|Overall Study|Physician Decision|50|||
145697069|NCT04052997|525407481|FG000|Overall Study|Death|43|||
145697070|NCT04052997|525407481|FG000|Overall Study|Lost to Follow-up|5|||
145697071|NCT04052997|525407481|FG000|Overall Study|Progression of Disease|1|||
145697072|NCT00514813|525407492|FG000|Overall Study|Study terminated|14|||
145697073|NCT00514813|525407493|FG001|Overall Study|Study terminated|74|||
145697074|NCT00514813|525407494|FG002|Overall Study|Study terminated|40|||
145697075|NCT00514813|525407495|FG003|Overall Study|Study terminated|2|||
145697076|NCT00514813|525407492|FG000|Overall Study|Adverse Event|0|||
145697077|NCT00514813|525407493|FG001|Overall Study|Adverse Event|2|||
145697078|NCT00514813|525407494|FG002|Overall Study|Adverse Event|2|||
145697079|NCT00514813|525407495|FG003|Overall Study|Adverse Event|0|||
145697080|NCT00514813|525407492|FG000|Overall Study|Protocol Violation|1|||
145697081|NCT00514813|525407493|FG001|Overall Study|Protocol Violation|0|||
145697082|NCT00514813|525407494|FG002|Overall Study|Protocol Violation|0|||
145697083|NCT00514813|525407495|FG003|Overall Study|Protocol Violation|0|||
145697084|NCT00514813|525407492|FG000|Overall Study|Withdrawal by Subject|0|||
145697085|NCT00514813|525407493|FG001|Overall Study|Withdrawal by Subject|1|||
145697086|NCT00514813|525407494|FG002|Overall Study|Withdrawal by Subject|0|||
145697087|NCT00514813|525407495|FG003|Overall Study|Withdrawal by Subject|0|||
145697088|NCT00514813|525407492|FG000|Overall Study|Lack of Efficacy|0|||
145697089|NCT00514813|525407493|FG001|Overall Study|Lack of Efficacy|1|||
145697090|NCT00514813|525407494|FG002|Overall Study|Lack of Efficacy|0|||
145697091|NCT00514813|525407495|FG003|Overall Study|Lack of Efficacy|0|||
145697092|NCT00514813|525407492|FG000|Overall Study|Kidney transplant|0|||
145697093|NCT00514813|525407493|FG001|Overall Study|Kidney transplant|6|||
145697094|NCT00514813|525407494|FG002|Overall Study|Kidney transplant|2|||
145697095|NCT00514813|525407495|FG003|Overall Study|Kidney transplant|0|||
145697096|NCT00514813|525407492|FG000|Overall Study|Death|0|||
145697097|NCT00514813|525407493|FG001|Overall Study|Death|2|||
145697098|NCT00514813|525407494|FG002|Overall Study|Death|3|||
145697099|NCT00514813|525407495|FG003|Overall Study|Death|2|||
145697100|NCT02979613|525407496|FG000|Double-Blind Phase|Withdrew Consent|2|||
145697101|NCT02979613|525407497|FG001|Double-Blind Phase|Withdrew Consent|4|||
145697102|NCT02979613|525407496|FG000|Double-Blind Phase|Pregnancy|2|||
145697103|NCT02979613|525407497|FG001|Double-Blind Phase|Pregnancy|2|||
145697104|NCT02979613|525407496|FG000|Double-Blind Phase|Adverse Event|2|||
145697105|NCT02979613|525407497|FG001|Double-Blind Phase|Adverse Event|0|||
145697106|NCT02979613|525407496|FG000|Double-Blind Phase|Lost to Follow-up|1|||
145697107|NCT02979613|525407497|FG001|Double-Blind Phase|Lost to Follow-up|1|||
145697108|NCT02979613|525407496|FG000|Double-Blind Phase|Protocol Violation|1|||
145697109|NCT02979613|525407497|FG001|Double-Blind Phase|Protocol Violation|1|||
145697110|NCT02979613|525407496|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
145697111|NCT02979613|525407497|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
145697112|NCT02979613|525407496|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
145697113|NCT02979613|525407497|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
145697114|NCT02979613|525407496|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
145697115|NCT02979613|525407497|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
145697116|NCT02979613|525407496|FG000|Open-Label Extension (OLE) Phase|Death|0|||
145697117|NCT02979613|525407497|FG001|Open-Label Extension (OLE) Phase|Death|1|||
145697118|NCT02979613|525407496|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
145697119|NCT02979613|525407497|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
145697120|NCT01075100|525407500|FG000|Overall Study|Adverse Event|15|||
145697121|NCT01075100|525407501|FG001|Overall Study|Adverse Event|18|||
145697122|NCT01075100|525407500|FG000|Overall Study|Patient Request|4|||
145697123|NCT01075100|525407501|FG001|Overall Study|Patient Request|4|||
145697124|NCT01075100|525407500|FG000|Overall Study|Investigator Request|2|||
145697125|NCT01075100|525407501|FG001|Overall Study|Investigator Request|1|||
145697126|NCT01075100|525407500|FG000|Overall Study|Disease Progression|25|||
145697127|NCT01075100|525407501|FG001|Overall Study|Disease Progression|29|||
145697128|NCT01075100|525407500|FG000|Overall Study|Other|3|||
145697129|NCT01075100|525407501|FG001|Overall Study|Other|1|||
145697130|NCT01568112|525407504|FG000|Overall Study|Randomized But Not Treated|0|||
145697131|NCT01568112|525407505|FG001|Overall Study|Randomized But Not Treated|1|||
145697132|NCT01568112|525407506|FG002|Overall Study|Randomized But Not Treated|0|||
145697133|NCT01568112|525407507|FG003|Overall Study|Randomized But Not Treated|0|||
145697134|NCT01568112|525407504|FG000|Overall Study|Withdrew due to Adverse Event|2|||
145697135|NCT01568112|525407505|FG001|Overall Study|Withdrew due to Adverse Event|4|||
145697136|NCT01568112|525407506|FG002|Overall Study|Withdrew due to Adverse Event|6|||
145697137|NCT01568112|525407507|FG003|Overall Study|Withdrew due to Adverse Event|3|||
145697138|NCT01568112|525407504|FG000|Overall Study|Lost to Follow-up|0|||
145697139|NCT01568112|525407505|FG001|Overall Study|Lost to Follow-up|0|||
145697140|NCT01568112|525407506|FG002|Overall Study|Lost to Follow-up|0|||
145697141|NCT01568112|525407507|FG003|Overall Study|Lost to Follow-up|1|||
145697142|NCT01568112|525407504|FG000|Overall Study|Withdrawal by Subject|2|||
145697143|NCT01568112|525407505|FG001|Overall Study|Withdrawal by Subject|3|||
145697144|NCT01568112|525407506|FG002|Overall Study|Withdrawal by Subject|0|||
145697145|NCT01568112|525407507|FG003|Overall Study|Withdrawal by Subject|7|||
145697146|NCT01568112|525407504|FG000|Overall Study|Withdrawal by Physician|1|||
145697147|NCT01568112|525407505|FG001|Overall Study|Withdrawal by Physician|0|||
145697148|NCT01568112|525407506|FG002|Overall Study|Withdrawal by Physician|1|||
145697149|NCT01568112|525407507|FG003|Overall Study|Withdrawal by Physician|1|||
145697150|NCT02388347|525409692|FG000|Overall Study|Withdrawal by Subject|0|||
145697151|NCT02388347|525409693|FG001|Overall Study|Withdrawal by Subject|0|||
145697152|NCT02388347|525409694|FG002|Overall Study|Withdrawal by Subject|1|||
145697153|NCT02388347|525409695|FG003|Overall Study|Withdrawal by Subject|0|||
145697154|NCT02388347|525409696|FG004|Overall Study|Withdrawal by Subject|0|||
145697155|NCT02820597|525409697|FG000|Overall Study|Lost to Follow-up|12|||
145697156|NCT01053247|525409698|FG000|Overall Study|Withdrawal by Subject|9|||
145697157|NCT01053247|525409699|FG001|Overall Study|Withdrawal by Subject|4|||
145697158|NCT01053247|525409700|FG002|Overall Study|Withdrawal by Subject|15|||
145697159|NCT01053247|525409698|FG000|Overall Study|Lack of Efficacy|1|||
145697160|NCT01053247|525409699|FG001|Overall Study|Lack of Efficacy|0|||
145697161|NCT01053247|525409700|FG002|Overall Study|Lack of Efficacy|1|||
145697162|NCT01053247|525409698|FG000|Overall Study|Protocol Violation|2|||
145697163|NCT01053247|525409699|FG001|Overall Study|Protocol Violation|1|||
145697164|NCT01053247|525409700|FG002|Overall Study|Protocol Violation|2|||
145697165|NCT01053247|525409698|FG000|Overall Study|Lost to Follow-up|8|||
145697166|NCT01053247|525409699|FG001|Overall Study|Lost to Follow-up|5|||
145697167|NCT01053247|525409700|FG002|Overall Study|Lost to Follow-up|7|||
145697168|NCT01053247|525409698|FG000|Overall Study|Adverse Event|0|||
145697169|NCT01053247|525409699|FG001|Overall Study|Adverse Event|9|||
145697170|NCT01053247|525409700|FG002|Overall Study|Adverse Event|3|||
145697171|NCT03898700|525409701|FG000|Overall Study|Withdrawal by Subject|2|||
145697172|NCT04398368|525409704|FG000|Overall Study|Withdrawal by Subject|2|||
145697173|NCT03568812|525409705|FG000|Overall Study|Physician Decision|0|||
145697174|NCT03568812|525409706|FG001|Overall Study|Physician Decision|1|||
145697175|NCT03194867|525409710|FG000|Overall Study|Incorrect completion of end of study form|0|||
145697176|NCT03194867|525409711|FG001|Overall Study|Incorrect completion of end of study form|0|||
145697177|NCT03194867|525409712|FG002|Overall Study|Incorrect completion of end of study form|1|||
145697178|NCT03194867|525409713|FG003|Overall Study|Incorrect completion of end of study form|0|||
145697179|NCT00634842|525409714|FG000|Overall Study|Adverse Event|2|||
145697180|NCT00634842|525409715|FG001|Overall Study|Adverse Event|3|||
145697181|NCT00634842|525409714|FG000|Overall Study|Protocol Violation|8|||
145697182|NCT00634842|525409715|FG001|Overall Study|Protocol Violation|4|||
145697183|NCT00634842|525409714|FG000|Overall Study|Move to another state|1|||
145697184|NCT00634842|525409715|FG001|Overall Study|Move to another state|0|||
145697185|NCT00634842|525409714|FG000|Overall Study|Inclusion criteria were not met|1|||
145697186|NCT00634842|525409715|FG001|Overall Study|Inclusion criteria were not met|0|||
145697187|NCT00634842|525409714|FG000|Overall Study|Lost to Follow-up|1|||
145697188|NCT00634842|525409715|FG001|Overall Study|Lost to Follow-up|2|||
145697189|NCT00634842|525409714|FG000|Overall Study|Physician Decision|1|||
145697190|NCT00634842|525409715|FG001|Overall Study|Physician Decision|0|||
145697191|NCT00634842|525409714|FG000|Overall Study|Withdrawal by Subject|1|||
145697192|NCT00634842|525409715|FG001|Overall Study|Withdrawal by Subject|3|||
145697193|NCT00634842|525409714|FG000|Overall Study|Lack of time and intolerance to drug|0|||
145697194|NCT00634842|525409715|FG001|Overall Study|Lack of time and intolerance to drug|1|||
145697195|NCT00634842|525409714|FG000|Overall Study|Discontinued due to injection|0|||
145697196|NCT00634842|525409715|FG001|Overall Study|Discontinued due to injection|2|||
145697197|NCT00634842|525409714|FG000|Overall Study|No need of study drug to treat diabetes|0|||
145697198|NCT00634842|525409715|FG001|Overall Study|No need of study drug to treat diabetes|1|||
145697199|NCT00634842|525409714|FG000|Overall Study|No wish to keep taking Avandia|0|||
145697200|NCT00634842|525409715|FG001|Overall Study|No wish to keep taking Avandia|1|||
145697201|NCT00634842|525409714|FG000|Overall Study|Subject off study drug for too long|0|||
145697202|NCT00634842|525409715|FG001|Overall Study|Subject off study drug for too long|1|||
145697203|NCT00464945|525409716|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
145697204|NCT00464945|525409717|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
145697205|NCT00464945|525409716|FG000|Infant Series|Protocol Violation|1|||
145697206|NCT00464945|525409717|FG001|Infant Series|Protocol Violation|0|||
145697207|NCT00464945|525409716|FG000|Infant Series|Lost to Follow-up|1|||
145697208|NCT00464945|525409717|FG001|Infant Series|Lost to Follow-up|0|||
145697209|NCT00464945|525409716|FG000|After Infant Series|Withdrawal by Subject|0|||
145697210|NCT00464945|525409717|FG001|After Infant Series|Withdrawal by Subject|2|||
145697211|NCT00464945|525409716|FG000|Toddler Dose|Lost to Follow-up|0|||
145697212|NCT00464945|525409717|FG001|Toddler Dose|Lost to Follow-up|1|||
145697213|NCT03305809|525409720|FG000|Overall Study|Adverse Event|2|||
145697214|NCT03305809|525409721|FG001|Overall Study|Adverse Event|2|||
145697215|NCT03305809|525409722|FG002|Overall Study|Adverse Event|6|||
145697216|NCT03305809|525409723|FG003|Overall Study|Adverse Event|6|||
145697217|NCT03305809|525409720|FG000|Overall Study|Death|0|||
145697218|NCT03305809|525409721|FG001|Overall Study|Death|0|||
145697219|NCT03305809|525409722|FG002|Overall Study|Death|1|||
145697220|NCT03305809|525409723|FG003|Overall Study|Death|1|||
145697221|NCT03305809|525409720|FG000|Overall Study|Lost to Follow-up|1|||
145697222|NCT03305809|525409721|FG001|Overall Study|Lost to Follow-up|2|||
145697223|NCT03305809|525409722|FG002|Overall Study|Lost to Follow-up|0|||
145697224|NCT03305809|525409723|FG003|Overall Study|Lost to Follow-up|0|||
145697225|NCT03305809|525409720|FG000|Overall Study|Sponsor Decision|1|||
145697226|NCT03305809|525409721|FG001|Overall Study|Sponsor Decision|0|||
145697227|NCT03305809|525409722|FG002|Overall Study|Sponsor Decision|1|||
145697228|NCT03305809|525409723|FG003|Overall Study|Sponsor Decision|8|||
145697229|NCT03305809|525409720|FG000|Overall Study|Physician Decision|0|||
145697230|NCT03305809|525409721|FG001|Overall Study|Physician Decision|0|||
145697231|NCT03305809|525409722|FG002|Overall Study|Physician Decision|2|||
145697232|NCT03305809|525409723|FG003|Overall Study|Physician Decision|4|||
145697233|NCT03305809|525409720|FG000|Overall Study|Progressive Disease|0|||
145697234|NCT03305809|525409721|FG001|Overall Study|Progressive Disease|0|||
145697235|NCT03305809|525409722|FG002|Overall Study|Progressive Disease|1|||
145697236|NCT03305809|525409723|FG003|Overall Study|Progressive Disease|0|||
145697237|NCT03305809|525409720|FG000|Overall Study|Protocol Violation|1|||
145697238|NCT03305809|525409721|FG001|Overall Study|Protocol Violation|0|||
145697239|NCT03305809|525409722|FG002|Overall Study|Protocol Violation|2|||
145697240|NCT03305809|525409723|FG003|Overall Study|Protocol Violation|3|||
145697241|NCT03305809|525409720|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
145697242|NCT03305809|525409721|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
145697243|NCT03305809|525409722|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
145697244|NCT03305809|525409723|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
145697245|NCT03305809|525409720|FG000|Overall Study|Withdrawal by Subject|2|||
145697246|NCT03305809|525409721|FG001|Overall Study|Withdrawal by Subject|4|||
145697247|NCT03305809|525409722|FG002|Overall Study|Withdrawal by Subject|5|||
145697248|NCT03305809|525409723|FG003|Overall Study|Withdrawal by Subject|2|||
145697249|NCT03305809|525409720|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
145697250|NCT03305809|525409721|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
145697251|NCT03305809|525409722|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
145697252|NCT03305809|525409723|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
145697253|NCT04014790|525409724|FG000|Overall Study|Death|4|||
145697254|NCT04014790|525409724|FG000|Overall Study|Adverse Event|1|||
145697255|NCT04014790|525409724|FG000|Overall Study|Withdrawal by Subject|1|||
145697256|NCT02438371|525409725|FG000|Overall Study|Lost to Follow-up|3|||
145697257|NCT02438371|525409726|FG001|Overall Study|Lost to Follow-up|2|||
145697258|NCT02438371|525409725|FG000|Overall Study|Withdrawal by Subject|1|||
145697259|NCT02438371|525409726|FG001|Overall Study|Withdrawal by Subject|1|||
145697260|NCT03546816|525409727|FG000|Overall Study|Adverse Event|5|||
145697261|NCT03546816|525409728|FG001|Overall Study|Adverse Event|3|||
145697262|NCT03546816|525409727|FG000|Overall Study|Lack of Efficacy|2|||
145697263|NCT03546816|525409728|FG001|Overall Study|Lack of Efficacy|4|||
145697264|NCT03546816|525409727|FG000|Overall Study|Pregnancy|1|||
145697265|NCT03546816|525409728|FG001|Overall Study|Pregnancy|0|||
145697266|NCT03546816|525409727|FG000|Overall Study|Physician Decision|2|||
145697267|NCT03546816|525409728|FG001|Overall Study|Physician Decision|0|||
145697268|NCT03546816|525409727|FG000|Overall Study|Withdrawal by Subject|8|||
145697269|NCT03546816|525409728|FG001|Overall Study|Withdrawal by Subject|10|||
145697270|NCT03546816|525409727|FG000|Overall Study|Lost to Follow-up|3|||
145697271|NCT03546816|525409728|FG001|Overall Study|Lost to Follow-up|2|||
145697272|NCT03065933|525409731|FG000|Overall Study|study terminated|5|||
145697273|NCT01010204|525409732|FG000|Overall Study|Lost to Follow-up|2|||
145697274|NCT01010204|525409733|FG001|Overall Study|Lost to Follow-up|2|||
145697275|NCT01010204|525409732|FG000|Overall Study|Adverse Event|1|||
145697276|NCT01010204|525409733|FG001|Overall Study|Adverse Event|3|||
145697277|NCT01010204|525409732|FG000|Overall Study|Withdrawal by Subject|2|||
145697278|NCT01010204|525409733|FG001|Overall Study|Withdrawal by Subject|3|||
145697279|NCT01010204|525409732|FG000|Overall Study|psychiatric hospitalization|2|||
145697280|NCT01010204|525409733|FG001|Overall Study|psychiatric hospitalization|1|||
145697281|NCT01513330|525409734|FG000|SenSura Mio First,|Adverse Event|2|||
145697282|NCT01513330|525409735|FG001|SenSura Mio First,|Adverse Event|0|||
145697283|NCT01513330|525409734|FG000|SenSura Mio First,|Lack of Efficacy|0|||
145697284|NCT01513330|525409735|FG001|SenSura Mio First,|Lack of Efficacy|1|||
145697285|NCT01513330|525409734|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
145697286|NCT01513330|525409735|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
145697287|NCT01513330|525409734|FG000|SenSura Mio First,|Other|1|||
145697288|NCT01513330|525409735|FG001|SenSura Mio First,|Other|0|||
145697289|NCT01513330|525409734|FG000|Standard Care First,|Lack of Efficacy|2|||
145697290|NCT01513330|525409735|FG001|Standard Care First,|Lack of Efficacy|2|||
145697291|NCT01513330|525409734|FG000|Standard Care First,|Withdrawal by Subject|1|||
145697292|NCT01513330|525409735|FG001|Standard Care First,|Withdrawal by Subject|2|||
145697293|NCT01513330|525409734|FG000|Standard Care First,|Other|1|||
145697294|NCT01513330|525409735|FG001|Standard Care First,|Other|0|||
145697295|NCT01519778|525409736|FG000|Overall Study|Withdrawal by Subject|3|||
145697296|NCT01519778|525409736|FG000|Overall Study|Lost to Follow-up|10|||
145697297|NCT01519778|525409736|FG000|Overall Study|Physician Decision|1|||
145697298|NCT02330562|525409737|FG000|Overall Study|Adverse Event|0|||
145697299|NCT02330562|525409738|FG001|Overall Study|Adverse Event|0|||
145697300|NCT02330562|525409739|FG002|Overall Study|Adverse Event|3|||
145697301|NCT02330562|525409740|FG003|Overall Study|Adverse Event|0|||
145697302|NCT02330562|525409741|FG004|Overall Study|Adverse Event|3|||
145697303|NCT02330562|525409742|FG005|Overall Study|Adverse Event|1|||
145697304|NCT02330562|525409743|FG006|Overall Study|Adverse Event|0|||
145697305|NCT02330562|525409744|FG007|Overall Study|Adverse Event|0|||
145697306|NCT02330562|525409745|FG008|Overall Study|Adverse Event|0|||
145697307|NCT02330562|525409746|FG009|Overall Study|Adverse Event|1|||
145697308|NCT02330562|525409747|FG010|Overall Study|Adverse Event|1|||
145697309|NCT02330562|525409737|FG000|Overall Study|Participant decision|1|||
145697310|NCT02330562|525409738|FG001|Overall Study|Participant decision|0|||
145697311|NCT02330562|525409739|FG002|Overall Study|Participant decision|4|||
145697312|NCT02330562|525409740|FG003|Overall Study|Participant decision|1|||
145697313|NCT02330562|525409741|FG004|Overall Study|Participant decision|5|||
145697314|NCT02330562|525409742|FG005|Overall Study|Participant decision|2|||
145697315|NCT02330562|525409743|FG006|Overall Study|Participant decision|0|||
145697316|NCT02330562|525409744|FG007|Overall Study|Participant decision|0|||
145697317|NCT02330562|525409745|FG008|Overall Study|Participant decision|0|||
145697318|NCT02330562|525409746|FG009|Overall Study|Participant decision|3|||
145697319|NCT02330562|525409747|FG010|Overall Study|Participant decision|0|||
145697320|NCT02330562|525409737|FG000|Overall Study|Disease progression|5|||
145697321|NCT02330562|525409738|FG001|Overall Study|Disease progression|3|||
145697322|NCT02330562|525409739|FG002|Overall Study|Disease progression|20|||
145697323|NCT02330562|525409740|FG003|Overall Study|Disease progression|28|||
145697324|NCT02330562|525409741|FG004|Overall Study|Disease progression|23|||
145697325|NCT02330562|525409742|FG005|Overall Study|Disease progression|7|||
145697326|NCT02330562|525409743|FG006|Overall Study|Disease progression|1|||
145697327|NCT02330562|525409744|FG007|Overall Study|Disease progression|1|||
145697328|NCT02330562|525409745|FG008|Overall Study|Disease progression|1|||
145697329|NCT02330562|525409746|FG009|Overall Study|Disease progression|0|||
145697330|NCT02330562|525409747|FG010|Overall Study|Disease progression|5|||
145697331|NCT02330562|525409737|FG000|Overall Study|Other reasons|0|||
145697332|NCT02330562|525409738|FG001|Overall Study|Other reasons|0|||
145697333|NCT02330562|525409739|FG002|Overall Study|Other reasons|0|||
145697334|NCT02330562|525409740|FG003|Overall Study|Other reasons|1|||
145697335|NCT02330562|525409741|FG004|Overall Study|Other reasons|0|||
145697336|NCT02330562|525409742|FG005|Overall Study|Other reasons|0|||
145697337|NCT02330562|525409743|FG006|Overall Study|Other reasons|0|||
145697338|NCT02330562|525409744|FG007|Overall Study|Other reasons|0|||
145697339|NCT02330562|525409745|FG008|Overall Study|Other reasons|0|||
145697340|NCT02330562|525409746|FG009|Overall Study|Other reasons|0|||
145697341|NCT02330562|525409747|FG010|Overall Study|Other reasons|0|||
145697342|NCT02330562|525409737|FG000|Overall Study|Withdrawal by Subject|0|||
145697343|NCT02330562|525409738|FG001|Overall Study|Withdrawal by Subject|0|||
145697344|NCT02330562|525409739|FG002|Overall Study|Withdrawal by Subject|0|||
145697345|NCT02330562|525409740|FG003|Overall Study|Withdrawal by Subject|0|||
145697346|NCT02330562|525409741|FG004|Overall Study|Withdrawal by Subject|0|||
145697347|NCT02330562|525409742|FG005|Overall Study|Withdrawal by Subject|0|||
145697348|NCT02330562|525409743|FG006|Overall Study|Withdrawal by Subject|0|||
145697349|NCT02330562|525409744|FG007|Overall Study|Withdrawal by Subject|0|||
145697350|NCT02330562|525409745|FG008|Overall Study|Withdrawal by Subject|0|||
145697351|NCT02330562|525409746|FG009|Overall Study|Withdrawal by Subject|1|||
145697352|NCT02330562|525409747|FG010|Overall Study|Withdrawal by Subject|0|||
145697353|NCT01547117|525409749|FG000|Overall Study|Physician Decision|0|||
145697354|NCT01547117|525409750|FG001|Overall Study|Physician Decision|1|||
145697355|NCT01547117|525409751|FG002|Overall Study|Physician Decision|1|||
145697356|NCT01547117|525409752|FG003|Overall Study|Physician Decision|3|||
145697357|NCT01547117|525409749|FG000|Overall Study|Withdrawal by Subject|1|||
145697358|NCT01547117|525409750|FG001|Overall Study|Withdrawal by Subject|2|||
145697359|NCT01547117|525409751|FG002|Overall Study|Withdrawal by Subject|1|||
145697360|NCT01547117|525409752|FG003|Overall Study|Withdrawal by Subject|2|||
145697361|NCT03021551|525409755|FG000|Overall Study|Equipment Issues|2|||
145697362|NCT03021551|525409755|FG000|Overall Study|Protocol Violation|1|||
145697363|NCT00551135|525409760|FG000|Overall Study|Adverse Event|1|||
145697364|NCT00551135|525409761|FG001|Overall Study|Adverse Event|0|||
145697365|NCT00551135|525409762|FG002|Overall Study|Adverse Event|1|||
145697366|NCT00551135|525409763|FG003|Overall Study|Adverse Event|1|||
145697367|NCT00551135|525409760|FG000|Overall Study|Lost to Follow-up|0|||
145697368|NCT00551135|525409761|FG001|Overall Study|Lost to Follow-up|0|||
145697369|NCT00551135|525409762|FG002|Overall Study|Lost to Follow-up|0|||
145697370|NCT00551135|525409763|FG003|Overall Study|Lost to Follow-up|1|||
145697371|NCT00551135|525409760|FG000|Overall Study|Other|3|||
145697372|NCT00551135|525409761|FG001|Overall Study|Other|2|||
145697373|NCT00551135|525409762|FG002|Overall Study|Other|1|||
145697374|NCT00551135|525409763|FG003|Overall Study|Other|2|||
145697375|NCT00551135|525409760|FG000|Overall Study|Withdrawal by Subject|1|||
145697376|NCT00551135|525409761|FG001|Overall Study|Withdrawal by Subject|0|||
145697377|NCT00551135|525409762|FG002|Overall Study|Withdrawal by Subject|3|||
145697378|NCT00551135|525409763|FG003|Overall Study|Withdrawal by Subject|1|||
145697379|NCT04799418|525409764|FG000|Overall Study|Death|1|||
145697380|NCT04799418|525409765|FG001|Overall Study|Death|1|||
145697381|NCT04799418|525409764|FG000|Overall Study|Lack of Efficacy|14|||
145697382|NCT04799418|525409765|FG001|Overall Study|Lack of Efficacy|14|||
145697383|NCT04799418|525409764|FG000|Overall Study|Withdrawal by Subject|10|||
145697384|NCT04799418|525409765|FG001|Overall Study|Withdrawal by Subject|7|||
145697385|NCT04799418|525409764|FG000|Overall Study|Adverse Event|3|||
145697386|NCT04799418|525409765|FG001|Overall Study|Adverse Event|2|||
145697387|NCT01379703|525409766|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
145697388|NCT01379703|525409767|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
145697389|NCT01379703|525409768|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
145697390|NCT01379703|525409766|FG000|Study Start Through 9 Months|Adverse Event|0|||
145697391|NCT01379703|525409767|FG001|Study Start Through 9 Months|Adverse Event|14|||
145697392|NCT01379703|525409768|FG002|Study Start Through 9 Months|Adverse Event|10|||
145697393|NCT01379703|525409766|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
145697394|NCT01379703|525409767|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
145697395|NCT01379703|525409768|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
145697396|NCT01379703|525409766|FG000|Study Start Through 9 Months|Treatment Failure|0|||
145697397|NCT01379703|525409767|FG001|Study Start Through 9 Months|Treatment Failure|2|||
145697398|NCT01379703|525409768|FG002|Study Start Through 9 Months|Treatment Failure|2|||
145697399|NCT01379703|525409766|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
145697400|NCT01379703|525409767|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
145697401|NCT01379703|525409768|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
145697402|NCT01379703|525409766|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
145697403|NCT01379703|525409767|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
145697404|NCT01379703|525409768|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
145697405|NCT01379703|525409766|FG000|Study Start Through 9 Months|Medication not available|0|||
145697406|NCT01379703|525409767|FG001|Study Start Through 9 Months|Medication not available|2|||
145697407|NCT01379703|525409768|FG002|Study Start Through 9 Months|Medication not available|1|||
145697408|NCT01379703|525409766|FG000|Study Start Through 9 Months|Poor general condition|0|||
145697409|NCT01379703|525409767|FG001|Study Start Through 9 Months|Poor general condition|1|||
145697410|NCT01379703|525409768|FG002|Study Start Through 9 Months|Poor general condition|0|||
145697411|NCT01379703|525409766|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
145697412|NCT01379703|525409767|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
145697413|NCT01379703|525409768|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
145697414|NCT01379703|525409766|FG000|Study Start Through 9 Months|Reason unknown|2|||
145697415|NCT01379703|525409767|FG001|Study Start Through 9 Months|Reason unknown|31|||
145697416|NCT01379703|525409768|FG002|Study Start Through 9 Months|Reason unknown|24|||
145697417|NCT01379703|525409766|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
145697418|NCT01379703|525409767|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
145697419|NCT01379703|525409768|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
145697420|NCT01379703|525409766|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
145697421|NCT01379703|525409767|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
145697422|NCT01379703|525409768|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
145697423|NCT01379703|525409766|FG000|9 Months Through 18 Months|Adverse Event|0|||
145697424|NCT01379703|525409767|FG001|9 Months Through 18 Months|Adverse Event|6|||
145697425|NCT01379703|525409768|FG002|9 Months Through 18 Months|Adverse Event|0|||
145697426|NCT01379703|525409766|FG000|9 Months Through 18 Months|Treatment failure|0|||
145697427|NCT01379703|525409767|FG001|9 Months Through 18 Months|Treatment failure|5|||
145697428|NCT01379703|525409768|FG002|9 Months Through 18 Months|Treatment failure|0|||
145697429|NCT01379703|525409766|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
145697430|NCT01379703|525409767|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
145697431|NCT01379703|525409768|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
145697432|NCT01379703|525409766|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
145697433|NCT01379703|525409767|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
145697434|NCT01379703|525409768|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
145697435|NCT01379703|525409766|FG000|9 Months Through 18 Months|Fatigue|0|||
145697436|NCT01379703|525409767|FG001|9 Months Through 18 Months|Fatigue|1|||
145697437|NCT01379703|525409768|FG002|9 Months Through 18 Months|Fatigue|0|||
145697438|NCT01379703|525409766|FG000|9 Months Through 18 Months|Reason Unknown|0|||
145697439|NCT01379703|525409767|FG001|9 Months Through 18 Months|Reason Unknown|23|||
145697440|NCT01379703|525409768|FG002|9 Months Through 18 Months|Reason Unknown|0|||
145697441|NCT03463577|525409769|FG000|Overall Study|Lost to Follow-up|238|||
145697442|NCT03463577|525409770|FG001|Overall Study|Lost to Follow-up|435|||
145697443|NCT03463577|525409771|FG002|Overall Study|Lost to Follow-up|0|||
145697444|NCT03463577|525409772|FG003|Overall Study|Lost to Follow-up|0|||
145697445|NCT03463577|525409773|FG004|Overall Study|Lost to Follow-up|0|||
145697446|NCT03463577|525409774|FG005|Overall Study|Lost to Follow-up|0|||
145697447|NCT03463577|525409769|FG000|Overall Study|With unknown pregnancy outcome|0|||
145697448|NCT03463577|525409770|FG001|Overall Study|With unknown pregnancy outcome|5|||
145697449|NCT03463577|525409771|FG002|Overall Study|With unknown pregnancy outcome|0|||
145697450|NCT03463577|525409772|FG003|Overall Study|With unknown pregnancy outcome|0|||
145697451|NCT03463577|525409773|FG004|Overall Study|With unknown pregnancy outcome|0|||
145697452|NCT03463577|525409774|FG005|Overall Study|With unknown pregnancy outcome|0|||
145697453|NCT03463577|525409769|FG000|Overall Study|Maternal death|2|||
145697454|NCT03463577|525409770|FG001|Overall Study|Maternal death|0|||
145697455|NCT03463577|525409771|FG002|Overall Study|Maternal death|0|||
145697456|NCT03463577|525409772|FG003|Overall Study|Maternal death|0|||
145697457|NCT03463577|525409773|FG004|Overall Study|Maternal death|0|||
145697458|NCT03463577|525409774|FG005|Overall Study|Maternal death|0|||
145697459|NCT03463577|525409769|FG000|Overall Study|Neonatal death|0|||
145697460|NCT03463577|525409770|FG001|Overall Study|Neonatal death|0|||
145697461|NCT03463577|525409771|FG002|Overall Study|Neonatal death|0|||
145697462|NCT03463577|525409772|FG003|Overall Study|Neonatal death|15|||
145697463|NCT03463577|525409773|FG004|Overall Study|Neonatal death|17|||
145697464|NCT03463577|525409774|FG005|Overall Study|Neonatal death|0|||
145697465|NCT00236184|525409775|FG000|Overall Study|Adverse Event|5|||
145697466|NCT00236184|525409776|FG001|Overall Study|Adverse Event|2|||
145697467|NCT00236184|525409775|FG000|Overall Study|Lack of Efficacy|0|||
145697468|NCT00236184|525409776|FG001|Overall Study|Lack of Efficacy|1|||
145697469|NCT00236184|525409775|FG000|Overall Study|Lost to Follow-up|3|||
145697470|NCT00236184|525409776|FG001|Overall Study|Lost to Follow-up|4|||
145697471|NCT00236184|525409775|FG000|Overall Study|Physician Decision|1|||
145697472|NCT00236184|525409776|FG001|Overall Study|Physician Decision|1|||
145697473|NCT00236184|525409775|FG000|Overall Study|Withdrawal by Subject|3|||
145697474|NCT00236184|525409776|FG001|Overall Study|Withdrawal by Subject|0|||
145697475|NCT00236184|525409775|FG000|Overall Study|Protocol Violation|3|||
145697476|NCT00236184|525409776|FG001|Overall Study|Protocol Violation|0|||
145697477|NCT00236184|525409775|FG000|Overall Study|non-compliance with study drug|2|||
145697478|NCT00236184|525409776|FG001|Overall Study|non-compliance with study drug|1|||
145697479|NCT00236184|525409775|FG000|Overall Study|other|1|||
145697480|NCT00236184|525409776|FG001|Overall Study|other|2|||
145697481|NCT01101997|525409777|FG000|Overall Study|Withdrawal by Subject|2|||
145697482|NCT00469456|525409778|FG000|Overall Study|Adverse Event|4|||
145697483|NCT00469456|525409779|FG001|Overall Study|Adverse Event|3|||
145697484|NCT00469456|525409778|FG000|Overall Study|Protocol Violation|1|||
145697485|NCT00469456|525409779|FG001|Overall Study|Protocol Violation|0|||
145697486|NCT00469456|525409778|FG000|Overall Study|Withdrawal by Subject|4|||
145697487|NCT00469456|525409779|FG001|Overall Study|Withdrawal by Subject|1|||
145697488|NCT02669407|525409782|FG000|Overall Study|Physician Decision|3|||
145697489|NCT00704171|525409783|FG000|Overall Study|Withdrawal by Subject|1|||
145697490|NCT00704171|525409784|FG001|Overall Study|Withdrawal by Subject|0|||
145697491|NCT03634839|525409785|FG000|First Intervention (2 Hours)|Adverse Event|0|||
145697492|NCT03634839|525409786|FG001|First Intervention (2 Hours)|Adverse Event|2|||
145697493|NCT01588366|525409794|FG000|Overall Study|Adverse Event|0|||
145697494|NCT01588366|525409795|FG001|Overall Study|Adverse Event|1|||
145697495|NCT01588366|525409796|FG002|Overall Study|Adverse Event|0|||
145697496|NCT01588366|525409797|FG003|Overall Study|Adverse Event|1|||
145697497|NCT01588366|525409798|FG004|Overall Study|Adverse Event|0|||
145697498|NCT01588366|525409799|FG005|Overall Study|Adverse Event|2|||
145697499|NCT00719043|525409800|FG000|Overall Study|Adverse Event|5|||
145697500|NCT00719043|525409801|FG001|Overall Study|Adverse Event|1|||
145697501|NCT00719043|525409802|FG002|Overall Study|Adverse Event|2|||
145697502|NCT00719043|525409803|FG003|Overall Study|Adverse Event|2|||
145697503|NCT00719043|525409804|FG004|Overall Study|Adverse Event|1|||
145697504|NCT00719043|525409805|FG005|Overall Study|Adverse Event|4|||
145697505|NCT00719043|525409806|FG006|Overall Study|Adverse Event|4|||
145697506|NCT00719043|525409800|FG000|Overall Study|Lost to Follow-up|14|||
145697507|NCT00719043|525409801|FG001|Overall Study|Lost to Follow-up|10|||
145697508|NCT00719043|525409802|FG002|Overall Study|Lost to Follow-up|8|||
145697509|NCT00719043|525409803|FG003|Overall Study|Lost to Follow-up|9|||
145697510|NCT00719043|525409804|FG004|Overall Study|Lost to Follow-up|10|||
145697511|NCT00719043|525409805|FG005|Overall Study|Lost to Follow-up|9|||
145697512|NCT00719043|525409806|FG006|Overall Study|Lost to Follow-up|9|||
145697513|NCT00719043|525409800|FG000|Overall Study|Protocol Violation|0|||
145697514|NCT00719043|525409801|FG001|Overall Study|Protocol Violation|0|||
145697515|NCT00719043|525409802|FG002|Overall Study|Protocol Violation|0|||
145697516|NCT00719043|525409803|FG003|Overall Study|Protocol Violation|0|||
145697517|NCT00719043|525409804|FG004|Overall Study|Protocol Violation|0|||
145697518|NCT00719043|525409805|FG005|Overall Study|Protocol Violation|1|||
145697519|NCT00719043|525409806|FG006|Overall Study|Protocol Violation|0|||
145697520|NCT00719043|525409800|FG000|Overall Study|Other|1|||
145697521|NCT00719043|525409801|FG001|Overall Study|Other|0|||
145697522|NCT00719043|525409802|FG002|Overall Study|Other|1|||
145697523|NCT00719043|525409803|FG003|Overall Study|Other|2|||
145697524|NCT00719043|525409804|FG004|Overall Study|Other|0|||
145697525|NCT00719043|525409805|FG005|Overall Study|Other|2|||
145697526|NCT00719043|525409806|FG006|Overall Study|Other|1|||
145697527|NCT00719043|525409800|FG000|Overall Study|Withdrawal by Subject|12|||
145697528|NCT00719043|525409801|FG001|Overall Study|Withdrawal by Subject|14|||
145697529|NCT00719043|525409802|FG002|Overall Study|Withdrawal by Subject|9|||
145697530|NCT00719043|525409803|FG003|Overall Study|Withdrawal by Subject|10|||
145697531|NCT00719043|525409804|FG004|Overall Study|Withdrawal by Subject|16|||
145697532|NCT00719043|525409805|FG005|Overall Study|Withdrawal by Subject|18|||
145697533|NCT00719043|525409806|FG006|Overall Study|Withdrawal by Subject|14|||
145697534|NCT00302159|525409807|FG000|Overall Study|pt declined before treatment started|1|||
145697535|NCT00302159|525409807|FG000|Overall Study|pt started Avastin|1|||
145697536|NCT00813098|525409808|FG000|Overall Study|Adverse Event|2|||
145697537|NCT00813098|525409809|FG001|Overall Study|Adverse Event|4|||
145697538|NCT00813098|525409810|FG002|Overall Study|Adverse Event|1|||
145697539|NCT00813098|525409808|FG000|Overall Study|Withdrawal by Subject|0|||
145697540|NCT00813098|525409809|FG001|Overall Study|Withdrawal by Subject|1|||
145697541|NCT00813098|525409810|FG002|Overall Study|Withdrawal by Subject|0|||
145697542|NCT00813098|525409808|FG000|Overall Study|Inability to complete study procedures|1|||
145697543|NCT00813098|525409809|FG001|Overall Study|Inability to complete study procedures|0|||
145697544|NCT00813098|525409810|FG002|Overall Study|Inability to complete study procedures|0|||
145697545|NCT00813098|525409808|FG000|Overall Study|Lost to Follow-up|0|||
145697546|NCT00813098|525409809|FG001|Overall Study|Lost to Follow-up|1|||
145697547|NCT00813098|525409810|FG002|Overall Study|Lost to Follow-up|0|||
145697548|NCT00813098|525409808|FG000|Overall Study|Protocol Violation|0|||
145697549|NCT00813098|525409809|FG001|Overall Study|Protocol Violation|0|||
145697550|NCT00813098|525409810|FG002|Overall Study|Protocol Violation|1|||
145697551|NCT00813098|525409808|FG000|Overall Study|Principal Investigator decision|0|||
145697552|NCT00813098|525409809|FG001|Overall Study|Principal Investigator decision|1|||
145697553|NCT00813098|525409810|FG002|Overall Study|Principal Investigator decision|0|||
145697554|NCT00813098|525409808|FG000|Overall Study|Withdrew Consent|0|||
145697555|NCT00813098|525409809|FG001|Overall Study|Withdrew Consent|1|||
145697556|NCT00813098|525409810|FG002|Overall Study|Withdrew Consent|0|||
145697557|NCT04962698|525409811|FG000|Motor Imagery|Technical difficulty|1|||
145697558|NCT04962698|525409812|FG001|Motor Imagery|Technical difficulty|0|||
145697559|NCT04962698|525409811|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
145697560|NCT04962698|525409812|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
145697561|NCT04962698|525409811|FG000|Kinesthetic MI|Technical difficulty|1|||
145697562|NCT04962698|525409812|FG001|Kinesthetic MI|Technical difficulty|0|||
145697563|NCT04962698|525409811|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
145697564|NCT04962698|525409812|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
145697565|NCT04962698|525409811|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
145697566|NCT04962698|525409812|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
145697567|NCT04962698|525409811|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
145697568|NCT04962698|525409812|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
145697569|NCT04962698|525409811|FG000|Virtual-hand Interaction|Technical difficulty|1|||
145697570|NCT04962698|525409812|FG001|Virtual-hand Interaction|Technical difficulty|0|||
145697571|NCT04962698|525409811|FG000|Robotic Action Observation|Technical difficulty|1|||
145697572|NCT04962698|525409812|FG001|Robotic Action Observation|Technical difficulty|0|||
145697573|NCT04962698|525409811|FG000|Rest|Technical difficulty|1|||
145697574|NCT04962698|525409812|FG001|Rest|Technical difficulty|0|||
145697575|NCT04962698|525409811|FG000|Rest|Exclusion criteria met after enrollment|0|||
145697576|NCT04962698|525409812|FG001|Rest|Exclusion criteria met after enrollment|2|||
145697577|NCT00853229|525409813|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
145697578|NCT00853229|525409814|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
145697579|NCT03470545|525409815|FG000|Overall Study|Death|0|||
145697580|NCT03470545|525409816|FG001|Overall Study|Death|1|||
145697581|NCT03470545|525409815|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
145697582|NCT03470545|525409816|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
145697583|NCT03470545|525409815|FG000|Overall Study|Adverse Event|2|||
145697584|NCT03470545|525409816|FG001|Overall Study|Adverse Event|0|||
145697585|NCT03470545|525409815|FG000|Overall Study|Withdrawal by Subject|1|||
145697586|NCT03470545|525409816|FG001|Overall Study|Withdrawal by Subject|1|||
145697587|NCT03470545|525409815|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
145697588|NCT03470545|525409816|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
145697589|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
145697590|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
145697591|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
145697592|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
145697593|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
145697594|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
145697595|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
145697596|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
145697597|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
145697598|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
145697599|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
145697600|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
145697601|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
145697602|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
145697603|NCT01664923|525409817|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
145697604|NCT01664923|525409818|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
145697605|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
145697606|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
145697607|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
145697608|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
145697609|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
145697610|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
145697611|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
145697612|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
145697613|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
145697614|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
145697615|NCT01664923|525409817|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
145697616|NCT01664923|525409818|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
145697617|NCT03672175|525409823|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
145697618|NCT03672175|525409824|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
145697619|NCT03672175|525409825|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
145697620|NCT03672175|525409823|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
145697621|NCT03672175|525409824|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
145697622|NCT03672175|525409825|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
145697623|NCT03672175|525409823|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
145697624|NCT03672175|525409824|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
145697625|NCT03672175|525409825|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
145697626|NCT03672175|525409823|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
145697627|NCT03672175|525409824|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
145697628|NCT03672175|525409825|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
145697629|NCT03672175|525409823|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
145697630|NCT03672175|525409824|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
145697631|NCT03672175|525409825|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
145697632|NCT03672175|525409823|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
145697633|NCT03672175|525409824|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
145697634|NCT03672175|525409825|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
145697635|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
145697636|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
145697637|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
145697638|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
145697639|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
145697640|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
145697641|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
145697642|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
145697643|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
145697644|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
145697645|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
145697646|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
145697647|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
145697648|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
145697649|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
145697650|NCT03672175|525409823|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
145697651|NCT03672175|525409824|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
145697652|NCT03672175|525409825|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
145697653|NCT02586415|525409827|FG000|Overall Study|Death|13|||
145697654|NCT02586415|525409828|FG001|Overall Study|Death|23|||
145697655|NCT02586415|525409827|FG000|Overall Study|Lost to Follow-up|1|||
145697656|NCT02586415|525409828|FG001|Overall Study|Lost to Follow-up|2|||
145697657|NCT02777242|525409829|FG000|Overall Study|Other|2|||
145697658|NCT02777242|525409829|FG000|Overall Study|Lost to Follow-up|1|||
145697659|NCT02777242|525409829|FG000|Overall Study|Multiple|1|||
145697660|NCT02777242|525409829|FG000|Overall Study|Sponsor's request|1|||
145697661|NCT02777242|525409829|FG000|Overall Study|Withdrawal by Subject|1|||
145697662|NCT00255944|525409830|FG000|Overall Study|Lost to Follow-up|797|||
145697663|NCT00255944|525409831|FG001|Overall Study|Lost to Follow-up|834|||
145697664|NCT05178979|525409832|FG000|Overall Study|Death|0|||
145697665|NCT05178979|525409833|FG001|Overall Study|Death|5|||
145697666|NCT05178979|525409834|FG002|Overall Study|Death|0|||
145697667|NCT05178979|525409835|FG003|Overall Study|Death|3|||
145697668|NCT05178979|525409832|FG000|Overall Study|Adverse Event|0|||
145697669|NCT05178979|525409833|FG001|Overall Study|Adverse Event|1|||
145697670|NCT05178979|525409834|FG002|Overall Study|Adverse Event|0|||
145697671|NCT05178979|525409835|FG003|Overall Study|Adverse Event|0|||
145697672|NCT05178979|525409832|FG000|Overall Study|Lost to Follow-up|1|||
145697673|NCT05178979|525409833|FG001|Overall Study|Lost to Follow-up|8|||
145697674|NCT05178979|525409834|FG002|Overall Study|Lost to Follow-up|3|||
145697675|NCT05178979|525409835|FG003|Overall Study|Lost to Follow-up|8|||
145697676|NCT01129115|525409837|FG000|Overall Study|Adverse Event|1|||
145697677|NCT01129115|525409838|FG001|Overall Study|Adverse Event|2|||
145697678|NCT01129115|525409839|FG002|Overall Study|Adverse Event|3|||
145697679|NCT01129115|525409840|FG003|Overall Study|Adverse Event|3|||
145697680|NCT01129115|525409837|FG000|Overall Study|Withdrawal by Subject|1|||
145697681|NCT01129115|525409838|FG001|Overall Study|Withdrawal by Subject|3|||
145697682|NCT01129115|525409839|FG002|Overall Study|Withdrawal by Subject|1|||
145697683|NCT01129115|525409840|FG003|Overall Study|Withdrawal by Subject|4|||
145697684|NCT01129115|525409837|FG000|Overall Study|Protocol Violation|0|||
145697685|NCT01129115|525409838|FG001|Overall Study|Protocol Violation|2|||
145697686|NCT01129115|525409839|FG002|Overall Study|Protocol Violation|2|||
145697687|NCT01129115|525409840|FG003|Overall Study|Protocol Violation|2|||
145697688|NCT01435798|525409843|FG000|Overall Study|Withdrawal by Subject|1|||
145697689|NCT00817336|525409844|FG000|Overall Study|Withdrawal by Subject|1|||
145697690|NCT00817336|525409845|FG001|Overall Study|Withdrawal by Subject|1|||
145697691|NCT00690378|525409846|FG000|Overall Study|Adverse Event|1|||
145697692|NCT00690378|525409847|FG001|Overall Study|Adverse Event|0|||
145697693|NCT00690378|525409846|FG000|Overall Study|Withdrawal by Subject|2|||
145697694|NCT00690378|525409847|FG001|Overall Study|Withdrawal by Subject|0|||
145697695|NCT00690378|525409846|FG000|Overall Study|Protocol Violation|1|||
145697696|NCT00690378|525409847|FG001|Overall Study|Protocol Violation|0|||
145697697|NCT00690378|525409846|FG000|Overall Study|Lost to Follow-up|2|||
145697698|NCT00690378|525409847|FG001|Overall Study|Lost to Follow-up|3|||
145697699|NCT00690378|525409846|FG000|Overall Study|Did not meet inc/exc criteria|13|||
145697700|NCT00690378|525409847|FG001|Overall Study|Did not meet inc/exc criteria|11|||
145697701|NCT00690378|525409846|FG000|Overall Study|Social problem|1|||
145697702|NCT00690378|525409847|FG001|Overall Study|Social problem|0|||
145697703|NCT00935259|525409854|FG000|Period 1|Administrative (scheduling conflict)|1|||
145697704|NCT00935259|525409855|FG001|Period 1|Administrative (scheduling conflict)|1|||
145697705|NCT02019641|525409856|FG000|10-Week Follow up|Withdrawal by investigator|2|||
145697706|NCT02019641|525409857|FG001|10-Week Follow up|Withdrawal by investigator|0|||
145697707|NCT02019641|525409858|FG002|10-Week Follow up|Withdrawal by investigator|0|||
145697708|NCT02019641|525409856|FG000|10-Week Follow up|Withdrawal by Subject|1|||
145697709|NCT02019641|525409857|FG001|10-Week Follow up|Withdrawal by Subject|1|||
145697710|NCT02019641|525409858|FG002|10-Week Follow up|Withdrawal by Subject|0|||
145697711|NCT02019641|525409856|FG000|20-Week Follow up|Withdrawal by investigator|0|||
145697712|NCT02019641|525409857|FG001|20-Week Follow up|Withdrawal by investigator|0|||
145697713|NCT02019641|525409858|FG002|20-Week Follow up|Withdrawal by investigator|1|||
145697714|NCT03318783|525409859|FG000|Overall Study|Withdrawal by Subject|0|||
145697715|NCT03318783|525409860|FG001|Overall Study|Withdrawal by Subject|1|||
145697716|NCT03318783|525409859|FG000|Overall Study|Death|0|||
145697717|NCT03318783|525409860|FG001|Overall Study|Death|1|||
145697718|NCT03410108|525409863|FG000|Overall Study|Ongoing|41|||
145697719|NCT03410108|525409863|FG000|Overall Study|Adverse Event|4|||
145697720|NCT03410108|525409863|FG000|Overall Study|Progressive Disease|58|||
145697721|NCT03410108|525409863|FG000|Overall Study|Withdrawal by Subject|1|||
145697722|NCT03856047|525409864|FG000|Overall Study|Withdrawal by Subject|0|||
145697723|NCT03856047|525409865|FG001|Overall Study|Withdrawal by Subject|1|||
145697724|NCT03856047|525409866|FG002|Overall Study|Withdrawal by Subject|1|||
145697725|NCT03856047|525409867|FG003|Overall Study|Withdrawal by Subject|0|||
145697726|NCT03856047|525409868|FG004|Overall Study|Withdrawal by Subject|3|||
145697727|NCT03856047|525409869|FG005|Overall Study|Withdrawal by Subject|0|||
145697728|NCT03856047|525409870|FG006|Overall Study|Withdrawal by Subject|2|||
145697729|NCT03856047|525409864|FG000|Overall Study|Lost to Follow-up|4|||
145697730|NCT03856047|525409865|FG001|Overall Study|Lost to Follow-up|2|||
145697731|NCT03856047|525409866|FG002|Overall Study|Lost to Follow-up|3|||
145697732|NCT03856047|525409867|FG003|Overall Study|Lost to Follow-up|1|||
145697733|NCT03856047|525409868|FG004|Overall Study|Lost to Follow-up|4|||
145697734|NCT03856047|525409869|FG005|Overall Study|Lost to Follow-up|4|||
145697735|NCT03856047|525409870|FG006|Overall Study|Lost to Follow-up|4|||
145697736|NCT00239681|525409877|FG000|Overall Study|Adverse Event|100|||
145697737|NCT00239681|525409878|FG001|Overall Study|Adverse Event|99|||
145697738|NCT00239681|525409877|FG000|Overall Study|Withdrawal by Subject|458|||
145697739|NCT00239681|525409878|FG001|Overall Study|Withdrawal by Subject|489|||
145697740|NCT00239681|525409877|FG000|Overall Study|Lost to Follow-up|28|||
145697741|NCT00239681|525409878|FG001|Overall Study|Lost to Follow-up|22|||
145697742|NCT00239681|525409877|FG000|Overall Study|Protocol Violation|4|||
145697743|NCT00239681|525409878|FG001|Overall Study|Protocol Violation|4|||
145697744|NCT00239681|525409877|FG000|Overall Study|Physician Decision|13|||
145697745|NCT00239681|525409878|FG001|Overall Study|Physician Decision|17|||
145697746|NCT00239681|525409877|FG000|Overall Study|No information chacked on CaseReportForm|90|||
145697747|NCT00239681|525409878|FG001|Overall Study|No information chacked on CaseReportForm|84|||
145697748|NCT02447718|525409879|FG000|Overall Study|Lost to Follow-up|8|||
145697749|NCT02447718|525409880|FG001|Overall Study|Lost to Follow-up|0|||
145697750|NCT02447718|525409879|FG000|Overall Study|Withdrawal by Subject|3|||
145697751|NCT02447718|525409880|FG001|Overall Study|Withdrawal by Subject|0|||
145697752|NCT02447718|525409879|FG000|Overall Study|Screen Failure|1|||
145697753|NCT02447718|525409880|FG001|Overall Study|Screen Failure|0|||
145697754|NCT02654132|525409883|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
145697755|NCT02654132|525409884|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
145697756|NCT02654132|525409883|FG000|Treatment Period|Disease progression|43|||
145697757|NCT02654132|525409884|FG001|Treatment Period|Disease progression|38|||
145697758|NCT02654132|525409883|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
145697759|NCT02654132|525409884|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
145697760|NCT02654132|525409883|FG000|Treatment Period|Other reasons|4|||
145697761|NCT02654132|525409884|FG001|Treatment Period|Other reasons|2|||
145697762|NCT02654132|525409883|FG000|Treatment Period|Study drug toxicity|2|||
145697763|NCT02654132|525409884|FG001|Treatment Period|Study drug toxicity|2|||
145697764|NCT02654132|525409883|FG000|Treatment Period|Withdrawal by Subject|2|||
145697765|NCT02654132|525409884|FG001|Treatment Period|Withdrawal by Subject|1|||
145697766|NCT02654132|525409883|FG000|Treatment Period|Maximum Clinical Benefit|0|||
145697767|NCT02654132|525409884|FG001|Treatment Period|Maximum Clinical Benefit|2|||
145697768|NCT02654132|525409883|FG000|Treatment Period|Participant request to discontinue|2|||
145697769|NCT02654132|525409884|FG001|Treatment Period|Participant request to discontinue|0|||
145697770|NCT02654132|525409883|FG000|Treatment Period|Administrative reasons by sponsor|0|||
145697771|NCT02654132|525409884|FG001|Treatment Period|Administrative reasons by sponsor|1|||
145697772|NCT02654132|525409883|FG000|Treatment Period|Death|1|||
145697773|NCT02654132|525409884|FG001|Treatment Period|Death|0|||
145697774|NCT01209598|525409887|FG000|Overall Study|Withdrawal by Subject|1|||
145697775|NCT01209598|525409888|FG001|Overall Study|Withdrawal by Subject|0|||
145697776|NCT02601209|525409889|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
145697777|NCT02601209|525409890|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
145697778|NCT02601209|525409891|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
145697779|NCT02601209|525409892|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697780|NCT02601209|525409893|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697781|NCT02601209|525409894|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697782|NCT02601209|525409895|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697783|NCT02601209|525409896|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697784|NCT02601209|525409897|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
145697785|NCT02601209|525409889|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697786|NCT02601209|525409890|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697787|NCT02601209|525409891|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697788|NCT02601209|525409892|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697789|NCT02601209|525409893|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
145697790|NCT02601209|525409894|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
145697791|NCT02601209|525409895|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
145697792|NCT02601209|525409896|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697793|NCT02601209|525409897|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
145697794|NCT01174264|525409898|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
145697795|NCT01174264|525409899|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
145697796|NCT01174264|525409900|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
145697797|NCT01174264|525409898|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
145697798|NCT01174264|525409899|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
145697799|NCT01174264|525409900|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
145697800|NCT01174264|525409898|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
145697801|NCT01174264|525409899|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
145697802|NCT01174264|525409900|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
145697803|NCT00934700|525409908|FG000|Overall Study|missing scan|5|||
145697804|NCT00934700|525409909|FG001|Overall Study|missing scan|9|||
145697805|NCT00934700|525409908|FG000|Overall Study|Death|8|||
145697806|NCT00934700|525409909|FG001|Overall Study|Death|3|||
145697807|NCT03049306|525409912|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
145697808|NCT03049306|525409913|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
145697809|NCT03151551|525409914|FG000|Open-Label Treatment Period|Adverse Event|0|||
145697810|NCT03151551|525409915|FG001|Open-Label Treatment Period|Adverse Event|2|||
145697811|NCT03151551|525409914|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
145697812|NCT03151551|525409915|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
145697813|NCT03151551|525409914|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
145697814|NCT03151551|525409915|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
145697815|NCT03151551|525409914|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
145697816|NCT03151551|525409915|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
145697817|NCT03151551|525409914|FG000|Open-Label Treatment Period|Physician Decision|3|||
145697818|NCT03151551|525409915|FG001|Open-Label Treatment Period|Physician Decision|0|||
145697819|NCT03151551|525409914|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
145697820|NCT03151551|525409915|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
145697821|NCT03151551|525409914|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
145697822|NCT03151551|525409915|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
145697823|NCT03151551|525409914|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
145697824|NCT03151551|525409915|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
145697825|NCT03151551|525409914|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
145697826|NCT03151551|525409915|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
145697827|NCT03151551|525409914|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
145697828|NCT03151551|525409915|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
145697829|NCT05896696|525409916|FG000|Overall Study|Screening Failure|7|||
145697830|NCT05896696|525409916|FG000|Overall Study|Withdrawal by Subject|2|||
145697831|NCT00143598|525409917|FG000|Overall Study|Lost to Follow-up|23|||
145697832|NCT00143598|525409918|FG001|Overall Study|Lost to Follow-up|21|||
145697833|NCT00143598|525409917|FG000|Overall Study|Withdrawal by Subject|33|||
145697834|NCT00143598|525409918|FG001|Overall Study|Withdrawal by Subject|37|||
145697835|NCT00143598|525409917|FG000|Overall Study|Death|36|||
145697836|NCT00143598|525409918|FG001|Overall Study|Death|36|||
145697837|NCT03900715|525409919|FG000|Overall Study|Protocol Deviation|1|||
145697838|NCT03900715|525409919|FG000|Overall Study|Lack of Efficacy|1|||
145697839|NCT03900715|525409919|FG000|Overall Study|Progressive Disease|6|||
145697840|NCT03900715|525409919|FG000|Overall Study|Adverse Event|2|||
145697841|NCT03900715|525409919|FG000|Overall Study|Other reasons|11|||
145697842|NCT01639742|525411921|FG000|Overall Study|Study Ongoing|17|||
145697843|NCT01639742|525411921|FG000|Overall Study|Lost to Follow-up|1|||
145697844|NCT04469465|525411922|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
145697845|NCT04469465|525411923|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
145697846|NCT04469465|525411922|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
145697847|NCT04469465|525411923|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
145697848|NCT04469465|525411922|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
145697849|NCT04469465|525411923|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
145697850|NCT04469465|525411922|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
145697851|NCT04469465|525411923|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
145697852|NCT04469465|525411922|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
145697853|NCT04469465|525411923|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
145697854|NCT04469465|525411922|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
145697855|NCT04469465|525411923|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
145697856|NCT04469465|525411922|FG000|Long-Term Extension (LTE)|Death|0|||
145697857|NCT04469465|525411923|FG001|Long-Term Extension (LTE)|Death|1|||
145697858|NCT04469465|525411922|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
145697859|NCT04469465|525411923|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
145697860|NCT04120376|525411924|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
145697861|NCT04120376|525411925|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
145697862|NCT00781937|525411930|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
145697863|NCT00781937|525411931|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
145697864|NCT00781937|525411930|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
145697865|NCT00781937|525411931|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
145697866|NCT00781937|525411930|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
145697867|NCT00781937|525411931|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
145697868|NCT00781937|525411930|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
145697869|NCT00781937|525411931|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
145697870|NCT00781937|525411930|FG000|Main Trial Period Through Week 56|Unclassified|10|||
145697871|NCT00781937|525411931|FG001|Main Trial Period Through Week 56|Unclassified|15|||
145697872|NCT00781937|525411930|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
145697873|NCT00781937|525411931|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
145697874|NCT00781937|525411930|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
145697875|NCT00781937|525411931|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
145697876|NCT01663506|525411933|FG000|Overall Study|Lack of Efficacy|3|||
145697877|NCT01663506|525411933|FG000|Overall Study|Consent Withdrawal by Subject|1|||
145697878|NCT01663506|525411933|FG000|Overall Study|Lost to Follow-up|1|||
145697879|NCT01663506|525411933|FG000|Overall Study|Adverse Event|1|||
145697880|NCT01663506|525411933|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
145697881|NCT02094898|525411939|FG000|Overall Study|Clinical Worsening|2|||
145697882|NCT02094898|525411939|FG000|Overall Study|Adverse Event|2|||
145697883|NCT02094898|525411939|FG000|Overall Study|Lack of Efficacy|1|||
145697884|NCT03520075|525411940|FG000|Phase 1 (Dose Escalation)|Death|2|||
145697885|NCT03520075|525411941|FG001|Phase 1 (Dose Escalation)|Death|2|||
145697886|NCT03520075|525411942|FG002|Phase 1 (Dose Escalation)|Death|3|||
145697887|NCT03520075|525411943|FG003|Phase 1 (Dose Escalation)|Death|2|||
145697888|NCT03520075|525411944|FG004|Phase 1 (Dose Escalation)|Death|6|||
145697889|NCT03520075|525411945|FG005|Phase 1 (Dose Escalation)|Death|5|||
145697890|NCT03520075|525411946|FG006|Phase 1 (Dose Escalation)|Death|3|||
145697891|NCT03520075|525411947|FG007|Phase 1 (Dose Escalation)|Death|2|||
145697892|NCT03520075|525411948|FG008|Phase 1 (Dose Escalation)|Death|3|||
145697893|NCT03520075|525411949|FG009|Phase 1 (Dose Escalation)|Death|1|||
145697894|NCT03520075|525411950|FG010|Phase 1 (Dose Escalation)|Death|5|||
145697895|NCT03520075|525411951|FG011|Phase 1 (Dose Escalation)|Death|7|||
145697896|NCT03520075|525411952|FG012|Phase 1 (Dose Escalation)|Death|11|||
145697897|NCT03520075|525411953|FG013|Phase 1 (Dose Escalation)|Death|0|||
145697898|NCT03520075|525411954|FG014|Phase 1 (Dose Escalation)|Death|0|||
145697899|NCT03520075|525411955|FG015|Phase 1 (Dose Escalation)|Death|0|||
145697900|NCT03520075|525411956|FG016|Phase 1 (Dose Escalation)|Death|0|||
145697901|NCT03520075|525411957|FG017|Phase 1 (Dose Escalation)|Death|0|||
145697902|NCT03520075|525411958|FG018|Phase 1 (Dose Escalation)|Death|0|||
145697903|NCT03520075|525411940|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
145697904|NCT03520075|525411941|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697905|NCT03520075|525411942|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697906|NCT03520075|525411943|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
145697907|NCT03520075|525411944|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
145697908|NCT03520075|525411945|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
145697909|NCT03520075|525411946|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697910|NCT03520075|525411947|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
145697911|NCT03520075|525411948|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697912|NCT03520075|525411949|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
145697913|NCT03520075|525411950|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697914|NCT03520075|525411951|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697915|NCT03520075|525411952|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
145697916|NCT03520075|525411953|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697917|NCT03520075|525411954|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697918|NCT03520075|525411955|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697919|NCT03520075|525411956|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697920|NCT03520075|525411957|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697921|NCT03520075|525411958|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
145697922|NCT03520075|525411940|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697923|NCT03520075|525411941|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
145697924|NCT03520075|525411942|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697925|NCT03520075|525411943|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
145697926|NCT03520075|525411944|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
145697927|NCT03520075|525411945|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697928|NCT03520075|525411946|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697929|NCT03520075|525411947|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697930|NCT03520075|525411948|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697931|NCT03520075|525411949|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697932|NCT03520075|525411950|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
145697933|NCT03520075|525411951|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697934|NCT03520075|525411952|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
145697935|NCT03520075|525411953|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697936|NCT03520075|525411954|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697937|NCT03520075|525411955|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697938|NCT03520075|525411956|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697939|NCT03520075|525411957|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697940|NCT03520075|525411958|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
145697941|NCT03520075|525411940|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697942|NCT03520075|525411941|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697943|NCT03520075|525411942|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697944|NCT03520075|525411943|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697945|NCT03520075|525411944|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697946|NCT03520075|525411945|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697947|NCT03520075|525411946|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697948|NCT03520075|525411947|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697949|NCT03520075|525411948|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697950|NCT03520075|525411949|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
145697951|NCT03520075|525411950|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697952|NCT03520075|525411951|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697953|NCT03520075|525411952|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
145697954|NCT03520075|525411953|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697955|NCT03520075|525411954|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697956|NCT03520075|525411955|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697957|NCT03520075|525411956|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697958|NCT03520075|525411957|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697959|NCT03520075|525411958|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
145697960|NCT03520075|525411940|FG000|Phase 2 (Dose Expansion)|Death|0|||
145697961|NCT03520075|525411941|FG001|Phase 2 (Dose Expansion)|Death|0|||
145697962|NCT03520075|525411942|FG002|Phase 2 (Dose Expansion)|Death|0|||
145697963|NCT03520075|525411943|FG003|Phase 2 (Dose Expansion)|Death|0|||
145697964|NCT03520075|525411944|FG004|Phase 2 (Dose Expansion)|Death|0|||
145697965|NCT03520075|525411945|FG005|Phase 2 (Dose Expansion)|Death|0|||
145697966|NCT03520075|525411946|FG006|Phase 2 (Dose Expansion)|Death|0|||
145697967|NCT03520075|525411947|FG007|Phase 2 (Dose Expansion)|Death|0|||
145697968|NCT03520075|525411948|FG008|Phase 2 (Dose Expansion)|Death|0|||
145697969|NCT03520075|525411949|FG009|Phase 2 (Dose Expansion)|Death|0|||
145697970|NCT03520075|525411950|FG010|Phase 2 (Dose Expansion)|Death|0|||
145697971|NCT03520075|525411951|FG011|Phase 2 (Dose Expansion)|Death|0|||
145697972|NCT03520075|525411952|FG012|Phase 2 (Dose Expansion)|Death|0|||
145697973|NCT03520075|525411953|FG013|Phase 2 (Dose Expansion)|Death|20|||
145697974|NCT03520075|525411954|FG014|Phase 2 (Dose Expansion)|Death|13|||
145697975|NCT03520075|525411955|FG015|Phase 2 (Dose Expansion)|Death|9|||
145697976|NCT03520075|525411956|FG016|Phase 2 (Dose Expansion)|Death|5|||
145697977|NCT03520075|525411957|FG017|Phase 2 (Dose Expansion)|Death|14|||
145697978|NCT03520075|525411958|FG018|Phase 2 (Dose Expansion)|Death|12|||
145697979|NCT03520075|525411940|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697980|NCT03520075|525411941|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697981|NCT03520075|525411942|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697982|NCT03520075|525411943|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697983|NCT03520075|525411944|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697984|NCT03520075|525411945|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697985|NCT03520075|525411946|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697986|NCT03520075|525411947|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697987|NCT03520075|525411948|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697988|NCT03520075|525411949|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697989|NCT03520075|525411950|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697990|NCT03520075|525411951|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145491427|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
145697991|NCT03520075|525411952|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697992|NCT03520075|525411953|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
145697993|NCT03520075|525411954|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
145697994|NCT03520075|525411955|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
145697995|NCT03520075|525411956|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
145697996|NCT03520075|525411957|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
145697997|NCT03520075|525411958|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
145697998|NCT03520075|525411940|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145697999|NCT03520075|525411941|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698000|NCT03520075|525411942|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698001|NCT03520075|525411943|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698002|NCT03520075|525411944|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698003|NCT03520075|525411945|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698004|NCT03520075|525411946|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698005|NCT03520075|525411947|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698006|NCT03520075|525411948|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698007|NCT03520075|525411949|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698008|NCT03520075|525411950|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698009|NCT03520075|525411951|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698010|NCT03520075|525411952|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698011|NCT03520075|525411953|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698012|NCT03520075|525411954|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
145698013|NCT03520075|525411955|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
145698014|NCT03520075|525411956|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698015|NCT03520075|525411957|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
145698016|NCT03520075|525411958|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
145698017|NCT03520075|525411940|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698018|NCT03520075|525411941|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698019|NCT03520075|525411942|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698020|NCT03520075|525411943|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698021|NCT03520075|525411944|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698022|NCT03520075|525411945|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698023|NCT03520075|525411946|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698024|NCT03520075|525411947|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698025|NCT03520075|525411948|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698026|NCT03520075|525411949|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698027|NCT03520075|525411950|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698028|NCT03520075|525411951|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698029|NCT03520075|525411952|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698030|NCT03520075|525411953|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
145698031|NCT03520075|525411954|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698032|NCT03520075|525411955|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698033|NCT03520075|525411956|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
145698034|NCT03520075|525411957|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
145698035|NCT03520075|525411958|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
145698036|NCT00328562|525411959|FG000|Overall Study|Disease progression|1|||
145698037|NCT00816556|525411960|FG000|Overall Study|Adverse Event|1|||
145698038|NCT00816556|525411961|FG001|Overall Study|Adverse Event|1|||
145698039|NCT00816556|525411962|FG002|Overall Study|Adverse Event|1|||
145698040|NCT00816556|525411960|FG000|Overall Study|Withdrawal by Subject|1|||
145698041|NCT00816556|525411961|FG001|Overall Study|Withdrawal by Subject|1|||
145698042|NCT00816556|525411962|FG002|Overall Study|Withdrawal by Subject|1|||
145698043|NCT00816556|525411960|FG000|Overall Study|Lost to Follow-up|0|||
145698044|NCT00816556|525411961|FG001|Overall Study|Lost to Follow-up|0|||
145698045|NCT00816556|525411962|FG002|Overall Study|Lost to Follow-up|1|||
145698046|NCT01161446|525411963|FG000|Overall Study|Lost to Follow-up|18|||
145698047|NCT01161446|525411964|FG001|Overall Study|Lost to Follow-up|14|||
145698048|NCT01161446|525411963|FG000|Overall Study|Withdrawal by Subject|0|||
145698049|NCT01161446|525411964|FG001|Overall Study|Withdrawal by Subject|1|||
145698050|NCT00810342|525411965|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
145698051|NCT00810342|525411966|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
145698052|NCT00810342|525411965|FG000|Month 1 Follow-up|Pregnancy|1|||
145698053|NCT00810342|525411966|FG001|Month 1 Follow-up|Pregnancy|0|||
145698054|NCT00810342|525411965|FG000|6-month Follow-up|Lost to Follow-up|18|||
145698055|NCT00810342|525411966|FG001|6-month Follow-up|Lost to Follow-up|6|||
145698056|NCT00810342|525411965|FG000|6-month Follow-up|Pregnancy|6|||
145698057|NCT00810342|525411966|FG001|6-month Follow-up|Pregnancy|2|||
145698058|NCT00810342|525411965|FG000|12-month Followup|Pregnancy|9|||
145698059|NCT00810342|525411966|FG001|12-month Followup|Pregnancy|10|||
145698060|NCT00810342|525411965|FG000|12-month Followup|Lost to Follow-up|3|||
145698061|NCT00810342|525411966|FG001|12-month Followup|Lost to Follow-up|1|||
145698062|NCT00412880|525411973|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
145698063|NCT00412880|525411973|FG000|Overall Study|Consent withdrawn|1|||
145698064|NCT00412880|525411973|FG000|Overall Study|Adverse Event|1|||
145698065|NCT00412880|525411973|FG000|Overall Study|Progressive disease|20|||
145698066|NCT02706951|525411975|FG000|Period 1|Adverse Event|1|||
145698067|NCT02706951|525411976|FG001|Period 1|Adverse Event|5|||
145698068|NCT02706951|525411977|FG002|Period 1|Adverse Event|3|||
145698069|NCT02706951|525411978|FG003|Period 1|Adverse Event|0|||
145698070|NCT02706951|525411979|FG004|Period 1|Adverse Event|0|||
145698071|NCT02706951|525411975|FG000|Period 1|Withdrawal by Subject|10|||
145698072|NCT02706951|525411976|FG001|Period 1|Withdrawal by Subject|6|||
145698073|NCT02706951|525411977|FG002|Period 1|Withdrawal by Subject|6|||
145698074|NCT02706951|525411978|FG003|Period 1|Withdrawal by Subject|0|||
145698075|NCT02706951|525411979|FG004|Period 1|Withdrawal by Subject|0|||
145698076|NCT02706951|525411975|FG000|Period 1|Lost to Follow-up|0|||
145698077|NCT02706951|525411976|FG001|Period 1|Lost to Follow-up|4|||
145698078|NCT02706951|525411977|FG002|Period 1|Lost to Follow-up|1|||
145698079|NCT02706951|525411978|FG003|Period 1|Lost to Follow-up|0|||
145698080|NCT02706951|525411979|FG004|Period 1|Lost to Follow-up|0|||
145698081|NCT02706951|525411975|FG000|Period 1|Other|2|||
145698082|NCT02706951|525411976|FG001|Period 1|Other|1|||
145698083|NCT02706951|525411977|FG002|Period 1|Other|0|||
145698084|NCT02706951|525411978|FG003|Period 1|Other|0|||
145698085|NCT02706951|525411979|FG004|Period 1|Other|0|||
145698086|NCT02706951|525411975|FG000|Period 2|Adverse Event|0|||
145698087|NCT02706951|525411976|FG001|Period 2|Adverse Event|0|||
145698088|NCT02706951|525411977|FG002|Period 2|Adverse Event|0|||
145698089|NCT02706951|525411978|FG003|Period 2|Adverse Event|25|||
145698090|NCT02706951|525411979|FG004|Period 2|Adverse Event|34|||
145698091|NCT02706951|525411975|FG000|Period 2|Withdrawal by Subject|0|||
145698092|NCT02706951|525411976|FG001|Period 2|Withdrawal by Subject|0|||
145698093|NCT02706951|525411977|FG002|Period 2|Withdrawal by Subject|0|||
145698094|NCT02706951|525411978|FG003|Period 2|Withdrawal by Subject|38|||
145698095|NCT02706951|525411979|FG004|Period 2|Withdrawal by Subject|44|||
145698096|NCT02706951|525411975|FG000|Period 2|Lost to Follow-up|0|||
145698097|NCT02706951|525411976|FG001|Period 2|Lost to Follow-up|0|||
145698098|NCT02706951|525411977|FG002|Period 2|Lost to Follow-up|0|||
145698099|NCT02706951|525411978|FG003|Period 2|Lost to Follow-up|17|||
145698100|NCT02706951|525411979|FG004|Period 2|Lost to Follow-up|9|||
145698101|NCT02706951|525411975|FG000|Period 2|COVID-19 Related|0|||
145698102|NCT02706951|525411976|FG001|Period 2|COVID-19 Related|0|||
145698103|NCT02706951|525411977|FG002|Period 2|COVID-19 Related|0|||
145698104|NCT02706951|525411978|FG003|Period 2|COVID-19 Related|1|||
145698105|NCT02706951|525411979|FG004|Period 2|COVID-19 Related|2|||
145698106|NCT02706951|525411975|FG000|Period 2|Other|0|||
145698107|NCT02706951|525411976|FG001|Period 2|Other|0|||
145698108|NCT02706951|525411977|FG002|Period 2|Other|0|||
145698109|NCT02706951|525411978|FG003|Period 2|Other|37|||
145698110|NCT02706951|525411979|FG004|Period 2|Other|31|||
145698111|NCT02165397|525411982|FG000|Overall Study|Death|7|||
145698112|NCT02165397|525411983|FG001|Overall Study|Death|10|||
145698113|NCT02165397|525411984|FG002|Overall Study|Death|8|||
145698114|NCT02165397|525411982|FG000|Overall Study|Lost to Follow-up|1|||
145698115|NCT02165397|525411983|FG001|Overall Study|Lost to Follow-up|3|||
145698116|NCT02165397|525411984|FG002|Overall Study|Lost to Follow-up|0|||
145698117|NCT02165397|525411982|FG000|Overall Study|Withdrawal by Subject|6|||
145698118|NCT02165397|525411983|FG001|Overall Study|Withdrawal by Subject|6|||
145698119|NCT02165397|525411984|FG002|Overall Study|Withdrawal by Subject|1|||
145698120|NCT02165397|525411982|FG000|Overall Study|Other, Not Specified|0|||
145698121|NCT02165397|525411983|FG001|Overall Study|Other, Not Specified|0|||
145698122|NCT02165397|525411984|FG002|Overall Study|Other, Not Specified|1|||
145698123|NCT00611715|525411987|FG000|Overall Study|Disease Progression|24|||
145698124|NCT00611715|525411988|FG001|Overall Study|Disease Progression|4|||
145698125|NCT00611715|525411987|FG000|Overall Study|Withdrawal by Subject|5|||
145698126|NCT00611715|525411988|FG001|Overall Study|Withdrawal by Subject|1|||
145698127|NCT00611715|525411987|FG000|Overall Study|Adverse Event|9|||
145698128|NCT00611715|525411988|FG001|Overall Study|Adverse Event|1|||
145698129|NCT00611715|525411987|FG000|Overall Study|Death|1|||
145698130|NCT00611715|525411988|FG001|Overall Study|Death|0|||
145698131|NCT00611715|525411987|FG000|Overall Study|two patients are still on treatment|2|||
145698132|NCT00611715|525411988|FG001|Overall Study|two patients are still on treatment|0|||
145698133|NCT00107978|525411989|FG000|Overall Study|Adverse Event|1|||
145698134|NCT00107978|525411990|FG001|Overall Study|Adverse Event|5|||
145698135|NCT00107978|525411989|FG000|Overall Study|Death|3|||
145698136|NCT00107978|525411990|FG001|Overall Study|Death|3|||
145698137|NCT00107978|525411989|FG000|Overall Study|Lost to Follow-up|20|||
145698138|NCT00107978|525411990|FG001|Overall Study|Lost to Follow-up|28|||
145698139|NCT00107978|525411989|FG000|Overall Study|Withdrawal by Subject|4|||
145698140|NCT00107978|525411990|FG001|Overall Study|Withdrawal by Subject|9|||
145698141|NCT00107978|525411989|FG000|Overall Study|Protocol Violation|0|||
145698142|NCT00107978|525411990|FG001|Overall Study|Protocol Violation|1|||
145698143|NCT00107978|525411989|FG000|Overall Study|Other|5|||
145698144|NCT00107978|525411990|FG001|Overall Study|Other|4|||
145698145|NCT00350298|525411993|FG000|Overall Study|Death|7|||
145698146|NCT00350298|525411994|FG001|Overall Study|Death|8|||
145698147|NCT00350298|525411993|FG000|Overall Study|Lost to Follow-up|1|||
145698148|NCT00350298|525411994|FG001|Overall Study|Lost to Follow-up|2|||
145698149|NCT00350298|525411993|FG000|Overall Study|Withdrawal by Subject|1|||
145698150|NCT00350298|525411994|FG001|Overall Study|Withdrawal by Subject|3|||
145698151|NCT00233389|525411997|FG000|Overall Study|Adverse Event|5|||
145698152|NCT00233389|525411998|FG001|Overall Study|Adverse Event|5|||
145698153|NCT00233389|525411997|FG000|Overall Study|Lack of Efficacy|11|||
145698154|NCT00233389|525411998|FG001|Overall Study|Lack of Efficacy|8|||
145698155|NCT00233389|525411997|FG000|Overall Study|Lost to Follow-up|1|||
145698156|NCT00233389|525411998|FG001|Overall Study|Lost to Follow-up|1|||
145698157|NCT00233389|525411997|FG000|Overall Study|Physician Decision|1|||
145698158|NCT00233389|525411998|FG001|Overall Study|Physician Decision|0|||
145698159|NCT00233389|525411997|FG000|Overall Study|Protocol Violation|0|||
145698160|NCT00233389|525411998|FG001|Overall Study|Protocol Violation|1|||
145698161|NCT00233389|525411997|FG000|Overall Study|Withdrawal by Subject|0|||
145698162|NCT00233389|525411998|FG001|Overall Study|Withdrawal by Subject|1|||
145698163|NCT02312206|525412007|FG000|Overall Study|Adverse Event|3|||
145698164|NCT02312206|525412008|FG001|Overall Study|Adverse Event|6|||
145698165|NCT02312206|525412007|FG000|Overall Study|Withdrawal by Subject|6|||
145698166|NCT02312206|525412008|FG001|Overall Study|Withdrawal by Subject|6|||
145698167|NCT02312206|525412007|FG000|Overall Study|Physician Decision|7|||
145698168|NCT02312206|525412008|FG001|Overall Study|Physician Decision|6|||
145698169|NCT02312206|525412007|FG000|Overall Study|Death|31|||
145698170|NCT02312206|525412008|FG001|Overall Study|Death|36|||
145698171|NCT02312206|525412007|FG000|Overall Study|Study Terminated by Sponsor|81|||
145698172|NCT02312206|525412008|FG001|Overall Study|Study Terminated by Sponsor|74|||
145698173|NCT02312206|525412007|FG000|Overall Study|Patient transferred to hospice|0|||
145698174|NCT02312206|525412008|FG001|Overall Study|Patient transferred to hospice|1|||
145698175|NCT02312206|525412007|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
145698176|NCT02312206|525412008|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
145698177|NCT02312206|525412007|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
145698178|NCT02312206|525412008|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
145698179|NCT02312206|525412007|FG000|Overall Study|Disease Progression|1|||
145698180|NCT02312206|525412008|FG001|Overall Study|Disease Progression|0|||
145698181|NCT03082612|525412009|FG000|Overall Study|Lost to Follow-up|2|||
145698182|NCT03082612|525412010|FG001|Overall Study|Lost to Follow-up|0|||
145698183|NCT01006616|525412011|FG000|Period 1 (6 Months)|Adverse Event|10|||
145698184|NCT01006616|525412012|FG001|Period 1 (6 Months)|Adverse Event|31|||
145698185|NCT01006616|525412013|FG002|Period 1 (6 Months)|Adverse Event|37|||
145698186|NCT01006616|525412014|FG003|Period 1 (6 Months)|Adverse Event|9|||
145698187|NCT01006616|525412011|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
145698188|NCT01006616|525412012|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
145698189|NCT01006616|525412013|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
145698190|NCT01006616|525412014|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
145698191|NCT01006616|525412011|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
145698192|NCT01006616|525412012|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
145698193|NCT01006616|525412013|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
145698194|NCT01006616|525412014|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
145698195|NCT01006616|525412011|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
145698196|NCT01006616|525412012|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
145698197|NCT01006616|525412013|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
145698198|NCT01006616|525412014|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
145698199|NCT01006616|525412011|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
145698200|NCT01006616|525412012|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
145698201|NCT01006616|525412013|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
145698202|NCT01006616|525412014|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
145698203|NCT01006616|525412011|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
145698204|NCT01006616|525412012|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
145698205|NCT01006616|525412013|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
145698206|NCT01006616|525412014|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
145698207|NCT01006616|525412011|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
145698208|NCT01006616|525412012|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
145698209|NCT01006616|525412013|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
145698210|NCT01006616|525412014|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
145698211|NCT01006616|525412011|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
145698212|NCT01006616|525412012|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
145698213|NCT01006616|525412013|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
145698214|NCT01006616|525412014|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
145698215|NCT01006616|525412011|FG000|Period 1 (6 Months)|Not Treated|0|||
145698216|NCT01006616|525412012|FG001|Period 1 (6 Months)|Not Treated|0|||
145698217|NCT01006616|525412013|FG002|Period 1 (6 Months)|Not Treated|1|||
145698218|NCT01006616|525412014|FG003|Period 1 (6 Months)|Not Treated|1|||
145698219|NCT01006616|525412011|FG000|Period 2 (18 Months)|Adverse Event|6|||
145698220|NCT01006616|525412012|FG001|Period 2 (18 Months)|Adverse Event|6|||
145698221|NCT01006616|525412013|FG002|Period 2 (18 Months)|Adverse Event|6|||
145698222|NCT01006616|525412014|FG003|Period 2 (18 Months)|Adverse Event|4|||
145698223|NCT01006616|525412011|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
145698224|NCT01006616|525412012|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
145698225|NCT01006616|525412013|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
145698226|NCT01006616|525412014|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
145698227|NCT01006616|525412011|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
145698228|NCT01006616|525412012|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
145698229|NCT01006616|525412013|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
145698230|NCT01006616|525412014|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
145698231|NCT01006616|525412011|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
145698232|NCT01006616|525412012|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
145698233|NCT01006616|525412013|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
145698234|NCT01006616|525412014|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
145698235|NCT01006616|525412011|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
145698236|NCT01006616|525412012|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
145698237|NCT01006616|525412013|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
145698238|NCT01006616|525412014|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
145698239|NCT01006616|525412011|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
145698240|NCT01006616|525412012|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
145698241|NCT01006616|525412013|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
145698242|NCT01006616|525412014|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
145698243|NCT01006616|525412011|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
145698244|NCT01006616|525412012|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
145698245|NCT01006616|525412013|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
145698246|NCT01006616|525412014|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
145698247|NCT01006616|525412011|FG000|Period 2 (18 Months)|Study Terminated|63|||
145698248|NCT01006616|525412012|FG001|Period 2 (18 Months)|Study Terminated|46|||
145698249|NCT01006616|525412013|FG002|Period 2 (18 Months)|Study Terminated|44|||
145698250|NCT01006616|525412014|FG003|Period 2 (18 Months)|Study Terminated|70|||
145698251|NCT00952848|525412019|FG000|Overall Study|Withdrawal by Subject|4|||
145698252|NCT02250534|525412020|FG000|Overall Study|Lost to Follow-up|18|||
145698253|NCT02250534|525412021|FG001|Overall Study|Lost to Follow-up|28|||
145698254|NCT02250534|525412022|FG002|Overall Study|Lost to Follow-up|33|||
145698255|NCT02250534|525412020|FG000|Overall Study|Personal reasons|7|||
145698256|NCT02250534|525412021|FG001|Overall Study|Personal reasons|8|||
145698257|NCT02250534|525412022|FG002|Overall Study|Personal reasons|14|||
145698258|NCT02250534|525412020|FG000|Overall Study|Adverse Event|6|||
145698259|NCT02250534|525412021|FG001|Overall Study|Adverse Event|3|||
145698260|NCT02250534|525412022|FG002|Overall Study|Adverse Event|8|||
145698261|NCT02250534|525412020|FG000|Overall Study|incarcerated|2|||
145698262|NCT02250534|525412021|FG001|Overall Study|incarcerated|1|||
145698263|NCT02250534|525412022|FG002|Overall Study|incarcerated|2|||
145698264|NCT02250534|525412020|FG000|Overall Study|Withdrawal by Subject|0|||
145698265|NCT02250534|525412021|FG001|Overall Study|Withdrawal by Subject|1|||
145698266|NCT02250534|525412022|FG002|Overall Study|Withdrawal by Subject|2|||
145698267|NCT02250534|525412020|FG000|Overall Study|Death|0|||
145698268|NCT02250534|525412021|FG001|Overall Study|Death|1|||
145698269|NCT02250534|525412022|FG002|Overall Study|Death|1|||
145698270|NCT02250534|525412020|FG000|Overall Study|Physician Decision|1|||
145698271|NCT02250534|525412021|FG001|Overall Study|Physician Decision|3|||
145698272|NCT02250534|525412022|FG002|Overall Study|Physician Decision|1|||
145698273|NCT02250534|525412020|FG000|Overall Study|Protocol Violation|1|||
145698274|NCT02250534|525412021|FG001|Overall Study|Protocol Violation|0|||
145698275|NCT02250534|525412022|FG002|Overall Study|Protocol Violation|1|||
145698276|NCT02250534|525412020|FG000|Overall Study|Reason unknown|1|||
145698277|NCT02250534|525412021|FG001|Overall Study|Reason unknown|0|||
145698278|NCT02250534|525412022|FG002|Overall Study|Reason unknown|0|||
145698279|NCT00458393|525412023|FG000|Overall Study|Withdrawal by Subject|67|||
145698280|NCT00458393|525412024|FG001|Overall Study|Withdrawal by Subject|80|||
145698281|NCT00458393|525412023|FG000|Overall Study|Physician Decision|31|||
145698282|NCT00458393|525412024|FG001|Overall Study|Physician Decision|22|||
145698283|NCT00458393|525412023|FG000|Overall Study|Relocated|77|||
145698284|NCT00458393|525412024|FG001|Overall Study|Relocated|81|||
145698285|NCT00458393|525412023|FG000|Overall Study|Lost to Follow-up|115|||
145698286|NCT00458393|525412024|FG001|Overall Study|Lost to Follow-up|92|||
145698287|NCT00458393|525412023|FG000|Overall Study|Sites marked other on the form.|19|||
145698288|NCT00458393|525412024|FG001|Overall Study|Sites marked other on the form.|20|||
145698289|NCT01253447|525412026|FG000|Overall Study|Adverse Event|2|||
145698290|NCT02299427|525412027|FG000|Overall Study|Withdrawal by Subject|1|||
145698291|NCT02299427|525412028|FG001|Overall Study|Withdrawal by Subject|0|||
145698292|NCT02299427|525412027|FG000|Overall Study|Lost to Follow-up|1|||
145698293|NCT02299427|525412028|FG001|Overall Study|Lost to Follow-up|3|||
145698294|NCT02299427|525412027|FG000|Overall Study|not adherent to dog website use|21|||
145265482|NCT00945815|523819373|FG000|Overall Study|Not protocol specified|1|||
145698295|NCT02299427|525412028|FG001|Overall Study|not adherent to dog website use|0|||
145698296|NCT01121913|525412031|FG000|First Intervention Period|Adverse Event|0|||
145698297|NCT01121913|525412032|FG001|First Intervention Period|Adverse Event|0|||
145698298|NCT01121913|525412033|FG002|First Intervention Period|Adverse Event|1|||
145698299|NCT01121913|525412034|FG003|First Intervention Period|Adverse Event|0|||
145698300|NCT01121913|525412031|FG000|First Washout Period|Withdrawal by Subject|1|||
145698301|NCT01121913|525412032|FG001|First Washout Period|Withdrawal by Subject|0|||
145698302|NCT01121913|525412033|FG002|First Washout Period|Withdrawal by Subject|0|||
145698303|NCT01121913|525412034|FG003|First Washout Period|Withdrawal by Subject|0|||
145698304|NCT01121913|525412031|FG000|Second Intervention Period|Adverse Event|0|||
145698305|NCT01121913|525412032|FG001|Second Intervention Period|Adverse Event|0|||
145698306|NCT01121913|525412033|FG002|Second Intervention Period|Adverse Event|1|||
145698307|NCT01121913|525412034|FG003|Second Intervention Period|Adverse Event|0|||
145698308|NCT01121913|525412031|FG000|Second Washout Period|Withdrawal by Subject|0|||
145698309|NCT01121913|525412032|FG001|Second Washout Period|Withdrawal by Subject|0|||
145698310|NCT01121913|525412033|FG002|Second Washout Period|Withdrawal by Subject|1|||
145698311|NCT01121913|525412034|FG003|Second Washout Period|Withdrawal by Subject|0|||
145698312|NCT01121913|525412031|FG000|Third Washout Period|Adverse Event|1|||
145698313|NCT01121913|525412032|FG001|Third Washout Period|Adverse Event|0|||
145698314|NCT01121913|525412033|FG002|Third Washout Period|Adverse Event|0|||
145698315|NCT01121913|525412034|FG003|Third Washout Period|Adverse Event|0|||
145698316|NCT00937521|525412035|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698317|NCT00937521|525412036|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698318|NCT00937521|525412037|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
145698319|NCT00937521|525412038|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698320|NCT00937521|525412039|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698321|NCT00937521|525412040|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698322|NCT00937521|525412041|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
145698323|NCT00937521|525412042|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
145698324|NCT00937521|525412035|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
145698325|NCT00937521|525412036|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
145698326|NCT00937521|525412037|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
145698327|NCT00937521|525412038|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
145698328|NCT00937521|525412039|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
145698329|NCT00937521|525412040|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
145698330|NCT00937521|525412041|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
145698331|NCT00937521|525412042|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
145698332|NCT00937521|525412035|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698333|NCT00937521|525412036|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698334|NCT00937521|525412037|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
145698335|NCT00937521|525412038|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
145698336|NCT00937521|525412039|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698337|NCT00937521|525412040|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698338|NCT00937521|525412041|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698339|NCT00937521|525412042|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
145698340|NCT00937521|525412035|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
145698341|NCT00937521|525412036|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
145698342|NCT00937521|525412037|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
145698343|NCT00937521|525412038|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
145698344|NCT00937521|525412039|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
145698345|NCT00937521|525412040|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
145698346|NCT00937521|525412041|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
145698347|NCT00937521|525412042|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
145698348|NCT00937521|525412035|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
145698349|NCT00937521|525412036|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698350|NCT00937521|525412037|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698351|NCT00937521|525412038|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698352|NCT00937521|525412039|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698353|NCT00937521|525412040|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698354|NCT00937521|525412041|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
145698355|NCT00937521|525412042|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
145698356|NCT00937521|525412035|FG000|Booster Phase|Adverse Event|0|||
145698357|NCT00937521|525412036|FG001|Booster Phase|Adverse Event|0|||
145698358|NCT00937521|525412037|FG002|Booster Phase|Adverse Event|0|||
145698359|NCT00937521|525412038|FG003|Booster Phase|Adverse Event|0|||
145698360|NCT00937521|525412039|FG004|Booster Phase|Adverse Event|0|||
145698361|NCT00937521|525412040|FG005|Booster Phase|Adverse Event|0|||
145698362|NCT00937521|525412041|FG006|Booster Phase|Adverse Event|1|||
145698363|NCT00937521|525412042|FG007|Booster Phase|Adverse Event|0|||
145698364|NCT00937521|525412035|FG000|Booster Phase|Withdrawal by Subject|1|||
145698365|NCT00937521|525412036|FG001|Booster Phase|Withdrawal by Subject|0|||
145698366|NCT00937521|525412037|FG002|Booster Phase|Withdrawal by Subject|0|||
145698367|NCT00937521|525412038|FG003|Booster Phase|Withdrawal by Subject|1|||
145698368|NCT00937521|525412039|FG004|Booster Phase|Withdrawal by Subject|0|||
145698369|NCT00937521|525412040|FG005|Booster Phase|Withdrawal by Subject|0|||
145698370|NCT00937521|525412041|FG006|Booster Phase|Withdrawal by Subject|0|||
145698371|NCT00937521|525412042|FG007|Booster Phase|Withdrawal by Subject|2|||
145698372|NCT00937521|525412035|FG000|Booster Phase|Lost to Follow-up|2|||
145698373|NCT00937521|525412036|FG001|Booster Phase|Lost to Follow-up|2|||
145698374|NCT00937521|525412037|FG002|Booster Phase|Lost to Follow-up|4|||
145698375|NCT00937521|525412038|FG003|Booster Phase|Lost to Follow-up|2|||
145698376|NCT00937521|525412039|FG004|Booster Phase|Lost to Follow-up|4|||
145698377|NCT00937521|525412040|FG005|Booster Phase|Lost to Follow-up|4|||
145698378|NCT00937521|525412041|FG006|Booster Phase|Lost to Follow-up|3|||
145698379|NCT00937521|525412042|FG007|Booster Phase|Lost to Follow-up|0|||
145698380|NCT00937521|525412035|FG000|Booster Phase|Administrative Reason|0|||
145698381|NCT00937521|525412036|FG001|Booster Phase|Administrative Reason|0|||
145698382|NCT00937521|525412037|FG002|Booster Phase|Administrative Reason|1|||
145698383|NCT00937521|525412038|FG003|Booster Phase|Administrative Reason|0|||
145698384|NCT00937521|525412039|FG004|Booster Phase|Administrative Reason|1|||
145698385|NCT00937521|525412040|FG005|Booster Phase|Administrative Reason|1|||
145698386|NCT00937521|525412041|FG006|Booster Phase|Administrative Reason|0|||
145698387|NCT00937521|525412042|FG007|Booster Phase|Administrative Reason|0|||
145698388|NCT00937521|525412035|FG000|Booster Phase|Protocol Deviation|0|||
145698389|NCT00937521|525412036|FG001|Booster Phase|Protocol Deviation|0|||
145698390|NCT00937521|525412037|FG002|Booster Phase|Protocol Deviation|0|||
145698391|NCT00937521|525412038|FG003|Booster Phase|Protocol Deviation|0|||
145698392|NCT00937521|525412039|FG004|Booster Phase|Protocol Deviation|0|||
145698393|NCT00937521|525412040|FG005|Booster Phase|Protocol Deviation|0|||
145698394|NCT00937521|525412041|FG006|Booster Phase|Protocol Deviation|1|||
145698395|NCT00937521|525412042|FG007|Booster Phase|Protocol Deviation|0|||
145698396|NCT03269695|525412045|FG000|Overall Study|Adverse Event|2|||
145698397|NCT03269695|525412046|FG001|Overall Study|Adverse Event|1|||
145698398|NCT03269695|525412045|FG000|Overall Study|Lack of Efficacy|0|||
145698399|NCT03269695|525412046|FG001|Overall Study|Lack of Efficacy|1|||
145698400|NCT03269695|525412045|FG000|Overall Study|Withdrawal by Subject|0|||
145698401|NCT03269695|525412046|FG001|Overall Study|Withdrawal by Subject|1|||
145698402|NCT00104637|525412047|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
145698403|NCT00104637|525412048|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
145698404|NCT01313624|525412049|FG000|Double-Blind Phase|Adverse Event|27|||
145698405|NCT01313624|525412050|FG001|Double-Blind Phase|Adverse Event|4|||
145698406|NCT01313624|525412049|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
145698407|NCT01313624|525412050|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
145698408|NCT01313624|525412049|FG000|Double-Blind Phase|Lost to Follow-up|0|||
145698409|NCT01313624|525412050|FG001|Double-Blind Phase|Lost to Follow-up|2|||
145698410|NCT01313624|525412049|FG000|Double-Blind Phase|Physician Decision|1|||
145698411|NCT01313624|525412050|FG001|Double-Blind Phase|Physician Decision|0|||
145698412|NCT01313624|525412049|FG000|Double-Blind Phase|Lack of Efficacy|1|||
145698413|NCT01313624|525412050|FG001|Double-Blind Phase|Lack of Efficacy|0|||
145698414|NCT01313624|525412049|FG000|Open-Label Phase|Adverse Event|1|||
145698415|NCT01313624|525412050|FG001|Open-Label Phase|Adverse Event|10|||
145698416|NCT01313624|525412049|FG000|Open-Label Phase|Withdrawal by Subject|2|||
145698417|NCT01313624|525412050|FG001|Open-Label Phase|Withdrawal by Subject|2|||
145698418|NCT01313624|525412049|FG000|Open-Label Phase|Lost to Follow-up|1|||
145698419|NCT01313624|525412050|FG001|Open-Label Phase|Lost to Follow-up|1|||
145698420|NCT01880437|525412051|FG000|Overall Study|Death|12|||
145698421|NCT01880437|525412052|FG001|Overall Study|Death|4|||
145698422|NCT01880437|525412053|FG002|Overall Study|Death|17|||
145698423|NCT01880437|525412051|FG000|Overall Study|Study terminated by Sponsor|3|||
145698424|NCT01880437|525412052|FG001|Overall Study|Study terminated by Sponsor|0|||
145698425|NCT01880437|525412053|FG002|Overall Study|Study terminated by Sponsor|2|||
145698426|NCT03713320|525412054|FG000|Randomized Period|Adverse Event|1|||
145698427|NCT03713320|525412055|FG001|Randomized Period|Adverse Event|5|||
145698428|NCT03713320|525412056|FG002|Randomized Period|Adverse Event|0|||
145698429|NCT03713320|525412054|FG000|Randomized Period|Physician Decision|1|||
145698430|NCT03713320|525412055|FG001|Randomized Period|Physician Decision|1|||
145698431|NCT03713320|525412056|FG002|Randomized Period|Physician Decision|0|||
145698432|NCT03713320|525412054|FG000|Randomized Period|Withdrawal by Subject|4|||
145698433|NCT03713320|525412055|FG001|Randomized Period|Withdrawal by Subject|0|||
145698434|NCT03713320|525412056|FG002|Randomized Period|Withdrawal by Subject|0|||
145698435|NCT03713320|525412054|FG000|Randomized Period|Participant decision|3|||
145265483|NCT00945815|523819373|FG000|Overall Study|Ineligible|3|||
145698436|NCT03713320|525412055|FG001|Randomized Period|Participant decision|1|||
145698437|NCT03713320|525412056|FG002|Randomized Period|Participant decision|0|||
145698438|NCT03713320|525412054|FG000|Randomized Period|Study terminated by sponsor|6|||
145698439|NCT03713320|525412055|FG001|Randomized Period|Study terminated by sponsor|3|||
145698440|NCT03713320|525412056|FG002|Randomized Period|Study terminated by sponsor|0|||
145698441|NCT03713320|525412054|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
145698442|NCT03713320|525412055|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
145698443|NCT03713320|525412056|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
145698444|NCT03713320|525412054|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
145698445|NCT03713320|525412055|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
145698446|NCT03713320|525412056|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
145698447|NCT00909532|525412057|FG000|Overall Study|Adverse Event|4|||
145698448|NCT00909532|525412058|FG001|Overall Study|Adverse Event|1|||
145698449|NCT00909532|525412057|FG000|Overall Study|Pregnancy|0|||
145698450|NCT00909532|525412058|FG001|Overall Study|Pregnancy|1|||
145698451|NCT00909532|525412057|FG000|Overall Study|Prohibited Medication|2|||
145698452|NCT00909532|525412058|FG001|Overall Study|Prohibited Medication|1|||
145698453|NCT00909532|525412057|FG000|Overall Study|Withdrawal of Consent|1|||
145698454|NCT00909532|525412058|FG001|Overall Study|Withdrawal of Consent|1|||
145698455|NCT00909532|525412057|FG000|Overall Study|Noncompliance with Study Requirements|0|||
145698456|NCT00909532|525412058|FG001|Overall Study|Noncompliance with Study Requirements|2|||
145698457|NCT00909532|525412057|FG000|Overall Study|Physician Decision|1|||
145698458|NCT00909532|525412058|FG001|Overall Study|Physician Decision|0|||
145698459|NCT00909532|525412057|FG000|Overall Study|Wrong Genotype|1|||
145698460|NCT00909532|525412058|FG001|Overall Study|Wrong Genotype|0|||
145698461|NCT00909532|525412057|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
145698462|NCT00909532|525412058|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
145698463|NCT02287233|525412059|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
145698464|NCT02287233|525412060|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
145698465|NCT02287233|525412061|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
145698466|NCT02287233|525412059|FG000|Overall Study|Adverse Event Related to Progression|0|||
145698467|NCT02287233|525412060|FG001|Overall Study|Adverse Event Related to Progression|2|||
145698468|NCT02287233|525412061|FG002|Overall Study|Adverse Event Related to Progression|8|||
145698469|NCT02287233|525412059|FG000|Overall Study|Physician Decision|1|||
145698470|NCT02287233|525412060|FG001|Overall Study|Physician Decision|2|||
145698471|NCT02287233|525412061|FG002|Overall Study|Physician Decision|4|||
145698472|NCT02287233|525412059|FG000|Overall Study|Progressive Disease with Death|0|||
145698473|NCT02287233|525412060|FG001|Overall Study|Progressive Disease with Death|0|||
145698474|NCT02287233|525412061|FG002|Overall Study|Progressive Disease with Death|10|||
145698475|NCT02287233|525412059|FG000|Overall Study|Progressive Disease Without Death|2|||
145698476|NCT02287233|525412060|FG001|Overall Study|Progressive Disease Without Death|3|||
145698477|NCT02287233|525412061|FG002|Overall Study|Progressive Disease Without Death|20|||
145698478|NCT02287233|525412059|FG000|Overall Study|Withdrawal by Subject|1|||
145698479|NCT02287233|525412060|FG001|Overall Study|Withdrawal by Subject|1|||
145698480|NCT02287233|525412061|FG002|Overall Study|Withdrawal by Subject|7|||
145698481|NCT02287233|525412059|FG000|Overall Study|Other|3|||
145698482|NCT02287233|525412060|FG001|Overall Study|Other|0|||
145698483|NCT02287233|525412061|FG002|Overall Study|Other|15|||
145698484|NCT02287233|525412059|FG000|Overall Study|Did Not Receive Treatment|0|||
145698485|NCT02287233|525412060|FG001|Overall Study|Did Not Receive Treatment|0|||
145698486|NCT02287233|525412061|FG002|Overall Study|Did Not Receive Treatment|2|||
145698487|NCT00085566|525412062|FG000|Overall Study|Adverse Event|0|||
145698488|NCT00085566|525412063|FG001|Overall Study|Adverse Event|0|||
145698489|NCT00085566|525412064|FG002|Overall Study|Adverse Event|10|||
145698490|NCT00085566|525412062|FG000|Overall Study|Patient Not treated|0|||
145698491|NCT00085566|525412063|FG001|Overall Study|Patient Not treated|0|||
145698492|NCT00085566|525412064|FG002|Overall Study|Patient Not treated|3|||
145698493|NCT00085566|525412062|FG000|Overall Study|Clinical progression|0|||
145698494|NCT00085566|525412063|FG001|Overall Study|Clinical progression|0|||
145698495|NCT00085566|525412064|FG002|Overall Study|Clinical progression|1|||
145698496|NCT02804399|525412065|FG000|Period 2|Adverse Event|0|||
145698497|NCT02804399|525412066|FG001|Period 2|Adverse Event|1|||
145698498|NCT01774305|525412067|FG000|Overall Study|Physician Decision|1|||
145698499|NCT01774305|525412068|FG001|Overall Study|Physician Decision|0|||
145698500|NCT01157377|525412070|FG000|Overall Study|Lost to Follow-up|0|||
145698501|NCT01157377|525412071|FG001|Overall Study|Lost to Follow-up|0|||
145698502|NCT01157377|525412072|FG002|Overall Study|Lost to Follow-up|1|||
145698503|NCT01157377|525412073|FG003|Overall Study|Lost to Follow-up|0|||
145698504|NCT01157377|525412074|FG004|Overall Study|Lost to Follow-up|1|||
145698505|NCT01157377|525412075|FG005|Overall Study|Lost to Follow-up|1|||
145698506|NCT01157377|525412076|FG006|Overall Study|Lost to Follow-up|0|||
145698507|NCT01157377|525412070|FG000|Overall Study|Personal Reasons|2|||
145698508|NCT01157377|525412071|FG001|Overall Study|Personal Reasons|1|||
145698509|NCT01157377|525412072|FG002|Overall Study|Personal Reasons|0|||
145698510|NCT01157377|525412073|FG003|Overall Study|Personal Reasons|1|||
145698511|NCT01157377|525412074|FG004|Overall Study|Personal Reasons|0|||
145698512|NCT01157377|525412075|FG005|Overall Study|Personal Reasons|0|||
145698513|NCT01157377|525412076|FG006|Overall Study|Personal Reasons|0|||
145698514|NCT01157377|525412070|FG000|Overall Study|Protocol Violation|0|||
145698515|NCT01157377|525412071|FG001|Overall Study|Protocol Violation|0|||
145698516|NCT01157377|525412072|FG002|Overall Study|Protocol Violation|0|||
145698517|NCT01157377|525412073|FG003|Overall Study|Protocol Violation|0|||
145698518|NCT01157377|525412074|FG004|Overall Study|Protocol Violation|0|||
145698519|NCT01157377|525412075|FG005|Overall Study|Protocol Violation|1|||
145698520|NCT01157377|525412076|FG006|Overall Study|Protocol Violation|0|||
145698521|NCT01157377|525412070|FG000|Overall Study|Lack of Efficacy|0|||
145698522|NCT01157377|525412071|FG001|Overall Study|Lack of Efficacy|0|||
145698523|NCT01157377|525412072|FG002|Overall Study|Lack of Efficacy|0|||
145698524|NCT01157377|525412073|FG003|Overall Study|Lack of Efficacy|0|||
145698525|NCT01157377|525412074|FG004|Overall Study|Lack of Efficacy|0|||
145698526|NCT01157377|525412075|FG005|Overall Study|Lack of Efficacy|0|||
145698527|NCT01157377|525412076|FG006|Overall Study|Lack of Efficacy|1|||
145698528|NCT01157377|525412070|FG000|Overall Study|Other Miscellaneous Reasons|0|||
145698529|NCT01157377|525412071|FG001|Overall Study|Other Miscellaneous Reasons|2|||
145698530|NCT01157377|525412072|FG002|Overall Study|Other Miscellaneous Reasons|0|||
145698531|NCT01157377|525412073|FG003|Overall Study|Other Miscellaneous Reasons|0|||
145698532|NCT01157377|525412074|FG004|Overall Study|Other Miscellaneous Reasons|1|||
145698533|NCT01157377|525412075|FG005|Overall Study|Other Miscellaneous Reasons|1|||
145698534|NCT01157377|525412076|FG006|Overall Study|Other Miscellaneous Reasons|1|||
145698535|NCT00087555|525412077|FG000|Overall Study|Adverse Event|3|||
145698536|NCT00087555|525412078|FG001|Overall Study|Adverse Event|6|||
145698537|NCT00087555|525412079|FG002|Overall Study|Adverse Event|14|||
145698538|NCT00087555|525412077|FG000|Overall Study|Lost to Follow-up|0|||
145698539|NCT00087555|525412078|FG001|Overall Study|Lost to Follow-up|1|||
145698540|NCT00087555|525412079|FG002|Overall Study|Lost to Follow-up|1|||
145698541|NCT00087555|525412077|FG000|Overall Study|Non - Compliance|1|||
145698542|NCT00087555|525412078|FG001|Overall Study|Non - Compliance|0|||
145698543|NCT00087555|525412079|FG002|Overall Study|Non - Compliance|0|||
145698544|NCT00087555|525412077|FG000|Overall Study|Protocol Violation|0|||
145698545|NCT00087555|525412078|FG001|Overall Study|Protocol Violation|0|||
145698546|NCT00087555|525412079|FG002|Overall Study|Protocol Violation|2|||
145698547|NCT00087555|525412077|FG000|Overall Study|Screen Failure|1|||
145698548|NCT00087555|525412078|FG001|Overall Study|Screen Failure|1|||
145698549|NCT00087555|525412079|FG002|Overall Study|Screen Failure|0|||
145698550|NCT00087555|525412077|FG000|Overall Study|Pregnancy|0|||
145698551|NCT00087555|525412078|FG001|Overall Study|Pregnancy|1|||
145698552|NCT00087555|525412079|FG002|Overall Study|Pregnancy|1|||
145698553|NCT00087555|525412077|FG000|Overall Study|Withdrawal by Subject|3|||
145698554|NCT00087555|525412078|FG001|Overall Study|Withdrawal by Subject|2|||
145698555|NCT00087555|525412079|FG002|Overall Study|Withdrawal by Subject|1|||
145698556|NCT00087555|525412077|FG000|Overall Study|Lack of Efficacy|2|||
145698557|NCT00087555|525412078|FG001|Overall Study|Lack of Efficacy|0|||
145698558|NCT00087555|525412079|FG002|Overall Study|Lack of Efficacy|1|||
145698559|NCT00087555|525412077|FG000|Overall Study|Non Compliance|0|||
145698560|NCT00087555|525412078|FG001|Overall Study|Non Compliance|0|||
145698561|NCT00087555|525412079|FG002|Overall Study|Non Compliance|1|||
145698562|NCT00087555|525412077|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
145698563|NCT00087555|525412078|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
145698564|NCT00087555|525412079|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
145698565|NCT00087555|525412077|FG000|Overall Study|Patient wanted to go back on Med|1|||
145698566|NCT00087555|525412078|FG001|Overall Study|Patient wanted to go back on Med|0|||
145698567|NCT00087555|525412079|FG002|Overall Study|Patient wanted to go back on Med|0|||
145698568|NCT05523219|525412080|FG000|Overall Study|Wrong inclusion|1|||
145698569|NCT05523219|525412080|FG000|Overall Study|Lost to Follow-up|7|||
145698570|NCT03772613|525412081|FG000|Overall Study|Lost to Follow-up|0|||
145698571|NCT03772613|525412082|FG001|Overall Study|Lost to Follow-up|1|||
145698572|NCT03772613|525412083|FG002|Overall Study|Lost to Follow-up|1|||
145698573|NCT00661713|525412084|FG000|Overall Study|Death|1|||
145698574|NCT00661713|525412085|FG001|Overall Study|Death|0|||
145698575|NCT00661713|525412086|FG002|Overall Study|Death|0|||
145698576|NCT00661713|525412087|FG003|Overall Study|Death|0|||
145698577|NCT00661713|525412088|FG004|Overall Study|Death|1|||
145698578|NCT00661713|525412089|FG005|Overall Study|Death|0|||
145698579|NCT00661713|525412090|FG006|Overall Study|Death|0|||
145698580|NCT00661713|525412091|FG007|Overall Study|Death|0|||
145698581|NCT00661713|525412084|FG000|Overall Study|Unable to Classify|1|||
145698582|NCT00661713|525412085|FG001|Overall Study|Unable to Classify|0|||
145698583|NCT00661713|525412086|FG002|Overall Study|Unable to Classify|0|||
145698584|NCT00661713|525412087|FG003|Overall Study|Unable to Classify|0|||
145698585|NCT00661713|525412088|FG004|Overall Study|Unable to Classify|0|||
145698586|NCT00661713|525412089|FG005|Overall Study|Unable to Classify|0|||
145698587|NCT00661713|525412090|FG006|Overall Study|Unable to Classify|0|||
145698588|NCT00661713|525412091|FG007|Overall Study|Unable to Classify|0|||
145698589|NCT00661713|525412084|FG000|Overall Study|Protocol Violation|1|||
145698590|NCT00661713|525412085|FG001|Overall Study|Protocol Violation|6|||
145698591|NCT00661713|525412086|FG002|Overall Study|Protocol Violation|3|||
145698592|NCT00661713|525412087|FG003|Overall Study|Protocol Violation|3|||
145698593|NCT00661713|525412088|FG004|Overall Study|Protocol Violation|0|||
145698594|NCT00661713|525412089|FG005|Overall Study|Protocol Violation|2|||
145698595|NCT00661713|525412090|FG006|Overall Study|Protocol Violation|2|||
145698596|NCT00661713|525412091|FG007|Overall Study|Protocol Violation|1|||
145698597|NCT00661713|525412084|FG000|Overall Study|Withdrawal by Subject|11|||
145698598|NCT00661713|525412085|FG001|Overall Study|Withdrawal by Subject|25|||
145698599|NCT00661713|525412086|FG002|Overall Study|Withdrawal by Subject|12|||
145698600|NCT00661713|525412087|FG003|Overall Study|Withdrawal by Subject|21|||
145698601|NCT00661713|525412088|FG004|Overall Study|Withdrawal by Subject|12|||
145698602|NCT00661713|525412089|FG005|Overall Study|Withdrawal by Subject|26|||
145698603|NCT00661713|525412090|FG006|Overall Study|Withdrawal by Subject|45|||
145698604|NCT00661713|525412091|FG007|Overall Study|Withdrawal by Subject|9|||
145698605|NCT00661713|525412084|FG000|Overall Study|Lost to Follow-up|2|||
145698606|NCT00661713|525412085|FG001|Overall Study|Lost to Follow-up|7|||
145698607|NCT00661713|525412086|FG002|Overall Study|Lost to Follow-up|2|||
145698608|NCT00661713|525412087|FG003|Overall Study|Lost to Follow-up|2|||
145698609|NCT00661713|525412088|FG004|Overall Study|Lost to Follow-up|5|||
145698610|NCT00661713|525412089|FG005|Overall Study|Lost to Follow-up|7|||
145698611|NCT00661713|525412090|FG006|Overall Study|Lost to Follow-up|14|||
145698612|NCT00661713|525412091|FG007|Overall Study|Lost to Follow-up|1|||
145698613|NCT00661713|525412084|FG000|Overall Study|Administrative Reason|0|||
145698614|NCT00661713|525412085|FG001|Overall Study|Administrative Reason|1|||
145698615|NCT00661713|525412086|FG002|Overall Study|Administrative Reason|0|||
145698616|NCT00661713|525412087|FG003|Overall Study|Administrative Reason|2|||
145698617|NCT00661713|525412088|FG004|Overall Study|Administrative Reason|2|||
145698618|NCT00661713|525412089|FG005|Overall Study|Administrative Reason|2|||
145698619|NCT00661713|525412090|FG006|Overall Study|Administrative Reason|1|||
145698620|NCT00661713|525412091|FG007|Overall Study|Administrative Reason|0|||
145698621|NCT00661713|525412084|FG000|Overall Study|Adverse Event|0|||
145698622|NCT00661713|525412085|FG001|Overall Study|Adverse Event|0|||
145698623|NCT00661713|525412086|FG002|Overall Study|Adverse Event|0|||
145698624|NCT00661713|525412087|FG003|Overall Study|Adverse Event|0|||
145698625|NCT00661713|525412088|FG004|Overall Study|Adverse Event|0|||
145698626|NCT00661713|525412089|FG005|Overall Study|Adverse Event|0|||
145698627|NCT00661713|525412090|FG006|Overall Study|Adverse Event|1|||
145698628|NCT00661713|525412091|FG007|Overall Study|Adverse Event|0|||
145698629|NCT00661713|525412084|FG000|Overall Study|Inappropriate Enrollment|0|||
145698630|NCT00661713|525412085|FG001|Overall Study|Inappropriate Enrollment|0|||
145698631|NCT00661713|525412086|FG002|Overall Study|Inappropriate Enrollment|0|||
145698632|NCT00661713|525412087|FG003|Overall Study|Inappropriate Enrollment|0|||
145698633|NCT00661713|525412088|FG004|Overall Study|Inappropriate Enrollment|0|||
145698634|NCT00661713|525412089|FG005|Overall Study|Inappropriate Enrollment|0|||
145698635|NCT00661713|525412090|FG006|Overall Study|Inappropriate Enrollment|1|||
145698636|NCT00661713|525412091|FG007|Overall Study|Inappropriate Enrollment|0|||
145698637|NCT01190449|525412092|FG000|Overall Study|Ineligible|0|||
145698638|NCT01190449|525412093|FG001|Overall Study|Ineligible|4|||
145698639|NCT04811339|525412094|FG000|Overall Study|lack of transportation not wanting to return|4|||
145698640|NCT04811339|525412095|FG001|Overall Study|lack of transportation not wanting to return|8|||
145698641|NCT04811339|525412096|FG002|Overall Study|lack of transportation not wanting to return|0|||
145698642|NCT04811339|525412094|FG000|Overall Study|Adverse Event|3|||
145698643|NCT04811339|525412095|FG001|Overall Study|Adverse Event|0|||
145698644|NCT04811339|525412096|FG002|Overall Study|Adverse Event|0|||
145698645|NCT04811339|525412094|FG000|Overall Study|Lost to Follow-up|1|||
145698646|NCT04811339|525412095|FG001|Overall Study|Lost to Follow-up|0|||
145698647|NCT04811339|525412096|FG002|Overall Study|Lost to Follow-up|0|||
145698648|NCT04811339|525412094|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
145698649|NCT04811339|525412095|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
145698650|NCT04811339|525412096|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
145698651|NCT04811339|525412094|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
145698652|NCT04811339|525412095|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
145698653|NCT04811339|525412096|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
145698654|NCT04811339|525412094|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
145698655|NCT04811339|525412095|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
145698656|NCT04811339|525412096|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
145698657|NCT04811339|525412094|FG000|Overall Study|Withdrawal by Subject|0|||
145698658|NCT04811339|525412095|FG001|Overall Study|Withdrawal by Subject|3|||
145698659|NCT04811339|525412096|FG002|Overall Study|Withdrawal by Subject|0|||
145698660|NCT04811339|525412094|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
145698661|NCT04811339|525412095|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
145698662|NCT04811339|525412096|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
145698663|NCT04811339|525412094|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
145698664|NCT04811339|525412095|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
145698665|NCT04811339|525412096|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
145698666|NCT01266018|525414606|FG000|Overall Study|Physician Decision|1|||
145698667|NCT01266018|525414607|FG001|Overall Study|Physician Decision|0|||
145698668|NCT01266018|525414606|FG000|Overall Study|Progressive disease|0|||
145698669|NCT01266018|525414607|FG001|Overall Study|Progressive disease|1|||
145698670|NCT02370251|525414609|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
145698671|NCT02370251|525414609|FG000|Overall Study|Death|4|||
145698672|NCT02053610|525414610|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
145698673|NCT02053610|525414611|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
145698674|NCT02053610|525414610|FG000|Overall Study|Withdrew Consent|2|||
145698675|NCT02053610|525414611|FG001|Overall Study|Withdrew Consent|9|||
145698676|NCT02053610|525414610|FG000|Overall Study|Death|5|||
145698677|NCT02053610|525414611|FG001|Overall Study|Death|5|||
145698678|NCT02053610|525414610|FG000|Overall Study|Administrative/Other|1|||
145698679|NCT02053610|525414611|FG001|Overall Study|Administrative/Other|1|||
145698680|NCT02053610|525414610|FG000|Overall Study|Disease Progression|2|||
145698681|NCT02053610|525414611|FG001|Overall Study|Disease Progression|3|||
145698682|NCT02053610|525414610|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
145698683|NCT02053610|525414611|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
145698684|NCT02053610|525414610|FG000|Overall Study|Did not Receive Treatment|4|||
145698685|NCT02053610|525414611|FG001|Overall Study|Did not Receive Treatment|2|||
145698686|NCT02053610|525414610|FG000|Overall Study|Insufficient Therapeutic Response|1|||
145698687|NCT02053610|525414611|FG001|Overall Study|Insufficient Therapeutic Response|1|||
145698688|NCT02053610|525414610|FG000|Overall Study|Violation of Selection Criteria|1|||
145698689|NCT02053610|525414611|FG001|Overall Study|Violation of Selection Criteria|0|||
145698690|NCT02641587|525414612|FG000|Confinement Period|Adverse Event|1|||
145698691|NCT02641587|525414613|FG001|Confinement Period|Adverse Event|0|||
145698692|NCT02641587|525414612|FG000|Confinement Period|Withdrawal by Subject|2|||
145698693|NCT02641587|525414613|FG001|Confinement Period|Withdrawal by Subject|1|||
145698694|NCT02641587|525414612|FG000|Ambulatory Period|Withdrawal by Subject|1|||
145698695|NCT02641587|525414613|FG001|Ambulatory Period|Withdrawal by Subject|0|||
145698696|NCT01165177|525414614|FG000|Overall Study|Serious Adverse Event|227|||
145698697|NCT01165177|525414615|FG001|Overall Study|Serious Adverse Event|235|||
145698698|NCT01165177|525414614|FG000|Overall Study|Withdrawal by Subject|368|||
145698699|NCT01165177|525414615|FG001|Overall Study|Withdrawal by Subject|354|||
145698700|NCT01165177|525414614|FG000|Overall Study|Protocol Violation|19|||
145698701|NCT01165177|525414615|FG001|Overall Study|Protocol Violation|21|||
145698702|NCT01165177|525414614|FG000|Overall Study|Non-serious adverse event|30|||
145698703|NCT01165177|525414615|FG001|Overall Study|Non-serious adverse event|18|||
145698704|NCT01165177|525414614|FG000|Overall Study|Other unspecified reasons|47|||
145698705|NCT01165177|525414615|FG001|Overall Study|Other unspecified reasons|35|||
145698706|NCT01165177|525414614|FG000|Overall Study|Suspected HZ episode|0|||
145698707|NCT01165177|525414615|FG001|Overall Study|Suspected HZ episode|2|||
145698708|NCT01165177|525414614|FG000|Overall Study|Lost to Follow-up|183|||
145698709|NCT01165177|525414615|FG001|Overall Study|Lost to Follow-up|194|||
145698710|NCT01165177|525414614|FG000|Overall Study|Migrated/ moved from study area|48|||
145698711|NCT01165177|525414615|FG001|Overall Study|Migrated/ moved from study area|43|||
145698712|NCT01150045|525414617|FG000|Overall Study|Protocol Violation|0|||
145698713|NCT01150045|525414618|FG001|Overall Study|Protocol Violation|1|||
145698714|NCT01150045|525414619|FG002|Overall Study|Protocol Violation|0|||
145698715|NCT01150045|525414620|FG003|Overall Study|Protocol Violation|1|||
145698716|NCT04504630|525414624|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
145698717|NCT04504630|525414625|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
145698718|NCT04504630|525414624|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
145698719|NCT04504630|525414625|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
145698720|NCT01288209|525414626|FG000|Overall Study|Withdrawal by Subject|1|||
145698721|NCT01288209|525414627|FG001|Overall Study|Withdrawal by Subject|3|||
145698722|NCT01288209|525414626|FG000|Overall Study|Other|1|||
145698723|NCT01288209|525414627|FG001|Overall Study|Other|0|||
145698724|NCT01496365|525414628|FG000|Overall Study|Adverse Event|2|||
145698725|NCT01496365|525414629|FG001|Overall Study|Adverse Event|3|||
145698726|NCT01496365|525414630|FG002|Overall Study|Adverse Event|3|||
145698727|NCT01496365|525414631|FG003|Overall Study|Adverse Event|2|||
145698728|NCT01496365|525414632|FG004|Overall Study|Adverse Event|5|||
145698729|NCT01496365|525414633|FG005|Overall Study|Adverse Event|6|||
145698730|NCT01496365|525414634|FG006|Overall Study|Adverse Event|4|||
145698731|NCT01496365|525414628|FG000|Overall Study|Withdrawal by Subject|6|||
145698732|NCT01496365|525414629|FG001|Overall Study|Withdrawal by Subject|6|||
145698733|NCT01496365|525414630|FG002|Overall Study|Withdrawal by Subject|0|||
145698734|NCT01496365|525414631|FG003|Overall Study|Withdrawal by Subject|1|||
145698735|NCT01496365|525414632|FG004|Overall Study|Withdrawal by Subject|3|||
145698736|NCT01496365|525414633|FG005|Overall Study|Withdrawal by Subject|2|||
145698737|NCT01496365|525414634|FG006|Overall Study|Withdrawal by Subject|1|||
145698738|NCT01496365|525414628|FG000|Overall Study|Protocol Violation|2|||
145698739|NCT01496365|525414629|FG001|Overall Study|Protocol Violation|1|||
145698740|NCT01496365|525414630|FG002|Overall Study|Protocol Violation|1|||
145698741|NCT01496365|525414631|FG003|Overall Study|Protocol Violation|0|||
145698742|NCT01496365|525414632|FG004|Overall Study|Protocol Violation|0|||
145698743|NCT01496365|525414633|FG005|Overall Study|Protocol Violation|1|||
145698744|NCT01496365|525414634|FG006|Overall Study|Protocol Violation|0|||
145698745|NCT01496365|525414628|FG000|Overall Study|Lack of Efficacy|1|||
145698746|NCT01496365|525414629|FG001|Overall Study|Lack of Efficacy|0|||
145698747|NCT01496365|525414630|FG002|Overall Study|Lack of Efficacy|0|||
145698748|NCT01496365|525414631|FG003|Overall Study|Lack of Efficacy|0|||
145698749|NCT01496365|525414632|FG004|Overall Study|Lack of Efficacy|0|||
145698750|NCT01496365|525414633|FG005|Overall Study|Lack of Efficacy|1|||
145698751|NCT01496365|525414634|FG006|Overall Study|Lack of Efficacy|0|||
145698752|NCT01496365|525414628|FG000|Overall Study|Lost to Follow-up|0|||
145698753|NCT01496365|525414629|FG001|Overall Study|Lost to Follow-up|1|||
145698754|NCT01496365|525414630|FG002|Overall Study|Lost to Follow-up|0|||
145698755|NCT01496365|525414631|FG003|Overall Study|Lost to Follow-up|0|||
145698756|NCT01496365|525414632|FG004|Overall Study|Lost to Follow-up|2|||
145698757|NCT01496365|525414633|FG005|Overall Study|Lost to Follow-up|0|||
145698758|NCT01496365|525414634|FG006|Overall Study|Lost to Follow-up|0|||
145698759|NCT01496365|525414628|FG000|Overall Study|Other|4|||
145698760|NCT01496365|525414629|FG001|Overall Study|Other|4|||
145698761|NCT01496365|525414630|FG002|Overall Study|Other|2|||
145698762|NCT01496365|525414631|FG003|Overall Study|Other|1|||
145698763|NCT01496365|525414632|FG004|Overall Study|Other|3|||
145698764|NCT01496365|525414633|FG005|Overall Study|Other|0|||
145698765|NCT01496365|525414634|FG006|Overall Study|Other|1|||
145698766|NCT01015677|525414635|FG000|Overall Study|Adverse Event|0|||
145698767|NCT01015677|525414636|FG001|Overall Study|Adverse Event|1|||
145698768|NCT01015677|525414637|FG002|Overall Study|Adverse Event|0|||
145698769|NCT01015677|525414635|FG000|Overall Study|Lack of Efficacy|0|||
145698770|NCT01015677|525414636|FG001|Overall Study|Lack of Efficacy|1|||
145698771|NCT01015677|525414637|FG002|Overall Study|Lack of Efficacy|0|||
145698772|NCT01015677|525414635|FG000|Overall Study|Protocol Violation|0|||
145698773|NCT01015677|525414636|FG001|Overall Study|Protocol Violation|1|||
145698774|NCT01015677|525414637|FG002|Overall Study|Protocol Violation|0|||
145698775|NCT01015677|525414635|FG000|Overall Study|Withdrawal by Subject|1|||
145698776|NCT01015677|525414636|FG001|Overall Study|Withdrawal by Subject|1|||
145698777|NCT01015677|525414637|FG002|Overall Study|Withdrawal by Subject|0|||
145698778|NCT02232399|525414638|FG000|Overall Study|Adverse Event|1|||
145698779|NCT02232399|525414639|FG001|Overall Study|Adverse Event|0|||
145491428|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
145491429|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Disease progression|75|||
145491430|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Disease progression|59|||
145491431|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Adverse Event|16|||
145698780|NCT02232399|525414638|FG000|Overall Study|Withdrawal by Subject|0|||
145698781|NCT02232399|525414639|FG001|Overall Study|Withdrawal by Subject|1|||
145698782|NCT03491215|525414640|FG000|Overall Study|Death|6|||
145698783|NCT03491215|525414641|FG001|Overall Study|Death|2|||
145698784|NCT03491215|525414642|FG002|Overall Study|Death|1|||
145698785|NCT03491215|525414643|FG003|Overall Study|Death|0|||
145698786|NCT03491215|525414640|FG000|Overall Study|Physician Decision|1|||
145698787|NCT03491215|525414641|FG001|Overall Study|Physician Decision|0|||
145698788|NCT03491215|525414642|FG002|Overall Study|Physician Decision|0|||
145698789|NCT03491215|525414643|FG003|Overall Study|Physician Decision|0|||
145698790|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
145698791|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
145698792|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
145698793|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
145698794|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
145698795|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
145698796|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
145698797|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
145698798|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
145698799|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
145698800|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
145698801|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
145698802|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
145698803|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
145698804|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
145698805|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
145698806|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
145698807|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
145698808|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
145698809|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
145698810|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
145698811|NCT04599855|525414644|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
145698812|NCT04599855|525414645|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
145698813|NCT04599855|525414646|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
145698814|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
145698815|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
145698816|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
145698817|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
145698818|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
145698819|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
145698820|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
145698821|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
145698822|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
145698823|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
145698824|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
145698825|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
145698826|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
145698827|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
145698828|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
145698829|NCT04599855|525414644|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
145698830|NCT04599855|525414645|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
145698831|NCT04599855|525414646|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
145698832|NCT04294667|525414647|FG000|Overall Study|Lack of Efficacy|4|||
145698833|NCT04294667|525414648|FG001|Overall Study|Lack of Efficacy|4|||
145698834|NCT04294667|525414647|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
145698835|NCT04294667|525414648|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
145698836|NCT04294667|525414647|FG000|Overall Study|Patient has a Renal Flare|1|||
145698837|NCT04294667|525414648|FG001|Overall Study|Patient has a Renal Flare|0|||
145698838|NCT04294667|525414647|FG000|Overall Study|SLE Worsening|0|||
145698839|NCT04294667|525414648|FG001|Overall Study|SLE Worsening|1|||
145698840|NCT04294667|525414647|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
145698841|NCT04294667|525414648|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
145698842|NCT04294667|525414647|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
145698843|NCT04294667|525414648|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
145698844|NCT04294667|525414647|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
145698845|NCT04294667|525414648|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
145698846|NCT04294667|525414647|FG000|Overall Study|Subject Moved to Another State|0|||
145698847|NCT04294667|525414648|FG001|Overall Study|Subject Moved to Another State|1|||
145698848|NCT04294667|525414647|FG000|Overall Study|Adverse event, serious fatal|0|||
145698849|NCT04294667|525414648|FG001|Overall Study|Adverse event, serious fatal|1|||
145698850|NCT04294667|525414647|FG000|Overall Study|Adverse event, non-fatal|3|||
145698851|NCT04294667|525414648|FG001|Overall Study|Adverse event, non-fatal|4|||
145698852|NCT03297398|525414649|FG000|Overall Study|Sponsor's decision|6|||
145698853|NCT03297398|525414650|FG001|Overall Study|Sponsor's decision|9|||
145698854|NCT03297398|525414651|FG002|Overall Study|Sponsor's decision|7|||
145698855|NCT03297398|525414649|FG000|Overall Study|Adverse Event|1|||
145698856|NCT03297398|525414650|FG001|Overall Study|Adverse Event|4|||
145698857|NCT03297398|525414651|FG002|Overall Study|Adverse Event|4|||
145698858|NCT03297398|525414649|FG000|Overall Study|Withdrawal by Subject|1|||
145698859|NCT03297398|525414650|FG001|Overall Study|Withdrawal by Subject|2|||
145698860|NCT03297398|525414651|FG002|Overall Study|Withdrawal by Subject|2|||
145698861|NCT03297398|525414649|FG000|Overall Study|Protocol Violation|0|||
145698862|NCT03297398|525414650|FG001|Overall Study|Protocol Violation|2|||
145698863|NCT03297398|525414651|FG002|Overall Study|Protocol Violation|0|||
145698864|NCT03297398|525414649|FG000|Overall Study|Physician Decision|0|||
145698865|NCT03297398|525414650|FG001|Overall Study|Physician Decision|0|||
145698866|NCT03297398|525414651|FG002|Overall Study|Physician Decision|1|||
145698867|NCT03297398|525414649|FG000|Overall Study|Lost to Follow-up|0|||
145698868|NCT03297398|525414650|FG001|Overall Study|Lost to Follow-up|0|||
145698869|NCT03297398|525414651|FG002|Overall Study|Lost to Follow-up|1|||
145698870|NCT03481556|525414654|FG000|Overall Study|Adverse Event|1|||
145698871|NCT03481556|525414655|FG001|Overall Study|Adverse Event|0|||
145698872|NCT03481556|525414656|FG002|Overall Study|Adverse Event|0|||
145698873|NCT03481556|525414657|FG003|Overall Study|Adverse Event|0|||
145698874|NCT03481556|525414654|FG000|Overall Study|Death|4|||
145698875|NCT03481556|525414655|FG001|Overall Study|Death|2|||
145698876|NCT03481556|525414656|FG002|Overall Study|Death|3|||
145698877|NCT03481556|525414657|FG003|Overall Study|Death|16|||
145698878|NCT03481556|525414654|FG000|Overall Study|Study Terminated by Sponsor|10|||
145698879|NCT03481556|525414655|FG001|Overall Study|Study Terminated by Sponsor|5|||
145698880|NCT03481556|525414656|FG002|Overall Study|Study Terminated by Sponsor|2|||
145698881|NCT03481556|525414657|FG003|Overall Study|Study Terminated by Sponsor|9|||
145698882|NCT01316887|525414658|FG000|Overall Study|Adverse Event|13|||
145698883|NCT01316887|525414659|FG001|Overall Study|Adverse Event|21|||
145698884|NCT01316887|525414660|FG002|Overall Study|Adverse Event|17|||
145698885|NCT01316887|525414658|FG000|Overall Study|Lack of Efficacy|9|||
145698886|NCT01316887|525414659|FG001|Overall Study|Lack of Efficacy|3|||
145698887|NCT01316887|525414660|FG002|Overall Study|Lack of Efficacy|1|||
145698888|NCT01316887|525414658|FG000|Overall Study|Protocol Violation|2|||
145698889|NCT01316887|525414659|FG001|Overall Study|Protocol Violation|6|||
145698890|NCT01316887|525414660|FG002|Overall Study|Protocol Violation|6|||
145698891|NCT01316887|525414658|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
145698892|NCT01316887|525414659|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
145698893|NCT01316887|525414660|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
145698894|NCT01316887|525414658|FG000|Overall Study|Study Closed/Terminated|2|||
145698895|NCT01316887|525414659|FG001|Overall Study|Study Closed/Terminated|4|||
145698896|NCT01316887|525414660|FG002|Overall Study|Study Closed/Terminated|3|||
145698897|NCT01316887|525414658|FG000|Overall Study|Lost to Follow-up|1|||
145698898|NCT01316887|525414659|FG001|Overall Study|Lost to Follow-up|7|||
145698899|NCT01316887|525414660|FG002|Overall Study|Lost to Follow-up|5|||
145698900|NCT01316887|525414658|FG000|Overall Study|Withdrawal by Subject|8|||
145698901|NCT01316887|525414659|FG001|Overall Study|Withdrawal by Subject|16|||
145698902|NCT01316887|525414660|FG002|Overall Study|Withdrawal by Subject|15|||
145698903|NCT02172950|525414661|FG000|Overall Study|Physician Decision|3|||
145698904|NCT02172950|525414662|FG001|Overall Study|Physician Decision|3|||
145698905|NCT02172950|525414661|FG000|Overall Study|Lack of Efficacy|1|||
145698906|NCT02172950|525414662|FG001|Overall Study|Lack of Efficacy|0|||
145698907|NCT02172950|525414661|FG000|Overall Study|Adverse Event|4|||
145698908|NCT02172950|525414662|FG001|Overall Study|Adverse Event|1|||
145698909|NCT02172950|525414661|FG000|Overall Study|Withdrawal by Subject|10|||
145698910|NCT02172950|525414662|FG001|Overall Study|Withdrawal by Subject|0|||
145698911|NCT02172950|525414661|FG000|Overall Study|Protocol Violation|1|||
145698912|NCT02172950|525414662|FG001|Overall Study|Protocol Violation|0|||
145698913|NCT02172950|525414661|FG000|Overall Study|Lost to Follow-up|1|||
145698914|NCT02172950|525414662|FG001|Overall Study|Lost to Follow-up|0|||
145698915|NCT02172950|525414661|FG000|Overall Study|Death|1|||
145698916|NCT02172950|525414662|FG001|Overall Study|Death|0|||
145698917|NCT02172950|525414661|FG000|Overall Study|Patient traveling|1|||
145698918|NCT02172950|525414662|FG001|Overall Study|Patient traveling|0|||
145698919|NCT02172950|525414661|FG000|Overall Study|Patient went to other country|1|||
145698920|NCT02172950|525414662|FG001|Overall Study|Patient went to other country|0|||
145698921|NCT02172950|525414661|FG000|Overall Study|Patient relocated overseas|1|||
145698922|NCT02172950|525414662|FG001|Overall Study|Patient relocated overseas|1|||
145698923|NCT02172950|525414661|FG000|Overall Study|Patient moving|1|||
145698924|NCT02172950|525414662|FG001|Overall Study|Patient moving|0|||
145698925|NCT00585975|525414663|FG000|Overall Study|Withdrawal by Subject|3|||
145698926|NCT00585975|525414664|FG001|Overall Study|Withdrawal by Subject|3|||
145698927|NCT00585975|525414663|FG000|Overall Study|Lost to Follow-up|2|||
145698928|NCT00585975|525414664|FG001|Overall Study|Lost to Follow-up|1|||
145698929|NCT00585975|525414663|FG000|Overall Study|Enrollment met/over-enrolled|10|||
145698930|NCT00585975|525414664|FG001|Overall Study|Enrollment met/over-enrolled|9|||
145698931|NCT00992992|525414667|FG000|Overall Study|Lost to Follow-up|3|||
145698932|NCT00992992|525414667|FG000|Overall Study|Death|16|||
145698933|NCT00992992|525414667|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
145698934|NCT00992992|525414667|FG000|Overall Study|Sponsor Closed the Study|4|||
145698935|NCT00217022|525414669|FG000|Overall Study|Withdrawal by Subject|1|||
145698936|NCT00217022|525414670|FG001|Overall Study|Withdrawal by Subject|1|||
145698937|NCT02108652|525414671|FG000|Overall Study|Death|253|||
145698938|NCT02108652|525414671|FG000|Overall Study|Lost to Follow-up|2|||
145698939|NCT02108652|525414671|FG000|Overall Study|Withdrawal by Subject|16|||
145698940|NCT02108652|525414671|FG000|Overall Study|Study Terminated By Sponsor|31|||
145698941|NCT02108652|525414671|FG000|Overall Study|Non-Compliance|1|||
145698942|NCT02108652|525414671|FG000|Overall Study|Physician Decision|6|||
145698943|NCT02108652|525414671|FG000|Overall Study|Progression Of Disease|1|||
145698944|NCT00511797|525414677|FG000|Overall Study|Adverse Event|1|||
145698945|NCT00511797|525414678|FG001|Overall Study|Adverse Event|2|||
145698946|NCT00511797|525414679|FG002|Overall Study|Adverse Event|2|||
145698947|NCT00511797|525414680|FG003|Overall Study|Adverse Event|2|||
145698948|NCT00511797|525414677|FG000|Overall Study|Lost to Follow-up|1|||
145698949|NCT00511797|525414678|FG001|Overall Study|Lost to Follow-up|0|||
145698950|NCT00511797|525414679|FG002|Overall Study|Lost to Follow-up|0|||
145698951|NCT00511797|525414680|FG003|Overall Study|Lost to Follow-up|1|||
145698952|NCT00511797|525414677|FG000|Overall Study|Pregnancy|0|||
145698953|NCT00511797|525414678|FG001|Overall Study|Pregnancy|0|||
145698954|NCT00511797|525414679|FG002|Overall Study|Pregnancy|0|||
145698955|NCT00511797|525414680|FG003|Overall Study|Pregnancy|1|||
145698956|NCT00511797|525414677|FG000|Overall Study|Protocol Violation|0|||
145698957|NCT00511797|525414678|FG001|Overall Study|Protocol Violation|2|||
145698958|NCT00511797|525414679|FG002|Overall Study|Protocol Violation|2|||
145698959|NCT00511797|525414680|FG003|Overall Study|Protocol Violation|3|||
145698960|NCT00511797|525414677|FG000|Overall Study|Withdrawal by Subject|3|||
145698961|NCT00511797|525414678|FG001|Overall Study|Withdrawal by Subject|3|||
145698962|NCT00511797|525414679|FG002|Overall Study|Withdrawal by Subject|4|||
145698963|NCT00511797|525414680|FG003|Overall Study|Withdrawal by Subject|2|||
145698964|NCT00511797|525414677|FG000|Overall Study|Never dispensed|1|||
145698965|NCT00511797|525414678|FG001|Overall Study|Never dispensed|0|||
145698966|NCT00511797|525414679|FG002|Overall Study|Never dispensed|1|||
145698967|NCT00511797|525414680|FG003|Overall Study|Never dispensed|3|||
145698968|NCT00511797|525414677|FG000|Overall Study|Study drug not taken|0|||
145698969|NCT00511797|525414678|FG001|Overall Study|Study drug not taken|1|||
145698970|NCT00511797|525414679|FG002|Overall Study|Study drug not taken|0|||
145698971|NCT00511797|525414680|FG003|Overall Study|Study drug not taken|1|||
145698972|NCT00511797|525414677|FG000|Overall Study|Partially missing diary|0|||
145698973|NCT00511797|525414678|FG001|Overall Study|Partially missing diary|0|||
145698974|NCT00511797|525414679|FG002|Overall Study|Partially missing diary|1|||
145698975|NCT00511797|525414680|FG003|Overall Study|Partially missing diary|0|||
145698976|NCT00511797|525414677|FG000|Overall Study|Other (moving etc)|1|||
145698977|NCT00511797|525414678|FG001|Overall Study|Other (moving etc)|0|||
145698978|NCT00511797|525414679|FG002|Overall Study|Other (moving etc)|1|||
145698979|NCT00511797|525414680|FG003|Overall Study|Other (moving etc)|2|||
145698980|NCT03845075|525414681|FG000|Part 1 - DB|Withdrawal by Subject|1|||
145698981|NCT03845075|525414682|FG001|Part 1 - DB|Withdrawal by Subject|1|||
145698982|NCT03845075|525414683|FG002|Part 1 - DB|Withdrawal by Subject|0|||
145698983|NCT03845075|525414684|FG003|Part 1 - DB|Withdrawal by Subject|0|||
145698984|NCT03845075|525414681|FG000|Part 1 - DB|Adverse Event|0|||
145698985|NCT03845075|525414682|FG001|Part 1 - DB|Adverse Event|1|||
145698986|NCT03845075|525414683|FG002|Part 1 - DB|Adverse Event|0|||
145698987|NCT03845075|525414684|FG003|Part 1 - DB|Adverse Event|0|||
145698988|NCT03845075|525414681|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
145698989|NCT03845075|525414682|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
145698990|NCT03845075|525414683|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
145698991|NCT03845075|525414684|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
145698992|NCT01017263|525414685|FG000|Overall Study|not eligible|12|||
145698993|NCT01560871|525414686|FG000|Overall Study|transportation issues|2|||
145698994|NCT01560871|525414687|FG001|Overall Study|transportation issues|1|||
145698995|NCT01560871|525414686|FG000|Overall Study|relocation|1|||
145698996|NCT01560871|525414687|FG001|Overall Study|relocation|0|||
145698997|NCT01560871|525414686|FG000|Overall Study|readmission to a hospital|2|||
145698998|NCT01560871|525414687|FG001|Overall Study|readmission to a hospital|1|||
145698999|NCT01560871|525414686|FG000|Overall Study|Lost to Follow-up|1|||
145699000|NCT01560871|525414687|FG001|Overall Study|Lost to Follow-up|0|||
145699001|NCT05043883|525414688|FG000|Overall Study|Minimum required measurements could not be taken|4|||
145699002|NCT02980705|525414689|FG000|Overall Study|Adverse Event|0|||
145699003|NCT02980705|525414690|FG001|Overall Study|Adverse Event|1|||
145699004|NCT02980705|525414689|FG000|Overall Study|Withdrawal by Subject|6|||
145699005|NCT02980705|525414690|FG001|Overall Study|Withdrawal by Subject|9|||
145699006|NCT02980705|525414689|FG000|Overall Study|withdrew participation|0|||
145699007|NCT02980705|525414690|FG001|Overall Study|withdrew participation|1|||
145699008|NCT02980705|525414689|FG000|Overall Study|Lost to Follow-up|2|||
145699009|NCT02980705|525414690|FG001|Overall Study|Lost to Follow-up|0|||
145699010|NCT00263575|525414691|FG000|Titration Period|Adverse Event|14|||
145699011|NCT00263575|525414691|FG000|Titration Period|Withdrawal by Subject|10|||
145699012|NCT00263575|525414691|FG000|Titration Period|Protocol Violation|9|||
145699013|NCT00263575|525414691|FG000|Titration Period|Sponsor Decision|2|||
145699014|NCT00263575|525414691|FG000|Titration Period|Other|2|||
145699015|NCT00263575|525414691|FG000|Titration Period|Lack of Efficacy|6|||
145699016|NCT00263575|525414691|FG000|Maintence Period|Adverse Event|23|||
145699017|NCT00263575|525414691|FG000|Maintence Period|Withdrawal by Subject|8|||
145699018|NCT00263575|525414691|FG000|Maintence Period|Protocol Violation|4|||
145699019|NCT00263575|525414691|FG000|Maintence Period|Lack of Efficacy|4|||
145699020|NCT00263575|525414691|FG000|Maintence Period|Physician Decision|6|||
145699021|NCT00263575|525414691|FG000|Maintence Period|Lost to Follow-up|1|||
145699022|NCT00263575|525414691|FG000|Maintence Period|Sponsor Decision|24|||
145699023|NCT00263575|525414691|FG000|Maintence Period|Other|7|||
145699024|NCT00537329|525414692|FG000|Overall Study|Death|10|||
145699025|NCT00537329|525414692|FG000|Overall Study|Adverse Event|3|||
145699026|NCT00537329|525414692|FG000|Overall Study|Lack of Efficacy|2|||
145699027|NCT00537329|525414692|FG000|Overall Study|Lost to Follow-up|6|||
145699028|NCT00537329|525414692|FG000|Overall Study|Withdrawal by Subject|4|||
145699029|NCT00537329|525414692|FG000|Overall Study|Other|1|||
145699030|NCT03599622|525414695|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
145699031|NCT03599622|525414696|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
145699032|NCT03599622|525414697|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
145699033|NCT03599622|525414698|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
145699034|NCT03599622|525414695|FG000|Pre-Treatment Period|Other reasons|1|||
145699035|NCT03599622|525414696|FG001|Pre-Treatment Period|Other reasons|1|||
145699036|NCT03599622|525414697|FG002|Pre-Treatment Period|Other reasons|1|||
145699037|NCT03599622|525414698|FG003|Pre-Treatment Period|Other reasons|0|||
145699038|NCT03599622|525414695|FG000|Treatment Period|Adverse Event|11|||
145699039|NCT03599622|525414696|FG001|Treatment Period|Adverse Event|20|||
145699040|NCT03599622|525414697|FG002|Treatment Period|Adverse Event|18|||
145699041|NCT03599622|525414698|FG003|Treatment Period|Adverse Event|2|||
145699042|NCT03599622|525414695|FG000|Treatment Period|Lack of Efficacy|18|||
145699043|NCT03599622|525414696|FG001|Treatment Period|Lack of Efficacy|12|||
145699044|NCT03599622|525414697|FG002|Treatment Period|Lack of Efficacy|13|||
145699045|NCT03599622|525414698|FG003|Treatment Period|Lack of Efficacy|2|||
145699046|NCT03599622|525414695|FG000|Treatment Period|Withdrawal by Subject|5|||
145699047|NCT03599622|525414696|FG001|Treatment Period|Withdrawal by Subject|11|||
145699048|NCT03599622|525414697|FG002|Treatment Period|Withdrawal by Subject|16|||
145699049|NCT03599622|525414698|FG003|Treatment Period|Withdrawal by Subject|1|||
145699050|NCT03599622|525414695|FG000|Treatment Period|Other reasons|4|||
145699051|NCT03599622|525414696|FG001|Treatment Period|Other reasons|6|||
145699052|NCT03599622|525414697|FG002|Treatment Period|Other reasons|7|||
145699053|NCT03599622|525414698|FG003|Treatment Period|Other reasons|0|||
145699054|NCT03599622|525414695|FG000|Treatment Period|Lost to Follow-up|1|||
145699055|NCT03599622|525414696|FG001|Treatment Period|Lost to Follow-up|0|||
145699056|NCT03599622|525414697|FG002|Treatment Period|Lost to Follow-up|0|||
145699057|NCT03599622|525414698|FG003|Treatment Period|Lost to Follow-up|0|||
145699058|NCT03599622|525414695|FG000|Treatment Period|Study terminated by sponsor|7|||
145699059|NCT03599622|525414696|FG001|Treatment Period|Study terminated by sponsor|20|||
145699060|NCT03599622|525414697|FG002|Treatment Period|Study terminated by sponsor|15|||
145699061|NCT03599622|525414698|FG003|Treatment Period|Study terminated by sponsor|0|||
145699062|NCT03599622|525414695|FG000|Treatment Period|Site terminated by sponsor|0|||
145699063|NCT03599622|525414696|FG001|Treatment Period|Site terminated by sponsor|1|||
145699064|NCT03599622|525414697|FG002|Treatment Period|Site terminated by sponsor|0|||
145699065|NCT03599622|525414698|FG003|Treatment Period|Site terminated by sponsor|0|||
145699066|NCT01278615|525414699|FG000|Overall Study|Withdrawal by Subject|2|||
145699067|NCT00905359|525414700|FG000|Overall Study|Lost to Follow-up|17|||
145699068|NCT00905359|525414701|FG001|Overall Study|Lost to Follow-up|10|||
145699069|NCT00905359|525414700|FG000|Overall Study|Death|2|||
145699070|NCT00905359|525414701|FG001|Overall Study|Death|0|||
145699071|NCT00905359|525414700|FG000|Overall Study|Withdrawal consent|5|||
145699072|NCT00905359|525414701|FG001|Overall Study|Withdrawal consent|6|||
145699073|NCT02138253|525414702|FG000|Overall Study|Adverse Event|3|||
145699074|NCT02138253|525414703|FG001|Overall Study|Adverse Event|3|||
145699075|NCT02138253|525414702|FG000|Overall Study|Lost to Follow-up|2|||
145699076|NCT02138253|525414703|FG001|Overall Study|Lost to Follow-up|1|||
145699077|NCT02138253|525414702|FG000|Overall Study|Physician Decision|2|||
145699078|NCT02138253|525414703|FG001|Overall Study|Physician Decision|0|||
145699079|NCT02138253|525414702|FG000|Overall Study|Non compliance|1|||
145699080|NCT02138253|525414703|FG001|Overall Study|Non compliance|0|||
145699081|NCT02138253|525414702|FG000|Overall Study|Withdrawal by Subject|1|||
145699082|NCT02138253|525414703|FG001|Overall Study|Withdrawal by Subject|0|||
145699083|NCT01006889|525414704|FG000|Overall Study|Withdrawal by Subject|3|||
145699084|NCT00243022|525414705|FG000|Overall Study|Withdrawal by Subject|1|||
145699085|NCT00243022|525414706|FG001|Overall Study|Withdrawal by Subject|0|||
145699086|NCT00243022|525414705|FG000|Overall Study|Death|1|||
145699087|NCT00243022|525414706|FG001|Overall Study|Death|0|||
145699088|NCT00243022|525414705|FG000|Overall Study|Difficult Travel Distance|0|||
145699089|NCT00243022|525414706|FG001|Overall Study|Difficult Travel Distance|1|||
145699090|NCT01390441|525414711|FG000|Treatment Period|Protocol Violation|0|||
145699091|NCT01390441|525414712|FG001|Treatment Period|Protocol Violation|1|||
145699092|NCT01390441|525414713|FG002|Treatment Period|Protocol Violation|0|||
145699093|NCT01390441|525414714|FG003|Treatment Period|Protocol Violation|0|||
145699094|NCT01390441|525414715|FG004|Treatment Period|Protocol Violation|0|||
145699095|NCT01390441|525414711|FG000|Treatment Period|Physician Decision|0|||
145699096|NCT01390441|525414712|FG001|Treatment Period|Physician Decision|0|||
145699097|NCT01390441|525414713|FG002|Treatment Period|Physician Decision|0|||
145699098|NCT01390441|525414714|FG003|Treatment Period|Physician Decision|1|||
145699099|NCT01390441|525414715|FG004|Treatment Period|Physician Decision|0|||
145699100|NCT01390441|525414711|FG000|Treatment Period|Lack of Efficacy|0|||
145699101|NCT01390441|525414712|FG001|Treatment Period|Lack of Efficacy|0|||
145699102|NCT01390441|525414713|FG002|Treatment Period|Lack of Efficacy|0|||
145699103|NCT01390441|525414714|FG003|Treatment Period|Lack of Efficacy|0|||
145699104|NCT01390441|525414715|FG004|Treatment Period|Lack of Efficacy|1|||
145699105|NCT01390441|525414711|FG000|Treatment Period|Unknown due to early stopping of study|0|||
145699106|NCT01390441|525414712|FG001|Treatment Period|Unknown due to early stopping of study|0|||
145699107|NCT01390441|525414713|FG002|Treatment Period|Unknown due to early stopping of study|8|||
145699108|NCT01390441|525414714|FG003|Treatment Period|Unknown due to early stopping of study|11|||
145699109|NCT01390441|525414715|FG004|Treatment Period|Unknown due to early stopping of study|7|||
145699110|NCT01390441|525414711|FG000|Treatment Period|Adverse Event|0|||
145699111|NCT01390441|525414712|FG001|Treatment Period|Adverse Event|0|||
145699112|NCT01390441|525414713|FG002|Treatment Period|Adverse Event|1|||
145699113|NCT01390441|525414714|FG003|Treatment Period|Adverse Event|1|||
145699114|NCT01390441|525414715|FG004|Treatment Period|Adverse Event|2|||
145699115|NCT01390441|525414711|FG000|Treatment Period|Withdrawal by Subject|0|||
145699116|NCT01390441|525414712|FG001|Treatment Period|Withdrawal by Subject|0|||
145699117|NCT01390441|525414713|FG002|Treatment Period|Withdrawal by Subject|1|||
145699118|NCT01390441|525414714|FG003|Treatment Period|Withdrawal by Subject|0|||
145265484|NCT00945815|523819373|FG000|Overall Study|Did not begin protocol therapy|1|||
145699119|NCT01390441|525414715|FG004|Treatment Period|Withdrawal by Subject|1|||
145699120|NCT01390441|525414711|FG000|Treatment Period|Lost to Follow-up|1|||
145699121|NCT01390441|525414712|FG001|Treatment Period|Lost to Follow-up|0|||
145699122|NCT01390441|525414713|FG002|Treatment Period|Lost to Follow-up|0|||
145699123|NCT01390441|525414714|FG003|Treatment Period|Lost to Follow-up|0|||
145699124|NCT01390441|525414715|FG004|Treatment Period|Lost to Follow-up|0|||
145699125|NCT01390441|525414711|FG000|Extension Period|Protocol Violation|3|||
145699126|NCT01390441|525414712|FG001|Extension Period|Protocol Violation|1|||
145699127|NCT01390441|525414713|FG002|Extension Period|Protocol Violation|0|||
145699128|NCT01390441|525414714|FG003|Extension Period|Protocol Violation|1|||
145699129|NCT01390441|525414715|FG004|Extension Period|Protocol Violation|0|||
145699130|NCT00823836|525414716|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
145699131|NCT00823836|525414717|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
145699132|NCT00823836|525414716|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
145699133|NCT00823836|525414717|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
145699134|NCT00823836|525414716|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
145699135|NCT00823836|525414717|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
145699136|NCT00823836|525414716|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
145699137|NCT00823836|525414717|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
145699138|NCT00823836|525414716|FG000|Long-term Phase|Adverse Event|3|||
145699139|NCT00823836|525414717|FG001|Long-term Phase|Adverse Event|2|||
145699140|NCT00823836|525414716|FG000|Long-term Phase|Physician Decision|1|||
145699141|NCT00823836|525414717|FG001|Long-term Phase|Physician Decision|2|||
145699142|NCT00823836|525414716|FG000|Long-term Phase|Withdrawal by Subject|1|||
145699143|NCT00823836|525414717|FG001|Long-term Phase|Withdrawal by Subject|1|||
145699144|NCT01099579|525414718|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
145699145|NCT01099579|525414719|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
145699146|NCT01099579|525414720|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
145699147|NCT01099579|525414718|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
145699148|NCT01099579|525414719|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
145699149|NCT01099579|525414720|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
145699150|NCT01099579|525414718|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
145699151|NCT01099579|525414719|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
145699152|NCT01099579|525414720|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
145699153|NCT01099579|525414718|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
145699154|NCT01099579|525414719|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
145699155|NCT01099579|525414720|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
145699156|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
145699157|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
145699158|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
145699159|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
145699160|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
145699161|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
145699162|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
145699163|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
145699164|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
145699165|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
145699166|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
145699167|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
145699168|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
145699169|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
145699170|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
145699171|NCT01099579|525414718|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
145699172|NCT01099579|525414719|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
145699173|NCT01099579|525414720|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
145699174|NCT02725528|525414721|FG000|Overall Study|Lost to Follow-up|1|||
145699175|NCT02725528|525414722|FG001|Overall Study|Lost to Follow-up|4|||
145699176|NCT02725528|525414721|FG000|Overall Study|Withdrawal by Subject|0|||
145699177|NCT02725528|525414722|FG001|Overall Study|Withdrawal by Subject|1|||
145699178|NCT00904722|525414725|FG000|Overall Study|Physician Decision|1|||
145699179|NCT01801982|525414729|FG000|Overall Study|Lost to Follow-up|1|||
145699180|NCT00727506|525414730|FG000|Overall Study|Adverse Event|0|||
145699181|NCT00727506|525414731|FG001|Overall Study|Adverse Event|0|||
145699182|NCT00727506|525414732|FG002|Overall Study|Adverse Event|4|||
145699183|NCT00727506|525414733|FG003|Overall Study|Adverse Event|4|||
145699184|NCT00727506|525414734|FG004|Overall Study|Adverse Event|1|||
145699185|NCT00727506|525414735|FG005|Overall Study|Adverse Event|8|||
145699186|NCT00727506|525414730|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145699187|NCT00727506|525414731|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145699188|NCT00727506|525414732|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
145699189|NCT00727506|525414733|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145699190|NCT00727506|525414734|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145699191|NCT00727506|525414735|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
145699192|NCT00727506|525414730|FG000|Overall Study|Progressive disease|4|||
145699193|NCT00727506|525414731|FG001|Overall Study|Progressive disease|7|||
145699194|NCT00727506|525414732|FG002|Overall Study|Progressive disease|9|||
145699195|NCT00727506|525414733|FG003|Overall Study|Progressive disease|28|||
145699196|NCT00727506|525414734|FG004|Overall Study|Progressive disease|38|||
145699197|NCT00727506|525414735|FG005|Overall Study|Progressive disease|28|||
145699198|NCT00727506|525414730|FG000|Overall Study|Refused to continue medication|0|||
145699199|NCT00727506|525414731|FG001|Overall Study|Refused to continue medication|1|||
145699200|NCT00727506|525414732|FG002|Overall Study|Refused to continue medication|2|||
145699201|NCT00727506|525414733|FG003|Overall Study|Refused to continue medication|3|||
145699202|NCT00727506|525414734|FG004|Overall Study|Refused to continue medication|1|||
145699203|NCT00727506|525414735|FG005|Overall Study|Refused to continue medication|2|||
145699204|NCT00727506|525414730|FG000|Overall Study|Other reason not described above|0|||
145699205|NCT00727506|525414731|FG001|Overall Study|Other reason not described above|0|||
145699206|NCT00727506|525414732|FG002|Overall Study|Other reason not described above|1|||
145699207|NCT00727506|525414733|FG003|Overall Study|Other reason not described above|4|||
145699208|NCT00727506|525414734|FG004|Overall Study|Other reason not described above|1|||
145699209|NCT00727506|525414735|FG005|Overall Study|Other reason not described above|1|||
145699210|NCT01482429|525414736|FG000|Care Usual|Protocol Violation|0|||
145699211|NCT01482429|525414737|FG001|Care Usual|Protocol Violation|172|||
145699212|NCT01482429|525414736|FG000|Care Usual|Lost to Follow-up|0|||
145699213|NCT01482429|525414737|FG001|Care Usual|Lost to Follow-up|1|||
145699214|NCT01482429|525414736|FG000|Protocol|Protocol Violation|275|||
145699215|NCT01482429|525414737|FG001|Protocol|Protocol Violation|0|||
145699216|NCT03561597|525414738|FG000|Overall Study|Lost to Follow-up|20|||
145699217|NCT04887506|525414739|FG000|Overall Study|Death|1|||
145699218|NCT04887506|525414740|FG001|Overall Study|Death|1|||
145699219|NCT04887506|525414739|FG000|Overall Study|Withdrawal by Subject|0|||
145699220|NCT04887506|525414740|FG001|Overall Study|Withdrawal by Subject|3|||
145699221|NCT04887506|525414739|FG000|Overall Study|Adverse Event|4|||
145699222|NCT04887506|525414740|FG001|Overall Study|Adverse Event|3|||
145699223|NCT04887506|525414739|FG000|Overall Study|Other - Not Reported|1|||
145699224|NCT04887506|525414740|FG001|Overall Study|Other - Not Reported|1|||
145699225|NCT02636608|525414741|FG000|Overall Study|Failure to Return|4|||
145699226|NCT02636608|525414741|FG000|Overall Study|Insufficient Virological Response|1|||
145699227|NCT02636608|525414741|FG000|Overall Study|Death|3|||
145699228|NCT02636608|525414741|FG000|Overall Study|Other|2|||
145699229|NCT02636608|525414741|FG000|Overall Study|Did Not Receive Treatment|1|||
145699230|NCT04594733|525414765|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
145699231|NCT04594733|525414766|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
145699232|NCT04594733|525414765|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
145699233|NCT04594733|525414766|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
145699234|NCT04594733|525414765|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
145699235|NCT04594733|525414766|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
145699236|NCT01024036|525414769|FG000|Blinded Treatment|Adverse Event|1|||
145699237|NCT01024036|525414770|FG001|Blinded Treatment|Adverse Event|1|||
145699238|NCT01024036|525414769|FG000|Blinded Treatment|Lack of Efficacy|16|||
145699239|NCT01024036|525414770|FG001|Blinded Treatment|Lack of Efficacy|14|||
145699240|NCT01024036|525414769|FG000|Blinded Treatment|Physician Decision|1|||
145699241|NCT01024036|525414770|FG001|Blinded Treatment|Physician Decision|0|||
145699242|NCT01024036|525414769|FG000|Blinded Treatment|Death|0|||
145699243|NCT01024036|525414770|FG001|Blinded Treatment|Death|2|||
145699244|NCT01024036|525414769|FG000|Blinded Treatment|Withdrawal by Subject|4|||
145699245|NCT01024036|525414770|FG001|Blinded Treatment|Withdrawal by Subject|3|||
145699246|NCT01024036|525414769|FG000|Unblinded Treatment|Adverse Event|0|||
145699247|NCT01024036|525414770|FG001|Unblinded Treatment|Adverse Event|1|||
145699248|NCT01024036|525414769|FG000|Unblinded Treatment|Lack of Efficacy|0|||
145699249|NCT01024036|525414770|FG001|Unblinded Treatment|Lack of Efficacy|2|||
145699250|NCT01024036|525414769|FG000|Follow-Up Period|Lost to Follow-up|1|||
145699251|NCT01024036|525414770|FG001|Follow-Up Period|Lost to Follow-up|1|||
145699252|NCT01024036|525414769|FG000|Follow-Up Period|Withdrawal by Subject|0|||
145699253|NCT01024036|525414770|FG001|Follow-Up Period|Withdrawal by Subject|1|||
145699254|NCT01024036|525414769|FG000|Follow-Up Period|Adverse Event|4|||
145699255|NCT01024036|525414770|FG001|Follow-Up Period|Adverse Event|1|||
145699256|NCT04680637|525414776|FG000|Overall Study|Lost to Follow-up|0|||
145699257|NCT04680637|525414777|FG001|Overall Study|Lost to Follow-up|1|||
145699258|NCT04680637|525414778|FG002|Overall Study|Lost to Follow-up|0|||
145699259|NCT04680637|525414779|FG003|Overall Study|Lost to Follow-up|1|||
145699260|NCT04680637|525414776|FG000|Overall Study|Death|1|||
145699261|NCT04680637|525414777|FG001|Overall Study|Death|0|||
145699262|NCT04680637|525414778|FG002|Overall Study|Death|0|||
145699263|NCT04680637|525414779|FG003|Overall Study|Death|0|||
145699264|NCT04680637|525414776|FG000|Overall Study|Withdrawal by Subject|7|||
145699265|NCT04680637|525414777|FG001|Overall Study|Withdrawal by Subject|10|||
145699266|NCT04680637|525414778|FG002|Overall Study|Withdrawal by Subject|17|||
145699267|NCT04680637|525414779|FG003|Overall Study|Withdrawal by Subject|15|||
145699268|NCT04680637|525414776|FG000|Overall Study|Decision by Sponsor|21|||
145699269|NCT04680637|525414777|FG001|Overall Study|Decision by Sponsor|15|||
145699270|NCT04680637|525414778|FG002|Overall Study|Decision by Sponsor|7|||
145699271|NCT04680637|525414779|FG003|Overall Study|Decision by Sponsor|32|||
145699272|NCT00691678|525414780|FG000|Overall Study|Adverse Event|5|||
145699273|NCT00691678|525414780|FG000|Overall Study|life events, pain|11|||
145699274|NCT00903760|525416303|FG000|Overall Study|Disease Progression/Death|8|||
145699275|NCT00903760|525416304|FG001|Overall Study|Disease Progression/Death|6|||
145699276|NCT00903760|525416303|FG000|Overall Study|Stem Cell Transplant|8|||
145699277|NCT00903760|525416304|FG001|Overall Study|Stem Cell Transplant|4|||
145699278|NCT00903760|525416303|FG000|Overall Study|Physician Decision|1|||
145699279|NCT00903760|525416304|FG001|Overall Study|Physician Decision|2|||
145699280|NCT00903760|525416303|FG000|Overall Study|Death|0|||
145699281|NCT00903760|525416304|FG001|Overall Study|Death|1|||
145699282|NCT00903760|525416303|FG000|Overall Study|Lost to Follow-up|1|||
145699283|NCT00903760|525416304|FG001|Overall Study|Lost to Follow-up|0|||
145699284|NCT00903760|525416303|FG000|Overall Study|Withdrawal by Subject|1|||
145699285|NCT00903760|525416304|FG001|Overall Study|Withdrawal by Subject|2|||
145699286|NCT00903760|525416303|FG000|Overall Study|Off treatment for long period|0|||
145699287|NCT00903760|525416304|FG001|Overall Study|Off treatment for long period|1|||
145699288|NCT01256671|525416310|FG000|Overall Study|Adverse Event|29|||
145699289|NCT01256671|525416310|FG000|Overall Study|Lost to Follow-up|16|||
145699290|NCT01256671|525416310|FG000|Overall Study|Withdrawal by Subject|31|||
145699291|NCT01256671|525416310|FG000|Overall Study|Physician Decision|3|||
145699292|NCT01256671|525416310|FG000|Overall Study|Lack of Efficacy|4|||
145699293|NCT01256671|525416310|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
145699294|NCT04411186|525416311|FG000|Overall Study|Withdrawn due to protocol violation|0|||
145699295|NCT04411186|525416312|FG001|Overall Study|Withdrawn due to protocol violation|1|||
145699296|NCT04367480|525416315|FG000|Overall Study|Adverse Event|1|||
145699297|NCT04367480|525416316|FG001|Overall Study|Adverse Event|1|||
145699298|NCT04367480|525416315|FG000|Overall Study|Death|1|||
145699299|NCT04367480|525416316|FG001|Overall Study|Death|0|||
145699300|NCT04367480|525416315|FG000|Overall Study|Lost to Follow-up|1|||
145699301|NCT04367480|525416316|FG001|Overall Study|Lost to Follow-up|1|||
145699302|NCT04367480|525416315|FG000|Overall Study|Withdrawal by Subject|0|||
145699303|NCT04367480|525416316|FG001|Overall Study|Withdrawal by Subject|3|||
145699304|NCT04367480|525416315|FG000|Overall Study|App glitch during the study|1|||
145699305|NCT04367480|525416316|FG001|Overall Study|App glitch during the study|0|||
145699306|NCT04367480|525416315|FG000|Overall Study|Device Distribution Error|0|||
145699307|NCT04367480|525416316|FG001|Overall Study|Device Distribution Error|2|||
145699308|NCT04367480|525416315|FG000|Overall Study|Ineligible after Randomization|0|||
145699309|NCT04367480|525416316|FG001|Overall Study|Ineligible after Randomization|1|||
145699310|NCT04367480|525416315|FG000|Overall Study|Other Medical Reasons|0|||
145699311|NCT04367480|525416316|FG001|Overall Study|Other Medical Reasons|2|||
145699312|NCT01131104|525416317|FG000|Overall Study|Withdrawal by Subject|3|||
145699313|NCT01131104|525416317|FG000|Overall Study|Physician Decision|4|||
145699314|NCT01131104|525416317|FG000|Overall Study|Information Not Available|5|||
145699315|NCT01131104|525416317|FG000|Overall Study|No Information on Index Date of Onset|1|||
145699316|NCT04836559|525416319|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
145699317|NCT04836559|525416320|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
145699318|NCT04836559|525416321|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
145699319|NCT04836559|525416322|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
145699320|NCT04836559|525416323|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
145699321|NCT04836559|525416324|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
145699322|NCT04836559|525416325|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
145699323|NCT04836559|525416326|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
145699324|NCT04836559|525416319|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145699325|NCT04836559|525416320|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
145699326|NCT04836559|525416321|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
145699327|NCT04836559|525416322|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
145699328|NCT04836559|525416323|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145699329|NCT04836559|525416324|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145699330|NCT04836559|525416325|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145699331|NCT04836559|525416326|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
145699332|NCT04836559|525416319|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
145699333|NCT04836559|525416320|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699334|NCT04836559|525416321|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699335|NCT04836559|525416322|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699336|NCT04836559|525416323|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699337|NCT04836559|525416324|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699338|NCT04836559|525416325|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699339|NCT04836559|525416326|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
145699340|NCT04836559|525416319|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
145699341|NCT04836559|525416320|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699342|NCT04836559|525416321|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699343|NCT04836559|525416322|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699344|NCT04836559|525416323|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699345|NCT04836559|525416324|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699346|NCT04836559|525416325|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699347|NCT04836559|525416326|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
145699348|NCT04836559|525416319|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699349|NCT04836559|525416320|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699350|NCT04836559|525416321|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699351|NCT04836559|525416322|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
145699352|NCT04836559|525416323|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699353|NCT04836559|525416324|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699354|NCT04836559|525416325|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699355|NCT04836559|525416326|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
145699356|NCT04836559|525416319|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
145699357|NCT04836559|525416320|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
145699358|NCT04836559|525416321|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
145699359|NCT04836559|525416322|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
145699360|NCT04836559|525416323|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
145699361|NCT04836559|525416324|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
145699362|NCT04836559|525416325|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
145699363|NCT04836559|525416326|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
145699364|NCT04836559|525416319|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
145699365|NCT04836559|525416320|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
145699366|NCT04836559|525416321|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
145699367|NCT04836559|525416322|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
145699368|NCT04836559|525416323|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
145699369|NCT04836559|525416324|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
145699370|NCT04836559|525416325|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
145699371|NCT04836559|525416326|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
145699372|NCT04836559|525416319|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
145699373|NCT04836559|525416320|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
145699374|NCT04836559|525416321|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
145699375|NCT04836559|525416322|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
145699376|NCT04836559|525416323|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
145699377|NCT04836559|525416324|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
145699378|NCT04836559|525416325|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
145699379|NCT04836559|525416326|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
145699380|NCT04836559|525416319|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699381|NCT04836559|525416320|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699382|NCT04836559|525416321|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699383|NCT04836559|525416322|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699384|NCT04836559|525416323|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699385|NCT04836559|525416324|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699386|NCT04836559|525416325|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
145699387|NCT04836559|525416326|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
145699388|NCT00730015|525416327|FG000|Overall Study|Adverse Event|11|||
145699389|NCT00730015|525416328|FG001|Overall Study|Adverse Event|10|||
145699390|NCT00730015|525416329|FG002|Overall Study|Adverse Event|8|||
145699391|NCT00730015|525416327|FG000|Overall Study|Protocol Violation|2|||
145699392|NCT00730015|525416328|FG001|Overall Study|Protocol Violation|6|||
145699393|NCT00730015|525416329|FG002|Overall Study|Protocol Violation|4|||
145699394|NCT00730015|525416327|FG000|Overall Study|Withdrawal by Subject|12|||
145699395|NCT00730015|525416328|FG001|Overall Study|Withdrawal by Subject|12|||
145699396|NCT00730015|525416329|FG002|Overall Study|Withdrawal by Subject|8|||
145699397|NCT00730015|525416327|FG000|Overall Study|Lost to Follow-up|4|||
145699398|NCT00730015|525416328|FG001|Overall Study|Lost to Follow-up|10|||
145699399|NCT00730015|525416329|FG002|Overall Study|Lost to Follow-up|3|||
145699400|NCT00730015|525416327|FG000|Overall Study|Lack of Efficacy|1|||
145699401|NCT00730015|525416328|FG001|Overall Study|Lack of Efficacy|2|||
145699402|NCT00730015|525416329|FG002|Overall Study|Lack of Efficacy|8|||
145699403|NCT00730015|525416327|FG000|Overall Study|Other Reason|1|||
145699404|NCT00730015|525416328|FG001|Overall Study|Other Reason|0|||
145699405|NCT00730015|525416329|FG002|Overall Study|Other Reason|1|||
145699406|NCT05382039|525416330|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
145699407|NCT05382039|525416331|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
145699408|NCT05382039|525416332|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
145699409|NCT05382039|525416330|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
145699410|NCT05382039|525416331|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
145699411|NCT05382039|525416332|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
145699412|NCT05382039|525416330|FG000|Overall Study|waiting for confirmation|0|||
145699413|NCT05382039|525416331|FG001|Overall Study|waiting for confirmation|0|||
145699414|NCT05382039|525416332|FG002|Overall Study|waiting for confirmation|1|||
145699415|NCT01432626|525416333|FG000|Overall Study|LV function recovered|2|||
145699416|NCT01432626|525416333|FG000|Overall Study|Withdrawal by Subject|2|||
145699417|NCT01432626|525416333|FG000|Overall Study|Only 1 image competed|2|||
145699418|NCT01432626|525416333|FG000|Overall Study|Imaging agent not available|1|||
145699419|NCT02270671|525416336|FG000|Overall Study|Withdrawal by Subject|1|||
145699420|NCT02270671|525416337|FG001|Overall Study|Withdrawal by Subject|1|||
145699421|NCT02270671|525416336|FG000|Overall Study|Protocol Violation|0|||
145699422|NCT02270671|525416337|FG001|Overall Study|Protocol Violation|1|||
145699423|NCT02270671|525416336|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
145699424|NCT02270671|525416337|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
145699425|NCT02270671|525416336|FG000|Overall Study|Lost to Follow-up|2|||
145699426|NCT02270671|525416337|FG001|Overall Study|Lost to Follow-up|1|||
145699427|NCT01657799|525416341|FG000|Overall Study|Adverse Event Related to progression|6|||
145699428|NCT01657799|525416342|FG001|Overall Study|Adverse Event Related to progression|8|||
145699429|NCT01657799|525416343|FG002|Overall Study|Adverse Event Related to progression|12|||
145699430|NCT01657799|525416341|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
145699431|NCT01657799|525416342|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
145699432|NCT01657799|525416343|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
145699433|NCT01657799|525416341|FG000|Overall Study|Withdrawal by Subject|13|||
145699434|NCT01657799|525416342|FG001|Overall Study|Withdrawal by Subject|10|||
145699435|NCT01657799|525416343|FG002|Overall Study|Withdrawal by Subject|10|||
145699436|NCT01657799|525416341|FG000|Overall Study|Lost to Follow-up|1|||
145699437|NCT01657799|525416342|FG001|Overall Study|Lost to Follow-up|0|||
145699438|NCT01657799|525416343|FG002|Overall Study|Lost to Follow-up|1|||
145699439|NCT01657799|525416341|FG000|Overall Study|Disease Progression|2|||
145699440|NCT01657799|525416342|FG001|Overall Study|Disease Progression|4|||
145699441|NCT01657799|525416343|FG002|Overall Study|Disease Progression|4|||
145699442|NCT01657799|525416341|FG000|Overall Study|Progressive Disease Clinical|7|||
145699443|NCT01657799|525416342|FG001|Overall Study|Progressive Disease Clinical|4|||
145699444|NCT01657799|525416343|FG002|Overall Study|Progressive Disease Clinical|7|||
145699445|NCT01657799|525416341|FG000|Overall Study|Radiographic & Clinical Progression|16|||
145699446|NCT01657799|525416342|FG001|Overall Study|Radiographic & Clinical Progression|11|||
145699447|NCT01657799|525416343|FG002|Overall Study|Radiographic & Clinical Progression|15|||
145699448|NCT01657799|525416341|FG000|Overall Study|Other|52|||
145699449|NCT01657799|525416342|FG001|Overall Study|Other|62|||
145699450|NCT01657799|525416343|FG002|Overall Study|Other|49|||
145699451|NCT00174447|525416344|FG000|Overall Study|Adverse Event|19|||
145699452|NCT00174447|525416344|FG000|Overall Study|Withdrawal by Subject|15|||
145699453|NCT00174447|525416344|FG000|Overall Study|Protocol Violation|1|||
145699454|NCT00174447|525416344|FG000|Overall Study|Lack of Efficacy|1|||
145699455|NCT00174447|525416344|FG000|Overall Study|Administrative reason/Other|2|||
145699456|NCT01660256|525416347|FG000|Overall Study|Adverse Event|4|||
145699457|NCT01660256|525416348|FG001|Overall Study|Adverse Event|0|||
145699458|NCT01660256|525416349|FG002|Overall Study|Adverse Event|2|||
145699459|NCT01660256|525416347|FG000|Overall Study|Withdrawal by Subject|1|||
145699460|NCT01660256|525416348|FG001|Overall Study|Withdrawal by Subject|0|||
145699461|NCT01660256|525416349|FG002|Overall Study|Withdrawal by Subject|2|||
145699462|NCT01646385|525416351|FG000|Overall Study|Death|202|||
145699463|NCT01646385|525416352|FG001|Overall Study|Death|222|||
145699464|NCT01646385|525416351|FG000|Overall Study|Switched to alternate biologic|636|||
145699465|NCT01646385|525416352|FG001|Overall Study|Switched to alternate biologic|649|||
145699466|NCT01777334|525416355|FG000|Overall Study|Adverse Event|18|||
145699467|NCT01777334|525416356|FG001|Overall Study|Adverse Event|14|||
145699468|NCT01777334|525416355|FG000|Overall Study|Lack of Efficacy|15|||
145699469|NCT01777334|525416356|FG001|Overall Study|Lack of Efficacy|29|||
145699470|NCT01777334|525416355|FG000|Overall Study|Protocol Violation|3|||
145699471|NCT01777334|525416356|FG001|Overall Study|Protocol Violation|7|||
145699472|NCT01777334|525416355|FG000|Overall Study|Lost to Follow-up|3|||
145699473|NCT01777334|525416356|FG001|Overall Study|Lost to Follow-up|2|||
145699474|NCT01777334|525416355|FG000|Overall Study|Withdrawal by Subject|14|||
145699475|NCT01777334|525416356|FG001|Overall Study|Withdrawal by Subject|11|||
145699476|NCT01841697|525416365|FG000|Overall Study|Death|0|||
145699477|NCT01841697|525416366|FG001|Overall Study|Death|1|||
145699478|NCT01841697|525416365|FG000|Overall Study|Lost to Follow-up|4|||
145699479|NCT01841697|525416366|FG001|Overall Study|Lost to Follow-up|1|||
145699480|NCT01841697|525416365|FG000|Overall Study|Withdrawal by Subject|16|||
145699481|NCT01841697|525416366|FG001|Overall Study|Withdrawal by Subject|16|||
145699482|NCT00727415|525416367|FG000|Phase I|Dose Limiting Toxicity|2|||
145699483|NCT00756457|525416369|FG000|Overall Study|Lost to Follow-up|1|||
145699484|NCT00756457|525416370|FG001|Overall Study|Lost to Follow-up|2|||
145699485|NCT01777490|525416374|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
145699486|NCT01777490|525416375|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
145699487|NCT01777490|525416376|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
145699488|NCT01777490|525416377|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
145699489|NCT03414047|525416380|FG000|Overall Study|Adverse Event|0|||
145699490|NCT03414047|525416381|FG001|Overall Study|Adverse Event|0|||
145699491|NCT03414047|525416382|FG002|Overall Study|Adverse Event|1|||
145699492|NCT03414047|525416383|FG003|Overall Study|Adverse Event|1|||
145699493|NCT03414047|525416380|FG000|Overall Study|Physician Decision|1|||
145699494|NCT03414047|525416381|FG001|Overall Study|Physician Decision|0|||
145699495|NCT03414047|525416382|FG002|Overall Study|Physician Decision|0|||
145699496|NCT03414047|525416383|FG003|Overall Study|Physician Decision|1|||
145699497|NCT03414047|525416380|FG000|Overall Study|Withdrawal by Subject|1|||
145699498|NCT03414047|525416381|FG001|Overall Study|Withdrawal by Subject|0|||
145699499|NCT03414047|525416382|FG002|Overall Study|Withdrawal by Subject|2|||
145699500|NCT03414047|525416383|FG003|Overall Study|Withdrawal by Subject|0|||
145699501|NCT02564718|525416385|FG000|Overall Study|Withdrew from treatment|0|||
145699502|NCT02564718|525416386|FG001|Overall Study|Withdrew from treatment|1|||
145699503|NCT01918371|525416389|FG000|Overall Study|Missing Data|1|||
145699504|NCT01918371|525416390|FG001|Overall Study|Missing Data|1|||
145699505|NCT00621192|525416391|FG000|Overall Study|Withdrawal by Subject|0|||
145699506|NCT00621192|525416392|FG001|Overall Study|Withdrawal by Subject|0|||
145699507|NCT00621192|525416393|FG002|Overall Study|Withdrawal by Subject|2|||
145699508|NCT00621192|525416394|FG003|Overall Study|Withdrawal by Subject|0|||
145699509|NCT00621192|525416391|FG000|Overall Study|Physician Decision|1|||
145699510|NCT00621192|525416392|FG001|Overall Study|Physician Decision|3|||
145699511|NCT00621192|525416393|FG002|Overall Study|Physician Decision|0|||
145699512|NCT00621192|525416394|FG003|Overall Study|Physician Decision|0|||
145699513|NCT00621192|525416391|FG000|Overall Study|Protocol Violation|1|||
145699514|NCT00621192|525416392|FG001|Overall Study|Protocol Violation|0|||
145699515|NCT00621192|525416393|FG002|Overall Study|Protocol Violation|0|||
145699516|NCT00621192|525416394|FG003|Overall Study|Protocol Violation|1|||
145699517|NCT00621192|525416391|FG000|Overall Study|Adverse Event|0|||
145699518|NCT00621192|525416392|FG001|Overall Study|Adverse Event|1|||
145699519|NCT00621192|525416393|FG002|Overall Study|Adverse Event|0|||
145699520|NCT00621192|525416394|FG003|Overall Study|Adverse Event|1|||
145699521|NCT00621192|525416391|FG000|Overall Study|Death|2|||
145699522|NCT00621192|525416392|FG001|Overall Study|Death|5|||
145699523|NCT00621192|525416393|FG002|Overall Study|Death|0|||
145699524|NCT00621192|525416394|FG003|Overall Study|Death|0|||
145699525|NCT00621192|525416391|FG000|Overall Study|Final Assessments not Completed|0|||
145699526|NCT00621192|525416392|FG001|Overall Study|Final Assessments not Completed|0|||
145699527|NCT00621192|525416393|FG002|Overall Study|Final Assessments not Completed|3|||
145699528|NCT00621192|525416394|FG003|Overall Study|Final Assessments not Completed|1|||
145699529|NCT04706793|525416395|FG000|Treatment|Disease worsening|10|||
145699530|NCT04706793|525416396|FG001|Treatment|Disease worsening|10|||
145699531|NCT04706793|525416395|FG000|Follow-up|Lack of Efficacy|1|||
145699532|NCT04706793|525416396|FG001|Follow-up|Lack of Efficacy|0|||
145699533|NCT04706793|525416395|FG000|Follow-up|Disease worsening|8|||
145699534|NCT04706793|525416396|FG001|Follow-up|Disease worsening|10|||
145699535|NCT04706793|525416395|FG000|Follow-up|Adverse Event|1|||
145699536|NCT04706793|525416396|FG001|Follow-up|Adverse Event|0|||
145699537|NCT01130168|525416404|FG000|Period 1|Withdrawal by Subject|0|||
145699538|NCT01130168|525416405|FG001|Period 1|Withdrawal by Subject|1|||
145699539|NCT01130168|525416406|FG002|Period 1|Withdrawal by Subject|0|||
145699540|NCT01130168|525416407|FG003|Period 1|Withdrawal by Subject|1|||
145699541|NCT01130168|525416408|FG004|Period 1|Withdrawal by Subject|0|||
145699542|NCT01130168|525416409|FG005|Period 1|Withdrawal by Subject|0|||
145699543|NCT01130168|525416404|FG000|Period 1|Discontinued For Other Reason|0|||
145699544|NCT01130168|525416405|FG001|Period 1|Discontinued For Other Reason|0|||
145699545|NCT01130168|525416406|FG002|Period 1|Discontinued For Other Reason|1|||
145699546|NCT01130168|525416407|FG003|Period 1|Discontinued For Other Reason|1|||
145699547|NCT01130168|525416408|FG004|Period 1|Discontinued For Other Reason|0|||
145699548|NCT01130168|525416409|FG005|Period 1|Discontinued For Other Reason|0|||
145699549|NCT01130168|525416404|FG000|Period 1|Adverse Event|0|||
145699550|NCT01130168|525416405|FG001|Period 1|Adverse Event|0|||
145699551|NCT01130168|525416406|FG002|Period 1|Adverse Event|0|||
145699552|NCT01130168|525416407|FG003|Period 1|Adverse Event|1|||
145699553|NCT01130168|525416408|FG004|Period 1|Adverse Event|0|||
145699554|NCT01130168|525416409|FG005|Period 1|Adverse Event|0|||
145699555|NCT02569957|525416411|FG000|Overall Study|Withdrawal by Subject|0|||
145699556|NCT02569957|525416412|FG001|Overall Study|Withdrawal by Subject|1|||
145699557|NCT02635386|525416414|FG000|Overall Study|Pregnancy|2|||
145699558|NCT02635386|525416415|FG001|Overall Study|Pregnancy|0|||
145699559|NCT02635386|525416416|FG002|Overall Study|Pregnancy|0|||
145699560|NCT02635386|525416417|FG003|Overall Study|Pregnancy|0|||
145699561|NCT02635386|525416418|FG004|Overall Study|Pregnancy|2|||
145699562|NCT02635386|525416414|FG000|Overall Study|Withdrawal by Subject|1|||
145699563|NCT02635386|525416415|FG001|Overall Study|Withdrawal by Subject|1|||
145699564|NCT02635386|525416416|FG002|Overall Study|Withdrawal by Subject|0|||
145699565|NCT02635386|525416417|FG003|Overall Study|Withdrawal by Subject|1|||
145699566|NCT02635386|525416418|FG004|Overall Study|Withdrawal by Subject|0|||
145699567|NCT02635386|525416414|FG000|Overall Study|Physician Decision|0|||
145699568|NCT02635386|525416415|FG001|Overall Study|Physician Decision|1|||
145699569|NCT02635386|525416416|FG002|Overall Study|Physician Decision|0|||
145699570|NCT02635386|525416417|FG003|Overall Study|Physician Decision|0|||
145699571|NCT02635386|525416418|FG004|Overall Study|Physician Decision|0|||
145699572|NCT02635386|525416414|FG000|Overall Study|Moved Out of State|0|||
145699573|NCT02635386|525416415|FG001|Overall Study|Moved Out of State|1|||
145699574|NCT02635386|525416416|FG002|Overall Study|Moved Out of State|0|||
145699575|NCT02635386|525416417|FG003|Overall Study|Moved Out of State|0|||
145699576|NCT02635386|525416418|FG004|Overall Study|Moved Out of State|0|||
145699577|NCT02635386|525416414|FG000|Overall Study|Noncompliant|0|||
145699578|NCT02635386|525416415|FG001|Overall Study|Noncompliant|2|||
145699579|NCT02635386|525416416|FG002|Overall Study|Noncompliant|1|||
145699580|NCT02635386|525416417|FG003|Overall Study|Noncompliant|1|||
145699581|NCT02635386|525416418|FG004|Overall Study|Noncompliant|1|||
145699582|NCT02635386|525416414|FG000|Overall Study|side effects|0|||
145699583|NCT02635386|525416415|FG001|Overall Study|side effects|0|||
145699584|NCT02635386|525416416|FG002|Overall Study|side effects|1|||
145699585|NCT02635386|525416417|FG003|Overall Study|side effects|4|||
145699586|NCT02635386|525416418|FG004|Overall Study|side effects|6|||
145699587|NCT02635386|525416414|FG000|Overall Study|needed other major surgery|0|||
145699588|NCT02635386|525416415|FG001|Overall Study|needed other major surgery|1|||
145699589|NCT02635386|525416416|FG002|Overall Study|needed other major surgery|0|||
145699590|NCT02635386|525416417|FG003|Overall Study|needed other major surgery|0|||
145699591|NCT02635386|525416418|FG004|Overall Study|needed other major surgery|0|||
145699592|NCT02635386|525416414|FG000|Overall Study|Other medical problems not drug related|0|||
145699593|NCT02635386|525416415|FG001|Overall Study|Other medical problems not drug related|0|||
145699594|NCT02635386|525416416|FG002|Overall Study|Other medical problems not drug related|0|||
145699595|NCT02635386|525416417|FG003|Overall Study|Other medical problems not drug related|1|||
145699596|NCT02635386|525416418|FG004|Overall Study|Other medical problems not drug related|0|||
145699597|NCT04354168|525416419|FG000|Overall Study|Lost to Follow-up|22|||
145699598|NCT01781832|525416420|FG000|Overall Study|Withdrawal by Subject|1|||
145699599|NCT02706847|525416425|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
145699600|NCT02706847|525416426|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
145699601|NCT02706847|525416427|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
145699602|NCT02706847|525416428|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
145699603|NCT02706847|525416425|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
145699604|NCT02706847|525416426|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
145699605|NCT02706847|525416427|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
145699606|NCT02706847|525416428|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
145699607|NCT02706847|525416425|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
145699608|NCT02706847|525416426|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
145699609|NCT02706847|525416427|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
145699610|NCT02706847|525416428|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
145699611|NCT02706847|525416425|FG000|Period 1: Day 1 to Week 12|Other|4|||
145699612|NCT02706847|525416426|FG001|Period 1: Day 1 to Week 12|Other|4|||
145699613|NCT02706847|525416427|FG002|Period 1: Day 1 to Week 12|Other|2|||
145699614|NCT02706847|525416428|FG003|Period 1: Day 1 to Week 12|Other|2|||
145699615|NCT02706847|525416425|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
145699616|NCT02706847|525416426|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
145699617|NCT02706847|525416427|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
145699618|NCT02706847|525416428|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
145699619|NCT02706847|525416425|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
145699620|NCT02706847|525416426|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
145699621|NCT02706847|525416427|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
145699622|NCT02706847|525416428|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
145699623|NCT02706847|525416425|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
145699624|NCT02706847|525416426|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
145699625|NCT02706847|525416427|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
145699626|NCT02706847|525416428|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
145699627|NCT02706847|525416425|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
145699628|NCT02706847|525416426|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
145699629|NCT02706847|525416427|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
145699630|NCT02706847|525416428|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
145699631|NCT02706847|525416425|FG000|Period 1: Week 12 to Week 24|Other|1|||
145699632|NCT02706847|525416426|FG001|Period 1: Week 12 to Week 24|Other|0|||
145699633|NCT02706847|525416427|FG002|Period 1: Week 12 to Week 24|Other|1|||
145699634|NCT02706847|525416428|FG003|Period 1: Week 12 to Week 24|Other|4|||
145699635|NCT02706847|525416425|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
145699636|NCT02706847|525416426|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
145699637|NCT02706847|525416427|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
145699638|NCT02706847|525416428|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
145699639|NCT02706847|525416425|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
145699640|NCT02706847|525416426|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
145699641|NCT02706847|525416427|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
145699642|NCT02706847|525416428|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
145699643|NCT02706847|525416425|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
145699644|NCT02706847|525416426|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
145699645|NCT02706847|525416427|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
145699646|NCT02706847|525416428|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
145699647|NCT02706847|525416425|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
145699648|NCT02706847|525416426|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
145699649|NCT02706847|525416427|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
145699650|NCT02706847|525416428|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
145699651|NCT02706847|525416425|FG000|Period 2: Week 24 to Week 260|Other|8|||
145699652|NCT02706847|525416426|FG001|Period 2: Week 24 to Week 260|Other|5|||
145699653|NCT02706847|525416427|FG002|Period 2: Week 24 to Week 260|Other|15|||
145699654|NCT02706847|525416428|FG003|Period 2: Week 24 to Week 260|Other|15|||
145699655|NCT03432390|525416429|FG000|Apnea Period|Protocol Violation|2|||
145699656|NCT03432390|525416430|FG001|Apnea Period|Protocol Violation|2|||
145699657|NCT01087814|525416431|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
145699658|NCT01087814|525416432|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
145699659|NCT01087814|525416431|FG000|Second Intervention (5 Days)|Physician Decision|1|||
145699660|NCT01087814|525416432|FG001|Second Intervention (5 Days)|Physician Decision|0|||
145699661|NCT01427738|525416433|FG000|Overall Study|Death|12|||
145699662|NCT01427738|525416434|FG001|Overall Study|Death|9|||
145699663|NCT01427738|525416433|FG000|Overall Study|Severe debilitation, unable to continue|0|||
145699664|NCT01427738|525416434|FG001|Overall Study|Severe debilitation, unable to continue|1|||
145699665|NCT01427738|525416433|FG000|Overall Study|Subject unable to get to clinic|5|||
145699666|NCT01427738|525416434|FG001|Overall Study|Subject unable to get to clinic|2|||
145699667|NCT01427738|525416433|FG000|Overall Study|Withdrawal by Subject|0|||
145699668|NCT01427738|525416434|FG001|Overall Study|Withdrawal by Subject|2|||
145699669|NCT01427738|525416433|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
145699670|NCT01427738|525416434|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
145699671|NCT01427738|525416433|FG000|Overall Study|Lost to Follow-up|1|||
145699672|NCT01427738|525416434|FG001|Overall Study|Lost to Follow-up|5|||
145699673|NCT05314374|525416435|FG000|Overall Study|Adverse Event|2|||
145699674|NCT05314374|525416436|FG001|Overall Study|Adverse Event|2|||
145699675|NCT02658175|525416437|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
145699676|NCT02658175|525416438|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
145699677|NCT02658175|525416439|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
145699678|NCT02658175|525416437|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
145699679|NCT02658175|525416438|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
145699680|NCT02658175|525416439|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
145699681|NCT02658175|525416437|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
145699682|NCT02658175|525416438|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
145699683|NCT02658175|525416439|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
145699684|NCT02658175|525416437|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
145699685|NCT02658175|525416438|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
145699686|NCT02658175|525416439|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
145699687|NCT02658175|525416437|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
145699688|NCT02658175|525416438|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
145699689|NCT02658175|525416439|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
145699690|NCT02658175|525416437|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
145699691|NCT02658175|525416438|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
145699692|NCT02658175|525416439|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
145699693|NCT02658175|525416437|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
145699694|NCT02658175|525416438|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
145699695|NCT02658175|525416439|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
145699696|NCT02658175|525416437|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
145699697|NCT02658175|525416438|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
145699698|NCT02658175|525416439|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
145699699|NCT02658175|525416437|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
145699700|NCT02658175|525416438|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
145699701|NCT02658175|525416439|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
145699702|NCT02658175|525416437|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
145699703|NCT02658175|525416438|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
145699704|NCT02658175|525416439|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
145699705|NCT02918292|525416440|FG000|Study Enrollment Prior to Transplant|Death|1|||
145699706|NCT02918292|525416440|FG000|Study Follow up After Transplant|Death|6|||
145699707|NCT02650466|525416443|FG000|Overall Study|Physician Decision|1|||
145699708|NCT02650466|525416443|FG000|Overall Study|Withdrawal by Subject|5|||
145699709|NCT02650466|525416443|FG000|Overall Study|Lost to Follow-up|1|||
145699710|NCT01214421|525416444|FG000|Overall Study|Lost to Follow-up|7|||
145699711|NCT01214421|525416445|FG001|Overall Study|Lost to Follow-up|3|||
145699712|NCT01214421|525416446|FG002|Overall Study|Lost to Follow-up|7|||
145699713|NCT01214421|525416447|FG003|Overall Study|Lost to Follow-up|3|||
145699714|NCT01214421|525416444|FG000|Overall Study|Adverse Event|16|||
145699715|NCT01214421|525416445|FG001|Overall Study|Adverse Event|35|||
145699716|NCT01214421|525416446|FG002|Overall Study|Adverse Event|14|||
145699717|NCT01214421|525416447|FG003|Overall Study|Adverse Event|3|||
145699718|NCT01214421|525416444|FG000|Overall Study|Sponsor Discontinued Site|1|||
145699719|NCT01214421|525416445|FG001|Overall Study|Sponsor Discontinued Site|2|||
145699720|NCT01214421|525416446|FG002|Overall Study|Sponsor Discontinued Site|0|||
145699721|NCT01214421|525416447|FG003|Overall Study|Sponsor Discontinued Site|0|||
145699722|NCT01214421|525416444|FG000|Overall Study|Withdrawal Criteria Met|3|||
145699723|NCT01214421|525416445|FG001|Overall Study|Withdrawal Criteria Met|0|||
145699724|NCT01214421|525416446|FG002|Overall Study|Withdrawal Criteria Met|2|||
145699725|NCT01214421|525416447|FG003|Overall Study|Withdrawal Criteria Met|1|||
145699726|NCT01214421|525416444|FG000|Overall Study|Physician Decision|2|||
145699727|NCT01214421|525416445|FG001|Overall Study|Physician Decision|0|||
145699728|NCT01214421|525416446|FG002|Overall Study|Physician Decision|4|||
145699729|NCT01214421|525416447|FG003|Overall Study|Physician Decision|0|||
145699730|NCT01214421|525416444|FG000|Overall Study|Withdrawal by Subject|21|||
145699731|NCT01214421|525416445|FG001|Overall Study|Withdrawal by Subject|18|||
145699732|NCT01214421|525416446|FG002|Overall Study|Withdrawal by Subject|11|||
145699733|NCT01214421|525416447|FG003|Overall Study|Withdrawal by Subject|2|||
145699734|NCT03783689|525416451|FG000|Overall Study|Adverse Event|2|||
145699735|NCT03783689|525416452|FG001|Overall Study|Adverse Event|0|||
145699736|NCT03783689|525416451|FG000|Overall Study|Lost to Follow-up|2|||
145699737|NCT03783689|525416452|FG001|Overall Study|Lost to Follow-up|1|||
145699738|NCT03783689|525416451|FG000|Overall Study|Physician Decision|2|||
145699739|NCT03783689|525416452|FG001|Overall Study|Physician Decision|1|||
145699740|NCT03783689|525416451|FG000|Overall Study|Withdrawal by Subject|3|||
145699741|NCT03783689|525416452|FG001|Overall Study|Withdrawal by Subject|3|||
145699742|NCT01251887|525416454|FG000|Overall Study|Scheduling conflict|1|||
145699743|NCT01251887|525416455|FG001|Overall Study|Scheduling conflict|2|||
145699744|NCT01251887|525416456|FG002|Overall Study|Scheduling conflict|2|||
145699745|NCT01251887|525416454|FG000|Overall Study|Physician Decision|0|||
145699746|NCT01251887|525416455|FG001|Overall Study|Physician Decision|1|||
145699747|NCT01251887|525416456|FG002|Overall Study|Physician Decision|0|||
145699748|NCT00575042|525418224|FG000|Overall Study|Adverse Event|2|||
145699749|NCT00575042|525418224|FG000|Overall Study|Lost to Follow-up|1|||
145699750|NCT03167151|525418225|FG000|Overall Study|Withdrawal by Subject|1|||
145699751|NCT03167151|525418226|FG001|Overall Study|Withdrawal by Subject|0|||
145699752|NCT03167151|525418227|FG002|Overall Study|Withdrawal by Subject|0|||
145699753|NCT03167151|525418225|FG000|Overall Study|No evidence of tumour at surgery|0|||
145699754|NCT03167151|525418226|FG001|Overall Study|No evidence of tumour at surgery|1|||
145699755|NCT03167151|525418227|FG002|Overall Study|No evidence of tumour at surgery|1|||
145699756|NCT01458522|525418228|FG000|Overall Study|Withdrawal by Subject|2|||
145699757|NCT01458522|525418229|FG001|Overall Study|Withdrawal by Subject|2|||
145699758|NCT01458522|525418228|FG000|Overall Study|Physician Decision|1|||
145699759|NCT01458522|525418229|FG001|Overall Study|Physician Decision|9|||
145699760|NCT00516139|525418230|FG000|Overall Study|Adverse Event|27|||
145699761|NCT00516139|525418230|FG000|Overall Study|Lost to Follow-up|1|||
145699762|NCT00516139|525418230|FG000|Overall Study|Protocol Violation|1|||
145699763|NCT00516139|525418230|FG000|Overall Study|Withdrawal by Subject|8|||
145699764|NCT00516139|525418230|FG000|Overall Study|Lack of Efficacy|1|||
145699765|NCT00416598|525418231|FG000|Induction & Intensification|Adverse Event|38|||
145699766|NCT00416598|525418231|FG000|Induction & Intensification|Death|32|||
145699767|NCT00416598|525418231|FG000|Induction & Intensification|Withdrawal by Subject|46|||
145699768|NCT00416598|525418231|FG000|Induction & Intensification|Alternative Treatment|135|||
145699769|NCT00416598|525418231|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
145699770|NCT00416598|525418231|FG000|Induction & Intensification|Relapse/progression|29|||
145699771|NCT00416598|525418231|FG000|Induction & Intensification|Failed induction|87|||
145699772|NCT00416598|525418231|FG000|Decitabine Maintenance|Adverse Event|5|||
145699773|NCT00416598|525418231|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
145699774|NCT00416598|525418231|FG000|Decitabine Maintenance|Progression/relapse|38|||
145699775|NCT00416598|525418231|FG000|Decitabine Maintenance|Alternative treatment|2|||
145699776|NCT00416598|525418231|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
145699777|NCT02166476|525418238|FG000|Overall Study|Withdrawal by Subject|5|||
145699778|NCT02166476|525418239|FG001|Overall Study|Withdrawal by Subject|7|||
145699779|NCT02166476|525418238|FG000|Overall Study|Adverse Event|3|||
145699780|NCT02166476|525418239|FG001|Overall Study|Adverse Event|3|||
145699781|NCT02166476|525418238|FG000|Overall Study|Lost to Follow-up|5|||
145699782|NCT02166476|525418239|FG001|Overall Study|Lost to Follow-up|10|||
145699783|NCT02166476|525418238|FG000|Overall Study|Physician Decision|1|||
145699784|NCT02166476|525418239|FG001|Overall Study|Physician Decision|0|||
145699785|NCT02166476|525418238|FG000|Overall Study|Unable to Come for Visit|0|||
145699786|NCT02166476|525418239|FG001|Overall Study|Unable to Come for Visit|3|||
145699787|NCT03382561|525418244|FG000|Overall Study|Disease progression|47|||
145699788|NCT03382561|525418245|FG001|Overall Study|Disease progression|6|||
145699789|NCT03382561|525418244|FG000|Overall Study|Adverse Event|10|||
145699790|NCT03382561|525418245|FG001|Overall Study|Adverse Event|2|||
145699791|NCT03382561|525418244|FG000|Overall Study|Death|8|||
145699792|NCT03382561|525418245|FG001|Overall Study|Death|3|||
145699793|NCT03382561|525418244|FG000|Overall Study|Withdrawal by Subject|6|||
145699794|NCT03382561|525418245|FG001|Overall Study|Withdrawal by Subject|5|||
145699795|NCT03382561|525418244|FG000|Overall Study|Alternative therapy|2|||
145699796|NCT03382561|525418245|FG001|Overall Study|Alternative therapy|8|||
145699797|NCT03382561|525418244|FG000|Overall Study|Never started treatment|3|||
145699798|NCT03382561|525418245|FG001|Overall Study|Never started treatment|6|||
145699799|NCT03382561|525418244|FG000|Overall Study|Lack of Efficacy|0|||
145699800|NCT03382561|525418245|FG001|Overall Study|Lack of Efficacy|1|||
145699801|NCT03382561|525418244|FG000|Overall Study|Physician Decision|0|||
145699802|NCT03382561|525418245|FG001|Overall Study|Physician Decision|1|||
145699803|NCT03382561|525418244|FG000|Overall Study|Other complicating disease|0|||
145699804|NCT03382561|525418245|FG001|Overall Study|Other complicating disease|1|||
145699805|NCT04978350|525418246|FG000|Overall Study|Lost to Follow-up|6|||
145699806|NCT03210519|525418247|FG000|Overall Study|Adverse Event|2|||
145699807|NCT03210519|525418248|FG001|Overall Study|Adverse Event|0|||
145699808|NCT04486313|525418249|FG000|Overall Study|Lost to Follow-up|7|||
145699809|NCT04486313|525418250|FG001|Overall Study|Lost to Follow-up|9|||
145699810|NCT04486313|525418249|FG000|Overall Study|Withdrawal by Subject|8|||
145699811|NCT04486313|525418250|FG001|Overall Study|Withdrawal by Subject|6|||
145699812|NCT04486313|525418249|FG000|Overall Study|Physician Decision|1|||
145699813|NCT04486313|525418250|FG001|Overall Study|Physician Decision|1|||
145699814|NCT04486313|525418249|FG000|Overall Study|Death|2|||
145699815|NCT04486313|525418250|FG001|Overall Study|Death|0|||
145699816|NCT04486313|525418249|FG000|Overall Study|Protocol Violation|1|||
145699817|NCT04486313|525418250|FG001|Overall Study|Protocol Violation|1|||
145699818|NCT01271504|525418257|FG000|Overall Study|Death|7|||
145699819|NCT01271504|525418258|FG001|Overall Study|Death|6|||
145699820|NCT01271504|525418259|FG002|Overall Study|Death|32|||
145699821|NCT01271504|525418260|FG003|Overall Study|Death|32|||
145699822|NCT01271504|525418257|FG000|Overall Study|Lost to Follow-up|0|||
145699823|NCT01271504|525418258|FG001|Overall Study|Lost to Follow-up|1|||
145699824|NCT01271504|525418259|FG002|Overall Study|Lost to Follow-up|3|||
145699825|NCT01271504|525418260|FG003|Overall Study|Lost to Follow-up|1|||
145699826|NCT01271504|525418257|FG000|Overall Study|Protocol Violation|0|||
145699827|NCT01271504|525418258|FG001|Overall Study|Protocol Violation|0|||
145699828|NCT01271504|525418259|FG002|Overall Study|Protocol Violation|0|||
145699829|NCT01271504|525418260|FG003|Overall Study|Protocol Violation|2|||
145699830|NCT01271504|525418257|FG000|Overall Study|Administrative Reasons|0|||
145699831|NCT01271504|525418258|FG001|Overall Study|Administrative Reasons|0|||
145699832|NCT01271504|525418259|FG002|Overall Study|Administrative Reasons|6|||
145699833|NCT01271504|525418260|FG003|Overall Study|Administrative Reasons|5|||
145699834|NCT01271504|525418257|FG000|Overall Study|Withdrawal by Subject|0|||
145699835|NCT01271504|525418258|FG001|Overall Study|Withdrawal by Subject|0|||
145699836|NCT01271504|525418259|FG002|Overall Study|Withdrawal by Subject|1|||
145699837|NCT01271504|525418260|FG003|Overall Study|Withdrawal by Subject|3|||
145699838|NCT01271504|525418257|FG000|Overall Study|Other|0|||
145699839|NCT01271504|525418258|FG001|Overall Study|Other|1|||
145699840|NCT01271504|525418259|FG002|Overall Study|Other|2|||
145699841|NCT01271504|525418260|FG003|Overall Study|Other|0|||
145699842|NCT03865953|525418271|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
145699843|NCT03865953|525418272|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
145699844|NCT03865953|525418271|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
145699845|NCT03865953|525418272|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
145699846|NCT03865953|525418271|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
145699847|NCT03865953|525418272|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
145699848|NCT00882115|525418273|FG000|Overall Study|Withdrawal by Subject|3|||
145699849|NCT00882115|525418273|FG000|Overall Study|did not respond to DEP challe|6|||
145699850|NCT00940875|525418278|FG000|Treatment Phase|Adverse Event|9|||
145699851|NCT00940875|525418279|FG001|Treatment Phase|Adverse Event|3|||
145699852|NCT00940875|525418278|FG000|Treatment Phase|Death|3|||
145699853|NCT00940875|525418279|FG001|Treatment Phase|Death|5|||
145699854|NCT00940875|525418278|FG000|Treatment Phase|Lack of Efficacy|1|||
145699855|NCT00940875|525418279|FG001|Treatment Phase|Lack of Efficacy|0|||
145699856|NCT00940875|525418278|FG000|Treatment Phase|Withdrawal by Subject|3|||
145699857|NCT00940875|525418279|FG001|Treatment Phase|Withdrawal by Subject|0|||
145699858|NCT00940875|525418278|FG000|Treatment Phase|Disease progression|9|||
145699859|NCT00940875|525418279|FG001|Treatment Phase|Disease progression|11|||
145699860|NCT00940875|525418278|FG000|Treatment Phase|Physician Decision|1|||
145699861|NCT00940875|525418279|FG001|Treatment Phase|Physician Decision|0|||
145699862|NCT00940875|525418278|FG000|Post-Study Treatment|Death|0|||
145699863|NCT00940875|525418279|FG001|Post-Study Treatment|Death|1|||
145699864|NCT00940875|525418278|FG000|Post-Study Treatment|Disease Progression|0|||
145699865|NCT00940875|525418279|FG001|Post-Study Treatment|Disease Progression|2|||
145699866|NCT00490945|525418280|FG000|Overall Study|Adverse Event|0|||
145699867|NCT00490945|525418281|FG001|Overall Study|Adverse Event|1|||
145699868|NCT00490945|525418282|FG002|Overall Study|Adverse Event|0|||
145699869|NCT00490945|525418283|FG003|Overall Study|Adverse Event|0|||
145699870|NCT00490945|525418284|FG004|Overall Study|Adverse Event|0|||
145699871|NCT03603639|525418287|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
145699872|NCT03603639|525418288|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
145699873|NCT03603639|525418289|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
145699874|NCT03603639|525418290|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
145699875|NCT03603639|525418291|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
145699876|NCT03603639|525418292|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
145699877|NCT03603639|525418287|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
145699878|NCT03603639|525418288|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
145699879|NCT03603639|525418289|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
145699880|NCT03603639|525418290|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
145699881|NCT03603639|525418291|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
145699882|NCT03603639|525418292|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
145699883|NCT02947100|525418295|FG000|Overall Study|study terminated early|3|||
145699884|NCT02947100|525418295|FG000|Overall Study|did not meet inclusion criteria|1|||
145699885|NCT00822770|525418296|FG000|Overall Study|Not treated|1|||
145699886|NCT00822770|525418297|FG001|Overall Study|Not treated|0|||
145699887|NCT00822770|525418296|FG000|Overall Study|Complication/Incomplete treatment|1|||
145699888|NCT00822770|525418297|FG001|Overall Study|Complication/Incomplete treatment|0|||
145699889|NCT00822770|525418296|FG000|Overall Study|Death|1|||
145699890|NCT00822770|525418297|FG001|Overall Study|Death|1|||
145699891|NCT02402322|525418298|FG000|Pretreatment|Withdrawal by Subject|3|||
145699892|NCT02402322|525418299|FG001|Pretreatment|Withdrawal by Subject|1|||
145699893|NCT02402322|525418300|FG002|Pretreatment|Withdrawal by Subject|1|||
145699894|NCT02402322|525418298|FG000|Follow-up|Withdrawal by Subject|6|||
145699895|NCT02402322|525418299|FG001|Follow-up|Withdrawal by Subject|3|||
145699896|NCT02402322|525418300|FG002|Follow-up|Withdrawal by Subject|24|||
145699897|NCT02818998|525418301|FG000|Overall Study|Adverse Event|3|||
145699898|NCT02818998|525418302|FG001|Overall Study|Adverse Event|2|||
145699899|NCT02818998|525418303|FG002|Overall Study|Adverse Event|1|||
145699900|NCT02818998|525418301|FG000|Overall Study|Lost to Follow-up|4|||
145699901|NCT02818998|525418302|FG001|Overall Study|Lost to Follow-up|1|||
145699902|NCT02818998|525418303|FG002|Overall Study|Lost to Follow-up|2|||
145699903|NCT02818998|525418301|FG000|Overall Study|Withdrawal by sponsor|0|||
145699904|NCT02818998|525418302|FG001|Overall Study|Withdrawal by sponsor|1|||
145699905|NCT02818998|525418303|FG002|Overall Study|Withdrawal by sponsor|1|||
145699906|NCT02818998|525418301|FG000|Overall Study|Death|3|||
145699907|NCT02818998|525418302|FG001|Overall Study|Death|6|||
145699908|NCT02818998|525418303|FG002|Overall Study|Death|8|||
145699909|NCT02818998|525418301|FG000|Overall Study|Withdrawal by Subject|7|||
145699910|NCT02818998|525418302|FG001|Overall Study|Withdrawal by Subject|6|||
145699911|NCT02818998|525418303|FG002|Overall Study|Withdrawal by Subject|6|||
145699912|NCT02818998|525418301|FG000|Overall Study|Physician Decision|1|||
145699913|NCT02818998|525418302|FG001|Overall Study|Physician Decision|0|||
145699914|NCT02818998|525418303|FG002|Overall Study|Physician Decision|0|||
145699915|NCT04593823|525418307|FG000|Overall Study|Withdrawal by Subject|1|||
145699916|NCT04593823|525418308|FG001|Overall Study|Withdrawal by Subject|1|||
145699917|NCT04593823|525418307|FG000|Overall Study|Lost to Follow-up|0|||
145699918|NCT04593823|525418308|FG001|Overall Study|Lost to Follow-up|1|||
145699919|NCT02472145|525418309|FG000|Overall Study|Death|10|||
145699920|NCT02472145|525418310|FG001|Overall Study|Death|101|||
145699921|NCT02472145|525418311|FG002|Overall Study|Death|99|||
145699922|NCT02472145|525418309|FG000|Overall Study|Lost to Follow-up|0|||
145699923|NCT02472145|525418310|FG001|Overall Study|Lost to Follow-up|1|||
145699924|NCT02472145|525418311|FG002|Overall Study|Lost to Follow-up|0|||
145699925|NCT02472145|525418309|FG000|Overall Study|Withdrawal by Subject|0|||
145699926|NCT02472145|525418310|FG001|Overall Study|Withdrawal by Subject|9|||
145699927|NCT02472145|525418311|FG002|Overall Study|Withdrawal by Subject|13|||
145699928|NCT02472145|525418309|FG000|Overall Study|Sponsor decision|0|||
145699929|NCT02472145|525418310|FG001|Overall Study|Sponsor decision|3|||
145699930|NCT02472145|525418311|FG002|Overall Study|Sponsor decision|2|||
145699931|NCT02472145|525418309|FG000|Overall Study|Other|0|||
145699932|NCT02472145|525418310|FG001|Overall Study|Other|45|||
145699933|NCT02472145|525418311|FG002|Overall Study|Other|43|||
145699934|NCT01080326|525418312|FG000|Overall Study|Patient deterioration prior to procedure|3|||
145699935|NCT01080326|525418312|FG000|Overall Study|Surgeon decision|1|||
145699936|NCT01296555|525418313|FG000|Overall Study|Adverse Event|0|||
145699937|NCT01296555|525418314|FG001|Overall Study|Adverse Event|0|||
145699938|NCT01296555|525418315|FG002|Overall Study|Adverse Event|1|||
145699939|NCT01296555|525418316|FG003|Overall Study|Adverse Event|1|||
145699940|NCT01296555|525418317|FG004|Overall Study|Adverse Event|2|||
145699941|NCT01296555|525418318|FG005|Overall Study|Adverse Event|4|||
145699942|NCT01296555|525418319|FG006|Overall Study|Adverse Event|1|||
145699943|NCT01296555|525418320|FG007|Overall Study|Adverse Event|4|||
145699944|NCT01296555|525418321|FG008|Overall Study|Adverse Event|3|||
145699945|NCT01296555|525418322|FG009|Overall Study|Adverse Event|1|||
145699946|NCT01296555|525418323|FG010|Overall Study|Adverse Event|0|||
145699947|NCT01296555|525418324|FG011|Overall Study|Adverse Event|4|||
145699948|NCT01296555|525418325|FG012|Overall Study|Adverse Event|1|||
145699949|NCT01296555|525418326|FG013|Overall Study|Adverse Event|4|||
145699950|NCT01296555|525418327|FG014|Overall Study|Adverse Event|0|||
145699951|NCT01296555|525418328|FG015|Overall Study|Adverse Event|0|||
145699952|NCT01296555|525418329|FG016|Overall Study|Adverse Event|0|||
145699953|NCT01296555|525418330|FG017|Overall Study|Adverse Event|0|||
145699954|NCT01296555|525418331|FG018|Overall Study|Adverse Event|0|||
145699955|NCT01296555|525418332|FG019|Overall Study|Adverse Event|1|||
145699956|NCT01296555|525418333|FG020|Overall Study|Adverse Event|0|||
145699957|NCT01296555|525418334|FG021|Overall Study|Adverse Event|0|||
145699958|NCT01296555|525418335|FG022|Overall Study|Adverse Event|0|||
145699959|NCT01296555|525418336|FG023|Overall Study|Adverse Event|0|||
145699960|NCT01296555|525418337|FG024|Overall Study|Adverse Event|0|||
145699961|NCT01296555|525418338|FG025|Overall Study|Adverse Event|0|||
145699962|NCT01296555|525418339|FG026|Overall Study|Adverse Event|0|||
145699963|NCT01296555|525418340|FG027|Overall Study|Adverse Event|0|||
145699964|NCT01296555|525418341|FG028|Overall Study|Adverse Event|0|||
145699965|NCT01296555|525418313|FG000|Overall Study|Reason Not Specified|0|||
145699966|NCT01296555|525418314|FG001|Overall Study|Reason Not Specified|0|||
145699967|NCT01296555|525418315|FG002|Overall Study|Reason Not Specified|0|||
145699968|NCT01296555|525418316|FG003|Overall Study|Reason Not Specified|0|||
145699969|NCT01296555|525418317|FG004|Overall Study|Reason Not Specified|0|||
145699970|NCT01296555|525418318|FG005|Overall Study|Reason Not Specified|0|||
145699971|NCT01296555|525418319|FG006|Overall Study|Reason Not Specified|0|||
145699972|NCT01296555|525418320|FG007|Overall Study|Reason Not Specified|0|||
145699973|NCT01296555|525418321|FG008|Overall Study|Reason Not Specified|0|||
145699974|NCT01296555|525418322|FG009|Overall Study|Reason Not Specified|0|||
145699975|NCT01296555|525418323|FG010|Overall Study|Reason Not Specified|0|||
145699976|NCT01296555|525418324|FG011|Overall Study|Reason Not Specified|0|||
145699977|NCT01296555|525418325|FG012|Overall Study|Reason Not Specified|0|||
145699978|NCT01296555|525418326|FG013|Overall Study|Reason Not Specified|1|||
145699979|NCT01296555|525418327|FG014|Overall Study|Reason Not Specified|2|||
145699980|NCT01296555|525418328|FG015|Overall Study|Reason Not Specified|3|||
145699981|NCT01296555|525418329|FG016|Overall Study|Reason Not Specified|7|||
145699982|NCT01296555|525418330|FG017|Overall Study|Reason Not Specified|4|||
145699983|NCT01296555|525418331|FG018|Overall Study|Reason Not Specified|3|||
145699984|NCT01296555|525418332|FG019|Overall Study|Reason Not Specified|7|||
145699985|NCT01296555|525418333|FG020|Overall Study|Reason Not Specified|11|||
145699986|NCT01296555|525418334|FG021|Overall Study|Reason Not Specified|5|||
145699987|NCT01296555|525418335|FG022|Overall Study|Reason Not Specified|5|||
145699988|NCT01296555|525418336|FG023|Overall Study|Reason Not Specified|7|||
145699989|NCT01296555|525418337|FG024|Overall Study|Reason Not Specified|2|||
145699990|NCT01296555|525418338|FG025|Overall Study|Reason Not Specified|2|||
145699991|NCT01296555|525418339|FG026|Overall Study|Reason Not Specified|19|||
145699992|NCT01296555|525418340|FG027|Overall Study|Reason Not Specified|11|||
145699993|NCT01296555|525418341|FG028|Overall Study|Reason Not Specified|9|||
145699994|NCT01296555|525418313|FG000|Overall Study|Physician Decision|0|||
145699995|NCT01296555|525418314|FG001|Overall Study|Physician Decision|0|||
145699996|NCT01296555|525418315|FG002|Overall Study|Physician Decision|0|||
145699997|NCT01296555|525418316|FG003|Overall Study|Physician Decision|0|||
145699998|NCT01296555|525418317|FG004|Overall Study|Physician Decision|1|||
145699999|NCT01296555|525418318|FG005|Overall Study|Physician Decision|0|||
145700000|NCT01296555|525418319|FG006|Overall Study|Physician Decision|0|||
145700001|NCT01296555|525418320|FG007|Overall Study|Physician Decision|0|||
145700002|NCT01296555|525418321|FG008|Overall Study|Physician Decision|0|||
145700003|NCT01296555|525418322|FG009|Overall Study|Physician Decision|0|||
145700004|NCT01296555|525418323|FG010|Overall Study|Physician Decision|0|||
145700005|NCT01296555|525418324|FG011|Overall Study|Physician Decision|0|||
145700006|NCT01296555|525418325|FG012|Overall Study|Physician Decision|0|||
145700007|NCT01296555|525418326|FG013|Overall Study|Physician Decision|1|||
145700008|NCT01296555|525418327|FG014|Overall Study|Physician Decision|0|||
145700009|NCT01296555|525418328|FG015|Overall Study|Physician Decision|0|||
145700010|NCT01296555|525418329|FG016|Overall Study|Physician Decision|0|||
145700011|NCT01296555|525418330|FG017|Overall Study|Physician Decision|0|||
145700012|NCT01296555|525418331|FG018|Overall Study|Physician Decision|0|||
145700013|NCT01296555|525418332|FG019|Overall Study|Physician Decision|1|||
145700014|NCT01296555|525418333|FG020|Overall Study|Physician Decision|0|||
145378459|NCT03309696|524237246|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
145700015|NCT01296555|525418334|FG021|Overall Study|Physician Decision|0|||
145700016|NCT01296555|525418335|FG022|Overall Study|Physician Decision|0|||
145700017|NCT01296555|525418336|FG023|Overall Study|Physician Decision|0|||
145700018|NCT01296555|525418337|FG024|Overall Study|Physician Decision|0|||
145700019|NCT01296555|525418338|FG025|Overall Study|Physician Decision|0|||
145700020|NCT01296555|525418339|FG026|Overall Study|Physician Decision|0|||
145700021|NCT01296555|525418340|FG027|Overall Study|Physician Decision|0|||
145700022|NCT01296555|525418341|FG028|Overall Study|Physician Decision|0|||
145700023|NCT01296555|525418313|FG000|Overall Study|Progressive Disease|6|||
145700024|NCT01296555|525418314|FG001|Overall Study|Progressive Disease|3|||
145700025|NCT01296555|525418315|FG002|Overall Study|Progressive Disease|3|||
145700026|NCT01296555|525418316|FG003|Overall Study|Progressive Disease|7|||
145700027|NCT01296555|525418317|FG004|Overall Study|Progressive Disease|6|||
145700028|NCT01296555|525418318|FG005|Overall Study|Progressive Disease|16|||
145700029|NCT01296555|525418319|FG006|Overall Study|Progressive Disease|16|||
145700030|NCT01296555|525418320|FG007|Overall Study|Progressive Disease|8|||
145700031|NCT01296555|525418321|FG008|Overall Study|Progressive Disease|7|||
145700032|NCT01296555|525418322|FG009|Overall Study|Progressive Disease|18|||
145700033|NCT01296555|525418323|FG010|Overall Study|Progressive Disease|7|||
145700034|NCT01296555|525418324|FG011|Overall Study|Progressive Disease|14|||
145700035|NCT01296555|525418325|FG012|Overall Study|Progressive Disease|5|||
145700036|NCT01296555|525418326|FG013|Overall Study|Progressive Disease|12|||
145700037|NCT01296555|525418327|FG014|Overall Study|Progressive Disease|1|||
145700038|NCT01296555|525418328|FG015|Overall Study|Progressive Disease|1|||
145700039|NCT01296555|525418329|FG016|Overall Study|Progressive Disease|0|||
145700040|NCT01296555|525418330|FG017|Overall Study|Progressive Disease|0|||
145700041|NCT01296555|525418331|FG018|Overall Study|Progressive Disease|0|||
145700042|NCT01296555|525418332|FG019|Overall Study|Progressive Disease|1|||
145700043|NCT01296555|525418333|FG020|Overall Study|Progressive Disease|0|||
145700044|NCT01296555|525418334|FG021|Overall Study|Progressive Disease|0|||
145700045|NCT01296555|525418335|FG022|Overall Study|Progressive Disease|0|||
145700046|NCT01296555|525418336|FG023|Overall Study|Progressive Disease|0|||
145700047|NCT01296555|525418337|FG024|Overall Study|Progressive Disease|1|||
145700048|NCT01296555|525418338|FG025|Overall Study|Progressive Disease|0|||
145700049|NCT01296555|525418339|FG026|Overall Study|Progressive Disease|5|||
145700050|NCT01296555|525418340|FG027|Overall Study|Progressive Disease|1|||
145700051|NCT01296555|525418341|FG028|Overall Study|Progressive Disease|0|||
145700052|NCT01296555|525418313|FG000|Overall Study|Protocol Violation|0|||
145700053|NCT01296555|525418314|FG001|Overall Study|Protocol Violation|0|||
145700054|NCT01296555|525418315|FG002|Overall Study|Protocol Violation|0|||
145700055|NCT01296555|525418316|FG003|Overall Study|Protocol Violation|0|||
145700056|NCT01296555|525418317|FG004|Overall Study|Protocol Violation|0|||
145700057|NCT01296555|525418318|FG005|Overall Study|Protocol Violation|0|||
145700058|NCT01296555|525418319|FG006|Overall Study|Protocol Violation|0|||
145700059|NCT01296555|525418320|FG007|Overall Study|Protocol Violation|0|||
145700060|NCT01296555|525418321|FG008|Overall Study|Protocol Violation|0|||
145700061|NCT01296555|525418322|FG009|Overall Study|Protocol Violation|0|||
145700062|NCT01296555|525418323|FG010|Overall Study|Protocol Violation|0|||
145700063|NCT01296555|525418324|FG011|Overall Study|Protocol Violation|0|||
145700064|NCT01296555|525418325|FG012|Overall Study|Protocol Violation|0|||
145700065|NCT01296555|525418326|FG013|Overall Study|Protocol Violation|1|||
145700066|NCT01296555|525418327|FG014|Overall Study|Protocol Violation|0|||
145700067|NCT01296555|525418328|FG015|Overall Study|Protocol Violation|0|||
145700068|NCT01296555|525418329|FG016|Overall Study|Protocol Violation|0|||
145700069|NCT01296555|525418330|FG017|Overall Study|Protocol Violation|0|||
145700070|NCT01296555|525418331|FG018|Overall Study|Protocol Violation|0|||
145700071|NCT01296555|525418332|FG019|Overall Study|Protocol Violation|0|||
145700072|NCT01296555|525418333|FG020|Overall Study|Protocol Violation|0|||
145700073|NCT01296555|525418334|FG021|Overall Study|Protocol Violation|0|||
145700074|NCT01296555|525418335|FG022|Overall Study|Protocol Violation|0|||
145700075|NCT01296555|525418336|FG023|Overall Study|Protocol Violation|0|||
145700076|NCT01296555|525418337|FG024|Overall Study|Protocol Violation|0|||
145700077|NCT01296555|525418338|FG025|Overall Study|Protocol Violation|0|||
145700078|NCT01296555|525418339|FG026|Overall Study|Protocol Violation|0|||
145700079|NCT01296555|525418340|FG027|Overall Study|Protocol Violation|0|||
145700080|NCT01296555|525418341|FG028|Overall Study|Protocol Violation|0|||
145700081|NCT01296555|525418313|FG000|Overall Study|Study Terminated By Sponsor|0|||
145700082|NCT01296555|525418314|FG001|Overall Study|Study Terminated By Sponsor|0|||
145700083|NCT01296555|525418315|FG002|Overall Study|Study Terminated By Sponsor|0|||
145700084|NCT01296555|525418316|FG003|Overall Study|Study Terminated By Sponsor|0|||
145700085|NCT01296555|525418317|FG004|Overall Study|Study Terminated By Sponsor|0|||
145700086|NCT01296555|525418318|FG005|Overall Study|Study Terminated By Sponsor|0|||
145700087|NCT01296555|525418319|FG006|Overall Study|Study Terminated By Sponsor|0|||
145700088|NCT01296555|525418320|FG007|Overall Study|Study Terminated By Sponsor|0|||
145700089|NCT01296555|525418321|FG008|Overall Study|Study Terminated By Sponsor|0|||
145700090|NCT01296555|525418322|FG009|Overall Study|Study Terminated By Sponsor|0|||
145700091|NCT01296555|525418323|FG010|Overall Study|Study Terminated By Sponsor|0|||
145700092|NCT01296555|525418324|FG011|Overall Study|Study Terminated By Sponsor|0|||
145700093|NCT01296555|525418325|FG012|Overall Study|Study Terminated By Sponsor|0|||
145700094|NCT01296555|525418326|FG013|Overall Study|Study Terminated By Sponsor|0|||
145700095|NCT01296555|525418327|FG014|Overall Study|Study Terminated By Sponsor|0|||
145700096|NCT01296555|525418328|FG015|Overall Study|Study Terminated By Sponsor|0|||
145700097|NCT01296555|525418329|FG016|Overall Study|Study Terminated By Sponsor|0|||
145700098|NCT01296555|525418330|FG017|Overall Study|Study Terminated By Sponsor|0|||
145700099|NCT01296555|525418331|FG018|Overall Study|Study Terminated By Sponsor|0|||
145700100|NCT01296555|525418332|FG019|Overall Study|Study Terminated By Sponsor|0|||
145700101|NCT01296555|525418333|FG020|Overall Study|Study Terminated By Sponsor|0|||
145700102|NCT01296555|525418334|FG021|Overall Study|Study Terminated By Sponsor|0|||
145700103|NCT01296555|525418335|FG022|Overall Study|Study Terminated By Sponsor|0|||
145700104|NCT01296555|525418336|FG023|Overall Study|Study Terminated By Sponsor|0|||
145700105|NCT01296555|525418337|FG024|Overall Study|Study Terminated By Sponsor|0|||
145700106|NCT01296555|525418338|FG025|Overall Study|Study Terminated By Sponsor|1|||
145700107|NCT01296555|525418339|FG026|Overall Study|Study Terminated By Sponsor|0|||
145700108|NCT01296555|525418340|FG027|Overall Study|Study Terminated By Sponsor|0|||
145700109|NCT01296555|525418341|FG028|Overall Study|Study Terminated By Sponsor|0|||
145700110|NCT01296555|525418313|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700111|NCT01296555|525418314|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700112|NCT01296555|525418315|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700113|NCT01296555|525418316|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700114|NCT01296555|525418317|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700115|NCT01296555|525418318|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700116|NCT01296555|525418319|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700117|NCT01296555|525418320|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700118|NCT01296555|525418321|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700119|NCT01296555|525418322|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700120|NCT01296555|525418323|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700121|NCT01296555|525418324|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700122|NCT01296555|525418325|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700123|NCT01296555|525418326|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700124|NCT01296555|525418327|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700125|NCT01296555|525418328|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700126|NCT01296555|525418329|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700127|NCT01296555|525418330|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700128|NCT01296555|525418331|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700129|NCT01296555|525418332|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
145700130|NCT01296555|525418333|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700131|NCT01296555|525418334|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700132|NCT01296555|525418335|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700133|NCT01296555|525418336|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700134|NCT01296555|525418337|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700135|NCT01296555|525418338|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700136|NCT01296555|525418339|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700137|NCT01296555|525418340|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700138|NCT01296555|525418341|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
145700139|NCT01296555|525418313|FG000|Overall Study|Death|0|||
145700140|NCT01296555|525418314|FG001|Overall Study|Death|0|||
145700141|NCT01296555|525418315|FG002|Overall Study|Death|0|||
145700142|NCT01296555|525418316|FG003|Overall Study|Death|2|||
145700143|NCT01296555|525418317|FG004|Overall Study|Death|1|||
145700144|NCT01296555|525418318|FG005|Overall Study|Death|0|||
145700145|NCT01296555|525418319|FG006|Overall Study|Death|2|||
145700146|NCT01296555|525418320|FG007|Overall Study|Death|0|||
145700147|NCT01296555|525418321|FG008|Overall Study|Death|0|||
145700148|NCT01296555|525418322|FG009|Overall Study|Death|1|||
145700149|NCT01296555|525418323|FG010|Overall Study|Death|0|||
145700150|NCT01296555|525418324|FG011|Overall Study|Death|1|||
145700151|NCT01296555|525418325|FG012|Overall Study|Death|0|||
145700152|NCT01296555|525418326|FG013|Overall Study|Death|2|||
145700153|NCT01296555|525418327|FG014|Overall Study|Death|27|||
145700154|NCT01296555|525418328|FG015|Overall Study|Death|15|||
145700155|NCT01296555|525418329|FG016|Overall Study|Death|11|||
145700156|NCT01296555|525418330|FG017|Overall Study|Death|11|||
145700157|NCT01296555|525418331|FG018|Overall Study|Death|17|||
145700158|NCT01296555|525418332|FG019|Overall Study|Death|12|||
145700159|NCT01296555|525418333|FG020|Overall Study|Death|13|||
145700160|NCT01296555|525418334|FG021|Overall Study|Death|12|||
145700161|NCT01296555|525418335|FG022|Overall Study|Death|12|||
145700162|NCT01296555|525418336|FG023|Overall Study|Death|13|||
145700163|NCT01296555|525418337|FG024|Overall Study|Death|7|||
145700164|NCT01296555|525418338|FG025|Overall Study|Death|7|||
145700165|NCT01296555|525418339|FG026|Overall Study|Death|35|||
145700166|NCT01296555|525418340|FG027|Overall Study|Death|92|||
145700167|NCT01296555|525418341|FG028|Overall Study|Death|44|||
145700168|NCT01296555|525418313|FG000|Overall Study|Lost to Follow-up|0|||
145700169|NCT01296555|525418314|FG001|Overall Study|Lost to Follow-up|0|||
145700170|NCT01296555|525418315|FG002|Overall Study|Lost to Follow-up|0|||
145700171|NCT01296555|525418316|FG003|Overall Study|Lost to Follow-up|0|||
145700172|NCT01296555|525418317|FG004|Overall Study|Lost to Follow-up|0|||
145700173|NCT01296555|525418318|FG005|Overall Study|Lost to Follow-up|0|||
145700174|NCT01296555|525418319|FG006|Overall Study|Lost to Follow-up|0|||
145700175|NCT01296555|525418320|FG007|Overall Study|Lost to Follow-up|0|||
145700176|NCT01296555|525418321|FG008|Overall Study|Lost to Follow-up|0|||
145700177|NCT01296555|525418322|FG009|Overall Study|Lost to Follow-up|0|||
145700178|NCT01296555|525418323|FG010|Overall Study|Lost to Follow-up|0|||
145700179|NCT01296555|525418324|FG011|Overall Study|Lost to Follow-up|0|||
145700180|NCT01296555|525418325|FG012|Overall Study|Lost to Follow-up|0|||
145700181|NCT01296555|525418326|FG013|Overall Study|Lost to Follow-up|0|||
145700182|NCT01296555|525418327|FG014|Overall Study|Lost to Follow-up|2|||
145700183|NCT01296555|525418328|FG015|Overall Study|Lost to Follow-up|1|||
145700184|NCT01296555|525418329|FG016|Overall Study|Lost to Follow-up|0|||
145700185|NCT01296555|525418330|FG017|Overall Study|Lost to Follow-up|2|||
145700186|NCT01296555|525418331|FG018|Overall Study|Lost to Follow-up|0|||
145700187|NCT01296555|525418332|FG019|Overall Study|Lost to Follow-up|2|||
145700188|NCT01296555|525418333|FG020|Overall Study|Lost to Follow-up|3|||
145700189|NCT01296555|525418334|FG021|Overall Study|Lost to Follow-up|2|||
145700190|NCT01296555|525418335|FG022|Overall Study|Lost to Follow-up|0|||
145700191|NCT01296555|525418336|FG023|Overall Study|Lost to Follow-up|0|||
145700192|NCT01296555|525418337|FG024|Overall Study|Lost to Follow-up|0|||
145700193|NCT01296555|525418338|FG025|Overall Study|Lost to Follow-up|0|||
145700194|NCT01296555|525418339|FG026|Overall Study|Lost to Follow-up|3|||
145700195|NCT01296555|525418340|FG027|Overall Study|Lost to Follow-up|13|||
145700196|NCT01296555|525418341|FG028|Overall Study|Lost to Follow-up|5|||
145700197|NCT01296555|525418313|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145700198|NCT01296555|525418314|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145700199|NCT01296555|525418315|FG002|Overall Study|Non-Compliance With Study Drug|0|||
145700200|NCT01296555|525418316|FG003|Overall Study|Non-Compliance With Study Drug|0|||
145700201|NCT01296555|525418317|FG004|Overall Study|Non-Compliance With Study Drug|0|||
145700202|NCT01296555|525418318|FG005|Overall Study|Non-Compliance With Study Drug|0|||
145700203|NCT01296555|525418319|FG006|Overall Study|Non-Compliance With Study Drug|0|||
145700204|NCT01296555|525418320|FG007|Overall Study|Non-Compliance With Study Drug|1|||
145700205|NCT01296555|525418321|FG008|Overall Study|Non-Compliance With Study Drug|0|||
145700206|NCT01296555|525418322|FG009|Overall Study|Non-Compliance With Study Drug|0|||
145700207|NCT01296555|525418323|FG010|Overall Study|Non-Compliance With Study Drug|0|||
145700208|NCT01296555|525418324|FG011|Overall Study|Non-Compliance With Study Drug|0|||
145700209|NCT01296555|525418325|FG012|Overall Study|Non-Compliance With Study Drug|0|||
145700210|NCT01296555|525418326|FG013|Overall Study|Non-Compliance With Study Drug|0|||
145700211|NCT01296555|525418327|FG014|Overall Study|Non-Compliance With Study Drug|0|||
145700212|NCT01296555|525418328|FG015|Overall Study|Non-Compliance With Study Drug|0|||
145700213|NCT01296555|525418329|FG016|Overall Study|Non-Compliance With Study Drug|0|||
145700214|NCT01296555|525418330|FG017|Overall Study|Non-Compliance With Study Drug|0|||
145700215|NCT01296555|525418331|FG018|Overall Study|Non-Compliance With Study Drug|0|||
145700216|NCT01296555|525418332|FG019|Overall Study|Non-Compliance With Study Drug|0|||
145700217|NCT01296555|525418333|FG020|Overall Study|Non-Compliance With Study Drug|0|||
145700218|NCT01296555|525418334|FG021|Overall Study|Non-Compliance With Study Drug|0|||
145700219|NCT01296555|525418335|FG022|Overall Study|Non-Compliance With Study Drug|0|||
145700220|NCT01296555|525418336|FG023|Overall Study|Non-Compliance With Study Drug|0|||
145700221|NCT01296555|525418337|FG024|Overall Study|Non-Compliance With Study Drug|0|||
145700222|NCT01296555|525418338|FG025|Overall Study|Non-Compliance With Study Drug|0|||
145700223|NCT01296555|525418339|FG026|Overall Study|Non-Compliance With Study Drug|0|||
145700224|NCT01296555|525418340|FG027|Overall Study|Non-Compliance With Study Drug|0|||
145700225|NCT01296555|525418341|FG028|Overall Study|Non-Compliance With Study Drug|0|||
145700226|NCT01296555|525418313|FG000|Overall Study|Withdrawal by Subject|0|||
145700227|NCT01296555|525418314|FG001|Overall Study|Withdrawal by Subject|0|||
145700228|NCT01296555|525418315|FG002|Overall Study|Withdrawal by Subject|0|||
145700229|NCT01296555|525418316|FG003|Overall Study|Withdrawal by Subject|0|||
145700230|NCT01296555|525418317|FG004|Overall Study|Withdrawal by Subject|1|||
145700231|NCT01296555|525418318|FG005|Overall Study|Withdrawal by Subject|0|||
145700232|NCT01296555|525418319|FG006|Overall Study|Withdrawal by Subject|1|||
145700233|NCT01296555|525418320|FG007|Overall Study|Withdrawal by Subject|0|||
145700234|NCT01296555|525418321|FG008|Overall Study|Withdrawal by Subject|0|||
145700235|NCT01296555|525418322|FG009|Overall Study|Withdrawal by Subject|0|||
145700236|NCT01296555|525418323|FG010|Overall Study|Withdrawal by Subject|1|||
145700237|NCT01296555|525418324|FG011|Overall Study|Withdrawal by Subject|1|||
145700238|NCT01296555|525418325|FG012|Overall Study|Withdrawal by Subject|0|||
145700239|NCT01296555|525418326|FG013|Overall Study|Withdrawal by Subject|0|||
145700240|NCT01296555|525418327|FG014|Overall Study|Withdrawal by Subject|3|||
145700241|NCT01296555|525418328|FG015|Overall Study|Withdrawal by Subject|0|||
145700242|NCT01296555|525418329|FG016|Overall Study|Withdrawal by Subject|2|||
145700243|NCT01296555|525418330|FG017|Overall Study|Withdrawal by Subject|1|||
145700244|NCT01296555|525418331|FG018|Overall Study|Withdrawal by Subject|0|||
145700245|NCT01296555|525418332|FG019|Overall Study|Withdrawal by Subject|1|||
145700246|NCT01296555|525418333|FG020|Overall Study|Withdrawal by Subject|1|||
145700247|NCT01296555|525418334|FG021|Overall Study|Withdrawal by Subject|1|||
145700248|NCT01296555|525418335|FG022|Overall Study|Withdrawal by Subject|3|||
145700249|NCT01296555|525418336|FG023|Overall Study|Withdrawal by Subject|0|||
145700250|NCT01296555|525418337|FG024|Overall Study|Withdrawal by Subject|0|||
145700251|NCT01296555|525418338|FG025|Overall Study|Withdrawal by Subject|0|||
145700252|NCT01296555|525418339|FG026|Overall Study|Withdrawal by Subject|8|||
145700253|NCT01296555|525418340|FG027|Overall Study|Withdrawal by Subject|4|||
145700254|NCT01296555|525418341|FG028|Overall Study|Withdrawal by Subject|2|||
145700255|NCT01628692|525418344|FG000|Overall Study|Lack of Efficacy|4|||
145700256|NCT01628692|525418345|FG001|Overall Study|Lack of Efficacy|4|||
145700257|NCT01628692|525418346|FG002|Overall Study|Lack of Efficacy|5|||
145700258|NCT01628692|525418347|FG003|Overall Study|Lack of Efficacy|1|||
145700259|NCT01628692|525418348|FG004|Overall Study|Lack of Efficacy|4|||
145700260|NCT01628692|525418349|FG005|Overall Study|Lack of Efficacy|7|||
145700261|NCT01628692|525418344|FG000|Overall Study|Adverse Event|2|||
145700262|NCT01628692|525418345|FG001|Overall Study|Adverse Event|0|||
145700263|NCT01628692|525418346|FG002|Overall Study|Adverse Event|2|||
145700264|NCT01628692|525418347|FG003|Overall Study|Adverse Event|0|||
145700265|NCT01628692|525418348|FG004|Overall Study|Adverse Event|0|||
145700266|NCT01628692|525418349|FG005|Overall Study|Adverse Event|0|||
145700267|NCT01628692|525418344|FG000|Overall Study|Withdrawal by Subject|0|||
145700268|NCT01628692|525418345|FG001|Overall Study|Withdrawal by Subject|1|||
145700269|NCT01628692|525418346|FG002|Overall Study|Withdrawal by Subject|1|||
145700270|NCT01628692|525418347|FG003|Overall Study|Withdrawal by Subject|0|||
145700271|NCT01628692|525418348|FG004|Overall Study|Withdrawal by Subject|0|||
145700272|NCT01628692|525418349|FG005|Overall Study|Withdrawal by Subject|0|||
145700273|NCT01628692|525418344|FG000|Overall Study|Death|0|||
145700274|NCT01628692|525418345|FG001|Overall Study|Death|1|||
145700275|NCT01628692|525418346|FG002|Overall Study|Death|0|||
145700276|NCT01628692|525418347|FG003|Overall Study|Death|0|||
145700277|NCT01628692|525418348|FG004|Overall Study|Death|0|||
145700278|NCT01628692|525418349|FG005|Overall Study|Death|0|||
145700279|NCT01628692|525418344|FG000|Overall Study|Poor compliance/noncompliance|1|||
145700280|NCT01628692|525418345|FG001|Overall Study|Poor compliance/noncompliance|0|||
145700281|NCT01628692|525418346|FG002|Overall Study|Poor compliance/noncompliance|0|||
145700282|NCT01628692|525418347|FG003|Overall Study|Poor compliance/noncompliance|0|||
145700283|NCT01628692|525418348|FG004|Overall Study|Poor compliance/noncompliance|0|||
145700284|NCT01628692|525418349|FG005|Overall Study|Poor compliance/noncompliance|0|||
145700285|NCT01628692|525418344|FG000|Overall Study|Administrative reason by sponsor|0|||
145700286|NCT01628692|525418345|FG001|Overall Study|Administrative reason by sponsor|0|||
145700287|NCT01628692|525418346|FG002|Overall Study|Administrative reason by sponsor|0|||
145700288|NCT01628692|525418347|FG003|Overall Study|Administrative reason by sponsor|0|||
145700289|NCT01628692|525418348|FG004|Overall Study|Administrative reason by sponsor|0|||
145700290|NCT01628692|525418349|FG005|Overall Study|Administrative reason by sponsor|1|||
145700291|NCT01628692|525418344|FG000|Overall Study|Completed 12 Week only|0|||
145700292|NCT01628692|525418345|FG001|Overall Study|Completed 12 Week only|0|||
145700293|NCT01628692|525418346|FG002|Overall Study|Completed 12 Week only|0|||
145700294|NCT01628692|525418347|FG003|Overall Study|Completed 12 Week only|0|||
145700295|NCT01628692|525418348|FG004|Overall Study|Completed 12 Week only|0|||
145700296|NCT01628692|525418349|FG005|Overall Study|Completed 12 Week only|1|||
145700297|NCT01182181|525418350|FG000|First Intervention|Adverse Event|1|||
145700298|NCT01182181|525418351|FG001|First Intervention|Adverse Event|0|||
145700299|NCT01182181|525418350|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
145700300|NCT01182181|525418351|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
145700301|NCT01704547|525418352|FG000|Overall Study|Physician Decision|4|||
145700302|NCT01704547|525418352|FG000|Overall Study|Withdrawal by Subject|1|||
145700303|NCT02413593|525418355|FG000|Overall Study|Lost to Follow-up|3|||
145700304|NCT02413593|525418355|FG000|Overall Study|Adverse Event|1|||
145700305|NCT02058836|525418356|FG000|Overall Study|Withdrawal by Subject|1|||
145700306|NCT02058836|525418357|FG001|Overall Study|Withdrawal by Subject|1|||
145700307|NCT00267098|525418358|FG000|Overall Study|Death|0|||
145700308|NCT00267098|525418359|FG001|Overall Study|Death|0|||
145700309|NCT00267098|525418360|FG002|Overall Study|Death|57|||
145700310|NCT00267098|525418361|FG003|Overall Study|Death|66|||
145700311|NCT00267098|525418362|FG004|Overall Study|Death|14|||
145700312|NCT00267098|525418363|FG005|Overall Study|Death|23|||
145700313|NCT00267098|525418364|FG006|Overall Study|Death|28|||
145700314|NCT00267098|525418365|FG007|Overall Study|Death|9|||
145700315|NCT00267098|525418358|FG000|Overall Study|Lost to Follow-up|0|||
145700316|NCT00267098|525418359|FG001|Overall Study|Lost to Follow-up|0|||
145700317|NCT00267098|525418360|FG002|Overall Study|Lost to Follow-up|6|||
145700318|NCT00267098|525418361|FG003|Overall Study|Lost to Follow-up|5|||
145700319|NCT00267098|525418362|FG004|Overall Study|Lost to Follow-up|2|||
145700320|NCT00267098|525418363|FG005|Overall Study|Lost to Follow-up|3|||
145700321|NCT00267098|525418364|FG006|Overall Study|Lost to Follow-up|1|||
145700322|NCT00267098|525418365|FG007|Overall Study|Lost to Follow-up|1|||
145700323|NCT00267098|525418358|FG000|Overall Study|Withdrawal by Subject|8|||
145700324|NCT00267098|525418359|FG001|Overall Study|Withdrawal by Subject|0|||
145700325|NCT00267098|525418360|FG002|Overall Study|Withdrawal by Subject|24|||
145700326|NCT00267098|525418361|FG003|Overall Study|Withdrawal by Subject|21|||
145700327|NCT00267098|525418362|FG004|Overall Study|Withdrawal by Subject|12|||
145700328|NCT00267098|525418363|FG005|Overall Study|Withdrawal by Subject|9|||
145700329|NCT00267098|525418364|FG006|Overall Study|Withdrawal by Subject|12|||
145700330|NCT00267098|525418365|FG007|Overall Study|Withdrawal by Subject|5|||
145700331|NCT00267098|525418358|FG000|Overall Study|Physician Decision|5|||
145700332|NCT00267098|525418359|FG001|Overall Study|Physician Decision|0|||
145700333|NCT00267098|525418360|FG002|Overall Study|Physician Decision|7|||
145700334|NCT00267098|525418361|FG003|Overall Study|Physician Decision|11|||
145700335|NCT00267098|525418362|FG004|Overall Study|Physician Decision|5|||
145700336|NCT00267098|525418363|FG005|Overall Study|Physician Decision|4|||
145700337|NCT00267098|525418364|FG006|Overall Study|Physician Decision|3|||
145700338|NCT00267098|525418365|FG007|Overall Study|Physician Decision|0|||
145700339|NCT00267098|525418358|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
145700340|NCT00267098|525418359|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700341|NCT00267098|525418360|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700342|NCT00267098|525418361|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700343|NCT00267098|525418362|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
145700344|NCT00267098|525418363|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700345|NCT00267098|525418364|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700346|NCT00267098|525418365|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
145700347|NCT00267098|525418358|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700348|NCT00267098|525418359|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
145700349|NCT00267098|525418360|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700350|NCT00267098|525418361|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700351|NCT00267098|525418362|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700352|NCT00267098|525418363|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700353|NCT00267098|525418364|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700354|NCT00267098|525418365|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
145700355|NCT00267098|525418358|FG000|Overall Study|Site closure|0|||
145700356|NCT00267098|525418359|FG001|Overall Study|Site closure|0|||
145700357|NCT00267098|525418360|FG002|Overall Study|Site closure|0|||
145700358|NCT00267098|525418361|FG003|Overall Study|Site closure|1|||
145700359|NCT00267098|525418362|FG004|Overall Study|Site closure|0|||
145700360|NCT00267098|525418363|FG005|Overall Study|Site closure|1|||
145700361|NCT00267098|525418364|FG006|Overall Study|Site closure|1|||
145700362|NCT00267098|525418365|FG007|Overall Study|Site closure|0|||
145700363|NCT00267098|525418358|FG000|Overall Study|Explanted Medtronic device|0|||
145700364|NCT00267098|525418359|FG001|Overall Study|Explanted Medtronic device|0|||
145700365|NCT00267098|525418360|FG002|Overall Study|Explanted Medtronic device|0|||
145700366|NCT00267098|525418361|FG003|Overall Study|Explanted Medtronic device|1|||
145700367|NCT00267098|525418362|FG004|Overall Study|Explanted Medtronic device|0|||
145700368|NCT00267098|525418363|FG005|Overall Study|Explanted Medtronic device|0|||
145700369|NCT00267098|525418364|FG006|Overall Study|Explanted Medtronic device|0|||
145700370|NCT00267098|525418365|FG007|Overall Study|Explanted Medtronic device|0|||
145700371|NCT00267098|525418358|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700372|NCT00267098|525418359|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700373|NCT00267098|525418360|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700374|NCT00267098|525418361|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700375|NCT00267098|525418362|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
145700376|NCT00267098|525418363|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700377|NCT00267098|525418364|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700378|NCT00267098|525418365|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
145700379|NCT00267098|525418358|FG000|Overall Study|Subject listed for heart transplant|0|||
145700380|NCT00267098|525418359|FG001|Overall Study|Subject listed for heart transplant|0|||
145700381|NCT00267098|525418360|FG002|Overall Study|Subject listed for heart transplant|0|||
145700382|NCT00267098|525418361|FG003|Overall Study|Subject listed for heart transplant|0|||
145700383|NCT00267098|525418362|FG004|Overall Study|Subject listed for heart transplant|0|||
145700384|NCT00267098|525418363|FG005|Overall Study|Subject listed for heart transplant|0|||
145700385|NCT00267098|525418364|FG006|Overall Study|Subject listed for heart transplant|1|||
145700386|NCT00267098|525418365|FG007|Overall Study|Subject listed for heart transplant|0|||
145700387|NCT00267098|525418358|FG000|Overall Study|Sponsor withdrew subject|0|||
145700388|NCT00267098|525418359|FG001|Overall Study|Sponsor withdrew subject|0|||
145700389|NCT00267098|525418360|FG002|Overall Study|Sponsor withdrew subject|0|||
145700390|NCT00267098|525418361|FG003|Overall Study|Sponsor withdrew subject|1|||
145700391|NCT00267098|525418362|FG004|Overall Study|Sponsor withdrew subject|0|||
145700392|NCT00267098|525418363|FG005|Overall Study|Sponsor withdrew subject|0|||
145700393|NCT00267098|525418364|FG006|Overall Study|Sponsor withdrew subject|0|||
145700394|NCT00267098|525418365|FG007|Overall Study|Sponsor withdrew subject|0|||
145700395|NCT00763451|525418369|FG000|Overall Study|Adverse Event|4|||
145700396|NCT00763451|525418370|FG001|Overall Study|Adverse Event|6|||
145700397|NCT00763451|525418371|FG002|Overall Study|Adverse Event|19|||
145700398|NCT00763451|525418372|FG003|Overall Study|Adverse Event|14|||
145700399|NCT00763451|525418369|FG000|Overall Study|Lack of Efficacy|1|||
145700400|NCT00763451|525418370|FG001|Overall Study|Lack of Efficacy|4|||
145700401|NCT00763451|525418371|FG002|Overall Study|Lack of Efficacy|3|||
145700402|NCT00763451|525418372|FG003|Overall Study|Lack of Efficacy|2|||
145700403|NCT00763451|525418369|FG000|Overall Study|Withdrawal by Subject|1|||
145700404|NCT00763451|525418370|FG001|Overall Study|Withdrawal by Subject|6|||
145700405|NCT00763451|525418371|FG002|Overall Study|Withdrawal by Subject|9|||
145700406|NCT00763451|525418372|FG003|Overall Study|Withdrawal by Subject|7|||
145700407|NCT00763451|525418369|FG000|Overall Study|Protocol Violation|0|||
145700408|NCT00763451|525418370|FG001|Overall Study|Protocol Violation|0|||
145700409|NCT00763451|525418371|FG002|Overall Study|Protocol Violation|1|||
145700410|NCT00763451|525418372|FG003|Overall Study|Protocol Violation|0|||
145700411|NCT00763451|525418369|FG000|Overall Study|Poor Compliance to Protocol|1|||
145700412|NCT00763451|525418370|FG001|Overall Study|Poor Compliance to Protocol|1|||
145700413|NCT00763451|525418371|FG002|Overall Study|Poor Compliance to Protocol|2|||
145700414|NCT00763451|525418372|FG003|Overall Study|Poor Compliance to Protocol|2|||
145700415|NCT00763451|525418369|FG000|Overall Study|Familial and Personal Reasons|5|||
145700416|NCT00763451|525418370|FG001|Overall Study|Familial and Personal Reasons|3|||
145700417|NCT00763451|525418371|FG002|Overall Study|Familial and Personal Reasons|5|||
145700418|NCT00763451|525418372|FG003|Overall Study|Familial and Personal Reasons|4|||
145700419|NCT00763451|525418369|FG000|Overall Study|Randomized but not Treated|1|||
145700420|NCT00763451|525418370|FG001|Overall Study|Randomized but not Treated|1|||
145700421|NCT00763451|525418371|FG002|Overall Study|Randomized but not Treated|0|||
145700422|NCT00763451|525418372|FG003|Overall Study|Randomized but not Treated|0|||
145700423|NCT00763451|525418369|FG000|Overall Study|Study Site Reason|0|||
145700424|NCT00763451|525418370|FG001|Overall Study|Study Site Reason|1|||
145700425|NCT00763451|525418371|FG002|Overall Study|Study Site Reason|1|||
145700426|NCT00763451|525418372|FG003|Overall Study|Study Site Reason|1|||
145700427|NCT00725543|525418376|FG000|Overall Study|Adverse Event|10|||
145700428|NCT00725543|525418376|FG000|Overall Study|Lack of Efficacy|3|||
145700429|NCT00725543|525418376|FG000|Overall Study|Withdrawal by Subject|10|||
145700430|NCT00725543|525418376|FG000|Overall Study|Physician Decision|5|||
145700431|NCT00725543|525418376|FG000|Overall Study|Lost to Follow-up|4|||
145700432|NCT00725543|525418376|FG000|Overall Study|Non-compliance|2|||
145700433|NCT00725543|525418376|FG000|Overall Study|Other|119|||
145700434|NCT02168478|525418385|FG000|Overall Study|Withdrawal by Subject|1|||
145700435|NCT02168478|525418385|FG000|Overall Study|Did Not Consent to Participation|2|||
145700436|NCT02168478|525418385|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
145700437|NCT01062971|525418387|FG000|Overall Study|Protocol Violation|1|||
145700438|NCT01062971|525418388|FG001|Overall Study|Protocol Violation|3|||
145700439|NCT01062971|525418387|FG000|Overall Study|Lost to Follow-up|3|||
145700440|NCT01062971|525418388|FG001|Overall Study|Lost to Follow-up|4|||
145700441|NCT01530087|525418389|FG000|Overall Study|Physician Decision|2|||
145700442|NCT02760485|525418398|FG000|Phase 1|Death|3|||
145700443|NCT02760485|525418399|FG001|Phase 1|Death|6|||
145700444|NCT02760485|525418400|FG002|Phase 1|Death|0|||
145700445|NCT02760485|525418398|FG000|Phase 1|Withdrawal by Subject|2|||
145700446|NCT02760485|525418399|FG001|Phase 1|Withdrawal by Subject|0|||
145700447|NCT02760485|525418400|FG002|Phase 1|Withdrawal by Subject|0|||
145700448|NCT02760485|525418398|FG000|Phase 1|Progressive Disease|1|||
145700449|NCT02760485|525418399|FG001|Phase 1|Progressive Disease|0|||
145700450|NCT02760485|525418400|FG002|Phase 1|Progressive Disease|0|||
145700451|NCT02760485|525418398|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
145700452|NCT02760485|525418399|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
145700453|NCT02760485|525418400|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
145700454|NCT02760485|525418398|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
145700455|NCT02760485|525418399|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
145700456|NCT02760485|525418400|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
145700457|NCT02760485|525418398|FG000|Phase 2|Death|0|||
145700458|NCT02760485|525418399|FG001|Phase 2|Death|0|||
145700459|NCT02760485|525418400|FG002|Phase 2|Death|12|||
145700460|NCT02760485|525418398|FG000|Phase 2|Withdrawal by Subject|0|||
145700461|NCT02760485|525418399|FG001|Phase 2|Withdrawal by Subject|0|||
145700462|NCT02760485|525418400|FG002|Phase 2|Withdrawal by Subject|3|||
145700463|NCT02760485|525418398|FG000|Phase 2|Progressive Disease|0|||
145700464|NCT02760485|525418399|FG001|Phase 2|Progressive Disease|0|||
145700465|NCT02760485|525418400|FG002|Phase 2|Progressive Disease|1|||
145700466|NCT02760485|525418398|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
145700467|NCT02760485|525418399|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
145700468|NCT02760485|525418400|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
145700469|NCT01182207|525418401|FG000|First Intervention|Positive Hepatitis Results|0|||
145700470|NCT01182207|525418402|FG001|First Intervention|Positive Hepatitis Results|1|||
145700471|NCT01182207|525418401|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
145700472|NCT01182207|525418402|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
145700473|NCT02581059|525418407|FG000|Study Treatment|Disease Progression|1|||
145700474|NCT02581059|525418408|FG001|Study Treatment|Disease Progression|1|||
145700475|NCT02581059|525418407|FG000|Study Treatment|Adverse Event|2|||
145700476|NCT02581059|525418408|FG001|Study Treatment|Adverse Event|1|||
145700477|NCT02581059|525418407|FG000|Study Treatment|Death|1|||
145700478|NCT02581059|525418408|FG001|Study Treatment|Death|1|||
145700479|NCT02581059|525418407|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
145700480|NCT02581059|525418408|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
145700481|NCT02581059|525418407|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
145700482|NCT02581059|525418408|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
145700483|NCT02581059|525418407|FG000|Follow up|Death|1|||
145700484|NCT02581059|525418408|FG001|Follow up|Death|3|||
145700485|NCT02581059|525418407|FG000|Follow up|study terminated|1|||
145700486|NCT02581059|525418408|FG001|Follow up|study terminated|1|||
145700487|NCT02581059|525418407|FG000|Follow up|screen failure|0|||
145700488|NCT02581059|525418408|FG001|Follow up|screen failure|1|||
145700489|NCT02581059|525418407|FG000|Follow up|Patient started new clinical trial|1|||
145700490|NCT02581059|525418408|FG001|Follow up|Patient started new clinical trial|0|||
145700491|NCT02392104|525418409|FG000|Overall Study|discontinuation of warfarin|3|||
145700492|NCT02392104|525418409|FG000|Overall Study|bleeding event|1|||
145700493|NCT02392104|525418409|FG000|Overall Study|transferred care to another doctor|2|||
145700494|NCT02392104|525418409|FG000|Overall Study|INR goal range changed|1|||
145700495|NCT02392104|525418409|FG000|Overall Study|admitted to skilled nursing facility|3|||
145700496|NCT02392104|525418409|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
145700497|NCT03912532|525418413|FG000|Overall Study|Adverse Event|3|||
145700498|NCT03912532|525418414|FG001|Overall Study|Adverse Event|3|||
145700499|NCT03912532|525418415|FG002|Overall Study|Adverse Event|2|||
145700500|NCT03912532|525418416|FG003|Overall Study|Adverse Event|2|||
145700501|NCT03912532|525418413|FG000|Overall Study|Lost to Follow-up|3|||
145700502|NCT03912532|525418414|FG001|Overall Study|Lost to Follow-up|2|||
145700503|NCT03912532|525418415|FG002|Overall Study|Lost to Follow-up|1|||
145700504|NCT03912532|525418416|FG003|Overall Study|Lost to Follow-up|2|||
145700505|NCT03912532|525418413|FG000|Overall Study|Withdrawal by Subject|1|||
145700506|NCT03912532|525418414|FG001|Overall Study|Withdrawal by Subject|1|||
145700507|NCT03912532|525418415|FG002|Overall Study|Withdrawal by Subject|2|||
145700508|NCT03912532|525418416|FG003|Overall Study|Withdrawal by Subject|0|||
145700509|NCT03912532|525418413|FG000|Overall Study|Physician Decision|1|||
145700510|NCT03912532|525418414|FG001|Overall Study|Physician Decision|0|||
145700511|NCT03912532|525418415|FG002|Overall Study|Physician Decision|0|||
145700512|NCT03912532|525418416|FG003|Overall Study|Physician Decision|3|||
145700513|NCT03912532|525418413|FG000|Overall Study|Other|0|||
145700514|NCT03912532|525418414|FG001|Overall Study|Other|1|||
145700515|NCT03912532|525418415|FG002|Overall Study|Other|1|||
145700516|NCT03912532|525418416|FG003|Overall Study|Other|0|||
145700517|NCT04913948|525418417|FG000|Overall Study|Withdrawal by Subject|2|||
145700518|NCT04913948|525418417|FG000|Overall Study|Sample processing issues|1|||
145700519|NCT04913948|525418417|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
145700520|NCT03783871|525418420|FG000|Overall Study|Withdrawal by Subject|15|||
145700521|NCT03783871|525418420|FG000|Overall Study|Death|13|||
145700522|NCT03783871|525418420|FG000|Overall Study|Lost to Follow-up|2|||
145700523|NCT03569891|525418422|FG000|Lead-in|Ineligible during lead-in|8|||
145700524|NCT03569891|525418422|FG000|Lead-in|Withdrawal by Subject|3|||
145700525|NCT03569891|525418422|FG000|Lead-in|Risks related to COVID-19|2|||
145700526|NCT03569891|525418422|FG000|AMT-061|Adverse Event|1|||
145700527|NCT05990387|525418423|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
145700528|NCT05990387|525418424|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
145700529|NCT00815919|525418425|FG000|Overall Study|Unrelated Fungal Infection|1|||
145700530|NCT00815919|525418425|FG000|Overall Study|AML Relapse|1|||
145700531|NCT00815919|525418425|FG000|Overall Study|Lack of Efficacy|2|||
145700532|NCT03522389|525418426|FG000|Overall Study|Lost to Follow-up|1|||
145700533|NCT03522389|525418427|FG001|Overall Study|Lost to Follow-up|1|||
145700534|NCT03522389|525418428|FG002|Overall Study|Lost to Follow-up|2|||
145700535|NCT03522389|525418426|FG000|Overall Study|had herniated nucleus pulposus|0|||
145700536|NCT03522389|525418427|FG001|Overall Study|had herniated nucleus pulposus|1|||
145700537|NCT03522389|525418428|FG002|Overall Study|had herniated nucleus pulposus|0|||
145700538|NCT03522389|525418426|FG000|Overall Study|go to work in other province|1|||
145700539|NCT03522389|525418427|FG001|Overall Study|go to work in other province|0|||
145700540|NCT03522389|525418428|FG002|Overall Study|go to work in other province|0|||
145700541|NCT04750577|525418429|FG000|Overall Study|Adverse Event|2|||
145700542|NCT04750577|525418430|FG001|Overall Study|Adverse Event|10|||
145700543|NCT04750577|525418431|FG002|Overall Study|Adverse Event|8|||
145700544|NCT04750577|525418432|FG003|Overall Study|Adverse Event|1|||
145700545|NCT04750577|525418429|FG000|Overall Study|Change of residence|0|||
145700546|NCT04750577|525418430|FG001|Overall Study|Change of residence|0|||
145700547|NCT04750577|525418431|FG002|Overall Study|Change of residence|1|||
145700548|NCT04750577|525418432|FG003|Overall Study|Change of residence|0|||
145700549|NCT04750577|525418429|FG000|Overall Study|Burden of study procedures|0|||
145700550|NCT04750577|525418430|FG001|Overall Study|Burden of study procedures|2|||
145700551|NCT04750577|525418431|FG002|Overall Study|Burden of study procedures|2|||
145700552|NCT04750577|525418432|FG003|Overall Study|Burden of study procedures|0|||
145700553|NCT04750577|525418429|FG000|Overall Study|Prematurely discontinued|0|||
145700554|NCT04750577|525418430|FG001|Overall Study|Prematurely discontinued|0|||
145700555|NCT04750577|525418431|FG002|Overall Study|Prematurely discontinued|0|||
145700556|NCT04750577|525418432|FG003|Overall Study|Prematurely discontinued|2|||
145700557|NCT04750577|525418429|FG000|Overall Study|Protocol deviation|1|||
145700558|NCT04750577|525418430|FG001|Overall Study|Protocol deviation|1|||
145700559|NCT04750577|525418431|FG002|Overall Study|Protocol deviation|1|||
145700560|NCT04750577|525418432|FG003|Overall Study|Protocol deviation|1|||
145700561|NCT04750577|525418429|FG000|Overall Study|Other than listed|3|||
145700562|NCT04750577|525418430|FG001|Overall Study|Other than listed|2|||
145700563|NCT04750577|525418431|FG002|Overall Study|Other than listed|2|||
145700564|NCT04750577|525418432|FG003|Overall Study|Other than listed|1|||
145700565|NCT04750577|525418429|FG000|Overall Study|Not treated|0|||
145700566|NCT04750577|525418430|FG001|Overall Study|Not treated|0|||
145700567|NCT04750577|525418431|FG002|Overall Study|Not treated|0|||
145700568|NCT04750577|525418432|FG003|Overall Study|Not treated|2|||
145700569|NCT00604188|525418437|FG000|Overall Study|Adverse Event|1|||
145700570|NCT00604188|525418438|FG001|Overall Study|Adverse Event|4|||
145700571|NCT00604188|525418437|FG000|Overall Study|Lost to Follow-up|17|||
145700572|NCT00604188|525418438|FG001|Overall Study|Lost to Follow-up|15|||
145700573|NCT00604188|525418437|FG000|Overall Study|Withdrawal by Subject|5|||
145700574|NCT00604188|525418438|FG001|Overall Study|Withdrawal by Subject|1|||
145700575|NCT00604188|525418437|FG000|Overall Study|Non-compliance with protocol|4|||
145700576|NCT00604188|525418438|FG001|Overall Study|Non-compliance with protocol|4|||
145700577|NCT00604188|525418437|FG000|Overall Study|Did not receive study drug|0|||
145700578|NCT00604188|525418438|FG001|Overall Study|Did not receive study drug|1|||
145700579|NCT03668223|525418440|FG000|Overall Study|Death|10|||
145700580|NCT03668223|525418441|FG001|Overall Study|Death|5|||
145700581|NCT03668223|525418440|FG000|Overall Study|Lost to Follow-up|12|||
145700582|NCT03668223|525418441|FG001|Overall Study|Lost to Follow-up|12|||
145700583|NCT03668223|525418440|FG000|Overall Study|Withdrawal by Subject|8|||
145700584|NCT03668223|525418441|FG001|Overall Study|Withdrawal by Subject|3|||
145700585|NCT00443599|525418445|FG000|Overall Study|Physician Decision|2|||
145700586|NCT00443599|525418446|FG001|Overall Study|Physician Decision|1|||
145700587|NCT00443599|525418445|FG000|Overall Study|Death|1|||
145700588|NCT00443599|525418446|FG001|Overall Study|Death|1|||
145700589|NCT00443599|525418445|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
145700590|NCT00443599|525418446|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
145700591|NCT00826228|525420278|FG000|Overall Study|Withdrawal by Subject|1|||
145700592|NCT00966264|525420279|FG000|Overall Study|Lost to Follow-up|4|||
145700593|NCT00966264|525420280|FG001|Overall Study|Lost to Follow-up|3|||
145700594|NCT00487825|525420282|FG000|Overall Study|Adverse Event|2|||
145700595|NCT00487825|525420283|FG001|Overall Study|Adverse Event|2|||
145700596|NCT00487825|525420282|FG000|Overall Study|Lack of Efficacy|1|||
145700597|NCT00487825|525420283|FG001|Overall Study|Lack of Efficacy|1|||
145700598|NCT00487825|525420282|FG000|Overall Study|Other|3|||
145700599|NCT00487825|525420283|FG001|Overall Study|Other|2|||
145700600|NCT01638390|525420284|FG000|Overall Study|screening failures|21|||
145700601|NCT01536587|525420291|FG000|Overall Study|Adverse Event|2|||
145700602|NCT02666664|525420292|FG000|Overall Study|Physician Decision|0|||
145700603|NCT02666664|525420293|FG001|Overall Study|Physician Decision|1|||
145700604|NCT02666664|525420292|FG000|Overall Study|Protocol Violation|0|||
145700605|NCT02666664|525420293|FG001|Overall Study|Protocol Violation|2|||
145700606|NCT02666664|525420292|FG000|Overall Study|Other|0|||
145700607|NCT02666664|525420293|FG001|Overall Study|Other|1|||
145700608|NCT02666664|525420292|FG000|Overall Study|Adverse Event|12|||
145700609|NCT02666664|525420293|FG001|Overall Study|Adverse Event|37|||
145700610|NCT02666664|525420292|FG000|Overall Study|Withdrawal by participant|23|||
145700611|NCT02666664|525420293|FG001|Overall Study|Withdrawal by participant|40|||
145700612|NCT02666664|525420292|FG000|Overall Study|Sponsor decision|0|||
145700613|NCT02666664|525420293|FG001|Overall Study|Sponsor decision|1|||
145700614|NCT02666664|525420292|FG000|Overall Study|Lost to Follow-up|1|||
145700615|NCT02666664|525420293|FG001|Overall Study|Lost to Follow-up|2|||
145700616|NCT04596995|525420294|FG000|Overall Study|Lack of Efficacy|8|||
145700617|NCT04596995|525420294|FG000|Overall Study|Lost to Follow-up|3|||
145700618|NCT04596995|525420294|FG000|Overall Study|Withdrawal by Subject|12|||
145700619|NCT04596995|525420294|FG000|Overall Study|Sponsor decision|3|||
145700620|NCT04596995|525420294|FG000|Overall Study|Enrolled in managed access program|3|||
145700621|NCT00129935|525420295|FG000|Overall Study|Adverse Event|18|||
145700622|NCT00129935|525420296|FG001|Overall Study|Adverse Event|56|||
145700623|NCT00129935|525420295|FG000|Overall Study|Death|1|||
145700624|NCT00129935|525420296|FG001|Overall Study|Death|1|||
145700625|NCT00129935|525420295|FG000|Overall Study|Withdrawal by Subject|7|||
145700626|NCT00129935|525420296|FG001|Overall Study|Withdrawal by Subject|20|||
145700627|NCT00129935|525420295|FG000|Overall Study|Protocol Violation|0|||
145700628|NCT00129935|525420296|FG001|Overall Study|Protocol Violation|4|||
145700629|NCT00129935|525420295|FG000|Overall Study|Physician Decision|3|||
145700630|NCT00129935|525420296|FG001|Overall Study|Physician Decision|4|||
145700631|NCT00129935|525420295|FG000|Overall Study|Recurrence|1|||
145700632|NCT00129935|525420296|FG001|Overall Study|Recurrence|3|||
145700633|NCT00129935|525420295|FG000|Overall Study|Second primary|0|||
145700634|NCT00129935|525420296|FG001|Overall Study|Second primary|1|||
145700635|NCT00129935|525420295|FG000|Overall Study|Other|3|||
145700636|NCT00129935|525420296|FG001|Overall Study|Other|2|||
145700637|NCT00129935|525420295|FG000|Overall Study|Crossed to the other arm|2|||
145700638|NCT00129935|525420296|FG001|Overall Study|Crossed to the other arm|1|||
145700639|NCT00129935|525420295|FG000|Overall Study|Incorrect study treatment|1|||
145700640|NCT00129935|525420296|FG001|Overall Study|Incorrect study treatment|0|||
145700641|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
145700642|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
145700643|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
145700644|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Death|4|||
145700645|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Death|2|||
145700646|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Death|3|||
145700647|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145700648|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
145700649|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
145700650|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
145700651|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
145700652|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
145700653|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
145700654|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
145700655|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
145700656|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
145700657|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
145700658|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
145700659|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
145700660|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
145700661|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
145700662|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
145700663|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
145700664|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
145700665|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
145700666|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
145700667|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
145491432|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Adverse Event|16|||
145700668|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
145700669|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
145700670|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
145700671|NCT02783573|525420298|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
145700672|NCT02783573|525420299|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
145700673|NCT02783573|525420300|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
145700674|NCT02783573|525420298|FG000|Delayed-Start Period|Sponsor Decision|0|||
145700675|NCT02783573|525420299|FG001|Delayed-Start Period|Sponsor Decision|17|||
145700676|NCT02783573|525420300|FG002|Delayed-Start Period|Sponsor Decision|12|||
145700677|NCT03020069|525420301|FG000|Overall Study|Lost to Follow-up|0|||
145700678|NCT03020069|525420302|FG001|Overall Study|Lost to Follow-up|1|||
145700679|NCT00589303|525420303|FG000|Overall Study|Withdrawal by Subject|2|||
145700680|NCT00589303|525420304|FG001|Overall Study|Withdrawal by Subject|1|||
145700681|NCT02056626|525420305|FG000|Overall Study|patient did not follow directions|3|||
145700682|NCT02056626|525420306|FG001|Overall Study|patient did not follow directions|1|||
145700683|NCT02056626|525420307|FG002|Overall Study|patient did not follow directions|0|||
145700684|NCT02056626|525420308|FG003|Overall Study|patient did not follow directions|0|||
145700685|NCT00013611|525420311|FG000|Overall Study|Lost to Follow-up|91|||
145700686|NCT00013611|525420312|FG001|Overall Study|Lost to Follow-up|100|||
145700687|NCT02577003|525420313|FG000|Overall Study|Adverse Event|2|||
145700688|NCT02577003|525420314|FG001|Overall Study|Adverse Event|4|||
145700689|NCT02577003|525420313|FG000|Overall Study|Withdrawal by Subject|0|||
145700690|NCT02577003|525420314|FG001|Overall Study|Withdrawal by Subject|1|||
145700691|NCT02786004|525420315|FG000|Overall Study|Withdrawal by Subject|0|||
145700692|NCT02786004|525420316|FG001|Overall Study|Withdrawal by Subject|1|||
145700693|NCT00126659|525420319|FG000|Overall Study|Adverse Event|0|||
145700694|NCT00126659|525420320|FG001|Overall Study|Adverse Event|0|||
145700695|NCT00126659|525420321|FG002|Overall Study|Adverse Event|2|||
145700696|NCT02229578|525420322|FG000|Overall Study|Withdrawal by Subject|1|||
145700697|NCT02229578|525420323|FG001|Overall Study|Withdrawal by Subject|3|||
145700698|NCT02229578|525420322|FG000|Overall Study|Protocol Violation|2|||
145491433|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Death|2|||
145491434|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Death|3|||
145700699|NCT02229578|525420323|FG001|Overall Study|Protocol Violation|0|||
145700700|NCT00943787|525420325|FG000|Overall Study|Physician Decision|4|||
145700701|NCT00943787|525420325|FG000|Overall Study|Withdrawal by Subject|3|||
145700702|NCT04071301|525420326|FG000|Overall Study|Withdrawal by Subject|6|||
145700703|NCT04071301|525420326|FG000|Overall Study|Death|1|||
145700704|NCT01850589|525420332|FG000|Overall Study|Withdrawal by Subject|8|||
145700705|NCT01850589|525420333|FG001|Overall Study|Withdrawal by Subject|0|||
145700706|NCT03721705|525420337|FG000|Overall Study|Adverse Event|2|||
145700707|NCT03721705|525420338|FG001|Overall Study|Adverse Event|0|||
145700708|NCT03721705|525420337|FG000|Overall Study|Withdrawal by Subject|4|||
145700709|NCT03721705|525420338|FG001|Overall Study|Withdrawal by Subject|10|||
145700710|NCT03721705|525420337|FG000|Overall Study|No Suitable Study Partner|1|||
145700711|NCT03721705|525420338|FG001|Overall Study|No Suitable Study Partner|0|||
145700712|NCT03721705|525420337|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
145700713|NCT03721705|525420338|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
145700714|NCT03721705|525420337|FG000|Overall Study|Death|0|||
145700715|NCT03721705|525420338|FG001|Overall Study|Death|1|||
145700716|NCT01843777|525420339|FG000|Overall Study|Withdrawal by Subject|1|||
145700717|NCT01843777|525420340|FG001|Overall Study|Withdrawal by Subject|0|||
145700718|NCT03721172|525420342|FG000|Placebo-controlled Phase|Adverse Event|7|||
145700719|NCT03721172|525420343|FG001|Placebo-controlled Phase|Adverse Event|7|||
145700720|NCT03721172|525420344|FG002|Placebo-controlled Phase|Adverse Event|0|||
145700721|NCT03721172|525420342|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
145700722|NCT03721172|525420343|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
145700723|NCT03721172|525420344|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
145700724|NCT03721172|525420342|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
145700725|NCT03721172|525420343|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
145700726|NCT03721172|525420344|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
145700727|NCT03721172|525420342|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
145700728|NCT03721172|525420343|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
145700729|NCT03721172|525420344|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
145700730|NCT03721172|525420342|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
145700731|NCT03721172|525420343|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
145700732|NCT03721172|525420344|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
145700733|NCT03721172|525420342|FG000|Placebo-controlled Phase|Other|3|||
145700734|NCT03721172|525420343|FG001|Placebo-controlled Phase|Other|0|||
145700735|NCT03721172|525420344|FG002|Placebo-controlled Phase|Other|0|||
145700736|NCT03721172|525420342|FG000|Apremilast Extension Phase|Adverse Event|0|||
145700737|NCT03721172|525420343|FG001|Apremilast Extension Phase|Adverse Event|0|||
145700738|NCT03721172|525420344|FG002|Apremilast Extension Phase|Adverse Event|10|||
145700739|NCT03721172|525420342|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
145700740|NCT03721172|525420343|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
145700741|NCT03721172|525420344|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
145700742|NCT03721172|525420342|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
145700743|NCT03721172|525420343|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
145700744|NCT03721172|525420344|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
145700745|NCT03721172|525420342|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
145700746|NCT03721172|525420343|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
145700747|NCT03721172|525420344|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
145700748|NCT03721172|525420342|FG000|Apremilast Extension Phase|Protocol Violation|0|||
145700749|NCT03721172|525420343|FG001|Apremilast Extension Phase|Protocol Violation|0|||
145700750|NCT03721172|525420344|FG002|Apremilast Extension Phase|Protocol Violation|1|||
145700751|NCT03721172|525420342|FG000|Apremilast Extension Phase|Physician Decision|0|||
145700752|NCT03721172|525420343|FG001|Apremilast Extension Phase|Physician Decision|0|||
145700753|NCT03721172|525420344|FG002|Apremilast Extension Phase|Physician Decision|1|||
145700754|NCT03721172|525420342|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
145700755|NCT03721172|525420343|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
145700756|NCT03721172|525420344|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
145700757|NCT03721172|525420342|FG000|Apremilast Extension Phase|Other|0|||
145700758|NCT03721172|525420343|FG001|Apremilast Extension Phase|Other|0|||
145700759|NCT03721172|525420344|FG002|Apremilast Extension Phase|Other|3|||
145700760|NCT03721172|525420342|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
145700761|NCT03721172|525420343|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
145700762|NCT03721172|525420344|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
145700763|NCT01162135|525420346|FG000|Overall Study|Withdrawal by Subject|1|||
145700764|NCT01162135|525420346|FG000|Overall Study|Severe back pain|1|||
145700765|NCT01162135|525420346|FG000|Overall Study|Ineligible|1|||
145700766|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
145700767|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
145700768|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
145700769|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
145700770|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
145700771|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
145700772|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
145700773|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
145700774|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
145700775|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
145700776|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
145700777|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
145700778|NCT01216072|525420349|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
145700779|NCT01216072|525420350|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
145700780|NCT01216072|525420349|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
145700781|NCT01216072|525420350|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
145700782|NCT01216072|525420349|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
145700783|NCT01216072|525420350|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
145700784|NCT01216072|525420349|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
145700785|NCT01216072|525420350|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
145700786|NCT01101061|525420354|FG000|Overall Study|Adverse Event|0|||
145700787|NCT01101061|525420355|FG001|Overall Study|Adverse Event|0|||
145700788|NCT01101061|525420356|FG002|Overall Study|Adverse Event|1|||
145700789|NCT01101061|525420357|FG003|Overall Study|Adverse Event|0|||
145700790|NCT01101061|525420358|FG004|Overall Study|Adverse Event|0|||
145700791|NCT01101061|525420359|FG005|Overall Study|Adverse Event|0|||
145700792|NCT00857233|525420360|FG000|Overall Study|Adverse Event|24|||
145700793|NCT00857233|525420360|FG000|Overall Study|Lack of Efficacy|1|||
145700794|NCT00857233|525420360|FG000|Overall Study|Non-compliance|1|||
145700795|NCT00857233|525420360|FG000|Overall Study|Withdrawal of Consent|9|||
145700796|NCT00857233|525420360|FG000|Overall Study|Lost to Follow-up|4|||
145700797|NCT00857233|525420360|FG000|Overall Study|Nursing Home Placement|14|||
145700798|NCT00857233|525420360|FG000|Overall Study|Other Reasons|2|||
145700799|NCT01587118|525420361|FG000|Overall Study|Adverse Event|3|||
145700800|NCT01587118|525420361|FG000|Overall Study|Lost to Follow-up|2|||
145700801|NCT01587118|525420361|FG000|Overall Study|Relocation|1|||
145700802|NCT01587118|525420361|FG000|Overall Study|nonresponse|1|||
145700803|NCT00409409|525420362|FG000|Overall Study|Adverse Event|7|||
145700804|NCT00409409|525420363|FG001|Overall Study|Adverse Event|2|||
145700805|NCT00409409|525420362|FG000|Overall Study|Withdrawal by Subject|1|||
145700806|NCT00409409|525420363|FG001|Overall Study|Withdrawal by Subject|1|||
145700807|NCT00409409|525420362|FG000|Overall Study|Any other reason not above-mentioned|0|||
145700808|NCT00409409|525420363|FG001|Overall Study|Any other reason not above-mentioned|1|||
145700809|NCT02049515|525420364|FG000|Overall Study|Adverse Event|46|||
145700810|NCT02049515|525420365|FG001|Overall Study|Adverse Event|2|||
145700811|NCT02049515|525420364|FG000|Overall Study|Protocol-specified Disease Progression|23|||
145700812|NCT02049515|525420365|FG001|Overall Study|Protocol-specified Disease Progression|2|||
145700813|NCT02049515|525420364|FG000|Overall Study|Death|6|||
145700814|NCT02049515|525420365|FG001|Overall Study|Death|0|||
145700815|NCT02049515|525420364|FG000|Overall Study|Physician Decision|5|||
145700816|NCT02049515|525420365|FG001|Overall Study|Physician Decision|1|||
145700817|NCT02049515|525420364|FG000|Overall Study|Withdrawal by Subject|3|||
145700818|NCT02049515|525420365|FG001|Overall Study|Withdrawal by Subject|0|||
145700819|NCT02049515|525420364|FG000|Overall Study|Termination of the Study by Sponsor|2|||
145700820|NCT02049515|525420365|FG001|Overall Study|Termination of the Study by Sponsor|0|||
145700821|NCT02049515|525420364|FG000|Overall Study|Protocol Violation|1|||
145700822|NCT02049515|525420365|FG001|Overall Study|Protocol Violation|1|||
145700823|NCT02049515|525420364|FG000|Overall Study|Clinical Deterioration|1|||
145700824|NCT02049515|525420365|FG001|Overall Study|Clinical Deterioration|0|||
145700825|NCT02049515|525420364|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
145700826|NCT02049515|525420365|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
145700827|NCT02049515|525420364|FG000|Overall Study|Treatment Interruption >42 Days|1|||
145700828|NCT02049515|525420365|FG001|Overall Study|Treatment Interruption >42 Days|0|||
145700829|NCT02049515|525420364|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
145700830|NCT02049515|525420365|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
145700831|NCT00224029|525420370|FG000|Overall Study|Lost to Follow-up|1|||
145700832|NCT00224029|525420370|FG000|Overall Study|Withdrawal by Subject|4|||
145700833|NCT00224029|525420370|FG000|Overall Study|Other|1|||
145700834|NCT02872012|525420371|FG000|Overall Study|Withdrawal by Subject|1|||
145700835|NCT02872012|525420372|FG001|Overall Study|Withdrawal by Subject|0|||
145700836|NCT02872012|525420373|FG002|Overall Study|Withdrawal by Subject|0|||
145700837|NCT02872012|525420374|FG003|Overall Study|Withdrawal by Subject|0|||
145700838|NCT02872012|525420375|FG004|Overall Study|Withdrawal by Subject|0|||
145700839|NCT01728623|525420376|FG000|Overall Study|Disease progression|26|||
145700840|NCT01728623|525420376|FG000|Overall Study|Adverse Event|1|||
145700841|NCT01728623|525420376|FG000|Overall Study|Withdrawal by Subject|1|||
145700842|NCT03000348|525420377|FG000|Overall Study|Adverse Event|1|||
145700843|NCT03000348|525420378|FG001|Overall Study|Adverse Event|1|||
145700844|NCT03000348|525420379|FG002|Overall Study|Adverse Event|1|||
145700845|NCT03000348|525420380|FG003|Overall Study|Adverse Event|1|||
145700846|NCT03000348|525420381|FG004|Overall Study|Adverse Event|1|||
145700847|NCT03000348|525420382|FG005|Overall Study|Adverse Event|1|||
145700848|NCT03000348|525420377|FG000|Overall Study|Lost to Follow-up|0|||
145700849|NCT03000348|525420378|FG001|Overall Study|Lost to Follow-up|0|||
145700850|NCT03000348|525420379|FG002|Overall Study|Lost to Follow-up|1|||
145700851|NCT03000348|525420380|FG003|Overall Study|Lost to Follow-up|0|||
145700852|NCT03000348|525420381|FG004|Overall Study|Lost to Follow-up|0|||
145700853|NCT03000348|525420382|FG005|Overall Study|Lost to Follow-up|0|||
145700854|NCT03000348|525420377|FG000|Overall Study|Withdrawal by Subject|0|||
145700855|NCT03000348|525420378|FG001|Overall Study|Withdrawal by Subject|1|||
145700856|NCT03000348|525420379|FG002|Overall Study|Withdrawal by Subject|0|||
145700857|NCT03000348|525420380|FG003|Overall Study|Withdrawal by Subject|0|||
145700858|NCT03000348|525420381|FG004|Overall Study|Withdrawal by Subject|0|||
145700859|NCT03000348|525420382|FG005|Overall Study|Withdrawal by Subject|0|||
145700860|NCT03000348|525420377|FG000|Overall Study|Consent|0|||
145700861|NCT03000348|525420378|FG001|Overall Study|Consent|0|||
145700862|NCT03000348|525420379|FG002|Overall Study|Consent|0|||
145700863|NCT03000348|525420380|FG003|Overall Study|Consent|0|||
145700864|NCT03000348|525420381|FG004|Overall Study|Consent|1|||
145700865|NCT03000348|525420382|FG005|Overall Study|Consent|0|||
145700866|NCT03000348|525420377|FG000|Overall Study|Failure to expectorate sputum|1|||
145700867|NCT03000348|525420378|FG001|Overall Study|Failure to expectorate sputum|0|||
145700868|NCT03000348|525420379|FG002|Overall Study|Failure to expectorate sputum|1|||
145700869|NCT03000348|525420380|FG003|Overall Study|Failure to expectorate sputum|0|||
145700870|NCT03000348|525420381|FG004|Overall Study|Failure to expectorate sputum|1|||
145700871|NCT03000348|525420382|FG005|Overall Study|Failure to expectorate sputum|0|||
145700872|NCT03000348|525420377|FG000|Overall Study|No gram negative|1|||
145700873|NCT03000348|525420378|FG001|Overall Study|No gram negative|2|||
145700874|NCT03000348|525420379|FG002|Overall Study|No gram negative|1|||
145700875|NCT03000348|525420380|FG003|Overall Study|No gram negative|1|||
145700876|NCT03000348|525420381|FG004|Overall Study|No gram negative|1|||
145700877|NCT03000348|525420382|FG005|Overall Study|No gram negative|1|||
145700878|NCT03000348|525420377|FG000|Overall Study|Patient had no transport|0|||
145700879|NCT03000348|525420378|FG001|Overall Study|Patient had no transport|0|||
145700880|NCT03000348|525420379|FG002|Overall Study|Patient had no transport|0|||
145700881|NCT03000348|525420380|FG003|Overall Study|Patient had no transport|1|||
145700882|NCT03000348|525420381|FG004|Overall Study|Patient had no transport|0|||
145700883|NCT03000348|525420382|FG005|Overall Study|Patient had no transport|0|||
145700884|NCT03000348|525420377|FG000|Overall Study|Dosing|0|||
145700885|NCT03000348|525420378|FG001|Overall Study|Dosing|0|||
145700886|NCT03000348|525420379|FG002|Overall Study|Dosing|0|||
145700887|NCT03000348|525420380|FG003|Overall Study|Dosing|0|||
145700888|NCT03000348|525420381|FG004|Overall Study|Dosing|1|||
145700889|NCT03000348|525420382|FG005|Overall Study|Dosing|0|||
145700890|NCT00745498|525420384|FG000|Overall Study|Lost to Follow-up|1|||
145700891|NCT00745498|525420385|FG001|Overall Study|Lost to Follow-up|1|||
145700892|NCT00745498|525420386|FG002|Overall Study|Lost to Follow-up|3|||
145700893|NCT00745498|525420384|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
145700894|NCT00745498|525420385|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
145700895|NCT00745498|525420386|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
145700896|NCT00745498|525420384|FG000|Overall Study|Non-PDR related VH|0|||
145700897|NCT00745498|525420385|FG001|Overall Study|Non-PDR related VH|1|||
145700898|NCT00745498|525420386|FG002|Overall Study|Non-PDR related VH|1|||
145700899|NCT00745498|525420384|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
145700900|NCT00745498|525420385|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
145700901|NCT00745498|525420386|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
145700902|NCT03174782|525420387|FG000|Overall Study|Protocol Violation|1|||
145700903|NCT03174782|525420388|FG001|Overall Study|Protocol Violation|0|||
145700904|NCT03174782|525420387|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
145700905|NCT03174782|525420388|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
145700906|NCT03178045|525420389|FG000|Overall Study|Withdrawal by Subject|5|||
145700907|NCT03178045|525420390|FG001|Overall Study|Withdrawal by Subject|7|||
145700908|NCT03178045|525420389|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
145700909|NCT03178045|525420390|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
145700910|NCT03178045|525420389|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
145700911|NCT03178045|525420390|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
145700912|NCT03636373|525420391|FG000|Overall Study|Study closure due to Covid-19|1|||
145700913|NCT03636373|525420392|FG001|Overall Study|Study closure due to Covid-19|0|||
145700914|NCT00572533|525420403|FG000|Overall Study|Death|4|||
145700915|NCT00572533|525420404|FG001|Overall Study|Death|1|||
145700916|NCT00572533|525420403|FG000|Overall Study|Received Kidney Transplant|2|||
145700917|NCT00572533|525420404|FG001|Overall Study|Received Kidney Transplant|1|||
145700918|NCT00572533|525420403|FG000|Overall Study|Social Issues|1|||
145700919|NCT00572533|525420404|FG001|Overall Study|Social Issues|0|||
145700920|NCT00572533|525420403|FG000|Overall Study|Transfer out of Facility|0|||
145700921|NCT00572533|525420404|FG001|Overall Study|Transfer out of Facility|1|||
145700922|NCT01575873|525420407|FG000|Overall Study|Withdrawal by Subject|15|||
145700923|NCT01575873|525420408|FG001|Overall Study|Withdrawal by Subject|20|||
145700924|NCT01575873|525420409|FG002|Overall Study|Withdrawal by Subject|34|||
145700925|NCT01575873|525420410|FG003|Overall Study|Withdrawal by Subject|34|||
145700926|NCT01575873|525420407|FG000|Overall Study|Adverse Event|7|||
145700927|NCT01575873|525420408|FG001|Overall Study|Adverse Event|7|||
145700928|NCT01575873|525420409|FG002|Overall Study|Adverse Event|9|||
145700929|NCT01575873|525420410|FG003|Overall Study|Adverse Event|12|||
145700930|NCT01575873|525420407|FG000|Overall Study|Lost to Follow-up|1|||
145700931|NCT01575873|525420408|FG001|Overall Study|Lost to Follow-up|3|||
145700932|NCT01575873|525420409|FG002|Overall Study|Lost to Follow-up|13|||
145700933|NCT01575873|525420410|FG003|Overall Study|Lost to Follow-up|5|||
145700934|NCT01575873|525420407|FG000|Overall Study|Death|3|||
145700935|NCT01575873|525420408|FG001|Overall Study|Death|2|||
145700936|NCT01575873|525420409|FG002|Overall Study|Death|8|||
145700937|NCT01575873|525420410|FG003|Overall Study|Death|9|||
145700938|NCT01575873|525420407|FG000|Overall Study|Noncompliance|1|||
145700939|NCT01575873|525420408|FG001|Overall Study|Noncompliance|2|||
145700940|NCT01575873|525420409|FG002|Overall Study|Noncompliance|4|||
145700941|NCT01575873|525420410|FG003|Overall Study|Noncompliance|3|||
145700942|NCT01575873|525420407|FG000|Overall Study|Administrative decision|1|||
145700943|NCT01575873|525420408|FG001|Overall Study|Administrative decision|1|||
145700944|NCT01575873|525420409|FG002|Overall Study|Administrative decision|1|||
145700945|NCT01575873|525420410|FG003|Overall Study|Administrative decision|0|||
145700946|NCT01575873|525420407|FG000|Overall Study|Protocol deviation|0|||
145700947|NCT01575873|525420408|FG001|Overall Study|Protocol deviation|1|||
145700948|NCT01575873|525420409|FG002|Overall Study|Protocol deviation|0|||
145700949|NCT01575873|525420410|FG003|Overall Study|Protocol deviation|1|||
145700950|NCT01575873|525420407|FG000|Overall Study|Requirement for Alternative Therapy|0|||
145700951|NCT01575873|525420408|FG001|Overall Study|Requirement for Alternative Therapy|0|||
145700952|NCT01575873|525420409|FG002|Overall Study|Requirement for Alternative Therapy|1|||
145700953|NCT01575873|525420410|FG003|Overall Study|Requirement for Alternative Therapy|1|||
145700954|NCT01575873|525420407|FG000|Overall Study|Other|0|||
145700955|NCT01575873|525420408|FG001|Overall Study|Other|0|||
145700956|NCT01575873|525420409|FG002|Overall Study|Other|4|||
145700957|NCT01575873|525420410|FG003|Overall Study|Other|2|||
145700958|NCT00798304|525420411|FG000|Overall Study|Adverse Event|0|||
145700959|NCT00798304|525420412|FG001|Overall Study|Adverse Event|1|||
145700960|NCT00798304|525420413|FG002|Overall Study|Adverse Event|1|||
145700961|NCT00798304|525420411|FG000|Overall Study|Discontinuation by Sponsor|14|||
145700962|NCT00798304|525420412|FG001|Overall Study|Discontinuation by Sponsor|21|||
145700963|NCT00798304|525420413|FG002|Overall Study|Discontinuation by Sponsor|9|||
145700964|NCT04211389|525420414|FG000|Overall Study|Adverse Event|1|||
145700965|NCT04211389|525420415|FG001|Overall Study|Adverse Event|2|||
145700966|NCT04211389|525420414|FG000|Overall Study|Lost to Follow-up|15|||
145700967|NCT04211389|525420415|FG001|Overall Study|Lost to Follow-up|7|||
145700968|NCT04211389|525420414|FG000|Overall Study|Protocol Violation|0|||
145700969|NCT04211389|525420415|FG001|Overall Study|Protocol Violation|1|||
145700970|NCT04211389|525420414|FG000|Overall Study|Withdrawal by Subject|10|||
145700971|NCT04211389|525420415|FG001|Overall Study|Withdrawal by Subject|11|||
145700972|NCT00547534|525420418|FG000|Overall Study|Adverse Event|7|||
145700973|NCT00547534|525420418|FG000|Overall Study|Disease Progression|4|||
145700974|NCT02688530|525420427|FG000|Overall Study|Withdrawal by Subject|0|||
145700975|NCT02688530|525420428|FG001|Overall Study|Withdrawal by Subject|1|||
145700976|NCT02688530|525420429|FG002|Overall Study|Withdrawal by Subject|0|||
145700977|NCT02688530|525420430|FG003|Overall Study|Withdrawal by Subject|0|||
145700978|NCT02688530|525420427|FG000|Overall Study|Lost to Follow-up|0|||
145700979|NCT02688530|525420428|FG001|Overall Study|Lost to Follow-up|0|||
145700980|NCT02688530|525420429|FG002|Overall Study|Lost to Follow-up|2|||
145700981|NCT02688530|525420430|FG003|Overall Study|Lost to Follow-up|0|||
145700982|NCT01658020|525420431|FG000|Overall Study|Adverse Event|3|||
145700983|NCT01658020|525420432|FG001|Overall Study|Adverse Event|3|||
145700984|NCT01658020|525420431|FG000|Overall Study|Lost to Follow-up|1|||
145700985|NCT01658020|525420432|FG001|Overall Study|Lost to Follow-up|0|||
145700986|NCT01658020|525420431|FG000|Overall Study|Withdrawal by Subject|4|||
145700987|NCT01658020|525420432|FG001|Overall Study|Withdrawal by Subject|5|||
145700988|NCT01658020|525420431|FG000|Overall Study|Protocol Violation|0|||
145700989|NCT01658020|525420432|FG001|Overall Study|Protocol Violation|1|||
145700990|NCT04206085|525420433|FG000|Overall Study|Lost to Follow-up|0|||
145700991|NCT04206085|525420434|FG001|Overall Study|Lost to Follow-up|1|||
145700992|NCT04206085|525420435|FG002|Overall Study|Lost to Follow-up|0|||
145700993|NCT04206085|525420433|FG000|Overall Study|Lost to Follow-up|0|||
145700994|NCT04206085|525420434|FG001|Overall Study|Lost to Follow-up|0|||
145700995|NCT04206085|525420435|FG002|Overall Study|Lost to Follow-up|1|||
145700996|NCT05594589|525420436|FG000|Overall Study|Other|0|||
145700997|NCT05594589|525420437|FG001|Overall Study|Other|1|||
145700998|NCT05594589|525420438|FG002|Overall Study|Other|0|||
145700999|NCT02647645|525420441|FG000|Overall Study|Lost to Follow-up|2|||
145701000|NCT02647645|525420442|FG001|Overall Study|Lost to Follow-up|1|||
145701001|NCT02037256|525420443|FG000|Overall Study|Protocol Violation|0|||
145701002|NCT02037256|525420444|FG001|Overall Study|Protocol Violation|1|||
145701003|NCT02037256|525420443|FG000|Overall Study|Withdrawn prior to Velcade|0|||
145701004|NCT02037256|525420444|FG001|Overall Study|Withdrawn prior to Velcade|2|||
145701005|NCT04599907|525420447|FG000|Overall Study|Withdrawal by Subject|1|||
145701006|NCT04599907|525420448|FG001|Overall Study|Withdrawal by Subject|7|||
145701007|NCT04599907|525420449|FG002|Overall Study|Withdrawal by Subject|6|||
145701008|NCT04599907|525420447|FG000|Overall Study|Lost to Follow-up|0|||
145701009|NCT04599907|525420448|FG001|Overall Study|Lost to Follow-up|1|||
145701010|NCT04599907|525420449|FG002|Overall Study|Lost to Follow-up|0|||
145701011|NCT01466790|525420452|FG000|Overall Study|Adverse Event|1|||
145701012|NCT01466790|525420453|FG001|Overall Study|Adverse Event|0|||
145701013|NCT01466790|525420454|FG002|Overall Study|Adverse Event|0|||
145701014|NCT01466790|525420455|FG003|Overall Study|Adverse Event|0|||
145701015|NCT01466790|525420456|FG004|Overall Study|Adverse Event|2|||
145701016|NCT01466790|525420457|FG005|Overall Study|Adverse Event|0|||
145701017|NCT01466790|525420458|FG006|Overall Study|Adverse Event|0|||
145701018|NCT01466790|525420459|FG007|Overall Study|Adverse Event|0|||
145701019|NCT01466790|525420452|FG000|Overall Study|Lost to Follow-up|2|||
145701020|NCT01466790|525420453|FG001|Overall Study|Lost to Follow-up|0|||
145701021|NCT01466790|525420454|FG002|Overall Study|Lost to Follow-up|0|||
145701022|NCT01466790|525420455|FG003|Overall Study|Lost to Follow-up|0|||
145701023|NCT01466790|525420456|FG004|Overall Study|Lost to Follow-up|0|||
145701024|NCT01466790|525420457|FG005|Overall Study|Lost to Follow-up|0|||
145701025|NCT01466790|525420458|FG006|Overall Study|Lost to Follow-up|0|||
145701026|NCT01466790|525420459|FG007|Overall Study|Lost to Follow-up|0|||
145701027|NCT01466790|525420452|FG000|Overall Study|Withdrawal by Subject|1|||
145701028|NCT01466790|525420453|FG001|Overall Study|Withdrawal by Subject|1|||
145701029|NCT01466790|525420454|FG002|Overall Study|Withdrawal by Subject|0|||
145701030|NCT01466790|525420455|FG003|Overall Study|Withdrawal by Subject|0|||
145701031|NCT01466790|525420456|FG004|Overall Study|Withdrawal by Subject|1|||
145701032|NCT01466790|525420457|FG005|Overall Study|Withdrawal by Subject|0|||
145701033|NCT01466790|525420458|FG006|Overall Study|Withdrawal by Subject|1|||
145701034|NCT01466790|525420459|FG007|Overall Study|Withdrawal by Subject|1|||
145701035|NCT00356811|525420461|FG000|Overall Study|Death|35|||
145701036|NCT00356811|525420461|FG000|Overall Study|Lost to Follow-up|2|||
145701037|NCT00356811|525420461|FG000|Overall Study|Withdrawal by Subject|6|||
145701038|NCT00356811|525420461|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
145701039|NCT00356811|525420461|FG000|Overall Study|Study Is Terminating|3|||
145701040|NCT00356811|525420461|FG000|Overall Study|Site Closed during Follow-up|2|||
145701041|NCT02386839|525420462|FG000|Overall Study|Death|1|||
145701042|NCT02386839|525420463|FG001|Overall Study|Death|0|||
145701043|NCT02386839|525420462|FG000|Overall Study|Withdrawal by Subject|9|||
145701044|NCT02386839|525420463|FG001|Overall Study|Withdrawal by Subject|10|||
145701045|NCT02386839|525420462|FG000|Overall Study|Lost to Follow-up|4|||
145701046|NCT02386839|525420463|FG001|Overall Study|Lost to Follow-up|4|||
145701047|NCT02386839|525420462|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
145701048|NCT02386839|525420463|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
145701049|NCT02386839|525420462|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
145701050|NCT02386839|525420463|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
145701051|NCT02386839|525420462|FG000|Overall Study|Other (unspecified)|1|||
145701052|NCT02386839|525420463|FG001|Overall Study|Other (unspecified)|0|||
145701053|NCT02242643|525420466|FG000|Overall Study|Protocol Violation|1|||
145701054|NCT02242643|525420467|FG001|Overall Study|Protocol Violation|2|||
145701055|NCT02242643|525420466|FG000|Overall Study|Withdrawal by Subject|15|||
145701056|NCT02242643|525420467|FG001|Overall Study|Withdrawal by Subject|10|||
145701057|NCT02242643|525420466|FG000|Overall Study|Migrated/moved from study area|1|||
145701058|NCT02242643|525420467|FG001|Overall Study|Migrated/moved from study area|3|||
145701059|NCT02242643|525420466|FG000|Overall Study|Lost to Follow-up|54|||
145701060|NCT02242643|525420467|FG001|Overall Study|Lost to Follow-up|61|||
145701061|NCT02242643|525420466|FG000|Overall Study|Child placed in foster care by family|0|||
145701062|NCT02242643|525420467|FG001|Overall Study|Child placed in foster care by family|1|||
145701063|NCT02242643|525420466|FG000|Overall Study|Non-compliance|1|||
145701064|NCT02242643|525420467|FG001|Overall Study|Non-compliance|0|||
145701065|NCT02242643|525420466|FG000|Overall Study|Consent withdrawal by parent|1|||
145701066|NCT02242643|525420467|FG001|Overall Study|Consent withdrawal by parent|0|||
145701067|NCT02242643|525420466|FG000|Overall Study|Protocol requirements not followed|1|||
145701068|NCT02242643|525420467|FG001|Overall Study|Protocol requirements not followed|0|||
145701069|NCT02242643|525420466|FG000|Overall Study|Language barrier|1|||
145701070|NCT02242643|525420467|FG001|Overall Study|Language barrier|0|||
145701071|NCT02242643|525420466|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
145701072|NCT02242643|525420467|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
145701073|NCT02101983|525420471|FG000|Overall Study|Physician Decision|1|||
145701074|NCT02101983|525420472|FG001|Overall Study|Physician Decision|0|||
145701075|NCT01103232|525420473|FG000|Overall Study|Withdrawal by Subject|1|||
145701076|NCT01103232|525420474|FG001|Overall Study|Withdrawal by Subject|1|||
145701077|NCT01103232|525420473|FG000|Overall Study|Protocol Violation|0|||
145701078|NCT01103232|525420474|FG001|Overall Study|Protocol Violation|1|||
145701079|NCT03733899|525420475|FG000|Period 1|Protocol Violation|0|||
145701080|NCT03733899|525420476|FG001|Period 1|Protocol Violation|0|||
145701081|NCT03733899|525420477|FG002|Period 1|Protocol Violation|0|||
145701082|NCT03733899|525420478|FG003|Period 1|Protocol Violation|0|||
145701083|NCT03733899|525420479|FG004|Period 1|Protocol Violation|0|||
145701084|NCT03733899|525420480|FG005|Period 1|Protocol Violation|1|||
145701085|NCT03733899|525420475|FG000|Period 2|Unscuccessful Treatment|0|||
145701086|NCT03733899|525420476|FG001|Period 2|Unscuccessful Treatment|1|||
145701087|NCT03733899|525420477|FG002|Period 2|Unscuccessful Treatment|0|||
145701088|NCT03733899|525420478|FG003|Period 2|Unscuccessful Treatment|0|||
145701089|NCT03733899|525420479|FG004|Period 2|Unscuccessful Treatment|0|||
145701090|NCT03733899|525420480|FG005|Period 2|Unscuccessful Treatment|0|||
145701091|NCT03733899|525420475|FG000|Period 3|Withdrawal by Subject|1|||
145701092|NCT03733899|525420476|FG001|Period 3|Withdrawal by Subject|0|||
145701093|NCT03733899|525420477|FG002|Period 3|Withdrawal by Subject|0|||
145701094|NCT03733899|525420478|FG003|Period 3|Withdrawal by Subject|0|||
145701095|NCT03733899|525420479|FG004|Period 3|Withdrawal by Subject|0|||
145701096|NCT03733899|525420480|FG005|Period 3|Withdrawal by Subject|0|||
145701097|NCT02035696|525422585|FG000|Overall Study|Lost to Follow-up|0|||
145701098|NCT02035696|525422586|FG001|Overall Study|Lost to Follow-up|3|||
145701099|NCT02035696|525422587|FG002|Overall Study|Lost to Follow-up|1|||
145701100|NCT02035696|525422588|FG003|Overall Study|Lost to Follow-up|2|||
145701101|NCT02035696|525422585|FG000|Overall Study|Withdrawal by Subject|3|||
145701102|NCT02035696|525422586|FG001|Overall Study|Withdrawal by Subject|0|||
145701103|NCT02035696|525422587|FG002|Overall Study|Withdrawal by Subject|2|||
145701104|NCT02035696|525422588|FG003|Overall Study|Withdrawal by Subject|1|||
145701105|NCT01246999|525422590|FG000|Overall Study|Lost to Follow-up|0|||
145701106|NCT01246999|525422591|FG001|Overall Study|Lost to Follow-up|1|||
145701107|NCT01246999|525422592|FG002|Overall Study|Lost to Follow-up|0|||
145701108|NCT01246999|525422593|FG003|Overall Study|Lost to Follow-up|0|||
145701109|NCT01246999|525422590|FG000|Overall Study|Withdrawal by Subject|0|||
145701110|NCT01246999|525422591|FG001|Overall Study|Withdrawal by Subject|0|||
145701111|NCT01246999|525422592|FG002|Overall Study|Withdrawal by Subject|0|||
145701112|NCT01246999|525422593|FG003|Overall Study|Withdrawal by Subject|2|||
145701113|NCT01867047|525422594|FG000|Overall Study|Lost to Follow-up|3|||
145701114|NCT01867047|525422595|FG001|Overall Study|Lost to Follow-up|3|||
145701115|NCT01867047|525422594|FG000|Overall Study|Withdrawal by Subject|2|||
145701116|NCT01867047|525422595|FG001|Overall Study|Withdrawal by Subject|0|||
145701117|NCT01867047|525422594|FG000|Overall Study|Physician Decision|2|||
145701118|NCT01867047|525422595|FG001|Overall Study|Physician Decision|0|||
145701119|NCT01867047|525422594|FG000|Overall Study|surgery not indicated in protocol|1|||
145701120|NCT01867047|525422595|FG001|Overall Study|surgery not indicated in protocol|2|||
145701121|NCT04650698|525422596|FG000|Overall Study|Protocol Violation|2|||
145701122|NCT04650698|525422597|FG001|Overall Study|Protocol Violation|1|||
145701123|NCT04650698|525422596|FG000|Overall Study|Withdrawal by Subject|0|||
145701124|NCT04650698|525422597|FG001|Overall Study|Withdrawal by Subject|1|||
145701125|NCT01090011|525422598|FG000|Overall Study|Progressive disease|128|||
145701126|NCT01090011|525422598|FG000|Overall Study|Adverse Event|32|||
145701127|NCT01090011|525422598|FG000|Overall Study|Protocol Violation|1|||
145701128|NCT01090011|525422598|FG000|Overall Study|Refusal to start/continue medication|5|||
145701129|NCT01090011|525422598|FG000|Overall Study|Other reason not defined above|5|||
145701130|NCT00307047|525422599|FG000|Overall Study|Lost to Follow-up|35|||
145701131|NCT00307047|525422600|FG001|Overall Study|Lost to Follow-up|24|||
145701132|NCT00307047|525422599|FG000|Overall Study|Withdrawal by Subject|6|||
145701133|NCT00307047|525422600|FG001|Overall Study|Withdrawal by Subject|6|||
145701134|NCT00307047|525422599|FG000|Overall Study|Physician Decision|1|||
145701135|NCT00307047|525422600|FG001|Overall Study|Physician Decision|2|||
145701136|NCT00307047|525422599|FG000|Overall Study|Lost to follow-up for other reasons|0|||
145701137|NCT00307047|525422600|FG001|Overall Study|Lost to follow-up for other reasons|1|||
145701138|NCT00307047|525422599|FG000|Overall Study|All death, all MI, all Revascularization|27|||
145701139|NCT00307047|525422600|FG001|Overall Study|All death, all MI, all Revascularization|16|||
145701140|NCT00379769|525422601|FG000|Main Study|Death|57|||
145701141|NCT00379769|525422602|FG001|Main Study|Death|67|||
145701142|NCT00379769|525422603|FG002|Main Study|Death|54|||
145701143|NCT00379769|525422604|FG003|Main Study|Death|72|||
145701144|NCT00379769|525422605|FG004|Main Study|Death|0|||
145701145|NCT00379769|525422606|FG005|Main Study|Death|0|||
145701146|NCT00379769|525422601|FG000|Main Study|Adverse Event|5|||
145701147|NCT00379769|525422602|FG001|Main Study|Adverse Event|8|||
145701148|NCT00379769|525422603|FG002|Main Study|Adverse Event|10|||
145701149|NCT00379769|525422604|FG003|Main Study|Adverse Event|11|||
145701150|NCT00379769|525422605|FG004|Main Study|Adverse Event|0|||
145701151|NCT00379769|525422606|FG005|Main Study|Adverse Event|0|||
145701152|NCT00379769|525422601|FG000|Main Study|Lost to Follow-up|29|||
145701153|NCT00379769|525422602|FG001|Main Study|Lost to Follow-up|29|||
145701154|NCT00379769|525422603|FG002|Main Study|Lost to Follow-up|25|||
145701155|NCT00379769|525422604|FG003|Main Study|Lost to Follow-up|26|||
145701156|NCT00379769|525422605|FG004|Main Study|Lost to Follow-up|0|||
145701157|NCT00379769|525422606|FG005|Main Study|Lost to Follow-up|0|||
145701158|NCT00379769|525422601|FG000|Main Study|Withdrawal by Subject|46|||
145701159|NCT00379769|525422602|FG001|Main Study|Withdrawal by Subject|56|||
145701160|NCT00379769|525422603|FG002|Main Study|Withdrawal by Subject|72|||
145701161|NCT00379769|525422604|FG003|Main Study|Withdrawal by Subject|70|||
145701162|NCT00379769|525422605|FG004|Main Study|Withdrawal by Subject|0|||
145701163|NCT00379769|525422606|FG005|Main Study|Withdrawal by Subject|0|||
145701164|NCT00379769|525422601|FG000|Main Study|Moved to survival status follow-up only|27|||
145701165|NCT00379769|525422602|FG001|Main Study|Moved to survival status follow-up only|25|||
145701166|NCT00379769|525422603|FG002|Main Study|Moved to survival status follow-up only|32|||
145701167|NCT00379769|525422604|FG003|Main Study|Moved to survival status follow-up only|36|||
145701168|NCT00379769|525422605|FG004|Main Study|Moved to survival status follow-up only|0|||
145701169|NCT00379769|525422606|FG005|Main Study|Moved to survival status follow-up only|0|||
145701170|NCT00379769|525422601|FG000|Main Study|Participant moved|3|||
145701171|NCT00379769|525422602|FG001|Main Study|Participant moved|2|||
145701172|NCT00379769|525422603|FG002|Main Study|Participant moved|3|||
145701173|NCT00379769|525422604|FG003|Main Study|Participant moved|3|||
145701174|NCT00379769|525422605|FG004|Main Study|Participant moved|0|||
145701175|NCT00379769|525422606|FG005|Main Study|Participant moved|0|||
145701176|NCT00379769|525422601|FG000|Main Study|Poor compliance|3|||
145701177|NCT00379769|525422602|FG001|Main Study|Poor compliance|2|||
145701178|NCT00379769|525422603|FG002|Main Study|Poor compliance|2|||
145701179|NCT00379769|525422604|FG003|Main Study|Poor compliance|1|||
145701180|NCT00379769|525422605|FG004|Main Study|Poor compliance|0|||
145701181|NCT00379769|525422606|FG005|Main Study|Poor compliance|0|||
145701182|NCT00379769|525422601|FG000|Main Study|Prohibited glucose lowering medication|0|||
145701183|NCT00379769|525422602|FG001|Main Study|Prohibited glucose lowering medication|3|||
145701184|NCT00379769|525422603|FG002|Main Study|Prohibited glucose lowering medication|0|||
145701185|NCT00379769|525422604|FG003|Main Study|Prohibited glucose lowering medication|1|||
145701186|NCT00379769|525422605|FG004|Main Study|Prohibited glucose lowering medication|0|||
145701187|NCT00379769|525422606|FG005|Main Study|Prohibited glucose lowering medication|0|||
145701188|NCT00379769|525422601|FG000|Main Study|Site closed|4|||
145701189|NCT00379769|525422602|FG001|Main Study|Site closed|4|||
145701190|NCT00379769|525422603|FG002|Main Study|Site closed|4|||
145701191|NCT00379769|525422604|FG003|Main Study|Site closed|8|||
145701192|NCT00379769|525422605|FG004|Main Study|Site closed|0|||
145701193|NCT00379769|525422606|FG005|Main Study|Site closed|0|||
145701194|NCT00379769|525422601|FG000|Main Study|Entry criteria violation|0|||
145701195|NCT00379769|525422602|FG001|Main Study|Entry criteria violation|0|||
145701196|NCT00379769|525422603|FG002|Main Study|Entry criteria violation|1|||
145701197|NCT00379769|525422604|FG003|Main Study|Entry criteria violation|1|||
145701198|NCT00379769|525422605|FG004|Main Study|Entry criteria violation|0|||
145701199|NCT00379769|525422606|FG005|Main Study|Entry criteria violation|0|||
145701200|NCT00379769|525422601|FG000|Main Study|Participant did not take study drug|0|||
145701201|NCT00379769|525422602|FG001|Main Study|Participant did not take study drug|0|||
145701202|NCT00379769|525422603|FG002|Main Study|Participant did not take study drug|1|||
145701203|NCT00379769|525422604|FG003|Main Study|Participant did not take study drug|0|||
145701204|NCT00379769|525422605|FG004|Main Study|Participant did not take study drug|0|||
145701205|NCT00379769|525422606|FG005|Main Study|Participant did not take study drug|0|||
145701206|NCT00379769|525422601|FG000|Main Study|Physician Decision|2|||
145701207|NCT00379769|525422602|FG001|Main Study|Physician Decision|2|||
145701208|NCT00379769|525422603|FG002|Main Study|Physician Decision|1|||
145701209|NCT00379769|525422604|FG003|Main Study|Physician Decision|1|||
145701210|NCT00379769|525422605|FG004|Main Study|Physician Decision|0|||
145701211|NCT00379769|525422606|FG005|Main Study|Physician Decision|0|||
145701212|NCT00379769|525422601|FG000|Main Study|Participant completed study at visit 27|1|||
145701213|NCT00379769|525422602|FG001|Main Study|Participant completed study at visit 27|0|||
145701214|NCT00379769|525422603|FG002|Main Study|Participant completed study at visit 27|0|||
145701215|NCT00379769|525422604|FG003|Main Study|Participant completed study at visit 27|0|||
145701216|NCT00379769|525422605|FG004|Main Study|Participant completed study at visit 27|0|||
145701217|NCT00379769|525422606|FG005|Main Study|Participant completed study at visit 27|0|||
145701218|NCT00379769|525422601|FG000|Main Study|Personal reasons|1|||
145701219|NCT00379769|525422602|FG001|Main Study|Personal reasons|0|||
145701220|NCT00379769|525422603|FG002|Main Study|Personal reasons|0|||
145701221|NCT00379769|525422604|FG003|Main Study|Personal reasons|0|||
145701222|NCT00379769|525422605|FG004|Main Study|Personal reasons|0|||
145701223|NCT00379769|525422606|FG005|Main Study|Personal reasons|0|||
145701224|NCT00379769|525422601|FG000|Main Study|Risk of heart failure|0|||
145701225|NCT00379769|525422602|FG001|Main Study|Risk of heart failure|1|||
145701226|NCT00379769|525422603|FG002|Main Study|Risk of heart failure|0|||
145701227|NCT00379769|525422604|FG003|Main Study|Risk of heart failure|0|||
145701228|NCT00379769|525422605|FG004|Main Study|Risk of heart failure|0|||
145701229|NCT00379769|525422606|FG005|Main Study|Risk of heart failure|0|||
145701230|NCT00379769|525422601|FG000|Main Study|Investigator refused to log temperature|0|||
145701231|NCT00379769|525422602|FG001|Main Study|Investigator refused to log temperature|0|||
145701232|NCT00379769|525422603|FG002|Main Study|Investigator refused to log temperature|1|||
145701233|NCT00379769|525422604|FG003|Main Study|Investigator refused to log temperature|0|||
145701234|NCT00379769|525422605|FG004|Main Study|Investigator refused to log temperature|0|||
145701235|NCT00379769|525422606|FG005|Main Study|Investigator refused to log temperature|0|||
145701236|NCT00379769|525422601|FG000|Main Study|Reason unspecified|0|||
145701237|NCT00379769|525422602|FG001|Main Study|Reason unspecified|0|||
145701238|NCT00379769|525422603|FG002|Main Study|Reason unspecified|1|||
145701239|NCT00379769|525422604|FG003|Main Study|Reason unspecified|0|||
145701240|NCT00379769|525422605|FG004|Main Study|Reason unspecified|0|||
145701241|NCT00379769|525422606|FG005|Main Study|Reason unspecified|0|||
145701242|NCT00379769|525422601|FG000|Observational Follow-up|Death|0|||
145701243|NCT00379769|525422602|FG001|Observational Follow-up|Death|0|||
145701244|NCT00379769|525422603|FG002|Observational Follow-up|Death|0|||
145701245|NCT00379769|525422604|FG003|Observational Follow-up|Death|0|||
145701246|NCT00379769|525422605|FG004|Observational Follow-up|Death|78|||
145701247|NCT00379769|525422606|FG005|Observational Follow-up|Death|70|||
145701248|NCT00379769|525422601|FG000|Observational Follow-up|Adverse Event|0|||
145701249|NCT00379769|525422602|FG001|Observational Follow-up|Adverse Event|0|||
145701250|NCT00379769|525422603|FG002|Observational Follow-up|Adverse Event|0|||
145701251|NCT00379769|525422604|FG003|Observational Follow-up|Adverse Event|0|||
145701252|NCT00379769|525422605|FG004|Observational Follow-up|Adverse Event|1|||
145701253|NCT00379769|525422606|FG005|Observational Follow-up|Adverse Event|0|||
145701254|NCT00379769|525422601|FG000|Observational Follow-up|Lost to Follow-up|0|||
145701255|NCT00379769|525422602|FG001|Observational Follow-up|Lost to Follow-up|0|||
145701256|NCT00379769|525422603|FG002|Observational Follow-up|Lost to Follow-up|0|||
145701257|NCT00379769|525422604|FG003|Observational Follow-up|Lost to Follow-up|0|||
145701258|NCT00379769|525422605|FG004|Observational Follow-up|Lost to Follow-up|25|||
145701259|NCT00379769|525422606|FG005|Observational Follow-up|Lost to Follow-up|27|||
145701260|NCT00379769|525422601|FG000|Observational Follow-up|Withdrawal by Subject|0|||
145701261|NCT00379769|525422602|FG001|Observational Follow-up|Withdrawal by Subject|0|||
145701262|NCT00379769|525422603|FG002|Observational Follow-up|Withdrawal by Subject|0|||
145701263|NCT00379769|525422604|FG003|Observational Follow-up|Withdrawal by Subject|0|||
145701264|NCT00379769|525422605|FG004|Observational Follow-up|Withdrawal by Subject|12|||
145701265|NCT00379769|525422606|FG005|Observational Follow-up|Withdrawal by Subject|12|||
145701266|NCT00379769|525422601|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
145701267|NCT00379769|525422602|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
145701268|NCT00379769|525422603|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
145701269|NCT00379769|525422604|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
145701270|NCT00379769|525422605|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
145701271|NCT00379769|525422606|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
145701272|NCT00379769|525422601|FG000|Observational Follow-up|Physician Decision|0|||
145701273|NCT00379769|525422602|FG001|Observational Follow-up|Physician Decision|0|||
145701274|NCT00379769|525422603|FG002|Observational Follow-up|Physician Decision|0|||
145701275|NCT00379769|525422604|FG003|Observational Follow-up|Physician Decision|0|||
145701276|NCT00379769|525422605|FG004|Observational Follow-up|Physician Decision|8|||
145701277|NCT00379769|525422606|FG005|Observational Follow-up|Physician Decision|8|||
145701278|NCT00379769|525422601|FG000|Observational Follow-up|Site Closed Early|0|||
145701279|NCT00379769|525422602|FG001|Observational Follow-up|Site Closed Early|0|||
145701280|NCT00379769|525422603|FG002|Observational Follow-up|Site Closed Early|0|||
145701281|NCT00379769|525422604|FG003|Observational Follow-up|Site Closed Early|0|||
145701282|NCT00379769|525422605|FG004|Observational Follow-up|Site Closed Early|6|||
145701283|NCT00379769|525422606|FG005|Observational Follow-up|Site Closed Early|7|||
145701284|NCT00379769|525422601|FG000|Observational Follow-up|Participant Moved|0|||
145701285|NCT00379769|525422602|FG001|Observational Follow-up|Participant Moved|0|||
145701286|NCT00379769|525422603|FG002|Observational Follow-up|Participant Moved|0|||
145701287|NCT00379769|525422604|FG003|Observational Follow-up|Participant Moved|0|||
145701288|NCT00379769|525422605|FG004|Observational Follow-up|Participant Moved|0|||
145701289|NCT00379769|525422606|FG005|Observational Follow-up|Participant Moved|1|||
145701290|NCT00379769|525422601|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
145701291|NCT00379769|525422602|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
145701292|NCT00379769|525422603|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
145701293|NCT00379769|525422604|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
145701294|NCT00379769|525422605|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
145701295|NCT00379769|525422606|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
145701296|NCT03778294|525422607|FG000|Overall Study|Death|1|||
145701297|NCT03778294|525422607|FG000|Overall Study|Issues with insurance|1|||
145701298|NCT03778294|525422607|FG000|Overall Study|disease progression before treatment|2|||
145701299|NCT02825251|525422610|FG000|Overall Study|Adverse Event|0|||
145701300|NCT02825251|525422611|FG001|Overall Study|Adverse Event|1|||
145701301|NCT02825251|525422610|FG000|Overall Study|Lost to Follow-up|0|||
145701302|NCT02825251|525422611|FG001|Overall Study|Lost to Follow-up|1|||
145701303|NCT02825251|525422610|FG000|Overall Study|Withdrawal by Subject|1|||
145701304|NCT02825251|525422611|FG001|Overall Study|Withdrawal by Subject|4|||
145701305|NCT02825251|525422610|FG000|Overall Study|Unclassified|2|||
145701306|NCT02825251|525422611|FG001|Overall Study|Unclassified|0|||
145701307|NCT01689363|525422618|FG000|Overall Study|Protocol Violation|0|||
145701308|NCT01689363|525422619|FG001|Overall Study|Protocol Violation|1|||
145701309|NCT01689363|525422620|FG002|Overall Study|Protocol Violation|0|||
145701310|NCT01689363|525422621|FG003|Overall Study|Protocol Violation|0|||
145701311|NCT01689363|525422622|FG004|Overall Study|Protocol Violation|0|||
145701312|NCT01689363|525422623|FG005|Overall Study|Protocol Violation|0|||
145701313|NCT01689363|525422624|FG006|Overall Study|Protocol Violation|0|||
145701314|NCT01689363|525422625|FG007|Overall Study|Protocol Violation|0|||
145701315|NCT02104505|525422626|FG000|First Intervention (14 Days)|Adverse Event|2|||
145701316|NCT02104505|525422627|FG001|First Intervention (14 Days)|Adverse Event|0|||
145701317|NCT02104505|525422626|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
145701318|NCT02104505|525422627|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
145701319|NCT02104505|525422626|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
145701320|NCT02104505|525422627|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
145701321|NCT02104505|525422626|FG000|First Intervention (14 Days)|exclusionary condition|0|||
145701322|NCT02104505|525422627|FG001|First Intervention (14 Days)|exclusionary condition|1|||
145701323|NCT02104505|525422626|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
145701324|NCT02104505|525422627|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
145701325|NCT02104505|525422626|FG000|Second Intervention (14 Days)|Adverse Event|2|||
145701326|NCT02104505|525422627|FG001|Second Intervention (14 Days)|Adverse Event|0|||
145701327|NCT01845805|525422628|FG000|Overall Study|Withdrawal by Subject|1|||
145701328|NCT01845805|525422629|FG001|Overall Study|Withdrawal by Subject|2|||
145701329|NCT01845805|525422628|FG000|Overall Study|Disease Progression|13|||
145701330|NCT01845805|525422629|FG001|Overall Study|Disease Progression|14|||
145701331|NCT01845805|525422628|FG000|Overall Study|Drug-related Toxicity|4|||
145701332|NCT01845805|525422629|FG001|Overall Study|Drug-related Toxicity|0|||
145701333|NCT02859064|525422630|FG000|Overall Study|Progressive Disease|3|||
145701334|NCT02859064|525422630|FG000|Overall Study|Physician Decision|1|||
145701335|NCT02859064|525422630|FG000|Overall Study|Withdrawal by Subject|1|||
145701336|NCT02859064|525422630|FG000|Overall Study|Death|1|||
145701337|NCT00321685|525422633|FG000|Overall Study|Adverse Event|18|||
145701338|NCT00321685|525422633|FG000|Overall Study|Death|2|||
145701339|NCT00321685|525422633|FG000|Overall Study|Withdrawal by Subject|8|||
145701340|NCT00321685|525422633|FG000|Overall Study|Alternative therapy|1|||
145701341|NCT00321685|525422633|FG000|Overall Study|Complicating disese|1|||
145701342|NCT00321685|525422633|FG000|Overall Study|Other|5|||
145701343|NCT00321685|525422633|FG000|Overall Study|Not start protocol therapy|2|||
145701344|NCT00321685|525422633|FG000|Overall Study|Ineligible|2|||
145701345|NCT01986114|525422637|FG000|Overall Study|Adverse Event|59|||
145701346|NCT01986114|525422637|FG000|Overall Study|Lack of Efficacy|23|||
145701347|NCT01986114|525422637|FG000|Overall Study|Withdrawal by Subject|58|||
145701348|NCT01986114|525422637|FG000|Overall Study|Noncompliance|3|||
145701349|NCT01986114|525422637|FG000|Overall Study|Protocol Violation|1|||
145701350|NCT01986114|525422637|FG000|Overall Study|Lost to Follow-up|5|||
145701351|NCT01986114|525422637|FG000|Overall Study|Other reason|7|||
145701352|NCT01190644|525422638|FG000|Overall Study|Death|2|||
145701353|NCT01190644|525422638|FG000|Overall Study|Disease progression|1|||
145701354|NCT02366143|525422639|FG000|Overall Study|Death|307|||
145701355|NCT02366143|525422640|FG001|Overall Study|Death|278|||
145701356|NCT02366143|525422641|FG002|Overall Study|Death|280|||
145701357|NCT02366143|525422639|FG000|Overall Study|Lost to Follow-up|2|||
145701358|NCT02366143|525422640|FG001|Overall Study|Lost to Follow-up|4|||
145701359|NCT02366143|525422641|FG002|Overall Study|Lost to Follow-up|2|||
145701360|NCT02366143|525422639|FG000|Overall Study|Physician Decision|1|||
145701361|NCT02366143|525422640|FG001|Overall Study|Physician Decision|2|||
145701362|NCT02366143|525422641|FG002|Overall Study|Physician Decision|1|||
145701363|NCT02366143|525422639|FG000|Overall Study|Protocol Violation|0|||
145701364|NCT02366143|525422640|FG001|Overall Study|Protocol Violation|0|||
145701365|NCT02366143|525422641|FG002|Overall Study|Protocol Violation|2|||
145701366|NCT02366143|525422639|FG000|Overall Study|Withdrawal by Subject|16|||
145701367|NCT02366143|525422640|FG001|Overall Study|Withdrawal by Subject|17|||
145701368|NCT02366143|525422641|FG002|Overall Study|Withdrawal by Subject|22|||
145701369|NCT02366143|525422639|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
145701370|NCT02366143|525422640|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
145701371|NCT02366143|525422641|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
145701372|NCT02366143|525422639|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
145701373|NCT02366143|525422640|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
145701374|NCT02366143|525422641|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
145701375|NCT02366143|525422639|FG000|Overall Study|Randomization Error|1|||
145701376|NCT02366143|525422640|FG001|Overall Study|Randomization Error|0|||
145701377|NCT02366143|525422641|FG002|Overall Study|Randomization Error|0|||
145701378|NCT02366143|525422639|FG000|Overall Study|PI Move and Site Closure|1|||
145701379|NCT02366143|525422640|FG001|Overall Study|PI Move and Site Closure|0|||
145701380|NCT02366143|525422641|FG002|Overall Study|PI Move and Site Closure|1|||
145701381|NCT02366143|525422639|FG000|Overall Study|Study Terminated By Sponsor|0|||
145701382|NCT02366143|525422640|FG001|Overall Study|Study Terminated By Sponsor|0|||
145701383|NCT02366143|525422641|FG002|Overall Study|Study Terminated By Sponsor|2|||
145701384|NCT02366143|525422639|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
145701385|NCT02366143|525422640|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
145701386|NCT02366143|525422641|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
145701387|NCT02366143|525422639|FG000|Overall Study|Patient moved to roll-over study|1|||
145701388|NCT02366143|525422640|FG001|Overall Study|Patient moved to roll-over study|19|||
145701389|NCT02366143|525422641|FG002|Overall Study|Patient moved to roll-over study|28|||
145701390|NCT02366143|525422639|FG000|Overall Study|Patient moved to commercial stock|0|||
145701391|NCT02366143|525422640|FG001|Overall Study|Patient moved to commercial stock|0|||
145701392|NCT02366143|525422641|FG002|Overall Study|Patient moved to commercial stock|1|||
145701393|NCT02366143|525422639|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
145701394|NCT02366143|525422640|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
145701395|NCT02366143|525422641|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
145701396|NCT02366143|525422639|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
145701397|NCT02366143|525422640|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
145701398|NCT02366143|525422641|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
145701399|NCT02366143|525422639|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
145701400|NCT02366143|525422640|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
145701401|NCT02366143|525422641|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
145701402|NCT02366143|525422639|FG000|Overall Study|Requester's instructions|1|||
145701403|NCT02366143|525422640|FG001|Overall Study|Requester's instructions|1|||
145701404|NCT02366143|525422641|FG002|Overall Study|Requester's instructions|1|||
145701405|NCT02366143|525422639|FG000|Overall Study|Uneligible|0|||
145701406|NCT02366143|525422640|FG001|Overall Study|Uneligible|1|||
145701407|NCT02366143|525422641|FG002|Overall Study|Uneligible|0|||
145701408|NCT02366143|525422639|FG000|Overall Study|Post Trial Migration|0|||
145701409|NCT02366143|525422640|FG001|Overall Study|Post Trial Migration|1|||
145701410|NCT02366143|525422641|FG002|Overall Study|Post Trial Migration|0|||
145701411|NCT02366143|525422639|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
145701412|NCT02366143|525422640|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
145701413|NCT02366143|525422641|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
145701414|NCT02366143|525422639|FG000|Overall Study|Patient switched to PTAP|0|||
145701415|NCT02366143|525422640|FG001|Overall Study|Patient switched to PTAP|1|||
145701416|NCT02366143|525422641|FG002|Overall Study|Patient switched to PTAP|0|||
145701417|NCT02366143|525422639|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
145701418|NCT02366143|525422640|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
145701419|NCT02366143|525422641|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
145701420|NCT02172911|525422642|FG000|Overall Study|Serious Adverse Event|0|||
145701421|NCT02172911|525422643|FG001|Overall Study|Serious Adverse Event|1|||
145701422|NCT02172911|525422642|FG000|Overall Study|Progression of Disease|0|||
145701423|NCT02172911|525422643|FG001|Overall Study|Progression of Disease|1|||
145701424|NCT02172911|525422642|FG000|Overall Study|Loss of insurance coverage|1|||
145701425|NCT02172911|525422643|FG001|Overall Study|Loss of insurance coverage|0|||
145701426|NCT04795336|525422648|FG000|Overall Study|Withdrawal by Subject|3|||
145701427|NCT04795336|525422649|FG001|Overall Study|Withdrawal by Subject|4|||
145701428|NCT04795336|525422650|FG002|Overall Study|Withdrawal by Subject|3|||
145701429|NCT04795336|525422651|FG003|Overall Study|Withdrawal by Subject|12|||
145701430|NCT04795336|525422648|FG000|Overall Study|Lost study logs|0|||
145701431|NCT04795336|525422649|FG001|Overall Study|Lost study logs|1|||
145701432|NCT04795336|525422650|FG002|Overall Study|Lost study logs|0|||
145701433|NCT04795336|525422651|FG003|Overall Study|Lost study logs|2|||
145701434|NCT04795336|525422648|FG000|Overall Study|Did not take study medication|2|||
145701435|NCT04795336|525422649|FG001|Overall Study|Did not take study medication|0|||
145701436|NCT04795336|525422650|FG002|Overall Study|Did not take study medication|0|||
145701437|NCT04795336|525422651|FG003|Overall Study|Did not take study medication|0|||
145701438|NCT03023722|525422652|FG000|Overall Study|No follow-up assessment|4|||
145701439|NCT03616964|525422653|FG000|Overall Study|Adverse Event|15|||
145701440|NCT03616964|525422654|FG001|Overall Study|Adverse Event|10|||
145701441|NCT03616964|525422655|FG002|Overall Study|Adverse Event|16|||
145701442|NCT03616964|525422653|FG000|Overall Study|Death|3|||
145701443|NCT03616964|525422654|FG001|Overall Study|Death|0|||
145701444|NCT03616964|525422655|FG002|Overall Study|Death|4|||
145701445|NCT03616964|525422653|FG000|Overall Study|Lack of Efficacy|4|||
145701446|NCT03616964|525422654|FG001|Overall Study|Lack of Efficacy|8|||
145701447|NCT03616964|525422655|FG002|Overall Study|Lack of Efficacy|8|||
145701448|NCT03616964|525422653|FG000|Overall Study|Lost to Follow-up|2|||
145701449|NCT03616964|525422654|FG001|Overall Study|Lost to Follow-up|1|||
145701450|NCT03616964|525422655|FG002|Overall Study|Lost to Follow-up|3|||
145701451|NCT03616964|525422653|FG000|Overall Study|Withdrawal by Subject|18|||
145701452|NCT03616964|525422654|FG001|Overall Study|Withdrawal by Subject|14|||
145701453|NCT03616964|525422655|FG002|Overall Study|Withdrawal by Subject|21|||
145701454|NCT03616964|525422653|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
145701455|NCT03616964|525422654|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
145701456|NCT03616964|525422655|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
145701457|NCT03616964|525422653|FG000|Overall Study|Sponsor's Decision|1|||
145701458|NCT03616964|525422654|FG001|Overall Study|Sponsor's Decision|0|||
145701459|NCT03616964|525422655|FG002|Overall Study|Sponsor's Decision|0|||
145701460|NCT03616964|525422653|FG000|Overall Study|Physician Decision|0|||
145701461|NCT03616964|525422654|FG001|Overall Study|Physician Decision|2|||
145701462|NCT03616964|525422655|FG002|Overall Study|Physician Decision|0|||
145701463|NCT03616964|525422653|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
145701464|NCT03616964|525422654|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
145701465|NCT03616964|525422655|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
145701466|NCT03616964|525422653|FG000|Overall Study|Protocol Violation|0|||
145701467|NCT03616964|525422654|FG001|Overall Study|Protocol Violation|1|||
145701468|NCT03616964|525422655|FG002|Overall Study|Protocol Violation|0|||
145701469|NCT03616964|525422653|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
145701470|NCT03616964|525422654|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
145701471|NCT03616964|525422655|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
145701472|NCT03616964|525422653|FG000|Overall Study|Randomized but Never Treated|1|||
145701473|NCT03616964|525422654|FG001|Overall Study|Randomized but Never Treated|1|||
145701474|NCT03616964|525422655|FG002|Overall Study|Randomized but Never Treated|1|||
145701475|NCT01385748|525422656|FG000|Overall Study|Withdrawal by Subject|7|||
145701476|NCT01385748|525422657|FG001|Overall Study|Withdrawal by Subject|4|||
145701477|NCT01385748|525422658|FG002|Overall Study|Withdrawal by Subject|5|||
145701478|NCT01385748|525422656|FG000|Overall Study|Noncompliance|3|||
145701479|NCT01385748|525422657|FG001|Overall Study|Noncompliance|1|||
145701480|NCT01385748|525422658|FG002|Overall Study|Noncompliance|6|||
145701481|NCT01385748|525422656|FG000|Overall Study|Other|1|||
145701482|NCT01385748|525422657|FG001|Overall Study|Other|7|||
145701483|NCT01385748|525422658|FG002|Overall Study|Other|1|||
145701484|NCT01385748|525422656|FG000|Overall Study|Adverse Event|4|||
145701485|NCT01385748|525422657|FG001|Overall Study|Adverse Event|2|||
145701486|NCT01385748|525422658|FG002|Overall Study|Adverse Event|1|||
145701487|NCT02354651|525422659|FG000|Overall Study|Withdrawal by Subject|2|||
145701488|NCT02354651|525422659|FG000|Overall Study|Physician Decision|1|||
145701489|NCT00590564|525422660|FG000|Overall Study|Withdrawal by Subject|4|||
145701490|NCT00590564|525422660|FG000|Overall Study|Lost to Follow-up|6|||
145701491|NCT00590564|525422660|FG000|Overall Study|Protocol Violation|1|||
145701492|NCT00590564|525422660|FG000|Overall Study|Patient Found to be Ineligible|1|||
145701493|NCT00590564|525422660|FG000|Overall Study|Patient Non-compliance|6|||
145701494|NCT01377389|525422663|FG000|Overall Study|Withdrawal by Subject|1|||
145701495|NCT01377389|525422663|FG000|Overall Study|Screen failure|2|||
145701496|NCT01434680|525422670|FG000|Overall Study|Withdrawal by Subject|1|||
145701497|NCT01434680|525422671|FG001|Overall Study|Withdrawal by Subject|0|||
145701498|NCT01434680|525422672|FG002|Overall Study|Withdrawal by Subject|2|||
145701499|NCT01434680|525422673|FG003|Overall Study|Withdrawal by Subject|0|||
145701500|NCT01434680|525422670|FG000|Overall Study|Lost to Follow-up|1|||
145701501|NCT01434680|525422671|FG001|Overall Study|Lost to Follow-up|1|||
145701502|NCT01434680|525422672|FG002|Overall Study|Lost to Follow-up|0|||
145701503|NCT01434680|525422673|FG003|Overall Study|Lost to Follow-up|0|||
145701504|NCT01434680|525422670|FG000|Overall Study|Protocol Violation|1|||
145701505|NCT01434680|525422671|FG001|Overall Study|Protocol Violation|1|||
145701506|NCT01434680|525422672|FG002|Overall Study|Protocol Violation|0|||
145701507|NCT01434680|525422673|FG003|Overall Study|Protocol Violation|0|||
145701508|NCT00725712|525422675|FG000|Overall Study|Withdrawal by Subject|2|||
145701509|NCT00725712|525422676|FG001|Overall Study|Withdrawal by Subject|1|||
145701510|NCT00725712|525422675|FG000|Overall Study|Protocol Violation|1|||
145701511|NCT00725712|525422676|FG001|Overall Study|Protocol Violation|0|||
145701512|NCT00725712|525422675|FG000|Overall Study|Progressive disease|37|||
145701513|NCT00725712|525422676|FG001|Overall Study|Progressive disease|16|||
145701514|NCT00725712|525422675|FG000|Overall Study|Clinical progression not based on RECIST|0|||
145701515|NCT00725712|525422676|FG001|Overall Study|Clinical progression not based on RECIST|3|||
145701516|NCT00725712|525422675|FG000|Overall Study|Adverse Event|5|||
145701517|NCT00725712|525422676|FG001|Overall Study|Adverse Event|5|||
145701518|NCT00725712|525422675|FG000|Overall Study|Death|2|||
145701519|NCT00725712|525422676|FG001|Overall Study|Death|0|||
145701520|NCT00725712|525422675|FG000|Overall Study|Other: Death|1|||
145701521|NCT00725712|525422676|FG001|Overall Study|Other: Death|0|||
145701522|NCT00725712|525422675|FG000|Overall Study|Hospitalized, unable to continue|0|||
145701523|NCT00725712|525422676|FG001|Overall Study|Hospitalized, unable to continue|1|||
145701524|NCT02037477|525422680|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
145701525|NCT02037477|525422681|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
145701526|NCT02037477|525422682|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
145701527|NCT02037477|525422683|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
145701528|NCT00983749|525422684|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
145701529|NCT00983749|525422685|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
145701530|NCT05765435|525422686|FG000|Overall Study|Lost to Follow-up|0|||
145701531|NCT05765435|525422687|FG001|Overall Study|Lost to Follow-up|1|||
145701532|NCT05765435|525422688|FG002|Overall Study|Lost to Follow-up|0|||
145701533|NCT05765435|525422686|FG000|Overall Study|Withdrawal by Subject|0|||
145701534|NCT05765435|525422687|FG001|Overall Study|Withdrawal by Subject|0|||
145701535|NCT05765435|525422688|FG002|Overall Study|Withdrawal by Subject|1|||
145701536|NCT01952847|525422689|FG000|Overall Study|Ineligible|1|||
145701537|NCT01952847|525422690|FG001|Overall Study|Ineligible|0|||
145701538|NCT01952847|525422691|FG002|Overall Study|Ineligible|0|||
145701539|NCT01952847|525422692|FG003|Overall Study|Ineligible|0|||
145701540|NCT01952847|525422689|FG000|Overall Study|Lack of Insurance Coverage|0|||
145701541|NCT01952847|525422690|FG001|Overall Study|Lack of Insurance Coverage|1|||
145701542|NCT01952847|525422691|FG002|Overall Study|Lack of Insurance Coverage|0|||
145701543|NCT01952847|525422692|FG003|Overall Study|Lack of Insurance Coverage|0|||
145701544|NCT01952847|525422689|FG000|Overall Study|Withdrawal by Subject|1|||
145701545|NCT01952847|525422690|FG001|Overall Study|Withdrawal by Subject|1|||
145701546|NCT01952847|525422691|FG002|Overall Study|Withdrawal by Subject|0|||
145701547|NCT01952847|525422692|FG003|Overall Study|Withdrawal by Subject|1|||
145701548|NCT01234883|525422693|FG000|Overall Study|Early treatment release|8|||
145701549|NCT01234883|525422694|FG001|Overall Study|Early treatment release|10|||
145701550|NCT01234883|525422693|FG000|Overall Study|Parent/guardian withdrew consent|1|||
145701551|NCT01234883|525422694|FG001|Overall Study|Parent/guardian withdrew consent|2|||
145701552|NCT01234883|525422693|FG000|Overall Study|Technical difficulties with IV infusion|0|||
145701553|NCT01234883|525422694|FG001|Overall Study|Technical difficulties with IV infusion|1|||
145701554|NCT01234883|525422693|FG000|Overall Study|Inclusion/exclusion failure|1|||
145701555|NCT01234883|525422694|FG001|Overall Study|Inclusion/exclusion failure|0|||
145701556|NCT04351269|525422695|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
145701557|NCT04351269|525422696|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
145701558|NCT04351269|525422697|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
145701559|NCT04351269|525422695|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
145701560|NCT04351269|525422696|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
145701561|NCT04351269|525422697|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
145701562|NCT04351269|525422695|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
145701563|NCT04351269|525422696|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
145701564|NCT04351269|525422697|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
145701565|NCT04351269|525422695|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
145701566|NCT04351269|525422696|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
145701567|NCT04351269|525422697|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
145701568|NCT04351269|525422695|FG000|Overall Study|Lost to Follow-up|1|||
145701569|NCT04351269|525422696|FG001|Overall Study|Lost to Follow-up|3|||
145701570|NCT04351269|525422697|FG002|Overall Study|Lost to Follow-up|0|||
145701571|NCT01013961|525422698|FG000|Overall Study|Adverse Event|2|||
145701572|NCT01013961|525422699|FG001|Overall Study|Adverse Event|2|||
145701573|NCT01013961|525422698|FG000|Overall Study|Withdrawal by Subject|1|||
145701574|NCT01013961|525422699|FG001|Overall Study|Withdrawal by Subject|0|||
145701575|NCT01013961|525422698|FG000|Overall Study|Physician Decision|0|||
145701576|NCT01013961|525422699|FG001|Overall Study|Physician Decision|1|||
145701577|NCT00632021|525422704|FG000|Overall Study|Withdrawal/death|4|||
145701578|NCT00632021|525422705|FG001|Overall Study|Withdrawal/death|7|||
145701579|NCT01807182|525422708|FG000|Overall Study|Death|1|||
145701580|NCT01807182|525422708|FG000|Overall Study|New therapy|1|||
145701581|NCT01807182|525422708|FG000|Overall Study|Moved to hospice care|1|||
145701582|NCT03513068|525422709|FG000|Overall Study|Death|1|||
145701583|NCT03513068|525422710|FG001|Overall Study|Death|0|||
145701584|NCT03513068|525422709|FG000|Overall Study|Withdrawal by Subject|4|||
145701585|NCT03513068|525422710|FG001|Overall Study|Withdrawal by Subject|6|||
145701586|NCT00778921|525422711|FG000|Overall Study|Adverse Event|9|||
145701587|NCT00778921|525422712|FG001|Overall Study|Adverse Event|10|||
145701588|NCT00778921|525422713|FG002|Overall Study|Adverse Event|14|||
145701589|NCT00778921|525422711|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
145701590|NCT00778921|525422712|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
145701591|NCT00778921|525422713|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
145701592|NCT00778921|525422711|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
145701593|NCT00778921|525422712|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
145701594|NCT00778921|525422713|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
145701595|NCT00778921|525422711|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
145701596|NCT00778921|525422712|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
145701597|NCT00778921|525422713|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
145701598|NCT00778921|525422711|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
145701599|NCT00778921|525422712|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
145701600|NCT00778921|525422713|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
145701601|NCT00778921|525422711|FG000|Overall Study|Patient withdrew request|3|||
145701602|NCT00778921|525422712|FG001|Overall Study|Patient withdrew request|1|||
145701603|NCT00778921|525422713|FG002|Overall Study|Patient withdrew request|6|||
145701604|NCT00778921|525422711|FG000|Overall Study|Lost to Follow-up|0|||
145701605|NCT00778921|525422712|FG001|Overall Study|Lost to Follow-up|2|||
145701606|NCT00778921|525422713|FG002|Overall Study|Lost to Follow-up|1|||
145701607|NCT00778921|525422711|FG000|Overall Study|Administrative Problems|1|||
145701608|NCT00778921|525422712|FG001|Overall Study|Administrative Problems|2|||
145701609|NCT00778921|525422713|FG002|Overall Study|Administrative Problems|0|||
145701610|NCT00778921|525422711|FG000|Overall Study|Protocol Violation|3|||
145701611|NCT00778921|525422712|FG001|Overall Study|Protocol Violation|0|||
145701612|NCT00778921|525422713|FG002|Overall Study|Protocol Violation|2|||
145701613|NCT00778921|525422711|FG000|Overall Study|Not treated|0|||
145701614|NCT00778921|525422712|FG001|Overall Study|Not treated|2|||
145701615|NCT00778921|525422713|FG002|Overall Study|Not treated|2|||
145701616|NCT01791413|525422714|FG000|Overall Study|Lost to Follow-up|5|||
145701617|NCT01791413|525422715|FG001|Overall Study|Lost to Follow-up|1|||
145701618|NCT01078922|525422716|FG000|Overall Study|Adverse Event|1|||
145701619|NCT01236352|525422717|FG000|Overall Study|Death|0|||
145701620|NCT01236352|525422718|FG001|Overall Study|Death|0|||
145701621|NCT01236352|525422719|FG002|Overall Study|Death|0|||
145701622|NCT01236352|525422720|FG003|Overall Study|Death|0|||
145701623|NCT01236352|525422721|FG004|Overall Study|Death|0|||
145701624|NCT01236352|525422722|FG005|Overall Study|Death|0|||
145701625|NCT01236352|525422723|FG006|Overall Study|Death|0|||
145701626|NCT01236352|525422724|FG007|Overall Study|Death|1|||
145701627|NCT01236352|525422725|FG008|Overall Study|Death|0|||
145701628|NCT01236352|525422726|FG009|Overall Study|Death|0|||
145701629|NCT01236352|525422727|FG010|Overall Study|Death|0|||
145701630|NCT01236352|525422717|FG000|Overall Study|Withdrawal by Subject|0|||
145701631|NCT01236352|525422718|FG001|Overall Study|Withdrawal by Subject|0|||
145701632|NCT01236352|525422719|FG002|Overall Study|Withdrawal by Subject|0|||
145701633|NCT01236352|525422720|FG003|Overall Study|Withdrawal by Subject|0|||
145701634|NCT01236352|525422721|FG004|Overall Study|Withdrawal by Subject|0|||
145701635|NCT01236352|525422722|FG005|Overall Study|Withdrawal by Subject|0|||
145701636|NCT01236352|525422723|FG006|Overall Study|Withdrawal by Subject|0|||
145701637|NCT01236352|525422724|FG007|Overall Study|Withdrawal by Subject|0|||
145701638|NCT01236352|525422725|FG008|Overall Study|Withdrawal by Subject|0|||
145701639|NCT01236352|525422726|FG009|Overall Study|Withdrawal by Subject|2|||
145701640|NCT01236352|525422727|FG010|Overall Study|Withdrawal by Subject|1|||
145701641|NCT01236352|525422717|FG000|Overall Study|Adverse Event|0|||
145701642|NCT01236352|525422718|FG001|Overall Study|Adverse Event|0|||
145701643|NCT01236352|525422719|FG002|Overall Study|Adverse Event|0|||
145701644|NCT01236352|525422720|FG003|Overall Study|Adverse Event|0|||
145701645|NCT01236352|525422721|FG004|Overall Study|Adverse Event|0|||
145701646|NCT01236352|525422722|FG005|Overall Study|Adverse Event|0|||
145701647|NCT01236352|525422723|FG006|Overall Study|Adverse Event|2|||
145701648|NCT01236352|525422724|FG007|Overall Study|Adverse Event|0|||
145701649|NCT01236352|525422725|FG008|Overall Study|Adverse Event|0|||
145701650|NCT01236352|525422726|FG009|Overall Study|Adverse Event|4|||
145701651|NCT01236352|525422727|FG010|Overall Study|Adverse Event|1|||
145701652|NCT01236352|525422717|FG000|Overall Study|Study drug toxicity|0|||
145701653|NCT01236352|525422718|FG001|Overall Study|Study drug toxicity|0|||
145701654|NCT01236352|525422719|FG002|Overall Study|Study drug toxicity|0|||
145701655|NCT01236352|525422720|FG003|Overall Study|Study drug toxicity|0|||
145701656|NCT01236352|525422721|FG004|Overall Study|Study drug toxicity|0|||
145701657|NCT01236352|525422722|FG005|Overall Study|Study drug toxicity|1|||
145701658|NCT01236352|525422723|FG006|Overall Study|Study drug toxicity|1|||
145701659|NCT01236352|525422724|FG007|Overall Study|Study drug toxicity|0|||
145701660|NCT01236352|525422725|FG008|Overall Study|Study drug toxicity|0|||
145701661|NCT01236352|525422726|FG009|Overall Study|Study drug toxicity|2|||
145701662|NCT01236352|525422727|FG010|Overall Study|Study drug toxicity|2|||
145701663|NCT01236352|525422717|FG000|Overall Study|Disease progression|1|||
145701664|NCT01236352|525422718|FG001|Overall Study|Disease progression|2|||
145701665|NCT01236352|525422719|FG002|Overall Study|Disease progression|1|||
145701666|NCT01236352|525422720|FG003|Overall Study|Disease progression|2|||
145701667|NCT01236352|525422721|FG004|Overall Study|Disease progression|2|||
145701668|NCT01236352|525422722|FG005|Overall Study|Disease progression|2|||
145701669|NCT01236352|525422723|FG006|Overall Study|Disease progression|1|||
145701670|NCT01236352|525422724|FG007|Overall Study|Disease progression|3|||
145701671|NCT01236352|525422725|FG008|Overall Study|Disease progression|2|||
145701672|NCT01236352|525422726|FG009|Overall Study|Disease progression|2|||
145701673|NCT01236352|525422727|FG010|Overall Study|Disease progression|2|||
145701674|NCT01236352|525422717|FG000|Overall Study|Poor/Non-compliance|1|||
145701675|NCT01236352|525422718|FG001|Overall Study|Poor/Non-compliance|0|||
145701676|NCT01236352|525422719|FG002|Overall Study|Poor/Non-compliance|0|||
145701677|NCT01236352|525422720|FG003|Overall Study|Poor/Non-compliance|0|||
145701678|NCT01236352|525422721|FG004|Overall Study|Poor/Non-compliance|0|||
145701679|NCT01236352|525422722|FG005|Overall Study|Poor/Non-compliance|0|||
145701680|NCT01236352|525422723|FG006|Overall Study|Poor/Non-compliance|0|||
145701681|NCT01236352|525422724|FG007|Overall Study|Poor/Non-compliance|0|||
145701682|NCT01236352|525422725|FG008|Overall Study|Poor/Non-compliance|0|||
145701683|NCT01236352|525422726|FG009|Overall Study|Poor/Non-compliance|0|||
145701684|NCT01236352|525422727|FG010|Overall Study|Poor/Non-compliance|0|||
145701685|NCT01236352|525422717|FG000|Overall Study|Maximum clinical benefit|1|||
145701686|NCT01236352|525422718|FG001|Overall Study|Maximum clinical benefit|1|||
145701687|NCT01236352|525422719|FG002|Overall Study|Maximum clinical benefit|1|||
145701688|NCT01236352|525422720|FG003|Overall Study|Maximum clinical benefit|0|||
145701689|NCT01236352|525422721|FG004|Overall Study|Maximum clinical benefit|2|||
145701690|NCT01236352|525422722|FG005|Overall Study|Maximum clinical benefit|0|||
145701691|NCT01236352|525422723|FG006|Overall Study|Maximum clinical benefit|3|||
145701692|NCT01236352|525422724|FG007|Overall Study|Maximum clinical benefit|1|||
145701693|NCT01236352|525422725|FG008|Overall Study|Maximum clinical benefit|1|||
145701694|NCT01236352|525422726|FG009|Overall Study|Maximum clinical benefit|4|||
145701695|NCT01236352|525422727|FG010|Overall Study|Maximum clinical benefit|2|||
145701696|NCT01236352|525422717|FG000|Overall Study|Subject request to discontinue treatment|0|||
145701697|NCT01236352|525422718|FG001|Overall Study|Subject request to discontinue treatment|0|||
145701698|NCT01236352|525422719|FG002|Overall Study|Subject request to discontinue treatment|1|||
145701699|NCT01236352|525422720|FG003|Overall Study|Subject request to discontinue treatment|1|||
145701700|NCT01236352|525422721|FG004|Overall Study|Subject request to discontinue treatment|0|||
145701701|NCT01236352|525422722|FG005|Overall Study|Subject request to discontinue treatment|1|||
145701702|NCT01236352|525422723|FG006|Overall Study|Subject request to discontinue treatment|0|||
145701703|NCT01236352|525422724|FG007|Overall Study|Subject request to discontinue treatment|0|||
145701704|NCT01236352|525422725|FG008|Overall Study|Subject request to discontinue treatment|0|||
145701705|NCT01236352|525422726|FG009|Overall Study|Subject request to discontinue treatment|1|||
145701706|NCT01236352|525422727|FG010|Overall Study|Subject request to discontinue treatment|4|||
145701707|NCT01236352|525422717|FG000|Overall Study|Subject to receive drug via EAP|1|||
145701708|NCT01236352|525422718|FG001|Overall Study|Subject to receive drug via EAP|1|||
145701709|NCT01236352|525422719|FG002|Overall Study|Subject to receive drug via EAP|1|||
145701710|NCT01236352|525422720|FG003|Overall Study|Subject to receive drug via EAP|0|||
145701711|NCT01236352|525422721|FG004|Overall Study|Subject to receive drug via EAP|0|||
145701712|NCT01236352|525422722|FG005|Overall Study|Subject to receive drug via EAP|0|||
145701713|NCT01236352|525422723|FG006|Overall Study|Subject to receive drug via EAP|0|||
145701714|NCT01236352|525422724|FG007|Overall Study|Subject to receive drug via EAP|2|||
145701715|NCT01236352|525422725|FG008|Overall Study|Subject to receive drug via EAP|0|||
145701716|NCT01236352|525422726|FG009|Overall Study|Subject to receive drug via EAP|4|||
145701717|NCT01236352|525422727|FG010|Overall Study|Subject to receive drug via EAP|0|||
145701718|NCT01236352|525422717|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
145701719|NCT01236352|525422718|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
145701720|NCT01236352|525422719|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
145701721|NCT01236352|525422720|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
145701722|NCT01236352|525422721|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
145701723|NCT01236352|525422722|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
145701724|NCT01236352|525422723|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
145701725|NCT01236352|525422724|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
145701726|NCT01236352|525422725|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
145701727|NCT01236352|525422726|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
145701728|NCT01236352|525422727|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
145701729|NCT01236352|525422717|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701730|NCT01236352|525422718|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701731|NCT01236352|525422719|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701732|NCT01236352|525422720|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701733|NCT01236352|525422721|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701734|NCT01236352|525422722|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701735|NCT01236352|525422723|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701736|NCT01236352|525422724|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701737|NCT01236352|525422725|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701738|NCT01236352|525422726|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
145701739|NCT01236352|525422727|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
145701740|NCT01236352|525422717|FG000|Overall Study|Lack of response to drug|0|||
145701741|NCT01236352|525422718|FG001|Overall Study|Lack of response to drug|0|||
145701742|NCT01236352|525422719|FG002|Overall Study|Lack of response to drug|0|||
145701743|NCT01236352|525422720|FG003|Overall Study|Lack of response to drug|0|||
145701744|NCT01236352|525422721|FG004|Overall Study|Lack of response to drug|0|||
145701745|NCT01236352|525422722|FG005|Overall Study|Lack of response to drug|0|||
145701746|NCT01236352|525422723|FG006|Overall Study|Lack of response to drug|0|||
145701747|NCT01236352|525422724|FG007|Overall Study|Lack of response to drug|0|||
145701748|NCT01236352|525422725|FG008|Overall Study|Lack of response to drug|0|||
145701749|NCT01236352|525422726|FG009|Overall Study|Lack of response to drug|1|||
145701750|NCT01236352|525422727|FG010|Overall Study|Lack of response to drug|1|||
145701751|NCT01236352|525422717|FG000|Overall Study|Patient transferred to IST|0|||
145701752|NCT01236352|525422718|FG001|Overall Study|Patient transferred to IST|0|||
145701753|NCT01236352|525422719|FG002|Overall Study|Patient transferred to IST|0|||
145701754|NCT01236352|525422720|FG003|Overall Study|Patient transferred to IST|0|||
145701755|NCT01236352|525422721|FG004|Overall Study|Patient transferred to IST|0|||
145701756|NCT01236352|525422722|FG005|Overall Study|Patient transferred to IST|0|||
145701757|NCT01236352|525422723|FG006|Overall Study|Patient transferred to IST|0|||
145701758|NCT01236352|525422724|FG007|Overall Study|Patient transferred to IST|0|||
145701759|NCT01236352|525422725|FG008|Overall Study|Patient transferred to IST|0|||
145701760|NCT01236352|525422726|FG009|Overall Study|Patient transferred to IST|2|||
145701761|NCT01236352|525422727|FG010|Overall Study|Patient transferred to IST|6|||
145701762|NCT02031536|525422728|FG000|Overall Study|ineligible|1|||
145701763|NCT02031536|525422729|FG001|Overall Study|ineligible|0|||
145701764|NCT01850030|525422730|FG000|Overall Study|Adverse Event|64|||
145701765|NCT01850030|525422731|FG001|Overall Study|Adverse Event|82|||
145701766|NCT01850030|525422730|FG000|Overall Study|Lack of Efficacy|3|||
145701767|NCT01850030|525422731|FG001|Overall Study|Lack of Efficacy|1|||
145701768|NCT01850030|525422730|FG000|Overall Study|Lost to Follow-up|5|||
145701769|NCT01850030|525422731|FG001|Overall Study|Lost to Follow-up|5|||
145701770|NCT01850030|525422730|FG000|Overall Study|Withdrawal by Subject|3|||
145701771|NCT01850030|525422731|FG001|Overall Study|Withdrawal by Subject|4|||
145701772|NCT01850030|525422730|FG000|Overall Study|Protocol Violation|24|||
145701773|NCT01850030|525422731|FG001|Overall Study|Protocol Violation|28|||
145701774|NCT01850030|525422730|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
145701775|NCT01850030|525422731|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
145701776|NCT03845023|525422733|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
145701777|NCT03845023|525422734|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
145701778|NCT03845023|525422735|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
145701779|NCT03845023|525422736|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
145701780|NCT03845023|525422733|FG000|Follow-Up (14 Days)|Adverse Event|0|||
145701781|NCT03845023|525422734|FG001|Follow-Up (14 Days)|Adverse Event|0|||
145701782|NCT03845023|525422735|FG002|Follow-Up (14 Days)|Adverse Event|1|||
145701783|NCT03845023|525422736|FG003|Follow-Up (14 Days)|Adverse Event|1|||
145701784|NCT02353871|525422737|FG000|Overall Study|Protocol deviation|0|||
145701785|NCT02353871|525422738|FG001|Overall Study|Protocol deviation|1|||
145701786|NCT02353871|525422737|FG000|Overall Study|Consent withdrawn|1|||
145701787|NCT02353871|525422738|FG001|Overall Study|Consent withdrawn|8|||
145701788|NCT02353871|525422737|FG000|Overall Study|Lost to Follow-up|2|||
145701789|NCT02353871|525422738|FG001|Overall Study|Lost to Follow-up|0|||
145701790|NCT00115336|525422739|FG000|Overall Study|Hospital discharge before study drug|0|||
145701791|NCT00115336|525422740|FG001|Overall Study|Hospital discharge before study drug|1|||
145701792|NCT02554383|525422741|FG000|Overall Study|Ineligible|3|||
145701793|NCT02554383|525422742|FG001|Overall Study|Ineligible|2|||
145701794|NCT02554383|525422741|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
145701795|NCT02554383|525422742|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
145701796|NCT02554383|525422741|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
145701797|NCT02554383|525422742|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
145701798|NCT02554383|525422741|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
145701799|NCT02554383|525422742|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
145701800|NCT02394665|525422745|FG000|Overall Study|Physician Decision|1|||
145701801|NCT02394665|525422746|FG001|Overall Study|Physician Decision|0|||
145701802|NCT02394665|525422747|FG002|Overall Study|Physician Decision|0|||
145701803|NCT03371823|525422750|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
145701804|NCT03371823|525422751|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
145701805|NCT05093504|525422753|FG000|Overall Study|Death|0|||
145701806|NCT05093504|525422754|FG001|Overall Study|Death|1|||
145701807|NCT05347485|525422759|FG000|Overall Study|Death|14|||
145701808|NCT05347485|525422759|FG000|Overall Study|Lost to Follow-up|2|||
145701809|NCT05347485|525422759|FG000|Overall Study|Withdrawal by Subject|13|||
145701810|NCT05347485|525422759|FG000|Overall Study|Progressive Disease|1|||
145701811|NCT05347485|525422759|FG000|Overall Study|Study Terminated by Sponsor|49|||
145701812|NCT05347485|525422759|FG000|Overall Study|Other|1|||
145701813|NCT05347485|525422759|FG000|Overall Study|Enrolled (consented) but not treated|4|||
145701814|NCT05347485|525422759|FG000|Overall Study|Disease Relapse|2|||
145701815|NCT04886518|525422760|FG000|Overall Study|Noncompliance with study drug|1|||
145701816|NCT04886518|525422761|FG001|Overall Study|Noncompliance with study drug|0|||
145701817|NCT04886518|525422762|FG002|Overall Study|Noncompliance with study drug|0|||
145701818|NCT04886518|525422760|FG000|Overall Study|Adverse Event|0|||
145701819|NCT04886518|525422761|FG001|Overall Study|Adverse Event|1|||
145701820|NCT04886518|525422762|FG002|Overall Study|Adverse Event|0|||
145701821|NCT04886518|525422760|FG000|Overall Study|Withdrawal by Subject|1|||
145701822|NCT04886518|525422761|FG001|Overall Study|Withdrawal by Subject|0|||
145701823|NCT04886518|525422762|FG002|Overall Study|Withdrawal by Subject|0|||
145701824|NCT00127842|525424015|FG000|Overall Study|Adverse Event|15|||
145701825|NCT00127842|525424015|FG000|Overall Study|Withdrawal by Subject|3|||
145377862|NCT03191864|524233637|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145701826|NCT00127842|525424015|FG000|Overall Study|Lost to Follow-up|1|||
145701827|NCT00127842|525424015|FG000|Overall Study|Lack of Efficacy|12|||
145701828|NCT00127842|525424015|FG000|Overall Study|Noncompliance|2|||
145701829|NCT00127842|525424015|FG000|Overall Study|Protocol Violation|1|||
145701830|NCT00127842|525424015|FG000|Overall Study|Other|5|||
145701831|NCT01730950|525424016|FG000|Overall Study|Protocol Violation|6|||
145701832|NCT01730950|525424017|FG001|Overall Study|Protocol Violation|6|||
145701833|NCT00667459|525424018|FG000|Overall Study|Death|0|||
145701834|NCT00667459|525424019|FG001|Overall Study|Death|2|||
145701835|NCT00667459|525424018|FG000|Overall Study|Lost to Follow-up|8|||
145701836|NCT00667459|525424019|FG001|Overall Study|Lost to Follow-up|43|||
145701837|NCT02568397|525424020|FG000|Period 2|Withdrawal by Subject|0|||
145701838|NCT02568397|525424021|FG001|Period 2|Withdrawal by Subject|1|||
145701839|NCT02568397|525424020|FG000|Period 2|Physician Decision|0|||
145701840|NCT02568397|525424021|FG001|Period 2|Physician Decision|1|||
145701841|NCT00581893|525424022|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
145701842|NCT00581893|525424023|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
145701843|NCT02684123|525424024|FG000|Phase 1|Lack of Efficacy|5|||
145701844|NCT02684123|525424025|FG001|Phase 1|Lack of Efficacy|0|||
145701845|NCT02684123|525424024|FG000|Phase 1|Adverse Event|3|||
145701846|NCT02684123|525424025|FG001|Phase 1|Adverse Event|0|||
145701847|NCT02684123|525424024|FG000|Phase 1|Lost to Follow-up|0|||
145701848|NCT02684123|525424025|FG001|Phase 1|Lost to Follow-up|1|||
145701849|NCT02684123|525424024|FG000|Phase 2|Lack of Efficacy|1|||
145701850|NCT02684123|525424025|FG001|Phase 2|Lack of Efficacy|8|||
145701851|NCT02367352|525424038|FG000|Overall Study|Progressive disease|7|||
145701852|NCT02367352|525424039|FG001|Overall Study|Progressive disease|0|||
145701853|NCT02367352|525424040|FG002|Overall Study|Progressive disease|0|||
145701854|NCT02367352|525424038|FG000|Overall Study|Participant Received Alternative Therapy|1|||
145701855|NCT02367352|525424039|FG001|Overall Study|Participant Received Alternative Therapy|0|||
145701856|NCT02367352|525424040|FG002|Overall Study|Participant Received Alternative Therapy|0|||
145701857|NCT02367352|525424038|FG000|Overall Study|Adverse Event|1|||
145701858|NCT02367352|525424039|FG001|Overall Study|Adverse Event|0|||
145701859|NCT02367352|525424040|FG002|Overall Study|Adverse Event|0|||
145701860|NCT01437423|525424041|FG000|Overall Study|Lost to Follow-up|12|||
145701861|NCT01437423|525424041|FG000|Overall Study|Off label usage|3|||
145701862|NCT05878873|525424042|FG000|Overall Study|Lost to Follow-up|2|||
145701863|NCT05878873|525424043|FG001|Overall Study|Lost to Follow-up|0|||
145701864|NCT01375751|525424044|FG000|Overall Study|Other|0|||
145701865|NCT01375751|525424045|FG001|Overall Study|Other|1|||
145701866|NCT01375751|525424046|FG002|Overall Study|Other|0|||
145701867|NCT02980523|525424047|FG000|Overall Study|Lost to Follow-up|1|||
145701868|NCT02980523|525424048|FG001|Overall Study|Lost to Follow-up|4|||
145701869|NCT02980523|525424049|FG002|Overall Study|Lost to Follow-up|1|||
145701870|NCT02980523|525424050|FG003|Overall Study|Lost to Follow-up|2|||
145701871|NCT02980523|525424051|FG004|Overall Study|Lost to Follow-up|1|||
145701872|NCT02980523|525424047|FG000|Overall Study|Excluded from analysis|1|||
145701873|NCT02980523|525424048|FG001|Overall Study|Excluded from analysis|3|||
145701874|NCT02980523|525424049|FG002|Overall Study|Excluded from analysis|1|||
145701875|NCT02980523|525424050|FG003|Overall Study|Excluded from analysis|1|||
145701876|NCT02980523|525424051|FG004|Overall Study|Excluded from analysis|1|||
145701877|NCT02980523|525424047|FG000|Overall Study|Lack of Efficacy|1|||
145701878|NCT02980523|525424048|FG001|Overall Study|Lack of Efficacy|4|||
145701879|NCT02980523|525424049|FG002|Overall Study|Lack of Efficacy|4|||
145701880|NCT02980523|525424050|FG003|Overall Study|Lack of Efficacy|5|||
145701881|NCT02980523|525424051|FG004|Overall Study|Lack of Efficacy|8|||
145701882|NCT02980523|525424047|FG000|Overall Study|Did not receive intervention|0|||
145701883|NCT02980523|525424048|FG001|Overall Study|Did not receive intervention|0|||
145701884|NCT02980523|525424049|FG002|Overall Study|Did not receive intervention|0|||
145701885|NCT02980523|525424050|FG003|Overall Study|Did not receive intervention|1|||
145701886|NCT02980523|525424051|FG004|Overall Study|Did not receive intervention|0|||
145701887|NCT00633945|525424052|FG000|Overall Study|Physician Decision|2|||
145701888|NCT02552147|525424053|FG000|First Intervention (7 Days)|Protocol Violation|1|||
145701889|NCT02552147|525424054|FG001|First Intervention (7 Days)|Protocol Violation|0|||
145701890|NCT02552147|525424053|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
145701891|NCT02552147|525424054|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
145701892|NCT00559377|525424055|FG000|Overall Study|Withdrawal by Subject|9|||
145701893|NCT00872001|525424061|FG000|Overall Study|Adverse Event|34|||
145701894|NCT00872001|525424062|FG001|Overall Study|Adverse Event|23|||
145701895|NCT00872001|525424061|FG000|Overall Study|Protocol Defined Clinical Event|5|||
145701896|NCT00872001|525424062|FG001|Overall Study|Protocol Defined Clinical Event|7|||
145701897|NCT00872001|525424061|FG000|Overall Study|Lost to Follow-up|13|||
145701898|NCT00872001|525424062|FG001|Overall Study|Lost to Follow-up|12|||
145701899|NCT00872001|525424061|FG000|Overall Study|Withdrawal by Subject|18|||
145701900|NCT00872001|525424062|FG001|Overall Study|Withdrawal by Subject|30|||
145701901|NCT00872001|525424061|FG000|Overall Study|Protocol Violation|5|||
145701902|NCT00872001|525424062|FG001|Overall Study|Protocol Violation|8|||
145701903|NCT00872001|525424061|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
145701904|NCT00872001|525424062|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
145701905|NCT00872001|525424061|FG000|Overall Study|Administrative|23|||
145701906|NCT00872001|525424062|FG001|Overall Study|Administrative|15|||
145701907|NCT01453023|525424065|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
145701908|NCT01453023|525424066|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
145701909|NCT01453023|525424065|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
145701910|NCT01453023|525424066|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
145701911|NCT01453023|525424065|FG000|Treatment Period 2|Protocol Violation|0|||
145701912|NCT01453023|525424066|FG001|Treatment Period 2|Protocol Violation|1|||
145701913|NCT04468230|525424069|FG000|Overall Study|Adverse Event|2|||
145701914|NCT01790295|525424071|FG000|Overall Study|Adverse Event|1|||
145701915|NCT01790295|525424071|FG000|Overall Study|Death|4|||
145701916|NCT01790295|525424071|FG000|Overall Study|Lack of Efficacy|2|||
145701917|NCT01790295|525424071|FG000|Overall Study|Study closure|4|||
145701918|NCT00420784|525424074|FG000|Overall Study|Adverse Event|11|||
145701919|NCT00420784|525424075|FG001|Overall Study|Adverse Event|29|||
145701920|NCT00420784|525424076|FG002|Overall Study|Adverse Event|10|||
145701921|NCT00420784|525424077|FG003|Overall Study|Adverse Event|5|||
145701922|NCT00420784|525424074|FG000|Overall Study|Withdrawal by Subject|0|||
145701923|NCT00420784|525424075|FG001|Overall Study|Withdrawal by Subject|1|||
145701924|NCT00420784|525424076|FG002|Overall Study|Withdrawal by Subject|0|||
145701925|NCT00420784|525424077|FG003|Overall Study|Withdrawal by Subject|0|||
145701926|NCT00420784|525424074|FG000|Overall Study|Lost to Follow-up|0|||
145701927|NCT00420784|525424075|FG001|Overall Study|Lost to Follow-up|0|||
145701928|NCT00420784|525424076|FG002|Overall Study|Lost to Follow-up|2|||
145701929|NCT00420784|525424077|FG003|Overall Study|Lost to Follow-up|1|||
145701930|NCT00420784|525424074|FG000|Overall Study|Virologic Stopping Rule|17|||
145701931|NCT00420784|525424075|FG001|Overall Study|Virologic Stopping Rule|26|||
145701932|NCT00420784|525424076|FG002|Overall Study|Virologic Stopping Rule|41|||
145701933|NCT00420784|525424077|FG003|Overall Study|Virologic Stopping Rule|67|||
145701934|NCT00420784|525424074|FG000|Overall Study|Other|1|||
145701935|NCT00420784|525424075|FG001|Overall Study|Other|2|||
145701936|NCT00420784|525424076|FG002|Overall Study|Other|0|||
145701937|NCT00420784|525424077|FG003|Overall Study|Other|5|||
145701938|NCT02417441|525424080|FG000|Overall Study|Inconclusive due to missing data|52|||
145701939|NCT02417441|525424081|FG001|Overall Study|Inconclusive due to missing data|19|||
145701940|NCT00983853|525424082|FG000|Overall Study|Lost to Follow-up|1|||
145701941|NCT00983853|525424083|FG001|Overall Study|Lost to Follow-up|1|||
145701942|NCT00983853|525424084|FG002|Overall Study|Lost to Follow-up|2|||
145701943|NCT00983853|525424085|FG003|Overall Study|Lost to Follow-up|2|||
145701944|NCT00983853|525424086|FG004|Overall Study|Lost to Follow-up|2|||
145701945|NCT00983853|525424087|FG005|Overall Study|Lost to Follow-up|1|||
145701946|NCT00983853|525424082|FG000|Overall Study|Withdrawal by Subject|0|||
145701947|NCT00983853|525424083|FG001|Overall Study|Withdrawal by Subject|0|||
145701948|NCT00983853|525424084|FG002|Overall Study|Withdrawal by Subject|1|||
145701949|NCT00983853|525424085|FG003|Overall Study|Withdrawal by Subject|0|||
145701950|NCT00983853|525424086|FG004|Overall Study|Withdrawal by Subject|1|||
145701951|NCT00983853|525424087|FG005|Overall Study|Withdrawal by Subject|0|||
145701952|NCT00983853|525424082|FG000|Overall Study|Unable to come to study follow-up visits|0|||
145701953|NCT00983853|525424083|FG001|Overall Study|Unable to come to study follow-up visits|1|||
145701954|NCT00983853|525424084|FG002|Overall Study|Unable to come to study follow-up visits|0|||
145701955|NCT00983853|525424085|FG003|Overall Study|Unable to come to study follow-up visits|0|||
145701956|NCT00983853|525424086|FG004|Overall Study|Unable to come to study follow-up visits|0|||
145701957|NCT00983853|525424087|FG005|Overall Study|Unable to come to study follow-up visits|0|||
145701958|NCT03016598|525424092|FG000|Overall Study|Lost to Follow-up|0|||
145701959|NCT03016598|525424093|FG001|Overall Study|Lost to Follow-up|2|||
145701960|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
145701961|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
145701962|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
145701963|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
145701964|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
145701965|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
145701966|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
145701967|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
145701968|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
145701969|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
145701970|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
145701971|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
145701972|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
145701973|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
145701974|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
145701975|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
145701976|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
145701977|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
145701978|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Missing|2|||
145701979|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Missing|1|||
145701980|NCT00443209|525424097|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
145701981|NCT00443209|525424098|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
145701982|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
145701983|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
145701984|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
145701985|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
145701986|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
145701987|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
145701988|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
145701989|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
145701990|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
145701991|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
145701992|NCT00443209|525424097|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
145701993|NCT00443209|525424098|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
145701994|NCT01318876|525424099|FG000|Day 8 Survey|email address invalid|96|||
145701995|NCT01318876|525424099|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
145701996|NCT01318876|525424099|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
145701997|NCT00825305|525424103|FG000|Overall Study|Adverse Event|1|||
145701998|NCT00825305|525424104|FG001|Overall Study|Adverse Event|1|||
145701999|NCT00825305|525424103|FG000|Overall Study|Withdrawal by Subject|6|||
145702000|NCT00825305|525424104|FG001|Overall Study|Withdrawal by Subject|12|||
145702001|NCT00825305|525424103|FG000|Overall Study|Inappropriate inclusion|1|||
145702002|NCT00825305|525424104|FG001|Overall Study|Inappropriate inclusion|0|||
145702003|NCT00825305|525424103|FG000|Overall Study|Protocol Violation|9|||
145702004|NCT00825305|525424104|FG001|Overall Study|Protocol Violation|9|||
145702005|NCT00825305|525424103|FG000|Overall Study|Can not be classified|0|||
145702006|NCT00825305|525424104|FG001|Overall Study|Can not be classified|1|||
145702007|NCT04016272|525424105|FG000|Overall Study|Withdrawal by Subject|1|||
145702008|NCT04016272|525424106|FG001|Overall Study|Withdrawal by Subject|2|||
145702009|NCT02353468|525424109|FG000|Overall Study|Study terminated|3|||
145702010|NCT00003477|525424110|FG000|Overall Study|Not evalauable|4|||
145702011|NCT00246090|525424113|FG000|Overall Study|Adverse Event|25|||
145702012|NCT00246090|525424113|FG000|Overall Study|Withdrawal by Subject|7|||
145702013|NCT00246090|525424113|FG000|Overall Study|Progressive Disease|212|||
145702014|NCT00246090|525424113|FG000|Overall Study|Clinical Progression|30|||
145702015|NCT00246090|525424113|FG000|Overall Study|Physician Decision|11|||
145702016|NCT00246090|525424113|FG000|Overall Study|Not Otherwise Specified|10|||
145702017|NCT01827046|525424119|FG000|Overall Study|Lost to Follow-up|1|||
145702018|NCT01827046|525424120|FG001|Overall Study|Lost to Follow-up|5|||
145702019|NCT01827046|525424119|FG000|Overall Study|Withdrawal by Subject|0|||
145702020|NCT01827046|525424120|FG001|Overall Study|Withdrawal by Subject|4|||
145702021|NCT00715117|525424128|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
145702022|NCT00715117|525424129|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
145702023|NCT01191008|525424133|FG000|Overall Study|Protocol Violation|7|||
145702024|NCT01191008|525424133|FG000|Overall Study|Lost to Follow-up|8|||
145702025|NCT00978562|525424134|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
145702026|NCT01806389|525424137|FG000|Overall Study|Withdrawal by Subject|4|||
145702027|NCT00926575|525424138|FG000|Overall Study|Adverse Event|1|||
145702028|NCT00926575|525424139|FG001|Overall Study|Adverse Event|1|||
145702029|NCT00926575|525424138|FG000|Overall Study|Death|4|||
145702030|NCT00926575|525424139|FG001|Overall Study|Death|4|||
145702031|NCT00926575|525424138|FG000|Overall Study|Lost to Follow-up|1|||
145702032|NCT00926575|525424139|FG001|Overall Study|Lost to Follow-up|1|||
145702033|NCT00926575|525424138|FG000|Overall Study|Physician Decision|1|||
145702034|NCT00926575|525424139|FG001|Overall Study|Physician Decision|2|||
145702035|NCT00926575|525424138|FG000|Overall Study|Protocol Violation|1|||
145702036|NCT00926575|525424139|FG001|Overall Study|Protocol Violation|0|||
145702037|NCT00926575|525424138|FG000|Overall Study|Withdrawal by Subject|8|||
145702038|NCT00926575|525424139|FG001|Overall Study|Withdrawal by Subject|9|||
145702039|NCT02559310|525424145|FG000|Overall Study|Death|4|||
145702040|NCT02559310|525424146|FG001|Overall Study|Death|3|||
145702041|NCT02559310|525424145|FG000|Overall Study|Lost to Follow-up|5|||
145702042|NCT02559310|525424146|FG001|Overall Study|Lost to Follow-up|3|||
145702043|NCT02559310|525424145|FG000|Overall Study|Physician Decision|2|||
145702044|NCT02559310|525424146|FG001|Overall Study|Physician Decision|1|||
145702045|NCT02559310|525424145|FG000|Overall Study|Withdrawal by Subject|13|||
145702046|NCT02559310|525424146|FG001|Overall Study|Withdrawal by Subject|9|||
145702047|NCT02559310|525424145|FG000|Overall Study|Sponsor Decision|0|||
145702048|NCT02559310|525424146|FG001|Overall Study|Sponsor Decision|1|||
145702049|NCT02559310|525424145|FG000|Overall Study|Randomized but not treated|3|||
145702050|NCT02559310|525424146|FG001|Overall Study|Randomized but not treated|2|||
145702051|NCT03595878|525424147|FG000|Overall Study|Death|2|||
145702052|NCT03595878|525424148|FG001|Overall Study|Death|1|||
145702053|NCT03595878|525424149|FG002|Overall Study|Death|0|||
145702054|NCT03595878|525424147|FG000|Overall Study|Disease progression|2|||
145702055|NCT03595878|525424148|FG001|Overall Study|Disease progression|1|||
145702056|NCT03595878|525424149|FG002|Overall Study|Disease progression|2|||
145377863|NCT03191864|524233638|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145377864|NCT03191864|524233639|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
145702057|NCT03494985|525424150|FG000|Overall Study|Adverse Event|3|||
145702058|NCT03494985|525424151|FG001|Overall Study|Adverse Event|2|||
145702059|NCT03494985|525424152|FG002|Overall Study|Adverse Event|3|||
145702060|NCT03494985|525424153|FG003|Overall Study|Adverse Event|0|||
145702061|NCT03494985|525424150|FG000|Overall Study|Other (Withdrawal of consent)|2|||
145702062|NCT03494985|525424151|FG001|Overall Study|Other (Withdrawal of consent)|3|||
145702063|NCT03494985|525424152|FG002|Overall Study|Other (Withdrawal of consent)|2|||
145702064|NCT03494985|525424153|FG003|Overall Study|Other (Withdrawal of consent)|5|||
145702065|NCT03494985|525424150|FG000|Overall Study|Other (Not specified)|0|||
145702066|NCT03494985|525424151|FG001|Overall Study|Other (Not specified)|1|||
145702067|NCT03494985|525424152|FG002|Overall Study|Other (Not specified)|1|||
145702068|NCT03494985|525424153|FG003|Overall Study|Other (Not specified)|0|||
145702069|NCT04124471|525424154|FG000|Overall Study|screen failure|1|||
145702070|NCT03036124|525424155|FG000|Overall Study|Lost to Follow-up|0|||
145702071|NCT03036124|525424156|FG001|Overall Study|Lost to Follow-up|2|||
145702072|NCT03036124|525424155|FG000|Overall Study|Withdrawal by Subject|5|||
145702073|NCT03036124|525424156|FG001|Overall Study|Withdrawal by Subject|4|||
145702074|NCT02282059|525424157|FG000|Overall Study|Other|15|||
145702075|NCT02282059|525424158|FG001|Overall Study|Other|3|||
145702076|NCT02282059|525424157|FG000|Overall Study|Participant refused further follow-up|8|||
145702077|NCT02282059|525424158|FG001|Overall Study|Participant refused further follow-up|4|||
145702078|NCT02282059|525424157|FG000|Overall Study|Lost to Follow-up|19|||
145702079|NCT02282059|525424158|FG001|Overall Study|Lost to Follow-up|3|||
145702080|NCT02282059|525424157|FG000|Overall Study|Death|40|||
145702081|NCT02282059|525424158|FG001|Overall Study|Death|8|||
145702082|NCT02394925|525424159|FG000|Overall Study|Adverse Event|1|||
145702083|NCT02394925|525424159|FG000|Overall Study|Lens Discomfort|3|||
145702084|NCT02394925|525424159|FG000|Overall Study|Lens handling difficulities|5|||
145702085|NCT02394925|525424159|FG000|Overall Study|Lost to Follow-up|9|||
145702086|NCT02394925|525424159|FG000|Overall Study|Protocol Violation|5|||
145702087|NCT02394925|525424159|FG000|Overall Study|No longer meet eligibility criteria|1|||
145702088|NCT02394925|525424159|FG000|Overall Study|Unsatisfactory Visual Response|5|||
145702089|NCT01245140|525426063|FG000|Overall Study|Adverse Event|1|||
145702090|NCT01245140|525426064|FG001|Overall Study|Adverse Event|3|||
145702091|NCT01245140|525426063|FG000|Overall Study|Lack of Efficacy|2|||
145702092|NCT01245140|525426064|FG001|Overall Study|Lack of Efficacy|4|||
145702093|NCT01245140|525426063|FG000|Overall Study|Protocol Violation|0|||
145702094|NCT01245140|525426064|FG001|Overall Study|Protocol Violation|1|||
145702095|NCT01245140|525426063|FG000|Overall Study|Withdrawal by Subject|0|||
145702096|NCT01245140|525426064|FG001|Overall Study|Withdrawal by Subject|1|||
145702097|NCT01245140|525426063|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
145702098|NCT01245140|525426064|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
145702099|NCT02635360|525426065|FG000|Overall Study|Adverse Event|0|||
145702100|NCT02635360|525426066|FG001|Overall Study|Adverse Event|3|||
145702101|NCT02635360|525426065|FG000|Overall Study|Withdrawal by Subject|2|||
145702102|NCT02635360|525426066|FG001|Overall Study|Withdrawal by Subject|0|||
145702103|NCT02635360|525426065|FG000|Overall Study|Non-Compliance|3|||
145702104|NCT02635360|525426066|FG001|Overall Study|Non-Compliance|1|||
145702105|NCT02635360|525426065|FG000|Overall Study|Disease Progression|0|||
145702106|NCT02635360|525426066|FG001|Overall Study|Disease Progression|2|||
145702107|NCT02635360|525426065|FG000|Overall Study|Lost to Follow-up|1|||
145702108|NCT02635360|525426066|FG001|Overall Study|Lost to Follow-up|1|||
145702109|NCT00334542|525426067|FG000|Overall Study|Adverse Event|3|||
145702110|NCT00334542|525426067|FG000|Overall Study|Withdrawal by Subject|1|||
145702111|NCT00334542|525426067|FG000|Overall Study|New cancer diagnosis|1|||
145702112|NCT01454739|525426072|FG000|Overall Study|Protocol Violation|2|||
145702113|NCT01454739|525426073|FG001|Overall Study|Protocol Violation|3|||
145702114|NCT01454739|525426072|FG000|Overall Study|Withdrawal by Subject|2|||
145702115|NCT01454739|525426073|FG001|Overall Study|Withdrawal by Subject|6|||
145702116|NCT01454739|525426072|FG000|Overall Study|Other|3|||
145702117|NCT01454739|525426073|FG001|Overall Study|Other|5|||
145702118|NCT01454739|525426072|FG000|Overall Study|Physician Decision|0|||
145702119|NCT01454739|525426073|FG001|Overall Study|Physician Decision|5|||
145702120|NCT01454739|525426072|FG000|Overall Study|Lost to Follow-up|0|||
145702121|NCT01454739|525426073|FG001|Overall Study|Lost to Follow-up|1|||
145702122|NCT01454739|525426072|FG000|Overall Study|Adverse Event|0|||
145702123|NCT01454739|525426073|FG001|Overall Study|Adverse Event|1|||
145702124|NCT02375347|525426088|FG000|Overall Study|Protocol Violation|1|||
145702125|NCT00193479|525426089|FG000|Induction Chemotherapy|Adverse Event|2|||
145702126|NCT00193479|525426089|FG000|Induction Chemotherapy|Disease Progression|1|||
145702127|NCT00193479|525426089|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
145702128|NCT00193479|525426089|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
145702129|NCT01547598|525426090|FG000|Overall Study|Withdrew consent|1|||
145702130|NCT01547598|525426091|FG001|Overall Study|Withdrew consent|1|||
145702131|NCT01547598|525426090|FG000|Overall Study|Lost to Follow-up|1|||
145702132|NCT01547598|525426091|FG001|Overall Study|Lost to Follow-up|1|||
145702133|NCT01547598|525426090|FG000|Overall Study|Adverse Event|1|||
145702134|NCT01547598|525426091|FG001|Overall Study|Adverse Event|1|||
145702135|NCT01547598|525426090|FG000|Overall Study|Protocol Violation|1|||
145702136|NCT01547598|525426091|FG001|Overall Study|Protocol Violation|1|||
145702137|NCT01547598|525426090|FG000|Overall Study|Other Miscellaneous Reasons|2|||
145702138|NCT01547598|525426091|FG001|Overall Study|Other Miscellaneous Reasons|1|||
145702139|NCT02229227|525426096|FG000|Overall Study|Adverse Event|14|||
145702140|NCT02229227|525426097|FG001|Overall Study|Adverse Event|9|||
145702141|NCT02229227|525426096|FG000|Overall Study|Lack of Efficacy|3|||
145702142|NCT02229227|525426097|FG001|Overall Study|Lack of Efficacy|3|||
145702143|NCT02229227|525426096|FG000|Overall Study|Protocol Violation|6|||
145702144|NCT02229227|525426097|FG001|Overall Study|Protocol Violation|8|||
145702145|NCT02229227|525426096|FG000|Overall Study|Protocol defined stopping criteria|1|||
145702146|NCT02229227|525426097|FG001|Overall Study|Protocol defined stopping criteria|3|||
145702147|NCT02229227|525426096|FG000|Overall Study|Lost to Follow-up|3|||
145702148|NCT02229227|525426097|FG001|Overall Study|Lost to Follow-up|3|||
145702149|NCT02229227|525426096|FG000|Overall Study|Study terminated by sponsor|11|||
145702150|NCT02229227|525426097|FG001|Overall Study|Study terminated by sponsor|11|||
145702151|NCT02229227|525426096|FG000|Overall Study|Withdrawal by Subject|8|||
145702152|NCT02229227|525426097|FG001|Overall Study|Withdrawal by Subject|12|||
145702153|NCT02229227|525426096|FG000|Overall Study|Other|0|||
145702154|NCT02229227|525426097|FG001|Overall Study|Other|1|||
145702155|NCT02229227|525426096|FG000|Overall Study|Physician Decision|5|||
145702156|NCT02229227|525426097|FG001|Overall Study|Physician Decision|12|||
145702157|NCT00340704|525426098|FG000|PK Study|Adverse Event|0|||
145702158|NCT00340704|525426099|FG001|PK Study|Adverse Event|1|||
145702159|NCT00340704|525426100|FG002|PK Study|Adverse Event|0|||
145702160|NCT00340704|525426101|FG003|PK Study|Adverse Event|0|||
145702161|NCT00340704|525426102|FG004|PK Study|Adverse Event|0|||
145702162|NCT00340704|525426103|FG005|PK Study|Adverse Event|0|||
145702163|NCT00340704|525426104|FG006|PK Study|Adverse Event|0|||
145702164|NCT00340704|525426105|FG007|PK Study|Adverse Event|0|||
145702165|NCT00340704|525426106|FG008|PK Study|Adverse Event|0|||
145702166|NCT00340704|525426098|FG000|PK Study|Not treated|0|||
145702167|NCT00340704|525426099|FG001|PK Study|Not treated|0|||
145702168|NCT00340704|525426100|FG002|PK Study|Not treated|1|||
145702169|NCT00340704|525426101|FG003|PK Study|Not treated|0|||
145702170|NCT00340704|525426102|FG004|PK Study|Not treated|0|||
145702171|NCT00340704|525426103|FG005|PK Study|Not treated|0|||
145702172|NCT00340704|525426104|FG006|PK Study|Not treated|0|||
145702173|NCT00340704|525426105|FG007|PK Study|Not treated|0|||
145702174|NCT00340704|525426106|FG008|PK Study|Not treated|0|||
145702175|NCT00340704|525426098|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
145702176|NCT00340704|525426099|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
145702177|NCT00340704|525426100|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
145702178|NCT00340704|525426101|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
145702179|NCT00340704|525426102|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
145702180|NCT00340704|525426103|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
145702181|NCT00340704|525426104|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
145702182|NCT00340704|525426105|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
145702183|NCT00340704|525426106|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
145702184|NCT00340704|525426098|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702185|NCT00340704|525426099|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702186|NCT00340704|525426100|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702187|NCT00340704|525426101|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702188|NCT00340704|525426102|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702189|NCT00340704|525426103|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
145702190|NCT00340704|525426104|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702191|NCT00340704|525426105|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702192|NCT00340704|525426106|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
145702193|NCT00340704|525426098|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702194|NCT00340704|525426099|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702195|NCT00340704|525426100|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702196|NCT00340704|525426101|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702197|NCT00340704|525426102|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
145702198|NCT00340704|525426103|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
145702199|NCT00340704|525426104|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702200|NCT00340704|525426105|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702201|NCT00340704|525426106|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
145702202|NCT00340704|525426098|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
145702203|NCT00340704|525426099|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
145702204|NCT00340704|525426100|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
145702205|NCT00340704|525426101|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
145702206|NCT00340704|525426102|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
145702207|NCT00340704|525426103|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
145702208|NCT00340704|525426104|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
145702209|NCT00340704|525426105|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
145702210|NCT00340704|525426106|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
145702211|NCT00121667|525426107|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
145702212|NCT00121667|525426108|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
145702213|NCT00121667|525426109|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
145702214|NCT00121667|525426110|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
145702215|NCT00121667|525426107|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
145702216|NCT00121667|525426108|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
145702217|NCT00121667|525426109|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
145702218|NCT00121667|525426110|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
145702219|NCT00121667|525426107|FG000|Short Term (ST) Period|Adverse Event|5|||
145702220|NCT00121667|525426108|FG001|Short Term (ST) Period|Adverse Event|6|||
145702221|NCT00121667|525426109|FG002|Short Term (ST) Period|Adverse Event|5|||
145702222|NCT00121667|525426110|FG003|Short Term (ST) Period|Adverse Event|3|||
145702223|NCT00121667|525426107|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
145702224|NCT00121667|525426108|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
145702225|NCT00121667|525426109|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
145702226|NCT00121667|525426110|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
145702227|NCT00121667|525426107|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
145702228|NCT00121667|525426108|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
145702229|NCT00121667|525426109|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
145702230|NCT00121667|525426110|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
145702231|NCT00121667|525426107|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
145702232|NCT00121667|525426108|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
145702233|NCT00121667|525426109|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
145702234|NCT00121667|525426110|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
145702235|NCT00121667|525426107|FG000|Short Term (ST) Period|Other Reason|3|||
145702236|NCT00121667|525426108|FG001|Short Term (ST) Period|Other Reason|0|||
145702237|NCT00121667|525426109|FG002|Short Term (ST) Period|Other Reason|0|||
145702238|NCT00121667|525426110|FG003|Short Term (ST) Period|Other Reason|0|||
145702239|NCT00121667|525426107|FG000|Short Term (ST) Period|Death|0|||
145702240|NCT00121667|525426108|FG001|Short Term (ST) Period|Death|0|||
145702241|NCT00121667|525426109|FG002|Short Term (ST) Period|Death|0|||
145702242|NCT00121667|525426110|FG003|Short Term (ST) Period|Death|1|||
145702243|NCT00121667|525426107|FG000|Short Term (ST) Period|Pregnancy|0|||
145702244|NCT00121667|525426108|FG001|Short Term (ST) Period|Pregnancy|0|||
145702245|NCT00121667|525426109|FG002|Short Term (ST) Period|Pregnancy|0|||
145702246|NCT00121667|525426110|FG003|Short Term (ST) Period|Pregnancy|1|||
145702247|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
145702248|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
145702249|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
145702250|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
145702251|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
145702252|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
145702253|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
145702254|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
145702255|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
145702256|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
145702257|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
145702258|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
145702259|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
145702260|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
145702261|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
145702262|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
145702263|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
145702264|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
145702265|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
145702266|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
145702267|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
145702268|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
145702269|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
145702270|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
145702271|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
145702272|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
145702273|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
145702274|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
145702275|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
145702276|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
145702277|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
145702278|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
145702279|NCT00121667|525426107|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
145702280|NCT00121667|525426108|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
145702281|NCT00121667|525426109|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
145702282|NCT00121667|525426110|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
145702283|NCT05186311|525426111|FG000|Part A: Serum|Withdrawal by Subject|1|||
145702284|NCT02879383|525426112|FG000|First 24 Weeks|Physician Decision|0|||
145702285|NCT02879383|525426113|FG001|First 24 Weeks|Physician Decision|1|||
145702286|NCT02879383|525426114|FG002|First 24 Weeks|Physician Decision|0|||
145702287|NCT02879383|525426115|FG003|First 24 Weeks|Physician Decision|0|||
145702288|NCT02125279|525426116|FG000|Overall Study|Lack of Efficacy|2|||
145702289|NCT02125279|525426116|FG000|Overall Study|Withdrawal by Subject|6|||
145702290|NCT02125279|525426116|FG000|Overall Study|Protocol Violation|1|||
145702291|NCT02125279|525426116|FG000|Overall Study|Lost to Follow-up|4|||
145702292|NCT01607879|525426121|FG000|Overall Study|Death|1|||
145702293|NCT01607879|525426122|FG001|Overall Study|Death|0|||
145702294|NCT03845140|525426126|FG000|Overall Study|Participant travelled outside study area|0|||
145702295|NCT03845140|525426127|FG001|Overall Study|Participant travelled outside study area|1|||
145702296|NCT03845140|525426128|FG002|Overall Study|Participant travelled outside study area|0|||
145702297|NCT03845140|525426129|FG003|Overall Study|Participant travelled outside study area|0|||
145702298|NCT03845140|525426130|FG004|Overall Study|Participant travelled outside study area|0|||
145702299|NCT03845140|525426131|FG005|Overall Study|Participant travelled outside study area|0|||
145702300|NCT01592045|525426141|FG000|Overall Study|Disease Progression|1|||
145702301|NCT01592045|525426142|FG001|Overall Study|Disease Progression|1|||
145702302|NCT01592045|525426141|FG000|Overall Study|Adverse Event|1|||
145702303|NCT01592045|525426142|FG001|Overall Study|Adverse Event|1|||
145702304|NCT01592045|525426141|FG000|Overall Study|Withdrawal by Subject|1|||
145702305|NCT01592045|525426142|FG001|Overall Study|Withdrawal by Subject|0|||
145702306|NCT01592045|525426141|FG000|Overall Study|Moved out of country|2|||
145702307|NCT01592045|525426142|FG001|Overall Study|Moved out of country|0|||
145702308|NCT02599688|525426152|FG000|Overall Study|Lack of Efficacy|1|||
145702309|NCT02599688|525426152|FG000|Overall Study|Withdrawal by Subject|1|||
145702310|NCT02599688|525426152|FG000|Overall Study|Termination by Sponsor|2|||
145702311|NCT00742326|525426154|FG000|Overall Study|Physician Decision|0|||
145702312|NCT00742326|525426155|FG001|Overall Study|Physician Decision|1|||
145702313|NCT01667549|525426167|FG000|Overall Study|Withdrawal by Subject|3|||
145702314|NCT01667549|525426168|FG001|Overall Study|Withdrawal by Subject|5|||
145702315|NCT01667549|525426169|FG002|Overall Study|Withdrawal by Subject|7|||
145702316|NCT01667549|525426170|FG003|Overall Study|Withdrawal by Subject|6|||
145702317|NCT01667549|525426171|FG004|Overall Study|Withdrawal by Subject|1|||
145702318|NCT01407276|525426172|FG000|Overall Study|Withdrawal by Subject|0|||
145702319|NCT01407276|525426173|FG001|Overall Study|Withdrawal by Subject|0|||
145702320|NCT01407276|525426174|FG002|Overall Study|Withdrawal by Subject|0|||
145702321|NCT01407276|525426175|FG003|Overall Study|Withdrawal by Subject|0|||
145702322|NCT01407276|525426176|FG004|Overall Study|Withdrawal by Subject|0|||
145702323|NCT01407276|525426177|FG005|Overall Study|Withdrawal by Subject|0|||
145702324|NCT01407276|525426178|FG006|Overall Study|Withdrawal by Subject|0|||
145702325|NCT01407276|525426179|FG007|Overall Study|Withdrawal by Subject|1|||
145702326|NCT01080300|525426183|FG000|Overall Study|Adverse Event|49|||
145702327|NCT01080300|525426184|FG001|Overall Study|Adverse Event|35|||
145702328|NCT01080300|525426183|FG000|Overall Study|Lack of Efficacy|12|||
145702329|NCT01080300|525426184|FG001|Overall Study|Lack of Efficacy|15|||
145702330|NCT01080300|525426183|FG000|Overall Study|Protocol Violation|7|||
145702331|NCT01080300|525426184|FG001|Overall Study|Protocol Violation|13|||
145702332|NCT01080300|525426183|FG000|Overall Study|Lost to Follow-up|10|||
145702333|NCT01080300|525426184|FG001|Overall Study|Lost to Follow-up|6|||
145702334|NCT01080300|525426183|FG000|Overall Study|Death|0|||
145702335|NCT01080300|525426184|FG001|Overall Study|Death|1|||
145702336|NCT01080300|525426183|FG000|Overall Study|Withdrawal by Subject|12|||
145702337|NCT01080300|525426184|FG001|Overall Study|Withdrawal by Subject|28|||
145702338|NCT01080300|525426183|FG000|Overall Study|Reasons not specified|4|||
145702339|NCT01080300|525426184|FG001|Overall Study|Reasons not specified|6|||
145702340|NCT00478205|525426187|FG000|Overall Study|Adverse Event|182|||
145702341|NCT00478205|525426188|FG001|Overall Study|Adverse Event|39|||
145702342|NCT00478205|525426187|FG000|Overall Study|Medication Non-compliance|9|||
145702343|NCT00478205|525426188|FG001|Overall Study|Medication Non-compliance|4|||
145702344|NCT00478205|525426187|FG000|Overall Study|Protocol Violation|15|||
145702345|NCT00478205|525426188|FG001|Overall Study|Protocol Violation|5|||
145702346|NCT00478205|525426187|FG000|Overall Study|Request of Investigator or Sponsor|4|||
145702347|NCT00478205|525426188|FG001|Overall Study|Request of Investigator or Sponsor|5|||
145702348|NCT00478205|525426187|FG000|Overall Study|Withdrawal by Subject|61|||
145702349|NCT00478205|525426188|FG001|Overall Study|Withdrawal by Subject|22|||
145702350|NCT00478205|525426187|FG000|Overall Study|Lack of Efficacy|1|||
145702351|NCT00478205|525426188|FG001|Overall Study|Lack of Efficacy|0|||
145702352|NCT00478205|525426187|FG000|Overall Study|Other|24|||
145702353|NCT00478205|525426188|FG001|Overall Study|Other|12|||
145702354|NCT00585078|525426194|FG000|Overall Study|Withdrawal by Subject|4|||
145702355|NCT00585078|525426194|FG000|Overall Study|Poor performance status|1|||
145702356|NCT00585078|525426194|FG000|Overall Study|Disease Progression|24|||
145702357|NCT00585078|525426194|FG000|Overall Study|Adverse Event|10|||
145702358|NCT00585078|525426194|FG000|Overall Study|Death|1|||
145702359|NCT01018732|525426195|FG000|Overall Study|Lost to Follow-up|0|||
145702360|NCT01018732|525426196|FG001|Overall Study|Lost to Follow-up|0|||
145702361|NCT01018732|525426197|FG002|Overall Study|Lost to Follow-up|3|||
145702362|NCT01018732|525426195|FG000|Overall Study|Protocol Violation|1|||
145702363|NCT01018732|525426196|FG001|Overall Study|Protocol Violation|1|||
145702364|NCT01018732|525426197|FG002|Overall Study|Protocol Violation|0|||
145702365|NCT01018732|525426195|FG000|Overall Study|Inappropriate Enrollment|0|||
145702366|NCT01018732|525426196|FG001|Overall Study|Inappropriate Enrollment|1|||
145702367|NCT01018732|525426197|FG002|Overall Study|Inappropriate Enrollment|0|||
145702368|NCT01018732|525426195|FG000|Overall Study|Unable to Classify|0|||
145702369|NCT01018732|525426196|FG001|Overall Study|Unable to Classify|0|||
145702370|NCT01018732|525426197|FG002|Overall Study|Unable to Classify|1|||
145702371|NCT01536171|525426198|FG000|Overall Study|Withdrawal by Subject|1|||
145702372|NCT02781311|525426201|FG000|Overall Study|Adverse Event|2|||
145702373|NCT02781311|525426202|FG001|Overall Study|Adverse Event|6|||
145702374|NCT02781311|525426203|FG002|Overall Study|Adverse Event|1|||
145702375|NCT02781311|525426201|FG000|Overall Study|Withdrawal of Consent|11|||
145702376|NCT02781311|525426202|FG001|Overall Study|Withdrawal of Consent|12|||
145702377|NCT02781311|525426203|FG002|Overall Study|Withdrawal of Consent|2|||
145702378|NCT02781311|525426201|FG000|Overall Study|Lost to Follow-up|11|||
145702379|NCT02781311|525426202|FG001|Overall Study|Lost to Follow-up|8|||
145702380|NCT02781311|525426203|FG002|Overall Study|Lost to Follow-up|1|||
145702381|NCT02781311|525426201|FG000|Overall Study|Non-Compliance with Study Drug|2|||
145702382|NCT02781311|525426202|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145702383|NCT02781311|525426203|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145702384|NCT02165826|525426204|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
145702385|NCT02165826|525426205|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
145702386|NCT02165826|525426206|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
145702387|NCT02165826|525426204|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
145702388|NCT02165826|525426205|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
145702389|NCT02165826|525426206|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
145702390|NCT02165826|525426204|FG000|Main Treatment Period|Lost to Follow-up|4|||
145702391|NCT02165826|525426205|FG001|Main Treatment Period|Lost to Follow-up|2|||
145702392|NCT02165826|525426206|FG002|Main Treatment Period|Lost to Follow-up|1|||
145702393|NCT02165826|525426204|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
145702394|NCT02165826|525426205|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
145702395|NCT02165826|525426206|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
145702396|NCT02165826|525426204|FG000|Main Treatment Period|Lack of Efficacy|2|||
145702397|NCT02165826|525426205|FG001|Main Treatment Period|Lack of Efficacy|0|||
145702398|NCT02165826|525426206|FG002|Main Treatment Period|Lack of Efficacy|0|||
145702399|NCT02165826|525426204|FG000|Main Treatment Period|Reason Not Specified|8|||
145702400|NCT02165826|525426205|FG001|Main Treatment Period|Reason Not Specified|5|||
145702401|NCT02165826|525426206|FG002|Main Treatment Period|Reason Not Specified|16|||
145702402|NCT02165826|525426204|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
145702403|NCT02165826|525426205|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
145702404|NCT02165826|525426206|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
145702405|NCT02165826|525426204|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
145702406|NCT02165826|525426205|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
145702407|NCT02165826|525426206|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
145702408|NCT02165826|525426204|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
145702409|NCT02165826|525426205|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
145702410|NCT02165826|525426206|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
145702411|NCT02165826|525426204|FG000|Down-Titration Period|Reason Not Specified|1|||
145702412|NCT02165826|525426205|FG001|Down-Titration Period|Reason Not Specified|0|||
145702413|NCT02165826|525426206|FG002|Down-Titration Period|Reason Not Specified|2|||
145702414|NCT00250432|525426209|FG000|Overall Study|Adverse Event|25|||
145702415|NCT00250432|525426210|FG001|Overall Study|Adverse Event|29|||
145702416|NCT00250432|525426209|FG000|Overall Study|Lack of Efficacy|2|||
145702417|NCT00250432|525426210|FG001|Overall Study|Lack of Efficacy|1|||
145702418|NCT00250432|525426209|FG000|Overall Study|Lost to Follow-up|6|||
145702419|NCT00250432|525426210|FG001|Overall Study|Lost to Follow-up|5|||
145702420|NCT00250432|525426209|FG000|Overall Study|Patient Moved|0|||
145702421|NCT00250432|525426210|FG001|Overall Study|Patient Moved|1|||
145702422|NCT00250432|525426209|FG000|Overall Study|Protocol Violation|0|||
145702423|NCT00250432|525426210|FG001|Overall Study|Protocol Violation|3|||
145702424|NCT00250432|525426209|FG000|Overall Study|Withdrawal by Subject|6|||
145702425|NCT00250432|525426210|FG001|Overall Study|Withdrawal by Subject|2|||
145702426|NCT00250432|525426209|FG000|Overall Study|Pt died out of posttherapy report period|6|||
145702427|NCT00250432|525426210|FG001|Overall Study|Pt died out of posttherapy report period|5|||
145702428|NCT00250432|525426209|FG000|Overall Study|Pt was considered untreatable|0|||
145702429|NCT00250432|525426210|FG001|Overall Study|Pt was considered untreatable|1|||
145702430|NCT01056263|525426211|FG000|Overall Study|Adverse Event|12|||
145702431|NCT01056263|525426211|FG000|Overall Study|Death|1|||
145702432|NCT01056263|525426211|FG000|Overall Study|Withdrawal by Subject|1|||
145702433|NCT01056263|525426211|FG000|Overall Study|Lack of Efficacy|29|||
145702434|NCT01056263|525426211|FG000|Overall Study|Progressive disease|2|||
145702435|NCT01056263|525426211|FG000|Overall Study|Neoplasm progression|1|||
145702436|NCT01056263|525426211|FG000|Overall Study|Objective progression or relapse|1|||
145702437|NCT01056263|525426211|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
145702438|NCT00658606|525426214|FG000|Overall Study|Adverse Event|2|||
145702439|NCT00658606|525426215|FG001|Overall Study|Adverse Event|1|||
145702440|NCT00658606|525426214|FG000|Overall Study|Lack of Efficacy|6|||
145702441|NCT00658606|525426215|FG001|Overall Study|Lack of Efficacy|3|||
145702442|NCT00658606|525426214|FG000|Overall Study|Lost to Follow-up|1|||
145702443|NCT00658606|525426215|FG001|Overall Study|Lost to Follow-up|0|||
145702444|NCT00658606|525426214|FG000|Overall Study|Withdrawal by Subject|7|||
145702445|NCT00658606|525426215|FG001|Overall Study|Withdrawal by Subject|16|||
145702446|NCT00658606|525426214|FG000|Overall Study|Lack of Compliance|0|||
145702447|NCT00658606|525426215|FG001|Overall Study|Lack of Compliance|3|||
145702448|NCT04905849|525426216|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
145702449|NCT04905849|525426217|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
145702450|NCT00838929|525426222|FG000|Overall Study|Protocol Violation|0|||
145702451|NCT00838929|525426223|FG001|Overall Study|Protocol Violation|1|||
145702452|NCT00838929|525426224|FG002|Overall Study|Protocol Violation|0|||
145702453|NCT00838929|525426222|FG000|Overall Study|Disease progression|0|||
145702454|NCT00838929|525426223|FG001|Overall Study|Disease progression|2|||
145702455|NCT00838929|525426224|FG002|Overall Study|Disease progression|1|||
145702456|NCT01068210|525426229|FG000|Overall Study|Lost to Follow-up|1|||
145702457|NCT01068210|525426230|FG001|Overall Study|Lost to Follow-up|2|||
145702458|NCT01068210|525426231|FG002|Overall Study|Lost to Follow-up|2|||
145702459|NCT01068210|525426232|FG003|Overall Study|Lost to Follow-up|1|||
145702460|NCT01068210|525426229|FG000|Overall Study|Second cancer|0|||
145702461|NCT01068210|525426230|FG001|Overall Study|Second cancer|1|||
145702462|NCT01068210|525426231|FG002|Overall Study|Second cancer|0|||
145702463|NCT01068210|525426232|FG003|Overall Study|Second cancer|0|||
145702464|NCT01068210|525426229|FG000|Overall Study|Disease progression|0|||
145702465|NCT01068210|525426230|FG001|Overall Study|Disease progression|0|||
145702466|NCT01068210|525426231|FG002|Overall Study|Disease progression|0|||
145702467|NCT01068210|525426232|FG003|Overall Study|Disease progression|2|||
145702468|NCT00699842|525426233|FG000|Overall Study|Death|0|||
145702469|NCT00699842|525426234|FG001|Overall Study|Death|1|||
145702470|NCT00699842|525426235|FG002|Overall Study|Death|0|||
145702471|NCT01310699|525426243|FG000|Overall Study|Patients did not complete tandem.|4|||
145702472|NCT01310699|525426244|FG001|Overall Study|Patients did not complete tandem.|6|||
145702473|NCT00490698|525426245|FG000|Overall Study|Withdrawal by Subject|1|||
145702474|NCT00490698|525426245|FG000|Overall Study|Disease Progression|7|||
145702475|NCT00490698|525426245|FG000|Overall Study|Physician Decision|2|||
145702476|NCT02201901|525426248|FG000|Overall Study|Randomized but never treated|0|||
145702477|NCT02201901|525426249|FG001|Overall Study|Randomized but never treated|1|||
145702478|NCT02201901|525426250|FG002|Overall Study|Randomized but never treated|0|||
145702479|NCT02201901|525426248|FG000|Overall Study|Lack of Efficacy|7|||
145702480|NCT02201901|525426249|FG001|Overall Study|Lack of Efficacy|1|||
145702481|NCT02201901|525426250|FG002|Overall Study|Lack of Efficacy|6|||
145702482|NCT02201901|525426248|FG000|Overall Study|Death|3|||
145702483|NCT02201901|525426249|FG001|Overall Study|Death|3|||
145702484|NCT02201901|525426250|FG002|Overall Study|Death|3|||
145702485|NCT02201901|525426248|FG000|Overall Study|Lost to Follow-up|2|||
145702486|NCT02201901|525426249|FG001|Overall Study|Lost to Follow-up|3|||
145702487|NCT02201901|525426250|FG002|Overall Study|Lost to Follow-up|2|||
145702488|NCT02201901|525426248|FG000|Overall Study|Withdrew Consent|2|||
145702489|NCT02201901|525426249|FG001|Overall Study|Withdrew Consent|0|||
145702490|NCT02201901|525426250|FG002|Overall Study|Withdrew Consent|2|||
145702491|NCT02201901|525426248|FG000|Overall Study|Adverse Event|1|||
145702492|NCT02201901|525426249|FG001|Overall Study|Adverse Event|1|||
145702493|NCT02201901|525426250|FG002|Overall Study|Adverse Event|0|||
145702494|NCT00738283|525426251|FG000|Overall Study|Death|1|||
145702495|NCT00738283|525426251|FG000|Overall Study|Transfer to another facility|2|||
145702496|NCT00738283|525426251|FG000|Overall Study|Discharge home prior to end of study|1|||
145702497|NCT02633397|525426252|FG000|Overall Study|Adverse Event|8|||
145702498|NCT02633397|525426253|FG001|Overall Study|Adverse Event|8|||
145702499|NCT02633397|525426252|FG000|Overall Study|Study Burden|4|||
145702500|NCT02633397|525426253|FG001|Overall Study|Study Burden|1|||
145702501|NCT02633397|525426252|FG000|Overall Study|Treatment interruption|2|||
145702502|NCT02633397|525426253|FG001|Overall Study|Treatment interruption|5|||
145702503|NCT02633397|525426252|FG000|Overall Study|Death|2|||
145702504|NCT02633397|525426253|FG001|Overall Study|Death|2|||
145702505|NCT02633397|525426252|FG000|Overall Study|Physician Decision|0|||
145702506|NCT02633397|525426253|FG001|Overall Study|Physician Decision|1|||
145702507|NCT00469859|525426254|FG000|Overall Study|Inevaluable|0|||
145702508|NCT00469859|525426255|FG001|Overall Study|Inevaluable|2|||
145702509|NCT01240551|525428314|FG000|Overall Study|Refused further treatment|3|||
145702510|NCT01240551|525428315|FG001|Overall Study|Refused further treatment|2|||
145702511|NCT01240551|525428314|FG000|Overall Study|Lost to Follow-up|1|||
145702512|NCT01240551|525428315|FG001|Overall Study|Lost to Follow-up|1|||
145702513|NCT02737826|525428318|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
145702514|NCT02737826|525428319|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
145702515|NCT02737826|525428320|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
145702516|NCT00078377|525428321|FG000|Overall Study|Adverse Event|2|||
145702517|NCT00078377|525428322|FG001|Overall Study|Adverse Event|5|||
145702518|NCT00078377|525428323|FG002|Overall Study|Adverse Event|1|||
145702519|NCT00078377|525428321|FG000|Overall Study|Lack of Efficacy|2|||
145702520|NCT00078377|525428322|FG001|Overall Study|Lack of Efficacy|0|||
145702521|NCT00078377|525428323|FG002|Overall Study|Lack of Efficacy|2|||
145702522|NCT00078377|525428321|FG000|Overall Study|Lost to Follow-up|0|||
145702523|NCT00078377|525428322|FG001|Overall Study|Lost to Follow-up|1|||
145702524|NCT00078377|525428323|FG002|Overall Study|Lost to Follow-up|1|||
145702525|NCT00078377|525428321|FG000|Overall Study|Physician Decision|2|||
145702526|NCT00078377|525428322|FG001|Overall Study|Physician Decision|0|||
145702527|NCT00078377|525428323|FG002|Overall Study|Physician Decision|0|||
145702528|NCT00078377|525428321|FG000|Overall Study|Withdrawal by Subject|3|||
145702529|NCT00078377|525428322|FG001|Overall Study|Withdrawal by Subject|4|||
145702530|NCT00078377|525428323|FG002|Overall Study|Withdrawal by Subject|4|||
145702531|NCT00078377|525428321|FG000|Overall Study|Miscellaneous|2|||
145702532|NCT00078377|525428322|FG001|Overall Study|Miscellaneous|6|||
145702533|NCT00078377|525428323|FG002|Overall Study|Miscellaneous|1|||
145702534|NCT04546217|525428324|FG000|Overall Study|Withdrawal by Subject|2|||
145702535|NCT04546217|525428325|FG001|Overall Study|Withdrawal by Subject|0|||
145702536|NCT04546217|525428324|FG000|Overall Study|Uncontrolled hypertension|1|||
145702537|NCT04546217|525428325|FG001|Overall Study|Uncontrolled hypertension|0|||
145702538|NCT00863512|525428326|FG000|Overall Study|Adverse Event|2|||
145702539|NCT00863512|525428327|FG001|Overall Study|Adverse Event|0|||
145702540|NCT00863512|525428326|FG000|Overall Study|Withdrawal by Subject|11|||
145702541|NCT00863512|525428327|FG001|Overall Study|Withdrawal by Subject|0|||
145702542|NCT00863512|525428326|FG000|Overall Study|Physician Decision|1|||
145702543|NCT00863512|525428327|FG001|Overall Study|Physician Decision|0|||
145702544|NCT04292470|525428330|FG000|Overall Study|Withdrawal by Subject|0|||
145702545|NCT04292470|525428331|FG001|Overall Study|Withdrawal by Subject|1|||
145702546|NCT02906020|525428332|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
145702547|NCT02906020|525428333|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
145702548|NCT02906020|525428334|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
145702549|NCT02906020|525428335|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
145702550|NCT02906020|525428336|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
145702551|NCT02906020|525428337|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
145702552|NCT02906020|525428338|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
145702553|NCT02906020|525428339|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
145702554|NCT02906020|525428340|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
145702555|NCT02906020|525428341|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
145702556|NCT02906020|525428342|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
145702557|NCT02906020|525428343|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
145702558|NCT02906020|525428344|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
145702559|NCT02906020|525428345|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
145702560|NCT02906020|525428346|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
145702561|NCT02906020|525428347|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
145702562|NCT02906020|525428332|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702563|NCT02906020|525428333|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702564|NCT02906020|525428334|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702565|NCT02906020|525428335|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702566|NCT02906020|525428336|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702567|NCT02906020|525428337|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702568|NCT02906020|525428338|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702569|NCT02906020|525428339|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702570|NCT02906020|525428340|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
145702571|NCT02906020|525428341|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
145702572|NCT02906020|525428342|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702573|NCT02906020|525428343|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702574|NCT02906020|525428344|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702575|NCT02906020|525428345|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702576|NCT02906020|525428346|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702577|NCT02906020|525428347|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
145702578|NCT02906020|525428332|FG000|Part 2: Double-blind Treatment Period|Other|0|||
145702579|NCT02906020|525428333|FG001|Part 2: Double-blind Treatment Period|Other|0|||
145702580|NCT02906020|525428334|FG002|Part 2: Double-blind Treatment Period|Other|0|||
145702581|NCT02906020|525428335|FG003|Part 2: Double-blind Treatment Period|Other|0|||
145702582|NCT02906020|525428336|FG004|Part 2: Double-blind Treatment Period|Other|0|||
145702583|NCT02906020|525428337|FG005|Part 2: Double-blind Treatment Period|Other|0|||
145702584|NCT02906020|525428338|FG006|Part 2: Double-blind Treatment Period|Other|0|||
145702585|NCT02906020|525428339|FG007|Part 2: Double-blind Treatment Period|Other|0|||
145702586|NCT02906020|525428340|FG008|Part 2: Double-blind Treatment Period|Other|6|||
145702587|NCT02906020|525428341|FG009|Part 2: Double-blind Treatment Period|Other|10|||
145702588|NCT02906020|525428342|FG010|Part 2: Double-blind Treatment Period|Other|0|||
145702589|NCT02906020|525428343|FG011|Part 2: Double-blind Treatment Period|Other|0|||
145702590|NCT02906020|525428344|FG012|Part 2: Double-blind Treatment Period|Other|0|||
145702591|NCT02906020|525428345|FG013|Part 2: Double-blind Treatment Period|Other|0|||
145702592|NCT02906020|525428346|FG014|Part 2: Double-blind Treatment Period|Other|0|||
145702593|NCT02906020|525428347|FG015|Part 2: Double-blind Treatment Period|Other|0|||
145702594|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702595|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702596|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702597|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702598|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702599|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702600|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702601|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702602|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702603|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702604|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702605|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702606|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
145702607|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
145702608|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702609|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
145702610|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702611|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702612|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702613|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702614|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702615|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702616|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702617|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702618|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702619|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702620|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702621|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702622|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
145702623|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
145702624|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
145702625|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
145702626|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702627|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702628|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702629|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702630|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702631|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702632|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702633|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702634|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702635|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702636|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702637|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702638|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
145702639|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
145702640|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702641|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
145702642|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702643|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702644|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702645|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702646|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702647|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702648|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702649|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702650|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702651|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702652|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702653|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702654|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
145491435|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
145491436|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
145702655|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
145702656|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702657|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
145702658|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702659|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702660|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702661|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702662|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702663|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702664|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702665|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702666|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702667|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702668|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702669|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
145702670|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
145702671|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
145702672|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
145702673|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
145702674|NCT02906020|525428332|FG000|Part 2: Long-term Follow-up Period|Other|0|||
145702675|NCT02906020|525428333|FG001|Part 2: Long-term Follow-up Period|Other|0|||
145702676|NCT02906020|525428334|FG002|Part 2: Long-term Follow-up Period|Other|0|||
145702677|NCT02906020|525428335|FG003|Part 2: Long-term Follow-up Period|Other|0|||
145702678|NCT02906020|525428336|FG004|Part 2: Long-term Follow-up Period|Other|0|||
145702679|NCT02906020|525428337|FG005|Part 2: Long-term Follow-up Period|Other|0|||
145702680|NCT02906020|525428338|FG006|Part 2: Long-term Follow-up Period|Other|0|||
145702681|NCT02906020|525428339|FG007|Part 2: Long-term Follow-up Period|Other|0|||
145702682|NCT02906020|525428340|FG008|Part 2: Long-term Follow-up Period|Other|0|||
145702683|NCT02906020|525428341|FG009|Part 2: Long-term Follow-up Period|Other|0|||
145702684|NCT02906020|525428342|FG010|Part 2: Long-term Follow-up Period|Other|0|||
145702685|NCT02906020|525428343|FG011|Part 2: Long-term Follow-up Period|Other|0|||
145702686|NCT02906020|525428344|FG012|Part 2: Long-term Follow-up Period|Other|13|||
145702687|NCT02906020|525428345|FG013|Part 2: Long-term Follow-up Period|Other|8|||
145702688|NCT02906020|525428346|FG014|Part 2: Long-term Follow-up Period|Other|3|||
145702689|NCT02906020|525428347|FG015|Part 2: Long-term Follow-up Period|Other|2|||
145702690|NCT04698915|525428348|FG000|Overall Study|Adverse Event|2|||
145702691|NCT04698915|525428349|FG001|Overall Study|Adverse Event|0|||
145702692|NCT04698915|525428348|FG000|Overall Study|Death|23|||
145702693|NCT04698915|525428349|FG001|Overall Study|Death|20|||
145702694|NCT04698915|525428348|FG000|Overall Study|Physician Decision|1|||
145702695|NCT04698915|525428349|FG001|Overall Study|Physician Decision|1|||
145702696|NCT04698915|525428348|FG000|Overall Study|Lost to Follow-up|1|||
145702697|NCT04698915|525428349|FG001|Overall Study|Lost to Follow-up|0|||
145702698|NCT04698915|525428348|FG000|Overall Study|Study Terminated by Sponsor|55|||
145702699|NCT04698915|525428349|FG001|Overall Study|Study Terminated by Sponsor|60|||
145702700|NCT04698915|525428348|FG000|Overall Study|Withdrawal by Subject|2|||
145702701|NCT04698915|525428349|FG001|Overall Study|Withdrawal by Subject|3|||
145702702|NCT00979953|525428350|FG000|Overall Study|Adverse Event|5|||
145702703|NCT00979953|525428351|FG001|Overall Study|Adverse Event|2|||
145702704|NCT00979953|525428352|FG002|Overall Study|Adverse Event|17|||
145702705|NCT00979953|525428353|FG003|Overall Study|Adverse Event|4|||
145702706|NCT00979953|525428350|FG000|Overall Study|Lack of Efficacy|1|||
145702707|NCT00979953|525428351|FG001|Overall Study|Lack of Efficacy|2|||
145702708|NCT00979953|525428352|FG002|Overall Study|Lack of Efficacy|0|||
145702709|NCT00979953|525428353|FG003|Overall Study|Lack of Efficacy|0|||
145702710|NCT00979953|525428350|FG000|Overall Study|Lost to Follow-up|1|||
145702711|NCT00979953|525428351|FG001|Overall Study|Lost to Follow-up|1|||
145702712|NCT00979953|525428352|FG002|Overall Study|Lost to Follow-up|1|||
145702713|NCT00979953|525428353|FG003|Overall Study|Lost to Follow-up|0|||
145702714|NCT00979953|525428350|FG000|Overall Study|Withdrawal by Subject|0|||
145702715|NCT00979953|525428351|FG001|Overall Study|Withdrawal by Subject|0|||
145702716|NCT00979953|525428352|FG002|Overall Study|Withdrawal by Subject|2|||
145702717|NCT00979953|525428353|FG003|Overall Study|Withdrawal by Subject|1|||
145702718|NCT00979953|525428350|FG000|Overall Study|Protocol Violation|1|||
145702719|NCT00979953|525428351|FG001|Overall Study|Protocol Violation|0|||
145702720|NCT00979953|525428352|FG002|Overall Study|Protocol Violation|2|||
145702721|NCT00979953|525428353|FG003|Overall Study|Protocol Violation|2|||
145702722|NCT01124097|525428354|FG000|Overall Study|Withdrawal by Subject|4|||
145702723|NCT01124097|525428355|FG001|Overall Study|Withdrawal by Subject|3|||
145702724|NCT01124097|525428356|FG002|Overall Study|Withdrawal by Subject|2|||
145702725|NCT01124097|525428357|FG003|Overall Study|Withdrawal by Subject|3|||
145702726|NCT01124097|525428354|FG000|Overall Study|Lack of Efficacy|2|||
145702727|NCT01124097|525428355|FG001|Overall Study|Lack of Efficacy|3|||
145702728|NCT01124097|525428356|FG002|Overall Study|Lack of Efficacy|1|||
145702729|NCT01124097|525428357|FG003|Overall Study|Lack of Efficacy|3|||
145702730|NCT01124097|525428354|FG000|Overall Study|Adverse Event|24|||
145702731|NCT01124097|525428355|FG001|Overall Study|Adverse Event|15|||
145702732|NCT01124097|525428356|FG002|Overall Study|Adverse Event|15|||
145702733|NCT01124097|525428357|FG003|Overall Study|Adverse Event|7|||
145702734|NCT01124097|525428354|FG000|Overall Study|Protocol Violation|2|||
145702735|NCT01124097|525428355|FG001|Overall Study|Protocol Violation|0|||
145702736|NCT01124097|525428356|FG002|Overall Study|Protocol Violation|2|||
145702737|NCT01124097|525428357|FG003|Overall Study|Protocol Violation|1|||
145702738|NCT01124097|525428354|FG000|Overall Study|Physician Decision|2|||
145702739|NCT01124097|525428355|FG001|Overall Study|Physician Decision|1|||
145702740|NCT01124097|525428356|FG002|Overall Study|Physician Decision|0|||
145702741|NCT01124097|525428357|FG003|Overall Study|Physician Decision|0|||
145702742|NCT04829747|525428363|FG000|Overall Study|Protocol Violation|1|||
145702743|NCT00079339|525428369|FG000|Overall Study|Adverse Event|1|||
145702744|NCT00079339|525428370|FG001|Overall Study|Adverse Event|7|||
145702745|NCT00079339|525428371|FG002|Overall Study|Adverse Event|2|||
145702746|NCT00079339|525428369|FG000|Overall Study|Death|1|||
145702747|NCT00079339|525428370|FG001|Overall Study|Death|0|||
145702748|NCT00079339|525428371|FG002|Overall Study|Death|0|||
145702749|NCT00079339|525428369|FG000|Overall Study|Non-compliance|0|||
145702750|NCT00079339|525428370|FG001|Overall Study|Non-compliance|0|||
145702751|NCT00079339|525428371|FG002|Overall Study|Non-compliance|1|||
145702752|NCT00079339|525428369|FG000|Overall Study|Withdrawal by Subject|0|||
145702753|NCT00079339|525428370|FG001|Overall Study|Withdrawal by Subject|4|||
145702754|NCT00079339|525428371|FG002|Overall Study|Withdrawal by Subject|1|||
145702755|NCT00079339|525428369|FG000|Overall Study|Disease progression|3|||
145702756|NCT00079339|525428370|FG001|Overall Study|Disease progression|28|||
145702757|NCT00079339|525428371|FG002|Overall Study|Disease progression|2|||
145702758|NCT03635086|525428375|FG000|Overall Study|Withdrawal of consent|0|||
145702759|NCT03635086|525428376|FG001|Overall Study|Withdrawal of consent|0|||
145702760|NCT03635086|525428377|FG002|Overall Study|Withdrawal of consent|1|||
145702761|NCT03635086|525428378|FG003|Overall Study|Withdrawal of consent|0|||
145702762|NCT03635086|525428379|FG004|Overall Study|Withdrawal of consent|0|||
145702763|NCT03635086|525428375|FG000|Overall Study|Adverse Event|0|||
145702764|NCT03635086|525428376|FG001|Overall Study|Adverse Event|1|||
145702765|NCT03635086|525428377|FG002|Overall Study|Adverse Event|0|||
145702766|NCT03635086|525428378|FG003|Overall Study|Adverse Event|0|||
145702767|NCT03635086|525428379|FG004|Overall Study|Adverse Event|0|||
145702768|NCT03635086|525428375|FG000|Overall Study|Lost to Follow-up|1|||
145702769|NCT03635086|525428376|FG001|Overall Study|Lost to Follow-up|0|||
145702770|NCT03635086|525428377|FG002|Overall Study|Lost to Follow-up|0|||
145702771|NCT03635086|525428378|FG003|Overall Study|Lost to Follow-up|0|||
145702772|NCT03635086|525428379|FG004|Overall Study|Lost to Follow-up|0|||
145702773|NCT00723125|525428380|FG000|Overall Study|Met Dx|1|||
145702774|NCT00723125|525428381|FG001|Overall Study|Met Dx|0|||
145702775|NCT00723125|525428380|FG000|Overall Study|Withdrawal by Subject|15|||
145702776|NCT00723125|525428381|FG001|Overall Study|Withdrawal by Subject|6|||
145702777|NCT00723125|525428380|FG000|Overall Study|Adverse Event|2|||
145702778|NCT00723125|525428381|FG001|Overall Study|Adverse Event|0|||
145702779|NCT02196077|525428382|FG000|Overall Study|Adverse Event|4|||
145702780|NCT02196077|525428382|FG000|Overall Study|Lack of Efficacy|1|||
145702781|NCT02196077|525428382|FG000|Overall Study|Withdrawal by Subject|14|||
145702782|NCT02196077|525428382|FG000|Overall Study|Physician Decision|1|||
145702783|NCT02196077|525428382|FG000|Overall Study|Lost to Follow-up|3|||
145702784|NCT02196077|525428382|FG000|Overall Study|Protocol Violation|24|||
145702785|NCT04042077|525428385|FG000|Overall Study|Adverse Event|0|||
145702786|NCT04042077|525428386|FG001|Overall Study|Adverse Event|1|||
145702787|NCT04042077|525428385|FG000|Overall Study|Death|2|||
145702788|NCT04042077|525428386|FG001|Overall Study|Death|1|||
145702789|NCT04042077|525428385|FG000|Overall Study|Physician Decision|2|||
145702790|NCT04042077|525428386|FG001|Overall Study|Physician Decision|0|||
145702791|NCT04042077|525428385|FG000|Overall Study|Withdrawal by Subject|3|||
145702792|NCT04042077|525428386|FG001|Overall Study|Withdrawal by Subject|2|||
145702793|NCT04042077|525428385|FG000|Overall Study|Lack of Efficacy|0|||
145702794|NCT04042077|525428386|FG001|Overall Study|Lack of Efficacy|1|||
145702795|NCT03482752|525428387|FG000|Overall Study|Withdrawal by Subject|2|||
145702796|NCT03482752|525428387|FG000|Overall Study|Lost to Follow-up|1|||
145702797|NCT03482752|525428387|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
145702798|NCT02844777|525428388|FG000|Overall Study|Withdrawal by Subject|2|||
145702799|NCT02844777|525428389|FG001|Overall Study|Withdrawal by Subject|0|||
145702800|NCT02844777|525428390|FG002|Overall Study|Withdrawal by Subject|0|||
145702801|NCT01776008|525428391|FG000|Overall Study|ineligible|2|||
145702802|NCT00150618|525428392|FG000|Overall Study|Adverse Event|2|||
145702803|NCT00150618|525428393|FG001|Overall Study|Adverse Event|2|||
145702804|NCT00150618|525428394|FG002|Overall Study|Adverse Event|6|||
145702805|NCT00150618|525428395|FG003|Overall Study|Adverse Event|9|||
145702806|NCT00150618|525428396|FG004|Overall Study|Adverse Event|5|||
145702807|NCT00150618|525428392|FG000|Overall Study|Withdrawal by Subject|6|||
145702808|NCT00150618|525428393|FG001|Overall Study|Withdrawal by Subject|8|||
145702809|NCT00150618|525428394|FG002|Overall Study|Withdrawal by Subject|8|||
145702810|NCT00150618|525428395|FG003|Overall Study|Withdrawal by Subject|4|||
145702811|NCT00150618|525428396|FG004|Overall Study|Withdrawal by Subject|5|||
145702812|NCT00150618|525428392|FG000|Overall Study|Lost to Follow-up|4|||
145702813|NCT00150618|525428393|FG001|Overall Study|Lost to Follow-up|1|||
145702814|NCT00150618|525428394|FG002|Overall Study|Lost to Follow-up|5|||
145702815|NCT00150618|525428395|FG003|Overall Study|Lost to Follow-up|8|||
145702816|NCT00150618|525428396|FG004|Overall Study|Lost to Follow-up|4|||
145702817|NCT00150618|525428392|FG000|Overall Study|Protocol Violation|1|||
145702818|NCT00150618|525428393|FG001|Overall Study|Protocol Violation|0|||
145702819|NCT00150618|525428394|FG002|Overall Study|Protocol Violation|0|||
145702820|NCT00150618|525428395|FG003|Overall Study|Protocol Violation|0|||
145702821|NCT00150618|525428396|FG004|Overall Study|Protocol Violation|1|||
145702822|NCT00150618|525428392|FG000|Overall Study|Lack of Efficacy|1|||
145702823|NCT00150618|525428393|FG001|Overall Study|Lack of Efficacy|4|||
145702824|NCT00150618|525428394|FG002|Overall Study|Lack of Efficacy|7|||
145702825|NCT00150618|525428395|FG003|Overall Study|Lack of Efficacy|4|||
145702826|NCT00150618|525428396|FG004|Overall Study|Lack of Efficacy|6|||
145702827|NCT00150618|525428392|FG000|Overall Study|No study meds|0|||
145702828|NCT00150618|525428393|FG001|Overall Study|No study meds|0|||
145702829|NCT00150618|525428394|FG002|Overall Study|No study meds|0|||
145702830|NCT00150618|525428395|FG003|Overall Study|No study meds|0|||
145702831|NCT00150618|525428396|FG004|Overall Study|No study meds|2|||
145702832|NCT00150618|525428392|FG000|Overall Study|Physician Decision|0|||
145702833|NCT00150618|525428393|FG001|Overall Study|Physician Decision|2|||
145702834|NCT00150618|525428394|FG002|Overall Study|Physician Decision|0|||
145702835|NCT00150618|525428395|FG003|Overall Study|Physician Decision|0|||
145702836|NCT00150618|525428396|FG004|Overall Study|Physician Decision|1|||
145702837|NCT00150618|525428392|FG000|Overall Study|Lack of compliance|2|||
145702838|NCT00150618|525428393|FG001|Overall Study|Lack of compliance|1|||
145702839|NCT00150618|525428394|FG002|Overall Study|Lack of compliance|1|||
145702840|NCT00150618|525428395|FG003|Overall Study|Lack of compliance|0|||
145702841|NCT00150618|525428396|FG004|Overall Study|Lack of compliance|1|||
145702842|NCT00150618|525428392|FG000|Overall Study|Abnormal ECG|1|||
145702843|NCT00150618|525428393|FG001|Overall Study|Abnormal ECG|0|||
145702844|NCT00150618|525428394|FG002|Overall Study|Abnormal ECG|0|||
145702845|NCT00150618|525428395|FG003|Overall Study|Abnormal ECG|0|||
145702846|NCT00150618|525428396|FG004|Overall Study|Abnormal ECG|0|||
145702847|NCT00150618|525428392|FG000|Overall Study|Sponsor's decision|0|||
145702848|NCT00150618|525428393|FG001|Overall Study|Sponsor's decision|0|||
145702849|NCT00150618|525428394|FG002|Overall Study|Sponsor's decision|0|||
145702850|NCT00150618|525428395|FG003|Overall Study|Sponsor's decision|1|||
145702851|NCT00150618|525428396|FG004|Overall Study|Sponsor's decision|0|||
145702852|NCT04092452|525428397|FG000|Overall Study|Adverse Event|1|||
145702853|NCT04092452|525428398|FG001|Overall Study|Adverse Event|3|||
145702854|NCT04092452|525428399|FG002|Overall Study|Adverse Event|3|||
145702855|NCT04092452|525428400|FG003|Overall Study|Adverse Event|7|||
145702856|NCT04092452|525428397|FG000|Overall Study|Lack of Efficacy|1|||
145702857|NCT04092452|525428398|FG001|Overall Study|Lack of Efficacy|1|||
145491437|NCT00883779|524653804|FG000|Primary Study Treatment Phase|Other|3|||
145702858|NCT04092452|525428399|FG002|Overall Study|Lack of Efficacy|1|||
145702859|NCT04092452|525428400|FG003|Overall Study|Lack of Efficacy|0|||
145702860|NCT04092452|525428397|FG000|Overall Study|Lost to Follow-up|4|||
145702861|NCT04092452|525428398|FG001|Overall Study|Lost to Follow-up|3|||
145702862|NCT04092452|525428399|FG002|Overall Study|Lost to Follow-up|5|||
145702863|NCT04092452|525428400|FG003|Overall Study|Lost to Follow-up|1|||
145702864|NCT04092452|525428397|FG000|Overall Study|Non-Compliance With Study Drug|0|||
145702865|NCT04092452|525428398|FG001|Overall Study|Non-Compliance With Study Drug|0|||
145702866|NCT04092452|525428399|FG002|Overall Study|Non-Compliance With Study Drug|1|||
145702867|NCT04092452|525428400|FG003|Overall Study|Non-Compliance With Study Drug|1|||
145702868|NCT04092452|525428397|FG000|Overall Study|Physician Decision|1|||
145702869|NCT04092452|525428398|FG001|Overall Study|Physician Decision|0|||
145702870|NCT04092452|525428399|FG002|Overall Study|Physician Decision|1|||
145702871|NCT04092452|525428400|FG003|Overall Study|Physician Decision|0|||
145702872|NCT04092452|525428397|FG000|Overall Study|Pregnancy|2|||
145702873|NCT04092452|525428398|FG001|Overall Study|Pregnancy|0|||
145702874|NCT04092452|525428399|FG002|Overall Study|Pregnancy|0|||
145702875|NCT04092452|525428400|FG003|Overall Study|Pregnancy|0|||
145702876|NCT04092452|525428397|FG000|Overall Study|Protocol Deviation|1|||
145702877|NCT04092452|525428398|FG001|Overall Study|Protocol Deviation|0|||
145702878|NCT04092452|525428399|FG002|Overall Study|Protocol Deviation|0|||
145702879|NCT04092452|525428400|FG003|Overall Study|Protocol Deviation|0|||
145702880|NCT04092452|525428397|FG000|Overall Study|Withdrawal by Subject|3|||
145702881|NCT04092452|525428398|FG001|Overall Study|Withdrawal by Subject|10|||
145702882|NCT04092452|525428399|FG002|Overall Study|Withdrawal by Subject|3|||
145702883|NCT04092452|525428400|FG003|Overall Study|Withdrawal by Subject|5|||
145702884|NCT04092452|525428397|FG000|Overall Study|Other|0|||
145702885|NCT04092452|525428398|FG001|Overall Study|Other|0|||
145702886|NCT04092452|525428399|FG002|Overall Study|Other|1|||
145702887|NCT04092452|525428400|FG003|Overall Study|Other|2|||
145702888|NCT01012947|525428408|FG000|Overall Study|Lost to Follow-up|131|||
145702889|NCT01012947|525428409|FG001|Overall Study|Lost to Follow-up|135|||
145702890|NCT01012947|525428410|FG002|Overall Study|Lost to Follow-up|130|||
145702891|NCT01012947|525428411|FG003|Overall Study|Lost to Follow-up|118|||
145702892|NCT01012947|525428412|FG004|Overall Study|Lost to Follow-up|142|||
145702893|NCT02127125|525428413|FG000|Overall Study|Lost to Follow-up|0|||
145702894|NCT02127125|525428414|FG001|Overall Study|Lost to Follow-up|0|||
145702895|NCT02127125|525428415|FG002|Overall Study|Lost to Follow-up|0|||
145702896|NCT02127125|525428416|FG003|Overall Study|Lost to Follow-up|0|||
145702897|NCT02127125|525428417|FG004|Overall Study|Lost to Follow-up|2|||
145702898|NCT02127125|525428418|FG005|Overall Study|Lost to Follow-up|1|||
145702899|NCT02127125|525428419|FG006|Overall Study|Lost to Follow-up|0|||
145702900|NCT02127125|525428420|FG007|Overall Study|Lost to Follow-up|0|||
145702901|NCT02127125|525428421|FG008|Overall Study|Lost to Follow-up|0|||
145702902|NCT02127125|525428413|FG000|Overall Study|Withdrawal by Subject|0|||
145702903|NCT02127125|525428414|FG001|Overall Study|Withdrawal by Subject|0|||
145702904|NCT02127125|525428415|FG002|Overall Study|Withdrawal by Subject|0|||
145702905|NCT02127125|525428416|FG003|Overall Study|Withdrawal by Subject|1|||
145702906|NCT02127125|525428417|FG004|Overall Study|Withdrawal by Subject|0|||
145702907|NCT02127125|525428418|FG005|Overall Study|Withdrawal by Subject|0|||
145702908|NCT02127125|525428419|FG006|Overall Study|Withdrawal by Subject|0|||
145702909|NCT02127125|525428420|FG007|Overall Study|Withdrawal by Subject|0|||
145702910|NCT02127125|525428421|FG008|Overall Study|Withdrawal by Subject|0|||
145702911|NCT02127125|525428413|FG000|Overall Study|Physician Decision|0|||
145702912|NCT02127125|525428414|FG001|Overall Study|Physician Decision|0|||
145702913|NCT02127125|525428415|FG002|Overall Study|Physician Decision|1|||
145702914|NCT02127125|525428416|FG003|Overall Study|Physician Decision|0|||
145702915|NCT02127125|525428417|FG004|Overall Study|Physician Decision|1|||
145702916|NCT02127125|525428418|FG005|Overall Study|Physician Decision|2|||
145702917|NCT02127125|525428419|FG006|Overall Study|Physician Decision|0|||
145702918|NCT02127125|525428420|FG007|Overall Study|Physician Decision|0|||
145702919|NCT02127125|525428421|FG008|Overall Study|Physician Decision|0|||
145702920|NCT02493946|525428425|FG000|DB Period|Withdrawal by Subject|8|||
145702921|NCT02493946|525428426|FG001|DB Period|Withdrawal by Subject|5|||
145702922|NCT02493946|525428427|FG002|DB Period|Withdrawal by Subject|0|||
145702923|NCT02493946|525428425|FG000|Open Label Period|Withdrawal by Subject|0|||
145702924|NCT02493946|525428426|FG001|Open Label Period|Withdrawal by Subject|0|||
145702925|NCT02493946|525428427|FG002|Open Label Period|Withdrawal by Subject|74|||
145702926|NCT02493946|525428425|FG000|Open Label Period|Adverse Event|0|||
145702927|NCT02493946|525428426|FG001|Open Label Period|Adverse Event|0|||
145702928|NCT02493946|525428427|FG002|Open Label Period|Adverse Event|4|||
145702929|NCT02493946|525428425|FG000|Open Label Period|Lost to Follow-up|0|||
145702930|NCT02493946|525428426|FG001|Open Label Period|Lost to Follow-up|0|||
145702931|NCT02493946|525428427|FG002|Open Label Period|Lost to Follow-up|1|||
145702932|NCT02493946|525428425|FG000|Open Label Period|Investigator decision, non-compliance|0|||
145702933|NCT02493946|525428426|FG001|Open Label Period|Investigator decision, non-compliance|0|||
145702934|NCT02493946|525428427|FG002|Open Label Period|Investigator decision, non-compliance|2|||
145702935|NCT02493946|525428425|FG000|Open Label Period|Investigator decision, non-availability|0|||
145702936|NCT02493946|525428426|FG001|Open Label Period|Investigator decision, non-availability|0|||
145702937|NCT02493946|525428427|FG002|Open Label Period|Investigator decision, non-availability|1|||
145702938|NCT02493946|525428425|FG000|Open Label Period|Pregnancy|0|||
145702939|NCT02493946|525428426|FG001|Open Label Period|Pregnancy|0|||
145702940|NCT02493946|525428427|FG002|Open Label Period|Pregnancy|3|||
145702941|NCT02493946|525428425|FG000|Open Label Period|Site error|0|||
145702942|NCT02493946|525428426|FG001|Open Label Period|Site error|0|||
145702943|NCT02493946|525428427|FG002|Open Label Period|Site error|1|||
145702944|NCT00762476|525428431|FG000|Overall Study|Adverse Event|7|||
145702945|NCT00762476|525428432|FG001|Overall Study|Adverse Event|1|||
145702946|NCT00762476|525428431|FG000|Overall Study|Lost to Follow-up|2|||
145702947|NCT00762476|525428432|FG001|Overall Study|Lost to Follow-up|0|||
145702948|NCT00762476|525428431|FG000|Overall Study|Protocol Violation|5|||
145702949|NCT00762476|525428432|FG001|Overall Study|Protocol Violation|6|||
145702950|NCT00762476|525428431|FG000|Overall Study|Physician Decision|2|||
145702951|NCT00762476|525428432|FG001|Overall Study|Physician Decision|14|||
145702952|NCT00762476|525428431|FG000|Overall Study|Withdrawal by Subject|6|||
145702953|NCT00762476|525428432|FG001|Overall Study|Withdrawal by Subject|12|||
145702954|NCT00762476|525428431|FG000|Overall Study|antibiotic use|0|||
145702955|NCT00762476|525428432|FG001|Overall Study|antibiotic use|1|||
145702956|NCT00762476|525428431|FG000|Overall Study|non-compliance with study visits|0|||
145702957|NCT00762476|525428432|FG001|Overall Study|non-compliance with study visits|2|||
145702958|NCT00762476|525428431|FG000|Overall Study|Seasonal allergies|1|||
145702959|NCT00762476|525428432|FG001|Overall Study|Seasonal allergies|0|||
145702960|NCT00965497|525428433|FG000|Overall Study|Physician Decision|1|||
145702961|NCT02878603|525428435|FG000|Overall Study|Lost to Follow-up|4|||
145702962|NCT02878603|525428436|FG001|Overall Study|Lost to Follow-up|1|||
145702963|NCT02878603|525428435|FG000|Overall Study|Withdrawal by Subject|1|||
145702964|NCT02878603|525428436|FG001|Overall Study|Withdrawal by Subject|1|||
145702965|NCT02878603|525428435|FG000|Overall Study|Death|1|||
145702966|NCT02878603|525428436|FG001|Overall Study|Death|0|||
145702967|NCT02878603|525428435|FG000|Overall Study|Physician Decision|0|||
145702968|NCT02878603|525428436|FG001|Overall Study|Physician Decision|3|||
145702969|NCT02689453|525428437|FG000|Overall Study|Progressive disease|0|||
145702970|NCT02689453|525428438|FG001|Overall Study|Progressive disease|1|||
145702971|NCT02689453|525428439|FG002|Overall Study|Progressive disease|1|||
145702972|NCT02638103|525428440|FG000|Overall Study|Adverse Event|13|||
145702973|NCT02638103|525428441|FG001|Overall Study|Adverse Event|12|||
145702974|NCT02638103|525428442|FG002|Overall Study|Adverse Event|19|||
145702975|NCT02638103|525428443|FG003|Overall Study|Adverse Event|12|||
145702976|NCT02638103|525428440|FG000|Overall Study|Withdrawal by Subject|43|||
145702977|NCT02638103|525428441|FG001|Overall Study|Withdrawal by Subject|53|||
145702978|NCT02638103|525428442|FG002|Overall Study|Withdrawal by Subject|30|||
145702979|NCT02638103|525428443|FG003|Overall Study|Withdrawal by Subject|61|||
145702980|NCT02638103|525428440|FG000|Overall Study|Protocol Violation|1|||
145702981|NCT02638103|525428441|FG001|Overall Study|Protocol Violation|2|||
145702982|NCT02638103|525428442|FG002|Overall Study|Protocol Violation|1|||
145702983|NCT02638103|525428443|FG003|Overall Study|Protocol Violation|4|||
145702984|NCT02638103|525428440|FG000|Overall Study|Pregnancy|2|||
145702985|NCT02638103|525428441|FG001|Overall Study|Pregnancy|3|||
145702986|NCT02638103|525428442|FG002|Overall Study|Pregnancy|0|||
145702987|NCT02638103|525428443|FG003|Overall Study|Pregnancy|1|||
145702988|NCT02638103|525428440|FG000|Overall Study|Non-compliance to Study Procedures|2|||
145702989|NCT02638103|525428441|FG001|Overall Study|Non-compliance to Study Procedures|1|||
145702990|NCT02638103|525428442|FG002|Overall Study|Non-compliance to Study Procedures|1|||
145702991|NCT02638103|525428443|FG003|Overall Study|Non-compliance to Study Procedures|1|||
145702992|NCT02638103|525428440|FG000|Overall Study|Lost to Follow-up|26|||
145702993|NCT02638103|525428441|FG001|Overall Study|Lost to Follow-up|33|||
145702994|NCT02638103|525428442|FG002|Overall Study|Lost to Follow-up|20|||
145702995|NCT02638103|525428443|FG003|Overall Study|Lost to Follow-up|37|||
145702996|NCT02638103|525428440|FG000|Overall Study|Lack of Efficacy|14|||
145702997|NCT02638103|525428441|FG001|Overall Study|Lack of Efficacy|10|||
145702998|NCT02638103|525428442|FG002|Overall Study|Lack of Efficacy|12|||
145702999|NCT02638103|525428443|FG003|Overall Study|Lack of Efficacy|22|||
145703000|NCT02638103|525428440|FG000|Overall Study|Other than specified|5|||
145703001|NCT02638103|525428441|FG001|Overall Study|Other than specified|4|||
145703002|NCT02638103|525428442|FG002|Overall Study|Other than specified|2|||
145703003|NCT02638103|525428443|FG003|Overall Study|Other than specified|4|||
145703004|NCT01358331|525428445|FG000|Overall Study|Lost to Follow-up|0|||
145703005|NCT01358331|525428446|FG001|Overall Study|Lost to Follow-up|0|||
145703006|NCT01358331|525428447|FG002|Overall Study|Lost to Follow-up|0|||
145703007|NCT01358331|525428448|FG003|Overall Study|Lost to Follow-up|1|||
145703008|NCT01358331|525428449|FG004|Overall Study|Lost to Follow-up|0|||
145703009|NCT01358331|525428450|FG005|Overall Study|Lost to Follow-up|0|||
145703010|NCT01358331|525428445|FG000|Overall Study|Withdrawal by Subject|0|||
145703011|NCT01358331|525428446|FG001|Overall Study|Withdrawal by Subject|0|||
145703012|NCT01358331|525428447|FG002|Overall Study|Withdrawal by Subject|0|||
145703013|NCT01358331|525428448|FG003|Overall Study|Withdrawal by Subject|1|||
145491438|NCT00883779|524653805|FG001|Primary Study Treatment Phase|Other|0|||
145491439|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Adverse Event|2|||
145703014|NCT01358331|525428449|FG004|Overall Study|Withdrawal by Subject|1|||
145703015|NCT01358331|525428450|FG005|Overall Study|Withdrawal by Subject|1|||
145703016|NCT01358331|525428445|FG000|Overall Study|Adverse Events|1|||
145703017|NCT01358331|525428446|FG001|Overall Study|Adverse Events|1|||
145703018|NCT01358331|525428447|FG002|Overall Study|Adverse Events|1|||
145703019|NCT01358331|525428448|FG003|Overall Study|Adverse Events|0|||
145703020|NCT01358331|525428449|FG004|Overall Study|Adverse Events|1|||
145703021|NCT01358331|525428450|FG005|Overall Study|Adverse Events|5|||
145703022|NCT01358331|525428445|FG000|Overall Study|Symptomatic Deterioration|0|||
145703023|NCT01358331|525428446|FG001|Overall Study|Symptomatic Deterioration|0|||
145703024|NCT01358331|525428447|FG002|Overall Study|Symptomatic Deterioration|0|||
145703025|NCT01358331|525428448|FG003|Overall Study|Symptomatic Deterioration|0|||
145703026|NCT01358331|525428449|FG004|Overall Study|Symptomatic Deterioration|1|||
145703027|NCT01358331|525428450|FG005|Overall Study|Symptomatic Deterioration|0|||
145703028|NCT01358331|525428445|FG000|Overall Study|Participants did not wish to continue|0|||
145703029|NCT01358331|525428446|FG001|Overall Study|Participants did not wish to continue|0|||
145703030|NCT01358331|525428447|FG002|Overall Study|Participants did not wish to continue|0|||
145703031|NCT01358331|525428448|FG003|Overall Study|Participants did not wish to continue|0|||
145703032|NCT01358331|525428449|FG004|Overall Study|Participants did not wish to continue|1|||
145703033|NCT01358331|525428450|FG005|Overall Study|Participants did not wish to continue|0|||
145703034|NCT01358331|525428445|FG000|Overall Study|Progress of disease under investigation|1|||
145703035|NCT01358331|525428446|FG001|Overall Study|Progress of disease under investigation|2|||
145703036|NCT01358331|525428447|FG002|Overall Study|Progress of disease under investigation|3|||
145703037|NCT01358331|525428448|FG003|Overall Study|Progress of disease under investigation|1|||
145703038|NCT01358331|525428449|FG004|Overall Study|Progress of disease under investigation|3|||
145703039|NCT01358331|525428450|FG005|Overall Study|Progress of disease under investigation|0|||
145703040|NCT04674189|525428451|FG000|Overall Study|Adverse Event|0|||
145703041|NCT04674189|525428452|FG001|Overall Study|Adverse Event|0|||
145703042|NCT04674189|525428453|FG002|Overall Study|Adverse Event|1|||
145703043|NCT04674189|525428451|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
145703044|NCT04674189|525428452|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
145703045|NCT04674189|525428453|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
145703046|NCT04674189|525428451|FG000|Overall Study|Physician Decision|1|||
145703047|NCT04674189|525428452|FG001|Overall Study|Physician Decision|0|||
145703048|NCT04674189|525428453|FG002|Overall Study|Physician Decision|0|||
145703049|NCT04674189|525428451|FG000|Overall Study|Withdrawal by Participant|83|||
145703050|NCT04674189|525428452|FG001|Overall Study|Withdrawal by Participant|71|||
145703051|NCT04674189|525428453|FG002|Overall Study|Withdrawal by Participant|142|||
145703052|NCT04674189|525428451|FG000|Overall Study|Lost to Follow-up|55|||
145703053|NCT04674189|525428452|FG001|Overall Study|Lost to Follow-up|53|||
145703054|NCT04674189|525428453|FG002|Overall Study|Lost to Follow-up|44|||
145703055|NCT04674189|525428451|FG000|Overall Study|Miscellaneous|27|||
145703056|NCT04674189|525428452|FG001|Overall Study|Miscellaneous|23|||
145703057|NCT04674189|525428453|FG002|Overall Study|Miscellaneous|207|||
145703058|NCT04674189|525428451|FG000|Overall Study|Did Not Receive Treatment|3|||
145703059|NCT04674189|525428452|FG001|Overall Study|Did Not Receive Treatment|1|||
145703060|NCT04674189|525428453|FG002|Overall Study|Did Not Receive Treatment|2|||
145703061|NCT02838134|525428454|FG000|Overall Study|Lost to Follow-up|1|||
145703062|NCT02838134|525428455|FG001|Overall Study|Lost to Follow-up|2|||
145703063|NCT02838134|525428454|FG000|Overall Study|logistic problems|1|||
145703064|NCT02838134|525428455|FG001|Overall Study|logistic problems|1|||
145703065|NCT01637077|525428459|FG000|Overall Study|Cancel|1|||
145703066|NCT01637077|525428460|FG001|Overall Study|Cancel|1|||
145703067|NCT01637077|525428459|FG000|Overall Study|Withdrawal by Subject|1|||
145703068|NCT01637077|525428460|FG001|Overall Study|Withdrawal by Subject|0|||
145703069|NCT01637077|525428459|FG000|Overall Study|No cycle 1 questionnaire data|2|||
145703070|NCT01637077|525428460|FG001|Overall Study|No cycle 1 questionnaire data|0|||
145703071|NCT01162486|525428462|FG000|Overall Study|low ANC|1|||
145703072|NCT01162486|525428463|FG001|Overall Study|low ANC|0|||
145703073|NCT01162486|525428464|FG002|Overall Study|low ANC|0|||
145703074|NCT01162486|525428465|FG003|Overall Study|low ANC|0|||
145703075|NCT01162486|525428466|FG004|Overall Study|low ANC|0|||
145703076|NCT01162486|525428462|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
145703077|NCT01162486|525428463|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
145703078|NCT01162486|525428464|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
145703079|NCT01162486|525428465|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
145703080|NCT01162486|525428466|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
145703081|NCT01162486|525428462|FG000|Overall Study|elevated LFTs|0|||
145703082|NCT01162486|525428463|FG001|Overall Study|elevated LFTs|0|||
145703083|NCT01162486|525428464|FG002|Overall Study|elevated LFTs|1|||
145703084|NCT01162486|525428465|FG003|Overall Study|elevated LFTs|0|||
145703085|NCT01162486|525428466|FG004|Overall Study|elevated LFTs|0|||
145703086|NCT01162486|525428462|FG000|Overall Study|Pregnancy|0|||
145703087|NCT01162486|525428463|FG001|Overall Study|Pregnancy|0|||
145703088|NCT01162486|525428464|FG002|Overall Study|Pregnancy|0|||
145703089|NCT01162486|525428465|FG003|Overall Study|Pregnancy|1|||
145703090|NCT01162486|525428466|FG004|Overall Study|Pregnancy|0|||
145703091|NCT00794924|525428467|FG000|Overall Study|Lost to Follow-up|6|||
145703092|NCT00794924|525428468|FG001|Overall Study|Lost to Follow-up|8|||
145703093|NCT00794924|525428467|FG000|Overall Study|Withdrawal by Subject|48|||
145703094|NCT00794924|525428468|FG001|Overall Study|Withdrawal by Subject|60|||
145703095|NCT00794924|525428467|FG000|Overall Study|Adverse Event|6|||
145703096|NCT00794924|525428468|FG001|Overall Study|Adverse Event|2|||
145703097|NCT00953615|525428469|FG000|Overall Study|Adverse Event|1|||
145703098|NCT03332784|525428470|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703099|NCT03332784|525428471|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
145703100|NCT03332784|525428472|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703101|NCT03332784|525428473|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703102|NCT03332784|525428474|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703103|NCT03332784|525428475|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703104|NCT03332784|525428476|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703105|NCT03332784|525428477|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703106|NCT03332784|525428478|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703107|NCT03332784|525428479|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703108|NCT03332784|525428480|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703109|NCT03332784|525428481|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703110|NCT03332784|525428482|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703111|NCT03332784|525428483|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703112|NCT03332784|525428484|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
145703113|NCT03332784|525428485|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703114|NCT03332784|525428486|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703115|NCT03332784|525428487|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703116|NCT03332784|525428488|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703117|NCT03332784|525428489|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
145703118|NCT01294436|525428499|FG000|Overall Study|Adverse Event|10|||
145703119|NCT01294436|525428500|FG001|Overall Study|Adverse Event|17|||
145703120|NCT01294436|525428499|FG000|Overall Study|Withdrawal by Subject|11|||
145703121|NCT01294436|525428500|FG001|Overall Study|Withdrawal by Subject|28|||
145703122|NCT01294436|525428499|FG000|Overall Study|subject no longer meets study criteria|5|||
145703123|NCT01294436|525428500|FG001|Overall Study|subject no longer meets study criteria|20|||
145703124|NCT01294436|525428499|FG000|Overall Study|poor/non-compliance|2|||
145703125|NCT01294436|525428500|FG001|Overall Study|poor/non-compliance|5|||
145703126|NCT02389764|525428501|FG000|Overall Study|Lack of Efficacy|9|||
145703127|NCT01255761|525428510|FG000|Overall Study|Adverse Event|29|||
145703128|NCT01255761|525428511|FG001|Overall Study|Adverse Event|43|||
145703129|NCT01255761|525428510|FG000|Overall Study|Lack of Efficacy|86|||
145703130|NCT01255761|525428511|FG001|Overall Study|Lack of Efficacy|74|||
145703131|NCT01255761|525428510|FG000|Overall Study|Protocol Violation|9|||
145703132|NCT01255761|525428511|FG001|Overall Study|Protocol Violation|5|||
145703133|NCT01255761|525428510|FG000|Overall Study|Lost to Follow-up|10|||
145703134|NCT01255761|525428511|FG001|Overall Study|Lost to Follow-up|8|||
145703135|NCT01255761|525428510|FG000|Overall Study|Withdrawal by Subject|11|||
145703136|NCT01255761|525428511|FG001|Overall Study|Withdrawal by Subject|27|||
145703137|NCT01255761|525428510|FG000|Overall Study|Other Reasons|37|||
145703138|NCT01255761|525428511|FG001|Overall Study|Other Reasons|18|||
145703139|NCT03170518|525428515|FG000|Overall Study|Lost to Follow-up|4|||
145703140|NCT03170518|525428516|FG001|Overall Study|Lost to Follow-up|1|||
145703141|NCT03170518|525428517|FG002|Overall Study|Lost to Follow-up|0|||
145703142|NCT03170518|525428515|FG000|Overall Study|Physician Decision|1|||
145703143|NCT03170518|525428516|FG001|Overall Study|Physician Decision|0|||
145703144|NCT03170518|525428517|FG002|Overall Study|Physician Decision|0|||
145703145|NCT03170518|525428515|FG000|Overall Study|Withdrawal by Subject|4|||
145703146|NCT03170518|525428516|FG001|Overall Study|Withdrawal by Subject|5|||
145703147|NCT03170518|525428517|FG002|Overall Study|Withdrawal by Subject|2|||
145703148|NCT03170518|525428515|FG000|Overall Study|Site terminated by sponsor|0|||
145703149|NCT03170518|525428516|FG001|Overall Study|Site terminated by sponsor|1|||
145703150|NCT03170518|525428517|FG002|Overall Study|Site terminated by sponsor|0|||
145703151|NCT03170518|525428515|FG000|Overall Study|Non-compliance with study drug|1|||
145703152|NCT03170518|525428516|FG001|Overall Study|Non-compliance with study drug|0|||
145703153|NCT03170518|525428517|FG002|Overall Study|Non-compliance with study drug|1|||
145703154|NCT03170518|525428515|FG000|Overall Study|Withdrawal by parent/guardian|2|||
145703155|NCT03170518|525428516|FG001|Overall Study|Withdrawal by parent/guardian|0|||
145703156|NCT03170518|525428517|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145703157|NCT03842436|525428518|FG000|Overall Study|Lost to Follow-up|1|||
145703158|NCT01263054|525428521|FG000|Overall Study|Death|1|||
145703159|NCT01263054|525428522|FG001|Overall Study|Death|0|||
145703160|NCT01263054|525428521|FG000|Overall Study|Lost to Follow-up|2|||
145703161|NCT01263054|525428522|FG001|Overall Study|Lost to Follow-up|2|||
145703162|NCT01263054|525428521|FG000|Overall Study|Withdrawal by Subject|1|||
145703163|NCT01263054|525428522|FG001|Overall Study|Withdrawal by Subject|3|||
145703164|NCT01263054|525428521|FG000|Overall Study|Qualification Violation|1|||
145703165|NCT01263054|525428522|FG001|Overall Study|Qualification Violation|0|||
145703166|NCT01263054|525428521|FG000|Overall Study|Other|0|||
145703167|NCT01263054|525428522|FG001|Overall Study|Other|1|||
145703168|NCT00936598|525428523|FG000|Overall Study|Withdrawal by Subject|1|||
145703169|NCT00936598|525428524|FG001|Overall Study|Withdrawal by Subject|0|||
145703170|NCT00936598|525428523|FG000|Overall Study|Ineligible after consent|1|||
145703171|NCT00936598|525428524|FG001|Overall Study|Ineligible after consent|0|||
145703172|NCT03358238|525428525|FG000|Overall Study|Withdrawal by Subject|0|||
145703173|NCT03358238|525428526|FG001|Overall Study|Withdrawal by Subject|1|||
145703174|NCT02358668|525430655|FG000|Overall Study|Adverse Event|2|||
145703175|NCT02358668|525430656|FG001|Overall Study|Adverse Event|0|||
145703176|NCT02358668|525430657|FG002|Overall Study|Adverse Event|0|||
145703177|NCT02358668|525430655|FG000|Overall Study|Withdrawal by Subject|0|||
145703178|NCT02358668|525430656|FG001|Overall Study|Withdrawal by Subject|1|||
145703179|NCT02358668|525430657|FG002|Overall Study|Withdrawal by Subject|0|||
145703180|NCT01317875|525430663|FG000|Overall Study|Other|0|||
145703181|NCT01317875|525430664|FG001|Overall Study|Other|0|||
145703182|NCT01317875|525430665|FG002|Overall Study|Other|1|||
145703183|NCT01317875|525430666|FG003|Overall Study|Other|0|||
145703184|NCT01317875|525430667|FG004|Overall Study|Other|0|||
145703185|NCT01317875|525430668|FG005|Overall Study|Other|0|||
145703186|NCT01317875|525430669|FG006|Overall Study|Other|0|||
145703187|NCT01317875|525430670|FG007|Overall Study|Other|0|||
145703188|NCT01317875|525430671|FG008|Overall Study|Other|0|||
145703189|NCT01317875|525430672|FG009|Overall Study|Other|0|||
145703190|NCT01317875|525430663|FG000|Overall Study|Noncompliance with study drug|0|||
145703191|NCT01317875|525430664|FG001|Overall Study|Noncompliance with study drug|0|||
145703192|NCT01317875|525430665|FG002|Overall Study|Noncompliance with study drug|1|||
145703193|NCT01317875|525430666|FG003|Overall Study|Noncompliance with study drug|0|||
145703194|NCT01317875|525430667|FG004|Overall Study|Noncompliance with study drug|0|||
145703195|NCT01317875|525430668|FG005|Overall Study|Noncompliance with study drug|0|||
145703196|NCT01317875|525430669|FG006|Overall Study|Noncompliance with study drug|0|||
145703197|NCT01317875|525430670|FG007|Overall Study|Noncompliance with study drug|0|||
145703198|NCT01317875|525430671|FG008|Overall Study|Noncompliance with study drug|0|||
145703199|NCT01317875|525430672|FG009|Overall Study|Noncompliance with study drug|0|||
145703200|NCT01317875|525430663|FG000|Overall Study|Progressive Disease|1|||
145703201|NCT01317875|525430664|FG001|Overall Study|Progressive Disease|0|||
145703202|NCT01317875|525430665|FG002|Overall Study|Progressive Disease|2|||
145703203|NCT01317875|525430666|FG003|Overall Study|Progressive Disease|0|||
145703204|NCT01317875|525430667|FG004|Overall Study|Progressive Disease|1|||
145703205|NCT01317875|525430668|FG005|Overall Study|Progressive Disease|0|||
145703206|NCT01317875|525430669|FG006|Overall Study|Progressive Disease|0|||
145703207|NCT01317875|525430670|FG007|Overall Study|Progressive Disease|1|||
145703208|NCT01317875|525430671|FG008|Overall Study|Progressive Disease|0|||
145703209|NCT01317875|525430672|FG009|Overall Study|Progressive Disease|0|||
145703210|NCT01317875|525430663|FG000|Overall Study|Withdrawal by Subject|0|||
145703211|NCT01317875|525430664|FG001|Overall Study|Withdrawal by Subject|0|||
145703212|NCT01317875|525430665|FG002|Overall Study|Withdrawal by Subject|0|||
145703213|NCT01317875|525430666|FG003|Overall Study|Withdrawal by Subject|0|||
145703214|NCT01317875|525430667|FG004|Overall Study|Withdrawal by Subject|1|||
145703215|NCT01317875|525430668|FG005|Overall Study|Withdrawal by Subject|0|||
145703216|NCT01317875|525430669|FG006|Overall Study|Withdrawal by Subject|0|||
145703217|NCT01317875|525430670|FG007|Overall Study|Withdrawal by Subject|3|||
145703218|NCT01317875|525430671|FG008|Overall Study|Withdrawal by Subject|0|||
145703219|NCT01317875|525430672|FG009|Overall Study|Withdrawal by Subject|0|||
145703220|NCT01317875|525430663|FG000|Overall Study|Physician Decision|0|||
145703221|NCT01317875|525430664|FG001|Overall Study|Physician Decision|1|||
145703222|NCT01317875|525430665|FG002|Overall Study|Physician Decision|1|||
145703223|NCT01317875|525430666|FG003|Overall Study|Physician Decision|0|||
145703224|NCT01317875|525430667|FG004|Overall Study|Physician Decision|2|||
145703225|NCT01317875|525430668|FG005|Overall Study|Physician Decision|0|||
145703226|NCT01317875|525430669|FG006|Overall Study|Physician Decision|0|||
145703227|NCT01317875|525430670|FG007|Overall Study|Physician Decision|2|||
145703228|NCT01317875|525430671|FG008|Overall Study|Physician Decision|0|||
145703229|NCT01317875|525430672|FG009|Overall Study|Physician Decision|0|||
145703230|NCT01317875|525430663|FG000|Overall Study|Death|0|||
145703231|NCT01317875|525430664|FG001|Overall Study|Death|0|||
145703232|NCT01317875|525430665|FG002|Overall Study|Death|2|||
145703233|NCT01317875|525430666|FG003|Overall Study|Death|1|||
145703234|NCT01317875|525430667|FG004|Overall Study|Death|0|||
145703235|NCT01317875|525430668|FG005|Overall Study|Death|1|||
145703236|NCT01317875|525430669|FG006|Overall Study|Death|0|||
145703237|NCT01317875|525430670|FG007|Overall Study|Death|4|||
145703238|NCT01317875|525430671|FG008|Overall Study|Death|0|||
145703239|NCT01317875|525430672|FG009|Overall Study|Death|0|||
145703240|NCT01317875|525430663|FG000|Overall Study|Adverse Event|2|||
145703241|NCT01317875|525430664|FG001|Overall Study|Adverse Event|1|||
145703242|NCT01317875|525430665|FG002|Overall Study|Adverse Event|2|||
145703243|NCT01317875|525430666|FG003|Overall Study|Adverse Event|1|||
145703244|NCT01317875|525430667|FG004|Overall Study|Adverse Event|5|||
145703245|NCT01317875|525430668|FG005|Overall Study|Adverse Event|1|||
145703246|NCT01317875|525430669|FG006|Overall Study|Adverse Event|2|||
145703247|NCT01317875|525430670|FG007|Overall Study|Adverse Event|5|||
145703248|NCT01317875|525430671|FG008|Overall Study|Adverse Event|0|||
145703249|NCT01317875|525430672|FG009|Overall Study|Adverse Event|0|||
145703250|NCT00233480|525430673|FG000|Overall Study|Underwent status II heart transplant|0|||
145703251|NCT00233480|525430674|FG001|Overall Study|Underwent status II heart transplant|1|||
145703252|NCT00592293|525430679|FG000|Overall Study|Withdrawal by Subject|1|||
145703253|NCT01606319|525430680|FG000|Overall Study|Lost to Follow-up|17|||
145703254|NCT01606319|525430681|FG001|Overall Study|Lost to Follow-up|14|||
145703255|NCT01606319|525430680|FG000|Overall Study|Withdrawal by Subject|9|||
145703256|NCT01606319|525430681|FG001|Overall Study|Withdrawal by Subject|12|||
145703257|NCT01606319|525430680|FG000|Overall Study|Physician Decision|1|||
145703258|NCT01606319|525430681|FG001|Overall Study|Physician Decision|2|||
145703259|NCT01606319|525430680|FG000|Overall Study|Lack of Efficacy|6|||
145703260|NCT01606319|525430681|FG001|Overall Study|Lack of Efficacy|8|||
145703261|NCT01606319|525430680|FG000|Overall Study|Adverse Event|1|||
145703262|NCT01606319|525430681|FG001|Overall Study|Adverse Event|4|||
145703263|NCT00022659|525430686|FG000|Overall Study|Ineligible: wrong primary|1|||
145703264|NCT00022659|525430686|FG000|Overall Study|Never treated|1|||
145703265|NCT01821937|525430693|FG000|Overall Study|Adverse Event|0|||
145703266|NCT01821937|525430694|FG001|Overall Study|Adverse Event|3|||
145703267|NCT02153905|525430695|FG000|Overall Study|Death|1|||
145703268|NCT02153905|525430696|FG001|Overall Study|Death|0|||
145703269|NCT00425607|525430701|FG000|Overall Study|Death|1|||
145703270|NCT00425607|525430701|FG000|Overall Study|Withdrawal by Subject|1|||
145703271|NCT02563548|525430702|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
145703272|NCT02563548|525430703|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
145703273|NCT02563548|525430704|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
145703274|NCT02563548|525430705|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
145703275|NCT02563548|525430706|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
145703276|NCT02563548|525430707|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
145703277|NCT02563548|525430702|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
145703278|NCT02563548|525430703|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
145703279|NCT02563548|525430704|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
145703280|NCT02563548|525430705|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
145703281|NCT02563548|525430706|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
145703282|NCT02563548|525430707|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
145703283|NCT02563548|525430702|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
145703284|NCT02563548|525430703|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
145703285|NCT02563548|525430704|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
145703286|NCT02563548|525430705|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
145703287|NCT02563548|525430706|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
145703288|NCT02563548|525430707|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
145703289|NCT02563548|525430702|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
145703290|NCT02563548|525430703|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
145703291|NCT02563548|525430704|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
145703292|NCT02563548|525430705|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
145703293|NCT02563548|525430706|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
145703294|NCT02563548|525430707|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
145703295|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
145703296|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
145703297|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
145703298|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
145703299|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
145703300|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
145703301|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
145703302|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
145703303|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
145703304|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
145703305|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
145703306|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
145703307|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
145703308|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
145703309|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
145703310|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
145703311|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
145703312|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
145703313|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
145703314|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
145703315|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
145703316|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
145703317|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
145703318|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
145703319|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
145703320|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
145703321|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
145703322|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
145703323|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
145703324|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
145703325|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
145703326|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
145703327|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
145703328|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
145703329|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
145703330|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
145703331|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
145703332|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
145703333|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
145703334|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
145703335|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
145703336|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
145703337|NCT02563548|525430702|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
145703338|NCT02563548|525430703|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
145703339|NCT02563548|525430704|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
145703340|NCT02563548|525430705|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
145703341|NCT02563548|525430706|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
145703342|NCT02563548|525430707|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
145703343|NCT00203047|525430708|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
145703344|NCT00203047|525430709|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
145703345|NCT00203047|525430708|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
145703346|NCT00203047|525430709|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
145703347|NCT00203047|525430708|FG000|Overall Study|Withdrawal by Subject|13|||
145703348|NCT00203047|525430709|FG001|Overall Study|Withdrawal by Subject|47|||
145703349|NCT00203047|525430708|FG000|Overall Study|Teva requested participant withdrawal|1|||
145703350|NCT00203047|525430709|FG001|Overall Study|Teva requested participant withdrawal|1|||
145703351|NCT00203047|525430708|FG000|Overall Study|Physician Decision|8|||
145703352|NCT00203047|525430709|FG001|Overall Study|Physician Decision|7|||
145703353|NCT00203047|525430708|FG000|Overall Study|Non-compliance|4|||
145703354|NCT00203047|525430709|FG001|Overall Study|Non-compliance|8|||
145703355|NCT00203047|525430708|FG000|Overall Study|Protocol Violation|1|||
145703356|NCT00203047|525430709|FG001|Overall Study|Protocol Violation|0|||
145703357|NCT00203047|525430708|FG000|Overall Study|Lost to Follow-up|11|||
145703358|NCT00203047|525430709|FG001|Overall Study|Lost to Follow-up|5|||
145703359|NCT00203047|525430708|FG000|Overall Study|Adverse Event|8|||
145703360|NCT00203047|525430709|FG001|Overall Study|Adverse Event|18|||
145703361|NCT00203047|525430708|FG000|Overall Study|Death|1|||
145703362|NCT00203047|525430709|FG001|Overall Study|Death|2|||
145703363|NCT00203047|525430708|FG000|Overall Study|Pregnancy|3|||
145703364|NCT00203047|525430709|FG001|Overall Study|Pregnancy|0|||
145703365|NCT00203047|525430708|FG000|Overall Study|Other|5|||
145703366|NCT00203047|525430709|FG001|Overall Study|Other|5|||
145703367|NCT00351377|525430710|FG000|Overall Study|Adverse Event|5|||
145703368|NCT00351377|525430710|FG000|Overall Study|Death|1|||
145703369|NCT00351377|525430710|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145703370|NCT01163474|525430714|FG000|Overall Study|Withdrawal by Subject|1|||
145703371|NCT01163474|525430714|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
145703372|NCT01163474|525430714|FG000|Overall Study|Lost to Follow-up|3|||
145703373|NCT03274895|525430715|FG000|Overall Study|Lack of Efficacy|1|||
145703374|NCT03274895|525430716|FG001|Overall Study|Lack of Efficacy|0|||
145703375|NCT03274895|525430715|FG000|Overall Study|Adverse Event|8|||
145703376|NCT03274895|525430716|FG001|Overall Study|Adverse Event|7|||
145703377|NCT03274895|525430715|FG000|Overall Study|Lost to Follow-up|1|||
145703378|NCT03274895|525430716|FG001|Overall Study|Lost to Follow-up|0|||
145703379|NCT03274895|525430715|FG000|Overall Study|Diagnosis not confirmed|3|||
145703380|NCT03274895|525430716|FG001|Overall Study|Diagnosis not confirmed|4|||
145703381|NCT01969851|525430717|FG000|Overall Study|Adverse Event|0|||
145703382|NCT01969851|525430718|FG001|Overall Study|Adverse Event|0|||
145703383|NCT01969851|525430719|FG002|Overall Study|Adverse Event|3|||
145703384|NCT01969851|525430717|FG000|Overall Study|Lack of Efficacy|0|||
145703385|NCT01969851|525430718|FG001|Overall Study|Lack of Efficacy|3|||
145703386|NCT01969851|525430719|FG002|Overall Study|Lack of Efficacy|1|||
145703387|NCT01969851|525430717|FG000|Overall Study|Withdrawal by Subject|1|||
145703388|NCT01969851|525430718|FG001|Overall Study|Withdrawal by Subject|0|||
145491440|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Adverse Event|3|||
145703389|NCT01969851|525430719|FG002|Overall Study|Withdrawal by Subject|1|||
145703390|NCT01969851|525430717|FG000|Overall Study|No effective dose in Titration period|0|||
145703391|NCT01969851|525430718|FG001|Overall Study|No effective dose in Titration period|0|||
145703392|NCT01969851|525430719|FG002|Overall Study|No effective dose in Titration period|1|||
145703393|NCT01969851|525430717|FG000|Overall Study|Sponsor decision|0|||
145703394|NCT01969851|525430718|FG001|Overall Study|Sponsor decision|0|||
145703395|NCT01969851|525430719|FG002|Overall Study|Sponsor decision|1|||
145703396|NCT02498236|525430720|FG000|Overall Study|Did not show for testing|1|||
145491441|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Death|1|||
145703397|NCT02498236|525430721|FG001|Overall Study|Did not show for testing|0|||
145703398|NCT02498236|525430722|FG002|Overall Study|Did not show for testing|0|||
145703399|NCT02498236|525430723|FG003|Overall Study|Did not show for testing|0|||
145703400|NCT02498236|525430724|FG004|Overall Study|Did not show for testing|0|||
145703401|NCT02498236|525430725|FG005|Overall Study|Did not show for testing|0|||
145703402|NCT02498236|525430726|FG006|Overall Study|Did not show for testing|0|||
145703403|NCT02498236|525430727|FG007|Overall Study|Did not show for testing|1|||
145703404|NCT02498236|525430720|FG000|Overall Study|Equipment failure|0|||
145703405|NCT02498236|525430721|FG001|Overall Study|Equipment failure|0|||
145703406|NCT02498236|525430722|FG002|Overall Study|Equipment failure|0|||
145703407|NCT02498236|525430723|FG003|Overall Study|Equipment failure|0|||
145703408|NCT02498236|525430724|FG004|Overall Study|Equipment failure|0|||
145703409|NCT02498236|525430725|FG005|Overall Study|Equipment failure|0|||
145703410|NCT02498236|525430726|FG006|Overall Study|Equipment failure|1|||
145703411|NCT02498236|525430727|FG007|Overall Study|Equipment failure|0|||
145703412|NCT02498236|525430720|FG000|Overall Study|Withdrawal by Subject|0|||
145703413|NCT02498236|525430721|FG001|Overall Study|Withdrawal by Subject|0|||
145703414|NCT02498236|525430722|FG002|Overall Study|Withdrawal by Subject|0|||
145703415|NCT02498236|525430723|FG003|Overall Study|Withdrawal by Subject|0|||
145703416|NCT02498236|525430724|FG004|Overall Study|Withdrawal by Subject|1|||
145703417|NCT02498236|525430725|FG005|Overall Study|Withdrawal by Subject|0|||
145703418|NCT02498236|525430726|FG006|Overall Study|Withdrawal by Subject|0|||
145703419|NCT02498236|525430727|FG007|Overall Study|Withdrawal by Subject|0|||
145703420|NCT02296892|525430728|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
145703421|NCT02296892|525430729|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
145703422|NCT02296892|525430730|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
145703423|NCT02296892|525430728|FG000|Overall Study|Lost to Follow-up|5|||
145703424|NCT02296892|525430729|FG001|Overall Study|Lost to Follow-up|0|||
145703425|NCT02296892|525430730|FG002|Overall Study|Lost to Follow-up|1|||
145703426|NCT00383123|525430733|FG000|Overall Study|Adverse Event|1|||
145703427|NCT00383123|525430734|FG001|Overall Study|Adverse Event|0|||
145703428|NCT00383123|525430733|FG000|Overall Study|Lost to Follow-up|68|||
145703429|NCT00383123|525430734|FG001|Overall Study|Lost to Follow-up|61|||
145703430|NCT00383123|525430733|FG000|Overall Study|Protocol Violation|5|||
145703431|NCT00383123|525430734|FG001|Overall Study|Protocol Violation|1|||
145703432|NCT00383123|525430733|FG000|Overall Study|Withdrawal by Subject|27|||
145703433|NCT00383123|525430734|FG001|Overall Study|Withdrawal by Subject|18|||
145703434|NCT00383123|525430733|FG000|Overall Study|Other reason|10|||
145703435|NCT00383123|525430734|FG001|Overall Study|Other reason|6|||
145703436|NCT01814072|525430735|FG000|Overall Study|Lost to Follow-up|2|||
145703437|NCT01814072|525430736|FG001|Overall Study|Lost to Follow-up|2|||
145703438|NCT01814072|525430737|FG002|Overall Study|Lost to Follow-up|2|||
145703439|NCT01814072|525430738|FG003|Overall Study|Lost to Follow-up|0|||
145703440|NCT01814072|525430739|FG004|Overall Study|Lost to Follow-up|2|||
145703441|NCT01814072|525430740|FG005|Overall Study|Lost to Follow-up|3|||
145703442|NCT01814072|525430741|FG006|Overall Study|Lost to Follow-up|3|||
145703443|NCT01814072|525430742|FG007|Overall Study|Lost to Follow-up|1|||
145703444|NCT01814072|525430743|FG008|Overall Study|Lost to Follow-up|2|||
145703445|NCT01814072|525430744|FG009|Overall Study|Lost to Follow-up|3|||
145703446|NCT01814072|525430745|FG010|Overall Study|Lost to Follow-up|1|||
145703447|NCT01814072|525430746|FG011|Overall Study|Lost to Follow-up|2|||
145703448|NCT01814072|525430747|FG012|Overall Study|Lost to Follow-up|2|||
145703449|NCT01814072|525430748|FG013|Overall Study|Lost to Follow-up|1|||
145703450|NCT01814072|525430749|FG014|Overall Study|Lost to Follow-up|2|||
145703451|NCT01814072|525430750|FG015|Overall Study|Lost to Follow-up|1|||
145703452|NCT01814072|525430751|FG016|Overall Study|Lost to Follow-up|3|||
145703453|NCT01814072|525430752|FG017|Overall Study|Lost to Follow-up|1|||
145703454|NCT01814072|525430753|FG018|Overall Study|Lost to Follow-up|3|||
145703455|NCT01814072|525430754|FG019|Overall Study|Lost to Follow-up|3|||
145703456|NCT01814072|525430755|FG020|Overall Study|Lost to Follow-up|2|||
145703457|NCT01814072|525430756|FG021|Overall Study|Lost to Follow-up|1|||
145703458|NCT01814072|525430757|FG022|Overall Study|Lost to Follow-up|3|||
145703459|NCT01814072|525430758|FG023|Overall Study|Lost to Follow-up|1|||
145703460|NCT01814072|525430759|FG024|Overall Study|Lost to Follow-up|4|||
145703461|NCT01814072|525430760|FG025|Overall Study|Lost to Follow-up|1|||
145703462|NCT01814072|525430761|FG026|Overall Study|Lost to Follow-up|1|||
145703463|NCT01814072|525430762|FG027|Overall Study|Lost to Follow-up|2|||
145703464|NCT01814072|525430763|FG028|Overall Study|Lost to Follow-up|3|||
145703465|NCT01814072|525430764|FG029|Overall Study|Lost to Follow-up|3|||
145703466|NCT01814072|525430765|FG030|Overall Study|Lost to Follow-up|2|||
145703467|NCT01814072|525430766|FG031|Overall Study|Lost to Follow-up|0|||
145703468|NCT01814072|525430735|FG000|Overall Study|Withdrawal by Subject|2|||
145703469|NCT01814072|525430736|FG001|Overall Study|Withdrawal by Subject|0|||
145703470|NCT01814072|525430737|FG002|Overall Study|Withdrawal by Subject|1|||
145703471|NCT01814072|525430738|FG003|Overall Study|Withdrawal by Subject|0|||
145703472|NCT01814072|525430739|FG004|Overall Study|Withdrawal by Subject|2|||
145703473|NCT01814072|525430740|FG005|Overall Study|Withdrawal by Subject|3|||
145703474|NCT01814072|525430741|FG006|Overall Study|Withdrawal by Subject|1|||
145703475|NCT01814072|525430742|FG007|Overall Study|Withdrawal by Subject|0|||
145703476|NCT01814072|525430743|FG008|Overall Study|Withdrawal by Subject|1|||
145703477|NCT01814072|525430744|FG009|Overall Study|Withdrawal by Subject|2|||
145703478|NCT01814072|525430745|FG010|Overall Study|Withdrawal by Subject|0|||
145703479|NCT01814072|525430746|FG011|Overall Study|Withdrawal by Subject|0|||
145703480|NCT01814072|525430747|FG012|Overall Study|Withdrawal by Subject|1|||
145703481|NCT01814072|525430748|FG013|Overall Study|Withdrawal by Subject|1|||
145703482|NCT01814072|525430749|FG014|Overall Study|Withdrawal by Subject|1|||
145703483|NCT01814072|525430750|FG015|Overall Study|Withdrawal by Subject|1|||
145703484|NCT01814072|525430751|FG016|Overall Study|Withdrawal by Subject|0|||
145703485|NCT01814072|525430752|FG017|Overall Study|Withdrawal by Subject|0|||
145703486|NCT01814072|525430753|FG018|Overall Study|Withdrawal by Subject|0|||
145703487|NCT01814072|525430754|FG019|Overall Study|Withdrawal by Subject|2|||
145703488|NCT01814072|525430755|FG020|Overall Study|Withdrawal by Subject|0|||
145703489|NCT01814072|525430756|FG021|Overall Study|Withdrawal by Subject|0|||
145703490|NCT01814072|525430757|FG022|Overall Study|Withdrawal by Subject|1|||
145703491|NCT01814072|525430758|FG023|Overall Study|Withdrawal by Subject|0|||
145703492|NCT01814072|525430759|FG024|Overall Study|Withdrawal by Subject|2|||
145703493|NCT01814072|525430760|FG025|Overall Study|Withdrawal by Subject|1|||
145703494|NCT01814072|525430761|FG026|Overall Study|Withdrawal by Subject|1|||
145703495|NCT01814072|525430762|FG027|Overall Study|Withdrawal by Subject|2|||
145703496|NCT01814072|525430763|FG028|Overall Study|Withdrawal by Subject|1|||
145703497|NCT01814072|525430764|FG029|Overall Study|Withdrawal by Subject|0|||
145703498|NCT01814072|525430765|FG030|Overall Study|Withdrawal by Subject|0|||
145703499|NCT01814072|525430766|FG031|Overall Study|Withdrawal by Subject|0|||
145703500|NCT03566979|525430767|FG000|Overall Study|Withdrawal by Subject|2|||
145703501|NCT03566979|525430768|FG001|Overall Study|Withdrawal by Subject|0|||
145703502|NCT03566979|525430769|FG002|Overall Study|Withdrawal by Subject|1|||
145703503|NCT03566979|525430770|FG003|Overall Study|Withdrawal by Subject|1|||
145703504|NCT03566979|525430767|FG000|Overall Study|Lost to Follow-up|2|||
145703505|NCT03566979|525430768|FG001|Overall Study|Lost to Follow-up|7|||
145703506|NCT03566979|525430769|FG002|Overall Study|Lost to Follow-up|9|||
145703507|NCT03566979|525430770|FG003|Overall Study|Lost to Follow-up|5|||
145703508|NCT03566979|525430767|FG000|Overall Study|Adverse Event|1|||
145703509|NCT03566979|525430768|FG001|Overall Study|Adverse Event|0|||
145703510|NCT03566979|525430769|FG002|Overall Study|Adverse Event|0|||
145703511|NCT03566979|525430770|FG003|Overall Study|Adverse Event|0|||
145703512|NCT04547023|525430775|FG000|Overall Study|Did Not Receive Intervention|3|||
145703513|NCT04547023|525430776|FG001|Overall Study|Did Not Receive Intervention|2|||
145703514|NCT04547023|525430775|FG000|Overall Study|Lost to Follow-up|1|||
145703515|NCT04547023|525430776|FG001|Overall Study|Lost to Follow-up|1|||
145703516|NCT01011868|525430777|FG000|After Week 18 Follow-up|Adverse Event|8|||
145703517|NCT01011868|525430778|FG001|After Week 18 Follow-up|Adverse Event|6|||
145703518|NCT01011868|525430779|FG002|After Week 18 Follow-up|Adverse Event|13|||
145703519|NCT01011868|525430777|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
145703520|NCT01011868|525430778|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
145703521|NCT01011868|525430779|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
145703522|NCT01011868|525430777|FG000|After Week 18 Follow-up|Protocol Violation|1|||
145703523|NCT01011868|525430778|FG001|After Week 18 Follow-up|Protocol Violation|1|||
145703524|NCT01011868|525430779|FG002|After Week 18 Follow-up|Protocol Violation|1|||
145703525|NCT01011868|525430777|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
145703526|NCT01011868|525430778|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
145703527|NCT01011868|525430779|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
145703528|NCT01011868|525430777|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
145703529|NCT01011868|525430778|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
145703530|NCT01011868|525430779|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
145703531|NCT01011868|525430777|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
145703532|NCT01011868|525430778|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
145703533|NCT01011868|525430779|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
145703534|NCT01011868|525430777|FG000|After Week 78 Follow-up|Adverse Event|14|||
145703535|NCT01011868|525430778|FG001|After Week 78 Follow-up|Adverse Event|18|||
145703536|NCT01011868|525430779|FG002|After Week 78 Follow-up|Adverse Event|21|||
145703537|NCT01011868|525430777|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
145703538|NCT01011868|525430778|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
145703539|NCT01011868|525430779|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
145703540|NCT01011868|525430777|FG000|After Week 78 Follow-up|Protocol Violation|9|||
145703541|NCT01011868|525430778|FG001|After Week 78 Follow-up|Protocol Violation|1|||
145703542|NCT01011868|525430779|FG002|After Week 78 Follow-up|Protocol Violation|2|||
145703543|NCT01011868|525430777|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
145703544|NCT01011868|525430778|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
145703545|NCT01011868|525430779|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
145703546|NCT01011868|525430777|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
145703547|NCT01011868|525430778|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
145703548|NCT01011868|525430779|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
145703549|NCT01011868|525430777|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
145703550|NCT01011868|525430778|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
145703551|NCT01011868|525430779|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
145703552|NCT01262092|525430780|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
145703553|NCT01262092|525430781|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
145703554|NCT01262092|525430780|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
145703555|NCT01262092|525430781|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
145703556|NCT01262092|525430780|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
145703557|NCT01262092|525430781|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
145703558|NCT01262092|525430780|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
145703559|NCT01262092|525430781|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
145703560|NCT03784820|525430782|FG000|Overall Study|Lost to Follow-up|5|||
145703561|NCT03784820|525430783|FG001|Overall Study|Lost to Follow-up|5|||
145703562|NCT03784820|525430784|FG002|Overall Study|Lost to Follow-up|3|||
145703563|NCT03784820|525430785|FG003|Overall Study|Lost to Follow-up|3|||
145703564|NCT04147858|525430787|FG000|Overall Study|Adverse Event|6|||
145703565|NCT04147858|525430788|FG001|Overall Study|Adverse Event|6|||
145703566|NCT04147858|525430789|FG002|Overall Study|Adverse Event|6|||
145703567|NCT04147858|525430787|FG000|Overall Study|Lack of Efficacy|3|||
145703568|NCT04147858|525430788|FG001|Overall Study|Lack of Efficacy|3|||
145703569|NCT04147858|525430789|FG002|Overall Study|Lack of Efficacy|1|||
145703570|NCT04147858|525430787|FG000|Overall Study|Lost to Follow-up|1|||
145703571|NCT04147858|525430788|FG001|Overall Study|Lost to Follow-up|6|||
145703572|NCT04147858|525430789|FG002|Overall Study|Lost to Follow-up|2|||
145703573|NCT04147858|525430787|FG000|Overall Study|Withdrawal by Subject|3|||
145703574|NCT04147858|525430788|FG001|Overall Study|Withdrawal by Subject|4|||
145703575|NCT04147858|525430789|FG002|Overall Study|Withdrawal by Subject|10|||
145703576|NCT04147858|525430787|FG000|Overall Study|Subject Noncompliance, Other|4|||
145703577|NCT04147858|525430788|FG001|Overall Study|Subject Noncompliance, Other|3|||
145703578|NCT04147858|525430789|FG002|Overall Study|Subject Noncompliance, Other|1|||
145703579|NCT02336425|525430790|FG000|Overall Study|Study terminated.|2|||
145703580|NCT02336425|525430791|FG001|Overall Study|Study terminated.|2|||
145703581|NCT02336425|525430792|FG002|Overall Study|Study terminated.|3|||
145703582|NCT02336425|525430793|FG003|Overall Study|Study terminated.|3|||
145703583|NCT04946942|525430797|FG000|Overall Study|Lost to Follow-up|6|||
145703584|NCT04946942|525430798|FG001|Overall Study|Lost to Follow-up|2|||
145703585|NCT04946942|525430799|FG002|Overall Study|Lost to Follow-up|0|||
145703586|NCT04907357|525430800|FG000|Overall Study|Death|0|||
145703587|NCT04907357|525430801|FG001|Overall Study|Death|1|||
145703588|NCT04907357|525430800|FG000|Overall Study|Lost to Follow-up|9|||
145703589|NCT04907357|525430801|FG001|Overall Study|Lost to Follow-up|18|||
145703590|NCT04907357|525430800|FG000|Overall Study|Physician Decision|1|||
145703591|NCT04907357|525430801|FG001|Overall Study|Physician Decision|0|||
145703592|NCT04907357|525430800|FG000|Overall Study|Withdrawal by Subject|0|||
145703593|NCT04907357|525430801|FG001|Overall Study|Withdrawal by Subject|1|||
145703594|NCT04907357|525430800|FG000|Overall Study|Unable to attend visits|1|||
145703595|NCT04907357|525430801|FG001|Overall Study|Unable to attend visits|0|||
145703596|NCT04907357|525430800|FG000|Overall Study|Incarcerated|1|||
145703597|NCT04907357|525430801|FG001|Overall Study|Incarcerated|1|||
145703598|NCT00365547|525430802|FG000|Overall Study|Insurance did not cover Avastin|1|||
145703599|NCT00365547|525430802|FG000|Overall Study|Screen failure|1|||
145703600|NCT00365547|525430802|FG000|Overall Study|Withdrawal by Subject|1|||
145703601|NCT00546078|525430803|FG000|Overall Study|Lost to Follow-up|1|||
145703602|NCT00546078|525430804|FG001|Overall Study|Lost to Follow-up|3|||
145703603|NCT00546078|525430803|FG000|Overall Study|Withdrawal by Subject|2|||
145703604|NCT00546078|525430804|FG001|Overall Study|Withdrawal by Subject|3|||
145703605|NCT00546078|525430803|FG000|Overall Study|Other reason|1|||
145703606|NCT00546078|525430804|FG001|Overall Study|Other reason|1|||
145703607|NCT02257918|525430805|FG000|Overall Study|Lost to Follow-up|4|||
145703608|NCT02257918|525430806|FG001|Overall Study|Lost to Follow-up|1|||
145703609|NCT02257918|525430807|FG002|Overall Study|Lost to Follow-up|0|||
145703610|NCT02257918|525430805|FG000|Overall Study|Withdrawal by Subject|0|||
145703611|NCT02257918|525430806|FG001|Overall Study|Withdrawal by Subject|0|||
145703612|NCT02257918|525430807|FG002|Overall Study|Withdrawal by Subject|1|||
145703613|NCT02257918|525430805|FG000|Overall Study|Pregnancy|0|||
145703614|NCT02257918|525430806|FG001|Overall Study|Pregnancy|0|||
145703615|NCT02257918|525430807|FG002|Overall Study|Pregnancy|1|||
145703616|NCT03023423|525430808|FG000|Overall Study|Death|5|||
145703617|NCT03023423|525430809|FG001|Overall Study|Death|12|||
145703618|NCT03023423|525430810|FG002|Overall Study|Death|20|||
145703619|NCT03023423|525430808|FG000|Overall Study|Other|0|||
145703620|NCT03023423|525430809|FG001|Overall Study|Other|2|||
145703621|NCT03023423|525430810|FG002|Overall Study|Other|2|||
145703622|NCT03023423|525430808|FG000|Overall Study|Ongoing|2|||
145703623|NCT03023423|525430809|FG001|Overall Study|Ongoing|32|||
145703624|NCT03023423|525430810|FG002|Overall Study|Ongoing|24|||
145703625|NCT03512197|525430811|FG000|Overall Study|Guardian decision|1|||
145703626|NCT03512197|525430812|FG001|Overall Study|Guardian decision|1|||
145703627|NCT03512197|525430811|FG000|Overall Study|Lack of Efficacy|19|||
145703628|NCT03512197|525430812|FG001|Overall Study|Lack of Efficacy|11|||
145703629|NCT03512197|525430811|FG000|Overall Study|New Therapy for Study Indication|16|||
145703630|NCT03512197|525430812|FG001|Overall Study|New Therapy for Study Indication|16|||
145703631|NCT03512197|525430811|FG000|Overall Study|Physician Decision|60|||
145703632|NCT03512197|525430812|FG001|Overall Study|Physician Decision|60|||
145703633|NCT03512197|525430811|FG000|Overall Study|Protocol Violation|0|||
145703634|NCT03512197|525430812|FG001|Overall Study|Protocol Violation|2|||
145703635|NCT03512197|525430811|FG000|Overall Study|Terminated by Sponsored|46|||
145703636|NCT03512197|525430812|FG001|Overall Study|Terminated by Sponsored|50|||
145703637|NCT03512197|525430811|FG000|Overall Study|Subject Decision|15|||
145703638|NCT03512197|525430812|FG001|Overall Study|Subject Decision|12|||
145703639|NCT03512197|525430811|FG000|Overall Study|Withdrawal of informed consent|20|||
145703640|NCT03512197|525430812|FG001|Overall Study|Withdrawal of informed consent|14|||
145703641|NCT03512197|525430811|FG000|Overall Study|Adverse Event|30|||
145703642|NCT03512197|525430812|FG001|Overall Study|Adverse Event|34|||
145703643|NCT03512197|525430811|FG000|Overall Study|Death|14|||
145703644|NCT03512197|525430812|FG001|Overall Study|Death|9|||
145703645|NCT03512197|525430811|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
145703646|NCT03512197|525430812|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
145703647|NCT03512197|525430811|FG000|Overall Study|Missing|3|||
145703648|NCT03512197|525430812|FG001|Overall Study|Missing|13|||
145703649|NCT04277507|525430815|FG000|Overall Study|Lost to Follow-up|17|||
145703650|NCT04277507|525430815|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
145703651|NCT04277507|525430815|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
145703652|NCT04277507|525430815|FG000|Overall Study|Withdrawal by Subject|3|||
145703653|NCT04277507|525430815|FG000|Overall Study|Death due to COVID-19|1|||
145703654|NCT04277507|525430815|FG000|Overall Study|Data missing for full evaluation|5|||
145703655|NCT01431950|525430818|FG000|Overall Study|Study Site Closed/Terminated|7|||
145703656|NCT01431950|525430819|FG001|Overall Study|Study Site Closed/Terminated|3|||
145703657|NCT01431950|525430818|FG000|Overall Study|Withdrawal by Subject|4|||
145703658|NCT01431950|525430819|FG001|Overall Study|Withdrawal by Subject|3|||
145703659|NCT01431950|525430818|FG000|Overall Study|Protocol Violation|2|||
145703660|NCT01431950|525430819|FG001|Overall Study|Protocol Violation|3|||
145703661|NCT01431950|525430818|FG000|Overall Study|Adverse Event|2|||
145703662|NCT01431950|525430819|FG001|Overall Study|Adverse Event|2|||
145703663|NCT01431950|525430818|FG000|Overall Study|Physician Decision|2|||
145703664|NCT01431950|525430819|FG001|Overall Study|Physician Decision|1|||
145703665|NCT01431950|525430818|FG000|Overall Study|Lack of Efficacy|2|||
145703666|NCT01431950|525430819|FG001|Overall Study|Lack of Efficacy|1|||
145703667|NCT01431950|525430818|FG000|Overall Study|Lost to Follow-up|0|||
145703668|NCT01431950|525430819|FG001|Overall Study|Lost to Follow-up|1|||
145703669|NCT01431950|525430818|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
145703670|NCT01431950|525430819|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
145703671|NCT00583947|525430820|FG000|Cross-over Period|Adverse Event|2|||
145703672|NCT00583947|525430821|FG001|Cross-over Period|Adverse Event|0|||
145703673|NCT00583947|525430820|FG000|Cross-over Period|Withdrawal by Subject|2|||
145703674|NCT00583947|525430821|FG001|Cross-over Period|Withdrawal by Subject|0|||
145703675|NCT00583947|525430820|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
145703676|NCT00583947|525430821|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
145703677|NCT00583947|525430820|FG000|Cross-over Period|Other|1|||
145703678|NCT00583947|525430821|FG001|Cross-over Period|Other|1|||
145703679|NCT00486252|525430823|FG000|Overall Study|Adverse Event|7|||
145703680|NCT00486252|525430823|FG000|Overall Study|Lack of Efficacy|9|||
145703681|NCT00486252|525430823|FG000|Overall Study|Lost to Follow-up|24|||
145703682|NCT00486252|525430823|FG000|Overall Study|Other|18|||
145703683|NCT01261247|525430824|FG000|Overall Study|Ineligible|2|||
145703684|NCT01210651|525430825|FG000|Overall Study|Lost to Follow-up|1|||
145703685|NCT01210651|525430826|FG001|Overall Study|Lost to Follow-up|1|||
145703686|NCT01210651|525430825|FG000|Overall Study|schedule conflicts|1|||
145703687|NCT01210651|525430826|FG001|Overall Study|schedule conflicts|5|||
145703688|NCT01210651|525430825|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
145703689|NCT01210651|525430826|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
145703690|NCT01210651|525430825|FG000|Overall Study|Withdrawal by Subject|1|||
145703691|NCT01210651|525430826|FG001|Overall Study|Withdrawal by Subject|1|||
145703692|NCT01210651|525430825|FG000|Overall Study|Injury outside study|2|||
145703693|NCT01210651|525430826|FG001|Overall Study|Injury outside study|0|||
145703694|NCT01740154|525430827|FG000|Overall Study|Adverse Event|1|||
145703695|NCT05226130|525430828|FG000|Overall Study|Lost to Follow-up|0|||
145703696|NCT05226130|525430829|FG001|Overall Study|Lost to Follow-up|1|||
145703697|NCT05226130|525430828|FG000|Overall Study|Not treatment adherent|0|||
145703698|NCT05226130|525430829|FG001|Overall Study|Not treatment adherent|2|||
145703699|NCT04013971|525430830|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
145703700|NCT04013971|525430831|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
145703701|NCT04013971|525430830|FG000|Overall Study|Missing biomechanical data|0|||
145703702|NCT04013971|525430831|FG001|Overall Study|Missing biomechanical data|1|||
145703703|NCT01340014|525430834|FG000|Period 1, First 7 Days|Adverse Event|1|||
145703704|NCT01340014|525430835|FG001|Period 1, First 7 Days|Adverse Event|0|||
145703705|NCT01340014|525430834|FG000|Period 1, First 7 Days|Personal Reasons|1|||
145703706|NCT01340014|525430835|FG001|Period 1, First 7 Days|Personal Reasons|0|||
145703707|NCT01340014|525430834|FG000|Period 2, Second 7 Days|Adverse Event|0|||
145703708|NCT01340014|525430835|FG001|Period 2, Second 7 Days|Adverse Event|1|||
145703709|NCT02520310|525430836|FG000|At 6 Months Clinical Follow-up|Death|1|||
145703710|NCT02520310|525430836|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
145703711|NCT02520310|525430836|FG000|AT 3 Year Clinical Follow-up|Death|2|||
145703712|NCT02520310|525430836|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
145703713|NCT02520310|525430836|FG000|AT 4 Year Clinical Follow-up|Death|1|||
145703714|NCT02520310|525430836|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
145703715|NCT05101993|525430839|FG000|Overall Study|Withdrawal by Subject|1|||
145703716|NCT04577573|525430840|FG000|Overall Study|Technical - invalid protocol|0|||
145703717|NCT04577573|525430841|FG001|Overall Study|Technical - invalid protocol|2|||
145703718|NCT04577573|525430842|FG002|Overall Study|Technical - invalid protocol|0|||
145703719|NCT01124838|525430843|FG000|Overall Study|Miscellaneous|4|||
145703720|NCT01124838|525430844|FG001|Overall Study|Miscellaneous|2|||
145703721|NCT01124838|525430843|FG000|Overall Study|Adverse Event|7|||
145703722|NCT01124838|525430844|FG001|Overall Study|Adverse Event|11|||
145703723|NCT01124838|525430843|FG000|Overall Study|Lack of Efficacy|2|||
145703724|NCT01124838|525430844|FG001|Overall Study|Lack of Efficacy|0|||
145703725|NCT01124838|525430843|FG000|Overall Study|Withdrawal by Subject|3|||
145703726|NCT01124838|525430844|FG001|Overall Study|Withdrawal by Subject|2|||
145703727|NCT01124838|525430843|FG000|Overall Study|Lost to Follow-up|2|||
145703728|NCT01124838|525430844|FG001|Overall Study|Lost to Follow-up|0|||
145703729|NCT04297618|525430845|FG000|Overall Study|Adverse Event|1|||
145703730|NCT04297618|525430845|FG000|Overall Study|Withdrawal by Subject|1|||
145703731|NCT02065882|525430846|FG000|Part I: PK/PD|Screening failure|5|||
145703732|NCT02065882|525430846|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
145703733|NCT02065882|525430846|FG000|Part I: PK/PD|Adverse Event|1|||
145703734|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|Screening failure|7|||
145703735|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
145703736|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
145703737|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
145703738|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
145703739|NCT02065882|525430846|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
145703740|NCT04949802|525432559|FG000|Overall Study|Lost to Follow-up|3|||
145703741|NCT02419417|525432561|FG000|Overall Study|Disease progression|5|||
145703742|NCT02419417|525432562|FG001|Overall Study|Disease progression|4|||
145703743|NCT02419417|525432563|FG002|Overall Study|Disease progression|13|||
145703744|NCT02419417|525432564|FG003|Overall Study|Disease progression|10|||
145703745|NCT02419417|525432565|FG004|Overall Study|Disease progression|10|||
145703746|NCT02419417|525432566|FG005|Overall Study|Disease progression|3|||
145703747|NCT02419417|525432567|FG006|Overall Study|Disease progression|4|||
145703748|NCT02419417|525432568|FG007|Overall Study|Disease progression|5|||
145703749|NCT02419417|525432569|FG008|Overall Study|Disease progression|13|||
145703750|NCT02419417|525432570|FG009|Overall Study|Disease progression|9|||
145703751|NCT02419417|525432571|FG010|Overall Study|Disease progression|0|||
145703752|NCT02419417|525432561|FG000|Overall Study|Study drug toxicity|0|||
145703753|NCT02419417|525432562|FG001|Overall Study|Study drug toxicity|0|||
145703754|NCT02419417|525432563|FG002|Overall Study|Study drug toxicity|0|||
145703755|NCT02419417|525432564|FG003|Overall Study|Study drug toxicity|0|||
145703756|NCT02419417|525432565|FG004|Overall Study|Study drug toxicity|1|||
145703757|NCT02419417|525432566|FG005|Overall Study|Study drug toxicity|0|||
145703758|NCT02419417|525432567|FG006|Overall Study|Study drug toxicity|0|||
145703759|NCT02419417|525432568|FG007|Overall Study|Study drug toxicity|0|||
145703760|NCT02419417|525432569|FG008|Overall Study|Study drug toxicity|0|||
145703761|NCT02419417|525432570|FG009|Overall Study|Study drug toxicity|0|||
145703762|NCT02419417|525432571|FG010|Overall Study|Study drug toxicity|0|||
145703763|NCT02419417|525432561|FG000|Overall Study|Adverse event unrelated to study drug|0|||
145703764|NCT02419417|525432562|FG001|Overall Study|Adverse event unrelated to study drug|0|||
145703765|NCT02419417|525432563|FG002|Overall Study|Adverse event unrelated to study drug|0|||
145703766|NCT02419417|525432564|FG003|Overall Study|Adverse event unrelated to study drug|0|||
145703767|NCT02419417|525432565|FG004|Overall Study|Adverse event unrelated to study drug|2|||
145703768|NCT02419417|525432566|FG005|Overall Study|Adverse event unrelated to study drug|1|||
145703769|NCT02419417|525432567|FG006|Overall Study|Adverse event unrelated to study drug|0|||
145703770|NCT02419417|525432568|FG007|Overall Study|Adverse event unrelated to study drug|1|||
145703771|NCT02419417|525432569|FG008|Overall Study|Adverse event unrelated to study drug|0|||
145703772|NCT02419417|525432570|FG009|Overall Study|Adverse event unrelated to study drug|0|||
145703773|NCT02419417|525432571|FG010|Overall Study|Adverse event unrelated to study drug|0|||
145703774|NCT02419417|525432561|FG000|Overall Study|Participant request to discontinue|0|||
145703775|NCT02419417|525432562|FG001|Overall Study|Participant request to discontinue|0|||
145703776|NCT02419417|525432563|FG002|Overall Study|Participant request to discontinue|0|||
145703777|NCT02419417|525432564|FG003|Overall Study|Participant request to discontinue|0|||
145703778|NCT02419417|525432565|FG004|Overall Study|Participant request to discontinue|0|||
145703779|NCT02419417|525432566|FG005|Overall Study|Participant request to discontinue|0|||
145703780|NCT02419417|525432567|FG006|Overall Study|Participant request to discontinue|0|||
145703781|NCT02419417|525432568|FG007|Overall Study|Participant request to discontinue|0|||
145703782|NCT02419417|525432569|FG008|Overall Study|Participant request to discontinue|0|||
145703783|NCT02419417|525432570|FG009|Overall Study|Participant request to discontinue|1|||
145703784|NCT02419417|525432571|FG010|Overall Study|Participant request to discontinue|0|||
145703785|NCT02419417|525432561|FG000|Overall Study|Withdrawal by Subject|0|||
145703786|NCT02419417|525432562|FG001|Overall Study|Withdrawal by Subject|0|||
145703787|NCT02419417|525432563|FG002|Overall Study|Withdrawal by Subject|0|||
145703788|NCT02419417|525432564|FG003|Overall Study|Withdrawal by Subject|0|||
145703789|NCT02419417|525432565|FG004|Overall Study|Withdrawal by Subject|0|||
145703790|NCT02419417|525432566|FG005|Overall Study|Withdrawal by Subject|0|||
145703791|NCT02419417|525432567|FG006|Overall Study|Withdrawal by Subject|0|||
145703792|NCT02419417|525432568|FG007|Overall Study|Withdrawal by Subject|0|||
145703793|NCT02419417|525432569|FG008|Overall Study|Withdrawal by Subject|0|||
145703794|NCT02419417|525432570|FG009|Overall Study|Withdrawal by Subject|0|||
145703795|NCT02419417|525432571|FG010|Overall Study|Withdrawal by Subject|1|||
145703796|NCT01381575|525432572|FG000|Overall Study|Serious Adverse Event|1|||
145703797|NCT01381575|525432573|FG001|Overall Study|Serious Adverse Event|0|||
145703798|NCT01381575|525432574|FG002|Overall Study|Serious Adverse Event|0|||
145703799|NCT01381575|525432572|FG000|Overall Study|Non-Serious Adverse Event|0|||
145703800|NCT01381575|525432573|FG001|Overall Study|Non-Serious Adverse Event|0|||
145703801|NCT01381575|525432574|FG002|Overall Study|Non-Serious Adverse Event|1|||
145703802|NCT01381575|525432572|FG000|Overall Study|Protocol Violation|0|||
145703803|NCT01381575|525432573|FG001|Overall Study|Protocol Violation|1|||
145703804|NCT01381575|525432574|FG002|Overall Study|Protocol Violation|1|||
145703805|NCT01381575|525432572|FG000|Overall Study|Withdrawal by Subject|15|||
145703806|NCT01381575|525432573|FG001|Overall Study|Withdrawal by Subject|9|||
145703807|NCT01381575|525432574|FG002|Overall Study|Withdrawal by Subject|7|||
145703808|NCT01381575|525432572|FG000|Overall Study|Migrated/moved from study area|2|||
145703809|NCT01381575|525432573|FG001|Overall Study|Migrated/moved from study area|12|||
145703810|NCT01381575|525432574|FG002|Overall Study|Migrated/moved from study area|2|||
145703811|NCT01381575|525432572|FG000|Overall Study|Lost to Follow-up|8|||
145703812|NCT01381575|525432573|FG001|Overall Study|Lost to Follow-up|17|||
145703813|NCT01381575|525432574|FG002|Overall Study|Lost to Follow-up|9|||
145703814|NCT01443403|525432575|FG000|Overall Study|Adverse Event|1|||
145703815|NCT01443403|525432576|FG001|Overall Study|Adverse Event|1|||
145703816|NCT01443403|525432577|FG002|Overall Study|Adverse Event|4|||
145703817|NCT01443403|525432578|FG003|Overall Study|Adverse Event|5|||
145703818|NCT01443403|525432575|FG000|Overall Study|Withdrawal by Subject|0|||
145703819|NCT01443403|525432576|FG001|Overall Study|Withdrawal by Subject|1|||
145703820|NCT01443403|525432577|FG002|Overall Study|Withdrawal by Subject|2|||
145703821|NCT01443403|525432578|FG003|Overall Study|Withdrawal by Subject|1|||
145703822|NCT01443403|525432575|FG000|Overall Study|Lost to Follow-up|0|||
145703823|NCT01443403|525432576|FG001|Overall Study|Lost to Follow-up|0|||
145703824|NCT01443403|525432577|FG002|Overall Study|Lost to Follow-up|0|||
145703825|NCT01443403|525432578|FG003|Overall Study|Lost to Follow-up|1|||
145703826|NCT01443403|525432575|FG000|Overall Study|Protocol Violation|2|||
145703827|NCT01443403|525432576|FG001|Overall Study|Protocol Violation|1|||
145703828|NCT01443403|525432577|FG002|Overall Study|Protocol Violation|1|||
145703829|NCT01443403|525432578|FG003|Overall Study|Protocol Violation|1|||
145703830|NCT01443403|525432575|FG000|Overall Study|Use of Prohibited Treatment|2|||
145703831|NCT01443403|525432576|FG001|Overall Study|Use of Prohibited Treatment|3|||
145703832|NCT01443403|525432577|FG002|Overall Study|Use of Prohibited Treatment|0|||
145703833|NCT01443403|525432578|FG003|Overall Study|Use of Prohibited Treatment|0|||
145703834|NCT01443403|525432575|FG000|Overall Study|Other - Miscellaneous|1|||
145703835|NCT01443403|525432576|FG001|Overall Study|Other - Miscellaneous|0|||
145703836|NCT01443403|525432577|FG002|Overall Study|Other - Miscellaneous|0|||
145703837|NCT01443403|525432578|FG003|Overall Study|Other - Miscellaneous|1|||
145703838|NCT01200342|525432579|FG000|Overall Study|Disease Progression|1|||
145703839|NCT02550938|525432580|FG000|Overall Study|Lost to Follow-up|8|||
145703840|NCT02550938|525432581|FG001|Overall Study|Lost to Follow-up|7|||
145703841|NCT02550938|525432582|FG002|Overall Study|Lost to Follow-up|12|||
145703842|NCT02550938|525432583|FG003|Overall Study|Lost to Follow-up|11|||
145703843|NCT01367847|525432584|FG000|Overall Study|Withdrawal by Subject|2|||
145703844|NCT01367847|525432585|FG001|Overall Study|Withdrawal by Subject|2|||
145703845|NCT01439867|525432586|FG000|Overall Study|Non-compliance|0|||
145703846|NCT01439867|525432587|FG001|Overall Study|Non-compliance|1|||
145703847|NCT01439867|525432586|FG000|Overall Study|Withdrawal by Subject|1|||
145703848|NCT01439867|525432587|FG001|Overall Study|Withdrawal by Subject|2|||
145703849|NCT01439867|525432586|FG000|Overall Study|Administrative Decision|4|||
145703850|NCT01439867|525432587|FG001|Overall Study|Administrative Decision|5|||
145703851|NCT01439867|525432586|FG000|Overall Study|Protocol-specified Criteria|1|||
145703852|NCT01439867|525432587|FG001|Overall Study|Protocol-specified Criteria|0|||
145703853|NCT02763215|525432588|FG000|Overall Study|Participants withdrew from study|3|||
145703854|NCT02763215|525432588|FG000|Overall Study|Missed visit|1|||
145703855|NCT02763215|525432588|FG000|Overall Study|Visit outside visit-window|1|||
145703856|NCT02763215|525432588|FG000|Overall Study|Death|1|||
145703857|NCT02763215|525432588|FG000|Overall Study|Lost to Follow-up|1|||
145703858|NCT03258723|525432589|FG000|Overall Study|COVID Interruption of study|54|||
145703859|NCT03258723|525432589|FG000|Overall Study|Lost to Follow-up|8|||
145703860|NCT01107899|525432590|FG000|Overall Study|Physician Decision|5|||
145703861|NCT01107899|525432591|FG001|Overall Study|Physician Decision|0|||
145703862|NCT01107899|525432592|FG002|Overall Study|Physician Decision|3|||
145703863|NCT01107899|525432590|FG000|Overall Study|Withdrawal by Subject|0|||
145703864|NCT01107899|525432591|FG001|Overall Study|Withdrawal by Subject|0|||
145703865|NCT01107899|525432592|FG002|Overall Study|Withdrawal by Subject|1|||
145703866|NCT00953771|525432593|FG000|Overall Study|Death|1|||
145703867|NCT00953771|525432594|FG001|Overall Study|Death|0|||
145703868|NCT00974259|525432595|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
145703869|NCT00974259|525432596|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
145703870|NCT01375673|525432603|FG000|Overall Study|Withdrawal by Subject|0|||
145703871|NCT01375673|525432604|FG001|Overall Study|Withdrawal by Subject|1|||
145703872|NCT01784523|525432607|FG000|Overall Study|Study closed early|7|||
145703873|NCT01784523|525432608|FG001|Overall Study|Study closed early|4|||
145703874|NCT02179177|525432611|FG000|Overall Study|Lost to Follow-up|1|||
145703875|NCT02179177|525432612|FG001|Overall Study|Lost to Follow-up|1|||
145703876|NCT02179177|525432611|FG000|Overall Study|Withdrawal by Subject|1|||
145703877|NCT02179177|525432612|FG001|Overall Study|Withdrawal by Subject|1|||
145703878|NCT04340947|525432613|FG000|7-day Washout Period|Lost to Follow-up|5|||
145703879|NCT04340947|525432614|FG001|7-day Washout Period|Lost to Follow-up|4|||
145703880|NCT01907906|525432617|FG000|Overall Study|Withdrawal by Subject|1|||
145703881|NCT01907906|525432618|FG001|Overall Study|Withdrawal by Subject|0|||
145703882|NCT01907906|525432617|FG000|Overall Study|Physician Decision|3|||
145703883|NCT01907906|525432618|FG001|Overall Study|Physician Decision|1|||
145703884|NCT00884650|525432619|FG000|Overall Study|Did not return complete pain diaries|7|||
145703885|NCT00884650|525432620|FG001|Overall Study|Did not return complete pain diaries|7|||
145703886|NCT00884650|525432619|FG000|Overall Study|Admitted Post-Op|1|||
145703887|NCT00884650|525432620|FG001|Overall Study|Admitted Post-Op|0|||
145703888|NCT00884650|525432619|FG000|Overall Study|Femoral Stress Fracture|1|||
145703889|NCT00884650|525432620|FG001|Overall Study|Femoral Stress Fracture|0|||
145703890|NCT00884650|525432619|FG000|Overall Study|Pain Pump Complication|0|||
145703891|NCT00884650|525432620|FG001|Overall Study|Pain Pump Complication|1|||
145703892|NCT04052425|525432623|FG000|24-Week Double-blind Period|Adverse Event|0|||
145703893|NCT04052425|525432624|FG001|24-Week Double-blind Period|Adverse Event|1|||
145703894|NCT04052425|525432625|FG002|24-Week Double-blind Period|Adverse Event|0|||
145703895|NCT04052425|525432626|FG003|24-Week Double-blind Period|Adverse Event|0|||
145703896|NCT04052425|525432623|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
145703897|NCT04052425|525432624|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
145703898|NCT04052425|525432625|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
145703899|NCT04052425|525432626|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
145703900|NCT04052425|525432623|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
145703901|NCT04052425|525432624|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
145703902|NCT04052425|525432625|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
145703903|NCT04052425|525432626|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
145703904|NCT04052425|525432623|FG000|24-Week Double-blind Period|Physician Decision|1|||
145703905|NCT04052425|525432624|FG001|24-Week Double-blind Period|Physician Decision|0|||
145703906|NCT04052425|525432625|FG002|24-Week Double-blind Period|Physician Decision|0|||
145703907|NCT04052425|525432626|FG003|24-Week Double-blind Period|Physician Decision|0|||
145703908|NCT04052425|525432623|FG000|24-Week Double-blind Period|Protocol Violation|1|||
145703909|NCT04052425|525432624|FG001|24-Week Double-blind Period|Protocol Violation|0|||
145703910|NCT04052425|525432625|FG002|24-Week Double-blind Period|Protocol Violation|0|||
145703911|NCT04052425|525432626|FG003|24-Week Double-blind Period|Protocol Violation|0|||
145703912|NCT04052425|525432623|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
145703913|NCT04052425|525432624|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
145703914|NCT04052425|525432625|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
145703915|NCT04052425|525432626|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
145703916|NCT04052425|525432623|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
145703917|NCT04052425|525432624|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
145703918|NCT04052425|525432625|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
145703919|NCT04052425|525432626|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
145703920|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
145703921|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
145703922|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
145703923|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
145703924|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
145491442|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Death|3|||
145703925|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
145703926|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
145703927|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
145703928|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
145703929|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
145703930|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
145703931|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
145703932|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
145703933|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
145703934|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
145703935|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
145703936|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145703937|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
145703938|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
145703939|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
145703940|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
145703941|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
145703942|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
145703943|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
145703944|NCT04052425|525432623|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
145703945|NCT04052425|525432624|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
145703946|NCT04052425|525432625|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
145703947|NCT04052425|525432626|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
145703948|NCT04334278|525432627|FG000|Overall Study|Lost to Follow-up|0|||
145703949|NCT04334278|525432628|FG001|Overall Study|Lost to Follow-up|3|||
145703950|NCT04334278|525432627|FG000|Overall Study|Withdrawal by Subject|4|||
145703951|NCT04334278|525432628|FG001|Overall Study|Withdrawal by Subject|2|||
145703952|NCT01677299|525432629|FG000|Overall Study|Adverse Event|0|||
145703953|NCT01677299|525432630|FG001|Overall Study|Adverse Event|2|||
145703954|NCT01677299|525432631|FG002|Overall Study|Adverse Event|1|||
145703955|NCT01677299|525432632|FG003|Overall Study|Adverse Event|0|||
145703956|NCT01677299|525432629|FG000|Overall Study|Withdrawal by Subject|0|||
145703957|NCT01677299|525432630|FG001|Overall Study|Withdrawal by Subject|1|||
145703958|NCT01677299|525432631|FG002|Overall Study|Withdrawal by Subject|0|||
145703959|NCT01677299|525432632|FG003|Overall Study|Withdrawal by Subject|1|||
145703960|NCT01732549|525432635|FG000|Overall Study|Adverse Event|13|||
145703961|NCT01732549|525432636|FG001|Overall Study|Adverse Event|3|||
145703962|NCT01732549|525432635|FG000|Overall Study|Consent withdrawn|13|||
145703963|NCT01732549|525432636|FG001|Overall Study|Consent withdrawn|6|||
145703964|NCT01732549|525432635|FG000|Overall Study|Disease progression|37|||
145703965|NCT01732549|525432636|FG001|Overall Study|Disease progression|50|||
145703966|NCT01732549|525432635|FG000|Overall Study|Other|8|||
145703967|NCT01732549|525432636|FG001|Overall Study|Other|14|||
145703968|NCT02030002|525432637|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
145703969|NCT02030002|525432637|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
145703970|NCT02030002|525432637|FG000|Follow-up|Lost to Follow-up|2|||
145703971|NCT03994731|525432639|FG000|Pegloticase + IMM Period|Death|2|||
145703972|NCT03994731|525432640|FG001|Pegloticase + IMM Period|Death|0|||
145703973|NCT03994731|525432639|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
145703974|NCT03994731|525432640|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
145703975|NCT03994731|525432639|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
145703976|NCT03994731|525432640|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
145703977|NCT01681992|525432643|FG000|Overall Study|Adverse Event|3|||
145703978|NCT01681992|525432644|FG001|Overall Study|Adverse Event|2|||
145703979|NCT01681992|525432645|FG002|Overall Study|Adverse Event|3|||
145703980|NCT01681992|525432643|FG000|Overall Study|Lost to Follow-up|36|||
145703981|NCT01681992|525432644|FG001|Overall Study|Lost to Follow-up|38|||
145703982|NCT01681992|525432645|FG002|Overall Study|Lost to Follow-up|53|||
145703983|NCT01681992|525432643|FG000|Overall Study|As Per Sponsor Decision|0|||
145703984|NCT01681992|525432644|FG001|Overall Study|As Per Sponsor Decision|0|||
145703985|NCT01681992|525432645|FG002|Overall Study|As Per Sponsor Decision|1|||
145703986|NCT01681992|525432643|FG000|Overall Study|Protocol Violation|0|||
145703987|NCT01681992|525432644|FG001|Overall Study|Protocol Violation|0|||
145703988|NCT01681992|525432645|FG002|Overall Study|Protocol Violation|1|||
145703989|NCT01681992|525432643|FG000|Overall Study|Withdrawal by Subject|27|||
145703990|NCT01681992|525432644|FG001|Overall Study|Withdrawal by Subject|30|||
145703991|NCT01681992|525432645|FG002|Overall Study|Withdrawal by Subject|25|||
145703992|NCT02406248|525432650|FG000|Overall Study|Death|7|||
145703993|NCT02406248|525432650|FG000|Overall Study|Withdrawal by Subject|2|||
145703994|NCT04805073|525432657|FG000|Overall Study|study personnel not available|2|||
145703995|NCT04805073|525432658|FG001|Overall Study|study personnel not available|0|||
145703996|NCT04805073|525432657|FG000|Overall Study|spinal anesthesia failure|0|||
145703997|NCT04805073|525432658|FG001|Overall Study|spinal anesthesia failure|1|||
145703998|NCT04805073|525432657|FG000|Overall Study|Lost to Follow-up|0|||
145703999|NCT04805073|525432658|FG001|Overall Study|Lost to Follow-up|2|||
145704000|NCT02975102|525432661|FG000|Overall Study|Adverse Event|2|||
145704001|NCT02975102|525432662|FG001|Overall Study|Adverse Event|1|||
145704002|NCT06719986|525432666|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
145704003|NCT06719986|525432667|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
145704004|NCT06719986|525432668|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
145704005|NCT06719986|525432666|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
145704006|NCT06719986|525432667|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
145704007|NCT06719986|525432668|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
145704008|NCT02600897|525432669|FG000|Overall Study|Death|1|||
145704009|NCT02600897|525432670|FG001|Overall Study|Death|2|||
145704010|NCT02600897|525432671|FG002|Overall Study|Death|1|||
145704011|NCT02600897|525432672|FG003|Overall Study|Death|2|||
145704012|NCT02600897|525432673|FG004|Overall Study|Death|3|||
145704013|NCT02600897|525432674|FG005|Overall Study|Death|2|||
145704014|NCT02600897|525432675|FG006|Overall Study|Death|10|||
145704015|NCT02600897|525432676|FG007|Overall Study|Death|7|||
145704016|NCT02600897|525432677|FG008|Overall Study|Death|20|||
145704017|NCT02600897|525432669|FG000|Overall Study|Lost to Follow-up|1|||
145704018|NCT02600897|525432670|FG001|Overall Study|Lost to Follow-up|0|||
145704019|NCT02600897|525432671|FG002|Overall Study|Lost to Follow-up|0|||
145704020|NCT02600897|525432672|FG003|Overall Study|Lost to Follow-up|0|||
145704021|NCT02600897|525432673|FG004|Overall Study|Lost to Follow-up|0|||
145704022|NCT02600897|525432674|FG005|Overall Study|Lost to Follow-up|0|||
145704023|NCT02600897|525432675|FG006|Overall Study|Lost to Follow-up|0|||
145704024|NCT02600897|525432676|FG007|Overall Study|Lost to Follow-up|1|||
145704025|NCT02600897|525432677|FG008|Overall Study|Lost to Follow-up|0|||
145704026|NCT02600897|525432669|FG000|Overall Study|Withdrawal by Subject|0|||
145704027|NCT02600897|525432670|FG001|Overall Study|Withdrawal by Subject|0|||
145704028|NCT02600897|525432671|FG002|Overall Study|Withdrawal by Subject|0|||
145704029|NCT02600897|525432672|FG003|Overall Study|Withdrawal by Subject|0|||
145704030|NCT02600897|525432673|FG004|Overall Study|Withdrawal by Subject|0|||
145704031|NCT02600897|525432674|FG005|Overall Study|Withdrawal by Subject|0|||
145704032|NCT02600897|525432675|FG006|Overall Study|Withdrawal by Subject|0|||
145704033|NCT02600897|525432676|FG007|Overall Study|Withdrawal by Subject|4|||
145704034|NCT02600897|525432677|FG008|Overall Study|Withdrawal by Subject|2|||
145704035|NCT02600897|525432669|FG000|Overall Study|Reason Not Specified|0|||
145704036|NCT02600897|525432670|FG001|Overall Study|Reason Not Specified|0|||
145704037|NCT02600897|525432671|FG002|Overall Study|Reason Not Specified|0|||
145704038|NCT02600897|525432672|FG003|Overall Study|Reason Not Specified|0|||
145704039|NCT02600897|525432673|FG004|Overall Study|Reason Not Specified|0|||
145704040|NCT02600897|525432674|FG005|Overall Study|Reason Not Specified|0|||
145704041|NCT02600897|525432675|FG006|Overall Study|Reason Not Specified|0|||
145704042|NCT02600897|525432676|FG007|Overall Study|Reason Not Specified|0|||
145704043|NCT02600897|525432677|FG008|Overall Study|Reason Not Specified|1|||
145704044|NCT03816761|525434639|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
145704045|NCT03816761|525434640|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
145704046|NCT03816761|525434641|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
145704047|NCT03816761|525434642|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
145704048|NCT03816761|525434643|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
145704049|NCT03816761|525434644|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
145704050|NCT03816761|525434639|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
145704051|NCT03816761|525434640|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
145704052|NCT03816761|525434641|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
145704053|NCT03816761|525434642|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
145704054|NCT03816761|525434643|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
145704055|NCT03816761|525434644|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
145704056|NCT00474526|525434645|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
145704057|NCT00474526|525434646|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
145704058|NCT00474526|525434647|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
145704059|NCT00474526|525434648|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
145704060|NCT00474526|525434649|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
145704061|NCT00474526|525434650|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
145704062|NCT00474526|525434651|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
145704063|NCT00474526|525434652|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
145704064|NCT00474526|525434653|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
145704065|NCT00474526|525434654|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
145704066|NCT00474526|525434655|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
145491443|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
145704067|NCT00474526|525434656|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
145704068|NCT00474526|525434657|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
145704069|NCT00474526|525434658|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
145704070|NCT00474526|525434659|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
145704071|NCT00474526|525434660|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
145704072|NCT00474526|525434661|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
145704073|NCT00474526|525434645|FG000|Overall Study|Adverse Event|2|||
145704074|NCT00474526|525434646|FG001|Overall Study|Adverse Event|0|||
145704075|NCT00474526|525434647|FG002|Overall Study|Adverse Event|2|||
145704076|NCT00474526|525434648|FG003|Overall Study|Adverse Event|4|||
145704077|NCT00474526|525434649|FG004|Overall Study|Adverse Event|2|||
145704078|NCT00474526|525434650|FG005|Overall Study|Adverse Event|1|||
145704079|NCT00474526|525434651|FG006|Overall Study|Adverse Event|1|||
145704080|NCT00474526|525434652|FG007|Overall Study|Adverse Event|0|||
145704081|NCT00474526|525434653|FG008|Overall Study|Adverse Event|0|||
145704082|NCT00474526|525434654|FG009|Overall Study|Adverse Event|0|||
145704083|NCT00474526|525434655|FG010|Overall Study|Adverse Event|0|||
145704084|NCT00474526|525434656|FG011|Overall Study|Adverse Event|0|||
145704085|NCT00474526|525434657|FG012|Overall Study|Adverse Event|0|||
145704086|NCT00474526|525434658|FG013|Overall Study|Adverse Event|0|||
145704087|NCT00474526|525434659|FG014|Overall Study|Adverse Event|1|||
145704088|NCT00474526|525434660|FG015|Overall Study|Adverse Event|1|||
145704089|NCT00474526|525434661|FG016|Overall Study|Adverse Event|0|||
145704090|NCT00474526|525434645|FG000|Overall Study|Death|0|||
145704091|NCT00474526|525434646|FG001|Overall Study|Death|0|||
145704092|NCT00474526|525434647|FG002|Overall Study|Death|0|||
145704093|NCT00474526|525434648|FG003|Overall Study|Death|0|||
145704094|NCT00474526|525434649|FG004|Overall Study|Death|0|||
145704095|NCT00474526|525434650|FG005|Overall Study|Death|0|||
145704096|NCT00474526|525434651|FG006|Overall Study|Death|0|||
145704097|NCT00474526|525434652|FG007|Overall Study|Death|0|||
145704098|NCT00474526|525434653|FG008|Overall Study|Death|0|||
145704099|NCT00474526|525434654|FG009|Overall Study|Death|0|||
145704100|NCT00474526|525434655|FG010|Overall Study|Death|0|||
145704101|NCT00474526|525434656|FG011|Overall Study|Death|0|||
145704102|NCT00474526|525434657|FG012|Overall Study|Death|0|||
145704103|NCT00474526|525434658|FG013|Overall Study|Death|3|||
145704104|NCT00474526|525434659|FG014|Overall Study|Death|0|||
145704105|NCT00474526|525434660|FG015|Overall Study|Death|0|||
145704106|NCT00474526|525434661|FG016|Overall Study|Death|0|||
145704107|NCT00474526|525434645|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704108|NCT00474526|525434646|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
145704109|NCT00474526|525434647|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704110|NCT00474526|525434648|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
145704111|NCT00474526|525434649|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
145704112|NCT00474526|525434650|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704113|NCT00474526|525434651|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704114|NCT00474526|525434652|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704115|NCT00474526|525434653|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704116|NCT00474526|525434654|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704117|NCT00474526|525434655|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704118|NCT00474526|525434656|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704119|NCT00474526|525434657|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704120|NCT00474526|525434658|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
145704121|NCT00474526|525434659|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
145704122|NCT00474526|525434660|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704123|NCT00474526|525434661|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
145704124|NCT00474526|525434645|FG000|Overall Study|Lost to Follow-up|8|||
145704125|NCT00474526|525434646|FG001|Overall Study|Lost to Follow-up|6|||
145704126|NCT00474526|525434647|FG002|Overall Study|Lost to Follow-up|13|||
145704127|NCT00474526|525434648|FG003|Overall Study|Lost to Follow-up|29|||
145704128|NCT00474526|525434649|FG004|Overall Study|Lost to Follow-up|11|||
145704129|NCT00474526|525434650|FG005|Overall Study|Lost to Follow-up|5|||
145704130|NCT00474526|525434651|FG006|Overall Study|Lost to Follow-up|8|||
145704131|NCT00474526|525434652|FG007|Overall Study|Lost to Follow-up|1|||
145704132|NCT00474526|525434653|FG008|Overall Study|Lost to Follow-up|0|||
145704133|NCT00474526|525434654|FG009|Overall Study|Lost to Follow-up|6|||
145704134|NCT00474526|525434655|FG010|Overall Study|Lost to Follow-up|2|||
145704135|NCT00474526|525434656|FG011|Overall Study|Lost to Follow-up|4|||
145704136|NCT00474526|525434657|FG012|Overall Study|Lost to Follow-up|6|||
145704137|NCT00474526|525434658|FG013|Overall Study|Lost to Follow-up|74|||
145704138|NCT00474526|525434659|FG014|Overall Study|Lost to Follow-up|29|||
145704139|NCT00474526|525434660|FG015|Overall Study|Lost to Follow-up|4|||
145704140|NCT00474526|525434661|FG016|Overall Study|Lost to Follow-up|5|||
145704141|NCT00474526|525434645|FG000|Overall Study|Protocol Violation|2|||
145704142|NCT00474526|525434646|FG001|Overall Study|Protocol Violation|6|||
145704143|NCT00474526|525434647|FG002|Overall Study|Protocol Violation|4|||
145704144|NCT00474526|525434648|FG003|Overall Study|Protocol Violation|12|||
145704145|NCT00474526|525434649|FG004|Overall Study|Protocol Violation|3|||
145704146|NCT00474526|525434650|FG005|Overall Study|Protocol Violation|1|||
145704147|NCT00474526|525434651|FG006|Overall Study|Protocol Violation|3|||
145704148|NCT00474526|525434652|FG007|Overall Study|Protocol Violation|0|||
145704149|NCT00474526|525434653|FG008|Overall Study|Protocol Violation|0|||
145704150|NCT00474526|525434654|FG009|Overall Study|Protocol Violation|4|||
145704151|NCT00474526|525434655|FG010|Overall Study|Protocol Violation|2|||
145704152|NCT00474526|525434656|FG011|Overall Study|Protocol Violation|2|||
145704153|NCT00474526|525434657|FG012|Overall Study|Protocol Violation|4|||
145704154|NCT00474526|525434658|FG013|Overall Study|Protocol Violation|19|||
145704155|NCT00474526|525434659|FG014|Overall Study|Protocol Violation|9|||
145704156|NCT00474526|525434660|FG015|Overall Study|Protocol Violation|6|||
145704157|NCT00474526|525434661|FG016|Overall Study|Protocol Violation|2|||
145704158|NCT00474526|525434645|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
145704159|NCT00474526|525434646|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
145704160|NCT00474526|525434647|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
145704161|NCT00474526|525434648|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
145704162|NCT00474526|525434649|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
145704163|NCT00474526|525434650|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
145704164|NCT00474526|525434651|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
145704165|NCT00474526|525434652|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
145704166|NCT00474526|525434653|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
145704167|NCT00474526|525434654|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
145704168|NCT00474526|525434655|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
145704169|NCT00474526|525434656|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
145704170|NCT00474526|525434657|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
145704171|NCT00474526|525434658|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
145704172|NCT00474526|525434659|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
145704173|NCT00474526|525434660|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
145704174|NCT00474526|525434661|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
145704175|NCT00474526|525434645|FG000|Overall Study|Withdrawal by Subject|9|||
145704176|NCT00474526|525434646|FG001|Overall Study|Withdrawal by Subject|24|||
145704177|NCT00474526|525434647|FG002|Overall Study|Withdrawal by Subject|21|||
145704178|NCT00474526|525434648|FG003|Overall Study|Withdrawal by Subject|52|||
145704179|NCT00474526|525434649|FG004|Overall Study|Withdrawal by Subject|38|||
145704180|NCT00474526|525434650|FG005|Overall Study|Withdrawal by Subject|6|||
145704181|NCT00474526|525434651|FG006|Overall Study|Withdrawal by Subject|12|||
145704182|NCT00474526|525434652|FG007|Overall Study|Withdrawal by Subject|4|||
145704183|NCT00474526|525434653|FG008|Overall Study|Withdrawal by Subject|4|||
145704184|NCT00474526|525434654|FG009|Overall Study|Withdrawal by Subject|13|||
145704185|NCT00474526|525434655|FG010|Overall Study|Withdrawal by Subject|5|||
145704186|NCT00474526|525434656|FG011|Overall Study|Withdrawal by Subject|4|||
145704187|NCT00474526|525434657|FG012|Overall Study|Withdrawal by Subject|4|||
145704188|NCT00474526|525434658|FG013|Overall Study|Withdrawal by Subject|37|||
145704189|NCT00474526|525434659|FG014|Overall Study|Withdrawal by Subject|22|||
145704190|NCT00474526|525434660|FG015|Overall Study|Withdrawal by Subject|1|||
145704191|NCT00474526|525434661|FG016|Overall Study|Withdrawal by Subject|1|||
145704192|NCT02797522|525434662|FG000|Overall Study|Study Terminated by Sponsor|0|||
145704193|NCT02797522|525434663|FG001|Overall Study|Study Terminated by Sponsor|0|||
145704194|NCT02797522|525434664|FG002|Overall Study|Study Terminated by Sponsor|0|||
145704195|NCT02797522|525434665|FG003|Overall Study|Study Terminated by Sponsor|0|||
145704196|NCT02797522|525434666|FG004|Overall Study|Study Terminated by Sponsor|0|||
145704197|NCT02797522|525434667|FG005|Overall Study|Study Terminated by Sponsor|0|||
145704198|NCT02797522|525434668|FG006|Overall Study|Study Terminated by Sponsor|0|||
145704199|NCT02797522|525434669|FG007|Overall Study|Study Terminated by Sponsor|4|||
145704200|NCT02797522|525434670|FG008|Overall Study|Study Terminated by Sponsor|2|||
145704201|NCT02797522|525434671|FG009|Overall Study|Study Terminated by Sponsor|4|||
145704202|NCT02797522|525434672|FG010|Overall Study|Study Terminated by Sponsor|1|||
145704203|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
145704204|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
145704205|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
145704206|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
145704207|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
145704208|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
145704209|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
145704210|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
145704211|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
145704212|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
145704213|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
145704214|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
145704215|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
145704216|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
145704217|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
145704218|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
145704219|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
145704220|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
145704221|NCT00132678|525434675|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
145704222|NCT00132678|525434676|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
145704223|NCT00132678|525434677|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
145704224|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Death|2|||
145704225|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Death|0|||
145704226|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Death|0|||
145704227|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
145704228|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
145704229|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
145704230|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
145704231|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
145704232|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
145704233|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
145704234|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
145704235|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
145704236|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
145704237|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
145704238|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
145704239|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
145704240|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
145704241|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
145704242|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
145704243|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
145704244|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
145704245|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
145704246|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
145704247|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
145704248|NCT00132678|525434675|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
145704249|NCT00132678|525434676|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
145704250|NCT00132678|525434677|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
145704251|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
145704252|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
145704253|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
145704254|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
145704255|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
145704256|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
145704257|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
145704258|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
145704259|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
145704260|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
145704261|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
145704262|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
145704263|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
145704264|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
145704265|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
145704266|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
145704267|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
145704268|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
145704269|NCT00132678|525434675|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
145704270|NCT00132678|525434676|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
145704271|NCT00132678|525434677|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
145704272|NCT00953147|525434680|FG000|Overall Study|Adverse Event|8|||
145704273|NCT00953147|525434681|FG001|Overall Study|Adverse Event|16|||
145704274|NCT00953147|525434682|FG002|Overall Study|Adverse Event|6|||
145704275|NCT00953147|525434680|FG000|Overall Study|Protocol Violation|2|||
145704276|NCT00953147|525434681|FG001|Overall Study|Protocol Violation|8|||
145704277|NCT00953147|525434682|FG002|Overall Study|Protocol Violation|4|||
145704278|NCT00953147|525434680|FG000|Overall Study|Withdrawal by Subject|13|||
145704279|NCT00953147|525434681|FG001|Overall Study|Withdrawal by Subject|15|||
145704280|NCT00953147|525434682|FG002|Overall Study|Withdrawal by Subject|12|||
145704281|NCT00953147|525434680|FG000|Overall Study|Lost to Follow-up|8|||
145704282|NCT00953147|525434681|FG001|Overall Study|Lost to Follow-up|9|||
145704283|NCT00953147|525434682|FG002|Overall Study|Lost to Follow-up|4|||
145704284|NCT00953147|525434680|FG000|Overall Study|Physician Decision|2|||
145704285|NCT00953147|525434681|FG001|Overall Study|Physician Decision|7|||
145704286|NCT00953147|525434682|FG002|Overall Study|Physician Decision|3|||
145704287|NCT00953147|525434680|FG000|Overall Study|Other|4|||
145704288|NCT00953147|525434681|FG001|Overall Study|Other|11|||
145704289|NCT00953147|525434682|FG002|Overall Study|Other|13|||
145704290|NCT01484431|525434683|FG000|Period 1: High Dose|Physician Decision|0|||
145704291|NCT01484431|525434684|FG001|Period 1: High Dose|Physician Decision|1|||
145704292|NCT01484431|525434685|FG002|Period 1: High Dose|Physician Decision|0|||
145704293|NCT01484431|525434683|FG000|Period 2|Death|0|||
145378460|NCT03309696|524237247|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
145704294|NCT01484431|525434684|FG001|Period 2|Death|1|||
145704295|NCT01484431|525434685|FG002|Period 2|Death|1|||
145704296|NCT01484431|525434683|FG000|Period 2|Physician Decision|0|||
145704297|NCT01484431|525434684|FG001|Period 2|Physician Decision|0|||
145704298|NCT01484431|525434685|FG002|Period 2|Physician Decision|1|||
145704299|NCT01484431|525434683|FG000|Period 2|Non-Compliance with Study Drug|1|||
145704300|NCT01484431|525434684|FG001|Period 2|Non-Compliance with Study Drug|0|||
145704301|NCT01484431|525434685|FG002|Period 2|Non-Compliance with Study Drug|0|||
145704302|NCT01251770|525434686|FG000|Overall Study|Protocol Violation|13|||
145704303|NCT01251770|525434687|FG001|Overall Study|Protocol Violation|7|||
145704304|NCT02514239|525434688|FG000|Overall Study|Refused to continue trial medication|0|||
145704305|NCT02514239|525434689|FG001|Overall Study|Refused to continue trial medication|0|||
145704306|NCT02514239|525434690|FG002|Overall Study|Refused to continue trial medication|0|||
145704307|NCT02514239|525434691|FG003|Overall Study|Refused to continue trial medication|0|||
145704308|NCT02514239|525434692|FG004|Overall Study|Refused to continue trial medication|0|||
145704309|NCT02514239|525434693|FG005|Overall Study|Refused to continue trial medication|0|||
145704310|NCT02514239|525434694|FG006|Overall Study|Refused to continue trial medication|0|||
145704311|NCT02514239|525434695|FG007|Overall Study|Refused to continue trial medication|0|||
145704312|NCT02514239|525434696|FG008|Overall Study|Refused to continue trial medication|0|||
145704313|NCT02514239|525434697|FG009|Overall Study|Refused to continue trial medication|1|||
145704314|NCT02514239|525434688|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704315|NCT02514239|525434689|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704316|NCT02514239|525434690|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704317|NCT02514239|525434691|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704318|NCT02514239|525434692|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704319|NCT02514239|525434693|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704320|NCT02514239|525434694|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704321|NCT02514239|525434695|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
145704322|NCT02514239|525434696|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
145704323|NCT02514239|525434697|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
145704324|NCT02514239|525434688|FG000|Overall Study|Not treated|0|||
145704325|NCT02514239|525434689|FG001|Overall Study|Not treated|1|||
145704326|NCT02514239|525434690|FG002|Overall Study|Not treated|0|||
145704327|NCT02514239|525434691|FG003|Overall Study|Not treated|0|||
145704328|NCT02514239|525434692|FG004|Overall Study|Not treated|0|||
145704329|NCT02514239|525434693|FG005|Overall Study|Not treated|0|||
145704330|NCT02514239|525434694|FG006|Overall Study|Not treated|0|||
145704331|NCT02514239|525434695|FG007|Overall Study|Not treated|0|||
145704332|NCT02514239|525434696|FG008|Overall Study|Not treated|0|||
145704333|NCT02514239|525434697|FG009|Overall Study|Not treated|0|||
145704334|NCT02514239|525434688|FG000|Overall Study|Other Adverse Events|2|||
145704335|NCT02514239|525434689|FG001|Overall Study|Other Adverse Events|0|||
145704336|NCT02514239|525434690|FG002|Overall Study|Other Adverse Events|0|||
145704337|NCT02514239|525434691|FG003|Overall Study|Other Adverse Events|1|||
145704338|NCT02514239|525434692|FG004|Overall Study|Other Adverse Events|0|||
145704339|NCT02514239|525434693|FG005|Overall Study|Other Adverse Events|1|||
145704340|NCT02514239|525434694|FG006|Overall Study|Other Adverse Events|0|||
145704341|NCT02514239|525434695|FG007|Overall Study|Other Adverse Events|1|||
145704342|NCT02514239|525434696|FG008|Overall Study|Other Adverse Events|2|||
145704343|NCT02514239|525434697|FG009|Overall Study|Other Adverse Events|0|||
145704344|NCT02514239|525434688|FG000|Overall Study|Progressive disease|3|||
145704345|NCT02514239|525434689|FG001|Overall Study|Progressive disease|3|||
145704346|NCT02514239|525434690|FG002|Overall Study|Progressive disease|2|||
145704347|NCT02514239|525434691|FG003|Overall Study|Progressive disease|2|||
145704348|NCT02514239|525434692|FG004|Overall Study|Progressive disease|3|||
145704349|NCT02514239|525434693|FG005|Overall Study|Progressive disease|3|||
145704350|NCT02514239|525434694|FG006|Overall Study|Progressive disease|4|||
145704351|NCT02514239|525434695|FG007|Overall Study|Progressive disease|2|||
145704352|NCT02514239|525434696|FG008|Overall Study|Progressive disease|5|||
145704353|NCT02514239|525434697|FG009|Overall Study|Progressive disease|0|||
145704354|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
145704355|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
145704356|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
145704357|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
145704358|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
145704359|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
145704360|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
145704361|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
145704362|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
145704363|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
145704364|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
145704365|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
145704366|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
145704367|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
145704368|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704369|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704370|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704371|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704372|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704373|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
145704374|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
145704375|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
145704376|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
145704377|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
145704378|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
145704379|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
145704380|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
145704381|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
145704382|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704383|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704384|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704385|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704386|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
145704387|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704388|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
145704389|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704390|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
145704391|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704392|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704393|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704394|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704395|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
145704396|NCT01888874|525434698|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
145704397|NCT01888874|525434699|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
145704398|NCT01888874|525434700|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
145704399|NCT01888874|525434701|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
145704400|NCT01888874|525434702|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
145704401|NCT01888874|525434703|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
145704402|NCT01888874|525434704|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
145704403|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
145704404|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
145704405|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
145704406|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145704407|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
145704408|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145704409|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
145704410|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704411|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704412|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704413|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704414|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
145704415|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704416|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
145704417|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
145704418|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
145704419|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
145704420|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
145704421|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
145704422|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
145704423|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
145704424|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704425|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704426|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
145704427|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704428|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704429|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704430|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
145704431|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
145704432|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
145704433|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
145704434|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
145704435|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
145704436|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
145704437|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
145704438|NCT01888874|525434698|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
145704439|NCT01888874|525434699|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
145704440|NCT01888874|525434700|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
145704441|NCT01888874|525434701|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
145704442|NCT01888874|525434702|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
145704443|NCT01888874|525434703|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
145704444|NCT01888874|525434704|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
145704445|NCT01411241|525434705|FG000|Overall Study|Protocol Violation|0|||
145704446|NCT01411241|525434706|FG001|Overall Study|Protocol Violation|5|||
145704447|NCT01411241|525434705|FG000|Overall Study|Withdrawal by Subject|9|||
145704448|NCT01411241|525434706|FG001|Overall Study|Withdrawal by Subject|10|||
145704449|NCT01411241|525434705|FG000|Overall Study|Serious Adverse Event|0|||
145704450|NCT01411241|525434706|FG001|Overall Study|Serious Adverse Event|3|||
145704451|NCT01411241|525434705|FG000|Overall Study|Lost to Follow-up|2|||
145704452|NCT01411241|525434706|FG001|Overall Study|Lost to Follow-up|4|||
145704453|NCT02980042|525434709|FG000|Overall Study|Lost to Follow-up|5|||
145704454|NCT02980042|525434710|FG001|Overall Study|Lost to Follow-up|0|||
145704455|NCT02980042|525434709|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
145704456|NCT02980042|525434710|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
145704457|NCT01020877|525434716|FG000|Second Intervention|Withdrawal by Subject|1|||
145704458|NCT01020877|525434717|FG001|Second Intervention|Withdrawal by Subject|0|||
145704459|NCT01483144|525434718|FG000|Overall Study|Adverse Event|9|||
145704460|NCT01483144|525434719|FG001|Overall Study|Adverse Event|4|||
145704461|NCT01483144|525434720|FG002|Overall Study|Adverse Event|6|||
145704462|NCT01483144|525434718|FG000|Overall Study|Withdrawal by Subject|0|||
145704463|NCT01483144|525434719|FG001|Overall Study|Withdrawal by Subject|2|||
145704464|NCT01483144|525434720|FG002|Overall Study|Withdrawal by Subject|5|||
145704465|NCT01483144|525434718|FG000|Overall Study|Physician Decision|1|||
145704466|NCT01483144|525434719|FG001|Overall Study|Physician Decision|0|||
145704467|NCT01483144|525434720|FG002|Overall Study|Physician Decision|0|||
145704468|NCT01483144|525434718|FG000|Overall Study|Lost to Follow-up|2|||
145704469|NCT01483144|525434719|FG001|Overall Study|Lost to Follow-up|4|||
145704470|NCT01483144|525434720|FG002|Overall Study|Lost to Follow-up|1|||
145704471|NCT01483144|525434718|FG000|Overall Study|Protocol Violation|3|||
145704472|NCT01483144|525434719|FG001|Overall Study|Protocol Violation|3|||
145704473|NCT01483144|525434720|FG002|Overall Study|Protocol Violation|3|||
145704474|NCT00944229|525434721|FG000|Overall Study|Withdrawal by Subject|11|||
145704475|NCT00944229|525434721|FG000|Overall Study|Physician Decision|14|||
145704476|NCT04400487|525434722|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
145704477|NCT04400487|525434722|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
145704478|NCT04400487|525434722|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
145704479|NCT00520845|525434723|FG000|Overall Study|Death|3|||
145704480|NCT00520845|525434723|FG000|Overall Study|Adverse Event|4|||
145704481|NCT00520845|525434723|FG000|Overall Study|Disease Progression, relapse|13|||
145704482|NCT00520845|525434723|FG000|Overall Study|Withdrawal by Subject|1|||
145704483|NCT00520845|525434723|FG000|Overall Study|Alternative Therapy|1|||
145704484|NCT03334253|525434724|FG000|Overall Study|Withdrawal by Subject|1|||
145704485|NCT03334253|525434725|FG001|Overall Study|Withdrawal by Subject|0|||
145704486|NCT03334253|525434724|FG000|Overall Study|Lost to Follow-up|4|||
145704487|NCT03334253|525434725|FG001|Overall Study|Lost to Follow-up|3|||
145704488|NCT03334253|525434724|FG000|Overall Study|Moved residence|2|||
145704489|NCT03334253|525434725|FG001|Overall Study|Moved residence|2|||
145704490|NCT01516749|525434726|FG000|Active Therapy|Lost to Follow-up|1|||
145704491|NCT01516749|525434726|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
145378615|NCT00334802|524237321|FG000|Overall Study|Adverse Event|0|||
145704492|NCT00945672|525434728|FG000|Overall Study|Withdrawal by Subject|0|||
145704493|NCT00945672|525434729|FG001|Overall Study|Withdrawal by Subject|0|||
145704494|NCT00945672|525434730|FG002|Overall Study|Withdrawal by Subject|0|||
145704495|NCT00945672|525434731|FG003|Overall Study|Withdrawal by Subject|1|||
145704496|NCT00447590|525434735|FG000|Overall Study|Withdrawal by Subject|26|||
145704497|NCT00447590|525434735|FG000|Overall Study|Lost to Follow-up|24|||
145704498|NCT00447590|525434735|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
145704499|NCT05569421|525434738|FG000|Overall Study|Withdrawal by Subject|1|||
145704500|NCT05569421|525434739|FG001|Overall Study|Withdrawal by Subject|0|||
145704501|NCT05569421|525434740|FG002|Overall Study|Withdrawal by Subject|0|||
145704502|NCT00504075|525434741|FG000|Overall Study|Adverse Event|1|||
145704503|NCT00504075|525434741|FG000|Overall Study|Lost to Follow-up|5|||
145704504|NCT00504075|525434741|FG000|Overall Study|Withdrawal by Subject|1|||
145704505|NCT00504075|525434741|FG000|Overall Study|Required other therapeutic intervention|1|||
145704506|NCT03812029|525434744|FG000|Overall Study|Protocol Violation|1|||
145704507|NCT03812029|525434745|FG001|Overall Study|Protocol Violation|0|||
145704508|NCT03812029|525434746|FG002|Overall Study|Protocol Violation|0|||
145704509|NCT03812029|525434747|FG003|Overall Study|Protocol Violation|1|||
145704510|NCT03812029|525434748|FG004|Overall Study|Protocol Violation|0|||
145704511|NCT03812029|525434744|FG000|Overall Study|Withdrawal by Subject|1|||
145704512|NCT03812029|525434745|FG001|Overall Study|Withdrawal by Subject|0|||
145704513|NCT03812029|525434746|FG002|Overall Study|Withdrawal by Subject|0|||
145704514|NCT03812029|525434747|FG003|Overall Study|Withdrawal by Subject|2|||
145704515|NCT03812029|525434748|FG004|Overall Study|Withdrawal by Subject|2|||
145704516|NCT03812029|525434744|FG000|Overall Study|Stopping rules|0|||
145704517|NCT03812029|525434745|FG001|Overall Study|Stopping rules|1|||
145704518|NCT03812029|525434746|FG002|Overall Study|Stopping rules|0|||
145704519|NCT03812029|525434747|FG003|Overall Study|Stopping rules|0|||
145704520|NCT03812029|525434748|FG004|Overall Study|Stopping rules|0|||
145704521|NCT03812029|525434744|FG000|Overall Study|Adverse Event|0|||
145704522|NCT03812029|525434745|FG001|Overall Study|Adverse Event|9|||
145704523|NCT03812029|525434746|FG002|Overall Study|Adverse Event|0|||
145704524|NCT03812029|525434747|FG003|Overall Study|Adverse Event|3|||
145704525|NCT03812029|525434748|FG004|Overall Study|Adverse Event|5|||
145704526|NCT03812029|525434744|FG000|Overall Study|Lost to Follow-up|0|||
145704527|NCT03812029|525434745|FG001|Overall Study|Lost to Follow-up|0|||
145704528|NCT03812029|525434746|FG002|Overall Study|Lost to Follow-up|0|||
145704529|NCT03812029|525434747|FG003|Overall Study|Lost to Follow-up|0|||
145704530|NCT03812029|525434748|FG004|Overall Study|Lost to Follow-up|3|||
145704531|NCT03149042|525434749|FG000|Overall Study|Invasive FFR not performed|21|||
145704532|NCT03149042|525434749|FG000|Overall Study|Poor CT Image Quality|1|||
145704533|NCT03149042|525434749|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
145704534|NCT00790205|525434750|FG000|Overall Study|Lost to Follow-up|61|||
145704535|NCT00790205|525434751|FG001|Overall Study|Lost to Follow-up|71|||
145704536|NCT00790205|525434750|FG000|Overall Study|Withdrawal by Subject|299|||
145704537|NCT00790205|525434751|FG001|Overall Study|Withdrawal by Subject|363|||
145704538|NCT02643628|525434752|FG000|Overall Study|Lost to Follow-up|1|||
145704539|NCT02643628|525434753|FG001|Overall Study|Lost to Follow-up|4|||
145704540|NCT02643628|525434752|FG000|Overall Study|Withdrawal by Subject|0|||
145704541|NCT02643628|525434753|FG001|Overall Study|Withdrawal by Subject|1|||
145704542|NCT02643628|525434752|FG000|Overall Study|Relocated out of state|0|||
145704543|NCT02643628|525434753|FG001|Overall Study|Relocated out of state|1|||
145704544|NCT00732992|525434754|FG000|Overall Study|Adverse Event|1|||
145704545|NCT00732992|525434755|FG001|Overall Study|Adverse Event|1|||
145704546|NCT00732992|525434754|FG000|Overall Study|Objective Progression or Relapse|3|||
145704547|NCT00732992|525434755|FG001|Overall Study|Objective Progression or Relapse|5|||
145704548|NCT00732992|525434754|FG000|Overall Study|Global Deterioration of Health Status|1|||
145704549|NCT00732992|525434755|FG001|Overall Study|Global Deterioration of Health Status|0|||
145704550|NCT00732992|525434754|FG000|Overall Study|Withdrawal by Subject|1|||
145704551|NCT00732992|525434755|FG001|Overall Study|Withdrawal by Subject|0|||
145704552|NCT03017742|525434762|FG000|Overall Study|Protocol Violation|36|||
145704553|NCT03017742|525434762|FG000|Overall Study|Withdrawal by Subject|37|||
145704554|NCT01441635|525434766|FG000|Overall Study|Adverse Event|4|||
145704555|NCT01441635|525434767|FG001|Overall Study|Adverse Event|3|||
145704556|NCT01441635|525434768|FG002|Overall Study|Adverse Event|1|||
145704557|NCT01441635|525434769|FG003|Overall Study|Adverse Event|5|||
145704558|NCT01441635|525434770|FG004|Overall Study|Adverse Event|1|||
145704559|NCT01441635|525434771|FG005|Overall Study|Adverse Event|2|||
145704560|NCT01441635|525434772|FG006|Overall Study|Adverse Event|2|||
145704561|NCT01441635|525434773|FG007|Overall Study|Adverse Event|2|||
145704562|NCT01441635|525434774|FG008|Overall Study|Adverse Event|1|||
145704563|NCT01441635|525434775|FG009|Overall Study|Adverse Event|0|||
145704564|NCT01441635|525434766|FG000|Overall Study|Withdrawal by Subject|1|||
145704565|NCT01441635|525434767|FG001|Overall Study|Withdrawal by Subject|1|||
145704566|NCT01441635|525434768|FG002|Overall Study|Withdrawal by Subject|0|||
145704567|NCT01441635|525434769|FG003|Overall Study|Withdrawal by Subject|1|||
145704568|NCT01441635|525434770|FG004|Overall Study|Withdrawal by Subject|0|||
145704569|NCT01441635|525434771|FG005|Overall Study|Withdrawal by Subject|0|||
145704570|NCT01441635|525434772|FG006|Overall Study|Withdrawal by Subject|2|||
145704571|NCT01441635|525434773|FG007|Overall Study|Withdrawal by Subject|0|||
145704572|NCT01441635|525434774|FG008|Overall Study|Withdrawal by Subject|1|||
145704573|NCT01441635|525434775|FG009|Overall Study|Withdrawal by Subject|1|||
145704574|NCT01441635|525434766|FG000|Overall Study|Lost to Follow-up|0|||
145704575|NCT01441635|525434767|FG001|Overall Study|Lost to Follow-up|1|||
145704576|NCT01441635|525434768|FG002|Overall Study|Lost to Follow-up|1|||
145704577|NCT01441635|525434769|FG003|Overall Study|Lost to Follow-up|1|||
145704578|NCT01441635|525434770|FG004|Overall Study|Lost to Follow-up|1|||
145704579|NCT01441635|525434771|FG005|Overall Study|Lost to Follow-up|3|||
145704580|NCT01441635|525434772|FG006|Overall Study|Lost to Follow-up|1|||
145704581|NCT01441635|525434773|FG007|Overall Study|Lost to Follow-up|1|||
145378616|NCT00334802|524237322|FG001|Overall Study|Adverse Event|3|||
145704582|NCT01441635|525434774|FG008|Overall Study|Lost to Follow-up|0|||
145704583|NCT01441635|525434775|FG009|Overall Study|Lost to Follow-up|1|||
145704584|NCT01441635|525434766|FG000|Overall Study|Noncompliance|0|||
145704585|NCT01441635|525434767|FG001|Overall Study|Noncompliance|1|||
145704586|NCT01441635|525434768|FG002|Overall Study|Noncompliance|0|||
145704587|NCT01441635|525434769|FG003|Overall Study|Noncompliance|0|||
145704588|NCT01441635|525434770|FG004|Overall Study|Noncompliance|0|||
145704589|NCT01441635|525434771|FG005|Overall Study|Noncompliance|0|||
145704590|NCT01441635|525434772|FG006|Overall Study|Noncompliance|1|||
145704591|NCT01441635|525434773|FG007|Overall Study|Noncompliance|0|||
145704592|NCT01441635|525434774|FG008|Overall Study|Noncompliance|0|||
145704593|NCT01441635|525434775|FG009|Overall Study|Noncompliance|0|||
145704594|NCT01441635|525434766|FG000|Overall Study|Surgery or Invasive Intervention|0|||
145704595|NCT01441635|525434767|FG001|Overall Study|Surgery or Invasive Intervention|0|||
145704596|NCT01441635|525434768|FG002|Overall Study|Surgery or Invasive Intervention|1|||
145704597|NCT01441635|525434769|FG003|Overall Study|Surgery or Invasive Intervention|0|||
145704598|NCT01441635|525434770|FG004|Overall Study|Surgery or Invasive Intervention|0|||
145704599|NCT01441635|525434771|FG005|Overall Study|Surgery or Invasive Intervention|0|||
145704600|NCT01441635|525434772|FG006|Overall Study|Surgery or Invasive Intervention|0|||
145704601|NCT01441635|525434773|FG007|Overall Study|Surgery or Invasive Intervention|0|||
145704602|NCT01441635|525434774|FG008|Overall Study|Surgery or Invasive Intervention|0|||
145704603|NCT01441635|525434775|FG009|Overall Study|Surgery or Invasive Intervention|0|||
145704604|NCT01441635|525434766|FG000|Overall Study|Received Exclusionary Medication|1|||
145704605|NCT01441635|525434767|FG001|Overall Study|Received Exclusionary Medication|0|||
145704606|NCT01441635|525434768|FG002|Overall Study|Received Exclusionary Medication|0|||
145704607|NCT01441635|525434769|FG003|Overall Study|Received Exclusionary Medication|0|||
145704608|NCT01441635|525434770|FG004|Overall Study|Received Exclusionary Medication|0|||
145704609|NCT01441635|525434771|FG005|Overall Study|Received Exclusionary Medication|0|||
145704610|NCT01441635|525434772|FG006|Overall Study|Received Exclusionary Medication|0|||
145704611|NCT01441635|525434773|FG007|Overall Study|Received Exclusionary Medication|0|||
145704612|NCT01441635|525434774|FG008|Overall Study|Received Exclusionary Medication|0|||
145704613|NCT01441635|525434775|FG009|Overall Study|Received Exclusionary Medication|0|||
145704614|NCT01441635|525434766|FG000|Overall Study|Other|0|||
145704615|NCT01441635|525434767|FG001|Overall Study|Other|0|||
145704616|NCT01441635|525434768|FG002|Overall Study|Other|0|||
145704617|NCT01441635|525434769|FG003|Overall Study|Other|0|||
145704618|NCT01441635|525434770|FG004|Overall Study|Other|0|||
145704619|NCT01441635|525434771|FG005|Overall Study|Other|0|||
145704620|NCT01441635|525434772|FG006|Overall Study|Other|0|||
145704621|NCT01441635|525434773|FG007|Overall Study|Other|1|||
145704622|NCT01441635|525434774|FG008|Overall Study|Other|0|||
145704623|NCT01441635|525434775|FG009|Overall Study|Other|0|||
145704624|NCT01825577|525434776|FG000|Overall Study|Physician Decision|2|||
145704625|NCT01825577|525434776|FG000|Overall Study|Withdrawal by Subject|1|||
145704626|NCT01825577|525434776|FG000|Overall Study|Withdrawn by family members|2|||
145704627|NCT01825577|525434776|FG000|Overall Study|Lack of Efficacy|3|||
145704628|NCT00358644|525434777|FG000|Overall Study|Progressive Disease|21|||
145704629|NCT00358644|525434777|FG000|Overall Study|Adverse Event|7|||
145704630|NCT00358644|525434777|FG000|Overall Study|Death|11|||
145704631|NCT00358644|525434777|FG000|Overall Study|Withdrawal by Subject|4|||
145704632|NCT00358644|525434777|FG000|Overall Study|Physician Decision|6|||
145704633|NCT00358644|525434777|FG000|Overall Study|Patient not eligible for study|1|||
145704634|NCT00513708|525434778|FG000|Overall Study|Lost to Follow-up|4|||
145704635|NCT00513708|525434779|FG001|Overall Study|Lost to Follow-up|4|||
145704636|NCT00513708|525434780|FG002|Overall Study|Lost to Follow-up|4|||
145704637|NCT03327831|525434781|FG000|Overall Study|Lost to Follow-up|2|||
145704638|NCT00368875|525434782|FG000|Overall Study|Adverse Event|0|||
145704639|NCT00368875|525434783|FG001|Overall Study|Adverse Event|12|||
145704640|NCT00368875|525434782|FG000|Overall Study|Progressive disease|3|||
145704641|NCT00368875|525434783|FG001|Overall Study|Progressive disease|27|||
145704642|NCT00368875|525434782|FG000|Overall Study|Withdrawal by Subject|2|||
145704643|NCT00368875|525434783|FG001|Overall Study|Withdrawal by Subject|6|||
145704644|NCT00368875|525434782|FG000|Overall Study|Other Reason|0|||
145704645|NCT00368875|525434783|FG001|Overall Study|Other Reason|2|||
145704646|NCT00368875|525434782|FG000|Overall Study|Alternative Therapy|1|||
145704647|NCT00368875|525434783|FG001|Overall Study|Alternative Therapy|1|||
145704648|NCT01564277|525434784|FG000|Overall Study|Protocol Violation|0|||
145704649|NCT01564277|525434785|FG001|Overall Study|Protocol Violation|1|||
145704650|NCT01564277|525434784|FG000|Overall Study|Physician Decision|1|||
145704651|NCT01564277|525434785|FG001|Overall Study|Physician Decision|0|||
145704652|NCT02595372|525434786|FG000|Overall Study|Adverse Event|6|||
145704653|NCT02595372|525434786|FG000|Overall Study|Physician Decision|2|||
145704654|NCT02595372|525434786|FG000|Overall Study|Disease Progression|1|||
145704655|NCT00401258|525434789|FG000|Overall Study|Adverse Event|7|||
145704656|NCT01245374|525434795|FG000|Overall Study|Protocol Violation|1|||
145704657|NCT01245374|525434795|FG000|Overall Study|Withdrawal by Subject|3|||
145704658|NCT01782690|525434797|FG000|Overall Study|Not reported|7|||
145704659|NCT01782690|525434797|FG000|Overall Study|Toxicity of gemcitabine|1|||
145704660|NCT01782690|525434797|FG000|Overall Study|Toxicity of erlotinib|1|||
145704661|NCT01782690|525434797|FG000|Overall Study|Lost to Follow-up|31|||
145704662|NCT01782690|525434797|FG000|Overall Study|Withdrawal of informed consent|2|||
145704663|NCT01782690|525434797|FG000|Overall Study|Absent rash|9|||
145704664|NCT01782690|525434797|FG000|Overall Study|Physician Decision|13|||
145704665|NCT01782690|525434797|FG000|Overall Study|Patient's wish|21|||
145704666|NCT01782690|525434797|FG000|Overall Study|Tumor progression|74|||
145704667|NCT01782690|525434797|FG000|Overall Study|Death|133|||
145704668|NCT01782690|525434797|FG000|Overall Study|Study completion unknown|7|||
145704669|NCT04199052|525434800|FG000|Overall Study|Lost to Follow-up|11|||
145704670|NCT04199052|525434801|FG001|Overall Study|Lost to Follow-up|18|||
145704671|NCT01948076|525434802|FG000|Overall Study|Withdrawal by Subject|0|||
145704672|NCT01948076|525434803|FG001|Overall Study|Withdrawal by Subject|1|||
145704673|NCT01151423|525434804|FG000|Overall Study|Study terminated by Sponsor|9|||
145704674|NCT01151423|525434805|FG001|Overall Study|Study terminated by Sponsor|10|||
145704675|NCT01151423|525434804|FG000|Overall Study|Protocol Violation|0|||
145704676|NCT01151423|525434805|FG001|Overall Study|Protocol Violation|1|||
145704677|NCT01151423|525434804|FG000|Overall Study|Physician Decision|1|||
145704678|NCT01151423|525434805|FG001|Overall Study|Physician Decision|1|||
145704679|NCT01151423|525434804|FG000|Overall Study|Pregnancy|0|||
145704680|NCT01151423|525434805|FG001|Overall Study|Pregnancy|1|||
145704681|NCT01151423|525434804|FG000|Overall Study|Death|0|||
145704682|NCT01151423|525434805|FG001|Overall Study|Death|1|||
145704683|NCT01151423|525434804|FG000|Overall Study|Adverse Event|3|||
145704684|NCT01151423|525434805|FG001|Overall Study|Adverse Event|0|||
145704685|NCT01151423|525434804|FG000|Overall Study|Withdrawal by Subject|1|||
145704686|NCT01151423|525434805|FG001|Overall Study|Withdrawal by Subject|3|||
145704687|NCT01151423|525434804|FG000|Overall Study|Lost to Follow-up|1|||
145704688|NCT01151423|525434805|FG001|Overall Study|Lost to Follow-up|0|||
145704689|NCT01151423|525434804|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
145704690|NCT01151423|525434805|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
145704691|NCT01151423|525434804|FG000|Overall Study|Participated in other clinical trial|1|||
145704692|NCT01151423|525434805|FG001|Overall Study|Participated in other clinical trial|0|||
145704693|NCT00681668|525434806|FG000|Overall Study|Protocol Violation|1|||
145704694|NCT00681668|525434806|FG000|Overall Study|Withdrawal by Subject|1|||
145704695|NCT05992922|525434818|FG000|Overall Study|Adverse Event|6|||
145704696|NCT05992922|525434819|FG001|Overall Study|Adverse Event|0|||
145704697|NCT05992922|525434818|FG000|Overall Study|Sponsor Termination of Study|14|||
145704698|NCT05992922|525434819|FG001|Overall Study|Sponsor Termination of Study|20|||
145704699|NCT02473965|525436438|FG000|Overall Study|Adverse Event|6|||
145704700|NCT02473965|525436439|FG001|Overall Study|Adverse Event|4|||
145704701|NCT02473965|525436438|FG000|Overall Study|MG worsening|4|||
145704702|NCT02473965|525436439|FG001|Overall Study|MG worsening|1|||
145704703|NCT02473965|525436438|FG000|Overall Study|Withdrawal by Subject|2|||
145704704|NCT02473965|525436439|FG001|Overall Study|Withdrawal by Subject|3|||
145704705|NCT02473965|525436438|FG000|Overall Study|Physician Decision|0|||
145704706|NCT02473965|525436439|FG001|Overall Study|Physician Decision|2|||
145704707|NCT01183390|525436440|FG000|First Intervention|Adverse Event|0|||
145704708|NCT01183390|525436441|FG001|First Intervention|Adverse Event|1|||
145704709|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Adverse Event|2|||
145704710|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Adverse Event|0|||
145704711|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Adverse Event|0|||
145704712|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Adverse Event|0|||
145704713|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
145704714|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
145704715|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
145704716|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
145704717|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
145704718|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
145704719|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
145704720|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
145704721|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Physician Decision|1|||
145704722|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Physician Decision|0|||
145704723|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Physician Decision|0|||
145704724|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Physician Decision|0|||
145704725|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Pregnancy|1|||
145704726|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Pregnancy|0|||
145704727|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Pregnancy|0|||
145704728|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Pregnancy|0|||
145704729|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
145704730|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
145704731|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145704732|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
145377865|NCT03191864|524233640|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
145704733|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
145704734|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
145704735|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
145704736|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
145704737|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
145704738|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
145704739|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
145704740|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
145704741|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
145704742|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
145704743|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
145704744|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
145704745|NCT04057573|525436442|FG000|24-Week Double-Blind Period|Not Treated|1|||
145704746|NCT04057573|525436443|FG001|24-Week Double-Blind Period|Not Treated|0|||
145704747|NCT04057573|525436444|FG002|24-Week Double-Blind Period|Not Treated|0|||
145704748|NCT04057573|525436445|FG003|24-Week Double-Blind Period|Not Treated|0|||
145704749|NCT04057573|525436442|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
145704750|NCT04057573|525436443|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
145704751|NCT04057573|525436444|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
145704752|NCT04057573|525436445|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
145704753|NCT04057573|525436442|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
145704754|NCT04057573|525436443|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
145704755|NCT04057573|525436444|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
145704756|NCT04057573|525436445|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
145704757|NCT04057573|525436442|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
145704758|NCT04057573|525436443|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
145704759|NCT04057573|525436444|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
145704760|NCT04057573|525436445|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
145704761|NCT04057573|525436442|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
145704762|NCT04057573|525436443|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
145704763|NCT04057573|525436444|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
145704764|NCT04057573|525436445|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
145704765|NCT04057573|525436442|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
145704766|NCT04057573|525436443|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
145704767|NCT04057573|525436444|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
145704768|NCT04057573|525436445|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
145704769|NCT04991753|525436446|FG000|Overall Study|Withdrawal by Subject|0|||
145704770|NCT04991753|525436447|FG001|Overall Study|Withdrawal by Subject|1|||
145704771|NCT02113124|525436454|FG000|Overall Study|Unable to retrieve blood sample|1|||
145704772|NCT02113124|525436455|FG001|Overall Study|Unable to retrieve blood sample|1|||
145704773|NCT03299049|525436456|FG000|Overall Study|On-going|486|||
145704774|NCT03299049|525436457|FG001|Overall Study|On-going|481|||
145704775|NCT03299049|525436456|FG000|Overall Study|Withdrawal by Subject|6|||
145704776|NCT03299049|525436457|FG001|Overall Study|Withdrawal by Subject|21|||
145704777|NCT03299049|525436456|FG000|Overall Study|Physician Decision|5|||
145704778|NCT03299049|525436457|FG001|Overall Study|Physician Decision|1|||
145704779|NCT03299049|525436456|FG000|Overall Study|Lost to Follow-up|2|||
145704780|NCT03299049|525436457|FG001|Overall Study|Lost to Follow-up|0|||
145704781|NCT03299049|525436456|FG000|Overall Study|Pregnancy|1|||
145704782|NCT03299049|525436457|FG001|Overall Study|Pregnancy|3|||
145704783|NCT03299049|525436456|FG000|Overall Study|Protocol Violation|1|||
145704784|NCT03299049|525436457|FG001|Overall Study|Protocol Violation|1|||
145704785|NCT03299049|525436456|FG000|Overall Study|Lack of Efficacy|9|||
145704786|NCT03299049|525436457|FG001|Overall Study|Lack of Efficacy|3|||
145704787|NCT03299049|525436456|FG000|Overall Study|Adverse Event|12|||
145704788|NCT03299049|525436457|FG001|Overall Study|Adverse Event|13|||
145704789|NCT01901419|525436458|FG000|Overall Study|Protocol Violation|2|||
145704790|NCT01901419|525436459|FG001|Overall Study|Protocol Violation|6|||
145704791|NCT01901419|525436458|FG000|Overall Study|unavailable researchers|6|||
145704792|NCT01901419|525436459|FG001|Overall Study|unavailable researchers|3|||
145704793|NCT00475644|525436461|FG000|Overall Study|Protocol Violation|13|||
145704794|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
145704795|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
145704796|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
145704797|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
145704798|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
145704799|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
145704800|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
145704801|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
145704802|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
145704803|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
145704804|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
145704805|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
145704806|NCT00790400|525436469|FG000|Double-blind Period (Core Phase)|Death|1|||
145704807|NCT00790400|525436470|FG001|Double-blind Period (Core Phase)|Death|0|||
145704808|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
145704809|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
145704810|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
145704811|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
145704812|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
145704813|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
145704814|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
145704815|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
145704816|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
145704817|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
145704818|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Death|1|||
145704819|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Death|0|||
145704820|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
145704821|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
145704822|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
145704823|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
145704824|NCT00790400|525436469|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
145704825|NCT00790400|525436470|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
145704826|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
145704827|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
145704828|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
145704829|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
145704830|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Death|13|||
145704831|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Death|12|||
145704832|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Progression|257|||
145704833|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Progression|218|||
145704834|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
145704835|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
145704836|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
145704837|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
145704838|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
145704839|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
145704840|NCT01006980|525436472|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
145704841|NCT01006980|525436473|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
145704842|NCT01006980|525436472|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
145704843|NCT01006980|525436473|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
145704844|NCT01006980|525436472|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
145704845|NCT01006980|525436473|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
145704846|NCT01006980|525436472|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
145704847|NCT01006980|525436473|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
145704848|NCT01006980|525436472|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
145704849|NCT01006980|525436473|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
145704850|NCT01006980|525436472|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
145704851|NCT01006980|525436473|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
145704852|NCT00078338|525436474|FG000|Overall Study|Adverse Event|31|||
145704853|NCT00078338|525436475|FG001|Overall Study|Adverse Event|24|||
145704854|NCT00078338|525436474|FG000|Overall Study|Lost to Follow-up|17|||
145704855|NCT00078338|525436475|FG001|Overall Study|Lost to Follow-up|2|||
145704856|NCT00078338|525436474|FG000|Overall Study|Protocol Violation|2|||
145704857|NCT00078338|525436475|FG001|Overall Study|Protocol Violation|2|||
145704858|NCT00078338|525436474|FG000|Overall Study|Disease Progression|4|||
145704859|NCT00078338|525436475|FG001|Overall Study|Disease Progression|7|||
145704860|NCT00078338|525436474|FG000|Overall Study|Other|28|||
145704861|NCT00078338|525436475|FG001|Overall Study|Other|16|||
145704862|NCT00078338|525436474|FG000|Overall Study|Subjects randomized, but not treated|3|||
145704863|NCT00078338|525436475|FG001|Overall Study|Subjects randomized, but not treated|3|||
145704864|NCT02460575|525436476|FG000|Overall Study|Lost to Follow-up|1|||
145704865|NCT02460575|525436477|FG001|Overall Study|Lost to Follow-up|0|||
145704866|NCT04307940|525436478|FG000|Overall Study|Adverse Event|1|||
145704867|NCT04307940|525436479|FG001|Overall Study|Adverse Event|0|||
145704868|NCT04307940|525436480|FG002|Overall Study|Adverse Event|0|||
145704869|NCT04307940|525436478|FG000|Overall Study|Withdrawal by Subject|2|||
145704870|NCT04307940|525436479|FG001|Overall Study|Withdrawal by Subject|3|||
145704871|NCT04307940|525436480|FG002|Overall Study|Withdrawal by Subject|1|||
145704872|NCT04307940|525436478|FG000|Overall Study|Lost to Follow-up|2|||
145704873|NCT04307940|525436479|FG001|Overall Study|Lost to Follow-up|0|||
145704874|NCT04307940|525436480|FG002|Overall Study|Lost to Follow-up|1|||
145704875|NCT02521363|525436481|FG000|Overall Study|Withdrawal by Subject|1|||
145704876|NCT02521363|525436482|FG001|Overall Study|Withdrawal by Subject|2|||
145704877|NCT05543174|525436483|FG000|Overall Study|Ongoing|7|||
145704878|NCT03104075|525436486|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
145704879|NCT03104075|525436487|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
145704880|NCT04024462|525436488|FG000|Overall Study|Withdrawal by Subject|6|||
145704881|NCT04024462|525436489|FG001|Overall Study|Withdrawal by Subject|7|||
145704882|NCT04024462|525436488|FG000|Overall Study|Progressive Disease|0|||
145704883|NCT04024462|525436489|FG001|Overall Study|Progressive Disease|1|||
145704884|NCT04024462|525436488|FG000|Overall Study|Adverse Event|0|||
145704885|NCT04024462|525436489|FG001|Overall Study|Adverse Event|1|||
145704886|NCT04024462|525436488|FG000|Overall Study|Death|0|||
145704887|NCT04024462|525436489|FG001|Overall Study|Death|1|||
145704888|NCT04024462|525436488|FG000|Overall Study|Lost to Follow-up|1|||
145704889|NCT04024462|525436489|FG001|Overall Study|Lost to Follow-up|0|||
145704890|NCT04024462|525436488|FG000|Overall Study|Ongoing in the Study|94|||
145704891|NCT04024462|525436489|FG001|Overall Study|Ongoing in the Study|89|||
145704892|NCT04896008|525436490|FG000|Overall Study|Ongoing|70|||
145704893|NCT04896008|525436491|FG001|Overall Study|Ongoing|38|||
145704894|NCT04896008|525436490|FG000|Overall Study|Adverse Event|0|||
145704895|NCT04896008|525436491|FG001|Overall Study|Adverse Event|2|||
145704896|NCT04896008|525436490|FG000|Overall Study|Death|5|||
145704897|NCT04896008|525436491|FG001|Overall Study|Death|10|||
145704898|NCT04896008|525436490|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
145704899|NCT04896008|525436491|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
145704900|NCT04896008|525436490|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
145704901|NCT04896008|525436491|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
145704902|NCT04896008|525436490|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
145704903|NCT04896008|525436491|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
145704904|NCT04896008|525436490|FG000|Overall Study|Withdrawal by Subject|1|||
145704905|NCT04896008|525436491|FG001|Overall Study|Withdrawal by Subject|4|||
145704906|NCT04896008|525436490|FG000|Overall Study|Investigator Decision|2|||
145704907|NCT04896008|525436491|FG001|Overall Study|Investigator Decision|0|||
145704908|NCT04896008|525436490|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
145704909|NCT04896008|525436491|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
145704910|NCT01270828|525436496|FG000|Pregabalin CR SB|Reason Unspecified|0|||
145704911|NCT01270828|525436497|FG001|Pregabalin CR SB|Reason Unspecified|0|||
145704912|NCT01270828|525436498|FG002|Pregabalin CR SB|Reason Unspecified|8|||
145704913|NCT01270828|525436496|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
145704914|NCT01270828|525436497|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
145704915|NCT01270828|525436498|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
145704916|NCT01270828|525436496|FG000|Pregabalin CR SB|Related adverse event|0|||
145704917|NCT01270828|525436497|FG001|Pregabalin CR SB|Related adverse event|0|||
145704918|NCT01270828|525436498|FG002|Pregabalin CR SB|Related adverse event|46|||
145704919|NCT01270828|525436496|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
145704920|NCT01270828|525436497|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
145704921|NCT01270828|525436498|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
145704922|NCT01270828|525436496|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
145704923|NCT01270828|525436497|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
145704924|NCT01270828|525436498|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
145704925|NCT01270828|525436496|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
145704926|NCT01270828|525436497|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
145704927|NCT01270828|525436498|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
145704928|NCT01270828|525436496|FG000|Pregabalin CR SB|Unrelated AE|0|||
145704929|NCT01270828|525436497|FG001|Pregabalin CR SB|Unrelated AE|0|||
145704930|NCT01270828|525436498|FG002|Pregabalin CR SB|Unrelated AE|8|||
145704931|NCT01270828|525436496|FG000|Pregabalin CR SB|Protocol Violation|0|||
145704932|NCT01270828|525436497|FG001|Pregabalin CR SB|Protocol Violation|0|||
145704933|NCT01270828|525436498|FG002|Pregabalin CR SB|Protocol Violation|8|||
145704934|NCT01270828|525436496|FG000|Double Blind Phase|Death|0|||
145704935|NCT01270828|525436497|FG001|Double Blind Phase|Death|1|||
145704936|NCT01270828|525436498|FG002|Double Blind Phase|Death|0|||
145704937|NCT01270828|525436496|FG000|Double Blind Phase|Protocol Violation|0|||
145704938|NCT01270828|525436497|FG001|Double Blind Phase|Protocol Violation|1|||
145704939|NCT01270828|525436498|FG002|Double Blind Phase|Protocol Violation|0|||
145704940|NCT01270828|525436496|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
145704941|NCT01270828|525436497|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
145704942|NCT01270828|525436498|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
145704943|NCT01270828|525436496|FG000|Double Blind Phase|Reason Unspecified|7|||
145704944|NCT01270828|525436497|FG001|Double Blind Phase|Reason Unspecified|4|||
145704945|NCT01270828|525436498|FG002|Double Blind Phase|Reason Unspecified|0|||
145704946|NCT01270828|525436496|FG000|Double Blind Phase|Withdrawal by Subject|6|||
145704947|NCT01270828|525436497|FG001|Double Blind Phase|Withdrawal by Subject|15|||
145704948|NCT01270828|525436498|FG002|Double Blind Phase|Withdrawal by Subject|0|||
145704949|NCT01270828|525436496|FG000|Double Blind Phase|Lost to Follow-up|1|||
145704950|NCT01270828|525436497|FG001|Double Blind Phase|Lost to Follow-up|2|||
145704951|NCT01270828|525436498|FG002|Double Blind Phase|Lost to Follow-up|0|||
145704952|NCT01270828|525436496|FG000|Double Blind Phase|Lack of Efficacy|2|||
145704953|NCT01270828|525436497|FG001|Double Blind Phase|Lack of Efficacy|11|||
145704954|NCT01270828|525436498|FG002|Double Blind Phase|Lack of Efficacy|0|||
145704955|NCT01270828|525436496|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
145704956|NCT01270828|525436497|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
145704957|NCT01270828|525436498|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
145704958|NCT01270828|525436496|FG000|Double Blind Phase|Adverse event related to study drug|5|||
145704959|NCT01270828|525436497|FG001|Double Blind Phase|Adverse event related to study drug|7|||
145704960|NCT01270828|525436498|FG002|Double Blind Phase|Adverse event related to study drug|0|||
145704961|NCT01810939|525436501|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
145704962|NCT01810939|525436502|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
145704963|NCT01810939|525436503|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
145704964|NCT01810939|525436501|FG000|Part A Treatment Period|Protocol Violation|2|||
145704965|NCT01810939|525436502|FG001|Part A Treatment Period|Protocol Violation|0|||
145704966|NCT01810939|525436503|FG002|Part A Treatment Period|Protocol Violation|0|||
145704967|NCT01810939|525436501|FG000|Part A Treatment Period|Adverse Event|10|||
145704968|NCT01810939|525436502|FG001|Part A Treatment Period|Adverse Event|0|||
145704969|NCT01810939|525436503|FG002|Part A Treatment Period|Adverse Event|0|||
145704970|NCT01810939|525436501|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
145704971|NCT01810939|525436502|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
145704972|NCT01810939|525436503|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
145704973|NCT01810939|525436501|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
145704974|NCT01810939|525436502|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
145704975|NCT01810939|525436503|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
145704976|NCT01810939|525436501|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
145704977|NCT01810939|525436502|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
145704978|NCT01810939|525436503|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
145704979|NCT01810939|525436501|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
145704980|NCT01810939|525436502|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
145704981|NCT01810939|525436503|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
145704982|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
145704983|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
145704984|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
145704985|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
145704986|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
145704987|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
145704988|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
145704989|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
145704990|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
145704991|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
145704992|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
145704993|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
145704994|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
145704995|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
145704996|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
145704997|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
145704998|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
145704999|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
145705000|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
145705001|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
145705002|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
145705003|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
145705004|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
145705005|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
145705006|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
145705007|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
145705008|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
145705009|NCT01810939|525436501|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
145705010|NCT01810939|525436502|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
145705011|NCT01810939|525436503|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
145705012|NCT02963090|525436504|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
145705013|NCT02963090|525436505|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
145377866|NCT03191864|524233635|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145705014|NCT00709228|525436509|FG000|Overall Study|Not treated|14|||
145705015|NCT00709228|525436509|FG000|Overall Study|Eligibility criteria not met|281|||
145705016|NCT00709228|525436509|FG000|Overall Study|Adverse events|2|||
145705017|NCT00709228|525436509|FG000|Overall Study|Discontinued treatment|14|||
145705018|NCT00709228|525436509|FG000|Overall Study|Did not enter follow-up|4|||
145705019|NCT00709228|525436509|FG000|Overall Study|Discontinued follow-up|5|||
145705020|NCT00709228|525436509|FG000|Overall Study|Disease progression|1|||
145705021|NCT00709228|525436509|FG000|Overall Study|Lost to Follow-up|6|||
145705022|NCT00709228|525436509|FG000|Overall Study|Non-compliance|5|||
145705023|NCT02870972|525436510|FG000|Overall Study|Adverse Event|1|||
145705024|NCT02870972|525436511|FG001|Overall Study|Adverse Event|0|||
145705025|NCT02870972|525436512|FG002|Overall Study|Adverse Event|0|||
145705026|NCT02870972|525436513|FG003|Overall Study|Adverse Event|0|||
145705027|NCT02870972|525436514|FG004|Overall Study|Adverse Event|0|||
145705028|NCT01594827|525436516|FG000|Overall Study|Adverse Event|1|||
145705029|NCT01594827|525436517|FG001|Overall Study|Adverse Event|0|||
145705030|NCT01594827|525436516|FG000|Overall Study|Physician Decision|3|||
145705031|NCT01594827|525436517|FG001|Overall Study|Physician Decision|0|||
145705032|NCT03054337|525436519|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
145705033|NCT03054337|525436520|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
145705034|NCT03054337|525436521|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
145705035|NCT03054337|525436522|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
145705036|NCT03054337|525436523|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
145705037|NCT03054337|525436524|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
145705038|NCT00609947|525436526|FG000|Overall Study|Death|1|||
145705039|NCT00581477|525436527|FG000|Overall Study|Physician Decision|2|||
145705040|NCT03106753|525436528|FG000|Overall Study|Withdrawal by Subject|0|||
145705041|NCT03106753|525436529|FG001|Overall Study|Withdrawal by Subject|1|||
145705042|NCT01643044|525436531|FG000|Overall Study|Lost to Follow-up|1|||
145705043|NCT01643044|525436532|FG001|Overall Study|Lost to Follow-up|1|||
145705044|NCT01643044|525436531|FG000|Overall Study|Miscarried baby|2|||
145705045|NCT01643044|525436532|FG001|Overall Study|Miscarried baby|2|||
145705046|NCT01643044|525436531|FG000|Overall Study|Delivered outside of hospital|1|||
145705047|NCT01643044|525436532|FG001|Overall Study|Delivered outside of hospital|2|||
145705048|NCT04148651|525436536|FG000|Overall Study|Lost to Follow-up|2|||
145705049|NCT03690427|525436539|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
145705050|NCT03690427|525436540|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
145705051|NCT03519204|525436545|FG000|Overall Study|Lost to Follow-up|3|||
145705052|NCT03519204|525436546|FG001|Overall Study|Lost to Follow-up|8|||
145705053|NCT03519204|525436545|FG000|Overall Study|Withdrawal by Subject|9|||
145705054|NCT03519204|525436546|FG001|Overall Study|Withdrawal by Subject|7|||
145705055|NCT03519204|525436545|FG000|Overall Study|Other Miscellaneous Reasons|1|||
145705056|NCT03519204|525436546|FG001|Overall Study|Other Miscellaneous Reasons|0|||
145705057|NCT01721954|525436547|FG000|Overall Study|Death|58|||
145705058|NCT01721954|525436548|FG001|Overall Study|Death|64|||
145705059|NCT01721954|525436547|FG000|Overall Study|Withdrawal by Subject|8|||
145705060|NCT01721954|525436548|FG001|Overall Study|Withdrawal by Subject|4|||
145705061|NCT01721954|525436547|FG000|Overall Study|Adverse Event|2|||
145705062|NCT01721954|525436548|FG001|Overall Study|Adverse Event|0|||
145705063|NCT01721954|525436547|FG000|Overall Study|Lost to Follow-up|2|||
145705064|NCT01721954|525436548|FG001|Overall Study|Lost to Follow-up|1|||
145705065|NCT02609672|525436549|FG000|Overall Study|Lost to Follow-up|3|||
145705066|NCT02609672|525436550|FG001|Overall Study|Lost to Follow-up|1|||
145705067|NCT02956837|525436553|FG000|Overall Study|Serious Adverse Events|0|||
145705068|NCT02956837|525436554|FG001|Overall Study|Serious Adverse Events|1|||
145705069|NCT02956837|525436555|FG002|Overall Study|Serious Adverse Events|0|||
145705070|NCT02956837|525436556|FG003|Overall Study|Serious Adverse Events|0|||
145705071|NCT02956837|525436553|FG000|Overall Study|Withdrawal by Subject|0|||
145705072|NCT02956837|525436554|FG001|Overall Study|Withdrawal by Subject|1|||
145705073|NCT02956837|525436555|FG002|Overall Study|Withdrawal by Subject|0|||
145705074|NCT02956837|525436556|FG003|Overall Study|Withdrawal by Subject|3|||
145705075|NCT02956837|525436553|FG000|Overall Study|Lost to Follow-up|0|||
145705076|NCT02956837|525436554|FG001|Overall Study|Lost to Follow-up|1|||
145705077|NCT02956837|525436555|FG002|Overall Study|Lost to Follow-up|2|||
145705078|NCT02956837|525436556|FG003|Overall Study|Lost to Follow-up|0|||
145705079|NCT02637323|525436561|FG000|Overall Study|Lost to Follow-up|2|||
145705080|NCT02637323|525436562|FG001|Overall Study|Lost to Follow-up|0|||
145705081|NCT02637323|525436561|FG000|Overall Study|Protocol Violation|0|||
145705082|NCT02637323|525436562|FG001|Overall Study|Protocol Violation|1|||
145705083|NCT01305239|525436563|FG000|Overall Study|Adverse Event|22|||
145705084|NCT01305239|525436563|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
145705085|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Adverse Event|10|||
145705086|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Adverse Event|9|||
145705087|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Adverse Event|7|||
145705088|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
145705089|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
145705090|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
145705091|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
145705092|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
145705093|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
145705094|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Physician Decision|7|||
145705095|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Physician Decision|3|||
145705096|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Physician Decision|2|||
145705097|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Pregnancy|2|||
145705098|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Pregnancy|1|||
145705099|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Pregnancy|3|||
145705100|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
145705101|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
145705102|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
145705103|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
145705104|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
145705105|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
145705106|NCT02614183|525436570|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
145705107|NCT02614183|525436571|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
145705108|NCT02614183|525436572|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
145705109|NCT02614183|525436570|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
145705110|NCT02614183|525436571|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
145705111|NCT02614183|525436572|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
145705112|NCT02614183|525436570|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
145705113|NCT02614183|525436571|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
145705114|NCT02614183|525436572|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
145705115|NCT02614183|525436570|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
145705116|NCT02614183|525436571|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
145705117|NCT02614183|525436572|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
145705118|NCT02614183|525436570|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
145705119|NCT02614183|525436571|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
145705120|NCT02614183|525436572|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
145705121|NCT02726945|525436573|FG000|Overall Study|Withdrawal by Subject|0|||
145705122|NCT02726945|525436574|FG001|Overall Study|Withdrawal by Subject|0|||
145705123|NCT02726945|525436575|FG002|Overall Study|Withdrawal by Subject|1|||
145705124|NCT02726945|525436573|FG000|Overall Study|Elected to have total knee replacement|0|||
145705125|NCT02726945|525436574|FG001|Overall Study|Elected to have total knee replacement|1|||
145705126|NCT02726945|525436575|FG002|Overall Study|Elected to have total knee replacement|0|||
145705127|NCT00699153|525438854|FG000|Overall Study|Lost to Follow-up|1|||
145705128|NCT00699153|525438855|FG001|Overall Study|Lost to Follow-up|0|||
145705129|NCT00699153|525438854|FG000|Overall Study|Adverse Event|0|||
145705130|NCT00699153|525438855|FG001|Overall Study|Adverse Event|2|||
145705131|NCT00699153|525438854|FG000|Overall Study|Protocol Violation|1|||
145705132|NCT00699153|525438855|FG001|Overall Study|Protocol Violation|0|||
145705133|NCT00699153|525438854|FG000|Overall Study|Travel Problem|1|||
145705134|NCT00699153|525438855|FG001|Overall Study|Travel Problem|0|||
145705135|NCT03559062|525438859|FG000|Overall Study|Other|0|||
145705136|NCT03559062|525438860|FG001|Overall Study|Other|1|||
145705137|NCT03559062|525438861|FG002|Overall Study|Other|0|||
145705138|NCT01967069|525438865|FG000|Overall Study|Adverse Event|2|||
145705139|NCT01967069|525438866|FG001|Overall Study|Adverse Event|2|||
145705140|NCT01967069|525438865|FG000|Overall Study|Lost to Follow-up|5|||
145705141|NCT01967069|525438866|FG001|Overall Study|Lost to Follow-up|2|||
145705142|NCT01967069|525438865|FG000|Overall Study|Withdrawal by Subject|1|||
145705143|NCT01967069|525438866|FG001|Overall Study|Withdrawal by Subject|3|||
145705144|NCT01967069|525438865|FG000|Overall Study|Lack of Efficacy|0|||
145705145|NCT01967069|525438866|FG001|Overall Study|Lack of Efficacy|1|||
145705146|NCT01689857|525438868|FG000|Overall Study|Lost to Follow-up|5|||
145705147|NCT01689857|525438869|FG001|Overall Study|Lost to Follow-up|2|||
145705148|NCT01730378|525438870|FG000|Overall Study|Lost to Follow-up|1|||
145705149|NCT01730378|525438871|FG001|Overall Study|Lost to Follow-up|0|||
145705150|NCT00874731|525438874|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
145705151|NCT00874731|525438875|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
145705152|NCT00874731|525438876|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
145705153|NCT00874731|525438874|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
145705154|NCT00874731|525438875|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
145705155|NCT00874731|525438876|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
145705156|NCT00874731|525438874|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
145705157|NCT00874731|525438875|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
145705158|NCT00874731|525438876|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
145705159|NCT05105087|525438877|FG000|Overall Study|Withdrawal by Subject|2|||
145705160|NCT05105087|525438877|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
145705161|NCT01016262|525438878|FG000|Double-blind Phase|Adverse Event|0|||
145705162|NCT01016262|525438879|FG001|Double-blind Phase|Adverse Event|0|||
145705163|NCT01016262|525438880|FG002|Double-blind Phase|Adverse Event|1|||
145705164|NCT01016262|525438881|FG003|Double-blind Phase|Adverse Event|0|||
145705165|NCT01016262|525438882|FG004|Double-blind Phase|Adverse Event|0|||
145705166|NCT01016262|525438883|FG005|Double-blind Phase|Adverse Event|0|||
145705167|NCT01016262|525438878|FG000|Double-blind Phase|Lack of Efficacy|1|||
145705168|NCT01016262|525438879|FG001|Double-blind Phase|Lack of Efficacy|0|||
145705169|NCT01016262|525438880|FG002|Double-blind Phase|Lack of Efficacy|5|||
145705170|NCT01016262|525438881|FG003|Double-blind Phase|Lack of Efficacy|0|||
145705171|NCT01016262|525438882|FG004|Double-blind Phase|Lack of Efficacy|0|||
145705172|NCT01016262|525438883|FG005|Double-blind Phase|Lack of Efficacy|0|||
145705173|NCT01016262|525438878|FG000|Double-blind Phase|Disease Progression|0|||
145705174|NCT01016262|525438879|FG001|Double-blind Phase|Disease Progression|1|||
145705175|NCT01016262|525438880|FG002|Double-blind Phase|Disease Progression|2|||
145705176|NCT01016262|525438881|FG003|Double-blind Phase|Disease Progression|0|||
145705177|NCT01016262|525438882|FG004|Double-blind Phase|Disease Progression|0|||
145705178|NCT01016262|525438883|FG005|Double-blind Phase|Disease Progression|0|||
145705179|NCT01016262|525438878|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
145705180|NCT01016262|525438879|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
145705181|NCT01016262|525438880|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
145705182|NCT01016262|525438881|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
145705183|NCT01016262|525438882|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
145705184|NCT01016262|525438883|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
145705185|NCT01016262|525438878|FG000|Open-Label Phase|Adverse Event|0|||
145705186|NCT01016262|525438879|FG001|Open-Label Phase|Adverse Event|0|||
145705187|NCT01016262|525438880|FG002|Open-Label Phase|Adverse Event|0|||
145705188|NCT01016262|525438881|FG003|Open-Label Phase|Adverse Event|1|||
145705189|NCT01016262|525438882|FG004|Open-Label Phase|Adverse Event|0|||
145705190|NCT01016262|525438883|FG005|Open-Label Phase|Adverse Event|0|||
145705191|NCT01016262|525438878|FG000|Open-Label Phase|Lost to Follow-up|0|||
145705192|NCT01016262|525438879|FG001|Open-Label Phase|Lost to Follow-up|0|||
145705193|NCT01016262|525438880|FG002|Open-Label Phase|Lost to Follow-up|0|||
145705194|NCT01016262|525438881|FG003|Open-Label Phase|Lost to Follow-up|0|||
145705195|NCT01016262|525438882|FG004|Open-Label Phase|Lost to Follow-up|1|||
145705196|NCT01016262|525438883|FG005|Open-Label Phase|Lost to Follow-up|0|||
145705197|NCT01016262|525438878|FG000|Open-Label Phase|Lack of Efficacy|0|||
145705198|NCT01016262|525438879|FG001|Open-Label Phase|Lack of Efficacy|0|||
145705199|NCT01016262|525438880|FG002|Open-Label Phase|Lack of Efficacy|0|||
145705200|NCT01016262|525438881|FG003|Open-Label Phase|Lack of Efficacy|1|||
145705201|NCT01016262|525438882|FG004|Open-Label Phase|Lack of Efficacy|0|||
145705202|NCT01016262|525438883|FG005|Open-Label Phase|Lack of Efficacy|0|||
145705203|NCT01016262|525438878|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
145705204|NCT01016262|525438879|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
145705205|NCT01016262|525438880|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
145705206|NCT01016262|525438881|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
145705207|NCT01016262|525438882|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
145705208|NCT01016262|525438883|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
145705209|NCT01736540|525438886|FG000|Overall Study|Did not complete scan within 45 days|2|||
145705210|NCT01736540|525438886|FG000|Overall Study|Death|1|||
145705211|NCT01736540|525438886|FG000|Overall Study|Abnormal test procedure|1|||
145705212|NCT01736540|525438886|FG000|Overall Study|Withdrawal by Subject|5|||
145705213|NCT01736540|525438886|FG000|Overall Study|Protocol Violation|1|||
145705214|NCT01736540|525438886|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
145705215|NCT01736540|525438886|FG000|Overall Study|No show for MRI appointment|1|||
145705216|NCT01736540|525438886|FG000|Overall Study|Unable to make MRI appointment|3|||
145705217|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
145705218|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
145705219|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
145705220|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
145705221|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
145705222|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
145705223|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
145705224|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
145705225|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
145705226|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
145705227|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
145705228|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
145705229|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
145705230|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
145705231|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
145705232|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
145705233|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
145705234|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
145705235|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
145705236|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
145705237|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
145705238|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
145705239|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
145705240|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
145705241|NCT00479882|525438887|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
145705242|NCT00479882|525438888|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
145705243|NCT00479882|525438889|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
145705244|NCT00479882|525438890|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
145705245|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
145705246|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
145705247|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
145705248|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
145705249|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
145705250|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
145705251|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
145705252|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
145705253|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
145705254|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
145705255|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
145705256|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
145705257|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
145705258|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
145705259|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
145705260|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
145705261|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
145705262|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
145705263|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
145705264|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
145705265|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
145705266|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
145705267|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
145705268|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
145705269|NCT00479882|525438887|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
145705270|NCT00479882|525438888|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
145705271|NCT00479882|525438889|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
145705272|NCT00479882|525438890|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
145705273|NCT01031628|525438902|FG000|Overall Study|Study terminated early|0|||
145705274|NCT01031628|525438903|FG001|Overall Study|Study terminated early|1|||
145705275|NCT01031628|525438904|FG002|Overall Study|Study terminated early|3|||
145705276|NCT01031628|525438905|FG003|Overall Study|Study terminated early|0|||
145705277|NCT02362503|525438906|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
145705278|NCT02362503|525438907|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
145705279|NCT02362503|525438908|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
145705280|NCT02362503|525438906|FG000|Double-blind Period-Up to 8 Days|Death|1|||
145705281|NCT02362503|525438907|FG001|Double-blind Period-Up to 8 Days|Death|0|||
145705282|NCT02362503|525438908|FG002|Double-blind Period-Up to 8 Days|Death|0|||
145705283|NCT02362503|525438906|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
145705284|NCT02362503|525438907|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
145705285|NCT02362503|525438908|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
145705286|NCT02362503|525438906|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
145705287|NCT02362503|525438907|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
145705288|NCT02362503|525438908|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
145705289|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
145705290|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
145705291|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
145705292|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
145705293|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
145705294|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
145705295|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
145705296|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
145705297|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
145705298|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
145705299|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
145705300|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
145705301|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
145705302|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
145705303|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
145705304|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
145705305|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
145705306|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
145705307|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
145705308|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
145705309|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
145705310|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
145705311|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
145705312|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
145705313|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
145705314|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
145705315|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
145705316|NCT02362503|525438906|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
145705317|NCT02362503|525438907|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
145705318|NCT02362503|525438908|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
145705319|NCT02803593|525438909|FG000|Overall Study|Lost to Follow-up|17|||
145705320|NCT02803593|525438910|FG001|Overall Study|Lost to Follow-up|35|||
145705321|NCT05143138|525438911|FG000|Overall Study|Death|5|||
145705322|NCT05143138|525438912|FG001|Overall Study|Death|35|||
145705323|NCT05143138|525438913|FG002|Overall Study|Death|1|||
145705324|NCT05143138|525438911|FG000|Overall Study|Lost to Follow-up|2|||
145705325|NCT05143138|525438912|FG001|Overall Study|Lost to Follow-up|4|||
145705326|NCT05143138|525438913|FG002|Overall Study|Lost to Follow-up|0|||
145705327|NCT05143138|525438911|FG000|Overall Study|withdrawal|1|||
145705328|NCT05143138|525438912|FG001|Overall Study|withdrawal|1|||
145705329|NCT05143138|525438913|FG002|Overall Study|withdrawal|0|||
145705330|NCT04245345|525438924|FG000|Overall Study|Death|1|||
145705331|NCT04245345|525438924|FG000|Overall Study|Exited prior to implant|5|||
145705332|NCT04245345|525438924|FG000|Overall Study|Exited prior to 1-month|9|||
145705333|NCT04245345|525438924|FG000|Overall Study|Missed 1-month visit|3|||
145705334|NCT04245345|525438924|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
145705335|NCT04245345|525438924|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
145705336|NCT01834586|525438925|FG000|Overall Study|Adverse Event|1|||
145705337|NCT03004404|525438928|FG000|Period 2|Adverse Event|0|||
145705338|NCT03004404|525438929|FG001|Period 2|Adverse Event|0|||
145705339|NCT03004404|525438930|FG002|Period 2|Adverse Event|0|||
145705340|NCT03004404|525438931|FG003|Period 2|Adverse Event|0|||
145705341|NCT03004404|525438932|FG004|Period 2|Adverse Event|0|||
145705342|NCT03004404|525438933|FG005|Period 2|Adverse Event|0|||
145705343|NCT03004404|525438934|FG006|Period 2|Adverse Event|0|||
145705344|NCT03004404|525438935|FG007|Period 2|Adverse Event|0|||
145705345|NCT03004404|525438936|FG008|Period 2|Adverse Event|1|||
145705346|NCT03004404|525438937|FG009|Period 2|Adverse Event|0|||
145705347|NCT03004404|525438938|FG010|Period 2|Adverse Event|0|||
145705348|NCT03004404|525438939|FG011|Period 2|Adverse Event|0|||
145705349|NCT03004404|525438940|FG012|Period 2|Adverse Event|0|||
145705350|NCT03004404|525438941|FG013|Period 2|Adverse Event|0|||
145705351|NCT03004404|525438942|FG014|Period 2|Adverse Event|0|||
145705352|NCT03004404|525438943|FG015|Period 2|Adverse Event|1|||
145705353|NCT03933462|525438946|FG000|Overall Study|Adverse Event|2|||
145705354|NCT03933462|525438947|FG001|Overall Study|Adverse Event|0|||
145705355|NCT02522728|525438952|FG000|Overall Study|Withdrawal by Subject|6|||
145705356|NCT02522728|525438953|FG001|Overall Study|Withdrawal by Subject|6|||
145705357|NCT02522728|525438952|FG000|Overall Study|Death|4|||
145705358|NCT02522728|525438953|FG001|Overall Study|Death|3|||
145705359|NCT02522728|525438952|FG000|Overall Study|Adverse Event|2|||
145705360|NCT02522728|525438953|FG001|Overall Study|Adverse Event|1|||
145705361|NCT02522728|525438952|FG000|Overall Study|Did not receive randomized study device|0|||
145705362|NCT02522728|525438953|FG001|Overall Study|Did not receive randomized study device|1|||
145705363|NCT01266161|525438960|FG000|Overall Study|Ineligible|1|||
145705364|NCT01266161|525438961|FG001|Overall Study|Ineligible|0|||
145705365|NCT01266161|525438960|FG000|Overall Study|Lack of Efficacy|0|||
145705366|NCT01266161|525438961|FG001|Overall Study|Lack of Efficacy|1|||
145705367|NCT01266161|525438960|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
145705368|NCT01266161|525438961|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
145705369|NCT02990468|525438962|FG000|Phase 2: MTD|Change in treatment|0|||
145705370|NCT02990468|525438963|FG001|Phase 2: MTD|Change in treatment|0|||
145705371|NCT02990468|525438964|FG002|Phase 2: MTD|Change in treatment|1|||
145705372|NCT01436305|525438966|FG000|Overall Study|Death|1|||
145705373|NCT01436305|525438967|FG001|Overall Study|Death|0|||
145705374|NCT01436305|525438968|FG002|Overall Study|Death|0|||
145705375|NCT01436305|525438966|FG000|Overall Study|Lost to Follow-up|0|||
145705376|NCT01436305|525438967|FG001|Overall Study|Lost to Follow-up|1|||
145705377|NCT01436305|525438968|FG002|Overall Study|Lost to Follow-up|0|||
145705378|NCT01436305|525438966|FG000|Overall Study|Withdrawal by Subject|1|||
145705379|NCT01436305|525438967|FG001|Overall Study|Withdrawal by Subject|3|||
145705380|NCT01436305|525438968|FG002|Overall Study|Withdrawal by Subject|0|||
145705381|NCT03392168|525438977|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
145705382|NCT03392168|525438978|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
145705383|NCT03392168|525438979|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
145705384|NCT03392168|525438980|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
145705385|NCT03392168|525438977|FG000|Period 2: Cohort 2|Other|0|||
145705386|NCT03392168|525438978|FG001|Period 2: Cohort 2|Other|1|||
145705387|NCT03392168|525438979|FG002|Period 2: Cohort 2|Other|0|||
145705388|NCT03392168|525438980|FG003|Period 2: Cohort 2|Other|0|||
145705389|NCT02597712|525438981|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
145705390|NCT02597712|525438982|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
145705391|NCT02597712|525438981|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
145705392|NCT02597712|525438982|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
145705393|NCT02597712|525438981|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
145705394|NCT02597712|525438982|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
145705395|NCT01727505|525438983|FG000|First 24 Hours|Adverse Event|0|||
145705396|NCT01727505|525438984|FG001|First 24 Hours|Adverse Event|1|||
145705397|NCT01727505|525438983|FG000|Second 24 Hours|Missing data|0|||
145705398|NCT01727505|525438984|FG001|Second 24 Hours|Missing data|1|||
145705399|NCT01594970|525438985|FG000|Overall Study|Non-Adverse Event Related|4|||
145705400|NCT01594970|525438986|FG001|Overall Study|Non-Adverse Event Related|5|||
145705401|NCT01594970|525438987|FG002|Overall Study|Non-Adverse Event Related|6|||
145705402|NCT01594970|525438985|FG000|Overall Study|Adverse Event|17|||
145705403|NCT01594970|525438986|FG001|Overall Study|Adverse Event|23|||
145705404|NCT01594970|525438987|FG002|Overall Study|Adverse Event|23|||
145705405|NCT01594970|525438985|FG000|Overall Study|Lost to Follow-up|54|||
145705406|NCT01594970|525438986|FG001|Overall Study|Lost to Follow-up|54|||
145705407|NCT01594970|525438987|FG002|Overall Study|Lost to Follow-up|37|||
145705408|NCT01427725|525438988|FG000|Overall Study|Lost to Follow-up|17|||
145705409|NCT01427725|525438988|FG000|Overall Study|Protocol Violation|1|||
145705410|NCT01427725|525438988|FG000|Overall Study|Drug not administered|1|||
145705411|NCT01427725|525438988|FG000|Overall Study|Failure to visit|7|||
145705412|NCT01427725|525438988|FG000|Overall Study|Adverse Event|46|||
145705413|NCT01427725|525438988|FG000|Overall Study|Failure to visit after administration|40|||
145705414|NCT01427725|525438988|FG000|Overall Study|Patient's rejection|27|||
145705415|NCT01427725|525438988|FG000|Overall Study|Transfer to a different hospital|17|||
145705416|NCT01427725|525438988|FG000|Overall Study|Lack of Efficacy|8|||
145705417|NCT01427725|525438988|FG000|Overall Study|Death|7|||
145705418|NCT01427725|525438988|FG000|Overall Study|Symptom improvement|6|||
145705419|NCT01427725|525438988|FG000|Overall Study|AE and Patient's rejection|5|||
145705420|NCT01427725|525438988|FG000|Overall Study|Physician Decision|5|||
145705421|NCT01427725|525438988|FG000|Overall Study|Exacerbation of underlying disease|5|||
145705422|NCT01427725|525438988|FG000|Overall Study|Oral feeding difficulty|5|||
145705423|NCT01427725|525438988|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
145705424|NCT01427725|525438988|FG000|Overall Study|Forgetting prescription|1|||
145705425|NCT01427725|525438988|FG000|Overall Study|Other|2|||
145705426|NCT01299480|525438989|FG000|Overall Study|No longer willing to participate|19|||
145705427|NCT01299480|525438990|FG001|Overall Study|No longer willing to participate|17|||
145705428|NCT01299480|525438991|FG002|Overall Study|No longer willing to participate|14|||
145705429|NCT01299480|525438992|FG003|Overall Study|No longer willing to participate|13|||
145705430|NCT01299480|525438993|FG004|Overall Study|No longer willing to participate|10|||
145705431|NCT01299480|525438989|FG000|Overall Study|Protocol Violation|7|||
145705432|NCT01299480|525438990|FG001|Overall Study|Protocol Violation|5|||
145705433|NCT01299480|525438991|FG002|Overall Study|Protocol Violation|8|||
145705434|NCT01299480|525438992|FG003|Overall Study|Protocol Violation|1|||
145705435|NCT01299480|525438993|FG004|Overall Study|Protocol Violation|1|||
145705436|NCT01299480|525438989|FG000|Overall Study|Withdrawal by Subject|3|||
145705437|NCT01299480|525438990|FG001|Overall Study|Withdrawal by Subject|4|||
145705438|NCT01299480|525438991|FG002|Overall Study|Withdrawal by Subject|7|||
145705439|NCT01299480|525438992|FG003|Overall Study|Withdrawal by Subject|3|||
145705440|NCT01299480|525438993|FG004|Overall Study|Withdrawal by Subject|4|||
145705441|NCT01299480|525438989|FG000|Overall Study|Adverse Event|6|||
145705442|NCT01299480|525438990|FG001|Overall Study|Adverse Event|4|||
145705443|NCT01299480|525438991|FG002|Overall Study|Adverse Event|5|||
145705444|NCT01299480|525438992|FG003|Overall Study|Adverse Event|4|||
145705445|NCT01299480|525438993|FG004|Overall Study|Adverse Event|0|||
145705446|NCT01299480|525438989|FG000|Overall Study|Withdrawal due to pregnancy|0|||
145705447|NCT01299480|525438990|FG001|Overall Study|Withdrawal due to pregnancy|1|||
145705448|NCT01299480|525438991|FG002|Overall Study|Withdrawal due to pregnancy|1|||
145705449|NCT01299480|525438992|FG003|Overall Study|Withdrawal due to pregnancy|0|||
145705450|NCT01299480|525438993|FG004|Overall Study|Withdrawal due to pregnancy|0|||
145705451|NCT01299480|525438989|FG000|Overall Study|Physician Decision|1|||
145705452|NCT01299480|525438990|FG001|Overall Study|Physician Decision|1|||
145705453|NCT01299480|525438991|FG002|Overall Study|Physician Decision|0|||
145705454|NCT01299480|525438992|FG003|Overall Study|Physician Decision|2|||
145705455|NCT01299480|525438993|FG004|Overall Study|Physician Decision|0|||
145705456|NCT01299480|525438989|FG000|Overall Study|Lost to Follow-up|3|||
145705457|NCT01299480|525438990|FG001|Overall Study|Lost to Follow-up|1|||
145705458|NCT01299480|525438991|FG002|Overall Study|Lost to Follow-up|2|||
145705459|NCT01299480|525438992|FG003|Overall Study|Lost to Follow-up|1|||
145705460|NCT01299480|525438993|FG004|Overall Study|Lost to Follow-up|2|||
145705461|NCT01299480|525438989|FG000|Overall Study|Other|3|||
145705462|NCT01299480|525438990|FG001|Overall Study|Other|2|||
145705463|NCT01299480|525438991|FG002|Overall Study|Other|3|||
145705464|NCT01299480|525438992|FG003|Overall Study|Other|0|||
145705465|NCT01299480|525438993|FG004|Overall Study|Other|3|||
145705466|NCT01299480|525438989|FG000|Overall Study|Started, but not vaccinated|0|||
145705467|NCT01299480|525438990|FG001|Overall Study|Started, but not vaccinated|0|||
145705468|NCT01299480|525438991|FG002|Overall Study|Started, but not vaccinated|1|||
145705469|NCT01299480|525438992|FG003|Overall Study|Started, but not vaccinated|1|||
145705470|NCT01299480|525438993|FG004|Overall Study|Started, but not vaccinated|0|||
145705471|NCT01430468|525439000|FG000|Overall Study|Physician Decision|2|||
145705472|NCT01430468|525439001|FG001|Overall Study|Physician Decision|1|||
145705473|NCT01430468|525439000|FG000|Overall Study|Withdrawal by Subject|5|||
145705474|NCT01430468|525439001|FG001|Overall Study|Withdrawal by Subject|5|||
145705475|NCT01281839|525439002|FG000|Overall Study|Lost to Follow-up|6|||
145705476|NCT01281839|525439003|FG001|Overall Study|Lost to Follow-up|3|||
145705477|NCT01281839|525439002|FG000|Overall Study|Withdrawal by Subject|4|||
145705478|NCT01281839|525439003|FG001|Overall Study|Withdrawal by Subject|10|||
145705479|NCT01281839|525439002|FG000|Overall Study|Reason not specified|0|||
145705480|NCT01281839|525439003|FG001|Overall Study|Reason not specified|1|||
145705481|NCT01754753|525439004|FG000|Overall Study|Study close|43|||
145705482|NCT01754753|525439005|FG001|Overall Study|Study close|44|||
145705483|NCT01754753|525439004|FG000|Overall Study|Lost to Follow-up|9|||
145705484|NCT01754753|525439005|FG001|Overall Study|Lost to Follow-up|5|||
145705485|NCT00617929|525439006|FG000|Overall Study|Physician Decision|1|||
145705486|NCT03229486|525439007|FG000|Overall Study|Protocol Violation|0|||
145705487|NCT03229486|525439008|FG001|Overall Study|Protocol Violation|1|||
145705488|NCT00760747|525439015|FG000|Study Period II|Adverse Event|3|||
145705489|NCT00760747|525439016|FG001|Study Period II|Adverse Event|4|||
145705490|NCT00760747|525439015|FG000|Study Period II|Lack of Efficacy|0|||
145705491|NCT00760747|525439016|FG001|Study Period II|Lack of Efficacy|6|||
145705492|NCT00760747|525439015|FG000|Study Period II|Parent/Caregiver Decision|3|||
145705493|NCT00760747|525439016|FG001|Study Period II|Parent/Caregiver Decision|0|||
145705494|NCT00760747|525439015|FG000|Study Period II|Protocol Violation|6|||
145705495|NCT00760747|525439016|FG001|Study Period II|Protocol Violation|3|||
145705496|NCT00760747|525439015|FG000|Study Period II|Withdrawal by Subject|1|||
145705497|NCT00760747|525439016|FG001|Study Period II|Withdrawal by Subject|0|||
145705498|NCT00760747|525439015|FG000|Study Period II|No drug administered|0|||
145705499|NCT00760747|525439016|FG001|Study Period II|No drug administered|1|||
145705500|NCT00760747|525439015|FG000|Study Period III|Adverse Event|1|||
145705501|NCT00760747|525439016|FG001|Study Period III|Adverse Event|0|||
145705502|NCT00760747|525439015|FG000|Study Period III|Lack of Efficacy|1|||
145705503|NCT00760747|525439016|FG001|Study Period III|Lack of Efficacy|0|||
145705504|NCT00760747|525439015|FG000|Study Period III|Parent/Caregiver Decision|0|||
145705505|NCT00760747|525439016|FG001|Study Period III|Parent/Caregiver Decision|1|||
145705506|NCT00760747|525439015|FG000|Study Period III|Protocol Violation|1|||
145705507|NCT00760747|525439016|FG001|Study Period III|Protocol Violation|1|||
145705508|NCT00760747|525439015|FG000|Study Period III|Physician Decision|0|||
145705509|NCT00760747|525439016|FG001|Study Period III|Physician Decision|1|||
145705510|NCT00844597|525439017|FG000|Overall Study|Adverse Event|0|||
145705511|NCT00844597|525439018|FG001|Overall Study|Adverse Event|0|||
145705512|NCT00844597|525439019|FG002|Overall Study|Adverse Event|0|||
145705513|NCT00844597|525439020|FG003|Overall Study|Adverse Event|1|||
145705514|NCT00844597|525439021|FG004|Overall Study|Adverse Event|0|||
145705515|NCT00844597|525439022|FG005|Overall Study|Adverse Event|0|||
145705516|NCT00455741|525439024|FG000|Overall Study|Physician Decision|0|||
145705517|NCT00455741|525439025|FG001|Overall Study|Physician Decision|1|||
145705518|NCT04855734|525439030|FG000|Overall Study|Lost to Follow-up|2|||
145705519|NCT04855734|525439031|FG001|Overall Study|Lost to Follow-up|2|||
145705520|NCT03358472|525439032|FG000|Overall Study|Death|6|||
145705521|NCT03358472|525439033|FG001|Overall Study|Death|3|||
145705522|NCT03358472|525439034|FG002|Overall Study|Death|10|||
145705523|NCT03358472|525439032|FG000|Overall Study|Physician Decision|0|||
145705524|NCT03358472|525439033|FG001|Overall Study|Physician Decision|1|||
145705525|NCT03358472|525439034|FG002|Overall Study|Physician Decision|0|||
145705526|NCT03358472|525439032|FG000|Overall Study|Withdrawal by Subject|0|||
145705527|NCT03358472|525439033|FG001|Overall Study|Withdrawal by Subject|0|||
145705528|NCT03358472|525439034|FG002|Overall Study|Withdrawal by Subject|1|||
145705529|NCT03358472|525439032|FG000|Overall Study|On-going at clinical cut off date|9|||
145705530|NCT03358472|525439033|FG001|Overall Study|On-going at clinical cut off date|6|||
145705531|NCT03358472|525439034|FG002|Overall Study|On-going at clinical cut off date|5|||
145705532|NCT04535544|525439037|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
145705533|NCT04535544|525439038|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
145705534|NCT04535544|525439039|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
145705535|NCT04535544|525439040|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
145705536|NCT04535544|525439037|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
145705537|NCT04535544|525439038|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
145705538|NCT04535544|525439039|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
145705539|NCT04535544|525439040|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
145705540|NCT04535544|525439037|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
145705541|NCT04535544|525439038|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
145705542|NCT04535544|525439039|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
145705543|NCT04535544|525439040|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
145705544|NCT04535544|525439037|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
145705545|NCT04535544|525439038|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
145705546|NCT04535544|525439039|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
145705547|NCT04535544|525439040|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
145705548|NCT04535544|525439037|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
145705549|NCT04535544|525439038|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
145705550|NCT04535544|525439039|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
145705551|NCT04535544|525439040|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
145705552|NCT04535544|525439037|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
145705553|NCT04535544|525439038|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
145705554|NCT04535544|525439039|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
145705555|NCT04535544|525439040|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
145705556|NCT04535544|525439037|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
145705557|NCT04535544|525439038|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
145705558|NCT04535544|525439039|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
145705559|NCT04535544|525439040|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
145705560|NCT04535544|525439037|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
145705561|NCT04535544|525439038|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
145705562|NCT04535544|525439039|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
145705563|NCT04535544|525439040|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
145705564|NCT00344032|525439043|FG000|Overall Study|Adverse Event|0|||
145705565|NCT00344032|525439044|FG001|Overall Study|Adverse Event|1|||
145705566|NCT00344032|525439043|FG000|Overall Study|Withdrawal by Subject|6|||
145705567|NCT00344032|525439044|FG001|Overall Study|Withdrawal by Subject|2|||
145705568|NCT00344032|525439043|FG000|Overall Study|Lost to Follow-up|4|||
145705569|NCT00344032|525439044|FG001|Overall Study|Lost to Follow-up|6|||
145705570|NCT00344032|525439043|FG000|Overall Study|Physician Decision|4|||
145705571|NCT00344032|525439044|FG001|Overall Study|Physician Decision|1|||
145705572|NCT05131477|525439051|FG000|PART 1|Withdrawal by Subject|2|||
145705573|NCT05131477|525439052|FG001|PART 1|Withdrawal by Subject|9|||
145705574|NCT05131477|525439053|FG002|PART 1|Withdrawal by Subject|6|||
145705575|NCT05131477|525439054|FG003|PART 1|Withdrawal by Subject|2|||
145705576|NCT05131477|525439055|FG004|PART 1|Withdrawal by Subject|8|||
145705577|NCT05131477|525439056|FG005|PART 1|Withdrawal by Subject|0|||
145705578|NCT05131477|525439057|FG006|PART 1|Withdrawal by Subject|0|||
145705579|NCT05131477|525439058|FG007|PART 1|Withdrawal by Subject|0|||
145705580|NCT05131477|525439059|FG008|PART 1|Withdrawal by Subject|0|||
145705581|NCT05131477|525439060|FG009|PART 1|Withdrawal by Subject|0|||
145705582|NCT05131477|525439061|FG010|PART 1|Withdrawal by Subject|0|||
145705583|NCT05131477|525439062|FG011|PART 1|Withdrawal by Subject|0|||
145705584|NCT05131477|525439063|FG012|PART 1|Withdrawal by Subject|0|||
145705585|NCT05131477|525439064|FG013|PART 1|Withdrawal by Subject|0|||
145705586|NCT05131477|525439051|FG000|PART 1|Physician Decision|1|||
145705587|NCT05131477|525439052|FG001|PART 1|Physician Decision|0|||
145705588|NCT05131477|525439053|FG002|PART 1|Physician Decision|0|||
145705589|NCT05131477|525439054|FG003|PART 1|Physician Decision|0|||
145705590|NCT05131477|525439055|FG004|PART 1|Physician Decision|0|||
145705591|NCT05131477|525439056|FG005|PART 1|Physician Decision|0|||
145705592|NCT05131477|525439057|FG006|PART 1|Physician Decision|0|||
145705593|NCT05131477|525439058|FG007|PART 1|Physician Decision|0|||
145705594|NCT05131477|525439059|FG008|PART 1|Physician Decision|0|||
145705595|NCT05131477|525439060|FG009|PART 1|Physician Decision|0|||
145705596|NCT05131477|525439061|FG010|PART 1|Physician Decision|0|||
145705597|NCT05131477|525439062|FG011|PART 1|Physician Decision|0|||
145705598|NCT05131477|525439063|FG012|PART 1|Physician Decision|0|||
145705599|NCT05131477|525439064|FG013|PART 1|Physician Decision|0|||
145705600|NCT05131477|525439051|FG000|PART 1|Adverse Event|3|||
145705601|NCT05131477|525439052|FG001|PART 1|Adverse Event|5|||
145705602|NCT05131477|525439053|FG002|PART 1|Adverse Event|1|||
145705603|NCT05131477|525439054|FG003|PART 1|Adverse Event|6|||
145705604|NCT05131477|525439055|FG004|PART 1|Adverse Event|4|||
145705605|NCT05131477|525439056|FG005|PART 1|Adverse Event|0|||
145705606|NCT05131477|525439057|FG006|PART 1|Adverse Event|0|||
145705607|NCT05131477|525439058|FG007|PART 1|Adverse Event|0|||
145705608|NCT05131477|525439059|FG008|PART 1|Adverse Event|0|||
145705609|NCT05131477|525439060|FG009|PART 1|Adverse Event|0|||
145705610|NCT05131477|525439061|FG010|PART 1|Adverse Event|0|||
145705611|NCT05131477|525439062|FG011|PART 1|Adverse Event|0|||
145705612|NCT05131477|525439063|FG012|PART 1|Adverse Event|0|||
145705613|NCT05131477|525439064|FG013|PART 1|Adverse Event|0|||
145705614|NCT05131477|525439051|FG000|PART 1|unclassified|1|||
145705615|NCT05131477|525439052|FG001|PART 1|unclassified|1|||
145705616|NCT05131477|525439053|FG002|PART 1|unclassified|0|||
145705617|NCT05131477|525439054|FG003|PART 1|unclassified|0|||
145705618|NCT05131477|525439055|FG004|PART 1|unclassified|4|||
145705619|NCT05131477|525439056|FG005|PART 1|unclassified|0|||
145705620|NCT05131477|525439057|FG006|PART 1|unclassified|0|||
145705621|NCT05131477|525439058|FG007|PART 1|unclassified|0|||
145705622|NCT05131477|525439059|FG008|PART 1|unclassified|0|||
145705623|NCT05131477|525439060|FG009|PART 1|unclassified|0|||
145705624|NCT05131477|525439061|FG010|PART 1|unclassified|0|||
145705625|NCT05131477|525439062|FG011|PART 1|unclassified|0|||
145705626|NCT05131477|525439063|FG012|PART 1|unclassified|0|||
145705627|NCT05131477|525439064|FG013|PART 1|unclassified|0|||
145705628|NCT05131477|525439051|FG000|PART 1|Randomized and not treated|0|||
145705629|NCT05131477|525439052|FG001|PART 1|Randomized and not treated|0|||
145705630|NCT05131477|525439053|FG002|PART 1|Randomized and not treated|0|||
145705631|NCT05131477|525439054|FG003|PART 1|Randomized and not treated|1|||
145705632|NCT05131477|525439055|FG004|PART 1|Randomized and not treated|1|||
145705633|NCT05131477|525439056|FG005|PART 1|Randomized and not treated|0|||
145705634|NCT05131477|525439057|FG006|PART 1|Randomized and not treated|0|||
145705635|NCT05131477|525439058|FG007|PART 1|Randomized and not treated|0|||
145705636|NCT05131477|525439059|FG008|PART 1|Randomized and not treated|0|||
145705637|NCT05131477|525439060|FG009|PART 1|Randomized and not treated|0|||
145705638|NCT05131477|525439061|FG010|PART 1|Randomized and not treated|0|||
145705639|NCT05131477|525439062|FG011|PART 1|Randomized and not treated|0|||
145705640|NCT05131477|525439063|FG012|PART 1|Randomized and not treated|0|||
145705641|NCT05131477|525439064|FG013|PART 1|Randomized and not treated|0|||
145705642|NCT05131477|525439051|FG000|PART 1|Protocol Violation|2|||
145705643|NCT05131477|525439052|FG001|PART 1|Protocol Violation|0|||
145705644|NCT05131477|525439053|FG002|PART 1|Protocol Violation|0|||
145705645|NCT05131477|525439054|FG003|PART 1|Protocol Violation|1|||
145705646|NCT05131477|525439055|FG004|PART 1|Protocol Violation|0|||
145705647|NCT05131477|525439056|FG005|PART 1|Protocol Violation|0|||
145705648|NCT05131477|525439057|FG006|PART 1|Protocol Violation|0|||
145705649|NCT05131477|525439058|FG007|PART 1|Protocol Violation|0|||
145705650|NCT05131477|525439059|FG008|PART 1|Protocol Violation|0|||
145705651|NCT05131477|525439060|FG009|PART 1|Protocol Violation|0|||
145705652|NCT05131477|525439061|FG010|PART 1|Protocol Violation|0|||
145705653|NCT05131477|525439062|FG011|PART 1|Protocol Violation|0|||
145705654|NCT05131477|525439063|FG012|PART 1|Protocol Violation|0|||
145705655|NCT05131477|525439064|FG013|PART 1|Protocol Violation|0|||
145705656|NCT05131477|525439051|FG000|PART 1|Lack of Efficacy|0|||
145705657|NCT05131477|525439052|FG001|PART 1|Lack of Efficacy|1|||
145705658|NCT05131477|525439053|FG002|PART 1|Lack of Efficacy|1|||
145705659|NCT05131477|525439054|FG003|PART 1|Lack of Efficacy|2|||
145705660|NCT05131477|525439055|FG004|PART 1|Lack of Efficacy|5|||
145705661|NCT05131477|525439056|FG005|PART 1|Lack of Efficacy|0|||
145705662|NCT05131477|525439057|FG006|PART 1|Lack of Efficacy|0|||
145705663|NCT05131477|525439058|FG007|PART 1|Lack of Efficacy|0|||
145705664|NCT05131477|525439059|FG008|PART 1|Lack of Efficacy|0|||
145705665|NCT05131477|525439060|FG009|PART 1|Lack of Efficacy|0|||
145705666|NCT05131477|525439061|FG010|PART 1|Lack of Efficacy|0|||
145705667|NCT05131477|525439062|FG011|PART 1|Lack of Efficacy|0|||
145705668|NCT05131477|525439063|FG012|PART 1|Lack of Efficacy|0|||
145705669|NCT05131477|525439064|FG013|PART 1|Lack of Efficacy|0|||
145705670|NCT05131477|525439051|FG000|PART 2|Withdrawal by Subject|0|||
145705671|NCT05131477|525439052|FG001|PART 2|Withdrawal by Subject|0|||
145705672|NCT05131477|525439053|FG002|PART 2|Withdrawal by Subject|0|||
145705673|NCT05131477|525439054|FG003|PART 2|Withdrawal by Subject|0|||
145705674|NCT05131477|525439055|FG004|PART 2|Withdrawal by Subject|0|||
145705675|NCT05131477|525439056|FG005|PART 2|Withdrawal by Subject|0|||
145705676|NCT05131477|525439057|FG006|PART 2|Withdrawal by Subject|2|||
145705677|NCT05131477|525439058|FG007|PART 2|Withdrawal by Subject|0|||
145705678|NCT05131477|525439059|FG008|PART 2|Withdrawal by Subject|0|||
145705679|NCT05131477|525439060|FG009|PART 2|Withdrawal by Subject|0|||
145705680|NCT05131477|525439061|FG010|PART 2|Withdrawal by Subject|2|||
145705681|NCT05131477|525439062|FG011|PART 2|Withdrawal by Subject|0|||
145705682|NCT05131477|525439063|FG012|PART 2|Withdrawal by Subject|2|||
145705683|NCT05131477|525439064|FG013|PART 2|Withdrawal by Subject|2|||
145705684|NCT05131477|525439051|FG000|PART 2|Other|0|||
145705685|NCT05131477|525439052|FG001|PART 2|Other|0|||
145705686|NCT05131477|525439053|FG002|PART 2|Other|0|||
145705687|NCT05131477|525439054|FG003|PART 2|Other|0|||
145705688|NCT05131477|525439055|FG004|PART 2|Other|0|||
145705689|NCT05131477|525439056|FG005|PART 2|Other|0|||
145705690|NCT05131477|525439057|FG006|PART 2|Other|0|||
145705691|NCT05131477|525439058|FG007|PART 2|Other|0|||
145705692|NCT05131477|525439059|FG008|PART 2|Other|1|||
145705693|NCT05131477|525439060|FG009|PART 2|Other|1|||
145705694|NCT05131477|525439061|FG010|PART 2|Other|0|||
145705695|NCT05131477|525439062|FG011|PART 2|Other|0|||
145705696|NCT05131477|525439063|FG012|PART 2|Other|1|||
145705697|NCT05131477|525439064|FG013|PART 2|Other|0|||
145705698|NCT05131477|525439051|FG000|PART 2|Lack of Efficacy|0|||
145705699|NCT05131477|525439052|FG001|PART 2|Lack of Efficacy|0|||
145705700|NCT05131477|525439053|FG002|PART 2|Lack of Efficacy|0|||
145705701|NCT05131477|525439054|FG003|PART 2|Lack of Efficacy|0|||
145705702|NCT05131477|525439055|FG004|PART 2|Lack of Efficacy|0|||
145705703|NCT05131477|525439056|FG005|PART 2|Lack of Efficacy|1|||
145705704|NCT05131477|525439057|FG006|PART 2|Lack of Efficacy|1|||
145705705|NCT05131477|525439058|FG007|PART 2|Lack of Efficacy|0|||
145705706|NCT05131477|525439059|FG008|PART 2|Lack of Efficacy|3|||
145705707|NCT05131477|525439060|FG009|PART 2|Lack of Efficacy|0|||
145705708|NCT05131477|525439061|FG010|PART 2|Lack of Efficacy|1|||
145705709|NCT05131477|525439062|FG011|PART 2|Lack of Efficacy|0|||
145705710|NCT05131477|525439063|FG012|PART 2|Lack of Efficacy|2|||
145705711|NCT05131477|525439064|FG013|PART 2|Lack of Efficacy|0|||
145705712|NCT05131477|525439051|FG000|PART 2|Unclassified|0|||
145705713|NCT05131477|525439052|FG001|PART 2|Unclassified|0|||
145705714|NCT05131477|525439053|FG002|PART 2|Unclassified|0|||
145705715|NCT05131477|525439054|FG003|PART 2|Unclassified|0|||
145705716|NCT05131477|525439055|FG004|PART 2|Unclassified|0|||
145705717|NCT05131477|525439056|FG005|PART 2|Unclassified|0|||
145705718|NCT05131477|525439057|FG006|PART 2|Unclassified|0|||
145705719|NCT05131477|525439058|FG007|PART 2|Unclassified|0|||
145705720|NCT05131477|525439059|FG008|PART 2|Unclassified|0|||
145705721|NCT05131477|525439060|FG009|PART 2|Unclassified|0|||
145705722|NCT05131477|525439061|FG010|PART 2|Unclassified|1|||
145705723|NCT05131477|525439062|FG011|PART 2|Unclassified|0|||
145705724|NCT05131477|525439063|FG012|PART 2|Unclassified|0|||
145705725|NCT05131477|525439064|FG013|PART 2|Unclassified|0|||
145705726|NCT05131477|525439051|FG000|PART 2|Re-randomized and not treated|0|||
145705727|NCT05131477|525439052|FG001|PART 2|Re-randomized and not treated|0|||
145705728|NCT05131477|525439053|FG002|PART 2|Re-randomized and not treated|0|||
145705729|NCT05131477|525439054|FG003|PART 2|Re-randomized and not treated|0|||
145705730|NCT05131477|525439055|FG004|PART 2|Re-randomized and not treated|0|||
145705731|NCT05131477|525439056|FG005|PART 2|Re-randomized and not treated|0|||
145705732|NCT05131477|525439057|FG006|PART 2|Re-randomized and not treated|0|||
145705733|NCT05131477|525439058|FG007|PART 2|Re-randomized and not treated|1|||
145705734|NCT05131477|525439059|FG008|PART 2|Re-randomized and not treated|0|||
145705735|NCT05131477|525439060|FG009|PART 2|Re-randomized and not treated|0|||
145705736|NCT05131477|525439061|FG010|PART 2|Re-randomized and not treated|1|||
145705737|NCT05131477|525439062|FG011|PART 2|Re-randomized and not treated|0|||
145705738|NCT05131477|525439063|FG012|PART 2|Re-randomized and not treated|1|||
145705739|NCT05131477|525439064|FG013|PART 2|Re-randomized and not treated|1|||
145705740|NCT02194829|525439065|FG000|Overall Study|Adverse Event|2|||
145705741|NCT02194829|525439066|FG001|Overall Study|Adverse Event|2|||
145705742|NCT02194829|525439065|FG000|Overall Study|Death|0|||
145705743|NCT02194829|525439066|FG001|Overall Study|Death|1|||
145705744|NCT02194829|525439065|FG000|Overall Study|Disease progression|0|||
145705745|NCT02194829|525439066|FG001|Overall Study|Disease progression|1|||
145705746|NCT02194829|525439065|FG000|Overall Study|Withdrawal by Subject|0|||
145705747|NCT02194829|525439066|FG001|Overall Study|Withdrawal by Subject|1|||
145705748|NCT02194829|525439065|FG000|Overall Study|Never started protocol therapy|0|||
145705749|NCT02194829|525439066|FG001|Overall Study|Never started protocol therapy|1|||
145705750|NCT06840769|525439067|FG000|Overall Study|Withdrawal by Subject|1|||
145705751|NCT06840769|525439068|FG001|Overall Study|Withdrawal by Subject|0|||
145705752|NCT06840769|525439069|FG002|Overall Study|Withdrawal by Subject|0|||
145705753|NCT06840769|525439070|FG003|Overall Study|Withdrawal by Subject|0|||
145705754|NCT06840769|525439071|FG004|Overall Study|Withdrawal by Subject|0|||
145705755|NCT02412735|525441434|FG000|Overall Study|Adverse Event|0|||
145705756|NCT02412735|525441435|FG001|Overall Study|Adverse Event|1|||
145705757|NCT02412735|525441436|FG002|Overall Study|Adverse Event|2|||
145705758|NCT02412735|525441434|FG000|Overall Study|Withdrawal by Subject|23|||
145705759|NCT02412735|525441435|FG001|Overall Study|Withdrawal by Subject|27|||
145705760|NCT02412735|525441436|FG002|Overall Study|Withdrawal by Subject|22|||
145705761|NCT02412735|525441434|FG000|Overall Study|Investigator Decision|3|||
145705762|NCT02412735|525441435|FG001|Overall Study|Investigator Decision|3|||
145705763|NCT02412735|525441436|FG002|Overall Study|Investigator Decision|2|||
145705764|NCT02412735|525441434|FG000|Overall Study|Lost to Follow-up|17|||
145705765|NCT02412735|525441435|FG001|Overall Study|Lost to Follow-up|11|||
145705766|NCT02412735|525441436|FG002|Overall Study|Lost to Follow-up|18|||
145705767|NCT02412735|525441434|FG000|Overall Study|Reason not Specified|3|||
145705768|NCT02412735|525441435|FG001|Overall Study|Reason not Specified|2|||
145705769|NCT02412735|525441436|FG002|Overall Study|Reason not Specified|2|||
145705770|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
145705771|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
145705772|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
145705773|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
145705774|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145705775|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
145705776|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
145705777|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
145705778|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
145705779|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
145705780|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
145705781|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
145705782|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
145705783|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
145705784|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
145705785|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
145705786|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
145705787|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
145705788|NCT00603525|525441437|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
145705789|NCT00603525|525441438|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
145705790|NCT00603525|525441439|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
145705791|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
145705792|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
145705793|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
145705794|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
145705795|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
145705796|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
145705797|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
145705798|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
145705799|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
145705800|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
145705801|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
145705802|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
145705803|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
145705804|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
145705805|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
145705806|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
145705807|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
145705808|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
145705809|NCT00603525|525441437|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
145705810|NCT00603525|525441438|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
145705811|NCT00603525|525441439|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
145705812|NCT00603525|525441437|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
145705813|NCT00603525|525441438|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
145705814|NCT00603525|525441439|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
145705815|NCT04043143|525441440|FG000|Overall Study|Lost to Follow-up|5|||
145705816|NCT04043143|525441441|FG001|Overall Study|Lost to Follow-up|5|||
145705817|NCT04043143|525441440|FG000|Overall Study|screen failure|1|||
145705818|NCT04043143|525441441|FG001|Overall Study|screen failure|0|||
145705819|NCT04201288|525441453|FG000|Overall Study|Death|1|||
145705820|NCT04201288|525441454|FG001|Overall Study|Death|1|||
145705821|NCT04201288|525441453|FG000|Overall Study|Lost to Follow-up|5|||
145705822|NCT04201288|525441454|FG001|Overall Study|Lost to Follow-up|3|||
145705823|NCT04201288|525441453|FG000|Overall Study|Withdrawal by Subject|1|||
145705824|NCT04201288|525441454|FG001|Overall Study|Withdrawal by Subject|0|||
145705825|NCT04497389|525441457|FG000|Overall Study|Withdrawal by Subject|1|||
145705826|NCT04497389|525441458|FG001|Overall Study|Withdrawal by Subject|0|||
145705827|NCT00789360|525441461|FG000|Overall Study|Protocol Violation|3|||
145705828|NCT00789360|525441462|FG001|Overall Study|Protocol Violation|1|||
145705829|NCT03322540|525441467|FG000|Overall Study|Death|21|||
145705830|NCT03322540|525441468|FG001|Overall Study|Death|28|||
145705831|NCT03322540|525441467|FG000|Overall Study|Lost to Follow-up|0|||
145705832|NCT03322540|525441468|FG001|Overall Study|Lost to Follow-up|1|||
145705833|NCT03322540|525441467|FG000|Overall Study|Physician Decision|7|||
145705834|NCT03322540|525441468|FG001|Overall Study|Physician Decision|6|||
145705835|NCT03322540|525441467|FG000|Overall Study|Withdrawal by Subject|3|||
145705836|NCT03322540|525441468|FG001|Overall Study|Withdrawal by Subject|1|||
145705837|NCT03322540|525441467|FG000|Overall Study|Study terminated by sponsor|0|||
145705838|NCT03322540|525441468|FG001|Overall Study|Study terminated by sponsor|1|||
145705839|NCT03445533|525441469|FG000|Overall Study|Progressive Disease|48|||
145705840|NCT03445533|525441470|FG001|Overall Study|Progressive Disease|81|||
145705841|NCT03445533|525441469|FG000|Overall Study|Adverse Event|60|||
145705842|NCT03445533|525441470|FG001|Overall Study|Adverse Event|64|||
145705843|NCT03445533|525441469|FG000|Overall Study|Death|9|||
145705844|NCT03445533|525441470|FG001|Overall Study|Death|19|||
145705845|NCT03445533|525441469|FG000|Overall Study|Miscellaneous|0|||
145705846|NCT03445533|525441470|FG001|Overall Study|Miscellaneous|16|||
145705847|NCT03445533|525441469|FG000|Overall Study|Withdrawal by Subject|3|||
145705848|NCT03445533|525441470|FG001|Overall Study|Withdrawal by Subject|4|||
145705849|NCT03445533|525441469|FG000|Overall Study|Physician Decision|1|||
145705850|NCT03445533|525441470|FG001|Overall Study|Physician Decision|3|||
145705851|NCT03445533|525441469|FG000|Overall Study|Sponsor Decision|0|||
145705852|NCT03445533|525441470|FG001|Overall Study|Sponsor Decision|1|||
145705853|NCT03445533|525441469|FG000|Overall Study|Lost to Follow-up|0|||
145705854|NCT03445533|525441470|FG001|Overall Study|Lost to Follow-up|1|||
145705855|NCT03445533|525441469|FG000|Overall Study|Never Received any Study Treatment|7|||
145705856|NCT03445533|525441470|FG001|Overall Study|Never Received any Study Treatment|4|||
145705857|NCT02615509|525441471|FG000|Overall Study|Lost to Follow-up|134|||
145705858|NCT02615509|525441471|FG000|Overall Study|Death|4|||
145705859|NCT02615509|525441471|FG000|Overall Study|Withdrawal by Subject|8|||
145705860|NCT03274453|525441472|FG000|Overall Study|Lost to Follow-up|2|||
145705861|NCT03274453|525441473|FG001|Overall Study|Lost to Follow-up|5|||
145705862|NCT03274453|525441474|FG002|Overall Study|Lost to Follow-up|4|||
145705863|NCT03274453|525441475|FG003|Overall Study|Lost to Follow-up|1|||
145705864|NCT03274453|525441472|FG000|Overall Study|Physician Decision|2|||
145705865|NCT03274453|525441473|FG001|Overall Study|Physician Decision|0|||
145705866|NCT03274453|525441474|FG002|Overall Study|Physician Decision|0|||
145705867|NCT03274453|525441475|FG003|Overall Study|Physician Decision|3|||
145705868|NCT03274453|525441472|FG000|Overall Study|Surgery Cancelled|0|||
145705869|NCT03274453|525441473|FG001|Overall Study|Surgery Cancelled|1|||
145705870|NCT03274453|525441474|FG002|Overall Study|Surgery Cancelled|0|||
145705871|NCT03274453|525441475|FG003|Overall Study|Surgery Cancelled|0|||
145705872|NCT00968526|525441477|FG000|Overall Study|Adverse Event|2|||
145705873|NCT00968526|525441478|FG001|Overall Study|Adverse Event|0|||
145705874|NCT00968526|525441477|FG000|Overall Study|Migrated/moved from study area|1|||
145705875|NCT00968526|525441478|FG001|Overall Study|Migrated/moved from study area|0|||
145705876|NCT04703192|525441482|FG000|Overall Study|Withdrawal by Subject|2|||
145705877|NCT04703192|525441483|FG001|Overall Study|Withdrawal by Subject|0|||
145705878|NCT04703192|525441482|FG000|Overall Study|Death|3|||
145705879|NCT04703192|525441483|FG001|Overall Study|Death|1|||
145705880|NCT04703192|525441482|FG000|Overall Study|Adverse Event|13|||
145705881|NCT04703192|525441483|FG001|Overall Study|Adverse Event|2|||
145705882|NCT04703192|525441482|FG000|Overall Study|Progressive or Relapsed Disease|46|||
145705883|NCT04703192|525441483|FG001|Overall Study|Progressive or Relapsed Disease|7|||
145705884|NCT04703192|525441482|FG000|Overall Study|Clinical Progression|19|||
145705885|NCT04703192|525441483|FG001|Overall Study|Clinical Progression|8|||
145705886|NCT04703192|525441482|FG000|Overall Study|Lost to Follow-up|1|||
145705887|NCT04703192|525441483|FG001|Overall Study|Lost to Follow-up|0|||
145705888|NCT04703192|525441482|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
145705889|NCT04703192|525441483|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
145705890|NCT04703192|525441482|FG000|Overall Study|Other|5|||
145705891|NCT04703192|525441483|FG001|Overall Study|Other|1|||
145705892|NCT02493062|525441484|FG000|Overall Study|Physician Decision|12|||
145705893|NCT03926195|525441485|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
145705894|NCT03926195|525441486|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
145705895|NCT03926195|525441485|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
145705896|NCT03926195|525441486|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
145705897|NCT03926195|525441485|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
145705898|NCT03926195|525441486|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
145705899|NCT03926195|525441485|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
145705900|NCT03926195|525441486|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
145705901|NCT03926195|525441485|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
145705902|NCT03926195|525441486|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
145705903|NCT03926195|525441485|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
145705904|NCT03926195|525441486|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
145705905|NCT01327612|525441487|FG000|Overall Study|Withdrawal by Subject|0|||
145705906|NCT01327612|525441488|FG001|Overall Study|Withdrawal by Subject|0|||
145705907|NCT01327612|525441489|FG002|Overall Study|Withdrawal by Subject|0|||
145705908|NCT01327612|525441490|FG003|Overall Study|Withdrawal by Subject|0|||
145705909|NCT01327612|525441491|FG004|Overall Study|Withdrawal by Subject|0|||
145705910|NCT01327612|525441492|FG005|Overall Study|Withdrawal by Subject|1|||
145705911|NCT01327612|525441493|FG006|Overall Study|Withdrawal by Subject|0|||
145705912|NCT01327612|525441487|FG000|Overall Study|Disease Progression|1|||
145705913|NCT01327612|525441488|FG001|Overall Study|Disease Progression|1|||
145705914|NCT01327612|525441489|FG002|Overall Study|Disease Progression|1|||
145705915|NCT01327612|525441490|FG003|Overall Study|Disease Progression|0|||
145705916|NCT01327612|525441491|FG004|Overall Study|Disease Progression|1|||
145705917|NCT01327612|525441492|FG005|Overall Study|Disease Progression|2|||
145705918|NCT01327612|525441493|FG006|Overall Study|Disease Progression|2|||
145705919|NCT01327612|525441487|FG000|Overall Study|Administrative Decision|0|||
145705920|NCT01327612|525441488|FG001|Overall Study|Administrative Decision|0|||
145705921|NCT01327612|525441489|FG002|Overall Study|Administrative Decision|0|||
145705922|NCT01327612|525441490|FG003|Overall Study|Administrative Decision|1|||
145705923|NCT01327612|525441491|FG004|Overall Study|Administrative Decision|0|||
145705924|NCT01327612|525441492|FG005|Overall Study|Administrative Decision|0|||
145705925|NCT01327612|525441493|FG006|Overall Study|Administrative Decision|0|||
145705926|NCT01327612|525441487|FG000|Overall Study|Death|0|||
145705927|NCT01327612|525441488|FG001|Overall Study|Death|0|||
145705928|NCT01327612|525441489|FG002|Overall Study|Death|0|||
145705929|NCT01327612|525441490|FG003|Overall Study|Death|0|||
145705930|NCT01327612|525441491|FG004|Overall Study|Death|1|||
145705931|NCT01327612|525441492|FG005|Overall Study|Death|0|||
145705932|NCT01327612|525441493|FG006|Overall Study|Death|0|||
145705933|NCT01661205|525441494|FG000|Overall Study|Physician Decision|2|||
145705934|NCT00426127|525441495|FG000|Overall Study|Adverse Event|1|||
145705935|NCT00426127|525441495|FG000|Overall Study|Removed due to disease progression|1|||
145705936|NCT03111095|525441499|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
145705937|NCT03111095|525441500|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
145705938|NCT03111095|525441499|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
145705939|NCT03111095|525441500|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
145705940|NCT00955708|525441501|FG000|Overall Study|Death|269|||
145705941|NCT00955708|525441501|FG000|Overall Study|Lost to Follow-up|72|||
145705942|NCT00955708|525441501|FG000|Overall Study|Physician Decision|36|||
145705943|NCT00955708|525441501|FG000|Overall Study|Protocol Violation|134|||
145705944|NCT00955708|525441501|FG000|Overall Study|Registry Conclusion|186|||
145705945|NCT00955708|525441501|FG000|Overall Study|Product removed from service|94|||
145705946|NCT00955708|525441501|FG000|Overall Study|Patient Refused to participate further|116|||
145705947|NCT00955708|525441501|FG000|Overall Study|Closure of study location|60|||
145705948|NCT00955708|525441501|FG000|Overall Study|Patient changed care provider/moved|91|||
145705949|NCT03738475|525441502|FG000|Overall Study|Participant Non-Compliance|1|||
145705950|NCT03738475|525441503|FG001|Overall Study|Participant Non-Compliance|0|||
145705951|NCT00737477|525441504|FG000|Overall Study|Adverse Event|9|||
145705952|NCT00737477|525441504|FG000|Overall Study|Death|9|||
145705953|NCT00737477|525441504|FG000|Overall Study|Treatment Refusal|1|||
145705954|NCT00737477|525441504|FG000|Overall Study|Withdrawal by Subject|1|||
145705955|NCT00737477|525441504|FG000|Overall Study|Renal Transplantation|10|||
145705956|NCT00737477|525441504|FG000|Overall Study|Other|4|||
145705957|NCT01132820|525441505|FG000|Overall Study|Ineligible: wrong cell type|1|||
145705958|NCT01132820|525441505|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
145705959|NCT01132820|525441505|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
145705960|NCT01132820|525441505|FG000|Overall Study|Never treated|1|||
145705961|NCT01132820|525441505|FG000|Overall Study|Inadequate data|1|||
145705962|NCT01370655|525441506|FG000|Period 1|Adverse Event|2|||
145705963|NCT01370655|525441507|FG001|Period 1|Adverse Event|0|||
145705964|NCT01370655|525441508|FG002|Period 1|Adverse Event|0|||
145705965|NCT01370655|525441509|FG003|Period 1|Adverse Event|0|||
145705966|NCT01370655|525441510|FG004|Period 1|Adverse Event|0|||
145705967|NCT01370655|525441511|FG005|Period 1|Adverse Event|0|||
145705968|NCT01370655|525441512|FG006|Period 1|Adverse Event|1|||
145705969|NCT01370655|525441513|FG007|Period 1|Adverse Event|0|||
145705970|NCT01370655|525441514|FG008|Period 1|Adverse Event|0|||
145705971|NCT01370655|525441515|FG009|Period 1|Adverse Event|0|||
145705972|NCT01370655|525441516|FG010|Period 1|Adverse Event|0|||
145705973|NCT01370655|525441517|FG011|Period 1|Adverse Event|0|||
145705974|NCT01370655|525441506|FG000|Period 2|Adverse Event|0|||
145705975|NCT01370655|525441507|FG001|Period 2|Adverse Event|0|||
145705976|NCT01370655|525441508|FG002|Period 2|Adverse Event|1|||
145705977|NCT01370655|525441509|FG003|Period 2|Adverse Event|0|||
145705978|NCT01370655|525441510|FG004|Period 2|Adverse Event|1|||
145705979|NCT01370655|525441511|FG005|Period 2|Adverse Event|0|||
145705980|NCT01370655|525441512|FG006|Period 2|Adverse Event|0|||
145705981|NCT01370655|525441513|FG007|Period 2|Adverse Event|1|||
145705982|NCT01370655|525441514|FG008|Period 2|Adverse Event|0|||
145705983|NCT01370655|525441515|FG009|Period 2|Adverse Event|0|||
145705984|NCT01370655|525441516|FG010|Period 2|Adverse Event|0|||
145705985|NCT01370655|525441517|FG011|Period 2|Adverse Event|0|||
145705986|NCT01370655|525441506|FG000|Period 2|met protocol specified stopping criteria|0|||
145705987|NCT01370655|525441507|FG001|Period 2|met protocol specified stopping criteria|0|||
145705988|NCT01370655|525441508|FG002|Period 2|met protocol specified stopping criteria|1|||
145705989|NCT01370655|525441509|FG003|Period 2|met protocol specified stopping criteria|0|||
145705990|NCT01370655|525441510|FG004|Period 2|met protocol specified stopping criteria|0|||
145705991|NCT01370655|525441511|FG005|Period 2|met protocol specified stopping criteria|0|||
145705992|NCT01370655|525441512|FG006|Period 2|met protocol specified stopping criteria|1|||
145705993|NCT01370655|525441513|FG007|Period 2|met protocol specified stopping criteria|0|||
145705994|NCT01370655|525441514|FG008|Period 2|met protocol specified stopping criteria|1|||
145705995|NCT01370655|525441515|FG009|Period 2|met protocol specified stopping criteria|0|||
145491444|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
145705996|NCT01370655|525441516|FG010|Period 2|met protocol specified stopping criteria|1|||
145705997|NCT01370655|525441517|FG011|Period 2|met protocol specified stopping criteria|0|||
145705998|NCT01370655|525441506|FG000|Period 2|Withdrawal by Subject|0|||
145705999|NCT01370655|525441507|FG001|Period 2|Withdrawal by Subject|0|||
145706000|NCT01370655|525441508|FG002|Period 2|Withdrawal by Subject|0|||
145706001|NCT01370655|525441509|FG003|Period 2|Withdrawal by Subject|0|||
145706002|NCT01370655|525441510|FG004|Period 2|Withdrawal by Subject|0|||
145706003|NCT01370655|525441511|FG005|Period 2|Withdrawal by Subject|0|||
145706004|NCT01370655|525441512|FG006|Period 2|Withdrawal by Subject|0|||
145706005|NCT01370655|525441513|FG007|Period 2|Withdrawal by Subject|0|||
145706006|NCT01370655|525441514|FG008|Period 2|Withdrawal by Subject|1|||
145706007|NCT01370655|525441515|FG009|Period 2|Withdrawal by Subject|0|||
145706008|NCT01370655|525441516|FG010|Period 2|Withdrawal by Subject|0|||
145706009|NCT01370655|525441517|FG011|Period 2|Withdrawal by Subject|0|||
145706010|NCT01853475|525441520|FG000|Overall Study|Withdrawal by Subject|0|||
145706011|NCT01853475|525441521|FG001|Overall Study|Withdrawal by Subject|1|||
145706012|NCT01853475|525441522|FG002|Overall Study|Withdrawal by Subject|0|||
145706013|NCT00659880|525441523|FG000|Overall Study|Lost to Follow-up|5|||
145706014|NCT03199469|525441524|FG000|Overall Study|Randomized, not treated|0|||
145706015|NCT03199469|525441525|FG001|Overall Study|Randomized, not treated|3|||
145706016|NCT03199469|525441524|FG000|Overall Study|Withdrawal by Subject|1|||
145706017|NCT03199469|525441525|FG001|Overall Study|Withdrawal by Subject|0|||
145706018|NCT03199469|525441524|FG000|Overall Study|Death|1|||
145706019|NCT03199469|525441525|FG001|Overall Study|Death|3|||
145706020|NCT03199469|525441524|FG000|Overall Study|Ongoing|5|||
145706021|NCT03199469|525441525|FG001|Overall Study|Ongoing|14|||
145706022|NCT01023958|525441530|FG000|Overall Study|Progressive disease|48|||
145706023|NCT01023958|525441530|FG000|Overall Study|Other adverse event|1|||
145706024|NCT01023958|525441530|FG000|Overall Study|Refused to continue medication|1|||
145706025|NCT02159040|525441531|FG000|Overall Study|Death|1|||
145706026|NCT01304498|525441532|FG000|Overall Study|Adverse Event|1|||
145706027|NCT01304498|525441533|FG001|Overall Study|Adverse Event|1|||
145706028|NCT01304498|525441532|FG000|Overall Study|Withdrawal by Subject|2|||
145706029|NCT01304498|525441533|FG001|Overall Study|Withdrawal by Subject|3|||
145706030|NCT01304498|525441532|FG000|Overall Study|Protocol Violation|1|||
145706031|NCT01304498|525441533|FG001|Overall Study|Protocol Violation|0|||
145706032|NCT01304498|525441532|FG000|Overall Study|Lost to Follow-up|2|||
145706033|NCT01304498|525441533|FG001|Overall Study|Lost to Follow-up|1|||
145706034|NCT03080493|525441534|FG000|Overall Study|Did not provide NRS pain results|1|||
145706035|NCT03080493|525441535|FG001|Overall Study|Did not provide NRS pain results|0|||
145706036|NCT03080493|525441534|FG000|Overall Study|Adverse Event|0|||
145706037|NCT03080493|525441535|FG001|Overall Study|Adverse Event|1|||
145706038|NCT03080493|525441534|FG000|Overall Study|Randomization error (parity group)|0|||
145706039|NCT03080493|525441535|FG001|Overall Study|Randomization error (parity group)|1|||
145706040|NCT00755417|525441537|FG000|Overall Study|Adverse Event|28|||
145706041|NCT00755417|525441538|FG001|Overall Study|Adverse Event|20|||
145706042|NCT00755417|525441539|FG002|Overall Study|Adverse Event|7|||
145706043|NCT00755417|525441537|FG000|Overall Study|Lack of Efficacy|8|||
145706044|NCT00755417|525441538|FG001|Overall Study|Lack of Efficacy|4|||
145706045|NCT00755417|525441539|FG002|Overall Study|Lack of Efficacy|9|||
145706046|NCT00755417|525441537|FG000|Overall Study|Protocol Violation|2|||
145706047|NCT00755417|525441538|FG001|Overall Study|Protocol Violation|1|||
145706048|NCT00755417|525441539|FG002|Overall Study|Protocol Violation|1|||
145706049|NCT00755417|525441537|FG000|Overall Study|Lost to Follow-up|3|||
145706050|NCT00755417|525441538|FG001|Overall Study|Lost to Follow-up|0|||
145706051|NCT00755417|525441539|FG002|Overall Study|Lost to Follow-up|1|||
145706052|NCT00755417|525441537|FG000|Overall Study|Withdrawal by Subject|12|||
145706053|NCT00755417|525441538|FG001|Overall Study|Withdrawal by Subject|12|||
145706054|NCT00755417|525441539|FG002|Overall Study|Withdrawal by Subject|12|||
145706055|NCT00755417|525441537|FG000|Overall Study|Not specified or missing data|9|||
145706056|NCT00755417|525441538|FG001|Overall Study|Not specified or missing data|18|||
145706057|NCT00755417|525441539|FG002|Overall Study|Not specified or missing data|12|||
145706058|NCT03443414|525441541|FG000|Overall Study|Adverse Event|6|||
145706059|NCT03443414|525441542|FG001|Overall Study|Adverse Event|0|||
145706060|NCT03443414|525441543|FG002|Overall Study|Adverse Event|4|||
145706061|NCT03443414|525441544|FG003|Overall Study|Adverse Event|2|||
145706062|NCT03443414|525441545|FG004|Overall Study|Adverse Event|3|||
145706063|NCT03443414|525441541|FG000|Overall Study|Withdrawal by Subject|3|||
145706064|NCT03443414|525441542|FG001|Overall Study|Withdrawal by Subject|2|||
145706065|NCT03443414|525441543|FG002|Overall Study|Withdrawal by Subject|2|||
145706066|NCT03443414|525441544|FG003|Overall Study|Withdrawal by Subject|2|||
145706067|NCT03443414|525441545|FG004|Overall Study|Withdrawal by Subject|1|||
145706068|NCT03443414|525441541|FG000|Overall Study|Death|0|||
145706069|NCT03443414|525441542|FG001|Overall Study|Death|1|||
145706070|NCT03443414|525441543|FG002|Overall Study|Death|0|||
145706071|NCT03443414|525441544|FG003|Overall Study|Death|1|||
145706072|NCT03443414|525441545|FG004|Overall Study|Death|0|||
145706073|NCT03443414|525441541|FG000|Overall Study|Reason not specified|2|||
145706074|NCT03443414|525441542|FG001|Overall Study|Reason not specified|0|||
145706075|NCT03443414|525441543|FG002|Overall Study|Reason not specified|0|||
145706076|NCT03443414|525441544|FG003|Overall Study|Reason not specified|0|||
145706077|NCT03443414|525441545|FG004|Overall Study|Reason not specified|1|||
145706078|NCT03325777|525441546|FG000|Overall Study|Lost to Follow-up|9|||
145706079|NCT03325777|525441547|FG001|Overall Study|Lost to Follow-up|12|||
145706080|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
145706081|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
145706082|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
145706083|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
145706084|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
145706085|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
145706086|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
145706087|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
145706088|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
145706089|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
145706090|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
145706091|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
145706092|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
145706093|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
145706094|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
145706095|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
145706096|NCT04210843|525441549|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
145706097|NCT04210843|525441550|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
145706098|NCT04210843|525441549|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
145706099|NCT04210843|525441550|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
145706100|NCT04210843|525441549|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
145706101|NCT04210843|525441550|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
145706102|NCT04210843|525441549|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
145706103|NCT04210843|525441550|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
145706104|NCT04210843|525441549|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
145706105|NCT04210843|525441550|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
145706106|NCT04210843|525441549|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
145706107|NCT04210843|525441550|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
145706108|NCT04210843|525441549|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
145706109|NCT04210843|525441550|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
145706110|NCT04210843|525441549|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
145706111|NCT04210843|525441550|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
145706112|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
145706113|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
145706114|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
145706115|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
145706116|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
145706117|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
145706118|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
145706119|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
145706120|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
145706121|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
145706122|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
145706123|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
145706124|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
145706125|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
145706126|NCT04210843|525441549|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
145706127|NCT04210843|525441550|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
145706128|NCT01099917|525441551|FG000|Overall Study|Adverse Event|3|||
145706129|NCT01099917|525441551|FG000|Overall Study|Not Treated|24|||
145706130|NCT01485120|525441552|FG000|Overall Study|Withdrawal by Subject|2|||
145706131|NCT00422734|525441553|FG000|Overall Study|Physician Decision|1|||
145706132|NCT00422734|525441554|FG001|Overall Study|Physician Decision|1|||
145706133|NCT00422734|525441553|FG000|Overall Study|Protocol Violation|1|||
145706134|NCT00422734|525441554|FG001|Overall Study|Protocol Violation|6|||
145706135|NCT00422734|525441553|FG000|Overall Study|Withdrawal by Subject|12|||
145706136|NCT00422734|525441554|FG001|Overall Study|Withdrawal by Subject|8|||
145706137|NCT00422734|525441553|FG000|Overall Study|Adverse Event|0|||
145706138|NCT00422734|525441554|FG001|Overall Study|Adverse Event|3|||
145706139|NCT00422734|525441553|FG000|Overall Study|Partner Decision|0|||
145706140|NCT00422734|525441554|FG001|Overall Study|Partner Decision|3|||
145706141|NCT02344342|525441555|FG000|Overall Study|Industry partner dropped out|11|||
145706142|NCT02344342|525441556|FG001|Overall Study|Industry partner dropped out|9|||
145706143|NCT02344342|525441557|FG002|Overall Study|Industry partner dropped out|14|||
145706144|NCT02344342|525441558|FG003|Overall Study|Industry partner dropped out|10|||
145706145|NCT00848484|525441559|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
145706146|NCT00848484|525441560|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
145706147|NCT00848484|525441559|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
145706148|NCT00848484|525441560|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
145706149|NCT00848484|525441559|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
145706150|NCT00848484|525441560|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
145706151|NCT00848484|525441559|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
145706152|NCT00848484|525441560|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
145706153|NCT00848484|525441559|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
145706154|NCT00848484|525441560|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
145706155|NCT01081886|525441564|FG000|Overall Study|Study termination|11|||
145706156|NCT01081886|525441565|FG001|Overall Study|Study termination|13|||
145706157|NCT03355209|525441566|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
145706158|NCT03355209|525441567|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
145706159|NCT03355209|525441568|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
145706160|NCT03355209|525441569|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
145706161|NCT03355209|525441570|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
145706162|NCT03355209|525441571|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
145706163|NCT03355209|525441566|FG000|Part 1: Double-Blind Period|Death|0|||
145706164|NCT03355209|525441567|FG001|Part 1: Double-Blind Period|Death|0|||
145706165|NCT03355209|525441568|FG002|Part 1: Double-Blind Period|Death|1|||
145706166|NCT03355209|525441569|FG003|Part 1: Double-Blind Period|Death|0|||
145706167|NCT03355209|525441570|FG004|Part 1: Double-Blind Period|Death|0|||
145706168|NCT03355209|525441571|FG005|Part 1: Double-Blind Period|Death|0|||
145706169|NCT03355209|525441566|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
145706170|NCT03355209|525441567|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
145706171|NCT03355209|525441568|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
145706172|NCT03355209|525441569|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
145706173|NCT03355209|525441570|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
145706174|NCT03355209|525441571|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
145706175|NCT03355209|525441566|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
145706176|NCT03355209|525441567|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
145706177|NCT03355209|525441568|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
145706178|NCT03355209|525441569|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145706179|NCT03355209|525441570|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145706180|NCT03355209|525441571|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
145706181|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
145706182|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
145706183|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
145706184|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
145706185|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
145706186|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
145706187|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
145706188|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
145706189|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
145706190|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
145706191|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
145706192|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
145706193|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
145706194|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
145706195|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
145706196|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
145706197|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
145706198|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
145706199|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
145706200|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
145706201|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
145706202|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
145706203|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
145706204|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
145706205|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
145706206|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
145706207|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
145706208|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145706209|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
145706210|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
145706211|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
145706212|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
145706213|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
145706214|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
145706215|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
145706216|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
145706217|NCT03355209|525441566|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
145706218|NCT03355209|525441567|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
145706219|NCT03355209|525441568|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
145706220|NCT03355209|525441569|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
145706221|NCT03355209|525441570|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
145706222|NCT03355209|525441571|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
145706223|NCT02567708|525441572|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
145706224|NCT02567708|525441573|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
145706225|NCT02567708|525441572|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
145706226|NCT02567708|525441573|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
145706227|NCT02567708|525441572|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
145706228|NCT02567708|525441573|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
145706229|NCT02567708|525441572|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
145706230|NCT02567708|525441573|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
145706231|NCT00706654|525441574|FG000|Conversion Phase|Lost to Follow-up|4|||
145706232|NCT00706654|525441575|FG001|Conversion Phase|Lost to Follow-up|0|||
145706233|NCT00706654|525441576|FG002|Conversion Phase|Lost to Follow-up|0|||
145706234|NCT00706654|525441577|FG003|Conversion Phase|Lost to Follow-up|0|||
145706235|NCT00706654|525441574|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
145706236|NCT00706654|525441575|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
145706237|NCT00706654|525441576|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
145706238|NCT00706654|525441577|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
145706239|NCT00706654|525441574|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
145706240|NCT00706654|525441575|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
145706241|NCT00706654|525441576|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
145706242|NCT00706654|525441577|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
145706243|NCT00706654|525441574|FG000|Conversion Phase|Withdrawn by Investigator|14|||
145706244|NCT00706654|525441575|FG001|Conversion Phase|Withdrawn by Investigator|0|||
145706245|NCT00706654|525441576|FG002|Conversion Phase|Withdrawn by Investigator|0|||
145706246|NCT00706654|525441577|FG003|Conversion Phase|Withdrawn by Investigator|0|||
145706247|NCT00706654|525441574|FG000|Conversion Phase|Withdrew Consent|38|||
145706248|NCT00706654|525441575|FG001|Conversion Phase|Withdrew Consent|0|||
145706249|NCT00706654|525441576|FG002|Conversion Phase|Withdrew Consent|0|||
145706250|NCT00706654|525441577|FG003|Conversion Phase|Withdrew Consent|0|||
145706251|NCT00706654|525441574|FG000|Conversion Phase|Adverse Event|18|||
145706252|NCT00706654|525441575|FG001|Conversion Phase|Adverse Event|0|||
145706253|NCT00706654|525441576|FG002|Conversion Phase|Adverse Event|0|||
145706254|NCT00706654|525441577|FG003|Conversion Phase|Adverse Event|0|||
145706255|NCT00706654|525441574|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
145706256|NCT00706654|525441575|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
145706257|NCT00706654|525441576|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
145706258|NCT00706654|525441577|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
145706259|NCT00706654|525441574|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
145706260|NCT00706654|525441575|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
145706261|NCT00706654|525441576|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
145706262|NCT00706654|525441577|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
145706263|NCT00706654|525441574|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
145706264|NCT00706654|525441575|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
145706265|NCT00706654|525441576|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
145706266|NCT00706654|525441577|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
145706267|NCT00706654|525441574|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
145706268|NCT00706654|525441575|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
145706269|NCT00706654|525441576|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
145706270|NCT00706654|525441577|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
145706271|NCT00706654|525441574|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
145706272|NCT00706654|525441575|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
145706273|NCT00706654|525441576|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
145706274|NCT00706654|525441577|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
145706275|NCT00706654|525441574|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
145706276|NCT00706654|525441575|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
145706277|NCT00706654|525441576|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
145706278|NCT00706654|525441577|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
145706279|NCT00706654|525441574|FG000|Oral Stabilization Phase|Withdrew consent|55|||
145706280|NCT00706654|525441575|FG001|Oral Stabilization Phase|Withdrew consent|0|||
145706281|NCT00706654|525441576|FG002|Oral Stabilization Phase|Withdrew consent|0|||
145706282|NCT00706654|525441577|FG003|Oral Stabilization Phase|Withdrew consent|0|||
145706283|NCT00706654|525441574|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
145706284|NCT00706654|525441575|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
145706285|NCT00706654|525441576|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
145706286|NCT00706654|525441577|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
145706287|NCT00706654|525441574|FG000|Oral Stabilization Phase|Adverse Event|21|||
145706288|NCT00706654|525441575|FG001|Oral Stabilization Phase|Adverse Event|0|||
145706289|NCT00706654|525441576|FG002|Oral Stabilization Phase|Adverse Event|0|||
145706290|NCT00706654|525441577|FG003|Oral Stabilization Phase|Adverse Event|0|||
145706291|NCT00706654|525441574|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
145706292|NCT00706654|525441575|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145706293|NCT00706654|525441576|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145706294|NCT00706654|525441577|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
145706295|NCT00706654|525441574|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
145706296|NCT00706654|525441575|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145706297|NCT00706654|525441576|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145706298|NCT00706654|525441577|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
145706299|NCT00706654|525441574|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
145706300|NCT00706654|525441575|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
145706301|NCT00706654|525441576|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
145706302|NCT00706654|525441577|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
145706303|NCT00706654|525441574|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
145706304|NCT00706654|525441575|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
145706305|NCT00706654|525441576|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
145706306|NCT00706654|525441577|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
145706307|NCT00706654|525441574|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
145706308|NCT00706654|525441575|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
145706309|NCT00706654|525441576|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
145706310|NCT00706654|525441577|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
145706311|NCT00706654|525441574|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
145706312|NCT00706654|525441575|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
145706313|NCT00706654|525441576|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
145706314|NCT00706654|525441577|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
145706315|NCT00706654|525441574|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
145706316|NCT00706654|525441575|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
145706317|NCT00706654|525441576|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
145706318|NCT00706654|525441577|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
145706319|NCT00706654|525441574|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
145706320|NCT00706654|525441575|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
145706321|NCT00706654|525441576|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
145706322|NCT00706654|525441577|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
145706323|NCT00706654|525441574|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
145706324|NCT00706654|525441575|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
145706325|NCT00706654|525441576|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
145706326|NCT00706654|525441577|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
145706327|NCT00706654|525441574|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
145706328|NCT00706654|525441575|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
145706329|NCT00706654|525441576|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
145706330|NCT00706654|525441577|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
145706331|NCT05262751|525441578|FG000|Washout Period 2|Adverse Event|1|||
145706332|NCT05262751|525441579|FG001|Washout Period 2|Adverse Event|0|||
145706333|NCT05262751|525441580|FG002|Washout Period 2|Adverse Event|0|||
145706334|NCT05262751|525441581|FG003|Washout Period 2|Adverse Event|0|||
145706335|NCT05262751|525441582|FG004|Washout Period 2|Adverse Event|0|||
145706336|NCT05262751|525441583|FG005|Washout Period 2|Adverse Event|0|||
145706337|NCT05262751|525441578|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
145706338|NCT05262751|525441579|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
145706339|NCT05262751|525441580|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
145706340|NCT05262751|525441581|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
145706341|NCT05262751|525441582|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
145706342|NCT05262751|525441583|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
145706343|NCT01151215|525441584|FG000|Overall Study|Worsening of condition under study|1|||
145706344|NCT01151215|525441585|FG001|Overall Study|Worsening of condition under study|1|||
145706345|NCT01151215|525441586|FG002|Overall Study|Worsening of condition under study|1|||
145706346|NCT01151215|525441584|FG000|Overall Study|Death|16|||
145706347|NCT01151215|525441585|FG001|Overall Study|Death|20|||
145706348|NCT01151215|525441586|FG002|Overall Study|Death|11|||
145706349|NCT01151215|525441584|FG000|Overall Study|Lost to Follow-up|0|||
145706350|NCT01151215|525441585|FG001|Overall Study|Lost to Follow-up|0|||
145706351|NCT01151215|525441586|FG002|Overall Study|Lost to Follow-up|3|||
145706352|NCT01151215|525441584|FG000|Overall Study|Withdrawal by Subject|3|||
145491445|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
145706353|NCT01151215|525441585|FG001|Overall Study|Withdrawal by Subject|1|||
145706354|NCT01151215|525441586|FG002|Overall Study|Withdrawal by Subject|2|||
145706355|NCT01151215|525441584|FG000|Overall Study|Disease progression|0|||
145706356|NCT01151215|525441585|FG001|Overall Study|Disease progression|1|||
145706357|NCT01151215|525441586|FG002|Overall Study|Disease progression|1|||
145706358|NCT01151215|525441584|FG000|Overall Study|Safety as judged by the investigator|0|||
145706359|NCT01151215|525441585|FG001|Overall Study|Safety as judged by the investigator|0|||
145706360|NCT01151215|525441586|FG002|Overall Study|Safety as judged by the investigator|1|||
145706361|NCT01154140|525441588|FG000|Overall Study|Death|71|||
145706362|NCT01154140|525441589|FG001|Overall Study|Death|81|||
145706363|NCT01154140|525441588|FG000|Overall Study|Lost to Follow-up|4|||
145706364|NCT01154140|525441589|FG001|Overall Study|Lost to Follow-up|5|||
145706365|NCT01154140|525441588|FG000|Overall Study|Withdrawal by Subject|12|||
145706366|NCT01154140|525441589|FG001|Overall Study|Withdrawal by Subject|13|||
145706367|NCT01154140|525441588|FG000|Overall Study|Other|3|||
145706368|NCT01154140|525441589|FG001|Overall Study|Other|1|||
145706369|NCT01154140|525441588|FG000|Overall Study|Randomized but not treated|1|||
145706370|NCT01154140|525441589|FG001|Overall Study|Randomized but not treated|2|||
145706371|NCT04276051|525441592|FG000|Overall Study|Lost to Follow-up|0|||
145706372|NCT04276051|525441593|FG001|Overall Study|Lost to Follow-up|1|||
145706373|NCT04276051|525441592|FG000|Overall Study|Physician Decision|0|||
145706374|NCT04276051|525441593|FG001|Overall Study|Physician Decision|1|||
145706375|NCT04276051|525441592|FG000|Overall Study|Withdrawal by Subject|1|||
145706376|NCT04276051|525441593|FG001|Overall Study|Withdrawal by Subject|1|||
145706377|NCT01912404|525441594|FG000|Overall Study|Due to personal reasons|1|||
145706378|NCT01912404|525441595|FG001|Overall Study|Due to personal reasons|0|||
145706379|NCT04160988|525441596|FG000|Overall Study|poor image quality|28|||
145706380|NCT01426347|525441600|FG000|Overall Study|Lost to Follow-up|0|||
145706381|NCT01426347|525441601|FG001|Overall Study|Lost to Follow-up|3|||
145706382|NCT01426347|525441600|FG000|Overall Study|Protocol Violation|2|||
145706383|NCT01426347|525441601|FG001|Overall Study|Protocol Violation|0|||
145706384|NCT01426347|525441600|FG000|Overall Study|Withdrawal by Subject|5|||
145706385|NCT01426347|525441601|FG001|Overall Study|Withdrawal by Subject|0|||
145706386|NCT00475228|525441602|FG000|Overall Study|Lost to Follow-up|17|||
145706387|NCT00475228|525441603|FG001|Overall Study|Lost to Follow-up|17|||
145706388|NCT02209181|525441605|FG000|Overall Study|Adverse Event|1|||
145706389|NCT02209181|525441606|FG001|Overall Study|Adverse Event|0|||
145706390|NCT02209181|525441607|FG002|Overall Study|Adverse Event|1|||
145706391|NCT02209181|525441608|FG003|Overall Study|Adverse Event|0|||
145706392|NCT02209181|525441605|FG000|Overall Study|Withdrawal by Subject|0|||
145706393|NCT02209181|525441606|FG001|Overall Study|Withdrawal by Subject|1|||
145706394|NCT02209181|525441607|FG002|Overall Study|Withdrawal by Subject|0|||
145706395|NCT02209181|525441608|FG003|Overall Study|Withdrawal by Subject|0|||
145706396|NCT00975676|525441609|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
145706397|NCT00975676|525441610|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
145706398|NCT02548078|525441611|FG000|Overall Study|Serious adverse event/Adverse event|1|||
145706399|NCT02548078|525441612|FG001|Overall Study|Serious adverse event/Adverse event|0|||
145706400|NCT02548078|525441611|FG000|Overall Study|Moved from study area|3|||
145706401|NCT02548078|525441612|FG001|Overall Study|Moved from study area|3|||
145706402|NCT02548078|525441611|FG000|Overall Study|Lost to Follow-up|1|||
145706403|NCT02548078|525441612|FG001|Overall Study|Lost to Follow-up|3|||
145706404|NCT02579772|525441613|FG000|Overall Study|Withdrawal by Subject|0|||
145706405|NCT02579772|525441614|FG001|Overall Study|Withdrawal by Subject|1|||
145706406|NCT02579772|525441613|FG000|Overall Study|Usage of additional antioxidants|1|||
145706407|NCT02579772|525441614|FG001|Overall Study|Usage of additional antioxidants|0|||
145706408|NCT02579772|525441613|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
145706409|NCT02579772|525441614|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
145706410|NCT04641962|525441616|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
145706411|NCT04641962|525441617|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
145706412|NCT04641962|525441618|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
145706413|NCT04641962|525441619|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
145706414|NCT04641962|525441620|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
145706415|NCT04641962|525441616|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
145706416|NCT04641962|525441617|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
145706417|NCT04641962|525441618|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
145706418|NCT04641962|525441619|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
145706419|NCT04641962|525441620|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
145706420|NCT04641962|525441616|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
145706421|NCT04641962|525441617|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
145706422|NCT04641962|525441618|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
145706423|NCT04641962|525441619|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
145706424|NCT04641962|525441620|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
145706425|NCT04641962|525441616|FG000|DBT Period: Up to 52 Weeks|Death|1|||
145706426|NCT04641962|525441617|FG001|DBT Period: Up to 52 Weeks|Death|0|||
145706427|NCT04641962|525441618|FG002|DBT Period: Up to 52 Weeks|Death|0|||
145706428|NCT04641962|525441619|FG003|DBT Period: Up to 52 Weeks|Death|0|||
145706429|NCT04641962|525441620|FG004|DBT Period: Up to 52 Weeks|Death|0|||
145706430|NCT04641962|525441616|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
145706431|NCT04641962|525441617|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
145706432|NCT04641962|525441618|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
145706433|NCT04641962|525441619|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
145706434|NCT04641962|525441620|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
145706435|NCT04641962|525441616|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
145706436|NCT04641962|525441617|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
145706437|NCT04641962|525441618|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
145706438|NCT04641962|525441619|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
145706439|NCT04641962|525441620|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
145706440|NCT04641962|525441616|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
145706441|NCT04641962|525441617|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
145706442|NCT04641962|525441618|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
145706443|NCT04641962|525441619|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
145706444|NCT04641962|525441620|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
145706445|NCT00862836|525441622|FG000|Overall Study|Withdrawal by Subject|1|||
145706446|NCT04463680|525441623|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
145706447|NCT04463680|525441623|FG000|Overall Study|Not eligible due to implant duration of use|1|||
145706448|NCT04463680|525441623|FG000|Overall Study|Withdrawal by Subject|3|||
145706449|NCT02592707|525441626|FG000|Overall Study|Consent Withdrawn|0|||
145706450|NCT02592707|525441627|FG001|Overall Study|Consent Withdrawn|1|||
145706451|NCT02592707|525441628|FG002|Overall Study|Consent Withdrawn|2|||
145706452|NCT02592707|525441629|FG003|Overall Study|Consent Withdrawn|0|||
145706453|NCT02592707|525441626|FG000|Overall Study|Death|1|||
145706454|NCT02592707|525441627|FG001|Overall Study|Death|0|||
145706455|NCT02592707|525441628|FG002|Overall Study|Death|0|||
145706456|NCT02592707|525441629|FG003|Overall Study|Death|0|||
145706457|NCT02592707|525441626|FG000|Overall Study|Progressive Disease|4|||
145706458|NCT02592707|525441627|FG001|Overall Study|Progressive Disease|4|||
145706459|NCT02592707|525441628|FG002|Overall Study|Progressive Disease|3|||
145706460|NCT02592707|525441629|FG003|Overall Study|Progressive Disease|3|||
145706461|NCT02592707|525441626|FG000|Overall Study|Other|0|||
145706462|NCT02592707|525441627|FG001|Overall Study|Other|0|||
145706463|NCT02592707|525441628|FG002|Overall Study|Other|1|||
145706464|NCT02592707|525441629|FG003|Overall Study|Other|2|||
145706465|NCT02592707|525441626|FG000|Overall Study|Never entered LTFU period|1|||
145706466|NCT02592707|525441627|FG001|Overall Study|Never entered LTFU period|0|||
145706467|NCT02592707|525441628|FG002|Overall Study|Never entered LTFU period|0|||
145706468|NCT02592707|525441629|FG003|Overall Study|Never entered LTFU period|2|||
145706469|NCT01088984|525443125|FG000|Phase 1|Death|2|||
145706470|NCT01088984|525443126|FG001|Phase 1|Death|1|||
145706471|NCT01088984|525443125|FG000|Phase 1|Disease Progression|2|||
145706472|NCT01088984|525443126|FG001|Phase 1|Disease Progression|4|||
145706473|NCT01088984|525443125|FG000|Phase 1|Other|1|||
145706474|NCT01088984|525443126|FG001|Phase 1|Other|1|||
145706475|NCT01088984|525443125|FG000|Phase 2|Death|0|||
145706476|NCT01088984|525443126|FG001|Phase 2|Death|5|||
145706477|NCT01088984|525443125|FG000|Phase 2|Withdrawal by Subject|0|||
145706478|NCT01088984|525443126|FG001|Phase 2|Withdrawal by Subject|1|||
145706479|NCT01088984|525443125|FG000|Phase 2|DIsease Progression|0|||
145706480|NCT01088984|525443126|FG001|Phase 2|DIsease Progression|25|||
145706481|NCT01088984|525443125|FG000|Phase 2|Other|0|||
145706482|NCT01088984|525443126|FG001|Phase 2|Other|1|||
145706483|NCT02124811|525443127|FG000|Overall Study|Early termination|2|||
145706484|NCT02124811|525443128|FG001|Overall Study|Early termination|2|||
145706485|NCT02124811|525443127|FG000|Overall Study|Withdrawal by Subject|1|||
145706486|NCT02124811|525443128|FG001|Overall Study|Withdrawal by Subject|0|||
145706487|NCT03480932|525443129|FG000|Overall Study|Death|1|||
145706488|NCT03480932|525443130|FG001|Overall Study|Death|1|||
145706489|NCT03480932|525443131|FG002|Overall Study|Death|0|||
145706490|NCT03480932|525443129|FG000|Overall Study|Lost to Follow-up|0|||
145706491|NCT03480932|525443130|FG001|Overall Study|Lost to Follow-up|2|||
145706492|NCT03480932|525443131|FG002|Overall Study|Lost to Follow-up|3|||
145706493|NCT03480932|525443129|FG000|Overall Study|Incarcerated|2|||
145706494|NCT03480932|525443130|FG001|Overall Study|Incarcerated|2|||
145706495|NCT03480932|525443131|FG002|Overall Study|Incarcerated|2|||
145706496|NCT04624243|525443132|FG000|Overall Study|Death|0|||
145706497|NCT04624243|525443133|FG001|Overall Study|Death|1|||
145706498|NCT04624243|525443134|FG002|Overall Study|Death|0|||
145706499|NCT04624243|525443135|FG003|Overall Study|Death|0|||
145706500|NCT04624243|525443136|FG004|Overall Study|Death|0|||
145706501|NCT04624243|525443132|FG000|Overall Study|Lost to Follow-up|2|||
145706502|NCT04624243|525443133|FG001|Overall Study|Lost to Follow-up|3|||
145706503|NCT04624243|525443134|FG002|Overall Study|Lost to Follow-up|7|||
145706504|NCT04624243|525443135|FG003|Overall Study|Lost to Follow-up|1|||
145706505|NCT04624243|525443136|FG004|Overall Study|Lost to Follow-up|3|||
145706506|NCT04624243|525443132|FG000|Overall Study|Physician Decision|3|||
145706507|NCT04624243|525443133|FG001|Overall Study|Physician Decision|8|||
145706508|NCT04624243|525443134|FG002|Overall Study|Physician Decision|15|||
145706509|NCT04624243|525443135|FG003|Overall Study|Physician Decision|2|||
145706510|NCT04624243|525443136|FG004|Overall Study|Physician Decision|11|||
145706511|NCT04624243|525443132|FG000|Overall Study|Withdrawal by Subject|19|||
145706512|NCT04624243|525443133|FG001|Overall Study|Withdrawal by Subject|44|||
145706513|NCT04624243|525443134|FG002|Overall Study|Withdrawal by Subject|40|||
145706514|NCT04624243|525443135|FG003|Overall Study|Withdrawal by Subject|21|||
145706515|NCT04624243|525443136|FG004|Overall Study|Withdrawal by Subject|39|||
145706516|NCT04624243|525443132|FG000|Overall Study|Miscellaneous|3|||
145706517|NCT04624243|525443133|FG001|Overall Study|Miscellaneous|12|||
145706518|NCT04624243|525443134|FG002|Overall Study|Miscellaneous|9|||
145706519|NCT04624243|525443135|FG003|Overall Study|Miscellaneous|4|||
145706520|NCT04624243|525443136|FG004|Overall Study|Miscellaneous|6|||
145706521|NCT04079868|525443137|FG000|Overall Study|Lost to Follow-up|100|||
145706522|NCT04079868|525443138|FG001|Overall Study|Lost to Follow-up|200|||
145706523|NCT04079868|525443137|FG000|Overall Study|Physician Decision|100|||
145706524|NCT04079868|525443138|FG001|Overall Study|Physician Decision|0|||
145706525|NCT03374488|525443139|FG000|Overall Study|Death|13|||
145706526|NCT03374488|525443140|FG001|Overall Study|Death|13|||
145706527|NCT03374488|525443139|FG000|Overall Study|Withdrawal by Subject|3|||
145706528|NCT03374488|525443140|FG001|Overall Study|Withdrawal by Subject|1|||
145706529|NCT03374488|525443139|FG000|Overall Study|Physician Decision|3|||
145706530|NCT03374488|525443140|FG001|Overall Study|Physician Decision|0|||
145706531|NCT01294397|525443141|FG000|Overall Study|Withdrawal by Subject|1|||
145706532|NCT01294397|525443141|FG000|Overall Study|Administrative Decision|1|||
145706533|NCT02057575|525443148|FG000|Overall Study|Adverse Event|0|||
145706534|NCT02057575|525443149|FG001|Overall Study|Adverse Event|2|||
145706535|NCT02057575|525443150|FG002|Overall Study|Adverse Event|0|||
145706536|NCT02057575|525443151|FG003|Overall Study|Adverse Event|1|||
145706537|NCT02057575|525443148|FG000|Overall Study|Withdrawal by Subject|1|||
145706538|NCT02057575|525443149|FG001|Overall Study|Withdrawal by Subject|0|||
145706539|NCT02057575|525443150|FG002|Overall Study|Withdrawal by Subject|0|||
145706540|NCT02057575|525443151|FG003|Overall Study|Withdrawal by Subject|0|||
145706541|NCT02057575|525443148|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
145706542|NCT02057575|525443149|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
145706543|NCT02057575|525443150|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
145706544|NCT02057575|525443151|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
145706545|NCT02057575|525443148|FG000|Overall Study|Protocol Violation|0|||
145706546|NCT02057575|525443149|FG001|Overall Study|Protocol Violation|1|||
145706547|NCT02057575|525443150|FG002|Overall Study|Protocol Violation|0|||
145706548|NCT02057575|525443151|FG003|Overall Study|Protocol Violation|0|||
145706549|NCT00332462|525443152|FG000|Overall Study|Adverse Event|5|||
145706550|NCT00332462|525443152|FG000|Overall Study|Abnormal Lab Value|1|||
145706551|NCT00332462|525443152|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
145706552|NCT00332462|525443152|FG000|Overall Study|no longer requires study drug|1|||
145706553|NCT00332462|525443152|FG000|Overall Study|Death|3|||
145706554|NCT00332462|525443152|FG000|Overall Study|Graft Loss|2|||
145706555|NCT02922023|525443153|FG000|Overall Study|Lost to Follow-up|2|||
145706556|NCT02922023|525443154|FG001|Overall Study|Lost to Follow-up|0|||
145706557|NCT00863681|525443155|FG000|Overall Study|Other|2|||
145706558|NCT00863681|525443156|FG001|Overall Study|Other|0|||
145706559|NCT00863681|525443157|FG002|Overall Study|Other|0|||
145706560|NCT00863681|525443155|FG000|Overall Study|Missing|1|||
145706561|NCT00863681|525443156|FG001|Overall Study|Missing|0|||
145706562|NCT00863681|525443157|FG002|Overall Study|Missing|0|||
145706563|NCT00863681|525443155|FG000|Overall Study|Death|40|||
145706564|NCT00863681|525443156|FG001|Overall Study|Death|23|||
145706565|NCT00863681|525443157|FG002|Overall Study|Death|6|||
145706566|NCT00863681|525443155|FG000|Overall Study|Withdrawal by Subject|12|||
145706567|NCT00863681|525443156|FG001|Overall Study|Withdrawal by Subject|5|||
145706568|NCT00863681|525443157|FG002|Overall Study|Withdrawal by Subject|2|||
145706569|NCT00863681|525443155|FG000|Overall Study|Protocol Violation|2|||
145706570|NCT00863681|525443156|FG001|Overall Study|Protocol Violation|0|||
145706571|NCT00863681|525443157|FG002|Overall Study|Protocol Violation|0|||
145706572|NCT00863681|525443155|FG000|Overall Study|Lost to Follow-up|3|||
145706573|NCT00863681|525443156|FG001|Overall Study|Lost to Follow-up|0|||
145706574|NCT00863681|525443157|FG002|Overall Study|Lost to Follow-up|3|||
145706575|NCT00863681|525443155|FG000|Overall Study|Adverse Event|28|||
145706576|NCT00863681|525443156|FG001|Overall Study|Adverse Event|10|||
145706577|NCT00863681|525443157|FG002|Overall Study|Adverse Event|6|||
145706578|NCT00863681|525443155|FG000|Overall Study|Lack of Efficacy|2|||
145706579|NCT00863681|525443156|FG001|Overall Study|Lack of Efficacy|2|||
145706580|NCT00863681|525443157|FG002|Overall Study|Lack of Efficacy|1|||
145706581|NCT00863681|525443155|FG000|Overall Study|Non-compliance with study drug|1|||
145706582|NCT00863681|525443156|FG001|Overall Study|Non-compliance with study drug|3|||
145706583|NCT00863681|525443157|FG002|Overall Study|Non-compliance with study drug|0|||
145706584|NCT01735175|525443158|FG000|Overall Study|Withdrawal by Subject|9|||
145706585|NCT01735175|525443159|FG001|Overall Study|Withdrawal by Subject|2|||
145706586|NCT01735175|525443158|FG000|Overall Study|Lost to Follow-up|4|||
145706587|NCT01735175|525443159|FG001|Overall Study|Lost to Follow-up|2|||
145706588|NCT01735175|525443158|FG000|Overall Study|Death|3|||
145706589|NCT01735175|525443159|FG001|Overall Study|Death|2|||
145706590|NCT01735175|525443158|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
145706591|NCT01735175|525443159|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
145706592|NCT01374568|525443164|FG000|Overall Study|Lab unable to analyze BTM|0|||
145706593|NCT01374568|525443165|FG001|Overall Study|Lab unable to analyze BTM|2|||
145706594|NCT02269423|525443169|FG000|Overall Study|Discontinued due to change in residence|0|||
145706595|NCT02269423|525443170|FG001|Overall Study|Discontinued due to change in residence|1|||
145706596|NCT02269423|525443171|FG002|Overall Study|Discontinued due to change in residence|0|||
145706597|NCT02269423|525443172|FG003|Overall Study|Discontinued due to change in residence|1|||
145706598|NCT04916730|525443175|FG000|Overall Study|Withdrawal by Subject|4|||
145706599|NCT04916730|525443176|FG001|Overall Study|Withdrawal by Subject|2|||
145706600|NCT04916730|525443175|FG000|Overall Study|Lost to Follow-up|0|||
145706601|NCT04916730|525443176|FG001|Overall Study|Lost to Follow-up|2|||
145706602|NCT04916730|525443175|FG000|Overall Study|Physician Decision|1|||
145706603|NCT04916730|525443176|FG001|Overall Study|Physician Decision|0|||
145706604|NCT00856245|525443182|FG000|Overall Study|Was not transplanted|5|||
145706605|NCT01443923|525443183|FG000|Overall Study|Adverse Event|1|||
145706606|NCT01443923|525443184|FG001|Overall Study|Adverse Event|0|||
145706607|NCT01250509|525443187|FG000|Overall Study|Lost to Follow-up|5|||
145706608|NCT01250509|525443188|FG001|Overall Study|Lost to Follow-up|2|||
145706609|NCT02670122|525443189|FG000|Overall Study|Lost to Follow-up|4|||
145706610|NCT02762903|525443192|FG000|Overall Study|Lost to Follow-up|0|||
145706611|NCT02762903|525443193|FG001|Overall Study|Lost to Follow-up|1|||
145706612|NCT01228175|525443194|FG000|Overall Study|Lost to Follow-up|64|||
145706613|NCT01228175|525443195|FG001|Overall Study|Lost to Follow-up|50|||
145706614|NCT01228175|525443194|FG000|Overall Study|Withdrawal by Subject|1|||
145706615|NCT01228175|525443195|FG001|Overall Study|Withdrawal by Subject|2|||
145706616|NCT01228175|525443194|FG000|Overall Study|Physician Decision|1|||
145706617|NCT01228175|525443195|FG001|Overall Study|Physician Decision|1|||
145706618|NCT00108745|525443196|FG000|Overall Study|Withdrawal by Subject|19|||
145706619|NCT00108745|525443197|FG001|Overall Study|Withdrawal by Subject|12|||
145706620|NCT00108745|525443198|FG002|Overall Study|Withdrawal by Subject|12|||
145706621|NCT00108745|525443196|FG000|Overall Study|Never Treated|8|||
145706622|NCT00108745|525443197|FG001|Overall Study|Never Treated|10|||
145706623|NCT00108745|525443198|FG002|Overall Study|Never Treated|12|||
145706624|NCT00108745|525443196|FG000|Overall Study|Ineligible|7|||
145706625|NCT00108745|525443197|FG001|Overall Study|Ineligible|13|||
145706626|NCT00108745|525443198|FG002|Overall Study|Ineligible|13|||
145706627|NCT01889069|525443199|FG000|Overall Study|Death|18|||
145706628|NCT01889069|525443199|FG000|Overall Study|Progression of Disease|14|||
145706629|NCT01889069|525443199|FG000|Overall Study|Lost to Follow-up|6|||
145706630|NCT01889069|525443199|FG000|Overall Study|Other|4|||
145706631|NCT01889069|525443199|FG000|Overall Study|Consent Withdrawal|3|||
145706632|NCT00243074|525443203|FG000|Overall Study|Ineligible|6|||
145706633|NCT00243074|525443203|FG000|Overall Study|Adverse Event|6|||
145706634|NCT00243074|525443203|FG000|Overall Study|Withdrawal by Subject|2|||
145706635|NCT00243074|525443203|FG000|Overall Study|Lack of Efficacy|36|||
145706636|NCT00243074|525443203|FG000|Overall Study|Death|2|||
145706637|NCT00243074|525443203|FG000|Overall Study|not protocol specified|1|||
145706638|NCT00243074|525443203|FG000|Overall Study|Did not receive any treatment|1|||
145706639|NCT00664534|525443204|FG000|Overall Study|Adverse Event|2|||
145706640|NCT00664534|525443205|FG001|Overall Study|Adverse Event|3|||
145706641|NCT00664534|525443204|FG000|Overall Study|Lost to Follow-up|6|||
145706642|NCT00664534|525443205|FG001|Overall Study|Lost to Follow-up|10|||
145706643|NCT00664534|525443204|FG000|Overall Study|Protocol Violation|10|||
145706644|NCT00664534|525443205|FG001|Overall Study|Protocol Violation|8|||
145706645|NCT00664534|525443204|FG000|Overall Study|Withdrawal by Subject|7|||
145706646|NCT00664534|525443205|FG001|Overall Study|Withdrawal by Subject|6|||
145706647|NCT00664534|525443204|FG000|Overall Study|Physician Decision|8|||
145706648|NCT00664534|525443205|FG001|Overall Study|Physician Decision|0|||
145706649|NCT00664534|525443204|FG000|Overall Study|Sponsor decision|8|||
145706650|NCT00664534|525443205|FG001|Overall Study|Sponsor decision|6|||
145706651|NCT03041792|525443206|FG000|Overall Study|Adverse Event|4|||
145706652|NCT03041792|525443207|FG001|Overall Study|Adverse Event|0|||
145706653|NCT03041792|525443206|FG000|Overall Study|Death in the family|0|||
145706654|NCT03041792|525443207|FG001|Overall Study|Death in the family|2|||
145706655|NCT03041792|525443206|FG000|Overall Study|Randomized but not treated|0|||
145706656|NCT03041792|525443207|FG001|Overall Study|Randomized but not treated|1|||
145706657|NCT04978090|525443210|FG000|Overall Study|unable to adequately fit device|2|||
145706658|NCT02227992|525443213|FG000|Overall Study|Lost to Follow-up|1|||
145706659|NCT02227992|525443214|FG001|Overall Study|Lost to Follow-up|1|||
145706660|NCT00935532|525443217|FG000|Overall Study|Adverse Event|11|||
145706661|NCT00935532|525443218|FG001|Overall Study|Adverse Event|6|||
145706662|NCT00935532|525443217|FG000|Overall Study|Death|1|||
145706663|NCT00935532|525443218|FG001|Overall Study|Death|0|||
145706664|NCT00935532|525443217|FG000|Overall Study|Lost to Follow-up|1|||
145706665|NCT00935532|525443218|FG001|Overall Study|Lost to Follow-up|0|||
145706666|NCT00935532|525443217|FG000|Overall Study|Physician Decision|1|||
145706667|NCT00935532|525443218|FG001|Overall Study|Physician Decision|2|||
145706668|NCT00935532|525443217|FG000|Overall Study|Protocol Violation|2|||
145706669|NCT00935532|525443218|FG001|Overall Study|Protocol Violation|1|||
145706670|NCT00935532|525443217|FG000|Overall Study|Subject Decision|2|||
145706671|NCT00935532|525443218|FG001|Overall Study|Subject Decision|1|||
145706672|NCT00935532|525443217|FG000|Overall Study|Sponsor Decision|0|||
145706673|NCT00935532|525443218|FG001|Overall Study|Sponsor Decision|1|||
145706674|NCT00935532|525443217|FG000|Overall Study|Loss Glucose Control|4|||
145706675|NCT00935532|525443218|FG001|Overall Study|Loss Glucose Control|0|||
145706676|NCT01371708|525443223|FG000|Overall Study|Insufficient clinical response|3|||
145706677|NCT01371708|525443224|FG001|Overall Study|Insufficient clinical response|2|||
145706678|NCT01371708|525443225|FG002|Overall Study|Insufficient clinical response|0|||
145706679|NCT01371708|525443223|FG000|Overall Study|Lost to Follow-up|5|||
145706680|NCT01371708|525443224|FG001|Overall Study|Lost to Follow-up|9|||
145706681|NCT01371708|525443225|FG002|Overall Study|Lost to Follow-up|7|||
145706682|NCT01371708|525443223|FG000|Overall Study|Protocol Violation|2|||
145706683|NCT01371708|525443224|FG001|Overall Study|Protocol Violation|1|||
145706684|NCT01371708|525443225|FG002|Overall Study|Protocol Violation|2|||
145706685|NCT01371708|525443223|FG000|Overall Study|No longer willing to participate|7|||
145706686|NCT01371708|525443224|FG001|Overall Study|No longer willing to participate|7|||
145706687|NCT01371708|525443225|FG002|Overall Study|No longer willing to participate|13|||
145706688|NCT01371708|525443223|FG000|Overall Study|Medication error/not related to AE|0|||
145706689|NCT01371708|525443224|FG001|Overall Study|Medication error/not related to AE|1|||
145706690|NCT01371708|525443225|FG002|Overall Study|Medication error/not related to AE|0|||
145706691|NCT01371708|525443223|FG000|Overall Study|Other|3|||
145706692|NCT01371708|525443224|FG001|Overall Study|Other|2|||
145706693|NCT01371708|525443225|FG002|Overall Study|Other|4|||
145706694|NCT01371708|525443223|FG000|Overall Study|Adverse Event|5|||
145706695|NCT01371708|525443224|FG001|Overall Study|Adverse Event|8|||
145706696|NCT01371708|525443225|FG002|Overall Study|Adverse Event|12|||
145706697|NCT01371708|525443223|FG000|Overall Study|Started but did not receive treatment|1|||
145706698|NCT01371708|525443224|FG001|Overall Study|Started but did not receive treatment|0|||
145706699|NCT01371708|525443225|FG002|Overall Study|Started but did not receive treatment|1|||
145706700|NCT00402051|525443226|FG000|Overall Study|Progressive Disease|13|||
145706701|NCT00402051|525443227|FG001|Overall Study|Progressive Disease|20|||
145706702|NCT00402051|525443226|FG000|Overall Study|Adverse Event|11|||
145706703|NCT00402051|525443227|FG001|Overall Study|Adverse Event|4|||
145706704|NCT00402051|525443226|FG000|Overall Study|Physician Decision|7|||
145706705|NCT00402051|525443227|FG001|Overall Study|Physician Decision|3|||
145706706|NCT00402051|525443226|FG000|Overall Study|Withdrawal by Subject|3|||
145706707|NCT00402051|525443227|FG001|Overall Study|Withdrawal by Subject|3|||
145706708|NCT00402051|525443226|FG000|Overall Study|Death - Related to Study Drug|1|||
145706709|NCT00402051|525443227|FG001|Overall Study|Death - Related to Study Drug|2|||
145706710|NCT00402051|525443226|FG000|Overall Study|Death Due to Study Disease|2|||
145706711|NCT00402051|525443227|FG001|Overall Study|Death Due to Study Disease|1|||
145706712|NCT00402051|525443226|FG000|Overall Study|Death Due to Adverse Event|0|||
145706713|NCT00402051|525443227|FG001|Overall Study|Death Due to Adverse Event|2|||
145706714|NCT00402051|525443226|FG000|Overall Study|Lost to Follow-up|1|||
145706715|NCT00402051|525443227|FG001|Overall Study|Lost to Follow-up|0|||
145706716|NCT00996606|525443238|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
145706717|NCT00996606|525443238|FG000|Overall Study|Insufficient Therapeutic Response|2|||
145706718|NCT00996606|525443238|FG000|Overall Study|Protocol Violation|1|||
145706719|NCT00996606|525443238|FG000|Overall Study|Withdrawal by Subject|3|||
145706720|NCT00632502|525443240|FG000|Overall Study|Adverse Event|0|||
145706721|NCT00632502|525443241|FG001|Overall Study|Adverse Event|1|||
145706722|NCT00632502|525443240|FG000|Overall Study|Randomized not treated|3|||
145706723|NCT00632502|525443241|FG001|Overall Study|Randomized not treated|0|||
145706724|NCT04954326|525443242|FG000|Overall Study|Protocol Violation|0|||
145706725|NCT04954326|525443243|FG001|Overall Study|Protocol Violation|1|||
145706726|NCT04954326|525443242|FG000|Overall Study|Death|0|||
145706727|NCT04954326|525443243|FG001|Overall Study|Death|2|||
145706728|NCT04954326|525443242|FG000|Overall Study|Physician Decision|0|||
145377867|NCT03191864|524233636|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145377868|NCT03191864|524233637|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
145377869|NCT03191864|524233638|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145377870|NCT03191864|524233639|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
145377871|NCT03191864|524233640|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
145377872|NCT03191864|524233635|FG000|Part 1 - Induction|Adverse Event|0|||
145377873|NCT03191864|524233636|FG001|Part 1 - Induction|Adverse Event|2|||
145377874|NCT03191864|524233637|FG002|Part 1 - Induction|Adverse Event|0|||
145377875|NCT03191864|524233638|FG003|Part 1 - Induction|Adverse Event|1|||
145377876|NCT03191864|524233639|FG004|Part 1 - Induction|Adverse Event|0|||
145377877|NCT03191864|524233640|FG005|Part 1 - Induction|Adverse Event|2|||
145377878|NCT03191864|524233635|FG000|Part 1 - Induction|Randomized but never dosed|0|||
145706729|NCT04954326|525443243|FG001|Overall Study|Physician Decision|1|||
145706730|NCT01213524|525443244|FG000|Baseline|Withdrawal by Subject|5|||
145706731|NCT01213524|525443244|FG000|Baseline|high breath alcohol levels|1|||
145706732|NCT01213524|525443244|FG000|Baseline|Physician Decision|1|||
145706733|NCT01213524|525443244|FG000|Session 2|Withdrawal by Subject|5|||
145706734|NCT01213524|525443244|FG000|Session 3|Withdrawal by Subject|4|||
145706735|NCT01213524|525443244|FG000|Session 4|Physician Decision|1|||
145706736|NCT01213524|525443244|FG000|Session 4|Withdrawal by Subject|2|||
145706737|NCT02519348|525443248|FG000|Overall Study|Death|31|||
145706738|NCT02519348|525443249|FG001|Overall Study|Death|74|||
145706739|NCT02519348|525443250|FG002|Overall Study|Death|47|||
145706740|NCT02519348|525443251|FG003|Overall Study|Death|54|||
145706741|NCT02519348|525443252|FG004|Overall Study|Death|63|||
145706742|NCT02519348|525443253|FG005|Overall Study|Death|18|||
145706743|NCT02519348|525443254|FG006|Overall Study|Death|2|||
145706744|NCT02519348|525443255|FG007|Overall Study|Death|5|||
145706745|NCT02519348|525443256|FG008|Overall Study|Death|5|||
145706746|NCT02519348|525443248|FG000|Overall Study|Withdrawal by Subject|4|||
145706747|NCT02519348|525443249|FG001|Overall Study|Withdrawal by Subject|7|||
145706748|NCT02519348|525443250|FG002|Overall Study|Withdrawal by Subject|4|||
145706749|NCT02519348|525443251|FG003|Overall Study|Withdrawal by Subject|3|||
145706750|NCT02519348|525443252|FG004|Overall Study|Withdrawal by Subject|3|||
145706751|NCT02519348|525443253|FG005|Overall Study|Withdrawal by Subject|2|||
145706752|NCT02519348|525443254|FG006|Overall Study|Withdrawal by Subject|0|||
145706753|NCT02519348|525443255|FG007|Overall Study|Withdrawal by Subject|0|||
145706754|NCT02519348|525443256|FG008|Overall Study|Withdrawal by Subject|1|||
145706755|NCT02519348|525443248|FG000|Overall Study|Lost to Follow-up|0|||
145706756|NCT02519348|525443249|FG001|Overall Study|Lost to Follow-up|0|||
145706757|NCT02519348|525443250|FG002|Overall Study|Lost to Follow-up|1|||
145706758|NCT02519348|525443251|FG003|Overall Study|Lost to Follow-up|0|||
145706759|NCT02519348|525443252|FG004|Overall Study|Lost to Follow-up|2|||
145706760|NCT02519348|525443253|FG005|Overall Study|Lost to Follow-up|1|||
145706761|NCT02519348|525443254|FG006|Overall Study|Lost to Follow-up|1|||
145706762|NCT02519348|525443255|FG007|Overall Study|Lost to Follow-up|0|||
145706763|NCT02519348|525443256|FG008|Overall Study|Lost to Follow-up|0|||
145706764|NCT02519348|525443248|FG000|Overall Study|Other|0|||
145706765|NCT02519348|525443249|FG001|Overall Study|Other|3|||
145706766|NCT02519348|525443250|FG002|Overall Study|Other|0|||
145706767|NCT02519348|525443251|FG003|Overall Study|Other|0|||
145706768|NCT02519348|525443252|FG004|Overall Study|Other|1|||
145706769|NCT02519348|525443253|FG005|Overall Study|Other|0|||
145706770|NCT02519348|525443254|FG006|Overall Study|Other|0|||
145706771|NCT02519348|525443255|FG007|Overall Study|Other|0|||
145706772|NCT02519348|525443256|FG008|Overall Study|Other|0|||
145706773|NCT02519348|525443248|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
145706774|NCT02519348|525443249|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
145706775|NCT02519348|525443250|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
145706776|NCT02519348|525443251|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
145706777|NCT02519348|525443252|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
145706778|NCT02519348|525443253|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
145706779|NCT02519348|525443254|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
145706780|NCT02519348|525443255|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
145706781|NCT02519348|525443256|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
145706782|NCT05415748|525443260|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
145706783|NCT05415748|525443261|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
145706784|NCT05415748|525443262|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
145706785|NCT05415748|525443263|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
145706786|NCT05415748|525443260|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
145706787|NCT05415748|525443261|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
145706788|NCT05415748|525443262|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
145706789|NCT05415748|525443263|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
145706790|NCT03075527|525443264|FG000|Overall Study|Death|1|||
145706791|NCT03075527|525443264|FG000|Overall Study|Withdrawal by Subject|1|||
145706792|NCT03075527|525443264|FG000|Overall Study|Physician Decision|3|||
145706793|NCT03075527|525443264|FG000|Overall Study|Progression/Relapse|14|||
145706794|NCT00281320|525443267|FG000|Overall Study|Adverse Event|12|||
145706795|NCT00281320|525443268|FG001|Overall Study|Adverse Event|9|||
145706796|NCT00281320|525443267|FG000|Overall Study|Lack of Efficacy|4|||
145706797|NCT00281320|525443268|FG001|Overall Study|Lack of Efficacy|3|||
145706798|NCT00281320|525443267|FG000|Overall Study|Withdrawal by Subject|5|||
145706799|NCT00281320|525443268|FG001|Overall Study|Withdrawal by Subject|6|||
145706800|NCT00281320|525443267|FG000|Overall Study|Lost to Follow-up|1|||
145706801|NCT00281320|525443268|FG001|Overall Study|Lost to Follow-up|2|||
145706802|NCT00281320|525443267|FG000|Overall Study|Other|3|||
145706803|NCT00281320|525443268|FG001|Overall Study|Other|1|||
145706804|NCT03128671|525443271|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
145706805|NCT03128671|525443272|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
145706806|NCT03128671|525443271|FG000|Allocation|Death|1|||
145706807|NCT03128671|525443272|FG001|Allocation|Death|0|||
145706808|NCT03128671|525443271|FG000|Allocation|Withdrawal by Subject|4|||
145706809|NCT03128671|525443272|FG001|Allocation|Withdrawal by Subject|0|||
145706810|NCT03128671|525443271|FG000|Intervention|Withdrawal by Subject|11|||
145706811|NCT03128671|525443272|FG001|Intervention|Withdrawal by Subject|10|||
145706812|NCT03128671|525443271|FG000|Intervention|Palliative/hospice care initiated|9|||
145706813|NCT03128671|525443272|FG001|Intervention|Palliative/hospice care initiated|10|||
145706814|NCT03128671|525443271|FG000|Intervention|Death|13|||
145706815|NCT03128671|525443272|FG001|Intervention|Death|11|||
145706816|NCT03128671|525443271|FG000|Intervention|Interrupted by hurricane|1|||
145706817|NCT03128671|525443272|FG001|Intervention|Interrupted by hurricane|0|||
145706818|NCT03128671|525443271|FG000|Intervention|Physician Decision|2|||
145706819|NCT03128671|525443272|FG001|Intervention|Physician Decision|3|||
145706820|NCT03832595|525443277|FG000|Overall Study|Death|142|||
145706821|NCT03832595|525443278|FG001|Overall Study|Death|130|||
145706822|NCT03832595|525443277|FG000|Overall Study|Medical management without dialysis|37|||
145706823|NCT03832595|525443278|FG001|Overall Study|Medical management without dialysis|1|||
145706824|NCT03277352|525443279|FG000|Overall Study|Study Terminated By Sponsor|2|||
145706825|NCT03277352|525443279|FG000|Overall Study|Withdrawal by Subject|4|||
145706826|NCT03277352|525443279|FG000|Overall Study|Death|4|||
145706827|NCT04147195|525443280|FG000|Overall Study|Adverse Event|0|||
145706828|NCT04147195|525443281|FG001|Overall Study|Adverse Event|3|||
145706829|NCT04147195|525443280|FG000|Overall Study|Study Terminated by Sponsor|4|||
145706830|NCT04147195|525443281|FG001|Overall Study|Study Terminated by Sponsor|2|||
145706831|NCT04147195|525443280|FG000|Overall Study|Withdrawal by Subject|0|||
145706832|NCT04147195|525443281|FG001|Overall Study|Withdrawal by Subject|1|||
145706833|NCT03939689|525445254|FG000|Overall Study|Radiographic progression|14|||
145706834|NCT03939689|525445255|FG001|Overall Study|Radiographic progression|17|||
145706835|NCT03939689|525445254|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
145706836|NCT03939689|525445255|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
145706837|NCT03939689|525445254|FG000|Overall Study|Adverse Event|1|||
145706838|NCT03939689|525445255|FG001|Overall Study|Adverse Event|8|||
145706839|NCT03939689|525445254|FG000|Overall Study|Unequivocal clinical progression|2|||
145706840|NCT03939689|525445255|FG001|Overall Study|Unequivocal clinical progression|5|||
145706841|NCT03939689|525445254|FG000|Overall Study|Other|1|||
145706842|NCT03939689|525445255|FG001|Overall Study|Other|4|||
145706843|NCT03939689|525445254|FG000|Overall Study|Death|0|||
145706844|NCT03939689|525445255|FG001|Overall Study|Death|3|||
145706845|NCT03939689|525445254|FG000|Overall Study|Participant decision|0|||
145706846|NCT03939689|525445255|FG001|Overall Study|Participant decision|3|||
145706847|NCT03939689|525445254|FG000|Overall Study|Withdrawal of consent|2|||
145706848|NCT03939689|525445255|FG001|Overall Study|Withdrawal of consent|1|||
145706849|NCT03939689|525445254|FG000|Overall Study|Investigator decision|1|||
145706850|NCT03939689|525445255|FG001|Overall Study|Investigator decision|0|||
145706851|NCT04427280|525445256|FG000|Overall Study|Withdrawal by Subject|0|||
145706852|NCT04427280|525445257|FG001|Overall Study|Withdrawal by Subject|2|||
145706853|NCT01667926|525445268|FG000|Overall Study|Withdrawal by Subject|1|||
145706854|NCT01667926|525445269|FG001|Overall Study|Withdrawal by Subject|2|||
145706855|NCT01667926|525445270|FG002|Overall Study|Withdrawal by Subject|2|||
145706856|NCT01667926|525445268|FG000|Overall Study|Physician Decision|0|||
145706857|NCT01667926|525445269|FG001|Overall Study|Physician Decision|0|||
145706858|NCT01667926|525445270|FG002|Overall Study|Physician Decision|1|||
145706859|NCT01667926|525445268|FG000|Overall Study|Time committment|0|||
145706860|NCT01667926|525445269|FG001|Overall Study|Time committment|0|||
145706861|NCT01667926|525445270|FG002|Overall Study|Time committment|2|||
145706862|NCT01667926|525445268|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
145706863|NCT01667926|525445269|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
145706864|NCT01667926|525445270|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
145706865|NCT01667926|525445268|FG000|Overall Study|Lost to Follow-up|1|||
145706866|NCT01667926|525445269|FG001|Overall Study|Lost to Follow-up|2|||
145706867|NCT01667926|525445270|FG002|Overall Study|Lost to Follow-up|1|||
145706868|NCT01667926|525445268|FG000|Overall Study|Side effects|3|||
145706869|NCT01667926|525445269|FG001|Overall Study|Side effects|0|||
145706870|NCT01667926|525445270|FG002|Overall Study|Side effects|0|||
145706871|NCT02271984|525445271|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706872|NCT02271984|525445272|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706873|NCT02271984|525445273|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706874|NCT02271984|525445274|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706875|NCT02271984|525445275|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706876|NCT02271984|525445276|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
145706877|NCT02271984|525445277|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706878|NCT02271984|525445278|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
145706879|NCT02271984|525445279|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706880|NCT02271984|525445280|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706881|NCT02271984|525445281|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706882|NCT02271984|525445282|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
145706883|NCT01228318|525445287|FG000|Overall Study|Clinic no show to receive intervention|1|||
145706884|NCT01228318|525445288|FG001|Overall Study|Clinic no show to receive intervention|0|||
145706885|NCT01228318|525445287|FG000|Overall Study|Unable to contact|2|||
145706886|NCT01228318|525445288|FG001|Overall Study|Unable to contact|5|||
145706887|NCT01228318|525445287|FG000|Overall Study|Moved|0|||
145706888|NCT01228318|525445288|FG001|Overall Study|Moved|2|||
145706889|NCT01228318|525445287|FG000|Overall Study|Incarcerated|1|||
145706890|NCT01228318|525445288|FG001|Overall Study|Incarcerated|0|||
145706891|NCT00770029|525445293|FG000|Overall Study|Lost to Follow-up|2|||
145706892|NCT00770029|525445294|FG001|Overall Study|Lost to Follow-up|0|||
145706893|NCT00770029|525445293|FG000|Overall Study|Withdrawal by Subject|3|||
145706894|NCT00770029|525445294|FG001|Overall Study|Withdrawal by Subject|3|||
145706895|NCT00770029|525445293|FG000|Overall Study|Adverse Event|1|||
145706896|NCT00770029|525445294|FG001|Overall Study|Adverse Event|0|||
145706897|NCT04996004|525445295|FG000|Phase I|Death|1|||
145706898|NCT04996004|525445296|FG001|Phase I|Death|2|||
145706899|NCT04996004|525445297|FG002|Phase I|Death|1|||
145706900|NCT04996004|525445298|FG003|Phase I|Death|0|||
145706901|NCT04996004|525445299|FG004|Phase I|Death|0|||
145706902|NCT04996004|525445300|FG005|Phase I|Death|0|||
145706903|NCT04996004|525445295|FG000|Phase I|Study terminated by sponsor|2|||
145706904|NCT04996004|525445296|FG001|Phase I|Study terminated by sponsor|1|||
145706905|NCT04996004|525445297|FG002|Phase I|Study terminated by sponsor|2|||
145706906|NCT04996004|525445298|FG003|Phase I|Study terminated by sponsor|0|||
145706907|NCT04996004|525445299|FG004|Phase I|Study terminated by sponsor|0|||
145706908|NCT04996004|525445300|FG005|Phase I|Study terminated by sponsor|0|||
145706909|NCT04996004|525445295|FG000|Phase II|Study terminated by sponsor|0|||
145706910|NCT04996004|525445296|FG001|Phase II|Study terminated by sponsor|0|||
145706911|NCT04996004|525445297|FG002|Phase II|Study terminated by sponsor|0|||
145706912|NCT04996004|525445298|FG003|Phase II|Study terminated by sponsor|20|||
145706913|NCT04996004|525445299|FG004|Phase II|Study terminated by sponsor|10|||
145706914|NCT04996004|525445300|FG005|Phase II|Study terminated by sponsor|10|||
145706915|NCT04996004|525445295|FG000|Phase II|Withdrawal by Subject|0|||
145706916|NCT04996004|525445296|FG001|Phase II|Withdrawal by Subject|0|||
145706917|NCT04996004|525445297|FG002|Phase II|Withdrawal by Subject|0|||
145706918|NCT04996004|525445298|FG003|Phase II|Withdrawal by Subject|0|||
145706919|NCT04996004|525445299|FG004|Phase II|Withdrawal by Subject|1|||
145706920|NCT04996004|525445300|FG005|Phase II|Withdrawal by Subject|2|||
145706921|NCT04996004|525445295|FG000|Phase II|Death|0|||
145706922|NCT04996004|525445296|FG001|Phase II|Death|0|||
145706923|NCT04996004|525445297|FG002|Phase II|Death|0|||
145706924|NCT04996004|525445298|FG003|Phase II|Death|12|||
145706925|NCT04996004|525445299|FG004|Phase II|Death|2|||
145706926|NCT04996004|525445300|FG005|Phase II|Death|9|||
145706927|NCT04996004|525445295|FG000|Phase II|Other|0|||
145706928|NCT04996004|525445296|FG001|Phase II|Other|0|||
145706929|NCT04996004|525445297|FG002|Phase II|Other|0|||
145706930|NCT04996004|525445298|FG003|Phase II|Other|0|||
145706931|NCT04996004|525445299|FG004|Phase II|Other|0|||
145706932|NCT04996004|525445300|FG005|Phase II|Other|1|||
145706933|NCT05620108|525445301|FG000|Overall Study|Physician Decision|1|||
145706934|NCT05620108|525445302|FG001|Overall Study|Physician Decision|2|||
145706935|NCT02038842|525445303|FG000|Overall Study|Withdrawal by Subject|2|||
145706936|NCT02038842|525445304|FG001|Overall Study|Withdrawal by Subject|2|||
145706937|NCT02038842|525445305|FG002|Overall Study|Withdrawal by Subject|0|||
145706938|NCT02038842|525445306|FG003|Overall Study|Withdrawal by Subject|0|||
145706939|NCT02038842|525445303|FG000|Overall Study|Participant decision|0|||
145706940|NCT02038842|525445304|FG001|Overall Study|Participant decision|0|||
145706941|NCT02038842|525445305|FG002|Overall Study|Participant decision|2|||
145706942|NCT02038842|525445306|FG003|Overall Study|Participant decision|1|||
145706943|NCT02038842|525445303|FG000|Overall Study|Adverse Event|0|||
145706944|NCT02038842|525445304|FG001|Overall Study|Adverse Event|0|||
145706945|NCT02038842|525445305|FG002|Overall Study|Adverse Event|3|||
145706946|NCT02038842|525445306|FG003|Overall Study|Adverse Event|1|||
145706947|NCT02038842|525445303|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
145706948|NCT02038842|525445304|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
145706949|NCT02038842|525445305|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
145706950|NCT02038842|525445306|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
145706951|NCT01757197|525445309|FG000|Overall Study|Death|2|||
145706952|NCT05332912|525445310|FG000|Overall Study|Withdrawal by Subject|0|||
145706953|NCT05332912|525445311|FG001|Overall Study|Withdrawal by Subject|1|||
145706954|NCT05332912|525445312|FG002|Overall Study|Withdrawal by Subject|2|||
145706955|NCT05332912|525445313|FG003|Overall Study|Withdrawal by Subject|0|||
145706956|NCT05332912|525445310|FG000|Overall Study|Lost to Follow-up|0|||
145706957|NCT05332912|525445311|FG001|Overall Study|Lost to Follow-up|0|||
145706958|NCT05332912|525445312|FG002|Overall Study|Lost to Follow-up|1|||
145706959|NCT05332912|525445313|FG003|Overall Study|Lost to Follow-up|0|||
145706960|NCT02088957|525445314|FG000|Overall Study|Lack of Efficacy|1|||
145706961|NCT02088957|525445315|FG001|Overall Study|Lack of Efficacy|0|||
145706962|NCT01923662|525445316|FG000|Overall Study|Withdrawal by Subject|1|||
145706963|NCT00667394|525445317|FG000|Overall Study|Adverse Event|3|||
145706964|NCT00667394|525445318|FG001|Overall Study|Adverse Event|0|||
145706965|NCT00667394|525445317|FG000|Overall Study|Progressive disease|1|||
145706966|NCT00667394|525445318|FG001|Overall Study|Progressive disease|0|||
145706967|NCT05000216|525445320|FG000|Stage 1|Lost to Follow-up|0|||
145706968|NCT05000216|525445321|FG001|Stage 1|Lost to Follow-up|0|||
145706969|NCT05000216|525445322|FG002|Stage 1|Lost to Follow-up|0|||
145706970|NCT05000216|525445323|FG003|Stage 1|Lost to Follow-up|0|||
145706971|NCT05000216|525445324|FG004|Stage 1|Lost to Follow-up|0|||
145706972|NCT05000216|525445325|FG005|Stage 1|Lost to Follow-up|0|||
145706973|NCT05000216|525445326|FG006|Stage 1|Lost to Follow-up|1|||
145706974|NCT05000216|525445327|FG007|Stage 1|Lost to Follow-up|1|||
145706975|NCT05000216|525445328|FG008|Stage 1|Lost to Follow-up|0|||
145706976|NCT05000216|525445329|FG009|Stage 1|Lost to Follow-up|2|||
145706977|NCT05000216|525445330|FG010|Stage 1|Lost to Follow-up|3|||
145706978|NCT05000216|525445331|FG011|Stage 1|Lost to Follow-up|0|||
145706979|NCT05000216|525445332|FG012|Stage 1|Lost to Follow-up|0|||
145706980|NCT05000216|525445333|FG013|Stage 1|Lost to Follow-up|0|||
145706981|NCT05000216|525445334|FG014|Stage 1|Lost to Follow-up|0|||
145706982|NCT05000216|525445335|FG015|Stage 1|Lost to Follow-up|0|||
145706983|NCT05000216|525445336|FG016|Stage 1|Lost to Follow-up|0|||
145706984|NCT05000216|525445337|FG017|Stage 1|Lost to Follow-up|0|||
145706985|NCT05000216|525445338|FG018|Stage 1|Lost to Follow-up|0|||
145706986|NCT05000216|525445339|FG019|Stage 1|Lost to Follow-up|0|||
145706987|NCT05000216|525445340|FG020|Stage 1|Lost to Follow-up|0|||
145706988|NCT05000216|525445341|FG021|Stage 1|Lost to Follow-up|0|||
145706989|NCT05000216|525445320|FG000|Stage 1|Physician Decision|0|||
145706990|NCT05000216|525445321|FG001|Stage 1|Physician Decision|0|||
145706991|NCT05000216|525445322|FG002|Stage 1|Physician Decision|0|||
145706992|NCT05000216|525445323|FG003|Stage 1|Physician Decision|0|||
145706993|NCT05000216|525445324|FG004|Stage 1|Physician Decision|0|||
145706994|NCT05000216|525445325|FG005|Stage 1|Physician Decision|0|||
145706995|NCT05000216|525445326|FG006|Stage 1|Physician Decision|0|||
145706996|NCT05000216|525445327|FG007|Stage 1|Physician Decision|1|||
145706997|NCT05000216|525445328|FG008|Stage 1|Physician Decision|1|||
145706998|NCT05000216|525445329|FG009|Stage 1|Physician Decision|0|||
145706999|NCT05000216|525445330|FG010|Stage 1|Physician Decision|0|||
145707000|NCT05000216|525445331|FG011|Stage 1|Physician Decision|0|||
145707001|NCT05000216|525445332|FG012|Stage 1|Physician Decision|0|||
145707002|NCT05000216|525445333|FG013|Stage 1|Physician Decision|0|||
145707003|NCT05000216|525445334|FG014|Stage 1|Physician Decision|0|||
145707004|NCT05000216|525445335|FG015|Stage 1|Physician Decision|0|||
145707005|NCT05000216|525445336|FG016|Stage 1|Physician Decision|0|||
145707006|NCT05000216|525445337|FG017|Stage 1|Physician Decision|0|||
145707007|NCT05000216|525445338|FG018|Stage 1|Physician Decision|0|||
145707008|NCT05000216|525445339|FG019|Stage 1|Physician Decision|0|||
145707009|NCT05000216|525445340|FG020|Stage 1|Physician Decision|0|||
145707010|NCT05000216|525445341|FG021|Stage 1|Physician Decision|0|||
145707011|NCT05000216|525445320|FG000|Stage 1|Withdrawal by Subject|0|||
145707012|NCT05000216|525445321|FG001|Stage 1|Withdrawal by Subject|1|||
145707013|NCT05000216|525445322|FG002|Stage 1|Withdrawal by Subject|0|||
145707014|NCT05000216|525445323|FG003|Stage 1|Withdrawal by Subject|0|||
145707015|NCT05000216|525445324|FG004|Stage 1|Withdrawal by Subject|0|||
145707016|NCT05000216|525445325|FG005|Stage 1|Withdrawal by Subject|0|||
145707017|NCT05000216|525445326|FG006|Stage 1|Withdrawal by Subject|0|||
145707018|NCT05000216|525445327|FG007|Stage 1|Withdrawal by Subject|0|||
145707019|NCT05000216|525445328|FG008|Stage 1|Withdrawal by Subject|0|||
145707020|NCT05000216|525445329|FG009|Stage 1|Withdrawal by Subject|3|||
145707021|NCT05000216|525445330|FG010|Stage 1|Withdrawal by Subject|10|||
145707022|NCT05000216|525445331|FG011|Stage 1|Withdrawal by Subject|0|||
145707023|NCT05000216|525445332|FG012|Stage 1|Withdrawal by Subject|0|||
145707024|NCT05000216|525445333|FG013|Stage 1|Withdrawal by Subject|0|||
145707025|NCT05000216|525445334|FG014|Stage 1|Withdrawal by Subject|0|||
145707026|NCT05000216|525445335|FG015|Stage 1|Withdrawal by Subject|0|||
145707027|NCT05000216|525445336|FG016|Stage 1|Withdrawal by Subject|0|||
145707028|NCT05000216|525445337|FG017|Stage 1|Withdrawal by Subject|0|||
145707029|NCT05000216|525445338|FG018|Stage 1|Withdrawal by Subject|0|||
145707030|NCT05000216|525445339|FG019|Stage 1|Withdrawal by Subject|0|||
145707031|NCT05000216|525445340|FG020|Stage 1|Withdrawal by Subject|0|||
145491446|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
145707032|NCT05000216|525445341|FG021|Stage 1|Withdrawal by Subject|0|||
145707033|NCT05000216|525445320|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
145707034|NCT05000216|525445321|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
145707035|NCT05000216|525445322|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
145707036|NCT05000216|525445323|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
145707037|NCT05000216|525445324|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
145707038|NCT05000216|525445325|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
145707039|NCT05000216|525445326|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
145707040|NCT05000216|525445327|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
145707041|NCT05000216|525445328|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
145707042|NCT05000216|525445329|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
145707043|NCT05000216|525445330|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
145707044|NCT05000216|525445331|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
145707045|NCT05000216|525445332|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
145707046|NCT05000216|525445333|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
145707047|NCT05000216|525445334|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
145707048|NCT05000216|525445335|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
145707049|NCT05000216|525445336|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
145707050|NCT05000216|525445337|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
145707051|NCT05000216|525445338|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
145707052|NCT05000216|525445339|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
145707053|NCT05000216|525445340|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
145707054|NCT05000216|525445341|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
145707055|NCT05000216|525445320|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707056|NCT05000216|525445321|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707057|NCT05000216|525445322|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707058|NCT05000216|525445323|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707059|NCT05000216|525445324|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707060|NCT05000216|525445325|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707061|NCT05000216|525445326|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707062|NCT05000216|525445327|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707063|NCT05000216|525445328|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
145707064|NCT05000216|525445329|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707065|NCT05000216|525445330|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707066|NCT05000216|525445331|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707067|NCT05000216|525445332|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707068|NCT05000216|525445333|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707069|NCT05000216|525445334|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707070|NCT05000216|525445335|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707071|NCT05000216|525445336|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707072|NCT05000216|525445337|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707073|NCT05000216|525445338|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707074|NCT05000216|525445339|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707075|NCT05000216|525445340|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707076|NCT05000216|525445341|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
145707077|NCT05000216|525445320|FG000|Stage 1|Other|0|||
145707078|NCT05000216|525445321|FG001|Stage 1|Other|0|||
145707079|NCT05000216|525445322|FG002|Stage 1|Other|0|||
145707080|NCT05000216|525445323|FG003|Stage 1|Other|0|||
145707081|NCT05000216|525445324|FG004|Stage 1|Other|1|||
145707082|NCT05000216|525445325|FG005|Stage 1|Other|0|||
145707083|NCT05000216|525445326|FG006|Stage 1|Other|0|||
145707084|NCT05000216|525445327|FG007|Stage 1|Other|2|||
145707085|NCT05000216|525445328|FG008|Stage 1|Other|0|||
145707086|NCT05000216|525445329|FG009|Stage 1|Other|0|||
145707087|NCT05000216|525445330|FG010|Stage 1|Other|1|||
145707088|NCT05000216|525445331|FG011|Stage 1|Other|1|||
145707089|NCT05000216|525445332|FG012|Stage 1|Other|0|||
145707090|NCT05000216|525445333|FG013|Stage 1|Other|0|||
145707091|NCT05000216|525445334|FG014|Stage 1|Other|0|||
145707092|NCT05000216|525445335|FG015|Stage 1|Other|0|||
145707093|NCT05000216|525445336|FG016|Stage 1|Other|0|||
145707094|NCT05000216|525445337|FG017|Stage 1|Other|0|||
145707095|NCT05000216|525445338|FG018|Stage 1|Other|0|||
145707096|NCT05000216|525445339|FG019|Stage 1|Other|0|||
145707097|NCT05000216|525445340|FG020|Stage 1|Other|0|||
145707098|NCT05000216|525445341|FG021|Stage 1|Other|0|||
145707099|NCT05000216|525445320|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
145707100|NCT05000216|525445321|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
145707101|NCT05000216|525445322|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
145707102|NCT05000216|525445323|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
145707103|NCT05000216|525445324|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
145707104|NCT05000216|525445325|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
145707105|NCT05000216|525445326|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
145707106|NCT05000216|525445327|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
145707107|NCT05000216|525445328|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
145707108|NCT05000216|525445329|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
145707109|NCT05000216|525445330|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
145707110|NCT05000216|525445331|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
145707111|NCT05000216|525445332|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
145707112|NCT05000216|525445333|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
145707113|NCT05000216|525445334|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
145707114|NCT05000216|525445335|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
145707115|NCT05000216|525445336|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
145707116|NCT05000216|525445337|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
145707117|NCT05000216|525445338|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
145707118|NCT05000216|525445339|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
145707119|NCT05000216|525445340|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
145707120|NCT05000216|525445341|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
145707121|NCT05000216|525445320|FG000|Stage 2|Lost to Follow-up|0|||
145707122|NCT05000216|525445321|FG001|Stage 2|Lost to Follow-up|0|||
145707123|NCT05000216|525445322|FG002|Stage 2|Lost to Follow-up|0|||
145707124|NCT05000216|525445323|FG003|Stage 2|Lost to Follow-up|0|||
145707125|NCT05000216|525445324|FG004|Stage 2|Lost to Follow-up|0|||
145707126|NCT05000216|525445325|FG005|Stage 2|Lost to Follow-up|0|||
145707127|NCT05000216|525445326|FG006|Stage 2|Lost to Follow-up|0|||
145707128|NCT05000216|525445327|FG007|Stage 2|Lost to Follow-up|0|||
145707129|NCT05000216|525445328|FG008|Stage 2|Lost to Follow-up|0|||
145707130|NCT05000216|525445329|FG009|Stage 2|Lost to Follow-up|0|||
145707131|NCT05000216|525445330|FG010|Stage 2|Lost to Follow-up|0|||
145707132|NCT05000216|525445331|FG011|Stage 2|Lost to Follow-up|0|||
145707133|NCT05000216|525445332|FG012|Stage 2|Lost to Follow-up|0|||
145707134|NCT05000216|525445333|FG013|Stage 2|Lost to Follow-up|0|||
145707135|NCT05000216|525445334|FG014|Stage 2|Lost to Follow-up|0|||
145707136|NCT05000216|525445335|FG015|Stage 2|Lost to Follow-up|0|||
145707137|NCT05000216|525445336|FG016|Stage 2|Lost to Follow-up|4|||
145707138|NCT05000216|525445337|FG017|Stage 2|Lost to Follow-up|0|||
145707139|NCT05000216|525445338|FG018|Stage 2|Lost to Follow-up|0|||
145707140|NCT05000216|525445339|FG019|Stage 2|Lost to Follow-up|0|||
145707141|NCT05000216|525445340|FG020|Stage 2|Lost to Follow-up|0|||
145707142|NCT05000216|525445341|FG021|Stage 2|Lost to Follow-up|0|||
145707143|NCT05000216|525445320|FG000|Stage 2|Physician Decision|0|||
145707144|NCT05000216|525445321|FG001|Stage 2|Physician Decision|0|||
145707145|NCT05000216|525445322|FG002|Stage 2|Physician Decision|0|||
145707146|NCT05000216|525445323|FG003|Stage 2|Physician Decision|0|||
145707147|NCT05000216|525445324|FG004|Stage 2|Physician Decision|0|||
145707148|NCT05000216|525445325|FG005|Stage 2|Physician Decision|0|||
145707149|NCT05000216|525445326|FG006|Stage 2|Physician Decision|0|||
145707150|NCT05000216|525445327|FG007|Stage 2|Physician Decision|0|||
145707151|NCT05000216|525445328|FG008|Stage 2|Physician Decision|0|||
145707152|NCT05000216|525445329|FG009|Stage 2|Physician Decision|0|||
145707153|NCT05000216|525445330|FG010|Stage 2|Physician Decision|0|||
145707154|NCT05000216|525445331|FG011|Stage 2|Physician Decision|0|||
145707155|NCT05000216|525445332|FG012|Stage 2|Physician Decision|1|||
145707156|NCT05000216|525445333|FG013|Stage 2|Physician Decision|0|||
145707157|NCT05000216|525445334|FG014|Stage 2|Physician Decision|0|||
145707158|NCT05000216|525445335|FG015|Stage 2|Physician Decision|0|||
145707159|NCT05000216|525445336|FG016|Stage 2|Physician Decision|0|||
145707160|NCT05000216|525445337|FG017|Stage 2|Physician Decision|0|||
145707161|NCT05000216|525445338|FG018|Stage 2|Physician Decision|0|||
145707162|NCT05000216|525445339|FG019|Stage 2|Physician Decision|0|||
145707163|NCT05000216|525445340|FG020|Stage 2|Physician Decision|0|||
145707164|NCT05000216|525445341|FG021|Stage 2|Physician Decision|0|||
145707165|NCT05000216|525445320|FG000|Stage 2|Withdrawal by Subject|0|||
145707166|NCT05000216|525445321|FG001|Stage 2|Withdrawal by Subject|0|||
145707167|NCT05000216|525445322|FG002|Stage 2|Withdrawal by Subject|0|||
145707168|NCT05000216|525445323|FG003|Stage 2|Withdrawal by Subject|0|||
145707169|NCT05000216|525445324|FG004|Stage 2|Withdrawal by Subject|0|||
145707170|NCT05000216|525445325|FG005|Stage 2|Withdrawal by Subject|0|||
145707171|NCT05000216|525445326|FG006|Stage 2|Withdrawal by Subject|0|||
145707172|NCT05000216|525445327|FG007|Stage 2|Withdrawal by Subject|0|||
145707173|NCT05000216|525445328|FG008|Stage 2|Withdrawal by Subject|0|||
145707174|NCT05000216|525445329|FG009|Stage 2|Withdrawal by Subject|0|||
145707175|NCT05000216|525445330|FG010|Stage 2|Withdrawal by Subject|0|||
145707176|NCT05000216|525445331|FG011|Stage 2|Withdrawal by Subject|0|||
145707177|NCT05000216|525445332|FG012|Stage 2|Withdrawal by Subject|0|||
145707178|NCT05000216|525445333|FG013|Stage 2|Withdrawal by Subject|0|||
145707179|NCT05000216|525445334|FG014|Stage 2|Withdrawal by Subject|2|||
145707180|NCT05000216|525445335|FG015|Stage 2|Withdrawal by Subject|0|||
145707181|NCT05000216|525445336|FG016|Stage 2|Withdrawal by Subject|9|||
145707182|NCT05000216|525445337|FG017|Stage 2|Withdrawal by Subject|0|||
145707183|NCT05000216|525445338|FG018|Stage 2|Withdrawal by Subject|0|||
145707184|NCT05000216|525445339|FG019|Stage 2|Withdrawal by Subject|0|||
145707185|NCT05000216|525445340|FG020|Stage 2|Withdrawal by Subject|0|||
145707186|NCT05000216|525445341|FG021|Stage 2|Withdrawal by Subject|0|||
145707187|NCT05000216|525445320|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
145707188|NCT05000216|525445321|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
145707189|NCT05000216|525445322|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
145707190|NCT05000216|525445323|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
145707191|NCT05000216|525445324|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
145707192|NCT05000216|525445325|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
145707193|NCT05000216|525445326|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
145707194|NCT05000216|525445327|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
145707195|NCT05000216|525445328|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
145707196|NCT05000216|525445329|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
145707197|NCT05000216|525445330|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
145707198|NCT05000216|525445331|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
145707199|NCT05000216|525445332|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
145707200|NCT05000216|525445333|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
145707201|NCT05000216|525445334|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
145707202|NCT05000216|525445335|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
145707203|NCT05000216|525445336|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
145707204|NCT05000216|525445337|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
145707205|NCT05000216|525445338|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
145707206|NCT05000216|525445339|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
145707207|NCT05000216|525445340|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
145707208|NCT05000216|525445341|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
145707209|NCT05000216|525445320|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707210|NCT05000216|525445321|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707211|NCT05000216|525445322|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707212|NCT05000216|525445323|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707213|NCT05000216|525445324|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707214|NCT05000216|525445325|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707215|NCT05000216|525445326|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707216|NCT05000216|525445327|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707217|NCT05000216|525445328|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707218|NCT05000216|525445329|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707219|NCT05000216|525445330|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707220|NCT05000216|525445331|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707221|NCT05000216|525445332|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707222|NCT05000216|525445333|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707223|NCT05000216|525445334|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
145707224|NCT05000216|525445335|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707225|NCT05000216|525445336|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
145707226|NCT05000216|525445337|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707227|NCT05000216|525445338|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707228|NCT05000216|525445339|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707229|NCT05000216|525445340|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707230|NCT05000216|525445341|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
145707231|NCT05000216|525445320|FG000|Stage 2|Other reason|0|||
145707232|NCT05000216|525445321|FG001|Stage 2|Other reason|0|||
145707233|NCT05000216|525445322|FG002|Stage 2|Other reason|0|||
145707234|NCT05000216|525445323|FG003|Stage 2|Other reason|0|||
145707235|NCT05000216|525445324|FG004|Stage 2|Other reason|0|||
145707236|NCT05000216|525445325|FG005|Stage 2|Other reason|0|||
145707237|NCT05000216|525445326|FG006|Stage 2|Other reason|0|||
145707238|NCT05000216|525445327|FG007|Stage 2|Other reason|0|||
145707239|NCT05000216|525445328|FG008|Stage 2|Other reason|0|||
145707240|NCT05000216|525445329|FG009|Stage 2|Other reason|0|||
145707241|NCT05000216|525445330|FG010|Stage 2|Other reason|0|||
145707242|NCT05000216|525445331|FG011|Stage 2|Other reason|0|||
145707243|NCT05000216|525445332|FG012|Stage 2|Other reason|0|||
145707244|NCT05000216|525445333|FG013|Stage 2|Other reason|0|||
145707245|NCT05000216|525445334|FG014|Stage 2|Other reason|0|||
145707246|NCT05000216|525445335|FG015|Stage 2|Other reason|0|||
145707247|NCT05000216|525445336|FG016|Stage 2|Other reason|1|||
145707248|NCT05000216|525445337|FG017|Stage 2|Other reason|0|||
145707249|NCT05000216|525445338|FG018|Stage 2|Other reason|0|||
145707250|NCT05000216|525445339|FG019|Stage 2|Other reason|0|||
145707251|NCT05000216|525445340|FG020|Stage 2|Other reason|0|||
145707252|NCT05000216|525445341|FG021|Stage 2|Other reason|0|||
145707253|NCT05000216|525445320|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
145707254|NCT05000216|525445321|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
145707255|NCT05000216|525445322|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
145707256|NCT05000216|525445323|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
145707257|NCT05000216|525445324|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
145707258|NCT05000216|525445325|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
145707259|NCT05000216|525445326|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
145707260|NCT05000216|525445327|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
145707261|NCT05000216|525445328|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
145707262|NCT05000216|525445329|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
145707263|NCT05000216|525445330|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
145707264|NCT05000216|525445331|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
145707265|NCT05000216|525445332|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
145707266|NCT05000216|525445333|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
145707267|NCT05000216|525445334|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
145707268|NCT05000216|525445335|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
145707269|NCT05000216|525445336|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
145707270|NCT05000216|525445337|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
145707271|NCT05000216|525445338|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
145707272|NCT05000216|525445339|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
145707273|NCT05000216|525445340|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
145707274|NCT05000216|525445341|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
145707275|NCT05000216|525445320|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707276|NCT05000216|525445321|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707277|NCT05000216|525445322|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707278|NCT05000216|525445323|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707279|NCT05000216|525445324|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707280|NCT05000216|525445325|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707281|NCT05000216|525445326|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707282|NCT05000216|525445327|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707283|NCT05000216|525445328|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707284|NCT05000216|525445329|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707285|NCT05000216|525445330|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707286|NCT05000216|525445331|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707287|NCT05000216|525445332|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707288|NCT05000216|525445333|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707289|NCT05000216|525445334|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707290|NCT05000216|525445335|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
145707291|NCT05000216|525445336|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707292|NCT05000216|525445337|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707293|NCT05000216|525445338|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707294|NCT05000216|525445339|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707295|NCT05000216|525445340|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707296|NCT05000216|525445341|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
145707297|NCT05000216|525445320|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707298|NCT05000216|525445321|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707299|NCT05000216|525445322|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707300|NCT05000216|525445323|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707301|NCT05000216|525445324|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707302|NCT05000216|525445325|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707303|NCT05000216|525445326|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707304|NCT05000216|525445327|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707305|NCT05000216|525445328|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707306|NCT05000216|525445329|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707307|NCT05000216|525445330|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707308|NCT05000216|525445331|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707309|NCT05000216|525445332|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707310|NCT05000216|525445333|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
145707311|NCT05000216|525445334|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707312|NCT05000216|525445335|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
145707313|NCT05000216|525445336|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707314|NCT05000216|525445337|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707315|NCT05000216|525445338|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
145707316|NCT05000216|525445339|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707317|NCT05000216|525445340|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707318|NCT05000216|525445341|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
145707319|NCT04638660|525445342|FG000|Overall Study|Withdrawal by Subject|2|||
145707320|NCT04638660|525445343|FG001|Overall Study|Withdrawal by Subject|0|||
145707321|NCT04638660|525445342|FG000|Overall Study|Lost to Follow-up|1|||
145707322|NCT04638660|525445343|FG001|Overall Study|Lost to Follow-up|0|||
145707323|NCT03842228|525445345|FG000|Overall Study|Adverse Event|1|||
145707324|NCT03842228|525445346|FG001|Overall Study|Adverse Event|1|||
145707325|NCT03842228|525445347|FG002|Overall Study|Adverse Event|1|||
145707326|NCT03842228|525445348|FG003|Overall Study|Adverse Event|0|||
145707327|NCT03842228|525445349|FG004|Overall Study|Adverse Event|0|||
145707328|NCT03842228|525445350|FG005|Overall Study|Adverse Event|0|||
145707329|NCT03842228|525445351|FG006|Overall Study|Adverse Event|0|||
145707330|NCT03842228|525445345|FG000|Overall Study|Death|0|||
145707331|NCT03842228|525445346|FG001|Overall Study|Death|1|||
145707332|NCT03842228|525445347|FG002|Overall Study|Death|0|||
145707333|NCT03842228|525445348|FG003|Overall Study|Death|0|||
145707334|NCT03842228|525445349|FG004|Overall Study|Death|0|||
145707335|NCT03842228|525445350|FG005|Overall Study|Death|0|||
145707336|NCT03842228|525445351|FG006|Overall Study|Death|0|||
145707337|NCT03842228|525445345|FG000|Overall Study|Withdrawal by Subject|0|||
145707338|NCT03842228|525445346|FG001|Overall Study|Withdrawal by Subject|0|||
145707339|NCT03842228|525445347|FG002|Overall Study|Withdrawal by Subject|2|||
145707340|NCT03842228|525445348|FG003|Overall Study|Withdrawal by Subject|1|||
145707341|NCT03842228|525445349|FG004|Overall Study|Withdrawal by Subject|0|||
145707342|NCT03842228|525445350|FG005|Overall Study|Withdrawal by Subject|0|||
145707343|NCT03842228|525445351|FG006|Overall Study|Withdrawal by Subject|2|||
145707344|NCT03842228|525445345|FG000|Overall Study|Progression|8|||
145707345|NCT03842228|525445346|FG001|Overall Study|Progression|1|||
145707346|NCT03842228|525445347|FG002|Overall Study|Progression|7|||
145707347|NCT03842228|525445348|FG003|Overall Study|Progression|5|||
145707348|NCT03842228|525445349|FG004|Overall Study|Progression|4|||
145707349|NCT03842228|525445350|FG005|Overall Study|Progression|2|||
145707350|NCT03842228|525445351|FG006|Overall Study|Progression|3|||
145707351|NCT01263509|525445352|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
145707352|NCT01263509|525445353|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
145707353|NCT01263509|525445354|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
145707354|NCT01263509|525445355|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
145377879|NCT03191864|524233636|FG001|Part 1 - Induction|Randomized but never dosed|0|||
145707355|NCT01263509|525445352|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145707356|NCT01263509|525445353|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
145707357|NCT01263509|525445354|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
145707358|NCT01263509|525445355|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
145707359|NCT01263509|525445352|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
145707360|NCT01263509|525445353|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
145707361|NCT01263509|525445354|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145707362|NCT01263509|525445355|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
145707363|NCT01263509|525445352|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
145707364|NCT01263509|525445353|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
145707365|NCT01263509|525445354|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145707366|NCT01263509|525445355|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
145707367|NCT01263509|525445352|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
145707368|NCT01263509|525445353|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
145707369|NCT01263509|525445354|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
145707370|NCT01263509|525445355|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
145707371|NCT01602510|525445356|FG000|Open Label Phase|Adverse Event|46|||
145707372|NCT01602510|525445357|FG001|Open Label Phase|Adverse Event|0|||
145707373|NCT01602510|525445358|FG002|Open Label Phase|Adverse Event|0|||
145707374|NCT01602510|525445356|FG000|Open Label Phase|Lack of Efficacy|22|||
145707375|NCT01602510|525445357|FG001|Open Label Phase|Lack of Efficacy|0|||
145707376|NCT01602510|525445358|FG002|Open Label Phase|Lack of Efficacy|0|||
145707377|NCT01602510|525445356|FG000|Open Label Phase|Protocol Violation|15|||
145707378|NCT01602510|525445357|FG001|Open Label Phase|Protocol Violation|0|||
145707379|NCT01602510|525445358|FG002|Open Label Phase|Protocol Violation|0|||
145707380|NCT01602510|525445356|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
145707381|NCT01602510|525445357|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
145707382|NCT01602510|525445358|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
145707383|NCT01602510|525445356|FG000|Open Label Phase|Lost to Follow-up|22|||
145707384|NCT01602510|525445357|FG001|Open Label Phase|Lost to Follow-up|0|||
145707385|NCT01602510|525445358|FG002|Open Label Phase|Lost to Follow-up|0|||
145707386|NCT01602510|525445356|FG000|Open Label Phase|Physician Decision|19|||
145707387|NCT01602510|525445357|FG001|Open Label Phase|Physician Decision|0|||
145707388|NCT01602510|525445358|FG002|Open Label Phase|Physician Decision|0|||
145707389|NCT01602510|525445356|FG000|Open Label Phase|Withdrawal by Subject|57|||
145707390|NCT01602510|525445357|FG001|Open Label Phase|Withdrawal by Subject|0|||
145707391|NCT01602510|525445358|FG002|Open Label Phase|Withdrawal by Subject|0|||
145707392|NCT01602510|525445356|FG000|Randomized Phase|Adverse Event|0|||
145707393|NCT01602510|525445357|FG001|Randomized Phase|Adverse Event|2|||
145707394|NCT01602510|525445358|FG002|Randomized Phase|Adverse Event|6|||
145707395|NCT01602510|525445356|FG000|Randomized Phase|Lack of Efficacy|0|||
145707396|NCT01602510|525445357|FG001|Randomized Phase|Lack of Efficacy|4|||
145707397|NCT01602510|525445358|FG002|Randomized Phase|Lack of Efficacy|4|||
145707398|NCT01602510|525445356|FG000|Randomized Phase|Protocol Violation|0|||
145707399|NCT01602510|525445357|FG001|Randomized Phase|Protocol Violation|3|||
145707400|NCT01602510|525445358|FG002|Randomized Phase|Protocol Violation|3|||
145707401|NCT01602510|525445356|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
145707402|NCT01602510|525445357|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
145707403|NCT01602510|525445358|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
145707404|NCT01602510|525445356|FG000|Randomized Phase|Lost to Follow-up|0|||
145707405|NCT01602510|525445357|FG001|Randomized Phase|Lost to Follow-up|1|||
145707406|NCT01602510|525445358|FG002|Randomized Phase|Lost to Follow-up|3|||
145707407|NCT01602510|525445356|FG000|Randomized Phase|Physician Decision|0|||
145707408|NCT01602510|525445357|FG001|Randomized Phase|Physician Decision|0|||
145707409|NCT01602510|525445358|FG002|Randomized Phase|Physician Decision|2|||
145707410|NCT01602510|525445356|FG000|Randomized Phase|Withdrawal by Subject|0|||
145707411|NCT01602510|525445357|FG001|Randomized Phase|Withdrawal by Subject|6|||
145707412|NCT01602510|525445358|FG002|Randomized Phase|Withdrawal by Subject|7|||
145707413|NCT01001390|525445359|FG000|Overall Study|Failure to wear AFO device|2|||
145707414|NCT01001390|525445360|FG001|Overall Study|Failure to wear AFO device|0|||
145707415|NCT01261000|525445361|FG000|Overall Study|Screen failure|1|||
145707416|NCT00600613|525445366|FG000|Overall Study|Protocol Deviation|1|||
145707417|NCT01509547|525445369|FG000|Overall Study|Lost to Follow-up|24|||
145707418|NCT01509547|525445370|FG001|Overall Study|Lost to Follow-up|14|||
145707419|NCT01509547|525445369|FG000|Overall Study|Withdrawal by Subject|11|||
145707420|NCT01509547|525445370|FG001|Overall Study|Withdrawal by Subject|24|||
145707421|NCT01509547|525445369|FG000|Overall Study|Physician Decision|0|||
145707422|NCT01509547|525445370|FG001|Overall Study|Physician Decision|1|||
145707423|NCT02514551|525445371|FG000|Overall Study|Lost to Follow-up|0|||
145707424|NCT02514551|525445372|FG001|Overall Study|Lost to Follow-up|1|||
145707425|NCT02514551|525445371|FG000|Overall Study|Participant Never Treated|0|||
145707426|NCT02514551|525445372|FG001|Overall Study|Participant Never Treated|2|||
145707427|NCT00570908|525445376|FG000|Overall Study|Adverse Event|5|||
145707428|NCT00570908|525445376|FG000|Overall Study|Withdrawal by Subject|2|||
145707429|NCT00277095|525445377|FG000|Overall Study|Death|2|||
145707430|NCT00277095|525445377|FG000|Overall Study|Explanted|7|||
145707431|NCT00277095|525445377|FG000|Overall Study|Lost to Follow-up|2|||
145707432|NCT00277095|525445377|FG000|Overall Study|Missed Follow-up|9|||
145707433|NCT00277095|525445377|FG000|Overall Study|Physician Decision|1|||
145707434|NCT01447576|525445383|FG000|Overall Study|Lost to Follow-up|52|||
145707435|NCT01447576|525445383|FG000|Overall Study|Adverse Event|127|||
145707436|NCT01447576|525445383|FG000|Overall Study|Participant met withdrawal criteria|40|||
145707437|NCT01447576|525445383|FG000|Overall Study|Withdrawal by Subject|100|||
145707438|NCT01447576|525445383|FG000|Overall Study|Protocol deviation|83|||
145707439|NCT01447576|525445383|FG000|Overall Study|Lack of Efficacy|68|||
145707440|NCT01447576|525445383|FG000|Overall Study|Physician Decision|6|||
145707441|NCT05239598|525445384|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
145707442|NCT05239598|525445385|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
145707443|NCT05239598|525445384|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
145707444|NCT05239598|525445385|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
145707445|NCT02998476|525445388|FG000|Overall Study|Lost to Follow-up|1|||
145707446|NCT02998476|525445389|FG001|Overall Study|Lost to Follow-up|0|||
145707447|NCT02998476|525445388|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
145707448|NCT02998476|525445389|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
145707449|NCT02998476|525445388|FG000|Overall Study|Withdrawal by Subject|1|||
145707450|NCT02998476|525445389|FG001|Overall Study|Withdrawal by Subject|2|||
145707451|NCT02998476|525445388|FG000|Overall Study|Death|45|||
145707452|NCT02998476|525445389|FG001|Overall Study|Death|2|||
145707453|NCT02998476|525445388|FG000|Overall Study|Other|6|||
145707454|NCT02998476|525445389|FG001|Overall Study|Other|1|||
145707455|NCT05855967|525445390|FG000|Overall Study|Withdrawal by Subject|7|||
145707456|NCT05855967|525445391|FG001|Overall Study|Withdrawal by Subject|5|||
145707457|NCT05855967|525445390|FG000|Overall Study|Lost to Follow-up|2|||
145707458|NCT05855967|525445391|FG001|Overall Study|Lost to Follow-up|1|||
145707459|NCT01435772|525445393|FG000|Overall Study|Adverse Event|1|||
145707460|NCT01435772|525445394|FG001|Overall Study|Adverse Event|0|||
145707461|NCT01435772|525445395|FG002|Overall Study|Adverse Event|2|||
145707462|NCT01435772|525445393|FG000|Overall Study|Withdrawal by Subject|0|||
145707463|NCT01435772|525445394|FG001|Overall Study|Withdrawal by Subject|1|||
145707464|NCT01435772|525445395|FG002|Overall Study|Withdrawal by Subject|3|||
145707465|NCT01435772|525445393|FG000|Overall Study|Other - study termination|2|||
145707466|NCT01435772|525445394|FG001|Overall Study|Other - study termination|2|||
145707467|NCT01435772|525445395|FG002|Overall Study|Other - study termination|10|||
145707468|NCT03238963|525445396|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
145707469|NCT03238963|525445397|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
145707470|NCT03238963|525445396|FG000|Overall Study|Withdrawal by Subject|1|||
145707471|NCT03238963|525445397|FG001|Overall Study|Withdrawal by Subject|1|||
145707472|NCT03238963|525445396|FG000|Overall Study|Lost to Follow-up|1|||
145707473|NCT03238963|525445397|FG001|Overall Study|Lost to Follow-up|0|||
145707474|NCT03238963|525445396|FG000|Overall Study|Protocol Violation|1|||
145707475|NCT03238963|525445397|FG001|Overall Study|Protocol Violation|1|||
145707476|NCT03238963|525445396|FG000|Overall Study|Adverse Event|1|||
145707477|NCT03238963|525445397|FG001|Overall Study|Adverse Event|0|||
145707478|NCT06926673|525445398|FG000|Overall Study|Lost to Follow-up|0|||
145707479|NCT06926673|525445399|FG001|Overall Study|Lost to Follow-up|0|||
145707480|NCT06926673|525445400|FG002|Overall Study|Lost to Follow-up|0|||
145707481|NCT06926673|525445401|FG003|Overall Study|Lost to Follow-up|1|||
145707482|NCT06926673|525445402|FG004|Overall Study|Lost to Follow-up|0|||
145707483|NCT06926673|525445403|FG005|Overall Study|Lost to Follow-up|0|||
145707484|NCT06926673|525445404|FG006|Overall Study|Lost to Follow-up|0|||
145707485|NCT06926673|525445398|FG000|Overall Study|Physician Decision|0|||
145707486|NCT06926673|525445399|FG001|Overall Study|Physician Decision|0|||
145707487|NCT06926673|525445400|FG002|Overall Study|Physician Decision|0|||
145707488|NCT06926673|525445401|FG003|Overall Study|Physician Decision|0|||
145707489|NCT06926673|525445402|FG004|Overall Study|Physician Decision|0|||
145707490|NCT06926673|525445403|FG005|Overall Study|Physician Decision|0|||
145707491|NCT06926673|525445404|FG006|Overall Study|Physician Decision|1|||
145707492|NCT06926673|525445398|FG000|Overall Study|Withdrawal by Subject|0|||
145707493|NCT06926673|525445399|FG001|Overall Study|Withdrawal by Subject|3|||
145707494|NCT06926673|525445400|FG002|Overall Study|Withdrawal by Subject|2|||
145707495|NCT06926673|525445401|FG003|Overall Study|Withdrawal by Subject|1|||
145707496|NCT06926673|525445402|FG004|Overall Study|Withdrawal by Subject|0|||
145707497|NCT06926673|525445403|FG005|Overall Study|Withdrawal by Subject|2|||
145707498|NCT06926673|525445404|FG006|Overall Study|Withdrawal by Subject|0|||
145707499|NCT01424813|525445405|FG000|Overall Study|Withdrawal by Subject|3|||
145707500|NCT01424813|525445406|FG001|Overall Study|Withdrawal by Subject|0|||
145707501|NCT01424813|525445405|FG000|Overall Study|Protocol Violation|1|||
145707502|NCT01424813|525445406|FG001|Overall Study|Protocol Violation|0|||
145707503|NCT01424813|525445405|FG000|Overall Study|Other|1|||
145707504|NCT01424813|525445406|FG001|Overall Study|Other|2|||
145707505|NCT01920477|525447620|FG000|Overall Study|Adverse Event|0|||
145707506|NCT01920477|525447621|FG001|Overall Study|Adverse Event|1|||
145707507|NCT01920477|525447620|FG000|Overall Study|Lack of Efficacy|1|||
145707508|NCT01920477|525447621|FG001|Overall Study|Lack of Efficacy|0|||
145707509|NCT01920477|525447620|FG000|Overall Study|Study closed/terminated|14|||
145707510|NCT01920477|525447621|FG001|Overall Study|Study closed/terminated|15|||
145707511|NCT01920477|525447620|FG000|Overall Study|Withdrawal by Subject|0|||
145707512|NCT01920477|525447621|FG001|Overall Study|Withdrawal by Subject|1|||
145707513|NCT01681277|525447622|FG000|Overall Study|Adverse Event|1|||
145707514|NCT01681277|525447623|FG001|Overall Study|Adverse Event|0|||
145707515|NCT01681277|525447624|FG002|Overall Study|Adverse Event|0|||
145707516|NCT01681277|525447625|FG003|Overall Study|Adverse Event|0|||
145707517|NCT01681277|525447626|FG004|Overall Study|Adverse Event|0|||
145707518|NCT03838731|525447627|FG000|Overall Study|Pregnancy|0|||
145707519|NCT03838731|525447628|FG001|Overall Study|Pregnancy|1|||
145707520|NCT03838731|525447627|FG000|Overall Study|Withdrawal of consent|1|||
145707521|NCT03838731|525447628|FG001|Overall Study|Withdrawal of consent|0|||
145707522|NCT04707664|525447629|FG000|Overall Study|Adverse Event|2|||
145707523|NCT04707664|525447630|FG001|Overall Study|Adverse Event|0|||
145707524|NCT04707664|525447629|FG000|Overall Study|Death|1|||
145707525|NCT04707664|525447630|FG001|Overall Study|Death|2|||
145707526|NCT04707664|525447629|FG000|Overall Study|Withdrawal by Subject|13|||
145707527|NCT04707664|525447630|FG001|Overall Study|Withdrawal by Subject|21|||
145707528|NCT04707664|525447629|FG000|Overall Study|Lost to Follow-up|11|||
145707529|NCT04707664|525447630|FG001|Overall Study|Lost to Follow-up|13|||
145707530|NCT04707664|525447629|FG000|Overall Study|Not treated|2|||
145707531|NCT04707664|525447630|FG001|Overall Study|Not treated|0|||
145707532|NCT01182441|525447631|FG000|Overall Study|Patient Still in Follow-up|152|||
145707533|NCT01182441|525447632|FG001|Overall Study|Patient Still in Follow-up|72|||
145707534|NCT01182441|525447631|FG000|Overall Study|Death|37|||
145707535|NCT01182441|525447632|FG001|Overall Study|Death|25|||
145707536|NCT01182441|525447631|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
145707537|NCT01182441|525447632|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
145707538|NCT01182441|525447631|FG000|Overall Study|Lost to Follow-up|5|||
145707539|NCT01182441|525447632|FG001|Overall Study|Lost to Follow-up|8|||
145707540|NCT01182441|525447631|FG000|Overall Study|Withdrawal by Subject|6|||
145707541|NCT01182441|525447632|FG001|Overall Study|Withdrawal by Subject|13|||
145707542|NCT01182441|525447631|FG000|Overall Study|Implant Not Attempted|4|||
145707543|NCT01182441|525447632|FG001|Overall Study|Implant Not Attempted|0|||
145707544|NCT01182441|525447631|FG000|Overall Study|Adverse Event|2|||
145707545|NCT01182441|525447632|FG001|Overall Study|Adverse Event|0|||
145707546|NCT01182441|525447631|FG000|Overall Study|Physician Decision|1|||
145707547|NCT01182441|525447632|FG001|Overall Study|Physician Decision|1|||
145707548|NCT02304705|525447633|FG000|Overall Study|Withdrawal by Subject|2|||
145707549|NCT02304705|525447634|FG001|Overall Study|Withdrawal by Subject|0|||
145707550|NCT02304705|525447633|FG000|Overall Study|Physician Decision|2|||
145707551|NCT02304705|525447634|FG001|Overall Study|Physician Decision|4|||
145707552|NCT02304705|525447633|FG000|Overall Study|Death|0|||
145707553|NCT02304705|525447634|FG001|Overall Study|Death|1|||
145707554|NCT02304705|525447633|FG000|Overall Study|Lost to Follow-up|0|||
145707555|NCT02304705|525447634|FG001|Overall Study|Lost to Follow-up|2|||
145707556|NCT01195948|525447635|FG000|Overall Study|Lost to Follow-up|0|||
145707557|NCT01195948|525447636|FG001|Overall Study|Lost to Follow-up|1|||
145707558|NCT01195948|525447637|FG002|Overall Study|Lost to Follow-up|2|||
145707559|NCT01174446|525447638|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
145707560|NCT01174446|525447639|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
145707561|NCT01174446|525447640|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
145707562|NCT01174446|525447641|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
145707563|NCT01174446|525447638|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
145707564|NCT01174446|525447639|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
145707565|NCT01174446|525447640|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
145707566|NCT01174446|525447641|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
145707567|NCT01174446|525447638|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
145707568|NCT01174446|525447639|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
145707569|NCT01174446|525447640|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
145707570|NCT01174446|525447641|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
145707571|NCT01174446|525447638|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
145707572|NCT01174446|525447639|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
145707573|NCT01174446|525447640|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
145707574|NCT01174446|525447641|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
145707575|NCT03057847|525447642|FG000|Overall Study|Lost to Follow-up|16|||
145707576|NCT01706705|525447644|FG000|Overall Study|Death|1|||
145707577|NCT01706705|525447644|FG000|Overall Study|Lack of Efficacy|13|||
145707578|NCT01706705|525447644|FG000|Overall Study|Non-clinical|6|||
145707579|NCT03510455|525447645|FG000|Overall Study|Physician Decision|1|||
145707580|NCT02942004|525447646|FG000|Overall Study|Withdrawal by Subject|0|||
145707581|NCT02942004|525447647|FG001|Overall Study|Withdrawal by Subject|2|||
145707582|NCT02942004|525447648|FG002|Overall Study|Withdrawal by Subject|3|||
145707583|NCT02942004|525447646|FG000|Overall Study|Lost to Follow-up|1|||
145707584|NCT02942004|525447647|FG001|Overall Study|Lost to Follow-up|1|||
145707585|NCT02942004|525447648|FG002|Overall Study|Lost to Follow-up|2|||
145707586|NCT02942004|525447646|FG000|Overall Study|Randomized but not dosed|3|||
145707587|NCT02942004|525447647|FG001|Overall Study|Randomized but not dosed|9|||
145707588|NCT02942004|525447648|FG002|Overall Study|Randomized but not dosed|4|||
145707589|NCT04517669|525447649|FG000|Overall Study|Lost to Follow-up|2|||
145707590|NCT04517669|525447649|FG000|Overall Study|Withdrawal by Subject|3|||
145707591|NCT04517669|525447649|FG000|Overall Study|Drug withdrawn|44|||
145707592|NCT04517669|525447649|FG000|Overall Study|Other|1|||
145707593|NCT04517669|525447649|FG000|Overall Study|Eligibility criteria not met|4|||
145707594|NCT04517669|525447649|FG000|Overall Study|Did not receive treatment|3|||
145707595|NCT02138786|525447650|FG000|Overall Study|Adverse Event|0|||
145707596|NCT02138786|525447651|FG001|Overall Study|Adverse Event|2|||
145707597|NCT02138786|525447652|FG002|Overall Study|Adverse Event|1|||
145707598|NCT02138786|525447650|FG000|Overall Study|Death|1|||
145707599|NCT02138786|525447651|FG001|Overall Study|Death|7|||
145707600|NCT02138786|525447652|FG002|Overall Study|Death|2|||
145707601|NCT02138786|525447650|FG000|Overall Study|Disease Progression|1|||
145707602|NCT02138786|525447651|FG001|Overall Study|Disease Progression|1|||
145707603|NCT02138786|525447652|FG002|Overall Study|Disease Progression|3|||
145707604|NCT02138786|525447650|FG000|Overall Study|Withdrawal by Subject|1|||
145707605|NCT02138786|525447651|FG001|Overall Study|Withdrawal by Subject|2|||
145707606|NCT02138786|525447652|FG002|Overall Study|Withdrawal by Subject|0|||
145707607|NCT02138786|525447650|FG000|Overall Study|Patient's Wish|0|||
145707608|NCT02138786|525447651|FG001|Overall Study|Patient's Wish|2|||
145707609|NCT02138786|525447652|FG002|Overall Study|Patient's Wish|0|||
145707610|NCT02138786|525447650|FG000|Overall Study|Sponsor Terminated Study|0|||
145707611|NCT02138786|525447651|FG001|Overall Study|Sponsor Terminated Study|1|||
145707612|NCT02138786|525447652|FG002|Overall Study|Sponsor Terminated Study|1|||
145707613|NCT02138786|525447650|FG000|Overall Study|Non-Compliance|0|||
145707614|NCT02138786|525447651|FG001|Overall Study|Non-Compliance|0|||
145707615|NCT02138786|525447652|FG002|Overall Study|Non-Compliance|1|||
145707616|NCT01199068|525447656|FG000|Overall Study|Unacceptable toxicity|0|||
145707617|NCT01199068|525447657|FG001|Overall Study|Unacceptable toxicity|0|||
145707618|NCT01199068|525447658|FG002|Overall Study|Unacceptable toxicity|2|||
145707619|NCT01199068|525447656|FG000|Overall Study|Progressive disease|3|||
145707620|NCT01199068|525447657|FG001|Overall Study|Progressive disease|3|||
145707621|NCT01199068|525447658|FG002|Overall Study|Progressive disease|6|||
145707622|NCT01199068|525447656|FG000|Overall Study|Withdrawal by Subject|0|||
145707623|NCT01199068|525447657|FG001|Overall Study|Withdrawal by Subject|0|||
145707624|NCT01199068|525447658|FG002|Overall Study|Withdrawal by Subject|1|||
145707625|NCT01250925|525447659|FG000|Overall Study|Lost to Follow-up|1|||
145707626|NCT01250925|525447660|FG001|Overall Study|Lost to Follow-up|1|||
145707627|NCT01250925|525447661|FG002|Overall Study|Lost to Follow-up|0|||
145707628|NCT01250925|525447659|FG000|Overall Study|Withdrawal by Subject|2|||
145707629|NCT01250925|525447660|FG001|Overall Study|Withdrawal by Subject|0|||
145707630|NCT01250925|525447661|FG002|Overall Study|Withdrawal by Subject|0|||
145707631|NCT01250925|525447659|FG000|Overall Study|Protocol Violation|2|||
145707632|NCT01250925|525447660|FG001|Overall Study|Protocol Violation|0|||
145707633|NCT01250925|525447661|FG002|Overall Study|Protocol Violation|0|||
145707634|NCT01250925|525447659|FG000|Overall Study|Physician Decision|0|||
145707635|NCT01250925|525447660|FG001|Overall Study|Physician Decision|2|||
145707636|NCT01250925|525447661|FG002|Overall Study|Physician Decision|1|||
145707637|NCT01250925|525447659|FG000|Overall Study|Adverse Event|0|||
145707638|NCT01250925|525447660|FG001|Overall Study|Adverse Event|0|||
145707639|NCT01250925|525447661|FG002|Overall Study|Adverse Event|1|||
145707640|NCT00677534|525447666|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
145707641|NCT00677534|525447666|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
145707642|NCT00677534|525447666|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
145707643|NCT02687035|525447667|FG000|Overall Study|Withdrawal by Subject|1|||
145707644|NCT02687035|525447667|FG000|Overall Study|Death|87|||
145707645|NCT02687035|525447667|FG000|Overall Study|Lost to Follow-up|1|||
145707646|NCT02687035|525447667|FG000|Overall Study|Missed Visit|87|||
145707647|NCT02687035|525447667|FG000|Overall Study|Did not receive Study Device|8|||
145707648|NCT04481373|525447674|FG000|Overall Study|Protocol Violation|1|||
145707649|NCT04481373|525447675|FG001|Overall Study|Protocol Violation|0|||
145707650|NCT04481373|525447674|FG000|Overall Study|Viral load in hospital not over 1000|2|||
145707651|NCT04481373|525447675|FG001|Overall Study|Viral load in hospital not over 1000|1|||
145707652|NCT04481373|525447674|FG000|Overall Study|Death before hospital discharge|1|||
145377880|NCT03191864|524233637|FG002|Part 1 - Induction|Randomized but never dosed|1|||
145707653|NCT04481373|525447675|FG001|Overall Study|Death before hospital discharge|0|||
145707654|NCT02224703|525447676|FG000|Overall Study|Adverse Event|0|||
145707655|NCT02224703|525447677|FG001|Overall Study|Adverse Event|5|||
145707656|NCT02224703|525447678|FG002|Overall Study|Adverse Event|0|||
145707657|NCT02224703|525447676|FG000|Overall Study|Withdrawn by investigator|1|||
145707658|NCT02224703|525447677|FG001|Overall Study|Withdrawn by investigator|0|||
145707659|NCT02224703|525447678|FG002|Overall Study|Withdrawn by investigator|0|||
145707660|NCT02224703|525447676|FG000|Overall Study|Advised by medical monitor|1|||
145707661|NCT02224703|525447677|FG001|Overall Study|Advised by medical monitor|0|||
145707662|NCT02224703|525447678|FG002|Overall Study|Advised by medical monitor|0|||
145707663|NCT02224703|525447676|FG000|Overall Study|Withdrawn by parent/guardian|0|||
145707664|NCT02224703|525447677|FG001|Overall Study|Withdrawn by parent/guardian|1|||
145707665|NCT02224703|525447678|FG002|Overall Study|Withdrawn by parent/guardian|0|||
145707666|NCT02224703|525447676|FG000|Overall Study|Lack of Efficacy|1|||
145707667|NCT02224703|525447677|FG001|Overall Study|Lack of Efficacy|0|||
145707668|NCT02224703|525447678|FG002|Overall Study|Lack of Efficacy|0|||
145707669|NCT01886287|525447693|FG000|Overall Study|Radiographic disease progression|1|||
145707670|NCT01886287|525447693|FG000|Overall Study|Clinical progression due to disease|1|||
145707671|NCT03596762|525447694|FG000|Overall Study|Protocol Violation|0|||
145707672|NCT03596762|525447695|FG001|Overall Study|Protocol Violation|0|||
145707673|NCT03596762|525447696|FG002|Overall Study|Protocol Violation|0|||
145707674|NCT03596762|525447697|FG003|Overall Study|Protocol Violation|0|||
145707675|NCT03596762|525447698|FG004|Overall Study|Protocol Violation|1|||
145707676|NCT03596762|525447694|FG000|Overall Study|Adverse Event|2|||
145707677|NCT03596762|525447695|FG001|Overall Study|Adverse Event|0|||
145707678|NCT03596762|525447696|FG002|Overall Study|Adverse Event|1|||
145707679|NCT03596762|525447697|FG003|Overall Study|Adverse Event|0|||
145707680|NCT03596762|525447698|FG004|Overall Study|Adverse Event|5|||
145707681|NCT03596762|525447694|FG000|Overall Study|Withdrawal by Subject|2|||
145707682|NCT03596762|525447695|FG001|Overall Study|Withdrawal by Subject|1|||
145707683|NCT03596762|525447696|FG002|Overall Study|Withdrawal by Subject|0|||
145707684|NCT03596762|525447697|FG003|Overall Study|Withdrawal by Subject|1|||
145707685|NCT03596762|525447698|FG004|Overall Study|Withdrawal by Subject|1|||
145707686|NCT02195479|525447699|FG000|Overall Study|Lost to Follow-up|18|||
145707687|NCT02195479|525447700|FG001|Overall Study|Lost to Follow-up|15|||
145707688|NCT02195479|525447699|FG000|Overall Study|Death|217|||
145707689|NCT02195479|525447700|FG001|Overall Study|Death|171|||
145707690|NCT02195479|525447699|FG000|Overall Study|Physician Decision|1|||
145707691|NCT02195479|525447700|FG001|Overall Study|Physician Decision|0|||
145707692|NCT02195479|525447699|FG000|Overall Study|Withdrawal by Subject|30|||
145707693|NCT02195479|525447700|FG001|Overall Study|Withdrawal by Subject|30|||
145707694|NCT02195479|525447699|FG000|Overall Study|Other|3|||
145707695|NCT02195479|525447700|FG001|Overall Study|Other|4|||
145707696|NCT02195479|525447699|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
145707697|NCT02195479|525447700|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
145707698|NCT02593123|525447701|FG000|Overall Study|Physician Decision|2|||
145707699|NCT02593123|525447702|FG001|Overall Study|Physician Decision|1|||
145707700|NCT02593123|525447701|FG000|Overall Study|Relapse|1|||
145707701|NCT02593123|525447702|FG001|Overall Study|Relapse|1|||
145707702|NCT05071053|525447703|FG000|Overall Study|Progressive disease|30|||
145707703|NCT05071053|525447703|FG000|Overall Study|Adverse Event|5|||
145707704|NCT00895895|525447711|FG000|Period 1|Adverse Event|7|||
145707705|NCT00895895|525447712|FG001|Period 1|Adverse Event|6|||
145707706|NCT00895895|525447713|FG002|Period 1|Adverse Event|4|||
145707707|NCT00895895|525447714|FG003|Period 1|Adverse Event|6|||
145707708|NCT00895895|525447715|FG004|Period 1|Adverse Event|7|||
145707709|NCT00895895|525447711|FG000|Period 1|Death|0|||
145707710|NCT00895895|525447712|FG001|Period 1|Death|0|||
145707711|NCT00895895|525447713|FG002|Period 1|Death|0|||
145707712|NCT00895895|525447714|FG003|Period 1|Death|0|||
145707713|NCT00895895|525447715|FG004|Period 1|Death|1|||
145707714|NCT00895895|525447711|FG000|Period 1|discontinued by sponsor|2|||
145707715|NCT00895895|525447712|FG001|Period 1|discontinued by sponsor|1|||
145707716|NCT00895895|525447713|FG002|Period 1|discontinued by sponsor|2|||
145707717|NCT00895895|525447714|FG003|Period 1|discontinued by sponsor|1|||
145707718|NCT00895895|525447715|FG004|Period 1|discontinued by sponsor|1|||
145707719|NCT00895895|525447711|FG000|Period 1|failed to return|0|||
145707720|NCT00895895|525447712|FG001|Period 1|failed to return|0|||
145707721|NCT00895895|525447713|FG002|Period 1|failed to return|1|||
145707722|NCT00895895|525447714|FG003|Period 1|failed to return|0|||
145707723|NCT00895895|525447715|FG004|Period 1|failed to return|1|||
145707724|NCT00895895|525447711|FG000|Period 1|investigator request|0|||
145707725|NCT00895895|525447712|FG001|Period 1|investigator request|1|||
145707726|NCT00895895|525447713|FG002|Period 1|investigator request|0|||
145707727|NCT00895895|525447714|FG003|Period 1|investigator request|0|||
145707728|NCT00895895|525447715|FG004|Period 1|investigator request|0|||
145707729|NCT00895895|525447711|FG000|Period 1|Lost to Follow-up|2|||
145707730|NCT00895895|525447712|FG001|Period 1|Lost to Follow-up|1|||
145707731|NCT00895895|525447713|FG002|Period 1|Lost to Follow-up|3|||
145707732|NCT00895895|525447714|FG003|Period 1|Lost to Follow-up|2|||
145707733|NCT00895895|525447715|FG004|Period 1|Lost to Follow-up|3|||
145707734|NCT00895895|525447711|FG000|Period 1|Other|1|||
145707735|NCT00895895|525447712|FG001|Period 1|Other|2|||
145707736|NCT00895895|525447713|FG002|Period 1|Other|1|||
145707737|NCT00895895|525447714|FG003|Period 1|Other|1|||
145707738|NCT00895895|525447715|FG004|Period 1|Other|1|||
145707739|NCT00895895|525447711|FG000|Period 1|Protocol Violation|0|||
145707740|NCT00895895|525447712|FG001|Period 1|Protocol Violation|1|||
145707741|NCT00895895|525447713|FG002|Period 1|Protocol Violation|0|||
145707742|NCT00895895|525447714|FG003|Period 1|Protocol Violation|0|||
145707743|NCT00895895|525447715|FG004|Period 1|Protocol Violation|0|||
145707744|NCT00895895|525447711|FG000|Period 1|Withdrawal by Subject|6|||
145707745|NCT00895895|525447712|FG001|Period 1|Withdrawal by Subject|6|||
145707746|NCT00895895|525447713|FG002|Period 1|Withdrawal by Subject|8|||
145707747|NCT00895895|525447714|FG003|Period 1|Withdrawal by Subject|2|||
145707748|NCT00895895|525447715|FG004|Period 1|Withdrawal by Subject|4|||
145707749|NCT00895895|525447711|FG000|Period 1|unsatisfactory response-efficacy|2|||
145707750|NCT00895895|525447712|FG001|Period 1|unsatisfactory response-efficacy|0|||
145707751|NCT00895895|525447713|FG002|Period 1|unsatisfactory response-efficacy|0|||
145707752|NCT00895895|525447714|FG003|Period 1|unsatisfactory response-efficacy|0|||
145707753|NCT00895895|525447715|FG004|Period 1|unsatisfactory response-efficacy|0|||
145707754|NCT00895895|525447711|FG000|Period 1|randomized and not treated|1|||
145707755|NCT00895895|525447712|FG001|Period 1|randomized and not treated|3|||
145707756|NCT00895895|525447713|FG002|Period 1|randomized and not treated|1|||
145707757|NCT00895895|525447714|FG003|Period 1|randomized and not treated|1|||
145707758|NCT00895895|525447715|FG004|Period 1|randomized and not treated|2|||
145707759|NCT00895895|525447711|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
145707760|NCT00895895|525447712|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
145707761|NCT00895895|525447713|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
145707762|NCT00895895|525447714|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
145707763|NCT00895895|525447715|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
145707764|NCT00895895|525447711|FG000|After Period 1, Prior to Period 2|Other|0|||
145707765|NCT00895895|525447712|FG001|After Period 1, Prior to Period 2|Other|0|||
145707766|NCT00895895|525447713|FG002|After Period 1, Prior to Period 2|Other|1|||
145707767|NCT00895895|525447714|FG003|After Period 1, Prior to Period 2|Other|0|||
145707768|NCT00895895|525447715|FG004|After Period 1, Prior to Period 2|Other|0|||
145707769|NCT00895895|525447711|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
145707770|NCT00895895|525447712|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
145707771|NCT00895895|525447713|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
145707772|NCT00895895|525447714|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
145707773|NCT00895895|525447715|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
145707774|NCT00895895|525447711|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
145707775|NCT00895895|525447712|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
145707776|NCT00895895|525447713|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
145707777|NCT00895895|525447714|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
145707778|NCT00895895|525447715|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
145707779|NCT00895895|525447711|FG000|Period 2|Adverse Event|3|||
145707780|NCT00895895|525447712|FG001|Period 2|Adverse Event|3|||
145707781|NCT00895895|525447713|FG002|Period 2|Adverse Event|5|||
145707782|NCT00895895|525447714|FG003|Period 2|Adverse Event|2|||
145707783|NCT00895895|525447715|FG004|Period 2|Adverse Event|5|||
145707784|NCT00895895|525447711|FG000|Period 2|Death|0|||
145707785|NCT00895895|525447712|FG001|Period 2|Death|0|||
145707786|NCT00895895|525447713|FG002|Period 2|Death|1|||
145707787|NCT00895895|525447714|FG003|Period 2|Death|0|||
145707788|NCT00895895|525447715|FG004|Period 2|Death|0|||
145707789|NCT00895895|525447711|FG000|Period 2|discontinued by sponsor|44|||
145707790|NCT00895895|525447712|FG001|Period 2|discontinued by sponsor|44|||
145707791|NCT00895895|525447713|FG002|Period 2|discontinued by sponsor|38|||
145707792|NCT00895895|525447714|FG003|Period 2|discontinued by sponsor|46|||
145707793|NCT00895895|525447715|FG004|Period 2|discontinued by sponsor|37|||
145707794|NCT00895895|525447711|FG000|Period 2|failed to return|2|||
145707795|NCT00895895|525447712|FG001|Period 2|failed to return|0|||
145707796|NCT00895895|525447713|FG002|Period 2|failed to return|0|||
145707797|NCT00895895|525447714|FG003|Period 2|failed to return|0|||
145707798|NCT00895895|525447715|FG004|Period 2|failed to return|0|||
145707799|NCT00895895|525447711|FG000|Period 2|investigator request|2|||
145707800|NCT00895895|525447712|FG001|Period 2|investigator request|0|||
145707801|NCT00895895|525447713|FG002|Period 2|investigator request|0|||
145707802|NCT00895895|525447714|FG003|Period 2|investigator request|0|||
145707803|NCT00895895|525447715|FG004|Period 2|investigator request|0|||
145707804|NCT00895895|525447711|FG000|Period 2|Lost to Follow-up|1|||
145707805|NCT00895895|525447712|FG001|Period 2|Lost to Follow-up|2|||
145707806|NCT00895895|525447713|FG002|Period 2|Lost to Follow-up|1|||
145707807|NCT00895895|525447714|FG003|Period 2|Lost to Follow-up|1|||
145707808|NCT00895895|525447715|FG004|Period 2|Lost to Follow-up|0|||
145707809|NCT00895895|525447711|FG000|Period 2|Other|1|||
145707810|NCT00895895|525447712|FG001|Period 2|Other|1|||
145707811|NCT00895895|525447713|FG002|Period 2|Other|3|||
145707812|NCT00895895|525447714|FG003|Period 2|Other|1|||
145707813|NCT00895895|525447715|FG004|Period 2|Other|1|||
145707814|NCT00895895|525447711|FG000|Period 2|Protocol Violation|1|||
145707815|NCT00895895|525447712|FG001|Period 2|Protocol Violation|0|||
145707816|NCT00895895|525447713|FG002|Period 2|Protocol Violation|1|||
145707817|NCT00895895|525447714|FG003|Period 2|Protocol Violation|1|||
145707818|NCT00895895|525447715|FG004|Period 2|Protocol Violation|1|||
145707819|NCT00895895|525447711|FG000|Period 2|Withdrawal by Subject|0|||
145707820|NCT00895895|525447712|FG001|Period 2|Withdrawal by Subject|2|||
145707821|NCT00895895|525447713|FG002|Period 2|Withdrawal by Subject|0|||
145707822|NCT00895895|525447714|FG003|Period 2|Withdrawal by Subject|3|||
145707823|NCT00895895|525447715|FG004|Period 2|Withdrawal by Subject|5|||
145707824|NCT00895895|525447711|FG000|Period 2|unsatisfactory response-efficacy|2|||
145707825|NCT00895895|525447712|FG001|Period 2|unsatisfactory response-efficacy|1|||
145707826|NCT00895895|525447713|FG002|Period 2|unsatisfactory response-efficacy|0|||
145707827|NCT00895895|525447714|FG003|Period 2|unsatisfactory response-efficacy|0|||
145707828|NCT00895895|525447715|FG004|Period 2|unsatisfactory response-efficacy|0|||
145707829|NCT03019640|525447716|FG000|Overall Study|Screen Failures|4|||
145707830|NCT03019640|525447716|FG000|Overall Study|Adverse Event|3|||
145707831|NCT03019640|525447716|FG000|Overall Study|Participant Relapsed|1|||
145707832|NCT00504777|525447717|FG000|Overall Study|Adverse Event|1|||
145707833|NCT01195623|525447721|FG000|Overall Study|Lost to Follow-up|35|||
145707834|NCT01195623|525447722|FG001|Overall Study|Lost to Follow-up|37|||
145707835|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
145707836|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
145707837|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
145707838|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
145707839|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
145707840|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
145707841|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
145707842|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
145707843|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
145707844|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
145707845|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707846|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707847|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
145707848|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
145707849|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707850|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707851|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707852|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
145707853|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
145707854|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707855|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707856|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707857|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
145707858|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707859|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707860|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707861|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
145707862|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
145707863|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
145707864|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
145707865|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
145707866|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
145707867|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
145707868|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
145707869|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
145707870|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
145707871|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
145707872|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
145707873|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
145707874|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
145707875|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
145707876|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
145707877|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
145707878|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
145707879|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
145707880|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
145707881|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
145707882|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
145707883|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
145707884|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
145707885|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
145707886|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
145707887|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
145707888|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
145707889|NCT00477490|525447727|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
145707890|NCT00477490|525447728|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
145707891|NCT00477490|525447729|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
145707892|NCT00477490|525447730|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
145707893|NCT00477490|525447731|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
145707894|NCT00477490|525447732|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
145707895|NCT00477490|525447733|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
145707896|NCT00477490|525447734|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
145707897|NCT00477490|525447735|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
145707898|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
145707899|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
145707900|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
145707901|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
145707902|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
145707903|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
145707904|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
145707905|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
145707906|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
145707907|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
145707908|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
145707909|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
145707910|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
145707911|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
145707912|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
145707913|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
145707914|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
145707915|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
145707916|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
145707917|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
145707918|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
145707919|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
145707920|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
145707921|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
145707922|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
145707923|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
145707924|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
145707925|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707926|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707927|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707928|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707929|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
145707930|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707931|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
145707932|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
145707933|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
145707934|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707935|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
145707936|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707937|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707938|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707939|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707940|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707941|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707942|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
145707943|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
145707944|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
145707945|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
145707946|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
145707947|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
145707948|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
145707949|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
145707950|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
145707951|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
145707952|NCT00477490|525447727|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707953|NCT00477490|525447728|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
145491447|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Disease progression|103|||
145491448|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Disease progression|122|||
145707954|NCT00477490|525447729|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
145707955|NCT00477490|525447730|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707956|NCT00477490|525447731|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
145707957|NCT00477490|525447732|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707958|NCT00477490|525447733|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707959|NCT00477490|525447734|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707960|NCT00477490|525447735|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
145707961|NCT01110408|525447738|FG000|Overall Study|Protocol Violation|1|||
145707962|NCT01110408|525447739|FG001|Overall Study|Protocol Violation|0|||
145707963|NCT00669877|525447740|FG000|Overall Study|Disease Progression/Death|4|||
145707964|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
145707965|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
145707966|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
145707967|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
145707968|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707969|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707970|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707971|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707972|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707973|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707974|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707975|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
145707976|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
145707977|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
145707978|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
145707979|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
145707980|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707981|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707982|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707983|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707984|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707985|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707986|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707987|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
145707988|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
145707989|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
145707990|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
145707991|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
145707992|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707993|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707994|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707995|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707996|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707997|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707998|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145707999|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
145708000|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
145708001|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
145708002|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
145708003|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
145708004|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708005|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708006|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708007|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708008|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708009|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708010|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708011|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
145708012|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708013|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708014|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
145708015|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
145708016|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708017|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708018|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708019|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708020|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708021|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708022|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708023|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
145708024|NCT01646177|525447741|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
145708025|NCT01646177|525447742|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
145708026|NCT01646177|525447743|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
145708027|NCT01646177|525447744|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708028|NCT01646177|525447745|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708029|NCT01646177|525447746|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708030|NCT01646177|525447747|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708031|NCT01646177|525447748|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708032|NCT01646177|525447749|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708033|NCT01646177|525447750|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708034|NCT01646177|525447751|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708035|NCT01646177|525447752|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
145708036|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708037|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708038|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708039|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708040|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
145708041|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
145708042|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
145708043|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
145708044|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708045|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708046|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708047|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
145708048|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708049|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708050|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708051|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708052|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
145708053|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
145708054|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
145708055|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
145708056|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708057|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708058|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708059|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
145708060|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708061|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708062|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708063|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708064|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
145708065|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
145708066|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
145708067|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
145708068|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708069|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708070|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708071|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
145708072|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708073|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708074|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708075|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708076|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
145708077|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
145708078|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
145708079|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
145708080|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708081|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708082|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708083|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
145708084|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708085|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708086|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708087|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708088|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
145708089|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
145708090|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
145708091|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
145708092|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708093|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708094|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708095|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
145708096|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708097|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708098|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708099|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708100|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
145708101|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
145708102|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708103|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
145708104|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708105|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708106|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708107|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
145708108|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708109|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708110|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708111|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708112|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
145708113|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
145708114|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
145708115|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
145708116|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708117|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708118|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708119|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
145708120|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
145708121|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
145708122|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
145708123|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
145708124|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
145708125|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
145708126|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
145708127|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
145708128|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
145708129|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
145708130|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
145708131|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
145708132|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708133|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708134|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708135|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708136|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
145708137|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
145708138|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
145708139|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
145708140|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708141|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708142|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708143|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
145708144|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708145|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145491449|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Other|3|||
145708146|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708147|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708148|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708149|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708150|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708151|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
145708152|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708153|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708154|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708155|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
145708156|NCT01646177|525447741|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708157|NCT01646177|525447742|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708158|NCT01646177|525447743|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708159|NCT01646177|525447744|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708160|NCT01646177|525447745|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708161|NCT01646177|525447746|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
145708162|NCT01646177|525447747|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
145708163|NCT01646177|525447748|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
145708164|NCT01646177|525447749|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708165|NCT01646177|525447750|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708166|NCT01646177|525447751|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708167|NCT01646177|525447752|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
145708168|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708169|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708170|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708171|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708172|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708173|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708174|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708175|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
145708176|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
145708177|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
145708178|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
145708179|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
145708180|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708181|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708182|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708183|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708184|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708185|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708186|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708187|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
145708188|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
145708189|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
145708190|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
145708191|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
145708192|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708193|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708194|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708195|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708196|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708197|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708198|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708199|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
145708200|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
145708201|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
145708202|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
145708203|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
145708204|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708205|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708206|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708207|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708208|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708209|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708210|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708211|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
145708212|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
145708213|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
145708214|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
145708215|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
145708216|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708217|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708218|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708219|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708220|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708221|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708222|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708223|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
145708224|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
145708225|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
145708226|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
145708227|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
145708228|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708229|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708230|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708231|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708232|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708233|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708234|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708235|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
145708236|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
145708237|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
145708238|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
145708239|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
145708240|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708241|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708242|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708243|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708244|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708245|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708246|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708247|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708248|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
145708249|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
145708250|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
145708251|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
145708252|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708253|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708254|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708255|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708256|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708257|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708258|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708259|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708260|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
145708261|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
145708262|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
145708263|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
145708264|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708265|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708266|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708267|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708268|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708269|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708270|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708271|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708272|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
145708273|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
145708274|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
145708275|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
145708276|NCT01646177|525447741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708277|NCT01646177|525447742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708278|NCT01646177|525447743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708279|NCT01646177|525447744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708280|NCT01646177|525447745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708281|NCT01646177|525447746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708282|NCT01646177|525447747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708283|NCT01646177|525447748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708284|NCT01646177|525447749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708285|NCT01646177|525447750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
145708286|NCT01646177|525447751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
145708287|NCT01646177|525447752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
145708288|NCT02920970|525447753|FG000|First Intervention|Protocol Violation|0|||
145708289|NCT02920970|525447754|FG001|First Intervention|Protocol Violation|1|||
145708290|NCT02920970|525447753|FG000|First Intervention|Adverse Event|0|||
145708291|NCT02920970|525447754|FG001|First Intervention|Adverse Event|1|||
145708292|NCT02920970|525447753|FG000|Second Intervention|Poor Lens Fit|1|||
145708293|NCT02920970|525447754|FG001|Second Intervention|Poor Lens Fit|0|||
145708294|NCT01711853|525447755|FG000|Overall Study|Not treated|3|||
145708295|NCT04230122|525447756|FG000|Overall Study|Lost to Follow-up|1|||
145708296|NCT04230122|525447757|FG001|Overall Study|Lost to Follow-up|0|||
145708297|NCT01277887|525447758|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
145708298|NCT01277887|525447759|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
145708299|NCT01277887|525447758|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
145708300|NCT01277887|525447759|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
145708301|NCT01277887|525447758|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
145708302|NCT01277887|525447759|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
145708303|NCT03651700|525447760|FG000|Overall Study|Withdrawal by Subject|1|||
145708304|NCT03651700|525447761|FG001|Overall Study|Withdrawal by Subject|0|||
145708305|NCT05479734|525447764|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
145708306|NCT05479734|525447765|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
145708307|NCT05479734|525447764|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
145708308|NCT05479734|525447765|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
145708309|NCT05479734|525447764|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
145708310|NCT05479734|525447765|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
145708311|NCT05479734|525447764|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
145708312|NCT05479734|525447765|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
145708313|NCT03945825|525447766|FG000|Overall Study|Enrolled but treatment not administered|0|||
145708314|NCT03945825|525447767|FG001|Overall Study|Enrolled but treatment not administered|0|||
145708315|NCT03945825|525447768|FG002|Overall Study|Enrolled but treatment not administered|0|||
145708316|NCT03945825|525447769|FG003|Overall Study|Enrolled but treatment not administered|0|||
145708317|NCT03945825|525447770|FG004|Overall Study|Enrolled but treatment not administered|1|||
145708318|NCT03945825|525447771|FG005|Overall Study|Enrolled but treatment not administered|0|||
145708319|NCT03945825|525447766|FG000|Overall Study|Lost to Follow-up|1|||
145708320|NCT03945825|525447767|FG001|Overall Study|Lost to Follow-up|5|||
145708321|NCT03945825|525447768|FG002|Overall Study|Lost to Follow-up|0|||
145708322|NCT03945825|525447769|FG003|Overall Study|Lost to Follow-up|1|||
145708323|NCT03945825|525447770|FG004|Overall Study|Lost to Follow-up|2|||
145708324|NCT03945825|525447771|FG005|Overall Study|Lost to Follow-up|2|||
145708325|NCT03945825|525447766|FG000|Overall Study|Withdrawal by Subject|1|||
145708326|NCT03945825|525447767|FG001|Overall Study|Withdrawal by Subject|0|||
145708327|NCT03945825|525447768|FG002|Overall Study|Withdrawal by Subject|1|||
145708328|NCT03945825|525447769|FG003|Overall Study|Withdrawal by Subject|1|||
145708329|NCT03945825|525447770|FG004|Overall Study|Withdrawal by Subject|0|||
145708330|NCT03945825|525447771|FG005|Overall Study|Withdrawal by Subject|1|||
145708331|NCT01461005|525447772|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
145708332|NCT01399918|525447773|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
145708333|NCT04844879|525447776|FG000|Overall Study|Death|1|||
145708334|NCT04844879|525447776|FG000|Overall Study|Withdrawal by Subject|1|||
145708335|NCT04844879|525447776|FG000|Overall Study|Adverse Event|1|||
145708336|NCT04520659|525447777|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
145708337|NCT04520659|525447778|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
145708338|NCT04520659|525447779|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
145708339|NCT04520659|525447780|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
145708340|NCT07149155|525447784|FG000|Overall Study|Lost to Follow-up|10|||
145708341|NCT03345576|525447785|FG000|Overall Study|Withdrawal by Subject|2|||
145708342|NCT03345576|525447786|FG001|Overall Study|Withdrawal by Subject|2|||
145491450|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Other|0|||
145708343|NCT03345576|525447785|FG000|Overall Study|Adverse Event|1|||
145708344|NCT03345576|525447786|FG001|Overall Study|Adverse Event|0|||
145708345|NCT04942366|525449334|FG000|Overall Study|Withdrawal by Subject|5|||
145708346|NCT04942366|525449335|FG001|Overall Study|Withdrawal by Subject|5|||
145708347|NCT02706405|525449341|FG000|Overall Study|Death|3|||
145708348|NCT02706405|525449342|FG001|Overall Study|Death|2|||
145708349|NCT02706405|525449343|FG002|Overall Study|Death|0|||
145708350|NCT02706405|525449344|FG003|Overall Study|Death|1|||
145708351|NCT02706405|525449345|FG004|Overall Study|Death|0|||
145708352|NCT02706405|525449346|FG005|Overall Study|Death|0|||
145708353|NCT02706405|525449347|FG006|Overall Study|Death|3|||
145708354|NCT02706405|525449348|FG007|Overall Study|Death|4|||
145708355|NCT02706405|525449341|FG000|Overall Study|Disease progression|0|||
145708356|NCT02706405|525449342|FG001|Overall Study|Disease progression|0|||
145708357|NCT02706405|525449343|FG002|Overall Study|Disease progression|0|||
145708358|NCT02706405|525449344|FG003|Overall Study|Disease progression|0|||
145708359|NCT02706405|525449345|FG004|Overall Study|Disease progression|0|||
145708360|NCT02706405|525449346|FG005|Overall Study|Disease progression|0|||
145708361|NCT02706405|525449347|FG006|Overall Study|Disease progression|0|||
145708362|NCT02706405|525449348|FG007|Overall Study|Disease progression|1|||
145708363|NCT02706405|525449341|FG000|Overall Study|Pt moved to new therapy|0|||
145708364|NCT02706405|525449342|FG001|Overall Study|Pt moved to new therapy|0|||
145708365|NCT02706405|525449343|FG002|Overall Study|Pt moved to new therapy|0|||
145708366|NCT02706405|525449344|FG003|Overall Study|Pt moved to new therapy|0|||
145708367|NCT02706405|525449345|FG004|Overall Study|Pt moved to new therapy|0|||
145708368|NCT02706405|525449346|FG005|Overall Study|Pt moved to new therapy|1|||
145708369|NCT02706405|525449347|FG006|Overall Study|Pt moved to new therapy|0|||
145708370|NCT02706405|525449348|FG007|Overall Study|Pt moved to new therapy|1|||
145708371|NCT02706405|525449341|FG000|Overall Study|Physician Decision|1|||
145708372|NCT02706405|525449342|FG001|Overall Study|Physician Decision|0|||
145708373|NCT02706405|525449343|FG002|Overall Study|Physician Decision|0|||
145708374|NCT02706405|525449344|FG003|Overall Study|Physician Decision|0|||
145708375|NCT02706405|525449345|FG004|Overall Study|Physician Decision|0|||
145708376|NCT02706405|525449346|FG005|Overall Study|Physician Decision|0|||
145708377|NCT02706405|525449347|FG006|Overall Study|Physician Decision|0|||
145708378|NCT02706405|525449348|FG007|Overall Study|Physician Decision|0|||
145708379|NCT03140280|525449349|FG000|Overall Study|Physician Decision|5|||
145708380|NCT05577715|525449358|FG000|Overall Study|Withdrawal by Subject|1|||
145708381|NCT05577715|525449358|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
145708382|NCT05577715|525449358|FG000|Overall Study|Lost to Follow-up|1|||
145708383|NCT05577715|525449358|FG000|Overall Study|Death|6|||
145708384|NCT03412773|525449359|FG000|Overall Study|Lost to Follow-up|0|||
145708385|NCT03412773|525449360|FG001|Overall Study|Lost to Follow-up|7|||
145708386|NCT03412773|525449361|FG002|Overall Study|Lost to Follow-up|6|||
145708387|NCT03412773|525449359|FG000|Overall Study|Withdrawal by Subject|0|||
145708388|NCT03412773|525449360|FG001|Overall Study|Withdrawal by Subject|15|||
145708389|NCT03412773|525449361|FG002|Overall Study|Withdrawal by Subject|19|||
145708390|NCT03412773|525449359|FG000|Overall Study|Study Closed By Sponsor|3|||
145708391|NCT03412773|525449360|FG001|Overall Study|Study Closed By Sponsor|46|||
145708392|NCT03412773|525449361|FG002|Overall Study|Study Closed By Sponsor|33|||
145708393|NCT03412773|525449359|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
145708394|NCT03412773|525449360|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
145708395|NCT03412773|525449361|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
145708396|NCT03412773|525449359|FG000|Overall Study|Death|7|||
145708397|NCT03412773|525449360|FG001|Overall Study|Death|259|||
145708398|NCT03412773|525449361|FG002|Overall Study|Death|273|||
145708399|NCT03412773|525449359|FG000|Overall Study|Physician Decision|0|||
145708400|NCT03412773|525449360|FG001|Overall Study|Physician Decision|0|||
145708401|NCT03412773|525449361|FG002|Overall Study|Physician Decision|1|||
145708402|NCT00384189|525449370|FG000|Overall Study|Reason Not Specified|50|||
145708403|NCT00384189|525449371|FG001|Overall Study|Reason Not Specified|57|||
145708404|NCT00384189|525449372|FG002|Overall Study|Reason Not Specified|58|||
145708405|NCT00384189|525449373|FG003|Overall Study|Reason Not Specified|40|||
145708406|NCT04958642|525449374|FG000|Overall Study|Transferred to OLEX program|3|||
145708407|NCT04958642|525449375|FG001|Overall Study|Transferred to OLEX program|0|||
145708408|NCT04958642|525449376|FG002|Overall Study|Transferred to OLEX program|5|||
145708409|NCT04958642|525449374|FG000|Overall Study|Death|0|||
145708410|NCT04958642|525449375|FG001|Overall Study|Death|0|||
145708411|NCT04958642|525449376|FG002|Overall Study|Death|1|||
145708412|NCT04958642|525449374|FG000|Overall Study|Withdrawal by Subject|4|||
145708413|NCT04958642|525449375|FG001|Overall Study|Withdrawal by Subject|9|||
145708414|NCT04958642|525449376|FG002|Overall Study|Withdrawal by Subject|13|||
145708415|NCT04958642|525449374|FG000|Overall Study|Investigator's Decision|0|||
145708416|NCT04958642|525449375|FG001|Overall Study|Investigator's Decision|0|||
145377881|NCT03191864|524233638|FG003|Part 1 - Induction|Randomized but never dosed|0|||
145708417|NCT04958642|525449376|FG002|Overall Study|Investigator's Decision|1|||
145708418|NCT04958642|525449374|FG000|Overall Study|Adverse Event|1|||
145708419|NCT04958642|525449375|FG001|Overall Study|Adverse Event|0|||
145708420|NCT04958642|525449376|FG002|Overall Study|Adverse Event|1|||
145708421|NCT04958642|525449374|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
145708422|NCT04958642|525449375|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
145708423|NCT04958642|525449376|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
145708424|NCT04958642|525449374|FG000|Overall Study|Lost to Follow-up|1|||
145708425|NCT04958642|525449375|FG001|Overall Study|Lost to Follow-up|0|||
145708426|NCT04958642|525449376|FG002|Overall Study|Lost to Follow-up|0|||
145708427|NCT04958642|525449374|FG000|Overall Study|Transferred to EAP following study termination|0|||
145708428|NCT04958642|525449375|FG001|Overall Study|Transferred to EAP following study termination|0|||
145708429|NCT04958642|525449376|FG002|Overall Study|Transferred to EAP following study termination|1|||
145708430|NCT04958642|525449374|FG000|Overall Study|Transferred to Expanded Access Program|1|||
145708431|NCT04958642|525449375|FG001|Overall Study|Transferred to Expanded Access Program|0|||
145708432|NCT04958642|525449376|FG002|Overall Study|Transferred to Expanded Access Program|0|||
145708433|NCT05627258|525449377|FG000|Overall Study|Lost to Follow-up|1|||
145708434|NCT05627258|525449378|FG001|Overall Study|Lost to Follow-up|0|||
145708435|NCT05627258|525449379|FG002|Overall Study|Lost to Follow-up|0|||
145708436|NCT05627258|525449380|FG003|Overall Study|Lost to Follow-up|0|||
145708437|NCT05627258|525449381|FG004|Overall Study|Lost to Follow-up|0|||
145708438|NCT05627258|525449382|FG005|Overall Study|Lost to Follow-up|0|||
145708439|NCT05627258|525449377|FG000|Overall Study|Withdrawal by Subject|0|||
145708440|NCT05627258|525449378|FG001|Overall Study|Withdrawal by Subject|0|||
145708441|NCT05627258|525449379|FG002|Overall Study|Withdrawal by Subject|0|||
145708442|NCT05627258|525449380|FG003|Overall Study|Withdrawal by Subject|0|||
145708443|NCT05627258|525449381|FG004|Overall Study|Withdrawal by Subject|2|||
145708444|NCT05627258|525449382|FG005|Overall Study|Withdrawal by Subject|0|||
145708445|NCT05627258|525449377|FG000|Overall Study|Enrolled, but product not administered|1|||
145708446|NCT05627258|525449378|FG001|Overall Study|Enrolled, but product not administered|0|||
145708447|NCT05627258|525449379|FG002|Overall Study|Enrolled, but product not administered|0|||
145708448|NCT05627258|525449380|FG003|Overall Study|Enrolled, but product not administered|0|||
145708449|NCT05627258|525449381|FG004|Overall Study|Enrolled, but product not administered|0|||
145708450|NCT05627258|525449382|FG005|Overall Study|Enrolled, but product not administered|0|||
145708451|NCT05627258|525449377|FG000|Overall Study|Other subject illness/injury|1|||
145708452|NCT05627258|525449378|FG001|Overall Study|Other subject illness/injury|0|||
145708453|NCT05627258|525449379|FG002|Overall Study|Other subject illness/injury|0|||
145708454|NCT05627258|525449380|FG003|Overall Study|Other subject illness/injury|0|||
145708455|NCT05627258|525449381|FG004|Overall Study|Other subject illness/injury|0|||
145708456|NCT05627258|525449382|FG005|Overall Study|Other subject illness/injury|0|||
145708457|NCT05627258|525449377|FG000|Overall Study|Subject moved from area|0|||
145708458|NCT05627258|525449378|FG001|Overall Study|Subject moved from area|0|||
145708459|NCT05627258|525449379|FG002|Overall Study|Subject moved from area|1|||
145708460|NCT05627258|525449380|FG003|Overall Study|Subject moved from area|0|||
145708461|NCT05627258|525449381|FG004|Overall Study|Subject moved from area|0|||
145708462|NCT05627258|525449382|FG005|Overall Study|Subject moved from area|0|||
145708463|NCT00678301|525449383|FG000|Overall Study|Non-compliance with study procedures|0|||
145708464|NCT00678301|525449384|FG001|Overall Study|Non-compliance with study procedures|1|||
145708465|NCT00678301|525449383|FG000|Overall Study|Adverse Event|1|||
145708466|NCT00678301|525449384|FG001|Overall Study|Adverse Event|0|||
145708467|NCT00678301|525449383|FG000|Overall Study|Withdrawal by Subject|4|||
145708468|NCT00678301|525449384|FG001|Overall Study|Withdrawal by Subject|0|||
145708469|NCT00678301|525449383|FG000|Overall Study|Lost to Follow-up|3|||
145708470|NCT00678301|525449384|FG001|Overall Study|Lost to Follow-up|1|||
145708471|NCT03338296|525449385|FG000|Overall Study|Adverse Event|0|||
145708472|NCT03338296|525449386|FG001|Overall Study|Adverse Event|1|||
145708473|NCT03338296|525449385|FG000|Overall Study|Withdrawal by Subject|14|||
145708474|NCT03338296|525449386|FG001|Overall Study|Withdrawal by Subject|13|||
145708475|NCT03338296|525449385|FG000|Overall Study|Lost to Follow-up|10|||
145708476|NCT03338296|525449386|FG001|Overall Study|Lost to Follow-up|10|||
145708477|NCT03338296|525449385|FG000|Overall Study|Study Terminated by Sponsor|77|||
145708478|NCT03338296|525449386|FG001|Overall Study|Study Terminated by Sponsor|76|||
145708479|NCT03338296|525449385|FG000|Overall Study|Other|2|||
145708480|NCT03338296|525449386|FG001|Overall Study|Other|7|||
145708481|NCT03338296|525449385|FG000|Overall Study|Missing|0|||
145708482|NCT03338296|525449386|FG001|Overall Study|Missing|1|||
145708483|NCT01939353|525449387|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
145708484|NCT01939353|525449387|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
145708485|NCT01939353|525449387|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
145708486|NCT01939353|525449387|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
145708487|NCT01939353|525449387|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
145708488|NCT04421950|525449393|FG000|Overall Study|Dropped or lost to follow up|4|||
145708489|NCT04421950|525449394|FG001|Overall Study|Dropped or lost to follow up|2|||
145708490|NCT05048238|525449395|FG000|Overall Study|Withdrawal by Subject|1|||
145708491|NCT00335140|525449398|FG000|Overall Study|Ineligible|1|||
145708492|NCT04546425|525449399|FG000|Overall Study|Protocol Violation|1|||
145708493|NCT04546425|525449400|FG001|Overall Study|Protocol Violation|1|||
145708494|NCT04546425|525449401|FG002|Overall Study|Protocol Violation|0|||
145708495|NCT04546425|525449402|FG003|Overall Study|Protocol Violation|0|||
145708496|NCT04546425|525449399|FG000|Overall Study|Adverse Event|3|||
145708497|NCT04546425|525449400|FG001|Overall Study|Adverse Event|0|||
145708498|NCT04546425|525449401|FG002|Overall Study|Adverse Event|0|||
145708499|NCT04546425|525449402|FG003|Overall Study|Adverse Event|0|||
145708500|NCT04546425|525449399|FG000|Overall Study|Lost to Follow-up|5|||
145708501|NCT04546425|525449400|FG001|Overall Study|Lost to Follow-up|4|||
145708502|NCT04546425|525449401|FG002|Overall Study|Lost to Follow-up|0|||
145708503|NCT04546425|525449402|FG003|Overall Study|Lost to Follow-up|0|||
145708504|NCT04546425|525449399|FG000|Overall Study|No Longer met eligibility criteria|3|||
145708505|NCT04546425|525449400|FG001|Overall Study|No Longer met eligibility criteria|3|||
145708506|NCT04546425|525449401|FG002|Overall Study|No Longer met eligibility criteria|1|||
145708507|NCT04546425|525449402|FG003|Overall Study|No Longer met eligibility criteria|1|||
145708508|NCT04546425|525449399|FG000|Overall Study|Withdrawal by parent/guardian|6|||
145708509|NCT04546425|525449400|FG001|Overall Study|Withdrawal by parent/guardian|5|||
145708510|NCT04546425|525449401|FG002|Overall Study|Withdrawal by parent/guardian|1|||
145708511|NCT04546425|525449402|FG003|Overall Study|Withdrawal by parent/guardian|1|||
145708512|NCT04076943|525449406|FG000|Overall Study|Withdrawal by Subject|12|||
145708513|NCT04076943|525449406|FG000|Overall Study|Adverse Event|1|||
145708514|NCT04076943|525449406|FG000|Overall Study|Progressive Disease|2|||
145708515|NCT04076943|525449406|FG000|Overall Study|Death|13|||
145708516|NCT04076943|525449406|FG000|Overall Study|Other than specified|6|||
145708517|NCT02766777|525449416|FG000|Overall Study|Adverse Event|12|||
145708518|NCT02766777|525449416|FG000|Overall Study|Lost to Follow-up|16|||
145708519|NCT02766777|525449416|FG000|Overall Study|Non-Compliance With Study Drug|1|||
145708520|NCT02766777|525449416|FG000|Overall Study|Protocol Violation|1|||
145708521|NCT02766777|525449416|FG000|Overall Study|Withdrawal by Subject|4|||
145708522|NCT02964325|525449417|FG000|Overall Study|Lost to Follow-up|3|||
145708523|NCT02964325|525449418|FG001|Overall Study|Lost to Follow-up|3|||
145708524|NCT02964325|525449417|FG000|Overall Study|Physician Decision|5|||
145708525|NCT02964325|525449418|FG001|Overall Study|Physician Decision|4|||
145708526|NCT02964325|525449417|FG000|Overall Study|Death|1|||
145708527|NCT02964325|525449418|FG001|Overall Study|Death|3|||
145708528|NCT02964325|525449417|FG000|Overall Study|Withdrawal by Subject|2|||
145708529|NCT02964325|525449418|FG001|Overall Study|Withdrawal by Subject|1|||
145708530|NCT02964325|525449417|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
145708531|NCT02964325|525449418|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
145708532|NCT01371825|525449423|FG000|Overall Study|Death|4|||
145708533|NCT00534495|525449424|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
145708534|NCT00534495|525449425|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
145708535|NCT00534495|525449426|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
145708536|NCT00534495|525449424|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
145708537|NCT00534495|525449425|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
145708538|NCT00534495|525449426|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
145708539|NCT00534495|525449424|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
145708540|NCT00534495|525449425|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
145708541|NCT00534495|525449426|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
145708542|NCT00534495|525449424|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
145708543|NCT00534495|525449425|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
145708544|NCT00534495|525449426|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
145708545|NCT00534495|525449424|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
145708546|NCT00534495|525449425|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
145708547|NCT00534495|525449426|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
145708548|NCT00534495|525449424|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
145708549|NCT00534495|525449425|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
145708550|NCT00534495|525449426|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
145708551|NCT00534495|525449424|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
145708552|NCT00534495|525449425|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
145708553|NCT00534495|525449426|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
145708554|NCT00534495|525449424|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
145708555|NCT00534495|525449425|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
145708556|NCT00534495|525449426|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
145708557|NCT00534495|525449424|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
145708558|NCT00534495|525449425|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
145708559|NCT00534495|525449426|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
145708560|NCT04868539|525449427|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
145708561|NCT04868539|525449428|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
145708562|NCT01572740|525449429|FG000|Overall Study|Adverse Event|1|||
145708563|NCT01572740|525449430|FG001|Overall Study|Adverse Event|1|||
145708564|NCT01572740|525449429|FG000|Overall Study|Withdrawal by Subject|1|||
145708565|NCT01572740|525449430|FG001|Overall Study|Withdrawal by Subject|1|||
145708566|NCT01572740|525449429|FG000|Overall Study|unclassified|4|||
145708567|NCT01572740|525449430|FG001|Overall Study|unclassified|3|||
145708568|NCT00214019|525449431|FG000|Overall Study|Lost to Follow-up|11|||
145708569|NCT00214019|525449431|FG000|Overall Study|Withdrawal by Subject|2|||
145708570|NCT00214019|525449431|FG000|Overall Study|Screen Failed prior to randomization|17|||
145708571|NCT04879849|525449433|FG000|Overall Study|Lost to Follow-up|0|||
145708572|NCT04879849|525449434|FG001|Overall Study|Lost to Follow-up|0|||
145708573|NCT04879849|525449435|FG002|Overall Study|Lost to Follow-up|0|||
145708574|NCT04879849|525449436|FG003|Overall Study|Lost to Follow-up|1|||
145708575|NCT04879849|525449437|FG004|Overall Study|Lost to Follow-up|0|||
145708576|NCT04879849|525449438|FG005|Overall Study|Lost to Follow-up|0|||
145708577|NCT04879849|525449439|FG006|Overall Study|Lost to Follow-up|0|||
145708578|NCT04879849|525449440|FG007|Overall Study|Lost to Follow-up|0|||
145708579|NCT04879849|525449433|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
145708580|NCT04879849|525449434|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
145708581|NCT04879849|525449435|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
145708582|NCT04879849|525449436|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
145708583|NCT04879849|525449437|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
145708584|NCT04879849|525449438|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
145708585|NCT04879849|525449439|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
145708586|NCT04879849|525449440|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
145708587|NCT04879849|525449433|FG000|Overall Study|Withdrawal by Subject|0|||
145708588|NCT04879849|525449434|FG001|Overall Study|Withdrawal by Subject|0|||
145708589|NCT04879849|525449435|FG002|Overall Study|Withdrawal by Subject|0|||
145708590|NCT04879849|525449436|FG003|Overall Study|Withdrawal by Subject|0|||
145708591|NCT04879849|525449437|FG004|Overall Study|Withdrawal by Subject|2|||
145708592|NCT04879849|525449438|FG005|Overall Study|Withdrawal by Subject|0|||
145708593|NCT04879849|525449439|FG006|Overall Study|Withdrawal by Subject|1|||
145708594|NCT04879849|525449440|FG007|Overall Study|Withdrawal by Subject|0|||
145708595|NCT04879849|525449433|FG000|Overall Study|Progressive Disease|0|||
145708596|NCT04879849|525449434|FG001|Overall Study|Progressive Disease|0|||
145708597|NCT04879849|525449435|FG002|Overall Study|Progressive Disease|1|||
145708598|NCT04879849|525449436|FG003|Overall Study|Progressive Disease|0|||
145708599|NCT04879849|525449437|FG004|Overall Study|Progressive Disease|0|||
145708600|NCT04879849|525449438|FG005|Overall Study|Progressive Disease|0|||
145708601|NCT04879849|525449439|FG006|Overall Study|Progressive Disease|0|||
145708602|NCT04879849|525449440|FG007|Overall Study|Progressive Disease|0|||
145708603|NCT04879849|525449433|FG000|Overall Study|Death|0|||
145708604|NCT04879849|525449434|FG001|Overall Study|Death|0|||
145708605|NCT04879849|525449435|FG002|Overall Study|Death|1|||
145708606|NCT04879849|525449436|FG003|Overall Study|Death|1|||
145708607|NCT04879849|525449437|FG004|Overall Study|Death|1|||
145708608|NCT04879849|525449438|FG005|Overall Study|Death|2|||
145708609|NCT04879849|525449439|FG006|Overall Study|Death|1|||
145708610|NCT04879849|525449440|FG007|Overall Study|Death|2|||
145708611|NCT04879849|525449433|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
145708612|NCT04879849|525449434|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
145708613|NCT04879849|525449435|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
145708614|NCT04879849|525449436|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
145708615|NCT04879849|525449437|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
145708616|NCT04879849|525449438|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
145708617|NCT04879849|525449439|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
145708618|NCT04879849|525449440|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
145708619|NCT04879849|525449433|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708620|NCT04879849|525449434|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708621|NCT04879849|525449435|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708622|NCT04879849|525449436|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708623|NCT04879849|525449437|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708624|NCT04879849|525449438|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708625|NCT04879849|525449439|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
145708626|NCT04879849|525449440|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
145708627|NCT04879849|525449433|FG000|Overall Study|Reason Not Specified|1|||
145708628|NCT04879849|525449434|FG001|Overall Study|Reason Not Specified|0|||
145708629|NCT04879849|525449435|FG002|Overall Study|Reason Not Specified|0|||
145708630|NCT04879849|525449436|FG003|Overall Study|Reason Not Specified|0|||
145708631|NCT04879849|525449437|FG004|Overall Study|Reason Not Specified|0|||
145708632|NCT04879849|525449438|FG005|Overall Study|Reason Not Specified|0|||
145708633|NCT04879849|525449439|FG006|Overall Study|Reason Not Specified|0|||
145708634|NCT04879849|525449440|FG007|Overall Study|Reason Not Specified|0|||
145708635|NCT03361865|525449441|FG000|Overall Study|Death|17|||
145708636|NCT03361865|525449442|FG001|Overall Study|Death|18|||
145708637|NCT03361865|525449441|FG000|Overall Study|Physician Decision|1|||
145708638|NCT03361865|525449442|FG001|Overall Study|Physician Decision|9|||
145708639|NCT03361865|525449441|FG000|Overall Study|Withdrawal by Subject|1|||
145708640|NCT03361865|525449442|FG001|Overall Study|Withdrawal by Subject|0|||
145708641|NCT04201262|525449444|FG000|Primary Treatment Period|Adverse Event|1|||
145708642|NCT04201262|525449445|FG001|Primary Treatment Period|Adverse Event|2|||
145708643|NCT04201262|525449444|FG000|Primary Treatment Period|Physician Decision|1|||
145708644|NCT04201262|525449445|FG001|Primary Treatment Period|Physician Decision|1|||
145708645|NCT04201262|525449444|FG000|Long-term Extension Period|Death|1|||
145708646|NCT04201262|525449445|FG001|Long-term Extension Period|Death|0|||
145708647|NCT04103892|525449447|FG000|Overall Study|Adverse Event|0|||
145708648|NCT04103892|525449448|FG001|Overall Study|Adverse Event|0|||
145708649|NCT04103892|525449449|FG002|Overall Study|Adverse Event|0|||
145708650|NCT04103892|525449450|FG003|Overall Study|Adverse Event|3|||
145708651|NCT04103892|525449447|FG000|Overall Study|Lost to Follow-up|0|||
145708652|NCT04103892|525449448|FG001|Overall Study|Lost to Follow-up|0|||
145708653|NCT04103892|525449449|FG002|Overall Study|Lost to Follow-up|2|||
145708654|NCT04103892|525449450|FG003|Overall Study|Lost to Follow-up|0|||
145708655|NCT04103892|525449447|FG000|Overall Study|Protocol Violation|0|||
145708656|NCT04103892|525449448|FG001|Overall Study|Protocol Violation|0|||
145708657|NCT04103892|525449449|FG002|Overall Study|Protocol Violation|1|||
145708658|NCT04103892|525449450|FG003|Overall Study|Protocol Violation|1|||
145708659|NCT04103892|525449447|FG000|Overall Study|Withdrawal by Subject|1|||
145708660|NCT04103892|525449448|FG001|Overall Study|Withdrawal by Subject|0|||
145708661|NCT04103892|525449449|FG002|Overall Study|Withdrawal by Subject|2|||
145708662|NCT04103892|525449450|FG003|Overall Study|Withdrawal by Subject|5|||
145708663|NCT04103892|525449447|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
145708664|NCT04103892|525449448|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
145708665|NCT04103892|525449449|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
145708666|NCT04103892|525449450|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
145708667|NCT02819024|525449451|FG000|Overall Study|Withdrawal by Subject|1|||
145708668|NCT05576662|525449452|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
145708669|NCT05576662|525449453|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
145708670|NCT05576662|525449452|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
145708671|NCT05576662|525449453|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
145708672|NCT05576662|525449452|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
145708673|NCT05576662|525449453|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
145708674|NCT05576662|525449452|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
145708675|NCT05576662|525449453|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
145708676|NCT03008005|525449461|FG000|Overall Study|Physician Decision|1|||
145708677|NCT03008005|525449462|FG001|Overall Study|Physician Decision|0|||
145708678|NCT03008005|525449463|FG002|Overall Study|Physician Decision|0|||
145708679|NCT03008005|525449461|FG000|Overall Study|Withdrawal by Subject|1|||
145708680|NCT03008005|525449462|FG001|Overall Study|Withdrawal by Subject|0|||
145708681|NCT03008005|525449463|FG002|Overall Study|Withdrawal by Subject|0|||
145708682|NCT03008005|525449461|FG000|Overall Study|Ineligible|0|||
145708683|NCT03008005|525449462|FG001|Overall Study|Ineligible|1|||
145708684|NCT03008005|525449463|FG002|Overall Study|Ineligible|0|||
145708685|NCT05217641|525449464|FG000|Overall Study|Lost to Follow-up|1|||
145708686|NCT05217641|525449465|FG001|Overall Study|Lost to Follow-up|1|||
145708687|NCT05217641|525449466|FG002|Overall Study|Lost to Follow-up|0|||
145708688|NCT05217641|525449467|FG003|Overall Study|Lost to Follow-up|1|||
145708689|NCT05217641|525449468|FG004|Overall Study|Lost to Follow-up|1|||
145708690|NCT05217641|525449469|FG005|Overall Study|Lost to Follow-up|0|||
145708691|NCT05217641|525449464|FG000|Overall Study|Withdrawal by Subject|0|||
145708692|NCT05217641|525449465|FG001|Overall Study|Withdrawal by Subject|0|||
145708693|NCT05217641|525449466|FG002|Overall Study|Withdrawal by Subject|0|||
145708694|NCT05217641|525449467|FG003|Overall Study|Withdrawal by Subject|3|||
145708695|NCT05217641|525449468|FG004|Overall Study|Withdrawal by Subject|1|||
145708696|NCT05217641|525449469|FG005|Overall Study|Withdrawal by Subject|0|||
145708697|NCT05217641|525449464|FG000|Overall Study|Other: participant did not specify reason|0|||
145708698|NCT05217641|525449465|FG001|Overall Study|Other: participant did not specify reason|0|||
145708699|NCT05217641|525449466|FG002|Overall Study|Other: participant did not specify reason|0|||
145708700|NCT05217641|525449467|FG003|Overall Study|Other: participant did not specify reason|0|||
145708701|NCT05217641|525449468|FG004|Overall Study|Other: participant did not specify reason|1|||
145708702|NCT05217641|525449469|FG005|Overall Study|Other: participant did not specify reason|0|||
145708703|NCT05217641|525449464|FG000|Overall Study|Extended Follow up|1|||
145708704|NCT05217641|525449465|FG001|Overall Study|Extended Follow up|1|||
145708705|NCT05217641|525449466|FG002|Overall Study|Extended Follow up|0|||
145708706|NCT05217641|525449467|FG003|Overall Study|Extended Follow up|0|||
145491451|NCT00883779|524653804|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
145708707|NCT05217641|525449468|FG004|Overall Study|Extended Follow up|1|||
145708708|NCT05217641|525449469|FG005|Overall Study|Extended Follow up|0|||
145708709|NCT03007420|525449475|FG000|Overall Study|Withdrawal by Subject|0|||
145708710|NCT03007420|525449476|FG001|Overall Study|Withdrawal by Subject|2|||
145708711|NCT03007420|525449475|FG000|Overall Study|Physician Decision|0|||
145708712|NCT03007420|525449476|FG001|Overall Study|Physician Decision|1|||
145708713|NCT05823012|525449477|FG000|Titration Period|Adverse Event|1|||
145708714|NCT05823012|525449477|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
145708715|NCT05823012|525449477|FG000|Maintenance Period|Adverse Event|1|||
145708716|NCT05823012|525449477|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
145708717|NCT05823012|525449477|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
145708718|NCT03829501|525451444|FG000|Overall Study|Withdrawal of Consent|2|||
145708719|NCT03829501|525451445|FG001|Overall Study|Withdrawal of Consent|0|||
145708720|NCT03829501|525451446|FG002|Overall Study|Withdrawal of Consent|3|||
145708721|NCT03829501|525451447|FG003|Overall Study|Withdrawal of Consent|0|||
145708722|NCT03829501|525451448|FG004|Overall Study|Withdrawal of Consent|1|||
145708723|NCT03829501|525451449|FG005|Overall Study|Withdrawal of Consent|1|||
145708724|NCT03829501|525451450|FG006|Overall Study|Withdrawal of Consent|0|||
145708725|NCT03829501|525451451|FG007|Overall Study|Withdrawal of Consent|10|||
145708726|NCT03829501|525451452|FG008|Overall Study|Withdrawal of Consent|10|||
145708727|NCT03829501|525451453|FG009|Overall Study|Withdrawal of Consent|3|||
145708728|NCT03829501|525451454|FG010|Overall Study|Withdrawal of Consent|4|||
145708729|NCT03829501|525451455|FG011|Overall Study|Withdrawal of Consent|4|||
145708730|NCT03829501|525451456|FG012|Overall Study|Withdrawal of Consent|4|||
145708731|NCT03829501|525451457|FG013|Overall Study|Withdrawal of Consent|0|||
145708732|NCT03829501|525451458|FG014|Overall Study|Withdrawal of Consent|3|||
145708733|NCT03829501|525451459|FG015|Overall Study|Withdrawal of Consent|0|||
145708734|NCT03829501|525451460|FG016|Overall Study|Withdrawal of Consent|1|||
145708735|NCT03829501|525451461|FG017|Overall Study|Withdrawal of Consent|1|||
145491452|NCT00883779|524653805|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
145491453|NCT00883779|524653804|FG000|Off-study Phase|Death|185|||
145491454|NCT00883779|524653805|FG001|Off-study Phase|Death|174|||
145491455|NCT00883779|524653804|FG000|Off-study Phase|Refused treatment|1|||
145491456|NCT00883779|524653805|FG001|Off-study Phase|Refused treatment|1|||
145491457|NCT00883779|524653804|FG000|Off-study Phase|Failure to return|5|||
145491458|NCT00883779|524653805|FG001|Off-study Phase|Failure to return|6|||
145491459|NCT00883779|524653804|FG000|Off-study Phase|Other|18|||
145491460|NCT00883779|524653805|FG001|Off-study Phase|Other|21|||
145491461|NCT00079040|524653806|FG000|Overall Study|Withdrew before treatment|1|||
145491462|NCT00079040|524653806|FG000|Overall Study|Ineligible|1|||
145491463|NCT00739401|524653811|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
145491464|NCT00739401|524653811|FG000|Overall Study|Death|3|||
145491465|NCT00739401|524653811|FG000|Overall Study|Withdrawal by Subject|4|||
145491466|NCT04575155|524653812|FG000|2 Month|Withdrawal by Subject|1|||
145491467|NCT04575155|524653813|FG001|2 Month|Withdrawal by Subject|1|||
145491468|NCT04575155|524653812|FG000|2 Month|Lost to Follow-up|5|||
145491469|NCT04575155|524653813|FG001|2 Month|Lost to Follow-up|3|||
145491470|NCT04575155|524653812|FG000|2 Month|Ineligible|1|||
145491471|NCT04575155|524653813|FG001|2 Month|Ineligible|0|||
145491472|NCT00982735|524653814|FG000|Overall Study|Lost to Follow-up|6|||
145491473|NCT00982735|524653814|FG000|Overall Study|Patient ineligible for trial|224|||
145491474|NCT00689390|524653816|FG000|Overall Study|Adverse Event|19|||
145491475|NCT00689390|524653817|FG001|Overall Study|Adverse Event|0|||
145491476|NCT00689390|524653816|FG000|Overall Study|Lost to Follow-up|179|||
145491477|NCT00689390|524653817|FG001|Overall Study|Lost to Follow-up|7|||
145491478|NCT00689390|524653816|FG000|Overall Study|Withdrawal by Subject|117|||
145491479|NCT00689390|524653817|FG001|Overall Study|Withdrawal by Subject|3|||
145491480|NCT00689390|524653816|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
145491481|NCT00689390|524653817|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
145491482|NCT00689390|524653816|FG000|Overall Study|Non-Compliance With Protocol|21|||
145491483|NCT00689390|524653817|FG001|Overall Study|Non-Compliance With Protocol|0|||
145491484|NCT00689390|524653816|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
145491485|NCT00689390|524653817|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
145491486|NCT00689390|524653816|FG000|Overall Study|Administrative|37|||
145491487|NCT00689390|524653817|FG001|Overall Study|Administrative|0|||
145491488|NCT01290523|524653818|FG000|Overall Study|Death|3|||
145491489|NCT03071263|524653819|FG000|Overall Study|Adverse Event|1|||
145491490|NCT03071263|524653820|FG001|Overall Study|Adverse Event|3|||
145491491|NCT03071263|524653819|FG000|Overall Study|Withdrawal by Subject|1|||
145491492|NCT03071263|524653820|FG001|Overall Study|Withdrawal by Subject|3|||
145491493|NCT03071263|524653819|FG000|Overall Study|Physician Decision|1|||
145491494|NCT03071263|524653820|FG001|Overall Study|Physician Decision|0|||
145708736|NCT03829501|525451462|FG018|Overall Study|Withdrawal of Consent|0|||
145708737|NCT03829501|525451463|FG019|Overall Study|Withdrawal of Consent|0|||
145708738|NCT03829501|525451464|FG020|Overall Study|Withdrawal of Consent|3|||
145708739|NCT03829501|525451465|FG021|Overall Study|Withdrawal of Consent|0|||
145708740|NCT03829501|525451466|FG022|Overall Study|Withdrawal of Consent|1|||
145708741|NCT03829501|525451444|FG000|Overall Study|PD|0|||
145708742|NCT03829501|525451445|FG001|Overall Study|PD|0|||
145708743|NCT03829501|525451446|FG002|Overall Study|PD|0|||
145708744|NCT03829501|525451447|FG003|Overall Study|PD|2|||
145708745|NCT03829501|525451448|FG004|Overall Study|PD|0|||
145708746|NCT03829501|525451449|FG005|Overall Study|PD|0|||
145708747|NCT03829501|525451450|FG006|Overall Study|PD|0|||
145708748|NCT03829501|525451451|FG007|Overall Study|PD|0|||
145708749|NCT03829501|525451452|FG008|Overall Study|PD|0|||
145708750|NCT03829501|525451453|FG009|Overall Study|PD|0|||
145708751|NCT03829501|525451454|FG010|Overall Study|PD|0|||
145708752|NCT03829501|525451455|FG011|Overall Study|PD|0|||
145708753|NCT03829501|525451456|FG012|Overall Study|PD|0|||
145708754|NCT03829501|525451457|FG013|Overall Study|PD|0|||
145708755|NCT03829501|525451458|FG014|Overall Study|PD|0|||
145708756|NCT03829501|525451459|FG015|Overall Study|PD|1|||
145708757|NCT03829501|525451460|FG016|Overall Study|PD|0|||
145708758|NCT03829501|525451461|FG017|Overall Study|PD|0|||
145708759|NCT03829501|525451462|FG018|Overall Study|PD|0|||
145708760|NCT03829501|525451463|FG019|Overall Study|PD|0|||
145708761|NCT03829501|525451464|FG020|Overall Study|PD|1|||
145708762|NCT03829501|525451465|FG021|Overall Study|PD|0|||
145708763|NCT03829501|525451466|FG022|Overall Study|PD|0|||
145708764|NCT03829501|525451444|FG000|Overall Study|Study Terminated by Sponsor|0|||
145708765|NCT03829501|525451445|FG001|Overall Study|Study Terminated by Sponsor|0|||
145708766|NCT03829501|525451446|FG002|Overall Study|Study Terminated by Sponsor|0|||
145708767|NCT03829501|525451447|FG003|Overall Study|Study Terminated by Sponsor|0|||
145708768|NCT03829501|525451448|FG004|Overall Study|Study Terminated by Sponsor|0|||
145708769|NCT03829501|525451449|FG005|Overall Study|Study Terminated by Sponsor|0|||
145708770|NCT03829501|525451450|FG006|Overall Study|Study Terminated by Sponsor|0|||
145708771|NCT03829501|525451451|FG007|Overall Study|Study Terminated by Sponsor|3|||
145708772|NCT03829501|525451452|FG008|Overall Study|Study Terminated by Sponsor|1|||
145708773|NCT03829501|525451453|FG009|Overall Study|Study Terminated by Sponsor|0|||
145708774|NCT03829501|525451454|FG010|Overall Study|Study Terminated by Sponsor|0|||
145708775|NCT03829501|525451455|FG011|Overall Study|Study Terminated by Sponsor|0|||
145708776|NCT03829501|525451456|FG012|Overall Study|Study Terminated by Sponsor|0|||
145708777|NCT03829501|525451457|FG013|Overall Study|Study Terminated by Sponsor|0|||
145708778|NCT03829501|525451458|FG014|Overall Study|Study Terminated by Sponsor|3|||
145708779|NCT03829501|525451459|FG015|Overall Study|Study Terminated by Sponsor|2|||
145708780|NCT03829501|525451460|FG016|Overall Study|Study Terminated by Sponsor|2|||
145708781|NCT03829501|525451461|FG017|Overall Study|Study Terminated by Sponsor|0|||
145708782|NCT03829501|525451462|FG018|Overall Study|Study Terminated by Sponsor|0|||
145708783|NCT03829501|525451463|FG019|Overall Study|Study Terminated by Sponsor|0|||
145708784|NCT03829501|525451464|FG020|Overall Study|Study Terminated by Sponsor|1|||
145708785|NCT03829501|525451465|FG021|Overall Study|Study Terminated by Sponsor|0|||
145708786|NCT03829501|525451466|FG022|Overall Study|Study Terminated by Sponsor|3|||
145708787|NCT03829501|525451444|FG000|Overall Study|Lost to Follow Up|0|||
145708788|NCT03829501|525451445|FG001|Overall Study|Lost to Follow Up|0|||
145708789|NCT03829501|525451446|FG002|Overall Study|Lost to Follow Up|0|||
145708790|NCT03829501|525451447|FG003|Overall Study|Lost to Follow Up|0|||
145708791|NCT03829501|525451448|FG004|Overall Study|Lost to Follow Up|1|||
145708792|NCT03829501|525451449|FG005|Overall Study|Lost to Follow Up|0|||
145708793|NCT03829501|525451450|FG006|Overall Study|Lost to Follow Up|0|||
145708794|NCT03829501|525451451|FG007|Overall Study|Lost to Follow Up|2|||
145708795|NCT03829501|525451452|FG008|Overall Study|Lost to Follow Up|2|||
145708796|NCT03829501|525451453|FG009|Overall Study|Lost to Follow Up|0|||
145708797|NCT03829501|525451454|FG010|Overall Study|Lost to Follow Up|2|||
145708798|NCT03829501|525451455|FG011|Overall Study|Lost to Follow Up|1|||
145708799|NCT03829501|525451456|FG012|Overall Study|Lost to Follow Up|0|||
145708800|NCT03829501|525451457|FG013|Overall Study|Lost to Follow Up|1|||
145708801|NCT03829501|525451458|FG014|Overall Study|Lost to Follow Up|1|||
145708802|NCT03829501|525451459|FG015|Overall Study|Lost to Follow Up|0|||
145708803|NCT03829501|525451460|FG016|Overall Study|Lost to Follow Up|0|||
145708804|NCT03829501|525451461|FG017|Overall Study|Lost to Follow Up|0|||
145708805|NCT03829501|525451462|FG018|Overall Study|Lost to Follow Up|0|||
145708806|NCT03829501|525451463|FG019|Overall Study|Lost to Follow Up|0|||
145708807|NCT03829501|525451464|FG020|Overall Study|Lost to Follow Up|0|||
145708808|NCT03829501|525451465|FG021|Overall Study|Lost to Follow Up|0|||
145708809|NCT03829501|525451466|FG022|Overall Study|Lost to Follow Up|1|||
145708810|NCT03829501|525451444|FG000|Overall Study|Death|2|||
145708811|NCT03829501|525451445|FG001|Overall Study|Death|4|||
145708812|NCT03829501|525451446|FG002|Overall Study|Death|5|||
145708813|NCT03829501|525451447|FG003|Overall Study|Death|6|||
145708814|NCT03829501|525451448|FG004|Overall Study|Death|5|||
145708815|NCT03829501|525451449|FG005|Overall Study|Death|4|||
145708816|NCT03829501|525451450|FG006|Overall Study|Death|5|||
145708817|NCT03829501|525451451|FG007|Overall Study|Death|24|||
145708818|NCT03829501|525451452|FG008|Overall Study|Death|22|||
145708819|NCT03829501|525451453|FG009|Overall Study|Death|6|||
145708820|NCT03829501|525451454|FG010|Overall Study|Death|3|||
145708821|NCT03829501|525451455|FG011|Overall Study|Death|10|||
145708822|NCT03829501|525451456|FG012|Overall Study|Death|10|||
145708823|NCT03829501|525451457|FG013|Overall Study|Death|5|||
145708824|NCT03829501|525451458|FG014|Overall Study|Death|7|||
145708825|NCT03829501|525451459|FG015|Overall Study|Death|2|||
145708826|NCT03829501|525451460|FG016|Overall Study|Death|2|||
145708827|NCT03829501|525451461|FG017|Overall Study|Death|1|||
145708828|NCT03829501|525451462|FG018|Overall Study|Death|1|||
145708829|NCT03829501|525451463|FG019|Overall Study|Death|1|||
145708830|NCT03829501|525451464|FG020|Overall Study|Death|1|||
145708831|NCT03829501|525451465|FG021|Overall Study|Death|2|||
145708832|NCT03829501|525451466|FG022|Overall Study|Death|3|||
145708833|NCT03829501|525451444|FG000|Overall Study|Miscellaneous|0|||
145708834|NCT03829501|525451445|FG001|Overall Study|Miscellaneous|0|||
145708835|NCT03829501|525451446|FG002|Overall Study|Miscellaneous|1|||
145708836|NCT03829501|525451447|FG003|Overall Study|Miscellaneous|0|||
145708837|NCT03829501|525451448|FG004|Overall Study|Miscellaneous|0|||
145708838|NCT03829501|525451449|FG005|Overall Study|Miscellaneous|0|||
145708839|NCT03829501|525451450|FG006|Overall Study|Miscellaneous|0|||
145708840|NCT03829501|525451451|FG007|Overall Study|Miscellaneous|1|||
145708841|NCT03829501|525451452|FG008|Overall Study|Miscellaneous|0|||
145708842|NCT03829501|525451453|FG009|Overall Study|Miscellaneous|0|||
145708843|NCT03829501|525451454|FG010|Overall Study|Miscellaneous|0|||
145708844|NCT03829501|525451455|FG011|Overall Study|Miscellaneous|0|||
145708845|NCT03829501|525451456|FG012|Overall Study|Miscellaneous|0|||
145708846|NCT03829501|525451457|FG013|Overall Study|Miscellaneous|0|||
145708847|NCT03829501|525451458|FG014|Overall Study|Miscellaneous|0|||
145708848|NCT03829501|525451459|FG015|Overall Study|Miscellaneous|0|||
145708849|NCT03829501|525451460|FG016|Overall Study|Miscellaneous|0|||
145708850|NCT03829501|525451461|FG017|Overall Study|Miscellaneous|0|||
145708851|NCT03829501|525451462|FG018|Overall Study|Miscellaneous|0|||
145708852|NCT03829501|525451463|FG019|Overall Study|Miscellaneous|0|||
145708853|NCT03829501|525451464|FG020|Overall Study|Miscellaneous|0|||
145708854|NCT03829501|525451465|FG021|Overall Study|Miscellaneous|0|||
145708855|NCT03829501|525451466|FG022|Overall Study|Miscellaneous|1|||
145708856|NCT03301155|525451476|FG000|Overall Study|Сompliance with exclusion criteria|8|||
145708857|NCT03301155|525451477|FG001|Overall Study|Сompliance with exclusion criteria|7|||
145708858|NCT01125046|525451480|FG000|First 6 Months of Treatment|Death|1|||
145708859|NCT01125046|525451480|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
145708860|NCT01125046|525451480|FG000|First 6 Months of Treatment|Non-compliance|1|||
145708861|NCT01125046|525451480|FG000|First 6 Months of Treatment|Surgery|1|||
145708862|NCT01125046|525451480|FG000|First 6 Months of Treatment|Progressive Disease|7|||
145708863|NCT01125046|525451480|FG000|First 6 Months of Treatment|Adverse Event|2|||
145708864|NCT01125046|525451480|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
145708865|NCT01125046|525451480|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
145708866|NCT01125046|525451480|FG000|Follow-up/Data Cut Off Point|Death|29|||
145708867|NCT01125046|525451480|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
145708868|NCT01685229|525451481|FG000|Overall Study|Subjects missing Study Exit form|3|||
145708869|NCT01685229|525451482|FG001|Overall Study|Subjects missing Study Exit form|1|||
145708870|NCT01685229|525451481|FG000|Overall Study|Lost to Follow-up|16|||
145708871|NCT01685229|525451482|FG001|Overall Study|Lost to Follow-up|10|||
145708872|NCT01685229|525451481|FG000|Overall Study|Withdrawal by Subject|6|||
145708873|NCT01685229|525451482|FG001|Overall Study|Withdrawal by Subject|5|||
145708874|NCT01685229|525451481|FG000|Overall Study|Death|1|||
145708875|NCT01685229|525451482|FG001|Overall Study|Death|0|||
145708876|NCT01401153|525451485|FG000|First Test Day|Learning disabilities; illness|1|||
145708877|NCT01401153|525451486|FG001|First Test Day|Learning disabilities; illness|10|||
145708878|NCT01401153|525451485|FG000|Second Test Day|illness|0|||
145708879|NCT01401153|525451486|FG001|Second Test Day|illness|5|||
145708880|NCT01818531|525451489|FG000|Overall Study|Withdrawn for case delay after block|1|||
145708881|NCT01818531|525451490|FG001|Overall Study|Withdrawn for case delay after block|0|||
145708882|NCT01818531|525451489|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
145708883|NCT01818531|525451490|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
145708884|NCT01818531|525451489|FG000|Overall Study|Withdrawn for failure to place block|0|||
145708885|NCT01818531|525451490|FG001|Overall Study|Withdrawn for failure to place block|1|||
145708886|NCT03635099|525451493|FG000|Period 1|Adverse Event|1|||
145708887|NCT03635099|525451494|FG001|Period 1|Adverse Event|0|||
145708888|NCT03635099|525451495|FG002|Period 1|Adverse Event|0|||
145708889|NCT03635099|525451496|FG003|Period 1|Adverse Event|1|||
145708890|NCT03635099|525451497|FG004|Period 1|Adverse Event|0|||
145708891|NCT03635099|525451498|FG005|Period 1|Adverse Event|0|||
145708892|NCT03635099|525451499|FG006|Period 1|Adverse Event|0|||
145708893|NCT03635099|525451500|FG007|Period 1|Adverse Event|0|||
145708894|NCT03635099|525451493|FG000|Period 1|Protocol Violation|0|||
145708895|NCT03635099|525451494|FG001|Period 1|Protocol Violation|0|||
145708896|NCT03635099|525451495|FG002|Period 1|Protocol Violation|1|||
145708897|NCT03635099|525451496|FG003|Period 1|Protocol Violation|0|||
145708898|NCT03635099|525451497|FG004|Period 1|Protocol Violation|0|||
145708899|NCT03635099|525451498|FG005|Period 1|Protocol Violation|0|||
145708900|NCT03635099|525451499|FG006|Period 1|Protocol Violation|0|||
145708901|NCT03635099|525451500|FG007|Period 1|Protocol Violation|0|||
145708902|NCT03635099|525451493|FG000|Period 1|Lost to Follow-up|0|||
145708903|NCT03635099|525451494|FG001|Period 1|Lost to Follow-up|0|||
145708904|NCT03635099|525451495|FG002|Period 1|Lost to Follow-up|1|||
145708905|NCT03635099|525451496|FG003|Period 1|Lost to Follow-up|2|||
145708906|NCT03635099|525451497|FG004|Period 1|Lost to Follow-up|1|||
145708907|NCT03635099|525451498|FG005|Period 1|Lost to Follow-up|0|||
145708908|NCT03635099|525451499|FG006|Period 1|Lost to Follow-up|1|||
145708909|NCT03635099|525451500|FG007|Period 1|Lost to Follow-up|2|||
145708910|NCT03635099|525451493|FG000|Period 1|Withdrawal by Subject|3|||
145708911|NCT03635099|525451494|FG001|Period 1|Withdrawal by Subject|3|||
145708912|NCT03635099|525451495|FG002|Period 1|Withdrawal by Subject|5|||
145708913|NCT03635099|525451496|FG003|Period 1|Withdrawal by Subject|2|||
145708914|NCT03635099|525451497|FG004|Period 1|Withdrawal by Subject|2|||
145708915|NCT03635099|525451498|FG005|Period 1|Withdrawal by Subject|0|||
145708916|NCT03635099|525451499|FG006|Period 1|Withdrawal by Subject|3|||
145708917|NCT03635099|525451500|FG007|Period 1|Withdrawal by Subject|0|||
145708918|NCT03635099|525451493|FG000|Period 1|History of suicidal ideation|0|||
145708919|NCT03635099|525451494|FG001|Period 1|History of suicidal ideation|0|||
145708920|NCT03635099|525451495|FG002|Period 1|History of suicidal ideation|1|||
145708921|NCT03635099|525451496|FG003|Period 1|History of suicidal ideation|0|||
145708922|NCT03635099|525451497|FG004|Period 1|History of suicidal ideation|0|||
145708923|NCT03635099|525451498|FG005|Period 1|History of suicidal ideation|0|||
145708924|NCT03635099|525451499|FG006|Period 1|History of suicidal ideation|0|||
145708925|NCT03635099|525451500|FG007|Period 1|History of suicidal ideation|0|||
145708926|NCT03635099|525451493|FG000|Period 1|pursue other treatment options|0|||
145708927|NCT03635099|525451494|FG001|Period 1|pursue other treatment options|0|||
145708928|NCT03635099|525451495|FG002|Period 1|pursue other treatment options|0|||
145708929|NCT03635099|525451496|FG003|Period 1|pursue other treatment options|0|||
145708930|NCT03635099|525451497|FG004|Period 1|pursue other treatment options|0|||
145708931|NCT03635099|525451498|FG005|Period 1|pursue other treatment options|1|||
145708932|NCT03635099|525451499|FG006|Period 1|pursue other treatment options|0|||
145708933|NCT03635099|525451500|FG007|Period 1|pursue other treatment options|0|||
145708934|NCT03635099|525451493|FG000|Not Eligible for Period 2|Pregnancy|0|||
145708935|NCT03635099|525451494|FG001|Not Eligible for Period 2|Pregnancy|0|||
145708936|NCT03635099|525451495|FG002|Not Eligible for Period 2|Pregnancy|0|||
145708937|NCT03635099|525451496|FG003|Not Eligible for Period 2|Pregnancy|1|||
145708938|NCT03635099|525451497|FG004|Not Eligible for Period 2|Pregnancy|0|||
145708939|NCT03635099|525451498|FG005|Not Eligible for Period 2|Pregnancy|0|||
145708940|NCT03635099|525451499|FG006|Not Eligible for Period 2|Pregnancy|0|||
145708941|NCT03635099|525451500|FG007|Not Eligible for Period 2|Pregnancy|0|||
145708942|NCT03635099|525451493|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
145708943|NCT03635099|525451494|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708944|NCT03635099|525451495|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708945|NCT03635099|525451496|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708946|NCT03635099|525451497|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708947|NCT03635099|525451498|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708948|NCT03635099|525451499|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708949|NCT03635099|525451500|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
145708950|NCT03635099|525451493|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
145708951|NCT03635099|525451494|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
145708952|NCT03635099|525451495|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
145708953|NCT03635099|525451496|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
145708954|NCT03635099|525451497|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
145708955|NCT03635099|525451498|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
145708956|NCT03635099|525451499|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
145708957|NCT03635099|525451500|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
145708958|NCT03635099|525451493|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
145708959|NCT03635099|525451494|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
145708960|NCT03635099|525451495|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
145708961|NCT03635099|525451496|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
145708962|NCT03635099|525451497|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
145708963|NCT03635099|525451498|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
145708964|NCT03635099|525451499|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
145708965|NCT03635099|525451500|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
145708966|NCT03635099|525451493|FG000|Period 2|Adverse Event|0|||
145708967|NCT03635099|525451494|FG001|Period 2|Adverse Event|0|||
145708968|NCT03635099|525451495|FG002|Period 2|Adverse Event|1|||
145708969|NCT03635099|525451496|FG003|Period 2|Adverse Event|0|||
145708970|NCT03635099|525451497|FG004|Period 2|Adverse Event|1|||
145708971|NCT03635099|525451498|FG005|Period 2|Adverse Event|0|||
145708972|NCT03635099|525451499|FG006|Period 2|Adverse Event|0|||
145708973|NCT03635099|525451500|FG007|Period 2|Adverse Event|0|||
145708974|NCT03635099|525451493|FG000|Period 2|Lost to Follow-up|0|||
145708975|NCT03635099|525451494|FG001|Period 2|Lost to Follow-up|0|||
145708976|NCT03635099|525451495|FG002|Period 2|Lost to Follow-up|1|||
145708977|NCT03635099|525451496|FG003|Period 2|Lost to Follow-up|0|||
145708978|NCT03635099|525451497|FG004|Period 2|Lost to Follow-up|4|||
145708979|NCT03635099|525451498|FG005|Period 2|Lost to Follow-up|0|||
145708980|NCT03635099|525451499|FG006|Period 2|Lost to Follow-up|0|||
145708981|NCT03635099|525451500|FG007|Period 2|Lost to Follow-up|0|||
145708982|NCT03635099|525451493|FG000|Period 2|Withdrawal by Subject|0|||
145708983|NCT03635099|525451494|FG001|Period 2|Withdrawal by Subject|0|||
145708984|NCT03635099|525451495|FG002|Period 2|Withdrawal by Subject|7|||
145708985|NCT03635099|525451496|FG003|Period 2|Withdrawal by Subject|4|||
145708986|NCT03635099|525451497|FG004|Period 2|Withdrawal by Subject|7|||
145708987|NCT03635099|525451498|FG005|Period 2|Withdrawal by Subject|0|||
145708988|NCT03635099|525451499|FG006|Period 2|Withdrawal by Subject|0|||
145708989|NCT03635099|525451500|FG007|Period 2|Withdrawal by Subject|0|||
145708990|NCT01465763|525451501|FG000|Overall Study|Withdrawal by Subject|4|||
145708991|NCT01465763|525451502|FG001|Overall Study|Withdrawal by Subject|0|||
145708992|NCT01465763|525451503|FG002|Overall Study|Withdrawal by Subject|1|||
145708993|NCT01465763|525451501|FG000|Overall Study|Insufficient Clinical Response|11|||
145708994|NCT01465763|525451502|FG001|Overall Study|Insufficient Clinical Response|0|||
145708995|NCT01465763|525451503|FG002|Overall Study|Insufficient Clinical Response|1|||
145708996|NCT01465763|525451501|FG000|Overall Study|Adverse Event|9|||
145708997|NCT01465763|525451502|FG001|Overall Study|Adverse Event|0|||
145708998|NCT01465763|525451503|FG002|Overall Study|Adverse Event|1|||
145708999|NCT01465763|525451501|FG000|Overall Study|Other|2|||
145709000|NCT01465763|525451502|FG001|Overall Study|Other|0|||
145709001|NCT01465763|525451503|FG002|Overall Study|Other|0|||
145709002|NCT01465763|525451501|FG000|Overall Study|Protocol Violation|4|||
145709003|NCT01465763|525451502|FG001|Overall Study|Protocol Violation|1|||
145709004|NCT01465763|525451503|FG002|Overall Study|Protocol Violation|1|||
145709005|NCT01465763|525451501|FG000|Overall Study|Death|1|||
145709006|NCT01465763|525451502|FG001|Overall Study|Death|0|||
145709007|NCT01465763|525451503|FG002|Overall Study|Death|0|||
145709008|NCT01068665|525451504|FG000|Overall Study|Adverse Event|5|||
145709009|NCT01068665|525451505|FG001|Overall Study|Adverse Event|4|||
145709010|NCT01068665|525451504|FG000|Overall Study|Lack of Efficacy|0|||
145709011|NCT01068665|525451505|FG001|Overall Study|Lack of Efficacy|2|||
145709012|NCT01068665|525451504|FG000|Overall Study|Protocol Violation|5|||
145709013|NCT01068665|525451505|FG001|Overall Study|Protocol Violation|2|||
145709014|NCT01068665|525451504|FG000|Overall Study|Withdrawal Criteria|3|||
145709015|NCT01068665|525451505|FG001|Overall Study|Withdrawal Criteria|9|||
145709016|NCT01068665|525451504|FG000|Overall Study|Other|17|||
145709017|NCT01068665|525451505|FG001|Overall Study|Other|12|||
145709018|NCT02807272|525451509|FG000|Overall Study|Death|9|||
145709019|NCT02807272|525451510|FG001|Overall Study|Death|5|||
145709020|NCT02807272|525451511|FG002|Overall Study|Death|2|||
145709021|NCT02807272|525451512|FG003|Overall Study|Death|0|||
145709022|NCT02807272|525451513|FG004|Overall Study|Death|1|||
145709023|NCT02807272|525451509|FG000|Overall Study|Lost to Follow-up|1|||
145709024|NCT02807272|525451510|FG001|Overall Study|Lost to Follow-up|0|||
145709025|NCT02807272|525451511|FG002|Overall Study|Lost to Follow-up|0|||
145709026|NCT02807272|525451512|FG003|Overall Study|Lost to Follow-up|0|||
145709027|NCT02807272|525451513|FG004|Overall Study|Lost to Follow-up|0|||
145709028|NCT02807272|525451509|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
145709029|NCT02807272|525451510|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
145709030|NCT02807272|525451511|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
145709031|NCT02807272|525451512|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
145709032|NCT02807272|525451513|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
145709033|NCT02807272|525451509|FG000|Overall Study|Protocol-defined Disease Progression|0|||
145491495|NCT03071263|524653819|FG000|Overall Study|Participant moved to another city|0|||
145491496|NCT03071263|524653820|FG001|Overall Study|Participant moved to another city|1|||
145491497|NCT02922725|524653822|FG000|Overall Study|Withdrawal by Subject|1|||
145491498|NCT02922725|524653823|FG001|Overall Study|Withdrawal by Subject|0|||
145491499|NCT02922725|524653824|FG002|Overall Study|Withdrawal by Subject|0|||
145491500|NCT00360412|524653825|FG000|Overall Study|Adverse Event|37|||
145709034|NCT02807272|525451510|FG001|Overall Study|Protocol-defined Disease Progression|1|||
145709035|NCT02807272|525451511|FG002|Overall Study|Protocol-defined Disease Progression|0|||
145709036|NCT02807272|525451512|FG003|Overall Study|Protocol-defined Disease Progression|0|||
145709037|NCT02807272|525451513|FG004|Overall Study|Protocol-defined Disease Progression|1|||
145709038|NCT02807272|525451509|FG000|Overall Study|Study Terminated by Sponsor|1|||
145709039|NCT02807272|525451510|FG001|Overall Study|Study Terminated by Sponsor|0|||
145709040|NCT02807272|525451511|FG002|Overall Study|Study Terminated by Sponsor|0|||
145709041|NCT02807272|525451512|FG003|Overall Study|Study Terminated by Sponsor|1|||
145709042|NCT02807272|525451513|FG004|Overall Study|Study Terminated by Sponsor|0|||
145709043|NCT02807272|525451509|FG000|Overall Study|Other|1|||
145709044|NCT02807272|525451510|FG001|Overall Study|Other|0|||
145709045|NCT02807272|525451511|FG002|Overall Study|Other|0|||
145709046|NCT02807272|525451512|FG003|Overall Study|Other|0|||
145709047|NCT02807272|525451513|FG004|Overall Study|Other|1|||
145709048|NCT04191616|525451515|FG000|Pre-assignment Period|Did not receive study treatment|2|||
145491501|NCT00360412|524653826|FG001|Overall Study|Adverse Event|65|||
145491502|NCT00360412|524653825|FG000|Overall Study|Protocol Violation|2|||
145491503|NCT00360412|524653826|FG001|Overall Study|Protocol Violation|5|||
145491504|NCT00360412|524653825|FG000|Overall Study|Patient withdrew consent|27|||
145491505|NCT00360412|524653826|FG001|Overall Study|Patient withdrew consent|52|||
145491506|NCT00360412|524653825|FG000|Overall Study|Lack of therapeutic efficacy|46|||
145709049|NCT04191616|525451515|FG000|Treatment Period|Death|37|||
145709050|NCT04191616|525451515|FG000|Treatment Period|Sponsor decision|11|||
145709051|NCT04191616|525451515|FG000|Treatment Period|Withdrawal by Subject|4|||
145709052|NCT01038427|525451516|FG000|Overall Study|Lost to follow up|1|||
145709053|NCT01038427|525451517|FG001|Overall Study|Lost to follow up|1|||
145709054|NCT01038427|525451518|FG002|Overall Study|Lost to follow up|0|||
145709055|NCT01038427|525451516|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
145709056|NCT01038427|525451517|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
145709057|NCT01038427|525451518|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
145709058|NCT01038427|525451516|FG000|Overall Study|Withdrew consent|0|||
145709059|NCT01038427|525451517|FG001|Overall Study|Withdrew consent|0|||
145709060|NCT01038427|525451518|FG002|Overall Study|Withdrew consent|1|||
145709061|NCT01038427|525451516|FG000|Overall Study|Adverse Event|2|||
145709062|NCT01038427|525451517|FG001|Overall Study|Adverse Event|2|||
145709063|NCT01038427|525451518|FG002|Overall Study|Adverse Event|1|||
145709064|NCT01038427|525451516|FG000|Overall Study|Enrolled in error|0|||
145709065|NCT01038427|525451517|FG001|Overall Study|Enrolled in error|1|||
145709066|NCT01038427|525451518|FG002|Overall Study|Enrolled in error|1|||
145709067|NCT01038427|525451516|FG000|Overall Study|Other|0|||
145709068|NCT01038427|525451517|FG001|Overall Study|Other|2|||
145709069|NCT01038427|525451518|FG002|Overall Study|Other|0|||
145709070|NCT01162863|525451519|FG000|Overall Study|Lack of Efficacy|1|||
145709071|NCT01162863|525451520|FG001|Overall Study|Lack of Efficacy|0|||
145709072|NCT01162863|525451521|FG002|Overall Study|Lack of Efficacy|0|||
145709073|NCT01162863|525451519|FG000|Overall Study|Adverse Event|0|||
145709074|NCT01162863|525451520|FG001|Overall Study|Adverse Event|1|||
145709075|NCT01162863|525451521|FG002|Overall Study|Adverse Event|0|||
145709076|NCT02992691|525451522|FG000|Overall Study|Adverse Event|2|||
145709077|NCT02992691|525451522|FG000|Overall Study|Withdrawal by Subject|1|||
145709078|NCT00588692|525451523|FG000|Overall Study|Withdrawal by Subject|4|||
145709079|NCT00588692|525451524|FG001|Overall Study|Withdrawal by Subject|2|||
145709080|NCT00588692|525451523|FG000|Overall Study|Hip Surgery|0|||
145709081|NCT00588692|525451524|FG001|Overall Study|Hip Surgery|1|||
145709082|NCT00588692|525451523|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
145709083|NCT00588692|525451524|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
145709084|NCT00588692|525451523|FG000|Overall Study|Cancer|1|||
145709085|NCT00588692|525451524|FG001|Overall Study|Cancer|0|||
145709086|NCT00588692|525451523|FG000|Overall Study|Death|1|||
145709087|NCT00588692|525451524|FG001|Overall Study|Death|0|||
145709088|NCT00392925|525451526|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
145709089|NCT00392925|525451527|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
145709090|NCT00392925|525451528|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
145709091|NCT00392925|525451529|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
145709092|NCT00392925|525451526|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
145709093|NCT00392925|525451527|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
145709094|NCT00392925|525451528|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
145709095|NCT00392925|525451529|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
145709096|NCT00392925|525451526|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
145709097|NCT00392925|525451527|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
145709098|NCT00392925|525451528|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
145709099|NCT00392925|525451529|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
145709100|NCT00392925|525451526|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
145709101|NCT00392925|525451527|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
145709102|NCT00392925|525451528|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
145709103|NCT00392925|525451529|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
145709104|NCT00392925|525451526|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
145709105|NCT00392925|525451527|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
145709106|NCT00392925|525451528|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
145709107|NCT00392925|525451529|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
145709108|NCT00392925|525451526|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
145709109|NCT00392925|525451527|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
145709110|NCT00392925|525451528|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
145491507|NCT00360412|524653826|FG001|Overall Study|Lack of therapeutic efficacy|61|||
145491508|NCT00360412|524653825|FG000|Overall Study|Physician Decision|2|||
145709111|NCT00392925|525451529|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
145709112|NCT00392925|525451526|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
145709113|NCT00392925|525451527|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
145709114|NCT00392925|525451528|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
145709115|NCT00392925|525451529|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
145709116|NCT00392925|525451526|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
145709117|NCT00392925|525451527|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
145709118|NCT00392925|525451528|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
145709119|NCT00392925|525451529|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
145709120|NCT00392925|525451526|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
145709121|NCT00392925|525451527|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
145709122|NCT00392925|525451528|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
145709123|NCT00392925|525451529|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
145709124|NCT00820170|525451530|FG000|Overall Study|Adverse Event|0|||
145709125|NCT00820170|525451531|FG001|Overall Study|Adverse Event|0|||
145709126|NCT00820170|525451532|FG002|Overall Study|Adverse Event|0|||
145709127|NCT00820170|525451533|FG003|Overall Study|Adverse Event|0|||
145709128|NCT00820170|525451534|FG004|Overall Study|Adverse Event|2|||
145709129|NCT00820170|525451530|FG000|Overall Study|Progressive Disease|0|||
145709130|NCT00820170|525451531|FG001|Overall Study|Progressive Disease|0|||
145709131|NCT00820170|525451532|FG002|Overall Study|Progressive Disease|0|||
145709132|NCT00820170|525451533|FG003|Overall Study|Progressive Disease|0|||
145709133|NCT00820170|525451534|FG004|Overall Study|Progressive Disease|2|||
145709134|NCT03552523|525451537|FG000|Overall Study|Withdrawal by Subject|1|||
145709135|NCT03552523|525451538|FG001|Overall Study|Withdrawal by Subject|1|||
145709136|NCT03538938|525451539|FG000|Overall Study|Death|0|||
145709137|NCT03538938|525451540|FG001|Overall Study|Death|0|||
145709138|NCT03538938|525451541|FG002|Overall Study|Death|2|||
145709139|NCT03538938|525451542|FG003|Overall Study|Death|0|||
145709140|NCT03538938|525451543|FG004|Overall Study|Death|0|||
145709141|NCT03538938|525451544|FG005|Overall Study|Death|1|||
145709142|NCT03538938|525451545|FG006|Overall Study|Death|0|||
145709143|NCT03538938|525451546|FG007|Overall Study|Death|1|||
145709144|NCT03538938|525451547|FG008|Overall Study|Death|1|||
145709145|NCT03538938|525451548|FG009|Overall Study|Death|1|||
145709146|NCT03538938|525451549|FG010|Overall Study|Death|0|||
145709147|NCT03538938|525451550|FG011|Overall Study|Death|0|||
145709148|NCT03538938|525451551|FG012|Overall Study|Death|1|||
145709149|NCT03538938|525451552|FG013|Overall Study|Death|1|||
145709150|NCT03538938|525451553|FG014|Overall Study|Death|0|||
145709151|NCT03538938|525451554|FG015|Overall Study|Death|1|||
145709152|NCT03538938|525451539|FG000|Overall Study|Withdrawal by Subject|4|||
145709153|NCT03538938|525451540|FG001|Overall Study|Withdrawal by Subject|6|||
145709154|NCT03538938|525451541|FG002|Overall Study|Withdrawal by Subject|5|||
145709155|NCT03538938|525451542|FG003|Overall Study|Withdrawal by Subject|3|||
145709156|NCT03538938|525451543|FG004|Overall Study|Withdrawal by Subject|0|||
145709157|NCT03538938|525451544|FG005|Overall Study|Withdrawal by Subject|0|||
145709158|NCT03538938|525451545|FG006|Overall Study|Withdrawal by Subject|3|||
145709159|NCT03538938|525451546|FG007|Overall Study|Withdrawal by Subject|1|||
145709160|NCT03538938|525451547|FG008|Overall Study|Withdrawal by Subject|5|||
145709161|NCT03538938|525451548|FG009|Overall Study|Withdrawal by Subject|1|||
145709162|NCT03538938|525451549|FG010|Overall Study|Withdrawal by Subject|2|||
145709163|NCT03538938|525451550|FG011|Overall Study|Withdrawal by Subject|1|||
145709164|NCT03538938|525451551|FG012|Overall Study|Withdrawal by Subject|3|||
145709165|NCT03538938|525451552|FG013|Overall Study|Withdrawal by Subject|0|||
145709166|NCT03538938|525451553|FG014|Overall Study|Withdrawal by Subject|2|||
145709167|NCT03538938|525451554|FG015|Overall Study|Withdrawal by Subject|4|||
145709168|NCT03538938|525451539|FG000|Overall Study|Incarcerated|0|||
145709169|NCT03538938|525451540|FG001|Overall Study|Incarcerated|0|||
145709170|NCT03538938|525451541|FG002|Overall Study|Incarcerated|0|||
145709171|NCT03538938|525451542|FG003|Overall Study|Incarcerated|0|||
145709172|NCT03538938|525451543|FG004|Overall Study|Incarcerated|0|||
145709173|NCT03538938|525451544|FG005|Overall Study|Incarcerated|0|||
145709174|NCT03538938|525451545|FG006|Overall Study|Incarcerated|0|||
145709175|NCT03538938|525451546|FG007|Overall Study|Incarcerated|0|||
145709176|NCT03538938|525451547|FG008|Overall Study|Incarcerated|0|||
145709177|NCT03538938|525451548|FG009|Overall Study|Incarcerated|0|||
145709178|NCT03538938|525451549|FG010|Overall Study|Incarcerated|0|||
145709179|NCT03538938|525451550|FG011|Overall Study|Incarcerated|1|||
145709180|NCT03538938|525451551|FG012|Overall Study|Incarcerated|0|||
145709181|NCT03538938|525451552|FG013|Overall Study|Incarcerated|0|||
145709182|NCT03538938|525451553|FG014|Overall Study|Incarcerated|0|||
145709183|NCT03538938|525451554|FG015|Overall Study|Incarcerated|0|||
145709184|NCT00604708|525451555|FG000|Overall Study|Withdrawal by Subject|9|||
145709185|NCT00604708|525451556|FG001|Overall Study|Withdrawal by Subject|10|||
145709186|NCT00604708|525451555|FG000|Overall Study|Protocol Violation|2|||
145709187|NCT00604708|525451556|FG001|Overall Study|Protocol Violation|8|||
145709188|NCT00604708|525451555|FG000|Overall Study|Lost to Follow-up|5|||
145709189|NCT00604708|525451556|FG001|Overall Study|Lost to Follow-up|5|||
145709190|NCT00604708|525451555|FG000|Overall Study|administrative reasons|9|||
145709191|NCT00604708|525451556|FG001|Overall Study|administrative reasons|11|||
145709192|NCT00604708|525451555|FG000|Overall Study|Adverse Event|6|||
145709193|NCT00604708|525451556|FG001|Overall Study|Adverse Event|6|||
145709194|NCT03995316|525451558|FG000|Overall Study|Lost to Follow-up|10|||
145709195|NCT03995316|525451559|FG001|Overall Study|Lost to Follow-up|3|||
145709196|NCT02180243|525451560|FG000|Overall Study|Withdrawal by Subject|12|||
145709197|NCT02180243|525451561|FG001|Overall Study|Withdrawal by Subject|12|||
145709198|NCT02180243|525451560|FG000|Overall Study|Lost to Follow-up|12|||
145709199|NCT02180243|525451561|FG001|Overall Study|Lost to Follow-up|2|||
145709200|NCT02202785|525451562|FG000|Overall Study|Study Terminated by Sponsor|1|||
145709201|NCT02202785|525451563|FG001|Overall Study|Study Terminated by Sponsor|6|||
145709202|NCT02202785|525451564|FG002|Overall Study|Study Terminated by Sponsor|4|||
145709203|NCT02202785|525451562|FG000|Overall Study|Withdrawal by Subject|0|||
145709204|NCT02202785|525451563|FG001|Overall Study|Withdrawal by Subject|1|||
145709205|NCT02202785|525451564|FG002|Overall Study|Withdrawal by Subject|0|||
145709206|NCT02202785|525451562|FG000|Overall Study|Lost to Follow-up|0|||
145709207|NCT02202785|525451563|FG001|Overall Study|Lost to Follow-up|1|||
145709208|NCT02202785|525451564|FG002|Overall Study|Lost to Follow-up|0|||
145709209|NCT02202785|525451562|FG000|Overall Study|Reason not Specified|10|||
145709210|NCT02202785|525451563|FG001|Overall Study|Reason not Specified|7|||
145709211|NCT02202785|525451564|FG002|Overall Study|Reason not Specified|13|||
145709212|NCT01137578|525451565|FG000|Overall Study|Participant requested to Discontinue|3|||
145709213|NCT01137578|525451566|FG001|Overall Study|Participant requested to Discontinue|0|||
145709214|NCT01137578|525451567|FG002|Overall Study|Participant requested to Discontinue|0|||
145709215|NCT01137578|525451565|FG000|Overall Study|Withdrawal by Subject|1|||
145709216|NCT01137578|525451566|FG001|Overall Study|Withdrawal by Subject|0|||
145709217|NCT01137578|525451567|FG002|Overall Study|Withdrawal by Subject|0|||
145709218|NCT01137578|525451565|FG000|Overall Study|Other|12|||
145709219|NCT01137578|525451566|FG001|Overall Study|Other|2|||
145709220|NCT01137578|525451567|FG002|Overall Study|Other|6|||
145709221|NCT01361594|525451568|FG000|Overall Study|Withdrawal by Subject|1|||
145709222|NCT01361594|525451569|FG001|Overall Study|Withdrawal by Subject|2|||
145709223|NCT00415051|525451571|FG000|Overall Study|Protocol Violation|1|||
145709224|NCT01518153|525451574|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
145709225|NCT01518153|525451575|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
145709226|NCT01518153|525451576|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
145709227|NCT01518153|525451574|FG000|Stem Cell Transplant|Death|2|||
145709228|NCT01518153|525451575|FG001|Stem Cell Transplant|Death|0|||
145709229|NCT01518153|525451576|FG002|Stem Cell Transplant|Death|0|||
145709230|NCT01518153|525451574|FG000|Stem Cell Transplant|Secondary graft failure|1|||
145709231|NCT01518153|525451575|FG001|Stem Cell Transplant|Secondary graft failure|0|||
145709232|NCT01518153|525451576|FG002|Stem Cell Transplant|Secondary graft failure|0|||
145709233|NCT01518153|525451574|FG000|Stem Cell Transplant|Adverse Event|1|||
145709234|NCT01518153|525451575|FG001|Stem Cell Transplant|Adverse Event|0|||
145709235|NCT01518153|525451576|FG002|Stem Cell Transplant|Adverse Event|0|||
145709236|NCT01518153|525451574|FG000|Donor Lymphocyte Infusion|Death|0|||
145709237|NCT01518153|525451575|FG001|Donor Lymphocyte Infusion|Death|2|||
145709238|NCT01518153|525451576|FG002|Donor Lymphocyte Infusion|Death|1|||
145709239|NCT03197766|525451577|FG000|Overall Study|Withdrawal by Subject|2|||
145709240|NCT03197766|525451578|FG001|Overall Study|Withdrawal by Subject|0|||
145709241|NCT01436253|525451579|FG000|Overall Study|Lost to Follow-up|182|||
145709242|NCT01436253|525451579|FG000|Overall Study|Not meeting all eligibility criteria|117|||
145709243|NCT03083665|525451581|FG000|Double-Blind Period|Adverse Event|5|||
145709244|NCT03083665|525451582|FG001|Double-Blind Period|Adverse Event|4|||
145709245|NCT03083665|525451583|FG002|Double-Blind Period|Adverse Event|5|||
145709246|NCT03083665|525451584|FG003|Double-Blind Period|Adverse Event|0|||
145709247|NCT03083665|525451585|FG004|Double-Blind Period|Adverse Event|0|||
145709248|NCT03083665|525451586|FG005|Double-Blind Period|Adverse Event|0|||
145709249|NCT03083665|525451581|FG000|Double-Blind Period|Lack of Efficacy|0|||
145709250|NCT03083665|525451582|FG001|Double-Blind Period|Lack of Efficacy|0|||
145709251|NCT03083665|525451583|FG002|Double-Blind Period|Lack of Efficacy|1|||
145709252|NCT03083665|525451584|FG003|Double-Blind Period|Lack of Efficacy|0|||
145709253|NCT03083665|525451585|FG004|Double-Blind Period|Lack of Efficacy|0|||
145709254|NCT03083665|525451586|FG005|Double-Blind Period|Lack of Efficacy|0|||
145709255|NCT03083665|525451581|FG000|Double-Blind Period|Protocol Violation|1|||
145709256|NCT03083665|525451582|FG001|Double-Blind Period|Protocol Violation|0|||
145709257|NCT03083665|525451583|FG002|Double-Blind Period|Protocol Violation|1|||
145709258|NCT03083665|525451584|FG003|Double-Blind Period|Protocol Violation|0|||
145709259|NCT03083665|525451585|FG004|Double-Blind Period|Protocol Violation|0|||
145709260|NCT03083665|525451586|FG005|Double-Blind Period|Protocol Violation|0|||
145709261|NCT03083665|525451581|FG000|Double-Blind Period|Lost to Follow-up|1|||
145709262|NCT03083665|525451582|FG001|Double-Blind Period|Lost to Follow-up|0|||
145709263|NCT03083665|525451583|FG002|Double-Blind Period|Lost to Follow-up|1|||
145709264|NCT03083665|525451584|FG003|Double-Blind Period|Lost to Follow-up|0|||
145709265|NCT03083665|525451585|FG004|Double-Blind Period|Lost to Follow-up|0|||
145709266|NCT03083665|525451586|FG005|Double-Blind Period|Lost to Follow-up|0|||
145709267|NCT03083665|525451581|FG000|Double-Blind Period|Withdrawal by Subject|3|||
145709268|NCT03083665|525451582|FG001|Double-Blind Period|Withdrawal by Subject|0|||
145709269|NCT03083665|525451583|FG002|Double-Blind Period|Withdrawal by Subject|0|||
145709270|NCT03083665|525451584|FG003|Double-Blind Period|Withdrawal by Subject|0|||
145709271|NCT03083665|525451585|FG004|Double-Blind Period|Withdrawal by Subject|0|||
145709272|NCT03083665|525451586|FG005|Double-Blind Period|Withdrawal by Subject|0|||
145709273|NCT03083665|525451581|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
145709274|NCT03083665|525451582|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
145709275|NCT03083665|525451583|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
145709276|NCT03083665|525451584|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
145709277|NCT03083665|525451585|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
145709278|NCT03083665|525451586|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
145709279|NCT03083665|525451581|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
145709280|NCT03083665|525451582|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
145709281|NCT03083665|525451583|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
145709282|NCT03083665|525451584|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
145709283|NCT03083665|525451585|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
145709284|NCT03083665|525451586|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
145709285|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
145709286|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
145709287|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
145709288|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
145709289|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
145709290|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
145709291|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
145709292|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
145709293|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
145709294|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
145709295|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
145709296|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
145709297|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
145709298|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
145709299|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
145709300|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
145709301|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
145709302|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
145709303|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
145709304|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
145709305|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
145709306|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
145709307|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
145709308|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
145709309|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
145709310|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
145709311|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
145709312|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
145709313|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
145709314|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
145709315|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
145709316|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
145709317|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
145709318|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
145709319|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
145709320|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
145709321|NCT03083665|525451581|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
145709322|NCT03083665|525451582|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
145709323|NCT03083665|525451583|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
145709324|NCT03083665|525451584|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
145709325|NCT03083665|525451585|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
145709326|NCT03083665|525451586|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
145709327|NCT06285240|525451587|FG000|Overall Study|Withdrawal by Subject|2|||
145709328|NCT06285240|525451588|FG001|Overall Study|Withdrawal by Subject|0|||
145709329|NCT06285240|525451589|FG002|Overall Study|Withdrawal by Subject|0|||
145709330|NCT06285240|525451590|FG003|Overall Study|Withdrawal by Subject|0|||
145709331|NCT06285240|525451587|FG000|Overall Study|Serious Adverse Event|0|||
145709332|NCT06285240|525451588|FG001|Overall Study|Serious Adverse Event|0|||
145709333|NCT06285240|525451589|FG002|Overall Study|Serious Adverse Event|1|||
145709334|NCT06285240|525451590|FG003|Overall Study|Serious Adverse Event|0|||
145709335|NCT05140915|525451591|FG000|Overall Study|Lost to Follow-up|2|||
145709336|NCT05140915|525451592|FG001|Overall Study|Lost to Follow-up|1|||
145709337|NCT04485611|525451597|FG000|Prehabilitation|Physician Decision|1|||
145709338|NCT01647542|525451598|FG000|Overall Study|Major Protocol Deviation|1|||
145709339|NCT01647542|525451599|FG001|Overall Study|Major Protocol Deviation|0|||
145709340|NCT01647542|525451600|FG002|Overall Study|Major Protocol Deviation|0|||
145709341|NCT01647542|525451598|FG000|Overall Study|Adverse Event|4|||
145709342|NCT01647542|525451599|FG001|Overall Study|Adverse Event|5|||
145709343|NCT01647542|525451600|FG002|Overall Study|Adverse Event|4|||
145709344|NCT01647542|525451598|FG000|Overall Study|Lost to Follow-up|0|||
145709345|NCT01647542|525451599|FG001|Overall Study|Lost to Follow-up|2|||
145709346|NCT01647542|525451600|FG002|Overall Study|Lost to Follow-up|2|||
145709347|NCT01647542|525451598|FG000|Overall Study|Withdrawal by Subject|6|||
145709348|NCT01647542|525451599|FG001|Overall Study|Withdrawal by Subject|4|||
145709349|NCT01647542|525451600|FG002|Overall Study|Withdrawal by Subject|0|||
145709350|NCT01647542|525451598|FG000|Overall Study|Study Termination|64|||
145709351|NCT01647542|525451599|FG001|Overall Study|Study Termination|61|||
145709352|NCT01647542|525451600|FG002|Overall Study|Study Termination|65|||
145709353|NCT01647542|525451598|FG000|Overall Study|Lack of Efficacy|1|||
145709354|NCT01647542|525451599|FG001|Overall Study|Lack of Efficacy|1|||
145709355|NCT01647542|525451600|FG002|Overall Study|Lack of Efficacy|0|||
145709356|NCT01647542|525451598|FG000|Overall Study|Death|0|||
145709357|NCT01647542|525451599|FG001|Overall Study|Death|0|||
145709358|NCT01647542|525451600|FG002|Overall Study|Death|1|||
145709359|NCT05292586|525451601|FG000|Overall Study|Withdrawal by Subject|3|||
145709360|NCT05292586|525451602|FG001|Overall Study|Withdrawal by Subject|10|||
145709361|NCT05292586|525451601|FG000|Overall Study|Randomization error|3|||
145709362|NCT05292586|525451602|FG001|Overall Study|Randomization error|7|||
145709363|NCT05292586|525451601|FG000|Overall Study|Adverse Event|3|||
145709364|NCT05292586|525451602|FG001|Overall Study|Adverse Event|0|||
145709365|NCT05292586|525451601|FG000|Overall Study|Lost to Follow-up|0|||
145709366|NCT05292586|525451602|FG001|Overall Study|Lost to Follow-up|1|||
145709367|NCT05292586|525451601|FG000|Overall Study|Patient refused treatment|1|||
145709368|NCT05292586|525451602|FG001|Overall Study|Patient refused treatment|0|||
145709369|NCT05292586|525451601|FG000|Overall Study|Patient could not travel to the study site|1|||
145709370|NCT05292586|525451602|FG001|Overall Study|Patient could not travel to the study site|0|||
145709371|NCT05292586|525451601|FG000|Overall Study|Technical issues with the masterscope|0|||
145709372|NCT05292586|525451602|FG001|Overall Study|Technical issues with the masterscope|3|||
145709373|NCT05292586|525451601|FG000|Overall Study|Patient moved to a different state|0|||
145709374|NCT05292586|525451602|FG001|Overall Study|Patient moved to a different state|1|||
145709375|NCT01040169|525451616|FG000|Overall Study|Lost to Follow-up|3|||
145709376|NCT01040169|525451617|FG001|Overall Study|Lost to Follow-up|8|||
145709377|NCT00350727|525451618|FG000|Phase I: Dose Escalation|Adverse Event|4|||
145709378|NCT00350727|525451619|FG001|Phase I: Dose Escalation|Adverse Event|0|||
145709379|NCT00350727|525451620|FG002|Phase I: Dose Escalation|Adverse Event|0|||
145709380|NCT00350727|525451618|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
145709381|NCT00350727|525451619|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
145709382|NCT00350727|525451620|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
145709383|NCT00350727|525451618|FG000|Phase I: Dose Escalation|Death|1|||
145709384|NCT00350727|525451619|FG001|Phase I: Dose Escalation|Death|0|||
145709385|NCT00350727|525451620|FG002|Phase I: Dose Escalation|Death|0|||
145709386|NCT00350727|525451618|FG000|Phase I: Dose Escalation|Physician Decision|1|||
145709387|NCT00350727|525451619|FG001|Phase I: Dose Escalation|Physician Decision|0|||
145709388|NCT00350727|525451620|FG002|Phase I: Dose Escalation|Physician Decision|0|||
145709389|NCT00350727|525451618|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
145709390|NCT00350727|525451619|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
145709391|NCT00350727|525451620|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
145709392|NCT00350727|525451618|FG000|Phase II|Disease Progression|0|||
145709393|NCT00350727|525451619|FG001|Phase II|Disease Progression|15|||
145709394|NCT00350727|525451620|FG002|Phase II|Disease Progression|16|||
145709395|NCT00350727|525451618|FG000|Phase II|Clinical Deterioration|0|||
145709396|NCT00350727|525451619|FG001|Phase II|Clinical Deterioration|1|||
145709397|NCT00350727|525451620|FG002|Phase II|Clinical Deterioration|0|||
145709398|NCT00350727|525451618|FG000|Phase II|Withdrawal by Subject|0|||
145709399|NCT00350727|525451619|FG001|Phase II|Withdrawal by Subject|2|||
145709400|NCT00350727|525451620|FG002|Phase II|Withdrawal by Subject|1|||
145709401|NCT00350727|525451618|FG000|Phase II|Adverse Event|0|||
145709402|NCT00350727|525451619|FG001|Phase II|Adverse Event|1|||
145709403|NCT00350727|525451620|FG002|Phase II|Adverse Event|1|||
145709404|NCT00350727|525451618|FG000|Phase II|Death|0|||
145709405|NCT00350727|525451619|FG001|Phase II|Death|0|||
145709406|NCT00350727|525451620|FG002|Phase II|Death|2|||
145709407|NCT00350727|525451618|FG000|Phase II|Sponsor Terminated Study|0|||
145709408|NCT00350727|525451619|FG001|Phase II|Sponsor Terminated Study|0|||
145709409|NCT00350727|525451620|FG002|Phase II|Sponsor Terminated Study|1|||
145709410|NCT00350727|525451618|FG000|Phase II|Enrolled in Rollover Study|0|||
145709411|NCT00350727|525451619|FG001|Phase II|Enrolled in Rollover Study|0|||
145709412|NCT00350727|525451620|FG002|Phase II|Enrolled in Rollover Study|1|||
145709413|NCT03633799|525451625|FG000|Overall Study|Adverse Event|349|||
145709414|NCT03633799|525451625|FG000|Overall Study|Withdrawal by Subject|288|||
145709415|NCT03633799|525451625|FG000|Overall Study|Lost to Follow-up|97|||
145709416|NCT03633799|525451625|FG000|Overall Study|Physician Decision|9|||
145709417|NCT03633799|525451625|FG000|Overall Study|Protocol Violation|4|||
145709418|NCT03633799|525451625|FG000|Overall Study|Pregnancy|20|||
145709419|NCT03633799|525451625|FG000|Overall Study|other|39|||
145709420|NCT03633799|525451625|FG000|Overall Study|ongoing within third year of study|106|||
145709421|NCT03633799|525451625|FG000|Overall Study|unsuccessful study drug placement|19|||
145709422|NCT03551691|525451626|FG000|Overall Study|Withdrawal by Subject|3|||
145709423|NCT03551691|525451627|FG001|Overall Study|Withdrawal by Subject|3|||
145709424|NCT02367040|525451628|FG000|Overall Study|Lost to Follow-up|1|||
145709425|NCT02367040|525451629|FG001|Overall Study|Lost to Follow-up|1|||
145709426|NCT02367040|525451628|FG000|Overall Study|Lack of Efficacy|1|||
145709427|NCT02367040|525451629|FG001|Overall Study|Lack of Efficacy|0|||
145709428|NCT02367040|525451628|FG000|Overall Study|Additional primary malignancy|1|||
145709429|NCT02367040|525451629|FG001|Overall Study|Additional primary malignancy|1|||
145709430|NCT02367040|525451628|FG000|Overall Study|AE not associated with clinical disease progression|117|||
145709431|NCT02367040|525451629|FG001|Overall Study|AE not associated with clinical disease progression|12|||
145709432|NCT02367040|525451628|FG000|Overall Study|AE associated with clinical disease progression|1|||
145709433|NCT02367040|525451629|FG001|Overall Study|AE associated with clinical disease progression|4|||
145709434|NCT02367040|525451628|FG000|Overall Study|Physician Decision|2|||
145709435|NCT02367040|525451629|FG001|Overall Study|Physician Decision|8|||
145709436|NCT02367040|525451628|FG000|Overall Study|Non-compliance to study drug|1|||
145709437|NCT02367040|525451629|FG001|Overall Study|Non-compliance to study drug|0|||
145709438|NCT02367040|525451628|FG000|Overall Study|Failure to meet continuation criteria|1|||
145709439|NCT02367040|525451629|FG001|Overall Study|Failure to meet continuation criteria|0|||
145709440|NCT02367040|525451628|FG000|Overall Study|Switching to other therapy|2|||
145709441|NCT02367040|525451629|FG001|Overall Study|Switching to other therapy|0|||
145709442|NCT02367040|525451628|FG000|Overall Study|Withdrawal by Subject|51|||
145709443|NCT02367040|525451629|FG001|Overall Study|Withdrawal by Subject|16|||
145709444|NCT02367040|525451628|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
145709445|NCT02367040|525451629|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145709446|NCT02367040|525451628|FG000|Overall Study|Patient decision|40|||
145709447|NCT02367040|525451629|FG001|Overall Study|Patient decision|14|||
145709448|NCT02367040|525451628|FG000|Overall Study|Required procedure failed|1|||
145709449|NCT02367040|525451629|FG001|Overall Study|Required procedure failed|0|||
145709450|NCT02367040|525451628|FG000|Overall Study|Randomized by mistake with study treatment|1|||
145709451|NCT02367040|525451629|FG001|Overall Study|Randomized by mistake with study treatment|0|||
145709452|NCT02367040|525451628|FG000|Overall Study|Protocol Violation|1|||
145709453|NCT02367040|525451629|FG001|Overall Study|Protocol Violation|0|||
145709454|NCT02367040|525451628|FG000|Overall Study|Progressive disease - radiological progression|54|||
145709455|NCT02367040|525451629|FG001|Overall Study|Progressive disease - radiological progression|80|||
145709456|NCT02367040|525451628|FG000|Overall Study|Progressive disease - clinical progression|6|||
145709457|NCT02367040|525451629|FG001|Overall Study|Progressive disease - clinical progression|6|||
145709458|NCT02367040|525451628|FG000|Overall Study|Drug not administered|3|||
145709459|NCT02367040|525451629|FG001|Overall Study|Drug not administered|2|||
145709460|NCT02367040|525451628|FG000|Overall Study|Progressive disease|0|||
145709461|NCT02367040|525451629|FG001|Overall Study|Progressive disease|1|||
145709462|NCT02367040|525451628|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
145709463|NCT02367040|525451629|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
145709464|NCT02367040|525451628|FG000|Overall Study|Death|2|||
145709465|NCT02367040|525451629|FG001|Overall Study|Death|0|||
145709466|NCT02367040|525451628|FG000|Overall Study|Study terminated by sponsor|19|||
145709467|NCT02367040|525451629|FG001|Overall Study|Study terminated by sponsor|2|||
145709468|NCT02477618|525451630|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
145709469|NCT02477618|525451631|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
145709470|NCT02477618|525451630|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
145709471|NCT02477618|525451631|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
145709472|NCT02477618|525451630|FG000|Overall Study|Adverse Event|1|||
145709473|NCT02477618|525451631|FG001|Overall Study|Adverse Event|1|||
145709474|NCT02477618|525451630|FG000|Overall Study|Transferred Away from Study Site|1|||
145709475|NCT02477618|525451631|FG001|Overall Study|Transferred Away from Study Site|0|||
145709476|NCT02477618|525451630|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
145709477|NCT02477618|525451631|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
145709478|NCT02446821|525451632|FG000|Overall Study|Adverse Event|28|||
145709479|NCT02446821|525451632|FG000|Overall Study|Withdrawal by Subject|6|||
145709480|NCT02446821|525451632|FG000|Overall Study|Lost to Follow-up|22|||
145709481|NCT02446821|525451632|FG000|Overall Study|other|9|||
145709482|NCT02446821|525451632|FG000|Overall Study|insertion failure|3|||
145709483|NCT02284009|525451636|FG000|Overall Study|Adverse Event|3|||
145709484|NCT02284009|525451637|FG001|Overall Study|Adverse Event|0|||
145709485|NCT02284009|525451636|FG000|Overall Study|Lost to Follow-up|1|||
145709486|NCT02284009|525451637|FG001|Overall Study|Lost to Follow-up|3|||
145709487|NCT02284009|525451636|FG000|Overall Study|Physician Decision|0|||
145709488|NCT02284009|525451637|FG001|Overall Study|Physician Decision|2|||
145709489|NCT02284009|525451636|FG000|Overall Study|Withdrawal by Subject|2|||
145709490|NCT02284009|525451637|FG001|Overall Study|Withdrawal by Subject|5|||
145709491|NCT02397447|525451638|FG000|Overall Study|Lost to Follow-up|2|||
145709492|NCT02397447|525451639|FG001|Overall Study|Lost to Follow-up|2|||
145709493|NCT01876082|525453348|FG000|Overall Study|Withdrawal by Subject|0|||
145709494|NCT01876082|525453349|FG001|Overall Study|Withdrawal by Subject|2|||
145709495|NCT01876082|525453348|FG000|Overall Study|Protocol Violation|1|||
145709496|NCT01876082|525453349|FG001|Overall Study|Protocol Violation|0|||
145709497|NCT01876082|525453348|FG000|Overall Study|Adverse Event|1|||
145709498|NCT01876082|525453349|FG001|Overall Study|Adverse Event|1|||
145709499|NCT01876082|525453348|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
145709500|NCT01876082|525453349|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
145709501|NCT02964013|525453350|FG000|Overall Study|Death|58|||
145709502|NCT02964013|525453351|FG001|Overall Study|Death|239|||
145709503|NCT02964013|525453352|FG002|Overall Study|Death|38|||
145709504|NCT02964013|525453353|FG003|Overall Study|Death|10|||
145709505|NCT02964013|525453354|FG004|Overall Study|Death|33|||
145709506|NCT02964013|525453350|FG000|Overall Study|Lost to Follow-up|1|||
145709507|NCT02964013|525453351|FG001|Overall Study|Lost to Follow-up|4|||
145709508|NCT02964013|525453352|FG002|Overall Study|Lost to Follow-up|2|||
145709509|NCT02964013|525453353|FG003|Overall Study|Lost to Follow-up|0|||
145709510|NCT02964013|525453354|FG004|Overall Study|Lost to Follow-up|0|||
145709511|NCT02964013|525453350|FG000|Overall Study|Physician Decision|0|||
145709512|NCT02964013|525453351|FG001|Overall Study|Physician Decision|1|||
145709513|NCT02964013|525453352|FG002|Overall Study|Physician Decision|0|||
145709514|NCT02964013|525453353|FG003|Overall Study|Physician Decision|0|||
145709515|NCT02964013|525453354|FG004|Overall Study|Physician Decision|0|||
145709516|NCT02964013|525453350|FG000|Overall Study|Sponsor Decision|3|||
145709517|NCT02964013|525453351|FG001|Overall Study|Sponsor Decision|22|||
145709518|NCT02964013|525453352|FG002|Overall Study|Sponsor Decision|11|||
145709519|NCT02964013|525453353|FG003|Overall Study|Sponsor Decision|0|||
145709520|NCT02964013|525453354|FG004|Overall Study|Sponsor Decision|7|||
145709521|NCT02964013|525453350|FG000|Overall Study|Withdrawal by Subject|6|||
145709522|NCT02964013|525453351|FG001|Overall Study|Withdrawal by Subject|27|||
145709523|NCT02964013|525453352|FG002|Overall Study|Withdrawal by Subject|9|||
145709524|NCT02964013|525453353|FG003|Overall Study|Withdrawal by Subject|0|||
145709525|NCT02964013|525453354|FG004|Overall Study|Withdrawal by Subject|0|||
145709526|NCT02964013|525453350|FG000|Overall Study|Not Treated|0|||
145709527|NCT02964013|525453351|FG001|Overall Study|Not Treated|2|||
145709528|NCT02964013|525453352|FG002|Overall Study|Not Treated|0|||
145709529|NCT02964013|525453353|FG003|Overall Study|Not Treated|1|||
145709530|NCT02964013|525453354|FG004|Overall Study|Not Treated|0|||
145709531|NCT00747227|525453355|FG000|Overall Study|Death|3|||
145709532|NCT00747227|525453356|FG001|Overall Study|Death|1|||
145709533|NCT00747227|525453355|FG000|Overall Study|Withdrawal by Subject|1|||
145709534|NCT00747227|525453356|FG001|Overall Study|Withdrawal by Subject|0|||
145709535|NCT00747227|525453355|FG000|Overall Study|Lost to Follow-up|1|||
145709536|NCT00747227|525453356|FG001|Overall Study|Lost to Follow-up|2|||
145709537|NCT00747227|525453355|FG000|Overall Study|Illness|1|||
145709538|NCT00747227|525453356|FG001|Overall Study|Illness|1|||
145709539|NCT03284229|525453357|FG000|Overall Study|Lost to Follow-up|3|||
145709540|NCT03554629|525453358|FG000|Overall Study|Inadequate data|6|||
145709541|NCT00663702|525453363|FG000|Overall Study|Adverse Event|8|||
145709542|NCT00663702|525453364|FG001|Overall Study|Adverse Event|4|||
145709543|NCT00663702|525453363|FG000|Overall Study|Withdrawal by Subject|3|||
145709544|NCT00663702|525453364|FG001|Overall Study|Withdrawal by Subject|1|||
145709545|NCT00663702|525453363|FG000|Overall Study|Pregnancy|0|||
145709546|NCT00663702|525453364|FG001|Overall Study|Pregnancy|1|||
145709547|NCT00663702|525453363|FG000|Overall Study|Lost to Follow-up|3|||
145709548|NCT00663702|525453364|FG001|Overall Study|Lost to Follow-up|0|||
145709549|NCT00663702|525453363|FG000|Overall Study|Death|1|||
145709550|NCT00663702|525453364|FG001|Overall Study|Death|1|||
145709551|NCT00663702|525453363|FG000|Overall Study|Lack of Efficacy|3|||
145709552|NCT00663702|525453364|FG001|Overall Study|Lack of Efficacy|3|||
145709553|NCT01498887|525453365|FG000|Overall Study|Administrative problems|1|||
145709554|NCT01498887|525453366|FG001|Overall Study|Administrative problems|0|||
145709555|NCT01498887|525453365|FG000|Overall Study|Lost to Follow-up|1|||
145709556|NCT01498887|525453366|FG001|Overall Study|Lost to Follow-up|1|||
145709557|NCT01498887|525453365|FG000|Overall Study|Withdrawal by Subject|1|||
145709558|NCT01498887|525453366|FG001|Overall Study|Withdrawal by Subject|0|||
145709559|NCT01498887|525453365|FG000|Overall Study|Protocol Violation|1|||
145709560|NCT01498887|525453366|FG001|Overall Study|Protocol Violation|3|||
145709561|NCT01498887|525453365|FG000|Overall Study|Lack of Efficacy|5|||
145709562|NCT01498887|525453366|FG001|Overall Study|Lack of Efficacy|3|||
145709563|NCT01498887|525453365|FG000|Overall Study|Abnormal result from test procedure|1|||
145709564|NCT01498887|525453366|FG001|Overall Study|Abnormal result from test procedure|1|||
145709565|NCT01498887|525453365|FG000|Overall Study|Abnormal laboratory value|2|||
145709566|NCT01498887|525453366|FG001|Overall Study|Abnormal laboratory value|2|||
145709567|NCT01498887|525453365|FG000|Overall Study|Adverse Event|4|||
145709568|NCT01498887|525453366|FG001|Overall Study|Adverse Event|1|||
145709569|NCT00667225|525453369|FG000|Overall Study|Subject had no more lesions to treat.|1|||
145709570|NCT00667225|525453370|FG001|Overall Study|Subject had no more lesions to treat.|0|||
145709571|NCT00667225|525453369|FG000|Overall Study|Lost to Follow-up|0|||
145709572|NCT00667225|525453370|FG001|Overall Study|Lost to Follow-up|1|||
145709573|NCT03056300|525453371|FG000|Overall Study|Surgical reason per study protocol|3|||
145709574|NCT02993406|525453378|FG000|Overall Study|Withdrawal by Subject|170|||
145709575|NCT02993406|525453379|FG001|Overall Study|Withdrawal by Subject|196|||
145709576|NCT02993406|525453378|FG000|Overall Study|Physician Decision|3|||
145709577|NCT02993406|525453379|FG001|Overall Study|Physician Decision|5|||
145709578|NCT02993406|525453378|FG000|Overall Study|Lost to Follow-up|12|||
145709579|NCT02993406|525453379|FG001|Overall Study|Lost to Follow-up|13|||
145709580|NCT02993406|525453378|FG000|Overall Study|Unclassifiable Response|105|||
145709581|NCT02993406|525453379|FG001|Overall Study|Unclassifiable Response|139|||
145709582|NCT02993406|525453378|FG000|Overall Study|Administrative decision|1|||
145709583|NCT02993406|525453379|FG001|Overall Study|Administrative decision|0|||
145709584|NCT02993406|525453378|FG000|Overall Study|Sponsor decision|4|||
145709585|NCT02993406|525453379|FG001|Overall Study|Sponsor decision|5|||
145709586|NCT03563157|525453380|FG000|Overall Study|Progressive Disease|2|||
145709587|NCT02248818|525453381|FG000|Screening|Protocol Violation|0|||
145709588|NCT02248818|525453382|FG001|Screening|Protocol Violation|0|||
145709589|NCT02248818|525453383|FG002|Screening|Protocol Violation|0|||
145709590|NCT02248818|525453384|FG003|Screening|Protocol Violation|0|||
145709591|NCT02248818|525453385|FG004|Screening|Protocol Violation|0|||
145709592|NCT02248818|525453386|FG005|Screening|Protocol Violation|0|||
145709593|NCT02248818|525453387|FG006|Screening|Protocol Violation|0|||
145709594|NCT02248818|525453388|FG007|Screening|Protocol Violation|0|||
145709595|NCT02248818|525453389|FG008|Screening|Protocol Violation|7|||
145709596|NCT02248818|525453381|FG000|Screening|Study fully enrolled|0|||
145709597|NCT02248818|525453382|FG001|Screening|Study fully enrolled|0|||
145709598|NCT02248818|525453383|FG002|Screening|Study fully enrolled|0|||
145709599|NCT02248818|525453384|FG003|Screening|Study fully enrolled|0|||
145709600|NCT02248818|525453385|FG004|Screening|Study fully enrolled|0|||
145709601|NCT02248818|525453386|FG005|Screening|Study fully enrolled|0|||
145709602|NCT02248818|525453387|FG006|Screening|Study fully enrolled|0|||
145709603|NCT02248818|525453388|FG007|Screening|Study fully enrolled|0|||
145709604|NCT02248818|525453389|FG008|Screening|Study fully enrolled|14|||
145709605|NCT02248818|525453381|FG000|Screening|Physician Decision|0|||
145709606|NCT02248818|525453382|FG001|Screening|Physician Decision|0|||
145709607|NCT02248818|525453383|FG002|Screening|Physician Decision|0|||
145709608|NCT02248818|525453384|FG003|Screening|Physician Decision|0|||
145709609|NCT02248818|525453385|FG004|Screening|Physician Decision|0|||
145709610|NCT02248818|525453386|FG005|Screening|Physician Decision|0|||
145709611|NCT02248818|525453387|FG006|Screening|Physician Decision|0|||
145709612|NCT02248818|525453388|FG007|Screening|Physician Decision|0|||
145709613|NCT02248818|525453389|FG008|Screening|Physician Decision|73|||
145709614|NCT02248818|525453381|FG000|Screening|Withdrawal by Subject|0|||
145709615|NCT02248818|525453382|FG001|Screening|Withdrawal by Subject|0|||
145709616|NCT02248818|525453383|FG002|Screening|Withdrawal by Subject|0|||
145709617|NCT02248818|525453384|FG003|Screening|Withdrawal by Subject|0|||
145709618|NCT02248818|525453385|FG004|Screening|Withdrawal by Subject|0|||
145709619|NCT02248818|525453386|FG005|Screening|Withdrawal by Subject|0|||
145709620|NCT02248818|525453387|FG006|Screening|Withdrawal by Subject|0|||
145709621|NCT02248818|525453388|FG007|Screening|Withdrawal by Subject|0|||
145709622|NCT02248818|525453389|FG008|Screening|Withdrawal by Subject|6|||
145709623|NCT02248818|525453381|FG000|Screening|Lost to Follow-up|0|||
145709624|NCT02248818|525453382|FG001|Screening|Lost to Follow-up|0|||
145709625|NCT02248818|525453383|FG002|Screening|Lost to Follow-up|0|||
145709626|NCT02248818|525453384|FG003|Screening|Lost to Follow-up|0|||
145709627|NCT02248818|525453385|FG004|Screening|Lost to Follow-up|0|||
145709628|NCT02248818|525453386|FG005|Screening|Lost to Follow-up|0|||
145709629|NCT02248818|525453387|FG006|Screening|Lost to Follow-up|0|||
145709630|NCT02248818|525453388|FG007|Screening|Lost to Follow-up|0|||
145709631|NCT02248818|525453389|FG008|Screening|Lost to Follow-up|7|||
145709632|NCT02248818|525453381|FG000|Randomised Study|Administrative - randomization error|0|||
145709633|NCT02248818|525453382|FG001|Randomised Study|Administrative - randomization error|0|||
145709634|NCT02248818|525453383|FG002|Randomised Study|Administrative - randomization error|0|||
145709635|NCT02248818|525453384|FG003|Randomised Study|Administrative - randomization error|0|||
145709636|NCT02248818|525453385|FG004|Randomised Study|Administrative - randomization error|0|||
145709637|NCT02248818|525453386|FG005|Randomised Study|Administrative - randomization error|8|||
145709638|NCT02248818|525453387|FG006|Randomised Study|Administrative - randomization error|0|||
145709639|NCT02248818|525453388|FG007|Randomised Study|Administrative - randomization error|0|||
145709640|NCT02248818|525453389|FG008|Randomised Study|Administrative - randomization error|0|||
145709641|NCT01283152|525453390|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
145709642|NCT01283152|525453391|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
145709643|NCT01283152|525453390|FG000|Overall Study|Refused HESA|1|||
145709644|NCT01283152|525453391|FG001|Overall Study|Refused HESA|0|||
145709645|NCT00626197|525453394|FG000|Overall Study|Did not cooperate|2|||
145709646|NCT00626197|525453395|FG001|Overall Study|Did not cooperate|6|||
145709647|NCT00626197|525453396|FG002|Overall Study|Did not cooperate|1|||
145709648|NCT00626197|525453394|FG000|Overall Study|Failure to return|6|||
145709649|NCT00626197|525453395|FG001|Overall Study|Failure to return|5|||
145709650|NCT00626197|525453396|FG002|Overall Study|Failure to return|6|||
145709651|NCT00626197|525453394|FG000|Overall Study|Adverse event, serious fatal|3|||
145709652|NCT00626197|525453395|FG001|Overall Study|Adverse event, serious fatal|6|||
145709653|NCT00626197|525453396|FG002|Overall Study|Adverse event, serious fatal|6|||
145709654|NCT00626197|525453394|FG000|Overall Study|Adverse Event|1|||
145709655|NCT00626197|525453395|FG001|Overall Study|Adverse Event|1|||
145709656|NCT00626197|525453396|FG002|Overall Study|Adverse Event|2|||
145709657|NCT00626197|525453394|FG000|Overall Study|Withdrawal by Subject|17|||
145709658|NCT00626197|525453395|FG001|Overall Study|Withdrawal by Subject|17|||
145709659|NCT00626197|525453396|FG002|Overall Study|Withdrawal by Subject|7|||
145709660|NCT00626197|525453394|FG000|Overall Study|Administrative reasons|15|||
145709661|NCT00626197|525453395|FG001|Overall Study|Administrative reasons|19|||
145709662|NCT00626197|525453396|FG002|Overall Study|Administrative reasons|55|||
145709663|NCT00461981|525453403|FG000|Overall Study|Lost to Follow-up|9|||
145709664|NCT00461981|525453404|FG001|Overall Study|Lost to Follow-up|6|||
145709665|NCT00461981|525453403|FG000|Overall Study|Withdrawal by Subject|2|||
145709666|NCT00461981|525453404|FG001|Overall Study|Withdrawal by Subject|3|||
145709667|NCT01077128|525453410|FG000|Overall Study|Adverse Event|8|||
145709668|NCT01077128|525453410|FG000|Overall Study|Lack of Efficacy|1|||
145709669|NCT01077128|525453410|FG000|Overall Study|Disease exacerbation|1|||
145709670|NCT01077128|525453410|FG000|Overall Study|Adverse event and consent withdrawal|1|||
145709671|NCT01077128|525453410|FG000|Overall Study|Adverse event and disease exacerbation|1|||
145709672|NCT01077128|525453410|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
145709673|NCT01077128|525453410|FG000|Overall Study|Other|54|||
145709674|NCT00847626|525453411|FG000|Overall Study|Adverse Event|10|||
145709675|NCT00847626|525453412|FG001|Overall Study|Adverse Event|10|||
145709676|NCT00847626|525453413|FG002|Overall Study|Adverse Event|6|||
145709677|NCT00847626|525453414|FG003|Overall Study|Adverse Event|19|||
145709678|NCT00847626|525453415|FG004|Overall Study|Adverse Event|11|||
145709679|NCT00847626|525453416|FG005|Overall Study|Adverse Event|22|||
145709680|NCT00847626|525453417|FG006|Overall Study|Adverse Event|4|||
145709681|NCT00847626|525453418|FG007|Overall Study|Adverse Event|6|||
145709682|NCT00847626|525453419|FG008|Overall Study|Adverse Event|3|||
145709683|NCT00847626|525453420|FG009|Overall Study|Adverse Event|6|||
145709684|NCT00847626|525453421|FG010|Overall Study|Adverse Event|6|||
145709685|NCT00847626|525453411|FG000|Overall Study|Protocol Violation|2|||
145709686|NCT00847626|525453412|FG001|Overall Study|Protocol Violation|1|||
145709687|NCT00847626|525453413|FG002|Overall Study|Protocol Violation|2|||
145709688|NCT00847626|525453414|FG003|Overall Study|Protocol Violation|1|||
145709689|NCT00847626|525453415|FG004|Overall Study|Protocol Violation|1|||
145709690|NCT00847626|525453416|FG005|Overall Study|Protocol Violation|1|||
145709691|NCT00847626|525453417|FG006|Overall Study|Protocol Violation|1|||
145709692|NCT00847626|525453418|FG007|Overall Study|Protocol Violation|1|||
145709693|NCT00847626|525453419|FG008|Overall Study|Protocol Violation|0|||
145709694|NCT00847626|525453420|FG009|Overall Study|Protocol Violation|1|||
145709695|NCT00847626|525453421|FG010|Overall Study|Protocol Violation|1|||
145709696|NCT00847626|525453411|FG000|Overall Study|Lost to Follow-up|0|||
145709697|NCT00847626|525453412|FG001|Overall Study|Lost to Follow-up|1|||
145709698|NCT00847626|525453413|FG002|Overall Study|Lost to Follow-up|1|||
145709699|NCT00847626|525453414|FG003|Overall Study|Lost to Follow-up|1|||
145709700|NCT00847626|525453415|FG004|Overall Study|Lost to Follow-up|0|||
145709701|NCT00847626|525453416|FG005|Overall Study|Lost to Follow-up|3|||
145709702|NCT00847626|525453417|FG006|Overall Study|Lost to Follow-up|1|||
145709703|NCT00847626|525453418|FG007|Overall Study|Lost to Follow-up|3|||
145709704|NCT00847626|525453419|FG008|Overall Study|Lost to Follow-up|1|||
145709705|NCT00847626|525453420|FG009|Overall Study|Lost to Follow-up|0|||
145709706|NCT00847626|525453421|FG010|Overall Study|Lost to Follow-up|1|||
145709707|NCT00847626|525453411|FG000|Overall Study|Withdrawal by Subject|5|||
145709708|NCT00847626|525453412|FG001|Overall Study|Withdrawal by Subject|5|||
145709709|NCT00847626|525453413|FG002|Overall Study|Withdrawal by Subject|3|||
145709710|NCT00847626|525453414|FG003|Overall Study|Withdrawal by Subject|8|||
145709711|NCT00847626|525453415|FG004|Overall Study|Withdrawal by Subject|12|||
145709712|NCT00847626|525453416|FG005|Overall Study|Withdrawal by Subject|9|||
145709713|NCT00847626|525453417|FG006|Overall Study|Withdrawal by Subject|8|||
145709714|NCT00847626|525453418|FG007|Overall Study|Withdrawal by Subject|4|||
145709715|NCT00847626|525453419|FG008|Overall Study|Withdrawal by Subject|4|||
145709716|NCT00847626|525453420|FG009|Overall Study|Withdrawal by Subject|5|||
145709717|NCT00847626|525453421|FG010|Overall Study|Withdrawal by Subject|2|||
145709718|NCT00847626|525453411|FG000|Overall Study|Lack of Efficacy|3|||
145709719|NCT00847626|525453412|FG001|Overall Study|Lack of Efficacy|1|||
145709720|NCT00847626|525453413|FG002|Overall Study|Lack of Efficacy|0|||
145709721|NCT00847626|525453414|FG003|Overall Study|Lack of Efficacy|1|||
145709722|NCT00847626|525453415|FG004|Overall Study|Lack of Efficacy|2|||
145709723|NCT00847626|525453416|FG005|Overall Study|Lack of Efficacy|0|||
145709724|NCT00847626|525453417|FG006|Overall Study|Lack of Efficacy|6|||
145709725|NCT00847626|525453418|FG007|Overall Study|Lack of Efficacy|2|||
145709726|NCT00847626|525453419|FG008|Overall Study|Lack of Efficacy|5|||
145709727|NCT00847626|525453420|FG009|Overall Study|Lack of Efficacy|1|||
145709728|NCT00847626|525453421|FG010|Overall Study|Lack of Efficacy|7|||
145709729|NCT00847626|525453411|FG000|Overall Study|Other|1|||
145709730|NCT00847626|525453412|FG001|Overall Study|Other|5|||
145709731|NCT00847626|525453413|FG002|Overall Study|Other|4|||
145709732|NCT00847626|525453414|FG003|Overall Study|Other|1|||
145709733|NCT00847626|525453415|FG004|Overall Study|Other|2|||
145709734|NCT00847626|525453416|FG005|Overall Study|Other|2|||
145709735|NCT00847626|525453417|FG006|Overall Study|Other|2|||
145709736|NCT00847626|525453418|FG007|Overall Study|Other|3|||
145709737|NCT00847626|525453419|FG008|Overall Study|Other|1|||
145709738|NCT00847626|525453420|FG009|Overall Study|Other|1|||
145709739|NCT00847626|525453421|FG010|Overall Study|Other|3|||
145709740|NCT03809039|525453422|FG000|Part 1|Withdrawal by Subject|1|||
145709741|NCT03809039|525453423|FG001|Part 1|Withdrawal by Subject|0|||
145709742|NCT03809039|525453424|FG002|Part 1|Withdrawal by Subject|0|||
145709743|NCT03809039|525453425|FG003|Part 1|Withdrawal by Subject|1|||
145709744|NCT03809039|525453426|FG004|Part 1|Withdrawal by Subject|0|||
145709745|NCT03809039|525453427|FG005|Part 1|Withdrawal by Subject|0|||
145709746|NCT03809039|525453428|FG006|Part 1|Withdrawal by Subject|0|||
145709747|NCT03809039|525453429|FG007|Part 1|Withdrawal by Subject|0|||
145709748|NCT03809039|525453430|FG008|Part 1|Withdrawal by Subject|0|||
145709749|NCT03809039|525453422|FG000|Part 3|Withdrawn by study termination|0|||
145709750|NCT03809039|525453423|FG001|Part 3|Withdrawn by study termination|0|||
145709751|NCT03809039|525453424|FG002|Part 3|Withdrawn by study termination|0|||
145709752|NCT03809039|525453425|FG003|Part 3|Withdrawn by study termination|0|||
145709753|NCT03809039|525453426|FG004|Part 3|Withdrawn by study termination|0|||
145709754|NCT03809039|525453427|FG005|Part 3|Withdrawn by study termination|0|||
145709755|NCT03809039|525453428|FG006|Part 3|Withdrawn by study termination|0|||
145709756|NCT03809039|525453429|FG007|Part 3|Withdrawn by study termination|2|||
145709757|NCT03809039|525453430|FG008|Part 3|Withdrawn by study termination|6|||
145709758|NCT02476175|525453435|FG000|Overall Study|Adverse Event|2|||
145709759|NCT03031496|525453436|FG000|Period 1|Adverse Event|2|||
145709760|NCT03031496|525453437|FG001|Period 1|Adverse Event|0|||
145709761|NCT03031496|525453436|FG000|Period 1|Withdrawal by Subject|0|||
145709762|NCT03031496|525453437|FG001|Period 1|Withdrawal by Subject|2|||
145709763|NCT02979249|525453439|FG000|Overall Study|Lost to Follow-up|2|||
145709764|NCT02979249|525453439|FG000|Overall Study|Withdrawal by Subject|4|||
145709765|NCT03868787|525453440|FG000|Overall Study|Withdrawal by Subject|2|||
145709766|NCT03868787|525453441|FG001|Overall Study|Withdrawal by Subject|1|||
145709767|NCT01399697|525453442|FG000|Overall Study|Adverse Event|13|||
145709768|NCT01399697|525453443|FG001|Overall Study|Adverse Event|3|||
145709769|NCT01399697|525453444|FG002|Overall Study|Adverse Event|1|||
145709770|NCT01399697|525453442|FG000|Overall Study|Lost to Follow-up|2|||
145709771|NCT01399697|525453443|FG001|Overall Study|Lost to Follow-up|0|||
145709772|NCT01399697|525453444|FG002|Overall Study|Lost to Follow-up|0|||
145709773|NCT01399697|525453442|FG000|Overall Study|Withdrawal by Subject|8|||
145709774|NCT01399697|525453443|FG001|Overall Study|Withdrawal by Subject|0|||
145709775|NCT01399697|525453444|FG002|Overall Study|Withdrawal by Subject|0|||
145709776|NCT01399697|525453442|FG000|Overall Study|Investigator Decisión|1|||
145709777|NCT01399697|525453443|FG001|Overall Study|Investigator Decisión|0|||
145709778|NCT01399697|525453444|FG002|Overall Study|Investigator Decisión|2|||
145709779|NCT01399697|525453442|FG000|Overall Study|Lack of Efficacy|9|||
145709780|NCT01399697|525453443|FG001|Overall Study|Lack of Efficacy|0|||
145709781|NCT01399697|525453444|FG002|Overall Study|Lack of Efficacy|1|||
145709782|NCT01399697|525453442|FG000|Overall Study|Protocol Violation|2|||
145709783|NCT01399697|525453443|FG001|Overall Study|Protocol Violation|0|||
145709784|NCT01399697|525453444|FG002|Overall Study|Protocol Violation|0|||
145709785|NCT01399697|525453442|FG000|Overall Study|Non-Compliant|1|||
145709786|NCT01399697|525453443|FG001|Overall Study|Non-Compliant|0|||
145709787|NCT01399697|525453444|FG002|Overall Study|Non-Compliant|0|||
145709788|NCT01399697|525453442|FG000|Overall Study|Inclusion Error|2|||
145709789|NCT01399697|525453443|FG001|Overall Study|Inclusion Error|0|||
145709790|NCT01399697|525453444|FG002|Overall Study|Inclusion Error|0|||
145709791|NCT01399697|525453442|FG000|Overall Study|Positive result for hepatitis B|1|||
145709792|NCT01399697|525453443|FG001|Overall Study|Positive result for hepatitis B|0|||
145709793|NCT01399697|525453444|FG002|Overall Study|Positive result for hepatitis B|0|||
145709794|NCT01399697|525453442|FG000|Overall Study|Clinical RA remission|1|||
145709795|NCT01399697|525453443|FG001|Overall Study|Clinical RA remission|0|||
145709796|NCT01399697|525453444|FG002|Overall Study|Clinical RA remission|0|||
145709797|NCT01399697|525453442|FG000|Overall Study|Sponsor Decision|1|||
145709798|NCT01399697|525453443|FG001|Overall Study|Sponsor Decision|0|||
145709799|NCT01399697|525453444|FG002|Overall Study|Sponsor Decision|0|||
145709800|NCT02510040|525453445|FG000|Overall Study|Deemed no longer eligible|18|||
145709801|NCT02510040|525453446|FG001|Overall Study|Deemed no longer eligible|3|||
145709802|NCT02510040|525453447|FG002|Overall Study|Deemed no longer eligible|1|||
145709803|NCT00967005|525453451|FG000|Overall Study|Lost to Follow-up|7|||
145709804|NCT00967005|525453452|FG001|Overall Study|Lost to Follow-up|10|||
145709805|NCT01289210|525453455|FG000|Overall Study|Adverse Event|1|||
145709806|NCT02994069|525453456|FG000|Overall Study|Death|7|||
145709807|NCT02994069|525453457|FG001|Overall Study|Death|13|||
145709808|NCT02994069|525453456|FG000|Overall Study|Adverse Event|1|||
145709809|NCT02994069|525453457|FG001|Overall Study|Adverse Event|0|||
145709810|NCT02994069|525453456|FG000|Overall Study|Other|2|||
145709811|NCT02994069|525453457|FG001|Overall Study|Other|0|||
145709812|NCT02994069|525453456|FG000|Overall Study|still on follow up/treatment|5|||
145709813|NCT02994069|525453457|FG001|Overall Study|still on follow up/treatment|6|||
145709814|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
145709815|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
145709816|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
145709817|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
145709818|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
145709819|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
145709820|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
145709821|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
145709822|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
145709823|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
145709824|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
145709825|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
145709826|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
145709827|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
145709828|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
145709829|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
145709830|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
145709831|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
145709832|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
145709833|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
145709834|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
145709835|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
145709836|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
145709837|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
145709838|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
145709839|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
145709840|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
145709841|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
145709842|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
145709843|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
145709844|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
145709845|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
145709846|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
145709847|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
145709848|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
145709849|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
145709850|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
145709851|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
145709852|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
145709853|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
145709854|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
145709855|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
145709856|NCT03524092|525453460|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
145709857|NCT03524092|525453461|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
145709858|NCT03524092|525453462|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
145709859|NCT03524092|525453463|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
145709860|NCT03524092|525453464|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
145709861|NCT03524092|525453465|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
145709862|NCT03524092|525453460|FG000|Loss of Response Rescue Period|Adverse Event|0|||
145709863|NCT03524092|525453461|FG001|Loss of Response Rescue Period|Adverse Event|0|||
145709864|NCT03524092|525453462|FG002|Loss of Response Rescue Period|Adverse Event|0|||
145709865|NCT03524092|525453463|FG003|Loss of Response Rescue Period|Adverse Event|2|||
145709866|NCT03524092|525453464|FG004|Loss of Response Rescue Period|Adverse Event|0|||
145709867|NCT03524092|525453465|FG005|Loss of Response Rescue Period|Adverse Event|0|||
145709868|NCT03524092|525453460|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
145709869|NCT03524092|525453461|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
145709870|NCT03524092|525453462|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
145709871|NCT03524092|525453463|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
145709872|NCT03524092|525453464|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
145709873|NCT03524092|525453465|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
145709874|NCT03524092|525453460|FG000|Loss of Response Rescue Period|Pregnancy|0|||
145709875|NCT03524092|525453461|FG001|Loss of Response Rescue Period|Pregnancy|0|||
145709876|NCT03524092|525453462|FG002|Loss of Response Rescue Period|Pregnancy|0|||
145709877|NCT03524092|525453463|FG003|Loss of Response Rescue Period|Pregnancy|1|||
145709878|NCT03524092|525453464|FG004|Loss of Response Rescue Period|Pregnancy|0|||
145709879|NCT03524092|525453465|FG005|Loss of Response Rescue Period|Pregnancy|0|||
145709880|NCT03524092|525453460|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
145709881|NCT03524092|525453461|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
145709882|NCT03524092|525453462|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
145709883|NCT03524092|525453463|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
145709884|NCT03524092|525453464|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
145709885|NCT03524092|525453465|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
145709886|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
145709887|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
145709888|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
145709889|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
145709890|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
145709891|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
145709892|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
145709893|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
145709894|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
145709895|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
145709896|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
145709897|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
145709898|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
145709899|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
145709900|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
145709901|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
145709902|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
145709903|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
145709904|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
145709905|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
145709906|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
145709907|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
145709908|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
145709909|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
145709910|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
145709911|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
145709912|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
145709913|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
145709914|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
145709915|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
145709916|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
145709917|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
145709918|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
145709919|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
145709920|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
145709921|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
145709922|NCT03524092|525453460|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
145709923|NCT03524092|525453461|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
145709924|NCT03524092|525453462|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
145709925|NCT03524092|525453463|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
145709926|NCT03524092|525453464|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
145709927|NCT03524092|525453465|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
145709928|NCT03524092|525453460|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
145709929|NCT03524092|525453461|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
145709930|NCT03524092|525453462|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
145709931|NCT03524092|525453463|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
145709932|NCT03524092|525453464|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
145709933|NCT03524092|525453465|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
145709934|NCT03524092|525453460|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
145709935|NCT03524092|525453461|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
145709936|NCT03524092|525453462|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
145709937|NCT03524092|525453463|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
145709938|NCT03524092|525453464|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
145709939|NCT03524092|525453465|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
145709940|NCT03524092|525453460|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
145709941|NCT03524092|525453461|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
145709942|NCT03524092|525453462|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
145709943|NCT03524092|525453463|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
145709944|NCT03524092|525453464|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
145709945|NCT03524092|525453465|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
145709946|NCT03524092|525453460|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
145709947|NCT03524092|525453461|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
145709948|NCT03524092|525453462|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
145709949|NCT03524092|525453463|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
145709950|NCT03524092|525453464|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
145709951|NCT03524092|525453465|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
145709952|NCT04893460|525453466|FG000|Overall Study|Lost to Follow-up|18|||
145709953|NCT05262517|525454567|FG000|Overall Study|Randomized but not treated|5|||
145709954|NCT05262517|525454568|FG001|Overall Study|Randomized but not treated|11|||
145709955|NCT02942277|525454569|FG000|Year 1|Withdrawal by Subject|0|||
145709956|NCT02942277|525454570|FG001|Year 1|Withdrawal by Subject|0|||
145709957|NCT02942277|525454571|FG002|Year 1|Withdrawal by Subject|0|||
145709958|NCT02942277|525454572|FG003|Year 1|Withdrawal by Subject|0|||
145709959|NCT02942277|525454573|FG004|Year 1|Withdrawal by Subject|1|||
145709960|NCT02942277|525454574|FG005|Year 1|Withdrawal by Subject|3|||
145709961|NCT02942277|525454575|FG006|Year 1|Withdrawal by Subject|0|||
145709962|NCT02942277|525454576|FG007|Year 1|Withdrawal by Subject|1|||
145709963|NCT02942277|525454577|FG008|Year 1|Withdrawal by Subject|0|||
145709964|NCT02942277|525454578|FG009|Year 1|Withdrawal by Subject|0|||
145709965|NCT02942277|525454579|FG010|Year 1|Withdrawal by Subject|3|||
145709966|NCT02942277|525454569|FG000|Year 1|Travel|0|||
145709967|NCT02942277|525454570|FG001|Year 1|Travel|1|||
145709968|NCT02942277|525454571|FG002|Year 1|Travel|0|||
145709969|NCT02942277|525454572|FG003|Year 1|Travel|0|||
145709970|NCT02942277|525454573|FG004|Year 1|Travel|4|||
145709971|NCT02942277|525454574|FG005|Year 1|Travel|5|||
145709972|NCT02942277|525454575|FG006|Year 1|Travel|0|||
145709973|NCT02942277|525454576|FG007|Year 1|Travel|0|||
145709974|NCT02942277|525454577|FG008|Year 1|Travel|0|||
145709975|NCT02942277|525454578|FG009|Year 1|Travel|0|||
145709976|NCT02942277|525454579|FG010|Year 1|Travel|8|||
145709977|NCT02942277|525454569|FG000|Year 1|Joined Army|0|||
145709978|NCT02942277|525454570|FG001|Year 1|Joined Army|1|||
145709979|NCT02942277|525454571|FG002|Year 1|Joined Army|0|||
145709980|NCT02942277|525454572|FG003|Year 1|Joined Army|0|||
145709981|NCT02942277|525454573|FG004|Year 1|Joined Army|0|||
145709982|NCT02942277|525454574|FG005|Year 1|Joined Army|0|||
145709983|NCT02942277|525454575|FG006|Year 1|Joined Army|0|||
145709984|NCT02942277|525454576|FG007|Year 1|Joined Army|0|||
145709985|NCT02942277|525454577|FG008|Year 1|Joined Army|0|||
145709986|NCT02942277|525454578|FG009|Year 1|Joined Army|0|||
145709987|NCT02942277|525454579|FG010|Year 1|Joined Army|0|||
145709988|NCT02942277|525454569|FG000|Year 1|Subject met withdrawal criteria|0|||
145709989|NCT02942277|525454570|FG001|Year 1|Subject met withdrawal criteria|0|||
145709990|NCT02942277|525454571|FG002|Year 1|Subject met withdrawal criteria|0|||
145709991|NCT02942277|525454572|FG003|Year 1|Subject met withdrawal criteria|1|||
145709992|NCT02942277|525454573|FG004|Year 1|Subject met withdrawal criteria|0|||
145709993|NCT02942277|525454574|FG005|Year 1|Subject met withdrawal criteria|0|||
145709994|NCT02942277|525454575|FG006|Year 1|Subject met withdrawal criteria|0|||
145709995|NCT02942277|525454576|FG007|Year 1|Subject met withdrawal criteria|0|||
145709996|NCT02942277|525454577|FG008|Year 1|Subject met withdrawal criteria|0|||
145709997|NCT02942277|525454578|FG009|Year 1|Subject met withdrawal criteria|0|||
145709998|NCT02942277|525454579|FG010|Year 1|Subject met withdrawal criteria|0|||
145709999|NCT02942277|525454569|FG000|Year 1|Lost to Follow-up|0|||
145710000|NCT02942277|525454570|FG001|Year 1|Lost to Follow-up|0|||
145710001|NCT02942277|525454571|FG002|Year 1|Lost to Follow-up|0|||
145710002|NCT02942277|525454572|FG003|Year 1|Lost to Follow-up|0|||
145710003|NCT02942277|525454573|FG004|Year 1|Lost to Follow-up|1|||
145710004|NCT02942277|525454574|FG005|Year 1|Lost to Follow-up|0|||
145710005|NCT02942277|525454575|FG006|Year 1|Lost to Follow-up|0|||
145710006|NCT02942277|525454576|FG007|Year 1|Lost to Follow-up|0|||
145710007|NCT02942277|525454577|FG008|Year 1|Lost to Follow-up|0|||
145710008|NCT02942277|525454578|FG009|Year 1|Lost to Follow-up|0|||
145710009|NCT02942277|525454579|FG010|Year 1|Lost to Follow-up|2|||
145710010|NCT02942277|525454569|FG000|Year 1|Protocol Violation|0|||
145710011|NCT02942277|525454570|FG001|Year 1|Protocol Violation|0|||
145710012|NCT02942277|525454571|FG002|Year 1|Protocol Violation|0|||
145710013|NCT02942277|525454572|FG003|Year 1|Protocol Violation|0|||
145710014|NCT02942277|525454573|FG004|Year 1|Protocol Violation|1|||
145710015|NCT02942277|525454574|FG005|Year 1|Protocol Violation|1|||
145710016|NCT02942277|525454575|FG006|Year 1|Protocol Violation|0|||
145710017|NCT02942277|525454576|FG007|Year 1|Protocol Violation|0|||
145710018|NCT02942277|525454577|FG008|Year 1|Protocol Violation|0|||
145710019|NCT02942277|525454578|FG009|Year 1|Protocol Violation|0|||
145710020|NCT02942277|525454579|FG010|Year 1|Protocol Violation|2|||
145710021|NCT02942277|525454569|FG000|Year 1|Pregnancy|0|||
145710022|NCT02942277|525454570|FG001|Year 1|Pregnancy|0|||
145710023|NCT02942277|525454571|FG002|Year 1|Pregnancy|0|||
145710024|NCT02942277|525454572|FG003|Year 1|Pregnancy|0|||
145710025|NCT02942277|525454573|FG004|Year 1|Pregnancy|0|||
145710026|NCT02942277|525454574|FG005|Year 1|Pregnancy|1|||
145710027|NCT02942277|525454575|FG006|Year 1|Pregnancy|0|||
145710028|NCT02942277|525454576|FG007|Year 1|Pregnancy|0|||
145710029|NCT02942277|525454577|FG008|Year 1|Pregnancy|0|||
145710030|NCT02942277|525454578|FG009|Year 1|Pregnancy|0|||
145710031|NCT02942277|525454579|FG010|Year 1|Pregnancy|0|||
145710032|NCT02942277|525454569|FG000|Year 2|Lost to Follow-up|0|||
145710033|NCT02942277|525454570|FG001|Year 2|Lost to Follow-up|0|||
145710034|NCT02942277|525454571|FG002|Year 2|Lost to Follow-up|0|||
145710035|NCT02942277|525454572|FG003|Year 2|Lost to Follow-up|0|||
145710036|NCT02942277|525454573|FG004|Year 2|Lost to Follow-up|2|||
145710037|NCT02942277|525454574|FG005|Year 2|Lost to Follow-up|1|||
145710038|NCT02942277|525454575|FG006|Year 2|Lost to Follow-up|0|||
145710039|NCT02942277|525454576|FG007|Year 2|Lost to Follow-up|0|||
145710040|NCT02942277|525454577|FG008|Year 2|Lost to Follow-up|0|||
145710041|NCT02942277|525454578|FG009|Year 2|Lost to Follow-up|0|||
145710042|NCT02942277|525454579|FG010|Year 2|Lost to Follow-up|0|||
145710043|NCT02942277|525454569|FG000|Year 2|Did not rescreen|0|||
145710044|NCT02942277|525454570|FG001|Year 2|Did not rescreen|0|||
145710045|NCT02942277|525454571|FG002|Year 2|Did not rescreen|1|||
145710046|NCT02942277|525454572|FG003|Year 2|Did not rescreen|1|||
145710047|NCT02942277|525454573|FG004|Year 2|Did not rescreen|9|||
145710048|NCT02942277|525454574|FG005|Year 2|Did not rescreen|6|||
145710049|NCT02942277|525454575|FG006|Year 2|Did not rescreen|0|||
145710050|NCT02942277|525454576|FG007|Year 2|Did not rescreen|1|||
145710051|NCT02942277|525454577|FG008|Year 2|Did not rescreen|0|||
145710052|NCT02942277|525454578|FG009|Year 2|Did not rescreen|0|||
145710053|NCT02942277|525454579|FG010|Year 2|Did not rescreen|21|||
145710054|NCT02942277|525454569|FG000|Year 2|Met withdrawal criteria|0|||
145710055|NCT02942277|525454570|FG001|Year 2|Met withdrawal criteria|0|||
145710056|NCT02942277|525454571|FG002|Year 2|Met withdrawal criteria|0|||
145710057|NCT02942277|525454572|FG003|Year 2|Met withdrawal criteria|0|||
145710058|NCT02942277|525454573|FG004|Year 2|Met withdrawal criteria|1|||
145710059|NCT02942277|525454574|FG005|Year 2|Met withdrawal criteria|2|||
145710060|NCT02942277|525454575|FG006|Year 2|Met withdrawal criteria|0|||
145710061|NCT02942277|525454576|FG007|Year 2|Met withdrawal criteria|0|||
145710062|NCT02942277|525454577|FG008|Year 2|Met withdrawal criteria|0|||
145710063|NCT02942277|525454578|FG009|Year 2|Met withdrawal criteria|0|||
145710064|NCT02942277|525454579|FG010|Year 2|Met withdrawal criteria|1|||
145710065|NCT02942277|525454569|FG000|Year 2|Travel|0|||
145710066|NCT02942277|525454570|FG001|Year 2|Travel|1|||
145710067|NCT02942277|525454571|FG002|Year 2|Travel|0|||
145710068|NCT02942277|525454572|FG003|Year 2|Travel|0|||
145710069|NCT02942277|525454573|FG004|Year 2|Travel|0|||
145710070|NCT02942277|525454574|FG005|Year 2|Travel|1|||
145710071|NCT02942277|525454575|FG006|Year 2|Travel|0|||
145710072|NCT02942277|525454576|FG007|Year 2|Travel|0|||
145710073|NCT02942277|525454577|FG008|Year 2|Travel|0|||
145710074|NCT02942277|525454578|FG009|Year 2|Travel|1|||
145710075|NCT02942277|525454579|FG010|Year 2|Travel|3|||
145491509|NCT00360412|524653826|FG001|Overall Study|Physician Decision|4|||
145491510|NCT00360412|524653825|FG000|Overall Study|Other|5|||
145491511|NCT00360412|524653826|FG001|Overall Study|Other|6|||
145710076|NCT02942277|525454569|FG000|Year 2|Non-compliant|0|||
145710077|NCT02942277|525454570|FG001|Year 2|Non-compliant|0|||
145710078|NCT02942277|525454571|FG002|Year 2|Non-compliant|0|||
145710079|NCT02942277|525454572|FG003|Year 2|Non-compliant|0|||
145710080|NCT02942277|525454573|FG004|Year 2|Non-compliant|1|||
145710081|NCT02942277|525454574|FG005|Year 2|Non-compliant|1|||
145710082|NCT02942277|525454575|FG006|Year 2|Non-compliant|0|||
145710083|NCT02942277|525454576|FG007|Year 2|Non-compliant|0|||
145710084|NCT02942277|525454577|FG008|Year 2|Non-compliant|0|||
145710085|NCT02942277|525454578|FG009|Year 2|Non-compliant|0|||
145710086|NCT02942277|525454579|FG010|Year 2|Non-compliant|0|||
145710087|NCT02942277|525454569|FG000|Year 2|Withdrawal by Subject|0|||
145710088|NCT02942277|525454570|FG001|Year 2|Withdrawal by Subject|0|||
145710089|NCT02942277|525454571|FG002|Year 2|Withdrawal by Subject|0|||
145710090|NCT02942277|525454572|FG003|Year 2|Withdrawal by Subject|0|||
145710091|NCT02942277|525454573|FG004|Year 2|Withdrawal by Subject|0|||
145710092|NCT02942277|525454574|FG005|Year 2|Withdrawal by Subject|0|||
145710093|NCT02942277|525454575|FG006|Year 2|Withdrawal by Subject|1|||
145710094|NCT02942277|525454576|FG007|Year 2|Withdrawal by Subject|0|||
145710095|NCT02942277|525454577|FG008|Year 2|Withdrawal by Subject|0|||
145710096|NCT02942277|525454578|FG009|Year 2|Withdrawal by Subject|0|||
145710097|NCT02942277|525454579|FG010|Year 2|Withdrawal by Subject|0|||
145710098|NCT02187159|525454580|FG000|Overall Study|Protocol Violation|4|||
145710099|NCT02187159|525454581|FG001|Overall Study|Protocol Violation|6|||
145710100|NCT02187159|525454582|FG002|Overall Study|Protocol Violation|3|||
145710101|NCT02187159|525454583|FG003|Overall Study|Protocol Violation|4|||
145710102|NCT02187159|525454580|FG000|Overall Study|Lack of Efficacy|10|||
145710103|NCT02187159|525454581|FG001|Overall Study|Lack of Efficacy|5|||
145710104|NCT02187159|525454582|FG002|Overall Study|Lack of Efficacy|4|||
145710105|NCT02187159|525454583|FG003|Overall Study|Lack of Efficacy|7|||
145710106|NCT02187159|525454580|FG000|Overall Study|Adverse Event|28|||
145710107|NCT02187159|525454581|FG001|Overall Study|Adverse Event|33|||
145710108|NCT02187159|525454582|FG002|Overall Study|Adverse Event|42|||
145710109|NCT02187159|525454583|FG003|Overall Study|Adverse Event|50|||
145710110|NCT02187159|525454580|FG000|Overall Study|Withdrawal by Subject|24|||
145710111|NCT02187159|525454581|FG001|Overall Study|Withdrawal by Subject|28|||
145710112|NCT02187159|525454582|FG002|Overall Study|Withdrawal by Subject|25|||
145710113|NCT02187159|525454583|FG003|Overall Study|Withdrawal by Subject|26|||
145710114|NCT02187159|525454580|FG000|Overall Study|Other|3|||
145710115|NCT02187159|525454581|FG001|Overall Study|Other|7|||
145710116|NCT02187159|525454582|FG002|Overall Study|Other|3|||
145710117|NCT02187159|525454583|FG003|Overall Study|Other|9|||
145710118|NCT04325282|525454584|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
145710119|NCT04325282|525454585|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
145710120|NCT04325282|525454584|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
145710121|NCT04325282|525454585|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
145710122|NCT05282121|525454591|FG000|Overall Study|Adverse Event|1|||
145710123|NCT05282121|525454592|FG001|Overall Study|Adverse Event|1|||
145710124|NCT05282121|525454593|FG002|Overall Study|Adverse Event|4|||
145710125|NCT05282121|525454594|FG003|Overall Study|Adverse Event|1|||
145710126|NCT05282121|525454591|FG000|Overall Study|Study Terminated by Sponsor|1|||
145710127|NCT05282121|525454592|FG001|Overall Study|Study Terminated by Sponsor|2|||
145710128|NCT05282121|525454593|FG002|Overall Study|Study Terminated by Sponsor|2|||
145710129|NCT05282121|525454594|FG003|Overall Study|Study Terminated by Sponsor|2|||
145710130|NCT05282121|525454591|FG000|Overall Study|Other than listed|0|||
145710131|NCT05282121|525454592|FG001|Overall Study|Other than listed|0|||
145710132|NCT05282121|525454593|FG002|Overall Study|Other than listed|1|||
145710133|NCT05282121|525454594|FG003|Overall Study|Other than listed|0|||
145710134|NCT05282121|525454591|FG000|Overall Study|No reason available|0|||
145710135|NCT05282121|525454592|FG001|Overall Study|No reason available|0|||
145710136|NCT05282121|525454593|FG002|Overall Study|No reason available|1|||
145710137|NCT05282121|525454594|FG003|Overall Study|No reason available|0|||
145710138|NCT01736189|525454597|FG000|Overall Study|Violation of registration criteria|41|||
145710139|NCT01736189|525454597|FG000|Overall Study|Protocol Violation|4|||
145710140|NCT01736189|525454597|FG000|Overall Study|Criteria and protocol violations|1|||
145710141|NCT00608868|525454600|FG000|Overall Study|Withdrawal by Subject|7|||
145710142|NCT00608868|525454600|FG000|Overall Study|Protocol Violation|3|||
145710143|NCT00608868|525454600|FG000|Overall Study|Lost to Follow-up|2|||
145710144|NCT00608868|525454600|FG000|Overall Study|Adverse Event|1|||
145710145|NCT00608868|525454600|FG000|Overall Study|Physician Decision|2|||
145710146|NCT01712061|525454601|FG000|Overall Study|Adverse Event|4|||
145710147|NCT01712061|525454602|FG001|Overall Study|Adverse Event|9|||
145710148|NCT01712061|525454603|FG002|Overall Study|Adverse Event|5|||
145710149|NCT01712061|525454601|FG000|Overall Study|Death|0|||
145710150|NCT01712061|525454602|FG001|Overall Study|Death|0|||
145710151|NCT01712061|525454603|FG002|Overall Study|Death|1|||
145710152|NCT01712061|525454601|FG000|Overall Study|Lost to Follow-up|1|||
145710153|NCT01712061|525454602|FG001|Overall Study|Lost to Follow-up|0|||
145710154|NCT01712061|525454603|FG002|Overall Study|Lost to Follow-up|1|||
145710155|NCT01712061|525454601|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
145710156|NCT01712061|525454602|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
145710157|NCT01712061|525454603|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
145710158|NCT01712061|525454601|FG000|Overall Study|Medication Error Without Associated AE|0|||
145710159|NCT01712061|525454602|FG001|Overall Study|Medication Error Without Associated AE|1|||
145710160|NCT01712061|525454603|FG002|Overall Study|Medication Error Without Associated AE|0|||
145710161|NCT01712061|525454601|FG000|Overall Study|Withdrawal by Subject|1|||
145710162|NCT01712061|525454602|FG001|Overall Study|Withdrawal by Subject|7|||
145710163|NCT01712061|525454603|FG002|Overall Study|Withdrawal by Subject|1|||
145710164|NCT01712061|525454601|FG000|Overall Study|Other|0|||
145710165|NCT01712061|525454602|FG001|Overall Study|Other|3|||
145710166|NCT01712061|525454603|FG002|Overall Study|Other|0|||
145710167|NCT00879775|525454606|FG000|Overall Study|Lost to Follow-up|2|||
145710168|NCT00879775|525454607|FG001|Overall Study|Lost to Follow-up|1|||
145710169|NCT01677767|525454608|FG000|Overall Study|Adverse Event|1|||
145710170|NCT01677767|525454608|FG000|Overall Study|Death|4|||
145710171|NCT01677767|525454608|FG000|Overall Study|Protocol Violation|4|||
145710172|NCT01677767|525454608|FG000|Overall Study|Withdrawal by Subject|10|||
145710173|NCT01677767|525454608|FG000|Overall Study|Non-compliance by the participants|3|||
145710174|NCT00755105|525454609|FG000|Overall Study|Withdrawal by Subject|9|||
145710175|NCT00755105|525454610|FG001|Overall Study|Withdrawal by Subject|11|||
145710176|NCT00755105|525454611|FG002|Overall Study|Withdrawal by Subject|4|||
145710177|NCT00818779|525454614|FG000|Overall Study|Protocol Violation|1|||
145710178|NCT00818779|525454615|FG001|Overall Study|Protocol Violation|0|||
145710179|NCT00818779|525454614|FG000|Overall Study|Lost to Follow-up|1|||
145710180|NCT00818779|525454615|FG001|Overall Study|Lost to Follow-up|0|||
145710181|NCT00818779|525454614|FG000|Overall Study|Adverse Event|4|||
145710182|NCT00818779|525454615|FG001|Overall Study|Adverse Event|1|||
145710183|NCT01840410|525454619|FG000|Overall Study|Physician Decision|1|||
145710184|NCT01840410|525454620|FG001|Overall Study|Physician Decision|2|||
145710185|NCT01840410|525454619|FG000|Overall Study|Pregnancy|1|||
145710186|NCT01840410|525454620|FG001|Overall Study|Pregnancy|0|||
145710187|NCT01840410|525454619|FG000|Overall Study|Protocol deviation|1|||
145710188|NCT01840410|525454620|FG001|Overall Study|Protocol deviation|0|||
145710189|NCT01840410|525454619|FG000|Overall Study|Lost to Follow-up|1|||
145710190|NCT01840410|525454620|FG001|Overall Study|Lost to Follow-up|0|||
145710191|NCT01840410|525454619|FG000|Overall Study|Withdrawal by Subject|2|||
145710192|NCT01840410|525454620|FG001|Overall Study|Withdrawal by Subject|1|||
145710193|NCT01840410|525454619|FG000|Overall Study|Adverse Event|1|||
145710194|NCT01840410|525454620|FG001|Overall Study|Adverse Event|1|||
145710195|NCT00839956|525454621|FG000|Overall Study|Adverse Event|2|||
145710196|NCT00839956|525454621|FG000|Overall Study|Lack of Efficacy|6|||
145710197|NCT00839956|525454621|FG000|Overall Study|Physician Decision|1|||
145710198|NCT00839956|525454621|FG000|Overall Study|Withdrawal by Subject|3|||
145710199|NCT04343976|525454622|FG000|Overall Study|Withdrawal by Subject|0|||
145710200|NCT04343976|525454623|FG001|Overall Study|Withdrawal by Subject|1|||
145710201|NCT02807883|525454624|FG000|Overall Study|Withdrawal by Subject|2|||
145710202|NCT00594880|525454625|FG000|Overall Study|Withdrawal by Subject|1|||
145710203|NCT00594880|525454626|FG001|Overall Study|Withdrawal by Subject|1|||
145710204|NCT00594880|525454625|FG000|Overall Study|Lost to Follow-up|1|||
145710205|NCT00594880|525454626|FG001|Overall Study|Lost to Follow-up|0|||
145710206|NCT00694109|525454627|FG000|Overall Study|Physician Decision|3|||
145710207|NCT00694109|525454627|FG000|Overall Study|Adverse Event|74|||
145710208|NCT00694109|525454627|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
145710209|NCT00694109|525454627|FG000|Overall Study|Lack of Efficacy|2|||
145710210|NCT00694109|525454627|FG000|Overall Study|Withdrawal by Subject|13|||
145710211|NCT00694109|525454627|FG000|Overall Study|Pregnancy|1|||
145710212|NCT00694109|525454627|FG000|Overall Study|Enrolled but not treated|1|||
145710213|NCT00694109|525454627|FG000|Overall Study|Other|2|||
145710214|NCT00694109|525454627|FG000|Overall Study|Consented but no additional treatment|3|||
145710215|NCT01254747|525454630|FG000|Overall Study|Unacceptable subjective vision|0|||
145710216|NCT01254747|525454631|FG001|Overall Study|Unacceptable subjective vision|0|||
145710217|NCT01254747|525454632|FG002|Overall Study|Unacceptable subjective vision|0|||
145710218|NCT01254747|525454633|FG003|Overall Study|Unacceptable subjective vision|2|||
145710219|NCT01254747|525454630|FG000|Overall Study|Difficult removal handling|0|||
145710220|NCT01254747|525454631|FG001|Overall Study|Difficult removal handling|0|||
145710221|NCT01254747|525454632|FG002|Overall Study|Difficult removal handling|1|||
145710222|NCT01254747|525454633|FG003|Overall Study|Difficult removal handling|0|||
145710223|NCT01254747|525454630|FG000|Overall Study|Symptoms and problems|0|||
145710224|NCT01254747|525454631|FG001|Overall Study|Symptoms and problems|2|||
145710225|NCT01254747|525454632|FG002|Overall Study|Symptoms and problems|1|||
145710226|NCT01254747|525454633|FG003|Overall Study|Symptoms and problems|0|||
145710227|NCT01254747|525454630|FG000|Overall Study|Lost to Follow-up|0|||
145710228|NCT01254747|525454631|FG001|Overall Study|Lost to Follow-up|0|||
145710229|NCT01254747|525454632|FG002|Overall Study|Lost to Follow-up|1|||
145710230|NCT01254747|525454633|FG003|Overall Study|Lost to Follow-up|0|||
145710231|NCT01254747|525454630|FG000|Overall Study|Biomicroscopy|0|||
145710232|NCT01254747|525454631|FG001|Overall Study|Biomicroscopy|0|||
145710233|NCT01254747|525454632|FG002|Overall Study|Biomicroscopy|1|||
145710234|NCT01254747|525454633|FG003|Overall Study|Biomicroscopy|0|||
145710235|NCT01254747|525454630|FG000|Overall Study|Discomfort|0|||
145710236|NCT01254747|525454631|FG001|Overall Study|Discomfort|4|||
145710237|NCT01254747|525454632|FG002|Overall Study|Discomfort|0|||
145710238|NCT01254747|525454633|FG003|Overall Study|Discomfort|0|||
145710239|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
145710240|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
145710241|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
145710242|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
145710243|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
145710244|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
145710245|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
145710246|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
145710247|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
145710248|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
145710249|NCT00245960|525454635|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
145710250|NCT00245960|525454636|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
145710251|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
145710252|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
145710253|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
145710254|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
145710255|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
145710256|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
145710257|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
145710258|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
145710259|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
145710260|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
145710261|NCT00245960|525454635|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
145710262|NCT00245960|525454636|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
145710263|NCT02817906|525454637|FG000|Overall Study|Adverse Event|3|||
145710264|NCT02817906|525454638|FG001|Overall Study|Adverse Event|0|||
145710265|NCT02817906|525454637|FG000|Overall Study|Lack of Efficacy|1|||
145710266|NCT02817906|525454638|FG001|Overall Study|Lack of Efficacy|0|||
145710267|NCT02817906|525454637|FG000|Overall Study|Protocol Violation|1|||
145710268|NCT02817906|525454638|FG001|Overall Study|Protocol Violation|1|||
145710269|NCT02817906|525454637|FG000|Overall Study|Study Terminated by Sponsor|2|||
145710270|NCT02817906|525454638|FG001|Overall Study|Study Terminated by Sponsor|2|||
145710271|NCT02817906|525454637|FG000|Overall Study|Withdrawal by Subject|7|||
145710272|NCT02817906|525454638|FG001|Overall Study|Withdrawal by Subject|0|||
145710273|NCT02817906|525454637|FG000|Overall Study|Other|2|||
145710274|NCT02817906|525454638|FG001|Overall Study|Other|2|||
145710275|NCT04608773|525454642|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
145710276|NCT04608773|525454643|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
145710277|NCT04608773|525454642|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
145710278|NCT04608773|525454643|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
145710279|NCT04608773|525454642|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
145710280|NCT04608773|525454643|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
145710281|NCT04608773|525454642|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
145710282|NCT04608773|525454643|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
145710283|NCT04608773|525454642|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
145710284|NCT04608773|525454643|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
145710285|NCT01077518|525454646|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
145710286|NCT01077518|525454647|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
145710287|NCT01077518|525454648|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
145710288|NCT01077518|525454646|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
145710289|NCT01077518|525454647|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
145710290|NCT01077518|525454648|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
145710291|NCT01077518|525454646|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
145710292|NCT01077518|525454647|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
145710293|NCT01077518|525454648|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
145710294|NCT01077518|525454646|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
145710295|NCT01077518|525454647|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
145710296|NCT01077518|525454648|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
145710297|NCT01077518|525454646|FG000|Optional Ofa Phase|Physician Decision|0|||
145710298|NCT01077518|525454647|FG001|Optional Ofa Phase|Physician Decision|0|||
145710299|NCT01077518|525454648|FG002|Optional Ofa Phase|Physician Decision|1|||
145710300|NCT01077518|525454646|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
145710301|NCT01077518|525454647|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
145710302|NCT01077518|525454648|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
145710303|NCT01077518|525454646|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
145710304|NCT01077518|525454647|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
145710305|NCT01077518|525454648|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
145710306|NCT04958200|525454649|FG000|Overall Study|Withdrawal by Subject|0|||
145710307|NCT04958200|525454650|FG001|Overall Study|Withdrawal by Subject|2|||
145710308|NCT04958200|525454649|FG000|Overall Study|Lost to Follow-up|3|||
145710309|NCT04958200|525454650|FG001|Overall Study|Lost to Follow-up|2|||
145710310|NCT02387970|525454651|FG000|Overall Study|Did not complete 1-year follow up|1|||
145710311|NCT02387970|525454652|FG001|Overall Study|Did not complete 1-year follow up|2|||
145710312|NCT01495598|525454653|FG000|Overall Study|Death during follow up period|2|||
145710313|NCT01495598|525454653|FG000|Overall Study|Death on study|1|||
145710314|NCT01495598|525454653|FG000|Overall Study|Lost to Follow-up|3|||
145710315|NCT01495598|525454653|FG000|Overall Study|Physician Decision|8|||
145710316|NCT05511038|525454654|FG000|Overall|Withdrawal by Subject|5|||
145710317|NCT05511038|525454655|FG001|Overall|Withdrawal by Subject|3|||
145710318|NCT05511038|525454654|FG000|Overall|Screen Failure|20|||
145710319|NCT05511038|525454655|FG001|Overall|Screen Failure|1|||
145710320|NCT05511038|525454654|FG000|Overall|Physician Decision|3|||
145710321|NCT05511038|525454655|FG001|Overall|Physician Decision|0|||
145710322|NCT05511038|525454654|FG000|Overall|Lost to Follow-up|3|||
145710323|NCT05511038|525454655|FG001|Overall|Lost to Follow-up|0|||
145710324|NCT05511038|525454654|FG000|Overall|Death|1|||
145710325|NCT05511038|525454655|FG001|Overall|Death|0|||
145710326|NCT05511038|525454654|FG000|Screening|Withdrawal by Subject|1|||
145710327|NCT05511038|525454655|FG001|Screening|Withdrawal by Subject|0|||
145710328|NCT05511038|525454654|FG000|Screening|Lost to Follow Up (1 participant)|1|||
145710329|NCT05511038|525454655|FG001|Screening|Lost to Follow Up (1 participant)|0|||
145710330|NCT05511038|525454654|FG000|Screening|Screen Failure|3|||
145710331|NCT05511038|525454655|FG001|Screening|Screen Failure|0|||
145710332|NCT05511038|525454654|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
145710333|NCT05511038|525454655|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
145710334|NCT05511038|525454654|FG000|Treatment|Withdrawal by Subject|5|||
145710335|NCT05511038|525454655|FG001|Treatment|Withdrawal by Subject|3|||
145710336|NCT05511038|525454654|FG000|Treatment|Physician Decision|4|||
145710337|NCT05511038|525454655|FG001|Treatment|Physician Decision|0|||
145710338|NCT05511038|525454654|FG000|Treatment|Lost to Follow-up|2|||
145710339|NCT05511038|525454655|FG001|Treatment|Lost to Follow-up|0|||
145710340|NCT05511038|525454654|FG000|Treatment|Death|1|||
145710341|NCT05511038|525454655|FG001|Treatment|Death|0|||
145710342|NCT05511038|525454654|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
145710343|NCT05511038|525454655|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
145710344|NCT05511038|525454654|FG000|Treatment|Refuse by subject|1|||
145710345|NCT05511038|525454655|FG001|Treatment|Refuse by subject|0|||
145710346|NCT05511038|525454654|FG000|Treatment|Subject did not go to the site for visit|1|||
145710347|NCT05511038|525454655|FG001|Treatment|Subject did not go to the site for visit|0|||
145710348|NCT03852719|525454656|FG000|Overall Study|Withdrawal of consent|8|||
145710349|NCT03852719|525454657|FG001|Overall Study|Withdrawal of consent|8|||
145710350|NCT03852719|525454658|FG002|Overall Study|Withdrawal of consent|9|||
145710351|NCT03852719|525454656|FG000|Overall Study|Physician Decision|5|||
145710352|NCT03852719|525454657|FG001|Overall Study|Physician Decision|4|||
145710353|NCT03852719|525454658|FG002|Overall Study|Physician Decision|1|||
145710354|NCT03852719|525454656|FG000|Overall Study|Pregnancy|2|||
145710355|NCT03852719|525454657|FG001|Overall Study|Pregnancy|1|||
145710356|NCT03852719|525454658|FG002|Overall Study|Pregnancy|0|||
145710357|NCT03852719|525454656|FG000|Overall Study|Death|1|||
145710358|NCT03852719|525454657|FG001|Overall Study|Death|0|||
145710359|NCT03852719|525454658|FG002|Overall Study|Death|0|||
145710360|NCT03852719|525454656|FG000|Overall Study|Reason not Specified|3|||
145710361|NCT03852719|525454657|FG001|Overall Study|Reason not Specified|3|||
145710362|NCT03852719|525454658|FG002|Overall Study|Reason not Specified|5|||
145710363|NCT03852719|525454656|FG000|Overall Study|Adverse Event|2|||
145710364|NCT03852719|525454657|FG001|Overall Study|Adverse Event|1|||
145710365|NCT03852719|525454658|FG002|Overall Study|Adverse Event|4|||
145710366|NCT03852719|525454656|FG000|Overall Study|Progressive disease|1|||
145710367|NCT03852719|525454657|FG001|Overall Study|Progressive disease|4|||
145710368|NCT03852719|525454658|FG002|Overall Study|Progressive disease|1|||
145710369|NCT03852719|525454656|FG000|Overall Study|Lost to Follow-up|1|||
145710370|NCT03852719|525454657|FG001|Overall Study|Lost to Follow-up|0|||
145710371|NCT03852719|525454658|FG002|Overall Study|Lost to Follow-up|0|||
145710372|NCT05543187|525454661|FG000|Overall Study|Ongoing|3|||
145710373|NCT05543187|525454662|FG001|Overall Study|Ongoing|2|||
145710374|NCT04777864|525454663|FG000|Overall Study|Lost to Follow-up|8|||
145710375|NCT04777864|525454664|FG001|Overall Study|Lost to Follow-up|19|||
145710376|NCT03086655|525454667|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
145710377|NCT03086655|525454668|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
145710378|NCT03086655|525454667|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
145710379|NCT03086655|525454668|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
145710380|NCT03086655|525454667|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
145710381|NCT03086655|525454668|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
145710382|NCT03086655|525454667|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
145710383|NCT03086655|525454668|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
145710384|NCT03086655|525454667|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
145710385|NCT03086655|525454668|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
145710386|NCT03086655|525454667|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
145710387|NCT03086655|525454668|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
145710388|NCT03086655|525454667|FG000|12 Month Follow-up = Final Assessment|Death|0|||
145710389|NCT03086655|525454668|FG001|12 Month Follow-up = Final Assessment|Death|1|||
145710390|NCT03841526|525454670|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
145710391|NCT03841526|525454671|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
145710392|NCT03841526|525454672|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
145710393|NCT03841526|525454673|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
145710394|NCT03841526|525454674|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
145710395|NCT03841526|525454675|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
145710396|NCT03841526|525454670|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
145710397|NCT03841526|525454671|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
145710398|NCT03841526|525454672|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
145710399|NCT03841526|525454673|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
145710400|NCT03841526|525454674|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
145710401|NCT03841526|525454675|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
145710402|NCT03841526|525454670|FG000|Outpatient Phase Treatment|Physician Decision|0|||
145710403|NCT03841526|525454671|FG001|Outpatient Phase Treatment|Physician Decision|1|||
145710404|NCT03841526|525454672|FG002|Outpatient Phase Treatment|Physician Decision|0|||
145710405|NCT03841526|525454673|FG003|Outpatient Phase Treatment|Physician Decision|0|||
145710406|NCT03841526|525454674|FG004|Outpatient Phase Treatment|Physician Decision|0|||
145710407|NCT03841526|525454675|FG005|Outpatient Phase Treatment|Physician Decision|0|||
145710408|NCT03841526|525454670|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
145710409|NCT03841526|525454671|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
145710410|NCT03841526|525454672|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
145710411|NCT03841526|525454673|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
145710412|NCT03841526|525454674|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
145710413|NCT03841526|525454675|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
145710414|NCT04303780|525454683|FG000|Overall Study|Death|104|||
145710415|NCT04303780|525454684|FG001|Overall Study|Death|85|||
145710416|NCT04303780|525454683|FG000|Overall Study|Lost to Follow-up|5|||
145710417|NCT04303780|525454684|FG001|Overall Study|Lost to Follow-up|2|||
145710418|NCT04303780|525454683|FG000|Overall Study|Withdrawal by Subject|12|||
145710419|NCT04303780|525454684|FG001|Overall Study|Withdrawal by Subject|39|||
145710420|NCT04303780|525454683|FG000|Overall Study|Ongoing in study|50|||
145710421|NCT04303780|525454684|FG001|Overall Study|Ongoing in study|45|||
145710422|NCT01123070|525456480|FG000|Part B Double Blind Period|Protocol Violation|0|||
145710423|NCT01123070|525456481|FG001|Part B Double Blind Period|Protocol Violation|0|||
145710424|NCT01123070|525456482|FG002|Part B Double Blind Period|Protocol Violation|0|||
145710425|NCT01123070|525456483|FG003|Part B Double Blind Period|Protocol Violation|1|||
145710426|NCT01123070|525456480|FG000|Part B Double Blind Period|Adverse Event|0|||
145710427|NCT01123070|525456481|FG001|Part B Double Blind Period|Adverse Event|0|||
145710428|NCT01123070|525456482|FG002|Part B Double Blind Period|Adverse Event|2|||
145710429|NCT01123070|525456483|FG003|Part B Double Blind Period|Adverse Event|0|||
145710430|NCT01123070|525456480|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
145710431|NCT01123070|525456481|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
145710432|NCT01123070|525456482|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
145710433|NCT01123070|525456483|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
145710434|NCT01977677|525456484|FG000|Overall Study|Unrelated Adverse Event|0|||
145710435|NCT01977677|525456485|FG001|Overall Study|Unrelated Adverse Event|0|||
145710436|NCT01977677|525456486|FG002|Overall Study|Unrelated Adverse Event|1|||
145710437|NCT05602727|525456489|FG000|Overall Study|Physician Decision|0|||
145710438|NCT05602727|525456490|FG001|Overall Study|Physician Decision|1|||
145710439|NCT05602727|525456491|FG002|Overall Study|Physician Decision|0|||
145710440|NCT05602727|525456489|FG000|Overall Study|Randomized by mistake without study medication|1|||
145710441|NCT05602727|525456490|FG001|Overall Study|Randomized by mistake without study medication|0|||
145710442|NCT05602727|525456491|FG002|Overall Study|Randomized by mistake without study medication|0|||
145710443|NCT05602727|525456489|FG000|Overall Study|Study termination by Sponsor|18|||
145710444|NCT05602727|525456490|FG001|Overall Study|Study termination by Sponsor|15|||
145710445|NCT05602727|525456491|FG002|Overall Study|Study termination by Sponsor|19|||
145710446|NCT05602727|525456489|FG000|Overall Study|Withdrawal by Subject|2|||
145710447|NCT05602727|525456490|FG001|Overall Study|Withdrawal by Subject|1|||
145710448|NCT05602727|525456491|FG002|Overall Study|Withdrawal by Subject|1|||
145710449|NCT05602727|525456489|FG000|Overall Study|Various reasons|1|||
145710450|NCT05602727|525456490|FG001|Overall Study|Various reasons|6|||
145710451|NCT05602727|525456491|FG002|Overall Study|Various reasons|1|||
145710452|NCT04020185|525456492|FG000|Overall Study|Death|0|||
145710453|NCT04020185|525456493|FG001|Overall Study|Death|0|||
145710454|NCT04020185|525456494|FG002|Overall Study|Death|1|||
145710455|NCT04020185|525456495|FG003|Overall Study|Death|2|||
145710456|NCT04020185|525456496|FG004|Overall Study|Death|1|||
145710457|NCT04020185|525456497|FG005|Overall Study|Death|0|||
145710458|NCT04020185|525456498|FG006|Overall Study|Death|1|||
145710459|NCT04020185|525456499|FG007|Overall Study|Death|0|||
145710460|NCT04020185|525456492|FG000|Overall Study|Consent withdrawn|1|||
145710461|NCT04020185|525456493|FG001|Overall Study|Consent withdrawn|0|||
145710462|NCT04020185|525456494|FG002|Overall Study|Consent withdrawn|0|||
145710463|NCT04020185|525456495|FG003|Overall Study|Consent withdrawn|0|||
145710464|NCT04020185|525456496|FG004|Overall Study|Consent withdrawn|2|||
145710465|NCT04020185|525456497|FG005|Overall Study|Consent withdrawn|0|||
145710466|NCT04020185|525456498|FG006|Overall Study|Consent withdrawn|1|||
145710467|NCT04020185|525456499|FG007|Overall Study|Consent withdrawn|1|||
145710468|NCT04020185|525456492|FG000|Overall Study|Patient in hospice|0|||
145710469|NCT04020185|525456493|FG001|Overall Study|Patient in hospice|1|||
145710470|NCT04020185|525456494|FG002|Overall Study|Patient in hospice|0|||
145710471|NCT04020185|525456495|FG003|Overall Study|Patient in hospice|0|||
145710472|NCT04020185|525456496|FG004|Overall Study|Patient in hospice|0|||
145710473|NCT04020185|525456497|FG005|Overall Study|Patient in hospice|0|||
145710474|NCT04020185|525456498|FG006|Overall Study|Patient in hospice|0|||
145710475|NCT04020185|525456499|FG007|Overall Study|Patient in hospice|0|||
145710476|NCT04020185|525456492|FG000|Overall Study|Continuing on expanded access|0|||
145710477|NCT04020185|525456493|FG001|Overall Study|Continuing on expanded access|0|||
145710478|NCT04020185|525456494|FG002|Overall Study|Continuing on expanded access|0|||
145710479|NCT04020185|525456495|FG003|Overall Study|Continuing on expanded access|0|||
145710480|NCT04020185|525456496|FG004|Overall Study|Continuing on expanded access|0|||
145710481|NCT04020185|525456497|FG005|Overall Study|Continuing on expanded access|0|||
145710482|NCT04020185|525456498|FG006|Overall Study|Continuing on expanded access|1|||
145710483|NCT04020185|525456499|FG007|Overall Study|Continuing on expanded access|1|||
145710484|NCT00527787|525456502|FG000|Overall Study|Adverse Event|14|||
145710485|NCT00527787|525456503|FG001|Overall Study|Adverse Event|24|||
145710486|NCT00527787|525456502|FG000|Overall Study|Withdrawal by Subject|13|||
145710487|NCT00527787|525456503|FG001|Overall Study|Withdrawal by Subject|25|||
145710488|NCT00527787|525456502|FG000|Overall Study|Lost to Follow-up|5|||
145710489|NCT00527787|525456503|FG001|Overall Study|Lost to Follow-up|2|||
145710490|NCT00527787|525456502|FG000|Overall Study|Duodenal Ulcer|1|||
145710491|NCT00527787|525456503|FG001|Overall Study|Duodenal Ulcer|10|||
145710492|NCT00527787|525456502|FG000|Overall Study|misc|5|||
145710493|NCT00527787|525456503|FG001|Overall Study|misc|2|||
145710494|NCT02643303|525456504|FG000|Overall Study|Progressive Disease|4|||
145710495|NCT02643303|525456505|FG001|Overall Study|Progressive Disease|4|||
145710496|NCT02643303|525456506|FG002|Overall Study|Progressive Disease|1|||
145710497|NCT02643303|525456507|FG003|Overall Study|Progressive Disease|12|||
145710498|NCT02643303|525456508|FG004|Overall Study|Progressive Disease|6|||
145710499|NCT02643303|525456509|FG005|Overall Study|Progressive Disease|4|||
145710500|NCT02643303|525456510|FG006|Overall Study|Progressive Disease|8|||
145710501|NCT02643303|525456511|FG007|Overall Study|Progressive Disease|2|||
145710502|NCT02643303|525456512|FG008|Overall Study|Progressive Disease|6|||
145710503|NCT02643303|525456504|FG000|Overall Study|Adverse Event|0|||
145710504|NCT02643303|525456505|FG001|Overall Study|Adverse Event|1|||
145710505|NCT02643303|525456506|FG002|Overall Study|Adverse Event|0|||
145710506|NCT02643303|525456507|FG003|Overall Study|Adverse Event|0|||
145710507|NCT02643303|525456508|FG004|Overall Study|Adverse Event|1|||
145710508|NCT02643303|525456509|FG005|Overall Study|Adverse Event|0|||
145710509|NCT02643303|525456510|FG006|Overall Study|Adverse Event|0|||
145710510|NCT02643303|525456511|FG007|Overall Study|Adverse Event|0|||
145710511|NCT02643303|525456512|FG008|Overall Study|Adverse Event|0|||
145710512|NCT02643303|525456504|FG000|Overall Study|Withdrawal by Subject|0|||
145710513|NCT02643303|525456505|FG001|Overall Study|Withdrawal by Subject|0|||
145710514|NCT02643303|525456506|FG002|Overall Study|Withdrawal by Subject|0|||
145710515|NCT02643303|525456507|FG003|Overall Study|Withdrawal by Subject|1|||
145710516|NCT02643303|525456508|FG004|Overall Study|Withdrawal by Subject|0|||
145710517|NCT02643303|525456509|FG005|Overall Study|Withdrawal by Subject|0|||
145710518|NCT02643303|525456510|FG006|Overall Study|Withdrawal by Subject|1|||
145710519|NCT02643303|525456511|FG007|Overall Study|Withdrawal by Subject|1|||
145710520|NCT02643303|525456512|FG008|Overall Study|Withdrawal by Subject|1|||
145710521|NCT04833127|525456517|FG000|Overall Study|Lost to Follow-up|1|||
145710522|NCT04833127|525456518|FG001|Overall Study|Lost to Follow-up|1|||
145710523|NCT04335591|525456519|FG000|Overall Study|Adverse Event|5|||
145710524|NCT04335591|525456520|FG001|Overall Study|Adverse Event|2|||
145710525|NCT04335591|525456521|FG002|Overall Study|Adverse Event|3|||
145710526|NCT04335591|525456522|FG003|Overall Study|Adverse Event|2|||
145710527|NCT04335591|525456519|FG000|Overall Study|Protocol Violation|1|||
145710528|NCT04335591|525456520|FG001|Overall Study|Protocol Violation|0|||
145710529|NCT04335591|525456521|FG002|Overall Study|Protocol Violation|0|||
145710530|NCT04335591|525456522|FG003|Overall Study|Protocol Violation|0|||
145710531|NCT04335591|525456519|FG000|Overall Study|Withdrawal by Subject|8|||
145710532|NCT04335591|525456520|FG001|Overall Study|Withdrawal by Subject|4|||
145710533|NCT04335591|525456521|FG002|Overall Study|Withdrawal by Subject|4|||
145710534|NCT04335591|525456522|FG003|Overall Study|Withdrawal by Subject|5|||
145710535|NCT04335591|525456519|FG000|Overall Study|Subject planning pregnancy|0|||
145710536|NCT04335591|525456520|FG001|Overall Study|Subject planning pregnancy|1|||
145710537|NCT04335591|525456521|FG002|Overall Study|Subject planning pregnancy|0|||
145710538|NCT04335591|525456522|FG003|Overall Study|Subject planning pregnancy|0|||
145710539|NCT04335591|525456519|FG000|Overall Study|Ukrainian Russian war conflict|4|||
145710540|NCT04335591|525456520|FG001|Overall Study|Ukrainian Russian war conflict|5|||
145710541|NCT04335591|525456521|FG002|Overall Study|Ukrainian Russian war conflict|2|||
145710542|NCT04335591|525456522|FG003|Overall Study|Ukrainian Russian war conflict|0|||
145710543|NCT01499303|525456523|FG000|Overall Study|Ongoing|2|||
145710544|NCT01499303|525456524|FG001|Overall Study|Ongoing|1|||
145710545|NCT01499303|525456523|FG000|Overall Study|Withdrawal by Subject|0|||
145710546|NCT01499303|525456524|FG001|Overall Study|Withdrawal by Subject|1|||
145710547|NCT01499303|525456523|FG000|Overall Study|Adverse Event|1|||
145710548|NCT01499303|525456524|FG001|Overall Study|Adverse Event|4|||
145710549|NCT01499303|525456523|FG000|Overall Study|Other|0|||
145710550|NCT01499303|525456524|FG001|Overall Study|Other|1|||
145710551|NCT03853551|525456528|FG000|Overall Study|Death|2|||
145710552|NCT03853551|525456528|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
145710553|NCT01252355|525456529|FG000|Overall Study|Adverse Event|9|||
145710554|NCT01252355|525456530|FG001|Overall Study|Adverse Event|17|||
145710555|NCT01252355|525456531|FG002|Overall Study|Adverse Event|22|||
145710556|NCT01252355|525456529|FG000|Overall Study|Lack of Efficacy|6|||
145710557|NCT01252355|525456530|FG001|Overall Study|Lack of Efficacy|4|||
145710558|NCT01252355|525456531|FG002|Overall Study|Lack of Efficacy|2|||
145710559|NCT01252355|525456529|FG000|Overall Study|Lost to Follow-up|0|||
145710560|NCT01252355|525456530|FG001|Overall Study|Lost to Follow-up|0|||
145710561|NCT01252355|525456531|FG002|Overall Study|Lost to Follow-up|1|||
145710562|NCT01252355|525456529|FG000|Overall Study|Poor Compliance to Protocol|1|||
145710563|NCT01252355|525456530|FG001|Overall Study|Poor Compliance to Protocol|1|||
145710564|NCT01252355|525456531|FG002|Overall Study|Poor Compliance to Protocol|1|||
145710565|NCT01252355|525456529|FG000|Overall Study|Progressive Disease|2|||
145710566|NCT01252355|525456530|FG001|Overall Study|Progressive Disease|0|||
145710567|NCT01252355|525456531|FG002|Overall Study|Progressive Disease|0|||
145710568|NCT01252355|525456529|FG000|Overall Study|Sponsor Early Termination of Study|149|||
145710569|NCT01252355|525456530|FG001|Overall Study|Sponsor Early Termination of Study|149|||
145710570|NCT01252355|525456531|FG002|Overall Study|Sponsor Early Termination of Study|146|||
145710571|NCT01252355|525456529|FG000|Overall Study|Randomized but not Treated|2|||
145710572|NCT01252355|525456530|FG001|Overall Study|Randomized but not Treated|0|||
145710573|NCT01252355|525456531|FG002|Overall Study|Randomized but not Treated|0|||
145710574|NCT01252355|525456529|FG000|Overall Study|Other Than Above|8|||
145710575|NCT01252355|525456530|FG001|Overall Study|Other Than Above|7|||
145710576|NCT01252355|525456531|FG002|Overall Study|Other Than Above|7|||
145710577|NCT01876901|525456532|FG000|Overall Study|Protocol Violation|10|||
145710578|NCT01876901|525456533|FG001|Overall Study|Protocol Violation|2|||
145710579|NCT01876901|525456532|FG000|Overall Study|No or other surgical intervention|7|||
145710580|NCT01876901|525456533|FG001|Overall Study|No or other surgical intervention|5|||
145710581|NCT02242097|525456534|FG000|Ibrutinib Treatment|Adverse Event|16|||
145710582|NCT02242097|525456534|FG000|Ibrutinib Treatment|Physician Decision|1|||
145710583|NCT02242097|525456534|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
145710584|NCT02242097|525456534|FG000|Ibrutinib Treatment|Death|1|||
145710585|NCT02242097|525456534|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
145710586|NCT02242097|525456534|FG000|Post Therapy Follow Up|Death|3|||
145710587|NCT02242097|525456534|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
145710588|NCT03435692|525456537|FG000|Overall Study|Lack of Efficacy|2|||
145710589|NCT03435692|525456538|FG001|Overall Study|Lack of Efficacy|2|||
145710590|NCT03435692|525456539|FG002|Overall Study|Lack of Efficacy|0|||
145710591|NCT04313608|525456540|FG000|Overall Study|Death|12|||
145710592|NCT04313608|525456541|FG001|Overall Study|Death|3|||
145710593|NCT01145898|525456542|FG000|3-year Treatment|medication change by treating physician|3|||
145710594|NCT01145898|525456543|FG001|3-year Treatment|medication change by treating physician|16|||
145710595|NCT02440425|525456544|FG000|Overall Study|Death likely due to disease progression|1|||
145710596|NCT02440425|525456544|FG000|Overall Study|Withdrawal by Subject|2|||
145710597|NCT02440425|525456544|FG000|Overall Study|Adverse Event|1|||
145710598|NCT02440425|525456544|FG000|Overall Study|Adverse Event/Ineligible|1|||
145710599|NCT00842244|525456545|FG000|Overall Study|Death|3|||
145710600|NCT00842244|525456545|FG000|Overall Study|Withdrawal by Subject|1|||
145710601|NCT00842244|525456545|FG000|Overall Study|Other|17|||
145710602|NCT04145700|525456546|FG000|Overall Study|Withdrawal by Subject|8|||
145710603|NCT04145700|525456547|FG001|Overall Study|Withdrawal by Subject|3|||
145710604|NCT00780559|525456548|FG000|Overall Study|Lost to Follow-up|2|||
145710605|NCT00780559|525456549|FG001|Overall Study|Lost to Follow-up|7|||
145710606|NCT00780559|525456548|FG000|Overall Study|Death|1|||
145710607|NCT00780559|525456549|FG001|Overall Study|Death|0|||
145710608|NCT01327846|525456551|FG000|Core Phase|Subject decision (vital status: missing)|1|||
145710609|NCT01327846|525456552|FG001|Core Phase|Subject decision (vital status: missing)|2|||
145710610|NCT01327846|525456553|FG002|Core Phase|Subject decision (vital status: missing)|2|||
145710611|NCT01327846|525456554|FG003|Core Phase|Subject decision (vital status: missing)|1|||
145710612|NCT01327846|525456551|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
145710613|NCT01327846|525456552|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
145710614|NCT01327846|525456553|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
145710615|NCT01327846|525456554|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
145710616|NCT01327846|525456551|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
145710617|NCT01327846|525456552|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
145710618|NCT01327846|525456553|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
145710619|NCT01327846|525456554|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
145710620|NCT01327846|525456551|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
145710621|NCT01327846|525456552|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
145710622|NCT01327846|525456553|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
145710623|NCT01327846|525456554|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
145710624|NCT01327846|525456551|FG000|Core Phase|Lost to Follow-up|3|||
145710625|NCT01327846|525456552|FG001|Core Phase|Lost to Follow-up|3|||
145710626|NCT01327846|525456553|FG002|Core Phase|Lost to Follow-up|4|||
145710627|NCT01327846|525456554|FG003|Core Phase|Lost to Follow-up|5|||
145710628|NCT01327846|525456551|FG000|Extension Phase|Study terminated by sponsor|1073|||
145710629|NCT01327846|525456552|FG001|Extension Phase|Study terminated by sponsor|1124|||
145710630|NCT01327846|525456553|FG002|Extension Phase|Study terminated by sponsor|1067|||
145710631|NCT01327846|525456554|FG003|Extension Phase|Study terminated by sponsor|1660|||
145710632|NCT01327846|525456551|FG000|Extension Phase|Withdrawal by Subject|20|||
145710633|NCT01327846|525456552|FG001|Extension Phase|Withdrawal by Subject|13|||
145710634|NCT01327846|525456553|FG002|Extension Phase|Withdrawal by Subject|19|||
145710635|NCT01327846|525456554|FG003|Extension Phase|Withdrawal by Subject|37|||
145710636|NCT01327846|525456551|FG000|Extension Phase|Lost to Follow-up|4|||
145710637|NCT01327846|525456552|FG001|Extension Phase|Lost to Follow-up|3|||
145710638|NCT01327846|525456553|FG002|Extension Phase|Lost to Follow-up|4|||
145710639|NCT01327846|525456554|FG003|Extension Phase|Lost to Follow-up|7|||
145710640|NCT01327846|525456551|FG000|Extension Phase|Technical Problems|2|||
145710641|NCT01327846|525456552|FG001|Extension Phase|Technical Problems|4|||
145710642|NCT01327846|525456553|FG002|Extension Phase|Technical Problems|2|||
145710643|NCT01327846|525456554|FG003|Extension Phase|Technical Problems|2|||
145710644|NCT00203268|525456560|FG000|Early Treatment|only treated one headache|2|||
145710645|NCT00203268|525456560|FG000|Early Treatment|Lost to Follow-up|1|||
145710646|NCT00203268|525456560|FG000|Early Treatment|Withdrawal by Subject|1|||
145710647|NCT00846807|525456561|FG000|Overall Study|Adverse Event|270|||
145710648|NCT00846807|525456561|FG000|Overall Study|Lost to Follow-up|94|||
145710649|NCT00846807|525456561|FG000|Overall Study|Withdrawal by Subject|56|||
145710650|NCT00846807|525456561|FG000|Overall Study|Non compliant with European label|7|||
145710651|NCT00846807|525456561|FG000|Overall Study|Switch to other anticoagulants|89|||
145710652|NCT00846807|525456561|FG000|Overall Study|No prescription after hospital discharge|56|||
145710653|NCT00846807|525456561|FG000|Overall Study|Other|60|||
145710654|NCT00737698|525456562|FG000|Overall Study|Withdrawal by Subject|6|||
145710655|NCT00737698|525456563|FG001|Overall Study|Withdrawal by Subject|5|||
145710656|NCT00737698|525456564|FG002|Overall Study|Withdrawal by Subject|3|||
145710657|NCT00737698|525456562|FG000|Overall Study|Death|0|||
145710658|NCT00737698|525456563|FG001|Overall Study|Death|0|||
145710659|NCT00737698|525456564|FG002|Overall Study|Death|1|||
145710660|NCT01067846|525456565|FG000|Overall Study|Lost to Follow-up|17|||
145710661|NCT01067846|525456566|FG001|Overall Study|Lost to Follow-up|19|||
145710662|NCT01067846|525456565|FG000|Overall Study|Withdrawal by Subject|1|||
145710663|NCT01067846|525456566|FG001|Overall Study|Withdrawal by Subject|0|||
145710664|NCT01067846|525456565|FG000|Overall Study|participation in other tx study|1|||
145710665|NCT01067846|525456566|FG001|Overall Study|participation in other tx study|0|||
145710666|NCT03686423|525456572|FG000|Overall Study|Withdrawal by Subject|9|||
145710667|NCT03686423|525456572|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
145710668|NCT02833077|525456573|FG000|Overall Study|Adverse Event|1|||
145710669|NCT02833077|525456574|FG001|Overall Study|Adverse Event|2|||
145710670|NCT02833077|525456573|FG000|Overall Study|Lost to Follow-up|10|||
145710671|NCT02833077|525456574|FG001|Overall Study|Lost to Follow-up|1|||
145710672|NCT02833077|525456573|FG000|Overall Study|Personal Reasons|6|||
145710673|NCT02833077|525456574|FG001|Overall Study|Personal Reasons|4|||
145710674|NCT02833077|525456573|FG000|Overall Study|Protocol Deviation|0|||
145710675|NCT02833077|525456574|FG001|Overall Study|Protocol Deviation|1|||
145710676|NCT00972322|525456575|FG000|Overall Study|Adverse Event|2|||
145710677|NCT00972322|525456576|FG001|Overall Study|Adverse Event|1|||
145710678|NCT00972322|525456575|FG000|Overall Study|Positive drug screen|0|||
145710679|NCT00972322|525456576|FG001|Overall Study|Positive drug screen|1|||
145710680|NCT00972322|525456575|FG000|Overall Study|Lost to Follow-up|0|||
145710681|NCT00972322|525456576|FG001|Overall Study|Lost to Follow-up|1|||
145710682|NCT00972322|525456575|FG000|Overall Study|Consistently high glucose values|1|||
145710683|NCT00972322|525456576|FG001|Overall Study|Consistently high glucose values|0|||
145710684|NCT00316017|525456583|FG000|Overall Study|Protocol Violation|11|||
145710685|NCT00316017|525456584|FG001|Overall Study|Protocol Violation|13|||
145710686|NCT00316017|525456585|FG002|Overall Study|Protocol Violation|19|||
145710687|NCT05235269|525456605|FG000|Overall Study|Adverse Event|1|||
145710688|NCT05235269|525456605|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
145710689|NCT05235269|525456605|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
145710690|NCT03810235|525456606|FG000|Overall Study|Withdrawal by Subject|2|||
145710691|NCT03810235|525456607|FG001|Overall Study|Withdrawal by Subject|0|||
145710692|NCT00798434|525456608|FG000|Double-Blind|Adverse Event|22|||
145710693|NCT00798434|525456609|FG001|Double-Blind|Adverse Event|46|||
145710694|NCT00798434|525456608|FG000|Double-Blind|Death|0|||
145710695|NCT00798434|525456609|FG001|Double-Blind|Death|1|||
145710696|NCT00798434|525456608|FG000|Double-Blind|Lost to Follow-up|1|||
145710697|NCT00798434|525456609|FG001|Double-Blind|Lost to Follow-up|0|||
145710698|NCT00798434|525456608|FG000|Double-Blind|Lack of Efficacy|8|||
145710699|NCT00798434|525456609|FG001|Double-Blind|Lack of Efficacy|12|||
145710700|NCT00798434|525456608|FG000|Double-Blind|Withdrawal by Subject|17|||
145710701|NCT00798434|525456609|FG001|Double-Blind|Withdrawal by Subject|14|||
145710702|NCT00798434|525456608|FG000|Double-Blind|Protocol Violation|1|||
145710703|NCT00798434|525456609|FG001|Double-Blind|Protocol Violation|4|||
145710704|NCT00798434|525456608|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
145710705|NCT00798434|525456609|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
145710706|NCT00798434|525456608|FG000|Double-Blind|Other|1|||
145710707|NCT00798434|525456609|FG001|Double-Blind|Other|0|||
145710708|NCT00798434|525456608|FG000|Double-Blind|Not Treated|3|||
145710709|NCT00798434|525456609|FG001|Double-Blind|Not Treated|6|||
145710710|NCT00798434|525456608|FG000|Open-Label|Adverse Event|33|||
145710711|NCT00798434|525456609|FG001|Open-Label|Adverse Event|11|||
145710712|NCT00798434|525456608|FG000|Open-Label|Lack of Efficacy|5|||
145710713|NCT00798434|525456609|FG001|Open-Label|Lack of Efficacy|11|||
145710714|NCT00798434|525456608|FG000|Open-Label|Withdrawal by Subject|2|||
145710715|NCT00798434|525456609|FG001|Open-Label|Withdrawal by Subject|7|||
145710716|NCT00798434|525456608|FG000|Open-Label|Protocol Violation|1|||
145710717|NCT00798434|525456609|FG001|Open-Label|Protocol Violation|0|||
145710718|NCT00798434|525456608|FG000|Open-Label|Other|1|||
145710719|NCT00798434|525456609|FG001|Open-Label|Other|2|||
145710720|NCT00798434|525456608|FG000|Open-Label|Not Treated|0|||
145710721|NCT00798434|525456609|FG001|Open-Label|Not Treated|1|||
145710722|NCT03682185|525456615|FG000|Overall Study|Lost to Follow-up|4|||
145710723|NCT03682185|525456616|FG001|Overall Study|Lost to Follow-up|7|||
145710724|NCT03682185|525456617|FG002|Overall Study|Lost to Follow-up|4|||
145710725|NCT03682185|525456618|FG003|Overall Study|Lost to Follow-up|7|||
145710726|NCT03682185|525456619|FG004|Overall Study|Lost to Follow-up|1|||
145710727|NCT03682185|525456615|FG000|Overall Study|Withdrawal by Subject|7|||
145710728|NCT03682185|525456616|FG001|Overall Study|Withdrawal by Subject|3|||
145710729|NCT03682185|525456617|FG002|Overall Study|Withdrawal by Subject|7|||
145710730|NCT03682185|525456618|FG003|Overall Study|Withdrawal by Subject|3|||
145710731|NCT03682185|525456619|FG004|Overall Study|Withdrawal by Subject|0|||
145710732|NCT04908631|525456620|FG000|Overall Study|Lost to Follow-up|1|||
145710733|NCT04908631|525456620|FG000|Overall Study|Physician Decision|1|||
145710734|NCT04908631|525456620|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
145710735|NCT02336451|525456624|FG000|Overall Study|Adverse Event|1|||
145710736|NCT02336451|525456625|FG001|Overall Study|Adverse Event|2|||
145710737|NCT02336451|525456626|FG002|Overall Study|Adverse Event|0|||
145710738|NCT02336451|525456627|FG003|Overall Study|Adverse Event|6|||
145710739|NCT02336451|525456628|FG004|Overall Study|Adverse Event|4|||
145710740|NCT02336451|525456624|FG000|Overall Study|Death|6|||
145710741|NCT02336451|525456625|FG001|Overall Study|Death|2|||
145710742|NCT02336451|525456626|FG002|Overall Study|Death|3|||
145710743|NCT02336451|525456627|FG003|Overall Study|Death|6|||
145710744|NCT02336451|525456628|FG004|Overall Study|Death|6|||
145710745|NCT02336451|525456624|FG000|Overall Study|Physician Decision|9|||
145710746|NCT02336451|525456625|FG001|Overall Study|Physician Decision|6|||
145710747|NCT02336451|525456626|FG002|Overall Study|Physician Decision|7|||
145710748|NCT02336451|525456627|FG003|Overall Study|Physician Decision|16|||
145710749|NCT02336451|525456628|FG004|Overall Study|Physician Decision|3|||
145710750|NCT02336451|525456624|FG000|Overall Study|Progressive disease|23|||
145710751|NCT02336451|525456625|FG001|Overall Study|Progressive disease|26|||
145710752|NCT02336451|525456626|FG002|Overall Study|Progressive disease|2|||
145710753|NCT02336451|525456627|FG003|Overall Study|Progressive disease|14|||
145710754|NCT02336451|525456628|FG004|Overall Study|Progressive disease|4|||
145710755|NCT02336451|525456624|FG000|Overall Study|Protocol Violation|1|||
145710756|NCT02336451|525456625|FG001|Overall Study|Protocol Violation|0|||
145710757|NCT02336451|525456626|FG002|Overall Study|Protocol Violation|0|||
145710758|NCT02336451|525456627|FG003|Overall Study|Protocol Violation|0|||
145710759|NCT02336451|525456628|FG004|Overall Study|Protocol Violation|0|||
145710760|NCT02336451|525456624|FG000|Overall Study|Patient/guardian decision|2|||
145710761|NCT02336451|525456625|FG001|Overall Study|Patient/guardian decision|4|||
145710762|NCT02336451|525456626|FG002|Overall Study|Patient/guardian decision|0|||
145710763|NCT02336451|525456627|FG003|Overall Study|Patient/guardian decision|2|||
145710764|NCT02336451|525456628|FG004|Overall Study|Patient/guardian decision|1|||
145710765|NCT03520712|525456630|FG000|Overall Study|Early termination of the study by Sponsor|2|||
145710766|NCT02344290|525456637|FG000|Overall Study|Withdrawal by Subject|315|||
145710767|NCT02344290|525456638|FG001|Overall Study|Withdrawal by Subject|324|||
145710768|NCT02344290|525456637|FG000|Overall Study|Lost to Follow-up|258|||
145710769|NCT02344290|525456638|FG001|Overall Study|Lost to Follow-up|249|||
145710770|NCT02344290|525456637|FG000|Overall Study|Unable to get to clinic|69|||
145710771|NCT02344290|525456638|FG001|Overall Study|Unable to get to clinic|60|||
145710772|NCT02344290|525456637|FG000|Overall Study|Physician Decision|25|||
145710773|NCT02344290|525456638|FG001|Overall Study|Physician Decision|25|||
145710774|NCT02344290|525456637|FG000|Overall Study|Site Closure|15|||
145710775|NCT02344290|525456638|FG001|Overall Study|Site Closure|19|||
145710776|NCT02344290|525456637|FG000|Overall Study|Other|5|||
145710777|NCT02344290|525456638|FG001|Overall Study|Other|3|||
145710778|NCT04047862|525456645|FG000|Overall Study|Death|0|||
145710779|NCT04047862|525456646|FG001|Overall Study|Death|0|||
145710780|NCT04047862|525456647|FG002|Overall Study|Death|4|||
145710781|NCT04047862|525456648|FG003|Overall Study|Death|7|||
145710782|NCT04047862|525456649|FG004|Overall Study|Death|2|||
145710783|NCT04047862|525456650|FG005|Overall Study|Death|4|||
145710784|NCT04047862|525456651|FG006|Overall Study|Death|3|||
145710785|NCT04047862|525456652|FG007|Overall Study|Death|24|||
145710786|NCT04047862|525456653|FG008|Overall Study|Death|24|||
145710787|NCT04047862|525456654|FG009|Overall Study|Death|22|||
145710788|NCT04047862|525456655|FG010|Overall Study|Death|35|||
145710789|NCT04047862|525456656|FG011|Overall Study|Death|18|||
145710790|NCT04047862|525456657|FG012|Overall Study|Death|14|||
145710791|NCT04047862|525456658|FG013|Overall Study|Death|6|||
145710792|NCT04047862|525456659|FG014|Overall Study|Death|19|||
145710793|NCT04047862|525456660|FG015|Overall Study|Death|42|||
145710794|NCT04047862|525456661|FG016|Overall Study|Death|9|||
145710795|NCT04047862|525456662|FG017|Overall Study|Death|8|||
145710796|NCT04047862|525456663|FG018|Overall Study|Death|10|||
145710797|NCT04047862|525456645|FG000|Overall Study|Withdrawal by Subject|0|||
145710798|NCT04047862|525456646|FG001|Overall Study|Withdrawal by Subject|0|||
145710799|NCT04047862|525456647|FG002|Overall Study|Withdrawal by Subject|0|||
145710800|NCT04047862|525456648|FG003|Overall Study|Withdrawal by Subject|5|||
145710801|NCT04047862|525456649|FG004|Overall Study|Withdrawal by Subject|2|||
145710802|NCT04047862|525456650|FG005|Overall Study|Withdrawal by Subject|0|||
145710803|NCT04047862|525456651|FG006|Overall Study|Withdrawal by Subject|1|||
145710804|NCT04047862|525456652|FG007|Overall Study|Withdrawal by Subject|0|||
145710805|NCT04047862|525456653|FG008|Overall Study|Withdrawal by Subject|4|||
145710806|NCT04047862|525456654|FG009|Overall Study|Withdrawal by Subject|4|||
145710807|NCT04047862|525456655|FG010|Overall Study|Withdrawal by Subject|4|||
145710808|NCT04047862|525456656|FG011|Overall Study|Withdrawal by Subject|2|||
145710809|NCT04047862|525456657|FG012|Overall Study|Withdrawal by Subject|3|||
145710810|NCT04047862|525456658|FG013|Overall Study|Withdrawal by Subject|0|||
145710811|NCT04047862|525456659|FG014|Overall Study|Withdrawal by Subject|9|||
145710812|NCT04047862|525456660|FG015|Overall Study|Withdrawal by Subject|5|||
145710813|NCT04047862|525456661|FG016|Overall Study|Withdrawal by Subject|1|||
145710814|NCT04047862|525456662|FG017|Overall Study|Withdrawal by Subject|3|||
145710815|NCT04047862|525456663|FG018|Overall Study|Withdrawal by Subject|1|||
145710816|NCT04047862|525456645|FG000|Overall Study|Lost to Follow-up|0|||
145710817|NCT04047862|525456646|FG001|Overall Study|Lost to Follow-up|0|||
145710818|NCT04047862|525456647|FG002|Overall Study|Lost to Follow-up|1|||
145710819|NCT04047862|525456648|FG003|Overall Study|Lost to Follow-up|0|||
145710820|NCT04047862|525456649|FG004|Overall Study|Lost to Follow-up|0|||
145710821|NCT04047862|525456650|FG005|Overall Study|Lost to Follow-up|0|||
145710822|NCT04047862|525456651|FG006|Overall Study|Lost to Follow-up|0|||
145710823|NCT04047862|525456652|FG007|Overall Study|Lost to Follow-up|1|||
145710824|NCT04047862|525456653|FG008|Overall Study|Lost to Follow-up|0|||
145710825|NCT04047862|525456654|FG009|Overall Study|Lost to Follow-up|1|||
145710826|NCT04047862|525456655|FG010|Overall Study|Lost to Follow-up|0|||
145710827|NCT04047862|525456656|FG011|Overall Study|Lost to Follow-up|3|||
145710828|NCT04047862|525456657|FG012|Overall Study|Lost to Follow-up|0|||
145710829|NCT04047862|525456658|FG013|Overall Study|Lost to Follow-up|0|||
145710830|NCT04047862|525456659|FG014|Overall Study|Lost to Follow-up|2|||
145710831|NCT04047862|525456660|FG015|Overall Study|Lost to Follow-up|2|||
145710832|NCT04047862|525456661|FG016|Overall Study|Lost to Follow-up|1|||
145710833|NCT04047862|525456662|FG017|Overall Study|Lost to Follow-up|0|||
145710834|NCT04047862|525456663|FG018|Overall Study|Lost to Follow-up|0|||
145710835|NCT04047862|525456645|FG000|Overall Study|Physician Decision|0|||
145710836|NCT04047862|525456646|FG001|Overall Study|Physician Decision|0|||
145710837|NCT04047862|525456647|FG002|Overall Study|Physician Decision|0|||
145710838|NCT04047862|525456648|FG003|Overall Study|Physician Decision|1|||
145710839|NCT04047862|525456649|FG004|Overall Study|Physician Decision|0|||
145710840|NCT04047862|525456650|FG005|Overall Study|Physician Decision|0|||
145710841|NCT04047862|525456651|FG006|Overall Study|Physician Decision|0|||
145710842|NCT04047862|525456652|FG007|Overall Study|Physician Decision|0|||
145710843|NCT04047862|525456653|FG008|Overall Study|Physician Decision|0|||
145710844|NCT04047862|525456654|FG009|Overall Study|Physician Decision|0|||
145710845|NCT04047862|525456655|FG010|Overall Study|Physician Decision|0|||
145710846|NCT04047862|525456656|FG011|Overall Study|Physician Decision|0|||
145710847|NCT04047862|525456657|FG012|Overall Study|Physician Decision|0|||
145710848|NCT04047862|525456658|FG013|Overall Study|Physician Decision|0|||
145710849|NCT04047862|525456659|FG014|Overall Study|Physician Decision|1|||
145710850|NCT04047862|525456660|FG015|Overall Study|Physician Decision|0|||
145710851|NCT04047862|525456661|FG016|Overall Study|Physician Decision|1|||
145710852|NCT04047862|525456662|FG017|Overall Study|Physician Decision|0|||
145710853|NCT04047862|525456663|FG018|Overall Study|Physician Decision|0|||
145710854|NCT04047862|525456645|FG000|Overall Study|Completed all Assessments|1|||
145710855|NCT04047862|525456646|FG001|Overall Study|Completed all Assessments|3|||
145710856|NCT04047862|525456647|FG002|Overall Study|Completed all Assessments|1|||
145710857|NCT04047862|525456648|FG003|Overall Study|Completed all Assessments|3|||
145710858|NCT04047862|525456649|FG004|Overall Study|Completed all Assessments|2|||
145710859|NCT04047862|525456650|FG005|Overall Study|Completed all Assessments|5|||
145710860|NCT04047862|525456651|FG006|Overall Study|Completed all Assessments|7|||
145710861|NCT04047862|525456652|FG007|Overall Study|Completed all Assessments|0|||
145710862|NCT04047862|525456653|FG008|Overall Study|Completed all Assessments|0|||
145710863|NCT04047862|525456654|FG009|Overall Study|Completed all Assessments|0|||
145710864|NCT04047862|525456655|FG010|Overall Study|Completed all Assessments|0|||
145710865|NCT04047862|525456656|FG011|Overall Study|Completed all Assessments|0|||
145710866|NCT04047862|525456657|FG012|Overall Study|Completed all Assessments|0|||
145710867|NCT04047862|525456658|FG013|Overall Study|Completed all Assessments|0|||
145710868|NCT04047862|525456659|FG014|Overall Study|Completed all Assessments|0|||
145710869|NCT04047862|525456660|FG015|Overall Study|Completed all Assessments|0|||
145710870|NCT04047862|525456661|FG016|Overall Study|Completed all Assessments|0|||
145710871|NCT04047862|525456662|FG017|Overall Study|Completed all Assessments|0|||
145710872|NCT04047862|525456663|FG018|Overall Study|Completed all Assessments|0|||
145710873|NCT04047862|525456645|FG000|Overall Study|Sponsor Decision|0|||
145710874|NCT04047862|525456646|FG001|Overall Study|Sponsor Decision|0|||
145710875|NCT04047862|525456647|FG002|Overall Study|Sponsor Decision|0|||
145710876|NCT04047862|525456648|FG003|Overall Study|Sponsor Decision|0|||
145710877|NCT04047862|525456649|FG004|Overall Study|Sponsor Decision|0|||
145710878|NCT04047862|525456650|FG005|Overall Study|Sponsor Decision|0|||
145710879|NCT04047862|525456651|FG006|Overall Study|Sponsor Decision|0|||
145710880|NCT04047862|525456652|FG007|Overall Study|Sponsor Decision|13|||
145710881|NCT04047862|525456653|FG008|Overall Study|Sponsor Decision|10|||
145710882|NCT04047862|525456654|FG009|Overall Study|Sponsor Decision|18|||
145710883|NCT04047862|525456655|FG010|Overall Study|Sponsor Decision|3|||
145710884|NCT04047862|525456656|FG011|Overall Study|Sponsor Decision|3|||
145710885|NCT04047862|525456657|FG012|Overall Study|Sponsor Decision|4|||
145710886|NCT04047862|525456658|FG013|Overall Study|Sponsor Decision|0|||
145710887|NCT04047862|525456659|FG014|Overall Study|Sponsor Decision|7|||
145710888|NCT04047862|525456660|FG015|Overall Study|Sponsor Decision|8|||
145710889|NCT04047862|525456661|FG016|Overall Study|Sponsor Decision|9|||
145710890|NCT04047862|525456662|FG017|Overall Study|Sponsor Decision|7|||
145710891|NCT04047862|525456663|FG018|Overall Study|Sponsor Decision|8|||
145710892|NCT04047862|525456645|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710893|NCT04047862|525456646|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710894|NCT04047862|525456647|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710895|NCT04047862|525456648|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710896|NCT04047862|525456649|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710897|NCT04047862|525456650|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710898|NCT04047862|525456651|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710899|NCT04047862|525456652|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
145710900|NCT04047862|525456653|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
145710901|NCT04047862|525456654|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710902|NCT04047862|525456655|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
145710903|NCT04047862|525456656|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710904|NCT04047862|525456657|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710905|NCT04047862|525456658|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
145710906|NCT04047862|525456659|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
145710907|NCT04047862|525456660|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
145710908|NCT04047862|525456661|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
145710909|NCT04047862|525456662|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
145710910|NCT04047862|525456663|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
145710911|NCT04047862|525456645|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710912|NCT04047862|525456646|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710913|NCT04047862|525456647|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710914|NCT04047862|525456648|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710915|NCT04047862|525456649|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710916|NCT04047862|525456650|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710917|NCT04047862|525456651|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710918|NCT04047862|525456652|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710919|NCT04047862|525456653|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710920|NCT04047862|525456654|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710921|NCT04047862|525456655|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710922|NCT04047862|525456656|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710923|NCT04047862|525456657|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710924|NCT04047862|525456658|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710925|NCT04047862|525456659|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710926|NCT04047862|525456660|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
145710927|NCT04047862|525456661|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710928|NCT04047862|525456662|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
145710929|NCT04047862|525456663|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
145710930|NCT04047862|525456645|FG000|Overall Study|Other|0|||
145710931|NCT04047862|525456646|FG001|Overall Study|Other|0|||
145710932|NCT04047862|525456647|FG002|Overall Study|Other|0|||
145710933|NCT04047862|525456648|FG003|Overall Study|Other|0|||
145710934|NCT04047862|525456649|FG004|Overall Study|Other|0|||
145710935|NCT04047862|525456650|FG005|Overall Study|Other|0|||
145710936|NCT04047862|525456651|FG006|Overall Study|Other|0|||
145710937|NCT04047862|525456652|FG007|Overall Study|Other|0|||
145710938|NCT04047862|525456653|FG008|Overall Study|Other|0|||
145710939|NCT04047862|525456654|FG009|Overall Study|Other|0|||
145710940|NCT04047862|525456655|FG010|Overall Study|Other|0|||
145710941|NCT04047862|525456656|FG011|Overall Study|Other|0|||
145710942|NCT04047862|525456657|FG012|Overall Study|Other|0|||
145710943|NCT04047862|525456658|FG013|Overall Study|Other|0|||
145710944|NCT04047862|525456659|FG014|Overall Study|Other|2|||
145710945|NCT04047862|525456660|FG015|Overall Study|Other|1|||
145710946|NCT04047862|525456661|FG016|Overall Study|Other|1|||
145710947|NCT04047862|525456662|FG017|Overall Study|Other|1|||
145710948|NCT04047862|525456663|FG018|Overall Study|Other|0|||
145710949|NCT05718466|525458255|FG000|Overall Study|Withdrawal by Subject|1|||
145710950|NCT05718466|525458256|FG001|Overall Study|Withdrawal by Subject|2|||
145710951|NCT05718466|525458255|FG000|Overall Study|Death|0|||
145710952|NCT05718466|525458256|FG001|Overall Study|Death|1|||
145710953|NCT00387426|525458257|FG000|Overall Study|Lack of Response|7|||
145710954|NCT00387426|525458257|FG000|Overall Study|Toxicities|4|||
145710955|NCT00387426|525458257|FG000|Overall Study|Disease Progression|3|||
145710956|NCT01253135|525458258|FG000|Original Protocol|Protocol Amendment|15|||
145710957|NCT01253135|525458258|FG000|Amended Protocol|Non-compliance|1|||
145710958|NCT01901432|525458259|FG000|Overall Study|Adverse Event|0|||
145710959|NCT01901432|525458260|FG001|Overall Study|Adverse Event|1|||
145710960|NCT01901432|525458261|FG002|Overall Study|Adverse Event|1|||
145710961|NCT01901432|525458262|FG003|Overall Study|Adverse Event|0|||
145710962|NCT01901432|525458263|FG004|Overall Study|Adverse Event|1|||
145710963|NCT01901432|525458259|FG000|Overall Study|Withdrawal by Subject|0|||
145710964|NCT01901432|525458260|FG001|Overall Study|Withdrawal by Subject|0|||
145710965|NCT01901432|525458261|FG002|Overall Study|Withdrawal by Subject|1|||
145710966|NCT01901432|525458262|FG003|Overall Study|Withdrawal by Subject|0|||
145710967|NCT01901432|525458263|FG004|Overall Study|Withdrawal by Subject|5|||
145710968|NCT01901432|525458259|FG000|Overall Study|Physician Decision|0|||
145710969|NCT01901432|525458260|FG001|Overall Study|Physician Decision|0|||
145710970|NCT01901432|525458261|FG002|Overall Study|Physician Decision|0|||
145710971|NCT01901432|525458262|FG003|Overall Study|Physician Decision|0|||
145710972|NCT01901432|525458263|FG004|Overall Study|Physician Decision|2|||
145710973|NCT01901432|525458259|FG000|Overall Study|Patient decision to stop study drug|0|||
145710974|NCT01901432|525458260|FG001|Overall Study|Patient decision to stop study drug|0|||
145710975|NCT01901432|525458261|FG002|Overall Study|Patient decision to stop study drug|0|||
145710976|NCT01901432|525458262|FG003|Overall Study|Patient decision to stop study drug|0|||
145710977|NCT01901432|525458263|FG004|Overall Study|Patient decision to stop study drug|1|||
145710978|NCT00379288|525458264|FG000|Overall Study|Adverse Event|5|||
145710979|NCT00379288|525458265|FG001|Overall Study|Adverse Event|6|||
145710980|NCT00379288|525458266|FG002|Overall Study|Adverse Event|2|||
145710981|NCT00379288|525458267|FG003|Overall Study|Adverse Event|0|||
145710982|NCT00379288|525458264|FG000|Overall Study|Treatment Failure|0|||
145710983|NCT00379288|525458265|FG001|Overall Study|Treatment Failure|1|||
145710984|NCT00379288|525458266|FG002|Overall Study|Treatment Failure|0|||
145710985|NCT00379288|525458267|FG003|Overall Study|Treatment Failure|1|||
145710986|NCT00379288|525458264|FG000|Overall Study|Lost to Follow-up|3|||
145710987|NCT00379288|525458265|FG001|Overall Study|Lost to Follow-up|3|||
145710988|NCT00379288|525458266|FG002|Overall Study|Lost to Follow-up|2|||
145710989|NCT00379288|525458267|FG003|Overall Study|Lost to Follow-up|0|||
145710990|NCT00379288|525458264|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
145710991|NCT00379288|525458265|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
145710992|NCT00379288|525458266|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
145710993|NCT00379288|525458267|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
145710994|NCT00379288|525458264|FG000|Overall Study|Subject withdrew-related to study drug|1|||
145710995|NCT00379288|525458265|FG001|Overall Study|Subject withdrew-related to study drug|0|||
145710996|NCT00379288|525458266|FG002|Overall Study|Subject withdrew-related to study drug|0|||
145710997|NCT00379288|525458267|FG003|Overall Study|Subject withdrew-related to study drug|1|||
145710998|NCT00379288|525458264|FG000|Overall Study|Noncompliance with protocol|8|||
145491512|NCT00360412|524653825|FG000|Overall Study|Study termination by Sponsor|214|||
145710999|NCT00379288|525458265|FG001|Overall Study|Noncompliance with protocol|6|||
145711000|NCT00379288|525458266|FG002|Overall Study|Noncompliance with protocol|2|||
145711001|NCT00379288|525458267|FG003|Overall Study|Noncompliance with protocol|1|||
145711002|NCT00379288|525458264|FG000|Overall Study|Did not meet protocol eligibility|0|||
145711003|NCT00379288|525458265|FG001|Overall Study|Did not meet protocol eligibility|1|||
145711004|NCT00379288|525458266|FG002|Overall Study|Did not meet protocol eligibility|0|||
145711005|NCT00379288|525458267|FG003|Overall Study|Did not meet protocol eligibility|2|||
145711006|NCT00379288|525458264|FG000|Overall Study|Administrative|2|||
145711007|NCT00379288|525458265|FG001|Overall Study|Administrative|2|||
145711008|NCT00379288|525458266|FG002|Overall Study|Administrative|0|||
145711009|NCT00379288|525458267|FG003|Overall Study|Administrative|1|||
145711010|NCT00918879|525458268|FG000|Overall Study|Withdrawal by Subject|4|||
145711011|NCT00918879|525458269|FG001|Overall Study|Withdrawal by Subject|4|||
145711012|NCT00918879|525458268|FG000|Overall Study|Lost to Follow-up|1|||
145711013|NCT00918879|525458269|FG001|Overall Study|Lost to Follow-up|1|||
145711014|NCT00918879|525458268|FG000|Overall Study|Severe non-compliance to protocol|1|||
145711015|NCT00918879|525458269|FG001|Overall Study|Severe non-compliance to protocol|1|||
145711016|NCT00357110|525458272|FG000|Overall Study|Early study termination|5|||
145711017|NCT00357110|525458273|FG001|Overall Study|Early study termination|5|||
145711018|NCT01255631|525458276|FG000|Overall Study|poor enrollment, no data analyzed|9|||
145711019|NCT01255631|525458277|FG001|Overall Study|poor enrollment, no data analyzed|6|||
145711020|NCT03339245|525458280|FG000|Overall Study|Adverse Event|1|||
145711021|NCT03339245|525458281|FG001|Overall Study|Adverse Event|1|||
145711022|NCT03339245|525458280|FG000|Overall Study|Withdrawal by Subject|1|||
145711023|NCT03339245|525458281|FG001|Overall Study|Withdrawal by Subject|0|||
145711024|NCT00515671|525458282|FG000|Overall Study|Lost to Follow-up|13|||
145711025|NCT00515671|525458283|FG001|Overall Study|Lost to Follow-up|10|||
145711026|NCT00515671|525458282|FG000|Overall Study|Withdrawal by Subject|3|||
145711027|NCT00515671|525458283|FG001|Overall Study|Withdrawal by Subject|5|||
145711028|NCT00515671|525458282|FG000|Overall Study|incarcerated|1|||
145711029|NCT00515671|525458283|FG001|Overall Study|incarcerated|2|||
145711030|NCT00288639|525458295|FG000|Overall Study|Adverse Event|5|||
145711031|NCT00288639|525458295|FG000|Overall Study|Lack of Efficacy|4|||
145711032|NCT00288639|525458295|FG000|Overall Study|Withdrawal by Subject|2|||
145711033|NCT00288639|525458295|FG000|Overall Study|Other|1|||
145711034|NCT02815579|525458301|FG000|Overall Study|Non-payment of loan down-payment|16|||
145711035|NCT02815579|525458302|FG001|Overall Study|Non-payment of loan down-payment|0|||
145711036|NCT02815579|525458301|FG000|Overall Study|Withdrawal by Subject|7|||
145711037|NCT02815579|525458302|FG001|Overall Study|Withdrawal by Subject|1|||
145711038|NCT02815579|525458301|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
145711039|NCT02815579|525458302|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
145711040|NCT02815579|525458301|FG000|Overall Study|Lost to Follow-up|7|||
145711041|NCT02815579|525458302|FG001|Overall Study|Lost to Follow-up|4|||
145711042|NCT02815579|525458301|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
145711043|NCT02815579|525458302|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
145711044|NCT02815579|525458301|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
145711045|NCT02815579|525458302|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
145711046|NCT02815579|525458301|FG000|Overall Study|Death|5|||
145711047|NCT02815579|525458302|FG001|Overall Study|Death|4|||
145711048|NCT02815579|525458301|FG000|Overall Study|Imprisoned|0|||
145711049|NCT02815579|525458302|FG001|Overall Study|Imprisoned|2|||
145711050|NCT02815579|525458301|FG000|Overall Study|Did not meet enrollment criteria|0|||
145711051|NCT02815579|525458302|FG001|Overall Study|Did not meet enrollment criteria|1|||
145711052|NCT02311673|525458306|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
145711053|NCT02311673|525458307|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
145711054|NCT02311673|525458308|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
145711055|NCT02311673|525458309|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
145711056|NCT01014208|525458310|FG000|Overall Study|Lost to Follow-up|2|||
145711057|NCT01014208|525458311|FG001|Overall Study|Lost to Follow-up|5|||
145711058|NCT01014208|525458310|FG000|Overall Study|Participant Withdrew Consent|12|||
145711059|NCT01014208|525458311|FG001|Overall Study|Participant Withdrew Consent|12|||
145711060|NCT01014208|525458310|FG000|Overall Study|Did Not Receive Study Drug|2|||
145711061|NCT01014208|525458311|FG001|Overall Study|Did Not Receive Study Drug|0|||
145711062|NCT01014208|525458310|FG000|Overall Study|Study Closed/terminated|78|||
145711063|NCT01014208|525458311|FG001|Overall Study|Study Closed/terminated|83|||
145711064|NCT00414908|525458314|FG000|Overall Study|Protocol Violation|1|||
145711065|NCT00414908|525458315|FG001|Overall Study|Protocol Violation|1|||
145711066|NCT01076153|525458316|FG000|Overall Study|Symptoms improved/resolved|10|||
145711067|NCT01076153|525458316|FG000|Overall Study|Adverse Event|1|||
145711068|NCT04165031|525458317|FG000|Overall Study|Adverse Event|1|||
145711069|NCT04165031|525458318|FG001|Overall Study|Adverse Event|1|||
145711070|NCT04165031|525458319|FG002|Overall Study|Adverse Event|0|||
145711071|NCT04165031|525458320|FG003|Overall Study|Adverse Event|0|||
145711072|NCT04165031|525458321|FG004|Overall Study|Adverse Event|0|||
145711073|NCT04165031|525458322|FG005|Overall Study|Adverse Event|0|||
145711074|NCT04165031|525458317|FG000|Overall Study|Withdrawal by Subject|0|||
145711075|NCT04165031|525458318|FG001|Overall Study|Withdrawal by Subject|0|||
145711076|NCT04165031|525458319|FG002|Overall Study|Withdrawal by Subject|1|||
145711077|NCT04165031|525458320|FG003|Overall Study|Withdrawal by Subject|0|||
145711078|NCT04165031|525458321|FG004|Overall Study|Withdrawal by Subject|0|||
145711079|NCT04165031|525458322|FG005|Overall Study|Withdrawal by Subject|0|||
145711080|NCT01332630|525458323|FG000|Overall Study|Withdrawal by Subject|3|||
145711081|NCT00567567|525458329|FG000|Overall Study|Adverse Event|0|||
145711082|NCT00567567|525458330|FG001|Overall Study|Adverse Event|2|||
145711083|NCT00567567|525458331|FG002|Overall Study|Adverse Event|5|||
145711084|NCT00567567|525458329|FG000|Overall Study|Death|8|||
145711085|NCT00567567|525458330|FG001|Overall Study|Death|1|||
145711086|NCT00567567|525458331|FG002|Overall Study|Death|5|||
145711087|NCT00567567|525458329|FG000|Overall Study|Lack of Efficacy|16|||
145711088|NCT00567567|525458330|FG001|Overall Study|Lack of Efficacy|17|||
145711089|NCT00567567|525458331|FG002|Overall Study|Lack of Efficacy|48|||
145711090|NCT00567567|525458329|FG000|Overall Study|Lost to Follow-up|0|||
145711091|NCT00567567|525458330|FG001|Overall Study|Lost to Follow-up|0|||
145711092|NCT00567567|525458331|FG002|Overall Study|Lost to Follow-up|1|||
145711093|NCT00567567|525458329|FG000|Overall Study|Physician Decision|16|||
145711094|NCT00567567|525458330|FG001|Overall Study|Physician Decision|18|||
145711095|NCT00567567|525458331|FG002|Overall Study|Physician Decision|84|||
145711096|NCT00567567|525458329|FG000|Overall Study|Withdrawal by Subject|0|||
145711097|NCT00567567|525458330|FG001|Overall Study|Withdrawal by Subject|0|||
145711098|NCT00567567|525458331|FG002|Overall Study|Withdrawal by Subject|2|||
145711099|NCT00567567|525458329|FG000|Overall Study|Ineligible|4|||
145711100|NCT00567567|525458330|FG001|Overall Study|Ineligible|0|||
145711101|NCT00567567|525458331|FG002|Overall Study|Ineligible|9|||
145711102|NCT00567567|525458329|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
145711103|NCT00567567|525458330|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
145711104|NCT00567567|525458331|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
145711105|NCT00567567|525458329|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
145711106|NCT00567567|525458330|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
145711107|NCT00567567|525458331|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
145711108|NCT00567567|525458329|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
145711109|NCT00567567|525458330|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
145711110|NCT00567567|525458331|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
145711111|NCT03330405|525458332|FG000|Overall Study|Other|1|||
145711112|NCT03330405|525458333|FG001|Overall Study|Other|3|||
145711113|NCT03330405|525458334|FG002|Overall Study|Other|1|||
145711114|NCT03330405|525458335|FG003|Overall Study|Other|0|||
145711115|NCT03330405|525458336|FG004|Overall Study|Other|2|||
145711116|NCT03330405|525458337|FG005|Overall Study|Other|0|||
145711117|NCT03330405|525458338|FG006|Overall Study|Other|1|||
145711118|NCT03330405|525458339|FG007|Overall Study|Other|0|||
145711119|NCT03330405|525458340|FG008|Overall Study|Other|0|||
145711120|NCT03330405|525458341|FG009|Overall Study|Other|0|||
145711121|NCT03330405|525458342|FG010|Overall Study|Other|0|||
145711122|NCT03330405|525458332|FG000|Overall Study|Progressive disease|8|||
145711123|NCT03330405|525458333|FG001|Overall Study|Progressive disease|27|||
145711124|NCT03330405|525458334|FG002|Overall Study|Progressive disease|4|||
145711125|NCT03330405|525458335|FG003|Overall Study|Progressive disease|18|||
145711126|NCT03330405|525458336|FG004|Overall Study|Progressive disease|16|||
145711127|NCT03330405|525458337|FG005|Overall Study|Progressive disease|14|||
145711128|NCT03330405|525458338|FG006|Overall Study|Progressive disease|7|||
145711129|NCT03330405|525458339|FG007|Overall Study|Progressive disease|29|||
145711130|NCT03330405|525458340|FG008|Overall Study|Progressive disease|9|||
145711131|NCT03330405|525458341|FG009|Overall Study|Progressive disease|11|||
145711132|NCT03330405|525458342|FG010|Overall Study|Progressive disease|5|||
145711133|NCT03330405|525458332|FG000|Overall Study|Withdrawal by Subject|1|||
145711134|NCT03330405|525458333|FG001|Overall Study|Withdrawal by Subject|4|||
145711135|NCT03330405|525458334|FG002|Overall Study|Withdrawal by Subject|0|||
145711136|NCT03330405|525458335|FG003|Overall Study|Withdrawal by Subject|1|||
145711137|NCT03330405|525458336|FG004|Overall Study|Withdrawal by Subject|1|||
145711138|NCT03330405|525458337|FG005|Overall Study|Withdrawal by Subject|1|||
145711139|NCT03330405|525458338|FG006|Overall Study|Withdrawal by Subject|0|||
145711140|NCT03330405|525458339|FG007|Overall Study|Withdrawal by Subject|2|||
145711141|NCT03330405|525458340|FG008|Overall Study|Withdrawal by Subject|2|||
145711142|NCT03330405|525458341|FG009|Overall Study|Withdrawal by Subject|1|||
145711143|NCT03330405|525458342|FG010|Overall Study|Withdrawal by Subject|1|||
145711144|NCT03330405|525458332|FG000|Overall Study|Global deterioration of health status|2|||
145711145|NCT03330405|525458333|FG001|Overall Study|Global deterioration of health status|3|||
145711146|NCT03330405|525458334|FG002|Overall Study|Global deterioration of health status|0|||
145711147|NCT03330405|525458335|FG003|Overall Study|Global deterioration of health status|2|||
145711148|NCT03330405|525458336|FG004|Overall Study|Global deterioration of health status|3|||
145711149|NCT03330405|525458337|FG005|Overall Study|Global deterioration of health status|3|||
145711150|NCT03330405|525458338|FG006|Overall Study|Global deterioration of health status|0|||
145711151|NCT03330405|525458339|FG007|Overall Study|Global deterioration of health status|2|||
145711152|NCT03330405|525458340|FG008|Overall Study|Global deterioration of health status|8|||
145711153|NCT03330405|525458341|FG009|Overall Study|Global deterioration of health status|4|||
145711154|NCT03330405|525458342|FG010|Overall Study|Global deterioration of health status|1|||
145711155|NCT03330405|525458332|FG000|Overall Study|Adverse Event|0|||
145711156|NCT03330405|525458333|FG001|Overall Study|Adverse Event|1|||
145711157|NCT03330405|525458334|FG002|Overall Study|Adverse Event|0|||
145711158|NCT03330405|525458335|FG003|Overall Study|Adverse Event|1|||
145711159|NCT03330405|525458336|FG004|Overall Study|Adverse Event|1|||
145711160|NCT03330405|525458337|FG005|Overall Study|Adverse Event|1|||
145711161|NCT03330405|525458338|FG006|Overall Study|Adverse Event|3|||
145711162|NCT03330405|525458339|FG007|Overall Study|Adverse Event|4|||
145711163|NCT03330405|525458340|FG008|Overall Study|Adverse Event|2|||
145711164|NCT03330405|525458341|FG009|Overall Study|Adverse Event|2|||
145711165|NCT03330405|525458342|FG010|Overall Study|Adverse Event|2|||
145711166|NCT03330405|525458332|FG000|Overall Study|Death|0|||
145711167|NCT03330405|525458333|FG001|Overall Study|Death|4|||
145711168|NCT03330405|525458334|FG002|Overall Study|Death|0|||
145711169|NCT03330405|525458335|FG003|Overall Study|Death|0|||
145711170|NCT03330405|525458336|FG004|Overall Study|Death|0|||
145711171|NCT03330405|525458337|FG005|Overall Study|Death|1|||
145711172|NCT03330405|525458338|FG006|Overall Study|Death|0|||
145711173|NCT03330405|525458339|FG007|Overall Study|Death|2|||
145711174|NCT03330405|525458340|FG008|Overall Study|Death|0|||
145711175|NCT03330405|525458341|FG009|Overall Study|Death|0|||
145711176|NCT03330405|525458342|FG010|Overall Study|Death|0|||
145711177|NCT03330405|525458332|FG000|Overall Study|Physician Decision|0|||
145711178|NCT03330405|525458333|FG001|Overall Study|Physician Decision|0|||
145711179|NCT03330405|525458334|FG002|Overall Study|Physician Decision|0|||
145711180|NCT03330405|525458335|FG003|Overall Study|Physician Decision|0|||
145711181|NCT03330405|525458336|FG004|Overall Study|Physician Decision|0|||
145711182|NCT03330405|525458337|FG005|Overall Study|Physician Decision|0|||
145711183|NCT03330405|525458338|FG006|Overall Study|Physician Decision|0|||
145711184|NCT03330405|525458339|FG007|Overall Study|Physician Decision|1|||
145711185|NCT03330405|525458340|FG008|Overall Study|Physician Decision|0|||
145711186|NCT03330405|525458341|FG009|Overall Study|Physician Decision|0|||
145711187|NCT03330405|525458342|FG010|Overall Study|Physician Decision|0|||
145711188|NCT00731133|525458345|FG000|Overall Study|Withdrawal by Subject|10|||
145711189|NCT01725126|525458346|FG000|Overall Study|Protocol Violation|0|||
145711190|NCT01725126|525458347|FG001|Overall Study|Protocol Violation|1|||
145711191|NCT01725126|525458348|FG002|Overall Study|Protocol Violation|0|||
145711192|NCT01725126|525458349|FG003|Overall Study|Protocol Violation|0|||
145711193|NCT01725126|525458350|FG004|Overall Study|Protocol Violation|0|||
145711194|NCT01725126|525458351|FG005|Overall Study|Protocol Violation|0|||
145711195|NCT01725126|525458346|FG000|Overall Study|Withdrawal by Subject|0|||
145711196|NCT01725126|525458347|FG001|Overall Study|Withdrawal by Subject|0|||
145711197|NCT01725126|525458348|FG002|Overall Study|Withdrawal by Subject|0|||
145711198|NCT01725126|525458349|FG003|Overall Study|Withdrawal by Subject|1|||
145711199|NCT01725126|525458350|FG004|Overall Study|Withdrawal by Subject|0|||
145711200|NCT01725126|525458351|FG005|Overall Study|Withdrawal by Subject|0|||
145711201|NCT01240915|525458356|FG000|Overall Study|Adverse Event|0|||
145711202|NCT01240915|525458357|FG001|Overall Study|Adverse Event|0|||
145711203|NCT01240915|525458358|FG002|Overall Study|Adverse Event|0|||
145711204|NCT01240915|525458359|FG003|Overall Study|Adverse Event|1|||
145711205|NCT01240915|525458360|FG004|Overall Study|Adverse Event|0|||
145711206|NCT01240915|525458361|FG005|Overall Study|Adverse Event|2|||
145711207|NCT01240915|525458362|FG006|Overall Study|Adverse Event|0|||
145711208|NCT01240915|525458363|FG007|Overall Study|Adverse Event|0|||
145711209|NCT01240915|525458364|FG008|Overall Study|Adverse Event|1|||
145711210|NCT01240915|525458356|FG000|Overall Study|Lost to Follow-up|0|||
145711211|NCT01240915|525458357|FG001|Overall Study|Lost to Follow-up|0|||
145711212|NCT01240915|525458358|FG002|Overall Study|Lost to Follow-up|0|||
145711213|NCT01240915|525458359|FG003|Overall Study|Lost to Follow-up|0|||
145711214|NCT01240915|525458360|FG004|Overall Study|Lost to Follow-up|1|||
145711215|NCT01240915|525458361|FG005|Overall Study|Lost to Follow-up|1|||
145711216|NCT01240915|525458362|FG006|Overall Study|Lost to Follow-up|0|||
145711217|NCT01240915|525458363|FG007|Overall Study|Lost to Follow-up|1|||
145711218|NCT01240915|525458364|FG008|Overall Study|Lost to Follow-up|1|||
145711219|NCT01240915|525458356|FG000|Overall Study|Withdrawal by Subject|2|||
145711220|NCT01240915|525458357|FG001|Overall Study|Withdrawal by Subject|1|||
145711221|NCT01240915|525458358|FG002|Overall Study|Withdrawal by Subject|0|||
145711222|NCT01240915|525458359|FG003|Overall Study|Withdrawal by Subject|2|||
145711223|NCT01240915|525458360|FG004|Overall Study|Withdrawal by Subject|0|||
145711224|NCT01240915|525458361|FG005|Overall Study|Withdrawal by Subject|4|||
145711225|NCT01240915|525458362|FG006|Overall Study|Withdrawal by Subject|2|||
145711226|NCT01240915|525458363|FG007|Overall Study|Withdrawal by Subject|3|||
145711227|NCT01240915|525458364|FG008|Overall Study|Withdrawal by Subject|3|||
145711228|NCT01240915|525458356|FG000|Overall Study|Other|0|||
145711229|NCT01240915|525458357|FG001|Overall Study|Other|0|||
145711230|NCT01240915|525458358|FG002|Overall Study|Other|0|||
145711231|NCT01240915|525458359|FG003|Overall Study|Other|0|||
145711232|NCT01240915|525458360|FG004|Overall Study|Other|2|||
145711233|NCT01240915|525458361|FG005|Overall Study|Other|0|||
145711234|NCT01240915|525458362|FG006|Overall Study|Other|0|||
145711235|NCT01240915|525458363|FG007|Overall Study|Other|0|||
145711236|NCT01240915|525458364|FG008|Overall Study|Other|0|||
145711237|NCT01240915|525458356|FG000|Overall Study|Insufficient Clinical Response|0|||
145711238|NCT01240915|525458357|FG001|Overall Study|Insufficient Clinical Response|0|||
145711239|NCT01240915|525458358|FG002|Overall Study|Insufficient Clinical Response|0|||
145711240|NCT01240915|525458359|FG003|Overall Study|Insufficient Clinical Response|0|||
145711241|NCT01240915|525458360|FG004|Overall Study|Insufficient Clinical Response|1|||
145711242|NCT01240915|525458361|FG005|Overall Study|Insufficient Clinical Response|3|||
145711243|NCT01240915|525458362|FG006|Overall Study|Insufficient Clinical Response|6|||
145711244|NCT01240915|525458363|FG007|Overall Study|Insufficient Clinical Response|0|||
145711245|NCT01240915|525458364|FG008|Overall Study|Insufficient Clinical Response|3|||
145711246|NCT01598662|525458366|FG000|Overall Study|Lost to Follow-up|10|||
145711247|NCT01598662|525458367|FG001|Overall Study|Lost to Follow-up|17|||
145711248|NCT01598662|525458366|FG000|Overall Study|Physician Decision|1|||
145711249|NCT01598662|525458367|FG001|Overall Study|Physician Decision|2|||
145711250|NCT01598662|525458366|FG000|Overall Study|IUD expelled before month 6|0|||
145711251|NCT01598662|525458367|FG001|Overall Study|IUD expelled before month 6|2|||
145711252|NCT02574845|525458370|FG000|Overall Study|Consent withdrawn further participation|0|||
145711253|NCT02574845|525458371|FG001|Overall Study|Consent withdrawn further participation|0|||
145711254|NCT02574845|525458372|FG002|Overall Study|Consent withdrawn further participation|0|||
145711255|NCT02574845|525458373|FG003|Overall Study|Consent withdrawn further participation|0|||
145711256|NCT02574845|525458374|FG004|Overall Study|Consent withdrawn further participation|1|||
145711257|NCT02574845|525458375|FG005|Overall Study|Consent withdrawn further participation|0|||
145711258|NCT02574845|525458370|FG000|Overall Study|Adverse Event|0|||
145711259|NCT02574845|525458371|FG001|Overall Study|Adverse Event|1|||
145711260|NCT02574845|525458372|FG002|Overall Study|Adverse Event|0|||
145711261|NCT02574845|525458373|FG003|Overall Study|Adverse Event|0|||
145711262|NCT02574845|525458374|FG004|Overall Study|Adverse Event|0|||
145711263|NCT02574845|525458375|FG005|Overall Study|Adverse Event|1|||
145711264|NCT02781090|525458376|FG000|3-Month Follow-Up|Missed Visit|20|||
145711265|NCT02781090|525458377|FG001|3-Month Follow-Up|Missed Visit|20|||
145711266|NCT02781090|525458376|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
145711267|NCT02781090|525458377|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
145711268|NCT02781090|525458376|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
145711269|NCT02781090|525458377|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
145711270|NCT02781090|525458376|FG000|3-Month Follow-Up|Death|1|||
145711271|NCT02781090|525458377|FG001|3-Month Follow-Up|Death|0|||
145711272|NCT02781090|525458376|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
145711273|NCT02781090|525458377|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
145711274|NCT02781090|525458376|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
145711275|NCT02781090|525458377|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
145711276|NCT02781090|525458376|FG000|6-Month Follow-Up|Death|0|||
145711277|NCT02781090|525458377|FG001|6-Month Follow-Up|Death|1|||
145711278|NCT01867333|525458378|FG000|Overall Study|Withdrawal by Subject|1|||
145711279|NCT01867333|525458379|FG001|Overall Study|Withdrawal by Subject|0|||
145711280|NCT01867333|525458378|FG000|Overall Study|Adverse Event|1|||
145711281|NCT01867333|525458379|FG001|Overall Study|Adverse Event|0|||
145711282|NCT01867333|525458378|FG000|Overall Study|Participant choice|1|||
145711283|NCT01867333|525458379|FG001|Overall Study|Participant choice|2|||
145711284|NCT01867333|525458378|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
145711285|NCT01867333|525458379|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
145711286|NCT01867333|525458378|FG000|Overall Study|Death|0|||
145711287|NCT01867333|525458379|FG001|Overall Study|Death|1|||
145711288|NCT01867333|525458378|FG000|Overall Study|Physician Decision|3|||
145711289|NCT01867333|525458379|FG001|Overall Study|Physician Decision|2|||
145711290|NCT01867333|525458378|FG000|Overall Study|Switched to alternative treatment|1|||
145711291|NCT01867333|525458379|FG001|Overall Study|Switched to alternative treatment|0|||
145711292|NCT02683785|525458380|FG000|Overall Study|Withdrawal by Subject|1|||
145711293|NCT02683785|525458381|FG001|Overall Study|Withdrawal by Subject|1|||
145711294|NCT02683785|525458380|FG000|Overall Study|Lost to Follow-up|0|||
145711295|NCT02683785|525458381|FG001|Overall Study|Lost to Follow-up|1|||
145711296|NCT02683785|525458380|FG000|Overall Study|Adverse Event|0|||
145711297|NCT02683785|525458381|FG001|Overall Study|Adverse Event|2|||
145711298|NCT04462289|525458390|FG000|Overall Study|Lost to Follow-up|4|||
145711299|NCT04462289|525458391|FG001|Overall Study|Lost to Follow-up|5|||
145711300|NCT04462289|525458390|FG000|Overall Study|Death|0|||
145711301|NCT04462289|525458391|FG001|Overall Study|Death|3|||
145711302|NCT04462289|525458390|FG000|Overall Study|Withdrawal by Subject|1|||
145711303|NCT04462289|525458391|FG001|Overall Study|Withdrawal by Subject|3|||
145711304|NCT02206061|525458392|FG000|Overall Study|Withdrawal by Subject|4|||
145711305|NCT02206061|525458393|FG001|Overall Study|Withdrawal by Subject|7|||
145711306|NCT02206061|525458394|FG002|Overall Study|Withdrawal by Subject|1|||
145711307|NCT02206061|525458392|FG000|Overall Study|Lost to Follow-up|14|||
145711308|NCT02206061|525458393|FG001|Overall Study|Lost to Follow-up|7|||
145711309|NCT02206061|525458394|FG002|Overall Study|Lost to Follow-up|20|||
145711310|NCT04187326|525458395|FG000|Overall Study|Lost to Follow-up|2|||
145711311|NCT04187326|525458396|FG001|Overall Study|Lost to Follow-up|1|||
145711312|NCT04187326|525458395|FG000|Overall Study|Computer error- task was only partially completed.|0|||
145711313|NCT04187326|525458396|FG001|Overall Study|Computer error- task was only partially completed.|1|||
145711314|NCT04998812|525458401|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
145711315|NCT04998812|525458402|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
145711316|NCT04998812|525458401|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
145711317|NCT04998812|525458402|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
145711318|NCT04998812|525458401|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
145711319|NCT04998812|525458402|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
145711320|NCT04998812|525458401|FG000|Vaccination Period|Ongoing in study|23|||
145711321|NCT04998812|525458402|FG001|Vaccination Period|Ongoing in study|23|||
145711322|NCT01015560|525459871|FG000|Overall Study|Adverse Event|1|||
145711323|NCT01015560|525459871|FG000|Overall Study|Not protocol specified|1|||
145711324|NCT01015560|525459871|FG000|Overall Study|Withdrawal by Subject|1|||
145711325|NCT02787044|525459878|FG000|Overall Study|Lost to Follow-up|15|||
145711326|NCT02787044|525459879|FG001|Overall Study|Lost to Follow-up|19|||
145711327|NCT03433677|525459880|FG000|Period 1|Protocol Violation|1|||
145711328|NCT03433677|525459881|FG001|Period 1|Protocol Violation|0|||
145711329|NCT03433677|525459880|FG000|Period 2|Withdrawal by Subject|1|||
145711330|NCT03433677|525459881|FG001|Period 2|Withdrawal by Subject|1|||
145711331|NCT03889704|525459883|FG000|Overall Study|Study terminated due to pandemic|1|||
145711332|NCT03482466|525459884|FG000|Overall Study|Protocol Violation|2|||
145711333|NCT04552899|525459885|FG000|Overall Study|Adverse Event|4|||
145711334|NCT04552899|525459886|FG001|Overall Study|Adverse Event|3|||
145711335|NCT04552899|525459885|FG000|Overall Study|Death|4|||
145711336|NCT04552899|525459886|FG001|Overall Study|Death|4|||
145711337|NCT04552899|525459885|FG000|Overall Study|Lost to Follow-up|8|||
145711338|NCT04552899|525459886|FG001|Overall Study|Lost to Follow-up|13|||
145711339|NCT04552899|525459885|FG000|Overall Study|Lung Transplant|4|||
145711340|NCT04552899|525459886|FG001|Overall Study|Lung Transplant|3|||
145711341|NCT04552899|525459885|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
145711342|NCT04552899|525459886|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
145711343|NCT04552899|525459885|FG000|Overall Study|Physician Decision|3|||
145711344|NCT04552899|525459886|FG001|Overall Study|Physician Decision|4|||
145711345|NCT04552899|525459885|FG000|Overall Study|Study Terminated By Sponsor|237|||
145711346|NCT04552899|525459886|FG001|Overall Study|Study Terminated By Sponsor|239|||
145711347|NCT04552899|525459885|FG000|Overall Study|Withdrawal by Subject|15|||
145711348|NCT04552899|525459886|FG001|Overall Study|Withdrawal by Subject|17|||
145711349|NCT03268603|525459887|FG000|Overall Study|Withdrawal by Subject|6|||
145711350|NCT03268603|525459887|FG000|Overall Study|Physician Decision|1|||
145711351|NCT03268603|525459887|FG000|Overall Study|Withdrawn due to disease progression|2|||
145711352|NCT02591953|525459888|FG000|Overall Study|Lost to Follow-up|6|||
145711353|NCT02591953|525459889|FG001|Overall Study|Lost to Follow-up|6|||
145711354|NCT02060370|525459890|FG000|Overall Study|Physician Decision|1|||
145711355|NCT04939701|525459891|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
145711356|NCT04939701|525459892|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
145711357|NCT04939701|525459893|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
145711358|NCT04939701|525459891|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
145711359|NCT04939701|525459892|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
145711360|NCT04939701|525459893|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
145711361|NCT04939701|525459891|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
145491513|NCT00360412|524653826|FG001|Overall Study|Study termination by Sponsor|469|||
145711362|NCT04939701|525459892|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
145711363|NCT04939701|525459893|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
145711364|NCT04939701|525459891|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
145711365|NCT04939701|525459892|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
145711366|NCT04939701|525459893|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
145711367|NCT04939701|525459891|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
145711368|NCT04939701|525459892|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
145711369|NCT04939701|525459893|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
145711370|NCT04939701|525459891|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
145711371|NCT04939701|525459892|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
145711372|NCT04939701|525459893|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
145711373|NCT04939701|525459891|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
145711374|NCT04939701|525459892|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
145711375|NCT04939701|525459893|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
145711376|NCT02383940|525459898|FG000|Overall Study|Adverse Event|1|||
145711377|NCT02383940|525459899|FG001|Overall Study|Adverse Event|0|||
145711378|NCT02383940|525459898|FG000|Overall Study|Lost to Follow-up|2|||
145711379|NCT02383940|525459899|FG001|Overall Study|Lost to Follow-up|2|||
145711380|NCT02383940|525459898|FG000|Overall Study|Physician Decision|2|||
145711381|NCT02383940|525459899|FG001|Overall Study|Physician Decision|0|||
145711382|NCT02383940|525459898|FG000|Overall Study|Withdrawal by Subject|1|||
145711383|NCT02383940|525459899|FG001|Overall Study|Withdrawal by Subject|1|||
145711384|NCT02383940|525459898|FG000|Overall Study|Randomized but not treated|2|||
145711385|NCT02383940|525459899|FG001|Overall Study|Randomized but not treated|0|||
145711386|NCT02383940|525459898|FG000|Overall Study|Other than specified above|1|||
145711387|NCT02383940|525459899|FG001|Overall Study|Other than specified above|0|||
145711388|NCT01517295|525459900|FG000|Overall Study|Physician Decision|1|||
145711389|NCT01517295|525459901|FG001|Overall Study|Physician Decision|0|||
145711390|NCT05487586|525459903|FG000|Overall Study|Death|22|||
145711391|NCT05487586|525459903|FG000|Overall Study|Physician Decision|1|||
145711392|NCT05487586|525459903|FG000|Overall Study|Transfer to another hospital|4|||
145711393|NCT05487586|525459903|FG000|Overall Study|Other|1|||
145711394|NCT01493427|525459904|FG000|Overall Study|Adverse Event|10|||
145711395|NCT01493427|525459904|FG000|Overall Study|Personal Reasons|4|||
145711396|NCT01493427|525459904|FG000|Overall Study|Lost to Follow-up|2|||
145711397|NCT01493427|525459904|FG000|Overall Study|Inability to Follow Instructions|2|||
145711398|NCT01493427|525459904|FG000|Overall Study|Other|2|||
145711399|NCT02233803|525459908|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
145711400|NCT02233803|525459909|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
145711401|NCT02233803|525459908|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
145711402|NCT02233803|525459909|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
145711403|NCT02233803|525459908|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
145711404|NCT02233803|525459909|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
145711405|NCT02233803|525459908|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
145711406|NCT02233803|525459909|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
145711407|NCT02233803|525459908|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
145711408|NCT02233803|525459909|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
145711409|NCT02233803|525459908|FG000|Washout Period (4-Wks)|Physician Decision|1|||
145711410|NCT02233803|525459909|FG001|Washout Period (4-Wks)|Physician Decision|0|||
145711411|NCT02233803|525459908|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
145711412|NCT02233803|525459909|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
145711413|NCT02233803|525459908|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
145711414|NCT02233803|525459909|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
145711415|NCT02233803|525459908|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
145711416|NCT02233803|525459909|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
145711417|NCT01559129|525459914|FG000|Treatment Phase|Adverse Event|0|||
145711418|NCT01559129|525459915|FG001|Treatment Phase|Adverse Event|2|||
145711419|NCT01559129|525459914|FG000|Treatment Phase|Progressive Disease|1|||
145711420|NCT01559129|525459915|FG001|Treatment Phase|Progressive Disease|1|||
145711421|NCT01559129|525459914|FG000|Treatment Phase|Lack of Efficacy|0|||
145711422|NCT01559129|525459915|FG001|Treatment Phase|Lack of Efficacy|1|||
145711423|NCT01559129|525459914|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
145711424|NCT01559129|525459915|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
145711425|NCT01559129|525459914|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
145711426|NCT01559129|525459915|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
145711427|NCT01559129|525459914|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
145711428|NCT01559129|525459915|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
145711429|NCT01559129|525459914|FG000|Open-label Extension Period|Adverse Event|1|||
145711430|NCT01559129|525459915|FG001|Open-label Extension Period|Adverse Event|0|||
145711431|NCT01559129|525459914|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
145711432|NCT01559129|525459915|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
145711433|NCT00368927|525459916|FG000|Overall Study|Lost to Follow-up|2|||
145711434|NCT00368927|525459917|FG001|Overall Study|Lost to Follow-up|0|||
145711435|NCT00368927|525459916|FG000|Overall Study|Adverse Event|1|||
145711436|NCT00368927|525459917|FG001|Overall Study|Adverse Event|1|||
145711437|NCT00368927|525459916|FG000|Overall Study|Withdrawal by Subject|1|||
145711438|NCT00368927|525459917|FG001|Overall Study|Withdrawal by Subject|2|||
145711439|NCT00368927|525459916|FG000|Overall Study|Physician Decision|1|||
145711440|NCT00368927|525459917|FG001|Overall Study|Physician Decision|0|||
145711441|NCT03525392|525459918|FG000|Overall Study|Adverse Event|1|||
145711442|NCT03525392|525459919|FG001|Overall Study|Adverse Event|0|||
145711443|NCT03525392|525459920|FG002|Overall Study|Adverse Event|2|||
145711444|NCT03525392|525459921|FG003|Overall Study|Adverse Event|0|||
145711445|NCT03525392|525459922|FG004|Overall Study|Adverse Event|0|||
145711446|NCT03525392|525459918|FG000|Overall Study|Progressive disease|0|||
145711447|NCT03525392|525459919|FG001|Overall Study|Progressive disease|1|||
145711448|NCT03525392|525459920|FG002|Overall Study|Progressive disease|1|||
145711449|NCT03525392|525459921|FG003|Overall Study|Progressive disease|3|||
145491514|NCT04612725|524653827|FG000|Overall Study|Adverse Event|1|||
145711450|NCT03525392|525459922|FG004|Overall Study|Progressive disease|1|||
145711451|NCT03284203|525459923|FG000|Overall Study|Lost to Follow-up|3|||
145711452|NCT03309813|525459924|FG000|Main Randomized Study|Withdrawal by Subject|1|||
145711453|NCT03309813|525459925|FG001|Main Randomized Study|Withdrawal by Subject|0|||
145711454|NCT04978493|525459926|FG000|Overall Study|No reason available|0|||
145711455|NCT04978493|525459927|FG001|Overall Study|No reason available|1|||
145711456|NCT04978493|525459926|FG000|Overall Study|Adverse Event|1|||
145711457|NCT04978493|525459927|FG001|Overall Study|Adverse Event|0|||
145711458|NCT01128114|525459928|FG000|Overall Study|Treatment Withdrawn|6|||
145711459|NCT01128114|525459928|FG000|Overall Study|Screening Failed|2|||
145711460|NCT00208325|525459929|FG000|Overall Study|Death|18|||
145711461|NCT00208325|525459930|FG001|Overall Study|Death|19|||
145711462|NCT00208325|525459931|FG002|Overall Study|Death|7|||
145711463|NCT00208325|525459932|FG003|Overall Study|Death|5|||
145711464|NCT00208325|525459929|FG000|Overall Study|Withdrawal by Subject|0|||
145711465|NCT00208325|525459930|FG001|Overall Study|Withdrawal by Subject|1|||
145711466|NCT00208325|525459931|FG002|Overall Study|Withdrawal by Subject|0|||
145711467|NCT00208325|525459932|FG003|Overall Study|Withdrawal by Subject|0|||
145711468|NCT00208325|525459929|FG000|Overall Study|Revision|4|||
145711469|NCT00208325|525459930|FG001|Overall Study|Revision|1|||
145711470|NCT00208325|525459931|FG002|Overall Study|Revision|0|||
145711471|NCT00208325|525459932|FG003|Overall Study|Revision|4|||
145711472|NCT00208325|525459929|FG000|Overall Study|Lost to Follow-up|1|||
145711473|NCT00208325|525459930|FG001|Overall Study|Lost to Follow-up|0|||
145711474|NCT00208325|525459931|FG002|Overall Study|Lost to Follow-up|2|||
145711475|NCT00208325|525459932|FG003|Overall Study|Lost to Follow-up|0|||
145711476|NCT00208325|525459929|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
145711477|NCT00208325|525459930|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
145711478|NCT00208325|525459931|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
145711479|NCT00208325|525459932|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
145711480|NCT00208325|525459929|FG000|Overall Study|Does not wish to Continue in Study|5|||
145711481|NCT00208325|525459930|FG001|Overall Study|Does not wish to Continue in Study|8|||
145711482|NCT00208325|525459931|FG002|Overall Study|Does not wish to Continue in Study|3|||
145711483|NCT00208325|525459932|FG003|Overall Study|Does not wish to Continue in Study|2|||
145711484|NCT00208325|525459929|FG000|Overall Study|Other|2|||
145711485|NCT00208325|525459930|FG001|Overall Study|Other|1|||
145711486|NCT00208325|525459931|FG002|Overall Study|Other|1|||
145711487|NCT00208325|525459932|FG003|Overall Study|Other|0|||
145711488|NCT00208325|525459929|FG000|Overall Study|Mis-Randomized|17|||
145711489|NCT00208325|525459930|FG001|Overall Study|Mis-Randomized|20|||
145711490|NCT00208325|525459931|FG002|Overall Study|Mis-Randomized|0|||
145711491|NCT00208325|525459932|FG003|Overall Study|Mis-Randomized|0|||
145711492|NCT00586612|525459933|FG000|Primary Phase|Protocol Violation|1|||
145711493|NCT00586612|525459934|FG001|Primary Phase|Protocol Violation|0|||
145711494|NCT00586612|525459933|FG000|Primary Phase|Lost to Follow-up|0|||
145711495|NCT00586612|525459934|FG001|Primary Phase|Lost to Follow-up|1|||
145711496|NCT00586612|525459933|FG000|Primary Phase|Withdrawal by Subject|0|||
145711497|NCT00586612|525459934|FG001|Primary Phase|Withdrawal by Subject|2|||
145711498|NCT00586612|525459933|FG000|Booster Phase|Lost to Follow-up|3|||
145711499|NCT00586612|525459934|FG001|Booster Phase|Lost to Follow-up|1|||
145711500|NCT02738853|525459935|FG000|Enrollment|Inclusion/Exclusion not met|21|||
145711501|NCT02738853|525459935|FG000|Enrollment|Withdrawal by Subject|3|||
145711502|NCT02738853|525459935|FG000|Enrollment|Subject treated with commercially available device|6|||
145711503|NCT02738853|525459935|FG000|Enrollment|Study Enrollment Closed|3|||
145711504|NCT02738853|525459935|FG000|Procedure|Death|1|||
145711505|NCT02738853|525459935|FG000|1 Month|Death|2|||
145711506|NCT02738853|525459935|FG000|6 Month|Death|4|||
145711507|NCT02738853|525459935|FG000|6 Month|Withdrawal by Subject|2|||
145711508|NCT02738853|525459935|FG000|1 Year|Death|6|||
145711509|NCT02738853|525459935|FG000|1 Year|Withdrawal by Subject|1|||
145711510|NCT02738853|525459935|FG000|2 Year|Death|2|||
145711511|NCT02738853|525459935|FG000|2 Year|Lost to Follow-up|1|||
145711512|NCT02738853|525459935|FG000|3 Year|Death|2|||
145711513|NCT02738853|525459935|FG000|3 Year|Withdrawal by Subject|1|||
145711514|NCT02738853|525459935|FG000|4 Year|Death|9|||
145711515|NCT02738853|525459935|FG000|5 Year|Lost to Follow-up|4|||
145711516|NCT04157400|525459937|FG000|Overall Study|Withdrawal by Subject|1|||
145711517|NCT04157400|525459937|FG000|Overall Study|Lost to Follow-up|3|||
145711518|NCT00623805|525459939|FG000|Overall Study|Adverse Event|9|||
145711519|NCT00623805|525459940|FG001|Overall Study|Adverse Event|6|||
145711520|NCT00623805|525459939|FG000|Overall Study|Death|2|||
145711521|NCT00623805|525459940|FG001|Overall Study|Death|0|||
145711522|NCT00623805|525459939|FG000|Overall Study|Lack of Efficacy|3|||
145711523|NCT00623805|525459940|FG001|Overall Study|Lack of Efficacy|7|||
145711524|NCT00623805|525459939|FG000|Overall Study|Lost to Follow-up|2|||
145711525|NCT00623805|525459940|FG001|Overall Study|Lost to Follow-up|2|||
145711526|NCT00623805|525459939|FG000|Overall Study|Protocol Violation|1|||
145711527|NCT00623805|525459940|FG001|Overall Study|Protocol Violation|1|||
145711528|NCT00623805|525459939|FG000|Overall Study|Reason not Specified|3|||
145711529|NCT00623805|525459940|FG001|Overall Study|Reason not Specified|6|||
145711530|NCT01803282|525459943|FG000|Overall Study|Progressive Disease|4|||
145711531|NCT01803282|525459944|FG001|Overall Study|Progressive Disease|3|||
145711532|NCT01803282|525459945|FG002|Overall Study|Progressive Disease|6|||
145711533|NCT01803282|525459946|FG003|Overall Study|Progressive Disease|22|||
145711534|NCT01803282|525459947|FG004|Overall Study|Progressive Disease|5|||
145711535|NCT01803282|525459948|FG005|Overall Study|Progressive Disease|8|||
145711536|NCT01803282|525459949|FG006|Overall Study|Progressive Disease|23|||
145711537|NCT01803282|525459950|FG007|Overall Study|Progressive Disease|24|||
145711538|NCT01803282|525459951|FG008|Overall Study|Progressive Disease|3|||
145711539|NCT01803282|525459952|FG009|Overall Study|Progressive Disease|29|||
145711540|NCT01803282|525459953|FG010|Overall Study|Progressive Disease|6|||
145711541|NCT01803282|525459954|FG011|Overall Study|Progressive Disease|11|||
145711542|NCT01803282|525459943|FG000|Overall Study|Death|0|||
145711543|NCT01803282|525459944|FG001|Overall Study|Death|0|||
145711544|NCT01803282|525459945|FG002|Overall Study|Death|0|||
145711545|NCT01803282|525459946|FG003|Overall Study|Death|0|||
145711546|NCT01803282|525459947|FG004|Overall Study|Death|2|||
145711547|NCT01803282|525459948|FG005|Overall Study|Death|1|||
145711548|NCT01803282|525459949|FG006|Overall Study|Death|1|||
145711549|NCT01803282|525459950|FG007|Overall Study|Death|5|||
145711550|NCT01803282|525459951|FG008|Overall Study|Death|1|||
145711551|NCT01803282|525459952|FG009|Overall Study|Death|1|||
145711552|NCT01803282|525459953|FG010|Overall Study|Death|0|||
145711553|NCT01803282|525459954|FG011|Overall Study|Death|0|||
145711554|NCT01803282|525459943|FG000|Overall Study|Withdrew Consent|0|||
145711555|NCT01803282|525459944|FG001|Overall Study|Withdrew Consent|0|||
145711556|NCT01803282|525459945|FG002|Overall Study|Withdrew Consent|0|||
145711557|NCT01803282|525459946|FG003|Overall Study|Withdrew Consent|6|||
145711558|NCT01803282|525459947|FG004|Overall Study|Withdrew Consent|1|||
145711559|NCT01803282|525459948|FG005|Overall Study|Withdrew Consent|0|||
145711560|NCT01803282|525459949|FG006|Overall Study|Withdrew Consent|8|||
145711561|NCT01803282|525459950|FG007|Overall Study|Withdrew Consent|3|||
145711562|NCT01803282|525459951|FG008|Overall Study|Withdrew Consent|1|||
145711563|NCT01803282|525459952|FG009|Overall Study|Withdrew Consent|5|||
145711564|NCT01803282|525459953|FG010|Overall Study|Withdrew Consent|0|||
145711565|NCT01803282|525459954|FG011|Overall Study|Withdrew Consent|1|||
145711566|NCT01803282|525459943|FG000|Overall Study|Investigator's Discretion|0|||
145711567|NCT01803282|525459944|FG001|Overall Study|Investigator's Discretion|0|||
145711568|NCT01803282|525459945|FG002|Overall Study|Investigator's Discretion|0|||
145711569|NCT01803282|525459946|FG003|Overall Study|Investigator's Discretion|7|||
145711570|NCT01803282|525459947|FG004|Overall Study|Investigator's Discretion|2|||
145711571|NCT01803282|525459948|FG005|Overall Study|Investigator's Discretion|1|||
145711572|NCT01803282|525459949|FG006|Overall Study|Investigator's Discretion|7|||
145711573|NCT01803282|525459950|FG007|Overall Study|Investigator's Discretion|10|||
145711574|NCT01803282|525459951|FG008|Overall Study|Investigator's Discretion|6|||
145711575|NCT01803282|525459952|FG009|Overall Study|Investigator's Discretion|7|||
145711576|NCT01803282|525459953|FG010|Overall Study|Investigator's Discretion|1|||
145711577|NCT01803282|525459954|FG011|Overall Study|Investigator's Discretion|0|||
145711578|NCT01803282|525459943|FG000|Overall Study|Adverse Event|0|||
145711579|NCT01803282|525459944|FG001|Overall Study|Adverse Event|0|||
145711580|NCT01803282|525459945|FG002|Overall Study|Adverse Event|0|||
145711581|NCT01803282|525459946|FG003|Overall Study|Adverse Event|0|||
145711582|NCT01803282|525459947|FG004|Overall Study|Adverse Event|0|||
145711583|NCT01803282|525459948|FG005|Overall Study|Adverse Event|0|||
145711584|NCT01803282|525459949|FG006|Overall Study|Adverse Event|1|||
145711585|NCT01803282|525459950|FG007|Overall Study|Adverse Event|2|||
145711586|NCT01803282|525459951|FG008|Overall Study|Adverse Event|0|||
145711587|NCT01803282|525459952|FG009|Overall Study|Adverse Event|1|||
145711588|NCT01803282|525459953|FG010|Overall Study|Adverse Event|0|||
145711589|NCT01803282|525459954|FG011|Overall Study|Adverse Event|3|||
145711590|NCT01803282|525459943|FG000|Overall Study|Non-Compliance with Study Drug|0|||
145711591|NCT01803282|525459944|FG001|Overall Study|Non-Compliance with Study Drug|0|||
145711592|NCT01803282|525459945|FG002|Overall Study|Non-Compliance with Study Drug|0|||
145711593|NCT01803282|525459946|FG003|Overall Study|Non-Compliance with Study Drug|1|||
145711594|NCT01803282|525459947|FG004|Overall Study|Non-Compliance with Study Drug|0|||
145711595|NCT01803282|525459948|FG005|Overall Study|Non-Compliance with Study Drug|0|||
145711596|NCT01803282|525459949|FG006|Overall Study|Non-Compliance with Study Drug|0|||
145711597|NCT01803282|525459950|FG007|Overall Study|Non-Compliance with Study Drug|0|||
145711598|NCT01803282|525459951|FG008|Overall Study|Non-Compliance with Study Drug|0|||
145711599|NCT01803282|525459952|FG009|Overall Study|Non-Compliance with Study Drug|0|||
145711600|NCT01803282|525459953|FG010|Overall Study|Non-Compliance with Study Drug|0|||
145711601|NCT01803282|525459954|FG011|Overall Study|Non-Compliance with Study Drug|0|||
145711602|NCT01803282|525459943|FG000|Overall Study|Unknown Reason|0|||
145711603|NCT01803282|525459944|FG001|Overall Study|Unknown Reason|0|||
145711604|NCT01803282|525459945|FG002|Overall Study|Unknown Reason|0|||
145711605|NCT01803282|525459946|FG003|Overall Study|Unknown Reason|0|||
145711606|NCT01803282|525459947|FG004|Overall Study|Unknown Reason|0|||
145711607|NCT01803282|525459948|FG005|Overall Study|Unknown Reason|0|||
145711608|NCT01803282|525459949|FG006|Overall Study|Unknown Reason|0|||
145711609|NCT01803282|525459950|FG007|Overall Study|Unknown Reason|1|||
145711610|NCT01803282|525459951|FG008|Overall Study|Unknown Reason|0|||
145711611|NCT01803282|525459952|FG009|Overall Study|Unknown Reason|0|||
145711612|NCT01803282|525459953|FG010|Overall Study|Unknown Reason|0|||
145711613|NCT01803282|525459954|FG011|Overall Study|Unknown Reason|0|||
145711614|NCT01803282|525459943|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
145711615|NCT01803282|525459944|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
145711616|NCT01803282|525459945|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
145711617|NCT01803282|525459946|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
145711618|NCT01803282|525459947|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
145711619|NCT01803282|525459948|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
145711620|NCT01803282|525459949|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
145711621|NCT01803282|525459950|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
145711622|NCT01803282|525459951|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
145711623|NCT01803282|525459952|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
145711624|NCT01803282|525459953|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
145711625|NCT01803282|525459954|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
145711626|NCT01803282|525459943|FG000|Overall Study|Enrolled but Never Treated|0|||
145711627|NCT01803282|525459944|FG001|Overall Study|Enrolled but Never Treated|0|||
145711628|NCT01803282|525459945|FG002|Overall Study|Enrolled but Never Treated|0|||
145711629|NCT01803282|525459946|FG003|Overall Study|Enrolled but Never Treated|0|||
145711630|NCT01803282|525459947|FG004|Overall Study|Enrolled but Never Treated|1|||
145711631|NCT01803282|525459948|FG005|Overall Study|Enrolled but Never Treated|0|||
145711632|NCT01803282|525459949|FG006|Overall Study|Enrolled but Never Treated|1|||
145711633|NCT01803282|525459950|FG007|Overall Study|Enrolled but Never Treated|1|||
145711634|NCT01803282|525459951|FG008|Overall Study|Enrolled but Never Treated|0|||
145711635|NCT01803282|525459952|FG009|Overall Study|Enrolled but Never Treated|1|||
145711636|NCT01803282|525459953|FG010|Overall Study|Enrolled but Never Treated|0|||
145711637|NCT01803282|525459954|FG011|Overall Study|Enrolled but Never Treated|0|||
145711638|NCT02671500|525459955|FG000|Overall Study|Lack of Efficacy|12|||
145711639|NCT02671500|525459955|FG000|Overall Study|Lost to Follow-up|2|||
145711640|NCT01217437|525459958|FG000|Overall Study|Adverse Event|0|||
145711641|NCT01217437|525459959|FG001|Overall Study|Adverse Event|8|||
145711642|NCT01217437|525459958|FG000|Overall Study|Death|5|||
145711643|NCT01217437|525459959|FG001|Overall Study|Death|0|||
145711644|NCT01217437|525459958|FG000|Overall Study|Lack of Efficacy|29|||
145711645|NCT01217437|525459959|FG001|Overall Study|Lack of Efficacy|25|||
145711646|NCT01217437|525459958|FG000|Overall Study|Physician Decision|8|||
145711647|NCT01217437|525459959|FG001|Overall Study|Physician Decision|5|||
145711648|NCT01217437|525459958|FG000|Overall Study|Withdrawal by Subject|0|||
145711649|NCT01217437|525459959|FG001|Overall Study|Withdrawal by Subject|2|||
145711650|NCT01217437|525459958|FG000|Overall Study|Ineligible|1|||
145711651|NCT01217437|525459959|FG001|Overall Study|Ineligible|1|||
145711652|NCT03548220|525459960|FG000|Overall Study|Lost to Follow-up|1|||
145711653|NCT03548220|525459961|FG001|Overall Study|Lost to Follow-up|0|||
145711654|NCT03548220|525459962|FG002|Overall Study|Lost to Follow-up|0|||
145711655|NCT03548220|525459963|FG003|Overall Study|Lost to Follow-up|0|||
145711656|NCT02906007|525459964|FG000|Overall Study|Physician Decision|0|||
145711657|NCT02906007|525459965|FG001|Overall Study|Physician Decision|0|||
145711658|NCT02906007|525459966|FG002|Overall Study|Physician Decision|1|||
145711659|NCT02906007|525459964|FG000|Overall Study|Died|1|||
145711660|NCT02906007|525459965|FG001|Overall Study|Died|0|||
145711661|NCT02906007|525459966|FG002|Overall Study|Died|0|||
145711662|NCT04531982|525459967|FG000|Overall Study|Withdrawal by Subject|10|||
145711663|NCT04531982|525459968|FG001|Overall Study|Withdrawal by Subject|11|||
145711664|NCT04531982|525459967|FG000|Overall Study|Adverse Event|6|||
145711665|NCT04531982|525459968|FG001|Overall Study|Adverse Event|14|||
145711666|NCT04531982|525459967|FG000|Overall Study|Protocol Violation|6|||
145711667|NCT04531982|525459968|FG001|Overall Study|Protocol Violation|9|||
145711668|NCT04531982|525459967|FG000|Overall Study|Non-compliance with study drug|3|||
145711669|NCT04531982|525459968|FG001|Overall Study|Non-compliance with study drug|2|||
145711670|NCT04531982|525459967|FG000|Overall Study|Use of prohibited medication|2|||
145711671|NCT04531982|525459968|FG001|Overall Study|Use of prohibited medication|0|||
145711672|NCT04531982|525459967|FG000|Overall Study|Lost to Follow-up|0|||
145711673|NCT04531982|525459968|FG001|Overall Study|Lost to Follow-up|1|||
145711674|NCT04531982|525459967|FG000|Overall Study|Geopolitical conflict|2|||
145711675|NCT04531982|525459968|FG001|Overall Study|Geopolitical conflict|0|||
145711676|NCT04531982|525459967|FG000|Overall Study|Lack of Efficacy|3|||
145711677|NCT04531982|525459968|FG001|Overall Study|Lack of Efficacy|1|||
145711678|NCT06655558|525459969|FG000|Overall Study|Protocol Violation|1|||
145711679|NCT03820947|525459977|FG000|Overall Study|Physician Decision|0|||
145711680|NCT03820947|525459978|FG001|Overall Study|Physician Decision|1|||
145711681|NCT03820947|525459979|FG002|Overall Study|Physician Decision|1|||
145711682|NCT03820947|525459980|FG003|Overall Study|Physician Decision|0|||
145711683|NCT03820947|525459981|FG004|Overall Study|Physician Decision|3|||
145711684|NCT03820947|525459977|FG000|Overall Study|Withdrawal by Subject|6|||
145711685|NCT03820947|525459978|FG001|Overall Study|Withdrawal by Subject|10|||
145711686|NCT03820947|525459979|FG002|Overall Study|Withdrawal by Subject|3|||
145711687|NCT03820947|525459980|FG003|Overall Study|Withdrawal by Subject|8|||
145711688|NCT03820947|525459981|FG004|Overall Study|Withdrawal by Subject|5|||
145711689|NCT03820947|525459977|FG000|Overall Study|Procedure Not Attempted|0|||
145711690|NCT03820947|525459978|FG001|Overall Study|Procedure Not Attempted|2|||
145711691|NCT03820947|525459979|FG002|Overall Study|Procedure Not Attempted|1|||
145711692|NCT03820947|525459980|FG003|Overall Study|Procedure Not Attempted|0|||
145711693|NCT03820947|525459981|FG004|Overall Study|Procedure Not Attempted|0|||
145711694|NCT03820947|525459977|FG000|Overall Study|Other Exit|1|||
145711695|NCT03820947|525459978|FG001|Overall Study|Other Exit|3|||
145711696|NCT03820947|525459979|FG002|Overall Study|Other Exit|3|||
145711697|NCT03820947|525459980|FG003|Overall Study|Other Exit|3|||
145711698|NCT03820947|525459981|FG004|Overall Study|Other Exit|0|||
145711699|NCT03820947|525459977|FG000|Overall Study|Follow-up Not Done|10|||
145711700|NCT03820947|525459978|FG001|Overall Study|Follow-up Not Done|13|||
145711701|NCT03820947|525459979|FG002|Overall Study|Follow-up Not Done|2|||
145711702|NCT03820947|525459980|FG003|Overall Study|Follow-up Not Done|3|||
145711703|NCT03820947|525459981|FG004|Overall Study|Follow-up Not Done|12|||
145711704|NCT03820947|525459977|FG000|Overall Study|Death|0|||
145711705|NCT03820947|525459978|FG001|Overall Study|Death|0|||
145711706|NCT03820947|525459979|FG002|Overall Study|Death|0|||
145711707|NCT03820947|525459980|FG003|Overall Study|Death|0|||
145711708|NCT03820947|525459981|FG004|Overall Study|Death|9|||
145711709|NCT03820947|525459977|FG000|Overall Study|Lost to Follow-up|4|||
145711710|NCT03820947|525459978|FG001|Overall Study|Lost to Follow-up|6|||
145711711|NCT03820947|525459979|FG002|Overall Study|Lost to Follow-up|0|||
145711712|NCT03820947|525459980|FG003|Overall Study|Lost to Follow-up|0|||
145711713|NCT03820947|525459981|FG004|Overall Study|Lost to Follow-up|9|||
145711714|NCT06748729|525459982|FG000|Overall Study|Withdrawal by Subject|1|||
145711715|NCT03578887|525459983|FG000|Overall Study|Withdrawal by Subject|7|||
145711716|NCT03578887|525459984|FG001|Overall Study|Withdrawal by Subject|2|||
145711717|NCT03578887|525459985|FG002|Overall Study|Withdrawal by Subject|1|||
145711718|NCT03578887|525459983|FG000|Overall Study|Lost to Follow-up|13|||
145711719|NCT03578887|525459984|FG001|Overall Study|Lost to Follow-up|1|||
145711720|NCT03578887|525459985|FG002|Overall Study|Lost to Follow-up|4|||
145711721|NCT03578887|525459983|FG000|Overall Study|Physician Decision|0|||
145711722|NCT03578887|525459984|FG001|Overall Study|Physician Decision|1|||
145711723|NCT03578887|525459985|FG002|Overall Study|Physician Decision|1|||
145711724|NCT00890695|525461371|FG000|Overall Study|Protocol Violation|1|||
145711725|NCT00890695|525461372|FG001|Overall Study|Protocol Violation|0|||
145711726|NCT00833261|525461381|FG000|Overall Study|Withdrawal by Subject|4|||
145711727|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
145711728|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
145711729|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
145711730|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
145711731|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
145711732|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
145711733|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
145711734|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
145711735|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
145711736|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
145711737|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
145711738|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
145711739|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Death|1|||
145711740|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Death|2|||
145711741|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Death|2|||
145711742|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Death|0|||
145711743|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Death|0|||
145711744|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Death|0|||
145711745|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
145711746|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
145711747|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
145711748|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
145711749|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
145711750|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
145711751|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
145711752|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
145711753|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
145711754|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
145711755|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
145711756|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
145711757|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
145711758|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
145711759|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
145491515|NCT04612725|524653828|FG001|Overall Study|Adverse Event|3|||
145491516|NCT04612725|524653829|FG002|Overall Study|Adverse Event|1|||
145711760|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
145711761|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
145711762|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
145711763|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
145711764|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
145711765|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
145711766|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
145711767|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
145711768|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
145711769|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
145711770|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
145711771|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
145711772|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
145711773|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
145711774|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
145711775|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
145711776|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
145711777|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
145711778|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
145711779|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
145711780|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
145711781|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
145711782|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
145711783|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
145711784|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
145711785|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
145711786|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
145711787|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Site closure|0|||
145711788|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Site closure|0|||
145711789|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Site closure|1|||
145711790|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Site closure|0|||
145711791|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Site closure|0|||
145711792|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Site closure|0|||
145711793|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
145711794|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
145711795|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
145711796|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
145711797|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
145711798|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
145711799|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
145711800|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
145711801|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
145711802|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
145711803|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
145711804|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
145711805|NCT03439254|525461382|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
145711806|NCT03439254|525461383|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
145711807|NCT03439254|525461384|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
145711808|NCT03439254|525461385|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
145711809|NCT03439254|525461386|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
145711810|NCT03439254|525461387|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
145711811|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
145711812|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
145711813|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
145711814|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
145711815|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
145711816|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
145711817|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
145711818|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
145711819|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
145711820|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
145711821|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
145711822|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
145711823|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
145491517|NCT04612725|524653830|FG003|Overall Study|Adverse Event|0|||
145711824|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
145711825|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
145711826|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
145711827|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
145711828|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
145711829|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
145711830|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
145711831|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
145711832|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
145711833|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
145711834|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
145711835|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
145711836|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
145711837|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
145711838|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
145711839|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
145711840|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
145711841|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
145711842|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
145711843|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
145711844|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
145711845|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
145711846|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
145711847|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
145711848|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
145711849|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
145711850|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
145711851|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
145711852|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
145711853|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
145711854|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
145711855|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
145711856|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
145711857|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
145711858|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
145711859|NCT03439254|525461382|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
145711860|NCT03439254|525461383|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
145711861|NCT03439254|525461384|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
145711862|NCT03439254|525461385|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
145711863|NCT03439254|525461386|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
145711864|NCT03439254|525461387|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
145711865|NCT00568178|525461388|FG000|Double Blind Base Study|Adverse Event|0|||
145711866|NCT00568178|525461389|FG001|Double Blind Base Study|Adverse Event|2|||
145711867|NCT00568178|525461390|FG002|Double Blind Base Study|Adverse Event|1|||
145711868|NCT00568178|525461391|FG003|Double Blind Base Study|Adverse Event|2|||
145711869|NCT00568178|525461392|FG004|Double Blind Base Study|Adverse Event|0|||
145711870|NCT00568178|525461393|FG005|Double Blind Base Study|Adverse Event|0|||
145711871|NCT00568178|525461388|FG000|Double Blind Base Study|Lost to Follow-up|1|||
145711872|NCT00568178|525461389|FG001|Double Blind Base Study|Lost to Follow-up|0|||
145711873|NCT00568178|525461390|FG002|Double Blind Base Study|Lost to Follow-up|0|||
145711874|NCT00568178|525461391|FG003|Double Blind Base Study|Lost to Follow-up|1|||
145711875|NCT00568178|525461392|FG004|Double Blind Base Study|Lost to Follow-up|0|||
145711876|NCT00568178|525461393|FG005|Double Blind Base Study|Lost to Follow-up|0|||
145711877|NCT00568178|525461388|FG000|Double Blind Base Study|Physician Decision|1|||
145711878|NCT00568178|525461389|FG001|Double Blind Base Study|Physician Decision|1|||
145711879|NCT00568178|525461390|FG002|Double Blind Base Study|Physician Decision|0|||
145711880|NCT00568178|525461391|FG003|Double Blind Base Study|Physician Decision|1|||
145711881|NCT00568178|525461392|FG004|Double Blind Base Study|Physician Decision|0|||
145711882|NCT00568178|525461393|FG005|Double Blind Base Study|Physician Decision|0|||
145711883|NCT00568178|525461388|FG000|Double Blind Base Study|Protocol Violation|3|||
145711884|NCT00568178|525461389|FG001|Double Blind Base Study|Protocol Violation|2|||
145711885|NCT00568178|525461390|FG002|Double Blind Base Study|Protocol Violation|0|||
145711886|NCT00568178|525461391|FG003|Double Blind Base Study|Protocol Violation|0|||
145711887|NCT00568178|525461392|FG004|Double Blind Base Study|Protocol Violation|0|||
145711888|NCT00568178|525461393|FG005|Double Blind Base Study|Protocol Violation|0|||
145711889|NCT00568178|525461388|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
145711890|NCT00568178|525461389|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
145711891|NCT00568178|525461390|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
145711892|NCT00568178|525461391|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
145711893|NCT00568178|525461392|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
145711894|NCT00568178|525461393|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
145711895|NCT00568178|525461388|FG000|Double Blind Base Study|Progressive Disease|0|||
145711896|NCT00568178|525461389|FG001|Double Blind Base Study|Progressive Disease|0|||
145711897|NCT00568178|525461390|FG002|Double Blind Base Study|Progressive Disease|0|||
145711898|NCT00568178|525461391|FG003|Double Blind Base Study|Progressive Disease|1|||
145711899|NCT00568178|525461392|FG004|Double Blind Base Study|Progressive Disease|0|||
145711900|NCT00568178|525461393|FG005|Double Blind Base Study|Progressive Disease|0|||
145711901|NCT00568178|525461388|FG000|Open Label Extension|Adverse Event|0|||
145711902|NCT00568178|525461389|FG001|Open Label Extension|Adverse Event|0|||
145711903|NCT00568178|525461390|FG002|Open Label Extension|Adverse Event|0|||
145711904|NCT00568178|525461391|FG003|Open Label Extension|Adverse Event|0|||
145711905|NCT00568178|525461392|FG004|Open Label Extension|Adverse Event|11|||
145711906|NCT00568178|525461393|FG005|Open Label Extension|Adverse Event|8|||
145711907|NCT00568178|525461388|FG000|Open Label Extension|Protocol Violation|0|||
145711908|NCT00568178|525461389|FG001|Open Label Extension|Protocol Violation|0|||
145711909|NCT00568178|525461390|FG002|Open Label Extension|Protocol Violation|0|||
145711910|NCT00568178|525461391|FG003|Open Label Extension|Protocol Violation|0|||
145711911|NCT00568178|525461392|FG004|Open Label Extension|Protocol Violation|1|||
145711912|NCT00568178|525461393|FG005|Open Label Extension|Protocol Violation|0|||
145711913|NCT00568178|525461388|FG000|Open Label Extension|Lost to Follow-up|0|||
145711914|NCT00568178|525461389|FG001|Open Label Extension|Lost to Follow-up|0|||
145711915|NCT00568178|525461390|FG002|Open Label Extension|Lost to Follow-up|0|||
145711916|NCT00568178|525461391|FG003|Open Label Extension|Lost to Follow-up|0|||
145711917|NCT00568178|525461392|FG004|Open Label Extension|Lost to Follow-up|6|||
145711918|NCT00568178|525461393|FG005|Open Label Extension|Lost to Follow-up|11|||
145711919|NCT00568178|525461388|FG000|Open Label Extension|Physician Decision|0|||
145711920|NCT00568178|525461389|FG001|Open Label Extension|Physician Decision|0|||
145711921|NCT00568178|525461390|FG002|Open Label Extension|Physician Decision|0|||
145711922|NCT00568178|525461391|FG003|Open Label Extension|Physician Decision|0|||
145711923|NCT00568178|525461392|FG004|Open Label Extension|Physician Decision|9|||
145711924|NCT00568178|525461393|FG005|Open Label Extension|Physician Decision|8|||
145711925|NCT00568178|525461388|FG000|Open Label Extension|Pregnancy|0|||
145711926|NCT00568178|525461389|FG001|Open Label Extension|Pregnancy|0|||
145711927|NCT00568178|525461390|FG002|Open Label Extension|Pregnancy|0|||
145711928|NCT00568178|525461391|FG003|Open Label Extension|Pregnancy|0|||
145711929|NCT00568178|525461392|FG004|Open Label Extension|Pregnancy|0|||
145711930|NCT00568178|525461393|FG005|Open Label Extension|Pregnancy|1|||
145711931|NCT00568178|525461388|FG000|Open Label Extension|Progressive Disease|0|||
145711932|NCT00568178|525461389|FG001|Open Label Extension|Progressive Disease|0|||
145711933|NCT00568178|525461390|FG002|Open Label Extension|Progressive Disease|0|||
145711934|NCT00568178|525461391|FG003|Open Label Extension|Progressive Disease|0|||
145711935|NCT00568178|525461392|FG004|Open Label Extension|Progressive Disease|3|||
145711936|NCT00568178|525461393|FG005|Open Label Extension|Progressive Disease|1|||
145711937|NCT00568178|525461388|FG000|Open Label Extension|Termination of Trial|0|||
145711938|NCT00568178|525461389|FG001|Open Label Extension|Termination of Trial|0|||
145711939|NCT00568178|525461390|FG002|Open Label Extension|Termination of Trial|0|||
145711940|NCT00568178|525461391|FG003|Open Label Extension|Termination of Trial|0|||
145711941|NCT00568178|525461392|FG004|Open Label Extension|Termination of Trial|45|||
145711942|NCT00568178|525461393|FG005|Open Label Extension|Termination of Trial|47|||
145711943|NCT00568178|525461388|FG000|Open Label Extension|Withdrawal by Subject|0|||
145711944|NCT00568178|525461389|FG001|Open Label Extension|Withdrawal by Subject|0|||
145711945|NCT00568178|525461390|FG002|Open Label Extension|Withdrawal by Subject|0|||
145711946|NCT00568178|525461391|FG003|Open Label Extension|Withdrawal by Subject|0|||
145711947|NCT00568178|525461392|FG004|Open Label Extension|Withdrawal by Subject|4|||
145711948|NCT00568178|525461393|FG005|Open Label Extension|Withdrawal by Subject|4|||
145711949|NCT01531673|525461394|FG000|Overall Study|Non-Compliance|0|||
145711950|NCT01531673|525461395|FG001|Overall Study|Non-Compliance|0|||
145711951|NCT01531673|525461396|FG002|Overall Study|Non-Compliance|0|||
145711952|NCT01531673|525461397|FG003|Overall Study|Non-Compliance|0|||
145711953|NCT01531673|525461398|FG004|Overall Study|Non-Compliance|0|||
145711954|NCT01531673|525461399|FG005|Overall Study|Non-Compliance|1|||
145711955|NCT01531673|525461400|FG006|Overall Study|Non-Compliance|0|||
145711956|NCT01531673|525461401|FG007|Overall Study|Non-Compliance|0|||
145711957|NCT01531673|525461402|FG008|Overall Study|Non-Compliance|0|||
145711958|NCT01531673|525461403|FG009|Overall Study|Non-Compliance|0|||
145711959|NCT01531673|525461404|FG010|Overall Study|Non-Compliance|0|||
145711960|NCT01531673|525461405|FG011|Overall Study|Non-Compliance|0|||
145711961|NCT01531673|525461406|FG012|Overall Study|Non-Compliance|0|||
145711962|NCT01531673|525461394|FG000|Overall Study|Adverse Event|0|||
145711963|NCT01531673|525461395|FG001|Overall Study|Adverse Event|1|||
145711964|NCT01531673|525461396|FG002|Overall Study|Adverse Event|0|||
145711965|NCT01531673|525461397|FG003|Overall Study|Adverse Event|0|||
145711966|NCT01531673|525461398|FG004|Overall Study|Adverse Event|0|||
145711967|NCT01531673|525461399|FG005|Overall Study|Adverse Event|0|||
145711968|NCT01531673|525461400|FG006|Overall Study|Adverse Event|0|||
145711969|NCT01531673|525461401|FG007|Overall Study|Adverse Event|0|||
145711970|NCT01531673|525461402|FG008|Overall Study|Adverse Event|0|||
145711971|NCT01531673|525461403|FG009|Overall Study|Adverse Event|0|||
145711972|NCT01531673|525461404|FG010|Overall Study|Adverse Event|0|||
145711973|NCT01531673|525461405|FG011|Overall Study|Adverse Event|0|||
145711974|NCT01531673|525461406|FG012|Overall Study|Adverse Event|0|||
145711975|NCT01531673|525461394|FG000|Overall Study|Lost to Follow-up|0|||
145711976|NCT01531673|525461395|FG001|Overall Study|Lost to Follow-up|0|||
145711977|NCT01531673|525461396|FG002|Overall Study|Lost to Follow-up|0|||
145711978|NCT01531673|525461397|FG003|Overall Study|Lost to Follow-up|0|||
145711979|NCT01531673|525461398|FG004|Overall Study|Lost to Follow-up|1|||
145711980|NCT01531673|525461399|FG005|Overall Study|Lost to Follow-up|0|||
145711981|NCT01531673|525461400|FG006|Overall Study|Lost to Follow-up|0|||
145711982|NCT01531673|525461401|FG007|Overall Study|Lost to Follow-up|0|||
145711983|NCT01531673|525461402|FG008|Overall Study|Lost to Follow-up|0|||
145711984|NCT01531673|525461403|FG009|Overall Study|Lost to Follow-up|0|||
145711985|NCT01531673|525461404|FG010|Overall Study|Lost to Follow-up|0|||
145711986|NCT01531673|525461405|FG011|Overall Study|Lost to Follow-up|0|||
145711987|NCT01531673|525461406|FG012|Overall Study|Lost to Follow-up|0|||
145711988|NCT01531673|525461394|FG000|Overall Study|Other|0|||
145711989|NCT01531673|525461395|FG001|Overall Study|Other|0|||
145711990|NCT01531673|525461396|FG002|Overall Study|Other|0|||
145711991|NCT01531673|525461397|FG003|Overall Study|Other|1|||
145711992|NCT01531673|525461398|FG004|Overall Study|Other|0|||
145711993|NCT01531673|525461399|FG005|Overall Study|Other|0|||
145711994|NCT01531673|525461400|FG006|Overall Study|Other|0|||
145711995|NCT01531673|525461401|FG007|Overall Study|Other|0|||
145711996|NCT01531673|525461402|FG008|Overall Study|Other|0|||
145711997|NCT01531673|525461403|FG009|Overall Study|Other|1|||
145711998|NCT01531673|525461404|FG010|Overall Study|Other|0|||
145711999|NCT01531673|525461405|FG011|Overall Study|Other|0|||
145712000|NCT01531673|525461406|FG012|Overall Study|Other|0|||
145712001|NCT00264303|525461407|FG000|Overall Study|Adverse Event|4|||
145712002|NCT00264303|525461408|FG001|Overall Study|Adverse Event|3|||
145712003|NCT00264303|525461407|FG000|Overall Study|Lack of Efficacy|10|||
145712004|NCT00264303|525461408|FG001|Overall Study|Lack of Efficacy|13|||
145712005|NCT00264303|525461407|FG000|Overall Study|Lost to Follow-up|3|||
145712006|NCT00264303|525461408|FG001|Overall Study|Lost to Follow-up|3|||
145712007|NCT00264303|525461407|FG000|Overall Study|Withdrawal by Subject|2|||
145712008|NCT00264303|525461408|FG001|Overall Study|Withdrawal by Subject|3|||
145712009|NCT00264303|525461407|FG000|Overall Study|Various reasons listed in study report|6|||
145712010|NCT00264303|525461408|FG001|Overall Study|Various reasons listed in study report|7|||
145712011|NCT02389452|525461409|FG000|Overall Study|Lost to Follow-up|13|||
145712012|NCT02389452|525461409|FG000|Overall Study|Adverse Event|1|||
145712013|NCT02389452|525461409|FG000|Overall Study|Withdrawal by Subject|5|||
145712014|NCT02389452|525461409|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
145712015|NCT00837694|525461412|FG000|Overall Study|Lost to Follow-up|2|||
145712016|NCT00837694|525461413|FG001|Overall Study|Lost to Follow-up|0|||
145712017|NCT00837694|525461414|FG002|Overall Study|Lost to Follow-up|2|||
145712018|NCT00837694|525461415|FG003|Overall Study|Lost to Follow-up|1|||
145712019|NCT00837694|525461416|FG004|Overall Study|Lost to Follow-up|1|||
145712020|NCT00837694|525461417|FG005|Overall Study|Lost to Follow-up|1|||
145712021|NCT00818168|525461423|FG000|Overall Study|Lack of Efficacy|18|||
145712022|NCT00818168|525461423|FG000|Overall Study|Pregnancy|2|||
145712023|NCT00818168|525461423|FG000|Overall Study|Withdrawal by Subject|16|||
145712024|NCT00818168|525461423|FG000|Overall Study|Lost to Follow-up|7|||
145712025|NCT00818168|525461423|FG000|Overall Study|Adverse Event|19|||
145712026|NCT00818168|525461423|FG000|Overall Study|Reason for Non-completion Not reported|6|||
145712027|NCT00818168|525461423|FG000|Overall Study|Participant Moved|2|||
145712028|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Physician Decision|2|||
145712029|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Physician Decision|0|||
145712030|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Physician Decision|0|||
145712031|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Adverse Event|33|||
145712032|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Adverse Event|0|||
145712033|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Adverse Event|0|||
145712034|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
145712035|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
145712036|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
145712037|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
145712038|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
145712039|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
145712040|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
145712041|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
145712042|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
145712043|NCT01008553|525461424|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
145712044|NCT01008553|525461425|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
145712045|NCT01008553|525461426|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
145712046|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
145712047|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
145712048|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
145712049|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
145712050|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
145712051|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
145712052|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
145712053|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
145712054|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
145712055|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
145712056|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
145712057|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
145712058|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
145712059|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
145712060|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
145712061|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
145712062|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
145712063|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
145712064|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
145712065|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
145712066|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
145712067|NCT01008553|525461424|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
145712068|NCT01008553|525461425|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
145712069|NCT01008553|525461426|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
145712070|NCT01008410|525461427|FG000|Overall Study|Adverse Event|13|||
145712071|NCT01008410|525461428|FG001|Overall Study|Adverse Event|7|||
145712072|NCT01008410|525461427|FG000|Overall Study|Withdrawal by Subject|6|||
145712073|NCT01008410|525461428|FG001|Overall Study|Withdrawal by Subject|2|||
145712074|NCT01008410|525461427|FG000|Overall Study|Lost to Follow-up|1|||
145712075|NCT01008410|525461428|FG001|Overall Study|Lost to Follow-up|0|||
145712076|NCT01008410|525461427|FG000|Overall Study|Noncompliance|1|||
145712077|NCT01008410|525461428|FG001|Overall Study|Noncompliance|0|||
145712078|NCT01008410|525461427|FG000|Overall Study|Low Cortisol|2|||
145712079|NCT01008410|525461428|FG001|Overall Study|Low Cortisol|0|||
145712080|NCT01008410|525461427|FG000|Overall Study|Lack of Efficacy|2|||
145712081|NCT01008410|525461428|FG001|Overall Study|Lack of Efficacy|6|||
145712082|NCT01008410|525461427|FG000|Overall Study|Met Exclusion Criterion|0|||
145712083|NCT01008410|525461428|FG001|Overall Study|Met Exclusion Criterion|1|||
145712084|NCT02672852|525461433|FG000|Part A1|Disease Worsening|1|||
145712085|NCT02672852|525461434|FG001|Part A1|Disease Worsening|0|||
145712086|NCT02672852|525461435|FG002|Part A1|Disease Worsening|0|||
145712087|NCT02672852|525461436|FG003|Part A1|Disease Worsening|0|||
145712088|NCT02672852|525461437|FG004|Part A1|Disease Worsening|0|||
145712089|NCT02672852|525461438|FG005|Part A1|Disease Worsening|0|||
145712090|NCT02672852|525461439|FG006|Part A1|Disease Worsening|0|||
145712091|NCT02672852|525461433|FG000|Part A1|Adverse Event|0|||
145712092|NCT02672852|525461434|FG001|Part A1|Adverse Event|1|||
145712093|NCT02672852|525461435|FG002|Part A1|Adverse Event|0|||
145712094|NCT02672852|525461436|FG003|Part A1|Adverse Event|0|||
145712095|NCT02672852|525461437|FG004|Part A1|Adverse Event|0|||
145712096|NCT02672852|525461438|FG005|Part A1|Adverse Event|0|||
145712097|NCT02672852|525461439|FG006|Part A1|Adverse Event|0|||
145712098|NCT02672852|525461433|FG000|Part A1|Lost to Follow-up|1|||
145712099|NCT02672852|525461434|FG001|Part A1|Lost to Follow-up|2|||
145712100|NCT02672852|525461435|FG002|Part A1|Lost to Follow-up|0|||
145712101|NCT02672852|525461436|FG003|Part A1|Lost to Follow-up|0|||
145712102|NCT02672852|525461437|FG004|Part A1|Lost to Follow-up|0|||
145712103|NCT02672852|525461438|FG005|Part A1|Lost to Follow-up|0|||
145712104|NCT02672852|525461439|FG006|Part A1|Lost to Follow-up|0|||
145712105|NCT02672852|525461433|FG000|Part A1|Withdrawal by Subject|1|||
145712106|NCT02672852|525461434|FG001|Part A1|Withdrawal by Subject|1|||
145712107|NCT02672852|525461435|FG002|Part A1|Withdrawal by Subject|0|||
145712108|NCT02672852|525461436|FG003|Part A1|Withdrawal by Subject|0|||
145712109|NCT02672852|525461437|FG004|Part A1|Withdrawal by Subject|0|||
145712110|NCT02672852|525461438|FG005|Part A1|Withdrawal by Subject|0|||
145712111|NCT02672852|525461439|FG006|Part A1|Withdrawal by Subject|0|||
145712112|NCT02672852|525461433|FG000|Part A2|Disease worsening|0|||
145712113|NCT02672852|525461434|FG001|Part A2|Disease worsening|0|||
145712114|NCT02672852|525461435|FG002|Part A2|Disease worsening|1|||
145712115|NCT02672852|525461436|FG003|Part A2|Disease worsening|0|||
145712116|NCT02672852|525461437|FG004|Part A2|Disease worsening|0|||
145712117|NCT02672852|525461438|FG005|Part A2|Disease worsening|0|||
145712118|NCT02672852|525461439|FG006|Part A2|Disease worsening|0|||
145712119|NCT02672852|525461433|FG000|Part A2|Adverse Event|0|||
145712120|NCT02672852|525461434|FG001|Part A2|Adverse Event|0|||
145712121|NCT02672852|525461435|FG002|Part A2|Adverse Event|3|||
145712122|NCT02672852|525461436|FG003|Part A2|Adverse Event|0|||
145712123|NCT02672852|525461437|FG004|Part A2|Adverse Event|0|||
145712124|NCT02672852|525461438|FG005|Part A2|Adverse Event|0|||
145712125|NCT02672852|525461439|FG006|Part A2|Adverse Event|0|||
145712126|NCT02672852|525461433|FG000|Part A2|Lost to Follow-up|0|||
145712127|NCT02672852|525461434|FG001|Part A2|Lost to Follow-up|0|||
145712128|NCT02672852|525461435|FG002|Part A2|Lost to Follow-up|2|||
145712129|NCT02672852|525461436|FG003|Part A2|Lost to Follow-up|0|||
145712130|NCT02672852|525461437|FG004|Part A2|Lost to Follow-up|0|||
145712131|NCT02672852|525461438|FG005|Part A2|Lost to Follow-up|0|||
145712132|NCT02672852|525461439|FG006|Part A2|Lost to Follow-up|0|||
145712133|NCT02672852|525461433|FG000|Part A2|Withdrawal by Subject|0|||
145712134|NCT02672852|525461434|FG001|Part A2|Withdrawal by Subject|0|||
145712135|NCT02672852|525461435|FG002|Part A2|Withdrawal by Subject|1|||
145712136|NCT02672852|525461436|FG003|Part A2|Withdrawal by Subject|0|||
145712137|NCT02672852|525461437|FG004|Part A2|Withdrawal by Subject|0|||
145712138|NCT02672852|525461438|FG005|Part A2|Withdrawal by Subject|0|||
145712139|NCT02672852|525461439|FG006|Part A2|Withdrawal by Subject|0|||
145712140|NCT02672852|525461433|FG000|Part A2|Other|0|||
145712141|NCT02672852|525461434|FG001|Part A2|Other|0|||
145712142|NCT02672852|525461435|FG002|Part A2|Other|3|||
145712143|NCT02672852|525461436|FG003|Part A2|Other|0|||
145712144|NCT02672852|525461437|FG004|Part A2|Other|0|||
145712145|NCT02672852|525461438|FG005|Part A2|Other|0|||
145712146|NCT02672852|525461439|FG006|Part A2|Other|0|||
145712147|NCT02672852|525461433|FG000|Part A2|Not entered in Part B|0|||
145712148|NCT02672852|525461434|FG001|Part A2|Not entered in Part B|0|||
145712149|NCT02672852|525461435|FG002|Part A2|Not entered in Part B|0|||
145712150|NCT02672852|525461436|FG003|Part A2|Not entered in Part B|4|||
145712151|NCT02672852|525461437|FG004|Part A2|Not entered in Part B|0|||
145712152|NCT02672852|525461438|FG005|Part A2|Not entered in Part B|0|||
145712153|NCT02672852|525461439|FG006|Part A2|Not entered in Part B|0|||
145712154|NCT02672852|525461433|FG000|Part B|Disease worsening|0|||
145712155|NCT02672852|525461434|FG001|Part B|Disease worsening|0|||
145712156|NCT02672852|525461435|FG002|Part B|Disease worsening|0|||
145712157|NCT02672852|525461436|FG003|Part B|Disease worsening|0|||
145712158|NCT02672852|525461437|FG004|Part B|Disease worsening|1|||
145712159|NCT02672852|525461438|FG005|Part B|Disease worsening|0|||
145712160|NCT02672852|525461439|FG006|Part B|Disease worsening|1|||
145712161|NCT02672852|525461433|FG000|Part B|Worsening pre-existing condition|0|||
145712162|NCT02672852|525461434|FG001|Part B|Worsening pre-existing condition|0|||
145712163|NCT02672852|525461435|FG002|Part B|Worsening pre-existing condition|0|||
145712164|NCT02672852|525461436|FG003|Part B|Worsening pre-existing condition|0|||
145712165|NCT02672852|525461437|FG004|Part B|Worsening pre-existing condition|0|||
145712166|NCT02672852|525461438|FG005|Part B|Worsening pre-existing condition|1|||
145712167|NCT02672852|525461439|FG006|Part B|Worsening pre-existing condition|0|||
145712168|NCT02672852|525461433|FG000|Part B|Other adverse event|0|||
145712169|NCT02672852|525461434|FG001|Part B|Other adverse event|0|||
145712170|NCT02672852|525461435|FG002|Part B|Other adverse event|0|||
145712171|NCT02672852|525461436|FG003|Part B|Other adverse event|0|||
145712172|NCT02672852|525461437|FG004|Part B|Other adverse event|3|||
145712173|NCT02672852|525461438|FG005|Part B|Other adverse event|5|||
145712174|NCT02672852|525461439|FG006|Part B|Other adverse event|1|||
145712175|NCT02672852|525461433|FG000|Part B|Lost to Follow-up|0|||
145712176|NCT02672852|525461434|FG001|Part B|Lost to Follow-up|0|||
145712177|NCT02672852|525461435|FG002|Part B|Lost to Follow-up|0|||
145712178|NCT02672852|525461436|FG003|Part B|Lost to Follow-up|0|||
145712179|NCT02672852|525461437|FG004|Part B|Lost to Follow-up|3|||
145712180|NCT02672852|525461438|FG005|Part B|Lost to Follow-up|4|||
145712181|NCT02672852|525461439|FG006|Part B|Lost to Follow-up|1|||
145712182|NCT02672852|525461433|FG000|Part B|Withdrawal by Subject|0|||
145712183|NCT02672852|525461434|FG001|Part B|Withdrawal by Subject|0|||
145712184|NCT02672852|525461435|FG002|Part B|Withdrawal by Subject|0|||
145712185|NCT02672852|525461436|FG003|Part B|Withdrawal by Subject|0|||
145712186|NCT02672852|525461437|FG004|Part B|Withdrawal by Subject|5|||
145712187|NCT02672852|525461438|FG005|Part B|Withdrawal by Subject|0|||
145712188|NCT02672852|525461439|FG006|Part B|Withdrawal by Subject|7|||
145712189|NCT02672852|525461433|FG000|Part B|Other|0|||
145712190|NCT02672852|525461434|FG001|Part B|Other|0|||
145712191|NCT02672852|525461435|FG002|Part B|Other|0|||
145712192|NCT02672852|525461436|FG003|Part B|Other|0|||
145712193|NCT02672852|525461437|FG004|Part B|Other|4|||
145712194|NCT02672852|525461438|FG005|Part B|Other|1|||
145712195|NCT02672852|525461439|FG006|Part B|Other|2|||
145712196|NCT03248882|525461440|FG000|Overall Study|Adverse Event|3|||
145712197|NCT03248882|525461441|FG001|Overall Study|Adverse Event|3|||
145712198|NCT03248882|525461442|FG002|Overall Study|Adverse Event|2|||
145712199|NCT03248882|525461443|FG003|Overall Study|Adverse Event|6|||
145712200|NCT03248882|525461444|FG004|Overall Study|Adverse Event|9|||
145712201|NCT03248882|525461440|FG000|Overall Study|Lost to Follow-up|0|||
145712202|NCT03248882|525461441|FG001|Overall Study|Lost to Follow-up|0|||
145712203|NCT03248882|525461442|FG002|Overall Study|Lost to Follow-up|0|||
145712204|NCT03248882|525461443|FG003|Overall Study|Lost to Follow-up|0|||
145712205|NCT03248882|525461444|FG004|Overall Study|Lost to Follow-up|1|||
145712206|NCT03248882|525461440|FG000|Overall Study|Protocol Violation|2|||
145712207|NCT03248882|525461441|FG001|Overall Study|Protocol Violation|0|||
145712208|NCT03248882|525461442|FG002|Overall Study|Protocol Violation|2|||
145712209|NCT03248882|525461443|FG003|Overall Study|Protocol Violation|0|||
145712210|NCT03248882|525461444|FG004|Overall Study|Protocol Violation|1|||
145712211|NCT03248882|525461440|FG000|Overall Study|Withdrawal by Subject|2|||
145712212|NCT03248882|525461441|FG001|Overall Study|Withdrawal by Subject|2|||
145712213|NCT03248882|525461442|FG002|Overall Study|Withdrawal by Subject|3|||
145712214|NCT03248882|525461443|FG003|Overall Study|Withdrawal by Subject|4|||
145712215|NCT03248882|525461444|FG004|Overall Study|Withdrawal by Subject|2|||
145712216|NCT04308590|525461445|FG000|Overall Study|Adverse Event|12|||
145712217|NCT04308590|525461446|FG001|Overall Study|Adverse Event|2|||
145712218|NCT04308590|525461445|FG000|Overall Study|Withdrawal by Subject|10|||
145712219|NCT04308590|525461446|FG001|Overall Study|Withdrawal by Subject|4|||
145712220|NCT04308590|525461445|FG000|Overall Study|Death|1|||
145712221|NCT04308590|525461446|FG001|Overall Study|Death|0|||
145712222|NCT04308590|525461445|FG000|Overall Study|Lost to Follow-up|1|||
145712223|NCT04308590|525461446|FG001|Overall Study|Lost to Follow-up|1|||
145712224|NCT04308590|525461445|FG000|Overall Study|Physician Decision|1|||
145712225|NCT04308590|525461446|FG001|Overall Study|Physician Decision|0|||
145712226|NCT04308590|525461445|FG000|Overall Study|Subject does not want to continue with Pi|0|||
145712227|NCT04308590|525461446|FG001|Overall Study|Subject does not want to continue with Pi|1|||
145712228|NCT00356408|525461447|FG000|Overall Study|Adverse Event|9|||
145712229|NCT00356408|525461447|FG000|Overall Study|Lack of Efficacy|36|||
145712230|NCT00356408|525461447|FG000|Overall Study|Lost to Follow-up|2|||
145712231|NCT00356408|525461447|FG000|Overall Study|Withdrawal by Subject|6|||
145712232|NCT00356408|525461447|FG000|Overall Study|Other: Principal investigator discretion|3|||
145712233|NCT00356408|525461447|FG000|Overall Study|Other: Sponsor request|1|||
145712234|NCT00356408|525461447|FG000|Overall Study|Other: Azathioprine stopped|1|||
145712235|NCT00356408|525461447|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
145712236|NCT00356408|525461447|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
145712237|NCT01156376|525461449|FG000|Overall Study|Adverse Event|1|||
145712238|NCT01156376|525461450|FG001|Overall Study|Adverse Event|0|||
145712239|NCT01156376|525461451|FG002|Overall Study|Adverse Event|1|||
145712240|NCT01156376|525461449|FG000|Overall Study|Withdrawal by Subject|0|||
145712241|NCT01156376|525461450|FG001|Overall Study|Withdrawal by Subject|0|||
145712242|NCT01156376|525461451|FG002|Overall Study|Withdrawal by Subject|3|||
145712243|NCT00565773|525461452|FG000|Overall Study|Withdrawal by Subject|1|||
145712244|NCT00565773|525461452|FG000|Overall Study|Physician Decision|1|||
145712245|NCT05775991|525461453|FG000|Overall Study|Withdrawal by Subject|0|||
145712246|NCT05775991|525461454|FG001|Overall Study|Withdrawal by Subject|0|||
145712247|NCT05775991|525461455|FG002|Overall Study|Withdrawal by Subject|2|||
145712248|NCT00702962|525461456|FG000|Overall Study|Progressive disease|0|||
145712249|NCT00702962|525461457|FG001|Overall Study|Progressive disease|1|||
145712250|NCT00702962|525461456|FG000|Overall Study|Hospitalized for other health disorder|1|||
145712251|NCT00702962|525461457|FG001|Overall Study|Hospitalized for other health disorder|0|||
145712252|NCT02175641|525461459|FG000|Overall Study|Death|3|||
145712253|NCT02175641|525461460|FG001|Overall Study|Death|4|||
145712254|NCT02175641|525461459|FG000|Overall Study|Lost to Follow-up|4|||
145712255|NCT02175641|525461460|FG001|Overall Study|Lost to Follow-up|4|||
145712256|NCT02175641|525461459|FG000|Overall Study|Withdrawal by Subject|7|||
145712257|NCT02175641|525461460|FG001|Overall Study|Withdrawal by Subject|4|||
145712258|NCT02175641|525461459|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
145712259|NCT02175641|525461460|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
145712260|NCT02175641|525461459|FG000|Overall Study|Developed Contraindicated Condition|8|||
145712261|NCT02175641|525461460|FG001|Overall Study|Developed Contraindicated Condition|0|||
145712262|NCT01923467|525461463|FG000|Overall Study|Lost to Follow-up|62|||
145712263|NCT01923467|525461463|FG000|Overall Study|Subject non-interest|479|||
145712264|NCT01075958|525461464|FG000|Overall Study|Blood sample could not be obtained|44|||
145712265|NCT00643617|525461465|FG000|Overall Study|Death|6|||
145712266|NCT00643617|525461466|FG001|Overall Study|Death|9|||
145712267|NCT00643617|525461465|FG000|Overall Study|Lost to Follow-up|42|||
145712268|NCT00643617|525461466|FG001|Overall Study|Lost to Follow-up|51|||
145712269|NCT02075073|525461467|FG000|Overall Study|Withdrawal by Subject|0|||
145712270|NCT02075073|525461468|FG001|Overall Study|Withdrawal by Subject|1|||
145712271|NCT02075073|525461469|FG002|Overall Study|Withdrawal by Subject|0|||
145712272|NCT00416195|525461485|FG000|Overall Study|Adverse Event|1|||
145712273|NCT00416195|525461486|FG001|Overall Study|Adverse Event|2|||
145712274|NCT00416195|525461485|FG000|Overall Study|Protocol Violation|1|||
145712275|NCT00416195|525461486|FG001|Overall Study|Protocol Violation|1|||
145712276|NCT00416195|525461485|FG000|Overall Study|Other|0|||
145712277|NCT00416195|525461486|FG001|Overall Study|Other|1|||
145712278|NCT03361605|525461491|FG000|Overall Study|Analyzable data not available|3|||
145712279|NCT00831129|525461494|FG000|Overall Study|Adverse Event|0|||
145712280|NCT00831129|525461495|FG001|Overall Study|Adverse Event|1|||
145712281|NCT00831129|525461494|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
145712282|NCT00831129|525461495|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
145712283|NCT01877239|525461497|FG000|Overall Study|Adverse Event|4|||
145712284|NCT01877239|525461497|FG000|Overall Study|Disease Remission|1|||
145712285|NCT01877239|525461497|FG000|Overall Study|Withdrawal by Subject|4|||
145712286|NCT01877239|525461497|FG000|Overall Study|Other|2|||
145712287|NCT01877239|525461497|FG000|Overall Study|Lack of Efficacy|4|||
145712288|NCT01877239|525461497|FG000|Overall Study|Data not available|35|||
145712289|NCT04531904|525461500|FG000|Overall Study|Lost to Follow-up|1|||
145712290|NCT04531904|525461500|FG000|Overall Study|Death|14|||
145712291|NCT02145468|525461501|FG000|Overall Study|Withdrawal by Subject|5|||
145712292|NCT02145468|525461502|FG001|Overall Study|Withdrawal by Subject|8|||
145712293|NCT04372121|525461509|FG000|Overall Study|Lost to Follow-up|0|||
145712294|NCT04372121|525461510|FG001|Overall Study|Lost to Follow-up|0|||
145712295|NCT04372121|525461511|FG002|Overall Study|Lost to Follow-up|0|||
145712296|NCT04372121|525461512|FG003|Overall Study|Lost to Follow-up|1|||
145712297|NCT04372121|525461509|FG000|Overall Study|Protocol Violation|0|||
145712298|NCT04372121|525461510|FG001|Overall Study|Protocol Violation|0|||
145712299|NCT04372121|525461511|FG002|Overall Study|Protocol Violation|1|||
145712300|NCT04372121|525461512|FG003|Overall Study|Protocol Violation|0|||
145712301|NCT04372121|525461509|FG000|Overall Study|Withdrawal by Subject|3|||
145712302|NCT04372121|525461510|FG001|Overall Study|Withdrawal by Subject|1|||
145712303|NCT04372121|525461511|FG002|Overall Study|Withdrawal by Subject|0|||
145712304|NCT04372121|525461512|FG003|Overall Study|Withdrawal by Subject|0|||
145712305|NCT04372121|525461509|FG000|Overall Study|Study termination|6|||
145712306|NCT04372121|525461510|FG001|Overall Study|Study termination|5|||
145712307|NCT04372121|525461511|FG002|Overall Study|Study termination|1|||
145712308|NCT04372121|525461512|FG003|Overall Study|Study termination|1|||
145712309|NCT04372121|525461509|FG000|Overall Study|Hysterectomy planned|1|||
145712310|NCT04372121|525461510|FG001|Overall Study|Hysterectomy planned|0|||
145712311|NCT04372121|525461511|FG002|Overall Study|Hysterectomy planned|0|||
145712312|NCT04372121|525461512|FG003|Overall Study|Hysterectomy planned|0|||
145712313|NCT01967147|525463064|FG000|Overall Study|Adverse Event|5|||
145712314|NCT01967147|525463065|FG001|Overall Study|Adverse Event|2|||
145712315|NCT01967147|525463064|FG000|Overall Study|Lack of Efficacy|1|||
145712316|NCT01967147|525463065|FG001|Overall Study|Lack of Efficacy|4|||
145712317|NCT01967147|525463064|FG000|Overall Study|Lost to Follow-up|1|||
145712318|NCT01967147|525463065|FG001|Overall Study|Lost to Follow-up|2|||
145712319|NCT01967147|525463064|FG000|Overall Study|Withdrawal by Subject|2|||
145712320|NCT01967147|525463065|FG001|Overall Study|Withdrawal by Subject|4|||
145712321|NCT01967147|525463064|FG000|Overall Study|Non-compliance with Study Drug|0|||
145712322|NCT01967147|525463065|FG001|Overall Study|Non-compliance with Study Drug|3|||
145712323|NCT01967147|525463064|FG000|Overall Study|Other|4|||
145712324|NCT01967147|525463065|FG001|Overall Study|Other|5|||
145712325|NCT03986944|525463068|FG000|Overall Study|Adverse Event|1|||
145712326|NCT03986944|525463069|FG001|Overall Study|Adverse Event|2|||
145712327|NCT03986944|525463070|FG002|Overall Study|Adverse Event|3|||
145712328|NCT03986944|525463068|FG000|Overall Study|Protocol Violation|0|||
145712329|NCT03986944|525463069|FG001|Overall Study|Protocol Violation|1|||
145712330|NCT03986944|525463070|FG002|Overall Study|Protocol Violation|1|||
145712331|NCT03986944|525463068|FG000|Overall Study|Withdrawal by Subject|3|||
145712332|NCT03986944|525463069|FG001|Overall Study|Withdrawal by Subject|5|||
145712333|NCT03986944|525463070|FG002|Overall Study|Withdrawal by Subject|5|||
145712334|NCT03986944|525463068|FG000|Overall Study|Study termination|10|||
145712335|NCT03986944|525463069|FG001|Overall Study|Study termination|10|||
145712336|NCT03986944|525463070|FG002|Overall Study|Study termination|10|||
145712337|NCT03986944|525463068|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
145712338|NCT03986944|525463069|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
145712339|NCT03986944|525463070|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
145712340|NCT03986944|525463068|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
145712341|NCT03986944|525463069|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
145712342|NCT03986944|525463070|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
145712343|NCT01302080|525463076|FG000|Overall Study|Withdrew Consent|92|||
145712344|NCT01302080|525463077|FG001|Overall Study|Withdrew Consent|39|||
145712345|NCT01302080|525463076|FG000|Overall Study|Patient/Family Moved|28|||
145712346|NCT01302080|525463077|FG001|Overall Study|Patient/Family Moved|3|||
145712347|NCT01302080|525463076|FG000|Overall Study|Lost to Follow-up|192|||
145712348|NCT01302080|525463077|FG001|Overall Study|Lost to Follow-up|93|||
145712349|NCT01302080|525463076|FG000|Overall Study|Death|1|||
145712350|NCT01302080|525463077|FG001|Overall Study|Death|0|||
145712351|NCT01302080|525463076|FG000|Overall Study|Other|52|||
145712352|NCT01302080|525463077|FG001|Overall Study|Other|8|||
145712353|NCT01302080|525463076|FG000|Overall Study|Reason Missing For Discontinuation|1|||
145712354|NCT01302080|525463077|FG001|Overall Study|Reason Missing For Discontinuation|0|||
145712355|NCT01305408|525463085|FG000|Overall Study|Adverse Event|10|||
145712356|NCT01305408|525463086|FG001|Overall Study|Adverse Event|7|||
145712357|NCT01305408|525463085|FG000|Overall Study|Lack of Efficacy|3|||
145712358|NCT01305408|525463086|FG001|Overall Study|Lack of Efficacy|4|||
145712359|NCT01305408|525463085|FG000|Overall Study|Withdrawal by Subject|9|||
145712360|NCT01305408|525463086|FG001|Overall Study|Withdrawal by Subject|9|||
145712361|NCT01305408|525463085|FG000|Overall Study|Protocol Violation|4|||
145712362|NCT01305408|525463086|FG001|Overall Study|Protocol Violation|6|||
145712363|NCT01305408|525463085|FG000|Overall Study|Lost to Follow-up|5|||
145712364|NCT01305408|525463086|FG001|Overall Study|Lost to Follow-up|3|||
145712365|NCT01305408|525463085|FG000|Overall Study|Noncompliance with study medication|0|||
145712366|NCT01305408|525463086|FG001|Overall Study|Noncompliance with study medication|1|||
145712367|NCT01305408|525463085|FG000|Overall Study|Noncompliance with study procedures|0|||
145712368|NCT01305408|525463086|FG001|Overall Study|Noncompliance with study procedures|1|||
145712369|NCT01305408|525463085|FG000|Overall Study|Other|1|||
145712370|NCT01305408|525463086|FG001|Overall Study|Other|0|||
145712371|NCT03101462|525463087|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
145712372|NCT03101462|525463088|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
145712373|NCT02530970|525463089|FG000|Overall Study|Adverse Event|8|||
145712374|NCT02530970|525463089|FG000|Overall Study|Lost to Follow-up|88|||
145712375|NCT02530970|525463089|FG000|Overall Study|Physician Decision|5|||
145712376|NCT02530970|525463089|FG000|Overall Study|Withdrawal by Subject|14|||
145712377|NCT02530970|525463089|FG000|Overall Study|Death|6|||
145712378|NCT02530970|525463089|FG000|Overall Study|Hospitalization|1|||
145712379|NCT02530970|525463089|FG000|Overall Study|Insurance|2|||
145712380|NCT02530970|525463089|FG000|Overall Study|Explant|2|||
145712381|NCT02530970|525463089|FG000|Overall Study|Change in Provider|5|||
145712382|NCT02530970|525463089|FG000|Overall Study|Relocation|3|||
145712383|NCT02770612|525463091|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
145712384|NCT03846453|525463093|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
145712385|NCT03846453|525463094|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
145712386|NCT03846453|525463095|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
145712387|NCT03846453|525463093|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
145712388|NCT03846453|525463094|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
145712389|NCT03846453|525463095|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
145712390|NCT03846453|525463093|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
145712391|NCT03846453|525463094|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
145712392|NCT03846453|525463095|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
145712393|NCT03846453|525463093|FG000|Placebo Run-in (14 Days)|Other|2|||
145712394|NCT03846453|525463094|FG001|Placebo Run-in (14 Days)|Other|0|||
145712395|NCT03846453|525463095|FG002|Placebo Run-in (14 Days)|Other|0|||
145712396|NCT03846453|525463093|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
145712397|NCT03846453|525463094|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
145712398|NCT03846453|525463095|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
145712399|NCT03846453|525463093|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
145712400|NCT03846453|525463094|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
145712401|NCT03846453|525463095|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
145712402|NCT03846453|525463093|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
145712403|NCT03846453|525463094|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
145712404|NCT03846453|525463095|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
145712405|NCT03846453|525463093|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
145712406|NCT03846453|525463094|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
145712407|NCT03846453|525463095|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
145712408|NCT03846453|525463093|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
145712409|NCT03846453|525463094|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
145712410|NCT03846453|525463095|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
145712411|NCT00468143|525463096|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
145712412|NCT00468143|525463097|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
145712413|NCT00468143|525463096|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
145712414|NCT00468143|525463097|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
145712415|NCT01606670|525463098|FG000|Overall Study|Adverse Event|6|||
145712416|NCT01606670|525463098|FG000|Overall Study|Lack of Efficacy|2|||
145712417|NCT01606670|525463098|FG000|Overall Study|Lost to Follow-up|3|||
145712418|NCT01606670|525463098|FG000|Overall Study|Withdrawal by Subject|3|||
145712419|NCT01606670|525463098|FG000|Overall Study|Other Reason|2|||
145712420|NCT02636725|525463099|FG000|Overall Study|Adverse Event|1|||
145712421|NCT03653208|525463102|FG000|Overall Study|Withdrawal by Subject|0|||
145712422|NCT03653208|525463103|FG001|Overall Study|Withdrawal by Subject|0|||
145712423|NCT03653208|525463104|FG002|Overall Study|Withdrawal by Subject|0|||
145712424|NCT03653208|525463105|FG003|Overall Study|Withdrawal by Subject|0|||
145712425|NCT03653208|525463106|FG004|Overall Study|Withdrawal by Subject|1|||
145712426|NCT03653208|525463107|FG005|Overall Study|Withdrawal by Subject|0|||
145712427|NCT03653208|525463108|FG006|Overall Study|Withdrawal by Subject|0|||
145712428|NCT03653208|525463109|FG007|Overall Study|Withdrawal by Subject|1|||
145712429|NCT03653208|525463110|FG008|Overall Study|Withdrawal by Subject|1|||
145712430|NCT01696045|525463112|FG000|Overall Study|Study drug toxicity|1|||
145712431|NCT01696045|525463113|FG001|Overall Study|Study drug toxicity|5|||
145712432|NCT01696045|525463112|FG000|Overall Study|Disease progression|2|||
145712433|NCT01696045|525463113|FG001|Overall Study|Disease progression|2|||
145712434|NCT01152814|525463115|FG000|Overall Study|Lost to Follow-up|2|||
145712435|NCT01283516|525463118|FG000|Overall Study|Adverse Event|0|||
145712436|NCT01283516|525463119|FG001|Overall Study|Adverse Event|0|||
145712437|NCT01283516|525463120|FG002|Overall Study|Adverse Event|0|||
145712438|NCT01283516|525463121|FG003|Overall Study|Adverse Event|0|||
145712439|NCT01283516|525463122|FG004|Overall Study|Adverse Event|0|||
145712440|NCT01283516|525463123|FG005|Overall Study|Adverse Event|0|||
145712441|NCT01283516|525463124|FG006|Overall Study|Adverse Event|2|||
145712442|NCT01283516|525463125|FG007|Overall Study|Adverse Event|0|||
145712443|NCT01283516|525463126|FG008|Overall Study|Adverse Event|28|||
145712444|NCT01283516|525463118|FG000|Overall Study|Death|0|||
145712445|NCT01283516|525463119|FG001|Overall Study|Death|0|||
145712446|NCT01283516|525463120|FG002|Overall Study|Death|0|||
145712447|NCT01283516|525463121|FG003|Overall Study|Death|0|||
145712448|NCT01283516|525463122|FG004|Overall Study|Death|0|||
145712449|NCT01283516|525463123|FG005|Overall Study|Death|1|||
145712450|NCT01283516|525463124|FG006|Overall Study|Death|0|||
145712451|NCT01283516|525463125|FG007|Overall Study|Death|1|||
145712452|NCT01283516|525463126|FG008|Overall Study|Death|12|||
145712453|NCT01283516|525463118|FG000|Overall Study|Disease Progression|2|||
145712454|NCT01283516|525463119|FG001|Overall Study|Disease Progression|2|||
145712455|NCT01283516|525463120|FG002|Overall Study|Disease Progression|3|||
145712456|NCT01283516|525463121|FG003|Overall Study|Disease Progression|3|||
145712457|NCT01283516|525463122|FG004|Overall Study|Disease Progression|13|||
145712458|NCT01283516|525463123|FG005|Overall Study|Disease Progression|8|||
145712459|NCT01283516|525463124|FG006|Overall Study|Disease Progression|6|||
145712460|NCT01283516|525463125|FG007|Overall Study|Disease Progression|3|||
145712461|NCT01283516|525463126|FG008|Overall Study|Disease Progression|139|||
145712462|NCT01283516|525463118|FG000|Overall Study|Withdrawal by Subject|0|||
145712463|NCT01283516|525463119|FG001|Overall Study|Withdrawal by Subject|0|||
145712464|NCT01283516|525463120|FG002|Overall Study|Withdrawal by Subject|0|||
145712465|NCT01283516|525463121|FG003|Overall Study|Withdrawal by Subject|0|||
145712466|NCT01283516|525463122|FG004|Overall Study|Withdrawal by Subject|1|||
145712467|NCT01283516|525463123|FG005|Overall Study|Withdrawal by Subject|0|||
145712468|NCT01283516|525463124|FG006|Overall Study|Withdrawal by Subject|1|||
145712469|NCT01283516|525463125|FG007|Overall Study|Withdrawal by Subject|0|||
145712470|NCT01283516|525463126|FG008|Overall Study|Withdrawal by Subject|36|||
145712471|NCT01283516|525463118|FG000|Overall Study|Administrative problems|0|||
145712472|NCT01283516|525463119|FG001|Overall Study|Administrative problems|0|||
145712473|NCT01283516|525463120|FG002|Overall Study|Administrative problems|0|||
145712474|NCT01283516|525463121|FG003|Overall Study|Administrative problems|0|||
145712475|NCT01283516|525463122|FG004|Overall Study|Administrative problems|0|||
145712476|NCT01283516|525463123|FG005|Overall Study|Administrative problems|1|||
145712477|NCT01283516|525463124|FG006|Overall Study|Administrative problems|1|||
145712478|NCT01283516|525463125|FG007|Overall Study|Administrative problems|1|||
145712479|NCT01283516|525463126|FG008|Overall Study|Administrative problems|39|||
145712480|NCT01283516|525463118|FG000|Overall Study|Lost to Follow-up|0|||
145712481|NCT01283516|525463119|FG001|Overall Study|Lost to Follow-up|0|||
145712482|NCT01283516|525463120|FG002|Overall Study|Lost to Follow-up|0|||
145712483|NCT01283516|525463121|FG003|Overall Study|Lost to Follow-up|0|||
145712484|NCT01283516|525463122|FG004|Overall Study|Lost to Follow-up|0|||
145712485|NCT01283516|525463123|FG005|Overall Study|Lost to Follow-up|0|||
145712486|NCT01283516|525463124|FG006|Overall Study|Lost to Follow-up|0|||
145712487|NCT01283516|525463125|FG007|Overall Study|Lost to Follow-up|0|||
145712488|NCT01283516|525463126|FG008|Overall Study|Lost to Follow-up|1|||
145712489|NCT00132873|525463127|FG000|Overall Study|Adverse Event|3|||
145712490|NCT00132873|525463127|FG000|Overall Study|Lost to Follow-up|1|||
145712491|NCT00132873|525463127|FG000|Overall Study|Lack of Efficacy|1|||
145712492|NCT00132873|525463127|FG000|Overall Study|Withdrawal by Subject|3|||
145712493|NCT00132873|525463127|FG000|Overall Study|Planned Pregnancy|1|||
145712494|NCT01204710|525463131|FG000|Randomization Treatment|Lost to Follow-up|1|||
145712495|NCT01204710|525463132|FG001|Randomization Treatment|Lost to Follow-up|0|||
145712496|NCT01204710|525463131|FG000|Randomization Treatment|Withdrawal by Subject|6|||
145491518|NCT04612725|524653831|FG004|Overall Study|Adverse Event|1|||
145712497|NCT01204710|525463132|FG001|Randomization Treatment|Withdrawal by Subject|5|||
145712498|NCT01204710|525463131|FG000|Randomization Treatment|Physician Decision|3|||
145712499|NCT01204710|525463132|FG001|Randomization Treatment|Physician Decision|2|||
145712500|NCT01204710|525463131|FG000|Randomization Treatment|Entry criteria not met|0|||
145712501|NCT01204710|525463132|FG001|Randomization Treatment|Entry criteria not met|1|||
145712502|NCT01204710|525463131|FG000|Randomization Treatment|Adverse Event|4|||
145712503|NCT01204710|525463132|FG001|Randomization Treatment|Adverse Event|2|||
145712504|NCT01204710|525463131|FG000|Randomization Treatment|Sponsor Decision|0|||
145712505|NCT01204710|525463132|FG001|Randomization Treatment|Sponsor Decision|1|||
145712506|NCT01204710|525463131|FG000|Randomization Treatment|Worsening of General condition|0|||
145712507|NCT01204710|525463132|FG001|Randomization Treatment|Worsening of General condition|1|||
145712508|NCT01204710|525463131|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
145712509|NCT01204710|525463132|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
145712510|NCT01204710|525463131|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
145712511|NCT01204710|525463132|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
145712512|NCT01204710|525463131|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
145712513|NCT01204710|525463132|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
145712514|NCT01204710|525463131|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
145712515|NCT01204710|525463132|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
145712516|NCT00743431|525463133|FG000|Overall Study|Toxicity|6|||
145712517|NCT00743431|525463133|FG000|Overall Study|Tumor progression|56|||
145712518|NCT00743431|525463133|FG000|Overall Study|Withdrawal by Subject|13|||
145712519|NCT00743431|525463133|FG000|Overall Study|Death|9|||
145712520|NCT00743431|525463133|FG000|Overall Study|Reason for discontinuation not specified|29|||
145712521|NCT00743431|525463133|FG000|Overall Study|No documentation available|13|||
145712522|NCT03291288|525463134|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
145712523|NCT03291288|525463135|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
145712524|NCT03291288|525463134|FG000|Drug-drug Interaction Phase|Disease progression|1|||
145712525|NCT03291288|525463135|FG001|Drug-drug Interaction Phase|Disease progression|0|||
145712526|NCT03291288|525463134|FG000|Drug-drug Interaction Phase|Other|3|||
145712527|NCT03291288|525463135|FG001|Drug-drug Interaction Phase|Other|0|||
145712528|NCT03291288|525463134|FG000|Pexidartinib Only|Ongoing|0|||
145712529|NCT03291288|525463135|FG001|Pexidartinib Only|Ongoing|2|||
145712530|NCT04276415|525463136|FG000|Overall Study|Adverse Event|0|||
145712531|NCT04276415|525463137|FG001|Overall Study|Adverse Event|0|||
145712532|NCT04276415|525463138|FG002|Overall Study|Adverse Event|0|||
145712533|NCT04276415|525463139|FG003|Overall Study|Adverse Event|3|||
145712534|NCT04276415|525463140|FG004|Overall Study|Adverse Event|0|||
145712535|NCT04276415|525463141|FG005|Overall Study|Adverse Event|0|||
145712536|NCT04276415|525463136|FG000|Overall Study|Clinical progression|1|||
145712537|NCT04276415|525463137|FG001|Overall Study|Clinical progression|1|||
145712538|NCT04276415|525463138|FG002|Overall Study|Clinical progression|0|||
145712539|NCT04276415|525463139|FG003|Overall Study|Clinical progression|0|||
145712540|NCT04276415|525463140|FG004|Overall Study|Clinical progression|1|||
145712541|NCT04276415|525463141|FG005|Overall Study|Clinical progression|0|||
145712542|NCT04276415|525463136|FG000|Overall Study|Other|0|||
145712543|NCT04276415|525463137|FG001|Overall Study|Other|0|||
145712544|NCT04276415|525463138|FG002|Overall Study|Other|0|||
145712545|NCT04276415|525463139|FG003|Overall Study|Other|1|||
145712546|NCT04276415|525463140|FG004|Overall Study|Other|0|||
145712547|NCT04276415|525463141|FG005|Overall Study|Other|0|||
145712548|NCT04276415|525463136|FG000|Overall Study|Physician Decision|0|||
145712549|NCT04276415|525463137|FG001|Overall Study|Physician Decision|0|||
145712550|NCT04276415|525463138|FG002|Overall Study|Physician Decision|1|||
145712551|NCT04276415|525463139|FG003|Overall Study|Physician Decision|3|||
145712552|NCT04276415|525463140|FG004|Overall Study|Physician Decision|2|||
145712553|NCT04276415|525463141|FG005|Overall Study|Physician Decision|0|||
145712554|NCT04276415|525463136|FG000|Overall Study|Progressive disease|3|||
145712555|NCT04276415|525463137|FG001|Overall Study|Progressive disease|3|||
145712556|NCT04276415|525463138|FG002|Overall Study|Progressive disease|4|||
145712557|NCT04276415|525463139|FG003|Overall Study|Progressive disease|5|||
145712558|NCT04276415|525463140|FG004|Overall Study|Progressive disease|1|||
145712559|NCT04276415|525463141|FG005|Overall Study|Progressive disease|2|||
145712560|NCT04276415|525463136|FG000|Overall Study|Withdrawal by patient|0|||
145712561|NCT04276415|525463137|FG001|Overall Study|Withdrawal by patient|0|||
145712562|NCT04276415|525463138|FG002|Overall Study|Withdrawal by patient|0|||
145712563|NCT04276415|525463139|FG003|Overall Study|Withdrawal by patient|1|||
145712564|NCT04276415|525463140|FG004|Overall Study|Withdrawal by patient|2|||
145712565|NCT04276415|525463141|FG005|Overall Study|Withdrawal by patient|0|||
145712566|NCT01896726|525463142|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
145712567|NCT01896726|525463142|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
145712568|NCT02406677|525463143|FG000|Overall Study|Death|16|||
145712569|NCT02406677|525463144|FG001|Overall Study|Death|8|||
145712570|NCT02406677|525463143|FG000|Overall Study|Discharged without P2Y12|1|||
145712571|NCT02406677|525463144|FG001|Overall Study|Discharged without P2Y12|3|||
145712572|NCT02406677|525463143|FG000|Overall Study|Discharged on prasugrel|283|||
145712573|NCT02406677|525463144|FG001|Overall Study|Discharged on prasugrel|587|||
145712574|NCT02406677|525463143|FG000|Overall Study|Withdrawal by Subject|1|||
145712575|NCT02406677|525463144|FG001|Overall Study|Withdrawal by Subject|0|||
145712576|NCT01114880|525463145|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
145712577|NCT01114880|525463146|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
145712578|NCT01114880|525463145|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
145712579|NCT01114880|525463146|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
145712580|NCT01114880|525463145|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
145712581|NCT01114880|525463146|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
145712582|NCT01114880|525463145|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
145712583|NCT01114880|525463146|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
145712584|NCT01114880|525463145|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
145712585|NCT01114880|525463146|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
145712586|NCT01114880|525463145|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
145712587|NCT01114880|525463146|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
145712588|NCT04531098|525463150|FG000|Stage I|Adverse Event|0|||
145712589|NCT04531098|525463151|FG001|Stage I|Adverse Event|0|||
145712590|NCT04531098|525463152|FG002|Stage I|Adverse Event|3|||
145712591|NCT04531098|525463150|FG000|Stage I|Protocol Violation|0|||
145712592|NCT04531098|525463151|FG001|Stage I|Protocol Violation|0|||
145712593|NCT04531098|525463152|FG002|Stage I|Protocol Violation|5|||
145712594|NCT04531098|525463150|FG000|Stage I|Withdrawal by Subject|0|||
145712595|NCT04531098|525463151|FG001|Stage I|Withdrawal by Subject|5|||
145712596|NCT04531098|525463152|FG002|Stage I|Withdrawal by Subject|10|||
145712597|NCT04531098|525463150|FG000|Stage II|Adverse Event|1|||
145712598|NCT04531098|525463151|FG001|Stage II|Adverse Event|2|||
145712599|NCT04531098|525463152|FG002|Stage II|Adverse Event|0|||
145712600|NCT04531098|525463150|FG000|Stage II|Protocol Violation|1|||
145712601|NCT04531098|525463151|FG001|Stage II|Protocol Violation|2|||
145712602|NCT04531098|525463152|FG002|Stage II|Protocol Violation|0|||
145712603|NCT04531098|525463150|FG000|Stage II|Withdrawal by Subject|3|||
145712604|NCT04531098|525463151|FG001|Stage II|Withdrawal by Subject|1|||
145712605|NCT04531098|525463152|FG002|Stage II|Withdrawal by Subject|0|||
145712606|NCT04531098|525463150|FG000|Stage II|Moved from study area|8|||
145712607|NCT04531098|525463151|FG001|Stage II|Moved from study area|5|||
145712608|NCT04531098|525463152|FG002|Stage II|Moved from study area|0|||
145712609|NCT00283244|525463153|FG000|Overall Study|Adverse Event|0|||
145712610|NCT00283244|525463154|FG001|Overall Study|Adverse Event|8|||
145712611|NCT00283244|525463155|FG002|Overall Study|Adverse Event|11|||
145712612|NCT00283244|525463153|FG000|Overall Study|Death|4|||
145712613|NCT00283244|525463154|FG001|Overall Study|Death|3|||
145712614|NCT00283244|525463155|FG002|Overall Study|Death|2|||
145712615|NCT00283244|525463153|FG000|Overall Study|Lack of Efficacy|8|||
145712616|NCT00283244|525463154|FG001|Overall Study|Lack of Efficacy|32|||
145712617|NCT00283244|525463155|FG002|Overall Study|Lack of Efficacy|26|||
145712618|NCT00283244|525463153|FG000|Overall Study|Withdrawal by Subject|1|||
145712619|NCT00283244|525463154|FG001|Overall Study|Withdrawal by Subject|2|||
145712620|NCT00283244|525463155|FG002|Overall Study|Withdrawal by Subject|2|||
145712621|NCT00283244|525463153|FG000|Overall Study|Physician Decision|0|||
145712622|NCT00283244|525463154|FG001|Overall Study|Physician Decision|0|||
145712623|NCT00283244|525463155|FG002|Overall Study|Physician Decision|1|||
145712624|NCT00283244|525463153|FG000|Overall Study|Medical illness (other complicating dz)|4|||
145712625|NCT00283244|525463154|FG001|Overall Study|Medical illness (other complicating dz)|3|||
145712626|NCT00283244|525463155|FG002|Overall Study|Medical illness (other complicating dz)|6|||
145712627|NCT00283244|525463153|FG000|Overall Study|Clinical deterioration|1|||
145712628|NCT00283244|525463154|FG001|Overall Study|Clinical deterioration|3|||
145712629|NCT00283244|525463155|FG002|Overall Study|Clinical deterioration|3|||
145712630|NCT02628028|525463156|FG000|Dosing Period|Withdrawal by Subject|0|||
145712631|NCT02628028|525463157|FG001|Dosing Period|Withdrawal by Subject|0|||
145712632|NCT02628028|525463158|FG002|Dosing Period|Withdrawal by Subject|1|||
145712633|NCT02628028|525463159|FG003|Dosing Period|Withdrawal by Subject|0|||
145712634|NCT02628028|525463160|FG004|Dosing Period|Withdrawal by Subject|2|||
145712635|NCT02628028|525463161|FG005|Dosing Period|Withdrawal by Subject|4|||
145712636|NCT02628028|525463162|FG006|Dosing Period|Withdrawal by Subject|1|||
145712637|NCT02628028|525463163|FG007|Dosing Period|Withdrawal by Subject|1|||
145712638|NCT02628028|525463156|FG000|Dosing Period|Adverse Event|0|||
145712639|NCT02628028|525463157|FG001|Dosing Period|Adverse Event|0|||
145712640|NCT02628028|525463158|FG002|Dosing Period|Adverse Event|0|||
145712641|NCT02628028|525463159|FG003|Dosing Period|Adverse Event|0|||
145712642|NCT02628028|525463160|FG004|Dosing Period|Adverse Event|2|||
145712643|NCT02628028|525463161|FG005|Dosing Period|Adverse Event|1|||
145712644|NCT02628028|525463162|FG006|Dosing Period|Adverse Event|3|||
145712645|NCT02628028|525463163|FG007|Dosing Period|Adverse Event|2|||
145712646|NCT02628028|525463156|FG000|Dosing Period|Death|0|||
145712647|NCT02628028|525463157|FG001|Dosing Period|Death|0|||
145712648|NCT02628028|525463158|FG002|Dosing Period|Death|0|||
145712649|NCT02628028|525463159|FG003|Dosing Period|Death|0|||
145712650|NCT02628028|525463160|FG004|Dosing Period|Death|0|||
145712651|NCT02628028|525463161|FG005|Dosing Period|Death|0|||
145712652|NCT02628028|525463162|FG006|Dosing Period|Death|0|||
145712653|NCT02628028|525463163|FG007|Dosing Period|Death|1|||
145712654|NCT02628028|525463156|FG000|Dosing Period|Lack of Efficacy|0|||
145712655|NCT02628028|525463157|FG001|Dosing Period|Lack of Efficacy|0|||
145712656|NCT02628028|525463158|FG002|Dosing Period|Lack of Efficacy|0|||
145712657|NCT02628028|525463159|FG003|Dosing Period|Lack of Efficacy|0|||
145712658|NCT02628028|525463160|FG004|Dosing Period|Lack of Efficacy|3|||
145712659|NCT02628028|525463161|FG005|Dosing Period|Lack of Efficacy|0|||
145712660|NCT02628028|525463162|FG006|Dosing Period|Lack of Efficacy|1|||
145712661|NCT02628028|525463163|FG007|Dosing Period|Lack of Efficacy|0|||
145712662|NCT02628028|525463156|FG000|Dosing Period|Study Terminated by Sponsor|0|||
145712663|NCT02628028|525463157|FG001|Dosing Period|Study Terminated by Sponsor|0|||
145712664|NCT02628028|525463158|FG002|Dosing Period|Study Terminated by Sponsor|0|||
145712665|NCT02628028|525463159|FG003|Dosing Period|Study Terminated by Sponsor|0|||
145712666|NCT02628028|525463160|FG004|Dosing Period|Study Terminated by Sponsor|7|||
145712667|NCT02628028|525463161|FG005|Dosing Period|Study Terminated by Sponsor|6|||
145712668|NCT02628028|525463162|FG006|Dosing Period|Study Terminated by Sponsor|7|||
145712669|NCT02628028|525463163|FG007|Dosing Period|Study Terminated by Sponsor|7|||
145712670|NCT02628028|525463156|FG000|Dosing Period|Physician Decision|0|||
145712671|NCT02628028|525463157|FG001|Dosing Period|Physician Decision|0|||
145712672|NCT02628028|525463158|FG002|Dosing Period|Physician Decision|0|||
145712673|NCT02628028|525463159|FG003|Dosing Period|Physician Decision|0|||
145712674|NCT02628028|525463160|FG004|Dosing Period|Physician Decision|0|||
145712675|NCT02628028|525463161|FG005|Dosing Period|Physician Decision|1|||
145712676|NCT02628028|525463162|FG006|Dosing Period|Physician Decision|0|||
145712677|NCT02628028|525463163|FG007|Dosing Period|Physician Decision|0|||
145712678|NCT02628028|525463156|FG000|Dosing Period|Site Terminated by Sponsor|0|||
145712679|NCT02628028|525463157|FG001|Dosing Period|Site Terminated by Sponsor|0|||
145712680|NCT02628028|525463158|FG002|Dosing Period|Site Terminated by Sponsor|0|||
145712681|NCT02628028|525463159|FG003|Dosing Period|Site Terminated by Sponsor|0|||
145712682|NCT02628028|525463160|FG004|Dosing Period|Site Terminated by Sponsor|0|||
145712683|NCT02628028|525463161|FG005|Dosing Period|Site Terminated by Sponsor|1|||
145712684|NCT02628028|525463162|FG006|Dosing Period|Site Terminated by Sponsor|1|||
145712685|NCT02628028|525463163|FG007|Dosing Period|Site Terminated by Sponsor|0|||
145712686|NCT02628028|525463156|FG000|Dosing Period|Lost to Follow-up|0|||
145712687|NCT02628028|525463157|FG001|Dosing Period|Lost to Follow-up|0|||
145712688|NCT02628028|525463158|FG002|Dosing Period|Lost to Follow-up|0|||
145712689|NCT02628028|525463159|FG003|Dosing Period|Lost to Follow-up|0|||
145712690|NCT02628028|525463160|FG004|Dosing Period|Lost to Follow-up|0|||
145712691|NCT02628028|525463161|FG005|Dosing Period|Lost to Follow-up|0|||
145712692|NCT02628028|525463162|FG006|Dosing Period|Lost to Follow-up|1|||
145712693|NCT02628028|525463163|FG007|Dosing Period|Lost to Follow-up|0|||
145712694|NCT02628028|525463156|FG000|Dosing Period|Other|0|||
145712695|NCT02628028|525463157|FG001|Dosing Period|Other|0|||
145712696|NCT02628028|525463158|FG002|Dosing Period|Other|0|||
145712697|NCT02628028|525463159|FG003|Dosing Period|Other|0|||
145712698|NCT02628028|525463160|FG004|Dosing Period|Other|2|||
145712699|NCT02628028|525463161|FG005|Dosing Period|Other|1|||
145712700|NCT02628028|525463162|FG006|Dosing Period|Other|2|||
145712701|NCT02628028|525463163|FG007|Dosing Period|Other|4|||
145712702|NCT02628028|525463156|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
145712703|NCT02628028|525463157|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
145712704|NCT02628028|525463158|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
145712705|NCT02628028|525463159|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
145712706|NCT02628028|525463160|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
145712707|NCT02628028|525463161|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
145712708|NCT02628028|525463162|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
145712709|NCT02628028|525463163|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
145712710|NCT02628028|525463156|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712711|NCT02628028|525463157|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712712|NCT02628028|525463158|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712713|NCT02628028|525463159|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712714|NCT02628028|525463160|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712715|NCT02628028|525463161|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
145712716|NCT02628028|525463162|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
145712717|NCT02628028|525463163|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
145712718|NCT02628028|525463156|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
145712719|NCT02628028|525463157|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
145712720|NCT02628028|525463158|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
145712721|NCT02628028|525463159|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
145712722|NCT02628028|525463160|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
145712723|NCT02628028|525463161|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
145712724|NCT02628028|525463162|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
145712725|NCT02628028|525463163|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
145712726|NCT02628028|525463156|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
145712727|NCT02628028|525463157|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
145712728|NCT02628028|525463158|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
145712729|NCT02628028|525463159|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
145712730|NCT02628028|525463160|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
145712731|NCT02628028|525463161|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
145712732|NCT02628028|525463162|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
145712733|NCT02628028|525463163|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
145712734|NCT02628028|525463156|FG000|Long-term Extension (LTE) Period|Other|0|||
145712735|NCT02628028|525463157|FG001|Long-term Extension (LTE) Period|Other|0|||
145712736|NCT02628028|525463158|FG002|Long-term Extension (LTE) Period|Other|0|||
145712737|NCT02628028|525463159|FG003|Long-term Extension (LTE) Period|Other|0|||
145712738|NCT02628028|525463160|FG004|Long-term Extension (LTE) Period|Other|0|||
145712739|NCT02628028|525463161|FG005|Long-term Extension (LTE) Period|Other|3|||
145712740|NCT02628028|525463162|FG006|Long-term Extension (LTE) Period|Other|4|||
145712741|NCT02628028|525463163|FG007|Long-term Extension (LTE) Period|Other|3|||
145712742|NCT00658788|525463164|FG000|Overall Study|Adverse Event|11|||
145712743|NCT00658788|525463164|FG000|Overall Study|Withdrawal by Subject|13|||
145712744|NCT00658788|525463164|FG000|Overall Study|Lost to Follow-up|18|||
145712745|NCT00658788|525463164|FG000|Overall Study|Treatment Discontinuation|32|||
145712746|NCT00653523|525463165|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
145712747|NCT00653523|525463165|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
145712748|NCT00653523|525463165|FG000|Overall Study|Adverse Event|7|||
145712749|NCT00653523|525463165|FG000|Overall Study|Withdrawal by Subject|6|||
145712750|NCT00653523|525463165|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
145712751|NCT00653523|525463165|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
145712752|NCT03519997|525463168|FG000|Overall Study|Adverse Event|4|||
145712753|NCT03519997|525463168|FG000|Overall Study|Withdrawal by Subject|2|||
145712754|NCT03519997|525463168|FG000|Overall Study|Protocol Violation|1|||
145712755|NCT05543707|525463169|FG000|Overall Study|Study drug non-compliance/|5|||
145712756|NCT05543707|525463170|FG001|Overall Study|Study drug non-compliance/|0|||
145712757|NCT05543707|525463169|FG000|Overall Study|Withdrawal by Subject|1|||
145712758|NCT05543707|525463170|FG001|Overall Study|Withdrawal by Subject|1|||
145712759|NCT05543707|525463169|FG000|Overall Study|Adverse Event|1|||
145712760|NCT05543707|525463170|FG001|Overall Study|Adverse Event|0|||
145712761|NCT05543707|525463169|FG000|Overall Study|concurrent illness|0|||
145712762|NCT05543707|525463170|FG001|Overall Study|concurrent illness|1|||
145712763|NCT05543707|525463169|FG000|Overall Study|Pregnancy|1|||
145712764|NCT05543707|525463170|FG001|Overall Study|Pregnancy|1|||
145712765|NCT00186888|525463171|FG000|Overall Study|Toxicity|0|||
145712766|NCT00186888|525463172|FG001|Overall Study|Toxicity|1|||
145712767|NCT00186888|525463173|FG002|Overall Study|Toxicity|0|||
145712768|NCT00186888|525463171|FG000|Overall Study|Relapse or progression of disease|4|||
145712769|NCT00186888|525463172|FG001|Overall Study|Relapse or progression of disease|2|||
145712770|NCT00186888|525463173|FG002|Overall Study|Relapse or progression of disease|0|||
145712771|NCT03898167|525463174|FG000|Overall Study|Terminated phone call early|7|||
145712772|NCT03898167|525463175|FG001|Overall Study|Terminated phone call early|0|||
145712773|NCT03898167|525463176|FG002|Overall Study|Terminated phone call early|0|||
145712774|NCT03898167|525463174|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
145712775|NCT03898167|525463175|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
145712776|NCT03898167|525463176|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
145712777|NCT00384397|525463177|FG000|Overall Study|Adverse Event|0|||
145712778|NCT00384397|525463178|FG001|Overall Study|Adverse Event|1|||
145712779|NCT00384397|525463179|FG002|Overall Study|Adverse Event|2|||
145712780|NCT00384397|525463177|FG000|Overall Study|Protocol Violation|7|||
145712781|NCT00384397|525463178|FG001|Overall Study|Protocol Violation|15|||
145712782|NCT00384397|525463179|FG002|Overall Study|Protocol Violation|13|||
145712783|NCT00384397|525463177|FG000|Overall Study|Lost to Follow-up|11|||
145712784|NCT00384397|525463178|FG001|Overall Study|Lost to Follow-up|13|||
145712785|NCT00384397|525463179|FG002|Overall Study|Lost to Follow-up|3|||
145712786|NCT00384397|525463177|FG000|Overall Study|Withdrawal by Subject|14|||
145712787|NCT00384397|525463178|FG001|Overall Study|Withdrawal by Subject|17|||
145712788|NCT00384397|525463179|FG002|Overall Study|Withdrawal by Subject|15|||
145712789|NCT01214642|525463180|FG000|Overall Study|Progressive Disease|3|||
145712790|NCT01214642|525463181|FG001|Overall Study|Progressive Disease|2|||
145712791|NCT01214642|525463182|FG002|Overall Study|Progressive Disease|3|||
145712792|NCT01214642|525463183|FG003|Overall Study|Progressive Disease|5|||
145712793|NCT01214642|525463184|FG004|Overall Study|Progressive Disease|5|||
145712794|NCT01214642|525463185|FG005|Overall Study|Progressive Disease|3|||
145712795|NCT01214642|525463186|FG006|Overall Study|Progressive Disease|5|||
145712796|NCT01214642|525463187|FG007|Overall Study|Progressive Disease|3|||
145712797|NCT01214642|525463188|FG008|Overall Study|Progressive Disease|10|||
145712798|NCT01214642|525463189|FG009|Overall Study|Progressive Disease|2|||
145712799|NCT01214642|525463190|FG010|Overall Study|Progressive Disease|1|||
145712800|NCT01214642|525463191|FG011|Overall Study|Progressive Disease|4|||
145712801|NCT01214642|525463180|FG000|Overall Study|Adverse Event|0|||
145712802|NCT01214642|525463181|FG001|Overall Study|Adverse Event|1|||
145712803|NCT01214642|525463182|FG002|Overall Study|Adverse Event|0|||
145712804|NCT01214642|525463183|FG003|Overall Study|Adverse Event|0|||
145712805|NCT01214642|525463184|FG004|Overall Study|Adverse Event|0|||
145712806|NCT01214642|525463185|FG005|Overall Study|Adverse Event|0|||
145712807|NCT01214642|525463186|FG006|Overall Study|Adverse Event|1|||
145712808|NCT01214642|525463187|FG007|Overall Study|Adverse Event|0|||
145712809|NCT01214642|525463188|FG008|Overall Study|Adverse Event|0|||
145712810|NCT01214642|525463189|FG009|Overall Study|Adverse Event|1|||
145712811|NCT01214642|525463190|FG010|Overall Study|Adverse Event|1|||
145712812|NCT01214642|525463191|FG011|Overall Study|Adverse Event|0|||
145712813|NCT01214642|525463180|FG000|Overall Study|Death|0|||
145712814|NCT01214642|525463181|FG001|Overall Study|Death|0|||
145712815|NCT01214642|525463182|FG002|Overall Study|Death|1|||
145712816|NCT01214642|525463183|FG003|Overall Study|Death|0|||
145712817|NCT01214642|525463184|FG004|Overall Study|Death|0|||
145712818|NCT01214642|525463185|FG005|Overall Study|Death|0|||
145712819|NCT01214642|525463186|FG006|Overall Study|Death|0|||
145712820|NCT01214642|525463187|FG007|Overall Study|Death|0|||
145712821|NCT01214642|525463188|FG008|Overall Study|Death|0|||
145712822|NCT01214642|525463189|FG009|Overall Study|Death|0|||
145712823|NCT01214642|525463190|FG010|Overall Study|Death|1|||
145712824|NCT01214642|525463191|FG011|Overall Study|Death|0|||
145712825|NCT01214642|525463180|FG000|Overall Study|Withdrawal by Subject|0|||
145712826|NCT01214642|525463181|FG001|Overall Study|Withdrawal by Subject|0|||
145712827|NCT01214642|525463182|FG002|Overall Study|Withdrawal by Subject|1|||
145712828|NCT01214642|525463183|FG003|Overall Study|Withdrawal by Subject|0|||
145712829|NCT01214642|525463184|FG004|Overall Study|Withdrawal by Subject|0|||
145712830|NCT01214642|525463185|FG005|Overall Study|Withdrawal by Subject|0|||
145712831|NCT01214642|525463186|FG006|Overall Study|Withdrawal by Subject|0|||
145712832|NCT01214642|525463187|FG007|Overall Study|Withdrawal by Subject|0|||
145712833|NCT01214642|525463188|FG008|Overall Study|Withdrawal by Subject|3|||
145712834|NCT01214642|525463189|FG009|Overall Study|Withdrawal by Subject|1|||
145712835|NCT01214642|525463190|FG010|Overall Study|Withdrawal by Subject|1|||
145712836|NCT01214642|525463191|FG011|Overall Study|Withdrawal by Subject|0|||
145712837|NCT01214642|525463180|FG000|Overall Study|Physician Decision|0|||
145712838|NCT01214642|525463181|FG001|Overall Study|Physician Decision|0|||
145712839|NCT01214642|525463182|FG002|Overall Study|Physician Decision|1|||
145712840|NCT01214642|525463183|FG003|Overall Study|Physician Decision|1|||
145712841|NCT01214642|525463184|FG004|Overall Study|Physician Decision|1|||
145712842|NCT01214642|525463185|FG005|Overall Study|Physician Decision|0|||
145712843|NCT01214642|525463186|FG006|Overall Study|Physician Decision|0|||
145712844|NCT01214642|525463187|FG007|Overall Study|Physician Decision|0|||
145712845|NCT01214642|525463188|FG008|Overall Study|Physician Decision|0|||
145712846|NCT01214642|525463189|FG009|Overall Study|Physician Decision|0|||
145712847|NCT01214642|525463190|FG010|Overall Study|Physician Decision|0|||
145712848|NCT01214642|525463191|FG011|Overall Study|Physician Decision|2|||
145712849|NCT01946529|525463194|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
145712850|NCT01946529|525463195|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
145712851|NCT01946529|525463196|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
145712852|NCT01946529|525463194|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
145712853|NCT01946529|525463195|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
145712854|NCT01946529|525463196|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
145712855|NCT03826030|525463201|FG000|Overall Study|Withdrawal by Subject|2|||
145712856|NCT03826030|525463202|FG001|Overall Study|Withdrawal by Subject|0|||
145712857|NCT03826030|525463203|FG002|Overall Study|Withdrawal by Subject|1|||
145712858|NCT03826030|525463201|FG000|Overall Study|Lost to Follow-up|1|||
145712859|NCT03826030|525463202|FG001|Overall Study|Lost to Follow-up|1|||
145712860|NCT03826030|525463203|FG002|Overall Study|Lost to Follow-up|1|||
145712861|NCT03826030|525463201|FG000|Overall Study|Too busy to return for visits|1|||
145712862|NCT03826030|525463202|FG001|Overall Study|Too busy to return for visits|0|||
145712863|NCT03826030|525463203|FG002|Overall Study|Too busy to return for visits|0|||
145712864|NCT04500769|525465324|FG000|Overall Study|Withdrawal by Subject|5|||
145712865|NCT03843554|525465325|FG000|Overall Study|Physician Decision|0|||
145712866|NCT03843554|525465326|FG001|Overall Study|Physician Decision|2|||
145712867|NCT01099215|525465327|FG000|Overall Study|Withdrawal by Subject|1|||
145712868|NCT01099215|525465328|FG001|Overall Study|Withdrawal by Subject|0|||
145712869|NCT01099215|525465327|FG000|Overall Study|Adverse Event|0|||
145712870|NCT01099215|525465328|FG001|Overall Study|Adverse Event|1|||
145712871|NCT02218606|525465329|FG000|Overall Study|Adverse Event|1|||
145712872|NCT02218606|525465330|FG001|Overall Study|Adverse Event|1|||
145712873|NCT02218606|525465329|FG000|Overall Study|Death|15|||
145712874|NCT02218606|525465330|FG001|Overall Study|Death|28|||
145712875|NCT02218606|525465329|FG000|Overall Study|Physician Decision|0|||
145712876|NCT02218606|525465330|FG001|Overall Study|Physician Decision|1|||
145712877|NCT02218606|525465329|FG000|Overall Study|Withdrawal by Subject|4|||
145712878|NCT02218606|525465330|FG001|Overall Study|Withdrawal by Subject|0|||
145712879|NCT02218606|525465329|FG000|Overall Study|Noncompliance|1|||
145712880|NCT02218606|525465330|FG001|Overall Study|Noncompliance|0|||
145712881|NCT02218606|525465329|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
145712882|NCT02218606|525465330|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
145712883|NCT02218606|525465329|FG000|Overall Study|Other|2|||
145712884|NCT02218606|525465330|FG001|Overall Study|Other|1|||
145712885|NCT02218606|525465329|FG000|Overall Study|Never started treatment|0|||
145712886|NCT02218606|525465330|FG001|Overall Study|Never started treatment|1|||
145712887|NCT04396366|525465337|FG000|Overall Study|Adverse Event|1|||
145712888|NCT04396366|525465338|FG001|Overall Study|Adverse Event|0|||
145712889|NCT00166712|525465340|FG000|Overall Study|Death|0|||
145712890|NCT00166712|525465341|FG001|Overall Study|Death|1|||
145712891|NCT00166712|525465340|FG000|Overall Study|Adverse Event|1|||
145712892|NCT00166712|525465341|FG001|Overall Study|Adverse Event|0|||
145712893|NCT00166712|525465340|FG000|Overall Study|Withdrawal by Subject|1|||
145712894|NCT00166712|525465341|FG001|Overall Study|Withdrawal by Subject|2|||
145712895|NCT00166712|525465340|FG000|Overall Study|Physician Decision|0|||
145712896|NCT00166712|525465341|FG001|Overall Study|Physician Decision|2|||
145712897|NCT04684394|525465342|FG000|Overall Study|Death|1|||
145712898|NCT04684394|525465343|FG001|Overall Study|Death|2|||
145712899|NCT04684394|525465342|FG000|Overall Study|Lost to Follow-up|1|||
145712900|NCT04684394|525465343|FG001|Overall Study|Lost to Follow-up|0|||
145712901|NCT04684394|525465342|FG000|Overall Study|Withdrawal by Subject|2|||
145712902|NCT04684394|525465343|FG001|Overall Study|Withdrawal by Subject|0|||
145712903|NCT04684394|525465342|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
145712904|NCT04684394|525465343|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
145712905|NCT03002220|525465344|FG000|Overall Study|Lack of Efficacy|2|||
145712906|NCT03002220|525465344|FG000|Overall Study|Withdrawal by Subject|3|||
145712907|NCT03002220|525465344|FG000|Overall Study|Adverse Event|2|||
145712908|NCT03002220|525465344|FG000|Overall Study|Disease progression|13|||
145712909|NCT03002220|525465344|FG000|Overall Study|Physician Decision|1|||
145712910|NCT00640133|525465345|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
145712911|NCT00640133|525465346|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
145712912|NCT00640133|525465345|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
145712913|NCT00640133|525465346|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
145712914|NCT00640133|525465345|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
145712915|NCT00640133|525465346|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
145712916|NCT01183260|525465347|FG000|Overall Study|Intraop screen failure|2|||
145712917|NCT01183260|525465348|FG001|Overall Study|Intraop screen failure|0|||
145712918|NCT01183260|525465347|FG000|Overall Study|Withdrawal by Subject|1|||
145712919|NCT01183260|525465348|FG001|Overall Study|Withdrawal by Subject|1|||
145712920|NCT01183260|525465347|FG000|Overall Study|Revised within 30 days|0|||
145712921|NCT01183260|525465348|FG001|Overall Study|Revised within 30 days|1|||
145712922|NCT01183260|525465347|FG000|Overall Study|Death|1|||
145712923|NCT01183260|525465348|FG001|Overall Study|Death|0|||
145712924|NCT00128102|525465349|FG000|Overall Study|Site Discontinued|3|||
145712925|NCT00128102|525465350|FG001|Overall Study|Site Discontinued|6|||
145712926|NCT00128102|525465349|FG000|Overall Study|Other|0|||
145712927|NCT00128102|525465350|FG001|Overall Study|Other|1|||
145712928|NCT00128102|525465349|FG000|Overall Study|Progressive Disease|255|||
145712929|NCT00128102|525465350|FG001|Overall Study|Progressive Disease|285|||
145712930|NCT00128102|525465349|FG000|Overall Study|Adverse Event|34|||
145712931|NCT00128102|525465350|FG001|Overall Study|Adverse Event|11|||
145712932|NCT00128102|525465349|FG000|Overall Study|Death|12|||
145712933|NCT00128102|525465350|FG001|Overall Study|Death|13|||
145712934|NCT00128102|525465349|FG000|Overall Study|Physician Decision|3|||
145712935|NCT00128102|525465350|FG001|Overall Study|Physician Decision|3|||
145712936|NCT00128102|525465349|FG000|Overall Study|Withdrawal by Subject|19|||
145712937|NCT00128102|525465350|FG001|Overall Study|Withdrawal by Subject|11|||
145712938|NCT00128102|525465349|FG000|Overall Study|Protocol Violation|2|||
145712939|NCT00128102|525465350|FG001|Overall Study|Protocol Violation|2|||
145712940|NCT01202903|525465351|FG000|Overall Study|Administrative Probelms|1|||
145712941|NCT01202903|525465352|FG001|Overall Study|Administrative Probelms|4|||
145712942|NCT01202903|525465351|FG000|Overall Study|Protocol Violation|0|||
145712943|NCT01202903|525465352|FG001|Overall Study|Protocol Violation|1|||
145712944|NCT01202903|525465351|FG000|Overall Study|Death|1|||
145712945|NCT01202903|525465352|FG001|Overall Study|Death|0|||
145712946|NCT01202903|525465351|FG000|Overall Study|Lost to Follow-up|1|||
145712947|NCT01202903|525465352|FG001|Overall Study|Lost to Follow-up|1|||
145712948|NCT01202903|525465351|FG000|Overall Study|Lack of Efficacy|1|||
145712949|NCT01202903|525465352|FG001|Overall Study|Lack of Efficacy|3|||
145712950|NCT01202903|525465351|FG000|Overall Study|Adverse Event|3|||
145712951|NCT01202903|525465352|FG001|Overall Study|Adverse Event|3|||
145712952|NCT01202903|525465351|FG000|Overall Study|Withdrawal by Subject|4|||
145712953|NCT01202903|525465352|FG001|Overall Study|Withdrawal by Subject|4|||
145712954|NCT02040259|525465355|FG000|Overall Study|Death|280|||
145712955|NCT02040259|525465355|FG000|Overall Study|Lost to Follow-up|76|||
145712956|NCT02040259|525465355|FG000|Overall Study|Assessment not completed|3|||
145712957|NCT02040259|525465355|FG000|Overall Study|Withdrawal by Subject|4|||
145712958|NCT04476251|525465356|FG000|Overall Study|Not treated|1|||
145712959|NCT00297427|525465364|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
145712960|NCT00297427|525465365|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
145712961|NCT00297427|525465364|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
145712962|NCT00297427|525465365|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
145712963|NCT00297427|525465364|FG000|Phase 1: Initial Intervention|Death|0|||
145712964|NCT00297427|525465365|FG001|Phase 1: Initial Intervention|Death|1|||
145712965|NCT00297427|525465364|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
145712966|NCT00297427|525465365|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
145712967|NCT00297427|525465364|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
145712968|NCT00297427|525465365|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
145712969|NCT00297427|525465364|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
145712970|NCT00297427|525465365|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
145712971|NCT00297427|525465364|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
145712972|NCT00297427|525465365|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
145712973|NCT00297427|525465364|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
145712974|NCT00297427|525465365|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
145712975|NCT01127893|525465366|FG000|Overall Study|Study Termination by the Sponsor|1|||
145712976|NCT05816330|525465370|FG000|Overall Study|Withdrawal by Subject|4|||
145712977|NCT05816330|525465371|FG001|Overall Study|Withdrawal by Subject|1|||
145712978|NCT00996476|525465372|FG000|Overall Study|Withdrawal by Subject|1|||
145712979|NCT00996476|525465373|FG001|Overall Study|Withdrawal by Subject|2|||
145712980|NCT00996476|525465374|FG002|Overall Study|Withdrawal by Subject|1|||
145712981|NCT00996476|525465375|FG003|Overall Study|Withdrawal by Subject|0|||
145712982|NCT00996476|525465376|FG004|Overall Study|Withdrawal by Subject|1|||
145712983|NCT00996476|525465372|FG000|Overall Study|Adverse Event|0|||
145712984|NCT00996476|525465373|FG001|Overall Study|Adverse Event|1|||
145712985|NCT00996476|525465374|FG002|Overall Study|Adverse Event|0|||
145712986|NCT00996476|525465375|FG003|Overall Study|Adverse Event|0|||
145712987|NCT00996476|525465376|FG004|Overall Study|Adverse Event|1|||
145712988|NCT03339583|525465379|FG000|First Intervention (14 Days)|Adverse Event|1|||
145712989|NCT03339583|525465380|FG001|First Intervention (14 Days)|Adverse Event|0|||
145712990|NCT03339583|525465379|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
145712991|NCT03339583|525465380|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
145712992|NCT03339583|525465379|FG000|Second Intervention (14 Days)|Adverse Event|0|||
145712993|NCT03339583|525465380|FG001|Second Intervention (14 Days)|Adverse Event|1|||
145712994|NCT03339583|525465379|FG000|Follow-up (14 Days)|Physician Decision|6|||
145712995|NCT03339583|525465380|FG001|Follow-up (14 Days)|Physician Decision|3|||
145712996|NCT01896557|525465381|FG000|Clopidogrel Alone|Adverse Event|1|||
145712997|NCT01896557|525465382|FG001|Clopidogrel Alone|Adverse Event|0|||
145712998|NCT01896557|525465381|FG000|Clopidogrel + GI Protector|low adherence|1|||
145712999|NCT01896557|525465382|FG001|Clopidogrel + GI Protector|low adherence|1|||
145713000|NCT01896557|525465381|FG000|Clopidogrel + GI Protector|Reading error|1|||
145713001|NCT01896557|525465382|FG001|Clopidogrel + GI Protector|Reading error|3|||
145713002|NCT00734591|525465383|FG000|Screening for Prospective Period|Site did not participate|1604|||
145713003|NCT00734591|525465384|FG001|Screening for Prospective Period|Site did not participate|1488|||
145713004|NCT00734591|525465383|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
145713005|NCT00734591|525465384|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
145713006|NCT00734591|525465383|FG000|Prospective Period|Withdrawal by Subject|11|||
145713007|NCT00734591|525465384|FG001|Prospective Period|Withdrawal by Subject|9|||
145713008|NCT00734591|525465383|FG000|Prospective Period|Lost to Follow-up|37|||
145713009|NCT00734591|525465384|FG001|Prospective Period|Lost to Follow-up|33|||
145713010|NCT00734591|525465383|FG000|Prospective Period|Study Terminated|1|||
145713011|NCT00734591|525465384|FG001|Prospective Period|Study Terminated|0|||
145713012|NCT00734591|525465383|FG000|Prospective Period|Other|2|||
145713013|NCT00734591|525465384|FG001|Prospective Period|Other|2|||
145713014|NCT02182947|525465385|FG000|Overall Study|Withdrawal by Subject|7|||
145713015|NCT02182947|525465385|FG000|Overall Study|Lost to Follow-up|3|||
145713016|NCT02182947|525465385|FG000|Overall Study|Failed screening activities|8|||
145713017|NCT01656200|525465386|FG000|Overall Study|Withdrawal by Subject|1|||
145713018|NCT02236988|525465387|FG000|Overall Study|Lost to Follow-up|0|||
145713019|NCT02236988|525465388|FG001|Overall Study|Lost to Follow-up|0|||
145713020|NCT02236988|525465389|FG002|Overall Study|Lost to Follow-up|0|||
145713021|NCT02236988|525465390|FG003|Overall Study|Lost to Follow-up|1|||
145713022|NCT02236988|525465387|FG000|Overall Study|Unable to Comply with Study Visits|0|||
145713023|NCT02236988|525465388|FG001|Overall Study|Unable to Comply with Study Visits|0|||
145713024|NCT02236988|525465389|FG002|Overall Study|Unable to Comply with Study Visits|0|||
145713025|NCT02236988|525465390|FG003|Overall Study|Unable to Comply with Study Visits|2|||
145713026|NCT03015129|525465394|FG000|Overall Study|Death|2|||
145713027|NCT03015129|525465395|FG001|Overall Study|Death|2|||
145713028|NCT03015129|525465394|FG000|Overall Study|Lost to Follow-up|0|||
145713029|NCT03015129|525465395|FG001|Overall Study|Lost to Follow-up|1|||
145713030|NCT03015129|525465394|FG000|Overall Study|Progression of disease|38|||
145713031|NCT03015129|525465395|FG001|Overall Study|Progression of disease|33|||
145713032|NCT03015129|525465394|FG000|Overall Study|Adverse Event|0|||
145713033|NCT03015129|525465395|FG001|Overall Study|Adverse Event|4|||
145713034|NCT01072630|525465401|FG000|Overall Study|Adverse Event|11|||
145713035|NCT01072630|525465402|FG001|Overall Study|Adverse Event|19|||
145713036|NCT01072630|525465403|FG002|Overall Study|Adverse Event|2|||
145713037|NCT01072630|525465401|FG000|Overall Study|Lack of Efficacy|10|||
145713038|NCT01072630|525465402|FG001|Overall Study|Lack of Efficacy|10|||
145713039|NCT01072630|525465403|FG002|Overall Study|Lack of Efficacy|1|||
145713040|NCT01072630|525465401|FG000|Overall Study|Withdrawal by Subject|8|||
145713041|NCT01072630|525465402|FG001|Overall Study|Withdrawal by Subject|7|||
145713042|NCT01072630|525465403|FG002|Overall Study|Withdrawal by Subject|2|||
145713043|NCT01072630|525465401|FG000|Overall Study|Protocol Violation|10|||
145713044|NCT01072630|525465402|FG001|Overall Study|Protocol Violation|8|||
145713045|NCT01072630|525465403|FG002|Overall Study|Protocol Violation|4|||
145713046|NCT01072630|525465401|FG000|Overall Study|Lost to Follow-up|11|||
145713047|NCT01072630|525465402|FG001|Overall Study|Lost to Follow-up|11|||
145713048|NCT01072630|525465403|FG002|Overall Study|Lost to Follow-up|1|||
145713049|NCT01072630|525465401|FG000|Overall Study|Noncompliance with study medication|1|||
145713050|NCT01072630|525465402|FG001|Overall Study|Noncompliance with study medication|1|||
145713051|NCT01072630|525465403|FG002|Overall Study|Noncompliance with study medication|1|||
145713052|NCT01072630|525465401|FG000|Overall Study|Noncompliance with study procedures|1|||
145713053|NCT01072630|525465402|FG001|Overall Study|Noncompliance with study procedures|2|||
145713054|NCT01072630|525465403|FG002|Overall Study|Noncompliance with study procedures|1|||
145713055|NCT01072630|525465401|FG000|Overall Study|Other|3|||
145713056|NCT01072630|525465402|FG001|Overall Study|Other|2|||
145713057|NCT01072630|525465403|FG002|Overall Study|Other|1|||
145713058|NCT03046121|525465404|FG000|Overall Study|Death|32|||
145713059|NCT03046121|525465405|FG001|Overall Study|Death|60|||
145713060|NCT03046121|525465404|FG000|Overall Study|Withdrawal by Subject|14|||
145713061|NCT03046121|525465405|FG001|Overall Study|Withdrawal by Subject|12|||
145713062|NCT04514510|525465406|FG000|Overall Study|Lost to Follow-up|0|||
145713063|NCT04514510|525465407|FG001|Overall Study|Lost to Follow-up|1|||
145713064|NCT04514510|525465406|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
145713065|NCT04514510|525465407|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
145713066|NCT00821587|525465412|FG000|Overall Study|Physician Decision|0|||
145713067|NCT00821587|525465413|FG001|Overall Study|Physician Decision|1|||
145713068|NCT04488770|525465416|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713069|NCT04488770|525465417|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713070|NCT04488770|525465418|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713071|NCT04488770|525465419|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
145713072|NCT04488770|525465420|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713073|NCT04488770|525465421|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713074|NCT04488770|525465422|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713075|NCT04488770|525465423|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713076|NCT04488770|525465424|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713077|NCT04488770|525465425|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713078|NCT04488770|525465426|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713079|NCT04488770|525465427|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713080|NCT04488770|525465428|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
145713081|NCT04488770|525465416|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
145713082|NCT04488770|525465417|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713083|NCT04488770|525465418|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713084|NCT04488770|525465419|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713085|NCT04488770|525465420|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713086|NCT04488770|525465421|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713087|NCT04488770|525465422|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713088|NCT04488770|525465423|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713089|NCT04488770|525465424|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713090|NCT04488770|525465425|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713091|NCT04488770|525465426|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713092|NCT04488770|525465427|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713093|NCT04488770|525465428|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
145713094|NCT04488770|525465416|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713095|NCT04488770|525465417|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713096|NCT04488770|525465418|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713097|NCT04488770|525465419|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713098|NCT04488770|525465420|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713099|NCT04488770|525465421|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
145713100|NCT04488770|525465422|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
145713101|NCT04488770|525465423|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713102|NCT04488770|525465424|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713103|NCT04488770|525465425|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713104|NCT04488770|525465426|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713105|NCT04488770|525465427|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713106|NCT04488770|525465428|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
145713107|NCT04488770|525465416|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713108|NCT04488770|525465417|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713109|NCT04488770|525465418|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713110|NCT04488770|525465419|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713111|NCT04488770|525465420|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
145713112|NCT04488770|525465421|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713113|NCT04488770|525465422|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713114|NCT04488770|525465423|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713115|NCT04488770|525465424|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713116|NCT04488770|525465425|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713117|NCT04488770|525465426|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713118|NCT04488770|525465427|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713119|NCT04488770|525465428|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
145713120|NCT01208103|525465429|FG000|Overall Study|Adverse Event|1|||
145713121|NCT01208103|525465429|FG000|Overall Study|Withdrawal by Subject|1|||
145713122|NCT00886795|525465430|FG000|Overall Study|Lack of Efficacy|1|||
145713123|NCT01669577|525465436|FG000|Overall Study|Death|22|||
145713124|NCT01669577|525465436|FG000|Overall Study|Lost to Follow-up|78|||
145713125|NCT01669577|525465436|FG000|Overall Study|Physician Decision|34|||
145713126|NCT03466073|525465437|FG000|Overall Study|Death|1|||
145713127|NCT03466073|525465438|FG001|Overall Study|Death|0|||
145713128|NCT03466073|525465439|FG002|Overall Study|Death|0|||
145713129|NCT03466073|525465440|FG003|Overall Study|Death|0|||
145713130|NCT03466073|525465441|FG004|Overall Study|Death|0|||
145713131|NCT03466073|525465442|FG005|Overall Study|Death|1|||
145713132|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
145713133|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
145713134|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
145713135|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
145713136|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
145713137|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
145713138|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
145713139|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
145713140|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
145713141|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
145713142|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Adverse Event|0|||
145713143|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Adverse Event|0|||
145713144|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Adverse Event|3|||
145713145|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Adverse Event|2|||
145713146|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Adverse Event|13|||
145713147|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
145713148|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
145713149|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
145713150|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
145713151|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
145713152|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Patient's wish|0|||
145713153|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Patient's wish|0|||
145713154|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Patient's wish|19|||
145713155|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Patient's wish|9|||
145713156|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Patient's wish|20|||
145713157|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
145713158|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
145713159|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
145713160|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
145713161|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
145713162|NCT00444275|525465446|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
145713163|NCT00444275|525465447|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
145713164|NCT00444275|525465448|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
145713165|NCT00444275|525465449|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
145713166|NCT00444275|525465450|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
145713167|NCT02045875|525465451|FG000|Overall Study|Lost to Follow-up|3|||
145713168|NCT02045875|525465452|FG001|Overall Study|Lost to Follow-up|0|||
145713169|NCT02045875|525465451|FG000|Overall Study|Withdrawal by Subject|4|||
145713170|NCT02045875|525465452|FG001|Overall Study|Withdrawal by Subject|3|||
145713171|NCT01276379|525465453|FG000|Overall Study|Screening failure|40|||
145713172|NCT00864253|525465454|FG000|Overall Study|Adverse Event|56|||
145713173|NCT00864253|525465455|FG001|Overall Study|Adverse Event|11|||
145713174|NCT00864253|525465454|FG000|Overall Study|Unrelated Adverse Event|3|||
145713175|NCT00864253|525465455|FG001|Overall Study|Unrelated Adverse Event|1|||
145713176|NCT00864253|525465454|FG000|Overall Study|Physician Decision|11|||
145713177|NCT00864253|525465455|FG001|Overall Study|Physician Decision|15|||
145713178|NCT00864253|525465454|FG000|Overall Study|Protocol Violation|0|||
145713179|NCT00864253|525465455|FG001|Overall Study|Protocol Violation|2|||
145713180|NCT00864253|525465454|FG000|Overall Study|Lost to Follow-up|1|||
145713181|NCT00864253|525465455|FG001|Overall Study|Lost to Follow-up|1|||
145713182|NCT00864253|525465454|FG000|Overall Study|Withdrawal by Subject|18|||
145713183|NCT00864253|525465455|FG001|Overall Study|Withdrawal by Subject|18|||
145713184|NCT00864253|525465454|FG000|Overall Study|Death|1|||
145713185|NCT00864253|525465455|FG001|Overall Study|Death|0|||
145713186|NCT00864253|525465454|FG000|Overall Study|Ongoing|2|||
145713187|NCT00864253|525465455|FG001|Overall Study|Ongoing|3|||
145713188|NCT00864253|525465454|FG000|Overall Study|Untreated|7|||
145713189|NCT00864253|525465455|FG001|Overall Study|Untreated|7|||
145713190|NCT01111240|525465458|FG000|Overall Study|Adverse Event|190|||
145713191|NCT01111240|525465458|FG000|Overall Study|Lack of Efficacy|545|||
145713192|NCT01111240|525465458|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
145713193|NCT01111240|525465458|FG000|Overall Study|Other|312|||
145713194|NCT04662931|525465459|FG000|Overall Study|Withdrawal by Subject|17|||
145713195|NCT04662931|525465459|FG000|Overall Study|Death|3|||
145713196|NCT04662931|525465459|FG000|Overall Study|Lost to Follow-up|3|||
145713197|NCT04662931|525465459|FG000|Overall Study|Guardian Decision|1|||
145713198|NCT01989169|525465460|FG000|Period 2|Adverse Event|0|||
145713199|NCT01989169|525465461|FG001|Period 2|Adverse Event|1|||
145713200|NCT01585155|525465462|FG000|Overall Study|Adverse Event|1|||
145713201|NCT01585155|525465462|FG000|Overall Study|Lack of Efficacy|2|||
145713202|NCT01585155|525465462|FG000|Overall Study|Worsening ulcerative colitis|2|||
145713203|NCT01743989|525465463|FG000|Treatment Phase|Unstable MR4.0|0|||
145713204|NCT01743989|525465464|FG001|Treatment Phase|Unstable MR4.0|6|||
145713205|NCT01743989|525465465|FG002|Treatment Phase|Unstable MR4.0|263|||
145713206|NCT01743989|525465463|FG000|Treatment Phase|Adverse Event|0|||
145713207|NCT01743989|525465464|FG001|Treatment Phase|Adverse Event|4|||
145713208|NCT01743989|525465465|FG002|Treatment Phase|Adverse Event|67|||
145713209|NCT01743989|525465463|FG000|Treatment Phase|Withdrawal by Subject|1|||
145713210|NCT01743989|525465464|FG001|Treatment Phase|Withdrawal by Subject|3|||
145713211|NCT01743989|525465465|FG002|Treatment Phase|Withdrawal by Subject|28|||
145713212|NCT01743989|525465463|FG000|Treatment Phase|Death|0|||
145713213|NCT01743989|525465464|FG001|Treatment Phase|Death|1|||
145713214|NCT01743989|525465465|FG002|Treatment Phase|Death|3|||
145713215|NCT01743989|525465463|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
145713216|NCT01743989|525465464|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
145713217|NCT01743989|525465465|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
145713218|NCT01743989|525465463|FG000|Treatment Phase|Protocol deviation|0|||
145713219|NCT01743989|525465464|FG001|Treatment Phase|Protocol deviation|0|||
145713220|NCT01743989|525465465|FG002|Treatment Phase|Protocol deviation|3|||
145713221|NCT01743989|525465463|FG000|Treatment Phase|Pregnancy|0|||
145713222|NCT01743989|525465464|FG001|Treatment Phase|Pregnancy|0|||
145713223|NCT01743989|525465465|FG002|Treatment Phase|Pregnancy|2|||
145713224|NCT01743989|525465463|FG000|Treatment Phase|Lost to Follow-up|0|||
145713225|NCT01743989|525465464|FG001|Treatment Phase|Lost to Follow-up|0|||
145713226|NCT01743989|525465465|FG002|Treatment Phase|Lost to Follow-up|2|||
145713227|NCT01743989|525465463|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
145713228|NCT01743989|525465464|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
145713229|NCT01743989|525465465|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
145713230|NCT01743989|525465463|FG000|Treatment Phase|Administrative problems|0|||
145713231|NCT01743989|525465464|FG001|Treatment Phase|Administrative problems|0|||
145713232|NCT01743989|525465465|FG002|Treatment Phase|Administrative problems|1|||
145713233|NCT01743989|525465463|FG000|Treatment Phase|New cancer (CML) therapy|0|||
145713234|NCT01743989|525465464|FG001|Treatment Phase|New cancer (CML) therapy|1|||
145713235|NCT01743989|525465465|FG002|Treatment Phase|New cancer (CML) therapy|0|||
145713236|NCT01743989|525465463|FG000|Treatment Phase|Physician Decision|0|||
145713237|NCT01743989|525465464|FG001|Treatment Phase|Physician Decision|0|||
145713238|NCT01743989|525465465|FG002|Treatment Phase|Physician Decision|3|||
145713239|NCT01743989|525465463|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
145713240|NCT01743989|525465464|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
145713241|NCT01743989|525465465|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
145713242|NCT01743989|525465463|FG000|Treatment Phase|Not randomized by mistake|0|||
145713243|NCT01743989|525465464|FG001|Treatment Phase|Not randomized by mistake|0|||
145713244|NCT01743989|525465465|FG002|Treatment Phase|Not randomized by mistake|1|||
145713245|NCT01743989|525465463|FG000|Treatment Phase|Included by mistake|0|||
145713246|NCT01743989|525465464|FG001|Treatment Phase|Included by mistake|0|||
145377882|NCT03191864|524233639|FG004|Part 1 - Induction|Randomized but never dosed|0|||
145713247|NCT01743989|525465465|FG002|Treatment Phase|Included by mistake|1|||
145713248|NCT01743989|525465463|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
145713249|NCT01743989|525465464|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
145713250|NCT01743989|525465465|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
145713251|NCT01743989|525465463|FG000|TFR Phase|Adverse Event|0|||
145713252|NCT01743989|525465464|FG001|TFR Phase|Adverse Event|1|||
145713253|NCT01743989|525465465|FG002|TFR Phase|Adverse Event|0|||
145713254|NCT01743989|525465463|FG000|TFR Phase|Lost to Follow-up|0|||
145713255|NCT01743989|525465464|FG001|TFR Phase|Lost to Follow-up|2|||
145713256|NCT01743989|525465465|FG002|TFR Phase|Lost to Follow-up|0|||
145713257|NCT01743989|525465463|FG000|TFR Phase|Physician Decision|0|||
145713258|NCT01743989|525465464|FG001|TFR Phase|Physician Decision|1|||
145713259|NCT01743989|525465465|FG002|TFR Phase|Physician Decision|0|||
145713260|NCT01743989|525465463|FG000|TFR Phase|Logistical problems|0|||
145713261|NCT01743989|525465464|FG001|TFR Phase|Logistical problems|2|||
145713262|NCT01743989|525465465|FG002|TFR Phase|Logistical problems|0|||
145713263|NCT01743989|525465463|FG000|TFR Phase|Protocol deviation|0|||
145713264|NCT01743989|525465464|FG001|TFR Phase|Protocol deviation|1|||
145713265|NCT01743989|525465465|FG002|TFR Phase|Protocol deviation|0|||
145713266|NCT01743989|525465463|FG000|TFR Phase|Withdrawal by Subject|0|||
145713267|NCT01743989|525465464|FG001|TFR Phase|Withdrawal by Subject|2|||
145713268|NCT01743989|525465465|FG002|TFR Phase|Withdrawal by Subject|0|||
145713269|NCT01743989|525465463|FG000|Re-treatment Phase|Adverse Event|8|||
145713270|NCT01743989|525465464|FG001|Re-treatment Phase|Adverse Event|4|||
145713271|NCT01743989|525465465|FG002|Re-treatment Phase|Adverse Event|0|||
145713272|NCT01743989|525465463|FG000|Re-treatment Phase|Death|1|||
145713273|NCT01743989|525465464|FG001|Re-treatment Phase|Death|1|||
145713274|NCT01743989|525465465|FG002|Re-treatment Phase|Death|0|||
145713275|NCT01743989|525465463|FG000|Re-treatment Phase|Administrative problems|1|||
145713276|NCT01743989|525465464|FG001|Re-treatment Phase|Administrative problems|1|||
145713277|NCT01743989|525465465|FG002|Re-treatment Phase|Administrative problems|0|||
145713278|NCT01743989|525465463|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
145713279|NCT01743989|525465464|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
145713280|NCT01743989|525465465|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
145713281|NCT01743989|525465463|FG000|Re-treatment Phase|Unstable MR|1|||
145713282|NCT01743989|525465464|FG001|Re-treatment Phase|Unstable MR|0|||
145713283|NCT01743989|525465465|FG002|Re-treatment Phase|Unstable MR|0|||
145713284|NCT01743989|525465463|FG000|Re-treatment Phase|Physician Decision|0|||
145713285|NCT01743989|525465464|FG001|Re-treatment Phase|Physician Decision|1|||
145713286|NCT01743989|525465465|FG002|Re-treatment Phase|Physician Decision|0|||
145713287|NCT01743989|525465463|FG000|Re-treatment Phase|Lost to Follow-up|0|||
145713288|NCT01743989|525465464|FG001|Re-treatment Phase|Lost to Follow-up|1|||
145713289|NCT01743989|525465465|FG002|Re-treatment Phase|Lost to Follow-up|0|||
145713290|NCT02235311|525465472|FG000|Overall Study|Lost to Follow-up|0|||
145713291|NCT02235311|525465473|FG001|Overall Study|Lost to Follow-up|1|||
145713292|NCT02235311|525465472|FG000|Overall Study|Protocol Violation|0|||
145713293|NCT02235311|525465473|FG001|Overall Study|Protocol Violation|1|||
145713294|NCT04655027|525465474|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
145713295|NCT04655027|525465475|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
145713296|NCT02108964|525465476|FG000|Overall Study|Progressive disease|15|||
145713297|NCT02108964|525465477|FG001|Overall Study|Progressive disease|31|||
145713298|NCT02108964|525465478|FG002|Overall Study|Progressive disease|54|||
145713299|NCT02108964|525465479|FG003|Overall Study|Progressive disease|7|||
145713300|NCT02108964|525465480|FG004|Overall Study|Progressive disease|20|||
145713301|NCT02108964|525465481|FG005|Overall Study|Progressive disease|4|||
145713302|NCT02108964|525465482|FG006|Overall Study|Progressive disease|6|||
145713303|NCT02108964|525465483|FG007|Overall Study|Progressive disease|33|||
145713304|NCT02108964|525465476|FG000|Overall Study|Physician Decision|1|||
145713305|NCT02108964|525465477|FG001|Overall Study|Physician Decision|5|||
145713306|NCT02108964|525465478|FG002|Overall Study|Physician Decision|7|||
145713307|NCT02108964|525465479|FG003|Overall Study|Physician Decision|1|||
145713308|NCT02108964|525465480|FG004|Overall Study|Physician Decision|2|||
145713309|NCT02108964|525465481|FG005|Overall Study|Physician Decision|1|||
145713310|NCT02108964|525465482|FG006|Overall Study|Physician Decision|1|||
145713311|NCT02108964|525465483|FG007|Overall Study|Physician Decision|3|||
145713312|NCT02108964|525465476|FG000|Overall Study|Adverse Event|0|||
145713313|NCT02108964|525465477|FG001|Overall Study|Adverse Event|0|||
145713314|NCT02108964|525465478|FG002|Overall Study|Adverse Event|4|||
145713315|NCT02108964|525465479|FG003|Overall Study|Adverse Event|0|||
145713316|NCT02108964|525465480|FG004|Overall Study|Adverse Event|1|||
145713317|NCT02108964|525465481|FG005|Overall Study|Adverse Event|0|||
145713318|NCT02108964|525465482|FG006|Overall Study|Adverse Event|3|||
145713319|NCT02108964|525465483|FG007|Overall Study|Adverse Event|2|||
145713320|NCT02108964|525465476|FG000|Overall Study|Death|1|||
145713321|NCT02108964|525465477|FG001|Overall Study|Death|1|||
145713322|NCT02108964|525465478|FG002|Overall Study|Death|4|||
145713323|NCT02108964|525465479|FG003|Overall Study|Death|0|||
145713324|NCT02108964|525465480|FG004|Overall Study|Death|3|||
145713325|NCT02108964|525465481|FG005|Overall Study|Death|0|||
145713326|NCT02108964|525465482|FG006|Overall Study|Death|0|||
145713327|NCT02108964|525465483|FG007|Overall Study|Death|2|||
145713328|NCT02108964|525465476|FG000|Overall Study|Subject/Guardian decision|0|||
145713329|NCT02108964|525465477|FG001|Overall Study|Subject/Guardian decision|1|||
145713330|NCT02108964|525465478|FG002|Overall Study|Subject/Guardian decision|4|||
145713331|NCT02108964|525465479|FG003|Overall Study|Subject/Guardian decision|0|||
145713332|NCT02108964|525465480|FG004|Overall Study|Subject/Guardian decision|2|||
145713333|NCT02108964|525465481|FG005|Overall Study|Subject/Guardian decision|0|||
145713334|NCT02108964|525465482|FG006|Overall Study|Subject/Guardian decision|1|||
145713335|NCT02108964|525465483|FG007|Overall Study|Subject/Guardian decision|2|||
145713336|NCT02108964|525465476|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713337|NCT02108964|525465477|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713338|NCT02108964|525465478|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713339|NCT02108964|525465479|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713340|NCT02108964|525465480|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713341|NCT02108964|525465481|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713342|NCT02108964|525465482|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
145713343|NCT02108964|525465483|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
145713344|NCT03006848|525465484|FG000|Overall Study|Adverse Event|1|||
145713345|NCT03006848|525465484|FG000|Overall Study|Physician Decision|1|||
145713346|NCT03006848|525465484|FG000|Overall Study|Lack of Efficacy|16|||
145713347|NCT05384938|525465485|FG000|Overall Study|Withdrawal by Subject|8|||
145713348|NCT05384938|525465485|FG000|Overall Study|Lost to Follow-up|6|||
145713349|NCT05384938|525465485|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
145713350|NCT01525238|525465487|FG000|Overall Study|Withdrawal by Subject|1|||
145713351|NCT01525238|525465488|FG001|Overall Study|Withdrawal by Subject|0|||
145713352|NCT01525238|525465489|FG002|Overall Study|Withdrawal by Subject|0|||
145713353|NCT04696653|525465490|FG000|Overall Study|left organization|18|||
145713354|NCT04696653|525465490|FG000|Overall Study|Lost to Follow-up|3|||
145713355|NCT03203473|525468118|FG000|Induction Phase|Never started primary treatment|2|||
145713356|NCT03203473|525468119|FG001|Induction Phase|Never started primary treatment|0|||
145713357|NCT03203473|525468120|FG002|Induction Phase|Never started primary treatment|0|||
145713358|NCT03203473|525468118|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
145713359|NCT03203473|525468119|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
145713360|NCT03203473|525468120|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
145713361|NCT03203473|525468118|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
145713362|NCT03203473|525468119|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
145713363|NCT03203473|525468120|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
145713364|NCT03203473|525468118|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
145713365|NCT03203473|525468119|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
145713366|NCT03203473|525468120|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
145713367|NCT03203473|525468118|FG000|Arm Allocation Phase|started salvage therapy|0|||
145713368|NCT03203473|525468119|FG001|Arm Allocation Phase|started salvage therapy|5|||
145713369|NCT03203473|525468120|FG002|Arm Allocation Phase|started salvage therapy|0|||
145713370|NCT03203473|525468118|FG000|Arm Allocation Phase|Disease progression|0|||
145713371|NCT03203473|525468119|FG001|Arm Allocation Phase|Disease progression|0|||
145713372|NCT03203473|525468120|FG002|Arm Allocation Phase|Disease progression|37|||
145713373|NCT03203473|525468118|FG000|Arm Allocation Phase|Adverse Event|0|||
145713374|NCT03203473|525468119|FG001|Arm Allocation Phase|Adverse Event|0|||
145713375|NCT03203473|525468120|FG002|Arm Allocation Phase|Adverse Event|11|||
145713376|NCT03203473|525468118|FG000|Arm Allocation Phase|Physician Decision|0|||
145713377|NCT03203473|525468119|FG001|Arm Allocation Phase|Physician Decision|0|||
145713378|NCT03203473|525468120|FG002|Arm Allocation Phase|Physician Decision|3|||
145713379|NCT03203473|525468118|FG000|Arm Allocation Phase|Death|0|||
145713380|NCT03203473|525468119|FG001|Arm Allocation Phase|Death|0|||
145713381|NCT03203473|525468120|FG002|Arm Allocation Phase|Death|1|||
145713382|NCT03203473|525468118|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
145713383|NCT03203473|525468119|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
145713384|NCT03203473|525468120|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
145713385|NCT03203473|525468118|FG000|Arm Allocation Phase|Intercurrent illness|0|||
145713386|NCT03203473|525468119|FG001|Arm Allocation Phase|Intercurrent illness|0|||
145713387|NCT03203473|525468120|FG002|Arm Allocation Phase|Intercurrent illness|1|||
145713388|NCT03203473|525468118|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
145713389|NCT03203473|525468119|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
145713390|NCT03203473|525468120|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
145713391|NCT02314780|525468121|FG000|Overall Study|organizational reasons|0|||
145713392|NCT02314780|525468122|FG001|Overall Study|organizational reasons|2|||
145713393|NCT02314780|525468123|FG002|Overall Study|organizational reasons|0|||
145713394|NCT02314780|525468121|FG000|Overall Study|Adverse Event|0|||
145713395|NCT02314780|525468122|FG001|Overall Study|Adverse Event|1|||
145713396|NCT02314780|525468123|FG002|Overall Study|Adverse Event|0|||
145713397|NCT01077271|525468127|FG000|Overall Study|Parental desire|8|||
145713398|NCT01077271|525468127|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
145713399|NCT01077271|525468127|FG000|Overall Study|Noncompliance|2|||
145713400|NCT01077271|525468127|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
145713401|NCT01077271|525468127|FG000|Overall Study|Changed doctors|2|||
145713402|NCT01077271|525468127|FG000|Overall Study|Parents thought too many injections|2|||
145713403|NCT01077271|525468127|FG000|Overall Study|End of RSV season nearly reached|1|||
145713404|NCT01077271|525468127|FG000|Overall Study|Mother unconvinced of the necessity|1|||
145713405|NCT00215137|525468128|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
145713406|NCT00215137|525468129|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
145713407|NCT00215137|525468130|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
145713408|NCT00215137|525468128|FG000|Randomization Period|Lost to Follow-up|0|||
145713409|NCT00215137|525468129|FG001|Randomization Period|Lost to Follow-up|1|||
145713410|NCT00215137|525468130|FG002|Randomization Period|Lost to Follow-up|0|||
145713411|NCT00215137|525468128|FG000|Randomization Period|Withdrawal by Subject|0|||
145713412|NCT00215137|525468129|FG001|Randomization Period|Withdrawal by Subject|1|||
145713413|NCT00215137|525468130|FG002|Randomization Period|Withdrawal by Subject|0|||
145713414|NCT03333876|525468131|FG000|Screening Period|Screen Failure|4|||
145713415|NCT03333876|525468131|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
145713416|NCT03333876|525468131|FG000|Mandibular Advancement|Adverse Event|2|||
145713417|NCT03333876|525468131|FG000|Mandibular Advancement|Product Damage|2|||
145713418|NCT00095498|525468135|FG000|Overall Study|Physician Decision|9|||
145713419|NCT00095498|525468136|FG001|Overall Study|Physician Decision|10|||
145713420|NCT00095498|525468137|FG002|Overall Study|Physician Decision|8|||
145713421|NCT00095498|525468135|FG000|Overall Study|Adverse Event|1|||
145713422|NCT00095498|525468136|FG001|Overall Study|Adverse Event|0|||
145713423|NCT00095498|525468137|FG002|Overall Study|Adverse Event|1|||
145713424|NCT00095498|525468135|FG000|Overall Study|Withdrawal by Subject|15|||
145713425|NCT00095498|525468136|FG001|Overall Study|Withdrawal by Subject|16|||
145713426|NCT00095498|525468137|FG002|Overall Study|Withdrawal by Subject|15|||
145713427|NCT00095498|525468135|FG000|Overall Study|Disease progression|0|||
145713428|NCT00095498|525468136|FG001|Overall Study|Disease progression|1|||
145713429|NCT00095498|525468137|FG002|Overall Study|Disease progression|1|||
145713430|NCT00095498|525468135|FG000|Overall Study|Ineligibility determined|3|||
145713431|NCT00095498|525468136|FG001|Overall Study|Ineligibility determined|0|||
145713432|NCT00095498|525468137|FG002|Overall Study|Ineligibility determined|2|||
145713433|NCT00095498|525468135|FG000|Overall Study|Lost to Follow-up|1|||
145713434|NCT00095498|525468136|FG001|Overall Study|Lost to Follow-up|1|||
145713435|NCT00095498|525468137|FG002|Overall Study|Lost to Follow-up|2|||
145713436|NCT00095498|525468135|FG000|Overall Study|Noncompliance|1|||
145713437|NCT00095498|525468136|FG001|Overall Study|Noncompliance|0|||
145713438|NCT00095498|525468137|FG002|Overall Study|Noncompliance|1|||
145713439|NCT00095498|525468135|FG000|Overall Study|Other|6|||
145713440|NCT00095498|525468136|FG001|Overall Study|Other|7|||
145713441|NCT00095498|525468137|FG002|Overall Study|Other|6|||
145713442|NCT00095498|525468135|FG000|Overall Study|Protocol Violation|0|||
145713443|NCT00095498|525468136|FG001|Overall Study|Protocol Violation|0|||
145713444|NCT00095498|525468137|FG002|Overall Study|Protocol Violation|1|||
145713445|NCT00095498|525468135|FG000|Overall Study|Requirement for alternative therapy|1|||
145713446|NCT00095498|525468136|FG001|Overall Study|Requirement for alternative therapy|0|||
145713447|NCT00095498|525468137|FG002|Overall Study|Requirement for alternative therapy|2|||
145713448|NCT05020327|525468138|FG000|Overall Study|Physician Decision|3|||
145713449|NCT05020327|525468139|FG001|Overall Study|Physician Decision|0|||
145713450|NCT05020327|525468140|FG002|Overall Study|Physician Decision|0|||
145713451|NCT05020327|525468138|FG000|Overall Study|Withdrawal by Subject|1|||
145713452|NCT05020327|525468139|FG001|Overall Study|Withdrawal by Subject|1|||
145713453|NCT05020327|525468140|FG002|Overall Study|Withdrawal by Subject|0|||
145713454|NCT05020327|525468138|FG000|Overall Study|personal/cultural, ineligible|12|||
145713455|NCT05020327|525468139|FG001|Overall Study|personal/cultural, ineligible|0|||
145713456|NCT05020327|525468140|FG002|Overall Study|personal/cultural, ineligible|0|||
145713457|NCT00306670|525468145|FG000|Overall Study|patients recruited; Genentech, the st|0|||
145713458|NCT00306670|525468146|FG001|Overall Study|patients recruited; Genentech, the st|2|||
145713459|NCT00503139|525468147|FG000|Overall Study|Case Report Forms were not collected|4|||
145713460|NCT00503139|525468147|FG000|Overall Study|Protocol Violation|4|||
145713461|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
145713462|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
145713463|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
145713464|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
145713465|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
145713466|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
145713467|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
145713468|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
145713469|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
145713470|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
145713471|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713472|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713473|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
145713474|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
145713475|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
145713476|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
145713477|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
145713478|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
145713479|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
145713480|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
145713481|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
145713482|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
145713483|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
145713484|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
145713485|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
145713486|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713487|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
145713488|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713489|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713490|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713491|NCT00833833|525468151|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
145713492|NCT00833833|525468152|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
145713493|NCT00833833|525468153|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
145713494|NCT00833833|525468154|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
145713495|NCT00833833|525468155|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
145713496|NCT00833833|525468156|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
145713497|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
145713498|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
145713499|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
145713500|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
145713501|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
145713502|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
145713503|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
145713504|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
145713505|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
145713506|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
145713507|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
145713508|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
145713509|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
145713510|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
145713511|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
145713512|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
145713513|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
145713514|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
145713515|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713516|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713517|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713518|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
145713519|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
145713520|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
145713521|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713522|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713523|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713524|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
145713525|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
145713526|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
145713527|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
145713528|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
145713529|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
145713530|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
145713531|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
145713532|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
145713533|NCT00833833|525468151|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
145713534|NCT00833833|525468152|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
145713535|NCT00833833|525468153|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
145713536|NCT00833833|525468154|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
145713537|NCT00833833|525468155|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
145713538|NCT00833833|525468156|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
145713539|NCT01262677|525468164|FG000|Overall Study|Does not meet entrance criteria|0|||
145713540|NCT01262677|525468165|FG001|Overall Study|Does not meet entrance criteria|2|||
145713541|NCT01262677|525468166|FG002|Overall Study|Does not meet entrance criteria|0|||
145713542|NCT01262677|525468164|FG000|Overall Study|Insufficient clinical response|0|||
145713543|NCT01262677|525468165|FG001|Overall Study|Insufficient clinical response|0|||
145713544|NCT01262677|525468166|FG002|Overall Study|Insufficient clinical response|1|||
145713545|NCT01262677|525468164|FG000|Overall Study|Lost to Follow-up|1|||
145713546|NCT01262677|525468165|FG001|Overall Study|Lost to Follow-up|0|||
145713547|NCT01262677|525468166|FG002|Overall Study|Lost to Follow-up|2|||
145713548|NCT01262677|525468164|FG000|Overall Study|No longer willing to participate|3|||
145713549|NCT01262677|525468165|FG001|Overall Study|No longer willing to participate|3|||
145713550|NCT01262677|525468166|FG002|Overall Study|No longer willing to participate|2|||
145713551|NCT01262677|525468164|FG000|Overall Study|Reason not provided|2|||
145713552|NCT01262677|525468165|FG001|Overall Study|Reason not provided|1|||
145713553|NCT01262677|525468166|FG002|Overall Study|Reason not provided|3|||
145713554|NCT01262677|525468164|FG000|Overall Study|Protocol Violation|0|||
145713555|NCT01262677|525468165|FG001|Overall Study|Protocol Violation|1|||
145713556|NCT01262677|525468166|FG002|Overall Study|Protocol Violation|1|||
145713557|NCT01262677|525468164|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
145713558|NCT01262677|525468165|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
145713559|NCT01262677|525468166|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
145713560|NCT01470001|525468173|FG000|Overall Study|Lost to Follow-up|1|||
145713561|NCT01470001|525468174|FG001|Overall Study|Lost to Follow-up|1|||
145713562|NCT01470001|525468173|FG000|Overall Study|Physician Decision|2|||
145713563|NCT01470001|525468174|FG001|Overall Study|Physician Decision|0|||
145713564|NCT01470001|525468173|FG000|Overall Study|Withdrawal by Subject|2|||
145713565|NCT01470001|525468174|FG001|Overall Study|Withdrawal by Subject|1|||
145713566|NCT01895101|525468175|FG000|Overall Study|OPCAB procedure|1|||
145713567|NCT01895101|525468176|FG001|Overall Study|OPCAB procedure|1|||
145713568|NCT01895101|525468177|FG002|Overall Study|OPCAB procedure|3|||
145713569|NCT01895101|525468175|FG000|Overall Study|Withdrawal by Subject|0|||
145713570|NCT01895101|525468176|FG001|Overall Study|Withdrawal by Subject|1|||
145713571|NCT01895101|525468177|FG002|Overall Study|Withdrawal by Subject|2|||
145713572|NCT01895101|525468175|FG000|Overall Study|another study, enrolled in other study|0|||
145713573|NCT01895101|525468176|FG001|Overall Study|another study, enrolled in other study|1|||
145713574|NCT01895101|525468177|FG002|Overall Study|another study, enrolled in other study|0|||
145713575|NCT01895101|525468175|FG000|Overall Study|Death|0|||
145713576|NCT01895101|525468176|FG001|Overall Study|Death|1|||
145713577|NCT01895101|525468177|FG002|Overall Study|Death|0|||
145713578|NCT01895101|525468175|FG000|Overall Study|coagulation disorder|0|||
145713579|NCT01895101|525468176|FG001|Overall Study|coagulation disorder|1|||
145713580|NCT01895101|525468177|FG002|Overall Study|coagulation disorder|0|||
145713581|NCT00730275|525468178|FG000|Overall Study|Withdrawal by Subject|0|||
145713582|NCT00730275|525468179|FG001|Overall Study|Withdrawal by Subject|0|||
145713583|NCT00730275|525468180|FG002|Overall Study|Withdrawal by Subject|0|||
145713584|NCT00730275|525468181|FG003|Overall Study|Withdrawal by Subject|1|||
145713585|NCT03921723|525468184|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
145713586|NCT03921723|525468184|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
145713587|NCT01461811|525468185|FG000|Overall Study|Adverse Event|2|||
145713588|NCT01461811|525468186|FG001|Overall Study|Adverse Event|1|||
145713589|NCT01461811|525468185|FG000|Overall Study|Subject decision unrelated to an AE|1|||
145713590|NCT01461811|525468186|FG001|Overall Study|Subject decision unrelated to an AE|1|||
145713591|NCT01461811|525468185|FG000|Overall Study|Noncompliance|1|||
145713592|NCT01461811|525468186|FG001|Overall Study|Noncompliance|1|||
145713593|NCT00338962|525468187|FG000|Overall Study|Lost to Follow-up|3|||
145713594|NCT00338962|525468188|FG001|Overall Study|Lost to Follow-up|3|||
145713595|NCT00338962|525468189|FG002|Overall Study|Lost to Follow-up|2|||
145713596|NCT00338962|525468190|FG003|Overall Study|Lost to Follow-up|3|||
145713597|NCT00338962|525468187|FG000|Overall Study|Withdrawal by Subject|1|||
145713598|NCT00338962|525468188|FG001|Overall Study|Withdrawal by Subject|0|||
145713599|NCT00338962|525468189|FG002|Overall Study|Withdrawal by Subject|0|||
145713600|NCT00338962|525468190|FG003|Overall Study|Withdrawal by Subject|0|||
145713601|NCT00338962|525468187|FG000|Overall Study|No Transportation|2|||
145713602|NCT00338962|525468188|FG001|Overall Study|No Transportation|0|||
145713603|NCT00338962|525468189|FG002|Overall Study|No Transportation|0|||
145713604|NCT00338962|525468190|FG003|Overall Study|No Transportation|0|||
145713605|NCT00338962|525468187|FG000|Overall Study|Time Constraint|2|||
145713606|NCT00338962|525468188|FG001|Overall Study|Time Constraint|0|||
145713607|NCT00338962|525468189|FG002|Overall Study|Time Constraint|0|||
145713608|NCT00338962|525468190|FG003|Overall Study|Time Constraint|0|||
145713609|NCT00338962|525468187|FG000|Overall Study|Moved|0|||
145713610|NCT00338962|525468188|FG001|Overall Study|Moved|1|||
145713611|NCT00338962|525468189|FG002|Overall Study|Moved|0|||
145713612|NCT00338962|525468190|FG003|Overall Study|Moved|0|||
145713613|NCT00338962|525468187|FG000|Overall Study|Adverse Event|0|||
145713614|NCT00338962|525468188|FG001|Overall Study|Adverse Event|0|||
145713615|NCT00338962|525468189|FG002|Overall Study|Adverse Event|2|||
145713616|NCT00338962|525468190|FG003|Overall Study|Adverse Event|0|||
145713617|NCT00338962|525468187|FG000|Overall Study|Poor Compliance|0|||
145713618|NCT00338962|525468188|FG001|Overall Study|Poor Compliance|0|||
145713619|NCT00338962|525468189|FG002|Overall Study|Poor Compliance|2|||
145713620|NCT00338962|525468190|FG003|Overall Study|Poor Compliance|0|||
145713621|NCT03733314|525468191|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
145713622|NCT03733314|525468192|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
145713623|NCT03733314|525468191|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
145713624|NCT03733314|525468192|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
145713625|NCT03733314|525468191|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
145713626|NCT03733314|525468192|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
145713627|NCT03733314|525468191|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
145713628|NCT03733314|525468192|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
145713629|NCT03733314|525468191|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
145713630|NCT03733314|525468192|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
145713631|NCT03733314|525468191|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
145713632|NCT03733314|525468192|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
145713633|NCT03214640|525468193|FG000|Overall Study|Protocol Violation|1|||
145713634|NCT03214640|525468194|FG001|Overall Study|Protocol Violation|2|||
145713635|NCT03214640|525468195|FG002|Overall Study|Protocol Violation|1|||
145713636|NCT03214640|525468196|FG003|Overall Study|Protocol Violation|4|||
145713637|NCT04155047|525468197|FG000|Overall Study|Adverse Event|1|||
145713638|NCT04155047|525468198|FG001|Overall Study|Adverse Event|0|||
145713639|NCT04155047|525468197|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
145713640|NCT04155047|525468198|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
145713641|NCT00406692|525468203|FG000|Overall Study|Withdrawal by Subject|4|||
145713642|NCT00406692|525468203|FG000|Overall Study|Physician Decision|1|||
145713643|NCT00406692|525468203|FG000|Overall Study|Adverse Event|1|||
145713644|NCT00406692|525468203|FG000|Overall Study|Lack of Efficacy|1|||
145713645|NCT00400725|525468204|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
145713646|NCT00400725|525468205|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
145713647|NCT00400725|525468206|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
145713648|NCT00400725|525468204|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
145713649|NCT00400725|525468205|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
145713650|NCT00400725|525468206|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
145713651|NCT00400725|525468204|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
145713652|NCT00400725|525468205|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
145713653|NCT00400725|525468206|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
145713654|NCT00400725|525468204|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
145713655|NCT00400725|525468205|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
145713656|NCT00400725|525468206|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
145713657|NCT00400725|525468204|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
145713658|NCT00400725|525468205|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
145713659|NCT00400725|525468206|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
145713660|NCT00400725|525468204|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
145713661|NCT00400725|525468205|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
145713662|NCT00400725|525468206|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
145713663|NCT00400725|525468204|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
145713664|NCT00400725|525468205|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
145713665|NCT00400725|525468206|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
145713666|NCT00400725|525468204|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
145713667|NCT00400725|525468205|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
145713668|NCT00400725|525468206|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
145713669|NCT00400725|525468204|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
145713670|NCT00400725|525468205|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
145713671|NCT00400725|525468206|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
145713672|NCT03547739|525468207|FG000|Overall Study|Death|0|||
145713673|NCT03547739|525468208|FG001|Overall Study|Death|1|||
145713674|NCT03547739|525468209|FG002|Overall Study|Death|5|||
145713675|NCT03547739|525468207|FG000|Overall Study|Adverse Event|24|||
145713676|NCT03547739|525468208|FG001|Overall Study|Adverse Event|11|||
145713677|NCT03547739|525468209|FG002|Overall Study|Adverse Event|13|||
145713678|NCT03547739|525468207|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
145713679|NCT03547739|525468208|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
145713680|NCT03547739|525468209|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
145713681|NCT03547739|525468207|FG000|Overall Study|Lost to Follow-up|80|||
145713682|NCT03547739|525468208|FG001|Overall Study|Lost to Follow-up|84|||
145713683|NCT03547739|525468209|FG002|Overall Study|Lost to Follow-up|116|||
145713684|NCT00635661|525468221|FG000|Overall Study|Withdrawal by Subject|4|||
145713685|NCT01641159|525468235|FG000|Overall Study|Lost to Follow-up|2|||
145713686|NCT01641159|525468236|FG001|Overall Study|Lost to Follow-up|1|||
145491519|NCT04612725|524653827|FG000|Overall Study|Lost to Follow-up|0|||
145491520|NCT04612725|524653828|FG001|Overall Study|Lost to Follow-up|1|||
145713687|NCT01641159|525468235|FG000|Overall Study|Withdrawal by Subject|0|||
145713688|NCT01641159|525468236|FG001|Overall Study|Withdrawal by Subject|1|||
145713689|NCT05330676|525468239|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
145713690|NCT05330676|525468240|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
145713691|NCT02229851|525468243|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
145713692|NCT02229851|525468244|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
145713693|NCT02229851|525468245|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
145713694|NCT02229851|525468246|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
145713695|NCT02229851|525468247|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
145713696|NCT02229851|525468248|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
145713697|NCT02229851|525468249|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
145713698|NCT02229851|525468243|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713699|NCT02229851|525468244|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
145713700|NCT02229851|525468245|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713701|NCT02229851|525468246|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713702|NCT02229851|525468247|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713703|NCT02229851|525468248|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713704|NCT02229851|525468249|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
145713705|NCT02229851|525468243|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
145713706|NCT02229851|525468244|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
145713707|NCT02229851|525468245|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
145713708|NCT02229851|525468246|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
145713709|NCT02229851|525468247|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
145713710|NCT02229851|525468248|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
145713711|NCT02229851|525468249|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
145713712|NCT02229851|525468243|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713713|NCT02229851|525468244|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713714|NCT02229851|525468245|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
145713715|NCT02229851|525468246|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713716|NCT02229851|525468247|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713717|NCT02229851|525468248|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713718|NCT02229851|525468249|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
145713719|NCT02229851|525468243|FG000|Main Phase (Double-blind Phase)|Death|1|||
145713720|NCT02229851|525468244|FG001|Main Phase (Double-blind Phase)|Death|1|||
145713721|NCT02229851|525468245|FG002|Main Phase (Double-blind Phase)|Death|0|||
145713722|NCT02229851|525468246|FG003|Main Phase (Double-blind Phase)|Death|0|||
145713723|NCT02229851|525468247|FG004|Main Phase (Double-blind Phase)|Death|0|||
145713724|NCT02229851|525468248|FG005|Main Phase (Double-blind Phase)|Death|0|||
145713725|NCT02229851|525468249|FG006|Main Phase (Double-blind Phase)|Death|0|||
145713726|NCT02229851|525468243|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
145713727|NCT02229851|525468244|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
145713728|NCT02229851|525468245|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
145713729|NCT02229851|525468246|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
145713730|NCT02229851|525468247|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
145713731|NCT02229851|525468248|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
145713732|NCT02229851|525468249|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
145713733|NCT02229851|525468243|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
145713734|NCT02229851|525468244|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
145713735|NCT02229851|525468245|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
145713736|NCT02229851|525468246|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
145713737|NCT02229851|525468247|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
145713738|NCT02229851|525468248|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
145713739|NCT02229851|525468249|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
145713740|NCT02229851|525468243|FG000|Extension Phase (Open-label Phase)|Death|0|||
145713741|NCT02229851|525468244|FG001|Extension Phase (Open-label Phase)|Death|0|||
145713742|NCT02229851|525468245|FG002|Extension Phase (Open-label Phase)|Death|0|||
145713743|NCT02229851|525468246|FG003|Extension Phase (Open-label Phase)|Death|1|||
145713744|NCT02229851|525468247|FG004|Extension Phase (Open-label Phase)|Death|0|||
145713745|NCT02229851|525468248|FG005|Extension Phase (Open-label Phase)|Death|1|||
145713746|NCT02229851|525468249|FG006|Extension Phase (Open-label Phase)|Death|1|||
145713747|NCT03541200|525468250|FG000|Overall Study|Adverse Event|19|||
145713748|NCT03541200|525468250|FG000|Overall Study|Death|1|||
145713749|NCT03541200|525468250|FG000|Overall Study|Lost to Follow-up|10|||
145713750|NCT03541200|525468250|FG000|Overall Study|Physician Decision|1|||
145713751|NCT03541200|525468250|FG000|Overall Study|Protocol Violation|51|||
145713752|NCT03541200|525468250|FG000|Overall Study|Withdrawal by Subject|23|||
145713753|NCT03541200|525468250|FG000|Overall Study|other|8|||
145713754|NCT01607476|525468252|FG000|Overall Study|Withdrawal by Subject|1|||
145713755|NCT01607476|525468253|FG001|Overall Study|Withdrawal by Subject|0|||
145713756|NCT01607476|525468254|FG002|Overall Study|Withdrawal by Subject|1|||
145713757|NCT01607476|525468252|FG000|Overall Study|Lost to Follow-up|0|||
145713758|NCT01607476|525468253|FG001|Overall Study|Lost to Follow-up|0|||
145713759|NCT01607476|525468254|FG002|Overall Study|Lost to Follow-up|2|||
145713760|NCT04445987|525468255|FG000|Overall Study|Adverse Event|0|||
145713761|NCT04445987|525468256|FG001|Overall Study|Adverse Event|0|||
145713762|NCT04445987|525468257|FG002|Overall Study|Adverse Event|1|||
145713763|NCT04445987|525468258|FG003|Overall Study|Adverse Event|0|||
145713764|NCT04445987|525468259|FG004|Overall Study|Adverse Event|4|||
145713765|NCT04445987|525468260|FG005|Overall Study|Adverse Event|0|||
145713766|NCT04445987|525468255|FG000|Overall Study|Lost to Follow-up|4|||
145713767|NCT04445987|525468256|FG001|Overall Study|Lost to Follow-up|3|||
145713768|NCT04445987|525468257|FG002|Overall Study|Lost to Follow-up|1|||
145713769|NCT04445987|525468258|FG003|Overall Study|Lost to Follow-up|1|||
145713770|NCT04445987|525468259|FG004|Overall Study|Lost to Follow-up|29|||
145713771|NCT04445987|525468260|FG005|Overall Study|Lost to Follow-up|0|||
145713772|NCT04445987|525468255|FG000|Overall Study|Physician Decision|0|||
145713773|NCT04445987|525468256|FG001|Overall Study|Physician Decision|0|||
145713774|NCT04445987|525468257|FG002|Overall Study|Physician Decision|0|||
145713775|NCT04445987|525468258|FG003|Overall Study|Physician Decision|0|||
145713776|NCT04445987|525468259|FG004|Overall Study|Physician Decision|1|||
145713777|NCT04445987|525468260|FG005|Overall Study|Physician Decision|0|||
145713778|NCT04445987|525468255|FG000|Overall Study|Protocol Violation|1|||
145713779|NCT04445987|525468256|FG001|Overall Study|Protocol Violation|0|||
145713780|NCT04445987|525468257|FG002|Overall Study|Protocol Violation|0|||
145713781|NCT04445987|525468258|FG003|Overall Study|Protocol Violation|0|||
145713782|NCT04445987|525468259|FG004|Overall Study|Protocol Violation|2|||
145713783|NCT04445987|525468260|FG005|Overall Study|Protocol Violation|0|||
145713784|NCT04445987|525468255|FG000|Overall Study|Withdrawal by Subject|4|||
145713785|NCT04445987|525468256|FG001|Overall Study|Withdrawal by Subject|0|||
145713786|NCT04445987|525468257|FG002|Overall Study|Withdrawal by Subject|1|||
145713787|NCT04445987|525468258|FG003|Overall Study|Withdrawal by Subject|0|||
145713788|NCT04445987|525468259|FG004|Overall Study|Withdrawal by Subject|18|||
145713789|NCT04445987|525468260|FG005|Overall Study|Withdrawal by Subject|1|||
145713790|NCT04445987|525468255|FG000|Overall Study|Other reason|0|||
145713791|NCT04445987|525468256|FG001|Overall Study|Other reason|0|||
145713792|NCT04445987|525468257|FG002|Overall Study|Other reason|1|||
145713793|NCT04445987|525468258|FG003|Overall Study|Other reason|0|||
145713794|NCT04445987|525468259|FG004|Overall Study|Other reason|2|||
145713795|NCT04445987|525468260|FG005|Overall Study|Other reason|0|||
145713796|NCT00293059|525468263|FG000|Overall Study|Adverse Event|12|||
145713797|NCT00293059|525468264|FG001|Overall Study|Adverse Event|4|||
145713798|NCT00293059|525468263|FG000|Overall Study|Lack of Efficacy|2|||
145713799|NCT00293059|525468264|FG001|Overall Study|Lack of Efficacy|0|||
145713800|NCT00293059|525468263|FG000|Overall Study|Lost to Follow-up|2|||
145713801|NCT00293059|525468264|FG001|Overall Study|Lost to Follow-up|3|||
145713802|NCT00293059|525468263|FG000|Overall Study|Pregnancy|1|||
145713803|NCT00293059|525468264|FG001|Overall Study|Pregnancy|1|||
145713804|NCT00293059|525468263|FG000|Overall Study|Protocol Violation|2|||
145713805|NCT00293059|525468264|FG001|Overall Study|Protocol Violation|0|||
145713806|NCT00293059|525468263|FG000|Overall Study|Withdrawal by Subject|11|||
145713807|NCT00293059|525468264|FG001|Overall Study|Withdrawal by Subject|5|||
145713808|NCT00293059|525468263|FG000|Overall Study|Participant moved out of state|1|||
145713809|NCT00293059|525468264|FG001|Overall Study|Participant moved out of state|0|||
145713810|NCT00293059|525468263|FG000|Overall Study|Participant stopped study drug|1|||
145713811|NCT00293059|525468264|FG001|Overall Study|Participant stopped study drug|0|||
145713812|NCT00293059|525468263|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
145713813|NCT00293059|525468264|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
145713814|NCT00293059|525468263|FG000|Overall Study|missing|3|||
145713815|NCT00293059|525468264|FG001|Overall Study|missing|5|||
145713816|NCT02001064|525468265|FG000|Overall Study|Withdrawal by Subject|2|||
145713817|NCT02001064|525468266|FG001|Overall Study|Withdrawal by Subject|1|||
145713818|NCT00680992|525468267|FG000|Overall Study|Complete Resection (as per protocol)|25|||
145713819|NCT00680992|525468268|FG001|Overall Study|Complete Resection (as per protocol)|121|||
145713820|NCT00680992|525468269|FG002|Overall Study|Complete Resection (as per protocol)|0|||
145713821|NCT00680992|525468267|FG000|Overall Study|Administrative Decision|83|||
145713822|NCT00680992|525468268|FG001|Overall Study|Administrative Decision|42|||
145713823|NCT00680992|525468269|FG002|Overall Study|Administrative Decision|5|||
145713824|NCT00680992|525468267|FG000|Overall Study|End of Trial|32|||
145713825|NCT00680992|525468268|FG001|Overall Study|End of Trial|12|||
145713826|NCT00680992|525468269|FG002|Overall Study|End of Trial|3|||
145713827|NCT00680992|525468267|FG000|Overall Study|Withdrawal by Subject|33|||
145713828|NCT00680992|525468268|FG001|Overall Study|Withdrawal by Subject|11|||
145713829|NCT00680992|525468269|FG002|Overall Study|Withdrawal by Subject|1|||
145713830|NCT00680992|525468267|FG000|Overall Study|Adverse Event|21|||
145713831|NCT00680992|525468268|FG001|Overall Study|Adverse Event|19|||
145713832|NCT00680992|525468269|FG002|Overall Study|Adverse Event|1|||
145713833|NCT00680992|525468267|FG000|Overall Study|Other|19|||
145713834|NCT00680992|525468268|FG001|Overall Study|Other|14|||
145713835|NCT00680992|525468269|FG002|Overall Study|Other|1|||
145713836|NCT00680992|525468267|FG000|Overall Study|Disease Progression|21|||
145713837|NCT00680992|525468268|FG001|Overall Study|Disease Progression|9|||
145713838|NCT00680992|525468269|FG002|Overall Study|Disease Progression|0|||
145713839|NCT00680992|525468267|FG000|Overall Study|Lost to Follow-up|12|||
145713840|NCT00680992|525468268|FG001|Overall Study|Lost to Follow-up|14|||
145713841|NCT00680992|525468269|FG002|Overall Study|Lost to Follow-up|0|||
145713842|NCT00680992|525468267|FG000|Overall Study|Noncompliance|4|||
145713843|NCT00680992|525468268|FG001|Overall Study|Noncompliance|6|||
145713844|NCT00680992|525468269|FG002|Overall Study|Noncompliance|0|||
145491521|NCT04612725|524653829|FG002|Overall Study|Lost to Follow-up|0|||
145491522|NCT04612725|524653830|FG003|Overall Study|Lost to Follow-up|0|||
145713845|NCT00680992|525468267|FG000|Overall Study|Requirement for Alternative Therapy|8|||
145713846|NCT00680992|525468268|FG001|Overall Study|Requirement for Alternative Therapy|2|||
145713847|NCT00680992|525468269|FG002|Overall Study|Requirement for Alternative Therapy|0|||
145713848|NCT00680992|525468267|FG000|Overall Study|Pregnancy|5|||
145713849|NCT00680992|525468268|FG001|Overall Study|Pregnancy|0|||
145713850|NCT00680992|525468269|FG002|Overall Study|Pregnancy|1|||
145713851|NCT00680992|525468267|FG000|Overall Study|Death|5|||
145713852|NCT00680992|525468268|FG001|Overall Study|Death|1|||
145713853|NCT00680992|525468269|FG002|Overall Study|Death|0|||
145713854|NCT00680992|525468267|FG000|Overall Study|Ineligibility Determined|0|||
145713855|NCT00680992|525468268|FG001|Overall Study|Ineligibility Determined|1|||
145713856|NCT00680992|525468269|FG002|Overall Study|Ineligibility Determined|0|||
145713857|NCT02425904|525468270|FG000|Overall Study|Lost to Follow-up|1|||
145713858|NCT02425904|525468271|FG001|Overall Study|Lost to Follow-up|0|||
145713859|NCT02425904|525468270|FG000|Overall Study|Withdrawal by Subject|2|||
145713860|NCT02425904|525468271|FG001|Overall Study|Withdrawal by Subject|0|||
145713861|NCT02425904|525468270|FG000|Overall Study|Death|0|||
145713862|NCT02425904|525468271|FG001|Overall Study|Death|3|||
145713863|NCT05148962|525468272|FG000|Overall Study|Withdrawal by Subject|1|||
145713864|NCT05148962|525468273|FG001|Overall Study|Withdrawal by Subject|1|||
145713865|NCT05148962|525468274|FG002|Overall Study|Withdrawal by Subject|0|||
145713866|NCT05148962|525468275|FG003|Overall Study|Withdrawal by Subject|1|||
145713867|NCT05148962|525468276|FG004|Overall Study|Withdrawal by Subject|0|||
145713868|NCT05148962|525468272|FG000|Overall Study|Participant was early terminated per protocol|0|||
145713869|NCT05148962|525468273|FG001|Overall Study|Participant was early terminated per protocol|0|||
145713870|NCT05148962|525468274|FG002|Overall Study|Participant was early terminated per protocol|3|||
145713871|NCT05148962|525468275|FG003|Overall Study|Participant was early terminated per protocol|5|||
145713872|NCT05148962|525468276|FG004|Overall Study|Participant was early terminated per protocol|2|||
145713873|NCT05148962|525468272|FG000|Overall Study|Miscellaneous|0|||
145713874|NCT05148962|525468273|FG001|Overall Study|Miscellaneous|0|||
145713875|NCT05148962|525468274|FG002|Overall Study|Miscellaneous|0|||
145713876|NCT05148962|525468275|FG003|Overall Study|Miscellaneous|1|||
145713877|NCT05148962|525468276|FG004|Overall Study|Miscellaneous|0|||
145713878|NCT01732822|525469873|FG000|Overall Study|Withdrawal by Subject|123|||
145713879|NCT01732822|525469874|FG001|Overall Study|Withdrawal by Subject|113|||
145713880|NCT00591370|525469875|FG000|Overall Study|Not Treated|2|||
145713881|NCT00316602|525469876|FG000|Overall Study|Withdrawal by Subject|3|||
145713882|NCT00316602|525469877|FG001|Overall Study|Withdrawal by Subject|2|||
145713883|NCT00316602|525469876|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
145713884|NCT00316602|525469877|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
145713885|NCT00316602|525469876|FG000|Overall Study|Adverse Event|1|||
145713886|NCT00316602|525469877|FG001|Overall Study|Adverse Event|0|||
145713887|NCT00316602|525469876|FG000|Overall Study|Other|3|||
145713888|NCT00316602|525469877|FG001|Overall Study|Other|6|||
145713889|NCT01142232|525469878|FG000|Overall Study|Adverse Event|1|||
145713890|NCT01142232|525469879|FG001|Overall Study|Adverse Event|2|||
145713891|NCT01142232|525469880|FG002|Overall Study|Adverse Event|1|||
145713892|NCT01142232|525469881|FG003|Overall Study|Adverse Event|0|||
145713893|NCT01142232|525469882|FG004|Overall Study|Adverse Event|4|||
145713894|NCT01142232|525469878|FG000|Overall Study|Death|0|||
145713895|NCT01142232|525469879|FG001|Overall Study|Death|0|||
145713896|NCT01142232|525469880|FG002|Overall Study|Death|0|||
145713897|NCT01142232|525469881|FG003|Overall Study|Death|0|||
145713898|NCT01142232|525469882|FG004|Overall Study|Death|1|||
145713899|NCT01142232|525469878|FG000|Overall Study|Disease Progression|2|||
145713900|NCT01142232|525469879|FG001|Overall Study|Disease Progression|0|||
145713901|NCT01142232|525469880|FG002|Overall Study|Disease Progression|1|||
145713902|NCT01142232|525469881|FG003|Overall Study|Disease Progression|2|||
145713903|NCT01142232|525469882|FG004|Overall Study|Disease Progression|12|||
145713904|NCT01142232|525469878|FG000|Overall Study|Withdrawal by Subject|0|||
145713905|NCT01142232|525469879|FG001|Overall Study|Withdrawal by Subject|0|||
145713906|NCT01142232|525469880|FG002|Overall Study|Withdrawal by Subject|0|||
145713907|NCT01142232|525469881|FG003|Overall Study|Withdrawal by Subject|1|||
145713908|NCT01142232|525469882|FG004|Overall Study|Withdrawal by Subject|3|||
145713909|NCT01142232|525469878|FG000|Overall Study|Physician Decision|0|||
145713910|NCT01142232|525469879|FG001|Overall Study|Physician Decision|1|||
145713911|NCT01142232|525469880|FG002|Overall Study|Physician Decision|0|||
145713912|NCT01142232|525469881|FG003|Overall Study|Physician Decision|2|||
145713913|NCT01142232|525469882|FG004|Overall Study|Physician Decision|10|||
145713914|NCT01142232|525469878|FG000|Overall Study|Alternative Therapy|0|||
145713915|NCT01142232|525469879|FG001|Overall Study|Alternative Therapy|1|||
145713916|NCT01142232|525469880|FG002|Overall Study|Alternative Therapy|1|||
145713917|NCT01142232|525469881|FG003|Overall Study|Alternative Therapy|0|||
145713918|NCT01142232|525469882|FG004|Overall Study|Alternative Therapy|1|||
145713919|NCT01142232|525469878|FG000|Overall Study|Off Trt for other complicating disease|0|||
145713920|NCT01142232|525469879|FG001|Overall Study|Off Trt for other complicating disease|0|||
145713921|NCT01142232|525469880|FG002|Overall Study|Off Trt for other complicating disease|0|||
145713922|NCT01142232|525469881|FG003|Overall Study|Off Trt for other complicating disease|0|||
145713923|NCT01142232|525469882|FG004|Overall Study|Off Trt for other complicating disease|1|||
145713924|NCT01142232|525469878|FG000|Overall Study|Noncompliance|0|||
145713925|NCT01142232|525469879|FG001|Overall Study|Noncompliance|0|||
145713926|NCT01142232|525469880|FG002|Overall Study|Noncompliance|0|||
145713927|NCT01142232|525469881|FG003|Overall Study|Noncompliance|0|||
145713928|NCT01142232|525469882|FG004|Overall Study|Noncompliance|2|||
145713929|NCT00626990|525469883|FG000|Overall Study|Lack of Efficacy|6|||
145713930|NCT00626990|525469884|FG001|Overall Study|Lack of Efficacy|7|||
145713931|NCT00626990|525469885|FG002|Overall Study|Lack of Efficacy|49|||
145713932|NCT00626990|525469886|FG003|Overall Study|Lack of Efficacy|40|||
145713933|NCT00626990|525469883|FG000|Overall Study|Adverse Event|1|||
145713934|NCT00626990|525469884|FG001|Overall Study|Adverse Event|7|||
145713935|NCT00626990|525469885|FG002|Overall Study|Adverse Event|14|||
145713936|NCT00626990|525469886|FG003|Overall Study|Adverse Event|28|||
145713937|NCT00626990|525469883|FG000|Overall Study|Death|0|||
145713938|NCT00626990|525469884|FG001|Overall Study|Death|1|||
145713939|NCT00626990|525469885|FG002|Overall Study|Death|0|||
145713940|NCT00626990|525469886|FG003|Overall Study|Death|0|||
145713941|NCT00626990|525469883|FG000|Overall Study|Withdrawal by Subject|3|||
145713942|NCT00626990|525469884|FG001|Overall Study|Withdrawal by Subject|1|||
145713943|NCT00626990|525469885|FG002|Overall Study|Withdrawal by Subject|5|||
145713944|NCT00626990|525469886|FG003|Overall Study|Withdrawal by Subject|11|||
145713945|NCT00626990|525469883|FG000|Overall Study|Protocol Violation|0|||
145713946|NCT00626990|525469884|FG001|Overall Study|Protocol Violation|1|||
145713947|NCT00626990|525469885|FG002|Overall Study|Protocol Violation|1|||
145713948|NCT00626990|525469886|FG003|Overall Study|Protocol Violation|0|||
145713949|NCT00626990|525469883|FG000|Overall Study|Various different reasons/missing|4|||
145713950|NCT00626990|525469884|FG001|Overall Study|Various different reasons/missing|8|||
145713951|NCT00626990|525469885|FG002|Overall Study|Various different reasons/missing|8|||
145713952|NCT00626990|525469886|FG003|Overall Study|Various different reasons/missing|16|||
145713953|NCT04138576|525469887|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
145713954|NCT01994837|525469888|FG000|Overall Study|Progressive disease per protocol|23|||
145713955|NCT01994837|525469888|FG000|Overall Study|Adv event related to progressive disease|3|||
145713956|NCT01994837|525469888|FG000|Overall Study|Fatal progressive disease|2|||
145713957|NCT01994837|525469888|FG000|Overall Study|Adverse event not related to progression|1|||
145713958|NCT01994837|525469888|FG000|Overall Study|Chose palliative care|1|||
145713959|NCT01994837|525469888|FG000|Overall Study|Proceeded to transplant|1|||
145713960|NCT01994837|525469888|FG000|Overall Study|Removed from study due to no response|1|||
145713961|NCT00574873|525469890|FG000|Overall Study|Withdrawal by Subject|18|||
145713962|NCT00574873|525469891|FG001|Overall Study|Withdrawal by Subject|19|||
145713963|NCT00574873|525469890|FG000|Overall Study|Investigator request|18|||
145713964|NCT00574873|525469891|FG001|Overall Study|Investigator request|8|||
145713965|NCT00574873|525469890|FG000|Overall Study|Death|15|||
145713966|NCT00574873|525469891|FG001|Overall Study|Death|14|||
145713967|NCT00574873|525469890|FG000|Overall Study|Lost to Follow-up|14|||
145713968|NCT00574873|525469891|FG001|Overall Study|Lost to Follow-up|5|||
145713969|NCT00574873|525469890|FG000|Overall Study|Other|40|||
145713970|NCT00574873|525469891|FG001|Overall Study|Other|4|||
145713971|NCT00574873|525469890|FG000|Overall Study|Discontinuation of study by sponsor|5|||
145713972|NCT00574873|525469891|FG001|Overall Study|Discontinuation of study by sponsor|199|||
145713973|NCT00574873|525469890|FG000|Overall Study|Blank, site closed per local regulations|2|||
145713974|NCT00574873|525469891|FG001|Overall Study|Blank, site closed per local regulations|2|||
145713975|NCT00574873|525469890|FG000|Overall Study|Extension Study|126|||
145713976|NCT00574873|525469891|FG001|Overall Study|Extension Study|0|||
145713977|NCT00581555|525469893|FG000|Overall Study|Adverse Event|4|||
145713978|NCT00581555|525469894|FG001|Overall Study|Adverse Event|3|||
145713979|NCT00581555|525469893|FG000|Overall Study|Physician Decision|3|||
145713980|NCT00581555|525469894|FG001|Overall Study|Physician Decision|2|||
145713981|NCT00581555|525469893|FG000|Overall Study|Withdrawal by Subject|18|||
145713982|NCT00581555|525469894|FG001|Overall Study|Withdrawal by Subject|9|||
145713983|NCT00581555|525469893|FG000|Overall Study|Lost to Follow-up|2|||
145713984|NCT00581555|525469894|FG001|Overall Study|Lost to Follow-up|2|||
145491523|NCT04612725|524653831|FG004|Overall Study|Lost to Follow-up|0|||
145491524|NCT04612725|524653827|FG000|Overall Study|Physician Decision|2|||
145713985|NCT00581555|525469893|FG000|Overall Study|Other reasons|16|||
145713986|NCT00581555|525469894|FG001|Overall Study|Other reasons|4|||
145713987|NCT00201643|525469895|FG000|Overall Study|Withdrawal by Subject|5|||
145713988|NCT00201643|525469896|FG001|Overall Study|Withdrawal by Subject|4|||
145713989|NCT03446781|525469897|FG000|Overall Study|Lost to Follow-up|11|||
145713990|NCT03446781|525469898|FG001|Overall Study|Lost to Follow-up|5|||
145491525|NCT04612725|524653828|FG001|Overall Study|Physician Decision|0|||
145713991|NCT03446781|525469897|FG000|Overall Study|Withdrawal by Subject|9|||
145713992|NCT03446781|525469898|FG001|Overall Study|Withdrawal by Subject|7|||
145713993|NCT03446781|525469897|FG000|Overall Study|Adverse Event|8|||
145713994|NCT03446781|525469898|FG001|Overall Study|Adverse Event|2|||
145713995|NCT03446781|525469897|FG000|Overall Study|Protocol Violation|0|||
145713996|NCT03446781|525469898|FG001|Overall Study|Protocol Violation|3|||
145713997|NCT03568318|525469905|FG000|Overall Study|Adverse Event|3|||
145713998|NCT03568318|525469906|FG001|Overall Study|Adverse Event|1|||
145713999|NCT03568318|525469907|FG002|Overall Study|Adverse Event|1|||
145714000|NCT03568318|525469908|FG003|Overall Study|Adverse Event|0|||
145714001|NCT03568318|525469909|FG004|Overall Study|Adverse Event|1|||
145714002|NCT03568318|525469910|FG005|Overall Study|Adverse Event|0|||
145714003|NCT03568318|525469905|FG000|Overall Study|Withdrawal by Subject|6|||
145714004|NCT03568318|525469906|FG001|Overall Study|Withdrawal by Subject|5|||
145714005|NCT03568318|525469907|FG002|Overall Study|Withdrawal by Subject|2|||
145714006|NCT03568318|525469908|FG003|Overall Study|Withdrawal by Subject|1|||
145714007|NCT03568318|525469909|FG004|Overall Study|Withdrawal by Subject|0|||
145714008|NCT03568318|525469910|FG005|Overall Study|Withdrawal by Subject|0|||
145714009|NCT03568318|525469905|FG000|Overall Study|Lost to Follow-up|3|||
145714010|NCT03568318|525469906|FG001|Overall Study|Lost to Follow-up|2|||
145714011|NCT03568318|525469907|FG002|Overall Study|Lost to Follow-up|2|||
145714012|NCT03568318|525469908|FG003|Overall Study|Lost to Follow-up|2|||
145714013|NCT03568318|525469909|FG004|Overall Study|Lost to Follow-up|1|||
145714014|NCT03568318|525469910|FG005|Overall Study|Lost to Follow-up|0|||
145714015|NCT03568318|525469905|FG000|Overall Study|Other|3|||
145714016|NCT03568318|525469906|FG001|Overall Study|Other|1|||
145714017|NCT03568318|525469907|FG002|Overall Study|Other|3|||
145714018|NCT03568318|525469908|FG003|Overall Study|Other|0|||
145714019|NCT03568318|525469909|FG004|Overall Study|Other|0|||
145714020|NCT03568318|525469910|FG005|Overall Study|Other|0|||
145714021|NCT03568318|525469905|FG000|Overall Study|Ongoing at Time of Analysis|5|||
145714022|NCT03568318|525469906|FG001|Overall Study|Ongoing at Time of Analysis|3|||
145714023|NCT03568318|525469907|FG002|Overall Study|Ongoing at Time of Analysis|2|||
145714024|NCT03568318|525469908|FG003|Overall Study|Ongoing at Time of Analysis|1|||
145714025|NCT03568318|525469909|FG004|Overall Study|Ongoing at Time of Analysis|0|||
145714026|NCT03568318|525469910|FG005|Overall Study|Ongoing at Time of Analysis|0|||
145714027|NCT02898077|525469911|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
145714028|NCT02898077|525469912|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
145714029|NCT02898077|525469911|FG000|Overall Study|Lost to Follow-up|4|||
145714030|NCT02898077|525469912|FG001|Overall Study|Lost to Follow-up|3|||
145714031|NCT02898077|525469911|FG000|Overall Study|Physician Decision|0|||
145714032|NCT02898077|525469912|FG001|Overall Study|Physician Decision|2|||
145714033|NCT02898077|525469911|FG000|Overall Study|Sponsor Decision|32|||
145714034|NCT02898077|525469912|FG001|Overall Study|Sponsor Decision|13|||
145714035|NCT02898077|525469911|FG000|Overall Study|Withdrawal by Subject|6|||
145714036|NCT02898077|525469912|FG001|Overall Study|Withdrawal by Subject|3|||
145714037|NCT02898077|525469911|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
145714038|NCT02898077|525469912|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
145714039|NCT02898077|525469911|FG000|Overall Study|Ended extension period|3|||
145714040|NCT02898077|525469912|FG001|Overall Study|Ended extension period|0|||
145714041|NCT04410523|525469913|FG000|Overall Study|Study terminated by sponsor|1|||
145714042|NCT04410523|525469914|FG001|Overall Study|Study terminated by sponsor|3|||
145714043|NCT04410523|525469915|FG002|Overall Study|Study terminated by sponsor|2|||
145714044|NCT04410523|525469916|FG003|Overall Study|Study terminated by sponsor|6|||
145714045|NCT04410523|525469917|FG004|Overall Study|Study terminated by sponsor|3|||
145714046|NCT04410523|525469918|FG005|Overall Study|Study terminated by sponsor|4|||
145714047|NCT04410523|525469913|FG000|Overall Study|Adverse Event|1|||
145714048|NCT04410523|525469914|FG001|Overall Study|Adverse Event|0|||
145714049|NCT04410523|525469915|FG002|Overall Study|Adverse Event|0|||
145714050|NCT04410523|525469916|FG003|Overall Study|Adverse Event|0|||
145714051|NCT04410523|525469917|FG004|Overall Study|Adverse Event|0|||
145714052|NCT04410523|525469918|FG005|Overall Study|Adverse Event|2|||
145714053|NCT04410523|525469913|FG000|Overall Study|Lost to Follow-up|0|||
145714054|NCT04410523|525469914|FG001|Overall Study|Lost to Follow-up|1|||
145714055|NCT04410523|525469915|FG002|Overall Study|Lost to Follow-up|0|||
145714056|NCT04410523|525469916|FG003|Overall Study|Lost to Follow-up|0|||
145714057|NCT04410523|525469917|FG004|Overall Study|Lost to Follow-up|0|||
145714058|NCT04410523|525469918|FG005|Overall Study|Lost to Follow-up|0|||
145714059|NCT04410523|525469913|FG000|Overall Study|Physician Decision|0|||
145714060|NCT04410523|525469914|FG001|Overall Study|Physician Decision|1|||
145714061|NCT04410523|525469915|FG002|Overall Study|Physician Decision|0|||
145714062|NCT04410523|525469916|FG003|Overall Study|Physician Decision|0|||
145714063|NCT04410523|525469917|FG004|Overall Study|Physician Decision|0|||
145714064|NCT04410523|525469918|FG005|Overall Study|Physician Decision|0|||
145714065|NCT04410523|525469913|FG000|Overall Study|Pregnancy|0|||
145714066|NCT04410523|525469914|FG001|Overall Study|Pregnancy|0|||
145714067|NCT04410523|525469915|FG002|Overall Study|Pregnancy|0|||
145714068|NCT04410523|525469916|FG003|Overall Study|Pregnancy|0|||
145714069|NCT04410523|525469917|FG004|Overall Study|Pregnancy|0|||
145714070|NCT04410523|525469918|FG005|Overall Study|Pregnancy|1|||
145714071|NCT04410523|525469913|FG000|Overall Study|Protocol deviation|0|||
145714072|NCT04410523|525469914|FG001|Overall Study|Protocol deviation|0|||
145714073|NCT04410523|525469915|FG002|Overall Study|Protocol deviation|0|||
145714074|NCT04410523|525469916|FG003|Overall Study|Protocol deviation|0|||
145714075|NCT04410523|525469917|FG004|Overall Study|Protocol deviation|0|||
145714076|NCT04410523|525469918|FG005|Overall Study|Protocol deviation|2|||
145714077|NCT04410523|525469913|FG000|Overall Study|Subject decision|2|||
145714078|NCT04410523|525469914|FG001|Overall Study|Subject decision|0|||
145714079|NCT04410523|525469915|FG002|Overall Study|Subject decision|0|||
145714080|NCT04410523|525469916|FG003|Overall Study|Subject decision|1|||
145714081|NCT04410523|525469917|FG004|Overall Study|Subject decision|0|||
145714082|NCT04410523|525469918|FG005|Overall Study|Subject decision|1|||
145714083|NCT01638429|525469921|FG000|Overall Study|Withdrawal by Subject|1|||
145714084|NCT03207451|525469922|FG000|Overall Study|scheduling conflict|1|||
145714085|NCT03207451|525469923|FG001|Overall Study|scheduling conflict|0|||
145714086|NCT03207451|525469924|FG002|Overall Study|scheduling conflict|2|||
145714087|NCT03207451|525469925|FG003|Overall Study|scheduling conflict|2|||
145714088|NCT03207451|525469922|FG000|Overall Study|Adverse Event|0|||
145714089|NCT03207451|525469923|FG001|Overall Study|Adverse Event|0|||
145714090|NCT03207451|525469924|FG002|Overall Study|Adverse Event|0|||
145714091|NCT03207451|525469925|FG003|Overall Study|Adverse Event|1|||
145714092|NCT02040584|525469927|FG000|Overall Study|Adverse Event|13|||
145714093|NCT02040584|525469928|FG001|Overall Study|Adverse Event|6|||
145714094|NCT02040584|525469927|FG000|Overall Study|Protocol Violation|9|||
145714095|NCT02040584|525469928|FG001|Overall Study|Protocol Violation|11|||
145714096|NCT02040584|525469927|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145714097|NCT02040584|525469928|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145714098|NCT02040584|525469927|FG000|Overall Study|Death|6|||
145714099|NCT02040584|525469928|FG001|Overall Study|Death|3|||
145714100|NCT02040584|525469927|FG000|Overall Study|Transplant rejection/retransplant|0|||
145714101|NCT02040584|525469928|FG001|Overall Study|Transplant rejection/retransplant|1|||
145714102|NCT02040584|525469927|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
145714103|NCT02040584|525469928|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
145714104|NCT01802567|525469929|FG000|Overall Study|Withdrawal by Subject|2|||
145714105|NCT01802567|525469929|FG000|Overall Study|Physician Decision|1|||
145714106|NCT01802567|525469929|FG000|Overall Study|Lack of Efficacy|7|||
145714107|NCT01802567|525469929|FG000|Overall Study|Consented but did not start therapy|7|||
145714108|NCT01802567|525469929|FG000|Overall Study|Protocol Violation|1|||
145714109|NCT01940939|525469930|FG000|Overall Study|Withdrawal by Subject|2|||
145714110|NCT01940939|525469931|FG001|Overall Study|Withdrawal by Subject|8|||
145714111|NCT03896152|525469935|FG000|Overall Study|Patient/guardian decision|1|||
145714112|NCT03896152|525469936|FG001|Overall Study|Patient/guardian decision|1|||
145714113|NCT03896152|525469935|FG000|Overall Study|Adverse Event|0|||
145714114|NCT03896152|525469936|FG001|Overall Study|Adverse Event|1|||
145714115|NCT03896152|525469935|FG000|Overall Study|Physician Decision|1|||
145714116|NCT03896152|525469936|FG001|Overall Study|Physician Decision|0|||
145714117|NCT03896152|525469935|FG000|Overall Study|Technical problems|1|||
145714118|NCT03896152|525469936|FG001|Overall Study|Technical problems|0|||
145714119|NCT00436852|525469937|FG000|Overall Study|Death|23|||
145714120|NCT00436852|525469938|FG001|Overall Study|Death|34|||
145714121|NCT00436852|525469937|FG000|Overall Study|Lack of Efficacy|9|||
145714122|NCT00436852|525469938|FG001|Overall Study|Lack of Efficacy|7|||
145714123|NCT00436852|525469937|FG000|Overall Study|Withdrawal by Subject|2|||
145714124|NCT00436852|525469938|FG001|Overall Study|Withdrawal by Subject|4|||
145714125|NCT00436852|525469937|FG000|Overall Study|Ineligible|1|||
145714126|NCT00436852|525469938|FG001|Overall Study|Ineligible|0|||
145714127|NCT00370682|525469939|FG000|Overall Study|Moved from area|0|||
145714128|NCT00370682|525469940|FG001|Overall Study|Moved from area|2|||
145714129|NCT00370682|525469941|FG002|Overall Study|Moved from area|0|||
145714130|NCT00370682|525469939|FG000|Overall Study|Lost to Follow-up|0|||
145714131|NCT00370682|525469940|FG001|Overall Study|Lost to Follow-up|1|||
145714132|NCT00370682|525469941|FG002|Overall Study|Lost to Follow-up|1|||
145714133|NCT03167359|525469942|FG000|Overall Study|Physician Decision|1|||
145714134|NCT03167359|525469942|FG000|Overall Study|Lost to Follow-up|1|||
145714135|NCT00943852|525469943|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714136|NCT00943852|525469944|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714137|NCT00943852|525469945|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714138|NCT00943852|525469946|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
145714139|NCT00943852|525469947|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145491526|NCT04612725|524653829|FG002|Overall Study|Physician Decision|0|||
145714140|NCT00943852|525469948|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714141|NCT00943852|525469949|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714142|NCT00943852|525469950|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145491527|NCT04612725|524653830|FG003|Overall Study|Physician Decision|0|||
145491528|NCT04612725|524653831|FG004|Overall Study|Physician Decision|0|||
145714143|NCT00943852|525469951|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714144|NCT00943852|525469952|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
145714145|NCT00943852|525469943|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714146|NCT00943852|525469944|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714147|NCT00943852|525469945|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714148|NCT00943852|525469946|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714149|NCT00943852|525469947|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714150|NCT00943852|525469948|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
145714151|NCT00943852|525469949|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714152|NCT00943852|525469950|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714153|NCT00943852|525469951|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714154|NCT00943852|525469952|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
145714155|NCT00943852|525469943|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714156|NCT00943852|525469944|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714157|NCT00943852|525469945|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714158|NCT00943852|525469946|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714159|NCT00943852|525469947|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714160|NCT00943852|525469948|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714161|NCT00943852|525469949|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
145714162|NCT00943852|525469950|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714163|NCT00943852|525469951|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714164|NCT00943852|525469952|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
145714165|NCT00943852|525469943|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714166|NCT00943852|525469944|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714167|NCT00943852|525469945|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714168|NCT00943852|525469946|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714169|NCT00943852|525469947|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714170|NCT00943852|525469948|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714171|NCT00943852|525469949|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714172|NCT00943852|525469950|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
145714173|NCT00943852|525469951|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714174|NCT00943852|525469952|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
145714175|NCT00943852|525469943|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
145714176|NCT00943852|525469944|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714177|NCT00943852|525469945|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
145714178|NCT00943852|525469946|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
145714179|NCT00943852|525469947|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714180|NCT00943852|525469948|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714181|NCT00943852|525469949|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
145714182|NCT00943852|525469950|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714183|NCT00943852|525469951|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714184|NCT00943852|525469952|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
145714185|NCT00772330|525469953|FG000|Overall Study|Lost to Follow-up|3|||
145714186|NCT01519089|525469954|FG000|Overall Study|Adverse Event|4|||
145714187|NCT01519089|525469955|FG001|Overall Study|Adverse Event|4|||
145714188|NCT01519089|525469954|FG000|Overall Study|Lack of Efficacy|0|||
145714189|NCT01519089|525469955|FG001|Overall Study|Lack of Efficacy|2|||
145714190|NCT01519089|525469954|FG000|Overall Study|Lost to Follow-up|1|||
145714191|NCT01519089|525469955|FG001|Overall Study|Lost to Follow-up|0|||
145714192|NCT01519089|525469954|FG000|Overall Study|Withdrawal by Subject|0|||
145714193|NCT01519089|525469955|FG001|Overall Study|Withdrawal by Subject|2|||
145714194|NCT01519089|525469954|FG000|Overall Study|Other|2|||
145714195|NCT01519089|525469955|FG001|Overall Study|Other|6|||
145714196|NCT01519089|525469954|FG000|Overall Study|Not received study drug|0|||
145714197|NCT01519089|525469955|FG001|Overall Study|Not received study drug|1|||
145714198|NCT00127205|525469956|FG000|Overall Study|Adverse Event|228|||
145714199|NCT00127205|525469957|FG001|Overall Study|Adverse Event|387|||
145714200|NCT00127205|525469958|FG002|Overall Study|Adverse Event|273|||
145714201|NCT00127205|525469956|FG000|Overall Study|Death|8|||
145714202|NCT00127205|525469957|FG001|Overall Study|Death|6|||
145714203|NCT00127205|525469958|FG002|Overall Study|Death|5|||
145714204|NCT00127205|525469956|FG000|Overall Study|Withdrawal by Subject|318|||
145714205|NCT00127205|525469957|FG001|Overall Study|Withdrawal by Subject|310|||
145714206|NCT00127205|525469958|FG002|Overall Study|Withdrawal by Subject|172|||
145714207|NCT00127205|525469956|FG000|Overall Study|Other-non protocol specified|142|||
145714208|NCT00127205|525469957|FG001|Overall Study|Other-non protocol specified|129|||
145714209|NCT00127205|525469958|FG002|Overall Study|Other-non protocol specified|77|||
145714210|NCT00127205|525469956|FG000|Overall Study|Data not reported|6|||
145714211|NCT00127205|525469957|FG001|Overall Study|Data not reported|10|||
145714212|NCT00127205|525469958|FG002|Overall Study|Data not reported|1|||
145714213|NCT00127205|525469956|FG000|Overall Study|Progression|127|||
145714214|NCT00127205|525469957|FG001|Overall Study|Progression|131|||
145714215|NCT00127205|525469958|FG002|Overall Study|Progression|84|||
145714216|NCT05032872|525469959|FG000|Overall Study|Adverse Event|1|||
145714217|NCT05032872|525469960|FG001|Overall Study|Adverse Event|0|||
145714218|NCT05032872|525469959|FG000|Overall Study|Lost to Follow-up|2|||
145714219|NCT05032872|525469960|FG001|Overall Study|Lost to Follow-up|4|||
145714220|NCT05032872|525469959|FG000|Overall Study|Withdrawal by Subject|4|||
145714221|NCT05032872|525469960|FG001|Overall Study|Withdrawal by Subject|3|||
145714222|NCT00910039|525469961|FG000|Overall Study|Physician Decision|1|||
145714223|NCT03192475|525469967|FG000|Overall Study|Death|0|||
145714224|NCT03192475|525469968|FG001|Overall Study|Death|1|||
145714225|NCT03192475|525469967|FG000|Overall Study|Lost to Follow-up|13|||
145714226|NCT03192475|525469968|FG001|Overall Study|Lost to Follow-up|8|||
145714227|NCT00798590|525469969|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
145714228|NCT00798590|525469970|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
145714229|NCT00436605|525469974|FG000|Overall Study|Protocol Violation|3|||
145714230|NCT03014011|525469975|FG000|First Intervention|Withdrawal by Subject|1|||
145714231|NCT03014011|525469976|FG001|First Intervention|Withdrawal by Subject|0|||
145714232|NCT03014011|525469975|FG000|Washout|Withdrawal by Subject|1|||
145714233|NCT03014011|525469976|FG001|Washout|Withdrawal by Subject|0|||
145714234|NCT00573859|525469977|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
145714235|NCT00573859|525469977|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
145714236|NCT00688870|525469984|FG000|Infant Series|Parent or legal guardian request|4|||
145714237|NCT00688870|525469985|FG001|Infant Series|Parent or legal guardian request|0|||
145714238|NCT01253018|525469988|FG000|Overall Study|Lost to Follow-up|1|||
145714239|NCT01253018|525469989|FG001|Overall Study|Lost to Follow-up|1|||
145714240|NCT01253018|525469988|FG000|Overall Study|Robot Repair Issues|2|||
145714241|NCT01253018|525469989|FG001|Overall Study|Robot Repair Issues|0|||
145714242|NCT01253018|525469988|FG000|Overall Study|Withdrawal by Subject|1|||
145714243|NCT01253018|525469989|FG001|Overall Study|Withdrawal by Subject|1|||
145714244|NCT03449901|525469990|FG000|Overall Study|Progression|57|||
145714245|NCT03449901|525469991|FG001|Overall Study|Progression|12|||
145714246|NCT03449901|525469990|FG000|Overall Study|Adverse Event|3|||
145714247|NCT03449901|525469991|FG001|Overall Study|Adverse Event|0|||
145714248|NCT03449901|525469990|FG000|Overall Study|Death|6|||
145714249|NCT03449901|525469991|FG001|Overall Study|Death|2|||
145714250|NCT03449901|525469990|FG000|Overall Study|Withdrawal by Subject|12|||
145714251|NCT03449901|525469991|FG001|Overall Study|Withdrawal by Subject|1|||
145714252|NCT03449901|525469990|FG000|Overall Study|Physician Decision|1|||
145714253|NCT03449901|525469991|FG001|Overall Study|Physician Decision|0|||
145714254|NCT03449901|525469990|FG000|Overall Study|Patient elected for surgical intervention|1|||
145714255|NCT03449901|525469991|FG001|Overall Study|Patient elected for surgical intervention|0|||
145714256|NCT03449901|525469990|FG000|Overall Study|Patient off for other complicating disease|1|||
145714257|NCT03449901|525469991|FG001|Overall Study|Patient off for other complicating disease|0|||
145714258|NCT00744757|525469992|FG000|Overall Study|Objective disease progression|7|||
145714259|NCT00744757|525469992|FG000|Overall Study|Physician Decision|5|||
145714260|NCT00744757|525469992|FG000|Overall Study|Withdrawal by Subject|1|||
145714261|NCT00744757|525469992|FG000|Overall Study|Death|6|||
145714262|NCT00744757|525469992|FG000|Overall Study|Adverse Event|2|||
145714263|NCT03682302|525469993|FG000|Overall Study|Lost to Follow-up|1|||
145714264|NCT03682302|525469994|FG001|Overall Study|Lost to Follow-up|2|||
145714265|NCT03682302|525469995|FG002|Overall Study|Lost to Follow-up|0|||
145714266|NCT03682302|525469996|FG003|Overall Study|Lost to Follow-up|1|||
145714267|NCT03682302|525469993|FG000|Overall Study|Study drug was not administered|0|||
145714268|NCT03682302|525469994|FG001|Overall Study|Study drug was not administered|0|||
145714269|NCT03682302|525469995|FG002|Overall Study|Study drug was not administered|1|||
145714270|NCT03682302|525469996|FG003|Overall Study|Study drug was not administered|1|||
145714271|NCT00532493|525469997|FG000|Overall Study|Death|1|||
145714272|NCT00532493|525469998|FG001|Overall Study|Death|1|||
145714273|NCT00532493|525469997|FG000|Overall Study|Lost to Follow-up|10|||
145714274|NCT00532493|525469998|FG001|Overall Study|Lost to Follow-up|7|||
145714275|NCT00532493|525469997|FG000|Overall Study|Withdrawal by Subject|7|||
145714276|NCT00532493|525469998|FG001|Overall Study|Withdrawal by Subject|9|||
145714277|NCT00532493|525469997|FG000|Overall Study|Physician Decision|1|||
145714278|NCT00532493|525469998|FG001|Overall Study|Physician Decision|6|||
145714279|NCT00532493|525469997|FG000|Overall Study|Adverse Event|6|||
145714280|NCT00532493|525469998|FG001|Overall Study|Adverse Event|5|||
145714281|NCT00532493|525469997|FG000|Overall Study|Protocol Deviation|1|||
145714282|NCT00532493|525469998|FG001|Overall Study|Protocol Deviation|0|||
145714283|NCT00532493|525469997|FG000|Overall Study|Subject Moved Away|3|||
145714284|NCT00532493|525469998|FG001|Overall Study|Subject Moved Away|1|||
145714285|NCT00532493|525469997|FG000|Overall Study|Contraindicative Medication|1|||
145714286|NCT00532493|525469998|FG001|Overall Study|Contraindicative Medication|0|||
145714287|NCT01769326|525470004|FG000|Overall Study|Lost to Follow-up|1|||
145714288|NCT01769326|525470005|FG001|Overall Study|Lost to Follow-up|2|||
145714289|NCT01769326|525470006|FG002|Overall Study|Lost to Follow-up|0|||
145714290|NCT01769326|525470007|FG003|Overall Study|Lost to Follow-up|0|||
145714291|NCT01769326|525470004|FG000|Overall Study|unrelated injry|1|||
145714292|NCT01769326|525470005|FG001|Overall Study|unrelated injry|1|||
145714293|NCT01769326|525470006|FG002|Overall Study|unrelated injry|0|||
145714294|NCT01769326|525470007|FG003|Overall Study|unrelated injry|0|||
145714295|NCT01769326|525470004|FG000|Overall Study|got a job|0|||
145714296|NCT01769326|525470005|FG001|Overall Study|got a job|1|||
145714297|NCT01769326|525470006|FG002|Overall Study|got a job|0|||
145714298|NCT01769326|525470007|FG003|Overall Study|got a job|0|||
145714299|NCT01769326|525470004|FG000|Overall Study|Got sick and could not complete study|0|||
145714300|NCT01769326|525470005|FG001|Overall Study|Got sick and could not complete study|0|||
145714301|NCT01769326|525470006|FG002|Overall Study|Got sick and could not complete study|1|||
145714302|NCT01769326|525470007|FG003|Overall Study|Got sick and could not complete study|0|||
145714303|NCT03459443|525470008|FG000|Overall Study|Lack of Efficacy|3|||
145714304|NCT03459443|525470008|FG000|Overall Study|Adverse Event|1|||
145714305|NCT03459443|525470008|FG000|Overall Study|Sponsor's decision to close the study|18|||
145714306|NCT00888927|525470009|FG000|Overall Study|Adverse Event|0|||
145714307|NCT00888927|525470010|FG001|Overall Study|Adverse Event|0|||
145714308|NCT00888927|525470011|FG002|Overall Study|Adverse Event|0|||
145714309|NCT00888927|525470012|FG003|Overall Study|Adverse Event|1|||
145714310|NCT00888927|525470009|FG000|Overall Study|Withdrawal of consent|0|||
145714311|NCT00888927|525470010|FG001|Overall Study|Withdrawal of consent|0|||
145714312|NCT00888927|525470011|FG002|Overall Study|Withdrawal of consent|0|||
145714313|NCT00888927|525470012|FG003|Overall Study|Withdrawal of consent|1|||
145714314|NCT02153073|525470013|FG000|Overall Study|Case Report Forms Uncollected|230|||
145714315|NCT02153073|525470013|FG000|Overall Study|Protocol Deviation|68|||
145714316|NCT03702231|525470014|FG000|Overall Study|Withdrawal by Subject|1|||
145714317|NCT03702231|525470015|FG001|Overall Study|Withdrawal by Subject|0|||
145714318|NCT03702231|525470016|FG002|Overall Study|Withdrawal by Subject|0|||
145714319|NCT03702231|525470014|FG000|Overall Study|Protocol Violation|0|||
145714320|NCT03702231|525470015|FG001|Overall Study|Protocol Violation|0|||
145714321|NCT03702231|525470016|FG002|Overall Study|Protocol Violation|1|||
145714322|NCT03702231|525470014|FG000|Overall Study|Change in CLL Treatment|0|||
145714323|NCT03702231|525470015|FG001|Overall Study|Change in CLL Treatment|0|||
145714324|NCT03702231|525470016|FG002|Overall Study|Change in CLL Treatment|1|||
145714325|NCT03702231|525470014|FG000|Overall Study|COVID Pandemic|1|||
145714326|NCT03702231|525470015|FG001|Overall Study|COVID Pandemic|4|||
145714327|NCT03702231|525470016|FG002|Overall Study|COVID Pandemic|1|||
145714328|NCT03702231|525470014|FG000|Overall Study|Non-compliance|0|||
145714329|NCT03702231|525470015|FG001|Overall Study|Non-compliance|0|||
145714330|NCT03702231|525470016|FG002|Overall Study|Non-compliance|1|||
145714331|NCT01609062|525470017|FG000|Extension Phase|Terminated by Sponsor|14|||
145714332|NCT01609062|525470018|FG001|Extension Phase|Terminated by Sponsor|9|||
145714333|NCT01609062|525470017|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
145714334|NCT01609062|525470018|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
145714335|NCT01609062|525470017|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
145714336|NCT01609062|525470018|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
145714337|NCT03772587|525470019|FG000|Overall Study|COVID-19|0|||
145714338|NCT03772587|525470020|FG001|Overall Study|COVID-19|0|||
145714339|NCT03772587|525470021|FG002|Overall Study|COVID-19|1|||
145714340|NCT03772587|525470022|FG003|Overall Study|COVID-19|1|||
145714341|NCT03772587|525470023|FG004|Overall Study|COVID-19|0|||
145714342|NCT03772587|525470019|FG000|Overall Study|Withdrawal by Subject|1|||
145714343|NCT03772587|525470020|FG001|Overall Study|Withdrawal by Subject|0|||
145714344|NCT03772587|525470021|FG002|Overall Study|Withdrawal by Subject|0|||
145714345|NCT03772587|525470022|FG003|Overall Study|Withdrawal by Subject|0|||
145714346|NCT03772587|525470023|FG004|Overall Study|Withdrawal by Subject|0|||
145714347|NCT06665919|525470024|FG000|Overall Study|Withdrawal by Subject|4|||
145714348|NCT06665919|525470025|FG001|Overall Study|Withdrawal by Subject|4|||
145714349|NCT06665919|525470026|FG002|Overall Study|Withdrawal by Subject|4|||
145714350|NCT06665919|525470024|FG000|Overall Study|Non-compliance to Treatment|4|||
145714351|NCT06665919|525470025|FG001|Overall Study|Non-compliance to Treatment|1|||
145714352|NCT06665919|525470026|FG002|Overall Study|Non-compliance to Treatment|6|||
145714353|NCT06665919|525470024|FG000|Overall Study|Lost to Follow-up|3|||
145714354|NCT06665919|525470025|FG001|Overall Study|Lost to Follow-up|0|||
145714355|NCT06665919|525470026|FG002|Overall Study|Lost to Follow-up|2|||
145714356|NCT06665919|525470024|FG000|Overall Study|Physician Decision|4|||
145714357|NCT06665919|525470025|FG001|Overall Study|Physician Decision|0|||
145714358|NCT06665919|525470026|FG002|Overall Study|Physician Decision|1|||
145714359|NCT00095056|525471697|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
145714360|NCT00095056|525471698|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
145714361|NCT00095056|525471697|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
145714362|NCT00095056|525471698|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
145714363|NCT00095056|525471697|FG000|Phase A (Weeks 0-12)|Death|1|||
145714364|NCT00095056|525471698|FG001|Phase A (Weeks 0-12)|Death|0|||
145714365|NCT00095056|525471697|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
145714366|NCT00095056|525471698|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
145714367|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
145714368|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
145714369|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
145714370|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
145714371|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
145714372|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
145714373|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
145714374|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
145714375|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Death|3|||
145714376|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Death|1|||
145714377|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
145714378|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
145714379|NCT00095056|525471697|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
145714380|NCT00095056|525471698|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
145714381|NCT02735577|525471704|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
145714382|NCT02735577|525471704|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
145714383|NCT02731690|525471705|FG000|Overall Study|Adverse Event|1|||
145714384|NCT02731690|525471705|FG000|Overall Study|Withdrawal by Subject|3|||
145714385|NCT02731690|525471705|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
145714386|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Adverse Event|6|||
145714387|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Adverse Event|6|||
145714388|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Death|1|||
145714389|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Death|1|||
145714390|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
145714391|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
145714392|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
145714393|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
145714394|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Physician Decision|1|||
145714395|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Physician Decision|4|||
145714396|NCT03828747|525471713|FG000|Double-Blind Treatment Period|Various reasons|5|||
145714397|NCT03828747|525471714|FG001|Double-Blind Treatment Period|Various reasons|3|||
145714398|NCT03828747|525471713|FG000|Open-Label Extension|Adverse Event|9|||
145714399|NCT03828747|525471714|FG001|Open-Label Extension|Adverse Event|7|||
145714400|NCT03828747|525471713|FG000|Open-Label Extension|Death|0|||
145714401|NCT03828747|525471714|FG001|Open-Label Extension|Death|2|||
145714402|NCT03828747|525471713|FG000|Open-Label Extension|Lost to Follow-up|4|||
145714403|NCT03828747|525471714|FG001|Open-Label Extension|Lost to Follow-up|0|||
145714404|NCT03828747|525471713|FG000|Open-Label Extension|Withdrawal by Subject|31|||
145714405|NCT03828747|525471714|FG001|Open-Label Extension|Withdrawal by Subject|30|||
145714406|NCT03828747|525471713|FG000|Open-Label Extension|Various reasons|4|||
145714407|NCT03828747|525471714|FG001|Open-Label Extension|Various reasons|4|||
145714408|NCT03828747|525471713|FG000|Open-Label Extension|Physician Decision|6|||
145714409|NCT03828747|525471714|FG001|Open-Label Extension|Physician Decision|2|||
145714410|NCT00836745|525471722|FG000|Overall Study|Death|2|||
145714411|NCT00836745|525471722|FG000|Overall Study|Lost to Follow-up|10|||
145714412|NCT00836745|525471722|FG000|Overall Study|Adverse Event|3|||
145714413|NCT00836745|525471722|FG000|Overall Study|Objective progression or relapse|4|||
145714414|NCT00836745|525471722|FG000|Overall Study|Other|2|||
145714415|NCT02366468|525471723|FG000|Overall Study|Adverse Event|2|||
145714416|NCT02366468|525471724|FG001|Overall Study|Adverse Event|0|||
145714417|NCT02366468|525471723|FG000|Overall Study|Withdrawal by Subject|1|||
145714418|NCT02366468|525471724|FG001|Overall Study|Withdrawal by Subject|5|||
145714419|NCT02366468|525471723|FG000|Overall Study|Lost to Follow-up|2|||
145714420|NCT02366468|525471724|FG001|Overall Study|Lost to Follow-up|0|||
145714421|NCT02366468|525471723|FG000|Overall Study|Death|1|||
145714422|NCT02366468|525471724|FG001|Overall Study|Death|2|||
145714423|NCT02366468|525471723|FG000|Overall Study|Other|0|||
145714424|NCT02366468|525471724|FG001|Overall Study|Other|2|||
145714425|NCT00490490|525471725|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
145714426|NCT00490490|525471725|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
145714427|NCT05540717|525471726|FG000|Overall Study|Lost to Follow-up|2|||
145714428|NCT05540717|525471727|FG001|Overall Study|Lost to Follow-up|5|||
145714429|NCT05540717|525471726|FG000|Overall Study|Withdrawal by Subject|6|||
145714430|NCT05540717|525471727|FG001|Overall Study|Withdrawal by Subject|6|||
145714431|NCT05540717|525471726|FG000|Overall Study|Sponsor request|1|||
145714432|NCT05540717|525471727|FG001|Overall Study|Sponsor request|0|||
145714433|NCT05540717|525471726|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
145714434|NCT05540717|525471727|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
145714435|NCT05540717|525471726|FG000|Overall Study|Other|0|||
145714436|NCT05540717|525471727|FG001|Overall Study|Other|1|||
145714437|NCT02141620|525471728|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
145714438|NCT02141620|525471729|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
145714439|NCT03651622|525471730|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
145714440|NCT03651622|525471731|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
145714441|NCT03651622|525471732|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
145714442|NCT03651622|525471730|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
145714443|NCT03651622|525471731|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
145714444|NCT03651622|525471732|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
145714445|NCT03651622|525471730|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
145714446|NCT03651622|525471731|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
145714447|NCT03651622|525471732|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
145714448|NCT03651622|525471730|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
145714449|NCT03651622|525471731|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
145714450|NCT03651622|525471732|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
145714451|NCT03651622|525471730|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
145714452|NCT03651622|525471731|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
145714453|NCT03651622|525471732|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
145714454|NCT00307684|525471733|FG000|Open Label Phase|Lack of Efficacy|0|||
145714455|NCT00307684|525471734|FG001|Open Label Phase|Lack of Efficacy|0|||
145714456|NCT00307684|525471735|FG002|Open Label Phase|Lack of Efficacy|3|||
145714457|NCT00307684|525471733|FG000|Open Label Phase|Adverse Event|0|||
145714458|NCT00307684|525471734|FG001|Open Label Phase|Adverse Event|0|||
145714459|NCT00307684|525471735|FG002|Open Label Phase|Adverse Event|16|||
145714460|NCT00307684|525471733|FG000|Open Label Phase|Withdrawal by Subject|0|||
145714461|NCT00307684|525471734|FG001|Open Label Phase|Withdrawal by Subject|0|||
145714462|NCT00307684|525471735|FG002|Open Label Phase|Withdrawal by Subject|15|||
145714463|NCT00307684|525471733|FG000|Open Label Phase|Lost to Follow-up|0|||
145714464|NCT00307684|525471734|FG001|Open Label Phase|Lost to Follow-up|0|||
145714465|NCT00307684|525471735|FG002|Open Label Phase|Lost to Follow-up|11|||
145714466|NCT00307684|525471733|FG000|Open Label Phase|non compliance|0|||
145714467|NCT00307684|525471734|FG001|Open Label Phase|non compliance|0|||
145714468|NCT00307684|525471735|FG002|Open Label Phase|non compliance|5|||
145714469|NCT00307684|525471733|FG000|Open Label Phase|other|0|||
145714470|NCT00307684|525471734|FG001|Open Label Phase|other|0|||
145714471|NCT00307684|525471735|FG002|Open Label Phase|other|6|||
145714472|NCT00307684|525471733|FG000|Double Blind Phase|Lack of Efficacy|2|||
145714473|NCT00307684|525471734|FG001|Double Blind Phase|Lack of Efficacy|5|||
145714474|NCT00307684|525471735|FG002|Double Blind Phase|Lack of Efficacy|0|||
145714475|NCT02580305|525471736|FG000|Overall Study|Adverse Event|15|||
145714476|NCT02580305|525471737|FG001|Overall Study|Adverse Event|19|||
145714477|NCT02580305|525471738|FG002|Overall Study|Adverse Event|10|||
145714478|NCT02580305|525471736|FG000|Overall Study|Lack of Efficacy|5|||
145714479|NCT02580305|525471737|FG001|Overall Study|Lack of Efficacy|0|||
145714480|NCT02580305|525471738|FG002|Overall Study|Lack of Efficacy|2|||
145714481|NCT02580305|525471736|FG000|Overall Study|Protocol Violation|4|||
145714482|NCT02580305|525471737|FG001|Overall Study|Protocol Violation|9|||
145714483|NCT02580305|525471738|FG002|Overall Study|Protocol Violation|6|||
145714484|NCT02580305|525471736|FG000|Overall Study|Lost to Follow-up|4|||
145714485|NCT02580305|525471737|FG001|Overall Study|Lost to Follow-up|4|||
145714486|NCT02580305|525471738|FG002|Overall Study|Lost to Follow-up|2|||
145714487|NCT02580305|525471736|FG000|Overall Study|Withdrawal by Subject|11|||
145714488|NCT02580305|525471737|FG001|Overall Study|Withdrawal by Subject|9|||
145714489|NCT02580305|525471738|FG002|Overall Study|Withdrawal by Subject|7|||
145714490|NCT02580305|525471736|FG000|Overall Study|Randomized in error and never treated|4|||
145714491|NCT02580305|525471737|FG001|Overall Study|Randomized in error and never treated|8|||
145714492|NCT02580305|525471738|FG002|Overall Study|Randomized in error and never treated|5|||
145714493|NCT00224887|525471739|FG000|Overall Study|Pregnancy|6|||
145714494|NCT00224887|525471740|FG001|Overall Study|Pregnancy|6|||
145714495|NCT01353859|525471743|FG000|Overall Study|Adverse Event|3|||
145714496|NCT01353859|525471743|FG000|Overall Study|Lack of Efficacy|1|||
145714497|NCT03582943|525471744|FG000|Allocated to Groups|Withdrawal by Subject|1|||
145714498|NCT03582943|525471745|FG001|Allocated to Groups|Withdrawal by Subject|1|||
145714499|NCT03582943|525471744|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
145714500|NCT03582943|525471745|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
145714501|NCT03582943|525471744|FG000|Analyzed|Protocol Violation|4|||
145714502|NCT03582943|525471745|FG001|Analyzed|Protocol Violation|1|||
145714503|NCT04032613|525471746|FG000|Overall Study|Did not complete post-program assessment|5|||
145714504|NCT04032613|525471747|FG001|Overall Study|Did not complete post-program assessment|2|||
145714505|NCT01659853|525471748|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
145714506|NCT01659853|525471749|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
145714507|NCT01659853|525471748|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
145714508|NCT01659853|525471749|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
145714509|NCT03053518|525471752|FG000|Overall Study|Withdrawal by Subject|3|||
145714510|NCT03053518|525471752|FG000|Overall Study|Lost to Follow-up|2|||
145714511|NCT03053518|525471752|FG000|Overall Study|Ineligible|5|||
145714512|NCT02683876|525471753|FG000|Overall Study|samples damaged during shipping|2|||
145714513|NCT02683876|525471754|FG001|Overall Study|samples damaged during shipping|0|||
145714514|NCT00488475|525471758|FG000|Overall Study|Other|1754|||
145714515|NCT01744392|525471760|FG000|Overall Study|Physician Decision|1|||
145714516|NCT01365481|525471761|FG000|Overall Study|Adverse Event|6|||
145714517|NCT01365481|525471762|FG001|Overall Study|Adverse Event|9|||
145714518|NCT01365481|525471763|FG002|Overall Study|Adverse Event|0|||
145714519|NCT01365481|525471764|FG003|Overall Study|Adverse Event|2|||
145714520|NCT01365481|525471761|FG000|Overall Study|Withdrawal by Subject|0|||
145714521|NCT01365481|525471762|FG001|Overall Study|Withdrawal by Subject|2|||
145714522|NCT01365481|525471763|FG002|Overall Study|Withdrawal by Subject|1|||
145714523|NCT01365481|525471764|FG003|Overall Study|Withdrawal by Subject|1|||
145714524|NCT01365481|525471761|FG000|Overall Study|Lost to Follow-up|1|||
145714525|NCT01365481|525471762|FG001|Overall Study|Lost to Follow-up|1|||
145714526|NCT01365481|525471763|FG002|Overall Study|Lost to Follow-up|2|||
145714527|NCT01365481|525471764|FG003|Overall Study|Lost to Follow-up|3|||
145714528|NCT01365481|525471761|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145714529|NCT01365481|525471762|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145714530|NCT01365481|525471763|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145714531|NCT01365481|525471764|FG003|Overall Study|Abnormal laboratory value(s)|0|||
145714532|NCT01365481|525471761|FG000|Overall Study|Administrative problems|0|||
145714533|NCT01365481|525471762|FG001|Overall Study|Administrative problems|1|||
145714534|NCT01365481|525471763|FG002|Overall Study|Administrative problems|0|||
145714535|NCT01365481|525471764|FG003|Overall Study|Administrative problems|0|||
145714536|NCT01365481|525471761|FG000|Overall Study|Protocol deviation|0|||
145714537|NCT01365481|525471762|FG001|Overall Study|Protocol deviation|1|||
145714538|NCT01365481|525471763|FG002|Overall Study|Protocol deviation|0|||
145714539|NCT01365481|525471764|FG003|Overall Study|Protocol deviation|1|||
145714540|NCT01365481|525471761|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
145714541|NCT01365481|525471762|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
145714542|NCT01365481|525471763|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
145714543|NCT01365481|525471764|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
145714544|NCT00757627|525471765|FG000|Overall Study|Adverse Event|15|||
145714545|NCT00757627|525471765|FG000|Overall Study|Lack of Efficacy|10|||
145714546|NCT00757627|525471765|FG000|Overall Study|Lost to Follow-up|28|||
145714547|NCT00757627|525471765|FG000|Overall Study|Withdrawal by Subject|27|||
145714548|NCT00757627|525471765|FG000|Overall Study|Other|1|||
145714549|NCT00958841|525471768|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145714550|NCT00958841|525471768|FG000|Overall Study|Abnormal test procedure result(s)|3|||
145714551|NCT00958841|525471768|FG000|Overall Study|Administrative problems|1|||
145714552|NCT00958841|525471768|FG000|Overall Study|Adverse Event|8|||
145714553|NCT00958841|525471768|FG000|Overall Study|New cancer therapy|5|||
145714554|NCT00958841|525471768|FG000|Overall Study|Withdrawal by Subject|1|||
145714555|NCT00958841|525471768|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
145714556|NCT00958841|525471768|FG000|Overall Study|Completed M6/did not enter extension|27|||
145714557|NCT00958841|525471768|FG000|Overall Study|Discontinued prior to M*|28|||
145714558|NCT00403767|525471769|FG000|Overall Study|Adverse Event|993|||
145714559|NCT00403767|525471770|FG001|Overall Study|Adverse Event|919|||
145714560|NCT00403767|525471769|FG000|Overall Study|Non-compliant with study medication|134|||
145714561|NCT00403767|525471770|FG001|Overall Study|Non-compliant with study medication|164|||
145714562|NCT00403767|525471769|FG000|Overall Study|Consent withdrawn|671|||
145714563|NCT00403767|525471770|FG001|Overall Study|Consent withdrawn|673|||
145714564|NCT00403767|525471769|FG000|Overall Study|Investigator dec./not protocol-related|191|||
145714565|NCT00403767|525471770|FG001|Overall Study|Investigator dec./not protocol-related|178|||
145714566|NCT00403767|525471769|FG000|Overall Study|Lost to Follow-up|6|||
145714567|NCT00403767|525471770|FG001|Overall Study|Lost to Follow-up|8|||
145714568|NCT00403767|525471769|FG000|Overall Study|Protocol Violation|142|||
145714569|NCT00403767|525471770|FG001|Overall Study|Protocol Violation|124|||
145714570|NCT00403767|525471769|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
145714571|NCT00403767|525471770|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
145714572|NCT00403767|525471769|FG000|Overall Study|Study terminated by sponsor|82|||
145714573|NCT00403767|525471770|FG001|Overall Study|Study terminated by sponsor|69|||
145714574|NCT00403767|525471769|FG000|Overall Study|Missing/incomplete data|1|||
145714575|NCT00403767|525471770|FG001|Overall Study|Missing/incomplete data|1|||
145714576|NCT01696955|525471771|FG000|Main Study|Protocol Violation|1|||
145714577|NCT01696955|525471772|FG001|Main Study|Protocol Violation|0|||
145714578|NCT01696955|525471771|FG000|Main Study|Withdrawal by Subject|1|||
145714579|NCT01696955|525471772|FG001|Main Study|Withdrawal by Subject|1|||
145714580|NCT02416453|525471775|FG000|Overall Study|Adverse Event|0|||
145714581|NCT02416453|525471776|FG001|Overall Study|Adverse Event|0|||
145714582|NCT02416453|525471777|FG002|Overall Study|Adverse Event|0|||
145714583|NCT02416453|525471778|FG003|Overall Study|Adverse Event|2|||
145714584|NCT02416453|525471779|FG004|Overall Study|Adverse Event|0|||
145714585|NCT02416453|525471780|FG005|Overall Study|Adverse Event|1|||
145714586|NCT02416453|525471781|FG006|Overall Study|Adverse Event|0|||
145714587|NCT02416453|525471782|FG007|Overall Study|Adverse Event|0|||
145714588|NCT02416453|525471783|FG008|Overall Study|Adverse Event|0|||
145714589|NCT02416453|525471784|FG009|Overall Study|Adverse Event|0|||
145714590|NCT02416453|525471785|FG010|Overall Study|Adverse Event|0|||
145714591|NCT02416453|525471775|FG000|Overall Study|Lost to Follow-up|1|||
145714592|NCT02416453|525471776|FG001|Overall Study|Lost to Follow-up|3|||
145714593|NCT02416453|525471777|FG002|Overall Study|Lost to Follow-up|0|||
145714594|NCT02416453|525471778|FG003|Overall Study|Lost to Follow-up|8|||
145714595|NCT02416453|525471779|FG004|Overall Study|Lost to Follow-up|0|||
145714596|NCT02416453|525471780|FG005|Overall Study|Lost to Follow-up|5|||
145714597|NCT02416453|525471781|FG006|Overall Study|Lost to Follow-up|1|||
145714598|NCT02416453|525471782|FG007|Overall Study|Lost to Follow-up|3|||
145714599|NCT02416453|525471783|FG008|Overall Study|Lost to Follow-up|1|||
145714600|NCT02416453|525471784|FG009|Overall Study|Lost to Follow-up|0|||
145714601|NCT02416453|525471785|FG010|Overall Study|Lost to Follow-up|0|||
145714602|NCT02416453|525471775|FG000|Overall Study|Physician Decision|0|||
145714603|NCT02416453|525471776|FG001|Overall Study|Physician Decision|0|||
145714604|NCT02416453|525471777|FG002|Overall Study|Physician Decision|0|||
145714605|NCT02416453|525471778|FG003|Overall Study|Physician Decision|0|||
145714606|NCT02416453|525471779|FG004|Overall Study|Physician Decision|0|||
145714607|NCT02416453|525471780|FG005|Overall Study|Physician Decision|1|||
145714608|NCT02416453|525471781|FG006|Overall Study|Physician Decision|1|||
145714609|NCT02416453|525471782|FG007|Overall Study|Physician Decision|1|||
145714610|NCT02416453|525471783|FG008|Overall Study|Physician Decision|0|||
145714611|NCT02416453|525471784|FG009|Overall Study|Physician Decision|0|||
145714612|NCT02416453|525471785|FG010|Overall Study|Physician Decision|0|||
145714613|NCT02416453|525471775|FG000|Overall Study|Withdrawal by Subject|2|||
145714614|NCT02416453|525471776|FG001|Overall Study|Withdrawal by Subject|0|||
145714615|NCT02416453|525471777|FG002|Overall Study|Withdrawal by Subject|0|||
145714616|NCT02416453|525471778|FG003|Overall Study|Withdrawal by Subject|5|||
145714617|NCT02416453|525471779|FG004|Overall Study|Withdrawal by Subject|1|||
145714618|NCT02416453|525471780|FG005|Overall Study|Withdrawal by Subject|8|||
145714619|NCT02416453|525471781|FG006|Overall Study|Withdrawal by Subject|0|||
145714620|NCT02416453|525471782|FG007|Overall Study|Withdrawal by Subject|8|||
145714621|NCT02416453|525471783|FG008|Overall Study|Withdrawal by Subject|4|||
145714622|NCT02416453|525471784|FG009|Overall Study|Withdrawal by Subject|0|||
145714623|NCT02416453|525471785|FG010|Overall Study|Withdrawal by Subject|0|||
145714624|NCT02416453|525471775|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714625|NCT02416453|525471776|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714626|NCT02416453|525471777|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
145714627|NCT02416453|525471778|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714628|NCT02416453|525471779|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714629|NCT02416453|525471780|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714630|NCT02416453|525471781|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714631|NCT02416453|525471782|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714632|NCT02416453|525471783|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714633|NCT02416453|525471784|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714634|NCT02416453|525471785|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
145714635|NCT02416453|525471775|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714636|NCT02416453|525471776|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714637|NCT02416453|525471777|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714638|NCT02416453|525471778|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714639|NCT02416453|525471779|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714640|NCT02416453|525471780|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
145714641|NCT02416453|525471781|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714642|NCT02416453|525471782|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714643|NCT02416453|525471783|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714644|NCT02416453|525471784|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714645|NCT02416453|525471785|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
145714646|NCT01259089|525471793|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
145714647|NCT01259089|525471794|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
145714648|NCT01259089|525471795|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
145714649|NCT01259089|525471796|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
145714650|NCT01259089|525471797|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
145714651|NCT01259089|525471798|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
145714652|NCT01259089|525471793|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
145714653|NCT01259089|525471794|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
145714654|NCT01259089|525471795|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
145714655|NCT01259089|525471796|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
145714656|NCT01259089|525471797|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
145714657|NCT01259089|525471798|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
145714658|NCT01259089|525471793|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
145714659|NCT01259089|525471794|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
145714660|NCT01259089|525471795|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
145714661|NCT01259089|525471796|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
145714662|NCT01259089|525471797|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
145714663|NCT01259089|525471798|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
145714664|NCT01259089|525471793|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
145714665|NCT01259089|525471794|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
145714666|NCT01259089|525471795|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
145714667|NCT01259089|525471796|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
145714668|NCT01259089|525471797|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
145714669|NCT01259089|525471798|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
145714670|NCT01259089|525471793|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
145714671|NCT01259089|525471794|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
145714672|NCT01259089|525471795|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
145714673|NCT01259089|525471796|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
145714674|NCT01259089|525471797|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
145714675|NCT01259089|525471798|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
145714676|NCT01259089|525471793|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
145714677|NCT01259089|525471794|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
145714678|NCT01259089|525471795|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
145714679|NCT01259089|525471796|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
145714680|NCT01259089|525471797|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
145714681|NCT01259089|525471798|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
145714682|NCT01259089|525471793|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
145714683|NCT01259089|525471794|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
145714684|NCT01259089|525471795|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
145714685|NCT01259089|525471796|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
145714686|NCT01259089|525471797|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
145714687|NCT01259089|525471798|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
145714688|NCT01259089|525471793|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
145714689|NCT01259089|525471794|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
145714690|NCT01259089|525471795|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
145714691|NCT01259089|525471796|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
145714692|NCT01259089|525471797|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
145714693|NCT01259089|525471798|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
145714694|NCT01259089|525471793|FG000|Survival Follow up for Two Years|Death|3|||
145714695|NCT01259089|525471794|FG001|Survival Follow up for Two Years|Death|2|||
145714696|NCT01259089|525471795|FG002|Survival Follow up for Two Years|Death|2|||
145714697|NCT01259089|525471796|FG003|Survival Follow up for Two Years|Death|3|||
145714698|NCT01259089|525471797|FG004|Survival Follow up for Two Years|Death|6|||
145714699|NCT01259089|525471798|FG005|Survival Follow up for Two Years|Death|13|||
145714700|NCT01259089|525471793|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
145714701|NCT01259089|525471794|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
145714702|NCT01259089|525471795|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
145714703|NCT01259089|525471796|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
145714704|NCT01259089|525471797|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
145714705|NCT01259089|525471798|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
145714706|NCT01259089|525471793|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
145714707|NCT01259089|525471794|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
145714708|NCT01259089|525471795|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
145714709|NCT01259089|525471796|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
145714710|NCT01259089|525471797|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
145714711|NCT01259089|525471798|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
145714712|NCT02310100|525471803|FG000|Overall Study|Physician Decision|3|||
145714713|NCT02310100|525471803|FG000|Overall Study|Withdrawal by Subject|10|||
145714714|NCT02310100|525471803|FG000|Overall Study|Enrollment closure|1|||
145714715|NCT02310100|525471803|FG000|Overall Study|Unapproved ablation operator|1|||
145714716|NCT02310100|525471803|FG000|Overall Study|Visit compliance|1|||
145714717|NCT02310100|525471803|FG000|Overall Study|Lost to Follow-up|2|||
145714718|NCT05051462|525471810|FG000|Overall Study|Lost to Follow-up|1|||
145714719|NCT05051462|525471811|FG001|Overall Study|Lost to Follow-up|8|||
145714720|NCT05051462|525471810|FG000|Overall Study|Withdrawal by Subject|1|||
145714721|NCT05051462|525471811|FG001|Overall Study|Withdrawal by Subject|0|||
145714722|NCT05051462|525471810|FG000|Overall Study|Protocol Violation|0|||
145714723|NCT05051462|525471811|FG001|Overall Study|Protocol Violation|2|||
145714724|NCT05260021|525471816|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
145714725|NCT05260021|525471817|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
145714726|NCT05260021|525471818|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
145714727|NCT05260021|525471816|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
145714728|NCT05260021|525471817|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
145377883|NCT03191864|524233640|FG005|Part 1 - Induction|Randomized but never dosed|0|||
145714729|NCT05260021|525471818|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
145714730|NCT05260021|525471816|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
145714731|NCT05260021|525471817|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
145714732|NCT05260021|525471818|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
145714733|NCT05260021|525471816|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
145714734|NCT05260021|525471817|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
145714735|NCT05260021|525471818|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
145714736|NCT05260021|525471816|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
145714737|NCT05260021|525471817|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
145714738|NCT05260021|525471818|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
145714739|NCT03842358|525471819|FG000|Overall Study|Poor DOT probe contact with breast|2|||
145714740|NCT03842358|525471819|FG000|Overall Study|DOT system problem|1|||
145714741|NCT03842358|525471819|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
145714742|NCT03842358|525471819|FG000|Overall Study|No biopsy after physician review|4|||
145714743|NCT03842358|525471819|FG000|Overall Study|Patient withdrew|2|||
145714744|NCT02626455|525471820|FG000|Overall Study|Other|1|||
145714745|NCT02626455|525471821|FG001|Overall Study|Other|1|||
145714746|NCT02626455|525471822|FG002|Overall Study|Other|0|||
145714747|NCT02626455|525471823|FG003|Overall Study|Other|0|||
145714748|NCT02626455|525471824|FG004|Overall Study|Other|0|||
145714749|NCT02626455|525471825|FG005|Overall Study|Other|17|||
145714750|NCT02626455|525471826|FG006|Overall Study|Other|23|||
145714751|NCT02626455|525471820|FG000|Overall Study|Withdrawal by Subject|1|||
145714752|NCT02626455|525471821|FG001|Overall Study|Withdrawal by Subject|0|||
145714753|NCT02626455|525471822|FG002|Overall Study|Withdrawal by Subject|0|||
145714754|NCT02626455|525471823|FG003|Overall Study|Withdrawal by Subject|0|||
145714755|NCT02626455|525471824|FG004|Overall Study|Withdrawal by Subject|0|||
145714756|NCT02626455|525471825|FG005|Overall Study|Withdrawal by Subject|10|||
145714757|NCT02626455|525471826|FG006|Overall Study|Withdrawal by Subject|6|||
145714758|NCT02626455|525471820|FG000|Overall Study|Physician Decision|0|||
145714759|NCT02626455|525471821|FG001|Overall Study|Physician Decision|2|||
145714760|NCT02626455|525471822|FG002|Overall Study|Physician Decision|2|||
145714761|NCT02626455|525471823|FG003|Overall Study|Physician Decision|2|||
145714762|NCT02626455|525471824|FG004|Overall Study|Physician Decision|1|||
145714763|NCT02626455|525471825|FG005|Overall Study|Physician Decision|10|||
145714764|NCT02626455|525471826|FG006|Overall Study|Physician Decision|3|||
145714765|NCT02626455|525471820|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714766|NCT02626455|525471821|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714767|NCT02626455|525471822|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714768|NCT02626455|525471823|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714769|NCT02626455|525471824|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714770|NCT02626455|525471825|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
145714771|NCT02626455|525471826|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
145714772|NCT02626455|525471820|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714773|NCT02626455|525471821|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714774|NCT02626455|525471822|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714775|NCT02626455|525471823|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714776|NCT02626455|525471824|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714777|NCT02626455|525471825|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
145714778|NCT02626455|525471826|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
145714779|NCT02626455|525471820|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
145714780|NCT02626455|525471821|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
145714781|NCT02626455|525471822|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
145714782|NCT02626455|525471823|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
145714783|NCT02626455|525471824|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
145714784|NCT02626455|525471825|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
145714785|NCT02626455|525471826|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
145714786|NCT02626455|525471820|FG000|Overall Study|Patient decision|0|||
145714787|NCT02626455|525471821|FG001|Overall Study|Patient decision|1|||
145714788|NCT02626455|525471822|FG002|Overall Study|Patient decision|0|||
145714789|NCT02626455|525471823|FG003|Overall Study|Patient decision|0|||
145714790|NCT02626455|525471824|FG004|Overall Study|Patient decision|1|||
145714791|NCT02626455|525471825|FG005|Overall Study|Patient decision|36|||
145714792|NCT02626455|525471826|FG006|Overall Study|Patient decision|22|||
145714793|NCT02626455|525471820|FG000|Overall Study|Protocol Violation|0|||
145714794|NCT02626455|525471821|FG001|Overall Study|Protocol Violation|0|||
145714795|NCT02626455|525471822|FG002|Overall Study|Protocol Violation|0|||
145714796|NCT02626455|525471823|FG003|Overall Study|Protocol Violation|0|||
145714797|NCT02626455|525471824|FG004|Overall Study|Protocol Violation|0|||
145714798|NCT02626455|525471825|FG005|Overall Study|Protocol Violation|0|||
145714799|NCT02626455|525471826|FG006|Overall Study|Protocol Violation|1|||
145714800|NCT02626455|525471820|FG000|Overall Study|Progressive disease - radiological progression|0|||
145714801|NCT02626455|525471821|FG001|Overall Study|Progressive disease - radiological progression|0|||
145714802|NCT02626455|525471822|FG002|Overall Study|Progressive disease - radiological progression|0|||
145714803|NCT02626455|525471823|FG003|Overall Study|Progressive disease - radiological progression|0|||
145714804|NCT02626455|525471824|FG004|Overall Study|Progressive disease - radiological progression|0|||
145714805|NCT02626455|525471825|FG005|Overall Study|Progressive disease - radiological progression|11|||
145714806|NCT02626455|525471826|FG006|Overall Study|Progressive disease - radiological progression|22|||
145714807|NCT02626455|525471820|FG000|Overall Study|Progressive disease - clinical progression|0|||
145714808|NCT02626455|525471821|FG001|Overall Study|Progressive disease - clinical progression|0|||
145714809|NCT02626455|525471822|FG002|Overall Study|Progressive disease - clinical progression|0|||
145714810|NCT02626455|525471823|FG003|Overall Study|Progressive disease - clinical progression|0|||
145714811|NCT02626455|525471824|FG004|Overall Study|Progressive disease - clinical progression|0|||
145714812|NCT02626455|525471825|FG005|Overall Study|Progressive disease - clinical progression|1|||
145714813|NCT02626455|525471826|FG006|Overall Study|Progressive disease - clinical progression|2|||
145714814|NCT02626455|525471820|FG000|Overall Study|Lost to Follow-up|0|||
145714815|NCT02626455|525471821|FG001|Overall Study|Lost to Follow-up|0|||
145714816|NCT02626455|525471822|FG002|Overall Study|Lost to Follow-up|0|||
145714817|NCT02626455|525471823|FG003|Overall Study|Lost to Follow-up|0|||
145714818|NCT02626455|525471824|FG004|Overall Study|Lost to Follow-up|0|||
145714819|NCT02626455|525471825|FG005|Overall Study|Lost to Follow-up|1|||
145714820|NCT02626455|525471826|FG006|Overall Study|Lost to Follow-up|0|||
145714821|NCT02626455|525471820|FG000|Overall Study|AE not associated with clinical disease progression|1|||
145714822|NCT02626455|525471821|FG001|Overall Study|AE not associated with clinical disease progression|1|||
145714823|NCT02626455|525471822|FG002|Overall Study|AE not associated with clinical disease progression|0|||
145714824|NCT02626455|525471823|FG003|Overall Study|AE not associated with clinical disease progression|2|||
145714825|NCT02626455|525471824|FG004|Overall Study|AE not associated with clinical disease progression|1|||
145714826|NCT02626455|525471825|FG005|Overall Study|AE not associated with clinical disease progression|65|||
145714827|NCT02626455|525471826|FG006|Overall Study|AE not associated with clinical disease progression|21|||
145714828|NCT02626455|525471820|FG000|Overall Study|AE associated with clinical disease progression|0|||
145714829|NCT02626455|525471821|FG001|Overall Study|AE associated with clinical disease progression|0|||
145714830|NCT02626455|525471822|FG002|Overall Study|AE associated with clinical disease progression|0|||
145714831|NCT02626455|525471823|FG003|Overall Study|AE associated with clinical disease progression|0|||
145714832|NCT02626455|525471824|FG004|Overall Study|AE associated with clinical disease progression|0|||
145714833|NCT02626455|525471825|FG005|Overall Study|AE associated with clinical disease progression|1|||
145714834|NCT02626455|525471826|FG006|Overall Study|AE associated with clinical disease progression|2|||
145714835|NCT02626455|525471820|FG000|Overall Study|Study intervention never administered|0|||
145714836|NCT02626455|525471821|FG001|Overall Study|Study intervention never administered|0|||
145714837|NCT02626455|525471822|FG002|Overall Study|Study intervention never administered|0|||
145714838|NCT02626455|525471823|FG003|Overall Study|Study intervention never administered|0|||
145714839|NCT02626455|525471824|FG004|Overall Study|Study intervention never administered|0|||
145714840|NCT02626455|525471825|FG005|Overall Study|Study intervention never administered|1|||
145714841|NCT02626455|525471826|FG006|Overall Study|Study intervention never administered|3|||
145714842|NCT01200290|525471827|FG000|Treatment Period|Adverse Event|1|||
145714843|NCT01200290|525471827|FG000|Post-Treatment Follow-Up Period|Death|2|||
145714844|NCT01144377|525471828|FG000|52 Week Treatment Period|Adverse Event|0|||
145714845|NCT01144377|525471829|FG001|52 Week Treatment Period|Adverse Event|0|||
145714846|NCT01144377|525471830|FG002|52 Week Treatment Period|Adverse Event|3|||
145714847|NCT01144377|525471831|FG003|52 Week Treatment Period|Adverse Event|2|||
145714848|NCT01144377|525471832|FG004|52 Week Treatment Period|Adverse Event|1|||
145714849|NCT01144377|525471828|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
145714850|NCT01144377|525471829|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
145714851|NCT01144377|525471830|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
145714852|NCT01144377|525471831|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
145714853|NCT01144377|525471832|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
145714854|NCT01144377|525471828|FG000|52 Week Treatment Period|Protocol Violation|0|||
145714855|NCT01144377|525471829|FG001|52 Week Treatment Period|Protocol Violation|0|||
145714856|NCT01144377|525471830|FG002|52 Week Treatment Period|Protocol Violation|0|||
145714857|NCT01144377|525471831|FG003|52 Week Treatment Period|Protocol Violation|0|||
145714858|NCT01144377|525471832|FG004|52 Week Treatment Period|Protocol Violation|1|||
145714859|NCT01144377|525471828|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
145714860|NCT01144377|525471829|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
145714861|NCT01144377|525471830|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
145714862|NCT01144377|525471831|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
145714863|NCT01144377|525471832|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
145714864|NCT01144377|525471828|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
145714865|NCT01144377|525471829|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
145714866|NCT01144377|525471830|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
145714867|NCT01144377|525471831|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
145714868|NCT01144377|525471832|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
145714869|NCT01144377|525471828|FG000|52 Week Treatment Period|Sponsor Decision|0|||
145714870|NCT01144377|525471829|FG001|52 Week Treatment Period|Sponsor Decision|0|||
145714871|NCT01144377|525471830|FG002|52 Week Treatment Period|Sponsor Decision|0|||
145714872|NCT01144377|525471831|FG003|52 Week Treatment Period|Sponsor Decision|0|||
145714873|NCT01144377|525471832|FG004|52 Week Treatment Period|Sponsor Decision|1|||
145714874|NCT01144377|525471828|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
145714875|NCT01144377|525471829|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
145714876|NCT01144377|525471830|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
145714877|NCT01144377|525471831|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
145714878|NCT01144377|525471832|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
145714879|NCT01144377|525471828|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
145714880|NCT01144377|525471829|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
145714881|NCT01144377|525471830|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
145714882|NCT01144377|525471831|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
145714883|NCT01144377|525471832|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
145714884|NCT01144377|525471828|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
145714885|NCT01144377|525471829|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
145714886|NCT01144377|525471830|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
145714887|NCT01144377|525471831|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
145714888|NCT01144377|525471832|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
145714889|NCT00607724|525471833|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
145714890|NCT00607724|525471834|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
145714891|NCT00607724|525471835|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
145714892|NCT00607724|525471836|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
145714893|NCT00607724|525471837|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
145714894|NCT00607724|525471838|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
145714895|NCT00607724|525471839|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
145714896|NCT00607724|525471833|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
145714897|NCT00607724|525471834|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
145714898|NCT00607724|525471835|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
145714899|NCT00607724|525471836|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
145714900|NCT00607724|525471837|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
145714901|NCT00607724|525471838|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
145714902|NCT00607724|525471839|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
145714903|NCT00607724|525471833|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
145714904|NCT00607724|525471834|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
145714905|NCT00607724|525471835|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
145714906|NCT00607724|525471836|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
145714907|NCT00607724|525471837|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
145714908|NCT00607724|525471838|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
145714909|NCT00607724|525471839|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
145714910|NCT00607724|525471833|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
145714911|NCT00607724|525471834|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
145714912|NCT00607724|525471835|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
145714913|NCT00607724|525471836|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
145714914|NCT00607724|525471837|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
145714915|NCT00607724|525471838|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
145714916|NCT00607724|525471839|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
145714917|NCT00607724|525471833|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714918|NCT00607724|525471834|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714919|NCT00607724|525471835|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714920|NCT00607724|525471836|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
145714921|NCT00607724|525471837|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714922|NCT00607724|525471838|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714923|NCT00607724|525471839|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
145714924|NCT00151281|525471840|FG000|Overall Study|Not evaluable|3|||
145714925|NCT01133418|525471843|FG000|Overall Study|Lost to Follow-up|5|||
145714926|NCT01133418|525471844|FG001|Overall Study|Lost to Follow-up|6|||
145714927|NCT04150068|525471845|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
145714928|NCT04150068|525471846|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
145714929|NCT04150068|525471847|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
145714930|NCT04150068|525471845|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
145714931|NCT04150068|525471846|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
145714932|NCT04150068|525471847|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
145714933|NCT05316701|525471848|FG000|Overall Study|Adverse Event|0|||
145714934|NCT05316701|525471849|FG001|Overall Study|Adverse Event|1|||
145714935|NCT05316701|525471848|FG000|Overall Study|Death|3|||
145377884|NCT03191864|524233635|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
145714936|NCT05316701|525471849|FG001|Overall Study|Death|9|||
145714937|NCT05316701|525471848|FG000|Overall Study|Lost to Follow-up|1|||
145714938|NCT05316701|525471849|FG001|Overall Study|Lost to Follow-up|0|||
145714939|NCT05316701|525471848|FG000|Overall Study|Physician Decision|1|||
145714940|NCT05316701|525471849|FG001|Overall Study|Physician Decision|4|||
145714941|NCT05316701|525471848|FG000|Overall Study|Withdrawal by Subject|3|||
145714942|NCT05316701|525471849|FG001|Overall Study|Withdrawal by Subject|5|||
145714943|NCT05316701|525471848|FG000|Overall Study|Progression/Relapse|14|||
145714944|NCT05316701|525471849|FG001|Overall Study|Progression/Relapse|9|||
145714945|NCT05316701|525471848|FG000|Overall Study|Received Standard of Care|1|||
145714946|NCT05316701|525471849|FG001|Overall Study|Received Standard of Care|0|||
145714947|NCT05316701|525471848|FG000|Overall Study|Ongoing|70|||
145714948|NCT05316701|525471849|FG001|Overall Study|Ongoing|64|||
145714949|NCT04679935|525471850|FG000|Overall Study|Death|0|||
145714950|NCT04679935|525471851|FG001|Overall Study|Death|1|||
145714951|NCT04362189|525471852|FG000|Overall Study|Lost to Follow-up|0|||
145714952|NCT04362189|525471853|FG001|Overall Study|Lost to Follow-up|1|||
145714953|NCT04362189|525471852|FG000|Overall Study|Withdrawal by Subject|1|||
145714954|NCT04362189|525471853|FG001|Overall Study|Withdrawal by Subject|0|||
145714955|NCT04362189|525471852|FG000|Overall Study|FDA Clinical Hold|7|||
145714956|NCT04362189|525471853|FG001|Overall Study|FDA Clinical Hold|2|||
145714957|NCT04362189|525471852|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
145714958|NCT04362189|525471853|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
145714959|NCT04362189|525471852|FG000|Overall Study|Adverse Event|0|||
145714960|NCT04362189|525471853|FG001|Overall Study|Adverse Event|2|||
145714961|NCT04362189|525471852|FG000|Overall Study|Death|4|||
145714962|NCT04362189|525471853|FG001|Overall Study|Death|1|||
145714963|NCT02111681|525471854|FG000|Overall Study|Death|5|||
145714964|NCT02111681|525471854|FG000|Overall Study|Lack of Efficacy|2|||
145714965|NCT02111681|525471854|FG000|Overall Study|Progression of disease|4|||
145714966|NCT00775463|525472983|FG000|Overall Study|Withdrawal by Subject|0|||
145714967|NCT00775463|525472984|FG001|Overall Study|Withdrawal by Subject|1|||
145714968|NCT00775463|525472983|FG000|Overall Study|Adverse Event|7|||
145714969|NCT00775463|525472984|FG001|Overall Study|Adverse Event|9|||
145714970|NCT00775463|525472983|FG000|Overall Study|Protocol Violation|2|||
145714971|NCT00775463|525472984|FG001|Overall Study|Protocol Violation|2|||
145714972|NCT00775463|525472983|FG000|Overall Study|Lost to Follow-up|1|||
145714973|NCT00775463|525472984|FG001|Overall Study|Lost to Follow-up|0|||
145714974|NCT00775463|525472983|FG000|Overall Study|Lack of Efficacy|1|||
145714975|NCT00775463|525472984|FG001|Overall Study|Lack of Efficacy|1|||
145714976|NCT00969709|525472985|FG000|Overall Study|Adverse Event|3|||
145714977|NCT00969709|525472986|FG001|Overall Study|Adverse Event|13|||
145714978|NCT00969709|525472987|FG002|Overall Study|Adverse Event|26|||
145714979|NCT00969709|525472988|FG003|Overall Study|Adverse Event|12|||
145714980|NCT00969709|525472985|FG000|Overall Study|Lack of Efficacy|7|||
145714981|NCT00969709|525472986|FG001|Overall Study|Lack of Efficacy|4|||
145714982|NCT00969709|525472987|FG002|Overall Study|Lack of Efficacy|1|||
145714983|NCT00969709|525472988|FG003|Overall Study|Lack of Efficacy|3|||
145714984|NCT00969709|525472985|FG000|Overall Study|Protocol Violation|9|||
145714985|NCT00969709|525472986|FG001|Overall Study|Protocol Violation|5|||
145714986|NCT00969709|525472987|FG002|Overall Study|Protocol Violation|9|||
145714987|NCT00969709|525472988|FG003|Overall Study|Protocol Violation|10|||
145714988|NCT00969709|525472985|FG000|Overall Study|Withdrawal by Subject|9|||
145714989|NCT00969709|525472986|FG001|Overall Study|Withdrawal by Subject|12|||
145714990|NCT00969709|525472987|FG002|Overall Study|Withdrawal by Subject|11|||
145714991|NCT00969709|525472988|FG003|Overall Study|Withdrawal by Subject|23|||
145714992|NCT00969709|525472985|FG000|Overall Study|Lost to Follow-up|10|||
145714993|NCT00969709|525472986|FG001|Overall Study|Lost to Follow-up|14|||
145714994|NCT00969709|525472987|FG002|Overall Study|Lost to Follow-up|8|||
145714995|NCT00969709|525472988|FG003|Overall Study|Lost to Follow-up|15|||
145714996|NCT00969709|525472985|FG000|Overall Study|Other reasons|0|||
145714997|NCT00969709|525472986|FG001|Overall Study|Other reasons|0|||
145714998|NCT00969709|525472987|FG002|Overall Study|Other reasons|3|||
145714999|NCT00969709|525472988|FG003|Overall Study|Other reasons|0|||
145715000|NCT03527550|525472993|FG000|Overall Study|Lost to Follow-up|4|||
145715001|NCT03527550|525472994|FG001|Overall Study|Lost to Follow-up|2|||
145715002|NCT03527550|525472993|FG000|Overall Study|Withdrawal by Subject|4|||
145715003|NCT03527550|525472994|FG001|Overall Study|Withdrawal by Subject|1|||
145715004|NCT03527550|525472993|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
145715005|NCT03527550|525472994|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
145715006|NCT02071290|525472995|FG000|Overall Study|Death|1|||
145715007|NCT02071290|525472996|FG001|Overall Study|Death|0|||
145715008|NCT02071290|525472995|FG000|Overall Study|Withdrawal by Subject|0|||
145715009|NCT02071290|525472996|FG001|Overall Study|Withdrawal by Subject|1|||
145715010|NCT02071290|525472995|FG000|Overall Study|Protocol Violation|3|||
145715011|NCT02071290|525472996|FG001|Overall Study|Protocol Violation|5|||
145715012|NCT02071290|525472995|FG000|Overall Study|Physician Decision|0|||
145715013|NCT02071290|525472996|FG001|Overall Study|Physician Decision|1|||
145715014|NCT05560243|525473001|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
145715015|NCT00939822|525473002|FG000|Overall Study|Lost to Follow-up|1|||
145715016|NCT00939822|525473003|FG001|Overall Study|Lost to Follow-up|0|||
145715017|NCT00939822|525473002|FG000|Overall Study|withdrew from study due to busy schedule|1|||
145715018|NCT00939822|525473003|FG001|Overall Study|withdrew from study due to busy schedule|1|||
145715019|NCT00939822|525473002|FG000|Overall Study|Mental health issues|0|||
145715020|NCT00939822|525473003|FG001|Overall Study|Mental health issues|2|||
145715021|NCT01232738|525473004|FG000|Overall Study|Death|3|||
145715022|NCT01232738|525473004|FG000|Overall Study|Physician Decision|2|||
145715023|NCT01232738|525473004|FG000|Overall Study|Lost to Follow-up|1|||
145715024|NCT01232738|525473004|FG000|Overall Study|Withdrawal by Subject|2|||
145715025|NCT01232738|525473004|FG000|Overall Study|Adverse Event|5|||
145715026|NCT05870228|525473005|FG000|Overall Study|Lost to Follow-up|2|||
145715027|NCT05870228|525473006|FG001|Overall Study|Lost to Follow-up|0|||
145715028|NCT05870228|525473005|FG000|Overall Study|Withdrawal by Subject|1|||
145715029|NCT05870228|525473006|FG001|Overall Study|Withdrawal by Subject|0|||
145715030|NCT03231800|525473007|FG000|Overall Study|Lost to Follow-up|0|||
145715031|NCT03231800|525473008|FG001|Overall Study|Lost to Follow-up|2|||
145715032|NCT03231800|525473007|FG000|Overall Study|Protocol Violation|1|||
145715033|NCT03231800|525473008|FG001|Overall Study|Protocol Violation|1|||
145715034|NCT03231800|525473007|FG000|Overall Study|reason not provided|2|||
145715035|NCT03231800|525473008|FG001|Overall Study|reason not provided|0|||
145715036|NCT00859222|525473010|FG000|Overall Study|Adverse Event|2|||
145715037|NCT00859222|525473011|FG001|Overall Study|Adverse Event|3|||
145715038|NCT00859222|525473012|FG002|Overall Study|Adverse Event|6|||
145715039|NCT00859222|525473013|FG003|Overall Study|Adverse Event|24|||
145715040|NCT00859222|525473014|FG004|Overall Study|Adverse Event|15|||
145715041|NCT00859222|525473010|FG000|Overall Study|DLT|1|||
145715042|NCT00859222|525473011|FG001|Overall Study|DLT|0|||
145715043|NCT00859222|525473012|FG002|Overall Study|DLT|0|||
145715044|NCT00859222|525473013|FG003|Overall Study|DLT|0|||
145715045|NCT00859222|525473014|FG004|Overall Study|DLT|0|||
145715046|NCT00941070|525473025|FG000|Overall Study|Patient non-compliant|1|||
145715047|NCT03174431|525473026|FG000|Overall Study|Withdrawal by Subject|14|||
145715048|NCT03174431|525473027|FG001|Overall Study|Withdrawal by Subject|11|||
145715049|NCT03174431|525473026|FG000|Overall Study|alternative treatment|2|||
145715050|NCT03174431|525473027|FG001|Overall Study|alternative treatment|0|||
145715051|NCT03174431|525473026|FG000|Overall Study|Lost to Follow-up|1|||
145715052|NCT03174431|525473027|FG001|Overall Study|Lost to Follow-up|5|||
145715053|NCT04075994|525473028|FG000|Overall Study|Withdrawal by Subject|8|||
145715054|NCT04075994|525473029|FG001|Overall Study|Withdrawal by Subject|9|||
145715055|NCT04075994|525473028|FG000|Overall Study|Adverse Event|2|||
145715056|NCT04075994|525473029|FG001|Overall Study|Adverse Event|2|||
145715057|NCT04075994|525473028|FG000|Overall Study|Investigator withdrew|3|||
145715058|NCT04075994|525473029|FG001|Overall Study|Investigator withdrew|1|||
145715059|NCT02797080|525473030|FG000|Overall Study|Lost to Follow-up|1|||
145715060|NCT02797080|525473030|FG000|Overall Study|Withdrawal by Subject|1|||
145715061|NCT04035499|525473033|FG000|Overall Study|Death|2|||
145715062|NCT04035499|525473033|FG000|Overall Study|Withdrawal by Subject|1|||
145715063|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Adverse Event|1|||
145715064|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Adverse Event|1|||
145715065|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Adverse Event|2|||
145715066|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Adverse Event|5|||
145715067|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Adverse Event|0|||
145715068|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
145715069|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
145715070|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
145715071|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
145715072|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
145715073|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
145715074|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
145715075|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
145715076|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
145715077|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
145715078|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
145715079|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
145715080|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
145715081|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
145715082|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
145715083|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
145715084|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
145715085|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
145715086|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
145715087|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
145715088|NCT00951015|525473034|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
145715089|NCT00951015|525473035|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
145715090|NCT00951015|525473036|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
145715091|NCT00951015|525473037|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
145715092|NCT00951015|525473038|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
145715093|NCT00951015|525473034|FG000|Open-label Phase|Adverse Event|0|||
145715094|NCT00951015|525473035|FG001|Open-label Phase|Adverse Event|0|||
145715095|NCT00951015|525473036|FG002|Open-label Phase|Adverse Event|0|||
145715096|NCT00951015|525473037|FG003|Open-label Phase|Adverse Event|0|||
145715097|NCT00951015|525473038|FG004|Open-label Phase|Adverse Event|3|||
145715098|NCT00951015|525473034|FG000|Open-label Phase|Lack of Efficacy|0|||
145715099|NCT00951015|525473035|FG001|Open-label Phase|Lack of Efficacy|0|||
145715100|NCT00951015|525473036|FG002|Open-label Phase|Lack of Efficacy|0|||
145715101|NCT00951015|525473037|FG003|Open-label Phase|Lack of Efficacy|0|||
145715102|NCT00951015|525473038|FG004|Open-label Phase|Lack of Efficacy|1|||
145715103|NCT00951015|525473034|FG000|Open-label Phase|Protocol Violation|0|||
145715104|NCT00951015|525473035|FG001|Open-label Phase|Protocol Violation|0|||
145715105|NCT00951015|525473036|FG002|Open-label Phase|Protocol Violation|0|||
145715106|NCT00951015|525473037|FG003|Open-label Phase|Protocol Violation|0|||
145715107|NCT00951015|525473038|FG004|Open-label Phase|Protocol Violation|12|||
145715108|NCT00951015|525473034|FG000|Open-label Phase|Lost to Follow-up|0|||
145715109|NCT00951015|525473035|FG001|Open-label Phase|Lost to Follow-up|0|||
145715110|NCT00951015|525473036|FG002|Open-label Phase|Lost to Follow-up|0|||
145715111|NCT00951015|525473037|FG003|Open-label Phase|Lost to Follow-up|0|||
145715112|NCT00951015|525473038|FG004|Open-label Phase|Lost to Follow-up|12|||
145715113|NCT00951015|525473034|FG000|Open-label Phase|Withdrawal by Subject|0|||
145715114|NCT00951015|525473035|FG001|Open-label Phase|Withdrawal by Subject|0|||
145715115|NCT00951015|525473036|FG002|Open-label Phase|Withdrawal by Subject|0|||
145715116|NCT00951015|525473037|FG003|Open-label Phase|Withdrawal by Subject|0|||
145715117|NCT00951015|525473038|FG004|Open-label Phase|Withdrawal by Subject|14|||
145715118|NCT00951015|525473034|FG000|Open-label Phase|Physician Decision|0|||
145715119|NCT00951015|525473035|FG001|Open-label Phase|Physician Decision|0|||
145715120|NCT00951015|525473036|FG002|Open-label Phase|Physician Decision|0|||
145715121|NCT00951015|525473037|FG003|Open-label Phase|Physician Decision|0|||
145715122|NCT00951015|525473038|FG004|Open-label Phase|Physician Decision|8|||
145715123|NCT03819634|525473040|FG000|Overall Study|Physician Decision|2|||
145715124|NCT00299494|525473041|FG000|Overall Study|Withdrawal by Subject|0|||
145715125|NCT00299494|525473042|FG001|Overall Study|Withdrawal by Subject|0|||
145715126|NCT00299494|525473043|FG002|Overall Study|Withdrawal by Subject|0|||
145715127|NCT00299494|525473044|FG003|Overall Study|Withdrawal by Subject|3|||
145491529|NCT04612725|524653827|FG000|Overall Study|Study terminated by sponsor|3|||
145491530|NCT04612725|524653828|FG001|Overall Study|Study terminated by sponsor|1|||
145491531|NCT04612725|524653829|FG002|Overall Study|Study terminated by sponsor|2|||
145491532|NCT04612725|524653830|FG003|Overall Study|Study terminated by sponsor|4|||
145491533|NCT04612725|524653831|FG004|Overall Study|Study terminated by sponsor|5|||
145491534|NCT04612725|524653827|FG000|Overall Study|Withdrawal by Subject|8|||
145491535|NCT04612725|524653828|FG001|Overall Study|Withdrawal by Subject|3|||
145491536|NCT04612725|524653829|FG002|Overall Study|Withdrawal by Subject|5|||
145715128|NCT00299494|525473045|FG004|Overall Study|Withdrawal by Subject|1|||
145715129|NCT00299494|525473046|FG005|Overall Study|Withdrawal by Subject|4|||
145715130|NCT00299494|525473041|FG000|Overall Study|Physician Decision|0|||
145715131|NCT00299494|525473042|FG001|Overall Study|Physician Decision|0|||
145715132|NCT00299494|525473043|FG002|Overall Study|Physician Decision|0|||
145715133|NCT00299494|525473044|FG003|Overall Study|Physician Decision|0|||
145715134|NCT00299494|525473045|FG004|Overall Study|Physician Decision|1|||
145715135|NCT00299494|525473046|FG005|Overall Study|Physician Decision|0|||
145715136|NCT00299494|525473041|FG000|Overall Study|Death|3|||
145715137|NCT00299494|525473042|FG001|Overall Study|Death|1|||
145715138|NCT00299494|525473043|FG002|Overall Study|Death|4|||
145715139|NCT00299494|525473044|FG003|Overall Study|Death|6|||
145715140|NCT00299494|525473045|FG004|Overall Study|Death|18|||
145715141|NCT00299494|525473046|FG005|Overall Study|Death|19|||
145715142|NCT00299494|525473041|FG000|Overall Study|Lost to Follow-up|0|||
145715143|NCT00299494|525473042|FG001|Overall Study|Lost to Follow-up|0|||
145715144|NCT00299494|525473043|FG002|Overall Study|Lost to Follow-up|0|||
145491537|NCT04612725|524653830|FG003|Overall Study|Withdrawal by Subject|1|||
145491538|NCT04612725|524653831|FG004|Overall Study|Withdrawal by Subject|9|||
145715145|NCT00299494|525473044|FG003|Overall Study|Lost to Follow-up|0|||
145715146|NCT00299494|525473045|FG004|Overall Study|Lost to Follow-up|3|||
145715147|NCT00299494|525473046|FG005|Overall Study|Lost to Follow-up|1|||
145715148|NCT00299494|525473041|FG000|Overall Study|Other - Unspecified|0|||
145715149|NCT00299494|525473042|FG001|Overall Study|Other - Unspecified|0|||
145715150|NCT00299494|525473043|FG002|Overall Study|Other - Unspecified|0|||
145715151|NCT00299494|525473044|FG003|Overall Study|Other - Unspecified|0|||
145491539|NCT04612725|524653827|FG000|Overall Study|Other|0|||
145715152|NCT00299494|525473045|FG004|Overall Study|Other - Unspecified|3|||
145715153|NCT00299494|525473046|FG005|Overall Study|Other - Unspecified|1|||
145715154|NCT00299494|525473041|FG000|Overall Study|Other - site closure|0|||
145715155|NCT00299494|525473042|FG001|Overall Study|Other - site closure|0|||
145715156|NCT00299494|525473043|FG002|Overall Study|Other - site closure|0|||
145715157|NCT00299494|525473044|FG003|Overall Study|Other - site closure|1|||
145715158|NCT00299494|525473045|FG004|Overall Study|Other - site closure|1|||
145715159|NCT00299494|525473046|FG005|Overall Study|Other - site closure|1|||
145715160|NCT01417104|525473050|FG000|Overall Study|Withdrawal by Subject|5|||
145715161|NCT01417104|525473051|FG001|Overall Study|Withdrawal by Subject|1|||
145715162|NCT01417104|525473050|FG000|Overall Study|Failure to make contact|0|||
145715163|NCT01417104|525473051|FG001|Overall Study|Failure to make contact|1|||
145715164|NCT01417104|525473050|FG000|Overall Study|Adverse Event|1|||
145715165|NCT01417104|525473051|FG001|Overall Study|Adverse Event|0|||
145715166|NCT02755818|525473055|FG000|Overall Study|Withdrawal by Subject|0|||
145715167|NCT02755818|525473056|FG001|Overall Study|Withdrawal by Subject|0|||
145715168|NCT02755818|525473057|FG002|Overall Study|Withdrawal by Subject|0|||
145715169|NCT02755818|525473058|FG003|Overall Study|Withdrawal by Subject|2|||
145715170|NCT02755818|525473055|FG000|Overall Study|withdrawal by PI|0|||
145715171|NCT02755818|525473056|FG001|Overall Study|withdrawal by PI|0|||
145715172|NCT02755818|525473057|FG002|Overall Study|withdrawal by PI|1|||
145715173|NCT02755818|525473058|FG003|Overall Study|withdrawal by PI|1|||
145715174|NCT01280357|525473059|FG000|Overall Study|Excluded no internal monitoring|14|||
145715175|NCT01280357|525473059|FG000|Overall Study|IInsufficient data/No data supplied|12|||
145715176|NCT00992225|525473060|FG000|Overall Study|Entry Criteria Not Met|8|||
145715177|NCT00992225|525473060|FG000|Overall Study|Adverse Event|2|||
145715178|NCT01036438|525473064|FG000|Overall Study|Adverse Event|7|||
145715179|NCT01036438|525473065|FG001|Overall Study|Adverse Event|8|||
145715180|NCT01036438|525473064|FG000|Overall Study|Death|0|||
145715181|NCT01036438|525473065|FG001|Overall Study|Death|1|||
145715182|NCT01036438|525473064|FG000|Overall Study|No effect of study treatment|3|||
145715183|NCT01036438|525473065|FG001|Overall Study|No effect of study treatment|1|||
145715184|NCT03592745|525473066|FG000|Overall Study|Adverse Event|0|||
145715185|NCT03592745|525473067|FG001|Overall Study|Adverse Event|2|||
145715186|NCT03592745|525473066|FG000|Overall Study|Lost to Follow-up|2|||
145715187|NCT03592745|525473067|FG001|Overall Study|Lost to Follow-up|0|||
145491540|NCT04612725|524653828|FG001|Overall Study|Other|0|||
145491541|NCT04612725|524653829|FG002|Overall Study|Other|0|||
145491542|NCT04612725|524653830|FG003|Overall Study|Other|0|||
145491543|NCT04612725|524653831|FG004|Overall Study|Other|1|||
145491544|NCT02354235|524653832|FG000|Overall Study|Adverse Event|2|||
145491545|NCT02354235|524653833|FG001|Overall Study|Adverse Event|2|||
145491546|NCT02354235|524653832|FG000|Overall Study|Physician Decision|0|||
145491547|NCT02354235|524653833|FG001|Overall Study|Physician Decision|1|||
145491548|NCT02354235|524653832|FG000|Overall Study|Withdrawal by Subject|1|||
145491549|NCT02354235|524653833|FG001|Overall Study|Withdrawal by Subject|3|||
145491550|NCT02354235|524653832|FG000|Overall Study|Conflict with the stopping criteria|0|||
145491551|NCT02354235|524653833|FG001|Overall Study|Conflict with the stopping criteria|1|||
145491552|NCT03069352|524653834|FG000|Overall Study|Ongoing|12|||
145491553|NCT03069352|524653835|FG001|Overall Study|Ongoing|40|||
145491554|NCT02621424|524653836|FG000|Overall Study|Withdrawal by Subject|1|||
145491555|NCT02621424|524653837|FG001|Overall Study|Withdrawal by Subject|2|||
145491556|NCT05148234|524653839|FG000|Phase I|Ineligible|0|||
145491557|NCT05148234|524653840|FG001|Phase I|Ineligible|0|||
145491558|NCT05148234|524653841|FG002|Phase I|Ineligible|0|||
145491559|NCT05148234|524653842|FG003|Phase I|Ineligible|0|||
145491560|NCT05148234|524653843|FG004|Phase I|Ineligible|0|||
145491561|NCT05148234|524653844|FG005|Phase I|Ineligible|0|||
145491562|NCT05148234|524653845|FG006|Phase I|Ineligible|0|||
145491563|NCT05148234|524653846|FG007|Phase I|Ineligible|1|||
145491564|NCT05148234|524653839|FG000|Phase I|Company closed the trial.|0|||
145491565|NCT05148234|524653840|FG001|Phase I|Company closed the trial.|1|||
145491566|NCT05148234|524653841|FG002|Phase I|Company closed the trial.|0|||
145491567|NCT05148234|524653842|FG003|Phase I|Company closed the trial.|0|||
145491568|NCT05148234|524653843|FG004|Phase I|Company closed the trial.|0|||
145491569|NCT05148234|524653844|FG005|Phase I|Company closed the trial.|0|||
145491570|NCT05148234|524653845|FG006|Phase I|Company closed the trial.|0|||
145491571|NCT05148234|524653846|FG007|Phase I|Company closed the trial.|0|||
145491572|NCT01928927|524653847|FG000|Overall Study|Lost to Follow-up|1|||
145491573|NCT01928927|524653848|FG001|Overall Study|Lost to Follow-up|0|||
145491574|NCT01928927|524653847|FG000|Overall Study|Withdrawal by Subject|1|||
145491575|NCT01928927|524653848|FG001|Overall Study|Withdrawal by Subject|1|||
145491576|NCT03409796|524655289|FG000|Overall Study|Adverse Event|2|||
145491577|NCT03409796|524655290|FG001|Overall Study|Adverse Event|0|||
145491578|NCT03409796|524655289|FG000|Overall Study|Other|0|||
145491579|NCT03409796|524655290|FG001|Overall Study|Other|1|||
145491580|NCT01453049|524655305|FG000|Overall Study|Protocol Violation|2|||
145715188|NCT03592745|525473066|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
145715189|NCT03592745|525473067|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
145715190|NCT02729831|525473069|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
145715191|NCT02729831|525473070|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
145715192|NCT02729831|525473071|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
145491581|NCT01453049|524655306|FG001|Overall Study|Protocol Violation|5|||
145491582|NCT01453049|524655305|FG000|Overall Study|Lost to Follow-up|2|||
145491583|NCT01453049|524655306|FG001|Overall Study|Lost to Follow-up|1|||
145491584|NCT01453049|524655305|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
145491585|NCT01453049|524655306|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
145715193|NCT02729831|525473072|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
145715194|NCT02729831|525473069|FG000|1 Week Post-visit|Lost to Follow-up|43|||
145715195|NCT02729831|525473070|FG001|1 Week Post-visit|Lost to Follow-up|40|||
145715196|NCT02729831|525473071|FG002|1 Week Post-visit|Lost to Follow-up|38|||
145715197|NCT02729831|525473072|FG003|1 Week Post-visit|Lost to Follow-up|36|||
145715198|NCT02729831|525473069|FG000|6 Month Follow-up|Lost to Follow-up|54|||
145715199|NCT02729831|525473070|FG001|6 Month Follow-up|Lost to Follow-up|51|||
145715200|NCT02729831|525473071|FG002|6 Month Follow-up|Lost to Follow-up|48|||
145715201|NCT02729831|525473072|FG003|6 Month Follow-up|Lost to Follow-up|42|||
145715202|NCT02729831|525473069|FG000|6 Month Follow-up|Death|1|||
145715203|NCT02729831|525473070|FG001|6 Month Follow-up|Death|3|||
145715204|NCT02729831|525473071|FG002|6 Month Follow-up|Death|0|||
145715205|NCT02729831|525473072|FG003|6 Month Follow-up|Death|1|||
145715206|NCT01413503|525473073|FG000|Overall Study|Lost to Follow-up|1|||
145715207|NCT05597787|525473081|FG000|Overall Study|Withdrawal by Subject|0|||
145715208|NCT05597787|525473082|FG001|Overall Study|Withdrawal by Subject|0|||
145715209|NCT05597787|525473083|FG002|Overall Study|Withdrawal by Subject|1|||
145715210|NCT01241604|525473084|FG000|Screening Period|Screen Failure|3|||
145715211|NCT01241604|525473085|FG001|Screening Period|Screen Failure|0|||
145715212|NCT01241604|525473086|FG002|Screening Period|Screen Failure|0|||
145715213|NCT04349631|525473088|FG000|Overall Study|Lost to Follow-up|3|||
145715214|NCT04349631|525473088|FG000|Overall Study|Withdrawal by Subject|7|||
145715215|NCT03377699|525474385|FG000|Overall Study|Withdrawal by Subject|2|||
145715216|NCT03377699|525474386|FG001|Overall Study|Withdrawal by Subject|9|||
145715217|NCT03377699|525474385|FG000|Overall Study|Lost to Follow-up|1|||
145715218|NCT03377699|525474386|FG001|Overall Study|Lost to Follow-up|1|||
145715219|NCT03377699|525474385|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
145715220|NCT03377699|525474386|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
145715221|NCT03377699|525474385|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
145715222|NCT03377699|525474386|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
145715223|NCT03377699|525474385|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
145715224|NCT03377699|525474386|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
145715225|NCT03377699|525474385|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
145715226|NCT03377699|525474386|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
145715227|NCT00774930|525474390|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
145715228|NCT00774930|525474391|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
145715229|NCT00774930|525474390|FG000|DB Phase|Adverse Event|1|||
145715230|NCT00774930|525474391|FG001|DB Phase|Adverse Event|2|||
145715231|NCT00774930|525474390|FG000|DB Phase|Subject Decision|1|||
145715232|NCT00774930|525474391|FG001|DB Phase|Subject Decision|5|||
145715233|NCT00774930|525474390|FG000|DB Phase|Sponsor Decision|0|||
145715234|NCT00774930|525474391|FG001|DB Phase|Sponsor Decision|1|||
145715235|NCT00774930|525474390|FG000|DB Phase|Disease Progression|1|||
145715236|NCT00774930|525474391|FG001|DB Phase|Disease Progression|1|||
145715237|NCT00774930|525474390|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
145715238|NCT00774930|525474391|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
145715239|NCT00774930|525474390|FG000|IOL Phase|Adverse Event|1|||
145715240|NCT00774930|525474391|FG001|IOL Phase|Adverse Event|1|||
145715241|NCT00774930|525474390|FG000|IOL Phase|Subject Decision|4|||
145715242|NCT00774930|525474391|FG001|IOL Phase|Subject Decision|3|||
145715243|NCT00774930|525474390|FG000|IOL Phase|Physician Decision|3|||
145715244|NCT00774930|525474391|FG001|IOL Phase|Physician Decision|2|||
145715245|NCT00774930|525474390|FG000|IOL Phase|Sponsor Decision|1|||
145715246|NCT00774930|525474391|FG001|IOL Phase|Sponsor Decision|0|||
145715247|NCT00774930|525474390|FG000|IOL Phase|Disease Progression|2|||
145715248|NCT00774930|525474391|FG001|IOL Phase|Disease Progression|1|||
145715249|NCT00774930|525474390|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
145715250|NCT00774930|525474391|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
145715251|NCT00774930|525474390|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
145491586|NCT01453049|524655305|FG000|Overall Study|Withdrawal by Subject|1|||
145491587|NCT01453049|524655306|FG001|Overall Study|Withdrawal by Subject|0|||
145715252|NCT00774930|525474391|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
145715253|NCT00774930|525474390|FG000|IOL Phase|Other|1|||
145715254|NCT00774930|525474391|FG001|IOL Phase|Other|0|||
145715255|NCT00774930|525474390|FG000|IOL Phase|Brain radiation|0|||
145715256|NCT00774930|525474391|FG001|IOL Phase|Brain radiation|1|||
145715257|NCT00774930|525474390|FG000|LTOLE Phase|Adverse Event|7|||
145715258|NCT00774930|525474391|FG001|LTOLE Phase|Adverse Event|3|||
145715259|NCT00774930|525474390|FG000|LTOLE Phase|Subject decision|0|||
145715260|NCT00774930|525474391|FG001|LTOLE Phase|Subject decision|5|||
145715261|NCT00774930|525474390|FG000|LTOLE Phase|Physician Decision|4|||
145715262|NCT00774930|525474391|FG001|LTOLE Phase|Physician Decision|1|||
145715263|NCT00774930|525474390|FG000|LTOLE Phase|Sponsor decision|2|||
145715264|NCT00774930|525474391|FG001|LTOLE Phase|Sponsor decision|1|||
145715265|NCT00774930|525474390|FG000|LTOLE Phase|Disease Progression|2|||
145715266|NCT00774930|525474391|FG001|LTOLE Phase|Disease Progression|5|||
145715267|NCT00774930|525474390|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
145715268|NCT00774930|525474391|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
145715269|NCT00774930|525474390|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
145715270|NCT00774930|525474391|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
145715271|NCT01153321|525474392|FG000|Overall Study|Development of study withdrawal criteria|0|||
145715272|NCT01153321|525474393|FG001|Overall Study|Development of study withdrawal criteria|1|||
145715273|NCT01153321|525474392|FG000|Overall Study|Withdrawal by Subject|0|||
145715274|NCT01153321|525474393|FG001|Overall Study|Withdrawal by Subject|1|||
145715275|NCT01153321|525474392|FG000|Overall Study|Adverse Event|1|||
145715276|NCT01153321|525474393|FG001|Overall Study|Adverse Event|1|||
145715277|NCT01177800|525474394|FG000|Overall Study|Adverse Event|9|||
145715278|NCT01177800|525474395|FG001|Overall Study|Adverse Event|3|||
145715279|NCT01177800|525474394|FG000|Overall Study|Protocol Violation|0|||
145715280|NCT01177800|525474395|FG001|Overall Study|Protocol Violation|1|||
145715281|NCT01177800|525474394|FG000|Overall Study|Physician Decision|1|||
145715282|NCT01177800|525474395|FG001|Overall Study|Physician Decision|0|||
145715283|NCT01177800|525474394|FG000|Overall Study|Withdrawal of informed consent|0|||
145715284|NCT01177800|525474395|FG001|Overall Study|Withdrawal of informed consent|1|||
145715285|NCT01941719|525474405|FG000|Overall Study|Lost to Follow-up|20|||
145715286|NCT01941719|525474406|FG001|Overall Study|Lost to Follow-up|19|||
145715287|NCT00252577|525474407|FG000|Overall Study|Lost to Follow-up|20|||
145715288|NCT01416389|525474410|FG000|Overall Study|Lost to Follow-up|1|||
145715289|NCT01416389|525474411|FG001|Overall Study|Lost to Follow-up|0|||
145715290|NCT01416389|525474410|FG000|Overall Study|Started New Therapy|2|||
145715291|NCT01416389|525474411|FG001|Overall Study|Started New Therapy|0|||
145715292|NCT01125514|525474412|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
145715293|NCT01125514|525474412|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
145715294|NCT01125514|525474412|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
145715295|NCT01125514|525474412|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
145715296|NCT01125514|525474412|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
145715297|NCT01125514|525474412|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
145715298|NCT00858364|525474413|FG000|Overall Study|Administrative Decision|3|||
145715299|NCT00858364|525474414|FG001|Overall Study|Administrative Decision|2|||
145715300|NCT00858364|525474413|FG000|Overall Study|Adverse Event|5|||
145715301|NCT00858364|525474414|FG001|Overall Study|Adverse Event|2|||
145715302|NCT00858364|525474413|FG000|Overall Study|Withdrawal by Subject|44|||
145715303|NCT00858364|525474414|FG001|Overall Study|Withdrawal by Subject|118|||
145715304|NCT00858364|525474413|FG000|Overall Study|Ineligibility Determined|1|||
145715305|NCT00858364|525474414|FG001|Overall Study|Ineligibility Determined|10|||
145715306|NCT00858364|525474413|FG000|Overall Study|Lost to Follow-up|24|||
145715307|NCT00858364|525474414|FG001|Overall Study|Lost to Follow-up|54|||
145715308|NCT00858364|525474413|FG000|Overall Study|Noncompliance|3|||
145715309|NCT00858364|525474414|FG001|Overall Study|Noncompliance|4|||
145715310|NCT00858364|525474413|FG000|Overall Study|Protocol Deviation|0|||
145715311|NCT00858364|525474414|FG001|Overall Study|Protocol Deviation|2|||
145715312|NCT00858364|525474413|FG000|Overall Study|Other|9|||
145715313|NCT00858364|525474414|FG001|Overall Study|Other|17|||
145715314|NCT00858364|525474413|FG000|Overall Study|Missing|1|||
145715315|NCT00858364|525474414|FG001|Overall Study|Missing|1|||
145715316|NCT00858364|525474413|FG000|Overall Study|Still on-study|114|||
145715317|NCT00858364|525474414|FG001|Overall Study|Still on-study|247|||
145715318|NCT03980808|525474415|FG000|Overall Study|Lost to Follow-up|2|||
145715319|NCT03980808|525474416|FG001|Overall Study|Lost to Follow-up|2|||
145715320|NCT01655693|525474417|FG000|Overall Study|Progression of Disease|92|||
145715321|NCT01655693|525474418|FG001|Overall Study|Progression of Disease|76|||
145715322|NCT01655693|525474419|FG002|Overall Study|Progression of Disease|58|||
145715323|NCT01655693|525474417|FG000|Overall Study|Death|8|||
145715324|NCT01655693|525474418|FG001|Overall Study|Death|9|||
145715325|NCT01655693|525474419|FG002|Overall Study|Death|12|||
145715326|NCT01655693|525474417|FG000|Overall Study|Serious Adverse Event|3|||
145715327|NCT01655693|525474418|FG001|Overall Study|Serious Adverse Event|15|||
145715328|NCT01655693|525474419|FG002|Overall Study|Serious Adverse Event|11|||
145715329|NCT01655693|525474417|FG000|Overall Study|Withdrawal by Subject|3|||
145715330|NCT01655693|525474418|FG001|Overall Study|Withdrawal by Subject|2|||
145715331|NCT01655693|525474419|FG002|Overall Study|Withdrawal by Subject|20|||
145715332|NCT01655693|525474417|FG000|Overall Study|Adverse Event|3|||
145715333|NCT01655693|525474418|FG001|Overall Study|Adverse Event|11|||
145715334|NCT01655693|525474419|FG002|Overall Study|Adverse Event|3|||
145715335|NCT01655693|525474417|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
145715336|NCT01655693|525474418|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
145715337|NCT01655693|525474419|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
145715338|NCT01655693|525474417|FG000|Overall Study|Non-Compliance|0|||
145715339|NCT01655693|525474418|FG001|Overall Study|Non-Compliance|0|||
145715340|NCT01655693|525474419|FG002|Overall Study|Non-Compliance|7|||
145715341|NCT01655693|525474417|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
145715342|NCT01655693|525474418|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
145715343|NCT01655693|525474419|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
145715344|NCT01655693|525474417|FG000|Overall Study|Protocol Violation|1|||
145715345|NCT01655693|525474418|FG001|Overall Study|Protocol Violation|0|||
145715346|NCT01655693|525474419|FG002|Overall Study|Protocol Violation|3|||
145715347|NCT01655693|525474417|FG000|Overall Study|Lost to Follow-up|1|||
145715348|NCT01655693|525474418|FG001|Overall Study|Lost to Follow-up|0|||
145715349|NCT01655693|525474419|FG002|Overall Study|Lost to Follow-up|1|||
145715350|NCT01655693|525474417|FG000|Overall Study|Screening Failure|1|||
145715351|NCT01655693|525474418|FG001|Overall Study|Screening Failure|0|||
145715352|NCT01655693|525474419|FG002|Overall Study|Screening Failure|0|||
145715353|NCT01655693|525474417|FG000|Overall Study|Other|8|||
145715354|NCT01655693|525474418|FG001|Overall Study|Other|6|||
145715355|NCT01655693|525474419|FG002|Overall Study|Other|15|||
145715356|NCT00929110|525474422|FG000|Overall Study|Adverse Event|40|||
145715357|NCT00929110|525474423|FG001|Overall Study|Adverse Event|29|||
145715358|NCT00929110|525474424|FG002|Overall Study|Adverse Event|18|||
145715359|NCT00929110|525474422|FG000|Overall Study|Subject withdrew consent|40|||
145715360|NCT00929110|525474423|FG001|Overall Study|Subject withdrew consent|23|||
145715361|NCT00929110|525474424|FG002|Overall Study|Subject withdrew consent|26|||
145715362|NCT00929110|525474422|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
145715363|NCT00929110|525474423|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
145715364|NCT00929110|525474424|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
145715365|NCT00929110|525474422|FG000|Overall Study|Lost to Follow-up|7|||
145715366|NCT00929110|525474423|FG001|Overall Study|Lost to Follow-up|7|||
145715367|NCT00929110|525474424|FG002|Overall Study|Lost to Follow-up|3|||
145715368|NCT00929110|525474422|FG000|Overall Study|Protocol deviation|5|||
145715369|NCT00929110|525474423|FG001|Overall Study|Protocol deviation|2|||
145715370|NCT00929110|525474424|FG002|Overall Study|Protocol deviation|4|||
145715371|NCT00929110|525474422|FG000|Overall Study|Administrative problems|4|||
145715372|NCT00929110|525474423|FG001|Overall Study|Administrative problems|1|||
145715373|NCT00929110|525474424|FG002|Overall Study|Administrative problems|2|||
145715374|NCT00929110|525474422|FG000|Overall Study|Death|2|||
145715375|NCT00929110|525474423|FG001|Overall Study|Death|2|||
145715376|NCT00929110|525474424|FG002|Overall Study|Death|2|||
145715377|NCT00929110|525474422|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145715378|NCT00929110|525474423|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145715379|NCT00929110|525474424|FG002|Overall Study|Abnormal laboratory value(s)|0|||
145715380|NCT00929110|525474422|FG000|Overall Study|Abnormal test procedure result(s)|0|||
145491588|NCT01453049|524655305|FG000|Overall Study|Randomized in Error|1|||
145491589|NCT01453049|524655306|FG001|Overall Study|Randomized in Error|0|||
145491590|NCT03287791|524655311|FG000|Overall Study|Insufficient Therapeutic Response|0|||
145491591|NCT03287791|524655312|FG001|Overall Study|Insufficient Therapeutic Response|0|||
145491592|NCT03287791|524655313|FG002|Overall Study|Insufficient Therapeutic Response|1|||
145491593|NCT03287791|524655311|FG000|Overall Study|Adverse Event|0|||
145491594|NCT03287791|524655312|FG001|Overall Study|Adverse Event|4|||
145491595|NCT03287791|524655313|FG002|Overall Study|Adverse Event|3|||
145491596|NCT03287791|524655311|FG000|Overall Study|Withdrawal by Subject|12|||
145491597|NCT03287791|524655312|FG001|Overall Study|Withdrawal by Subject|12|||
145491598|NCT03287791|524655313|FG002|Overall Study|Withdrawal by Subject|17|||
145491599|NCT03287791|524655311|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
145715381|NCT00929110|525474423|FG001|Overall Study|Abnormal test procedure result(s)|1|||
145715382|NCT00929110|525474424|FG002|Overall Study|Abnormal test procedure result(s)|1|||
145715383|NCT00929110|525474422|FG000|Overall Study|Patient inability to use the device|0|||
145715384|NCT00929110|525474423|FG001|Overall Study|Patient inability to use the device|1|||
145715385|NCT00929110|525474424|FG002|Overall Study|Patient inability to use the device|0|||
145715386|NCT01163292|525474428|FG000|Overall Study|Lack of Efficacy|9|||
145715387|NCT01163292|525474429|FG001|Overall Study|Lack of Efficacy|0|||
145715388|NCT01163292|525474428|FG000|Overall Study|Adverse Event|6|||
145715389|NCT01163292|525474429|FG001|Overall Study|Adverse Event|0|||
145715390|NCT01163292|525474428|FG000|Overall Study|Initiation of biological therapy|0|||
145715391|NCT01163292|525474429|FG001|Overall Study|Initiation of biological therapy|15|||
145715392|NCT01163292|525474428|FG000|Overall Study|Sufficient response to adalimumab|8|||
145715393|NCT01163292|525474429|FG001|Overall Study|Sufficient response to adalimumab|0|||
145715394|NCT01163292|525474428|FG000|Overall Study|Refusal to receive adalimumab|7|||
145715395|NCT01163292|525474429|FG001|Overall Study|Refusal to receive adalimumab|0|||
145715396|NCT01163292|525474428|FG000|Overall Study|Economic reasons|6|||
145715397|NCT01163292|525474429|FG001|Overall Study|Economic reasons|0|||
145715398|NCT01163292|525474428|FG000|Overall Study|No further visits|5|||
145715399|NCT01163292|525474429|FG001|Overall Study|No further visits|7|||
145715400|NCT01258595|525474430|FG000|Overall Study|Lost to Follow-up|1|||
145715401|NCT01258595|525474431|FG001|Overall Study|Lost to Follow-up|0|||
145715402|NCT01258595|525474430|FG000|Overall Study|Withdrawal by Subject|0|||
145715403|NCT01258595|525474431|FG001|Overall Study|Withdrawal by Subject|1|||
145715404|NCT01012414|525474432|FG000|Overall Study|Withdrawal by Subject|2|||
145715405|NCT01012414|525474432|FG000|Overall Study|Lost to Follow-up|1|||
145715406|NCT01012414|525474432|FG000|Overall Study|Trial was stopped before completed|7|||
145715407|NCT01215188|525474433|FG000|Overall Study|Lost to Follow-up|22|||
145715408|NCT01215188|525474434|FG001|Overall Study|Lost to Follow-up|22|||
145715409|NCT01215188|525474435|FG002|Overall Study|Lost to Follow-up|16|||
145715410|NCT01215188|525474433|FG000|Overall Study|Adverse Event|1|||
145715411|NCT01215188|525474434|FG001|Overall Study|Adverse Event|1|||
145715412|NCT01215188|525474435|FG002|Overall Study|Adverse Event|3|||
145715413|NCT01215188|525474433|FG000|Overall Study|Physician Decision|2|||
145715414|NCT01215188|525474434|FG001|Overall Study|Physician Decision|1|||
145715415|NCT01215188|525474435|FG002|Overall Study|Physician Decision|0|||
145715416|NCT01215188|525474433|FG000|Overall Study|Lack of Efficacy|0|||
145715417|NCT01215188|525474434|FG001|Overall Study|Lack of Efficacy|0|||
145715418|NCT01215188|525474435|FG002|Overall Study|Lack of Efficacy|1|||
145715419|NCT01215188|525474433|FG000|Overall Study|Protocol Violation|1|||
145715420|NCT01215188|525474434|FG001|Overall Study|Protocol Violation|1|||
145715421|NCT01215188|525474435|FG002|Overall Study|Protocol Violation|1|||
145715422|NCT01215188|525474433|FG000|Overall Study|Withdrawal by Subject|32|||
145715423|NCT01215188|525474434|FG001|Overall Study|Withdrawal by Subject|34|||
145715424|NCT01215188|525474435|FG002|Overall Study|Withdrawal by Subject|31|||
145715425|NCT02601300|525474436|FG000|Induction Phase|Lack of Efficacy|2|||
145715426|NCT02601300|525474436|FG000|Induction Phase|Protocol Violation|1|||
145715427|NCT02601300|525474436|FG000|Extension Phase|Withdrawal by Subject|3|||
145491600|NCT03287791|524655312|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
145491601|NCT03287791|524655313|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
145491602|NCT03287791|524655311|FG000|Overall Study|Lost to Follow-up|8|||
145491603|NCT03287791|524655312|FG001|Overall Study|Lost to Follow-up|14|||
145491604|NCT03287791|524655313|FG002|Overall Study|Lost to Follow-up|11|||
145491605|NCT03287791|524655311|FG000|Overall Study|Protocol Violation|7|||
145491606|NCT03287791|524655312|FG001|Overall Study|Protocol Violation|2|||
145491607|NCT03287791|524655313|FG002|Overall Study|Protocol Violation|1|||
145491608|NCT03287791|524655311|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
145491609|NCT03287791|524655312|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
145491610|NCT03287791|524655313|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
145491611|NCT03287791|524655311|FG000|Overall Study|Too much time between 2 visits|0|||
145491612|NCT03287791|524655312|FG001|Overall Study|Too much time between 2 visits|1|||
145491613|NCT03287791|524655313|FG002|Overall Study|Too much time between 2 visits|0|||
145491614|NCT03287791|524655311|FG000|Overall Study|Non-compliance|0|||
145491615|NCT03287791|524655312|FG001|Overall Study|Non-compliance|1|||
145491616|NCT03287791|524655313|FG002|Overall Study|Non-compliance|0|||
145491617|NCT03287791|524655311|FG000|Overall Study|Did not meet inclusion criteria|1|||
145491618|NCT03287791|524655312|FG001|Overall Study|Did not meet inclusion criteria|0|||
145491619|NCT03287791|524655313|FG002|Overall Study|Did not meet inclusion criteria|0|||
145491620|NCT03095651|524655315|FG000|Overall Study|Lost to Follow-up|1|||
145491621|NCT03095651|524655316|FG001|Overall Study|Lost to Follow-up|1|||
145491622|NCT03095651|524655317|FG002|Overall Study|Lost to Follow-up|0|||
145491623|NCT03095651|524655318|FG003|Overall Study|Lost to Follow-up|1|||
145491624|NCT03095651|524655319|FG004|Overall Study|Lost to Follow-up|0|||
145491625|NCT03095651|524655320|FG005|Overall Study|Lost to Follow-up|0|||
145491626|NCT03095651|524655321|FG006|Overall Study|Lost to Follow-up|0|||
145491627|NCT03095651|524655322|FG007|Overall Study|Lost to Follow-up|0|||
145491628|NCT03095651|524655315|FG000|Overall Study|Withdrawal by Subject|0|||
145491629|NCT03095651|524655316|FG001|Overall Study|Withdrawal by Subject|0|||
145491630|NCT03095651|524655317|FG002|Overall Study|Withdrawal by Subject|0|||
145491631|NCT03095651|524655318|FG003|Overall Study|Withdrawal by Subject|0|||
145491632|NCT03095651|524655319|FG004|Overall Study|Withdrawal by Subject|0|||
145491633|NCT03095651|524655320|FG005|Overall Study|Withdrawal by Subject|1|||
145491634|NCT03095651|524655321|FG006|Overall Study|Withdrawal by Subject|0|||
145491635|NCT03095651|524655322|FG007|Overall Study|Withdrawal by Subject|0|||
145491636|NCT02891174|524655328|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
145491637|NCT02891174|524655329|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
145491638|NCT02891174|524655328|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
145491639|NCT02891174|524655329|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
145491640|NCT02891174|524655328|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
145491641|NCT02891174|524655329|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
145491642|NCT02891174|524655328|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
145491643|NCT02891174|524655329|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
145491644|NCT02891174|524655328|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
145715428|NCT02601300|525474436|FG000|Extension Phase|Adverse Event|4|||
145715429|NCT02601300|525474436|FG000|Extension Phase|Lack of Efficacy|10|||
145715430|NCT01127763|525474437|FG000|Overall Study|Adverse Event|2|||
145715431|NCT01127763|525474437|FG000|Overall Study|Withdrawal by Subject|1|||
145715432|NCT01127763|525474437|FG000|Overall Study|Physician Decision|2|||
145715433|NCT00528931|525474438|FG000|Overall Study|Lost to Follow-up|1|||
145491645|NCT02891174|524655329|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
145491646|NCT02891174|524655328|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
145491647|NCT02891174|524655329|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
145491648|NCT02891174|524655328|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
145491649|NCT02891174|524655329|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
145491650|NCT04235140|524655330|FG000|Overall Study|Adverse Event|2|||
145491651|NCT04235140|524655330|FG000|Overall Study|Lost to Follow-up|1|||
145491652|NCT04235140|524655330|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
145491653|NCT04235140|524655330|FG000|Overall Study|Commercial drug is available for participants|7|||
145491654|NCT00768989|524655333|FG000|Prior to Week 24|Withdrawal by Subject|1|||
145491655|NCT00768989|524655334|FG001|Prior to Week 24|Withdrawal by Subject|0|||
145491656|NCT00768989|524655333|FG000|Prior to Week 24|Adverse Event|3|||
145491657|NCT00768989|524655334|FG001|Prior to Week 24|Adverse Event|0|||
145491658|NCT00768989|524655333|FG000|Prior to Week 24|Lost to Follow-up|0|||
145491659|NCT00768989|524655334|FG001|Prior to Week 24|Lost to Follow-up|1|||
145491660|NCT00768989|524655333|FG000|Prior to Week 24|Protocol Violation|0|||
145491661|NCT00768989|524655334|FG001|Prior to Week 24|Protocol Violation|2|||
145491662|NCT00768989|524655333|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
145491663|NCT00768989|524655334|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
145491664|NCT00768989|524655333|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
145491665|NCT00768989|524655334|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
145491666|NCT00768989|524655333|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
145491667|NCT00768989|524655334|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
145491668|NCT00768989|524655333|FG000|On or After Week 36|Lack of Efficacy|1|||
145491669|NCT00768989|524655334|FG001|On or After Week 36|Lack of Efficacy|0|||
145491670|NCT00768989|524655333|FG000|On or After Week 36|Adverse Event|0|||
145491671|NCT00768989|524655334|FG001|On or After Week 36|Adverse Event|1|||
145491672|NCT00768989|524655333|FG000|On or After Week 36|Lost to Follow-up|1|||
145491673|NCT00768989|524655334|FG001|On or After Week 36|Lost to Follow-up|0|||
145491674|NCT00768989|524655333|FG000|On or After Week 36|Poor Compliance|1|||
145491675|NCT00768989|524655334|FG001|On or After Week 36|Poor Compliance|0|||
145491676|NCT00768989|524655333|FG000|On or After Week 36|Protocol Violation|1|||
145491677|NCT00768989|524655334|FG001|On or After Week 36|Protocol Violation|0|||
145491678|NCT00768989|524655333|FG000|On or After Week 36|Did not attend termination visit|2|||
145491679|NCT00768989|524655334|FG001|On or After Week 36|Did not attend termination visit|0|||
145491680|NCT00768989|524655333|FG000|On or After Week 36|Sponsor Termination|45|||
145491681|NCT00768989|524655334|FG001|On or After Week 36|Sponsor Termination|26|||
145491682|NCT00866177|524655337|FG000|Overall Study|Withdrawal by Subject|1|||
145491683|NCT00866177|524655337|FG000|Overall Study|Not Treated|151|||
145491684|NCT03585660|524655341|FG000|Overall Study|operator error|1|||
145491685|NCT03585660|524655341|FG000|Overall Study|technical error|2|||
145491686|NCT03585660|524655341|FG000|Overall Study|hip prosthesis|2|||
145491687|NCT03585660|524655341|FG000|Overall Study|did not undergo biopsy|8|||
145491688|NCT03585660|524655341|FG000|Overall Study|scanner problem|2|||
145491689|NCT05635461|524655342|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
145491690|NCT05635461|524655343|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
145491691|NCT05635461|524655344|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
145491692|NCT05635461|524655345|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
145491693|NCT05635461|524655346|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
145491694|NCT05635461|524655347|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
145491695|NCT05635461|524655342|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
145491696|NCT05635461|524655343|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
145491697|NCT05635461|524655344|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
145491698|NCT05635461|524655345|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
145491699|NCT05635461|524655346|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
145491700|NCT05635461|524655347|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
145491701|NCT05635461|524655342|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
145491702|NCT05635461|524655343|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
145491703|NCT05635461|524655344|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
145491704|NCT05635461|524655345|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
145491705|NCT05635461|524655346|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
145491706|NCT05635461|524655347|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
145491707|NCT00117637|524655348|FG000|First Intervention (Period 1)|Adverse Event|11|||
145491708|NCT00117637|524655349|FG001|First Intervention (Period 1)|Adverse Event|16|||
145491709|NCT00117637|524655348|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
145491710|NCT00117637|524655349|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
145491711|NCT00117637|524655348|FG000|First Intervention (Period 1)|Protocol Violation|1|||
145491712|NCT00117637|524655349|FG001|First Intervention (Period 1)|Protocol Violation|0|||
145491713|NCT00117637|524655348|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
145491714|NCT00117637|524655349|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
145491715|NCT00117637|524655348|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
145491716|NCT00117637|524655349|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
145491717|NCT00117637|524655348|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
145491718|NCT00117637|524655349|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
145491719|NCT00117637|524655348|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
145491720|NCT00117637|524655349|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
145491721|NCT00117637|524655348|FG000|First Intervention (Period 1)|reason not reported|0|||
145491722|NCT00117637|524655349|FG001|First Intervention (Period 1)|reason not reported|1|||
145491723|NCT00117637|524655348|FG000|Second Intervention (Period 2)|Adverse Event|0|||
145491724|NCT00117637|524655349|FG001|Second Intervention (Period 2)|Adverse Event|9|||
145491725|NCT00117637|524655348|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
145491726|NCT00117637|524655349|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
145491727|NCT00117637|524655348|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
145491728|NCT00117637|524655349|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
145491729|NCT00117637|524655348|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
145491730|NCT00117637|524655349|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
145491731|NCT00117637|524655348|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
145491732|NCT00117637|524655349|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
145491733|NCT00117637|524655348|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
145491734|NCT00117637|524655349|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
145491735|NCT00117637|524655348|FG000|Second Intervention (Period 2)|reason not reported|1|||
145491736|NCT00117637|524655349|FG001|Second Intervention (Period 2)|reason not reported|0|||
145491737|NCT01620060|524655351|FG000|Overall Study|Adverse Event|9|||
145491738|NCT01620060|524655351|FG000|Overall Study|Protocol Violation|1|||
145491739|NCT01620060|524655351|FG000|Overall Study|Withdrawal by Subject|1|||
145491740|NCT01620060|524655351|FG000|Overall Study|Did not comply with Study Produre|1|||
145491741|NCT01620060|524655351|FG000|Overall Study|Family emergency|1|||
145491742|NCT01620060|524655351|FG000|Overall Study|Per Sponsor Decision|2|||
145491743|NCT02269124|524655352|FG000|Overall Study|Lost to Follow-up|1|||
145491744|NCT02269124|524655353|FG001|Overall Study|Lost to Follow-up|0|||
145491745|NCT02269124|524655352|FG000|Overall Study|Withdrawal by Subject|0|||
145491746|NCT02269124|524655353|FG001|Overall Study|Withdrawal by Subject|2|||
145491747|NCT01582061|524655354|FG000|Overall Study|Lack of Efficacy|3|||
145491748|NCT01582061|524655355|FG001|Overall Study|Lack of Efficacy|23|||
145491749|NCT01582061|524655354|FG000|Overall Study|Adverse Event|12|||
145491750|NCT01582061|524655355|FG001|Overall Study|Adverse Event|8|||
145491751|NCT01582061|524655354|FG000|Overall Study|Withdrawal by Subject|10|||
145491752|NCT01582061|524655355|FG001|Overall Study|Withdrawal by Subject|4|||
145491753|NCT01582061|524655354|FG000|Overall Study|Abnormal laboratory value(s)|1|||
145491754|NCT01582061|524655355|FG001|Overall Study|Abnormal laboratory value(s)|0|||
145491755|NCT01582061|524655354|FG000|Overall Study|Death|0|||
145491756|NCT01582061|524655355|FG001|Overall Study|Death|1|||
145491757|NCT01582061|524655354|FG000|Overall Study|condition no longer requires study drug|1|||
145491758|NCT01582061|524655355|FG001|Overall Study|condition no longer requires study drug|0|||
145491759|NCT01582061|524655354|FG000|Overall Study|Lost to Follow-up|1|||
145491760|NCT01582061|524655355|FG001|Overall Study|Lost to Follow-up|0|||
145491761|NCT04664153|524655358|FG000|Overall Study|Lack of Efficacy|0|||
145491762|NCT04664153|524655359|FG001|Overall Study|Lack of Efficacy|0|||
145491763|NCT04664153|524655360|FG002|Overall Study|Lack of Efficacy|1|||
145491764|NCT04664153|524655361|FG003|Overall Study|Lack of Efficacy|0|||
145491765|NCT04664153|524655358|FG000|Overall Study|Physician Decision|0|||
145491766|NCT04664153|524655359|FG001|Overall Study|Physician Decision|0|||
145491767|NCT04664153|524655360|FG002|Overall Study|Physician Decision|1|||
145491768|NCT04664153|524655361|FG003|Overall Study|Physician Decision|0|||
145491769|NCT04664153|524655358|FG000|Overall Study|Withdrawal by Subject|3|||
145491770|NCT04664153|524655359|FG001|Overall Study|Withdrawal by Subject|2|||
145491771|NCT04664153|524655360|FG002|Overall Study|Withdrawal by Subject|1|||
145491772|NCT04664153|524655361|FG003|Overall Study|Withdrawal by Subject|2|||
145491773|NCT04664153|524655358|FG000|Overall Study|Other|0|||
145491774|NCT04664153|524655359|FG001|Overall Study|Other|1|||
145491775|NCT04664153|524655360|FG002|Overall Study|Other|0|||
145491776|NCT04664153|524655361|FG003|Overall Study|Other|0|||
145491777|NCT04664153|524655358|FG000|Overall Study|Adverse Event|4|||
145491778|NCT04664153|524655359|FG001|Overall Study|Adverse Event|0|||
145491779|NCT04664153|524655360|FG002|Overall Study|Adverse Event|1|||
145491780|NCT04664153|524655361|FG003|Overall Study|Adverse Event|0|||
145491781|NCT00097500|524655362|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
145491782|NCT00097500|524655363|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
145491783|NCT00097500|524655362|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
145491784|NCT00097500|524655363|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
145491785|NCT00097500|524655362|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
145491786|NCT00097500|524655363|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
145491787|NCT00097500|524655362|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
145491788|NCT00097500|524655363|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
145491789|NCT00097500|524655362|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
145491790|NCT00097500|524655363|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
145491791|NCT00097500|524655362|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
145491792|NCT00097500|524655363|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
145491793|NCT00097500|524655362|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
145491794|NCT00097500|524655363|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
145491795|NCT00642356|524655367|FG000|Overall Study|Adverse Event|1|||
145491796|NCT00642356|524655368|FG001|Overall Study|Adverse Event|0|||
145491797|NCT00642356|524655367|FG000|Overall Study|Protocol Violation|0|||
145491798|NCT00642356|524655368|FG001|Overall Study|Protocol Violation|3|||
145491799|NCT00642356|524655367|FG000|Overall Study|Lack of Efficacy|1|||
145491800|NCT00642356|524655368|FG001|Overall Study|Lack of Efficacy|0|||
145491801|NCT01009060|524655377|FG000|Overall Study|Adverse Event|1|||
145491802|NCT01009060|524655378|FG001|Overall Study|Adverse Event|2|||
145491803|NCT01009060|524655377|FG000|Overall Study|Protocol Violation|0|||
145491804|NCT01009060|524655378|FG001|Overall Study|Protocol Violation|1|||
145491805|NCT01009060|524655377|FG000|Overall Study|Lost to Follow-up|1|||
145491806|NCT01009060|524655378|FG001|Overall Study|Lost to Follow-up|0|||
145491807|NCT01009060|524655377|FG000|Overall Study|Physician Decision|1|||
145491808|NCT01009060|524655378|FG001|Overall Study|Physician Decision|1|||
145491809|NCT01009060|524655377|FG000|Overall Study|Withdrawal by Subject|1|||
145491810|NCT01009060|524655378|FG001|Overall Study|Withdrawal by Subject|1|||
145491811|NCT00005906|524655379|FG000|Overall Study|Lack of Efficacy|3|||
145491812|NCT02694744|524655380|FG000|Overall Study|Adverse Event|2|||
145491813|NCT02694744|524655381|FG001|Overall Study|Adverse Event|1|||
145491814|NCT02694744|524655380|FG000|Overall Study|Withdrawal by Subject|2|||
145491815|NCT02694744|524655381|FG001|Overall Study|Withdrawal by Subject|1|||
145491816|NCT02694744|524655380|FG000|Overall Study|Physician Decision|1|||
145491817|NCT02694744|524655381|FG001|Overall Study|Physician Decision|2|||
145491818|NCT02694744|524655380|FG000|Overall Study|Lost to Follow-up|1|||
145491819|NCT02694744|524655381|FG001|Overall Study|Lost to Follow-up|0|||
145491820|NCT02694744|524655380|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
145491821|NCT02694744|524655381|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
145491822|NCT00667888|524655382|FG000|Overall Study|Death|1|||
145491823|NCT00667888|524655383|FG001|Overall Study|Death|1|||
145491824|NCT00667888|524655382|FG000|Overall Study|Withdrawal by Subject|6|||
145491825|NCT00667888|524655383|FG001|Overall Study|Withdrawal by Subject|3|||
145491826|NCT00667888|524655382|FG000|Overall Study|Proceed with other treatment|3|||
145491827|NCT00667888|524655383|FG001|Overall Study|Proceed with other treatment|3|||
145491828|NCT00667888|524655382|FG000|Overall Study|Ineligible after SIM|0|||
145491829|NCT00667888|524655383|FG001|Overall Study|Ineligible after SIM|2|||
145491830|NCT02140047|524655384|FG000|Overall Study|Withdrawal by parent/guardian|1|||
145491831|NCT02140047|524655385|FG001|Overall Study|Withdrawal by parent/guardian|1|||
145491832|NCT02140047|524655386|FG002|Overall Study|Withdrawal by parent/guardian|0|||
145491833|NCT02174731|524655387|FG000|Overall Study|Participant decision|67|||
145491834|NCT02174731|524655388|FG001|Overall Study|Participant decision|64|||
145491835|NCT02174731|524655387|FG000|Overall Study|Incorrect enrolment before randomization|0|||
145491836|NCT02174731|524655388|FG001|Overall Study|Incorrect enrolment before randomization|1|||
145491837|NCT02174731|524655387|FG000|Overall Study|Missing|2|||
145491838|NCT02174731|524655388|FG001|Overall Study|Missing|0|||
145491839|NCT03119259|524655389|FG000|Overall Study|Withdrawn as no longer eligible|1|||
145491840|NCT03119259|524655390|FG001|Overall Study|Withdrawn as no longer eligible|0|||
145491841|NCT03119259|524655389|FG000|Overall Study|Withdrawal by Subject|4|||
145491842|NCT03119259|524655390|FG001|Overall Study|Withdrawal by Subject|2|||
145491843|NCT03119259|524655389|FG000|Overall Study|Lost to Follow-up|0|||
145491844|NCT03119259|524655390|FG001|Overall Study|Lost to Follow-up|1|||
145491845|NCT00325897|524655391|FG000|Overall Study|Lost to Follow-up|12|||
145491846|NCT00325897|524655392|FG001|Overall Study|Lost to Follow-up|13|||
145491847|NCT01362348|524655393|FG000|Overall Study|Protocol-defined stopping criteria|9|||
145491848|NCT01362348|524655393|FG000|Overall Study|Study closed/terminated|5|||
145491849|NCT02675907|524655394|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
145491850|NCT02675907|524655395|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
145491851|NCT02675907|524655394|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
145491852|NCT02675907|524655395|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
145491853|NCT02675907|524655394|FG000|Study Overall|Lack of Efficacy|1|||
145491854|NCT02675907|524655395|FG001|Study Overall|Lack of Efficacy|0|||
145491855|NCT02675907|524655394|FG000|Study Overall|Withdrawal by Subject|2|||
145491856|NCT02675907|524655395|FG001|Study Overall|Withdrawal by Subject|2|||
145491857|NCT02675907|524655394|FG000|Study Overall|Lost to Follow-up|0|||
145491858|NCT02675907|524655395|FG001|Study Overall|Lost to Follow-up|2|||
145491859|NCT01611792|524655396|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
145491860|NCT01611792|524655397|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
145491861|NCT01611792|524655396|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
145491862|NCT01611792|524655397|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
145491863|NCT02898454|524655401|FG000|Overall Study|Adverse Event|4|||
145491864|NCT02898454|524655402|FG001|Overall Study|Adverse Event|1|||
145491865|NCT02898454|524655403|FG002|Overall Study|Adverse Event|2|||
145491866|NCT02898454|524655401|FG000|Overall Study|Protocol Violation|1|||
145491867|NCT02898454|524655402|FG001|Overall Study|Protocol Violation|0|||
145491868|NCT02898454|524655403|FG002|Overall Study|Protocol Violation|1|||
145491869|NCT02898454|524655401|FG000|Overall Study|Lack of Efficacy|4|||
145491870|NCT02898454|524655402|FG001|Overall Study|Lack of Efficacy|1|||
145491871|NCT02898454|524655403|FG002|Overall Study|Lack of Efficacy|0|||
145491872|NCT02898454|524655401|FG000|Overall Study|Withdrawal by Subject|6|||
145491873|NCT02898454|524655402|FG001|Overall Study|Withdrawal by Subject|3|||
145491874|NCT02898454|524655403|FG002|Overall Study|Withdrawal by Subject|3|||
145491875|NCT02898454|524655401|FG000|Overall Study|Lost to Follow-up|1|||
145491876|NCT02898454|524655402|FG001|Overall Study|Lost to Follow-up|0|||
145491877|NCT02898454|524655403|FG002|Overall Study|Lost to Follow-up|0|||
145491878|NCT02898454|524655401|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
145491879|NCT02898454|524655402|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
145491880|NCT02898454|524655403|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
145491881|NCT02343263|524655404|FG000|Overall Study|Physician Decision|5|||
145491882|NCT02343263|524655405|FG001|Overall Study|Physician Decision|3|||
145491883|NCT02343263|524655406|FG002|Overall Study|Physician Decision|1|||
145491884|NCT04264442|524655410|FG000|Overall Study|Lack of Efficacy|6|||
145491885|NCT04264442|524655410|FG000|Overall Study|Lost to Follow-up|2|||
145491886|NCT04264442|524655410|FG000|Overall Study|Sponsor Decision|23|||
145491887|NCT04264442|524655410|FG000|Overall Study|Withdrawal by Subject|11|||
145491888|NCT04264442|524655410|FG000|Overall Study|Study Termination|5|||
145491889|NCT03289208|524655413|FG000|Overall Study|Adverse Event|1|||
145491890|NCT03289208|524655414|FG001|Overall Study|Adverse Event|0|||
145491891|NCT03289208|524655415|FG002|Overall Study|Adverse Event|0|||
145491892|NCT00647296|524655416|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
145491893|NCT00647296|524655417|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
145491894|NCT00647296|524655418|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
145491895|NCT00647296|524655419|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
145491896|NCT00647296|524655416|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
145491897|NCT00647296|524655417|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
145491898|NCT00647296|524655418|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
145491899|NCT00647296|524655419|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
145491900|NCT00647296|524655416|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
145491901|NCT00647296|524655417|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
145491902|NCT00647296|524655418|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
145491903|NCT00647296|524655419|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
145491904|NCT00647296|524655416|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
145491905|NCT00647296|524655417|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
145491906|NCT00647296|524655418|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
145491907|NCT00647296|524655419|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
145491908|NCT00647296|524655416|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
145491909|NCT00647296|524655417|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
145491910|NCT00647296|524655418|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
145491911|NCT00647296|524655419|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
145491912|NCT00647296|524655416|FG000|Part 2: 4-week Placebo Washout|Death|3|||
145491913|NCT00647296|524655417|FG001|Part 2: 4-week Placebo Washout|Death|0|||
145491914|NCT00647296|524655418|FG002|Part 2: 4-week Placebo Washout|Death|0|||
145491915|NCT00647296|524655419|FG003|Part 2: 4-week Placebo Washout|Death|0|||
145491916|NCT00647296|524655416|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
145491917|NCT00647296|524655417|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
145491918|NCT00647296|524655418|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
145491919|NCT00647296|524655419|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
145491920|NCT00647296|524655416|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
145491921|NCT00647296|524655417|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
145491922|NCT00647296|524655418|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
145491923|NCT00647296|524655419|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
145491924|NCT00647296|524655416|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
145491925|NCT00647296|524655417|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
145491926|NCT00647296|524655418|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
145491927|NCT00647296|524655419|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
145491928|NCT00647296|524655416|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
145491929|NCT00647296|524655417|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
145491930|NCT00647296|524655418|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
145491931|NCT00647296|524655419|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
145491932|NCT00647296|524655416|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
145491933|NCT00647296|524655417|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
145491934|NCT00647296|524655418|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
145491935|NCT00647296|524655419|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
145491936|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
145491937|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
145491938|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
145491939|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
145491940|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
145491941|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
145491942|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
145491943|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
145491944|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
145491945|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
145491946|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
145491947|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
145491948|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
145491949|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
145491950|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
145491951|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
145491952|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
145491953|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
145491954|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
145491955|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
145491956|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
145491957|NCT00550407|524655420|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
145491958|NCT00550407|524655421|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
145491959|NCT00550407|524655422|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
145491960|NCT00550407|524655420|FG000|26-Week Randomized Phase|Adverse Event|0|||
145491961|NCT00550407|524655421|FG001|26-Week Randomized Phase|Adverse Event|5|||
145491962|NCT00550407|524655422|FG002|26-Week Randomized Phase|Adverse Event|2|||
145715434|NCT02285153|525474444|FG000|Overall Study|Adverse Event|1|||
145715435|NCT02285153|525474445|FG001|Overall Study|Adverse Event|0|||
145715436|NCT01489891|525474448|FG000|Overall Study|Endoscopy failure|1|||
145715437|NCT01489891|525474449|FG001|Overall Study|Endoscopy failure|0|||
145715438|NCT02576587|525474450|FG000|Baseline|Equipment failure|0|||
145715439|NCT02576587|525474451|FG001|Baseline|Equipment failure|1|||
145715440|NCT02576587|525474450|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
145715441|NCT02576587|525474451|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
145715442|NCT02576587|525474450|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
145715443|NCT02576587|525474451|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
145715444|NCT02576587|525474450|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
145715445|NCT02576587|525474451|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
145715446|NCT00777088|525474452|FG000|Overall Study|PED Treatment not attempted|1|||
145715447|NCT01278173|525474453|FG000|Overall Study|Lack of Efficacy|13|||
145715448|NCT01278173|525474453|FG000|Overall Study|Adverse Event|8|||
145715449|NCT01278173|525474453|FG000|Overall Study|Administrative or other reason|4|||
145715450|NCT01278173|525474453|FG000|Overall Study|Protocol Violation|1|||
145715451|NCT01278173|525474453|FG000|Overall Study|Withdrawal by Subject|1|||
145715452|NCT02546921|525474454|FG000|Overall Study|Adverse Event|0|||
145715453|NCT02546921|525474455|FG001|Overall Study|Adverse Event|5|||
145715454|NCT02546921|525474456|FG002|Overall Study|Adverse Event|2|||
145715455|NCT02546921|525474457|FG003|Overall Study|Adverse Event|0|||
145715456|NCT02546921|525474458|FG004|Overall Study|Adverse Event|0|||
145715457|NCT02546921|525474459|FG005|Overall Study|Adverse Event|0|||
145715458|NCT02546921|525474460|FG006|Overall Study|Adverse Event|0|||
145715459|NCT02546921|525474454|FG000|Overall Study|Evidence of Disease Progression|1|||
145715460|NCT02546921|525474455|FG001|Overall Study|Evidence of Disease Progression|0|||
145715461|NCT02546921|525474456|FG002|Overall Study|Evidence of Disease Progression|0|||
145715462|NCT02546921|525474457|FG003|Overall Study|Evidence of Disease Progression|0|||
145715463|NCT02546921|525474458|FG004|Overall Study|Evidence of Disease Progression|1|||
145715464|NCT02546921|525474459|FG005|Overall Study|Evidence of Disease Progression|0|||
145715465|NCT02546921|525474460|FG006|Overall Study|Evidence of Disease Progression|0|||
145715466|NCT02546921|525474454|FG000|Overall Study|Patient Choice|0|||
145715467|NCT02546921|525474455|FG001|Overall Study|Patient Choice|1|||
145715468|NCT02546921|525474456|FG002|Overall Study|Patient Choice|0|||
145715469|NCT02546921|525474457|FG003|Overall Study|Patient Choice|0|||
145715470|NCT02546921|525474458|FG004|Overall Study|Patient Choice|0|||
145715471|NCT02546921|525474459|FG005|Overall Study|Patient Choice|1|||
145715472|NCT02546921|525474460|FG006|Overall Study|Patient Choice|0|||
145715473|NCT02091206|525474461|FG000|Treatment Period|Adverse Event|0|||
145715474|NCT02091206|525474462|FG001|Treatment Period|Adverse Event|1|||
145715475|NCT02091206|525474463|FG002|Treatment Period|Adverse Event|0|||
145715476|NCT02091206|525474464|FG003|Treatment Period|Adverse Event|0|||
145715477|NCT02091206|525474461|FG000|Treatment Period|Met withdrawal criteria|0|||
145715478|NCT02091206|525474462|FG001|Treatment Period|Met withdrawal criteria|0|||
145715479|NCT02091206|525474463|FG002|Treatment Period|Met withdrawal criteria|1|||
145715480|NCT02091206|525474464|FG003|Treatment Period|Met withdrawal criteria|0|||
145715481|NCT02091206|525474461|FG000|Taper Period|Participant refused study drug|1|||
145715482|NCT02091206|525474462|FG001|Taper Period|Participant refused study drug|0|||
145715483|NCT02091206|525474463|FG002|Taper Period|Participant refused study drug|0|||
145715484|NCT02091206|525474464|FG003|Taper Period|Participant refused study drug|1|||
145715485|NCT02091206|525474461|FG000|Taper Period|Lost to Follow-up|0|||
145715486|NCT02091206|525474462|FG001|Taper Period|Lost to Follow-up|0|||
145715487|NCT02091206|525474463|FG002|Taper Period|Lost to Follow-up|0|||
145715488|NCT02091206|525474464|FG003|Taper Period|Lost to Follow-up|1|||
145715489|NCT01373151|525474465|FG000|Period 1|Lack of Efficacy|3|||
145715490|NCT01373151|525474466|FG001|Period 1|Lack of Efficacy|0|||
145715491|NCT01373151|525474467|FG002|Period 1|Lack of Efficacy|0|||
145715492|NCT01373151|525474468|FG003|Period 1|Lack of Efficacy|0|||
145715493|NCT01373151|525474469|FG004|Period 1|Lack of Efficacy|1|||
145715494|NCT01373151|525474470|FG005|Period 1|Lack of Efficacy|0|||
145715495|NCT01373151|525474471|FG006|Period 1|Lack of Efficacy|0|||
145715496|NCT01373151|525474465|FG000|Period 1|Adverse Event|0|||
145715497|NCT01373151|525474466|FG001|Period 1|Adverse Event|0|||
145715498|NCT01373151|525474467|FG002|Period 1|Adverse Event|1|||
145715499|NCT01373151|525474468|FG003|Period 1|Adverse Event|0|||
145715500|NCT01373151|525474469|FG004|Period 1|Adverse Event|4|||
145715501|NCT01373151|525474470|FG005|Period 1|Adverse Event|3|||
145715502|NCT01373151|525474471|FG006|Period 1|Adverse Event|0|||
145715503|NCT01373151|525474465|FG000|Period 1|Withdrawal by Subject|2|||
145715504|NCT01373151|525474466|FG001|Period 1|Withdrawal by Subject|0|||
145715505|NCT01373151|525474467|FG002|Period 1|Withdrawal by Subject|3|||
145715506|NCT01373151|525474468|FG003|Period 1|Withdrawal by Subject|1|||
145715507|NCT01373151|525474469|FG004|Period 1|Withdrawal by Subject|0|||
145715508|NCT01373151|525474470|FG005|Period 1|Withdrawal by Subject|1|||
145715509|NCT01373151|525474471|FG006|Period 1|Withdrawal by Subject|0|||
145715510|NCT01373151|525474465|FG000|Period 2|Lack of Efficacy|9|||
145715511|NCT01373151|525474466|FG001|Period 2|Lack of Efficacy|0|||
145715512|NCT01373151|525474467|FG002|Period 2|Lack of Efficacy|0|||
145715513|NCT01373151|525474468|FG003|Period 2|Lack of Efficacy|1|||
145715514|NCT01373151|525474469|FG004|Period 2|Lack of Efficacy|2|||
145715515|NCT01373151|525474470|FG005|Period 2|Lack of Efficacy|0|||
145715516|NCT01373151|525474471|FG006|Period 2|Lack of Efficacy|3|||
145715517|NCT01373151|525474465|FG000|Period 2|Adverse Event|0|||
145715518|NCT01373151|525474466|FG001|Period 2|Adverse Event|0|||
145715519|NCT01373151|525474467|FG002|Period 2|Adverse Event|3|||
145715520|NCT01373151|525474468|FG003|Period 2|Adverse Event|3|||
145715521|NCT01373151|525474469|FG004|Period 2|Adverse Event|0|||
145715522|NCT01373151|525474470|FG005|Period 2|Adverse Event|0|||
145715523|NCT01373151|525474471|FG006|Period 2|Adverse Event|1|||
145715524|NCT01373151|525474465|FG000|Period 2|subject request to discontinue|0|||
145715525|NCT01373151|525474466|FG001|Period 2|subject request to discontinue|1|||
145715526|NCT01373151|525474467|FG002|Period 2|subject request to discontinue|0|||
145715527|NCT01373151|525474468|FG003|Period 2|subject request to discontinue|0|||
145715528|NCT01373151|525474469|FG004|Period 2|subject request to discontinue|0|||
145715529|NCT01373151|525474470|FG005|Period 2|subject request to discontinue|0|||
145715530|NCT01373151|525474471|FG006|Period 2|subject request to discontinue|0|||
145715531|NCT01373151|525474465|FG000|Period 2|Withdrawal by Subject|0|||
145715532|NCT01373151|525474466|FG001|Period 2|Withdrawal by Subject|0|||
145715533|NCT01373151|525474467|FG002|Period 2|Withdrawal by Subject|0|||
145715534|NCT01373151|525474468|FG003|Period 2|Withdrawal by Subject|1|||
145715535|NCT01373151|525474469|FG004|Period 2|Withdrawal by Subject|0|||
145715536|NCT01373151|525474470|FG005|Period 2|Withdrawal by Subject|0|||
145715537|NCT01373151|525474471|FG006|Period 2|Withdrawal by Subject|0|||
145715538|NCT01373151|525474465|FG000|Period 2|Other|0|||
145715539|NCT01373151|525474466|FG001|Period 2|Other|0|||
145715540|NCT01373151|525474467|FG002|Period 2|Other|1|||
145715541|NCT01373151|525474468|FG003|Period 2|Other|0|||
145715542|NCT01373151|525474469|FG004|Period 2|Other|0|||
145715543|NCT01373151|525474470|FG005|Period 2|Other|0|||
145715544|NCT01373151|525474471|FG006|Period 2|Other|1|||
145715545|NCT03026075|525474476|FG000|Overall Study|Physician Decision|1|||
145715546|NCT03381339|525474479|FG000|Overall Study|Protocol Violation|4|||
145715547|NCT03381339|525474480|FG001|Overall Study|Protocol Violation|3|||
145715548|NCT03381339|525474479|FG000|Overall Study|Lost to Follow-up|0|||
145715549|NCT03381339|525474480|FG001|Overall Study|Lost to Follow-up|1|||
145715550|NCT04927247|525474482|FG000|Overall Study|Other|2|||
145715551|NCT04927247|525474483|FG001|Overall Study|Other|1|||
145715552|NCT04927247|525474482|FG000|Overall Study|Physician Decision|0|||
145715553|NCT04927247|525474483|FG001|Overall Study|Physician Decision|1|||
145715554|NCT04927247|525474482|FG000|Overall Study|Adverse Event|1|||
145715555|NCT04927247|525474483|FG001|Overall Study|Adverse Event|0|||
145715556|NCT04828837|525474485|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
145715557|NCT04828837|525474486|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
145715558|NCT04828837|525474485|FG000|Overall Study|Lost to Follow-up|2|||
145715559|NCT04828837|525474486|FG001|Overall Study|Lost to Follow-up|6|||
145715560|NCT04828837|525474485|FG000|Overall Study|Lack of Efficacy|1|||
145715561|NCT04828837|525474486|FG001|Overall Study|Lack of Efficacy|0|||
145715562|NCT04828837|525474485|FG000|Overall Study|Admitted due to pneumothorax.|1|||
145715563|NCT04828837|525474486|FG001|Overall Study|Admitted due to pneumothorax.|0|||
145715564|NCT04828837|525474485|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
145715565|NCT04828837|525474486|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
145715566|NCT01397422|525474487|FG000|Overall Study|Adverse Event|0|||
145715567|NCT01397422|525474488|FG001|Overall Study|Adverse Event|3|||
145715568|NCT01397422|525474489|FG002|Overall Study|Adverse Event|3|||
145715569|NCT01397422|525474490|FG003|Overall Study|Adverse Event|8|||
145715570|NCT01397422|525474487|FG000|Overall Study|Withdrawal by Subject|1|||
145715571|NCT01397422|525474488|FG001|Overall Study|Withdrawal by Subject|0|||
145715572|NCT01397422|525474489|FG002|Overall Study|Withdrawal by Subject|0|||
145715573|NCT01397422|525474490|FG003|Overall Study|Withdrawal by Subject|0|||
145715574|NCT01397422|525474487|FG000|Overall Study|Increased bradykinesia related to PD|1|||
145715575|NCT01397422|525474488|FG001|Overall Study|Increased bradykinesia related to PD|0|||
145715576|NCT01397422|525474489|FG002|Overall Study|Increased bradykinesia related to PD|0|||
145715577|NCT01397422|525474490|FG003|Overall Study|Increased bradykinesia related to PD|0|||
145715578|NCT00545753|525474491|FG000|Overall Study|Withdrawal by Subject|0|||
145715579|NCT00545753|525474492|FG001|Overall Study|Withdrawal by Subject|1|||
145715580|NCT00545753|525474493|FG002|Overall Study|Withdrawal by Subject|10|||
145715581|NCT00545753|525474491|FG000|Overall Study|Lost to Follow-up|13|||
145715582|NCT00545753|525474492|FG001|Overall Study|Lost to Follow-up|3|||
145715583|NCT00545753|525474493|FG002|Overall Study|Lost to Follow-up|12|||
145715584|NCT00545753|525474491|FG000|Overall Study|Protocol Violation|3|||
145715585|NCT00545753|525474492|FG001|Overall Study|Protocol Violation|1|||
145715586|NCT00545753|525474493|FG002|Overall Study|Protocol Violation|4|||
145715587|NCT02489968|525474504|FG000|Open-label Treatment Period|Adverse Event|14|||
145715588|NCT02489968|525474505|FG001|Open-label Treatment Period|Adverse Event|7|||
145715589|NCT02489968|525474506|FG002|Open-label Treatment Period|Adverse Event|0|||
145715590|NCT02489968|525474507|FG003|Open-label Treatment Period|Adverse Event|0|||
145715591|NCT02489968|525474508|FG004|Open-label Treatment Period|Adverse Event|0|||
145715592|NCT02489968|525474509|FG005|Open-label Treatment Period|Adverse Event|0|||
145715593|NCT02489968|525474504|FG000|Open-label Treatment Period|Protocol Violation|2|||
145715594|NCT02489968|525474505|FG001|Open-label Treatment Period|Protocol Violation|2|||
145715595|NCT02489968|525474506|FG002|Open-label Treatment Period|Protocol Violation|0|||
145715596|NCT02489968|525474507|FG003|Open-label Treatment Period|Protocol Violation|0|||
145715597|NCT02489968|525474508|FG004|Open-label Treatment Period|Protocol Violation|0|||
145715598|NCT02489968|525474509|FG005|Open-label Treatment Period|Protocol Violation|0|||
145715599|NCT02489968|525474504|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
145715600|NCT02489968|525474505|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
145715601|NCT02489968|525474506|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
145715602|NCT02489968|525474507|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
145715603|NCT02489968|525474508|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
145715604|NCT02489968|525474509|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
145715605|NCT02489968|525474504|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
145715606|NCT02489968|525474505|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
145715607|NCT02489968|525474506|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
145715608|NCT02489968|525474507|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
145715609|NCT02489968|525474508|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
145715610|NCT02489968|525474509|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
145715611|NCT02489968|525474504|FG000|Open-label Treatment Period|Other than specified above|204|||
145715612|NCT02489968|525474505|FG001|Open-label Treatment Period|Other than specified above|189|||
145715613|NCT02489968|525474506|FG002|Open-label Treatment Period|Other than specified above|0|||
145715614|NCT02489968|525474507|FG003|Open-label Treatment Period|Other than specified above|0|||
145715615|NCT02489968|525474508|FG004|Open-label Treatment Period|Other than specified above|0|||
145715616|NCT02489968|525474509|FG005|Open-label Treatment Period|Other than specified above|0|||
145715617|NCT02489968|525474504|FG000|Double-blind Treatment Period|Adverse Event|0|||
145715618|NCT02489968|525474505|FG001|Double-blind Treatment Period|Adverse Event|0|||
145715619|NCT02489968|525474506|FG002|Double-blind Treatment Period|Adverse Event|2|||
145715620|NCT02489968|525474507|FG003|Double-blind Treatment Period|Adverse Event|6|||
145715621|NCT02489968|525474508|FG004|Double-blind Treatment Period|Adverse Event|4|||
145715622|NCT02489968|525474509|FG005|Double-blind Treatment Period|Adverse Event|5|||
145715623|NCT02489968|525474504|FG000|Double-blind Treatment Period|Protocol Violation|0|||
145715624|NCT02489968|525474505|FG001|Double-blind Treatment Period|Protocol Violation|0|||
145715625|NCT02489968|525474506|FG002|Double-blind Treatment Period|Protocol Violation|0|||
145715626|NCT02489968|525474507|FG003|Double-blind Treatment Period|Protocol Violation|0|||
145715627|NCT02489968|525474508|FG004|Double-blind Treatment Period|Protocol Violation|1|||
145715628|NCT02489968|525474509|FG005|Double-blind Treatment Period|Protocol Violation|1|||
145715629|NCT02489968|525474504|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
145715630|NCT02489968|525474505|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145715631|NCT02489968|525474506|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145715632|NCT02489968|525474507|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
145715633|NCT02489968|525474508|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
145715634|NCT02489968|525474509|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
145715635|NCT02489968|525474504|FG000|Double-blind Treatment Period|Other than specified above|0|||
145715636|NCT02489968|525474505|FG001|Double-blind Treatment Period|Other than specified above|0|||
145715637|NCT02489968|525474506|FG002|Double-blind Treatment Period|Other than specified above|0|||
145715638|NCT02489968|525474507|FG003|Double-blind Treatment Period|Other than specified above|0|||
145715639|NCT02489968|525474508|FG004|Double-blind Treatment Period|Other than specified above|1|||
145715640|NCT02489968|525474509|FG005|Double-blind Treatment Period|Other than specified above|0|||
145715641|NCT04577001|525474510|FG000|Overall Study|Subject became ineligible|0|||
145715642|NCT04577001|525474511|FG001|Overall Study|Subject became ineligible|1|||
145715643|NCT02980731|525475946|FG000|Overall Study|Death|63|||
145715644|NCT02980731|525475946|FG000|Overall Study|Withdrawal by Subject|6|||
145715645|NCT02980731|525475946|FG000|Overall Study|Lost to Follow-up|5|||
145715646|NCT02980731|525475946|FG000|Overall Study|Study terminated by Sponsor|4|||
145715647|NCT02980731|525475946|FG000|Overall Study|Completed survival follow-up period|65|||
145715648|NCT02980731|525475946|FG000|Overall Study|COVID-19 infection|1|||
145715649|NCT02980731|525475946|FG000|Overall Study|Other, not specified|66|||
145715650|NCT03037931|525475947|FG000|Overall Study|Death|354|||
145715651|NCT03037931|525475948|FG001|Overall Study|Death|367|||
145715652|NCT03037931|525475947|FG000|Overall Study|Lost to Follow-up|7|||
145715653|NCT03037931|525475948|FG001|Overall Study|Lost to Follow-up|4|||
145715654|NCT03037931|525475947|FG000|Overall Study|Withdrawal by Subject|48|||
145715655|NCT03037931|525475948|FG001|Overall Study|Withdrawal by Subject|41|||
145715656|NCT02075476|525475949|FG000|Overall Study|Death|2|||
145715657|NCT02075476|525475950|FG001|Overall Study|Death|2|||
145715658|NCT02075476|525475949|FG000|Overall Study|Lost to Follow-up|1|||
145715659|NCT02075476|525475950|FG001|Overall Study|Lost to Follow-up|3|||
145715660|NCT00091169|525475953|FG000|Overall Study|Disease progression|3|||
145715661|NCT00091169|525475954|FG001|Overall Study|Disease progression|1|||
145715662|NCT00091169|525475953|FG000|Overall Study|Adverse Event|11|||
145715663|NCT00091169|525475954|FG001|Overall Study|Adverse Event|17|||
145715664|NCT00091169|525475953|FG000|Overall Study|Death|4|||
145715665|NCT00091169|525475954|FG001|Overall Study|Death|1|||
145715666|NCT00091169|525475953|FG000|Overall Study|Withdrawal by Subject|10|||
145715667|NCT00091169|525475954|FG001|Overall Study|Withdrawal by Subject|13|||
145715668|NCT00091169|525475953|FG000|Overall Study|Other|3|||
145715669|NCT00091169|525475954|FG001|Overall Study|Other|4|||
145715670|NCT00091169|525475953|FG000|Overall Study|Not start protocol therapy|26|||
145715671|NCT00091169|525475954|FG001|Overall Study|Not start protocol therapy|17|||
145715672|NCT03809429|525475955|FG000|Overall Study|Withdrawal by Subject|7|||
145715673|NCT03809429|525475956|FG001|Overall Study|Withdrawal by Subject|3|||
145715674|NCT03809429|525475955|FG000|Overall Study|Adverse Event|6|||
145715675|NCT03809429|525475956|FG001|Overall Study|Adverse Event|9|||
145715676|NCT03809429|525475955|FG000|Overall Study|COVID-19|3|||
145715677|NCT03809429|525475956|FG001|Overall Study|COVID-19|1|||
145715678|NCT03809429|525475955|FG000|Overall Study|Participant was discontinued by investigator|12|||
145715679|NCT03809429|525475956|FG001|Overall Study|Participant was discontinued by investigator|7|||
145715680|NCT00901186|525475957|FG000|Overall Study|Lack of Efficacy|0|||
145715681|NCT00901186|525475958|FG001|Overall Study|Lack of Efficacy|1|||
145715682|NCT00901186|525475957|FG000|Overall Study|Abnormal laboratory values|0|||
145715683|NCT00901186|525475958|FG001|Overall Study|Abnormal laboratory values|1|||
145715684|NCT00901186|525475957|FG000|Overall Study|Lost to Follow-up|2|||
145715685|NCT00901186|525475958|FG001|Overall Study|Lost to Follow-up|0|||
145715686|NCT00901186|525475957|FG000|Overall Study|Adverse Event|2|||
145715687|NCT00901186|525475958|FG001|Overall Study|Adverse Event|4|||
145715688|NCT00901186|525475957|FG000|Overall Study|Administration problems|0|||
145715689|NCT00901186|525475958|FG001|Overall Study|Administration problems|1|||
145715690|NCT00901186|525475957|FG000|Overall Study|Protocol deviations|5|||
145715691|NCT00901186|525475958|FG001|Overall Study|Protocol deviations|4|||
145715692|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
145715693|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
145715694|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
145715695|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
145715696|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
145715697|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
145715698|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
145715699|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
145715700|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
145715701|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
145715702|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
145715703|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
145715704|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
145715705|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
145715706|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
145715707|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
145715708|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
145715709|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
145715710|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
145715711|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
145715712|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
145715713|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
145715714|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
145715715|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
145715716|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
145715717|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
145715718|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
145715719|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
145715720|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
145715721|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
145715722|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
145715723|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
145715724|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
145715725|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
145715726|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
145715727|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
145715728|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
145715729|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
145715730|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
145715731|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
145715732|NCT00700427|525475969|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
145715733|NCT00700427|525475970|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
145715734|NCT00700427|525475971|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
145715735|NCT00700427|525475972|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
145715736|NCT00700427|525475973|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
145715737|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
145715738|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
145715739|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
145715740|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
145715741|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
145715742|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
145715743|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
145715744|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
145715745|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
145715746|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
145715747|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
145715748|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
145715749|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
145715750|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
145715751|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
145715752|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
145715753|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
145715754|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
145715755|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
145715756|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
145715757|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
145715758|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
145715759|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
145715760|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
145715761|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
145715762|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
145715763|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
145715764|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
145715765|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
145715766|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
145715767|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
145715768|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
145715769|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
145715770|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
145715771|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
145715772|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
145715773|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
145715774|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
145715775|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
145715776|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
145715777|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
145715778|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
145715779|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
145715780|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
145715781|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
145715782|NCT00700427|525475969|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
145715783|NCT00700427|525475970|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
145715784|NCT00700427|525475971|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
145715785|NCT00700427|525475972|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
145715786|NCT00700427|525475973|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
145715787|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
145715788|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
145715789|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
145715790|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
145715791|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
145715792|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
145715793|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
145715794|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
145715795|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
145715796|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
145715797|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
145715798|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
145715799|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
145715800|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
145715801|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
145715802|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
145715803|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
145715804|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
145715805|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
145715806|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
145715807|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
145715808|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
145715809|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
145715810|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
145715811|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
145715812|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
145715813|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
145715814|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
145715815|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
145715816|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
145715817|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
145715818|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
145715819|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
145715820|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
145715821|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
145715822|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
145715823|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
145715824|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
145715825|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
145715826|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
145715827|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
145715828|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
145715829|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
145715830|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
145715831|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
145715832|NCT00700427|525475969|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
145715833|NCT00700427|525475970|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
145715834|NCT00700427|525475971|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
145715835|NCT00700427|525475972|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
145715836|NCT00700427|525475973|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
145715837|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
145715838|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
145715839|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
145715840|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
145715841|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
145715842|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
145715843|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
145715844|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
145715845|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
145715846|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
145715847|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
145715848|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
145715849|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
145715850|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
145715851|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
145715852|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
145715853|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
145715854|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
145715855|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
145715856|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
145715857|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
145715858|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
145715859|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
145715860|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
145715861|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
145715862|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
145715863|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
145715864|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
145715865|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
145715866|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
145715867|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
145715868|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
145715869|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
145715870|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
145715871|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
145715872|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
145715873|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
145715874|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
145715875|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
145715876|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
145715877|NCT00700427|525475969|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
145715878|NCT00700427|525475970|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
145715879|NCT00700427|525475971|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
145715880|NCT00700427|525475972|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
145715881|NCT00700427|525475973|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
145715882|NCT00424385|525475974|FG000|Cohort 0|Withdrawal by Subject|5|||
145715883|NCT00424385|525475974|FG000|Cohort 0|Physician Decision|1|||
145715884|NCT00424385|525475974|FG000|Cohort 1|Withdrawal by Subject|1|||
145715885|NCT02535091|525475981|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
145715886|NCT02535091|525475982|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
145715887|NCT02535091|525475983|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
145715888|NCT02535091|525475981|FG000|Overall Study|Withdrawal by Subject|14|||
145715889|NCT02535091|525475982|FG001|Overall Study|Withdrawal by Subject|5|||
145715890|NCT02535091|525475983|FG002|Overall Study|Withdrawal by Subject|121|||
145715891|NCT02535091|525475981|FG000|Overall Study|Adverse Event|9|||
145715892|NCT02535091|525475982|FG001|Overall Study|Adverse Event|4|||
145715893|NCT02535091|525475983|FG002|Overall Study|Adverse Event|170|||
145715894|NCT02535091|525475981|FG000|Overall Study|Other|4|||
145715895|NCT02535091|525475982|FG001|Overall Study|Other|3|||
145715896|NCT02535091|525475983|FG002|Overall Study|Other|81|||
145715897|NCT02535091|525475981|FG000|Overall Study|Lost to Follow-up|0|||
145715898|NCT02535091|525475982|FG001|Overall Study|Lost to Follow-up|1|||
145715899|NCT02535091|525475983|FG002|Overall Study|Lost to Follow-up|19|||
145715900|NCT02535091|525475981|FG000|Overall Study|Protocol Violation|0|||
145715901|NCT02535091|525475982|FG001|Overall Study|Protocol Violation|1|||
145715902|NCT02535091|525475983|FG002|Overall Study|Protocol Violation|11|||
145715903|NCT02535091|525475981|FG000|Overall Study|Pregnancy|0|||
145715904|NCT02535091|525475982|FG001|Overall Study|Pregnancy|0|||
145715905|NCT02535091|525475983|FG002|Overall Study|Pregnancy|7|||
145715906|NCT03223662|525475984|FG000|Overall Study|Physician Decision|1|||
145715907|NCT03223662|525475984|FG000|Overall Study|Study closure|1|||
145715908|NCT02643472|525475985|FG000|Overall Study|Death|2|||
145715909|NCT02643472|525475986|FG001|Overall Study|Death|5|||
145715910|NCT02643472|525475985|FG000|Overall Study|Withdrawal by Subject|3|||
145715911|NCT02643472|525475986|FG001|Overall Study|Withdrawal by Subject|2|||
145715912|NCT02643472|525475985|FG000|Overall Study|Protocol Violation|0|||
145715913|NCT02643472|525475986|FG001|Overall Study|Protocol Violation|1|||
145715914|NCT02643472|525475985|FG000|Overall Study|Lost to Follow-up|22|||
145715915|NCT02643472|525475986|FG001|Overall Study|Lost to Follow-up|26|||
145715916|NCT00506441|525475987|FG000|Period 1; Open-label Period|Adverse Event|21|||
145715917|NCT00506441|525475988|FG001|Period 1; Open-label Period|Adverse Event|0|||
145715918|NCT00506441|525475987|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
145715919|NCT00506441|525475988|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
145715920|NCT00506441|525475987|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
145715921|NCT00506441|525475988|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
145715922|NCT00506441|525475987|FG000|Period 1; Open-label Period|Physician Decision|5|||
145715923|NCT00506441|525475988|FG001|Period 1; Open-label Period|Physician Decision|0|||
145715924|NCT00506441|525475987|FG000|Period 1; Open-label Period|Protocol Violation|9|||
145715925|NCT00506441|525475988|FG001|Period 1; Open-label Period|Protocol Violation|0|||
145715926|NCT00506441|525475987|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
145715927|NCT00506441|525475988|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
145715928|NCT00506441|525475987|FG000|Period 1; Open-label Period|Other Reasons|13|||
145715929|NCT00506441|525475988|FG001|Period 1; Open-label Period|Other Reasons|0|||
145715930|NCT00506441|525475987|FG000|Period 2; Double-blind Period|Adverse Event|0|||
145715931|NCT00506441|525475988|FG001|Period 2; Double-blind Period|Adverse Event|1|||
145715932|NCT00506441|525475987|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
145715933|NCT00506441|525475988|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
145715934|NCT00506441|525475987|FG000|Period 2; Double-blind Period|Physician Decision|1|||
145715935|NCT00506441|525475988|FG001|Period 2; Double-blind Period|Physician Decision|1|||
145715936|NCT00506441|525475987|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
145715937|NCT00506441|525475988|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
145715938|NCT00506441|525475987|FG000|Period 2; Double-blind Period|Other Reason|1|||
145715939|NCT00506441|525475988|FG001|Period 2; Double-blind Period|Other Reason|1|||
145715940|NCT03122223|525475992|FG000|Overall Study|Withdrawal by Subject|2|||
145715941|NCT03122223|525475993|FG001|Overall Study|Withdrawal by Subject|2|||
145715942|NCT03122223|525475994|FG002|Overall Study|Withdrawal by Subject|1|||
145715943|NCT03122223|525475995|FG003|Overall Study|Withdrawal by Subject|0|||
145715944|NCT03122223|525475992|FG000|Overall Study|Lost to Follow-up|0|||
145715945|NCT03122223|525475993|FG001|Overall Study|Lost to Follow-up|2|||
145715946|NCT03122223|525475994|FG002|Overall Study|Lost to Follow-up|2|||
145715947|NCT03122223|525475995|FG003|Overall Study|Lost to Follow-up|0|||
145715948|NCT03122223|525475992|FG000|Overall Study|Participant unable to adhere|1|||
145715949|NCT03122223|525475993|FG001|Overall Study|Participant unable to adhere|1|||
145715950|NCT03122223|525475994|FG002|Overall Study|Participant unable to adhere|1|||
145715951|NCT03122223|525475995|FG003|Overall Study|Participant unable to adhere|0|||
145715952|NCT00291642|525475997|FG000|Overall Study|Adverse Event|1|||
145715953|NCT00291642|525475998|FG001|Overall Study|Adverse Event|0|||
145715954|NCT00291642|525475999|FG002|Overall Study|Adverse Event|1|||
145715955|NCT00291642|525476000|FG003|Overall Study|Adverse Event|0|||
145715956|NCT00291642|525476001|FG004|Overall Study|Adverse Event|1|||
145715957|NCT00291642|525475997|FG000|Overall Study|Patient missed visit|0|||
145715958|NCT00291642|525475998|FG001|Overall Study|Patient missed visit|0|||
145715959|NCT00291642|525475999|FG002|Overall Study|Patient missed visit|1|||
145715960|NCT00291642|525476000|FG003|Overall Study|Patient missed visit|0|||
145715961|NCT00291642|525476001|FG004|Overall Study|Patient missed visit|0|||
145715962|NCT00291642|525475997|FG000|Overall Study|Intake of prohibited medication|1|||
145715963|NCT00291642|525475998|FG001|Overall Study|Intake of prohibited medication|0|||
145715964|NCT00291642|525475999|FG002|Overall Study|Intake of prohibited medication|0|||
145715965|NCT00291642|525476000|FG003|Overall Study|Intake of prohibited medication|0|||
145715966|NCT00291642|525476001|FG004|Overall Study|Intake of prohibited medication|0|||
145715967|NCT01820585|525476002|FG000|Overall Study|Adverse Event|9|||
145715968|NCT01820585|525476003|FG001|Overall Study|Adverse Event|13|||
145715969|NCT01820585|525476004|FG002|Overall Study|Adverse Event|23|||
145715970|NCT01820585|525476005|FG003|Overall Study|Adverse Event|34|||
145715971|NCT01820585|525476002|FG000|Overall Study|Lack of Efficacy|9|||
145715972|NCT01820585|525476003|FG001|Overall Study|Lack of Efficacy|7|||
145715973|NCT01820585|525476004|FG002|Overall Study|Lack of Efficacy|5|||
145715974|NCT01820585|525476005|FG003|Overall Study|Lack of Efficacy|1|||
145715975|NCT01820585|525476002|FG000|Overall Study|Withdrawal by Subject|3|||
145715976|NCT01820585|525476003|FG001|Overall Study|Withdrawal by Subject|7|||
145715977|NCT01820585|525476004|FG002|Overall Study|Withdrawal by Subject|3|||
145715978|NCT01820585|525476005|FG003|Overall Study|Withdrawal by Subject|8|||
145715979|NCT01820585|525476002|FG000|Overall Study|Lost to Follow-up|3|||
145715980|NCT01820585|525476003|FG001|Overall Study|Lost to Follow-up|3|||
145715981|NCT01820585|525476004|FG002|Overall Study|Lost to Follow-up|0|||
145715982|NCT01820585|525476005|FG003|Overall Study|Lost to Follow-up|3|||
145715983|NCT01820585|525476002|FG000|Overall Study|Protocol Violation|3|||
145715984|NCT01820585|525476003|FG001|Overall Study|Protocol Violation|1|||
145715985|NCT01820585|525476004|FG002|Overall Study|Protocol Violation|1|||
145715986|NCT01820585|525476005|FG003|Overall Study|Protocol Violation|1|||
145715987|NCT01820585|525476002|FG000|Overall Study|Subject non-compliance|0|||
145715988|NCT01820585|525476003|FG001|Overall Study|Subject non-compliance|0|||
145715989|NCT01820585|525476004|FG002|Overall Study|Subject non-compliance|1|||
145715990|NCT01820585|525476005|FG003|Overall Study|Subject non-compliance|2|||
145715991|NCT01820585|525476002|FG000|Overall Study|at sponsor request|0|||
145715992|NCT01820585|525476003|FG001|Overall Study|at sponsor request|0|||
145715993|NCT01820585|525476004|FG002|Overall Study|at sponsor request|1|||
145715994|NCT01820585|525476005|FG003|Overall Study|at sponsor request|0|||
145715995|NCT01820585|525476002|FG000|Overall Study|Pregnancy|0|||
145715996|NCT01820585|525476003|FG001|Overall Study|Pregnancy|1|||
145715997|NCT01820585|525476004|FG002|Overall Study|Pregnancy|0|||
145715998|NCT01820585|525476005|FG003|Overall Study|Pregnancy|0|||
145715999|NCT00735475|525476006|FG000|Overall Study|Adverse Event|0|||
145716000|NCT00735475|525476007|FG001|Overall Study|Adverse Event|1|||
145716001|NCT00735475|525476006|FG000|Overall Study|Death|1|||
145716002|NCT00735475|525476007|FG001|Overall Study|Death|1|||
145716003|NCT00735475|525476006|FG000|Overall Study|Lost to Follow-up|3|||
145716004|NCT00735475|525476007|FG001|Overall Study|Lost to Follow-up|3|||
145716005|NCT00735475|525476006|FG000|Overall Study|Physician Decision|0|||
145716006|NCT00735475|525476007|FG001|Overall Study|Physician Decision|1|||
145716007|NCT00735475|525476006|FG000|Overall Study|Withdrawal by Subject|4|||
145716008|NCT00735475|525476007|FG001|Overall Study|Withdrawal by Subject|5|||
145716009|NCT01712659|525476008|FG000|Dose Escalation|Physician Decision|0|||
145716010|NCT01712659|525476009|FG001|Dose Escalation|Physician Decision|1|||
145716011|NCT01712659|525476010|FG002|Dose Escalation|Physician Decision|0|||
145716012|NCT01712659|525476011|FG003|Dose Escalation|Physician Decision|0|||
145716013|NCT01712659|525476012|FG004|Dose Escalation|Physician Decision|0|||
145716014|NCT01712659|525476008|FG000|Dose Escalation|Unable to take study drug|0|||
145716015|NCT01712659|525476009|FG001|Dose Escalation|Unable to take study drug|1|||
145716016|NCT01712659|525476010|FG002|Dose Escalation|Unable to take study drug|0|||
145716017|NCT01712659|525476011|FG003|Dose Escalation|Unable to take study drug|0|||
145716018|NCT01712659|525476012|FG004|Dose Escalation|Unable to take study drug|0|||
145716019|NCT01712659|525476008|FG000|Dose Expansion|Early disease progression|1|||
145716020|NCT01712659|525476009|FG001|Dose Expansion|Early disease progression|0|||
145716021|NCT01712659|525476010|FG002|Dose Expansion|Early disease progression|0|||
145716022|NCT01712659|525476011|FG003|Dose Expansion|Early disease progression|0|||
145716023|NCT01712659|525476012|FG004|Dose Expansion|Early disease progression|0|||
145716024|NCT01712659|525476008|FG000|Dose Expansion|Physician Decision|1|||
145716025|NCT01712659|525476009|FG001|Dose Expansion|Physician Decision|0|||
145716026|NCT01712659|525476010|FG002|Dose Expansion|Physician Decision|0|||
145716027|NCT01712659|525476011|FG003|Dose Expansion|Physician Decision|0|||
145716028|NCT01712659|525476012|FG004|Dose Expansion|Physician Decision|0|||
145716029|NCT00548262|525476013|FG000|Overall Study|Death|21|||
145716030|NCT00548262|525476013|FG000|Overall Study|Adverse Event|2|||
145716031|NCT00548262|525476013|FG000|Overall Study|Lack of Efficacy|4|||
145716032|NCT00548262|525476013|FG000|Overall Study|Lost to Follow-up|1|||
145716033|NCT00548262|525476013|FG000|Overall Study|Other|3|||
145716034|NCT00548262|525476013|FG000|Overall Study|Withdrawal by Subject|1|||
145716035|NCT02544451|525476018|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
145716036|NCT02544451|525476019|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
145716037|NCT02544451|525476020|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
145716038|NCT02544451|525476021|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
145716039|NCT02544451|525476018|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
145716040|NCT02544451|525476019|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
145716041|NCT02544451|525476020|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
145716042|NCT02544451|525476021|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
145716043|NCT02544451|525476018|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
145716044|NCT02544451|525476019|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
145716045|NCT02544451|525476020|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
145716046|NCT02544451|525476021|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
145716047|NCT02544451|525476018|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
145716048|NCT02544451|525476019|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
145716049|NCT02544451|525476020|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
145716050|NCT02544451|525476021|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
145716051|NCT02544451|525476018|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
145716052|NCT02544451|525476019|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
145716053|NCT02544451|525476020|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
145716054|NCT02544451|525476021|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
145716055|NCT02544451|525476018|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
145716056|NCT02544451|525476019|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
145716057|NCT02544451|525476020|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
145716058|NCT02544451|525476021|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
145716059|NCT00844532|525476027|FG000|Overall Study|Death|16|||
145716060|NCT00844532|525476027|FG000|Overall Study|Withdrawal by Subject|16|||
145716061|NCT00844532|525476027|FG000|Overall Study|Lost to Follow-up|7|||
145716062|NCT00948766|525476028|FG000|Core Study|Adverse Event|73|||
145716063|NCT00948766|525476029|FG001|Core Study|Adverse Event|51|||
145716064|NCT00948766|525476028|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
145716065|NCT00948766|525476029|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
145716066|NCT00948766|525476028|FG000|Core Study|Patient Withdrew Consent|27|||
145716067|NCT00948766|525476029|FG001|Core Study|Patient Withdrew Consent|46|||
145716068|NCT00948766|525476028|FG000|Core Study|Lost to Follow-up|3|||
145716069|NCT00948766|525476029|FG001|Core Study|Lost to Follow-up|2|||
145716070|NCT00948766|525476028|FG000|Core Study|Administrative Problems|2|||
145716071|NCT00948766|525476029|FG001|Core Study|Administrative Problems|2|||
145716072|NCT00948766|525476028|FG000|Core Study|Death|1|||
145716073|NCT00948766|525476029|FG001|Core Study|Death|1|||
145716074|NCT00948766|525476028|FG000|Core Study|Protocol Deviation|8|||
145716075|NCT00948766|525476029|FG001|Core Study|Protocol Deviation|10|||
145716076|NCT00948766|525476028|FG000|Extension Study|Adverse Event|43|||
145716077|NCT00948766|525476029|FG001|Extension Study|Adverse Event|0|||
145716078|NCT00948766|525476028|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
145716079|NCT00948766|525476029|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
145716080|NCT00948766|525476028|FG000|Extension Study|Study Drug No Longer Required|1|||
145716081|NCT00948766|525476029|FG001|Extension Study|Study Drug No Longer Required|0|||
145716082|NCT00948766|525476028|FG000|Extension Study|Patient Withdrew Consent|32|||
145716083|NCT00948766|525476029|FG001|Extension Study|Patient Withdrew Consent|0|||
145716084|NCT00948766|525476028|FG000|Extension Study|Lost to Follow-up|8|||
145716085|NCT00948766|525476029|FG001|Extension Study|Lost to Follow-up|0|||
145716086|NCT00948766|525476028|FG000|Extension Study|Administrative Problems|1|||
145716087|NCT00948766|525476029|FG001|Extension Study|Administrative Problems|0|||
145716088|NCT00948766|525476028|FG000|Extension Study|Death|4|||
145716089|NCT00948766|525476029|FG001|Extension Study|Death|0|||
145716090|NCT03189745|525476030|FG000|Overall Study|Conflict in work schedule of participant|1|||
145716091|NCT03189745|525476031|FG001|Overall Study|Conflict in work schedule of participant|1|||
145716092|NCT03590366|525476032|FG000|Overall Study|Adverse Event|0|||
145716093|NCT03590366|525476033|FG001|Overall Study|Adverse Event|3|||
145716094|NCT03590366|525476032|FG000|Overall Study|Lost to Follow-up|3|||
145716095|NCT03590366|525476033|FG001|Overall Study|Lost to Follow-up|3|||
145716096|NCT03590366|525476032|FG000|Overall Study|Withdrawal by Subject|0|||
145716097|NCT03590366|525476033|FG001|Overall Study|Withdrawal by Subject|2|||
145716098|NCT00738894|525476035|FG000|Overall Study|Lost to Follow-up|23|||
145716099|NCT00738894|525476036|FG001|Overall Study|Lost to Follow-up|13|||
145716100|NCT00738894|525476035|FG000|Overall Study|Withdrawal by Subject|10|||
145716101|NCT00738894|525476036|FG001|Overall Study|Withdrawal by Subject|15|||
145716102|NCT00738894|525476035|FG000|Overall Study|Physician Decision|4|||
145716103|NCT00738894|525476036|FG001|Overall Study|Physician Decision|5|||
145716104|NCT00738894|525476035|FG000|Overall Study|Death|2|||
145716105|NCT00738894|525476036|FG001|Overall Study|Death|0|||
145716106|NCT05017103|525476037|FG000|Overall Study|Death|2|||
145716107|NCT02656329|525476038|FG000|Overall Study|Lost to Follow-up|2|||
145716108|NCT02656329|525476039|FG001|Overall Study|Lost to Follow-up|3|||
145716109|NCT02656329|525476038|FG000|Overall Study|Withdrawal by Subject|7|||
145716110|NCT02656329|525476039|FG001|Overall Study|Withdrawal by Subject|6|||
145716111|NCT02656329|525476038|FG000|Overall Study|Study termination by Sponsor|150|||
145716112|NCT02656329|525476039|FG001|Overall Study|Study termination by Sponsor|142|||
145716113|NCT02656329|525476038|FG000|Overall Study|Other than specified above|5|||
145716114|NCT02656329|525476039|FG001|Overall Study|Other than specified above|6|||
145716115|NCT01081665|525476040|FG000|Overall Study|Death|41|||
145716116|NCT01081665|525476040|FG000|Overall Study|Lost to Follow-up|18|||
145716117|NCT01081665|525476040|FG000|Overall Study|Withdrawal by Subject|17|||
145716118|NCT01081665|525476040|FG000|Overall Study|Change of dialysis unit|10|||
145716119|NCT01081665|525476040|FG000|Overall Study|Regulation of iPTH|5|||
145716120|NCT01081665|525476040|FG000|Overall Study|Change in renal replacement therapy|2|||
145716121|NCT01081665|525476040|FG000|Overall Study|Adverse Event|1|||
145716122|NCT01081665|525476040|FG000|Overall Study|Lack of Efficacy|1|||
145716123|NCT01747551|525476053|FG000|Overall Study|Progressive Disease|24|||
145716124|NCT01747551|525476054|FG001|Overall Study|Progressive Disease|17|||
145716125|NCT01747551|525476053|FG000|Overall Study|Death|3|||
145716126|NCT01747551|525476054|FG001|Overall Study|Death|1|||
145716127|NCT01747551|525476053|FG000|Overall Study|Adverse Event|7|||
145716128|NCT01747551|525476054|FG001|Overall Study|Adverse Event|1|||
145716129|NCT01747551|525476053|FG000|Overall Study|Prolonged Treatment Delay|2|||
145716130|NCT01747551|525476054|FG001|Overall Study|Prolonged Treatment Delay|0|||
145716131|NCT01747551|525476053|FG000|Overall Study|Withdrawal by Subject|3|||
145716132|NCT01747551|525476054|FG001|Overall Study|Withdrawal by Subject|1|||
145716133|NCT01747551|525476053|FG000|Overall Study|Physician Decision|2|||
145716134|NCT01747551|525476054|FG001|Overall Study|Physician Decision|1|||
145716135|NCT01747551|525476053|FG000|Overall Study|Other|2|||
145716136|NCT01747551|525476054|FG001|Overall Study|Other|0|||
145716137|NCT03117998|525476058|FG000|Overall Study|Adverse Event|1|||
145716138|NCT03117998|525476059|FG001|Overall Study|Adverse Event|0|||
145716139|NCT03117998|525476060|FG002|Overall Study|Adverse Event|0|||
145716140|NCT03117998|525476061|FG003|Overall Study|Adverse Event|0|||
145716141|NCT03117998|525476062|FG004|Overall Study|Adverse Event|0|||
145716142|NCT03117998|525476063|FG005|Overall Study|Adverse Event|0|||
145716143|NCT03117998|525476058|FG000|Overall Study|Withdrawal by Subject|0|||
145716144|NCT03117998|525476059|FG001|Overall Study|Withdrawal by Subject|0|||
145716145|NCT03117998|525476060|FG002|Overall Study|Withdrawal by Subject|2|||
145716146|NCT03117998|525476061|FG003|Overall Study|Withdrawal by Subject|3|||
145716147|NCT03117998|525476062|FG004|Overall Study|Withdrawal by Subject|3|||
145716148|NCT03117998|525476063|FG005|Overall Study|Withdrawal by Subject|0|||
145716149|NCT03117998|525476058|FG000|Overall Study|Physician Decision|0|||
145716150|NCT03117998|525476059|FG001|Overall Study|Physician Decision|1|||
145716151|NCT03117998|525476060|FG002|Overall Study|Physician Decision|1|||
145716152|NCT03117998|525476061|FG003|Overall Study|Physician Decision|0|||
145716153|NCT03117998|525476062|FG004|Overall Study|Physician Decision|0|||
145716154|NCT03117998|525476063|FG005|Overall Study|Physician Decision|0|||
145716155|NCT03117998|525476058|FG000|Overall Study|Lost to Follow-up|0|||
145716156|NCT03117998|525476059|FG001|Overall Study|Lost to Follow-up|0|||
145716157|NCT03117998|525476060|FG002|Overall Study|Lost to Follow-up|0|||
145716158|NCT03117998|525476061|FG003|Overall Study|Lost to Follow-up|1|||
145716159|NCT03117998|525476062|FG004|Overall Study|Lost to Follow-up|4|||
145716160|NCT03117998|525476063|FG005|Overall Study|Lost to Follow-up|0|||
145716161|NCT03117998|525476058|FG000|Overall Study|Subject noncompliance|0|||
145716162|NCT03117998|525476059|FG001|Overall Study|Subject noncompliance|0|||
145716163|NCT03117998|525476060|FG002|Overall Study|Subject noncompliance|1|||
145716164|NCT03117998|525476061|FG003|Overall Study|Subject noncompliance|0|||
145716165|NCT03117998|525476062|FG004|Overall Study|Subject noncompliance|0|||
145716166|NCT03117998|525476063|FG005|Overall Study|Subject noncompliance|2|||
145716167|NCT03117998|525476058|FG000|Overall Study|Protocol Violation|0|||
145716168|NCT03117998|525476059|FG001|Overall Study|Protocol Violation|0|||
145716169|NCT03117998|525476060|FG002|Overall Study|Protocol Violation|0|||
145716170|NCT03117998|525476061|FG003|Overall Study|Protocol Violation|0|||
145716171|NCT03117998|525476062|FG004|Overall Study|Protocol Violation|0|||
145716172|NCT03117998|525476063|FG005|Overall Study|Protocol Violation|1|||
145716173|NCT01593787|525476064|FG000|Overall Study|Adverse Event|1|||
145716174|NCT01593787|525476065|FG001|Overall Study|Adverse Event|0|||
145716175|NCT01593787|525476066|FG002|Overall Study|Adverse Event|0|||
145716176|NCT01865747|525476067|FG000|Overall Study (ITT)|Adverse Event|32|||
145716177|NCT01865747|525476068|FG001|Overall Study (ITT)|Adverse Event|31|||
145716178|NCT01865747|525476067|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
145716179|NCT01865747|525476068|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
145716180|NCT01865747|525476067|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
145716181|NCT01865747|525476068|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
145716182|NCT01865747|525476067|FG000|Overall Study (ITT)|Protocol Violation|1|||
145716183|NCT01865747|525476068|FG001|Overall Study (ITT)|Protocol Violation|1|||
145716184|NCT01865747|525476067|FG000|Overall Study (ITT)|Physician Decision|5|||
145716185|NCT01865747|525476068|FG001|Overall Study (ITT)|Physician Decision|2|||
145716186|NCT01865747|525476067|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
145716187|NCT01865747|525476068|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
145716188|NCT01865747|525476067|FG000|Overall Study (ITT)|Sponsor Decision|0|||
145716189|NCT01865747|525476068|FG001|Overall Study (ITT)|Sponsor Decision|1|||
145716190|NCT01865747|525476067|FG000|Overall Study (ITT)|Progressive Disease|122|||
145716191|NCT01865747|525476068|FG001|Overall Study (ITT)|Progressive Disease|158|||
145716192|NCT01865747|525476067|FG000|Overall Study (ITT)|Reason Not Provided|0|||
145716193|NCT01865747|525476068|FG001|Overall Study (ITT)|Reason Not Provided|1|||
145716194|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
145716195|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
145716196|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
145716197|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
145716198|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
145716199|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
145716200|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
145716201|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
145716202|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
145716203|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
145716204|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
145716205|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
145716206|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
145716207|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
145716208|NCT01865747|525476067|FG000|Primary Intent to Treat (PITT)|Other|0|||
145716209|NCT01865747|525476068|FG001|Primary Intent to Treat (PITT)|Other|1|||
145716210|NCT03973931|525476069|FG000|Overall Study|Lost to Follow-up|47|||
145716211|NCT03973931|525476070|FG001|Overall Study|Lost to Follow-up|63|||
145716212|NCT03973931|525476071|FG002|Overall Study|Lost to Follow-up|51|||
145716213|NCT03973931|525476072|FG003|Overall Study|Lost to Follow-up|54|||
145716214|NCT03973931|525476069|FG000|Overall Study|opted out|6|||
145716215|NCT03973931|525476070|FG001|Overall Study|opted out|5|||
145716216|NCT03973931|525476071|FG002|Overall Study|opted out|5|||
145716217|NCT03973931|525476072|FG003|Overall Study|opted out|1|||
145716218|NCT01022112|525476073|FG000|Overall Study|Adverse Event|1|||
145716219|NCT01022112|525476074|FG001|Overall Study|Adverse Event|2|||
145716220|NCT01022112|525476075|FG002|Overall Study|Adverse Event|0|||
145716221|NCT01022112|525476076|FG003|Overall Study|Adverse Event|1|||
145716222|NCT01022112|525476077|FG004|Overall Study|Adverse Event|0|||
145716223|NCT01022112|525476073|FG000|Overall Study|Lack of Efficacy|1|||
145716224|NCT01022112|525476074|FG001|Overall Study|Lack of Efficacy|0|||
145716225|NCT01022112|525476075|FG002|Overall Study|Lack of Efficacy|0|||
145716226|NCT01022112|525476076|FG003|Overall Study|Lack of Efficacy|0|||
145716227|NCT01022112|525476077|FG004|Overall Study|Lack of Efficacy|1|||
145716228|NCT01022112|525476073|FG000|Overall Study|Physician Decision|0|||
145716229|NCT01022112|525476074|FG001|Overall Study|Physician Decision|0|||
145716230|NCT01022112|525476075|FG002|Overall Study|Physician Decision|1|||
145716231|NCT01022112|525476076|FG003|Overall Study|Physician Decision|0|||
145716232|NCT01022112|525476077|FG004|Overall Study|Physician Decision|1|||
145716233|NCT01022112|525476073|FG000|Overall Study|Withdrawal by Subject|0|||
145716234|NCT01022112|525476074|FG001|Overall Study|Withdrawal by Subject|1|||
145716235|NCT01022112|525476075|FG002|Overall Study|Withdrawal by Subject|2|||
145716236|NCT01022112|525476076|FG003|Overall Study|Withdrawal by Subject|2|||
145716237|NCT01022112|525476077|FG004|Overall Study|Withdrawal by Subject|1|||
145716238|NCT01022112|525476073|FG000|Overall Study|Fasting plasma glucose level increased|1|||
145716239|NCT01022112|525476074|FG001|Overall Study|Fasting plasma glucose level increased|0|||
145716240|NCT01022112|525476075|FG002|Overall Study|Fasting plasma glucose level increased|0|||
145716241|NCT01022112|525476076|FG003|Overall Study|Fasting plasma glucose level increased|0|||
145716242|NCT01022112|525476077|FG004|Overall Study|Fasting plasma glucose level increased|7|||
145716243|NCT01982448|525476078|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
145716244|NCT01982448|525476079|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
145716245|NCT01982448|525476078|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
145716246|NCT01982448|525476079|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
145716247|NCT01982448|525476078|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
145716248|NCT01982448|525476079|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
145716249|NCT01982448|525476078|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
145716250|NCT01982448|525476079|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
145716251|NCT00872989|525477512|FG000|Overall Study|Adverse Event|7|||
145716252|NCT00872989|525477513|FG001|Overall Study|Adverse Event|15|||
145716253|NCT00872989|525477512|FG000|Overall Study|Withdrawal by Subject|8|||
145716254|NCT00872989|525477513|FG001|Overall Study|Withdrawal by Subject|5|||
145716255|NCT00872989|525477512|FG000|Overall Study|Progression/relapse|47|||
145716256|NCT00872989|525477513|FG001|Overall Study|Progression/relapse|35|||
145716257|NCT00872989|525477512|FG000|Overall Study|Not protocol specified|3|||
145716258|NCT00872989|525477513|FG001|Overall Study|Not protocol specified|8|||
145716259|NCT02407990|525477514|FG000|Overall Study|Death|2|||
145716260|NCT02407990|525477515|FG001|Overall Study|Death|22|||
145716261|NCT02407990|525477516|FG002|Overall Study|Death|23|||
145716262|NCT02407990|525477517|FG003|Overall Study|Death|7|||
145716263|NCT02407990|525477518|FG004|Overall Study|Death|17|||
145716264|NCT02407990|525477519|FG005|Overall Study|Death|16|||
145716265|NCT02407990|525477520|FG006|Overall Study|Death|10|||
145716266|NCT02407990|525477521|FG007|Overall Study|Death|248|||
145716267|NCT02407990|525477514|FG000|Overall Study|Lost to Follow-up|0|||
145716268|NCT02407990|525477515|FG001|Overall Study|Lost to Follow-up|1|||
145716269|NCT02407990|525477516|FG002|Overall Study|Lost to Follow-up|0|||
145716270|NCT02407990|525477517|FG003|Overall Study|Lost to Follow-up|0|||
145716271|NCT02407990|525477518|FG004|Overall Study|Lost to Follow-up|0|||
145716272|NCT02407990|525477519|FG005|Overall Study|Lost to Follow-up|0|||
145716273|NCT02407990|525477520|FG006|Overall Study|Lost to Follow-up|0|||
145716274|NCT02407990|525477521|FG007|Overall Study|Lost to Follow-up|17|||
145716275|NCT02407990|525477514|FG000|Overall Study|Progressive Disease|0|||
145716276|NCT02407990|525477515|FG001|Overall Study|Progressive Disease|0|||
145716277|NCT02407990|525477516|FG002|Overall Study|Progressive Disease|0|||
145716278|NCT02407990|525477517|FG003|Overall Study|Progressive Disease|0|||
145716279|NCT02407990|525477518|FG004|Overall Study|Progressive Disease|0|||
145716280|NCT02407990|525477519|FG005|Overall Study|Progressive Disease|0|||
145716281|NCT02407990|525477520|FG006|Overall Study|Progressive Disease|0|||
145716282|NCT02407990|525477521|FG007|Overall Study|Progressive Disease|1|||
145716283|NCT02407990|525477514|FG000|Overall Study|Withdrawal by Subject|0|||
145716284|NCT02407990|525477515|FG001|Overall Study|Withdrawal by Subject|0|||
145716285|NCT02407990|525477516|FG002|Overall Study|Withdrawal by Subject|0|||
145716286|NCT02407990|525477517|FG003|Overall Study|Withdrawal by Subject|0|||
145716287|NCT02407990|525477518|FG004|Overall Study|Withdrawal by Subject|1|||
145716288|NCT02407990|525477519|FG005|Overall Study|Withdrawal by Subject|0|||
145716289|NCT02407990|525477520|FG006|Overall Study|Withdrawal by Subject|0|||
145716290|NCT02407990|525477521|FG007|Overall Study|Withdrawal by Subject|30|||
145716291|NCT02407990|525477514|FG000|Overall Study|Study Terminated by Sponsor|1|||
145716292|NCT02407990|525477515|FG001|Overall Study|Study Terminated by Sponsor|3|||
145716293|NCT02407990|525477516|FG002|Overall Study|Study Terminated by Sponsor|3|||
145716294|NCT02407990|525477517|FG003|Overall Study|Study Terminated by Sponsor|0|||
145716295|NCT02407990|525477518|FG004|Overall Study|Study Terminated by Sponsor|3|||
145716296|NCT02407990|525477519|FG005|Overall Study|Study Terminated by Sponsor|4|||
145716297|NCT02407990|525477520|FG006|Overall Study|Study Terminated by Sponsor|3|||
145716298|NCT02407990|525477521|FG007|Overall Study|Study Terminated by Sponsor|37|||
145716299|NCT02407990|525477514|FG000|Overall Study|Logistics|0|||
145716300|NCT02407990|525477515|FG001|Overall Study|Logistics|0|||
145716301|NCT02407990|525477516|FG002|Overall Study|Logistics|0|||
145716302|NCT02407990|525477517|FG003|Overall Study|Logistics|0|||
145716303|NCT02407990|525477518|FG004|Overall Study|Logistics|0|||
145716304|NCT02407990|525477519|FG005|Overall Study|Logistics|0|||
145716305|NCT02407990|525477520|FG006|Overall Study|Logistics|0|||
145716306|NCT02407990|525477521|FG007|Overall Study|Logistics|1|||
145716307|NCT02407990|525477514|FG000|Overall Study|Rolled into long-term extension study|0|||
145716308|NCT02407990|525477515|FG001|Overall Study|Rolled into long-term extension study|0|||
145716309|NCT02407990|525477516|FG002|Overall Study|Rolled into long-term extension study|0|||
145716310|NCT02407990|525477517|FG003|Overall Study|Rolled into long-term extension study|0|||
145716311|NCT02407990|525477518|FG004|Overall Study|Rolled into long-term extension study|0|||
145716312|NCT02407990|525477519|FG005|Overall Study|Rolled into long-term extension study|0|||
145716313|NCT02407990|525477520|FG006|Overall Study|Rolled into long-term extension study|0|||
145716314|NCT02407990|525477521|FG007|Overall Study|Rolled into long-term extension study|1|||
145716315|NCT00923260|525477522|FG000|Overall Study|Lost to Follow-up|1|||
145716316|NCT00923260|525477523|FG001|Overall Study|Lost to Follow-up|1|||
145716317|NCT01238900|525477524|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
145716318|NCT01238900|525477524|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
145716319|NCT00591721|525477525|FG000|Overall Study|Withdrawal by Subject|10|||
145716320|NCT00591721|525477526|FG001|Overall Study|Withdrawal by Subject|10|||
145716321|NCT00591721|525477525|FG000|Overall Study|Lost to Follow-up|1|||
145716322|NCT00591721|525477526|FG001|Overall Study|Lost to Follow-up|4|||
145716323|NCT00591721|525477525|FG000|Overall Study|Intervention not received|10|||
145716324|NCT00591721|525477526|FG001|Overall Study|Intervention not received|8|||
145716325|NCT03725085|525477527|FG000|Overall Study|Lost to Follow-up|2|||
145716326|NCT02704754|525477528|FG000|Overall Study|Lost to Follow-up|1|||
145716327|NCT02704754|525477529|FG001|Overall Study|Lost to Follow-up|1|||
145716328|NCT02704754|525477528|FG000|Overall Study|Lack of Efficacy|1|||
145716329|NCT02704754|525477529|FG001|Overall Study|Lack of Efficacy|0|||
145716330|NCT02704754|525477528|FG000|Overall Study|Withdrawal by Subject|1|||
145716331|NCT02704754|525477529|FG001|Overall Study|Withdrawal by Subject|0|||
145716332|NCT00423943|525477530|FG000|Overall Study|Withdrawal by Subject|3|||
145716333|NCT00423943|525477531|FG001|Overall Study|Withdrawal by Subject|1|||
145716334|NCT02134977|525477532|FG000|Overall Study|Protocol Deviation|102|||
145716335|NCT02383056|525477541|FG000|Overall Study|Adverse Event|1|||
145716336|NCT02383056|525477542|FG001|Overall Study|Adverse Event|0|||
145716337|NCT02383056|525477541|FG000|Overall Study|Lost to Follow-up|0|||
145716338|NCT02383056|525477542|FG001|Overall Study|Lost to Follow-up|2|||
145716339|NCT04187989|525477543|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
145716340|NCT04187989|525477544|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
145716341|NCT04187989|525477543|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
145716342|NCT04187989|525477544|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
145716343|NCT03646656|525477545|FG000|Overall Study|Lost to Follow-up|1|||
145716344|NCT03646656|525477546|FG001|Overall Study|Lost to Follow-up|0|||
145716345|NCT03646656|525477545|FG000|Overall Study|Withdrawal by Subject|2|||
145716346|NCT03646656|525477546|FG001|Overall Study|Withdrawal by Subject|0|||
145716347|NCT03900416|525477547|FG000|Six Week Follow-up|Lost to Follow-up|1|||
145716348|NCT03900416|525477548|FG001|Six Week Follow-up|Lost to Follow-up|0|||
145716349|NCT03900416|525477547|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
145716350|NCT03900416|525477548|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
145716351|NCT03900416|525477547|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
145716352|NCT03900416|525477548|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
145716353|NCT03900416|525477547|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
145716354|NCT03900416|525477548|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
145716355|NCT03900416|525477547|FG000|Twelve Week Follow-up|Adverse Event|1|||
145716356|NCT03900416|525477548|FG001|Twelve Week Follow-up|Adverse Event|1|||
145716357|NCT03900416|525477547|FG000|Six Month Follow-up|Lost to Follow-up|4|||
145716358|NCT03900416|525477548|FG001|Six Month Follow-up|Lost to Follow-up|3|||
145716359|NCT03900416|525477547|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
145716360|NCT03900416|525477548|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
145716361|NCT03507777|525477549|FG000|Overall Study|Lost to Follow-up|5|||
145716362|NCT03507777|525477550|FG001|Overall Study|Lost to Follow-up|7|||
145716363|NCT03507777|525477549|FG000|Overall Study|Withdrawal by Subject|6|||
145716364|NCT03507777|525477550|FG001|Overall Study|Withdrawal by Subject|11|||
145716365|NCT03507777|525477549|FG000|Overall Study|Death|30|||
145716366|NCT03507777|525477550|FG001|Overall Study|Death|44|||
145716367|NCT03507777|525477549|FG000|Overall Study|Other Reasons|3|||
145716368|NCT03507777|525477550|FG001|Overall Study|Other Reasons|8|||
145716369|NCT02245737|525477551|FG000|Overall Study|Adverse Event|23|||
145716370|NCT02245737|525477552|FG001|Overall Study|Adverse Event|26|||
145716371|NCT02245737|525477553|FG002|Overall Study|Adverse Event|33|||
145716372|NCT02245737|525477551|FG000|Overall Study|Condition Worsened|9|||
145716373|NCT02245737|525477552|FG001|Overall Study|Condition Worsened|10|||
145716374|NCT02245737|525477553|FG002|Overall Study|Condition Worsened|9|||
145716375|NCT02245737|525477551|FG000|Overall Study|Death|2|||
145716376|NCT02245737|525477552|FG001|Overall Study|Death|4|||
145716377|NCT02245737|525477553|FG002|Overall Study|Death|4|||
145716378|NCT02245737|525477551|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
145716379|NCT02245737|525477552|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
145716380|NCT02245737|525477553|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
145716381|NCT02245737|525477551|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
145716382|NCT02245737|525477552|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
145716383|NCT02245737|525477553|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
145716384|NCT02245737|525477551|FG000|Overall Study|Lost to Follow-up|2|||
145716385|NCT02245737|525477552|FG001|Overall Study|Lost to Follow-up|5|||
145716386|NCT02245737|525477553|FG002|Overall Study|Lost to Follow-up|4|||
145716387|NCT02245737|525477551|FG000|Overall Study|Other-determined by Investigator|9|||
145716388|NCT02245737|525477552|FG001|Overall Study|Other-determined by Investigator|10|||
145716389|NCT02245737|525477553|FG002|Overall Study|Other-determined by Investigator|10|||
145716390|NCT02245737|525477551|FG000|Overall Study|Physician Decision|6|||
145716391|NCT02245737|525477552|FG001|Overall Study|Physician Decision|3|||
145716392|NCT02245737|525477553|FG002|Overall Study|Physician Decision|6|||
145716393|NCT02245737|525477551|FG000|Overall Study|Protocol Violation|3|||
145716394|NCT02245737|525477552|FG001|Overall Study|Protocol Violation|2|||
145716395|NCT02245737|525477553|FG002|Overall Study|Protocol Violation|3|||
145716396|NCT02245737|525477551|FG000|Overall Study|Withdrawal by Subject|40|||
145716397|NCT02245737|525477552|FG001|Overall Study|Withdrawal by Subject|41|||
145716398|NCT02245737|525477553|FG002|Overall Study|Withdrawal by Subject|44|||
145716399|NCT02245737|525477551|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
145716400|NCT02245737|525477552|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
145716401|NCT02245737|525477553|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
145716402|NCT02245737|525477551|FG000|Overall Study|Sponsor Decision|445|||
145716403|NCT02245737|525477552|FG001|Overall Study|Sponsor Decision|430|||
145716404|NCT02245737|525477553|FG002|Overall Study|Sponsor Decision|432|||
145716405|NCT04988867|525477555|FG000|Overall Study|Study terminated by Sponsor|12|||
145716406|NCT04988867|525477555|FG000|Overall Study|Adverse Event|2|||
145716407|NCT04988867|525477555|FG000|Overall Study|Study drug noncompliance|1|||
145716408|NCT01327495|525477556|FG000|Overall Study|Adverse Event|2|||
145716409|NCT01327495|525477557|FG001|Overall Study|Adverse Event|1|||
145716410|NCT01327495|525477558|FG002|Overall Study|Adverse Event|1|||
145716411|NCT01327495|525477559|FG003|Overall Study|Adverse Event|0|||
145716412|NCT01327495|525477560|FG004|Overall Study|Adverse Event|0|||
145716413|NCT01327495|525477561|FG005|Overall Study|Adverse Event|2|||
145716414|NCT01327495|525477556|FG000|Overall Study|Withdrawal by Subject|0|||
145716415|NCT01327495|525477557|FG001|Overall Study|Withdrawal by Subject|1|||
145716416|NCT01327495|525477558|FG002|Overall Study|Withdrawal by Subject|1|||
145716417|NCT01327495|525477559|FG003|Overall Study|Withdrawal by Subject|0|||
145716418|NCT01327495|525477560|FG004|Overall Study|Withdrawal by Subject|1|||
145716419|NCT01327495|525477561|FG005|Overall Study|Withdrawal by Subject|0|||
145716420|NCT01327495|525477556|FG000|Overall Study|Physician Decision|0|||
145716421|NCT01327495|525477557|FG001|Overall Study|Physician Decision|0|||
145491963|NCT00550407|524655420|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
145491964|NCT00550407|524655421|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
145491965|NCT00550407|524655422|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
145491966|NCT00550407|524655420|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
145491967|NCT00550407|524655421|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
145491968|NCT00550407|524655422|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
145716422|NCT01327495|525477558|FG002|Overall Study|Physician Decision|0|||
145491969|NCT00550407|524655420|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
145716423|NCT01327495|525477559|FG003|Overall Study|Physician Decision|0|||
145716424|NCT01327495|525477560|FG004|Overall Study|Physician Decision|2|||
145716425|NCT01327495|525477561|FG005|Overall Study|Physician Decision|0|||
145716426|NCT03020576|525477568|FG000|Overall Study|Withdrawal by Subject|1|||
145491970|NCT00550407|524655421|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
145491971|NCT00550407|524655422|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
145491972|NCT00584415|524655423|FG000|Overall Study|Adverse Event|7|||
145491973|NCT00556894|524655424|FG000|Overall Study|Adverse Event|2|||
145491974|NCT00556894|524655425|FG001|Overall Study|Adverse Event|3|||
145491975|NCT00556894|524655426|FG002|Overall Study|Adverse Event|3|||
145491976|NCT00556894|524655424|FG000|Overall Study|Death|1|||
145491977|NCT00556894|524655425|FG001|Overall Study|Death|0|||
145491978|NCT00556894|524655426|FG002|Overall Study|Death|0|||
145491979|NCT00556894|524655424|FG000|Overall Study|regulatory decision in Bulgaria|10|||
145491980|NCT00556894|524655425|FG001|Overall Study|regulatory decision in Bulgaria|14|||
145491981|NCT00556894|524655426|FG002|Overall Study|regulatory decision in Bulgaria|13|||
145491982|NCT00556894|524655424|FG000|Overall Study|Change in therapy|2|||
145491983|NCT00556894|524655425|FG001|Overall Study|Change in therapy|1|||
145491984|NCT00556894|524655426|FG002|Overall Study|Change in therapy|2|||
145491985|NCT00556894|524655424|FG000|Overall Study|Withdrawal by Subject|1|||
145491986|NCT00556894|524655425|FG001|Overall Study|Withdrawal by Subject|1|||
145491987|NCT00556894|524655426|FG002|Overall Study|Withdrawal by Subject|1|||
145491988|NCT04750642|524655427|FG000|Overall Study|Adverse Event|1|||
145491989|NCT04750642|524655428|FG001|Overall Study|Adverse Event|0|||
145491990|NCT04750642|524655427|FG000|Overall Study|Withdrawal by Subject|0|||
145491991|NCT04750642|524655428|FG001|Overall Study|Withdrawal by Subject|1|||
145491992|NCT04750642|524655427|FG000|Overall Study|Protocol Violation|0|||
145491993|NCT04750642|524655428|FG001|Overall Study|Protocol Violation|1|||
145491994|NCT00410956|524655429|FG000|Overall Study|Adverse Event|1|||
145491995|NCT00410956|524655429|FG000|Overall Study|Death|2|||
145491996|NCT00410956|524655429|FG000|Overall Study|Lack of Efficacy|10|||
145491997|NCT00410956|524655429|FG000|Overall Study|Physician Decision|6|||
145491998|NCT01650194|524655431|FG000|Overall Study|Progressive Disease (PD)|35|||
145491999|NCT01650194|524655431|FG000|Overall Study|Withdrawal by Subject|2|||
145492000|NCT01650194|524655431|FG000|Overall Study|Miscellaneous|10|||
145716427|NCT03020576|525477569|FG001|Overall Study|Withdrawal by Subject|2|||
145716428|NCT01151410|525477573|FG000|Overall Study|Withdrawal by Subject|3|||
145716429|NCT01151410|525477574|FG001|Overall Study|Withdrawal by Subject|5|||
145716430|NCT01151410|525477573|FG000|Overall Study|Lost to Follow-up|3|||
145716431|NCT01151410|525477574|FG001|Overall Study|Lost to Follow-up|4|||
145716432|NCT01151410|525477573|FG000|Overall Study|Adverse Event|1|||
145716433|NCT01151410|525477574|FG001|Overall Study|Adverse Event|2|||
145716434|NCT01151410|525477573|FG000|Overall Study|Protocol deviation|2|||
145716435|NCT01151410|525477574|FG001|Overall Study|Protocol deviation|1|||
145716436|NCT01151410|525477573|FG000|Overall Study|Administrative problems|1|||
145716437|NCT01151410|525477574|FG001|Overall Study|Administrative problems|1|||
145716438|NCT01151410|525477573|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
145716439|NCT01151410|525477574|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
145716440|NCT01151410|525477573|FG000|Overall Study|Abnormal laboratory value(s)|0|||
145716441|NCT01151410|525477574|FG001|Overall Study|Abnormal laboratory value(s)|1|||
145716442|NCT05086276|525477575|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
145716443|NCT05086276|525477576|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
145716444|NCT01468181|525477578|FG000|Overall Study|Adverse Event|8|||
145716445|NCT01468181|525477579|FG001|Overall Study|Adverse Event|1|||
145716446|NCT01468181|525477580|FG002|Overall Study|Adverse Event|6|||
145716447|NCT01468181|525477581|FG003|Overall Study|Adverse Event|2|||
145716448|NCT01468181|525477582|FG004|Overall Study|Adverse Event|2|||
145716449|NCT01468181|525477578|FG000|Overall Study|Protocol Violation|2|||
145716450|NCT01468181|525477579|FG001|Overall Study|Protocol Violation|0|||
145716451|NCT01468181|525477580|FG002|Overall Study|Protocol Violation|1|||
145716452|NCT01468181|525477581|FG003|Overall Study|Protocol Violation|0|||
145716453|NCT01468181|525477582|FG004|Overall Study|Protocol Violation|1|||
145716454|NCT01468181|525477578|FG000|Overall Study|Physician Decision|0|||
145716455|NCT01468181|525477579|FG001|Overall Study|Physician Decision|0|||
145716456|NCT01468181|525477580|FG002|Overall Study|Physician Decision|0|||
145716457|NCT01468181|525477581|FG003|Overall Study|Physician Decision|1|||
145716458|NCT01468181|525477582|FG004|Overall Study|Physician Decision|1|||
145716459|NCT01468181|525477578|FG000|Overall Study|Lost to Follow-up|0|||
145716460|NCT01468181|525477579|FG001|Overall Study|Lost to Follow-up|0|||
145716461|NCT01468181|525477580|FG002|Overall Study|Lost to Follow-up|1|||
145716462|NCT01468181|525477581|FG003|Overall Study|Lost to Follow-up|0|||
145716463|NCT01468181|525477582|FG004|Overall Study|Lost to Follow-up|1|||
145716464|NCT01468181|525477578|FG000|Overall Study|Withdrawal by Subject|0|||
145716465|NCT01468181|525477579|FG001|Overall Study|Withdrawal by Subject|1|||
145716466|NCT01468181|525477580|FG002|Overall Study|Withdrawal by Subject|0|||
145716467|NCT01468181|525477581|FG003|Overall Study|Withdrawal by Subject|0|||
145716468|NCT01468181|525477582|FG004|Overall Study|Withdrawal by Subject|0|||
145716469|NCT04664400|525477583|FG000|Overall Study|Withdrawal by Subject|2|||
145716470|NCT01011153|525477586|FG000|Overall Study|Less than 78 cases completed|8|||
145716471|NCT01011153|525477587|FG001|Overall Study|Less than 78 cases completed|11|||
145716472|NCT01011153|525477588|FG002|Overall Study|Less than 78 cases completed|9|||
145716473|NCT01081132|525477591|FG000|Overall Study|Lack of Efficacy|25|||
145716474|NCT01081132|525477592|FG001|Overall Study|Lack of Efficacy|9|||
145716475|NCT01081132|525477591|FG000|Overall Study|Withdrawal by Subject|13|||
145716476|NCT01081132|525477592|FG001|Overall Study|Withdrawal by Subject|16|||
145716477|NCT01081132|525477591|FG000|Overall Study|Lost to Follow-up|4|||
145716478|NCT01081132|525477592|FG001|Overall Study|Lost to Follow-up|11|||
145716479|NCT01081132|525477591|FG000|Overall Study|Adverse Event|3|||
145716480|NCT01081132|525477592|FG001|Overall Study|Adverse Event|9|||
145716481|NCT01081132|525477591|FG000|Overall Study|Non Compliance|4|||
145716482|NCT01081132|525477592|FG001|Overall Study|Non Compliance|2|||
145716483|NCT01081132|525477591|FG000|Overall Study|Lack Of Compliance|0|||
145716484|NCT01081132|525477592|FG001|Overall Study|Lack Of Compliance|1|||
145716485|NCT01081132|525477591|FG000|Overall Study|Missed Visits|1|||
145716486|NCT01081132|525477592|FG001|Overall Study|Missed Visits|1|||
145716487|NCT01081132|525477591|FG000|Overall Study|Stopped Taking Meds|2|||
145716488|NCT01081132|525477592|FG001|Overall Study|Stopped Taking Meds|0|||
145716489|NCT01081132|525477591|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
145716490|NCT01081132|525477592|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
145716491|NCT01081132|525477591|FG000|Overall Study|Declined Taper Phase|0|||
145716492|NCT01081132|525477592|FG001|Overall Study|Declined Taper Phase|1|||
145716493|NCT01081132|525477591|FG000|Overall Study|Protocol Violation|3|||
145716494|NCT01081132|525477592|FG001|Overall Study|Protocol Violation|1|||
145716495|NCT02297139|525477593|FG000|Overall Study|Disease progression|0|||
145716496|NCT02297139|525477594|FG001|Overall Study|Disease progression|1|||
145716497|NCT02297139|525477593|FG000|Overall Study|Study drug toxicity|0|||
145716498|NCT02297139|525477594|FG001|Overall Study|Study drug toxicity|4|||
145716499|NCT02297139|525477593|FG000|Overall Study|Participant request to discontinue study treatment|0|||
145716500|NCT02297139|525477594|FG001|Overall Study|Participant request to discontinue study treatment|1|||
145716501|NCT02297139|525477593|FG000|Overall Study|Maximum clinical benefit|1|||
145716502|NCT02297139|525477594|FG001|Overall Study|Maximum clinical benefit|0|||
145716503|NCT02297139|525477593|FG000|Overall Study|Administrative reason by sponsor|0|||
145716504|NCT02297139|525477594|FG001|Overall Study|Administrative reason by sponsor|2|||
145716505|NCT02297139|525477593|FG000|Overall Study|Other reasons|0|||
145716506|NCT02297139|525477594|FG001|Overall Study|Other reasons|8|||
145716507|NCT02101385|525477597|FG000|Study Treatment|Disease Progression|9|||
145716508|NCT02101385|525477598|FG001|Study Treatment|Disease Progression|3|||
145716509|NCT02101385|525477597|FG000|Study Treatment|Alternative therapy|0|||
145716510|NCT02101385|525477598|FG001|Study Treatment|Alternative therapy|1|||
145716511|NCT02101385|525477597|FG000|Study Treatment|No treatment, per protocol criteria|0|||
145716512|NCT02101385|525477598|FG001|Study Treatment|No treatment, per protocol criteria|4|||
145716513|NCT02101385|525477597|FG000|Study Treatment|Patient Non compliance|0|||
145716514|NCT02101385|525477598|FG001|Study Treatment|Patient Non compliance|2|||
145716515|NCT02101385|525477597|FG000|Study Treatment|Withdrawal by Subject|5|||
145716516|NCT02101385|525477598|FG001|Study Treatment|Withdrawal by Subject|2|||
145716517|NCT02101385|525477597|FG000|Study Treatment|screen failure|1|||
145716518|NCT02101385|525477598|FG001|Study Treatment|screen failure|0|||
145716519|NCT02101385|525477597|FG000|Study Treatment|AE/Side Effects/Complications|8|||
145716520|NCT02101385|525477598|FG001|Study Treatment|AE/Side Effects/Complications|0|||
145716521|NCT02101385|525477597|FG000|Study Treatment|Lost to Follow-up|1|||
145716522|NCT02101385|525477598|FG001|Study Treatment|Lost to Follow-up|0|||
145716523|NCT02101385|525477597|FG000|Study Treatment|Disease Progression before treatment|1|||
145716524|NCT02101385|525477598|FG001|Study Treatment|Disease Progression before treatment|0|||
145716525|NCT02101385|525477597|FG000|Study Treatment|Death|1|||
145716526|NCT02101385|525477598|FG001|Study Treatment|Death|0|||
145716527|NCT02101385|525477597|FG000|Follow up|Lost to Follow-up|4|||
145716528|NCT02101385|525477598|FG001|Follow up|Lost to Follow-up|9|||
145716529|NCT02101385|525477597|FG000|Follow up|Refused to follow up|5|||
145716530|NCT02101385|525477598|FG001|Follow up|Refused to follow up|4|||
145716531|NCT02101385|525477597|FG000|Follow up|Death|21|||
145716532|NCT02101385|525477598|FG001|Follow up|Death|39|||
145716533|NCT02101385|525477597|FG000|Follow up|study completed|33|||
145716534|NCT02101385|525477598|FG001|Follow up|study completed|52|||
145716535|NCT02101385|525477597|FG000|Follow up|screen failure|2|||
145716536|NCT02101385|525477598|FG001|Follow up|screen failure|0|||
145716537|NCT02101385|525477597|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
145716538|NCT02101385|525477598|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
145716539|NCT02101385|525477597|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
145716540|NCT02101385|525477598|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
145716541|NCT02101385|525477597|FG000|Follow up|Withdrawal by Subject|2|||
145716542|NCT02101385|525477598|FG001|Follow up|Withdrawal by Subject|2|||
145716543|NCT02101385|525477597|FG000|Follow up|PI requested closure of site|0|||
145716544|NCT02101385|525477598|FG001|Follow up|PI requested closure of site|5|||
145377885|NCT03191864|524233636|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
145716545|NCT02432196|525477599|FG000|Overall Study|Exit - did not receive study device|1|||
145716546|NCT02432196|525477599|FG000|Overall Study|Death|2|||
145716547|NCT02432196|525477599|FG000|Overall Study|Reoperation|3|||
145716548|NCT01905150|525477601|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
145716549|NCT01905150|525477602|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
145716550|NCT03738423|525477607|FG000|Overall Study|Withdrawal by Subject|9|||
145716551|NCT03738423|525477608|FG001|Overall Study|Withdrawal by Subject|12|||
145716552|NCT03738423|525477609|FG002|Overall Study|Withdrawal by Subject|9|||
145716553|NCT03738423|525477610|FG003|Overall Study|Withdrawal by Subject|12|||
145716554|NCT03738423|525477611|FG004|Overall Study|Withdrawal by Subject|10|||
145716555|NCT03738423|525477607|FG000|Overall Study|Lack of Efficacy|3|||
145716556|NCT03738423|525477608|FG001|Overall Study|Lack of Efficacy|1|||
145716557|NCT03738423|525477609|FG002|Overall Study|Lack of Efficacy|1|||
145716558|NCT03738423|525477610|FG003|Overall Study|Lack of Efficacy|1|||
145716559|NCT03738423|525477611|FG004|Overall Study|Lack of Efficacy|2|||
145716560|NCT03738423|525477607|FG000|Overall Study|Lost to Follow-up|1|||
145716561|NCT03738423|525477608|FG001|Overall Study|Lost to Follow-up|0|||
145716562|NCT03738423|525477609|FG002|Overall Study|Lost to Follow-up|1|||
145716563|NCT03738423|525477610|FG003|Overall Study|Lost to Follow-up|1|||
145716564|NCT03738423|525477611|FG004|Overall Study|Lost to Follow-up|0|||
145716565|NCT03738423|525477607|FG000|Overall Study|Protocol Violation|1|||
145716566|NCT03738423|525477608|FG001|Overall Study|Protocol Violation|0|||
145716567|NCT03738423|525477609|FG002|Overall Study|Protocol Violation|0|||
145716568|NCT03738423|525477610|FG003|Overall Study|Protocol Violation|0|||
145716569|NCT03738423|525477611|FG004|Overall Study|Protocol Violation|1|||
145716570|NCT03738423|525477607|FG000|Overall Study|Physician Decision|0|||
145716571|NCT03738423|525477608|FG001|Overall Study|Physician Decision|0|||
145716572|NCT03738423|525477609|FG002|Overall Study|Physician Decision|1|||
145716573|NCT03738423|525477610|FG003|Overall Study|Physician Decision|0|||
145716574|NCT03738423|525477611|FG004|Overall Study|Physician Decision|1|||
145716575|NCT03738423|525477607|FG000|Overall Study|Death|0|||
145716576|NCT03738423|525477608|FG001|Overall Study|Death|0|||
145716577|NCT03738423|525477609|FG002|Overall Study|Death|0|||
145716578|NCT03738423|525477610|FG003|Overall Study|Death|0|||
145716579|NCT03738423|525477611|FG004|Overall Study|Death|1|||
145716580|NCT03738423|525477607|FG000|Overall Study|Randomized but never treated|0|||
145716581|NCT03738423|525477608|FG001|Overall Study|Randomized but never treated|0|||
145716582|NCT03738423|525477609|FG002|Overall Study|Randomized but never treated|1|||
145716583|NCT03738423|525477610|FG003|Overall Study|Randomized but never treated|1|||
145716584|NCT03738423|525477611|FG004|Overall Study|Randomized but never treated|0|||
145716585|NCT02592876|525477618|FG000|Overall Study|Withdrawal by Subject|3|||
145716586|NCT02592876|525477619|FG001|Overall Study|Withdrawal by Subject|3|||
145716587|NCT02592876|525477618|FG000|Overall Study|Study Termination by Sponsor|32|||
145716588|NCT02592876|525477619|FG001|Overall Study|Study Termination by Sponsor|27|||
145716589|NCT02592876|525477618|FG000|Overall Study|Lost to Follow-up|0|||
145716590|NCT02592876|525477619|FG001|Overall Study|Lost to Follow-up|1|||
145716591|NCT02592876|525477618|FG000|Overall Study|Death|6|||
145716592|NCT02592876|525477619|FG001|Overall Study|Death|9|||
145716593|NCT00611975|525477622|FG000|Overall Study|Withdrawal by Subject|3|||
145716594|NCT00611975|525477623|FG001|Overall Study|Withdrawal by Subject|7|||
145716595|NCT00611975|525477622|FG000|Overall Study|Pregnancy|2|||
145716596|NCT00611975|525477623|FG001|Overall Study|Pregnancy|1|||
145716597|NCT03465904|525477624|FG000|Overall Study|Withdrawal by Subject|9|||
145716598|NCT03465904|525477625|FG001|Overall Study|Withdrawal by Subject|5|||
145716599|NCT03465904|525477624|FG000|Overall Study|Lost to Follow-up|11|||
145716600|NCT03465904|525477625|FG001|Overall Study|Lost to Follow-up|9|||
145716601|NCT03465904|525477624|FG000|Overall Study|Protocol Violation|20|||
145716602|NCT03465904|525477625|FG001|Overall Study|Protocol Violation|15|||
145716603|NCT04625413|525477626|FG000|Overall Study|Hospice|2|||
145716604|NCT04625413|525477626|FG000|Overall Study|Distress|1|||
145716605|NCT04625413|525477626|FG000|Overall Study|Not feeling well|1|||
145716606|NCT01305200|525477627|FG000|Overall Study|Physician Decision|4|||
145716607|NCT01305200|525477628|FG001|Overall Study|Physician Decision|6|||
145716608|NCT01305200|525477629|FG002|Overall Study|Physician Decision|1|||
145716609|NCT01305200|525477627|FG000|Overall Study|Withdrawal by Subject|24|||
145716610|NCT01305200|525477628|FG001|Overall Study|Withdrawal by Subject|21|||
145716611|NCT01305200|525477629|FG002|Overall Study|Withdrawal by Subject|1|||
145716612|NCT01305200|525477627|FG000|Overall Study|Ineligible|1|||
145716613|NCT01305200|525477628|FG001|Overall Study|Ineligible|2|||
145716614|NCT01305200|525477629|FG002|Overall Study|Ineligible|1|||
145716615|NCT01305200|525477627|FG000|Overall Study|Death|0|||
145716616|NCT01305200|525477628|FG001|Overall Study|Death|2|||
145716617|NCT01305200|525477629|FG002|Overall Study|Death|0|||
145716618|NCT03981861|525477630|FG000|Overall Study|Withdrawal by Subject|3|||
145716619|NCT05618912|525477631|FG000|Overall Study|Lost to Follow-up|14|||
145716620|NCT05618912|525477632|FG001|Overall Study|Lost to Follow-up|19|||
145716621|NCT00925353|525477633|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
145716622|NCT02516332|525479761|FG000|Overall Study|Withdrawal by Subject|2|||
145716623|NCT02516332|525479762|FG001|Overall Study|Withdrawal by Subject|1|||
145716624|NCT02516332|525479763|FG002|Overall Study|Withdrawal by Subject|2|||
145716625|NCT03695237|525479764|FG000|Overall Study|Withdrawal by Subject|1|||
145716626|NCT03695237|525479765|FG001|Overall Study|Withdrawal by Subject|3|||
145716627|NCT03695237|525479764|FG000|Overall Study|Lost to Follow-up|1|||
145716628|NCT03695237|525479765|FG001|Overall Study|Lost to Follow-up|2|||
145716629|NCT03695237|525479764|FG000|Overall Study|Other, Not Specified|8|||
145716630|NCT03695237|525479765|FG001|Overall Study|Other, Not Specified|2|||
145716631|NCT03541174|525479768|FG000|Part 1 Double-Blind|Adverse Event|6|||
145716632|NCT03541174|525479769|FG001|Part 1 Double-Blind|Adverse Event|5|||
145716633|NCT03541174|525479770|FG002|Part 1 Double-Blind|Adverse Event|2|||
145716634|NCT03541174|525479771|FG003|Part 1 Double-Blind|Adverse Event|0|||
145716635|NCT03541174|525479772|FG004|Part 1 Double-Blind|Adverse Event|0|||
145716636|NCT03541174|525479773|FG005|Part 1 Double-Blind|Adverse Event|0|||
145716637|NCT03541174|525479768|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
145716638|NCT03541174|525479769|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
145716639|NCT03541174|525479770|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
145716640|NCT03541174|525479771|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
145716641|NCT03541174|525479772|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
145716642|NCT03541174|525479773|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
145716643|NCT03541174|525479768|FG000|Part 1 Double-Blind|Other reasons|3|||
145716644|NCT03541174|525479769|FG001|Part 1 Double-Blind|Other reasons|2|||
145716645|NCT03541174|525479770|FG002|Part 1 Double-Blind|Other reasons|3|||
145716646|NCT03541174|525479771|FG003|Part 1 Double-Blind|Other reasons|0|||
145716647|NCT03541174|525479772|FG004|Part 1 Double-Blind|Other reasons|0|||
145716648|NCT03541174|525479773|FG005|Part 1 Double-Blind|Other reasons|0|||
145716649|NCT03541174|525479768|FG000|Part 2 Single-Blind|Adverse Event|0|||
145716650|NCT03541174|525479769|FG001|Part 2 Single-Blind|Adverse Event|0|||
145716651|NCT03541174|525479770|FG002|Part 2 Single-Blind|Adverse Event|0|||
145716652|NCT03541174|525479771|FG003|Part 2 Single-Blind|Adverse Event|25|||
145716653|NCT03541174|525479772|FG004|Part 2 Single-Blind|Adverse Event|0|||
145716654|NCT03541174|525479773|FG005|Part 2 Single-Blind|Adverse Event|0|||
145716655|NCT03541174|525479768|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
145716656|NCT03541174|525479769|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
145716657|NCT03541174|525479770|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
145716658|NCT03541174|525479771|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
145716659|NCT03541174|525479772|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
145716660|NCT03541174|525479773|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
145716661|NCT03541174|525479768|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
145716662|NCT03541174|525479769|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
145716663|NCT03541174|525479770|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
145716664|NCT03541174|525479771|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
145716665|NCT03541174|525479772|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
145716666|NCT03541174|525479773|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
145716667|NCT03541174|525479768|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
145716668|NCT03541174|525479769|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
145716669|NCT03541174|525479770|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
145716670|NCT03541174|525479771|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
145716671|NCT03541174|525479772|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
145716672|NCT03541174|525479773|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
145716673|NCT03541174|525479768|FG000|Part 2 Single-Blind|Death|0|||
145716674|NCT03541174|525479769|FG001|Part 2 Single-Blind|Death|0|||
145716675|NCT03541174|525479770|FG002|Part 2 Single-Blind|Death|0|||
145716676|NCT03541174|525479771|FG003|Part 2 Single-Blind|Death|5|||
145716677|NCT03541174|525479772|FG004|Part 2 Single-Blind|Death|0|||
145716678|NCT03541174|525479773|FG005|Part 2 Single-Blind|Death|0|||
145716679|NCT03541174|525479768|FG000|Part 2 Single-Blind|Pregnancy|0|||
145716680|NCT03541174|525479769|FG001|Part 2 Single-Blind|Pregnancy|0|||
145716681|NCT03541174|525479770|FG002|Part 2 Single-Blind|Pregnancy|0|||
145716682|NCT03541174|525479771|FG003|Part 2 Single-Blind|Pregnancy|1|||
145716683|NCT03541174|525479772|FG004|Part 2 Single-Blind|Pregnancy|0|||
145716684|NCT03541174|525479773|FG005|Part 2 Single-Blind|Pregnancy|0|||
145716685|NCT03541174|525479768|FG000|Part 2 Single-Blind|Other reasons|0|||
145716686|NCT03541174|525479769|FG001|Part 2 Single-Blind|Other reasons|0|||
145716687|NCT03541174|525479770|FG002|Part 2 Single-Blind|Other reasons|0|||
145716688|NCT03541174|525479771|FG003|Part 2 Single-Blind|Other reasons|32|||
145716689|NCT03541174|525479772|FG004|Part 2 Single-Blind|Other reasons|0|||
145716690|NCT03541174|525479773|FG005|Part 2 Single-Blind|Other reasons|0|||
145716691|NCT03541174|525479768|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
145716692|NCT03541174|525479769|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
145716693|NCT03541174|525479770|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
145716694|NCT03541174|525479771|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
145716695|NCT03541174|525479772|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
145716696|NCT03541174|525479773|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
145716697|NCT03541174|525479768|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
145716698|NCT03541174|525479769|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
145716699|NCT03541174|525479770|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
145716700|NCT03541174|525479771|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
145716701|NCT03541174|525479772|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
145716702|NCT03541174|525479773|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
145716703|NCT03541174|525479768|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
145716704|NCT03541174|525479769|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
145716705|NCT03541174|525479770|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
145716706|NCT03541174|525479771|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
145716707|NCT03541174|525479772|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
145716708|NCT03541174|525479773|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
145716709|NCT03541174|525479768|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
145716710|NCT03541174|525479769|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
145716711|NCT03541174|525479770|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
145716712|NCT03541174|525479771|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
145716713|NCT03541174|525479772|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
145716714|NCT03541174|525479773|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
145716715|NCT03541174|525479768|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
145716716|NCT03541174|525479769|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
145716717|NCT03541174|525479770|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
145716718|NCT03541174|525479771|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
145716719|NCT03541174|525479772|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
145716720|NCT03541174|525479773|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
145716721|NCT00605215|525479774|FG000|Overall Study|Death|0|||
145716722|NCT00605215|525479775|FG001|Overall Study|Death|0|||
145716723|NCT00605215|525479776|FG002|Overall Study|Death|1|||
145716724|NCT00605215|525479774|FG000|Overall Study|Adverse Event|19|||
145716725|NCT00605215|525479775|FG001|Overall Study|Adverse Event|21|||
145716726|NCT00605215|525479776|FG002|Overall Study|Adverse Event|26|||
145716727|NCT00605215|525479774|FG000|Overall Study|Refusal to sign the re-consent form|8|||
145716728|NCT00605215|525479775|FG001|Overall Study|Refusal to sign the re-consent form|3|||
145716729|NCT00605215|525479776|FG002|Overall Study|Refusal to sign the re-consent form|3|||
145716730|NCT00605215|525479774|FG000|Overall Study|Withdrawal by Subject|39|||
145716731|NCT00605215|525479775|FG001|Overall Study|Withdrawal by Subject|37|||
145716732|NCT00605215|525479776|FG002|Overall Study|Withdrawal by Subject|27|||
145716733|NCT00605215|525479774|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
145716734|NCT00605215|525479775|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
145716735|NCT00605215|525479776|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
145716736|NCT00605215|525479774|FG000|Overall Study|Protocol Violation|3|||
145716737|NCT00605215|525479775|FG001|Overall Study|Protocol Violation|4|||
145716738|NCT00605215|525479776|FG002|Overall Study|Protocol Violation|1|||
145716739|NCT00605215|525479774|FG000|Overall Study|Pregnancy|8|||
145716740|NCT00605215|525479775|FG001|Overall Study|Pregnancy|5|||
145716741|NCT00605215|525479776|FG002|Overall Study|Pregnancy|4|||
145716742|NCT00605215|525479774|FG000|Overall Study|Lost to Follow-up|8|||
145716743|NCT00605215|525479775|FG001|Overall Study|Lost to Follow-up|5|||
145716744|NCT00605215|525479776|FG002|Overall Study|Lost to Follow-up|2|||
145716745|NCT00605215|525479774|FG000|Overall Study|Other than specified|0|||
145716746|NCT00605215|525479775|FG001|Overall Study|Other than specified|2|||
145716747|NCT00605215|525479776|FG002|Overall Study|Other than specified|1|||
145716748|NCT01342341|525479777|FG000|Overall Study|Lost to Follow-up|4|||
145716749|NCT01342341|525479778|FG001|Overall Study|Lost to Follow-up|4|||
145716750|NCT01789567|525479779|FG000|Overall Study|Death|6|||
145716751|NCT02914275|525479780|FG000|Overall Study|Lost to Follow-up|84|||
145716752|NCT02914275|525479781|FG001|Overall Study|Lost to Follow-up|29|||
145716753|NCT02914275|525479780|FG000|Overall Study|Withdrawal by Subject|26|||
145716754|NCT02914275|525479781|FG001|Overall Study|Withdrawal by Subject|10|||
145716755|NCT02914275|525479780|FG000|Overall Study|Protocol Violation|1|||
145716756|NCT02914275|525479781|FG001|Overall Study|Protocol Violation|1|||
145716757|NCT02914275|525479780|FG000|Overall Study|Physician Decision|3|||
145716758|NCT02914275|525479781|FG001|Overall Study|Physician Decision|1|||
145716759|NCT02914275|525479780|FG000|Overall Study|Other|4|||
145716760|NCT02914275|525479781|FG001|Overall Study|Other|1|||
145716761|NCT02914275|525479780|FG000|Overall Study|Excluded due to invalid informed consent|3|||
145716762|NCT02914275|525479781|FG001|Overall Study|Excluded due to invalid informed consent|0|||
145716763|NCT01302067|525479786|FG000|Overall Study|Death|0|||
145716764|NCT01302067|525479787|FG001|Overall Study|Death|0|||
145716765|NCT01302067|525479788|FG002|Overall Study|Death|1|||
145716766|NCT01302067|525479786|FG000|Overall Study|Physician Decision|9|||
145716767|NCT01302067|525479787|FG001|Overall Study|Physician Decision|5|||
145716768|NCT01302067|525479788|FG002|Overall Study|Physician Decision|14|||
145716769|NCT01302067|525479786|FG000|Overall Study|Lack of Efficacy|8|||
145716770|NCT01302067|525479787|FG001|Overall Study|Lack of Efficacy|4|||
145716771|NCT01302067|525479788|FG002|Overall Study|Lack of Efficacy|2|||
145377886|NCT03191864|524233637|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
145377887|NCT03191864|524233638|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
145716772|NCT01302067|525479786|FG000|Overall Study|Lost to Follow-up|9|||
145716773|NCT01302067|525479787|FG001|Overall Study|Lost to Follow-up|4|||
145716774|NCT01302067|525479788|FG002|Overall Study|Lost to Follow-up|15|||
145716775|NCT01302067|525479786|FG000|Overall Study|Withdrawal by Subject|13|||
145716776|NCT01302067|525479787|FG001|Overall Study|Withdrawal by Subject|6|||
145716777|NCT01302067|525479788|FG002|Overall Study|Withdrawal by Subject|10|||
145716778|NCT01302067|525479786|FG000|Overall Study|Other|1|||
145716779|NCT01302067|525479787|FG001|Overall Study|Other|1|||
145716780|NCT01302067|525479788|FG002|Overall Study|Other|3|||
145716781|NCT01302067|525479786|FG000|Overall Study|Protocol Violation|11|||
145716782|NCT01302067|525479787|FG001|Overall Study|Protocol Violation|0|||
145716783|NCT01302067|525479788|FG002|Overall Study|Protocol Violation|8|||
145716784|NCT01302067|525479786|FG000|Overall Study|Adverse Event|27|||
145716785|NCT01302067|525479787|FG001|Overall Study|Adverse Event|14|||
145716786|NCT01302067|525479788|FG002|Overall Study|Adverse Event|45|||
145716787|NCT02738203|525479790|FG000|Overall Study|Failed IUD Insertion|2|||
145716788|NCT02738203|525479791|FG001|Overall Study|Failed IUD Insertion|2|||
145716789|NCT02738203|525479790|FG000|Overall Study|Protocol Violation|0|||
145716790|NCT02738203|525479791|FG001|Overall Study|Protocol Violation|1|||
145716791|NCT00266227|525479792|FG000|Initial Treatment|Adverse Event|0|||
145716792|NCT00266227|525479793|FG001|Initial Treatment|Adverse Event|0|||
145716793|NCT00266227|525479794|FG002|Initial Treatment|Adverse Event|13|||
145716794|NCT00266227|525479792|FG000|Initial Treatment|Lost to Follow-up|0|||
145716795|NCT00266227|525479793|FG001|Initial Treatment|Lost to Follow-up|0|||
145716796|NCT00266227|525479794|FG002|Initial Treatment|Lost to Follow-up|6|||
145716797|NCT00266227|525479792|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
145716798|NCT00266227|525479793|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
145716799|NCT00266227|525479794|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
145716800|NCT00266227|525479792|FG000|Initial Treatment|Physician decision to withdraw|0|||
145716801|NCT00266227|525479793|FG001|Initial Treatment|Physician decision to withdraw|0|||
145716802|NCT00266227|525479794|FG002|Initial Treatment|Physician decision to withdraw|12|||
145716803|NCT00266227|525479792|FG000|Initial Treatment|Pregnancy|0|||
145716804|NCT00266227|525479793|FG001|Initial Treatment|Pregnancy|0|||
145716805|NCT00266227|525479794|FG002|Initial Treatment|Pregnancy|1|||
145716806|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Death|1|||
145716807|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Death|0|||
145716808|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Death|0|||
145716809|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
145716810|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
145716811|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
145716812|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
145716813|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
145716814|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
145716815|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
145716816|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
145716817|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
145716818|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
145716819|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
145716820|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
145716821|NCT00266227|525479792|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
145716822|NCT00266227|525479793|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
145716823|NCT00266227|525479794|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
145716824|NCT00266227|525479792|FG000|Retreatment: Week 48 to Week 72|Death|1|||
145716825|NCT00266227|525479793|FG001|Retreatment: Week 48 to Week 72|Death|1|||
145716826|NCT00266227|525479794|FG002|Retreatment: Week 48 to Week 72|Death|0|||
145716827|NCT00266227|525479792|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
145716828|NCT00266227|525479793|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
145716829|NCT00266227|525479794|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
145716830|NCT00266227|525479792|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
145716831|NCT00266227|525479793|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
145716832|NCT00266227|525479794|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
145716833|NCT00266227|525479792|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
145716834|NCT00266227|525479793|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
145716835|NCT00266227|525479794|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
145716836|NCT00266227|525479792|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
145716837|NCT00266227|525479793|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
145716838|NCT00266227|525479794|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
145716839|NCT03241927|525479795|FG000|Overall Study|study terminated|1|||
145716840|NCT03241927|525479796|FG001|Overall Study|study terminated|0|||
145716841|NCT01198756|525479797|FG000|Overall Study|Adverse Event|0|||
145716842|NCT01198756|525479798|FG001|Overall Study|Adverse Event|0|||
145716843|NCT01198756|525479799|FG002|Overall Study|Adverse Event|0|||
145716844|NCT01198756|525479800|FG003|Overall Study|Adverse Event|1|||
145716845|NCT01198756|525479797|FG000|Overall Study|Protocol Violation|0|||
145716846|NCT01198756|525479798|FG001|Overall Study|Protocol Violation|0|||
145716847|NCT01198756|525479799|FG002|Overall Study|Protocol Violation|0|||
145716848|NCT01198756|525479800|FG003|Overall Study|Protocol Violation|2|||
145716849|NCT01198756|525479797|FG000|Overall Study|Withdrawal by Subject|9|||
145716850|NCT01198756|525479798|FG001|Overall Study|Withdrawal by Subject|4|||
145716851|NCT01198756|525479799|FG002|Overall Study|Withdrawal by Subject|7|||
145716852|NCT01198756|525479800|FG003|Overall Study|Withdrawal by Subject|5|||
145716853|NCT01198756|525479797|FG000|Overall Study|Lost to Follow-up|29|||
145716854|NCT01198756|525479798|FG001|Overall Study|Lost to Follow-up|36|||
145716855|NCT01198756|525479799|FG002|Overall Study|Lost to Follow-up|23|||
145716856|NCT01198756|525479800|FG003|Overall Study|Lost to Follow-up|18|||
145716857|NCT02915302|525479803|FG000|Overall Study|Adverse Event|3|||
145716858|NCT02915302|525479804|FG001|Overall Study|Adverse Event|0|||
145716859|NCT02915302|525479803|FG000|Overall Study|Protocol Violation|20|||
145716860|NCT02915302|525479804|FG001|Overall Study|Protocol Violation|27|||
145716861|NCT02915302|525479803|FG000|Overall Study|Lost to Follow-up|19|||
145716862|NCT02915302|525479804|FG001|Overall Study|Lost to Follow-up|22|||
145716863|NCT02915302|525479803|FG000|Overall Study|Withdrawal by Subject|22|||
145716864|NCT02915302|525479804|FG001|Overall Study|Withdrawal by Subject|29|||
145716865|NCT02915302|525479803|FG000|Overall Study|Other|1|||
145716866|NCT02915302|525479804|FG001|Overall Study|Other|0|||
145716867|NCT04343872|525479808|FG000|Overall Study|Lost to Follow-up|6|||
145716868|NCT04343872|525479809|FG001|Overall Study|Lost to Follow-up|3|||
145716869|NCT01850446|525479810|FG000|Overall Study|Lack of Efficacy|1|||
145716870|NCT01850446|525479811|FG001|Overall Study|Lack of Efficacy|0|||
145716871|NCT01850446|525479810|FG000|Overall Study|Withdrawal by Subject|4|||
145716872|NCT01850446|525479811|FG001|Overall Study|Withdrawal by Subject|0|||
145716873|NCT01850446|525479810|FG000|Overall Study|Protocol Violation|0|||
145716874|NCT01850446|525479811|FG001|Overall Study|Protocol Violation|2|||
145716875|NCT01290315|525479812|FG000|Overall Study|Adverse Event|0|||
145716876|NCT01290315|525479813|FG001|Overall Study|Adverse Event|0|||
145716877|NCT01290315|525479814|FG002|Overall Study|Adverse Event|0|||
145716878|NCT01290315|525479815|FG003|Overall Study|Adverse Event|3|||
145716879|NCT01290315|525479812|FG000|Overall Study|Selection criteria/compliance|2|||
145716880|NCT01290315|525479813|FG001|Overall Study|Selection criteria/compliance|1|||
145716881|NCT01290315|525479814|FG002|Overall Study|Selection criteria/compliance|0|||
145716882|NCT01290315|525479815|FG003|Overall Study|Selection criteria/compliance|2|||
145716883|NCT01290315|525479812|FG000|Overall Study|Lost to Follow-up|0|||
145716884|NCT01290315|525479813|FG001|Overall Study|Lost to Follow-up|1|||
145716885|NCT01290315|525479814|FG002|Overall Study|Lost to Follow-up|0|||
145716886|NCT01290315|525479815|FG003|Overall Study|Lost to Follow-up|0|||
145716887|NCT01290315|525479812|FG000|Overall Study|Withdrawal by Subject|1|||
145716888|NCT01290315|525479813|FG001|Overall Study|Withdrawal by Subject|1|||
145716889|NCT01290315|525479814|FG002|Overall Study|Withdrawal by Subject|0|||
145716890|NCT01290315|525479815|FG003|Overall Study|Withdrawal by Subject|0|||
145716891|NCT00621777|525479817|FG000|Open Phase|Adverse Event|20|||
145716892|NCT00621777|525479818|FG001|Open Phase|Adverse Event|0|||
145716893|NCT00621777|525479817|FG000|Open Phase|Did not abstain during open phase|56|||
145716894|NCT00621777|525479818|FG001|Open Phase|Did not abstain during open phase|0|||
145716895|NCT00621777|525479817|FG000|Open Phase|Withdrawal by Subject|17|||
145716896|NCT00621777|525479818|FG001|Open Phase|Withdrawal by Subject|0|||
145716897|NCT00621777|525479817|FG000|Open Phase|administrative|13|||
145716898|NCT00621777|525479818|FG001|Open Phase|administrative|0|||
145716899|NCT00621777|525479817|FG000|Open Phase|Lost to Follow-up|10|||
145716900|NCT00621777|525479818|FG001|Open Phase|Lost to Follow-up|0|||
145716901|NCT00621777|525479817|FG000|Randomized Phase|Adverse Event|3|||
145716902|NCT00621777|525479818|FG001|Randomized Phase|Adverse Event|3|||
145716903|NCT00621777|525479817|FG000|Randomized Phase|Lost to Follow-up|3|||
145716904|NCT00621777|525479818|FG001|Randomized Phase|Lost to Follow-up|3|||
145716905|NCT00621777|525479817|FG000|Randomized Phase|Withdrawal by Subject|1|||
145716906|NCT00621777|525479818|FG001|Randomized Phase|Withdrawal by Subject|9|||
145716907|NCT00621777|525479817|FG000|Randomized Phase|administrative|0|||
145716908|NCT00621777|525479818|FG001|Randomized Phase|administrative|3|||
145716909|NCT00621777|525479817|FG000|Randomized Phase|Death|0|||
145716910|NCT00621777|525479818|FG001|Randomized Phase|Death|1|||
145716911|NCT00446043|525479819|FG000|Overall Study|Adverse Event|9|||
145716912|NCT00446043|525479819|FG000|Overall Study|Withdrawal by Subject|70|||
145716913|NCT00446043|525479819|FG000|Overall Study|Protocol Violation|2|||
145716914|NCT00446043|525479819|FG000|Overall Study|Lost to Follow-up|42|||
145716915|NCT00446043|525479819|FG000|Overall Study|Pregnancy|2|||
145716916|NCT01239043|525479820|FG000|Overall Study|Protocol Violation|2|||
145716917|NCT01239043|525479821|FG001|Overall Study|Protocol Violation|1|||
145716918|NCT02929329|525479824|FG000|Overall Study|Withdrawal by Subject|24|||
145716919|NCT02929329|525479825|FG001|Overall Study|Withdrawal by Subject|21|||
145716920|NCT02929329|525479824|FG000|Overall Study|Lost to Follow-up|26|||
145716921|NCT02929329|525479825|FG001|Overall Study|Lost to Follow-up|20|||
145716922|NCT02929329|525479824|FG000|Overall Study|Death|1054|||
145716923|NCT02929329|525479825|FG001|Overall Study|Death|1051|||
145716924|NCT02121301|525479826|FG000|Overall Study|Protocol Violation|1|||
145716925|NCT02121301|525479827|FG001|Overall Study|Protocol Violation|4|||
145716926|NCT02121301|525479828|FG002|Overall Study|Protocol Violation|1|||
145716927|NCT02663518|525479831|FG000|Part 1: Phase 1a Escalation|Death|0|||
145716928|NCT02663518|525479832|FG001|Part 1: Phase 1a Escalation|Death|0|||
145716929|NCT02663518|525479833|FG002|Part 1: Phase 1a Escalation|Death|1|||
145716930|NCT02663518|525479834|FG003|Part 1: Phase 1a Escalation|Death|0|||
145716931|NCT02663518|525479835|FG004|Part 1: Phase 1a Escalation|Death|0|||
145716932|NCT02663518|525479836|FG005|Part 1: Phase 1a Escalation|Death|0|||
145716933|NCT02663518|525479837|FG006|Part 1: Phase 1a Escalation|Death|0|||
145716934|NCT02663518|525479838|FG007|Part 1: Phase 1a Escalation|Death|0|||
145716935|NCT02663518|525479839|FG008|Part 1: Phase 1a Escalation|Death|0|||
145716936|NCT02663518|525479840|FG009|Part 1: Phase 1a Escalation|Death|0|||
145716937|NCT02663518|525479841|FG010|Part 1: Phase 1a Escalation|Death|0|||
145716938|NCT02663518|525479842|FG011|Part 1: Phase 1a Escalation|Death|0|||
145716939|NCT02663518|525479843|FG012|Part 1: Phase 1a Escalation|Death|0|||
145716940|NCT02663518|525479844|FG013|Part 1: Phase 1a Escalation|Death|0|||
145716941|NCT02663518|525479831|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716942|NCT02663518|525479832|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716943|NCT02663518|525479833|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
145716944|NCT02663518|525479834|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716945|NCT02663518|525479835|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716946|NCT02663518|525479836|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716947|NCT02663518|525479837|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716948|NCT02663518|525479838|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716949|NCT02663518|525479839|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716950|NCT02663518|525479840|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716951|NCT02663518|525479841|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716952|NCT02663518|525479842|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716953|NCT02663518|525479843|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716954|NCT02663518|525479844|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
145716955|NCT02663518|525479831|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
145716956|NCT02663518|525479832|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
145716957|NCT02663518|525479833|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
145716958|NCT02663518|525479834|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
145716959|NCT02663518|525479835|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716960|NCT02663518|525479836|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716961|NCT02663518|525479837|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716962|NCT02663518|525479838|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716963|NCT02663518|525479839|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716964|NCT02663518|525479840|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716965|NCT02663518|525479841|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716966|NCT02663518|525479842|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716967|NCT02663518|525479843|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716968|NCT02663518|525479844|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
145716969|NCT02663518|525479831|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
145716970|NCT02663518|525479832|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716971|NCT02663518|525479833|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
145716972|NCT02663518|525479834|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
145716973|NCT02663518|525479835|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716974|NCT02663518|525479836|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716975|NCT02663518|525479837|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716976|NCT02663518|525479838|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716977|NCT02663518|525479839|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716978|NCT02663518|525479840|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716979|NCT02663518|525479841|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716980|NCT02663518|525479842|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716981|NCT02663518|525479843|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716982|NCT02663518|525479844|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
145716983|NCT02663518|525479831|FG000|Part 1: Phase 1a Escalation|Other|0|||
145716984|NCT02663518|525479832|FG001|Part 1: Phase 1a Escalation|Other|0|||
145716985|NCT02663518|525479833|FG002|Part 1: Phase 1a Escalation|Other|2|||
145716986|NCT02663518|525479834|FG003|Part 1: Phase 1a Escalation|Other|0|||
145716987|NCT02663518|525479835|FG004|Part 1: Phase 1a Escalation|Other|0|||
145716988|NCT02663518|525479836|FG005|Part 1: Phase 1a Escalation|Other|0|||
145716989|NCT02663518|525479837|FG006|Part 1: Phase 1a Escalation|Other|0|||
145716990|NCT02663518|525479838|FG007|Part 1: Phase 1a Escalation|Other|0|||
145716991|NCT02663518|525479839|FG008|Part 1: Phase 1a Escalation|Other|0|||
145716992|NCT02663518|525479840|FG009|Part 1: Phase 1a Escalation|Other|0|||
145716993|NCT02663518|525479841|FG010|Part 1: Phase 1a Escalation|Other|0|||
145716994|NCT02663518|525479842|FG011|Part 1: Phase 1a Escalation|Other|0|||
145716995|NCT02663518|525479843|FG012|Part 1: Phase 1a Escalation|Other|0|||
145716996|NCT02663518|525479844|FG013|Part 1: Phase 1a Escalation|Other|0|||
145716997|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
145716998|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
145716999|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717000|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717001|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
145717002|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717003|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
145717004|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
145717005|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717006|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717007|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717008|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717009|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717010|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
145717011|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717012|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717013|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717014|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717015|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
145717016|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717017|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
145717018|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
145717019|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717020|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717021|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717022|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717023|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717024|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
145717025|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717026|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717027|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717028|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717029|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
145717030|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717031|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717032|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717033|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717034|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717035|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717036|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717037|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717038|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
145717039|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717040|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717041|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717042|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717043|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
145717044|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
145717045|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
145717046|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
145717047|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717048|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717049|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717050|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717051|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717052|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
145717053|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717054|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717055|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717056|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717057|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
145717058|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717059|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
145717060|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717061|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717062|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717063|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717064|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717065|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717066|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
145717067|NCT02663518|525479831|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717068|NCT02663518|525479832|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717069|NCT02663518|525479833|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717070|NCT02663518|525479834|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717071|NCT02663518|525479835|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717072|NCT02663518|525479836|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717073|NCT02663518|525479837|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
145717074|NCT02663518|525479838|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717075|NCT02663518|525479839|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717076|NCT02663518|525479840|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717077|NCT02663518|525479841|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717078|NCT02663518|525479842|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717079|NCT02663518|525479843|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717080|NCT02663518|525479844|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
145717081|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
145717082|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
145717083|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
145717084|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
145717085|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
145717086|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
145717087|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
145717088|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
145717089|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
145717090|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
145717091|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
145717092|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
145717093|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
145717094|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
145717095|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717096|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717097|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717098|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717099|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717100|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717101|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717102|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717103|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717104|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717105|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717106|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717107|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
145717108|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
145717109|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717110|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717111|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717112|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717113|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717114|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717115|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717116|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717117|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717118|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717119|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717120|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
145717121|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717122|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
145717123|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717124|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717125|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717126|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717127|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717128|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717129|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717130|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717131|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717132|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
145717133|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
145717134|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
145717135|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
145717136|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
145717137|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
145717138|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
145717139|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
145717140|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
145717141|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
145717142|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
145717143|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
145717144|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
145717145|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
145717146|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
145717147|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
145717148|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
145717149|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
145717150|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
145717151|NCT02663518|525479831|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717152|NCT02663518|525479832|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717153|NCT02663518|525479833|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717154|NCT02663518|525479834|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717155|NCT02663518|525479835|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717156|NCT02663518|525479836|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717157|NCT02663518|525479837|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717158|NCT02663518|525479838|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717159|NCT02663518|525479839|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717160|NCT02663518|525479840|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717161|NCT02663518|525479841|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717162|NCT02663518|525479842|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717163|NCT02663518|525479843|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
145717164|NCT02663518|525479844|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
145717165|NCT01144052|525479847|FG000|Overall Study|Withdrawal by Subject|1|||
145717166|NCT01144052|525479848|FG001|Overall Study|Withdrawal by Subject|1|||
145717167|NCT03836716|525479852|FG000|Overall Study|Adverse Event|3|||
145717168|NCT03836716|525479852|FG000|Overall Study|Death|22|||
145717169|NCT03836716|525479852|FG000|Overall Study|Withdrawal by Subject|8|||
145717170|NCT03836716|525479852|FG000|Overall Study|Study terminated by sponsor|87|||
145717171|NCT01879722|525479853|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
145717172|NCT01879722|525479854|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
145717173|NCT01879722|525479855|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
145717174|NCT01879722|525479856|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
145717175|NCT01879722|525479857|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
145717176|NCT01879722|525479858|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
145717177|NCT01879722|525479859|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
145717178|NCT01879722|525479860|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
145717179|NCT01879722|525479861|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
145717180|NCT01879722|525479862|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
145717181|NCT01879722|525479853|FG000|Overall Study|Voluntary Withdrawal|0|||
145717182|NCT01879722|525479854|FG001|Overall Study|Voluntary Withdrawal|0|||
145717183|NCT01879722|525479855|FG002|Overall Study|Voluntary Withdrawal|0|||
145717184|NCT01879722|525479856|FG003|Overall Study|Voluntary Withdrawal|0|||
145717185|NCT01879722|525479857|FG004|Overall Study|Voluntary Withdrawal|0|||
145717186|NCT01879722|525479858|FG005|Overall Study|Voluntary Withdrawal|0|||
145717187|NCT01879722|525479859|FG006|Overall Study|Voluntary Withdrawal|0|||
145717188|NCT01879722|525479860|FG007|Overall Study|Voluntary Withdrawal|0|||
145717189|NCT01879722|525479861|FG008|Overall Study|Voluntary Withdrawal|1|||
145717190|NCT01879722|525479862|FG009|Overall Study|Voluntary Withdrawal|0|||
145717191|NCT01983254|525479863|FG000|Overall Study|Death|6|||
145717192|NCT01983254|525479864|FG001|Overall Study|Death|6|||
145717193|NCT01983254|525479863|FG000|Overall Study|Lost to Follow-up|17|||
145717194|NCT01983254|525479864|FG001|Overall Study|Lost to Follow-up|16|||
145717195|NCT01983254|525479863|FG000|Overall Study|too ill|11|||
145717196|NCT01983254|525479864|FG001|Overall Study|too ill|8|||
145717197|NCT00434213|525479867|FG000|Overall Study|Adverse Event|12|||
145717198|NCT00434213|525479867|FG000|Overall Study|Lack of Efficacy|9|||
145717199|NCT00434213|525479867|FG000|Overall Study|Lost to Follow-up|14|||
145717200|NCT00434213|525479867|FG000|Overall Study|Withdrawal by Subject|7|||
145717201|NCT00434213|525479867|FG000|Overall Study|Protocol Violation|3|||
145717202|NCT00434213|525479867|FG000|Overall Study|Unable to comply with study visit window|2|||
145717203|NCT00434213|525479867|FG000|Overall Study|Application site reaction|1|||
145717204|NCT00434213|525479867|FG000|Overall Study|Non-compliant to study schedule|1|||
145717205|NCT00037830|525479868|FG000|Overall Study|Adverse Event|2|||
145717206|NCT00037830|525479869|FG001|Overall Study|Adverse Event|0|||
145717207|NCT00037830|525479870|FG002|Overall Study|Adverse Event|0|||
145717208|NCT00037830|525479868|FG000|Overall Study|Withdrawal by Subject|4|||
145717209|NCT00037830|525479869|FG001|Overall Study|Withdrawal by Subject|5|||
145717210|NCT00037830|525479870|FG002|Overall Study|Withdrawal by Subject|1|||
145717211|NCT00037830|525479868|FG000|Overall Study|Protocol Violation|2|||
145717212|NCT00037830|525479869|FG001|Overall Study|Protocol Violation|2|||
145717213|NCT00037830|525479870|FG002|Overall Study|Protocol Violation|0|||
145717214|NCT00037830|525479868|FG000|Overall Study|Unrelated Medical Problem|2|||
145717215|NCT00037830|525479869|FG001|Overall Study|Unrelated Medical Problem|0|||
145717216|NCT00037830|525479870|FG002|Overall Study|Unrelated Medical Problem|0|||
145717217|NCT01253304|525479871|FG000|Overall Study|Adverse Event|0|||
145717218|NCT01253304|525479872|FG001|Overall Study|Adverse Event|0|||
145717219|NCT01253304|525479873|FG002|Overall Study|Adverse Event|0|||
145717220|NCT01253304|525479874|FG003|Overall Study|Adverse Event|1|||
145717221|NCT01699503|525479875|FG000|Overall Study|Death|31|||
145717222|NCT01699503|525479876|FG001|Overall Study|Death|40|||
145717223|NCT01699503|525479875|FG000|Overall Study|Withdrawal by Subject|65|||
145717224|NCT01699503|525479876|FG001|Overall Study|Withdrawal by Subject|57|||
145717225|NCT01699503|525479875|FG000|Overall Study|Lost to Follow-up|121|||
145717226|NCT01699503|525479876|FG001|Overall Study|Lost to Follow-up|117|||
145717227|NCT01699503|525479875|FG000|Overall Study|Excluded due to quality|783|||
145717228|NCT01699503|525479876|FG001|Overall Study|Excluded due to quality|791|||
145717229|NCT00006011|525479880|FG000|Overall Study|Disease progression|13|||
145717230|NCT00006011|525479881|FG001|Overall Study|Disease progression|6|||
145717231|NCT00006011|525479882|FG002|Overall Study|Disease progression|26|||
145717232|NCT00006011|525479880|FG000|Overall Study|Refused further treatment|15|||
145717233|NCT00006011|525479881|FG001|Overall Study|Refused further treatment|13|||
145717234|NCT00006011|525479882|FG002|Overall Study|Refused further treatment|26|||
145717235|NCT00006011|525479880|FG000|Overall Study|Adverse Event|15|||
145717236|NCT00006011|525479881|FG001|Overall Study|Adverse Event|39|||
145717237|NCT00006011|525479882|FG002|Overall Study|Adverse Event|5|||
145717238|NCT00006011|525479880|FG000|Overall Study|Death|0|||
145717239|NCT00006011|525479881|FG001|Overall Study|Death|1|||
145717240|NCT00006011|525479882|FG002|Overall Study|Death|2|||
145717241|NCT00006011|525479880|FG000|Overall Study|Other|4|||
145717242|NCT00006011|525479881|FG001|Overall Study|Other|2|||
145717243|NCT00006011|525479882|FG002|Overall Study|Other|5|||
145717244|NCT00006011|525479880|FG000|Overall Study|Ineligible|18|||
145717245|NCT00006011|525479881|FG001|Overall Study|Ineligible|16|||
145717246|NCT00006011|525479882|FG002|Overall Study|Ineligible|9|||
145717247|NCT01639560|525479883|FG000|Overall Study|Withdrawal by Subject|9|||
145717248|NCT01639560|525479884|FG001|Overall Study|Withdrawal by Subject|14|||
145717249|NCT01639560|525479883|FG000|Overall Study|Lack of Efficacy|1|||
145717250|NCT01639560|525479884|FG001|Overall Study|Lack of Efficacy|2|||
145717251|NCT01639560|525479883|FG000|Overall Study|Lost to Follow-up|9|||
145717252|NCT01639560|525479884|FG001|Overall Study|Lost to Follow-up|11|||
145717253|NCT01639560|525479883|FG000|Overall Study|Adverse Event|0|||
145717254|NCT01639560|525479884|FG001|Overall Study|Adverse Event|2|||
145717255|NCT00911937|525479892|FG000|Overall Study|Death|1|||
145717256|NCT00911937|525479893|FG001|Overall Study|Death|0|||
145717257|NCT00911937|525479892|FG000|Overall Study|Lost to Follow-up|8|||
145717258|NCT00911937|525479893|FG001|Overall Study|Lost to Follow-up|5|||
145717259|NCT00911937|525479892|FG000|Overall Study|Withdrawal by Subject|10|||
145717260|NCT00911937|525479893|FG001|Overall Study|Withdrawal by Subject|7|||
145717261|NCT00911937|525479892|FG000|Overall Study|Withdrawn due to pregnancy|1|||
145717262|NCT00911937|525479893|FG001|Overall Study|Withdrawn due to pregnancy|0|||
145717263|NCT00911937|525479892|FG000|Overall Study|Adverse Event|11|||
145717264|NCT00911937|525479893|FG001|Overall Study|Adverse Event|25|||
145717265|NCT00911937|525479892|FG000|Overall Study|Lack of Efficacy|11|||
145717266|NCT00911937|525479893|FG001|Overall Study|Lack of Efficacy|6|||
145717267|NCT00911937|525479892|FG000|Overall Study|Did not meet inclusion criteria|9|||
145717268|NCT00911937|525479893|FG001|Overall Study|Did not meet inclusion criteria|11|||
145717269|NCT00911937|525479892|FG000|Overall Study|Protocol Violation|14|||
145717270|NCT00911937|525479893|FG001|Overall Study|Protocol Violation|23|||
145717271|NCT00911937|525479892|FG000|Overall Study|Randomized but not treated|13|||
145717272|NCT00911937|525479893|FG001|Overall Study|Randomized but not treated|13|||
145717273|NCT00911937|525479892|FG000|Overall Study|Other|9|||
145717274|NCT00911937|525479893|FG001|Overall Study|Other|5|||
145717275|NCT03500159|525479899|FG000|Overall Study|Study Terminated|2|||
145717276|NCT03500159|525479900|FG001|Overall Study|Study Terminated|1|||
145717277|NCT03484273|525479905|FG000|Overall Study|Equipment Malfunction|1|||
145717278|NCT03484273|525479905|FG000|Overall Study|Data excluded from analysis|1|||
145717279|NCT02217475|525479916|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
145717280|NCT02217475|525479917|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
145717281|NCT02217475|525479918|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
145717282|NCT02217475|525479916|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
145717283|NCT02217475|525479917|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
145717284|NCT02217475|525479918|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
145717285|NCT02217475|525479916|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
145717286|NCT02217475|525479917|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
145717287|NCT02217475|525479918|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
145717288|NCT02217475|525479916|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
145717289|NCT02217475|525479917|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
145717290|NCT02217475|525479918|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
145717291|NCT02217475|525479916|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
145717292|NCT02217475|525479917|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
145717293|NCT02217475|525479918|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
145717294|NCT02217475|525479916|FG000|Discontinued After Period 1|Adverse Event|1|||
145717295|NCT02217475|525479917|FG001|Discontinued After Period 1|Adverse Event|2|||
145717296|NCT02217475|525479918|FG002|Discontinued After Period 1|Adverse Event|0|||
145717297|NCT02217475|525479916|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
145717298|NCT02217475|525479917|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
145717299|NCT02217475|525479918|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
145717300|NCT02217475|525479916|FG000|Discontinued After Period 1|Physician Decision|0|||
145717301|NCT02217475|525479917|FG001|Discontinued After Period 1|Physician Decision|0|||
145717302|NCT02217475|525479918|FG002|Discontinued After Period 1|Physician Decision|1|||
145717303|NCT02217475|525479916|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
145717304|NCT02217475|525479917|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
145717305|NCT02217475|525479918|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
145717306|NCT02217475|525479916|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
145717307|NCT02217475|525479917|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
145717308|NCT02217475|525479918|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
145717309|NCT02217475|525479916|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
145717310|NCT02217475|525479917|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
145717311|NCT02217475|525479918|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
145717312|NCT02217475|525479916|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
145717313|NCT02217475|525479917|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
145717314|NCT02217475|525479918|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
145717315|NCT02217475|525479916|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
145717316|NCT02217475|525479917|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
145717317|NCT02217475|525479918|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
145717318|NCT04738292|525479923|FG000|Overall Study|Death|1|||
145717319|NCT04602221|525479924|FG000|Overall Study|Discontinuation of trial treatment|0|||
145717320|NCT04602221|525479925|FG001|Overall Study|Discontinuation of trial treatment|0|||
145717321|NCT04602221|525479926|FG002|Overall Study|Discontinuation of trial treatment|1|||
145717322|NCT04602221|525479927|FG003|Overall Study|Discontinuation of trial treatment|0|||
145717323|NCT04602221|525479928|FG004|Overall Study|Discontinuation of trial treatment|0|||
145717324|NCT04602221|525479929|FG005|Overall Study|Discontinuation of trial treatment|0|||
145717325|NCT04602221|525479930|FG006|Overall Study|Discontinuation of trial treatment|0|||
145717326|NCT04602221|525479931|FG007|Overall Study|Discontinuation of trial treatment|0|||
145717327|NCT04602221|525479932|FG008|Overall Study|Discontinuation of trial treatment|0|||
145717328|NCT04602221|525479933|FG009|Overall Study|Discontinuation of trial treatment|0|||
145717329|NCT04602221|525479934|FG010|Overall Study|Discontinuation of trial treatment|0|||
145717330|NCT04602221|525479935|FG011|Overall Study|Discontinuation of trial treatment|0|||
145717331|NCT04602221|525479936|FG012|Overall Study|Discontinuation of trial treatment|0|||
145717332|NCT04602221|525479937|FG013|Overall Study|Discontinuation of trial treatment|0|||
145717333|NCT04602221|525479938|FG014|Overall Study|Discontinuation of trial treatment|0|||
145717334|NCT04602221|525479939|FG015|Overall Study|Discontinuation of trial treatment|0|||
145717335|NCT04602221|525479940|FG016|Overall Study|Discontinuation of trial treatment|0|||
145717336|NCT04602221|525479941|FG017|Overall Study|Discontinuation of trial treatment|0|||
145717337|NCT04602221|525479924|FG000|Overall Study|Other than listed|0|||
145717338|NCT04602221|525479925|FG001|Overall Study|Other than listed|0|||
145717339|NCT04602221|525479926|FG002|Overall Study|Other than listed|0|||
145717340|NCT04602221|525479927|FG003|Overall Study|Other than listed|0|||
145717341|NCT04602221|525479928|FG004|Overall Study|Other than listed|0|||
145717342|NCT04602221|525479929|FG005|Overall Study|Other than listed|0|||
145717343|NCT04602221|525479930|FG006|Overall Study|Other than listed|0|||
145717344|NCT04602221|525479931|FG007|Overall Study|Other than listed|0|||
145717345|NCT04602221|525479932|FG008|Overall Study|Other than listed|0|||
145717346|NCT04602221|525479933|FG009|Overall Study|Other than listed|0|||
145717347|NCT04602221|525479934|FG010|Overall Study|Other than listed|0|||
145717348|NCT04602221|525479935|FG011|Overall Study|Other than listed|0|||
145717349|NCT04602221|525479936|FG012|Overall Study|Other than listed|0|||
145717350|NCT04602221|525479937|FG013|Overall Study|Other than listed|0|||
145717351|NCT04602221|525479938|FG014|Overall Study|Other than listed|0|||
145717352|NCT04602221|525479939|FG015|Overall Study|Other than listed|1|||
145717353|NCT04602221|525479940|FG016|Overall Study|Other than listed|0|||
145717354|NCT04602221|525479941|FG017|Overall Study|Other than listed|1|||
145717355|NCT04602221|525479924|FG000|Overall Study|Withdrawal by Subject|0|||
145717356|NCT04602221|525479925|FG001|Overall Study|Withdrawal by Subject|0|||
145717357|NCT04602221|525479926|FG002|Overall Study|Withdrawal by Subject|0|||
145717358|NCT04602221|525479927|FG003|Overall Study|Withdrawal by Subject|0|||
145717359|NCT04602221|525479928|FG004|Overall Study|Withdrawal by Subject|0|||
145717360|NCT04602221|525479929|FG005|Overall Study|Withdrawal by Subject|0|||
145717361|NCT04602221|525479930|FG006|Overall Study|Withdrawal by Subject|0|||
145717362|NCT04602221|525479931|FG007|Overall Study|Withdrawal by Subject|0|||
145717363|NCT04602221|525479932|FG008|Overall Study|Withdrawal by Subject|0|||
145717364|NCT04602221|525479933|FG009|Overall Study|Withdrawal by Subject|0|||
145717365|NCT04602221|525479934|FG010|Overall Study|Withdrawal by Subject|0|||
145717366|NCT04602221|525479935|FG011|Overall Study|Withdrawal by Subject|0|||
145717367|NCT04602221|525479936|FG012|Overall Study|Withdrawal by Subject|1|||
145717368|NCT04602221|525479937|FG013|Overall Study|Withdrawal by Subject|0|||
145717369|NCT04602221|525479938|FG014|Overall Study|Withdrawal by Subject|0|||
145717370|NCT04602221|525479939|FG015|Overall Study|Withdrawal by Subject|0|||
145717371|NCT04602221|525479940|FG016|Overall Study|Withdrawal by Subject|0|||
145717372|NCT04602221|525479941|FG017|Overall Study|Withdrawal by Subject|0|||
145717373|NCT04602221|525479924|FG000|Overall Study|Lost to Follow-up|0|||
145717374|NCT04602221|525479925|FG001|Overall Study|Lost to Follow-up|0|||
145717375|NCT04602221|525479926|FG002|Overall Study|Lost to Follow-up|0|||
145717376|NCT04602221|525479927|FG003|Overall Study|Lost to Follow-up|0|||
145717377|NCT04602221|525479928|FG004|Overall Study|Lost to Follow-up|0|||
145717378|NCT04602221|525479929|FG005|Overall Study|Lost to Follow-up|1|||
145717379|NCT04602221|525479930|FG006|Overall Study|Lost to Follow-up|0|||
145717380|NCT04602221|525479931|FG007|Overall Study|Lost to Follow-up|0|||
145717381|NCT04602221|525479932|FG008|Overall Study|Lost to Follow-up|0|||
145717382|NCT04602221|525479933|FG009|Overall Study|Lost to Follow-up|0|||
145717383|NCT04602221|525479934|FG010|Overall Study|Lost to Follow-up|0|||
145717384|NCT04602221|525479935|FG011|Overall Study|Lost to Follow-up|0|||
145717385|NCT04602221|525479936|FG012|Overall Study|Lost to Follow-up|0|||
145717386|NCT04602221|525479937|FG013|Overall Study|Lost to Follow-up|0|||
145717387|NCT04602221|525479938|FG014|Overall Study|Lost to Follow-up|0|||
145717388|NCT04602221|525479939|FG015|Overall Study|Lost to Follow-up|0|||
145717389|NCT04602221|525479940|FG016|Overall Study|Lost to Follow-up|0|||
145717390|NCT04602221|525479941|FG017|Overall Study|Lost to Follow-up|0|||
145717391|NCT03001076|525479942|FG000|Overall Study|Withdrawal by patient|2|||
145717392|NCT03001076|525479943|FG001|Overall Study|Withdrawal by patient|0|||
145717393|NCT03001076|525479942|FG000|Overall Study|Other|1|||
145717394|NCT03001076|525479943|FG001|Overall Study|Other|0|||
145717395|NCT03001076|525479942|FG000|Overall Study|Adverse Event|3|||
145717396|NCT03001076|525479943|FG001|Overall Study|Adverse Event|3|||
145717397|NCT03001076|525479942|FG000|Overall Study|Sponsor decision|1|||
145717398|NCT03001076|525479943|FG001|Overall Study|Sponsor decision|0|||
145717399|NCT03001076|525479942|FG000|Overall Study|Lost to Follow-up|0|||
145717400|NCT03001076|525479943|FG001|Overall Study|Lost to Follow-up|2|||
145717401|NCT01056718|525479944|FG000|Overall Study|Withdrawal by Subject|2|||
145717402|NCT01056718|525479944|FG000|Overall Study|Ischemia on baseline stress test|1|||
145717403|NCT02270515|525479945|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
145717404|NCT02270515|525479945|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
145717405|NCT02270515|525479945|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
145717406|NCT02270515|525479945|FG000|Intervention Period 1: 0-6 Months|Death|7|||
145717407|NCT02270515|525479945|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
145717408|NCT02270515|525479945|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
145717409|NCT02270515|525479945|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
145717410|NCT02270515|525479945|FG000|Intervention Period 2: 6-12 Months|Death|5|||
145717411|NCT02270515|525479945|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
145717412|NCT02270515|525479945|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
145717413|NCT02270515|525479945|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
145717414|NCT02270515|525479945|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
145717415|NCT02270515|525479945|FG000|Intervention Period 3: 12-18 Months|Death|3|||
145717416|NCT02270515|525479945|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
145717417|NCT01139580|525479946|FG000|Overall Study|Adverse Event|5|||
145717418|NCT01139580|525479947|FG001|Overall Study|Adverse Event|4|||
145717419|NCT01139580|525479946|FG000|Overall Study|Lost to Follow-up|9|||
145717420|NCT01139580|525479947|FG001|Overall Study|Lost to Follow-up|1|||
145717421|NCT01139580|525479946|FG000|Overall Study|Lack of Efficacy|0|||
145717422|NCT01139580|525479947|FG001|Overall Study|Lack of Efficacy|2|||
145717423|NCT01139580|525479946|FG000|Overall Study|Withdrawal by Subject|6|||
145717424|NCT01139580|525479947|FG001|Overall Study|Withdrawal by Subject|9|||
145717425|NCT01139580|525479946|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
145717426|NCT01139580|525479947|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
145717427|NCT01139580|525479946|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
145717428|NCT01139580|525479947|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
145717429|NCT01139580|525479946|FG000|Overall Study|Misrandomized|1|||
145717430|NCT01139580|525479947|FG001|Overall Study|Misrandomized|0|||
145717431|NCT01139580|525479946|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
145717432|NCT01139580|525479947|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
145717433|NCT01139580|525479946|FG000|Overall Study|Participant Randomization in Error|0|||
145717434|NCT01139580|525479947|FG001|Overall Study|Participant Randomization in Error|1|||
145717435|NCT00633880|525479948|FG000|Open Label Titration|Lack of Efficacy|1|||
145717436|NCT00633880|525479949|FG001|Open Label Titration|Lack of Efficacy|0|||
145717437|NCT00633880|525479950|FG002|Open Label Titration|Lack of Efficacy|0|||
145717438|NCT00633880|525479948|FG000|Open Label Titration|Adverse Event|13|||
145717439|NCT00633880|525479949|FG001|Open Label Titration|Adverse Event|0|||
145717440|NCT00633880|525479950|FG002|Open Label Titration|Adverse Event|0|||
145717441|NCT00633880|525479948|FG000|Open Label Titration|Treatment Failure|55|||
145717442|NCT00633880|525479949|FG001|Open Label Titration|Treatment Failure|0|||
145717443|NCT00633880|525479950|FG002|Open Label Titration|Treatment Failure|0|||
145717444|NCT00633880|525479948|FG000|Open Label Titration|Protocol Violation|6|||
145717445|NCT00633880|525479949|FG001|Open Label Titration|Protocol Violation|0|||
145717446|NCT00633880|525479950|FG002|Open Label Titration|Protocol Violation|0|||
145717447|NCT00633880|525479948|FG000|Open Label Titration|Physician Decision|1|||
145717448|NCT00633880|525479949|FG001|Open Label Titration|Physician Decision|0|||
145717449|NCT00633880|525479950|FG002|Open Label Titration|Physician Decision|0|||
145717450|NCT00633880|525479948|FG000|Open Label Titration|Withdrawal by Subject|4|||
145717451|NCT00633880|525479949|FG001|Open Label Titration|Withdrawal by Subject|0|||
145717452|NCT00633880|525479950|FG002|Open Label Titration|Withdrawal by Subject|0|||
145717453|NCT00350103|525479951|FG000|Overall Study|Adverse Event|12|||
145717454|NCT00350103|525479952|FG001|Overall Study|Adverse Event|29|||
145717455|NCT00350103|525479953|FG002|Overall Study|Adverse Event|17|||
145717456|NCT00350103|525479951|FG000|Overall Study|Lack of Efficacy|5|||
145717457|NCT00350103|525479952|FG001|Overall Study|Lack of Efficacy|1|||
145717458|NCT00350103|525479953|FG002|Overall Study|Lack of Efficacy|3|||
145717459|NCT00350103|525479951|FG000|Overall Study|Withdrawal by Subject|6|||
145717460|NCT00350103|525479952|FG001|Overall Study|Withdrawal by Subject|6|||
145717461|NCT00350103|525479953|FG002|Overall Study|Withdrawal by Subject|8|||
145717462|NCT00350103|525479951|FG000|Overall Study|Protocol Violation|0|||
145717463|NCT00350103|525479952|FG001|Overall Study|Protocol Violation|0|||
145717464|NCT00350103|525479953|FG002|Overall Study|Protocol Violation|1|||
145717465|NCT00350103|525479951|FG000|Overall Study|Unsatisfactory Compliance|2|||
145717466|NCT00350103|525479952|FG001|Overall Study|Unsatisfactory Compliance|2|||
145717467|NCT00350103|525479953|FG002|Overall Study|Unsatisfactory Compliance|1|||
145717468|NCT00350103|525479951|FG000|Overall Study|Investigator´s decision|1|||
145717469|NCT00350103|525479952|FG001|Overall Study|Investigator´s decision|1|||
145717470|NCT00350103|525479953|FG002|Overall Study|Investigator´s decision|0|||
145717471|NCT00350103|525479951|FG000|Overall Study|Exclusion criteria met|0|||
145717472|NCT00350103|525479952|FG001|Overall Study|Exclusion criteria met|0|||
145717473|NCT00350103|525479953|FG002|Overall Study|Exclusion criteria met|1|||
145717474|NCT00350103|525479951|FG000|Overall Study|Patient relocated|0|||
145717475|NCT00350103|525479952|FG001|Overall Study|Patient relocated|0|||
145717476|NCT00350103|525479953|FG002|Overall Study|Patient relocated|1|||
145717477|NCT00350103|525479951|FG000|Overall Study|Need for prohibited medication|1|||
145717478|NCT00350103|525479952|FG001|Overall Study|Need for prohibited medication|0|||
145717479|NCT00350103|525479953|FG002|Overall Study|Need for prohibited medication|0|||
145717480|NCT00350103|525479951|FG000|Overall Study|Personal reasons|0|||
145717481|NCT00350103|525479952|FG001|Overall Study|Personal reasons|0|||
145717482|NCT00350103|525479953|FG002|Overall Study|Personal reasons|1|||
145717483|NCT00350103|525479951|FG000|Overall Study|Patient stopped feeling pain|1|||
145717484|NCT00350103|525479952|FG001|Overall Study|Patient stopped feeling pain|0|||
145717485|NCT00350103|525479953|FG002|Overall Study|Patient stopped feeling pain|0|||
145717486|NCT00350103|525479951|FG000|Overall Study|PR greater than 250ms|0|||
145717487|NCT00350103|525479952|FG001|Overall Study|PR greater than 250ms|0|||
145717488|NCT00350103|525479953|FG002|Overall Study|PR greater than 250ms|1|||
145717489|NCT00350103|525479951|FG000|Overall Study|Wrong calculation of QT interval|0|||
145717490|NCT00350103|525479952|FG001|Overall Study|Wrong calculation of QT interval|0|||
145717491|NCT00350103|525479953|FG002|Overall Study|Wrong calculation of QT interval|1|||
145717492|NCT00350103|525479951|FG000|Overall Study|Sponsor mistake|1|||
145717493|NCT00350103|525479952|FG001|Overall Study|Sponsor mistake|0|||
145717494|NCT00350103|525479953|FG002|Overall Study|Sponsor mistake|0|||
145717495|NCT00350103|525479951|FG000|Overall Study|Randomization mistake|0|||
145717496|NCT00350103|525479952|FG001|Overall Study|Randomization mistake|1|||
145717497|NCT00350103|525479953|FG002|Overall Study|Randomization mistake|1|||
145717498|NCT00350103|525479951|FG000|Overall Study|Sponsor´s decision|0|||
145717499|NCT00350103|525479952|FG001|Overall Study|Sponsor´s decision|1|||
145717500|NCT00350103|525479953|FG002|Overall Study|Sponsor´s decision|0|||
145717501|NCT00350103|525479951|FG000|Overall Study|Lost, Reason unknown|1|||
145717502|NCT00350103|525479952|FG001|Overall Study|Lost, Reason unknown|1|||
145717503|NCT00350103|525479953|FG002|Overall Study|Lost, Reason unknown|0|||
145717504|NCT02842151|525479954|FG000|Overall Study|Adverse Event|1|||
145717505|NCT02842151|525479954|FG000|Overall Study|Subject moved too far away|1|||
145717506|NCT02559895|525479955|FG000|Overall Study|Adverse Event|3|||
145717507|NCT02559895|525479956|FG001|Overall Study|Adverse Event|3|||
145717508|NCT02559895|525479957|FG002|Overall Study|Adverse Event|2|||
145717509|NCT02559895|525479958|FG003|Overall Study|Adverse Event|1|||
145717510|NCT02559895|525479955|FG000|Overall Study|Lack of Efficacy|2|||
145717511|NCT02559895|525479956|FG001|Overall Study|Lack of Efficacy|3|||
145717512|NCT02559895|525479957|FG002|Overall Study|Lack of Efficacy|2|||
145717513|NCT02559895|525479958|FG003|Overall Study|Lack of Efficacy|8|||
145717514|NCT02559895|525479955|FG000|Overall Study|Lost to Follow-up|22|||
145717515|NCT02559895|525479956|FG001|Overall Study|Lost to Follow-up|16|||
145717516|NCT02559895|525479957|FG002|Overall Study|Lost to Follow-up|12|||
145717517|NCT02559895|525479958|FG003|Overall Study|Lost to Follow-up|17|||
145717518|NCT02559895|525479955|FG000|Overall Study|Physician Decision|1|||
145717519|NCT02559895|525479956|FG001|Overall Study|Physician Decision|1|||
145717520|NCT02559895|525479957|FG002|Overall Study|Physician Decision|3|||
145717521|NCT02559895|525479958|FG003|Overall Study|Physician Decision|0|||
145717522|NCT02559895|525479955|FG000|Overall Study|Withdrawal by Subject|16|||
145717523|NCT02559895|525479956|FG001|Overall Study|Withdrawal by Subject|9|||
145717524|NCT02559895|525479957|FG002|Overall Study|Withdrawal by Subject|20|||
145717525|NCT02559895|525479958|FG003|Overall Study|Withdrawal by Subject|9|||
145717526|NCT02559895|525479955|FG000|Overall Study|Study Burden|10|||
145717527|NCT02559895|525479956|FG001|Overall Study|Study Burden|16|||
145717528|NCT02559895|525479957|FG002|Overall Study|Study Burden|12|||
145717529|NCT02559895|525479958|FG003|Overall Study|Study Burden|22|||
145717530|NCT02559895|525479955|FG000|Overall Study|Other|1|||
145717531|NCT02559895|525479956|FG001|Overall Study|Other|5|||
145717532|NCT02559895|525479957|FG002|Overall Study|Other|3|||
145717533|NCT02559895|525479958|FG003|Overall Study|Other|3|||
145717534|NCT00760474|525479959|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
145717535|NCT00760474|525479960|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
145717536|NCT00760474|525479959|FG000|Placebo Washout Period|Other|0|||
145717537|NCT00760474|525479960|FG001|Placebo Washout Period|Other|1|||
145717538|NCT00760474|525479959|FG000|Period 2 (P2)|Lost to Follow-up|1|||
145717539|NCT00760474|525479960|FG001|Period 2 (P2)|Lost to Follow-up|0|||
145717540|NCT00760474|525479959|FG000|Period 2 (P2)|Adverse Event|0|||
145717541|NCT00760474|525479960|FG001|Period 2 (P2)|Adverse Event|1|||
145717542|NCT01934790|525479961|FG000|Treatment|Adverse Event|3|||
145717543|NCT01934790|525479961|FG000|Treatment|Clinical progression|6|||
145717544|NCT01934790|525479961|FG000|Treatment|Radiological progression|4|||
145717545|NCT01934790|525479961|FG000|Treatment|Withdrawal by Subject|2|||
145717546|NCT01934790|525479961|FG000|Treatment|Study drug never administered|1|||
145717547|NCT01934790|525479961|FG000|Active Follow up|Death|20|||
145717548|NCT01934790|525479961|FG000|Active Follow up|Physician Decision|2|||
145717549|NCT01934790|525479961|FG000|Active Follow up|Progressive disease|1|||
145717550|NCT01934790|525479961|FG000|Active Follow up|Other reason|1|||
145717551|NCT00055601|525481337|FG000|Overall Study|Protocol Violation|1|||
145717552|NCT00055601|525481338|FG001|Overall Study|Protocol Violation|1|||
145717553|NCT00055601|525481337|FG000|Overall Study|No protocol treatment received|1|||
145717554|NCT00055601|525481338|FG001|Overall Study|No protocol treatment received|1|||
145717555|NCT00275262|525481345|FG000|Overall Study|Adverse Event|2|||
145717556|NCT00275262|525481346|FG001|Overall Study|Adverse Event|0|||
145717557|NCT00275262|525481345|FG000|Overall Study|Disease progression|2|||
145717558|NCT00275262|525481346|FG001|Overall Study|Disease progression|5|||
145717559|NCT00275262|525481345|FG000|Overall Study|Lost to Follow-up|0|||
145717560|NCT00275262|525481346|FG001|Overall Study|Lost to Follow-up|2|||
145717561|NCT00275262|525481345|FG000|Overall Study|Protocol Violation|0|||
145717562|NCT00275262|525481346|FG001|Overall Study|Protocol Violation|2|||
145717563|NCT00275262|525481345|FG000|Overall Study|Death|1|||
145717564|NCT00275262|525481346|FG001|Overall Study|Death|0|||
145717565|NCT00275262|525481345|FG000|Overall Study|Started Chemotherapy|1|||
145717566|NCT00275262|525481346|FG001|Overall Study|Started Chemotherapy|0|||
145717567|NCT02217332|525481349|FG000|Overall Study|Adverse Event|3|||
145717568|NCT02217332|525481349|FG000|Overall Study|Dose interruption >1 month|1|||
145717569|NCT02217332|525481349|FG000|Overall Study|Protocol Violation (eligibility)|1|||
145717570|NCT02217332|525481349|FG000|Overall Study|Withdrawal by Subject|1|||
145717571|NCT02217332|525481349|FG000|Overall Study|Lost to Follow-up|1|||
145717572|NCT03573583|525481350|FG000|Overall Study|Lost to Follow-up|1|||
145717573|NCT03573583|525481351|FG001|Overall Study|Lost to Follow-up|0|||
145717574|NCT03573583|525481350|FG000|Overall Study|Withdrawal by Subject|1|||
145717575|NCT03573583|525481351|FG001|Overall Study|Withdrawal by Subject|1|||
145717576|NCT01658150|525481356|FG000|Overall Study|Withdrawal by Subject|1|||
145717577|NCT03602066|525481357|FG000|Overall Study|Withdrawal by Subject|2|||
145717578|NCT03602066|525481358|FG001|Overall Study|Withdrawal by Subject|0|||
145717579|NCT03602066|525481357|FG000|Overall Study|Physician Decision|1|||
145717580|NCT03602066|525481358|FG001|Overall Study|Physician Decision|0|||
145717581|NCT04772898|525481361|FG000|Overall Study|Withdrawal by Subject|0|||
145717582|NCT04772898|525481362|FG001|Overall Study|Withdrawal by Subject|1|||
145717583|NCT01004848|525481364|FG000|Overall Study|Lost to Follow-up|55|||
145717584|NCT01004848|525481365|FG001|Overall Study|Lost to Follow-up|45|||
145717585|NCT01631227|525481367|FG000|Overall Study|withdrawn consent|27|||
145717586|NCT01631227|525481368|FG001|Overall Study|withdrawn consent|21|||
145717587|NCT01631227|525481367|FG000|Overall Study|Adverse Event|1|||
145717588|NCT01631227|525481368|FG001|Overall Study|Adverse Event|0|||
145717589|NCT01631227|525481367|FG000|Overall Study|administrative|2|||
145717590|NCT01631227|525481368|FG001|Overall Study|administrative|1|||
145717591|NCT00766363|525481369|FG000|Overall Study|Withdrawal by Subject|1|||
145717592|NCT00766363|525481370|FG001|Overall Study|Withdrawal by Subject|0|||
145717593|NCT00766363|525481371|FG002|Overall Study|Withdrawal by Subject|0|||
145717594|NCT00766363|525481372|FG003|Overall Study|Withdrawal by Subject|0|||
145717595|NCT00766363|525481369|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
145717596|NCT00766363|525481370|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
145717597|NCT00766363|525481371|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
145717598|NCT00766363|525481372|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
145717599|NCT03292432|525481373|FG000|Overall Study|Lost to Follow-up|11|||
145717600|NCT03292432|525481374|FG001|Overall Study|Lost to Follow-up|8|||
145717601|NCT03292432|525481373|FG000|Overall Study|Death|2|||
145717602|NCT03292432|525481374|FG001|Overall Study|Death|1|||
145717603|NCT03292432|525481373|FG000|Overall Study|Withdrawal by Subject|1|||
145717604|NCT03292432|525481374|FG001|Overall Study|Withdrawal by Subject|2|||
145717605|NCT03292432|525481373|FG000|Overall Study|Site closed before any data collected|1|||
145717606|NCT03292432|525481374|FG001|Overall Study|Site closed before any data collected|0|||
145717607|NCT01498679|525481375|FG000|Overall Study|Adverse Event|1|||
145717608|NCT01498679|525481376|FG001|Overall Study|Adverse Event|4|||
145717609|NCT01498679|525481375|FG000|Overall Study|Lack of Efficacy|72|||
145717610|NCT01498679|525481376|FG001|Overall Study|Lack of Efficacy|12|||
145717611|NCT01498679|525481375|FG000|Overall Study|Protocol Violation|4|||
145717612|NCT01498679|525481376|FG001|Overall Study|Protocol Violation|0|||
145717613|NCT01498679|525481375|FG000|Overall Study|Physician Decision|0|||
145717614|NCT01498679|525481376|FG001|Overall Study|Physician Decision|2|||
145717615|NCT01498679|525481375|FG000|Overall Study|Withdrawal by Subject|12|||
145717616|NCT01498679|525481376|FG001|Overall Study|Withdrawal by Subject|4|||
145717617|NCT00158860|525481382|FG000|Overall Study|Adverse Event|3|||
145717618|NCT00158860|525481383|FG001|Overall Study|Adverse Event|6|||
145717619|NCT00158860|525481382|FG000|Overall Study|Lost to Follow-up|11|||
145717620|NCT00158860|525481383|FG001|Overall Study|Lost to Follow-up|17|||
145717621|NCT00158860|525481382|FG000|Overall Study|Protocol Violation|8|||
145717622|NCT00158860|525481383|FG001|Overall Study|Protocol Violation|23|||
145717623|NCT00158860|525481382|FG000|Overall Study|Withdrawal by Subject|7|||
145717624|NCT00158860|525481383|FG001|Overall Study|Withdrawal by Subject|17|||
145717625|NCT00158860|525481382|FG000|Overall Study|MOVING OUT OF STATE|1|||
145717626|NCT00158860|525481383|FG001|Overall Study|MOVING OUT OF STATE|0|||
145717627|NCT00158860|525481382|FG000|Overall Study|Pregnancy|3|||
145717628|NCT00158860|525481383|FG001|Overall Study|Pregnancy|3|||
145717629|NCT00158860|525481382|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
145717630|NCT00158860|525481383|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
145717631|NCT00158860|525481382|FG000|Overall Study|SPONSOR REQUEST|0|||
145717632|NCT00158860|525481383|FG001|Overall Study|SPONSOR REQUEST|1|||
145717633|NCT00158860|525481382|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
145717634|NCT00158860|525481383|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
145717635|NCT00158860|525481382|FG000|Overall Study|Closed per sponsor|0|||
145717636|NCT00158860|525481383|FG001|Overall Study|Closed per sponsor|1|||
145717637|NCT00964886|525481384|FG000|Overall Study|Lost to Follow-up|2|||
145717638|NCT00964886|525481385|FG001|Overall Study|Lost to Follow-up|2|||
145717639|NCT00964886|525481386|FG002|Overall Study|Lost to Follow-up|6|||
145717640|NCT00964886|525481387|FG003|Overall Study|Lost to Follow-up|4|||
145717641|NCT00964886|525481384|FG000|Overall Study|Withdrawal by Subject|6|||
145717642|NCT00964886|525481385|FG001|Overall Study|Withdrawal by Subject|2|||
145717643|NCT00964886|525481386|FG002|Overall Study|Withdrawal by Subject|5|||
145717644|NCT00964886|525481387|FG003|Overall Study|Withdrawal by Subject|3|||
145717645|NCT00964886|525481384|FG000|Overall Study|Adverse Event|3|||
145717646|NCT00964886|525481385|FG001|Overall Study|Adverse Event|1|||
145717647|NCT00964886|525481386|FG002|Overall Study|Adverse Event|5|||
145717648|NCT00964886|525481387|FG003|Overall Study|Adverse Event|2|||
145717649|NCT00964886|525481384|FG000|Overall Study|Protocol Violation|0|||
145717650|NCT00964886|525481385|FG001|Overall Study|Protocol Violation|2|||
145717651|NCT00964886|525481386|FG002|Overall Study|Protocol Violation|0|||
145717652|NCT00964886|525481387|FG003|Overall Study|Protocol Violation|0|||
145717653|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
145717654|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
145717655|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
145717656|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
145717657|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
145717658|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
145717659|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
145717660|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
145717661|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
145717662|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
145717663|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
145717664|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
145717665|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
145717666|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
145717667|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
145717668|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
145717669|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
145717670|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
145717671|NCT03412747|525481390|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
145717672|NCT03412747|525481391|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
145717673|NCT03412747|525481392|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
145717674|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
145717675|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
145717676|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
145717677|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
145717678|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
145717679|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
145717680|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
145717681|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
145717682|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
145717683|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
145717684|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
145717685|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
145717686|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
145717687|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
145717688|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
145717689|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
145717690|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
145717691|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
145717692|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
145717693|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
145717694|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
145717695|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
145717696|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
145717697|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
145717698|NCT03412747|525481390|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
145717699|NCT03412747|525481391|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
145717700|NCT03412747|525481392|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
145717701|NCT01263665|525481395|FG000|Overall Study|Withdrew Consent|1|||
145717702|NCT01263665|525481395|FG000|Overall Study|Lost to Follow-up|3|||
145717703|NCT01263665|525481395|FG000|Overall Study|Death|2|||
145717704|NCT01263665|525481395|FG000|Overall Study|Amputation above the ankle|1|||
145717705|NCT01263665|525481395|FG000|Overall Study|Surgical Bypass|2|||
145717706|NCT00560066|525481398|FG000|Overall Study|Death|2|||
145717707|NCT00560066|525481399|FG001|Overall Study|Death|1|||
145717708|NCT00560066|525481398|FG000|Overall Study|Withdrawal by Subject|0|||
145717709|NCT00560066|525481399|FG001|Overall Study|Withdrawal by Subject|3|||
145717710|NCT00560066|525481398|FG000|Overall Study|Lost to Follow-up|4|||
145717711|NCT00560066|525481399|FG001|Overall Study|Lost to Follow-up|10|||
145717712|NCT00560066|525481398|FG000|Overall Study|Protocol Violation|0|||
145717713|NCT00560066|525481399|FG001|Overall Study|Protocol Violation|1|||
145717714|NCT00560066|525481398|FG000|Overall Study|Administrative reason|0|||
145717715|NCT00560066|525481399|FG001|Overall Study|Administrative reason|5|||
145717716|NCT00560066|525481398|FG000|Overall Study|Missing primary reason|0|||
145717717|NCT00560066|525481399|FG001|Overall Study|Missing primary reason|2|||
145717718|NCT01435616|525481400|FG000|Overall Study|Adverse Event|39|||
145717719|NCT01435616|525481401|FG001|Overall Study|Adverse Event|21|||
145717720|NCT01435616|525481400|FG000|Overall Study|Death|7|||
145717721|NCT01435616|525481401|FG001|Overall Study|Death|2|||
145717722|NCT01435616|525481400|FG000|Overall Study|Lost to Follow-up|22|||
145717723|NCT01435616|525481401|FG001|Overall Study|Lost to Follow-up|13|||
145717724|NCT01435616|525481400|FG000|Overall Study|Protocol Violation|16|||
145717725|NCT01435616|525481401|FG001|Overall Study|Protocol Violation|13|||
145717726|NCT01435616|525481400|FG000|Overall Study|Withdrawal by Subject|66|||
145717727|NCT01435616|525481401|FG001|Overall Study|Withdrawal by Subject|24|||
145717728|NCT01435616|525481400|FG000|Overall Study|Physician Decision|20|||
145717729|NCT01435616|525481401|FG001|Overall Study|Physician Decision|7|||
145717730|NCT01435616|525481400|FG000|Overall Study|Sponsor Decision|1|||
145717731|NCT01435616|525481401|FG001|Overall Study|Sponsor Decision|0|||
145717732|NCT02442336|525481409|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
145717733|NCT02442336|525481409|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
145717734|NCT02442336|525481409|FG000|Overall Study|Lost to Follow-up|11|||
145717735|NCT01011387|525481410|FG000|Overall Study|Withdrawal by Subject|3|||
145717736|NCT01011387|525481410|FG000|Overall Study|Adverse Event|2|||
145717737|NCT01011387|525481410|FG000|Overall Study|Protocol Violation|1|||
145717738|NCT01142115|525481411|FG000|First Intervention|Lack of Efficacy|1|||
145717739|NCT01142115|525481412|FG001|First Intervention|Lack of Efficacy|1|||
145717740|NCT01142115|525481411|FG000|First Intervention|Adverse Event|1|||
145717741|NCT01142115|525481412|FG001|First Intervention|Adverse Event|0|||
145717742|NCT03208036|525481413|FG000|Baseline Assessment|Withdrawal by Subject|1|||
145717743|NCT03208036|525481414|FG001|Baseline Assessment|Withdrawal by Subject|1|||
145717744|NCT03208036|525481413|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
145717745|NCT03208036|525481414|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
145717746|NCT03208036|525481413|FG000|Intervention|Withdrawal by Subject|3|||
145717747|NCT03208036|525481414|FG001|Intervention|Withdrawal by Subject|2|||
145717748|NCT03208036|525481413|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
145717749|NCT03208036|525481414|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
145717750|NCT03406078|525481415|FG000|Overall Study|Death|1|||
145717751|NCT03406078|525481416|FG001|Overall Study|Death|0|||
145717752|NCT03406078|525481415|FG000|Overall Study|Lost to Follow-up|0|||
145717753|NCT03406078|525481416|FG001|Overall Study|Lost to Follow-up|1|||
145717754|NCT03406078|525481415|FG000|Overall Study|Withdrawal by Subject|5|||
145717755|NCT03406078|525481416|FG001|Overall Study|Withdrawal by Subject|2|||
145717756|NCT00700778|525481417|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
145717757|NCT01879553|525481420|FG000|Overall Study|Withdrawal by Subject|1|||
145717758|NCT01879553|525481421|FG001|Overall Study|Withdrawal by Subject|0|||
145717759|NCT00591851|525481422|FG000|Overall Study|Withdrawal by Subject|3|||
145717760|NCT00591851|525481422|FG000|Overall Study|Adverse Event|2|||
145717761|NCT00591851|525481422|FG000|Overall Study|Progressive Disease|1|||
145717762|NCT00438672|525481423|FG000|Overall Study|Lost to Follow-up|7|||
145717763|NCT00438672|525481424|FG001|Overall Study|Lost to Follow-up|9|||
145717764|NCT00320528|525481428|FG000|Study Period II|Adverse Event|3|||
145717765|NCT00320528|525481429|FG001|Study Period II|Adverse Event|4|||
145717766|NCT00320528|525481430|FG002|Study Period II|Adverse Event|8|||
145717767|NCT00320528|525481428|FG000|Study Period II|Parent/Caregiver Decision|8|||
145717768|NCT00320528|525481429|FG001|Study Period II|Parent/Caregiver Decision|3|||
145717769|NCT00320528|525481430|FG002|Study Period II|Parent/Caregiver Decision|11|||
145717770|NCT00320528|525481428|FG000|Study Period II|Withdrawal by Subject|0|||
145717771|NCT00320528|525481429|FG001|Study Period II|Withdrawal by Subject|1|||
145717772|NCT00320528|525481430|FG002|Study Period II|Withdrawal by Subject|1|||
145717773|NCT00320528|525481428|FG000|Study Period II|Entry Criteria Exclusion|0|||
145717774|NCT00320528|525481429|FG001|Study Period II|Entry Criteria Exclusion|2|||
145717775|NCT00320528|525481430|FG002|Study Period II|Entry Criteria Exclusion|2|||
145717776|NCT00320528|525481428|FG000|Study Period III|Adverse Event|1|||
145717777|NCT00320528|525481429|FG001|Study Period III|Adverse Event|0|||
145717778|NCT00320528|525481430|FG002|Study Period III|Adverse Event|0|||
145717779|NCT00320528|525481428|FG000|Study Period III|Lost to Follow-up|1|||
145717780|NCT00320528|525481429|FG001|Study Period III|Lost to Follow-up|0|||
145717781|NCT00320528|525481430|FG002|Study Period III|Lost to Follow-up|0|||
145717782|NCT00320528|525481428|FG000|Study Period III|Withdrawal by Subject|1|||
145717783|NCT00320528|525481429|FG001|Study Period III|Withdrawal by Subject|1|||
145717784|NCT00320528|525481430|FG002|Study Period III|Withdrawal by Subject|2|||
145717785|NCT00320528|525481428|FG000|Study Period III|Lack of Efficacy|2|||
145717786|NCT00320528|525481429|FG001|Study Period III|Lack of Efficacy|0|||
145717787|NCT00320528|525481430|FG002|Study Period III|Lack of Efficacy|0|||
145717788|NCT00320528|525481428|FG000|Study Period III|Parent/Caregiver Decision|14|||
145717789|NCT00320528|525481429|FG001|Study Period III|Parent/Caregiver Decision|3|||
145717790|NCT00320528|525481430|FG002|Study Period III|Parent/Caregiver Decision|11|||
145717791|NCT00320528|525481428|FG000|Study Period III|Protocol Violation|0|||
145717792|NCT00320528|525481429|FG001|Study Period III|Protocol Violation|1|||
145717793|NCT00320528|525481430|FG002|Study Period III|Protocol Violation|0|||
145717794|NCT00320528|525481428|FG000|Study Period III|Physician Decision|0|||
145717795|NCT00320528|525481429|FG001|Study Period III|Physician Decision|1|||
145717796|NCT00320528|525481430|FG002|Study Period III|Physician Decision|2|||
145717797|NCT00320528|525481428|FG000|Study Period III|Sponsor Decision|0|||
145717798|NCT00320528|525481429|FG001|Study Period III|Sponsor Decision|0|||
145717799|NCT00320528|525481430|FG002|Study Period III|Sponsor Decision|1|||
145717800|NCT00320528|525481428|FG000|Study Period III|Atomoxetine Commercially Available|68|||
145717801|NCT00320528|525481429|FG001|Study Period III|Atomoxetine Commercially Available|25|||
145717802|NCT00320528|525481430|FG002|Study Period III|Atomoxetine Commercially Available|90|||
145717803|NCT04540887|525481438|FG000|Overall Study|Withdrawal by Subject|2|||
145717804|NCT00513305|525481439|FG000|Overall Study|Adverse Event|6|||
145717805|NCT00513305|525481440|FG001|Overall Study|Adverse Event|2|||
145717806|NCT00513305|525481439|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
145717807|NCT00513305|525481440|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
145717808|NCT00513305|525481439|FG000|Overall Study|Lack of Efficacy|8|||
145717809|NCT00513305|525481440|FG001|Overall Study|Lack of Efficacy|13|||
145717810|NCT00513305|525481439|FG000|Overall Study|Withdrawal by Subject|1|||
145717811|NCT00513305|525481440|FG001|Overall Study|Withdrawal by Subject|2|||
145717812|NCT00513305|525481439|FG000|Overall Study|Disease progression|8|||
145717813|NCT00513305|525481440|FG001|Overall Study|Disease progression|5|||
145717814|NCT00513305|525481439|FG000|Overall Study|Eligible for stem cell transplant|1|||
145717815|NCT00513305|525481440|FG001|Overall Study|Eligible for stem cell transplant|0|||
145717816|NCT00513305|525481439|FG000|Overall Study|Hematologic counts did not recover|1|||
145717817|NCT00513305|525481440|FG001|Overall Study|Hematologic counts did not recover|0|||
145717818|NCT00513305|525481439|FG000|Overall Study|Physician Decision|1|||
145717819|NCT00513305|525481440|FG001|Overall Study|Physician Decision|0|||
145717820|NCT00513305|525481439|FG000|Overall Study|Persistent hypocellularity|0|||
145717821|NCT00513305|525481440|FG001|Overall Study|Persistent hypocellularity|1|||
145717822|NCT00513305|525481439|FG000|Overall Study|Sponsor Decision|0|||
145717823|NCT00513305|525481440|FG001|Overall Study|Sponsor Decision|2|||
145717824|NCT01262027|525481441|FG000|Overall Study|Adverse Event|1|||
145717825|NCT01262027|525481441|FG000|Overall Study|Withdrawal by Subject|3|||
145717826|NCT01262027|525481441|FG000|Overall Study|Protocol Violation|1|||
145717827|NCT03014479|525481442|FG000|Overall Study|Adverse Event|0|||
145717828|NCT03014479|525481443|FG001|Overall Study|Adverse Event|1|||
145717829|NCT03014479|525481442|FG000|Overall Study|Voluntary Withdrawal|0|||
145717830|NCT03014479|525481443|FG001|Overall Study|Voluntary Withdrawal|2|||
145717831|NCT03014479|525481442|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
145717832|NCT03014479|525481443|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
145717833|NCT02217501|525481449|FG000|Overall Study|Death|3|||
145717834|NCT02217501|525481450|FG001|Overall Study|Death|4|||
145717835|NCT01394978|525481451|FG000|Overall Study|Withdrawal by Subject|2|||
145717836|NCT01394978|525481452|FG001|Overall Study|Withdrawal by Subject|4|||
145717837|NCT01394978|525481451|FG000|Overall Study|Lost to Follow-up|13|||
145717838|NCT01394978|525481452|FG001|Overall Study|Lost to Follow-up|20|||
145717839|NCT01394978|525481451|FG000|Overall Study|Death|6|||
145717840|NCT01394978|525481452|FG001|Overall Study|Death|7|||
145717841|NCT02019667|525481453|FG000|First Intervention (6 Months)|Adverse Event|0|||
145717842|NCT02019667|525481454|FG001|First Intervention (6 Months)|Adverse Event|1|||
145717843|NCT02019667|525481453|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
145717844|NCT02019667|525481454|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
145717845|NCT02019667|525481453|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
145717846|NCT02019667|525481454|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
145717847|NCT01942785|525481455|FG000|Overall Study|Adverse Event|2|||
145717848|NCT01942785|525481455|FG000|Overall Study|Withdrawal by Subject|1|||
145717849|NCT01942785|525481455|FG000|Overall Study|Protocol Violation|1|||
145717850|NCT05038163|525481459|FG000|Stage 1|Did not complete survey|374|||
145717851|NCT05038163|525481460|FG001|Stage 1|Did not complete survey|0|||
145717852|NCT05038163|525481461|FG002|Stage 1|Did not complete survey|0|||
145717853|NCT05038163|525481462|FG003|Stage 1|Did not complete survey|0|||
145717854|NCT05038163|525481463|FG004|Stage 1|Did not complete survey|0|||
145717855|NCT05038163|525481464|FG005|Stage 1|Did not complete survey|0|||
145717856|NCT05038163|525481459|FG000|Stage 2|Did not complete Stage 2 survey|0|||
145717857|NCT05038163|525481460|FG001|Stage 2|Did not complete Stage 2 survey|29|||
145717858|NCT05038163|525481461|FG002|Stage 2|Did not complete Stage 2 survey|30|||
145717859|NCT05038163|525481462|FG003|Stage 2|Did not complete Stage 2 survey|24|||
145717860|NCT05038163|525481463|FG004|Stage 2|Did not complete Stage 2 survey|21|||
145717861|NCT05038163|525481464|FG005|Stage 2|Did not complete Stage 2 survey|100|||
145717862|NCT05453201|525481465|FG000|Overall Study|Withdrawal by Subject|1|||
145717863|NCT03798691|525481468|FG000|Overall Study|Lost to Follow-up|2|||
145717864|NCT03798691|525481469|FG001|Overall Study|Lost to Follow-up|2|||
145717865|NCT00552929|525481470|FG000|Overall Study|Lost to Follow-up|0|||
145717866|NCT00552929|525481471|FG001|Overall Study|Lost to Follow-up|0|||
145717867|NCT00552929|525481472|FG002|Overall Study|Lost to Follow-up|0|||
145717868|NCT00552929|525481473|FG003|Overall Study|Lost to Follow-up|0|||
145717869|NCT00552929|525481474|FG004|Overall Study|Lost to Follow-up|0|||
145717870|NCT00552929|525481475|FG005|Overall Study|Lost to Follow-up|0|||
145717871|NCT00552929|525481476|FG006|Overall Study|Lost to Follow-up|0|||
145717872|NCT00552929|525481477|FG007|Overall Study|Lost to Follow-up|0|||
145717873|NCT00552929|525481478|FG008|Overall Study|Lost to Follow-up|1|||
145717874|NCT00552929|525481479|FG009|Overall Study|Lost to Follow-up|0|||
145717875|NCT00552929|525481470|FG000|Overall Study|Not Eligible|0|||
145717876|NCT00552929|525481471|FG001|Overall Study|Not Eligible|0|||
145717877|NCT00552929|525481472|FG002|Overall Study|Not Eligible|0|||
145717878|NCT00552929|525481473|FG003|Overall Study|Not Eligible|0|||
145717879|NCT00552929|525481474|FG004|Overall Study|Not Eligible|0|||
145717880|NCT00552929|525481475|FG005|Overall Study|Not Eligible|1|||
145717881|NCT00552929|525481476|FG006|Overall Study|Not Eligible|0|||
145717882|NCT00552929|525481477|FG007|Overall Study|Not Eligible|0|||
145717883|NCT00552929|525481478|FG008|Overall Study|Not Eligible|0|||
145717884|NCT00552929|525481479|FG009|Overall Study|Not Eligible|0|||
145717885|NCT01147536|525481483|FG000|Overall Study|Administrative study close|2|||
145717886|NCT01147536|525481483|FG000|Overall Study|Death|1|||
145717887|NCT03762200|525481484|FG000|Overall Study|Death|2|||
145717888|NCT05559476|525481489|FG000|Overall Study|Adverse Event|2|||
145717889|NCT05559476|525481490|FG001|Overall Study|Adverse Event|0|||
145717890|NCT05559476|525481489|FG000|Overall Study|Lost to Follow-up|13|||
145717891|NCT05559476|525481490|FG001|Overall Study|Lost to Follow-up|12|||
145717892|NCT05559476|525481489|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
145717893|NCT05559476|525481490|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
145717894|NCT05559476|525481489|FG000|Overall Study|Other|0|||
145717895|NCT05559476|525481490|FG001|Overall Study|Other|2|||
145717896|NCT05110690|525481491|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
145717897|NCT05110690|525481491|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
145717898|NCT05110690|525481491|FG000|Completion of Intervention|Lost to Follow-up|1|||
145717899|NCT05110690|525481491|FG000|Completion of Intervention|Death|1|||
145717900|NCT05110690|525481491|FG000|Completion of Intervention|Withdrawal by Subject|2|||
145377888|NCT03191864|524233639|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
145377889|NCT03191864|524233640|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
145377890|NCT03191864|524233635|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145377891|NCT03191864|524233636|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145377892|NCT03191864|524233637|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
145377893|NCT03191864|524233638|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145377894|NCT03191864|524233639|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145377895|NCT03191864|524233640|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
145377896|NCT03191864|524233635|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
145377897|NCT03191864|524233636|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145377898|NCT03191864|524233637|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145377899|NCT03191864|524233638|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145377900|NCT03191864|524233639|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145377901|NCT03191864|524233640|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
145377902|NCT03191864|524233635|FG000|Part 2 - Maintenance|Physician Decision|1|||
145377903|NCT03191864|524233636|FG001|Part 2 - Maintenance|Physician Decision|0|||
145377904|NCT03191864|524233637|FG002|Part 2 - Maintenance|Physician Decision|0|||
145377905|NCT03191864|524233638|FG003|Part 2 - Maintenance|Physician Decision|0|||
145377906|NCT03191864|524233639|FG004|Part 2 - Maintenance|Physician Decision|0|||
145377907|NCT03191864|524233640|FG005|Part 2 - Maintenance|Physician Decision|0|||
145377908|NCT03191864|524233635|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
145377909|NCT03191864|524233636|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
145377910|NCT03191864|524233637|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
145377911|NCT03191864|524233638|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
145377912|NCT03191864|524233639|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
145377913|NCT03191864|524233640|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
145377914|NCT03191864|524233635|FG000|Part 2 - Maintenance|Adverse Event|0|||
145377915|NCT03191864|524233636|FG001|Part 2 - Maintenance|Adverse Event|0|||
145377916|NCT03191864|524233637|FG002|Part 2 - Maintenance|Adverse Event|0|||
145377917|NCT03191864|524233638|FG003|Part 2 - Maintenance|Adverse Event|0|||
145377918|NCT03191864|524233639|FG004|Part 2 - Maintenance|Adverse Event|1|||
145377919|NCT03191864|524233640|FG005|Part 2 - Maintenance|Adverse Event|0|||
145377920|NCT03191864|524233635|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
145377921|NCT03191864|524233636|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
145377922|NCT03191864|524233637|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
145377923|NCT03191864|524233638|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
145377924|NCT03191864|524233639|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
145377925|NCT03191864|524233640|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
145377926|NCT03191864|524233635|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145377927|NCT03191864|524233636|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145377928|NCT03191864|524233637|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145377929|NCT03191864|524233638|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145377930|NCT03191864|524233639|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
145377931|NCT03191864|524233640|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
145377932|NCT02044874|524233641|FG000|Overall Study|Adverse Event|5|||
145377933|NCT02044874|524233642|FG001|Overall Study|Adverse Event|6|||
145377934|NCT02044874|524233643|FG002|Overall Study|Adverse Event|6|||
145377935|NCT02044874|524233641|FG000|Overall Study|Withdrawal by Subject|8|||
145377936|NCT02044874|524233642|FG001|Overall Study|Withdrawal by Subject|16|||
145377937|NCT02044874|524233643|FG002|Overall Study|Withdrawal by Subject|23|||
145377938|NCT02044874|524233641|FG000|Overall Study|Physician Decision|0|||
145377939|NCT02044874|524233642|FG001|Overall Study|Physician Decision|2|||
145377940|NCT02044874|524233643|FG002|Overall Study|Physician Decision|1|||
145377941|NCT02044874|524233641|FG000|Overall Study|Lost to Follow-up|10|||
145377942|NCT02044874|524233642|FG001|Overall Study|Lost to Follow-up|27|||
145377943|NCT02044874|524233643|FG002|Overall Study|Lost to Follow-up|21|||
145377944|NCT02044874|524233641|FG000|Overall Study|Sponsor Decision|0|||
145377945|NCT02044874|524233642|FG001|Overall Study|Sponsor Decision|1|||
145377946|NCT02044874|524233643|FG002|Overall Study|Sponsor Decision|1|||
145377947|NCT02044874|524233641|FG000|Overall Study|Other|7|||
145377948|NCT02044874|524233642|FG001|Overall Study|Other|3|||
145377949|NCT02044874|524233643|FG002|Overall Study|Other|8|||
145377950|NCT02889835|524233644|FG000|Overall Study|Lost to Follow-up|13|||
145377951|NCT02889835|524233645|FG001|Overall Study|Lost to Follow-up|13|||
145377952|NCT02889835|524233646|FG002|Overall Study|Lost to Follow-up|13|||
145377953|NCT02889835|524233644|FG000|Overall Study|Withdrawal by Subject|2|||
145377954|NCT02889835|524233645|FG001|Overall Study|Withdrawal by Subject|2|||
145377955|NCT02889835|524233646|FG002|Overall Study|Withdrawal by Subject|2|||
145377956|NCT02889835|524233644|FG000|Overall Study|Protocol Violation|1|||
145377957|NCT02889835|524233645|FG001|Overall Study|Protocol Violation|1|||
145377958|NCT02889835|524233646|FG002|Overall Study|Protocol Violation|1|||
145377959|NCT02889835|524233644|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
145377960|NCT02889835|524233645|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
145377961|NCT02889835|524233646|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
145377962|NCT02889835|524233644|FG000|Overall Study|Death|1|||
145377963|NCT02889835|524233645|FG001|Overall Study|Death|1|||
145377964|NCT02889835|524233646|FG002|Overall Study|Death|1|||
145377965|NCT05072964|524233647|FG000|Overall Study|Withdrawal by Subject|4|||
145377966|NCT05072964|524233647|FG000|Overall Study|Death|1|||
145377967|NCT02987972|524233648|FG000|Overall Study|Adverse Event|1|||
145377968|NCT02987972|524233649|FG001|Overall Study|Adverse Event|1|||
145377969|NCT02987972|524233650|FG002|Overall Study|Adverse Event|0|||
145377970|NCT02987972|524233648|FG000|Overall Study|Death|1|||
145377971|NCT02987972|524233649|FG001|Overall Study|Death|0|||
145377972|NCT02987972|524233650|FG002|Overall Study|Death|0|||
145377973|NCT02987972|524233648|FG000|Overall Study|Lack of Efficacy|9|||
145377974|NCT02987972|524233649|FG001|Overall Study|Lack of Efficacy|12|||
145377975|NCT02987972|524233650|FG002|Overall Study|Lack of Efficacy|12|||
145377976|NCT02987972|524233648|FG000|Overall Study|Lost to Follow-up|7|||
145377977|NCT02987972|524233649|FG001|Overall Study|Lost to Follow-up|8|||
145377978|NCT02987972|524233650|FG002|Overall Study|Lost to Follow-up|4|||
145377979|NCT02987972|524233648|FG000|Overall Study|Physician Decision|1|||
145377980|NCT02987972|524233649|FG001|Overall Study|Physician Decision|6|||
145377981|NCT02987972|524233650|FG002|Overall Study|Physician Decision|0|||
145377982|NCT02987972|524233648|FG000|Overall Study|Protocol Violation|2|||
145377983|NCT02987972|524233649|FG001|Overall Study|Protocol Violation|1|||
145377984|NCT02987972|524233650|FG002|Overall Study|Protocol Violation|5|||
145377985|NCT02987972|524233648|FG000|Overall Study|Withdrawal by Subject|22|||
145377986|NCT02987972|524233649|FG001|Overall Study|Withdrawal by Subject|17|||
145377987|NCT02987972|524233650|FG002|Overall Study|Withdrawal by Subject|21|||
145377988|NCT02342548|524233651|FG000|Overall Study|Adverse Event|12|||
145377989|NCT02342548|524233652|FG001|Overall Study|Adverse Event|17|||
145377990|NCT02342548|524233653|FG002|Overall Study|Adverse Event|13|||
145377991|NCT02342548|524233651|FG000|Overall Study|Lost to Follow-up|0|||
145377992|NCT02342548|524233652|FG001|Overall Study|Lost to Follow-up|1|||
145377993|NCT02342548|524233653|FG002|Overall Study|Lost to Follow-up|0|||
145377994|NCT02342548|524233651|FG000|Overall Study|Study terminated by sponsor|20|||
145377995|NCT02342548|524233652|FG001|Overall Study|Study terminated by sponsor|39|||
145377996|NCT02342548|524233653|FG002|Overall Study|Study terminated by sponsor|25|||
145377997|NCT02342548|524233651|FG000|Overall Study|Protocol Violation|0|||
145377998|NCT02342548|524233652|FG001|Overall Study|Protocol Violation|1|||
145377999|NCT02342548|524233653|FG002|Overall Study|Protocol Violation|0|||
145378000|NCT02342548|524233651|FG000|Overall Study|Withdrawal by Subject|1|||
145378001|NCT02342548|524233652|FG001|Overall Study|Withdrawal by Subject|3|||
145378002|NCT02342548|524233653|FG002|Overall Study|Withdrawal by Subject|4|||
145378003|NCT02342548|524233651|FG000|Overall Study|Other|1|||
145378004|NCT02342548|524233652|FG001|Overall Study|Other|1|||
145378005|NCT02342548|524233653|FG002|Overall Study|Other|1|||
145378006|NCT01047332|524233656|FG000|Overall Study|SEMS Obstruction|11|||
145378007|NCT01047332|524233657|FG001|Overall Study|SEMS Obstruction|20|||
145378008|NCT01047332|524233656|FG000|Overall Study|Died Unobstructed|38|||
145378009|NCT01047332|524233657|FG001|Overall Study|Died Unobstructed|41|||
145378010|NCT01047332|524233656|FG000|Overall Study|Lost to Follow-up|8|||
145378011|NCT01047332|524233657|FG001|Overall Study|Lost to Follow-up|3|||
145378012|NCT00073983|524233663|FG000|Overall Study|not evaluable|1|||
145378013|NCT03800836|524233665|FG000|Overall Study|Other|2|||
145378014|NCT03800836|524233666|FG001|Overall Study|Other|1|||
145378015|NCT03800836|524233667|FG002|Overall Study|Other|0|||
145378016|NCT03800836|524233668|FG003|Overall Study|Other|2|||
145378017|NCT03800836|524233669|FG004|Overall Study|Other|0|||
145378018|NCT03800836|524233670|FG005|Overall Study|Other|1|||
145378019|NCT03800836|524233665|FG000|Overall Study|Lost to Follow-up|2|||
145378020|NCT03800836|524233666|FG001|Overall Study|Lost to Follow-up|0|||
145378021|NCT03800836|524233667|FG002|Overall Study|Lost to Follow-up|1|||
145378022|NCT03800836|524233668|FG003|Overall Study|Lost to Follow-up|1|||
145378023|NCT03800836|524233669|FG004|Overall Study|Lost to Follow-up|3|||
145378024|NCT03800836|524233670|FG005|Overall Study|Lost to Follow-up|0|||
145378025|NCT03800836|524233665|FG000|Overall Study|Withdrawal by Subject|1|||
145378026|NCT03800836|524233666|FG001|Overall Study|Withdrawal by Subject|0|||
145378027|NCT03800836|524233667|FG002|Overall Study|Withdrawal by Subject|0|||
145378028|NCT03800836|524233668|FG003|Overall Study|Withdrawal by Subject|0|||
145378029|NCT03800836|524233669|FG004|Overall Study|Withdrawal by Subject|0|||
145378030|NCT03800836|524233670|FG005|Overall Study|Withdrawal by Subject|0|||
145378031|NCT03800836|524233665|FG000|Overall Study|Physician Decision|31|||
145378032|NCT03800836|524233666|FG001|Overall Study|Physician Decision|3|||
145378033|NCT03800836|524233667|FG002|Overall Study|Physician Decision|6|||
145378034|NCT03800836|524233668|FG003|Overall Study|Physician Decision|4|||
145378035|NCT03800836|524233669|FG004|Overall Study|Physician Decision|4|||
145378036|NCT03800836|524233670|FG005|Overall Study|Physician Decision|5|||
145378037|NCT03800836|524233665|FG000|Overall Study|Death|34|||
145378038|NCT03800836|524233666|FG001|Overall Study|Death|16|||
145378039|NCT03800836|524233667|FG002|Overall Study|Death|5|||
145378040|NCT03800836|524233668|FG003|Overall Study|Death|5|||
145378041|NCT03800836|524233669|FG004|Overall Study|Death|10|||
145378042|NCT03800836|524233670|FG005|Overall Study|Death|0|||
145378043|NCT03800836|524233665|FG000|Overall Study|Symptomatic Deterioration|1|||
145378044|NCT03800836|524233666|FG001|Overall Study|Symptomatic Deterioration|0|||
145378045|NCT03800836|524233667|FG002|Overall Study|Symptomatic Deterioration|1|||
145378046|NCT03800836|524233668|FG003|Overall Study|Symptomatic Deterioration|0|||
145378047|NCT03800836|524233669|FG004|Overall Study|Symptomatic Deterioration|0|||
145378048|NCT03800836|524233670|FG005|Overall Study|Symptomatic Deterioration|0|||
145378049|NCT02542293|524235878|FG000|Overall Study|Death|367|||
145378050|NCT02542293|524235879|FG001|Overall Study|Death|377|||
145378051|NCT02542293|524235878|FG000|Overall Study|Withdrawal by Subject|8|||
145378052|NCT02542293|524235879|FG001|Overall Study|Withdrawal by Subject|19|||
145378053|NCT03030118|524235880|FG000|Overall Study|Achieved SLE Diagnosis|11|||
145378054|NCT03030118|524235881|FG001|Overall Study|Achieved SLE Diagnosis|10|||
145378055|NCT03030118|524235880|FG000|Overall Study|Adverse Event|1|||
145378056|NCT03030118|524235881|FG001|Overall Study|Adverse Event|1|||
145378057|NCT03030118|524235880|FG000|Overall Study|Pregnancy|2|||
145378058|NCT03030118|524235881|FG001|Overall Study|Pregnancy|2|||
145378059|NCT03030118|524235880|FG000|Overall Study|Lost to Follow-up|5|||
145378060|NCT03030118|524235881|FG001|Overall Study|Lost to Follow-up|6|||
145378061|NCT03030118|524235880|FG000|Overall Study|Concomitant Medications|1|||
145378062|NCT03030118|524235881|FG001|Overall Study|Concomitant Medications|1|||
145378063|NCT03030118|524235880|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
145378064|NCT03030118|524235881|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
145378065|NCT03030118|524235880|FG000|Overall Study|Other|2|||
145378066|NCT03030118|524235881|FG001|Overall Study|Other|0|||
145378067|NCT03030118|524235880|FG000|Overall Study|Withdrawal by Subject|26|||
145378068|NCT03030118|524235881|FG001|Overall Study|Withdrawal by Subject|21|||
145378069|NCT03030118|524235880|FG000|Overall Study|Protocol Violation|1|||
145378070|NCT03030118|524235881|FG001|Overall Study|Protocol Violation|6|||
145378071|NCT04529850|524235882|FG000|Overall Study|Death|2|||
145378072|NCT04529850|524235882|FG000|Overall Study|Physician Decision|1|||
145378073|NCT04529850|524235882|FG000|Overall Study|Withdrawal by Subject|2|||
145378074|NCT00078949|524235885|FG000|Overall Study|No treated|4|||
145378075|NCT00078949|524235886|FG001|Overall Study|No treated|5|||
145378076|NCT00078949|524235887|FG002|Overall Study|No treated|3|||
145378077|NCT00078949|524235888|FG003|Overall Study|No treated|3|||
145378078|NCT01004432|524235889|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
145378079|NCT01004432|524235890|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145378080|NCT01004432|524235891|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145378081|NCT01004432|524235892|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145378082|NCT01004432|524235893|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
145378083|NCT01004432|524235889|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
145378084|NCT01004432|524235890|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145378085|NCT01004432|524235891|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145378086|NCT01004432|524235892|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145378087|NCT01004432|524235893|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
145378088|NCT01004432|524235889|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
145378089|NCT01004432|524235890|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145378090|NCT01004432|524235891|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145378091|NCT01004432|524235892|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145378092|NCT01004432|524235893|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
145378093|NCT01004432|524235889|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
145378094|NCT01004432|524235890|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145378095|NCT01004432|524235891|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145378096|NCT01004432|524235892|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145378097|NCT01004432|524235893|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
145378098|NCT01004432|524235889|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
145378099|NCT01004432|524235890|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145378100|NCT01004432|524235891|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145378101|NCT01004432|524235892|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145378102|NCT01004432|524235893|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
145378103|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
145378104|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
145378105|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
145378106|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
145378107|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
145378108|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
145378109|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
145378110|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
145378111|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
145378112|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
145378113|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
145378114|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
145378115|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
145378116|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
145378117|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
145378118|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145378119|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145378120|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145378121|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
145378122|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
145378123|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
145378124|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
145378125|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
145378126|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
145378127|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
145378128|NCT01004432|524235889|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
145378129|NCT01004432|524235890|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
145378130|NCT01004432|524235891|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
145378131|NCT01004432|524235892|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
145378132|NCT01004432|524235893|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
145378133|NCT01004432|524235889|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145378134|NCT01004432|524235890|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145378135|NCT01004432|524235891|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145378136|NCT01004432|524235892|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
145378137|NCT01004432|524235893|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
145378138|NCT01004432|524235889|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145378139|NCT01004432|524235890|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145378140|NCT01004432|524235891|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145378141|NCT01004432|524235892|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
145378142|NCT01004432|524235893|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
145378143|NCT01004432|524235889|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145378144|NCT01004432|524235890|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145378145|NCT01004432|524235891|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145378146|NCT01004432|524235892|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
145378147|NCT01004432|524235893|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
145378148|NCT01004432|524235889|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145378149|NCT01004432|524235890|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145378150|NCT01004432|524235891|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145378151|NCT01004432|524235892|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
145378152|NCT01004432|524235893|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
145378153|NCT04829331|524235894|FG000|Overall Study|Lost to Follow-up|1|||
145378154|NCT04829331|524235895|FG001|Overall Study|Lost to Follow-up|0|||
145378155|NCT02604550|524235898|FG000|Overall Study|Lost to Follow-up|7|||
145378156|NCT02604550|524235899|FG001|Overall Study|Lost to Follow-up|6|||
145378157|NCT02604550|524235898|FG000|Overall Study|Withdrawal by Subject|0|||
145378158|NCT02604550|524235899|FG001|Overall Study|Withdrawal by Subject|1|||
145378159|NCT02604550|524235898|FG000|Overall Study|Incomplete data using paper journal|18|||
145378160|NCT02604550|524235899|FG001|Overall Study|Incomplete data using paper journal|19|||
145378161|NCT01404208|524235900|FG000|Overall Study|Discontinued|3|||
145378162|NCT01404208|524235901|FG001|Overall Study|Discontinued|0|||
145378163|NCT00908076|524235904|FG000|Overall Study|Lack of Efficacy|1|||
145378164|NCT00908076|524235905|FG001|Overall Study|Lack of Efficacy|1|||
145378165|NCT02382796|524235906|FG000|Overall Study|Global deterioration of health status|1|||
145378166|NCT02382796|524235906|FG000|Overall Study|Objective progression or relapse|3|||
145378167|NCT02382796|524235906|FG000|Overall Study|Commercial dacomitinib became available|3|||
145378168|NCT03769675|524235913|FG000|Overall Study|Lost to Follow-up|1|||
145378169|NCT04068688|524235914|FG000|Overall Study|Lost to Follow-up|1|||
145378170|NCT04068688|524235915|FG001|Overall Study|Lost to Follow-up|1|||
145378171|NCT04068688|524235916|FG002|Overall Study|Lost to Follow-up|0|||
145378172|NCT04068688|524235917|FG003|Overall Study|Lost to Follow-up|0|||
145378173|NCT04068688|524235918|FG004|Overall Study|Lost to Follow-up|5|||
145378174|NCT04068688|524235919|FG005|Overall Study|Lost to Follow-up|5|||
145378175|NCT04068688|524235920|FG006|Overall Study|Lost to Follow-up|0|||
145378176|NCT04068688|524235921|FG007|Overall Study|Lost to Follow-up|0|||
145378177|NCT04068688|524235922|FG008|Overall Study|Lost to Follow-up|1|||
145378178|NCT04068688|524235923|FG009|Overall Study|Lost to Follow-up|0|||
145378179|NCT04068688|524235914|FG000|Overall Study|Withdrawal by Subject|1|||
145378180|NCT04068688|524235915|FG001|Overall Study|Withdrawal by Subject|1|||
145378181|NCT04068688|524235916|FG002|Overall Study|Withdrawal by Subject|0|||
145378182|NCT04068688|524235917|FG003|Overall Study|Withdrawal by Subject|0|||
145378183|NCT04068688|524235918|FG004|Overall Study|Withdrawal by Subject|0|||
145378184|NCT04068688|524235919|FG005|Overall Study|Withdrawal by Subject|0|||
145378185|NCT04068688|524235920|FG006|Overall Study|Withdrawal by Subject|0|||
145378186|NCT04068688|524235921|FG007|Overall Study|Withdrawal by Subject|0|||
145378187|NCT04068688|524235922|FG008|Overall Study|Withdrawal by Subject|0|||
145378188|NCT04068688|524235923|FG009|Overall Study|Withdrawal by Subject|0|||
145378189|NCT04068688|524235914|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
145378190|NCT04068688|524235915|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
145378191|NCT04068688|524235916|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378192|NCT04068688|524235917|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378193|NCT04068688|524235918|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378194|NCT04068688|524235919|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378195|NCT04068688|524235920|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378196|NCT04068688|524235921|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378197|NCT04068688|524235922|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378198|NCT04068688|524235923|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
145378199|NCT02554318|524235926|FG000|Overall Study|Withdrawal by Subject|10|||
145378200|NCT02554318|524235927|FG001|Overall Study|Withdrawal by Subject|8|||
145378201|NCT03436199|524235928|FG000|Overall Study|Adverse Event|15|||
145378202|NCT03436199|524235929|FG001|Overall Study|Adverse Event|40|||
145378203|NCT03436199|524235930|FG002|Overall Study|Adverse Event|7|||
145378204|NCT03436199|524235928|FG000|Overall Study|Withdrawal by Subject|4|||
145378205|NCT03436199|524235929|FG001|Overall Study|Withdrawal by Subject|10|||
145378206|NCT03436199|524235930|FG002|Overall Study|Withdrawal by Subject|3|||
145378207|NCT03436199|524235928|FG000|Overall Study|Lost to Follow-up|1|||
145378208|NCT03436199|524235929|FG001|Overall Study|Lost to Follow-up|0|||
145378209|NCT03436199|524235930|FG002|Overall Study|Lost to Follow-up|2|||
145378210|NCT03436199|524235928|FG000|Overall Study|Protocol Violation|1|||
145378211|NCT03436199|524235929|FG001|Overall Study|Protocol Violation|1|||
145378212|NCT03436199|524235930|FG002|Overall Study|Protocol Violation|0|||
145378213|NCT03436199|524235928|FG000|Overall Study|Physician Decision|0|||
145378214|NCT03436199|524235929|FG001|Overall Study|Physician Decision|1|||
145378215|NCT03436199|524235930|FG002|Overall Study|Physician Decision|0|||
145378216|NCT03436199|524235928|FG000|Overall Study|Could not return to clinic|1|||
145378217|NCT03436199|524235929|FG001|Overall Study|Could not return to clinic|0|||
145378218|NCT03436199|524235930|FG002|Overall Study|Could not return to clinic|0|||
145378219|NCT03436199|524235928|FG000|Overall Study|Withdrawn per physician|0|||
145378220|NCT03436199|524235929|FG001|Overall Study|Withdrawn per physician|1|||
145378221|NCT03436199|524235930|FG002|Overall Study|Withdrawn per physician|0|||
145378222|NCT02631070|524235931|FG000|Overall Study|Withdrawal by Subject|35|||
145378223|NCT02631070|524235932|FG001|Overall Study|Withdrawal by Subject|13|||
145378224|NCT02631070|524235931|FG000|Overall Study|Death|45|||
145378225|NCT02631070|524235932|FG001|Overall Study|Death|24|||
145378226|NCT02631070|524235931|FG000|Overall Study|Lost to Follow-up|5|||
145378227|NCT02631070|524235932|FG001|Overall Study|Lost to Follow-up|1|||
145378228|NCT02631070|524235931|FG000|Overall Study|Transition to rollover protocol|52|||
145378229|NCT02631070|524235932|FG001|Overall Study|Transition to rollover protocol|21|||
145378230|NCT02631070|524235931|FG000|Overall Study|Other reasons|12|||
145378231|NCT02631070|524235932|FG001|Overall Study|Other reasons|5|||
145378232|NCT00085098|524235938|FG000|Overall Study|Withdrawal by Subject|0|||
145378233|NCT00085098|524235939|FG001|Overall Study|Withdrawal by Subject|1|||
145378234|NCT00085098|524235938|FG000|Overall Study|Ineligible|1|||
145378235|NCT00085098|524235939|FG001|Overall Study|Ineligible|1|||
145378236|NCT01195844|524235942|FG000|Overall Study|Fecal sample not collected|40|||
145378237|NCT00980018|524235947|FG000|Overall Study|Adverse Event|8|||
145378238|NCT00980018|524235947|FG000|Overall Study|Patient withdrew consent|3|||
145378239|NCT00980018|524235947|FG000|Overall Study|Lost to Follow-up|1|||
145378240|NCT01432275|524235948|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
145378241|NCT01432275|524235949|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
145378242|NCT01432275|524235948|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
145378243|NCT01432275|524235949|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
145378244|NCT01432275|524235948|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
145378245|NCT01432275|524235949|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
145378246|NCT01432275|524235948|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
145378247|NCT01432275|524235949|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
145378248|NCT01432275|524235948|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
145378249|NCT01432275|524235949|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
145378250|NCT01432275|524235948|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
145378251|NCT01432275|524235949|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
145378252|NCT01432275|524235948|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
145378253|NCT01432275|524235949|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
145378254|NCT01432275|524235948|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
145378255|NCT01432275|524235949|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
145378256|NCT01432275|524235948|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
145378257|NCT01432275|524235949|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
145378258|NCT02565706|524235950|FG000|Overall Study|Withdrawal by Subject|5|||
145378259|NCT02565706|524235951|FG001|Overall Study|Withdrawal by Subject|7|||
145378260|NCT02565706|524235952|FG002|Overall Study|Withdrawal by Subject|7|||
145378261|NCT02565706|524235953|FG003|Overall Study|Withdrawal by Subject|11|||
145378262|NCT02565706|524235950|FG000|Overall Study|Lost to Follow-up|72|||
145378263|NCT02565706|524235951|FG001|Overall Study|Lost to Follow-up|75|||
145378264|NCT02565706|524235952|FG002|Overall Study|Lost to Follow-up|82|||
145378265|NCT02565706|524235953|FG003|Overall Study|Lost to Follow-up|74|||
145378266|NCT00934856|524235954|FG000|Feasibility Part|Progressive disease|4|||
145378267|NCT00934856|524235955|FG001|Feasibility Part|Progressive disease|4|||
145378268|NCT00934856|524235956|FG002|Feasibility Part|Progressive disease|2|||
145378269|NCT00934856|524235957|FG003|Feasibility Part|Progressive disease|3|||
145378270|NCT00934856|524235958|FG004|Feasibility Part|Progressive disease|0|||
145378271|NCT00934856|524235959|FG005|Feasibility Part|Progressive disease|0|||
145378272|NCT00934856|524235954|FG000|Feasibility Part|Physician Decision|0|||
145378273|NCT00934856|524235955|FG001|Feasibility Part|Physician Decision|0|||
145378274|NCT00934856|524235956|FG002|Feasibility Part|Physician Decision|1|||
145378275|NCT00934856|524235957|FG003|Feasibility Part|Physician Decision|0|||
145378276|NCT00934856|524235958|FG004|Feasibility Part|Physician Decision|0|||
145378277|NCT00934856|524235959|FG005|Feasibility Part|Physician Decision|0|||
145378278|NCT00934856|524235954|FG000|Feasibility Part|Adverse Event|1|||
145378279|NCT00934856|524235955|FG001|Feasibility Part|Adverse Event|1|||
145378280|NCT00934856|524235956|FG002|Feasibility Part|Adverse Event|0|||
145378281|NCT00934856|524235957|FG003|Feasibility Part|Adverse Event|1|||
145378282|NCT00934856|524235958|FG004|Feasibility Part|Adverse Event|0|||
145378283|NCT00934856|524235959|FG005|Feasibility Part|Adverse Event|2|||
145378284|NCT00934856|524235954|FG000|Feasibility Part|Withdrawal by Subject|0|||
145378285|NCT00934856|524235955|FG001|Feasibility Part|Withdrawal by Subject|0|||
145378286|NCT00934856|524235956|FG002|Feasibility Part|Withdrawal by Subject|0|||
145378287|NCT00934856|524235957|FG003|Feasibility Part|Withdrawal by Subject|1|||
145378288|NCT00934856|524235958|FG004|Feasibility Part|Withdrawal by Subject|0|||
145378289|NCT00934856|524235959|FG005|Feasibility Part|Withdrawal by Subject|1|||
145378290|NCT00934856|524235954|FG000|Extension Part|Adverse Event|0|||
145378291|NCT00934856|524235955|FG001|Extension Part|Adverse Event|0|||
145378292|NCT00934856|524235956|FG002|Extension Part|Adverse Event|0|||
145378293|NCT00934856|524235957|FG003|Extension Part|Adverse Event|1|||
145378294|NCT00934856|524235958|FG004|Extension Part|Adverse Event|4|||
145378295|NCT00934856|524235959|FG005|Extension Part|Adverse Event|4|||
145378296|NCT00934856|524235954|FG000|Extension Part|Progressive disease|0|||
145378297|NCT00934856|524235955|FG001|Extension Part|Progressive disease|0|||
145378298|NCT00934856|524235956|FG002|Extension Part|Progressive disease|0|||
145378299|NCT00934856|524235957|FG003|Extension Part|Progressive disease|1|||
145378300|NCT00934856|524235958|FG004|Extension Part|Progressive disease|0|||
145378301|NCT00934856|524235959|FG005|Extension Part|Progressive disease|0|||
145378302|NCT00934856|524235954|FG000|Extension Part|Non-compliance with drug|0|||
145378303|NCT00934856|524235955|FG001|Extension Part|Non-compliance with drug|0|||
145378304|NCT00934856|524235956|FG002|Extension Part|Non-compliance with drug|0|||
145378305|NCT00934856|524235957|FG003|Extension Part|Non-compliance with drug|0|||
145378306|NCT00934856|524235958|FG004|Extension Part|Non-compliance with drug|0|||
145378307|NCT00934856|524235959|FG005|Extension Part|Non-compliance with drug|1|||
145378308|NCT00772005|524235964|FG000|Overall Study|Adverse Event|9|||
145378309|NCT00772005|524235965|FG001|Overall Study|Adverse Event|14|||
145378310|NCT00772005|524235966|FG002|Overall Study|Adverse Event|10|||
145378311|NCT00772005|524235967|FG003|Overall Study|Adverse Event|13|||
145378312|NCT00772005|524235964|FG000|Overall Study|Lack of Efficacy|0|||
145378313|NCT00772005|524235965|FG001|Overall Study|Lack of Efficacy|1|||
145378314|NCT00772005|524235966|FG002|Overall Study|Lack of Efficacy|0|||
145378315|NCT00772005|524235967|FG003|Overall Study|Lack of Efficacy|0|||
145378316|NCT00772005|524235964|FG000|Overall Study|Withdrawal by Subject|3|||
145378317|NCT00772005|524235965|FG001|Overall Study|Withdrawal by Subject|7|||
145378318|NCT00772005|524235966|FG002|Overall Study|Withdrawal by Subject|10|||
145378319|NCT00772005|524235967|FG003|Overall Study|Withdrawal by Subject|2|||
145378320|NCT00772005|524235964|FG000|Overall Study|Protocol Violation|2|||
145378321|NCT00772005|524235965|FG001|Overall Study|Protocol Violation|4|||
145378322|NCT00772005|524235966|FG002|Overall Study|Protocol Violation|1|||
145378323|NCT00772005|524235967|FG003|Overall Study|Protocol Violation|6|||
145378324|NCT00772005|524235964|FG000|Overall Study|Lost to Follow-up|7|||
145378325|NCT00772005|524235965|FG001|Overall Study|Lost to Follow-up|3|||
145378326|NCT00772005|524235966|FG002|Overall Study|Lost to Follow-up|6|||
145378327|NCT00772005|524235967|FG003|Overall Study|Lost to Follow-up|3|||
145378328|NCT00772005|524235964|FG000|Overall Study|Non-compliance with study procedures|1|||
145378329|NCT00772005|524235965|FG001|Overall Study|Non-compliance with study procedures|1|||
145378330|NCT00772005|524235966|FG002|Overall Study|Non-compliance with study procedures|0|||
145378331|NCT00772005|524235967|FG003|Overall Study|Non-compliance with study procedures|1|||
145378332|NCT00772005|524235964|FG000|Overall Study|Non-compliance with drug administration|3|||
145378333|NCT00772005|524235965|FG001|Overall Study|Non-compliance with drug administration|0|||
145378334|NCT00772005|524235966|FG002|Overall Study|Non-compliance with drug administration|1|||
145378335|NCT00772005|524235967|FG003|Overall Study|Non-compliance with drug administration|1|||
145378336|NCT03887117|524235980|FG000|Overall Study|Discontinued prematurely|0|||
145378337|NCT03887117|524235981|FG001|Overall Study|Discontinued prematurely|1|||
145378338|NCT03887117|524235982|FG002|Overall Study|Discontinued prematurely|1|||
145378339|NCT03887117|524235983|FG003|Overall Study|Discontinued prematurely|2|||
145378340|NCT02584959|524235984|FG000|Period 1|Withdrawn from study|3|||
145378341|NCT02584959|524235985|FG001|Period 1|Withdrawn from study|4|||
145378342|NCT02584959|524235986|FG002|Period 1|Withdrawn from study|0|||
145378343|NCT02584959|524235984|FG000|Period 2|Withdrawn from study|6|||
145378344|NCT02584959|524235985|FG001|Period 2|Withdrawn from study|1|||
145378345|NCT02584959|524235986|FG002|Period 2|Withdrawn from study|2|||
145378346|NCT00513357|524235989|FG000|Overall Study|did not receive allocated placebo|2|||
145378347|NCT00513357|524235990|FG001|Overall Study|did not receive allocated placebo|3|||
145378348|NCT00513357|524235989|FG000|Overall Study|Adverse Event|4|||
145378349|NCT00513357|524235990|FG001|Overall Study|Adverse Event|2|||
145378350|NCT00513357|524235989|FG000|Overall Study|Death|2|||
145378351|NCT00513357|524235990|FG001|Overall Study|Death|0|||
145378352|NCT00513357|524235989|FG000|Overall Study|Withdrawal by Subject|5|||
145378353|NCT00513357|524235990|FG001|Overall Study|Withdrawal by Subject|4|||
145378354|NCT00513357|524235989|FG000|Overall Study|Disease Progression|2|||
145378355|NCT00513357|524235990|FG001|Overall Study|Disease Progression|1|||
145378356|NCT03301844|524235991|FG000|Overall Study|suspected colon cancer|1|||
145378357|NCT03301844|524235992|FG001|Overall Study|suspected colon cancer|1|||
145378358|NCT00501059|524235993|FG000|Overall Study|Protocol Violation|80|||
145378359|NCT00501059|524235994|FG001|Overall Study|Protocol Violation|69|||
145378360|NCT00501059|524235993|FG000|Overall Study|Death|140|||
145378361|NCT00501059|524235994|FG001|Overall Study|Death|137|||
145378362|NCT00501059|524235993|FG000|Overall Study|Other|236|||
145378363|NCT00501059|524235994|FG001|Overall Study|Other|239|||
145378364|NCT00501059|524235993|FG000|Overall Study|Missing end-of-study page|91|||
145378365|NCT00501059|524235994|FG001|Overall Study|Missing end-of-study page|92|||
145378366|NCT00501059|524235993|FG000|Overall Study|Clinical endpoint reached|110|||
145378367|NCT00501059|524235994|FG001|Overall Study|Clinical endpoint reached|123|||
145378368|NCT00501059|524235993|FG000|Overall Study|Insufficient therapeutic effect|4|||
145378369|NCT00501059|524235994|FG001|Overall Study|Insufficient therapeutic effect|5|||
145378370|NCT00501059|524235993|FG000|Overall Study|Consent withdrawn by subject|817|||
145378371|NCT00501059|524235994|FG001|Overall Study|Consent withdrawn by subject|873|||
145378372|NCT00501059|524235993|FG000|Overall Study|Non-compliant with study treatment|23|||
145378373|NCT00501059|524235994|FG001|Overall Study|Non-compliant with study treatment|16|||
145378374|NCT00501059|524235993|FG000|Overall Study|Reason not given|3|||
145378375|NCT00501059|524235994|FG001|Overall Study|Reason not given|1|||
145378376|NCT00501059|524235993|FG000|Overall Study|Adverse Event|129|||
145378377|NCT00501059|524235994|FG001|Overall Study|Adverse Event|122|||
145378378|NCT00501059|524235993|FG000|Overall Study|Lost to Follow-up|210|||
145378379|NCT00501059|524235994|FG001|Overall Study|Lost to Follow-up|198|||
145378380|NCT00501059|524235993|FG000|Overall Study|Not treated|25|||
145378381|NCT00501059|524235994|FG001|Overall Study|Not treated|17|||
145378382|NCT00637806|524235997|FG000|Double-blind Phase|Study Discontinued|2|||
145378383|NCT00637806|524235998|FG001|Double-blind Phase|Study Discontinued|0|||
145378384|NCT00637806|524235999|FG002|Double-blind Phase|Study Discontinued|1|||
145378385|NCT00637806|524236000|FG003|Double-blind Phase|Study Discontinued|0|||
145378386|NCT00637806|524235997|FG000|Extension Phase|Study Discontinued|0|||
145378387|NCT00637806|524235998|FG001|Extension Phase|Study Discontinued|0|||
145378388|NCT00637806|524235999|FG002|Extension Phase|Study Discontinued|0|||
145378389|NCT00637806|524236000|FG003|Extension Phase|Study Discontinued|1|||
145378390|NCT01592292|524236001|FG000|Overall Study|Follow-up loss|3|||
145378391|NCT01592292|524236002|FG001|Overall Study|Follow-up loss|3|||
145378392|NCT01592292|524236003|FG002|Overall Study|Follow-up loss|1|||
145378393|NCT01592292|524236004|FG003|Overall Study|Follow-up loss|0|||
145378394|NCT01592292|524236001|FG000|Overall Study|Withdrew consent|2|||
145378395|NCT01592292|524236002|FG001|Overall Study|Withdrew consent|1|||
145378396|NCT01592292|524236003|FG002|Overall Study|Withdrew consent|0|||
145378397|NCT01592292|524236004|FG003|Overall Study|Withdrew consent|0|||
145378398|NCT01592292|524236001|FG000|Overall Study|Other|1|||
145378399|NCT01592292|524236002|FG001|Overall Study|Other|1|||
145378400|NCT01592292|524236003|FG002|Overall Study|Other|2|||
145378401|NCT01592292|524236004|FG003|Overall Study|Other|1|||
145378402|NCT00819780|524236005|FG000|Overall Study|Did not receive study drug|3|||
145378403|NCT00819780|524236006|FG001|Overall Study|Did not receive study drug|4|||
145378404|NCT00819780|524236005|FG000|Overall Study|Still in treatment|25|||
145378405|NCT00819780|524236006|FG001|Overall Study|Still in treatment|17|||
145378406|NCT00948506|524236007|FG000|Overall Study|Withdrawal by Subject|3|||
145378407|NCT00948506|524236008|FG001|Overall Study|Withdrawal by Subject|1|||
145378408|NCT00157248|524236009|FG000|Overall Study|Adverse Event|36|||
145378409|NCT00157248|524236010|FG001|Overall Study|Adverse Event|25|||
145378410|NCT00157248|524236011|FG002|Overall Study|Adverse Event|13|||
145378411|NCT00157248|524236012|FG003|Overall Study|Adverse Event|33|||
145378412|NCT00157248|524236009|FG000|Overall Study|Protocol Violation|4|||
145378413|NCT00157248|524236010|FG001|Overall Study|Protocol Violation|0|||
145378414|NCT00157248|524236011|FG002|Overall Study|Protocol Violation|2|||
145378415|NCT00157248|524236012|FG003|Overall Study|Protocol Violation|2|||
145378416|NCT00157248|524236009|FG000|Overall Study|Lost to Follow-up|0|||
145378417|NCT00157248|524236010|FG001|Overall Study|Lost to Follow-up|1|||
145378418|NCT00157248|524236011|FG002|Overall Study|Lost to Follow-up|0|||
145378419|NCT00157248|524236012|FG003|Overall Study|Lost to Follow-up|0|||
145378420|NCT00157248|524236009|FG000|Overall Study|Withdrawal by Subject|1|||
145378421|NCT00157248|524236010|FG001|Overall Study|Withdrawal by Subject|4|||
145378422|NCT00157248|524236011|FG002|Overall Study|Withdrawal by Subject|3|||
145378423|NCT00157248|524236012|FG003|Overall Study|Withdrawal by Subject|3|||
145378424|NCT00157248|524236009|FG000|Overall Study|site closures, subject moving|7|||
145378425|NCT00157248|524236010|FG001|Overall Study|site closures, subject moving|7|||
145378426|NCT00157248|524236011|FG002|Overall Study|site closures, subject moving|3|||
145378427|NCT00157248|524236012|FG003|Overall Study|site closures, subject moving|9|||
145378428|NCT01447927|524236013|FG000|Overall Study|Adverse Event|4|||
145378429|NCT01447927|524236014|FG001|Overall Study|Adverse Event|3|||
145378430|NCT01447927|524236013|FG000|Overall Study|Withdrawal by Subject|1|||
145378431|NCT01447927|524236014|FG001|Overall Study|Withdrawal by Subject|0|||
145378432|NCT02093390|524236019|FG000|Overall Study|Withdrawal by Subject|0|||
145378433|NCT02093390|524236020|FG001|Overall Study|Withdrawal by Subject|1|||
145378434|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
145378435|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
145378436|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
145378437|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
145378438|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
145378439|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
145378440|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
145378441|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
145378442|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
145378443|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
145378444|NCT01777139|524237240|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
145378445|NCT01777139|524237241|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
145378446|NCT01777139|524237240|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
145378447|NCT01777139|524237241|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
145378448|NCT01777139|524237240|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
145378449|NCT01777139|524237241|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
145378450|NCT01887288|524237242|FG000|Overall Study|The study was terminated and the PI has|16|||
145378451|NCT01092637|524237243|FG000|Overall Study|Death|47|||
145378452|NCT01092637|524237244|FG001|Overall Study|Death|49|||
145378453|NCT00593606|524237245|FG000|Overall Study|Adverse Event|13|||
145378454|NCT00593606|524237245|FG000|Overall Study|Withdrawal by Subject|1|||
145378455|NCT00593606|524237245|FG000|Overall Study|Protocol Violation|3|||
145378456|NCT00593606|524237245|FG000|Overall Study|Lost to Follow-up|2|||
145378457|NCT00593606|524237245|FG000|Overall Study|Run-In Failure|5|||
145378458|NCT00593606|524237245|FG000|Overall Study|Screen Failure|3|||
145378461|NCT03309696|524237248|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
145378462|NCT03309696|524237249|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
145378463|NCT02278367|524237250|FG000|Overall Study|Physician Decision|5|||
145378464|NCT02278367|524237251|FG001|Overall Study|Physician Decision|0|||
145378465|NCT02278367|524237250|FG000|Overall Study|Withdrawal by Subject|5|||
145378466|NCT02278367|524237251|FG001|Overall Study|Withdrawal by Subject|0|||
145378467|NCT04643964|524237253|FG000|Overall Study|Lost to Follow-up|55|||
145378468|NCT04643964|524237254|FG001|Overall Study|Lost to Follow-up|59|||
145378469|NCT04643964|524237255|FG002|Overall Study|Lost to Follow-up|54|||
145378470|NCT04643964|524237256|FG003|Overall Study|Lost to Follow-up|129|||
145378471|NCT04643964|524237257|FG004|Overall Study|Lost to Follow-up|48|||
145378472|NCT04643964|524237253|FG000|Overall Study|Failed attention check|1|||
145378473|NCT04643964|524237254|FG001|Overall Study|Failed attention check|8|||
145378474|NCT04643964|524237255|FG002|Overall Study|Failed attention check|2|||
145378475|NCT04643964|524237256|FG003|Overall Study|Failed attention check|14|||
145378476|NCT04643964|524237257|FG004|Overall Study|Failed attention check|11|||
145378477|NCT02638129|524237258|FG000|Overall Study|Study terminated|28|||
145378478|NCT02638129|524237259|FG001|Overall Study|Study terminated|30|||
145378479|NCT00869557|524237260|FG000|Randomized Phase|Lost to Follow-up|2|||
145378480|NCT00869557|524237261|FG001|Randomized Phase|Lost to Follow-up|1|||
145378481|NCT00869557|524237260|FG000|Randomized Phase|Investigator's Discretion|1|||
145378482|NCT00869557|524237261|FG001|Randomized Phase|Investigator's Discretion|0|||
145378483|NCT00869557|524237260|FG000|Randomized Phase|Withdrew Consent|0|||
145378484|NCT00869557|524237261|FG001|Randomized Phase|Withdrew Consent|1|||
145378485|NCT00869557|524237260|FG000|Extension Phase|Adverse Event|2|||
145378486|NCT00869557|524237261|FG001|Extension Phase|Adverse Event|2|||
145378487|NCT00869557|524237260|FG000|Extension Phase|Lack of Efficacy|1|||
145378488|NCT00869557|524237261|FG001|Extension Phase|Lack of Efficacy|0|||
145378489|NCT00869557|524237260|FG000|Extension Phase|Lost to Follow-up|3|||
145378490|NCT00869557|524237261|FG001|Extension Phase|Lost to Follow-up|1|||
145378491|NCT00869557|524237260|FG000|Extension Phase|Investigator's Discretion|2|||
145378492|NCT00869557|524237261|FG001|Extension Phase|Investigator's Discretion|0|||
145378493|NCT00869557|524237260|FG000|Extension Phase|Withdrew Consent|2|||
145378494|NCT00869557|524237261|FG001|Extension Phase|Withdrew Consent|0|||
145378495|NCT02368210|524237262|FG000|Overall Study|Withdrawal by Subject|1|||
145378496|NCT02368210|524237263|FG001|Overall Study|Withdrawal by Subject|0|||
145378497|NCT02368210|524237262|FG000|Overall Study|Adverse Event|0|||
145378498|NCT02368210|524237263|FG001|Overall Study|Adverse Event|1|||
145378499|NCT00577005|524237264|FG000|Overall Study|Lost to Follow-up|3|||
145378500|NCT00577005|524237265|FG001|Overall Study|Lost to Follow-up|2|||
145378501|NCT00577005|524237264|FG000|Overall Study|Withdrawal by Subject|2|||
145378502|NCT00577005|524237265|FG001|Overall Study|Withdrawal by Subject|1|||
145378503|NCT01149421|524237269|FG000|Overall Study|Adverse Event|22|||
145378504|NCT01149421|524237270|FG001|Overall Study|Adverse Event|6|||
145378505|NCT01149421|524237271|FG002|Overall Study|Adverse Event|11|||
145378506|NCT01149421|524237269|FG000|Overall Study|Withdrawal by Subject|20|||
145378507|NCT01149421|524237270|FG001|Overall Study|Withdrawal by Subject|12|||
145378508|NCT01149421|524237271|FG002|Overall Study|Withdrawal by Subject|13|||
145378509|NCT01149421|524237269|FG000|Overall Study|Sponsor Decision|0|||
145378510|NCT01149421|524237270|FG001|Overall Study|Sponsor Decision|1|||
145378511|NCT01149421|524237271|FG002|Overall Study|Sponsor Decision|1|||
145378512|NCT01149421|524237269|FG000|Overall Study|Lost to Follow-up|2|||
145378513|NCT01149421|524237270|FG001|Overall Study|Lost to Follow-up|4|||
145378514|NCT01149421|524237271|FG002|Overall Study|Lost to Follow-up|5|||
145378515|NCT01149421|524237269|FG000|Overall Study|Physician Decision|5|||
145378516|NCT01149421|524237270|FG001|Overall Study|Physician Decision|3|||
145378517|NCT01149421|524237271|FG002|Overall Study|Physician Decision|6|||
145378518|NCT01149421|524237269|FG000|Overall Study|Entry Criteria Not Met|1|||
145378519|NCT01149421|524237270|FG001|Overall Study|Entry Criteria Not Met|1|||
145378520|NCT01149421|524237271|FG002|Overall Study|Entry Criteria Not Met|2|||
145378521|NCT01149421|524237269|FG000|Overall Study|Protocol Violation|2|||
145378522|NCT01149421|524237270|FG001|Overall Study|Protocol Violation|2|||
145378523|NCT01149421|524237271|FG002|Overall Study|Protocol Violation|6|||
145378524|NCT03738800|524237279|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
145378525|NCT03738800|524237280|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
145378526|NCT03738800|524237281|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
145378527|NCT03738800|524237279|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
145378528|NCT03738800|524237280|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
145378529|NCT03738800|524237281|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
145378530|NCT03738800|524237279|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
145378531|NCT03738800|524237280|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
145378532|NCT03738800|524237281|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
145378533|NCT02223819|524237283|FG000|Overall Study|Lost to Follow-up|2|||
145378534|NCT02956057|524237285|FG000|Overall Study|Discontinued intervention|14|||
145378535|NCT02956057|524237286|FG001|Overall Study|Discontinued intervention|10|||
145378536|NCT02956057|524237287|FG002|Overall Study|Discontinued intervention|7|||
145378537|NCT02956057|524237288|FG003|Overall Study|Discontinued intervention|14|||
145378538|NCT02956057|524237289|FG004|Overall Study|Discontinued intervention|4|||
145378539|NCT02956057|524237290|FG005|Overall Study|Discontinued intervention|17|||
145378540|NCT02956057|524237285|FG000|Overall Study|Lost to Follow-up|0|||
145378541|NCT02956057|524237286|FG001|Overall Study|Lost to Follow-up|2|||
145378542|NCT02956057|524237287|FG002|Overall Study|Lost to Follow-up|1|||
145378543|NCT02956057|524237288|FG003|Overall Study|Lost to Follow-up|1|||
145378544|NCT02956057|524237289|FG004|Overall Study|Lost to Follow-up|1|||
145378545|NCT02956057|524237290|FG005|Overall Study|Lost to Follow-up|0|||
145378546|NCT03435224|524237293|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
145378547|NCT04007107|524237298|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145378548|NCT04007107|524237299|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
145378549|NCT04007107|524237300|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145378550|NCT04007107|524237301|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
145378551|NCT04526574|524237302|FG000|Overall Study|Protocol Violation|3|||
145378552|NCT04526574|524237303|FG001|Overall Study|Protocol Violation|1|||
145378553|NCT04526574|524237302|FG000|Overall Study|Withdrawal by Subject|12|||
145378554|NCT04526574|524237303|FG001|Overall Study|Withdrawal by Subject|9|||
145378555|NCT04526574|524237302|FG000|Overall Study|Other|1|||
145378556|NCT04526574|524237303|FG001|Overall Study|Other|2|||
145378557|NCT04526574|524237302|FG000|Overall Study|Adverse Event|1|||
145378558|NCT04526574|524237303|FG001|Overall Study|Adverse Event|1|||
145378559|NCT04526574|524237302|FG000|Overall Study|Death|2|||
145378560|NCT04526574|524237303|FG001|Overall Study|Death|3|||
145378561|NCT04526574|524237302|FG000|Overall Study|Lost to Follow-up|9|||
145378562|NCT04526574|524237303|FG001|Overall Study|Lost to Follow-up|9|||
145378563|NCT04526574|524237302|FG000|Overall Study|No longer meets eligibility criteria|8|||
145378564|NCT04526574|524237303|FG001|Overall Study|No longer meets eligibility criteria|8|||
145378565|NCT04679051|524237309|FG000|Overall Study|felt tired after restricted time in bed|3|||
145378566|NCT04679051|524237310|FG001|Overall Study|felt tired after restricted time in bed|0|||
145378567|NCT04679051|524237309|FG000|Overall Study|discomfort with blood pressure cuff|2|||
145378568|NCT04679051|524237310|FG001|Overall Study|discomfort with blood pressure cuff|0|||
145378569|NCT04679051|524237309|FG000|Overall Study|scheduling conflict|1|||
145378570|NCT04679051|524237310|FG001|Overall Study|scheduling conflict|1|||
145378571|NCT04679051|524237309|FG000|Overall Study|Protocol Violation|0|||
145378572|NCT04679051|524237310|FG001|Overall Study|Protocol Violation|4|||
145378573|NCT00426660|524237311|FG000|Overall Study|Death|14|||
145378574|NCT00426660|524237311|FG000|Overall Study|Adverse Event|23|||
145378575|NCT00426660|524237311|FG000|Overall Study|Insufficient Clinical Response|22|||
145378576|NCT00426660|524237311|FG000|Overall Study|Lost to Follow-up|15|||
145378577|NCT00426660|524237311|FG000|Overall Study|Other|23|||
145378578|NCT00426660|524237311|FG000|Overall Study|Withdrawal by Subject|18|||
145378579|NCT00426660|524237311|FG000|Overall Study|Protocol Violation|1|||
145378580|NCT00426660|524237311|FG000|Overall Study|Enrolled Not Treated|15|||
145378581|NCT00980174|524237312|FG000|Overall Study|Withdrawal by Subject|1|||
145378582|NCT00980174|524237313|FG001|Overall Study|Withdrawal by Subject|4|||
145378583|NCT00980174|524237312|FG000|Overall Study|Adverse Event|0|||
145378584|NCT00980174|524237313|FG001|Overall Study|Adverse Event|3|||
145378585|NCT00980174|524237312|FG000|Overall Study|Ineligibility determined|2|||
145378586|NCT00980174|524237313|FG001|Overall Study|Ineligibility determined|1|||
145378587|NCT00980174|524237312|FG000|Overall Study|Death|1|||
145378588|NCT00980174|524237313|FG001|Overall Study|Death|1|||
145378589|NCT00980174|524237312|FG000|Overall Study|Other|0|||
145378590|NCT00980174|524237313|FG001|Overall Study|Other|1|||
145378591|NCT00329641|524237315|FG000|Overall Study|Did not start treatment|1|||
145378592|NCT00329641|524237315|FG000|Overall Study|Not eligible|1|||
145378593|NCT00329641|524237315|FG000|Overall Study|Adverse Event|3|||
145378594|NCT00329641|524237315|FG000|Overall Study|Other reason, not protocol specified|1|||
145378595|NCT00396877|524237317|FG000|Overall Study|Lost to Follow-up|2|||
145378596|NCT00396877|524237318|FG001|Overall Study|Lost to Follow-up|1|||
145378597|NCT00396877|524237317|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
145378598|NCT00396877|524237318|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
145378599|NCT02945254|524237319|FG000|Overall Study|Lost to Follow-up|1|||
145378600|NCT02945254|524237320|FG001|Overall Study|Lost to Follow-up|0|||
145378601|NCT02945254|524237319|FG000|Overall Study|Withdrawal by Subject|1|||
145378602|NCT02945254|524237320|FG001|Overall Study|Withdrawal by Subject|0|||
145378603|NCT00334802|524237321|FG000|Overall Study|Progressive Disease|2|||
145378604|NCT00334802|524237322|FG001|Overall Study|Progressive Disease|24|||
145378605|NCT00334802|524237321|FG000|Overall Study|Toxicity|1|||
145378606|NCT00334802|524237322|FG001|Overall Study|Toxicity|5|||
145378607|NCT00334802|524237321|FG000|Overall Study|Lack of Efficacy|1|||
145378608|NCT00334802|524237322|FG001|Overall Study|Lack of Efficacy|3|||
145378609|NCT00334802|524237321|FG000|Overall Study|Patient Condition Aggrevated|1|||
145378610|NCT00334802|524237322|FG001|Overall Study|Patient Condition Aggrevated|0|||
145378611|NCT00334802|524237321|FG000|Overall Study|Physician Decision|1|||
145378612|NCT00334802|524237322|FG001|Overall Study|Physician Decision|0|||
145378613|NCT00334802|524237321|FG000|Overall Study|Withdrawal by Subject|0|||
145378614|NCT00334802|524237322|FG001|Overall Study|Withdrawal by Subject|4|||
145378617|NCT00334802|524237321|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
145378618|NCT00334802|524237322|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
145378619|NCT02470403|524237323|FG000|Overall Study|Adverse Event|1|||
145378620|NCT02470403|524237324|FG001|Overall Study|Adverse Event|0|||
145378621|NCT02470403|524237325|FG002|Overall Study|Adverse Event|0|||
145378622|NCT02470403|524237326|FG003|Overall Study|Adverse Event|0|||
145378623|NCT02470403|524237327|FG004|Overall Study|Adverse Event|0|||
145378624|NCT02470403|524237323|FG000|Overall Study|Lost to Follow-up|0|||
145378625|NCT02470403|524237324|FG001|Overall Study|Lost to Follow-up|1|||
145378626|NCT02470403|524237325|FG002|Overall Study|Lost to Follow-up|0|||
145378627|NCT02470403|524237326|FG003|Overall Study|Lost to Follow-up|0|||
145378628|NCT02470403|524237327|FG004|Overall Study|Lost to Follow-up|0|||
145378629|NCT02470403|524237323|FG000|Overall Study|Subject/guardian decision|1|||
145378630|NCT02470403|524237324|FG001|Overall Study|Subject/guardian decision|0|||
145378631|NCT02470403|524237325|FG002|Overall Study|Subject/guardian decision|0|||
145378632|NCT02470403|524237326|FG003|Overall Study|Subject/guardian decision|4|||
145378633|NCT02470403|524237327|FG004|Overall Study|Subject/guardian decision|0|||
145378634|NCT03422159|524237328|FG000|Overall Study|Exclusion due to terminal disease|2|||
145378635|NCT03422159|524237329|FG001|Overall Study|Exclusion due to terminal disease|1|||
145378636|NCT03329248|524237330|FG000|Overall Study|Progressive Disease|6|||
145378637|NCT01886781|524237331|FG000|Overall Study|Protocol Violation|5|||
145378638|NCT01886781|524237332|FG001|Overall Study|Protocol Violation|0|||
145378639|NCT01886781|524237331|FG000|Overall Study|Adverse Event|1|||
145378640|NCT01886781|524237332|FG001|Overall Study|Adverse Event|0|||
145378641|NCT01886781|524237331|FG000|Overall Study|Lost to Follow-up|5|||
145378642|NCT01886781|524237332|FG001|Overall Study|Lost to Follow-up|0|||
145378643|NCT01886781|524237331|FG000|Overall Study|Withdrawal by Subject|2|||
145378644|NCT01886781|524237332|FG001|Overall Study|Withdrawal by Subject|1|||
145378645|NCT01886781|524237331|FG000|Overall Study|Worsening of symptoms|1|||
145378646|NCT01886781|524237332|FG001|Overall Study|Worsening of symptoms|1|||
145378647|NCT01522235|524237333|FG000|Overall Study|Physician Decision|1|||
145378648|NCT01522235|524237334|FG001|Overall Study|Physician Decision|1|||
145378649|NCT00987402|524237335|FG000|Overall Study|Insufficient data entry|86|||
145378650|NCT00987402|524237336|FG001|Overall Study|Insufficient data entry|98|||
145378651|NCT03000530|524237337|FG000|Overall Study|Adverse Event|0|||
145378652|NCT03000530|524237338|FG001|Overall Study|Adverse Event|0|||
145378653|NCT03000530|524237339|FG002|Overall Study|Adverse Event|2|||
145378654|NCT03000530|524237337|FG000|Overall Study|Lost to Follow-up|0|||
145378655|NCT03000530|524237338|FG001|Overall Study|Lost to Follow-up|3|||
145378656|NCT03000530|524237339|FG002|Overall Study|Lost to Follow-up|1|||
145378657|NCT03000530|524237337|FG000|Overall Study|Withdrawal by Subject|0|||
145378658|NCT03000530|524237338|FG001|Overall Study|Withdrawal by Subject|2|||
145378659|NCT03000530|524237339|FG002|Overall Study|Withdrawal by Subject|1|||
145378660|NCT01430624|524237343|FG000|Overall Study|Lost to Follow-up|23|||
145378661|NCT01430624|524237344|FG001|Overall Study|Lost to Follow-up|29|||
145378662|NCT01430624|524237345|FG002|Overall Study|Lost to Follow-up|27|||
145378663|NCT01430624|524237343|FG000|Overall Study|technical or eligibility|5|||
145378664|NCT01430624|524237344|FG001|Overall Study|technical or eligibility|5|||
145378665|NCT01430624|524237345|FG002|Overall Study|technical or eligibility|2|||
145378666|NCT01362517|524237346|FG000|Overall Study|Protocol Violation|1|||
145378667|NCT01362517|524237346|FG000|Overall Study|Lost to Follow-up|1|||
145378668|NCT00195494|524237351|FG000|Year 1|Adverse Event|0|||
145378669|NCT00195494|524237352|FG001|Year 1|Adverse Event|0|||
145378670|NCT00195494|524237353|FG002|Year 1|Adverse Event|0|||
145378671|NCT00195494|524237354|FG003|Year 1|Adverse Event|0|||
145378672|NCT00195494|524237355|FG004|Year 1|Adverse Event|34|||
145378673|NCT00195494|524237356|FG005|Year 1|Adverse Event|27|||
145378674|NCT00195494|524237351|FG000|Year 1|System Toxicity|0|||
145378675|NCT00195494|524237352|FG001|Year 1|System Toxicity|0|||
145378676|NCT00195494|524237353|FG002|Year 1|System Toxicity|0|||
145378677|NCT00195494|524237354|FG003|Year 1|System Toxicity|0|||
145378678|NCT00195494|524237355|FG004|Year 1|System Toxicity|0|||
145378679|NCT00195494|524237356|FG005|Year 1|System Toxicity|1|||
145378680|NCT00195494|524237351|FG000|Year 1|Lack of Efficacy|0|||
145378681|NCT00195494|524237352|FG001|Year 1|Lack of Efficacy|0|||
145378682|NCT00195494|524237353|FG002|Year 1|Lack of Efficacy|0|||
145378683|NCT00195494|524237354|FG003|Year 1|Lack of Efficacy|0|||
145378684|NCT00195494|524237355|FG004|Year 1|Lack of Efficacy|24|||
145378685|NCT00195494|524237356|FG005|Year 1|Lack of Efficacy|9|||
145378686|NCT00195494|524237351|FG000|Year 1|Compliance|0|||
145378687|NCT00195494|524237352|FG001|Year 1|Compliance|0|||
145378688|NCT00195494|524237353|FG002|Year 1|Compliance|0|||
145378689|NCT00195494|524237354|FG003|Year 1|Compliance|0|||
145378690|NCT00195494|524237355|FG004|Year 1|Compliance|5|||
145378691|NCT00195494|524237356|FG005|Year 1|Compliance|1|||
145378692|NCT00195494|524237351|FG000|Year 1|Lost to Follow-up|0|||
145378693|NCT00195494|524237352|FG001|Year 1|Lost to Follow-up|0|||
145378694|NCT00195494|524237353|FG002|Year 1|Lost to Follow-up|0|||
145378695|NCT00195494|524237354|FG003|Year 1|Lost to Follow-up|0|||
145378696|NCT00195494|524237355|FG004|Year 1|Lost to Follow-up|1|||
145378697|NCT00195494|524237356|FG005|Year 1|Lost to Follow-up|0|||
145378698|NCT00195494|524237351|FG000|Year 1|Missed >4 consecutive doses|0|||
145378699|NCT00195494|524237352|FG001|Year 1|Missed >4 consecutive doses|0|||
145378700|NCT00195494|524237353|FG002|Year 1|Missed >4 consecutive doses|0|||
145378701|NCT00195494|524237354|FG003|Year 1|Missed >4 consecutive doses|0|||
145378702|NCT00195494|524237355|FG004|Year 1|Missed >4 consecutive doses|3|||
145378703|NCT00195494|524237356|FG005|Year 1|Missed >4 consecutive doses|2|||
145378704|NCT00195494|524237351|FG000|Year 1|Protocol deviation|0|||
145378705|NCT00195494|524237352|FG001|Year 1|Protocol deviation|0|||
145378706|NCT00195494|524237353|FG002|Year 1|Protocol deviation|0|||
145378707|NCT00195494|524237354|FG003|Year 1|Protocol deviation|0|||
145378708|NCT00195494|524237355|FG004|Year 1|Protocol deviation|2|||
145378709|NCT00195494|524237356|FG005|Year 1|Protocol deviation|3|||
145378710|NCT00195494|524237351|FG000|Year 1|Physician Decision|0|||
145378711|NCT00195494|524237352|FG001|Year 1|Physician Decision|0|||
145378712|NCT00195494|524237353|FG002|Year 1|Physician Decision|0|||
145378713|NCT00195494|524237354|FG003|Year 1|Physician Decision|0|||
145378714|NCT00195494|524237355|FG004|Year 1|Physician Decision|1|||
145378715|NCT00195494|524237356|FG005|Year 1|Physician Decision|0|||
145378716|NCT00195494|524237351|FG000|Year 1|Withdrawal by Subject|0|||
145378717|NCT00195494|524237352|FG001|Year 1|Withdrawal by Subject|0|||
145378718|NCT00195494|524237353|FG002|Year 1|Withdrawal by Subject|0|||
145378719|NCT00195494|524237354|FG003|Year 1|Withdrawal by Subject|0|||
145378720|NCT00195494|524237355|FG004|Year 1|Withdrawal by Subject|8|||
145378721|NCT00195494|524237356|FG005|Year 1|Withdrawal by Subject|9|||
145378722|NCT00195494|524237351|FG000|Year 1|Protocol Violation|0|||
145378723|NCT00195494|524237352|FG001|Year 1|Protocol Violation|0|||
145378724|NCT00195494|524237353|FG002|Year 1|Protocol Violation|0|||
145378725|NCT00195494|524237354|FG003|Year 1|Protocol Violation|0|||
145378726|NCT00195494|524237355|FG004|Year 1|Protocol Violation|1|||
145378727|NCT00195494|524237356|FG005|Year 1|Protocol Violation|1|||
145378728|NCT00195494|524237351|FG000|Year 2|Adverse Event|3|||
145378729|NCT00195494|524237352|FG001|Year 2|Adverse Event|7|||
145378730|NCT00195494|524237353|FG002|Year 2|Adverse Event|5|||
145378731|NCT00195494|524237354|FG003|Year 2|Adverse Event|9|||
145378732|NCT00195494|524237355|FG004|Year 2|Adverse Event|0|||
145378733|NCT00195494|524237356|FG005|Year 2|Adverse Event|0|||
145378734|NCT00195494|524237351|FG000|Year 2|Lack of Efficacy|0|||
145378735|NCT00195494|524237352|FG001|Year 2|Lack of Efficacy|1|||
145378736|NCT00195494|524237353|FG002|Year 2|Lack of Efficacy|7|||
145378737|NCT00195494|524237354|FG003|Year 2|Lack of Efficacy|7|||
145378738|NCT00195494|524237355|FG004|Year 2|Lack of Efficacy|0|||
145378739|NCT00195494|524237356|FG005|Year 2|Lack of Efficacy|0|||
145378740|NCT00195494|524237351|FG000|Year 2|Compliance|1|||
145378741|NCT00195494|524237352|FG001|Year 2|Compliance|0|||
145378742|NCT00195494|524237353|FG002|Year 2|Compliance|0|||
145378743|NCT00195494|524237354|FG003|Year 2|Compliance|2|||
145378744|NCT00195494|524237355|FG004|Year 2|Compliance|0|||
145378745|NCT00195494|524237356|FG005|Year 2|Compliance|0|||
145378746|NCT00195494|524237351|FG000|Year 2|Lost to Follow-up|0|||
145378747|NCT00195494|524237352|FG001|Year 2|Lost to Follow-up|0|||
145378748|NCT00195494|524237353|FG002|Year 2|Lost to Follow-up|1|||
145378749|NCT00195494|524237354|FG003|Year 2|Lost to Follow-up|1|||
145378750|NCT00195494|524237355|FG004|Year 2|Lost to Follow-up|0|||
145378751|NCT00195494|524237356|FG005|Year 2|Lost to Follow-up|0|||
145378752|NCT00195494|524237351|FG000|Year 2|Missed >4 consecutive doses|1|||
145378753|NCT00195494|524237352|FG001|Year 2|Missed >4 consecutive doses|1|||
145378754|NCT00195494|524237353|FG002|Year 2|Missed >4 consecutive doses|1|||
145378755|NCT00195494|524237354|FG003|Year 2|Missed >4 consecutive doses|0|||
145378756|NCT00195494|524237355|FG004|Year 2|Missed >4 consecutive doses|0|||
145378757|NCT00195494|524237356|FG005|Year 2|Missed >4 consecutive doses|0|||
145378758|NCT00195494|524237351|FG000|Year 2|Protocol deviation|0|||
145378759|NCT00195494|524237352|FG001|Year 2|Protocol deviation|1|||
145378760|NCT00195494|524237353|FG002|Year 2|Protocol deviation|0|||
145378761|NCT00195494|524237354|FG003|Year 2|Protocol deviation|0|||
145378762|NCT00195494|524237355|FG004|Year 2|Protocol deviation|0|||
145378763|NCT00195494|524237356|FG005|Year 2|Protocol deviation|0|||
145378764|NCT00195494|524237351|FG000|Year 2|Physician Decision|1|||
145378765|NCT00195494|524237352|FG001|Year 2|Physician Decision|1|||
145378766|NCT00195494|524237353|FG002|Year 2|Physician Decision|0|||
145378767|NCT00195494|524237354|FG003|Year 2|Physician Decision|0|||
145378768|NCT00195494|524237355|FG004|Year 2|Physician Decision|0|||
145378769|NCT00195494|524237356|FG005|Year 2|Physician Decision|0|||
145378770|NCT00195494|524237351|FG000|Year 2|Withdrawal by Subject|1|||
145378771|NCT00195494|524237352|FG001|Year 2|Withdrawal by Subject|5|||
145378772|NCT00195494|524237353|FG002|Year 2|Withdrawal by Subject|4|||
145378773|NCT00195494|524237354|FG003|Year 2|Withdrawal by Subject|3|||
145378774|NCT00195494|524237355|FG004|Year 2|Withdrawal by Subject|0|||
145378775|NCT00195494|524237356|FG005|Year 2|Withdrawal by Subject|0|||
145378776|NCT00195494|524237351|FG000|Year 2|System toxicity|0|||
145378777|NCT00195494|524237352|FG001|Year 2|System toxicity|0|||
145378778|NCT00195494|524237353|FG002|Year 2|System toxicity|0|||
145378779|NCT00195494|524237354|FG003|Year 2|System toxicity|1|||
145378780|NCT00195494|524237355|FG004|Year 2|System toxicity|0|||
145378781|NCT00195494|524237356|FG005|Year 2|System toxicity|0|||
145378782|NCT02020512|524237357|FG000|Overall Study|Adverse Event|1|||
145378783|NCT02020512|524237357|FG000|Overall Study|Lost to Follow-up|3|||
145378784|NCT02020512|524237357|FG000|Overall Study|Protocol Violation|4|||
145378785|NCT04249622|524237358|FG000|Overall Study|Withdrawal by Subject|1|||
145378786|NCT04249622|524237359|FG001|Overall Study|Withdrawal by Subject|1|||
145378787|NCT04249622|524237358|FG000|Overall Study|Alternative therapy|1|||
145378788|NCT04249622|524237359|FG001|Overall Study|Alternative therapy|0|||
145378789|NCT04249622|524237358|FG000|Overall Study|Discontinuation of pertuzumab|1|||
145378790|NCT04249622|524237359|FG001|Overall Study|Discontinuation of pertuzumab|0|||
145378791|NCT04438499|524237364|FG000|Overall Study|Lack of Efficacy|3|||
